Citrus Sinensis ID: 004959

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430-------440-------450-------460-------470-------480-------490-------500-------510-------520-------530-------540-------550-------560-------570-------580-------590-------600-------610-------620-------630-------640-------650-------660-------670-------680-------690-------700-------710-------720-
Protein Sequence
MRWLHNISFSSAPSSSSSSPVSAYSSRAKRDFFYLKNSRKIHFKNLNSNNNNNSSNSNKKNSRGPRLTRQKKLRHLSDQEVVGVTRLANPDVSESVSSRDNNSNDHSSSALRTSTSSPVPLPLPLPVPLRVDDERDRDGLSDRDRVDCAAPDRVSNSSSNSPIASVFSRRVGRKMPEFFDTKSSRSVNLALNYVERSRDNFRLNIPAKSAPTSPFTSPVRSPQRSVGGMFQYKVPNGNQGWSAPEMPTLDIPGLPPPAFFDYTVFSAESSPFHSPRSRSPCRNAISPSGPSSPIHSKLSRESTVRIEVHPLPLPPGAAVLSPSATIPQVAAKPEPLPMNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQPDVPSCSLSFSGMQLTEKPHSPREKADAKYDQVAALSSSRSSRKATLESENGRRSHLETSDLTVASTCSPRSTLEALPCLSPLHSGPSTRHSSASAIVLGLIGRGSKKNRVGR
Secondary Structure (PSIPRED)
ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccEEcccccccEEEEEEcccccEEEEEEEEccccccccHHHHHHHHHHHHHHHcccccccEEEEEEEEEccEEEEEEEEcccccHHHHHHHHcccccHHHHHHHHHHHHHHHHHHccccccccccccccEEEcccccEEEEcccccccccccccccccccccccccccccHHHHcccccccccccccHHHHHHHHHHHHccccccccccHHHHHHHHccccccccccccHHHHHHHHHHHcccccccccHHHHHccccccccccccccccccccccccccccccccccccccHHHHHHccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Secondary Structure Prediction (SSPRO)
ccccccEEEcccccccccccccccccccccEEEEccccccccccccccccccccccccccccccccccHHHHHcccccHHcccccccccccccccccccccccccccHHHHcccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccHccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccHEEEEEEccccHHEEEEEEEccccHHHHHHHHHHcHHccccHHHHHHHHHHHHHHcccccccEccEEEEccccccccEEEEcccccEHHHHHcccHccccHHHHHHHHHHHHHHHHHHHcccEEcccccHHHEEEcccccEEEccccccEcccHHHHHcccccccccccHHHHcccccccccccccccEEHHHHHHHHHHHHccccccccccHHHHHHHHHcccccccccccHHHHHHHHHHccccHcccccHHHHHccHHHHcccccHcccccccccccccccccccccccccccccHHcccccccccccHHHcccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Coil and Loop (DISEMBL)
mrwlhnisfssapsssssspvsayssrakrdffylkNSRKIHFKNlnsnnnnnssnsnkknsrgprltrqkklrhlsdqevvgvtrlanpdvsesvssrdnnsndhsssalrtstsspvplplplpvplrvdderdrdglsdrdrvdcaapdrvsnsssnspiasvfsrrvgrkmpeffdtkssrsVNLALNYVErsrdnfrlnipaksaptspftspvrspqrsvggmfqykvpngnqgwsapemptldipglpppaffdytvfsaesspfhsprsrspcrnaispsgpsspihsklsrestvrievhplplppgaavlspsatipqvaakpeplpmnsqwqkgkligrgtfGSVYVASNRETGALCAmkevdifpddpksaESIKQLEQEIKVLSHlkhpnivqyygseiveDKFYIYLEYvhpgsinkyVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLvdasgvvkladfgmakhltgqkadlsmkgspywmaPELMMAVMQKgkssdsalAVDIWSLGCTIiemytgkppwseyeGAAAMFKVmrdtpaipdslspegkDFLRCcfqrnpadrppasLLLEHRFlknsqqpdvpscslsfsgmqltekphsprekadaKYDQVAALSssrssrkatlesengrrshletsdltvastcsprstlealpclsplhsgpstrhssaSAIVLGLIgrgskknrvgr
Flexible Loop (DISEMBL)
mrwlhnisfssapsssssspvsaYSSRAKRDFFYLKNSRKIHfknlnsnnnnnssnsnkknsrgprltrqkklrhlsdqevvgvtrlanpdvsesvssrdnnsndhsssalrtstsspvplplplpvplrvdDERDrdglsdrdrvdcaapdrvsnsssnspiasvfsrrvgrkmpeffdtkssrsvnLALNYVERSRDNFrlnipaksaptspftspvrspQRSVGGMFQYKVPNGNQGWSAPEMPTLDIPGLPPPAFFDYTVFSAESSPFHSPRSRSPCrnaispsgpsspihsKLSRESTVRIEVHPLPLPPGAAVLSPSATIPQVAAKPEPLPMNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHltgqkadlsmkGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQPDVPSCSLSFSGMQLTEKphsprekadaKYDQVAalsssrssrkatlesengrrshletsdltvasTCSPRSTLEALPCLSPLHSGPSTRHSSASAIVlgligrgskknrvgr
Low Complexity Region (SEG)
MRWLHNIsfssapsssssspvsayssRAKRDFFYLKNSRKIHFknlnsnnnnnssnsnkknsRGPRLTRQKKLRHLSDQEVVGVTRLANPdvsesvssrdnnsndhsssalrtstsspvplplplpvplrvDDERDRDGLSDRDRVDCAAPDRVsnsssnsPIASVFSRRVGRKMPEFFDTKSSRSVNLALNYVERSRDNFRLNIPAKSAPTSPFTSPVRSPQRSVGGMFQYKVPNGNQGWSAPEMPTLDIPGLPPPAFFDYTVFSAEsspfhsprsrspcrNAIspsgpsspIHSKLSRESTVRIEVHPLPLPPGAAVLSPSATIPQVAAKPEPLPMNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQPDVPSCSLSFSGMQLTEKPHSPREKADAKYDQVAALsssrssrKATLESENGRRSHLETSDLTVASTCSPRSTLEALPCLSPLHSGPSTRHSSASAIVLGLIGRGSKKNRVGR
Disordered region (IsUnstruct)
*******************************FFYLK********************************************************************************************************************************************************LALNYV********************************************************IPGLPPPAFFDYTVF****************************************************************************WQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIF*************EQEIKVLSHLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPYWMAPELMMAVM*******SALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRD*************DFLRCCFQ***********************************************************************************************************************IVLGLI***********
Disordered Region (DISOPRED)
******************************************************************************************************************************************************************************************************************************************************************************************************************************************************QKGKLIGRGTFGSVYVASNRETGALCAMKEVDI**************EQEIKVLSHLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPYWMAPELMMAVMQKGK*SDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLK*********************************************************************************************************************
Disordered Region (DISEMBL)
*************************SRAKRDFFYLKNSRKIHFKNLNSNNN*****************RQKKLRHLSDQEVVGVTRLAN****************************PVPLPLPLPVPLRVDDERDRDGLSDRDRVDCAA***********PIASVFSRRVGRKMPEFFDTKSSRSVNLALNYVERSRDNFRLNIPAKS***************SVGGMFQYKVPNGNQGWSAPEMPTLDIPGLPPPAFFDYTVFSAE**********************************TVRIEVHPLPLPPGAAVLSPSATIPQVAAKPEPLPMNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPYWMAPELMMAVM********ALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQPDVPSCSLSFSG********************************************LETSDLTVASTCSPRSTLEALPCLSPL*********SASAIVLGLIGRGSKKNRVGR
Disordered Region (DISPRO)
*****************************R*F***K*****************************RLTRQKKLRHLSDQEVVGVT*******************************************************************************************************************FRL*************************MFQ*****************L**************************************************************************************LPMNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQPDVPSCSLSFSGMQLTE*******KADAKYDQVAALSSSRSSRK**LE*****************************************************************
Transmembrane Helix (TMHMM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Transmembrane Helix (MEMSAT)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooohhhhhhhhhhhhhhhhhhhiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (MEMSAT_SVM)
SSSSSSSSSSSSSSSSSSSSSSSSSSSSiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (Phobius)
SSSSSSSSSSSSSSSSSSSSSSSoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MRWLHNISFSSAPSSSSSSPVSAYSSRAKRDFFYLKNSRKIHFKNLNSNNNNNSSNSNKKNSRGPRLTRQKKLRHLSDQEVVGVTRLANPDVSESVSSRDNNSNDHSSSALRTSTSSPVPLPLPLPVPLRVDDERDRDGLSDRDRVDCAAPDRVSNSSSNSPIASVFSRRVGRKMPEFFDTKSSRSVNLALNYVERSRDNFRLNIPAKSAPTSPFTSPVRSPQRSVGGMFQYKVPNGNQGWSAPEMPTLDIPGLPPPAFFDYTVFSAESSPFHSPRSRSPCRNAISPSGPSSPIHSKLSRESTVRIEVHPLPLPPGAAVLSPSATIPQVAAKPEPLPMNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQPDVPSCSLSFSGMQLTEKPHSPREKADAKYDQVAALSSSRSSRKATLESENGRRSHLETSDLTVASTCSPRSTLEALPCLSPLHSGPSTRHSSASAIVLGLIGRGSKKNRVGR
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	721	2.2.26 [Sep-21-2011]
O22040	666	Mitogen-activated protein	no	no	0.348	0.376	0.492	1e-66
Q9FZ36	651	Mitogen-activated protein	no	no	0.403	0.447	0.442	4e-66
Q54R82	942	Mitogen-activated protein	no	no	0.359	0.274	0.446	1e-63
O22042	651	Mitogen-activated protein	no	no	0.367	0.407	0.450	1e-62
Q39008	608	Mitogen-activated protein	no	no	0.364	0.432	0.459	2e-61
Q99759	626	Mitogen-activated protein	yes	no	0.349	0.402	0.440	2e-61
Q61084	626	Mitogen-activated protein	yes	no	0.349	0.402	0.440	7e-61
Q10407	1116	MAP kinase kinase kinase	yes	no	0.402	0.259	0.401	2e-59
Q01389	1478	Serine/threonine-protein	yes	no	0.350	0.171	0.413	2e-57
Q9Y2U5	619	Mitogen-activated protein	no	no	0.382	0.445	0.401	2e-56

>sp|O22040|ANP1_ARATH Mitogen-activated protein kinase kinase kinase ANP1 OS=Arabidopsis thaliana GN=ANP1 PE=1 SV=2

 Score =  255 bits (651), Expect = 1e-66,   Method: Compositional matrix adjust.
 Identities = 135/274 (49%), Positives = 180/274 (65%), Gaps = 23/274 (8%)

Query: 342 WQKGKLIGRGTFGSVYVASNRETGALCAMKEVDI---FPDDPKSAESIKQLEQEIKVLSH 398
           W+KG+LIGRG FG+VY+  N ++G L A+K+V I   F    K+   I++LE+E+K+L +
Sbjct: 69  WRKGQLIGRGAFGTVYMGMNLDSGELLAVKQVLIAANFASKEKTQAHIQELEEEVKLLKN 128

Query: 399 LKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAY 458
           L HPNIV+Y G+   +D   I LE+V  GSI+  + E  G   ESVVR +TR +L GL Y
Sbjct: 129 LSHPNIVRYLGTVREDDTLNILLEFVPGGSISSLL-EKFGPFPESVVRTYTRQLLLGLEY 187

Query: 459 LHSKKTIHRDIKGANLLVDASGVVKLADFGMAKH------LTGQKADLSMKGSPYWMAPE 512
           LH+   +HRDIKGAN+LVD  G +KLADFG +K       +TG K   SMKG+PYWMAPE
Sbjct: 188 LHNHAIMHRDIKGANILVDNKGCIKLADFGASKQVAELATMTGAK---SMKGTPYWMAPE 244

Query: 513 LMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWS-EYEGAAAMFKV--MRDTPAIP 569
           +   ++Q G S     + DIWS+GCT+IEM TGK PWS +Y+  AA+F +   +  P IP
Sbjct: 245 V---ILQTGHS----FSADIWSVGCTVIEMVTGKAPWSQQYKEVAAIFFIGTTKSHPPIP 297

Query: 570 DSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFL 603
           D+LS + KDFL  C Q  P  RP AS LL+H F+
Sbjct: 298 DTLSSDAKDFLLKCLQEVPNLRPTASELLKHPFV 331

May be involved in an oxidative stress-mediated signaling cascade that phosphorylates downstream MAP kinases MPK3 and MPK6. May suppress auxin signaling that promotes cell cycle. Functionally redundant to ANP2 and ANP3 in the positive regulation of cytokinesis.
Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 2EC: 5

>sp|Q9FZ36|M3K2_ARATH Mitogen-activated protein kinase kinase kinase 2 OS=Arabidopsis thaliana GN=ANP2 PE=2 SV=1

 Score =  253 bits (646), Expect = 4e-66,   Method: Compositional matrix adjust.
 Identities = 143/323 (44%), Positives = 198/323 (61%), Gaps = 32/323 (9%)

Query: 307 EVHPLPLPPGAA-VLSPSATIPQVAAKPEPLPMNS--------QWQKGKLIGRGTFGSVY 357
           E HP P P   A  ++       V AK +  P NS        +W+KG+LIGRG FG+VY
Sbjct: 24  ENHPPPFPSLLADKITSCIRKSMVFAKSQSPPNNSTVQIKPPIRWRKGQLIGRGAFGTVY 83

Query: 358 VASNRETGALCAMKEVDIFPD---DPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVE 414
           +  N ++G L A+K+V I  +     K+   I++LE+E+K+L +L HPNIV+Y G+   +
Sbjct: 84  MGMNLDSGELLAVKQVLITSNCASKEKTQAHIQELEEEVKLLKNLSHPNIVRYLGTVRED 143

Query: 415 DKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANL 474
           +   I LE+V  GSI+  + E  GA  ESVVR +T  +L GL YLH+   +HRDIKGAN+
Sbjct: 144 ETLNILLEFVPGGSISSLL-EKFGAFPESVVRTYTNQLLLGLEYLHNHAIMHRDIKGANI 202

Query: 475 LVDASGVVKLADFGMAKH------LTGQKADLSMKGSPYWMAPELMMAVMQKGKSSDSAL 528
           LVD  G +KLADFG +K       ++G K   SMKG+PYWMAPE+   ++Q G S     
Sbjct: 203 LVDNQGCIKLADFGASKQVAELATISGAK---SMKGTPYWMAPEV---ILQTGHS----F 252

Query: 529 AVDIWSLGCTIIEMYTGKPPWS-EYEGAAAMFKV--MRDTPAIPDSLSPEGKDFLRCCFQ 585
           + DIWS+GCT+IEM TGK PWS +Y+  AA+F +   +  P IPD++S +  DFL  C Q
Sbjct: 253 SADIWSVGCTVIEMVTGKAPWSQQYKEIAAIFHIGTTKSHPPIPDNISSDANDFLLKCLQ 312

Query: 586 RNPADRPPASLLLEHRFLKNSQQ 608
           + P  RP AS LL+H F+   Q+
Sbjct: 313 QEPNLRPTASELLKHPFVTGKQK 335

Involved in cortical microtubules organization and stabilization by regulating the phosphorylation state of microtubule-associated proteins such as MAP65-1.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 5

>sp|Q54R82|MKKA_DICDI Mitogen-activated protein kinase kinase kinase A OS=Dictyostelium discoideum GN=mkkA PE=1 SV=2

 Score =  245 bits (625), Expect = 1e-63,   Method: Compositional matrix adjust.
 Identities = 122/273 (44%), Positives = 179/273 (65%), Gaps = 14/273 (5%)

Query: 339 NSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDI--FPDDPKSAESIKQLEQEIKVL 396
           N +WQKG+++GRG +GSVY+  N++TG L A+K+++I     DPK    I    +EI+V+
Sbjct: 167 NIKWQKGQILGRGGYGSVYLGLNKDTGELFAVKQLEIVDINSDPKLKNMILSFSKEIEVM 226

Query: 397 SHLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGL 456
             L+H NIV+Y G+ + +    ++LEY+  GSI+  + +  GA +E+V++ +T+ IL GL
Sbjct: 227 RSLRHDNIVRYLGTSLDQSFLSVFLEYIPGGSISSLLGKF-GAFSENVIKVYTKQILQGL 285

Query: 457 AYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADL-SMKGSPYWMAPELMM 515
           ++LH+   IHRDIKGAN+L+D  G+VKL+DFG +K  +G  +   SM+G+PYWMAPE+  
Sbjct: 286 SFLHANSIIHRDIKGANILIDTKGIVKLSDFGCSKSFSGIVSQFKSMQGTPYWMAPEV-- 343

Query: 516 AVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEY-EGAAAMFKVM--RDTPAIPDSL 572
            + Q G    S    DIWSLGC I+EM T +PPWS   E AA M+ +      P IP  +
Sbjct: 344 -IKQTGHGRSS----DIWSLGCVIVEMATAQPPWSNITELAAVMYHIASSNSIPNIPSHM 398

Query: 573 SPEGKDFLRCCFQRNPADRPPASLLLEHRFLKN 605
           S E  DFL  CF+R+P +RP A+ LL+H F+ N
Sbjct: 399 SQEAFDFLNLCFKRDPKERPDANQLLKHPFIMN 431

Regulates cell-type differentiation and spatial patterning, required for the proper induction and maintenance of prespore cell differentiation.

Dictyostelium discoideum (taxid: 44689)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 5

>sp|O22042|M3K3_ARATH Mitogen-activated protein kinase kinase kinase 3 OS=Arabidopsis thaliana GN=ANP3 PE=1 SV=1

 Score =  241 bits (616), Expect = 1e-62,   Method: Compositional matrix adjust.
 Identities = 127/282 (45%), Positives = 178/282 (63%), Gaps = 17/282 (6%)

Query: 341 QWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDP---KSAESIKQLEQEIKVLS 397
           +W+KG+LIG G FG VY+  N ++G L A+K+V I P      K+   I++LE+E+++L 
Sbjct: 67  RWRKGELIGCGAFGRVYMGMNLDSGELLAIKQVLIAPSSASKEKTQGHIRELEEEVQLLK 126

Query: 398 HLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLA 457
           +L HPNIV+Y G+    D   I +E+V  GSI+  + E  G+  E V+  +T+ +L GL 
Sbjct: 127 NLSHPNIVRYLGTVRESDSLNILMEFVPGGSISSLL-EKFGSFPEPVIIMYTKQLLLGLE 185

Query: 458 YLHSKKTIHRDIKGANLLVDASGVVKLADFGMAK---HLTGQKADLSMKGSPYWMAPELM 514
           YLH+   +HRDIKGAN+LVD  G ++LADFG +K    L       SMKG+PYWMAPE+ 
Sbjct: 186 YLHNNGIMHRDIKGANILVDNKGCIRLADFGASKKVVELATVNGAKSMKGTPYWMAPEV- 244

Query: 515 MAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSE-YEGAAAMFKVMRDT--PAIPDS 571
             ++Q G S     + DIWS+GCT+IEM TGKPPWSE Y+  AA+  + R    P IP+ 
Sbjct: 245 --ILQTGHS----FSADIWSVGCTVIEMATGKPPWSEQYQQFAAVLHIGRTKAHPPIPED 298

Query: 572 LSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQPDVPS 613
           LSPE KDFL  C  + P+ R  A+ LL+H F+   +Q   P+
Sbjct: 299 LSPEAKDFLMKCLHKEPSLRLSATELLQHPFVTGKRQEPYPA 340

Involved in cortical microtubules organization and stabilization by regulating the phosphorylation state of microtubule-associated proteins such as MAP65-1.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 5

>sp|Q39008|M3K1_ARATH Mitogen-activated protein kinase kinase kinase 1 OS=Arabidopsis thaliana GN=MEKK1 PE=1 SV=2

 Score =  237 bits (605), Expect = 2e-61,   Method: Compositional matrix adjust.
 Identities = 126/274 (45%), Positives = 177/274 (64%), Gaps = 11/274 (4%)

Query: 333 PEPLPMNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQE 392
           P+   + + WQKG+L+GRG+FGSVY   + + G   A+KEV +     ++ E I+QLE E
Sbjct: 324 PDGGAIITSWQKGQLLGRGSFGSVYEGISGD-GDFFAVKEVSLLDQGSQAQECIQQLEGE 382

Query: 393 IKVLSHLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHI 452
           IK+LS L+H NIV+Y G+       YI+LE V  GS+ K  + +   + +SVV  +TR I
Sbjct: 383 IKLLSQLQHQNIVRYRGTAKDGSNLYIFLELVTQGSLLKLYQRY--QLRDSVVSLYTRQI 440

Query: 453 LSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADL-SMKGSPYWMAP 511
           L GL YLH K  IHRDIK AN+LVDA+G VKLADFG+AK    +  D+ S KG+P+WMAP
Sbjct: 441 LDGLKYLHDKGFIHRDIKCANILVDANGAVKLADFGLAK--VSKFNDIKSCKGTPFWMAP 498

Query: 512 ELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDT-PAIPD 570
           E    V+ +  S       DIWSLGCT++EM TG+ P+S+ E   A+F++ R T P +PD
Sbjct: 499 E----VINRKDSDGYGSPADIWSLGCTVLEMCTGQIPYSDLEPVQALFRIGRGTLPEVPD 554

Query: 571 SLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLK 604
           +LS + + F+  C + NP +RP A+ LL H F++
Sbjct: 555 TLSLDARLFILKCLKVNPEERPTAAELLNHPFVR 588

Involved in the innate immune MAP kinase signaling cascade (MEKK1, MKK4/MKK5 and MPK3/MPK6) downstream of bacterial flagellin receptor FLS2. May be involved in the cold and salinity stress-mediated MAP kinase signaling cascade (MEKK1, MEK1/MKK2 and MPK4/MPK6). Activates downstream MKK2, MKK4 and MKK5.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 5

>sp|Q99759|M3K3_HUMAN Mitogen-activated protein kinase kinase kinase 3 OS=Homo sapiens GN=MAP3K3 PE=1 SV=2

 Score =  237 bits (605), Expect = 2e-61,   Method: Compositional matrix adjust.
 Identities = 122/277 (44%), Positives = 173/277 (62%), Gaps = 25/277 (9%)

Query: 337 PMNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVL 396
           P+N  W++GKL+G+G FG VY+  + +TG   A K+V   PD P++++ +  LE EI++L
Sbjct: 359 PIN--WRRGKLLGQGAFGRVYLCYDVDTGRELASKQVQFDPDSPETSKEVSALECEIQLL 416

Query: 397 SHLKHPNIVQYYGS--EIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILS 454
            +L+H  IVQYYG   +  E    I++EY+  GS+   ++ + GA+TESV R +TR IL 
Sbjct: 417 KNLQHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAY-GALTESVTRKYTRQILE 475

Query: 455 GLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHL-------TGQKADLSMKGSPY 507
           G++YLHS   +HRDIKGAN+L D++G VKL DFG +K L       TG +   S+ G+PY
Sbjct: 476 GMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGMR---SVTGTPY 532

Query: 508 WMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRD--T 565
           WM+PE++       K+       D+WSLGCT++EM T KPPW+EYE  AA+FK+      
Sbjct: 533 WMSPEVISGEGYGRKA-------DVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTN 585

Query: 566 PAIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRF 602
           P +P  +S  G+DFLR  F      RP A  LL H F
Sbjct: 586 PQLPSHISEHGRDFLRRIFV-EARQRPSAEELLTHHF 621

Component of a protein kinase signal transduction cascade. Mediates activation of the NF-kappa-B, AP1 and DDIT3 transcriptional regulators.

Homo sapiens (taxid: 9606)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 5

>sp|Q61084|M3K3_MOUSE Mitogen-activated protein kinase kinase kinase 3 OS=Mus musculus GN=Map3k3 PE=1 SV=1

 Score =  236 bits (601), Expect = 7e-61,   Method: Compositional matrix adjust.
 Identities = 122/277 (44%), Positives = 173/277 (62%), Gaps = 25/277 (9%)

Query: 337 PMNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVL 396
           P+N  W++GKL+G+G FG VY+  + +TG   A K+V   PD P++++ +  LE EI++L
Sbjct: 359 PIN--WRRGKLLGQGAFGRVYLCYDVDTGRELASKQVQFDPDSPETSKEVSALECEIQLL 416

Query: 397 SHLKHPNIVQYYGS--EIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILS 454
            +L+H  IVQYYG   +  E    I++EY+  GS+   ++ + GA+TESV R +TR IL 
Sbjct: 417 KNLQHERIVQYYGCLRDRAEKILTIFMEYMPGGSVKDQLKAY-GALTESVTRKYTRQILE 475

Query: 455 GLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHL-------TGQKADLSMKGSPY 507
           G++YLHS   +HRDIKGAN+L D++G VKL DFG +K L       TG +   S+ G+PY
Sbjct: 476 GMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIR---SVTGTPY 532

Query: 508 WMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRD--T 565
           WM+PE++       K+       D+WSLGCT++EM T KPPW+EYE  AA+FK+      
Sbjct: 533 WMSPEVISGEGYGRKA-------DVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTN 585

Query: 566 PAIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRF 602
           P +P  +S  G+DFLR  F      RP A  LL H F
Sbjct: 586 PQLPSHISEHGRDFLRRIFV-EARQRPSAEELLTHHF 621

Component of a protein kinase signal transduction cascade. Mediates activation of the NF-kappa-B, AP1 and DDIT3 transcriptional regulators.

Mus musculus (taxid: 10090)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 5

>sp|Q10407|MKH1_SCHPO MAP kinase kinase kinase mkh1 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) GN=mkh1 PE=3 SV=1

 Score =  231 bits (588), Expect = 2e-59,   Method: Compositional matrix adjust.
 Identities = 131/326 (40%), Positives = 182/326 (55%), Gaps = 36/326 (11%)

Query: 306  IEVHPLPLPPGAAVLSPSATIPQVAAKPEPLPMNSQWQKGKLIGRGTFGSVYVASNRETG 365
            +E+ P       +V+S +AT               +W KG+LIG GT+G V++A N  TG
Sbjct: 803  VELKPDTTITSGSVVSQNATF--------------KWMKGELIGNGTYGKVFLAMNINTG 848

Query: 366  ALCAMKEVDIFPD------DPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYI 419
             L A+K+V+I P       D    + +  +  EI +++ L H NIVQY G E  E    I
Sbjct: 849  ELIAVKQVEI-PQTINGRHDQLRKDIVDSINAEISMIADLDHLNIVQYLGFEKTETDISI 907

Query: 420  YLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDAS 479
            +LEYV  GSI + +R + G   E +VR  +R +L GL+YLHSK  IHRD+K  NLL+D  
Sbjct: 908  FLEYVSGGSIGRCLRNY-GPFEEQLVRFVSRQVLYGLSYLHSKGIIHRDLKADNLLIDFD 966

Query: 480  GVVKLADFGMAKH---LTGQKADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLG 536
            GV K++DFG++KH   +    A+LSM+GS +WMAPE++    Q G S+     VD+WSLG
Sbjct: 967  GVCKISDFGISKHSDNVYDNDANLSMQGSIFWMAPEVIHNDHQ-GYSA----KVDVWSLG 1021

Query: 537  CTIIEMYTGKPPWSEYEGAAAMFKV--MRDTPAIPDSL----SPEGKDFLRCCFQRNPAD 590
            C ++EM  G+ PWS  E   AMFK+   +  P IP  L    SPE   FL  CF  N   
Sbjct: 1022 CVVLEMLAGRRPWSTDEAIQAMFKLGTEKKAPPIPSELVSQVSPEAIQFLNACFTVNADV 1081

Query: 591  RPPASLLLEHRFLKNSQQPDVPSCSL 616
            RP A  LL H F+K  ++ +    +L
Sbjct: 1082 RPTAEELLNHPFMKCDEEFNFKDTNL 1107

May regulate cell morphology, cell wall integrity, salt resistance, cell cycle reentry from stationary-phase arrest, and filamentous growth in response to stress. Activates the MAP kinase kinase skh1/pek1 by phosphorylation.

Schizosaccharomyces pombe (strain 972 / ATCC 24843) (taxid: 284812)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 5

>sp|Q01389|BCK1_YEAST Serine/threonine-protein kinase BCK1/SLK1/SSP31 OS=Saccharomyces cerevisiae (strain ATCC 204508 / S288c) GN=BCK1 PE=1 SV=1

 Score =  224 bits (571), Expect = 2e-57,   Method: Compositional matrix adjust.
 Identities = 113/273 (41%), Positives = 168/273 (61%), Gaps = 20/273 (7%)

Query: 342  WQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESI----KQLEQEIKVLS 397
            W KG++IG+G+FG+VY+  N  TG + A+K+V++ P      E+I    + L  E+  L 
Sbjct: 1175 WMKGEMIGKGSFGAVYLCLNVTTGEMMAVKQVEV-PKYSSQNEAILSTVEALRSEVSTLK 1233

Query: 398  HLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLA 457
             L H NIVQY G E   + + ++LEYV  GS+   +R + G   E ++++ T  +L GLA
Sbjct: 1234 DLDHLNIVQYLGFENKNNIYSLFLEYVAGGSVGSLIRMY-GRFDEPLIKHLTTQVLKGLA 1292

Query: 458  YLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTG--QKADLSMKGSPYWMAPELMM 515
            YLHSK  +HRD+K  NLL+D  G+ K++DFG+++        +D++M+G+ +WMAPE  M
Sbjct: 1293 YLHSKGILHRDMKADNLLLDQDGICKISDFGISRKSKDIYSNSDMTMRGTVFWMAPE--M 1350

Query: 516  AVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKV--MRDTPAIPDS-- 571
               ++G S+     VDIWSLGC ++EM+ GK PWS  E  AAMFK+   +  P IP+   
Sbjct: 1351 VDTKQGYSA----KVDIWSLGCIVLEMFAGKRPWSNLEVVAAMFKIGKSKSAPPIPEDTL 1406

Query: 572  --LSPEGKDFLRCCFQRNPADRPPASLLLEHRF 602
              +S  G++FL  CF+ NP  RP A+ LL H F
Sbjct: 1407 PLISQIGRNFLDACFEINPEKRPTANELLSHPF 1439

Serine/threonine protein kinase involved in a signal transduction pathway that play a role in yeast cell morphogenesis and cell growth. This pathway seems to starts by SMP3; then involve the kinase PKC1 that may act on this kinase. BCK1 probably phosphorylates MKK1 and MKK2 which themselves phosphorylate the MPK1 kinase.

Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (taxid: 559292)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9Y2U5|M3K2_HUMAN Mitogen-activated protein kinase kinase kinase 2 OS=Homo sapiens GN=MAP3K2 PE=1 SV=2

 Score =  221 bits (563), Expect = 2e-56,   Method: Compositional matrix adjust.
 Identities = 120/299 (40%), Positives = 178/299 (59%), Gaps = 23/299 (7%)

Query: 316 GAAVLSPSATIPQVAAKPEPLPMNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDI 375
           G+ + +P+ T+  ++         + W+ GKL+G+G FG VY+  + +TG   A+K+V  
Sbjct: 330 GSDIDNPTLTVMDISPPSRSPRAPTNWRLGKLLGQGAFGRVYLCYDVDTGRELAVKQVQF 389

Query: 376 FPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGS--EIVEDKFYIYLEYVHPGSINKYV 433
            PD P++++ +  LE EI++L +L H  IVQYYG   +  E    I++EY+  GSI   +
Sbjct: 390 DPDSPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPQEKTLSIFMEYMPGGSIKDQL 449

Query: 434 REHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHL 493
           + + GA+TE+V R +TR IL G+ YLHS   +HRDIKGAN+L D++G VKL DFG +K L
Sbjct: 450 KAY-GALTENVTRKYTRQILEGVHYLHSNMIVHRDIKGANILRDSTGNVKLGDFGASKRL 508

Query: 494 -------TGQKADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGK 546
                  TG K   S+ G+PYWM+PE++       K+       DIWS+ CT++EM T K
Sbjct: 509 QTICLSGTGMK---SVTGTPYWMSPEVISGEGYGRKA-------DIWSVACTVVEMLTEK 558

Query: 547 PPWSEYEGAAAMFKVMRD--TPAIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFL 603
           PPW+E+E  AA+FK+      P +P  +S   +DFL+  F      RP A  LL H F+
Sbjct: 559 PPWAEFEAMAAIFKIATQPTNPKLPPHVSDYTRDFLKRIFVEAKL-RPSADELLRHMFV 616

Component of a protein kinase signal transduction cascade. Regulates the JNK and ERK5 pathways by phosphorylating and activating MAP2K5 and MAP2K7 (By similarity). Plays a role in caveolae kiss-and-run dynamics.

Homo sapiens (taxid: 9606)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 5

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	721
225470467	707	PREDICTED: uncharacterized protein LOC10	0.904	0.922	0.587	0.0
449448516	760	PREDICTED: uncharacterized protein LOC10	0.957	0.907	0.532	0.0
255562635	709	conserved hypothetical protein [Ricinus	0.904	0.919	0.565	0.0
449521088	604	PREDICTED: uncharacterized protein LOC10	0.743	0.887	0.622	0.0
297794325	722	hypothetical protein ARALYDRAFT_496915 [	0.898	0.897	0.568	0.0
15982852	716	AT5g66850/MUD21_11 [Arabidopsis thaliana	0.830	0.836	0.583	0.0
18425121	716	mitogen-activated protein kinase kinase	0.830	0.836	0.583	0.0
356565641	637	PREDICTED: uncharacterized protein LOC10	0.762	0.863	0.600	0.0
356495460	763	PREDICTED: uncharacterized protein LOC10	0.760	0.718	0.578	1e-175
356514005	634	PREDICTED: mitogen-activated protein kin	0.743	0.845	0.597	1e-174

>gi|225470467|ref|XP_002263088.1| PREDICTED: uncharacterized protein LOC100245919 [Vitis vinifera] gi|296084711|emb|CBI25853.3| unnamed protein product [Vitis vinifera]

 Score =  723 bits (1865), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 401/682 (58%), Positives = 467/682 (68%), Gaps = 30/682 (4%)

Query: 67  LTRQKKLRHLSDQEVVGVTRLANPDVSESVSSRDNNSNDHSSSALRTSTSSPVPLPLP-- 124
           LTR +KLRH+    +  + R  +    + +    ++S+    S+ R S+  P PLP P  
Sbjct: 25  LTRARKLRHVRGNHIDALVRSRSSAEPKDLLPLPSSSSSFDHSSERLSSVVPHPLPRPEL 84

Query: 125 ---------------LPVPLRVDDERDRDGLSDRDRVDCAAPDRVSNSS-SNSPIASVFS 168
                             PL    E    G  DRD+ +    D     + S++   S   
Sbjct: 85  ALLFRRNGGSNSNLNCDRPLPSPKEGLSRGFEDRDKGNSFVGDGNGEVAVSSTATGSKVG 144

Query: 169 RRVGRKMPEFFDTKSSRSVNLALNYVERSRDNFRLNIPAKSAPTSPFTSPVRSPQR-SVG 227
               RK  E FDT SSR +    N V+ +R NF+L++P +SAPTS  +SP  SPQR S G
Sbjct: 145 YNEARKSMEQFDTLSSRYLPQGQNSVKNNRVNFKLDVPTRSAPTSSLSSPAVSPQRTSPG 204

Query: 228 GMF--QYKVPNGNQGWSAPEMPTLD-IPGLPPPAFFDYTVFSAESSPFHSPRSRSPCRNA 284
            +F  Q   P   QGWSAPEMP  D + G  P    + T+FS ++SP HSP  +SP  N 
Sbjct: 205 NLFLSQNVSPQVFQGWSAPEMPVFDMVTGFTPQMSPEQTMFSTDNSPLHSPTVKSPHVNP 264

Query: 285 ISPSGPSSPIHSKLSRE-STVRIE------VHPLPLPPGAAVLSPSATIPQVAAKPEPLP 337
            SPSGP+SP+H K+S E ST R E      VH LPLPPG      +++I  V AK E  P
Sbjct: 265 RSPSGPASPLHPKISLETSTARRENNSHANVHRLPLPPGVVAPPQASSIHPVIAKTESFP 324

Query: 338 MNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLS 397
           M +QWQKGKLIGRGTFGSVYVA+NRETGALCAMKEV++ PDDPKSAESIKQLEQEIK+LS
Sbjct: 325 MTTQWQKGKLIGRGTFGSVYVATNRETGALCAMKEVELLPDDPKSAESIKQLEQEIKILS 384

Query: 398 HLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLA 457
            LKHPNIVQY+GSE VED+ YIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLA
Sbjct: 385 QLKHPNIVQYFGSETVEDRLYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLA 444

Query: 458 YLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPYWMAPELMMAV 517
           YLHS KTIHRDIKGANLLVDASGVVKLADFGM+KHLTG  ADLS+KGSPYWMAPELM AV
Sbjct: 445 YLHSTKTIHRDIKGANLLVDASGVVKLADFGMSKHLTGAAADLSLKGSPYWMAPELMQAV 504

Query: 518 MQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDSLSPEGK 577
           MQK  SSD A AVDIWSLGCTIIEM  GKPPWSEYEGAAAMFKVMR++P IP +LS EGK
Sbjct: 505 MQKDHSSDLAFAVDIWSLGCTIIEMLNGKPPWSEYEGAAAMFKVMRESPPIPKTLSSEGK 564

Query: 578 DFLRCCFQRNPADRPPASLLLEHRFLKNSQQPDVPSCSLSFSGMQLTEKPHSPREKADAK 637
           DFLRCCF+RNPA+RPPA  LLEHRFLKNS Q DVP  + +FSGM+L +K +  REK++ +
Sbjct: 565 DFLRCCFRRNPAERPPAIKLLEHRFLKNSTQLDVPLLTQAFSGMKLPDKANKSREKSNDR 624

Query: 638 YDQVAALSSSRSSRKATLESENGRRSHLETSDLTVASTCSPRSTLEALPCLSPLHSGPST 697
            D V  +S  + + K    S  G++SH ETSDLTVAS  SPRSTLEALP LSP HSG   
Sbjct: 625 VDPV-PISPRKKTSKGKKASGTGQQSHRETSDLTVASHHSPRSTLEALPSLSPPHSGQRA 683

Query: 698 RHSSASAIVLGLIGRGSKKNRV 719
            H S  A V   I  G+KK R 
Sbjct: 684 YHLSPPANVPSPINYGAKKKRT 705

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449448516|ref|XP_004142012.1| PREDICTED: uncharacterized protein LOC101219486 [Cucumis sativus]

 Score =  718 bits (1854), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 419/787 (53%), Positives = 512/787 (65%), Gaps = 97/787 (12%)

Query: 1   MRWLHNISFSSA-----PSSSSS---SPVSAYSSRAKRDFFYLKNSRKIHFKNLNSNNNN 52
           MRWL NISF+ +     P S++    SP    ++R   +     N R I ++   S    
Sbjct: 1   MRWLRNISFTPSSMVRLPGSTTGGGDSPTRRSTTRGSAE----NNYRGIVWRFGAS---- 52

Query: 53  NSSNSNKKNSRGPRLTRQKKLRHLSDQEVVGVTRLANPDVS-ESVS-SRDNNSNDHSSSA 110
                        R +R +KLR+LS +E V  +     D + E VS SR  +++DH +  
Sbjct: 53  -------------RYSRHRKLRNLSGREHVDSSLAKWSDTAPEPVSLSRSPSTSDHPAVP 99

Query: 111 L-------------RTSTSSPV------PLPLPLPVPLRVDDERDRDGLSDRDRVDCAAP 151
           L             R STS+        PLP P     R  DERD     DRDR   A P
Sbjct: 100 LPLPEVSPLFQPRERISTSNSAGGEGDCPLPSPKGSRGRAGDERD----VDRDR--NAPP 153

Query: 152 DRVSNS-SSNSPIASVFSRRVG---RKMPEFFDTKSSRSVNLALNYVERSRDNFRLNIPA 207
            ++    S N+ I SV S  VG   +K  +     S R+   A  Y E SR+ F +++P+
Sbjct: 154 QKIGGGISPNASIKSV-SDSVGERHKKEGQIEARLSGRANQDARRYPENSRNGFWIDVPS 212

Query: 208 KSAPTSPFTSPVRSPQRSVGGM---FQYKVPNGNQGWSAPEMPTL------------DIP 252
           +SAPTSP+TSP  SPQR++ G    F Y  P GNQGWSAPE+P                P
Sbjct: 213 RSAPTSPYTSPTPSPQRNISGNISNFHYMSPVGNQGWSAPELPNFPCVAAPVGNHVWSAP 272

Query: 253 GLP--------PPAFFDYTVFSAESSPFHSPRSRSPCRNAISPSGPSSPIHSKLS----- 299
            LP        PPAFFD +  S ESSP HSPR +SP  +  SP+GP+SP+H+K+S     
Sbjct: 273 ELPSSAMMRGVPPAFFDCSTLSTESSPMHSPRGKSPHLDPRSPTGPTSPLHAKISHETHA 332

Query: 300 --RESTVRIEVHPLPLPPGA---AVLSPSATIPQVAAKPEPLPMNSQWQKGKLIGRGTFG 354
             RE +  + VHPLPLPPG    +  SPS  I Q   K E + M +QWQKGKLIGRGTFG
Sbjct: 333 MRREGSGHVSVHPLPLPPGVPMPSASSPSTPISQANTKSESISMKNQWQKGKLIGRGTFG 392

Query: 355 SVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVE 414
           SVYVASNR+ GALCAMKEV++F DDPKSAESIKQLEQEIK+LS LKHPNIVQYYGS+I++
Sbjct: 393 SVYVASNRQNGALCAMKEVELFHDDPKSAESIKQLEQEIKLLSQLKHPNIVQYYGSDIID 452

Query: 415 DKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANL 474
           D+ YIYLEYVHPGSINKYVREHCGA+TESVVRNFTRHILSGLAYLHS KTIHRDIKGANL
Sbjct: 453 DRLYIYLEYVHPGSINKYVREHCGAMTESVVRNFTRHILSGLAYLHSTKTIHRDIKGANL 512

Query: 475 LVDASGVVKLADFGMAKHLTGQKADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWS 534
           LVD+ GVVKLADFGMAKHLTGQ ADLS+KGSPYWMAPEL+++VMQK  + D ALAVDIWS
Sbjct: 513 LVDSCGVVKLADFGMAKHLTGQVADLSLKGSPYWMAPELLLSVMQKDNTPDLALAVDIWS 572

Query: 535 LGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDSLSPEGKDFLRCCFQRNPADRPPA 594
           LGCTIIEM+TGKPPWSEYEGAAAMFKVM+DTP +P+SLS E +DFL+CCFQRNPA+RP A
Sbjct: 573 LGCTIIEMFTGKPPWSEYEGAAAMFKVMKDTPPMPESLSYEARDFLKCCFQRNPAERPTA 632

Query: 595 SLLLEHRFLKNSQQPDVPSCSLSFSGMQLTEKPHSPREKADAKYDQVAALSSSRSSRKAT 654
           ++LLEH F+KN Q  D  SCS   +G  L +K +SP ++  +K DQ + L S ++S K  
Sbjct: 633 AMLLEHPFMKNLQYTDASSCSQVVAGASLMDKCYSPSKQYSSKSDQSSMLPSPQNS-KGK 691

Query: 655 LESEN--GRRSHLETSDLTVASTCSPRSTLEALPCLSPLHSGPSTRHSSASAIVLGLIGR 712
           L ++N  G  SH ETSDLTV S  SPRSTLEALP +SPL S P+  H  +      ++ +
Sbjct: 692 LAADNVIGPLSHHETSDLTVMSRYSPRSTLEALPMVSPLRSVPNAHHYGSPTNAADIVNQ 751

Query: 713 GSKKNRV 719
            ++KN  
Sbjct: 752 INRKNHT 758

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255562635|ref|XP_002522323.1| conserved hypothetical protein [Ricinus communis] gi|223538401|gb|EEF40007.1| conserved hypothetical protein [Ricinus communis]

 Score =  716 bits (1849), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 392/693 (56%), Positives = 485/693 (69%), Gaps = 41/693 (5%)

Query: 1   MRWLHNISFSSAPSSSSSSPVSAYSSRAKRDFFYLKNSRKIHFKNLNSNNNNNSSNSNKK 60
           MRWL NISFS+  ++++++  S  SS          +S      N +S +++ S      
Sbjct: 1   MRWLQNISFSAYNNNNNNNNNSTPSSPKPVLSSSASSSATTGDHNFSSKHHHRSYLRGGG 60

Query: 61  NSRGPRLTRQKKLRHLSDQEVVGVTRLA-------NPDVSESVSSRDNNSNDHSSSALRT 113
                  TR +KLR+ ++ +V      A       N   S + ++   +S + +++AL  
Sbjct: 61  LGFR-FGTRHRKLRYFTENDVTAAPAAATATAGQNNRASSSTATAAVKSSAETTAAALSG 119

Query: 114 STSSPVPLPLPLP----------------------VPLRVDDERDRDGLSDRDRVDCAAP 151
           S+ +   +  P                        +P   + E++RDG+S R+R+D    
Sbjct: 120 SSCAAAAVVPPRLSSSVPVPLPLPLPVHSGDADSRIPSPREKEKERDGVSSRERIDGVNG 179

Query: 152 DRVSNSSSNSPIASVFSRRVGRKMPEFFDTKSSRSVNLALNYVERSRDNFRLNIPAKSAP 211
           D +S  SSNSP AS+ + R GR+  +  D +S R V+   + V+   D  R+N P +SAP
Sbjct: 180 DGLS--SSNSPKASILAGRQGRRKVDPLDIRSPRKVHPDFS-VDHCADYSRINAPIRSAP 236

Query: 212 TSPFTSPVRSPQRSVGGMFQYKVPNGNQGWSAPEMPTLDIPGLPPPAFFDYTVFSAESSP 271
           TSPF+SP +    +    +   +  GNQ WSAPEM TLDIPGLPPPAFFDYT FS ++SP
Sbjct: 237 TSPFSSPQKLTTAADFLPYYQMIAKGNQVWSAPEMATLDIPGLPPPAFFDYTAFSTDTSP 296

Query: 272 FHSPRSRSPCRNAISPSGPSSPIHSKLS----RESTVRIEVHPLPLPPGAAVLSPSAT-- 325
            HSP SRSP RN  SP+G  + ++++LS    RE    +EVHPLPLPPGA+   PS +  
Sbjct: 297 LHSPPSRSPRRNPKSPTGGPASLNARLSIETSRECNANLEVHPLPLPPGASSSRPSISSS 356

Query: 326 IPQVAAKPEPLPMNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAES 385
           +PQV +K E +P+ SQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVD+FPDDPKSAES
Sbjct: 357 VPQVISKAESIPLKSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDMFPDDPKSAES 416

Query: 386 IKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVV 445
           IKQLEQEIKVLSHLKHPNIVQYYGSEIV D FYIYLEYVHPGSINKYVREHCGAITE+VV
Sbjct: 417 IKQLEQEIKVLSHLKHPNIVQYYGSEIVGDHFYIYLEYVHPGSINKYVREHCGAITENVV 476

Query: 446 RNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGS 505
           R+F+RHILSGLAYLHS KTIHRDIKGANLLVDASGVVKLADFGM+KHLTGQ A+LS+KGS
Sbjct: 477 RSFSRHILSGLAYLHSMKTIHRDIKGANLLVDASGVVKLADFGMSKHLTGQAAELSLKGS 536

Query: 506 PYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDT 565
           PYWMAPELM AVMQK  SSD ALAVDIWSLGCTIIEM+TGKPPWS+YEGAAAMFKV+RD 
Sbjct: 537 PYWMAPELMQAVMQKDTSSDLALAVDIWSLGCTIIEMFTGKPPWSDYEGAAAMFKVLRDI 596

Query: 566 PAIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQPDVPSCSLSFSGMQLTE 625
           P IP++LSPEGKDFL CCFQRNPADRP AS+LLEHR+L+NSQQ D PS + S +G++L +
Sbjct: 597 PPIPETLSPEGKDFLHCCFQRNPADRPSASMLLEHRWLRNSQQLDFPSSTRSINGIKLMD 656

Query: 626 KPHSPREKADAKYDQVAALSSSRSSR-KATLES 657
             HS    ++ K DQ+    +S+S++ K T ES
Sbjct: 657 LTHS-SNGSEVKLDQMPIPPASQSAKGKVTSES 688

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449521088|ref|XP_004167563.1| PREDICTED: uncharacterized protein LOC101228290 [Cucumis sativus]

 Score =  699 bits (1803), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 356/572 (62%), Positives = 424/572 (74%), Gaps = 36/572 (6%)

Query: 183 SSRSVNLALNYVERSRDNFRLNIPAKSAPTSPFTSPVRSPQRSVGGM---FQYKVPNGNQ 239
           S R+   A  Y E SR+ F +++P++SAPTSP+TSP  SPQR++ G    F Y  P GNQ
Sbjct: 32  SGRANQDARRYPENSRNGFWIDVPSRSAPTSPYTSPTPSPQRNISGNISNFHYMSPVGNQ 91

Query: 240 GWSAPEMPTL------------DIPGLP--------PPAFFDYTVFSAESSPFHSPRSRS 279
           GWSAPE+P                P LP        PPAFFD +  S ESSP HSPR +S
Sbjct: 92  GWSAPELPNFPCVAAPVGNHVWSAPELPSSAMMRGVPPAFFDCSTLSTESSPMHSPRGKS 151

Query: 280 PCRNAISPSGPSSPIHSKLS-------RESTVRIEVHPLPLPPGA---AVLSPSATIPQV 329
           P  +  SP+GP+SP+H+K+S       RE +  + VHPLPLPPG    +  SPS  I Q 
Sbjct: 152 PHLDPRSPTGPTSPLHAKISHETHAMRREGSGHVSVHPLPLPPGVPMPSASSPSTPISQA 211

Query: 330 AAKPEPLPMNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQL 389
             K E + M +QWQKGKLIGRGTFGSVYVASNR+ GALCAMKEV++F DDPKSAESIKQL
Sbjct: 212 NTKSESISMKNQWQKGKLIGRGTFGSVYVASNRQNGALCAMKEVELFHDDPKSAESIKQL 271

Query: 390 EQEIKVLSHLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFT 449
           EQEIK+LS LKHPNIVQYYGS+I++D+ YIYLEYVHPGSINKYVREHCGA+TESVVRNFT
Sbjct: 272 EQEIKLLSQLKHPNIVQYYGSDIIDDRLYIYLEYVHPGSINKYVREHCGAMTESVVRNFT 331

Query: 450 RHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPYWM 509
           RHILSGLAYLHS KTIHRDIKGANLLVD+ GVVKLADFGMAKHLTGQ ADLS+KGSPYWM
Sbjct: 332 RHILSGLAYLHSTKTIHRDIKGANLLVDSCGVVKLADFGMAKHLTGQVADLSLKGSPYWM 391

Query: 510 APELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIP 569
           APEL+++VMQK  + D ALAVDIWSLGCTIIEM+TGKPPWSEYEGAAAMFKVM+DTP +P
Sbjct: 392 APELLLSVMQKDNTPDLALAVDIWSLGCTIIEMFTGKPPWSEYEGAAAMFKVMKDTPPMP 451

Query: 570 DSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQPDVPSCSLSFSGMQLTEKPHS 629
           +SLS E +DFL+CCFQRNPA+RP A++LLEH F+KN Q  D  SCS   +G  L +K +S
Sbjct: 452 ESLSYEARDFLKCCFQRNPAERPTAAMLLEHPFMKNLQYTDASSCSQVVAGASLMDKCYS 511

Query: 630 PREKADAKYDQVAALSSSRSSRKATLESEN--GRRSHLETSDLTVASTCSPRSTLEALPC 687
           P ++  +K DQ + L S ++S K  L ++N  G  SH ETSDLTV S  SPRSTLEALP 
Sbjct: 512 PSKQYSSKSDQSSMLPSPQNS-KGKLAADNVIGPLSHHETSDLTVMSRYSPRSTLEALPM 570

Query: 688 LSPLHSGPSTRHSSASAIVLGLIGRGSKKNRV 719
           +SPL S P+  H  +      ++ + ++KN  
Sbjct: 571 VSPLRSVPNAHHYGSPTNAADIVNQINRKNHT 602

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|297794325|ref|XP_002865047.1| hypothetical protein ARALYDRAFT_496915 [Arabidopsis lyrata subsp. lyrata] gi|297310882|gb|EFH41306.1| hypothetical protein ARALYDRAFT_496915 [Arabidopsis lyrata subsp. lyrata]

 Score =  672 bits (1735), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 423/744 (56%), Positives = 500/744 (67%), Gaps = 96/744 (12%)

Query: 1   MRWLHNISFSSAPSSSSSS--PVSAYSSRAKRDFFYLKNSRKIHFKNLNSNNNNNSSNSN 58
           MRWL  ISFSS  SS SSS  PV++YS  A  D    ++  + H +    N         
Sbjct: 1   MRWLPQISFSSPSSSPSSSLKPVASYSESADPD--RNQDRDRFHRRLFRFN--------- 49

Query: 59  KKNSRGPRLTRQKKLRHLSDQEVVGVTRLANPDVSESVSSRDNNSNDHSSSALRTSTSSP 118
               RG RLTRQ+KLRHL+D +V+   R A    S S S+ D+     S SA      SP
Sbjct: 50  ----RG-RLTRQRKLRHLTDDDVLLGERRA----STSSSTFDSGLT-RSPSAFTAVPRSP 99

Query: 119 VPLPLPLPVPL-RVDDERDRD---GLSDRDRVDCAAPDRV--SNSSSNSPIASV---FSR 169
             +PLPLP+PL  V   R+     GL +RDR     P+RV    +SS  P+ SV   F+R
Sbjct: 100 SAVPLPLPLPLPEVAGNRNAGNGRGLDERDR----DPERVIADRTSSGPPLTSVNGGFAR 155

Query: 170 RVGRKMPEFFDTKSSRSVNLALNYVERSRDNFRLNIPAKSAPTSPFTSPVRSPQRSVGGM 229
                     D++ +   +   ++  R+R+ + +NIP  SAPTSP+ SPV SPQR   G 
Sbjct: 156 ----------DSRKATENSSYQDFSPRNRNGYWVNIPTMSAPTSPYMSPVPSPQRKSTGQ 205

Query: 230 ---FQYKVPNGNQGWSAPEMPTLDIPGLPPPAFFDYTVFSAESSPFHSPRSRSPCRNA-- 284
              F Y  P  NQ WSAP+MP LD  GLPPPAF+D T FS ++SP HSP+ RSP R    
Sbjct: 206 DLPFFYLPPKSNQAWSAPDMP-LDTSGLPPPAFYDITAFSTDNSPIHSPQPRSPRRQIRS 264

Query: 285 -------------ISP--SGP-----SSPIHSKLSRESTV----RIEVHPLPLPPGAAVL 320
                        +SP  S P     SSP+H +LS + T        VHPLPLPPGAA  
Sbjct: 265 PQPSRPSSPLHSILSPDSSAPPRDSVSSPLHPRLSTDVTNGRRDSCNVHPLPLPPGAACP 324

Query: 321 SPSATIP---QVAAKPEPLPMNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFP 377
           S SA      Q   K +  PMNSQW+KGKLIGRGTFGSVYVASN ETGALCAMKEV++FP
Sbjct: 325 SSSAASLPSPQAPLKLDSFPMNSQWKKGKLIGRGTFGSVYVASNSETGALCAMKEVELFP 384

Query: 378 DDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHC 437
           DDPKSAE IKQLEQEIK+LS+L+HPNIVQY+GSE VED+F+IYLEYVHPGSINKY+R+HC
Sbjct: 385 DDPKSAECIKQLEQEIKLLSNLQHPNIVQYFGSETVEDRFFIYLEYVHPGSINKYIRDHC 444

Query: 438 GAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQK 497
           G +TESVVRNFTRHILSGLAYLH+KKT+HRDIKGANLLVDASGVVKLADFGMAKHLTGQ+
Sbjct: 445 GTMTESVVRNFTRHILSGLAYLHNKKTVHRDIKGANLLVDASGVVKLADFGMAKHLTGQR 504

Query: 498 ADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAA 557
           ADLS+KGSPYWMAPELM AVMQK  + D A AVDIWSLGCTIIEM+TGKPPWSE+EGAAA
Sbjct: 505 ADLSLKGSPYWMAPELMQAVMQKDSNPDLAFAVDIWSLGCTIIEMFTGKPPWSEFEGAAA 564

Query: 558 MFKVMRDTPAIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQP------DV 611
           MFKVMRD+P IP+S+SPEGKDFLR CFQRNPA+RP AS+LLEHRFLKNS QP      DV
Sbjct: 565 MFKVMRDSPPIPESMSPEGKDFLRLCFQRNPAERPTASMLLEHRFLKNSLQPTSPSNNDV 624

Query: 612 PSCSLSFSGMQLTEKPHSPREKADAKYDQVAALSSSRSSRKATLESENG---RRSHLETS 668
            +CS  F+GM +TE P S REK + K DQV      R+    + ESE+G   ++    + 
Sbjct: 625 SNCSQLFNGMNITE-PSSRREKPNFKLDQVP-----RARNVTSSESESGQQQQQQQYRSP 678

Query: 669 DL--TVASTCSPRSTLEALPCLSP 690
           DL  T  +  SPRSTLEA+P  SP
Sbjct: 679 DLTGTTVNRLSPRSTLEAIPSPSP 702

Source: Arabidopsis lyrata subsp. lyrata

Species: Arabidopsis lyrata

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|15982852|gb|AAL09773.1| AT5g66850/MUD21_11 [Arabidopsis thaliana]

 Score =  670 bits (1728), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 391/670 (58%), Positives = 466/670 (69%), Gaps = 71/670 (10%)

Query: 66  RLTRQKKLRHLSDQEVVGVTRLANPDVSESVSSRDNNSNDHSSSALRTSTSSPVPLPLPL 125
           RLTRQ+KLRHL+D +V+   R A    S S S+ D+     S SA      SP  +PLPL
Sbjct: 52  RLTRQRKLRHLTDDDVLLGERRA----STSSSTFDSGLT-RSPSAFTAVPRSPSAVPLPL 106

Query: 126 PVPLR----VDDERDRDGLSDRDRVDCAAPDRV--SNSSSNSPIASV---FSRRVGRKMP 176
           P+PL     + +  +  GL DRDR     P+R+    +SS  P+ SV   F+R       
Sbjct: 107 PLPLPEVAGIRNAANARGLDDRDR----DPERLISDRTSSGPPLTSVNGGFAR------- 155

Query: 177 EFFDTKSSRSVNLALNYVERSRDNFRLNIPAKSAPTSPFTSPVRSPQRSVGGM---FQYK 233
              D++ +   +   ++  R+R+ + +NIP  SAPTSP+ SPV SPQR   G    F Y 
Sbjct: 156 ---DSRKATENSSYQDFSPRNRNGYWVNIPTMSAPTSPYMSPVPSPQRKSTGHDLPFFYL 212

Query: 234 VPNGNQGWSAPEMPTLDIPGLPPPAFFDYTVFSAESSPFHSPRSRSPCR----------- 282
            P  NQ WSAP+MP LD  GLPPPAF+D T FS ++SP HSP+ RSP +           
Sbjct: 213 PPKSNQAWSAPDMP-LDTSGLPPPAFYDITAFSTDNSPIHSPQPRSPRKQIRSPQPSRPS 271

Query: 283 ---NAISPSGP-----SSPIHSKLSRESTVR----IEVHPLPLPPGAAVLSPSATIP--- 327
              +++  S P     SSP+H +LS + T        VHPLPLPPGA   S SA      
Sbjct: 272 SPLHSVDSSAPPRDSVSSPLHPRLSTDVTNGRRDCCNVHPLPLPPGATCSSSSAASVPSP 331

Query: 328 QVAAKPEPLPMNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIK 387
           Q   K +  PMNSQW+KGKLIGRGTFGSVYVASN ETGALCAMKEV++FPDDPKSAE IK
Sbjct: 332 QAPLKLDSFPMNSQWEKGKLIGRGTFGSVYVASNSETGALCAMKEVELFPDDPKSAECIK 391

Query: 388 QLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRN 447
           QLEQEIK+LS+L+HPNIVQY+GSE VED+F+IYLEYVHPGSINKY+R+HCG +TESVVRN
Sbjct: 392 QLEQEIKLLSNLQHPNIVQYFGSETVEDRFFIYLEYVHPGSINKYIRDHCGTMTESVVRN 451

Query: 448 FTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPY 507
           FTRHILSGLAYLH+KKT+HRDIKGANLLVDASGVVKLADFGMAKHLTGQ+ADLS+KGSPY
Sbjct: 452 FTRHILSGLAYLHNKKTVHRDIKGANLLVDASGVVKLADFGMAKHLTGQRADLSLKGSPY 511

Query: 508 WMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPA 567
           WMAPELM AVMQK  + D A AVDIWSLGCTIIEM+TGKPPWSE+EGAAAMFKVMRD+P 
Sbjct: 512 WMAPELMQAVMQKDSNPDLAFAVDIWSLGCTIIEMFTGKPPWSEFEGAAAMFKVMRDSPP 571

Query: 568 IPDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQPDVPS---CSLSFSGMQLT 624
           IP+S+SPEGKDFLR CFQRNPA+RP AS+LLEHRFLKNS QP  PS    S  F+GM +T
Sbjct: 572 IPESMSPEGKDFLRLCFQRNPAERPTASMLLEHRFLKNSLQPTSPSNSDVSQLFNGMNIT 631

Query: 625 EKPHSPREKADAKYDQVAALSSSRSSRKATLESENG---RRSHLETSDLT-VASTCSPRS 680
           E P S REK + K DQV      R+    + ESE+G   ++    + DLT   +  SPRS
Sbjct: 632 E-PSSRREKPNFKLDQVP-----RARNMTSSESESGQQQQQQQYRSPDLTGTVNRLSPRS 685

Query: 681 TLEALPCLSP 690
           TLEA+P   P
Sbjct: 686 TLEAIPSPCP 695

Source: Arabidopsis thaliana

Species: Arabidopsis thaliana

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|18425121|ref|NP_569040.1| mitogen-activated protein kinase kinase kinase 5 [Arabidopsis thaliana] gi|13430660|gb|AAK25952.1|AF360242_1 putative MAP protein kinase [Arabidopsis thaliana] gi|14532832|gb|AAK64098.1| putative MAP protein kinase [Arabidopsis thaliana] gi|332010888|gb|AED98271.1| mitogen-activated protein kinase kinase kinase 5 [Arabidopsis thaliana]

 Score =  669 bits (1727), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 391/670 (58%), Positives = 466/670 (69%), Gaps = 71/670 (10%)

Query: 66  RLTRQKKLRHLSDQEVVGVTRLANPDVSESVSSRDNNSNDHSSSALRTSTSSPVPLPLPL 125
           RLTRQ+KLRHL+D +V+   R A    S S S+ D+     S SA      SP  +PLPL
Sbjct: 52  RLTRQRKLRHLTDDDVLLGERRA----STSSSTFDSGLT-RSPSAFTAVPRSPSAVPLPL 106

Query: 126 PVPLR----VDDERDRDGLSDRDRVDCAAPDRV--SNSSSNSPIASV---FSRRVGRKMP 176
           P+PL     + +  +  GL DRDR     P+R+    +SS  P+ SV   F+R       
Sbjct: 107 PLPLPEVAGIRNAANARGLDDRDR----DPERLISDRTSSGPPLTSVNGGFAR------- 155

Query: 177 EFFDTKSSRSVNLALNYVERSRDNFRLNIPAKSAPTSPFTSPVRSPQRSVGGM---FQYK 233
              D++ +   +   ++  R+R+ + +NIP  SAPTSP+ SPV SPQR   G    F Y 
Sbjct: 156 ---DSRKATENSSYQDFSPRNRNGYWVNIPTMSAPTSPYMSPVPSPQRKSTGHDLPFFYL 212

Query: 234 VPNGNQGWSAPEMPTLDIPGLPPPAFFDYTVFSAESSPFHSPRSRSPCR----------- 282
            P  NQ WSAP+MP LD  GLPPPAF+D T FS ++SP HSP+ RSP +           
Sbjct: 213 PPKSNQAWSAPDMP-LDTSGLPPPAFYDITAFSTDNSPIHSPQPRSPRKQIRSPQPSRPS 271

Query: 283 ---NAISPSGP-----SSPIHSKLSRESTVR----IEVHPLPLPPGAAVLSPSATIP--- 327
              +++  S P     SSP+H +LS + T        VHPLPLPPGA   S SA      
Sbjct: 272 SPLHSVDSSAPPRDSVSSPLHPRLSTDVTNGRRDCCNVHPLPLPPGATCSSSSAASVPSP 331

Query: 328 QVAAKPEPLPMNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIK 387
           Q   K +  PMNSQW+KGKLIGRGTFGSVYVASN ETGALCAMKEV++FPDDPKSAE IK
Sbjct: 332 QAPLKLDSFPMNSQWKKGKLIGRGTFGSVYVASNSETGALCAMKEVELFPDDPKSAECIK 391

Query: 388 QLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRN 447
           QLEQEIK+LS+L+HPNIVQY+GSE VED+F+IYLEYVHPGSINKY+R+HCG +TESVVRN
Sbjct: 392 QLEQEIKLLSNLQHPNIVQYFGSETVEDRFFIYLEYVHPGSINKYIRDHCGTMTESVVRN 451

Query: 448 FTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPY 507
           FTRHILSGLAYLH+KKT+HRDIKGANLLVDASGVVKLADFGMAKHLTGQ+ADLS+KGSPY
Sbjct: 452 FTRHILSGLAYLHNKKTVHRDIKGANLLVDASGVVKLADFGMAKHLTGQRADLSLKGSPY 511

Query: 508 WMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPA 567
           WMAPELM AVMQK  + D A AVDIWSLGCTIIEM+TGKPPWSE+EGAAAMFKVMRD+P 
Sbjct: 512 WMAPELMQAVMQKDSNPDLAFAVDIWSLGCTIIEMFTGKPPWSEFEGAAAMFKVMRDSPP 571

Query: 568 IPDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQPDVPS---CSLSFSGMQLT 624
           IP+S+SPEGKDFLR CFQRNPA+RP AS+LLEHRFLKNS QP  PS    S  F+GM +T
Sbjct: 572 IPESMSPEGKDFLRLCFQRNPAERPTASMLLEHRFLKNSLQPTSPSNSDVSQLFNGMNIT 631

Query: 625 EKPHSPREKADAKYDQVAALSSSRSSRKATLESENG---RRSHLETSDLT-VASTCSPRS 680
           E P S REK + K DQV      R+    + ESE+G   ++    + DLT   +  SPRS
Sbjct: 632 E-PSSRREKPNFKLDQVP-----RARNMTSSESESGQQQQQQQYRSPDLTGTVNRLSPRS 685

Query: 681 TLEALPCLSP 690
           TLEA+P   P
Sbjct: 686 TLEAIPSPCP 695

Source: Arabidopsis thaliana

Species: Arabidopsis thaliana

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356565641|ref|XP_003551047.1| PREDICTED: uncharacterized protein LOC100790701 [Glycine max]

 Score =  647 bits (1670), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 349/581 (60%), Positives = 418/581 (71%), Gaps = 31/581 (5%)

Query: 95  SVSSRDNNSNDHSSSALRTSTSSPVPLPLP-LPVPLRVDDERDRDGLSDRDRVDCAAPDR 153
           S   R  +  DH   AL +S  +P PLPLP L V   V   R RDG         AAP  
Sbjct: 46  SAKKRTCHVGDHDEDALVSSPGTPQPLPLPELAVSAAV--LRQRDGECRLPSPKDAAP-- 101

Query: 154 VSNSSSNSPIASVFSRRVGRKMPEFFDTKSSRSVNL-ALNYVERSRDNFR---LNIPAKS 209
            S +++   + SVF+ +  R+  E  +T+SSR V   A    E +RDN     +N+P + 
Sbjct: 102 -STTTTGFRMRSVFASQETRRNMEQAETRSSRMVQQDASGCRESARDNSNNNLVNVPHRR 160

Query: 210 APTSPFTSPVRSPQRSVGGMF---QYKVPNGNQGWSAPEMPTLDIPGLPPPAFFDYTVFS 266
           + +    SP  SPQ++  G F    Y  P GNQ WS PEMPT D  GL PPAFFD +  S
Sbjct: 161 SISG---SPSMSPQKTRNGDFVPYYYACPKGNQFWSTPEMPTCDA-GLLPPAFFDLSALS 216

Query: 267 AESS----PFHSPRSRSPCRNAISPSGPSSPIHSKLSRE-STVR-------IEVHPLPLP 314
            E+S       SP+ +SP ++  + SGP SPIH  LS E  TVR       + VHPLPLP
Sbjct: 217 TETSLSPNSHQSPQRKSPQKHTRTFSGPPSPIHPMLSLEIPTVRHENNAPPVAVHPLPLP 276

Query: 315 PGAAVLSP--SATIPQVAAKPEPLPMNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKE 372
           P A + SP  +AT      K E LPM SQW+KGKLIGRGTFGSVYVA+NRETGALCAMKE
Sbjct: 277 PRAGLTSPPAAATFSHAMVKSESLPMKSQWKKGKLIGRGTFGSVYVATNRETGALCAMKE 336

Query: 373 VDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKY 432
           V++FPDDPKSAE IKQLEQEIKVLS+LKH NIVQYYGSEIVED+FYIYLEYVHPGSINKY
Sbjct: 337 VELFPDDPKSAECIKQLEQEIKVLSNLKHSNIVQYYGSEIVEDRFYIYLEYVHPGSINKY 396

Query: 433 VREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKH 492
           VR+HCGAITESV+RNFTRHILSGLAYLHSKKTIHRDIKGANLLVD++GVVKLADFGMAKH
Sbjct: 397 VRDHCGAITESVIRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDSAGVVKLADFGMAKH 456

Query: 493 LTGQKADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEY 552
           LTG +A+LS++GSPYWMAPEL+ AV+QK  S D A A+DIWSLGCTIIEM+TGKPPWSEY
Sbjct: 457 LTGFEANLSLRGSPYWMAPELLQAVIQKDNSPDLAFAIDIWSLGCTIIEMFTGKPPWSEY 516

Query: 553 EGAAAMFKVMRDTPAIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQPDVP 612
           EGAAA+FKVM++TP IP++LS EGKDFLRCCF+RNPA+RP A++LLEHRFLKNSQQPD  
Sbjct: 517 EGAAALFKVMKETPPIPETLSSEGKDFLRCCFKRNPAERPTAAVLLEHRFLKNSQQPDAI 576

Query: 613 SCSLSFSGMQLTEKPHSPREKADAKYDQVAALSSSRSSRKA 653
           S +  ++G    +KPH+P  +++ +Y Q +   +  +  KA
Sbjct: 577 SPTQLYNGTSFMDKPHTPSGQSENRYGQFSTPCAKIAKGKA 617

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356495460|ref|XP_003516595.1| PREDICTED: uncharacterized protein LOC100793654 [Glycine max]

 Score =  622 bits (1604), Expect = e-175,   Method: Compositional matrix adjust.
 Identities = 343/593 (57%), Positives = 401/593 (67%), Gaps = 45/593 (7%)

Query: 69  RQKKLRHLSDQEVVGVTRLANPDVSESVSSRDNNSNDHSSSALRTSTSSPVPLPLPLPVP 128
           R KKL H     V  +  L  P +S S S+ D           R+STS   P PLPLP  
Sbjct: 185 RSKKLTH-----VAVLDSLVVPPLSRSSSTFD-----------RSSTSCVQPQPLPLP-- 226

Query: 129 LRVDDERDRDGLSDRDRVDCAAPDRVSNSSSNSPIASVFSRRVGRKMPEFFDTKSSRSVN 188
            R  D R        DR D A    ++                G +M   F  + +RS  
Sbjct: 227 -RDADYRSPSPKDAADRPDAAVDVTLTP---------------GFRMRSVFARQETRSAG 270

Query: 189 LALNYVERSRDNFRLNIPAKSAPTSPFTSPVRSPQRSVGGMFQYKVPNGNQGWSAPEMPT 248
           +         D F L++P +SAPTSP  SP       +   + Y  P GNQ WSAPEMPT
Sbjct: 271 VVAEQERSEGDKFWLSVPPRSAPTSPLGSPSNKNDDDLVPYY-YVSPKGNQFWSAPEMPT 329

Query: 249 LDIPGLPPPAFFDYTVFSAESSPFHSPRSRSPCRNAISPSGPSSPIHSKLSR-ESTVRIE 307
            D    PPPAFFD +    ++ P  SP  +SP R +     P   + + ++R E+T  + 
Sbjct: 330 FD-SSHPPPAFFDLSALHTDNIP--SPH-QSPTRLSSLSIPPKLSLDTSIARRETTAPLA 385

Query: 308 VHPLPLPPGAA----VLSPSATIPQVAAKPEPLPMNSQWQKGKLIGRGTFGSVYVASNRE 363
           VHPLPLPP A     +LSPS+T     AK E LPM +QWQKGKL+GRGTFG+VYVA+NR+
Sbjct: 386 VHPLPLPPWAGPGPPLLSPSSTFSPPVAKTESLPMKNQWQKGKLLGRGTFGTVYVATNRK 445

Query: 364 TGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYIYLEY 423
           TGALCAMKE +IF DDPKSAE IKQLEQEIKVLSHL+HPNIVQYYGSEIVED+FYIYLEY
Sbjct: 446 TGALCAMKEAEIFSDDPKSAECIKQLEQEIKVLSHLQHPNIVQYYGSEIVEDRFYIYLEY 505

Query: 424 VHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVK 483
           VHPGS+NKYVREHCGAITE VVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVD++GVVK
Sbjct: 506 VHPGSMNKYVREHCGAITECVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDSAGVVK 565

Query: 484 LADFGMAKHLTGQKADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMY 543
           LADFGMAKHLTG  ADLS+KGSPYWMAPEL  A +QK  SSD A AVDIWSLGCTIIEM+
Sbjct: 566 LADFGMAKHLTGHVADLSLKGSPYWMAPELFQAGVQKDNSSDLAFAVDIWSLGCTIIEMF 625

Query: 544 TGKPPWSEYEGAAAMFKVMRDTPAIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFL 603
           TGKPPWSEYEGAAAMFKVM+DTP IP++LS EGKDFLR CF RNPA+RP AS+LL+HRFL
Sbjct: 626 TGKPPWSEYEGAAAMFKVMKDTPPIPETLSAEGKDFLRLCFIRNPAERPTASMLLQHRFL 685

Query: 604 KNSQQPDVPSCSLSFSGMQLTEKPHSPREKADAKYDQVAALSSSRSSRKATLE 656
           KN QQPDV S    ++G  L +  HSP+E ++ K DQ++  S+  +  K   E
Sbjct: 686 KNLQQPDVSSSMQLYNGTSLMDI-HSPKELSENKLDQISIPSAHIAKGKLATE 737

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356514005|ref|XP_003525698.1| PREDICTED: mitogen-activated protein kinase kinase kinase 3-like [Glycine max]

 Score =  620 bits (1598), Expect = e-174,   Method: Compositional matrix adjust.
 Identities = 338/566 (59%), Positives = 405/566 (71%), Gaps = 30/566 (5%)

Query: 99  RDNNSNDHSSSALRTSTSSPVPLPLPLPVPLRVDDERDRDGLSDRDRVDCAAPDRVSNSS 158
           R  +  DH   AL +S  +P  LPLP      V   R +DG          +P   + ++
Sbjct: 46  RACHVGDHDEDALVSSPGTPQQLPLPELSAAAV--LRQQDG-----ECRLPSPKDAAPTT 98

Query: 159 SNSPIASVFSRRVGRKMPEFFDTKSSRSVNL-ALNYVERSRDNFRLNI----PAKSAPTS 213
           +   + SVF+ +  R+  E  +T+S R V   A    E +RDN   N+      +S   S
Sbjct: 99  TGFRMRSVFASQETRRNMEQAETRSPRMVQQDASGCSESARDNSNNNLVNVPRRRSISGS 158

Query: 214 PFTSPVRSPQRSVGGMF---QYKVPNGNQGWSAPEMPTLDIPGLPPPAFFDYTVFSAESS 270
              SP  SPQ++  G F    Y    GNQ WSAPEMP+ +  GL PPAFFD +  S E+S
Sbjct: 159 SSASPSMSPQKTRNGDFVPYYYTYSKGNQFWSAPEMPSCEA-GLLPPAFFDLSALSTEAS 217

Query: 271 ----PFHSPRSRSPCRNAISPSGPSSPIHSKLSRE-STVRIE-------VHPLPLPPGAA 318
                  S + +S  ++  + SGP SPIHS L  E ST R E       VHPLPLPPGAA
Sbjct: 218 LSPNSHQSLQMKSSQKHTRTFSGPPSPIHSMLPLEISTARHESNAPPVGVHPLPLPPGAA 277

Query: 319 VLSP--SATIPQVAAKPEPLPMNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIF 376
           + SP  +AT     AK E  PM SQW+KGKLIGRGTFGSVYVA+NRETGALCAMKEV++F
Sbjct: 278 LTSPPAAATFSHAVAKSESFPMKSQWKKGKLIGRGTFGSVYVATNRETGALCAMKEVELF 337

Query: 377 PDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREH 436
           PDDPKSAE IKQLEQEIKVLS+LKH NIVQYYGSEIVED+FYIYLEYVHPGSINKYVREH
Sbjct: 338 PDDPKSAECIKQLEQEIKVLSNLKHSNIVQYYGSEIVEDRFYIYLEYVHPGSINKYVREH 397

Query: 437 CGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQ 496
           CGAITESV+RNFTRHILSGLAYLHSKKTIHRDIKGANLLVD++GVVKLADFGMAKHLTG 
Sbjct: 398 CGAITESVIRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDSAGVVKLADFGMAKHLTGF 457

Query: 497 KADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAA 556
           +A+LS++GSPYWMAPEL+ AV+QK  S D A A+DIWSLGCTIIEM+TGKPPWSEYEGAA
Sbjct: 458 EANLSLRGSPYWMAPELLQAVIQKDNSPDLAFAIDIWSLGCTIIEMFTGKPPWSEYEGAA 517

Query: 557 AMFKVMRDTPAIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQPDVPSCSL 616
           A+FKVM++TP IP++LS EGKDFLRCCF+RNPA+RP A++LLEHRFLKNSQ  DV S + 
Sbjct: 518 ALFKVMKETPPIPETLSSEGKDFLRCCFKRNPAERPTAAVLLEHRFLKNSQLLDVLSSTQ 577

Query: 617 SFSGMQLTEKPHSPREKADAKYDQVA 642
            ++     +KPH+P  +++  YDQ++
Sbjct: 578 LYNETSFMDKPHTPSRQSENSYDQLS 603

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	721
TAIR|locus:2174969	716	MAPKKK5 "mitogen-activated pro	0.554	0.558	0.694	1.3e-174
TAIR|locus:2026674	883	YDA "YODA" [Arabidopsis thalia	0.421	0.344	0.564	2.3e-93
TAIR|locus:2024832	609	MAP3KA "mitogen-activated prot	0.442	0.523	0.533	8.6e-88
TAIR|locus:2035989	666	NP1 "NPK1-related protein kina	0.421	0.456	0.444	2.1e-61
DICTYBASE|DDB_G0283265	1267	mkkA "octicosapeptide/Phox/Bem	0.407	0.232	0.412	3.3e-61
UNIPROTKB|Q40541	690	Q40541 "Protein kinase" [Nicot	0.420	0.439	0.426	2.2e-59
TAIR|locus:2080394	651	NP3 "NPK1-related protein kina	0.421	0.466	0.420	9.3e-59
UNIPROTKB|F1MH06	626	MAP3K3 "Uncharacterized protei	0.360	0.415	0.435	9.6e-57
UNIPROTKB|F1P750	626	MAP3K3 "Uncharacterized protei	0.360	0.415	0.435	9.6e-57
UNIPROTKB|J3KRN4	622	MAP3K3 "Mitogen-activated prot	0.360	0.418	0.435	9.6e-57

TAIR|locus:2174969 MAPKKK5 "mitogen-activated protein kinase kinase kinase 5" [Arabidopsis thaliana (taxid:3702)]

 Score = 1444 (513.4 bits), Expect = 1.3e-174, Sum P(3) = 1.3e-174
 Identities = 295/425 (69%), Positives = 336/425 (79%)

Query:   294 IHSKLSRESTVR----IEVHPLPLPPGAAVLSPSATI---PQVAAKPEPLPMNSQWQKGK 346
             +H +LS + T        VHPLPLPPGA   S SA     PQ   K +  PMNSQW+KGK
Sbjct:   291 LHPRLSTDVTNGRRDCCNVHPLPLPPGATCSSSSAASVPSPQAPLKLDSFPMNSQWKKGK 350

Query:   347 LIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQ 406
             LIGRGTFGSVYVASN ETGALCAMKEV++FPDDPKSAE IKQLEQEIK+LS+L+HPNIVQ
Sbjct:   351 LIGRGTFGSVYVASNSETGALCAMKEVELFPDDPKSAECIKQLEQEIKLLSNLQHPNIVQ 410

Query:   407 YYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIH 466
             Y+GSE VED+F+IYLEYVHPGSINKY+R+HCG +TESVVRNFTRHILSGLAYLH+KKT+H
Sbjct:   411 YFGSETVEDRFFIYLEYVHPGSINKYIRDHCGTMTESVVRNFTRHILSGLAYLHNKKTVH 470

Query:   467 RDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPYWMAPELMMAVMQKGKSSDS 526
             RDIKGANLLVDASGVVKLADFGMAKHLTGQ+ADLS+KGSPYWMAPELM AVMQK  + D 
Sbjct:   471 RDIKGANLLVDASGVVKLADFGMAKHLTGQRADLSLKGSPYWMAPELMQAVMQKDSNPDL 530

Query:   527 ALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDSLSPEGKDFLRCCFQR 586
             A AVDIWSLGCTIIEM+TGKPPWSE+EGAAAMFKVMRD+P IP+S+SPEGKDFLR CFQR
Sbjct:   531 AFAVDIWSLGCTIIEMFTGKPPWSEFEGAAAMFKVMRDSPPIPESMSPEGKDFLRLCFQR 590

Query:   587 NPADRPPASLLLEHRFLKNSQQPDVPSCS-LS--FSGMQLTEKPHSPREKADAKYDQVAA 643
             NPA+RP AS+LLEHRFLKNS QP  PS S +S  F+GM +TE P S REK + K DQV  
Sbjct:   591 NPAERPTASMLLEHRFLKNSLQPTSPSNSDVSQLFNGMNITE-PSSRREKPNFKLDQVPR 649

Query:   644 LXXXXXXXKATLESENGRRSHLE---TSDLT-VASTCSPRSTLEALPCLSPLHSGPSTRH 699
                         ESE+G++   +   + DLT   +  SPRSTLEA+P  SP    PS R 
Sbjct:   650 ARNMTSS-----ESESGQQQQQQQYRSPDLTGTVNRLSPRSTLEAIP--SPC---PSQRP 699

Query:   700 SSASA 704
               +S+
Sbjct:   700 KPSSS 704

GO:0004672 "protein kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IDA

GO:0046777 "protein autophosphorylation" evidence=IDA

TAIR|locus:2026674 YDA "YODA" [Arabidopsis thaliana (taxid:3702)]

 Score = 899 (321.5 bits), Expect = 2.3e-93, Sum P(2) = 2.3e-93
 Identities = 183/324 (56%), Positives = 226/324 (69%)

Query:   305 RIEVHPLPLPP----GAAVLSPS---ATIPQVAAKPE----PLPMNSQWQKGKLIGRGTF 353
             R + H LPLPP         SP+   AT P V   P      +   S+W+KG+L+G G+F
Sbjct:   352 RQQSHRLPLPPLLISNTCPFSPTYSAATSPSVPRSPARAEATVSPGSRWKKGRLLGMGSF 411

Query:   354 GSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIV 413
             G VY+  N E+G +CAMKEV +  DDPKS ES +QL QEI VLS L+H NIVQYYGSE V
Sbjct:   412 GHVYLGFNSESGEMCAMKEVTLCSDDPKSRESAQQLGQEISVLSRLRHQNIVQYYGSETV 471

Query:   414 EDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGAN 473
             +DK YIYLEYV  GSI K ++E+ G   E+ +RN+T+ ILSGLAYLH+K T+HRDIKGAN
Sbjct:   472 DDKLYIYLEYVSGGSIYKLLQEY-GQFGENAIRNYTQQILSGLAYLHAKNTVHRDIKGAN 530

Query:   474 LLVDASGVVKLADFGMAKHLTGQKADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIW 533
             +LVD  G VK+ADFGMAKH+T Q   LS KGSPYWMAPE++        S+ S LAVDIW
Sbjct:   531 ILVDPHGRVKVADFGMAKHITAQSGPLSFKGSPYWMAPEVIK------NSNGSNLAVDIW 584

Query:   534 SLGCTIIEMYTGKPPWSEYEGAAAMFKV--MRDTPAIPDSLSPEGKDFLRCCFQRNPADR 591
             SLGCT++EM T KPPWS+YEG  AMFK+   ++ P IPD LS EGKDF+R C QRNPA+R
Sbjct:   585 SLGCTVLEMATTKPPWSQYEGVPAMFKIGNSKELPDIPDHLSEEGKDFVRKCLQRNPANR 644

Query:   592 PPASLLLEHRFLKNSQQPDVPSCS 615
             P A+ LL+H F++N    + P  S
Sbjct:   645 PTAAQLLDHAFVRNVMPMERPIVS 668

GO:0004672 "protein kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005737 "cytoplasm" evidence=ISM

GO:0009793 "embryo development ending in seed dormancy" evidence=IMP

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0010103 "stomatal complex morphogenesis" evidence=IMP

GO:0007155 "cell adhesion" evidence=RCA

GO:0010090 "trichome morphogenesis" evidence=RCA

GO:0045010 "actin nucleation" evidence=RCA

GO:0048765 "root hair cell differentiation" evidence=RCA

GO:0071555 "cell wall organization" evidence=RCA

GO:0010229 "inflorescence development" evidence=IMP

TAIR|locus:2024832 MAP3KA "mitogen-activated protein kinase kinase kinase 3" [Arabidopsis thaliana (taxid:3702)]

 Score = 877 (313.8 bits), Expect = 8.6e-88, P = 8.6e-88
 Identities = 183/343 (53%), Positives = 234/343 (68%)

Query:   307 EVHPLPLPPGAAVLSPSATI-PQVAAKPEPLPMN-SQWQKGKLIGRGTFGSVYVASNRET 364
             E HPLP PP +   SPSA    ++    E  P   S W+KGK +G GTFG VY+  N E 
Sbjct:   178 ECHPLPRPPTSPT-SPSAVHGSRIGGGYETSPSGFSTWKKGKFLGSGTFGQVYLGFNSEK 236

Query:   365 GALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYIYLEYV 424
             G +CA+KEV +  DD  S E +KQL QEI +L+ L HPNIVQYYGSE+ E+   +YLEYV
Sbjct:   237 GKMCAIKEVKVISDDQTSKECLKQLNQEINLLNQLCHPNIVQYYGSELSEETLSVYLEYV 296

Query:   425 HPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKL 484
               GSI+K ++++ G+ TE V++N+TR IL+GLAYLH + T+HRDIKGAN+LVD +G +KL
Sbjct:   297 SGGSIHKLLKDY-GSFTEPVIQNYTRQILAGLAYLHGRNTVHRDIKGANILVDPNGEIKL 355

Query:   485 ADFGMAKHLTGQKADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT 544
             ADFGMAKH+T     LS KGSPYWMAPE++M+  Q G +     AVDIWSLGCTI+EM T
Sbjct:   356 ADFGMAKHVTAFSTMLSFKGSPYWMAPEVVMS--QNGYTH----AVDIWSLGCTILEMAT 409

Query:   545 GKPPWSEYEGAAAMFKV--MRDTPAIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRF 602
              KPPWS++EG AA+FK+   +DTP IPD LS + K+F+R C QRNP  RP AS LLEH F
Sbjct:   410 SKPPWSQFEGVAAIFKIGNSKDTPEIPDHLSNDAKNFIRLCLQRNPTVRPTASQLLEHPF 469

Query:   603 LKNSQQPDVPSCSL-------SFSG---MQLTEKPHSPREKAD 635
             L+N+ +  V S SL       S+ G   +Q T +P+  R   D
Sbjct:   470 LRNTTR--VASTSLPKDFPPRSYDGNFSLQPTREPYPGRLSHD 510

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0006487 "protein N-linked glycosylation" evidence=RCA

TAIR|locus:2035989 NP1 "NPK1-related protein kinase 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 628 (226.1 bits), Expect = 2.1e-61, P = 2.1e-61
 Identities = 149/335 (44%), Positives = 202/335 (60%)

Query:   320 LSPSATIPQVAAKPEPLPMNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDI---F 376
             + PS + P  A   +  P  S W+KG+LIGRG FG+VY+  N ++G L A+K+V I   F
Sbjct:    48 IKPSFSPPPPANTVDMAPPIS-WRKGQLIGRGAFGTVYMGMNLDSGELLAVKQVLIAANF 106

Query:   377 PDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREH 436
                 K+   I++LE+E+K+L +L HPNIV+Y G+   +D   I LE+V  GSI+  + E 
Sbjct:   107 ASKEKTQAHIQELEEEVKLLKNLSHPNIVRYLGTVREDDTLNILLEFVPGGSISSLL-EK 165

Query:   437 CGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKH---- 492
              G   ESVVR +TR +L GL YLH+   +HRDIKGAN+LVD  G +KLADFG +K     
Sbjct:   166 FGPFPESVVRTYTRQLLLGLEYLHNHAIMHRDIKGANILVDNKGCIKLADFGASKQVAEL 225

Query:   493 --LTGQKADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWS 550
               +TG K   SMKG+PYWMAPE+   ++Q G S     + DIWS+GCT+IEM TGK PWS
Sbjct:   226 ATMTGAK---SMKGTPYWMAPEV---ILQTGHS----FSADIWSVGCTVIEMVTGKAPWS 275

Query:   551 E-YEGAAAMFKV--MRDTPAIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFL---- 603
             + Y+  AA+F +   +  P IPD+LS + KDFL  C Q  P  RP AS LL+H F+    
Sbjct:   276 QQYKEVAAIFFIGTTKSHPPIPDTLSSDAKDFLLKCLQEVPNLRPTASELLKHPFVMGKH 335

Query:   604 KNSQQPDVPSCSLSFSG---MQLTEKPHSPREKAD 635
             K S   D+ S   + S    +Q+     +P    D
Sbjct:   336 KESASTDLGSVLNNLSTPLPLQINNTKSTPDSTCD 370

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005737 "cytoplasm" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0006979 "response to oxidative stress" evidence=IDA

GO:0009908 "flower development" evidence=IGI

GO:0046777 "protein autophosphorylation" evidence=IDA

GO:0007155 "cell adhesion" evidence=RCA

GO:0010090 "trichome morphogenesis" evidence=RCA

GO:0045010 "actin nucleation" evidence=RCA

GO:0048765 "root hair cell differentiation" evidence=RCA

GO:0071555 "cell wall organization" evidence=RCA

GO:0004709 "MAP kinase kinase kinase activity" evidence=ISS

DICTYBASE|DDB_G0283265 mkkA "octicosapeptide/Phox/Bem1p domain-containing protein" [Dictyostelium discoideum (taxid:44689)]

 Score = 617 (222.3 bits), Expect = 3.3e-61, Sum P(2) = 3.3e-61
 Identities = 129/313 (41%), Positives = 194/313 (61%)

Query:   339 NSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFP--DDPKSAESIKQLEQEIKVL 396
             N +WQKG+++GRG +GSVY+  N++TG L A+K+++I     DPK    I    +EI+V+
Sbjct:   492 NIKWQKGQILGRGGYGSVYLGLNKDTGELFAVKQLEIVDINSDPKLKNMILSFSKEIEVM 551

Query:   397 SHLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGL 456
               L+H NIV+Y G+ + +    ++LEY+  GSI+  + +  GA +E+V++ +T+ IL GL
Sbjct:   552 RSLRHDNIVRYLGTSLDQSFLSVFLEYIPGGSISSLLGKF-GAFSENVIKVYTKQILQGL 610

Query:   457 AYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADL-SMKGSPYWMAPELMM 515
             ++LH+   IHRDIKGAN+L+D  G+VKL+DFG +K  +G  +   SM+G+PYWMAPE+  
Sbjct:   611 SFLHANSIIHRDIKGANILIDTKGIVKLSDFGCSKSFSGIVSQFKSMQGTPYWMAPEV-- 668

Query:   516 AVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEY-EGAAAMFKVMRDT--PAIPDSL 572
              + Q G    S    DIWSLGC I+EM T +PPWS   E AA M+ +      P IP  +
Sbjct:   669 -IKQTGHGRSS----DIWSLGCVIVEMATAQPPWSNITELAAVMYHIASSNSIPNIPSHM 723

Query:   573 SPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNS----QQPDV-PSCSLSFSGMQLTEKP 627
             S E  DFL  CF+R+P +RP A+ LL+H F+ N     Q P + P+ +LS +    T   
Sbjct:   724 SQEAFDFLNLCFKRDPKERPDANQLLKHPFIMNLDDNIQLPTISPTTTLSTNTTNTTATT 783

Query:   628 HSPREKADAKYDQ 640
              +     ++  +Q
Sbjct:   784 TTTNNATNSNINQ 796

GO:0030587 "sorocarp development" evidence=IMP

GO:0009653 "anatomical structure morphogenesis" evidence=IMP

GO:0005938 "cell cortex" evidence=IDA

GO:0004709 "MAP kinase kinase kinase activity" evidence=IEA;ISS

GO:0000186 "activation of MAPKK activity" evidence=IEA;ISS

GO:0000165 "MAPK cascade" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004672 "protein kinase activity" evidence=IEA

GO:0046872 "metal ion binding" evidence=IEA

GO:0030435 "sporulation resulting in formation of a cellular spore" evidence=IEA

GO:0016740 "transferase activity" evidence=IEA

GO:0016310 "phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=IEA

GO:0016021 "integral to membrane" evidence=IEA

GO:0016020 "membrane" evidence=IEA

GO:0000166 "nucleotide binding" evidence=IEA

UNIPROTKB|Q40541 Q40541 "Protein kinase" [Nicotiana tabacum (taxid:4097)]

 Score = 609 (219.4 bits), Expect = 2.2e-59, P = 2.2e-59
 Identities = 143/335 (42%), Positives = 201/335 (60%)

Query:   300 RESTVRI--EVHPLPLPPGAAVLSPSATIPQVAAKPEPLPMNSQWQKGKLIGRGTFGSVY 357
             R+S++ I  + H +P  P  +     A +P  A K +  P+  +W+KG++IG G FG VY
Sbjct:    43 RKSSIGIFSKAH-VPALPSIS----KAELPAKARKDDTPPI--RWRKGEMIGCGAFGRVY 95

Query:   358 VASNRETGALCAMKEVDIFPDDP---KSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVE 414
             +  N ++G L A+KEV I  +     ++   +++LE+E+ +L +L HPNIV+Y G+    
Sbjct:    96 MGMNVDSGELLAIKEVSIAMNGASRERAQAHVRELEEEVNLLKNLSHPNIVRYLGTAREA 155

Query:   415 DKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANL 474
                 I LE+V  GSI+  + +  G+  ESV+R +T+ +L GL YLH    +HRDIKGAN+
Sbjct:   156 GSLNILLEFVPGGSISSLLGKF-GSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANI 214

Query:   475 LVDASGVVKLADFGMAKH------LTGQKADLSMKGSPYWMAPELMMAVMQKGKSSDSAL 528
             LVD  G +KLADFG +K       +TG K   SMKG+PYWMAPE+   ++Q G S     
Sbjct:   215 LVDNKGCIKLADFGASKKVVELATMTGAK---SMKGTPYWMAPEV---ILQTGHS----F 264

Query:   529 AVDIWSLGCTIIEMYTGKPPWSE-YEGAAAMFKV--MRDTPAIPDSLSPEGKDFLRCCFQ 585
             + DIWS+GCTIIEM TGKPPWS+ Y+  AA+F +   +  P IP+ LS E KDFL  C Q
Sbjct:   265 SADIWSVGCTIIEMATGKPPWSQQYQEVAALFHIGTTKSHPPIPEHLSAESKDFLLKCLQ 324

Query:   586 RNPADRPPASLLLEHRFLKNSQQPDVPSCSLSFSG 620
             + P  R  AS LL+H F+    Q   P    SF G
Sbjct:   325 KEPHLRHSASNLLQHPFVTAEHQEARPFLRSSFMG 359

GO:0005515 "protein binding" evidence=IPI

TAIR|locus:2080394 NP3 "NPK1-related protein kinase 3" [Arabidopsis thaliana (taxid:3702)]

 Score = 603 (217.3 bits), Expect = 9.3e-59, P = 9.3e-59
 Identities = 137/326 (42%), Positives = 197/326 (60%)

Query:   322 PSATIPQVAAKPEPLPMNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDP- 380
             P   +P  A + E  P + +W+KG+LIG G FG VY+  N ++G L A+K+V I P    
Sbjct:    51 PPPGLP--APRKEEAP-SIRWRKGELIGCGAFGRVYMGMNLDSGELLAIKQVLIAPSSAS 107

Query:   381 --KSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCG 438
               K+   I++LE+E+++L +L HPNIV+Y G+    D   I +E+V  GSI+  + E  G
Sbjct:   108 KEKTQGHIRELEEEVQLLKNLSHPNIVRYLGTVRESDSLNILMEFVPGGSISSLL-EKFG 166

Query:   439 AITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAK---HLTG 495
             +  E V+  +T+ +L GL YLH+   +HRDIKGAN+LVD  G ++LADFG +K    L  
Sbjct:   167 SFPEPVIIMYTKQLLLGLEYLHNNGIMHRDIKGANILVDNKGCIRLADFGASKKVVELAT 226

Query:   496 QKADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSE-YEG 554
                  SMKG+PYWMAPE+   ++Q G S     + DIWS+GCT+IEM TGKPPWSE Y+ 
Sbjct:   227 VNGAKSMKGTPYWMAPEV---ILQTGHS----FSADIWSVGCTVIEMATGKPPWSEQYQQ 279

Query:   555 AAAMFKVMRDT--PAIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQPDVP 612
              AA+  + R    P IP+ LSPE KDFL  C  + P+ R  A+ LL+H F+   +Q   P
Sbjct:   280 FAAVLHIGRTKAHPPIPEDLSPEAKDFLMKCLHKEPSLRLSATELLQHPFVTGKRQEPYP 339

Query:   613 SC--SLSFSGMQLTEKPHSPREKADA 636
             +   SL+  G  +T +  + R   ++
Sbjct:   340 AYRNSLTECGNPITTQGMNVRSSINS 365

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0048046 "apoplast" evidence=IDA

GO:0043622 "cortical microtubule organization" evidence=IMP

GO:0046777 "protein autophosphorylation" evidence=IDA

GO:0000911 "cytokinesis by cell plate formation" evidence=RCA

GO:0006260 "DNA replication" evidence=RCA

GO:0006270 "DNA replication initiation" evidence=RCA

GO:0006275 "regulation of DNA replication" evidence=RCA

GO:0006306 "DNA methylation" evidence=RCA

GO:0008283 "cell proliferation" evidence=RCA

GO:0016572 "histone phosphorylation" evidence=RCA

GO:0051567 "histone H3-K9 methylation" evidence=RCA

GO:0051726 "regulation of cell cycle" evidence=RCA

UNIPROTKB|F1MH06 MAP3K3 "Uncharacterized protein" [Bos taurus (taxid:9913)]

 Score = 584 (210.6 bits), Expect = 9.6e-57, P = 9.6e-57
 Identities = 124/285 (43%), Positives = 176/285 (61%)

Query:   329 VAAKPEPLPMNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQ 388
             V  K    P+N  W++GKL+G+G FG VY+  + +TG   A K+V   PD P++++ +  
Sbjct:   351 VPTKSPSAPIN--WRRGKLLGQGAFGRVYLCYDVDTGRELASKQVQFDPDSPETSKEVSA 408

Query:   389 LEQEIKVLSHLKHPNIVQYYGS--EIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVR 446
             LE EI++L +L+H  IVQYYG   +  E    I++EY+  GS+   ++ + GA+TESV R
Sbjct:   409 LECEIQLLKNLQHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAY-GALTESVTR 467

Query:   447 NFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHL-------TGQKAD 499
              +TR IL G++YLHS   +HRDIKGAN+L D++G VKL DFG +K L       TG +  
Sbjct:   468 KYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGMR-- 525

Query:   500 LSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMF 559
              S+ G+PYWM+PE++     +G    +    D+WSLGCT++EM T KPPW+EYE  AA+F
Sbjct:   526 -SVTGTPYWMSPEVISG---EGYGRKA----DVWSLGCTVVEMLTEKPPWAEYEAMAAIF 577

Query:   560 KVMRD--TPAIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRF 602
             K+      P +P  +S  G+DFLR  F      RP A  LL H F
Sbjct:   578 KIATQPTNPQLPSHISEHGRDFLRRIFVE-ARQRPSAEELLTHHF 621

GO:0046777 "protein autophosphorylation" evidence=IEA

GO:0043123 "positive regulation of I-kappaB kinase/NF-kappaB cascade" evidence=IEA

GO:0007243 "intracellular protein kinase cascade" evidence=IEA

GO:0004672 "protein kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

UNIPROTKB|F1P750 MAP3K3 "Uncharacterized protein" [Canis lupus familiaris (taxid:9615)]

 Score = 584 (210.6 bits), Expect = 9.6e-57, P = 9.6e-57
 Identities = 124/285 (43%), Positives = 176/285 (61%)

Query:   329 VAAKPEPLPMNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQ 388
             V  K    P+N  W++GKL+G+G FG VY+  + +TG   A K+V   PD P++++ +  
Sbjct:   351 VPTKSPSAPIN--WRRGKLLGQGAFGRVYLCYDVDTGRELASKQVQFDPDSPETSKEVSA 408

Query:   389 LEQEIKVLSHLKHPNIVQYYGS--EIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVR 446
             LE EI++L +L+H  IVQYYG   +  E    I++EY+  GS+   ++ + GA+TESV R
Sbjct:   409 LECEIQLLKNLQHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAY-GALTESVTR 467

Query:   447 NFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHL-------TGQKAD 499
              +TR IL G++YLHS   +HRDIKGAN+L D++G VKL DFG +K L       TG +  
Sbjct:   468 KYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGMR-- 525

Query:   500 LSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMF 559
              S+ G+PYWM+PE++     +G    +    D+WSLGCT++EM T KPPW+EYE  AA+F
Sbjct:   526 -SVTGTPYWMSPEVISG---EGYGRKA----DVWSLGCTVVEMLTEKPPWAEYEAMAAIF 577

Query:   560 KVMRD--TPAIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRF 602
             K+      P +P  +S  G+DFLR  F      RP A  LL H F
Sbjct:   578 KIATQPTNPQLPSHISEHGRDFLRRIFVE-ARQRPSAEELLTHHF 621

GO:0005524 "ATP binding" evidence=IEA

GO:0004672 "protein kinase activity" evidence=IEA

UNIPROTKB|J3KRN4 MAP3K3 "Mitogen-activated protein kinase kinase kinase 3" [Homo sapiens (taxid:9606)]

 Score = 584 (210.6 bits), Expect = 9.6e-57, P = 9.6e-57
 Identities = 124/285 (43%), Positives = 176/285 (61%)

Query:   329 VAAKPEPLPMNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQ 388
             V  K    P+N  W++GKL+G+G FG VY+  + +TG   A K+V   PD P++++ +  
Sbjct:   347 VPTKSPSAPIN--WRRGKLLGQGAFGRVYLCYDVDTGRELASKQVQFDPDSPETSKEVSA 404

Query:   389 LEQEIKVLSHLKHPNIVQYYGS--EIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVR 446
             LE EI++L +L+H  IVQYYG   +  E    I++EY+  GS+   ++ + GA+TESV R
Sbjct:   405 LECEIQLLKNLQHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAY-GALTESVTR 463

Query:   447 NFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHL-------TGQKAD 499
              +TR IL G++YLHS   +HRDIKGAN+L D++G VKL DFG +K L       TG +  
Sbjct:   464 KYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGMR-- 521

Query:   500 LSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMF 559
              S+ G+PYWM+PE++     +G    +    D+WSLGCT++EM T KPPW+EYE  AA+F
Sbjct:   522 -SVTGTPYWMSPEVISG---EGYGRKA----DVWSLGCTVVEMLTEKPPWAEYEAMAAIF 573

Query:   560 KVMRD--TPAIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRF 602
             K+      P +P  +S  G+DFLR  F      RP A  LL H F
Sbjct:   574 KIATQPTNPQLPSHISEHGRDFLRRIFVE-ARQRPSAEELLTHHF 617

GO:0004672 "protein kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

No confident hit for EC number transfering in SWISSPROT detected by BLAST

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	LOW CONFIDENCE prediction!
3rd Layer	2.7.11	0.691

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Your Input: GSVIVG00009700001 SubName- Full=Chromosome undetermined scaffold_245, whole genome shotgun sequence; (592 aa) (Vitis vinifera)

Predicted Functional Partners:

Sorry, there are no predicted associations at the current settings.

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	721
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	1e-134
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	1e-124
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	2e-97
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	4e-95
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	1e-94
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	2e-88
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	7e-87
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	3e-85
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	2e-78
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	3e-77
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	6e-74
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	6e-71
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	8e-70
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	3e-69
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	2e-68
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	5e-68
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	1e-66
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	1e-66
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	3e-66
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	7e-66
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	3e-65
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	3e-65
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	3e-62
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	5e-62
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	3e-61
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	4e-58
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	2e-54
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	4e-54
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	9e-54
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	1e-53
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	7e-53
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	3e-52
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	4e-51
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	1e-50
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	3e-50
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	6e-50
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	6e-50
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	1e-49
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	2e-49
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	3e-49
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	6e-49
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	3e-48
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	4e-48
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	5e-48
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	1e-47
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	8e-47
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	1e-46
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	1e-44
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	2e-44
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	3e-44
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	4e-44
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	1e-43
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	1e-43
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	1e-43
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	2e-43
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	3e-43
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	3e-43
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	1e-42
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	8e-42
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	9e-42
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	1e-41
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	1e-41
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	5e-41
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	5e-41
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	5e-41
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	6e-41
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	2e-40
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	2e-40
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	4e-40
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	2e-39
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	3e-39
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	8e-39
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	1e-38
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	3e-38
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	6e-38
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	7e-38
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	1e-37
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	2e-37
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	3e-37
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	5e-37
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	1e-36
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	5e-36
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	2e-35
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	2e-35
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	3e-35
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	4e-35
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	4e-35
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	7e-35
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	1e-34
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	1e-34
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	2e-34
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	3e-34
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	4e-34
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	5e-34
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	2e-33
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	2e-33
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	2e-33
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	3e-33
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	3e-33
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	7e-33
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	2e-32
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	3e-32
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	3e-32
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	4e-32
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	8e-32
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	1e-31
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	1e-31
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	3e-31
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	4e-31
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	6e-31
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	7e-31
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	8e-31
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	9e-31
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	8e-30
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	1e-29
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	2e-29
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	3e-29
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	3e-29
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	3e-29
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	8e-29
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	9e-29
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	1e-28
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	2e-28
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	2e-28
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	3e-28
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	8e-28
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	1e-27
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	1e-27
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	1e-27
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	2e-27
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	3e-27
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	3e-27
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	3e-27
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	5e-27
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	7e-27
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	1e-26
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	1e-26
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	1e-26
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	2e-26
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	3e-26
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	3e-26
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	5e-26
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	5e-26
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	7e-26
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	8e-26
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	2e-25
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	2e-25
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	2e-25
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	3e-25
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	3e-25
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	3e-25
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	5e-25
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	9e-25
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	1e-24
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	1e-24
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	1e-24
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	1e-24
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	1e-24
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	2e-24
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	2e-24
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	2e-24
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	3e-24
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	3e-24
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	3e-24
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	3e-24
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	3e-24
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	5e-24
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	5e-24
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	5e-24
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	6e-24
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	7e-24
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	9e-24
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	1e-23
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	1e-23
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	1e-23
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	1e-23
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	1e-23
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	2e-23
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	2e-23
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	3e-23
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	3e-23
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	4e-23
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	5e-23
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	6e-23
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	7e-23
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	7e-23
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	7e-23
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	1e-22
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	1e-22
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	2e-22
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	3e-22
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	3e-22
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	3e-22
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	4e-22
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	4e-22
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	4e-22
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	5e-22
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	6e-22
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	6e-22
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	7e-22
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	1e-21
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	2e-21
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	2e-21
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	3e-21
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	4e-21
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	4e-21
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	6e-21
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	8e-21
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	8e-21
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	1e-20
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	1e-20
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	3e-20
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	3e-20
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	3e-20
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	9e-20
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	1e-19
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	1e-19
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	1e-19
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	2e-19
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	3e-19
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	6e-19
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	6e-19
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	6e-19
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	8e-19
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	1e-18
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	2e-18
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	2e-18
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	2e-18
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	2e-18
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	3e-18
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	3e-18
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	4e-18
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	6e-18
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	1e-17
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	1e-17
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	2e-17
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	2e-17
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	2e-17
cd08226	328	cd08226, PK_STRAD_beta, Pseudokinase domain of STE	3e-17
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	4e-17
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	4e-17
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	5e-17
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	7e-17
cd08227	327	cd08227, PK_STRAD_alpha, Pseudokinase domain of ST	1e-16
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	2e-16
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	2e-16
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	2e-16
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	2e-16
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	4e-16
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	5e-16
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	5e-16
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	6e-16
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	7e-16
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	7e-16
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	8e-16
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	9e-16
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	9e-16
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	1e-15
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	2e-15
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	2e-15
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	3e-15
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	3e-15
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	4e-15
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	5e-15
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	6e-15
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	1e-14
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	1e-14
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	2e-14
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	7e-14
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	7e-14
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	4e-13
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	1e-12
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	1e-12
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	2e-12
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	3e-12
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	3e-12
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	4e-12
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	4e-12
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	4e-12
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	5e-12
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	1e-11
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	1e-11
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	2e-11
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	2e-11
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	2e-11
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	4e-11
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	4e-11
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	7e-11
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	9e-11
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	2e-10
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	5e-10
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	5e-10
smart00750	176	smart00750, KIND, kinase non-catalytic C-lobe doma	8e-10
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	1e-09
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	1e-09
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	1e-09
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	3e-09
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	5e-09
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	2e-08
PHA02882	294	PHA02882, PHA02882, putative serine/threonine kina	8e-08
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	9e-08
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	1e-07
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	1e-06
cd05077	262	cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do	1e-06
PLN03224	507	PLN03224, PLN03224, probable serine/threonine prot	7e-06
cd05076	274	cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do	1e-05
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	5e-05
cd05120	155	cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot	9e-04
PRK09605	535	PRK09605, PRK09605, bifunctional UGMP family prote	0.001
PLN03225	566	PLN03225, PLN03225, Serine/threonine-protein kinas	0.002
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	0.004

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score =  396 bits (1018), Expect = e-134
 Identities = 146/264 (55%), Positives = 186/264 (70%), Gaps = 9/264 (3%)

Query: 342 WQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKH 401
           W+KG+L+G G+FGSVY   N + G   A+KEV +  D     E++KQLEQEI +LS L+H
Sbjct: 2   WRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQH 61

Query: 402 PNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHS 461
           PNIVQY G+E  ED  YI+LE V  GS+ K ++++ G+  E V+R +TR IL GL YLH 
Sbjct: 62  PNIVQYLGTEREEDNLYIFLELVPGGSLAKLLKKY-GSFPEPVIRLYTRQILLGLEYLHD 120

Query: 462 KKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPYWMAPELMMAVMQKG 521
           + T+HRDIKGAN+LVD +GVVKLADFGMAK +       S KGSPYWMAPE+   + Q+G
Sbjct: 121 RNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKSFKGSPYWMAPEV---IAQQG 177

Query: 522 KSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMR--DTPAIPDSLSPEGKDF 579
                 LA DIWSLGCT++EM TGKPPWS+ EG AA+FK+ R  + P IPD LS E KDF
Sbjct: 178 GYG---LAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSDEAKDF 234

Query: 580 LRCCFQRNPADRPPASLLLEHRFL 603
           +  C QR+P+ RP A+ LLEH F+
Sbjct: 235 ILKCLQRDPSLRPTAAELLEHPFV 258

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  370 bits (952), Expect = e-124
 Identities = 138/271 (50%), Positives = 186/271 (68%), Gaps = 19/271 (7%)

Query: 341 QWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLK 400
           +W +G+L+GRG+FGSVY+A +++TG L A+K V++  D  +  E+   LE+EI++LS L+
Sbjct: 1   EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEA---LEREIRILSSLQ 57

Query: 401 HPNIVQYYGSEIVEDK--FYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAY 458
           HPNIV+YYGSE  E+K    I+LEYV  GS++  +++  G + E V+R +TR IL GLAY
Sbjct: 58  HPNIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKK-FGKLPEPVIRKYTRQILEGLAY 116

Query: 459 LHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHL---TGQKADLSMKGSPYWMAPELMM 515
           LHS   +HRDIKGAN+LVD+ GVVKLADFG AK L      +   S++G+PYWMAPE++ 
Sbjct: 117 LHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVI- 175

Query: 516 AVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGA-AAMFKVMRDT--PAIPDSL 572
                 +  +   A DIWSLGCT+IEM TGKPPWSE     AA++K+      P IP+ L
Sbjct: 176 ------RGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHL 229

Query: 573 SPEGKDFLRCCFQRNPADRPPASLLLEHRFL 603
           S E KDFLR C +R+P  RP A  LL+H FL
Sbjct: 230 SEEAKDFLRKCLRRDPKKRPTADELLQHPFL 260

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  300 bits (771), Expect = 2e-97
 Identities = 98/266 (36%), Positives = 149/266 (56%), Gaps = 16/266 (6%)

Query: 342 WQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKH 401
           ++  + +G G+FG VY+A +++TG L A+K +          +  +++ +EIK+L  LKH
Sbjct: 1   YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIK----KDRERILREIKILKKLKH 56

Query: 402 PNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHS 461
           PNIV+ Y     EDK Y+ +EY   G +   +++  G ++E   R + R ILS L YLHS
Sbjct: 57  PNIVRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKR-GRLSEDEARFYLRQILSALEYLHS 115

Query: 462 KKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPYWMAPELMMAVMQKG 521
           K  +HRD+K  N+L+D  G VKLADFG+A+ L   +   +  G+P +MAPE+   ++ KG
Sbjct: 116 KGIVHRDLKPENILLDEDGHVKLADFGLARQLDPGEKLTTFVGTPEYMAPEV---LLGKG 172

Query: 522 KSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMR----DTPAIPDSLSPEGK 577
                  AVDIWSLG  + E+ TGKPP+   +    +FK +       P     +SPE K
Sbjct: 173 YGK----AVDIWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWDISPEAK 228

Query: 578 DFLRCCFQRNPADRPPASLLLEHRFL 603
           D +R    ++P  R  A   L+H F 
Sbjct: 229 DLIRKLLVKDPEKRLTAEEALQHPFF 254

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  294 bits (756), Expect = 4e-95
 Identities = 124/265 (46%), Positives = 164/265 (61%), Gaps = 13/265 (4%)

Query: 341 QWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLK 400
            +Q G LIGRG FG VY   N ETG   A+K++ +        E++K + QEI +L +LK
Sbjct: 1   NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKE---EALKSIMQEIDLLKNLK 57

Query: 401 HPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLH 460
           HPNIV+Y GS    D  YI LEY   GS+ + +++  G   ES+V  +   +L GLAYLH
Sbjct: 58  HPNIVKYIGSIETSDSLYIILEYAENGSLRQIIKKF-GPFPESLVAVYVYQVLQGLAYLH 116

Query: 461 SKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQ-KADLSMKGSPYWMAPELMMAVMQ 519
            +  IHRDIK AN+L    GVVKLADFG+A  L    K D S+ G+PYWMAPE    +  
Sbjct: 117 EQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVVGTPYWMAPE---VIEM 173

Query: 520 KGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFK-VMRDTPAIPDSLSPEGKD 578
            G S+ S    DIWSLGCT+IE+ TG PP+ +    AA+F+ V  D P +P+ +SPE KD
Sbjct: 174 SGASTAS----DIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDHPPLPEGISPELKD 229

Query: 579 FLRCCFQRNPADRPPASLLLEHRFL 603
           FL  CFQ++P  RP A  LL+H ++
Sbjct: 230 FLMQCFQKDPNLRPTAKQLLKHPWI 254

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score =  293 bits (753), Expect = 1e-94
 Identities = 130/272 (47%), Positives = 171/272 (62%), Gaps = 17/272 (6%)

Query: 341 QWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLK 400
           +WQ+G  IG GTFG VY A N +TG L A+KE+ I  +DPK+   IK++  E+KVL  LK
Sbjct: 1   RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKT---IKEIADEMKVLELLK 57

Query: 401 HPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLH 460
           HPN+V+YYG E+  +K YI++EY   G++ + + EH   + E V+R +T  +L GLAYLH
Sbjct: 58  HPNLVKYYGVEVHREKVYIFMEYCSGGTLEELL-EHGRILDEHVIRVYTLQLLEGLAYLH 116

Query: 461 SKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADL-----SMKGSPYWMAPELMM 515
           S   +HRDIK AN+ +D +GV+KL DFG A  L      +     S+ G+P +MAPE   
Sbjct: 117 SHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPE--- 173

Query: 516 AVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGA-AAMFKV-MRDTPAIPDS-- 571
            V+  GK      A DIWSLGC ++EM TGK PWSE +     MF V     P IPDS  
Sbjct: 174 -VITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIPDSLQ 232

Query: 572 LSPEGKDFLRCCFQRNPADRPPASLLLEHRFL 603
           LSPEGKDFL  C + +P  RP AS LL+H F+
Sbjct: 233 LSPEGKDFLDRCLESDPKKRPTASELLQHPFV 264

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score =  278 bits (712), Expect = 2e-88
 Identities = 119/275 (43%), Positives = 173/275 (62%), Gaps = 22/275 (8%)

Query: 337 PMNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVL 396
           P N  W++GKL+G+G FG VY+  + +TG   A+K+V   PD P++ + +  LE EI++L
Sbjct: 1   PTN--WRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLL 58

Query: 397 SHLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGL 456
            +L+H  IVQYYG    ++   I++EY+  GS+   ++ + GA+TE+V R +TR IL G+
Sbjct: 59  KNLQHERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAY-GALTETVTRKYTRQILEGV 117

Query: 457 AYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHL-------TGQKADLSMKGSPYWM 509
            YLHS   +HRDIKGAN+L D++G VKL DFG +K L       TG K   S+ G+PYWM
Sbjct: 118 EYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMK---SVTGTPYWM 174

Query: 510 APELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRD--TPA 567
           +PE++       K+       D+WS+GCT++EM T KPPW+E+E  AA+FK+      P 
Sbjct: 175 SPEVISGEGYGRKA-------DVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQ 227

Query: 568 IPDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRF 602
           +P  +SP+ ++FLR  F  N   RP A  LL H F
Sbjct: 228 LPSHVSPDARNFLRRTFVENAKKRPSAEELLRHFF 262

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score =  273 bits (701), Expect = 7e-87
 Identities = 126/275 (45%), Positives = 170/275 (61%), Gaps = 20/275 (7%)

Query: 342 WQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFP-----DDPKSAESIKQLEQEIKVL 396
           W KG+LIG+GT+G VY+A N  TG + A+K+V++        D +  + +K L  EI+ L
Sbjct: 3   WVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETL 62

Query: 397 SHLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGL 456
             L H NIVQY G E  E+   I+LEYV  GSI   +R + G   E +VR FT  +L GL
Sbjct: 63  KDLDHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTY-GRFEEQLVRFFTEQVLEGL 121

Query: 457 AYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKH---LTGQKADLSMKGSPYWMAPEL 513
           AYLHSK  +HRD+K  NLLVDA G+ K++DFG++K    +     ++SM+GS +WMAPE 
Sbjct: 122 AYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPE- 180

Query: 514 MMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKV--MRDTPAIPD- 570
           ++    +G S+     VDIWSLGC ++EM+ G+ PWS+ E  AAMFK+   R  P IP  
Sbjct: 181 VIHSYSQGYSAK----VDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPD 236

Query: 571 ---SLSPEGKDFLRCCFQRNPADRPPASLLLEHRF 602
              +LSP   DFL  CF  NP +RP A  LL+H F
Sbjct: 237 VSMNLSPVALDFLNACFTINPDNRPTARELLQHPF 271

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  269 bits (689), Expect = 3e-85
 Identities = 107/264 (40%), Positives = 154/264 (58%), Gaps = 15/264 (5%)

Query: 342 WQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKH 401
           ++  + IG+G FG VY A ++ TG   A+K + +     +S E  +++  EI++L   KH
Sbjct: 2   FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKL-----ESKEKKEKIINEIQILKKCKH 56

Query: 402 PNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHS 461
           PNIV+YYGS + +D+ +I +E+   GS+   ++     +TES +    + +L GL YLHS
Sbjct: 57  PNIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHS 116

Query: 462 KKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPYWMAPELMMAVMQKG 521
              IHRDIK AN+L+ + G VKL DFG++  L+  KA  +M G+PYWMAPE    V+   
Sbjct: 117 NGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMVGTPYWMAPE----VINGK 172

Query: 522 KSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMR-DTPAIPDS--LSPEGKD 578
                    DIWSLG T IE+  GKPP+SE     A+FK+     P + +    S E KD
Sbjct: 173 PYD---YKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGLRNPEKWSDEFKD 229

Query: 579 FLRCCFQRNPADRPPASLLLEHRF 602
           FL+ C Q+NP  RP A  LL+H F
Sbjct: 230 FLKKCLQKNPEKRPTAEQLLKHPF 253

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  251 bits (643), Expect = 2e-78
 Identities = 92/270 (34%), Positives = 143/270 (52%), Gaps = 18/270 (6%)

Query: 342 WQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKH 401
           ++  + +G G+FG+VY A ++ TG + A+K +       KS +      +EI++L  L H
Sbjct: 1   YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKK--RSEKSKKDQTAR-REIRILRRLSH 57

Query: 402 PNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHS 461
           PNIV+   +   +D  Y+ +EY   G +  Y+    G ++E   +     IL GL YLHS
Sbjct: 58  PNIVRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRG-GPLSEDEAKKIALQILRGLEYLHS 116

Query: 462 KKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADL-SMKGSPYWMAPELMMAVMQK 520
              IHRD+K  N+L+D +GVVK+ADFG+AK L    + L +  G+P++MAPE    V+  
Sbjct: 117 NGIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPE----VLLG 172

Query: 521 GKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIP-------DSLS 573
           G        VD+WSLG  + E+ TGKPP+S       +  + R              S S
Sbjct: 173 GNGYGP--KVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEFDEPKWSSGS 230

Query: 574 PEGKDFLRCCFQRNPADRPPASLLLEHRFL 603
            E KD ++ C  ++P+ RP A  +L+H + 
Sbjct: 231 EEAKDLIKKCLNKDPSKRPTAEEILQHPWF 260

Length = 260

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score =  249 bits (637), Expect = 3e-77
 Identities = 96/269 (35%), Positives = 151/269 (56%), Gaps = 16/269 (5%)

Query: 340 SQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHL 399
             +   + IG+G+FG VY A ++ T  + A+K +D+     ++ + I+ ++QEI+ LS  
Sbjct: 1   ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDL----EEAEDEIEDIQQEIQFLSQC 56

Query: 400 KHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYL 459
           + P I +YYGS +   K +I +EY   GS    ++   G + E+ +    R +L GL YL
Sbjct: 57  RSPYITKYYGSFLKGSKLWIIMEYCGGGSCLDLLK--PGKLDETYIAFILREVLLGLEYL 114

Query: 460 HSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLT-GQKADLSMKGSPYWMAPELMMAVM 518
           H +  IHRDIK AN+L+   G VKLADFG++  LT       +  G+P+WMAPE    V+
Sbjct: 115 HEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFVGTPFWMAPE----VI 170

Query: 519 QKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAI--PDSLSPEG 576
           ++    + A   DIWSLG T IE+  G+PP S+      +F + ++ P     +  S   
Sbjct: 171 KQSGYDEKA---DIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNPPSLEGNKFSKPF 227

Query: 577 KDFLRCCFQRNPADRPPASLLLEHRFLKN 605
           KDF+  C  ++P +RP A  LL+H+F+K 
Sbjct: 228 KDFVSLCLNKDPKERPSAKELLKHKFIKK 256

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score =  239 bits (612), Expect = 6e-74
 Identities = 116/275 (42%), Positives = 164/275 (59%), Gaps = 20/275 (7%)

Query: 341 QWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDI----FPDDPKSAESIKQLEQEIKVL 396
           +W KG LIG G+FGSVY+  N  +G L A+K+V++         +    +  L +EI +L
Sbjct: 1   KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALL 60

Query: 397 SHLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGL 456
             L+H NIVQY GS +  D   I+LEYV  GS+   +  + GA  E++VRNF R IL GL
Sbjct: 61  KELQHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNY-GAFEETLVRNFVRQILKGL 119

Query: 457 AYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHL-------TGQKADLSMKGSPYWM 509
            YLH++  IHRDIKGAN+LVD  G +K++DFG++K L           A  S++GS +WM
Sbjct: 120 NYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWM 179

Query: 510 APELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRD-TPAI 568
           APE++       K+       DIWSLGC ++EM TGK P+ +     A+FK+  + +P I
Sbjct: 180 APEVVKQTSYTRKA-------DIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENASPEI 232

Query: 569 PDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFL 603
           P ++S E  DFL   F+ +   RP A+ LL+H FL
Sbjct: 233 PSNISSEAIDFLEKTFEIDHNKRPTAAELLKHPFL 267

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score =  231 bits (592), Expect = 6e-71
 Identities = 100/261 (38%), Positives = 149/261 (57%), Gaps = 18/261 (6%)

Query: 347 LIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQ 406
            +G G++GSVY A ++ETG + A+K V +  D       ++++ +EI +L     P IV+
Sbjct: 10  KLGEGSYGSVYKAIHKETGQVVAIKVVPVEED-------LQEIIKEISILKQCDSPYIVK 62

Query: 407 YYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIH 466
           YYGS       +I +EY   GS++  ++     +TE  +       L GL YLHS K IH
Sbjct: 63  YYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIH 122

Query: 467 RDIKGANLLVDASGVVKLADFGMAKHLTGQKADL-SMKGSPYWMAPELMMAVMQKGKSSD 525
           RDIK  N+L++  G  KLADFG++  LT   A   ++ G+P+WMAPE    V+Q+   ++
Sbjct: 123 RDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPE----VIQEIGYNN 178

Query: 526 SALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTP---AIPDSLSPEGKDFLRC 582
            A   DIWSLG T IEM  GKPP+S+     A+F +    P   + P+  SPE  DF++ 
Sbjct: 179 KA---DIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSDPEKWSPEFNDFVKK 235

Query: 583 CFQRNPADRPPASLLLEHRFL 603
           C  ++P +RP A  LL+H F+
Sbjct: 236 CLVKDPEERPSAIQLLQHPFI 256

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score =  229 bits (584), Expect = 8e-70
 Identities = 120/277 (43%), Positives = 172/277 (62%), Gaps = 25/277 (9%)

Query: 337 PMNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVL 396
           P+N  W++GKL+G+G FG VY+  + +TG   A K+V   P+ P++++ +  LE EI++L
Sbjct: 1   PIN--WRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLL 58

Query: 397 SHLKHPNIVQYYG--SEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILS 454
            +L+H  IVQYYG   +  E    I++EY+  GS+   ++ + GA+TESV R +TR IL 
Sbjct: 59  KNLQHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAY-GALTESVTRKYTRQILE 117

Query: 455 GLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHL-------TGQKADLSMKGSPY 507
           G++YLHS   +HRDIKGAN+L D++G VKL DFG +K L       TG +   S+ G+PY
Sbjct: 118 GMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIR---SVTGTPY 174

Query: 508 WMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRD--T 565
           WM+PE++       K+       D+WSLGCT++EM T KPPW+EYE  AA+FK+      
Sbjct: 175 WMSPEVISGEGYGRKA-------DVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTN 227

Query: 566 PAIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRF 602
           P +P  +S   +DFL C F      RP A  LL H F
Sbjct: 228 PQLPSHISEHARDFLGCIFVE-ARHRPSAEELLRHPF 263

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score =  227 bits (581), Expect = 3e-69
 Identities = 103/261 (39%), Positives = 140/261 (53%), Gaps = 15/261 (5%)

Query: 348 IGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQY 407
           IG GT+G VY A +  TG L A+K + + P D       + ++QEI +L   +HPNIV Y
Sbjct: 11  IGSGTYGDVYKARDIATGELVAIKVIKLEPGD-----DFEIIQQEISMLKECRHPNIVAY 65

Query: 408 YGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHR 467
           +GS +  DK +I +EY   GS+    +   G ++E  +    R  L GLAYLH    IHR
Sbjct: 66  FGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHR 125

Query: 468 DIKGANLLVDASGVVKLADFGMAKHLTGQKAD-LSMKGSPYWMAPELMMAVMQKGKSSDS 526
           DIKGAN+L+   G VKLADFG++  LT   A   S  G+PYWMAPE    V    +    
Sbjct: 126 DIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFIGTPYWMAPE----VAAVERKGGY 181

Query: 527 ALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMF---KVMRDTPAIPDS--LSPEGKDFLR 581
               DIW+LG T IE+   +PP  +     A+F   K     P + D    SP   DF++
Sbjct: 182 DGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEKWSPVFHDFIK 241

Query: 582 CCFQRNPADRPPASLLLEHRF 602
            C  ++P  RP A+ LL+H F
Sbjct: 242 KCLTKDPKKRPTATKLLQHPF 262

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score =  225 bits (574), Expect = 2e-68
 Identities = 107/274 (39%), Positives = 163/274 (59%), Gaps = 20/274 (7%)

Query: 341 QWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAE-SIKQLEQEIKVLSHL 399
           +W KG+++G+G +G+VY       G L A+K+V++   +  +AE   ++L++E+ +L  L
Sbjct: 1   EWTKGEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSL 59

Query: 400 KHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYL 459
           KH NIVQY G+ + ++   I++E+V  GSI+  +    G + E V   +T+ IL G+AYL
Sbjct: 60  KHVNIVQYLGTCLDDNTISIFMEFVPGGSISSILNRF-GPLPEPVFCKYTKQILDGVAYL 118

Query: 460 HSKKTIHRDIKGANLLVDASGVVKLADFGMAKHL-----TGQKADL--SMKGSPYWMAPE 512
           H+   +HRDIKG N+++  +G++KL DFG A+ L      G  +++  SM G+PYWMAPE
Sbjct: 119 HNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPE 178

Query: 513 LMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRD---TPAIP 569
           ++       KS       DIWS+GCT+ EM TGKPP +  +  AAMF +       P +P
Sbjct: 179 VINESGYGRKS-------DIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLP 231

Query: 570 DSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFL 603
           DS S    DF+  C  R+  +RP A  LL H FL
Sbjct: 232 DSFSAAAIDFVTSCLTRDQHERPSALQLLRHDFL 265

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score =  224 bits (574), Expect = 5e-68
 Identities = 105/269 (39%), Positives = 151/269 (56%), Gaps = 20/269 (7%)

Query: 342 WQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKH 401
            +K   IG G  G VY A++R TG   A+K++ +        ++ + +  EI ++   KH
Sbjct: 24  LEK---IGEGASGEVYKATDRATGKEVAIKKMRL------RKQNKELIINEILIMKDCKH 74

Query: 402 PNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHS 461
           PNIV YY S +V D+ ++ +EY+  GS+   + ++   + E  +    R +L GL YLHS
Sbjct: 75  PNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHS 134

Query: 462 KKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADL-SMKGSPYWMAPELMMAVMQK 520
           +  IHRDIK  N+L+   G VKLADFG A  LT +K+   S+ G+PYWMAPE++      
Sbjct: 135 QNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVVGTPYWMAPEVI------ 188

Query: 521 GKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKV-MRDTPAI--PDSLSPEGK 577
            K  D    VDIWSLG   IEM  G+PP+       A+F +  +  P +  P+  SPE K
Sbjct: 189 -KRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNPEKWSPEFK 247

Query: 578 DFLRCCFQRNPADRPPASLLLEHRFLKNS 606
           DFL  C  ++P  RP A  LL+H FLK +
Sbjct: 248 DFLNKCLVKDPEKRPSAEELLQHPFLKKA 276

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  218 bits (557), Expect = 1e-66
 Identities = 91/255 (35%), Positives = 137/255 (53%), Gaps = 43/255 (16%)

Query: 348 IGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQY 407
           +G G FG+VY+A +++TG   A+K +        S+  +++L +EI++L  L HPNIV+ 
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKK----EDSSSLLEELLREIEILKKLNHPNIVKL 56

Query: 408 YGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHR 467
           YG    E+  Y+ +EY   GS+   ++E+ G ++E  +      IL GL YLHS   IHR
Sbjct: 57  YGVFEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHR 116

Query: 468 DIKGANLLVDA-SGVVKLADFGMAKHLTGQKADL-SMKGSPYWMAPELMMAVMQKGKSSD 525
           D+K  N+L+D+ +G VKLADFG++K LT  K+ L ++ G+P +MAPE++      GK   
Sbjct: 117 DLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVL-----LGKGYY 171

Query: 526 SALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDSLSPEGKDFLRCCFQ 585
           S    DIWSLG  + E+                               PE KD +R   Q
Sbjct: 172 SE-KSDIWSLGVILYEL-------------------------------PELKDLIRKMLQ 199

Query: 586 RNPADRPPASLLLEH 600
           ++P  RP A  +LEH
Sbjct: 200 KDPEKRPSAKEILEH 214

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score =  220 bits (561), Expect = 1e-66
 Identities = 120/277 (43%), Positives = 172/277 (62%), Gaps = 25/277 (9%)

Query: 337 PMNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVL 396
           P+N  W+ GKL+GRG FG VY+  + +TG   A+K+V   PD  ++++ +  LE EI++L
Sbjct: 1   PVN--WRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLL 58

Query: 397 SHLKHPNIVQYYG--SEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILS 454
            +L+H  IVQYYG   +  E K  I++EY+  GSI   ++ + GA+TE+V R +TR IL 
Sbjct: 59  KNLRHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAY-GALTENVTRRYTRQILQ 117

Query: 455 GLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHL-------TGQKADLSMKGSPY 507
           G++YLHS   +HRDIKGAN+L D++G VKL DFG +K +       TG K   S+ G+PY
Sbjct: 118 GVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIK---SVTGTPY 174

Query: 508 WMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRD--T 565
           WM+PE++       K+       D+WS+ CT++EM T KPPW+EYE  AA+FK+      
Sbjct: 175 WMSPEVISGEGYGRKA-------DVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTK 227

Query: 566 PAIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRF 602
           P +PD +S   +DFL+  F      RP A  LL H F
Sbjct: 228 PMLPDGVSDACRDFLKQIFVEEKR-RPTAEFLLRHPF 263

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score =  219 bits (559), Expect = 3e-66
 Identities = 100/272 (36%), Positives = 163/272 (59%), Gaps = 20/272 (7%)

Query: 341 QWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQ-LEQEIKVLSHL 399
           +W KG+ +G G F S Y A + +TG L A+K+V    +     E + + L +EI++++ L
Sbjct: 1   EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARL 60

Query: 400 KHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYL 459
            HP+I++  G+   +  F +++E++  GS++  + ++ GA  E+V+ N+T  +L GL+YL
Sbjct: 61  NHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKY-GAFKEAVIINYTEQLLRGLSYL 119

Query: 460 HSKKTIHRDIKGANLLVDASG-VVKLADFGMAKHLTGQ--KADL---SMKGSPYWMAPEL 513
           H  + IHRD+KGANLL+D++G  +++ADFG A  L  +   A      + G+  +MAPE+
Sbjct: 120 HENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEV 179

Query: 514 MMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGA---AAMFKV--MRDTPAI 568
           +    Q G+S       D+WS+GC IIEM T KPPW+  + +   A +FK+      P+I
Sbjct: 180 LRG-EQYGRSC------DVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSI 232

Query: 569 PDSLSPEGKDFLRCCFQRNPADRPPASLLLEH 600
           P+ LSP  +D    C +  P DRPP+  LL+H
Sbjct: 233 PEHLSPGLRDVTLRCLELQPEDRPPSRELLKH 264

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score =  218 bits (557), Expect = 7e-66
 Identities = 114/264 (43%), Positives = 158/264 (59%), Gaps = 17/264 (6%)

Query: 347 LIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQ 406
           ++G+GT+G VY A +  T    A+KE+       + +  ++ L +EI + S+LKH NIVQ
Sbjct: 15  VLGKGTYGIVYAARDLSTQVRIAIKEIPE-----RDSRYVQPLHEEIALHSYLKHRNIVQ 69

Query: 407 YYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAIT--ESVVRNFTRHILSGLAYLHSKKT 464
           Y GS+     F I++E V  GS++  +R   G +   E  +  +T+ IL GL YLH  + 
Sbjct: 70  YLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQI 129

Query: 465 IHRDIKGANLLVDA-SGVVKLADFGMAKHLTG-QKADLSMKGSPYWMAPELMMAVMQKGK 522
           +HRDIKG N+LV+  SGVVK++DFG +K L G      +  G+  +MAPE    V+ KG 
Sbjct: 130 VHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFTGTLQYMAPE----VIDKGP 185

Query: 523 SSDSALAVDIWSLGCTIIEMYTGKPPWSEY-EGAAAMFKV--MRDTPAIPDSLSPEGKDF 579
               A A DIWSLGCTI+EM TGKPP+ E  E  AAMFKV   +  P IP+SLS E K+F
Sbjct: 186 RGYGAPA-DIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPESLSAEAKNF 244

Query: 580 LRCCFQRNPADRPPASLLLEHRFL 603
           +  CF+ +P  R  A  LL+  FL
Sbjct: 245 ILRCFEPDPDKRASAHDLLQDPFL 268

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score =  216 bits (552), Expect = 3e-65
 Identities = 116/275 (42%), Positives = 170/275 (61%), Gaps = 23/275 (8%)

Query: 340 SQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHL 399
           + W+ GKL+G+G FG VY+  + +TG   A+K+V   P+ P++++ +  LE EI++L +L
Sbjct: 2   TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNL 61

Query: 400 KHPNIVQYYG--SEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLA 457
            H  IVQYYG   + +E    I++E++  GSI   ++ + GA+TE+V R +TR IL G++
Sbjct: 62  LHERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSY-GALTENVTRKYTRQILEGVS 120

Query: 458 YLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHL-------TGQKADLSMKGSPYWMA 510
           YLHS   +HRDIKGAN+L D+ G VKL DFG +K L       TG K   S+ G+PYWM+
Sbjct: 121 YLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMK---SVTGTPYWMS 177

Query: 511 PELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRD--TPAI 568
           PE++       K+       DIWS+GCT++EM T KPPW+E+E  AA+FK+      P +
Sbjct: 178 PEVISGEGYGRKA-------DIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVL 230

Query: 569 PDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFL 603
           P  +S   +DFL+  F      RP A  LL H F+
Sbjct: 231 PPHVSDHCRDFLKRIFVEAKL-RPSADELLRHTFV 264

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  216 bits (552), Expect = 3e-65
 Identities = 83/260 (31%), Positives = 139/260 (53%), Gaps = 17/260 (6%)

Query: 346 KLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIV 405
           K IG+G+FG VY+   +  G L  +KE+D+     K     +    E+K+L  L HPNI+
Sbjct: 6   KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKE---REDALNEVKILKKLNHPNII 62

Query: 406 QYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGA---ITESVVRNFTRHILSGLAYLHSK 462
           +YY S   + K  I +EY   G +++ +++         E  + ++   +   L YLHS+
Sbjct: 63  KYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR 122

Query: 463 KTIHRDIKGANLLVDASGVVKLADFGMAKHL--TGQKADLSMKGSPYWMAPELMMAVMQK 520
           K +HRDIK  N+ + ++G+VKL DFG++K L  T   A  ++ G+PY+++PEL      +
Sbjct: 123 KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLA-KTVVGTPYYLSPELC-----Q 176

Query: 521 GKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMR-DTPAIPDSLSPEGKDF 579
            K  +     DIWSLGC + E+ T K P+          K+++   P IP   S E ++ 
Sbjct: 177 NKPYNY--KSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYPPIPSQYSSELRNL 234

Query: 580 LRCCFQRNPADRPPASLLLE 599
           +    Q++P +RP  + +L+
Sbjct: 235 VSSLLQKDPEERPSIAQILQ 254

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  208 bits (533), Expect = 3e-62
 Identities = 98/276 (35%), Positives = 155/276 (56%), Gaps = 19/276 (6%)

Query: 340 SQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHL 399
           S  ++ K++G+G+ G VY   ++ TG + A+K++ +  D+    E  KQL +E+K L   
Sbjct: 1   SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE----EFRKQLLRELKTLRSC 56

Query: 400 KHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYL 459
           + P +V+ YG+   E +  I LEY+  GS+   +++  G I E V+    R IL GL YL
Sbjct: 57  ESPYVVKCYGAFYKEGEISIVLEYMDGGSLADLLKKV-GKIPEPVLAYIARQILKGLDYL 115

Query: 460 HSK-KTIHRDIKGANLLVDASGVVKLADFGMAKHL-TGQKADLSMKGSPYWMAPELMMAV 517
           H+K   IHRDIK +NLL+++ G VK+ADFG++K L        +  G+  +M+PE +   
Sbjct: 116 HTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFVGTVTYMSPERI--- 172

Query: 518 MQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWS--EYEGAAAMFKVMRDTPAI---PDSL 572
             +G+ S S  A DIWSLG T++E   GK P+          + + + D P      +  
Sbjct: 173 --QGE-SYSYAA-DIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEF 228

Query: 573 SPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQ 608
           SPE +DF+  C Q++P  RP A+ LL+H F+K +  
Sbjct: 229 SPEFRDFISACLQKDPKKRPSAAELLQHPFIKKADN 264

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score =  208 bits (532), Expect = 5e-62
 Identities = 104/272 (38%), Positives = 149/272 (54%), Gaps = 13/272 (4%)

Query: 339 NSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSH 398
           N  W+    +G G FG VY A ++ETG   A K + I     +S E ++    EI +LS 
Sbjct: 4   NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQI-----ESEEELEDFMVEIDILSE 58

Query: 399 LKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAY 458
            KHPNIV  Y +   E+K +I +E+   G+++  + E    +TE  +R   R +L  L +
Sbjct: 59  CKHPNIVGLYEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNF 118

Query: 459 LHSKKTIHRDIKGANLLVDASGVVKLADFGM-AKHL-TGQKADLSMKGSPYWMAPELMMA 516
           LHS K IHRD+K  N+L+   G VKLADFG+ AK+  T QK D +  G+PYWMAPE++  
Sbjct: 119 LHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRD-TFIGTPYWMAPEVVAC 177

Query: 517 VMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTP---AIPDSLS 573
              K    D     DIWSLG T+IE+   +PP  E      + K+++  P     P   S
Sbjct: 178 ETFKDNPYDY--KADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTLDQPSKWS 235

Query: 574 PEGKDFLRCCFQRNPADRPPASLLLEHRFLKN 605
               DFL+ C  ++P DRP A+ LL+H F+ +
Sbjct: 236 SSFNDFLKSCLVKDPDDRPTAAELLKHPFVSD 267

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score =  206 bits (526), Expect = 3e-61
 Identities = 100/284 (35%), Positives = 152/284 (53%), Gaps = 20/284 (7%)

Query: 340 SQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHL 399
           S +Q+ +LIGRG +G+VY   +  TG + A+K +++   D    + +  +++E+ +LS L
Sbjct: 1   SLYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPD----DDVSDIQREVALLSQL 56

Query: 400 KH---PNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGL 456
           +    PNI +YYGS +   + +I +EY   GS+   ++   G I E  +    R +L  L
Sbjct: 57  RQSQPPNITKYYGSYLKGPRLWIIMEYAEGGSVRTLMK--AGPIAEKYISVIIREVLVAL 114

Query: 457 AYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHL-TGQKADLSMKGSPYWMAPELMM 515
            Y+H    IHRDIK AN+LV  +G VKL DFG+A  L        +  G+PYWMAPE   
Sbjct: 115 KYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPE--- 171

Query: 516 AVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPA-IPD-SLS 573
            V+ +GK  D+    DIWSLG TI EM TG PP+S+ +   AM  + +  P  + D   S
Sbjct: 172 -VITEGKYYDT--KADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKPPRLEDNGYS 228

Query: 574 PEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQPDVPSCSLS 617
              ++F+  C    P +R  A  LL+ +++K       P   L 
Sbjct: 229 KLLREFVAACLDEEPKERLSAEELLKSKWIK--AHSKTPVSILK 270

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score =  198 bits (505), Expect = 4e-58
 Identities = 100/279 (35%), Positives = 148/279 (53%), Gaps = 28/279 (10%)

Query: 342 WQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHL-K 400
           ++  ++IG GT+G VY A +++TG L A+K +DI  D        +++++E  +L     
Sbjct: 8   FELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED------EEEEIKEEYNILRKYSN 61

Query: 401 HPNIVQYYG------SEIVEDKFYIYLEYVHPGSIN---KYVREHCGAITESVVRNFTRH 451
           HPNI  +YG          +D+ ++ +E    GS+    K +R+    + E  +    R 
Sbjct: 62  HPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRE 121

Query: 452 ILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHL--TGQKADLSMKGSPYWM 509
            L GLAYLH  K IHRDIKG N+L+  +  VKL DFG++  L  T  + +  + G+PYWM
Sbjct: 122 TLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFI-GTPYWM 180

Query: 510 APELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIP 569
           APE++    Q   S D+    D+WSLG T IE+  GKPP  +     A+FK+ R+ P  P
Sbjct: 181 APEVIACDEQPDASYDA--RSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNPP--P 236

Query: 570 DSLSPEG-----KDFLRCCFQRNPADRPPASLLLEHRFL 603
              SPE       DF+  C  +N   RP    LLEH F+
Sbjct: 237 TLKSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI 275

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score =  188 bits (479), Expect = 2e-54
 Identities = 106/278 (38%), Positives = 154/278 (55%), Gaps = 15/278 (5%)

Query: 339 NSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSH 398
           N  W+    +G G FG VY A N+ETGAL A K ++      KS E ++    EI++L+ 
Sbjct: 11  NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIET-----KSEEELEDYMVEIEILAT 65

Query: 399 LKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAY 458
             HP IV+  G+   + K +I +E+   G+++  + E    +TE  ++   R +L  L Y
Sbjct: 66  CNHPYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQY 125

Query: 459 LHSKKTIHRDIKGANLLVDASGVVKLADFGM-AKHL-TGQKADLSMKGSPYWMAPELMMA 516
           LHS K IHRD+K  N+L+   G +KLADFG+ AK++ T Q+ D S  G+PYWMAPE++M 
Sbjct: 126 LHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRD-SFIGTPYWMAPEVVMC 184

Query: 517 VMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTP---AIPDSLS 573
              K    D     DIWSLG T+IEM   +PP  E      + K+ +  P   + P   S
Sbjct: 185 ETMKDTPYD--YKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQPSKWS 242

Query: 574 PEGKDFLRCCFQRNPADRPPASLLLEHRFLK--NSQQP 609
            E +DFL+    ++P  RP A+ LLEH F+    S +P
Sbjct: 243 MEFRDFLKTALDKHPETRPSAAQLLEHPFVSSVTSNRP 280

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score =  186 bits (474), Expect = 4e-54
 Identities = 89/266 (33%), Positives = 142/266 (53%), Gaps = 28/266 (10%)

Query: 348 IGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQ----EIKVLSHLKHPN 403
           +G+G+FG V +   ++TG L AMK +       K     ++  +    E  +LS + HP 
Sbjct: 1   LGKGSFGKVLLVRKKDTGKLYAMKVLK------KKKIIKRKEVEHTLTERNILSRINHPF 54

Query: 404 IVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKK 463
           IV+ + +   E+K Y+ LEY   G +  ++ +  G  +E   R +   I+  L YLHS  
Sbjct: 55  IVKLHYAFQTEEKLYLVLEYAPGGELFSHLSKE-GRFSEERARFYAAEIVLALEYLHSLG 113

Query: 464 TIHRDIKGANLLVDASGVVKLADFGMAKHL--TGQKADLSMKGSPYWMAPELMMAVMQKG 521
            I+RD+K  N+L+DA G +KL DFG+AK L   G + + +  G+P ++APE+   ++ KG
Sbjct: 114 IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTN-TFCGTPEYLAPEV---LLGKG 169

Query: 522 KSSDSALAVDIWSLGCTIIEMYTGKPP-WSEYEGAAAMF-KVMRDTPAIPDSLSPEGKDF 579
                  AVD WSLG  + EM TGKPP ++E      ++ K+++D    P+ LSPE +D 
Sbjct: 170 YGK----AVDWWSLGVLLYEMLTGKPPFYAEDR--KEIYEKILKDPLRFPEFLSPEARDL 223

Query: 580 LRCCFQRNPADR---PPASLLLEHRF 602
           +    Q++P  R     A  +  H F
Sbjct: 224 ISGLLQKDPTKRLGSGGAEEIKAHPF 249

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  185 bits (472), Expect = 9e-54
 Identities = 77/259 (29%), Positives = 126/259 (48%), Gaps = 21/259 (8%)

Query: 343 QKGKLIGRGTFGSVYVA----SNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSH 398
             GK +G G FG VY         +     A+K +     +  S + I++  +E +++  
Sbjct: 2   TLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLK----EDASEQQIEEFLREARIMRK 57

Query: 399 LKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAY 458
           L HPN+V+  G    E+  YI +EY+  G +  Y+R++   ++ S + +F   I  G+ Y
Sbjct: 58  LDHPNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEY 117

Query: 459 LHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKG-SPY-WMAPELMMA 516
           L SK  IHRD+   N LV  + VVK++DFG+++ L          G  P  WMAPE    
Sbjct: 118 LESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPE---- 173

Query: 517 VMQKGK-SSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFKVMRD-TPAIPDSLS 573
            +++GK +S S    D+WS G  + E++T G+ P+        +  +        P +  
Sbjct: 174 SLKEGKFTSKS----DVWSFGVLLWEIFTLGEQPYPGMSNEEVLEYLKNGYRLPQPPNCP 229

Query: 574 PEGKDFLRCCFQRNPADRP 592
           PE  D +  C+  +P DRP
Sbjct: 230 PELYDLMLQCWAEDPEDRP 248

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score =  185 bits (472), Expect = 1e-53
 Identities = 89/265 (33%), Positives = 143/265 (53%), Gaps = 20/265 (7%)

Query: 348 IGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQY 407
           +G G  G V    +R TG + A+K + +   +   A   KQ+ +E+ +L     P IV +
Sbjct: 9   LGAGNSGVVSKVLHRPTGKIMAVKTIRL---EINEAI-QKQILRELDILHKCNSPYIVGF 64

Query: 408 YGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSK-KTIH 466
           YG+        I +EY+  GS++K ++E  G I E ++      +L GL YLH K K IH
Sbjct: 65  YGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIH 124

Query: 467 RDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPYWMAPELMMAVMQKGKSSDS 526
           RD+K +N+LV++ G +KL DFG++  L    A   +  S Y MAPE +       + +D 
Sbjct: 125 RDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKTFVGTSSY-MAPERI-------QGNDY 176

Query: 527 ALAVDIWSLGCTIIEMYTGK-PPWSEYEGAAAMFKVMR-----DTPAIP-DSLSPEGKDF 579
           ++  DIWSLG ++IE+ TG+ P   E +    +F++++       P +P    SP+ +DF
Sbjct: 177 SVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPSGKFSPDFQDF 236

Query: 580 LRCCFQRNPADRPPASLLLEHRFLK 604
           +  C  ++P +RP    LLEH F+K
Sbjct: 237 VNLCLIKDPRERPSYKELLEHPFIK 261

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score =  183 bits (466), Expect = 7e-53
 Identities = 89/268 (33%), Positives = 138/268 (51%), Gaps = 23/268 (8%)

Query: 348 IGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQY 407
           IG G    VY A         A+K +D+     K   S+ +L +E++ +S   HPN+V+Y
Sbjct: 9   IGVGATAVVYAAICLPNNEKVAIKRIDL----EKCQTSVDELRKEVQAMSQCNHPNVVKY 64

Query: 408 YGSEIVEDKFYIYLEYVHPGSINKYVRE--HCGAITESVVRNFTRHILSGLAYLHSKKTI 465
           Y S +V D+ ++ + Y+  GS+   ++     G + E+++    + +L GL YLHS   I
Sbjct: 65  YTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQI 124

Query: 466 HRDIKGANLLVDASGVVKLADFGMAKHL--TGQKADLSMK---GSPYWMAPELMMAVMQK 520
           HRDIK  N+L+   G VK+ADFG++  L   G +     K   G+P WMAPE    VM++
Sbjct: 125 HRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPE----VMEQ 180

Query: 521 GKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTP------AIPDSLSP 574
               D     DIWS G T IE+ TG  P+S+Y     +   +++ P      A     S 
Sbjct: 181 VHGYDF--KADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGADYKKYSK 238

Query: 575 EGKDFLRCCFQRNPADRPPASLLLEHRF 602
             +  +  C Q++P+ RP A  LL+H+F
Sbjct: 239 SFRKMISLCLQKDPSKRPTAEELLKHKF 266

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  181 bits (462), Expect = 3e-52
 Identities = 77/259 (29%), Positives = 125/259 (48%), Gaps = 22/259 (8%)

Query: 344 KGKLIGRGTFGSVYVA----SNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHL 399
            GK +G G FG VY               A+K +     +  S + I++  +E +++  L
Sbjct: 3   LGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLK----EDASEQQIEEFLREARIMRKL 58

Query: 400 KHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREH-CGAITESVVRNFTRHILSGLAY 458
            HPNIV+  G    E+   I +EY+  G +  Y+R++    ++ S + +F   I  G+ Y
Sbjct: 59  DHPNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEY 118

Query: 459 LHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKG-SPY-WMAPELMMA 516
           L SK  IHRD+   N LV  + VVK++DFG+++ L          G  P  WMAPE    
Sbjct: 119 LESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPE---- 174

Query: 517 VMQKGK-SSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFKVMR-DTPAIPDSLS 573
            +++GK +S S    D+WS G  + E++T G+ P+     A  +  + +      P +  
Sbjct: 175 SLKEGKFTSKS----DVWSFGVLLWEIFTLGEEPYPGMSNAEVLEYLKKGYRLPKPPNCP 230

Query: 574 PEGKDFLRCCFQRNPADRP 592
           PE    +  C+  +P DRP
Sbjct: 231 PELYKLMLQCWAEDPEDRP 249

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  178 bits (453), Expect = 4e-51
 Identities = 75/272 (27%), Positives = 123/272 (45%), Gaps = 30/272 (11%)

Query: 343 QKGKLIGRGTFGSVY----VASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSH 398
           + GK +G G FG VY          T    A+K +     +    E  ++  +E  ++  
Sbjct: 2   ELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASE----EEREEFLEEASIMKK 57

Query: 399 LKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAY 458
           L HPNIV+  G     +  YI  EY+  G +  ++R+H   +T   +      I  G+ Y
Sbjct: 58  LSHPNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEY 117

Query: 459 LHSKKTIHRDIKGANLLVDASGVVKLADFGMAK-------HLTGQKADLSMKGSPYWMAP 511
           L SK  +HRD+   N LV  + VVK++DFG+++       +       L +K    WMAP
Sbjct: 118 LESKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIK----WMAP 173

Query: 512 ELMMAVMQKGK-SSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFKVMRDT-PAI 568
           E     ++ GK +S S    D+WS G  + E++T G+ P+        +  +        
Sbjct: 174 E----SLKDGKFTSKS----DVWSFGVLLWEIFTLGEQPYPGMSNEEVLELLEDGYRLPR 225

Query: 569 PDSLSPEGKDFLRCCFQRNPADRPPASLLLEH 600
           P++   E  + +  C+  +P DRP  S L+E 
Sbjct: 226 PENCPDELYELMLQCWAYDPEDRPTFSELVED 257

Length = 258

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score =  178 bits (453), Expect = 1e-50
 Identities = 95/302 (31%), Positives = 150/302 (49%), Gaps = 62/302 (20%)

Query: 343 QKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDD---PKSAESIKQLEQEIKVLSHL 399
           +K + +G GT+G VY A +++TG + A+K++ +  ++   P +A  ++    EI +L  L
Sbjct: 2   EKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTA--LR----EISLLKEL 55

Query: 400 KHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYL 459
           KHPNIV+       E K Y+  EY     + KY+ +  G ++ +++++    +L GLAY 
Sbjct: 56  KHPNIVKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYC 114

Query: 460 HSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPY-------WM-AP 511
           HS + +HRD+K  N+L++  GV+KLADFG+A+          +    Y       W  AP
Sbjct: 115 HSHRILHRDLKPQNILINRDGVLKLADFGLAR-------AFGIPLRTYTHEVVTLWYRAP 167

Query: 512 ELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPW---SEYEGAAAMFKVMRDTP-- 566
           E+++       S   + AVDIWS+GC   EM TGKP +   SE +    +F+++  TP  
Sbjct: 168 EILL------GSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQIL-GTPTE 220

Query: 567 -------AIPD------------------SLSPEGKDFLRCCFQRNPADRPPASLLLEHR 601
                   +PD                   L PEG D L    Q NPA R  A   L+H 
Sbjct: 221 ESWPGVTKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHP 280

Query: 602 FL 603
           + 
Sbjct: 281 YF 282

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score =  176 bits (447), Expect = 3e-50
 Identities = 98/258 (37%), Positives = 147/258 (56%), Gaps = 15/258 (5%)

Query: 348 IGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQY 407
           IG+G+FG VY   +  T  + A+K +D+     ++ + I+ ++QEI VLS    P I +Y
Sbjct: 12  IGKGSFGEVYKGIDNRTKEVVAIKIIDL----EEAEDEIEDIQQEITVLSQCDSPYITRY 67

Query: 408 YGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHR 467
           YGS +   K +I +EY+  GS    ++   G + E+ +    R IL GL YLHS++ IHR
Sbjct: 68  YGSYLKGTKLWIIMEYLGGGSALDLLKP--GPLEETYIATILREILKGLDYLHSERKIHR 125

Query: 468 DIKGANLLVDASGVVKLADFGMAKHLTG-QKADLSMKGSPYWMAPELMMAVMQKGKSSDS 526
           DIK AN+L+   G VKLADFG+A  LT  Q    +  G+P+WMAPE++       K S  
Sbjct: 126 DIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVI-------KQSAY 178

Query: 527 ALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDT-PAIPDSLSPEGKDFLRCCFQ 585
               DIWSLG T IE+  G+PP S+      +F + +++ P +    S   K+F+  C  
Sbjct: 179 DFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPPTLEGQYSKPFKEFVEACLN 238

Query: 586 RNPADRPPASLLLEHRFL 603
           ++P  RP A  LL+H+F+
Sbjct: 239 KDPRFRPTAKELLKHKFI 256

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score =  176 bits (449), Expect = 6e-50
 Identities = 95/266 (35%), Positives = 148/266 (55%), Gaps = 12/266 (4%)

Query: 348 IGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQY 407
           IG G+FG+VY A +  T  + A+K++       +S E  + + +E++ L  L+HPN ++Y
Sbjct: 23  IGHGSFGAVYFARDVRTNEVVAIKKMSY--SGKQSNEKWQDIIKEVRFLQQLRHPNTIEY 80

Query: 408 YGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHR 467
            G  + E   ++ +EY   GS +  +  H   + E  +       L GLAYLHS + IHR
Sbjct: 81  KGCYLREHTAWLVMEYC-LGSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHR 139

Query: 468 DIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPYWMAPELMMAVMQKGKSSDSA 527
           DIK  N+L+   G VKLADFG A  ++      S  G+PYWMAPE+++A M +G+     
Sbjct: 140 DIKAGNILLTEPGTVKLADFGSASLVSPAN---SFVGTPYWMAPEVILA-MDEGQYDGK- 194

Query: 528 LAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMR-DTPAI-PDSLSPEGKDFLRCCFQ 585
             VD+WSLG T IE+   KPP       +A++ + + D+P +  +  S   ++F+  C Q
Sbjct: 195 --VDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLSSNDWSDYFRNFVDSCLQ 252

Query: 586 RNPADRPPASLLLEHRFLKNSQQPDV 611
           + P DRP +  LL+HRF+   + P V
Sbjct: 253 KIPQDRPSSEELLKHRFVLRERPPTV 278

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score =  175 bits (446), Expect = 6e-50
 Identities = 104/274 (37%), Positives = 148/274 (54%), Gaps = 14/274 (5%)

Query: 342 WQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKH 401
           W+    +G G FG VY A N+ETG L A K +D      KS E ++    EI +L+   H
Sbjct: 7   WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDT-----KSEEELEDYMVEIDILASCDH 61

Query: 402 PNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHS 461
           PNIV+   +   E+  +I +E+   G+++  + E    +TE  +R   +  L  L YLH 
Sbjct: 62  PNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHE 121

Query: 462 KKTIHRDIKGANLLVDASGVVKLADFGM-AKHL-TGQKADLSMKGSPYWMAPELMMAVMQ 519
            K IHRD+K  N+L    G +KLADFG+ AK+  T Q+ D S  G+PYWMAPE++M    
Sbjct: 122 NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRD-SFIGTPYWMAPEVVMCETS 180

Query: 520 KGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTP---AIPDSLSPEG 576
           K +  D     D+WSLG T+IEM   +PP  E      + K+ +  P   A P   S E 
Sbjct: 181 KDRPYD--YKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSEF 238

Query: 577 KDFLRCCFQRNPADRPPASLLLEHRFLK-NSQQP 609
           KDFL+ C ++N   R   + LL+H F+  NS +P
Sbjct: 239 KDFLKKCLEKNVDARWTTTQLLQHPFVTVNSNKP 272

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  174 bits (444), Expect = 1e-49
 Identities = 74/276 (26%), Positives = 122/276 (44%), Gaps = 37/276 (13%)

Query: 346 KLIGRGTFGSVYVA---SNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHP 402
           K +G G FG VY              A+K +     + +     K   +E +V+  L HP
Sbjct: 1   KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEE----RKDFLKEARVMKKLGHP 56

Query: 403 NIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHC--------GAITESVVRNFTRHILS 454
           N+V+  G    E+  Y+ LEY+  G +  Y+R+            ++   + +F   I  
Sbjct: 57  NVVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAK 116

Query: 455 GLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHL-------TGQKADLSMKGSPY 507
           G+ YL SKK +HRD+   N LV    VVK++DFG+++ +             L ++    
Sbjct: 117 GMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIR---- 172

Query: 508 WMAPELMMAVMQKGK-SSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFKVMRDT 565
           WMAPE     ++ G  +S S    D+WS G  + E++T G  P+        +  + +  
Sbjct: 173 WMAPE----SLKDGIFTSKS----DVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGY 224

Query: 566 -PAIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEH 600
               P+    E  + +  C+Q +P DRP  S L+E 
Sbjct: 225 RLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVER 260

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score =  174 bits (444), Expect = 2e-49
 Identities = 80/224 (35%), Positives = 125/224 (55%), Gaps = 21/224 (9%)

Query: 348 IGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQY 407
           IG GT+G VY A N++TG L A+K++    ++ K    I  +  EIK+L  L+HPNIV+ 
Sbjct: 7   IGEGTYGQVYKARNKKTGELVALKKIR--MENEKEGFPITAIR-EIKLLQKLRHPNIVRL 63

Query: 408 YGSEIVEDK----FYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKK 463
              EIV  K     Y+  EY+    +   +       TES ++ + + +L GL YLHS  
Sbjct: 64  K--EIVTSKGKGSIYMVFEYM-DHDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNG 120

Query: 464 TIHRDIKGANLLVDASGVVKLADFGMAKHLTG-QKADLSMKGSPYWM-APELMMAVMQKG 521
            +HRDIKG+N+L++  GV+KLADFG+A+  T    AD + +    W   PEL++      
Sbjct: 121 ILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWYRPPELLLG----- 175

Query: 522 KSSDSALAVDIWSLGCTIIEMYTGKPPW---SEYEGAAAMFKVM 562
            ++     VD+WS+GC + E++ GKP +   +E E    +F++ 
Sbjct: 176 -ATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELC 218

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score =  174 bits (441), Expect = 3e-49
 Identities = 100/264 (37%), Positives = 151/264 (57%), Gaps = 16/264 (6%)

Query: 348 IGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQY 407
           IG+G+FG V+   +  T  + A+K +D+     ++ + I+ ++QEI VLS    P + +Y
Sbjct: 12  IGKGSFGEVFKGIDNRTQQVVAIKIIDL----EEAEDEIEDIQQEITVLSQCDSPYVTKY 67

Query: 408 YGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHR 467
           YGS +   K +I +EY+  GS    +R   G   E  +    + IL GL YLHS+K IHR
Sbjct: 68  YGSYLKGTKLWIIMEYLGGGSALDLLR--AGPFDEFQIATMLKEILKGLDYLHSEKKIHR 125

Query: 468 DIKGANLLVDASGVVKLADFGMAKHLTG-QKADLSMKGSPYWMAPELMMAVMQKGKSSDS 526
           DIK AN+L+   G VKLADFG+A  LT  Q    +  G+P+WMAPE    V+Q+      
Sbjct: 126 DIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPE----VIQQSAYDSK 181

Query: 527 ALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMR-DTPAIPDSLSPEGKDFLRCCFQ 585
           A   DIWSLG T IE+  G+PP S+      +F + + + P +    S   K+F+  C  
Sbjct: 182 A---DIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNPPTLTGEFSKPFKEFIDACLN 238

Query: 586 RNPADRPPASLLLEHRFL-KNSQQ 608
           ++P+ RP A  LL+H+F+ KN+++
Sbjct: 239 KDPSFRPTAKELLKHKFIVKNAKK 262

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score =  173 bits (439), Expect = 6e-49
 Identities = 98/264 (37%), Positives = 153/264 (57%), Gaps = 16/264 (6%)

Query: 348 IGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQY 407
           IG+G+FG V+   +  T  + A+K +D+     ++ + I+ ++QEI VLS    P + +Y
Sbjct: 12  IGKGSFGEVFKGIDNRTQKVVAIKIIDL----EEAEDEIEDIQQEITVLSQCDSPYVTKY 67

Query: 408 YGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHR 467
           YGS + + K +I +EY+  GS    +    G + E+ +    R IL GL YLHS+K IHR
Sbjct: 68  YGSYLKDTKLWIIMEYLGGGSALDLLEP--GPLDETQIATILREILKGLDYLHSEKKIHR 125

Query: 468 DIKGANLLVDASGVVKLADFGMAKHLTGQKADLS-MKGSPYWMAPELMMAVMQKGKSSDS 526
           DIK AN+L+   G VKLADFG+A  LT  +   +   G+P+WMAPE++     K  + DS
Sbjct: 126 DIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVI-----KQSAYDS 180

Query: 527 ALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDT-PAIPDSLSPEGKDFLRCCFQ 585
               DIWSLG T IE+  G+PP SE      +F + ++  P +  + S   K+F+  C  
Sbjct: 181 --KADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACLN 238

Query: 586 RNPADRPPASLLLEHRF-LKNSQQ 608
           + P+ RP A  LL+H+F ++ +++
Sbjct: 239 KEPSFRPTAKELLKHKFIVRFAKK 262

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score =  170 bits (433), Expect = 3e-48
 Identities = 86/274 (31%), Positives = 122/274 (44%), Gaps = 30/274 (10%)

Query: 346 KLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIV 405
           + IG+G+FG+V     +  G +   KE+D      K  +   QL  E+ +L  LKHPNIV
Sbjct: 6   ETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQ---QLVSEVNILRELKHPNIV 62

Query: 406 QYYGSEIVEDK--FYIYLEYVHPGS----INKYVREHCGAITESVVRNFTRHILSGLAYL 459
           +YY   I       YI +EY   G     I K  +E    I E  +      +L  L   
Sbjct: 63  RYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKER-KYIEEEFIWRILTQLLLALYEC 121

Query: 460 H-----SKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMK----GSPYWMA 510
           H         +HRD+K AN+ +DA+  VKL DFG+AK L     D S      G+PY+M+
Sbjct: 122 HNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGH---DSSFAKTYVGTPYYMS 178

Query: 511 PELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMR-DTPAIP 569
           PE +  +    KS       DIWSLGC I E+    PP++         K+       IP
Sbjct: 179 PEQLNHMSYDEKS-------DIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKFRRIP 231

Query: 570 DSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFL 603
              S E  + ++     +P  RP    LL+   +
Sbjct: 232 YRYSSELNEVIKSMLNVDPDKRPSTEELLQLPLI 265

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score =  170 bits (432), Expect = 4e-48
 Identities = 101/261 (38%), Positives = 143/261 (54%), Gaps = 16/261 (6%)

Query: 348 IGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQY 407
           +G GT+G VY A N  TG L A+K + + P D  S      ++QEI ++   KH NIV Y
Sbjct: 17  VGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSL-----IQQEIFMVKECKHCNIVAY 71

Query: 408 YGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHR 467
           +GS +  +K +I +EY   GS+   +    G ++E  +    R  L GLAYLHSK  +HR
Sbjct: 72  FGSYLSREKLWICMEYCGGGSLQD-IYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHR 130

Query: 468 DIKGANLLVDASGVVKLADFGMAKHLTGQKADL-SMKGSPYWMAPELMMAVMQKGKSSDS 526
           DIKGAN+L+  +G VKLADFG+A  +T   A   S  G+PYWMAPE+  AV + G  +  
Sbjct: 131 DIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEV-AAVEKNGGYNQ- 188

Query: 527 ALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDT---PAIPDSL--SPEGKDFLR 581
               DIW++G T IE+   +PP  +     A+F + +     P + D    S    +F++
Sbjct: 189 --LCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKWSSTFHNFVK 246

Query: 582 CCFQRNPADRPPASLLLEHRF 602
               +NP  RP A  LL H F
Sbjct: 247 ISLTKNPKKRPTAERLLTHLF 267

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score =  170 bits (433), Expect = 5e-48
 Identities = 100/270 (37%), Positives = 145/270 (53%), Gaps = 18/270 (6%)

Query: 339 NSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSH 398
             ++ + + IG+G  G+VY A +  TG   A+K++++    PK    I     EI V+  
Sbjct: 18  KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNL-QQQPKKELII----NEILVMRE 72

Query: 399 LKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAY 458
            KHPNIV Y  S +V D+ ++ +EY+  GS+   V E C  + E  +    R  L  L +
Sbjct: 73  NKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC--MDEGQIAAVCRECLQALEF 130

Query: 459 LHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLS-MKGSPYWMAPELMMAV 517
           LHS + IHRDIK  N+L+   G VKL DFG    +T +++  S M G+PYWMAPE+   V
Sbjct: 131 LHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEV---V 187

Query: 518 MQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRD-TPAI--PDSLSP 574
            +K         VDIWSLG   IEM  G+PP+       A++ +  + TP +  P+ LS 
Sbjct: 188 TRKAYGPK----VDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSA 243

Query: 575 EGKDFLRCCFQRNPADRPPASLLLEHRFLK 604
             +DFL  C + +   R  A  LL+H FLK
Sbjct: 244 IFRDFLNRCLEMDVEKRGSAKELLQHPFLK 273

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score =  169 bits (428), Expect = 1e-47
 Identities = 101/261 (38%), Positives = 145/261 (55%), Gaps = 16/261 (6%)

Query: 348 IGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQY 407
           IG GT+G VY A N  TG L A+K + + P      E    ++QEI ++   KH NIV Y
Sbjct: 17  IGSGTYGDVYKARNVNTGELAAIKVIKLEP-----GEDFAVVQQEIIMMKDCKHSNIVAY 71

Query: 408 YGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHR 467
           +GS +  DK +I +E+   GS+   +    G ++ES +   +R  L GL YLHSK  +HR
Sbjct: 72  FGSYLRRDKLWICMEFCGGGSLQD-IYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHR 130

Query: 468 DIKGANLLVDASGVVKLADFGMAKHLTGQKADL-SMKGSPYWMAPELMMAVMQKGKSSDS 526
           DIKGAN+L+  +G VKLADFG++  +T   A   S  G+PYWMAPE+  AV +KG  +  
Sbjct: 131 DIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEV-AAVERKGGYNQ- 188

Query: 527 ALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDT---PAIPDSL--SPEGKDFLR 581
               DIW++G T IE+   +PP  +     A+F + +     P + D +  S     F++
Sbjct: 189 --LCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWSNSFHHFVK 246

Query: 582 CCFQRNPADRPPASLLLEHRF 602
               +NP  RP A  LL+H F
Sbjct: 247 MALTKNPKKRPTAEKLLQHPF 267

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score =  167 bits (424), Expect = 8e-47
 Identities = 86/269 (31%), Positives = 140/269 (52%), Gaps = 20/269 (7%)

Query: 348 IGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQY 407
           IG G+ G V +A+++ TG   A+K++D+     +  +  + L  E+ ++   +HPNIV+ 
Sbjct: 27  IGEGSTGIVCIATDKSTGRQVAVKKMDL-----RKQQRRELLFNEVVIMRDYQHPNIVEM 81

Query: 408 YGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHR 467
           Y S +V D+ ++ +E++  G++   V      + E  +      +L  L++LH++  IHR
Sbjct: 82  YSSYLVGDELWVVMEFLEGGALTDIVTH--TRMNEEQIATVCLAVLKALSFLHAQGVIHR 139

Query: 468 DIKGANLLVDASGVVKLADFGMAKHLTGQ-KADLSMKGSPYWMAPELMMAVMQKGKSSDS 526
           DIK  ++L+ + G VKL+DFG    ++ +     S+ G+PYWMAPE++            
Sbjct: 140 DIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPEVI-------SRLPY 192

Query: 527 ALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAI----PDSLSPEGKDFLRC 582
              VDIWSLG  +IEM  G+PP+       AM K +RD           +SP  + FL  
Sbjct: 193 GTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAM-KRIRDNLPPKLKNLHKVSPRLRSFLDR 251

Query: 583 CFQRNPADRPPASLLLEHRFLKNSQQPDV 611
              R+PA R  A+ LL H FL  +  P  
Sbjct: 252 MLVRDPAQRATAAELLNHPFLAKAGPPSS 280

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score =  165 bits (420), Expect = 1e-46
 Identities = 83/255 (32%), Positives = 130/255 (50%), Gaps = 15/255 (5%)

Query: 348 IGRGTFGSVYVASNRETGALCAMKEVDIFPDDPK-SAESIKQLEQEIKVLSHLKHPNIVQ 406
           IG+G+FG V+    +    + AMK++D+   + +   E+I     E +VL+ L    I++
Sbjct: 8   IGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAID----EARVLAKLDSSYIIR 63

Query: 407 YYGSEIVEDKFYIYLEYVHPGSINKYVREHCGA-ITESVVRNFTRHILSGLAYLHSKKTI 465
           YY S + + K  I +EY   G ++K ++   G  + E  V  F   IL GLA+LHSKK +
Sbjct: 64  YYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKIL 123

Query: 466 HRDIKGANLLVDASGVVKLADFGMAKHLTGQKA-DLSMKGSPYWMAPELMMAVMQKGKSS 524
           HRDIK  NL +DA   VK+ D G+AK L+       ++ G+PY+++PEL        KS 
Sbjct: 124 HRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPELCEDKPYNEKS- 182

Query: 525 DSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDT-PAIPDSLSPEGKDFLRCC 583
                 D+W+LG  + E  TGK P+      A + K++R   P +    S +    +  C
Sbjct: 183 ------DVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPVSQMYSQQLAQLIDQC 236

Query: 584 FQRNPADRPPASLLL 598
             ++   RP    LL
Sbjct: 237 LTKDYRQRPDTFQLL 251

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score =  162 bits (410), Expect = 1e-44
 Identities = 94/266 (35%), Positives = 146/266 (54%), Gaps = 12/266 (4%)

Query: 348 IGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQY 407
           IG G+FG+VY A+N  T  + A+K++       ++ E  + + +E+K L  LKHPN ++Y
Sbjct: 29  IGHGSFGAVYFATNSHTNEVVAVKKMSY--SGKQTNEKWQDIIKEVKFLQQLKHPNTIEY 86

Query: 408 YGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHR 467
            G  + E   ++ +EY   GS +  +  H   + E  +   T   L GLAYLHS   IHR
Sbjct: 87  KGCYLKEHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHR 145

Query: 468 DIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPYWMAPELMMAVMQKGKSSDSA 527
           DIK  N+L+   G VKLADFG A   +      S  G+PYWMAPE+++A M +G+     
Sbjct: 146 DIKAGNILLTEPGQVKLADFGSASKSSPAN---SFVGTPYWMAPEVILA-MDEGQYDGK- 200

Query: 528 LAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMR-DTPAI-PDSLSPEGKDFLRCCFQ 585
             VD+WSLG T IE+   KPP       +A++ + + D+P +  +  +   + F+  C Q
Sbjct: 201 --VDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNEWTDSFRGFVDYCLQ 258

Query: 586 RNPADRPPASLLLEHRFLKNSQQPDV 611
           + P +RP ++ LL H F++  +   V
Sbjct: 259 KIPQERPASAELLRHDFVRRDRPARV 284

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score =  160 bits (407), Expect = 2e-44
 Identities = 91/272 (33%), Positives = 144/272 (52%), Gaps = 15/272 (5%)

Query: 348 IGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQY 407
           +G+G +GSVY   +R TG   AMKE+ +  D+ K  + I +L+    +L     P IV +
Sbjct: 9   LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELD----ILHKAVSPYIVDF 64

Query: 408 YGSEIVEDKFYIYLEYVHPGSINKYVRE--HCGAITESVVRNFTRHILSGLAYLHSK-KT 464
           YG+  +E   Y+ +EY+  GS++K          I E V+R  T  ++ GL +L  +   
Sbjct: 65  YGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNI 124

Query: 465 IHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPYWMAPELMMAVMQKGKSS 524
           IHRD+K  N+LV+ +G VKL DFG++ +L    A  ++ G   +MAPE + +       +
Sbjct: 125 IHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTNI-GCQSYMAPERIKSGGPNQNPT 183

Query: 525 DSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFK-----VMRDTPAIPDSLSPEGKDF 579
            +  + D+WSLG +I+EM  G+ P+   E  A +F      V  D P +P   S + +DF
Sbjct: 184 YTVQS-DVWSLGLSILEMALGRYPYPP-ETYANIFAQLSAIVDGDPPTLPSGYSDDAQDF 241

Query: 580 LRCCFQRNPADRPPASLLLEHRFLKNSQQPDV 611
           +  C  + P  RP  + LLEH +L   +  DV
Sbjct: 242 VAKCLNKIPNRRPTYAQLLEHPWLVKYKNADV 273

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score =  162 bits (411), Expect = 3e-44
 Identities = 102/310 (32%), Positives = 162/310 (52%), Gaps = 18/310 (5%)

Query: 310 PLPLPPGAAVLSPSATIPQVAAKPEPLPMNSQWQKGKLIGRGTFGSVYVASNRETGALCA 369
           PLPLPP ++  S S++     + P      S+ ++   IG G  G+VY   +R TG L A
Sbjct: 44  PLPLPPPSSSSSSSSSSSASGSAPSAAKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYA 103

Query: 370 MKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSI 429
           +K +    +D       +Q+ +EI++L  + HPN+V+ +       +  + LE++  GS+
Sbjct: 104 LKVIYGNHED----TVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSL 159

Query: 430 NKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGM 489
                E      E  + +  R ILSG+AYLH +  +HRDIK +NLL++++  VK+ADFG+
Sbjct: 160 -----EGTHIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGV 214

Query: 490 AKHLTGQKADL--SMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKP 547
           ++ L  Q  D   S  G+  +M+PE +   +  G       A DIWSLG +I+E Y G+ 
Sbjct: 215 SRIL-AQTMDPCNSSVGTIAYMSPERINTDLNHGAY--DGYAGDIWSLGVSILEFYLGRF 271

Query: 548 PWS---EYEGAAAMFKV-MRDTPAIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFL 603
           P+    + + A+ M  + M   P  P + S E + F+ CC QR PA R  A  LL+H F+
Sbjct: 272 PFGVGRQGDWASLMCAICMSQPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQHPFI 331

Query: 604 KNSQQPDVPS 613
             +Q      
Sbjct: 332 LRAQPGQGQG 341

Length = 353

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score =  160 bits (406), Expect = 4e-44
 Identities = 97/303 (32%), Positives = 144/303 (47%), Gaps = 69/303 (22%)

Query: 346 KLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQ-----EIKVLSHLK 400
           K +G GTFGSVY+A N+ETG L A+K         K  +     E+     E+K L  L 
Sbjct: 5   KQLGDGTFGSVYLARNKETGELVAIK---------KMKKKFYSWEECMNLREVKSLRKLN 55

Query: 401 -HPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCG-AITESVVRNFTRHILSGLAY 458
            HPNIV+        D+ Y   EY+  G++ + +++  G   +ESV+R+    IL GLA+
Sbjct: 56  EHPNIVKLKEVFRENDELYFVFEYME-GNLYQLMKDRKGKPFSESVIRSIIYQILQGLAH 114

Query: 459 LHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPY-------WM-A 510
           +H     HRD+K  NLLV    VVK+ADFG+A+ +       S    PY       W  A
Sbjct: 115 IHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREI------RSRP--PYTDYVSTRWYRA 166

Query: 511 PELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKP----------------------- 547
           PE+++      +S+  +  VDIW+LGC + E+YT +P                       
Sbjct: 167 PEILL------RSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTK 220

Query: 548 -PWSE-YEGAAAM-FKVMRDTPAIPDSL----SPEGKDFLRCCFQRNPADRPPASLLLEH 600
             W E Y+ A+ + F+  +  P     L    SPE  D ++   + +P  RP AS  L+H
Sbjct: 221 QDWPEGYKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH 280

Query: 601 RFL 603
            + 
Sbjct: 281 PYF 283

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  161 bits (408), Expect = 1e-43
 Identities = 99/386 (25%), Positives = 171/386 (44%), Gaps = 33/386 (8%)

Query: 342 WQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKH 401
           ++  + +G G+FG VY+A +R+     A+K +         ++ +++  +EI++L+ L H
Sbjct: 2   YRILRKLGEGSFGEVYLARDRKL---VALKVLA--KKLESKSKEVERFLREIQILASLNH 56

Query: 402 P-NIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREH--CGAITESVVRNFTRHILSGLAY 458
           P NIV+ Y     E   Y+ +EYV  GS+   +++    G ++ES        ILS L Y
Sbjct: 57  PPNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEY 116

Query: 459 LHSKKTIHRDIKGANLLVDASG-VVKLADFGMAKHLTGQKADL-------SMKGSPYWMA 510
           LHSK  IHRDIK  N+L+D  G VVKL DFG+AK L    +         +  G+P +MA
Sbjct: 117 LHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMA 176

Query: 511 PELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMR------- 563
           PE    V+     + ++ + DIWSLG T+ E+ TG PP+   + ++A  + ++       
Sbjct: 177 PE----VLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPT 232

Query: 564 ------DTPAIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQPDVPSCSLS 617
                  +P+ P+ +S    D L+    ++P +R  +S  L H  L + +  +     L 
Sbjct: 233 PSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLKLKESDLSDLL 292

Query: 618 FSGMQLTEKPHSPREKADAKYDQVAALSSSRSSRKATLESENGRRSHLETSDLTVASTCS 677
                   +   P           +   S    +            +  +S    +S+  
Sbjct: 293 KPDDSAPLRLSLPPSLEALISSLNSLAISGSDLKLDDSNFSKELAPNGVSSSPHNSSSLL 352

Query: 678 PRSTLEALPCLSPLHSGPSTRHSSAS 703
             +       L  + +  S    S+S
Sbjct: 353 LSTASSKRSSLPKISARSSPSSLSSS 378

Length = 384

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score =  159 bits (403), Expect = 1e-43
 Identities = 90/262 (34%), Positives = 141/262 (53%), Gaps = 12/262 (4%)

Query: 348 IGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQY 407
           IG G+FG+VY A +     + A+K++       +S E  + + +E++ L  L+HPN +QY
Sbjct: 23  IGHGSFGAVYFARDVRNSEVVAIKKMSY--SGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 80

Query: 408 YGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHR 467
            G  + E   ++ +EY   GS +  +  H   + E  +   T   L GLAYLHS   IHR
Sbjct: 81  RGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHR 139

Query: 468 DIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPYWMAPELMMAVMQKGKSSDSA 527
           D+K  N+L+   G+VKL DFG A  +          G+PYWMAPE+++A M +G+     
Sbjct: 140 DVKAGNILLSEPGLVKLGDFGSASIMAPAN---XFVGTPYWMAPEVILA-MDEGQYDGK- 194

Query: 528 LAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDS--LSPEGKDFLRCCFQ 585
             VD+WSLG T IE+   KPP       +A++ + ++      S   S   ++F+  C Q
Sbjct: 195 --VDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQ 252

Query: 586 RNPADRPPASLLLEHRFLKNSQ 607
           + P DRP + +LL+HRF+   +
Sbjct: 253 KIPQDRPTSEVLLKHRFVLRER 274

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score =  158 bits (401), Expect = 1e-43
 Identities = 95/284 (33%), Positives = 151/284 (53%), Gaps = 24/284 (8%)

Query: 333 PEPLPMNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQE 392
           P+P   +  W+  + IG+GT+G V+   N++ G+  A+K +D   D  +      ++E E
Sbjct: 14  PDP---SDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDE------EIEAE 64

Query: 393 IKVLSHLK-HPNIVQYYG-----SEIVEDKFYIYLEYVHPGSINKYVR---EHCGAITES 443
             +L  L  HPN+V++YG          D+ ++ LE  + GS+   V+   +    + E 
Sbjct: 65  YNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEP 124

Query: 444 VVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMK 503
           ++       L GL +LH  KTIHRD+KG N+L+   G VKL DFG++  LT  +   +  
Sbjct: 125 IIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTS 184

Query: 504 -GSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVM 562
            G+P+WMAPE++    Q   + D+    D+WSLG T IE+  G PP ++     A+FK+ 
Sbjct: 185 VGTPFWMAPEVIACEQQLDSTYDA--RCDVWSLGITAIELGDGDPPLADLHPMRALFKIP 242

Query: 563 RDTPAI---PDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFL 603
           R+ P     P+  S E  DF+R C  ++   RP  S LL+H F+
Sbjct: 243 RNPPPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score =  157 bits (400), Expect = 2e-43
 Identities = 89/276 (32%), Positives = 142/276 (51%), Gaps = 29/276 (10%)

Query: 348 IGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQY 407
           +G G  GSV     + TG + A+K +   P+     +  KQ+ +E+++    K P IV+Y
Sbjct: 9   LGEGAGGSVTKCRLKNTGMIFALKTITTDPNP----DLQKQILRELEINKSCKSPYIVKY 64

Query: 408 YGSEIVE--DKFYIYLEYVHPGS---INKYVREHCGAITESVVRNFTRHILSGLAYLHSK 462
           YG+ + E      I +EY   GS   I K V++  G I E V+      +L GL+YLHS+
Sbjct: 65  YGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR 124

Query: 463 KTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPYWMAPELMMAVMQKGK 522
           K IHRDIK +N+L+   G VKL DFG++  L       +  G+ ++MAPE +     +GK
Sbjct: 125 KIIHRDIKPSNILLTRKGQVKLCDFGVSGEL-VNSLAGTFTGTSFYMAPERI-----QGK 178

Query: 523 SSDSALAVDIWSLGCTIIEMYTGKPPW-SEYEGAAAMFKV-----------MRDTPAIPD 570
               ++  D+WSLG T++E+   + P+  E E      ++           ++D P    
Sbjct: 179 P--YSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPGNGI 236

Query: 571 SLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNS 606
             S E KDF++ C +++P  RP    +LEH ++K  
Sbjct: 237 KWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQ 272

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score =  157 bits (400), Expect = 3e-43
 Identities = 83/297 (27%), Positives = 132/297 (44%), Gaps = 56/297 (18%)

Query: 347 LIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQ 406
           ++G G +G V    N+ TG + A+K+     DD    ++  +   E+KVL  L+H NIV 
Sbjct: 8   VVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALR---EVKVLRQLRHENIVN 64

Query: 407 YYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIH 466
              +   + + Y+  EYV   ++ + +    G +    VR++   +L  +AY HS   IH
Sbjct: 65  LKEAFRRKGRLYLVFEYV-ERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIH 123

Query: 467 RDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPY-------WM-APELMMAVM 518
           RDIK  N+LV  SGV+KL DFG A+ L  + A      SP        W  APEL++   
Sbjct: 124 RDIKPENILVSESGVLKLCDFGFARALRARPA------SPLTDYVATRWYRAPELLVGDT 177

Query: 519 QKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMR--------------- 563
             GK       VD+W++GC + E+  G+P +        ++ + +               
Sbjct: 178 NYGK------PVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSS 231

Query: 564 -------DTPAI--PDSL--------SPEGKDFLRCCFQRNPADRPPASLLLEHRFL 603
                    P    P+SL        S    DFL+ C + +P +R     LL+H + 
Sbjct: 232 NPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score =  157 bits (399), Expect = 3e-43
 Identities = 95/278 (34%), Positives = 151/278 (54%), Gaps = 25/278 (8%)

Query: 342 WQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHL-K 400
           W+  + IG+GT+G VY  +N++ G+L A+K +D   D  +      ++E E  +L  L  
Sbjct: 24  WEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDE------EIEAEYNILQSLPN 77

Query: 401 HPNIVQYYG-----SEIVEDKFYIYLEYVHPGSINKYVRE--HCGA-ITESVVRNFTRHI 452
           HPN+V++YG      ++V  + ++ LE  + GS+ + V+    CG  + E+++       
Sbjct: 78  HPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGA 137

Query: 453 LSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMK-GSPYWMAP 511
           L GL +LH+ + IHRD+KG N+L+   G VKL DFG++  LT  +   +   G+P+WMAP
Sbjct: 138 LLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAP 197

Query: 512 ELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDS 571
           E++    Q   S D+    D+WSLG T IE+  G PP  +      +FK+ R+ P  P  
Sbjct: 198 EVIACEQQYDYSYDA--RCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNPP--PTL 253

Query: 572 LSPEG-----KDFLRCCFQRNPADRPPASLLLEHRFLK 604
           L PE        F+  C  ++   RP  + LLEH F+K
Sbjct: 254 LHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK 291

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score =  156 bits (395), Expect = 1e-42
 Identities = 97/268 (36%), Positives = 147/268 (54%), Gaps = 18/268 (6%)

Query: 341 QWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLK 400
           ++ + + IG+G  G+V+ A +  TG   A+K++++    PK    I     EI V+  LK
Sbjct: 20  KYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINL-QKQPKKELII----NEILVMKELK 74

Query: 401 HPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLH 460
           +PNIV +  S +V D+ ++ +EY+  GS+   V E C  + E+ +    R  L  L +LH
Sbjct: 75  NPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTETC--MDEAQIAAVCRECLQALEFLH 132

Query: 461 SKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLS-MKGSPYWMAPELMMAVMQ 519
           + + IHRDIK  N+L+   G VKL DFG    +T +++  S M G+PYWMAPE++     
Sbjct: 133 ANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAY 192

Query: 520 KGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRD-TPAI--PDSLSPEG 576
             K       VDIWSLG   IEM  G+PP+       A++ +  + TP +  P+ LSP  
Sbjct: 193 GPK-------VDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSPIF 245

Query: 577 KDFLRCCFQRNPADRPPASLLLEHRFLK 604
           +DFL  C + +   R  A  LL+H FLK
Sbjct: 246 RDFLNRCLEMDVEKRGSAKELLQHPFLK 273

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score =  153 bits (388), Expect = 8e-42
 Identities = 97/270 (35%), Positives = 142/270 (52%), Gaps = 21/270 (7%)

Query: 346 KLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIV 405
           +++G GT+G VY   + +TG L A+K +D+  D+    E IK     +K  SH  H NI 
Sbjct: 22  EVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDE---EEEIKLEINMLKKYSH--HRNIA 76

Query: 406 QYYGSEIV------EDKFYIYLEYVHPGSINKYVREHCG-AITESVVRNFTRHILSGLAY 458
            YYG+ I       +D+ ++ +E+   GS+   V+   G A+ E  +    R IL GLA+
Sbjct: 77  TYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAH 136

Query: 459 LHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHL---TGQKADLSMKGSPYWMAPELMM 515
           LH+ K IHRDIKG N+L+  +  VKL DFG++  L    G++   +  G+PYWMAPE++ 
Sbjct: 137 LHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRN--TFIGTPYWMAPEVIA 194

Query: 516 AVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDSLSPE 575
               +   +      DIWSLG T IEM  G PP  +     A+F + R+ P    S    
Sbjct: 195 C--DENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKLKSKKWS 252

Query: 576 GK--DFLRCCFQRNPADRPPASLLLEHRFL 603
            K  DF+  C  +N   RP    LL+H F+
Sbjct: 253 KKFIDFIEGCLVKNYLSRPSTEQLLKHPFI 282

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score =  154 bits (390), Expect = 9e-42
 Identities = 95/260 (36%), Positives = 140/260 (53%), Gaps = 16/260 (6%)

Query: 348 IGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQY 407
           IG G+FG+VY A +  T  + A+K++       +S E  + + +E+K L  +KHPN ++Y
Sbjct: 33  IGHGSFGAVYFARDVRTNEVVAIKKMSY--SGKQSNEKWQDIIKEVKFLQRIKHPNSIEY 90

Query: 408 YGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHR 467
            G  + E   ++ +EY   GS +  +  H   + E  +   T   L GLAYLHS   IHR
Sbjct: 91  KGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHR 149

Query: 468 DIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPYWMAPELMMAVMQKGKSSDSA 527
           DIK  N+L+   G VKLADFG A   +      S  G+PYWMAPE+++A M +G+     
Sbjct: 150 DIKAGNILLTEPGQVKLADFGSASIASPAN---SFVGTPYWMAPEVILA-MDEGQYDGK- 204

Query: 528 LAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDSLSPEGKDFLR----CC 583
             VD+WSLG T IE+   KPP       +A++ + ++    P   S E  D+ R     C
Sbjct: 205 --VDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNES--PTLQSNEWSDYFRNFVDSC 260

Query: 584 FQRNPADRPPASLLLEHRFL 603
            Q+ P DRP +  LL+H F+
Sbjct: 261 LQKIPQDRPTSEELLKHMFV 280

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score =  153 bits (388), Expect = 1e-41
 Identities = 97/268 (36%), Positives = 144/268 (53%), Gaps = 18/268 (6%)

Query: 341 QWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLK 400
           ++ + + IG+G  G+VY A +  TG   A++++++    PK    I     EI V+   K
Sbjct: 21  KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNL-QQQPKKELII----NEILVMRENK 75

Query: 401 HPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLH 460
           +PNIV Y  S +V D+ ++ +EY+  GS+   V E C  + E  +    R  L  L +LH
Sbjct: 76  NPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC--MDEGQIAAVCRECLQALEFLH 133

Query: 461 SKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLS-MKGSPYWMAPELMMAVMQ 519
           S + IHRDIK  N+L+   G VKL DFG    +T +++  S M G+PYWMAPE++     
Sbjct: 134 SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAY 193

Query: 520 KGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRD-TPAI--PDSLSPEG 576
             K       VDIWSLG   IEM  G+PP+       A++ +  + TP +  P+ LS   
Sbjct: 194 GPK-------VDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIF 246

Query: 577 KDFLRCCFQRNPADRPPASLLLEHRFLK 604
           +DFL  C   +   R  A  LL+H+FLK
Sbjct: 247 RDFLNRCLDMDVEKRGSAKELLQHQFLK 274

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score =  152 bits (385), Expect = 1e-41
 Identities = 76/249 (30%), Positives = 117/249 (46%), Gaps = 17/249 (6%)

Query: 348 IGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQY 407
           IG+G FG V +   R+T  + AMK   +         S++ +  E ++L  L HP +V  
Sbjct: 8   IGKGAFGKVCIVQKRDTKKMFAMKY--MNKQKCVEKGSVRNVLNERRILQELNHPFLVNL 65

Query: 408 YGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHR 467
           + S   E+  Y+ ++ +  G + +Y        +E  V+ +   I+  L YLHSK  IHR
Sbjct: 66  WYSFQDEENMYLVVDLLLGGDL-RYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHR 124

Query: 468 DIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPYWMAPELMMAVMQKGKSSDSA 527
           DIK  N+L+D  G V + DF +A  +T      S  G+P +MAPE++     +G S    
Sbjct: 125 DIKPDNILLDEQGHVHITDFNIATKVTPDTLTTSTSGTPGYMAPEVLCR---QGYSV--- 178

Query: 528 LAVDIWSLGCTIIEMYTGKPPW-----SEYEGAAAMFKVMRDTPAIPDSLSPEGKDFLRC 582
            AVD WSLG T  E   GK P+     +  +   A  +        P + S E  D +  
Sbjct: 179 -AVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQE--TADVLYPATWSTEAIDAINK 235

Query: 583 CFQRNPADR 591
             +R+P  R
Sbjct: 236 LLERDPQKR 244

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score =  151 bits (383), Expect = 5e-41
 Identities = 98/268 (36%), Positives = 144/268 (53%), Gaps = 18/268 (6%)

Query: 341 QWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLK 400
           ++ + + IG+G  G+VY A +  TG   A+K++++    PK    I     EI V+   K
Sbjct: 20  KYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNL-QQQPKKELII----NEILVMRENK 74

Query: 401 HPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLH 460
           +PNIV Y  S +V D+ ++ +EY+  GS+   V E C  + E  +    R  L  L +LH
Sbjct: 75  NPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC--MDEGQIAAVCRECLQALDFLH 132

Query: 461 SKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLS-MKGSPYWMAPELMMAVMQ 519
           S + IHRDIK  N+L+   G VKL DFG    +T +++  S M G+PYWMAPE++     
Sbjct: 133 SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAY 192

Query: 520 KGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRD-TPAI--PDSLSPEG 576
             K       VDIWSLG   IEM  G+PP+       A++ +  + TP +  P+ LS   
Sbjct: 193 GPK-------VDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLSAVF 245

Query: 577 KDFLRCCFQRNPADRPPASLLLEHRFLK 604
           +DFL  C + +   R  A  LL+H FLK
Sbjct: 246 RDFLNRCLEMDVDRRGSAKELLQHPFLK 273

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score =  150 bits (381), Expect = 5e-41
 Identities = 87/265 (32%), Positives = 137/265 (51%), Gaps = 23/265 (8%)

Query: 346 KLIGRGTFGSVYVASNRETGALCAMKEVDIFP-DDPKSAESIKQLEQEIKVLSHLKHPNI 404
           K IG+G F  VY A     G + A+K+V IF   D K+ +      +EI +L  L HPN+
Sbjct: 8   KKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQ---DCLKEIDLLKQLDHPNV 64

Query: 405 VQYYGSEIVEDKFYIYLEYVHPGSIN---KYVREHCGAITESVVRNFTRHILSGLAYLHS 461
           ++Y  S I  ++  I LE    G ++   K+ ++    I E  +  +   + S L ++HS
Sbjct: 65  IKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHS 124

Query: 462 KKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQK-ADLSMKGSPYWMAPELMMAVMQK 520
           K+ +HRDIK AN+ + A+GVVKL D G+ +  + +  A  S+ G+PY+M+PE +      
Sbjct: 125 KRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYN 184

Query: 521 GKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMR-----DTPAIP-DSLSP 574
            KS       DIWSLGC + EM   + P+  Y     ++ + +     D P +P D  S 
Sbjct: 185 FKS-------DIWSLGCLLYEMAALQSPF--YGDKMNLYSLCKKIEKCDYPPLPADHYSE 235

Query: 575 EGKDFLRCCFQRNPADRPPASLLLE 599
           E +D +  C   +P  RP  S +L+
Sbjct: 236 ELRDLVSRCINPDPEKRPDISYVLQ 260

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score =  150 bits (381), Expect = 5e-41
 Identities = 79/257 (30%), Positives = 127/257 (49%), Gaps = 32/257 (12%)

Query: 348 IGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEI----KVLSHLKHPN 403
           +G G FG V +   +      A+K V       K        ++ I    ++L    HP 
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCV------KKRHIVETGQQEHIFSEKEILEECNHPF 54

Query: 404 IVQYYGSEIVEDKFYIY--LEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHS 461
           IV+ Y +   +DK YIY  +EY   G +   +R+  G   E   R +   ++    YLH+
Sbjct: 55  IVKLYRT--FKDKKYIYMLMEYCLGGELWTILRDR-GLFDEYTARFYIACVVLAFEYLHN 111

Query: 462 KKTIHRDIKGANLLVDASGVVKLADFGMAKHL-TGQKADLSMKGSPYWMAPELMMAVMQK 520
           +  I+RD+K  NLL+D++G VKL DFG AK L +GQK   +  G+P ++APE+   ++ K
Sbjct: 112 RGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKT-WTFCGTPEYVAPEI---ILNK 167

Query: 521 GKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRD----TPAI--PDSLSP 574
           G       +VD WSLG  + E+ TG+PP+ E +      ++  D       +  P+ +  
Sbjct: 168 GYD----FSVDYWSLGILLYELLTGRPPFGEDDEDP--MEIYNDILKGNGKLEFPNYIDK 221

Query: 575 EGKDFLRCCFQRNPADR 591
             KD ++   +RNP +R
Sbjct: 222 AAKDLIKQLLRRNPEER 238

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score =  149 bits (379), Expect = 6e-41
 Identities = 86/264 (32%), Positives = 133/264 (50%), Gaps = 25/264 (9%)

Query: 346 KLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQ-----EIKVLSHLK 400
           K +G+G++GSVY           A+KEVD+         S+ Q E+     EI++L+ + 
Sbjct: 6   KKLGKGSYGSVYKVKRLSDNQFYALKEVDL--------GSMSQKEREDAVNEIRILASVN 57

Query: 401 HPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGA---ITESVVRNFTRHILSGLA 457
           HPNI+ Y  + +  +K  I +EY   G ++K + +       I E  +      +L GL 
Sbjct: 58  HPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQ 117

Query: 458 YLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPYWMAPELMMAV 517
            LH +K +HRD+K AN+L+ A+ +VK+ D G++K L    A   + G+P++MAPE+    
Sbjct: 118 ALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKTQI-GTPHYMAPEVW--- 173

Query: 518 MQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDT-PAIPDSLSPEG 576
             KG+        DIWSLGC + EM T  PP+         +KV R   P IP   S + 
Sbjct: 174 --KGRPYSY--KSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPPIPPIYSQDL 229

Query: 577 KDFLRCCFQRNPADRPPASLLLEH 600
           ++F+R   Q  P  RP    +L  
Sbjct: 230 QNFIRSMLQVKPKLRPNCDKILAS 253

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score =  149 bits (377), Expect = 2e-40
 Identities = 93/270 (34%), Positives = 144/270 (53%), Gaps = 21/270 (7%)

Query: 346 KLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIV 405
           +L+G GT+G VY   + +TG L A+K +D+  D+    E IKQ    +K  SH  H NI 
Sbjct: 12  ELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE---EEEIKQEINMLKKYSH--HRNIA 66

Query: 406 QYYGSEI------VEDKFYIYLEYVHPGSINKYVREHCG-AITESVVRNFTRHILSGLAY 458
            YYG+ I      ++D+ ++ +E+   GS+   ++   G  + E  +    R IL GL++
Sbjct: 67  TYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSH 126

Query: 459 LHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHL---TGQKADLSMKGSPYWMAPELMM 515
           LH  K IHRDIKG N+L+  +  VKL DFG++  L    G++   +  G+PYWMAPE++ 
Sbjct: 127 LHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRN--TFIGTPYWMAPEVIA 184

Query: 516 AVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRD-TPAIPD-SLS 573
                  + D     D+WSLG T IEM  G PP  +     A+F + R+  P +     S
Sbjct: 185 CDENPDATYD--FKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKSKKWS 242

Query: 574 PEGKDFLRCCFQRNPADRPPASLLLEHRFL 603
            + + F+  C  +N + RP    L++H F+
Sbjct: 243 KKFQSFIESCLVKNHSQRPTTEQLMKHPFI 272

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score =  149 bits (378), Expect = 2e-40
 Identities = 88/296 (29%), Positives = 138/296 (46%), Gaps = 60/296 (20%)

Query: 345 GKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKV--------- 395
           GK+IG G+F +V +A  +ET    A+K +D            +QL +E KV         
Sbjct: 6   GKIIGEGSFSTVVLAKEKETNKEYAIKILDK-----------RQLIKEKKVKYVKIEKEV 54

Query: 396 LSHLK-HPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILS 454
           L+ L  HP I++ Y +   E+  Y  LEY   G + +Y+R++ G++ E   R +   IL 
Sbjct: 55  LTRLNGHPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKY-GSLDEKCTRFYAAEILL 113

Query: 455 GLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLT-------------------- 494
            L YLHSK  IHRD+K  N+L+D    +K+ DFG AK L                     
Sbjct: 114 ALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIE 173

Query: 495 -GQKADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPW---S 550
             ++   S  G+  +++PEL+           +  + D+W+LGC I +M TGKPP+   +
Sbjct: 174 KNRRRFASFVGTAEYVSPELL-------NEKPAGKSSDLWALGCIIYQMLTGKPPFRGSN 226

Query: 551 EYEGAAAMFKVMRDTPAIPDSLSPEGKDFLRCCFQRNPADRPPASL----LLEHRF 602
           EY       K+++   + P +  P+ KD +      +P DR   +     L  H F
Sbjct: 227 EYL---TFQKILKLEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPF 279

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score =  149 bits (378), Expect = 4e-40
 Identities = 91/318 (28%), Positives = 132/318 (41%), Gaps = 81/318 (25%)

Query: 345 GKLIGRGTFGSVYVASNRETGALCAMKEV------DIFPDDPKSAESIKQLEQEIKVLSH 398
           GKL G GTFG VY A   +TG + A+K++      D FP        I  L +EIK+L  
Sbjct: 14  GKL-GEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFP--------ITAL-REIKILKK 63

Query: 399 LKHPNIVQY------YGSEIVEDK--FYIYLEY-VHPGS---INKYVREHCGAITESVVR 446
           LKHPN+V           +    +   Y+   Y  H  S    N  V+     +TES ++
Sbjct: 64  LKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVK-----LTESQIK 118

Query: 447 NFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSP 506
            +   +L G+ YLH    +HRDIK AN+L+D  G++K+ADFG+A+   G   +    G  
Sbjct: 119 CYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGG 178

Query: 507 ------------YWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKP------- 547
                       ++  PEL++   +         AVDIW +GC   EM+T +P       
Sbjct: 179 GTRKYTNLVVTRWYRPPELLLGERRYTT------AVDIWGIGCVFAEMFTRRPILQGKSD 232

Query: 548 -----------------PWSEYE---GAAAMFKVMRDTPAIPD---SLSPEGKDFLRCCF 584
                             W  +    G   +         + +    L PEG D L    
Sbjct: 233 IDQLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLL 292

Query: 585 QRNPADRPPASLLLEHRF 602
             +P  R  AS  LEH +
Sbjct: 293 SLDPYKRLTASDALEHPY 310

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score =  145 bits (369), Expect = 2e-39
 Identities = 78/275 (28%), Positives = 129/275 (46%), Gaps = 30/275 (10%)

Query: 348 IGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAE-SIKQLEQEIKVLSHLKHPNIVQ 406
           I +G +G V++A  + TG + A+K   +        +  + Q+  E  +LS  + P +V+
Sbjct: 1   ISKGAYGRVFLAKKKSTGDIYAIK---VIKKADMIRKNQVDQVLTERDILSQAQSPYVVK 57

Query: 407 YYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIH 466
            Y S   +   Y+ +EY+  G +   + E+ G++ E V R +   I+  L YLHS   IH
Sbjct: 58  LYYSFQGKKNLYLVMEYLPGGDL-ASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIH 116

Query: 467 RDIKGANLLVDASGVVKLADFGMAK---------HLTGQKADLSMKGSPYWMAPELMMAV 517
           RD+K  N+L+D++G +KL DFG++K             +K D  + G+P ++APE++   
Sbjct: 117 RDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVI--- 173

Query: 518 MQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIP----DSLS 573
                    +  VD WSLGC + E   G PP+   E    +F+ +     I       +S
Sbjct: 174 ----LGQGHSKTVDWWSLGCILYEFLVGIPPFHG-ETPEEIFQNIL-NGKIEWPEDVEVS 227

Query: 574 PEGKDFLRCCFQRNPADRPPASLLLE---HRFLKN 605
            E  D +      +P  R  A  + E   H F K 
Sbjct: 228 DEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFFKG 262

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score =  146 bits (371), Expect = 3e-39
 Identities = 81/257 (31%), Positives = 130/257 (50%), Gaps = 34/257 (13%)

Query: 346 KLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESI--KQLEQ---EIKVLSHLK 400
           K +G G+FG V +  ++ +G   A+K +         A+ +  KQ+E    E ++L  ++
Sbjct: 7   KTLGTGSFGRVMLVRHKGSGKYYALKILSK-------AKIVKLKQVEHVLNEKRILQSIR 59

Query: 401 HPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLH 460
           HP +V  YGS   +   Y+ +EYV  G +  ++R+  G   E V R +   ++  L YLH
Sbjct: 60  HPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRK-SGRFPEPVARFYAAQVVLALEYLH 118

Query: 461 SKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPYWMAPELMMAVMQK 520
           S   ++RD+K  NLL+D+ G +K+ DFG AK + G+   L   G+P ++APE+++     
Sbjct: 119 SLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRTYTLC--GTPEYLAPEIIL----- 171

Query: 521 GKSSDSALAVDIWSLGCTIIEMYTGKPP-WSE-----YEGAAAMFKVMRDTPAIPDSLSP 574
             S     AVD W+LG  I EM  G PP + +     YE      K++      P   SP
Sbjct: 172 --SKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYE------KILEGKVRFPSFFSP 223

Query: 575 EGKDFLRCCFQRNPADR 591
           + KD +R   Q +   R
Sbjct: 224 DAKDLIRNLLQVDLTKR 240

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score =  144 bits (366), Expect = 8e-39
 Identities = 80/297 (26%), Positives = 135/297 (45%), Gaps = 49/297 (16%)

Query: 342 WQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKH 401
           +QK   IG GT+G VY A ++ TG + A+K++ +  +        K   +EIK+L  L H
Sbjct: 1   YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIP---KTALREIKLLKELNH 57

Query: 402 PNIVQYYGSEIV--EDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYL 459
           PNI++    ++   +   Y+  E++    + K +++    + ES+++++   +L GLA+ 
Sbjct: 58  PNIIKLL--DVFRHKGDLYLVFEFMDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFC 114

Query: 460 HSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPYWM-APELMMAVM 518
           HS   +HRD+K  NLL++  GV+KLADFG+A+         +      W  APEL++   
Sbjct: 115 HSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLLGDK 174

Query: 519 QKGKSSDSALAVDIWSLGCTIIEMYTGKPPW---SEYEGAAAMFKVMRDTPA-------- 567
                      VDIWS+GC   E+ + +P +   SE +    +F+ +  TP         
Sbjct: 175 GYSTP------VDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTL-GTPDPEVWPKFT 227

Query: 568 ---------------------IPDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFL 603
                                 P+  SP+  D L      +P  R  A   L H + 
Sbjct: 228 SLARNYKFSFPKKAGMPLPKLFPN-ASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score =  143 bits (363), Expect = 1e-38
 Identities = 79/262 (30%), Positives = 135/262 (51%), Gaps = 15/262 (5%)

Query: 346 KLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIV 405
           +++G+G FG   +    E  +L   KEV++     K     +    EI +LS L+HPNI+
Sbjct: 6   RVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKER---RDALNEIVILSLLQHPNII 62

Query: 406 QYYGSEIVEDKFYIYLEYVHPGSI-NKYVREHCGAITESVVRNFTRHILSGLAYLHSKKT 464
            YY   + ++   I +EY + G++ +K VR+      E +V  +   I+S ++Y+H    
Sbjct: 63  AYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGI 122

Query: 465 IHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADL-SMKGSPYWMAPELMMAVMQKGKS 523
           +HRDIK  N+ +  +G++KL DFG++K L  + +   ++ G+PY+M+PEL   V    KS
Sbjct: 123 LHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVVGTPYYMSPELCQGVKYNFKS 182

Query: 524 SDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRD--TPAIPDSLSPEGKDFLR 581
                  DIW+LGC + E+ T K  +        + K+++   TP +    S E    + 
Sbjct: 183 -------DIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTP-VVSVYSSELISLVH 234

Query: 582 CCFQRNPADRPPASLLLEHRFL 603
              Q++P  RP A  +L+   L
Sbjct: 235 SLLQQDPEKRPTADEVLDQPLL 256

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score =  142 bits (360), Expect = 3e-38
 Identities = 86/267 (32%), Positives = 139/267 (52%), Gaps = 15/267 (5%)

Query: 341 QWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLK 400
           ++ K K IG G+FG   +  ++E G    +KE++I    PK  E  ++   E+ VLS++K
Sbjct: 1   KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRK---EVAVLSNMK 57

Query: 401 HPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCG-AITESVVRNFTRHILSGLAYL 459
           HPNIVQY  S       YI ++Y   G + K +    G    E  + ++   I   L ++
Sbjct: 58  HPNIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHV 117

Query: 460 HSKKTIHRDIKGANLLVDASGVVKLADFGMAKHL--TGQKADLSMKGSPYWMAPELMMAV 517
           H +K +HRDIK  N+ +   G +KL DFG+A+ L  T + A   + G+PY+++PE+    
Sbjct: 118 HDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCI-GTPYYLSPEICENR 176

Query: 518 MQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDT-PAIPDSLSPEG 576
               KS       DIW+LGC + EM T K  +        + K++R + P +    S + 
Sbjct: 177 PYNNKS-------DIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYPPVSSHYSYDL 229

Query: 577 KDFLRCCFQRNPADRPPASLLLEHRFL 603
           ++ +   F+RNP DRP  + +LE  F+
Sbjct: 230 RNLVSQLFKRNPRDRPSVNSILEKNFI 256

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score =  142 bits (361), Expect = 6e-38
 Identities = 82/290 (28%), Positives = 141/290 (48%), Gaps = 46/290 (15%)

Query: 348 IGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESI-KQLEQEIKVLSHLKHPNIVQ 406
           IG G  G V+ A +RETG   A+K+V +     +    I  Q  +EIK L   +HP +V+
Sbjct: 8   IGEGAHGIVFKAKDRETGETVALKKVAL----RRLEGGIPNQALREIKALQACQHPYVVK 63

Query: 407 YYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIH 466
                     F + +EY+ P  +++ +R+    + E+ V+++ R +L G+AY+H+   +H
Sbjct: 64  LLDVFPHGSGFVLVMEYM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMH 122

Query: 467 RDIKGANLLVDASGVVKLADFGMAKHLTGQKADL--SMKGSPYWMAPELMMAVMQKGKSS 524
           RD+K ANLL+ A GV+K+ADFG+A+  + ++  L      + ++ APEL+        + 
Sbjct: 123 RDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYG------AR 176

Query: 525 DSALAVDIWSLGCTIIEMYTGKPPW---SEYEGAAAMFKVMRDTP---------AIPD-- 570
                VD+W++GC   E+  G P +   ++ E  A +F+ +  TP         ++PD  
Sbjct: 177 KYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTL-GTPNEETWPGLTSLPDYN 235

Query: 571 -----------------SLSPEGKDFLRCCFQRNPADRPPASLLLEHRFL 603
                              SPE  D L+     +P+ R  A+  L H + 
Sbjct: 236 KITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYF 285

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score =  142 bits (360), Expect = 7e-38
 Identities = 87/270 (32%), Positives = 138/270 (51%), Gaps = 24/270 (8%)

Query: 348 IGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQY 407
           IG G+ G V +A  + +G   A+K +D+     +  +  + L  E+ ++   +H N+V+ 
Sbjct: 29  IGEGSTGIVCIAREKHSGRQVAVKMMDL-----RKQQRRELLFNEVVIMRDYQHQNVVEM 83

Query: 408 YGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHR 467
           Y S +V ++ ++ +E++  G++   V +    + E  +      +L  L YLHS+  IHR
Sbjct: 84  YKSYLVGEELWVLMEFLQGGALTDIVSQT--RLNEEQIATVCESVLQALCYLHSQGVIHR 141

Query: 468 DIKGANLLVDASGVVKLADFGMAKHLTGQ-KADLSMKGSPYWMAPELMMAVMQKGKSSDS 526
           DIK  ++L+   G VKL+DFG    ++       S+ G+PYWMAPE++            
Sbjct: 142 DIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRTPY------- 194

Query: 527 ALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDSL------SPEGKDFL 580
              VDIWSLG  +IEM  G+PP+       AM K +RD+P  P  L      SP  +DFL
Sbjct: 195 GTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAM-KRLRDSP--PPKLKNAHKISPVLRDFL 251

Query: 581 RCCFQRNPADRPPASLLLEHRFLKNSQQPD 610
                R P +R  A  LL+H FL  +  P+
Sbjct: 252 ERMLTREPQERATAQELLDHPFLLQTGLPE 281

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score =  143 bits (362), Expect = 1e-37
 Identities = 91/329 (27%), Positives = 143/329 (43%), Gaps = 63/329 (19%)

Query: 346 KLIGRGTFGSVYVASNRETGALCAMKEV-DIFPDDPKSAESIKQLEQEIKVLSHLKHPNI 404
           K IG G +G V  A ++ TG   A+K++ ++F DD   A   K++ +EIK+L HL+H NI
Sbjct: 6   KPIGSGAYGVVCSAVDKRTGRKVAIKKISNVF-DDLIDA---KRILREIKLLRHLRHENI 61

Query: 405 VQ-----YYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYL 459
           +         S    +  YI  E +   +    V +    +T+  ++ F   IL GL YL
Sbjct: 62  IGLLDILRPPSPEDFNDVYIVTELME--TDLHKVIKSPQPLTDDHIQYFLYQILRGLKYL 119

Query: 460 HSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPY----WM-APELM 514
           HS   IHRD+K +N+LV+++  +K+ DFG+A+ +   + +     + Y    W  APEL+
Sbjct: 120 HSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFL-TEYVVTRWYRAPELL 178

Query: 515 MAVMQKGKSSDSALAVDIWSLGCTIIEMYT---------------------GKPPWS--E 551
           ++  +  K      A+DIWS+GC   E+ T                     G P     +
Sbjct: 179 LSSSRYTK------AIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLK 232

Query: 552 YEGAAAMFKVMRDTPA---------IPDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRF 602
           +  +      ++  P           P + SPE  D L      +P  R  A   L H +
Sbjct: 233 FITSEKARNYLKSLPKKPKKPLSKLFPGA-SPEAIDLLEKMLVFDPKKRITADEALAHPY 291

Query: 603 LKNSQQP-DVPSC-----SLSFSGMQLTE 625
           L     P D P          F   +LTE
Sbjct: 292 LAQLHDPEDEPVAKPPFDFDFFDDDELTE 320

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score =  140 bits (356), Expect = 2e-37
 Identities = 90/291 (30%), Positives = 134/291 (46%), Gaps = 48/291 (16%)

Query: 347 LIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQ 406
           L+G G++G V    ++ETG + A+K    F +        K   +EI++L  L+H N+V 
Sbjct: 8   LVGEGSYGMVMKCKHKETGQIVAIK---KFLESEDDKMVKKIAMREIRMLKQLRHENLVN 64

Query: 407 YYGSEIVEDK--FYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKT 464
               E+   K   Y+  E+V    ++  + ++   + ES VR +   IL G+ + HS   
Sbjct: 65  LI--EVFRRKKRLYLVFEFVDHTVLDD-LEKYPNGLDESRVRKYLFQILRGIEFCHSHNI 121

Query: 465 IHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPYWM-APELMMAVMQKGKS 523
           IHRDIK  N+LV  SGVVKL DFG A+ L       +   +  W  APEL++   + G+ 
Sbjct: 122 IHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLVGDTKYGR- 180

Query: 524 SDSALAVDIWSLGCTIIEMYTGKP--PWS---------------------EYEGAAAMFK 560
                AVDIW++GC + EM TG+P  P                       E      +F 
Sbjct: 181 -----AVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFA 235

Query: 561 VMRDTPAIPD---------SLSPEGKDFLRCCFQRNPADRPPASLLLEHRF 602
            MR  P + +          LS    D  + C + +P DRP +S LL H F
Sbjct: 236 GMR-LPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEF 285

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score =  140 bits (355), Expect = 3e-37
 Identities = 87/293 (29%), Positives = 139/293 (47%), Gaps = 43/293 (14%)

Query: 342 WQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKH 401
           +QK + IG GT+G VY A N+ TG + A+K++ +   D ++        +EI +L  L H
Sbjct: 2   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL---DTETEGVPSTAIREISLLKELNH 58

Query: 402 PNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVR-EHCGAITESVVRNFTRHILSGLAYLH 460
           PNIV+       E+K Y+  E++H   + K++       I   +++++   +L GLA+ H
Sbjct: 59  PNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCH 117

Query: 461 SKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPYWM-APELMMAVMQ 519
           S + +HRD+K  NLL++  G +KLADFG+A+         + +    W  APE+++    
Sbjct: 118 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG--- 174

Query: 520 KGKSSDSALAVDIWSLGCTIIEMYTGK---PPWSEYEGAAAMFKVMRDTP---------A 567
                  + AVDIWSLGC   EM T +   P  SE +    +F+ +  TP         +
Sbjct: 175 ---CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTL-GTPDEVVWPGVTS 230

Query: 568 IPD------------------SLSPEGKDFLRCCFQRNPADRPPASLLLEHRF 602
           +PD                   L  +G+D L      +P  R  A   L H F
Sbjct: 231 LPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPF 283

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score =  139 bits (351), Expect = 5e-37
 Identities = 76/263 (28%), Positives = 141/263 (53%), Gaps = 13/263 (4%)

Query: 341 QWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLK 400
           +++K +++GRG FG V++   +    L  +K++   P +  + +     + E +VL  L 
Sbjct: 1   KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQI---PVEQMTKDERLAAQNECQVLKLLS 57

Query: 401 HPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGA-ITESVVRNFTRHILSGLAYL 459
           HPNI++YY + + +    I +EY   G++ +Y+++ C + + E  + +F   IL  L ++
Sbjct: 58  HPNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHV 117

Query: 460 HSKKTIHRDIKGANLLVDA-SGVVKLADFGMAKHLTGQKADLSMKGSPYWMAPELMMAVM 518
           H+K  +HRD+K  N+L+D    VVK+ DFG++K L+ +    ++ G+P +++PEL     
Sbjct: 118 HTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTVVGTPCYISPELCEGKP 177

Query: 519 QKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPA-IPDSLSPEGK 577
              KS       DIW+LGC + E+ + K  +      A + K+M  T A I D  SP+ +
Sbjct: 178 YNQKS-------DIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAPISDRYSPDLR 230

Query: 578 DFLRCCFQRNPADRPPASLLLEH 600
             +      +P+ RP  S ++  
Sbjct: 231 QLILSMLNLDPSKRPQLSQIMAQ 253

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score =  138 bits (350), Expect = 1e-36
 Identities = 88/308 (28%), Positives = 145/308 (47%), Gaps = 71/308 (23%)

Query: 342 WQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDD---PKSAESIKQLEQEIKVLSH 398
           +QK + IG GT+G VY A ++ TG + A+K++ +  +D   P +A  I+    EI +L  
Sbjct: 1   YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTA--IR----EISLLKE 54

Query: 399 LKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCG--AITESVVRNFTRHILSGL 456
           L HPNIV+       E+K Y+  E++    + KY+ +      +   +++++   +L G+
Sbjct: 55  LNHPNIVRLLDVVHSENKLYLVFEFLDL-DLKKYM-DSSPLTGLDPPLIKSYLYQLLQGI 112

Query: 457 AYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSP---------- 506
           AY HS + +HRD+K  NLL+D  G +KLADFG+A+            G P          
Sbjct: 113 AYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAF----------GVPVRTYTHEVVT 162

Query: 507 -YWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPW---SEYEGAAAMFKVM 562
            ++ APE+++   Q       +  VDIWS+GC   EM   +P +   SE +    +F+ +
Sbjct: 163 LWYRAPEILLGSRQ------YSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTL 216

Query: 563 RDTP---------AIPD------------------SLSPEGKDFLRCCFQRNPADRPPAS 595
             TP         ++PD                  +L  +G D L      +PA R  A 
Sbjct: 217 -GTPDEDVWPGVTSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAK 275

Query: 596 LLLEHRFL 603
             L+H + 
Sbjct: 276 AALQHPYF 283

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score =  136 bits (344), Expect = 5e-36
 Identities = 85/257 (33%), Positives = 136/257 (52%), Gaps = 21/257 (8%)

Query: 346 KLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIV 405
           K IGRG F  VY A+    G   A+K+V IF  D   A++     +EI +L  L HPN++
Sbjct: 8   KKIGRGQFSEVYRATCLLDGVPVALKKVQIF--DLMDAKARADCIKEIDLLKQLNHPNVI 65

Query: 406 QYYGSEIVEDKFYIYLEYVHPGSINKYVR---EHCGAITESVVRNFTRHILSGLAYLHSK 462
           +YY S I +++  I LE    G +++ ++   +    I E  V  +   + S L ++HS+
Sbjct: 66  KYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSR 125

Query: 463 KTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQ-KADLSMKGSPYWMAPELMMAVMQKG 521
           + +HRDIK AN+ + A+GVVKL D G+ +  + +  A  S+ G+PY+M+PE    + + G
Sbjct: 126 RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPE---RIHENG 182

Query: 522 KSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMR-----DTPAIP-DSLSPE 575
            +  S    DIWSLGC + EM   + P+  Y     ++ + +     D P +P D  S E
Sbjct: 183 YNFKS----DIWSLGCLLYEMAALQSPF--YGDKMNLYSLCKKIEQCDYPPLPSDHYSEE 236

Query: 576 GKDFLRCCFQRNPADRP 592
            +  +  C   +P  RP
Sbjct: 237 LRQLVNMCINPDPEKRP 253

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score =  136 bits (343), Expect = 2e-35
 Identities = 76/245 (31%), Positives = 125/245 (51%), Gaps = 18/245 (7%)

Query: 340 SQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQ---EIKVL 396
              ++ K +G GTFG V++  +R +    A+K + I P+       +KQ +    E +VL
Sbjct: 1   DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAI-PE----VIRLKQEQHVHNEKRVL 55

Query: 397 SHLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGL 456
             + HP I++ + +E  +   Y+ +EYV  G +  Y+R   G  + S    +   I+  L
Sbjct: 56  KEVSHPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNS-GRFSNSTGLFYASEIVCAL 114

Query: 457 AYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPYWMAPELMMA 516
            YLHSK+ ++RD+K  N+L+D  G +KL DFG AK L  +    ++ G+P ++APE+   
Sbjct: 115 EYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRT--WTLCGTPEYLAPEV--- 169

Query: 517 VMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDSLSPEG 576
           +  KG +     AVD W+LG  I EM  G PP+ +        K++      P  L    
Sbjct: 170 IQSKGHNK----AVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLEFPRHLDLYA 225

Query: 577 KDFLR 581
           KD ++
Sbjct: 226 KDLIK 230

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score =  135 bits (341), Expect = 2e-35
 Identities = 83/303 (27%), Positives = 139/303 (45%), Gaps = 57/303 (18%)

Query: 342 WQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQ-LEQEIKVLSHLK 400
           +++   IG G +G+VY A +  TG   A+K+V +    P S E I     +EI +L  L+
Sbjct: 1   YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRV----PLSEEGIPLSTLREIALLKQLE 56

Query: 401 ---HPNIVQ--------YYGSEIVEDKFYIYLEYVHPGSINKYVREHCGA--ITESVVRN 447
              HPNIV+            E+   K  +  E+V    +  Y+   C    +    +++
Sbjct: 57  SFEHPNIVRLLDVCHGPRTDREL---KLTLVFEHVDQ-DLATYL-SKCPKPGLPPETIKD 111

Query: 448 FTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPY 507
             R +L G+ +LHS + +HRD+K  N+LV + G VK+ADFG+A+  + + A  S+  + +
Sbjct: 112 LMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMALTSVVVTLW 171

Query: 508 WMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPW---SEYEGAAAMFKVM-- 562
           + APE+++        S  A  VD+WS+GC   E++  +P +   SE +    +F V+  
Sbjct: 172 YRAPEVLLQ-------SSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGL 224

Query: 563 -------RDTPAIPDS---------------LSPEGKDFLRCCFQRNPADRPPASLLLEH 600
                  R+      S               +  EG D L+     NP  R  A   L+H
Sbjct: 225 PSEEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQH 284

Query: 601 RFL 603
            + 
Sbjct: 285 PYF 287

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score =  134 bits (340), Expect = 3e-35
 Identities = 84/290 (28%), Positives = 135/290 (46%), Gaps = 48/290 (16%)

Query: 348 IGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLE-QEIKVLSHLKHPNIVQ 406
           IG G++G V+   NRETG + A+K+     DDP     IK++  +EI++L  LKHPN+V 
Sbjct: 9   IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDP----VIKKIALREIRMLKQLKHPNLVN 64

Query: 407 YYGSEIVEDKFYIYL--EYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKT 464
               E+   K  ++L  EY     +N+  + +   + E +++      L  + + H    
Sbjct: 65  LI--EVFRRKRKLHLVFEYCDHTVLNELEK-NPRGVPEHLIKKIIWQTLQAVNFCHKHNC 121

Query: 465 IHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPYWM-APELMMAVMQKGKS 523
           IHRD+K  N+L+   G +KL DFG A+ LTG   D +   +  W  APEL++   Q G  
Sbjct: 122 IHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATRWYRAPELLVGDTQYGP- 180

Query: 524 SDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRD----TP------------- 566
                 VD+W++GC   E+ TG+P W        ++ + +      P             
Sbjct: 181 -----PVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFK 235

Query: 567 --AIPD------------SLSPEGKDFLRCCFQRNPADRPPASLLLEHRF 602
             +IP+            ++S     FL+ C Q +P +R     LLEH +
Sbjct: 236 GLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPY 285

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score =  133 bits (336), Expect = 4e-35
 Identities = 80/262 (30%), Positives = 138/262 (52%), Gaps = 14/262 (5%)

Query: 346 KLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIV 405
           K IG G+FG +Y+A  +     C +KE+D+     K  E+ K+   E+ +L+ +KHPNIV
Sbjct: 6   KKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKK---EVILLAKMKHPNIV 62

Query: 406 QYYGSEIVEDKFYIYLEYVHPGSINKYV-REHCGAITESVVRNFTRHILSGLAYLHSKKT 464
            ++ S     + +I +EY   G + K + R+     +E  + ++   I  GL ++H +K 
Sbjct: 63  TFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKI 122

Query: 465 IHRDIKGANLLVDASGVV-KLADFGMAKHLT-GQKADLSMKGSPYWMAPELMMAVMQKGK 522
           +HRDIK  N+ +  +G+V KL DFG+A+ L    +   +  G+PY+++PE+        K
Sbjct: 123 LHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVGTPYYLSPEICQNRPYNNK 182

Query: 523 SSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPA-IPDSLSPEGKDFLR 581
           +       DIWSLGC + E+ T K P+        + K+ +   A I  + S + +  + 
Sbjct: 183 T-------DIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAPISPNFSRDLRSLIS 235

Query: 582 CCFQRNPADRPPASLLLEHRFL 603
             F+ +P DRP  + +L+  FL
Sbjct: 236 QLFKVSPRDRPSITSILKRPFL 257

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score =  134 bits (339), Expect = 4e-35
 Identities = 88/267 (32%), Positives = 145/267 (54%), Gaps = 20/267 (7%)

Query: 348 IGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQY 407
           IG G+ G V +A+ + +G L A+K++D+     +  +  + L  E+ ++   +H N+V+ 
Sbjct: 28  IGEGSTGIVCIATVKSSGKLVAVKKMDL-----RKQQRRELLFNEVVIMRDYQHENVVEM 82

Query: 408 YGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHR 467
           Y S +V D+ ++ +E++  G++   V      + E  +      +L  L+ LH++  IHR
Sbjct: 83  YNSYLVGDELWVVMEFLEGGALTDIVTH--TRMNEEQIAAVCLAVLKALSVLHAQGVIHR 140

Query: 468 DIKGANLLVDASGVVKLADFGMAKHLTGQ-KADLSMKGSPYWMAPELMMAVMQKGKSSDS 526
           DIK  ++L+   G VKL+DFG    ++ +     S+ G+PYWMAPEL ++ +  G     
Sbjct: 141 DIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPEL-ISRLPYGPE--- 196

Query: 527 ALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDT--PAIPD--SLSPEGKDFLRC 582
              VDIWSLG  +IEM  G+PP+       AM K++RD   P + +   +SP  K FL  
Sbjct: 197 ---VDIWSLGIMVIEMVDGEPPYFNEPPLKAM-KMIRDNLPPKLKNLHKVSPSLKGFLDR 252

Query: 583 CFQRNPADRPPASLLLEHRFLKNSQQP 609
              R+PA R  A+ LL+H FL  +  P
Sbjct: 253 LLVRDPAQRATAAELLKHPFLAKAGPP 279

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score =  134 bits (340), Expect = 7e-35
 Identities = 80/272 (29%), Positives = 133/272 (48%), Gaps = 27/272 (9%)

Query: 346 KLIGRGTFGSVYVASNRETGALCAMKEV---DIFPDDPKSAESIKQLEQEIKVLSHL-KH 401
           K++G+G+FG V +A  + T  L A+K +    I  DD      ++    E +VL+   KH
Sbjct: 1   KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDD-----DVECTMTEKRVLALAGKH 55

Query: 402 PNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHS 461
           P + Q +     +D+ +  +EYV+ G +  +++   G   E   R +   I+ GL +LH 
Sbjct: 56  PFLTQLHSCFQTKDRLFFVMEYVNGGDLMFHIQR-SGRFDEPRARFYAAEIVLGLQFLHE 114

Query: 462 KKTIHRDIKGANLLVDASGVVKLADFGMAKH--LTGQKADLSMKGSPYWMAPELMMAVMQ 519
           +  I+RD+K  N+L+D+ G +K+ADFGM K   L G     +  G+P ++APE++     
Sbjct: 115 RGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTS-TFCGTPDYIAPEIL----- 168

Query: 520 KGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFK-VMRDTPAIPDSLSPEGKD 578
                    AVD W+LG  + EM  G+ P+ E +    +F+ ++ D    P  LS E K 
Sbjct: 169 --SYQPYGPAVDWWALGVLLYEMLAGQSPF-EGDDEDELFQSILEDEVRYPRWLSKEAKS 225

Query: 579 FLRCCFQRNPADRPPASL-----LLEHRFLKN 605
            L+    +NP  R          +  H F + 
Sbjct: 226 ILKSFLTKNPEKRLGCLPTGEQDIKGHPFFRE 257

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score =  133 bits (336), Expect = 1e-34
 Identities = 78/265 (29%), Positives = 134/265 (50%), Gaps = 28/265 (10%)

Query: 341 QWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLK 400
            +++ + +G GT+ +VY   NR TG + A+KE+ +  ++   + +I+    EI ++  LK
Sbjct: 1   NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIR----EISLMKELK 56

Query: 401 HPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYV--REHCGAITESVVRNFTRHILSGLAY 458
           H NIV+ +     E+K  +  EY+    + KY+      GA+  + V++FT  +L G+A+
Sbjct: 57  HENIVRLHDVIHTENKLMLVFEYMD-KDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAF 115

Query: 459 LHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPYWM-APELMMAV 517
            H  + +HRD+K  NLL++  G +KLADFG+A+         S +    W  AP++++  
Sbjct: 116 CHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVVTLWYRAPDVLLG- 174

Query: 518 MQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMR--DTP---AIPD-S 571
                S   + ++DIWS+GC + EM TG+P +        + K+ R   TP     P  S
Sbjct: 175 -----SRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGIS 229

Query: 572 LSPEGKDFLRCCFQRNPADRPPASL 596
             PE        ++      PP  L
Sbjct: 230 QLPE--------YKPTFPRYPPQDL 246

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score =  132 bits (333), Expect = 1e-34
 Identities = 78/256 (30%), Positives = 134/256 (52%), Gaps = 14/256 (5%)

Query: 346 KLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIV 405
           +++G G+FG   +  +  +    AMKE+ +    PKS+ +++   +E  +L+ +KHPNIV
Sbjct: 6   RVVGEGSFGRALLVQHVNSDQKYAMKEIRL----PKSSSAVEDSRKEAVLLAKMKHPNIV 61

Query: 406 QYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAI-TESVVRNFTRHILSGLAYLHSKKT 464
            +  S   +   YI +EY   G + + ++   G +  E  +  +   +  G+ ++H K+ 
Sbjct: 62  AFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRV 121

Query: 465 IHRDIKGANLLVDASGVVKLADFGMAKHLTGQKA-DLSMKGSPYWMAPELMMAVMQKGKS 523
           +HRDIK  N+ +  +G VKL DFG A+ LT   A   +  G+PY++ PE+   +    KS
Sbjct: 122 LHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYVGTPYYVPPEIWENMPYNNKS 181

Query: 524 SDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDT-PAIPDSLSPEGKDFLRC 582
                  DIWSLGC + E+ T K P+        + KV + +   +P   S E +  ++ 
Sbjct: 182 -------DIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKPLPSHYSYELRSLIKQ 234

Query: 583 CFQRNPADRPPASLLL 598
            F+RNP  RP A+ +L
Sbjct: 235 MFKRNPRSRPSATTIL 250

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score =  132 bits (334), Expect = 2e-34
 Identities = 91/280 (32%), Positives = 142/280 (50%), Gaps = 26/280 (9%)

Query: 348 IGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKH-PNIVQ 406
           +GRG +G V    +  TG + A+K +        S E  K+L  ++ +       P  V 
Sbjct: 9   LGRGAYGVVDKMRHVPTGTIMAVKRI---RATVNSQEQ-KRLLMDLDISMRSVDCPYTVT 64

Query: 407 YYGSEIVEDKFYIYLEYVHPGSINKY---VREHCGAITESVVRNFTRHILSGLAYLHSK- 462
           +YG+   E   +I +E V   S++K+   V +    I E ++      I+  L YLHSK 
Sbjct: 65  FYGALFREGDVWICME-VMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKL 123

Query: 463 KTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPYWMAPELMMAVM-QKG 521
             IHRD+K +N+L++ +G VKL DFG++ +L    A     G   +MAPE +   + QKG
Sbjct: 124 SVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAKTIDAGCKPYMAPERINPELNQKG 183

Query: 522 KSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMF----KVMRDT-PAIP-DSLSPE 575
               S    D+WSLG T+IE+ TG+ P   Y+     F    +V+ +  P +P +  SPE
Sbjct: 184 YDVKS----DVWSLGITMIELATGRFP---YDSWKTPFQQLKQVVEEPSPQLPAEKFSPE 236

Query: 576 GKDFLRCCFQRNPADRPPASLLLEHRFLK--NSQQPDVPS 613
            +DF+  C ++N  +RP    LL+H F +   S+  DV S
Sbjct: 237 FQDFVNKCLKKNYKERPNYPELLQHPFFELHLSKNTDVAS 276

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score =  131 bits (330), Expect = 3e-34
 Identities = 78/265 (29%), Positives = 148/265 (55%), Gaps = 21/265 (7%)

Query: 348 IGRGTFGSVYVASNRETGA---LCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNI 404
           +G+G+FG+VY+  +++  A   L  +KE+ +   +    E++ Q  QE ++LS L HP I
Sbjct: 8   LGKGSFGTVYLVKDKKAVAEERLKVLKEIPV--GELNPNETV-QANQEAQLLSKLDHPAI 64

Query: 405 VQYYGSEIVEDKFYIYLEYVHPGSINKYVRE--HCG-AITESVVRNFTRHILSGLAYLHS 461
           V+++ S +  D F I  EY     ++  + E  H G  ++E+ V  +   +L G+ Y+H 
Sbjct: 65  VKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQ 124

Query: 462 KKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADL--SMKGSPYWMAPELMMAVMQ 519
           ++ +HRD+K  N+ +  + ++K+ DFG+++ L G   DL  +  G+PY+M+PE   A+  
Sbjct: 125 RRILHRDLKAKNIFL-KNNLLKIGDFGVSRLLMGS-CDLATTFTGTPYYMSPE---ALKH 179

Query: 520 KGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMR-DTPAIPDSLSPEGKD 578
           +G  S S    DIWSLGC + EM      +      + + +++   TP++P++ S +   
Sbjct: 180 QGYDSKS----DIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTPSLPETYSRQLNS 235

Query: 579 FLRCCFQRNPADRPPASLLLEHRFL 603
            ++    ++P+ RP A+ +L + F+
Sbjct: 236 IMQSMLNKDPSLRPSAAEILRNPFI 260

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score =  131 bits (332), Expect = 4e-34
 Identities = 86/281 (30%), Positives = 141/281 (50%), Gaps = 28/281 (9%)

Query: 347 LIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKS--AESIKQLEQEIKV--LSHLKHP 402
            IG GT G VY    ++TG + A+K++       ++   E  K++  ++ V   SH   P
Sbjct: 22  EIGSGTCGQVYKMRFKKTGHVMAVKQM------RRTGNKEENKRILMDLDVVLKSH-DCP 74

Query: 403 NIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSK 462
            IV+ YG  I +   +I +E +    ++K ++   G I E ++   T  I+  L YL  K
Sbjct: 75  YIVKCYGYFITDSDVFICMELMST-CLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEK 133

Query: 463 K-TIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPYWMAPELMMAVMQKG 521
              IHRD+K +N+L+DASG VKL DFG++  L   KA     G   +MAPE +       
Sbjct: 134 HGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKTRSAGCAAYMAPERIDPPDPNP 193

Query: 522 KSSDSALAVDIWSLGCTIIEMYTGKPPW----SEYEGAAAMFKVMRDTPAIPD---SLSP 574
           K    A   D+WSLG +++E+ TG+ P+    +E+E    + K++++ P         SP
Sbjct: 194 KYDIRA---DVWSLGISLVELATGQFPYKNCKTEFE---VLTKILQEEPPSLPPNEGFSP 247

Query: 575 EGKDFLRCCFQRNPADRPPASLLLEHRFLK--NSQQPDVPS 613
           +   F+  C  ++   RP    LL+H F++   + + DV  
Sbjct: 248 DFCSFVDLCLTKDHRKRPKYRELLQHPFIRRYETAEVDVAG 288

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score =  131 bits (332), Expect = 5e-34
 Identities = 89/314 (28%), Positives = 141/314 (44%), Gaps = 60/314 (19%)

Query: 341 QWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSA-ESIKQ-LEQEIKVLSH 398
           +++KGK +G GT+  VY A ++ETG + A+K+  I   + K A + I     +EIK+L  
Sbjct: 1   RYEKGKKLGEGTYAVVYKARDKETGRIVAIKK--IKLGERKEAKDGINFTALREIKLLQE 58

Query: 399 LKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAY 458
           LKHPNI+        +    +  E++    + K +++    +T + ++++    L GL Y
Sbjct: 59  LKHPNIIGLLDVFGHKSNINLVFEFME-TDLEKVIKDKSIVLTPADIKSYMLMTLRGLEY 117

Query: 459 LHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSP-----------Y 507
           LHS   +HRD+K  NLL+ + GV+KLADFG+A+            GSP           +
Sbjct: 118 LHSNWILHRDLKPNNLLIASDGVLKLADFGLAR----------SFGSPNRKMTHQVVTRW 167

Query: 508 WMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKP-------------------- 547
           + APEL+      G      + VD+WS+GC   E+    P                    
Sbjct: 168 YRAPELLFGARHYG------VGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGT 221

Query: 548 PWSE-YEGAAAM--FKVMRDTPAIP-----DSLSPEGKDFLRCCFQRNPADRPPASLLLE 599
           P  E + G  ++  +   +  P  P      + S +  D L+     NP  R  A   LE
Sbjct: 222 PTEENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALE 281

Query: 600 HRFLKNSQQPDVPS 613
           H +  N   P  PS
Sbjct: 282 HPYFSNDPAPTPPS 295

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score =  129 bits (327), Expect = 2e-33
 Identities = 87/296 (29%), Positives = 139/296 (46%), Gaps = 47/296 (15%)

Query: 341 QWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDD---PKSAESIKQLEQEIKVLS 397
           +++K + IG GT+G+V+ A NRET  + A+K V +  DD   P SA       +EI +L 
Sbjct: 1   KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSAL------REICLLK 54

Query: 398 HLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLA 457
            LKH NIV+ Y     + K  +  EY     + KY     G I   +V++F   +L GLA
Sbjct: 55  ELKHKNIVRLYDVLHSDKKLTLVFEYCDQ-DLKKYFDSCNGDIDPEIVKSFMFQLLKGLA 113

Query: 458 YLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPYWM-APELMMA 516
           + HS   +HRD+K  NLL++ +G +KLADFG+A+         S +    W   P+++  
Sbjct: 114 FCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFG 173

Query: 517 VMQKGKSSDSALAVDIWSLGCTIIEMYT-GKP--PWSEYEGA-AAMFKVM---------- 562
              K  S+    ++D+WS GC   E+   G+P  P ++ +     +F+++          
Sbjct: 174 A--KLYST----SIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPG 227

Query: 563 -------RDTPAIP---------DSLSPEGKDFLRCCFQRNPADRPPASLLLEHRF 602
                  +  P  P           L+  G+D L+     NP  R  A   L+H +
Sbjct: 228 VSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPY 283

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score =  129 bits (325), Expect = 2e-33
 Identities = 83/270 (30%), Positives = 141/270 (52%), Gaps = 21/270 (7%)

Query: 340 SQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHL 399
           + +Q  K IGRG F  VY A+        A+K+V IF  +   A++ +   +EI +L  L
Sbjct: 2   ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIF--EMMDAKARQDCVKEIDLLKQL 59

Query: 400 KHPNIVQYYGSEIVEDKFYIYLEYVHPGSIN---KYVREHCGAITESVVRNFTRHILSGL 456
            HPN+++Y  S I +++  I LE    G ++   KY ++    I E  V  +   + S +
Sbjct: 60  NHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAV 119

Query: 457 AYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQ-KADLSMKGSPYWMAPELMM 515
            ++HS++ +HRDIK AN+ + A+GVVKL D G+ +  + +  A  S+ G+PY+M+PE   
Sbjct: 120 EHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPE--- 176

Query: 516 AVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMR-----DTPAIP- 569
            + + G +  S    DIWSLGC + EM   + P+  Y     +F + +     D P +P 
Sbjct: 177 RIHENGYNFKS----DIWSLGCLLYEMAALQSPF--YGDKMNLFSLCQKIEQCDYPPLPT 230

Query: 570 DSLSPEGKDFLRCCFQRNPADRPPASLLLE 599
           +  S + ++ +  C   +P  RP    + +
Sbjct: 231 EHYSEKLRELVSMCIYPDPDQRPDIGYVHQ 260

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score =  128 bits (324), Expect = 2e-33
 Identities = 79/269 (29%), Positives = 127/269 (47%), Gaps = 23/269 (8%)

Query: 346 KLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVL-SHLKHPNI 404
           K I +G FGSVY+A  R TG   A+K   +   D  +   +  ++ E  ++    + P +
Sbjct: 2   KPISKGAFGSVYLAKKRSTGDYFAIKV--LKKSDMIAKNQVTNVKAERAIMMIQGESPYV 59

Query: 405 VQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKT 464
            + Y S   +D  Y+ +EY++ G     ++   G + E   + +   ++ G+  LH +  
Sbjct: 60  AKLYYSFQSKDYLYLVMEYLNGGDCASLIKT-LGGLPEDWAKQYIAEVVLGVEDLHQRGI 118

Query: 465 IHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPYWMAPELMMAVMQKGKSS 524
           IHRDIK  NLL+D +G +KL DFG++++    K      G+P ++APE ++ V       
Sbjct: 119 IHRDIKPENLLIDQTGHLKLTDFGLSRNGLENK---KFVGTPDYLAPETILGV------- 168

Query: 525 DSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMF-KVMRDTPAIPD----SLSPEGKDF 579
                 D WSLGC I E   G PP+   E   A+F  ++      P+      SPE  D 
Sbjct: 169 GDDKMSDWWSLGCVIFEFLFGYPPF-HAETPDAVFDNILSRRINWPEEVKEFCSPEAVDL 227

Query: 580 LRCCFQRNPADRPPASLLLE---HRFLKN 605
           +      +PA R  A+   E   H F K+
Sbjct: 228 INRLLCMDPAKRLGANGYQEIKSHPFFKS 256

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score =  129 bits (325), Expect = 3e-33
 Identities = 85/267 (31%), Positives = 140/267 (52%), Gaps = 20/267 (7%)

Query: 348 IGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQY 407
           IG G+ G V +A+ + TG   A+K++D+     +  +  + L  E+ ++    H N+V  
Sbjct: 30  IGEGSTGIVCIATEKHTGKQVAVKKMDL-----RKQQRRELLFNEVVIMRDYHHENVVDM 84

Query: 408 YGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHR 467
           Y S +V D+ ++ +E++  G++   V      + E  +      +L  L+YLH++  IHR
Sbjct: 85  YNSYLVGDELWVVMEFLEGGALTDIVTH--TRMNEEQIATVCLSVLRALSYLHNQGVIHR 142

Query: 468 DIKGANLLVDASGVVKLADFGMAKHLTGQ-KADLSMKGSPYWMAPELMMAVMQKGKSSDS 526
           DIK  ++L+ + G +KL+DFG    ++ +     S+ G+PYWMAPE++  +         
Sbjct: 143 DIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVISRL-------PY 195

Query: 527 ALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDT--PAIPDS--LSPEGKDFLRC 582
              VDIWSLG  +IEM  G+PP+       AM ++ RD   P + DS  +S   + FL  
Sbjct: 196 GTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRI-RDNLPPRVKDSHKVSSVLRGFLDL 254

Query: 583 CFQRNPADRPPASLLLEHRFLKNSQQP 609
              R P+ R  A  LL+H FLK +  P
Sbjct: 255 MLVREPSQRATAQELLQHPFLKLAGPP 281

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score =  129 bits (327), Expect = 3e-33
 Identities = 85/305 (27%), Positives = 136/305 (44%), Gaps = 57/305 (18%)

Query: 347 LIGRGTFG--SVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNI 404
           LIG+       V++A ++ T  L A+K++++   D  S E +K L+QEI     L+HPNI
Sbjct: 5   LIGKCFEDLMIVHLAKHKPTNTLVAVKKINL---DSCSKEDLKLLQQEIITSRQLQHPNI 61

Query: 405 VQYYGSEIVEDKFYIYLEYVHPGSINKYVREH-CGAITESVVRNFTRHILSGLAYLHSKK 463
           + Y  S IV+ + Y+    +  GS    ++ H    + E  +    + +L+ L Y+HSK 
Sbjct: 62  LPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKG 121

Query: 464 TIHRDIKGANLLVDASGVVKLADF----GMAKHLTGQKA---DLSMKGSP---YWMAPEL 513
            IHR +K +++L+   G V L+       M KH  G++        K S     W++PE+
Sbjct: 122 FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKH--GKRQRVVHDFPKSSVKNLPWLSPEV 179

Query: 514 MMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSE---------------------- 551
           +   +Q G +  S    DI+S+G T  E+  G  P+ +                      
Sbjct: 180 LQQNLQ-GYNEKS----DIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKS 234

Query: 552 ----YEGAAA------MFKVMRDTPAIP--DSLSPEGKDFLRCCFQRNPADRPPASLLLE 599
               YE + +           RD+   P   + S     F+  C QR+P  RP AS LL 
Sbjct: 235 TYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLN 294

Query: 600 HRFLK 604
           H F K
Sbjct: 295 HSFFK 299

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score =  128 bits (324), Expect = 7e-33
 Identities = 74/230 (32%), Positives = 116/230 (50%), Gaps = 41/230 (17%)

Query: 340 SQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHL 399
           S+++K   IG+GTFG V+ A +++T  + A+K+V +  ++ K    I  L +EIK+L  L
Sbjct: 12  SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLM--ENEKEGFPITAL-REIKILQLL 68

Query: 400 KHPNIVQYYGSEIVEDK----------FYIYLEYVHPG----SINKYVREHCGAITESVV 445
           KH N+V     EI   K          FY+  E+          NK V+      T S +
Sbjct: 69  KHENVVNLI--EICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVK-----FTLSEI 121

Query: 446 RNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGS 505
           +   + +L+GL Y+H  K +HRD+K AN+L+   G++KLADFG+A+  +  K     K +
Sbjct: 122 KKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNS---KPN 178

Query: 506 PY-------WM-APELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKP 547
            Y       W   PEL++     G        +D+W  GC + EM+T  P
Sbjct: 179 RYTNRVVTLWYRPPELLLGERDYGP------PIDMWGAGCIMAEMWTRSP 222

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score =  126 bits (319), Expect = 2e-32
 Identities = 83/288 (28%), Positives = 146/288 (50%), Gaps = 28/288 (9%)

Query: 339 NSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSH 398
           N   +    +G G  GSV    +  TG + A K V I     KS+   KQ+ +E++++  
Sbjct: 4   NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHI---GAKSSVR-KQILRELQIMHE 59

Query: 399 LKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAY 458
            + P IV +YG+ + E+   + +E++  GS+++  ++  G I   ++      ++ GL Y
Sbjct: 60  CRSPYIVSFYGAFLNENNICMCMEFMDCGSLDRIYKKG-GPIPVEILGKIAVAVVEGLTY 118

Query: 459 LHSK-KTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPYWMAPELMMAV 517
           L++  + +HRDIK +N+LV++ G +KL DFG++  L    AD +  G+  +M+PE     
Sbjct: 119 LYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIAD-TFVGTSTYMSPER---- 173

Query: 518 MQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGA-------AAMFK-----VMRDT 565
           +Q GK +   +  D+WSLG +IIE+  GK P++              +       V    
Sbjct: 174 IQGGKYT---VKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPP 230

Query: 566 PAIPDSLSPE-GKDFLRCCFQRNPADRP-PASLLLEHRFLKNSQQPDV 611
           P +P S  PE  +DF+  C  ++P +RP P  L     F++  +  +V
Sbjct: 231 PRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQALRASNV 278

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score =  126 bits (317), Expect = 3e-32
 Identities = 83/285 (29%), Positives = 138/285 (48%), Gaps = 26/285 (9%)

Query: 341 QWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLK 400
             Q  +++G G  G+VY A +  T  + A+K   + P D  + E  KQ+  E+++L    
Sbjct: 2   DIQYQEILGHGNGGTVYKAYHLLTRRILAVK---VIPLD-ITVELQKQIMSELEILYKCD 57

Query: 401 HPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLH 460
            P I+ +YG+  VE++  I  E++  GS++ Y       I E V+      ++ GL YL 
Sbjct: 58  SPYIIGFYGAFFVENRISICTEFMDGGSLDVY-----RKIPEHVLGRIAVAVVKGLTYLW 112

Query: 461 SKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPYWMAPELMMAVMQK 520
           S K +HRD+K +N+LV+  G VKL DFG++  L    A  +  G+  +MAPE +    Q 
Sbjct: 113 SLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAK-TYVGTNAYMAPERISG-EQY 170

Query: 521 GKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFK--------VMRDTPAIPDSL 572
           G  S      D+WSLG + +E+  G+ P+ + +               V  D P +P   
Sbjct: 171 GIHS------DVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQ 224

Query: 573 -SPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQPDVPSCSL 616
            S +   F+  C ++ P +RP    L++H F+      +    S+
Sbjct: 225 FSEKFVHFITQCMRKQPKERPAPENLMDHPFIVQYNDGNAEVVSM 269

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score =  127 bits (320), Expect = 3e-32
 Identities = 74/252 (29%), Positives = 130/252 (51%), Gaps = 20/252 (7%)

Query: 346 KLIGRGTFGSVYVASNRETGALCAMK----EVDIFPDDPKSAESIKQLEQEIKVLSHLKH 401
           K++G+G+FG V +A  + T    A+K    +V +  DD +       +E+ +  L+  +H
Sbjct: 1   KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECT----MVERRVLALA-WEH 55

Query: 402 PNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHS 461
           P +   + +   ++  +  +EY++ G +  +++   G   E+  R +   I+ GL +LH 
Sbjct: 56  PFLTHLFCTFQTKEHLFFVMEYLNGGDLMFHIQS-SGRFDEARARFYAAEIICGLQFLHK 114

Query: 462 KKTIHRDIKGANLLVDASGVVKLADFGMAK-HLTGQKADLSMKGSPYWMAPELMMAVMQK 520
           K  I+RD+K  N+L+D  G +K+ADFGM K ++ G+    +  G+P ++APE++      
Sbjct: 115 KGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEIL------ 168

Query: 521 GKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMR-DTPAIPDSLSPEGKDF 579
            K      +VD WS G  + EM  G+ P+   E    +F  +  D P  P  +S E KD 
Sbjct: 169 -KGQKYNESVDWWSFGVLLYEMLIGQSPFHG-EDEDELFDSILNDRPHFPRWISKEAKDC 226

Query: 580 LRCCFQRNPADR 591
           L   F+R+P  R
Sbjct: 227 LSKLFERDPTKR 238

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score =  126 bits (318), Expect = 4e-32
 Identities = 71/214 (33%), Positives = 109/214 (50%), Gaps = 35/214 (16%)

Query: 348 IGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQY 407
           I  GT+G VY A +++TG + A+K++ +  +  K    I  L +EI +L  L+HPNIV  
Sbjct: 13  IEEGTYGVVYRARDKKTGEIVALKKLKM--EKEKEGFPITSL-REINILLKLQHPNIVTV 69

Query: 408 YGSEIV----EDKFYIYLEYVHPGSINKYVREH---------CGAITESVVRNFTRHILS 454
              E+V     DK Y+ +EYV          EH              +S V+     +LS
Sbjct: 70  --KEVVVGSNLDKIYMVMEYV----------EHDLKSLMETMKQPFLQSEVKCLMLQLLS 117

Query: 455 GLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPYWM-APEL 513
           G+A+LH    +HRD+K +NLL++  G++K+ DFG+A+         +      W  APEL
Sbjct: 118 GVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVVTLWYRAPEL 177

Query: 514 MMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKP 547
           ++     G    S  A+D+WS+GC   E+ T KP
Sbjct: 178 LL-----GAKEYST-AIDMWSVGCIFAELLTKKP 205

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score =  124 bits (312), Expect = 8e-32
 Identities = 77/263 (29%), Positives = 135/263 (51%), Gaps = 16/263 (6%)

Query: 346 KLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIV 405
           +++G+G++G V +  +R  G    +K++++      S    K  EQE ++LS LKHPNIV
Sbjct: 6   RVVGKGSYGEVSLVRHRTDGKQYVIKKLNL---RNASRRERKAAEQEAQLLSQLKHPNIV 62

Query: 406 QYYGSEIVED-KFYIYLEYVHPGSINKYVREHCGAI-TESVVRNFTRHILSGLAYLHSKK 463
            Y  S   ED   YI + +   G +   ++E  G +  E+ V  +   I   L YLH K 
Sbjct: 63  AYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKH 122

Query: 464 TIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADL--SMKGSPYWMAPELMMAVMQKG 521
            +HRD+K  N+ +  + ++K+ D G+A+ L  Q  D+  ++ G+PY+M+PEL        
Sbjct: 123 ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQ-CDMASTLIGTPYYMSPELFSNKPYNY 181

Query: 522 KSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMR-DTPAIPDSLSPEGKDFL 580
           KS       D+W+LGC + EM T K  ++  +  + +++++    P +P   SPE  + +
Sbjct: 182 KS-------DVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPPMPKDYSPELGELI 234

Query: 581 RCCFQRNPADRPPASLLLEHRFL 603
                + P  RP    +L   ++
Sbjct: 235 ATMLSKRPEKRPSVKSILRQPYI 257

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score =  124 bits (314), Expect = 1e-31
 Identities = 86/302 (28%), Positives = 140/302 (46%), Gaps = 70/302 (23%)

Query: 348 IGRGTFGSVYVASNRETGALCAMKEVDIFPDD---PKSAESIKQLEQEIKVLSHLKHPNI 404
           IG GT+G VY   N++TG + AMK++ +  ++   P +A       +EI +L  L+HPNI
Sbjct: 8   IGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAI------REISLLKELQHPNI 61

Query: 405 VQYYGSEIVEDKFYIYLEYVHPGSINKYVRE--HCGAITESVVRNFTRHILSGLAYLHSK 462
           V      + E + Y+  E++    + KY+        +   +V+++   IL G+ + HS+
Sbjct: 62  VCLQDVLMQESRLYLIFEFLSM-DLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSR 120

Query: 463 KTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSP-----------YWMAP 511
           + +HRD+K  NLL+D  GV+KLADFG+A+            G P           ++ AP
Sbjct: 121 RVLHRDLKPQNLLIDNKGVIKLADFGLARAF----------GIPVRVYTHEVVTLWYRAP 170

Query: 512 ELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPW---SEYEGAAAMFKVMRDTP-- 566
           E+++       S   +  VDIWS+G    EM T KP +   SE +    +F+++  TP  
Sbjct: 171 EVLLG------SPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRIL-GTPTE 223

Query: 567 -------AIPD------------------SLSPEGKDFLRCCFQRNPADRPPASLLLEHR 601
                  ++PD                  +L  +G D L      +PA R  A   L H 
Sbjct: 224 DVWPGVTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHP 283

Query: 602 FL 603
           + 
Sbjct: 284 YF 285

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score =  124 bits (313), Expect = 1e-31
 Identities = 88/293 (30%), Positives = 142/293 (48%), Gaps = 51/293 (17%)

Query: 347 LIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIK-VLSHLKHPNIV 405
            IGRG FG+V    ++ +G + A+K +    D+    +  K+L  ++  V+     P IV
Sbjct: 11  EIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE----KEQKRLLMDLDVVMRSSDCPYIV 66

Query: 406 QYYGS--------------EIVEDKFYIYLEYVHPGSINKYVREH-CGAITESVVRNFTR 450
           ++YG+              +I  DKFY   +YV+   +   + E   G I  + V+    
Sbjct: 67  KFYGALFREGDCWICMELMDISLDKFY---KYVY-EVLKSVIPEEILGKIAVATVK---- 118

Query: 451 HILSGLAYLHSK-KTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKG-SPYW 508
                L YL  + K IHRD+K +N+L+D +G +KL DFG++  L    A     G  PY 
Sbjct: 119 ----ALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAKTRDAGCRPY- 173

Query: 509 MAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFK-----VMR 563
           MAPE +    + G    S    D+WSLG T+ E+ TGK P+ ++    ++F      V  
Sbjct: 174 MAPERIDPSARDGYDVRS----DVWSLGITLYEVATGKFPYPKWN---SVFDQLTQVVKG 226

Query: 564 DTPAIPDSL----SPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQPDVP 612
           D P + +S     SP   +F+  C  ++ + RP    LLEH F+K+ ++ +V 
Sbjct: 227 DPPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKDYEERNVD 279

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score =  125 bits (315), Expect = 3e-31
 Identities = 88/329 (26%), Positives = 138/329 (41%), Gaps = 74/329 (22%)

Query: 340 SQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQ-----LEQEIK 394
             ++  K+IGRG FG V++  +++TG + AMK +       + ++ IK+     +  E  
Sbjct: 1   DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVL-------RKSDMIKRNQIAHVRAERD 53

Query: 395 VLSHLKHPNIVQYYGSEIVEDKFYIYL--EYVHPGS--INKYVREHCGAITESVVRNFTR 450
           +L+    P IV+ Y S   +D+ ++YL  EY+ PG   +N  +R+      E   R +  
Sbjct: 54  ILADADSPWIVKLYYS--FQDEEHLYLVMEYM-PGGDLMNLLIRKDV--FPEETARFYIA 108

Query: 451 HILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMK------- 503
            ++  L  +H    IHRDIK  N+L+DA G +KLADFG+ K +   K             
Sbjct: 109 ELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLL 168

Query: 504 -----------------------GSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTII 540
                                  G+P ++APE++      G      L  D WSLG  + 
Sbjct: 169 FRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLR-----GTPYG--LECDWWSLGVILY 221

Query: 541 EMYTGKPPWSEYEGAAAMFKVMRDT-----PAIPDSLSPEGKDFLRCCFQRNPADR-PPA 594
           EM  G PP+          K++        P  P  +SPE  D +       P DR    
Sbjct: 222 EMLYGFPPFYSDTLQETYNKIINWKESLRFPPDPP-VSPEAIDLICRLLCD-PEDRLGSF 279

Query: 595 SLLLEHRF--------LKNSQQPDVPSCS 615
             +  H F        L+ ++ P VP  S
Sbjct: 280 EEIKSHPFFKGIDWENLRETKPPFVPELS 308

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score =  123 bits (311), Expect = 4e-31
 Identities = 86/310 (27%), Positives = 148/310 (47%), Gaps = 56/310 (18%)

Query: 343 QKGKLIGRGTFGSVYVASNRETGALCAMKEV--DIFPDDPKSAESIKQLEQEIKVLSHLK 400
           +K   +G G  G V    +R +G + A K +  +I P          Q+ +E+KVL    
Sbjct: 4   EKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKP------AIRNQIIRELKVLHECN 57

Query: 401 HPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLH 460
            P IV +YG+   + +  I +E++  GS+++ +++  G I E+++   +  +L GL YL 
Sbjct: 58  SPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK-AGRIPENILGKISIAVLRGLTYLR 116

Query: 461 SK-KTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPYWMAPELMMAVMQ 519
            K K +HRD+K +N+LV++ G +KL DFG++  L    A+ S  G+  +M+PE +     
Sbjct: 117 EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN-SFVGTRSYMSPERL----- 170

Query: 520 KGKSSDSALAVDIWSLGCTIIEMYTGK---PPWSEYEGAA-------------------- 556
             + +   +  DIWSLG +++EM  G+   PP    E  A                    
Sbjct: 171 --QGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSG 228

Query: 557 ---------AMFK-----VMRDTPAIPDS-LSPEGKDFLRCCFQRNPADRPPASLLLEHR 601
                    A+F+     V    P +P    S E +DF+  C ++NP +R     L +H 
Sbjct: 229 HPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHP 288

Query: 602 FLKNSQQPDV 611
           F+K ++  +V
Sbjct: 289 FIKRAELEEV 298

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score =  122 bits (309), Expect = 6e-31
 Identities = 75/222 (33%), Positives = 117/222 (52%), Gaps = 42/222 (18%)

Query: 348 IGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQY 407
           IG GT+G VY A +++TG L A+K+V +  D+ K    I  + +EIK+L  L H NIV  
Sbjct: 15  IGEGTYGQVYKARDKDTGELVALKKVRL--DNEKEGFPITAI-REIKILRQLNHRNIVNL 71

Query: 408 YGSEIVEDK------------FYIYLEYV--------HPGSINKYVREHCGAITESVVRN 447
              EIV DK            FY+  EY+          G ++ +  +H        +++
Sbjct: 72  K--EIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVH-FSEDH--------IKS 120

Query: 448 FTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAK-HLTGQKADLSMKGSP 506
           F + +L GL Y H K  +HRDIK +N+L++  G +KLADFG+A+ + + +    + K   
Sbjct: 121 FMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVIT 180

Query: 507 YWM-APELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKP 547
            W   PEL++   + G       A+D+WS GC + E++T KP
Sbjct: 181 LWYRPPELLLGEERYGP------AIDVWSCGCILGELFTKKP 216

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score =  122 bits (307), Expect = 7e-31
 Identities = 67/249 (26%), Positives = 118/249 (47%), Gaps = 14/249 (5%)

Query: 348 IGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQY 407
           +G+G FG V     + TG + A K++D      +  E +   E++I  L  +    IV  
Sbjct: 1   LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKI--LEKVSSRFIVSL 58

Query: 408 YGSEIVEDKFYIYLEYVHPGSINKYVREHCGA-ITESVVRNFTRHILSGLAYLHSKKTIH 466
             +   +D   + +  ++ G +  ++         E+    +   I+ GL +LH ++ ++
Sbjct: 59  AYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVY 118

Query: 467 RDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPYWMAPELMMAVMQKGKSSDS 526
           RD+K  N+L+D  G V+++D G+A  L G K      G+P +MAPE++      G+  D 
Sbjct: 119 RDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRAGTPGYMAPEVLQ-----GEVYDF 173

Query: 527 ALAVDIWSLGCTIIEMYTGKPPWSEY----EGAAAMFKVMRDTPAIPDSLSPEGKDFLRC 582
             +VD ++LGCT+ EM  G+ P+ +     E      + +      PD  SPE KD    
Sbjct: 174 --SVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLCEA 231

Query: 583 CFQRNPADR 591
             Q++P  R
Sbjct: 232 LLQKDPEKR 240

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score =  123 bits (309), Expect = 8e-31
 Identities = 86/279 (30%), Positives = 135/279 (48%), Gaps = 30/279 (10%)

Query: 346 KLIGRGTFGSVYVASNRETGALCAMK----EVDIFPDDPKSAESIKQLEQEIKVLSHLKH 401
           KL+G+GTFG V +   + TG   AMK    EV I  D+      +     E +VL + +H
Sbjct: 1   KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDE------VAHTVTESRVLQNTRH 54

Query: 402 PNIVQYYGSEIVEDKFYIYLEYVHPGSINKYV-REHCGAITESVVRNFTRHILSGLAYLH 460
           P +     +    D+    +EY + G +  ++ RE     TE   R +   I+S L YLH
Sbjct: 55  PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRER--VFTEERARFYGAEIVSALEYLH 112

Query: 461 SKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMK---GSPYWMAPELMMAV 517
           S+  ++RDIK  NL++D  G +K+ DFG+ K   G     +MK   G+P ++APE++   
Sbjct: 113 SRDVVYRDIKLENLMLDKDGHIKITDFGLCKE--GISDGATMKTFCGTPEYLAPEVL--- 167

Query: 518 MQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDSLSPEGK 577
               + +D   AVD W LG  + EM  G+ P+   +       ++ +    P +LSPE K
Sbjct: 168 ----EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAK 223

Query: 578 DFLRCCFQRNPADR-----PPASLLLEHRFLKNSQQPDV 611
             L    +++P  R       A  ++EHRF  +    DV
Sbjct: 224 SLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDV 262

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score =  121 bits (306), Expect = 9e-31
 Identities = 74/271 (27%), Positives = 125/271 (46%), Gaps = 42/271 (15%)

Query: 348 IGRGTFGSVYVA-----SNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHP 402
           +G G FG V++             L A+K +     +  S ++ K  E+E ++L++ +H 
Sbjct: 13  LGEGAFGKVFLGECYHLEPENDKELVAVKTLK----ETASNDARKDFEREAELLTNFQHE 68

Query: 403 NIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREH-------------CGAITESVVRNFT 449
           NIV++YG     D   +  EY+  G +NK++R H              G +T S +    
Sbjct: 69  NIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIA 128

Query: 450 RHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHL-------TGQKADLSM 502
             I SG+ YL S+  +HRD+   N LV    VVK+ DFGM++ +        G    L +
Sbjct: 129 VQIASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPI 188

Query: 503 KGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFKV 561
           +    WM PE   ++M +  +++S    D+WS G  + E++T GK PW        +  +
Sbjct: 189 R----WMPPE---SIMYRKFTTES----DVWSFGVVLWEIFTYGKQPWYGLSNEEVIECI 237

Query: 562 MRDTPAI-PDSLSPEGKDFLRCCFQRNPADR 591
            +      P +   E  D +  C++R+P  R
Sbjct: 238 TQGRLLQRPRTCPSEVYDIMLGCWKRDPQQR 268

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score =  120 bits (302), Expect = 8e-30
 Identities = 83/278 (29%), Positives = 132/278 (47%), Gaps = 28/278 (10%)

Query: 346 KLIGRGTFGSVYVASNRETGALCAMK----EVDIFPDDPKSAESIKQLEQEIKVLSHLKH 401
           KL+G+GTFG V +   + TG   AMK    EV I  D+      +     E +VL + +H
Sbjct: 1   KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDE------VAHTLTESRVLQNTRH 54

Query: 402 PNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHS 461
           P +     S    D+    +EY + G +  ++       +E   R +   I+S L YLHS
Sbjct: 55  PFLTALKYSFQTHDRLCFVMEYANGGELFFHLS-RERVFSEDRARFYGAEIVSALGYLHS 113

Query: 462 KKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMK---GSPYWMAPELMMAVM 518
              ++RD+K  NL++D  G +K+ DFG+ K   G     +MK   G+P ++APE++    
Sbjct: 114 CDVVYRDLKLENLMLDKDGHIKITDFGLCKE--GISDGATMKTFCGTPEYLAPEVL---- 167

Query: 519 QKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDSLSPEGKD 578
              + +D   AVD W LG  + EM  G+ P+   +       ++ +    P +LSPE K 
Sbjct: 168 ---EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKS 224

Query: 579 FLRCCFQRNPADR-----PPASLLLEHRFLKNSQQPDV 611
            L    +++P  R       A  ++EHRF  +    DV
Sbjct: 225 LLAGLLKKDPKQRLGGGPEDAKEIMEHRFFASINWQDV 262

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score =  117 bits (296), Expect = 1e-29
 Identities = 81/265 (30%), Positives = 124/265 (46%), Gaps = 30/265 (11%)

Query: 343 QKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHP 402
           + G  IG+G FG V +   R  G   A+K +    DD  +A+       E  V++ L+HP
Sbjct: 9   KLGATIGKGEFGDVMLGDYR--GQKVAVKCLK---DDSTAAQ---AFLAEASVMTTLRHP 60

Query: 403 NIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGA-ITESVVRNFTRHILSGLAYLHS 461
           N+VQ  G  +  +  YI  EY+  GS+  Y+R    A IT +    F   +  G+ YL  
Sbjct: 61  NLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEE 120

Query: 462 KKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPY---WMAPELMMAVM 518
           K  +HRD+   N+LV    V K++DFG+AK     +A            W APE   A+ 
Sbjct: 121 KNFVHRDLAARNVLVSEDLVAKVSDFGLAK-----EASQGQDSGKLPVKWTAPE---ALR 172

Query: 519 QKGKSSDSALAVDIWSLGCTIIEMYT-GKPPW---SEYEGAAAMFKVMRDTPAIPDSLSP 574
           +K  S+ S    D+WS G  + E+Y+ G+ P+      +    + K  R     P+   P
Sbjct: 173 EKKFSTKS----DVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGYRMEA--PEGCPP 226

Query: 575 EGKDFLRCCFQRNPADRPPASLLLE 599
           E    ++ C++ +PA RP    L E
Sbjct: 227 EVYKVMKDCWELDPAKRPTFKQLRE 251

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score =  119 bits (299), Expect = 2e-29
 Identities = 81/252 (32%), Positives = 129/252 (51%), Gaps = 20/252 (7%)

Query: 346 KLIGRGTFGSVYVASNRETGALCAMK----EVDIFPDDPKSAESIKQLEQEIKVLSHLKH 401
            ++G+G+FG V +A  + T  L A+K    +V I  DD +       +E+ +  L   K 
Sbjct: 6   MVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECT----MVEKRVLALPG-KP 60

Query: 402 PNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHS 461
           P + Q +      D+ Y  +EYV+ G +  Y  +  G   E     +   I  GL +LHS
Sbjct: 61  PFLTQLHSCFQTMDRLYFVMEYVNGGDL-MYHIQQVGKFKEPHAVFYAAEIAIGLFFLHS 119

Query: 462 KKTIHRDIKGANLLVDASGVVKLADFGMAK-HLTGQKADLSMKGSPYWMAPELMMAVMQK 520
           K  I+RD+K  N+++DA G +K+ADFGM K ++ G K   +  G+P ++APE+ +A    
Sbjct: 120 KGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRTFCGTPDYIAPEI-IAYQPY 178

Query: 521 GKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFK-VMRDTPAIPDSLSPEGKDF 579
           GKS      VD W+ G  + EM  G+PP+ + E    +F+ +M    + P SLS E    
Sbjct: 179 GKS------VDWWAFGVLLYEMLAGQPPF-DGEDEDELFQSIMEHNVSYPKSLSKEAVSI 231

Query: 580 LRCCFQRNPADR 591
            +    ++PA R
Sbjct: 232 CKGLLTKHPAKR 243

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score =  118 bits (298), Expect = 3e-29
 Identities = 77/253 (30%), Positives = 126/253 (49%), Gaps = 19/253 (7%)

Query: 346 KLIGRGTFGSVYVA---SNRETGALCAMK---EVDIFPDDPKSAESIKQLEQEIKVLSHL 399
           K++G+G +G V+     +  +TG + AMK   +  I     ++ +     + E  +L  +
Sbjct: 2   KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIV----RNQKDTAHTKAERNILEAV 57

Query: 400 KHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYL 459
           KHP IV    +     K Y+ LEY+  G +  ++ E  G   E     +   I   L +L
Sbjct: 58  KHPFIVDLIYAFQTGGKLYLILEYLSGGELFMHL-EREGIFMEDTACFYLSEISLALEHL 116

Query: 460 HSKKTIHRDIKGANLLVDASGVVKLADFGMAK-HLTGQKADLSMKGSPYWMAPELMMAVM 518
           H +  I+RD+K  N+L+DA G VKL DFG+ K  +       +  G+  +MAPE++M   
Sbjct: 117 HQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTFCGTIEYMAPEILM--- 173

Query: 519 QKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDSLSPEGKD 578
                S    AVD WSLG  + +M TG PP++       + K+++    +P  L+PE +D
Sbjct: 174 ----RSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLPPYLTPEARD 229

Query: 579 FLRCCFQRNPADR 591
            L+   +RNP+ R
Sbjct: 230 LLKKLLKRNPSSR 242

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score =  118 bits (298), Expect = 3e-29
 Identities = 69/208 (33%), Positives = 112/208 (53%), Gaps = 22/208 (10%)

Query: 348 IGRGTFGSVYVASNRETGALCAMKEVD---IFPDDPKSAESIKQLEQEIKVLSHLKHPNI 404
           +G+G +G V++A  ++TG + A+K +    +F         ++ +  E  +L+  K   +
Sbjct: 9   VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLF-----KLNEVRHVLTERDILTTTKSEWL 63

Query: 405 VQYYGSEIVEDKFYIYL--EYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSK 462
           V+   +   +D  Y+YL  EYV PG   + +  + G ++E   R +   +   +  LH  
Sbjct: 64  VKLLYA--FQDDEYLYLAMEYV-PGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHEL 120

Query: 463 KTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPYWMAPELMMAVMQKGK 522
             IHRD+K  N L+DASG +KL DFG++K +    A+ S+ GSP +MAPE++     +GK
Sbjct: 121 GYIHRDLKPENFLIDASGHIKLTDFGLSKGIV-TYAN-SVVGSPDYMAPEVL-----RGK 173

Query: 523 SSDSALAVDIWSLGCTIIEMYTGKPPWS 550
             D    VD WSLGC + E   G PP+S
Sbjct: 174 GYD--FTVDYWSLGCMLYEFLCGFPPFS 199

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score =  117 bits (295), Expect = 3e-29
 Identities = 80/273 (29%), Positives = 125/273 (45%), Gaps = 37/273 (13%)

Query: 346 KLIGRGTFGSVYVA----SNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKH 401
           K +G G FG V +         TG   A+K ++      +  +     E+EI++L  L H
Sbjct: 10  KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLN--HSGEE--QHRSDFEREIEILRTLDH 65

Query: 402 PNIVQYYG--SEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYL 459
            NIV+Y G   +       + +EY+  GS+  Y++ H   I    +  F+  I  G+ YL
Sbjct: 66  ENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYL 125

Query: 460 HSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKG---SP-YWMAPELMM 515
            S++ IHRD+   N+LV++  +VK++DFG+AK L   K    +K    SP +W APE   
Sbjct: 126 GSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPE--- 182

Query: 516 AVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFKVMRDTPAI------ 568
            +     SS S    D+WS G T+ E++T G P  S       M  + +    +      
Sbjct: 183 CLRTSKFSSAS----DVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLEL 238

Query: 569 ---------PDSLSPEGKDFLRCCFQRNPADRP 592
                    P S   E  D ++ C++  P DRP
Sbjct: 239 LKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRP 271

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score =  116 bits (293), Expect = 8e-29
 Identities = 87/306 (28%), Positives = 141/306 (46%), Gaps = 60/306 (19%)

Query: 341 QWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDD---PKSAESIKQLEQEIKVLS 397
           Q++K + IG GT+G VY A +R T    A+K++ +  +D   P +A       +EI +L 
Sbjct: 3   QYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAI------REISLLK 56

Query: 398 HLKHPNIVQYYGSEIVEDKFYIYLEYV------HPGSINKYVREHCGAITESVVRNFTRH 451
            ++H NIV+       E + Y+  EY+      H  S   + +         +++ +   
Sbjct: 57  EMQHGNIVRLQDVVHSEKRLYLVFEYLDLDLKKHMDSSPDFAKNP------RLIKTYLYQ 110

Query: 452 ILSGLAYLHSKKTIHRDIKGANLLVDAS-GVVKLADFGMAKHLTGQKADLSMKGSPYWM- 509
           IL G+AY HS + +HRD+K  NLL+D     +KLADFG+A+         + +    W  
Sbjct: 111 ILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVVTLWYR 170

Query: 510 APELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPW---SEYEGAAAMFKVMRDTP 566
           APE+++       S   +  VDIWS+GC   EM   KP +   SE +    +F+++  TP
Sbjct: 171 APEILLG------SRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRIL-GTP 223

Query: 567 ---------AIPD------------------SLSPEGKDFLRCCFQRNPADRPPASLLLE 599
                    ++PD                  +L P G D L    + +P+ R  A   LE
Sbjct: 224 NEETWPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE 283

Query: 600 HRFLKN 605
           H + K+
Sbjct: 284 HEYFKD 289

Length = 294

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score =  117 bits (294), Expect = 9e-29
 Identities = 76/263 (28%), Positives = 126/263 (47%), Gaps = 23/263 (8%)

Query: 337 PMNSQWQ-----KGKLIGRGTFGSVYVASNRETG---ALCAMKEVDIFPDDPKSAESIKQ 388
           P  S W+      G+ +G G+FG V +A ++ TG   A+  +K+ +I        + ++ 
Sbjct: 10  PDTSSWKLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREIL-----KMKQVQH 64

Query: 389 LEQEIKVLSHLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNF 448
           + QE  +L  L HP IV    S   E++ Y  LE+V  G +  ++R+  G     V + +
Sbjct: 65  VAQEKSILMELSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRK-AGRFPNDVAKFY 123

Query: 449 TRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPYW 508
              ++    YLHSK  I+RD+K  NLL+D  G VK+ DFG AK +  +   L   G+P +
Sbjct: 124 HAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRTFTLC--GTPEY 181

Query: 509 MAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAI 568
           +APE+   +  KG       AVD W++G  + E   G PP+ +        K++      
Sbjct: 182 LAPEV---IQSKGHGK----AVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKF 234

Query: 569 PDSLSPEGKDFLRCCFQRNPADR 591
           P+      +D ++   Q +   R
Sbjct: 235 PNWFDGRARDLVKGLLQTDHTKR 257

Length = 329

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score =  116 bits (292), Expect = 1e-28
 Identities = 76/253 (30%), Positives = 133/253 (52%), Gaps = 21/253 (8%)

Query: 346 KLIGRGTFGSVYVA---SNRETGALCAMKEVDIFPDDPKSAESIK---QLEQEIKVLSHL 399
           K++G+G+FG V++    +  + G L AMK +       K+   ++   + + E  +L+ +
Sbjct: 2   KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLK------KATLKVRDRVRTKMERDILAEV 55

Query: 400 KHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYL 459
            HP IV+ + +   E K Y+ L+++  G +   + +     TE  V+ +   +   L +L
Sbjct: 56  NHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEV-MFTEEDVKFYLAELALALDHL 114

Query: 460 HSKKTIHRDIKGANLLVDASGVVKLADFGMAKH-LTGQKADLSMKGSPYWMAPELMMAVM 518
           HS   I+RD+K  N+L+D  G +KL DFG++K  +  +K   S  G+  +MAPE+   V 
Sbjct: 115 HSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEV---VN 171

Query: 519 QKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDSLSPEGKD 578
           ++G +     + D WS G  + EM TG  P+   +    M  +++    +P  LSPE + 
Sbjct: 172 RRGHTQ----SADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMPQFLSPEAQS 227

Query: 579 FLRCCFQRNPADR 591
            LR  F+RNPA+R
Sbjct: 228 LLRALFKRNPANR 240

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score =  116 bits (292), Expect = 2e-28
 Identities = 84/280 (30%), Positives = 136/280 (48%), Gaps = 31/280 (11%)

Query: 346 KLIGRGTFGSVYVASNRETGALCAMK----EVDIFPDDPKSAESIKQLEQEIKVLSHLKH 401
           KL+G+GTFG V +   + TG   AMK    EV +  D+      +     E +VL + +H
Sbjct: 1   KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDE------VAHTLTENRVLQNSRH 54

Query: 402 PNIVQYYGSEIVEDKFYIYLEYVHPGSINKYV-REHCGAITESVVRNFTRHILSGLAYLH 460
           P +     S    D+    +EY + G +  ++ RE     +E   R +   I+S L YLH
Sbjct: 55  PFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRER--VFSEDRARFYGAEIVSALDYLH 112

Query: 461 SKK-TIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMK---GSPYWMAPELMMA 516
           S+K  ++RD+K  NL++D  G +K+ DFG+ K   G K   +MK   G+P ++APE++  
Sbjct: 113 SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKE--GIKDGATMKTFCGTPEYLAPEVL-- 168

Query: 517 VMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDSLSPEG 576
                + +D   AVD W LG  + EM  G+ P+   +       ++ +    P +LSPE 
Sbjct: 169 -----EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEA 223

Query: 577 KDFLRCCFQRNPADR-----PPASLLLEHRFLKNSQQPDV 611
           K  L    +++P  R       A  +++H+F       DV
Sbjct: 224 KSLLSGLLKKDPKQRLGGGPDDAKEIMQHKFFAGIVWQDV 263

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score =  115 bits (290), Expect = 2e-28
 Identities = 81/276 (29%), Positives = 140/276 (50%), Gaps = 28/276 (10%)

Query: 346 KLIGRGTFGSVYVA---SNRETGALCAMKEVD--IFPDDPKSAESIKQLEQEIKVLSHLK 400
           +++G G +G V++       + G L AMK +         K+AE  +    E +VL  ++
Sbjct: 6   RVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRT---ERQVLEAVR 62

Query: 401 H-PNIVQYYGSEIVEDKFYIYLEYVHPGSI--NKYVREHCGAITESVVRNFTRHILSGLA 457
             P +V  + +   + K ++ L+YV+ G +  + Y REH    TES VR +   I+  L 
Sbjct: 63  RCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREH---FTESEVRVYIAEIVLALD 119

Query: 458 YLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKAD--LSMKGSPYWMAPELMM 515
           +LH    I+RDIK  N+L+D+ G V L DFG++K    ++ +   S  G+  +MAPE++ 
Sbjct: 120 HLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVI- 178

Query: 516 AVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWS---EYEGAAAMFK-VMRDTPAIPDS 571
               +G S     AVD WSLG    E+ TG  P++   E    + + + +++  P  P +
Sbjct: 179 ----RGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPPFPKT 234

Query: 572 LSPEGKDFLRCCFQRNPADR---PPASLLLEHRFLK 604
           +S E +DF++   +++P  R     A  +  H F +
Sbjct: 235 MSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQ 270

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score =  115 bits (289), Expect = 3e-28
 Identities = 75/251 (29%), Positives = 128/251 (50%), Gaps = 18/251 (7%)

Query: 346 KLIGRGTFGSVYVASNRETG---ALCAMKEVDIFPDDPKSAESIKQLEQEIKVLS-HLKH 401
           K++G+G+FG V++A  + T    A+ A+K+  +  DD      +     E +VLS   +H
Sbjct: 1   KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMV-----EKRVLSLAWEH 55

Query: 402 PNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHS 461
           P +   Y +   ++  +  +EY++ G +  ++ + C          +   I+ GL +LHS
Sbjct: 56  PFLTHLYCTFQTKENLFFVMEYLNGGDLMFHI-QSCHKFDLPRATFYAAEIICGLQFLHS 114

Query: 462 KKTIHRDIKGANLLVDASGVVKLADFGMAK-HLTGQKADLSMKGSPYWMAPELMMAVMQK 520
           K  ++RD+K  N+L+D  G +K+ADFGM K ++ G     +  G+P ++APE+++   QK
Sbjct: 115 KGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLG--QK 172

Query: 521 GKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDSLSPEGKDFL 580
             +S     VD WS G  + EM  G+ P+  ++       +  D P  P  L+ E KD L
Sbjct: 173 YNTS-----VDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPCYPRWLTREAKDIL 227

Query: 581 RCCFQRNPADR 591
              F R P  R
Sbjct: 228 VKLFVREPERR 238

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score =  114 bits (287), Expect = 8e-28
 Identities = 79/278 (28%), Positives = 127/278 (45%), Gaps = 20/278 (7%)

Query: 348 IGRGTFGSVYVASNRETGALCAMKEV---DIFPDDPKSAESIKQLEQEIKVLSHLKHPNI 404
           +GRG FG V +A  ++TG L A+K +   DI   D    ES+   ++  +  +  +HP +
Sbjct: 7   LGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARD--EVESLMCEKRIFETANSERHPFL 64

Query: 405 VQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKT 464
           V  +     ED     +EY   G +  ++  H    +E     +   ++ GL YLH  K 
Sbjct: 65  VNLFACFQTEDHVCFVMEYAAGGDLMMHI--HTDVFSEPRAVFYAACVVLGLQYLHENKI 122

Query: 465 IHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLS-MKGSPYWMAPELMMAVMQKGKS 523
           ++RD+K  NLL+D  G VK+ADFG+ K   G     S   G+P ++APE++        S
Sbjct: 123 VYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTSTFCGTPEFLAPEVLT-----ETS 177

Query: 524 SDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDSLSPEGKDFLRCC 583
                AVD W LG  I EM  G+ P+   +       ++ D    P  LS E    +R  
Sbjct: 178 YTR--AVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSREAISIMRRL 235

Query: 584 FQRNPADRPPASL-----LLEHRFLKNSQQPDVPSCSL 616
            +RNP  R  +       + +  F ++    D+ +  +
Sbjct: 236 LRRNPERRLGSGEKDAEDVKKQPFFRDINWDDLLARKI 273

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score =  112 bits (282), Expect = 1e-27
 Identities = 83/268 (30%), Positives = 141/268 (52%), Gaps = 19/268 (7%)

Query: 347 LIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQ-EIKVLSHLKHPNIV 405
           +IGRG FG VY     +TG + AMK +D      K  E++   E+  + ++S    P IV
Sbjct: 1   IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60

Query: 406 QYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTI 465
               +    DK    L+ ++ G ++ ++ +H G  +E  +R +   I+ GL ++H++  +
Sbjct: 61  CMTYAFHTPDKLCFILDLMNGGDLHYHLSQH-GVFSEKEMRFYATEIILGLEHMHNRFVV 119

Query: 466 HRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPYWMAPELMMAVMQKGKSSD 525
           +RD+K AN+L+D  G V+++D G+A   + +K   S+ G+  +MAPE    V+QKG + D
Sbjct: 120 YRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV-GTHGYMAPE----VLQKGTAYD 174

Query: 526 SALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAI----PDSLSPEGKDFLR 581
           S  + D +SLGC + ++  G  P+ +++      ++ R T  +    PDS SPE K  L 
Sbjct: 175 S--SADWFSLGCMLFKLLRGHSPFRQHK-TKDKHEIDRMTLTVNVELPDSFSPELKSLLE 231

Query: 582 CCFQRNPADR-----PPASLLLEHRFLK 604
              QR+ + R       A  + EH F K
Sbjct: 232 GLLQRDVSKRLGCLGRGAQEVKEHVFFK 259

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score =  113 bits (285), Expect = 1e-27
 Identities = 78/251 (31%), Positives = 126/251 (50%), Gaps = 18/251 (7%)

Query: 346 KLIGRGTFGSVYVASNRETGALCAMKEVD---IFPDDPKSAESIKQLEQEIKVLSHLKHP 402
           +++G+G+FG V +A  +E+G L A+K +    I  DD          E+ I  L+   HP
Sbjct: 1   RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVEC---TMTEKRILSLAR-NHP 56

Query: 403 NIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSK 462
            + Q Y      D+ +  +E+V+ G +  ++++      E+  R +   I S L +LH K
Sbjct: 57  FLTQLYCCFQTPDRLFFVMEFVNGGDLMFHIQK-SRRFDEARARFYAAEITSALMFLHDK 115

Query: 463 KTIHRDIKGANLLVDASGVVKLADFGMAKH-LTGQKADLSMKGSPYWMAPELMMAVMQKG 521
             I+RD+K  N+L+D  G  KLADFGM K  +   K   +  G+P ++APE++   M  G
Sbjct: 116 GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQE-MLYG 174

Query: 522 KSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFK-VMRDTPAIPDSLSPEGKDFL 580
            S      VD W++G  + EM  G  P+ E E    +F+ ++ D    P  LS +  D L
Sbjct: 175 PS------VDWWAMGVLLYEMLCGHAPF-EAENEDDLFEAILNDEVVYPTWLSQDAVDIL 227

Query: 581 RCCFQRNPADR 591
           +    +NP  R
Sbjct: 228 KAFMTKNPTMR 238

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score =  113 bits (286), Expect = 1e-27
 Identities = 84/318 (26%), Positives = 137/318 (43%), Gaps = 62/318 (19%)

Query: 348 IGRGTFGSVYVASNRETGALCAMKEV-DIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQ 406
           IG G +G V  A +  +G   A+K++   F D P  A   K+  +E+K+L H KH NI+ 
Sbjct: 13  IGSGAYGVVCSAIDTRSGKKVAIKKIPHAF-DVPTLA---KRTLRELKILRHFKHDNIIA 68

Query: 407 YYGSEIVEDK------FYIYLEYVHPGSINKYVREHCGA-ITESVVRNFTRHILSGLAYL 459
               +I+          Y+ ++ +    ++  +  H    +TE  +R F   +L GL Y+
Sbjct: 69  I--RDILRPPGADFKDVYVVMDLME-SDLHHII--HSDQPLTEEHIRYFLYQLLRGLKYI 123

Query: 460 HSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPY-----WMAPELM 514
           HS   IHRD+K +NLLV+    +++ DFGMA+ L+    +     + Y     + APEL+
Sbjct: 124 HSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELL 183

Query: 515 MAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKP--PWSEYEGAAAMFKVMRDTPA----- 567
           +++       +   A+D+WS+GC   EM   +   P   Y     +   +  +P+     
Sbjct: 184 LSL------PEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLN 237

Query: 568 -------------------------IPDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRF 602
                                     P + SPE  D L    Q +P +R      L+H F
Sbjct: 238 RIGSDRVRKYIQNLPRKQPVPWSKIFPKA-SPEALDLLSQMLQFDPEERITVEQALQHPF 296

Query: 603 LKNSQQP-DVPSCSLSFS 619
           L     P D P+C   F 
Sbjct: 297 LAQYHDPDDEPTCPPPFD 314

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score =  113 bits (285), Expect = 2e-27
 Identities = 83/322 (25%), Positives = 142/322 (44%), Gaps = 57/322 (17%)

Query: 342 WQKGKLIGRGTFGSVYVASNRET--GALCAMKEV-DIFPDDPKSAESIKQLEQEIKVLSH 398
           ++  K +G+G +G V  A N ET      A+K++ ++F          K+  +E+K+L H
Sbjct: 2   YELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVF----SKKILAKRALRELKLLRH 57

Query: 399 LK-HPNIVQYYGSEIVE----DKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHIL 453
            + H NI   Y  +IV     ++ Y+Y E +    +++ +R     +T++  ++F   IL
Sbjct: 58  FRGHKNITCLYDMDIVFPGNFNELYLYEELME-ADLHQIIRSG-QPLTDAHFQSFIYQIL 115

Query: 454 SGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAK--HLTGQKADLSMKG---SPYW 508
            GL Y+HS   +HRD+K  NLLV+A   +K+ DFG+A+       +    M     + ++
Sbjct: 116 CGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWY 175

Query: 509 MAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVM------ 562
            APE+M++     K      A+D+WS+GC + E+   KP +   +    + +++      
Sbjct: 176 RAPEIMLSFQSYTK------AIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTP 229

Query: 563 -----------------RDTPAIPD--------SLSPEGKDFLRCCFQRNPADRPPASLL 597
                            R  P IP         + +P   D L      +P  R      
Sbjct: 230 DEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEA 289

Query: 598 LEHRFLKNSQQP-DVPSCSLSF 618
           LEH +L     P D P C   F
Sbjct: 290 LEHPYLAIWHDPDDEPVCQKPF 311

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score =  111 bits (279), Expect = 3e-27
 Identities = 71/216 (32%), Positives = 111/216 (51%), Gaps = 31/216 (14%)

Query: 343 QKGKLIGRGTFGSV----YVASNRETGALCAMKEVDIFPDDPKSAESIKQLE----QEIK 394
           +K +++G G FG V    Y  +N  TG + A+K +          E  +Q      +EI 
Sbjct: 7   KKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTL--------KRECGQQNTSGWKKEIN 58

Query: 395 VLSHLKHPNIVQYYG--SEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHI 452
           +L  L H NIV+Y G  SE       + +EYV  GS+  Y+ +H   + + ++  F + I
Sbjct: 59  ILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQLLL--FAQQI 116

Query: 453 LSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHL-TGQK-ADLSMKG-SP-YW 508
             G+AYLHS+  IHRD+   N+L+D   +VK+ DFG+AK +  G +   +   G SP +W
Sbjct: 117 CEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFW 176

Query: 509 MAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT 544
            A E +       K +  + A D+WS G T+ E+ T
Sbjct: 177 YAVECL-------KENKFSYASDVWSFGVTLYELLT 205

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score =  112 bits (282), Expect = 3e-27
 Identities = 90/319 (28%), Positives = 135/319 (42%), Gaps = 75/319 (23%)

Query: 348 IGRGTFGSVYVA--SNRETGALCAMKEVDIFPDDPKSAESIKQLE-QEIKVLSHLKHPNI 404
           IGRGT+G VY A   N + G   A+K+   F  D +    I Q   +EI +L  LKH N+
Sbjct: 8   IGRGTYGRVYKAKRKNGKDGKEYAIKK---FKGDKEQYTGISQSACREIALLRELKHENV 64

Query: 405 VQYYGSEIVED---KFYIYLEYV-HP-GSINKYVREHCG-AITESVVRNFTRHILSGLAY 458
           V       +E      Y+  +Y  H    I K+ R+    +I  S+V++    IL+G+ Y
Sbjct: 65  VSLVEV-FLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHY 123

Query: 459 LHSKKTIHRDIKGANLLV----DASGVVKLADFGMAKHLTGQKADLSMKGSP----YWM- 509
           LHS   +HRD+K AN+LV       GVVK+ D G+A+        L+    P     W  
Sbjct: 124 LHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLA-DLDPVVVTIWYR 182

Query: 510 APELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWS------------EYEGAAA 557
           APEL++      K      A+DIW++GC   E+ T +P +             + +    
Sbjct: 183 APELLLGARHYTK------AIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER 236

Query: 558 MFKVM-----RDTPAI---PD--------------------------SLSPEGKDFLRCC 583
           +F+V+     +D P I   P+                              +G D LR  
Sbjct: 237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKL 296

Query: 584 FQRNPADRPPASLLLEHRF 602
            + +P  R  A   LEH +
Sbjct: 297 LEYDPTKRITAEEALEHPY 315

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score =  112 bits (282), Expect = 3e-27
 Identities = 78/253 (30%), Positives = 123/253 (48%), Gaps = 22/253 (8%)

Query: 346 KLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSA----ESIKQLEQEIKVL-SHLK 400
           K+IG+G+FG V +A ++  G   A+K +       K A    +  K +  E  VL  ++K
Sbjct: 1   KVIGKGSFGKVLLAKHKADGKFYAVKVLQ------KKAILKKKEQKHIMAERNVLLKNVK 54

Query: 401 HPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYV-REHCGAITESVVRNFTRHILSGLAYL 459
           HP +V  + S    DK Y  L+YV+ G +  ++ RE      E   R +   I S L YL
Sbjct: 55  HPFLVGLHYSFQTADKLYFVLDYVNGGELFFHLQRERS--FPEPRARFYAAEIASALGYL 112

Query: 460 HSKKTIHRDIKGANLLVDASGVVKLADFGMAKH-LTGQKADLSMKGSPYWMAPELMMAVM 518
           HS   I+RD+K  N+L+D+ G V L DFG+ K  +   K   +  G+P ++APE    V+
Sbjct: 113 HSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPE----VL 168

Query: 519 QKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDSLSPEGKD 578
           +K +  D    VD W LG  + EM  G PP+   + A     ++     +  ++S   + 
Sbjct: 169 RK-QPYDR--TVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLRLKPNISVSARH 225

Query: 579 FLRCCFQRNPADR 591
            L    Q++   R
Sbjct: 226 LLEGLLQKDRTKR 238

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score =  110 bits (277), Expect = 5e-27
 Identities = 73/267 (27%), Positives = 119/267 (44%), Gaps = 34/267 (12%)

Query: 345 GKLIGRGTFGSVYVAS--NRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHP 402
            K +G G FG V++     +   A+  ++E  +  DD           +E KV+  L HP
Sbjct: 9   LKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMSEDD---------FIEEAKVMMKLSHP 59

Query: 403 NIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSK 462
           N+VQ YG    +   +I  EY+  G +  Y+RE  G +    + +    +   + YL S 
Sbjct: 60  NLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESN 119

Query: 463 KTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPY---WMAPELMMAVMQ 519
             IHRD+   N LV    VVK++DFG+A+++   +   S +G+ +   W  PE+      
Sbjct: 120 GFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSS-QGTKFPVKWAPPEVFDYSRF 178

Query: 520 KGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEY------EGAAAMFKVMRDTPAIPDSL 572
             KS       D+WS G  + E+++ GK P+  +      E  +A +++ R     P   
Sbjct: 179 SSKS-------DVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRLYR-----PKLA 226

Query: 573 SPEGKDFLRCCFQRNPADRPPASLLLE 599
             E    +  C+   P DRP    LL 
Sbjct: 227 PTEVYTIMYSCWHEKPEDRPAFKKLLS 253

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score =  111 bits (279), Expect = 7e-27
 Identities = 80/277 (28%), Positives = 131/277 (47%), Gaps = 26/277 (9%)

Query: 346 KLIGRGTFGSVYVASNRETGALCAMK----EVDIFPDDPKSAESIKQLEQEIKVLSHLKH 401
           KL+G+GTFG V +   + +G   AMK    EV I  D+      +     E +VL + +H
Sbjct: 1   KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDE------VAHTLTESRVLKNTRH 54

Query: 402 PNIVQYYGSEIVEDKFYIYLEYVHPGSINKYV-REHCGAITESVVRNFTRHILSGLAYLH 460
           P +     S   +D+    +EYV+ G +  ++ RE     +E   R +   I+S L YLH
Sbjct: 55  PFLTSLKYSFQTKDRLCFVMEYVNGGELFFHLSRER--VFSEDRTRFYGAEIVSALDYLH 112

Query: 461 SKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADL-SMKGSPYWMAPELMMAVMQ 519
           S K ++RD+K  NL++D  G +K+ DFG+ K      A + +  G+P ++APE++     
Sbjct: 113 SGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGTPEYLAPEVL----- 167

Query: 520 KGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDSLSPEGKDF 579
             + +D   AVD W LG  + EM  G+ P+   +       ++ +    P +LS + K  
Sbjct: 168 --EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFPRTLSADAKSL 225

Query: 580 LRCCFQRNPADR-----PPASLLLEHRFLKNSQQPDV 611
           L     ++P  R       A  ++ H F       DV
Sbjct: 226 LSGLLIKDPNKRLGGGPDDAKEIMRHSFFTGVNWQDV 262

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score =  110 bits (277), Expect = 1e-26
 Identities = 87/304 (28%), Positives = 141/304 (46%), Gaps = 56/304 (18%)

Query: 342 WQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDD---PKSAESIKQLEQEIKVLSH 398
           ++K + IG GT+G VY A ++ TG L A+K+  +  D+   P +A       +EI +L  
Sbjct: 3   YEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTAL------REISLLQM 56

Query: 399 LKH-PNIVQYYGSEIVEDK-----FYIYLEYVHP---GSINKYVREHCGAITESVVRNFT 449
           L     IV+    E VE+K      Y+  EY+       ++   R     +    +++F 
Sbjct: 57  LSESIYIVRLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFM 116

Query: 450 RHILSGLAYLHSKKTIHRDIKGANLLVD-ASGVVKLADFGMAKHLTGQKADLSMKGSPYW 508
             +L G+A+ H    +HRD+K  NLLVD   G++K+AD G+ +  +      + +    W
Sbjct: 117 YQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIVTLW 176

Query: 509 M-APELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPW---SEYEGAAAMFKVM-- 562
             APE+++       S+  +  VDIWS+GC   EM   +P +   SE +    +FK++  
Sbjct: 177 YRAPEVLLG------STHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGT 230

Query: 563 ------------RD------------TPAIPDSLSPEGKDFLRCCFQRNPADRPPASLLL 598
                       RD            + A+PD LSPEG D L+   + +PA R  A   L
Sbjct: 231 PTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPD-LSPEGLDLLQKMLRYDPAKRISAKAAL 289

Query: 599 EHRF 602
            H +
Sbjct: 290 THPY 293

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score =  110 bits (277), Expect = 1e-26
 Identities = 68/213 (31%), Positives = 113/213 (53%), Gaps = 17/213 (7%)

Query: 340 SQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHL 399
           ++++K   IG GT+G VY A +  +G + A+K+V +  D+ +    I  L +EI +L +L
Sbjct: 7   TEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRM--DNERDGIPISSL-REITLLLNL 63

Query: 400 KHPNIVQYYGSEIVE----DKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSG 455
           +HPNIV+    E+V     D  ++ +EY     +   +       +ES V+     +L G
Sbjct: 64  RHPNIVEL--KEVVVGKHLDSIFLVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRG 120

Query: 456 LAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPYWM-APELM 514
           L YLH    IHRD+K +NLL+   G +K+ADFG+A+        ++ K    W  APEL+
Sbjct: 121 LQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVVTLWYRAPELL 180

Query: 515 MAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKP 547
           +        +    A+D+W++GC + E+   KP
Sbjct: 181 LG------CTTYTTAIDMWAVGCILAELLAHKP 207

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score =  109 bits (274), Expect = 1e-26
 Identities = 75/276 (27%), Positives = 128/276 (46%), Gaps = 52/276 (18%)

Query: 348 IGRGTFGSVYVA--------SNRETGALCAMKEVDIFPDDPKSAESIKQ-LEQEIKVLSH 398
           +G G FG V++A         ++   A+ A+KE           ES +Q  ++E ++L+ 
Sbjct: 13  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS---------ESARQDFQREAELLTV 63

Query: 399 LKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREH--------------CGAITESV 444
           L+H +IV++YG         +  EY+  G +N+++R H               G +T   
Sbjct: 64  LQHQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQ 123

Query: 445 VRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHL-------TGQK 497
           +      I SG+ YL S   +HRD+   N LV    VVK+ DFGM++ +        G +
Sbjct: 124 MLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGR 183

Query: 498 ADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAA 556
             L ++    WM PE   +++ +  +++S    DIWS G  + E++T GK PW +     
Sbjct: 184 TMLPIR----WMPPE---SILYRKFTTES----DIWSFGVVLWEIFTYGKQPWYQLSNTE 232

Query: 557 AMFKVMRDTP-AIPDSLSPEGKDFLRCCFQRNPADR 591
           A+  + +      P +  PE    ++ C+QR P  R
Sbjct: 233 AIECITQGRELERPRTCPPEVYAIMQGCWQREPQQR 268

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score =  110 bits (278), Expect = 2e-26
 Identities = 68/225 (30%), Positives = 117/225 (52%), Gaps = 32/225 (14%)

Query: 341 QWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDP-KSAESIKQLEQEIKVLSHL 399
           ++Q    +G G +G V  A + +TG   A+K++      P +SA   K+  +E+++L H+
Sbjct: 16  RYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLS----RPFQSAIHAKRTYRELRLLKHM 71

Query: 400 KHPNIVQ----YYGSEIVEDKFYIYLEYVHP---GSINKYVREHCGAITESVVRNFTRHI 452
            H N++     +  +  +ED   +YL  V       +N  V+  C  +++  ++     I
Sbjct: 72  DHENVIGLLDVFTPASSLEDFQDVYL--VTHLMGADLNNIVK--CQKLSDDHIQFLVYQI 127

Query: 453 LSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKG---SPYWM 509
           L GL Y+HS   IHRD+K +N+ V+    +K+ DFG+A+H      D  M G   + ++ 
Sbjct: 128 LRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARH-----TDDEMTGYVATRWYR 182

Query: 510 APELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKP--PWSEY 552
           APE+M+  M   +       VDIWS+GC + E+ TGK   P S++
Sbjct: 183 APEIMLNWMHYNQ------TVDIWSVGCIMAELLTGKTLFPGSDH 221

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score =  109 bits (274), Expect = 3e-26
 Identities = 72/252 (28%), Positives = 122/252 (48%), Gaps = 20/252 (7%)

Query: 346 KLIGRGTFGSVYVASNRETGALCAMK----EVDIFPDDPKSAESIKQLEQEIKVLSHLKH 401
           K++G+G+FG V +A  + T  + A+K    +V +  DD          E+ I  L+  KH
Sbjct: 1   KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCT----MTEKRILALAA-KH 55

Query: 402 PNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHS 461
           P +   +     +D+ +  +EYV+ G +  +  +      E   R +   +   L +LH 
Sbjct: 56  PFLTALHCCFQTKDRLFFVMEYVNGGDL-MFQIQRSRKFDEPRSRFYAAEVTLALMFLHR 114

Query: 462 KKTIHRDIKGANLLVDASGVVKLADFGMAKH-LTGQKADLSMKGSPYWMAPELMMAVMQK 520
              I+RD+K  N+L+DA G  KLADFGM K  +       +  G+P ++APE++      
Sbjct: 115 HGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEIL------ 168

Query: 521 GKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFK-VMRDTPAIPDSLSPEGKDF 579
            +  +   +VD W+LG  + EM  G+PP+ E +    +F+ ++ D    P  LS E    
Sbjct: 169 -QELEYGPSVDWWALGVLMYEMMAGQPPF-EADNEDDLFESILHDDVLYPVWLSKEAVSI 226

Query: 580 LRCCFQRNPADR 591
           L+    +NP  R
Sbjct: 227 LKAFMTKNPNKR 238

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score =  108 bits (271), Expect = 3e-26
 Identities = 81/268 (30%), Positives = 140/268 (52%), Gaps = 17/268 (6%)

Query: 347 LIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQ-EIKVLSHLKHPNIV 405
           +IGRG FG VY     +TG + AMK +D      K  E++   E+  + ++S    P IV
Sbjct: 1   IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60

Query: 406 QYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTI 465
               +    DK    L+ ++ G ++ ++ +H G  +E+ +R +   I+ GL ++H++  +
Sbjct: 61  CMSYAFHTPDKLSFILDLMNGGDLHYHLSQH-GVFSEAEMRFYAAEIILGLEHMHNRFVV 119

Query: 466 HRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPYWMAPELMMAVMQKGKSSD 525
           +RD+K AN+L+D  G V+++D G+A   + +K   S+ G+  +MAPE    V+QKG + D
Sbjct: 120 YRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV-GTHGYMAPE----VLQKGVAYD 174

Query: 526 SALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAM-FKVMRDT--PAIPDSLSPEGKDFLRC 582
           S  + D +SLGC + ++  G  P+ +++         M  T    +PDS SPE +  L  
Sbjct: 175 S--SADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEG 232

Query: 583 CFQRNPADR-----PPASLLLEHRFLKN 605
             QR+   R       A  + EH F ++
Sbjct: 233 LLQRDVNRRLGCLGRGAQEVKEHPFFRS 260

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score =  108 bits (271), Expect = 5e-26
 Identities = 63/203 (31%), Positives = 106/203 (52%), Gaps = 12/203 (5%)

Query: 346 KLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIV 405
           + +G G++ +VY   +R  G L A+K + +  ++     +I+    E  +L  LKH NIV
Sbjct: 11  EKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIR----EASLLKGLKHANIV 66

Query: 406 QYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTI 465
             +     ++      EY+H   + +Y+ +H G +    VR F   +L GLAY+H +  +
Sbjct: 67  LLHDIIHTKETLTFVFEYMHT-DLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHIL 125

Query: 466 HRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPYWM-APELMMAVMQKGKSS 524
           HRD+K  NLL+   G +KLADFG+A+  +      S +    W   P++++       ++
Sbjct: 126 HRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVVTLWYRPPDVLLG------AT 179

Query: 525 DSALAVDIWSLGCTIIEMYTGKP 547
           D + A+DIW  GC  IEM  G+P
Sbjct: 180 DYSSALDIWGAGCIFIEMLQGQP 202

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score =  109 bits (273), Expect = 5e-26
 Identities = 69/222 (31%), Positives = 107/222 (48%), Gaps = 13/222 (5%)

Query: 347 LIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSA----ESIKQLEQEIKVLSHLKHP 402
           L+GRG FG V V   + TG + AMK +       KS     E++   E+E  +LS    P
Sbjct: 8   LVGRGHFGEVQVVREKATGDIYAMKVMK------KSVLLAQETVSFFEEERDILSISNSP 61

Query: 403 NIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSK 462
            I Q   +   +D  Y+ +EY   G +   +  +     E + + +   ++  +  +H  
Sbjct: 62  WIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQM 121

Query: 463 KTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMK--GSPYWMAPELMMAVMQK 520
             +HRDIK  N+L+D +G +KLADFG A  LT  K   S    G+P ++APE++  +   
Sbjct: 122 GYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGD 181

Query: 521 GKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVM 562
           GK +   +  D WSLG    EM  G+ P+ E   A     +M
Sbjct: 182 GKGT-YGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIM 222

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score =  107 bits (268), Expect = 7e-26
 Identities = 78/260 (30%), Positives = 122/260 (46%), Gaps = 31/260 (11%)

Query: 344 KGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPN 403
           K KL G G +G VY    ++     A+K +       +    +++  +E  V+  +KHPN
Sbjct: 11  KHKL-GGGQYGEVYEGVWKKYSLTVAVKTLK------EDTMEVEEFLKEAAVMKEIKHPN 63

Query: 404 IVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCG--AITESVVRNFTRHILSGLAYLHS 461
           +VQ  G    E  FYI  E++  G++  Y+RE C    +   V+      I S + YL  
Sbjct: 64  LVQLLGVCTREPPFYIITEFMTYGNLLDYLRE-CNRQEVNAVVLLYMATQISSAMEYLEK 122

Query: 462 KKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQ--KADLSMKGSPYWMAPELMMAVMQ 519
           K  IHRD+   N LV  + +VK+ADFG+++ +TG    A    K    W APE +     
Sbjct: 123 KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKF 182

Query: 520 KGKSSDSALAVDIWSLGCTIIEMYT-GKPPW------SEYEGAAAMFKVMRDTPAIPDSL 572
             KS       D+W+ G  + E+ T G  P+        YE     +++ R     P+  
Sbjct: 183 SIKS-------DVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYRMER-----PEGC 230

Query: 573 SPEGKDFLRCCFQRNPADRP 592
            P+  + +R C+Q NP+DRP
Sbjct: 231 PPKVYELMRACWQWNPSDRP 250

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score =  106 bits (267), Expect = 8e-26
 Identities = 64/213 (30%), Positives = 104/213 (48%), Gaps = 13/213 (6%)

Query: 391 QEIKVLSHLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTR 450
           +E KV+  L H  +VQ YG    +   YI  EY+  G +  Y+REH      S +    +
Sbjct: 48  EEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCK 107

Query: 451 HILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPY--- 507
            +  G+AYL SK+ IHRD+   N LVD  G VK++DFG+++++   +   S+ GS +   
Sbjct: 108 DVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSV-GSKFPVR 166

Query: 508 WMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFKVMRDTP 566
           W  PE+++      KS       D+W+ G  + E+Y+ GK P+  +  +  + KV +   
Sbjct: 167 WSPPEVLLYSKFSSKS-------DVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLR 219

Query: 567 AI-PDSLSPEGKDFLRCCFQRNPADRPPASLLL 598
              P   S +    +  C+     +RP    LL
Sbjct: 220 LYRPHLASEKVYAIMYSCWHEKAEERPTFQQLL 252

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score =  107 bits (270), Expect = 2e-25
 Identities = 91/335 (27%), Positives = 144/335 (42%), Gaps = 70/335 (20%)

Query: 338 MNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLS 397
           + S++   + +G G+ G V+ A + +     A+K+  I   DP+S   +K   +EIK++ 
Sbjct: 3   LGSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKK--IVLTDPQS---VKHALREIKIIR 57

Query: 398 HLKHPNIVQYY------GSEIVED--------KFYIYLEYVHPGSINKYVREHCGAITES 443
            L H NIV+ Y      GS++ ED          YI  EY+     N  V E  G ++E 
Sbjct: 58  RLDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETDLAN--VLEQ-GPLSEE 114

Query: 444 VVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASG-VVKLADFGMAKHLT---GQKAD 499
             R F   +L GL Y+HS   +HRD+K AN+ ++    V+K+ DFG+A+ +      K  
Sbjct: 115 HARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGY 174

Query: 500 LSMKGSPYWM-APELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAM 558
           LS      W  +P L+++       ++   A+D+W+ GC   EM TGKP    + GA  +
Sbjct: 175 LSEGLVTKWYRSPRLLLS------PNNYTKAIDMWAAGCIFAEMLTGKP---LFAGAHEL 225

Query: 559 FKVMRDTPAIP---------------------------------DSLSPEGKDFLRCCFQ 585
            ++     ++P                                   ++PE  DFL     
Sbjct: 226 EQMQLILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILT 285

Query: 586 RNPADRPPASLLLEHRFLKNSQQP-DVPSCSLSFS 619
            NP DR  A   L H ++     P D P     F 
Sbjct: 286 FNPMDRLTAEEALMHPYMSCYSCPFDEPVSLHPFH 320

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score =  107 bits (268), Expect = 2e-25
 Identities = 70/252 (27%), Positives = 131/252 (51%), Gaps = 20/252 (7%)

Query: 346 KLIGRGTFGSVYVASNRETGALCAMK----EVDIFPDDPKSAESIKQLEQEIKVLSHLKH 401
           K++G+G+FG V +A  +  G   A+K    +V +  DD +       +E+ +  L+  ++
Sbjct: 1   KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECT----MVEKRVLALA-WEN 55

Query: 402 PNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHS 461
           P +   Y +   ++  +  +E+++ G +  ++++  G         +   I+ GL +LHS
Sbjct: 56  PFLTHLYCTFQTKEHLFFVMEFLNGGDLMFHIQDK-GRFDLYRATFYAAEIVCGLQFLHS 114

Query: 462 KKTIHRDIKGANLLVDASGVVKLADFGMAK-HLTGQKADLSMKGSPYWMAPELMMAVMQK 520
           K  I+RD+K  N+++D  G +K+ADFGM K ++ G     +  G+P ++APE++  +   
Sbjct: 115 KGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQGL--- 171

Query: 521 GKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMR-DTPAIPDSLSPEGKDF 579
                   +VD WS G  + EM  G+ P+   +    +F+ +R DTP  P  ++ E KD 
Sbjct: 172 ----KYTFSVDWWSFGVLLYEMLIGQSPFHG-DDEDELFESIRVDTPHYPRWITKESKDI 226

Query: 580 LRCCFQRNPADR 591
           L   F+R+P  R
Sbjct: 227 LEKLFERDPTRR 238

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score =  107 bits (268), Expect = 2e-25
 Identities = 84/278 (30%), Positives = 141/278 (50%), Gaps = 29/278 (10%)

Query: 346 KLIGRGTFGSVYV---ASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKH- 401
           K++G G +G V++    +  +TG L AMK V       + A++++    E  VL H++  
Sbjct: 6   KVLGTGAYGKVFLVRKVTGHDTGKLYAMK-VLQKAALVQKAKTVEHTRTERNVLEHVRQS 64

Query: 402 PNIVQYYGSEIVEDKFYIYLEYVHPGSI--NKYVREHCGAITESVVRNFTRHILSGLAYL 459
           P +V  + +   E K ++ L+YV  G +  + Y R++    +E  VR ++  I+  L +L
Sbjct: 65  PFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDN---FSEDEVRFYSGEIILALEHL 121

Query: 460 HSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKAD--LSMKGSPYWMAPELMMAV 517
           H    ++RDIK  N+L+D+ G V L DFG++K    ++ +   S  G+  +MAPE++   
Sbjct: 122 HKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRGK 181

Query: 518 MQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEG-----AAAMFKVMRDTPAIPDSL 572
              GK      AVD WSLG  I E+ TG  P++  EG     +    ++++  P  P  +
Sbjct: 182 GGHGK------AVDWWSLGILIFELLTGASPFT-LEGERNTQSEVSRRILKCDPPFPSFI 234

Query: 573 SPEGKDFLRCCFQRNPADR-----PPASLLLEHRFLKN 605
            PE +D L    +++P  R       AS + EH F K 
Sbjct: 235 GPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKG 272

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score =  106 bits (266), Expect = 3e-25
 Identities = 64/209 (30%), Positives = 114/209 (54%), Gaps = 16/209 (7%)

Query: 342 WQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKH 401
           ++K   +G G++ +VY   ++ TG L A+KE+ +  ++     +I+    E  +L  LKH
Sbjct: 7   YKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIR----EASLLKDLKH 62

Query: 402 PNIVQYYGSEIVEDKFYIYL--EYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYL 459
            NIV  +  +I+  K  + L  EY+    + +Y+ +  G ++   VR F   +L GLAY 
Sbjct: 63  ANIVTLH--DIIHTKKTLTLVFEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYC 119

Query: 460 HSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPYWM-APELMMAVM 518
           H ++ +HRD+K  NLL+   G +KLADFG+A+  +      S +    W   P++++   
Sbjct: 120 HQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSNEVVTLWYRPPDVLLG-- 177

Query: 519 QKGKSSDSALAVDIWSLGCTIIEMYTGKP 547
               S++ + ++D+W +GC   EM TG+P
Sbjct: 178 ----STEYSTSLDMWGVGCIFYEMATGRP 202

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score =  105 bits (263), Expect = 3e-25
 Identities = 68/258 (26%), Positives = 113/258 (43%), Gaps = 30/258 (11%)

Query: 348 IGRGTFGSVYVASNRETGAL---CAMKEVDIFPDDPKSAESIKQLEQEI----KVLSHLK 400
           +G G FGSV               A+K +          E I   ++E      V++ L 
Sbjct: 3   LGHGNFGSVVKGVYLMKSGKEVEVAVKTL--------KQEHIAAGKKEFLREASVMAQLD 54

Query: 401 HPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLH 460
           HP IV+  G     +   + +E    G + KY+++    I  S ++     +  G+AYL 
Sbjct: 55  HPCIVRLIGV-CKGEPLMLVMELAPLGPLLKYLKKR-REIPVSDLKELAHQVAMGMAYLE 112

Query: 461 SKKTIHRDIKGANLLVDASGVVKLADFGMAKHL-TGQ---KADLSMKGSPYWMAPELMMA 516
           SK  +HRD+   N+L+      K++DFGM++ L  G    +A  + +    W APE    
Sbjct: 113 SKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPE---- 168

Query: 517 VMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFKVMR-DTPAIPDSLSP 574
            +  GK S  +   D+WS G T+ E ++ G  P+ E +GA  +  +   +    P+    
Sbjct: 169 CINYGKFSSKS---DVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGERLPRPEECPQ 225

Query: 575 EGKDFLRCCFQRNPADRP 592
           E    +  C++  P DRP
Sbjct: 226 EIYSIMLSCWKYRPEDRP 243

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score =  105 bits (264), Expect = 3e-25
 Identities = 73/271 (26%), Positives = 126/271 (46%), Gaps = 39/271 (14%)

Query: 348 IGRGTFGSV----YVASNRETGALCAMKEVDIFPDDPKSAES-IKQLEQEIKVLSHLKHP 402
           +G G FG V    Y      TG   A+K +      P+S  + I  L++EI++L +L H 
Sbjct: 12  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLK-----PESGGNHIADLKKEIEILRNLYHE 66

Query: 403 NIVQYYG--SEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLH 460
           NIV+Y G  +E   +   + +E++  GS+ +Y+  +   I       +   I  G+ YL 
Sbjct: 67  NIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLG 126

Query: 461 SKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMK---GSP-YWMAPELMMA 516
           S++ +HRD+   N+LV++   VK+ DFG+ K +   K   ++K    SP +W APE ++ 
Sbjct: 127 SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLI- 185

Query: 517 VMQKGKSSDSALAVDIWSLGCTIIEMYT----GKPPWSEY-------EG---AAAMFKVM 562
                  S   +A D+WS G T+ E+ T       P + +        G      + +V+
Sbjct: 186 ------QSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVL 239

Query: 563 RDTP--AIPDSLSPEGKDFLRCCFQRNPADR 591
            +      P +   E    +R C++  P+ R
Sbjct: 240 EEGKRLPRPPNCPEEVYQLMRKCWEFQPSKR 270

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score =  104 bits (261), Expect = 5e-25
 Identities = 75/263 (28%), Positives = 120/263 (45%), Gaps = 25/263 (9%)

Query: 346 KLIGRGTFGSVYVASNRETGALCAMK--EVDIFPDDPKSAESIKQLEQEIKVLSHLKHPN 403
           + IG+G FG VY    +      A+K     + PD        K L QE ++L    HPN
Sbjct: 1   EKIGKGNFGDVYKGVLK-GNTEVAVKTCRSTLPPDL-----KRKFL-QEAEILKQYDHPN 53

Query: 404 IVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKK 463
           IV+  G  + +   YI +E V  GS+  ++R+    +T   +   +    +G+ YL SK 
Sbjct: 54  IVKLIGVCVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKN 113

Query: 464 TIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLS--MKGSPY-WMAPELMMAVMQK 520
            IHRD+   N LV  + V+K++DFGM++   G    +S  +K  P  W APE     +  
Sbjct: 114 CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPE----ALNY 169

Query: 521 GK-SSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFKVMRD--TPAIPDSLSPEG 576
           G+ +S+S    D+WS G  + E ++ G  P+          ++      PA P     E 
Sbjct: 170 GRYTSES----DVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYRMPA-PQLCPEEI 224

Query: 577 KDFLRCCFQRNPADRPPASLLLE 599
              +  C+  +P +RP  S +  
Sbjct: 225 YRLMLQCWAYDPENRPSFSEIYN 247

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score =  104 bits (261), Expect = 9e-25
 Identities = 64/220 (29%), Positives = 106/220 (48%), Gaps = 23/220 (10%)

Query: 343 QKGKLIGRGTFGSVY----VASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSH 398
           +K K++G G FG+VY    +    +     A+K +     +  S ++ K++  E  V++ 
Sbjct: 10  EKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLR----EETSPKANKEILDEAYVMAS 65

Query: 399 LKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAY 458
           + HP++V+  G  +      I  + +  G +  YVR H   I    + N+   I  G++Y
Sbjct: 66  VDHPHVVRLLGICLSSQVQLI-TQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSY 124

Query: 459 LHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPY---WMAPELMM 515
           L  K+ +HRD+   N+LV     VK+ DFG+AK L   + +   +G      WMA E ++
Sbjct: 125 LEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESIL 184

Query: 516 AVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEG 554
             +   KS       D+WS G T+ E+ T G  P   YEG
Sbjct: 185 HRIYTHKS-------DVWSYGVTVWELMTFGAKP---YEG 214

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score =  103 bits (258), Expect = 1e-24
 Identities = 76/265 (28%), Positives = 125/265 (47%), Gaps = 26/265 (9%)

Query: 340 SQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHL 399
            +   G++IG G FG+V       TG   A+K +       K   + +   +E  V++ L
Sbjct: 6   QKLTLGEIIGEGEFGAVL--QGEYTGQKVAVKNI-------KCDVTAQAFLEETAVMTKL 56

Query: 400 KHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESV-VRNFTRHILSGLAY 458
            H N+V+  G  I+ +  YI +E +  G++  ++R    A+   + +  F+  +  G+ Y
Sbjct: 57  HHKNLVRLLGV-ILHNGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEY 115

Query: 459 LHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPYWMAPELMMAVM 518
           L SKK +HRD+   N+LV   GV K++DFG+A+   G     + K    W APE   A+ 
Sbjct: 116 LESKKLVHRDLAARNILVSEDGVAKVSDFGLAR--VGSMGVDNSKLPVKWTAPE---ALK 170

Query: 519 QKGKSSDSALAVDIWSLGCTIIEMYT-GKPPW---SEYEGAAAMFKVMRDTPAIPDSLSP 574
            K  SS S    D+WS G  + E+++ G+ P+   S  E    + K  R  P  P+    
Sbjct: 171 HKKFSSKS----DVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYRMEP--PEGCPA 224

Query: 575 EGKDFLRCCFQRNPADRPPASLLLE 599
           +    +  C++  P  RP    L E
Sbjct: 225 DVYVLMTSCWETEPKKRPSFHKLRE 249

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score =  104 bits (261), Expect = 1e-24
 Identities = 78/280 (27%), Positives = 134/280 (47%), Gaps = 41/280 (14%)

Query: 346 KLIGRGTFGSV----YVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKH 401
           + +G+G FGSV    Y      TG + A+K++        +AE ++  E+EI++L  L+H
Sbjct: 10  QQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQ-----HSTAEHLRDFEREIEILKSLQH 64

Query: 402 PNIVQYYGSEIVEDKFYIYL--EYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYL 459
            NIV+Y G      +  + L  EY+  GS+  Y+++H   +    +  +   I  G+ YL
Sbjct: 65  DNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYL 124

Query: 460 HSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMK---GSP-YWMAPELMM 515
            SK+ +HRD+   N+LV++   VK+ DFG+ K L   K    ++    SP +W APE + 
Sbjct: 125 GSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESL- 183

Query: 516 AVMQKGKSSDSALAVDIWSLGCTIIEMYT----GKPPWSEY--------EGAAAMFKVM- 562
                   S  ++A D+WS G  + E++T       P +E+        +G   ++ ++ 
Sbjct: 184 ------TESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIE 237

Query: 563 -----RDTPAIPDSLSPEGKDFLRCCFQRNPADRPPASLL 597
                   PA P     E    ++ C+  +P+ RP  S L
Sbjct: 238 LLKNNGRLPA-PPGCPAEIYAIMKECWNNDPSQRPSFSEL 276

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score =  104 bits (260), Expect = 1e-24
 Identities = 68/259 (26%), Positives = 123/259 (47%), Gaps = 20/259 (7%)

Query: 347 LIGRGTFGSVYVASNRETGA-LCAMKEVDIF-PDDPKSA----ESIKQLEQEIKVL-SHL 399
            +G G FG VY    +  G  L A+KE+++  P   K      +SI  +  E+ ++   L
Sbjct: 7   HLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQL 66

Query: 400 KHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKY---VREHCGAITESVVRNFTRHILSGL 456
           +HPNIV+YY + +  D+ YI ++ +    + ++   ++E     TE  + N    ++  L
Sbjct: 67  RHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLAL 126

Query: 457 AYLH-SKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPYWMAPELMM 515
            YLH  K+ +HRD+   N+++     V + DFG+AK    +    S+ G+  +  PE++ 
Sbjct: 127 RYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKLTSVVGTILYSCPEIV- 185

Query: 516 AVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPP-WSEYEGAAAMFKVMRDTPAIPDSL-S 573
                 K+       D+W+ GC + +M T +PP +S    + A   V      +P+ + S
Sbjct: 186 ------KNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLPEGMYS 239

Query: 574 PEGKDFLRCCFQRNPADRP 592
            +  D +  C   +   RP
Sbjct: 240 EDVTDVITSCLTPDAEARP 258

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score =  103 bits (258), Expect = 1e-24
 Identities = 70/261 (26%), Positives = 120/261 (45%), Gaps = 24/261 (9%)

Query: 346 KLIGRGTFGSVYVASNRET--GALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPN 403
           K +G G FG V++   R     A+ A+ E  +  +D           +E KV+  L HP 
Sbjct: 10  KELGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEED---------FIEEAKVMMKLSHPK 60

Query: 404 IVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKK 463
           +VQ YG    +   YI  E++  G +  Y+R+  G +++ ++ +  + +  G+ YL    
Sbjct: 61  LVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNS 120

Query: 464 TIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPY---WMAPELMMAVMQK 520
            IHRD+   N LV ++GVVK++DFGM +++   +   S  G+ +   W  PE+       
Sbjct: 121 FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEY-TSSSGAKFPVKWSPPEVFNFSKYS 179

Query: 521 GKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFKVMRDTPAIPDSLSPEG-KD 578
            KS       D+WS G  + E++T GK P+ +      +  + R        L+     +
Sbjct: 180 SKS-------DVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYRPKLASMTVYE 232

Query: 579 FLRCCFQRNPADRPPASLLLE 599
            +  C+   P  RP  + LL 
Sbjct: 233 VMYSCWHEKPEGRPTFAELLR 253

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score =  103 bits (258), Expect = 1e-24
 Identities = 68/255 (26%), Positives = 120/255 (47%), Gaps = 17/255 (6%)

Query: 346 KLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIV 405
           K +G G+FG V       +G       V     D K ++ +    +E  ++  L H N++
Sbjct: 1   KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSD-KLSDIMDDFLKEAAIMHSLDHENLI 59

Query: 406 QYYGSEIVEDKFYIYLEYVHPGSINKYVREHC-GAITESVVRNFTRHILSGLAYLHSKKT 464
           + YG  ++     +  E    GS+   +R+   G    S + ++   I +G+ YL SK+ 
Sbjct: 60  RLYGV-VLTHPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRF 118

Query: 465 IHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSM---KGSPY-WMAPELMMAVMQK 520
           IHRD+   N+L+ +   VK+ DFG+ + L   +    M      P+ W APE     ++ 
Sbjct: 119 IHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPE----SLRT 174

Query: 521 GKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFKVMRDTPAI--PDSLSPEGK 577
              S    A D+W  G T+ EM+T G+ PW+   G+  + K+ ++   +  P++   +  
Sbjct: 175 RTFSH---ASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLERPEACPQDIY 231

Query: 578 DFLRCCFQRNPADRP 592
           + +  C+  NPADRP
Sbjct: 232 NVMLQCWAHNPADRP 246

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score =  103 bits (259), Expect = 2e-24
 Identities = 61/201 (30%), Positives = 105/201 (52%), Gaps = 12/201 (5%)

Query: 348 IGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQY 407
           +G GT+ +VY   ++ T  L A+KE+ +  ++     +I+    E+ +L  LKH NIV  
Sbjct: 14  LGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIR----EVSLLKDLKHANIVTL 69

Query: 408 YGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHR 467
           +     E    +  EY+    + +Y+ +   +I    V+ F   +L GL Y H +K +HR
Sbjct: 70  HDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHR 128

Query: 468 DIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPYWM-APELMMAVMQKGKSSDS 526
           D+K  NLL++  G +KLADFG+A+  +      S +    W   P++++       S+D 
Sbjct: 129 DLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDILLG------STDY 182

Query: 527 ALAVDIWSLGCTIIEMYTGKP 547
           +  +D+W +GC   EM TG+P
Sbjct: 183 STQIDMWGVGCIFYEMSTGRP 203

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score =  104 bits (261), Expect = 2e-24
 Identities = 85/322 (26%), Positives = 158/322 (49%), Gaps = 53/322 (16%)

Query: 346 KLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESI-KQLEQEIKVLSHLKHPNI 404
           K +G G +G+V  A +R TGA  A+K++      P  +E   K+  +E+++L H+KH N+
Sbjct: 21  KQVGSGAYGTVCSALDRRTGAKVAIKKLY----RPFQSELFAKRAYRELRLLKHMKHENV 76

Query: 405 ---VQYYGSEIVEDKFY-IYLEYVHP------GSINKYVREHCGAITESVVRNFTRHILS 454
              +  +  ++  D+F+  YL  V P      G + K+ +     ++E  ++     +L 
Sbjct: 77  IGLLDVFTPDLSLDRFHDFYL--VMPFMGTDLGKLMKHEK-----LSEDRIQFLVYQMLK 129

Query: 455 GLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKG---SPYWMAP 511
           GL Y+H+   IHRD+K  NL V+    +K+ DFG+A+       D  M G   + ++ AP
Sbjct: 130 GLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQ-----TDSEMTGYVVTRWYRAP 184

Query: 512 ELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDS 571
           E+++  M   ++      VDIWS+GC + EM TGKP +  ++    + ++M+ T      
Sbjct: 185 EVILNWMHYTQT------VDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKE 238

Query: 572 L-----SPEGKDFLRCC--FQRN------PADRPPASLLLEHRFLKNSQQPDVPSCSLSF 618
                 S + K++++    F++       P   P A  +LE   + +++     + +L+ 
Sbjct: 239 FVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAH 298

Query: 619 SGMQLTEKPHSPREKADA-KYD 639
                 E+ H P ++ +A  YD
Sbjct: 299 P---YFEEFHDPEDETEAPPYD 317

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score =  104 bits (261), Expect = 2e-24
 Identities = 85/323 (26%), Positives = 143/323 (44%), Gaps = 60/323 (18%)

Query: 343 QKGKLIGRGTFGSVYVASNRETGALCAMKEV---DIFPDDPKSAESIKQ------LEQEI 393
           QKG  +G GT+G V  A +  TG + A+K+V   +I  D  K  + +          +E+
Sbjct: 12  QKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLREL 71

Query: 394 KVLSHLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHIL 453
           K+++ +KH NI+      +  D   + ++ +    + K V      +TES V+     IL
Sbjct: 72  KIMNEIKHENIMGLVDVYVEGDFINLVMDIMA-SDLKKVVDRKI-RLTESQVKCILLQIL 129

Query: 454 SGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAK--------------HLTGQKAD 499
           +GL  LH    +HRD+  AN+ +++ G+ K+ADFG+A+                  ++ +
Sbjct: 130 NGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREE 189

Query: 500 LSMKGSPYWM-APELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPW---SEYEGA 555
           ++ K    W  APEL+M       +     AVD+WS+GC   E+ TGKP +   +E +  
Sbjct: 190 MTSKVVTLWYRAPELLMG------AEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQL 243

Query: 556 AAMFKVMRD------------------TPAIPDSLSPEGK-------DFLRCCFQRNPAD 590
             +F+++                    TP  P  L            D L+   + NP +
Sbjct: 244 GRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLE 303

Query: 591 RPPASLLLEHRFLKNSQQPDVPS 613
           R  A   L+H + K+   P  PS
Sbjct: 304 RISAKEALKHEYFKSDPLPCDPS 326

Length = 335

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score =  106 bits (265), Expect = 3e-24
 Identities = 71/224 (31%), Positives = 120/224 (53%), Gaps = 28/224 (12%)

Query: 339 NSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSH 398
           N  ++ G +IG G+FG VY A   +T    A+K+V     DP+         +E+ ++ +
Sbjct: 65  NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKV---LQDPQYKN------RELLIMKN 115

Query: 399 LKHPNIV---QYYGSEIVEDK-----FYIYLEYVHPGSINKYVREHC---GAITESVVRN 447
           L H NI+    YY +E  +         + +E++ P +++KY++ +     A+   +V+ 
Sbjct: 116 LNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFI-PQTVHKYMKHYARNNHALPLFLVKL 174

Query: 448 FTRHILSGLAYLHSKKTIHRDIKGANLLVDA-SGVVKLADFGMAKHLTGQKADLSMKGSP 506
           ++  +   LAY+HSK   HRD+K  NLL+D  +  +KL DFG AK+L   +  +S   S 
Sbjct: 175 YSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYICSR 234

Query: 507 YWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWS 550
           ++ APELM+       +++    +D+WSLGC I EM  G P +S
Sbjct: 235 FYRAPELMLG------ATNYTTHIDLWSLGCIIAEMILGYPIFS 272

Length = 440

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score =  103 bits (259), Expect = 3e-24
 Identities = 76/250 (30%), Positives = 121/250 (48%), Gaps = 21/250 (8%)

Query: 348 IGRGTFGSVYVASNRETG---ALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNI 404
           IG+G+FG V     R+T    AL  +++  I      S   +     E  VL+ +  P I
Sbjct: 1   IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIV-----SRSEVTHTLAERTVLAQVNCPFI 55

Query: 405 VQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKT 464
           V    S    +K Y+ L +++ G +  +++   G    S  R +T  +L  L  LH    
Sbjct: 56  VPLKFSFQSPEKLYLVLAFINGGELFHHLQRE-GRFDLSRARFYTAELLCALENLHKFNV 114

Query: 465 IHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLS--MKGSPYWMAPELMMAVMQKGK 522
           I+RD+K  N+L+D  G + L DFG+ K L  +  D +    G+P ++APEL++     G 
Sbjct: 115 IYRDLKPENILLDYQGHIALCDFGLCK-LNMKDDDKTNTFCGTPEYLAPELLLGH---GY 170

Query: 523 SSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMF-KVMRDTPAIPDSLSPEGKDFLR 581
           +     AVD W+LG  + EM TG PP+ + E    M+ K++++    PD    + KD L 
Sbjct: 171 TK----AVDWWTLGVLLYEMLTGLPPFYD-ENVNEMYRKILQEPLRFPDGFDRDAKDLLI 225

Query: 582 CCFQRNPADR 591
               R+P  R
Sbjct: 226 GLLSRDPTRR 235

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score =  103 bits (259), Expect = 3e-24
 Identities = 78/252 (30%), Positives = 126/252 (50%), Gaps = 20/252 (7%)

Query: 346 KLIGRGTFGSVYVASNRETGALCAMK----EVDIFPDDPKSAESIKQLEQEIKVLSHLKH 401
            ++G+G+FG V +A  + T  L A+K    +V I  DD +       +E+ +  LS  K 
Sbjct: 6   MVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECT----MVEKRVLALSG-KP 60

Query: 402 PNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHS 461
           P + Q +      D+ Y  +EYV+ G +  Y  +  G   E     +   I  GL +LHS
Sbjct: 61  PFLTQLHSCFQTMDRLYFVMEYVNGGDL-MYQIQQVGRFKEPHAVFYAAEIAIGLFFLHS 119

Query: 462 KKTIHRDIKGANLLVDASGVVKLADFGMAK-HLTGQKADLSMKGSPYWMAPELMMAVMQK 520
           K  I+RD+K  N+++D+ G +K+ADFGM K ++       +  G+P ++APE+ +A    
Sbjct: 120 KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKTFCGTPDYIAPEI-IAYQPY 178

Query: 521 GKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFK-VMRDTPAIPDSLSPEGKDF 579
           GKS      VD W+ G  + EM  G+ P+ E E    +F+ +M    A P S+S E    
Sbjct: 179 GKS------VDWWAFGVLLYEMLAGQAPF-EGEDEDELFQSIMEHNVAYPKSMSKEAVAI 231

Query: 580 LRCCFQRNPADR 591
            +    ++P  R
Sbjct: 232 CKGLMTKHPGKR 243

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score =  103 bits (259), Expect = 3e-24
 Identities = 74/251 (29%), Positives = 125/251 (49%), Gaps = 20/251 (7%)

Query: 347 LIGRGTFGSVYVASNRETGALCAMK----EVDIFPDDPKSAESIKQLEQEIKVLSHL-KH 401
           ++G+G+FG V +A  + T  L A+K    +V I  DD      ++    E +VL+   K 
Sbjct: 7   VLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDD------VECTMVEKRVLALQDKP 60

Query: 402 PNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHS 461
           P + Q +      D+ Y  +EYV+ G +  ++++  G   E     +   I  GL +LH 
Sbjct: 61  PFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQ-VGKFKEPQAVFYAAEISVGLFFLHR 119

Query: 462 KKTIHRDIKGANLLVDASGVVKLADFGMAK-HLTGQKADLSMKGSPYWMAPELMMAVMQK 520
           +  I+RD+K  N+++D+ G +K+ADFGM K H+       +  G+P ++APE+ +A    
Sbjct: 120 RGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEI-IAYQPY 178

Query: 521 GKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDSLSPEGKDFL 580
           GKS      VD W+ G  + EM  G+PP+   +       +M    + P SLS E     
Sbjct: 179 GKS------VDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSIC 232

Query: 581 RCCFQRNPADR 591
           +    ++P+ R
Sbjct: 233 KGLMTKHPSKR 243

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score =  103 bits (257), Expect = 3e-24
 Identities = 60/202 (29%), Positives = 112/202 (55%), Gaps = 14/202 (6%)

Query: 348 IGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQY 407
           +G GT+ +V+   ++ T  L A+KE+ +  ++     +I+    E+ +L +LKH NIV  
Sbjct: 13  LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIR----EVSLLKNLKHANIVTL 68

Query: 408 YGSEIVEDKFYIYLEYVHPGSINKYVREHCGAI-TESVVRNFTRHILSGLAYLHSKKTIH 466
           +  +I+  +  + L + +  S  K   ++CG + +   V+ F   +L GL+Y H +K +H
Sbjct: 69  H--DIIHTERCLTLVFEYLDSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILH 126

Query: 467 RDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPYWM-APELMMAVMQKGKSSD 525
           RD+K  NLL++  G +KLADFG+A+  +      S +    W   P++++       S++
Sbjct: 127 RDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLG------STE 180

Query: 526 SALAVDIWSLGCTIIEMYTGKP 547
            +  +D+W +GC + EM TG+P
Sbjct: 181 YSTPIDMWGVGCILYEMATGRP 202

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score =  103 bits (259), Expect = 5e-24
 Identities = 71/225 (31%), Positives = 111/225 (49%), Gaps = 39/225 (17%)

Query: 346 KLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIV 405
           K IGRG +G V  A N ET    A+K++    D+   A   K+  +EIK+L HL H N++
Sbjct: 11  KPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDA---KRTLREIKLLRHLDHENVI 67

Query: 406 QYY------GSEIVEDKFYIYLEY------VHP--GSINKYVREHCGAITESVVRNFTRH 451
                      E   D   +Y+ Y      +H    S      +HC        + F   
Sbjct: 68  AIKDIMPPPHREAFND---VYIVYELMDTDLHQIIRSSQTLSDDHC--------QYFLYQ 116

Query: 452 ILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMK--GSPYWM 509
           +L GL Y+HS   +HRD+K +NLL++A+  +K+ DFG+A+  T +K D   +   + ++ 
Sbjct: 117 LLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR-TTSEKGDFMTEYVVTRWYR 175

Query: 510 APELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKP--PWSEY 552
           APEL++        S+   A+D+WS+GC   E+   KP  P  +Y
Sbjct: 176 APELLLN------CSEYTTAIDVWSVGCIFAELLGRKPLFPGKDY 214

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score =  102 bits (255), Expect = 5e-24
 Identities = 77/274 (28%), Positives = 130/274 (47%), Gaps = 47/274 (17%)

Query: 348 IGRGTFGSVYVA-----SNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHP 402
           +G G FG V++A     S  +   L A+K +     DP  A   K  ++E ++L++L+H 
Sbjct: 13  LGEGAFGKVFLAECYNLSPTKDKMLVAVKALK----DPTLAAR-KDFQREAELLTNLQHE 67

Query: 403 NIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHC---------------GAITESVVRN 447
           +IV++YG     D   +  EY+  G +NK++R H                G +  S + +
Sbjct: 68  HIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLH 127

Query: 448 FTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHL-------TGQKADL 500
               I SG+ YL S+  +HRD+   N LV A+ +VK+ DFGM++ +        G    L
Sbjct: 128 IASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTML 187

Query: 501 SMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMF 559
            ++    WM PE   ++M +  +++S    D+WS G  + E++T GK PW +      + 
Sbjct: 188 PIR----WMPPE---SIMYRKFTTES----DVWSFGVILWEIFTYGKQPWFQL-SNTEVI 235

Query: 560 KVMRDTPAI--PDSLSPEGKDFLRCCFQRNPADR 591
           + +     +  P     E  D +  C+QR P  R
Sbjct: 236 ECITQGRVLERPRVCPKEVYDIMLGCWQREPQQR 269

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score =  102 bits (255), Expect = 5e-24
 Identities = 83/300 (27%), Positives = 135/300 (45%), Gaps = 50/300 (16%)

Query: 341 QWQKGKLIGRGTFGSVYVASN-RETGALCAMKEVDIFPDDPKSAESIKQLE--QEIKVLS 397
           Q++    IG G +G V+ A + +  G   A+K V +     ++ E    L   +E+ VL 
Sbjct: 2   QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRV-----QTGEEGMPLSTIREVAVLR 56

Query: 398 HLK---HPNIVQYYGSEIV-----EDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFT 449
           HL+   HPN+V+ +    V     E K  +  E+V         +     +    +++  
Sbjct: 57  HLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMM 116

Query: 450 RHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPYWM 509
             +L GL +LHS + +HRD+K  N+LV +SG +KLADFG+A+  + Q A  S+  + ++ 
Sbjct: 117 FQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYR 176

Query: 510 APELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPW---SEYEGAAAMFKVM---- 562
           APE+++        S  A  VD+WS+GC   EM+  KP +   S+ +    +  V+    
Sbjct: 177 APEVLL-------QSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPG 229

Query: 563 ---------------RDTPAIP-DSLSPE----GKDFLRCCFQRNPADRPPASLLLEHRF 602
                              A P +    +    GKD L  C   NPA R  A   L H +
Sbjct: 230 EEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPY 289

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score =  102 bits (255), Expect = 6e-24
 Identities = 75/270 (27%), Positives = 131/270 (48%), Gaps = 42/270 (15%)

Query: 348 IGRGTFGSVYVASNRETGALCAMKE-----VDIFPDDPKSAESIKQLEQEIKVLSHLKHP 402
           +G G FG V++A   E   LC  ++     V    D   +A   K   +E ++L++L+H 
Sbjct: 13  LGEGAFGKVFLA---ECYNLCPEQDKILVAVKTLKDASDNAR--KDFHREAELLTNLQHE 67

Query: 403 NIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHC------------GAITESVVRNFTR 450
           +IV++YG  +  D   +  EY+  G +NK++R H               +T+S + +  +
Sbjct: 68  HIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQ 127

Query: 451 HILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHL-------TGQKADLSMK 503
            I +G+ YL S+  +HRD+   N LV  + +VK+ DFGM++ +        G    L ++
Sbjct: 128 QIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIR 187

Query: 504 GSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFKVM 562
               WM PE   ++M +  +++S    D+WSLG  + E++T GK PW +      +  + 
Sbjct: 188 ----WMPPE---SIMYRKFTTES----DVWSLGVVLWEIFTYGKQPWYQLSNNEVIECIT 236

Query: 563 RD-TPAIPDSLSPEGKDFLRCCFQRNPADR 591
           +      P +   E  D +  C+QR P  R
Sbjct: 237 QGRVLQRPRTCPKEVYDLMLGCWQREPHMR 266

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score =  102 bits (256), Expect = 7e-24
 Identities = 71/302 (23%), Positives = 127/302 (42%), Gaps = 56/302 (18%)

Query: 345 GKLIGRGTFGSVYVASN-RETGALCAMKEVDIFPDDPK-----------SAESIKQLEQE 392
            + +G G FG V++                +   D P            S  + +   +E
Sbjct: 10  VEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKE 69

Query: 393 IKVLSHLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGA----------ITE 442
           +K+LS L  PNI +  G   V+    + +EY+  G +N+++++H             ++ 
Sbjct: 70  VKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSF 129

Query: 443 SVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLS- 501
           S +      I SG+ YL S   +HRD+   N LV  +  +K+ADFGM+++L    +D   
Sbjct: 130 STLLYMATQIASGMRYLESLNFVHRDLATRNCLVGKNYTIKIADFGMSRNL--YSSDYYR 187

Query: 502 MKGSP----YWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT--GKPPWSEY--- 552
           ++G       WMA E ++     GK +  +   D+W+ G T+ E+ T   + P+      
Sbjct: 188 VQGRAPLPIRWMAWESVL----LGKFTTKS---DVWAFGVTLWEILTLCREQPYEHLTDQ 240

Query: 553 ---EGAAAMFK------VMRDTPAIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFL 603
              E A   F+       +   P  P  +     + +  C++R+  DRP    +  H FL
Sbjct: 241 QVIENAGHFFRDDGRQIYLPRPPNCPKDIY----ELMLECWRRDEEDRPTFREI--HLFL 294

Query: 604 KN 605
           + 
Sbjct: 295 QR 296

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score =  102 bits (255), Expect = 9e-24
 Identities = 74/286 (25%), Positives = 139/286 (48%), Gaps = 42/286 (14%)

Query: 346 KLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIK-QLEQ---EIKVLSHLKH 401
           KLI  G +G+VY+  ++ET    AMK+++      K    ++ Q++Q   E  +L+  ++
Sbjct: 7   KLISNGAYGAVYLVRHKETRQRFAMKKIN------KQNLILRNQIQQVFVERDILTFAEN 60

Query: 402 PNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHS 461
           P +V  + S   +    + +EYV  G     ++ + GA+   + R +    +  L YLH+
Sbjct: 61  PFVVSMFCSFETKRHLCMVMEYVEGGDCATLLK-NIGALPVDMARMYFAETVLALEYLHN 119

Query: 462 KKTIHRDIKGANLLVDASGVVKLADFGMAK-------------HL---TGQKADLSMKGS 505
              +HRD+K  NLL+ + G +KL DFG++K             H+   T +  D  + G+
Sbjct: 120 YGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGT 179

Query: 506 PYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMF-KVMRD 564
           P ++APE+   ++++G        VD W++G  + E   G  P+   +    +F +V+ D
Sbjct: 180 PEYIAPEV---ILRQGYGK----PVDWWAMGIILYEFLVGCVPFFG-DTPEELFGQVISD 231

Query: 565 TPAIP---DSLSPEGKDFLRCCFQRNPADR---PPASLLLEHRFLK 604
               P   ++L  + +D +    ++NP +R     A  + +HRF  
Sbjct: 232 DIEWPEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFL 277

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score =  101 bits (253), Expect = 1e-23
 Identities = 72/286 (25%), Positives = 140/286 (48%), Gaps = 28/286 (9%)

Query: 346 KLIGRGTFGSVYVA---SNRETGALCAMK---EVDIFPDDPKSAESIKQLEQEIKVLSHL 399
           K++G G +G V++    S  ++G L AMK   +  I     + A++ +    E +VL H+
Sbjct: 6   KVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIV----QKAKTTEHTRTERQVLEHI 61

Query: 400 KH-PNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAY 458
           +  P +V  + +   + K ++ L+Y++ G +  ++ +      E  V+ ++  I+  L +
Sbjct: 62  RQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRE-RFKEQEVQIYSGEIVLALEH 120

Query: 459 LHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKAD--LSMKGSPYWMAPELMMA 516
           LH    I+RDIK  N+L+D++G V L DFG++K     + +   S  G+  +MAP+++  
Sbjct: 121 LHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIV-- 178

Query: 517 VMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWS----EYEGAAAMFKVMRDTPAIPDSL 572
              +G       AVD WS+G  + E+ TG  P++    +   A    ++++  P  P  +
Sbjct: 179 ---RGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEM 235

Query: 573 SPEGKDFLRCCFQRNPADR-----PPASLLLEHRFLKNSQQPDVPS 613
           S   KD ++    ++P  R       A  + +H F +     D+ +
Sbjct: 236 SALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKINWDDLAA 281

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score =  101 bits (253), Expect = 1e-23
 Identities = 67/223 (30%), Positives = 112/223 (50%), Gaps = 14/223 (6%)

Query: 348 IGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQY 407
           +G GT+ +V+   ++ T  L A+KE+ +  ++     +I+    E+ +L  LKH NIV  
Sbjct: 14  LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIR----EVSLLKDLKHANIVTL 69

Query: 408 YGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITE-SVVRNFTRHILSGLAYLHSKKTIH 466
           +     +    +  EY+    + +Y+ + CG I     V+ F   IL GLAY H +K +H
Sbjct: 70  HDIVHTDKSLTLVFEYLDK-DLKQYM-DDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLH 127

Query: 467 RDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPYWMAPELMMAVMQKGKSSDS 526
           RD+K  NLL++  G +KLADFG+A+  +      S +    W  P  ++       SS+ 
Sbjct: 128 RDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLL-----GSSEY 182

Query: 527 ALAVDIWSLGCTIIEMYTGKP--PWSEYEGAAAMFKVMRDTPA 567
           +  +D+W +GC   EM +G+P  P S  E    +   +  TP 
Sbjct: 183 STQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPT 225

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score =  100 bits (250), Expect = 1e-23
 Identities = 73/263 (27%), Positives = 120/263 (45%), Gaps = 34/263 (12%)

Query: 348 IGRGTFGSVYVAS--NRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIV 405
           IG G FG V++     +   A+  ++E          A S +   +E +V+  L HP +V
Sbjct: 12  IGSGQFGLVWLGYWLEKRKVAIKTIRE---------GAMSEEDFIEEAQVMMKLSHPKLV 62

Query: 406 QYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTI 465
           Q YG         +  E++  G ++ Y+R   G  ++  +      +  G+AYL S   I
Sbjct: 63  QLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVI 122

Query: 466 HRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPY---WMAPELMMAVMQKGK 522
           HRD+   N LV  + VVK++DFGM + +   +   S  G+ +   W +PE    V    K
Sbjct: 123 HRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYT-SSTGTKFPVKWSSPE----VFSFSK 177

Query: 523 SSDSALAVDIWSLGCTIIEMYT-GKPPWSE------YEGAAAMFKVMRDTPAIPDSLSPE 575
            S  +   D+WS G  + E+++ GK P+         E   A F++ +     P   S  
Sbjct: 178 YSSKS---DVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLYK-----PRLASQS 229

Query: 576 GKDFLRCCFQRNPADRPPASLLL 598
             + ++ C++  P DRP  SLLL
Sbjct: 230 VYELMQHCWKERPEDRPSFSLLL 252

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score =  101 bits (252), Expect = 1e-23
 Identities = 82/299 (27%), Positives = 125/299 (41%), Gaps = 61/299 (20%)

Query: 348 IGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQY 407
           IG G +G+VY A +  +G   A+K V +  ++     S  +    +K L    HPNIV+ 
Sbjct: 8   IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67

Query: 408 YGS----------------EIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRH 451
                              E V+     YL+ V P             +    +++  R 
Sbjct: 68  MDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPP-----------GLPAETIKDLMRQ 116

Query: 452 ILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPYWMAP 511
            L GL +LH+   +HRD+K  N+LV + G VKLADFG+A+  + Q A   +  + ++ AP
Sbjct: 117 FLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYSCQMALTPVVVTLWYRAP 176

Query: 512 ELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPW---SEYEGAAAMFKVM------ 562
           E+++        S  A  VD+WS+GC   EM+  KP +   SE +    +F ++      
Sbjct: 177 EVLL-------QSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPED 229

Query: 563 ---RD-----------TPAIPDSLSPE----GKDFLRCCFQRNPADRPPASLLLEHRFL 603
              RD            P    S+ PE    G   L      NP  R  A   L+H F 
Sbjct: 230 DWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score =  100 bits (251), Expect = 1e-23
 Identities = 69/251 (27%), Positives = 120/251 (47%), Gaps = 17/251 (6%)

Query: 348 IGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQY 407
           +G+G FG V     + TG + A K++D      KS E +  LE+EI  L  +  P IV  
Sbjct: 1   LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEI--LEKVNSPFIVNL 58

Query: 408 YGSEIVEDKFYIYLEYVHPGSINKYVREHCG--AITESVVRNFTRHILSGLAYLHSKKTI 465
             +   +    + +  ++ G + KY   + G   +    V +++  I  G+ +LHS   +
Sbjct: 59  AYAFESKTHLCLVMSLMNGGDL-KYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIV 117

Query: 466 HRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPYWMAPELMMAVMQKGKSSD 525
           +RD+K  N+L+D  G  +L+D G+A  L   K      G+  +MAPE++    ++  S  
Sbjct: 118 YRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRAGTNGYMAPEIL---KEEPYSY- 173

Query: 526 SALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIP-----DSLSPEGKDFL 580
               VD +++GC+I EM  G+ P+ +++   A  ++ R T          + + E KD  
Sbjct: 174 ---PVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFEHQNFTEESKDIC 230

Query: 581 RCCFQRNPADR 591
           R    + P DR
Sbjct: 231 RLFLAKKPEDR 241

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score =  102 bits (256), Expect = 2e-23
 Identities = 88/317 (27%), Positives = 134/317 (42%), Gaps = 81/317 (25%)

Query: 346 KLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQ------EIKVLSHL 399
           K+IGRG FG V +   ++TG + AMK++       + +E +++ EQ      E  +L+  
Sbjct: 7   KVIGRGAFGEVRLVQKKDTGHIYAMKKL-------RKSEMLEK-EQVAHVRAERDILAEA 58

Query: 400 KHPNIVQYYGSEIVEDKFYIYL--EYVHPGS-----INKYVREHCGAITESVVRNFTRHI 452
            +P +V+ Y S   +D+ Y+YL  EY+ PG      + K         TE   R +    
Sbjct: 59  DNPWVVKLYYS--FQDENYLYLIMEYL-PGGDMMTLLMKK-----DTFTEEETRFYIAET 110

Query: 453 LSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAK-----HLT-----------GQ 496
           +  +  +H    IHRDIK  NLL+DA G +KL+DFG+       H T             
Sbjct: 111 ILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSN 170

Query: 497 KADLSMK-----------------------GSPYWMAPELMMAVMQKGKSSDSALAVDIW 533
             D   K                       G+P ++APE+    +Q G +       D W
Sbjct: 171 FLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVF---LQTGYNK----ECDWW 223

Query: 534 SLGCTIIEMYTGKPPWSEYEGAAAMFKVM--RDTPAIPDS--LSPEGKDFLR--CCFQRN 587
           SLG  + EM  G PP+          K++  ++T   PD   LSPE KD ++  CC    
Sbjct: 224 SLGVIMYEMLVGYPPFCSDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCCEAER 283

Query: 588 PADRPPASLLLEHRFLK 604
                  + +  H F K
Sbjct: 284 RLGNNGVNEIKSHPFFK 300

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score =  101 bits (254), Expect = 2e-23
 Identities = 73/280 (26%), Positives = 131/280 (46%), Gaps = 33/280 (11%)

Query: 346 KLIGRGTFGSVYVASNRETGALCAMKEV--DIFPDDPKSAESIKQLEQEIKVLSHL-KHP 402
           ++IGRG++  V +   ++T  + AMK +  ++  DD    E I  ++ E  V      HP
Sbjct: 1   RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDD----EDIDWVQTEKHVFETASNHP 56

Query: 403 NIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSK 462
            +V  +     E + +  +E+V  G +  +++     + E   R ++  I   L +LH +
Sbjct: 57  FLVGLHSCFQTESRLFFVIEFVSGGDLMFHMQRQ-RKLPEEHARFYSAEISLALNFLHER 115

Query: 463 KTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMK--GSPYWMAPELMMAVMQK 520
             I+RD+K  N+L+DA G +KL D+GM K       D +    G+P ++APE++      
Sbjct: 116 GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIR-PGDTTSTFCGTPNYIAPEIL------ 168

Query: 521 GKSSDSALAVDIWSLGCTIIEMYTGKPPW--------SEYEGAAAMFKVMRDTPA-IPDS 571
            +  D   +VD W+LG  + EM  G+ P+         +      +F+V+ +    IP S
Sbjct: 169 -RGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPRS 227

Query: 572 LSPEGKDFLRCCFQRNPADR----PPASL--LLEHRFLKN 605
           LS +    L+    ++P +R    P      +  H F +N
Sbjct: 228 LSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRN 267

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score =  101 bits (252), Expect = 3e-23
 Identities = 83/305 (27%), Positives = 149/305 (48%), Gaps = 20/305 (6%)

Query: 339 NSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSH 398
           +  ++K   +G G  G V+  S++ +G + A K + +   + K A    Q+ +E++VL  
Sbjct: 4   DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHL---EIKPAIR-NQIIRELQVLHE 59

Query: 399 LKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAY 458
              P IV +YG+   + +  I +E++  GS+++ +++  G I E ++   +  ++ GL Y
Sbjct: 60  CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK-AGRIPEQILGKVSIAVIKGLTY 118

Query: 459 LHSK-KTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPYWMAPELMMAV 517
           L  K K +HRD+K +N+LV++ G +KL DFG++  L    A+ S  G+  +M+PE +   
Sbjct: 119 LREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN-SFVGTRSYMSPERL--- 174

Query: 518 MQKGKSSDSALAVDIWSLGCTIIEMYTGK---PPWSEYEGAAAMFKVMRDTPAIPDSLSP 574
               + +  ++  DIWS+G +++EM  G+   PP    E    MF    +        SP
Sbjct: 175 ----QGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKE-LELMFGCPVEGDPAESETSP 229

Query: 575 EGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQPDVPSCSLSFSGMQLTEK--PHSPRE 632
             +   R      P  RPP ++     ++ N   P +PS            K    +P E
Sbjct: 230 RPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAE 289

Query: 633 KADAK 637
           +AD K
Sbjct: 290 RADLK 294

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score =  100 bits (249), Expect = 3e-23
 Identities = 68/226 (30%), Positives = 117/226 (51%), Gaps = 16/226 (7%)

Query: 347 LIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQ 406
           ++G G +G V    ++ET  + A+K+   F D  ++ E  +   +E+K+L  LK  NIV+
Sbjct: 8   VVGEGAYGVVLKCRHKETKEIVAIKK---FKDSEENEEVKETTLRELKMLRTLKQENIVE 64

Query: 407 YYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIH 466
              +     K Y+  EYV    + + + E    +    VR++   ++  + + H    +H
Sbjct: 65  LKEAFRRRGKLYLVFEYVEKNML-ELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVH 123

Query: 467 RDIKGANLLVDASGVVKLADFGMAKHLT-GQKADLSMKGSPYWM-APELMMAVMQKGKSS 524
           RDIK  NLL+  + V+KL DFG A++L+ G  A+ +   +  W  +PEL++     GK  
Sbjct: 124 RDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGA-PYGK-- 180

Query: 525 DSALAVDIWSLGCTIIEMYTGKPPW---SEYEGAAAMFKVMRDTPA 567
               AVD+WS+GC + E+  G+P +   SE +    + KV+   PA
Sbjct: 181 ----AVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPA 222

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score =  100 bits (251), Expect = 4e-23
 Identities = 79/270 (29%), Positives = 129/270 (47%), Gaps = 24/270 (8%)

Query: 348 IGRGTFGSVYVASNRETGALCAMKEVD--IFPDDPKSAESIKQLEQEIKVLSHLKH-PNI 404
           IG+GTFG VY    ++T  + AMK +         + A +I   E+ I V + L   P I
Sbjct: 1   IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIG--ERNILVRTLLDESPFI 58

Query: 405 VQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKT 464
           V    S   +   Y+  +Y+  G +  ++ +  G  +E   + +   ++  L +LH    
Sbjct: 59  VGLKFSFQTDSDLYLVTDYMSGGELFWHL-QKEGRFSEDRAKFYIAELVLALEHLHKYDI 117

Query: 465 IHRDIKGANLLVDASGVVKLADFGMAK-HLTGQKADLSMKGSPYWMAPELMMAVMQKGKS 523
           ++RD+K  N+L+DA+G + L DFG++K +LT  K   +  G+  ++APE+++      K 
Sbjct: 118 VYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEKGYTKH 177

Query: 524 SDSALAVDIWSLGCTIIEMYTGKPPWSEY--EGAAAMFK-VMRDTPAIP-DSLSPEGKDF 579
                 VD WSLG  + EM  G   WS +  E    M++ +       P + LS EG+ F
Sbjct: 178 ------VDFWSLGVLVFEMCCG---WSPFYAEDTQQMYRNIAFGKVRFPKNVLSDEGRQF 228

Query: 580 LRCCFQRNPADR----PPASLLLEHRFLKN 605
           ++    RNP  R      A  L EH F  +
Sbjct: 229 VKGLLNRNPQHRLGAHRDAVELKEHPFFAD 258

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score =  100 bits (252), Expect = 5e-23
 Identities = 87/315 (27%), Positives = 136/315 (43%), Gaps = 67/315 (21%)

Query: 348 IGRGTFGSVYVASNRETGALCAMKEV-DIFPDDPKSAESIKQLEQEIKVLSHLK-HPNIV 405
           +G+G +G V+ A +R T  + A+K++ D F +   +  + +    EI  L  L  HPNIV
Sbjct: 15  LGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFR----EIMFLQELGDHPNIV 70

Query: 406 QYYGSEIVEDKFYIYL--EY----VHPGSINKYVREHCGAITESVVRNF-TRHILSGLAY 458
           +       E+   IYL  EY    +H   I          I E V + +    +L  L Y
Sbjct: 71  KLLNVIKAENDKDIYLVFEYMETDLH-AVIRA-------NILEDVHKRYIMYQLLKALKY 122

Query: 459 LHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMK------GSPYWMAPE 512
           +HS   IHRD+K +N+L+++   VKLADFG+A+ L+  + +           + ++ APE
Sbjct: 123 IHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATRWYRAPE 182

Query: 513 LMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKP--------------------PWSE- 551
           +++       S+     VD+WS+GC + EM  GKP                    P +E 
Sbjct: 183 ILLG------STRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAED 236

Query: 552 -----YEGAAAMFKVM----RDTPA--IPDSLSPEGKDFLRCCFQRNPADRPPASLLLEH 600
                   AA M   +    R      +P + S +  D L+     NP  R  A   LEH
Sbjct: 237 IESIKSPFAATMLDSLPSRPRKPLDELLPKA-SDDALDLLKKLLVFNPNKRLTAEEALEH 295

Query: 601 RFLKNSQQP-DVPSC 614
            ++     P D P  
Sbjct: 296 PYVAQFHNPSDEPVL 310

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 98.5 bits (246), Expect = 6e-23
 Identities = 70/268 (26%), Positives = 118/268 (44%), Gaps = 39/268 (14%)

Query: 340 SQWQKGKLIGRGTFGSVYVASNRETG--ALCAMKEVDIFPDDPKSAESIKQLEQEIKVLS 397
              +  + +G G FG V++ +   T   A+  +K   + P+            QE +++ 
Sbjct: 6   ESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPEA---------FLQEAQIMK 56

Query: 398 HLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCG-AITESVVRNFTRHILSGL 456
            L+H  +VQ Y     E+  YI  EY+  GS+  +++   G  +    + +    I  G+
Sbjct: 57  KLRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGM 116

Query: 457 AYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAK------HLTGQKADLSMKGSPYWMA 510
           AYL S+  IHRD+   N+LV  + V K+ADFG+A+      +   + A   +K    W A
Sbjct: 117 AYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIK----WTA 172

Query: 511 PELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFKVMRD----- 564
           PE         KS       D+WS G  + E+ T G+ P+        + +V R      
Sbjct: 173 PEAANYGRFTIKS-------DVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRMPR 225

Query: 565 TPAIPDSLSPEGKDFLRCCFQRNPADRP 592
            P  P+ L     D +  C+ ++P +RP
Sbjct: 226 PPNCPEEL----YDLMLQCWDKDPEERP 249

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score =  100 bits (250), Expect = 7e-23
 Identities = 84/307 (27%), Positives = 139/307 (45%), Gaps = 62/307 (20%)

Query: 346 KLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESI-KQLEQEIKVLSHLKHPNI 404
           K +G G +GSV  A ++ TG   A+K++      P  +E   K+  +E+ +L H++H N+
Sbjct: 21  KQVGSGAYGSVCSAIDKRTGEKVAIKKLS----RPFQSEIFAKRAYRELTLLKHMQHENV 76

Query: 405 V---QYYGSEIVEDK---FYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAY 458
           +     + S +  D+   FY+ + Y+    + K +      ++E  V+     +L GL Y
Sbjct: 77  IGLLDVFTSAVSGDEFQDFYLVMPYMQT-DLQKIMGHP---LSEDKVQYLVYQMLCGLKY 132

Query: 459 LHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKG---SPYWMAPELMM 515
           +HS   IHRD+K  NL V+    +K+ DFG+A+H     AD  M G   + ++ APE+++
Sbjct: 133 IHSAGIIHRDLKPGNLAVNEDCELKILDFGLARH-----ADAEMTGYVVTRWYRAPEVIL 187

Query: 516 AVMQKGKSSDSALAVDIWSLGCTIIEMYTGKP--------------------PWSEY--- 552
             M   ++      VDIWS+GC + EM TGK                     P  E+   
Sbjct: 188 NWMHYNQT------VDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQK 241

Query: 553 -EGAAAMFKVMRDTPAIPD--------SLSPEGKDFLRCCFQRNPADRPPASLLLEHRFL 603
            E  AA    ++  P  P           SP+  D L    + +   R  A+  LEH + 
Sbjct: 242 LEDKAAK-SYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYF 300

Query: 604 KNSQQPD 610
            + +  D
Sbjct: 301 DSFRDAD 307

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score =  100 bits (250), Expect = 7e-23
 Identities = 81/311 (26%), Positives = 129/311 (41%), Gaps = 67/311 (21%)

Query: 340 SQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHL 399
            ++Q    IG G +G V  A+++ TG   A+K++  F          + L +EIK+L   
Sbjct: 5   PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFE---HQTFCQRTL-REIKILRRF 60

Query: 400 KHPNIVQYYGSEIVED-----KFYIYLEYVHPGSINKYVR------EHCGAITESVVRNF 448
           KH NI+                 YI  E +    + K ++      +H         + F
Sbjct: 61  KHENIIGILDIIRPPSFESFNDVYIVQELM-ETDLYKLIKTQHLSNDHI--------QYF 111

Query: 449 TRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPY- 507
              IL GL Y+HS   +HRD+K +NLL++ +  +K+ DFG+A+ +   + D +   + Y 
Sbjct: 112 LYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLAR-IADPEHDHTGFLTEYV 170

Query: 508 ---WM-APELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKP--PWSEY--------- 552
              W  APE+M+    KG +     A+DIWS+GC + EM + +P  P  +Y         
Sbjct: 171 ATRWYRAPEIMLN--SKGYTK----AIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILG 224

Query: 553 ---------------EGAAAMFKVMRDTPAIP-DSL----SPEGKDFLRCCFQRNPADRP 592
                            A    K +   P +P + L     P+  D L      NP  R 
Sbjct: 225 VLGTPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRI 284

Query: 593 PASLLLEHRFL 603
                L H +L
Sbjct: 285 TVEEALAHPYL 295

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 98.1 bits (244), Expect = 7e-23
 Identities = 76/259 (29%), Positives = 121/259 (46%), Gaps = 28/259 (10%)

Query: 348 IGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQY 407
           IG+G FG V +   R  G   A+K +       K+  + +    E  V++ L+H N+VQ 
Sbjct: 14  IGKGEFGDVMLGDYR--GNKVAVKCI-------KNDATAQAFLAEASVMTQLRHSNLVQL 64

Query: 408 YGSEIVEDK--FYIYLEYVHPGSINKYVREHCGAITE-SVVRNFTRHILSGLAYLHSKKT 464
            G  IVE+K   YI  EY+  GS+  Y+R    ++     +  F+  +   + YL +   
Sbjct: 65  LGV-IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNF 123

Query: 465 IHRDIKGANLLVDASGVVKLADFGMAKHL--TGQKADLSMKGSPYWMAPELMMAVMQKGK 522
           +HRD+   N+LV    V K++DFG+ K    T     L +K    W APE   A+ +K  
Sbjct: 124 VHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVK----WTAPE---ALREKKF 176

Query: 523 SSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFKVMRDTPA-IPDSLSPEGKDFL 580
           S+ S    D+WS G  + E+Y+ G+ P+        + +V +      PD   P   D +
Sbjct: 177 STKS----DVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPVVYDVM 232

Query: 581 RCCFQRNPADRPPASLLLE 599
           + C+  + A RP    L E
Sbjct: 233 KQCWHLDAATRPSFLQLRE 251

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 98.9 bits (247), Expect = 1e-22
 Identities = 71/301 (23%), Positives = 128/301 (42%), Gaps = 46/301 (15%)

Query: 346 KLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIV 405
           KL+G+G  G V++   + TG L A+K +D      ++   +K++  E ++L+ L HP + 
Sbjct: 7   KLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRN--KVKRVLTEQEILATLDHPFLP 64

Query: 406 QYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGA-ITESVVRNFTRHILSGLAYLHSKKT 464
             Y S   E    + ++Y   G + + ++   G  ++E V R +   +L  L YLH    
Sbjct: 65  TLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGI 124

Query: 465 IHRDIKGANLLVDASGVVKLADFGMAKHL---TGQKADLSMKGSPY-------------- 507
           ++RD+K  N+L+  SG + L+DF ++K         +    KGS                
Sbjct: 125 VYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEE 184

Query: 508 -------------WMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEG 554
                        ++APE++      G    S  AVD W+LG  + EM  G  P+     
Sbjct: 185 PSFRSNSFVGTEEYIAPEVI-----SGDGHGS--AVDWWTLGILLYEMLYGTTPFKGSNR 237

Query: 555 AAAMFKVMRDTPAIPDS--LSPEGKDFLRCCFQRNPADR----PPASLLLEHRFLKNSQQ 608
                 +++     P S  +S   +D +R    ++P+ R      A+ + +H F +    
Sbjct: 238 DETFSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRGVNW 297

Query: 609 P 609
            
Sbjct: 298 A 298

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 99.3 bits (247), Expect = 1e-22
 Identities = 69/248 (27%), Positives = 120/248 (48%), Gaps = 12/248 (4%)

Query: 346 KLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIV 405
           K+IG+G+FG V +A  +  G+  A+K +       K  ++    E+ + +L +LKHP +V
Sbjct: 1   KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNV-LLKNLKHPFLV 59

Query: 406 QYYGSEIVEDKFYIYLEYVHPGSINKYV-REHCGAITESVVRNFTRHILSGLAYLHSKKT 464
             + S    +K Y  L+YV+ G +  ++ RE C    E   R +   + S + YLHS   
Sbjct: 60  GLHYSFQTAEKLYFVLDYVNGGELFFHLQRERC--FLEPRARFYAAEVASAIGYLHSLNI 117

Query: 465 IHRDIKGANLLVDASGVVKLADFGMAKH-LTGQKADLSMKGSPYWMAPELMMAVMQKGKS 523
           I+RD+K  N+L+D+ G V L DFG+ K  +  ++   +  G+P ++APE++       + 
Sbjct: 118 IYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFCGTPEYLAPEVL-------RK 170

Query: 524 SDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDSLSPEGKDFLRCC 583
                 VD W LG  + EM  G PP+   + +     ++     +P   +    D L   
Sbjct: 171 EPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQLPGGKTVAACDLLVGL 230

Query: 584 FQRNPADR 591
             ++   R
Sbjct: 231 LHKDQRRR 238

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 98.2 bits (244), Expect = 2e-22
 Identities = 58/204 (28%), Positives = 107/204 (52%), Gaps = 10/204 (4%)

Query: 342 WQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKH 401
           ++K + +G G++ +VY   ++  G L A+K + +  ++     +I+    E  +L  LKH
Sbjct: 7   YEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIR----EASLLKGLKH 62

Query: 402 PNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHS 461
            NIV  +     ++   +  EYVH   + +Y+ +H G +    V+ F   +L GL+Y+H 
Sbjct: 63  ANIVLLHDIIHTKETLTLVFEYVHT-DLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQ 121

Query: 462 KKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPYWMAPELMMAVMQKG 521
           +  +HRD+K  NLL+  +G +KLADFG+A+  +      S +    W  P  ++      
Sbjct: 122 RYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVLL----- 176

Query: 522 KSSDSALAVDIWSLGCTIIEMYTG 545
            S++ +  +D+W +GC  +EM  G
Sbjct: 177 GSTEYSTCLDMWGVGCIFVEMIQG 200

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 96.6 bits (241), Expect = 3e-22
 Identities = 76/262 (29%), Positives = 121/262 (46%), Gaps = 33/262 (12%)

Query: 346 KLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQ---LEQEIKVLSHLKHP 402
           K+IG G FG V     +  G     KE+D+     K+  S KQ      E  ++    HP
Sbjct: 10  KVIGGGEFGEVCRGRLKLPGK----KEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHP 65

Query: 403 NIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSK 462
           NI++  G         I  EY+  GS++K++RE+ G  T   +    R I SG+ YL   
Sbjct: 66  NIIRLEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEM 125

Query: 463 KTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKG--SPY-WMAPELMMAVMQ 519
             +HRD+   N+LV+++ V K++DFG+++ L   +A  + KG   P  W APE   A+  
Sbjct: 126 NYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPE---AIAY 182

Query: 520 KGKSSDSALAVDIWSLGCTIIE-MYTGKPPWSEYEGAAAMFKVM--------RDTPAIPD 570
           +  +S S    D+WS G  + E M  G+ P+ +      +  V          D P+   
Sbjct: 183 RKFTSAS----DVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYRLPPPMDCPSALY 238

Query: 571 SLSPEGKDFLRCCFQRNPADRP 592
            L  +       C+Q++  +RP
Sbjct: 239 QLMLD-------CWQKDRNERP 253

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 97.2 bits (242), Expect = 3e-22
 Identities = 73/281 (25%), Positives = 129/281 (45%), Gaps = 46/281 (16%)

Query: 348 IGRGTFGSVYVASNRETGALC----AMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPN 403
           IG+G FG V+ A  R  G L      M  V +  ++  SA+     ++E  +++   HPN
Sbjct: 13  IGQGAFGRVFQA--RAPGLLPYEPFTMVAVKMLKEE-ASADMQADFQREAALMAEFDHPN 69

Query: 404 IVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTR------------- 450
           IV+  G   V     +  EY+  G +N+++R        S+  + +              
Sbjct: 70  IVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSC 129

Query: 451 --------HILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQ---KAD 499
                    + +G+AYL  +K +HRD+   N LV  + VVK+ADFG+++++      KA 
Sbjct: 130 TEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKAS 189

Query: 500 LSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAA-- 556
            +      WM PE   ++     +++S    D+W+ G  + E+++ G  P   Y G A  
Sbjct: 190 ENDAIPIRWMPPE---SIFYNRYTTES----DVWAYGVVLWEIFSYGMQP---YYGMAHE 239

Query: 557 AMFKVMRD--TPAIPDSLSPEGKDFLRCCFQRNPADRPPAS 595
            +   +RD    + PD+   E  + +R C+ + P+DRP  +
Sbjct: 240 EVIYYVRDGNVLSCPDNCPLELYNLMRLCWSKLPSDRPSFA 280

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 98.6 bits (245), Expect = 3e-22
 Identities = 86/325 (26%), Positives = 157/325 (48%), Gaps = 47/325 (14%)

Query: 341 QWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESI---KQLEQEIKVLS 397
           ++Q    +G G +GSV  A + +TG   A+K++       +  +SI   K+  +E+++L 
Sbjct: 18  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS------RPFQSIIHAKRTYRELRLLK 71

Query: 398 HLKHPNIVQ----YYGSEIVEDKFYIYL-EYVHPGSINKYVREHCGAITESVVRNFTRHI 452
           H+KH N++     +  +  +E+   +YL  ++    +N  V+  C  +T+  V+     I
Sbjct: 72  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQI 129

Query: 453 LSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKG---SPYWM 509
           L GL Y+HS   IHRD+K +NL V+    +K+ DFG+A+H      D  M G   + ++ 
Sbjct: 130 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARH-----TDDEMTGYVATRWYR 184

Query: 510 APELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIP 569
           APE+M+  M   ++      VDIWS+GC + E+ TG+  +   +    +  ++R      
Sbjct: 185 APEIMLNWMHYNQT------VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG 238

Query: 570 DSL-----SPEGKDFLRCCFQ---RNPAD-----RPPASLLLEHRFLKNSQQPDVPSCSL 616
             L     S   +++++   Q    N A+      P A  LLE   + +S +    + +L
Sbjct: 239 AELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQAL 298

Query: 617 SFSGMQLTEKPHSPREKADAK-YDQ 640
           + +      + H P ++  A  YDQ
Sbjct: 299 AHAYFA---QYHDPDDEPVADPYDQ 320

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 97.8 bits (243), Expect = 4e-22
 Identities = 68/257 (26%), Positives = 124/257 (48%), Gaps = 23/257 (8%)

Query: 346 KLIGRGTFGSVYVASNRETGALCAMKEV--DIFPDDPKSAESIKQLEQEIKVLSHLK-HP 402
           ++IGRG++  V +   ++   + AMK V  ++  DD    E I  ++ E  V      +P
Sbjct: 1   RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDD----EDIDWVQTEKHVFEQASSNP 56

Query: 403 NIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSK 462
            +V  +       + ++ +EYV+ G +  +++     + E   R +   I   L +LH +
Sbjct: 57  FLVGLHSCFQTTSRLFLVIEYVNGGDLMFHMQRQ-RKLPEEHARFYAAEICIALNFLHER 115

Query: 463 KTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLS-MKGSPYWMAPELMMAVMQKG 521
             I+RD+K  N+L+DA G +KL D+GM K   G     S   G+P ++APE++       
Sbjct: 116 GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEIL------- 168

Query: 522 KSSDSALAVDIWSLGCTIIEMYTGKPPWS------EYEGAAAMFKVMRDTPA-IPDSLSP 574
           +  +   +VD W+LG  + EM  G+ P+       +      +F+V+ + P  IP  LS 
Sbjct: 169 RGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPRFLSV 228

Query: 575 EGKDFLRCCFQRNPADR 591
           +    L+    ++P +R
Sbjct: 229 KASHVLKGFLNKDPKER 245

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 96.6 bits (241), Expect = 4e-22
 Identities = 71/271 (26%), Positives = 115/271 (42%), Gaps = 44/271 (16%)

Query: 348 IGRGTFGSVY--VASNRETGAL---CAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHP 402
           +G+G+FG VY  +A     G      A+K V+   ++    E I+ L  E  V+      
Sbjct: 14  LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVN---ENASMRERIEFL-NEASVMKEFNCH 69

Query: 403 NIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREH---------CGAITESVVRNFTRHIL 453
           ++V+  G         + +E +  G +  Y+R            G  T          I 
Sbjct: 70  HVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIA 129

Query: 454 SGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHL-------TGQKADLSMKGSP 506
            G+AYL +KK +HRD+   N +V     VK+ DFGM + +        G K  L ++   
Sbjct: 130 DGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVR--- 186

Query: 507 YWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAA---AMFKVM 562
            WMAPE +   +   KS       D+WS G  + EM T  + P   Y+G +    +  V+
Sbjct: 187 -WMAPESLKDGVFTTKS-------DVWSFGVVLWEMATLAEQP---YQGLSNEEVLKFVI 235

Query: 563 -RDTPAIPDSLSPEGKDFLRCCFQRNPADRP 592
                 +P++   +  + +R C+Q NP  RP
Sbjct: 236 DGGHLDLPENCPDKLLELMRMCWQYNPKMRP 266

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 98.3 bits (245), Expect = 4e-22
 Identities = 84/297 (28%), Positives = 140/297 (47%), Gaps = 32/297 (10%)

Query: 328 QVAAKPEPLPMNSQ-WQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESI 386
           + A K   L M ++ +   K+IGRG FG V +  ++ +  + AMK +  F       E I
Sbjct: 30  KAAEKITKLRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKF-------EMI 82

Query: 387 KQLE-----QEIKVLSHLKHPNIVQYYGSEIVEDKFYIYL--EYVHPGSINKYVREHCGA 439
           K+ +     +E  +++H     IVQ + +   +D  Y+Y+  EY+  G +   +  +   
Sbjct: 83  KRSDSAFFWEERDIMAHANSEWIVQLHYA--FQDDKYLYMVMEYMPGGDLVNLMSNY--D 138

Query: 440 ITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFG--MAKHLTGQK 497
           I E   R +T  ++  L  +HS   IHRD+K  N+L+D SG +KLADFG  M     G  
Sbjct: 139 IPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMV 198

Query: 498 ADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAA 557
              +  G+P +++PE++ +   +G         D WS+G  + EM  G  P+        
Sbjct: 199 RCDTAVGTPDYISPEVLKS---QGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGT 255

Query: 558 MFKVM--RDTPAIPD--SLSPEGKDFLRCCFQRNPADRPPASLLLE---HRFLKNSQ 607
             K+M  +++   PD   +S + KD + C F  +   R   + + E   H F KN Q
Sbjct: 256 YSKIMDHKNSLTFPDDIEISKQAKDLI-CAFLTDREVRLGRNGVDEIKSHPFFKNDQ 311

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 97.4 bits (242), Expect = 5e-22
 Identities = 71/259 (27%), Positives = 126/259 (48%), Gaps = 25/259 (9%)

Query: 346 KLIGRGTFGSVYVASNRETGALCAMKEV--DIFPDDPKSAESIKQLEQEIKVLSHL-KHP 402
           ++IGRG++  V +   ++T  + AMK V  ++  DD    E I  ++ E  V      HP
Sbjct: 1   RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDD----EDIDWVQTEKHVFEQASNHP 56

Query: 403 NIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSK 462
            +V  +     E + +  +EYV+ G +  +++     + E   R ++  I   L YLH +
Sbjct: 57  FLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQ-RKLPEEHARFYSAEISLALNYLHER 115

Query: 463 KTIHRDIKGANLLVDASGVVKLADFGMAKH-LTGQKADLSMKGSPYWMAPELMMAVMQKG 521
             I+RD+K  N+L+D+ G +KL D+GM K  L       +  G+P ++APE++       
Sbjct: 116 GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEIL------- 168

Query: 522 KSSDSALAVDIWSLGCTIIEMYTGKPPWS--------EYEGAAAMFKVMRDTPA-IPDSL 572
           +  D   +VD W+LG  + EM  G+ P+         +      +F+V+ +    IP SL
Sbjct: 169 RGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSL 228

Query: 573 SPEGKDFLRCCFQRNPADR 591
           S +    L+    ++P +R
Sbjct: 229 SVKAASVLKSFLNKDPKER 247

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 95.6 bits (238), Expect = 6e-22
 Identities = 71/264 (26%), Positives = 120/264 (45%), Gaps = 43/264 (16%)

Query: 346 KLIGRGTFGSVY--VASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPN 403
           + +G G FG V+  + +N    A+  +K   + P D            E +++  L+HP 
Sbjct: 12  RKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPKD---------FLAEAQIMKKLRHPK 62

Query: 404 IVQYYGSEIVEDKFYIYLEYVHPGSINKYVR-EHCGAITESVVRNFTRHILSGLAYLHSK 462
           ++Q Y    +E+  YI  E +  GS+ +Y++     A+    + +    + SG+AYL ++
Sbjct: 63  LIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQ 122

Query: 463 KTIHRDIKGANLLVDASGVVKLADFGMAKHL--------TGQKADLSMKGSPYWMAPELM 514
             IHRD+   N+LV  + + K+ADFG+A+ +         G K    +K    W APE  
Sbjct: 123 NYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAK--FPIK----WTAPEAA 176

Query: 515 MAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFKV-----MRDTPAI 568
           +      KS       D+WS G  + E+ T G+ P+     A  + +V     M   P  
Sbjct: 177 LYNRFSIKS-------DVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYRMPCPPGC 229

Query: 569 PDSLSPEGKDFLRCCFQRNPADRP 592
           P  L     D +  C++ +P DRP
Sbjct: 230 PKELY----DIMLDCWKEDPDDRP 249

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 97.4 bits (242), Expect = 6e-22
 Identities = 81/313 (25%), Positives = 151/313 (48%), Gaps = 62/313 (19%)

Query: 348 IGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQY 407
           +G G  G V    ++ +G + A K + +   + K A    Q+ +E++VL     P IV +
Sbjct: 13  LGAGNGGVVTKVQHKPSGLIMARKLIHL---EIKPAIR-NQIIRELQVLHECNSPYIVGF 68

Query: 408 YGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTI-H 466
           YG+   + +  I +E++  GS+++ ++E    I E ++   +  +L GLAYL  K  I H
Sbjct: 69  YGAFYSDGEISICMEHMDGGSLDQVLKE-AKRIPEEILGKVSIAVLRGLAYLREKHQIMH 127

Query: 467 RDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPYWMAPELMMAVMQKGKSSDS 526
           RD+K +N+LV++ G +KL DFG++  L    A+ S  G+  +M+PE +       + +  
Sbjct: 128 RDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN-SFVGTRSYMSPERL-------QGTHY 179

Query: 527 ALAVDIWSLGCTIIEMYTG-----------------------------------KPPWSE 551
           ++  DIWS+G +++E+  G                                   +PP   
Sbjct: 180 SVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRPPGRP 239

Query: 552 YEG-------AAAMFKVM-----RDTPAIPDSL-SPEGKDFLRCCFQRNPADRPPASLLL 598
             G       A A+F+++        P +P+ + +P+ ++F+  C  +NPA+R    +L+
Sbjct: 240 VSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLM 299

Query: 599 EHRFLKNSQQPDV 611
            H F+K S+  +V
Sbjct: 300 NHTFIKRSEVEEV 312

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 97.2 bits (242), Expect = 7e-22
 Identities = 66/215 (30%), Positives = 107/215 (49%), Gaps = 43/215 (20%)

Query: 348 IGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESI-KQLEQEIKVLSHLKHPNIVQ 406
           +G G FG V  A ++ TG   A+K++      P S   + K+  +E+K+L HL+H NI+ 
Sbjct: 18  VGMGAFGLVCSARDQLTGQNVAIKKIM----KPFSTPVLAKRTYRELKLLKHLRHENIIS 73

Query: 407 YYGSEIVEDKFYIYLEYVHPGSINKYVREHCGA----------ITESVVRNFTRHILSGL 456
                 + D F   LE ++      +V E  G           + +  ++ F   IL GL
Sbjct: 74  ------LSDIFISPLEDIY------FVTELLGTDLHRLLTSRPLEKQFIQYFLYQILRGL 121

Query: 457 AYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAK----HLTGQKADLSMKGSPYWMAPE 512
            Y+HS   +HRD+K +N+L++ +  +K+ DFG+A+     +TG  +      + Y+ APE
Sbjct: 122 KYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQDPQMTGYVS------TRYYRAPE 175

Query: 513 LMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKP 547
           +M+   +        + VDIWS GC   EM  GKP
Sbjct: 176 IMLTWQKYD------VEVDIWSAGCIFAEMLEGKP 204

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 94.8 bits (236), Expect = 1e-21
 Identities = 71/263 (26%), Positives = 119/263 (45%), Gaps = 29/263 (11%)

Query: 340 SQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQ--LEQEIKVLS 397
            ++   + +G G FG V+    +    + A+K +       KS + +KQ   ++E++ L 
Sbjct: 6   EEFTLERKLGSGYFGEVWEGLWKNRVRV-AIKIL-------KSDDLLKQQDFQKEVQALK 57

Query: 398 HLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCG-AITESVVRNFTRHILSGL 456
            L+H +++  +    V +  YI  E +  GS+  ++R   G  +  + + +    +  G+
Sbjct: 58  RLRHKHLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGM 117

Query: 457 AYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPY-WMAPELMM 515
           AYL  + +IHRD+   N+LV    V K+ADFG+A+ +       S K  PY W APE   
Sbjct: 118 AYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPYKWTAPE--- 174

Query: 516 AVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAA---AMFKVMRD--TPAIP 569
           A      S+ S    D+WS G  + EM+T G+ P   Y G        ++      P  P
Sbjct: 175 AASHGTFSTKS----DVWSFGILLYEMFTYGQVP---YPGMNNHEVYDQITAGYRMPC-P 226

Query: 570 DSLSPEGKDFLRCCFQRNPADRP 592
                E    +  C+   P DRP
Sbjct: 227 AKCPQEIYKIMLECWAAEPEDRP 249

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 94.4 bits (235), Expect = 2e-21
 Identities = 68/268 (25%), Positives = 122/268 (45%), Gaps = 45/268 (16%)

Query: 345 GKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIK------------QLEQE 392
           G+ IG G FG VY               V + P++ K A ++K            +  QE
Sbjct: 11  GRCIGEGQFGDVYQG-------------VYMSPENEKIAVAVKTCKNCTSPSVREKFLQE 57

Query: 393 IKVLSHLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHI 452
             ++    HP+IV+  G  I E+  +I +E    G +  Y++ +  ++  + +  ++  +
Sbjct: 58  AYIMRQFDHPHIVKLIGV-ITENPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQL 116

Query: 453 LSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHL------TGQKADLSMKGSP 506
            + LAYL SK+ +HRDI   N+LV +   VKL DFG++++L         K  L +K   
Sbjct: 117 STALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIK--- 173

Query: 507 YWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFKVMR-D 564
            WMAPE   ++  +  +S S    D+W  G  + E+   G  P+   +    + ++   +
Sbjct: 174 -WMAPE---SINFRRFTSAS----DVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGE 225

Query: 565 TPAIPDSLSPEGKDFLRCCFQRNPADRP 592
              +P +  P     +  C+  +P+ RP
Sbjct: 226 RLPMPPNCPPTLYSLMTKCWAYDPSKRP 253

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 93.9 bits (233), Expect = 2e-21
 Identities = 69/254 (27%), Positives = 115/254 (45%), Gaps = 16/254 (6%)

Query: 346 KLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIV 405
           +L+G+G FG V+  + ++   +      +  P + K    IK L  E ++L    HPNIV
Sbjct: 1   ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELK----IKFL-SEARILKQYDHPNIV 55

Query: 406 QYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTI 465
           +  G        YI +E V  G    ++R+    +    +  F     +G+AYL SK  I
Sbjct: 56  KLIGVCTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCI 115

Query: 466 HRDIKGANLLVDASGVVKLADFGMAKHLT-GQKADLSMKGSPY-WMAPELMMAVMQKGKS 523
           HRD+   N LV  + V+K++DFGM++    G  +   +K  P  W APE     +  G+ 
Sbjct: 116 HRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPE----ALNYGRY 171

Query: 524 SDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFKVMRD-TPAIPDSLSPEGKDFLR 581
           S  +   D+WS G  + E ++ G  P+       A  +V +    + P     +    ++
Sbjct: 172 SSES---DVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYRMSCPQKCPDDVYKVMQ 228

Query: 582 CCFQRNPADRPPAS 595
            C+   P +RP  S
Sbjct: 229 RCWDYKPENRPKFS 242

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 95.1 bits (236), Expect = 3e-21
 Identities = 70/248 (28%), Positives = 119/248 (47%), Gaps = 12/248 (4%)

Query: 346 KLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIV 405
           K+IG+G+FG V +A ++      A+K +       K  E     E+ + +L ++KHP +V
Sbjct: 1   KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNV-LLKNVKHPFLV 59

Query: 406 QYYGSEIVEDKFYIYLEYVHPGSINKYV-REHCGAITESVVRNFTRHILSGLAYLHSKKT 464
             + S    DK Y  L+Y++ G +  ++ RE C    E   R +   I S L YLHS   
Sbjct: 60  GLHFSFQTADKLYFVLDYINGGELFYHLQRERC--FLEPRARFYAAEIASALGYLHSLNI 117

Query: 465 IHRDIKGANLLVDASGVVKLADFGMAK-HLTGQKADLSMKGSPYWMAPELMMAVMQKGKS 523
           ++RD+K  N+L+D+ G + L DFG+ K ++       +  G+P ++APE    V+ K   
Sbjct: 118 VYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPE----VLHKQPY 173

Query: 524 SDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDSLSPEGKDFLRCC 583
             +   VD W LG  + EM  G PP+     A     ++     +  +++   +  L   
Sbjct: 174 DRT---VDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHLLEGL 230

Query: 584 FQRNPADR 591
            Q++   R
Sbjct: 231 LQKDRTKR 238

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 94.0 bits (234), Expect = 4e-21
 Identities = 79/307 (25%), Positives = 136/307 (44%), Gaps = 64/307 (20%)

Query: 336 LPMNSQWQ-------KGKLIGRGTFGSVYVAS-----NRETGALCAMKEVDIFPDDPKSA 383
           LP++ +W+        GK +G G FG V  A      N    +  A+K +     +   +
Sbjct: 1   LPLDPEWELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLS 60

Query: 384 ESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVR--------- 434
           + + ++E  +K++   KH NI+   G    E   Y+ +EY   G++  ++R         
Sbjct: 61  DLVSEMEM-MKMIG--KHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYA 117

Query: 435 ------EHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFG 488
                      +T+  + +F   +  G+ +L SKK IHRD+   N+LV    V+K+ADFG
Sbjct: 118 SPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIADFG 177

Query: 489 MA----------KHLTGQKADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCT 538
           +A          K   G+   L +K    WMAPE +   +   +S       D+WS G  
Sbjct: 178 LARDIHHIDYYRKTTNGR---LPVK----WMAPEALFDRVYTHQS-------DVWSFGVL 223

Query: 539 IIEMYT--GKPPWSEYEGAAA--MFKVMRDTPAI--PDSLSPEGKDFLRCCFQRNPADRP 592
           + E++T  G P    Y G     +FK++++   +  P + + E    +R C+   P+ RP
Sbjct: 224 LWEIFTLGGSP----YPGIPVEELFKLLKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRP 279

Query: 593 PASLLLE 599
               L+E
Sbjct: 280 TFKQLVE 286

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 95.6 bits (238), Expect = 4e-21
 Identities = 67/225 (29%), Positives = 106/225 (47%), Gaps = 56/225 (24%)

Query: 348 IGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQY 407
           IG G FG V+  ++   G   A+K++   P+  ++  S K++ +E+K+L   KH N++  
Sbjct: 8   IGYGAFGVVWSVTDPRDGKRVALKKM---PNVFQNLVSCKRVFRELKMLCFFKHDNVLSA 64

Query: 408 YGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESV------------------VRNFT 449
                        L+ + P  I+ +  E    +TE +                  V+ F 
Sbjct: 65  -------------LDILQPPHIDPF--EEIYVVTELMQSDLHKIIVSPQPLSSDHVKVFL 109

Query: 450 RHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMA--------KHLTGQKADLS 501
             IL GL YLHS   +HRDIK  NLLV+++ V+K+ DFG+A        KH+T +     
Sbjct: 110 YQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVV--- 166

Query: 502 MKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGK 546
              + Y+ APE++M       S     AVDIWS+GC   E+   +
Sbjct: 167 ---TQYYRAPEILMG------SRHYTSAVDIWSVGCIFAELLGRR 202

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 97.9 bits (243), Expect = 6e-21
 Identities = 79/297 (26%), Positives = 139/297 (46%), Gaps = 44/297 (14%)

Query: 346 KLIGRGTFGSVYVASNRETGALCAMKEVDI--FPDDPKSAESIKQLEQEIKVLSHLKHPN 403
           K IG G FG V++  ++ T      K +      +  KS     QL  E+ V+  LKH N
Sbjct: 19  KKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKS-----QLVIEVNVMRELKHKN 73

Query: 404 IVQYYGSEI--VEDKFYIYLEYVHPGSINKYVREHC----GAITESVVRNFTRHILSGLA 457
           IV+Y    +     K YI +E+   G +++ +++ C    G I E  + + TR +L  LA
Sbjct: 74  IVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQK-CYKMFGKIEEHAIVDITRQLLHALA 132

Query: 458 YLHS-------KKTIHRDIKGANLLV-----------------DASGVVKLADFGMAKHL 493
           Y H+       ++ +HRD+K  N+ +                 +   + K+ DFG++K++
Sbjct: 133 YCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNI 192

Query: 494 TGQKADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYE 553
             +    S  G+PY+ +PEL++    + KS D     D+W+LGC I E+ +GK P+ +  
Sbjct: 193 GIESMAHSCVGTPYYWSPELLL---HETKSYDDK--SDMWALGCIIYELCSGKTPFHKAN 247

Query: 554 GAAAMFKVMRDTPAIP-DSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQP 609
             + +   ++  P +P    S E    ++     +  +RP A   L ++ +KN   P
Sbjct: 248 NFSQLISELKRGPDLPIKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNVGPP 304

Length = 1021

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 96.1 bits (239), Expect = 8e-21
 Identities = 81/300 (27%), Positives = 137/300 (45%), Gaps = 54/300 (18%)

Query: 346 KLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIV 405
           +++G G  G+V  A     G   A+K VD+   +  S     + + E+  L +    +IV
Sbjct: 38  RVLGSGATGTVLCAKRVSDGEPFAVKVVDM---EGMSEADKNRAQAEVCCLLNCDFFSIV 94

Query: 406 QYYGSEIVEDK--------FYIYLEYVHPGSINKYVREHCGAITESVVRNFTRH------ 451
           + +     +D           + L+Y + G + + ++           R F  H      
Sbjct: 95  KCHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKT-----NRTFREHEAGLLF 149

Query: 452 --ILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMK---GSP 506
             +L  + ++HSK  IHRDIK AN+L+ ++G+VKL DFG +K      +D   +   G+P
Sbjct: 150 IQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTP 209

Query: 507 YWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTP 566
           Y++APE    + ++   S  A   D++SLG  + E+ T K P+        M +VM  T 
Sbjct: 210 YYVAPE----IWRRKPYSKKA---DMFSLGVLLYELLTLKRPFD----GENMEEVMHKTL 258

Query: 567 A-----IPDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQPDVPSCSLSFSGM 621
           A     +P S+SPE ++ +      +P  RP +S LL           ++P C L  SG+
Sbjct: 259 AGRYDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLL-----------NMPICKLFISGL 307

Length = 496

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 92.9 bits (231), Expect = 8e-21
 Identities = 74/282 (26%), Positives = 113/282 (40%), Gaps = 40/282 (14%)

Query: 343 QKGKLIGRGTFGSVY--VASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLK 400
              + +G G FG VY  +   R+  A+     V   P+     +    L  E  ++S   
Sbjct: 9   TLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFL-MEALIMSKFN 67

Query: 401 HPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVRE------HCGAITESVVRNFTRHILS 454
           H NIV+  G        +I LE +  G +  ++RE         ++T   +    R +  
Sbjct: 68  HQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAK 127

Query: 455 GLAYLHSKKTIHRDIKGANLLVDASG---VVKLADFGMAKHL-------TGQKADLSMKG 504
           G  YL     IHRDI   N L+   G   V K+ADFGMA+ +        G +A L +K 
Sbjct: 128 GCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIK- 186

Query: 505 SPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFKVMR 563
              WM PE  +  +   K+       D+WS G  + E+++ G  P+        M  V  
Sbjct: 187 ---WMPPEAFLDGIFTSKT-------DVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTG 236

Query: 564 ----DTPA-IPDSLSPEGKDFLRCCFQRNPADRPPASLLLEH 600
               D P   P  +       +  C+Q  P DRP  + +LE 
Sbjct: 237 GGRLDPPKGCPGPVY----RIMTDCWQHTPEDRPNFATILER 274

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 92.9 bits (231), Expect = 1e-20
 Identities = 74/278 (26%), Positives = 132/278 (47%), Gaps = 27/278 (9%)

Query: 333 PEPLPMNSQW-------QKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAES 385
           P  LP + +W         GK +G G FG V  A+        A+ +V +    P +  S
Sbjct: 21  PTQLPYDLKWEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSS 80

Query: 386 IKQ-LEQEIKVLSHL-KHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVRE--HCGAIT 441
            ++ L  E+K++SHL  H NIV   G+  +     +  EY   G +  ++R         
Sbjct: 81  EREALMSELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTL 140

Query: 442 ESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLS 501
           E ++ +F+  +  G+A+L SK  IHRD+   N+L+    +VK+ DFG+A+ +    ++  
Sbjct: 141 EDLL-SFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIM-NDSNYV 198

Query: 502 MKGSPY----WMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAA 556
           +KG+      WMAPE +   +   +S       D+WS G  + E+++ G  P+      +
Sbjct: 199 VKGNARLPVKWMAPESIFNCVYTFES-------DVWSYGILLWEIFSLGSNPYPGMPVDS 251

Query: 557 AMFKVMRD--TPAIPDSLSPEGKDFLRCCFQRNPADRP 592
             +K++++    A P+    E  D ++ C+  +P  RP
Sbjct: 252 KFYKLIKEGYRMAQPEHAPAEIYDIMKTCWDADPLKRP 289

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 92.8 bits (230), Expect = 1e-20
 Identities = 81/305 (26%), Positives = 137/305 (44%), Gaps = 58/305 (19%)

Query: 336 LPMNSQWQK-------GKLIGRGTFGSVYVAS---------NRETGALCAMKEVDIFPDD 379
           LP + +W+        GK +G G FG V +A          NR T     M + D     
Sbjct: 7   LPEDPRWEVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSD----- 61

Query: 380 PKSAESIKQLEQEIKVLSHL-KHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVR---- 434
             + + +  L  E++++  + KH NI+   G+   +   Y+ +EY   G++ +Y+R    
Sbjct: 62  -ATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRP 120

Query: 435 ---EHCGAITESVVRNFT--------RHILSGLAYLHSKKTIHRDIKGANLLVDASGVVK 483
              E+C   T+      +          +  G+ YL SKK IHRD+   N+LV    V+K
Sbjct: 121 PGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMK 180

Query: 484 LADFGMAK---HLTGQKADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTII 540
           +ADFG+A+   H+   K   + +    WMAPE +   +   +S       D+WS G  + 
Sbjct: 181 IADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQS-------DVWSFGVLLW 233

Query: 541 EMYT--GKPPWSEYEGAAA--MFKVMRDTPAI--PDSLSPEGKDFLRCCFQRNPADRPPA 594
           E++T  G P    Y G     +FK++++   +  P + + E    +R C+   P+ RP  
Sbjct: 234 EIFTLGGSP----YPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTF 289

Query: 595 SLLLE 599
             L+E
Sbjct: 290 KQLVE 294

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 92.4 bits (229), Expect = 3e-20
 Identities = 72/244 (29%), Positives = 111/244 (45%), Gaps = 27/244 (11%)

Query: 346 KLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQ--------EIKVLS 397
           + +G G+FG V +A+          K  D  P   K  E  K ++Q        E K+L+
Sbjct: 36  RTLGTGSFGRVILAT---------YKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILN 86

Query: 398 HLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLA 457
           ++ HP  V  YGS   E   Y+ LE+V  G    ++R +       V   +   I+    
Sbjct: 87  YINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRN-KRFPNDVGCFYAAQIVLIFE 145

Query: 458 YLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPYWMAPELMMAV 517
           YL S   ++RD+K  NLL+D  G +K+ DFG AK +  +   L   G+P ++APE+++ V
Sbjct: 146 YLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTRTYTLC--GTPEYIAPEILLNV 203

Query: 518 MQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDSLSPEGK 577
              GK      A D W+LG  I E+  G PP+   E      K++      P  L    K
Sbjct: 204 GH-GK------AADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIYFPKFLDNNCK 256

Query: 578 DFLR 581
             ++
Sbjct: 257 HLMK 260

Length = 340

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 94.3 bits (234), Expect = 3e-20
 Identities = 76/266 (28%), Positives = 126/266 (47%), Gaps = 20/266 (7%)

Query: 347 LIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQ 406
           L+GR    + +VA+         + +  +  D+ ++A +      E+  L+   H  IV+
Sbjct: 74  LVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYA----RSELHCLAACDHFGIVK 129

Query: 407 YYGSEIVEDKFYIYLEYVHPGSINKYVR----EHCGAITESVVRNFTRHILSGLAYLHSK 462
           ++     +DK  + +EY   G +NK ++    EH     E  V      I+  L  +HS+
Sbjct: 130 HFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHL-PFQEYEVGLLFYQIVLALDEVHSR 188

Query: 463 KTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKA-DL--SMKGSPYWMAPELMMAVMQ 519
           K +HRD+K AN+ +  +G++KL DFG +K  +   + D+  S  G+PY++APEL     +
Sbjct: 189 KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPEL----WE 244

Query: 520 KGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMR-DTPAIPDSLSPEGKD 578
           + + S  A   D+WSLG  + E+ T   P+        M +V+       P  +S   K 
Sbjct: 245 RKRYSKKA---DMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDPFPCPVSSGMKA 301

Query: 579 FLRCCFQRNPADRPPASLLLEHRFLK 604
            L     +NPA RP    LL   FLK
Sbjct: 302 LLDPLLSKNPALRPTTQQLLHTEFLK 327

Length = 478

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 90.5 bits (224), Expect = 3e-20
 Identities = 68/255 (26%), Positives = 119/255 (46%), Gaps = 25/255 (9%)

Query: 346 KLIGRGTFGSVYVA--SNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPN 403
           K +G G FG V++   +N    A+  +K        P +  S++   +E  ++  L+H  
Sbjct: 12  KKLGAGQFGEVWMGYYNNSTKVAVKTLK--------PGTM-SVQAFLEEANLMKTLQHDK 62

Query: 404 IVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGA-ITESVVRNFTRHILSGLAYLHSK 462
           +V+ Y     E+  YI  EY+  GS+  +++   G  +    + +F+  I  G+AY+  K
Sbjct: 63  LVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERK 122

Query: 463 KTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQK--ADLSMKGSPYWMAPELMMAVMQK 520
             IHRD++ AN+LV  S + K+ADFG+A+ +   +  A    K    W APE +      
Sbjct: 123 NYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAI------ 176

Query: 521 GKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFKVMRD--TPAIPDSLSPEGK 577
                  +  D+WS G  + E+ T GK P+     +  M  + R    P   ++   E  
Sbjct: 177 -NFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRMPR-MENCPDELY 234

Query: 578 DFLRCCFQRNPADRP 592
           D ++ C++    +RP
Sbjct: 235 DIMKTCWKEKAEERP 249

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 88.9 bits (220), Expect = 9e-20
 Identities = 70/260 (26%), Positives = 112/260 (43%), Gaps = 26/260 (10%)

Query: 348 IGRGTFGSVYVASNRETGALCAMKEV-DIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQ 406
           IGRG FG V+    R      A+K   +  P D K+     +  QE ++L    HPNIV+
Sbjct: 3   IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKA-----KFLQEARILKQYSHPNIVR 57

Query: 407 YYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIH 466
             G    +   YI +E V  G    ++R     +    +     +  +G+ YL SK  IH
Sbjct: 58  LIGVCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIH 117

Query: 467 RDIKGANLLVDASGVVKLADFGMAKHLTGQKAD------LSMKGSPY-WMAPELMMAVMQ 519
           RD+   N LV    V+K++DFGM++    ++ D        MK  P  W APE     + 
Sbjct: 118 RDLAARNCLVTEKNVLKISDFGMSR----EEEDGVYASTGGMKQIPVKWTAPE----ALN 169

Query: 520 KGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFKVMRDTPAIPDSLSPEG-K 577
            G+ S  +   D+WS G  + E ++ G  P++          + +        L P+   
Sbjct: 170 YGRYSSES---DVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRLPCPELCPDAVY 226

Query: 578 DFLRCCFQRNPADRPPASLL 597
             +  C++ +P  RP  S +
Sbjct: 227 RLMERCWEYDPGQRPSFSTV 246

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 89.5 bits (222), Expect = 1e-19
 Identities = 71/255 (27%), Positives = 120/255 (47%), Gaps = 23/255 (9%)

Query: 348 IGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQ---EIKVLSHLKHPNI 404
           +G+G FG V     R TG L A K+++      K  +  K  E    E ++L+ +    I
Sbjct: 1   LGKGGFGEVSACQMRATGKLYACKKLN-----KKRLKKRKGYEGAMVEKRILAKVHSRFI 55

Query: 405 VQYYGSEIVEDKFYIYLEYVHPGSINKY---VREHCGAITESVVRNFTRHILSGLAYLHS 461
           V    +   +    + +  ++ G +  +   V E      E     +T  I+SGL +LH 
Sbjct: 56  VSLAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQ 115

Query: 462 KKTIHRDIKGANLLVDASGVVKLADFGMAKHLT-GQKADLSMKGSPYWMAPELMMAVMQK 520
           ++ I+RD+K  N+L+D  G V+++D G+A  L  GQ       G+P +MAPEL+     +
Sbjct: 116 RRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGTPGFMAPELL-----Q 170

Query: 521 GKSSDSALAVDIWSLGCTIIEMYTGKPPW----SEYEGAAAMFKVMRDTPAIPDSLSPEG 576
           G+  D   +VD ++LG T+ EM   + P+     + E      +++ D+   PD  SP  
Sbjct: 171 GEEYD--FSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPDKFSPAS 228

Query: 577 KDFLRCCFQRNPADR 591
           K F      ++P  R
Sbjct: 229 KSFCEALLAKDPEKR 243

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 90.5 bits (224), Expect = 1e-19
 Identities = 64/206 (31%), Positives = 108/206 (52%), Gaps = 12/206 (5%)

Query: 346 KLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIV 405
           K+IG+G+FG V +A  +  G   A+K +       +  +     E+ + +L ++KHP +V
Sbjct: 1   KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNV-LLKNVKHPFLV 59

Query: 406 QYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTI 465
             + S    +K Y  L++V+ G +  +++    +  E   R +   I S L YLHS   +
Sbjct: 60  GLHYSFQTTEKLYFVLDFVNGGELFFHLQRE-RSFPEPRARFYAAEIASALGYLHSINIV 118

Query: 466 HRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMK--GSPYWMAPELMMAVMQKGKS 523
           +RD+K  N+L+D+ G V L DFG+ K    Q +D +    G+P ++APE    V++K   
Sbjct: 119 YRDLKPENILLDSQGHVVLTDFGLCKEGIAQ-SDTTTTFCGTPEYLAPE----VIRKQPY 173

Query: 524 SDSALAVDIWSLGCTIIEMYTGKPPW 549
            ++   VD W LG  + EM  G PP+
Sbjct: 174 DNT---VDWWCLGAVLYEMLYGLPPF 196

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 89.0 bits (220), Expect = 1e-19
 Identities = 73/258 (28%), Positives = 119/258 (46%), Gaps = 36/258 (13%)

Query: 348 IGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQY 407
           +G+G FG V++      G       V I    P +  S +   QE +V+  L+H  +VQ 
Sbjct: 14  LGQGCFGEVWM------GTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQL 66

Query: 408 YGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITE-SVVRNFTRHILSGLAYLHSKKTIH 466
           Y + + E+  YI  EY+  GS+  +++   G       + +    I SG+AY+     +H
Sbjct: 67  Y-AVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVH 125

Query: 467 RDIKGANLLVDASGVVKLADFGMAK------HLTGQKADLSMKGSPYWMAPELMMAVMQK 520
           RD++ AN+LV  + V K+ADFG+A+      +   Q A   +K    W APE  +     
Sbjct: 126 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK----WTAPEAALYGRFT 181

Query: 521 GKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFKVMRD-----TPAIPDSLSP 574
            KS       D+WS G  + E+ T G+ P+        + +V R       P  P+SL  
Sbjct: 182 IKS-------DVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESL-- 232

Query: 575 EGKDFLRCCFQRNPADRP 592
              D +  C+++ P +RP
Sbjct: 233 --HDLMCQCWRKEPEERP 248

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 90.1 bits (223), Expect = 2e-19
 Identities = 75/272 (27%), Positives = 132/272 (48%), Gaps = 19/272 (6%)

Query: 346 KLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIV 405
           K+IGRG FG V +  ++ T  + AMK +  F    +S  +    E++I   ++   P +V
Sbjct: 49  KVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFAN--SPWVV 106

Query: 406 QYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTI 465
           Q + +   +   Y+ +EY+  G +   +  +   + E   R +T  ++  L  +HS   I
Sbjct: 107 QLFYAFQDDRYLYMVMEYMPGGDLVNLMSNY--DVPEKWARFYTAEVVLALDAIHSMGFI 164

Query: 466 HRDIKGANLLVDASGVVKLADFGMAKHLTGQ---KADLSMKGSPYWMAPELMMAVMQKGK 522
           HRD+K  N+L+D SG +KLADFG    +  +   + D ++ G+P +++PE++ +   +G 
Sbjct: 165 HRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-GTPDYISPEVLKS---QGG 220

Query: 523 SSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVM--RDTPAIPD--SLSPEGKD 578
                   D WS+G  + EM  G  P+          K+M  +++   PD   +S E K+
Sbjct: 221 DGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAKN 280

Query: 579 FLRCCFQRNPADRPPASLLLE---HRFLKNSQ 607
            + C F  +   R   + + E   H F KN Q
Sbjct: 281 LI-CAFLTDREVRLGRNGVEEIKRHLFFKNDQ 311

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 88.9 bits (220), Expect = 3e-19
 Identities = 79/301 (26%), Positives = 135/301 (44%), Gaps = 50/301 (16%)

Query: 336 LPMNSQWQ-------KGKLIGRGTFGSVYVA-------SNRETGALCAMKEVDIFPDDPK 381
           LP++ +W+        GK +G G FG V  A       S  +     A+K +     D  
Sbjct: 1   LPLDPKWEFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKD 60

Query: 382 SAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVR------- 434
            A+ I ++E  +K++   KH NI+   G    E   Y+ +EY   G++ +++R       
Sbjct: 61  LADLISEMEL-MKLIG--KHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGP 117

Query: 435 EHCGAITESVVRNFT--------RHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLAD 486
           ++   IT+      +          +  G+ YL S++ IHRD+   N+LV    V+K+AD
Sbjct: 118 DYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTEDNVMKIAD 177

Query: 487 FGMAK---HLTGQKADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMY 543
           FG+A+    +   K   + +    WMAPE +   +   +S       D+WS G  + E++
Sbjct: 178 FGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQS-------DVWSFGILMWEIF 230

Query: 544 T--GKP-PWSEYEGAAAMFKVMRDTPAI--PDSLSPEGKDFLRCCFQRNPADRPPASLLL 598
           T  G P P    E    +FK++R+   +  P + + E    +R C+   P  RP    L+
Sbjct: 231 TLGGSPYPGIPVE---ELFKLLREGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLV 287

Query: 599 E 599
           E
Sbjct: 288 E 288

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 88.6 bits (219), Expect = 6e-19
 Identities = 63/223 (28%), Positives = 117/223 (52%), Gaps = 28/223 (12%)

Query: 341 QWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDP-KSAESIKQLEQEIKVLSHL 399
           ++Q    +G G +GSV  A +       A+K++      P +S    ++  +E+++L H+
Sbjct: 16  RYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLS----RPFQSLIHARRTYRELRLLKHM 71

Query: 400 KHPNIVQ----YYGSEIVEDKFYIYLEYVHPGS-INKYVREHCGAITESVVRNFTRHILS 454
           KH N++     +  +  +E+   +YL     G+ +N  V+  C  +++  V+     +L 
Sbjct: 72  KHENVIGLLDVFTPATSIENFNEVYLVTNLMGADLNNIVK--CQKLSDEHVQFLIYQLLR 129

Query: 455 GLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKG---SPYWMAP 511
           GL Y+HS   IHRD+K +N+ V+    +++ DFG+A+     +AD  M G   + ++ AP
Sbjct: 130 GLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLAR-----QADDEMTGYVATRWYRAP 184

Query: 512 ELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKP--PWSEY 552
           E+M+  M   ++      VDIWS+GC + E+  GK   P ++Y
Sbjct: 185 EIMLNWMHYNQT------VDIWSVGCIMAELLKGKALFPGNDY 221

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 87.7 bits (217), Expect = 6e-19
 Identities = 86/314 (27%), Positives = 135/314 (42%), Gaps = 68/314 (21%)

Query: 336 LPMNSQWQKGKLIGRGTFGSVY------------VASNRETG--ALCAMKEVDIFPDDPK 381
            P      K KL G G FG V+              +    G   L A+K +    D  K
Sbjct: 2   FPRQQLRLKEKL-GEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLR--ADVTK 58

Query: 382 SAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYV--RE---- 435
           +A +     +EIK++S LK+PNI++  G  + +D   +  EY+  G +N+++  RE    
Sbjct: 59  TARN--DFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIEST 116

Query: 436 --HCGAITESVVRNF---TRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMA 490
             H   I    + N       I SG+ YL S   +HRD+   N LV     +K+ADFGM+
Sbjct: 117 FTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADFGMS 176

Query: 491 KHLTGQ-------KADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMY 543
           ++L          +A L ++    WMA E ++     GK +    A D+W+ G T+ EM+
Sbjct: 177 RNLYSGDYYRIQGRAVLPIR----WMAWESILL----GKFTT---ASDVWAFGVTLWEMF 225

Query: 544 T--GKPPWSEY------EGAAAMFK------VMRDTPAIPDSLSPEGKDFLRCCFQRNPA 589
           T   + P+S        E     F+       +  TP  P  +       +  C+ R+  
Sbjct: 226 TLCKEQPYSLLSDEQVIENTGEFFRNQGRQIYLSQTPLCPSPVF----KLMMRCWSRDIK 281

Query: 590 DRPPASLLLEHRFL 603
           DRP  + +  H FL
Sbjct: 282 DRPTFNKI--HHFL 293

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 87.8 bits (217), Expect = 6e-19
 Identities = 77/300 (25%), Positives = 138/300 (46%), Gaps = 48/300 (16%)

Query: 336 LPMNSQWQ-------KGKLIGRGTFGSVYVAS----NRETGALCAMKEVDIFPDDPKSAE 384
           LP + +W+        GK +G G FG V +A     +++         V +  DD  + +
Sbjct: 4   LPEDPRWEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDD-ATEK 62

Query: 385 SIKQLEQEIKVLSHL-KHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVR-------EH 436
            +  L  E++++  + KH NI+   G+   +   Y+ +EY   G++ +Y+R       E+
Sbjct: 63  DLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEY 122

Query: 437 CGAITE--------SVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFG 488
              I            + + T  +  G+ YL S+K IHRD+   N+LV  + V+K+ADFG
Sbjct: 123 SYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFG 182

Query: 489 MAKHLTG---QKADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT- 544
           +A+ +      K   + +    WMAPE +   +   +S       D+WS G  + E++T 
Sbjct: 183 LARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQS-------DVWSFGVLMWEIFTL 235

Query: 545 -GKPPWSEYEG--AAAMFKVMRDTPAI--PDSLSPEGKDFLRCCFQRNPADRPPASLLLE 599
            G P    Y G     +FK++++   +  P + + E    +R C+   P+ RP    L+E
Sbjct: 236 GGSP----YPGIPVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVE 291

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 87.2 bits (216), Expect = 8e-19
 Identities = 63/271 (23%), Positives = 117/271 (43%), Gaps = 21/271 (7%)

Query: 346 KLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIV 405
           +++G+G FG V     R TG + A K+++      +  E++   E++I  L  +    +V
Sbjct: 6   RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQI--LEKVNSRFVV 63

Query: 406 QYYGSEIVEDKFYIYLEYVHPGSINKYVREHCG--AITESVVRNFTRHILSGLAYLHSKK 463
               +   +D   + L  ++ G + K+   + G     E     +   I  GL  LH ++
Sbjct: 64  SLAYAYETKDALCLVLTLMNGGDL-KFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRER 122

Query: 464 TIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPYWMAPELMMAVMQKGKS 523
            ++RD+K  N+L+D  G ++++D G+A  +   +      G+  +MAPE++       K+
Sbjct: 123 IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRGRVGTVGYMAPEVV-------KN 175

Query: 524 SDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMR----DTPAIPDSLSPEGKDF 579
                + D W LGC I EM  GK P+ + +      +V R    D     +  S   +  
Sbjct: 176 ERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFSEAARSI 235

Query: 580 LRCCFQRNPADR-----PPASLLLEHRFLKN 605
            R    ++P  R       A  +  H F + 
Sbjct: 236 CRQLLTKDPGFRLGCRGEGAEEVKAHPFFRT 266

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 88.2 bits (218), Expect = 1e-18
 Identities = 71/271 (26%), Positives = 127/271 (46%), Gaps = 17/271 (6%)

Query: 346 KLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIV 405
           K+IGRG FG V +  ++ +  + AMK +  F    +S  +    E++I   ++   P +V
Sbjct: 49  KVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFAN--SPWVV 106

Query: 406 QYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTI 465
           Q + +   +   Y+ +EY+  G +   +  +   + E   + +T  ++  L  +HS   I
Sbjct: 107 QLFCAFQDDKYLYMVMEYMPGGDLVNLMSNY--DVPEKWAKFYTAEVVLALDAIHSMGLI 164

Query: 466 HRDIKGANLLVDASGVVKLADFG--MAKHLTGQKADLSMKGSPYWMAPELMMAVMQKGKS 523
           HRD+K  N+L+D  G +KLADFG  M    TG     +  G+P +++PE++ +   +G  
Sbjct: 165 HRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLKS---QGGD 221

Query: 524 SDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVM--RDTPAIPD--SLSPEGKDF 579
                  D WS+G  + EM  G  P+          K+M  +++   P+   +S   K+ 
Sbjct: 222 GYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPEDVEISKHAKNL 281

Query: 580 LRCCFQRNPA---DRPPASLLLEHRFLKNSQ 607
           + C F  +      R     + +H F KN Q
Sbjct: 282 I-CAFLTDREVRLGRNGVEEIKQHPFFKNDQ 311

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 87.1 bits (216), Expect = 2e-18
 Identities = 82/306 (26%), Positives = 125/306 (40%), Gaps = 62/306 (20%)

Query: 346 KLIGRGTFGSVYVASNRETGALCAMKEV-DIFPDDPKSAESIKQLEQEIKVLSHLKHPNI 404
           ++IG+G++G V  A +  TG   A+K++ D+F +    A  I +   EIK+L  L+HP+I
Sbjct: 6   EVIGKGSYGVVCSAIDTHTGEKVAIKKINDVF-EHVSDATRILR---EIKLLRLLRHPDI 61

Query: 405 VQYYGSEIVEDK-----FYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYL 459
           V+     +   +      Y+  E +   S    V +    +T    + F   +L  L Y+
Sbjct: 62  VEIKHIMLPPSRREFKDIYVVFELM--ESDLHQVIKANDDLTPEHHQFFLYQLLRALKYI 119

Query: 460 HSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPYWM---------A 510
           H+    HRD+K  N+L +A   +K+ DFG+A+      A      + +W          A
Sbjct: 120 HTANVFHRDLKPKNILANADCKLKICDFGLAR-----VAFNDTPTAIFWTDYVATRWYRA 174

Query: 511 PELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKP--------------------PWS 550
           PEL  +   K        A+DIWS+GC   E+ TGKP                    P  
Sbjct: 175 PELCGSFFSKYTP-----AIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSP 229

Query: 551 EY------EGAAAMFKVMRDTPAIPDSLSPEGKDFLRCC-FQR----NPADRPPASLLLE 599
           E       E A      MR    +P S      D L     +R    +P DRP A   L 
Sbjct: 230 ETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALA 289

Query: 600 HRFLKN 605
             + K 
Sbjct: 290 DPYFKG 295

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 86.8 bits (215), Expect = 2e-18
 Identities = 80/287 (27%), Positives = 127/287 (44%), Gaps = 21/287 (7%)

Query: 346 KLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIV 405
           K+IGRG FG V V   + TG + AMK ++ + +  K AE+     +E  VL +     I 
Sbjct: 7   KVIGRGAFGEVAVVKMKNTGQVYAMKILNKW-EMLKRAET-ACFREERDVLVNGDRRWIT 64

Query: 406 QYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTI 465
             + +   E+  Y+ ++Y   G +   + +    + E + R +   ++  +  +H    +
Sbjct: 65  NLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYV 124

Query: 466 HRDIKGANLLVDASGVVKLADFGMAKHLT--GQKADLSMKGSPYWMAPELMMAVMQKGKS 523
           HRDIK  N+L+D +G ++LADFG    L   G        G+P +++PE++ A M+ GK 
Sbjct: 125 HRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQA-MEDGKG 183

Query: 524 SDSALAVDIWSLGCTIIEMYTGKPPW-----SEYEGAAAMFKVMRDTPAIPDSLSPEGKD 578
                  D WSLG  + EM  G+ P+      E  G     K     P     +S E KD
Sbjct: 184 R-YGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDVTDVSEEAKD 242

Query: 579 FLR--CCFQRNPADRPPASLLLEHRF--------LKNSQQPDVPSCS 615
            +R   C       R       +H F        ++NS  P VP  S
Sbjct: 243 LIRRLICSPETRLGRNGLQDFKDHPFFEGIDWDNIRNSTAPYVPEVS 289

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 85.3 bits (211), Expect = 2e-18
 Identities = 69/265 (26%), Positives = 123/265 (46%), Gaps = 46/265 (17%)

Query: 346 KLIGRGTFGSVYVA--SNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPN 403
           K +G G FG V++   +     A+ ++K+  + P+             E  ++  L+HP 
Sbjct: 12  KKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPE---------AFLAEANLMKQLQHPR 62

Query: 404 IVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGA-ITESVVRNFTRHILSGLAYLHSK 462
           +V+ Y + + ++  YI  EY+  GS+  +++   G  +T + + +    I  G+A++  K
Sbjct: 63  LVRLY-AVVTQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERK 121

Query: 463 KTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPY---WMAPELMMAVMQ 519
             IHRD++ AN+LV  +   K+ADFG+A+ L       + +G+ +   W APE +     
Sbjct: 122 NYIHRDLRAANILVSETLCCKIADFGLAR-LIEDNEYTAREGAKFPIKWTAPEAINYGTF 180

Query: 520 KGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFKVMRDTPAI---------- 568
             KS       D+WS G  + E+ T G+ P   Y G       M +   I          
Sbjct: 181 TIKS-------DVWSFGILLTEIVTYGRIP---YPG-------MTNPEVIQNLERGYRMP 223

Query: 569 -PDSLSPEGKDFLRCCFQRNPADRP 592
            PD+   E  + +R C++  P +RP
Sbjct: 224 RPDNCPEELYELMRLCWKEKPEERP 248

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 86.6 bits (214), Expect = 2e-18
 Identities = 75/298 (25%), Positives = 137/298 (45%), Gaps = 44/298 (14%)

Query: 336 LPMNSQWQ-------KGKLIGRGTFGSVYVAS----NRETGALCAMKEVDIFPDDPKSAE 384
           LP + +W+        GK +G G FG V +A     +++         V +  DD  + +
Sbjct: 1   LPADPKWELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDD-ATDK 59

Query: 385 SIKQLEQEIKVLSHL-KHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVR--------- 434
            +  L  E++++  + KH NI+   G+   +   Y+ +EY   G++ +Y+R         
Sbjct: 60  DLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDY 119

Query: 435 --EHCGAITESV----VRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFG 488
             + C    E +    + +    +  G+ YL S+K IHRD+   N+LV    V+K+ADFG
Sbjct: 120 SFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFG 179

Query: 489 MAK---HLTGQKADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTG 545
           +A+   ++   K   + +    WMAPE +   +   +S       D+WS G  + E++T 
Sbjct: 180 LARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQS-------DVWSFGVLLWEIFTL 232

Query: 546 KPPWSEYEG--AAAMFKVMRDTPAI--PDSLSPEGKDFLRCCFQRNPADRPPASLLLE 599
               S Y G     +FK++++   +  P + + E    +R C+   P+ RP    L+E
Sbjct: 233 GG--SPYPGIPVEELFKLLKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVE 288

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 85.8 bits (212), Expect = 3e-18
 Identities = 64/284 (22%), Positives = 116/284 (40%), Gaps = 46/284 (16%)

Query: 343 QKGKLIGRGTFGSVYVASNRETGALCAMKEVDI-FPDDPKSAESIKQLEQEIKVLSHLKH 401
             GK +G G FG V  A+            V +    +  S+  ++ L  E  +L  + H
Sbjct: 3   VLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNH 62

Query: 402 PNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREH----CGAITESVVRN---------- 447
           P++++ YG+   +    + +EY   GS+  ++RE        +     RN          
Sbjct: 63  PHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDER 122

Query: 448 ---------FTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKA 498
                    F   I  G+ YL   K +HRD+   N+LV     +K++DFG+++ +  + +
Sbjct: 123 ALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDS 182

Query: 499 DL--SMKGSPY-WMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEM-------YTGKPP 548
            +  S    P  WMA E +   +   +S       D+WS G  + E+       Y G  P
Sbjct: 183 YVKRSKGRIPVKWMAIESLFDHIYTTQS-------DVWSFGVLLWEIVTLGGNPYPGIAP 235

Query: 549 WSEYEGAAAMFKVMRDTPAIPDSLSPEGKDFLRCCFQRNPADRP 592
              +      +++ R     P++ S E  + +  C+++ P  RP
Sbjct: 236 ERLFNLLKTGYRMER-----PENCSEEMYNLMLTCWKQEPDKRP 274

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 84.7 bits (209), Expect = 3e-18
 Identities = 65/253 (25%), Positives = 123/253 (48%), Gaps = 22/253 (8%)

Query: 346 KLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIV 405
           K +G G FG V++ +      + A+K +      P+S        +E +++  L+H  +V
Sbjct: 12  KKLGNGQFGEVWMGTWNGNTKV-AVKTLKPGTMSPES------FLEEAQIMKKLRHDKLV 64

Query: 406 QYYGSEIVEDKFYIYLEYVHPGSINKYVREHCG-AITESVVRNFTRHILSGLAYLHSKKT 464
           Q Y + + E+  YI  EY+  GS+  ++++  G A+    + +    + +G+AY+     
Sbjct: 65  QLY-AVVSEEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNY 123

Query: 465 IHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPY---WMAPELMMAVMQKG 521
           IHRD++ AN+LV    V K+ADFG+A+ L       + +G+ +   W APE  +     G
Sbjct: 124 IHRDLRSANILVGDGLVCKIADFGLAR-LIEDNEYTARQGAKFPIKWTAPEAALY----G 178

Query: 522 KSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFKVMRD-TPAIPDSLSPEGKDF 579
           + +   +  D+WS G  + E+ T G+ P+        + +V R      P        + 
Sbjct: 179 RFT---IKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMPCPQDCPISLHEL 235

Query: 580 LRCCFQRNPADRP 592
           +  C++++P +RP
Sbjct: 236 MLQCWKKDPEERP 248

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 85.3 bits (211), Expect = 4e-18
 Identities = 82/296 (27%), Positives = 133/296 (44%), Gaps = 67/296 (22%)

Query: 344 KGKLIGRGTFGSVYVASNRETGALCAMKE---VDIFPDDP-------------KSAESIK 387
           K KL G G FG V++      G    M +   +D+  + P             K+A +  
Sbjct: 10  KEKL-GEGQFGEVHLCEAE--GMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARN-- 64

Query: 388 QLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREH----------C 437
              +EIK++S LK PNI++     I  D   +  EY+  G +N+++  H           
Sbjct: 65  DFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADV 124

Query: 438 GAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHL-TGQ 496
             I+ S +      I SG+ YL S   +HRD+   N LV  +  +K+ADFGM+++L +G 
Sbjct: 125 VTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGD 184

Query: 497 ------KADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT--GKPP 548
                 +A L ++    WM+ E ++     GK +    A D+W+ G T+ E+ T   + P
Sbjct: 185 YYRIQGRAVLPIR----WMSWESILL----GKFT---TASDVWAFGVTLWEILTLCKEQP 233

Query: 549 WSEY------EGAAAMFK-----VMRDTPAI-PDSLSPEGKDFLRCCFQRNPADRP 592
           +S+       E     F+     V    PA+ PDSL       +  C++RN  +RP
Sbjct: 234 YSQLSDEQVIENTGEFFRDQGRQVYLPKPALCPDSLY----KLMLSCWRRNAKERP 285

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 84.2 bits (209), Expect = 6e-18
 Identities = 60/214 (28%), Positives = 98/214 (45%), Gaps = 37/214 (17%)

Query: 348 IGRGTFGSVYVASNRETGALCAMKEV-DIFPDDPKSAESIKQLE--QEIKVLSHLKHPNI 404
           IG GTF  V  A +R+TG   A+K +   F    KS E +  L   Q ++ LS   HPNI
Sbjct: 7   IGEGTFSEVLKAQSRKTGKYYAIKCMKKHF----KSLEQVNNLREIQALRRLSP--HPNI 60

Query: 405 VQYYGSEIVEDKFYIYLEYVHP---GSINKYVREHCGAITESVVRNFTRHILSGLAYLHS 461
           ++    E++ D+    L  V      ++ + ++     + E  V+++   +L  L ++H 
Sbjct: 61  LRLI--EVLFDRKTGRLALVFELMDMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHR 118

Query: 462 KKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPY-------WM-APEL 513
               HRDIK  N+L+    ++KLADFG  + +  +         PY       W  APE 
Sbjct: 119 NGIFHRDIKPENILIK-DDILKLADFGSCRGIYSKP--------PYTEYISTRWYRAPEC 169

Query: 514 MMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKP 547
           ++     G        +DIW++GC   E+ +  P
Sbjct: 170 LLTDGYYGP------KMDIWAVGCVFFEILSLFP 197

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 83.1 bits (205), Expect = 1e-17
 Identities = 67/259 (25%), Positives = 125/259 (48%), Gaps = 34/259 (13%)

Query: 346 KLIGRGTFGSVYVAS-NRETG-ALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPN 403
           K +G G FG V++A+ N+ T  A+  MK        P S  S++    E  V+  L+H  
Sbjct: 12  KKLGAGQFGEVWMATYNKHTKVAVKTMK--------PGSM-SVEAFLAEANVMKTLQHDK 62

Query: 404 IVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCG-AITESVVRNFTRHILSGLAYLHSK 462
           +V+ + + + ++  YI  E++  GS+  +++   G       + +F+  I  G+A++  +
Sbjct: 63  LVKLH-AVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR 121

Query: 463 KTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPY---WMAPELMMAVMQ 519
             IHRD++ AN+LV AS V K+ADFG+A+ +   +   + +G+ +   W APE +     
Sbjct: 122 NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEY-TAREGAKFPIKWTAPEAI----- 175

Query: 520 KGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFKV-----MRDTPAIPDSLS 573
                   +  D+WS G  ++E+ T G+ P+        +  +     M      P+ L 
Sbjct: 176 --NFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEELY 233

Query: 574 PEGKDFLRCCFQRNPADRP 592
               + +  C++  P +RP
Sbjct: 234 ----NIMMRCWKNRPEERP 248

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 85.1 bits (210), Expect = 1e-17
 Identities = 77/305 (25%), Positives = 123/305 (40%), Gaps = 65/305 (21%)

Query: 340 SQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHL 399
           S + K K +G G FG V +A   +T AL AMK +     D      +  ++ E  +L+  
Sbjct: 1   SMFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLR--KKDVLLRNQVAHVKAERDILAEA 58

Query: 400 KHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYL 459
            +  +V+ Y S   +D  Y  ++Y+ PG     +    G   E + R +   +   +  +
Sbjct: 59  DNEWVVRLYYSFQDKDNLYFVMDYI-PGGDMMSLLIRMGIFPEDLARFYIAELTCAVESV 117

Query: 460 HSKKTIHRDIKGANLLVDASGVVKLADFGM---------------AKHLTGQKADLSMK- 503
           H    IHRDIK  N+L+D  G +KL DFG+                 H+     D S + 
Sbjct: 118 HKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEW 177

Query: 504 --------------------------------GSPYWMAPELMMAVMQKGKSSDSALAVD 531
                                           G+P ++APE+++      ++  + L  D
Sbjct: 178 GDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLL------RTGYTQLC-D 230

Query: 532 IWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMR--DTPAIP--DSLSPEGKDF-LRCCFQR 586
            WS+G  + EM  G+PP+          KV+    +  IP    LSPE  D  ++ C  R
Sbjct: 231 WWSVGVILYEMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLC--R 288

Query: 587 NPADR 591
            P DR
Sbjct: 289 GPEDR 293

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 82.7 bits (204), Expect = 2e-17
 Identities = 74/260 (28%), Positives = 122/260 (46%), Gaps = 24/260 (9%)

Query: 344 KGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQ---EIKVLSHLK 400
           K K+IG G FG V+    +  G     KEV +     K   + KQ +    E  ++    
Sbjct: 9   KQKVIGAGEFGEVFRGILKMPGR----KEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFS 64

Query: 401 HPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLH 460
           H NI++  G         I  EY+  G+++KY+R+H G  +   +    R I +G+ YL 
Sbjct: 65  HHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLS 124

Query: 461 SKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQ-KADLSMKGSPY---WMAPELMMA 516
               +HRD+   N+LV+++   K++DFG+++ L    +   +  G      W APE   A
Sbjct: 125 DMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPE---A 181

Query: 517 VMQKGKSSDSALAVDIWSLGCTIIEM--YTGKPPW--SEYEGAAAMFKVMRDTPAIPDSL 572
           +  +  +S    A D+WS G  + E+  +  +P W  S +E   A+    R  PA  D  
Sbjct: 182 IAYRKFTS----ASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFR-LPAPMDCP 236

Query: 573 SPEGKDFLRCCFQRNPADRP 592
           S   +  L+ C+Q++ A RP
Sbjct: 237 SAVYQLMLQ-CWQQDRARRP 255

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 82.6 bits (204), Expect = 2e-17
 Identities = 69/276 (25%), Positives = 120/276 (43%), Gaps = 32/276 (11%)

Query: 348 IGRGTFGSVYVAS-NRETG-ALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIV 405
           IG G FG V +   +R    A   +KE+        + +      QE++    L HPN++
Sbjct: 3   IGNGWFGKVLLGEAHRGMSKARVVVKELR----ASATPDEQLLFLQEVQPYRELNHPNVL 58

Query: 406 QYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITES----VVRNFTRHILSGLAYLHS 461
           Q  G  I    + + LE+   G +  Y+R + G + +     V++     + SGL +LH 
Sbjct: 59  QCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQ 118

Query: 462 KKTIHRDIKGANLLVDASGVVKLADFGMA-------KHLTGQKADLSMKGSPYWMAPELM 514
              IH D+   N  + A   VK+ D+G+A        ++T     + ++    W+APEL+
Sbjct: 119 ADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLR----WLAPELV 174

Query: 515 MAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFKVMRD------TPA 567
               Q     D     +IWSLG T+ E++T    P+ +      + +V+R+       P 
Sbjct: 175 EIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKPQ 234

Query: 568 IPDSLSPEGKDFLRCCFQRNPADRPPAS---LLLEH 600
           +    S    + ++ C+  +P  RP A     LL +
Sbjct: 235 LDLKYSDRWYEVMQFCWL-DPETRPTAEEVHELLTY 269

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 82.0 bits (202), Expect = 2e-17
 Identities = 68/260 (26%), Positives = 122/260 (46%), Gaps = 40/260 (15%)

Query: 348 IGRGTFGSVYVASNRETG--ALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIV 405
           +G+G FG V++ +   T   A+  +K   + P+            QE +++  L+H  +V
Sbjct: 14  LGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPE---------AFLQEAQIMKKLRHDKLV 64

Query: 406 QYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGA-ITESVVRNFTRHILSGLAYLHSKKT 464
             Y + + E+  YI  E++  GS+  +++E  G  +    + +    I  G+AY+     
Sbjct: 65  PLY-AVVSEEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNY 123

Query: 465 IHRDIKGANLLVDASGVVKLADFGMAK------HLTGQKADLSMKGSPYWMAPELMMAVM 518
           IHRD++ AN+LV  + V K+ADFG+A+      +   Q A   +K    W APE  +   
Sbjct: 124 IHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIK----WTAPEAALYGR 179

Query: 519 QKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFKVMRD-----TPAIPDSL 572
              KS       D+WS G  + E+ T G+ P+        + +V R          P+SL
Sbjct: 180 FTIKS-------DVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRMPCPQGCPESL 232

Query: 573 SPEGKDFLRCCFQRNPADRP 592
                + ++ C++++P +RP
Sbjct: 233 ----HELMKLCWKKDPDERP 248

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta

 Score = 83.1 bits (205), Expect = 3e-17
 Identities = 84/320 (26%), Positives = 138/320 (43%), Gaps = 76/320 (23%)

Query: 348 IGRG--TFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHL-KHPNI 404
           IGRG     SVY+A +  TG L  ++  D+   +  + E +K L+ E+ VLSH  +HPNI
Sbjct: 6   IGRGFCNLTSVYLARHTPTGTLVTVRITDL---ENCTEEHLKALQNEV-VLSHFFRHPNI 61

Query: 405 VQYYGSEIVEDKFYIYLEYVHPGSINKYVREHC-GAITESVVRNFTRHILSGLAYLHSKK 463
           +  +         ++   ++  GS N  ++ +    ++E+++ N     L GL YLH   
Sbjct: 62  MTSWTVFTTGSWLWVISPFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNG 121

Query: 464 TIHRDIKGANLLVDASGVVKLAD----FGMAKHLTGQKA-------DLSMKGSPYWMAPE 512
            IHR+IK +++L+   G+V L+     + + ++  GQKA         S    P W++PE
Sbjct: 122 YIHRNIKASHILISGDGLVSLSGLSHLYSLVRN--GQKAKVVYDFPQFSTSVLP-WLSPE 178

Query: 513 LMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPW----------------------- 549
           L+     +       +  DI+S+G T  E+ TG+ P+                       
Sbjct: 179 LL-----RQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDI 233

Query: 550 ---------------------SEYEGAAAMFKVMRD----TPAIPDSLSPEGKDFLRCCF 584
                                 E   AA M + M      TP+   + SP  ++ +  C 
Sbjct: 234 TTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPS-SKTFSPAFQNLVELCL 292

Query: 585 QRNPADRPPASLLLEHRFLK 604
           Q++P  RP AS LL H F K
Sbjct: 293 QQDPEKRPSASSLLSHAFFK 312

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 81.5 bits (201), Expect = 4e-17
 Identities = 65/255 (25%), Positives = 112/255 (43%), Gaps = 24/255 (9%)

Query: 348 IGRGTFGSVY--VASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIV 405
           +G G FG+V   +   +++    A+K   I  +D        +L +E  V+  L +P IV
Sbjct: 3   LGSGNFGTVKKGMYKMKKSEKTVAVK---ILKNDNNDPALKDELLREANVMQQLDNPYIV 59

Query: 406 QYYGSEIVE-DKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKT 464
           +  G  I E + + + +E    G +NK+++++   +TE  +      +  G+ YL     
Sbjct: 60  RMIG--ICEAESWMLVMELAELGPLNKFLQKN-KHVTEKNITELVHQVSMGMKYLEETNF 116

Query: 465 IHRDIKGANLLVDASGVVKLADFGMAKHLTGQ----KADLSMKGSPYWMAPELMMAVMQK 520
           +HRD+   N+L+      K++DFG++K L       KA    K    W APE M      
Sbjct: 117 VHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFS 176

Query: 521 GKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEG--AAAMFKVMRDTPAIPDSLSPEGK 577
            KS       D+WS G  + E ++ G+ P+   +G     M +        P    PE  
Sbjct: 177 SKS-------DVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGERMEC-PQRCPPEMY 228

Query: 578 DFLRCCFQRNPADRP 592
           D ++ C+     +RP
Sbjct: 229 DLMKLCWTYGVDERP 243

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 82.3 bits (203), Expect = 4e-17
 Identities = 75/266 (28%), Positives = 120/266 (45%), Gaps = 58/266 (21%)

Query: 377 PDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREH 436
           PD  K+A +     +E+K+LS LK PNI++  G  + ED   +  EY+  G +N+++  H
Sbjct: 56  PDANKNARN--DFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSH 113

Query: 437 -----------------CG-AITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDA 478
                            C  AI+ S + +    I SG+ YL S   +HRD+   N LV  
Sbjct: 114 HLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATRNCLVGE 173

Query: 479 SGVVKLADFGMAKHLTG-------QKADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVD 531
           +  +K+ADFGM+++L          +A L ++    WMA E ++     GK +    A D
Sbjct: 174 NLTIKIADFGMSRNLYAGDYYRIQGRAVLPIR----WMAWECILM----GKFTT---ASD 222

Query: 532 IWSLGCTIIE--MYTGKPPWSEY------EGAAAMFK------VMRDTPAIPDSLSPEGK 577
           +W+ G T+ E  M   + P+ E       E A   F+       +   P  P  L     
Sbjct: 223 VWAFGVTLWEILMLCKEQPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLY---- 278

Query: 578 DFLRCCFQRNPADRPPASLLLEHRFL 603
           + +  C+ R+  +RP  S +  H FL
Sbjct: 279 ELMLQCWSRDCRERPSFSDI--HAFL 302

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 83.4 bits (206), Expect = 5e-17
 Identities = 82/318 (25%), Positives = 134/318 (42%), Gaps = 74/318 (23%)

Query: 346 KLIGRGTFGSVYVASNRETGALCAMKEV---DIFPDDPKSAESIKQLEQEIKVLSHLKHP 402
           K+IG+G FG V +   ++TG + AMK +   ++F  D      +  ++ E  VL+    P
Sbjct: 7   KVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKD-----QLAHVKAERDVLAESDSP 61

Query: 403 NIVQYYGSEIVEDKFYIYL--EYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLH 460
            +V  Y S   +D  Y+YL  E++  G +   + ++    +E V R +    +  +  +H
Sbjct: 62  WVVSLYYS--FQDAQYLYLIMEFLPGGDLMTMLIKY-DTFSEDVTRFYMAECVLAIEAVH 118

Query: 461 SKKTIHRDIKGANLLVDASGVVKLADFGMA-------------KHLTGQKA--------- 498
               IHRDIK  N+L+D  G +KL+DFG++             K L G+           
Sbjct: 119 KLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNS 178

Query: 499 ------DLSMK--------------------GSPYWMAPELMMAVMQKGKSSDSALAVDI 532
                 +L+M                     G+P ++APE+    +Q+G   +     D 
Sbjct: 179 VAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIF---LQQGYGQE----CDW 231

Query: 533 WSLGCTIIEMYTGKPPWSEYEGAAAMFKVM--RDTPAIPD--SLSPEGKDFLR--CCFQR 586
           WSLG  + E   G PP+          K++  R+T   PD   LS E +D +R       
Sbjct: 232 WSLGAIMFECLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLITNAE 291

Query: 587 NPADRPPASLLLEHRFLK 604
           N   R  A  +  H F +
Sbjct: 292 NRLGRGGAHEIKSHPFFR 309

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 81.2 bits (200), Expect = 7e-17
 Identities = 60/252 (23%), Positives = 117/252 (46%), Gaps = 16/252 (6%)

Query: 346 KLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIV 405
           +++G+G FG V     R TG + A K+++      +  ES+   E++I  L  +    +V
Sbjct: 6   RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQI--LEKVNSRFVV 63

Query: 406 QYYGSEIVEDKFYIYLEYVHPGSINKYVREHCG--AITESVVRNFTRHILSGLAYLHSKK 463
               +   +D   + L  ++ G + K+   H G     E     +   I  GL  LH ++
Sbjct: 64  SLAYAYETKDALCLVLTLMNGGDL-KFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQER 122

Query: 464 TIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPYWMAPELMMAVMQKGKS 523
            ++RD+K  N+L+D  G ++++D G+A H+   +      G+  +MAPE++       K+
Sbjct: 123 IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVV-------KN 175

Query: 524 SDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDS----LSPEGKDF 579
                + D W+LGC + EM  G+ P+ + +      +V R    + +      SP+ +  
Sbjct: 176 ERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEYSEKFSPDARSL 235

Query: 580 LRCCFQRNPADR 591
            +    ++P +R
Sbjct: 236 CKMLLCKDPKER 247

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha

 Score = 81.5 bits (201), Expect = 1e-16
 Identities = 77/318 (24%), Positives = 131/318 (41%), Gaps = 71/318 (22%)

Query: 347 LIGRG--TFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNI 404
           +IGRG     +V +A  + TG    ++ +++   +  + E +  L+ E+ V     HPNI
Sbjct: 5   VIGRGFEDLMTVNLARYKPTGEYVTVRRINL---EACTNEMVTFLQGELHVSKLFNHPNI 61

Query: 405 VQYYGSEIVEDKFYIYLEYVHPGSINKYVREH-CGAITESVVRNFTRHILSGLAYLHSKK 463
           V Y  + I +++ ++   ++  GS    +  H    ++E  +    + +L  L Y+H   
Sbjct: 62  VPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMG 121

Query: 464 TIHRDIKGANLLVDASGVVKL----ADFGMAKHLTGQKADL-------SMKGSPYWMAPE 512
            +HR +K +++L+   G V L    ++  M  H  GQ+  +       S+K  P W++PE
Sbjct: 122 YVHRSVKASHILISVDGKVYLSGLRSNLSMINH--GQRLRVVHDFPKYSVKVLP-WLSPE 178

Query: 513 LMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEY-------EGAAAMFKVMRDT 565
           ++   +Q G  + S    DI+S+G T  E+  G  P+ +        E        + DT
Sbjct: 179 VLQQNLQ-GYDAKS----DIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDT 233

Query: 566 PAIP---------------------------------------DSLSPEGKDFLRCCFQR 586
             IP                                        + SP    F+  C QR
Sbjct: 234 TTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQR 293

Query: 587 NPADRPPASLLLEHRFLK 604
           NP  RP AS LL H F K
Sbjct: 294 NPDARPSASTLLNHSFFK 311

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 80.5 bits (198), Expect = 2e-16
 Identities = 69/230 (30%), Positives = 104/230 (45%), Gaps = 46/230 (20%)

Query: 344 KGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLE---------QEIK 394
           +G  +GRGT+G VY A  ++              DD   A  +KQ+E         +EI 
Sbjct: 5   EGCKVGRGTYGHVYKAKRKDG------------KDDRDYA--LKQIEGTGISMSACREIA 50

Query: 395 VLSHLKHPNIV--QYYGSEIVEDKFYIYLEYVHPG--SINKYVREHCG-----AITESVV 445
           +L  LKHPN++  Q       + K ++  +Y       I K+ R          +   +V
Sbjct: 51  LLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMV 110

Query: 446 RNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGV----VKLADFGMAKHLTG---QKA 498
           ++    IL G+ YLH+   +HRD+K AN+LV   G     VK+AD G A+         A
Sbjct: 111 KSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLA 170

Query: 499 DLSMKGSPYWM-APELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKP 547
           DL      +W  APEL++      K      A+DIW++GC   E+ T +P
Sbjct: 171 DLDPVVVTFWYRAPELLLGARHYTK------AIDIWAIGCIFAELLTSEP 214

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 79.6 bits (196), Expect = 2e-16
 Identities = 64/213 (30%), Positives = 102/213 (47%), Gaps = 20/213 (9%)

Query: 346 KLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQ---EIKVLSHLKHP 402
           K+IG G FG V   S R    L   +E+ +     K+  + KQ      E  ++    HP
Sbjct: 10  KVIGAGEFGEV--CSGRLK--LPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHP 65

Query: 403 NIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSK 462
           NI+   G         I  EY+  GS++ ++R+H G  T   +    R I SG+ YL   
Sbjct: 66  NIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDM 125

Query: 463 KTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQ-KADLSMKGSPY---WMAPELMMAVM 518
             +HRD+   N+LV+++ V K++DFG+++ L    +A  + +G      W APE   A+ 
Sbjct: 126 GYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPE---AIA 182

Query: 519 QKGKSSDSALAVDIWSLGCTIIEM--YTGKPPW 549
            +  +S S    D+WS G  + E+  Y  +P W
Sbjct: 183 YRKFTSAS----DVWSYGIVMWEVMSYGERPYW 211

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 80.0 bits (197), Expect = 2e-16
 Identities = 73/280 (26%), Positives = 120/280 (42%), Gaps = 53/280 (18%)

Query: 347 LIGRGTFGSVYVA-----SNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHL-K 400
           +IG G FG V  A       +   A+  +KE         S    +    E++VL  L  
Sbjct: 9   VIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEF-------ASENDHRDFAGELEVLCKLGH 61

Query: 401 HPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVR-------------EHCGA--ITESVV 445
           HPNI+   G+       YI +EY   G++  ++R             EH  A  +T   +
Sbjct: 62  HPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQL 121

Query: 446 RNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADL--SMK 503
             F   + +G+ YL  K+ IHRD+   N+LV  +   K+ADFG+++   G++  +  +M 
Sbjct: 122 LQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSR---GEEVYVKKTMG 178

Query: 504 GSPY-WMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEM-------YTGKPPWSEYEGA 555
             P  WMA E +   +   KS       D+WS G  + E+       Y G      YE  
Sbjct: 179 RLPVRWMAIESLNYSVYTTKS-------DVWSFGVLLWEIVSLGGTPYCGMTCAELYEKL 231

Query: 556 AAMFKVMRDTPAIPDSLSPEGKDFLRCCFQRNPADRPPAS 595
              +++ +     P +   E  + +R C++  P +RPP +
Sbjct: 232 PQGYRMEK-----PRNCDDEVYELMRQCWRDRPYERPPFA 266

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 80.1 bits (197), Expect = 2e-16
 Identities = 62/238 (26%), Positives = 108/238 (45%), Gaps = 25/238 (10%)

Query: 340 SQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHL 399
           ++ ++ K++G G FG+VY       G    +       ++    ++  +   E  +++ +
Sbjct: 7   TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASM 66

Query: 400 KHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYL 459
            HP++V+  G   +     +  + +  G +  YV EH   I   ++ N+   I  G+ YL
Sbjct: 67  DHPHLVRLLGV-CLSPTIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYL 125

Query: 460 HSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPY---WMAPELMMA 516
             ++ +HRD+   N+LV +   VK+ DFG+A+ L G + + +  G      WMA E +  
Sbjct: 126 EERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHY 185

Query: 517 VMQKGKSSDSALAVDIWSLGCTIIEMYT--GKPPWSEYEGAAAMFKVMRDTPAIPDSL 572
                +S       D+WS G TI E+ T  GKP    Y+G          T  IPD L
Sbjct: 186 RKFTHQS-------DVWSYGVTIWELMTFGGKP----YDGIP--------TREIPDLL 224

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 79.7 bits (196), Expect = 4e-16
 Identities = 70/287 (24%), Positives = 128/287 (44%), Gaps = 21/287 (7%)

Query: 346 KLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIV 405
           K+IGRG FG V V   +    + AMK ++ +    ++  +  + E+++ V    +    +
Sbjct: 7   KVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTL 66

Query: 406 QYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTI 465
            Y   +  E+  Y+ ++Y   G +   + +    + E + R +   ++  +  +H    +
Sbjct: 67  HYAFQD--ENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYV 124

Query: 466 HRDIKGANLLVDASGVVKLADFGMAKHLT--GQKADLSMKGSPYWMAPELMMAVMQKGKS 523
           HRDIK  N+L+D +G ++LADFG    L   G        G+P +++PE++ A M+ GK 
Sbjct: 125 HRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQA-MEDGKG 183

Query: 524 SDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDT-----PAIPDSLSPEGKD 578
                  D WSLG  + EM  G+ P+          K+M        PA    +S + KD
Sbjct: 184 KYGP-ECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTDVSEDAKD 242

Query: 579 FLR--CCFQRNPADRPPASLLLEHRF--------LKNSQQPDVPSCS 615
            +R   C + +   +       +H F        ++N + P +P  S
Sbjct: 243 LIRRLICSREHRLGQNGIEDFKQHPFFTGIDWDNIRNCEAPYIPEVS 289

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 80.4 bits (198), Expect = 5e-16
 Identities = 80/318 (25%), Positives = 129/318 (40%), Gaps = 64/318 (20%)

Query: 340 SQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHL 399
           S + K K +G G FG V +A   +T AL AMK +     D  +   +  ++ E  +L+  
Sbjct: 1   SMFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLR--KKDVLNRNQVAHVKAERDILAEA 58

Query: 400 KHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYL 459
            +  +V+ Y S   +D  Y  ++Y+ PG     +        E + R +   +   +  +
Sbjct: 59  DNEWVVKLYYSFQDKDNLYFVMDYI-PGGDMMSLLIRMEVFPEVLARFYIAELTLAIESV 117

Query: 460 HSKKTIHRDIKGANLLVDASGVVKLADFGM---------------AKHL---TGQKADL- 500
           H    IHRDIK  N+L+D  G +KL DFG+                 H+   + + +DL 
Sbjct: 118 HKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLW 177

Query: 501 -----------------------------SMKGSPYWMAPELMMAVMQKGKSSDSALAVD 531
                                        S+ G+P ++APE++   ++KG +       D
Sbjct: 178 DDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVL---LRKGYTQ----LCD 230

Query: 532 IWSLGCTIIEMYTGKPPWSEYEGAAAMFKVM--RDTPAIPDS--LSPEGKDFLR--CCFQ 585
            WS+G  + EM  G+PP+          KV+   +T  IP    LSPE  D +   CC  
Sbjct: 231 WWSVGVILFEMLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSA 290

Query: 586 RNPADRPPASLLLEHRFL 603
                R  A  +  H F 
Sbjct: 291 EERLGRNGADDIKAHPFF 308

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 79.3 bits (195), Expect = 5e-16
 Identities = 69/230 (30%), Positives = 106/230 (46%), Gaps = 46/230 (20%)

Query: 344 KGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLE---------QEIK 394
           +G  +GRGT+G VY A  ++              D+ + A  +KQ+E         +EI 
Sbjct: 5   EGCKVGRGTYGHVYKAKRKDG------------KDEKEYA--LKQIEGTGISMSACREIA 50

Query: 395 VLSHLKHPNIV--QYYGSEIVEDKFYIYLEYVHPG--SINKYVREHCG-----AITESVV 445
           +L  LKHPN++  Q       + K ++  +Y       I K+ R          +  S+V
Sbjct: 51  LLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMV 110

Query: 446 RNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGV----VKLADFGMAKHLTG---QKA 498
           ++    IL G+ YLH+   +HRD+K AN+LV   G     VK+AD G A+         A
Sbjct: 111 KSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLA 170

Query: 499 DLSMKGSPYWM-APELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKP 547
           DL      +W  APEL++      K      A+DIW++GC   E+ T +P
Sbjct: 171 DLDPVVVTFWYRAPELLLGARHYTK------AIDIWAIGCIFAELLTSEP 214

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 78.0 bits (192), Expect = 6e-16
 Identities = 67/259 (25%), Positives = 117/259 (45%), Gaps = 24/259 (9%)

Query: 346 KLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQ---EIKVLSHLKHP 402
           ++IG G FG V     +  G     +E+ +     KS  + KQ      E  ++    HP
Sbjct: 10  EVIGAGEFGEVCRGRLKLPGK----REIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHP 65

Query: 403 NIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSK 462
           NI+   G         I  E++  G+++ ++R++ G  T   +    R I +G+ YL   
Sbjct: 66  NIIHLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEM 125

Query: 463 KTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKAD------LSMKGSPYWMAPELMMA 516
             +HRD+   N+LV+++ V K++DFG+++ L    +D      L  K    W APE   A
Sbjct: 126 NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPE---A 182

Query: 517 VMQKGKSSDSALAVDIWSLGCTIIE-MYTGKPPWSEYEGAAAMFKVMRD--TPAIPDSLS 573
           +  +  +S S    D+WS G  + E M  G+ P+ +      +  + +D   P   D  +
Sbjct: 183 IAYRKFTSAS----DVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDYRLPPPMDCPT 238

Query: 574 PEGKDFLRCCFQRNPADRP 592
              +  L  C+Q++   RP
Sbjct: 239 ALHQLMLD-CWQKDRNARP 256

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 79.7 bits (196), Expect = 7e-16
 Identities = 79/283 (27%), Positives = 123/283 (43%), Gaps = 59/283 (20%)

Query: 346 KLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIV 405
           K+IGRG FG V +   ++TG + AMK +     D    E +  +  E  +L       +V
Sbjct: 7   KVIGRGAFGEVRLVQKKDTGHVYAMKILR--KADMLEKEQVGHIRAERDILVEADSLWVV 64

Query: 406 QYYGSEIVEDKFYIYL--EYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKK 463
           + + S   +DK  +YL  E++  G +   + +    +TE   + +    +  +  +H   
Sbjct: 65  KMFYS--FQDKLNLYLIMEFLPGGDMMTLLMKK-DTLTEEETQFYIAETVLAIDSIHQLG 121

Query: 464 TIHRDIKGANLLVDASGVVKLADFGMAKHL--------------------------TGQK 497
            IHRDIK  NLL+D+ G VKL+DFG+   L                          + +K
Sbjct: 122 FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRK 181

Query: 498 AD----------LSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKP 547
           A+           S  G+P ++APE+    MQ G +       D WSLG  + EM  G P
Sbjct: 182 AETWKRNRRQLAFSTVGTPDYIAPEVF---MQTGYNK----LCDWWSLGVIMYEMLIGYP 234

Query: 548 PWSEYEGAAAMFKVM--RDT----PAIPDSLSPEGKDF-LRCC 583
           P+          KVM  ++T    P +P  +S + KD  LR C
Sbjct: 235 PFCSETPQETYKKVMNWKETLIFPPEVP--ISEKAKDLILRFC 275

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 77.9 bits (192), Expect = 7e-16
 Identities = 62/258 (24%), Positives = 115/258 (44%), Gaps = 22/258 (8%)

Query: 348 IGRGTFGSVYVASNRETGALCAM---KEVDIFPDDPKSAESIKQLEQE-IKVLSHLKHPN 403
           +G+GTF ++Y    R    L  +   +EV +      S         E   ++S L H +
Sbjct: 3   LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62

Query: 404 IVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKK 463
           +V+ YG   V D+  +  EYV  G ++ ++      ++     +  + + S L YL  KK
Sbjct: 63  LVKLYGV-CVRDENIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKK 121

Query: 464 TIHRDIKGANLLV-----DASGV--VKLADFGMAKHLTGQKADLSMKGSPYWMAPELMMA 516
            +H ++ G N+LV     +   V  +KL+D G+   +T    +  ++  P W+APE +  
Sbjct: 122 LVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIP--ITVLSREERVERIP-WIAPECI-- 176

Query: 517 VMQKGKSSDSALAVDIWSLGCTIIEM-YTGKPPWSEYEGAAAMFKVMRDTPAIPDSLSPE 575
              +   +   +A D WS G T++E+   G+ P S    ++   +  +D   +P     E
Sbjct: 177 ---RNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLS-SSEKERFYQDQHRLPMPDCAE 232

Query: 576 GKDFLRCCFQRNPADRPP 593
             + +  C+  +P  RP 
Sbjct: 233 LANLINQCWTYDPTKRPS 250

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 78.1 bits (192), Expect = 8e-16
 Identities = 63/270 (23%), Positives = 116/270 (42%), Gaps = 19/270 (7%)

Query: 346 KLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIV 405
           +++G+G FG V     R TG + A K ++      +  ES+   E++I  L  +    +V
Sbjct: 6   RVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQI--LEKVNSQFVV 63

Query: 406 QYYGSEIVEDKFYIYLEYVHPGSINKYVREHCG-AITESVVRNFTRHILSGLAYLHSKKT 464
               +   +D   + L  ++ G +  ++         E     +   IL GL  LH + T
Sbjct: 64  NLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENT 123

Query: 465 IHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPYWMAPELMMAVMQKGKSS 524
           ++RD+K  N+L+D  G ++++D G+A  +   ++     G+  +MAPE++        + 
Sbjct: 124 VYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGRVGTVGYMAPEVL-------NNQ 176

Query: 525 DSALAVDIWSLGCTIIEMYTGKPPW----SEYEGAAAMFKVMRDTPAIPDSLSPEGKDFL 580
              L+ D W LGC I EM  G+ P+     + +      +V+          S E K   
Sbjct: 177 RYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKSIC 236

Query: 581 RCCFQRNPADR-----PPASLLLEHRFLKN 605
           +    ++P  R       A  +  H F +N
Sbjct: 237 KMLLTKDPKQRLGCQEEGAGEVKRHPFFRN 266

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 79.3 bits (195), Expect = 9e-16
 Identities = 76/281 (27%), Positives = 121/281 (43%), Gaps = 55/281 (19%)

Query: 346 KLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIV 405
           K+IGRG FG V +   ++TG + AMK +     D    E +  +  E  +L       +V
Sbjct: 7   KVIGRGAFGEVRLVQKKDTGHIYAMKILR--KADMLEKEQVAHIRAERDILVEADGAWVV 64

Query: 406 QYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTI 465
           + + S   +   Y+ +E++  G +   + +    ++E   + +    +  +  +H    I
Sbjct: 65  KMFYSFQDKRNLYLIMEFLPGGDMMTLLMKK-DTLSEEATQFYIAETVLAIDAIHQLGFI 123

Query: 466 HRDIKGANLLVDASGVVKLADFGMAKHL--------------------------TGQKAD 499
           HRDIK  NLL+DA G VKL+DFG+   L                          + +KA+
Sbjct: 124 HRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAE 183

Query: 500 ----------LSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPW 549
                      S  G+P ++APE+    MQ G +       D WSLG  + EM  G PP+
Sbjct: 184 TWKKNRRQLAYSTVGTPDYIAPEVF---MQTGYNK----LCDWWSLGVIMYEMLIGYPPF 236

Query: 550 SEYEGAAAMFKVM--RDT----PAIPDSLSPEGKDF-LRCC 583
                     KVM  ++T    P +P  +S + KD  LR C
Sbjct: 237 CSETPQETYRKVMNWKETLVFPPEVP--ISEKAKDLILRFC 275

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 78.5 bits (193), Expect = 9e-16
 Identities = 61/226 (26%), Positives = 111/226 (49%), Gaps = 23/226 (10%)

Query: 340 SQWQKGKLIGRGTFGSVY----VASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKV 395
           ++++K K++G G FG+VY    +    +     A+KE+     +  S ++ K++  E  V
Sbjct: 7   TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR----EATSPKANKEILDEAYV 62

Query: 396 LSHLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSG 455
           ++ + +P++ +  G   +     +  + +  G +  YVREH   I    + N+   I  G
Sbjct: 63  MASVDNPHVCRLLGI-CLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKG 121

Query: 456 LAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPY---WMAPE 512
           + YL  ++ +HRD+   N+LV     VK+ DFG+AK L   + +   +G      WMA E
Sbjct: 122 MNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALE 181

Query: 513 LMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAA 557
              +++ +  +  S    D+WS G T+ E+ T G  P   Y+G  A
Sbjct: 182 ---SILHRIYTHQS----DVWSYGVTVWELMTFGSKP---YDGIPA 217

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 77.6 bits (191), Expect = 1e-15
 Identities = 67/278 (24%), Positives = 114/278 (41%), Gaps = 51/278 (18%)

Query: 346 KLIGRGTFGSVY---------VASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVL 396
             +G G FG VY           S     A+  +++           +  K+  +E  ++
Sbjct: 1   NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGAT-------DQEKKEFLKEAHLM 53

Query: 397 SHLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTR------ 450
           S+  HPNIV+  G  ++ +  YI +E +  G +  Y+R+         +           
Sbjct: 54  SNFNHPNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICL 113

Query: 451 HILSGLAYLHSKKTIHRDIKGANLLV-----DASGVVKLADFGMAKHLTGQKADLSMKGS 505
            +  G  YL     IHRD+   N LV     DA  VVK+ DFG+A+ +   K+D   K  
Sbjct: 114 DVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDI--YKSDYYRKEG 171

Query: 506 P-----YWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMF 559
                  WMAPE ++     GK +  +   D+WS G  + E+ T G+ P+        + 
Sbjct: 172 EGLLPVRWMAPESLL----DGKFTTQS---DVWSFGVLMWEILTLGQQPYPALNNQEVLQ 224

Query: 560 KV-----MRDTPAIPDSLSPEGKDFLRCCFQRNPADRP 592
            V     ++     PD +       +  C+ ++P++RP
Sbjct: 225 HVTAGGRLQKPENCPDKI----YQLMTNCWAQDPSERP 258

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 77.0 bits (189), Expect = 2e-15
 Identities = 56/251 (22%), Positives = 109/251 (43%), Gaps = 14/251 (5%)

Query: 346 KLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIV 405
           +++G+G FG V     R TG + A K+++      +  E++   E+ I  L  +    +V
Sbjct: 6   RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRI--LEKVNSRFVV 63

Query: 406 QYYGSEIVEDKFYIYLEYVHPGSINKYVREHCG-AITESVVRNFTRHILSGLAYLHSKKT 464
               +   +D   + L  ++ G +  ++         E     +   +  GL  L  ++ 
Sbjct: 64  SLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERI 123

Query: 465 IHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPYWMAPELMMAVMQKGKSS 524
           ++RD+K  N+L+D  G ++++D G+A  +   +      G+  +MAPE++        + 
Sbjct: 124 VYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGRVGTVGYMAPEVI-------NNE 176

Query: 525 DSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMR----DTPAIPDSLSPEGKDFL 580
               + D W LGC I EM  G+ P+ + +      +V R    D     +  S + K   
Sbjct: 177 KYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFSEDAKSIC 236

Query: 581 RCCFQRNPADR 591
           R    +NP +R
Sbjct: 237 RMLLTKNPKER 247

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 77.0 bits (189), Expect = 2e-15
 Identities = 66/274 (24%), Positives = 118/274 (43%), Gaps = 44/274 (16%)

Query: 348 IGRGTFGSVYVA----SNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPN 403
           +G   FG +Y         +   L A+K +     D  + +   + +QE  +++ L HPN
Sbjct: 13  LGECAFGKIYKGHLYLPGMDHAQLVAIKTLK----DINNPQQWGEFQQEASLMAELHHPN 68

Query: 404 IVQYYGSEIVEDKFYIYLEYVHPGSINKYV---REH----CGAITESVVRNFTRH----- 451
           IV   G    E    +  EY++ G +++++     H    C +  +  V++   H     
Sbjct: 69  IVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLH 128

Query: 452 ----ILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQ-------KADL 500
               I +G+ YL S   +H+D+   N+L+     VK++D G+++ +          K+ L
Sbjct: 129 IAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLL 188

Query: 501 SMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMF 559
            ++    WM PE   A+M    SSDS    DIWS G  + E+++ G  P+  +     + 
Sbjct: 189 PIR----WMPPE---AIMYGKFSSDS----DIWSFGVVLWEIFSFGLQPYYGFSNQEVIE 237

Query: 560 KV-MRDTPAIPDSLSPEGKDFLRCCFQRNPADRP 592
            V  R      +   P     +  C+Q  P+ RP
Sbjct: 238 MVRKRQLLPCSEDCPPRMYSLMTECWQEGPSRRP 271

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 76.0 bits (187), Expect = 3e-15
 Identities = 61/220 (27%), Positives = 103/220 (46%), Gaps = 29/220 (13%)

Query: 346 KLIGRGTFGSVY---VASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHP 402
           ++IG+G FG VY   +  +      CA+K ++   D     E ++Q  +E  ++    HP
Sbjct: 1   RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITD----LEEVEQFLKEGIIMKDFSHP 56

Query: 403 NIVQYYGSEIVEDKF-YIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHS 461
           N++   G  +  +    + L Y+  G +  ++R      T   +  F   +  G+ YL S
Sbjct: 57  NVLSLLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLAS 116

Query: 462 KKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQK---------ADLSMKGSPYWMAPE 512
           KK +HRD+   N ++D S  VK+ADFG+A+ +  ++         A L +K    WMA E
Sbjct: 117 KKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVK----WMALE 172

Query: 513 LMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSE 551
            +       KS       D+WS G  + E+ T G PP+ +
Sbjct: 173 SLQTQKFTTKS-------DVWSFGVLLWELMTRGAPPYPD 205

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 77.5 bits (191), Expect = 3e-15
 Identities = 80/305 (26%), Positives = 120/305 (39%), Gaps = 69/305 (22%)

Query: 340 SQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHL 399
           S + K K IG G FG V +    +T AL AMK +     D         ++ E  +L+  
Sbjct: 1   SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLR--KADVLMRNQAAHVKAERDILAEA 58

Query: 400 KHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYL 459
            +  +V+ Y S   +D  Y  ++Y+ PG     +    G   E + R +   +   +  +
Sbjct: 59  DNEWVVKLYYSFQDKDNLYFVMDYI-PGGDMMSLLIRLGIFEEDLARFYIAELTCAIESV 117

Query: 460 HSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTG----------QKAD---------- 499
           H    IHRDIK  N+L+D  G +KL DFG+    TG          QK D          
Sbjct: 118 HKMGFIHRDIKPDNILIDRDGHIKLTDFGLC---TGFRWTHDSKYYQKGDHHRQDSMEPS 174

Query: 500 ---------------------------LSMKGSPYWMAPELMMAVMQKGKSSDSALAVDI 532
                                       S+ G+P ++APE++   ++ G +       D 
Sbjct: 175 EEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVL---LRTGYTQ----LCDW 227

Query: 533 WSLGCTIIEMYTGKPPWSEYEGAAAMFKVM--RDTPAIPD--SLSPEGKDFLR--CCFQR 586
           WS+G  + EM  G+PP+     A    KV+    T  IP    LS E  D +   CC   
Sbjct: 228 WSVGVILYEMLVGQPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLCC--- 284

Query: 587 NPADR 591
              DR
Sbjct: 285 GAEDR 289

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 76.6 bits (188), Expect = 4e-15
 Identities = 77/294 (26%), Positives = 128/294 (43%), Gaps = 60/294 (20%)

Query: 341 QWQKGK---LIGRGTFGSVYVASNRETG-----ALCAMKEVDIFPDDPKSAESIKQLEQE 392
           +W   K   +IG G FG V  A  ++ G     A+  MKE         S +  +    E
Sbjct: 5   EWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-------ASKDDHRDFAGE 57

Query: 393 IKVLSHL-KHPNIVQYYGSEIVEDKFYIYL--EYVHPGSINKYVREH------------- 436
           ++VL  L  HPNI+   G+   E + Y+YL  EY   G++  ++R+              
Sbjct: 58  LEVLCKLGHHPNIINLLGA--CEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIAN 115

Query: 437 --CGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLT 494
                ++   + +F   +  G+ YL  K+ IHRD+   N+LV  + V K+ADFG+++   
Sbjct: 116 STASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR--- 172

Query: 495 GQKADL--SMKGSPY-WMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEM-------YT 544
           GQ+  +  +M   P  WMA E +   +    S       D+WS G  + E+       Y 
Sbjct: 173 GQEVYVKKTMGRLPVRWMAIESLNYSVYTTNS-------DVWSYGVLLWEIVSLGGTPYC 225

Query: 545 GKPPWSEYEGAAAMFKVMRDTPAIPDSLSPEGKDFLRCCFQRNPADRPPASLLL 598
           G      YE     +++ +     P +   E  D +R C++  P +RP  + +L
Sbjct: 226 GMTCAELYEKLPQGYRLEK-----PLNCDDEVYDLMRQCWREKPYERPSFAQIL 274

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 76.6 bits (188), Expect = 5e-15
 Identities = 63/245 (25%), Positives = 115/245 (46%), Gaps = 15/245 (6%)

Query: 346 KLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIV 405
           K+IGRG FG V V   + T  + AMK ++ +    ++  +  + E+ + V    +    +
Sbjct: 7   KVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTL 66

Query: 406 QYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTI 465
            Y   +  E+  Y+ ++Y   G +   + +    + E + R +   ++  +  +H    +
Sbjct: 67  HYAFQD--ENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYV 124

Query: 466 HRDIKGANLLVDASGVVKLADFG----MAKHLTGQKADLSMKGSPYWMAPELMMAVMQKG 521
           HRDIK  N+L+D +G ++LADFG    M +  T Q +     G+P +++PE++ A M+ G
Sbjct: 125 HRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSS--VAVGTPDYISPEILQA-MEDG 181

Query: 522 KSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDT-----PAIPDSLSPEG 576
                    D WSLG  + EM  G+ P+          K+M        P+    +S E 
Sbjct: 182 MGKYGP-ECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHITDVSEEA 240

Query: 577 KDFLR 581
           KD ++
Sbjct: 241 KDLIQ 245

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 75.5 bits (186), Expect = 6e-15
 Identities = 71/274 (25%), Positives = 121/274 (44%), Gaps = 38/274 (13%)

Query: 347 LIGRGTFGSVYVASNRETGALCAMKEVDIFP-DDPKSAESIKQLEQEIKVLSHLKHPNIV 405
           L+  GTFG ++     +       +EV +    D  S   +  L QE  +L  L H NI+
Sbjct: 13  LLQEGTFGRIFYGILIDE-KPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNIL 71

Query: 406 QYYGSEIVE-DKFYIYLEYVHPGSINKYVRE-------HCGAITESVVRNFTRHILSGLA 457
                 I + +  ++   Y++ G++  ++++       +  A++   + +    I  G++
Sbjct: 72  PILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMS 131

Query: 458 YLHSKKTIHRDIKGANLLVDASGVVKLAD-------FGMAKHLTGQKADLSMKGSPYWMA 510
           YLH +  IH+DI   N ++D    VK+ D       F M  H  G   +  +K    WMA
Sbjct: 132 YLHKRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVK----WMA 187

Query: 511 PELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSE---YEGAAAMFKVMR--D 564
            E   +++ K  SS S    D+WS G  + E+ T G+ P+ E   +E AA +    R   
Sbjct: 188 LE---SLVNKEYSSAS----DVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDGYRLAQ 240

Query: 565 TPAIPDSLSPEGKDFLRCCFQRNPADRPPASLLL 598
               PD L       + CC+  +P +RP  S L+
Sbjct: 241 PINCPDELF----AVMACCWALDPEERPSFSQLV 270

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 74.8 bits (184), Expect = 1e-14
 Identities = 70/280 (25%), Positives = 117/280 (41%), Gaps = 54/280 (19%)

Query: 348 IGRGTFGSVYVA-----SNRETGALCAMKEVDIFPDDPKSAESIKQLE--QEIKVLSHLK 400
           +G G FG VY       + R +    A+K +       ++AE   Q E  QE +++S L+
Sbjct: 13  LGEGAFGKVYKGELTGPNERLSATSVAIKTLK------ENAEPKVQQEFRQEAELMSDLQ 66

Query: 401 HPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREH-------CGAITESVVR------- 446
           HPNIV   G    E    +  EY+  G +++++  +         +  E+V         
Sbjct: 67  HPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDF 126

Query: 447 -NFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGS 505
            +    I +G+ YL S   +HRD+   N LV     VK++DFG+++ +           S
Sbjct: 127 LHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKS 186

Query: 506 PY---WMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFKV 561
                WM PE   A++    +++S    DIWS G  + E+++ G  P+  +     +  +
Sbjct: 187 LLPVRWMPPE---AILYGKFTTES----DIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMI 239

Query: 562 MR--------DTPAIPDSLSPEGKDFLRCCFQRNPADRPP 593
                     D PA   +L  E       C+   PA RP 
Sbjct: 240 RSRQLLPCPEDCPARVYALMIE-------CWNEIPARRPR 272

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 74.3 bits (182), Expect = 1e-14
 Identities = 73/278 (26%), Positives = 118/278 (42%), Gaps = 53/278 (19%)

Query: 347 LIGRGTFGSVYVASNRETG-----ALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHL-K 400
           +IG G FG V  A  ++ G     A+  MKE         S +  +    E++VL  L  
Sbjct: 2   VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-------ASKDDHRDFAGELEVLCKLGH 54

Query: 401 HPNIVQYYGSEIVEDKFYIYLEYVHPGSI-------------NKYVREHCGAITESV--V 445
           HPNI+   G+       Y+ +EY   G++               +   +  A T S   +
Sbjct: 55  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 114

Query: 446 RNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADL--SMK 503
            +F   +  G+ YL  K+ IHRD+   N+LV  + V K+ADFG+++   GQ+  +  +M 
Sbjct: 115 LHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKKTMG 171

Query: 504 GSPY-WMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEM-------YTGKPPWSEYEGA 555
             P  WMA E +   +    S       D+WS G  + E+       Y G      YE  
Sbjct: 172 RLPVRWMAIESLNYSVYTTNS-------DVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL 224

Query: 556 AAMFKVMRDTPAIPDSLSPEGKDFLRCCFQRNPADRPP 593
              +++ +     P +   E  D +R C++  P +RP 
Sbjct: 225 PQGYRLEK-----PLNCDDEVYDLMRQCWREKPYERPS 257

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 76.8 bits (189), Expect = 2e-14
 Identities = 62/255 (24%), Positives = 104/255 (40%), Gaps = 26/255 (10%)

Query: 363 ETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKF-YIYL 421
            TG   A+K +    D P+      +  +E  + + L HPNIV    S        +   
Sbjct: 1   MTGHEVAIKLLRT--DAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVF 58

Query: 422 EYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGV 481
           EYV PG   + V    GA+           +L  LA  H++  +HRD+K  N++V  +GV
Sbjct: 59  EYV-PGRTLREVLAADGALPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVSQTGV 117

Query: 482 ---VKLADFGMAKHLTGQKADL--------SMKGSPYWMAPELMMAVMQKGKSSDSALAV 530
               K+ DFG+   L G +            + G+P + APE +        S       
Sbjct: 118 RPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNS------- 170

Query: 531 DIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTP-AIPDSLS--PEGKDFLRCCFQRN 587
           D+++ G   +E  TG+        A  +++ +     ++P  ++  P G   LR    ++
Sbjct: 171 DLYAWGLIFLECLTGQRVVQGASVAEILYQQLSPVDVSLPPWIAGHPLG-QVLRKALNKD 229

Query: 588 PADRPPASLLLEHRF 602
           P  R  ++  L  RF
Sbjct: 230 PRQRAASAPALAERF 244

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 72.3 bits (177), Expect = 7e-14
 Identities = 52/219 (23%), Positives = 100/219 (45%), Gaps = 20/219 (9%)

Query: 340 SQWQKGKLIGRGTFGSV----YVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKV 395
           ++ +K KL+G G FG+V    ++          A+K +     D    ++ +++   +  
Sbjct: 7   TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQ----DRSGRQTFQEITDHMLA 62

Query: 396 LSHLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSG 455
           +  L H  IV+  G         +  +    GS+  +VR+H  ++    + N+   I  G
Sbjct: 63  MGSLDHAYIVRLLGI-CPGASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKG 121

Query: 456 LAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADL---SMKGSPYWMAPE 512
           + YL   + +HR++   N+L+ +  +V++ADFG+A  L            K    WMA E
Sbjct: 122 MYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALE 181

Query: 513 LMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWS 550
            ++     G+ +  +   D+WS G T+ EM + G  P++
Sbjct: 182 SILF----GRYTHQS---DVWSYGVTVWEMMSYGAEPYA 213

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 73.1 bits (179), Expect = 7e-14
 Identities = 47/159 (29%), Positives = 85/159 (53%), Gaps = 15/159 (9%)

Query: 448 FTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPY 507
           ++  +  G+ +L S+K IHRD+   N+L+  + VVK+ DFG+A+ +  +  D   KGS  
Sbjct: 179 YSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIY-KDPDYVRKGSAR 237

Query: 508 ----WMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFKVM 562
               WMAPE   ++  K  ++ S    D+WS G  + E+++ G  P+   +      + +
Sbjct: 238 LPLKWMAPE---SIFDKVYTTQS----DVWSFGVLLWEIFSLGASPYPGVQINEEFCQRL 290

Query: 563 RDTPAI--PDSLSPEGKDFLRCCFQRNPADRPPASLLLE 599
           +D   +  P++ +PE    +  C+Q +P +RP  S L+E
Sbjct: 291 KDGTRMRAPENATPEIYRIMLACWQGDPKERPTFSALVE 329

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 70.2 bits (172), Expect = 4e-13
 Identities = 64/280 (22%), Positives = 116/280 (41%), Gaps = 41/280 (14%)

Query: 343 QKGKLIGRGTFGSVYVASNRETG-----ALCAMKEVDIFPDDPKSAESIKQLEQEIKVLS 397
           Q+   +GRG FG V++A  +         L  +K +    D+   +E  ++L+    +  
Sbjct: 8   QEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELD----MFR 63

Query: 398 HLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNF-TRHILS-- 454
            L H N+V+  G     +  Y+ LEY   G + +++R       +       T+  ++  
Sbjct: 64  KLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALC 123

Query: 455 -----GLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAK--------HLTGQKADLS 501
                G+ +L + + +HRD+   N LV +   VK++   ++K         L      L 
Sbjct: 124 TQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPLR 183

Query: 502 MKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEY--EGAAAM 558
                 W+APE   AV +   S+ S    D+WS G  + E++T G+ P+     E     
Sbjct: 184 ------WLAPE---AVQEDDFSTKS----DVWSFGVLMWEVFTQGELPFYGLSDEEVLNR 230

Query: 559 FKVMRDTPAIPDSLSPEGKDFLRCCFQRNPADRPPASLLL 598
            +  +    +P+         +  C+  NP DRP  S L+
Sbjct: 231 LQAGKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELV 270

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 68.9 bits (168), Expect = 1e-12
 Identities = 66/283 (23%), Positives = 123/283 (43%), Gaps = 30/283 (10%)

Query: 340 SQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHL 399
           ++ +K K++G G FG+VY       G    +        +  S ++ K++  E  V++ +
Sbjct: 7   TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGV 66

Query: 400 KHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYL 459
             P + +  G   +     +  + +  G +  YVRE+   I    + N+   I  G++YL
Sbjct: 67  GSPYVCRLLGI-CLTSTVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYL 125

Query: 460 HSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPY---WMAPELMMA 516
              + +HRD+   N+LV +   VK+ DFG+A+ L   + +    G      WMA E   +
Sbjct: 126 EEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALE---S 182

Query: 517 VMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFKVMRDTPAI------- 568
           ++ +  +  S    D+WS G T+ E+ T G  P   Y+G  A     R+ P +       
Sbjct: 183 ILHRRFTHQS----DVWSYGVTVWELMTFGAKP---YDGIPA-----REIPDLLEKGERL 230

Query: 569 --PDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQP 609
             P   + +    +  C+  +   RP    L+   F + ++ P
Sbjct: 231 PQPPICTIDVYMIMVKCWMIDSECRPRFRELV-DEFSRMARDP 272

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 71.3 bits (175), Expect = 1e-12
 Identities = 70/265 (26%), Positives = 115/265 (43%), Gaps = 47/265 (17%)

Query: 346 KLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIV 405
           +LIG+G  G VY+A +       A+K+  I  D  ++    K+  +E K+ + L HP IV
Sbjct: 8   RLIGKGGMGEVYLAYDPVCSRRVALKK--IREDLSENPLLKKRFLREAKIAADLIHPGIV 65

Query: 406 QYYGSEIVEDKFYIYLEYVHP---GSINKYVREHCG-----AITESV---VRNFTRHILS 454
             Y      D  Y  + Y+      S+ K V +        A   SV   +  F + I +
Sbjct: 66  PVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHK-ICA 124

Query: 455 GLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADL-------------S 501
            + Y+HSK  +HRD+K  N+L+   G V + D+G A     ++ DL             S
Sbjct: 125 TIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSS 184

Query: 502 MK------GSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGA 555
           M       G+P +MAPE       +     ++ + DI++LG  + +M T   P+   +G 
Sbjct: 185 MTIPGKIVGTPDYMAPE-------RLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGR 237

Query: 556 AAMFKVMRDTPA-------IPDSLS 573
              ++ +  +P        IP  LS
Sbjct: 238 KISYRDVILSPIEVAPYREIPPFLS 262

Length = 932

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 67.5 bits (165), Expect = 2e-12
 Identities = 67/283 (23%), Positives = 122/283 (43%), Gaps = 45/283 (15%)

Query: 345 GKLIGRGTFGSVYVAS-NRETG-----ALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSH 398
           GK++G G FGSV     +++ G     A+  MK +DI      +   I++   E   +  
Sbjct: 4   GKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMK-LDIH-----TYSEIEEFLSEAACMKD 57

Query: 399 LKHPNIVQYYGSEIVED------KFYIYLEYVHPGSINKY-----VREHCGAITESVVRN 447
             HPN+++  G            K  + L ++  G ++ +     +      +    +  
Sbjct: 58  FDHPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLK 117

Query: 448 FTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHL-------TGQKADL 500
           F   I  G+ YL ++  IHRD+   N ++     V +ADFG++K +        G+ A +
Sbjct: 118 FMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKM 177

Query: 501 SMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMF 559
            +K    W+A E +   +   KS       D+W+ G T+ E+ T G+ P+   E    ++
Sbjct: 178 PVK----WIAIESLADRVYTSKS-------DVWAFGVTMWEIATRGQTPYPGVEN-HEIY 225

Query: 560 KVMRDTPAI--PDSLSPEGKDFLRCCFQRNPADRPPASLLLEH 600
             +R    +  P+    E  D +  C++ +P DRP  + L E 
Sbjct: 226 DYLRHGNRLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREV 268

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 67.4 bits (164), Expect = 3e-12
 Identities = 74/283 (26%), Positives = 122/283 (43%), Gaps = 62/283 (21%)

Query: 345 GKLIGRGTFGSVY------------VASNRETGALCAMKEVDIFPDDPKSAESIKQLEQE 392
           GK +G G FGSV             VA      A+C   E++ F               E
Sbjct: 4   GKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDF-------------LSE 50

Query: 393 IKVLSHLKHPNIVQYYGS--EIVEDKFY----IYLEYVHPGSINKYV-REHCGAI----- 440
              +    HPN+++  G   + VE + Y    + L ++  G ++ ++     G       
Sbjct: 51  AVCMKEFDHPNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLP 110

Query: 441 TESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHL------- 493
           T+ +V+ F   I SG+ YL SK  IHRD+   N +++ +  V +ADFG++K +       
Sbjct: 111 TQMLVK-FMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYR 169

Query: 494 TGQKADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEY 552
            G+ A + +K    W+A E +   +   KS       D+WS G T+ E+ T G+ P+   
Sbjct: 170 QGRIAKMPVK----WIAIESLADRVYTTKS-------DVWSFGVTMWEIATRGQTPYPGV 218

Query: 553 EGAAAMFKVMRDTPAI---PDSLSPEGKDFLRCCFQRNPADRP 592
           E  + ++  +R    +   PD L       +  C+  NP DRP
Sbjct: 219 EN-SEIYDYLRQGNRLKQPPDCLDGL-YSLMSSCWLLNPKDRP 259

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 66.9 bits (163), Expect = 3e-12
 Identities = 57/211 (27%), Positives = 96/211 (45%), Gaps = 14/211 (6%)

Query: 388 QLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRN 447
           ++ +E +++  L +P IV+  G    E    + +E    G +NK++      IT S V  
Sbjct: 41  EMMREAEIMHQLDNPYIVRMIGVCEAEA-LMLVMEMASGGPLNKFLSGKKDEITVSNVVE 99

Query: 448 FTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQ----KADLSMK 503
               +  G+ YL  K  +HRD+   N+L+      K++DFG++K L       KA  + K
Sbjct: 100 LMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGK 159

Query: 504 GSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFKVM 562
               W APE    +  +  SS S    D+WS G T+ E ++ G+ P+ + +G   M  + 
Sbjct: 160 WPLKWYAPE---CINFRKFSSRS----DVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIE 212

Query: 563 RDTP-AIPDSLSPEGKDFLRCCFQRNPADRP 592
           +      P    PE    ++ C+     DRP
Sbjct: 213 QGKRLDCPAECPPEMYALMKDCWIYKWEDRP 243

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 68.4 bits (167), Expect = 4e-12
 Identities = 39/160 (24%), Positives = 81/160 (50%), Gaps = 15/160 (9%)

Query: 447 NFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSP 506
           +F+  +  G+++L SK  IHRD+   N+L+    + K+ DFG+A+ +    ++  +KG+ 
Sbjct: 218 SFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIR-NDSNYVVKGNA 276

Query: 507 Y----WMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFKV 561
                WMAPE +   +   +S       D+WS G  + E+++ G  P+      +  +K+
Sbjct: 277 RLPVKWMAPESIFNCVYTFES-------DVWSYGILLWEIFSLGSSPYPGMPVDSKFYKM 329

Query: 562 MRDTPAI--PDSLSPEGKDFLRCCFQRNPADRPPASLLLE 599
           +++   +  P+    E  D ++ C+  +P  RP    +++
Sbjct: 330 IKEGYRMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQ 369

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 68.0 bits (166), Expect = 4e-12
 Identities = 46/153 (30%), Positives = 79/153 (51%), Gaps = 15/153 (9%)

Query: 455 GLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPY----WMA 510
           G+ +L S+K IHRD+   N+L+  + VVK+ DFG+A+ +  +  D   KG       WMA
Sbjct: 185 GMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIY-KDPDYVRKGDARLPLKWMA 243

Query: 511 PELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFKVMRDTPAI- 568
           PE   ++  K  ++ S    D+WS G  + E+++ G  P+   +      + +++   + 
Sbjct: 244 PE---SIFDKVYTTQS----DVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMR 296

Query: 569 -PDSLSPEGKDFLRCCFQRNPADRPPASLLLEH 600
            P+  +PE    +  C+  NP DRP  S L+E 
Sbjct: 297 APEYATPEIYSIMLDCWHNNPEDRPTFSELVEI 329

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 67.9 bits (166), Expect = 4e-12
 Identities = 42/152 (27%), Positives = 76/152 (50%), Gaps = 15/152 (9%)

Query: 448 FTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPY 507
           F+  +  G+ +L SK  IHRD+   N+L+    V K+ DFG+A+ +    ++  +KG+  
Sbjct: 217 FSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIM-NDSNYVVKGNAR 275

Query: 508 ----WMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFKVM 562
               WMAPE +   +   +S       D+WS G  + E+++ GK P+      +  +K++
Sbjct: 276 LPVKWMAPESIFDCVYTVQS-------DVWSYGILLWEIFSLGKSPYPGILVNSKFYKMV 328

Query: 563 RD--TPAIPDSLSPEGKDFLRCCFQRNPADRP 592
           +     + PD   PE    ++ C+   P +RP
Sbjct: 329 KRGYQMSRPDFAPPEIYSIMKMCWNLEPTERP 360

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 67.4 bits (164), Expect = 5e-12
 Identities = 45/160 (28%), Positives = 80/160 (50%), Gaps = 15/160 (9%)

Query: 448 FTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPY 507
           ++  +  G+ +L S+K IHRD+   N+L+  + VVK+ DFG+A+ +  +  D   KG   
Sbjct: 184 YSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIY-KDPDYVRKGDAR 242

Query: 508 ----WMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFKVM 562
               WMAPE    +  +  +  S    D+WS G  + E+++ G  P+   +      + +
Sbjct: 243 LPLKWMAPE---TIFDRVYTIQS----DVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL 295

Query: 563 RDTPAI--PDSLSPEGKDFLRCCFQRNPADRPPASLLLEH 600
           ++   +  PD  +PE    +  C+   P+ RP  S L+EH
Sbjct: 296 KEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 335

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 67.6 bits (165), Expect = 1e-11
 Identities = 49/151 (32%), Positives = 71/151 (47%), Gaps = 13/151 (8%)

Query: 346 KLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESI-----KQLEQEIKVLSHLK 400
           K I RG FG VY+   +    L A+K V       K A+ I      Q++ E   L+  K
Sbjct: 10  KPISRGAFGKVYLGRKKNNSKLYAVKVV-------KKADMINKNMVHQVQAERDALALSK 62

Query: 401 HPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLH 460
            P IV  Y S    +  Y+ +EY+  G + K +    G   E +   +   +   L YLH
Sbjct: 63  SPFIVHLYYSLQSANNVYLVMEYLIGGDV-KSLLHIYGYFDEEMAVKYISEVALALDYLH 121

Query: 461 SKKTIHRDIKGANLLVDASGVVKLADFGMAK 491
               IHRD+K  N+L+   G +KL DFG++K
Sbjct: 122 RHGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 65.3 bits (159), Expect = 1e-11
 Identities = 64/279 (22%), Positives = 114/279 (40%), Gaps = 38/279 (13%)

Query: 348 IGRGTFGSV-----YVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKV---LSHL 399
           IG G FG V     Y  +     A   +KE+       K+  S K+  + ++       L
Sbjct: 3   IGNGWFGKVLLSEIYTDT---GVARVVVKEL-------KANASSKEQNEFLQQGDPYRIL 52

Query: 400 KHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTR---HILSGL 456
           +HPNI+Q  G  +    + +  EY   G +  Y+ +       S +    R    I +G+
Sbjct: 53  QHPNILQCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGV 112

Query: 457 AYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADL----SMKGSPY-WMAP 511
            ++H    +H D+   N  + +   VK+ D+G+    +  K D       K  P  W+AP
Sbjct: 113 THMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIG--PSRYKEDYIETEDDKCVPLRWLAP 170

Query: 512 ELMMAVMQKGKSSDSALAVDIWSLGCTIIEMY-TGKPPWSEYEGAAAMFKVMRD------ 564
           EL+        +++     ++W+LG T+ E++     P+S       +  V++D      
Sbjct: 171 ELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLF 230

Query: 565 TPAIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFL 603
            P +    S    + L+ C+  +P  R  A  +  HR L
Sbjct: 231 KPQLELPYSERWYEVLQFCWL-SPEKRATAEEV--HRLL 266

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 65.0 bits (158), Expect = 2e-11
 Identities = 52/175 (29%), Positives = 80/175 (45%), Gaps = 24/175 (13%)

Query: 452 ILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSP----- 506
           I  G+AYL++KK +HRD+   N +V     VK+ DFGM + +   + D   KG       
Sbjct: 128 IADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDI--YETDYYRKGGKGLLPV 185

Query: 507 YWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAA--AMFKVMR 563
            WMAPE +       K      + D+WS G  + E+ +  + P   Y+G +   + K + 
Sbjct: 186 RWMAPESL-------KDGVFTTSSDMWSFGVVLWEITSLAEQP---YQGLSNEQVLKFVM 235

Query: 564 DTPAI--PDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQPDVPSCSL 616
           D   +  PD+      D +R C+Q NP  RP    ++    LK+   P  P  S 
Sbjct: 236 DGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVN--LLKDDLHPSFPEVSF 288

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 64.6 bits (157), Expect = 2e-11
 Identities = 54/210 (25%), Positives = 91/210 (43%), Gaps = 15/210 (7%)

Query: 392 EIKVLSHLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRH 451
           E   L    H NIV+  G     +   I  EY+  G+++ ++R+H G +    +      
Sbjct: 56  EALTLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPG 115

Query: 452 ILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKG-SP-YWM 509
           + SG+ YL     +H+ +    +LV++  V K++ F   +    +    +M G SP  W 
Sbjct: 116 LASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSGKSPVLWA 175

Query: 510 APELMMAVMQKGKSSDSALAVDIWSLGCTIIE-MYTGKPPWSEYEGAAAMFKVMRD---T 565
           APE     +Q    S    A D+WS G  + E M  G+ P+ +  G   + K + D    
Sbjct: 176 APE----AIQYHHFSS---ASDVWSFGIVMWEVMSYGERPYWDMSGQDVI-KAVEDGFRL 227

Query: 566 PAIPDSLSPEGKDFLRCCFQRNPADRPPAS 595
           PA P +        +  C+Q+   +RP  S
Sbjct: 228 PA-PRNCPNLLHQLMLDCWQKERGERPRFS 256

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 64.6 bits (157), Expect = 2e-11
 Identities = 58/235 (24%), Positives = 103/235 (43%), Gaps = 26/235 (11%)

Query: 346 KLIGRGTFGSVYVAS--NRETGALCAMKEVDIFPDDPKSAESIKQLE--QEIKVLSHLKH 401
           K IG G FG V +    +  T A   +KE+ +      SA   +Q++  +E +    L+H
Sbjct: 1   KEIGNGWFGKVILGEVNSGYTPAQVVVKELRV------SASVQEQMKFLEEAQPYRSLQH 54

Query: 402 PNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITES----VVRNFTRHILSGLA 457
            N++Q  G       + + +E+   G +  Y+R    A   +     ++     I  GL 
Sbjct: 55  SNLLQCLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLL 114

Query: 458 YLHSKKTIHRDIKGANLLVDASGVVKLADFGMAK-------HLTGQKADLSMKGSPYWMA 510
           +LH    IH D+   N L+ A   VK+ D+G++        ++T  +  + ++    W+A
Sbjct: 115 HLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLR----WIA 170

Query: 511 PELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFKVMRD 564
           PEL+  V       D     ++WSLG TI E++  G  P+        +   +R+
Sbjct: 171 PELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVRE 225

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 64.9 bits (158), Expect = 4e-11
 Identities = 31/93 (33%), Positives = 46/93 (49%), Gaps = 7/93 (7%)

Query: 450 RHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPYWM 509
           + IL GL YLH+++ IHRD+K  N+ ++    V + D G A+      A L + G+    
Sbjct: 164 KQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLGLAGTVETN 223

Query: 510 APELMMAVMQKGKSSDSALAVDIWSLGCTIIEM 542
           APE++       K        DIWS G  + EM
Sbjct: 224 APEVLARDKYNSK-------ADIWSAGIVLFEM 249

Length = 357

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 63.7 bits (156), Expect = 4e-11
 Identities = 60/240 (25%), Positives = 104/240 (43%), Gaps = 31/240 (12%)

Query: 351 GTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHL--KHPNIVQYY 408
           G FG V V  ++ T  L   K +       K+  +I     E  V   L   +PN ++ Y
Sbjct: 27  GKFGKVSVLKHKPTQKLFVQKIIK-----AKNFNAI-----EPMV-HQLMKDNPNFIKLY 75

Query: 409 GSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRD 468
            S        + ++Y+  G +   +++  G ++E+ V+   R ++  L  LH    IH D
Sbjct: 76  YSVTTLKGHVLIMDYIKDGDLFDLLKKE-GKLSEAEVKKIIRQLVEALNDLHKHNIIHND 134

Query: 469 IKGANLLVD-ASGVVKLADFGMAKHLTGQKADLSMKGSPYWMAPELMMAVMQKGKSSDSA 527
           IK  N+L D A   + L D+G+ K   G  +     G+  + +PE       K K  +  
Sbjct: 135 IKLENVLYDRAKDRIYLCDYGLCKI-IGTPS--CYDGTLDYFSPE-------KIKGHNYD 184

Query: 528 LAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVM-----RDTPAIPDSLSPEGKDFLRC 582
           ++ D W++G    E+ TGK P+ E E      + +     +  P I  ++S    DF++ 
Sbjct: 185 VSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKKLPFIK-NVSKNANDFVQS 243

Length = 267

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 63.0 bits (153), Expect = 7e-11
 Identities = 60/237 (25%), Positives = 110/237 (46%), Gaps = 44/237 (18%)

Query: 345 GKLIGRGTFGSVYVA---SNRETGALCAMK--EVDIFPDDPKSAESIKQLEQEIKVLSHL 399
           G+++G+G FGSV  A   S   +    A+K  + DIF     S+  I++  +E   +   
Sbjct: 4   GRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIF-----SSSDIEEFLREAACMKEF 58

Query: 400 KHPNIVQYYGSEI---VEDKFYI---YLEYVHPGSINKY-----VREHCGAITESVVRNF 448
            HPN+++  G  +    + +  I    L ++  G ++ +     + E    +    +  F
Sbjct: 59  DHPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRF 118

Query: 449 TRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHL-------TGQKADLS 501
              I SG+ YL SK  IHRD+   N +++ +  V +ADFG++K +        G  + L 
Sbjct: 119 MIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLP 178

Query: 502 MKGSPYWMAPELMMAVMQKGKSSDSALAV--DIWSLGCTIIEMYT-GKPPWSEYEGA 555
           +K    W+A E +         +D+      D+W+ G T+ E+ T G+ P++  E +
Sbjct: 179 VK----WLALESL---------ADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENS 222

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 63.6 bits (155), Expect = 9e-11
 Identities = 35/100 (35%), Positives = 55/100 (55%), Gaps = 17/100 (17%)

Query: 452 ILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSP----- 506
           +L G+ +LHS   IHRD+K +N++V +   +K+ DFG+A+      A  S   +P     
Sbjct: 127 MLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR-----TAGTSFMMTPYVVTR 181

Query: 507 YWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGK 546
           Y+ APE+++ +  K         VDIWS+GC + EM  G 
Sbjct: 182 YYRAPEVILGMGYKEN-------VDIWSVGCIMGEMIRGT 214

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 62.0 bits (150), Expect = 2e-10
 Identities = 65/277 (23%), Positives = 110/277 (39%), Gaps = 56/277 (20%)

Query: 348 IGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQ------------EIKV 395
           +G+G+FG VY    +            +  D+P++  +IK + +            E  V
Sbjct: 14  LGQGSFGMVYEGIAK-----------GVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 62

Query: 396 LSHLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVR------EHCGAITESVVRNFT 449
           +      ++V+  G         + +E +  G +  Y+R      E+        ++   
Sbjct: 63  MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMI 122

Query: 450 R---HILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSP 506
           +    I  G+AYL++ K +HRD+   N +V     VK+ DFGM + +   + D   KG  
Sbjct: 123 QMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDI--YETDYYRKGGK 180

Query: 507 -----YWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFK 560
                 WM+PE +       K        D+WS G  + E+ T  + P+        +  
Sbjct: 181 GLLPVRWMSPESL-------KDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRF 233

Query: 561 VMR----DTP-AIPDSLSPEGKDFLRCCFQRNPADRP 592
           VM     D P   PD L     + +R C+Q NP  RP
Sbjct: 234 VMEGGLLDKPDNCPDMLF----ELMRMCWQYNPKMRP 266

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 61.6 bits (149), Expect = 5e-10
 Identities = 31/95 (32%), Positives = 52/95 (54%), Gaps = 7/95 (7%)

Query: 451 HILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPYWMA 510
            +L G+ +LHS   IHRD+K +N++V +   +K+ DFG+A+             + Y+ A
Sbjct: 131 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTPYVVTRYYRA 190

Query: 511 PELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTG 545
           PE+++ +  K         VDIWS+GC + E+  G
Sbjct: 191 PEVILGMGYKEN-------VDIWSVGCIMGELVKG 218

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 61.6 bits (149), Expect = 5e-10
 Identities = 44/158 (27%), Positives = 76/158 (48%), Gaps = 15/158 (9%)

Query: 448 FTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPY 507
           F+  + +G+ +L SK  +HRD+   N+L+    +VK+ DFG+A+ +      +S KGS +
Sbjct: 244 FSYQVANGMEFLASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYIS-KGSTF 302

Query: 508 ----WMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFKVM 562
               WMAPE +   +    S       D+WS G  + E++T G  P+ E       +  +
Sbjct: 303 LPLKWMAPESIFNNLYTTLS-------DVWSFGILLWEIFTLGGTPYPELPMNEQFYNAI 355

Query: 563 RD--TPAIPDSLSPEGKDFLRCCFQRNPADRPPASLLL 598
           +     A P   S E  + ++ C++     RP  S L+
Sbjct: 356 KRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLV 393

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain

 Score = 58.2 bits (141), Expect = 8e-10
 Identities = 37/163 (22%), Positives = 60/163 (36%), Gaps = 29/163 (17%)

Query: 453 LSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPYWMAPE 512
           L  L  LH +      +   + L+   G V              K     +  PY+MAPE
Sbjct: 27  LGALRELHRQAKSGNILLTWDGLLKLDGSV------------AFKTPEQSRPDPYFMAPE 74

Query: 513 LMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPA---IP 569
           ++                DI+SLG T+ E    + P++E    +A+ +++ +        
Sbjct: 75  VIQGQ-------SYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPR 127

Query: 570 DSLSPEG-------KDFLRCCFQRNPADRPPASLLLEHRFLKN 605
           D  + EG       +DF+R C  R P  R  A+  L H     
Sbjct: 128 DRSNLEGVSAARSFEDFMRLCASRLPQRREAANHYLAHCRALF 170

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score = 59.1 bits (143), Expect = 1e-09
 Identities = 46/199 (23%), Positives = 84/199 (42%), Gaps = 32/199 (16%)

Query: 402 PNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHS 461
           PN+V  +   + ED  ++ L++   G +  ++ +    I E  V+ +   ++  L  LH 
Sbjct: 45  PNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLN-IPEECVKRWAAEMVVALDALHR 103

Query: 462 KKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPYWMAPELMMAVMQKG 521
           +  + RD+   N+L+D  G ++L  F     +       ++     + APE+       G
Sbjct: 104 EGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAV--ENMYCAPEV-------G 154

Query: 522 KSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPA---------IPDSL 572
             S+   A D WSLG  + E+ TGK              ++   P+         IP+ +
Sbjct: 155 GISEETEACDWWSLGAILFELLTGK-------------TLVECHPSGINTHTTLNIPEWV 201

Query: 573 SPEGKDFLRCCFQRNPADR 591
           S E +  L+   Q NP +R
Sbjct: 202 SEEARSLLQQLLQFNPTER 220

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 60.4 bits (146), Expect = 1e-09
 Identities = 35/101 (34%), Positives = 55/101 (54%), Gaps = 17/101 (16%)

Query: 451 HILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSP---- 506
            +L G+ +LHS   IHRD+K +N++V +   +K+ DFG+A+      A  S   +P    
Sbjct: 134 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR-----TAGTSFMMTPYVVT 188

Query: 507 -YWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGK 546
            Y+ APE+++ +  K         VDIWS+GC + EM  G 
Sbjct: 189 RYYRAPEVILGMGYKEN-------VDIWSVGCIMGEMIKGG 222

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 59.1 bits (143), Expect = 1e-09
 Identities = 57/256 (22%), Positives = 111/256 (43%), Gaps = 21/256 (8%)

Query: 348 IGRGTFGSVYVASNRETGALCAMKEVDIFPD--DPKSAESIKQLEQEIKVLSHLKHPNIV 405
           +G+GTF  ++    RE G    + + ++     D       +   +   ++S L H ++V
Sbjct: 3   LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62

Query: 406 QYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTI 465
             YG  +  D+  +  EYV  GS++ Y++++   I  S      + +   L +L  K   
Sbjct: 63  LNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLT 122

Query: 466 HRDIKGANLLV-----DASG---VVKLADFGMAKHLTGQKADLSMKGSPYWMAPELMMAV 517
           H ++   N+L+       +G    +KL+D G++  +T    ++ ++  P W+ PE +   
Sbjct: 123 HGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS--ITVLPKEILLERIP-WVPPECI--- 176

Query: 518 MQKGKSSDSALAVDIWSLGCTIIEMYTG-KPPWSEYEGAAAMFKVMRDTPAIPDSLSPEG 576
                  + +LA D WS G T+ E+++G   P S  +    + +   D   +P     E 
Sbjct: 177 ---ENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKL-QFYEDRHQLPAPKWTEL 232

Query: 577 KDFLRCCFQRNPADRP 592
            + +  C    P  RP
Sbjct: 233 ANLINQCMDYEPDFRP 248

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 59.3 bits (143), Expect = 3e-09
 Identities = 43/153 (28%), Positives = 73/153 (47%), Gaps = 15/153 (9%)

Query: 447 NFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSP 506
           +FT  +  G+ +L SK  +HRD+   N+L+    +VK+ DFG+A+ +      +S KGS 
Sbjct: 241 SFTYQVARGMEFLASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVS-KGST 299

Query: 507 Y----WMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFKV 561
           +    WMAPE +   +    S       D+WS G  + E+++ G  P+      +  +  
Sbjct: 300 FLPVKWMAPESIFDNLYTTLS-------DVWSYGILLWEIFSLGGTPYPGMIVDSTFYNK 352

Query: 562 MRD--TPAIPDSLSPEGKDFLRCCFQRNPADRP 592
           ++     A PD  + E  D +  C+   P  RP
Sbjct: 353 IKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRP 385

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 58.6 bits (141), Expect = 5e-09
 Identities = 35/101 (34%), Positives = 55/101 (54%), Gaps = 17/101 (16%)

Query: 451 HILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSP---- 506
            +L G+ +LHS   IHRD+K +N++V +   +K+ DFG+A+      A  S   +P    
Sbjct: 127 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR-----TAGTSFMMTPYVVT 181

Query: 507 -YWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGK 546
            Y+ APE+++ +  K         VDIWS+GC + EM   K
Sbjct: 182 RYYRAPEVILGMGYKEN-------VDIWSVGCIMGEMVRHK 215

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 56.5 bits (136), Expect = 2e-08
 Identities = 48/165 (29%), Positives = 70/165 (42%), Gaps = 11/165 (6%)

Query: 392 EIKVLSHLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRH 451
           E  +L  + HP+I+Q  G+    +KF   +   +   +  Y+      I    +    R 
Sbjct: 133 EAHILRAINHPSIIQLKGT-FTYNKFTCLILPRYKTDLYCYLAAK-RNIAICDILAIERS 190

Query: 452 ILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKAD--LSMKGSPYWM 509
           +L  + YLH  + IHRDIK  N+ ++  G V L DFG A       A+      G+    
Sbjct: 191 VLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGWAGTIATN 250

Query: 510 APELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEG 554
           APEL+              AVDIWS G  + EM T      E +G
Sbjct: 251 APELL-------ARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDG 288

Length = 391

>gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional

 Score = 54.2 bits (130), Expect = 8e-08
 Identities = 54/241 (22%), Positives = 98/241 (40%), Gaps = 24/241 (9%)

Query: 341 QWQKGKLIGRGTFGSVYVASNRETGALC--AMKEVDIFPDDPKSAESIK----------Q 388
           +W+  KLIG G FG VY         +   A+ +++   ++    E++            
Sbjct: 13  EWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIA 72

Query: 389 LEQEIKVLSHLKHPNIVQYYG-SEIVEDKFY---IYLEYVHPGSINKYVREHCGAITESV 444
           L + I  + HL  P   +YYG       + Y   I LE +   +   + R  C    + +
Sbjct: 73  LWKNIHNIDHLGIP---KYYGCGSFKRCRMYYRFILLEKLVENTKEIFKRIKC--KNKKL 127

Query: 445 VRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKH--LTGQKADLSM 502
           ++N  + +L+ L Y+H     H DIK  N++VD +    + D+G+A H  + G+  + S 
Sbjct: 128 IKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGYIIDYGIASHFIIHGKHIEYS- 186

Query: 503 KGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVM 562
           K         L  A +     +      D+ SLG  +++    K PW  +     +    
Sbjct: 187 KEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHAA 246

Query: 563 R 563
           +
Sbjct: 247 K 247

Length = 294

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 53.9 bits (129), Expect = 9e-08
 Identities = 56/248 (22%), Positives = 95/248 (38%), Gaps = 39/248 (15%)

Query: 377 PDDPKSAESIKQLE------------QEIKVLSHLKHPNIVQYYGSEIVEDKFYIYLEYV 424
           P +   A +IK L+             E  + S L+HPNIV   G    E    +   Y 
Sbjct: 31  PGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYC 90

Query: 425 HPGSINKYV---------------REHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDI 469
               +++++               +     +  +   +    I +G+ +L S   +H+D+
Sbjct: 91  SHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDL 150

Query: 470 KGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPY---WMAPELMMAVMQKGKSSDS 526
              N+LV     VK++D G+ + +        M  S     WM+PE   A+M    S DS
Sbjct: 151 ATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPE---AIMYGKFSIDS 207

Query: 527 ALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFKVM-RDTPAIPDSLSPEGKDFLRCCF 584
               DIWS G  + E+++ G  P+  Y     +  +  R     PD         +  C+
Sbjct: 208 ----DIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIRNRQVLPCPDDCPAWVYTLMLECW 263

Query: 585 QRNPADRP 592
              P+ RP
Sbjct: 264 NEFPSRRP 271

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 54.3 bits (130), Expect = 1e-07
 Identities = 44/168 (26%), Positives = 73/168 (43%), Gaps = 28/168 (16%)

Query: 388 QLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYIYL----------EYVHPGSINKYVREHC 437
           QLE EI  L  L H NI++    EI+  +   Y+           +++  + +   R   
Sbjct: 209 QLENEILALGRLNHENILKI--EEILRSEANTYMITQKYDFDLYSFMYDEAFDWKDRPLL 266

Query: 438 GAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQK 497
                   R   + +L  + Y+H KK IHRDIK  N+ ++  G + L DFG A     ++
Sbjct: 267 KQ-----TRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKER 321

Query: 498 A--DLSMKGSPYWMAPELMMAVMQKGKSSDSALAV-DIWSLGCTIIEM 542
              D    G+    +PE++        + D    + DIWS G  +++M
Sbjct: 322 EAFDYGWVGTVATNSPEIL--------AGDGYCEITDIWSCGLILLDM 361

Length = 501

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 51.4 bits (123), Expect = 1e-06
 Identities = 45/170 (26%), Positives = 65/170 (38%), Gaps = 34/170 (20%)

Query: 387 KQLEQEIKVLSHLKHPNIVQ----YYGSEIV-------EDKFYIYLEYVHPGSINKYVRE 435
           K   +EI +L  + H  I+     Y     V       +   + Y++   P  + +    
Sbjct: 131 KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMPKYKCDLFTYVDRSGPLPLEQ---- 186

Query: 436 HCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTG 495
              AIT        R +L  LAYLH +  IHRD+K  N+ +D      L DFG A  L  
Sbjct: 187 ---AIT------IQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDA 237

Query: 496 ---QKADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEM 542
                      G+    +PEL+       K+       DIWS G  + EM
Sbjct: 238 HPDTPQCYGWSGTLETNSPELLALDPYCAKT-------DIWSAGLVLFEM 280

Length = 392

>gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 50.3 bits (120), Expect = 1e-06
 Identities = 58/261 (22%), Positives = 106/261 (40%), Gaps = 27/261 (10%)

Query: 348 IGRGTFGSVYVA-----SNRETGALCAMKEVDIFPD--DPKSAESIKQLEQEIKVLSHLK 400
           +GRGT   +Y        + E       KE+ +     DP   +      +   ++  + 
Sbjct: 3   LGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVS 62

Query: 401 HPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLH 460
           H +IV  YG  + + +  +  E+V  G ++ ++      +T        + + S L+YL 
Sbjct: 63  HKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLE 122

Query: 461 SKKTIHRDIKGANLLVDASGV-------VKLADFGMAKHLTGQKADLSMKGSPYWMAPEL 513
            K  +H ++   N+L+   G+       +KL+D G+   +T       ++  P W+APE 
Sbjct: 123 DKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIP--ITVLSRQECVERIP-WIAPEC 179

Query: 514 MMAVMQKGKSSDSALAVDIWSLGCTIIEM-YTGKPPWSEYEGA-AAMFKVMRDTPAIPDS 571
           +        S + ++A D WS G T+ E+ Y G+ P  +   A    F   +     P  
Sbjct: 180 VE------DSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKERFYEGQCMLVTPS- 232

Query: 572 LSPEGKDFLRCCFQRNPADRP 592
              E  D +  C   +P  RP
Sbjct: 233 -CKELADLMTHCMNYDPNQRP 252

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262

>gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional

 Score = 48.9 bits (116), Expect = 7e-06
 Identities = 23/48 (47%), Positives = 30/48 (62%)

Query: 443 SVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMA 490
           +V++   R +L+GL  LH    +HRDIK  NLLV   G VK+ DFG A
Sbjct: 309 NVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAA 356

Length = 507

>gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 47.2 bits (112), Expect = 1e-05
 Identities = 43/206 (20%), Positives = 89/206 (43%), Gaps = 18/206 (8%)

Query: 395 VLSHLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILS 454
           ++S + H ++   +G  +   +  +  E+V  G ++  +R+  G +  +      + + S
Sbjct: 69  LMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLAS 128

Query: 455 GLAYLHSKKTIHRDIKGANLLVDASGV-------VKLADFGMAKHLTGQKADLSMKGSPY 507
            L+YL  K  +H ++   N+L+   G+       +KL+D G++   T    +  ++  P 
Sbjct: 129 ALSYLEDKNLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVS--FTALSREERVERIP- 185

Query: 508 WMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEM-YTGKPPWSEYEGAAAMFKVMRDTP 566
           W+APE +         +  + A D WS G T++E+ + G+ P  E    +   +      
Sbjct: 186 WIAPECVPGG------NSLSTAADKWSFGTTLLEICFDGEVPLKE-RTPSEKERFYEKKH 238

Query: 567 AIPDSLSPEGKDFLRCCFQRNPADRP 592
            +P+    E    +  C    P  RP
Sbjct: 239 RLPEPSCKELATLISQCLTYEPTQRP 264

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 46.0 bits (109), Expect = 5e-05
 Identities = 32/96 (33%), Positives = 45/96 (46%), Gaps = 10/96 (10%)

Query: 449 TRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKAD---LSMKGS 505
            R +LS + Y+H +  IHRDIK  N+LV+    + L DFG A    G  +      + G+
Sbjct: 266 ARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGT 325

Query: 506 PYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIE 541
               APE++              +VDIWS G  I E
Sbjct: 326 VDTNAPEVLAG-------DPYTPSVDIWSAGLVIFE 354

Length = 461

>gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

 Score = 40.1 bits (94), Expect = 9e-04
 Identities = 24/127 (18%), Positives = 48/127 (37%), Gaps = 24/127 (18%)

Query: 387 KQLEQEIKVLSHL-KHPNIV-QYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESV 444
              E+E+ +L  L +    V +   S   +   Y+ +E++   ++++   E    I E +
Sbjct: 36  ADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGETLDEVSEEEKEDIAEQL 95

Query: 445 VRNFTRHILSGLAYLHSKKT---IHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLS 501
                      LA LH        H D+   N+LVD   ++ + D+           + +
Sbjct: 96  AEL--------LAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDW-----------EYA 136

Query: 502 MKGSPYW 508
             G P +
Sbjct: 137 GYGPPAF 143

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155

>gnl|CDD|236586 PRK09605, PRK09605, bifunctional UGMP family protein/serine/threonine protein kinase; Validated

 Score = 41.8 bits (99), Expect = 0.001
 Identities = 21/78 (26%), Positives = 34/78 (43%), Gaps = 10/78 (12%)

Query: 415 DKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANL 474
           ++  I +EY+  G   K V E        +VR     +    A LH    +H D+  +N 
Sbjct: 409 EEKTIVMEYIG-GKDLKDVLEG----NPELVRKVGEIV----AKLHKAGIVHGDLTTSNF 459

Query: 475 LVDASGVVKLADFGMAKH 492
           +V    +  L DFG+ K+
Sbjct: 460 IVRDDRLY-LIDFGLGKY 476

Length = 535

>gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional

 Score = 40.9 bits (96), Expect = 0.002
 Identities = 19/51 (37%), Positives = 27/51 (52%), Gaps = 1/51 (1%)

Query: 444 VVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVD-ASGVVKLADFGMAKHL 493
           +++   R IL  L  LHS   +HRD+K  N++    SG  K+ D G A  L
Sbjct: 256 IIQTIMRQILFALDGLHSTGIVHRDVKPQNIIFSEGSGSFKIIDLGAAADL 306

Length = 566

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 40.0 bits (93), Expect = 0.004
 Identities = 32/113 (28%), Positives = 52/113 (46%), Gaps = 9/113 (7%)

Query: 333 PEPLPMNSQWQ-------KGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAES 385
           P  LP +S+W+        G+++G G FG V   +         + +V +    P +  S
Sbjct: 23  PMQLPYDSRWEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSS 82

Query: 386 IKQ-LEQEIKVLSHL-KHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREH 436
            KQ L  E+K+++HL  H NIV   G+       YI  EY   G +  Y+ ++
Sbjct: 83  EKQALMSELKIMTHLGPHLNIVNLLGACTKSGPIYIITEYCFYGDLVNYLHKN 135

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	721
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
KOG0696	683	consensus Serine/threonine protein kinase [Signal	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	100.0
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	100.0
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
KOG0695	593	consensus Serine/threonine protein kinase [Signal	100.0
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	100.0
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	100.0
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	100.0
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	100.0
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	100.0
PLN03224	507	probable serine/threonine protein kinase; Provisio	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	100.0
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	100.0
KOG0576	829	consensus Mitogen-activated protein kinase kinase	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	100.0
KOG1290	590	consensus Serine/threonine protein kinase [Signal	100.0
KOG1027	903	consensus Serine/threonine protein kinase and endo	100.0
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.98
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	99.98
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	99.98
KOG1152	772	consensus Signal transduction serine/threonine kin	99.97
KOG3653	534	consensus Transforming growth factor beta/activin	99.97
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.97
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.97
KOG2052	513	consensus Activin A type IB receptor, serine/threo	99.97
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.97
PLN00181	793	protein SPA1-RELATED; Provisional	99.96
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	99.96
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.95
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.95
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.94
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.94
PRK09188	365	serine/threonine protein kinase; Provisional	99.93
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.93
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.92
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.91
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.89
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.88
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.88
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.88
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.87
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.87
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.87
PRK12274	218	serine/threonine protein kinase; Provisional	99.86
PRK10345	210	hypothetical protein; Provisional	99.83
smart00090	237	RIO RIO-like kinase.	99.81
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.8
PRK14879	211	serine/threonine protein kinase; Provisional	99.8
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.78
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.77
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.76
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.76
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.76
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.76
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.74
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.71
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.68
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.66
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.63
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.53
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.5
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.47
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.41
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.41
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.41
KOG1243	690	consensus Protein kinase [General function predict	99.39
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.39
KOG3087	229	consensus Serine/threonine protein kinase [General	99.22
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.19
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.19
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	99.07
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	99.03
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	98.98
KOG2137	700	consensus Protein kinase [Signal transduction mech	98.92
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.86
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.72
COG4248	637	Uncharacterized protein with protein kinase and he	98.6
PRK09902	216	hypothetical protein; Provisional	98.59
KOG0576	829	consensus Mitogen-activated protein kinase kinase	98.51
PF01636	239	APH: Phosphotransferase enzyme family This family	98.47
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	98.47
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.46
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.42
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.34
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.29
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.18
KOG1235	538	consensus Predicted unusual protein kinase [Genera	98.16
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	98.14
PLN02876	822	acyl-CoA dehydrogenase	98.01
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	97.94
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	97.88
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	97.86
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	97.8
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	97.74
PRK09550	401	mtnK methylthioribose kinase; Reviewed	97.57
PRK10593	297	hypothetical protein; Provisional	97.54
KOG2268	465	consensus Serine/threonine protein kinase [Signal	97.52
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	97.49
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	97.44
KOG2270	520	consensus Serine/threonine protein kinase involved	97.39
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	97.28
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	97.24
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	97.22
PRK05231	319	homoserine kinase; Provisional	97.2
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	96.99
KOG1093	725	consensus Predicted protein kinase (contains TBC a	96.87
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	96.71
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	96.68
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	96.66
PLN02236	344	choline kinase	96.49
PRK12396	409	5-methylribose kinase; Reviewed	96.21
PLN02756	418	S-methyl-5-thioribose kinase	96.19
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	96.18
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	96.16
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	95.99
PRK06148	1013	hypothetical protein; Provisional	95.47
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	95.3
PRK11768	325	serine/threonine protein kinase; Provisional	94.93
PTZ00384	383	choline kinase; Provisional	94.82
PF02958	294	EcKinase: Ecdysteroid kinase; InterPro: IPR004119	94.36
KOG1236	565	consensus Predicted unusual protein kinase [Genera	93.96
PTZ00296	442	choline kinase; Provisional	93.83
PF07387	308	Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099	93.05
COG3001	286	Uncharacterized protein conserved in bacteria [Fun	91.64

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.7e-57  Score=482.22  Aligned_cols=268  Identities=30%  Similarity=0.475  Sum_probs=232.6

Q ss_pred             CCCCCCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCccc--HHHHHHHHHHHHHHHhCCCCCeeeeeeeEEe
Q 004959          336 LPMNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKS--AESIKQLEQEIKVLSHLKHPNIVQYYGSEIV  413 (721)
Q Consensus       336 ~~l~~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~--~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~  413 (721)
                      ..+.+.|.+.+.||.|+||.|-+|..+.||+.||||++++.+.....  ......+.+|++||++|+|||||+++++|+.
T Consensus       168 ks~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~  247 (475)
T KOG0615|consen  168 KSFNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEV  247 (475)
T ss_pred             chhcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeec
Confidence            34678899999999999999999999999999999999764433222  1223446799999999999999999999999


Q ss_pred             cCeEEEEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCC---CceEEeecCCc
Q 004959          414 EDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDAS---GVVKLADFGMA  490 (721)
Q Consensus       414 ~~~~yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~---g~VKL~DFGlA  490 (721)
                      .+..|+||||++||+|++.+..+ +.+.|...+.+++||+.||.|||++||+||||||+|||+..+   ..+||+|||+|
T Consensus       248 ~ds~YmVlE~v~GGeLfd~vv~n-k~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlA  326 (475)
T KOG0615|consen  248 PDSSYMVLEYVEGGELFDKVVAN-KYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLA  326 (475)
T ss_pred             CCceEEEEEEecCccHHHHHHhc-cccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchh
Confidence            99999999999999999999876 789999999999999999999999999999999999999765   68999999999


Q ss_pred             cccCCCcccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHH-HHHHHhhcCC---
Q 004959          491 KHLTGQKADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAA-AMFKVMRDTP---  566 (721)
Q Consensus       491 ~~l~~~~~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~-~~~ki~~~~~---  566 (721)
                      +.......+.++||||.|.|||++....    ...+..++|||||||+||.+|+|.+||.+..... ...+|.++..   
T Consensus       327 K~~g~~sfm~TlCGTpsYvAPEVl~~kg----~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~  402 (475)
T KOG0615|consen  327 KVSGEGSFMKTLCGTPSYVAPEVLASKG----VEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAFG  402 (475)
T ss_pred             hccccceehhhhcCCccccChhheecCC----eecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCccccc
Confidence            9888777788999999999999996532    1223348999999999999999999998865555 5666666643   


Q ss_pred             -CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhccccccCCC
Q 004959          567 -AIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQ  608 (721)
Q Consensus       567 -~~p~~lS~el~dLI~~cL~~DP~kRPSa~eLL~Hp~f~~~~~  608 (721)
                       ..+..+++++++||.+||..||++|||++|+|+||||+....
T Consensus       403 p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~~~  445 (475)
T KOG0615|consen  403 PLQWDRISEEALDLINWMLVVDPENRPSADEALNHPWFKDAPC  445 (475)
T ss_pred             ChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhcccc
Confidence             344679999999999999999999999999999999997654

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=9.1e-55  Score=482.06  Aligned_cols=262  Identities=34%  Similarity=0.616  Sum_probs=242.7

Q ss_pred             CCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeEEE
Q 004959          340 SQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYI  419 (721)
Q Consensus       340 ~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~yL  419 (721)
                      ..|..+++||+|||+.||++++..+|+.||+|+|.+.  ........+.+.+||+|.+.|+|||||+++++|++.+.+||
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~--~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYi   95 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKK--LLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYI   95 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehH--HhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEE
Confidence            4799999999999999999999999999999999742  23344567889999999999999999999999999999999


Q ss_pred             EEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCC-cc
Q 004959          420 YLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQ-KA  498 (721)
Q Consensus       420 VmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~-~~  498 (721)
                      |+|+|..++|..+++. .+.++|.+++.|++||+.||.|||+++|||||||..|||++++.+|||+|||||..+... +.
T Consensus        96 vLELC~~~sL~el~Kr-rk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~Er  174 (592)
T KOG0575|consen   96 VLELCHRGSLMELLKR-RKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDGER  174 (592)
T ss_pred             EEEecCCccHHHHHHh-cCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceeeeecCcccc
Confidence            9999999999999984 489999999999999999999999999999999999999999999999999999998754 67


Q ss_pred             cccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhcCCCCCCCCCHHHHH
Q 004959          499 DLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDSLSPEGKD  578 (721)
Q Consensus       499 ~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~~~~~p~~lS~el~d  578 (721)
                      ..+.||||.|+|||++.       ....+..+||||+|||||.||.|++||....-.+.+.+|......+|..+|.++++
T Consensus       175 k~TlCGTPNYIAPEVl~-------k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y~~P~~ls~~A~d  247 (592)
T KOG0575|consen  175 KKTLCGTPNYIAPEVLN-------KSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEYSMPSHLSAEAKD  247 (592)
T ss_pred             cceecCCCcccChhHhc-------cCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCcccccccCHHHHH
Confidence            78999999999999995       34567789999999999999999999999999999999999999999999999999


Q ss_pred             HHHHhcccCCCCCCCHHHHHhccccccCCCCCC
Q 004959          579 FLRCCFQRNPADRPPASLLLEHRFLKNSQQPDV  611 (721)
Q Consensus       579 LI~~cL~~DP~kRPSa~eLL~Hp~f~~~~~~~~  611 (721)
                      ||.+||+.||.+|||++++|.|+||+....+..
T Consensus       248 LI~~lL~~~P~~Rpsl~~vL~h~Ff~~g~~p~~  280 (592)
T KOG0575|consen  248 LIRKLLRPNPSERPSLDEVLDHPFFKSGFTPAR  280 (592)
T ss_pred             HHHHHhcCCcccCCCHHHHhcCHhhhCCCcCCC
Confidence            999999999999999999999999977766644

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=1e-53  Score=451.88  Aligned_cols=259  Identities=33%  Similarity=0.650  Sum_probs=233.2

Q ss_pred             CCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecC-eEE
Q 004959          340 SQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVED-KFY  418 (721)
Q Consensus       340 ~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~-~~y  418 (721)
                      ++.+.++.||+|..|+||+|+|+.|++.+|+|+|..    .......+++.+|+++++.++||+||.+||.|.... .++
T Consensus        79 ~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~----~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~is  154 (364)
T KOG0581|consen   79 SDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILL----NIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEIS  154 (364)
T ss_pred             HHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecc----cCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEE
Confidence            467888999999999999999999999999999942    234556789999999999999999999999999998 599


Q ss_pred             EEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhh-CCeeccCCCCCcEEEcCCCceEEeecCCccccCCCc
Q 004959          419 IYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHS-KKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQK  497 (721)
Q Consensus       419 LVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs-~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~~  497 (721)
                      |+||||+||+|.+++... +.++|..+..++.||++||.|||+ ++||||||||+||||+..|+|||||||.+..+.+. 
T Consensus       155 I~mEYMDgGSLd~~~k~~-g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS-  232 (364)
T KOG0581|consen  155 ICMEYMDGGSLDDILKRV-GRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS-  232 (364)
T ss_pred             eehhhcCCCCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHHhhhh-
Confidence            999999999999999775 889999999999999999999995 99999999999999999999999999999988766 


Q ss_pred             ccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCch-----hhHHHHHHHhh-cCCCCCCC
Q 004959          498 ADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEY-----EGAAAMFKVMR-DTPAIPDS  571 (721)
Q Consensus       498 ~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~-----~~~~~~~ki~~-~~~~~p~~  571 (721)
                      ...+++||..|||||.+.       +..|+.++||||||+.++||++|+.||...     ...+.+..|.. ..+.+|..
T Consensus       233 ~a~tfvGT~~YMsPERi~-------g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~lP~~  305 (364)
T KOG0581|consen  233 IANTFVGTSAYMSPERIS-------GESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPRLPEG  305 (364)
T ss_pred             hcccccccccccChhhhc-------CCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCCCCcc
Confidence            446889999999999995       456777799999999999999999999764     56677777777 45678886


Q ss_pred             -CCHHHHHHHHHhcccCCCCCCCHHHHHhccccccCCCCCC
Q 004959          572 -LSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQPDV  611 (721)
Q Consensus       572 -lS~el~dLI~~cL~~DP~kRPSa~eLL~Hp~f~~~~~~~~  611 (721)
                       +|+|+++||.+||++||.+|+++.|||+|||+++...+++
T Consensus       306 ~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~~~~~v  346 (364)
T KOG0581|consen  306 EFSPEFRSFVSCCLRKDPSERPSAKQLLQHPFIKKFEDPNV  346 (364)
T ss_pred             cCCHHHHHHHHHHhcCCcccCCCHHHHhcCHHHhhcccccc
Confidence             9999999999999999999999999999999998765544

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=8.6e-53  Score=444.77  Aligned_cols=259  Identities=34%  Similarity=0.568  Sum_probs=235.1

Q ss_pred             CCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeEEE
Q 004959          340 SQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYI  419 (721)
Q Consensus       340 ~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~yL  419 (721)
                      ++|+++++||+|+||+||+++.++|++.||+|++++..  .......+....|..||..++||+||.++-.|++.+.+||
T Consensus        25 ~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~--iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLyl  102 (357)
T KOG0598|consen   25 DDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKK--IVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYL  102 (357)
T ss_pred             hheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhH--hhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEE
Confidence            58999999999999999999999999999999987532  2223457788999999999999999999999999999999


Q ss_pred             EEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCcccc-CCCcc
Q 004959          420 YLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHL-TGQKA  498 (721)
Q Consensus       420 VmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l-~~~~~  498 (721)
                      |+||+.||+|+..|.+. +.++|..++.|+..|+.||.|||++|||||||||||||+|.+|+|+|+||||++.. ..+..
T Consensus       103 Vld~~~GGeLf~hL~~e-g~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~~~  181 (357)
T KOG0598|consen  103 VLDYLNGGELFYHLQRE-GRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDGDA  181 (357)
T ss_pred             EEeccCCccHHHHHHhc-CCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccchhcccCCCc
Confidence            99999999999999765 88999999999999999999999999999999999999999999999999999954 44556


Q ss_pred             cccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhcC-CCCCCCCCHHHH
Q 004959          499 DLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDT-PAIPDSLSPEGK  577 (721)
Q Consensus       499 ~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~~-~~~p~~lS~el~  577 (721)
                      ..++|||+.|||||++.+       ..|+.++|+|||||+||||++|.+||.+.+....+.++.++. ...|..++.+++
T Consensus       182 t~tfcGT~eYmAPEil~~-------~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~~~~p~~ls~~ar  254 (357)
T KOG0598|consen  182 TRTFCGTPEYMAPEILLG-------KGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKLPLPPGYLSEEAR  254 (357)
T ss_pred             cccccCCccccChHHHhc-------CCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcCCCCCccCCHHHH
Confidence            677999999999999964       467788999999999999999999999999999999999988 555566999999


Q ss_pred             HHHHHhcccCCCCCC----CHHHHHhccccccCCC
Q 004959          578 DFLRCCFQRNPADRP----PASLLLEHRFLKNSQQ  608 (721)
Q Consensus       578 dLI~~cL~~DP~kRP----Sa~eLL~Hp~f~~~~~  608 (721)
                      +||+++|++||++|.    .+++|-+||||....-
T Consensus       255 dll~~LL~rdp~~RLg~~~d~~~ik~HpfF~~inW  289 (357)
T KOG0598|consen  255 DLLKKLLKRDPRQRLGGPGDAEEIKRHPFFKGINW  289 (357)
T ss_pred             HHHHHHhccCHHHhcCCCCChHHhhcCcccccCCH
Confidence            999999999999995    7999999999987543

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-51  Score=439.75  Aligned_cols=261  Identities=32%  Similarity=0.599  Sum_probs=235.1

Q ss_pred             CCCCCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCe
Q 004959          337 PMNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDK  416 (721)
Q Consensus       337 ~l~~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~  416 (721)
                      ...++|.+.+.||+|+||+||+|+++.++..||||.|.+.+   ......+.+..||+||+.++|||||.+++++...+.
T Consensus         7 ~~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~---l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~   83 (429)
T KOG0595|consen    7 RVVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKK---LNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDF   83 (429)
T ss_pred             cccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhc---cCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCe
Confidence            34568999999999999999999999999999999997532   245667889999999999999999999999999999


Q ss_pred             EEEEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCC------CceEEeecCCc
Q 004959          417 FYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDAS------GVVKLADFGMA  490 (721)
Q Consensus       417 ~yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~------g~VKL~DFGlA  490 (721)
                      +|||||||.||+|.+||+.+ +.++|..++.++.||+.||++||+++||||||||+||||+..      -.+||+|||+|
T Consensus        84 i~lVMEyC~gGDLs~yi~~~-~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfA  162 (429)
T KOG0595|consen   84 IYLVMEYCNGGDLSDYIRRR-GRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFA  162 (429)
T ss_pred             EEEEEEeCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchh
Confidence            99999999999999999876 789999999999999999999999999999999999999764      35899999999


Q ss_pred             cccCCCcccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhcC---CC
Q 004959          491 KHLTGQKADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDT---PA  567 (721)
Q Consensus       491 ~~l~~~~~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~~---~~  567 (721)
                      +.+.......+.||+|.|||||+++       ...|+.|+|+||+|+|||+|++|+.||......+.+..+.++.   +.
T Consensus       163 R~L~~~~~a~tlcGSplYMAPEV~~-------~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~~~~  235 (429)
T KOG0595|consen  163 RFLQPGSMAETLCGSPLYMAPEVIM-------SQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEIVPV  235 (429)
T ss_pred             hhCCchhHHHHhhCCccccCHHHHH-------hccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccccccCc
Confidence            9999888888999999999999996       3567778999999999999999999999888888777666553   44


Q ss_pred             CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhccccccCCC
Q 004959          568 IPDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQ  608 (721)
Q Consensus       568 ~p~~lS~el~dLI~~cL~~DP~kRPSa~eLL~Hp~f~~~~~  608 (721)
                      ++..++.++.+++...|++|+.+|.+..+.+.|+++.....
T Consensus       236 ~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~~~~~l~~~p~  276 (429)
T KOG0595|consen  236 LPAELSNPLRELLISLLQRNPKDRISFEDFFDHPFLAANPQ  276 (429)
T ss_pred             hhhhccCchhhhhhHHHhcCccccCchHHhhhhhhcccCcc
Confidence            56678899999999999999999999999999999876553

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.2e-52  Score=454.57  Aligned_cols=263  Identities=30%  Similarity=0.519  Sum_probs=237.6

Q ss_pred             CCCCCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCC-CCCeeeeeeeEEecC
Q 004959          337 PMNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLK-HPNIVQYYGSEIVED  415 (721)
Q Consensus       337 ~l~~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~-HPnIV~l~g~~~~~~  415 (721)
                      ...+.|.+++.||+|+||+||+|.+..+|+.||+|++.............+.+.+|+.+|+++. ||||+++++++....
T Consensus        14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~   93 (370)
T KOG0583|consen   14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT   93 (370)
T ss_pred             cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence            3457899999999999999999999999999999977643211111234567779999999999 999999999999999


Q ss_pred             eEEEEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCC-CceEEeecCCcccc-
Q 004959          416 KFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDAS-GVVKLADFGMAKHL-  493 (721)
Q Consensus       416 ~~yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~-g~VKL~DFGlA~~l-  493 (721)
                      .+|+|||||.||+|++++.+ .+++.|.+++.+++||++||+|||++||+||||||||||++.+ +++||+|||++... 
T Consensus        94 ~~~ivmEy~~gGdL~~~i~~-~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~  172 (370)
T KOG0583|consen   94 KIYIVMEYCSGGDLFDYIVN-KGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLSAISP  172 (370)
T ss_pred             eEEEEEEecCCccHHHHHHH-cCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEeccccccccC
Confidence            99999999999999999988 6899999999999999999999999999999999999999999 99999999999988 


Q ss_pred             CCCcccccCCCCCccCChhhHHHHh-hcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhcCCCCCCCC
Q 004959          494 TGQKADLSMKGSPYWMAPELMMAVM-QKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDSL  572 (721)
Q Consensus       494 ~~~~~~~s~~GT~~Y~APEvl~~~~-~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~~~~~p~~l  572 (721)
                      .......+.|||+.|+|||++.+.. |.      ..++||||+||+||.|++|+.||.+.+....+.++......+|..+
T Consensus       173 ~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~------g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~~~~~p~~~  246 (370)
T KOG0583|consen  173 GEDGLLKTFCGSPAYAAPEVLSGKGTYS------GKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKGEFKIPSYL  246 (370)
T ss_pred             CCCCcccCCCCCcccCCHHHhCCCCCcC------CchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcCCccCCCCc
Confidence            4556667899999999999997643 33      3579999999999999999999999888888999999999999999


Q ss_pred             -CHHHHHHHHHhcccCCCCCCCHHHHHhccccccC
Q 004959          573 -SPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNS  606 (721)
Q Consensus       573 -S~el~dLI~~cL~~DP~kRPSa~eLL~Hp~f~~~  606 (721)
                       |.++++||.+||..||.+|+++.+++.||||+..
T Consensus       247 ~S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~~  281 (370)
T KOG0583|consen  247 LSPEARSLIEKMLVPDPSTRITLLEILEHPWFQKE  281 (370)
T ss_pred             CCHHHHHHHHHHcCCCcccCCCHHHHhhChhhccC
Confidence             9999999999999999999999999999999973

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-51  Score=451.32  Aligned_cols=261  Identities=29%  Similarity=0.556  Sum_probs=236.1

Q ss_pred             CCCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhC-CCCCeeeeeeeEEecCeE
Q 004959          339 NSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHL-KHPNIVQYYGSEIVEDKF  417 (721)
Q Consensus       339 ~~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L-~HPnIV~l~g~~~~~~~~  417 (721)
                      ..+|..++.||+|+|++||+|+++.+++.||||++.+.  .......++.+..|-.+|.+| .||.||+|+-.|.++..+
T Consensus        72 ~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~--~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sL  149 (604)
T KOG0592|consen   72 PNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKR--YIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESL  149 (604)
T ss_pred             hhhcchhheeccccceeEEEeeecCCCceeeHhhhhHH--HHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccce
Confidence            36899999999999999999999999999999998642  222223356778888999999 799999999999999999


Q ss_pred             EEEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCCc
Q 004959          418 YIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQK  497 (721)
Q Consensus       418 yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~~  497 (721)
                      |+||||+++|+|.++|.+. +.|+|..++.|+.||+.||+|||++|||||||||||||||.+|.|||+|||.|+.+....
T Consensus       150 YFvLe~A~nGdll~~i~K~-Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~~  228 (604)
T KOG0592|consen  150 YFVLEYAPNGDLLDLIKKY-GSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKILSPSQ  228 (604)
T ss_pred             EEEEEecCCCcHHHHHHHh-CcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeeccccccCChhh
Confidence            9999999999999999876 899999999999999999999999999999999999999999999999999999875422


Q ss_pred             cc--------------ccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhh
Q 004959          498 AD--------------LSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMR  563 (721)
Q Consensus       498 ~~--------------~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~  563 (721)
                      ..              .+++||..|.+||+|.       ....+..+|||+||||||+|+.|.+||.+.+....+.+|+.
T Consensus       229 ~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~-------~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~  301 (604)
T KOG0592|consen  229 KSQENPVDPNQASSRRSSFVGTAEYVSPELLN-------DSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQA  301 (604)
T ss_pred             ccccCccCcccccCcccceeeeecccCHHHhc-------CCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHH
Confidence            11              3588999999999994       45566789999999999999999999999999999999999


Q ss_pred             cCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhccccccCCCC
Q 004959          564 DTPAIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQP  609 (721)
Q Consensus       564 ~~~~~p~~lS~el~dLI~~cL~~DP~kRPSa~eLL~Hp~f~~~~~~  609 (721)
                      ....+|..++++++|||+++|..||.+|+|++||.+||||.+....
T Consensus       302 l~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~Vdw~  347 (604)
T KOG0592|consen  302 LDYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEGVDWE  347 (604)
T ss_pred             hcccCCCCCCHHHHHHHHHHHccCccccccHHHHhhCcccccCChh
Confidence            9999999999999999999999999999999999999999876644

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.5e-52  Score=462.70  Aligned_cols=262  Identities=32%  Similarity=0.555  Sum_probs=243.6

Q ss_pred             CCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeEEE
Q 004959          340 SQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYI  419 (721)
Q Consensus       340 ~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~yL  419 (721)
                      +-|++++-||.|+-|.|-+|++..||+.+|||+|.+..  .........+++||.||+.+.||||+++|+++++..++|+
T Consensus        12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~--~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lyl   89 (786)
T KOG0588|consen   12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRS--ELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYL   89 (786)
T ss_pred             cceeccccccCCCCceehhhhcccccceeEEEeecccc--ccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEE
Confidence            57999999999999999999999999999999997543  2223345678999999999999999999999999999999


Q ss_pred             EEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCCccc
Q 004959          420 YLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKAD  499 (721)
Q Consensus       420 VmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~~~~  499 (721)
                      |+||++||.|++++..+ |.++|.++..+++||+.||.|||..+|+||||||||+|+|..++|||+|||+|..-.++...
T Consensus        90 vlEyv~gGELFdylv~k-G~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gklL  168 (786)
T KOG0588|consen   90 VLEYVPGGELFDYLVRK-GPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMASLEVPGKLL  168 (786)
T ss_pred             EEEecCCchhHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceeecccCCccc
Confidence            99999999999999876 89999999999999999999999999999999999999999999999999999987777788


Q ss_pred             ccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhcCCCCCCCCCHHHHHH
Q 004959          500 LSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDSLSPEGKDF  579 (721)
Q Consensus       500 ~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~~~~~p~~lS~el~dL  579 (721)
                      .+.||+|.|.|||+++|..|.+.      ++||||+|||||.||+|++||++.+....+.++.++....|..++.++++|
T Consensus       169 eTSCGSPHYA~PEIV~G~pYdG~------~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~f~MPs~Is~eaQdL  242 (786)
T KOG0588|consen  169 ETSCGSPHYAAPEIVSGRPYDGR------PSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGVFEMPSNISSEAQDL  242 (786)
T ss_pred             cccCCCcccCCchhhcCCCCCCC------ccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCcccCCCcCCHHHHHH
Confidence            89999999999999998777664      689999999999999999999999889999999999999999999999999


Q ss_pred             HHHhcccCCCCCCCHHHHHhccccccCCCCC
Q 004959          580 LRCCFQRNPADRPPASLLLEHRFLKNSQQPD  610 (721)
Q Consensus       580 I~~cL~~DP~kRPSa~eLL~Hp~f~~~~~~~  610 (721)
                      |.+||..||++|+|.+||++|||+.+.....
T Consensus       243 Lr~ml~VDp~~RiT~~eI~kHP~l~g~~~~~  273 (786)
T KOG0588|consen  243 LRRMLDVDPSTRITTEEILKHPFLSGYTSLP  273 (786)
T ss_pred             HHHHhccCccccccHHHHhhCchhhcCCCCC
Confidence            9999999999999999999999998766543

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=6.2e-52  Score=427.02  Aligned_cols=256  Identities=27%  Similarity=0.535  Sum_probs=224.4

Q ss_pred             CCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeEEE
Q 004959          340 SQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYI  419 (721)
Q Consensus       340 ~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~yL  419 (721)
                      +.|+.+..+|+|+||+||+|+++.||+.||||++-   ....+....+..++||++|++|+|+|+|.++++|.....++|
T Consensus         2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~---Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhL   78 (396)
T KOG0593|consen    2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFV---ESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHL   78 (396)
T ss_pred             cHHhhhhccccCcceEEEEeccCCcccEEEEEeec---cCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEE
Confidence            36888899999999999999999999999999874   334445566778999999999999999999999999999999


Q ss_pred             EEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCC-Ccc
Q 004959          420 YLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTG-QKA  498 (721)
Q Consensus       420 VmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~-~~~  498 (721)
                      |+|||+ -++.+-|......++++.++.|++|++.|+.|||++++||||||||||||+.+|.+||||||+|+.+.. +..
T Consensus        79 VFE~~d-hTvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd~  157 (396)
T KOG0593|consen   79 VFEYCD-HTVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLSAPGDN  157 (396)
T ss_pred             Eeeecc-hHHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhcCCcch
Confidence            999998 466666767778899999999999999999999999999999999999999999999999999999884 444


Q ss_pred             cccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhcCCC-----------
Q 004959          499 DLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPA-----------  567 (721)
Q Consensus       499 ~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~~~~-----------  567 (721)
                      ...++.|.||+|||++.+      ...|...+|||++||++.||++|.+.|.+..+.++++.|......           
T Consensus       158 YTDYVATRWYRaPELLvG------DtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~  231 (396)
T KOG0593|consen  158 YTDYVATRWYRAPELLVG------DTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSS  231 (396)
T ss_pred             hhhhhhhhhccChhhhcc------cCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhcc
Confidence            556889999999999986      345666799999999999999999999999998888877542211           


Q ss_pred             --------CC------------CCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccccc
Q 004959          568 --------IP------------DSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKN  605 (721)
Q Consensus       568 --------~p------------~~lS~el~dLI~~cL~~DP~kRPSa~eLL~Hp~f~~  605 (721)
                              +|            ..++.-+.||++.||+.||++|++.+|+|.|+||.+
T Consensus       232 N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd~  289 (396)
T KOG0593|consen  232 NPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFDG  289 (396)
T ss_pred             CCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChHHHH
Confidence                    11            246778899999999999999999999999999954

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-50  Score=416.73  Aligned_cols=256  Identities=31%  Similarity=0.563  Sum_probs=237.0

Q ss_pred             CCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeEEE
Q 004959          340 SQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYI  419 (721)
Q Consensus       340 ~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~yL  419 (721)
                      .+|+..+.||.|+||.|.+++++.+|..||+|++.+  .+.....+++...+|..+|+.+.||+++++++.+.+.+.+|+
T Consensus        44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k--~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lym  121 (355)
T KOG0616|consen   44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDK--QKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYM  121 (355)
T ss_pred             hhhhheeeeccCccceEEEEEEccCCceeehhhcCH--HHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEE
Confidence            589999999999999999999999999999999864  233344567788999999999999999999999999999999


Q ss_pred             EEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCCccc
Q 004959          420 YLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKAD  499 (721)
Q Consensus       420 VmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~~~~  499 (721)
                      ||||++||.|+.++++. ++++|..++.|+.||+.||+|||+++|++|||||||||||.+|.+||+|||+|+.+.+.  .
T Consensus       122 vmeyv~GGElFS~Lrk~-~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r--T  198 (355)
T KOG0616|consen  122 VMEYVPGGELFSYLRKS-GRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR--T  198 (355)
T ss_pred             EEeccCCccHHHHHHhc-CCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceEEecCc--E
Confidence            99999999999999875 89999999999999999999999999999999999999999999999999999988655  5


Q ss_pred             ccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhcCCCCCCCCCHHHHHH
Q 004959          500 LSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDSLSPEGKDF  579 (721)
Q Consensus       500 ~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~~~~~p~~lS~el~dL  579 (721)
                      .+.||||.|+|||++.       ...|..++|.|+|||++|||+.|.+||........+.+|+.+...+|..++.++++|
T Consensus       199 ~TlCGTPeYLAPEii~-------sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~v~fP~~fs~~~kdL  271 (355)
T KOG0616|consen  199 WTLCGTPEYLAPEIIQ-------SKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGKVKFPSYFSSDAKDL  271 (355)
T ss_pred             EEecCCccccChHHhh-------cCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCcccCCcccCHHHHHH
Confidence            7899999999999995       456777899999999999999999999998889999999999999999999999999


Q ss_pred             HHHhcccCCCCCC-----CHHHHHhccccccCC
Q 004959          580 LRCCFQRNPADRP-----PASLLLEHRFLKNSQ  607 (721)
Q Consensus       580 I~~cL~~DP~kRP-----Sa~eLL~Hp~f~~~~  607 (721)
                      |+.+|+.|-.+|.     -..+|..||||+...
T Consensus       272 l~~LL~vD~t~R~gnlknG~~dIk~H~wF~~v~  304 (355)
T KOG0616|consen  272 LKKLLQVDLTKRFGNLKNGVEDIKNHPWFKGVD  304 (355)
T ss_pred             HHHHHhhhhHhhhcCcCCCccccccCccccccc
Confidence            9999999999993     577899999998654

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-50  Score=430.56  Aligned_cols=259  Identities=53%  Similarity=0.936  Sum_probs=224.7

Q ss_pred             CCCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecC--e
Q 004959          339 NSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVED--K  416 (721)
Q Consensus       339 ~~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~--~  416 (721)
                      ...|..++.||+|+||.||++.+.++|+.+|||.+...     .....+.+.+|+.+|.+++|||||+++|......  .
T Consensus        16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~-----~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~   90 (313)
T KOG0198|consen   16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELE-----DSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDE   90 (313)
T ss_pred             cchhhhhccccCccceEEEEEEecCCCcceeeeeeecc-----cchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCee
Confidence            34799999999999999999999999999999998753     1112678999999999999999999999855544  6


Q ss_pred             EEEEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcC-CCceEEeecCCccccCC
Q 004959          417 FYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDA-SGVVKLADFGMAKHLTG  495 (721)
Q Consensus       417 ~yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~-~g~VKL~DFGlA~~l~~  495 (721)
                      ++|+|||+.||+|.+++.+.++.|+|..++.+.+||++||+|||++|||||||||+||||+. ++.+||+|||+++....
T Consensus        91 ~~i~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~  170 (313)
T KOG0198|consen   91 YNIFMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLES  170 (313)
T ss_pred             eEeeeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCcccccccc
Confidence            99999999999999999887668999999999999999999999999999999999999999 79999999999988764


Q ss_pred             ----CcccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCc-hhhHHHHHHHhhc--CCCC
Q 004959          496 ----QKADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSE-YEGAAAMFKVMRD--TPAI  568 (721)
Q Consensus       496 ----~~~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~-~~~~~~~~ki~~~--~~~~  568 (721)
                          ........||+.|||||++..      +.....++|||||||++.||+||+.||.+ ....+.+..+...  .+.+
T Consensus       171 ~~~~~~~~~~~~Gtp~~maPEvi~~------g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~~~P~i  244 (313)
T KOG0198|consen  171 KGTKSDSELSVQGTPNYMAPEVIRN------GEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGREDSLPEI  244 (313)
T ss_pred             ccccccccccccCCccccCchhhcC------CCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccCCCCCC
Confidence                222345789999999999953      11222479999999999999999999998 4555556666544  3788


Q ss_pred             CCCCCHHHHHHHHHhcccCCCCCCCHHHHHhccccccCCC
Q 004959          569 PDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQ  608 (721)
Q Consensus       569 p~~lS~el~dLI~~cL~~DP~kRPSa~eLL~Hp~f~~~~~  608 (721)
                      |..+|.++++||.+||++||++||||++||+|||+.....
T Consensus       245 p~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~~  284 (313)
T KOG0198|consen  245 PDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQNSI  284 (313)
T ss_pred             CcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhcccc
Confidence            9999999999999999999999999999999999987544

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-50  Score=437.93  Aligned_cols=261  Identities=29%  Similarity=0.520  Sum_probs=232.1

Q ss_pred             CCCCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCC-CCCeeeeeeeEEecC-
Q 004959          338 MNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLK-HPNIVQYYGSEIVED-  415 (721)
Q Consensus       338 l~~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~-HPnIV~l~g~~~~~~-  415 (721)
                      +.++|++.+.||.|+||.||+|+.+.+|+.||||.+...   ....++. .-.||++.|++|+ |||||++.+++.+.+ 
T Consensus         8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~K---f~s~ee~-~nLREvksL~kln~hpniikL~Evi~d~~~   83 (538)
T KOG0661|consen    8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKK---FYSWEEC-MNLREVKSLRKLNPHPNIIKLKEVIRDNDR   83 (538)
T ss_pred             HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhh---hccHHHH-HHHHHHHHHHhcCCCCcchhhHHHhhccCc
Confidence            446899999999999999999999999999999987532   2222222 3468999999999 999999999999887 


Q ss_pred             eEEEEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCC
Q 004959          416 KFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTG  495 (721)
Q Consensus       416 ~~yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~  495 (721)
                      .+|||||||+ .+|+++++.+...|+|..++.|+.||+.||+|+|++|++|||||||||||.....|||+|||+|+.+..
T Consensus        84 ~L~fVfE~Md-~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~S  162 (538)
T KOG0661|consen   84 ILYFVFEFMD-CNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLAREVRS  162 (538)
T ss_pred             eEeeeHHhhh-hhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEeccccccccccc
Confidence            9999999997 799999998888999999999999999999999999999999999999999889999999999999998


Q ss_pred             CcccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhcC----------
Q 004959          496 QKADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDT----------  565 (721)
Q Consensus       496 ~~~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~~----------  565 (721)
                      ......++.|.||+|||+|.      ++..|+.++|||++|||++|+.+-++.|.+.+..+++++|..-.          
T Consensus       163 kpPYTeYVSTRWYRAPEvLL------rs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~e  236 (538)
T KOG0661|consen  163 KPPYTEYVSTRWYRAPEVLL------RSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPE  236 (538)
T ss_pred             CCCcchhhhcccccchHHhh------hccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchh
Confidence            88888899999999999998      46778889999999999999999999999999999999885411          


Q ss_pred             ---------CCCC-----------CCCCHHHHHHHHHhcccCCCCCCCHHHHHhccccccCCCC
Q 004959          566 ---------PAIP-----------DSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQP  609 (721)
Q Consensus       566 ---------~~~p-----------~~lS~el~dLI~~cL~~DP~kRPSa~eLL~Hp~f~~~~~~  609 (721)
                               ..+|           ..++.++.++|.+||.+||++||||.|+|+||||+.....
T Consensus       237 g~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~~~~  300 (538)
T KOG0661|consen  237 GYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQVGRAS  300 (538)
T ss_pred             HHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCccccccccc
Confidence                     0111           2478999999999999999999999999999999876544

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9e-49  Score=438.59  Aligned_cols=257  Identities=27%  Similarity=0.489  Sum_probs=235.7

Q ss_pred             CCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCC-CCCeeeeeeeEEecCeEE
Q 004959          340 SQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLK-HPNIVQYYGSEIVEDKFY  418 (721)
Q Consensus       340 ~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~-HPnIV~l~g~~~~~~~~y  418 (721)
                      .+|.++++||+|.||+|++|..+.+++.||||++.+  ......+.++....|-+|+..+. ||.++.++..|.+.+++|
T Consensus       368 ~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK--~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~  445 (694)
T KOG0694|consen  368 DDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKK--GDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLF  445 (694)
T ss_pred             cceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeec--cceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEE
Confidence            589999999999999999999999999999999864  44555667888999999998886 999999999999999999


Q ss_pred             EEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccC-CCc
Q 004959          419 IYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLT-GQK  497 (721)
Q Consensus       419 LVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~-~~~  497 (721)
                      +||||+.||++..+++  .+.|+|..++.|+..|+.||.|||++||||||||.+|||+|.+|.+||+|||+++..- .+.
T Consensus       446 fvmey~~Ggdm~~~~~--~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~~g~  523 (694)
T KOG0694|consen  446 FVMEYVAGGDLMHHIH--TDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMGQGD  523 (694)
T ss_pred             EEEEecCCCcEEEEEe--cccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEecccccccccCCCCC
Confidence            9999999999655543  3689999999999999999999999999999999999999999999999999999754 445


Q ss_pred             ccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhcCCCCCCCCCHHHH
Q 004959          498 ADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDSLSPEGK  577 (721)
Q Consensus       498 ~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~~~~~p~~lS~el~  577 (721)
                      ...++||||.|||||++       ....|+.++|+|+|||+|||||.|..||.+.+..+.+..|+.+.+.+|.++|.|+.
T Consensus       524 ~TsTfCGTpey~aPEil-------~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d~~~yP~~ls~ea~  596 (694)
T KOG0694|consen  524 RTSTFCGTPEFLAPEVL-------TEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSKEAI  596 (694)
T ss_pred             ccccccCChhhcChhhh-------ccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCCcccHHHH
Confidence            66789999999999999       45678889999999999999999999999999999999999999999999999999


Q ss_pred             HHHHHhcccCCCCCCC-----HHHHHhccccccCC
Q 004959          578 DFLRCCFQRNPADRPP-----ASLLLEHRFLKNSQ  607 (721)
Q Consensus       578 dLI~~cL~~DP~kRPS-----a~eLL~Hp~f~~~~  607 (721)
                      ++|+++|.+||++|.-     +++|..||||+...
T Consensus       597 ~il~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~i~  631 (694)
T KOG0694|consen  597 AIMRRLLRKNPEKRLGSGERDAEDIKKHPFFRSID  631 (694)
T ss_pred             HHHHHHhccCcccccCCCCCCchhhhhCCccccCC
Confidence            9999999999999985     58899999998654

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.1e-49  Score=430.48  Aligned_cols=264  Identities=30%  Similarity=0.545  Sum_probs=229.0

Q ss_pred             CCCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEec--Ce
Q 004959          339 NSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVE--DK  416 (721)
Q Consensus       339 ~~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~--~~  416 (721)
                      .+.|+.++.||+|+||.||+|++..||+.||+|+|.....+   .+......+||.||++|+|||||+|.+.....  ..
T Consensus       116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~---~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~s  192 (560)
T KOG0600|consen  116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEK---EGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGS  192 (560)
T ss_pred             hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCC---CcchHHHHHHHHHHHhcCCCcccceeeEEEecCCce
Confidence            35789999999999999999999999999999999864332   34456778999999999999999999987776  68


Q ss_pred             EEEEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCC
Q 004959          417 FYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQ  496 (721)
Q Consensus       417 ~yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~  496 (721)
                      +|||+|||+ -||.-++....-.|++.+++.||+||+.||+|||.+||+|||||..|||||.+|.+||+|||||+.+...
T Consensus       193 iYlVFeYMd-hDL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~  271 (560)
T KOG0600|consen  193 IYLVFEYMD-HDLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVLKIADFGLARFYTPS  271 (560)
T ss_pred             EEEEEeccc-chhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCEEeccccceeeccCC
Confidence            999999997 6898888776678999999999999999999999999999999999999999999999999999987655


Q ss_pred             c--ccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhcCC--------
Q 004959          497 K--ADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTP--------  566 (721)
Q Consensus       497 ~--~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~~~--------  566 (721)
                      .  .....+-|.||+|||+|.|      ...|+.++|+||+||||.||++|++.|.+....+++.+|.+-..        
T Consensus       272 ~~~~~T~rVvTLWYRpPELLLG------~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~  345 (560)
T KOG0600|consen  272 GSAPYTSRVVTLWYRPPELLLG------ATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWP  345 (560)
T ss_pred             CCcccccceEEeeccChHHhcC------CcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccc
Confidence            4  3445668999999999986      46788899999999999999999999999988888887754210        


Q ss_pred             --CCC-------------------CCCCHHHHHHHHHhcccCCCCCCCHHHHHhccccccCCCCCCC
Q 004959          567 --AIP-------------------DSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQPDVP  612 (721)
Q Consensus       567 --~~p-------------------~~lS~el~dLI~~cL~~DP~kRPSa~eLL~Hp~f~~~~~~~~~  612 (721)
                        .+|                   ..++..+.+|+..||..||.+|.||.++|+|.||.....+..+
T Consensus       346 ~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF~t~p~~~~p  412 (560)
T KOG0600|consen  346 VSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEYFTTEPLPCDP  412 (560)
T ss_pred             cccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCcccccCCCCCCc
Confidence              111                   2468999999999999999999999999999999665554433

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=4.3e-49  Score=430.55  Aligned_cols=256  Identities=32%  Similarity=0.587  Sum_probs=236.2

Q ss_pred             CCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeEEE
Q 004959          340 SQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYI  419 (721)
Q Consensus       340 ~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~yL  419 (721)
                      ++|.+.+.||+|.||.||+|+.+.|.+.||||.+.+.   .+....++.+.+|++|++.|+|||||.+++.|++..++++
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~---gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~v   78 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKS---GRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWV   78 (808)
T ss_pred             cchhHHHHhcCCccceeeecccccceeEEEEEEehhc---CCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEE
Confidence            4688889999999999999999999999999999753   3455678899999999999999999999999999999999


Q ss_pred             EEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCCccc
Q 004959          420 YLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKAD  499 (721)
Q Consensus       420 VmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~~~~  499 (721)
                      |.|||.| +|+.+|... +.++|+.++.++.|++.||.|||+++|+|||+||.|||++..|.+||||||+|+........
T Consensus        79 Vte~a~g-~L~~il~~d-~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t~v  156 (808)
T KOG0597|consen   79 VTEYAVG-DLFTILEQD-GKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNTSV  156 (808)
T ss_pred             Eehhhhh-hHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhcccCcee
Confidence            9999986 999999775 88999999999999999999999999999999999999999999999999999987654433


Q ss_pred             -ccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhcCCCCCCCCCHHHHH
Q 004959          500 -LSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDSLSPEGKD  578 (721)
Q Consensus       500 -~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~~~~~p~~lS~el~d  578 (721)
                       ....|||.|||||++       +...|+..+|+||||||||||++|++||......+....|+.+....|..++.++.+
T Consensus       157 ltsikGtPlYmAPElv-------~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d~v~~p~~~S~~f~n  229 (808)
T KOG0597|consen  157 LTSIKGTPLYMAPELV-------EEQPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKDPVKPPSTASSSFVN  229 (808)
T ss_pred             eeeccCcccccCHHHH-------cCCCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcCCCCCcccccHHHHH
Confidence             457799999999999       457788889999999999999999999999888888999999999999999999999


Q ss_pred             HHHHhcccCCCCCCCHHHHHhccccccCC
Q 004959          579 FLRCCFQRNPADRPPASLLLEHRFLKNSQ  607 (721)
Q Consensus       579 LI~~cL~~DP~kRPSa~eLL~Hp~f~~~~  607 (721)
                      ||+.+|++||.+|.+..+++.|||++...
T Consensus       230 fl~gLL~kdP~~RltW~~Ll~HpF~k~~~  258 (808)
T KOG0597|consen  230 FLQGLLIKDPAQRLTWTDLLGHPFWKGKI  258 (808)
T ss_pred             HHHHHhhcChhhcccHHHHhcChHHhhhh
Confidence            99999999999999999999999998654

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=1e-48  Score=428.38  Aligned_cols=262  Identities=29%  Similarity=0.493  Sum_probs=230.5

Q ss_pred             CCCCCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCe
Q 004959          337 PMNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDK  416 (721)
Q Consensus       337 ~l~~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~  416 (721)
                      .-.++|++++.||+|+||.||+|+.+.||..||||++.+  .+.....+++.+..|-.||....+|+||+||-.|.+.++
T Consensus       138 ~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkK--S~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~  215 (550)
T KOG0605|consen  138 LSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKK--SEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEY  215 (550)
T ss_pred             CCcccchhheeeccccceeEEEEEEccCCcEEeeecccH--HHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCe
Confidence            345789999999999999999999999999999999874  344455678889999999999999999999999999999


Q ss_pred             EEEEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCC-
Q 004959          417 FYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTG-  495 (721)
Q Consensus       417 ~yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~-  495 (721)
                      +||||||++||++..+|.+. +.|+|.+++.|+.+++.||+.||+.|||||||||+|+|||..|+|||.||||+..+.. 
T Consensus       216 LYLiMEylPGGD~mTLL~~~-~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~  294 (550)
T KOG0605|consen  216 LYLIMEYLPGGDMMTLLMRK-DTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKK  294 (550)
T ss_pred             eEEEEEecCCccHHHHHHhc-CcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccccchhhhh
Confidence            99999999999999999775 8999999999999999999999999999999999999999999999999999854311 


Q ss_pred             ----------------------Ccc-----c--------------------ccCCCCCccCChhhHHHHhhcCCCCCCcc
Q 004959          496 ----------------------QKA-----D--------------------LSMKGSPYWMAPELMMAVMQKGKSSDSAL  528 (721)
Q Consensus       496 ----------------------~~~-----~--------------------~s~~GT~~Y~APEvl~~~~~~~k~~~~s~  528 (721)
                                            ...     .                    .+.+|||.|||||+|.+       ..|+.
T Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~-------kgY~~  367 (550)
T KOG0605|consen  295 HRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLG-------KGYGK  367 (550)
T ss_pred             hhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhc-------CCCCc
Confidence                                  000     0                    12469999999999975       34777


Q ss_pred             hhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhcC--CCCC--CCCCHHHHHHHHHhcccCCCCCCC---HHHHHhcc
Q 004959          529 AVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDT--PAIP--DSLSPEGKDFLRCCFQRNPADRPP---ASLLLEHR  601 (721)
Q Consensus       529 asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~~--~~~p--~~lS~el~dLI~~cL~~DP~kRPS---a~eLL~Hp  601 (721)
                      .+|+|||||||||||.|.+||...+..+.+.+|+...  ..+|  ..++++++|||.+||. ||++|.-   ++||.+||
T Consensus       368 ~cDwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~HP  446 (550)
T KOG0605|consen  368 ECDWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEEVDLSDEAKDLITRLLC-DPENRLGSKGAEEIKKHP  446 (550)
T ss_pred             cccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCcCcccHHHHHHHHHHhc-CHHHhcCcccHHHHhcCC
Confidence            8999999999999999999999999999999988754  3344  3578999999999999 9999974   99999999


Q ss_pred             ccccCCCC
Q 004959          602 FLKNSQQP  609 (721)
Q Consensus       602 ~f~~~~~~  609 (721)
                      ||+...-.
T Consensus       447 fF~~v~W~  454 (550)
T KOG0605|consen  447 FFKGVDWD  454 (550)
T ss_pred             ccccCCcc
Confidence            99986643

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-48  Score=411.39  Aligned_cols=295  Identities=28%  Similarity=0.467  Sum_probs=244.5

Q ss_pred             CCCCCCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEe--
Q 004959          336 LPMNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIV--  413 (721)
Q Consensus       336 ~~l~~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~--  413 (721)
                      ..+...|...+.||+|+||.|+.|.++.+|+.||||++..   -.......++..+|+++|+.++|+||+.+++++..  
T Consensus        18 ~~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~---~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~   94 (359)
T KOG0660|consen   18 FEIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILN---PFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPS   94 (359)
T ss_pred             EeccceecccccccCcceeeEEEEEEcCCCCEeehhhhhh---hhhchHHHHHHHHHHHHHHHhcCCCcceEEeeccccc
Confidence            4455677778999999999999999999999999998852   22445567899999999999999999999998765  


Q ss_pred             ---cCeEEEEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCc
Q 004959          414 ---EDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMA  490 (721)
Q Consensus       414 ---~~~~yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA  490 (721)
                         -+.+|+|+|+| +.+|.++|+.. ..|++..++.+++||++||+|+|+.+|+||||||.|||++.++.+||||||+|
T Consensus        95 ~~~f~DvYiV~elM-etDL~~iik~~-~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFGLA  172 (359)
T KOG0660|consen   95 RDKFNDVYLVFELM-ETDLHQIIKSQ-QDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFGLA  172 (359)
T ss_pred             ccccceeEEehhHH-hhHHHHHHHcC-ccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEeccccce
Confidence               35799999999 58999999764 55999999999999999999999999999999999999999999999999999


Q ss_pred             cccCC---CcccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhc---
Q 004959          491 KHLTG---QKADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRD---  564 (721)
Q Consensus       491 ~~l~~---~~~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~---  564 (721)
                      +.+..   ......++.|.+|+|||++.      ....|+.++||||+||||.|||+|++.|.+.+..+++..++.-   
T Consensus       173 R~~~~~~~~~~mTeYVaTRWYRAPElll------~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGt  246 (359)
T KOG0660|consen  173 RYLDKFFEDGFMTEYVATRWYRAPELLL------NSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGT  246 (359)
T ss_pred             eeccccCcccchhcceeeeeecCHHHHh------ccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCC
Confidence            98864   33345678999999999996      4677889999999999999999999999998877777665431   


Q ss_pred             --------------------CCCC--------CCCCCHHHHHHHHHhcccCCCCCCCHHHHHhccccccCCCCCCCC-cc
Q 004959          565 --------------------TPAI--------PDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQPDVPS-CS  615 (721)
Q Consensus       565 --------------------~~~~--------p~~lS~el~dLI~~cL~~DP~kRPSa~eLL~Hp~f~~~~~~~~~~-~~  615 (721)
                                          .+..        ....++++.+||++||..||.+|+|++|+|+|||+.....++.+. +.
T Consensus       247 P~~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hdp~dEP~~~  326 (359)
T KOG0660|consen  247 PSEEDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHDPEDEPVCQ  326 (359)
T ss_pred             CCHHHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcCCccCCCCC
Confidence                                1111        146789999999999999999999999999999999988886544 44


Q ss_pred             cccCCCCCCCCCCChhHHHhhhHHHHHhh
Q 004959          616 LSFSGMQLTEKPHSPREKADAKYDQVAAL  644 (721)
Q Consensus       616 ~~~~~~~l~~~~~~~~~~~~~~~d~~~~l  644 (721)
                      ..+..   .+......+.++..|.++...
T Consensus       327 ~~~~~---~~~~~~~~~~r~~i~~e~~~~  352 (359)
T KOG0660|consen  327 PIFDS---FEHELTEEELRELIYKEILDF  352 (359)
T ss_pred             CCCcc---ccccccHHHHHHHHHHHHHhh
Confidence            33322   222244566677788775543

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=3.5e-49  Score=417.50  Aligned_cols=265  Identities=28%  Similarity=0.523  Sum_probs=242.8

Q ss_pred             CCCCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeE
Q 004959          338 MNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKF  417 (721)
Q Consensus       338 l~~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~  417 (721)
                      +.-+|++.+.||+|.||+|-+|.....|+.||||.|.+  +..++.+.+-.+.+||+||..|+||||+.+|++|+..+.+
T Consensus        51 lkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrK--dkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKI  128 (668)
T KOG0611|consen   51 LKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRK--DKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKI  128 (668)
T ss_pred             hhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhh--hhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceE
Confidence            44589999999999999999999999999999998864  4556777888999999999999999999999999999999


Q ss_pred             EEEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCCc
Q 004959          418 YIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQK  497 (721)
Q Consensus       418 yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~~  497 (721)
                      .|||||..+|.|++||.+. +.|+|.+++.|++||+.|+.|||.++++|||||.+|||+|.++++||+||||+..+....
T Consensus       129 vivMEYaS~GeLYDYiSer-~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSNly~~~k  207 (668)
T KOG0611|consen  129 VIVMEYASGGELYDYISER-GSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSNLYADKK  207 (668)
T ss_pred             EEEEEecCCccHHHHHHHh-ccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchhhhhcccc
Confidence            9999999999999999875 889999999999999999999999999999999999999999999999999999998888


Q ss_pred             ccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhcCCCCCCCCCHHHH
Q 004959          498 ADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDSLSPEGK  577 (721)
Q Consensus       498 ~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~~~~~p~~lS~el~  577 (721)
                      ...++||+|.|.+||++.|.+|.+.      .+|.|||||+||.|++|..||++.+....+.+|.++.+.-|.. +.++.
T Consensus       208 fLqTFCGSPLYASPEIvNG~PY~GP------EVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYrEP~~-PSdA~  280 (668)
T KOG0611|consen  208 FLQTFCGSPLYASPEIVNGTPYKGP------EVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYREPET-PSDAS  280 (668)
T ss_pred             HHHHhcCCcccCCccccCCCCCCCC------ccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcccccCCCC-CchHH
Confidence            8889999999999999988777654      5899999999999999999999999988888888887665554 45678


Q ss_pred             HHHHHhcccCCCCCCCHHHHHhccccccCCCCCCC
Q 004959          578 DFLRCCFQRNPADRPPASLLLEHRFLKNSQQPDVP  612 (721)
Q Consensus       578 dLI~~cL~~DP~kRPSa~eLL~Hp~f~~~~~~~~~  612 (721)
                      -||++||..||++|.|.++|..|.|+...+.-.+.
T Consensus       281 gLIRwmLmVNP~RRATieDiAsHWWvNwgy~~~V~  315 (668)
T KOG0611|consen  281 GLIRWMLMVNPERRATIEDIASHWWVNWGYNMPVI  315 (668)
T ss_pred             HHHHHHHhcCcccchhHHHHhhhheeecccccccc
Confidence            99999999999999999999999999877655443

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1e-48  Score=423.08  Aligned_cols=265  Identities=28%  Similarity=0.480  Sum_probs=244.8

Q ss_pred             CCCCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeE
Q 004959          338 MNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKF  417 (721)
Q Consensus       338 l~~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~  417 (721)
                      +.+-|.+.+.||+|.|++|-+|++.-||+.||||+|.+.+.+..   ....+++|++.|+.++|||||+||++..+...+
T Consensus        16 IAGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~---st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKl   92 (864)
T KOG4717|consen   16 IAGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTL---STGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKL   92 (864)
T ss_pred             eeeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchh---hhhHHHHHHHHHHHhcCcCeeeeeehhcccceE
Confidence            33568899999999999999999999999999999987654432   345788999999999999999999999999999


Q ss_pred             EEEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEc-CCCceEEeecCCccccCCC
Q 004959          418 YIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVD-ASGVVKLADFGMAKHLTGQ  496 (721)
Q Consensus       418 yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld-~~g~VKL~DFGlA~~l~~~  496 (721)
                      |||+|+-+||+|++||.++...+.|..+++|++||+.|+.|||+..|||||||||||.+- .-|-|||.|||++..+..+
T Consensus        93 yLiLELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG  172 (864)
T KOG4717|consen   93 YLILELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPG  172 (864)
T ss_pred             EEEEEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccCCCc
Confidence            999999999999999999888999999999999999999999999999999999998774 5689999999999999999


Q ss_pred             cccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhcCCCCCCCCCHHH
Q 004959          497 KADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDSLSPEG  576 (721)
Q Consensus       497 ~~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~~~~~p~~lS~el  576 (721)
                      ....+.||+..|-|||+|.|..|.      .+++||||||||||.|+||++||...++.+.+-.|+.+.+.+|..+|.++
T Consensus       173 ~kL~TsCGSLAYSAPEILLGDsYD------APAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCKYtvPshvS~eC  246 (864)
T KOG4717|consen  173 KKLTTSCGSLAYSAPEILLGDSYD------APAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKYTVPSHVSKEC  246 (864)
T ss_pred             chhhcccchhhccCchhhhcCccC------CcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhcccccCchhhhHHH
Confidence            999999999999999999874433      35899999999999999999999999999999999999999999999999


Q ss_pred             HHHHHHhcccCCCCCCCHHHHHhccccccCCCCCC
Q 004959          577 KDFLRCCFQRNPADRPPASLLLEHRFLKNSQQPDV  611 (721)
Q Consensus       577 ~dLI~~cL~~DP~kRPSa~eLL~Hp~f~~~~~~~~  611 (721)
                      ++||..||+.||++|.+.+||..|+|++....+..
T Consensus       247 rdLI~sMLvRdPkkRAslEeI~s~~Wlq~~D~~~s  281 (864)
T KOG4717|consen  247 RDLIQSMLVRDPKKRASLEEIVSTSWLQAGDRGLS  281 (864)
T ss_pred             HHHHHHHHhcCchhhccHHHHhccccccCCCCCcc
Confidence            99999999999999999999999999998776543

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=3.1e-48  Score=394.27  Aligned_cols=261  Identities=28%  Similarity=0.475  Sum_probs=226.1

Q ss_pred             CCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeEEE
Q 004959          340 SQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYI  419 (721)
Q Consensus       340 ~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~yL  419 (721)
                      .+|...+.||+|.||+||+|++.+||+.||||+|....  .+ ........+||++|+.++|+||+.++++|-+.+.+.|
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~--~k-dGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~l   78 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGN--AK-DGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSL   78 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccc--cc-cCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEE
Confidence            46888999999999999999999999999999997531  11 1123457899999999999999999999999999999


Q ss_pred             EEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCCccc
Q 004959          420 YLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKAD  499 (721)
Q Consensus       420 VmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~~~~  499 (721)
                      |+|||+ .+|+..|+...-.++..+++.|+.|++.||+|||++.|+||||||.|+||+.+|.+||+|||+|+.+......
T Consensus        79 VfEfm~-tdLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~  157 (318)
T KOG0659|consen   79 VFEFMP-TDLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRI  157 (318)
T ss_pred             EEEecc-ccHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhccCCCCcc
Confidence            999996 7999999988788999999999999999999999999999999999999999999999999999988655433


Q ss_pred             c-cCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhcCCC-----------
Q 004959          500 L-SMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPA-----------  567 (721)
Q Consensus       500 ~-s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~~~~-----------  567 (721)
                      . ..+-|.+|+|||+++|..      .|...+||||.|||+.||+.|.+-|.+..+.+++..+.+....           
T Consensus       158 ~~~~V~TRWYRAPELLfGsr------~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~  231 (318)
T KOG0659|consen  158 QTHQVVTRWYRAPELLFGSR------QYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTS  231 (318)
T ss_pred             cccceeeeeccChHHhccch------hcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccc
Confidence            3 236899999999998753      4555799999999999999999999999888888877652110           


Q ss_pred             -----------------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhccccccCCCCC
Q 004959          568 -----------------IPDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQPD  610 (721)
Q Consensus       568 -----------------~p~~lS~el~dLI~~cL~~DP~kRPSa~eLL~Hp~f~~~~~~~  610 (721)
                                       +....+.++.|||.+||..||.+|+++.|+|+|+||+....+.
T Consensus       232 lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~~P~pt  291 (318)
T KOG0659|consen  232 LPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKSLPLPT  291 (318)
T ss_pred             cccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhcCCCCC
Confidence                             1123578899999999999999999999999999999865543

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-47  Score=403.76  Aligned_cols=256  Identities=30%  Similarity=0.513  Sum_probs=226.9

Q ss_pred             CCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeEEE
Q 004959          340 SQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYI  419 (721)
Q Consensus       340 ~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~yL  419 (721)
                      ++|++.+.||+|+||.||+|.+..+|+.||||++...  ........+.+.+|+.+|+.++||||+++++++.+.+.+|+
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l   78 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIP--EVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYM   78 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHH--HHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEE
Confidence            3689999999999999999999999999999998632  11122345678899999999999999999999999999999


Q ss_pred             EEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCCccc
Q 004959          420 YLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKAD  499 (721)
Q Consensus       420 VmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~~~~  499 (721)
                      ||||+.+|+|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++..+...  .
T Consensus        79 v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~--~  155 (291)
T cd05612          79 LMEYVPGGELFSYLRNS-GRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR--T  155 (291)
T ss_pred             EEeCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchhccCC--c
Confidence            99999999999999765 67999999999999999999999999999999999999999999999999999876432  2


Q ss_pred             ccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhcCCCCCCCCCHHHHHH
Q 004959          500 LSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDSLSPEGKDF  579 (721)
Q Consensus       500 ~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~~~~~p~~lS~el~dL  579 (721)
                      ...+||+.|+|||++.       ...++.++|||||||++|+|++|+.||.+....+....+......++..++.++++|
T Consensus       156 ~~~~gt~~y~aPE~~~-------~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~l  228 (291)
T cd05612         156 WTLCGTPEYLAPEVIQ-------SKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLEFPRHLDLYAKDL  228 (291)
T ss_pred             ccccCChhhcCHHHHc-------CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcCCCccCCHHHHHH
Confidence            3467999999999984       344677899999999999999999999988777777778777778888899999999


Q ss_pred             HHHhcccCCCCCCC-----HHHHHhccccccCC
Q 004959          580 LRCCFQRNPADRPP-----ASLLLEHRFLKNSQ  607 (721)
Q Consensus       580 I~~cL~~DP~kRPS-----a~eLL~Hp~f~~~~  607 (721)
                      |++||+.||.+|++     ++++++||||....
T Consensus       229 i~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~  261 (291)
T cd05612         229 IKKLLVVDRTRRLGNMKNGADDVKNHRWFKSVD  261 (291)
T ss_pred             HHHHcCCCHHHccCCccCCHHHHhcCccccCCC
Confidence            99999999999995     99999999997543

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=1.3e-47  Score=412.00  Aligned_cols=255  Identities=28%  Similarity=0.515  Sum_probs=227.0

Q ss_pred             CCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeEEE
Q 004959          340 SQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYI  419 (721)
Q Consensus       340 ~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~yL  419 (721)
                      .+|++.+.||+|+||.||+|+++.+|+.||||++...  ........+.+.+|+.+|++++||||+++++++..++.+|+
T Consensus        18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l   95 (329)
T PTZ00263         18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKR--EILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYF   95 (329)
T ss_pred             hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHH--HHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEE
Confidence            5899999999999999999999999999999998632  11122345678999999999999999999999999999999


Q ss_pred             EEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCCccc
Q 004959          420 YLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKAD  499 (721)
Q Consensus       420 VmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~~~~  499 (721)
                      ||||+.||+|.+++... +.+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+...  .
T Consensus        96 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~--~  172 (329)
T PTZ00263         96 LLEFVVGGELFTHLRKA-GRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR--T  172 (329)
T ss_pred             EEcCCCCChHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCceEcCCC--c
Confidence            99999999999999764 67999999999999999999999999999999999999999999999999999876433  2


Q ss_pred             ccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhcCCCCCCCCCHHHHHH
Q 004959          500 LSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDSLSPEGKDF  579 (721)
Q Consensus       500 ~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~~~~~p~~lS~el~dL  579 (721)
                      ...+||+.|+|||++.+       ..++.++|||||||++|+|++|..||.+....+.+..+......++..++.++++|
T Consensus       173 ~~~~gt~~y~aPE~~~~-------~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~l  245 (329)
T PTZ00263        173 FTLCGTPEYLAPEVIQS-------KGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFPNWFDGRARDL  245 (329)
T ss_pred             ceecCChhhcCHHHHcC-------CCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCcCCCCCCCHHHHHH
Confidence            34679999999999943       44567899999999999999999999887777777777777778888899999999


Q ss_pred             HHHhcccCCCCCCC-----HHHHHhccccccC
Q 004959          580 LRCCFQRNPADRPP-----ASLLLEHRFLKNS  606 (721)
Q Consensus       580 I~~cL~~DP~kRPS-----a~eLL~Hp~f~~~  606 (721)
                      |++||+.||++|++     +++|+.||||.+.
T Consensus       246 i~~~L~~dP~~R~~~~~~~~~~ll~hp~f~~~  277 (329)
T PTZ00263        246 VKGLLQTDHTKRLGTLKGGVADVKNHPYFHGA  277 (329)
T ss_pred             HHHHhhcCHHHcCCCCCCCHHHHhcCCccCCC
Confidence            99999999999997     7999999999863

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-49  Score=399.42  Aligned_cols=260  Identities=28%  Similarity=0.464  Sum_probs=232.0

Q ss_pred             CCCCCCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecC
Q 004959          336 LPMNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVED  415 (721)
Q Consensus       336 ~~l~~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~  415 (721)
                      ..+.++|++.++||+|.|++||+|.+..||+.+|+|+|+..+-..   ...+.+.+|++|-+.|+|||||++++.+..+.
T Consensus         7 ~~f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~---~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~   83 (355)
T KOG0033|consen    7 TKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSA---RDFQKLEREARICRKLQHPNIVRLHDSIQEES   83 (355)
T ss_pred             cccchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhcc---ccHHHHHHHHHHHHhcCCCcEeehhhhhcccc
Confidence            456788999999999999999999999999999999987543222   25678999999999999999999999999999


Q ss_pred             eEEEEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcC---CCceEEeecCCccc
Q 004959          416 KFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDA---SGVVKLADFGMAKH  492 (721)
Q Consensus       416 ~~yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~---~g~VKL~DFGlA~~  492 (721)
                      ..|||+|+|.|++|..-|-.. ..++|..+..+++||++||.|||.+||||||+||+|+|+-.   ..-|||+|||+|..
T Consensus        84 ~~ylvFe~m~G~dl~~eIV~R-~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~  162 (355)
T KOG0033|consen   84 FHYLVFDLVTGGELFEDIVAR-EFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIE  162 (355)
T ss_pred             eeEEEEecccchHHHHHHHHH-HHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEE
Confidence            999999999999997666544 57899999999999999999999999999999999999953   23699999999999


Q ss_pred             cCCCcccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhcCCCCC---
Q 004959          493 LTGQKADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIP---  569 (721)
Q Consensus       493 l~~~~~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~~~~~p---  569 (721)
                      +.++.......|||.|||||++       +...|+..+|||+.|||||.||.|.+||.+.+....+.+|+.+...++   
T Consensus       163 l~~g~~~~G~~GtP~fmaPEvv-------rkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~~~  235 (355)
T KOG0033|consen  163 VNDGEAWHGFAGTPGYLSPEVL-------KKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPSPE  235 (355)
T ss_pred             eCCccccccccCCCcccCHHHh-------hcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCCcc
Confidence            9877666778999999999999       456677789999999999999999999999888888888888765544   


Q ss_pred             -CCCCHHHHHHHHHhcccCCCCCCCHHHHHhccccccC
Q 004959          570 -DSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNS  606 (721)
Q Consensus       570 -~~lS~el~dLI~~cL~~DP~kRPSa~eLL~Hp~f~~~  606 (721)
                       +.+++++++||++||..||.+|+|+.|+|+|||+.+.
T Consensus       236 w~~is~~Ak~LvrrML~~dP~kRIta~EAL~HpWi~~r  273 (355)
T KOG0033|consen  236 WDTVTPEAKSLIRRMLTVNPKKRITADEALKHPWICNR  273 (355)
T ss_pred             cCcCCHHHHHHHHHHhccChhhhccHHHHhCCchhcch
Confidence             5799999999999999999999999999999999864

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=1.6e-47  Score=409.95  Aligned_cols=251  Identities=29%  Similarity=0.499  Sum_probs=221.0

Q ss_pred             eEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeEEEEEeecc
Q 004959          346 KLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYIYLEYVH  425 (721)
Q Consensus       346 k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~yLVmEy~~  425 (721)
                      ++||+|+||.||+|.+..+|+.||||++...  ..........+.+|+.+|++++||||+++++++...+.+||||||+.
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~   78 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKE--VIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYAN   78 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHH--HhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCC
Confidence            4799999999999999999999999998632  11223445678899999999999999999999999999999999999


Q ss_pred             CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCC-CcccccCCC
Q 004959          426 PGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTG-QKADLSMKG  504 (721)
Q Consensus       426 gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~-~~~~~s~~G  504 (721)
                      ||+|.+++... +.+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+++.... .......+|
T Consensus        79 ~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~g  157 (323)
T cd05571          79 GGELFFHLSRE-RVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCG  157 (323)
T ss_pred             CCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCCcccceec
Confidence            99999998764 6799999999999999999999999999999999999999999999999999975432 223345679


Q ss_pred             CCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhcCCCCCCCCCHHHHHHHHHhc
Q 004959          505 SPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDSLSPEGKDFLRCCF  584 (721)
Q Consensus       505 T~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~~~~~p~~lS~el~dLI~~cL  584 (721)
                      |+.|+|||++.       ...++.++|||||||++|||++|+.||...+.......+......++..++.++.+||++||
T Consensus       158 t~~y~aPE~~~-------~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L  230 (323)
T cd05571         158 TPEYLAPEVLE-------DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLAGLL  230 (323)
T ss_pred             CccccChhhhc-------CCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHc
Confidence            99999999984       34567789999999999999999999988777777777777777888999999999999999


Q ss_pred             ccCCCCCC-----CHHHHHhccccccC
Q 004959          585 QRNPADRP-----PASLLLEHRFLKNS  606 (721)
Q Consensus       585 ~~DP~kRP-----Sa~eLL~Hp~f~~~  606 (721)
                      +.||++||     ++.++++||||...
T Consensus       231 ~~dP~~R~~~~~~~~~~ll~h~~f~~~  257 (323)
T cd05571         231 KKDPKQRLGGGPEDAKEIMEHRFFASI  257 (323)
T ss_pred             cCCHHHcCCCCCCCHHHHHcCCCcCCC
Confidence            99999999     89999999999764

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.5e-48  Score=425.24  Aligned_cols=253  Identities=40%  Similarity=0.676  Sum_probs=226.7

Q ss_pred             CCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeEEE
Q 004959          340 SQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYI  419 (721)
Q Consensus       340 ~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~yL  419 (721)
                      ..|.....||+|+-|.||.|....+++.||||.+.+.....     .+.+.+|+.+|+..+|+|||.+++.|...+.+|+
T Consensus       273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~-----keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWV  347 (550)
T KOG0578|consen  273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPK-----KELLLNEILVMRDLHHPNIVNFLDSYLVGDELWV  347 (550)
T ss_pred             hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCc-----hhhhHHHHHHHHhccchHHHHHHHHhcccceeEE
Confidence            46888899999999999999999999999999998643322     3578999999999999999999999999999999


Q ss_pred             EEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCCc-c
Q 004959          420 YLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQK-A  498 (721)
Q Consensus       420 VmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~~-~  498 (721)
                      |||||+||+|.+++...  .++|.++..|+++++.||+|||.+||||||||-+|||++.+|.|||+|||+|..+.... .
T Consensus       348 VMEym~ggsLTDvVt~~--~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~K  425 (550)
T KOG0578|consen  348 VMEYMEGGSLTDVVTKT--RMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQSK  425 (550)
T ss_pred             EEeecCCCchhhhhhcc--cccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeeccccccCc
Confidence            99999999999999764  69999999999999999999999999999999999999999999999999999887665 5


Q ss_pred             cccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhc-CC--CCCCCCCHH
Q 004959          499 DLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRD-TP--AIPDSLSPE  575 (721)
Q Consensus       499 ~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~-~~--~~p~~lS~e  575 (721)
                      ..+.+|||+|||||++..       ..|..++||||||++++||+-|.+||-..+....++.|-.. .+  ..++.+|.+
T Consensus       426 R~TmVGTPYWMAPEVvtr-------k~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~P~lk~~~klS~~  498 (550)
T KOG0578|consen  426 RSTMVGTPYWMAPEVVTR-------KPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPKLKNPEKLSPE  498 (550)
T ss_pred             cccccCCCCccchhhhhh-------cccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCCCCcCCccccCHH
Confidence            567899999999999953       45677899999999999999999999877777777666543 22  456789999


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHHhccccccC
Q 004959          576 GKDFLRCCFQRNPADRPPASLLLEHRFLKNS  606 (721)
Q Consensus       576 l~dLI~~cL~~DP~kRPSa~eLL~Hp~f~~~  606 (721)
                      +++||.+||+.|+++|+++.|||+||||+..
T Consensus       499 ~kdFL~~cL~~dv~~RasA~eLL~HpFl~~a  529 (550)
T KOG0578|consen  499 LKDFLDRCLVVDVEQRASAKELLEHPFLKMA  529 (550)
T ss_pred             HHHHHHHHhhcchhcCCCHHHHhcChhhhhc
Confidence            9999999999999999999999999999543

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-46  Score=403.11  Aligned_cols=263  Identities=30%  Similarity=0.603  Sum_probs=233.4

Q ss_pred             CCCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeEE
Q 004959          339 NSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFY  418 (721)
Q Consensus       339 ~~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~y  418 (721)
                      .+.|++..+||.|.-++||+|+...+++.||||++++.    +....++.+.+|+..|..++|||||+++..|..+..+|
T Consensus        25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLE----kc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LW  100 (516)
T KOG0582|consen   25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLE----KCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELW  100 (516)
T ss_pred             ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehh----hhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeE
Confidence            46899999999999999999999999999999999863    23344789999999999999999999999999999999


Q ss_pred             EEEeeccCCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCCc
Q 004959          419 IYLEYVHPGSINKYVREH-CGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQK  497 (721)
Q Consensus       419 LVmEy~~gGsL~~~L~~~-~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~~  497 (721)
                      +||.||.+|++.++++.. ...|.|..+..|+++++.||.|||.+|.||||||+.||||+.+|.|||+|||.+..+....
T Consensus       101 vVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G  180 (516)
T KOG0582|consen  101 VVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSG  180 (516)
T ss_pred             EeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCceeeeeecccC
Confidence            999999999999999865 4569999999999999999999999999999999999999999999999999876654433


Q ss_pred             cc-----ccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhcCCCCC---
Q 004959          498 AD-----LSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIP---  569 (721)
Q Consensus       498 ~~-----~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~~~~~p---  569 (721)
                      ..     .+++||++|||||+++.     ....|+.|+||||||++..||.+|..||........+...+++.+..+   
T Consensus       181 ~R~~~rf~tfvgtp~wmAPEvl~q-----~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~t~  255 (516)
T KOG0582|consen  181 DRQVTRFNTFVGTPCWMAPEVLMQ-----QLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTLLTS  255 (516)
T ss_pred             ceeeEeeccccCcccccChHHhhh-----cccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCcccc
Confidence            21     45689999999999865     456788999999999999999999999999998888877777665422   


Q ss_pred             -------CCCCHHHHHHHHHhcccCCCCCCCHHHHHhccccccCCCCC
Q 004959          570 -------DSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQPD  610 (721)
Q Consensus       570 -------~~lS~el~dLI~~cL~~DP~kRPSa~eLL~Hp~f~~~~~~~  610 (721)
                             ..++..++++|..||++||.+|||++++|+|+||+.....+
T Consensus       256 ~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~k~~~  303 (516)
T KOG0582|consen  256 GLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKAKSKE  303 (516)
T ss_pred             cCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhccchh
Confidence                   23678899999999999999999999999999999876543

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=9.8e-49  Score=400.09  Aligned_cols=245  Identities=33%  Similarity=0.590  Sum_probs=217.3

Q ss_pred             CCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeee-eEEecCe-E
Q 004959          340 SQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYG-SEIVEDK-F  417 (721)
Q Consensus       340 ~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g-~~~~~~~-~  417 (721)
                      ..|++++.||+|.||.||++.+..+|..||.|.+..   +..+....+.+..||.+|++|+|||||++++ .|..+.+ +
T Consensus        19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f---~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evl   95 (375)
T KOG0591|consen   19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQF---GMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVL   95 (375)
T ss_pred             HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcch---hhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhh
Confidence            479999999999999999999999999999999873   3345566778899999999999999999998 4555555 9


Q ss_pred             EEEEeeccCCCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHhh--CC--eeccCCCCCcEEEcCCCceEEeecCCc
Q 004959          418 YIYLEYVHPGSINKYVRE---HCGAITESVVRNFTRHILSGLAYLHS--KK--TIHRDIKGANLLVDASGVVKLADFGMA  490 (721)
Q Consensus       418 yLVmEy~~gGsL~~~L~~---~~~~Lse~~i~~i~~QIl~AL~yLHs--~g--IIHrDLKPeNILld~~g~VKL~DFGlA  490 (721)
                      +||||||.+|+|.++|+.   .+..++|..++.++.|++.||.+||.  ..  |+||||||.||+|+.+|.|||+||||+
T Consensus        96 nivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~  175 (375)
T KOG0591|consen   96 NIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLG  175 (375)
T ss_pred             HHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhH
Confidence            999999999999999854   34679999999999999999999999  44  999999999999999999999999999


Q ss_pred             cccCCCcc-cccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhcCC-CC
Q 004959          491 KHLTGQKA-DLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTP-AI  568 (721)
Q Consensus       491 ~~l~~~~~-~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~~~-~~  568 (721)
                      +.+..... ..+++|||+||+||++.       ...|+.++||||+||++|||+.-.+||.+.+-.+...+|.++.. .+
T Consensus       176 r~l~s~~tfA~S~VGTPyYMSPE~i~-------~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd~~~~  248 (375)
T KOG0591|consen  176 RFLSSKTTFAHSLVGTPYYMSPERIH-------ESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGDYPPL  248 (375)
T ss_pred             hHhcchhHHHHhhcCCCcccCHHHHh-------cCCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCCCCCC
Confidence            98876543 35689999999999994       56788899999999999999999999999877777788877654 47


Q ss_pred             C-CCCCHHHHHHHHHhcccCCCCCCCH
Q 004959          569 P-DSLSPEGKDFLRCCFQRNPADRPPA  594 (721)
Q Consensus       569 p-~~lS~el~dLI~~cL~~DP~kRPSa  594 (721)
                      | +.+|.++..||..|+..|++.||+.
T Consensus       249 p~~~YS~~l~~li~~ci~vd~~~RP~t  275 (375)
T KOG0591|consen  249 PDEHYSTDLRELINMCIAVDPEQRPDT  275 (375)
T ss_pred             cHHHhhhHHHHHHHHHccCCcccCCCc
Confidence            7 6789999999999999999999986

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=8.5e-47  Score=414.86  Aligned_cols=261  Identities=29%  Similarity=0.502  Sum_probs=233.8

Q ss_pred             CCCCCCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCC-CCCeeeeeeeEEec
Q 004959          336 LPMNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLK-HPNIVQYYGSEIVE  414 (721)
Q Consensus       336 ~~l~~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~-HPnIV~l~g~~~~~  414 (721)
                      ..+...|++++.||+|.||+||+|+++.||+.||+|++.+...  ......+.+.+|+.||+++. |||||.++++|++.
T Consensus        31 ~~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~--~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~  108 (382)
T KOG0032|consen   31 EDIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKL--RGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDP  108 (382)
T ss_pred             ccccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhc--cccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcC
Confidence            3455689999999999999999999999999999999975332  22335678999999999999 99999999999999


Q ss_pred             CeEEEEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCC----CceEEeecCCc
Q 004959          415 DKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDAS----GVVKLADFGMA  490 (721)
Q Consensus       415 ~~~yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~----g~VKL~DFGlA  490 (721)
                      +.+|+|||+|.||.|++.|...  .++|..+..++.||+.|+.|||+.||+||||||||||+...    +.+|++|||++
T Consensus       109 ~~~~lvmEL~~GGeLfd~i~~~--~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla  186 (382)
T KOG0032|consen  109 DSVYLVMELCEGGELFDRIVKK--HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLA  186 (382)
T ss_pred             CeEEEEEEecCCchHHHHHHHc--cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCc
Confidence            9999999999999999999876  39999999999999999999999999999999999999532    47999999999


Q ss_pred             cccCCCcccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhcCCCC--
Q 004959          491 KHLTGQKADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAI--  568 (721)
Q Consensus       491 ~~l~~~~~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~~~~~--  568 (721)
                      ..+..+......+||++|+|||++.       ...|+..+||||+||++|.|++|.+||.+........++......+  
T Consensus       187 ~~~~~~~~~~~~~Gtp~y~APEvl~-------~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f~~  259 (382)
T KOG0032|consen  187 KFIKPGERLHTIVGTPEYVAPEVLG-------GRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDFTS  259 (382)
T ss_pred             eEccCCceEeeecCCccccCchhhc-------CCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCCCC
Confidence            9988866677899999999999994       4567888999999999999999999999988888888888875543  


Q ss_pred             --CCCCCHHHHHHHHHhcccCCCCCCCHHHHHhccccccCC
Q 004959          569 --PDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQ  607 (721)
Q Consensus       569 --p~~lS~el~dLI~~cL~~DP~kRPSa~eLL~Hp~f~~~~  607 (721)
                        .+.++..+++||++||..||.+|+|+.++|+|||+....
T Consensus       260 ~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~HpWi~~~~  300 (382)
T KOG0032|consen  260 EPWDDISESAKDFIRKLLEFDPRKRLTAAQALQHPWIKSIG  300 (382)
T ss_pred             CCccccCHHHHHHHHHhcccCcccCCCHHHHhcCccccCCc
Confidence              456899999999999999999999999999999998753

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=1.9e-46  Score=393.52  Aligned_cols=258  Identities=22%  Similarity=0.392  Sum_probs=218.7

Q ss_pred             CeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeEEEE
Q 004959          341 QWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYIY  420 (721)
Q Consensus       341 ~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~yLV  420 (721)
                      .|++.+.||+|+||.||+|.+..+|+.||+|.+....  .........+.+|+.+|..++|+||+.+++++.+.+..++|
T Consensus         1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~--~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv   78 (285)
T cd05631           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKR--IKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLV   78 (285)
T ss_pred             CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhh--hhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEE
Confidence            3789999999999999999999999999999886321  11223345678899999999999999999999999999999


Q ss_pred             EeeccCCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCCccc
Q 004959          421 LEYVHPGSINKYVREH-CGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKAD  499 (721)
Q Consensus       421 mEy~~gGsL~~~L~~~-~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~~~~  499 (721)
                      |||+.+|+|.+++... ...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++..+......
T Consensus        79 ~e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  158 (285)
T cd05631          79 LTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETV  158 (285)
T ss_pred             EEecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCCee
Confidence            9999999999888654 246899999999999999999999999999999999999999999999999999876544444


Q ss_pred             ccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhH---H-HHHHHhhcCCCCCCCCCHH
Q 004959          500 LSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGA---A-AMFKVMRDTPAIPDSLSPE  575 (721)
Q Consensus       500 ~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~---~-~~~ki~~~~~~~p~~lS~e  575 (721)
                      ....||+.|||||++.       ...++.++|||||||+||+|++|+.||......   + ....+......++..++.+
T Consensus       159 ~~~~g~~~y~aPE~~~-------~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~  231 (285)
T cd05631         159 RGRVGTVGYMAPEVIN-------NEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFSED  231 (285)
T ss_pred             cCCCCCCCccCHhhhc-------CCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcccccCCccCCHH
Confidence            4567999999999994       345677899999999999999999999764332   1 2222333344567789999


Q ss_pred             HHHHHHHhcccCCCCCCC-----HHHHHhccccccCC
Q 004959          576 GKDFLRCCFQRNPADRPP-----ASLLLEHRFLKNSQ  607 (721)
Q Consensus       576 l~dLI~~cL~~DP~kRPS-----a~eLL~Hp~f~~~~  607 (721)
                      +.+||++||+.||++|++     ++++++||||....
T Consensus       232 ~~~li~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~~~  268 (285)
T cd05631         232 AKSICRMLLTKNPKERLGCRGNGAAGVKQHPIFKNIN  268 (285)
T ss_pred             HHHHHHHHhhcCHHHhcCCCCCCHHHHhcCHhhcCCC
Confidence            999999999999999997     89999999998754

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-47  Score=412.90  Aligned_cols=266  Identities=29%  Similarity=0.468  Sum_probs=226.8

Q ss_pred             CCCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCc---------ccHHHHHHHHHHHHHHHhCCCCCeeeeee
Q 004959          339 NSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDP---------KSAESIKQLEQEIKVLSHLKHPNIVQYYG  409 (721)
Q Consensus       339 ~~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~---------~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g  409 (721)
                      .++|++++.||+|.||+|-+|++..+++.||||++.+.....         .....++++.+||.||++|+|||||+|++
T Consensus        96 lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiE  175 (576)
T KOG0585|consen   96 LNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIE  175 (576)
T ss_pred             hhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEE
Confidence            468999999999999999999999999999999997543211         11123468999999999999999999999


Q ss_pred             eEEe--cCeEEEEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeec
Q 004959          410 SEIV--EDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADF  487 (721)
Q Consensus       410 ~~~~--~~~~yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DF  487 (721)
                      +..+  .+.+|||+|||..|.+...- ..+..+.+.+++.|++.++.||+|||.+|||||||||.|+||+++|.|||+||
T Consensus       176 vLDDP~s~~~YlVley~s~G~v~w~p-~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g~VKIsDF  254 (576)
T KOG0585|consen  176 VLDDPESDKLYLVLEYCSKGEVKWCP-PDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDGTVKISDF  254 (576)
T ss_pred             eecCcccCceEEEEEeccCCccccCC-CCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCCcEEeecc
Confidence            9876  46899999999998875332 22233999999999999999999999999999999999999999999999999


Q ss_pred             CCccccCCC------cccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHH
Q 004959          488 GMAKHLTGQ------KADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKV  561 (721)
Q Consensus       488 GlA~~l~~~------~~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki  561 (721)
                      |.+.....+      ......+|||.|||||.+.+..   .......+.||||+||+||.|+.|+.||.+....+.+.+|
T Consensus       255 GVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~---~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~~KI  331 (576)
T KOG0585|consen  255 GVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGN---SFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELFDKI  331 (576)
T ss_pred             ceeeecccCCccccHHHHhhcCCCccccchHhhcCCC---CccccchhhhhhhhhhhHHHhhhccCCcccchHHHHHHHH
Confidence            999765221      1222367999999999996521   1234466899999999999999999999999999999999


Q ss_pred             hhcCCCCCCC--CCHHHHHHHHHhcccCCCCCCCHHHHHhccccccCCC
Q 004959          562 MRDTPAIPDS--LSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQ  608 (721)
Q Consensus       562 ~~~~~~~p~~--lS~el~dLI~~cL~~DP~kRPSa~eLL~Hp~f~~~~~  608 (721)
                      +.+...+|..  +.++++|||++||++||++|++..+|..|||......
T Consensus       332 vn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~g~  380 (576)
T KOG0585|consen  332 VNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRDGD  380 (576)
T ss_pred             hcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecceeccCCC
Confidence            9998888865  7999999999999999999999999999999987643

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-46  Score=400.43  Aligned_cols=249  Identities=29%  Similarity=0.486  Sum_probs=219.9

Q ss_pred             EeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeEEEEEeeccCC
Q 004959          348 IGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYIYLEYVHPG  427 (721)
Q Consensus       348 LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~yLVmEy~~gG  427 (721)
                      ||+|+||.||+|++..+++.||||++...  ..........+.+|+.+|++++|||||++++++...+.+|+||||+.||
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~--~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g   78 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKA--HIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGG   78 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHH--HhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCC
Confidence            79999999999999999999999998631  1123345667889999999999999999999999999999999999999


Q ss_pred             CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCC-cccccCCCCC
Q 004959          428 SINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQ-KADLSMKGSP  506 (721)
Q Consensus       428 sL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~-~~~~s~~GT~  506 (721)
                      +|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..... ......+||+
T Consensus        79 ~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~  157 (312)
T cd05585          79 ELFHHLQRE-GRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTP  157 (312)
T ss_pred             cHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCCCccccccCCc
Confidence            999999764 67999999999999999999999999999999999999999999999999999764322 2234567999


Q ss_pred             ccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhcCCCCCCCCCHHHHHHHHHhccc
Q 004959          507 YWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDSLSPEGKDFLRCCFQR  586 (721)
Q Consensus       507 ~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~~~~~p~~lS~el~dLI~~cL~~  586 (721)
                      .|+|||++.       ...++.++|||||||++|+|++|+.||.+....+.+..+......++..++.++.+||.+||+.
T Consensus       158 ~y~aPE~~~-------~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~  230 (312)
T cd05585         158 EYLAPELLL-------GHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLRFPDGFDRDAKDLLIGLLSR  230 (312)
T ss_pred             ccCCHHHHc-------CCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCCCCCcCCHHHHHHHHHHcCC
Confidence            999999984       3456778999999999999999999998877777777788888888899999999999999999


Q ss_pred             CCCCCC---CHHHHHhccccccC
Q 004959          587 NPADRP---PASLLLEHRFLKNS  606 (721)
Q Consensus       587 DP~kRP---Sa~eLL~Hp~f~~~  606 (721)
                      ||++||   ++.|+|.||||...
T Consensus       231 dp~~R~~~~~~~e~l~hp~~~~~  253 (312)
T cd05585         231 DPTRRLGYNGAQEIKNHPFFSQL  253 (312)
T ss_pred             CHHHcCCCCCHHHHHcCCCcCCC
Confidence            999997   58999999999864

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=2.2e-46  Score=402.66  Aligned_cols=251  Identities=28%  Similarity=0.483  Sum_probs=220.3

Q ss_pred             eEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeEEEEEeecc
Q 004959          346 KLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYIYLEYVH  425 (721)
Q Consensus       346 k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~yLVmEy~~  425 (721)
                      +.||+|+||.||+|.+..+|+.||||++...  ..........+.+|+.+|+.++||||+++++++...+.+||||||+.
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~--~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~   78 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKE--VIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVN   78 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHH--HhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCC
Confidence            4799999999999999999999999998632  11223456678899999999999999999999999999999999999


Q ss_pred             CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCC-cccccCCC
Q 004959          426 PGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQ-KADLSMKG  504 (721)
Q Consensus       426 gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~-~~~~s~~G  504 (721)
                      +|+|..++... ..+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+++..... ......+|
T Consensus        79 ~g~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~g  157 (328)
T cd05593          79 GGELFFHLSRE-RVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCG  157 (328)
T ss_pred             CCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCCcccccccccC
Confidence            99999888664 67999999999999999999999999999999999999999999999999998764322 22345679


Q ss_pred             CCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhcCCCCCCCCCHHHHHHHHHhc
Q 004959          505 SPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDSLSPEGKDFLRCCF  584 (721)
Q Consensus       505 T~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~~~~~p~~lS~el~dLI~~cL  584 (721)
                      |+.|+|||++.       ...++.++|||||||+||+|++|+.||......+....+......+|..++.++.+||++||
T Consensus       158 t~~y~aPE~~~-------~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L  230 (328)
T cd05593         158 TPEYLAPEVLE-------DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFPRTLSADAKSLLSGLL  230 (328)
T ss_pred             CcCccChhhhc-------CCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccCCccCCCCCCHHHHHHHHHHc
Confidence            99999999984       34567789999999999999999999988777677777777777888999999999999999


Q ss_pred             ccCCCCCC-----CHHHHHhccccccC
Q 004959          585 QRNPADRP-----PASLLLEHRFLKNS  606 (721)
Q Consensus       585 ~~DP~kRP-----Sa~eLL~Hp~f~~~  606 (721)
                      +.||++|+     ++.|+++|+||...
T Consensus       231 ~~dP~~R~~~~~~~~~~il~h~~~~~~  257 (328)
T cd05593         231 IKDPNKRLGGGPDDAKEIMRHSFFTGV  257 (328)
T ss_pred             CCCHHHcCCCCCCCHHHHhcCCCcCCC
Confidence            99999997     89999999999764

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=2.4e-46  Score=401.10  Aligned_cols=252  Identities=30%  Similarity=0.503  Sum_probs=220.7

Q ss_pred             eEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeEEEEEeecc
Q 004959          346 KLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYIYLEYVH  425 (721)
Q Consensus       346 k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~yLVmEy~~  425 (721)
                      +.||+|+||.||+|.+..+|+.||+|++....  .........+.+|+.+|+.++||||+++++++...+.+||||||+.
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~   78 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEV--IIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYAN   78 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHH--hhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCC
Confidence            47999999999999999999999999986321  1123445677889999999999999999999999999999999999


Q ss_pred             CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCC-CcccccCCC
Q 004959          426 PGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTG-QKADLSMKG  504 (721)
Q Consensus       426 gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~-~~~~~s~~G  504 (721)
                      +|+|..++... ..+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..... .......+|
T Consensus        79 ~~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~g  157 (323)
T cd05595          79 GGELFFHLSRE-RVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCG  157 (323)
T ss_pred             CCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCCCccccccC
Confidence            99999888654 6799999999999999999999999999999999999999999999999999876432 223345679


Q ss_pred             CCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhcCCCCCCCCCHHHHHHHHHhc
Q 004959          505 SPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDSLSPEGKDFLRCCF  584 (721)
Q Consensus       505 T~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~~~~~p~~lS~el~dLI~~cL  584 (721)
                      |+.|+|||++.       ...++.++|||||||+||||++|+.||...+.......+......+|..+++++.+||.+||
T Consensus       158 t~~y~aPE~~~-------~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L  230 (323)
T cd05595         158 TPEYLAPEVLE-------DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLL  230 (323)
T ss_pred             CcCcCCccccc-------CCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHc
Confidence            99999999984       34567789999999999999999999988777777777777777788899999999999999


Q ss_pred             ccCCCCCC-----CHHHHHhccccccCC
Q 004959          585 QRNPADRP-----PASLLLEHRFLKNSQ  607 (721)
Q Consensus       585 ~~DP~kRP-----Sa~eLL~Hp~f~~~~  607 (721)
                      +.||++|+     ++.++++|+||....
T Consensus       231 ~~dP~~R~~~~~~~~~~~l~h~~~~~~~  258 (323)
T cd05595         231 KKDPKQRLGGGPSDAKEVMEHRFFLSIN  258 (323)
T ss_pred             cCCHHHhCCCCCCCHHHHHcCCCcCCCC
Confidence            99999998     999999999998643

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=2.6e-46  Score=405.00  Aligned_cols=256  Identities=27%  Similarity=0.449  Sum_probs=225.4

Q ss_pred             CCCeeEeeEEeecCCeEEEEEEECCCC-cEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeE
Q 004959          339 NSQWQKGKLIGRGTFGSVYVASNRETG-ALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKF  417 (721)
Q Consensus       339 ~~~y~~~k~LG~G~fG~VY~a~~~~tg-~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~  417 (721)
                      .++|++.+.||+|+||.||+|.+..++ ..||+|++....  .......+.+.+|+.+|+.++|||||++++++.+.+.+
T Consensus        29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~  106 (340)
T PTZ00426         29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSK--IIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYL  106 (340)
T ss_pred             hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHH--hhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEE
Confidence            357999999999999999999876655 689999886321  11233456788999999999999999999999999999


Q ss_pred             EEEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCCc
Q 004959          418 YIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQK  497 (721)
Q Consensus       418 yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~~  497 (721)
                      |+||||+.||+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||++..+... 
T Consensus       107 ~lv~Ey~~~g~L~~~i~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~-  184 (340)
T PTZ00426        107 YLVLEFVIGGEFFTFLRRN-KRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR-  184 (340)
T ss_pred             EEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecCCCCeecCCC-
Confidence            9999999999999999765 67999999999999999999999999999999999999999999999999999876432 


Q ss_pred             ccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhcCCCCCCCCCHHHH
Q 004959          498 ADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDSLSPEGK  577 (721)
Q Consensus       498 ~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~~~~~p~~lS~el~  577 (721)
                       ....+||+.|||||++.+       ..++.++|||||||+||||++|..||...+.......+......+|..++.++.
T Consensus       185 -~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~  256 (340)
T PTZ00426        185 -TYTLCGTPEYIAPEILLN-------VGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIYFPKFLDNNCK  256 (340)
T ss_pred             -cceecCChhhcCHHHHhC-------CCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHH
Confidence             245679999999999953       345678999999999999999999999887777777888777788899999999


Q ss_pred             HHHHHhcccCCCCCC-----CHHHHHhccccccC
Q 004959          578 DFLRCCFQRNPADRP-----PASLLLEHRFLKNS  606 (721)
Q Consensus       578 dLI~~cL~~DP~kRP-----Sa~eLL~Hp~f~~~  606 (721)
                      ++|++||+.||++|+     +++++++||||.+.
T Consensus       257 ~li~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~~  290 (340)
T PTZ00426        257 HLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGNI  290 (340)
T ss_pred             HHHHHHcccCHHHcCCCCCCCHHHHHcCCCcCCC
Confidence            999999999999995     89999999999864

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=5.7e-46  Score=404.47  Aligned_cols=257  Identities=27%  Similarity=0.437  Sum_probs=217.3

Q ss_pred             CCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeEEE
Q 004959          340 SQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYI  419 (721)
Q Consensus       340 ~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~yL  419 (721)
                      ++|++.+.||+|+||+||+|.+..+|+.||||++...  ..........+.+|+.++..++|+||+++++.+.+.+.+||
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~l   78 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKA--DMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYL   78 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHH--HHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEE
Confidence            3799999999999999999999999999999998632  11223445678899999999999999999999999999999


Q ss_pred             EEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCCc--
Q 004959          420 YLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQK--  497 (721)
Q Consensus       420 VmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~~--  497 (721)
                      |||||+||+|.+++... +.+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+++.+....  
T Consensus        79 v~E~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~  157 (363)
T cd05628          79 IMEFLPGGDMMTLLMKK-DTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRT  157 (363)
T ss_pred             EEcCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCcccccccccc
Confidence            99999999999999764 689999999999999999999999999999999999999999999999999987543211  


Q ss_pred             ----------------------------------ccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHh
Q 004959          498 ----------------------------------ADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMY  543 (721)
Q Consensus       498 ----------------------------------~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELL  543 (721)
                                                        .....+||+.|+|||++.       ...++.++|||||||+||||+
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~-------~~~~~~~~DvwSlGvil~ell  230 (363)
T cd05628         158 EFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFM-------QTGYNKLCDWWSLGVIMYEML  230 (363)
T ss_pred             cccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHc-------CCCCCCchhhhhhHHHHHHHH
Confidence                                              012457999999999994       345677899999999999999


Q ss_pred             hCCCCCCchhhHHHHHHHhhc--CCCCCC--CCCHHHHHHHHHhcccCCC---CCCCHHHHHhccccccCC
Q 004959          544 TGKPPWSEYEGAAAMFKVMRD--TPAIPD--SLSPEGKDFLRCCFQRNPA---DRPPASLLLEHRFLKNSQ  607 (721)
Q Consensus       544 tG~~PF~~~~~~~~~~ki~~~--~~~~p~--~lS~el~dLI~~cL~~DP~---kRPSa~eLL~Hp~f~~~~  607 (721)
                      +|+.||.+....+.+.++...  ...+|.  .+++++++||.+|+. +|+   .||+++||++||||+...
T Consensus       231 ~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~~~~r~~r~~~~ei~~hp~f~~~~  300 (363)
T cd05628         231 IGYPPFCSETPQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCC-EWEHRIGAPGVEEIKTNPFFEGVD  300 (363)
T ss_pred             hCCCCCCCCCHHHHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhCCCCCCCCC
Confidence            999999887777777666643  233443  478999999999775 444   468999999999998653

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=2e-45  Score=398.33  Aligned_cols=258  Identities=34%  Similarity=0.554  Sum_probs=213.0

Q ss_pred             CCCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeEE
Q 004959          339 NSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFY  418 (721)
Q Consensus       339 ~~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~y  418 (721)
                      ..+|+.++.||+|+||.||+|++..+|+.||||++...    ......+.+.+|+.+|+.++|+||+++++++...+.+|
T Consensus        73 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  148 (353)
T PLN00034         73 LSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGN----HEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQ  148 (353)
T ss_pred             HHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecC----CcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEE
Confidence            35788999999999999999999999999999998532    23345577899999999999999999999999999999


Q ss_pred             EEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCCc-
Q 004959          419 IYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQK-  497 (721)
Q Consensus       419 LVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~~-  497 (721)
                      +||||+.+|+|.+.     ..+.+..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+.... 
T Consensus       149 lv~e~~~~~~L~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~  223 (353)
T PLN00034        149 VLLEFMDGGSLEGT-----HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD  223 (353)
T ss_pred             EEEecCCCCccccc-----ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccccceecccccc
Confidence            99999999998643     346788889999999999999999999999999999999999999999999998764332 


Q ss_pred             ccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhh---HHHHHHH-hhcCCCCCCCCC
Q 004959          498 ADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEG---AAAMFKV-MRDTPAIPDSLS  573 (721)
Q Consensus       498 ~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~---~~~~~ki-~~~~~~~p~~lS  573 (721)
                      ......||..|+|||++.....  .....+.++|||||||+||||++|+.||.....   ......+ .......+..++
T Consensus       224 ~~~~~~gt~~y~aPE~~~~~~~--~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (353)
T PLN00034        224 PCNSSVGTIAYMSPERINTDLN--HGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPPEAPATAS  301 (353)
T ss_pred             cccccccCccccCccccccccc--cCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccCCCCCCCccC
Confidence            2234579999999998843211  112334579999999999999999999974221   1122222 223345567889


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHHhccccccCC
Q 004959          574 PEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQ  607 (721)
Q Consensus       574 ~el~dLI~~cL~~DP~kRPSa~eLL~Hp~f~~~~  607 (721)
                      .++++||.+||+.||++||++.|+|+||||....
T Consensus       302 ~~l~~li~~~l~~~P~~Rpt~~ell~hp~~~~~~  335 (353)
T PLN00034        302 REFRHFISCCLQREPAKRWSAMQLLQHPFILRAQ  335 (353)
T ss_pred             HHHHHHHHHHccCChhhCcCHHHHhcCcccccCC
Confidence            9999999999999999999999999999998754

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=6.2e-46  Score=387.70  Aligned_cols=253  Identities=26%  Similarity=0.444  Sum_probs=210.3

Q ss_pred             CCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeEEE
Q 004959          340 SQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYI  419 (721)
Q Consensus       340 ~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~yL  419 (721)
                      ++|++.+.||+|+||.||+|+++.+++.||||++....   ......+.+.+|+.+++.++|+||+++++++...+.+|+
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   77 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSE---ENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYL   77 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEeccc---ccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEE
Confidence            36999999999999999999999999999999986422   122345678899999999999999999999999999999


Q ss_pred             EEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCCc--
Q 004959          420 YLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQK--  497 (721)
Q Consensus       420 VmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~~--  497 (721)
                      ||||+.++.|..+. .....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+....  
T Consensus        78 v~e~~~~~~l~~~~-~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  156 (287)
T cd07848          78 VFEYVEKNMLELLE-EMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNA  156 (287)
T ss_pred             EEecCCCCHHHHHH-hcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCcccccccccc
Confidence            99999987665544 334679999999999999999999999999999999999999999999999999998764322  


Q ss_pred             ccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhcCC-----------
Q 004959          498 ADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTP-----------  566 (721)
Q Consensus       498 ~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~~~-----------  566 (721)
                      ......||+.|+|||++.+       ..++.++|||||||++|||++|+.||......+....+.....           
T Consensus       157 ~~~~~~~~~~y~aPE~~~~-------~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (287)
T cd07848         157 NYTEYVATRWYRSPELLLG-------APYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFY  229 (287)
T ss_pred             cccccccccccCCcHHHcC-------CCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhh
Confidence            2234579999999999843       3466789999999999999999999987554443332221100           


Q ss_pred             ---------------------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccc
Q 004959          567 ---------------------AIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFL  603 (721)
Q Consensus       567 ---------------------~~p~~lS~el~dLI~~cL~~DP~kRPSa~eLL~Hp~f  603 (721)
                                           .....++.++.+||++||+.||++|||++|+|+||||
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f  287 (287)
T cd07848         230 SNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF  287 (287)
T ss_pred             ccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence                                 0112378899999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=1.1e-45  Score=388.24  Aligned_cols=253  Identities=26%  Similarity=0.468  Sum_probs=212.0

Q ss_pred             CCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeEEE
Q 004959          340 SQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYI  419 (721)
Q Consensus       340 ~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~yL  419 (721)
                      ++|++.+.||+|+||.||+|.+..+++.||+|++......    .....+.+|+.+|+.++||||+++++++.+++..|+
T Consensus         5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l   80 (288)
T cd07871           5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEE----GAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTL   80 (288)
T ss_pred             ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccC----CcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEE
Confidence            4799999999999999999999999999999998642211    123456789999999999999999999999999999


Q ss_pred             EEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCCc-c
Q 004959          420 YLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQK-A  498 (721)
Q Consensus       420 VmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~~-~  498 (721)
                      ||||+. ++|.+++......+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...... .
T Consensus        81 v~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~~  159 (288)
T cd07871          81 VFEYLD-SDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKT  159 (288)
T ss_pred             EEeCCC-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceeeccCCCcc
Confidence            999997 59999987765678999999999999999999999999999999999999999999999999997654322 2


Q ss_pred             cccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhcCC------------
Q 004959          499 DLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTP------------  566 (721)
Q Consensus       499 ~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~~~------------  566 (721)
                      .....|++.|+|||++.+      ...++.++|||||||++|+|++|+.||.+....+.+..+.....            
T Consensus       160 ~~~~~~~~~y~aPE~~~~------~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (288)
T cd07871         160 YSNEVVTLWYRPPDVLLG------STEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITS  233 (288)
T ss_pred             ccCceecccccChHHhcC------CcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhcccc
Confidence            234568999999999842      24567789999999999999999999987655544433321100            


Q ss_pred             -------C-----------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccc
Q 004959          567 -------A-----------IPDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFL  603 (721)
Q Consensus       567 -------~-----------~p~~lS~el~dLI~~cL~~DP~kRPSa~eLL~Hp~f  603 (721)
                             .           ....++.++++||++||+.||.+|||++|+|+||||
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f  288 (288)
T cd07871         234 NEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF  288 (288)
T ss_pred             chhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence                   0           112468899999999999999999999999999997

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=6.6e-47  Score=394.11  Aligned_cols=263  Identities=29%  Similarity=0.479  Sum_probs=225.6

Q ss_pred             CCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEe--cCeE
Q 004959          340 SQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIV--EDKF  417 (721)
Q Consensus       340 ~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~--~~~~  417 (721)
                      +.|+.+..|++|+||+||+|+++.|++.||+|.++..+..   ...--.-.+||.+|.+++|||||.+-++..-  -+.+
T Consensus        76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek---~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~i  152 (419)
T KOG0663|consen   76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEK---EGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKI  152 (419)
T ss_pred             HHHHHHhhcccCcceeEEEeccCCcceeEEeeeccccccc---CCCcchhHHHHHHHHhcCCCCeeeeEEEEecccccee
Confidence            5799999999999999999999999999999998753321   1111235789999999999999999987653  4679


Q ss_pred             EEEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCCc
Q 004959          418 YIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQK  497 (721)
Q Consensus       418 yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~~  497 (721)
                      |||||||+ -+|..++....+.|...+++.++.|++.||+|||.+.|+|||||++|+|++..|.+||+|||+|+.+....
T Consensus       153 y~VMe~~E-hDLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~  231 (419)
T KOG0663|consen  153 YIVMEYVE-HDLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGLAREYGSPL  231 (419)
T ss_pred             eeeHHHHH-hhHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccchhhhhcCCc
Confidence            99999997 79999998887899999999999999999999999999999999999999999999999999999987765


Q ss_pred             cc-ccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhcCC----------
Q 004959          498 AD-LSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTP----------  566 (721)
Q Consensus       498 ~~-~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~~~----------  566 (721)
                      .. ...+-|.||+|||+|.+      ...|+.++||||+|||+.||+++++.|.+....+++.+|.+...          
T Consensus       232 k~~T~lVVTLWYRaPELLLG------~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~  305 (419)
T KOG0663|consen  232 KPYTPLVVTLWYRAPELLLG------AKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGY  305 (419)
T ss_pred             ccCcceEEEeeecCHHHhcC------CcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCc
Confidence            43 44678999999999985      45688899999999999999999999999888888877754210          


Q ss_pred             -C--------------------CCC-CCCHHHHHHHHHhcccCCCCCCCHHHHHhccccccCCCCCCC
Q 004959          567 -A--------------------IPD-SLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQPDVP  612 (721)
Q Consensus       567 -~--------------------~p~-~lS~el~dLI~~cL~~DP~kRPSa~eLL~Hp~f~~~~~~~~~  612 (721)
                       .                    ++. .+++...+|+..+|.+||++|.|++|+|+|.||.+...+..+
T Consensus       306 ~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~P~p~~P  373 (419)
T KOG0663|consen  306 SELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRETPLPIDP  373 (419)
T ss_pred             cccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccccccCCCCCCh
Confidence             0                    111 156999999999999999999999999999999987666444

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=1.6e-45  Score=389.38  Aligned_cols=256  Identities=25%  Similarity=0.491  Sum_probs=210.5

Q ss_pred             CCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeEEE
Q 004959          340 SQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYI  419 (721)
Q Consensus       340 ~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~yL  419 (721)
                      ++|++.+.||+|+||.||+|.++.+|+.||||++......    .....+.+|+.+|+.++||||+++++++.+.+..|+
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l   80 (303)
T cd07869           5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEE----GTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTL   80 (303)
T ss_pred             ccceEeeeEEecCCEEEEEEEECCCCCEEEEEEecccccc----ccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEE
Confidence            5899999999999999999999999999999998643211    122356789999999999999999999999999999


Q ss_pred             EEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCCc-c
Q 004959          420 YLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQK-A  498 (721)
Q Consensus       420 VmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~~-~  498 (721)
                      ||||+. ++|.+++....+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++....... .
T Consensus        81 v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  159 (303)
T cd07869          81 VFEYVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHT  159 (303)
T ss_pred             EEECCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcceeccCCCcc
Confidence            999995 68888887766789999999999999999999999999999999999999999999999999987543322 2


Q ss_pred             cccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhH-HHHHHHhh---cC---------
Q 004959          499 DLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGA-AAMFKVMR---DT---------  565 (721)
Q Consensus       499 ~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~-~~~~ki~~---~~---------  565 (721)
                      .....||+.|+|||++.+      ...++.++|||||||++|+|++|..||.+.... +.+..+..   ..         
T Consensus       160 ~~~~~~~~~y~aPE~~~~------~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (303)
T cd07869         160 YSNEVVTLWYRPPDVLLG------STEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVH  233 (303)
T ss_pred             CCCCcccCCCCChHHHcC------CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchh
Confidence            234568999999999852      234677899999999999999999999764332 22222111   00         


Q ss_pred             --CC---------CC---------CCCCHHHHHHHHHhcccCCCCCCCHHHHHhccccccC
Q 004959          566 --PA---------IP---------DSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNS  606 (721)
Q Consensus       566 --~~---------~p---------~~lS~el~dLI~~cL~~DP~kRPSa~eLL~Hp~f~~~  606 (721)
                        +.         .+         ..++.++++||.+||+.||++|||+.|+|+||||++.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~~  294 (303)
T cd07869         234 SLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDL  294 (303)
T ss_pred             hccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcccccC
Confidence              00         00         1245789999999999999999999999999999865

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.1e-46  Score=403.48  Aligned_cols=256  Identities=30%  Similarity=0.510  Sum_probs=218.6

Q ss_pred             CCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeEEE
Q 004959          340 SQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYI  419 (721)
Q Consensus       340 ~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~yL  419 (721)
                      ++|++.+.||+|+||+||+|++..+|+.||||++...  ........+.+.+|+.+|+.++||||+++++++.+.+.+||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~l   78 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKS--EMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYL   78 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHH--HhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEE
Confidence            3799999999999999999999999999999998632  11123445678899999999999999999999999999999


Q ss_pred             EEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCCc--
Q 004959          420 YLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQK--  497 (721)
Q Consensus       420 VmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~~--  497 (721)
                      |||||.||+|.+++... +.+++..++.++.||+.||+|||++||+||||||+||||+.+|.+||+|||++..+....  
T Consensus        79 v~E~~~~g~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~  157 (364)
T cd05599          79 IMEYLPGGDMMTLLMKK-DTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRT  157 (364)
T ss_pred             EECCCCCcHHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceeccccccc
Confidence            99999999999999764 679999999999999999999999999999999999999999999999999987643211  


Q ss_pred             -------------------------------------ccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHH
Q 004959          498 -------------------------------------ADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTII  540 (721)
Q Consensus       498 -------------------------------------~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILy  540 (721)
                                                           .....+||+.|+|||++.       ...++.++|||||||++|
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~~DiwSlG~il~  230 (364)
T cd05599         158 EFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFL-------QTGYNKECDWWSLGVIMY  230 (364)
T ss_pred             cccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHc-------CCCCCCeeeeecchhHHH
Confidence                                                 011346999999999984       345677899999999999


Q ss_pred             HHhhCCCCCCchhhHHHHHHHhhcC--CCCCC--CCCHHHHHHHHHhcccCCCCCCC---HHHHHhccccccC
Q 004959          541 EMYTGKPPWSEYEGAAAMFKVMRDT--PAIPD--SLSPEGKDFLRCCFQRNPADRPP---ASLLLEHRFLKNS  606 (721)
Q Consensus       541 ELLtG~~PF~~~~~~~~~~ki~~~~--~~~p~--~lS~el~dLI~~cL~~DP~kRPS---a~eLL~Hp~f~~~  606 (721)
                      ||++|..||......+.+..+....  ..++.  .+++++++||++||. +|.+|++   +.|+++||||+..
T Consensus       231 el~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h~~~~~~  302 (364)
T cd05599         231 EMLVGYPPFCSDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHPFFKGV  302 (364)
T ss_pred             HhhcCCCCCCCCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcCCCcCCC
Confidence            9999999998877666666665432  22232  478999999999997 9999998   9999999999864

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=3.9e-46  Score=399.11  Aligned_cols=252  Identities=29%  Similarity=0.497  Sum_probs=219.9

Q ss_pred             eEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeEEEEEeecc
Q 004959          346 KLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYIYLEYVH  425 (721)
Q Consensus       346 k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~yLVmEy~~  425 (721)
                      ++||+|+||.||+|.+..+|+.||+|++....  .........+.+|+++++.++||||+++++++...+.+||||||+.
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~   78 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEV--IVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYAN   78 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHH--hhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCC
Confidence            47999999999999999999999999986321  1223345677889999999999999999999999999999999999


Q ss_pred             CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhh-CCeeccCCCCCcEEEcCCCceEEeecCCccccCCC-cccccCC
Q 004959          426 PGSINKYVREHCGAITESVVRNFTRHILSGLAYLHS-KKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQ-KADLSMK  503 (721)
Q Consensus       426 gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs-~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~-~~~~s~~  503 (721)
                      +|+|..++... ..+++..++.++.||+.||.|||+ +||+||||||+||||+.++.+||+|||++...... ......+
T Consensus        79 ~~~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~  157 (325)
T cd05594          79 GGELFFHLSRE-RVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFC  157 (325)
T ss_pred             CCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCccccccc
Confidence            99999888654 679999999999999999999997 79999999999999999999999999998754322 2233467


Q ss_pred             CCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhcCCCCCCCCCHHHHHHHHHh
Q 004959          504 GSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDSLSPEGKDFLRCC  583 (721)
Q Consensus       504 GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~~~~~p~~lS~el~dLI~~c  583 (721)
                      ||+.|||||++.       ...++.++|||||||+||+|++|..||.+.........+......++..+++++.+||++|
T Consensus       158 gt~~y~aPE~~~-------~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~  230 (325)
T cd05594         158 GTPEYLAPEVLE-------DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLSGL  230 (325)
T ss_pred             CCcccCCHHHHc-------cCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHH
Confidence            999999999984       3456778999999999999999999998877777777777777788889999999999999


Q ss_pred             cccCCCCCC-----CHHHHHhccccccCC
Q 004959          584 FQRNPADRP-----PASLLLEHRFLKNSQ  607 (721)
Q Consensus       584 L~~DP~kRP-----Sa~eLL~Hp~f~~~~  607 (721)
                      |+.||++|+     ++.++++|+||.+..
T Consensus       231 L~~dP~~R~~~~~~~~~~il~h~~~~~~~  259 (325)
T cd05594         231 LKKDPKQRLGGGPDDAKEIMQHKFFAGIV  259 (325)
T ss_pred             hhcCHHHhCCCCCCCHHHHhcCCCcCCCC
Confidence            999999997     999999999998643

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.5e-46  Score=397.46  Aligned_cols=255  Identities=27%  Similarity=0.443  Sum_probs=219.4

Q ss_pred             CCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeEEE
Q 004959          340 SQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYI  419 (721)
Q Consensus       340 ~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~yL  419 (721)
                      ++|++.+.||+|+||.||+|++..+|+.||||++....  .......+.+.+|+.+|..++||||+++++++...+..||
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~l   78 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSL--LFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYL   78 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHH--HhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEE
Confidence            37999999999999999999999999999999986321  1122345678899999999999999999999999999999


Q ss_pred             EEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCCccc
Q 004959          420 YLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKAD  499 (721)
Q Consensus       420 VmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~~~~  499 (721)
                      ||||++||+|.+++... +.+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++.....  ..
T Consensus        79 v~e~~~g~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~--~~  155 (333)
T cd05600          79 AMEYVPGGDFRTLLNNL-GVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT--YA  155 (333)
T ss_pred             EEeCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCccccc--cc
Confidence            99999999999999764 6799999999999999999999999999999999999999999999999999986543  23


Q ss_pred             ccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhcC--CCCC------CC
Q 004959          500 LSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDT--PAIP------DS  571 (721)
Q Consensus       500 ~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~~--~~~p------~~  571 (721)
                      ...+||+.|+|||++.       ...++.++|||||||+||||++|..||......+.+..+....  ...+      ..
T Consensus       156 ~~~~gt~~y~aPE~~~-------~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  228 (333)
T cd05600         156 NSVVGSPDYMAPEVLR-------GKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFN  228 (333)
T ss_pred             CCcccCccccChhHhc-------CCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccCCCCCccccc
Confidence            4567999999999984       3456778999999999999999999998776655555443321  1111      15


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHHHHhccccccC
Q 004959          572 LSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNS  606 (721)
Q Consensus       572 lS~el~dLI~~cL~~DP~kRPSa~eLL~Hp~f~~~  606 (721)
                      +++++.+||.+||..+|++||++.++++||||...
T Consensus       229 ~s~~~~~li~~~l~~~~~rr~s~~~ll~h~~~~~~  263 (333)
T cd05600         229 LSDEAWDLITKLINDPSRRFGSLEDIKNHPFFKEV  263 (333)
T ss_pred             cCHHHHHHHHHHhhChhhhcCCHHHHHhCcccCCC
Confidence            68999999999999999999999999999999875

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=3.6e-47  Score=386.79  Aligned_cols=267  Identities=24%  Similarity=0.423  Sum_probs=239.7

Q ss_pred             CCCCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCc---ccHHHHHHHHHHHHHHHhCC-CCCeeeeeeeEEe
Q 004959          338 MNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDP---KSAESIKQLEQEIKVLSHLK-HPNIVQYYGSEIV  413 (721)
Q Consensus       338 l~~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~---~~~~~~k~~~~Ei~iL~~L~-HPnIV~l~g~~~~  413 (721)
                      +...|...+.||+|..++|-.|.++.+|+.+|+|++.......   ......+.-.+|+.||+++. ||+|+++.++|+.
T Consensus        15 fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes   94 (411)
T KOG0599|consen   15 FYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYES   94 (411)
T ss_pred             HHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccC
Confidence            3456777889999999999999999999999999997543222   22344566788999999985 9999999999999


Q ss_pred             cCeEEEEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCcccc
Q 004959          414 EDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHL  493 (721)
Q Consensus       414 ~~~~yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l  493 (721)
                      ...+++|+|.|+.|.|+++|... -.++|...+.||+||++|++|||.++||||||||+|||++++.+|||.|||+++.+
T Consensus        95 ~sF~FlVFdl~prGELFDyLts~-VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDFGFa~~l  173 (411)
T KOG0599|consen   95 DAFVFLVFDLMPRGELFDYLTSK-VTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDFGFACQL  173 (411)
T ss_pred             cchhhhhhhhcccchHHHHhhhh-eeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEeccceeecc
Confidence            99999999999999999999875 68999999999999999999999999999999999999999999999999999999


Q ss_pred             CCCcccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhcCCCC----C
Q 004959          494 TGQKADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAI----P  569 (721)
Q Consensus       494 ~~~~~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~~~~~----p  569 (721)
                      ..++.....||||.|+|||.+.+..+.. ...|+..+|+|++|||||.||.|.+||-.....-++..|+.+...+    +
T Consensus       174 ~~GekLrelCGTPgYLAPEtikC~m~e~-~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyqF~speW  252 (411)
T KOG0599|consen  174 EPGEKLRELCGTPGYLAPETIKCSMYEN-HPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQFRSPEW  252 (411)
T ss_pred             CCchhHHHhcCCCcccChhheeeecccC-CCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccccCCcch
Confidence            9999989999999999999998877765 4688999999999999999999999999888777888888876554    3


Q ss_pred             CCCCHHHHHHHHHhcccCCCCCCCHHHHHhccccccC
Q 004959          570 DSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNS  606 (721)
Q Consensus       570 ~~lS~el~dLI~~cL~~DP~kRPSa~eLL~Hp~f~~~  606 (721)
                      ..++.+.+|||.+||+.||.+|+|++|+|.||||...
T Consensus       253 adis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q~  289 (411)
T KOG0599|consen  253 ADISATVKDLISRLLQVDPTKRITAKEALAHPFFIQI  289 (411)
T ss_pred             hhccccHHHHHHHHHeeCchhcccHHHHhcChHHHHH
Confidence            5689999999999999999999999999999999643

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=1.3e-45  Score=394.94  Aligned_cols=255  Identities=29%  Similarity=0.503  Sum_probs=220.4

Q ss_pred             eeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHH---HhCCCCCeeeeeeeEEecCeEE
Q 004959          342 WQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVL---SHLKHPNIVQYYGSEIVEDKFY  418 (721)
Q Consensus       342 y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL---~~L~HPnIV~l~g~~~~~~~~y  418 (721)
                      |++.+.||+|+||.||+|.+..+|+.||||++...  ........+.+.+|++++   +.++||||+++++++...+.+|
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~   78 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKG--DIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVC   78 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHH--HhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEE
Confidence            67899999999999999999999999999998632  111223345666776665   5667999999999999999999


Q ss_pred             EEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCC-c
Q 004959          419 IYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQ-K  497 (721)
Q Consensus       419 LVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~-~  497 (721)
                      +||||+.|++|..++..  +.+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++...... .
T Consensus        79 lv~E~~~~~~L~~~~~~--~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~  156 (324)
T cd05589          79 FVMEYAAGGDLMMHIHT--DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGD  156 (324)
T ss_pred             EEEcCCCCCcHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCccCCCCCC
Confidence            99999999999988854  57999999999999999999999999999999999999999999999999998754322 2


Q ss_pred             ccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhcCCCCCCCCCHHHH
Q 004959          498 ADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDSLSPEGK  577 (721)
Q Consensus       498 ~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~~~~~p~~lS~el~  577 (721)
                      .....+|++.|||||++.       ...++.++|||||||++|+|++|+.||.+....+.+..+......++..++.++.
T Consensus       157 ~~~~~~g~~~y~aPE~~~-------~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~  229 (324)
T cd05589         157 RTSTFCGTPEFLAPEVLT-------ETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSREAI  229 (324)
T ss_pred             cccccccCccccCHhHhc-------CCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHH
Confidence            334567999999999984       3456778999999999999999999999877777777777777788889999999


Q ss_pred             HHHHHhcccCCCCCC-----CHHHHHhccccccCC
Q 004959          578 DFLRCCFQRNPADRP-----PASLLLEHRFLKNSQ  607 (721)
Q Consensus       578 dLI~~cL~~DP~kRP-----Sa~eLL~Hp~f~~~~  607 (721)
                      +||.+||+.||++||     ++.++++||||.+..
T Consensus       230 ~li~~~L~~dP~~R~~~~~~~~~~l~~~~~f~~~~  264 (324)
T cd05589         230 SIMRRLLRRNPERRLGSGEKDAEDVKKQPFFRDIN  264 (324)
T ss_pred             HHHHHHhhcCHhHcCCCCCCCHHHHhhCCCcCCCC
Confidence            999999999999999     799999999998643

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2.3e-46  Score=399.31  Aligned_cols=261  Identities=26%  Similarity=0.441  Sum_probs=231.5

Q ss_pred             CCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeEEE
Q 004959          340 SQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYI  419 (721)
Q Consensus       340 ~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~yL  419 (721)
                      ..|++++.||+|.-|+||+|..+.++..+|||++.+.  .......+.+.+.|..||..++||.++.||..|+.++..|+
T Consensus        77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~--~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl  154 (459)
T KOG0610|consen   77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKE--SLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCL  154 (459)
T ss_pred             HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHH--HHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEE
Confidence            4789999999999999999999999999999999742  22335567788999999999999999999999999999999


Q ss_pred             EEeeccCCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCC---
Q 004959          420 YLEYVHPGSINKYVREH-CGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTG---  495 (721)
Q Consensus       420 VmEy~~gGsL~~~L~~~-~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~---  495 (721)
                      |||||.||+|..++++. ...|+|..++.|+..|+.||+|||-+|||+||||||||||.++|+|+|.||.|+..+..   
T Consensus       155 ~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIMLsDFDLS~~~~~~Pt  234 (459)
T KOG0610|consen  155 VMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLSDFDLSLRCPVSPT  234 (459)
T ss_pred             EEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEeeeccccccCCCCCe
Confidence            99999999999998765 56799999999999999999999999999999999999999999999999998643210   


Q ss_pred             ------------------------------C-c-----------------------ccccCCCCCccCChhhHHHHhhcC
Q 004959          496 ------------------------------Q-K-----------------------ADLSMKGSPYWMAPELMMAVMQKG  521 (721)
Q Consensus       496 ------------------------------~-~-----------------------~~~s~~GT~~Y~APEvl~~~~~~~  521 (721)
                                                    . .                       ...+++||-+|+|||++.      
T Consensus       235 ~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~------  308 (459)
T KOG0610|consen  235 LVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIR------  308 (459)
T ss_pred             eeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeee------
Confidence                                          0 0                       012367999999999994      


Q ss_pred             CCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhcCCCCCC--CCCHHHHHHHHHhcccCCCCCCC----HH
Q 004959          522 KSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPD--SLSPEGKDFLRCCFQRNPADRPP----AS  595 (721)
Q Consensus       522 k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~~~~~p~--~lS~el~dLI~~cL~~DP~kRPS----a~  595 (721)
                       +..-+.++|+|+|||+|||||+|..||.+.+..+.+.+|+.....+|.  .++..++|||+++|.+||.+|..    ++
T Consensus       309 -G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~kRlg~~rGA~  387 (459)
T KOG0610|consen  309 -GEGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPEEPEVSSAAKDLIRKLLVKDPSKRLGSKRGAA  387 (459)
T ss_pred             -cCCCCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCCCCcchhHHHHHHHHHhccChhhhhccccchH
Confidence             455667899999999999999999999999999999999998887775  57899999999999999999998    99


Q ss_pred             HHHhccccccCCCC
Q 004959          596 LLLEHRFLKNSQQP  609 (721)
Q Consensus       596 eLL~Hp~f~~~~~~  609 (721)
                      ||-+||||++..-.
T Consensus       388 eIK~HpFF~gVnWa  401 (459)
T KOG0610|consen  388 EIKRHPFFEGVNWA  401 (459)
T ss_pred             HhhcCccccCCChh
Confidence            99999999987654

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.3e-46  Score=399.95  Aligned_cols=256  Identities=31%  Similarity=0.521  Sum_probs=221.6

Q ss_pred             CCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeEEE
Q 004959          340 SQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYI  419 (721)
Q Consensus       340 ~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~yL  419 (721)
                      ++|++++.||+|+||+||+|.+..+|+.||||++...  ..........+.+|+.+|..++|+||+++++++.+.+.+|+
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~l   78 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKS--DMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYL   78 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHH--HHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEE
Confidence            3799999999999999999999999999999998632  11122345678899999999999999999999999999999


Q ss_pred             EEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCCc--
Q 004959          420 YLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQK--  497 (721)
Q Consensus       420 VmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~~--  497 (721)
                      ||||+.|++|.+++... +.+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+....  
T Consensus        79 v~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~  157 (350)
T cd05573          79 VMEYMPGGDLMNLLIRK-DVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDR  157 (350)
T ss_pred             EEcCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCcc
Confidence            99999999999999775 789999999999999999999999999999999999999999999999999998765433  


Q ss_pred             ----------------------------ccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCC
Q 004959          498 ----------------------------ADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPW  549 (721)
Q Consensus       498 ----------------------------~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF  549 (721)
                                                  ......||+.|+|||++.+       ..++.++|||||||+||||++|+.||
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwSlG~il~ell~g~~Pf  230 (350)
T cd05573         158 EYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRG-------TPYGLECDWWSLGVILYEMLYGFPPF  230 (350)
T ss_pred             cccccccccccccccccccccccccccccccccccCccccCHHHHcC-------CCCCCceeeEecchhhhhhccCCCCC
Confidence                                        1234569999999999953       35677899999999999999999999


Q ss_pred             CchhhHHHHHHHhh--cCCCCCC--CCCHHHHHHHHHhcccCCCCCCC-HHHHHhccccccC
Q 004959          550 SEYEGAAAMFKVMR--DTPAIPD--SLSPEGKDFLRCCFQRNPADRPP-ASLLLEHRFLKNS  606 (721)
Q Consensus       550 ~~~~~~~~~~ki~~--~~~~~p~--~lS~el~dLI~~cL~~DP~kRPS-a~eLL~Hp~f~~~  606 (721)
                      ......+...++..  ....+|.  .+++++.+||.+||. ||++|++ ++++++||||++.
T Consensus       231 ~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~~~~~  291 (350)
T cd05573         231 YSDTLQETYNKIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPFFKGI  291 (350)
T ss_pred             CCCCHHHHHHHHhccCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCCCcCCC
Confidence            88776666666665  3333333  369999999999997 9999999 9999999999864

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=5.3e-47  Score=380.66  Aligned_cols=256  Identities=28%  Similarity=0.526  Sum_probs=234.7

Q ss_pred             CCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeEEE
Q 004959          340 SQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYI  419 (721)
Q Consensus       340 ~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~yL  419 (721)
                      ++|++++.||+|-||.||+|+.+.++-.||+|++.+.  .....+..+++.+|++|...|+||||+++|++|.+...+||
T Consensus        22 ~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKs--qi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyL   99 (281)
T KOG0580|consen   22 DDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKS--QILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYL   99 (281)
T ss_pred             hhccccccccCCccccEeEeeeccCCcEEEEeeeeHH--HHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEE
Confidence            5899999999999999999999999999999998742  22333455789999999999999999999999999999999


Q ss_pred             EEeeccCCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCCcc
Q 004959          420 YLEYVHPGSINKYVREH-CGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKA  498 (721)
Q Consensus       420 VmEy~~gGsL~~~L~~~-~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~~~  498 (721)
                      ++||...|+|+..|... ...++|..+..|+.|++.||.|||.++||||||||+|+|++..|.+||+|||-+.... ...
T Consensus       100 ilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p-~~k  178 (281)
T KOG0580|consen  100 ILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP-SNK  178 (281)
T ss_pred             EEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCCceeecC-CCC
Confidence            99999999999999854 4679999999999999999999999999999999999999999999999999987654 556


Q ss_pred             cccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhcCCCCCCCCCHHHHH
Q 004959          499 DLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDSLSPEGKD  578 (721)
Q Consensus       499 ~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~~~~~p~~lS~el~d  578 (721)
                      ..+.|||..|.+||..       .+...+..+|+|++|++.||++.|.+||......+.+.+|.+....+|..++.++.|
T Consensus       179 R~tlcgt~dyl~pEmv-------~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~~~~p~~is~~a~d  251 (281)
T KOG0580|consen  179 RKTLCGTLDYLPPEMV-------EGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVDLKFPSTISGGAAD  251 (281)
T ss_pred             ceeeecccccCCHhhc-------CCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHccccCCcccChhHHH
Confidence            6789999999999998       455667789999999999999999999999988899999999889999999999999


Q ss_pred             HHHHhcccCCCCCCCHHHHHhcccccc
Q 004959          579 FLRCCFQRNPADRPPASLLLEHRFLKN  605 (721)
Q Consensus       579 LI~~cL~~DP~kRPSa~eLL~Hp~f~~  605 (721)
                      ||.+||.++|.+|.+..|++.|||+..
T Consensus       252 lI~~ll~~~p~~r~~l~~v~~hpwI~a  278 (281)
T KOG0580|consen  252 LISRLLVKNPIERLALTEVMDHPWIVA  278 (281)
T ss_pred             HHHHHhccCccccccHHHHhhhHHHHh
Confidence            999999999999999999999999864

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=3.3e-45  Score=391.01  Aligned_cols=259  Identities=25%  Similarity=0.447  Sum_probs=209.7

Q ss_pred             CeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEec-----C
Q 004959          341 QWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVE-----D  415 (721)
Q Consensus       341 ~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~-----~  415 (721)
                      +|++.+.||+|+||.||+|++..+|+.||||++....   ........+.+|+.+|+.++||||+++++++...     .
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~   77 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVF---EHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFK   77 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhh---ccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCc
Confidence            5899999999999999999999999999999885321   1223345788999999999999999999987643     3


Q ss_pred             eEEEEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCC
Q 004959          416 KFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTG  495 (721)
Q Consensus       416 ~~yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~  495 (721)
                      .+|+|||||. ++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus        78 ~~~lv~e~~~-~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~  155 (338)
T cd07859          78 DIYVVFELME-SDLHQVIKAN-DDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFN  155 (338)
T ss_pred             eEEEEEecCC-CCHHHHHHhc-ccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCcccccccc
Confidence            5899999995 7899988764 6799999999999999999999999999999999999999999999999999986533


Q ss_pred             Ccc----cccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHh---------
Q 004959          496 QKA----DLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVM---------  562 (721)
Q Consensus       496 ~~~----~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~---------  562 (721)
                      ...    ....+||+.|+|||++.+     ....++.++|||||||++|||++|+.||.+......+..+.         
T Consensus       156 ~~~~~~~~~~~~~t~~y~aPE~~~~-----~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~  230 (338)
T cd07859         156 DTPTAIFWTDYVATRWYRAPELCGS-----FFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPE  230 (338)
T ss_pred             ccCccccccCCCCCCCcCCHHHHhc-----cccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHH
Confidence            221    134579999999999853     12456778999999999999999999997654322211110         


Q ss_pred             -----------------hcCCC-----CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhccccccCCCC
Q 004959          563 -----------------RDTPA-----IPDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQP  609 (721)
Q Consensus       563 -----------------~~~~~-----~p~~lS~el~dLI~~cL~~DP~kRPSa~eLL~Hp~f~~~~~~  609 (721)
                                       .....     ....++.++.+||.+||+.||++||+++|+|+||||+.....
T Consensus       231 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~~~~  299 (338)
T cd07859         231 TISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLAKV  299 (338)
T ss_pred             HHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhcCcc
Confidence                             00000     112467889999999999999999999999999999876554

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=1.8e-45  Score=403.39  Aligned_cols=256  Identities=28%  Similarity=0.451  Sum_probs=214.9

Q ss_pred             CeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeEEEE
Q 004959          341 QWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYIY  420 (721)
Q Consensus       341 ~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~yLV  420 (721)
                      .|++++.||+|+||+||+|++..+++.||||++...  ........+.+.+|+.+|+.++|+|||++++++.+.+.+|+|
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~--~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv   79 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKK--DVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFV   79 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHH--HhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEE
Confidence            689999999999999999999999999999998632  122334567889999999999999999999999999999999


Q ss_pred             EeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCCc---
Q 004959          421 LEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQK---  497 (721)
Q Consensus       421 mEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~~---  497 (721)
                      |||+.||+|.+++... +.+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+....   
T Consensus        80 ~E~~~gg~L~~~l~~~-~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~  158 (381)
T cd05626          80 MDYIPGGDMMSLLIRM-EVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSK  158 (381)
T ss_pred             EecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCcccccccccc
Confidence            9999999999999765 679999999999999999999999999999999999999999999999999976431100   


Q ss_pred             ---------------------------------------------ccccCCCCCccCChhhHHHHhhcCCCCCCcchhhH
Q 004959          498 ---------------------------------------------ADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDI  532 (721)
Q Consensus       498 ---------------------------------------------~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDV  532 (721)
                                                                   .....+||+.|+|||++.+       ..++.++||
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-------~~~~~~~Di  231 (381)
T cd05626         159 YYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLR-------KGYTQLCDW  231 (381)
T ss_pred             cccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcC-------CCCCCccce
Confidence                                                         0123579999999999843       446778999


Q ss_pred             HHHHHHHHHHhhCCCCCCchhhHHHHHHHhhc--CCCCCC--CCCHHHHHHHHHhcc--cCCCCCCCHHHHHhccccccC
Q 004959          533 WSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRD--TPAIPD--SLSPEGKDFLRCCFQ--RNPADRPPASLLLEHRFLKNS  606 (721)
Q Consensus       533 WSLGVILyELLtG~~PF~~~~~~~~~~ki~~~--~~~~p~--~lS~el~dLI~~cL~--~DP~kRPSa~eLL~Hp~f~~~  606 (721)
                      |||||++|||++|..||......+...++...  ...++.  .+++++.+||.+||.  .++..|+++++++.||||...
T Consensus       232 wSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~hp~f~~~  311 (381)
T cd05626         232 WSVGVILFEMLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAHPFFSEV  311 (381)
T ss_pred             eehhhHHHHHHhCCCCCcCCCHHHHHHHHHccccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCcccCCC
Confidence            99999999999999999876665555555432  223333  589999999999654  455569999999999999864

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=8.9e-46  Score=396.26  Aligned_cols=251  Identities=29%  Similarity=0.486  Sum_probs=219.1

Q ss_pred             eEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhC-CCCCeeeeeeeEEecCeEEEEEeec
Q 004959          346 KLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHL-KHPNIVQYYGSEIVEDKFYIYLEYV  424 (721)
Q Consensus       346 k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L-~HPnIV~l~g~~~~~~~~yLVmEy~  424 (721)
                      ++||+|+||.||+|.++.+++.||||++....  .......+.+..|+.++..+ +||||+++++++...+.+|+||||+
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~   78 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDV--ILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFV   78 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHH--HhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCC
Confidence            47999999999999999999999999986311  11223456677888888876 6999999999999999999999999


Q ss_pred             cCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCC-CcccccCC
Q 004959          425 HPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTG-QKADLSMK  503 (721)
Q Consensus       425 ~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~-~~~~~s~~  503 (721)
                      .||+|.+++... ..+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..... .......+
T Consensus        79 ~~g~L~~~i~~~-~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~~~~~~~  157 (320)
T cd05590          79 NGGDLMFHIQKS-RRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFC  157 (320)
T ss_pred             CCchHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCCcccccc
Confidence            999999988765 6799999999999999999999999999999999999999999999999999876432 22334567


Q ss_pred             CCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhcCCCCCCCCCHHHHHHHHHh
Q 004959          504 GSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDSLSPEGKDFLRCC  583 (721)
Q Consensus       504 GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~~~~~p~~lS~el~dLI~~c  583 (721)
                      ||+.|+|||++.       ...++.++|||||||++|+|++|+.||......+.+..+......++..++.++.+||++|
T Consensus       158 gt~~y~aPE~~~-------~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~  230 (320)
T cd05590         158 GTPDYIAPEILQ-------EMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLSQDAVDILKAF  230 (320)
T ss_pred             cCccccCHHHHc-------CCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHH
Confidence            999999999984       3456678999999999999999999999887777777888777788889999999999999


Q ss_pred             cccCCCCCCCH------HHHHhccccccC
Q 004959          584 FQRNPADRPPA------SLLLEHRFLKNS  606 (721)
Q Consensus       584 L~~DP~kRPSa------~eLL~Hp~f~~~  606 (721)
                      |+.||++|+++      +++++||||...
T Consensus       231 L~~dP~~R~~~~~~~~~~~~~~h~~f~~~  259 (320)
T cd05590         231 MTKNPTMRLGSLTLGGEEAILRHPFFKEL  259 (320)
T ss_pred             cccCHHHCCCCCCCCCHHHHHcCCCcCCC
Confidence            99999999998      999999999764

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=1.9e-45  Score=393.69  Aligned_cols=256  Identities=29%  Similarity=0.471  Sum_probs=223.0

Q ss_pred             CeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCC-CeeeeeeeEEecCeEEE
Q 004959          341 QWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHP-NIVQYYGSEIVEDKFYI  419 (721)
Q Consensus       341 ~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HP-nIV~l~g~~~~~~~~yL  419 (721)
                      +|++.+.||+|+||.||+|.+..+++.||||++....  .......+.+..|+.++..+.|+ +|+.+++++...+.+|+
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~--~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~l   78 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDV--IIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF   78 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHH--hhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEE
Confidence            5889999999999999999999999999999986321  11223456788899999999765 68889999999999999


Q ss_pred             EEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccC-CCcc
Q 004959          420 YLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLT-GQKA  498 (721)
Q Consensus       420 VmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~-~~~~  498 (721)
                      ||||+.||+|.+++... +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.... ....
T Consensus        79 v~E~~~~g~L~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~  157 (324)
T cd05587          79 VMEYVNGGDLMYHIQQV-GKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKT  157 (324)
T ss_pred             EEcCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCCCc
Confidence            99999999999998764 679999999999999999999999999999999999999999999999999987532 2223


Q ss_pred             cccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhcCCCCCCCCCHHHHH
Q 004959          499 DLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDSLSPEGKD  578 (721)
Q Consensus       499 ~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~~~~~p~~lS~el~d  578 (721)
                      ....+||+.|+|||++.+       ..++.++|||||||++|+|++|+.||.+....+.+..+......++..++.++.+
T Consensus       158 ~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  230 (324)
T cd05587         158 TRTFCGTPDYIAPEIIAY-------QPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVS  230 (324)
T ss_pred             eeeecCCccccChhhhcC-------CCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHH
Confidence            345679999999999943       4466789999999999999999999998887777888887777888899999999


Q ss_pred             HHHHhcccCCCCCCCH-----HHHHhccccccC
Q 004959          579 FLRCCFQRNPADRPPA-----SLLLEHRFLKNS  606 (721)
Q Consensus       579 LI~~cL~~DP~kRPSa-----~eLL~Hp~f~~~  606 (721)
                      ||++||+.||++|++.     +++++||||...
T Consensus       231 li~~~l~~~P~~R~~~~~~~~~~~~~hp~~~~~  263 (324)
T cd05587         231 ICKGLLTKHPAKRLGCGPTGERDIREHAFFRRI  263 (324)
T ss_pred             HHHHHhhcCHHHcCCCCCCCHHHHhcCCCcCCC
Confidence            9999999999999986     899999999864

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=1.4e-45  Score=394.14  Aligned_cols=251  Identities=27%  Similarity=0.457  Sum_probs=219.7

Q ss_pred             eEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhC-CCCCeeeeeeeEEecCeEEEEEeec
Q 004959          346 KLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHL-KHPNIVQYYGSEIVEDKFYIYLEYV  424 (721)
Q Consensus       346 k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L-~HPnIV~l~g~~~~~~~~yLVmEy~  424 (721)
                      +.||+|+||+||+|++..+|+.||||++...  ........+.+..|+.++..+ +||||+++++++...+.+|+||||+
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~   78 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKD--VILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYV   78 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHH--HhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCC
Confidence            4699999999999999999999999998632  111233456677899998876 7999999999999999999999999


Q ss_pred             cCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCC-CcccccCC
Q 004959          425 HPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTG-QKADLSMK  503 (721)
Q Consensus       425 ~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~-~~~~~s~~  503 (721)
                      .+|+|..++... ..+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..... .......+
T Consensus        79 ~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~  157 (321)
T cd05591          79 NGGDLMFQIQRS-RKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFC  157 (321)
T ss_pred             CCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceecccCCccccccc
Confidence            999999998764 6799999999999999999999999999999999999999999999999999876432 22234567


Q ss_pred             CCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhcCCCCCCCCCHHHHHHHHHh
Q 004959          504 GSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDSLSPEGKDFLRCC  583 (721)
Q Consensus       504 GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~~~~~p~~lS~el~dLI~~c  583 (721)
                      ||+.|+|||++.       ...++.++|||||||++|+|++|+.||......+.+..+......+|..++.++.+||++|
T Consensus       158 gt~~y~aPE~~~-------~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ll~~~  230 (321)
T cd05591         158 GTPDYIAPEILQ-------ELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVLYPVWLSKEAVSILKAF  230 (321)
T ss_pred             cCccccCHHHHc-------CCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHH
Confidence            999999999984       3456778999999999999999999999888888888888887788888999999999999


Q ss_pred             cccCCCCCC-------CHHHHHhccccccC
Q 004959          584 FQRNPADRP-------PASLLLEHRFLKNS  606 (721)
Q Consensus       584 L~~DP~kRP-------Sa~eLL~Hp~f~~~  606 (721)
                      |+.||++|+       +++++++||||...
T Consensus       231 L~~dp~~R~~~~~~~~~~~~~~~hp~~~~~  260 (321)
T cd05591         231 MTKNPNKRLGCVASQGGEDAIKQHPFFKEI  260 (321)
T ss_pred             hccCHHHcCCCCCCCCCHHHHhcCCccCCC
Confidence            999999999       99999999999753

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-45  Score=403.18  Aligned_cols=256  Identities=28%  Similarity=0.480  Sum_probs=215.7

Q ss_pred             CCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeEEE
Q 004959          340 SQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYI  419 (721)
Q Consensus       340 ~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~yL  419 (721)
                      ++|++++.||+|+||.||+|.+..+|+.||||++...  .....+..+.+.+|+.+|+.++|||||++++++.+.+.+||
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~l   78 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKS--EMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYL   78 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHH--HHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEE
Confidence            3799999999999999999999999999999998532  11123456778899999999999999999999999999999


Q ss_pred             EEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCCcc-
Q 004959          420 YLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKA-  498 (721)
Q Consensus       420 VmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~~~-  498 (721)
                      ||||+.||+|.+++... +.+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+++.+..... 
T Consensus        79 v~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~  157 (377)
T cd05629          79 IMEFLPGGDLMTMLIKY-DTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDS  157 (377)
T ss_pred             EEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeeccccccccccccc
Confidence            99999999999999764 6799999999999999999999999999999999999999999999999999964321000 


Q ss_pred             -----------------------------------------------cccCCCCCccCChhhHHHHhhcCCCCCCcchhh
Q 004959          499 -----------------------------------------------DLSMKGSPYWMAPELMMAVMQKGKSSDSALAVD  531 (721)
Q Consensus       499 -----------------------------------------------~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asD  531 (721)
                                                                     ....+||+.|+|||++.+       ..++.++|
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~D  230 (377)
T cd05629         158 AYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQ-------QGYGQECD  230 (377)
T ss_pred             ccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHcc-------CCCCCcee
Confidence                                                           012469999999999843       45677899


Q ss_pred             HHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhc--CCCCCC--CCCHHHHHHHHHhcccCCCCC---CCHHHHHhccccc
Q 004959          532 IWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRD--TPAIPD--SLSPEGKDFLRCCFQRNPADR---PPASLLLEHRFLK  604 (721)
Q Consensus       532 VWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~--~~~~p~--~lS~el~dLI~~cL~~DP~kR---PSa~eLL~Hp~f~  604 (721)
                      ||||||+||||++|..||......+.+..+...  ...+|.  .++.++++||.+||. +|.+|   +++.|+++||||.
T Consensus       231 iwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~hp~~~  309 (377)
T cd05629         231 WWSLGAIMFECLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSHPFFR  309 (377)
T ss_pred             eEecchhhhhhhcCCCCCCCCCHHHHHHHHHccCCccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcCCCcC
Confidence            999999999999999999877666666655542  223343  478999999999998 67765   5999999999998


Q ss_pred             cC
Q 004959          605 NS  606 (721)
Q Consensus       605 ~~  606 (721)
                      +.
T Consensus       310 ~~  311 (377)
T cd05629         310 GV  311 (377)
T ss_pred             CC
Confidence            64

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=1.8e-45  Score=402.84  Aligned_cols=255  Identities=29%  Similarity=0.482  Sum_probs=216.3

Q ss_pred             CeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeEEEE
Q 004959          341 QWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYIY  420 (721)
Q Consensus       341 ~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~yLV  420 (721)
                      .|++++.||+|+||.||+|++..+++.||||++...  ........+.+.+|+.+|+.++|+|||++++.+.+.+.+|+|
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~--~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv   79 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKK--DVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFV   79 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHH--HhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEE
Confidence            589999999999999999999999999999998631  112234567889999999999999999999999999999999


Q ss_pred             EeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCC----
Q 004959          421 LEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQ----  496 (721)
Q Consensus       421 mEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~----  496 (721)
                      ||||.||+|.+++... +.+++..++.++.||+.||+|||++||+||||||+||||+.+|.+||+|||++..+...    
T Consensus        80 ~E~~~gg~L~~~l~~~-~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~  158 (382)
T cd05625          80 MDYIPGGDMMSLLIRM-GIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSK  158 (382)
T ss_pred             EeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCcccccccccc
Confidence            9999999999999764 67999999999999999999999999999999999999999999999999997533100    


Q ss_pred             --------------------------------------------cccccCCCCCccCChhhHHHHhhcCCCCCCcchhhH
Q 004959          497 --------------------------------------------KADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDI  532 (721)
Q Consensus       497 --------------------------------------------~~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDV  532 (721)
                                                                  ......+||+.|+|||++.+       ..++.++||
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-------~~~~~~~Di  231 (382)
T cd05625         159 YYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLR-------TGYTQLCDW  231 (382)
T ss_pred             ccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcC-------CCCCCeeeE
Confidence                                                        00123579999999999943       456778999


Q ss_pred             HHHHHHHHHHhhCCCCCCchhhHHHHHHHhhcC--CCCC--CCCCHHHHHHHHHhcccCCCCCCC---HHHHHhcccccc
Q 004959          533 WSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDT--PAIP--DSLSPEGKDFLRCCFQRNPADRPP---ASLLLEHRFLKN  605 (721)
Q Consensus       533 WSLGVILyELLtG~~PF~~~~~~~~~~ki~~~~--~~~p--~~lS~el~dLI~~cL~~DP~kRPS---a~eLL~Hp~f~~  605 (721)
                      |||||+||||++|+.||......+...++....  ..+|  ..+++++.+||.+|+ .+|++|++   ++++++||||+.
T Consensus       232 wSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~~  310 (382)
T cd05625         232 WSVGVILYEMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKAHPFFKT  310 (382)
T ss_pred             EechHHHHHHHhCCCCCCCCCHHHHHHHHHccCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhcCCCcCC
Confidence            999999999999999998877666666655422  2233  458999999999986 59999997   999999999986


Q ss_pred             C
Q 004959          606 S  606 (721)
Q Consensus       606 ~  606 (721)
                      .
T Consensus       311 ~  311 (382)
T cd05625         311 I  311 (382)
T ss_pred             c
Confidence            4

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=3.9e-45  Score=391.10  Aligned_cols=256  Identities=27%  Similarity=0.439  Sum_probs=223.0

Q ss_pred             CeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhC-CCCCeeeeeeeEEecCeEEE
Q 004959          341 QWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHL-KHPNIVQYYGSEIVEDKFYI  419 (721)
Q Consensus       341 ~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L-~HPnIV~l~g~~~~~~~~yL  419 (721)
                      +|++.+.||+|+||.||+|.+..+++.||||++....  .......+.+..|..++..+ +|++|+.+++++...+.+|+
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~l   78 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDV--VIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYF   78 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHH--hhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEE
Confidence            4889999999999999999999999999999986421  11223445677788888877 58999999999999999999


Q ss_pred             EEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCC-Ccc
Q 004959          420 YLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTG-QKA  498 (721)
Q Consensus       420 VmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~-~~~  498 (721)
                      ||||+.+|+|.+++... +.+++..+..++.||+.||+|||++||+||||||+||||+.++.+||+|||+++.... ...
T Consensus        79 v~E~~~~g~L~~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~~~  157 (323)
T cd05616          79 VMEYVNGGDLMYQIQQV-GRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVT  157 (323)
T ss_pred             EEcCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCceecCCCCCc
Confidence            99999999999998764 6799999999999999999999999999999999999999999999999999975432 223


Q ss_pred             cccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhcCCCCCCCCCHHHHH
Q 004959          499 DLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDSLSPEGKD  578 (721)
Q Consensus       499 ~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~~~~~p~~lS~el~d  578 (721)
                      ....+||+.|+|||++.       ...++.++|||||||++|||++|+.||.+....+.+..+......+|..++.++.+
T Consensus       158 ~~~~~gt~~y~aPE~~~-------~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~  230 (323)
T cd05616         158 TKTFCGTPDYIAPEIIA-------YQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVA  230 (323)
T ss_pred             cccCCCChhhcCHHHhc-------CCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcCCHHHHH
Confidence            34567999999999994       34567789999999999999999999998877777778877777888899999999


Q ss_pred             HHHHhcccCCCCCCC-----HHHHHhccccccC
Q 004959          579 FLRCCFQRNPADRPP-----ASLLLEHRFLKNS  606 (721)
Q Consensus       579 LI~~cL~~DP~kRPS-----a~eLL~Hp~f~~~  606 (721)
                      ||.+||+.||++|++     ..++++|+||...
T Consensus       231 li~~~l~~~p~~R~~~~~~~~~~i~~h~~~~~~  263 (323)
T cd05616         231 ICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYI  263 (323)
T ss_pred             HHHHHcccCHHhcCCCCCCCHHHHhcCCCcCCC
Confidence            999999999999998     4899999999764

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=3.4e-45  Score=393.27  Aligned_cols=251  Identities=27%  Similarity=0.474  Sum_probs=213.3

Q ss_pred             eEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhC-CCCCeeeeeeeEEecCeEEEEEeec
Q 004959          346 KLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHL-KHPNIVQYYGSEIVEDKFYIYLEYV  424 (721)
Q Consensus       346 k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L-~HPnIV~l~g~~~~~~~~yLVmEy~  424 (721)
                      ++||+|+||.||+|.+..+++.||||++...  ........+.+.+|+.++..+ +||||+++++++...+.+|+|||||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~--~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~   78 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKE--LVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFV   78 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHH--HhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCC
Confidence            4799999999999999999999999998632  112234456788999999998 6999999999999999999999999


Q ss_pred             cCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCcccc-CCCcccccCC
Q 004959          425 HPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHL-TGQKADLSMK  503 (721)
Q Consensus       425 ~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l-~~~~~~~s~~  503 (721)
                      +||+|.+++... +.+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.. .........+
T Consensus        79 ~~g~L~~~~~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~~~~~~  157 (329)
T cd05588          79 SGGDLMFHMQRQ-RKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFC  157 (329)
T ss_pred             CCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCccccccccCCCcccccc
Confidence            999999988664 68999999999999999999999999999999999999999999999999998753 2233334578


Q ss_pred             CCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCch--------hh-HHHHHHHhhcCCCCCCCCCH
Q 004959          504 GSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEY--------EG-AAAMFKVMRDTPAIPDSLSP  574 (721)
Q Consensus       504 GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~--------~~-~~~~~ki~~~~~~~p~~lS~  574 (721)
                      ||+.|+|||++.       ...++.++|||||||++|+|++|+.||...        .. ......+......+|..++.
T Consensus       158 gt~~y~aPE~~~-------~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~  230 (329)
T cd05588         158 GTPNYIAPEILR-------GEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPRSLSV  230 (329)
T ss_pred             CCccccCHHHHc-------CCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCCCCCCCCH
Confidence            999999999984       345667899999999999999999999631        11 12233445556678889999


Q ss_pred             HHHHHHHHhcccCCCCCCC------HHHHHhccccccC
Q 004959          575 EGKDFLRCCFQRNPADRPP------ASLLLEHRFLKNS  606 (721)
Q Consensus       575 el~dLI~~cL~~DP~kRPS------a~eLL~Hp~f~~~  606 (721)
                      ++.+||++||+.||++|++      ++++++||||...
T Consensus       231 ~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~~  268 (329)
T cd05588         231 KASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRNI  268 (329)
T ss_pred             HHHHHHHHHhccCHHHcCCCCCCCCHHHHhcCCCCCCC
Confidence            9999999999999999987      7999999999753

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=2.4e-45  Score=393.05  Aligned_cols=252  Identities=31%  Similarity=0.531  Sum_probs=218.5

Q ss_pred             eEEeecCCeEEEEEEEC---CCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeEEEEEe
Q 004959          346 KLIGRGTFGSVYVASNR---ETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYIYLE  422 (721)
Q Consensus       346 k~LG~G~fG~VY~a~~~---~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~yLVmE  422 (721)
                      +.||+|+||.||+|++.   .+|+.||||++..... .........+.+|+.+|+.++||||+++++++..++.+|+|||
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e   80 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATI-VRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILE   80 (323)
T ss_pred             ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHH-HhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEe
Confidence            68999999999999863   5789999999863211 1122334567889999999999999999999999999999999


Q ss_pred             eccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCC-ccccc
Q 004959          423 YVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQ-KADLS  501 (721)
Q Consensus       423 y~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~-~~~~s  501 (721)
                      |+.|++|.+++... +.+.+..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||+++..... .....
T Consensus        81 ~~~~~~L~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~  159 (323)
T cd05584          81 YLSGGELFMHLERE-GIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHT  159 (323)
T ss_pred             CCCCchHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCCcccc
Confidence            99999999999764 67899999999999999999999999999999999999999999999999998754332 22334


Q ss_pred             CCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhcCCCCCCCCCHHHHHHHH
Q 004959          502 MKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDSLSPEGKDFLR  581 (721)
Q Consensus       502 ~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~~~~~p~~lS~el~dLI~  581 (721)
                      .+||+.|+|||++.+       ..++.++|||||||+||||++|+.||........+..+......++..+++++.+||+
T Consensus       160 ~~gt~~y~aPE~~~~-------~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  232 (323)
T cd05584         160 FCGTIEYMAPEILMR-------SGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLPPYLTPEARDLLK  232 (323)
T ss_pred             cCCCccccChhhccC-------CCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence            679999999999843       3456789999999999999999999998877777778877777888999999999999


Q ss_pred             HhcccCCCCCC-----CHHHHHhccccccC
Q 004959          582 CCFQRNPADRP-----PASLLLEHRFLKNS  606 (721)
Q Consensus       582 ~cL~~DP~kRP-----Sa~eLL~Hp~f~~~  606 (721)
                      +||+.||++||     +++++++||||...
T Consensus       233 ~~l~~~p~~R~~~~~~~~~~l~~h~~~~~~  262 (323)
T cd05584         233 KLLKRNPSSRLGAGPGDAAEVQSHPFFRHV  262 (323)
T ss_pred             HHcccCHhHcCCCCCCCHHHHhcCCCcCCC
Confidence            99999999999     89999999999764

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=3.5e-45  Score=392.17  Aligned_cols=258  Identities=30%  Similarity=0.504  Sum_probs=217.2

Q ss_pred             CeeEeeEEeecCCeEEEEEEEC---CCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCC-CCCeeeeeeeEEecCe
Q 004959          341 QWQKGKLIGRGTFGSVYVASNR---ETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLK-HPNIVQYYGSEIVEDK  416 (721)
Q Consensus       341 ~y~~~k~LG~G~fG~VY~a~~~---~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~-HPnIV~l~g~~~~~~~  416 (721)
                      +|++++.||+|+||.||+|++.   .+|+.||+|++..... .......+.+..|+.+|+.+. |+||+.+++++...+.
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~   79 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAAL-VQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAK   79 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHH-hhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCE
Confidence            4899999999999999998764   5789999999863211 112334567889999999994 9999999999999999


Q ss_pred             EEEEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCC
Q 004959          417 FYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQ  496 (721)
Q Consensus       417 ~yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~  496 (721)
                      +|+||||+.||+|.+++... ..+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.+...
T Consensus        80 ~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~  158 (332)
T cd05614          80 LHLILDYVSGGEMFTHLYQR-DNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSE  158 (332)
T ss_pred             EEEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCcccccc
Confidence            99999999999999999764 67999999999999999999999999999999999999999999999999999865433


Q ss_pred             c--ccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCch----hhHHHHHHHhhcCCCCCC
Q 004959          497 K--ADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEY----EGAAAMFKVMRDTPAIPD  570 (721)
Q Consensus       497 ~--~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~----~~~~~~~ki~~~~~~~p~  570 (721)
                      .  .....+||+.|||||++.+      ...++.++|||||||+||||++|+.||...    ........+....+.++.
T Consensus       159 ~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  232 (332)
T cd05614         159 EKERTYSFCGTIEYMAPEIIRG------KGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPFPS  232 (332)
T ss_pred             CCCccccccCCccccCHHHhcC------CCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcCCCCCCC
Confidence            2  2234679999999999853      223566899999999999999999999642    222333445556667788


Q ss_pred             CCCHHHHHHHHHhcccCCCCCC-----CHHHHHhccccccC
Q 004959          571 SLSPEGKDFLRCCFQRNPADRP-----PASLLLEHRFLKNS  606 (721)
Q Consensus       571 ~lS~el~dLI~~cL~~DP~kRP-----Sa~eLL~Hp~f~~~  606 (721)
                      .++.++.+||.+||+.||++||     +++++++||||++.
T Consensus       233 ~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~  273 (332)
T cd05614         233 FIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGL  273 (332)
T ss_pred             CCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCCC
Confidence            8999999999999999999999     88999999999864

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=1.9e-45  Score=401.58  Aligned_cols=256  Identities=29%  Similarity=0.456  Sum_probs=215.3

Q ss_pred             CCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeEEE
Q 004959          340 SQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYI  419 (721)
Q Consensus       340 ~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~yL  419 (721)
                      ++|++.+.||+|+||.||+|++..+|+.||||++...  ........+.+.+|+.+|+.++|+||+++++.+.+.+.+||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~--~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~l   78 (376)
T cd05598           1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKA--DVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYF   78 (376)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHH--HHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEE
Confidence            3799999999999999999999999999999988531  11122345678899999999999999999999999999999


Q ss_pred             EEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCC---
Q 004959          420 YLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQ---  496 (721)
Q Consensus       420 VmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~---  496 (721)
                      |||||+||+|.+++... +.+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+|..+...   
T Consensus        79 v~E~~~~g~L~~~i~~~-~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~  157 (376)
T cd05598          79 VMDYIPGGDMMSLLIRL-GIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS  157 (376)
T ss_pred             EEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCccccccccc
Confidence            99999999999999764 67899999999999999999999999999999999999999999999999997533100   


Q ss_pred             -----------------------------------------cccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHH
Q 004959          497 -----------------------------------------KADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSL  535 (721)
Q Consensus       497 -----------------------------------------~~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSL  535 (721)
                                                               ......+||+.|||||++.       ...++.++|||||
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~~DiwSl  230 (376)
T cd05598         158 KYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLL-------RTGYTQLCDWWSV  230 (376)
T ss_pred             cccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHc-------CCCCCcceeeeec
Confidence                                                     0011357999999999994       3456778999999


Q ss_pred             HHHHHHHhhCCCCCCchhhHHHHHHHhhcC--CCCC--CCCCHHHHHHHHHhcccCCCCCC---CHHHHHhccccccC
Q 004959          536 GCTIIEMYTGKPPWSEYEGAAAMFKVMRDT--PAIP--DSLSPEGKDFLRCCFQRNPADRP---PASLLLEHRFLKNS  606 (721)
Q Consensus       536 GVILyELLtG~~PF~~~~~~~~~~ki~~~~--~~~p--~~lS~el~dLI~~cL~~DP~kRP---Sa~eLL~Hp~f~~~  606 (721)
                      ||+||||++|+.||.+....+....+....  ..++  ..++.++.+||.+|+ .+|++|+   ++.++++||||+..
T Consensus       231 Gvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h~~~~~~  307 (376)
T cd05598         231 GVILYEMLVGQPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAHPFFKGI  307 (376)
T ss_pred             cceeeehhhCCCCCCCCCHHHHHHHHhccCccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCCCCcCCC
Confidence            999999999999998876665555554322  2222  358999999999976 5999999   99999999999864

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=3.7e-45  Score=390.85  Aligned_cols=252  Identities=27%  Similarity=0.483  Sum_probs=216.2

Q ss_pred             eEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhC-CCCCeeeeeeeEEecCeEEEEEeec
Q 004959          346 KLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHL-KHPNIVQYYGSEIVEDKFYIYLEYV  424 (721)
Q Consensus       346 k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L-~HPnIV~l~g~~~~~~~~yLVmEy~  424 (721)
                      ++||+|+||.||+|.++.+|+.||||++.....  ......+.+..|+.++..+ +||||+++++++.+.+.+|+||||+
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~   78 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVV--LIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFL   78 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHh--hhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCC
Confidence            479999999999999999999999999863211  1112345667788888754 8999999999999999999999999


Q ss_pred             cCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCC-CcccccCC
Q 004959          425 HPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTG-QKADLSMK  503 (721)
Q Consensus       425 ~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~-~~~~~s~~  503 (721)
                      .||+|..++... +.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++..... .......+
T Consensus        79 ~~g~L~~~i~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  157 (316)
T cd05620          79 NGGDLMFHIQDK-GRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFC  157 (316)
T ss_pred             CCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeecccCCCceeccC
Confidence            999999998764 6799999999999999999999999999999999999999999999999999875322 22334567


Q ss_pred             CCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhcCCCCCCCCCHHHHHHHHHh
Q 004959          504 GSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDSLSPEGKDFLRCC  583 (721)
Q Consensus       504 GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~~~~~p~~lS~el~dLI~~c  583 (721)
                      ||+.|+|||++.       ...++.++|||||||++|||++|..||......+....+....+.++..++.++++||++|
T Consensus       158 gt~~y~aPE~~~-------~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  230 (316)
T cd05620         158 GTPDYIAPEILQ-------GLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYPRWITKESKDILEKL  230 (316)
T ss_pred             CCcCccCHHHHc-------CCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHHH
Confidence            999999999994       3456778999999999999999999998877766677776677778888999999999999


Q ss_pred             cccCCCCCCCH-HHHHhccccccCC
Q 004959          584 FQRNPADRPPA-SLLLEHRFLKNSQ  607 (721)
Q Consensus       584 L~~DP~kRPSa-~eLL~Hp~f~~~~  607 (721)
                      |+.||++|+++ +++++||||....
T Consensus       231 l~~dP~~R~~~~~~~~~h~~f~~~~  255 (316)
T cd05620         231 FERDPTRRLGVVGNIRGHPFFKTIN  255 (316)
T ss_pred             ccCCHHHcCCChHHHHcCCCcCCCC
Confidence            99999999997 5888999998643

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=1.7e-45  Score=394.17  Aligned_cols=264  Identities=27%  Similarity=0.405  Sum_probs=224.1

Q ss_pred             CCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeEEE
Q 004959          340 SQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYI  419 (721)
Q Consensus       340 ~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~yL  419 (721)
                      ++|++.+.||+|+||.||+|.+..+|+.||||++...  .....+..+.+.+|+.+++.++|+||+++++++.+.+.+||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~l   78 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKS--VLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYL   78 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHH--HhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEE
Confidence            3699999999999999999999999999999998632  11223456678899999999999999999999999999999


Q ss_pred             EEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCCccc
Q 004959          420 YLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKAD  499 (721)
Q Consensus       420 VmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~~~~  499 (721)
                      ||||++||+|.+++......+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+......
T Consensus        79 v~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~  158 (330)
T cd05601          79 VMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMV  158 (330)
T ss_pred             EECCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeECCCCCce
Confidence            99999999999999876678999999999999999999999999999999999999999999999999999876543322


Q ss_pred             --ccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhcC--CCCC--CCCC
Q 004959          500 --LSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDT--PAIP--DSLS  573 (721)
Q Consensus       500 --~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~~--~~~p--~~lS  573 (721)
                        ....||+.|+|||++...... ....++.++|||||||+||+|++|+.||........+.+++...  ..++  ..++
T Consensus       159 ~~~~~~gt~~y~aPE~~~~~~~~-~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  237 (330)
T cd05601         159 NSKLPVGTPDYIAPEVLTTMNGD-GKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDPKVS  237 (330)
T ss_pred             eeecccCCccccCHHHhcccccc-ccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCccCCCCCCCCC
Confidence              235699999999998643221 13456778999999999999999999998876666666655432  2233  3579


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHHhccccccCC
Q 004959          574 PEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQ  607 (721)
Q Consensus       574 ~el~dLI~~cL~~DP~kRPSa~eLL~Hp~f~~~~  607 (721)
                      .++.+||++||+ ||++||++++++.||||....
T Consensus       238 ~~~~~li~~ll~-~p~~R~t~~~l~~h~~~~~~~  270 (330)
T cd05601         238 SDFLDLIQSLLC-GQKERLGYEGLCCHPFFSKID  270 (330)
T ss_pred             HHHHHHHHHHcc-ChhhCCCHHHHhCCCCcCCCC
Confidence            999999999998 999999999999999998643

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=3.8e-45  Score=399.03  Aligned_cols=249  Identities=31%  Similarity=0.515  Sum_probs=215.1

Q ss_pred             CeeEeeEEeecCCeEEEEEEECCCCcE-EEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecC-eEE
Q 004959          341 QWQKGKLIGRGTFGSVYVASNRETGAL-CAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVED-KFY  418 (721)
Q Consensus       341 ~y~~~k~LG~G~fG~VY~a~~~~tg~~-vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~-~~y  418 (721)
                      .....+.||+|+||+||++..+  |+. ||+|++.....   .....+.|.+|+.+|.+++|||||+++|++.... .++
T Consensus        42 ~l~~~~~iG~G~~g~V~~~~~~--g~~~vavK~~~~~~~---~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~  116 (362)
T KOG0192|consen   42 ELPIEEVLGSGSFGTVYKGKWR--GTDVVAVKIISDPDF---DDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLC  116 (362)
T ss_pred             HhhhhhhcccCCceeEEEEEeC--CceeEEEEEecchhc---ChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceE
Confidence            4455667999999999999987  566 99998863221   2222789999999999999999999999998877 799


Q ss_pred             EEEeeccCCCHHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHhhCC-eeccCCCCCcEEEcCCC-ceEEeecCCccccCC
Q 004959          419 IYLEYVHPGSINKYVRE-HCGAITESVVRNFTRHILSGLAYLHSKK-TIHRDIKGANLLVDASG-VVKLADFGMAKHLTG  495 (721)
Q Consensus       419 LVmEy~~gGsL~~~L~~-~~~~Lse~~i~~i~~QIl~AL~yLHs~g-IIHrDLKPeNILld~~g-~VKL~DFGlA~~l~~  495 (721)
                      ||||||++|+|.+++.. ....++...+..|+.||++||.|||+++ |||||||++||||+.++ ++||||||+++....
T Consensus       117 iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~  196 (362)
T KOG0192|consen  117 IVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVI  196 (362)
T ss_pred             EEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCccceeecc
Confidence            99999999999999987 3688999999999999999999999999 99999999999999998 999999999987665


Q ss_pred             C-cccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhh--cCCCCCCCC
Q 004959          496 Q-KADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMR--DTPAIPDSL  572 (721)
Q Consensus       496 ~-~~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~--~~~~~p~~l  572 (721)
                      . .......||+.|||||++.+.     ...|+.++|||||||+||||+||+.||.+.........+..  ..+.+|..+
T Consensus       197 ~~~~~~~~~GT~~wMAPEv~~~~-----~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp~~p~~~  271 (362)
T KOG0192|consen  197 SKTSMTSVAGTYRWMAPEVLRGE-----KSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRPPIPKEC  271 (362)
T ss_pred             ccccccCCCCCccccChhhhcCC-----CCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCccC
Confidence            4 233347899999999999532     45788899999999999999999999999877665555543  356778889


Q ss_pred             CHHHHHHHHHhcccCCCCCCCHHHHHh
Q 004959          573 SPEGKDFLRCCFQRNPADRPPASLLLE  599 (721)
Q Consensus       573 S~el~dLI~~cL~~DP~kRPSa~eLL~  599 (721)
                      ++.+..||.+||..||++||++.+|+.
T Consensus       272 ~~~l~~l~~~CW~~dp~~RP~f~ei~~  298 (362)
T KOG0192|consen  272 PPHLSSLMERCWLVDPSRRPSFLEIVS  298 (362)
T ss_pred             CHHHHHHHHHhCCCCCCcCCCHHHHHH
Confidence            999999999999999999999999874

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=5.4e-45  Score=389.55  Aligned_cols=251  Identities=28%  Similarity=0.510  Sum_probs=215.3

Q ss_pred             eEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhC-CCCCeeeeeeeEEecCeEEEEEeec
Q 004959          346 KLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHL-KHPNIVQYYGSEIVEDKFYIYLEYV  424 (721)
Q Consensus       346 k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L-~HPnIV~l~g~~~~~~~~yLVmEy~  424 (721)
                      +.||+|+||+||+|.+..+++.||||++.....  ......+.+..|..++..+ +||||+++++++...+.+|+||||+
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~   78 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVV--LEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYL   78 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHh--hhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCC
Confidence            479999999999999999999999999863211  1122344556677777654 7999999999999999999999999


Q ss_pred             cCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCC-cccccCC
Q 004959          425 HPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQ-KADLSMK  503 (721)
Q Consensus       425 ~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~-~~~~s~~  503 (721)
                      .||+|..++... +.+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||++...... ......+
T Consensus        79 ~gg~L~~~~~~~-~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~  157 (316)
T cd05592          79 NGGDLMFHIQSS-GRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFC  157 (316)
T ss_pred             CCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCCcccccc
Confidence            999999998764 67999999999999999999999999999999999999999999999999999865332 2334567


Q ss_pred             CCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhcCCCCCCCCCHHHHHHHHHh
Q 004959          504 GSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDSLSPEGKDFLRCC  583 (721)
Q Consensus       504 GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~~~~~p~~lS~el~dLI~~c  583 (721)
                      ||+.|+|||++.+       ..++.++|||||||++|||++|+.||.+.+..+.+..+....+.++..++.++.+||.+|
T Consensus       158 gt~~y~aPE~~~~-------~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ll~~~  230 (316)
T cd05592         158 GTPDYIAPEILKG-------QKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPHFPRWISKEAKDCLSKL  230 (316)
T ss_pred             CCccccCHHHHcC-------CCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHH
Confidence            9999999999843       446678999999999999999999999877777777777777778889999999999999


Q ss_pred             cccCCCCCCCH-HHHHhccccccC
Q 004959          584 FQRNPADRPPA-SLLLEHRFLKNS  606 (721)
Q Consensus       584 L~~DP~kRPSa-~eLL~Hp~f~~~  606 (721)
                      |+.||++|+++ .++++||||...
T Consensus       231 l~~~P~~R~~~~~~l~~h~~~~~~  254 (316)
T cd05592         231 FERDPTKRLGVDGDIRQHPFFRGI  254 (316)
T ss_pred             ccCCHHHcCCChHHHHcCcccCCC
Confidence            99999999986 588899999764

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=3.4e-45  Score=391.57  Aligned_cols=251  Identities=29%  Similarity=0.474  Sum_probs=215.2

Q ss_pred             eEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHH-HHHhCCCCCeeeeeeeEEecCeEEEEEeec
Q 004959          346 KLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIK-VLSHLKHPNIVQYYGSEIVEDKFYIYLEYV  424 (721)
Q Consensus       346 k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~-iL~~L~HPnIV~l~g~~~~~~~~yLVmEy~  424 (721)
                      ++||+|+||+||+|.+..+|+.||||++....  .......+.+..|.. +++.++||||+++++.+...+.+|+||||+
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~   78 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKA--ILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYV   78 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHH--HhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCC
Confidence            47999999999999999999999999986321  111223345555555 567899999999999999999999999999


Q ss_pred             cCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCC-CcccccCC
Q 004959          425 HPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTG-QKADLSMK  503 (721)
Q Consensus       425 ~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~-~~~~~s~~  503 (721)
                      .||+|..++... +.+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..... .......+
T Consensus        79 ~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  157 (323)
T cd05575          79 NGGELFFHLQRE-RSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFC  157 (323)
T ss_pred             CCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCCcccccc
Confidence            999999998764 6799999999999999999999999999999999999999999999999999875432 22334567


Q ss_pred             CCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhcCCCCCCCCCHHHHHHHHHh
Q 004959          504 GSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDSLSPEGKDFLRCC  583 (721)
Q Consensus       504 GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~~~~~p~~lS~el~dLI~~c  583 (721)
                      ||+.|+|||++.       ...++.++|||||||++|+|++|..||...+..+.+..+......++..++.++.+||++|
T Consensus       158 gt~~y~aPE~~~-------~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~  230 (323)
T cd05575         158 GTPEYLAPEVLR-------KQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLRLKPNISVSARHLLEGL  230 (323)
T ss_pred             CChhhcChhhhc-------CCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHH
Confidence            999999999984       3456778999999999999999999999877777777777777777888999999999999


Q ss_pred             cccCCCCCCCH----HHHHhccccccC
Q 004959          584 FQRNPADRPPA----SLLLEHRFLKNS  606 (721)
Q Consensus       584 L~~DP~kRPSa----~eLL~Hp~f~~~  606 (721)
                      |+.||++||++    .++++||||...
T Consensus       231 l~~~p~~R~~~~~~~~~il~~~~~~~~  257 (323)
T cd05575         231 LQKDRTKRLGAKDDFLEIKNHVFFSSI  257 (323)
T ss_pred             hhcCHHhCCCCCCCHHHHHcCCCcCCC
Confidence            99999999987    699999999764

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-46  Score=400.97  Aligned_cols=254  Identities=41%  Similarity=0.723  Sum_probs=227.5

Q ss_pred             CCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeEEE
Q 004959          340 SQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYI  419 (721)
Q Consensus       340 ~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~yL  419 (721)
                      ..|...++||+|.||.||+|.+..+++.||||++...    ...+.++.+++|+.+|.+++++||.++|+.|..+..+++
T Consensus        13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le----~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~Lwi   88 (467)
T KOG0201|consen   13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLE----EAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWI   88 (467)
T ss_pred             cccccchhccccccceeeeeeeccccceEEEEEechh----hcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHH
Confidence            3678889999999999999999999999999999753    334567889999999999999999999999999999999


Q ss_pred             EEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCCccc
Q 004959          420 YLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKAD  499 (721)
Q Consensus       420 VmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~~~~  499 (721)
                      +||||.||++.+.++.. ..+.|.++..++++++.||.|||.++.+|||||+.||||..+|.|||+|||++..+......
T Consensus        89 iMey~~gGsv~~lL~~~-~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~r  167 (467)
T KOG0201|consen   89 IMEYCGGGSVLDLLKSG-NILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKR  167 (467)
T ss_pred             HHHHhcCcchhhhhccC-CCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeeeechhhc
Confidence            99999999999999753 55699999999999999999999999999999999999999999999999999888765433


Q ss_pred             -ccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhcC-CCCCCCCCHHHH
Q 004959          500 -LSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDT-PAIPDSLSPEGK  577 (721)
Q Consensus       500 -~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~~-~~~p~~lS~el~  577 (721)
                       .+++|||+|||||++.       ...|+.++||||||+++|||++|.+||........++.|.+.. +.+...+|+.++
T Consensus       168 r~tfvGTPfwMAPEVI~-------~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIpk~~PP~L~~~~S~~~k  240 (467)
T KOG0201|consen  168 RKTFVGTPFWMAPEVIK-------QSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPKSAPPRLDGDFSPPFK  240 (467)
T ss_pred             cccccccccccchhhhc-------cccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEeccCCCCCccccccCHHHH
Confidence             6889999999999994       4567788999999999999999999999888766555555543 445567899999


Q ss_pred             HHHHHhcccCCCCCCCHHHHHhcccccc
Q 004959          578 DFLRCCFQRNPADRPPASLLLEHRFLKN  605 (721)
Q Consensus       578 dLI~~cL~~DP~kRPSa~eLL~Hp~f~~  605 (721)
                      +||..||.+||+.||+|.+||+|.|++.
T Consensus       241 EFV~~CL~k~P~~RpsA~~LLKh~FIk~  268 (467)
T KOG0201|consen  241 EFVEACLDKNPEFRPSAKELLKHKFIKR  268 (467)
T ss_pred             HHHHHHhhcCcccCcCHHHHhhhHHHHh
Confidence            9999999999999999999999999987

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=5.8e-45  Score=389.30  Aligned_cols=251  Identities=29%  Similarity=0.490  Sum_probs=218.9

Q ss_pred             eEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhC-CCCCeeeeeeeEEecCeEEEEEeec
Q 004959          346 KLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHL-KHPNIVQYYGSEIVEDKFYIYLEYV  424 (721)
Q Consensus       346 k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L-~HPnIV~l~g~~~~~~~~yLVmEy~  424 (721)
                      ++||+|+||+||+|.+..+++.||||++....  .........+.+|+.++..+ +||||+++++++...+.+|+||||+
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~   78 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDV--ILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYV   78 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHH--HhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCC
Confidence            47999999999999999999999999986321  11223456678899999888 6999999999999999999999999


Q ss_pred             cCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCC-CcccccCC
Q 004959          425 HPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTG-QKADLSMK  503 (721)
Q Consensus       425 ~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~-~~~~~s~~  503 (721)
                      .||+|..++... +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... .......+
T Consensus        79 ~~~~L~~~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  157 (318)
T cd05570          79 NGGDLMFHIQRS-GRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFC  157 (318)
T ss_pred             CCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCCccccee
Confidence            999999988764 6799999999999999999999999999999999999999999999999999875322 22233467


Q ss_pred             CCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhcCCCCCCCCCHHHHHHHHHh
Q 004959          504 GSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDSLSPEGKDFLRCC  583 (721)
Q Consensus       504 GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~~~~~p~~lS~el~dLI~~c  583 (721)
                      ||+.|+|||++.       +..++.++|||||||++|+|++|+.||...........+......++..++.++.+||++|
T Consensus       158 g~~~y~aPE~~~-------~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~  230 (318)
T cd05570         158 GTPDYIAPEILS-------YQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRYPRWLSKEAKSILKSF  230 (318)
T ss_pred             cCccccCHHHhc-------CCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCcCCHHHHHHHHHH
Confidence            999999999994       3456778999999999999999999998877777777777777778888999999999999


Q ss_pred             cccCCCCCCCH-----HHHHhccccccC
Q 004959          584 FQRNPADRPPA-----SLLLEHRFLKNS  606 (721)
Q Consensus       584 L~~DP~kRPSa-----~eLL~Hp~f~~~  606 (721)
                      |+.||++||++     .++++||||...
T Consensus       231 l~~dP~~R~s~~~~~~~~ll~~~~~~~~  258 (318)
T cd05570         231 LTKNPEKRLGCLPTGEQDIKGHPFFREI  258 (318)
T ss_pred             ccCCHHHcCCCCCCCHHHHhcCCCcCCC
Confidence            99999999999     999999999864

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=1.4e-43  Score=399.26  Aligned_cols=252  Identities=19%  Similarity=0.343  Sum_probs=200.8

Q ss_pred             CCCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCC------CCeeeeeeeEE
Q 004959          339 NSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKH------PNIVQYYGSEI  412 (721)
Q Consensus       339 ~~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~H------PnIV~l~g~~~  412 (721)
                      ..+|+++++||+|+||+||+|.+..+++.||||++...      ......+..|+.+++.+.|      .+|+.+++++.
T Consensus       128 ~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~------~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~  201 (467)
T PTZ00284        128 TQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNV------PKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQ  201 (467)
T ss_pred             CCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecc------hhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEE
Confidence            46899999999999999999999999999999998532      1123345567777776654      46889998887


Q ss_pred             ec-CeEEEEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhh-CCeeccCCCCCcEEEcCCC----------
Q 004959          413 VE-DKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHS-KKTIHRDIKGANLLVDASG----------  480 (721)
Q Consensus       413 ~~-~~~yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs-~gIIHrDLKPeNILld~~g----------  480 (721)
                      .+ ..+|||||++ |++|.+++.+. +.+++..++.|+.||+.||.|||+ .|||||||||+||||+.++          
T Consensus       202 ~~~~~~~iv~~~~-g~~l~~~l~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~  279 (467)
T PTZ00284        202 NETGHMCIVMPKY-GPCLLDWIMKH-GPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRA  279 (467)
T ss_pred             cCCceEEEEEecc-CCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccc
Confidence            64 5789999998 78899988765 689999999999999999999998 5999999999999998765          


Q ss_pred             ------ceEEeecCCccccCCCcccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhh
Q 004959          481 ------VVKLADFGMAKHLTGQKADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEG  554 (721)
Q Consensus       481 ------~VKL~DFGlA~~l~~~~~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~  554 (721)
                            .+||+|||++....  ......+||+.|||||++.+       ..++.++|||||||+||||++|+.||.+...
T Consensus       280 ~~~~~~~vkl~DfG~~~~~~--~~~~~~~gt~~Y~APE~~~~-------~~~~~~~DiwSlGvil~elltG~~pf~~~~~  350 (467)
T PTZ00284        280 LPPDPCRVRICDLGGCCDER--HSRTAIVSTRHYRSPEVVLG-------LGWMYSTDMWSMGCIIYELYTGKLLYDTHDN  350 (467)
T ss_pred             cCCCCceEEECCCCccccCc--cccccccCCccccCcHHhhc-------CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh
Confidence                  49999999886432  22345789999999999953       4567789999999999999999999987655


Q ss_pred             HHHHHHHhhcCCCCC-----------------------------------------C-CCCHHHHHHHHHhcccCCCCCC
Q 004959          555 AAAMFKVMRDTPAIP-----------------------------------------D-SLSPEGKDFLRCCFQRNPADRP  592 (721)
Q Consensus       555 ~~~~~ki~~~~~~~p-----------------------------------------~-~lS~el~dLI~~cL~~DP~kRP  592 (721)
                      .+.+..+......+|                                         . ..++.+.|||.+||++||++||
T Consensus       351 ~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~  430 (467)
T PTZ00284        351 LEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRL  430 (467)
T ss_pred             HHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCC
Confidence            443332221110000                                         0 0145678999999999999999


Q ss_pred             CHHHHHhccccccCC
Q 004959          593 PASLLLEHRFLKNSQ  607 (721)
Q Consensus       593 Sa~eLL~Hp~f~~~~  607 (721)
                      |++|||+||||....
T Consensus       431 ta~e~L~Hp~~~~~~  445 (467)
T PTZ00284        431 NARQMTTHPYVLKYY  445 (467)
T ss_pred             CHHHHhcCccccccC
Confidence            999999999998744

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=2.9e-44  Score=385.96  Aligned_cols=256  Identities=27%  Similarity=0.536  Sum_probs=215.3

Q ss_pred             CCCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeEE
Q 004959          339 NSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFY  418 (721)
Q Consensus       339 ~~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~y  418 (721)
                      .++|++.+.||+|+||.||+|++..+|..||+|.+...    ......+.+.+|+++|+.++||||+++++++...+.+|
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~----~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   79 (331)
T cd06649           4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLE----IKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS   79 (331)
T ss_pred             cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecc----cCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEE
Confidence            36899999999999999999999999999999998632    22345678999999999999999999999999999999


Q ss_pred             EEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhC-CeeccCCCCCcEEEcCCCceEEeecCCccccCCCc
Q 004959          419 IYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSK-KTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQK  497 (721)
Q Consensus       419 LVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~-gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~~  497 (721)
                      +||||+++++|.+++... ..+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||++..+... 
T Consensus        80 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-  157 (331)
T cd06649          80 ICMEHMDGGSLDQVLKEA-KRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-  157 (331)
T ss_pred             EEeecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCccccccccc-
Confidence            999999999999999764 5799999999999999999999986 6999999999999999999999999999866432 


Q ss_pred             ccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHH----------------
Q 004959          498 ADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKV----------------  561 (721)
Q Consensus       498 ~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki----------------  561 (721)
                      ......||+.|+|||++.       ...++.++|||||||+||||++|+.||...+..+....+                
T Consensus       158 ~~~~~~g~~~y~aPE~~~-------~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (331)
T cd06649         158 MANSFVGTRSYMSPERLQ-------GTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSIS  230 (331)
T ss_pred             ccccCCCCcCcCCHhHhc-------CCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccC
Confidence            233467999999999984       345677899999999999999999999754332221110                


Q ss_pred             ------------------------------hhc-CCCC-CCCCCHHHHHHHHHhcccCCCCCCCHHHHHhccccccCC
Q 004959          562 ------------------------------MRD-TPAI-PDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQ  607 (721)
Q Consensus       562 ------------------------------~~~-~~~~-p~~lS~el~dLI~~cL~~DP~kRPSa~eLL~Hp~f~~~~  607 (721)
                                                    ... .+.. ...++.++++||.+||++||++|||+.+||+||||+...
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~~~  308 (331)
T cd06649         231 PRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKRSE  308 (331)
T ss_pred             cccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhhcc
Confidence                                          000 0111 124788999999999999999999999999999998643

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=4.6e-45  Score=396.54  Aligned_cols=257  Identities=27%  Similarity=0.459  Sum_probs=218.4

Q ss_pred             CCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeEEE
Q 004959          340 SQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYI  419 (721)
Q Consensus       340 ~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~yL  419 (721)
                      ++|++.+.||+|+||.||+|.++.+|+.||||++...  ..........+.+|+.+|..++|+||+++++.+.+.+.+||
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~l   78 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKA--DMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYL   78 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHH--HHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEE
Confidence            3689999999999999999999999999999998631  11223456778899999999999999999999999999999


Q ss_pred             EEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCCc--
Q 004959          420 YLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQK--  497 (721)
Q Consensus       420 VmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~~--  497 (721)
                      |||||.||+|.+++.+. +.+++..++.++.||+.||+|||++||+||||||+||||+.+|.+||+|||++..+....  
T Consensus        79 v~E~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~  157 (360)
T cd05627          79 IMEFLPGGDMMTLLMKK-DTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRT  157 (360)
T ss_pred             EEeCCCCccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCccccccccc
Confidence            99999999999999764 679999999999999999999999999999999999999999999999999987543211  


Q ss_pred             ----------------------------------ccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHh
Q 004959          498 ----------------------------------ADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMY  543 (721)
Q Consensus       498 ----------------------------------~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELL  543 (721)
                                                        .....+||+.|+|||++.       ...++.++|||||||+||||+
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~-------~~~~~~~~DiwSlGvilyel~  230 (360)
T cd05627         158 EFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFM-------QTGYNKLCDWWSLGVIMYEML  230 (360)
T ss_pred             ccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHc-------CCCCCCcceeccccceeeecc
Confidence                                              012357999999999984       345667899999999999999


Q ss_pred             hCCCCCCchhhHHHHHHHhhcC--CCCCC--CCCHHHHHHHHHhcccCCCCCC---CHHHHHhccccccCC
Q 004959          544 TGKPPWSEYEGAAAMFKVMRDT--PAIPD--SLSPEGKDFLRCCFQRNPADRP---PASLLLEHRFLKNSQ  607 (721)
Q Consensus       544 tG~~PF~~~~~~~~~~ki~~~~--~~~p~--~lS~el~dLI~~cL~~DP~kRP---Sa~eLL~Hp~f~~~~  607 (721)
                      +|+.||......+.+.++....  ..+|.  .++.++++||.+|+. ||++|+   +++++++||||.+..
T Consensus       231 tG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~hp~f~~~~  300 (360)
T cd05627         231 IGYPPFCSETPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFCT-DSENRIGSNGVEEIKSHPFFEGVD  300 (360)
T ss_pred             cCCCCCCCCCHHHHHHHHHcCCCceecCCCCCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhcCCCCCCCC
Confidence            9999998877766666665422  23333  378999999999874 999998   589999999998753

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-44  Score=379.13  Aligned_cols=257  Identities=23%  Similarity=0.389  Sum_probs=218.2

Q ss_pred             CeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeEEEE
Q 004959          341 QWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYIY  420 (721)
Q Consensus       341 ~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~yLV  420 (721)
                      .|++.++||+|+||+||++.+..+++.||||++...  ..........+.+|+.+++.++|+||+.+++.+...+.+|+|
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv   78 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKK--RIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV   78 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehh--hhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEE
Confidence            488999999999999999999999999999988532  111222345677899999999999999999999999999999


Q ss_pred             EeeccCCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCCccc
Q 004959          421 LEYVHPGSINKYVREH-CGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKAD  499 (721)
Q Consensus       421 mEy~~gGsL~~~L~~~-~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~~~~  499 (721)
                      |||+.||+|.+++... ...+++..+..++.||+.||.|||++||+||||||+|||+++++.++|+|||++..+......
T Consensus        79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~  158 (285)
T cd05605          79 LTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETI  158 (285)
T ss_pred             EeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCCcc
Confidence            9999999999888654 346999999999999999999999999999999999999999999999999999876544444


Q ss_pred             ccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHH----HHHhhcCCCCCCCCCHH
Q 004959          500 LSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAM----FKVMRDTPAIPDSLSPE  575 (721)
Q Consensus       500 ~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~----~ki~~~~~~~p~~lS~e  575 (721)
                      ...+|++.|+|||++.       ...++.++|||||||++|||++|..||.+.......    ..+......++..++..
T Consensus       159 ~~~~~~~~y~aPE~~~-------~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (285)
T cd05605         159 RGRVGTVGYMAPEVVK-------NERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFSEA  231 (285)
T ss_pred             ccccCCCCccCcHHhc-------CCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcccccCcccCHH
Confidence            4567999999999984       345667899999999999999999999875443222    22233344566779999


Q ss_pred             HHHHHHHhcccCCCCCC-----CHHHHHhccccccC
Q 004959          576 GKDFLRCCFQRNPADRP-----PASLLLEHRFLKNS  606 (721)
Q Consensus       576 l~dLI~~cL~~DP~kRP-----Sa~eLL~Hp~f~~~  606 (721)
                      +.+||.+||+.||++||     +++++++|+||...
T Consensus       232 ~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~  267 (285)
T cd05605         232 ARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTA  267 (285)
T ss_pred             HHHHHHHHccCCHHHhcCCCCCCHHHHhcCcCccCC
Confidence            99999999999999999     99999999999864

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=2.7e-45  Score=391.08  Aligned_cols=250  Identities=30%  Similarity=0.514  Sum_probs=218.4

Q ss_pred             eEEeecCCeEEEEEEE---CCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeEEEEEe
Q 004959          346 KLIGRGTFGSVYVASN---RETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYIYLE  422 (721)
Q Consensus       346 k~LG~G~fG~VY~a~~---~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~yLVmE  422 (721)
                      +.||+|+||.||++.+   ..+|+.||+|++....   ........+.+|+.+|++++||||+++++++...+.+|+|||
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e   78 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKAT---LKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILD   78 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHH---hhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEc
Confidence            5899999999999876   4678999999986321   112234567889999999999999999999999999999999


Q ss_pred             eccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCC-ccccc
Q 004959          423 YVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQ-KADLS  501 (721)
Q Consensus       423 y~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~-~~~~s  501 (721)
                      |+.+|+|.+++... ..+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++...... .....
T Consensus        79 ~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~  157 (318)
T cd05582          79 FLRGGDLFTRLSKE-VMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS  157 (318)
T ss_pred             CCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCCceec
Confidence            99999999999664 67999999999999999999999999999999999999999999999999999865443 23345


Q ss_pred             CCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhcCCCCCCCCCHHHHHHHH
Q 004959          502 MKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDSLSPEGKDFLR  581 (721)
Q Consensus       502 ~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~~~~~p~~lS~el~dLI~  581 (721)
                      .+||+.|+|||++.+       ..++.++|||||||++|||++|+.||......+.+..+......++..++.++.+||+
T Consensus       158 ~~g~~~y~aPE~~~~-------~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~  230 (318)
T cd05582         158 FCGTVEYMAPEVVNR-------RGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSLLR  230 (318)
T ss_pred             ccCChhhcCHHHHcC-------CCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence            679999999999843       3456789999999999999999999998877777777777777888899999999999


Q ss_pred             HhcccCCCCCCC-----HHHHHhccccccC
Q 004959          582 CCFQRNPADRPP-----ASLLLEHRFLKNS  606 (721)
Q Consensus       582 ~cL~~DP~kRPS-----a~eLL~Hp~f~~~  606 (721)
                      +||+.||++||+     +++++.|+||...
T Consensus       231 ~~l~~~P~~R~~a~~~~~~~~~~~~~~~~~  260 (318)
T cd05582         231 ALFKRNPANRLGAGPDGVEEIKRHPFFSTI  260 (318)
T ss_pred             HHhhcCHhHcCCCCCCCHHHHhCCCCcCCC
Confidence            999999999999     7889999999864

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=1.6e-44  Score=377.66  Aligned_cols=252  Identities=31%  Similarity=0.537  Sum_probs=205.7

Q ss_pred             CeeEeeEEeecCCeEEEEEEECC-CCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhC---CCCCeeeeeeeEEe---
Q 004959          341 QWQKGKLIGRGTFGSVYVASNRE-TGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHL---KHPNIVQYYGSEIV---  413 (721)
Q Consensus       341 ~y~~~k~LG~G~fG~VY~a~~~~-tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L---~HPnIV~l~g~~~~---  413 (721)
                      +|++.+.||+|+||+||+|.+.. +|+.||||.+........   ....+.+|+.+++.+   .||||+++++++..   
T Consensus         2 ~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~---~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~   78 (290)
T cd07862           2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEG---MPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT   78 (290)
T ss_pred             CcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCC---chHHHHHHHHHHHhhcccCCCCcceEEEEEecccC
Confidence            69999999999999999999864 468899998864322211   123455677776665   69999999998752   


Q ss_pred             --cCeEEEEEeeccCCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCc
Q 004959          414 --EDKFYIYLEYVHPGSINKYVREH-CGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMA  490 (721)
Q Consensus       414 --~~~~yLVmEy~~gGsL~~~L~~~-~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA  490 (721)
                        ...+++||||+. ++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus        79 ~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~  157 (290)
T cd07862          79 DRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLA  157 (290)
T ss_pred             CCCCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEccccce
Confidence              456899999996 6899998654 345899999999999999999999999999999999999999999999999999


Q ss_pred             cccCCCcccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhcCC----
Q 004959          491 KHLTGQKADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTP----  566 (721)
Q Consensus       491 ~~l~~~~~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~~~----  566 (721)
                      ..+..........||+.|+|||++.+       ..++.++|||||||++|||++|++||.+....+.+.++.....    
T Consensus       158 ~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~  230 (290)
T cd07862         158 RIYSFQMALTSVVVTLWYRAPEVLLQ-------SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGE  230 (290)
T ss_pred             EeccCCcccccccccccccChHHHhC-------CCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCCh
Confidence            87655544445679999999999843       3466789999999999999999999988766665555542110    


Q ss_pred             -----------------------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccc
Q 004959          567 -----------------------AIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFL  603 (721)
Q Consensus       567 -----------------------~~p~~lS~el~dLI~~cL~~DP~kRPSa~eLL~Hp~f  603 (721)
                                             .+...++..+++||.+||+.||++|||+.|+|+||||
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f  290 (290)
T cd07862         231 EDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF  290 (290)
T ss_pred             hhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence                                   0113467889999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=6.7e-45  Score=398.18  Aligned_cols=261  Identities=26%  Similarity=0.408  Sum_probs=222.1

Q ss_pred             CCCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeEE
Q 004959          339 NSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFY  418 (721)
Q Consensus       339 ~~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~y  418 (721)
                      ..+|++.+.||+|+||.||+|.+..+|+.||||++....  .......+.+.+|+.+|+.++||||+++++++.+.+.+|
T Consensus        42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~  119 (370)
T cd05596          42 AEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFE--MIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLY  119 (370)
T ss_pred             HHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHH--hhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEE
Confidence            358999999999999999999999999999999986321  111223456788999999999999999999999999999


Q ss_pred             EEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCCcc
Q 004959          419 IYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKA  498 (721)
Q Consensus       419 LVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~~~  498 (721)
                      +||||+.||+|.+++..  ..+++..+..++.||+.||+|||++||+||||||+||||+.++.+||+|||++..+.....
T Consensus       120 lv~Ey~~gg~L~~~l~~--~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~~  197 (370)
T cd05596         120 MVMEYMPGGDLVNLMSN--YDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGM  197 (370)
T ss_pred             EEEcCCCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEeccceeeccCCCc
Confidence            99999999999999865  4689999999999999999999999999999999999999999999999999987643322


Q ss_pred             --cccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhcC--CCCCC--CC
Q 004959          499 --DLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDT--PAIPD--SL  572 (721)
Q Consensus       499 --~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~~--~~~p~--~l  572 (721)
                        ....+||+.|||||++.+..   ....++.++|||||||+||||++|+.||........+.++....  ..++.  .+
T Consensus       198 ~~~~~~~gt~~y~aPE~~~~~~---~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  274 (370)
T cd05596         198 VRCDTAVGTPDYISPEVLKSQG---GDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDDIEI  274 (370)
T ss_pred             ccCCCCCCCcCeECHHHhccCC---CCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCcCCCCCcCCC
Confidence              23467999999999985421   12346778999999999999999999999877766666665532  33444  57


Q ss_pred             CHHHHHHHHHhcccCCCC--CCCHHHHHhccccccC
Q 004959          573 SPEGKDFLRCCFQRNPAD--RPPASLLLEHRFLKNS  606 (721)
Q Consensus       573 S~el~dLI~~cL~~DP~k--RPSa~eLL~Hp~f~~~  606 (721)
                      +.++++||++||+.+|++  |++++++++||||++.
T Consensus       275 s~~~~~li~~~L~~~p~r~~R~s~~ell~h~~~~~~  310 (370)
T cd05596         275 SKQAKDLICAFLTDREVRLGRNGVDEIKSHPFFKND  310 (370)
T ss_pred             CHHHHHHHHHHccChhhccCCCCHHHHhcCcccCCC
Confidence            999999999999999998  9999999999999864

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=1e-44  Score=389.92  Aligned_cols=251  Identities=27%  Similarity=0.488  Sum_probs=212.7

Q ss_pred             eEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhC-CCCCeeeeeeeEEecCeEEEEEeec
Q 004959          346 KLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHL-KHPNIVQYYGSEIVEDKFYIYLEYV  424 (721)
Q Consensus       346 k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L-~HPnIV~l~g~~~~~~~~yLVmEy~  424 (721)
                      ++||+|+||.||+|.+..+++.||+|++....  .......+.+.+|+.++.++ +||||+++++++...+.+|+||||+
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~   78 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKEL--VNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYV   78 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhH--hcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCC
Confidence            47999999999999999999999999986421  12334556788899988877 7999999999999999999999999


Q ss_pred             cCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCC-CcccccCC
Q 004959          425 HPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTG-QKADLSMK  503 (721)
Q Consensus       425 ~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~-~~~~~s~~  503 (721)
                      .+|+|..++... +.+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.... .......+
T Consensus        79 ~~~~L~~~~~~~-~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~~~~~~~  157 (329)
T cd05618          79 NGGDLMFHMQRQ-RKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFC  157 (329)
T ss_pred             CCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCCcccccc
Confidence            999999888664 6799999999999999999999999999999999999999999999999999975432 22334567


Q ss_pred             CCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCch---------hhHHHHHHHhhcCCCCCCCCCH
Q 004959          504 GSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEY---------EGAAAMFKVMRDTPAIPDSLSP  574 (721)
Q Consensus       504 GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~---------~~~~~~~ki~~~~~~~p~~lS~  574 (721)
                      ||+.|+|||++.       ...++.++|||||||++|+|++|+.||...         ........+......+|..++.
T Consensus       158 gt~~y~aPE~~~-------~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~~~~  230 (329)
T cd05618         158 GTPNYIAPEILR-------GEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSV  230 (329)
T ss_pred             CCccccCHHHHc-------CCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCCCCCCCCCH
Confidence            999999999994       345667899999999999999999999521         1112233445556678889999


Q ss_pred             HHHHHHHHhcccCCCCCCC------HHHHHhccccccC
Q 004959          575 EGKDFLRCCFQRNPADRPP------ASLLLEHRFLKNS  606 (721)
Q Consensus       575 el~dLI~~cL~~DP~kRPS------a~eLL~Hp~f~~~  606 (721)
                      ++.+||++||+.||++|++      ++++++||||...
T Consensus       231 ~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~~  268 (329)
T cd05618         231 KAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNV  268 (329)
T ss_pred             HHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcCCCCCCC
Confidence            9999999999999999998      5899999999764

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=2.2e-45  Score=387.75  Aligned_cols=259  Identities=32%  Similarity=0.595  Sum_probs=221.6

Q ss_pred             CCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCC-eeeeeeeEEecC---
Q 004959          340 SQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPN-IVQYYGSEIVED---  415 (721)
Q Consensus       340 ~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPn-IV~l~g~~~~~~---  415 (721)
                      ..|+.++.||+|+||+||+|+.+.+|+.||+|+++...++   +..-....+|+.+|+.|+|+| ||.+++++...+   
T Consensus        11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~---EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~   87 (323)
T KOG0594|consen   11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEE---EGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHR   87 (323)
T ss_pred             HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccc---cCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccc
Confidence            3578888899999999999999999999999999865432   112345689999999999999 999999998877   


Q ss_pred             ---eEEEEEeeccCCCHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCC
Q 004959          416 ---KFYIYLEYVHPGSINKYVREHC---GAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGM  489 (721)
Q Consensus       416 ---~~yLVmEy~~gGsL~~~L~~~~---~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGl  489 (721)
                         .+|+||||++ -+|.+++....   ..++...++.+++||+.||+|||++||+||||||+||||++.|.+||+|||+
T Consensus        88 ~~~~l~lvfe~~d-~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaDFGl  166 (323)
T KOG0594|consen   88 GIGKLYLVFEFLD-RDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLADFGL  166 (323)
T ss_pred             ccceEEEEEEeec-ccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeeeccch
Confidence               8999999997 79999998765   3688899999999999999999999999999999999999999999999999


Q ss_pred             ccccCCC-cccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhcC--C
Q 004959          490 AKHLTGQ-KADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDT--P  566 (721)
Q Consensus       490 A~~l~~~-~~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~~--~  566 (721)
                      |+.+.-. ......++|.+|+|||++.+      ...|+..+||||+|||++||++++..|.+....+++.+|.+-.  +
T Consensus       167 Ara~~ip~~~yt~evvTlWYRaPEvLlG------s~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP  240 (323)
T KOG0594|consen  167 ARAFSIPMRTYTPEVVTLWYRAPEVLLG------STSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTP  240 (323)
T ss_pred             HHHhcCCcccccccEEEeeccCHHHhcC------CCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCC
Confidence            9977633 33455679999999999975      3457778999999999999999999999988888887775411  0


Q ss_pred             ----------------CCC------------CCCCHHHHHHHHHhcccCCCCCCCHHHHHhccccccCCC
Q 004959          567 ----------------AIP------------DSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQ  608 (721)
Q Consensus       567 ----------------~~p------------~~lS~el~dLI~~cL~~DP~kRPSa~eLL~Hp~f~~~~~  608 (721)
                                      .++            ...+.+..+++.+||+.+|.+|.++..+|+||||.....
T Consensus       241 ~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~~~  310 (323)
T KOG0594|consen  241 NEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSELPE  310 (323)
T ss_pred             CccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhccccc
Confidence                            111            123468999999999999999999999999999987644

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=1.4e-45  Score=389.36  Aligned_cols=254  Identities=32%  Similarity=0.536  Sum_probs=221.1

Q ss_pred             CeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEec--C---
Q 004959          341 QWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVE--D---  415 (721)
Q Consensus       341 ~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~--~---  415 (721)
                      .|...+++|.|+||.||+|....+++.||||++-..+.         .-.+|+.+|+.++|||||+|.-+|...  +   
T Consensus        25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r---------~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~   95 (364)
T KOG0658|consen   25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR---------YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEV   95 (364)
T ss_pred             EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC---------cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchh
Confidence            68889999999999999999999999999998742211         234799999999999999999887652  2   


Q ss_pred             eEEEEEeeccCCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCC-CceEEeecCCcc
Q 004959          416 KFYIYLEYVHPGSINKYVREH---CGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDAS-GVVKLADFGMAK  491 (721)
Q Consensus       416 ~~yLVmEy~~gGsL~~~L~~~---~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~-g~VKL~DFGlA~  491 (721)
                      +..+|||||+ .+|..+++..   +..++.-.++.|++||++||.|||+.||+||||||+|||||.+ |.+||||||.|+
T Consensus        96 ~lnlVleymP-~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK  174 (364)
T KOG0658|consen   96 YLNLVLEYMP-ETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSAK  174 (364)
T ss_pred             HHHHHHHhch-HHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCcce
Confidence            4568999996 7999998743   4789999999999999999999999999999999999999975 899999999999


Q ss_pred             ccCCCcccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhcCC-----
Q 004959          492 HLTGQKADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTP-----  566 (721)
Q Consensus       492 ~l~~~~~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~~~-----  566 (721)
                      .+..++...++..|.+|+|||++.+      ...|+.+.||||.||++.||+-|++.|.+....+++..|.+-..     
T Consensus       175 ~L~~~epniSYicSRyYRaPELifg------a~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e  248 (364)
T KOG0658|consen  175 VLVKGEPNISYICSRYYRAPELIFG------ATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTRE  248 (364)
T ss_pred             eeccCCCceeEEEeccccCHHHHcC------ccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHH
Confidence            9998888889999999999999985      46788899999999999999999999999888887776654110     


Q ss_pred             ------------C------------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhccccccCCCCC
Q 004959          567 ------------A------------IPDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQPD  610 (721)
Q Consensus       567 ------------~------------~p~~lS~el~dLI~~cL~~DP~kRPSa~eLL~Hp~f~~~~~~~  610 (721)
                                  .            +....++++.+|+.++|+.+|++|.++.|+|.||||.....++
T Consensus       249 ~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~~~  316 (364)
T KOG0658|consen  249 DIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRDPN  316 (364)
T ss_pred             HHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhCcC
Confidence                        0            2235789999999999999999999999999999999877663

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=3.7e-44  Score=389.73  Aligned_cols=260  Identities=22%  Similarity=0.351  Sum_probs=213.4

Q ss_pred             CCCCCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEec--
Q 004959          337 PMNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVE--  414 (721)
Q Consensus       337 ~l~~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~--  414 (721)
                      .+.++|++++.||+|+||.||+|.+..+++.||||++...   .......+.+.+|+.+++.++||||+++++++...  
T Consensus        21 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~   97 (364)
T cd07875          21 TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRP---FQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKS   97 (364)
T ss_pred             chhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCcc---ccCchhHHHHHHHHHHHHhcCCCCccccceeeccccc
Confidence            3457899999999999999999999999999999988632   12234456788999999999999999999987543  


Q ss_pred             ----CeEEEEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCc
Q 004959          415 ----DKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMA  490 (721)
Q Consensus       415 ----~~~yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA  490 (721)
                          ..+|+||||+. ++|.+++..   .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus        98 ~~~~~~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a  173 (364)
T cd07875          98 LEEFQDVYIVMELMD-ANLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA  173 (364)
T ss_pred             ccccCeEEEEEeCCC-CCHHHHHHh---cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeCCCc
Confidence                35799999996 577777753   4889999999999999999999999999999999999999999999999999


Q ss_pred             cccCCCcccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhcC-----
Q 004959          491 KHLTGQKADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDT-----  565 (721)
Q Consensus       491 ~~l~~~~~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~~-----  565 (721)
                      +............||+.|+|||++.       +..++.++|||||||+||+|++|+.||.+.+..+.+.+++...     
T Consensus       174 ~~~~~~~~~~~~~~t~~y~aPE~~~-------~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~  246 (364)
T cd07875         174 RTAGTSFMMTPYVVTRYYRAPEVIL-------GMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCP  246 (364)
T ss_pred             cccCCCCcccCCcccCCcCCHHHHh-------CCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCH
Confidence            8765444444567999999999994       3456778999999999999999999998766555444433210     


Q ss_pred             -----------------CC--------------------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhccccccCCC
Q 004959          566 -----------------PA--------------------IPDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQ  608 (721)
Q Consensus       566 -----------------~~--------------------~p~~lS~el~dLI~~cL~~DP~kRPSa~eLL~Hp~f~~~~~  608 (721)
                                       +.                    .....+.++++||.+||+.||.+|||+.|+|+||||.....
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~~~~~  326 (364)
T cd07875         247 EFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYD  326 (364)
T ss_pred             HHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCcccccccC
Confidence                             00                    01123567899999999999999999999999999986555


Q ss_pred             CC
Q 004959          609 PD  610 (721)
Q Consensus       609 ~~  610 (721)
                      +.
T Consensus       327 ~~  328 (364)
T cd07875         327 PS  328 (364)
T ss_pred             cc
Confidence            43

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.7e-46  Score=408.83  Aligned_cols=262  Identities=35%  Similarity=0.642  Sum_probs=237.6

Q ss_pred             CCCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeEE
Q 004959          339 NSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFY  418 (721)
Q Consensus       339 ~~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~y  418 (721)
                      .+.|.++..||.|+||+||+|.++.++...|.|+|.     .+..+.++.+.-||.||..++||+||+|++.|..++.++
T Consensus        31 ~d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIe-----tkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLw  105 (1187)
T KOG0579|consen   31 RDHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIE-----TKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLW  105 (1187)
T ss_pred             HHHHHHHhhhcCccchhhhhhhcccchhhhhhhhhc-----ccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceE
Confidence            357999999999999999999999999999999885     356778899999999999999999999999999999999


Q ss_pred             EEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCC-c
Q 004959          419 IYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQ-K  497 (721)
Q Consensus       419 LVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~-~  497 (721)
                      |++|||.||-+..++-+.+..|+|.++..+++|+|+||.|||+++|||||||..|||++-+|.|+|+|||.+...... .
T Consensus       106 iliEFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~q  185 (1187)
T KOG0579|consen  106 ILIEFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTRQ  185 (1187)
T ss_pred             EEEeecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeecccccccchhHHh
Confidence            999999999999999888889999999999999999999999999999999999999999999999999998654432 3


Q ss_pred             ccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhcCCC---CCCCCCH
Q 004959          498 ADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPA---IPDSLSP  574 (721)
Q Consensus       498 ~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~~~~---~p~~lS~  574 (721)
                      ...++.|||+|||||+.++.-.  +...|+.++||||||++|.||..+.+|..+.+....+.+|.+..+.   -|..++.
T Consensus       186 kRDsFIGTPYWMAPEVvmCET~--KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSePPTLlqPS~Ws~  263 (1187)
T KOG0579|consen  186 KRDSFIGTPYWMAPEVVMCETF--KDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLLQPSHWSR  263 (1187)
T ss_pred             hhccccCCcccccchheeeccc--cCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcCCCcccCcchhhh
Confidence            4467899999999999987544  4567888999999999999999999999999999888888776543   4678999


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHHhccccccCC
Q 004959          575 EGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQ  607 (721)
Q Consensus       575 el~dLI~~cL~~DP~kRPSa~eLL~Hp~f~~~~  607 (721)
                      .+.|||++||.+||..||++.+||+||||++..
T Consensus       264 ~F~DfLk~cL~Knp~~Rp~aaqll~Hpfv~~~~  296 (1187)
T KOG0579|consen  264 SFSDFLKRCLVKNPRNRPPAAQLLKHPFVQNAP  296 (1187)
T ss_pred             HHHHHHHHHHhcCCccCCCHHHHhhCcccccCC
Confidence            999999999999999999999999999998653

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=1.7e-44  Score=385.97  Aligned_cols=252  Identities=27%  Similarity=0.492  Sum_probs=215.6

Q ss_pred             eEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHh-CCCCCeeeeeeeEEecCeEEEEEeec
Q 004959          346 KLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSH-LKHPNIVQYYGSEIVEDKFYIYLEYV  424 (721)
Q Consensus       346 k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~-L~HPnIV~l~g~~~~~~~~yLVmEy~  424 (721)
                      +.||+|+||+||+|.+..+++.||||++.....  ......+.+..|..++.. ++||||+++++++.+.+.+|+||||+
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~   78 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVV--LMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYL   78 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHh--hhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCC
Confidence            479999999999999999999999999863211  111234556678888876 48999999999999999999999999


Q ss_pred             cCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCC-CcccccCC
Q 004959          425 HPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTG-QKADLSMK  503 (721)
Q Consensus       425 ~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~-~~~~~s~~  503 (721)
                      .||+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... .......+
T Consensus        79 ~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  157 (316)
T cd05619          79 NGGDLMFHIQSC-HKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFC  157 (316)
T ss_pred             CCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCCceeeec
Confidence            999999999764 6799999999999999999999999999999999999999999999999999875422 22334567


Q ss_pred             CCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhcCCCCCCCCCHHHHHHHHHh
Q 004959          504 GSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDSLSPEGKDFLRCC  583 (721)
Q Consensus       504 GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~~~~~p~~lS~el~dLI~~c  583 (721)
                      ||+.|+|||++.       ...++.++|||||||++|||++|..||......+.+..+....+.++..++.++++||.+|
T Consensus       158 gt~~y~aPE~~~-------~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~  230 (316)
T cd05619         158 GTPDYIAPEILL-------GQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPCYPRWLTREAKDILVKL  230 (316)
T ss_pred             CCccccCHHHHc-------CCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHHH
Confidence            999999999984       3456778999999999999999999998877666666666666677888999999999999


Q ss_pred             cccCCCCCCCHH-HHHhccccccCC
Q 004959          584 FQRNPADRPPAS-LLLEHRFLKNSQ  607 (721)
Q Consensus       584 L~~DP~kRPSa~-eLL~Hp~f~~~~  607 (721)
                      |+.||++|+++. ++++||||....
T Consensus       231 l~~~P~~R~~~~~~l~~h~~~~~~~  255 (316)
T cd05619         231 FVREPERRLGVKGDIRQHPFFREID  255 (316)
T ss_pred             hccCHhhcCCChHHHHcCcccCCCC
Confidence            999999999996 899999998754

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=1.9e-44  Score=377.44  Aligned_cols=251  Identities=25%  Similarity=0.442  Sum_probs=211.6

Q ss_pred             EeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeEEEEEeeccCC
Q 004959          348 IGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYIYLEYVHPG  427 (721)
Q Consensus       348 LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~yLVmEy~~gG  427 (721)
                      ||+|+||+||+|.+..+|+.||+|++...  ........+.+..|+.+|+.++|+||+++++++.....+|+||||++||
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~--~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g   78 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKK--RLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGG   78 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHH--HHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCC
Confidence            69999999999999999999999998632  1122234567788999999999999999999999999999999999999


Q ss_pred             CHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCCcc-cccCC
Q 004959          428 SINKYVRE---HCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKA-DLSMK  503 (721)
Q Consensus       428 sL~~~L~~---~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~~~-~~s~~  503 (721)
                      +|..++..   ....+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+..... .....
T Consensus        79 ~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~  158 (280)
T cd05608          79 DLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYA  158 (280)
T ss_pred             CHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCccccccC
Confidence            99988753   235689999999999999999999999999999999999999999999999999987654332 23457


Q ss_pred             CCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhh----HHHHHHHhhcCCCCCCCCCHHHHHH
Q 004959          504 GSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEG----AAAMFKVMRDTPAIPDSLSPEGKDF  579 (721)
Q Consensus       504 GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~----~~~~~ki~~~~~~~p~~lS~el~dL  579 (721)
                      ||+.|+|||++.+       ..++.++|||||||++|+|++|+.||.....    ......+......++..++.++.+|
T Consensus       159 g~~~y~aPE~~~~-------~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  231 (280)
T cd05608         159 GTPGFMAPELLQG-------EEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPDKFSPASKSF  231 (280)
T ss_pred             CCcCccCHHHhcC-------CCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcccCCCCcccCCHHHHHH
Confidence            9999999999953       4566789999999999999999999975432    2223334444456677899999999


Q ss_pred             HHHhcccCCCCCC-----CHHHHHhccccccCC
Q 004959          580 LRCCFQRNPADRP-----PASLLLEHRFLKNSQ  607 (721)
Q Consensus       580 I~~cL~~DP~kRP-----Sa~eLL~Hp~f~~~~  607 (721)
                      |.+||+.||++|+     +++++++||||+...
T Consensus       232 i~~~l~~~P~~R~~~~~~~~~~~l~h~~~~~~~  264 (280)
T cd05608         232 CEALLAKDPEKRLGFRDGNCDGLRTHPLFRDLN  264 (280)
T ss_pred             HHHHhcCCHHHhcCCCCCCHHHHhcChhhhcCC
Confidence            9999999999999     889999999998643

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=6.8e-44  Score=386.92  Aligned_cols=258  Identities=23%  Similarity=0.369  Sum_probs=210.3

Q ss_pred             CCCCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecC--
Q 004959          338 MNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVED--  415 (721)
Q Consensus       338 l~~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~--  415 (721)
                      +..+|++.+.||+|+||.||+|.+..+|+.||||++...   .......+.+.+|+.+++.++||||+++++++...+  
T Consensus        19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~   95 (359)
T cd07876          19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRP---FQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSL   95 (359)
T ss_pred             hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEeccc---ccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCc
Confidence            456899999999999999999999999999999998532   123344567889999999999999999999886543  


Q ss_pred             ----eEEEEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCcc
Q 004959          416 ----KFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAK  491 (721)
Q Consensus       416 ----~~yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~  491 (721)
                          .+|+||||+.+ +|.+.+.   ..+++..+..++.||+.||.|||++||+||||||+||||+.+|.+||+|||+++
T Consensus        96 ~~~~~~~lv~e~~~~-~l~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~  171 (359)
T cd07876          96 EEFQDVYLVMELMDA-NLCQVIH---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR  171 (359)
T ss_pred             cccceeEEEEeCCCc-CHHHHHh---ccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEecCCCcc
Confidence                57999999974 6666664   358999999999999999999999999999999999999999999999999998


Q ss_pred             ccCCCcccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhh--------
Q 004959          492 HLTGQKADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMR--------  563 (721)
Q Consensus       492 ~l~~~~~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~--------  563 (721)
                      ............||+.|+|||++.+       ..++.++|||||||++|+|++|+.||.+.+..+.+..+..        
T Consensus       172 ~~~~~~~~~~~~~t~~y~aPE~~~~-------~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~  244 (359)
T cd07876         172 TACTNFMMTPYVVTRYYRAPEVILG-------MGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAE  244 (359)
T ss_pred             ccccCccCCCCcccCCCCCchhccC-------CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHH
Confidence            6654444455679999999999843       4566789999999999999999999986554332221111        


Q ss_pred             --------------cCCC--------------------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhccccccCCCC
Q 004959          564 --------------DTPA--------------------IPDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQP  609 (721)
Q Consensus       564 --------------~~~~--------------------~p~~lS~el~dLI~~cL~~DP~kRPSa~eLL~Hp~f~~~~~~  609 (721)
                                    ..+.                    .....+.++++||.+||+.||++|||+.|+|+||||.....+
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~~~  324 (359)
T cd07876         245 FMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITVWYDP  324 (359)
T ss_pred             HHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhhhhcCc
Confidence                          1000                    111246789999999999999999999999999999865443

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=1.1e-44  Score=387.02  Aligned_cols=251  Identities=27%  Similarity=0.455  Sum_probs=213.9

Q ss_pred             eEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHH-HHHhCCCCCeeeeeeeEEecCeEEEEEeec
Q 004959          346 KLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIK-VLSHLKHPNIVQYYGSEIVEDKFYIYLEYV  424 (721)
Q Consensus       346 k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~-iL~~L~HPnIV~l~g~~~~~~~~yLVmEy~  424 (721)
                      ++||+|+||+||+|++..+|+.||+|++....  .........+..|+. +++.++||||+++++++.+.+.+|+||||+
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~   78 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKT--ILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYV   78 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHH--HHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCC
Confidence            47999999999999999999999999986321  111223345555554 678899999999999999999999999999


Q ss_pred             cCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCC-CcccccCC
Q 004959          425 HPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTG-QKADLSMK  503 (721)
Q Consensus       425 ~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~-~~~~~s~~  503 (721)
                      +||+|..++... ..+++..++.++.||+.||.|||++||+||||||+||||+.+|.+||+|||++..... .......+
T Consensus        79 ~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  157 (321)
T cd05603          79 NGGELFFHLQRE-RCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFC  157 (321)
T ss_pred             CCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCCcccccc
Confidence            999999888654 6799999999999999999999999999999999999999999999999999875322 22334567


Q ss_pred             CCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhcCCCCCCCCCHHHHHHHHHh
Q 004959          504 GSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDSLSPEGKDFLRCC  583 (721)
Q Consensus       504 GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~~~~~p~~lS~el~dLI~~c  583 (721)
                      ||+.|+|||++.       ...++.++|||||||++|||++|..||...+.......+......++...+.++.++|.+|
T Consensus       158 gt~~y~aPE~~~-------~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~  230 (321)
T cd05603         158 GTPEYLAPEVLR-------KEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQLPGGKTVAACDLLVGL  230 (321)
T ss_pred             CCcccCCHHHhc-------CCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHH
Confidence            999999999984       3456678999999999999999999998877767777777777778888999999999999


Q ss_pred             cccCCCCCCCH----HHHHhccccccC
Q 004959          584 FQRNPADRPPA----SLLLEHRFLKNS  606 (721)
Q Consensus       584 L~~DP~kRPSa----~eLL~Hp~f~~~  606 (721)
                      |+.||++|+++    .++++|+||...
T Consensus       231 l~~~p~~R~~~~~~~~~~~~~~~~~~~  257 (321)
T cd05603         231 LHKDQRRRLGAKADFLEIKNHVFFSPI  257 (321)
T ss_pred             ccCCHhhcCCCCCCHHHHhCCCCcCCC
Confidence            99999999875    599999999754

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5e-44  Score=367.11  Aligned_cols=256  Identities=44%  Similarity=0.863  Sum_probs=220.3

Q ss_pred             CCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeEEE
Q 004959          340 SQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYI  419 (721)
Q Consensus       340 ~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~yL  419 (721)
                      +.|++++.||+|+||.||.|.+..+++.||||.+.............+.+.+|+.++++++||||+++++++...+..|+
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   81 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI   81 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence            46999999999999999999999999999999986433222333456788999999999999999999999999999999


Q ss_pred             EEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCCccc
Q 004959          420 YLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKAD  499 (721)
Q Consensus       420 VmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~~~~  499 (721)
                      ||||+.+++|.+++... +.+++..++.++.||+.||.|||+.||+||||||+||+++.++.++|+|||++..+......
T Consensus        82 v~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~~  160 (263)
T cd06625          82 FMEYMPGGSVKDQLKAY-GALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSS  160 (263)
T ss_pred             EEEECCCCcHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceeccccccc
Confidence            99999999999999765 67899999999999999999999999999999999999999999999999999765432211


Q ss_pred             ----ccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhc--CCCCCCCCC
Q 004959          500 ----LSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRD--TPAIPDSLS  573 (721)
Q Consensus       500 ----~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~--~~~~p~~lS  573 (721)
                          ....|+..|+|||++.+       ..++.++|||||||++|+|++|+.||...........+...  ...++..++
T Consensus       161 ~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (263)
T cd06625         161 GTGMKSVTGTPYWMSPEVISG-------EGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPSHVS  233 (263)
T ss_pred             cccccCCCcCccccCcceecc-------CCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccCCCCCCCccCC
Confidence                23568899999999853       34667899999999999999999999876655555544332  345677899


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHHhcccc
Q 004959          574 PEGKDFLRCCFQRNPADRPPASLLLEHRFL  603 (721)
Q Consensus       574 ~el~dLI~~cL~~DP~kRPSa~eLL~Hp~f  603 (721)
                      .++.+||.+||..+|++||++.++++|+||
T Consensus       234 ~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~  263 (263)
T cd06625         234 PDARNFLRRTFVENAKKRPSAEELLRHFFV  263 (263)
T ss_pred             HHHHHHHHHHhhcCcccCCCHHHHhhCCCC
Confidence            999999999999999999999999999997

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=2.5e-44  Score=403.14  Aligned_cols=254  Identities=29%  Similarity=0.510  Sum_probs=210.7

Q ss_pred             CCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEec-----
Q 004959          340 SQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVE-----  414 (721)
Q Consensus       340 ~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~-----  414 (721)
                      ..|++++.||+|+||.||+|.+..+++.||||++...   .      ....+|+.+|+.++|+|||++++++...     
T Consensus        66 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~---~------~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~  136 (440)
T PTZ00036         66 KSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQD---P------QYKNRELLIMKNLNHINIIFLKDYYYTECFKKN  136 (440)
T ss_pred             CeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecC---c------chHHHHHHHHHhcCCCCCcceeeeEeecccccC
Confidence            5799999999999999999999999999999987521   1      1345799999999999999999876542     


Q ss_pred             ---CeEEEEEeeccCCCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCC-ceEEeec
Q 004959          415 ---DKFYIYLEYVHPGSINKYVRE---HCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASG-VVKLADF  487 (721)
Q Consensus       415 ---~~~yLVmEy~~gGsL~~~L~~---~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g-~VKL~DF  487 (721)
                         ..+++||||+. ++|.+++..   ....+++..++.++.||+.||.|||++||+||||||+||||+.++ .+||+||
T Consensus       137 ~~~~~l~lvmE~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~DF  215 (440)
T PTZ00036        137 EKNIFLNVVMEFIP-QTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDF  215 (440)
T ss_pred             CCceEEEEEEecCC-ccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeeecc
Confidence               24779999997 577777643   346799999999999999999999999999999999999998665 7999999


Q ss_pred             CCccccCCCcccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhcC--
Q 004959          488 GMAKHLTGQKADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDT--  565 (721)
Q Consensus       488 GlA~~l~~~~~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~~--  565 (721)
                      |+++.+.........+||+.|||||++.+      ...++.++|||||||+||||++|.+||.+....+.+.++....  
T Consensus       216 Gla~~~~~~~~~~~~~~t~~y~aPE~~~~------~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~  289 (440)
T PTZ00036        216 GSAKNLLAGQRSVSYICSRFYRAPELMLG------ATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGT  289 (440)
T ss_pred             ccchhccCCCCcccCCCCcCccCHHHhcC------CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Confidence            99998766555556789999999999853      2356778999999999999999999998876555554443210  


Q ss_pred             ---------------------------CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhccccccCCCC
Q 004959          566 ---------------------------PAIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQP  609 (721)
Q Consensus       566 ---------------------------~~~p~~lS~el~dLI~~cL~~DP~kRPSa~eLL~Hp~f~~~~~~  609 (721)
                                                 ..+|...++++++||.+||++||++|+|+.|+|+||||.....+
T Consensus       290 p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~~~~  360 (440)
T PTZ00036        290 PTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLRDP  360 (440)
T ss_pred             CCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhhhcc
Confidence                                       01234578899999999999999999999999999999876543

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=3.6e-44  Score=384.35  Aligned_cols=256  Identities=26%  Similarity=0.447  Sum_probs=221.8

Q ss_pred             CeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCC-CCCeeeeeeeEEecCeEEE
Q 004959          341 QWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLK-HPNIVQYYGSEIVEDKFYI  419 (721)
Q Consensus       341 ~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~-HPnIV~l~g~~~~~~~~yL  419 (721)
                      +|+..+.||+|+||.||+|.++.+|+.||||++....  .......+.+..|+.++..+. |++|+++++++...+.+|+
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~l   78 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDV--VIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYF   78 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHH--hhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEE
Confidence            4788899999999999999999999999999986321  112234567788999998886 5778889999999999999


Q ss_pred             EEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCC-cc
Q 004959          420 YLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQ-KA  498 (721)
Q Consensus       420 VmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~-~~  498 (721)
                      ||||+.||+|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... ..
T Consensus        79 v~Ey~~~g~L~~~i~~~-~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~~~  157 (323)
T cd05615          79 VMEYVNGGDLMYHIQQV-GKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVT  157 (323)
T ss_pred             EEcCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccccccCCCCcc
Confidence            99999999999998764 67999999999999999999999999999999999999999999999999998764322 22


Q ss_pred             cccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhcCCCCCCCCCHHHHH
Q 004959          499 DLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDSLSPEGKD  578 (721)
Q Consensus       499 ~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~~~~~p~~lS~el~d  578 (721)
                      ....+||+.|+|||++.+       ..++.++|||||||++|+|++|+.||.+.........+......+|..++.++.+
T Consensus       158 ~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~  230 (323)
T cd05615         158 TRTFCGTPDYIAPEIIAY-------QPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVS  230 (323)
T ss_pred             ccCccCCccccCHHHHcC-------CCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHH
Confidence            345679999999999843       3466789999999999999999999998877777777777777888899999999


Q ss_pred             HHHHhcccCCCCCCC-----HHHHHhccccccC
Q 004959          579 FLRCCFQRNPADRPP-----ASLLLEHRFLKNS  606 (721)
Q Consensus       579 LI~~cL~~DP~kRPS-----a~eLL~Hp~f~~~  606 (721)
                      ||.+||+.||++|++     .+++++|+||...
T Consensus       231 li~~~l~~~p~~R~~~~~~~~~~i~~h~~f~~~  263 (323)
T cd05615         231 ICKGLMTKHPSKRLGCGPEGERDIREHAFFRRI  263 (323)
T ss_pred             HHHHHcccCHhhCCCCCCCCHHHHhcCcccCCC
Confidence            999999999999997     5799999999864

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=6.3e-44  Score=386.27  Aligned_cols=257  Identities=23%  Similarity=0.350  Sum_probs=210.7

Q ss_pred             CCCCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEec---
Q 004959          338 MNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVE---  414 (721)
Q Consensus       338 l~~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~---  414 (721)
                      +.++|++.+.||+|+||.||+|.+..+++.||||.+...   .......+.+.+|+.+|+.++||||+++++++...   
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~   91 (355)
T cd07874          15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRP---FQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSL   91 (355)
T ss_pred             hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCc---ccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccc
Confidence            457899999999999999999999999999999988532   22334456788999999999999999999987653   


Q ss_pred             ---CeEEEEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCcc
Q 004959          415 ---DKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAK  491 (721)
Q Consensus       415 ---~~~yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~  491 (721)
                         ...|+||||+++ +|.+++..   .+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++
T Consensus        92 ~~~~~~~lv~e~~~~-~l~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~Dfg~~~  167 (355)
T cd07874          92 EEFQDVYLVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR  167 (355)
T ss_pred             cccceeEEEhhhhcc-cHHHHHhh---cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEeeCcccc
Confidence               357999999974 67666643   58899999999999999999999999999999999999999999999999998


Q ss_pred             ccCCCcccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhc-------
Q 004959          492 HLTGQKADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRD-------  564 (721)
Q Consensus       492 ~l~~~~~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~-------  564 (721)
                      ............||+.|+|||++.       +..++.++|||||||++|+|++|+.||.+.+..+.+..++..       
T Consensus       168 ~~~~~~~~~~~~~t~~y~aPE~~~-------~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  240 (355)
T cd07874         168 TAGTSFMMTPYVVTRYYRAPEVIL-------GMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPE  240 (355)
T ss_pred             cCCCccccCCccccCCccCHHHHc-------CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHH
Confidence            765544445567999999999984       345677899999999999999999999875543333222110       


Q ss_pred             ---------------CC--------------------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhccccccCCC
Q 004959          565 ---------------TP--------------------AIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQ  608 (721)
Q Consensus       565 ---------------~~--------------------~~p~~lS~el~dLI~~cL~~DP~kRPSa~eLL~Hp~f~~~~~  608 (721)
                                     .+                    ......+.++++||.+||+.||++|||+.|+|+||||.....
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~~~~  319 (355)
T cd07874         241 FMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINVWYD  319 (355)
T ss_pred             HHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchhcccC
Confidence                           00                    011224578899999999999999999999999999986543

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.2e-44  Score=385.07  Aligned_cols=263  Identities=24%  Similarity=0.380  Sum_probs=218.7

Q ss_pred             CCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeEEE
Q 004959          340 SQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYI  419 (721)
Q Consensus       340 ~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~yL  419 (721)
                      ++|++++.||+|+||+||+|.+..+++.||||++.+.  +.......+.+.+|+.++..++|+||+.+++++.+.+.+|+
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~l   78 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKW--EMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYL   78 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHH--HHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEE
Confidence            4799999999999999999999999999999998631  11223345678899999999999999999999999999999


Q ss_pred             EEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCCccc
Q 004959          420 YLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKAD  499 (721)
Q Consensus       420 VmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~~~~  499 (721)
                      ||||+.||+|.+++.+....+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||++..+......
T Consensus        79 v~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  158 (331)
T cd05597          79 VMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTV  158 (331)
T ss_pred             EEecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCCCc
Confidence            99999999999999876678999999999999999999999999999999999999999999999999999766443322


Q ss_pred             --ccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhcC--CCC---CCCC
Q 004959          500 --LSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDT--PAI---PDSL  572 (721)
Q Consensus       500 --~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~~--~~~---p~~l  572 (721)
                        ...+||+.|||||++.....  ....++.++|||||||++|+|++|+.||......+.+.++....  ..+   ...+
T Consensus       159 ~~~~~~gt~~y~aPE~~~~~~~--~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  236 (331)
T cd05597         159 QSNVAVGTPDYISPEILQAMED--GKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDVTDV  236 (331)
T ss_pred             cccceeccccccCHHHHhhccc--cccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCcccCCCccCCC
Confidence              23469999999999964211  12345678999999999999999999998776666655554322  122   2357


Q ss_pred             CHHHHHHHHHhcccCCCC--CCCHHHHHhccccccC
Q 004959          573 SPEGKDFLRCCFQRNPAD--RPPASLLLEHRFLKNS  606 (721)
Q Consensus       573 S~el~dLI~~cL~~DP~k--RPSa~eLL~Hp~f~~~  606 (721)
                      ++++++||++||..++++  |+++.++++||||...
T Consensus       237 ~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~~  272 (331)
T cd05597         237 SEEAKDLIRRLICSPETRLGRNGLQDFKDHPFFEGI  272 (331)
T ss_pred             CHHHHHHHHHHccCcccccCCCCHHHHhcCCCCCCC
Confidence            999999999999765544  8899999999999764

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=2.1e-44  Score=394.60  Aligned_cols=261  Identities=24%  Similarity=0.410  Sum_probs=220.1

Q ss_pred             CCCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeEE
Q 004959          339 NSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFY  418 (721)
Q Consensus       339 ~~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~y  418 (721)
                      ..+|++.+.||+|+||.||+|.+..+++.||+|++.+..  .......+.+.+|+.+++.++||||+++++++.+++.+|
T Consensus        42 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~  119 (370)
T cd05621          42 AEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFE--MIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLY  119 (370)
T ss_pred             HHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHH--hhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEE
Confidence            468999999999999999999999999999999986321  112233456788999999999999999999999999999


Q ss_pred             EEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCCcc
Q 004959          419 IYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKA  498 (721)
Q Consensus       419 LVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~~~  498 (721)
                      +|||||.||+|.+++..  ..+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||++..+.....
T Consensus       120 lv~Ey~~gg~L~~~l~~--~~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~~  197 (370)
T cd05621         120 MVMEYMPGGDLVNLMSN--YDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGM  197 (370)
T ss_pred             EEEcCCCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEecccceecccCCc
Confidence            99999999999999965  3689999999999999999999999999999999999999999999999999987643322


Q ss_pred             --cccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhcC--CCCCC--CC
Q 004959          499 --DLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDT--PAIPD--SL  572 (721)
Q Consensus       499 --~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~~--~~~p~--~l  572 (721)
                        ....+||+.|||||++.+..   ....++.++|||||||+||+|++|+.||........+.++....  ..+|.  .+
T Consensus       198 ~~~~~~~gt~~Y~aPE~~~~~~---~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~  274 (370)
T cd05621         198 VRCDTAVGTPDYISPEVLKSQG---GDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPEDVEI  274 (370)
T ss_pred             eecccCCCCcccCCHHHHhccC---CCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcccCCCCcccC
Confidence              23567999999999996421   12336678999999999999999999998877666666665532  33444  46


Q ss_pred             CHHHHHHHHHhcccCCCC--CCCHHHHHhccccccC
Q 004959          573 SPEGKDFLRCCFQRNPAD--RPPASLLLEHRFLKNS  606 (721)
Q Consensus       573 S~el~dLI~~cL~~DP~k--RPSa~eLL~Hp~f~~~  606 (721)
                      +..++++|.+||+.++.+  |+++.|+++||||+..
T Consensus       275 s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~~  310 (370)
T cd05621         275 SKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKND  310 (370)
T ss_pred             CHHHHHHHHHHccCchhccCCCCHHHHhcCcccCCC
Confidence            999999999999866554  8999999999999864

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=1.2e-44  Score=387.58  Aligned_cols=251  Identities=27%  Similarity=0.432  Sum_probs=214.4

Q ss_pred             eEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHH-HHHhCCCCCeeeeeeeEEecCeEEEEEeec
Q 004959          346 KLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIK-VLSHLKHPNIVQYYGSEIVEDKFYIYLEYV  424 (721)
Q Consensus       346 k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~-iL~~L~HPnIV~l~g~~~~~~~~yLVmEy~  424 (721)
                      ++||+|+||+||+|.+..+|+.||||++....  .......+.+..|.. +++.++||||+++++++...+.+|+||||+
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~   78 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKI--VLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFV   78 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHH--hhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCC
Confidence            47999999999999999999999999986321  112233445556655 467799999999999999999999999999


Q ss_pred             cCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCC-CcccccCC
Q 004959          425 HPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTG-QKADLSMK  503 (721)
Q Consensus       425 ~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~-~~~~~s~~  503 (721)
                      .||+|..++... +.+++..++.++.||+.||+|||++||+||||||+||||+.+|.+||+|||++..... .......+
T Consensus        79 ~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~  157 (325)
T cd05604          79 NGGELFFHLQRE-RSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFC  157 (325)
T ss_pred             CCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCCCccccc
Confidence            999999888754 6799999999999999999999999999999999999999999999999999875432 22334567


Q ss_pred             CCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhcCCCCCCCCCHHHHHHHHHh
Q 004959          504 GSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDSLSPEGKDFLRCC  583 (721)
Q Consensus       504 GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~~~~~p~~lS~el~dLI~~c  583 (721)
                      ||+.|||||++.       ...++.++|||||||++|+|++|..||...+..+.+..+......++..++.++.++|++|
T Consensus       158 gt~~y~aPE~~~-------~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~l  230 (325)
T cd05604         158 GTPEYLAPEVIR-------KQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLRPGASLTAWSILEEL  230 (325)
T ss_pred             CChhhCCHHHHc-------CCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCCccCCCCCCHHHHHHHHHH
Confidence            999999999984       3456678999999999999999999998877777777777766667778999999999999


Q ss_pred             cccCCCCCCCH----HHHHhccccccC
Q 004959          584 FQRNPADRPPA----SLLLEHRFLKNS  606 (721)
Q Consensus       584 L~~DP~kRPSa----~eLL~Hp~f~~~  606 (721)
                      |+.||.+||++    .++++||||...
T Consensus       231 l~~~p~~R~~~~~~~~~i~~h~~f~~~  257 (325)
T cd05604         231 LEKDRQRRLGAKEDFLEIQEHPFFESL  257 (325)
T ss_pred             hccCHHhcCCCCCCHHHHhcCCCcCCC
Confidence            99999999976    699999999764

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=7.8e-44  Score=371.57  Aligned_cols=252  Identities=30%  Similarity=0.504  Sum_probs=205.0

Q ss_pred             CeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhC---CCCCeeeeeeeEEe----
Q 004959          341 QWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHL---KHPNIVQYYGSEIV----  413 (721)
Q Consensus       341 ~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L---~HPnIV~l~g~~~~----  413 (721)
                      +|++.+.||+|+||+||+|.++.+|+.||+|.+........   ....+.+|+.+++.+   +||||+++++++..    
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~---~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~   77 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDG---LPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTD   77 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCC---CchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCC
Confidence            58999999999999999999999999999999864321111   112345666666655   79999999998764    


Q ss_pred             -cCeEEEEEeeccCCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCcc
Q 004959          414 -EDKFYIYLEYVHPGSINKYVREHC-GAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAK  491 (721)
Q Consensus       414 -~~~~yLVmEy~~gGsL~~~L~~~~-~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~  491 (721)
                       ...+++||||+. ++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus        78 ~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg~~~  156 (288)
T cd07863          78 RETKVTLVFEHVD-QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLAR  156 (288)
T ss_pred             CCceEEEEEcccc-cCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccCccc
Confidence             345899999997 58988886542 458999999999999999999999999999999999999999999999999998


Q ss_pred             ccCCCcccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhcC------
Q 004959          492 HLTGQKADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDT------  565 (721)
Q Consensus       492 ~l~~~~~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~~------  565 (721)
                      .+..........||..|+|||++.+       ..++.++|||||||++|+|++|++||......+.+.++....      
T Consensus       157 ~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~  229 (288)
T cd07863         157 IYSCQMALTPVVVTLWYRAPEVLLQ-------STYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPED  229 (288)
T ss_pred             cccCcccCCCccccccccCchHhhC-------CCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChh
Confidence            7655444445678999999999843       346778999999999999999999998765554444432210      


Q ss_pred             ---------------------CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccc
Q 004959          566 ---------------------PAIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFL  603 (721)
Q Consensus       566 ---------------------~~~p~~lS~el~dLI~~cL~~DP~kRPSa~eLL~Hp~f  603 (721)
                                           ..+...++.++.+||.+||+.||++|||+.|++.||||
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f  288 (288)
T cd07863         230 DWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF  288 (288)
T ss_pred             hCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence                                 00113468889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=2.1e-44  Score=385.83  Aligned_cols=251  Identities=27%  Similarity=0.451  Sum_probs=213.0

Q ss_pred             eEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHH-HHHHhCCCCCeeeeeeeEEecCeEEEEEeec
Q 004959          346 KLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEI-KVLSHLKHPNIVQYYGSEIVEDKFYIYLEYV  424 (721)
Q Consensus       346 k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei-~iL~~L~HPnIV~l~g~~~~~~~~yLVmEy~  424 (721)
                      +.||+|+||+||+|++..+++.||+|++....  .........+..|. .+++.+.|+||+++++++...+.+|+||||+
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~   78 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKA--ILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYI   78 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHH--HHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCC
Confidence            47999999999999999999999999986321  11112233444444 4578899999999999999999999999999


Q ss_pred             cCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCC-CcccccCC
Q 004959          425 HPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTG-QKADLSMK  503 (721)
Q Consensus       425 ~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~-~~~~~s~~  503 (721)
                      .||+|.+++... +.+.+..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.... .......+
T Consensus        79 ~~~~L~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~~~~~~~  157 (325)
T cd05602          79 NGGELFYHLQRE-RCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFC  157 (325)
T ss_pred             CCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCcccccCCCCccccc
Confidence            999999999764 6789999999999999999999999999999999999999999999999999976432 22334567


Q ss_pred             CCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhcCCCCCCCCCHHHHHHHHHh
Q 004959          504 GSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDSLSPEGKDFLRCC  583 (721)
Q Consensus       504 GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~~~~~p~~lS~el~dLI~~c  583 (721)
                      ||+.|||||++.       ...++.++|||||||++|+|++|..||......+.+..+......++..++.++.++|++|
T Consensus       158 gt~~y~aPE~~~-------~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~  230 (325)
T cd05602         158 GTPEYLAPEVLH-------KQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHLLEGL  230 (325)
T ss_pred             CCccccCHHHHc-------CCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhCCcCCCCCCCHHHHHHHHHH
Confidence            999999999984       3456678999999999999999999998877777777777666677778999999999999


Q ss_pred             cccCCCCCCCHH----HHHhccccccC
Q 004959          584 FQRNPADRPPAS----LLLEHRFLKNS  606 (721)
Q Consensus       584 L~~DP~kRPSa~----eLL~Hp~f~~~  606 (721)
                      |+.||.+|+++.    ++++|+||...
T Consensus       231 l~~~p~~R~~~~~~~~~i~~~~~~~~~  257 (325)
T cd05602         231 LQKDRTKRLGAKDDFMEIKNHIFFSPI  257 (325)
T ss_pred             cccCHHHCCCCCCCHHHHhcCcccCCC
Confidence            999999999865    89999999753

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=9.7e-44  Score=376.86  Aligned_cols=257  Identities=26%  Similarity=0.480  Sum_probs=213.5

Q ss_pred             CCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeEEE
Q 004959          340 SQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYI  419 (721)
Q Consensus       340 ~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~yL  419 (721)
                      .+|++.+.||+|+||.||+|++..+++.||+|++.......    ....+.+|+.++++++|+||+++++++..++..|+
T Consensus         6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   81 (309)
T cd07872           6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEG----APCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTL   81 (309)
T ss_pred             CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCC----cchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEE
Confidence            57999999999999999999999999999999986432211    22356789999999999999999999999999999


Q ss_pred             EEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCCc-c
Q 004959          420 YLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQK-A  498 (721)
Q Consensus       420 VmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~~-~  498 (721)
                      ||||+. ++|.+++......+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++....... .
T Consensus        82 v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  160 (309)
T cd07872          82 VFEYLD-KDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKT  160 (309)
T ss_pred             EEeCCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccceecCCCccc
Confidence            999997 58888887665678999999999999999999999999999999999999999999999999997653322 2


Q ss_pred             cccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhcC-------------
Q 004959          499 DLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDT-------------  565 (721)
Q Consensus       499 ~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~~-------------  565 (721)
                      .....+|+.|+|||++.+      ...++.++|||||||++|+|++|+.||.+....+.+..+....             
T Consensus       161 ~~~~~~~~~y~aPE~~~~------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (309)
T cd07872         161 YSNEVVTLWYRPPDVLLG------SSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISS  234 (309)
T ss_pred             cccccccccccCCHHHhC------CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcc
Confidence            233568999999999853      2346778999999999999999999998755443333222100             


Q ss_pred             ---------C--------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhccccccCC
Q 004959          566 ---------P--------AIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQ  607 (721)
Q Consensus       566 ---------~--------~~p~~lS~el~dLI~~cL~~DP~kRPSa~eLL~Hp~f~~~~  607 (721)
                               +        .....++.++++||.+||+.||++|||+.|+|+||||+...
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~  293 (309)
T cd07872         235 NDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSLG  293 (309)
T ss_pred             hhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhcc
Confidence                     0        01124788999999999999999999999999999998754

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=5.5e-44  Score=383.53  Aligned_cols=252  Identities=26%  Similarity=0.474  Sum_probs=213.3

Q ss_pred             eEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhC-CCCCeeeeeeeEEecCeEEEEEeec
Q 004959          346 KLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHL-KHPNIVQYYGSEIVEDKFYIYLEYV  424 (721)
Q Consensus       346 k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L-~HPnIV~l~g~~~~~~~~yLVmEy~  424 (721)
                      ++||+|+||+||+|.+..+++.||+|++...  ........+.+.+|+.++.++ +||||+.+++++...+.+|+||||+
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~   78 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKE--LVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYV   78 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHH--HhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCC
Confidence            4799999999999999999999999998632  112234566788999999888 5999999999999999999999999


Q ss_pred             cCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCC-CcccccCC
Q 004959          425 HPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTG-QKADLSMK  503 (721)
Q Consensus       425 ~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~-~~~~~s~~  503 (721)
                      .||+|..++... +.+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+++.... .......+
T Consensus        79 ~~~~L~~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  157 (327)
T cd05617          79 NGGDLMFHMQRQ-RKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFC  157 (327)
T ss_pred             CCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCCCceeccc
Confidence            999999888654 6799999999999999999999999999999999999999999999999999975322 22334577


Q ss_pred             CCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCch------hhHH-HHHHHhhcCCCCCCCCCHHH
Q 004959          504 GSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEY------EGAA-AMFKVMRDTPAIPDSLSPEG  576 (721)
Q Consensus       504 GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~------~~~~-~~~ki~~~~~~~p~~lS~el  576 (721)
                      ||+.|+|||++.       ...++.++|||||||+||+|++|..||...      ...+ ....+......+|..++.++
T Consensus       158 gt~~y~aPE~~~-------~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~  230 (327)
T cd05617         158 GTPNYIAPEILR-------GEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPRFLSVKA  230 (327)
T ss_pred             CCcccCCHHHHC-------CCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCCCCCCCCCHHH
Confidence            999999999984       345677899999999999999999999531      1222 33334445556788899999


Q ss_pred             HHHHHHhcccCCCCCCC------HHHHHhccccccCC
Q 004959          577 KDFLRCCFQRNPADRPP------ASLLLEHRFLKNSQ  607 (721)
Q Consensus       577 ~dLI~~cL~~DP~kRPS------a~eLL~Hp~f~~~~  607 (721)
                      .++|++||+.||++|++      ++++++||||....
T Consensus       231 ~~li~~~L~~dP~~R~~~~~~~~~~~i~~h~~f~~~~  267 (327)
T cd05617         231 SHVLKGFLNKDPKERLGCQPQTGFSDIKSHTFFRSID  267 (327)
T ss_pred             HHHHHHHhccCHHHcCCCCCCCCHHHHHcCCCCCCCC
Confidence            99999999999999998      57999999998643

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-44  Score=387.69  Aligned_cols=250  Identities=28%  Similarity=0.465  Sum_probs=211.4

Q ss_pred             EeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhC---CCCCeeeeeeeEEecCeEEEEEeec
Q 004959          348 IGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHL---KHPNIVQYYGSEIVEDKFYIYLEYV  424 (721)
Q Consensus       348 LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L---~HPnIV~l~g~~~~~~~~yLVmEy~  424 (721)
                      ||+|+||+||+|++..+|+.||||++...  ..........+..|..++..+   .||||+.+++++...+.+|+||||+
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~--~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~   78 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKK--EIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYM   78 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHH--HHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCC
Confidence            79999999999999999999999998631  111122344556677777665   6999999999999999999999999


Q ss_pred             cCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCC-CcccccCC
Q 004959          425 HPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTG-QKADLSMK  503 (721)
Q Consensus       425 ~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~-~~~~~s~~  503 (721)
                      .+|+|..++... +.+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||++..... .......+
T Consensus        79 ~~g~L~~~l~~~-~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~  157 (330)
T cd05586          79 SGGELFWHLQKE-GRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFC  157 (330)
T ss_pred             CCChHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCCCccCcc
Confidence            999999998764 6799999999999999999999999999999999999999999999999999976432 33334577


Q ss_pred             CCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhcCCCCCC-CCCHHHHHHHHH
Q 004959          504 GSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPD-SLSPEGKDFLRC  582 (721)
Q Consensus       504 GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~~~~~p~-~lS~el~dLI~~  582 (721)
                      ||+.|||||++.+      ...++.++|||||||+||+|++|+.||......+.+..+......++. .+++++.+||++
T Consensus       158 gt~~y~aPE~~~~------~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~  231 (330)
T cd05586         158 GTTEYLAPEVLLD------EKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFPKNVLSDEGRQFVKG  231 (330)
T ss_pred             CCccccCHHHHcC------CCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHHHHHHHHH
Confidence            9999999999853      234567899999999999999999999887766666666655555554 579999999999


Q ss_pred             hcccCCCCCC----CHHHHHhccccccC
Q 004959          583 CFQRNPADRP----PASLLLEHRFLKNS  606 (721)
Q Consensus       583 cL~~DP~kRP----Sa~eLL~Hp~f~~~  606 (721)
                      ||+.||++||    +++++++||||...
T Consensus       232 ~L~~~P~~R~~~~~~~~~ll~h~~~~~~  259 (330)
T cd05586         232 LLNRNPQHRLGAHRDAVELKEHPFFADI  259 (330)
T ss_pred             HcCCCHHHCCCCCCCHHHHhcCccccCC
Confidence            9999999998    79999999999864

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=8.4e-44  Score=382.55  Aligned_cols=263  Identities=23%  Similarity=0.374  Sum_probs=220.3

Q ss_pred             CCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeEEE
Q 004959          340 SQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYI  419 (721)
Q Consensus       340 ~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~yL  419 (721)
                      ++|++.+.||+|+||.||+++++.+++.||+|++...  ..........+.+|+.++..++|+||+.+++++.+.+.+|+
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~l   78 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKW--EMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYL   78 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHH--HHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEE
Confidence            3799999999999999999999999999999998531  11122334567889999999999999999999999999999


Q ss_pred             EEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCCcc-
Q 004959          420 YLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKA-  498 (721)
Q Consensus       420 VmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~~~-  498 (721)
                      ||||+.+|+|.+++.+....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+..... 
T Consensus        79 v~ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~~  158 (332)
T cd05623          79 VMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTV  158 (332)
T ss_pred             EEeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchheecccCCcc
Confidence            9999999999999987667899999999999999999999999999999999999999999999999999976543322 


Q ss_pred             -cccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhcCC--CC---CCCC
Q 004959          499 -DLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTP--AI---PDSL  572 (721)
Q Consensus       499 -~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~~~--~~---p~~l  572 (721)
                       ....+||+.|||||++.+...  ....++.++|||||||+||||++|+.||......+.+.++.....  .+   ...+
T Consensus       159 ~~~~~~gt~~y~aPE~~~~~~~--~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~  236 (332)
T cd05623         159 QSSVAVGTPDYISPEILQAMED--GKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTDV  236 (332)
T ss_pred             eecccccCccccCHHHHhcccc--CCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCccccCCCccccC
Confidence             223579999999999964221  123467789999999999999999999988777777766655322  22   2457


Q ss_pred             CHHHHHHHHHhcccCCCC--CCCHHHHHhccccccC
Q 004959          573 SPEGKDFLRCCFQRNPAD--RPPASLLLEHRFLKNS  606 (721)
Q Consensus       573 S~el~dLI~~cL~~DP~k--RPSa~eLL~Hp~f~~~  606 (721)
                      +.++++||++||..++++  |++++++++||||...
T Consensus       237 s~~~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~~  272 (332)
T cd05623         237 SEDAKDLIRRLICSREHRLGQNGIEDFKQHPFFTGI  272 (332)
T ss_pred             CHHHHHHHHHHccChhhhcCCCCHHHHhCCCCcCCC
Confidence            999999999999765554  6899999999999864

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=1.1e-43  Score=362.74  Aligned_cols=252  Identities=35%  Similarity=0.584  Sum_probs=211.4

Q ss_pred             eeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeEEEEE
Q 004959          342 WQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYIYL  421 (721)
Q Consensus       342 y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~yLVm  421 (721)
                      |++++.||+|+||+||+|.+..+++.||+|++...   ...........+|+.++++++|+||+++++++.+.+..++||
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~---~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~   77 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKS---EIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVM   77 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEEST---THHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccc---cccccccchhhhhhhccccccccccccccccccccccccccc
Confidence            88999999999999999999999999999998742   122223334456999999999999999999999999999999


Q ss_pred             eeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCcccc-CCCcccc
Q 004959          422 EYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHL-TGQKADL  500 (721)
Q Consensus       422 Ey~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l-~~~~~~~  500 (721)
                      ||+.+++|.+++... ..+++.++..++.||++||.|||++||+|+||||+|||++.++.++|+|||++..+ .......
T Consensus        78 ~~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~~~~~  156 (260)
T PF00069_consen   78 EYCPGGSLQDYLQKN-KPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKLSENNENFN  156 (260)
T ss_dssp             EEETTEBHHHHHHHH-SSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEESTSTTSEBS
T ss_pred             ccccccccccccccc-cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence            999999999999843 78999999999999999999999999999999999999999999999999999764 2223334


Q ss_pred             cCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCch---hhHHHHHHHhhcC----CCCCCCCC
Q 004959          501 SMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEY---EGAAAMFKVMRDT----PAIPDSLS  573 (721)
Q Consensus       501 s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~---~~~~~~~ki~~~~----~~~p~~lS  573 (721)
                      ...++..|+|||++.      ....++.++||||||+++|+|++|..||...   .....+.+.....    ........
T Consensus       157 ~~~~~~~y~aPE~~~------~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (260)
T PF00069_consen  157 PFVGTPEYMAPEVLQ------QGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQSREKS  230 (260)
T ss_dssp             SSSSSGGGSCHHHHT------TTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTSHTTSH
T ss_pred             ccccccccccccccc------ccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccccccchhH
Confidence            567999999999984      2456778999999999999999999999876   3333333332211    11112234


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHHhcccc
Q 004959          574 PEGKDFLRCCFQRNPADRPPASLLLEHRFL  603 (721)
Q Consensus       574 ~el~dLI~~cL~~DP~kRPSa~eLL~Hp~f  603 (721)
                      .++.++|++||+.||++||++.++++||||
T Consensus       231 ~~l~~li~~~l~~~p~~R~~~~~l~~~~~~  260 (260)
T PF00069_consen  231 EELRDLIKKMLSKDPEQRPSAEELLKHPWF  260 (260)
T ss_dssp             HHHHHHHHHHSSSSGGGSTTHHHHHTSGGG
T ss_pred             HHHHHHHHHHccCChhHCcCHHHHhcCCCC
Confidence            899999999999999999999999999997

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.1e-43  Score=392.27  Aligned_cols=250  Identities=22%  Similarity=0.320  Sum_probs=205.7

Q ss_pred             CCCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeEE
Q 004959          339 NSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFY  418 (721)
Q Consensus       339 ~~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~y  418 (721)
                      ...|++++.||+|+||.||+|.+..+++.||||...           ...+.+|+.+|++|+|||||++++++......+
T Consensus        91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~-----------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~  159 (391)
T PHA03212         91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ-----------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTC  159 (391)
T ss_pred             cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh-----------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeE
Confidence            357999999999999999999999999999999643           134678999999999999999999999999999


Q ss_pred             EEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCCc-
Q 004959          419 IYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQK-  497 (721)
Q Consensus       419 LVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~~-  497 (721)
                      +|||++. ++|..++... ..+++..++.++.||+.||.|||++|||||||||+||||+.++.+||+|||++....... 
T Consensus       160 lv~e~~~-~~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~  237 (391)
T PHA03212        160 LILPRYK-TDLYCYLAAK-RNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINA  237 (391)
T ss_pred             EEEecCC-CCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCcccccccccc
Confidence            9999995 7898888664 679999999999999999999999999999999999999999999999999997543221 


Q ss_pred             -ccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchh-------hHHHHHHHh-------
Q 004959          498 -ADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYE-------GAAAMFKVM-------  562 (721)
Q Consensus       498 -~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~-------~~~~~~ki~-------  562 (721)
                       .....+||+.|+|||++.       ...++.++|||||||+||||++|..||.+..       ....+..+.       
T Consensus       238 ~~~~~~~gt~~y~aPE~~~-------~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p  310 (391)
T PHA03212        238 NKYYGWAGTIATNAPELLA-------RDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHP  310 (391)
T ss_pred             cccccccCccCCCChhhhc-------CCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCCh
Confidence             223467999999999984       3456788999999999999999998874321       011111111       


Q ss_pred             -------------------hcCCCCC---------CCCCHHHHHHHHHhcccCCCCCCCHHHHHhccccccCCC
Q 004959          563 -------------------RDTPAIP---------DSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQ  608 (721)
Q Consensus       563 -------------------~~~~~~p---------~~lS~el~dLI~~cL~~DP~kRPSa~eLL~Hp~f~~~~~  608 (721)
                                         ......+         ..++.++.+||.+||+.||++|||+.|+|+||||+....
T Consensus       311 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~~  384 (391)
T PHA03212        311 NEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQDIPD  384 (391)
T ss_pred             hhcCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhccCCC
Confidence                               0000001         124678999999999999999999999999999987543

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=1.1e-43  Score=389.00  Aligned_cols=261  Identities=25%  Similarity=0.420  Sum_probs=219.5

Q ss_pred             CCCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeEE
Q 004959          339 NSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFY  418 (721)
Q Consensus       339 ~~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~y  418 (721)
                      ..+|++.+.||+|+||.||+|.++.+++.||+|++...  ........+.+.+|+.+++.++||||+++++++...+.+|
T Consensus        42 ~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~--~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~  119 (371)
T cd05622          42 AEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKF--EMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLY  119 (371)
T ss_pred             hhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHH--HhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEE
Confidence            36899999999999999999999999999999998632  1112233456788999999999999999999999999999


Q ss_pred             EEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCCcc
Q 004959          419 IYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKA  498 (721)
Q Consensus       419 LVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~~~  498 (721)
                      +||||+.||+|.+++..  ..+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||++..+.....
T Consensus       120 lv~Ey~~gg~L~~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~~~  197 (371)
T cd05622         120 MVMEYMPGGDLVNLMSN--YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGM  197 (371)
T ss_pred             EEEcCCCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCCceeEcCcCCc
Confidence            99999999999999865  3689999999999999999999999999999999999999999999999999987654322


Q ss_pred             --cccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhcC--CCCC--CCC
Q 004959          499 --DLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDT--PAIP--DSL  572 (721)
Q Consensus       499 --~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~~--~~~p--~~l  572 (721)
                        ....+||+.|||||++.+..   ....++.++|||||||+||||++|..||...+....+.++....  ..++  ..+
T Consensus       198 ~~~~~~~gt~~y~aPE~l~~~~---~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  274 (371)
T cd05622         198 VRCDTAVGTPDYISPEVLKSQG---GDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDI  274 (371)
T ss_pred             ccccCcccCccccCHHHHhccC---CCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCcccCCCcCCC
Confidence              23567999999999996421   12336778999999999999999999998877666666665532  2333  368


Q ss_pred             CHHHHHHHHHhcccCCCC--CCCHHHHHhccccccC
Q 004959          573 SPEGKDFLRCCFQRNPAD--RPPASLLLEHRFLKNS  606 (721)
Q Consensus       573 S~el~dLI~~cL~~DP~k--RPSa~eLL~Hp~f~~~  606 (721)
                      +.++++||.+||..++.+  |++++++++|+||++.
T Consensus       275 s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~~  310 (371)
T cd05622         275 SKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKND  310 (371)
T ss_pred             CHHHHHHHHHHcCChhhhcCCCCHHHHhcCcccCCC
Confidence            999999999999854443  7899999999999864

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=1.3e-43  Score=386.87  Aligned_cols=256  Identities=27%  Similarity=0.429  Sum_probs=212.4

Q ss_pred             CeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecC-----
Q 004959          341 QWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVED-----  415 (721)
Q Consensus       341 ~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~-----  415 (721)
                      +|++++.||+|+||.||+|.+..+|+.||||++...   .......+++.+|+.+|+.++|+||+++++++...+     
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   77 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNV---FQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFE   77 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEecccc---ccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccc
Confidence            478899999999999999999999999999987532   123344567889999999999999999999988776     


Q ss_pred             eEEEEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCC
Q 004959          416 KFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTG  495 (721)
Q Consensus       416 ~~yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~  495 (721)
                      .+|+||||+. ++|.+++... ..+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++....
T Consensus        78 ~~~lv~e~~~-~~l~~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~  155 (372)
T cd07853          78 EIYVVTELMQ-SDLHKIIVSP-QPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEP  155 (372)
T ss_pred             eEEEEeeccc-cCHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccccceeeccc
Confidence            7999999996 6888887654 6799999999999999999999999999999999999999999999999999986543


Q ss_pred             Cc--ccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhh----------
Q 004959          496 QK--ADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMR----------  563 (721)
Q Consensus       496 ~~--~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~----------  563 (721)
                      ..  ......+++.|+|||++.+      ...++.++|||||||++|||++|+.||.+....+.+..+..          
T Consensus       156 ~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~  229 (372)
T cd07853         156 DESKHMTQEVVTQYYRAPEILMG------SRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAM  229 (372)
T ss_pred             CccccCCCCCcCCCcCCHHHHcC------CCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHH
Confidence            22  2233568999999999853      23467789999999999999999999987655444333221          


Q ss_pred             -------------cC---------CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhccccccCC
Q 004959          564 -------------DT---------PAIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQ  607 (721)
Q Consensus       564 -------------~~---------~~~p~~lS~el~dLI~~cL~~DP~kRPSa~eLL~Hp~f~~~~  607 (721)
                                   ..         ..+....++++.+||.+||+.||++|||+.|+|+||||....
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~  295 (372)
T cd07853         230 RSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEGR  295 (372)
T ss_pred             HHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCCCc
Confidence                         00         012345688999999999999999999999999999998753

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=3.1e-44  Score=401.83  Aligned_cols=254  Identities=26%  Similarity=0.483  Sum_probs=216.3

Q ss_pred             CCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCC-C-----CCeeeeeeeEEe
Q 004959          340 SQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLK-H-----PNIVQYYGSEIV  413 (721)
Q Consensus       340 ~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~-H-----PnIV~l~g~~~~  413 (721)
                      .+|.+.++||+|+||+|.+|.+..|++.||||+++.      ......+...|+.||..|+ |     -|||+++++|..
T Consensus       186 ~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN------~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~f  259 (586)
T KOG0667|consen  186 YRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKN------KKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYF  259 (586)
T ss_pred             EEEEEEEEecccccceeEEEEecCCCcEEEEEeecc------ChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccc
Confidence            478899999999999999999999999999999863      3345667788999999997 4     389999999999


Q ss_pred             cCeEEEEEeeccCCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCC--ceEEeecCCc
Q 004959          414 EDKFYIYLEYVHPGSINKYVREH-CGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASG--VVKLADFGMA  490 (721)
Q Consensus       414 ~~~~yLVmEy~~gGsL~~~L~~~-~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g--~VKL~DFGlA  490 (721)
                      .+++|||+|++. .+|+++|+.+ ...|+...++.|+.||+.||.+||+.||||+|||||||||..-+  .|||+|||.+
T Consensus       260 r~HlciVfELL~-~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSS  338 (586)
T KOG0667|consen  260 RNHLCIVFELLS-TNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGSS  338 (586)
T ss_pred             ccceeeeehhhh-hhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEecccc
Confidence            999999999995 8999999876 45699999999999999999999999999999999999996543  8999999999


Q ss_pred             cccCCCcccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhcCC----
Q 004959          491 KHLTGQKADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTP----  566 (721)
Q Consensus       491 ~~l~~~~~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~~~----  566 (721)
                      +.....  ..+++.+.+|+|||++.|       ..|+.+.||||||||++||++|.+.|.+.+..+++..|+.-..    
T Consensus       339 c~~~q~--vytYiQSRfYRAPEVILG-------lpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~  409 (586)
T KOG0667|consen  339 CFESQR--VYTYIQSRFYRAPEVILG-------LPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPP  409 (586)
T ss_pred             cccCCc--ceeeeeccccccchhhcc-------CCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCH
Confidence            865433  347889999999999976       4566689999999999999999999999888888876643100    


Q ss_pred             ------------------------------------------------CCC-C----------CCCHHHHHHHHHhcccC
Q 004959          567 ------------------------------------------------AIP-D----------SLSPEGKDFLRCCFQRN  587 (721)
Q Consensus       567 ------------------------------------------------~~p-~----------~lS~el~dLI~~cL~~D  587 (721)
                                                                      ..| .          .-...+.|||++||.+|
T Consensus       410 ~mL~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~d  489 (586)
T KOG0667|consen  410 KMLDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWD  489 (586)
T ss_pred             HHHHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccC
Confidence                                                            011 0          11356789999999999


Q ss_pred             CCCCCCHHHHHhccccccCCCC
Q 004959          588 PADRPPASLLLEHRFLKNSQQP  609 (721)
Q Consensus       588 P~kRPSa~eLL~Hp~f~~~~~~  609 (721)
                      |++|+|..|+|+||||......
T Consensus       490 P~~R~tp~qal~Hpfl~~~~~~  511 (586)
T KOG0667|consen  490 PAERITPAQALNHPFLTGTSLE  511 (586)
T ss_pred             chhcCCHHHHhcCccccccccc
Confidence            9999999999999999965543

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-45  Score=380.20  Aligned_cols=258  Identities=28%  Similarity=0.501  Sum_probs=236.2

Q ss_pred             CCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeEEE
Q 004959          340 SQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYI  419 (721)
Q Consensus       340 ~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~yL  419 (721)
                      ++|..+++||+|.||+|.+|+.+.+|+.||||++.+.  -....+.+..-..|-++|+..+||.+..+.-.|...+++|+
T Consensus       168 ~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKe--viiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCF  245 (516)
T KOG0690|consen  168 EDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKE--VIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCF  245 (516)
T ss_pred             chhhHHHHhcCCccceEEEEeecccCceeehhhhhhh--heeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEE
Confidence            5788999999999999999999999999999988632  23345567777889999999999999999999999999999


Q ss_pred             EEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccc-cCCCcc
Q 004959          420 YLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKH-LTGQKA  498 (721)
Q Consensus       420 VmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~-l~~~~~  498 (721)
                      ||||..||.|+-.|.+. ..++|.-++.|...|+.||.|||+++||+||||.+|+|+|.+|+|||+||||++. +..+..
T Consensus       246 VMeyanGGeLf~HLsre-r~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~g~t  324 (516)
T KOG0690|consen  246 VMEYANGGELFFHLSRE-RVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGLCKEEIKYGDT  324 (516)
T ss_pred             EEEEccCceEeeehhhh-hcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecccchhcccccce
Confidence            99999999999888654 7899999999999999999999999999999999999999999999999999986 455666


Q ss_pred             cccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhcCCCCCCCCCHHHHH
Q 004959          499 DLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDSLSPEGKD  578 (721)
Q Consensus       499 ~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~~~~~p~~lS~el~d  578 (721)
                      ..++||||.|+|||++       ...+|..++|.|.+||++|||+||++||...+....+..|+.+...+|..++++++.
T Consensus       325 ~kTFCGTPEYLAPEVl-------eDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ed~kFPr~ls~eAkt  397 (516)
T KOG0690|consen  325 TKTFCGTPEYLAPEVL-------EDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILMEDLKFPRTLSPEAKT  397 (516)
T ss_pred             eccccCChhhcCchhh-------ccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhhhccCCccCCHHHHH
Confidence            7789999999999999       567888999999999999999999999999998888889999999999999999999


Q ss_pred             HHHHhcccCCCCCC-----CHHHHHhccccccCC
Q 004959          579 FLRCCFQRNPADRP-----PASLLLEHRFLKNSQ  607 (721)
Q Consensus       579 LI~~cL~~DP~kRP-----Sa~eLL~Hp~f~~~~  607 (721)
                      ||..+|.+||++|.     .+.||++|+||....
T Consensus       398 LLsGLL~kdP~kRLGgGpdDakEi~~h~FF~~v~  431 (516)
T KOG0690|consen  398 LLSGLLKKDPKKRLGGGPDDAKEIMRHRFFASVD  431 (516)
T ss_pred             HHHHHhhcChHhhcCCCchhHHHHHhhhhhccCC
Confidence            99999999999996     589999999998754

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=3.2e-43  Score=378.86  Aligned_cols=255  Identities=29%  Similarity=0.560  Sum_probs=213.4

Q ss_pred             CCCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeEE
Q 004959          339 NSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFY  418 (721)
Q Consensus       339 ~~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~y  418 (721)
                      .++|++.+.||+|+||.||+|.+..+|..+|+|++...    ......+.+.+|+++|+.++|+|||++++++...+.+|
T Consensus         4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~----~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   79 (333)
T cd06650           4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLE----IKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS   79 (333)
T ss_pred             hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecc----cCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEE
Confidence            36899999999999999999999999999999988642    12344567899999999999999999999999999999


Q ss_pred             EEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhC-CeeccCCCCCcEEEcCCCceEEeecCCccccCCCc
Q 004959          419 IYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSK-KTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQK  497 (721)
Q Consensus       419 LVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~-gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~~  497 (721)
                      +||||+.+++|.+++... +.+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||++..+... 
T Consensus        80 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~-  157 (333)
T cd06650          80 ICMEHMDGGSLDQVLKKA-GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-  157 (333)
T ss_pred             EEEecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh-
Confidence            999999999999999764 6799999999999999999999975 7999999999999999999999999999765432 


Q ss_pred             ccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHH-----------------
Q 004959          498 ADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFK-----------------  560 (721)
Q Consensus       498 ~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~k-----------------  560 (721)
                      ......|+..|+|||++.       +..++.++|||||||++|+|++|+.||......+....                 
T Consensus       158 ~~~~~~~~~~y~aPE~~~-------~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (333)
T cd06650         158 MANSFVGTRSYMSPERLQ-------GTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPR  230 (333)
T ss_pred             ccccCCCCccccCHHHhc-------CCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcc
Confidence            223457999999999984       34567789999999999999999999975433221110                 


Q ss_pred             ---------------------------Hhhc-CCCCC-CCCCHHHHHHHHHhcccCCCCCCCHHHHHhccccccC
Q 004959          561 ---------------------------VMRD-TPAIP-DSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNS  606 (721)
Q Consensus       561 ---------------------------i~~~-~~~~p-~~lS~el~dLI~~cL~~DP~kRPSa~eLL~Hp~f~~~  606 (721)
                                                 +... .+.++ ..++.++++||.+||++||++|||+.|+++|+||+..
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~~  305 (333)
T cd06650         231 PRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS  305 (333)
T ss_pred             cCCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhcC
Confidence                                       0011 01111 2367899999999999999999999999999999864

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=1.1e-43  Score=381.80  Aligned_cols=263  Identities=23%  Similarity=0.370  Sum_probs=219.4

Q ss_pred             CCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeEEE
Q 004959          340 SQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYI  419 (721)
Q Consensus       340 ~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~yL  419 (721)
                      ++|++.+.||+|+||.||+|++..+++.||||++...  ..........+.+|+.++..+.|+||+.+++++...+..||
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~l   78 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKW--EMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYL   78 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHH--HHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEE
Confidence            4799999999999999999999999999999998631  11223345567889999999999999999999999999999


Q ss_pred             EEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCCccc
Q 004959          420 YLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKAD  499 (721)
Q Consensus       420 VmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~~~~  499 (721)
                      ||||+.||+|.+++......+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||++..+......
T Consensus        79 v~Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~  158 (331)
T cd05624          79 VMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTV  158 (331)
T ss_pred             EEeCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCCce
Confidence            99999999999999876578999999999999999999999999999999999999999999999999999876543322


Q ss_pred             --ccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhcC--CCCC---CCC
Q 004959          500 --LSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDT--PAIP---DSL  572 (721)
Q Consensus       500 --~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~~--~~~p---~~l  572 (721)
                        ...+||+.|+|||++.+...  ....++.++|||||||+||+|++|+.||......+.+.++....  ..++   ..+
T Consensus       159 ~~~~~~gt~~y~aPE~~~~~~~--~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~  236 (331)
T cd05624         159 QSSVAVGTPDYISPEILQAMED--GMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHITDV  236 (331)
T ss_pred             eeccccCCcccCCHHHHhcccc--CCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCcccCCCccccC
Confidence              23579999999999854211  11345678999999999999999999998876666666665432  2223   347


Q ss_pred             CHHHHHHHHHhcccCCCC--CCCHHHHHhccccccC
Q 004959          573 SPEGKDFLRCCFQRNPAD--RPPASLLLEHRFLKNS  606 (721)
Q Consensus       573 S~el~dLI~~cL~~DP~k--RPSa~eLL~Hp~f~~~  606 (721)
                      ++++++||.+||..++++  |++++++++|+||...
T Consensus       237 ~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~~  272 (331)
T cd05624         237 SEEAKDLIQRLICSRERRLGQNGIEDFKKHAFFEGI  272 (331)
T ss_pred             CHHHHHHHHHHccCchhhcCCCCHHHHhcCCCcCCC
Confidence            899999999999976655  5799999999999753

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.7e-43  Score=380.79  Aligned_cols=259  Identities=24%  Similarity=0.425  Sum_probs=212.6

Q ss_pred             CCCCCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEec--
Q 004959          337 PMNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVE--  414 (721)
Q Consensus       337 ~l~~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~--  414 (721)
                      .+.+.|++++.||+|+||.||+|.+..+++.||||++...   .......+.+.+|+.+|+.++|+||+++++++...  
T Consensus        12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   88 (343)
T cd07878          12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRP---FQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATS   88 (343)
T ss_pred             hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCch---hhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccc
Confidence            3456899999999999999999999999999999988532   12223456678999999999999999999987543  


Q ss_pred             ----CeEEEEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCc
Q 004959          415 ----DKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMA  490 (721)
Q Consensus       415 ----~~~yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA  490 (721)
                          ..+|++||++ +++|.+++..  ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus        89 ~~~~~~~~~~~~~~-~~~l~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~  165 (343)
T cd07878          89 IENFNEVYLVTNLM-GADLNNIVKC--QKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLA  165 (343)
T ss_pred             ccccCcEEEEeecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcCCccc
Confidence                4579999998 7899888753  57999999999999999999999999999999999999999999999999999


Q ss_pred             cccCCCcccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhc------
Q 004959          491 KHLTGQKADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRD------  564 (721)
Q Consensus       491 ~~l~~~~~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~------  564 (721)
                      ......  .....||+.|+|||++.+      ...++.++|||||||++|+|++|+.||.+.+..+.+..+...      
T Consensus       166 ~~~~~~--~~~~~~t~~y~aPE~~~~------~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~  237 (343)
T cd07878         166 RQADDE--MTGYVATRWYRAPEIMLN------WMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSP  237 (343)
T ss_pred             eecCCC--cCCccccccccCchHhcC------CccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCH
Confidence            876432  234679999999999853      234677899999999999999999999875544433332211      


Q ss_pred             -----------------CCCC--------CCCCCHHHHHHHHHhcccCCCCCCCHHHHHhccccccCCCC
Q 004959          565 -----------------TPAI--------PDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQP  609 (721)
Q Consensus       565 -----------------~~~~--------p~~lS~el~dLI~~cL~~DP~kRPSa~eLL~Hp~f~~~~~~  609 (721)
                                       .+..        ....++.+.+||.+||+.||++|||+.|+|+||||.....+
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~~~~~  307 (343)
T cd07878         238 EVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQYHDP  307 (343)
T ss_pred             HHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhccCCC
Confidence                             0111        12356778999999999999999999999999999876554

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=3.8e-43  Score=397.40  Aligned_cols=256  Identities=28%  Similarity=0.440  Sum_probs=221.4

Q ss_pred             CCCeeEeeEEeecCCeEEEEEEECCC-CcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeE
Q 004959          339 NSQWQKGKLIGRGTFGSVYVASNRET-GALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKF  417 (721)
Q Consensus       339 ~~~y~~~k~LG~G~fG~VY~a~~~~t-g~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~  417 (721)
                      ...|.+.++||+|+||.||+|.+..+ ++.||+|.+..     ........+.+|+.+|+.++|||||++++++...+.+
T Consensus        66 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~-----~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~  140 (478)
T PTZ00267         66 EHMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVML-----NDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKL  140 (478)
T ss_pred             ceeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEccc-----CCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEE
Confidence            34699999999999999999998877 78899997642     2234456778899999999999999999999999999


Q ss_pred             EEEEeeccCCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccC
Q 004959          418 YIYLEYVHPGSINKYVREH---CGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLT  494 (721)
Q Consensus       418 yLVmEy~~gGsL~~~L~~~---~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~  494 (721)
                      ||||||+.||+|.+++...   ...+++.++..++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.+.
T Consensus       141 ~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~  220 (478)
T PTZ00267        141 LLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYS  220 (478)
T ss_pred             EEEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCceecC
Confidence            9999999999999988542   3468999999999999999999999999999999999999999999999999998765


Q ss_pred             CCcc---cccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhcC-CCCCC
Q 004959          495 GQKA---DLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDT-PAIPD  570 (721)
Q Consensus       495 ~~~~---~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~~-~~~p~  570 (721)
                      ....   ....+||+.|+|||++.       ...++.++|||||||++|+|++|+.||......+.+..+.... ..++.
T Consensus       221 ~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~  293 (478)
T PTZ00267        221 DSVSLDVASSFCGTPYYLAPELWE-------RKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDPFPC  293 (478)
T ss_pred             CccccccccccCCCccccCHhHhC-------CCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCc
Confidence            4322   33567999999999984       3457788999999999999999999998877666666665543 34567


Q ss_pred             CCCHHHHHHHHHhcccCCCCCCCHHHHHhccccccC
Q 004959          571 SLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNS  606 (721)
Q Consensus       571 ~lS~el~dLI~~cL~~DP~kRPSa~eLL~Hp~f~~~  606 (721)
                      .++.++.+||.+||+.||++||++++++.|+|++..
T Consensus       294 ~~s~~~~~li~~~L~~dP~~Rps~~~~l~~~~~~~~  329 (478)
T PTZ00267        294 PVSSGMKALLDPLLSKNPALRPTTQQLLHTEFLKYV  329 (478)
T ss_pred             cCCHHHHHHHHHHhccChhhCcCHHHHHhCHHHHHH
Confidence            789999999999999999999999999999998753

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=3e-43  Score=369.70  Aligned_cols=257  Identities=22%  Similarity=0.411  Sum_probs=215.5

Q ss_pred             CeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeEEEE
Q 004959          341 QWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYIY  420 (721)
Q Consensus       341 ~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~yLV  420 (721)
                      .|++.+.||+|+||.||+|.+..+++.||+|.+...  ........+.+.+|+.+|++++|+||+.+++.+.+.+.+|+|
T Consensus         1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~--~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv   78 (285)
T cd05630           1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKK--RIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLV   78 (285)
T ss_pred             CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehh--hccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEE
Confidence            378889999999999999999999999999988632  122233345677899999999999999999999999999999


Q ss_pred             EeeccCCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCCccc
Q 004959          421 LEYVHPGSINKYVREH-CGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKAD  499 (721)
Q Consensus       421 mEy~~gGsL~~~L~~~-~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~~~~  499 (721)
                      |||+.|++|.+++... ...+++..+..++.||+.||.|||+.||+||||||+|||++.++.++|+|||++.........
T Consensus        79 ~e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~  158 (285)
T cd05630          79 LTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTI  158 (285)
T ss_pred             EEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCccc
Confidence            9999999999988654 246899999999999999999999999999999999999999999999999999876544444


Q ss_pred             ccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhh---HHHHHHHhh-cCCCCCCCCCHH
Q 004959          500 LSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEG---AAAMFKVMR-DTPAIPDSLSPE  575 (721)
Q Consensus       500 ~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~---~~~~~ki~~-~~~~~p~~lS~e  575 (721)
                      ....|+..|+|||++.       ...++.++|||||||++|+|++|+.||.....   .+....... ....++..++.+
T Consensus       159 ~~~~g~~~y~aPE~~~-------~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (285)
T cd05630         159 KGRVGTVGYMAPEVVK-------NERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEYSEKFSPD  231 (285)
T ss_pred             cCCCCCccccChHHHc-------CCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhhhhhcCccCCHH
Confidence            4567999999999984       34566789999999999999999999976432   112222211 123456678999


Q ss_pred             HHHHHHHhcccCCCCCCC-----HHHHHhccccccC
Q 004959          576 GKDFLRCCFQRNPADRPP-----ASLLLEHRFLKNS  606 (721)
Q Consensus       576 l~dLI~~cL~~DP~kRPS-----a~eLL~Hp~f~~~  606 (721)
                      +.+||++||+.||++||+     ++|+++||||+..
T Consensus       232 ~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~~  267 (285)
T cd05630         232 ARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQI  267 (285)
T ss_pred             HHHHHHHHhhcCHHHccCCCCCchHHHHcChhhhcc
Confidence            999999999999999999     9999999999753

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-44  Score=372.14  Aligned_cols=255  Identities=24%  Similarity=0.412  Sum_probs=219.4

Q ss_pred             CCCCCCeeEe-eEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhC-CCCCeeeeeeeEEe
Q 004959          336 LPMNSQWQKG-KLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHL-KHPNIVQYYGSEIV  413 (721)
Q Consensus       336 ~~l~~~y~~~-k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L-~HPnIV~l~g~~~~  413 (721)
                      ..+.++|++- ++||-|-.|+|-.|.++.||+.+|+|++.   +.       ...++|+++.-.. .|||||.++++|++
T Consensus        57 ~~itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~---Ds-------~KARrEVeLHw~~s~h~~iV~IidVyeN  126 (400)
T KOG0604|consen   57 YSITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLL---DS-------PKARREVELHWMASGHPHIVSIIDVYEN  126 (400)
T ss_pred             ccchhhheehhhhhccccCCceEEEEeccchhhhHHHHHh---cC-------HHHHhHhhhhhhhcCCCceEEeehhhhh
Confidence            4456677765 67999999999999999999999999874   11       3567888886666 49999999998875


Q ss_pred             ----cCeEEEEEeeccCCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcC---CCceEEe
Q 004959          414 ----EDKFYIYLEYVHPGSINKYVREHC-GAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDA---SGVVKLA  485 (721)
Q Consensus       414 ----~~~~yLVmEy~~gGsL~~~L~~~~-~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~---~g~VKL~  485 (721)
                          ..++.+|||.|+||.|++.|.+++ +.|+|.++..|++||..|+.|||+.+|.||||||||+|+..   +..+||+
T Consensus       127 s~~~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLt  206 (400)
T KOG0604|consen  127 SYQGRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLT  206 (400)
T ss_pred             hccCceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEec
Confidence                467899999999999999998763 56999999999999999999999999999999999999965   4579999


Q ss_pred             ecCCccccCCCcccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhh----HHHHHHH
Q 004959          486 DFGMAKHLTGQKADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEG----AAAMFKV  561 (721)
Q Consensus       486 DFGlA~~l~~~~~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~----~~~~~ki  561 (721)
                      |||+|+.-.......+.|-||+|.|||++..       ..|+..+|+||+|||+|.||||.+||....+    ..+..+|
T Consensus       207 DfGFAK~t~~~~~L~TPc~TPyYvaPevlg~-------eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI  279 (400)
T KOG0604|consen  207 DFGFAKETQEPGDLMTPCFTPYYVAPEVLGP-------EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRI  279 (400)
T ss_pred             ccccccccCCCccccCCcccccccCHHHhCc-------hhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHh
Confidence            9999998777777788999999999999943       4466679999999999999999999987544    2345566


Q ss_pred             hhcCCCCCC----CCCHHHHHHHHHhcccCCCCCCCHHHHHhccccccCC
Q 004959          562 MRDTPAIPD----SLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQ  607 (721)
Q Consensus       562 ~~~~~~~p~----~lS~el~dLI~~cL~~DP~kRPSa~eLL~Hp~f~~~~  607 (721)
                      ..+...+|.    .+|++++|+|+++|..+|.+|.|.+++|.|||+....
T Consensus       280 ~~gqy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~~  329 (400)
T KOG0604|consen  280 RTGQYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQYE  329 (400)
T ss_pred             hccCccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhcccc
Confidence            677777763    5899999999999999999999999999999998654

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2.2e-44  Score=394.01  Aligned_cols=256  Identities=30%  Similarity=0.540  Sum_probs=234.0

Q ss_pred             CCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCe-EE
Q 004959          340 SQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDK-FY  418 (721)
Q Consensus       340 ~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~-~y  418 (721)
                      +.|..++.+|+|+||.+++++++.++..|++|.|+.....   ....+...+|+.++.++.|||||.+++.|+.++. .+
T Consensus         4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t---~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~   80 (426)
T KOG0589|consen    4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLT---EPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLC   80 (426)
T ss_pred             chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccC---chhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEE
Confidence            5799999999999999999999999999999999864333   2334477899999999999999999999999888 99


Q ss_pred             EEEeeccCCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCCc
Q 004959          419 IYLEYVHPGSINKYVREHC-GAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQK  497 (721)
Q Consensus       419 LVmEy~~gGsL~~~L~~~~-~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~~  497 (721)
                      |||+||+||+|.+.|.+.+ ..++|+.+..|+.||+.||.|||++.|+|||||+.||+++.++.|||.|||+|+.+....
T Consensus        81 Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~  160 (426)
T KOG0589|consen   81 IVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPED  160 (426)
T ss_pred             EEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhhhcCCch
Confidence            9999999999999997664 678999999999999999999999999999999999999999999999999999988776


Q ss_pred             -ccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhcC-CCCCCCCCHH
Q 004959          498 -ADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDT-PAIPDSLSPE  575 (721)
Q Consensus       498 -~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~~-~~~p~~lS~e  575 (721)
                       ...+++||++||.||++.       +..|..++|||||||++|||++-+.+|...+....+.++.+.. ..+|..++.+
T Consensus       161 ~~a~tvvGTp~YmcPEil~-------d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~~Plp~~ys~e  233 (426)
T KOG0589|consen  161 SLASTVVGTPYYMCPEILS-------DIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLYSPLPSMYSSE  233 (426)
T ss_pred             hhhheecCCCcccCHHHhC-------CCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccCCCCCccccHH
Confidence             556789999999999994       5567778999999999999999999999999999999998876 6788999999


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHHhcccccc
Q 004959          576 GKDFLRCCFQRNPADRPPASLLLEHRFLKN  605 (721)
Q Consensus       576 l~dLI~~cL~~DP~kRPSa~eLL~Hp~f~~  605 (721)
                      ++.+|+.||..+|+.||++.+||.+|.+..
T Consensus       234 l~~lv~~~l~~~P~~RPsa~~LL~~P~l~~  263 (426)
T KOG0589|consen  234 LRSLVKSMLRKNPEHRPSALELLRRPHLLR  263 (426)
T ss_pred             HHHHHHHHhhcCCccCCCHHHHhhChhhhh
Confidence            999999999999999999999999988774

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=6e-43  Score=367.13  Aligned_cols=256  Identities=29%  Similarity=0.553  Sum_probs=225.7

Q ss_pred             CCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeEEE
Q 004959          340 SQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYI  419 (721)
Q Consensus       340 ~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~yL  419 (721)
                      ++|++.+.||+|+||.||+|.+..+++.||+|++...  ........+.+.+|+++|++++||||+++++++...+.+|+
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   78 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKA--KIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYL   78 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHH--HhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEE
Confidence            3699999999999999999999999999999988532  11223446778999999999999999999999999999999


Q ss_pred             EEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCCccc
Q 004959          420 YLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKAD  499 (721)
Q Consensus       420 VmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~~~~  499 (721)
                      ||||+.+++|.+++... +.+++..+..++.||+.||.|||++||+|+||+|.||||+.++.+||+|||++..+...  .
T Consensus        79 v~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~--~  155 (290)
T cd05580          79 VMEYVPGGELFSHLRKS-GRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR--T  155 (290)
T ss_pred             EEecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC--C
Confidence            99999999999999765 68999999999999999999999999999999999999999999999999999876544  3


Q ss_pred             ccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhcCCCCCCCCCHHHHHH
Q 004959          500 LSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDSLSPEGKDF  579 (721)
Q Consensus       500 ~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~~~~~p~~lS~el~dL  579 (721)
                      ...+|++.|+|||.+.+       ...+.++|||||||++|+|++|..||..........++......++..++..++++
T Consensus       156 ~~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  228 (290)
T cd05580         156 YTLCGTPEYLAPEIILS-------KGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVRFPSFFSPDAKDL  228 (290)
T ss_pred             CCCCCCccccChhhhcC-------CCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCccCCccCCHHHHHH
Confidence            44579999999999843       34566899999999999999999999877766666666666777888899999999


Q ss_pred             HHHhcccCCCCCC-----CHHHHHhccccccCC
Q 004959          580 LRCCFQRNPADRP-----PASLLLEHRFLKNSQ  607 (721)
Q Consensus       580 I~~cL~~DP~kRP-----Sa~eLL~Hp~f~~~~  607 (721)
                      |++||+.||++|+     +++|+++||||....
T Consensus       229 i~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~  261 (290)
T cd05580         229 IRNLLQVDLTKRLGNLKNGVNDIKNHPWFAGID  261 (290)
T ss_pred             HHHHccCCHHHccCcccCCHHHHHcCcccccCC
Confidence            9999999999999     999999999997654

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=8.4e-43  Score=367.93  Aligned_cols=257  Identities=26%  Similarity=0.457  Sum_probs=213.9

Q ss_pred             CCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeEEE
Q 004959          340 SQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYI  419 (721)
Q Consensus       340 ~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~yL  419 (721)
                      ++|++.+.||+|+||.||+|.+..+++.||+|.+.......    ....+.+|+.+++.++|+||+++++++...+..|+
T Consensus         6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~----~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~l   81 (301)
T cd07873           6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEG----APCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTL   81 (301)
T ss_pred             cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccC----chhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEE
Confidence            57999999999999999999999999999999986432211    22456789999999999999999999999999999


Q ss_pred             EEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCCc-c
Q 004959          420 YLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQK-A  498 (721)
Q Consensus       420 VmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~~-~  498 (721)
                      ||||+. ++|.+++......+++..++.++.||+.||.|||++||+|+||||+|||++.++.+||+|||++....... .
T Consensus        82 v~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~  160 (301)
T cd07873          82 VFEYLD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKT  160 (301)
T ss_pred             EEeccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCCc
Confidence            999997 68999987766679999999999999999999999999999999999999999999999999997643322 2


Q ss_pred             cccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhcC-------------
Q 004959          499 DLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDT-------------  565 (721)
Q Consensus       499 ~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~~-------------  565 (721)
                      .....+++.|+|||++.+      ...++.++|||||||++|+|++|++||...+..+....+....             
T Consensus       161 ~~~~~~~~~y~~PE~~~~------~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (301)
T cd07873         161 YSNEVVTLWYRPPDILLG------STDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILS  234 (301)
T ss_pred             ccccceeecccCcHHHhC------CCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhc
Confidence            223457899999999853      2346678999999999999999999998765544433222100             


Q ss_pred             ------CCC-----------CCCCCHHHHHHHHHhcccCCCCCCCHHHHHhccccccCC
Q 004959          566 ------PAI-----------PDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQ  607 (721)
Q Consensus       566 ------~~~-----------p~~lS~el~dLI~~cL~~DP~kRPSa~eLL~Hp~f~~~~  607 (721)
                            ...           ...+++++++||.+||+.||.+|||++|+|+||||+...
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~~  293 (301)
T cd07873         235 NEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCLG  293 (301)
T ss_pred             cccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccc
Confidence                  001           134788999999999999999999999999999998654

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=7.5e-43  Score=366.32  Aligned_cols=258  Identities=24%  Similarity=0.405  Sum_probs=217.8

Q ss_pred             CeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeEEEE
Q 004959          341 QWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYIY  420 (721)
Q Consensus       341 ~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~yLV  420 (721)
                      .|+..+.||+|+||+||+|.+..+|+.||+|++...  ..........+.+|+.+|+.++|+||+.+++.+..++..|+|
T Consensus         1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv   78 (285)
T cd05632           1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKK--RIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLV   78 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehh--hhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEE
Confidence            478889999999999999999999999999988532  112223345678899999999999999999999999999999


Q ss_pred             EeeccCCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCCccc
Q 004959          421 LEYVHPGSINKYVREH-CGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKAD  499 (721)
Q Consensus       421 mEy~~gGsL~~~L~~~-~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~~~~  499 (721)
                      |||+.+++|.+++... ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.........
T Consensus        79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~  158 (285)
T cd05632          79 LTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESI  158 (285)
T ss_pred             EEeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcceecCCCCcc
Confidence            9999999999888654 246999999999999999999999999999999999999999999999999999766544433


Q ss_pred             ccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHH----HHHhhcCCCCCCCCCHH
Q 004959          500 LSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAM----FKVMRDTPAIPDSLSPE  575 (721)
Q Consensus       500 ~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~----~ki~~~~~~~p~~lS~e  575 (721)
                      ....|+..|+|||++.       ...++.++|||||||++|+|++|..||.........    ..+......++..++.+
T Consensus       159 ~~~~g~~~~~aPE~~~-------~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (285)
T cd05632         159 RGRVGTVGYMAPEVLN-------NQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEE  231 (285)
T ss_pred             cCCCCCcCccChHHhc-------CCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccccccCccCCHH
Confidence            4567999999999984       345667899999999999999999999875443222    22233334556778999


Q ss_pred             HHHHHHHhcccCCCCCCC-----HHHHHhccccccCC
Q 004959          576 GKDFLRCCFQRNPADRPP-----ASLLLEHRFLKNSQ  607 (721)
Q Consensus       576 l~dLI~~cL~~DP~kRPS-----a~eLL~Hp~f~~~~  607 (721)
                      +.+||.+||+.||++||+     +.+++.|+||....
T Consensus       232 ~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~  268 (285)
T cd05632         232 AKSICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRNMN  268 (285)
T ss_pred             HHHHHHHHccCCHhHcCCCcccChHHHHcChhhhcCC
Confidence            999999999999999999     88999999998753

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=3.9e-43  Score=366.99  Aligned_cols=251  Identities=25%  Similarity=0.410  Sum_probs=206.7

Q ss_pred             EeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeEEEEEeeccCC
Q 004959          348 IGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYIYLEYVHPG  427 (721)
Q Consensus       348 LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~yLVmEy~~gG  427 (721)
                      ||+|+||.||++.++.+|+.||+|.+....  .......+.+..|+++|+.++||||+++++++.....+|+||||+.|+
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~   78 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKR--LKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGG   78 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHH--hhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCC
Confidence            699999999999999999999999985321  111122345567999999999999999999999999999999999999


Q ss_pred             CHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCCcccccCCCCC
Q 004959          428 SINKYVREHC-GAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSP  506 (721)
Q Consensus       428 sL~~~L~~~~-~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~~~~~s~~GT~  506 (721)
                      +|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++..+..........|+.
T Consensus        79 ~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~  158 (277)
T cd05607          79 DLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRAGTN  158 (277)
T ss_pred             CHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCceeeccCCCC
Confidence            9998886542 358899999999999999999999999999999999999999999999999998765544434467999


Q ss_pred             ccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhh----HHHHHHHhhcCCCC-CCCCCHHHHHHHH
Q 004959          507 YWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEG----AAAMFKVMRDTPAI-PDSLSPEGKDFLR  581 (721)
Q Consensus       507 ~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~----~~~~~ki~~~~~~~-p~~lS~el~dLI~  581 (721)
                      .|+|||++.+       ..++.++|||||||++|||++|+.||.....    .+............ ...++.++++||.
T Consensus       159 ~y~aPE~~~~-------~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  231 (277)
T cd05607         159 GYMAPEILKE-------EPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFEHQNFTEESKDICR  231 (277)
T ss_pred             CccCHHHHcc-------CCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhccccccccccCCHHHHHHHH
Confidence            9999999843       3467789999999999999999999975422    22222233222222 2468999999999


Q ss_pred             HhcccCCCCCCCH----HHHHhccccccCC
Q 004959          582 CCFQRNPADRPPA----SLLLEHRFLKNSQ  607 (721)
Q Consensus       582 ~cL~~DP~kRPSa----~eLL~Hp~f~~~~  607 (721)
                      +||+.||++||++    ++++.|+||+...
T Consensus       232 ~~L~~~P~~R~~~~~~~~~~~~h~~f~~~~  261 (277)
T cd05607         232 LFLAKKPEDRLGSREKNDDPRKHEFFKTIN  261 (277)
T ss_pred             HHhccCHhhCCCCccchhhhhcChhhcCCC
Confidence            9999999999999    6788999998643

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=1.2e-42  Score=358.25  Aligned_cols=255  Identities=45%  Similarity=0.817  Sum_probs=218.4

Q ss_pred             CeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCc----ccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCe
Q 004959          341 QWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDP----KSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDK  416 (721)
Q Consensus       341 ~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~----~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~  416 (721)
                      .|.+++.||+|+||.||+|.+..+++.||+|.+.......    ......+.+.+|+.++++++||||+++++++...+.
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH   80 (267)
T ss_pred             CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence            4888999999999999999999999999999886432211    122345778999999999999999999999999999


Q ss_pred             EEEEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCC
Q 004959          417 FYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQ  496 (721)
Q Consensus       417 ~yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~  496 (721)
                      .++||||+.+++|.+++... +.+++..+..++.||+.||.|||++|++||||||+|||++.++.+||+|||+++.+...
T Consensus        81 ~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~~  159 (267)
T cd06628          81 LNIFLEYVPGGSVAALLNNY-GAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEAN  159 (267)
T ss_pred             cEEEEEecCCCCHHHHHHhc-cCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccCCCcccccc
Confidence            99999999999999999765 67899999999999999999999999999999999999999999999999999876532


Q ss_pred             c-------ccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhc-CCCC
Q 004959          497 K-------ADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRD-TPAI  568 (721)
Q Consensus       497 ~-------~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~-~~~~  568 (721)
                      .       ......|+..|+|||++.       ...++.++|||||||++|+|++|+.||.+......+.++... .+.+
T Consensus       160 ~~~~~~~~~~~~~~~~~~y~~pe~~~-------~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~  232 (267)
T cd06628         160 SLSTKTNGARPSLQGSVFWMAPEVVK-------QTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENASPEI  232 (267)
T ss_pred             cccCCccccccccCCCcCccChhHhc-------cCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhccCCCcC
Confidence            1       112346889999999984       334567899999999999999999999876655555554433 4466


Q ss_pred             CCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccc
Q 004959          569 PDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFL  603 (721)
Q Consensus       569 p~~lS~el~dLI~~cL~~DP~kRPSa~eLL~Hp~f  603 (721)
                      +..++.++.++|++||+.||++||++.|+++|+||
T Consensus       233 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~  267 (267)
T cd06628         233 PSNISSEAIDFLEKTFEIDHNKRPTAAELLKHPFL  267 (267)
T ss_pred             CcccCHHHHHHHHHHccCCchhCcCHHHHhhCCCC
Confidence            77889999999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=9.9e-43  Score=396.02  Aligned_cols=259  Identities=27%  Similarity=0.417  Sum_probs=222.1

Q ss_pred             CCCCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecC--
Q 004959          338 MNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVED--  415 (721)
Q Consensus       338 l~~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~--  415 (721)
                      ...+|++.+.||+|+||+||+|.+..+|+.||||++...   .........+.+|+.+|..++|+||+++++.+...+  
T Consensus        30 ~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~---~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~  106 (496)
T PTZ00283         30 QAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDME---GMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPR  106 (496)
T ss_pred             cCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecc---cCCHHHHHHHHHHHHHHhcCCCCcEEEeecceeccccc
Confidence            346999999999999999999999999999999998642   233455677889999999999999999998765432  


Q ss_pred             ------eEEEEEeeccCCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEee
Q 004959          416 ------KFYIYLEYVHPGSINKYVREH---CGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLAD  486 (721)
Q Consensus       416 ------~~yLVmEy~~gGsL~~~L~~~---~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~D  486 (721)
                            .+++||||+.+|+|.++|...   ...+++..+..++.||+.||+|||++||+||||||+||||+.++.+||+|
T Consensus       107 ~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~vkL~D  186 (496)
T PTZ00283        107 NPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGD  186 (496)
T ss_pred             CcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCCEEEEe
Confidence                  378999999999999998653   24689999999999999999999999999999999999999999999999


Q ss_pred             cCCccccCCCc---ccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhh
Q 004959          487 FGMAKHLTGQK---ADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMR  563 (721)
Q Consensus       487 FGlA~~l~~~~---~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~  563 (721)
                      ||+++.+....   .....+||+.|+|||++.       ...++.++|||||||+||||++|+.||.+....+.+.++..
T Consensus       187 FGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~-------~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~  259 (496)
T PTZ00283        187 FGFSKMYAATVSDDVGRTFCGTPYYVAPEIWR-------RKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLA  259 (496)
T ss_pred             cccCeeccccccccccccccCCcceeCHHHhC-------CCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhc
Confidence            99998754321   223567999999999994       34577899999999999999999999988776666666554


Q ss_pred             cC-CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhccccccC
Q 004959          564 DT-PAIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNS  606 (721)
Q Consensus       564 ~~-~~~p~~lS~el~dLI~~cL~~DP~kRPSa~eLL~Hp~f~~~  606 (721)
                      .. ..++..+++++.+||.+||+.||++||++.++++|||++..
T Consensus       260 ~~~~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~~~~~  303 (496)
T PTZ00283        260 GRYDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKLF  303 (496)
T ss_pred             CCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhCHHHHHh
Confidence            43 35677899999999999999999999999999999998753

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=1.4e-42  Score=354.25  Aligned_cols=256  Identities=56%  Similarity=0.973  Sum_probs=221.7

Q ss_pred             CeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeEEEE
Q 004959          341 QWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYIY  420 (721)
Q Consensus       341 ~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~yLV  420 (721)
                      +|+..+.||+|+||+||+|.+..+++.|++|.+..........+..+.+.+|+.+++.++|+||+++++++.....+|+|
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF   80 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence            47888999999999999999998999999999875433334455678899999999999999999999999999999999


Q ss_pred             EeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCCcccc
Q 004959          421 LEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADL  500 (721)
Q Consensus       421 mEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~~~~~  500 (721)
                      |||+++++|.+++... +.+++..+..++.||+.||.|||+.||+|+||+|+||+++.++.+||+|||++..........
T Consensus        81 ~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~~~~  159 (258)
T cd06632          81 LELVPGGSLAKLLKKY-GSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAK  159 (258)
T ss_pred             EEecCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccceecccccccc
Confidence            9999999999999765 568999999999999999999999999999999999999999999999999998765444334


Q ss_pred             cCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhh--cCCCCCCCCCHHHHH
Q 004959          501 SMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMR--DTPAIPDSLSPEGKD  578 (721)
Q Consensus       501 s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~--~~~~~p~~lS~el~d  578 (721)
                      ...|+..|++||.+..      ...++.++|+|||||++|+|++|..||..........++..  ..+.++..++.++.+
T Consensus       160 ~~~~~~~y~~pe~~~~------~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (258)
T cd06632         160 SFKGSPYWMAPEVIAQ------QGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSDEAKD  233 (258)
T ss_pred             ccCCCcceeCHHHhcC------CCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhcccCCCcCCCcCHHHHH
Confidence            5678999999999842      11367789999999999999999999977665554444433  334566778999999


Q ss_pred             HHHHhcccCCCCCCCHHHHHhcccc
Q 004959          579 FLRCCFQRNPADRPPASLLLEHRFL  603 (721)
Q Consensus       579 LI~~cL~~DP~kRPSa~eLL~Hp~f  603 (721)
                      ||.+||+.+|++||++.+++.|||+
T Consensus       234 li~~~l~~~p~~Rp~~~~~l~~~~~  258 (258)
T cd06632         234 FILKCLQRDPSLRPTAAELLEHPFV  258 (258)
T ss_pred             HHHHHhhcCcccCcCHHHHhcCCCC
Confidence            9999999999999999999999996

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=5.3e-42  Score=386.55  Aligned_cols=249  Identities=22%  Similarity=0.339  Sum_probs=204.2

Q ss_pred             CCCCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeE
Q 004959          338 MNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKF  417 (721)
Q Consensus       338 l~~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~  417 (721)
                      ....|.+.+.||+|+||.||+|.+..+++.||||...           ...+.+|+++|++|+|+|||++++++...+..
T Consensus       167 ~~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~-----------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~  235 (461)
T PHA03211        167 AGLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW-----------YASSVHEARLLRRLSHPAVLALLDVRVVGGLT  235 (461)
T ss_pred             ccCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc-----------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEE
Confidence            3457999999999999999999999999999999542           12456899999999999999999999999999


Q ss_pred             EEEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCCc
Q 004959          418 YIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQK  497 (721)
Q Consensus       418 yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~~  497 (721)
                      |||||++. ++|..++......+++..++.|+.||+.||.|||++|||||||||+||||+.++.+||+|||+++.+....
T Consensus       236 ~lv~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~  314 (461)
T PHA03211        236 CLVLPKYR-SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSW  314 (461)
T ss_pred             EEEEEccC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCceeccccc
Confidence            99999995 78988887665679999999999999999999999999999999999999999999999999998764332


Q ss_pred             c---cccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchh-------hHHHHHHHhhcC--
Q 004959          498 A---DLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYE-------GAAAMFKVMRDT--  565 (721)
Q Consensus       498 ~---~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~-------~~~~~~ki~~~~--  565 (721)
                      .   ....+||+.|||||++.       +..++.++||||||||||||++|..++....       ....+.+++...  
T Consensus       315 ~~~~~~~~~GT~~Y~APE~~~-------~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~  387 (461)
T PHA03211        315 STPFHYGIAGTVDTNAPEVLA-------GDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQV  387 (461)
T ss_pred             ccccccccCCCcCCcCHHHHc-------CCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhcc
Confidence            1   22457999999999994       3456778999999999999999876542211       111222221110  


Q ss_pred             --CCCC-------------------------------CCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccccc
Q 004959          566 --PAIP-------------------------------DSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKN  605 (721)
Q Consensus       566 --~~~p-------------------------------~~lS~el~dLI~~cL~~DP~kRPSa~eLL~Hp~f~~  605 (721)
                        ..++                               ..++.++.+||.+||+.||++|||+.|||+||||+.
T Consensus       388 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~~  460 (461)
T PHA03211        388 HVDEFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQS  460 (461)
T ss_pred             ccccCCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCcccCC
Confidence              0000                               135678999999999999999999999999999974

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=2.6e-42  Score=352.49  Aligned_cols=253  Identities=31%  Similarity=0.543  Sum_probs=219.7

Q ss_pred             CeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeEEEE
Q 004959          341 QWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYIY  420 (721)
Q Consensus       341 ~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~yLV  420 (721)
                      +|.+.+.||+|+||.||+|.+..+|+.|++|.+....   ......+.+.+|+.+++.++||||+++++++...+..|+|
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   77 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSK---MNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIV   77 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhh---CCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEE
Confidence            4788999999999999999999999999999886421   2244567889999999999999999999999999999999


Q ss_pred             EeeccCCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCCcc-
Q 004959          421 LEYVHPGSINKYVREH-CGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKA-  498 (721)
Q Consensus       421 mEy~~gGsL~~~L~~~-~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~~~-  498 (721)
                      |||+.|++|.+++... ...+++..+..++.||+.||.|||++||+|+||||+||+++.++.+||+|||++..+..... 
T Consensus        78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~  157 (256)
T cd08529          78 MEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNF  157 (256)
T ss_pred             EEeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccceeccCccch
Confidence            9999999999999775 46789999999999999999999999999999999999999999999999999987654332 


Q ss_pred             cccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhc-CCCCCCCCCHHHH
Q 004959          499 DLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRD-TPAIPDSLSPEGK  577 (721)
Q Consensus       499 ~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~-~~~~p~~lS~el~  577 (721)
                      .....|++.|+|||++.+       ..++.++|||||||++|+|++|+.||...........+... ...++..++.++.
T Consensus       158 ~~~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (256)
T cd08529         158 ANTIVGTPYYLSPELCED-------KPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPVSQMYSQQLA  230 (256)
T ss_pred             hhccccCccccCHHHhcC-------CCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCccccCHHHH
Confidence            234568999999999843       34667899999999999999999999877665655555544 3345567899999


Q ss_pred             HHHHHhcccCCCCCCCHHHHHhcccc
Q 004959          578 DFLRCCFQRNPADRPPASLLLEHRFL  603 (721)
Q Consensus       578 dLI~~cL~~DP~kRPSa~eLL~Hp~f  603 (721)
                      ++|.+||+.+|++||++.++++|||+
T Consensus       231 ~~i~~~l~~~p~~Rp~~~~ll~~~~~  256 (256)
T cd08529         231 QLIDQCLTKDYRQRPDTFQLLRNPSL  256 (256)
T ss_pred             HHHHHHccCCcccCcCHHHHhhCCCC
Confidence            99999999999999999999999995

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=6.2e-43  Score=375.28  Aligned_cols=249  Identities=27%  Similarity=0.520  Sum_probs=203.5

Q ss_pred             CCeeEeeEEeecCCeEEEEEEE-----CCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhC-CCCCeeeeeeeEEe
Q 004959          340 SQWQKGKLIGRGTFGSVYVASN-----RETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHL-KHPNIVQYYGSEIV  413 (721)
Q Consensus       340 ~~y~~~k~LG~G~fG~VY~a~~-----~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L-~HPnIV~l~g~~~~  413 (721)
                      ++|++++.||+|+||.||+|.+     ..+++.||||++..    .......+.+.+|+.+|..+ +|||||++++++..
T Consensus         7 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~----~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~   82 (338)
T cd05102           7 DRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKE----GATASEHKALMSELKILIHIGNHLNVVNLLGACTK   82 (338)
T ss_pred             hHceeeeEeccCCcceEEEEEEeccCCcccchhhheecccc----ccchHHHHHHHHHHHHHHHhccCcceeeEEeEecC
Confidence            5799999999999999999975     24567899998752    12234456789999999999 89999999998776


Q ss_pred             c-CeEEEEEeeccCCCHHHHHHHhc-------------------------------------------------------
Q 004959          414 E-DKFYIYLEYVHPGSINKYVREHC-------------------------------------------------------  437 (721)
Q Consensus       414 ~-~~~yLVmEy~~gGsL~~~L~~~~-------------------------------------------------------  437 (721)
                      . +.+|+||||+++|+|.+++....                                                       
T Consensus        83 ~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (338)
T cd05102          83 PNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQE  162 (338)
T ss_pred             CCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchh
Confidence            4 46899999999999999986531                                                       


Q ss_pred             ------CCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCCccc---ccCCCCCcc
Q 004959          438 ------GAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKAD---LSMKGSPYW  508 (721)
Q Consensus       438 ------~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~~~~---~s~~GT~~Y  508 (721)
                            ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.+......   ....+++.|
T Consensus       163 ~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y  242 (338)
T cd05102         163 TDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKW  242 (338)
T ss_pred             ccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccc
Confidence                  24778889999999999999999999999999999999999999999999999865432211   223467889


Q ss_pred             CChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhh-CCCCCCchhhHHHHHHHhhc--CCCCCCCCCHHHHHHHHHhcc
Q 004959          509 MAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFKVMRD--TPAIPDSLSPEGKDFLRCCFQ  585 (721)
Q Consensus       509 ~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLt-G~~PF~~~~~~~~~~ki~~~--~~~~p~~lS~el~dLI~~cL~  585 (721)
                      ||||++.+       ..++.++|||||||+||||++ |..||.+....+.+...+..  ....+..+++++.+||.+||+
T Consensus       243 ~aPE~~~~-------~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~  315 (338)
T cd05102         243 MAPESIFD-------KVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMRAPENATPEIYRIMLACWQ  315 (338)
T ss_pred             cCcHHhhc-------CCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcc
Confidence            99999853       446778999999999999997 99999875443333333322  234567789999999999999


Q ss_pred             cCCCCCCCHHHHHh
Q 004959          586 RNPADRPPASLLLE  599 (721)
Q Consensus       586 ~DP~kRPSa~eLL~  599 (721)
                      .||++||++.||++
T Consensus       316 ~dp~~RPs~~el~~  329 (338)
T cd05102         316 GDPKERPTFSALVE  329 (338)
T ss_pred             CChhhCcCHHHHHH
Confidence            99999999999986

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=1.5e-42  Score=360.88  Aligned_cols=253  Identities=31%  Similarity=0.543  Sum_probs=208.6

Q ss_pred             CeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeEEEE
Q 004959          341 QWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYIY  420 (721)
Q Consensus       341 ~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~yLV  420 (721)
                      +|++.+.||+|+||.||+|++..+|+.||||.+.....+   ....+.+.+|+.++++++||||+++++++..++.+|+|
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v   77 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEE---EGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLI   77 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEecccccc---CCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEE
Confidence            588999999999999999999999999999988643211   22345678899999999999999999999999999999


Q ss_pred             EeeccCCCHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCCcc
Q 004959          421 LEYVHPGSINKYVREHC--GAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKA  498 (721)
Q Consensus       421 mEy~~gGsL~~~L~~~~--~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~~~  498 (721)
                      |||+. ++|.+++....  ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++........
T Consensus        78 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~  156 (285)
T cd07861          78 FEFLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVR  156 (285)
T ss_pred             EecCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceeecCCCcc
Confidence            99997 68888886532  5689999999999999999999999999999999999999999999999999976533221


Q ss_pred             -cccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhcC------------
Q 004959          499 -DLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDT------------  565 (721)
Q Consensus       499 -~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~~------------  565 (721)
                       .....+++.|+|||++.+      ...++.++|||||||++|+|++|+.||.+....+....+....            
T Consensus       157 ~~~~~~~~~~y~aPE~~~~------~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (285)
T cd07861         157 VYTHEVVTLWYRAPEVLLG------SPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVT  230 (285)
T ss_pred             cccCCcccccccChHHhcC------CCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcch
Confidence             223457899999999853      2345678999999999999999999998654433332221100            


Q ss_pred             -----------------CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccc
Q 004959          566 -----------------PAIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFL  603 (721)
Q Consensus       566 -----------------~~~p~~lS~el~dLI~~cL~~DP~kRPSa~eLL~Hp~f  603 (721)
                                       ......++.++.+||++||+.||++|||+.+|++||||
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~  285 (285)
T cd07861         231 SLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF  285 (285)
T ss_pred             hhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence                             01123478999999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=3.7e-42  Score=352.08  Aligned_cols=253  Identities=28%  Similarity=0.562  Sum_probs=216.0

Q ss_pred             CeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEe-cCeEEE
Q 004959          341 QWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIV-EDKFYI  419 (721)
Q Consensus       341 ~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~-~~~~yL  419 (721)
                      .|++.+.||+|+||.||++.+..+++.||+|.+...   .......+.+.+|+.++++++|+||+++++.+.. ...+|+
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~l   77 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLR---NASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYI   77 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehh---hcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEE
Confidence            489999999999999999999999999999998632   2233456678899999999999999999998764 446899


Q ss_pred             EEeeccCCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCCc-
Q 004959          420 YLEYVHPGSINKYVREH-CGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQK-  497 (721)
Q Consensus       420 VmEy~~gGsL~~~L~~~-~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~~-  497 (721)
                      ||||+.+++|.+++... ...+++.+++.++.||+.||.|||++||+|+||||+||+++.++.++|+|||++..+.... 
T Consensus        78 v~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~  157 (257)
T cd08223          78 VMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCD  157 (257)
T ss_pred             EecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEEecccCC
Confidence            99999999999999764 3468999999999999999999999999999999999999999999999999998764332 


Q ss_pred             ccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhcC-CCCCCCCCHHH
Q 004959          498 ADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDT-PAIPDSLSPEG  576 (721)
Q Consensus       498 ~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~~-~~~p~~lS~el  576 (721)
                      ......|++.|+|||++.       ...++.++|||||||++|+|++|+.||...+.......+.... +..+..++.++
T Consensus       158 ~~~~~~~~~~y~aPE~~~-------~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (257)
T cd08223         158 MASTLIGTPYYMSPELFS-------NKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPPMPKDYSPEL  230 (257)
T ss_pred             ccccccCCcCccChhHhc-------CCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCccccCHHH
Confidence            223456899999999984       3456678999999999999999999998766555555554433 34567789999


Q ss_pred             HHHHHHhcccCCCCCCCHHHHHhcccc
Q 004959          577 KDFLRCCFQRNPADRPPASLLLEHRFL  603 (721)
Q Consensus       577 ~dLI~~cL~~DP~kRPSa~eLL~Hp~f  603 (721)
                      .+||.+||+.||++||++.++++||||
T Consensus       231 ~~li~~~l~~~p~~Rp~~~~~l~~~~~  257 (257)
T cd08223         231 GELIATMLSKRPEKRPSVKSILRQPYI  257 (257)
T ss_pred             HHHHHHHhccCcccCCCHHHHhcCCCC
Confidence            999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.7e-43  Score=362.71  Aligned_cols=260  Identities=37%  Similarity=0.671  Sum_probs=223.5

Q ss_pred             CCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeEEE
Q 004959          340 SQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYI  419 (721)
Q Consensus       340 ~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~yL  419 (721)
                      +.|++.+.||.|+||.||+|.+..+++.||+|.+..     ......+.+.+|+.++++++|+||+++++.+......|+
T Consensus         5 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~-----~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   79 (280)
T cd06611           5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQI-----ESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWI   79 (280)
T ss_pred             hHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEee-----CCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEE
Confidence            469999999999999999999998999999999853     234456778899999999999999999999999999999


Q ss_pred             EEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCCc-c
Q 004959          420 YLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQK-A  498 (721)
Q Consensus       420 VmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~~-~  498 (721)
                      ||||+.+++|.+++......+++..++.++.||+.||.|||++||+|+||||+||+++.++.++|+|||++....... .
T Consensus        80 v~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~  159 (280)
T cd06611          80 LIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQK  159 (280)
T ss_pred             EeeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccchhhcccccc
Confidence            999999999999998766789999999999999999999999999999999999999999999999999987654322 2


Q ss_pred             cccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhcCC---CCCCCCCHH
Q 004959          499 DLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTP---AIPDSLSPE  575 (721)
Q Consensus       499 ~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~~~---~~p~~lS~e  575 (721)
                      .....|++.|+|||++.....  ....++.++|||||||++|+|++|+.||........+.++.....   ..+..++.+
T Consensus       160 ~~~~~~~~~y~~PE~~~~~~~--~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (280)
T cd06611         160 RDTFIGTPYWMAPEVVACETF--KDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTLDQPSKWSSS  237 (280)
T ss_pred             cceeecchhhcCHHHHhhccc--CCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCCCCCcCCcccCCHH
Confidence            234568999999999864322  223466789999999999999999999988766665555554422   235578999


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHHhccccccC
Q 004959          576 GKDFLRCCFQRNPADRPPASLLLEHRFLKNS  606 (721)
Q Consensus       576 l~dLI~~cL~~DP~kRPSa~eLL~Hp~f~~~  606 (721)
                      +.+||.+||+.||++||+++++++|+||.+.
T Consensus       238 ~~~li~~~l~~~p~~Rps~~~il~~~~~~~~  268 (280)
T cd06611         238 FNDFLKSCLVKDPDDRPTAAELLKHPFVSDQ  268 (280)
T ss_pred             HHHHHHHHhccChhhCcCHHHHhcChhhccc
Confidence            9999999999999999999999999999864

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=2.6e-42  Score=357.01  Aligned_cols=255  Identities=45%  Similarity=0.849  Sum_probs=215.4

Q ss_pred             CeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEe--cCeEE
Q 004959          341 QWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIV--EDKFY  418 (721)
Q Consensus       341 ~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~--~~~~y  418 (721)
                      .|+.++.||+|+||.||+|.+..+|..||+|++..........+..+.+.+|+.+++.++||||+++++++..  ...++
T Consensus         3 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   82 (266)
T cd06651           3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLT   82 (266)
T ss_pred             CccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEE
Confidence            6899999999999999999999999999999986543333444566789999999999999999999998775  36789


Q ss_pred             EEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCCc-
Q 004959          419 IYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQK-  497 (721)
Q Consensus       419 LVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~~-  497 (721)
                      ++|||+.+++|.+++... +.+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++..+.... 
T Consensus        83 l~~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~~  161 (266)
T cd06651          83 IFMEYMPGGSVKDQLKAY-GALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICM  161 (266)
T ss_pred             EEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCCCccccccccc
Confidence            999999999999999764 568999999999999999999999999999999999999999999999999997653211 


Q ss_pred             ---ccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhc--CCCCCCCC
Q 004959          498 ---ADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRD--TPAIPDSL  572 (721)
Q Consensus       498 ---~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~--~~~~p~~l  572 (721)
                         ......|+..|+|||++.       ...++.++|||||||++|||++|+.||........+.+....  .+.++..+
T Consensus       162 ~~~~~~~~~~~~~y~aPE~~~-------~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  234 (266)
T cd06651         162 SGTGIRSVTGTPYWMSPEVIS-------GEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLPSHI  234 (266)
T ss_pred             cCCccccCCccccccCHHHhC-------CCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcCCCCCCCchhc
Confidence               112345889999999984       345677899999999999999999999876555544443322  34556778


Q ss_pred             CHHHHHHHHHhcccCCCCCCCHHHHHhccccc
Q 004959          573 SPEGKDFLRCCFQRNPADRPPASLLLEHRFLK  604 (721)
Q Consensus       573 S~el~dLI~~cL~~DP~kRPSa~eLL~Hp~f~  604 (721)
                      ++.+++|| +||..+|++||+++||++||||+
T Consensus       235 ~~~~~~li-~~~~~~p~~Rp~~~eil~hp~~~  265 (266)
T cd06651         235 SEHARDFL-GCIFVEARHRPSAEELLRHPFAQ  265 (266)
T ss_pred             CHHHHHHH-HHhcCChhhCcCHHHHhcCcccc
Confidence            89999999 57778999999999999999986

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=4.3e-42  Score=354.73  Aligned_cols=256  Identities=43%  Similarity=0.806  Sum_probs=216.3

Q ss_pred             CCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEec--CeE
Q 004959          340 SQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVE--DKF  417 (721)
Q Consensus       340 ~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~--~~~  417 (721)
                      ..|++++.||+|+||.||+|.+..+|..||||++.............+.+.+|+.+++++.|+||+++++++.+.  ..+
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL   81 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence            479999999999999999999999999999998864333333445677899999999999999999999987763  568


Q ss_pred             EEEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCCc
Q 004959          418 YIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQK  497 (721)
Q Consensus       418 yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~~  497 (721)
                      |+||||+.+++|.+++... ..+++..+..++.||+.||.|||++||+|+||||+|||++.++.++|+|||++..+....
T Consensus        82 ~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~  160 (265)
T cd06652          82 SIFMEHMPGGSIKDQLKSY-GALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTIC  160 (265)
T ss_pred             EEEEEecCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCcccccccccc
Confidence            8999999999999998765 568999999999999999999999999999999999999999999999999997654211


Q ss_pred             ----ccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhc--CCCCCCC
Q 004959          498 ----ADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRD--TPAIPDS  571 (721)
Q Consensus       498 ----~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~--~~~~p~~  571 (721)
                          ......|+..|+|||++.+       ..++.++|||||||++|+|++|+.||........+.++...  .+..+..
T Consensus       161 ~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  233 (265)
T cd06652         161 LSGTGMKSVTGTPYWMSPEVISG-------EGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLPPH  233 (265)
T ss_pred             ccccccccCCCCccccChhhhcC-------CCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhcCCCCCCCchh
Confidence                1233568999999999842       34567899999999999999999999876555555444332  2445667


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHHHHhccccc
Q 004959          572 LSPEGKDFLRCCFQRNPADRPPASLLLEHRFLK  604 (721)
Q Consensus       572 lS~el~dLI~~cL~~DP~kRPSa~eLL~Hp~f~  604 (721)
                      ++..+.++|.+||. +|++||+++++++|+|+.
T Consensus       234 ~~~~~~~~i~~~l~-~p~~Rp~~~~il~~~~~~  265 (265)
T cd06652         234 VSDHCRDFLKRIFV-EAKLRPSADELLRHTFVH  265 (265)
T ss_pred             hCHHHHHHHHHHhc-ChhhCCCHHHHhcCcccC
Confidence            88999999999995 999999999999999973

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=1.4e-42  Score=371.60  Aligned_cols=255  Identities=25%  Similarity=0.462  Sum_probs=207.1

Q ss_pred             EeeEEeec--CCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeEEEEE
Q 004959          344 KGKLIGRG--TFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYIYL  421 (721)
Q Consensus       344 ~~k~LG~G--~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~yLVm  421 (721)
                      ++++||+|  +||+||++.++.+|+.||||.+...   .......+.+.+|+.+++.++|||||++++++..++..|+||
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~   78 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLE---ACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVT   78 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechh---hccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEE
Confidence            46789999  7899999999999999999988632   122345567888999999999999999999999999999999


Q ss_pred             eeccCCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCCcc--
Q 004959          422 EYVHPGSINKYVREH-CGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKA--  498 (721)
Q Consensus       422 Ey~~gGsL~~~L~~~-~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~~~--  498 (721)
                      ||+.+|+|.+++..+ ...+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||.+..+.....  
T Consensus        79 e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~  158 (327)
T cd08227          79 SFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRL  158 (327)
T ss_pred             eccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhccccccccc
Confidence            999999999999754 34689999999999999999999999999999999999999999999999987654322111  


Q ss_pred             ------cccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhcCC------
Q 004959          499 ------DLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTP------  566 (721)
Q Consensus       499 ------~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~~~------  566 (721)
                            .....++..|+|||++.+     ....++.++|||||||++|||++|+.||.................      
T Consensus       159 ~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  233 (327)
T cd08227         159 RVVHDFPKYSVKVLPWLSPEVLQQ-----NLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDT  233 (327)
T ss_pred             cccccccccccceecccChHHhhc-----ccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccc
Confidence                  112347788999999853     223567789999999999999999999976543333322221100      


Q ss_pred             ----------------------------------------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhccccccC
Q 004959          567 ----------------------------------------AIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNS  606 (721)
Q Consensus       567 ----------------------------------------~~p~~lS~el~dLI~~cL~~DP~kRPSa~eLL~Hp~f~~~  606 (721)
                                                              .....+++++.+||.+||+.||++|||++|+++||||+..
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~~  313 (327)
T cd08227         234 TTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQI  313 (327)
T ss_pred             cchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhhc
Confidence                                                    0112357789999999999999999999999999999764

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.3e-42  Score=365.45  Aligned_cols=260  Identities=26%  Similarity=0.487  Sum_probs=222.8

Q ss_pred             CCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeEEE
Q 004959          340 SQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYI  419 (721)
Q Consensus       340 ~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~yL  419 (721)
                      .+|++.+.||+|+||.||+|.+..+++.||||.+...  ........+.+..|+++|+.++|+||+++++.+...+..|+
T Consensus         1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l   78 (316)
T cd05574           1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKK--EMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCL   78 (316)
T ss_pred             CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEecc--ccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEE
Confidence            3699999999999999999999999999999998642  22223456788999999999999999999999999999999


Q ss_pred             EEeeccCCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCCcc
Q 004959          420 YLEYVHPGSINKYVREH-CGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKA  498 (721)
Q Consensus       420 VmEy~~gGsL~~~L~~~-~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~~~  498 (721)
                      ||||+.|++|.+++... ...+++..++.++.||+.||.|||++||+|+||||+||||+.++.++|+|||++........
T Consensus        79 v~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~  158 (316)
T cd05574          79 VMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPP  158 (316)
T ss_pred             EEEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhccccccc
Confidence            99999999999998754 35799999999999999999999999999999999999999999999999999875432110


Q ss_pred             ------------------------------cccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCC
Q 004959          499 ------------------------------DLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPP  548 (721)
Q Consensus       499 ------------------------------~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~P  548 (721)
                                                    .....||..|+|||++.       ...++.++|||||||++|+|++|+.|
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~-------~~~~~~~~Di~slG~ll~~l~~g~~p  231 (316)
T cd05574         159 PVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVIS-------GDGHGSAVDWWTLGILLYEMLYGTTP  231 (316)
T ss_pred             ccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHc-------CCCCCchHHHHHHHHHHHHHhhCCCC
Confidence                                          11246899999999984       34467789999999999999999999


Q ss_pred             CCchhhHHHHHHHhhcCCCCCCC--CCHHHHHHHHHhcccCCCCCCC----HHHHHhccccccCCC
Q 004959          549 WSEYEGAAAMFKVMRDTPAIPDS--LSPEGKDFLRCCFQRNPADRPP----ASLLLEHRFLKNSQQ  608 (721)
Q Consensus       549 F~~~~~~~~~~ki~~~~~~~p~~--lS~el~dLI~~cL~~DP~kRPS----a~eLL~Hp~f~~~~~  608 (721)
                      |.+......+.++......++..  ++.++.+||++||+.||++||+    ++|+|.||||+....
T Consensus       232 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~~~~~~~  297 (316)
T cd05574         232 FKGSNRDETFSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRGVNW  297 (316)
T ss_pred             CCCCchHHHHHHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCchhhcCCh
Confidence            98877777777666555444443  6999999999999999999999    999999999987543

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=2.7e-42  Score=358.61  Aligned_cols=254  Identities=30%  Similarity=0.569  Sum_probs=211.3

Q ss_pred             CCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeEEE
Q 004959          340 SQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYI  419 (721)
Q Consensus       340 ~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~yL  419 (721)
                      +.|++.+.||+|+||.||+|.++.+|+.||+|++......   ....+.+.+|+.++++++|+||+++++++.....+|+
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~---~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~   77 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDD---PVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHL   77 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccC---ccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEE
Confidence            3699999999999999999999999999999987532211   1223467899999999999999999999999999999


Q ss_pred             EEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCCc-c
Q 004959          420 YLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQK-A  498 (721)
Q Consensus       420 VmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~~-~  498 (721)
                      ||||++++.|..++... ..+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++..+.... .
T Consensus        78 v~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~  156 (286)
T cd07847          78 VFEYCDHTVLNELEKNP-RGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDD  156 (286)
T ss_pred             EEeccCccHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccceecCCCccc
Confidence            99999988887776543 579999999999999999999999999999999999999999999999999998765543 2


Q ss_pred             cccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhcC-------------
Q 004959          499 DLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDT-------------  565 (721)
Q Consensus       499 ~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~~-------------  565 (721)
                      .....++..|+|||++.+      ...++.++|||||||++|+|++|+.||.+....+....+....             
T Consensus       157 ~~~~~~~~~~~aPE~~~~------~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (286)
T cd07847         157 YTDYVATRWYRAPELLVG------DTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFST  230 (286)
T ss_pred             ccCcccccccCCHHHHhC------CCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhccc
Confidence            234568899999999853      2345678999999999999999999998765544443322100             


Q ss_pred             ---------CC---------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccc
Q 004959          566 ---------PA---------IPDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFL  603 (721)
Q Consensus       566 ---------~~---------~p~~lS~el~dLI~~cL~~DP~kRPSa~eLL~Hp~f  603 (721)
                               +.         ....++.++.+||.+||+.||++||++.|++.||||
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f  286 (286)
T cd07847         231 NQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF  286 (286)
T ss_pred             ccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence                     00         012468889999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=3.4e-42  Score=365.62  Aligned_cols=257  Identities=30%  Similarity=0.525  Sum_probs=213.9

Q ss_pred             CCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeEEE
Q 004959          340 SQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYI  419 (721)
Q Consensus       340 ~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~yL  419 (721)
                      ++|++.+.||+|+||.||+|.+..+|..||+|.+...    ......+.+.+|++++++++||||+++++++..++.+|+
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~----~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   76 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLE----IKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISI   76 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccc----cCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEE
Confidence            3699999999999999999999999999999987532    123455678899999999999999999999999999999


Q ss_pred             EEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhh-CCeeccCCCCCcEEEcCCCceEEeecCCccccCCCcc
Q 004959          420 YLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHS-KKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKA  498 (721)
Q Consensus       420 VmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs-~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~~~  498 (721)
                      ||||++|++|.+++... +.+++..+..++.||+.||.|||+ .+|+|+||||+|||++.++.+||+|||++..+.... 
T Consensus        77 v~ey~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~-  154 (308)
T cd06615          77 CMEHMDGGSLDQVLKKA-GRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM-  154 (308)
T ss_pred             EeeccCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCcccccccc-
Confidence            99999999999999765 679999999999999999999997 599999999999999999999999999987654332 


Q ss_pred             cccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhh---------------
Q 004959          499 DLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMR---------------  563 (721)
Q Consensus       499 ~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~---------------  563 (721)
                      ....+|+..|+|||++.       +..++.++|||||||++|+|++|+.||...+.......+..               
T Consensus       155 ~~~~~~~~~~~aPE~~~-------~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  227 (308)
T cd06615         155 ANSFVGTRSYMSPERLQ-------GTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVS  227 (308)
T ss_pred             cccCCCCcCccChhHhc-------CCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCccccc
Confidence            23467899999999984       23466789999999999999999999965432222111100               


Q ss_pred             ----------------------cCCCCC-CCCCHHHHHHHHHhcccCCCCCCCHHHHHhccccccCCCC
Q 004959          564 ----------------------DTPAIP-DSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQP  609 (721)
Q Consensus       564 ----------------------~~~~~p-~~lS~el~dLI~~cL~~DP~kRPSa~eLL~Hp~f~~~~~~  609 (721)
                                            ..+..+ ..++.++.+||.+||..||++||++.++++||||.....+
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~~  296 (308)
T cd06615         228 GHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRAELE  296 (308)
T ss_pred             CCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhhcccc
Confidence                                  011111 1367899999999999999999999999999999875444

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=1.1e-42  Score=362.32  Aligned_cols=253  Identities=30%  Similarity=0.528  Sum_probs=207.5

Q ss_pred             CeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeEEEE
Q 004959          341 QWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYIY  420 (721)
Q Consensus       341 ~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~yLV  420 (721)
                      +|++.+.||+|+||.||+|++..+|+.||+|.+.....   .......+.+|+.++++++|+||+++++++.+.+.+|+|
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~---~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv   77 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD---DEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLV   77 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccc---cccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEE
Confidence            48899999999999999999999999999999864321   122235677899999999999999999999999999999


Q ss_pred             EeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCCcc-c
Q 004959          421 LEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKA-D  499 (721)
Q Consensus       421 mEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~~~-~  499 (721)
                      |||+. ++|.+++....+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+..... .
T Consensus        78 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~  156 (284)
T cd07839          78 FEYCD-QDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCY  156 (284)
T ss_pred             EecCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCCCCc
Confidence            99996 688888876567899999999999999999999999999999999999999999999999999986543222 2


Q ss_pred             ccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCC-CchhhHHHHHHHhhc--------------
Q 004959          500 LSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPW-SEYEGAAAMFKVMRD--------------  564 (721)
Q Consensus       500 ~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF-~~~~~~~~~~ki~~~--------------  564 (721)
                      ....+++.|+|||++.+      ...++.++|||||||++|+|++|..|| .+.+..+.+..+...              
T Consensus       157 ~~~~~~~~y~aPE~~~~------~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (284)
T cd07839         157 SAEVVTLWYRPPDVLFG------AKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSK  230 (284)
T ss_pred             CCCccccCCcChHHHhC------CcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhh
Confidence            23567899999999853      234567899999999999999998885 333333332222110              


Q ss_pred             ------CC---------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccc
Q 004959          565 ------TP---------AIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFL  603 (721)
Q Consensus       565 ------~~---------~~p~~lS~el~dLI~~cL~~DP~kRPSa~eLL~Hp~f  603 (721)
                            ..         .....++.++.+||++||+.||++|||++++++||||
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f  284 (284)
T cd07839         231 LPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF  284 (284)
T ss_pred             cccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence                  00         1113478999999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=3.4e-42  Score=354.95  Aligned_cols=254  Identities=41%  Similarity=0.786  Sum_probs=215.0

Q ss_pred             CeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCC-cccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeEEE
Q 004959          341 QWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDD-PKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYI  419 (721)
Q Consensus       341 ~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~-~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~yL  419 (721)
                      +|++++.||+|+||.||+|.. .+|+.+|+|.+...... .......+.+.+|+.+|+.++|+||+++++++...+..|+
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l   79 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISI   79 (265)
T ss_pred             CccccceEeccCCeEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEE
Confidence            588999999999999999986 47899999988643221 1223455778999999999999999999999999999999


Q ss_pred             EEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCC---
Q 004959          420 YLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQ---  496 (721)
Q Consensus       420 VmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~---  496 (721)
                      ||||+.|++|.+++.+. +.+++..+..++.||+.||+|||+.||+|+||||+||+++.++.++|+|||++..+...   
T Consensus        80 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~  158 (265)
T cd06631          80 FMEFVPGGSISSILNRF-GPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLH  158 (265)
T ss_pred             EEecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhcccc
Confidence            99999999999999765 57899999999999999999999999999999999999999999999999998765321   


Q ss_pred             ----cccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhc---CCCCC
Q 004959          497 ----KADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRD---TPAIP  569 (721)
Q Consensus       497 ----~~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~---~~~~p  569 (721)
                          .......|+..|+|||++.       ...++.++|||||||++|+|++|..||...+.......+...   .+.++
T Consensus       159 ~~~~~~~~~~~~~~~~~~pe~~~-------~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  231 (265)
T cd06631         159 GTHSNMLKSMHGTPYWMAPEVIN-------ESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLP  231 (265)
T ss_pred             ccccccccccCCCccccChhhhc-------CCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCCCCCCC
Confidence                1112356899999999984       344567899999999999999999999876554444333322   34567


Q ss_pred             CCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccc
Q 004959          570 DSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFL  603 (721)
Q Consensus       570 ~~lS~el~dLI~~cL~~DP~kRPSa~eLL~Hp~f  603 (721)
                      ..++.++.+||++||+.+|++||++.++++||||
T Consensus       232 ~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~  265 (265)
T cd06631         232 DSFSAAAIDFVTSCLTRDQHERPSALQLLRHDFL  265 (265)
T ss_pred             CCCCHHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence            7789999999999999999999999999999997

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=3.3e-42  Score=361.45  Aligned_cols=262  Identities=37%  Similarity=0.645  Sum_probs=221.9

Q ss_pred             CCCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeEE
Q 004959          339 NSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFY  418 (721)
Q Consensus       339 ~~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~y  418 (721)
                      .+.|++++.||.|+||.||+|.+..+++.|++|.+..     ......+.+.+|+.+++.++|+||+++++.+..++.+|
T Consensus        11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~-----~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   85 (292)
T cd06644          11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIET-----KSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLW   85 (292)
T ss_pred             chhhhhhheecCCCCeEEEEEEECCCCceEEEEEecc-----CCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEE
Confidence            3679999999999999999999999999999998753     23455678889999999999999999999999999999


Q ss_pred             EEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCCc-
Q 004959          419 IYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQK-  497 (721)
Q Consensus       419 LVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~~-  497 (721)
                      +||||+.|++|..++.+....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... 
T Consensus        86 lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~  165 (292)
T cd06644          86 IMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQ  165 (292)
T ss_pred             EEEecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCccceecccccc
Confidence            9999999999998887666789999999999999999999999999999999999999999999999999987643322 


Q ss_pred             ccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhcCC---CCCCCCCH
Q 004959          498 ADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTP---AIPDSLSP  574 (721)
Q Consensus       498 ~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~~~---~~p~~lS~  574 (721)
                      ......|++.|+|||++.+...  ....++.++|||||||++|+|++|..||........+.++.....   ..+..++.
T Consensus       166 ~~~~~~~~~~y~aPE~~~~~~~--~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (292)
T cd06644         166 RRDSFIGTPYWMAPEVVMCETM--KDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQPSKWSM  243 (292)
T ss_pred             ccceecCCccccCceeeccccc--cCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcCCCccCCCCcccCH
Confidence            2234568999999999853221  223467789999999999999999999987665555544443322   23456889


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHHhccccccCC
Q 004959          575 EGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQ  607 (721)
Q Consensus       575 el~dLI~~cL~~DP~kRPSa~eLL~Hp~f~~~~  607 (721)
                      ++.+||++||+.||++||+++++++||||....
T Consensus       244 ~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~  276 (292)
T cd06644         244 EFRDFLKTALDKHPETRPSAAQLLEHPFVSSVT  276 (292)
T ss_pred             HHHHHHHHHhcCCcccCcCHHHHhcCccccccc
Confidence            999999999999999999999999999997543

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=3.2e-42  Score=359.33  Aligned_cols=259  Identities=37%  Similarity=0.616  Sum_probs=220.6

Q ss_pred             CeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeEEEE
Q 004959          341 QWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYIY  420 (721)
Q Consensus       341 ~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~yLV  420 (721)
                      .|++.+.||+|+||.||+|.+..++..+++|.+..     ......+.+.+|+.+++.++|+||+++++++...+..|+|
T Consensus         6 ~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~-----~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v   80 (282)
T cd06643           6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDT-----KSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWIL   80 (282)
T ss_pred             HHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCC-----CCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEE
Confidence            47888999999999999999999999999998752     2334567788999999999999999999999999999999


Q ss_pred             EeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCCc-cc
Q 004959          421 LEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQK-AD  499 (721)
Q Consensus       421 mEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~~-~~  499 (721)
                      |||+.+++|..++......+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||++....... ..
T Consensus        81 ~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~  160 (282)
T cd06643          81 IEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRR  160 (282)
T ss_pred             EEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEcccccccccccccccc
Confidence            99999999998887655679999999999999999999999999999999999999999999999999987654322 22


Q ss_pred             ccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhcC---CCCCCCCCHHH
Q 004959          500 LSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDT---PAIPDSLSPEG  576 (721)
Q Consensus       500 ~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~~---~~~p~~lS~el  576 (721)
                      ....|+..|+|||++.....  ....++.++|||||||++|+|++|+.||......+....+....   ...+..++.++
T Consensus       161 ~~~~~~~~y~aPE~~~~~~~--~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (282)
T cd06643         161 DSFIGTPYWMAPEVVMCETS--KDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSEF  238 (282)
T ss_pred             ccccccccccCHhhccccCC--CCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCCCCCCccccCHHH
Confidence            34568999999999853211  23446678999999999999999999998776655555554432   23455688999


Q ss_pred             HHHHHHhcccCCCCCCCHHHHHhccccccC
Q 004959          577 KDFLRCCFQRNPADRPPASLLLEHRFLKNS  606 (721)
Q Consensus       577 ~dLI~~cL~~DP~kRPSa~eLL~Hp~f~~~  606 (721)
                      .+||.+||+.||++||+++++++||||...
T Consensus       239 ~~li~~~l~~~p~~Rp~~~~il~~~~~~~~  268 (282)
T cd06643         239 KDFLKKCLEKNVDARWTTTQLLQHPFVTVN  268 (282)
T ss_pred             HHHHHHHccCChhhCcCHHHHhcCCCEecc
Confidence            999999999999999999999999999864

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-45  Score=377.79  Aligned_cols=254  Identities=37%  Similarity=0.669  Sum_probs=227.9

Q ss_pred             CeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeEEEE
Q 004959          341 QWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYIY  420 (721)
Q Consensus       341 ~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~yLV  420 (721)
                      -|.++..||+|+||.||+|.++++|+.+|||.+...       ..++++..||.||++++.|+||++||.|.....++||
T Consensus        34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~-------sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIV  106 (502)
T KOG0574|consen   34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD-------TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIV  106 (502)
T ss_pred             HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc-------chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEee
Confidence            477888999999999999999999999999988532       2367889999999999999999999999999999999


Q ss_pred             EeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCCc-cc
Q 004959          421 LEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQK-AD  499 (721)
Q Consensus       421 mEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~~-~~  499 (721)
                      ||||..|++.++++.+...|+|+++..+++.-+.||+|||...-||||||..|||++.+|..||+|||.|..+.... ..
T Consensus       107 MEYCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMAKR  186 (502)
T KOG0574|consen  107 MEYCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMAKR  186 (502)
T ss_pred             hhhcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccchhhhhHHhh
Confidence            99999999999999888999999999999999999999999999999999999999999999999999998886654 34


Q ss_pred             ccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhcCC---CCCCCCCHHH
Q 004959          500 LSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTP---AIPDSLSPEG  576 (721)
Q Consensus       500 ~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~~~---~~p~~lS~el  576 (721)
                      .++.|||.|||||++..       ..|+.++||||||++..||..|++||.+......++.|-...+   ..|+.+|.++
T Consensus       187 NTVIGTPFWMAPEVI~E-------IGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIPT~PPPTF~KPE~WS~~F  259 (502)
T KOG0574|consen  187 NTVIGTPFWMAPEVIEE-------IGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIPTKPPPTFKKPEEWSSEF  259 (502)
T ss_pred             CccccCcccccHHHHHH-------hccchhhhHhhhcchhhhhhcCCCCcccccccceeEeccCCCCCCCCChHhhhhHH
Confidence            67889999999999965       3456678999999999999999999998877776666654433   3456789999


Q ss_pred             HHHHHHhcccCCCCCCCHHHHHhccccccCCC
Q 004959          577 KDFLRCCFQRNPADRPPASLLLEHRFLKNSQQ  608 (721)
Q Consensus       577 ~dLI~~cL~~DP~kRPSa~eLL~Hp~f~~~~~  608 (721)
                      .|||++||.++|++|.|+.+|++|+|+++...
T Consensus       260 ~DFi~~CLiK~PE~R~TA~~L~~H~FiknA~g  291 (502)
T KOG0574|consen  260 NDFIRSCLIKKPEERKTALRLCEHTFIKNAPG  291 (502)
T ss_pred             HHHHHHHhcCCHHHHHHHHHHhhhhhhcCCCc
Confidence            99999999999999999999999999997654

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=3.8e-42  Score=357.49  Aligned_cols=254  Identities=30%  Similarity=0.533  Sum_probs=214.1

Q ss_pred             CeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeEEEE
Q 004959          341 QWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYIY  420 (721)
Q Consensus       341 ~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~yLV  420 (721)
                      +|++++.||+|+||.||+|.+..+|+.||+|++....   ......+.+.+|+.++++++|+||+++++++......|+|
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~---~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v   77 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRR---LEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLV   77 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEccc---ccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEE
Confidence            5899999999999999999999999999999986422   1123356788999999999999999999999999999999


Q ss_pred             EeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCCcc--
Q 004959          421 LEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKA--  498 (721)
Q Consensus       421 mEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~~~--  498 (721)
                      |||+ +++|.+++......+++..++.++.||+.||.|||++||+|+||||+||+++.++.++|+|||++........  
T Consensus        78 ~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~  156 (286)
T cd07832          78 MEYM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRL  156 (286)
T ss_pred             eccc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCCc
Confidence            9999 9999999977667799999999999999999999999999999999999999999999999999987654331  


Q ss_pred             cccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhcCC------------
Q 004959          499 DLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTP------------  566 (721)
Q Consensus       499 ~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~~~------------  566 (721)
                      .....|+..|+|||.+.+      ...++.++|||||||++|+|++|.++|.+......+..+.....            
T Consensus       157 ~~~~~~~~~y~aPE~~~~------~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (286)
T cd07832         157 YSHQVATRWYRAPELLYG------ARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTS  230 (286)
T ss_pred             cccccCcccccCceeeec------cccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccC
Confidence            234568999999998843      23456789999999999999999988877655444433322100            


Q ss_pred             ------------------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhccccc
Q 004959          567 ------------------AIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLK  604 (721)
Q Consensus       567 ------------------~~p~~lS~el~dLI~~cL~~DP~kRPSa~eLL~Hp~f~  604 (721)
                                        .....++.++.+||++||+.||++||+++++|+||||.
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~~  286 (286)
T cd07832         231 LPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT  286 (286)
T ss_pred             cchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcCcC
Confidence                              01134678999999999999999999999999999984

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2.5e-43  Score=391.43  Aligned_cols=261  Identities=30%  Similarity=0.491  Sum_probs=240.3

Q ss_pred             CCCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeEE
Q 004959          339 NSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFY  418 (721)
Q Consensus       339 ~~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~y  418 (721)
                      ...|.+.+.||+|.|++|.+|++..+|..||||.+.+...   .......+.+|+++|..|+|||||+++.+.+.+..+|
T Consensus        55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~l---n~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~ly  131 (596)
T KOG0586|consen   55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQL---NPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLY  131 (596)
T ss_pred             ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhccc---ChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeE
Confidence            3579999999999999999999999999999999875433   3334455899999999999999999999999999999


Q ss_pred             EEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCCcc
Q 004959          419 IYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKA  498 (721)
Q Consensus       419 LVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~~~  498 (721)
                      +||||+.+|.+++++.++ +.+.|.+++.++.|++.|++|||+++|||||||++||||+.+.+|||+|||++..+.....
T Consensus       132 lV~eya~~ge~~~yl~~~-gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~~~  210 (596)
T KOG0586|consen  132 LVMEYASGGELFDYLVKH-GRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFSTFFDYGLM  210 (596)
T ss_pred             EEEEeccCchhHHHHHhc-ccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeeccccceeeccccc
Confidence            999999999999999887 7888899999999999999999999999999999999999999999999999999998888


Q ss_pred             cccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhcCCCCCCCCCHHHHH
Q 004959          499 DLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDSLSPEGKD  578 (721)
Q Consensus       499 ~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~~~~~p~~lS~el~d  578 (721)
                      ..++||++.|.|||++.+..|.+      +.+|+||+|++||-|++|.+||++..-.+.-.+++.....+|..++.++.+
T Consensus       211 lqt~cgsppyAaPEl~~g~~y~g------pe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk~rIp~~ms~dce~  284 (596)
T KOG0586|consen  211 LQTFCGSPPYAAPELFNGKKYDG------PEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRGKYRIPFYMSCDCED  284 (596)
T ss_pred             ccccCCCCCccChHhhcCcccCC------cceehhhhhhhheeeeecccccCCcccccccchheeeeecccceeechhHH
Confidence            88999999999999998755443      469999999999999999999999888888888888889999999999999


Q ss_pred             HHHHhcccCCCCCCCHHHHHhccccccCCCC
Q 004959          579 FLRCCFQRNPADRPPASLLLEHRFLKNSQQP  609 (721)
Q Consensus       579 LI~~cL~~DP~kRPSa~eLL~Hp~f~~~~~~  609 (721)
                      +|+++|.++|.+|++.+++++|.|+......
T Consensus       285 lLrk~lvl~Pskr~~~dqim~~~W~n~~~~~  315 (596)
T KOG0586|consen  285 LLRKFLVLNPSKRGPCDQIMKDRWRNDLLEA  315 (596)
T ss_pred             HHHHhhccCccccCCHHHhhhhcccchhhhh
Confidence            9999999999999999999999999876654

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=2.6e-42  Score=356.22  Aligned_cols=254  Identities=37%  Similarity=0.615  Sum_probs=212.2

Q ss_pred             CCCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeEE
Q 004959          339 NSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFY  418 (721)
Q Consensus       339 ~~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~y  418 (721)
                      ..+|++++.||+|+||.||+|++..+|+.||+|++...     .......+.+|+.+++.++||||+++++++..++.+|
T Consensus         8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~-----~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~   82 (267)
T cd06646           8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLE-----PGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLW   82 (267)
T ss_pred             hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecC-----ccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEE
Confidence            35799999999999999999999999999999988632     1123456889999999999999999999999999999


Q ss_pred             EEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCCc-
Q 004959          419 IYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQK-  497 (721)
Q Consensus       419 LVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~~-  497 (721)
                      +||||+.+++|.+++... +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+.... 
T Consensus        83 iv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~  161 (267)
T cd06646          83 ICMEYCGGGSLQDIYHVT-GPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIA  161 (267)
T ss_pred             EEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccceeeccccc
Confidence            999999999999998754 679999999999999999999999999999999999999999999999999998764332 


Q ss_pred             ccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhcCCC-----CCCCC
Q 004959          498 ADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPA-----IPDSL  572 (721)
Q Consensus       498 ~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~~~~-----~p~~l  572 (721)
                      ......|++.|+|||.+...    ....++.++|||||||++|||++|..||......+....+......     ....+
T Consensus       162 ~~~~~~~~~~y~~PE~~~~~----~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (267)
T cd06646         162 KRKSFIGTPYWMAPEVAAVE----KNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKW  237 (267)
T ss_pred             ccCccccCccccCHhHcccc----cCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCCCCCcccccc
Confidence            22345689999999988431    2234567899999999999999999999765444333322222111     12357


Q ss_pred             CHHHHHHHHHhcccCCCCCCCHHHHHhccc
Q 004959          573 SPEGKDFLRCCFQRNPADRPPASLLLEHRF  602 (721)
Q Consensus       573 S~el~dLI~~cL~~DP~kRPSa~eLL~Hp~  602 (721)
                      +.++.+||++||+.||++||++++|++|+|
T Consensus       238 ~~~~~~li~~~l~~~P~~Rp~~~~il~~l~  267 (267)
T cd06646         238 SSTFHNFVKISLTKNPKKRPTAERLLTHLF  267 (267)
T ss_pred             CHHHHHHHHHHhhCChhhCcCHHHHhcCCC
Confidence            899999999999999999999999999987

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=5.4e-42  Score=359.91  Aligned_cols=263  Identities=29%  Similarity=0.493  Sum_probs=217.4

Q ss_pred             CeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeEEEE
Q 004959          341 QWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYIY  420 (721)
Q Consensus       341 ~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~yLV  420 (721)
                      +|++.+.||+|+||.||+|.+..+|+.||||.+...............+..|+.++++++|+||+++++++.+.+..|+|
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV   80 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence            48889999999999999999999999999999864322211233445678899999999999999999999999999999


Q ss_pred             EeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCCcc-c
Q 004959          421 LEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKA-D  499 (721)
Q Consensus       421 mEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~~~-~  499 (721)
                      |||+ +++|.+++......+++..++.++.||+.||.|||++||+|+||||+|||++.++.+||+|||++..+..... .
T Consensus        81 ~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~~  159 (298)
T cd07841          81 FEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKM  159 (298)
T ss_pred             Eccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeeeeccCCCccc
Confidence            9999 8999999976544799999999999999999999999999999999999999999999999999987654322 2


Q ss_pred             ccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhcCC-------------
Q 004959          500 LSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTP-------------  566 (721)
Q Consensus       500 ~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~~~-------------  566 (721)
                      ....+++.|+|||++.+      ...++.++|||||||++|+|++|.++|......+.+.++.....             
T Consensus       160 ~~~~~~~~y~aPE~~~~------~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (298)
T cd07841         160 THQVVTRWYRAPELLFG------ARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSL  233 (298)
T ss_pred             cccccceeeeCHHHHhC------CCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcccc
Confidence            23457889999999842      23457789999999999999999888876655444433322100             


Q ss_pred             ---------------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhccccccCCCCC
Q 004959          567 ---------------AIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQPD  610 (721)
Q Consensus       567 ---------------~~p~~lS~el~dLI~~cL~~DP~kRPSa~eLL~Hp~f~~~~~~~  610 (721)
                                     .....++.++.+||.+||+.||++||++.|+|+|+||.+...+.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~~~~~  292 (298)
T cd07841         234 PDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDPAPT  292 (298)
T ss_pred             cccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCCCCCC
Confidence                           01134578999999999999999999999999999999877654

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=7.5e-42  Score=350.67  Aligned_cols=254  Identities=33%  Similarity=0.656  Sum_probs=217.1

Q ss_pred             CCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeEEE
Q 004959          340 SQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYI  419 (721)
Q Consensus       340 ~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~yL  419 (721)
                      ++|++++.||.|+||.||+|....++..+|+|++....    .....+.+.+|+.+|+.++|+||+++++.+...+..|+
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~----~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~i   76 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEK----CQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWL   76 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCC----cchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEE
Confidence            47999999999999999999999899999999885321    12256788999999999999999999999999999999


Q ss_pred             EEeeccCCCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCCc
Q 004959          420 YLEYVHPGSINKYVREH--CGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQK  497 (721)
Q Consensus       420 VmEy~~gGsL~~~L~~~--~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~~  497 (721)
                      ||||+.|++|.+++...  ...+++..+..++.||+.||.|||++||+||||||+||++++++.++|+|||++..+....
T Consensus        77 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~  156 (267)
T cd06610          77 VMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGG  156 (267)
T ss_pred             EEeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCc
Confidence            99999999999999764  2468999999999999999999999999999999999999999999999999987765432


Q ss_pred             cc-----ccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhcCCC-CC--
Q 004959          498 AD-----LSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPA-IP--  569 (721)
Q Consensus       498 ~~-----~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~~~~-~p--  569 (721)
                      ..     ....|+..|+|||++...      ..++.++|+|||||++|+|++|+.||........+.++...... ++  
T Consensus       157 ~~~~~~~~~~~~~~~y~~Pe~~~~~------~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  230 (267)
T cd06610         157 DRTRKVRKTFVGTPCWMAPEVMEQV------HGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETG  230 (267)
T ss_pred             cccccccccccCChhhcChHHHccc------cCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcCCCCCcCCc
Confidence            22     345689999999998531      24667899999999999999999999877665555555443221 11  


Q ss_pred             ---CCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccc
Q 004959          570 ---DSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFL  603 (721)
Q Consensus       570 ---~~lS~el~dLI~~cL~~DP~kRPSa~eLL~Hp~f  603 (721)
                         ..++.++.+||.+||+.||++||++.+|++||||
T Consensus       231 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~p~~  267 (267)
T cd06610         231 ADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKHKFF  267 (267)
T ss_pred             cccccccHHHHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence               2578899999999999999999999999999997

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=2.9e-42  Score=365.97  Aligned_cols=245  Identities=25%  Similarity=0.457  Sum_probs=191.9

Q ss_pred             eeEEeecCCeEEEEEEEC--CCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEe--cCeEEEE
Q 004959          345 GKLIGRGTFGSVYVASNR--ETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIV--EDKFYIY  420 (721)
Q Consensus       345 ~k~LG~G~fG~VY~a~~~--~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~--~~~~yLV  420 (721)
                      ++.||+|+||+||+|+++  .+++.||+|.+...   ..    ...+.+|+.+|++++||||+++++++..  ...+|+|
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~---~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv   78 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGT---GI----SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLL   78 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCC---CC----cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEE
Confidence            568999999999999865  46789999988532   11    2346789999999999999999998864  4568999


Q ss_pred             EeeccCCCHHHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEE----cCCCceEEeecC
Q 004959          421 LEYVHPGSINKYVREHC--------GAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLV----DASGVVKLADFG  488 (721)
Q Consensus       421 mEy~~gGsL~~~L~~~~--------~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILl----d~~g~VKL~DFG  488 (721)
                      |||+. ++|.+++....        ..+++..++.++.||+.||.|||++||+||||||+|||+    +..+.+||+|||
T Consensus        79 ~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG  157 (317)
T cd07868          79 FDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMG  157 (317)
T ss_pred             EeccC-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecC
Confidence            99995 68888875321        258999999999999999999999999999999999999    456789999999


Q ss_pred             CccccCCCc----ccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhh---------H
Q 004959          489 MAKHLTGQK----ADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEG---------A  555 (721)
Q Consensus       489 lA~~l~~~~----~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~---------~  555 (721)
                      +++.+....    ......||+.|+|||++.+      ...++.++|||||||++|+|++|++||.....         .
T Consensus       158 ~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~------~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~  231 (317)
T cd07868         158 FARLFNSPLKPLADLDPVVVTFWYRAPELLLG------ARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHH  231 (317)
T ss_pred             ceeccCCCCccccccCCccccccccCCHHHcC------CCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccH
Confidence            998764332    1234678999999999853      23467789999999999999999999964221         0


Q ss_pred             HHHHHHhhc--------------CC------------------------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHH
Q 004959          556 AAMFKVMRD--------------TP------------------------AIPDSLSPEGKDFLRCCFQRNPADRPPASLL  597 (721)
Q Consensus       556 ~~~~ki~~~--------------~~------------------------~~p~~lS~el~dLI~~cL~~DP~kRPSa~eL  597 (721)
                      ..+..+...              .+                        ......+.++.+||++||+.||++|||++|+
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~  311 (317)
T cd07868         232 DQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQA  311 (317)
T ss_pred             HHHHHHHHhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHH
Confidence            111111100              00                        0001235678999999999999999999999


Q ss_pred             Hhcccc
Q 004959          598 LEHRFL  603 (721)
Q Consensus       598 L~Hp~f  603 (721)
                      |+||||
T Consensus       312 l~hp~f  317 (317)
T cd07868         312 MQDPYF  317 (317)
T ss_pred             hcCCCC
Confidence            999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.7e-42  Score=351.13  Aligned_cols=254  Identities=38%  Similarity=0.663  Sum_probs=216.8

Q ss_pred             CCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeEEE
Q 004959          340 SQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYI  419 (721)
Q Consensus       340 ~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~yL  419 (721)
                      ++|++.+.||.|+||.||+|.+..+++.+++|++...     .....+.+.+|+.++++++||||+++++++...+.+|+
T Consensus         3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~-----~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l   77 (262)
T cd06613           3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLE-----PGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWI   77 (262)
T ss_pred             cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcC-----chhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEE
Confidence            5799999999999999999999999999999998642     12246788999999999999999999999999999999


Q ss_pred             EEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCCc-c
Q 004959          420 YLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQK-A  498 (721)
Q Consensus       420 VmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~~-~  498 (721)
                      +|||+.+++|.+++......+++..+..++.||+.||.|||++||+|+||||+||+++.++.+||+|||++..+.... .
T Consensus        78 ~~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~  157 (262)
T cd06613          78 VMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAK  157 (262)
T ss_pred             EEeCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccchhhhhhhhc
Confidence            999999999999997765789999999999999999999999999999999999999999999999999998765432 2


Q ss_pred             cccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhcCC-----CCCCCCC
Q 004959          499 DLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTP-----AIPDSLS  573 (721)
Q Consensus       499 ~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~~~-----~~p~~lS  573 (721)
                      .....|+..|+|||++.+.    ....++.++|||||||++|+|++|+.||...........+.....     ..+..++
T Consensus       158 ~~~~~~~~~y~~Pe~~~~~----~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (262)
T cd06613         158 RKSFIGTPYWMAPEVAAVE----RKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEKWS  233 (262)
T ss_pred             cccccCCccccCchhhccc----ccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCccccchhhhh
Confidence            2345789999999998531    112566789999999999999999999987665554444433311     1233467


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHHhccc
Q 004959          574 PEGKDFLRCCFQRNPADRPPASLLLEHRF  602 (721)
Q Consensus       574 ~el~dLI~~cL~~DP~kRPSa~eLL~Hp~  602 (721)
                      .++.+||++||..||.+||++.+++.|+|
T Consensus       234 ~~~~~li~~~l~~~p~~Rpt~~~il~~~~  262 (262)
T cd06613         234 PVFHDFIKKCLTKDPKKRPTATKLLQHPF  262 (262)
T ss_pred             HHHHHHHHHHcCCChhhCCCHHHHhcCCC
Confidence            88999999999999999999999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=8.6e-42  Score=348.63  Aligned_cols=253  Identities=28%  Similarity=0.562  Sum_probs=219.2

Q ss_pred             CeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeEEEE
Q 004959          341 QWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYIY  420 (721)
Q Consensus       341 ~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~yLV  420 (721)
                      +|+..+.||+|+||.||+|.+..+++.+|||.+....   ......+.+.+|+.+|++++|+||+++++.+...+..++|
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv   77 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQ---MTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIV   77 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccc---cccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEE
Confidence            5899999999999999999999999999999986422   2334567889999999999999999999999999999999


Q ss_pred             EeeccCCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCC-ceEEeecCCccccCCCcc
Q 004959          421 LEYVHPGSINKYVREHC-GAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASG-VVKLADFGMAKHLTGQKA  498 (721)
Q Consensus       421 mEy~~gGsL~~~L~~~~-~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g-~VKL~DFGlA~~l~~~~~  498 (721)
                      |||+.+++|.+++.... ..+++..+..++.||+.||.|||++||+|+||||+||+++.++ .+||+|||++..+.....
T Consensus        78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~  157 (256)
T cd08220          78 MEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSK  157 (256)
T ss_pred             EecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCcc
Confidence            99999999999997653 4589999999999999999999999999999999999998654 689999999987765544


Q ss_pred             cccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhc-CCCCCCCCCHHHH
Q 004959          499 DLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRD-TPAIPDSLSPEGK  577 (721)
Q Consensus       499 ~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~-~~~~p~~lS~el~  577 (721)
                      .....|+..|+|||.+.       ...++.++|||||||++|+|++|+.||...+.......+... ...++..++.++.
T Consensus       158 ~~~~~~~~~y~aPE~~~-------~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  230 (256)
T cd08220         158 AYTVVGTPCYISPELCE-------GKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAPISDRYSPDLR  230 (256)
T ss_pred             ccccccCCcccCchhcc-------CCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcCCCCCCCCcCHHHH
Confidence            44567899999999984       334667899999999999999999999887665555555443 3456677899999


Q ss_pred             HHHHHhcccCCCCCCCHHHHHhcccc
Q 004959          578 DFLRCCFQRNPADRPPASLLLEHRFL  603 (721)
Q Consensus       578 dLI~~cL~~DP~kRPSa~eLL~Hp~f  603 (721)
                      ++|.+||+.||++|||+.|+++||||
T Consensus       231 ~li~~~l~~~p~~Rpt~~~ll~~p~~  256 (256)
T cd08220         231 QLILSMLNLDPSKRPQLSQIMAQPIC  256 (256)
T ss_pred             HHHHHHccCChhhCCCHHHHhhCCCC
Confidence            99999999999999999999999996

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=2.1e-42  Score=355.13  Aligned_cols=253  Identities=29%  Similarity=0.478  Sum_probs=220.6

Q ss_pred             CeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeEEEE
Q 004959          341 QWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYIY  420 (721)
Q Consensus       341 ~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~yLV  420 (721)
                      .|++.+.||.|+||.||+|.+..+++.||+|++...  ........+.+.+|++++++++||||+++++++...+..|+|
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   78 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQ--KCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLV   78 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehh--hhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEE
Confidence            489999999999999999999999999999998642  222334567899999999999999999999999999999999


Q ss_pred             EeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCCcccc
Q 004959          421 LEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADL  500 (721)
Q Consensus       421 mEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~~~~~  500 (721)
                      |||+.|++|.+++... ..+++..+..++.||+.||.|||++||+|+||||+||+++.++.++|+|||++..........
T Consensus        79 ~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~  157 (258)
T cd05578          79 VDLLLGGDLRYHLSQK-VKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTT  157 (258)
T ss_pred             EeCCCCCCHHHHHHhc-CCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCcccc
Confidence            9999999999999765 689999999999999999999999999999999999999999999999999998765544444


Q ss_pred             cCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhh--HHHHHHHhh-cCCCCCCCCCHHHH
Q 004959          501 SMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEG--AAAMFKVMR-DTPAIPDSLSPEGK  577 (721)
Q Consensus       501 s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~--~~~~~ki~~-~~~~~p~~lS~el~  577 (721)
                      ...|+..|+|||++..       ..++.++|+|||||++|+|++|..||.....  .+.+..... .....+..++.++.
T Consensus       158 ~~~~~~~y~~PE~~~~-------~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (258)
T cd05578         158 STSGTPGYMAPEVLCR-------QGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLYPATWSTEAI  230 (258)
T ss_pred             ccCCChhhcCHHHHcc-------cCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhccccccCcccCcHHHH
Confidence            5678999999999843       3366789999999999999999999987653  333333333 55677788999999


Q ss_pred             HHHHHhcccCCCCCCCH--HHHHhcccc
Q 004959          578 DFLRCCFQRNPADRPPA--SLLLEHRFL  603 (721)
Q Consensus       578 dLI~~cL~~DP~kRPSa--~eLL~Hp~f  603 (721)
                      ++|.+||+.||.+||++  .|+++||||
T Consensus       231 ~~i~~~l~~~p~~R~~~~~~~l~~~~~~  258 (258)
T cd05578         231 DAINKLLERDPQKRLGDNLKDLKNHPYF  258 (258)
T ss_pred             HHHHHHccCChhHcCCccHHHHhcCCCC
Confidence            99999999999999999  999999997

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=4.2e-42  Score=355.07  Aligned_cols=257  Identities=33%  Similarity=0.634  Sum_probs=213.2

Q ss_pred             CCCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhC-CCCCeeeeeeeEEec---
Q 004959          339 NSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHL-KHPNIVQYYGSEIVE---  414 (721)
Q Consensus       339 ~~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L-~HPnIV~l~g~~~~~---  414 (721)
                      .+.|++.+.||+|+||.||+|.+..+++.||+|++....      .....+.+|+.++.++ +|+||+++++++...   
T Consensus         5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~------~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~   78 (272)
T cd06637           5 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG------DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPP   78 (272)
T ss_pred             hhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC------ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCC
Confidence            357889999999999999999999999999999986421      1234678899999998 699999999998753   


Q ss_pred             ---CeEEEEEeeccCCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCc
Q 004959          415 ---DKFYIYLEYVHPGSINKYVREH-CGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMA  490 (721)
Q Consensus       415 ---~~~yLVmEy~~gGsL~~~L~~~-~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA  490 (721)
                         ..+|+||||+.+++|.+++... ...+++..+..++.||+.||.|||++||+|+||||+||+++.++.+||+|||++
T Consensus        79 ~~~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~Dfg~~  158 (272)
T cd06637          79 GMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVS  158 (272)
T ss_pred             CCCcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEccCCCc
Confidence               4689999999999999999764 356899999999999999999999999999999999999999999999999999


Q ss_pred             cccCCCc-ccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhcC--CC
Q 004959          491 KHLTGQK-ADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDT--PA  567 (721)
Q Consensus       491 ~~l~~~~-~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~~--~~  567 (721)
                      ..+.... ......|++.|+|||++.+...  ....++.++|||||||++|||++|..||...........+....  ..
T Consensus       159 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~--~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~  236 (272)
T cd06637         159 AQLDRTVGRRNTFIGTPYWMAPEVIACDEN--PDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRL  236 (272)
T ss_pred             eecccccccCCcccccccccCHhHhccccC--cCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcCCCCCC
Confidence            8654322 2344679999999999853211  23456778999999999999999999997655544444433322  12


Q ss_pred             CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccc
Q 004959          568 IPDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFL  603 (721)
Q Consensus       568 ~p~~lS~el~dLI~~cL~~DP~kRPSa~eLL~Hp~f  603 (721)
                      ....++.++.+||.+||..||.+||++.++++||||
T Consensus       237 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~~  272 (272)
T cd06637         237 KSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI  272 (272)
T ss_pred             CCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence            234678999999999999999999999999999997

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=1.8e-41  Score=403.50  Aligned_cols=264  Identities=28%  Similarity=0.544  Sum_probs=221.1

Q ss_pred             CCCCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEe--cC
Q 004959          338 MNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIV--ED  415 (721)
Q Consensus       338 l~~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~--~~  415 (721)
                      ...+|++++.||+|+||.||+|++..+++.||+|++...   .........+..|+.+|+.|+|||||+++++|..  ..
T Consensus        11 ~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~---~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~   87 (1021)
T PTZ00266         11 RLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYR---GLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQ   87 (1021)
T ss_pred             ccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEecc---ccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCC
Confidence            346899999999999999999999999999999998642   2233456788999999999999999999998865  35


Q ss_pred             eEEEEEeeccCCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHhhC-------CeeccCCCCCcEEEcCC------
Q 004959          416 KFYIYLEYVHPGSINKYVREH---CGAITESVVRNFTRHILSGLAYLHSK-------KTIHRDIKGANLLVDAS------  479 (721)
Q Consensus       416 ~~yLVmEy~~gGsL~~~L~~~---~~~Lse~~i~~i~~QIl~AL~yLHs~-------gIIHrDLKPeNILld~~------  479 (721)
                      .+||||||+.+|+|.++|...   .+.+++..++.|+.||+.||.|||+.       +||||||||+||||+..      
T Consensus        88 ~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~  167 (1021)
T PTZ00266         88 KLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGK  167 (1021)
T ss_pred             EEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccc
Confidence            699999999999999999653   35799999999999999999999985       49999999999999642      


Q ss_pred             -----------CceEEeecCCccccCCCcccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCC
Q 004959          480 -----------GVVKLADFGMAKHLTGQKADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPP  548 (721)
Q Consensus       480 -----------g~VKL~DFGlA~~l~~~~~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~P  548 (721)
                                 +.+||+|||++..+.........+||+.|+|||++.+     ....++.++||||||||||+|++|..|
T Consensus       168 i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~g-----e~~~~s~KSDVWSLG~ILYELLTGk~P  242 (1021)
T PTZ00266        168 ITAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLH-----ETKSYDDKSDMWALGCIIYELCSGKTP  242 (1021)
T ss_pred             ccccccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhc-----cCCCCCchhHHHHHHHHHHHHHHCCCC
Confidence                       3589999999987654444445679999999999854     223467789999999999999999999


Q ss_pred             CCchhhHHHHHHHhhcCCCCC-CCCCHHHHHHHHHhcccCCCCCCCHHHHHhccccccCCCC
Q 004959          549 WSEYEGAAAMFKVMRDTPAIP-DSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQP  609 (721)
Q Consensus       549 F~~~~~~~~~~ki~~~~~~~p-~~lS~el~dLI~~cL~~DP~kRPSa~eLL~Hp~f~~~~~~  609 (721)
                      |........+...+...+.++ ..++.++.+||..||+.+|++||++.|+|.|+||+....+
T Consensus       243 F~~~~~~~qli~~lk~~p~lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i~~p  304 (1021)
T PTZ00266        243 FHKANNFSQLISELKRGPDLPIKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNVGPP  304 (1021)
T ss_pred             CCcCCcHHHHHHHHhcCCCCCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhcCCC
Confidence            987666555555555444443 4578999999999999999999999999999999866543

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.2e-42  Score=376.13  Aligned_cols=247  Identities=21%  Similarity=0.333  Sum_probs=202.5

Q ss_pred             CCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeEEE
Q 004959          340 SQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYI  419 (721)
Q Consensus       340 ~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~yL  419 (721)
                      ..|++++.||+|+||.||+|.+..+++.||+|+...           .....|+.+|++++|+|||++++++......|+
T Consensus        66 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~-----------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  134 (357)
T PHA03209         66 LGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQK-----------GTTLIEAMLLQNVNHPSVIRMKDTLVSGAITCM  134 (357)
T ss_pred             cCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCc-----------cccHHHHHHHHhCCCCCCcChhheEEeCCeeEE
Confidence            479999999999999999999999999999997431           123568999999999999999999999999999


Q ss_pred             EEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCCccc
Q 004959          420 YLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKAD  499 (721)
Q Consensus       420 VmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~~~~  499 (721)
                      ||||+. ++|.+++......+++..++.|+.||+.||.|||++|||||||||+|||++.++.+||+|||++.........
T Consensus       135 v~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~  213 (357)
T PHA03209        135 VLPHYS-SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAF  213 (357)
T ss_pred             EEEccC-CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCccccccccCccc
Confidence            999995 6899888776678999999999999999999999999999999999999999999999999999754443344


Q ss_pred             ccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCC-CCchhh---------HHHHHHHhhcC----
Q 004959          500 LSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPP-WSEYEG---------AAAMFKVMRDT----  565 (721)
Q Consensus       500 ~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~P-F~~~~~---------~~~~~ki~~~~----  565 (721)
                      ....||+.|+|||++.       ...++.++|||||||+||||+++..+ |.....         ...+.+++...    
T Consensus       214 ~~~~gt~~y~aPE~~~-------~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~  286 (357)
T PHA03209        214 LGLAGTVETNAPEVLA-------RDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHP  286 (357)
T ss_pred             ccccccccccCCeecC-------CCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccCh
Confidence            4567999999999984       34567789999999999999985544 432111         11111111110    


Q ss_pred             CCCC------------------------------CCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccccc
Q 004959          566 PAIP------------------------------DSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKN  605 (721)
Q Consensus       566 ~~~p------------------------------~~lS~el~dLI~~cL~~DP~kRPSa~eLL~Hp~f~~  605 (721)
                      ..++                              ..++.++.+||.+||+.||++|||+.|+|+||||++
T Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~~  356 (357)
T PHA03209        287 EEFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQ  356 (357)
T ss_pred             hhcCCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhcc
Confidence            0011                              135678889999999999999999999999999975

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=1.1e-41  Score=368.91  Aligned_cols=258  Identities=23%  Similarity=0.379  Sum_probs=210.7

Q ss_pred             CCCCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEec---
Q 004959          338 MNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVE---  414 (721)
Q Consensus       338 l~~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~---  414 (721)
                      +..+|++.+.||+|+||.||+|.+..+|+.||||++...   .......+.+.+|+.++++++|+||+++++++...   
T Consensus        14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   90 (353)
T cd07850          14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRP---FQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSL   90 (353)
T ss_pred             hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCcc---ccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCc
Confidence            456899999999999999999999999999999987532   12334456778899999999999999999987643   


Q ss_pred             ---CeEEEEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCcc
Q 004959          415 ---DKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAK  491 (721)
Q Consensus       415 ---~~~yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~  491 (721)
                         ...|+||||+. ++|.+++..   .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++.
T Consensus        91 ~~~~~~~lv~e~~~-~~l~~~~~~---~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~  166 (353)
T cd07850          91 EEFQDVYLVMELMD-ANLCQVIQM---DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR  166 (353)
T ss_pred             cccCcEEEEEeccC-CCHHHHHhh---cCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCccce
Confidence               35799999996 588888754   28999999999999999999999999999999999999999999999999998


Q ss_pred             ccCCCcccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhcC------
Q 004959          492 HLTGQKADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDT------  565 (721)
Q Consensus       492 ~l~~~~~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~~------  565 (721)
                      ............|++.|+|||++.+       ..++.++|||||||++|+|++|+.||...+....+.++....      
T Consensus       167 ~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  239 (353)
T cd07850         167 TAGTSFMMTPYVVTRYYRAPEVILG-------MGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDE  239 (353)
T ss_pred             eCCCCCCCCCCcccccccCHHHHhC-------CCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHH
Confidence            7655444445668999999999853       456678999999999999999999997655433333222100      


Q ss_pred             ----------------CC--------------C-------CCCCCHHHHHHHHHhcccCCCCCCCHHHHHhccccccCCC
Q 004959          566 ----------------PA--------------I-------PDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQ  608 (721)
Q Consensus       566 ----------------~~--------------~-------p~~lS~el~dLI~~cL~~DP~kRPSa~eLL~Hp~f~~~~~  608 (721)
                                      +.              .       +...+.++++||.+||+.||++|||+.|+|+||||.....
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~~~~~  319 (353)
T cd07850         240 FMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYINVWYD  319 (353)
T ss_pred             HHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHhhccC
Confidence                            00              0       1134667899999999999999999999999999986554


Q ss_pred             C
Q 004959          609 P  609 (721)
Q Consensus       609 ~  609 (721)
                      +
T Consensus       320 ~  320 (353)
T cd07850         320 P  320 (353)
T ss_pred             C
Confidence            4

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.7e-42  Score=354.95  Aligned_cols=256  Identities=37%  Similarity=0.690  Sum_probs=220.1

Q ss_pred             CCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeEEE
Q 004959          340 SQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYI  419 (721)
Q Consensus       340 ~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~yL  419 (721)
                      ++|++.+.||.|+||.||+|.+..+|+.||+|.+...    ........+.+|+.+++.++|+||+++++++..+..+|+
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~----~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   76 (274)
T cd06609           1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLE----EAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWI   76 (274)
T ss_pred             ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeecc----ccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEE
Confidence            3688999999999999999999999999999998632    123345678899999999999999999999999999999


Q ss_pred             EEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCCc-c
Q 004959          420 YLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQK-A  498 (721)
Q Consensus       420 VmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~~-~  498 (721)
                      |+||+.+++|.+++...  .+++..++.++.||+.||.|||++||+|+||+|+||+++.++.++|+|||++..+.... .
T Consensus        77 v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~  154 (274)
T cd06609          77 IMEYCGGGSCLDLLKPG--KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSK  154 (274)
T ss_pred             EEEeeCCCcHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceeecccccc
Confidence            99999999999998753  79999999999999999999999999999999999999999999999999998775442 2


Q ss_pred             cccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhc-CCCCCCC-CCHHH
Q 004959          499 DLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRD-TPAIPDS-LSPEG  576 (721)
Q Consensus       499 ~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~-~~~~p~~-lS~el  576 (721)
                      .....|+..|+|||++.+       ..++.++|||||||++|+|++|..||...........+... .+.++.. ++.++
T Consensus       155 ~~~~~~~~~y~~PE~~~~-------~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  227 (274)
T cd06609         155 RNTFVGTPFWMAPEVIKQ-------SGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNPPSLEGNKFSKPF  227 (274)
T ss_pred             cccccCCccccChhhhcc-------CCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhcCCCCCcccccCHHH
Confidence            334678999999999953       33777899999999999999999999876555544444433 2334444 78999


Q ss_pred             HHHHHHhcccCCCCCCCHHHHHhccccccCCC
Q 004959          577 KDFLRCCFQRNPADRPPASLLLEHRFLKNSQQ  608 (721)
Q Consensus       577 ~dLI~~cL~~DP~kRPSa~eLL~Hp~f~~~~~  608 (721)
                      .++|.+||..||++||+++++++|+||.....
T Consensus       228 ~~~l~~~l~~~p~~Rpt~~~il~~~~~~~~~~  259 (274)
T cd06609         228 KDFVSLCLNKDPKERPSAKELLKHKFIKKAKK  259 (274)
T ss_pred             HHHHHHHhhCChhhCcCHHHHhhChhhcCCCc
Confidence            99999999999999999999999999987544

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=3.7e-42  Score=355.08  Aligned_cols=253  Identities=37%  Similarity=0.633  Sum_probs=211.6

Q ss_pred             CCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeEEE
Q 004959          340 SQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYI  419 (721)
Q Consensus       340 ~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~yL  419 (721)
                      ++|++.+.||+|+||.||+|.+..+++.||+|++...     .......+.+|+.+++.++||||+++++.+...+..|+
T Consensus         9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~-----~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~l   83 (267)
T cd06645           9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLE-----PGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWI   83 (267)
T ss_pred             HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecC-----chhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEE
Confidence            4789999999999999999999999999999988632     12234567889999999999999999999999999999


Q ss_pred             EEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCCc-c
Q 004959          420 YLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQK-A  498 (721)
Q Consensus       420 VmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~~-~  498 (721)
                      ||||+.+++|.+++... +.+++..++.++.||+.||.|||++||+|+||||+|||++.++.+||+|||++..+.... .
T Consensus        84 v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~  162 (267)
T cd06645          84 CMEFCGGGSLQDIYHVT-GPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAK  162 (267)
T ss_pred             EEeccCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeeeEccCcccc
Confidence            99999999999998764 689999999999999999999999999999999999999999999999999987654322 2


Q ss_pred             cccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhcCCC---C--CCCCC
Q 004959          499 DLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPA---I--PDSLS  573 (721)
Q Consensus       499 ~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~~~~---~--p~~lS  573 (721)
                      .....|+..|+|||++...    ....++.++|||||||++|+|++|..||..................   .  ...++
T Consensus       163 ~~~~~~~~~y~aPE~~~~~----~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (267)
T cd06645         163 RKSFIGTPYWMAPEVAAVE----RKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWS  238 (267)
T ss_pred             cccccCcccccChhhhccc----cCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCCcccccCCCC
Confidence            2345799999999997421    2234667899999999999999999999765443333332222111   1  12467


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHHhccc
Q 004959          574 PEGKDFLRCCFQRNPADRPPASLLLEHRF  602 (721)
Q Consensus       574 ~el~dLI~~cL~~DP~kRPSa~eLL~Hp~  602 (721)
                      ..+.+||.+||+.||++||++++|++|||
T Consensus       239 ~~~~~li~~~l~~~P~~R~~~~~ll~~~~  267 (267)
T cd06645         239 NSFHHFVKMALTKNPKKRPTAEKLLQHPF  267 (267)
T ss_pred             HHHHHHHHHHccCCchhCcCHHHHhcCCC
Confidence            89999999999999999999999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=5.3e-42  Score=353.04  Aligned_cols=256  Identities=37%  Similarity=0.760  Sum_probs=214.5

Q ss_pred             CeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCc-ccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeEEE
Q 004959          341 QWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDP-KSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYI  419 (721)
Q Consensus       341 ~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~-~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~yL  419 (721)
                      .|+.++.||+|+||.||+|.+..+|+.||+|++....... ......+.+.+|+++|++++|+||+++++++.+.+.+++
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   80 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL   80 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence            4888999999999999999999999999999986432211 122356789999999999999999999999999999999


Q ss_pred             EEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCC-ceEEeecCCccccCCCcc
Q 004959          420 YLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASG-VVKLADFGMAKHLTGQKA  498 (721)
Q Consensus       420 VmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g-~VKL~DFGlA~~l~~~~~  498 (721)
                      ||||+.|++|.+++.+. +.+++..+..++.||+.||.|||++||+|+||||+||+++.++ .+||+|||++..+.....
T Consensus        81 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~~  159 (268)
T cd06630          81 FVEWMAGGSVSHLLSKY-GAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGT  159 (268)
T ss_pred             EEeccCCCcHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEcccccccccccccc
Confidence            99999999999999764 6799999999999999999999999999999999999998776 699999999987654321


Q ss_pred             -----cccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHH---HHHHHh--hcCCCC
Q 004959          499 -----DLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAA---AMFKVM--RDTPAI  568 (721)
Q Consensus       499 -----~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~---~~~ki~--~~~~~~  568 (721)
                           .....|+..|+|||++.+       ..++.++|||||||++|+|++|..||.......   ....+.  .....+
T Consensus       160 ~~~~~~~~~~~~~~~~~PE~~~~-------~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  232 (268)
T cd06630         160 GAGEFQGQLLGTIAFMAPEVLRG-------EQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSI  232 (268)
T ss_pred             cCCccccccccccceeCHhHhcc-------CCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCCCCC
Confidence                 123468899999999843       345678999999999999999999996543222   222221  223456


Q ss_pred             CCCCCHHHHHHHHHhcccCCCCCCCHHHHHhccccc
Q 004959          569 PDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLK  604 (721)
Q Consensus       569 p~~lS~el~dLI~~cL~~DP~kRPSa~eLL~Hp~f~  604 (721)
                      +..++.++.++|.+||+.||++||++.++++||||+
T Consensus       233 ~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~~~~~  268 (268)
T cd06630         233 PEHLSPGLRDVTLRCLELQPEDRPPSRELLKHPVFR  268 (268)
T ss_pred             chhhCHHHHHHHHHHcCCCcccCcCHHHHhcCcccC
Confidence            677899999999999999999999999999999984

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.5e-43  Score=388.08  Aligned_cols=253  Identities=42%  Similarity=0.760  Sum_probs=223.2

Q ss_pred             EEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeEEEEEeeccC
Q 004959          347 LIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYIYLEYVHP  426 (721)
Q Consensus       347 ~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~yLVmEy~~g  426 (721)
                      +||+|.||+||.|++..|....|||.|.-     +..+..+-+..||.+.++|+|.|||+++|.+...+.+-|+||.++|
T Consensus       582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpe-----kdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPG  656 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAARDMDTQVRIAIKEIPE-----KDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPG  656 (1226)
T ss_pred             EeecCceeEEEeeccccceeEEEeeeccc-----ccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCC
Confidence            69999999999999999999999998852     3345567788999999999999999999999999999999999999


Q ss_pred             CCHHHHHHHhcCCC--CHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEc-CCCceEEeecCCccccCCCc-ccccC
Q 004959          427 GSINKYVREHCGAI--TESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVD-ASGVVKLADFGMAKHLTGQK-ADLSM  502 (721)
Q Consensus       427 GsL~~~L~~~~~~L--se~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld-~~g~VKL~DFGlA~~l~~~~-~~~s~  502 (721)
                      |+|.++|+..=|++  +|..+..|.+||++||.|||++.|||||||.+||||+ -.|.+||.|||.++.+.+-. ...++
T Consensus       657 GSLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~TETF  736 (1226)
T KOG4279|consen  657 GSLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCTETF  736 (1226)
T ss_pred             CcHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhccCCcccccc
Confidence            99999999887888  8899999999999999999999999999999999996 47899999999999887644 34568


Q ss_pred             CCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchh-hHHHHHHH--hhcCCCCCCCCCHHHHHH
Q 004959          503 KGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYE-GAAAMFKV--MRDTPAIPDSLSPEGKDF  579 (721)
Q Consensus       503 ~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~-~~~~~~ki--~~~~~~~p~~lS~el~dL  579 (721)
                      .||.-|||||++..     ....|..++|||||||++.||.||++||.+.. ....++++  .+.-+.+|..++.+++.|
T Consensus       737 TGTLQYMAPEvIDq-----G~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmyKvHP~iPeelsaeak~F  811 (1226)
T KOG4279|consen  737 TGTLQYMAPEVIDQ-----GPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMYKVHPPIPEELSAEAKNF  811 (1226)
T ss_pred             ccchhhhChHhhcc-----CCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcceecCCCCcHHHHHHHHHH
Confidence            89999999999964     23567889999999999999999999997743 34444443  345678999999999999


Q ss_pred             HHHhcccCCCCCCCHHHHHhccccccCCCC
Q 004959          580 LRCCFQRNPADRPPASLLLEHRFLKNSQQP  609 (721)
Q Consensus       580 I~~cL~~DP~kRPSa~eLL~Hp~f~~~~~~  609 (721)
                      |.+|+..||.+||++.+||+.||++...+.
T Consensus       812 ilrcFepd~~~R~sA~~LL~DpFlq~~~kk  841 (1226)
T KOG4279|consen  812 ILRCFEPDPCDRPSAKDLLQDPFLQHNNKK  841 (1226)
T ss_pred             HHHHcCCCcccCccHHHhccCcccccCCCC
Confidence            999999999999999999999999987443

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=7.1e-42  Score=352.01  Aligned_cols=249  Identities=28%  Similarity=0.516  Sum_probs=216.3

Q ss_pred             EeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeEEEEEeeccCC
Q 004959          348 IGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYIYLEYVHPG  427 (721)
Q Consensus       348 LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~yLVmEy~~gG  427 (721)
                      ||.|+||.||+|++..+++.||+|++...  ........+.+.+|+.+++.++|+||+++++.+.+++.+|+||||++++
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~--~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~   78 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKR--HIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGG   78 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehh--cchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCC
Confidence            69999999999999999999999998642  1222344578999999999999999999999999999999999999999


Q ss_pred             CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCCcccccCCCCCc
Q 004959          428 SINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPY  507 (721)
Q Consensus       428 sL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~~~~~s~~GT~~  507 (721)
                      +|.+++... ..+++..+..++.||+.||.|||++|++|+||||+||+|+.++.++|+|||++..+..........|++.
T Consensus        79 ~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~  157 (262)
T cd05572          79 ELWTILRDR-GLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFCGTPE  157 (262)
T ss_pred             cHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCcccccccccCCcC
Confidence            999999764 5689999999999999999999999999999999999999999999999999987765544445678999


Q ss_pred             cCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchh--hHHHHHHHh--hcCCCCCCCCCHHHHHHHHHh
Q 004959          508 WMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYE--GAAAMFKVM--RDTPAIPDSLSPEGKDFLRCC  583 (721)
Q Consensus       508 Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~--~~~~~~ki~--~~~~~~p~~lS~el~dLI~~c  583 (721)
                      |++||.+.       ...++.++|+|||||++|+|++|..||....  ..+.+.++.  .....+|..++.++.+||.+|
T Consensus       158 ~~~PE~~~-------~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~  230 (262)
T cd05572         158 YVAPEIIL-------NKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDLIKQL  230 (262)
T ss_pred             ccChhHhc-------CCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCCCCCcccCHHHHHHHHHH
Confidence            99999984       2345678999999999999999999997765  445555555  345566777899999999999


Q ss_pred             cccCCCCCCC-----HHHHHhccccccC
Q 004959          584 FQRNPADRPP-----ASLLLEHRFLKNS  606 (721)
Q Consensus       584 L~~DP~kRPS-----a~eLL~Hp~f~~~  606 (721)
                      |+.||++|++     ++|+++||||++.
T Consensus       231 l~~~p~~R~~~~~~~~~~l~~~~~~~~~  258 (262)
T cd05572         231 LRRNPEERLGNLKGGIKDIKKHKWFNGF  258 (262)
T ss_pred             ccCChhhCcCCcccCHHHHhcChhhhCC
Confidence            9999999999     9999999999864

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=6.1e-42  Score=349.76  Aligned_cols=250  Identities=38%  Similarity=0.690  Sum_probs=216.1

Q ss_pred             CCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeEEE
Q 004959          340 SQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYI  419 (721)
Q Consensus       340 ~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~yL  419 (721)
                      ++|++.+.||.|+||.||+|.+..+++.|++|.+...       ...+.+.+|+.+++.++|+||+++++.+......|+
T Consensus         3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~-------~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l   75 (256)
T cd06612           3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVE-------EDLQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWI   75 (256)
T ss_pred             ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecH-------HHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEE
Confidence            5799999999999999999999998999999988531       116789999999999999999999999999999999


Q ss_pred             EEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCCc-c
Q 004959          420 YLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQK-A  498 (721)
Q Consensus       420 VmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~~-~  498 (721)
                      +|||+.+++|.+++......+++..++.++.||+.||.|||+.||+|+||+|.||+++.++.+||+|||++..+.... .
T Consensus        76 ~~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~~  155 (256)
T cd06612          76 VMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAK  155 (256)
T ss_pred             EEecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccchhcccCccc
Confidence            999999999999998766789999999999999999999999999999999999999999999999999998765443 2


Q ss_pred             cccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhcC---CCCCCCCCHH
Q 004959          499 DLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDT---PAIPDSLSPE  575 (721)
Q Consensus       499 ~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~~---~~~p~~lS~e  575 (721)
                      .....|+..|+|||++.+       ..++.++|||||||++|+|++|+.||...........+....   ...+..++.+
T Consensus       156 ~~~~~~~~~y~~PE~~~~-------~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (256)
T cd06612         156 RNTVIGTPFWMAPEVIQE-------IGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSDPEKWSPE  228 (256)
T ss_pred             cccccCCccccCHHHHhc-------CCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccCCCCCCCchhhcCHH
Confidence            233558999999999843       356778999999999999999999998765544443332221   2234467889


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHHhcccc
Q 004959          576 GKDFLRCCFQRNPADRPPASLLLEHRFL  603 (721)
Q Consensus       576 l~dLI~~cL~~DP~kRPSa~eLL~Hp~f  603 (721)
                      +.+||.+||+.||++||++.|+|+||||
T Consensus       229 ~~~~i~~~l~~~P~~Rps~~~il~~~~~  256 (256)
T cd06612         229 FNDFVKKCLVKDPEERPSAIQLLQHPFI  256 (256)
T ss_pred             HHHHHHHHHhcChhhCcCHHHHhcCCCC
Confidence            9999999999999999999999999997

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=1.9e-41  Score=346.09  Aligned_cols=253  Identities=31%  Similarity=0.543  Sum_probs=216.6

Q ss_pred             CeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEe--cCeEE
Q 004959          341 QWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIV--EDKFY  418 (721)
Q Consensus       341 ~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~--~~~~y  418 (721)
                      +|++.+.||.|+||.||+|.+..+|+.||+|.+...   .......+++..|+.+++.++|+||+++++++..  ....|
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~   77 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYG---NMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLY   77 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecc---cCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEE
Confidence            588999999999999999999999999999988632   2334556788999999999999999999997754  45689


Q ss_pred             EEEeeccCCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHh-----hCCeeccCCCCCcEEEcCCCceEEeecCCc
Q 004959          419 IYLEYVHPGSINKYVREH---CGAITESVVRNFTRHILSGLAYLH-----SKKTIHRDIKGANLLVDASGVVKLADFGMA  490 (721)
Q Consensus       419 LVmEy~~gGsL~~~L~~~---~~~Lse~~i~~i~~QIl~AL~yLH-----s~gIIHrDLKPeNILld~~g~VKL~DFGlA  490 (721)
                      ++|||+.+++|.+++...   ...+++..++.++.||+.||.|||     +.+|+|+||||+||+++.++.+||+|||++
T Consensus        78 ~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~  157 (265)
T cd08217          78 IVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLA  157 (265)
T ss_pred             EEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEeccccc
Confidence            999999999999998654   467999999999999999999999     999999999999999999999999999999


Q ss_pred             cccCCCcc-cccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhc-CCCC
Q 004959          491 KHLTGQKA-DLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRD-TPAI  568 (721)
Q Consensus       491 ~~l~~~~~-~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~-~~~~  568 (721)
                      ..+..... .....|++.|+|||.+.       ...++.++|||||||++|+|++|..||...+.......+... ...+
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~pE~~~-------~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~  230 (265)
T cd08217         158 KILGHDSSFAKTYVGTPYYMSPEQLN-------HMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKFRRI  230 (265)
T ss_pred             ccccCCcccccccccCCCccChhhhc-------CCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhcCCCCCC
Confidence            87755443 33457899999999984       334677899999999999999999999877644444444333 2356


Q ss_pred             CCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccc
Q 004959          569 PDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFL  603 (721)
Q Consensus       569 p~~lS~el~dLI~~cL~~DP~kRPSa~eLL~Hp~f  603 (721)
                      +..++.++.++|.+||+.+|++||++.+|++|||+
T Consensus       231 ~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~~~~  265 (265)
T cd08217         231 PYRYSSELNEVIKSMLNVDPDKRPSTEELLQLPLI  265 (265)
T ss_pred             ccccCHHHHHHHHHHccCCcccCCCHHHHhhCCCC
Confidence            67889999999999999999999999999999996

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=2.5e-41  Score=346.32  Aligned_cols=253  Identities=28%  Similarity=0.532  Sum_probs=219.2

Q ss_pred             CeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeEEEE
Q 004959          341 QWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYIY  420 (721)
Q Consensus       341 ~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~yLV  420 (721)
                      .|+..++||.|+||.||.+.+..+++.+++|.+....   ......+.+.+|+.+|++++|+||+++++++.+.+.+++|
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~   77 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTR---LSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIE   77 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecc---cchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEE
Confidence            4899999999999999999999999999999886422   2234466788999999999999999999999999999999


Q ss_pred             EeeccCCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCCc-c
Q 004959          421 LEYVHPGSINKYVREH-CGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQK-A  498 (721)
Q Consensus       421 mEy~~gGsL~~~L~~~-~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~~-~  498 (721)
                      |||+.+++|.+++... ...+++..+..++.||+.||.|||+.|++|+||||+||+++.++.+||+|||++....... .
T Consensus        78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~~  157 (256)
T cd08221          78 MEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSM  157 (256)
T ss_pred             EEecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEEccccccc
Confidence            9999999999999765 4568999999999999999999999999999999999999999999999999998764433 2


Q ss_pred             cccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhcC-CCCCCCCCHHHH
Q 004959          499 DLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDT-PAIPDSLSPEGK  577 (721)
Q Consensus       499 ~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~~-~~~p~~lS~el~  577 (721)
                      .....|++.|+|||++.+       ..++.++|||||||++|+|++|..||......+....+.... ...+..++.++.
T Consensus       158 ~~~~~~~~~y~ape~~~~-------~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (256)
T cd08221         158 AETVVGTPYYMSPELCQG-------VKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVVSVYSSELI  230 (256)
T ss_pred             ccccCCCccccCHhhcCC-------CCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccCHHHH
Confidence            234568999999999843       345667999999999999999999998877666666655442 234466899999


Q ss_pred             HHHHHhcccCCCCCCCHHHHHhcccc
Q 004959          578 DFLRCCFQRNPADRPPASLLLEHRFL  603 (721)
Q Consensus       578 dLI~~cL~~DP~kRPSa~eLL~Hp~f  603 (721)
                      ++|.+||..||++||++.++|+|+|+
T Consensus       231 ~~i~~~l~~~p~~R~s~~~ll~~~~l  256 (256)
T cd08221         231 SLVHSLLQQDPEKRPTADEVLDQPLL  256 (256)
T ss_pred             HHHHHHcccCcccCCCHHHHhhCcCC
Confidence            99999999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=5.2e-42  Score=357.97  Aligned_cols=264  Identities=31%  Similarity=0.574  Sum_probs=219.1

Q ss_pred             CCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeEEE
Q 004959          340 SQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYI  419 (721)
Q Consensus       340 ~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~yL  419 (721)
                      ++|++.+.||+|+||.||+|.+..+|+.||+|.+...    ........+.+|+.++++++|+||+++++.+...+.+|+
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~----~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~l   76 (286)
T cd06622           1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLE----LDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYM   76 (286)
T ss_pred             ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecc----cCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEE
Confidence            3689999999999999999999999999999988532    223345678899999999999999999999999999999


Q ss_pred             EEeeccCCCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHhh-CCeeccCCCCCcEEEcCCCceEEeecCCccccCCC
Q 004959          420 YLEYVHPGSINKYVREH--CGAITESVVRNFTRHILSGLAYLHS-KKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQ  496 (721)
Q Consensus       420 VmEy~~gGsL~~~L~~~--~~~Lse~~i~~i~~QIl~AL~yLHs-~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~  496 (721)
                      ||||+.|++|..++...  ...+++..+..++.||+.||.|||+ .||+|+||||+|||++.++.+||+|||++..+...
T Consensus        77 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~  156 (286)
T cd06622          77 CMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS  156 (286)
T ss_pred             EEeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCC
Confidence            99999999999988753  2479999999999999999999997 59999999999999999999999999999765332


Q ss_pred             cccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHH---HHHhh-cCCCCCCCC
Q 004959          497 KADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAM---FKVMR-DTPAIPDSL  572 (721)
Q Consensus       497 ~~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~---~ki~~-~~~~~p~~l  572 (721)
                       ......|++.|+|||++.+.... ....++.++|||||||++|+|++|+.||.........   ..+.. ....++..+
T Consensus       157 -~~~~~~~~~~y~aPE~~~~~~~~-~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (286)
T cd06622         157 -LAKTNIGCQSYMAPERIKSGGPN-QNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPSGY  234 (286)
T ss_pred             -ccccCCCccCccCcchhcCCCCC-ccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCCCCCCccc
Confidence             22345688999999998542211 1234577899999999999999999999764333222   22222 234566779


Q ss_pred             CHHHHHHHHHhcccCCCCCCCHHHHHhccccccCCCC
Q 004959          573 SPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQP  609 (721)
Q Consensus       573 S~el~dLI~~cL~~DP~kRPSa~eLL~Hp~f~~~~~~  609 (721)
                      +.++.+||.+||+.+|++||++.+++.||||......
T Consensus       235 ~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~~~~  271 (286)
T cd06622         235 SDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYKNA  271 (286)
T ss_pred             CHHHHHHHHHHcccCcccCCCHHHHhcChhhhhccCC
Confidence            9999999999999999999999999999999876543

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.1e-42  Score=351.37  Aligned_cols=257  Identities=36%  Similarity=0.665  Sum_probs=214.8

Q ss_pred             CCCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhC-CCCCeeeeeeeEEecC--
Q 004959          339 NSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHL-KHPNIVQYYGSEIVED--  415 (721)
Q Consensus       339 ~~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L-~HPnIV~l~g~~~~~~--  415 (721)
                      .++|++.+.||+|+||.||+|.+..+++.|++|++....      ...+.+.+|+.+++++ .|+||+++++++....  
T Consensus         5 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~------~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~   78 (275)
T cd06608           5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE------DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPP   78 (275)
T ss_pred             hhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCc------hhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCC
Confidence            468999999999999999999999999999999886321      2346788999999999 6999999999987644  


Q ss_pred             ----eEEEEEeeccCCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecC
Q 004959          416 ----KFYIYLEYVHPGSINKYVREH---CGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFG  488 (721)
Q Consensus       416 ----~~yLVmEy~~gGsL~~~L~~~---~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFG  488 (721)
                          .+|+||||+.+++|.+++...   ...+++..++.++.||+.||.|||++||+|+||+|+||+++.++.+||+|||
T Consensus        79 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~l~d~~  158 (275)
T cd06608          79 GNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFG  158 (275)
T ss_pred             CcceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEEECCCc
Confidence                489999999999999998653   3679999999999999999999999999999999999999999999999999


Q ss_pred             CccccCCCc-ccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhcCC-
Q 004959          489 MAKHLTGQK-ADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTP-  566 (721)
Q Consensus       489 lA~~l~~~~-~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~~~-  566 (721)
                      ++....... ......|+..|+|||++......  ...++.++|||||||+||+|++|+.||..........++..... 
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~--~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~  236 (275)
T cd06608         159 VSAQLDSTLGRRNTFIGTPYWMAPEVIACDEQP--DASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNPPP  236 (275)
T ss_pred             cceecccchhhhcCccccccccCHhHhcccccc--cCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhccCCC
Confidence            987654322 22345689999999998543221  34566789999999999999999999987655555555544322 


Q ss_pred             --CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccc
Q 004959          567 --AIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFL  603 (721)
Q Consensus       567 --~~p~~lS~el~dLI~~cL~~DP~kRPSa~eLL~Hp~f  603 (721)
                        ..+..++.++++||.+||..||++|||+.++++|||+
T Consensus       237 ~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~  275 (275)
T cd06608         237 TLKSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI  275 (275)
T ss_pred             CCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence              1223478899999999999999999999999999996

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=1.9e-41  Score=347.19  Aligned_cols=253  Identities=31%  Similarity=0.567  Sum_probs=218.6

Q ss_pred             CeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeEEEE
Q 004959          341 QWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYIY  420 (721)
Q Consensus       341 ~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~yLV  420 (721)
                      +|++.+.||+|+||.||++.+..+|+.||+|.+....   ......+.+.+|+.+++.++|+||+++++++...+..|+|
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   77 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISK---MSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIV   77 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHh---CChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEE
Confidence            5899999999999999999999999999999986421   1233456789999999999999999999999999999999


Q ss_pred             EeeccCCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCCccc
Q 004959          421 LEYVHPGSINKYVREHC-GAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKAD  499 (721)
Q Consensus       421 mEy~~gGsL~~~L~~~~-~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~~~~  499 (721)
                      |||+.+++|.+++.... ..+++..+..++.||+.||.|||++|++|+||+|+|||++.++.++|+|||++..+......
T Consensus        78 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~~  157 (256)
T cd08218          78 MDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVEL  157 (256)
T ss_pred             EecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchhh
Confidence            99999999999987643 46899999999999999999999999999999999999999999999999999866443222


Q ss_pred             -ccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhcC-CCCCCCCCHHHH
Q 004959          500 -LSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDT-PAIPDSLSPEGK  577 (721)
Q Consensus       500 -~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~~-~~~p~~lS~el~  577 (721)
                       ....|++.|+|||++.       ...++.++|||||||++|+|++|+.||......+...++.... ...+..++.++.
T Consensus       158 ~~~~~~~~~~~~pe~~~-------~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (256)
T cd08218         158 ARTCIGTPYYLSPEICE-------NRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYPPVSSHYSYDLR  230 (256)
T ss_pred             hhhccCCccccCHHHhC-------CCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcCCCCCCcccCCHHHH
Confidence             2345889999999984       3446678999999999999999999998766666666655443 346678899999


Q ss_pred             HHHHHhcccCCCCCCCHHHHHhcccc
Q 004959          578 DFLRCCFQRNPADRPPASLLLEHRFL  603 (721)
Q Consensus       578 dLI~~cL~~DP~kRPSa~eLL~Hp~f  603 (721)
                      ++|.+||+.+|++||++.++++||||
T Consensus       231 ~li~~~l~~~p~~Rp~~~~vl~~~~~  256 (256)
T cd08218         231 NLVSQLFKRNPRDRPSVNSILEKNFI  256 (256)
T ss_pred             HHHHHHhhCChhhCcCHHHHhhCcCC
Confidence            99999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=1.6e-41  Score=358.57  Aligned_cols=254  Identities=35%  Similarity=0.623  Sum_probs=216.0

Q ss_pred             CCCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeEE
Q 004959          339 NSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFY  418 (721)
Q Consensus       339 ~~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~y  418 (721)
                      ..+|++.+.||+|+||.||+|.+..+++.||+|.+....     ....+.+.+|+.+++.+.|+||+++++.+......|
T Consensus        19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~-----~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~   93 (296)
T cd06654          19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQ-----QPKKELIINEILVMRENKNPNIVNYLDSYLVGDELW   93 (296)
T ss_pred             ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCC-----cchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEE
Confidence            358999999999999999999999999999999886421     122467889999999999999999999999999999


Q ss_pred             EEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCCcc
Q 004959          419 IYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKA  498 (721)
Q Consensus       419 LVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~~~  498 (721)
                      +||||+.|++|.+++..  ..+++.++..++.||+.||.|||++||+||||||+|||++.++.+||+|||++........
T Consensus        94 lv~e~~~~~~L~~~~~~--~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~  171 (296)
T cd06654          94 VVMEYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS  171 (296)
T ss_pred             EeecccCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccchhcccccc
Confidence            99999999999999864  4689999999999999999999999999999999999999999999999999876543322


Q ss_pred             -cccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhcC---CCCCCCCCH
Q 004959          499 -DLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDT---PAIPDSLSP  574 (721)
Q Consensus       499 -~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~~---~~~p~~lS~  574 (721)
                       .....|++.|+|||.+.       ...++.++|||||||++|+|++|+.||...........+....   ...+..++.
T Consensus       172 ~~~~~~~~~~y~aPE~~~-------~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (296)
T cd06654         172 KRSTMVGTPYWMAPEVVT-------RKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSA  244 (296)
T ss_pred             ccCcccCCccccCHHHHc-------CCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcCCCCCCCCccccCH
Confidence             23356899999999984       3445678999999999999999999997765544433333221   123556889


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHHhccccccC
Q 004959          575 EGKDFLRCCFQRNPADRPPASLLLEHRFLKNS  606 (721)
Q Consensus       575 el~dLI~~cL~~DP~kRPSa~eLL~Hp~f~~~  606 (721)
                      .+.+||.+||..||++||++.++++|+||...
T Consensus       245 ~l~~li~~~l~~~p~~Rpt~~eil~~~~~~~~  276 (296)
T cd06654         245 IFRDFLNRCLDMDVEKRGSAKELLQHQFLKIA  276 (296)
T ss_pred             HHHHHHHHHCcCCcccCcCHHHHhhChhhhcc
Confidence            99999999999999999999999999999754

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=1.2e-41  Score=352.92  Aligned_cols=250  Identities=25%  Similarity=0.413  Sum_probs=206.2

Q ss_pred             eeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCC-CCCeeeeeeeEEec--CeEE
Q 004959          342 WQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLK-HPNIVQYYGSEIVE--DKFY  418 (721)
Q Consensus       342 y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~-HPnIV~l~g~~~~~--~~~y  418 (721)
                      |++.+.||+|+||.||+|.+..+++.||+|++.....   .... ....+|+.++.++. |+||+++++++.+.  +.++
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~---~~~~-~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~   76 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFK---SLEQ-VNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLA   76 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccC---Cchh-hhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEE
Confidence            6788999999999999999999999999998753211   1112 23457888898885 99999999999887  8899


Q ss_pred             EEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCCcc
Q 004959          419 IYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKA  498 (721)
Q Consensus       419 LVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~~~  498 (721)
                      +||||+. ++|.+++......+++..++.++.||+.||+|||++||+||||||+||+++. +.+||+|||++..+.....
T Consensus        77 lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~  154 (282)
T cd07831          77 LVFELMD-MNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPP  154 (282)
T ss_pred             EEEecCC-ccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CCeEEEecccccccccCCC
Confidence            9999997 5888888765567999999999999999999999999999999999999999 9999999999987755444


Q ss_pred             cccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhcC-------------
Q 004959          499 DLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDT-------------  565 (721)
Q Consensus       499 ~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~~-------------  565 (721)
                      .....++..|+|||++..      ...++.++|||||||++|||++|..||.+.+..+.+..+....             
T Consensus       155 ~~~~~~~~~y~aPE~~~~------~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (282)
T cd07831         155 YTEYISTRWYRAPECLLT------DGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRK  228 (282)
T ss_pred             cCCCCCCcccCChhHhhc------CCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcc
Confidence            445668999999998742      2345668999999999999999999998765544333322100             


Q ss_pred             -----CCC-----------CCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccc
Q 004959          566 -----PAI-----------PDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFL  603 (721)
Q Consensus       566 -----~~~-----------p~~lS~el~dLI~~cL~~DP~kRPSa~eLL~Hp~f  603 (721)
                           ..+           ...++.++.+||.+||+.||++||+++++++||||
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~  282 (282)
T cd07831         229 SRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF  282 (282)
T ss_pred             cccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence                 011           12468999999999999999999999999999997

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=8.4e-43  Score=381.55  Aligned_cols=298  Identities=25%  Similarity=0.440  Sum_probs=230.5

Q ss_pred             CCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCC-CCCeeeeeeeEEecCeEE
Q 004959          340 SQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLK-HPNIVQYYGSEIVEDKFY  418 (721)
Q Consensus       340 ~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~-HPnIV~l~g~~~~~~~~y  418 (721)
                      ..|++++.||+||-+.||++..-. .+.||+|.+..   ...+.+.+.-+.+||.+|.+|+ |.+||+||++...++.+|
T Consensus       361 ~~Yeilk~iG~GGSSkV~kV~~s~-~~iyalkkv~~---~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lY  436 (677)
T KOG0596|consen  361 REYEILKQIGSGGSSKVFKVLNSD-KQIYALKKVVL---LEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLY  436 (677)
T ss_pred             chhhHHHhhcCCCcceeeeeecCC-CcchhhhHHHH---hhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEE
Confidence            579999999999999999998654 56778777653   3344567788999999999996 999999999999999999


Q ss_pred             EEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCCcc
Q 004959          419 IYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKA  498 (721)
Q Consensus       419 LVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~~~  498 (721)
                      +||||-+ .+|.++|......++.-.++.|..|+|.|+.++|..||||.||||.|+|+ -.|.+||+|||+|..+..+..
T Consensus       437 mvmE~Gd-~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLl-VkG~LKLIDFGIA~aI~~DTT  514 (677)
T KOG0596|consen  437 MVMECGD-IDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLL-VKGRLKLIDFGIANAIQPDTT  514 (677)
T ss_pred             EEeeccc-ccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEE-EeeeEEeeeechhcccCcccc
Confidence            9999985 79999999877777767999999999999999999999999999999999 568999999999998876654


Q ss_pred             c---ccCCCCCccCChhhHHHHhhcCCC----CCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhcC-C--CC
Q 004959          499 D---LSMKGSPYWMAPELMMAVMQKGKS----SDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDT-P--AI  568 (721)
Q Consensus       499 ~---~s~~GT~~Y~APEvl~~~~~~~k~----~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~~-~--~~  568 (721)
                      .   .+.+||+.||+||.+....+....    -..++++||||||||||+|++|+.||............+.+. .  ++
T Consensus       515 sI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~aI~~P~~~Ief  594 (677)
T KOG0596|consen  515 SIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKLHAITDPNHEIEF  594 (677)
T ss_pred             ceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHHHhhcCCCccccc
Confidence            3   357899999999999876554222    236778999999999999999999998766443333333322 2  34


Q ss_pred             CCCCCH-HHHHHHHHhcccCCCCCCCHHHHHhccccccCCCCCCCCcccccCCCCCCCCCCChhHHHhhhHHHHHh
Q 004959          569 PDSLSP-EGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQPDVPSCSLSFSGMQLTEKPHSPREKADAKYDQVAA  643 (721)
Q Consensus       569 p~~lS~-el~dLI~~cL~~DP~kRPSa~eLL~Hp~f~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~d~~~~  643 (721)
                      |..-.. ++.++++.||++||++||++.|||+|||++....+..+........+.+.+..+...+....+.+++..
T Consensus       595 p~~~~~~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~~~i~~~~m~~~~~~~~k~~e~~~v~~d~~n~i~~ql~~  670 (677)
T KOG0596|consen  595 PDIPENDELIDVMKCCLARDPKKRWSIPELLQHPFLQIQPIPVEQMAKLTTNEMKYVEGQLVDLDSPNSILKQLKT  670 (677)
T ss_pred             cCCCCchHHHHHHHHHHhcCcccCCCcHHHhcCcccccccccchHHHHHHHHHHHhcccCCCCcccHHHHHHHHHH
Confidence            443333 399999999999999999999999999998754443332222222222333333333344444444443

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=1.5e-41  Score=359.79  Aligned_cols=260  Identities=28%  Similarity=0.468  Sum_probs=214.2

Q ss_pred             CCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEec--CeE
Q 004959          340 SQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVE--DKF  417 (721)
Q Consensus       340 ~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~--~~~  417 (721)
                      ++|++.+.||+|+||.||+|.+..+|+.||+|.+.......   .....+.+|+.+|++++|+||+++++++...  +.+
T Consensus         7 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (309)
T cd07845           7 TEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERD---GIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSI   83 (309)
T ss_pred             cceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCC---CCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeE
Confidence            57999999999999999999999999999999986432111   1123456799999999999999999998765  568


Q ss_pred             EEEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCCc
Q 004959          418 YIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQK  497 (721)
Q Consensus       418 yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~~  497 (721)
                      |+||||+. ++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+....
T Consensus        84 ~lv~e~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~  162 (309)
T cd07845          84 FLVMEYCE-QDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPA  162 (309)
T ss_pred             EEEEecCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccceeeecCCcc
Confidence            99999996 58988887655779999999999999999999999999999999999999999999999999998765432


Q ss_pred             c-cccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhcCC----------
Q 004959          498 A-DLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTP----------  566 (721)
Q Consensus       498 ~-~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~~~----------  566 (721)
                      . .....+++.|+|||++.+      ...++.++|||||||++|+|++|..||...+..+.+..+.....          
T Consensus       163 ~~~~~~~~~~~y~aPE~~~~------~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (309)
T cd07845         163 KPMTPKVVTLWYRAPELLLG------CTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGF  236 (309)
T ss_pred             CCCCcccccccccChhhhcC------CCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhh
Confidence            2 223346888999999853      23466789999999999999999999987766655544432100          


Q ss_pred             ---------CC-----------CCCCCHHHHHHHHHhcccCCCCCCCHHHHHhccccccCCCC
Q 004959          567 ---------AI-----------PDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQP  609 (721)
Q Consensus       567 ---------~~-----------p~~lS~el~dLI~~cL~~DP~kRPSa~eLL~Hp~f~~~~~~  609 (721)
                               .+           ...+++++.+||.+||+.||++|||+.++++||||.+...+
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~~~~  299 (309)
T cd07845         237 SDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEKPLP  299 (309)
T ss_pred             hcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccCCCC
Confidence                     00           02358899999999999999999999999999999977655

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=1.7e-41  Score=354.15  Aligned_cols=249  Identities=29%  Similarity=0.552  Sum_probs=208.4

Q ss_pred             CeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeEEEE
Q 004959          341 QWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYIY  420 (721)
Q Consensus       341 ~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~yLV  420 (721)
                      +|++.++||+|+||.||+|.+..+++.||||.+...    ......+.+.+|+.+|++++||||+++++.+...+..++|
T Consensus         2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~----~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv   77 (279)
T cd06619           2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLD----ITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISIC   77 (279)
T ss_pred             cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecC----CChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEE
Confidence            688899999999999999999999999999988632    1234456788999999999999999999999999999999


Q ss_pred             EeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCCcccc
Q 004959          421 LEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADL  500 (721)
Q Consensus       421 mEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~~~~~  500 (721)
                      |||+++++|..+     ..+++..+..++.||+.||.|||++||+|+||||+|||++.++.+||+|||++..+... ...
T Consensus        78 ~e~~~~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~-~~~  151 (279)
T cd06619          78 TEFMDGGSLDVY-----RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS-IAK  151 (279)
T ss_pred             EecCCCCChHHh-----hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceecccc-ccc
Confidence            999999998654     35789999999999999999999999999999999999999999999999999865433 233


Q ss_pred             cCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhH-------HHHHHHhhc-CCCC-CCC
Q 004959          501 SMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGA-------AAMFKVMRD-TPAI-PDS  571 (721)
Q Consensus       501 s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~-------~~~~ki~~~-~~~~-p~~  571 (721)
                      ..+|+..|+|||++.       ...++.++|||||||++|+|++|+.||......       .....+... .... ...
T Consensus       152 ~~~~~~~y~aPE~~~-------~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  224 (279)
T cd06619         152 TYVGTNAYMAPERIS-------GEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQ  224 (279)
T ss_pred             CCCCChhhcCceeec-------CCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCCCCCCc
Confidence            467999999999984       334677899999999999999999999653211       111111111 1122 245


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHHHHhccccccC
Q 004959          572 LSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNS  606 (721)
Q Consensus       572 lS~el~dLI~~cL~~DP~kRPSa~eLL~Hp~f~~~  606 (721)
                      ++.++.+||.+||+.||++||+++++++||||...
T Consensus       225 ~~~~~~~li~~~l~~~P~~Rp~~~eil~~~~~~~~  259 (279)
T cd06619         225 FSEKFVHFITQCMRKQPKERPAPENLMDHPFIVQY  259 (279)
T ss_pred             CCHHHHHHHHHHhhCChhhCCCHHHHhcCcccccc
Confidence            78899999999999999999999999999999765

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=1.7e-41  Score=358.54  Aligned_cols=258  Identities=35%  Similarity=0.606  Sum_probs=218.1

Q ss_pred             CCCCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeE
Q 004959          338 MNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKF  417 (721)
Q Consensus       338 l~~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~  417 (721)
                      ...+|++.+.||+|+||.||+|.+..+|+.||||.+....     ....+.+.+|+.+++.++|+||+++++++...+..
T Consensus        17 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~   91 (297)
T cd06656          17 PKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQ-----QPKKELIINEILVMRENKNPNIVNYLDSYLVGDEL   91 (297)
T ss_pred             hhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCc-----cchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEE
Confidence            3468999999999999999999999999999999886321     12245688999999999999999999999999999


Q ss_pred             EEEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCCc
Q 004959          418 YIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQK  497 (721)
Q Consensus       418 yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~~  497 (721)
                      |+||||+++++|.+++.+  ..+++..+..++.||+.||.|||+.||+||||||+||||+.++.++|+|||++.......
T Consensus        92 ~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~  169 (297)
T cd06656          92 WVVMEYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ  169 (297)
T ss_pred             EEeecccCCCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccceEccCCc
Confidence            999999999999999865  468999999999999999999999999999999999999999999999999998664433


Q ss_pred             c-cccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhc---CCCCCCCCC
Q 004959          498 A-DLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRD---TPAIPDSLS  573 (721)
Q Consensus       498 ~-~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~---~~~~p~~lS  573 (721)
                      . .....|++.|+|||.+.       ...++.++|||||||++|+|++|+.||...+.......+...   ....+..++
T Consensus       170 ~~~~~~~~~~~y~aPE~~~-------~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (297)
T cd06656         170 SKRSTMVGTPYWMAPEVVT-------RKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLS  242 (297)
T ss_pred             cCcCcccCCccccCHHHHc-------CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccCCCCCCCCccccC
Confidence            2 22356899999999984       345667899999999999999999999765543333322221   112456688


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHHhccccccCCCC
Q 004959          574 PEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQP  609 (721)
Q Consensus       574 ~el~dLI~~cL~~DP~kRPSa~eLL~Hp~f~~~~~~  609 (721)
                      ..+++||.+||+.||++||++.++++||||......
T Consensus       243 ~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~  278 (297)
T cd06656         243 AVFRDFLNRCLEMDVDRRGSAKELLQHPFLKLAKPL  278 (297)
T ss_pred             HHHHHHHHHHccCChhhCcCHHHHhcCchhcccccc
Confidence            999999999999999999999999999999876543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=3.1e-41  Score=357.04  Aligned_cols=258  Identities=26%  Similarity=0.452  Sum_probs=216.9

Q ss_pred             CCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeEEE
Q 004959          340 SQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYI  419 (721)
Q Consensus       340 ~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~yL  419 (721)
                      ++|++.+.||+|+||.||+|.+..+++.||||.+...  ........+.+.+|+.+++.++||||+++++.+...+.+|+
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~--~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~l   78 (305)
T cd05609           1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQ--NLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCM   78 (305)
T ss_pred             CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehh--hhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEE
Confidence            3689999999999999999999999999999987632  11223445678899999999999999999999999999999


Q ss_pred             EEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCC---
Q 004959          420 YLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQ---  496 (721)
Q Consensus       420 VmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~---  496 (721)
                      ||||+.|++|.+++... +.+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.....   
T Consensus        79 v~e~~~g~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~  157 (305)
T cd05609          79 VMEYVEGGDCATLLKNI-GALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTT  157 (305)
T ss_pred             EEecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCccccCcCccc
Confidence            99999999999999765 67999999999999999999999999999999999999999999999999998632100   


Q ss_pred             -------------cccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhh
Q 004959          497 -------------KADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMR  563 (721)
Q Consensus       497 -------------~~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~  563 (721)
                                   .......|+..|+|||.+.       ...++.++|||||||++|||++|..||.+....+....+..
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-------~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~  230 (305)
T cd05609         158 NLYEGHIEKDTREFLDKQVCGTPEYIAPEVIL-------RQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVIS  230 (305)
T ss_pred             cccccccccchhhccccCCccCccccCchhcc-------CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Confidence                         0111245788999999984       24467789999999999999999999987666665655554


Q ss_pred             cCCCC---CCCCCHHHHHHHHHhcccCCCCCCC---HHHHHhccccccCC
Q 004959          564 DTPAI---PDSLSPEGKDFLRCCFQRNPADRPP---ASLLLEHRFLKNSQ  607 (721)
Q Consensus       564 ~~~~~---p~~lS~el~dLI~~cL~~DP~kRPS---a~eLL~Hp~f~~~~  607 (721)
                      .....   ...++.++.+||++||+.||++||+   +.++|+||||....
T Consensus       231 ~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~~~  280 (305)
T cd05609         231 DDIEWPEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLGLD  280 (305)
T ss_pred             cccCCCCccccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccCCC
Confidence            43222   2367899999999999999999998   79999999997643

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-42  Score=379.44  Aligned_cols=243  Identities=28%  Similarity=0.513  Sum_probs=210.3

Q ss_pred             eeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeEEEEE
Q 004959          342 WQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYIYL  421 (721)
Q Consensus       342 y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~yLVm  421 (721)
                      +++++.||+|-||.||+|.... ...||+|.+.-..      ...+.|.+|+++|++|+|+|||++++++..++.+||||
T Consensus       208 l~l~~~LG~G~FG~V~~g~~~~-~~~vavk~ik~~~------m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVt  280 (468)
T KOG0197|consen  208 LKLIRELGSGQFGEVWLGKWNG-STKVAVKTIKEGS------MSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVT  280 (468)
T ss_pred             HHHHHHhcCCccceEEEEEEcC-CCcccceEEeccc------cChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEE
Confidence            4557889999999999999874 3489999886321      12356779999999999999999999999988999999


Q ss_pred             eeccCCCHHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCCcccc
Q 004959          422 EYVHPGSINKYVRE-HCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADL  500 (721)
Q Consensus       422 Ey~~gGsL~~~L~~-~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~~~~~  500 (721)
                      |||..|+|.++|+. .+..+...+...|+.||++||+||+++++|||||.+.||||++++.+||+|||||+.+.++....
T Consensus       281 E~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~  360 (468)
T KOG0197|consen  281 EYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTA  360 (468)
T ss_pred             EecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCceEEEcccccccccCCCceee
Confidence            99999999999987 46789999999999999999999999999999999999999999999999999999554433322


Q ss_pred             cC--CCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhh-CCCCCCchhhHHHHHHHhhcC-CCCCCCCCHHH
Q 004959          501 SM--KGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFKVMRDT-PAIPDSLSPEG  576 (721)
Q Consensus       501 s~--~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLt-G~~PF~~~~~~~~~~ki~~~~-~~~p~~lS~el  576 (721)
                      ..  .--..|.|||.+.       ...++.++|||||||+||||+| |+.||.+....+.+..+.++. ...|..+++++
T Consensus       361 ~~~~kfPIkWtAPEa~~-------~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~GyRlp~P~~CP~~v  433 (468)
T KOG0197|consen  361 SEGGKFPIKWTAPEALN-------YGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGYRLPRPEGCPDEV  433 (468)
T ss_pred             cCCCCCCceecCHHHHh-------hCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCcCCCCCCCCHHH
Confidence            21  1234599999994       4567888999999999999999 999999999999888887764 45678999999


Q ss_pred             HHHHHHhcccCCCCCCCHHHHH
Q 004959          577 KDFLRCCFQRNPADRPPASLLL  598 (721)
Q Consensus       577 ~dLI~~cL~~DP~kRPSa~eLL  598 (721)
                      .++|+.||..+|++|||++.+.
T Consensus       434 Y~lM~~CW~~~P~~RPtF~~L~  455 (468)
T KOG0197|consen  434 YELMKSCWHEDPEDRPTFETLR  455 (468)
T ss_pred             HHHHHHHhhCCcccCCCHHHHH
Confidence            9999999999999999999775

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=2.4e-41  Score=349.97  Aligned_cols=257  Identities=48%  Similarity=0.854  Sum_probs=214.6

Q ss_pred             CeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCC-----cccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecC
Q 004959          341 QWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDD-----PKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVED  415 (721)
Q Consensus       341 ~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~-----~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~  415 (721)
                      +|.+.+.||.|+||.||+|.+..+|+.||||.+......     .......+.+.+|+.+++.++|+||+++++++...+
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   81 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE   81 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence            589999999999999999999999999999988532111     112234567889999999999999999999999999


Q ss_pred             eEEEEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCC
Q 004959          416 KFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTG  495 (721)
Q Consensus       416 ~~yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~  495 (721)
                      .+++||||+.+++|.+++... +.+++..++.++.||+.||.|||++|++||||+|+||+++.++.++|+|||++.....
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~  160 (272)
T cd06629          82 YLSIFLEYVPGGSIGSCLRTY-GRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSDD  160 (272)
T ss_pred             ceEEEEecCCCCcHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEeeccccccccc
Confidence            999999999999999999775 6799999999999999999999999999999999999999999999999999976542


Q ss_pred             Cc---ccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhc--CCCCC-
Q 004959          496 QK---ADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRD--TPAIP-  569 (721)
Q Consensus       496 ~~---~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~--~~~~p-  569 (721)
                      ..   ......|+..|+|||++..     ....++.++|+|||||++|+|++|..||......+.+.++...  ...++ 
T Consensus       161 ~~~~~~~~~~~~~~~y~~PE~~~~-----~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  235 (272)
T cd06629         161 IYDNDQNMSMQGSVFWMAPEVIHS-----YSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPP  235 (272)
T ss_pred             cccccccccccCCccccCHHHhcc-----ccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCCcCCc
Confidence            21   1234568999999999853     1124677899999999999999999999765555444443222  12222 


Q ss_pred             ---CCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccc
Q 004959          570 ---DSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFL  603 (721)
Q Consensus       570 ---~~lS~el~dLI~~cL~~DP~kRPSa~eLL~Hp~f  603 (721)
                         ..++.++.+||.+||..||++||+++++|+||||
T Consensus       236 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~  272 (272)
T cd06629         236 DVSMNLSPVALDFLNACFTINPDNRPTARELLQHPFI  272 (272)
T ss_pred             cccccCCHHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence               3468999999999999999999999999999996

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=2.5e-41  Score=357.42  Aligned_cols=254  Identities=35%  Similarity=0.635  Sum_probs=218.0

Q ss_pred             CCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeEEE
Q 004959          340 SQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYI  419 (721)
Q Consensus       340 ~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~yL  419 (721)
                      ..|++.+.||.|+||.||+|.+..+|+.||||.+....     ....+.+.+|+.+++.++|+||+++++++...+.+|+
T Consensus        19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~-----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l   93 (296)
T cd06655          19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQK-----QPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFV   93 (296)
T ss_pred             ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEeccc-----CchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEE
Confidence            57999999999999999999999999999999886321     1234678899999999999999999999999999999


Q ss_pred             EEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCCcc-
Q 004959          420 YLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKA-  498 (721)
Q Consensus       420 VmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~~~-  498 (721)
                      ||||+.+++|..++..  ..+++.++..++.||+.||+|||++|++||||||+||+++.++.+||+|||++..+..... 
T Consensus        94 v~e~~~~~~L~~~~~~--~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~  171 (296)
T cd06655          94 VMEYLAGGSLTDVVTE--TCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSK  171 (296)
T ss_pred             EEEecCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccchhccccccc
Confidence            9999999999998865  4689999999999999999999999999999999999999999999999999886654332 


Q ss_pred             cccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhc---CCCCCCCCCHH
Q 004959          499 DLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRD---TPAIPDSLSPE  575 (721)
Q Consensus       499 ~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~---~~~~p~~lS~e  575 (721)
                      .....|+..|+|||.+.       ...++.++|||||||++|+|++|+.||........+..+...   ....+..++.+
T Consensus       172 ~~~~~~~~~y~aPE~~~-------~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (296)
T cd06655         172 RSTMVGTPYWMAPEVVT-------RKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSPI  244 (296)
T ss_pred             CCCcCCCccccCcchhc-------CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCcccCCcccCCHH
Confidence            23356899999999984       344667899999999999999999999876655544444332   12345678999


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHHhccccccCC
Q 004959          576 GKDFLRCCFQRNPADRPPASLLLEHRFLKNSQ  607 (721)
Q Consensus       576 l~dLI~~cL~~DP~kRPSa~eLL~Hp~f~~~~  607 (721)
                      +.+||++||..||++||++.+++.||||....
T Consensus       245 ~~~li~~~l~~dp~~Rpt~~~il~~~~~~~~~  276 (296)
T cd06655         245 FRDFLNRCLEMDVEKRGSAKELLQHPFLKLAK  276 (296)
T ss_pred             HHHHHHHHhhcChhhCCCHHHHhhChHhhhcc
Confidence            99999999999999999999999999998644

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=2.1e-41  Score=352.85  Aligned_cols=258  Identities=35%  Similarity=0.643  Sum_probs=212.1

Q ss_pred             CCCCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhC-CCCCeeeeeeeEE----
Q 004959          338 MNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHL-KHPNIVQYYGSEI----  412 (721)
Q Consensus       338 l~~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L-~HPnIV~l~g~~~----  412 (721)
                      ..++|++.+.||+|+||.||+|.+..+|+.||+|++...      ......+.+|+.+++.+ +|+||+++++++.    
T Consensus        16 ~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~------~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~   89 (286)
T cd06638          16 PSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPI------HDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDV   89 (286)
T ss_pred             cccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccc------cchHHHHHHHHHHHHHHhcCCCeeeeeeeeeeccc
Confidence            456899999999999999999999999999999987521      11234677899999999 6999999999874    


Q ss_pred             -ecCeEEEEEeeccCCCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecC
Q 004959          413 -VEDKFYIYLEYVHPGSINKYVRE---HCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFG  488 (721)
Q Consensus       413 -~~~~~yLVmEy~~gGsL~~~L~~---~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFG  488 (721)
                       ..+.+|+||||++|++|.+++..   ....+++..++.++.||+.||.|||+++|+||||||+||+++.++.+||+|||
T Consensus        90 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~kl~dfg  169 (286)
T cd06638          90 KNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFG  169 (286)
T ss_pred             CCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCEEEccCC
Confidence             34578999999999999998753   23568999999999999999999999999999999999999999999999999


Q ss_pred             CccccCCCc-ccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhcC--
Q 004959          489 MAKHLTGQK-ADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDT--  565 (721)
Q Consensus       489 lA~~l~~~~-~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~~--  565 (721)
                      ++..+.... ......|++.|+|||++.....  ....++.++|||||||++|+|++|+.||........+.++....  
T Consensus       170 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~--~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~~  247 (286)
T cd06638         170 VSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQ--LDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRNPPP  247 (286)
T ss_pred             ceeecccCCCccccccCCCcccChhhhchhhh--ccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhccccCCC
Confidence            998764332 2234569999999999854221  12346778999999999999999999998765544444433221  


Q ss_pred             -CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccc
Q 004959          566 -PAIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFL  603 (721)
Q Consensus       566 -~~~p~~lS~el~dLI~~cL~~DP~kRPSa~eLL~Hp~f  603 (721)
                       ...+..++.++.+||.+||+.||++||++.|+++|+||
T Consensus       248 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~  286 (286)
T cd06638         248 TLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI  286 (286)
T ss_pred             cccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence             12345578899999999999999999999999999997

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.5e-43  Score=385.02  Aligned_cols=260  Identities=35%  Similarity=0.654  Sum_probs=230.7

Q ss_pred             CeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeEEEE
Q 004959          341 QWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYIY  420 (721)
Q Consensus       341 ~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~yLV  420 (721)
                      -|.-++.||.|+||.||.|++..+.+.||||++....  ....+.+..|..|+.+|+++.|||+|.+.|+|..+...|||
T Consensus        27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySG--KQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLV  104 (948)
T KOG0577|consen   27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSG--KQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLV  104 (948)
T ss_pred             HHHHHHHhcCCccceeEEeeccCccceeeeeeccccc--cccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHH
Confidence            4777899999999999999999999999999987543  34456688999999999999999999999999999999999


Q ss_pred             EeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCCcccc
Q 004959          421 LEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADL  500 (721)
Q Consensus       421 mEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~~~~~  500 (721)
                      ||||- |+-.+++.-++.++-|-++..|+.+.+.||.|||+.+.||||||..|||+++.|.|||+|||.|.....   ..
T Consensus       105 MEYCl-GSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P---An  180 (948)
T KOG0577|consen  105 MEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGSASIMAP---AN  180 (948)
T ss_pred             HHHHh-ccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeeccccchhhcCc---hh
Confidence            99996 788888877778999999999999999999999999999999999999999999999999999986543   35


Q ss_pred             cCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhcC-CCCC-CCCCHHHHH
Q 004959          501 SMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDT-PAIP-DSLSPEGKD  578 (721)
Q Consensus       501 s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~~-~~~p-~~lS~el~d  578 (721)
                      +++|||+|||||++...    ..+.|+-++||||||++..||...++|+-..+....++.|-+.. +.+. ..+|+.++.
T Consensus       181 sFvGTPywMAPEVILAM----DEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNesPtLqs~eWS~~F~~  256 (948)
T KOG0577|consen  181 SFVGTPYWMAPEVILAM----DEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRN  256 (948)
T ss_pred             cccCCccccchhHheec----cccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCCCCCCCchhHHHHHH
Confidence            78999999999999654    34567778999999999999999999998888888888887654 3343 458999999


Q ss_pred             HHHHhcccCCCCCCCHHHHHhccccccCCCCC
Q 004959          579 FLRCCFQRNPADRPPASLLLEHRFLKNSQQPD  610 (721)
Q Consensus       579 LI~~cL~~DP~kRPSa~eLL~Hp~f~~~~~~~  610 (721)
                      |+..||++-|.+|||.++||.|+|+.-...+.
T Consensus       257 Fvd~CLqKipqeRptse~ll~H~fv~R~Rp~t  288 (948)
T KOG0577|consen  257 FVDSCLQKIPQERPTSEELLKHRFVLRERPPT  288 (948)
T ss_pred             HHHHHHhhCcccCCcHHHHhhcchhccCCCch
Confidence            99999999999999999999999998665443

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=4.7e-41  Score=347.49  Aligned_cols=249  Identities=43%  Similarity=0.739  Sum_probs=209.6

Q ss_pred             eeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeEEEEEeec
Q 004959          345 GKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYIYLEYV  424 (721)
Q Consensus       345 ~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~yLVmEy~  424 (721)
                      ...||+|+||.||+|.+..++..||+|.+..     ......+.+.+|+.++++++|+||+++++++...+..++||||+
T Consensus        13 ~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~-----~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   87 (268)
T cd06624          13 RVVLGKGTYGIVYAARDLSTQVRIAIKEIPE-----RDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQV   87 (268)
T ss_pred             eEEEecCCceEEEEeEecCCCcEEEEEEecC-----CCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEecC
Confidence            3589999999999999999999999998753     23345678899999999999999999999999999999999999


Q ss_pred             cCCCHHHHHHHhcCCC--CHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcC-CCceEEeecCCccccCCCcc-cc
Q 004959          425 HPGSINKYVREHCGAI--TESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDA-SGVVKLADFGMAKHLTGQKA-DL  500 (721)
Q Consensus       425 ~gGsL~~~L~~~~~~L--se~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~-~g~VKL~DFGlA~~l~~~~~-~~  500 (721)
                      .+++|.+++......+  ++..+..++.||+.||.|||++||+||||||+||+++. ++.+||+|||++..+..... ..
T Consensus        88 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~  167 (268)
T cd06624          88 PGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTE  167 (268)
T ss_pred             CCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheecccCCCccc
Confidence            9999999998654556  88899999999999999999999999999999999976 67999999999976643322 22


Q ss_pred             cCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHH-HHHH--HhhcCCCCCCCCCHHHH
Q 004959          501 SMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAA-AMFK--VMRDTPAIPDSLSPEGK  577 (721)
Q Consensus       501 s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~-~~~k--i~~~~~~~p~~lS~el~  577 (721)
                      ...|++.|+|||++..     ....++.++|||||||++|+|++|+.||....... ....  .....+.++..++++++
T Consensus       168 ~~~~~~~~~aPE~~~~-----~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (268)
T cd06624         168 TFTGTLQYMAPEVIDK-----GPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPESLSAEAK  242 (268)
T ss_pred             cCCCCccccChhhhcc-----ccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhhccCCCCCcccCHHHH
Confidence            3468999999999843     22345678999999999999999999997643222 1211  22334567778999999


Q ss_pred             HHHHHhcccCCCCCCCHHHHHhcccc
Q 004959          578 DFLRCCFQRNPADRPPASLLLEHRFL  603 (721)
Q Consensus       578 dLI~~cL~~DP~kRPSa~eLL~Hp~f  603 (721)
                      +||++||+.+|++||++.|+++||||
T Consensus       243 ~li~~~l~~~p~~Rpt~~~ll~~~~~  268 (268)
T cd06624         243 NFILRCFEPDPDKRASAHDLLQDPFL  268 (268)
T ss_pred             HHHHHHcCCCchhCCCHHHHHhCCCC
Confidence            99999999999999999999999997

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5.2e-44  Score=419.15  Aligned_cols=262  Identities=45%  Similarity=0.803  Sum_probs=228.1

Q ss_pred             CCCCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeE
Q 004959          338 MNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKF  417 (721)
Q Consensus       338 l~~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~  417 (721)
                      +.-+|+.+..||.|.||.||-|.+..+|+..|+|.+.+-..+   ....+.+.+|+.+|..|+|||||++||+..+.+..
T Consensus      1233 V~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~---~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv 1309 (1509)
T KOG4645|consen 1233 VTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSD---HKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKV 1309 (1509)
T ss_pred             ceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccc---cccCcchHHHHHHHHhccCccccccCceeecHHHH
Confidence            345799999999999999999999999999999998764333   44567889999999999999999999999999999


Q ss_pred             EEEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCCc
Q 004959          418 YIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQK  497 (721)
Q Consensus       418 yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~~  497 (721)
                      ||.||||+||+|.++++. ++...|...+.|..|++.||.|||+.|||||||||+|||++.+|.||++|||.|..+.+..
T Consensus      1310 ~IFMEyC~~GsLa~ll~~-gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~ 1388 (1509)
T KOG4645|consen 1310 YIFMEYCEGGSLASLLEH-GRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNA 1388 (1509)
T ss_pred             HHHHHHhccCcHHHHHHh-cchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeEecCch
Confidence            999999999999999965 4667888899999999999999999999999999999999999999999999999886653


Q ss_pred             c-----cccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHH-HHHHHh-hcCCCCCC
Q 004959          498 A-----DLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAA-AMFKVM-RDTPAIPD  570 (721)
Q Consensus       498 ~-----~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~-~~~ki~-~~~~~~p~  570 (721)
                      .     ...+.||+.|||||++.+....++    ..++|||||||++.||+||+.||...+..- .++++- ...+.+|.
T Consensus      1389 ~~~~~el~~~~GT~~YMAPEvit~t~~kG~----~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~Pq~P~ 1464 (1509)
T KOG4645|consen 1389 QTMPGELQSMMGTPMYMAPEVITGTKGKGH----GGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHKPQIPE 1464 (1509)
T ss_pred             hcCCHHHHhhcCCchhcCchhhcccccCCC----CcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCCCCCch
Confidence            2     235779999999999987543333    347899999999999999999998866544 344443 34678999


Q ss_pred             CCCHHHHHHHHHhcccCCCCCCCHHHHHhccccccCC
Q 004959          571 SLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQ  607 (721)
Q Consensus       571 ~lS~el~dLI~~cL~~DP~kRPSa~eLL~Hp~f~~~~  607 (721)
                      .+|.+.++||.+||+.||++|+++.||++|.|-+...
T Consensus      1465 ~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~f~~~~~ 1501 (1509)
T KOG4645|consen 1465 RLSSEGRDFLEHCLEQDPKMRWTASQLLEHAFGKSCT 1501 (1509)
T ss_pred             hhhHhHHHHHHHHHhcCchhhhHHHHHHHhhcccccc
Confidence            9999999999999999999999999999999876543

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=3.7e-41  Score=349.29  Aligned_cols=249  Identities=21%  Similarity=0.376  Sum_probs=209.2

Q ss_pred             CCeeEeeEEeecCCeEEEEEEEC---CCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCe
Q 004959          340 SQWQKGKLIGRGTFGSVYVASNR---ETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDK  416 (721)
Q Consensus       340 ~~y~~~k~LG~G~fG~VY~a~~~---~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~  416 (721)
                      .+|++.+.||+|+||.||+|.++   ..+..||+|.+...    ........+.+|+.+|++++||||+++++++...+.
T Consensus         5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~----~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~   80 (266)
T cd05064           5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAG----CSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNT   80 (266)
T ss_pred             HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCC----CCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCC
Confidence            47999999999999999999765   45678999987532    223445678999999999999999999999999999


Q ss_pred             EEEEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCC
Q 004959          417 FYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQ  496 (721)
Q Consensus       417 ~yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~  496 (721)
                      .|+||||+.+|+|.+++......+++..++.++.||+.||+|||++|++||||||+||||+.++.+||+|||.+......
T Consensus        81 ~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~  160 (266)
T cd05064          81 MMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSE  160 (266)
T ss_pred             cEEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCccccccccc
Confidence            99999999999999999876568999999999999999999999999999999999999999999999999987654322


Q ss_pred             ccc--ccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhh-CCCCCCchhhHHHHHHHhhc-CCCCCCCC
Q 004959          497 KAD--LSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFKVMRD-TPAIPDSL  572 (721)
Q Consensus       497 ~~~--~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLt-G~~PF~~~~~~~~~~ki~~~-~~~~p~~l  572 (721)
                      ...  ....++..|+|||++.+       ..++.++|||||||++|||++ |..||.+....+.+..+... ....+..+
T Consensus       161 ~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  233 (266)
T cd05064         161 AIYTTMSGKSPVLWAAPEAIQY-------HHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFRLPAPRNC  233 (266)
T ss_pred             chhcccCCCCceeecCHHHHhh-------CCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCCCCCCC
Confidence            211  12335678999999853       456778999999999999775 99999877666555554433 23456778


Q ss_pred             CHHHHHHHHHhcccCCCCCCCHHHHHh
Q 004959          573 SPEGKDFLRCCFQRNPADRPPASLLLE  599 (721)
Q Consensus       573 S~el~dLI~~cL~~DP~kRPSa~eLL~  599 (721)
                      +..+.+++.+||+.+|++||++++|++
T Consensus       234 ~~~~~~li~~c~~~~p~~RP~~~~i~~  260 (266)
T cd05064         234 PNLLHQLMLDCWQKERGERPRFSQIHS  260 (266)
T ss_pred             CHHHHHHHHHHcCCCchhCCCHHHHHH
Confidence            999999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=5.1e-41  Score=344.29  Aligned_cols=249  Identities=30%  Similarity=0.555  Sum_probs=214.9

Q ss_pred             CeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeEEEE
Q 004959          341 QWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYIY  420 (721)
Q Consensus       341 ~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~yLV  420 (721)
                      +|++.+.||+|+||.||++.+..+++.||+|.+...    ......+.+.+|+.+++.++|+||+++++.+...+.+|+|
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~----~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   76 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLP----KSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIV   76 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcC----cchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEE
Confidence            588999999999999999999999999999998642    2233467788999999999999999999999999999999


Q ss_pred             EeeccCCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCCcc-
Q 004959          421 LEYVHPGSINKYVREH-CGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKA-  498 (721)
Q Consensus       421 mEy~~gGsL~~~L~~~-~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~~~-  498 (721)
                      |||+++++|.+++... ...+++..+..++.||+.||.|||++||+|+||||+|||++.++.++|+|||++..+..... 
T Consensus        77 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~  156 (255)
T cd08219          77 MEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAY  156 (255)
T ss_pred             EeeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcceeecccccc
Confidence            9999999999988653 34689999999999999999999999999999999999999999999999999986644322 


Q ss_pred             cccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhcC-CCCCCCCCHHHH
Q 004959          499 DLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDT-PAIPDSLSPEGK  577 (721)
Q Consensus       499 ~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~~-~~~p~~lS~el~  577 (721)
                      .....|++.|+|||++.       ...++.++|||||||++|+|++|..||...+.......+.... ..++..++.++.
T Consensus       157 ~~~~~~~~~~~aPE~~~-------~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (255)
T cd08219         157 ACTYVGTPYYVPPEIWE-------NMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKPLPSHYSYELR  229 (255)
T ss_pred             cccccCCccccCHHHHc-------cCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCCCCCCCcccCHHHH
Confidence            23456899999999984       3446778999999999999999999998776665555554443 345677899999


Q ss_pred             HHHHHhcccCCCCCCCHHHHHhc
Q 004959          578 DFLRCCFQRNPADRPPASLLLEH  600 (721)
Q Consensus       578 dLI~~cL~~DP~kRPSa~eLL~H  600 (721)
                      +||.+||+.||++||++.+++.-
T Consensus       230 ~li~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         230 SLIKQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             HHHHHHHhCCcccCCCHHHHhhc
Confidence            99999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.5e-41  Score=374.30  Aligned_cols=250  Identities=22%  Similarity=0.309  Sum_probs=204.6

Q ss_pred             CCCeeEeeEEeecCCeEEEEEEEC--CCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCe
Q 004959          339 NSQWQKGKLIGRGTFGSVYVASNR--ETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDK  416 (721)
Q Consensus       339 ~~~y~~~k~LG~G~fG~VY~a~~~--~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~  416 (721)
                      ..+|++++.||+|+||.||+|...  .++..||+|.+...          +...+|+.+|+.++|||||++++++.....
T Consensus        91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~----------~~~~~E~~il~~l~h~~iv~~~~~~~~~~~  160 (392)
T PHA03207         91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG----------KTPGREIDILKTISHRAIINLIHAYRWKST  160 (392)
T ss_pred             cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc----------ccHHHHHHHHHhcCCCCccceeeeEeeCCE
Confidence            458999999999999999999754  45688999987421          234689999999999999999999999999


Q ss_pred             EEEEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCC
Q 004959          417 FYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQ  496 (721)
Q Consensus       417 ~yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~  496 (721)
                      .|+|||++. ++|.+++.. .+.+++.+++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+...
T Consensus       161 ~~lv~e~~~-~~l~~~l~~-~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~  238 (392)
T PHA03207        161 VCMVMPKYK-CDLFTYVDR-SGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAH  238 (392)
T ss_pred             EEEEehhcC-CCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCccccccCcc
Confidence            999999995 788888844 478999999999999999999999999999999999999999999999999999766543


Q ss_pred             cc---cccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhh---HHHHHHHhhc------
Q 004959          497 KA---DLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEG---AAAMFKVMRD------  564 (721)
Q Consensus       497 ~~---~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~---~~~~~ki~~~------  564 (721)
                      ..   .....||+.|+|||++.       ...++.++|||||||+||||++|+.||.+...   ...+..+...      
T Consensus       239 ~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~  311 (392)
T PHA03207        239 PDTPQCYGWSGTLETNSPELLA-------LDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPL  311 (392)
T ss_pred             cccccccccccccCccCHhHhc-------CCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCcc
Confidence            22   23467999999999984       34567789999999999999999999965321   1111111110      


Q ss_pred             -----------------------CCCCC-----CCCCHHHHHHHHHhcccCCCCCCCHHHHHhccccccCC
Q 004959          565 -----------------------TPAIP-----DSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQ  607 (721)
Q Consensus       565 -----------------------~~~~p-----~~lS~el~dLI~~cL~~DP~kRPSa~eLL~Hp~f~~~~  607 (721)
                                             ...++     ..++.++++||++||+.||++||++.|+|.||||....
T Consensus       312 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~~~  382 (392)
T PHA03207        312 EFPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTKEP  382 (392)
T ss_pred             ccCCccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhccc
Confidence                                   00111     23567899999999999999999999999999998643

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=4.8e-41  Score=351.52  Aligned_cols=253  Identities=27%  Similarity=0.523  Sum_probs=206.0

Q ss_pred             CCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeEEE
Q 004959          340 SQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYI  419 (721)
Q Consensus       340 ~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~yL  419 (721)
                      +.|++.+.||+|+||.||+|.++.+|+.||||.+.......    ....+.+|+.++++++|+||+++++++...+..|+
T Consensus         5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l   80 (291)
T cd07844           5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEG----APFTAIREASLLKDLKHANIVTLHDIIHTKKTLTL   80 (291)
T ss_pred             cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccC----CchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEE
Confidence            58999999999999999999999999999999986432211    12346689999999999999999999999999999


Q ss_pred             EEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCCc-c
Q 004959          420 YLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQK-A  498 (721)
Q Consensus       420 VmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~~-~  498 (721)
                      ||||+. ++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... .
T Consensus        81 v~e~~~-~~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~  159 (291)
T cd07844          81 VFEYLD-TDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKT  159 (291)
T ss_pred             EEecCC-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccccccccCCCCcc
Confidence            999997 59999987766678999999999999999999999999999999999999999999999999987543221 1


Q ss_pred             cccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchh-hHHHHHHHhh---cC---------
Q 004959          499 DLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYE-GAAAMFKVMR---DT---------  565 (721)
Q Consensus       499 ~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~-~~~~~~ki~~---~~---------  565 (721)
                      .....++..|+|||++.+      ...++.++|||||||++|+|++|+.||.... ..+.+..+..   ..         
T Consensus       160 ~~~~~~~~~~~aPE~~~~------~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (291)
T cd07844         160 YSNEVVTLWYRPPDVLLG------STEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVS  233 (291)
T ss_pred             ccccccccccCCcHHhhc------CcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhh
Confidence            122357889999999853      2345678999999999999999999997644 2222221111   00         


Q ss_pred             ----------C--------CCCCCCC--HHHHHHHHHhcccCCCCCCCHHHHHhcccc
Q 004959          566 ----------P--------AIPDSLS--PEGKDFLRCCFQRNPADRPPASLLLEHRFL  603 (721)
Q Consensus       566 ----------~--------~~p~~lS--~el~dLI~~cL~~DP~kRPSa~eLL~Hp~f  603 (721)
                                .        .....++  .++.++|.+||+.||++||++.|+++||||
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f  291 (291)
T cd07844         234 SNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF  291 (291)
T ss_pred             hccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence                      0        0001244  888999999999999999999999999998

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=2.3e-41  Score=352.40  Aligned_cols=257  Identities=35%  Similarity=0.639  Sum_probs=212.5

Q ss_pred             CCCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhC-CCCCeeeeeeeEEe----
Q 004959          339 NSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHL-KHPNIVQYYGSEIV----  413 (721)
Q Consensus       339 ~~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L-~HPnIV~l~g~~~~----  413 (721)
                      .+.|++.+.||+|+||.||+|.+..+++.||+|++...      ......+..|+.++.++ +|+||+++++++..    
T Consensus        15 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~------~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~   88 (282)
T cd06636          15 AGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVT------EDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPP   88 (282)
T ss_pred             hhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecC------hHHHHHHHHHHHHHHHhcCCCcEEEEeeehhccccc
Confidence            35899999999999999999999999999999987532      22345688899999998 69999999998853    


Q ss_pred             --cCeEEEEEeeccCCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCc
Q 004959          414 --EDKFYIYLEYVHPGSINKYVREH-CGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMA  490 (721)
Q Consensus       414 --~~~~yLVmEy~~gGsL~~~L~~~-~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA  490 (721)
                        .+.+|+||||+.+|+|.+++... ...+++..+..++.||+.||.|||++||+|+||||+||+|+.++.++|+|||++
T Consensus        89 ~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~l~dfg~~  168 (282)
T cd06636          89 GHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVS  168 (282)
T ss_pred             CCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCcch
Confidence              46789999999999999999764 346889999999999999999999999999999999999999999999999998


Q ss_pred             cccCCCc-ccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhcCC--C
Q 004959          491 KHLTGQK-ADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTP--A  567 (721)
Q Consensus       491 ~~l~~~~-~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~~~--~  567 (721)
                      ....... ......|++.|+|||++....  .....++.++|||||||++|||++|..||...........+.....  .
T Consensus       169 ~~~~~~~~~~~~~~~~~~y~aPE~l~~~~--~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~  246 (282)
T cd06636         169 AQLDRTVGRRNTFIGTPYWMAPEVIACDE--NPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKL  246 (282)
T ss_pred             hhhhccccCCCcccccccccCHhhcCccc--CcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhhCCCCCC
Confidence            7654322 223466899999999984311  1134567789999999999999999999977655444444333321  2


Q ss_pred             CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccc
Q 004959          568 IPDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFL  603 (721)
Q Consensus       568 ~p~~lS~el~dLI~~cL~~DP~kRPSa~eLL~Hp~f  603 (721)
                      ....++.++.+||.+||+.||.+||++.|||+||||
T Consensus       247 ~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~~  282 (282)
T cd06636         247 KSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI  282 (282)
T ss_pred             cccccCHHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence            234578999999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=1.4e-41  Score=353.72  Aligned_cols=254  Identities=31%  Similarity=0.548  Sum_probs=210.8

Q ss_pred             CCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeEEE
Q 004959          340 SQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYI  419 (721)
Q Consensus       340 ~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~yL  419 (721)
                      ++|++.+.||+|+||.||+|.+..+|+.||+|.+....   ......+.+.+|+.+|+.++||||+++++++..++..|+
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~---~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   77 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESE---DDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYL   77 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhcc---CcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEE
Confidence            36999999999999999999999999999999875321   112344567889999999999999999999999999999


Q ss_pred             EEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCCcc-
Q 004959          420 YLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKA-  498 (721)
Q Consensus       420 VmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~~~-  498 (721)
                      ||||+.++.|..++... ..+++..++.++.||+.||.|||+.||+|+||+|+||+++.++.++|+|||++..+..... 
T Consensus        78 v~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~  156 (286)
T cd07846          78 VFEFVDHTVLDDLEKYP-NGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEV  156 (286)
T ss_pred             EEecCCccHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCccc
Confidence            99999998888776543 5699999999999999999999999999999999999999999999999999987644332 


Q ss_pred             cccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhcCC------------
Q 004959          499 DLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTP------------  566 (721)
Q Consensus       499 ~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~~~------------  566 (721)
                      .....|+..|+|||++.+      ...++.++|||||||++|||++|++||......+....+.....            
T Consensus       157 ~~~~~~~~~y~aPE~~~~------~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (286)
T cd07846         157 YTDYVATRWYRAPELLVG------DTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQK  230 (286)
T ss_pred             cCcccceeeccCcHHhcc------ccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhcc
Confidence            233568899999999853      23456689999999999999999999976554443333221000            


Q ss_pred             -------------------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccc
Q 004959          567 -------------------AIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFL  603 (721)
Q Consensus       567 -------------------~~p~~lS~el~dLI~~cL~~DP~kRPSa~eLL~Hp~f  603 (721)
                                         .....++.++.+||.+||+.||++||++.++++|+||
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~  286 (286)
T cd07846         231 NPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF  286 (286)
T ss_pred             chHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence                               0123578899999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=5.7e-41  Score=351.47  Aligned_cols=258  Identities=33%  Similarity=0.640  Sum_probs=214.1

Q ss_pred             CCCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhC-CCCCeeeeeeeEEec---
Q 004959          339 NSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHL-KHPNIVQYYGSEIVE---  414 (721)
Q Consensus       339 ~~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L-~HPnIV~l~g~~~~~---  414 (721)
                      .++|++.+.||+|+||.||+|.+..+|+.+|+|++...      ......+.+|+.+++++ +||||+++++++...   
T Consensus        21 ~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~------~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~   94 (291)
T cd06639          21 TDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPI------SDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKL   94 (291)
T ss_pred             CCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEeccc------ccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEecccc
Confidence            56899999999999999999999999999999987531      11235678899999999 799999999988754   


Q ss_pred             --CeEEEEEeeccCCCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCC
Q 004959          415 --DKFYIYLEYVHPGSINKYVRE---HCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGM  489 (721)
Q Consensus       415 --~~~yLVmEy~~gGsL~~~L~~---~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGl  489 (721)
                        +..|+||||+.|++|.+++..   ....+++..++.++.||+.||+|||+.||+||||||+||+++.++.+||+|||+
T Consensus        95 ~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~kl~dfg~  174 (291)
T cd06639          95 VGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGV  174 (291)
T ss_pred             CCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEeeccc
Confidence              358999999999999998863   235789999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCCc-ccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhcCC--
Q 004959          490 AKHLTGQK-ADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTP--  566 (721)
Q Consensus       490 A~~l~~~~-~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~~~--  566 (721)
                      +..+.... ......|+..|+|||++.....  ....++.++|||||||++|+|++|+.||........+.++.....  
T Consensus       175 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~--~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~~~  252 (291)
T cd06639         175 SAQLTSTRLRRNTSVGTPFWMAPEVIACEQQ--YDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNPPPT  252 (291)
T ss_pred             chhcccccccccCccCCccccChhhhcCCCC--cccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhcCCCCC
Confidence            98754332 2234568999999999853211  112356789999999999999999999987766555555544322  


Q ss_pred             -CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhccccc
Q 004959          567 -AIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLK  604 (721)
Q Consensus       567 -~~p~~lS~el~dLI~~cL~~DP~kRPSa~eLL~Hp~f~  604 (721)
                       ..+..++.++.+||.+||+.||++||++.||++||||+
T Consensus       253 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~  291 (291)
T cd06639         253 LLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK  291 (291)
T ss_pred             CCcccccCHHHHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence             23456778999999999999999999999999999984

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.5e-41  Score=345.70  Aligned_cols=255  Identities=44%  Similarity=0.830  Sum_probs=216.4

Q ss_pred             CCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEec--CeE
Q 004959          340 SQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVE--DKF  417 (721)
Q Consensus       340 ~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~--~~~  417 (721)
                      ..|+++++||+|+||.||+|.+..+|+.||+|.+..........+..+.+.+|+.++++++|+||+++++++.+.  ..+
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL   81 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence            479999999999999999999999999999998754322223345667899999999999999999999988764  468


Q ss_pred             EEEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCCc
Q 004959          418 YIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQK  497 (721)
Q Consensus       418 yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~~  497 (721)
                      ++||||+.+++|.+++... +.+++..++.++.||+.||.|||++||+|+||||+||+++.++.++|+|||++..+....
T Consensus        82 ~~v~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~  160 (264)
T cd06653          82 SIFVEYMPGGSIKDQLKAY-GALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTIC  160 (264)
T ss_pred             EEEEEeCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcccccccccccc
Confidence            9999999999999998764 568999999999999999999999999999999999999999999999999998654311


Q ss_pred             ----ccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhc--CCCCCCC
Q 004959          498 ----ADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRD--TPAIPDS  571 (721)
Q Consensus       498 ----~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~--~~~~p~~  571 (721)
                          ......|+..|+|||++.       ...++.++|||||||++|+|++|+.||........+.++...  .+.+|..
T Consensus       161 ~~~~~~~~~~~~~~y~aPE~~~-------~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~  233 (264)
T cd06653         161 MSGTGIKSVTGTPYWMSPEVIS-------GEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLPDG  233 (264)
T ss_pred             ccCccccccCCcccccCHhhhc-------CCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHcCCCCCCCCcc
Confidence                112356899999999984       334567899999999999999999999876655555554432  3457888


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHHHHhcccc
Q 004959          572 LSPEGKDFLRCCFQRNPADRPPASLLLEHRFL  603 (721)
Q Consensus       572 lS~el~dLI~~cL~~DP~kRPSa~eLL~Hp~f  603 (721)
                      +++++.++|.+||+ ++.+||++.+++.|||+
T Consensus       234 ~~~~~~~~i~~~l~-~~~~r~~~~~~~~~~~~  264 (264)
T cd06653         234 VSDACRDFLKQIFV-EEKRRPTAEFLLRHPFV  264 (264)
T ss_pred             cCHHHHHHHHHHhc-CcccCccHHHHhcCCCC
Confidence            99999999999999 57999999999999984

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=4.2e-41  Score=354.15  Aligned_cols=243  Identities=19%  Similarity=0.272  Sum_probs=206.1

Q ss_pred             eEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEe----cCeEEEEE
Q 004959          346 KLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIV----EDKFYIYL  421 (721)
Q Consensus       346 k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~----~~~~yLVm  421 (721)
                      ..||+|++|.||+|..  +|+.||||.+...  ........+.+.+|+.+|++++|||||++++++.+    ...+++||
T Consensus        26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~--~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~  101 (283)
T PHA02988         26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKF--HKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLIL  101 (283)
T ss_pred             eEEeeCCceEEEEEEE--CCEEEEEEecccc--ccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEE
Confidence            5899999999999987  5899999988642  22333446788899999999999999999999876    35789999


Q ss_pred             eeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhC-CeeccCCCCCcEEEcCCCceEEeecCCccccCCCcccc
Q 004959          422 EYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSK-KTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADL  500 (721)
Q Consensus       422 Ey~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~-gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~~~~~  500 (721)
                      ||+.||+|.+++... ..+++.....++.||+.||.|||+. +++||||||+|||++.++.+||+|||+++.+....  .
T Consensus       102 Ey~~~g~L~~~l~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~--~  178 (283)
T PHA02988        102 EYCTRGYLREVLDKE-KDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP--F  178 (283)
T ss_pred             EeCCCCcHHHHHhhC-CCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccchHhhhcccc--c
Confidence            999999999999765 6789999999999999999999984 99999999999999999999999999998654322  3


Q ss_pred             cCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhc--CCCCCCCCCHHHHH
Q 004959          501 SMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRD--TPAIPDSLSPEGKD  578 (721)
Q Consensus       501 s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~--~~~~p~~lS~el~d  578 (721)
                      ...|+..|+|||++.+     ....++.++|||||||++|||++|+.||.+....+....+...  ...++..++.++++
T Consensus       179 ~~~~~~~y~aPE~~~~-----~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~  253 (283)
T PHA02988        179 KNVNFMVYFSYKMLND-----IFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLKLPLDCPLEIKC  253 (283)
T ss_pred             cccCcccccCHHHhhh-----ccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCCcCcHHHHH
Confidence            4568999999999854     1245778999999999999999999999987666666555433  33455568999999


Q ss_pred             HHHHhcccCCCCCCCHHHHHhc
Q 004959          579 FLRCCFQRNPADRPPASLLLEH  600 (721)
Q Consensus       579 LI~~cL~~DP~kRPSa~eLL~H  600 (721)
                      ||.+||+.||++|||+.|+++.
T Consensus       254 li~~cl~~dp~~Rps~~ell~~  275 (283)
T PHA02988        254 IVEACTSHDSIKRPNIKEILYN  275 (283)
T ss_pred             HHHHHhcCCcccCcCHHHHHHH
Confidence            9999999999999999999863

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=3.6e-41  Score=362.57  Aligned_cols=263  Identities=27%  Similarity=0.457  Sum_probs=213.5

Q ss_pred             CCCCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEec---
Q 004959          338 MNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVE---  414 (721)
Q Consensus       338 l~~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~---  414 (721)
                      +..+|++.+.||+|+||.||+|.+..+|+.||||.+....   ........+.+|+.+++.++|+||+++++++...   
T Consensus         3 ~~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~   79 (337)
T cd07858           3 VDTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAF---DNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHRE   79 (337)
T ss_pred             cccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccc---cccchhHHHHHHHHHHHhcCCCCccchHHheeccccc
Confidence            4568999999999999999999999999999999875321   1222345677899999999999999999987654   


Q ss_pred             --CeEEEEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccc
Q 004959          415 --DKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKH  492 (721)
Q Consensus       415 --~~~yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~  492 (721)
                        ...|+||||+. ++|.+++... +.+++..+..++.||+.||.|||++|++||||||+|||++.++.+||+|||++..
T Consensus        80 ~~~~~~lv~e~~~-~~L~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~  157 (337)
T cd07858          80 AFNDVYIVYELMD-TDLHQIIRSS-QTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLART  157 (337)
T ss_pred             ccCcEEEEEeCCC-CCHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCccccc
Confidence              35899999995 7898888754 6799999999999999999999999999999999999999999999999999987


Q ss_pred             cCCC-cccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHh---------
Q 004959          493 LTGQ-KADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVM---------  562 (721)
Q Consensus       493 l~~~-~~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~---------  562 (721)
                      .... .......|+..|+|||.+..      ...++.++|||||||++|+|++|+.||.+.+.......+.         
T Consensus       158 ~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  231 (337)
T cd07858         158 TSEKGDFMTEYVVTRWYRAPELLLN------CSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEE  231 (337)
T ss_pred             cCCCcccccccccccCccChHHHhc------CCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChH
Confidence            6443 22234568999999999853      1236678999999999999999999997654322221111         


Q ss_pred             --------------hcC--------CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhccccccCCCCCC
Q 004959          563 --------------RDT--------PAIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQPDV  611 (721)
Q Consensus       563 --------------~~~--------~~~p~~lS~el~dLI~~cL~~DP~kRPSa~eLL~Hp~f~~~~~~~~  611 (721)
                                    ...        ......++.++.+||++||+.||++||+++++++||||.....+..
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~~~~~  302 (337)
T cd07858         232 DLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHDPSD  302 (337)
T ss_pred             HhhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhcCccc
Confidence                          000        0112457899999999999999999999999999999987665543

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=2.6e-41  Score=351.51  Aligned_cols=254  Identities=29%  Similarity=0.563  Sum_probs=211.7

Q ss_pred             CCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeEEE
Q 004959          340 SQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYI  419 (721)
Q Consensus       340 ~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~yL  419 (721)
                      ++|++.+.||+|+||.||+|.+..+++.||||.+....   ......+.+.+|+++|++++|+||+++++++...+..|+
T Consensus         1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~---~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~i   77 (288)
T cd07833           1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESE---DDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYL   77 (288)
T ss_pred             CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhc---ccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEE
Confidence            36999999999999999999999999999999875321   122345678999999999999999999999999999999


Q ss_pred             EEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCCc--
Q 004959          420 YLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQK--  497 (721)
Q Consensus       420 VmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~~--  497 (721)
                      ||||+.++.|..++.. ...+++..+..++.||+.||.|||++||+|+||+|+||+++.++.+||+|||++..+....  
T Consensus        78 v~e~~~~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~  156 (288)
T cd07833          78 VFEYVERTLLELLEAS-PGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPAS  156 (288)
T ss_pred             EEecCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCccc
Confidence            9999998666655544 4669999999999999999999999999999999999999999999999999998765543  


Q ss_pred             ccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhcC------------
Q 004959          498 ADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDT------------  565 (721)
Q Consensus       498 ~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~~------------  565 (721)
                      ......++..|+|||++.+      ...++.++|||||||++|+|++|+.||.+....+.+..+....            
T Consensus       157 ~~~~~~~~~~~~~PE~~~~------~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (288)
T cd07833         157 PLTDYVATRWYRAPELLVG------DTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFS  230 (288)
T ss_pred             cccCcccccCCcCCchhcC------CCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcc
Confidence            2234678999999999853      1256778999999999999999999998655444333321100            


Q ss_pred             --------------------CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccc
Q 004959          566 --------------------PAIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFL  603 (721)
Q Consensus       566 --------------------~~~p~~lS~el~dLI~~cL~~DP~kRPSa~eLL~Hp~f  603 (721)
                                          ..++..++.++.+||++||..||++||+++++++|+||
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f  288 (288)
T cd07833         231 SNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF  288 (288)
T ss_pred             cCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence                                01233458999999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.5e-43  Score=374.22  Aligned_cols=261  Identities=25%  Similarity=0.416  Sum_probs=230.7

Q ss_pred             CCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeEEE
Q 004959          340 SQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYI  419 (721)
Q Consensus       340 ~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~yL  419 (721)
                      +.|..-++||+|+||.||.|+.+.||+.||+|++.+.  ..+........++|-.||.+++.+.||.+--.|++.+.++|
T Consensus       185 n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KK--RiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LCl  262 (591)
T KOG0986|consen  185 NTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKK--RIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCL  262 (591)
T ss_pred             cceeeeEEEecccccceeEEEEecchhhHHHHHHHHH--HHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEE
Confidence            5688899999999999999999999999999988643  23333445567889999999999999999999999999999


Q ss_pred             EEeeccCCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCCcc
Q 004959          420 YLEYVHPGSINKYVREHC-GAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKA  498 (721)
Q Consensus       420 VmEy~~gGsL~~~L~~~~-~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~~~  498 (721)
                      ||..|.||+|.-.|-+.+ ..|+|+.++.|+.+|+.||++||..+||+|||||+|||+|+.|+|+|+|+|||..+..+..
T Consensus       263 VLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g~~  342 (591)
T KOG0986|consen  263 VLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLGLAVEIPEGKP  342 (591)
T ss_pred             EEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeeccceEEecCCCCc
Confidence            999999999987776653 4799999999999999999999999999999999999999999999999999999998888


Q ss_pred             cccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchh----hHHHHHHHhhcCCCCCCCCCH
Q 004959          499 DLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYE----GAAAMFKVMRDTPAIPDSLSP  574 (721)
Q Consensus       499 ~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~----~~~~~~ki~~~~~~~p~~lS~  574 (721)
                      ....+||..|||||++.       ...|+...|.|+|||+||||+.|+.||....    ..+.-..++.+...+++.+|+
T Consensus       343 ~~~rvGT~GYMAPEvl~-------ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~~~ey~~kFS~  415 (591)
T KOG0986|consen  343 IRGRVGTVGYMAPEVLQ-------NEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLEDPEEYSDKFSE  415 (591)
T ss_pred             cccccCcccccCHHHHc-------CCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcchhhcccccCH
Confidence            88889999999999995       3457888999999999999999999996532    334555667777889999999


Q ss_pred             HHHHHHHHhcccCCCCCC-----CHHHHHhccccccCCCC
Q 004959          575 EGKDFLRCCFQRNPADRP-----PASLLLEHRFLKNSQQP  609 (721)
Q Consensus       575 el~dLI~~cL~~DP~kRP-----Sa~eLL~Hp~f~~~~~~  609 (721)
                      ++++|.+.+|++||++|.     .++++-+||||++....
T Consensus       416 eakslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~lnw~  455 (591)
T KOG0986|consen  416 EAKSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKDLNWR  455 (591)
T ss_pred             HHHHHHHHHHccCHHHhccCCCcCcchhhhCcccccCCHh
Confidence            999999999999999997     56799999999986543

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=9.9e-41  Score=338.10  Aligned_cols=252  Identities=54%  Similarity=0.988  Sum_probs=219.1

Q ss_pred             CeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEec--CeEE
Q 004959          341 QWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVE--DKFY  418 (721)
Q Consensus       341 ~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~--~~~y  418 (721)
                      +|++.+.||+|+||.||+|.+..+++.|++|++....   ......+.+.+|+.++++++|+||+++++.+...  +.++
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~   77 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSG---DSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLN   77 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccc---cchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEE
Confidence            4888999999999999999999999999999986432   1245678899999999999999999999999888  8999


Q ss_pred             EEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCCcc
Q 004959          419 IYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKA  498 (721)
Q Consensus       419 LVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~~~  498 (721)
                      +||||+.+++|.+++... ..+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++........
T Consensus        78 lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~  156 (260)
T cd06606          78 IFLEYVSGGSLSSLLKKF-GKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIET  156 (260)
T ss_pred             EEEEecCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEecccccc
Confidence            999999999999999775 4899999999999999999999999999999999999999999999999999987765543


Q ss_pred             ---cccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchh-hHHHHHHHh--hcCCCCCCCC
Q 004959          499 ---DLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYE-GAAAMFKVM--RDTPAIPDSL  572 (721)
Q Consensus       499 ---~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~-~~~~~~ki~--~~~~~~p~~l  572 (721)
                         .....++..|++||.+.+       ...+.++|||||||++|+|++|..||.... .......+.  .....++..+
T Consensus       157 ~~~~~~~~~~~~y~~pE~~~~-------~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (260)
T cd06606         157 GEGTGSVRGTPYWMAPEVIRG-------EEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHL  229 (260)
T ss_pred             cccccCCCCCccccCHhhhcC-------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccccCCCcCCCccc
Confidence               344668999999999843       336778999999999999999999998765 233333333  2445677788


Q ss_pred             CHHHHHHHHHhcccCCCCCCCHHHHHhcccc
Q 004959          573 SPEGKDFLRCCFQRNPADRPPASLLLEHRFL  603 (721)
Q Consensus       573 S~el~dLI~~cL~~DP~kRPSa~eLL~Hp~f  603 (721)
                      +.++++||.+||+.||++||++.++++||||
T Consensus       230 ~~~l~~~i~~~l~~~p~~Rp~~~~ll~~~~~  260 (260)
T cd06606         230 SEEAKDFLRKCLRRDPKKRPTADELLQHPFL  260 (260)
T ss_pred             CHHHHHHHHHhCcCChhhCCCHHHHhhCCCC
Confidence            9999999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=6.2e-41  Score=354.19  Aligned_cols=249  Identities=27%  Similarity=0.413  Sum_probs=202.1

Q ss_pred             CCeeEeeEEeecCCeEEEEEEECC----------------CCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCC
Q 004959          340 SQWQKGKLIGRGTFGSVYVASNRE----------------TGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPN  403 (721)
Q Consensus       340 ~~y~~~k~LG~G~fG~VY~a~~~~----------------tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPn  403 (721)
                      ++|++.+.||+|+||.||+|.+..                ++..||+|++...    ........+.+|+.+|.+++|||
T Consensus         5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~~~E~~~l~~l~h~n   80 (304)
T cd05096           5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPD----ANKNARNDFLKEVKILSRLKDPN   80 (304)
T ss_pred             hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCC----CCHHHHHHHHHHHHHHhhcCCCC
Confidence            579999999999999999997532                3457999987531    23345677899999999999999


Q ss_pred             eeeeeeeEEecCeEEEEEeeccCCCHHHHHHHhc------------------CCCCHHHHHHHHHHHHHHHHHHhhCCee
Q 004959          404 IVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHC------------------GAITESVVRNFTRHILSGLAYLHSKKTI  465 (721)
Q Consensus       404 IV~l~g~~~~~~~~yLVmEy~~gGsL~~~L~~~~------------------~~Lse~~i~~i~~QIl~AL~yLHs~gII  465 (721)
                      |+++++++...+..|+||||+.+|+|.+++....                  ..+++..+..++.||+.||.|||++||+
T Consensus        81 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~iv  160 (304)
T cd05096          81 IIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFV  160 (304)
T ss_pred             eeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCcc
Confidence            9999999999999999999999999999986431                  2367788999999999999999999999


Q ss_pred             ccCCCCCcEEEcCCCceEEeecCCccccCCCcc---cccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHH
Q 004959          466 HRDIKGANLLVDASGVVKLADFGMAKHLTGQKA---DLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEM  542 (721)
Q Consensus       466 HrDLKPeNILld~~g~VKL~DFGlA~~l~~~~~---~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyEL  542 (721)
                      ||||||+||||+.++.+||+|||+++.+.....   .....++..|||||++.+       ..++.++|||||||++|||
T Consensus       161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~Dv~slG~~l~el  233 (304)
T cd05096         161 HRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILM-------GKFTTASDVWAFGVTLWEI  233 (304)
T ss_pred             ccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhc-------CCCCchhhhHHHHHHHHHH
Confidence            999999999999999999999999986643321   122346788999999853       3467789999999999999


Q ss_pred             hh--CCCCCCchhhHHHHHHHhh---c-----CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHh
Q 004959          543 YT--GKPPWSEYEGAAAMFKVMR---D-----TPAIPDSLSPEGKDFLRCCFQRNPADRPPASLLLE  599 (721)
Q Consensus       543 Lt--G~~PF~~~~~~~~~~ki~~---~-----~~~~p~~lS~el~dLI~~cL~~DP~kRPSa~eLL~  599 (721)
                      ++  |..||.+....+.+..+..   .     ....+..++..+.+||.+||+.||++|||+.+|.+
T Consensus       234 ~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~  300 (304)
T cd05096         234 LMLCKEQPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHA  300 (304)
T ss_pred             HHccCCCCCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHH
Confidence            86  6688876554443332211   1     12234567899999999999999999999999954

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=2.3e-41  Score=347.81  Aligned_cols=254  Identities=33%  Similarity=0.597  Sum_probs=215.9

Q ss_pred             CeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeEEEE
Q 004959          341 QWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYIY  420 (721)
Q Consensus       341 ~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~yLV  420 (721)
                      +|+..+.||.|+||.||+|.++.+++.||+|.+....    .....+.+.+|+.+++++.||||+++++++...+..|+|
T Consensus         2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~----~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv   77 (265)
T cd06605           2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEI----NEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISIC   77 (265)
T ss_pred             cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEeccc----ChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEE
Confidence            6788899999999999999999999999999886421    224567788999999999999999999999999999999


Q ss_pred             EeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhh-CCeeccCCCCCcEEEcCCCceEEeecCCccccCCCccc
Q 004959          421 LEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHS-KKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKAD  499 (721)
Q Consensus       421 mEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs-~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~~~~  499 (721)
                      |||+.+++|.+++......+++..+..++.||+.||.|||+ .|++|+||||+||+++.++.++|+|||++..+......
T Consensus        78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~  157 (265)
T cd06605          78 MEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAK  157 (265)
T ss_pred             EEecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHHhh
Confidence            99999999999998765789999999999999999999999 99999999999999999999999999998766433222


Q ss_pred             ccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCch-----hhHHHHHHHhhc-CCCCCCC-C
Q 004959          500 LSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEY-----EGAAAMFKVMRD-TPAIPDS-L  572 (721)
Q Consensus       500 ~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~-----~~~~~~~ki~~~-~~~~p~~-l  572 (721)
                       ...|+..|+|||++.+       ..++.++|||||||++|+|++|..||...     ...+.+..+... .+.++.. +
T Consensus       158 -~~~~~~~y~~PE~~~~-------~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (265)
T cd06605         158 -TFVGTSSYMAPERIQG-------NDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPSGKF  229 (265)
T ss_pred             -cccCChhccCHHHHcC-------CCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCCCCCChhhc
Confidence             2678999999999843       35677899999999999999999999654     122233333322 2334444 8


Q ss_pred             CHHHHHHHHHhcccCCCCCCCHHHHHhccccccC
Q 004959          573 SPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNS  606 (721)
Q Consensus       573 S~el~dLI~~cL~~DP~kRPSa~eLL~Hp~f~~~  606 (721)
                      +.++.+||.+||..||++||++.+++.||||+..
T Consensus       230 ~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~~~~  263 (265)
T cd06605         230 SPDFQDFVNLCLIKDPRERPSYKELLEHPFIKKY  263 (265)
T ss_pred             CHHHHHHHHHHcCCCchhCcCHHHHhhCchhhcc
Confidence            8999999999999999999999999999999753

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=9.2e-41  Score=358.89  Aligned_cols=259  Identities=27%  Similarity=0.495  Sum_probs=209.9

Q ss_pred             CCCCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEec---
Q 004959          338 MNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVE---  414 (721)
Q Consensus       338 l~~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~---  414 (721)
                      +.++|++.+.||+|+||.||+|.+..+|+.||||++....    .......+.+|+.+|+.++|+||+++++++...   
T Consensus         3 ~~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~   78 (336)
T cd07849           3 VGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFE----HQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFE   78 (336)
T ss_pred             cccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccc----cchhHHHHHHHHHHHHhCCCCCcCchhheeeccccc
Confidence            4578999999999999999999999999999999885321    123455678899999999999999999876654   


Q ss_pred             --CeEEEEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccc
Q 004959          415 --DKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKH  492 (721)
Q Consensus       415 --~~~yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~  492 (721)
                        ..+|+||||+. ++|.+++..  ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus        79 ~~~~~~lv~e~~~-~~l~~~~~~--~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~  155 (336)
T cd07849          79 SFNDVYIVQELME-TDLYKLIKT--QHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARI  155 (336)
T ss_pred             ccceEEEEehhcc-cCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECcccceee
Confidence              35899999996 588887754  5799999999999999999999999999999999999999999999999999986


Q ss_pred             cCCCcc----cccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhh-----
Q 004959          493 LTGQKA----DLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMR-----  563 (721)
Q Consensus       493 l~~~~~----~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~-----  563 (721)
                      ......    .....|++.|+|||++.+      ...++.++|||||||++|+|++|+.||.+.+....+..+..     
T Consensus       156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~  229 (336)
T cd07849         156 ADPEHDHTGFLTEYVATRWYRAPEIMLN------SKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTP  229 (336)
T ss_pred             ccccccccCCcCCcCcCCCccChHHhhC------CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCC
Confidence            543221    123568999999998742      23467789999999999999999999976543222211110     


Q ss_pred             ------------------cC---CC-----CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhccccccCCCC
Q 004959          564 ------------------DT---PA-----IPDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQP  609 (721)
Q Consensus       564 ------------------~~---~~-----~p~~lS~el~dLI~~cL~~DP~kRPSa~eLL~Hp~f~~~~~~  609 (721)
                                        ..   ..     ....++.++.+||.+||+.||++|||+.|+++||||.....+
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~~  301 (336)
T cd07849         230 SQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHDP  301 (336)
T ss_pred             CHHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCCC
Confidence                              00   00     113467889999999999999999999999999999977654

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=2.5e-41  Score=354.47  Aligned_cols=254  Identities=30%  Similarity=0.515  Sum_probs=211.2

Q ss_pred             CCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEec--CeE
Q 004959          340 SQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVE--DKF  417 (721)
Q Consensus       340 ~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~--~~~  417 (721)
                      ++|++.+.||.|+||.||+|.+..+++.||+|.+......   ......+.+|+.+++++.||||+++++++...  +..
T Consensus         5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~---~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~   81 (293)
T cd07843           5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEK---EGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKI   81 (293)
T ss_pred             hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeecccc---ccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcE
Confidence            4789999999999999999999999999999998643221   22334667899999999999999999998877  889


Q ss_pred             EEEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCCc
Q 004959          418 YIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQK  497 (721)
Q Consensus       418 yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~~  497 (721)
                      |+||||+. ++|.+++......+++..++.++.||+.||.|||++||+|+||||+|||++.++.+||+|||++..+....
T Consensus        82 ~lv~e~~~-~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~  160 (293)
T cd07843          82 YMVMEYVE-HDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPL  160 (293)
T ss_pred             EEEehhcC-cCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCceeeccCCc
Confidence            99999997 59999987765679999999999999999999999999999999999999999999999999998765442


Q ss_pred             -ccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhcC-----------
Q 004959          498 -ADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDT-----------  565 (721)
Q Consensus       498 -~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~~-----------  565 (721)
                       ......+++.|+|||++.+      ...++.++|||||||++|+|++|..||......+.+.++....           
T Consensus       161 ~~~~~~~~~~~~~aPE~~~~------~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (293)
T cd07843         161 KPYTQLVVTLWYRAPELLLG------AKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGF  234 (293)
T ss_pred             cccccccccccccCchhhcC------CccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHh
Confidence             2233557899999999853      2235678999999999999999999998765554444332110           


Q ss_pred             --------------------CCCCCC-CCHHHHHHHHHhcccCCCCCCCHHHHHhcccc
Q 004959          566 --------------------PAIPDS-LSPEGKDFLRCCFQRNPADRPPASLLLEHRFL  603 (721)
Q Consensus       566 --------------------~~~p~~-lS~el~dLI~~cL~~DP~kRPSa~eLL~Hp~f  603 (721)
                                          ..++.. +++.+.+||++||+.||++|||+.|+|+|+||
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f  293 (293)
T cd07843         235 SELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF  293 (293)
T ss_pred             hccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence                                112222 58899999999999999999999999999997

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=5e-41  Score=351.87  Aligned_cols=251  Identities=29%  Similarity=0.454  Sum_probs=203.1

Q ss_pred             EEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHH---HHhCCCCCeeeeeeeEEecCeEEEEEee
Q 004959          347 LIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKV---LSHLKHPNIVQYYGSEIVEDKFYIYLEY  423 (721)
Q Consensus       347 ~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~i---L~~L~HPnIV~l~g~~~~~~~~yLVmEy  423 (721)
                      +||+|+||.||+|.+..+|+.||+|++........  .....+.+|..+   +....|+||+.+++.+..++..|+||||
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~   78 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMK--QGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDL   78 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccc--hHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEec
Confidence            48999999999999999999999998864322211  112223344433   3445799999999999999999999999


Q ss_pred             ccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCCcccccCC
Q 004959          424 VHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMK  503 (721)
Q Consensus       424 ~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~~~~~s~~  503 (721)
                      +.|++|.+++... +.+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++....... .....
T Consensus        79 ~~~~~L~~~i~~~-~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~-~~~~~  156 (279)
T cd05633          79 MNGGDLHYHLSQH-GVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-PHASV  156 (279)
T ss_pred             CCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceeccccC-ccCcC
Confidence            9999999998765 679999999999999999999999999999999999999999999999999987654332 23456


Q ss_pred             CCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhh--HHHHH-HHhhcCCCCCCCCCHHHHHHH
Q 004959          504 GSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEG--AAAMF-KVMRDTPAIPDSLSPEGKDFL  580 (721)
Q Consensus       504 GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~--~~~~~-ki~~~~~~~p~~lS~el~dLI  580 (721)
                      |+..|+|||.+..      ...++.++|||||||++|+|++|..||.....  ..... ........++..++.++.+||
T Consensus       157 ~~~~y~aPE~~~~------~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  230 (279)
T cd05633         157 GTHGYMAPEVLQK------GTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVELPDSFSPELKSLL  230 (279)
T ss_pred             CCcCccCHHHhcC------CCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHhhcCCcCCccccCHHHHHHH
Confidence            9999999999742      23466789999999999999999999965322  11222 222334466778999999999


Q ss_pred             HHhcccCCCCCC-----CHHHHHhccccccCC
Q 004959          581 RCCFQRNPADRP-----PASLLLEHRFLKNSQ  607 (721)
Q Consensus       581 ~~cL~~DP~kRP-----Sa~eLL~Hp~f~~~~  607 (721)
                      ++||..||++|+     ++.|+++||||++..
T Consensus       231 ~~~l~~~p~~R~~~~~~~~~~~~~h~~~~~~~  262 (279)
T cd05633         231 EGLLQRDVSKRLGCLGRGAQEVKEHVFFKGID  262 (279)
T ss_pred             HHHhcCCHHHhcCCCCCCHHHHHhCccccCCC
Confidence            999999999999     699999999998743

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=5.8e-41  Score=348.58  Aligned_cols=260  Identities=30%  Similarity=0.547  Sum_probs=209.8

Q ss_pred             CCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHH-HHhCCCCCeeeeeeeEEecCeEE
Q 004959          340 SQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKV-LSHLKHPNIVQYYGSEIVEDKFY  418 (721)
Q Consensus       340 ~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~i-L~~L~HPnIV~l~g~~~~~~~~y  418 (721)
                      ++|++.+.||+|+||.||+|.+..+|+.||||++....   ... ....+..|+.+ ++.++||||+++++++...+..|
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~---~~~-~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~   76 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATV---NSQ-EQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVW   76 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCC---CcH-HHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEE
Confidence            36899999999999999999999999999999886321   112 22345556654 66778999999999999999999


Q ss_pred             EEEeeccCCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHhhC-CeeccCCCCCcEEEcCCCceEEeecCCccccC
Q 004959          419 IYLEYVHPGSINKYVREH---CGAITESVVRNFTRHILSGLAYLHSK-KTIHRDIKGANLLVDASGVVKLADFGMAKHLT  494 (721)
Q Consensus       419 LVmEy~~gGsL~~~L~~~---~~~Lse~~i~~i~~QIl~AL~yLHs~-gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~  494 (721)
                      +||||++ |+|.+++...   ...+++..++.++.||+.||.|||++ +++||||||+|||++.++.+||+|||++..+.
T Consensus        77 lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~  155 (283)
T cd06617          77 ICMEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLV  155 (283)
T ss_pred             EEhhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecccccccc
Confidence            9999996 7888887542   34689999999999999999999997 99999999999999999999999999998765


Q ss_pred             CCcccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCch-hhHHHHHHHhhc-CCCCC-CC
Q 004959          495 GQKADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEY-EGAAAMFKVMRD-TPAIP-DS  571 (721)
Q Consensus       495 ~~~~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~-~~~~~~~ki~~~-~~~~p-~~  571 (721)
                      .........|+..|+|||++.+..   ....++.++|+|||||++|+|++|+.||... ...+.+..+... ...++ ..
T Consensus       156 ~~~~~~~~~~~~~y~aPE~~~~~~---~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (283)
T cd06617         156 DSVAKTIDAGCKPYMAPERINPEL---NQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSPQLPAEK  232 (283)
T ss_pred             cccccccccCCccccChhhcCCcc---cccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcCCCCCCccc
Confidence            433333356899999999885321   1134567899999999999999999999653 223333333332 22333 45


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHHHHhccccccCC
Q 004959          572 LSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQ  607 (721)
Q Consensus       572 lS~el~dLI~~cL~~DP~kRPSa~eLL~Hp~f~~~~  607 (721)
                      ++.++.+||.+||..+|++||++.++++|+||....
T Consensus       233 ~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~  268 (283)
T cd06617         233 FSPEFQDFVNKCLKKNYKERPNYPELLQHPFFELHL  268 (283)
T ss_pred             cCHHHHHHHHHHccCChhhCcCHHHHhcCchhhhcc
Confidence            889999999999999999999999999999998754

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=3.7e-41  Score=350.89  Aligned_cols=251  Identities=27%  Similarity=0.460  Sum_probs=210.9

Q ss_pred             EeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeEEEEEeeccCC
Q 004959          348 IGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYIYLEYVHPG  427 (721)
Q Consensus       348 LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~yLVmEy~~gG  427 (721)
                      ||+|+||+||+|.+..+|+.||+|++...  ........+.+.+|+.+|++++||||+++++.+...+.+|+||||++++
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~   78 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKK--RLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGG   78 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehh--hhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCC
Confidence            69999999999999999999999988632  1112233456678999999999999999999999999999999999999


Q ss_pred             CHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCCcccccCCCCC
Q 004959          428 SINKYVREHC-GAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSP  506 (721)
Q Consensus       428 sL~~~L~~~~-~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~~~~~s~~GT~  506 (721)
                      +|.+++.... ..+++..+..++.||+.||.|||++||+||||+|+|||++.++.+||+|||++..+..........|+.
T Consensus        79 ~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~  158 (277)
T cd05577          79 DLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRAGTP  158 (277)
T ss_pred             cHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhccCCccccccCCC
Confidence            9999997653 369999999999999999999999999999999999999999999999999998765443334456889


Q ss_pred             ccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhh----HHHHHHHhhcCCCCCCCCCHHHHHHHHH
Q 004959          507 YWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEG----AAAMFKVMRDTPAIPDSLSPEGKDFLRC  582 (721)
Q Consensus       507 ~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~----~~~~~ki~~~~~~~p~~lS~el~dLI~~  582 (721)
                      .|+|||++.+       ..++.++|||||||++|+|++|+.||.....    ......+.......+..+++++.++|++
T Consensus       159 ~y~~PE~~~~-------~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  231 (277)
T cd05577         159 GYMAPEVLQG-------EVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLCEA  231 (277)
T ss_pred             CcCCHHHhcC-------CCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccccccccCCccCCHHHHHHHHH
Confidence            9999999843       3366789999999999999999999976433    2222223333445667789999999999


Q ss_pred             hcccCCCCCC-----CHHHHHhccccccCC
Q 004959          583 CFQRNPADRP-----PASLLLEHRFLKNSQ  607 (721)
Q Consensus       583 cL~~DP~kRP-----Sa~eLL~Hp~f~~~~  607 (721)
                      ||+.||++||     ++.++++||||....
T Consensus       232 ~l~~~p~~R~~~~~~~~~~ll~h~~~~~~~  261 (277)
T cd05577         232 LLQKDPEKRLGCRGGSADEVREHPLFKDLN  261 (277)
T ss_pred             HccCChhHccCCCcccHHHHHhChhhhcCC
Confidence            9999999999     899999999997643

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=9.5e-41  Score=342.47  Aligned_cols=255  Identities=48%  Similarity=0.876  Sum_probs=214.9

Q ss_pred             CeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeEEEE
Q 004959          341 QWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYIY  420 (721)
Q Consensus       341 ~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~yLV  420 (721)
                      +|++.+.||+|+||.||+|.+..+++.||+|.+....   ......+.+.+|+.+++.++|+||+++++++...+.+++|
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv   77 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQD---NDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIF   77 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcc---cchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEE
Confidence            5899999999999999999999999999999986432   2245678899999999999999999999999999999999


Q ss_pred             EeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCCccc-
Q 004959          421 LEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKAD-  499 (721)
Q Consensus       421 mEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~~~~-  499 (721)
                      +||+++++|.+++... ..+++..++.++.||+.||.|||++||+|+||+|+||+++.++.+||+|||++..+...... 
T Consensus        78 ~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~  156 (264)
T cd06626          78 MEYCSGGTLEELLEHG-RILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTM  156 (264)
T ss_pred             EecCCCCcHHHHHhhc-CCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCcc
Confidence            9999999999999764 56899999999999999999999999999999999999999999999999999876543221 


Q ss_pred             ----ccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhh-HHHHHHHhh-cCCCCCCCC-
Q 004959          500 ----LSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEG-AAAMFKVMR-DTPAIPDSL-  572 (721)
Q Consensus       500 ----~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~-~~~~~ki~~-~~~~~p~~l-  572 (721)
                          ....++..|+|||++.+.    ....++.++|||||||++|+|++|..||..... ......+.. ..+.++... 
T Consensus       157 ~~~~~~~~~~~~~~~PE~~~~~----~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (264)
T cd06626         157 GEEVQSLAGTPAYMAPEVITGG----KGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIPDSLQ  232 (264)
T ss_pred             cccccCCcCCcCccChhhccCC----CCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhcCCCCCCCcccc
Confidence                134688999999998532    113367789999999999999999999976532 222222222 233445444 


Q ss_pred             -CHHHHHHHHHhcccCCCCCCCHHHHHhcccc
Q 004959          573 -SPEGKDFLRCCFQRNPADRPPASLLLEHRFL  603 (721)
Q Consensus       573 -S~el~dLI~~cL~~DP~kRPSa~eLL~Hp~f  603 (721)
                       +.++.+||++||+.||++||++.+++.|||+
T Consensus       233 ~~~~~~~li~~~l~~~p~~R~~~~~i~~~~~~  264 (264)
T cd06626         233 LSPEGKDFLDRCLESDPKKRPTASELLQHPFV  264 (264)
T ss_pred             cCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence             8999999999999999999999999999996

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=5.2e-41  Score=349.75  Aligned_cols=255  Identities=38%  Similarity=0.692  Sum_probs=218.3

Q ss_pred             CCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeEEE
Q 004959          340 SQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYI  419 (721)
Q Consensus       340 ~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~yL  419 (721)
                      ..|+..+.||.|+||.||+|.+..+++.||||++...    ......+.+.+|+.+++.+.|+||+++++++......|+
T Consensus         4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~----~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   79 (277)
T cd06640           4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLE----EAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWI   79 (277)
T ss_pred             HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEecc----ccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEE
Confidence            4688889999999999999999999999999988632    223456789999999999999999999999999999999


Q ss_pred             EEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCCcc-
Q 004959          420 YLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKA-  498 (721)
Q Consensus       420 VmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~~~-  498 (721)
                      ||||+.|++|.+++..  +.+++..+..++.||+.||.|||+++++|+||+|+||+++.++.++|+|||++..+..... 
T Consensus        80 v~e~~~~~~L~~~i~~--~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~  157 (277)
T cd06640          80 IMEYLGGGSALDLLRA--GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIK  157 (277)
T ss_pred             EEecCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccceeccCCccc
Confidence            9999999999999864  5789999999999999999999999999999999999999999999999999977654332 


Q ss_pred             cccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhc-CCCCCCCCCHHHH
Q 004959          499 DLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRD-TPAIPDSLSPEGK  577 (721)
Q Consensus       499 ~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~-~~~~p~~lS~el~  577 (721)
                      .....++..|+|||++.       ...++.++|+|||||++|||++|..||...........+... .+.++..++.++.
T Consensus       158 ~~~~~~~~~y~apE~~~-------~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (277)
T cd06640         158 RNTFVGTPFWMAPEVIQ-------QSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNPPTLTGEFSKPFK  230 (277)
T ss_pred             cccccCcccccCHhHhc-------cCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhcCCCCCCchhhhHHHH
Confidence            22346889999999984       334677899999999999999999999876655544443322 3344556788999


Q ss_pred             HHHHHhcccCCCCCCCHHHHHhccccccCC
Q 004959          578 DFLRCCFQRNPADRPPASLLLEHRFLKNSQ  607 (721)
Q Consensus       578 dLI~~cL~~DP~kRPSa~eLL~Hp~f~~~~  607 (721)
                      +||.+||+.+|++||++.++++|+||....
T Consensus       231 ~li~~~l~~~p~~Rp~~~~il~~~~~~~~~  260 (277)
T cd06640         231 EFIDACLNKDPSFRPTAKELLKHKFIVKNA  260 (277)
T ss_pred             HHHHHHcccCcccCcCHHHHHhChHhhhcc
Confidence            999999999999999999999999997543

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=3.5e-41  Score=356.85  Aligned_cols=246  Identities=25%  Similarity=0.446  Sum_probs=191.4

Q ss_pred             EeeEEeecCCeEEEEEEECC--CCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEe--cCeEEE
Q 004959          344 KGKLIGRGTFGSVYVASNRE--TGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIV--EDKFYI  419 (721)
Q Consensus       344 ~~k~LG~G~fG~VY~a~~~~--tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~--~~~~yL  419 (721)
                      .+..||+|+||.||+|.++.  ++..||+|.+...   ..    ...+.+|+.+|+.++||||+++++++..  ...+|+
T Consensus         5 ~g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~---~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~l   77 (317)
T cd07867           5 EGCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGT---GI----SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWL   77 (317)
T ss_pred             eceEeccCCCeeEEEEEecCCCccceEEEEEecCC---CC----cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEE
Confidence            35689999999999998654  6789999987531   11    2356789999999999999999998854  567899


Q ss_pred             EEeeccCCCHHHHHHHh--------cCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEE----cCCCceEEeec
Q 004959          420 YLEYVHPGSINKYVREH--------CGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLV----DASGVVKLADF  487 (721)
Q Consensus       420 VmEy~~gGsL~~~L~~~--------~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILl----d~~g~VKL~DF  487 (721)
                      ||||+. ++|.+++...        ...+++..++.++.||+.||.|||++||+||||||+|||+    +.++.+||+||
T Consensus        78 v~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~Df  156 (317)
T cd07867          78 LFDYAE-HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADM  156 (317)
T ss_pred             EEeeeC-CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeec
Confidence            999996 5888877532        1248899999999999999999999999999999999999    45679999999


Q ss_pred             CCccccCCCcc----cccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhH--------
Q 004959          488 GMAKHLTGQKA----DLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGA--------  555 (721)
Q Consensus       488 GlA~~l~~~~~----~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~--------  555 (721)
                      |+++.+.....    .....||+.|+|||++.+      ...++.++|||||||++|||++|++||......        
T Consensus       157 G~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~------~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~  230 (317)
T cd07867         157 GFARLFNSPLKPLADLDPVVVTFWYRAPELLLG------ARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFH  230 (317)
T ss_pred             cceeccCCCcccccccCcceecccccCcHHhcC------CCccCcHHHHHhHHHHHHHHHhCCCCccccccccccccccc
Confidence            99987643321    223568999999999853      234677899999999999999999999642210        


Q ss_pred             -HHHHHHhh--------------cC------------------------CCCCCCCCHHHHHHHHHhcccCCCCCCCHHH
Q 004959          556 -AAMFKVMR--------------DT------------------------PAIPDSLSPEGKDFLRCCFQRNPADRPPASL  596 (721)
Q Consensus       556 -~~~~ki~~--------------~~------------------------~~~p~~lS~el~dLI~~cL~~DP~kRPSa~e  596 (721)
                       ..+.++..              ..                        .......+..+.+||.+||+.||.+|||++|
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e  310 (317)
T cd07867         231 HDQLDRIFSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQ  310 (317)
T ss_pred             HHHHHHHHHhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHH
Confidence             11111000              00                        0011124567889999999999999999999


Q ss_pred             HHhcccc
Q 004959          597 LLEHRFL  603 (721)
Q Consensus       597 LL~Hp~f  603 (721)
                      +|+||||
T Consensus       311 ~l~hp~f  317 (317)
T cd07867         311 ALQDPYF  317 (317)
T ss_pred             HhcCCCC
Confidence            9999997

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=2.7e-41  Score=351.79  Aligned_cols=253  Identities=31%  Similarity=0.573  Sum_probs=208.9

Q ss_pred             CeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeEEEE
Q 004959          341 QWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYIY  420 (721)
Q Consensus       341 ~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~yLV  420 (721)
                      .|++.+.||.|+||.||+|++..+|+.||||.+....   ......+.+.+|++++++++||||+++++++...+..|+|
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v   77 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDT---ETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLV   77 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccc---cccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEE
Confidence            4889999999999999999999999999999886422   1222345788999999999999999999999999999999


Q ss_pred             EeeccCCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCCcc-
Q 004959          421 LEYVHPGSINKYVREH-CGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKA-  498 (721)
Q Consensus       421 mEy~~gGsL~~~L~~~-~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~~~-  498 (721)
                      |||+. ++|.+++... ...+++..++.++.||+.||+|||++|++|+||+|+||+++.++.+||+|||++..+..... 
T Consensus        78 ~e~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~~  156 (284)
T cd07860          78 FEFLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT  156 (284)
T ss_pred             eeccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCccc
Confidence            99996 6898888653 35689999999999999999999999999999999999999999999999999876543222 


Q ss_pred             cccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhcCC------------
Q 004959          499 DLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTP------------  566 (721)
Q Consensus       499 ~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~~~------------  566 (721)
                      .....++..|+|||++.+      ...++.++|||||||++|+|++|+.||......+...++.....            
T Consensus       157 ~~~~~~~~~y~aPE~~~~------~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (284)
T cd07860         157 YTHEVVTLWYRAPEILLG------CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS  230 (284)
T ss_pred             cccccccccccCCeEEec------CCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhH
Confidence            223457889999998743      22346689999999999999999999977554444433322100            


Q ss_pred             -----------------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccc
Q 004959          567 -----------------AIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFL  603 (721)
Q Consensus       567 -----------------~~p~~lS~el~dLI~~cL~~DP~kRPSa~eLL~Hp~f  603 (721)
                                       .....++.+++++|.+||+.||++||+++++++||||
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f  284 (284)
T cd07860         231 LPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF  284 (284)
T ss_pred             HHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence                             1123478899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=5.2e-41  Score=352.91  Aligned_cols=255  Identities=28%  Similarity=0.484  Sum_probs=204.0

Q ss_pred             CCCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecC---
Q 004959          339 NSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVED---  415 (721)
Q Consensus       339 ~~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~---  415 (721)
                      -++|++.+.||+|+||.||+|.+..+|+.||||.+......   ......+.+|+.++++++||||+++++++....   
T Consensus        11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   87 (310)
T cd07865          11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEK---EGFPITALREIKILQLLKHENVVNLIEICRTKATPY   87 (310)
T ss_pred             hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCc---CCchhHHHHHHHHHHhCCCCCccceEEEEecccccc
Confidence            35799999999999999999999999999999988642211   112235568999999999999999999877643   


Q ss_pred             -----eEEEEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCc
Q 004959          416 -----KFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMA  490 (721)
Q Consensus       416 -----~~yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA  490 (721)
                           ..|+||||+. ++|.+++......+++.+++.++.||+.||.|||++||+|+||||+|||++.++.+||+|||++
T Consensus        88 ~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~  166 (310)
T cd07865          88 NRYKGSFYLVFEFCE-HDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLA  166 (310)
T ss_pred             cCCCceEEEEEcCCC-cCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEECcCCCc
Confidence                 4699999996 5888888765557999999999999999999999999999999999999999999999999999


Q ss_pred             cccCCCccc-----ccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhcC
Q 004959          491 KHLTGQKAD-----LSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDT  565 (721)
Q Consensus       491 ~~l~~~~~~-----~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~~  565 (721)
                      ..+......     ....++..|+|||++.+      ...++.++|||||||++|+|++|..||...........+..-.
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~  240 (310)
T cd07865         167 RAFSLSKNSKPNRYTNRVVTLWYRPPELLLG------ERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLC  240 (310)
T ss_pred             ccccCCcccCCCCccCcccCccccCcHHhcC------CcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Confidence            866432211     23457889999999853      2235668999999999999999999997654433222111100


Q ss_pred             -------------------CCCC-------------CCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccc
Q 004959          566 -------------------PAIP-------------DSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFL  603 (721)
Q Consensus       566 -------------------~~~p-------------~~lS~el~dLI~~cL~~DP~kRPSa~eLL~Hp~f  603 (721)
                                         ..++             ...+..+.+||.+||..||++|||++|+|+||||
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f  310 (310)
T cd07865         241 GSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF  310 (310)
T ss_pred             CCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence                               0001             1235778899999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2e-42  Score=358.26  Aligned_cols=262  Identities=25%  Similarity=0.412  Sum_probs=223.0

Q ss_pred             CCeeE-eeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCC-CCCeeeeeeeEEecCeE
Q 004959          340 SQWQK-GKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLK-HPNIVQYYGSEIVEDKF  417 (721)
Q Consensus       340 ~~y~~-~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~-HPnIV~l~g~~~~~~~~  417 (721)
                      +-|++ .++||+|+||.|--|....+|..||||+|.+.+     .-...++.+|++++.+++ |+||++|+++|++++.+
T Consensus        77 d~YkLt~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~-----gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~F  151 (463)
T KOG0607|consen   77 DMYKLTSELLGEGAYASVQTCVSIQTGKEYAVKIIDKQP-----GHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRF  151 (463)
T ss_pred             HHHHhHHHHhcCccceeeeeeeeeccchhhhhhhhhcCC-----chHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceE
Confidence            34554 468999999999999999999999999987532     234578999999999996 99999999999999999


Q ss_pred             EEEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCC---ceEEeecCCccccC
Q 004959          418 YIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASG---VVKLADFGMAKHLT  494 (721)
Q Consensus       418 yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g---~VKL~DFGlA~~l~  494 (721)
                      |||||-|.||.|...|.++ ..|+|.++..+.+.|+.||.|||.+||.||||||||||.....   -||||||.|...+.
T Consensus       152 YLVfEKm~GGplLshI~~~-~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k  230 (463)
T KOG0607|consen  152 YLVFEKMRGGPLLSHIQKR-KHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIK  230 (463)
T ss_pred             EEEEecccCchHHHHHHHh-hhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccc
Confidence            9999999999999999876 6899999999999999999999999999999999999996544   57999999886543


Q ss_pred             CC--------cccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchh-------------
Q 004959          495 GQ--------KADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYE-------------  553 (721)
Q Consensus       495 ~~--------~~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~-------------  553 (721)
                      ..        ....+.+|+..|||||+...  +.+....|+.++|.||||||||.||+|++||.+.-             
T Consensus       231 ~~~~~spastP~L~tPvGSAEfMAPEVVd~--fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr  308 (463)
T KOG0607|consen  231 LNNDCSPASTPELLTPVGSAEFMAPEVVDV--FVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCR  308 (463)
T ss_pred             cCCCCCCCCCccccCcccchhhcchhHHhh--hccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccH
Confidence            21        12346789999999999853  44566778889999999999999999999996532             


Q ss_pred             --hHHHHHHHhhcCCCCCC----CCCHHHHHHHHHhcccCCCCCCCHHHHHhccccccCCCC
Q 004959          554 --GAAAMFKVMRDTPAIPD----SLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQP  609 (721)
Q Consensus       554 --~~~~~~ki~~~~~~~p~----~lS~el~dLI~~cL~~DP~kRPSa~eLL~Hp~f~~~~~~  609 (721)
                        ....+..|..+.+++|+    .+|.+++|+|..+|.+|+.+|.++.++++|||++.....
T Consensus       309 ~CQ~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~~~e  370 (463)
T KOG0607|consen  309 VCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRCAPE  370 (463)
T ss_pred             HHHHHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCccccccchh
Confidence              12344556667778875    489999999999999999999999999999999876544

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=6.7e-41  Score=350.63  Aligned_cols=255  Identities=29%  Similarity=0.514  Sum_probs=207.7

Q ss_pred             CCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCC-CCCeeeeeeeEEecCe--
Q 004959          340 SQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLK-HPNIVQYYGSEIVEDK--  416 (721)
Q Consensus       340 ~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~-HPnIV~l~g~~~~~~~--  416 (721)
                      ++|++.+.||+|+||.||+|.+..+|+.||||++....   ......+.+.+|+.+++.+. |+||+++++++...+.  
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~---~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~   77 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEM---DEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNG   77 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhc---cccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCC
Confidence            36999999999999999999999999999999876422   11223356788999999995 6999999999887665  


Q ss_pred             ---EEEEEeeccCCCHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcC-CCceEEeecC
Q 004959          417 ---FYIYLEYVHPGSINKYVREHC----GAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDA-SGVVKLADFG  488 (721)
Q Consensus       417 ---~yLVmEy~~gGsL~~~L~~~~----~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~-~g~VKL~DFG  488 (721)
                         +|+||||+.+ +|.+++....    ..+++..++.++.||+.||.|||++||+||||||+||+++. ++.+||+|||
T Consensus        78 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg  156 (295)
T cd07837          78 KPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLG  156 (295)
T ss_pred             CceEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeecc
Confidence               8999999985 8988886532    35899999999999999999999999999999999999998 8899999999


Q ss_pred             CccccCCCc-ccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhcCC-
Q 004959          489 MAKHLTGQK-ADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTP-  566 (721)
Q Consensus       489 lA~~l~~~~-~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~~~-  566 (721)
                      ++..+.... ......+++.|+|||++.+      ...++.++|||||||++|+|++|..||.+....+...++..... 
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~------~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~  230 (295)
T cd07837         157 LGRAFSIPVKSYTHEIVTLWYRAPEVLLG------STHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGT  230 (295)
T ss_pred             cceecCCCccccCCcccccCCCChHHhhC------CCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCC
Confidence            998654322 1223357889999999853      23456789999999999999999999987655554444332100 


Q ss_pred             ---------------------------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhccccc
Q 004959          567 ---------------------------AIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLK  604 (721)
Q Consensus       567 ---------------------------~~p~~lS~el~dLI~~cL~~DP~kRPSa~eLL~Hp~f~  604 (721)
                                                 .....++.++.+||.+||+.||++||++.|+|.||||+
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~~  295 (295)
T cd07837         231 PTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD  295 (295)
T ss_pred             CChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCcC
Confidence                                       00134789999999999999999999999999999985

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.1e-43  Score=405.43  Aligned_cols=264  Identities=25%  Similarity=0.387  Sum_probs=231.1

Q ss_pred             CCCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeEE
Q 004959          339 NSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFY  418 (721)
Q Consensus       339 ~~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~y  418 (721)
                      .++|.++++||+|+||.|.+++++.|++.||+|+++++.  .........|..|-.||...+.+.||.++-.|.++.++|
T Consensus        74 ~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~e--MlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LY  151 (1317)
T KOG0612|consen   74 AEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWE--MLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLY  151 (1317)
T ss_pred             HHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHH--HhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceE
Confidence            368999999999999999999999999999999987531  111223356888999999999999999999999999999


Q ss_pred             EEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCCcc
Q 004959          419 IYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKA  498 (721)
Q Consensus       419 LVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~~~  498 (721)
                      +|||||+||+|..++.+.. .++|..++.|+..|+.||.-||+.|+|||||||+|||||..|+|||+|||.+-.+..++.
T Consensus       152 lVMdY~pGGDlltLlSk~~-~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGsClkm~~dG~  230 (1317)
T KOG0612|consen  152 LVMDYMPGGDLLTLLSKFD-RLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDADGT  230 (1317)
T ss_pred             EEEecccCchHHHHHhhcC-CChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchhHHhcCCCCc
Confidence            9999999999999998774 899999999999999999999999999999999999999999999999999987764443


Q ss_pred             --cccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhc--CCCCC--CCC
Q 004959          499 --DLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRD--TPAIP--DSL  572 (721)
Q Consensus       499 --~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~--~~~~p--~~l  572 (721)
                        ....+|||.|++||+|......  .+.|...+|+||+||++||||+|..||+...-.+.+-+|+.-  ...+|  ..+
T Consensus       231 V~s~~aVGTPDYISPEvLqs~~~~--~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~l~FP~~~~V  308 (1317)
T KOG0612|consen  231 VRSSVAVGTPDYISPEVLQSQGDG--KGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKESLSFPDETDV  308 (1317)
T ss_pred             EEeccccCCCCccCHHHHHhhcCC--ccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhhcCCCccccc
Confidence              3456799999999999764332  357888999999999999999999999999999999998764  45566  459


Q ss_pred             CHHHHHHHHHhcccCCCCCCC---HHHHHhccccccCCC
Q 004959          573 SPEGKDFLRCCFQRNPADRPP---ASLLLEHRFLKNSQQ  608 (721)
Q Consensus       573 S~el~dLI~~cL~~DP~kRPS---a~eLL~Hp~f~~~~~  608 (721)
                      |+++++||+++|. +|+.|..   ++++-.||||.+..-
T Consensus       309 SeeakdLI~~ll~-~~e~RLgrngiedik~HpFF~g~~W  346 (1317)
T KOG0612|consen  309 SEEAKDLIEALLC-DREVRLGRNGIEDIKNHPFFEGIDW  346 (1317)
T ss_pred             CHHHHHHHHHHhc-ChhhhcccccHHHHHhCccccCCCh
Confidence            9999999999885 5889988   999999999987654

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=8.1e-41  Score=349.71  Aligned_cols=251  Identities=28%  Similarity=0.453  Sum_probs=205.3

Q ss_pred             EEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHH---HHHHHhCCCCCeeeeeeeEEecCeEEEEEee
Q 004959          347 LIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQE---IKVLSHLKHPNIVQYYGSEIVEDKFYIYLEY  423 (721)
Q Consensus       347 ~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~E---i~iL~~L~HPnIV~l~g~~~~~~~~yLVmEy  423 (721)
                      +||+|+||.||+|.+..+|+.||||++........  .....+..|   +.+++...||+|+.+++++...+..|+||||
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~   78 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMK--QGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDL   78 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccc--hhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEec
Confidence            48999999999999999999999999864321111  111122333   3445556899999999999999999999999


Q ss_pred             ccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCCcccccCC
Q 004959          424 VHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMK  503 (721)
Q Consensus       424 ~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~~~~~s~~  503 (721)
                      +.|++|..++... +.+++..++.++.||+.||.|||+++|+||||||+|||++.++.+||+|||++..+.... ....+
T Consensus        79 ~~g~~L~~~l~~~-~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~-~~~~~  156 (278)
T cd05606          79 MNGGDLHYHLSQH-GVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-PHASV  156 (278)
T ss_pred             CCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccCccC-CcCcC
Confidence            9999999988654 679999999999999999999999999999999999999999999999999997654332 23457


Q ss_pred             CCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCch---hhHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 004959          504 GSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEY---EGAAAMFKVMRDTPAIPDSLSPEGKDFL  580 (721)
Q Consensus       504 GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~---~~~~~~~ki~~~~~~~p~~lS~el~dLI  580 (721)
                      |+..|+|||++.+      ...++.++|||||||++|+|++|+.||...   ...............++..++.++.++|
T Consensus       157 ~~~~y~aPE~~~~------~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li  230 (278)
T cd05606         157 GTHGYMAPEVLQK------GVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLL  230 (278)
T ss_pred             CCcCCcCcHHhcC------CCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhccCCCCCCcCCHHHHHHH
Confidence            9999999999842      234667899999999999999999999765   2222223333344567777899999999


Q ss_pred             HHhcccCCCCCC-----CHHHHHhccccccCC
Q 004959          581 RCCFQRNPADRP-----PASLLLEHRFLKNSQ  607 (721)
Q Consensus       581 ~~cL~~DP~kRP-----Sa~eLL~Hp~f~~~~  607 (721)
                      .+||..||.+|+     ++.++++||||....
T Consensus       231 ~~~l~~~p~~R~~~~~~~~~~ll~~~~~~~~~  262 (278)
T cd05606         231 EGLLQRDVNRRLGCLGRGAQEVKEHPFFRSLD  262 (278)
T ss_pred             HHHhhcCHHhccCCCCCCHHHHHhCccccCCC
Confidence            999999999999     999999999998753

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=1.7e-40  Score=335.04  Aligned_cols=250  Identities=42%  Similarity=0.748  Sum_probs=215.1

Q ss_pred             CeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeEEEE
Q 004959          341 QWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYIY  420 (721)
Q Consensus       341 ~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~yLV  420 (721)
                      +|.+.+.||+|+||.||++.+..+|+.|++|++....     ....+.+.+|+.+++.++|+||+++++++...+..+++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~-----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~   75 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLES-----KEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIV   75 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccc-----hhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEE
Confidence            4888999999999999999999999999999886321     14567889999999999999999999999999999999


Q ss_pred             EeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCCcccc
Q 004959          421 LEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADL  500 (721)
Q Consensus       421 mEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~~~~~  500 (721)
                      |||++|++|.+++......+++..+..++.||+.||.|||++|++||||+|+||+++.++.++|+|||++..........
T Consensus        76 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~  155 (253)
T cd05122          76 MEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARN  155 (253)
T ss_pred             EecCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeecccccccccccccc
Confidence            99999999999997765689999999999999999999999999999999999999999999999999998776544334


Q ss_pred             cCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhh-cCCCCCCC--CCHHHH
Q 004959          501 SMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMR-DTPAIPDS--LSPEGK  577 (721)
Q Consensus       501 s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~-~~~~~p~~--lS~el~  577 (721)
                      ...|+..|++||++.+       ..++.++|||||||++|+|++|..||.............. .....+..  ++.++.
T Consensus       156 ~~~~~~~~~~PE~~~~-------~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (253)
T cd05122         156 TMVGTPYWMAPEVING-------KPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGLRNPEKWSDEFK  228 (253)
T ss_pred             ceecCCcccCHHHHcC-------CCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcCCCCcCcccccCHHHH
Confidence            5678999999999843       3367789999999999999999999987644444333332 22333333  389999


Q ss_pred             HHHHHhcccCCCCCCCHHHHHhccc
Q 004959          578 DFLRCCFQRNPADRPPASLLLEHRF  602 (721)
Q Consensus       578 dLI~~cL~~DP~kRPSa~eLL~Hp~  602 (721)
                      ++|.+||+.||++|||+.++++|||
T Consensus       229 ~~i~~~l~~~p~~R~t~~~~l~~~~  253 (253)
T cd05122         229 DFLKKCLQKNPEKRPTAEQLLKHPF  253 (253)
T ss_pred             HHHHHHccCChhhCCCHHHHhcCCC
Confidence            9999999999999999999999998

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=6.4e-41  Score=348.73  Aligned_cols=250  Identities=23%  Similarity=0.420  Sum_probs=210.6

Q ss_pred             CCeeEeeEEeecCCeEEEEEEECCCC-----cEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEec
Q 004959          340 SQWQKGKLIGRGTFGSVYVASNRETG-----ALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVE  414 (721)
Q Consensus       340 ~~y~~~k~LG~G~fG~VY~a~~~~tg-----~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~  414 (721)
                      .+|++.+.||+|+||.||+|.....+     ..||+|.+..    .........+.+|+.+|..++||||+++++++...
T Consensus         5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~----~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~   80 (283)
T cd05048           5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKE----NAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKE   80 (283)
T ss_pred             HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEeccc----CCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCC
Confidence            36899999999999999999876554     7899998752    12344566789999999999999999999999999


Q ss_pred             CeEEEEEeeccCCCHHHHHHHhc---------------CCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCC
Q 004959          415 DKFYIYLEYVHPGSINKYVREHC---------------GAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDAS  479 (721)
Q Consensus       415 ~~~yLVmEy~~gGsL~~~L~~~~---------------~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~  479 (721)
                      +..|++|||+.+++|.+++....               ..+++..+..++.||+.||.|||++||+|+||||+|||++.+
T Consensus        81 ~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~~  160 (283)
T cd05048          81 QPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEG  160 (283)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcCC
Confidence            99999999999999999997531               457889999999999999999999999999999999999999


Q ss_pred             CceEEeecCCccccCCCcc---cccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhh-CCCCCCchhhH
Q 004959          480 GVVKLADFGMAKHLTGQKA---DLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGA  555 (721)
Q Consensus       480 g~VKL~DFGlA~~l~~~~~---~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLt-G~~PF~~~~~~  555 (721)
                      +.+||+|||++........   .....+++.|+|||++.       ...++.++|||||||++|||++ |..||.+....
T Consensus       161 ~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-------~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~  233 (283)
T cd05048         161 LTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAIL-------YGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQ  233 (283)
T ss_pred             CcEEECCCcceeeccccccccccCCCcccccccCHHHhc-------cCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHH
Confidence            9999999999976533221   12345688899999984       3446778999999999999998 99999887666


Q ss_pred             HHHHHHhhc-CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q 004959          556 AAMFKVMRD-TPAIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEH  600 (721)
Q Consensus       556 ~~~~ki~~~-~~~~p~~lS~el~dLI~~cL~~DP~kRPSa~eLL~H  600 (721)
                      +....+... ....+..++.++.+|+++||+.||++||++.|++++
T Consensus       234 ~~~~~i~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~  279 (283)
T cd05048         234 EVIEMIRSRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTR  279 (283)
T ss_pred             HHHHHHHcCCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            655555433 234567889999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-41  Score=346.27  Aligned_cols=258  Identities=31%  Similarity=0.538  Sum_probs=227.5

Q ss_pred             CCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCC-CCCeeeeeeeEEecCeEE
Q 004959          340 SQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLK-HPNIVQYYGSEIVEDKFY  418 (721)
Q Consensus       340 ~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~-HPnIV~l~g~~~~~~~~y  418 (721)
                      ++.+.+..||.|+-|+|++++.+.+|...|||.+..    ....+..++++..+.++...+ +|+||+++|+|..+...+
T Consensus        92 ndl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~r----t~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~  167 (391)
T KOG0983|consen   92 NDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRR----TGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVF  167 (391)
T ss_pred             HHhhhHHhhcCCCccceEEEEEcccceEEEEEeecc----cCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHH
Confidence            456677889999999999999999999999999863    345677889999998877765 999999999999999999


Q ss_pred             EEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhC-CeeccCCCCCcEEEcCCCceEEeecCCccccCCCc
Q 004959          419 IYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSK-KTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQK  497 (721)
Q Consensus       419 LVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~-gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~~  497 (721)
                      |.||.|. ..++.+++...+.++|..+-.+..-++.||.||.++ ||||||+||.|||+|+.|+|||||||++-.+.+..
T Consensus       168 IcMelMs-~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSk  246 (391)
T KOG0983|consen  168 ICMELMS-TCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSK  246 (391)
T ss_pred             HHHHHHH-HHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeecccccceeeccc
Confidence            9999994 678888888788999999999999999999999765 89999999999999999999999999999988888


Q ss_pred             ccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCc-hhhHHHHHHHhhcCCCC-C--CCCC
Q 004959          498 ADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSE-YEGAAAMFKVMRDTPAI-P--DSLS  573 (721)
Q Consensus       498 ~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~-~~~~~~~~ki~~~~~~~-p--~~lS  573 (721)
                      .+....|.+.|||||.+..    .....|+..+||||||+.|+||.||..||.+ ....+.+-+++++.+.. +  ..+|
T Consensus       247 AhtrsAGC~~YMaPERidp----~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~ePP~L~~~~gFS  322 (391)
T KOG0983|consen  247 AHTRSAGCAAYMAPERIDP----PDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEEPPLLPGHMGFS  322 (391)
T ss_pred             ccccccCCccccCccccCC----CCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcCCCCCCcccCcC
Confidence            8777889999999999853    1256788899999999999999999999987 35667777888765533 2  2489


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHHhccccccC
Q 004959          574 PEGKDFLRCCFQRNPADRPPASLLLEHRFLKNS  606 (721)
Q Consensus       574 ~el~dLI~~cL~~DP~kRPSa~eLL~Hp~f~~~  606 (721)
                      +++++|+..||++|+.+||.+.+||+|||+...
T Consensus       323 p~F~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~y  355 (391)
T KOG0983|consen  323 PDFQSFVKDCLTKDHRKRPKYNKLLEHPFIKRY  355 (391)
T ss_pred             HHHHHHHHHHhhcCcccCcchHHHhcCcceeec
Confidence            999999999999999999999999999999754

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=3.3e-41  Score=369.71  Aligned_cols=250  Identities=27%  Similarity=0.482  Sum_probs=206.2

Q ss_pred             CCeeEeeEEeecCCeEEEEEEECCC-----CcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhC-CCCCeeeeeeeEEe
Q 004959          340 SQWQKGKLIGRGTFGSVYVASNRET-----GALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHL-KHPNIVQYYGSEIV  413 (721)
Q Consensus       340 ~~y~~~k~LG~G~fG~VY~a~~~~t-----g~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L-~HPnIV~l~g~~~~  413 (721)
                      ++|++++.||+|+||.||+|++..+     +..||||++...    ...+..+.+.+|+.+|+.+ .|+|||++++++..
T Consensus        38 ~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~  113 (374)
T cd05106          38 DNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKAS----AHTDEREALMSELKILSHLGQHKNIVNLLGACTH  113 (374)
T ss_pred             HHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCC----CCHHHHHHHHHHHHHHHhhccCCceeeEeeEecC
Confidence            4699999999999999999986544     357999988532    2234466788999999999 89999999999999


Q ss_pred             cCeEEEEEeeccCCCHHHHHHHhc--------------------------------------------------------
Q 004959          414 EDKFYIYLEYVHPGSINKYVREHC--------------------------------------------------------  437 (721)
Q Consensus       414 ~~~~yLVmEy~~gGsL~~~L~~~~--------------------------------------------------------  437 (721)
                      .+.+|+|||||.+|+|.+++....                                                        
T Consensus       114 ~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  193 (374)
T cd05106         114 GGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQ  193 (374)
T ss_pred             CCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccc
Confidence            999999999999999999986431                                                        


Q ss_pred             -------------CCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCCccc---cc
Q 004959          438 -------------GAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKAD---LS  501 (721)
Q Consensus       438 -------------~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~~~~---~s  501 (721)
                                   ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.+......   ..
T Consensus       194 ~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~  273 (374)
T cd05106         194 SSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGN  273 (374)
T ss_pred             cccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccC
Confidence                         24788889999999999999999999999999999999999999999999999865433211   12


Q ss_pred             CCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhh-CCCCCCchhhHHHHHHHhhc--CCCCCCCCCHHHHH
Q 004959          502 MKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFKVMRD--TPAIPDSLSPEGKD  578 (721)
Q Consensus       502 ~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLt-G~~PF~~~~~~~~~~ki~~~--~~~~p~~lS~el~d  578 (721)
                      ..++..|||||++.       ...++.++|||||||++|||++ |+.||........+.+....  ....+..++.++.+
T Consensus       274 ~~~~~~y~aPE~~~-------~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  346 (374)
T cd05106         274 ARLPVKWMAPESIF-------DCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQMSRPDFAPPEIYS  346 (374)
T ss_pred             CCCccceeCHHHhc-------CCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCccCCCCCCHHHHH
Confidence            23566799999984       3456778999999999999997 99999876554444444433  23455678999999


Q ss_pred             HHHHhcccCCCCCCCHHHHHhc
Q 004959          579 FLRCCFQRNPADRPPASLLLEH  600 (721)
Q Consensus       579 LI~~cL~~DP~kRPSa~eLL~H  600 (721)
                      +|.+||+.||++||++.++++.
T Consensus       347 li~~cl~~dp~~RPs~~~l~~~  368 (374)
T cd05106         347 IMKMCWNLEPTERPTFSQISQL  368 (374)
T ss_pred             HHHHHcCCChhhCcCHHHHHHH
Confidence            9999999999999999999863

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=1.5e-40  Score=348.19  Aligned_cols=253  Identities=29%  Similarity=0.491  Sum_probs=204.7

Q ss_pred             CCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeEEE
Q 004959          340 SQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYI  419 (721)
Q Consensus       340 ~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~yL  419 (721)
                      ..|++.+.||+|+||.||+|.+..+|+.||||.+.......    ....+.+|+.+|+.++|+||+++++++...+..|+
T Consensus         5 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~----~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l   80 (291)
T cd07870           5 TSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEG----VPFTAIREASLLKGLKHANIVLLHDIIHTKETLTF   80 (291)
T ss_pred             ceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCC----CcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEE
Confidence            58999999999999999999999999999999986432111    12356789999999999999999999999999999


Q ss_pred             EEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCCc-c
Q 004959          420 YLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQK-A  498 (721)
Q Consensus       420 VmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~~-~  498 (721)
                      ||||+. ++|.+++......+.+..++.++.||+.||.|||++||+|+||||+|||++.++.+||+|||+++...... .
T Consensus        81 v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~  159 (291)
T cd07870          81 VFEYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQT  159 (291)
T ss_pred             EEeccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccccccCCCCCC
Confidence            999995 77877776555678899999999999999999999999999999999999999999999999987643322 2


Q ss_pred             cccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhH-HHHHHHhhc-------------
Q 004959          499 DLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGA-AAMFKVMRD-------------  564 (721)
Q Consensus       499 ~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~-~~~~ki~~~-------------  564 (721)
                      .....+++.|+|||++.+      ...++.++|||||||++|+|++|..||...... +.+.++...             
T Consensus       160 ~~~~~~~~~y~aPE~~~~------~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (291)
T cd07870         160 YSSEVVTLWYRPPDVLLG------ATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVS  233 (291)
T ss_pred             CCCccccccccCCceeec------CCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhh
Confidence            233457999999999842      234566899999999999999999999764432 222222110             


Q ss_pred             -CCC---------CC---------CCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccc
Q 004959          565 -TPA---------IP---------DSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFL  603 (721)
Q Consensus       565 -~~~---------~p---------~~lS~el~dLI~~cL~~DP~kRPSa~eLL~Hp~f  603 (721)
                       .+.         .+         ...+.++.+||.+||+.||++|||+.|+|.||||
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~  291 (291)
T cd07870         234 KLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF  291 (291)
T ss_pred             hcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence             000         00         0125788999999999999999999999999997

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=1.5e-40  Score=340.44  Aligned_cols=254  Identities=37%  Similarity=0.641  Sum_probs=218.2

Q ss_pred             CeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeEEEE
Q 004959          341 QWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYIY  420 (721)
Q Consensus       341 ~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~yLV  420 (721)
                      +|++.+.||+|+||.||+|.+..+|+.|+||++....    .....+.+.+|+.++.+++|+||+++++++...+..|+|
T Consensus         2 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~----~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   77 (264)
T cd06623           2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDG----DEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIV   77 (264)
T ss_pred             cceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCc----chHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEE
Confidence            6899999999999999999999999999999886421    114567899999999999999999999999999999999


Q ss_pred             EeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhh-CCeeccCCCCCcEEEcCCCceEEeecCCccccCCCccc
Q 004959          421 LEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHS-KKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKAD  499 (721)
Q Consensus       421 mEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs-~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~~~~  499 (721)
                      |||+++++|.+++... ..+++..+..++.||++||.|||+ +|++|+||+|+||+++.++.++|+|||++..+......
T Consensus        78 ~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~  156 (264)
T cd06623          78 LEYMDGGSLADLLKKV-GKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQ  156 (264)
T ss_pred             EEecCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceecccCCCc
Confidence            9999999999999765 779999999999999999999999 99999999999999999999999999999876544333


Q ss_pred             c-cCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchh---hHHHHHHHhhc-CCCCCCC-CC
Q 004959          500 L-SMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYE---GAAAMFKVMRD-TPAIPDS-LS  573 (721)
Q Consensus       500 ~-s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~---~~~~~~ki~~~-~~~~p~~-lS  573 (721)
                      . ...++..|+|||.+.       ...++.++|||||||++|+|++|..||....   ..+....+... ...++.. ++
T Consensus       157 ~~~~~~~~~y~~pE~~~-------~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (264)
T cd06623         157 CNTFVGTVTYMSPERIQ-------GESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEFS  229 (264)
T ss_pred             ccceeecccccCHhhhC-------CCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcCCCCCCCcccCC
Confidence            2 456889999999984       3356778999999999999999999997763   23333333322 2344455 88


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHHhccccccC
Q 004959          574 PEGKDFLRCCFQRNPADRPPASLLLEHRFLKNS  606 (721)
Q Consensus       574 ~el~dLI~~cL~~DP~kRPSa~eLL~Hp~f~~~  606 (721)
                      ..+.++|++||..+|++||++.++++||||+..
T Consensus       230 ~~l~~li~~~l~~~p~~R~~~~~ll~~~~~~~~  262 (264)
T cd06623         230 PEFRDFISACLQKDPKKRPSAAELLQHPFIKKA  262 (264)
T ss_pred             HHHHHHHHHHccCChhhCCCHHHHHhCHHHHhc
Confidence            999999999999999999999999999999753

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=4.9e-41  Score=347.03  Aligned_cols=254  Identities=33%  Similarity=0.586  Sum_probs=221.8

Q ss_pred             CCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCC-CCCeeeeeeeEEecCeEE
Q 004959          340 SQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLK-HPNIVQYYGSEIVEDKFY  418 (721)
Q Consensus       340 ~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~-HPnIV~l~g~~~~~~~~y  418 (721)
                      ++|++.+.||+|+||.||+|.+..+|+.||+|++...  ........+.+.+|+.+++++. |+||+++++++...+..+
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~   78 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKR--QLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLY   78 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechH--hccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEE
Confidence            3799999999999999999999999999999987532  1122334567889999999998 999999999999999999


Q ss_pred             EEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCCcc
Q 004959          419 IYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKA  498 (721)
Q Consensus       419 LVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~~~  498 (721)
                      +||||+.+++|.+++... +.+++..++.++.||+.||.|||++|++|+||||+||+|+.++.++|+|||++..+.....
T Consensus        79 lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~  157 (280)
T cd05581          79 FVLEYAPNGELLQYIRKY-GSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSS  157 (280)
T ss_pred             EEEcCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCccccccCCccc
Confidence            999999999999999765 5799999999999999999999999999999999999999999999999999886543221


Q ss_pred             ---------------------cccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHH
Q 004959          499 ---------------------DLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAA  557 (721)
Q Consensus       499 ---------------------~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~  557 (721)
                                           .....|+..|+|||++.       ...++.++|||||||++|+|++|..||........
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~-------~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~  230 (280)
T cd05581         158 PESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLN-------EKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLT  230 (280)
T ss_pred             cccCCCCCccccccccccccccccccCCccccCHHHhC-------CCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHH
Confidence                                 12345789999999884       34467789999999999999999999988766666


Q ss_pred             HHHHhhcCCCCCCCCCHHHHHHHHHhcccCCCCCCCH----HHHHhcccc
Q 004959          558 MFKVMRDTPAIPDSLSPEGKDFLRCCFQRNPADRPPA----SLLLEHRFL  603 (721)
Q Consensus       558 ~~ki~~~~~~~p~~lS~el~dLI~~cL~~DP~kRPSa----~eLL~Hp~f  603 (721)
                      +..+......++..+++++.+||++||+.||++||++    +++++||||
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~  280 (280)
T cd05581         231 FQKILKLEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF  280 (280)
T ss_pred             HHHHHhcCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence            6666666667888899999999999999999999999    999999997

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=3.1e-41  Score=355.99  Aligned_cols=257  Identities=32%  Similarity=0.580  Sum_probs=216.3

Q ss_pred             CCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeEEE
Q 004959          340 SQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYI  419 (721)
Q Consensus       340 ~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~yL  419 (721)
                      +.|.....||+|+||.||++.+..++..||||.+..     ......+.+.+|+.+++.++|+||+++++.+...+..|+
T Consensus        22 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~-----~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~l   96 (292)
T cd06658          22 EYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDL-----RKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWV   96 (292)
T ss_pred             HHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEec-----chHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEE
Confidence            456667789999999999999999999999998753     223445678899999999999999999999999999999


Q ss_pred             EEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCCcc-
Q 004959          420 YLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKA-  498 (721)
Q Consensus       420 VmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~~~-  498 (721)
                      ||||+.+++|.+++..  +.+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++..+..... 
T Consensus        97 v~e~~~~~~L~~~~~~--~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~  174 (292)
T cd06658          97 VMEFLEGGALTDIVTH--TRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPK  174 (292)
T ss_pred             EEeCCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchhhccccccc
Confidence            9999999999998854  4689999999999999999999999999999999999999999999999999876543222 


Q ss_pred             cccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhcCC---CCCCCCCHH
Q 004959          499 DLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTP---AIPDSLSPE  575 (721)
Q Consensus       499 ~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~~~---~~p~~lS~e  575 (721)
                      .....|+..|+|||++.       ...++.++|||||||++|||++|+.||........+..+.....   .....++.+
T Consensus       175 ~~~~~~~~~y~aPE~~~-------~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (292)
T cd06658         175 RKSLVGTPYWMAPEVIS-------RLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRVKDSHKVSSV  247 (292)
T ss_pred             CceeecCccccCHHHHc-------cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCccccccccCHH
Confidence            23356899999999984       33466789999999999999999999987655554444333221   222357889


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHHhccccccCCCCC
Q 004959          576 GKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQPD  610 (721)
Q Consensus       576 l~dLI~~cL~~DP~kRPSa~eLL~Hp~f~~~~~~~  610 (721)
                      +.+||.+||..||++|||++++++|+||.....+.
T Consensus       248 ~~~li~~~l~~~P~~Rpt~~~il~~~~~~~~~~~~  282 (292)
T cd06658         248 LRGFLDLMLVREPSQRATAQELLQHPFLKLAGPPS  282 (292)
T ss_pred             HHHHHHHHccCChhHCcCHHHHhhChhhhccCCcc
Confidence            99999999999999999999999999999766553

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=1.3e-40  Score=346.22  Aligned_cols=252  Identities=31%  Similarity=0.580  Sum_probs=209.4

Q ss_pred             CeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeEEEE
Q 004959          341 QWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYIY  420 (721)
Q Consensus       341 ~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~yLV  420 (721)
                      +|++.+.||.|+||.||+|++..+|+.||||++......    ...+.+.+|+.++++++|+||+++++++...+..|+|
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv   76 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEE----GTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLV   76 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccc----cchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEE
Confidence            489999999999999999999999999999998643221    1235677899999999999999999999999999999


Q ss_pred             EeeccCCCHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCCc-
Q 004959          421 LEYVHPGSINKYVREHC--GAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQK-  497 (721)
Q Consensus       421 mEy~~gGsL~~~L~~~~--~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~~-  497 (721)
                      |||+. ++|.+++....  ..+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++..+.... 
T Consensus        77 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~  155 (284)
T cd07836          77 FEYMD-KDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN  155 (284)
T ss_pred             EecCC-ccHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc
Confidence            99997 58988887653  468999999999999999999999999999999999999999999999999997654322 


Q ss_pred             ccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhcC------------
Q 004959          498 ADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDT------------  565 (721)
Q Consensus       498 ~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~~------------  565 (721)
                      ......++..|++||++.+      ...++.++|||||||++|+|++|+.||.+.+..+...++....            
T Consensus       156 ~~~~~~~~~~y~~PE~~~~------~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (284)
T cd07836         156 TFSNEVVTLWYRAPDVLLG------SRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGIS  229 (284)
T ss_pred             ccccccccccccChHHhcC------CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHh
Confidence            1223457899999999853      2345678999999999999999999998765554444332110            


Q ss_pred             --C----C-----------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccc
Q 004959          566 --P----A-----------IPDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFL  603 (721)
Q Consensus       566 --~----~-----------~p~~lS~el~dLI~~cL~~DP~kRPSa~eLL~Hp~f  603 (721)
                        .    .           +...++.++.++|.+||+.||++||++.++++||||
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f  284 (284)
T cd07836         230 QLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF  284 (284)
T ss_pred             cCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence              0    0           112467889999999999999999999999999998

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=5.5e-41  Score=342.77  Aligned_cols=249  Identities=30%  Similarity=0.560  Sum_probs=213.9

Q ss_pred             EeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeEEEEEeeccCC
Q 004959          348 IGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYIYLEYVHPG  427 (721)
Q Consensus       348 LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~yLVmEy~~gG  427 (721)
                      ||.|+||.||+|.+..+|+.|++|.+...  ........+.+.+|+.+++++.|+||+++++.+...+..|+||||+.++
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~   78 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKA--DMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGG   78 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecch--hhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCC
Confidence            68999999999999999999999988532  2222355678899999999999999999999999999999999999999


Q ss_pred             CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCCc---------c
Q 004959          428 SINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQK---------A  498 (721)
Q Consensus       428 sL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~~---------~  498 (721)
                      +|.+++... +.+++..+..++.||+.||.|||++||+|+||+|+|||++.++.++|+|||++.......         .
T Consensus        79 ~L~~~l~~~-~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~  157 (265)
T cd05579          79 DLASLLENV-GSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKE  157 (265)
T ss_pred             cHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccccccc
Confidence            999999765 479999999999999999999999999999999999999999999999999987643321         1


Q ss_pred             cccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhcCCCCCCCC--CHHH
Q 004959          499 DLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDSL--SPEG  576 (721)
Q Consensus       499 ~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~~~~~p~~l--S~el  576 (721)
                      .....++..|++||.+..       ...+.++|||||||++|+|++|..||......+....+.......+...  +.++
T Consensus       158 ~~~~~~~~~~~~Pe~~~~-------~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (265)
T cd05579         158 DKRIVGTPDYIAPEVILG-------QGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPEDVEVSDEA  230 (265)
T ss_pred             ccCcccCccccCHHHhcC-------CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCcCCCccccCCHHH
Confidence            223568899999999843       3366789999999999999999999987776666666655444555554  8999


Q ss_pred             HHHHHHhcccCCCCCCCH---HHHHhccccccC
Q 004959          577 KDFLRCCFQRNPADRPPA---SLLLEHRFLKNS  606 (721)
Q Consensus       577 ~dLI~~cL~~DP~kRPSa---~eLL~Hp~f~~~  606 (721)
                      .+||++||+.+|++|||+   .++|+||||++.
T Consensus       231 ~~~i~~~l~~~p~~Rpt~~~~~~~l~~~~~~~~  263 (265)
T cd05579         231 IDLISKLLVPDPEKRLGAKSIEEIKNHPFFKGI  263 (265)
T ss_pred             HHHHHHHhcCCHhhcCCCccHHHHhcCccccCC
Confidence            999999999999999999   999999999753

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=2e-40  Score=336.72  Aligned_cols=253  Identities=32%  Similarity=0.627  Sum_probs=219.3

Q ss_pred             CeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeEEEE
Q 004959          341 QWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYIY  420 (721)
Q Consensus       341 ~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~yLV  420 (721)
                      +|++.+.||.|+||.||+|.+..++..|++|++...   .......+.+.+|+++++.++|+||+++++.+...+..++|
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~---~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv   77 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLS---NMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIV   77 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecc---cCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEE
Confidence            588999999999999999999999999999998642   22345567788999999999999999999999999999999


Q ss_pred             EeeccCCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCCc
Q 004959          421 LEYVHPGSINKYVREH---CGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQK  497 (721)
Q Consensus       421 mEy~~gGsL~~~L~~~---~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~~  497 (721)
                      |||+++++|.+++...   ...+++..+..++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++.......
T Consensus        78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~  157 (258)
T cd08215          78 MEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV  157 (258)
T ss_pred             EEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence            9999999999999765   3779999999999999999999999999999999999999999999999999998765443


Q ss_pred             -ccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhc-CCCCCCCCCHH
Q 004959          498 -ADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRD-TPAIPDSLSPE  575 (721)
Q Consensus       498 -~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~-~~~~p~~lS~e  575 (721)
                       ......|++.|+|||.+.+       ..++.++||||||+++|+|++|..||............... ...++..++.+
T Consensus       158 ~~~~~~~~~~~y~~pe~~~~-------~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (258)
T cd08215         158 DLAKTVVGTPYYLSPELCQN-------KPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYPPIPSQYSSE  230 (258)
T ss_pred             ceecceeeeecccChhHhcc-------CCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCCCCCCCCCCCHH
Confidence             2234568999999999843       34667899999999999999999999876655555444433 44566688999


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHHhcccc
Q 004959          576 GKDFLRCCFQRNPADRPPASLLLEHRFL  603 (721)
Q Consensus       576 l~dLI~~cL~~DP~kRPSa~eLL~Hp~f  603 (721)
                      +.++|.+||..+|++||++.++|+||||
T Consensus       231 ~~~~i~~~l~~~p~~Rp~~~~ll~~~~~  258 (258)
T cd08215         231 LRNLVSSLLQKDPEERPSIAQILQSPFI  258 (258)
T ss_pred             HHHHHHHHcCCChhhCcCHHHHhcCCCC
Confidence            9999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1e-40  Score=346.20  Aligned_cols=255  Identities=36%  Similarity=0.694  Sum_probs=215.1

Q ss_pred             CeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCC---CCCeeeeeeeEEecCeE
Q 004959          341 QWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLK---HPNIVQYYGSEIVEDKF  417 (721)
Q Consensus       341 ~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~---HPnIV~l~g~~~~~~~~  417 (721)
                      .|++.+.||+|+||.||+|.+..+|+.||+|.+...    ......+.+.+|+.+++.+.   ||||+++++++......
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~----~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~   77 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLD----TPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRL   77 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCC----CCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEE
Confidence            478889999999999999999999999999987532    12234567889999999996   99999999999999999


Q ss_pred             EEEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCCc
Q 004959          418 YIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQK  497 (721)
Q Consensus       418 yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~~  497 (721)
                      |+||||+.|++|.+++..  +.+++..+..++.||+.||.|||+.||+|+||+|+||+++.++.++|+|||++..+....
T Consensus        78 ~lv~e~~~~~~L~~~~~~--~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~  155 (277)
T cd06917          78 WIIMEYAEGGSVRTLMKA--GPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNS  155 (277)
T ss_pred             EEEEecCCCCcHHHHHHc--cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCc
Confidence            999999999999999865  479999999999999999999999999999999999999999999999999998765433


Q ss_pred             c-cccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhc-CCCCCC-CCCH
Q 004959          498 A-DLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRD-TPAIPD-SLSP  574 (721)
Q Consensus       498 ~-~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~-~~~~p~-~lS~  574 (721)
                      . .....|+..|+|||.+.+      +..++.++|||||||++|+|++|..||...........+... .+.++. .++.
T Consensus       156 ~~~~~~~~~~~y~aPE~~~~------~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (277)
T cd06917         156 SKRSTFVGTPYWMAPEVITE------GKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKPPRLEDNGYSK  229 (277)
T ss_pred             cccccccCCcceeCHHHhcc------CCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccccCCCCCCCcccCCH
Confidence            2 234569999999999842      234567899999999999999999999876554444333222 223333 3788


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHHhccccccCC
Q 004959          575 EGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQ  607 (721)
Q Consensus       575 el~dLI~~cL~~DP~kRPSa~eLL~Hp~f~~~~  607 (721)
                      ++.+||.+||+.||++||++.+++.|+||+...
T Consensus       230 ~~~~~i~~~l~~~p~~R~~~~~il~~~~~~~~~  262 (277)
T cd06917         230 LLREFVAACLDEEPKERLSAEELLKSKWIKAHS  262 (277)
T ss_pred             HHHHHHHHHcCCCcccCcCHHHHhhChHhhccc
Confidence            999999999999999999999999999997654

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=2e-40  Score=345.40  Aligned_cols=253  Identities=38%  Similarity=0.701  Sum_probs=216.9

Q ss_pred             CeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeEEEE
Q 004959          341 QWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYIY  420 (721)
Q Consensus       341 ~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~yLV  420 (721)
                      -|++.+.||.|+||.||+|.+..+++.||||++...    ......+.+.+|+.++.+++|+||+++++++...+..|+|
T Consensus         5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~----~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   80 (277)
T cd06641           5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLE----EAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWII   80 (277)
T ss_pred             hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccc----cchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEE
Confidence            478889999999999999999999999999987531    2234557889999999999999999999999999999999


Q ss_pred             EeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCCcc-c
Q 004959          421 LEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKA-D  499 (721)
Q Consensus       421 mEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~~~-~  499 (721)
                      |||+.+++|.+++..  ..+++..+..++.||+.||.|||++|++|+||||.||+++.++.++|+|||++..+..... .
T Consensus        81 ~e~~~~~~l~~~i~~--~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~~~  158 (277)
T cd06641          81 MEYLGGGSALDLLEP--GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKR  158 (277)
T ss_pred             EEeCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceecccchhhh
Confidence            999999999999864  4789999999999999999999999999999999999999999999999999876644321 2


Q ss_pred             ccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhc-CCCCCCCCCHHHHH
Q 004959          500 LSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRD-TPAIPDSLSPEGKD  578 (721)
Q Consensus       500 ~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~-~~~~p~~lS~el~d  578 (721)
                      ....|+..|+|||.+.+       ...+.++|+|||||++|+|++|..||...........+... .+.++..++.++.+
T Consensus       159 ~~~~~~~~y~~PE~~~~-------~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (277)
T cd06641         159 NTFVGTPFWMAPEVIKQ-------SAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKE  231 (277)
T ss_pred             ccccCCccccChhhhcc-------CCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhcCCCCCCCcccCHHHHH
Confidence            33568999999999842       34566899999999999999999999876555444444332 33455678899999


Q ss_pred             HHHHhcccCCCCCCCHHHHHhccccccC
Q 004959          579 FLRCCFQRNPADRPPASLLLEHRFLKNS  606 (721)
Q Consensus       579 LI~~cL~~DP~kRPSa~eLL~Hp~f~~~  606 (721)
                      +|.+||+.+|++||++.++++||||...
T Consensus       232 ~i~~~l~~~p~~Rp~~~~~l~~~~~~~~  259 (277)
T cd06641         232 FVEACLNKEPSFRPTAKELLKHKFIVRF  259 (277)
T ss_pred             HHHHHccCChhhCcCHHHHHhCHHHhhh
Confidence            9999999999999999999999999874

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=1.2e-40  Score=340.95  Aligned_cols=243  Identities=25%  Similarity=0.441  Sum_probs=203.5

Q ss_pred             eEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeEEEEEeecc
Q 004959          346 KLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYIYLEYVH  425 (721)
Q Consensus       346 k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~yLVmEy~~  425 (721)
                      +.||+|+||.||+|++..+|+.||+|.+..    ....+....+.+|+++++.++||||+++++++...+..|+||||+.
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~----~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   76 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRE----TLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQ   76 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCc----cCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeecc
Confidence            368999999999999999999999998742    1234456778999999999999999999999999999999999999


Q ss_pred             CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCCcccc---cC
Q 004959          426 PGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADL---SM  502 (721)
Q Consensus       426 gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~~~~~---s~  502 (721)
                      +++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..........   ..
T Consensus        77 ~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~  156 (252)
T cd05084          77 GGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMK  156 (252)
T ss_pred             CCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCcccccccccccCCCC
Confidence            999999997765679999999999999999999999999999999999999999999999999987654321111   11


Q ss_pred             CCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhh-CCCCCCchhhHHHHHHHhhc-CCCCCCCCCHHHHHHH
Q 004959          503 KGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFKVMRD-TPAIPDSLSPEGKDFL  580 (721)
Q Consensus       503 ~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLt-G~~PF~~~~~~~~~~ki~~~-~~~~p~~lS~el~dLI  580 (721)
                      .++..|+|||.+.       ...++.++|||||||++|||++ |..||...........+... ....+..++.++.+||
T Consensus       157 ~~~~~y~aPE~~~-------~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  229 (252)
T cd05084         157 QIPVKWTAPEALN-------YGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRLPCPELCPDAVYRLM  229 (252)
T ss_pred             CCceeecCchhhc-------CCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCCcccCCHHHHHHH
Confidence            2345699999984       3446778999999999999997 99999765554444333332 3355667899999999


Q ss_pred             HHhcccCCCCCCCHHHHHh
Q 004959          581 RCCFQRNPADRPPASLLLE  599 (721)
Q Consensus       581 ~~cL~~DP~kRPSa~eLL~  599 (721)
                      .+||+.||++||++.++++
T Consensus       230 ~~~l~~~p~~Rps~~~~~~  248 (252)
T cd05084         230 ERCWEYDPGQRPSFSTVHQ  248 (252)
T ss_pred             HHHcCCChhhCcCHHHHHH
Confidence            9999999999999999975

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=5.5e-41  Score=360.34  Aligned_cols=262  Identities=27%  Similarity=0.479  Sum_probs=212.9

Q ss_pred             CCCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEe----c
Q 004959          339 NSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIV----E  414 (721)
Q Consensus       339 ~~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~----~  414 (721)
                      ...|++.+.||+|+||.||+|.+..+|+.||+|++....   ......+.+.+|+.+|++++||||+++++++..    .
T Consensus         4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~---~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   80 (334)
T cd07855           4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAF---DVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADF   80 (334)
T ss_pred             hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEecccc---ccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCC
Confidence            468999999999999999999999999999999886321   122345677889999999999999999998753    3


Q ss_pred             CeEEEEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccC
Q 004959          415 DKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLT  494 (721)
Q Consensus       415 ~~~yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~  494 (721)
                      ..+|+||||+. ++|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+.
T Consensus        81 ~~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~  158 (334)
T cd07855          81 KDVYVVMDLME-SDLHHIIHSD-QPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLS  158 (334)
T ss_pred             ceEEEEEehhh-hhHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEecccccceeec
Confidence            56899999995 6898888654 569999999999999999999999999999999999999999999999999997654


Q ss_pred             CCcc-----cccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhh------
Q 004959          495 GQKA-----DLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMR------  563 (721)
Q Consensus       495 ~~~~-----~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~------  563 (721)
                      ....     .....|+..|+|||++..      ...++.++|||||||++|+|++|+.||.+.+....+..+..      
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~------~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~  232 (334)
T cd07855         159 SSPTEHKYFMTEYVATRWYRAPELLLS------LPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPS  232 (334)
T ss_pred             ccCcCCCcccccccccccccChHHhcC------CcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCCh
Confidence            3221     123568999999999843      23466789999999999999999999976544332221111      


Q ss_pred             -----------------cC---CC-----CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhccccccCCCCCC
Q 004959          564 -----------------DT---PA-----IPDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQPDV  611 (721)
Q Consensus       564 -----------------~~---~~-----~p~~lS~el~dLI~~cL~~DP~kRPSa~eLL~Hp~f~~~~~~~~  611 (721)
                                       ..   ..     +...++.++.+||++||+.||++||++.+++.||||.....+..
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~~~~~~  305 (334)
T cd07855         233 EEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYHDPDD  305 (334)
T ss_pred             hHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhccCCcc
Confidence                             00   01     11346899999999999999999999999999999987766543

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=4.9e-41  Score=368.30  Aligned_cols=250  Identities=26%  Similarity=0.484  Sum_probs=205.7

Q ss_pred             CCeeEeeEEeecCCeEEEEEEE-----CCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhC-CCCCeeeeeeeEEe
Q 004959          340 SQWQKGKLIGRGTFGSVYVASN-----RETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHL-KHPNIVQYYGSEIV  413 (721)
Q Consensus       340 ~~y~~~k~LG~G~fG~VY~a~~-----~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L-~HPnIV~l~g~~~~  413 (721)
                      ++|++++.||+|+||.||+|+.     ..++..||||++...    ......+.+.+|+.+|..+ +|||||++++++..
T Consensus        35 ~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~----~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~  110 (375)
T cd05104          35 NRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPS----AHLTEREALMSELKVLSYLGNHINIVNLLGACTV  110 (375)
T ss_pred             HHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCC----cCcHHHHHHHHHHHHHHHhcCCcceeeeeeeecc
Confidence            4799999999999999999964     356778999987521    1223456788999999999 89999999999999


Q ss_pred             cCeEEEEEeeccCCCHHHHHHHhc--------------------------------------------------------
Q 004959          414 EDKFYIYLEYVHPGSINKYVREHC--------------------------------------------------------  437 (721)
Q Consensus       414 ~~~~yLVmEy~~gGsL~~~L~~~~--------------------------------------------------------  437 (721)
                      .+..|+|||||.||+|.+++....                                                        
T Consensus       111 ~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~  190 (375)
T cd05104         111 GGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVR  190 (375)
T ss_pred             CCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccc
Confidence            999999999999999999986532                                                        


Q ss_pred             ------------------CCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCCccc
Q 004959          438 ------------------GAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKAD  499 (721)
Q Consensus       438 ------------------~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~~~~  499 (721)
                                        ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.+......
T Consensus       191 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~  270 (375)
T cd05104         191 SGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNY  270 (375)
T ss_pred             cceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCccceeccCcccc
Confidence                              14678889999999999999999999999999999999999999999999999876433221


Q ss_pred             ---ccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhh-CCCCCCchhhHHHHHHHhhcC--CCCCCCCC
Q 004959          500 ---LSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFKVMRDT--PAIPDSLS  573 (721)
Q Consensus       500 ---~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLt-G~~PF~~~~~~~~~~ki~~~~--~~~p~~lS  573 (721)
                         ....++..|+|||++.       ...++.++|||||||++|||++ |..||........+.+.+...  ...+...+
T Consensus       271 ~~~~~~~~~~~y~aPE~~~-------~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  343 (375)
T cd05104         271 VVKGNARLPVKWMAPESIF-------NCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRMLSPECAP  343 (375)
T ss_pred             cccCCCCCCcceeChhHhc-------CCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCccCCCCCCCC
Confidence               1233556799999984       3456778999999999999998 999998765444444444332  23456678


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHHhc
Q 004959          574 PEGKDFLRCCFQRNPADRPPASLLLEH  600 (721)
Q Consensus       574 ~el~dLI~~cL~~DP~kRPSa~eLL~H  600 (721)
                      .++++||.+||+.||++||++.||++.
T Consensus       344 ~~l~~li~~cl~~dP~~RPs~~eil~~  370 (375)
T cd05104         344 SEMYDIMKSCWDADPLKRPTFKQIVQL  370 (375)
T ss_pred             HHHHHHHHHHccCChhHCcCHHHHHHH
Confidence            999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=3e-41  Score=351.11  Aligned_cols=254  Identities=38%  Similarity=0.703  Sum_probs=216.2

Q ss_pred             CCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeEEE
Q 004959          340 SQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYI  419 (721)
Q Consensus       340 ~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~yL  419 (721)
                      ..|+..+.||+|+||.||+|.+..+|+.||+|.+...    ......+.+.+|+.+++.++|+||+++++++...+..|+
T Consensus         4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~----~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   79 (277)
T cd06642           4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLE----EAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWI   79 (277)
T ss_pred             HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccc----cchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEE
Confidence            3577888999999999999999999999999987532    223456788999999999999999999999999999999


Q ss_pred             EEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCCcc-
Q 004959          420 YLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKA-  498 (721)
Q Consensus       420 VmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~~~-  498 (721)
                      ||||+.+++|.+++..  +.+++..++.++.||+.||.|||++||+|+||+|+||+++.++.++|+|||++..+..... 
T Consensus        80 v~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~  157 (277)
T cd06642          80 IMEYLGGGSALDLLKP--GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIK  157 (277)
T ss_pred             EEEccCCCcHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccccccccCcchh
Confidence            9999999999998864  5789999999999999999999999999999999999999999999999999987654322 


Q ss_pred             cccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhc-CCCCCCCCCHHHH
Q 004959          499 DLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRD-TPAIPDSLSPEGK  577 (721)
Q Consensus       499 ~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~-~~~~p~~lS~el~  577 (721)
                      .....|+..|+|||++.       ...++.++|||||||++|||++|..||...........+... .+.++..++.++.
T Consensus       158 ~~~~~~~~~y~aPE~~~-------~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (277)
T cd06642         158 RNTFVGTPFWMAPEVIK-------QSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPPTLEGQYSKPFK  230 (277)
T ss_pred             hhcccCcccccCHHHhC-------cCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhcCCCCCCCcccCHHHH
Confidence            23356899999999984       345677899999999999999999999765544444433322 2334556789999


Q ss_pred             HHHHHhcccCCCCCCCHHHHHhccccccC
Q 004959          578 DFLRCCFQRNPADRPPASLLLEHRFLKNS  606 (721)
Q Consensus       578 dLI~~cL~~DP~kRPSa~eLL~Hp~f~~~  606 (721)
                      ++|.+||+.+|++||++.++++|+||...
T Consensus       231 ~li~~~l~~~p~~Rp~~~~il~~~~~~~~  259 (277)
T cd06642         231 EFVEACLNKDPRFRPTAKELLKHKFITRY  259 (277)
T ss_pred             HHHHHHccCCcccCcCHHHHHHhHHHHHH
Confidence            99999999999999999999999999753

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=1.2e-40  Score=340.26  Aligned_cols=253  Identities=29%  Similarity=0.576  Sum_probs=214.6

Q ss_pred             CeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeEEEE
Q 004959          341 QWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYIY  420 (721)
Q Consensus       341 ~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~yLV  420 (721)
                      +|++.+.||+|+||.||+|.+..+|..||+|.+....   ......+.+.+|+.+++.++|+||+++++.+...+..|+|
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv   77 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTK---MPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIV   77 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhh---ccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEE
Confidence            4889999999999999999999999999999986421   1122345778999999999999999999999999999999


Q ss_pred             EeeccCCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCC-ceEEeecCCccccCCCcc
Q 004959          421 LEYVHPGSINKYVREHC-GAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASG-VVKLADFGMAKHLTGQKA  498 (721)
Q Consensus       421 mEy~~gGsL~~~L~~~~-~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g-~VKL~DFGlA~~l~~~~~  498 (721)
                      |||+.+++|.+++.... ..+++..+..++.||+.||.|||+++|+|+||||+||+++.++ .+||+|||++..+.....
T Consensus        78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~  157 (257)
T cd08225          78 MEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSME  157 (257)
T ss_pred             EecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccCCcc
Confidence            99999999999997643 3589999999999999999999999999999999999999886 469999999987654332


Q ss_pred             c-ccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhc-CCCCCCCCCHHH
Q 004959          499 D-LSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRD-TPAIPDSLSPEG  576 (721)
Q Consensus       499 ~-~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~-~~~~p~~lS~el  576 (721)
                      . ....|++.|+|||++.       ...++.++|||||||++|+|++|..||......+....+... .......++.++
T Consensus       158 ~~~~~~~~~~~~ape~~~-------~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (257)
T cd08225         158 LAYTCVGTPYYLSPEICQ-------NRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAPISPNFSRDL  230 (257)
T ss_pred             cccccCCCccccCHHHHc-------CCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcccCCCCCCCCCHHH
Confidence            2 2345899999999884       345667899999999999999999999876655555544433 234456788999


Q ss_pred             HHHHHHhcccCCCCCCCHHHHHhcccc
Q 004959          577 KDFLRCCFQRNPADRPPASLLLEHRFL  603 (721)
Q Consensus       577 ~dLI~~cL~~DP~kRPSa~eLL~Hp~f  603 (721)
                      .++|.+||+.+|++|||+.++++||||
T Consensus       231 ~~~i~~~l~~~p~~Rpt~~~ll~~~~~  257 (257)
T cd08225         231 RSLISQLFKVSPRDRPSITSILKRPFL  257 (257)
T ss_pred             HHHHHHHhccChhhCcCHHHHhhCCCC
Confidence            999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.4e-40  Score=334.53  Aligned_cols=252  Identities=48%  Similarity=0.868  Sum_probs=219.6

Q ss_pred             CeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeEEEE
Q 004959          341 QWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYIY  420 (721)
Q Consensus       341 ~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~yLV  420 (721)
                      +|++.+.||+|+||.||+|++..+++.|++|.+...   .......+.+.+|++++.++.|+||+++++++...+..|+|
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~---~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v   77 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLE---KIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYII   77 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEeccc---ccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEE
Confidence            488999999999999999999999999999998642   22235667899999999999999999999999999999999


Q ss_pred             EeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCCcc-c
Q 004959          421 LEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKA-D  499 (721)
Q Consensus       421 mEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~~~-~  499 (721)
                      |||+.+++|.+++... +.+++..+..++.||+.||.|||++||+||||||+||+++.++.++|+|||++........ .
T Consensus        78 ~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~  156 (254)
T cd06627          78 LEYAENGSLRQIIKKF-GPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDD  156 (254)
T ss_pred             EecCCCCcHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceecCCCcccc
Confidence            9999999999999765 6899999999999999999999999999999999999999999999999999987654433 2


Q ss_pred             ccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHh-hcCCCCCCCCCHHHHH
Q 004959          500 LSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVM-RDTPAIPDSLSPEGKD  578 (721)
Q Consensus       500 ~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~-~~~~~~p~~lS~el~d  578 (721)
                      ....|+..|+|||.+.+       ..++.++|||+||+++|+|++|..||..........+.. .....++..++.++.+
T Consensus       157 ~~~~~~~~y~~pe~~~~-------~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (254)
T cd06627         157 ASVVGTPYWMAPEVIEM-------SGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDHPPLPEGISPELKD  229 (254)
T ss_pred             cccccchhhcCHhhhcC-------CCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhccCCCCCCCCCCHHHHH
Confidence            34568999999999843       336678999999999999999999998765554444443 3445667788999999


Q ss_pred             HHHHhcccCCCCCCCHHHHHhcccc
Q 004959          579 FLRCCFQRNPADRPPASLLLEHRFL  603 (721)
Q Consensus       579 LI~~cL~~DP~kRPSa~eLL~Hp~f  603 (721)
                      +|.+||..+|++||++.+++.|+||
T Consensus       230 ~i~~~l~~~p~~R~~~~~~l~~~~~  254 (254)
T cd06627         230 FLMQCFQKDPNLRPTAKQLLKHPWI  254 (254)
T ss_pred             HHHHHHhCChhhCcCHHHHhcCCCC
Confidence            9999999999999999999999997

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=2.7e-40  Score=341.37  Aligned_cols=248  Identities=28%  Similarity=0.502  Sum_probs=210.5

Q ss_pred             CCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeEEE
Q 004959          340 SQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYI  419 (721)
Q Consensus       340 ~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~yL  419 (721)
                      .+|++.+.||+|+||.||+|.+..+++.||+|.+..   +   ....+.+.+|+.+|++++|+||+++++++..++.+++
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~---~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   79 (263)
T cd05052           6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE---D---TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI   79 (263)
T ss_pred             HHeEEeeecCCcccceEEEEEEecCCceEEEEEecC---C---chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEE
Confidence            368999999999999999999999999999998752   1   2234678899999999999999999999999999999


Q ss_pred             EEeeccCCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCCcc
Q 004959          420 YLEYVHPGSINKYVREH-CGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKA  498 (721)
Q Consensus       420 VmEy~~gGsL~~~L~~~-~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~~~  498 (721)
                      ||||+.+++|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..+.....
T Consensus        80 v~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~  159 (263)
T cd05052          80 ITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY  159 (263)
T ss_pred             EEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCcccccccccee
Confidence            99999999999999754 34689999999999999999999999999999999999999999999999999987654322


Q ss_pred             cc--cCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhh-CCCCCCchhhHHHHHHHhhc-CCCCCCCCCH
Q 004959          499 DL--SMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFKVMRD-TPAIPDSLSP  574 (721)
Q Consensus       499 ~~--s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLt-G~~PF~~~~~~~~~~ki~~~-~~~~p~~lS~  574 (721)
                      ..  ...++..|+|||++.       ...++.++|||||||++|||++ |..||.+....+....+... ....+..++.
T Consensus       160 ~~~~~~~~~~~y~aPE~~~-------~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (263)
T cd05052         160 TAHAGAKFPIKWTAPESLA-------YNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYRMERPEGCPP  232 (263)
T ss_pred             eccCCCCCccccCCHHHhc-------cCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCH
Confidence            11  223466799999884       3456678999999999999998 99999876655554444433 3456677899


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHHhc
Q 004959          575 EGKDFLRCCFQRNPADRPPASLLLEH  600 (721)
Q Consensus       575 el~dLI~~cL~~DP~kRPSa~eLL~H  600 (721)
                      ++.++|.+||+.||++||++.++++.
T Consensus       233 ~~~~li~~cl~~~p~~Rp~~~~l~~~  258 (263)
T cd05052         233 KVYELMRACWQWNPSDRPSFAEIHQA  258 (263)
T ss_pred             HHHHHHHHHccCCcccCCCHHHHHHH
Confidence            99999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=1.8e-40  Score=353.30  Aligned_cols=248  Identities=25%  Similarity=0.442  Sum_probs=206.4

Q ss_pred             CCeeEeeEEeecCCeEEEEEEECCCCcE----EEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecC
Q 004959          340 SQWQKGKLIGRGTFGSVYVASNRETGAL----CAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVED  415 (721)
Q Consensus       340 ~~y~~~k~LG~G~fG~VY~a~~~~tg~~----vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~  415 (721)
                      .+|++.+.||+|+||.||+|++..+|+.    ||||.+..    .......+++.+|+.+++.++||||+++++++... 
T Consensus         7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~----~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-   81 (316)
T cd05108           7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELRE----ATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-   81 (316)
T ss_pred             hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccc----cCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-
Confidence            4799999999999999999988766664    88998742    22334556788999999999999999999988764 


Q ss_pred             eEEEEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCC
Q 004959          416 KFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTG  495 (721)
Q Consensus       416 ~~yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~  495 (721)
                      ..++|+||+.+|+|.+++......+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.+..
T Consensus        82 ~~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~  161 (316)
T cd05108          82 TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA  161 (316)
T ss_pred             CceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEccccccccccC
Confidence            57899999999999999987666799999999999999999999999999999999999999999999999999987654


Q ss_pred             Ccccc---cCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhh-CCCCCCchhhHHHHHHHhhc--CCCCC
Q 004959          496 QKADL---SMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFKVMRD--TPAIP  569 (721)
Q Consensus       496 ~~~~~---s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLt-G~~PF~~~~~~~~~~ki~~~--~~~~p  569 (721)
                      .....   ...++..|+|||++.       ...++.++|||||||++|||++ |..||.+....+.. .+...  ....+
T Consensus       162 ~~~~~~~~~~~~~~~y~apE~~~-------~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~-~~~~~~~~~~~~  233 (316)
T cd05108         162 DEKEYHAEGGKVPIKWMALESIL-------HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS-SILEKGERLPQP  233 (316)
T ss_pred             CCcceeccCCccceeecChHHhc-------cCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHH-HHHhCCCCCCCC
Confidence            33322   223467899999984       3456778999999999999997 99999876544433 33322  22345


Q ss_pred             CCCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q 004959          570 DSLSPEGKDFLRCCFQRNPADRPPASLLLEH  600 (721)
Q Consensus       570 ~~lS~el~dLI~~cL~~DP~kRPSa~eLL~H  600 (721)
                      ..++.++.++|.+||+.||++||++.+++.+
T Consensus       234 ~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~  264 (316)
T cd05108         234 PICTIDVYMIMVKCWMIDADSRPKFRELIIE  264 (316)
T ss_pred             CCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            6688999999999999999999999999987

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=8.6e-41  Score=356.70  Aligned_cols=260  Identities=29%  Similarity=0.477  Sum_probs=217.5

Q ss_pred             CeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecC-----
Q 004959          341 QWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVED-----  415 (721)
Q Consensus       341 ~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~-----  415 (721)
                      +|++.+.||.|+||.||+|++..+|+.||||++....   ......+.+.+|+.+++.++|+||+++++++...+     
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~---~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~   77 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVF---DDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFN   77 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeecccc---ccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCccccc
Confidence            5889999999999999999999999999999886321   12344567899999999999999999999988775     


Q ss_pred             eEEEEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCC
Q 004959          416 KFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTG  495 (721)
Q Consensus       416 ~~yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~  495 (721)
                      .+|+||||+. ++|.+++... ..+++..++.++.||+.||.|||++||+||||||+||||+.++.++|+|||++.....
T Consensus        78 ~~~lv~e~~~-~~l~~~l~~~-~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~  155 (330)
T cd07834          78 DVYIVTELME-TDLHKVIKSP-QPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDP  155 (330)
T ss_pred             ceEEEecchh-hhHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCceEeecc
Confidence            7899999997 5898888654 5899999999999999999999999999999999999999999999999999987655


Q ss_pred             Cc----ccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhcCC-----
Q 004959          496 QK----ADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTP-----  566 (721)
Q Consensus       496 ~~----~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~~~-----  566 (721)
                      ..    ......++..|+|||++.+.      ..++.++|||||||++|+|++|..||......+.+..+.....     
T Consensus       156 ~~~~~~~~~~~~~~~~y~aPE~~~~~------~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~  229 (330)
T cd07834         156 DEDEKGFLTEYVVTRWYRAPELLLSS------SRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEE  229 (330)
T ss_pred             cccccccccccccccCcCCceeeecc------cCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChh
Confidence            43    12345689999999998531      2567789999999999999999999987665554444333111     


Q ss_pred             --------------------------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhccccccCCCCCC
Q 004959          567 --------------------------AIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQPDV  611 (721)
Q Consensus       567 --------------------------~~p~~lS~el~dLI~~cL~~DP~kRPSa~eLL~Hp~f~~~~~~~~  611 (721)
                                                .....++.++.+||.+||+.||++||++++++.||||.....+..
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~~~~  300 (330)
T cd07834         230 DLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHDPED  300 (330)
T ss_pred             HhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhccccc
Confidence                                      012346889999999999999999999999999999998766543

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=1.9e-40  Score=351.35  Aligned_cols=259  Identities=35%  Similarity=0.651  Sum_probs=218.0

Q ss_pred             CCCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeEE
Q 004959          339 NSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFY  418 (721)
Q Consensus       339 ~~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~y  418 (721)
                      ...|++.+.||+|+||.||+|.+..+|+.||+|++...  .....+..+.+.+|+.+++.++||||+++++++...+..|
T Consensus        14 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~   91 (307)
T cd06607          14 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYS--GKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAW   91 (307)
T ss_pred             chhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEecc--ccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEE
Confidence            35699999999999999999999999999999988532  2233455677899999999999999999999999999999


Q ss_pred             EEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCCcc
Q 004959          419 IYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKA  498 (721)
Q Consensus       419 LVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~~~  498 (721)
                      +||||+. |+|.+++......+++..+..++.||+.||.|||++||+||||+|+||+++.++.+||+|||++......  
T Consensus        92 lv~e~~~-g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~--  168 (307)
T cd06607          92 LVMEYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA--  168 (307)
T ss_pred             EEHHhhC-CCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCcceecCCC--
Confidence            9999997 6787777665577999999999999999999999999999999999999999999999999998765432  


Q ss_pred             cccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhcC-CCC-CCCCCHHH
Q 004959          499 DLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDT-PAI-PDSLSPEG  576 (721)
Q Consensus       499 ~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~~-~~~-p~~lS~el  576 (721)
                       ....|++.|+|||++.+.    ....++.++|||||||++|||++|+.||...........+.... +.. +..++.++
T Consensus       169 -~~~~~~~~y~aPE~~~~~----~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (307)
T cd06607         169 -NSFVGTPYWMAPEVILAM----DEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLSSNDWSDYF  243 (307)
T ss_pred             -CCccCCccccCceeeecc----CCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCCchhhCHHH
Confidence             245688999999987431    12446678999999999999999999998766555555444322 222 33578899


Q ss_pred             HHHHHHhcccCCCCCCCHHHHHhccccccCC
Q 004959          577 KDFLRCCFQRNPADRPPASLLLEHRFLKNSQ  607 (721)
Q Consensus       577 ~dLI~~cL~~DP~kRPSa~eLL~Hp~f~~~~  607 (721)
                      .++|.+||+.||++||++.+++.|+||....
T Consensus       244 ~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~  274 (307)
T cd06607         244 RNFVDSCLQKIPQDRPSSEELLKHRFVLRER  274 (307)
T ss_pred             HHHHHHHhcCChhhCcCHHHHhcChhhcccC
Confidence            9999999999999999999999999998653

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.4e-40  Score=347.79  Aligned_cols=256  Identities=27%  Similarity=0.518  Sum_probs=214.2

Q ss_pred             CCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeEEE
Q 004959          340 SQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYI  419 (721)
Q Consensus       340 ~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~yL  419 (721)
                      ++|++.+.||+|+||+||+|.+..+|+.||+|++...    ......+.+.+|+.+++.++||||+++++.+...+.+|+
T Consensus         5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~----~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l   80 (284)
T cd06620           5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIG----AKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICM   80 (284)
T ss_pred             HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEec----CcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEE
Confidence            4789999999999999999999999999999987632    123345788999999999999999999999999999999


Q ss_pred             EEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhh-CCeeccCCCCCcEEEcCCCceEEeecCCccccCCCcc
Q 004959          420 YLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHS-KKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKA  498 (721)
Q Consensus       420 VmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs-~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~~~  498 (721)
                      ||||+++++|.+++... +.+++..+..++.||+.||.|||+ .|++||||||+||+++.++.++|+|||++....... 
T Consensus        81 v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~-  158 (284)
T cd06620          81 CMEFMDCGSLDRIYKKG-GPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI-  158 (284)
T ss_pred             EEecCCCCCHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccchhhhc-
Confidence            99999999999998764 679999999999999999999997 699999999999999999999999999987653322 


Q ss_pred             cccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhH-----------HHHHHHhhc-CC
Q 004959          499 DLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGA-----------AAMFKVMRD-TP  566 (721)
Q Consensus       499 ~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~-----------~~~~ki~~~-~~  566 (721)
                      ....+|+..|+|||++.+       ..++.++|||||||++|+|++|..||......           +.+..+... .+
T Consensus       159 ~~~~~~~~~~~aPE~~~~-------~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (284)
T cd06620         159 ADTFVGTSTYMSPERIQG-------GKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPP  231 (284)
T ss_pred             cCccccCcccCCHHHHcc-------CCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccCC
Confidence            234579999999999843       35667899999999999999999999754321           222222222 22


Q ss_pred             CCCC-CCCHHHHHHHHHhcccCCCCCCCHHHHHhccccccCCC
Q 004959          567 AIPD-SLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQ  608 (721)
Q Consensus       567 ~~p~-~lS~el~dLI~~cL~~DP~kRPSa~eLL~Hp~f~~~~~  608 (721)
                      .++. .++.++.+||.+||+.||++||++.|+++|+||.....
T Consensus       232 ~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~~~  274 (284)
T cd06620         232 RLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQALR  274 (284)
T ss_pred             CCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccccc
Confidence            2333 37889999999999999999999999999999976543

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=9.6e-41  Score=369.18  Aligned_cols=249  Identities=26%  Similarity=0.435  Sum_probs=211.2

Q ss_pred             CCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeEEE
Q 004959          340 SQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYI  419 (721)
Q Consensus       340 ~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~yL  419 (721)
                      ++..++..||+|.||+||+|.+..   .||||+++..   .-..+.++.|.+|+.++++-+|.||+-+.|++..... .|
T Consensus       392 ~ev~l~~rIGsGsFGtV~Rg~whG---dVAVK~Lnv~---~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AI  464 (678)
T KOG0193|consen  392 EEVLLGERIGSGSFGTVYRGRWHG---DVAVKLLNVD---DPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AI  464 (678)
T ss_pred             HHhhccceeccccccceeeccccc---ceEEEEEecC---CCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-ee
Confidence            455678999999999999999864   5999998753   3345588999999999999999999999999887766 99


Q ss_pred             EEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCcccc---CCC
Q 004959          420 YLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHL---TGQ  496 (721)
Q Consensus       420 VmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l---~~~  496 (721)
                      |..+|+|.+|+.+|+-....|.....+.|++||+.||.|||.++|||||||..||++.+++.|||+||||+..-   .+.
T Consensus       465 iTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~g~  544 (678)
T KOG0193|consen  465 ITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRWSGE  544 (678)
T ss_pred             eehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEEEecccceeeeeeeccc
Confidence            99999999999999766678999999999999999999999999999999999999999999999999998653   233


Q ss_pred             cccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhcC-----CCCCCC
Q 004959          497 KADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDT-----PAIPDS  571 (721)
Q Consensus       497 ~~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~~-----~~~p~~  571 (721)
                      .......|...|||||+++..    ....|+..+|||||||++|||++|.+||........++.+-++.     ...-..
T Consensus       545 ~q~~qp~gsilwmAPEvIRmq----d~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~pd~s~~~s~  620 (678)
T KOG0193|consen  545 QQLEQPHGSLLWMAPEVIRMQ----DDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLMPDLSKIRSN  620 (678)
T ss_pred             cccCCCccchhhhcHHHHhhc----ccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccCccchhhhcc
Confidence            333445688999999999742    35678999999999999999999999999555555555544442     223345


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHHHHh
Q 004959          572 LSPEGKDFLRCCFQRNPADRPPASLLLE  599 (721)
Q Consensus       572 lS~el~dLI~~cL~~DP~kRPSa~eLL~  599 (721)
                      .+.++++|+..||.+++++||.+.+||.
T Consensus       621 ~pk~mk~Ll~~C~~~~~~eRP~F~~il~  648 (678)
T KOG0193|consen  621 CPKAMKRLLSDCWKFDREERPLFPQLLS  648 (678)
T ss_pred             CHHHHHHHHHHHHhcCcccCccHHHHHH
Confidence            6789999999999999999999999986

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=2.2e-40  Score=340.19  Aligned_cols=246  Identities=28%  Similarity=0.482  Sum_probs=207.9

Q ss_pred             CCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeEEE
Q 004959          340 SQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYI  419 (721)
Q Consensus       340 ~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~yL  419 (721)
                      ++|++.+.||+|+||.||++..+. +..+|+|.+...   ..   ..+.+.+|+.+|++++||||+++++++...+..|+
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~-~~~~a~K~~~~~---~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i   76 (256)
T cd05114           4 SELTFMKELGSGQFGVVHLGKWRA-QIKVAIKAINEG---AM---SEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYI   76 (256)
T ss_pred             HHcEEeeEecCCcCceEEEEEecc-CceEEEEecccC---Cc---cHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEE
Confidence            468999999999999999998764 568999986521   11   13567889999999999999999999999999999


Q ss_pred             EEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCCccc
Q 004959          420 YLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKAD  499 (721)
Q Consensus       420 VmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~~~~  499 (721)
                      ||||+++|+|.+++....+.+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++..+......
T Consensus        77 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~  156 (256)
T cd05114          77 VTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYT  156 (256)
T ss_pred             EEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCccccCCCcee
Confidence            99999999999999765567899999999999999999999999999999999999999999999999999865433221


Q ss_pred             --ccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhh-CCCCCCchhhHHHHHHHhhcC-CCCCCCCCHH
Q 004959          500 --LSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFKVMRDT-PAIPDSLSPE  575 (721)
Q Consensus       500 --~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLt-G~~PF~~~~~~~~~~ki~~~~-~~~p~~lS~e  575 (721)
                        ....++..|+|||++.       ...++.++|||||||++|+|++ |+.||......+.+..+.... ...+...+.+
T Consensus       157 ~~~~~~~~~~y~aPE~~~-------~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~  229 (256)
T cd05114         157 SSSGAKFPVKWSPPEVFN-------FSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYRPKLASMT  229 (256)
T ss_pred             ccCCCCCchhhCChhhcc-------cCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHH
Confidence              1223566899999984       2346678999999999999999 999998877666666665543 3345667889


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHHh
Q 004959          576 GKDFLRCCFQRNPADRPPASLLLE  599 (721)
Q Consensus       576 l~dLI~~cL~~DP~kRPSa~eLL~  599 (721)
                      +.+||.+||+.||++||++.++++
T Consensus       230 ~~~li~~c~~~~p~~Rps~~~l~~  253 (256)
T cd05114         230 VYEVMYSCWHEKPEGRPTFAELLR  253 (256)
T ss_pred             HHHHHHHHccCCcccCcCHHHHHH
Confidence            999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=4e-40  Score=339.41  Aligned_cols=252  Identities=30%  Similarity=0.538  Sum_probs=209.0

Q ss_pred             CCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeEEE
Q 004959          340 SQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYI  419 (721)
Q Consensus       340 ~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~yL  419 (721)
                      ++|++.+.||+|+||.||+|++..+|+.||||.+...  ..........+.+|+.+++.++||||+++++++...+..|+
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~--~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   79 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIF--EMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNI   79 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeecc--ccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEE
Confidence            4799999999999999999999999999999987642  22334556678899999999999999999999999999999


Q ss_pred             EEeeccCCCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCC
Q 004959          420 YLEYVHPGSINKYVRE---HCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQ  496 (721)
Q Consensus       420 VmEy~~gGsL~~~L~~---~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~  496 (721)
                      ||||+.+++|.+++..   ....+++..+..++.||+.||.|||++||+|+||||+||||+.++.++|+|||++..+...
T Consensus        80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~  159 (267)
T cd08228          80 VLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK  159 (267)
T ss_pred             EEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccccceeccch
Confidence            9999999999988853   2345899999999999999999999999999999999999999999999999998876443


Q ss_pred             cc-cccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhh--HHHHHHHhhc-CCC-CCCC
Q 004959          497 KA-DLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEG--AAAMFKVMRD-TPA-IPDS  571 (721)
Q Consensus       497 ~~-~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~--~~~~~ki~~~-~~~-~p~~  571 (721)
                      .. .....|++.|+|||.+.+       ..++.++|||||||++|+|++|..||.....  ......+... .+. ....
T Consensus       160 ~~~~~~~~~~~~~~aPE~~~~-------~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (267)
T cd08228         160 TTAAHSLVGTPYYMSPERIHE-------NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEH  232 (267)
T ss_pred             hHHHhcCCCCccccChhhhcc-------CCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCCCCCChhh
Confidence            22 223568999999999853       3456689999999999999999999965321  2222222221 122 2345


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q 004959          572 LSPEGKDFLRCCFQRNPADRPPASLLLEH  600 (721)
Q Consensus       572 lS~el~dLI~~cL~~DP~kRPSa~eLL~H  600 (721)
                      ++.++.++|.+||+.+|++||++.++++.
T Consensus       233 ~~~~~~~li~~cl~~~p~~Rp~~~~vl~~  261 (267)
T cd08228         233 YSEKLRELVSMCIYPDPDQRPDIGYVHQI  261 (267)
T ss_pred             cCHHHHHHHHHHCCCCcccCcCHHHHHHH
Confidence            78899999999999999999999999974

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=100.00  E-value=3.7e-42  Score=372.96  Aligned_cols=258  Identities=28%  Similarity=0.457  Sum_probs=220.7

Q ss_pred             CCCCeeE--eeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecC
Q 004959          338 MNSQWQK--GKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVED  415 (721)
Q Consensus       338 l~~~y~~--~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~  415 (721)
                      +..-|++  .++||.|-||+||-|+++.+|+.||||+|.+..-..+.   ...+++|+.||+.+.||.||.+.-.|++.+
T Consensus       560 ~stvYQif~devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kq---esqlR~EVaILq~l~HPGiV~le~M~ET~e  636 (888)
T KOG4236|consen  560 ISTVYQIFADEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQ---ESQLRNEVAILQNLHHPGIVNLECMFETPE  636 (888)
T ss_pred             HHHHHHhhhHhhccCCcceeeecceecccCceeeeeeeecccCCCch---HHHHHHHHHHHHhcCCCCeeEEEEeecCCc
Confidence            3344555  47999999999999999999999999999865322222   367899999999999999999999999999


Q ss_pred             eEEEEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCC---ceEEeecCCccc
Q 004959          416 KFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASG---VVKLADFGMAKH  492 (721)
Q Consensus       416 ~~yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g---~VKL~DFGlA~~  492 (721)
                      ++++|||-+.|.-|+-+|...++.|+|...+.++.||+.||.|||-++|+|+||||||||+....   ++||||||+|+.
T Consensus       637 rvFVVMEKl~GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARi  716 (888)
T KOG4236|consen  637 RVFVVMEKLHGDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARI  716 (888)
T ss_pred             eEEEEehhhcchHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceee
Confidence            99999999986666666666679999999999999999999999999999999999999996543   899999999999


Q ss_pred             cCCCcccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhcCCC----C
Q 004959          493 LTGQKADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPA----I  568 (721)
Q Consensus       493 l~~~~~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~~~~----~  568 (721)
                      +.+.....+.+|||.|+|||+|..       ..|...-||||+|||+|.-|.|..||.+.++  .-.+|.+....    .
T Consensus       717 IgEksFRrsVVGTPAYLaPEVLrn-------kGyNrSLDMWSVGVIiYVsLSGTFPFNEdEd--IndQIQNAaFMyPp~P  787 (888)
T KOG4236|consen  717 IGEKSFRRSVVGTPAYLAPEVLRN-------KGYNRSLDMWSVGVIIYVSLSGTFPFNEDED--INDQIQNAAFMYPPNP  787 (888)
T ss_pred             cchhhhhhhhcCCccccCHHHHhh-------ccccccccceeeeEEEEEEecccccCCCccc--hhHHhhccccccCCCc
Confidence            988777788999999999999954       4566778999999999999999999976432  22333333333    3


Q ss_pred             CCCCCHHHHHHHHHhcccCCCCCCCHHHHHhccccccCC
Q 004959          569 PDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQ  607 (721)
Q Consensus       569 p~~lS~el~dLI~~cL~~DP~kRPSa~eLL~Hp~f~~~~  607 (721)
                      +..++.++.|||..+|+..-.+|.++++.|.|||+++.+
T Consensus       788 W~eis~~AidlIn~LLqVkm~kRysvdk~lsh~Wlq~yq  826 (888)
T KOG4236|consen  788 WSEISPEAIDLINNLLQVKMRKRYSVDKSLSHPWLQDYQ  826 (888)
T ss_pred             hhhcCHHHHHHHHHHHHHHHHHhcchHhhccchhhhcch
Confidence            356999999999999999999999999999999998753

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=3.5e-40  Score=340.68  Aligned_cols=250  Identities=26%  Similarity=0.429  Sum_probs=210.7

Q ss_pred             CCeeEeeEEeecCCeEEEEEEECCC---CcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCe
Q 004959          340 SQWQKGKLIGRGTFGSVYVASNRET---GALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDK  416 (721)
Q Consensus       340 ~~y~~~k~LG~G~fG~VY~a~~~~t---g~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~  416 (721)
                      ++|++.+.||+|+||.||+|.+..+   ...||||.+...    ........+.+|+.+++.++|+||+++++++...+.
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~----~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   79 (266)
T cd05033           4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAG----SSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRP   79 (266)
T ss_pred             HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCC----CChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCc
Confidence            4789999999999999999987644   468999987531    233445678899999999999999999999999999


Q ss_pred             EEEEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCC
Q 004959          417 FYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQ  496 (721)
Q Consensus       417 ~yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~  496 (721)
                      .++||||+.+++|.+++....+.+++..+..++.||+.||.|||++||+|+||||+||||+.++.+||+|||++..+...
T Consensus        80 ~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~  159 (266)
T cd05033          80 VMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDS  159 (266)
T ss_pred             eEEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchhhccccc
Confidence            99999999999999999876678999999999999999999999999999999999999999999999999999877522


Q ss_pred             ccc---ccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhh-CCCCCCchhhHHHHHHHhhc-CCCCCCC
Q 004959          497 KAD---LSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFKVMRD-TPAIPDS  571 (721)
Q Consensus       497 ~~~---~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLt-G~~PF~~~~~~~~~~ki~~~-~~~~p~~  571 (721)
                      ...   ....++..|+|||.+.       ...++.++|||||||++|+|++ |..||......+....+... ....+..
T Consensus       160 ~~~~~~~~~~~~~~y~~Pe~~~-------~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  232 (266)
T cd05033         160 EATYTTKGGKIPIRWTAPEAIA-------YRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYRLPPPMD  232 (266)
T ss_pred             ccceeccCCCCCccccChhhhc-------cCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCCCCC
Confidence            211   1223567899999984       3456778999999999999998 99999776655555555443 2344567


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q 004959          572 LSPEGKDFLRCCFQRNPADRPPASLLLEH  600 (721)
Q Consensus       572 lS~el~dLI~~cL~~DP~kRPSa~eLL~H  600 (721)
                      ++.++.+||.+||+.+|++||++.|++++
T Consensus       233 ~~~~l~~li~~cl~~~p~~Rp~~~ei~~~  261 (266)
T cd05033         233 CPSALYQLMLDCWQKDRNERPTFSQIVST  261 (266)
T ss_pred             CCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            89999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=2.3e-40  Score=349.09  Aligned_cols=250  Identities=26%  Similarity=0.438  Sum_probs=207.2

Q ss_pred             CCeeEeeEEeecCCeEEEEEEECCCCc--EEEEEEeecCCCCcccHHHHHHHHHHHHHHHhC-CCCCeeeeeeeEEecCe
Q 004959          340 SQWQKGKLIGRGTFGSVYVASNRETGA--LCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHL-KHPNIVQYYGSEIVEDK  416 (721)
Q Consensus       340 ~~y~~~k~LG~G~fG~VY~a~~~~tg~--~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L-~HPnIV~l~g~~~~~~~  416 (721)
                      ++|++.++||+|+||+||+|....+|.  .+++|.+..    .......+.+.+|+.++.++ +||||+++++++...+.
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~----~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~   77 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKE----FASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGY   77 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccc----cCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCc
Confidence            579999999999999999999887775  468887642    12334456789999999999 79999999999999999


Q ss_pred             EEEEEeeccCCCHHHHHHHhc---------------CCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCc
Q 004959          417 FYIYLEYVHPGSINKYVREHC---------------GAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGV  481 (721)
Q Consensus       417 ~yLVmEy~~gGsL~~~L~~~~---------------~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~  481 (721)
                      +|+||||+++++|.+++....               ..+++..++.++.||+.||+|||++||+||||||+|||++.++.
T Consensus        78 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~  157 (297)
T cd05089          78 LYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLA  157 (297)
T ss_pred             ceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCCe
Confidence            999999999999999996532               35889999999999999999999999999999999999999999


Q ss_pred             eEEeecCCccccCCCcccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhh-CCCCCCchhhHHHHHH
Q 004959          482 VKLADFGMAKHLTGQKADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFK  560 (721)
Q Consensus       482 VKL~DFGlA~~l~~~~~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLt-G~~PF~~~~~~~~~~k  560 (721)
                      +||+|||++..............+..|+|||++.       ...++.++|||||||++|||++ |..||......+...+
T Consensus       158 ~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~-------~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~  230 (297)
T cd05089         158 SKIADFGLSRGEEVYVKKTMGRLPVRWMAIESLN-------YSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEK  230 (297)
T ss_pred             EEECCcCCCccccceeccCCCCcCccccCchhhc-------cCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence            9999999986433221222223356799999884       3446778999999999999997 9999988766665555


Q ss_pred             HhhcC-CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q 004959          561 VMRDT-PAIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEH  600 (721)
Q Consensus       561 i~~~~-~~~p~~lS~el~dLI~~cL~~DP~kRPSa~eLL~H  600 (721)
                      +.... ...+..++.++.+||.+||+.||.+||+++++++.
T Consensus       231 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~  271 (297)
T cd05089         231 LPQGYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQ  271 (297)
T ss_pred             HhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            55432 34566789999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=3.3e-40  Score=346.21  Aligned_cols=258  Identities=31%  Similarity=0.527  Sum_probs=210.4

Q ss_pred             CCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeEEE
Q 004959          340 SQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYI  419 (721)
Q Consensus       340 ~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~yL  419 (721)
                      ++|++.+.||+|+||.||+|.+..+|+.||||.+.....   .....+.+.+|++++++++|+||+++++++...+..|+
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   78 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQE---DEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYL   78 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccc---cccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEE
Confidence            479999999999999999999999999999998754221   12234567889999999999999999999999999999


Q ss_pred             EEeeccCCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcC-CCceEEeecCCccccCCCc
Q 004959          420 YLEYVHPGSINKYVREHC-GAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDA-SGVVKLADFGMAKHLTGQK  497 (721)
Q Consensus       420 VmEy~~gGsL~~~L~~~~-~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~-~g~VKL~DFGlA~~l~~~~  497 (721)
                      ||||+. ++|.+++.... ..+++..++.++.||+.||+|||++||+|+||||+||+++. ++.+||+|||++.......
T Consensus        79 v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~  157 (294)
T PLN00009         79 VFEYLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV  157 (294)
T ss_pred             EEeccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccCCCc
Confidence            999996 58888775542 23688899999999999999999999999999999999985 4579999999997653322


Q ss_pred             c-cccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhcC-----------
Q 004959          498 A-DLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDT-----------  565 (721)
Q Consensus       498 ~-~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~~-----------  565 (721)
                      . .....|++.|+|||++.+      ...++.++|||||||++|+|++|..||......+.+.++....           
T Consensus       158 ~~~~~~~~~~~y~~PE~~~~------~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (294)
T PLN00009        158 RTFTHEVVTLWYRAPEILLG------SRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGV  231 (294)
T ss_pred             cccccCceeecccCHHHHhC------CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhcccc
Confidence            1 223457899999999853      2346678999999999999999999998765555544432210           


Q ss_pred             ----------CC--------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhccccccCC
Q 004959          566 ----------PA--------IPDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQ  607 (721)
Q Consensus       566 ----------~~--------~p~~lS~el~dLI~~cL~~DP~kRPSa~eLL~Hp~f~~~~  607 (721)
                                +.        ....+++++.++|.+||+.||++||++.++++||||.+..
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~~~  291 (294)
T PLN00009        232 TSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDLG  291 (294)
T ss_pred             ccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhHHh
Confidence                      00        1235788999999999999999999999999999998754

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=1.3e-40  Score=352.12  Aligned_cols=255  Identities=32%  Similarity=0.584  Sum_probs=214.8

Q ss_pred             CeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeEEEE
Q 004959          341 QWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYIY  420 (721)
Q Consensus       341 ~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~yLV  420 (721)
                      .|.....||+|+||.||+|.+..+++.||||++....     ....+.+.+|+.+++.+.||||+++++++...+..|+|
T Consensus        22 ~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~-----~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv   96 (297)
T cd06659          22 LLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRK-----QQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVL   96 (297)
T ss_pred             hHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecc-----cchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEE
Confidence            4555668999999999999999999999999985321     12345688999999999999999999999999999999


Q ss_pred             EeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCCc-cc
Q 004959          421 LEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQK-AD  499 (721)
Q Consensus       421 mEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~~-~~  499 (721)
                      |||+++++|..++..  ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+.... ..
T Consensus        97 ~e~~~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~~  174 (297)
T cd06659          97 MEFLQGGALTDIVSQ--TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKR  174 (297)
T ss_pred             EecCCCCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhhcccccccc
Confidence            999999999988754  468999999999999999999999999999999999999999999999999987654332 22


Q ss_pred             ccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhcC---CCCCCCCCHHH
Q 004959          500 LSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDT---PAIPDSLSPEG  576 (721)
Q Consensus       500 ~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~~---~~~p~~lS~el  576 (721)
                      ....|+..|+|||++.+       ..++.++|||||||++|||++|+.||......+.+..+....   ...+..++.++
T Consensus       175 ~~~~~~~~y~aPE~~~~-------~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  247 (297)
T cd06659         175 KSLVGTPYWMAPEVISR-------TPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNAHKISPVL  247 (297)
T ss_pred             cceecCccccCHHHHcc-------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCccccCCCCHHH
Confidence            34679999999999843       346678999999999999999999997765555544443322   22334678899


Q ss_pred             HHHHHHhcccCCCCCCCHHHHHhccccccCCCC
Q 004959          577 KDFLRCCFQRNPADRPPASLLLEHRFLKNSQQP  609 (721)
Q Consensus       577 ~dLI~~cL~~DP~kRPSa~eLL~Hp~f~~~~~~  609 (721)
                      .++|.+||+.+|++||++.++++|+||.+...+
T Consensus       248 ~~~i~~~l~~~P~~Rps~~~ll~~~~~~~~~~~  280 (297)
T cd06659         248 RDFLERMLTREPQERATAQELLDHPFLLQTGLP  280 (297)
T ss_pred             HHHHHHHhcCCcccCcCHHHHhhChhhccCCCc
Confidence            999999999999999999999999999876543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=3.4e-40  Score=335.80  Aligned_cols=244  Identities=30%  Similarity=0.516  Sum_probs=210.3

Q ss_pred             eEEeecCCeEEEEEEECCC---CcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeEEEEEe
Q 004959          346 KLIGRGTFGSVYVASNRET---GALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYIYLE  422 (721)
Q Consensus       346 k~LG~G~fG~VY~a~~~~t---g~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~yLVmE  422 (721)
                      +.||+|+||.||+|.+...   +..|++|.+....    .....+.+.+|+.+++.++|+||+++++++.....+++|||
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~----~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e   76 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDA----SEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLE   76 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeecccc----chhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEE
Confidence            4799999999999998866   8999999886321    12256788999999999999999999999999999999999


Q ss_pred             eccCCCHHHHHHHh--------cCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccC
Q 004959          423 YVHPGSINKYVREH--------CGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLT  494 (721)
Q Consensus       423 y~~gGsL~~~L~~~--------~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~  494 (721)
                      |+.+++|.+++...        ...+++..++.++.||+.||+|||++||+|+||||+||+++.++.+||+|||++..+.
T Consensus        77 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~  156 (262)
T cd00192          77 YMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVY  156 (262)
T ss_pred             eccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEcccccccccc
Confidence            99999999999875        4779999999999999999999999999999999999999999999999999998765


Q ss_pred             CCc---ccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhh-CCCCCCchhhHHHHHHHhhc-CCCCC
Q 004959          495 GQK---ADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFKVMRD-TPAIP  569 (721)
Q Consensus       495 ~~~---~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLt-G~~PF~~~~~~~~~~ki~~~-~~~~p  569 (721)
                      ...   ......++..|+|||.+..       ..++.++|||||||++|+|++ |..||......+....+... ....+
T Consensus       157 ~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~  229 (262)
T cd00192         157 DDDYYRKKTGGKLPIRWMAPESLKD-------GIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYRLPKP  229 (262)
T ss_pred             cccccccccCCCcCccccCHHHhcc-------CCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCC
Confidence            432   2234557899999999843       356778999999999999999 69999887666655555533 34556


Q ss_pred             CCCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q 004959          570 DSLSPEGKDFLRCCFQRNPADRPPASLLLEH  600 (721)
Q Consensus       570 ~~lS~el~dLI~~cL~~DP~kRPSa~eLL~H  600 (721)
                      ..++.++.++|.+||+.||++||++.+++++
T Consensus       230 ~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~  260 (262)
T cd00192         230 EYCPDELYELMLSCWQLDPEDRPTFSELVER  260 (262)
T ss_pred             ccCChHHHHHHHHHccCCcccCcCHHHHHHh
Confidence            7789999999999999999999999999975

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=5.4e-40  Score=344.68  Aligned_cols=254  Identities=33%  Similarity=0.594  Sum_probs=215.6

Q ss_pred             CeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeEEEE
Q 004959          341 QWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYIY  420 (721)
Q Consensus       341 ~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~yLV  420 (721)
                      .|...+.||+|+||.||++.+..+++.+++|.+...     .....+.+.+|+.+++.+.|+||+++++++...+..|+|
T Consensus        20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~-----~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v   94 (285)
T cd06648          20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLR-----KQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVV   94 (285)
T ss_pred             hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEecc-----chhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEE
Confidence            566678999999999999999999999999987532     223345688999999999999999999999999999999


Q ss_pred             EeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCCc-cc
Q 004959          421 LEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQK-AD  499 (721)
Q Consensus       421 mEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~~-~~  499 (721)
                      |||+.|++|.+++..  +.+++..+..++.||+.||.|||++||+||||+|+||+++.++.++|+|||++....... ..
T Consensus        95 ~e~~~~~~L~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~~  172 (285)
T cd06648          95 MEFLEGGALTDIVTH--TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRR  172 (285)
T ss_pred             EeccCCCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhhccCCccc
Confidence            999999999999876  579999999999999999999999999999999999999999999999999887654322 22


Q ss_pred             ccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhcCCC---CCCCCCHHH
Q 004959          500 LSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPA---IPDSLSPEG  576 (721)
Q Consensus       500 ~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~~~~---~p~~lS~el  576 (721)
                      ....|++.|+|||.+.+       ..++.++|||||||++|+|++|+.||........+..+......   .+..++.++
T Consensus       173 ~~~~~~~~y~aPE~~~~-------~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  245 (285)
T cd06648         173 KSLVGTPYWMAPEVISR-------LPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKLKNLHKVSPRL  245 (285)
T ss_pred             ccccCCccccCHHHhcC-------CCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcCCCCCcccccCCHHH
Confidence            33568999999999843       34567899999999999999999999876655555554443221   123478999


Q ss_pred             HHHHHHhcccCCCCCCCHHHHHhccccccCCC
Q 004959          577 KDFLRCCFQRNPADRPPASLLLEHRFLKNSQQ  608 (721)
Q Consensus       577 ~dLI~~cL~~DP~kRPSa~eLL~Hp~f~~~~~  608 (721)
                      .+||.+||+.||++||++.++++|+||.....
T Consensus       246 ~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~  277 (285)
T cd06648         246 RSFLDRMLVRDPAQRATAAELLNHPFLAKAGP  277 (285)
T ss_pred             HHHHHHHcccChhhCcCHHHHccCcccccCCC
Confidence            99999999999999999999999999987654

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=2.5e-40  Score=350.60  Aligned_cols=250  Identities=26%  Similarity=0.456  Sum_probs=205.8

Q ss_pred             CCeeEeeEEeecCCeEEEEEEECCCCcEE--EEEEeecCCCCcccHHHHHHHHHHHHHHHhC-CCCCeeeeeeeEEecCe
Q 004959          340 SQWQKGKLIGRGTFGSVYVASNRETGALC--AMKEVDIFPDDPKSAESIKQLEQEIKVLSHL-KHPNIVQYYGSEIVEDK  416 (721)
Q Consensus       340 ~~y~~~k~LG~G~fG~VY~a~~~~tg~~v--AIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L-~HPnIV~l~g~~~~~~~  416 (721)
                      ++|++.+.||+|+||.||+|.++.+|..+  |+|.+.    ........+.+.+|+.++.++ +|+||+++++++...+.
T Consensus         7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~----~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~   82 (303)
T cd05088           7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMK----EYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGY   82 (303)
T ss_pred             hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEec----ccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCC
Confidence            57999999999999999999988888654  666543    122344567888999999999 89999999999999999


Q ss_pred             EEEEEeeccCCCHHHHHHHhc---------------CCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCc
Q 004959          417 FYIYLEYVHPGSINKYVREHC---------------GAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGV  481 (721)
Q Consensus       417 ~yLVmEy~~gGsL~~~L~~~~---------------~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~  481 (721)
                      +|+||||+++++|.+++....               ..+++..++.++.||+.||+|||++||+||||||+||||+.++.
T Consensus        83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~~~  162 (303)
T cd05088          83 LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYV  162 (303)
T ss_pred             ceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCCCc
Confidence            999999999999999997542               25789999999999999999999999999999999999999999


Q ss_pred             eEEeecCCccccCCCcccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhh-CCCCCCchhhHHHHHH
Q 004959          482 VKLADFGMAKHLTGQKADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFK  560 (721)
Q Consensus       482 VKL~DFGlA~~l~~~~~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLt-G~~PF~~~~~~~~~~k  560 (721)
                      +||+|||++.............++..|+|||++.+       ..++.++|||||||+||||++ |..||......+....
T Consensus       163 ~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~  235 (303)
T cd05088         163 AKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNY-------SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEK  235 (303)
T ss_pred             EEeCccccCcccchhhhcccCCCcccccCHHHHhc-------cCCcccccchhhhhHHHHHHhcCCCCcccCChHHHHHH
Confidence            99999999864322212222234667999998843       345678999999999999998 9999987665555444


Q ss_pred             Hhhc-CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q 004959          561 VMRD-TPAIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEH  600 (721)
Q Consensus       561 i~~~-~~~~p~~lS~el~dLI~~cL~~DP~kRPSa~eLL~H  600 (721)
                      +... ....+..++.++.+||.+||+.+|++||++++++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  276 (303)
T cd05088         236 LPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS  276 (303)
T ss_pred             HhcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            4333 223455688999999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=2.5e-40  Score=343.28  Aligned_cols=249  Identities=29%  Similarity=0.504  Sum_probs=209.4

Q ss_pred             CCeeEeeEEeecCCeEEEEEEEC-----CCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEec
Q 004959          340 SQWQKGKLIGRGTFGSVYVASNR-----ETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVE  414 (721)
Q Consensus       340 ~~y~~~k~LG~G~fG~VY~a~~~-----~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~  414 (721)
                      .+|.+.+.||+|+||.||+|.+.     .+++.||||.+...    ...+..+.+.+|+++|+.+.|+||+++++++...
T Consensus         5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   80 (280)
T cd05049           5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKET----ASNDARKDFEREAELLTNFQHENIVKFYGVCTEG   80 (280)
T ss_pred             HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeeccc----CCHHHHHHHHHHHHHHHhcCCCCchheeeEEecC
Confidence            46888999999999999999874     34688999987532    2233567889999999999999999999999999


Q ss_pred             CeEEEEEeeccCCCHHHHHHHhc-------------CCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCc
Q 004959          415 DKFYIYLEYVHPGSINKYVREHC-------------GAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGV  481 (721)
Q Consensus       415 ~~~yLVmEy~~gGsL~~~L~~~~-------------~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~  481 (721)
                      ...|+||||+.+++|.+++...+             ..+++..+..++.||+.||.|||++||+||||||+|||++.++.
T Consensus        81 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~  160 (280)
T cd05049          81 DPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLV  160 (280)
T ss_pred             CCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCCe
Confidence            99999999999999999997542             34788999999999999999999999999999999999999999


Q ss_pred             eEEeecCCccccCCCcc---cccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhh-CCCCCCchhhHHH
Q 004959          482 VKLADFGMAKHLTGQKA---DLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAA  557 (721)
Q Consensus       482 VKL~DFGlA~~l~~~~~---~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLt-G~~PF~~~~~~~~  557 (721)
                      +||+|||++..+.....   .....+++.|+|||++.       ...++.++|||||||++|||++ |..||......+.
T Consensus       161 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-------~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~  233 (280)
T cd05049         161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIM-------YRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEV  233 (280)
T ss_pred             EEECCcccceecccCcceecCCCCcccceecChhhhc-------cCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHH
Confidence            99999999976533221   12334678899999984       3456778999999999999998 9999987666665


Q ss_pred             HHHHhhcC-CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHh
Q 004959          558 MFKVMRDT-PAIPDSLSPEGKDFLRCCFQRNPADRPPASLLLE  599 (721)
Q Consensus       558 ~~ki~~~~-~~~p~~lS~el~dLI~~cL~~DP~kRPSa~eLL~  599 (721)
                      ...+.... ...+..++.++.+||.+||+.||++||++.|+++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~  276 (280)
T cd05049         234 IECITQGRLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHE  276 (280)
T ss_pred             HHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            55555433 2345678999999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=5.3e-40  Score=342.74  Aligned_cols=250  Identities=22%  Similarity=0.424  Sum_probs=208.2

Q ss_pred             CCeeEeeEEeecCCeEEEEEEE----CCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecC
Q 004959          340 SQWQKGKLIGRGTFGSVYVASN----RETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVED  415 (721)
Q Consensus       340 ~~y~~~k~LG~G~fG~VY~a~~----~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~  415 (721)
                      .+|++.+.||+|+||+||+|..    ..++..||+|.+..    ....+....+.+|+.+++.++||||+++++++...+
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~----~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~   80 (283)
T cd05090           5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKD----INNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQ   80 (283)
T ss_pred             hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccC----CCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCC
Confidence            4789999999999999999985    34668899998752    123445578889999999999999999999999999


Q ss_pred             eEEEEEeeccCCCHHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCC
Q 004959          416 KFYIYLEYVHPGSINKYVREHC----------------GAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDAS  479 (721)
Q Consensus       416 ~~yLVmEy~~gGsL~~~L~~~~----------------~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~  479 (721)
                      ..|+||||+.+++|.+++....                ..+++..+..++.||+.||.|||++||+||||||+|||++.+
T Consensus        81 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~~  160 (283)
T cd05090          81 PVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQ  160 (283)
T ss_pred             ceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcCC
Confidence            9999999999999999985321                247889999999999999999999999999999999999999


Q ss_pred             CceEEeecCCccccCCCc---ccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhh-CCCCCCchhhH
Q 004959          480 GVVKLADFGMAKHLTGQK---ADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGA  555 (721)
Q Consensus       480 g~VKL~DFGlA~~l~~~~---~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLt-G~~PF~~~~~~  555 (721)
                      +.+||+|||+++.+....   ......++..|+|||++.+       ..++.++|||||||++|||++ |..||.+....
T Consensus       161 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~  233 (283)
T cd05090         161 LHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMY-------GKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQ  233 (283)
T ss_pred             CcEEeccccccccccCCcceecccCCCccceecChHHhcc-------CCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH
Confidence            999999999998764332   1223446778999999842       346778999999999999998 99999876554


Q ss_pred             HHHHHHhhc-CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q 004959          556 AAMFKVMRD-TPAIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEH  600 (721)
Q Consensus       556 ~~~~ki~~~-~~~~p~~lS~el~dLI~~cL~~DP~kRPSa~eLL~H  600 (721)
                      +....+... ....+..++.++.++|.+||+.||++||++.+|+++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~  279 (283)
T cd05090         234 EVIEMVRKRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTR  279 (283)
T ss_pred             HHHHHHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence            444444332 234567789999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=4.9e-40  Score=341.99  Aligned_cols=251  Identities=23%  Similarity=0.385  Sum_probs=207.3

Q ss_pred             CCCeeEeeEEeecCCeEEEEEEEC-----CCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEe
Q 004959          339 NSQWQKGKLIGRGTFGSVYVASNR-----ETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIV  413 (721)
Q Consensus       339 ~~~y~~~k~LG~G~fG~VY~a~~~-----~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~  413 (721)
                      .++|++.+.||+|+||+||+|.+.     .++..||||.+..    .........+.+|+.+++.++|+||+++++++..
T Consensus         5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~----~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~   80 (277)
T cd05062           5 REKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNE----AASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ   80 (277)
T ss_pred             HHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccc----cCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcC
Confidence            457999999999999999999764     3457899998742    1223345678899999999999999999999999


Q ss_pred             cCeEEEEEeeccCCCHHHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEE
Q 004959          414 EDKFYIYLEYVHPGSINKYVREHC---------GAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKL  484 (721)
Q Consensus       414 ~~~~yLVmEy~~gGsL~~~L~~~~---------~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL  484 (721)
                      ....++||||+.+++|.+++....         ..+++..+..++.||+.||.|||++|++|+||||+|||++.++.+||
T Consensus        81 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~~~l  160 (277)
T cd05062          81 GQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKI  160 (277)
T ss_pred             CCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCCEEE
Confidence            999999999999999999997532         23567889999999999999999999999999999999999999999


Q ss_pred             eecCCccccCCCcc---cccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhh-CCCCCCchhhHHHHHH
Q 004959          485 ADFGMAKHLTGQKA---DLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFK  560 (721)
Q Consensus       485 ~DFGlA~~l~~~~~---~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLt-G~~PF~~~~~~~~~~k  560 (721)
                      +|||++..+.....   .....+++.|||||++.+       ..++.++|||||||++|||++ |..||.+....+....
T Consensus       161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~  233 (277)
T cd05062         161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKD-------GVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRF  233 (277)
T ss_pred             CCCCCccccCCcceeecCCCCccCHhhcChhHhhc-------CCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence            99999876543221   112345788999999853       446778999999999999999 7899987766555544


Q ss_pred             Hhhc-CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q 004959          561 VMRD-TPAIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEH  600 (721)
Q Consensus       561 i~~~-~~~~p~~lS~el~dLI~~cL~~DP~kRPSa~eLL~H  600 (721)
                      +... ....+..++.++.+||.+||+.||++||++.|++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~  274 (277)
T cd05062         234 VMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS  274 (277)
T ss_pred             HHcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            4433 345667789999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4e-40  Score=338.62  Aligned_cols=248  Identities=29%  Similarity=0.527  Sum_probs=204.6

Q ss_pred             eEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHH-HhCCCCCeeeeeeeEEecCeEEEEEeec
Q 004959          346 KLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVL-SHLKHPNIVQYYGSEIVEDKFYIYLEYV  424 (721)
Q Consensus       346 k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL-~~L~HPnIV~l~g~~~~~~~~yLVmEy~  424 (721)
                      +.||.|+||.||+|.+..+|+.||||.+...  ..........+..|..++ ..+.|+||+++++++...+.+|+||||+
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~--~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~   79 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKS--DMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYL   79 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecch--hhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEecc
Confidence            5799999999999999999999999987532  111122333445555544 4558999999999999999999999999


Q ss_pred             cCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCCcccccCCC
Q 004959          425 HPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKG  504 (721)
Q Consensus       425 ~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~~~~~s~~G  504 (721)
                      .+++|.+++... +.+++..+..++.||+.||.|||+.||+|+||+|.|||++.++.+||+|||++.....   .....|
T Consensus        80 ~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~---~~~~~~  155 (260)
T cd05611          80 NGGDCASLIKTL-GGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE---NKKFVG  155 (260)
T ss_pred             CCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceeccc---cccCCC
Confidence            999999999764 6799999999999999999999999999999999999999999999999999876433   234568


Q ss_pred             CCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhcCC----CCCCCCCHHHHHHH
Q 004959          505 SPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTP----AIPDSLSPEGKDFL  580 (721)
Q Consensus       505 T~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~~~----~~p~~lS~el~dLI  580 (721)
                      +..|+|||.+.+       ..++.++|||||||++|+|++|..||...........+.....    .....++.++.++|
T Consensus       156 ~~~y~~pe~~~~-------~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i  228 (260)
T cd05611         156 TPDYLAPETILG-------VGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLI  228 (260)
T ss_pred             CcCccChhhhcC-------CCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCCCCcccccCCHHHHHHH
Confidence            899999999853       2366789999999999999999999987666555554433322    23346789999999


Q ss_pred             HHhcccCCCCCC---CHHHHHhccccccC
Q 004959          581 RCCFQRNPADRP---PASLLLEHRFLKNS  606 (721)
Q Consensus       581 ~~cL~~DP~kRP---Sa~eLL~Hp~f~~~  606 (721)
                      .+||+.||++||   +++|+|.||||.+.
T Consensus       229 ~~~l~~~p~~R~~~~~~~~~l~~~~~~~~  257 (260)
T cd05611         229 NRLLCMDPAKRLGANGYQEIKSHPFFKSI  257 (260)
T ss_pred             HHHccCCHHHccCCCcHHHHHcChHhhcC
Confidence            999999999999   55899999999764

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=5e-40  Score=354.87  Aligned_cols=260  Identities=26%  Similarity=0.454  Sum_probs=215.8

Q ss_pred             CCCCCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCe
Q 004959          337 PMNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDK  416 (721)
Q Consensus       337 ~l~~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~  416 (721)
                      .+.++|++.+.||+|+||.||+|.+..+++.||||++...   .......+.+.+|+.+++.+.|+||+++++++...+.
T Consensus        12 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~---~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   88 (343)
T cd07851          12 EVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRP---FQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASS   88 (343)
T ss_pred             cccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccc---cchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccc
Confidence            4567899999999999999999999999999999987532   1223345677889999999999999999998776554


Q ss_pred             ------EEEEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCc
Q 004959          417 ------FYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMA  490 (721)
Q Consensus       417 ------~yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA  490 (721)
                            .|+|+||+ +++|.+++..  ..+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++
T Consensus        89 ~~~~~~~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~dfg~~  165 (343)
T cd07851          89 LEDFQDVYLVTHLM-GADLNNIVKC--QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLA  165 (343)
T ss_pred             ccccccEEEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEcccccc
Confidence                  89999999 6799998865  57999999999999999999999999999999999999999999999999999


Q ss_pred             cccCCCcccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhcCC----
Q 004959          491 KHLTGQKADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTP----  566 (721)
Q Consensus       491 ~~l~~~~~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~~~----  566 (721)
                      ......  .....++..|+|||++.+      ...++.++|||||||++|+|++|+.||........+..+.....    
T Consensus       166 ~~~~~~--~~~~~~~~~y~aPE~~~~------~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~  237 (343)
T cd07851         166 RHTDDE--MTGYVATRWYRAPEIMLN------WMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDE  237 (343)
T ss_pred             cccccc--ccCCcccccccCHHHHhC------CCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCH
Confidence            876433  234568999999999853      22466789999999999999999999987655544443322110    


Q ss_pred             ---------------------------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhccccccCCCCC
Q 004959          567 ---------------------------AIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQPD  610 (721)
Q Consensus       567 ---------------------------~~p~~lS~el~dLI~~cL~~DP~kRPSa~eLL~Hp~f~~~~~~~  610 (721)
                                                 .....++.++.+||.+||+.||++|||+.+|++||||.....+.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~~~~~  308 (343)
T cd07851         238 ELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYHDPE  308 (343)
T ss_pred             HHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCccccCCCc
Confidence                                       01124689999999999999999999999999999998766553

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.3e-39  Score=341.37  Aligned_cols=256  Identities=32%  Similarity=0.549  Sum_probs=209.5

Q ss_pred             CCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEec--CeE
Q 004959          340 SQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVE--DKF  417 (721)
Q Consensus       340 ~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~--~~~  417 (721)
                      +.|+..+.||.|+||.||+|.+..+++.||+|.+...    ........+.+|++++++++||||+++++++...  +.+
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~----~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   76 (287)
T cd06621           1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTD----PNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSI   76 (287)
T ss_pred             CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecC----CchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeE
Confidence            3689999999999999999999999999999988632    1224456789999999999999999999988653  478


Q ss_pred             EEEEeeccCCCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccC
Q 004959          418 YIYLEYVHPGSINKYVRE---HCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLT  494 (721)
Q Consensus       418 yLVmEy~~gGsL~~~L~~---~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~  494 (721)
                      |+||||++|++|.+++..   ....+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++....
T Consensus        77 ~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~  156 (287)
T cd06621          77 GIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELV  156 (287)
T ss_pred             EEEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeecccccccc
Confidence            999999999999988753   23568999999999999999999999999999999999999999999999999987654


Q ss_pred             CCcccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchh-----hHHHHHHHhh-cCCCC
Q 004959          495 GQKADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYE-----GAAAMFKVMR-DTPAI  568 (721)
Q Consensus       495 ~~~~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~-----~~~~~~ki~~-~~~~~  568 (721)
                      .... ....++..|+|||.+.       ...++.++|||||||++|+|++|..||....     ..+....+.. ....+
T Consensus       157 ~~~~-~~~~~~~~y~~pE~~~-------~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (287)
T cd06621         157 NSLA-GTFTGTSFYMAPERIQ-------GKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPEL  228 (287)
T ss_pred             cccc-ccccCCccccCHHHhc-------CCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhh
Confidence            3222 2356889999999984       3456778999999999999999999997651     1222222222 11111


Q ss_pred             C------CCCCHHHHHHHHHhcccCCCCCCCHHHHHhccccccCC
Q 004959          569 P------DSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQ  607 (721)
Q Consensus       569 p------~~lS~el~dLI~~cL~~DP~kRPSa~eLL~Hp~f~~~~  607 (721)
                      +      ..+++++.+||.+||..||++|||+.|+++|+||+...
T Consensus       229 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~~~  273 (287)
T cd06621         229 KDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQM  273 (287)
T ss_pred             ccCCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCccccccc
Confidence            1      23567899999999999999999999999999997643

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=5.5e-40  Score=338.47  Aligned_cols=249  Identities=23%  Similarity=0.407  Sum_probs=206.5

Q ss_pred             eeEeeEEeecCCeEEEEEEECC---CCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCe--
Q 004959          342 WQKGKLIGRGTFGSVYVASNRE---TGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDK--  416 (721)
Q Consensus       342 y~~~k~LG~G~fG~VY~a~~~~---tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~--  416 (721)
                      |++++.||+|+||.||+|....   ++..||||.+..   +.........+.+|+.+|+.++|+||+++++++.....  
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~---~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   77 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKL---DIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQ   77 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEecc---CcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccc
Confidence            5788999999999999998765   348899998753   22334556789999999999999999999998766544  


Q ss_pred             ----EEEEEeeccCCCHHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeec
Q 004959          417 ----FYIYLEYVHPGSINKYVREH-----CGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADF  487 (721)
Q Consensus       417 ----~yLVmEy~~gGsL~~~L~~~-----~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DF  487 (721)
                          .++||||+.+|+|..++...     ...+++..+..++.||+.||.|||++||+||||||+|||+++++.+||+||
T Consensus        78 ~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~df  157 (273)
T cd05035          78 KIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADF  157 (273)
T ss_pred             cCcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEECCc
Confidence                79999999999999998543     135899999999999999999999999999999999999999999999999


Q ss_pred             CCccccCCCccc---ccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhh-CCCCCCchhhHHHHHHHhh
Q 004959          488 GMAKHLTGQKAD---LSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFKVMR  563 (721)
Q Consensus       488 GlA~~l~~~~~~---~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLt-G~~PF~~~~~~~~~~ki~~  563 (721)
                      |+++.+......   ....++..|+|||.+.       ...++.++|||||||++|||++ |..||.+....+.+..+..
T Consensus       158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~-------~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~  230 (273)
T cd05035         158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLA-------DRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRH  230 (273)
T ss_pred             cceeeccccccccccccccCCccccCHhhcc-------cCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc
Confidence            999876433221   1123567899999983       3456778999999999999999 9999988766665555443


Q ss_pred             c-CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q 004959          564 D-TPAIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEH  600 (721)
Q Consensus       564 ~-~~~~p~~lS~el~dLI~~cL~~DP~kRPSa~eLL~H  600 (721)
                      . ....+..++.++.++|.+||+.||++||++.|++++
T Consensus       231 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~  268 (273)
T cd05035         231 GNRLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREV  268 (273)
T ss_pred             CCCCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            3 345677889999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=9.6e-40  Score=353.21  Aligned_cols=293  Identities=25%  Similarity=0.408  Sum_probs=225.2

Q ss_pred             CCCCCCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEec-
Q 004959          336 LPMNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVE-  414 (721)
Q Consensus       336 ~~l~~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~-  414 (721)
                      ..+.++|++.+.||+|+||.||+|.+..+|+.||+|++...   .......+.+.+|+.++++++|+||+++++++... 
T Consensus        13 ~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~   89 (345)
T cd07877          13 WEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP---FQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPAR   89 (345)
T ss_pred             hhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCc---chhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecc
Confidence            34567899999999999999999999999999999988531   12223356788899999999999999999987643 


Q ss_pred             -----CeEEEEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCC
Q 004959          415 -----DKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGM  489 (721)
Q Consensus       415 -----~~~yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGl  489 (721)
                           ..+|++++++ |++|.+++..  ..+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||+
T Consensus        90 ~~~~~~~~~lv~~~~-~~~L~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~dfg~  166 (345)
T cd07877          90 SLEEFNDVYLVTHLM-GADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGL  166 (345)
T ss_pred             cccccccEEEEehhc-ccCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEecccc
Confidence                 3478899988 7899888764  4699999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCCcccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhc-----
Q 004959          490 AKHLTGQKADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRD-----  564 (721)
Q Consensus       490 A~~l~~~~~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~-----  564 (721)
                      +.....  ......|+..|+|||++.+      ...++.++|||||||++|+|++|+.||........+..+...     
T Consensus       167 ~~~~~~--~~~~~~~~~~y~aPE~~~~------~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~  238 (345)
T cd07877         167 ARHTDD--EMTGYVATRWYRAPEIMLN------WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG  238 (345)
T ss_pred             cccccc--cccccccCCCccCHHHHhC------ccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence            876532  2234568999999999852      234567899999999999999999999765443332222110     


Q ss_pred             ------------------CCCC--------CCCCCHHHHHHHHHhcccCCCCCCCHHHHHhccccccCCCCCCCCccccc
Q 004959          565 ------------------TPAI--------PDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQPDVPSCSLSF  618 (721)
Q Consensus       565 ------------------~~~~--------p~~lS~el~dLI~~cL~~DP~kRPSa~eLL~Hp~f~~~~~~~~~~~~~~~  618 (721)
                                        ....        ....++++.+||.+||+.||++|+++.+++.||||+....+........+
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~~~~~~~~~~~~~~  318 (345)
T cd07877         239 AELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPY  318 (345)
T ss_pred             HHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhhcCCCCccccCCCc
Confidence                              0011        12357889999999999999999999999999999986665443322222


Q ss_pred             CCCCCCCCCCChhHHHhhhHHHHHh
Q 004959          619 SGMQLTEKPHSPREKADAKYDQVAA  643 (721)
Q Consensus       619 ~~~~l~~~~~~~~~~~~~~~d~~~~  643 (721)
                      .. .+........+.....|+++..
T Consensus       319 ~~-~~~~~~~~~~~~~~~~~~~~~~  342 (345)
T cd07877         319 DQ-SFESRDLLIDEWKSLTYDEVIS  342 (345)
T ss_pred             cC-cchhcccCHHHHHHHHHHHHHh
Confidence            11 1112222335556677777654

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=6.9e-40  Score=341.29  Aligned_cols=250  Identities=26%  Similarity=0.410  Sum_probs=207.9

Q ss_pred             CCeeEeeEEeecCCeEEEEEEECC-----CCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEec
Q 004959          340 SQWQKGKLIGRGTFGSVYVASNRE-----TGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVE  414 (721)
Q Consensus       340 ~~y~~~k~LG~G~fG~VY~a~~~~-----tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~  414 (721)
                      +.|++.+.||+|+||.||+|.+..     ++..||+|.+...    ........+.+|+.+++.++|+||+++++++...
T Consensus         6 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~----~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   81 (277)
T cd05036           6 DSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPES----CSEQDESDFLMEALIMSKFNHQNIVRLIGVSFER   81 (277)
T ss_pred             HHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCC----CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccC
Confidence            579999999999999999999877     7889999987532    2233446788999999999999999999999999


Q ss_pred             CeEEEEEeeccCCCHHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCC---ceEEe
Q 004959          415 DKFYIYLEYVHPGSINKYVREHC------GAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASG---VVKLA  485 (721)
Q Consensus       415 ~~~yLVmEy~~gGsL~~~L~~~~------~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g---~VKL~  485 (721)
                      +..|+||||+.|++|.+++....      ..+++..+..++.||+.||+|||++|++||||||+|||++.++   .+||+
T Consensus        82 ~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~  161 (277)
T cd05036          82 LPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIA  161 (277)
T ss_pred             CCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEec
Confidence            99999999999999999997653      2589999999999999999999999999999999999998765   58999


Q ss_pred             ecCCccccCCCccc---ccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhh-CCCCCCchhhHHHHHHH
Q 004959          486 DFGMAKHLTGQKAD---LSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFKV  561 (721)
Q Consensus       486 DFGlA~~l~~~~~~---~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLt-G~~PF~~~~~~~~~~ki  561 (721)
                      |||+++.+......   ....++..|+|||++.+       ..++.++|||||||++|||++ |..||......+....+
T Consensus       162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~  234 (277)
T cd05036         162 DFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLD-------GIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFV  234 (277)
T ss_pred             cCccccccCCccceecCCCCCccHhhCCHHHHhc-------CCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence            99999876332211   12223567999999953       446778999999999999997 99999876655544444


Q ss_pred             hhc-CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q 004959          562 MRD-TPAIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEH  600 (721)
Q Consensus       562 ~~~-~~~~p~~lS~el~dLI~~cL~~DP~kRPSa~eLL~H  600 (721)
                      ... ....+..++.++.+||.+||+.||++||++.++++|
T Consensus       235 ~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~  274 (277)
T cd05036         235 TGGGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILER  274 (277)
T ss_pred             HcCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            332 334567789999999999999999999999999987

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=3.3e-40  Score=348.23  Aligned_cols=254  Identities=29%  Similarity=0.502  Sum_probs=203.1

Q ss_pred             CeeEeeEEeecCCeEEEEEEECC--CCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEec--Ce
Q 004959          341 QWQKGKLIGRGTFGSVYVASNRE--TGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVE--DK  416 (721)
Q Consensus       341 ~y~~~k~LG~G~fG~VY~a~~~~--tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~--~~  416 (721)
                      +|++.+.||+|+||.||+|.+..  +|+.||||.+.....  ......+.+.+|+.++..++||||+++++++.+.  +.
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   78 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKE--QYTGISQSACREIALLRELKHENVVSLVEVFLEHADKS   78 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccc--cccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCce
Confidence            48899999999999999999988  899999999864221  1122235678899999999999999999999988  88


Q ss_pred             EEEEEeeccCCCHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcC----CCceEEeecC
Q 004959          417 FYIYLEYVHPGSINKYVREHC----GAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDA----SGVVKLADFG  488 (721)
Q Consensus       417 ~yLVmEy~~gGsL~~~L~~~~----~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~----~g~VKL~DFG  488 (721)
                      +|+||||+. ++|.+++....    ..+++..++.++.||+.||.|||++||+||||||+|||++.    ++.+||+|||
T Consensus        79 ~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg  157 (316)
T cd07842          79 VYLLFDYAE-HDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLG  157 (316)
T ss_pred             EEEEEeCCC-cCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCc
Confidence            999999996 57777765332    36899999999999999999999999999999999999999    8999999999


Q ss_pred             CccccCCCcc----cccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHH--------
Q 004959          489 MAKHLTGQKA----DLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAA--------  556 (721)
Q Consensus       489 lA~~l~~~~~----~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~--------  556 (721)
                      ++..+.....    .....++..|+|||++.+      ...++.++|||||||+||+|++|+.||.......        
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~  231 (316)
T cd07842         158 LARLFNAPLKPLADLDPVVVTIWYRAPELLLG------ARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQR  231 (316)
T ss_pred             cccccCCCcccccccCCccccccccCHHHHhC------CCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHH
Confidence            9987543322    223468899999999853      2345678999999999999999999997533211        


Q ss_pred             -HHHHHhh--------------------------cCCCCC-----------CCCCHHHHHHHHHhcccCCCCCCCHHHHH
Q 004959          557 -AMFKVMR--------------------------DTPAIP-----------DSLSPEGKDFLRCCFQRNPADRPPASLLL  598 (721)
Q Consensus       557 -~~~ki~~--------------------------~~~~~p-----------~~lS~el~dLI~~cL~~DP~kRPSa~eLL  598 (721)
                       .+..+..                          ....++           ...+.++.++|.+||+.||++|||+.|++
T Consensus       232 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil  311 (316)
T cd07842         232 DQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEAL  311 (316)
T ss_pred             HHHHHHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHh
Confidence             1111000                          000111           15677899999999999999999999999


Q ss_pred             hcccc
Q 004959          599 EHRFL  603 (721)
Q Consensus       599 ~Hp~f  603 (721)
                      +||||
T Consensus       312 ~~~~f  316 (316)
T cd07842         312 EHPYF  316 (316)
T ss_pred             cCCCC
Confidence            99998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=9.3e-40  Score=342.61  Aligned_cols=257  Identities=24%  Similarity=0.383  Sum_probs=209.3

Q ss_pred             CCCeeEeeEEeecCCeEEEEEEECC-----CCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEe
Q 004959          339 NSQWQKGKLIGRGTFGSVYVASNRE-----TGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIV  413 (721)
Q Consensus       339 ~~~y~~~k~LG~G~fG~VY~a~~~~-----tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~  413 (721)
                      .++|++.+.||+|+||.||+|..+.     .+..||+|.+...    ........+.+|+.+++.++|+||+++++++..
T Consensus         5 ~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~   80 (288)
T cd05061           5 REKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNES----ASLRERIEFLNEASVMKGFTCHHVVRLLGVVSK   80 (288)
T ss_pred             HHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCc----CCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcC
Confidence            3589999999999999999997542     3568999987521    222334467889999999999999999999999


Q ss_pred             cCeEEEEEeeccCCCHHHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEE
Q 004959          414 EDKFYIYLEYVHPGSINKYVREHC---------GAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKL  484 (721)
Q Consensus       414 ~~~~yLVmEy~~gGsL~~~L~~~~---------~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL  484 (721)
                      .+..|+||||+.+|+|.+++....         ..+....+..++.||+.||.|||++||+||||||+|||++.++.+||
T Consensus        81 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~~~L  160 (288)
T cd05061          81 GQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKI  160 (288)
T ss_pred             CCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCcEEE
Confidence            999999999999999999997532         23466788999999999999999999999999999999999999999


Q ss_pred             eecCCccccCCCcc---cccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhh-CCCCCCchhhHHHHHH
Q 004959          485 ADFGMAKHLTGQKA---DLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFK  560 (721)
Q Consensus       485 ~DFGlA~~l~~~~~---~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLt-G~~PF~~~~~~~~~~k  560 (721)
                      +|||+++.+.....   .....++..|+|||.+.       ...++.++|||||||++|||++ |..||.+....+....
T Consensus       161 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~-------~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~  233 (288)
T cd05061         161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLK-------DGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKF  233 (288)
T ss_pred             CcCCccccccccccccccCCCcccccccCHHHhc-------cCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence            99999986543221   11233567899999984       3456778999999999999998 8899987665555444


Q ss_pred             Hhhc-CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHh------ccccccC
Q 004959          561 VMRD-TPAIPDSLSPEGKDFLRCCFQRNPADRPPASLLLE------HRFLKNS  606 (721)
Q Consensus       561 i~~~-~~~~p~~lS~el~dLI~~cL~~DP~kRPSa~eLL~------Hp~f~~~  606 (721)
                      +... ....+..++.++.++|.+||+.||++||++.++++      ||||.+.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~~  286 (288)
T cd05061         234 VMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPEV  286 (288)
T ss_pred             HHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCCCC
Confidence            4433 34456677899999999999999999999999986      7777653

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=3e-40  Score=343.65  Aligned_cols=252  Identities=31%  Similarity=0.576  Sum_probs=207.8

Q ss_pred             eeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeEEEEE
Q 004959          342 WQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYIYL  421 (721)
Q Consensus       342 y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~yLVm  421 (721)
                      |++.+.||.|++|.||+|.+..+|..||+|++.....   .....+.+.+|+.+++.++|+||+++++++.+.+..|+||
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~---~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~   77 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETE---DEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVF   77 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccc---cccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEE
Confidence            6778899999999999999999999999998864221   1223356788999999999999999999999999999999


Q ss_pred             eeccCCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCCc-cc
Q 004959          422 EYVHPGSINKYVREHC-GAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQK-AD  499 (721)
Q Consensus       422 Ey~~gGsL~~~L~~~~-~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~~-~~  499 (721)
                      ||+. ++|.+++.... ..+++..+..++.||+.||.|||+++++||||+|+||+++.++.++|+|||++..+.... ..
T Consensus        78 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~  156 (283)
T cd07835          78 EFLD-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTY  156 (283)
T ss_pred             eccC-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCcccc
Confidence            9995 68999987653 368999999999999999999999999999999999999999999999999997653322 12


Q ss_pred             ccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhcC--------------
Q 004959          500 LSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDT--------------  565 (721)
Q Consensus       500 ~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~~--------------  565 (721)
                      ....++..|+|||++.+      ...++.++|||||||++|+|++|+.||........+.++....              
T Consensus       157 ~~~~~~~~~~aPE~~~~------~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (283)
T cd07835         157 THEVVTLWYRAPEILLG------SRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSL  230 (283)
T ss_pred             CccccccCCCCCceeec------CcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhc
Confidence            23457889999998742      2235678999999999999999999997665544433332210              


Q ss_pred             ---------------CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccc
Q 004959          566 ---------------PAIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFL  603 (721)
Q Consensus       566 ---------------~~~p~~lS~el~dLI~~cL~~DP~kRPSa~eLL~Hp~f  603 (721)
                                     ......++.++.++|.+||+.||++||+++|+++|+||
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~  283 (283)
T cd07835         231 PDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF  283 (283)
T ss_pred             hhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence                           01124577899999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.6e-39  Score=351.29  Aligned_cols=260  Identities=26%  Similarity=0.469  Sum_probs=214.6

Q ss_pred             CCCCCCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecC
Q 004959          336 LPMNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVED  415 (721)
Q Consensus       336 ~~l~~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~  415 (721)
                      ..+.++|++.+.||+|+||.||+|.+..+|+.||||++...   .......+.+.+|+.+|+.++|+||+++++++....
T Consensus        11 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   87 (343)
T cd07880          11 WEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRP---FQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDL   87 (343)
T ss_pred             hccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEeccc---ccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCc
Confidence            34667899999999999999999999999999999987531   122334567889999999999999999999887643


Q ss_pred             ------eEEEEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCC
Q 004959          416 ------KFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGM  489 (721)
Q Consensus       416 ------~~yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGl  489 (721)
                            .+++||||+ |++|.+++..  ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus        88 ~~~~~~~~~lv~e~~-~~~l~~~~~~--~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~dfg~  164 (343)
T cd07880          88 SLDRFHDFYLVMPFM-GTDLGKLMKH--EKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGL  164 (343)
T ss_pred             cccccceEEEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeccc
Confidence                  468999999 7899888864  5799999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCCcccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhcCC---
Q 004959          490 AKHLTGQKADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTP---  566 (721)
Q Consensus       490 A~~l~~~~~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~~~---  566 (721)
                      +......  .....+++.|+|||.+.+      ...++.++|||||||++|+|++|..||..........+++....   
T Consensus       165 ~~~~~~~--~~~~~~~~~y~aPE~~~~------~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  236 (343)
T cd07880         165 ARQTDSE--MTGYVVTRWYRAPEVILN------WMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPS  236 (343)
T ss_pred             ccccccC--ccccccCCcccCHHHHhC------CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence            9865432  234568999999999852      23466789999999999999999999987654444333322110   


Q ss_pred             ----------------------------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhccccccCCCC
Q 004959          567 ----------------------------AIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQP  609 (721)
Q Consensus       567 ----------------------------~~p~~lS~el~dLI~~cL~~DP~kRPSa~eLL~Hp~f~~~~~~  609 (721)
                                                  .+...++.++.++|.+||+.||++|||+.+++.||||+.....
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~~~  307 (343)
T cd07880         237 KEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHDP  307 (343)
T ss_pred             HHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhcCc
Confidence                                        1124578889999999999999999999999999999976554

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=2.2e-40  Score=346.04  Aligned_cols=257  Identities=30%  Similarity=0.533  Sum_probs=208.6

Q ss_pred             CeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCC-CCCeeeeeeeEEecCeEEE
Q 004959          341 QWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLK-HPNIVQYYGSEIVEDKFYI  419 (721)
Q Consensus       341 ~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~-HPnIV~l~g~~~~~~~~yL  419 (721)
                      +|+..+.||+|+||.||++.+..+|+.||||.+....    .......+.+|+.++.++. |+||+++++++..++..++
T Consensus         5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~----~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~   80 (288)
T cd06616           5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTV----DEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWI   80 (288)
T ss_pred             HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhcc----ChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEE
Confidence            5677789999999999999999999999999886321    1244567889999999996 9999999999999999999


Q ss_pred             EEeeccCCCHHHHHH---H-hcCCCCHHHHHHHHHHHHHHHHHHhhC-CeeccCCCCCcEEEcCCCceEEeecCCccccC
Q 004959          420 YLEYVHPGSINKYVR---E-HCGAITESVVRNFTRHILSGLAYLHSK-KTIHRDIKGANLLVDASGVVKLADFGMAKHLT  494 (721)
Q Consensus       420 VmEy~~gGsL~~~L~---~-~~~~Lse~~i~~i~~QIl~AL~yLHs~-gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~  494 (721)
                      +|||+. ++|.++..   . ....+++..+..++.||+.||+|||+. ||+||||||+|||++.++.+||+|||++..+.
T Consensus        81 ~~e~~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~  159 (288)
T cd06616          81 CMELMD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLV  159 (288)
T ss_pred             EEeccc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchhHHhc
Confidence            999996 46555432   2 236799999999999999999999975 99999999999999999999999999998765


Q ss_pred             CCcccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhh-HHHHHHHhhcC-CCC----
Q 004959          495 GQKADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEG-AAAMFKVMRDT-PAI----  568 (721)
Q Consensus       495 ~~~~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~-~~~~~ki~~~~-~~~----  568 (721)
                      .........|+..|+|||++.+..    ...++.++|||||||++|+|++|+.||..... .+.+.++.... +.+    
T Consensus       160 ~~~~~~~~~~~~~y~aPE~~~~~~----~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (288)
T cd06616         160 DSIAKTRDAGCRPYMAPERIDPSA----RDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSNSE  235 (288)
T ss_pred             cCCccccccCccCccCHHHhcccc----ccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhcCCCCCcCCCcC
Confidence            544444556899999999985311    13567789999999999999999999976432 22333332221 122    


Q ss_pred             CCCCCHHHHHHHHHhcccCCCCCCCHHHHHhccccccC
Q 004959          569 PDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNS  606 (721)
Q Consensus       569 p~~lS~el~dLI~~cL~~DP~kRPSa~eLL~Hp~f~~~  606 (721)
                      +..++.++.+||.+||+.||++||+++++++||||...
T Consensus       236 ~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~~  273 (288)
T cd06616         236 EREFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKDY  273 (288)
T ss_pred             CCccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhch
Confidence            23478999999999999999999999999999999753

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=8.8e-40  Score=337.79  Aligned_cols=248  Identities=24%  Similarity=0.391  Sum_probs=203.3

Q ss_pred             eEeeEEeecCCeEEEEEEECCCCc--EEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEec------
Q 004959          343 QKGKLIGRGTFGSVYVASNRETGA--LCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVE------  414 (721)
Q Consensus       343 ~~~k~LG~G~fG~VY~a~~~~tg~--~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~------  414 (721)
                      .+++.||+|+||.||+|.+..++.  .||+|.+...   .......+.+.+|+.+|+.++|+||+++++++...      
T Consensus         2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~---~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   78 (272)
T cd05075           2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIA---ICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGY   78 (272)
T ss_pred             ccccccCcccCceEEEeEEccCCCeeeEEEEecccC---cCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCC
Confidence            467899999999999999887775  6899987532   23345567889999999999999999999976432      


Q ss_pred             CeEEEEEeeccCCCHHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCC
Q 004959          415 DKFYIYLEYVHPGSINKYVREH-----CGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGM  489 (721)
Q Consensus       415 ~~~yLVmEy~~gGsL~~~L~~~-----~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGl  489 (721)
                      ...++||||+.+|+|.+++...     ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus        79 ~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~  158 (272)
T cd05075          79 PSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGL  158 (272)
T ss_pred             CCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEECCCCc
Confidence            2478999999999999887432     23488999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCCcc---cccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhh-CCCCCCchhhHHHHHHHhhcC
Q 004959          490 AKHLTGQKA---DLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFKVMRDT  565 (721)
Q Consensus       490 A~~l~~~~~---~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLt-G~~PF~~~~~~~~~~ki~~~~  565 (721)
                      ++.+.....   .....+++.|+|||++.       ...++.++|||||||++|||++ |..||......+....+....
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~-------~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~  231 (272)
T cd05075         159 SKKIYNGDYYRQGRIAKMPVKWIAIESLA-------DRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGN  231 (272)
T ss_pred             ccccCcccceecCCcccCCcccCCHHHcc-------CCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC
Confidence            987643321   12234677899999984       3456778999999999999999 899998766555554444432


Q ss_pred             -CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q 004959          566 -PAIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEH  600 (721)
Q Consensus       566 -~~~p~~lS~el~dLI~~cL~~DP~kRPSa~eLL~H  600 (721)
                       ...+..++..+.++|.+||+.||++|||+.+|+++
T Consensus       232 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~  267 (272)
T cd05075         232 RLKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCE  267 (272)
T ss_pred             CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence             24556788999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=2.4e-40  Score=354.46  Aligned_cols=255  Identities=27%  Similarity=0.497  Sum_probs=205.7

Q ss_pred             eEEeec--CCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeEEEEEee
Q 004959          346 KLIGRG--TFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYIYLEY  423 (721)
Q Consensus       346 k~LG~G--~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~yLVmEy  423 (721)
                      ..||+|  +||+||+|.+..+|+.||||++...   .......+.+.+|+.+++.++||||+++++++..++..|+||||
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~---~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~   80 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLE---NCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPF   80 (328)
T ss_pred             HHhCCcccCceeEEEEEEcCCCcEEEEEEeccc---cCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEec
Confidence            356666  9999999999999999999987632   22334567899999999999999999999999999999999999


Q ss_pred             ccCCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCCccc---
Q 004959          424 VHPGSINKYVREHC-GAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKAD---  499 (721)
Q Consensus       424 ~~gGsL~~~L~~~~-~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~~~~---  499 (721)
                      +.+++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.++++|||.+.........   
T Consensus        81 ~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (328)
T cd08226          81 MAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKV  160 (328)
T ss_pred             ccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccc
Confidence            99999999987652 45899999999999999999999999999999999999999999999999865433211110   


Q ss_pred             -----ccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhcCC--------
Q 004959          500 -----LSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTP--------  566 (721)
Q Consensus       500 -----~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~~~--------  566 (721)
                           ....++..|+|||++.+     ....++.++|||||||++|+|++|+.||............+....        
T Consensus       161 ~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (328)
T cd08226         161 VYDFPQFSTSVLPWLSPELLRQ-----DLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITT  235 (328)
T ss_pred             cccccccccCccCccChhhhcC-----CCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccc
Confidence                 11235677999999853     223467789999999999999999999987654444333322111        


Q ss_pred             ---------------------------------------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhccccccCC
Q 004959          567 ---------------------------------------AIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQ  607 (721)
Q Consensus       567 ---------------------------------------~~p~~lS~el~dLI~~cL~~DP~kRPSa~eLL~Hp~f~~~~  607 (721)
                                                             ..+..++.++.+||++||+.||++|||+.|+|+|+||....
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~~  315 (328)
T cd08226         236 FPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQVK  315 (328)
T ss_pred             cchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHHH
Confidence                                                   01123567899999999999999999999999999998754


Q ss_pred             C
Q 004959          608 Q  608 (721)
Q Consensus       608 ~  608 (721)
                      .
T Consensus       316 ~  316 (328)
T cd08226         316 E  316 (328)
T ss_pred             H
Confidence            4

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=3.3e-40  Score=347.97  Aligned_cols=254  Identities=37%  Similarity=0.645  Sum_probs=214.8

Q ss_pred             CCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeEEE
Q 004959          340 SQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYI  419 (721)
Q Consensus       340 ~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~yL  419 (721)
                      .+|++.+.||+|+||.||++.+..+++.||+|.+...     .....+.+.+|+.+++.++||||+++++.+...+..|+
T Consensus        19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~-----~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~l   93 (293)
T cd06647          19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQ-----QQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWV   93 (293)
T ss_pred             hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccc-----cchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEE
Confidence            5899999999999999999999989999999987532     12234678899999999999999999999999999999


Q ss_pred             EEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCCcc-
Q 004959          420 YLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKA-  498 (721)
Q Consensus       420 VmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~~~-  498 (721)
                      ||||+++++|.+++.+  ..+++..+..++.||+.||.|||++|++|+||||+||+++.++.+||+|||++..+..... 
T Consensus        94 v~e~~~~~~L~~~~~~--~~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~~  171 (293)
T cd06647          94 VMEYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK  171 (293)
T ss_pred             EEecCCCCcHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcceecccccccc
Confidence            9999999999999875  3688999999999999999999999999999999999999999999999999876543322 


Q ss_pred             cccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhc-CC--CCCCCCCHH
Q 004959          499 DLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRD-TP--AIPDSLSPE  575 (721)
Q Consensus       499 ~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~-~~--~~p~~lS~e  575 (721)
                      .....|++.|+|||.+..       ..++.++|||||||++|+|++|+.||........+..+... .+  ..+..++.+
T Consensus       172 ~~~~~~~~~y~~PE~~~~-------~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (293)
T cd06647         172 RSTMVGTPYWMAPEVVTR-------KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAI  244 (293)
T ss_pred             cccccCChhhcCchhhcc-------CCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcCCCCCCCCccccCHH
Confidence            233468999999999842       34567899999999999999999999876554443333222 11  223457889


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHHhccccccCC
Q 004959          576 GKDFLRCCFQRNPADRPPASLLLEHRFLKNSQ  607 (721)
Q Consensus       576 l~dLI~~cL~~DP~kRPSa~eLL~Hp~f~~~~  607 (721)
                      +.+||.+||..+|++||++.+++.|+||....
T Consensus       245 l~~li~~~l~~~p~~Rp~~~~il~h~~~~~~~  276 (293)
T cd06647         245 FRDFLNRCLEMDVEKRGSAKELLQHPFLKIAK  276 (293)
T ss_pred             HHHHHHHHccCChhhCcCHHHHhcCHHHhcCc
Confidence            99999999999999999999999999998654

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.2e-40  Score=338.63  Aligned_cols=246  Identities=28%  Similarity=0.459  Sum_probs=206.3

Q ss_pred             CeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeEEEE
Q 004959          341 QWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYIY  420 (721)
Q Consensus       341 ~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~yLV  420 (721)
                      +|++++.||+|+||.||+|.+. ++..+|+|.+...   ...   ...+.+|+.+++.++|+||+++++++...+..|+|
T Consensus         5 ~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~---~~~---~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   77 (256)
T cd05059           5 ELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREG---AMS---EDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIV   77 (256)
T ss_pred             HcchhhhhccCCCceEEEeEec-CCccEEEEEeccC---CCC---HHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEE
Confidence            6889999999999999999876 4678999987521   111   24577899999999999999999999999999999


Q ss_pred             EeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCCcccc
Q 004959          421 LEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADL  500 (721)
Q Consensus       421 mEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~~~~~  500 (721)
                      |||++|++|.+++....+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.........
T Consensus        78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~  157 (256)
T cd05059          78 TEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTS  157 (256)
T ss_pred             EecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccceecccccccc
Confidence            99999999999998765679999999999999999999999999999999999999999999999999997654322211


Q ss_pred             --cCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhh-CCCCCCchhhHHHHHHHhhc-CCCCCCCCCHHH
Q 004959          501 --SMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFKVMRD-TPAIPDSLSPEG  576 (721)
Q Consensus       501 --s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLt-G~~PF~~~~~~~~~~ki~~~-~~~~p~~lS~el  576 (721)
                        ...++..|+|||++.       ...++.++|||||||++|+|++ |+.||......+....+... ....+..++.++
T Consensus       158 ~~~~~~~~~y~~Pe~~~-------~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (256)
T cd05059         158 SQGTKFPVKWAPPEVFD-------YSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRLYRPKLAPTEV  230 (256)
T ss_pred             cCCCCCCccccCHHHhc-------cCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHH
Confidence              112345799999984       3446678999999999999999 89999876665555555443 234566789999


Q ss_pred             HHHHHHhcccCCCCCCCHHHHHhc
Q 004959          577 KDFLRCCFQRNPADRPPASLLLEH  600 (721)
Q Consensus       577 ~dLI~~cL~~DP~kRPSa~eLL~H  600 (721)
                      .+++.+||..+|++||++.++++.
T Consensus       231 ~~li~~cl~~~p~~Rpt~~~~l~~  254 (256)
T cd05059         231 YTIMYSCWHEKPEDRPAFKKLLSQ  254 (256)
T ss_pred             HHHHHHHhcCChhhCcCHHHHHHH
Confidence            999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=5.6e-40  Score=343.75  Aligned_cols=260  Identities=26%  Similarity=0.466  Sum_probs=215.5

Q ss_pred             CeeEeeEEeecCCeEEEEEEEC---CCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhC-CCCCeeeeeeeEEecCe
Q 004959          341 QWQKGKLIGRGTFGSVYVASNR---ETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHL-KHPNIVQYYGSEIVEDK  416 (721)
Q Consensus       341 ~y~~~k~LG~G~fG~VY~a~~~---~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L-~HPnIV~l~g~~~~~~~  416 (721)
                      .|++.+.||+|+||.||+|.+.   .+|+.||+|++..... .......+.+.+|+.+|+++ +|+||+.+++++..+..
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~-~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~   79 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATI-VQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTK   79 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhh-hhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCe
Confidence            4889999999999999999875   4799999998853211 11223346778899999999 59999999999999999


Q ss_pred             EEEEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCC
Q 004959          417 FYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQ  496 (721)
Q Consensus       417 ~yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~  496 (721)
                      +|+||||+++++|.+++... ..+++..+..++.||+.||.|||++|++||||||+|||++.++.+||+|||++..+...
T Consensus        80 ~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~  158 (290)
T cd05613          80 LHLILDYINGGELFTHLSQR-ERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHED  158 (290)
T ss_pred             EEEEEecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCccceecccc
Confidence            99999999999999999764 67899999999999999999999999999999999999999999999999999876443


Q ss_pred             c--ccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchh----hHHHHHHHhhcCCCCCC
Q 004959          497 K--ADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYE----GAAAMFKVMRDTPAIPD  570 (721)
Q Consensus       497 ~--~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~----~~~~~~ki~~~~~~~p~  570 (721)
                      .  ......|+..|+|||.+.+     ....++.++|||||||++|+|++|..||....    ..+....+......++.
T Consensus       159 ~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (290)
T cd05613         159 EVERAYSFCGTIEYMAPDIVRG-----GDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQ  233 (290)
T ss_pred             cccccccccCCcccCChhhccC-----CCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhccCCCCCc
Confidence            2  2234568999999999853     12345667999999999999999999996422    22333344445566777


Q ss_pred             CCCHHHHHHHHHhcccCCCCCC-----CHHHHHhccccccCC
Q 004959          571 SLSPEGKDFLRCCFQRNPADRP-----PASLLLEHRFLKNSQ  607 (721)
Q Consensus       571 ~lS~el~dLI~~cL~~DP~kRP-----Sa~eLL~Hp~f~~~~  607 (721)
                      .++..+.+||++||+.||++|+     ++++++.||||....
T Consensus       234 ~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~  275 (290)
T cd05613         234 EMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKIN  275 (290)
T ss_pred             cCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccCC
Confidence            8999999999999999999997     899999999998653

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=1.1e-39  Score=342.16  Aligned_cols=248  Identities=28%  Similarity=0.520  Sum_probs=209.2

Q ss_pred             CCeeEeeEEeecCCeEEEEEEE-----CCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEec
Q 004959          340 SQWQKGKLIGRGTFGSVYVASN-----RETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVE  414 (721)
Q Consensus       340 ~~y~~~k~LG~G~fG~VY~a~~-----~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~  414 (721)
                      .+|.+.+.||+|+||+||++..     ..++..+|+|.+..     ......+.+.+|+.+|++++|+||+++++++...
T Consensus         5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~-----~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   79 (288)
T cd05093           5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKD-----ASDNARKDFHREAELLTNLQHEHIVKFYGVCVEG   79 (288)
T ss_pred             HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCC-----cCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecC
Confidence            4689999999999999999975     33567799998752     2334567789999999999999999999999999


Q ss_pred             CeEEEEEeeccCCCHHHHHHHhc------------CCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCce
Q 004959          415 DKFYIYLEYVHPGSINKYVREHC------------GAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVV  482 (721)
Q Consensus       415 ~~~yLVmEy~~gGsL~~~L~~~~------------~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~V  482 (721)
                      +.+|+||||+.+++|.+++....            ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+
T Consensus        80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~~~  159 (288)
T cd05093          80 DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLV  159 (288)
T ss_pred             CccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcE
Confidence            99999999999999999997542            248999999999999999999999999999999999999999999


Q ss_pred             EEeecCCccccCCCcc---cccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhh-CCCCCCchhhHHHH
Q 004959          483 KLADFGMAKHLTGQKA---DLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAM  558 (721)
Q Consensus       483 KL~DFGlA~~l~~~~~---~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLt-G~~PF~~~~~~~~~  558 (721)
                      ||+|||++..+.....   .....++..|+|||++.       ...++.++|||||||++|+|++ |..||......+..
T Consensus       160 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-------~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~  232 (288)
T cd05093         160 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIM-------YRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVI  232 (288)
T ss_pred             EeccCCccccccCCceeecCCCCCccccccCHHHhc-------cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence            9999999986543321   12234577899999984       3456778999999999999998 99999877666666


Q ss_pred             HHHhhcC-CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHh
Q 004959          559 FKVMRDT-PAIPDSLSPEGKDFLRCCFQRNPADRPPASLLLE  599 (721)
Q Consensus       559 ~ki~~~~-~~~p~~lS~el~dLI~~cL~~DP~kRPSa~eLL~  599 (721)
                      ..+.... ...+..++.++.+||.+||+.||.+|||+.+++.
T Consensus       233 ~~i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~  274 (288)
T cd05093         233 ECITQGRVLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHS  274 (288)
T ss_pred             HHHHcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            6665543 3455678999999999999999999999999964

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=7.9e-40  Score=353.16  Aligned_cols=262  Identities=27%  Similarity=0.464  Sum_probs=211.0

Q ss_pred             CCCCCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEec--
Q 004959          337 PMNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVE--  414 (721)
Q Consensus       337 ~l~~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~--  414 (721)
                      .+..+|.+.+.||+|+||.||+|.+..+|+.||||++....   ........+.+|+.+++.+.|+||+++++++...  
T Consensus        12 ~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~   88 (342)
T cd07879          12 ELPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPF---QSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVS   88 (342)
T ss_pred             ccccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCcc---ccccchhHHHHHHHHHHhcCCCCccchhheeccccc
Confidence            44578999999999999999999999999999999875321   1122345678999999999999999999988754  


Q ss_pred             ----CeEEEEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCc
Q 004959          415 ----DKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMA  490 (721)
Q Consensus       415 ----~~~yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA  490 (721)
                          ..+|+||||+. .+|..++   ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus        89 ~~~~~~~~lv~e~~~-~~l~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL~dfg~~  164 (342)
T cd07879          89 GDEFQDFYLVMPYMQ-TDLQKIM---GHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLA  164 (342)
T ss_pred             CCCCceEEEEecccc-cCHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCCCC
Confidence                34699999996 5776654   246899999999999999999999999999999999999999999999999999


Q ss_pred             cccCCCcccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhc------
Q 004959          491 KHLTGQKADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRD------  564 (721)
Q Consensus       491 ~~l~~~~~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~------  564 (721)
                      +....  ......|+..|+|||++.+      ...++.++|||||||++|||++|+.||.+.+....+..+...      
T Consensus       165 ~~~~~--~~~~~~~~~~y~aPE~~~~------~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~  236 (342)
T cd07879         165 RHADA--EMTGYVVTRWYRAPEVILN------WMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGP  236 (342)
T ss_pred             cCCCC--CCCCceeeecccChhhhcC------ccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCH
Confidence            76532  2234568899999999842      234667899999999999999999999876544433332211      


Q ss_pred             -----------------CCCC--------CCCCCHHHHHHHHHhcccCCCCCCCHHHHHhccccccCCCCCCCC
Q 004959          565 -----------------TPAI--------PDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQPDVPS  613 (721)
Q Consensus       565 -----------------~~~~--------p~~lS~el~dLI~~cL~~DP~kRPSa~eLL~Hp~f~~~~~~~~~~  613 (721)
                                       .+..        ...++.++.+||.+||+.||++||++.+++.||||..........
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~~~~~~  310 (342)
T cd07879         237 EFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRDADEET  310 (342)
T ss_pred             HHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcccccccC
Confidence                             0011        124678899999999999999999999999999999876544333

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=4e-40  Score=346.39  Aligned_cols=255  Identities=30%  Similarity=0.546  Sum_probs=204.9

Q ss_pred             CCCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEec----
Q 004959          339 NSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVE----  414 (721)
Q Consensus       339 ~~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~----  414 (721)
                      .++|++.+.||+|+||.||+|.+..+++.||||++.......   .....+.+|+++++.++|+||+++++++...    
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   83 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKD---GFPITALREIKILKKLKHPNVVPLIDMAVERPDKS   83 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCC---CcchhHHHHHHHHHhcCCCCccchhhheecccccc
Confidence            468999999999999999999999999999999886432111   1123567899999999999999999987543    


Q ss_pred             ----CeEEEEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCc
Q 004959          415 ----DKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMA  490 (721)
Q Consensus       415 ----~~~yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA  490 (721)
                          ..+|+||||+. ++|...+......+++..++.++.||++||.|||++||+|+||||+|||++.++.+||+|||++
T Consensus        84 ~~~~~~~~lv~~~~~-~~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~  162 (311)
T cd07866          84 KRKRGSVYMVTPYMD-HDLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLA  162 (311)
T ss_pred             cccCceEEEEEecCC-cCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcCccc
Confidence                34799999996 5787777665568999999999999999999999999999999999999999999999999999


Q ss_pred             cccCCCcc------------cccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHH
Q 004959          491 KHLTGQKA------------DLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAM  558 (721)
Q Consensus       491 ~~l~~~~~------------~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~  558 (721)
                      ........            .....|++.|+|||++.+      ...++.++|||||||++|+|++|++||.+.......
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~  236 (311)
T cd07866         163 RPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLG------ERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQL  236 (311)
T ss_pred             hhccCCCcccccCCcccccccccceeccCcCChHHhhC------CCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence            76543221            112357889999999853      234566899999999999999999999876554443


Q ss_pred             HHHhhcC--------------C---------CC-------CCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccc
Q 004959          559 FKVMRDT--------------P---------AI-------PDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFL  603 (721)
Q Consensus       559 ~ki~~~~--------------~---------~~-------p~~lS~el~dLI~~cL~~DP~kRPSa~eLL~Hp~f  603 (721)
                      ..+....              +         ..       ...++.++.+||.+||+.||++|||+.|++.||||
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f  311 (311)
T cd07866         237 HLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF  311 (311)
T ss_pred             HHHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence            3322110              0         00       02345788999999999999999999999999997

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=4e-40  Score=341.27  Aligned_cols=252  Identities=31%  Similarity=0.564  Sum_probs=211.8

Q ss_pred             eeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeEEEEE
Q 004959          342 WQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYIYL  421 (721)
Q Consensus       342 y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~yLVm  421 (721)
                      |++.+.||.|++|.||+|.+..+|+.+++|.+....   ........+.+|+.+|++++|+||+++++++...+..|+||
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~   77 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRF---ESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVF   77 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEecccc---ccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEE
Confidence            567789999999999999999999999999886322   12234567888999999999999999999999999999999


Q ss_pred             eeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCCc-ccc
Q 004959          422 EYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQK-ADL  500 (721)
Q Consensus       422 Ey~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~~-~~~  500 (721)
                      ||+. ++|.+++......+++..+..++.||+.||.|||++||+|+||||+||+++.++.+||+|||++..+.... ...
T Consensus        78 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~~~~  156 (283)
T cd05118          78 EFMD-TDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYT  156 (283)
T ss_pred             eccC-CCHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCccccc
Confidence            9997 58988887765789999999999999999999999999999999999999999999999999998765443 223


Q ss_pred             cCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhcCC--------------
Q 004959          501 SMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTP--------------  566 (721)
Q Consensus       501 s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~~~--------------  566 (721)
                      ...++..|+|||.+.+      ...++.++|||||||++|+|++|+.||...+..+.+.++.....              
T Consensus       157 ~~~~~~~~~~PE~~~~------~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (283)
T cd05118         157 HYVVTRWYRAPELLLG------DKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLA  230 (283)
T ss_pred             CccCcccccCcHHHhc------CCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhh
Confidence            3558899999999853      22567789999999999999999999987666555444322100              


Q ss_pred             ----------------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccc
Q 004959          567 ----------------AIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFL  603 (721)
Q Consensus       567 ----------------~~p~~lS~el~dLI~~cL~~DP~kRPSa~eLL~Hp~f  603 (721)
                                      .....++.++.+||.+||+.||.+||++.+++.||||
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~  283 (283)
T cd05118         231 RNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF  283 (283)
T ss_pred             hhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence                            0122468899999999999999999999999999997

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=3.1e-40  Score=356.80  Aligned_cols=250  Identities=28%  Similarity=0.514  Sum_probs=204.3

Q ss_pred             CCeeEeeEEeecCCeEEEEEEEC-----CCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhC-CCCCeeeeeeeEEe
Q 004959          340 SQWQKGKLIGRGTFGSVYVASNR-----ETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHL-KHPNIVQYYGSEIV  413 (721)
Q Consensus       340 ~~y~~~k~LG~G~fG~VY~a~~~-----~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L-~HPnIV~l~g~~~~  413 (721)
                      ++|++++.||+|+||.||+|...     .+++.||+|++..    .......+.+.+|+.++.++ +|+||+++++++..
T Consensus         7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~----~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~   82 (337)
T cd05054           7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKE----GATASEYKALMTELKILIHIGHHLNVVNLLGACTK   82 (337)
T ss_pred             HHhhhhcccccCcCceEEeccccccccccccceeeeeeccC----CCCHHHHHHHHHHHHHHHhhccCcchhheeeeEec
Confidence            47999999999999999999743     3468899998752    12234556788999999999 79999999998765


Q ss_pred             -cCeEEEEEeeccCCCHHHHHHHhc-------------------------------------------------------
Q 004959          414 -EDKFYIYLEYVHPGSINKYVREHC-------------------------------------------------------  437 (721)
Q Consensus       414 -~~~~yLVmEy~~gGsL~~~L~~~~-------------------------------------------------------  437 (721)
                       +..++++|||+.+++|.++|....                                                       
T Consensus        83 ~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (337)
T cd05054          83 PGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEG  162 (337)
T ss_pred             CCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhh
Confidence             457899999999999999986421                                                       


Q ss_pred             -----CCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCCcc---cccCCCCCccC
Q 004959          438 -----GAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKA---DLSMKGSPYWM  509 (721)
Q Consensus       438 -----~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~~~---~~s~~GT~~Y~  509 (721)
                           ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+.....   .....++..|+
T Consensus       163 ~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~  242 (337)
T cd05054         163 DELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWM  242 (337)
T ss_pred             hHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcccc
Confidence                 2578999999999999999999999999999999999999999999999999987643322   12344677899


Q ss_pred             ChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhh-CCCCCCchhhHHHHHHHhhc--CCCCCCCCCHHHHHHHHHhccc
Q 004959          510 APELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFKVMRD--TPAIPDSLSPEGKDFLRCCFQR  586 (721)
Q Consensus       510 APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLt-G~~PF~~~~~~~~~~ki~~~--~~~~p~~lS~el~dLI~~cL~~  586 (721)
                      |||++.       ...++.++|||||||+||||++ |..||.+....+.+...+..  ....+..+++++.+++.+||+.
T Consensus       243 aPE~~~-------~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~  315 (337)
T cd05054         243 APESIF-------DKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMRAPEYATPEIYSIMLDCWHN  315 (337)
T ss_pred             CcHHhc-------CCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCCCCCccCCHHHHHHHHHHccC
Confidence            999984       3457778999999999999997 99999765433333333322  2344567889999999999999


Q ss_pred             CCCCCCCHHHHHhc
Q 004959          587 NPADRPPASLLLEH  600 (721)
Q Consensus       587 DP~kRPSa~eLL~H  600 (721)
                      +|++||++.||++|
T Consensus       316 ~p~~RPs~~ell~~  329 (337)
T cd05054         316 NPEDRPTFSELVEI  329 (337)
T ss_pred             ChhhCcCHHHHHHH
Confidence            99999999999986

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=9.7e-40  Score=332.96  Aligned_cols=252  Identities=32%  Similarity=0.539  Sum_probs=216.8

Q ss_pred             CeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeEEEE
Q 004959          341 QWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYIY  420 (721)
Q Consensus       341 ~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~yLV  420 (721)
                      +|++.+.||+|+||.||++.+..+|+.||||.+....   ........+.+|+.+++.++|+||+++++++......|+|
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v   77 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGS---MSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIV   77 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhh---ccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEE
Confidence            4889999999999999999999999999999886421   2234456778899999999999999999999999999999


Q ss_pred             EeeccCCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCCc
Q 004959          421 LEYVHPGSINKYVREH---CGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQK  497 (721)
Q Consensus       421 mEy~~gGsL~~~L~~~---~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~~  497 (721)
                      |||+++++|.+++...   ...+++..++.++.||+.||.|||++|++|+||+|.||+++.++.+||+|||++...... 
T Consensus        78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~-  156 (256)
T cd08530          78 MEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN-  156 (256)
T ss_pred             ehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccchhhhccC-
Confidence            9999999999998652   256899999999999999999999999999999999999999999999999999876554 


Q ss_pred             ccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhc-CCCCCCCCCHHH
Q 004959          498 ADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRD-TPAIPDSLSPEG  576 (721)
Q Consensus       498 ~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~-~~~~p~~lS~el  576 (721)
                      ......|++.|++||.+.       ...++.++|+||||+++|+|++|+.||...+..+....+... .+..+..++.++
T Consensus       157 ~~~~~~~~~~~~~Pe~~~-------~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (256)
T cd08530         157 MAKTQIGTPHYMAPEVWK-------GRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPPIPPIYSQDL  229 (256)
T ss_pred             CcccccCCccccCHHHHC-------CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCchhhCHHH
Confidence            333456899999999984       344667899999999999999999999887665554444433 244566789999


Q ss_pred             HHHHHHhcccCCCCCCCHHHHHhcccc
Q 004959          577 KDFLRCCFQRNPADRPPASLLLEHRFL  603 (721)
Q Consensus       577 ~dLI~~cL~~DP~kRPSa~eLL~Hp~f  603 (721)
                      +++|.+||+.+|++||++.++++||++
T Consensus       230 ~~li~~~l~~~p~~Rp~~~~~l~~p~~  256 (256)
T cd08530         230 QNFIRSMLQVKPKLRPNCDKILASPAV  256 (256)
T ss_pred             HHHHHHHcCCCcccCCCHHHHhcCCCC
Confidence            999999999999999999999999974

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-40  Score=381.54  Aligned_cols=250  Identities=28%  Similarity=0.460  Sum_probs=211.3

Q ss_pred             CCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCC-CCCeeeeee-eEEec---
Q 004959          340 SQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLK-HPNIVQYYG-SEIVE---  414 (721)
Q Consensus       340 ~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~-HPnIV~l~g-~~~~~---  414 (721)
                      .++++.++|.+|||+.||+|.+...|..||+|.+..     .+...++.+.+||.+|++|. |+|||.+++ .....   
T Consensus        37 ~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~-----~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~  111 (738)
T KOG1989|consen   37 HRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYV-----NDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSN  111 (738)
T ss_pred             EEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeec-----CCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCC
Confidence            367889999999999999999999889999998753     25667889999999999997 999999999 33221   


Q ss_pred             ---CeEEEEEeeccCCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhCC--eeccCCCCCcEEEcCCCceEEeecC
Q 004959          415 ---DKFYIYLEYVHPGSINKYVREH-CGAITESVVRNFTRHILSGLAYLHSKK--TIHRDIKGANLLVDASGVVKLADFG  488 (721)
Q Consensus       415 ---~~~yLVmEy~~gGsL~~~L~~~-~~~Lse~~i~~i~~QIl~AL~yLHs~g--IIHrDLKPeNILld~~g~VKL~DFG  488 (721)
                         -+++|.||||.||.|-+++..+ ...|+|.++++|++|+++||.+||..+  |||||||-|||||+.+|+.||||||
T Consensus       112 ~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KLCDFG  191 (738)
T KOG1989|consen  112 NGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKLCDFG  191 (738)
T ss_pred             CceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEeCccc
Confidence               3578999999999999999654 356999999999999999999999998  9999999999999999999999999


Q ss_pred             CccccCCCccc----------ccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHH
Q 004959          489 MAKHLTGQKAD----------LSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAM  558 (721)
Q Consensus       489 lA~~l~~~~~~----------~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~  558 (721)
                      .|.........          ....-|+-|+|||.+.-  |  .+..++.|+|||+|||+||-||+...||.+..    .
T Consensus       192 Satt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDl--y--sg~pI~eKsDIWALGclLYkLCy~t~PFe~sg----~  263 (738)
T KOG1989|consen  192 SATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDL--Y--SGLPIGEKSDIWALGCLLYKLCYFTTPFEESG----K  263 (738)
T ss_pred             ccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhh--h--cCCCCcchhHHHHHHHHHHHHHHhCCCcCcCc----c
Confidence            98754222110          11236899999999953  2  45678899999999999999999999998742    2


Q ss_pred             HHHhhcCCCCCC--CCCHHHHHHHHHhcccCCCCCCCHHHHHhccc
Q 004959          559 FKVMRDTPAIPD--SLSPEGKDFLRCCFQRNPADRPPASLLLEHRF  602 (721)
Q Consensus       559 ~ki~~~~~~~p~--~lS~el~dLI~~cL~~DP~kRPSa~eLL~Hp~  602 (721)
                      ..|+...+.+|.  .++..+++||+.||+.||++||++.|++.+-+
T Consensus       264 laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~  309 (738)
T KOG1989|consen  264 LAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIF  309 (738)
T ss_pred             eeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHH
Confidence            356666777775  69999999999999999999999999997744

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=1e-39  Score=336.68  Aligned_cols=247  Identities=29%  Similarity=0.478  Sum_probs=207.1

Q ss_pred             CCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeEEE
Q 004959          340 SQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYI  419 (721)
Q Consensus       340 ~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~yL  419 (721)
                      .+|++++.||+|+||.||+|.... +..+|||.+...   ..   ....+.+|+.++++++||||+++++++...+..|+
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~---~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   76 (256)
T cd05113           4 KDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEG---SM---SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYI   76 (256)
T ss_pred             HHeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCC---cc---cHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEE
Confidence            469999999999999999998754 456999987521   11   13568899999999999999999999998899999


Q ss_pred             EEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCCccc
Q 004959          420 YLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKAD  499 (721)
Q Consensus       420 VmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~~~~  499 (721)
                      ||||+.+|+|.+++......+++..++.++.||+.||.|||+.||+|+||||.|||++.++.+||+|||+++.+......
T Consensus        77 v~e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~  156 (256)
T cd05113          77 VTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYT  156 (256)
T ss_pred             EEEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCccceecCCCcee
Confidence            99999999999999775567999999999999999999999999999999999999999999999999998865433221


Q ss_pred             --ccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhh-CCCCCCchhhHHHHHHHhhcC-CCCCCCCCHH
Q 004959          500 --LSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFKVMRDT-PAIPDSLSPE  575 (721)
Q Consensus       500 --~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLt-G~~PF~~~~~~~~~~ki~~~~-~~~p~~lS~e  575 (721)
                        ....++..|++||++.+       ..++.++|||||||++|+|++ |..||......+....+.... ...+...+.+
T Consensus       157 ~~~~~~~~~~y~~pe~~~~-------~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (256)
T cd05113         157 SSVGSKFPVRWSPPEVLLY-------SKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLYRPHLASEK  229 (256)
T ss_pred             ecCCCccChhhCCHHHHhc-------CcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCCCCCCCCCCHH
Confidence              12235677999999853       346668999999999999998 999998766655555555443 2345667899


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHHhc
Q 004959          576 GKDFLRCCFQRNPADRPPASLLLEH  600 (721)
Q Consensus       576 l~dLI~~cL~~DP~kRPSa~eLL~H  600 (721)
                      ++++|.+||+.||++||++.+|+.+
T Consensus       230 ~~~li~~cl~~~p~~Rp~~~~ll~~  254 (256)
T cd05113         230 VYAIMYSCWHEKAEERPTFQQLLSS  254 (256)
T ss_pred             HHHHHHHHcCCCcccCCCHHHHHHh
Confidence            9999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.6e-40  Score=333.56  Aligned_cols=246  Identities=34%  Similarity=0.592  Sum_probs=215.9

Q ss_pred             EeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeEEEEEeeccCC
Q 004959          348 IGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYIYLEYVHPG  427 (721)
Q Consensus       348 LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~yLVmEy~~gG  427 (721)
                      ||+|+||.||+|.+..+++.||+|++...  ..........+..|+.+++.+.|+||+++++.+..++..|+||||+.++
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~   78 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKK--KIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGG   78 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehh--hhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCC
Confidence            69999999999999989999999988642  2233345678899999999999999999999999999999999999999


Q ss_pred             CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCC-cccccCCCCC
Q 004959          428 SINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQ-KADLSMKGSP  506 (721)
Q Consensus       428 sL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~-~~~~s~~GT~  506 (721)
                      +|.+++... ..+++..+..++.||+.||.|||+.+++|+||||+||+++.++.++|+|||++...... .......|+.
T Consensus        79 ~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~  157 (250)
T cd05123          79 ELFSHLSKE-GRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTP  157 (250)
T ss_pred             cHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceecccCCCcccCCcCCc
Confidence            999999765 57999999999999999999999999999999999999999999999999999876543 2234456899


Q ss_pred             ccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhcCCCCCCCCCHHHHHHHHHhccc
Q 004959          507 YWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDSLSPEGKDFLRCCFQR  586 (721)
Q Consensus       507 ~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~~~~~p~~lS~el~dLI~~cL~~  586 (721)
                      .|++||.+.+       ...+.++|+|||||++|+|++|..||...+.......+......++..++.++.+||++||..
T Consensus       158 ~~~~Pe~~~~-------~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~  230 (250)
T cd05123         158 EYLAPEVLLG-------KGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPLRFPEFLSPEARDLISGLLQK  230 (250)
T ss_pred             cccChHHhCC-------CCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHhcC
Confidence            9999999843       335668999999999999999999998776666666666666778888899999999999999


Q ss_pred             CCCCCCCH---HHHHhcccc
Q 004959          587 NPADRPPA---SLLLEHRFL  603 (721)
Q Consensus       587 DP~kRPSa---~eLL~Hp~f  603 (721)
                      ||++||++   +++++||||
T Consensus       231 ~p~~R~~~~~~~~l~~~~~f  250 (250)
T cd05123         231 DPTKRLGSGGAEEIKAHPFF  250 (250)
T ss_pred             CHhhCCCcccHHHHHhCCCC
Confidence            99999999   999999998

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=6.1e-40  Score=340.01  Aligned_cols=252  Identities=31%  Similarity=0.555  Sum_probs=209.1

Q ss_pred             eeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEec--CeEEE
Q 004959          342 WQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVE--DKFYI  419 (721)
Q Consensus       342 y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~--~~~yL  419 (721)
                      |++.+.||.|+||.||+|.+..+|+.||+|.+....   ......+.+.+|+.+++.+.|+||+++++++...  +..|+
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~---~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~l   77 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMEN---EKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYM   77 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEeccc---ccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEE
Confidence            678899999999999999999999999999987432   1223345688899999999999999999999888  89999


Q ss_pred             EEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCCc--
Q 004959          420 YLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQK--  497 (721)
Q Consensus       420 VmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~~--  497 (721)
                      ||||+. ++|..++......+++..++.++.||+.||+|||++|++|+||||+|||++.++.+||+|||++..+....  
T Consensus        78 v~e~~~-~~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~  156 (287)
T cd07840          78 VFEYMD-HDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSA  156 (287)
T ss_pred             Eecccc-ccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCcc
Confidence            999997 58988887655679999999999999999999999999999999999999999999999999998765443  


Q ss_pred             ccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhcCC-----------
Q 004959          498 ADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTP-----------  566 (721)
Q Consensus       498 ~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~~~-----------  566 (721)
                      ......++..|+|||.+.+      ...++.++|||||||++|+|++|+.||........+..+.....           
T Consensus       157 ~~~~~~~~~~y~~PE~~~~------~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (287)
T cd07840         157 DYTNRVITLWYRPPELLLG------ATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVS  230 (287)
T ss_pred             cccccccccccCCceeeEc------cccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccc
Confidence            1223457889999998743      23466789999999999999999999987665444443322100           


Q ss_pred             --------------------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccc
Q 004959          567 --------------------AIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFL  603 (721)
Q Consensus       567 --------------------~~p~~lS~el~dLI~~cL~~DP~kRPSa~eLL~Hp~f  603 (721)
                                          .+...++.++.++|++||+.||++||++.++++|+||
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~  287 (287)
T cd07840         231 KLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF  287 (287)
T ss_pred             cchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence                                0011138899999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=1.3e-39  Score=340.27  Aligned_cols=249  Identities=23%  Similarity=0.385  Sum_probs=204.3

Q ss_pred             CCeeEeeEEeecCCeEEEEEEECCCCcE----EEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecC
Q 004959          340 SQWQKGKLIGRGTFGSVYVASNRETGAL----CAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVED  415 (721)
Q Consensus       340 ~~y~~~k~LG~G~fG~VY~a~~~~tg~~----vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~  415 (721)
                      .+|++++.||+|+||+||+|.+..+|+.    +++|.+.    .........++..|+.++..+.||||+++++++. ..
T Consensus         7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~----~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~   81 (279)
T cd05111           7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQ----DRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GA   81 (279)
T ss_pred             hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecc----cccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CC
Confidence            5789999999999999999999887875    5556543    2223445677888999999999999999999865 45


Q ss_pred             eEEEEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCC
Q 004959          416 KFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTG  495 (721)
Q Consensus       416 ~~yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~  495 (721)
                      ..++||||+.+|+|.+++....+.+++..+..++.||+.||.|||++|++||||||+|||++.++.+||+|||+++.+..
T Consensus        82 ~~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~  161 (279)
T cd05111          82 SLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYP  161 (279)
T ss_pred             ccEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCccceeccC
Confidence            67899999999999999987667899999999999999999999999999999999999999999999999999987643


Q ss_pred             Cccc---ccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhh-CCCCCCchhhHHHHHHHhhc-CCCCCC
Q 004959          496 QKAD---LSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFKVMRD-TPAIPD  570 (721)
Q Consensus       496 ~~~~---~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLt-G~~PF~~~~~~~~~~ki~~~-~~~~p~  570 (721)
                      ....   ....|+..|+|||++.+       ..++.++|||||||++|||++ |..||.+.........+... ....+.
T Consensus       162 ~~~~~~~~~~~~~~~y~~pE~~~~-------~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~  234 (279)
T cd05111         162 DDKKYFYSEHKTPIKWMALESILF-------GRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKGERLAQPQ  234 (279)
T ss_pred             CCcccccCCCCCcccccCHHHhcc-------CCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCCCCC
Confidence            3221   23446778999999843       446778999999999999998 99999876544433322222 223345


Q ss_pred             CCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q 004959          571 SLSPEGKDFLRCCFQRNPADRPPASLLLEH  600 (721)
Q Consensus       571 ~lS~el~dLI~~cL~~DP~kRPSa~eLL~H  600 (721)
                      .++.++.+++.+||..||++||++.|+++.
T Consensus       235 ~~~~~~~~li~~c~~~~p~~Rps~~el~~~  264 (279)
T cd05111         235 ICTIDVYMVMVKCWMIDENVRPTFKELANE  264 (279)
T ss_pred             CCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            578899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=6.6e-40  Score=344.30  Aligned_cols=254  Identities=29%  Similarity=0.491  Sum_probs=207.9

Q ss_pred             CCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecC----
Q 004959          340 SQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVED----  415 (721)
Q Consensus       340 ~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~----  415 (721)
                      ++|++.+.||+|+||.||+|.++.+|+.||||.+......   ......+.+|+.++++++||||+++++++....    
T Consensus         7 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~---~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~   83 (302)
T cd07864           7 DKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEK---EGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD   83 (302)
T ss_pred             hhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccc---cCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence            5799999999999999999999999999999998643211   112346778999999999999999999887654    


Q ss_pred             ------eEEEEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCC
Q 004959          416 ------KFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGM  489 (721)
Q Consensus       416 ------~~yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGl  489 (721)
                            .+|+||||+.+ +|.+++......+++..++.++.||+.||.|||++||+|+||||+||+++.++.+||+|||+
T Consensus        84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~kl~dfg~  162 (302)
T cd07864          84 FKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGL  162 (302)
T ss_pred             ccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcEEeCcccc
Confidence                  79999999975 78777766556799999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCCcc--cccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhcC--
Q 004959          490 AKHLTGQKA--DLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDT--  565 (721)
Q Consensus       490 A~~l~~~~~--~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~~--  565 (721)
                      +..+.....  .....++..|+|||++.+      ...++.++|||||||++|+|++|+.||......+.+..+....  
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~------~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~  236 (302)
T cd07864         163 ARLYNSEESRPYTNKVITLWYRPPELLLG------EERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGS  236 (302)
T ss_pred             cccccCCcccccccceeccCccChHHhcC------CCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Confidence            987644321  122346788999998842      2335668999999999999999999998765544443332210  


Q ss_pred             C----------------------------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccc
Q 004959          566 P----------------------------AIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFL  603 (721)
Q Consensus       566 ~----------------------------~~p~~lS~el~dLI~~cL~~DP~kRPSa~eLL~Hp~f  603 (721)
                      +                            .....++..+.++|.+||+.||++||++.+++.||||
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~  302 (302)
T cd07864         237 PCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL  302 (302)
T ss_pred             CChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence            0                            0122468999999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=1.5e-39  Score=338.76  Aligned_cols=250  Identities=24%  Similarity=0.389  Sum_probs=206.7

Q ss_pred             CCCeeEeeEEeecCCeEEEEEEECCCCc----EEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEec
Q 004959          339 NSQWQKGKLIGRGTFGSVYVASNRETGA----LCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVE  414 (721)
Q Consensus       339 ~~~y~~~k~LG~G~fG~VY~a~~~~tg~----~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~  414 (721)
                      ..+|++.+.||+|+||+||+|.+..+|+    .||+|.+..    .......+.+.+|+.++..+.|+||+++++++.. 
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~----~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-   80 (279)
T cd05109           6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRE----NTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-   80 (279)
T ss_pred             hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecC----CCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-
Confidence            3579999999999999999999877776    479998752    1234455678899999999999999999998765 


Q ss_pred             CeEEEEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccC
Q 004959          415 DKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLT  494 (721)
Q Consensus       415 ~~~yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~  494 (721)
                      ...+++|||+++|+|.+++....+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.+.
T Consensus        81 ~~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~  160 (279)
T cd05109          81 STVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLD  160 (279)
T ss_pred             CCcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCceeecc
Confidence            45789999999999999998766779999999999999999999999999999999999999999999999999998765


Q ss_pred             CCcccc---cCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhh-CCCCCCchhhHHHHHHHhhc-CCCCC
Q 004959          495 GQKADL---SMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFKVMRD-TPAIP  569 (721)
Q Consensus       495 ~~~~~~---s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLt-G~~PF~~~~~~~~~~ki~~~-~~~~p  569 (721)
                      ......   ...++..|+|||.+.       ...++.++|||||||++|||++ |..||...........+... ....+
T Consensus       161 ~~~~~~~~~~~~~~~~y~~PE~~~-------~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~  233 (279)
T cd05109         161 IDETEYHADGGKVPIKWMALESIL-------HRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGERLPQP  233 (279)
T ss_pred             cccceeecCCCccchhhCCHHHhc-------cCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCCCC
Confidence            433221   123567899999984       3456778999999999999998 99999875544433333222 23445


Q ss_pred             CCCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q 004959          570 DSLSPEGKDFLRCCFQRNPADRPPASLLLEH  600 (721)
Q Consensus       570 ~~lS~el~dLI~~cL~~DP~kRPSa~eLL~H  600 (721)
                      ..++.++.++|.+||+.||++||++.++++.
T Consensus       234 ~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~  264 (279)
T cd05109         234 PICTIDVYMIMVKCWMIDSECRPRFRELVDE  264 (279)
T ss_pred             ccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            6789999999999999999999999999853

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=9.1e-40  Score=352.69  Aligned_cols=256  Identities=28%  Similarity=0.518  Sum_probs=208.0

Q ss_pred             CCCCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEec---
Q 004959          338 MNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVE---  414 (721)
Q Consensus       338 l~~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~---  414 (721)
                      +..+|++.+.||.|+||.||+|.+..+|+.||+|++....     ....+.+.+|+.+|+.++||||+++++++...   
T Consensus         3 ~~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~-----~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~   77 (342)
T cd07854           3 LGSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTD-----PQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSD   77 (342)
T ss_pred             cCcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCC-----CchHHHHHHHHHHHHhcCCCcchhhHhhhcccccc
Confidence            4578999999999999999999999999999999986422     13456788999999999999999999876543   


Q ss_pred             -----------CeEEEEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcC-CCce
Q 004959          415 -----------DKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDA-SGVV  482 (721)
Q Consensus       415 -----------~~~yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~-~g~V  482 (721)
                                 ...|+||||+. ++|.+++..  +.+++..++.++.||+.||.|||++||+||||||+|||++. ++.+
T Consensus        78 ~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~  154 (342)
T cd07854          78 LTEDVGSLTELNSVYIVQEYME-TDLANVLEQ--GPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVL  154 (342)
T ss_pred             cccccccccccceEEEEeeccc-ccHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceE
Confidence                       35799999997 689888754  47999999999999999999999999999999999999974 5578


Q ss_pred             EEeecCCccccCCCccc----ccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHH
Q 004959          483 KLADFGMAKHLTGQKAD----LSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAM  558 (721)
Q Consensus       483 KL~DFGlA~~l~~~~~~----~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~  558 (721)
                      ||+|||++..+......    ....|+..|+|||++..      ...++.++|||||||++|+|++|+.||......+..
T Consensus       155 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~  228 (342)
T cd07854         155 KIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLS------PNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQM  228 (342)
T ss_pred             EECCcccceecCCccccccccccccccccccCHHHHhC------ccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence            99999999765432211    12357899999998742      234667899999999999999999999765544443


Q ss_pred             HHHhhcCC------------------------------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhccccccCC
Q 004959          559 FKVMRDTP------------------------------AIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQ  607 (721)
Q Consensus       559 ~ki~~~~~------------------------------~~p~~lS~el~dLI~~cL~~DP~kRPSa~eLL~Hp~f~~~~  607 (721)
                      ..+....+                              .+...++.++.+||.+||+.||++||++.+++.||||+...
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~~~  307 (342)
T cd07854         229 QLILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSCYS  307 (342)
T ss_pred             HHHHHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCcccccc
Confidence            33322110                              01235788999999999999999999999999999998643

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.5e-39  Score=337.03  Aligned_cols=249  Identities=24%  Similarity=0.401  Sum_probs=208.2

Q ss_pred             CCeeEeeEEeecCCeEEEEEEECCC-----CcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEec
Q 004959          340 SQWQKGKLIGRGTFGSVYVASNRET-----GALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVE  414 (721)
Q Consensus       340 ~~y~~~k~LG~G~fG~VY~a~~~~t-----g~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~  414 (721)
                      ++|++.+.||+|+||.||+|..+..     +..||+|.+..    .........+.+|+.+|+.+.|+||+++++++...
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~----~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~   81 (277)
T cd05032           6 EKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNE----NASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTG   81 (277)
T ss_pred             HHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCC----ccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCC
Confidence            5799999999999999999987643     48899998742    12233456788999999999999999999999999


Q ss_pred             CeEEEEEeeccCCCHHHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEe
Q 004959          415 DKFYIYLEYVHPGSINKYVREHC---------GAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLA  485 (721)
Q Consensus       415 ~~~yLVmEy~~gGsL~~~L~~~~---------~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~  485 (721)
                      ...|+||||+.+|+|.+++....         ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+
T Consensus        82 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~~kl~  161 (277)
T cd05032          82 QPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIG  161 (277)
T ss_pred             CCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCCEEEC
Confidence            99999999999999999986431         246788999999999999999999999999999999999999999999


Q ss_pred             ecCCccccCCCcc---cccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhh-CCCCCCchhhHHHHHHH
Q 004959          486 DFGMAKHLTGQKA---DLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFKV  561 (721)
Q Consensus       486 DFGlA~~l~~~~~---~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLt-G~~PF~~~~~~~~~~ki  561 (721)
                      |||+++.+.....   .....++..|+|||.+.       ...++.++|||||||++|||++ |..||.+....+....+
T Consensus       162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-------~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~  234 (277)
T cd05032         162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLK-------DGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFV  234 (277)
T ss_pred             CcccchhhccCcccccCCCCCccccccCHHHHh-------cCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHH
Confidence            9999986543321   12344678899999984       2346678999999999999998 99999876655555444


Q ss_pred             hhc-CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHh
Q 004959          562 MRD-TPAIPDSLSPEGKDFLRCCFQRNPADRPPASLLLE  599 (721)
Q Consensus       562 ~~~-~~~~p~~lS~el~dLI~~cL~~DP~kRPSa~eLL~  599 (721)
                      ... ....+..++.++.+||.+||+.+|++|||+.++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~  273 (277)
T cd05032         235 IDGGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVS  273 (277)
T ss_pred             hcCCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence            432 34567778999999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=8.4e-40  Score=337.02  Aligned_cols=251  Identities=32%  Similarity=0.580  Sum_probs=208.2

Q ss_pred             CCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeEEE
Q 004959          340 SQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYI  419 (721)
Q Consensus       340 ~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~yL  419 (721)
                      ++|++.+.||+|+||.||+|.+..+|+.||||.+...  +.......+.+.+|+.+++.+.|+||+++++++...+..++
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~--~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~   79 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIF--DLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNI   79 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeeh--hhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEE
Confidence            4688999999999999999999999999999987642  22234455788899999999999999999999999999999


Q ss_pred             EEeeccCCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCC
Q 004959          420 YLEYVHPGSINKYVREH---CGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQ  496 (721)
Q Consensus       420 VmEy~~gGsL~~~L~~~---~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~  496 (721)
                      ||||+.|++|.+++...   ...+++..++.++.||+.||.|||++|++|+||||+||+++.++.++|+|||++..+...
T Consensus        80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~  159 (267)
T cd08229          80 VLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK  159 (267)
T ss_pred             EEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchhhhccccC
Confidence            99999999999988642   356899999999999999999999999999999999999999999999999998766433


Q ss_pred             cc-cccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhh--HHHHHHHhhc-CC-CCCCC
Q 004959          497 KA-DLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEG--AAAMFKVMRD-TP-AIPDS  571 (721)
Q Consensus       497 ~~-~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~--~~~~~ki~~~-~~-~~p~~  571 (721)
                      .. .....|+..|+|||.+.       ...++.++|||||||++|+|++|..||.....  ......+... .+ ..+..
T Consensus       160 ~~~~~~~~~~~~~~ape~~~-------~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (267)
T cd08229         160 TTAAHSLVGTPYYMSPERIH-------ENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDH  232 (267)
T ss_pred             CcccccccCCcCccCHHHhc-------CCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcCCCCCCCccc
Confidence            22 23456899999999984       34466789999999999999999999965432  1222222221 11 22346


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHHHHh
Q 004959          572 LSPEGKDFLRCCFQRNPADRPPASLLLE  599 (721)
Q Consensus       572 lS~el~dLI~~cL~~DP~kRPSa~eLL~  599 (721)
                      ++.++.+||.+||+.||++|||+.+|++
T Consensus       233 ~~~~~~~li~~~l~~~p~~Rpt~~~i~~  260 (267)
T cd08229         233 YSEELRQLVNMCINPDPEKRPDITYVYD  260 (267)
T ss_pred             ccHHHHHHHHHhcCCCcccCCCHHHHHH
Confidence            8899999999999999999999998875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-39  Score=337.78  Aligned_cols=251  Identities=29%  Similarity=0.496  Sum_probs=207.1

Q ss_pred             eeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhC---CCCCeeeeeeeEEecCe--
Q 004959          342 WQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHL---KHPNIVQYYGSEIVEDK--  416 (721)
Q Consensus       342 y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L---~HPnIV~l~g~~~~~~~--  416 (721)
                      |++.+.||+|+||.||+|+++.+|+.||+|.+.....   .......+.+|+.+++++   .|+||+++++++...+.  
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~---~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~   77 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLS---EEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDR   77 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccc---cchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCC
Confidence            6789999999999999999998999999999864322   122234566788777666   59999999999988776  


Q ss_pred             ---EEEEEeeccCCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccc
Q 004959          417 ---FYIYLEYVHPGSINKYVREHC-GAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKH  492 (721)
Q Consensus       417 ---~yLVmEy~~gGsL~~~L~~~~-~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~  492 (721)
                         ++++|||+. ++|.+++.... ..+++..++.++.||+.||.|||++||+|+||+|+|||++.++.+||+|||++..
T Consensus        78 ~~~~~l~~e~~~-~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~  156 (287)
T cd07838          78 ELKLTLVFEHVD-QDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARI  156 (287)
T ss_pred             CceeEEEehhcc-cCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEeccCccee
Confidence               999999997 58998887643 3689999999999999999999999999999999999999999999999999987


Q ss_pred             cCCCcccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhcCC------
Q 004959          493 LTGQKADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTP------  566 (721)
Q Consensus       493 l~~~~~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~~~------  566 (721)
                      +..........++..|+|||++.+       ..++.++|||||||++|+|++|.+||......+.+.++.....      
T Consensus       157 ~~~~~~~~~~~~~~~~~~PE~~~~-------~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (287)
T cd07838         157 YSFEMALTSVVVTLWYRAPEVLLQ-------SSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEE  229 (287)
T ss_pred             ccCCcccccccccccccChHHhcc-------CCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHh
Confidence            755444444568899999999853       3456689999999999999999999987766655554433110      


Q ss_pred             ---------------------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccc
Q 004959          567 ---------------------AIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFL  603 (721)
Q Consensus       567 ---------------------~~p~~lS~el~dLI~~cL~~DP~kRPSa~eLL~Hp~f  603 (721)
                                           .....++.++.+||++||+.||++||++.+++.||||
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~  287 (287)
T cd07838         230 WPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF  287 (287)
T ss_pred             cCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence                                 0012356788999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=1.5e-39  Score=334.67  Aligned_cols=242  Identities=24%  Similarity=0.442  Sum_probs=201.8

Q ss_pred             EEeecCCeEEEEEEE--CCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeEEEEEeec
Q 004959          347 LIGRGTFGSVYVASN--RETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYIYLEYV  424 (721)
Q Consensus       347 ~LG~G~fG~VY~a~~--~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~yLVmEy~  424 (721)
                      .||+|+||.||+|..  ..++..+|+|++..   ........+.+.+|+.+|+.+.|+||+++++++. .+..++||||+
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~---~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~   77 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKN---DNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELA   77 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccC---CCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecC
Confidence            689999999999964  56789999998753   2233455678899999999999999999999875 55779999999


Q ss_pred             cCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCCccc----c
Q 004959          425 HPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKAD----L  500 (721)
Q Consensus       425 ~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~~~~----~  500 (721)
                      .+|+|.+++... ..+++..+..++.||+.||+|||++||+||||||.|||++.++.+||+|||++..+......    .
T Consensus        78 ~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  156 (257)
T cd05116          78 ELGPLNKFLQKN-KHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKT  156 (257)
T ss_pred             CCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecC
Confidence            999999999754 57999999999999999999999999999999999999999999999999999876443221    1


Q ss_pred             cCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhh-CCCCCCchhhHHHHHHHhhc-CCCCCCCCCHHHHH
Q 004959          501 SMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFKVMRD-TPAIPDSLSPEGKD  578 (721)
Q Consensus       501 s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLt-G~~PF~~~~~~~~~~ki~~~-~~~~p~~lS~el~d  578 (721)
                      ...++..|+|||.+.       ...++.++|||||||++|||++ |..||......+....+... ....+..++.++.+
T Consensus       157 ~~~~~~~y~aPE~~~-------~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~  229 (257)
T cd05116         157 HGKWPVKWYAPECMN-------YYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGERMECPQRCPPEMYD  229 (257)
T ss_pred             CCCCCccccCHhHhc-------cCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHH
Confidence            223467899999884       3456678999999999999997 99999876655555554443 34567789999999


Q ss_pred             HHHHhcccCCCCCCCHHHHHhc
Q 004959          579 FLRCCFQRNPADRPPASLLLEH  600 (721)
Q Consensus       579 LI~~cL~~DP~kRPSa~eLL~H  600 (721)
                      ||.+||+.||++||++.+|.+.
T Consensus       230 li~~~~~~~p~~Rp~~~~i~~~  251 (257)
T cd05116         230 LMKLCWTYGVDERPGFAVVELR  251 (257)
T ss_pred             HHHHHhccCchhCcCHHHHHHH
Confidence            9999999999999999998753

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-41  Score=370.32  Aligned_cols=238  Identities=31%  Similarity=0.593  Sum_probs=212.7

Q ss_pred             EeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeEEEEEee
Q 004959          344 KGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYIYLEY  423 (721)
Q Consensus       344 ~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~yLVmEy  423 (721)
                      .++.||.|+.|.||+|+.+  ++.||||+++            +.-+.+|+-|++|+|+||+.+.|+|...-.+||||||
T Consensus       128 ELeWlGSGaQGAVF~Grl~--netVAVKKV~------------elkETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEf  193 (904)
T KOG4721|consen  128 ELEWLGSGAQGAVFLGRLH--NETVAVKKVR------------ELKETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEF  193 (904)
T ss_pred             hhhhhccCcccceeeeecc--CceehhHHHh------------hhhhhhHHHHHhccCcceeeEeeeecCCceeEEeeec
Confidence            3578999999999999876  7899999875            2235688899999999999999999999999999999


Q ss_pred             ccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCCcccccCC
Q 004959          424 VHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMK  503 (721)
Q Consensus       424 ~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~~~~~s~~  503 (721)
                      |..|-|..+|+.. ..++......|..+|+.||.|||.++|||||||.-||||..+..|||+|||.++.+........++
T Consensus       194 Ca~GqL~~VLka~-~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~STkMSFa  272 (904)
T KOG4721|consen  194 CAQGQLYEVLKAG-RPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISDFGTSKELSDKSTKMSFA  272 (904)
T ss_pred             cccccHHHHHhcc-CccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEeccccchHhhhhhhhhhhhh
Confidence            9999999999875 788999999999999999999999999999999999999999999999999999887777778899


Q ss_pred             CCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhcC--CCCCCCCCHHHHHHHH
Q 004959          504 GSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDT--PAIPDSLSPEGKDFLR  581 (721)
Q Consensus       504 GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~~--~~~p~~lS~el~dLI~  581 (721)
                      ||..|||||++       +....+.++|||||||+|||||||..||.+.+...+++-+-...  ...|..+++.++=||+
T Consensus       273 GTVaWMAPEvI-------rnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVGsNsL~LpvPstcP~GfklL~K  345 (904)
T KOG4721|consen  273 GTVAWMAPEVI-------RNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVGSNSLHLPVPSTCPDGFKLLLK  345 (904)
T ss_pred             hhHhhhCHHHh-------hcCCcccccceehhHHHHHHHHhcCCCccccchheeEEeccCCcccccCcccCchHHHHHHH
Confidence            99999999999       55677889999999999999999999999887766665543332  3567889999999999


Q ss_pred             HhcccCCCCCCCHHHHHhcccc
Q 004959          582 CCFQRNPADRPPASLLLEHRFL  603 (721)
Q Consensus       582 ~cL~~DP~kRPSa~eLL~Hp~f  603 (721)
                      +||+-.|..||++.+||.|.=+
T Consensus       346 qcw~sKpRNRPSFrqil~HldI  367 (904)
T KOG4721|consen  346 QCWNSKPRNRPSFRQILLHLDI  367 (904)
T ss_pred             HHHhcCCCCCccHHHHHHHHhh
Confidence            9999999999999999999533

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=1.8e-39  Score=333.97  Aligned_cols=246  Identities=26%  Similarity=0.473  Sum_probs=206.3

Q ss_pred             CCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeEEE
Q 004959          340 SQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYI  419 (721)
Q Consensus       340 ~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~yL  419 (721)
                      ++|++.+.||+|+||.||+|... ++..||+|.+...      ....+.+.+|+.+++.++|+||+++++.+...+..|+
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   78 (261)
T cd05072           6 ESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPG------TMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYI   78 (261)
T ss_pred             HHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCC------chhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEE
Confidence            57999999999999999999865 5678999986421      1234678899999999999999999999999999999


Q ss_pred             EEeeccCCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCCcc
Q 004959          420 YLEYVHPGSINKYVREH-CGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKA  498 (721)
Q Consensus       420 VmEy~~gGsL~~~L~~~-~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~~~  498 (721)
                      ||||+.+++|.+++... ...+++..+..++.||+.||+|||++|++||||||+|||++.++.+||+|||++........
T Consensus        79 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~  158 (261)
T cd05072          79 ITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEY  158 (261)
T ss_pred             EEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCccceecCCCce
Confidence            99999999999999754 35688999999999999999999999999999999999999999999999999987644321


Q ss_pred             c--ccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhh-CCCCCCchhhHHHHHHHhhcC-CCCCCCCCH
Q 004959          499 D--LSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFKVMRDT-PAIPDSLSP  574 (721)
Q Consensus       499 ~--~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLt-G~~PF~~~~~~~~~~ki~~~~-~~~p~~lS~  574 (721)
                      .  ....++..|+|||++.       ...++.++|||||||++|+|++ |..||...........+.... ...+..++.
T Consensus       159 ~~~~~~~~~~~y~aPE~~~-------~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (261)
T cd05072         159 TAREGAKFPIKWTAPEAIN-------FGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRMPRMENCPD  231 (261)
T ss_pred             eccCCCccceecCCHHHhc-------cCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCH
Confidence            1  2234567899999984       3446678999999999999998 999998766555555544332 233456889


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHHh
Q 004959          575 EGKDFLRCCFQRNPADRPPASLLLE  599 (721)
Q Consensus       575 el~dLI~~cL~~DP~kRPSa~eLL~  599 (721)
                      ++.++|.+||..+|++||+++++++
T Consensus       232 ~~~~li~~~l~~~p~~Rp~~~~i~~  256 (261)
T cd05072         232 ELYDIMKTCWKEKAEERPTFDYLQS  256 (261)
T ss_pred             HHHHHHHHHccCCcccCcCHHHHHH
Confidence            9999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.4e-39  Score=370.56  Aligned_cols=261  Identities=21%  Similarity=0.309  Sum_probs=197.1

Q ss_pred             CCCCeeEeeEEeecCCeEEEEEEECCC-CcEEEEEEeecC------------CCCcccHHHHHHHHHHHHHHHhCCCCCe
Q 004959          338 MNSQWQKGKLIGRGTFGSVYVASNRET-GALCAMKEVDIF------------PDDPKSAESIKQLEQEIKVLSHLKHPNI  404 (721)
Q Consensus       338 l~~~y~~~k~LG~G~fG~VY~a~~~~t-g~~vAIK~i~~~------------~~~~~~~~~~k~~~~Ei~iL~~L~HPnI  404 (721)
                      +..+|++++.||+|+||+||+|..+.. +..+++|.+...            +...........+.+|+.+|++++|+||
T Consensus       146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnI  225 (501)
T PHA03210        146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENI  225 (501)
T ss_pred             hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCc
Confidence            456899999999999999999976532 233333311100            0011122345678899999999999999


Q ss_pred             eeeeeeEEecCeEEEEEeeccCCCHHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCC
Q 004959          405 VQYYGSEIVEDKFYIYLEYVHPGSINKYVREH----CGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASG  480 (721)
Q Consensus       405 V~l~g~~~~~~~~yLVmEy~~gGsL~~~L~~~----~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g  480 (721)
                      |++++++...+..|+|||++. ++|..++...    ........++.|+.||+.||.|||++|||||||||+||||+.++
T Consensus       226 v~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~~~  304 (501)
T PHA03210        226 LKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDG  304 (501)
T ss_pred             CcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCC
Confidence            999999999999999999995 6777776532    12344677889999999999999999999999999999999999


Q ss_pred             ceEEeecCCccccCCCcc--cccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCC-CCch--hhH
Q 004959          481 VVKLADFGMAKHLTGQKA--DLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPP-WSEY--EGA  555 (721)
Q Consensus       481 ~VKL~DFGlA~~l~~~~~--~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~P-F~~~--~~~  555 (721)
                      .+||+|||++..+.....  ....+||+.|+|||++.+       ..++.++|||||||+||||++|..+ |...  ...
T Consensus       305 ~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~  377 (501)
T PHA03210        305 KIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAG-------DGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPG  377 (501)
T ss_pred             CEEEEeCCCceecCcccccccccccCCcCCCCchhhcC-------CCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHH
Confidence            999999999987654332  234679999999999853       4567789999999999999998754 4321  122


Q ss_pred             HHHHHHhhcC----CCCC----------------------------CCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccc
Q 004959          556 AAMFKVMRDT----PAIP----------------------------DSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFL  603 (721)
Q Consensus       556 ~~~~ki~~~~----~~~p----------------------------~~lS~el~dLI~~cL~~DP~kRPSa~eLL~Hp~f  603 (721)
                      ..+.+++...    ..++                            ..++.++.++|.+||+.||++|||+.|+|.||||
T Consensus       378 ~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~f  457 (501)
T PHA03210        378 KQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPLF  457 (501)
T ss_pred             HHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhChhh
Confidence            2222222110    0000                            1356778899999999999999999999999999


Q ss_pred             ccC
Q 004959          604 KNS  606 (721)
Q Consensus       604 ~~~  606 (721)
                      ...
T Consensus       458 ~~~  460 (501)
T PHA03210        458 SAE  460 (501)
T ss_pred             hcC
Confidence            764

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=1.1e-39  Score=349.63  Aligned_cols=264  Identities=28%  Similarity=0.468  Sum_probs=212.3

Q ss_pred             CCCCee-EeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccH---H------HHHHHHHHHHHHHhCCCCCeeee
Q 004959          338 MNSQWQ-KGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSA---E------SIKQLEQEIKVLSHLKHPNIVQY  407 (721)
Q Consensus       338 l~~~y~-~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~---~------~~k~~~~Ei~iL~~L~HPnIV~l  407 (721)
                      +.++|. +.+.||.|+||+||+|.+..+|+.||||++..........   +      ....+.+|+.+|+.++|+||+++
T Consensus         6 ~~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~   85 (335)
T PTZ00024          6 ISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGL   85 (335)
T ss_pred             cccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeee
Confidence            345675 5678999999999999999999999999986432111000   0      11257789999999999999999


Q ss_pred             eeeEEecCeEEEEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeec
Q 004959          408 YGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADF  487 (721)
Q Consensus       408 ~g~~~~~~~~yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DF  487 (721)
                      ++++...+..|+||||+. |+|.+++... ..+++..+..++.||+.||.|||++||+|+||||+|||++.++.+||+||
T Consensus        86 ~~~~~~~~~~~lv~e~~~-~~l~~~l~~~-~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~kl~df  163 (335)
T PTZ00024         86 VDVYVEGDFINLVMDIMA-SDLKKVVDRK-IRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADF  163 (335)
T ss_pred             eEEEecCCcEEEEEeccc-cCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCEEECCc
Confidence            999999999999999997 6899988654 67999999999999999999999999999999999999999999999999


Q ss_pred             CCccccCCC---------------cccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCch
Q 004959          488 GMAKHLTGQ---------------KADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEY  552 (721)
Q Consensus       488 GlA~~l~~~---------------~~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~  552 (721)
                      |++..+...               .......+++.|+|||++.+      ...++.++|||||||++|+|++|+.||...
T Consensus       164 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~~Dv~slG~~l~el~tg~~p~~~~  237 (335)
T PTZ00024        164 GLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMG------AEKYHFAVDMWSVGCIFAELLTGKPLFPGE  237 (335)
T ss_pred             cceeecccccccccccccccccccccccccccccCCCCChhccc------CCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            999765411               11122347889999999853      223567899999999999999999999877


Q ss_pred             hhHHHHHHHhhcCC----------------------------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhccccc
Q 004959          553 EGAAAMFKVMRDTP----------------------------AIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLK  604 (721)
Q Consensus       553 ~~~~~~~ki~~~~~----------------------------~~p~~lS~el~dLI~~cL~~DP~kRPSa~eLL~Hp~f~  604 (721)
                      +..+.+..+.....                            ......+.++.+||.+||+.||++||+++|+|.|+||+
T Consensus       238 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~~  317 (335)
T PTZ00024        238 NEIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYFK  317 (335)
T ss_pred             CHHHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCcccC
Confidence            66555444322100                            01134578899999999999999999999999999998


Q ss_pred             cCCCC
Q 004959          605 NSQQP  609 (721)
Q Consensus       605 ~~~~~  609 (721)
                      ....+
T Consensus       318 ~~~~~  322 (335)
T PTZ00024        318 SDPLP  322 (335)
T ss_pred             CCCCC
Confidence            76544

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=1.2e-39  Score=339.37  Aligned_cols=245  Identities=24%  Similarity=0.410  Sum_probs=199.6

Q ss_pred             CCeeEeeEE--eecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhC-CCCCeeeeeeeEEecCe
Q 004959          340 SQWQKGKLI--GRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHL-KHPNIVQYYGSEIVEDK  416 (721)
Q Consensus       340 ~~y~~~k~L--G~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L-~HPnIV~l~g~~~~~~~  416 (721)
                      +.|++.+.+  |+|+||.||+|.++.+|..+|+|.+.....        ..+  |+.++..+ +|+||+++++.+...+.
T Consensus        14 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~--------~~~--e~~~~~~~~~h~~iv~~~~~~~~~~~   83 (267)
T PHA03390         14 KNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNF--------NAI--EPMVHQLMKDNPNFIKLYYSVTTLKG   83 (267)
T ss_pred             HhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhc--------chh--hHHHHHHhhcCCCEEEEEEEEecCCe
Confidence            345555555  999999999999999999999998753210        011  22222222 69999999999999999


Q ss_pred             EEEEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCC-ceEEeecCCccccCC
Q 004959          417 FYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASG-VVKLADFGMAKHLTG  495 (721)
Q Consensus       417 ~yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g-~VKL~DFGlA~~l~~  495 (721)
                      .|+||||+++++|.+++... ..+++.+++.++.||+.||.|||+.||+||||||+||+++.++ .++|+|||++.....
T Consensus        84 ~~iv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~  162 (267)
T PHA03390         84 HVLIMDYIKDGDLFDLLKKE-GKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGT  162 (267)
T ss_pred             eEEEEEcCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceecCC
Confidence            99999999999999999765 4899999999999999999999999999999999999999988 999999999876543


Q ss_pred             CcccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhH----HHHHHHhhcCCCCCCC
Q 004959          496 QKADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGA----AAMFKVMRDTPAIPDS  571 (721)
Q Consensus       496 ~~~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~----~~~~ki~~~~~~~p~~  571 (721)
                      .   ....|+..|+|||++.+       ..++.++|||||||++|+|++|..||......    ..+..........+..
T Consensus       163 ~---~~~~~~~~y~aPE~~~~-------~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (267)
T PHA03390        163 P---SCYDGTLDYFSPEKIKG-------HNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKKLPFIKN  232 (267)
T ss_pred             C---ccCCCCCcccChhhhcC-------CCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhhcccCCcccc
Confidence            2   23468999999999843       34567899999999999999999999754322    1222222333445567


Q ss_pred             CCHHHHHHHHHhcccCCCCCCC-HHHHHhcccccc
Q 004959          572 LSPEGKDFLRCCFQRNPADRPP-ASLLLEHRFLKN  605 (721)
Q Consensus       572 lS~el~dLI~~cL~~DP~kRPS-a~eLL~Hp~f~~  605 (721)
                      ++..+.+||.+||+.||.+|++ ++|+|+||||++
T Consensus       233 ~~~~~~~li~~~l~~~p~~R~~~~~~~l~h~~~~~  267 (267)
T PHA03390        233 VSKNANDFVQSMLKYNINYRLTNYNEIIKHPFLKI  267 (267)
T ss_pred             cCHHHHHHHHHHhccChhhCCchHHHHhcCCcccC
Confidence            9999999999999999999996 699999999974

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=2.2e-39  Score=335.29  Aligned_cols=249  Identities=25%  Similarity=0.436  Sum_probs=207.6

Q ss_pred             CCeeEeeEEeecCCeEEEEEEECCCCc---EEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCe
Q 004959          340 SQWQKGKLIGRGTFGSVYVASNRETGA---LCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDK  416 (721)
Q Consensus       340 ~~y~~~k~LG~G~fG~VY~a~~~~tg~---~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~  416 (721)
                      .+|++++.||+|+||.||+|.++.++.   .+|+|.+...    ......+.+.+|+.++++++||||+++++++...+.
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~----~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   79 (267)
T cd05066           4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAG----YTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKP   79 (267)
T ss_pred             HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCC----CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCc
Confidence            479999999999999999998765443   7999987521    223446788999999999999999999999999999


Q ss_pred             EEEEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCC
Q 004959          417 FYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQ  496 (721)
Q Consensus       417 ~yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~  496 (721)
                      .|+||||+++++|.+++....+.+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++..+...
T Consensus        80 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~  159 (267)
T cd05066          80 VMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD  159 (267)
T ss_pred             cEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCcccccccc
Confidence            99999999999999999876667899999999999999999999999999999999999999999999999999876543


Q ss_pred             cccc----cCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhh-CCCCCCchhhHHHHHHHhhcC-CCCCC
Q 004959          497 KADL----SMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFKVMRDT-PAIPD  570 (721)
Q Consensus       497 ~~~~----s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLt-G~~PF~~~~~~~~~~ki~~~~-~~~p~  570 (721)
                      ....    ...++..|+|||++.+       ..++.++|+|||||++|+|++ |..||.+....+....+.... ...+.
T Consensus       160 ~~~~~~~~~~~~~~~y~~pe~~~~-------~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  232 (267)
T cd05066         160 PEAAYTTRGGKIPIRWTAPEAIAY-------RKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYRLPAPM  232 (267)
T ss_pred             cceeeecCCCccceeecCHhHhcc-------CccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCCCcCCCCC
Confidence            2211    1223567999999843       346678999999999999886 999998766555544444332 23345


Q ss_pred             CCCHHHHHHHHHhcccCCCCCCCHHHHHh
Q 004959          571 SLSPEGKDFLRCCFQRNPADRPPASLLLE  599 (721)
Q Consensus       571 ~lS~el~dLI~~cL~~DP~kRPSa~eLL~  599 (721)
                      .++.++.+++.+||+.+|++||++.++++
T Consensus       233 ~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  261 (267)
T cd05066         233 DCPAALHQLMLDCWQKDRNERPKFEQIVS  261 (267)
T ss_pred             CCCHHHHHHHHHHcccCchhCCCHHHHHH
Confidence            67899999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=1.5e-39  Score=340.59  Aligned_cols=251  Identities=26%  Similarity=0.478  Sum_probs=208.4

Q ss_pred             CCCeeEeeEEeecCCeEEEEEEECCC-----CcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhC-CCCCeeeeeeeEE
Q 004959          339 NSQWQKGKLIGRGTFGSVYVASNRET-----GALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHL-KHPNIVQYYGSEI  412 (721)
Q Consensus       339 ~~~y~~~k~LG~G~fG~VY~a~~~~t-----g~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L-~HPnIV~l~g~~~  412 (721)
                      .++|++.+.||+|+||.||++..+..     ...+|+|.+...    ........+.+|+.+++++ +|+||+++++++.
T Consensus        11 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~----~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~   86 (293)
T cd05053          11 RDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDD----ATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCT   86 (293)
T ss_pred             HhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCC----CCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEc
Confidence            35799999999999999999987643     378999987531    2234456788999999999 7999999999999


Q ss_pred             ecCeEEEEEeeccCCCHHHHHHHh---------------cCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEc
Q 004959          413 VEDKFYIYLEYVHPGSINKYVREH---------------CGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVD  477 (721)
Q Consensus       413 ~~~~~yLVmEy~~gGsL~~~L~~~---------------~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld  477 (721)
                      ..+.+|+||||+.+|+|.+++...               ...+++..+..++.||+.||.|||++||+||||||+|||++
T Consensus        87 ~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil~~  166 (293)
T cd05053          87 QEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVT  166 (293)
T ss_pred             CCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEEEc
Confidence            999999999999999999998642               34689999999999999999999999999999999999999


Q ss_pred             CCCceEEeecCCccccCCCcc---cccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhh-CCCCCCchh
Q 004959          478 ASGVVKLADFGMAKHLTGQKA---DLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYE  553 (721)
Q Consensus       478 ~~g~VKL~DFGlA~~l~~~~~---~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLt-G~~PF~~~~  553 (721)
                      .++.+||+|||+++.+.....   .....++..|+|||++.       ...++.++|||||||++|||++ |..||....
T Consensus       167 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-------~~~~~~~~Di~slG~il~el~~~g~~p~~~~~  239 (293)
T cd05053         167 EDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALF-------DRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIP  239 (293)
T ss_pred             CCCeEEeCccccccccccccceeccCCCCCCccccCHHHhc-------cCCcCcccceeehhhHHHHHhcCCCCCCCCCC
Confidence            999999999999987654321   11223567799999884       3456678999999999999997 999998766


Q ss_pred             hHHHHHHHhhc-CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q 004959          554 GAAAMFKVMRD-TPAIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEH  600 (721)
Q Consensus       554 ~~~~~~ki~~~-~~~~p~~lS~el~dLI~~cL~~DP~kRPSa~eLL~H  600 (721)
                      ..+....+... ....+..++.++.+||.+||..||++|||+.|++++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~  287 (293)
T cd05053         240 VEELFKLLKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVED  287 (293)
T ss_pred             HHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence            55544444333 234566788999999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=3.2e-39  Score=346.44  Aligned_cols=258  Identities=28%  Similarity=0.503  Sum_probs=208.0

Q ss_pred             CeeEeeEEeecCCeEEEEEEECCC--CcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhC-CCCCeeeeeeeEEec---
Q 004959          341 QWQKGKLIGRGTFGSVYVASNRET--GALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHL-KHPNIVQYYGSEIVE---  414 (721)
Q Consensus       341 ~y~~~k~LG~G~fG~VY~a~~~~t--g~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L-~HPnIV~l~g~~~~~---  414 (721)
                      +|++.+.||+|+||.||+|.+..+  +..||||.+....   ......+.+.+|+.+++++ .|+||+++++.+...   
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~---~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~   77 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVF---SKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGN   77 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEecccc---ccchhHHHHHHHHHHHHHhcCCCChheeeeeeeecccc
Confidence            488999999999999999999888  9999999875321   1223356778899999999 599999999875432   


Q ss_pred             -CeEEEEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCcccc
Q 004959          415 -DKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHL  493 (721)
Q Consensus       415 -~~~yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l  493 (721)
                       ..+|++|||+. ++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+
T Consensus        78 ~~~~~~~~e~~~-~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~  155 (332)
T cd07857          78 FNELYLYEELME-ADLHQIIRSG-QPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGF  155 (332)
T ss_pred             CCcEEEEEeccc-CCHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCceec
Confidence             45789999995 6899888654 67999999999999999999999999999999999999999999999999999876


Q ss_pred             CCCcc-----cccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhc----
Q 004959          494 TGQKA-----DLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRD----  564 (721)
Q Consensus       494 ~~~~~-----~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~----  564 (721)
                      .....     .....|++.|+|||++.+      ...++.++|||||||++|+|++|+.||...+....+..++..    
T Consensus       156 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~------~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  229 (332)
T cd07857         156 SENPGENAGFMTEYVATRWYRAPEIMLS------FQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTP  229 (332)
T ss_pred             ccccccccccccCcccCccccCcHHHhC------CCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCC
Confidence            43221     223568999999998842      234667899999999999999999999765433322221110    


Q ss_pred             ----------------------C-----CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhccccccCCCC
Q 004959          565 ----------------------T-----PAIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQP  609 (721)
Q Consensus       565 ----------------------~-----~~~p~~lS~el~dLI~~cL~~DP~kRPSa~eLL~Hp~f~~~~~~  609 (721)
                                            .     ......++.++.+||.+||+.||++|||+.+++.||||....++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~~~~~  301 (332)
T cd07857         230 DEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIWHDP  301 (332)
T ss_pred             CHHHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhhhcCc
Confidence                                  0     01112457899999999999999999999999999999877665

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=2.3e-39  Score=338.49  Aligned_cols=256  Identities=40%  Similarity=0.713  Sum_probs=217.9

Q ss_pred             CCCCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeE
Q 004959          338 MNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKF  417 (721)
Q Consensus       338 l~~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~  417 (721)
                      ....|+..+.||+|+||.||+|.+..+++.|++|++.....      ..+.+.+|+.+++.++|+||+++++.+...+..
T Consensus        17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   90 (286)
T cd06614          17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ------NKELIINEILIMKDCKHPNIVDYYDSYLVGDEL   90 (286)
T ss_pred             ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch------hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEE
Confidence            44578999999999999999999998999999999863211      456788999999999999999999999999999


Q ss_pred             EEEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCCc
Q 004959          418 YIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQK  497 (721)
Q Consensus       418 yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~~  497 (721)
                      |+||||++|++|.+++......+++..+..++.||+.||.|||+.||+|+||+|+||+++.++.++|+|||++..+....
T Consensus        91 ~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~  170 (286)
T cd06614          91 WVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEK  170 (286)
T ss_pred             EEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchhhhhccch
Confidence            99999999999999998764489999999999999999999999999999999999999999999999999987654332


Q ss_pred             -ccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhcC-CCC--CCCCC
Q 004959          498 -ADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDT-PAI--PDSLS  573 (721)
Q Consensus       498 -~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~~-~~~--p~~lS  573 (721)
                       ......|+..|++||++.+       ..++.++|||||||++|+|++|+.||...........+.... ...  +..++
T Consensus       171 ~~~~~~~~~~~y~~PE~~~~-------~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (286)
T cd06614         171 SKRNSVVGTPYWMAPEVIKR-------KDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNPEKWS  243 (286)
T ss_pred             hhhccccCCcccCCHhHhcC-------CCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCcchhhCC
Confidence             2233458899999999842       345678999999999999999999998766555444443322 222  23378


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHHhccccccC
Q 004959          574 PEGKDFLRCCFQRNPADRPPASLLLEHRFLKNS  606 (721)
Q Consensus       574 ~el~dLI~~cL~~DP~kRPSa~eLL~Hp~f~~~  606 (721)
                      .++++||.+||+.+|.+||++.++++|+||+..
T Consensus       244 ~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~  276 (286)
T cd06614         244 PEFKDFLNKCLVKDPEKRPSAEELLQHPFLKKA  276 (286)
T ss_pred             HHHHHHHHHHhccChhhCcCHHHHhhChHhhcc
Confidence            999999999999999999999999999999873

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=1.5e-39  Score=360.57  Aligned_cols=251  Identities=26%  Similarity=0.462  Sum_probs=205.2

Q ss_pred             CCCeeEeeEEeecCCeEEEEEEECC-----CCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCC-CCCeeeeeeeEE
Q 004959          339 NSQWQKGKLIGRGTFGSVYVASNRE-----TGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLK-HPNIVQYYGSEI  412 (721)
Q Consensus       339 ~~~y~~~k~LG~G~fG~VY~a~~~~-----tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~-HPnIV~l~g~~~  412 (721)
                      .++|+++++||+|+||.||+|++..     ++..||||++...    ......+.+.+|+++|.++. |||||++++++.
T Consensus        36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~----~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~  111 (400)
T cd05105          36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPT----ARSSEKQALMSELKIMTHLGPHLNIVNLLGACT  111 (400)
T ss_pred             ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCC----CChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEc
Confidence            3578999999999999999998643     3457999988532    22334567899999999996 999999999999


Q ss_pred             ecCeEEEEEeeccCCCHHHHHHHhc-------------------------------------------------------
Q 004959          413 VEDKFYIYLEYVHPGSINKYVREHC-------------------------------------------------------  437 (721)
Q Consensus       413 ~~~~~yLVmEy~~gGsL~~~L~~~~-------------------------------------------------------  437 (721)
                      ..+.+|||||||.+|+|.++|....                                                       
T Consensus       112 ~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  191 (400)
T cd05105         112 KSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPM  191 (400)
T ss_pred             cCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchh
Confidence            9999999999999999999886421                                                       


Q ss_pred             ----------------------------------------CCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEc
Q 004959          438 ----------------------------------------GAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVD  477 (721)
Q Consensus       438 ----------------------------------------~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld  477 (721)
                                                              ..+++..+..++.||+.||.|||++||+||||||+|||++
T Consensus       192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nill~  271 (400)
T cd05105         192 LEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLA  271 (400)
T ss_pred             hhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEEEe
Confidence                                                    2477888899999999999999999999999999999999


Q ss_pred             CCCceEEeecCCccccCCCcc---cccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhh-CCCCCCchh
Q 004959          478 ASGVVKLADFGMAKHLTGQKA---DLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYE  553 (721)
Q Consensus       478 ~~g~VKL~DFGlA~~l~~~~~---~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLt-G~~PF~~~~  553 (721)
                      .++.+||+|||+++.+.....   .....++..|+|||++.+       ..++.++|||||||+||||++ |..||....
T Consensus       272 ~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~DiwSlGvil~ellt~g~~P~~~~~  344 (400)
T cd05105         272 QGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFD-------NLYTTLSDVWSYGILLWEIFSLGGTPYPGMI  344 (400)
T ss_pred             CCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcC-------CCCCchhhHHHHHHHHHHHHHCCCCCCcccc
Confidence            999999999999986543222   122346788999999843       446778999999999999997 999998754


Q ss_pred             hHHHHHHHhhc--CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q 004959          554 GAAAMFKVMRD--TPAIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEH  600 (721)
Q Consensus       554 ~~~~~~ki~~~--~~~~p~~lS~el~dLI~~cL~~DP~kRPSa~eLL~H  600 (721)
                      ....+...+..  ....+..++.++.++|.+||+.||++||++.+|.+.
T Consensus       345 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~  393 (400)
T cd05105         345 VDSTFYNKIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDI  393 (400)
T ss_pred             hhHHHHHHHhcCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHH
Confidence            43333333332  234456789999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=9.8e-40  Score=335.44  Aligned_cols=247  Identities=24%  Similarity=0.434  Sum_probs=210.2

Q ss_pred             CCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeEEE
Q 004959          340 SQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYI  419 (721)
Q Consensus       340 ~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~yL  419 (721)
                      .+|++++.||.|+||.||+|.+.. ++.+|+|++..     ........+.+|+.+|+.++|+||+++++++...+..++
T Consensus         6 ~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~-----~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l   79 (261)
T cd05148           6 EEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKS-----DDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYI   79 (261)
T ss_pred             HHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccc-----cchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEE
Confidence            469999999999999999999987 89999998753     122235578899999999999999999999999999999


Q ss_pred             EEeeccCCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCCcc
Q 004959          420 YLEYVHPGSINKYVREH-CGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKA  498 (721)
Q Consensus       420 VmEy~~gGsL~~~L~~~-~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~~~  498 (721)
                      ||||+++++|.+++... ...+++..+..++.||+.||.|||++||+|+||||+||||+.++.+||+|||++..+.....
T Consensus        80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~  159 (261)
T cd05148          80 ITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVY  159 (261)
T ss_pred             EEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccchhhcCCccc
Confidence            99999999999999764 35689999999999999999999999999999999999999999999999999987643321


Q ss_pred             c-ccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhh-CCCCCCchhhHHHHHHHhhc-CCCCCCCCCHH
Q 004959          499 D-LSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFKVMRD-TPAIPDSLSPE  575 (721)
Q Consensus       499 ~-~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLt-G~~PF~~~~~~~~~~ki~~~-~~~~p~~lS~e  575 (721)
                      . ....++..|+|||++.       ...++.++|||||||++|+|++ |+.||......+.+..+... ....+..++++
T Consensus       160 ~~~~~~~~~~~~~PE~~~-------~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (261)
T cd05148         160 LSSDKKIPYKWTAPEAAS-------HGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRMPCPAKCPQE  232 (261)
T ss_pred             cccCCCCceEecCHHHHc-------cCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhCCcCCCCCCCCHH
Confidence            1 1234567899999984       3456678999999999999998 89999877666665555543 23456778999


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHHh
Q 004959          576 GKDFLRCCFQRNPADRPPASLLLE  599 (721)
Q Consensus       576 l~dLI~~cL~~DP~kRPSa~eLL~  599 (721)
                      +.++|.+||+.||++|||+.+|++
T Consensus       233 ~~~~i~~~l~~~p~~Rpt~~~l~~  256 (261)
T cd05148         233 IYKIMLECWAAEPEDRPSFKALRE  256 (261)
T ss_pred             HHHHHHHHcCCCchhCcCHHHHHH
Confidence            999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=5.2e-39  Score=330.16  Aligned_cols=251  Identities=32%  Similarity=0.577  Sum_probs=209.2

Q ss_pred             CCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeEEE
Q 004959          340 SQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYI  419 (721)
Q Consensus       340 ~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~yL  419 (721)
                      ++|++.+.||+|+||.||+|.+..+|+.||+|.+....  .......+.+.+|+.++++++|+||+++++++...+..++
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~l   79 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFE--MMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNI   79 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeeccc--ccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence            57999999999999999999999999999999886422  2233446788999999999999999999999999999999


Q ss_pred             EEeeccCCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCC
Q 004959          420 YLEYVHPGSINKYVREH---CGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQ  496 (721)
Q Consensus       420 VmEy~~gGsL~~~L~~~---~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~  496 (721)
                      ||||+.+++|..++...   ...+++..++.++.||+.||.|||+.||+||||||+||+++.++.++|+|||++..+...
T Consensus        80 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~  159 (267)
T cd08224          80 VLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSK  159 (267)
T ss_pred             EEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccceeeeccCC
Confidence            99999999999998642   345899999999999999999999999999999999999999999999999998765433


Q ss_pred             cc-cccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchh--hHHHHHHHhhc-CCCCCC-C
Q 004959          497 KA-DLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYE--GAAAMFKVMRD-TPAIPD-S  571 (721)
Q Consensus       497 ~~-~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~--~~~~~~ki~~~-~~~~p~-~  571 (721)
                      .. .....|+..|+|||.+.       ...++.++|||||||++|+|++|+.||....  ..+....+... ....+. .
T Consensus       160 ~~~~~~~~~~~~y~apE~~~-------~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (267)
T cd08224         160 TTAAHSLVGTPYYMSPERIH-------ENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLPADH  232 (267)
T ss_pred             CcccceecCCccccCHHHhc-------cCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCCCCCCChhh
Confidence            22 23356899999999984       3446678999999999999999999996532  12222222221 223343 6


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHHHHh
Q 004959          572 LSPEGKDFLRCCFQRNPADRPPASLLLE  599 (721)
Q Consensus       572 lS~el~dLI~~cL~~DP~kRPSa~eLL~  599 (721)
                      ++.++.++|.+||..+|++||++.+|++
T Consensus       233 ~~~~~~~~i~~cl~~~p~~Rp~~~~il~  260 (267)
T cd08224         233 YSEELRDLVSRCINPDPEKRPDISYVLQ  260 (267)
T ss_pred             cCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            8889999999999999999999999885

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=9e-40  Score=340.60  Aligned_cols=249  Identities=20%  Similarity=0.346  Sum_probs=208.1

Q ss_pred             CeeEeeEEeecCCeEEEEEEECC-----CCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecC
Q 004959          341 QWQKGKLIGRGTFGSVYVASNRE-----TGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVED  415 (721)
Q Consensus       341 ~y~~~k~LG~G~fG~VY~a~~~~-----tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~  415 (721)
                      +|++.+.||+|+||.||+|.+..     .++.||||++...    ......+.+.+|+.++..++|||||++++++...+
T Consensus         6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~   81 (283)
T cd05091           6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDK----AEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQ   81 (283)
T ss_pred             HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCC----CCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCC
Confidence            57888999999999999998754     3578999988532    22334567889999999999999999999999999


Q ss_pred             eEEEEEeeccCCCHHHHHHHh---------------cCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCC
Q 004959          416 KFYIYLEYVHPGSINKYVREH---------------CGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASG  480 (721)
Q Consensus       416 ~~yLVmEy~~gGsL~~~L~~~---------------~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g  480 (721)
                      ..++++||+.+++|.+++...               ...+++..+..++.||+.||.|||++||+||||||+|||++.++
T Consensus        82 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~~~  161 (283)
T cd05091          82 PLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKL  161 (283)
T ss_pred             ceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecCCC
Confidence            999999999999999998532               13478889999999999999999999999999999999999999


Q ss_pred             ceEEeecCCccccCCCcc---cccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhh-CCCCCCchhhHH
Q 004959          481 VVKLADFGMAKHLTGQKA---DLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAA  556 (721)
Q Consensus       481 ~VKL~DFGlA~~l~~~~~---~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLt-G~~PF~~~~~~~  556 (721)
                      .+||+|||+++.+.....   .....+++.|+|||.+.+       ..++.++|||||||++|||++ |..||.+....+
T Consensus       162 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~  234 (283)
T cd05091         162 NVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMY-------GKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQD  234 (283)
T ss_pred             ceEecccccccccccchheeeccCccCCccccCHHHHhc-------CCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHH
Confidence            999999999886543221   122346788999999843       346678999999999999998 889998876666


Q ss_pred             HHHHHhhcC-CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q 004959          557 AMFKVMRDT-PAIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEH  600 (721)
Q Consensus       557 ~~~ki~~~~-~~~p~~lS~el~dLI~~cL~~DP~kRPSa~eLL~H  600 (721)
                      ....+.... ..++..++.++.+|+.+||+.+|++||++.+|+..
T Consensus       235 ~~~~i~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~  279 (283)
T cd05091         235 VIEMIRNRQVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSR  279 (283)
T ss_pred             HHHHHHcCCcCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHH
Confidence            666555443 34567899999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=3.9e-39  Score=343.33  Aligned_cols=258  Identities=34%  Similarity=0.632  Sum_probs=216.2

Q ss_pred             CCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeEEE
Q 004959          340 SQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYI  419 (721)
Q Consensus       340 ~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~yL  419 (721)
                      +.|...+.||+|+||.||+|++..+|+.|+||++....  .......+.+.+|+.+++.++|+||+++++++.+.+..|+
T Consensus        21 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~--~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   98 (313)
T cd06633          21 EIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSG--KQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWL   98 (313)
T ss_pred             HHhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccc--cCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEE
Confidence            34777788999999999999999999999999986432  2234456678899999999999999999999999999999


Q ss_pred             EEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCCccc
Q 004959          420 YLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKAD  499 (721)
Q Consensus       420 VmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~~~~  499 (721)
                      ||||+. |+|.+++......+++..+..++.||+.||.|||++||+|+||||+||+++.++.+||+|||++....   ..
T Consensus        99 v~e~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~---~~  174 (313)
T cd06633          99 VMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSS---PA  174 (313)
T ss_pred             EEecCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCCcccC---CC
Confidence            999995 68888887666789999999999999999999999999999999999999999999999999986432   22


Q ss_pred             ccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhcCC-C-CCCCCCHHHH
Q 004959          500 LSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTP-A-IPDSLSPEGK  577 (721)
Q Consensus       500 ~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~~~-~-~p~~lS~el~  577 (721)
                      ....|+..|+|||++...    ....++.++|||||||++|+|++|..||...........+..... . ....++..++
T Consensus       175 ~~~~~~~~y~aPE~~~~~----~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  250 (313)
T cd06633         175 NSFVGTPYWMAPEVILAM----DEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNEWTDSFR  250 (313)
T ss_pred             CCccccccccChhhcccc----CCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCHHHH
Confidence            345689999999998421    123466789999999999999999999987666555555543322 2 2245778899


Q ss_pred             HHHHHhcccCCCCCCCHHHHHhccccccCC
Q 004959          578 DFLRCCFQRNPADRPPASLLLEHRFLKNSQ  607 (721)
Q Consensus       578 dLI~~cL~~DP~kRPSa~eLL~Hp~f~~~~  607 (721)
                      +||.+||+.+|++||++.+++.||||....
T Consensus       251 ~li~~~l~~~P~~Rp~~~~~l~~~~~~~~~  280 (313)
T cd06633         251 GFVDYCLQKIPQERPASAELLRHDFVRRDR  280 (313)
T ss_pred             HHHHHHccCChhhCcCHHHHhcCcccCCCc
Confidence            999999999999999999999999998643

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=8.4e-40  Score=346.27  Aligned_cols=255  Identities=28%  Similarity=0.465  Sum_probs=202.5

Q ss_pred             eEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeEEEEEe
Q 004959          343 QKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYIYLE  422 (721)
Q Consensus       343 ~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~yLVmE  422 (721)
                      .+++.+|.|  |.||.++...+|+.||||++...   .......+.+.+|+.+|+.++|+||+++++++...+..|++||
T Consensus         5 ~i~~~~~~~--~~v~~~~~~~~~~~~avK~~~~~---~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e   79 (314)
T cd08216           5 LIGKCFEDL--MIVHLAKHKPTNTLVAVKKINLD---SCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSP   79 (314)
T ss_pred             hhhHhhcCC--ceEEEEEecCCCCEEEEEEEecc---ccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEe
Confidence            344444444  55666666678999999998642   2234567789999999999999999999999999999999999


Q ss_pred             eccCCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCCcc---
Q 004959          423 YVHPGSINKYVREH-CGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKA---  498 (721)
Q Consensus       423 y~~gGsL~~~L~~~-~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~~~---  498 (721)
                      |+.+|+|.+++... ...+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||.+..+.....   
T Consensus        80 ~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~  159 (314)
T cd08216          80 LMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQR  159 (314)
T ss_pred             ccCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeecccccccc
Confidence            99999999999764 35689999999999999999999999999999999999999999999999998876532211   


Q ss_pred             -----cccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhcC--------
Q 004959          499 -----DLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDT--------  565 (721)
Q Consensus       499 -----~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~~--------  565 (721)
                           .....++..|+|||++..     ....++.++|||||||++|||++|+.||................        
T Consensus       160 ~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  234 (314)
T cd08216         160 VVHDFPKSSVKNLPWLSPEVLQQ-----NLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKS  234 (314)
T ss_pred             ccccccccccccccccCHHHhcC-----CCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccC
Confidence                 123457888999999853     22346778999999999999999999998654433332221100        


Q ss_pred             --------------------------CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhccccccCC
Q 004959          566 --------------------------PAIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQ  607 (721)
Q Consensus       566 --------------------------~~~p~~lS~el~dLI~~cL~~DP~kRPSa~eLL~Hp~f~~~~  607 (721)
                                                ......++.++.+||.+||+.||++|||+.++|+||||+...
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~~  302 (314)
T cd08216         235 TYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQCK  302 (314)
T ss_pred             chhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhhhc
Confidence                                      001123457889999999999999999999999999998654

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=2.6e-39  Score=334.67  Aligned_cols=250  Identities=23%  Similarity=0.433  Sum_probs=208.9

Q ss_pred             CCeeEeeEEeecCCeEEEEEEECCCCc---EEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCe
Q 004959          340 SQWQKGKLIGRGTFGSVYVASNRETGA---LCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDK  416 (721)
Q Consensus       340 ~~y~~~k~LG~G~fG~VY~a~~~~tg~---~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~  416 (721)
                      ..|++.+.||+|+||.||+|....+|+   .||||.+...    ......+.+..|+.+++.++||||+++++++..++.
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~   79 (269)
T cd05065           4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSG----YTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRP   79 (269)
T ss_pred             HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCC----CCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCc
Confidence            468999999999999999999887665   5999987531    234456789999999999999999999999999999


Q ss_pred             EEEEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCC
Q 004959          417 FYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQ  496 (721)
Q Consensus       417 ~yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~  496 (721)
                      .++||||+.+++|.+++....+.+++..++.++.||+.||.|||++|++|+||||+||||+.++.+||+|||++..+...
T Consensus        80 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~  159 (269)
T cd05065          80 VMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD  159 (269)
T ss_pred             eEEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCccccccccC
Confidence            99999999999999999876677999999999999999999999999999999999999999999999999998765433


Q ss_pred             cccccC---C---CCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhh-CCCCCCchhhHHHHHHHhhcC-CCC
Q 004959          497 KADLSM---K---GSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFKVMRDT-PAI  568 (721)
Q Consensus       497 ~~~~s~---~---GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLt-G~~PF~~~~~~~~~~ki~~~~-~~~  568 (721)
                      ......   .   ++..|+|||++.       ...++.++|||||||++|||++ |..||......+....+.... ...
T Consensus       160 ~~~~~~~~~~~~~~~~~y~~PE~~~-------~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~~~~~~  232 (269)
T cd05065         160 TSDPTYTSSLGGKIPIRWTAPEAIA-------YRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDYRLPP  232 (269)
T ss_pred             ccccccccccCCCcceeecCHhHhc-------cCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCcCCC
Confidence            221111   1   245799999984       3456678999999999999886 999998766555555543332 234


Q ss_pred             CCCCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q 004959          569 PDSLSPEGKDFLRCCFQRNPADRPPASLLLEH  600 (721)
Q Consensus       569 p~~lS~el~dLI~~cL~~DP~kRPSa~eLL~H  600 (721)
                      +..++.++.+++.+||+.+|++||++.+++..
T Consensus       233 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~  264 (269)
T cd05065         233 PMDCPTALHQLMLDCWQKDRNARPKFGQIVST  264 (269)
T ss_pred             cccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            45678999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=2.3e-39  Score=339.21  Aligned_cols=249  Identities=24%  Similarity=0.409  Sum_probs=206.1

Q ss_pred             CCeeEeeEEeecCCeEEEEEEECCCC----------------cEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCC
Q 004959          340 SQWQKGKLIGRGTFGSVYVASNRETG----------------ALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPN  403 (721)
Q Consensus       340 ~~y~~~k~LG~G~fG~VY~a~~~~tg----------------~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPn  403 (721)
                      .+|++++.||+|+||.||+|.+..++                ..||+|.+...    ......+.+.+|+++|++++|||
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~----~~~~~~~~~~~e~~~l~~l~~~~   80 (296)
T cd05051           5 QPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPD----ASDNAREDFLKEVKILSRLSDPN   80 (296)
T ss_pred             hhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCc----cCHHHHHHHHHHHHHHHhcCCCC
Confidence            47999999999999999999876544                56799987531    22355678899999999999999


Q ss_pred             eeeeeeeEEecCeEEEEEeeccCCCHHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCc
Q 004959          404 IVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHC----------GAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGAN  473 (721)
Q Consensus       404 IV~l~g~~~~~~~~yLVmEy~~gGsL~~~L~~~~----------~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeN  473 (721)
                      |+++++++..++..++||||+.+++|.+++....          ..+++..++.++.||+.||.|||++||+||||||+|
T Consensus        81 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~N  160 (296)
T cd05051          81 IARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRN  160 (296)
T ss_pred             EeEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhc
Confidence            9999999999999999999999999999997653          268999999999999999999999999999999999


Q ss_pred             EEEcCCCceEEeecCCccccCCCcc---cccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhh--CCCC
Q 004959          474 LLVDASGVVKLADFGMAKHLTGQKA---DLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT--GKPP  548 (721)
Q Consensus       474 ILld~~g~VKL~DFGlA~~l~~~~~---~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLt--G~~P  548 (721)
                      ||++.++.++|+|||++..+.....   .....+++.|+|||++.+       ..++.++|||||||++|||++  |..|
T Consensus       161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~Dv~slG~~l~el~~~~~~~p  233 (296)
T cd05051         161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLL-------GKFTTKSDVWAFGVTLWEILTLCREQP  233 (296)
T ss_pred             eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhc-------CCCCccchhhhhHHHHHHHHhcCCCCC
Confidence            9999999999999999986543321   223456788999999853       346678999999999999998  7889


Q ss_pred             CCchhhHHHHHHHhhc--------CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHh
Q 004959          549 WSEYEGAAAMFKVMRD--------TPAIPDSLSPEGKDFLRCCFQRNPADRPPASLLLE  599 (721)
Q Consensus       549 F~~~~~~~~~~ki~~~--------~~~~p~~lS~el~dLI~~cL~~DP~kRPSa~eLL~  599 (721)
                      |......+.+......        ....+..++.++.+||.+||+.||++||++.||++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~  292 (296)
T cd05051         234 YEHLTDQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHL  292 (296)
T ss_pred             CCCcChHHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHH
Confidence            9776555544443321        12234557899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=4.5e-39  Score=343.09  Aligned_cols=258  Identities=35%  Similarity=0.620  Sum_probs=217.9

Q ss_pred             CCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeEEE
Q 004959          340 SQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYI  419 (721)
Q Consensus       340 ~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~yL  419 (721)
                      ..|+..+.||+|+||.||+|.+..+|..||+|++...  .....+..+.+.+|+.+++.++|+||+++++++..++..|+
T Consensus        25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~--~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l  102 (317)
T cd06635          25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYS--GKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWL  102 (317)
T ss_pred             hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecC--CCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEE
Confidence            3588889999999999999999999999999988642  22334556788999999999999999999999999999999


Q ss_pred             EEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCCccc
Q 004959          420 YLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKAD  499 (721)
Q Consensus       420 VmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~~~~  499 (721)
                      ||||+. |+|.+++......+++..+..++.||+.||.|||++||+||||+|+||+++.++.+||+|||++......   
T Consensus       103 v~e~~~-g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~---  178 (317)
T cd06635         103 VMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASPA---  178 (317)
T ss_pred             EEeCCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCccccCCc---
Confidence            999997 5888888666678999999999999999999999999999999999999999999999999998754322   


Q ss_pred             ccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhcCC--CCCCCCCHHHH
Q 004959          500 LSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTP--AIPDSLSPEGK  577 (721)
Q Consensus       500 ~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~~~--~~p~~lS~el~  577 (721)
                      ....|++.|+|||++...    ....++.++|||||||++|+|++|+.||...........+.....  .....++..+.
T Consensus       179 ~~~~~~~~y~aPE~~~~~----~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  254 (317)
T cd06635         179 NSFVGTPYWMAPEVILAM----DEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFR  254 (317)
T ss_pred             ccccCCccccChhhhhcC----CCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCCCCCccccHHHH
Confidence            345689999999998431    123466789999999999999999999987666665555554432  22346788999


Q ss_pred             HHHHHhcccCCCCCCCHHHHHhccccccCC
Q 004959          578 DFLRCCFQRNPADRPPASLLLEHRFLKNSQ  607 (721)
Q Consensus       578 dLI~~cL~~DP~kRPSa~eLL~Hp~f~~~~  607 (721)
                      +||.+||+.+|++||++.++++|+|+....
T Consensus       255 ~li~~~l~~~p~~Rpt~~~il~~~~~~~~~  284 (317)
T cd06635         255 NFVDSCLQKIPQDRPTSEELLKHMFVLRER  284 (317)
T ss_pred             HHHHHHccCCcccCcCHHHHHhChhhhccC
Confidence            999999999999999999999999986543

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=1.2e-39  Score=337.88  Aligned_cols=246  Identities=30%  Similarity=0.560  Sum_probs=202.9

Q ss_pred             eEeeEEeecCCeEEEEEEEC----CCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeEE
Q 004959          343 QKGKLIGRGTFGSVYVASNR----ETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFY  418 (721)
Q Consensus       343 ~~~k~LG~G~fG~VY~a~~~----~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~y  418 (721)
                      .+.+.||.|.||.||+|...    ..+..|+||.+..    ....+..+.+.+|+++|++++||||++++|++...+..+
T Consensus         2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~----~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~   77 (259)
T PF07714_consen    2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKP----SSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLF   77 (259)
T ss_dssp             EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEEST----TSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEE
T ss_pred             EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEecc----ccccccceeeeeccccccccccccccccccccccccccc
Confidence            46789999999999999877    4578899998842    234455788999999999999999999999999888899


Q ss_pred             EEEeeccCCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCCc
Q 004959          419 IYLEYVHPGSINKYVREH-CGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQK  497 (721)
Q Consensus       419 LVmEy~~gGsL~~~L~~~-~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~~  497 (721)
                      +||||+.+|+|.++|... ...+++..+..|+.||+.||.|||+++|+|+||++.|||++.++.+||+|||++.......
T Consensus        78 lv~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~  157 (259)
T PF07714_consen   78 LVMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKS  157 (259)
T ss_dssp             EEEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSS
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence            999999999999999876 5789999999999999999999999999999999999999999999999999998763221


Q ss_pred             c---cccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhh-CCCCCCchhhHHHHHHHhhc-CCCCCCCC
Q 004959          498 A---DLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFKVMRD-TPAIPDSL  572 (721)
Q Consensus       498 ~---~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLt-G~~PF~~~~~~~~~~ki~~~-~~~~p~~l  572 (721)
                      .   .....+...|+|||++..       ..++.++||||||+++|||++ |+.||.+....+...++... ....+..+
T Consensus       158 ~~~~~~~~~~~~~~~aPE~~~~-------~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~  230 (259)
T PF07714_consen  158 KYKNDSSQQLPLRYLAPEVLKD-------GEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQRLPIPDNC  230 (259)
T ss_dssp             SEEESTTSESGGGGS-HHHHHH-------SEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTEETTSBTTS
T ss_pred             cccccccccccccccccccccc-------ccccccccccccccccccccccccccccccccccccccccccccceeccch
Confidence            1   123446788999999965       236789999999999999999 78999887666666555333 23456778


Q ss_pred             CHHHHHHHHHhcccCCCCCCCHHHHHh
Q 004959          573 SPEGKDFLRCCFQRNPADRPPASLLLE  599 (721)
Q Consensus       573 S~el~dLI~~cL~~DP~kRPSa~eLL~  599 (721)
                      +..+.++|.+||..||++||++.+|++
T Consensus       231 ~~~~~~li~~C~~~~p~~RPs~~~i~~  257 (259)
T PF07714_consen  231 PKDIYSLIQQCWSHDPEKRPSFQEILQ  257 (259)
T ss_dssp             BHHHHHHHHHHT-SSGGGS--HHHHHH
T ss_pred             hHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence            999999999999999999999999985

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=1.2e-39  Score=334.95  Aligned_cols=255  Identities=27%  Similarity=0.546  Sum_probs=212.4

Q ss_pred             CeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeEEEE
Q 004959          341 QWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYIY  420 (721)
Q Consensus       341 ~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~yLV  420 (721)
                      +|++.+.||+|+||.||++.+..++..+++|++...............+..|+.+++.++||||+++++++.+.+..++|
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII   80 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence            58899999999999999999988887787877653322222223345677899999999999999999999999999999


Q ss_pred             EeeccCCCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCCc
Q 004959          421 LEYVHPGSINKYVRE---HCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQK  497 (721)
Q Consensus       421 mEy~~gGsL~~~L~~---~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~~  497 (721)
                      |||+.+++|.+++..   ....+++..++.++.||+.||.|||++|++|+||||+||+++. +.+||+|||++..+....
T Consensus        81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~~~  159 (260)
T cd08222          81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGSC  159 (260)
T ss_pred             EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-CCEeecccCceeecCCCc
Confidence            999999999998864   2357999999999999999999999999999999999999974 679999999998764432


Q ss_pred             -ccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhc-CCCCCCCCCHH
Q 004959          498 -ADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRD-TPAIPDSLSPE  575 (721)
Q Consensus       498 -~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~-~~~~p~~lS~e  575 (721)
                       ......|++.|+|||.+.       ...++.++|+||||+++|+|++|..||..........++... .+..+..++.+
T Consensus       160 ~~~~~~~~~~~~~~pe~~~-------~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (260)
T cd08222         160 DLATTFTGTPYYMSPEALK-------HQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTPSLPETYSRQ  232 (260)
T ss_pred             ccccCCCCCcCccCHHHHc-------cCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCCCCcchhcHH
Confidence             223456899999999884       234566799999999999999999999876655555555443 34456678999


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHHhcccc
Q 004959          576 GKDFLRCCFQRNPADRPPASLLLEHRFL  603 (721)
Q Consensus       576 l~dLI~~cL~~DP~kRPSa~eLL~Hp~f  603 (721)
                      +.++|.+||..||++||++.++++||||
T Consensus       233 ~~~li~~~l~~~p~~Rp~~~~il~~~~~  260 (260)
T cd08222         233 LNSIMQSMLNKDPSLRPSAAEILRNPFI  260 (260)
T ss_pred             HHHHHHHHhcCChhhCcCHHHHhhCCCC
Confidence            9999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=3e-39  Score=342.18  Aligned_cols=251  Identities=26%  Similarity=0.461  Sum_probs=206.6

Q ss_pred             CCCeeEeeEEeecCCeEEEEEEECC-------CCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhC-CCCCeeeeeee
Q 004959          339 NSQWQKGKLIGRGTFGSVYVASNRE-------TGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHL-KHPNIVQYYGS  410 (721)
Q Consensus       339 ~~~y~~~k~LG~G~fG~VY~a~~~~-------tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L-~HPnIV~l~g~  410 (721)
                      .++|.+++.||+|+||.||+|.+..       ++..+|+|.+...    ........+.+|+.+++.+ +|+||++++++
T Consensus        17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~----~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~   92 (307)
T cd05098          17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSD----ATEKDLSDLISEMEMMKMIGKHKNIINLLGA   92 (307)
T ss_pred             hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCC----CChHHHHHHHHHHHHHHHhcCCCCEeeEEEE
Confidence            3589999999999999999997643       3357999987521    2234456788999999999 79999999999


Q ss_pred             EEecCeEEEEEeeccCCCHHHHHHHhc---------------CCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEE
Q 004959          411 EIVEDKFYIYLEYVHPGSINKYVREHC---------------GAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLL  475 (721)
Q Consensus       411 ~~~~~~~yLVmEy~~gGsL~~~L~~~~---------------~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNIL  475 (721)
                      +...+..|+||||+.+|+|.+++....               ..+++.++..++.||+.||+|||++|++||||||+|||
T Consensus        93 ~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nil  172 (307)
T cd05098          93 CTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVL  172 (307)
T ss_pred             EecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHheE
Confidence            999999999999999999999997642               24788999999999999999999999999999999999


Q ss_pred             EcCCCceEEeecCCccccCCCcc---cccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhh-CCCCCCc
Q 004959          476 VDASGVVKLADFGMAKHLTGQKA---DLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSE  551 (721)
Q Consensus       476 ld~~g~VKL~DFGlA~~l~~~~~---~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLt-G~~PF~~  551 (721)
                      ++.++.+||+|||++..+.....   .....+++.|+|||++.+       ..++.++|||||||++|||++ |..||..
T Consensus       173 l~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~DvwslG~~l~el~~~g~~p~~~  245 (307)
T cd05098         173 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFD-------RIYTHQSDVWSFGVLLWEIFTLGGSPYPG  245 (307)
T ss_pred             EcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhcc-------CCCCcHHHHHHHHHHHHHHHcCCCCCCCc
Confidence            99999999999999876543221   111234578999999843       456778999999999999998 8999987


Q ss_pred             hhhHHHHHHHhhcC-CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q 004959          552 YEGAAAMFKVMRDT-PAIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEH  600 (721)
Q Consensus       552 ~~~~~~~~ki~~~~-~~~p~~lS~el~dLI~~cL~~DP~kRPSa~eLL~H  600 (721)
                      ....+....+.... ...+..++.++.+||.+||..+|++||++.+++++
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~  295 (307)
T cd05098         246 VPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED  295 (307)
T ss_pred             CCHHHHHHHHHcCCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence            65544444443332 35567789999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-39  Score=338.60  Aligned_cols=251  Identities=34%  Similarity=0.574  Sum_probs=207.8

Q ss_pred             eeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCC-CCCeeeeeeeEEecCeEEEE
Q 004959          342 WQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLK-HPNIVQYYGSEIVEDKFYIY  420 (721)
Q Consensus       342 y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~-HPnIV~l~g~~~~~~~~yLV  420 (721)
                      |++.+.||+|+||.||+|+...+++.|+||.+.....   . .......+|+..++++. |+||+++++++...+..|+|
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~---~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv   76 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFY---S-WEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFV   76 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhcc---c-hhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEE
Confidence            6788999999999999999999999999998753211   1 12234457899999999 99999999999999999999


Q ss_pred             EeeccCCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCCccc
Q 004959          421 LEYVHPGSINKYVREHC-GAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKAD  499 (721)
Q Consensus       421 mEy~~gGsL~~~L~~~~-~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~~~~  499 (721)
                      |||+ +|+|.+++.... ..+++..+..++.||+.+|.|||++||+|+||+|.||+++.++.++|+|||++.........
T Consensus        77 ~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~~  155 (283)
T cd07830          77 FEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPY  155 (283)
T ss_pred             EecC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceeccCCCCc
Confidence            9999 789998887653 47899999999999999999999999999999999999999999999999999877654444


Q ss_pred             ccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhcC--------------
Q 004959          500 LSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDT--------------  565 (721)
Q Consensus       500 ~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~~--------------  565 (721)
                      ....|+..|+|||++..      ...++.++|||||||++|+|++|+.||......+.+.++....              
T Consensus       156 ~~~~~~~~~~aPE~~~~------~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (283)
T cd07830         156 TDYVSTRWYRAPEILLR------STSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKL  229 (283)
T ss_pred             CCCCCcccccCceeeec------CcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhh
Confidence            45678999999998742      2345678999999999999999999997665544443322110              


Q ss_pred             ----------------CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccc
Q 004959          566 ----------------PAIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFL  603 (721)
Q Consensus       566 ----------------~~~p~~lS~el~dLI~~cL~~DP~kRPSa~eLL~Hp~f  603 (721)
                                      .......+.++.+||++||+.||++||++.|++.||||
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~  283 (283)
T cd07830         230 ASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF  283 (283)
T ss_pred             hccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence                            00112236889999999999999999999999999997

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=5.2e-39  Score=331.80  Aligned_cols=250  Identities=25%  Similarity=0.427  Sum_probs=207.8

Q ss_pred             CCeeEeeEEeecCCeEEEEEEECCCCc---EEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCe
Q 004959          340 SQWQKGKLIGRGTFGSVYVASNRETGA---LCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDK  416 (721)
Q Consensus       340 ~~y~~~k~LG~G~fG~VY~a~~~~tg~---~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~  416 (721)
                      +.|+..+.||+|+||.||+|.+..++.   .+|+|.+...    ......+.+.+|+.+++.++|+||+++++++...+.
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~----~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (268)
T cd05063           5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPG----YTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKP   80 (268)
T ss_pred             HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEecccc----CCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCC
Confidence            468889999999999999999876665   7999987531    123345678899999999999999999999999999


Q ss_pred             EEEEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCC
Q 004959          417 FYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQ  496 (721)
Q Consensus       417 ~yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~  496 (721)
                      .|+||||+.+++|.+++....+.+++..+..++.||+.||.|||+.||+|+||||+|||++.++.+||+|||++..+...
T Consensus        81 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~  160 (268)
T cd05063          81 AMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDD  160 (268)
T ss_pred             cEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCccceecccc
Confidence            99999999999999999876678999999999999999999999999999999999999999999999999999866432


Q ss_pred             cccc----cCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhh-CCCCCCchhhHHHHHHHhhc-CCCCCC
Q 004959          497 KADL----SMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFKVMRD-TPAIPD  570 (721)
Q Consensus       497 ~~~~----s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLt-G~~PF~~~~~~~~~~ki~~~-~~~~p~  570 (721)
                      ....    ....+..|+|||++.       ...++.++|||||||++|||++ |..||......+....+... ....+.
T Consensus       161 ~~~~~~~~~~~~~~~y~~PE~~~-------~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~~~~~~~~  233 (268)
T cd05063         161 PEGTYTTSGGKIPIRWTAPEAIA-------YRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFRLPAPM  233 (268)
T ss_pred             cccceeccCCCcCceecCHHHhh-------cCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcCCCCCCCC
Confidence            2111    112345799999984       2346778999999999999997 99999776655555544432 223345


Q ss_pred             CCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q 004959          571 SLSPEGKDFLRCCFQRNPADRPPASLLLEH  600 (721)
Q Consensus       571 ~lS~el~dLI~~cL~~DP~kRPSa~eLL~H  600 (721)
                      .++.++.+||.+||+.+|++||++.++++.
T Consensus       234 ~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~  263 (268)
T cd05063         234 DCPSAVYQLMLQCWQQDRARRPRFVDIVNL  263 (268)
T ss_pred             CCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            678999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=4.3e-39  Score=338.09  Aligned_cols=249  Identities=28%  Similarity=0.501  Sum_probs=207.2

Q ss_pred             CCeeEeeEEeecCCeEEEEEEEC-----CCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEec
Q 004959          340 SQWQKGKLIGRGTFGSVYVASNR-----ETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVE  414 (721)
Q Consensus       340 ~~y~~~k~LG~G~fG~VY~a~~~-----~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~  414 (721)
                      .+|.+.+.||+|+||.||+|.+.     .++..+++|.+..     ......+.+.+|+.++++++|+||+++++++...
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~-----~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   79 (291)
T cd05094           5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKD-----PTLAARKDFQREAELLTNLQHEHIVKFYGVCGDG   79 (291)
T ss_pred             HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCC-----ccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccC
Confidence            36899999999999999999753     3556788997642     2234456788999999999999999999999999


Q ss_pred             CeEEEEEeeccCCCHHHHHHHhc---------------CCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCC
Q 004959          415 DKFYIYLEYVHPGSINKYVREHC---------------GAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDAS  479 (721)
Q Consensus       415 ~~~yLVmEy~~gGsL~~~L~~~~---------------~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~  479 (721)
                      +..++||||+.+++|.+++....               +.+++..++.++.||+.||.|||++||+||||||+|||++.+
T Consensus        80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~  159 (291)
T cd05094          80 DPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGAN  159 (291)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccC
Confidence            99999999999999999997542               348899999999999999999999999999999999999999


Q ss_pred             CceEEeecCCccccCCCcc---cccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhh-CCCCCCchhhH
Q 004959          480 GVVKLADFGMAKHLTGQKA---DLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGA  555 (721)
Q Consensus       480 g~VKL~DFGlA~~l~~~~~---~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLt-G~~PF~~~~~~  555 (721)
                      +.+||+|||++........   .....|+..|+|||++.       ...++.++|||||||++|||++ |+.||......
T Consensus       160 ~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~-------~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~  232 (291)
T cd05094         160 LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIM-------YRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNT  232 (291)
T ss_pred             CcEEECCCCcccccCCCceeecCCCCCcceeecChHHhc-------cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence            9999999999976543221   12345688899999984       3456678999999999999998 99999776655


Q ss_pred             HHHHHHhhcC-CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q 004959          556 AAMFKVMRDT-PAIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEH  600 (721)
Q Consensus       556 ~~~~ki~~~~-~~~p~~lS~el~dLI~~cL~~DP~kRPSa~eLL~H  600 (721)
                      +.+..+.... ...+..++.++.+||.+||+.||++||++.++++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~  278 (291)
T cd05094         233 EVIECITQGRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKI  278 (291)
T ss_pred             HHHHHHhCCCCCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence            5555444432 23456678999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=4.9e-39  Score=332.09  Aligned_cols=242  Identities=24%  Similarity=0.414  Sum_probs=200.3

Q ss_pred             EEeecCCeEEEEEEEC--CCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeEEEEEeec
Q 004959          347 LIGRGTFGSVYVASNR--ETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYIYLEYV  424 (721)
Q Consensus       347 ~LG~G~fG~VY~a~~~--~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~yLVmEy~  424 (721)
                      .||+|+||.||+|...  .++..||+|++...    ......+.+.+|+.+|++++|+||+++++++. ....++||||+
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~----~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~   76 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNE----NEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMA   76 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEcccc----cChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeC
Confidence            4899999999999765  45667999987521    22344567899999999999999999999875 45789999999


Q ss_pred             cCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCCccc----c
Q 004959          425 HPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKAD----L  500 (721)
Q Consensus       425 ~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~~~~----~  500 (721)
                      .+++|.+++......+++..+..++.||+.||.|||++|++||||||+|||++.++.+||+|||++..+......    .
T Consensus        77 ~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~  156 (257)
T cd05115          77 SGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARS  156 (257)
T ss_pred             CCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccCCccceeccC
Confidence            999999999766678999999999999999999999999999999999999999999999999999865433221    1


Q ss_pred             cCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhh-CCCCCCchhhHHHHHHHhhc-CCCCCCCCCHHHHH
Q 004959          501 SMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFKVMRD-TPAIPDSLSPEGKD  578 (721)
Q Consensus       501 s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLt-G~~PF~~~~~~~~~~ki~~~-~~~~p~~lS~el~d  578 (721)
                      ...++..|+|||++.       ...++.++|||||||++|+|++ |..||......+....+... ...++...++++.+
T Consensus       157 ~~~~~~~y~aPE~~~-------~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  229 (257)
T cd05115         157 AGKWPLKWYAPECIN-------FRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKRLDCPAECPPEMYA  229 (257)
T ss_pred             CCCCCcccCCHHHHc-------cCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCCCCCCCCHHHHH
Confidence            122357899999984       3346678999999999999996 99999887666555544443 34566778999999


Q ss_pred             HHHHhcccCCCCCCCHHHHHhc
Q 004959          579 FLRCCFQRNPADRPPASLLLEH  600 (721)
Q Consensus       579 LI~~cL~~DP~kRPSa~eLL~H  600 (721)
                      +|.+||..||++||++.++++.
T Consensus       230 li~~c~~~~~~~Rp~~~~i~~~  251 (257)
T cd05115         230 LMKDCWIYKWEDRPNFAKVEER  251 (257)
T ss_pred             HHHHHcCCChhhCcCHHHHHHH
Confidence            9999999999999999999753

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=3.7e-39  Score=333.50  Aligned_cols=249  Identities=27%  Similarity=0.454  Sum_probs=198.0

Q ss_pred             eEEeecCCeEEEEEEECC--CCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeEEEEEee
Q 004959          346 KLIGRGTFGSVYVASNRE--TGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYIYLEY  423 (721)
Q Consensus       346 k~LG~G~fG~VY~a~~~~--tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~yLVmEy  423 (721)
                      +.||+|+||+||+|....  ....+|+|.+..    .........+.+|+.+++.++|+||+++++.+...+..|+||||
T Consensus         1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~----~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~   76 (269)
T cd05042           1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRA----SATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEF   76 (269)
T ss_pred             CcCCccCCceEEEEEEecCCCCeEEEEeecCc----cCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEe
Confidence            368999999999996432  345788886642    12344456788999999999999999999999999999999999


Q ss_pred             ccCCCHHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCCcc-
Q 004959          424 VHPGSINKYVREHCG----AITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKA-  498 (721)
Q Consensus       424 ~~gGsL~~~L~~~~~----~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~~~-  498 (721)
                      +.+|+|.+++.....    .+.+..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++........ 
T Consensus        77 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~  156 (269)
T cd05042          77 CPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYY  156 (269)
T ss_pred             CCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEeccccccccccchhe
Confidence            999999999976432    346788899999999999999999999999999999999999999999999875433221 


Q ss_pred             --cccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhh-CCCCCCchhhHHHHHHHhhcC------CCCC
Q 004959          499 --DLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFKVMRDT------PAIP  569 (721)
Q Consensus       499 --~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLt-G~~PF~~~~~~~~~~ki~~~~------~~~p  569 (721)
                        .....++..|+|||++...........++.++|||||||++|||++ |..||......+.+..+....      +.++
T Consensus       157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (269)
T cd05042         157 ITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKPQLD  236 (269)
T ss_pred             eccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccCCCCccc
Confidence              1223456789999998653322233456789999999999999999 889998766555555443322      2334


Q ss_pred             CCCCHHHHHHHHHhcccCCCCCCCHHHHHh
Q 004959          570 DSLSPEGKDFLRCCFQRNPADRPPASLLLE  599 (721)
Q Consensus       570 ~~lS~el~dLI~~cL~~DP~kRPSa~eLL~  599 (721)
                      ..++..+.+++..|| .||++||++++|++
T Consensus       237 ~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~  265 (269)
T cd05042         237 LKYSDRWYEVMQFCW-LDPETRPTAEEVHE  265 (269)
T ss_pred             ccCCHHHHHHHHHHh-cCcccccCHHHHHH
Confidence            568899999999999 59999999999986

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=6.1e-39  Score=327.47  Aligned_cols=243  Identities=26%  Similarity=0.440  Sum_probs=202.9

Q ss_pred             eEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeEEEEEeecc
Q 004959          346 KLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYIYLEYVH  425 (721)
Q Consensus       346 k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~yLVmEy~~  425 (721)
                      ++||+|+||.||+|... ++..||+|.+...    ........+.+|+.+++.++||||+++++++...+..++||||+.
T Consensus         1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~----~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   75 (250)
T cd05085           1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKED----LPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVP   75 (250)
T ss_pred             CccCCCCCceEEEEEec-CCcEEEEEecCCc----CCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCC
Confidence            37899999999999864 6889999987521    223344578899999999999999999999999999999999999


Q ss_pred             CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCCccc--ccCC
Q 004959          426 PGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKAD--LSMK  503 (721)
Q Consensus       426 gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~~~~--~s~~  503 (721)
                      +++|.+++......+.+..+..++.||+.||.|||++|++||||||+||+++.++.+||+|||++.........  ....
T Consensus        76 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~  155 (250)
T cd05085          76 GGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQ  155 (250)
T ss_pred             CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceeccccccccCCCCC
Confidence            99999999766567899999999999999999999999999999999999999999999999998764432211  1223


Q ss_pred             CCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhh-CCCCCCchhhHHHHHHHhhc-CCCCCCCCCHHHHHHHH
Q 004959          504 GSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFKVMRD-TPAIPDSLSPEGKDFLR  581 (721)
Q Consensus       504 GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLt-G~~PF~~~~~~~~~~ki~~~-~~~~p~~lS~el~dLI~  581 (721)
                      ++..|+|||++.       ...++.++|||||||++|+|++ |..||...........+... ....+..++.++.+|+.
T Consensus       156 ~~~~y~aPE~~~-------~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  228 (250)
T cd05085         156 IPIKWTAPEALN-------YGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYRMSCPQKCPDDVYKVMQ  228 (250)
T ss_pred             CcccccCHHHhc-------cCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHH
Confidence            466799999984       3446778999999999999998 99999876555554444433 23456678999999999


Q ss_pred             HhcccCCCCCCCHHHHHhc
Q 004959          582 CCFQRNPADRPPASLLLEH  600 (721)
Q Consensus       582 ~cL~~DP~kRPSa~eLL~H  600 (721)
                      +||..+|++||++.++++.
T Consensus       229 ~~l~~~p~~Rp~~~~l~~~  247 (250)
T cd05085         229 RCWDYKPENRPKFSELQKE  247 (250)
T ss_pred             HHcccCcccCCCHHHHHHH
Confidence            9999999999999999864

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=1e-40  Score=322.92  Aligned_cols=256  Identities=30%  Similarity=0.527  Sum_probs=219.3

Q ss_pred             CeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeEEEE
Q 004959          341 QWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYIY  420 (721)
Q Consensus       341 ~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~yLV  420 (721)
                      .|...+.||+|.||+||+|+++++++.||+|.++...++.   ..-....+||-+|+.++|.|||+++++...+..+-+|
T Consensus         3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrldddde---gvpssalreicllkelkhknivrl~dvlhsdkkltlv   79 (292)
T KOG0662|consen    3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDE---GVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLV   79 (292)
T ss_pred             chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCC---CCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEe
Confidence            5777789999999999999999999999999998643332   2334678999999999999999999999999999999


Q ss_pred             EeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCCcc-c
Q 004959          421 LEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKA-D  499 (721)
Q Consensus       421 mEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~~~-~  499 (721)
                      +|||+ .+|..+.....+.+..+.++.++.|+++||.|||++++.||||||+|+||+.+|++||+|||+++.+.-... .
T Consensus        80 fe~cd-qdlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglarafgipvrcy  158 (292)
T KOG0662|consen   80 FEFCD-QDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCY  158 (292)
T ss_pred             HHHhh-HHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhcCCceEee
Confidence            99996 689999988889999999999999999999999999999999999999999999999999999997654332 2


Q ss_pred             ccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhh-CCCCCCchhhHHHHHHHhhcCC------------
Q 004959          500 LSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFKVMRDTP------------  566 (721)
Q Consensus       500 ~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLt-G~~PF~~~~~~~~~~ki~~~~~------------  566 (721)
                      ...+-|.+|++|.++.+.      .-|+...|+||.|||+.|+.. |++.|.+.+..+++.+|.+...            
T Consensus       159 saevvtlwyrppdvlfga------kly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~  232 (292)
T KOG0662|consen  159 SAEVVTLWYRPPDVLFGA------KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTK  232 (292)
T ss_pred             eceeeeeeccCcceeeee------ehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCcccc
Confidence            234579999999999863      346667999999999999987 8899999888888887754210            


Q ss_pred             --------CCC---------CCCCHHHHHHHHHhcccCCCCCCCHHHHHhccccccC
Q 004959          567 --------AIP---------DSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNS  606 (721)
Q Consensus       567 --------~~p---------~~lS~el~dLI~~cL~~DP~kRPSa~eLL~Hp~f~~~  606 (721)
                              .+|         +.+....+|+++++|..+|.+|++++++|+||||.+.
T Consensus       233 lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhpyf~d~  289 (292)
T KOG0662|consen  233 LPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSDF  289 (292)
T ss_pred             CCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCcccccc
Confidence                    111         2345667899999999999999999999999999864

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.6e-39  Score=332.15  Aligned_cols=246  Identities=26%  Similarity=0.460  Sum_probs=206.0

Q ss_pred             CCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeEEE
Q 004959          340 SQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYI  419 (721)
Q Consensus       340 ~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~yL  419 (721)
                      .+|++.+.||+|+||.||+|.+.. ++.||||.+....   .   ..+.+.+|+.++++++|+||+++++++...+..|+
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~~-~~~v~iK~~~~~~---~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   78 (261)
T cd05068           6 TSIQLLRKLGAGQFGEVWEGLWNN-TTPVAVKTLKPGT---M---DPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYI   78 (261)
T ss_pred             hheeeEEEecccCCccEEEEEecC-CeEEEEEeeCCCc---c---cHHHHHHHHHHHHHCCCCCccceeEEEecCCCeee
Confidence            579999999999999999998754 5789999875321   1   23568889999999999999999999999999999


Q ss_pred             EEeeccCCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCCcc
Q 004959          420 YLEYVHPGSINKYVREHC-GAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKA  498 (721)
Q Consensus       420 VmEy~~gGsL~~~L~~~~-~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~~~  498 (721)
                      ||||+.+++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+.....
T Consensus        79 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~  158 (261)
T cd05068          79 VTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIY  158 (261)
T ss_pred             eeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceEEEccCCcc
Confidence            999999999999997643 4689999999999999999999999999999999999999999999999999987653221


Q ss_pred             cc--cCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhh-CCCCCCchhhHHHHHHHhhcC-CCCCCCCCH
Q 004959          499 DL--SMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFKVMRDT-PAIPDSLSP  574 (721)
Q Consensus       499 ~~--s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLt-G~~PF~~~~~~~~~~ki~~~~-~~~p~~lS~  574 (721)
                      ..  ...++..|+|||++.       ...++.++|||||||++|||++ |+.||.+......+..+.... ...+..++.
T Consensus       159 ~~~~~~~~~~~y~aPE~~~-------~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (261)
T cd05068         159 EAREGAKFPIKWTAPEAAL-------YNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYRMPCPPGCPK  231 (261)
T ss_pred             cccCCCcCceeccCccccc-------cCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCH
Confidence            11  122345799999884       3456778999999999999999 999998876655555554432 234567889


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHHh
Q 004959          575 EGKDFLRCCFQRNPADRPPASLLLE  599 (721)
Q Consensus       575 el~dLI~~cL~~DP~kRPSa~eLL~  599 (721)
                      ++.++|.+||+.||++||++.+|++
T Consensus       232 ~~~~li~~~l~~~P~~Rp~~~~l~~  256 (261)
T cd05068         232 ELYDIMLDCWKEDPDDRPTFETLQW  256 (261)
T ss_pred             HHHHHHHHHhhcCcccCCCHHHHHH
Confidence            9999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=3.9e-39  Score=334.39  Aligned_cols=244  Identities=27%  Similarity=0.466  Sum_probs=200.0

Q ss_pred             eEEeecCCeEEEEEEECCCCcE--EEEEEeecCCCCcccHHHHHHHHHHHHHHHhC-CCCCeeeeeeeEEecCeEEEEEe
Q 004959          346 KLIGRGTFGSVYVASNRETGAL--CAMKEVDIFPDDPKSAESIKQLEQEIKVLSHL-KHPNIVQYYGSEIVEDKFYIYLE  422 (721)
Q Consensus       346 k~LG~G~fG~VY~a~~~~tg~~--vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L-~HPnIV~l~g~~~~~~~~yLVmE  422 (721)
                      ++||+|+||.||+|....+|..  +++|.+..    .......+.+.+|+.++.++ +||||+++++++...+..|+|||
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~----~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e   76 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKE----YASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIE   76 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEccc----cCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEE
Confidence            3689999999999999888764  57787642    12334556788999999999 79999999999999999999999


Q ss_pred             eccCCCHHHHHHHhc---------------CCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeec
Q 004959          423 YVHPGSINKYVREHC---------------GAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADF  487 (721)
Q Consensus       423 y~~gGsL~~~L~~~~---------------~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DF  487 (721)
                      |+.+|+|.+++....               ..+++..++.++.||+.||+|||++|++||||||+|||++.++.+||+||
T Consensus        77 ~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~df  156 (270)
T cd05047          77 YAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADF  156 (270)
T ss_pred             eCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEECCC
Confidence            999999999997532               24789999999999999999999999999999999999999999999999


Q ss_pred             CCccccCCCcccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhh-CCCCCCchhhHHHHHHHhhc-C
Q 004959          488 GMAKHLTGQKADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFKVMRD-T  565 (721)
Q Consensus       488 GlA~~l~~~~~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLt-G~~PF~~~~~~~~~~ki~~~-~  565 (721)
                      |++..............+..|+|||++.       ...++.++|||||||++|||++ |..||.+....+....+... .
T Consensus       157 gl~~~~~~~~~~~~~~~~~~y~apE~~~-------~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~  229 (270)
T cd05047         157 GLSRGQEVYVKKTMGRLPVRWMAIESLN-------YSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYR  229 (270)
T ss_pred             CCccccchhhhccCCCCccccCChHHHc-------cCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhCCCC
Confidence            9986432221122233466799999984       3456778999999999999997 99999876655555544433 2


Q ss_pred             CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q 004959          566 PAIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEH  600 (721)
Q Consensus       566 ~~~p~~lS~el~dLI~~cL~~DP~kRPSa~eLL~H  600 (721)
                      ...+..++.++.+||.+||..||.+||++.+++..
T Consensus       230 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  264 (270)
T cd05047         230 LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS  264 (270)
T ss_pred             CCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence            34556688999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=2.4e-39  Score=341.97  Aligned_cols=254  Identities=33%  Similarity=0.578  Sum_probs=213.2

Q ss_pred             eeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeEEEEE
Q 004959          342 WQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYIYL  421 (721)
Q Consensus       342 y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~yLVm  421 (721)
                      |.....||+|+||.||++....+|+.||||++...     .......+.+|+.+++.++|+||+++++.+...+..|+||
T Consensus        22 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~-----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   96 (292)
T cd06657          22 LDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLR-----KQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVM   96 (292)
T ss_pred             hhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEeccc-----chhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEE
Confidence            34456899999999999999999999999987531     2234567889999999999999999999999999999999


Q ss_pred             eeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCCc-ccc
Q 004959          422 EYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQK-ADL  500 (721)
Q Consensus       422 Ey~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~~-~~~  500 (721)
                      ||+.+++|.+++..  ..+++..+..++.||+.||+|||++||+|+||||+||+++.++.++|+|||++..+.... ...
T Consensus        97 e~~~~~~L~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~~~  174 (292)
T cd06657          97 EFLEGGALTDIVTH--TRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRK  174 (292)
T ss_pred             ecCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceeccccccccc
Confidence            99999999998754  468999999999999999999999999999999999999999999999999987654332 223


Q ss_pred             cCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhcCC---CCCCCCCHHHH
Q 004959          501 SMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTP---AIPDSLSPEGK  577 (721)
Q Consensus       501 s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~~~---~~p~~lS~el~  577 (721)
                      ...|++.|+|||++.       ...++.++|+|||||++|+|++|..||......+....+....+   .....++.++.
T Consensus       175 ~~~~~~~y~~pE~~~-------~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  247 (292)
T cd06657         175 SLVGTPYWMAPELIS-------RLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKLKNLHKVSPSLK  247 (292)
T ss_pred             ccccCccccCHHHhc-------CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCcccCCcccCCHHHH
Confidence            456899999999883       23456789999999999999999999987655444333322221   22345789999


Q ss_pred             HHHHHhcccCCCCCCCHHHHHhccccccCCCC
Q 004959          578 DFLRCCFQRNPADRPPASLLLEHRFLKNSQQP  609 (721)
Q Consensus       578 dLI~~cL~~DP~kRPSa~eLL~Hp~f~~~~~~  609 (721)
                      ++|.+||+.||.+||++.++++|+||.....+
T Consensus       248 ~li~~~l~~~P~~R~~~~~ll~~~~~~~~~~~  279 (292)
T cd06657         248 GFLDRLLVRDPAQRATAAELLKHPFLAKAGPP  279 (292)
T ss_pred             HHHHHHHhCCcccCcCHHHHhcChHHhccCCC
Confidence            99999999999999999999999999987643

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=5.1e-39  Score=336.97  Aligned_cols=248  Identities=25%  Similarity=0.448  Sum_probs=204.2

Q ss_pred             CeeEeeEEeecCCeEEEEEEECC-----CCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecC
Q 004959          341 QWQKGKLIGRGTFGSVYVASNRE-----TGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVED  415 (721)
Q Consensus       341 ~y~~~k~LG~G~fG~VY~a~~~~-----tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~  415 (721)
                      +|++.+.||+|+||.||+|.+..     ....+++|.+..    .......+.+.+|+.+++.+.||||+++++.+...+
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~----~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   76 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKE----NASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDG   76 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCC----CCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCC
Confidence            47889999999999999998653     235788887742    122344678899999999999999999999999999


Q ss_pred             eEEEEEeeccCCCHHHHHHHh-----------------------cCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCC
Q 004959          416 KFYIYLEYVHPGSINKYVREH-----------------------CGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGA  472 (721)
Q Consensus       416 ~~yLVmEy~~gGsL~~~L~~~-----------------------~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPe  472 (721)
                      ..|+||||+.+++|.+++...                       ...+++..+..++.||+.||+|||++||+||||||+
T Consensus        77 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~  156 (290)
T cd05045          77 PLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAAR  156 (290)
T ss_pred             CcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhh
Confidence            999999999999999998642                       124788999999999999999999999999999999


Q ss_pred             cEEEcCCCceEEeecCCccccCCCcc---cccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhh-CCCC
Q 004959          473 NLLVDASGVVKLADFGMAKHLTGQKA---DLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPP  548 (721)
Q Consensus       473 NILld~~g~VKL~DFGlA~~l~~~~~---~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLt-G~~P  548 (721)
                      |||+++++.+||+|||+++.+.....   .....++..|+|||.+.       ...++.++|||||||++|||++ |..|
T Consensus       157 nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~-------~~~~~~~~Di~slG~~l~el~t~g~~p  229 (290)
T cd05045         157 NVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLF-------DHIYTTQSDVWSFGVLLWEIVTLGGNP  229 (290)
T ss_pred             eEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHc-------cCCcchHhHHHHHHHHHHHHHhcCCCC
Confidence            99999999999999999986543221   12234677899999884       3446778999999999999998 9999


Q ss_pred             CCchhhHHHHHHHhhc-CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHh
Q 004959          549 WSEYEGAAAMFKVMRD-TPAIPDSLSPEGKDFLRCCFQRNPADRPPASLLLE  599 (721)
Q Consensus       549 F~~~~~~~~~~ki~~~-~~~~p~~lS~el~dLI~~cL~~DP~kRPSa~eLL~  599 (721)
                      |.+.........+... ....+..++.++.+||.+||+.||++||++.++++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~  281 (290)
T cd05045         230 YPGIAPERLFNLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISK  281 (290)
T ss_pred             CCCCCHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence            9876555444333322 23446778999999999999999999999999986

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=1.9e-39  Score=348.57  Aligned_cols=260  Identities=28%  Similarity=0.487  Sum_probs=211.0

Q ss_pred             CCCCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhC-CCCCeeeeeeeEEec--
Q 004959          338 MNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHL-KHPNIVQYYGSEIVE--  414 (721)
Q Consensus       338 l~~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L-~HPnIV~l~g~~~~~--  414 (721)
                      +.++|++.+.||+|+||.||+|.+..+|+.||||.+....   ........+.+|+.+++++ +|+||+++++++...  
T Consensus         5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~---~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~   81 (337)
T cd07852           5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAF---RNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAEND   81 (337)
T ss_pred             hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeecccc---CcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCC
Confidence            4568999999999999999999999999999999875321   1223345677899999999 999999999987654  


Q ss_pred             CeEEEEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccC
Q 004959          415 DKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLT  494 (721)
Q Consensus       415 ~~~yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~  494 (721)
                      ...|+||||+. ++|..++...  .+.+..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+.
T Consensus        82 ~~~~lv~e~~~-~~L~~~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~  158 (337)
T cd07852          82 KDIYLVFEYME-TDLHAVIRAN--ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLS  158 (337)
T ss_pred             ceEEEEecccc-cCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccchhccc
Confidence            36899999997 5999888653  78899999999999999999999999999999999999999999999999998664


Q ss_pred             CCc------ccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhcC---
Q 004959          495 GQK------ADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDT---  565 (721)
Q Consensus       495 ~~~------~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~~---  565 (721)
                      ...      ....+.|+..|+|||++.+      ...++.++|||||||++|+|++|+.||.+....+...++....   
T Consensus       159 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~  232 (337)
T cd07852         159 ELEENPENPVLTDYVATRWYRAPEILLG------STRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPP  232 (337)
T ss_pred             cccccccCcchhcccccccccCceeeec------cccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Confidence            332      1223568999999998743      2345668999999999999999999997654433332221110   


Q ss_pred             ----------------------------CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhccccccCCCC
Q 004959          566 ----------------------------PAIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQP  609 (721)
Q Consensus       566 ----------------------------~~~p~~lS~el~dLI~~cL~~DP~kRPSa~eLL~Hp~f~~~~~~  609 (721)
                                                  ......++.++.+||.+||+.||++||++.++++|+||.....+
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~~~~  304 (337)
T cd07852         233 SAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQFHNP  304 (337)
T ss_pred             CHHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhhccC
Confidence                                        01112378999999999999999999999999999999887554

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=4.4e-39  Score=341.83  Aligned_cols=259  Identities=34%  Similarity=0.636  Sum_probs=217.2

Q ss_pred             CCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeEEE
Q 004959          340 SQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYI  419 (721)
Q Consensus       340 ~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~yL  419 (721)
                      ..|+..+.||+|+||.||+|++..+++.||||.+...  ........+.+.+|+.+++.++|+||+++++++......|+
T Consensus        15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   92 (308)
T cd06634          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYS--GKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWL   92 (308)
T ss_pred             HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecc--cccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEE
Confidence            4588889999999999999999999999999988632  12233455678899999999999999999999999999999


Q ss_pred             EEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCCccc
Q 004959          420 YLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKAD  499 (721)
Q Consensus       420 VmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~~~~  499 (721)
                      ||||+. |+|.+++......+++..+..++.||+.||.|||++|++||||||+|||++.++.+||+|||++..+...   
T Consensus        93 v~e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~---  168 (308)
T cd06634          93 VMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA---  168 (308)
T ss_pred             EEEccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcccceeecCc---
Confidence            999996 6888887665567999999999999999999999999999999999999999999999999998765432   


Q ss_pred             ccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhcCC-C-CCCCCCHHHH
Q 004959          500 LSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTP-A-IPDSLSPEGK  577 (721)
Q Consensus       500 ~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~~~-~-~p~~lS~el~  577 (721)
                      ....|++.|+|||++.+.    ....++.++|||||||++|+|++|..||......+....+..... . ....++..+.
T Consensus       169 ~~~~~~~~y~aPE~~~~~----~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (308)
T cd06634         169 NXFVGTPYWMAPEVILAM----DEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFR  244 (308)
T ss_pred             ccccCCccccCHHHHhhc----ccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCCCCcCcccccHHHH
Confidence            345689999999998532    123456689999999999999999999977665555554443322 2 2346889999


Q ss_pred             HHHHHhcccCCCCCCCHHHHHhccccccCCC
Q 004959          578 DFLRCCFQRNPADRPPASLLLEHRFLKNSQQ  608 (721)
Q Consensus       578 dLI~~cL~~DP~kRPSa~eLL~Hp~f~~~~~  608 (721)
                      +||++||+.+|++||+++++++|+|+.....
T Consensus       245 ~li~~cl~~~P~~Rp~~~~ll~~~~~~~~~~  275 (308)
T cd06634         245 NFVDSCLQKIPQDRPTSEVLLKHRFVLRERP  275 (308)
T ss_pred             HHHHHHhhCCcccCCCHHHHhhCccccccCC
Confidence            9999999999999999999999999987543

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=6.6e-39  Score=328.86  Aligned_cols=244  Identities=30%  Similarity=0.526  Sum_probs=207.1

Q ss_pred             CCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeEEE
Q 004959          340 SQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYI  419 (721)
Q Consensus       340 ~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~yL  419 (721)
                      .+|++.+.||.|+||.||+|...  |+.||+|.+...      ....+++.+|+.+++.++|+||+++++++...+..|+
T Consensus         6 ~~~~~~~~ig~g~~g~v~~~~~~--~~~v~iK~~~~~------~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   77 (256)
T cd05039           6 KELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLKDD------STAAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYI   77 (256)
T ss_pred             hhccceeeeecCCCceEEEEEec--CcEEEEEEeccc------hhHHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEE
Confidence            47899999999999999999865  889999988531      1146788999999999999999999999998999999


Q ss_pred             EEeeccCCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCCcc
Q 004959          420 YLEYVHPGSINKYVREHC-GAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKA  498 (721)
Q Consensus       420 VmEy~~gGsL~~~L~~~~-~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~~~  498 (721)
                      ||||+.+++|.+++.... ..+++..+..++.||+.||.|||++||+|+||||+|||++.++.+||+|||++........
T Consensus        78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~  157 (256)
T cd05039          78 VTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD  157 (256)
T ss_pred             EEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEcccccccccccccc
Confidence            999999999999997653 3689999999999999999999999999999999999999999999999999987633222


Q ss_pred             cccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhh-CCCCCCchhhHHHHHHHhhc-CCCCCCCCCHHH
Q 004959          499 DLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFKVMRD-TPAIPDSLSPEG  576 (721)
Q Consensus       499 ~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLt-G~~PF~~~~~~~~~~ki~~~-~~~~p~~lS~el  576 (721)
                        ...++..|+|||.+.       ...++.++|||||||++|+|++ |..||......+....+... ....+..+++++
T Consensus       158 --~~~~~~~~~ape~~~-------~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (256)
T cd05039         158 --SGKLPVKWTAPEALR-------EKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGYRMEAPEGCPPEV  228 (256)
T ss_pred             --cCCCcccccCchhhc-------CCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCccCCCHHH
Confidence              334566799999984       3345668999999999999997 99999876655544444333 234566789999


Q ss_pred             HHHHHHhcccCCCCCCCHHHHHhc
Q 004959          577 KDFLRCCFQRNPADRPPASLLLEH  600 (721)
Q Consensus       577 ~dLI~~cL~~DP~kRPSa~eLL~H  600 (721)
                      .++|.+||..+|++||++.++++.
T Consensus       229 ~~li~~~l~~~p~~Rp~~~~l~~~  252 (256)
T cd05039         229 YKVMKDCWELDPAKRPTFKQLREQ  252 (256)
T ss_pred             HHHHHHHhccChhhCcCHHHHHHH
Confidence            999999999999999999999863

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=5.5e-39  Score=329.86  Aligned_cols=243  Identities=27%  Similarity=0.504  Sum_probs=202.9

Q ss_pred             CCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEE-ecCeEE
Q 004959          340 SQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEI-VEDKFY  418 (721)
Q Consensus       340 ~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~-~~~~~y  418 (721)
                      .+|++.+.||+|+||.||++...  |..||+|.+..   +    ...+.+.+|+.++++++|+||+++++++. ..+..|
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~--~~~~~~k~~~~---~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   76 (256)
T cd05082           6 KELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKN---D----ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLY   76 (256)
T ss_pred             HhCeeeeeecccCCCeEEEEEEc--CCcEEEEEeCC---C----chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceE
Confidence            47899999999999999999765  78899998742   1    12457889999999999999999999754 456799


Q ss_pred             EEEeeccCCCHHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCCc
Q 004959          419 IYLEYVHPGSINKYVREHCG-AITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQK  497 (721)
Q Consensus       419 LVmEy~~gGsL~~~L~~~~~-~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~~  497 (721)
                      +||||+.+++|.+++..... .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++.......
T Consensus        77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~  156 (256)
T cd05082          77 IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ  156 (256)
T ss_pred             EEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCccceeccccC
Confidence            99999999999999976533 48899999999999999999999999999999999999999999999999987654322


Q ss_pred             ccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhh-CCCCCCchhhHHHHHHHhhc-CCCCCCCCCHH
Q 004959          498 ADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFKVMRD-TPAIPDSLSPE  575 (721)
Q Consensus       498 ~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLt-G~~PF~~~~~~~~~~ki~~~-~~~~p~~lS~e  575 (721)
                        ....++..|+|||++.       ...++.++|||||||++|+|++ |+.||......+....+... ....+..++.+
T Consensus       157 --~~~~~~~~y~aPE~~~-------~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  227 (256)
T cd05082         157 --DTGKLPVKWTAPEALR-------EKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPV  227 (256)
T ss_pred             --CCCccceeecCHHHHc-------cCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCHH
Confidence              2334567899999984       3456778999999999999997 99999876555444444333 33456678999


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHHhc
Q 004959          576 GKDFLRCCFQRNPADRPPASLLLEH  600 (721)
Q Consensus       576 l~dLI~~cL~~DP~kRPSa~eLL~H  600 (721)
                      +.++|.+||+.||++|||+.+++++
T Consensus       228 ~~~li~~~l~~~p~~Rpt~~~l~~~  252 (256)
T cd05082         228 VYDVMKQCWHLDAATRPSFLQLREQ  252 (256)
T ss_pred             HHHHHHHHhcCChhhCcCHHHHHHH
Confidence            9999999999999999999999863

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=4.9e-39  Score=338.49  Aligned_cols=260  Identities=30%  Similarity=0.545  Sum_probs=211.9

Q ss_pred             CCCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCC-CCCeeeeeeeEEecCeE
Q 004959          339 NSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLK-HPNIVQYYGSEIVEDKF  417 (721)
Q Consensus       339 ~~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~-HPnIV~l~g~~~~~~~~  417 (721)
                      .++|++.+.||+|+||.||+|.+..+|+.||||.+...    ........+..|+.++.++. |+||+++++++......
T Consensus        14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~----~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~   89 (296)
T cd06618          14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRT----GNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDV   89 (296)
T ss_pred             cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEecc----CChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeE
Confidence            36799999999999999999999999999999998632    11233456677887776665 99999999999999999


Q ss_pred             EEEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhh-CCeeccCCCCCcEEEcCCCceEEeecCCccccCCC
Q 004959          418 YIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHS-KKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQ  496 (721)
Q Consensus       418 yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs-~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~  496 (721)
                      |+||||+. +.|.+++......+++..+..++.||+.||.|||+ .||+||||+|+|||++.++.+||+|||++..+...
T Consensus        90 ~~v~e~~~-~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~  168 (296)
T cd06618          90 FICMELMS-TCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDS  168 (296)
T ss_pred             EEEeeccC-cCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccccchhccCC
Confidence            99999995 68888876655689999999999999999999997 59999999999999999999999999999876544


Q ss_pred             cccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhh-HHHHHHHhhcC-CCCC--CCC
Q 004959          497 KADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEG-AAAMFKVMRDT-PAIP--DSL  572 (721)
Q Consensus       497 ~~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~-~~~~~ki~~~~-~~~p--~~l  572 (721)
                      .......|+..|+|||.+.+...   ...++.++|||||||++|+|++|+.||..... .+.+..+.... ...+  ..+
T Consensus       169 ~~~~~~~~~~~y~aPE~~~~~~~---~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (296)
T cd06618         169 KAKTRSAGCAAYMAPERIDPPDP---NPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSLPPNEGF  245 (296)
T ss_pred             CcccCCCCCccccCHhhcCCCCC---ccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCCCCCCCCCCCC
Confidence            44344568889999999853210   23466789999999999999999999976332 33344443332 2222  247


Q ss_pred             CHHHHHHHHHhcccCCCCCCCHHHHHhccccccC
Q 004959          573 SPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNS  606 (721)
Q Consensus       573 S~el~dLI~~cL~~DP~kRPSa~eLL~Hp~f~~~  606 (721)
                      +.++.+||.+||..||++||+++++++|+||...
T Consensus       246 ~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~  279 (296)
T cd06618         246 SPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRRY  279 (296)
T ss_pred             CHHHHHHHHHHccCChhhCCCHHHHhcChhhhcc
Confidence            8999999999999999999999999999999854

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=6.1e-39  Score=340.15  Aligned_cols=250  Identities=26%  Similarity=0.506  Sum_probs=207.3

Q ss_pred             CCeeEeeEEeecCCeEEEEEEE-----CCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhC-CCCCeeeeeeeEEe
Q 004959          340 SQWQKGKLIGRGTFGSVYVASN-----RETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHL-KHPNIVQYYGSEIV  413 (721)
Q Consensus       340 ~~y~~~k~LG~G~fG~VY~a~~-----~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L-~HPnIV~l~g~~~~  413 (721)
                      ++|++.+.||+|+||.||+|.+     ..++..||+|.+...    ......+.+.+|+.+++++ +|+||+++++++..
T Consensus        35 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~  110 (302)
T cd05055          35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPT----AHSSEREALMSELKIMSHLGNHENIVNLLGACTI  110 (302)
T ss_pred             HHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCcc----CChHHHHHHHHHHHHHHhccCCCCcceEEEEEec
Confidence            5799999999999999999975     345668999987532    2234456789999999999 79999999999999


Q ss_pred             cCeEEEEEeeccCCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccc
Q 004959          414 EDKFYIYLEYVHPGSINKYVREHC-GAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKH  492 (721)
Q Consensus       414 ~~~~yLVmEy~~gGsL~~~L~~~~-~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~  492 (721)
                      .+..|+||||+.+|+|.+++.... ..+++..+..++.||+.||.|||++||+|+||||+|||++.++.+||+|||++..
T Consensus       111 ~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~dfg~~~~  190 (302)
T cd05055         111 GGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLARD  190 (302)
T ss_pred             CCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEEECCCccccc
Confidence            999999999999999999997543 3489999999999999999999999999999999999999999999999999986


Q ss_pred             cCCCcc---cccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhh-CCCCCCchhhHHHHHHHhhcC--C
Q 004959          493 LTGQKA---DLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFKVMRDT--P  566 (721)
Q Consensus       493 l~~~~~---~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLt-G~~PF~~~~~~~~~~ki~~~~--~  566 (721)
                      +.....   .....++..|+|||.+.       ...++.++|||||||++|+|++ |..||......+.+.+.....  .
T Consensus       191 ~~~~~~~~~~~~~~~~~~y~aPE~~~-------~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~~~  263 (302)
T cd05055         191 IMNDSNYVVKGNARLPVKWMAPESIF-------NCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRM  263 (302)
T ss_pred             ccCCCceeecCCCCcccccCCHhhhc-------cCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCCcC
Confidence            643321   11234678899999984       3446778999999999999998 999998765554444443322  2


Q ss_pred             CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q 004959          567 AIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEH  600 (721)
Q Consensus       567 ~~p~~lS~el~dLI~~cL~~DP~kRPSa~eLL~H  600 (721)
                      ..+...+.++.+||.+||..+|++||++.|+++.
T Consensus       264 ~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~  297 (302)
T cd05055         264 AQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQL  297 (302)
T ss_pred             CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence            3455678999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=6.6e-39  Score=340.99  Aligned_cols=250  Identities=25%  Similarity=0.457  Sum_probs=206.4

Q ss_pred             CCeeEeeEEeecCCeEEEEEEEC-------CCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhC-CCCCeeeeeeeE
Q 004959          340 SQWQKGKLIGRGTFGSVYVASNR-------ETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHL-KHPNIVQYYGSE  411 (721)
Q Consensus       340 ~~y~~~k~LG~G~fG~VY~a~~~-------~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L-~HPnIV~l~g~~  411 (721)
                      .+|.+++.||+|+||.||+|.+.       ..+..||+|.+..    .........+.+|+.+++++ .||||+++++++
T Consensus        12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~----~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~   87 (314)
T cd05099          12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKD----NATDKDLADLISEMELMKLIGKHKNIINLLGVC   87 (314)
T ss_pred             HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCC----CCChHHHHHHHHHHHHHHhccCCCCeeeEEEEE
Confidence            57999999999999999999763       2345799998752    12334567788999999999 599999999999


Q ss_pred             EecCeEEEEEeeccCCCHHHHHHHhc---------------CCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEE
Q 004959          412 IVEDKFYIYLEYVHPGSINKYVREHC---------------GAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLV  476 (721)
Q Consensus       412 ~~~~~~yLVmEy~~gGsL~~~L~~~~---------------~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILl  476 (721)
                      ...+.+|+||||+.+|+|.+++....               ..+++..+..++.||+.||.|||++||+||||||+|||+
T Consensus        88 ~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill  167 (314)
T cd05099          88 TQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLV  167 (314)
T ss_pred             ccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeEEE
Confidence            99999999999999999999997532               348889999999999999999999999999999999999


Q ss_pred             cCCCceEEeecCCccccCCCcc---cccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhh-CCCCCCch
Q 004959          477 DASGVVKLADFGMAKHLTGQKA---DLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEY  552 (721)
Q Consensus       477 d~~g~VKL~DFGlA~~l~~~~~---~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLt-G~~PF~~~  552 (721)
                      +.++.+||+|||+++.+.....   .....++..|||||++.       ...++.++|||||||++|+|++ |..||...
T Consensus       168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-------~~~~~~~~DiwslG~~l~el~~~g~~p~~~~  240 (314)
T cd05099         168 TEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALF-------DRVYTHQSDVWSFGILMWEIFTLGGSPYPGI  240 (314)
T ss_pred             cCCCcEEEccccccccccccccccccccCCCCccccCHHHHc-------cCCcCccchhhHHHHHHHHHHhCCCCCCCCC
Confidence            9999999999999986643221   11223456799999984       3446678999999999999999 89999876


Q ss_pred             hhHHHHHHHhhcC-CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q 004959          553 EGAAAMFKVMRDT-PAIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEH  600 (721)
Q Consensus       553 ~~~~~~~ki~~~~-~~~p~~lS~el~dLI~~cL~~DP~kRPSa~eLL~H  600 (721)
                      ...+.+..+.... ...+..++.++++||.+||..||++||++.++++.
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~  289 (314)
T cd05099         241 PVEELFKLLREGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEA  289 (314)
T ss_pred             CHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            6555555444332 34567788999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=4.8e-39  Score=335.87  Aligned_cols=248  Identities=28%  Similarity=0.504  Sum_probs=207.5

Q ss_pred             CCeeEeeEEeecCCeEEEEEEEC-----CCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEec
Q 004959          340 SQWQKGKLIGRGTFGSVYVASNR-----ETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVE  414 (721)
Q Consensus       340 ~~y~~~k~LG~G~fG~VY~a~~~-----~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~  414 (721)
                      .+|+..+.||+|+||.||+|...     .++..+|+|.+..     ......+.+.+|+++++.++|+||+++++++...
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~-----~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   79 (280)
T cd05092           5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKE-----ASESARQDFQREAELLTVLQHQHIVRFYGVCTEG   79 (280)
T ss_pred             HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCc-----CCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecC
Confidence            46888999999999999999643     3577899997642     2344567899999999999999999999999999


Q ss_pred             CeEEEEEeeccCCCHHHHHHHhc--------------CCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCC
Q 004959          415 DKFYIYLEYVHPGSINKYVREHC--------------GAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASG  480 (721)
Q Consensus       415 ~~~yLVmEy~~gGsL~~~L~~~~--------------~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g  480 (721)
                      +..++||||+.+++|.+++....              ..+++..+..++.||+.||+|||++||+||||||+|||+++++
T Consensus        80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~~  159 (280)
T cd05092          80 RPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGL  159 (280)
T ss_pred             CceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCCC
Confidence            99999999999999999997643              2488999999999999999999999999999999999999999


Q ss_pred             ceEEeecCCccccCCCcc---cccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhh-CCCCCCchhhHH
Q 004959          481 VVKLADFGMAKHLTGQKA---DLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAA  556 (721)
Q Consensus       481 ~VKL~DFGlA~~l~~~~~---~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLt-G~~PF~~~~~~~  556 (721)
                      .+||+|||++..+.....   .....+++.|+|||++.+       ..++.++|||||||++|||++ |..||......+
T Consensus       160 ~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~  232 (280)
T cd05092         160 VVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILY-------RKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTE  232 (280)
T ss_pred             CEEECCCCceeEcCCCceeecCCCccccccccCHHHhcc-------CCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHH
Confidence            999999999976543221   112335788999999843       446778999999999999998 999997766555


Q ss_pred             HHHHHhhc-CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHh
Q 004959          557 AMFKVMRD-TPAIPDSLSPEGKDFLRCCFQRNPADRPPASLLLE  599 (721)
Q Consensus       557 ~~~ki~~~-~~~~p~~lS~el~dLI~~cL~~DP~kRPSa~eLL~  599 (721)
                      .+..+... ....+..++.++.+||.+||+.||++||++.+|++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~  276 (280)
T cd05092         233 AIECITQGRELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHS  276 (280)
T ss_pred             HHHHHHcCccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            55555443 33456778999999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=9.7e-40  Score=336.73  Aligned_cols=240  Identities=23%  Similarity=0.417  Sum_probs=198.3

Q ss_pred             eEEeecCCeEEEEEEECCCCcE-------EEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeEE
Q 004959          346 KLIGRGTFGSVYVASNRETGAL-------CAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFY  418 (721)
Q Consensus       346 k~LG~G~fG~VY~a~~~~tg~~-------vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~y  418 (721)
                      +.||+|+||.||+|.+..++..       ||+|.+..     ......+.+.+|+.+|+.+.|||||++++++...+..+
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~-----~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~   75 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDK-----SHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESI   75 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcc-----hhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcE
Confidence            3689999999999988665543       77776532     22344567888999999999999999999999999999


Q ss_pred             EEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCc--------eEEeecCCc
Q 004959          419 IYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGV--------VKLADFGMA  490 (721)
Q Consensus       419 LVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~--------VKL~DFGlA  490 (721)
                      +||||+.+|+|.+++......+++..+..++.||+.||+|||++||+||||||+|||++.++.        ++|+|||++
T Consensus        76 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~  155 (258)
T cd05078          76 MVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS  155 (258)
T ss_pred             EEEecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEecccccc
Confidence            999999999999999876567899999999999999999999999999999999999987764        699999998


Q ss_pred             cccCCCcccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCC-CCCCchhhHHHHHHHhhcCCCCC
Q 004959          491 KHLTGQKADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGK-PPWSEYEGAAAMFKVMRDTPAIP  569 (721)
Q Consensus       491 ~~l~~~~~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~-~PF~~~~~~~~~~ki~~~~~~~p  569 (721)
                      ......   ....++..|+|||++.+      ...++.++|||||||++|+|++|. .||........ .........++
T Consensus       156 ~~~~~~---~~~~~~~~y~aPE~~~~------~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~-~~~~~~~~~~~  225 (258)
T cd05078         156 ITVLPK---EILLERIPWVPPECIEN------PQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKK-LQFYEDRHQLP  225 (258)
T ss_pred             cccCCc---hhccccCCccCchhccC------CCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHH-HHHHHccccCC
Confidence            755332   23568899999999842      234667899999999999999984 66655443332 33344455677


Q ss_pred             CCCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q 004959          570 DSLSPEGKDFLRCCFQRNPADRPPASLLLEH  600 (721)
Q Consensus       570 ~~lS~el~dLI~~cL~~DP~kRPSa~eLL~H  600 (721)
                      ...+.++.+||.+||+.||++|||+++|++.
T Consensus       226 ~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  256 (258)
T cd05078         226 APKWTELANLINQCMDYEPDFRPSFRAIIRD  256 (258)
T ss_pred             CCCcHHHHHHHHHHhccChhhCCCHHHHHHh
Confidence            7788999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=8.1e-39  Score=333.16  Aligned_cols=248  Identities=26%  Similarity=0.421  Sum_probs=208.6

Q ss_pred             CCeeEeeEEeecCCeEEEEEEECCCCc----EEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecC
Q 004959          340 SQWQKGKLIGRGTFGSVYVASNRETGA----LCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVED  415 (721)
Q Consensus       340 ~~y~~~k~LG~G~fG~VY~a~~~~tg~----~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~  415 (721)
                      .+|++++.||+|+||.||+|.++.+|+    .||+|.+...    ........+.+|+.+|+++.|+||+++++++.. .
T Consensus         7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~----~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~   81 (279)
T cd05057           7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREE----TSPKANKEILDEAYVMASVDHPHVVRLLGICLS-S   81 (279)
T ss_pred             HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCC----CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-C
Confidence            579999999999999999999877665    5888876421    224556788999999999999999999998877 7


Q ss_pred             eEEEEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCC
Q 004959          416 KFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTG  495 (721)
Q Consensus       416 ~~yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~  495 (721)
                      ..++||||+.+|+|.+++......+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.+..
T Consensus        82 ~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~  161 (279)
T cd05057          82 QVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDV  161 (279)
T ss_pred             ceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCcccccccC
Confidence            89999999999999999987667799999999999999999999999999999999999999999999999999987654


Q ss_pred             Cccccc---CCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhh-CCCCCCchhhHHHHHHHhhc-CCCCCC
Q 004959          496 QKADLS---MKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFKVMRD-TPAIPD  570 (721)
Q Consensus       496 ~~~~~s---~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLt-G~~PF~~~~~~~~~~ki~~~-~~~~p~  570 (721)
                      ......   ..++..|+|||.+.       ...++.++|||||||++|||++ |+.||......+....+... ....+.
T Consensus       162 ~~~~~~~~~~~~~~~y~~PE~~~-------~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  234 (279)
T cd05057         162 DEKEYHAEGGKVPIKWMALESIL-------HRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGERLPQPP  234 (279)
T ss_pred             cccceecCCCcccccccCHHHhh-------cCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCCCCCCCC
Confidence            332221   22356799999884       3456678999999999999998 99999887655555444433 234556


Q ss_pred             CCCHHHHHHHHHhcccCCCCCCCHHHHHh
Q 004959          571 SLSPEGKDFLRCCFQRNPADRPPASLLLE  599 (721)
Q Consensus       571 ~lS~el~dLI~~cL~~DP~kRPSa~eLL~  599 (721)
                      ..+.++.++|.+||..||++||++.++++
T Consensus       235 ~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~  263 (279)
T cd05057         235 ICTIDVYMVLVKCWMIDAESRPTFKELIN  263 (279)
T ss_pred             CCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence            68899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=7.5e-39  Score=326.25  Aligned_cols=247  Identities=30%  Similarity=0.522  Sum_probs=208.6

Q ss_pred             eeEeeEEeecCCeEEEEEEECCCC----cEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeE
Q 004959          342 WQKGKLIGRGTFGSVYVASNRETG----ALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKF  417 (721)
Q Consensus       342 y~~~k~LG~G~fG~VY~a~~~~tg----~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~  417 (721)
                      +++.+.||.|+||.||+|.+...+    ..||+|.+...    ......+.+.+|+.+|+.++|+||+++++++.+.+..
T Consensus         1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   76 (258)
T smart00219        1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKED----ADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPL   76 (258)
T ss_pred             CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCC----CChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCee
Confidence            356789999999999999988766    99999988532    2223567889999999999999999999999999999


Q ss_pred             EEEEeeccCCCHHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCC
Q 004959          418 YIYLEYVHPGSINKYVREHCGA-ITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQ  496 (721)
Q Consensus       418 yLVmEy~~gGsL~~~L~~~~~~-Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~  496 (721)
                      |++|||+.+++|.+++...... +++..+..++.||+.||+|||+.|++|+||||+||+++.++.++|+|||++......
T Consensus        77 ~~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~  156 (258)
T smart00219       77 MIVMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDD  156 (258)
T ss_pred             EEEEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCceecccc
Confidence            9999999999999999765334 999999999999999999999999999999999999999999999999999876543


Q ss_pred             cccc--cCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhh-CCCCCCchhhHHHHHHHhhc-CCCCCCCC
Q 004959          497 KADL--SMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFKVMRD-TPAIPDSL  572 (721)
Q Consensus       497 ~~~~--s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLt-G~~PF~~~~~~~~~~ki~~~-~~~~p~~l  572 (721)
                      ....  ...+++.|+|||.+.       ...++.++|||||||++|+|++ |..||...........+... ....+..+
T Consensus       157 ~~~~~~~~~~~~~y~~Pe~~~-------~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  229 (258)
T smart00219      157 DYYKKKGGKLPIRWMAPESLK-------DGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGYRLPKPENC  229 (258)
T ss_pred             cccccccCCCcccccChHHhc-------cCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCcC
Confidence            2211  123678999999983       3456678999999999999998 89999876665555555443 23455668


Q ss_pred             CHHHHHHHHHhcccCCCCCCCHHHHHh
Q 004959          573 SPEGKDFLRCCFQRNPADRPPASLLLE  599 (721)
Q Consensus       573 S~el~dLI~~cL~~DP~kRPSa~eLL~  599 (721)
                      +.++.++|.+||..||++|||+.|+++
T Consensus       230 ~~~~~~~i~~~l~~~p~~Rpt~~~ll~  256 (258)
T smart00219      230 PPEIYKLMLQCWAEDPEDRPTFSELVE  256 (258)
T ss_pred             CHHHHHHHHHHCcCChhhCcCHHHHHh
Confidence            999999999999999999999999986

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=4.3e-39  Score=336.76  Aligned_cols=260  Identities=28%  Similarity=0.480  Sum_probs=214.1

Q ss_pred             CeeEeeEEeecCCeEEEEEEEC---CCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhC-CCCCeeeeeeeEEecCe
Q 004959          341 QWQKGKLIGRGTFGSVYVASNR---ETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHL-KHPNIVQYYGSEIVEDK  416 (721)
Q Consensus       341 ~y~~~k~LG~G~fG~VY~a~~~---~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L-~HPnIV~l~g~~~~~~~  416 (721)
                      .|++.+.||+|+||.||+|++.   .+++.||||++..... .......+.+.+|+.++.++ +|+||+++++.+.....
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~-~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~   79 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATI-VQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTK   79 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHH-HhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCE
Confidence            4889999999999999999754   4678999998853211 11223456788999999999 59999999999999999


Q ss_pred             EEEEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCC
Q 004959          417 FYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQ  496 (721)
Q Consensus       417 ~yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~  496 (721)
                      .|+||||+.+++|.+++... ..+++..++.++.||+.||.|||+.|++||||||.||+++.++.++|+|||++..+...
T Consensus        80 ~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~  158 (288)
T cd05583          80 LHLILDYVNGGELFTHLYQR-EHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAE  158 (288)
T ss_pred             EEEEEecCCCCcHHHHHhhc-CCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECccccccccc
Confidence            99999999999999998764 57999999999999999999999999999999999999999999999999998875443


Q ss_pred             cc--cccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchh----hHHHHHHHhhcCCCCCC
Q 004959          497 KA--DLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYE----GAAAMFKVMRDTPAIPD  570 (721)
Q Consensus       497 ~~--~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~----~~~~~~ki~~~~~~~p~  570 (721)
                      ..  .....|+..|+|||.+.+.     ....+.++||||||+++|+|++|..||....    ..+....+.......+.
T Consensus       159 ~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (288)
T cd05583         159 EEERAYSFCGTIEYMAPEVIRGG-----SGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPPFPK  233 (288)
T ss_pred             cccccccccCCccccCHHHhcCC-----CCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHccCCCCCc
Confidence            22  2235689999999998531     1235668999999999999999999995422    22333344455566778


Q ss_pred             CCCHHHHHHHHHhcccCCCCCCC---HHHHHhccccccCC
Q 004959          571 SLSPEGKDFLRCCFQRNPADRPP---ASLLLEHRFLKNSQ  607 (721)
Q Consensus       571 ~lS~el~dLI~~cL~~DP~kRPS---a~eLL~Hp~f~~~~  607 (721)
                      .++.++.+||.+||+.||++|||   +.++|+||||+...
T Consensus       234 ~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~~  273 (288)
T cd05583         234 TMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQGID  273 (288)
T ss_pred             ccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCcccccCC
Confidence            89999999999999999999998   57889999998754

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=2.1e-39  Score=335.72  Aligned_cols=252  Identities=35%  Similarity=0.613  Sum_probs=209.8

Q ss_pred             eeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeEEEEE
Q 004959          342 WQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYIYL  421 (721)
Q Consensus       342 y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~yLVm  421 (721)
                      |++.+.||+|+||.||+|++..+++.||+|++....   ......+.+.+|+.+++.++|+||+++++++...+..|+||
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~---~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~   77 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDN---EEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVF   77 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEecccc---ccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEe
Confidence            667889999999999999999999999999986432   12223456788999999999999999999999999999999


Q ss_pred             eeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCCc-ccc
Q 004959          422 EYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQK-ADL  500 (721)
Q Consensus       422 Ey~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~~-~~~  500 (721)
                      ||+. ++|.+++......+++..+..++.||+.||.|||++||+||||+|+||+++.++.+||+|||++....... ...
T Consensus        78 e~~~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~  156 (282)
T cd07829          78 EYCD-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYT  156 (282)
T ss_pred             cCcC-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccccCCCccccC
Confidence            9997 59999998765679999999999999999999999999999999999999999999999999998764433 222


Q ss_pred             cCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhcC---------------
Q 004959          501 SMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDT---------------  565 (721)
Q Consensus       501 s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~~---------------  565 (721)
                      ...++..|+|||.+.+      ...++.++|||||||++|||++|..||......+.+.++....               
T Consensus       157 ~~~~~~~~~aPE~~~~------~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (282)
T cd07829         157 HEVVTLWYRAPEILLG------SKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLP  230 (282)
T ss_pred             ccccCcCcCChHHhcC------CcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccc
Confidence            3456788999999853      2356678999999999999999999998765554443332210               


Q ss_pred             ------C--------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccc
Q 004959          566 ------P--------AIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFL  603 (721)
Q Consensus       566 ------~--------~~p~~lS~el~dLI~~cL~~DP~kRPSa~eLL~Hp~f  603 (721)
                            +        .....++.++.++|++||+.||++||++.+++.||||
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~  282 (282)
T cd07829         231 DYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF  282 (282)
T ss_pred             cccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence                  0        0112357889999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=9.3e-39  Score=328.37  Aligned_cols=241  Identities=27%  Similarity=0.454  Sum_probs=199.5

Q ss_pred             eEEeecCCeEEEEEEECCCC---cEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeEEEEEe
Q 004959          346 KLIGRGTFGSVYVASNRETG---ALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYIYLE  422 (721)
Q Consensus       346 k~LG~G~fG~VY~a~~~~tg---~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~yLVmE  422 (721)
                      +.||+|+||.||+|....++   ..||+|.+...    ......+.+.+|+.+|+.+.|+|||++++++. .+..++|||
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~----~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e   75 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQE----HIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVME   75 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccc----cchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEE
Confidence            47999999999999866544   78999987532    11145567899999999999999999999765 556899999


Q ss_pred             eccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCCcccc--
Q 004959          423 YVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADL--  500 (721)
Q Consensus       423 y~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~~~~~--  500 (721)
                      |+.+|+|.+++... ..+++..+..++.||+.||.|||.+||+|+||||+|||++.++.+||+|||+++.+.......  
T Consensus        76 ~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~  154 (257)
T cd05060          76 LAPLGPLLKYLKKR-REIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRA  154 (257)
T ss_pred             eCCCCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeecCCccccc
Confidence            99999999999765 479999999999999999999999999999999999999999999999999998764433211  


Q ss_pred             --cCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhh-CCCCCCchhhHHHHHHHhhc-CCCCCCCCCHHH
Q 004959          501 --SMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFKVMRD-TPAIPDSLSPEG  576 (721)
Q Consensus       501 --s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLt-G~~PF~~~~~~~~~~ki~~~-~~~~p~~lS~el  576 (721)
                        ...++..|+|||.+.       ...++.++|||||||++|+|++ |..||......+....+... ....+..++..+
T Consensus       155 ~~~~~~~~~y~aPE~~~-------~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  227 (257)
T cd05060         155 TTAGRWPLKWYAPECIN-------YGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGERLPRPEECPQEI  227 (257)
T ss_pred             ccCccccccccCHHHhc-------CCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCcCCCCCCCCHHH
Confidence              112346799999884       3456778999999999999998 99999876665554444333 234567789999


Q ss_pred             HHHHHHhcccCCCCCCCHHHHHh
Q 004959          577 KDFLRCCFQRNPADRPPASLLLE  599 (721)
Q Consensus       577 ~dLI~~cL~~DP~kRPSa~eLL~  599 (721)
                      +++|.+||..||++||++.++++
T Consensus       228 ~~li~~cl~~~p~~Rp~~~~l~~  250 (257)
T cd05060         228 YSIMLSCWKYRPEDRPTFSELES  250 (257)
T ss_pred             HHHHHHHhcCChhhCcCHHHHHH
Confidence            99999999999999999999985

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=4.4e-39  Score=331.32  Aligned_cols=245  Identities=26%  Similarity=0.478  Sum_probs=203.9

Q ss_pred             CCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeEEE
Q 004959          340 SQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYI  419 (721)
Q Consensus       340 ~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~yL  419 (721)
                      ++|++.+.||+|+||.||+|.+. .+..||+|.+....   ..   .+.+.+|+.+|++++|+||+++++++. .+..|+
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~---~~---~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~l   77 (260)
T cd05070           6 ESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGT---MS---PESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYI   77 (260)
T ss_pred             HHhhhhheeccccCceEEEEEec-CCceeEEEEecCCC---CC---HHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEE
Confidence            57999999999999999999865 56779999875321   11   246889999999999999999999874 566899


Q ss_pred             EEeeccCCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCCcc
Q 004959          420 YLEYVHPGSINKYVREH-CGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKA  498 (721)
Q Consensus       420 VmEy~~gGsL~~~L~~~-~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~~~  498 (721)
                      ||||+.+++|.+++... ...+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++..+.....
T Consensus        78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~  157 (260)
T cd05070          78 VTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEY  157 (260)
T ss_pred             EEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceeeeeccCccc
Confidence            99999999999999764 34589999999999999999999999999999999999999999999999999986643322


Q ss_pred             c--ccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhh-CCCCCCchhhHHHHHHHhhc-CCCCCCCCCH
Q 004959          499 D--LSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFKVMRD-TPAIPDSLSP  574 (721)
Q Consensus       499 ~--~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLt-G~~PF~~~~~~~~~~ki~~~-~~~~p~~lS~  574 (721)
                      .  ....++..|+|||++.+       ..++.++|||||||++|+|++ |..||.+....+....+... ....+...+.
T Consensus       158 ~~~~~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (260)
T cd05070         158 TARQGAKFPIKWTAPEAALY-------GRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMPCPQDCPI  230 (260)
T ss_pred             ccccCCCCCccccChHHHhc-------CCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCH
Confidence            1  12335667999998843       346678999999999999999 99999887666655555443 3345677899


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHHh
Q 004959          575 EGKDFLRCCFQRNPADRPPASLLLE  599 (721)
Q Consensus       575 el~dLI~~cL~~DP~kRPSa~eLL~  599 (721)
                      ++.+||.+||..||++|||+.++++
T Consensus       231 ~~~~li~~~l~~~p~~Rpt~~~l~~  255 (260)
T cd05070         231 SLHELMLQCWKKDPEERPTFEYLQS  255 (260)
T ss_pred             HHHHHHHHHcccCcccCcCHHHHHH
Confidence            9999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=7.6e-39  Score=327.90  Aligned_cols=247  Identities=27%  Similarity=0.486  Sum_probs=206.5

Q ss_pred             CCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeEEE
Q 004959          340 SQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYI  419 (721)
Q Consensus       340 ~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~yL  419 (721)
                      .+|++.+.||+|+||.||+|.+. .+..+|+|.+...   ...   ...+.+|+++++++.||||+++++++......|+
T Consensus         4 ~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~---~~~---~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   76 (256)
T cd05112           4 SELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREG---AMS---EEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICL   76 (256)
T ss_pred             hHeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCC---CCC---HHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEE
Confidence            47899999999999999999875 4778999987521   111   2467889999999999999999999999999999


Q ss_pred             EEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCCccc
Q 004959          420 YLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKAD  499 (721)
Q Consensus       420 VmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~~~~  499 (721)
                      ||||+.+++|.+++....+.+++..++.++.||+.||+|||++|++|+||||+||+++.++.+||+|||++.........
T Consensus        77 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~  156 (256)
T cd05112          77 VFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYT  156 (256)
T ss_pred             EEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcceeecccCccc
Confidence            99999999999999876667899999999999999999999999999999999999999999999999998765432211


Q ss_pred             --ccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhh-CCCCCCchhhHHHHHHHhhc-CCCCCCCCCHH
Q 004959          500 --LSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFKVMRD-TPAIPDSLSPE  575 (721)
Q Consensus       500 --~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLt-G~~PF~~~~~~~~~~ki~~~-~~~~p~~lS~e  575 (721)
                        ....++..|+|||++.+       ..++.++|||||||++|||++ |..||......+....+... ....+...+.+
T Consensus       157 ~~~~~~~~~~~~aPe~~~~-------~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (256)
T cd05112         157 SSTGTKFPVKWSSPEVFSF-------SKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLYKPRLASQS  229 (256)
T ss_pred             ccCCCccchhhcCHhHhcc-------CCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCCCCCCCCCCCHH
Confidence              12235678999999843       346678999999999999998 99999876655555554433 22345567899


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHHhc
Q 004959          576 GKDFLRCCFQRNPADRPPASLLLEH  600 (721)
Q Consensus       576 l~dLI~~cL~~DP~kRPSa~eLL~H  600 (721)
                      +.+|+.+||+.+|++||++.+++++
T Consensus       230 ~~~l~~~~l~~~p~~Rp~~~~~l~~  254 (256)
T cd05112         230 VYELMQHCWKERPEDRPSFSLLLHQ  254 (256)
T ss_pred             HHHHHHHHcccChhhCCCHHHHHHh
Confidence            9999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=8.3e-39  Score=329.75  Aligned_cols=245  Identities=24%  Similarity=0.468  Sum_probs=203.0

Q ss_pred             CCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeEEE
Q 004959          340 SQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYI  419 (721)
Q Consensus       340 ~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~yL  419 (721)
                      +.|++...||+|+||.||+|.+..+ ..+|+|.+...  . .   ..+.+.+|+.+++++.|+||+++++++. .+..|+
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~--~-~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~   77 (260)
T cd05069           6 ESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPG--T-M---MPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYI   77 (260)
T ss_pred             HHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccC--C-c---cHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEE
Confidence            4699999999999999999987654 46999986421  1 1   2356788999999999999999999874 567899


Q ss_pred             EEeeccCCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCCcc
Q 004959          420 YLEYVHPGSINKYVREHC-GAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKA  498 (721)
Q Consensus       420 VmEy~~gGsL~~~L~~~~-~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~~~  498 (721)
                      ||||+.+++|.+++.... ..+++..+..++.||+.||.|||+.||+|+||||+|||+++++.++|+|||++..+.....
T Consensus        78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~  157 (260)
T cd05069          78 VTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEY  157 (260)
T ss_pred             EEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccceEccCCcc
Confidence            999999999999997643 3588999999999999999999999999999999999999999999999999976643321


Q ss_pred             c--ccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhh-CCCCCCchhhHHHHHHHhhc-CCCCCCCCCH
Q 004959          499 D--LSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFKVMRD-TPAIPDSLSP  574 (721)
Q Consensus       499 ~--~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLt-G~~PF~~~~~~~~~~ki~~~-~~~~p~~lS~  574 (721)
                      .  ....++..|+|||.+.       ...++.++|||||||++|+|++ |..||.+....+....+... ....+..++.
T Consensus       158 ~~~~~~~~~~~y~~Pe~~~-------~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (260)
T cd05069         158 TARQGAKFPIKWTAPEAAL-------YGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRMPCPQGCPE  230 (260)
T ss_pred             cccCCCccchhhCCHHHhc-------cCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCcccCH
Confidence            1  1234667899999884       3456778999999999999999 99999887666555555443 2344567899


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHHh
Q 004959          575 EGKDFLRCCFQRNPADRPPASLLLE  599 (721)
Q Consensus       575 el~dLI~~cL~~DP~kRPSa~eLL~  599 (721)
                      .+.+||++||.+||++||+++++++
T Consensus       231 ~~~~li~~~l~~~p~~Rp~~~~i~~  255 (260)
T cd05069         231 SLHELMKLCWKKDPDERPTFEYIQS  255 (260)
T ss_pred             HHHHHHHHHccCCcccCcCHHHHHH
Confidence            9999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=7.8e-39  Score=338.19  Aligned_cols=252  Identities=26%  Similarity=0.474  Sum_probs=208.2

Q ss_pred             CCCCeeEeeEEeecCCeEEEEEEEC-------CCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhC-CCCCeeeeee
Q 004959          338 MNSQWQKGKLIGRGTFGSVYVASNR-------ETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHL-KHPNIVQYYG  409 (721)
Q Consensus       338 l~~~y~~~k~LG~G~fG~VY~a~~~-------~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L-~HPnIV~l~g  409 (721)
                      ...+|++++.||+|+||.||+|+..       .++..||+|.+..    .......+.+.+|+.+++.+ +||||+++++
T Consensus        13 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~----~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~   88 (304)
T cd05101          13 SRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKD----DATEKDLSDLVSEMEMMKMIGKHKNIINLLG   88 (304)
T ss_pred             cHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeeccc----ccchHHHHHHHHHHHHHHhhccCCCchheeE
Confidence            3468999999999999999999743       2455799998742    12234567889999999999 7999999999


Q ss_pred             eEEecCeEEEEEeeccCCCHHHHHHHhc---------------CCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcE
Q 004959          410 SEIVEDKFYIYLEYVHPGSINKYVREHC---------------GAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANL  474 (721)
Q Consensus       410 ~~~~~~~~yLVmEy~~gGsL~~~L~~~~---------------~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNI  474 (721)
                      ++......|+||||+.+|+|.+++....               ..+++..+..++.||+.||.|||++||+||||||+||
T Consensus        89 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Ni  168 (304)
T cd05101          89 ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNV  168 (304)
T ss_pred             EEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccceE
Confidence            9999999999999999999999997632               2477888999999999999999999999999999999


Q ss_pred             EEcCCCceEEeecCCccccCCCcc---cccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhh-CCCCCC
Q 004959          475 LVDASGVVKLADFGMAKHLTGQKA---DLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWS  550 (721)
Q Consensus       475 Lld~~g~VKL~DFGlA~~l~~~~~---~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLt-G~~PF~  550 (721)
                      |++.++.+||+|||+++.+.....   .....+++.|+|||++.+       ..++.++|||||||++|+|++ |..||.
T Consensus       169 li~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~~l~el~~~g~~p~~  241 (304)
T cd05101         169 LVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFD-------RVYTHQSDVWSFGVLMWEIFTLGGSPYP  241 (304)
T ss_pred             EEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhcc-------CCCCchhhHHHHHHHHHHHHcCCCCCcc
Confidence            999999999999999987643221   122345678999999843       456778999999999999998 889998


Q ss_pred             chhhHHHHHHHhhcC-CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q 004959          551 EYEGAAAMFKVMRDT-PAIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEH  600 (721)
Q Consensus       551 ~~~~~~~~~ki~~~~-~~~p~~lS~el~dLI~~cL~~DP~kRPSa~eLL~H  600 (721)
                      +....+....+.... ...+..++.++++||.+||..+|++||++.|+++.
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~  292 (304)
T cd05101         242 GIPVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVED  292 (304)
T ss_pred             cCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence            766655555544332 23456788999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.4e-41  Score=354.63  Aligned_cols=259  Identities=27%  Similarity=0.460  Sum_probs=228.5

Q ss_pred             CCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCC-CCCeeeeeeeEEecCeEE
Q 004959          340 SQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLK-HPNIVQYYGSEIVEDKFY  418 (721)
Q Consensus       340 ~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~-HPnIV~l~g~~~~~~~~y  418 (721)
                      .+|..+.+||+|+||+|.+|..+.+.+.||||++.+.-  ....+.++--..|-++|.... -|.+++++.+|.+-+++|
T Consensus       349 tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDV--iiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLy  426 (683)
T KOG0696|consen  349 TDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDV--IIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLY  426 (683)
T ss_pred             cccceEEEeccCccceeeeecccCcchhhhhhhhccce--eeecCcccceehhhhheecCCCCchHHHHHHHhhhhhhee
Confidence            47888999999999999999999999999999886321  112223444556777777764 678999999999999999


Q ss_pred             EEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccc-cCCCc
Q 004959          419 IYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKH-LTGQK  497 (721)
Q Consensus       419 LVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~-l~~~~  497 (721)
                      +||||+.||+|--.|+.- +.+.|..+..|+..|+-||-|||++|||+||||..|||+|.+|.|||+|||+++. +.++.
T Consensus       427 FVMEyvnGGDLMyhiQQ~-GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~~~~  505 (683)
T KOG0696|consen  427 FVMEYVNGGDLMYHIQQV-GKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIFDGV  505 (683)
T ss_pred             eEEEEecCchhhhHHHHh-cccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeecccccccccCCc
Confidence            999999999998888765 8899999999999999999999999999999999999999999999999999986 44556


Q ss_pred             ccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhcCCCCCCCCCHHHH
Q 004959          498 ADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDSLSPEGK  577 (721)
Q Consensus       498 ~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~~~~~p~~lS~el~  577 (721)
                      ...++||||.|+|||++.       ...|..++|+||+||+|||||.|.+||++.+..+.+..|+.....+|..+|.|+.
T Consensus       506 TTkTFCGTPdYiAPEIi~-------YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehnvsyPKslSkEAv  578 (683)
T KOG0696|consen  506 TTKTFCGTPDYIAPEIIA-------YQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHNVSYPKSLSKEAV  578 (683)
T ss_pred             ceeeecCCCcccccceEE-------ecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHccCcCcccccHHHH
Confidence            667899999999999994       4567778999999999999999999999999999999999999999999999999


Q ss_pred             HHHHHhcccCCCCCCCH-----HHHHhccccccCCC
Q 004959          578 DFLRCCFQRNPADRPPA-----SLLLEHRFLKNSQQ  608 (721)
Q Consensus       578 dLI~~cL~~DP~kRPSa-----~eLL~Hp~f~~~~~  608 (721)
                      ++.+.+|.+.|.+|.-+     .+|-+||||....-
T Consensus       579 ~ickg~ltK~P~kRLGcg~~ge~di~~H~FFR~iDW  614 (683)
T KOG0696|consen  579 AICKGLLTKHPGKRLGCGPEGERDIREHPFFRRIDW  614 (683)
T ss_pred             HHHHHHhhcCCccccCCCCccccchhhCcchhhccH
Confidence            99999999999999753     57899999986543

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=6.9e-39  Score=331.94  Aligned_cols=249  Identities=25%  Similarity=0.402  Sum_probs=194.9

Q ss_pred             eEEeecCCeEEEEEEEC--CCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeEEEEEee
Q 004959          346 KLIGRGTFGSVYVASNR--ETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYIYLEY  423 (721)
Q Consensus       346 k~LG~G~fG~VY~a~~~--~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~yLVmEy  423 (721)
                      +.||+|+||.||+|...  .++..+|+|.+...    ........+.+|+.++++++||||+++++++.+....++||||
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~----~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   76 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVS----ASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEF   76 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCC----CChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEEC
Confidence            36899999999999754  45678999987532    1223345788899999999999999999999998999999999


Q ss_pred             ccCCCHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCCcc-
Q 004959          424 VHPGSINKYVREHC----GAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKA-  498 (721)
Q Consensus       424 ~~gGsL~~~L~~~~----~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~~~-  498 (721)
                      +.+|+|.+++....    ..+++..+..++.||+.||+|||++||+|+||||+|||++.++.+||+|||++........ 
T Consensus        77 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~  156 (269)
T cd05087          77 CPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYY  156 (269)
T ss_pred             CCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccccccccCccee
Confidence            99999999996532    2456778889999999999999999999999999999999999999999999975433221 


Q ss_pred             --cccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhh-CCCCCCchhhHHHHHHHhhc-C-----CCCC
Q 004959          499 --DLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFKVMRD-T-----PAIP  569 (721)
Q Consensus       499 --~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLt-G~~PF~~~~~~~~~~ki~~~-~-----~~~p  569 (721)
                        .....|+..|+|||++.+.........++.++|||||||++|||++ |..||......+........ .     +.+.
T Consensus       157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (269)
T cd05087         157 VTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPRLK  236 (269)
T ss_pred             ecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCCCccC
Confidence              1224578889999998532111111245678999999999999996 99999775544443332221 1     2222


Q ss_pred             CCCCHHHHHHHHHhcccCCCCCCCHHHHHh
Q 004959          570 DSLSPEGKDFLRCCFQRNPADRPPASLLLE  599 (721)
Q Consensus       570 ~~lS~el~dLI~~cL~~DP~kRPSa~eLL~  599 (721)
                      ...++.+.++|++|| .+|++|||++||+.
T Consensus       237 ~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~  265 (269)
T cd05087         237 LPLSDRWYEVMQFCW-LQPEQRPSAEEVHL  265 (269)
T ss_pred             CCCChHHHHHHHHHh-cCcccCCCHHHHHH
Confidence            356889999999999 68999999999974

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=9.3e-39  Score=375.53  Aligned_cols=150  Identities=31%  Similarity=0.510  Sum_probs=136.9

Q ss_pred             CCCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeEE
Q 004959          339 NSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFY  418 (721)
Q Consensus       339 ~~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~y  418 (721)
                      .++|++++.||+|+||.||+|.+..+++.||||++...  ..........+..|+.++..++|+||+++++++...+.+|
T Consensus         3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~--~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~   80 (669)
T cd05610           3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKA--DMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVY   80 (669)
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehh--hccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEE
Confidence            35899999999999999999999999999999998632  2233455678899999999999999999999999999999


Q ss_pred             EEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCcc
Q 004959          419 IYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAK  491 (721)
Q Consensus       419 LVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~  491 (721)
                      |||||+.|++|.+++... +.+++..++.|+.||+.||.|||.+|||||||||+||||+.++.+||+|||+++
T Consensus        81 lVmEy~~g~~L~~li~~~-~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGls~  152 (669)
T cd05610          81 LVMEYLIGGDVKSLLHIY-GYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSK  152 (669)
T ss_pred             EEEeCCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence            999999999999999764 678999999999999999999999999999999999999999999999999875

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=7.5e-39  Score=329.63  Aligned_cols=246  Identities=26%  Similarity=0.476  Sum_probs=204.6

Q ss_pred             CCCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeEE
Q 004959          339 NSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFY  418 (721)
Q Consensus       339 ~~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~y  418 (721)
                      .++|++++.||+|+||.||+|... +++.||+|.+....   .   ..+.+.+|+.+|++++|+||+++++++ ..+..|
T Consensus         5 ~~~~~~~~~ig~G~~g~v~~~~~~-~~~~~a~K~~~~~~---~---~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~   76 (260)
T cd05067           5 RETLKLVKKLGAGQFGEVWMGYYN-GHTKVAIKSLKQGS---M---SPEAFLAEANLMKQLQHPRLVRLYAVV-TQEPIY   76 (260)
T ss_pred             hHHceeeeeeccCccceEEeeecC-CCceEEEEEecCCC---C---cHHHHHHHHHHHHhcCCcCeeeEEEEE-ccCCcE
Confidence            457999999999999999999865 57889999875321   1   135788999999999999999999986 456789


Q ss_pred             EEEeeccCCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCCc
Q 004959          419 IYLEYVHPGSINKYVREH-CGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQK  497 (721)
Q Consensus       419 LVmEy~~gGsL~~~L~~~-~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~~  497 (721)
                      +||||+.+++|.+++... ...+++..+..++.||+.||+|||+.|++||||||+||+++.++.++|+|||++..+....
T Consensus        77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~  156 (260)
T cd05067          77 IITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNE  156 (260)
T ss_pred             EEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCcceeecCCCC
Confidence            999999999999998654 3468999999999999999999999999999999999999999999999999997765322


Q ss_pred             cc--ccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhh-CCCCCCchhhHHHHHHHhhc-CCCCCCCCC
Q 004959          498 AD--LSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFKVMRD-TPAIPDSLS  573 (721)
Q Consensus       498 ~~--~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLt-G~~PF~~~~~~~~~~ki~~~-~~~~p~~lS  573 (721)
                      ..  ....++..|+|||++.       ...++.++|||||||++|||++ |+.||.+....+....+... ....+..++
T Consensus       157 ~~~~~~~~~~~~y~~pe~~~-------~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (260)
T cd05067         157 YTAREGAKFPIKWTAPEAIN-------YGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRMPRPDNCP  229 (260)
T ss_pred             cccccCCcccccccCHHHhc-------cCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCCCCCCCC
Confidence            11  2234667899999984       3446678999999999999999 99999876655555444333 234556788


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHHh
Q 004959          574 PEGKDFLRCCFQRNPADRPPASLLLE  599 (721)
Q Consensus       574 ~el~dLI~~cL~~DP~kRPSa~eLL~  599 (721)
                      .++.++|.+||..+|++||++++++.
T Consensus       230 ~~~~~li~~~l~~~p~~Rp~~~~l~~  255 (260)
T cd05067         230 EELYELMRLCWKEKPEERPTFEYLRS  255 (260)
T ss_pred             HHHHHHHHHHccCChhhCCCHHHHHH
Confidence            99999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=6.4e-39  Score=331.77  Aligned_cols=245  Identities=27%  Similarity=0.466  Sum_probs=202.8

Q ss_pred             CCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeEEE
Q 004959          340 SQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYI  419 (721)
Q Consensus       340 ~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~yL  419 (721)
                      .+|++++.||+|+||.||+|.+..+ ..||+|++...  . .   ..+.+.+|+.+++.++|+||+++++++. ++..|+
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~--~-~---~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~l   77 (262)
T cd05071           6 ESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPG--T-M---SPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYI   77 (262)
T ss_pred             HHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccC--c-c---CHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEE
Confidence            5799999999999999999988765 46999987531  1 1   1246889999999999999999999764 566899


Q ss_pred             EEeeccCCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCCcc
Q 004959          420 YLEYVHPGSINKYVREH-CGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKA  498 (721)
Q Consensus       420 VmEy~~gGsL~~~L~~~-~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~~~  498 (721)
                      ||||+.+|+|.+++... ...+++..+..++.||+.||+|||++||+|+||||+|||++.++.+||+|||++..+.....
T Consensus        78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~  157 (262)
T cd05071          78 VTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY  157 (262)
T ss_pred             EEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCceeecccccc
Confidence            99999999999999764 34589999999999999999999999999999999999999999999999999986643322


Q ss_pred             c--ccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhh-CCCCCCchhhHHHHHHHhhcC-CCCCCCCCH
Q 004959          499 D--LSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFKVMRDT-PAIPDSLSP  574 (721)
Q Consensus       499 ~--~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLt-G~~PF~~~~~~~~~~ki~~~~-~~~p~~lS~  574 (721)
                      .  ....++..|+|||++.       ...++.++|||||||++|+|++ |..||.+....+....+.... ...+..++.
T Consensus       158 ~~~~~~~~~~~y~~PE~~~-------~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (262)
T cd05071         158 TARQGAKFPIKWTAPEAAL-------YGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPE  230 (262)
T ss_pred             ccccCCcccceecCHhHhc-------cCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcCCCCCCccccCH
Confidence            1  1234667899999884       3446778999999999999999 899998766555555544332 234566889


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHHh
Q 004959          575 EGKDFLRCCFQRNPADRPPASLLLE  599 (721)
Q Consensus       575 el~dLI~~cL~~DP~kRPSa~eLL~  599 (721)
                      ++.+||.+||+.||++||++.++++
T Consensus       231 ~l~~li~~~l~~~p~~Rp~~~~~~~  255 (262)
T cd05071         231 SLHDLMCQCWRKEPEERPTFEYLQA  255 (262)
T ss_pred             HHHHHHHHHccCCcccCCCHHHHHH
Confidence            9999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.1e-38  Score=325.75  Aligned_cols=243  Identities=26%  Similarity=0.449  Sum_probs=203.3

Q ss_pred             eEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeEEEEEeecc
Q 004959          346 KLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYIYLEYVH  425 (721)
Q Consensus       346 k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~yLVmEy~~  425 (721)
                      +.||+|+||.||+|.+.. ++.||+|.+...    ......+.+.+|+.+++++.|+||+++++++......|+||||+.
T Consensus         1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~----~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~   75 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRST----LPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVP   75 (251)
T ss_pred             CccccCCCceEEEEEEeC-CCcEEEEecccc----CCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCC
Confidence            379999999999999887 999999987532    122456788999999999999999999999999999999999999


Q ss_pred             CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCCccc---ccC
Q 004959          426 PGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKAD---LSM  502 (721)
Q Consensus       426 gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~~~~---~s~  502 (721)
                      |++|.+++......+++..+..++.|++.||.|||++||+||||||+||||+.++.+||+|||++.........   ...
T Consensus        76 ~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~  155 (251)
T cd05041          76 GGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLK  155 (251)
T ss_pred             CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccC
Confidence            99999999776567899999999999999999999999999999999999999999999999999865422211   112


Q ss_pred             CCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhh-CCCCCCchhhHHHHHHHhhc-CCCCCCCCCHHHHHHH
Q 004959          503 KGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFKVMRD-TPAIPDSLSPEGKDFL  580 (721)
Q Consensus       503 ~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLt-G~~PF~~~~~~~~~~ki~~~-~~~~p~~lS~el~dLI  580 (721)
                      .++..|+|||.+.+       ..++.++|||||||++|+|++ |..||...........+... ....+..++.++.+||
T Consensus       156 ~~~~~y~~PE~~~~-------~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  228 (251)
T cd05041         156 QIPIKWTAPEALNY-------GRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYRMPAPQLCPEEIYRLM  228 (251)
T ss_pred             cceeccCChHhhcc-------CCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCCCCCCCccCCHHHHHHH
Confidence            34567999999843       346678999999999999998 89999776544444443332 2345667889999999


Q ss_pred             HHhcccCCCCCCCHHHHHhc
Q 004959          581 RCCFQRNPADRPPASLLLEH  600 (721)
Q Consensus       581 ~~cL~~DP~kRPSa~eLL~H  600 (721)
                      .+||+.+|++||++.|+++.
T Consensus       229 ~~~l~~~p~~Rp~~~ell~~  248 (251)
T cd05041         229 LQCWAYDPENRPSFSEIYNE  248 (251)
T ss_pred             HHHhccChhhCcCHHHHHHH
Confidence            99999999999999999863

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.1e-38  Score=327.76  Aligned_cols=247  Identities=26%  Similarity=0.456  Sum_probs=207.9

Q ss_pred             CCCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeEE
Q 004959          339 NSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFY  418 (721)
Q Consensus       339 ~~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~y  418 (721)
                      .++|++.+.||+|+||.||+|.+. .++.||||.+...   ..   ..+.+.+|+.+++.++|+||+++++++......+
T Consensus         5 ~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~---~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   77 (261)
T cd05034           5 RESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPG---TM---SPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIY   77 (261)
T ss_pred             hhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCC---cc---CHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceE
Confidence            358999999999999999999875 4578999987521   11   2356889999999999999999999999889999


Q ss_pred             EEEeeccCCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCCc
Q 004959          419 IYLEYVHPGSINKYVREHC-GAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQK  497 (721)
Q Consensus       419 LVmEy~~gGsL~~~L~~~~-~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~~  497 (721)
                      +||||+.+++|.+++.... ..+++..+..++.||+.||.|||++||+|+||||+||+|+.++.+||+|||++..+....
T Consensus        78 ~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~  157 (261)
T cd05034          78 IVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDE  157 (261)
T ss_pred             EEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECccccceeccchh
Confidence            9999999999999997653 468999999999999999999999999999999999999999999999999998664321


Q ss_pred             cc--ccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhh-CCCCCCchhhHHHHHHHhhcC-CCCCCCCC
Q 004959          498 AD--LSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFKVMRDT-PAIPDSLS  573 (721)
Q Consensus       498 ~~--~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLt-G~~PF~~~~~~~~~~ki~~~~-~~~p~~lS  573 (721)
                      ..  ....++..|+|||.+.       ...++.++|||||||++|+|++ |+.||.+......+..+.... ...+...+
T Consensus       158 ~~~~~~~~~~~~y~~PE~~~-------~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (261)
T cd05034         158 YTAREGAKFPIKWTAPEAAN-------YGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRMPRPPNCP  230 (261)
T ss_pred             hhhhhccCCCccccCHHHhc-------cCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCC
Confidence            11  1223457899999984       3456678999999999999998 999998876666666655442 34456678


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHHh
Q 004959          574 PEGKDFLRCCFQRNPADRPPASLLLE  599 (721)
Q Consensus       574 ~el~dLI~~cL~~DP~kRPSa~eLL~  599 (721)
                      .++.++|.+||+.||++||++.++++
T Consensus       231 ~~~~~~i~~~l~~~p~~Rp~~~~l~~  256 (261)
T cd05034         231 EELYDLMLQCWDKDPEERPTFEYLQS  256 (261)
T ss_pred             HHHHHHHHHHcccCcccCCCHHHHHH
Confidence            99999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=1.4e-38  Score=342.04  Aligned_cols=261  Identities=26%  Similarity=0.450  Sum_probs=211.5

Q ss_pred             CCCCCCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEe-c
Q 004959          336 LPMNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIV-E  414 (721)
Q Consensus       336 ~~l~~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~-~  414 (721)
                      ..+.++|++.+.||+|+||.||+|.+..+|+.||||++....   ......+.+.+|+.+++.++||||+++++++.. .
T Consensus         6 ~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~   82 (328)
T cd07856           6 FEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPF---STPVLAKRTYRELKLLKHLRHENIISLSDIFISPL   82 (328)
T ss_pred             eccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccc---cccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCC
Confidence            345678999999999999999999999999999999875321   122334677899999999999999999998865 5


Q ss_pred             CeEEEEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccC
Q 004959          415 DKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLT  494 (721)
Q Consensus       415 ~~~yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~  494 (721)
                      ...|+||||+ +++|..++..  ..+++..+..++.||+.||.|||++||+||||||.|||++.++.+||+|||++....
T Consensus        83 ~~~~lv~e~~-~~~L~~~~~~--~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~  159 (328)
T cd07856          83 EDIYFVTELL-GTDLHRLLTS--RPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQD  159 (328)
T ss_pred             CcEEEEeehh-ccCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCccccccccC
Confidence            6789999999 5789888864  468899999999999999999999999999999999999999999999999987543


Q ss_pred             CCcccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHh------------
Q 004959          495 GQKADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVM------------  562 (721)
Q Consensus       495 ~~~~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~------------  562 (721)
                      .  ......++..|+|||++.+      ...++.++|||||||++|+|++|+.||...........+.            
T Consensus       160 ~--~~~~~~~~~~y~aPE~~~~------~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~  231 (328)
T cd07856         160 P--QMTGYVSTRYYRAPEIMLT------WQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVIN  231 (328)
T ss_pred             C--CcCCCcccccccCceeeec------cCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence            2  2234568899999998742      2346778999999999999999999997654322111110            


Q ss_pred             -----------h---cCCC-----CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhccccccCCCCC
Q 004959          563 -----------R---DTPA-----IPDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQPD  610 (721)
Q Consensus       563 -----------~---~~~~-----~p~~lS~el~dLI~~cL~~DP~kRPSa~eLL~Hp~f~~~~~~~  610 (721)
                                 .   ....     ....++.++.++|++||+.+|++||++++++.|+||.....+.
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~~~~~  298 (328)
T cd07856         232 TICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYHDPT  298 (328)
T ss_pred             hccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCccccccCCc
Confidence                       0   0001     1134788999999999999999999999999999998776653

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=1.2e-38  Score=342.17  Aligned_cols=251  Identities=26%  Similarity=0.472  Sum_probs=207.3

Q ss_pred             CCCeeEeeEEeecCCeEEEEEEECC-------CCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhC-CCCCeeeeeee
Q 004959          339 NSQWQKGKLIGRGTFGSVYVASNRE-------TGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHL-KHPNIVQYYGS  410 (721)
Q Consensus       339 ~~~y~~~k~LG~G~fG~VY~a~~~~-------tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L-~HPnIV~l~g~  410 (721)
                      ..+|++++.||+|+||.||+|.+..       .+..||+|.+..    .......+.+.+|+.+++++ .|+||++++++
T Consensus        11 ~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~----~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~   86 (334)
T cd05100          11 RTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKD----DATDKDLSDLVSEMEMMKMIGKHKNIINLLGA   86 (334)
T ss_pred             HhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEccc----ccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEE
Confidence            3479999999999999999997643       234789997752    12334567889999999999 79999999999


Q ss_pred             EEecCeEEEEEeeccCCCHHHHHHHhc---------------CCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEE
Q 004959          411 EIVEDKFYIYLEYVHPGSINKYVREHC---------------GAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLL  475 (721)
Q Consensus       411 ~~~~~~~yLVmEy~~gGsL~~~L~~~~---------------~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNIL  475 (721)
                      +...+.+|+||||+.+|+|.+++....               ..++...+..++.||+.||.|||++||+||||||+|||
T Consensus        87 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nil  166 (334)
T cd05100          87 CTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVL  166 (334)
T ss_pred             EccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEE
Confidence            999999999999999999999997532               24778889999999999999999999999999999999


Q ss_pred             EcCCCceEEeecCCccccCCCcc---cccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhh-CCCCCCc
Q 004959          476 VDASGVVKLADFGMAKHLTGQKA---DLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSE  551 (721)
Q Consensus       476 ld~~g~VKL~DFGlA~~l~~~~~---~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLt-G~~PF~~  551 (721)
                      ++.++.+||+|||+++.+.....   .....++..|+|||++.       ...++.++|||||||+||||++ |..||.+
T Consensus       167 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-------~~~~~~~~Di~slG~il~el~~~g~~p~~~  239 (334)
T cd05100         167 VTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALF-------DRVYTHQSDVWSFGVLLWEIFTLGGSPYPG  239 (334)
T ss_pred             EcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhc-------cCCcCchhhhHHHHHHHHHHHhcCCCCCCC
Confidence            99999999999999986643221   11223456799999984       3456678999999999999998 8999988


Q ss_pred             hhhHHHHHHHhhc-CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q 004959          552 YEGAAAMFKVMRD-TPAIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEH  600 (721)
Q Consensus       552 ~~~~~~~~ki~~~-~~~~p~~lS~el~dLI~~cL~~DP~kRPSa~eLL~H  600 (721)
                      ....+....+... ....+..++.++.+||.+||+.+|++||++.|++++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~  289 (334)
T cd05100         240 IPVEELFKLLKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVED  289 (334)
T ss_pred             CCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence            7666655555443 234566788999999999999999999999999987

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=8.8e-39  Score=327.60  Aligned_cols=242  Identities=28%  Similarity=0.512  Sum_probs=202.4

Q ss_pred             eEEeecCCeEEEEEEECC-CC--cEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeEEEEEe
Q 004959          346 KLIGRGTFGSVYVASNRE-TG--ALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYIYLE  422 (721)
Q Consensus       346 k~LG~G~fG~VY~a~~~~-tg--~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~yLVmE  422 (721)
                      +.||+|+||.||+|.+.. .+  ..||||.+....   . ....+.+.+|+.++++++|+||+++++++.. ...++|||
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~---~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e   75 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDK---L-SDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTE   75 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcc---c-HHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEE
Confidence            368999999999998765 33  368999875321   1 1567889999999999999999999999888 89999999


Q ss_pred             eccCCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCCccc--
Q 004959          423 YVHPGSINKYVREHC-GAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKAD--  499 (721)
Q Consensus       423 y~~gGsL~~~L~~~~-~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~~~~--  499 (721)
                      |+.+++|.+++.... ..+++..++.++.||+.||.|||++|++|+||||+|||++.++.+||+|||++..+......  
T Consensus        76 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~  155 (257)
T cd05040          76 LAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYV  155 (257)
T ss_pred             ecCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEecccccccccccccccee
Confidence            999999999997754 56899999999999999999999999999999999999999999999999999876442211  


Q ss_pred             --ccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhh-CCCCCCchhhHHHHHHHhhc--CCCCCCCCCH
Q 004959          500 --LSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFKVMRD--TPAIPDSLSP  574 (721)
Q Consensus       500 --~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLt-G~~PF~~~~~~~~~~ki~~~--~~~~p~~lS~  574 (721)
                        ....++..|+|||++.       ...++.++|||||||++|+|++ |..||......+....+...  ....+..++.
T Consensus       156 ~~~~~~~~~~y~~pE~~~-------~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (257)
T cd05040         156 MEEHLKVPFAWCAPESLR-------TRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLERPEACPQ  228 (257)
T ss_pred             cccCCCCCceecCHHHhc-------ccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCcCCCCccCCH
Confidence              1245778899999984       3456778999999999999998 99999876665555544432  2234556789


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHHh
Q 004959          575 EGKDFLRCCFQRNPADRPPASLLLE  599 (721)
Q Consensus       575 el~dLI~~cL~~DP~kRPSa~eLL~  599 (721)
                      ++.++|.+||+.+|++||++.++++
T Consensus       229 ~~~~li~~~l~~~p~~Rps~~~~~~  253 (257)
T cd05040         229 DIYNVMLQCWAHNPADRPTFAALRE  253 (257)
T ss_pred             HHHHHHHHHCCCCcccCCCHHHHHH
Confidence            9999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=1.1e-38  Score=333.72  Aligned_cols=249  Identities=25%  Similarity=0.482  Sum_probs=206.7

Q ss_pred             CCeeEeeEEeecCCeEEEEEEEC-----CCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEec
Q 004959          340 SQWQKGKLIGRGTFGSVYVASNR-----ETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVE  414 (721)
Q Consensus       340 ~~y~~~k~LG~G~fG~VY~a~~~-----~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~  414 (721)
                      ++|++.+.||+|+||.||+|.+.     .++..||||++..    .......+.+.+|+.+++.+.||||+++++++.+.
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~----~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~   80 (288)
T cd05050           5 NNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKE----EASADMQADFQREAALMAEFDHPNIVKLLGVCAVG   80 (288)
T ss_pred             HhceecccccccccccEEEEEEcccCCCCcceeEEEEecCC----CcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCC
Confidence            57999999999999999999874     3678999998752    12234456788999999999999999999999999


Q ss_pred             CeEEEEEeeccCCCHHHHHHHhc---------------------CCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCc
Q 004959          415 DKFYIYLEYVHPGSINKYVREHC---------------------GAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGAN  473 (721)
Q Consensus       415 ~~~yLVmEy~~gGsL~~~L~~~~---------------------~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeN  473 (721)
                      +..|+||||+.+|+|.+++....                     ..+++..+..++.||+.||.|||++|++||||||.|
T Consensus        81 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~n  160 (288)
T cd05050          81 KPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRN  160 (288)
T ss_pred             CccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhh
Confidence            99999999999999999997532                     247788899999999999999999999999999999


Q ss_pred             EEEcCCCceEEeecCCccccCCCcc---cccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhh-CCCCC
Q 004959          474 LLVDASGVVKLADFGMAKHLTGQKA---DLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPW  549 (721)
Q Consensus       474 ILld~~g~VKL~DFGlA~~l~~~~~---~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLt-G~~PF  549 (721)
                      ||++.++.+||+|||++..+.....   .....++..|+|||.+.       ...++.++|||||||++|||++ |..||
T Consensus       161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-------~~~~~~~~Dv~slG~il~el~~~~~~p~  233 (288)
T cd05050         161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIF-------YNRYTTESDVWAYGVVLWEIFSYGMQPY  233 (288)
T ss_pred             eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHh-------cCCCCchhHHHHHHHHHHHHHhCCCCCC
Confidence            9999999999999999876543221   11223466799999884       3456778999999999999997 88999


Q ss_pred             CchhhHHHHHHHhhcC-CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHh
Q 004959          550 SEYEGAAAMFKVMRDT-PAIPDSLSPEGKDFLRCCFQRNPADRPPASLLLE  599 (721)
Q Consensus       550 ~~~~~~~~~~ki~~~~-~~~p~~lS~el~dLI~~cL~~DP~kRPSa~eLL~  599 (721)
                      .+....+....+.... ...+..++.++.+||.+||+.||++||++.|+++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~  284 (288)
T cd05050         234 YGMAHEEVIYYVRDGNVLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINR  284 (288)
T ss_pred             CCCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence            8766555555544332 2346678899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=1.5e-38  Score=329.25  Aligned_cols=249  Identities=25%  Similarity=0.429  Sum_probs=207.5

Q ss_pred             CCeeEeeEEeecCCeEEEEEEECCC---CcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCe
Q 004959          340 SQWQKGKLIGRGTFGSVYVASNRET---GALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDK  416 (721)
Q Consensus       340 ~~y~~~k~LG~G~fG~VY~a~~~~t---g~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~  416 (721)
                      .+|.+.+.||+|+||.||+|.+...   ...||||.+...    ......+.+.+|+.+++.+.|+||+++++++.+ +.
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~----~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~   80 (270)
T cd05056           6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNC----TSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NP   80 (270)
T ss_pred             hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCc----CCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CC
Confidence            4689999999999999999987644   457899977421    224456788999999999999999999998765 56


Q ss_pred             EEEEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCC
Q 004959          417 FYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQ  496 (721)
Q Consensus       417 ~yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~  496 (721)
                      .|+||||+.+|+|.+++......+++..+..++.||+.||.|||++|++|+||||+|||++.++.+||+|||++..+...
T Consensus        81 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~  160 (270)
T cd05056          81 VWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDE  160 (270)
T ss_pred             cEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCceeeecccc
Confidence            78999999999999999876557899999999999999999999999999999999999999999999999999876544


Q ss_pred             cccc--cCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhh-CCCCCCchhhHHHHHHHhhc-CCCCCCCC
Q 004959          497 KADL--SMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFKVMRD-TPAIPDSL  572 (721)
Q Consensus       497 ~~~~--s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLt-G~~PF~~~~~~~~~~ki~~~-~~~~p~~l  572 (721)
                      ....  ...++..|+|||.+.       ...++.++|||||||++|||++ |..||......+....+... ....+..+
T Consensus       161 ~~~~~~~~~~~~~y~aPE~~~-------~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  233 (270)
T cd05056         161 SYYKASKGKLPIKWMAPESIN-------FRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERLPMPPNC  233 (270)
T ss_pred             cceecCCCCccccccChhhhc-------cCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCcCCCCCCC
Confidence            2211  223456799999883       3456678999999999999986 99999887666655555443 33556788


Q ss_pred             CHHHHHHHHHhcccCCCCCCCHHHHHhc
Q 004959          573 SPEGKDFLRCCFQRNPADRPPASLLLEH  600 (721)
Q Consensus       573 S~el~dLI~~cL~~DP~kRPSa~eLL~H  600 (721)
                      +.++.++|.+||..+|++|||+.+++..
T Consensus       234 ~~~~~~li~~~l~~~P~~Rpt~~~~~~~  261 (270)
T cd05056         234 PPTLYSLMTKCWAYDPSKRPRFTELKAQ  261 (270)
T ss_pred             CHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            9999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=9.1e-39  Score=336.25  Aligned_cols=249  Identities=25%  Similarity=0.398  Sum_probs=201.8

Q ss_pred             CCeeEeeEEeecCCeEEEEEEECCCC--------------cEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCee
Q 004959          340 SQWQKGKLIGRGTFGSVYVASNRETG--------------ALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIV  405 (721)
Q Consensus       340 ~~y~~~k~LG~G~fG~VY~a~~~~tg--------------~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV  405 (721)
                      .+|++.+.||+|+||.||+|.+..++              ..||+|.+...    ........+.+|+++|++++|+||+
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~~ei~~l~~l~h~~i~   80 (295)
T cd05097           5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRAD----VTKTARNDFLKEIKIMSRLKNPNII   80 (295)
T ss_pred             HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCC----CCHHHHHHHHHHHHHHHhCCCCCcC
Confidence            47999999999999999999875432              35899987531    2234556789999999999999999


Q ss_pred             eeeeeEEecCeEEEEEeeccCCCHHHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcE
Q 004959          406 QYYGSEIVEDKFYIYLEYVHPGSINKYVREHC-----------GAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANL  474 (721)
Q Consensus       406 ~l~g~~~~~~~~yLVmEy~~gGsL~~~L~~~~-----------~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNI  474 (721)
                      ++++++...+..|+||||+.+++|.+++....           ..+++..+..++.||+.||.|||++|++||||||+||
T Consensus        81 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Ni  160 (295)
T cd05097          81 RLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNC  160 (295)
T ss_pred             eEEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhE
Confidence            99999999999999999999999999986431           1367888999999999999999999999999999999


Q ss_pred             EEcCCCceEEeecCCccccCCCccc---ccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhh--CCCCC
Q 004959          475 LVDASGVVKLADFGMAKHLTGQKAD---LSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT--GKPPW  549 (721)
Q Consensus       475 Lld~~g~VKL~DFGlA~~l~~~~~~---~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLt--G~~PF  549 (721)
                      |++.++.+||+|||++..+......   ....++..|+|||++.+       ..++.++|||||||++|+|++  |..||
T Consensus       161 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~DvwSlG~~l~el~~~~~~~p~  233 (295)
T cd05097         161 LVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILL-------GKFTTASDVWAFGVTLWEMFTLCKEQPY  233 (295)
T ss_pred             EEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhcc-------CCcCchhhHHHHHHHHHHHHHcCCCCCC
Confidence            9999999999999999765432211   12335678999999843       446778999999999999988  67888


Q ss_pred             CchhhHHHHHHHhh--------cCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHh
Q 004959          550 SEYEGAAAMFKVMR--------DTPAIPDSLSPEGKDFLRCCFQRNPADRPPASLLLE  599 (721)
Q Consensus       550 ~~~~~~~~~~ki~~--------~~~~~p~~lS~el~dLI~~cL~~DP~kRPSa~eLL~  599 (721)
                      ......+.+..+..        .....+..++..+.+||.+||+.||++||++.++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~  291 (295)
T cd05097         234 SLLSDEQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH  291 (295)
T ss_pred             cccChHHHHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence            76554443332211        112334567899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=1.3e-38  Score=327.29  Aligned_cols=244  Identities=26%  Similarity=0.490  Sum_probs=198.1

Q ss_pred             eEEeecCCeEEEEEEECC---CCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEE-ecCeEEEEE
Q 004959          346 KLIGRGTFGSVYVASNRE---TGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEI-VEDKFYIYL  421 (721)
Q Consensus       346 k~LG~G~fG~VY~a~~~~---tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~-~~~~~yLVm  421 (721)
                      ++||+|+||.||+|.+..   .+..||||.+..    .......+.+.+|+.+++.++||||+++++++. .++..|+||
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~----~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~   76 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNR----ITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVL   76 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCc----cCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEE
Confidence            478999999999998643   346799998742    123345678889999999999999999999765 456689999


Q ss_pred             eeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCCc----
Q 004959          422 EYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQK----  497 (721)
Q Consensus       422 Ey~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~~----  497 (721)
                      ||+.+|+|.+++......+.+..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.+....    
T Consensus        77 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~  156 (262)
T cd05058          77 PYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSV  156 (262)
T ss_pred             ecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCccccccccCCcceee
Confidence            9999999999997765667888889999999999999999999999999999999999999999999997654321    


Q ss_pred             -ccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhh-CCCCCCchhhHHHHHHHhhc-CCCCCCCCCH
Q 004959          498 -ADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFKVMRD-TPAIPDSLSP  574 (721)
Q Consensus       498 -~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLt-G~~PF~~~~~~~~~~ki~~~-~~~~p~~lS~  574 (721)
                       ......++..|+|||++.       ...++.++|||||||++|||++ |.+||......+....+... ....+..++.
T Consensus       157 ~~~~~~~~~~~y~aPE~~~-------~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (262)
T cd05058         157 HNHTGAKLPVKWMALESLQ-------TQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRRLLQPEYCPD  229 (262)
T ss_pred             cccccCcCCccccChhHhc-------cCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCCCCCCcCCH
Confidence             112334677899999984       3456778999999999999999 56777765555544444433 2334556789


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHHhc
Q 004959          575 EGKDFLRCCFQRNPADRPPASLLLEH  600 (721)
Q Consensus       575 el~dLI~~cL~~DP~kRPSa~eLL~H  600 (721)
                      .+.++|.+||+.+|++||++.++++.
T Consensus       230 ~~~~li~~cl~~~p~~Rp~~~~il~~  255 (262)
T cd05058         230 PLYEVMLSCWHPKPEMRPTFSELVSR  255 (262)
T ss_pred             HHHHHHHHHcCCChhhCCCHHHHHHH
Confidence            99999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=6.4e-39  Score=346.53  Aligned_cols=250  Identities=27%  Similarity=0.500  Sum_probs=202.1

Q ss_pred             CCeeEeeEEeecCCeEEEEEEE-----CCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhC-CCCCeeeeeeeEEe
Q 004959          340 SQWQKGKLIGRGTFGSVYVASN-----RETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHL-KHPNIVQYYGSEIV  413 (721)
Q Consensus       340 ~~y~~~k~LG~G~fG~VY~a~~-----~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L-~HPnIV~l~g~~~~  413 (721)
                      ++|++++.||+|+||+||+|.+     ..+++.||||++...    ........+.+|+.+|.++ +|+|||++++++..
T Consensus         7 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~   82 (343)
T cd05103           7 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG----ATHSEHRALMSELKILIHIGHHLNVVNLLGACTK   82 (343)
T ss_pred             hHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccC----CChHHHHHHHHHHHHHHhccCCccHhhhcceeec
Confidence            4799999999999999999974     356789999988531    2234456788999999999 68999999998765


Q ss_pred             c-CeEEEEEeeccCCCHHHHHHHhc-------------------------------------------------------
Q 004959          414 E-DKFYIYLEYVHPGSINKYVREHC-------------------------------------------------------  437 (721)
Q Consensus       414 ~-~~~yLVmEy~~gGsL~~~L~~~~-------------------------------------------------------  437 (721)
                      . ..+++|||||.+|+|.+++....                                                       
T Consensus        83 ~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (343)
T cd05103          83 PGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVE  162 (343)
T ss_pred             CCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccch
Confidence            4 56899999999999999986431                                                       


Q ss_pred             -----------CCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCCccc---ccCC
Q 004959          438 -----------GAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKAD---LSMK  503 (721)
Q Consensus       438 -----------~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~~~~---~s~~  503 (721)
                                 ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+......   ....
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~  242 (343)
T cd05103         163 EEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR  242 (343)
T ss_pred             hhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCC
Confidence                       23677888899999999999999999999999999999999999999999999865332211   1233


Q ss_pred             CCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhh-CCCCCCchhhHHHHHHHhhc--CCCCCCCCCHHHHHHH
Q 004959          504 GSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFKVMRD--TPAIPDSLSPEGKDFL  580 (721)
Q Consensus       504 GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLt-G~~PF~~~~~~~~~~ki~~~--~~~~p~~lS~el~dLI  580 (721)
                      ++..|+|||++.+       ..++.++|||||||++|+|++ |..||........+...+..  ....+..+++++.++|
T Consensus       243 ~~~~y~aPE~~~~-------~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (343)
T cd05103         243 LPLKWMAPETIFD-------RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTM  315 (343)
T ss_pred             CCcceECcHHhcC-------CCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCCCCCCCCCHHHHHHH
Confidence            5678999999843       456778999999999999997 99999765433333333322  2345566889999999


Q ss_pred             HHhcccCCCCCCCHHHHHhc
Q 004959          581 RCCFQRNPADRPPASLLLEH  600 (721)
Q Consensus       581 ~~cL~~DP~kRPSa~eLL~H  600 (721)
                      .+||+.||++||++.||++|
T Consensus       316 ~~cl~~~p~~Rps~~eil~~  335 (343)
T cd05103         316 LDCWHGEPSQRPTFSELVEH  335 (343)
T ss_pred             HHHccCChhhCcCHHHHHHH
Confidence            99999999999999999987

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=1.7e-38  Score=331.48  Aligned_cols=247  Identities=27%  Similarity=0.464  Sum_probs=198.2

Q ss_pred             CCe-eEeeEEeecCCeEEEEEE----ECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEec
Q 004959          340 SQW-QKGKLIGRGTFGSVYVAS----NRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVE  414 (721)
Q Consensus       340 ~~y-~~~k~LG~G~fG~VY~a~----~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~  414 (721)
                      ++| ++.+.||+|+||+||++.    ...++..||+|.+...    ......+.+.+|+.+|+.++||||+++++++...
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   78 (283)
T cd05080           3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRE----CGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQ   78 (283)
T ss_pred             hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccc----cChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC
Confidence            455 899999999999998764    4457889999987532    1223456788999999999999999999987653


Q ss_pred             --CeEEEEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccc
Q 004959          415 --DKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKH  492 (721)
Q Consensus       415 --~~~yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~  492 (721)
                        ..+|+||||+.+++|.+++..  ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus        79 ~~~~~~lv~e~~~~~~l~~~~~~--~~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~  156 (283)
T cd05080          79 GGKGLQLIMEYVPLGSLRDYLPK--HKLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKA  156 (283)
T ss_pred             CCceEEEEecCCCCCCHHHHHHH--cCCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeecccccc
Confidence              468999999999999999975  4699999999999999999999999999999999999999999999999999987


Q ss_pred             cCCCccc----ccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhH-H-----------
Q 004959          493 LTGQKAD----LSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGA-A-----------  556 (721)
Q Consensus       493 l~~~~~~----~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~-~-----------  556 (721)
                      +......    ....++..|+|||++.       ...++.++|||||||++|+|++|..||...... .           
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~PE~~~-------~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~  229 (283)
T cd05080         157 VPEGHEYYRVREDGDSPVFWYAVECLK-------ENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMT  229 (283)
T ss_pred             cCCcchhhccCCCCCCCceeeCHhHhc-------ccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccc
Confidence            6543221    1234667799999984       345667899999999999999999998643211 0           


Q ss_pred             --HHHHHhh--cCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHh
Q 004959          557 --AMFKVMR--DTPAIPDSLSPEGKDFLRCCFQRNPADRPPASLLLE  599 (721)
Q Consensus       557 --~~~ki~~--~~~~~p~~lS~el~dLI~~cL~~DP~kRPSa~eLL~  599 (721)
                        .+.....  .....+..++.++.+++.+||+.||++||++.++++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~  276 (283)
T cd05080         230 VVRLIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIP  276 (283)
T ss_pred             hhhhhhhhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence              0011111  112335667899999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=1.2e-38  Score=333.10  Aligned_cols=249  Identities=27%  Similarity=0.476  Sum_probs=201.8

Q ss_pred             CeeEeeEEeecCCeEEEEEEE----CCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEec--
Q 004959          341 QWQKGKLIGRGTFGSVYVASN----RETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVE--  414 (721)
Q Consensus       341 ~y~~~k~LG~G~fG~VY~a~~----~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~--  414 (721)
                      -|++.+.||+|+||.||+|..    ..++..||+|.+...    ......+.+.+|+.+|+.+.|+||+++++++...  
T Consensus         5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~----~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (284)
T cd05079           5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPE----SGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGG   80 (284)
T ss_pred             hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCcc----ccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCC
Confidence            478999999999999999974    567899999987521    2234456899999999999999999999988775  


Q ss_pred             CeEEEEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccC
Q 004959          415 DKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLT  494 (721)
Q Consensus       415 ~~~yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~  494 (721)
                      ...++||||++|++|.+++......+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++..+.
T Consensus        81 ~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~  160 (284)
T cd05079          81 NGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIE  160 (284)
T ss_pred             CceEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCccccccc
Confidence            56899999999999999997665578999999999999999999999999999999999999999999999999998765


Q ss_pred             CCccc----ccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchh--------------hHH
Q 004959          495 GQKAD----LSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYE--------------GAA  556 (721)
Q Consensus       495 ~~~~~----~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~--------------~~~  556 (721)
                      .....    ....|+..|+|||++.+       ..++.++|||||||++|+|+++..|+....              ...
T Consensus       161 ~~~~~~~~~~~~~~~~~y~apE~~~~-------~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (284)
T cd05079         161 TDKEYYTVKDDLDSPVFWYAPECLIQ-------SKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVT  233 (284)
T ss_pred             cCccceeecCCCCCCccccCHHHhcc-------CCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHH
Confidence            43221    23457778999999842       346678999999999999999876643210              011


Q ss_pred             HHHHHhhc--CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q 004959          557 AMFKVMRD--TPAIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEH  600 (721)
Q Consensus       557 ~~~ki~~~--~~~~p~~lS~el~dLI~~cL~~DP~kRPSa~eLL~H  600 (721)
                      ........  ....+..++.++.+||.+||+.||++||++.+++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~  279 (284)
T cd05079         234 RLVRVLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEG  279 (284)
T ss_pred             HHHHHHHcCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence            11111111  223456789999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=1.6e-38  Score=334.61  Aligned_cols=249  Identities=25%  Similarity=0.408  Sum_probs=201.3

Q ss_pred             CCeeEeeEEeecCCeEEEEEEECC----------------CCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCC
Q 004959          340 SQWQKGKLIGRGTFGSVYVASNRE----------------TGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPN  403 (721)
Q Consensus       340 ~~y~~~k~LG~G~fG~VY~a~~~~----------------tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPn  403 (721)
                      ++|++.+.||+|+||.||+|.+..                ++..||+|.+...    ......+.+.+|+.+|+.++|+|
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~----~~~~~~~~~~~E~~~l~~l~~~~   80 (296)
T cd05095           5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLRED----ANKNARNDFLKEIKIMSRLKDPN   80 (296)
T ss_pred             hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEecccc----CCHHHHHHHHHHHHHHHhCCCCC
Confidence            469999999999999999985432                3457899987521    23344568899999999999999


Q ss_pred             eeeeeeeEEecCeEEEEEeeccCCCHHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCc
Q 004959          404 IVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHC----------GAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGAN  473 (721)
Q Consensus       404 IV~l~g~~~~~~~~yLVmEy~~gGsL~~~L~~~~----------~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeN  473 (721)
                      |+++++++...+..|+||||+.+++|.+++....          ..+++..+..++.||+.||.|||++||+||||||+|
T Consensus        81 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~N  160 (296)
T cd05095          81 IIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRN  160 (296)
T ss_pred             cceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChhe
Confidence            9999999999999999999999999999997542          236778899999999999999999999999999999


Q ss_pred             EEEcCCCceEEeecCCccccCCCcc---cccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhh--CCCC
Q 004959          474 LLVDASGVVKLADFGMAKHLTGQKA---DLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT--GKPP  548 (721)
Q Consensus       474 ILld~~g~VKL~DFGlA~~l~~~~~---~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLt--G~~P  548 (721)
                      ||++.++.++|+|||++..+.....   .....++..|++||++.+       ..++.++|||||||++|||++  |..|
T Consensus       161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-------~~~~~~~DiwSlG~~l~el~~~~~~~p  233 (296)
T cd05095         161 CLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILL-------GKFTTASDVWAFGVTLWEILTLCKEQP  233 (296)
T ss_pred             EEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhc-------CCccchhhhhHHHHHHHHHHHhCCCCC
Confidence            9999999999999999986543321   112334678999998743       346778999999999999998  7889


Q ss_pred             CCchhhHHHHHHHh--------hcCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHh
Q 004959          549 WSEYEGAAAMFKVM--------RDTPAIPDSLSPEGKDFLRCCFQRNPADRPPASLLLE  599 (721)
Q Consensus       549 F~~~~~~~~~~ki~--------~~~~~~p~~lS~el~dLI~~cL~~DP~kRPSa~eLL~  599 (721)
                      |......+.+....        ......+..++..+.+||.+||+.||++||++.+|++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~  292 (296)
T cd05095         234 YSQLSDEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHA  292 (296)
T ss_pred             ccccChHHHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            97654444332221        1112334567899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=1.7e-38  Score=376.60  Aligned_cols=252  Identities=23%  Similarity=0.343  Sum_probs=205.3

Q ss_pred             CCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeEEE
Q 004959          340 SQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYI  419 (721)
Q Consensus       340 ~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~yL  419 (721)
                      ++|++++.||+|+||.||+|.+..+|+.||||++...  ........+++.+|+.+++.++|||||++++++.+.+..|+
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~--l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyL   79 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIRED--LSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYY   79 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcc--cccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEE
Confidence            4799999999999999999999999999999998632  12233456678999999999999999999999999999999


Q ss_pred             EEeeccCCCHHHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCC
Q 004959          420 YLEYVHPGSINKYVREH----------CGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGM  489 (721)
Q Consensus       420 VmEy~~gGsL~~~L~~~----------~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGl  489 (721)
                      ||||++||+|.+++...          ...++...+..++.||+.||+|||++||+||||||+|||++.+|.+||+|||+
T Consensus        80 VMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiDFGL  159 (932)
T PRK13184         80 TMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGA  159 (932)
T ss_pred             EEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEEEecCc
Confidence            99999999999998642          12355677889999999999999999999999999999999999999999999


Q ss_pred             ccccCCCc-------------------ccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCC
Q 004959          490 AKHLTGQK-------------------ADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWS  550 (721)
Q Consensus       490 A~~l~~~~-------------------~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~  550 (721)
                      +.......                   .....+||+.|||||++.       +..++.++|||||||++|||++|..||.
T Consensus       160 Ak~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~-------g~~~S~kSDIWSLGVILyELLTG~~PF~  232 (932)
T PRK13184        160 AIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLL-------GVPASESTDIYALGVILYQMLTLSFPYR  232 (932)
T ss_pred             ceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhc-------CCCCCcHhHHHHHHHHHHHHHHCCCCCC
Confidence            98652110                   011246999999999984       3456778999999999999999999998


Q ss_pred             chhhHHHHHHHhhcC-CC--CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q 004959          551 EYEGAAAMFKVMRDT-PA--IPDSLSPEGKDFLRCCFQRNPADRPPASLLLEH  600 (721)
Q Consensus       551 ~~~~~~~~~ki~~~~-~~--~p~~lS~el~dLI~~cL~~DP~kRPSa~eLL~H  600 (721)
                      ............... ..  ....+++.+.+++.+||+.||++|++..+.+.+
T Consensus       233 ~~~~~ki~~~~~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~  285 (932)
T PRK13184        233 RKKGRKISYRDVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQ  285 (932)
T ss_pred             CcchhhhhhhhhccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            755443332221111 11  123678999999999999999999887665544

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=2.6e-38  Score=329.04  Aligned_cols=250  Identities=24%  Similarity=0.392  Sum_probs=206.9

Q ss_pred             CCCeeEeeEEeecCCeEEEEEEECC----CCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEe-
Q 004959          339 NSQWQKGKLIGRGTFGSVYVASNRE----TGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIV-  413 (721)
Q Consensus       339 ~~~y~~~k~LG~G~fG~VY~a~~~~----tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~-  413 (721)
                      .++|++.++||+|+||.||+|.+..    ++..|++|.+.    ........+.+.+|+.+|+.+.|+||+++++++.. 
T Consensus         5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~----~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~   80 (280)
T cd05043           5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVK----DHASEIQVTLLLQESCLLYGLSHQNILPILHVCIED   80 (280)
T ss_pred             hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEcc----CCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecC
Confidence            4589999999999999999999876    36889999864    22344556788999999999999999999998765 


Q ss_pred             cCeEEEEEeeccCCCHHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEee
Q 004959          414 EDKFYIYLEYVHPGSINKYVREHC-------GAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLAD  486 (721)
Q Consensus       414 ~~~~yLVmEy~~gGsL~~~L~~~~-------~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~D  486 (721)
                      ....++++||+.+++|.+++....       ..+++..+..++.||+.||+|||+++++|+||||+|||++.++.+||+|
T Consensus        81 ~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~kl~d  160 (280)
T cd05043          81 GEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITD  160 (280)
T ss_pred             CCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcEEECC
Confidence            567899999999999999986532       4589999999999999999999999999999999999999999999999


Q ss_pred             cCCccccCCCccc---ccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhh-CCCCCCchhhHHHHHHHh
Q 004959          487 FGMAKHLTGQKAD---LSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFKVM  562 (721)
Q Consensus       487 FGlA~~l~~~~~~---~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLt-G~~PF~~~~~~~~~~ki~  562 (721)
                      ||+++.+......   ....++..|+|||++.+       ..++.++|||||||++|||++ |+.||......+....+.
T Consensus       161 ~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~-------~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~  233 (280)
T cd05043         161 NALSRDLFPMDYHCLGDNENRPVKWMALESLVN-------KEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLK  233 (280)
T ss_pred             CCCcccccCCceEEeCCCCCcchhccCHHHHhc-------CCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHH
Confidence            9999876433221   22346778999999843       446778999999999999998 999998766555444333


Q ss_pred             hcC-CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHh
Q 004959          563 RDT-PAIPDSLSPEGKDFLRCCFQRNPADRPPASLLLE  599 (721)
Q Consensus       563 ~~~-~~~p~~lS~el~dLI~~cL~~DP~kRPSa~eLL~  599 (721)
                      ... ...+..+++++.++|.+||..||++||++.++++
T Consensus       234 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~  271 (280)
T cd05043         234 DGYRLAQPINCPDELFAVMACCWALDPEERPSFSQLVQ  271 (280)
T ss_pred             cCCCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence            332 2334557899999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=1.1e-38  Score=333.28  Aligned_cols=239  Identities=21%  Similarity=0.357  Sum_probs=194.7

Q ss_pred             EEeecCCeEEEEEEECCC------------------------CcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCC
Q 004959          347 LIGRGTFGSVYVASNRET------------------------GALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHP  402 (721)
Q Consensus       347 ~LG~G~fG~VY~a~~~~t------------------------g~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HP  402 (721)
                      +||+|+||.||+|....+                        ...|++|.+..     ........+.+|+.+++.++||
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~-----~~~~~~~~~~~~~~~~~~l~h~   76 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDP-----SHRDIALAFFETASLMSQVSHI   76 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecCh-----HHHHHHHHHHHHHHHHhcCCCC
Confidence            699999999999974322                        24578887642     2233456788899999999999


Q ss_pred             CeeeeeeeEEecCeEEEEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCC--
Q 004959          403 NIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASG--  480 (721)
Q Consensus       403 nIV~l~g~~~~~~~~yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g--  480 (721)
                      ||+++++++......|+||||+++|+|..++....+.+++..+..++.||+.||+|||++||+||||||+|||++..+  
T Consensus        77 niv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~  156 (274)
T cd05076          77 HLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLA  156 (274)
T ss_pred             CeeeEEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCcc
Confidence            999999999999999999999999999999977667899999999999999999999999999999999999997654  


Q ss_pred             -----ceEEeecCCccccCCCcccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHh-hCCCCCCchhh
Q 004959          481 -----VVKLADFGMAKHLTGQKADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMY-TGKPPWSEYEG  554 (721)
Q Consensus       481 -----~VKL~DFGlA~~l~~~~~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELL-tG~~PF~~~~~  554 (721)
                           .+||+|||++......   ....++..|+|||++.+      ...++.++|||||||++|||+ +|..||.....
T Consensus       157 ~~~~~~~kl~d~g~~~~~~~~---~~~~~~~~~~aPe~~~~------~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~  227 (274)
T cd05076         157 EGTSPFIKLSDPGVSFTALSR---EERVERIPWIAPECVPG------GNSLSTAADKWSFGTTLLEICFDGEVPLKERTP  227 (274)
T ss_pred             cCccceeeecCCccccccccc---cccccCCcccCchhhcC------CCCCCcHHHHHHHHHHHHHHHhCCCCCccccCh
Confidence                 3899999988654322   22357888999998842      245677899999999999985 69999977544


Q ss_pred             HHHHHHHhhcCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q 004959          555 AAAMFKVMRDTPAIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEH  600 (721)
Q Consensus       555 ~~~~~ki~~~~~~~p~~lS~el~dLI~~cL~~DP~kRPSa~eLL~H  600 (721)
                      .+. .........++...+.++.++|.+||+.+|++||++.+++++
T Consensus       228 ~~~-~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~  272 (274)
T cd05076         228 SEK-ERFYEKKHRLPEPSCKELATLISQCLTYEPTQRPSFRTILRD  272 (274)
T ss_pred             HHH-HHHHHhccCCCCCCChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence            332 223333445566677899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=2.6e-38  Score=329.79  Aligned_cols=249  Identities=28%  Similarity=0.523  Sum_probs=200.5

Q ss_pred             CCeeEeeEEeecCCeEEEEEE----ECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEe--
Q 004959          340 SQWQKGKLIGRGTFGSVYVAS----NRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIV--  413 (721)
Q Consensus       340 ~~y~~~k~LG~G~fG~VY~a~----~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~--  413 (721)
                      ..|++.+.||+|+||.||+|.    +..+++.||||.+..     ......+.+.+|+++|+.++||||+++++++..  
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~-----~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~   78 (284)
T cd05081           4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQH-----STAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAG   78 (284)
T ss_pred             ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEecc-----CCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCC
Confidence            478999999999999999997    446789999998753     234456788999999999999999999997654  


Q ss_pred             cCeEEEEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCcccc
Q 004959          414 EDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHL  493 (721)
Q Consensus       414 ~~~~yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l  493 (721)
                      ...+++||||+.+++|.+++......+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+
T Consensus        79 ~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~  158 (284)
T cd05081          79 RRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVL  158 (284)
T ss_pred             CCceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCcccccc
Confidence            34689999999999999999766567999999999999999999999999999999999999999999999999999876


Q ss_pred             CCCccc----ccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhH--------------
Q 004959          494 TGQKAD----LSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGA--------------  555 (721)
Q Consensus       494 ~~~~~~----~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~--------------  555 (721)
                      ......    ....++..|+|||++.+       ..++.++|||||||++|||++|..++......              
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (284)
T cd05081         159 PQDKEYYKVREPGESPIFWYAPESLTE-------SKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMI  231 (284)
T ss_pred             cCCCcceeecCCCCCceEeeCHHHhcc-------CCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccc
Confidence            443221    11224456999999843       44677899999999999999987776432111              


Q ss_pred             -HHHHHHhhcC--CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q 004959          556 -AAMFKVMRDT--PAIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEH  600 (721)
Q Consensus       556 -~~~~ki~~~~--~~~p~~lS~el~dLI~~cL~~DP~kRPSa~eLL~H  600 (721)
                       ..+..++...  ...+..++.++.+||.+||..+|++|||+.|+++.
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~  279 (284)
T cd05081         232 VYHLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQ  279 (284)
T ss_pred             hHHHHHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHH
Confidence             0111122221  23345688999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=1.9e-38  Score=329.05  Aligned_cols=240  Identities=21%  Similarity=0.367  Sum_probs=194.2

Q ss_pred             eEEeecCCeEEEEEEECC------------CCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEe
Q 004959          346 KLIGRGTFGSVYVASNRE------------TGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIV  413 (721)
Q Consensus       346 k~LG~G~fG~VY~a~~~~------------tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~  413 (721)
                      +.||+|+||+||+|+...            ....|++|.+..     ........+.+|+.+++.++||||+++++++..
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~-----~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~   75 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDP-----SHRDISLAFFETASMMRQVSHKHIVLLYGVCVR   75 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecCh-----hhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence            368999999999997532            233588887642     223445678889999999999999999999999


Q ss_pred             cCeEEEEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCc-------eEEee
Q 004959          414 EDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGV-------VKLAD  486 (721)
Q Consensus       414 ~~~~yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~-------VKL~D  486 (721)
                      ....++||||+.+|+|..++......+++..++.++.||+.||+|||++||+||||||+||||+.++.       +||+|
T Consensus        76 ~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d  155 (262)
T cd05077          76 DVENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSD  155 (262)
T ss_pred             CCCCEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCC
Confidence            89999999999999999988766677999999999999999999999999999999999999987664       89999


Q ss_pred             cCCccccCCCcccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHh-hCCCCCCchhhHHHHHHHhhcC
Q 004959          487 FGMAKHLTGQKADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMY-TGKPPWSEYEGAAAMFKVMRDT  565 (721)
Q Consensus       487 FGlA~~l~~~~~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELL-tG~~PF~~~~~~~~~~ki~~~~  565 (721)
                      ||++..+...   ....|+..|+|||++..      ...++.++|||||||++|||+ .|..||......+. .......
T Consensus       156 ~g~~~~~~~~---~~~~~~~~y~aPE~~~~------~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~-~~~~~~~  225 (262)
T cd05077         156 PGIPITVLSR---QECVERIPWIAPECVED------SKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEK-ERFYEGQ  225 (262)
T ss_pred             CCCCccccCc---ccccccccccChhhhcC------CCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHH-HHHHhcC
Confidence            9998765322   23457889999998842      345677899999999999998 58999876543332 2222333


Q ss_pred             CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q 004959          566 PAIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEH  600 (721)
Q Consensus       566 ~~~p~~lS~el~dLI~~cL~~DP~kRPSa~eLL~H  600 (721)
                      .......++++.+||.+||+.||++||++.+|+++
T Consensus       226 ~~~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~  260 (262)
T cd05077         226 CMLVTPSCKELADLMTHCMNYDPNQRPFFRAIMRD  260 (262)
T ss_pred             ccCCCCChHHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence            33344456889999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=1.4e-38  Score=353.09  Aligned_cols=250  Identities=27%  Similarity=0.463  Sum_probs=205.7

Q ss_pred             CCeeEeeEEeecCCeEEEEEEEC-----CCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCC-CCCeeeeeeeEEe
Q 004959          340 SQWQKGKLIGRGTFGSVYVASNR-----ETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLK-HPNIVQYYGSEIV  413 (721)
Q Consensus       340 ~~y~~~k~LG~G~fG~VY~a~~~-----~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~-HPnIV~l~g~~~~  413 (721)
                      ++|.+++.||+|+||.||+|++.     .+++.||||++...    ......+.+.+|+.+|.++. |||||++++++..
T Consensus        37 ~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~----~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~  112 (401)
T cd05107          37 DNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKST----ARSSEKQALMSELKIMSHLGPHLNIVNLLGACTK  112 (401)
T ss_pred             HHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCC----CChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEcc
Confidence            46888999999999999999854     35578999998532    22233457889999999997 9999999999999


Q ss_pred             cCeEEEEEeeccCCCHHHHHHHhc--------------------------------------------------------
Q 004959          414 EDKFYIYLEYVHPGSINKYVREHC--------------------------------------------------------  437 (721)
Q Consensus       414 ~~~~yLVmEy~~gGsL~~~L~~~~--------------------------------------------------------  437 (721)
                      .+.+|+|||||.+|+|.+++....                                                        
T Consensus       113 ~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  192 (401)
T cd05107         113 GGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPM  192 (401)
T ss_pred             CCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccch
Confidence            999999999999999999996531                                                        


Q ss_pred             -----------------------------------------CCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEE
Q 004959          438 -----------------------------------------GAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLV  476 (721)
Q Consensus       438 -----------------------------------------~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILl  476 (721)
                                                               ..+++..+..|+.||+.||.|||++||+||||||+|||+
T Consensus       193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~NiLl  272 (401)
T cd05107         193 QDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLI  272 (401)
T ss_pred             hcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcceEEE
Confidence                                                     135667788999999999999999999999999999999


Q ss_pred             cCCCceEEeecCCccccCCCcc---cccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhh-CCCCCCch
Q 004959          477 DASGVVKLADFGMAKHLTGQKA---DLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEY  552 (721)
Q Consensus       477 d~~g~VKL~DFGlA~~l~~~~~---~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLt-G~~PF~~~  552 (721)
                      +.++.+||+|||+++.+.....   .....++..|||||++.       ...++.++|||||||++|||++ |..||...
T Consensus       273 ~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~-------~~~~~~~~DvwslGvil~e~l~~g~~P~~~~  345 (401)
T cd05107         273 CEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIF-------NNLYTTLSDVWSFGILLWEIFTLGGTPYPEL  345 (401)
T ss_pred             eCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhc-------CCCCCcHhHHHHHHHHHHHHHHcCCCCCCCC
Confidence            9999999999999986533221   12345788899999984       3446778999999999999998 89999876


Q ss_pred             hhHHHHHHHhhc--CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q 004959          553 EGAAAMFKVMRD--TPAIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEH  600 (721)
Q Consensus       553 ~~~~~~~ki~~~--~~~~p~~lS~el~dLI~~cL~~DP~kRPSa~eLL~H  600 (721)
                      ...+.....+..  ....+..++.++.+||.+||..+|++||++.+|++.
T Consensus       346 ~~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~  395 (401)
T cd05107         346 PMNEQFYNAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHL  395 (401)
T ss_pred             CchHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            555544443332  234566789999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=1.8e-38  Score=324.76  Aligned_cols=238  Identities=24%  Similarity=0.423  Sum_probs=193.9

Q ss_pred             eEEeecCCeEEEEEEECCCC----------cEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecC
Q 004959          346 KLIGRGTFGSVYVASNRETG----------ALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVED  415 (721)
Q Consensus       346 k~LG~G~fG~VY~a~~~~tg----------~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~  415 (721)
                      +.||+|+||.||+|.+..++          ..+++|.+...     . .....+.+|+.+|+.++|+||+++++++.. .
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~-----~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~   73 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSD-----H-RDSLAFFETASLMSQLSHKHLVKLYGVCVR-D   73 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccc-----h-hhHHHHHHHHHHHHcCCCcchhheeeEEec-C
Confidence            47899999999999998776          35777765421     1 115678899999999999999999999887 7


Q ss_pred             eEEEEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCC-------ceEEeecC
Q 004959          416 KFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASG-------VVKLADFG  488 (721)
Q Consensus       416 ~~yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g-------~VKL~DFG  488 (721)
                      ..++||||+.+|+|.+++......+++..+..++.||+.||.|||++||+||||||+|||++.++       .+||+|||
T Consensus        74 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg  153 (259)
T cd05037          74 ENIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPG  153 (259)
T ss_pred             CcEEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCC
Confidence            88999999999999999987655799999999999999999999999999999999999999887       79999999


Q ss_pred             CccccCCCcccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhh-CCCCCCchhhHHHHHHHhhcCCC
Q 004959          489 MAKHLTGQKADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFKVMRDTPA  567 (721)
Q Consensus       489 lA~~l~~~~~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLt-G~~PF~~~~~~~~~~ki~~~~~~  567 (721)
                      ++..+..   .....++..|+|||++.+     ....++.++|||||||++|+|++ |..||......+.... ......
T Consensus       154 ~a~~~~~---~~~~~~~~~y~aPE~~~~-----~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~-~~~~~~  224 (259)
T cd05037         154 IPITVLS---REERVERIPWIAPECIRN-----GQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERF-YQDQHR  224 (259)
T ss_pred             ccccccc---ccccccCCCccChhhhcC-----CCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHH-HhcCCC
Confidence            9986543   223457788999999853     11356778999999999999999 6888876543322222 222233


Q ss_pred             CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHh
Q 004959          568 IPDSLSPEGKDFLRCCFQRNPADRPPASLLLE  599 (721)
Q Consensus       568 ~p~~lS~el~dLI~~cL~~DP~kRPSa~eLL~  599 (721)
                      .+.....++.+||.+||..+|++||++.++++
T Consensus       225 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  256 (259)
T cd05037         225 LPMPDCAELANLINQCWTYDPTKRPSFRAILR  256 (259)
T ss_pred             CCCCCchHHHHHHHHHhccChhhCCCHHHHHH
Confidence            33334589999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=4.1e-38  Score=325.27  Aligned_cols=253  Identities=24%  Similarity=0.482  Sum_probs=209.8

Q ss_pred             CeeEeeEEeecCCeEEEEEEECC-CCcEEEEEEeecCCCC-----cccHHHHHHHHHHHHHHHh-CCCCCeeeeeeeEEe
Q 004959          341 QWQKGKLIGRGTFGSVYVASNRE-TGALCAMKEVDIFPDD-----PKSAESIKQLEQEIKVLSH-LKHPNIVQYYGSEIV  413 (721)
Q Consensus       341 ~y~~~k~LG~G~fG~VY~a~~~~-tg~~vAIK~i~~~~~~-----~~~~~~~k~~~~Ei~iL~~-L~HPnIV~l~g~~~~  413 (721)
                      .|++.+.||+|+||.||+|.+.. +++.+|+|.+......     .........+.+|+.++.. ++|+||+++++++..
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   80 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE   80 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence            47888999999999999999887 7889999988643211     1234456678889998875 799999999999999


Q ss_pred             cCeEEEEEeeccCCCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHhh-CCeeccCCCCCcEEEcCCCceEEeecCC
Q 004959          414 EDKFYIYLEYVHPGSINKYVRE---HCGAITESVVRNFTRHILSGLAYLHS-KKTIHRDIKGANLLVDASGVVKLADFGM  489 (721)
Q Consensus       414 ~~~~yLVmEy~~gGsL~~~L~~---~~~~Lse~~i~~i~~QIl~AL~yLHs-~gIIHrDLKPeNILld~~g~VKL~DFGl  489 (721)
                      .+..|+||||+.|++|.+++..   ....+++..++.++.||+.||.|||+ .||+|+||||+|||++.++.+||+|||+
T Consensus        81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l~dfg~  160 (269)
T cd08528          81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGL  160 (269)
T ss_pred             CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEEecccc
Confidence            9999999999999999988743   34578999999999999999999996 7899999999999999999999999999


Q ss_pred             ccccCCCcccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhcCC-CC
Q 004959          490 AKHLTGQKADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTP-AI  568 (721)
Q Consensus       490 A~~l~~~~~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~~~-~~  568 (721)
                      +.............|+..|++||.+.+       ..++.++|||||||++|+|++|+.||...........+..... ..
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~Pe~~~~-------~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~  233 (269)
T cd08528         161 AKQKQPESKLTSVVGTILYSCPEIVKN-------EPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPL  233 (269)
T ss_pred             eeecccccccccccCcccCcChhhhcC-------CCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCCcC
Confidence            987655544445678999999999843       3467789999999999999999999977655544444443322 12


Q ss_pred             -CCCCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q 004959          569 -PDSLSPEGKDFLRCCFQRNPADRPPASLLLEH  600 (721)
Q Consensus       569 -p~~lS~el~dLI~~cL~~DP~kRPSa~eLL~H  600 (721)
                       ...++.++.+||.+||+.||++||++.|+..+
T Consensus       234 ~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~  266 (269)
T cd08528         234 PEGMYSEDVTDVITSCLTPDAEARPDIIQVSAM  266 (269)
T ss_pred             CcccCCHHHHHHHHHHCCCCCccCCCHHHHHHH
Confidence             23678999999999999999999999999765

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=2.2e-38  Score=326.80  Aligned_cols=244  Identities=25%  Similarity=0.479  Sum_probs=200.3

Q ss_pred             eEEeecCCeEEEEEEECCCC------cEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeEEE
Q 004959          346 KLIGRGTFGSVYVASNRETG------ALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYI  419 (721)
Q Consensus       346 k~LG~G~fG~VY~a~~~~tg------~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~yL  419 (721)
                      +.||+|+||.||+|+....+      +.+|||.+...    ........+.+|+.+|+.++||||+++++++...+..|+
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~----~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   76 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKG----ATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYI   76 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhcc----cchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEE
Confidence            36899999999999876544      78999987521    122345678899999999999999999999999999999


Q ss_pred             EEeeccCCCHHHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCC-----ceEEeecC
Q 004959          420 YLEYVHPGSINKYVREH------CGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASG-----VVKLADFG  488 (721)
Q Consensus       420 VmEy~~gGsL~~~L~~~------~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g-----~VKL~DFG  488 (721)
                      ||||+.+++|.+++...      ...+++..+..++.||+.||.|||+++++|+||||+|||++.++     .++|+|||
T Consensus        77 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg  156 (269)
T cd05044          77 IMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFG  156 (269)
T ss_pred             EEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCcc
Confidence            99999999999999653      13478899999999999999999999999999999999999877     89999999


Q ss_pred             CccccCCCcc---cccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhh-CCCCCCchhhHHHHHHHhhc
Q 004959          489 MAKHLTGQKA---DLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFKVMRD  564 (721)
Q Consensus       489 lA~~l~~~~~---~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLt-G~~PF~~~~~~~~~~ki~~~  564 (721)
                      ++..+.....   .....++..|+|||++.+       ..++.++|||||||++|+|++ |..||......+....+...
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~  229 (269)
T cd05044         157 LARDIYKSDYYRKEGEGLLPVRWMAPESLLD-------GKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAG  229 (269)
T ss_pred             cccccccccccccCcccCCCccccCHHHHcc-------CCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhcC
Confidence            9976543221   112345788999999843       446778999999999999998 99999876655554444332


Q ss_pred             -CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q 004959          565 -TPAIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEH  600 (721)
Q Consensus       565 -~~~~p~~lS~el~dLI~~cL~~DP~kRPSa~eLL~H  600 (721)
                       ....+..++.++.+||.+||..+|++||++.++++.
T Consensus       230 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~  266 (269)
T cd05044         230 GRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEI  266 (269)
T ss_pred             CccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence             334566789999999999999999999999999763

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=7.3e-38  Score=322.72  Aligned_cols=246  Identities=25%  Similarity=0.465  Sum_probs=204.1

Q ss_pred             CCCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeEE
Q 004959          339 NSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFY  418 (721)
Q Consensus       339 ~~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~y  418 (721)
                      ..+|++.+.||+|+||.||++... .+..+|+|.+..      .....+.+.+|+.+++.++|+||+++++++.. ...|
T Consensus         5 ~~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~------~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~   76 (260)
T cd05073           5 RESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKP------GSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIY   76 (260)
T ss_pred             ccceeEEeEecCccceEEEEEEec-CCccEEEEecCC------ChhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeE
Confidence            358999999999999999999855 466799998742      12235678899999999999999999999877 7889


Q ss_pred             EEEeeccCCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCCc
Q 004959          419 IYLEYVHPGSINKYVREH-CGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQK  497 (721)
Q Consensus       419 LVmEy~~gGsL~~~L~~~-~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~~  497 (721)
                      +||||+.+++|.+++... ...+++..+..++.||+.||.|||+.|++|+||||+||+++.++.+||+|||++..+....
T Consensus        77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~  156 (260)
T cd05073          77 IITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNE  156 (260)
T ss_pred             EEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCcceeeccCCC
Confidence            999999999999999764 3457888999999999999999999999999999999999999999999999997664332


Q ss_pred             cc--ccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhh-CCCCCCchhhHHHHHHHhhcC-CCCCCCCC
Q 004959          498 AD--LSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFKVMRDT-PAIPDSLS  573 (721)
Q Consensus       498 ~~--~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLt-G~~PF~~~~~~~~~~ki~~~~-~~~p~~lS  573 (721)
                      ..  ....++..|+|||++.       ...++.++|||||||++|+|++ |..||...........+.... ...+..++
T Consensus       157 ~~~~~~~~~~~~y~~PE~~~-------~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (260)
T cd05073         157 YTAREGAKFPIKWTAPEAIN-------FGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCP  229 (260)
T ss_pred             cccccCCcccccccCHhHhc-------cCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCCCCCcccCC
Confidence            21  1233567799999984       3446778999999999999998 999998766555555444432 23456788


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHHh
Q 004959          574 PEGKDFLRCCFQRNPADRPPASLLLE  599 (721)
Q Consensus       574 ~el~dLI~~cL~~DP~kRPSa~eLL~  599 (721)
                      .++.+++.+||+.||++||++.++++
T Consensus       230 ~~~~~~i~~~l~~~p~~Rp~~~~l~~  255 (260)
T cd05073         230 EELYNIMMRCWKNRPEERPTFEYIQS  255 (260)
T ss_pred             HHHHHHHHHHcccCcccCcCHHHHHH
Confidence            99999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=3.3e-38  Score=326.98  Aligned_cols=250  Identities=23%  Similarity=0.434  Sum_probs=206.9

Q ss_pred             CCeeEeeEEeecCCeEEEEEEECC-----CCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEec
Q 004959          340 SQWQKGKLIGRGTFGSVYVASNRE-----TGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVE  414 (721)
Q Consensus       340 ~~y~~~k~LG~G~fG~VY~a~~~~-----tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~  414 (721)
                      ..|++.+.||+|+||.||+|+.+.     +.+.|++|.+..    .......+.+.+|+++|++++|+||+++++++.+.
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~----~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   80 (275)
T cd05046           5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQK----TKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREA   80 (275)
T ss_pred             HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCC----ccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCC
Confidence            478999999999999999998654     356789997642    22233567899999999999999999999999998


Q ss_pred             CeEEEEEeeccCCCHHHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEee
Q 004959          415 DKFYIYLEYVHPGSINKYVREHC--------GAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLAD  486 (721)
Q Consensus       415 ~~~yLVmEy~~gGsL~~~L~~~~--------~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~D  486 (721)
                      +..|+||||+++|+|.+++....        ..+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|
T Consensus        81 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~~  160 (275)
T cd05046          81 EPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSL  160 (275)
T ss_pred             CcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcEEEcc
Confidence            99999999999999999997643        1589999999999999999999999999999999999999999999999


Q ss_pred             cCCccccCCCc--ccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhh-CCCCCCchhhHHHHHHHhh
Q 004959          487 FGMAKHLTGQK--ADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFKVMR  563 (721)
Q Consensus       487 FGlA~~l~~~~--~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLt-G~~PF~~~~~~~~~~ki~~  563 (721)
                      ||++.......  ......++..|+|||.+.+       ..++.++|||||||++|+|++ |..||........+..+..
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-------~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~  233 (275)
T cd05046         161 LSLSKDVYNSEYYKLRNALIPLRWLAPEAVQE-------DDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQA  233 (275)
T ss_pred             cccccccCcccccccCCceeEEeecChhhhcc-------CCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHc
Confidence            99987543222  1122346778999998842       345678999999999999998 8899977655555554443


Q ss_pred             cC--CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q 004959          564 DT--PAIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEH  600 (721)
Q Consensus       564 ~~--~~~p~~lS~el~dLI~~cL~~DP~kRPSa~eLL~H  600 (721)
                      ..  ...+..++..+.++|.+||+.||++||++.|++.+
T Consensus       234 ~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~  272 (275)
T cd05046         234 GKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSA  272 (275)
T ss_pred             CCcCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence            32  23356788999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.2e-39  Score=367.36  Aligned_cols=258  Identities=34%  Similarity=0.633  Sum_probs=228.8

Q ss_pred             CCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCC-CCCeeeeeeeEEe-----
Q 004959          340 SQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLK-HPNIVQYYGSEIV-----  413 (721)
Q Consensus       340 ~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~-HPnIV~l~g~~~~-----  413 (721)
                      +.|++...||.|.+|.||+++++.+|+..|+|+.....      +.-++++.|+++|+.+. |||++.+||+|..     
T Consensus        19 d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~------d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~   92 (953)
T KOG0587|consen   19 DIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTE------DEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGN   92 (953)
T ss_pred             CccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCc------cccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCC
Confidence            47999999999999999999999999999999876321      22357788999998884 9999999999875     


Q ss_pred             cCeEEEEEeeccCCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccc
Q 004959          414 EDKFYIYLEYVHPGSINKYVREH-CGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKH  492 (721)
Q Consensus       414 ~~~~yLVmEy~~gGsL~~~L~~~-~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~  492 (721)
                      ++++|||||||.||+.-++++.. +..+.|+.+.+|++.++.||.+||.+.+||||||..|||++.+|.|||+|||++..
T Consensus        93 ~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKLvDFGvSaQ  172 (953)
T KOG0587|consen   93 GDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKLVDFGVSAQ  172 (953)
T ss_pred             CCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEEeeeeeeee
Confidence            57899999999999999999754 56799999999999999999999999999999999999999999999999999998


Q ss_pred             cCCCc-ccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhcCCC---C
Q 004959          493 LTGQK-ADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPA---I  568 (721)
Q Consensus       493 l~~~~-~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~~~~---~  568 (721)
                      ++... ...+.+|||+|||||++.+...  ....|+..+|+||||++..||.-|.+|+.+......+++|.+..+.   -
T Consensus       173 ldsT~grRnT~iGtP~WMAPEViac~e~--~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpRNPPPkLkr  250 (953)
T KOG0587|consen  173 LDSTVGRRNTFIGTPYWMAPEVIACDES--PDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKLKR  250 (953)
T ss_pred             eecccccccCcCCCcccccceeeecccC--CCCCcccccchhhccceeehhcCCCCCccCcchhhhhccCCCCCCccccc
Confidence            87654 3457889999999999977544  3456778899999999999999999999999999999998887553   3


Q ss_pred             CCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccccc
Q 004959          569 PDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKN  605 (721)
Q Consensus       569 p~~lS~el~dLI~~cL~~DP~kRPSa~eLL~Hp~f~~  605 (721)
                      |..++.++.+||..||.+|.++||+..++|+|||++.
T Consensus       251 p~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~e  287 (953)
T KOG0587|consen  251 PKKWSKKFNDFISTCLVKDYEQRPSTEELLKHPFITE  287 (953)
T ss_pred             hhhHHHHHHHHHHHHHhhccccCcchhhhccCCcccc
Confidence            5678999999999999999999999999999999983

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.5e-39  Score=358.40  Aligned_cols=246  Identities=25%  Similarity=0.401  Sum_probs=209.5

Q ss_pred             CCCCCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhC-CCCCeeeeeeeEEecC
Q 004959          337 PMNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHL-KHPNIVQYYGSEIVED  415 (721)
Q Consensus       337 ~l~~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L-~HPnIV~l~g~~~~~~  415 (721)
                      ++..+|.+...||.|+|+.|-.|.+..+++.+++|++.....         ...+|+.++... +||||+++++++.+..
T Consensus       319 ~~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~---------~~~~e~~~~~~~~~h~niv~~~~v~~~~~  389 (612)
T KOG0603|consen  319 PFTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRAD---------DNQDEIPISLLVRDHPNIVKSHDVYEDGK  389 (612)
T ss_pred             CcchhhccccccCCCCccceeeeeccccccchhheecccccc---------ccccccchhhhhcCCCcceeecceecCCc
Confidence            356688998899999999999999999999999999874311         234566555555 6999999999999999


Q ss_pred             eEEEEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEE-cCCCceEEeecCCccccC
Q 004959          416 KFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLV-DASGVVKLADFGMAKHLT  494 (721)
Q Consensus       416 ~~yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILl-d~~g~VKL~DFGlA~~l~  494 (721)
                      ..|+|||++.|+.|.+.+...  +....++..|++||+.||.|||++|||||||||+|||+ +..|+++|+|||.++.+.
T Consensus       390 ~~~~v~e~l~g~ell~ri~~~--~~~~~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~  467 (612)
T KOG0603|consen  390 EIYLVMELLDGGELLRRIRSK--PEFCSEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELE  467 (612)
T ss_pred             eeeeeehhccccHHHHHHHhc--chhHHHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhhCc
Confidence            999999999999998888754  23337888999999999999999999999999999999 588999999999999876


Q ss_pred             CCcccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhcCCCCCCCCCH
Q 004959          495 GQKADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDSLSP  574 (721)
Q Consensus       495 ~~~~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~~~~~p~~lS~  574 (721)
                      ..  ..+.|-|..|.|||++.       ...|+.++||||||++||+||+|+.||........+...+.. +.+-..+|+
T Consensus       468 ~~--~~tp~~t~~y~APEvl~-------~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i~~-~~~s~~vS~  537 (612)
T KOG0603|consen  468 RS--CDTPALTLQYVAPEVLA-------IQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRIQM-PKFSECVSD  537 (612)
T ss_pred             hh--hcccchhhcccChhhhc-------cCCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhhcC-CccccccCH
Confidence            55  34557789999999994       567889999999999999999999999876655333333322 234488999


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHHhcccc
Q 004959          575 EGKDFLRCCFQRNPADRPPASLLLEHRFL  603 (721)
Q Consensus       575 el~dLI~~cL~~DP~kRPSa~eLL~Hp~f  603 (721)
                      ++++||++||+.||.+|+++.+++.|+||
T Consensus       538 ~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~  566 (612)
T KOG0603|consen  538 EAKDLLQQLLQVDPALRLGADEIGAHPWF  566 (612)
T ss_pred             HHHHHHHHhccCChhhCcChhhhccCcch
Confidence            99999999999999999999999999999

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.2e-39  Score=356.23  Aligned_cols=251  Identities=28%  Similarity=0.554  Sum_probs=213.7

Q ss_pred             CCeeEeeEEeecCCeEEEEEEECCCCc---E-EEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecC
Q 004959          340 SQWQKGKLIGRGTFGSVYVASNRETGA---L-CAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVED  415 (721)
Q Consensus       340 ~~y~~~k~LG~G~fG~VY~a~~~~tg~---~-vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~  415 (721)
                      ++-.+++.||+|+||.||+|..+..+.   . ||+|....  ......+.++++.+|.++|++++|||||++||+...+.
T Consensus       157 ~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~--~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~  234 (474)
T KOG0194|consen  157 SDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKG--SSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEE  234 (474)
T ss_pred             cCccccceeecccccEEEEEEEEecCCceeeeeEEEeecc--cccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCC
Confidence            445567999999999999998665422   3 89997652  22345778899999999999999999999999999999


Q ss_pred             eEEEEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCC
Q 004959          416 KFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTG  495 (721)
Q Consensus       416 ~~yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~  495 (721)
                      .+|||||+|.||+|.++|++..+.++..+...++.|.++||+|||++++|||||-.+|+|++.++.+||+||||++.-..
T Consensus       235 Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~vKISDFGLs~~~~~  314 (474)
T KOG0194|consen  235 PLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGVVKISDFGLSRAGSQ  314 (474)
T ss_pred             ccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCeEEeCccccccCCcc
Confidence            99999999999999999998866799999999999999999999999999999999999999999999999999876432


Q ss_pred             CcccccC-CCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhh-CCCCCCchhhHHHHHHHhhcC--CCCCCC
Q 004959          496 QKADLSM-KGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFKVMRDT--PAIPDS  571 (721)
Q Consensus       496 ~~~~~s~-~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLt-G~~PF~~~~~~~~~~ki~~~~--~~~p~~  571 (721)
                      ....... .--..|+|||.+.       ...++.++|||||||++||+++ |..||.+....+...++....  ...+..
T Consensus       315 ~~~~~~~~klPirWLAPEtl~-------~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r~~~~~~  387 (474)
T KOG0194|consen  315 YVMKKFLKKLPIRWLAPETLN-------TGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGYRMPIPSK  387 (474)
T ss_pred             eeeccccccCcceecChhhhc-------cCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCccCCCCCC
Confidence            2211111 1346799999994       4578889999999999999999 899999998888888885533  345667


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHHHHh
Q 004959          572 LSPEGKDFLRCCFQRNPADRPPASLLLE  599 (721)
Q Consensus       572 lS~el~dLI~~cL~~DP~kRPSa~eLL~  599 (721)
                      .+.++..++.+||..||++||++.++.+
T Consensus       388 ~p~~~~~~~~~c~~~~p~~R~tm~~i~~  415 (474)
T KOG0194|consen  388 TPKELAKVMKQCWKKDPEDRPTMSTIKK  415 (474)
T ss_pred             CHHHHHHHHHHhccCChhhccCHHHHHH
Confidence            7889999999999999999999999875

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=5.2e-38  Score=332.52  Aligned_cols=248  Identities=24%  Similarity=0.430  Sum_probs=202.9

Q ss_pred             CCeeEeeEEeecCCeEEEEEEECCCCc----EEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecC
Q 004959          340 SQWQKGKLIGRGTFGSVYVASNRETGA----LCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVED  415 (721)
Q Consensus       340 ~~y~~~k~LG~G~fG~VY~a~~~~tg~----~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~  415 (721)
                      .+|+..+.||+|+||.||+|.+..+|+    .||+|.+..    .........+.+|+.+++.++||||+++++++... 
T Consensus         7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~----~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-   81 (303)
T cd05110           7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNE----TTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-   81 (303)
T ss_pred             hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccc----cCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-
Confidence            578999999999999999999887776    467887642    12233445688999999999999999999988654 


Q ss_pred             eEEEEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCC
Q 004959          416 KFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTG  495 (721)
Q Consensus       416 ~~yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~  495 (721)
                      ..++|+||+.+|+|.+++......+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.+..
T Consensus        82 ~~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~  161 (303)
T cd05110          82 TIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEG  161 (303)
T ss_pred             CceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEEccccccccccC
Confidence            57899999999999999987666799999999999999999999999999999999999999999999999999987654


Q ss_pred             Cccc---ccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhh-CCCCCCchhhHHHHHHHhhc--CCCCC
Q 004959          496 QKAD---LSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFKVMRD--TPAIP  569 (721)
Q Consensus       496 ~~~~---~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLt-G~~PF~~~~~~~~~~ki~~~--~~~~p  569 (721)
                      ....   ....++..|+|||++.       ...++.++|||||||++|||++ |..||.+....+.. .++..  ....+
T Consensus       162 ~~~~~~~~~~~~~~~y~~PE~~~-------~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~-~~~~~~~~~~~~  233 (303)
T cd05110         162 DEKEYNADGGKMPIKWMALECIH-------YRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIP-DLLEKGERLPQP  233 (303)
T ss_pred             cccccccCCCccccccCCHHHhc-------cCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHH-HHHHCCCCCCCC
Confidence            3321   1234577899999984       3456778999999999999997 99999765433322 22222  22334


Q ss_pred             CCCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q 004959          570 DSLSPEGKDFLRCCFQRNPADRPPASLLLEH  600 (721)
Q Consensus       570 ~~lS~el~dLI~~cL~~DP~kRPSa~eLL~H  600 (721)
                      ...+.++.++|.+||..+|++||++.++++.
T Consensus       234 ~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~  264 (303)
T cd05110         234 PICTIDVYMVMVKCWMIDADSRPKFKELAAE  264 (303)
T ss_pred             CCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            5678899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=5.4e-38  Score=325.94  Aligned_cols=248  Identities=21%  Similarity=0.379  Sum_probs=195.6

Q ss_pred             EEeecCCeEEEEEEECCC--CcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeEEEEEeec
Q 004959          347 LIGRGTFGSVYVASNRET--GALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYIYLEYV  424 (721)
Q Consensus       347 ~LG~G~fG~VY~a~~~~t--g~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~yLVmEy~  424 (721)
                      .||+|+||.||+|.....  ...+++|.+...    ......+.+.+|+.+++.++||||+++++.+......|+||||+
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~----~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~   77 (268)
T cd05086           2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKAN----ASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYC   77 (268)
T ss_pred             cCCCCcCceEEEEEEEcCCCcceEEEEEecCC----CChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecC
Confidence            689999999999975432  334566665421    22344678899999999999999999999999999999999999


Q ss_pred             cCCCHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCCc---c
Q 004959          425 HPGSINKYVREHC---GAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQK---A  498 (721)
Q Consensus       425 ~gGsL~~~L~~~~---~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~~---~  498 (721)
                      .+|+|.+++.+..   ..+.+..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||++.......   .
T Consensus        78 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~  157 (268)
T cd05086          78 ELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIET  157 (268)
T ss_pred             CCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccccCcchhhhc
Confidence            9999999997542   346777889999999999999999999999999999999999999999999986432211   1


Q ss_pred             cccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhh-CCCCCCchhhHHHHHHHhhcC------CCCCCC
Q 004959          499 DLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFKVMRDT------PAIPDS  571 (721)
Q Consensus       499 ~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLt-G~~PF~~~~~~~~~~ki~~~~------~~~p~~  571 (721)
                      ....+|+..|+|||++....+......++.++|||||||++|||++ |..||......+.+.++....      +.++..
T Consensus       158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (268)
T cd05086         158 EDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQLELP  237 (268)
T ss_pred             ccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCCCccCCC
Confidence            2245688999999998532222223345778999999999999997 678997766655555544332      233456


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHHHHh
Q 004959          572 LSPEGKDFLRCCFQRNPADRPPASLLLE  599 (721)
Q Consensus       572 lS~el~dLI~~cL~~DP~kRPSa~eLL~  599 (721)
                      +++.+.++|..|| .+|++||++.+|++
T Consensus       238 ~~~~~~~l~~~c~-~~P~~Rp~~~~i~~  264 (268)
T cd05086         238 YSERWYEVLQFCW-LSPEKRATAEEVHR  264 (268)
T ss_pred             CcHHHHHHHHHHh-hCcccCCCHHHHHH
Confidence            7899999999999 67999999999975

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=1.7e-39  Score=335.86  Aligned_cols=269  Identities=28%  Similarity=0.483  Sum_probs=213.5

Q ss_pred             CCCCCeeEeeEEeecCCeEEEEEEECCCCc----EEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEE
Q 004959          337 PMNSQWQKGKLIGRGTFGSVYVASNRETGA----LCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEI  412 (721)
Q Consensus       337 ~l~~~y~~~k~LG~G~fG~VY~a~~~~tg~----~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~  412 (721)
                      .....|+..+.||+|+||.||+|..++++.    .||||.+.-.++   ....-...-+||.+++.++|||||.|..+|.
T Consensus        21 e~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd---~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl   97 (438)
T KOG0666|consen   21 EDLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKD---GTGISMSACREIALLRELKHPNVISLVKVFL   97 (438)
T ss_pred             HHHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCC---CCCcCHHHHHHHHHHHHhcCCcchhHHHHHh
Confidence            444589999999999999999997665443    789998753221   1122235668999999999999999999988


Q ss_pred             e-cCeEEEEEeeccCCCHHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCC----CceE
Q 004959          413 V-EDKFYIYLEYVHPGSINKYVREH----CGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDAS----GVVK  483 (721)
Q Consensus       413 ~-~~~~yLVmEy~~gGsL~~~L~~~----~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~----g~VK  483 (721)
                      . +..+++++||.+ -+|.++|+-+    ...++...++.|++||+.|+.|||++=|+||||||.||||..+    |.||
T Consensus        98 ~~d~~v~l~fdYAE-hDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VK  176 (438)
T KOG0666|consen   98 SHDKKVWLLFDYAE-HDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVK  176 (438)
T ss_pred             ccCceEEEEehhhh-hhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeE
Confidence            7 888999999997 7999998643    2468899999999999999999999999999999999999877    8999


Q ss_pred             EeecCCccccCCCccc----ccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhh-----
Q 004959          484 LADFGMAKHLTGQKAD----LSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEG-----  554 (721)
Q Consensus       484 L~DFGlA~~l~~~~~~----~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~-----  554 (721)
                      |+|||+++.+...-..    ..++-|.+|+|||+|.|      ...|+.++|||++|||+.|||+-.+.|.+.+.     
T Consensus       177 IaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLG------a~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~  250 (438)
T KOG0666|consen  177 IADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLG------ARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTK  250 (438)
T ss_pred             eecccHHHHhhccccccccCCceEEEEEecChHHhcc------cccccchhhhHHHHHHHHHHHccCccccchhhhcccC
Confidence            9999999987654322    23567999999999986      45788899999999999999999998865321     


Q ss_pred             ----HHHHHHHhhc--C---------CCCCC--------------------------CCCHHHHHHHHHhcccCCCCCCC
Q 004959          555 ----AAAMFKVMRD--T---------PAIPD--------------------------SLSPEGKDFLRCCFQRNPADRPP  593 (721)
Q Consensus       555 ----~~~~~ki~~~--~---------~~~p~--------------------------~lS~el~dLI~~cL~~DP~kRPS  593 (721)
                          .+++.+|..-  .         ...|+                          .-++.+.+||.+||+.||.+|+|
T Consensus       251 ~Pfq~dQl~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIt  330 (438)
T KOG0666|consen  251 NPFQHDQLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRIT  330 (438)
T ss_pred             CCchHHHHHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhcc
Confidence                2333333221  0         01111                          12455889999999999999999


Q ss_pred             HHHHHhccccccCCCCCCCCcc
Q 004959          594 ASLLLEHRFLKNSQQPDVPSCS  615 (721)
Q Consensus       594 a~eLL~Hp~f~~~~~~~~~~~~  615 (721)
                      ++++|+|+||.....+..+...
T Consensus       331 a~qAleh~yF~~d~lpp~pt~~  352 (438)
T KOG0666|consen  331 AEQALEHPYFTEDPLPPLPTSD  352 (438)
T ss_pred             HHHHhcccccccCCCCCCcccc
Confidence            9999999999998777555443

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=3.6e-39  Score=358.67  Aligned_cols=252  Identities=33%  Similarity=0.605  Sum_probs=214.0

Q ss_pred             eEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCe--EEEE
Q 004959          343 QKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDK--FYIY  420 (721)
Q Consensus       343 ~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~--~yLV  420 (721)
                      +...+||+|+|-+||+|.+..+|..||--.+.+. +-.+..+..++|..|+.+|+.|+|+|||++|+.+.+...  +.+|
T Consensus        43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~-d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~i  121 (632)
T KOG0584|consen   43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIR-DVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFI  121 (632)
T ss_pred             ehhhhcccccceeeeeccccccchhhHHHHHhHH-HhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeee
Confidence            4457899999999999999999999986655432 223556678999999999999999999999999887654  8899


Q ss_pred             EeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCC--eeccCCCCCcEEEcC-CCceEEeecCCccccCCCc
Q 004959          421 LEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKK--TIHRDIKGANLLVDA-SGVVKLADFGMAKHLTGQK  497 (721)
Q Consensus       421 mEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~g--IIHrDLKPeNILld~-~g~VKL~DFGlA~~l~~~~  497 (721)
                      +|+|..|+|..|++++ +.++...++.|++||+.||.|||++.  |||||||-+||+|+. .|.|||+|+|||..+....
T Consensus       122 TEL~TSGtLr~Y~kk~-~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~  200 (632)
T KOG0584|consen  122 TELFTSGTLREYRKKH-RRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSH  200 (632)
T ss_pred             eecccCCcHHHHHHHh-ccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHhhccc
Confidence            9999999999999887 78999999999999999999999995  999999999999985 5899999999999775544


Q ss_pred             ccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHH-HHhhcCC--CCCCCCCH
Q 004959          498 ADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMF-KVMRDTP--AIPDSLSP  574 (721)
Q Consensus       498 ~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~-ki~~~~~--~~p~~lS~  574 (721)
                      . ...+|||.|||||.+.        ..|+..+||||||++|+||+|+..||.+-....+++ ++..+..  .+-.--.+
T Consensus       201 a-ksvIGTPEFMAPEmYE--------E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~kV~dP  271 (632)
T KOG0584|consen  201 A-KSVIGTPEFMAPEMYE--------ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALSKVKDP  271 (632)
T ss_pred             c-ceeccCccccChHHHh--------hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhhccCCH
Confidence            3 3478999999999984        457778999999999999999999998865555555 4444422  11222368


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHHhccccccC
Q 004959          575 EGKDFLRCCFQRNPADRPPASLLLEHRFLKNS  606 (721)
Q Consensus       575 el~dLI~~cL~~DP~kRPSa~eLL~Hp~f~~~  606 (721)
                      ++++||.+||.. ..+|+|+.|||.|+||...
T Consensus       272 evr~fIekCl~~-~~~R~sa~eLL~d~Ff~~d  302 (632)
T KOG0584|consen  272 EVREFIEKCLAT-KSERLSAKELLKDPFFDED  302 (632)
T ss_pred             HHHHHHHHHhcC-chhccCHHHHhhChhhccc
Confidence            999999999999 9999999999999999875

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=8.6e-38  Score=320.64  Aligned_cols=241  Identities=26%  Similarity=0.478  Sum_probs=200.4

Q ss_pred             CCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeEEE
Q 004959          340 SQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYI  419 (721)
Q Consensus       340 ~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~yL  419 (721)
                      .+|++.+.||+|+||.||++.  .+++.||+|.+...       ...+.+.+|+.++++++||||+++++++... ..|+
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~--~~~~~~~iK~~~~~-------~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~   75 (254)
T cd05083           6 QKLTLGEIIGEGEFGAVLQGE--YTGQKVAVKNIKCD-------VTAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYI   75 (254)
T ss_pred             HHceeeeeeccCCCCceEecc--cCCCceEEEeecCc-------chHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEE
Confidence            479999999999999999986  46889999987521       1235788999999999999999999988654 5799


Q ss_pred             EEeeccCCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCCcc
Q 004959          420 YLEYVHPGSINKYVREHC-GAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKA  498 (721)
Q Consensus       420 VmEy~~gGsL~~~L~~~~-~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~~~  498 (721)
                      ||||+.+++|.+++.... ..+++..+..++.||+.||.|||++|++||||||+|||++.++.+||+|||++....... 
T Consensus        76 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~-  154 (254)
T cd05083          76 VMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV-  154 (254)
T ss_pred             EEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCccceeccccC-
Confidence            999999999999997653 358999999999999999999999999999999999999999999999999987643221 


Q ss_pred             cccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhh-CCCCCCchhhHHHHHHHhhcC-CCCCCCCCHHH
Q 004959          499 DLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFKVMRDT-PAIPDSLSPEG  576 (721)
Q Consensus       499 ~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLt-G~~PF~~~~~~~~~~ki~~~~-~~~p~~lS~el  576 (721)
                       .....+..|+|||.+.       ...++.++|||||||++|+|++ |+.||......+....+.... ...+..++.++
T Consensus       155 -~~~~~~~~y~~pe~~~-------~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  226 (254)
T cd05083         155 -DNSKLPVKWTAPEALK-------HKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYRMEPPEGCPADV  226 (254)
T ss_pred             -CCCCCCceecCHHHhc-------cCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCCCCCCCCCcCCHHH
Confidence             2233457799999884       3456678999999999999997 999998766555444443332 23456788999


Q ss_pred             HHHHHHhcccCCCCCCCHHHHHh
Q 004959          577 KDFLRCCFQRNPADRPPASLLLE  599 (721)
Q Consensus       577 ~dLI~~cL~~DP~kRPSa~eLL~  599 (721)
                      .+||.+||+.+|++||++.++++
T Consensus       227 ~~li~~~l~~~p~~Rp~~~~l~~  249 (254)
T cd05083         227 YVLMTSCWETEPKKRPSFHKLRE  249 (254)
T ss_pred             HHHHHHHcCCChhhCcCHHHHHH
Confidence            99999999999999999999986

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=4.1e-39  Score=325.07  Aligned_cols=253  Identities=28%  Similarity=0.429  Sum_probs=208.2

Q ss_pred             CCCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEec----
Q 004959          339 NSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVE----  414 (721)
Q Consensus       339 ~~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~----  414 (721)
                      ..+|++.++||+|||+.||++++..+++.||+|.|...     ..+..+..++|+...++++||||++++++...+    
T Consensus        20 ~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~-----~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~   94 (302)
T KOG2345|consen   20 NKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCH-----SQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDG   94 (302)
T ss_pred             CceEEEeeeecCCCceeeeeecccCcccchhhheeecc-----chHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccC
Confidence            46899999999999999999999999999999998642     246678899999999999999999999865443    


Q ss_pred             -CeEEEEEeeccCCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHhhCC--eeccCCCCCcEEEcCCCceEEeecC
Q 004959          415 -DKFYIYLEYVHPGSINKYVREH---CGAITESVVRNFTRHILSGLAYLHSKK--TIHRDIKGANLLVDASGVVKLADFG  488 (721)
Q Consensus       415 -~~~yLVmEy~~gGsL~~~L~~~---~~~Lse~~i~~i~~QIl~AL~yLHs~g--IIHrDLKPeNILld~~g~VKL~DFG  488 (721)
                       ...||+++|...|+|.+.+...   +..++|.++..|+.+|++||++||+..  ++||||||.|||+.+.+.++|.|||
T Consensus        95 ~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~D~G  174 (302)
T KOG2345|consen   95 KHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLMDLG  174 (302)
T ss_pred             ceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEEecc
Confidence             3599999999999999998653   347999999999999999999999999  9999999999999999999999999


Q ss_pred             CccccCCCcc----c------ccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhH--H
Q 004959          489 MAKHLTGQKA----D------LSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGA--A  556 (721)
Q Consensus       489 lA~~l~~~~~----~------~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~--~  556 (721)
                      .++...-+..    .      .....|..|+|||++...    .....+.++|||||||+||.|++|..||+.....  .
T Consensus       175 S~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk----~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgS  250 (302)
T KOG2345|consen  175 SATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVK----SHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGS  250 (302)
T ss_pred             CccccceEeechHHHHHHHHHHHHhCCCcccCchheecc----cCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCe
Confidence            9876432111    0      123468999999999542    4567888999999999999999999999653221  1


Q ss_pred             HHHHHhhcCCCCC--CCCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q 004959          557 AMFKVMRDTPAIP--DSLSPEGKDFLRCCFQRNPADRPPASLLLEH  600 (721)
Q Consensus       557 ~~~ki~~~~~~~p--~~lS~el~dLI~~cL~~DP~kRPSa~eLL~H  600 (721)
                      ....+......+|  ..+|+.+.+||+.||+.||.+||++.+++.+
T Consensus       251 laLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~  296 (302)
T KOG2345|consen  251 LALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSK  296 (302)
T ss_pred             EEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence            1112222222333  3489999999999999999999999999875

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=7.8e-39  Score=366.68  Aligned_cols=247  Identities=25%  Similarity=0.478  Sum_probs=213.9

Q ss_pred             CeeEeeEEeecCCeEEEEEEEC-----CCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecC
Q 004959          341 QWQKGKLIGRGTFGSVYVASNR-----ETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVED  415 (721)
Q Consensus       341 ~y~~~k~LG~G~fG~VY~a~~~-----~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~  415 (721)
                      +.+..+.||+|+||+||+|+-.     ++...||||.++    +..+.+..++|++|+.+|..|+|||||+|+|++..++
T Consensus       487 ~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LK----d~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~  562 (774)
T KOG1026|consen  487 DIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALK----DKAENQARQDFRREAELLAELQHPNIVRLLGVCREGD  562 (774)
T ss_pred             heeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhc----ccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCC
Confidence            4567788999999999999643     345789999875    3445567889999999999999999999999999999


Q ss_pred             eEEEEEeeccCCCHHHHHHHhc-------------CCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCce
Q 004959          416 KFYIYLEYVHPGSINKYVREHC-------------GAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVV  482 (721)
Q Consensus       416 ~~yLVmEy~~gGsL~~~L~~~~-------------~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~V  482 (721)
                      .+|+|+|||..|||.++|+.+.             ..|+..+...|+.||+.||+||-++.+|||||-..|+||.++..|
T Consensus       563 P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVge~l~V  642 (774)
T KOG1026|consen  563 PLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVGENLVV  642 (774)
T ss_pred             eeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceeccceEE
Confidence            9999999999999999997542             127888999999999999999999999999999999999999999


Q ss_pred             EEeecCCccccCCCcccccC---CCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhh-CCCCCCchhhHHHH
Q 004959          483 KLADFGMAKHLTGQKADLSM---KGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAM  558 (721)
Q Consensus       483 KL~DFGlA~~l~~~~~~~s~---~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLt-G~~PF~~~~~~~~~  558 (721)
                      ||+||||++.+.........   .--..||+||.++       ...++.++||||+||+|||+++ |+.||.+..+.+.+
T Consensus       643 KIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIl-------y~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVI  715 (774)
T KOG1026|consen  643 KISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESIL-------YGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVI  715 (774)
T ss_pred             EecccccchhhhhhhhhcccCCceeeeecCCHHHhh-------cCcccchhhhhhhhhhhhhhhccccCcccccchHHHH
Confidence            99999999987654432211   1135699999996       3567888999999999999998 99999999999888


Q ss_pred             HHHhhcC-CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHH
Q 004959          559 FKVMRDT-PAIPDSLSPEGKDFLRCCFQRNPADRPPASLLL  598 (721)
Q Consensus       559 ~ki~~~~-~~~p~~lS~el~dLI~~cL~~DP~kRPSa~eLL  598 (721)
                      ..+..+. ...|+.++.++++||..||+.+|++||++.||-
T Consensus       716 e~i~~g~lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~  756 (774)
T KOG1026|consen  716 ECIRAGQLLSCPENCPTEVYSLMLECWNENPKRRPSFKEIH  756 (774)
T ss_pred             HHHHcCCcccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHH
Confidence            8876653 567899999999999999999999999999973

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-38  Score=373.41  Aligned_cols=249  Identities=26%  Similarity=0.489  Sum_probs=215.1

Q ss_pred             CCeeEeeEEeecCCeEEEEEEECCC-C----cEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEec
Q 004959          340 SQWQKGKLIGRGTFGSVYVASNRET-G----ALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVE  414 (721)
Q Consensus       340 ~~y~~~k~LG~G~fG~VY~a~~~~t-g----~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~  414 (721)
                      ...++++.||+|.||.||.|....- |    ..||||.+..    ..+.+...+|.+|..+|..++|||||+++|++.+.
T Consensus       692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~----~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~  767 (1025)
T KOG1095|consen  692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKR----LSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDS  767 (1025)
T ss_pred             hheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccc----cCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCC
Confidence            4577889999999999999976532 3    3489998753    34566788999999999999999999999999999


Q ss_pred             CeEEEEEeeccCCCHHHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecC
Q 004959          415 DKFYIYLEYVHPGSINKYVREH------CGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFG  488 (721)
Q Consensus       415 ~~~yLVmEy~~gGsL~~~L~~~------~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFG  488 (721)
                      ...+|++|||+||+|..+|++.      ...++..+...++.||+.|+.||+++++|||||...|+||++...|||+|||
T Consensus       768 ~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VKIaDFG  847 (1025)
T KOG1095|consen  768 GPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVVKIADFG  847 (1025)
T ss_pred             CCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcEEEcccc
Confidence            9999999999999999999887      5678999999999999999999999999999999999999999999999999


Q ss_pred             CccccCCCcccc-cCCC--CCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhh-CCCCCCchhhHHHHHHHhhc
Q 004959          489 MAKHLTGQKADL-SMKG--SPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFKVMRD  564 (721)
Q Consensus       489 lA~~l~~~~~~~-s~~G--T~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLt-G~~PF~~~~~~~~~~ki~~~  564 (721)
                      +|+.+....... ...+  -..|||||.|.       ...++.++|||||||+|||+++ |..||.+....+.+..++.+
T Consensus       848 lArDiy~~~yyr~~~~a~lPvkWm~PEsl~-------d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~g  920 (1025)
T KOG1095|consen  848 LARDIYDKDYYRKHGEAMLPVKWMPPESLK-------DGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEG  920 (1025)
T ss_pred             hhHhhhhchheeccCccccceecCCHHHHh-------hcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhC
Confidence            999654332211 1112  24699999995       3567778999999999999999 99999999888888766554


Q ss_pred             -CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHh
Q 004959          565 -TPAIPDSLSPEGKDFLRCCFQRNPADRPPASLLLE  599 (721)
Q Consensus       565 -~~~~p~~lS~el~dLI~~cL~~DP~kRPSa~eLL~  599 (721)
                       ....|..+++.+.++|.+||+.+|++||++..|++
T Consensus       921 gRL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~  956 (1025)
T KOG1095|consen  921 GRLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVE  956 (1025)
T ss_pred             CccCCCCCCChHHHHHHHHHccCChhhCccHHHHHh
Confidence             45667889999999999999999999999999987

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=2.2e-37  Score=327.00  Aligned_cols=252  Identities=20%  Similarity=0.315  Sum_probs=190.0

Q ss_pred             CCCCeeEeeEEeecCCeEEEEEEECCC---CcEEEEEEeecCCCCcccHHH------HHHHHHHHHHHHhCCCCCeeeee
Q 004959          338 MNSQWQKGKLIGRGTFGSVYVASNRET---GALCAMKEVDIFPDDPKSAES------IKQLEQEIKVLSHLKHPNIVQYY  408 (721)
Q Consensus       338 l~~~y~~~k~LG~G~fG~VY~a~~~~t---g~~vAIK~i~~~~~~~~~~~~------~k~~~~Ei~iL~~L~HPnIV~l~  408 (721)
                      ...+|++.++||+|+||+||+|.+..+   +..+|+|+.............      ......++..+..+.|+||+.++
T Consensus        10 ~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~   89 (294)
T PHA02882         10 TGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYY   89 (294)
T ss_pred             CCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEE
Confidence            346899999999999999999998877   677888865432211111100      01122344456667899999999


Q ss_pred             eeEEecC----eEEEEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEE
Q 004959          409 GSEIVED----KFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKL  484 (721)
Q Consensus       409 g~~~~~~----~~yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL  484 (721)
                      +++....    ..+++||++. .++.+++... ...++..++.++.||+.||.|||+++|+||||||+|||++.++.++|
T Consensus        90 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~~~l  167 (294)
T PHA02882         90 GCGSFKRCRMYYRFILLEKLV-ENTKEIFKRI-KCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGYI  167 (294)
T ss_pred             EeeeEecCCceEEEEEEehhc-cCHHHHHHhh-ccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCcEEE
Confidence            8765543    4578888874 5677666543 45788999999999999999999999999999999999999999999


Q ss_pred             eecCCccccCCCc--------ccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhH-
Q 004959          485 ADFGMAKHLTGQK--------ADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGA-  555 (721)
Q Consensus       485 ~DFGlA~~l~~~~--------~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~-  555 (721)
                      +|||+|+.+....        ......||+.|+|||++.       +..++.++|||||||+||||++|..||.+.... 
T Consensus       168 ~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~-------~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~  240 (294)
T PHA02882        168 IDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHN-------GACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNG  240 (294)
T ss_pred             EEcCCceeeccCCcccccccccccccCCCccccCHHHhC-------CCCCCcHHHHHHHHHHHHHHHhCCCCCCccccch
Confidence            9999998763221        112346999999999984       455778999999999999999999999765321 


Q ss_pred             HH--------HHHHhhcCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHh
Q 004959          556 AA--------MFKVMRDTPAIPDSLSPEGKDFLRCCFQRNPADRPPASLLLE  599 (721)
Q Consensus       556 ~~--------~~ki~~~~~~~p~~lS~el~dLI~~cL~~DP~kRPSa~eLL~  599 (721)
                      ..        +.++... .......++++.++++.||..+|++||++.+|++
T Consensus       241 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~  291 (294)
T PHA02882        241 NLIHAAKCDFIKRLHEG-KIKIKNANKFIYDFIECVTKLSYEEKPDYDALIK  291 (294)
T ss_pred             HHHHHhHHHHHHHhhhh-hhccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence            11        1122222 1223456899999999999999999999999975

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.2e-40  Score=355.88  Aligned_cols=259  Identities=25%  Similarity=0.445  Sum_probs=234.6

Q ss_pred             CCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeEEE
Q 004959          340 SQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYI  419 (721)
Q Consensus       340 ~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~yL  419 (721)
                      .+++++..||-|+||.|-++........+|+|++++  ....+..+.+.+..|-+||..++.|+||++|..|.+..++|+
T Consensus       420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK--~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYm  497 (732)
T KOG0614|consen  420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKK--KHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYM  497 (732)
T ss_pred             hhhhhhhhcccCccceEEEEEecccchHHHHHHHhH--hhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhh
Confidence            356777889999999999998776556699998864  344555667889999999999999999999999999999999


Q ss_pred             EEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCCccc
Q 004959          420 YLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKAD  499 (721)
Q Consensus       420 VmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~~~~  499 (721)
                      .||-|-||.|+.+|+.+ +.|.+..++.|+..+++|++|||++|||+|||||||+|++.+|-+||.|||+|+.+..+...
T Consensus       498 LmEaClGGElWTiLrdR-g~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~KT  576 (732)
T KOG0614|consen  498 LMEACLGGELWTILRDR-GSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGRKT  576 (732)
T ss_pred             hHHhhcCchhhhhhhhc-CCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeehhhHHHhccCCce
Confidence            99999999999999876 88999999999999999999999999999999999999999999999999999999999999


Q ss_pred             ccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhcC--CCCCCCCCHHHH
Q 004959          500 LSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDT--PAIPDSLSPEGK  577 (721)
Q Consensus       500 ~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~~--~~~p~~lS~el~  577 (721)
                      .++||||.|.|||++..       ...+.++|.|+||+++||||+|.+||.+.+....+..|+++.  ..+|..++..+.
T Consensus       577 wTFcGTpEYVAPEIILn-------KGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i~~Pr~I~k~a~  649 (732)
T KOG0614|consen  577 WTFCGTPEYVAPEIILN-------KGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKIEFPRRITKTAT  649 (732)
T ss_pred             eeecCCcccccchhhhc-------cCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhhhcccccchhHH
Confidence            99999999999999964       345568999999999999999999999999999999888864  467899999999


Q ss_pred             HHHHHhcccCCCCCCC-----HHHHHhccccccCCC
Q 004959          578 DFLRCCFQRNPADRPP-----ASLLLEHRFLKNSQQ  608 (721)
Q Consensus       578 dLI~~cL~~DP~kRPS-----a~eLL~Hp~f~~~~~  608 (721)
                      +||+++...+|.+|.-     +.+|-+|.||.+..-
T Consensus       650 ~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~gfdw  685 (732)
T KOG0614|consen  650 DLIKKLCRDNPTERLGYQKGGINDIKKHRWFEGFDW  685 (732)
T ss_pred             HHHHHHHhcCcHhhhccccCChHHHHhhhhhhcCCh
Confidence            9999999999999986     789999999987543

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=5.3e-39  Score=354.21  Aligned_cols=259  Identities=28%  Similarity=0.461  Sum_probs=219.1

Q ss_pred             CCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeEEE
Q 004959          340 SQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYI  419 (721)
Q Consensus       340 ~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~yL  419 (721)
                      +-|.+++.||-|+||+|.++...+|...||+|.+++  .+.....++..+..|-.||...+.+.||+||-.|.+++.+|+
T Consensus       629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrK--aDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYF  706 (1034)
T KOG0608|consen  629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRK--ADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYF  706 (1034)
T ss_pred             cceEEEeeecccccceeEEEeecchhhHHHHhhhHH--HHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEE
Confidence            457889999999999999999999999999998863  444555667778889999999999999999999999999999


Q ss_pred             EEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccC-----
Q 004959          420 YLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLT-----  494 (721)
Q Consensus       420 VmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~-----  494 (721)
                      ||||++||++-.+|.+. +.|.|..++.|+..|.+|++++|..|+|||||||+|||||.+|.|||.|||||.-+.     
T Consensus       707 VMdYIPGGDmMSLLIrm-gIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHds  785 (1034)
T KOG0608|consen  707 VMDYIPGGDMMSLLIRM-GIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS  785 (1034)
T ss_pred             EEeccCCccHHHHHHHh-ccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeeccccccceecccc
Confidence            99999999999998765 889999999999999999999999999999999999999999999999999986531     


Q ss_pred             ---CCcc-----------------------------------cccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHH
Q 004959          495 ---GQKA-----------------------------------DLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLG  536 (721)
Q Consensus       495 ---~~~~-----------------------------------~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLG  536 (721)
                         ....                                   ....+||+.|+|||+|.       ...|+..+|+||.|
T Consensus       786 kYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~-------r~g~~q~cdwws~g  858 (1034)
T KOG0608|consen  786 KYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLA-------RTGYTQLCDWWSVG  858 (1034)
T ss_pred             ccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhc-------ccCccccchhhHhh
Confidence               0000                                   01246999999999995       35677789999999


Q ss_pred             HHHHHHhhCCCCCCchhhHHHHHHHhhcC--CCCC--CCCCHHHHHHHHHhcccCCCCCC---CHHHHHhccccccCCCC
Q 004959          537 CTIIEMYTGKPPWSEYEGAAAMFKVMRDT--PAIP--DSLSPEGKDFLRCCFQRNPADRP---PASLLLEHRFLKNSQQP  609 (721)
Q Consensus       537 VILyELLtG~~PF~~~~~~~~~~ki~~~~--~~~p--~~lS~el~dLI~~cL~~DP~kRP---Sa~eLL~Hp~f~~~~~~  609 (721)
                      ||||||+.|++||......+...++++..  ..++  ..+|.|+.++|.++. .+++.|.   -++++-.||||+.....
T Consensus       859 vil~em~~g~~pf~~~tp~~tq~kv~nw~~~l~~~~~~~ls~e~~~li~kLc-~sad~RLGkng~d~vKaHpfFkgIDfs  937 (1034)
T KOG0608|consen  859 VILYEMLVGQPPFLADTPGETQYKVINWRNFLHIPYQGNLSKEALDLIQKLC-CSADSRLGKNGADQVKAHPFFKGIDFS  937 (1034)
T ss_pred             HHHHHHhhCCCCccCCCCCcceeeeeehhhccccccccccCHHHHHHHHHHh-cChhhhhcccchhhhhcCccccccchH
Confidence            99999999999998877766666665543  2233  569999999998865 4677886   47789999999976543

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=2e-37  Score=320.31  Aligned_cols=249  Identities=23%  Similarity=0.420  Sum_probs=201.5

Q ss_pred             eeEeeEEeecCCeEEEEEEEC---CCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecC---
Q 004959          342 WQKGKLIGRGTFGSVYVASNR---ETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVED---  415 (721)
Q Consensus       342 y~~~k~LG~G~fG~VY~a~~~---~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~---  415 (721)
                      |++.+.||+|+||.||+|...   .+++.||||++..   +.......+.+.+|+++|+.++||||+++++++...+   
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~---~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   77 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKA---DIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKG   77 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEecc---ccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCC
Confidence            567889999999999999854   4678999998853   2233445677899999999999999999999876542   


Q ss_pred             ---eEEEEEeeccCCCHHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeec
Q 004959          416 ---KFYIYLEYVHPGSINKYVREH-----CGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADF  487 (721)
Q Consensus       416 ---~~yLVmEy~~gGsL~~~L~~~-----~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DF  487 (721)
                         ..++++||+.+|+|.+++...     ...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+||
T Consensus        78 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl~df  157 (273)
T cd05074          78 RLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADF  157 (273)
T ss_pred             cccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEECcc
Confidence               347899999999999887432     124789999999999999999999999999999999999999999999999


Q ss_pred             CCccccCCCcc---cccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhh-CCCCCCchhhHHHHHHHhh
Q 004959          488 GMAKHLTGQKA---DLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFKVMR  563 (721)
Q Consensus       488 GlA~~l~~~~~---~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLt-G~~PF~~~~~~~~~~ki~~  563 (721)
                      |+++.+.....   .....+++.|++||.+.       ...++.++|||||||++|+|++ |+.||......+....+..
T Consensus       158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~-------~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~  230 (273)
T cd05074         158 GLSKKIYSGDYYRQGCASKLPVKWLALESLA-------DNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIK  230 (273)
T ss_pred             cccccccCCcceecCCCccCchhhcCHhHHh-------cCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHc
Confidence            99987643321   12234567899999984       3345678999999999999999 9999987665554444433


Q ss_pred             c-CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q 004959          564 D-TPAIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEH  600 (721)
Q Consensus       564 ~-~~~~p~~lS~el~dLI~~cL~~DP~kRPSa~eLL~H  600 (721)
                      . ....+..++.++.+++.+||+.+|++||++.+++++
T Consensus       231 ~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~  268 (273)
T cd05074         231 GNRLKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQ  268 (273)
T ss_pred             CCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            2 233445678999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=3.5e-38  Score=322.33  Aligned_cols=229  Identities=23%  Similarity=0.314  Sum_probs=190.7

Q ss_pred             cCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeEEEEEeeccCCCHH
Q 004959          351 GTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSIN  430 (721)
Q Consensus       351 G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~yLVmEy~~gGsL~  430 (721)
                      |.||.||+|.++.+|+.||+|.+....          ...+|...+....||||+++++++...+..|+||||+.||+|.
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~----------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~   73 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSS----------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLW   73 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchh----------hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHH
Confidence            899999999999999999999885321          2234445555567999999999999999999999999999999


Q ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCCcccccCCCCCccCC
Q 004959          431 KYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPYWMA  510 (721)
Q Consensus       431 ~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~~~~~s~~GT~~Y~A  510 (721)
                      +++... ..+++..+..++.||+.||.|||++||+||||||+||+++.++.++|+|||++..+...  .....++..|+|
T Consensus        74 ~~l~~~-~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~--~~~~~~~~~y~a  150 (237)
T cd05576          74 SHISKF-LNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS--CDGEAVENMYCA  150 (237)
T ss_pred             HHHHHh-cCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhccccc--cccCCcCccccC
Confidence            999765 56999999999999999999999999999999999999999999999999988765432  223456788999


Q ss_pred             hhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhcCCCCCCCCCHHHHHHHHHhcccCCCC
Q 004959          511 PELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDSLSPEGKDFLRCCFQRNPAD  590 (721)
Q Consensus       511 PEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~~~~~p~~lS~el~dLI~~cL~~DP~k  590 (721)
                      ||.+.       ...++.++||||+||++|||++|+.||.......  .  ......++..++.++++||.+||+.||++
T Consensus       151 PE~~~-------~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~--~--~~~~~~~~~~~~~~~~~li~~~l~~dp~~  219 (237)
T cd05576         151 PEVGG-------ISEETEACDWWSLGAILFELLTGKTLVECHPSGI--N--THTTLNIPEWVSEEARSLLQQLLQFNPTE  219 (237)
T ss_pred             CcccC-------CCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc--c--cccccCCcccCCHHHHHHHHHHccCCHHH
Confidence            99873       3445678999999999999999998876432110  0  01122466788999999999999999999


Q ss_pred             CCCH-----HHHHhcccc
Q 004959          591 RPPA-----SLLLEHRFL  603 (721)
Q Consensus       591 RPSa-----~eLL~Hp~f  603 (721)
                      |+++     +++++||||
T Consensus       220 R~~~~~~~~~~~~~h~~~  237 (237)
T cd05576         220 RLGAGVAGVEDIKSHPFF  237 (237)
T ss_pred             hcCCCccchHHHHcCCCC
Confidence            9985     999999997

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.6e-38  Score=342.44  Aligned_cols=249  Identities=26%  Similarity=0.444  Sum_probs=197.7

Q ss_pred             CCCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecC-eE
Q 004959          339 NSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVED-KF  417 (721)
Q Consensus       339 ~~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~-~~  417 (721)
                      ++.|....+||+|+||.||+|.... |..||||.+....   .. . .++|.+|+.+|.+++|||||+|+|+|.+.+ ..
T Consensus        74 T~~Fs~~~~ig~Ggfg~VYkG~l~~-~~~vAVK~~~~~~---~~-~-~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~~~  147 (361)
T KOG1187|consen   74 TNNFSESNLIGEGGFGTVYKGVLSD-GTVVAVKRLSSNS---GQ-G-EREFLNEVEILSRLRHPNLVKLLGYCLEGGEHR  147 (361)
T ss_pred             HhCCchhcceecCCCeEEEEEEECC-CCEEEEEEecCCC---Cc-c-hhHHHHHHHHHhcCCCcCcccEEEEEecCCceE
Confidence            3678888899999999999998765 4899999765321   11 1 456999999999999999999999999988 59


Q ss_pred             EEEEeeccCCCHHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHhhCC---eeccCCCCCcEEEcCCCceEEeecCCcccc
Q 004959          418 YIYLEYVHPGSINKYVREHCG-AITESVVRNFTRHILSGLAYLHSKK---TIHRDIKGANLLVDASGVVKLADFGMAKHL  493 (721)
Q Consensus       418 yLVmEy~~gGsL~~~L~~~~~-~Lse~~i~~i~~QIl~AL~yLHs~g---IIHrDLKPeNILld~~g~VKL~DFGlA~~l  493 (721)
                      +||+|||..|+|.++|..... .++|....+|+.+++.||+|||...   |||||||+.|||+|++.+.||+|||+|+..
T Consensus       148 ~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~~~  227 (361)
T KOG1187|consen  148 LLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAKLG  227 (361)
T ss_pred             EEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCcccC
Confidence            999999999999999987655 8999999999999999999999864   999999999999999999999999999755


Q ss_pred             CC-CcccccC-CCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchh------hHHHHHHHhhc-
Q 004959          494 TG-QKADLSM-KGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYE------GAAAMFKVMRD-  564 (721)
Q Consensus       494 ~~-~~~~~s~-~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~------~~~~~~ki~~~-  564 (721)
                      .. .....+. .||..|+|||++.       ....+.++|||||||+|+||++|+.+.+...      ..+.....+.. 
T Consensus       228 ~~~~~~~~~~~~gt~gY~~PEy~~-------~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~  300 (361)
T KOG1187|consen  228 PEGDTSVSTTVMGTFGYLAPEYAS-------TGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEG  300 (361)
T ss_pred             CccccceeeecCCCCccCChhhhc-------cCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCc
Confidence            44 3222233 7999999999994       3567778999999999999999998876421      11111111111 


Q ss_pred             ------CCCCC-CCCC--HH---HHHHHHHhcccCCCCCCCHHHHHhc
Q 004959          565 ------TPAIP-DSLS--PE---GKDFLRCCFQRNPADRPPASLLLEH  600 (721)
Q Consensus       565 ------~~~~p-~~lS--~e---l~dLI~~cL~~DP~kRPSa~eLL~H  600 (721)
                            .+.+. ....  .+   +..+..+|++.+|++||++.|+++.
T Consensus       301 ~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~  348 (361)
T KOG1187|consen  301 KLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKE  348 (361)
T ss_pred             chhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHH
Confidence                  11222 2333  23   3456779999999999999998653

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=1.9e-37  Score=321.35  Aligned_cols=250  Identities=30%  Similarity=0.517  Sum_probs=202.9

Q ss_pred             CCeeEeeEEeecCCeEEEEEEEC----CCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEe--
Q 004959          340 SQWQKGKLIGRGTFGSVYVASNR----ETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIV--  413 (721)
Q Consensus       340 ~~y~~~k~LG~G~fG~VY~a~~~----~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~--  413 (721)
                      ..|++.+.||+|+||.||+|...    .+++.||||.+....   . ....+.+.+|+.+++.+.|+||+++++++..  
T Consensus         4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~---~-~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~   79 (284)
T cd05038           4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSG---E-EQHRSDFEREIEILRTLDHENIVKYKGVCEKPG   79 (284)
T ss_pred             hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEecccc---c-hHHHHHHHHHHHHHHhCCCCChheEEeeeecCC
Confidence            46888899999999999999854    458899999886321   1 1456789999999999999999999998877  


Q ss_pred             cCeEEEEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCcccc
Q 004959          414 EDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHL  493 (721)
Q Consensus       414 ~~~~yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l  493 (721)
                      ....++||||+.+++|.+++......+++..+..++.||+.||+|||++||+|+||||+|||++.++.++|+|||++..+
T Consensus        80 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~  159 (284)
T cd05038          80 GRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVL  159 (284)
T ss_pred             CCceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEccccccccc
Confidence            55799999999999999999876557999999999999999999999999999999999999999999999999999876


Q ss_pred             CCCccc----ccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhH--------------
Q 004959          494 TGQKAD----LSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGA--------------  555 (721)
Q Consensus       494 ~~~~~~----~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~--------------  555 (721)
                      ......    ....++..|++||.+..       ..++.++|||||||++|||++|..||......              
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~Pe~~~~-------~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~  232 (284)
T cd05038         160 PEDKDYYYVKEPGESPIFWYAPECLRT-------SKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIV  232 (284)
T ss_pred             ccCCcceeccCCCCCcccccCcHHHcc-------CCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccH
Confidence            533221    11235567999998843       35667899999999999999999998653211              


Q ss_pred             HHHHHHhhcC--CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q 004959          556 AAMFKVMRDT--PAIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEH  600 (721)
Q Consensus       556 ~~~~ki~~~~--~~~p~~lS~el~dLI~~cL~~DP~kRPSa~eLL~H  600 (721)
                      ..+...+...  ...+..++.++.+||.+||+.+|++||++.|+++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~  279 (284)
T cd05038         233 TRLLELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILI  279 (284)
T ss_pred             HHHHHHHHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHH
Confidence            1112222221  22345677899999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-37  Score=323.04  Aligned_cols=258  Identities=27%  Similarity=0.500  Sum_probs=221.5

Q ss_pred             CCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhC-CCCCeeeeeeeEEecCeEE
Q 004959          340 SQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHL-KHPNIVQYYGSEIVEDKFY  418 (721)
Q Consensus       340 ~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L-~HPnIV~l~g~~~~~~~~y  418 (721)
                      .+|.++++||+|+|++|.+++++.|.+.||+|++.+.-  ....+.+.-++.|-.+..+. +||.+|-++.+|.++.+++
T Consensus       250 ~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel--~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlf  327 (593)
T KOG0695|consen  250 QDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKEL--VNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLF  327 (593)
T ss_pred             ccceeeeeecCcchhhhhheehcccceeeehhhHHHHh--cCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEE
Confidence            47999999999999999999999999999999986421  12223455667788888777 5999999999999999999


Q ss_pred             EEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccc-cCCCc
Q 004959          419 IYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKH-LTGQK  497 (721)
Q Consensus       419 LVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~-l~~~~  497 (721)
                      +|.||+.||+|--.+++. .+++|+.++.|...|+.||.|||++|||+||||..|||||.+|.|||.|+|+++. +..+.
T Consensus       328 fvieyv~ggdlmfhmqrq-rklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdygmcke~l~~gd  406 (593)
T KOG0695|consen  328 FVIEYVNGGDLMFHMQRQ-RKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLGPGD  406 (593)
T ss_pred             EEEEEecCcceeeehhhh-hcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeecccchhhcCCCCCc
Confidence            999999999997666554 6899999999999999999999999999999999999999999999999999986 44555


Q ss_pred             ccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCc-------hhhHHHHHH-HhhcCCCCC
Q 004959          498 ADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSE-------YEGAAAMFK-VMRDTPAIP  569 (721)
Q Consensus       498 ~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~-------~~~~~~~~k-i~~~~~~~p  569 (721)
                      ...++||||.|+|||++       ++..|...+|+|+|||+++||+.|+.||+-       .+..+.+++ |+.....+|
T Consensus       407 ~tstfcgtpnyiapeil-------rgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqirip  479 (593)
T KOG0695|consen  407 TTSTFCGTPNYIAPEIL-------RGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIRIP  479 (593)
T ss_pred             ccccccCCCcccchhhh-------cccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhccccc
Confidence            66789999999999999       456788889999999999999999999952       233444444 455667889


Q ss_pred             CCCCHHHHHHHHHhcccCCCCCC------CHHHHHhccccccCC
Q 004959          570 DSLSPEGKDFLRCCFQRNPADRP------PASLLLEHRFLKNSQ  607 (721)
Q Consensus       570 ~~lS~el~dLI~~cL~~DP~kRP------Sa~eLL~Hp~f~~~~  607 (721)
                      ..+|-.+-.+|+..|.+||.+|.      -+.++-.|+||....
T Consensus       480 rslsvkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~id  523 (593)
T KOG0695|consen  480 RSLSVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRSID  523 (593)
T ss_pred             ceeehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhhCC
Confidence            99999999999999999999996      478899999998543

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.1e-38  Score=333.63  Aligned_cols=253  Identities=26%  Similarity=0.405  Sum_probs=206.4

Q ss_pred             CCCCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCC--CC----CeeeeeeeE
Q 004959          338 MNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLK--HP----NIVQYYGSE  411 (721)
Q Consensus       338 l~~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~--HP----nIV~l~g~~  411 (721)
                      +..+|++.++||+|.||+|.+|.+..++..||||+++..      ....+...-||++|+++.  .|    -+|.+.++|
T Consensus        87 l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V------~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wF  160 (415)
T KOG0671|consen   87 LTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV------DKYREAALIEIEVLQKINESDPNGKFRCVQMRDWF  160 (415)
T ss_pred             cccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH------HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhh
Confidence            467899999999999999999999999999999988522      223345667999999994  22    478888889


Q ss_pred             EecCeEEEEEeeccCCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcC------------
Q 004959          412 IVEDKFYIYLEYVHPGSINKYVREH-CGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDA------------  478 (721)
Q Consensus       412 ~~~~~~yLVmEy~~gGsL~~~L~~~-~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~------------  478 (721)
                      ...+.++||+|.+ |-+++++|.++ ...++...++.+++||+.+++|||+++++|-||||||||+-.            
T Consensus       161 dyrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~  239 (415)
T KOG0671|consen  161 DYRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKK  239 (415)
T ss_pred             hccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCCc
Confidence            9999999999999 67999999874 457899999999999999999999999999999999999832            


Q ss_pred             --------CCceEEeecCCccccCCCcccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCC
Q 004959          479 --------SGVVKLADFGMAKHLTGQKADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWS  550 (721)
Q Consensus       479 --------~g~VKL~DFGlA~~l~~~~~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~  550 (721)
                              +..|||+|||.|+.-.  +.+.+.+.|..|+|||++.+       -+++..+||||+||||+||++|...|.
T Consensus       240 ~~~~r~~ks~~I~vIDFGsAtf~~--e~hs~iVsTRHYRAPEViLg-------LGwS~pCDvWSiGCIL~ElytG~~LFq  310 (415)
T KOG0671|consen  240 VCFIRPLKSTAIKVIDFGSATFDH--EHHSTIVSTRHYRAPEVILG-------LGWSQPCDVWSIGCILVELYTGETLFQ  310 (415)
T ss_pred             cceeccCCCcceEEEecCCcceec--cCcceeeeccccCCchheec-------cCcCCccCceeeeeEEEEeeccceecc
Confidence                    2258999999997543  33467789999999999975       456678999999999999999999998


Q ss_pred             chhhHH---HHHHHhhcCC------------------CCC-------------------------CCCCHHHHHHHHHhc
Q 004959          551 EYEGAA---AMFKVMRDTP------------------AIP-------------------------DSLSPEGKDFLRCCF  584 (721)
Q Consensus       551 ~~~~~~---~~~ki~~~~~------------------~~p-------------------------~~lS~el~dLI~~cL  584 (721)
                      ..++.+   ++.+++...+                  ..+                         +.-..++.|||++||
T Consensus       311 tHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL  390 (415)
T KOG0671|consen  311 THENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRML  390 (415)
T ss_pred             cCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHH
Confidence            765444   4444433111                  000                         011356789999999


Q ss_pred             ccCCCCCCCHHHHHhccccccC
Q 004959          585 QRNPADRPPASLLLEHRFLKNS  606 (721)
Q Consensus       585 ~~DP~kRPSa~eLL~Hp~f~~~  606 (721)
                      ..||.+|+|+.|+|.||||+..
T Consensus       391 ~fDP~~RiTl~EAL~HpFF~~~  412 (415)
T KOG0671|consen  391 EFDPARRITLREALSHPFFARL  412 (415)
T ss_pred             ccCccccccHHHHhcCHHhhcC
Confidence            9999999999999999999864

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=100.00  E-value=5e-36  Score=299.69  Aligned_cols=240  Identities=39%  Similarity=0.691  Sum_probs=203.1

Q ss_pred             CCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeEEEEEeeccCCCHHH
Q 004959          352 TFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINK  431 (721)
Q Consensus       352 ~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~yLVmEy~~gGsL~~  431 (721)
                      +||.||+|.+..+|+.+|+|++......    ...+.+.+|+.++++++|+||+++++++......+++|||+.+++|..
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~----~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~   76 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIK----KKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFD   76 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccc----cHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHH
Confidence            5899999999999999999998632111    115788999999999999999999999999999999999999999999


Q ss_pred             HHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCCcccccCCCCCccCCh
Q 004959          432 YVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPYWMAP  511 (721)
Q Consensus       432 ~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~~~~~s~~GT~~Y~AP  511 (721)
                      ++... ..+++..+..++.||+.+|.|||+.||+|+||+|.||+++.++.++|+|||++..+..........|+..|++|
T Consensus        77 ~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~p  155 (244)
T smart00220       77 LLKKR-GRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGGLLTTFVGTPEYMAP  155 (244)
T ss_pred             HHHhc-cCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeeccccccccccCCcCCCCH
Confidence            99765 34899999999999999999999999999999999999999999999999999887655444556789999999


Q ss_pred             hhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhh-cCCCCCCC---CCHHHHHHHHHhcccC
Q 004959          512 ELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMR-DTPAIPDS---LSPEGKDFLRCCFQRN  587 (721)
Q Consensus       512 Evl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~-~~~~~p~~---lS~el~dLI~~cL~~D  587 (721)
                      |.+.       ...++.++|||+||+++|+|++|..||.............. ........   ++.++.+++.+||..+
T Consensus       156 E~~~-------~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~  228 (244)
T smart00220      156 EVLL-------GKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWKISPEAKDLIRKLLVKD  228 (244)
T ss_pred             HHHc-------cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCccccccCCHHHHHHHHHHccCC
Confidence            9984       34456689999999999999999999987333333333333 22222222   8899999999999999


Q ss_pred             CCCCCCHHHHHhcccc
Q 004959          588 PADRPPASLLLEHRFL  603 (721)
Q Consensus       588 P~kRPSa~eLL~Hp~f  603 (721)
                      |++||++.++++||||
T Consensus       229 p~~Rp~~~~~~~~~~~  244 (244)
T smart00220      229 PEKRLTAEEALQHPFF  244 (244)
T ss_pred             chhccCHHHHhhCCCC
Confidence            9999999999999997

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.3e-38  Score=336.91  Aligned_cols=266  Identities=26%  Similarity=0.468  Sum_probs=219.6

Q ss_pred             CCCCCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCC--CcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEE-e
Q 004959          337 PMNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPD--DPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEI-V  413 (721)
Q Consensus       337 ~l~~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~--~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~-~  413 (721)
                      .+.++|-++.+||+|||+.||+|.+....+.||+|+-...+.  +.+.....+...+|..|.+.|+||.||++|++|. +
T Consensus       460 tLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslD  539 (775)
T KOG1151|consen  460 TLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLD  539 (775)
T ss_pred             chHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeec
Confidence            456789999999999999999999999999999998654332  2334455677889999999999999999999886 4


Q ss_pred             cCeEEEEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCC--eeccCCCCCcEEEc---CCCceEEeecC
Q 004959          414 EDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKK--TIHRDIKGANLLVD---ASGVVKLADFG  488 (721)
Q Consensus       414 ~~~~yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~g--IIHrDLKPeNILld---~~g~VKL~DFG  488 (721)
                      .+.+|-|+|||+|.+|.-||+.+ .-++|.+++.|+.||+.||.||.+..  |||-||||.|||+-   ..|.|||.|||
T Consensus       540 tdsFCTVLEYceGNDLDFYLKQh-klmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFG  618 (775)
T KOG1151|consen  540 TDSFCTVLEYCEGNDLDFYLKQH-KLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFG  618 (775)
T ss_pred             cccceeeeeecCCCchhHHHHhh-hhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecc
Confidence            56799999999999999999876 67999999999999999999999874  99999999999994   45789999999


Q ss_pred             CccccCCCccc--------ccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHH-
Q 004959          489 MAKHLTGQKAD--------LSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMF-  559 (721)
Q Consensus       489 lA~~l~~~~~~--------~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~-  559 (721)
                      |++.+.++...        ....||.||++||++.-.   .....++.++||||+|||+|.+++|+-||........+. 
T Consensus       619 LSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVg---kePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILq  695 (775)
T KOG1151|consen  619 LSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVG---KEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQ  695 (775)
T ss_pred             hhhhccCCccCcccceeeecccCceeeecCcceeecC---CCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHh
Confidence            99988654332        125699999999998531   234567889999999999999999999997654332222 


Q ss_pred             --HHhhc-CCCCC--CCCCHHHHHHHHHhcccCCCCCCCHHHHHhccccccC
Q 004959          560 --KVMRD-TPAIP--DSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNS  606 (721)
Q Consensus       560 --ki~~~-~~~~p--~~lS~el~dLI~~cL~~DP~kRPSa~eLL~Hp~f~~~  606 (721)
                        .|++. ...+|  +.++.++++||++||++.-++|..+.+|..||||...
T Consensus       696 eNTIlkAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyllPh  747 (775)
T KOG1151|consen  696 ENTILKATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLLPH  747 (775)
T ss_pred             hhchhcceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHccCccccch
Confidence              12222 22333  5689999999999999999999999999999999753

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=3.8e-37  Score=360.33  Aligned_cols=252  Identities=31%  Similarity=0.559  Sum_probs=197.7

Q ss_pred             CCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEe------
Q 004959          340 SQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIV------  413 (721)
Q Consensus       340 ~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~------  413 (721)
                      .+|+.+++||+||||.||+|+++-+|+.||||+|.+.   . +......+.+|+.+|.+|+|||||++|..+.+      
T Consensus       479 ~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~---~-s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~  554 (1351)
T KOG1035|consen  479 NDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLK---A-SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELT  554 (1351)
T ss_pred             hhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCc---h-HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccc
Confidence            4788899999999999999999999999999998753   2 45567889999999999999999976621110      


Q ss_pred             --------------------------------------------------------------------------------
Q 004959          414 --------------------------------------------------------------------------------  413 (721)
Q Consensus       414 --------------------------------------------------------------------------------  413 (721)
                                                                                                      
T Consensus       555 ~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS  634 (1351)
T KOG1035|consen  555 VLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTS  634 (1351)
T ss_pred             cccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccc
Confidence                                                                                            


Q ss_pred             -------------------------c--------CeEEEEEeeccCCCHHHHHHHhcCCC-CHHHHHHHHHHHHHHHHHH
Q 004959          414 -------------------------E--------DKFYIYLEYVHPGSINKYVREHCGAI-TESVVRNFTRHILSGLAYL  459 (721)
Q Consensus       414 -------------------------~--------~~~yLVmEy~~gGsL~~~L~~~~~~L-se~~i~~i~~QIl~AL~yL  459 (721)
                                               +        -.+||-||||+...|.++++++ ... .-..++.+++||++||.|+
T Consensus       635 ~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N-~~~~~~d~~wrLFreIlEGLaYI  713 (1351)
T KOG1035|consen  635 DSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRN-HFNSQRDEAWRLFREILEGLAYI  713 (1351)
T ss_pred             ccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhc-ccchhhHHHHHHHHHHHHHHHHH
Confidence                                     0        1258889999987777777664 222 4678999999999999999


Q ss_pred             hhCCeeccCCCCCcEEEcCCCceEEeecCCccccC-------------------CCcccccCCCCCccCChhhHHHHhhc
Q 004959          460 HSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLT-------------------GQKADLSMKGSPYWMAPELMMAVMQK  520 (721)
Q Consensus       460 Hs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~-------------------~~~~~~s~~GT~~Y~APEvl~~~~~~  520 (721)
                      |++|||||||||.||++++.+.|||+|||+|+...                   +.......+||..|+|||++.+.   
T Consensus       714 H~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~---  790 (1351)
T KOG1035|consen  714 HDQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDT---  790 (1351)
T ss_pred             HhCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccc---
Confidence            99999999999999999999999999999998721                   01122346799999999999642   


Q ss_pred             CCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhcCCCCCCC------CCHHHHHHHHHhcccCCCCCCCH
Q 004959          521 GKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDS------LSPEGKDFLRCCFQRNPADRPPA  594 (721)
Q Consensus       521 ~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~~~~~p~~------lS~el~dLI~~cL~~DP~kRPSa  594 (721)
                       ....|+.|+|||||||||+||++   ||.-.-........++ ...+|..      --+.-..+|++||+.||.+||||
T Consensus       791 -~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsMERa~iL~~LR-~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPtA  865 (1351)
T KOG1035|consen  791 -SSNKYNSKIDMYSLGIVLFEMLY---PFGTSMERASILTNLR-KGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPTA  865 (1351)
T ss_pred             -ccccccchhhhHHHHHHHHHHhc---cCCchHHHHHHHHhcc-cCCCCCCcccccccchHHHHHHHHHhcCCCccCCCH
Confidence             22468899999999999999996   4654332222223333 2223322      23455789999999999999999


Q ss_pred             HHHHhccccc
Q 004959          595 SLLLEHRFLK  604 (721)
Q Consensus       595 ~eLL~Hp~f~  604 (721)
                      .|||++.||.
T Consensus       866 ~eLL~s~llp  875 (1351)
T KOG1035|consen  866 TELLNSELLP  875 (1351)
T ss_pred             HHHhhccCCC
Confidence            9999999986

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=100.00  E-value=2e-36  Score=349.10  Aligned_cols=260  Identities=20%  Similarity=0.277  Sum_probs=182.2

Q ss_pred             CCCCeeEeeEEeecCCeEEEEEEECCC----CcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeee---
Q 004959          338 MNSQWQKGKLIGRGTFGSVYVASNRET----GALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGS---  410 (721)
Q Consensus       338 l~~~y~~~k~LG~G~fG~VY~a~~~~t----g~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~---  410 (721)
                      ..++|++++.||+|+||.||+|++..+    +..||||++...   ..    .+....|  .++...+.+++.++..   
T Consensus       130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~---~~----~e~~~~e--~l~~~~~~~~~~~~~~~~~  200 (566)
T PLN03225        130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEY---GA----VEIWMNE--RVRRACPNSCADFVYGFLE  200 (566)
T ss_pred             ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEeccc---ch----hHHHHHH--HHHhhchhhHHHHHHhhhc
Confidence            346899999999999999999999998    999999987521   11    1111111  1122222222222211   


Q ss_pred             ---EEecCeEEEEEeeccCCCHHHHHHHhcCC-------------------CCHHHHHHHHHHHHHHHHHHhhCCeeccC
Q 004959          411 ---EIVEDKFYIYLEYVHPGSINKYVREHCGA-------------------ITESVVRNFTRHILSGLAYLHSKKTIHRD  468 (721)
Q Consensus       411 ---~~~~~~~yLVmEy~~gGsL~~~L~~~~~~-------------------Lse~~i~~i~~QIl~AL~yLHs~gIIHrD  468 (721)
                         ......++|||||+.+++|.+++......                   ..+..+..++.||+.||+|||++||+|||
T Consensus       201 ~~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRD  280 (566)
T PLN03225        201 PVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRD  280 (566)
T ss_pred             ccccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCc
Confidence               23566899999999999999998653211                   12345678999999999999999999999


Q ss_pred             CCCCcEEEcC-CCceEEeecCCccccCCCc--ccccCCCCCccCChhhHHHHhhcCCC---------------CCCcchh
Q 004959          469 IKGANLLVDA-SGVVKLADFGMAKHLTGQK--ADLSMKGSPYWMAPELMMAVMQKGKS---------------SDSALAV  530 (721)
Q Consensus       469 LKPeNILld~-~g~VKL~DFGlA~~l~~~~--~~~s~~GT~~Y~APEvl~~~~~~~k~---------------~~~s~as  530 (721)
                      |||+||||+. ++.+||+|||+|+.+....  ....++||+.|||||.+....+....               ..+..++
T Consensus       281 LKP~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~  360 (566)
T PLN03225        281 VKPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRF  360 (566)
T ss_pred             CCHHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCc
Confidence            9999999986 5799999999998664332  22356799999999987543222111               1234567


Q ss_pred             hHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhcC----------------------CCCCCCCCHHHHHHHHHhcccCC
Q 004959          531 DIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDT----------------------PAIPDSLSPEGKDFLRCCFQRNP  588 (721)
Q Consensus       531 DVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~~----------------------~~~p~~lS~el~dLI~~cL~~DP  588 (721)
                      ||||||||||||+++..++...  ...+.+++...                      ..+.+....++.+||++||++||
T Consensus       361 DVwSlGviL~el~~~~~~~~~~--~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP  438 (566)
T PLN03225        361 DIYSAGLIFLQMAFPNLRSDSN--LIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKG  438 (566)
T ss_pred             ccHHHHHHHHHHHhCcCCCchH--HHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCc
Confidence            9999999999999988776532  11221111100                      01112223456699999999999


Q ss_pred             CCCCCHHHHHhccccccCCC
Q 004959          589 ADRPPASLLLEHRFLKNSQQ  608 (721)
Q Consensus       589 ~kRPSa~eLL~Hp~f~~~~~  608 (721)
                      ++|||+.|+|+||||.....
T Consensus       439 ~kR~ta~e~L~Hpff~~~~~  458 (566)
T PLN03225        439 RQRISAKAALAHPYFDREGL  458 (566)
T ss_pred             ccCCCHHHHhCCcCcCCCCc
Confidence            99999999999999987543

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.7e-38  Score=320.77  Aligned_cols=261  Identities=28%  Similarity=0.476  Sum_probs=212.4

Q ss_pred             CCCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEec----
Q 004959          339 NSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVE----  414 (721)
Q Consensus       339 ~~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~----  414 (721)
                      .+.|+....||+|.||.||+|+.+.+|+.||+|++....  .+ ...-....+|+.+|..|+|+|++.++++|...    
T Consensus        16 ~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmen--eK-eGfpitalreikiL~~lkHenv~nliEic~tk~Tp~   92 (376)
T KOG0669|consen   16 VSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMEN--EK-EGFPITALREIKILQLLKHENVVNLIEICRTKATPT   92 (376)
T ss_pred             chHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhc--cc-cCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCc
Confidence            457888899999999999999999999999999775321  11 11223567899999999999999999876542    


Q ss_pred             ----CeEEEEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCc
Q 004959          415 ----DKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMA  490 (721)
Q Consensus       415 ----~~~yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA  490 (721)
                          ..+|+||.+|+ -+|.-+|.+....++..+++.++.+++.||.|+|.+.|+|||+|++|+||+.+|.+||+|||++
T Consensus        93 ~r~r~t~ylVf~~ce-hDLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilklADFGla  171 (376)
T KOG0669|consen   93 NRDRATFYLVFDFCE-HDLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILKLADFGLA  171 (376)
T ss_pred             ccccceeeeeHHHhh-hhHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEEeeccccc
Confidence                34899999996 7999999777778999999999999999999999999999999999999999999999999999


Q ss_pred             cccCCCcc-----cccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhcC
Q 004959          491 KHLTGQKA-----DLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDT  565 (721)
Q Consensus       491 ~~l~~~~~-----~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~~  565 (721)
                      +.+.-...     ....+-|.+|+.||.+.|.      ..|+.+.|||..||||.||.+|.+.|.+.....++..|..-.
T Consensus       172 r~fs~~~n~~kprytnrvvTLwYrppEllLG~------r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~Lc  245 (376)
T KOG0669|consen  172 RAFSTSKNVVKPRYTNRVVTLWYRPPELLLGD------REYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLC  245 (376)
T ss_pred             cceecccccCCCCcccceeeeecCCHHHhhcc------cccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHh
Confidence            87643221     1223469999999999864      345667999999999999999999999887766665443210


Q ss_pred             ----------------------CCCCC-------------CCCHHHHHHHHHhcccCCCCCCCHHHHHhccccccCCCC
Q 004959          566 ----------------------PAIPD-------------SLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQP  609 (721)
Q Consensus       566 ----------------------~~~p~-------------~lS~el~dLI~~cL~~DP~kRPSa~eLL~Hp~f~~~~~~  609 (721)
                                            ..++.             .-.+++.+||.++|..||.+|+++.++|.|.||.....+
T Consensus       246 Gs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~kdp~p  324 (376)
T KOG0669|consen  246 GSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWKDPMP  324 (376)
T ss_pred             ccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhcCCcc
Confidence                                  01111             125688999999999999999999999999999876443

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=100.00  E-value=4.9e-37  Score=319.27  Aligned_cols=289  Identities=22%  Similarity=0.368  Sum_probs=234.1

Q ss_pred             CCCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEec----
Q 004959          339 NSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVE----  414 (721)
Q Consensus       339 ~~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~----  414 (721)
                      ..+|.-++.+|.|.- .|..|.+.-+++.||+|.+...   .......++..+|..+|..+.|+||++++.+|.-.    
T Consensus        16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~p---f~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~   91 (369)
T KOG0665|consen   16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRP---FQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLE   91 (369)
T ss_pred             eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCc---cccCccchhhhhhhhhhhhhcccceeeeeeccCccccHH
Confidence            357888999999999 8889999999999999987643   22244567889999999999999999999988643    


Q ss_pred             --CeEEEEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccc
Q 004959          415 --DKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKH  492 (721)
Q Consensus       415 --~~~yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~  492 (721)
                        ...|+|||||. .+|.+.+..   .+.-..+..++.|+++|++|||+.||+||||||+||+|..++.+||+|||+|+.
T Consensus        92 ~~~e~y~v~e~m~-~nl~~vi~~---elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~dfg~ar~  167 (369)
T KOG0665|consen   92 EFQEVYLVMELMD-ANLCQVILM---ELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKILDFGLART  167 (369)
T ss_pred             HHHhHHHHHHhhh-hHHHHHHHH---hcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheeeccchhhcc
Confidence              36899999996 788888863   477888999999999999999999999999999999999999999999999986


Q ss_pred             cCCCcccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhcCC------
Q 004959          493 LTGQKADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTP------  566 (721)
Q Consensus       493 l~~~~~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~~~------  566 (721)
                      ....-....++.|.+|.|||++.+.       .+...+||||+|||+.||++|+..|.+.+..+++.++.....      
T Consensus       168 e~~~~~mtpyVvtRyyrapevil~~-------~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F  240 (369)
T KOG0665|consen  168 EDTDFMMTPYVVTRYYRAPEVILGM-------GYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSF  240 (369)
T ss_pred             cCcccccCchhheeeccCchheecc-------CCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHH
Confidence            5544344567899999999999753       266679999999999999999999998887777766543110      


Q ss_pred             -------------------------CCCC-----------CCCHHHHHHHHHhcccCCCCCCCHHHHHhccccccCCCC-
Q 004959          567 -------------------------AIPD-----------SLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQP-  609 (721)
Q Consensus       567 -------------------------~~p~-----------~lS~el~dLI~~cL~~DP~kRPSa~eLL~Hp~f~~~~~~-  609 (721)
                                               .+|+           .-+..+++++.+||..||++|.+++++|+|||++-+..+ 
T Consensus       241 ~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~vw~~~~  320 (369)
T KOG0665|consen  241 MKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIKVWYDPD  320 (369)
T ss_pred             HHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeeeeecccc
Confidence                                     0111           123567899999999999999999999999999843333 


Q ss_pred             --CCCCcccccCCCCCCCCCCChhHHHhhhHHHHHhh
Q 004959          610 --DVPSCSLSFSGMQLTEKPHSPREKADAKYDQVAAL  644 (721)
Q Consensus       610 --~~~~~~~~~~~~~l~~~~~~~~~~~~~~~d~~~~l  644 (721)
                        ..+...  .....++..++...+.++..++++...
T Consensus       321 ev~ap~pe--~~d~~~d~~~~t~~e~ke~If~ev~~f  355 (369)
T KOG0665|consen  321 EVEAPPPE--IYDKQLDEREHTIEEWKELIFKEVQRF  355 (369)
T ss_pred             cccCCCCc--hhhhhcccccCCHHHHHHHHHHHHHhh
Confidence              222222  233556677777889999999998775

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=4.7e-37  Score=345.33  Aligned_cols=243  Identities=30%  Similarity=0.519  Sum_probs=199.4

Q ss_pred             CCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecC----
Q 004959          340 SQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVED----  415 (721)
Q Consensus       340 ~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~----  415 (721)
                      +.|...+.||+|+||.||+++++.+|+.||||.++...    .....+..-+|+++|++|+|+|||+++++.++..    
T Consensus        13 y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~----~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~   88 (732)
T KOG4250|consen   13 YLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKES----SLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLV   88 (732)
T ss_pred             cceeehhhhcCCccceeeeecccccccchhHHhhhhhc----ccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcc
Confidence            57899999999999999999999999999999986432    3344678889999999999999999999866543    


Q ss_pred             --eEEEEEeeccCCCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEc--CCC--ceEEeec
Q 004959          416 --KFYIYLEYVHPGSINKYVREH--CGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVD--ASG--VVKLADF  487 (721)
Q Consensus       416 --~~yLVmEy~~gGsL~~~L~~~--~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld--~~g--~VKL~DF  487 (721)
                        ...+|||||.||+|..+|.+-  ...|+|.++..++..|..||.|||++|||||||||.||++-  ++|  .-||+||
T Consensus        89 ~~~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDf  168 (732)
T KOG4250|consen   89 TRLPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDF  168 (732)
T ss_pred             cccceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeecc
Confidence              568999999999999999643  45799999999999999999999999999999999999984  334  3599999


Q ss_pred             CCccccCCCcccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhH----HHHHHHhh
Q 004959          488 GMAKHLTGQKADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGA----AAMFKVMR  563 (721)
Q Consensus       488 GlA~~l~~~~~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~----~~~~ki~~  563 (721)
                      |+|+.+..+....+++||+.|.+||++..      ...|+..+|.|||||++|+++||..||......    +.+..+..
T Consensus       169 G~Arel~d~s~~~S~vGT~~YLhPel~E~------q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~t  242 (732)
T KOG4250|consen  169 GAARELDDNSLFTSLVGTEEYLHPELYER------QKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIIT  242 (732)
T ss_pred             cccccCCCCCeeeeecCchhhcChHHHhh------ccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhc
Confidence            99999998888888999999999999953      345677799999999999999999999654322    33443332


Q ss_pred             cC---------------------CCCCCCCCHHH----HHHHHHhcccCCCCCC
Q 004959          564 DT---------------------PAIPDSLSPEG----KDFLRCCFQRNPADRP  592 (721)
Q Consensus       564 ~~---------------------~~~p~~lS~el----~dLI~~cL~~DP~kRP  592 (721)
                      ..                     .++|..++..+    -..|..+|..+|++|.
T Consensus       243 kkp~~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~  296 (732)
T KOG4250|consen  243 KKPSGVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRG  296 (732)
T ss_pred             cCCCceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhC
Confidence            11                     12233444443    3467788999999998

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-35  Score=324.96  Aligned_cols=249  Identities=28%  Similarity=0.441  Sum_probs=204.6

Q ss_pred             CCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeEEE
Q 004959          340 SQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYI  419 (721)
Q Consensus       340 ~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~yL  419 (721)
                      +...+++.||+|-||+|.+|.-.. +..||+|.++-    .......+.|.+||++|.+|+|||||+++|+|..++.+++
T Consensus       538 s~L~~~ekiGeGqFGEVhLCeveg-~lkVAVK~Lr~----~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicm  612 (807)
T KOG1094|consen  538 SRLRFKEKIGEGQFGEVHLCEVEG-PLKVAVKILRP----DATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCM  612 (807)
T ss_pred             hheehhhhhcCcccceeEEEEecC-ceEEEEeecCc----ccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHH
Confidence            356788999999999999997543 68999998752    1223346889999999999999999999999999999999


Q ss_pred             EEeeccCCCHHHHHHHhcCCC-CHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCCcc
Q 004959          420 YLEYVHPGSINKYVREHCGAI-TESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKA  498 (721)
Q Consensus       420 VmEy~~gGsL~~~L~~~~~~L-se~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~~~  498 (721)
                      |||||+.|+|.+++.++..+. .......|+.||+.||+||.+.++|||||.+.|+|++.++++||+|||+++-+..+..
T Consensus       613 I~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~y  692 (807)
T KOG1094|consen  613 ITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDY  692 (807)
T ss_pred             HHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEecCcccccccccCCc
Confidence            999999999999998774333 4445667999999999999999999999999999999999999999999997765543


Q ss_pred             ccc---CCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhh--CCCCCCchhhHHHHHHH---hhc-----C
Q 004959          499 DLS---MKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT--GKPPWSEYEGAAAMFKV---MRD-----T  565 (721)
Q Consensus       499 ~~s---~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLt--G~~PF~~~~~~~~~~ki---~~~-----~  565 (721)
                      ...   .+-...|||+|.+..       ..++.++|+|+|||+|||+++  ...||......+.....   ...     .
T Consensus       693 y~vqgr~vlpiRwmawEsill-------gkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~  765 (807)
T KOG1094|consen  693 YRVQGRAVLPIRWMAWESILL-------GKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVV  765 (807)
T ss_pred             eeeecceeeeeeehhHHHHHh-------ccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCccee
Confidence            321   223467999999853       456778999999999999764  88999877665554433   221     2


Q ss_pred             CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q 004959          566 PAIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEH  600 (721)
Q Consensus       566 ~~~p~~lS~el~dLI~~cL~~DP~kRPSa~eLL~H  600 (721)
                      ...|.-++.++.++|.+||..|-++||++++|..|
T Consensus       766 l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~  800 (807)
T KOG1094|consen  766 LSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLF  800 (807)
T ss_pred             ccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHH
Confidence            34566789999999999999999999999998543

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-36  Score=338.06  Aligned_cols=252  Identities=27%  Similarity=0.446  Sum_probs=215.7

Q ss_pred             CCeeEeeEEeecCCeEEEEEEECCC---CcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCe
Q 004959          340 SQWQKGKLIGRGTFGSVYVASNRET---GALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDK  416 (721)
Q Consensus       340 ~~y~~~k~LG~G~fG~VY~a~~~~t---g~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~  416 (721)
                      .+.+++++||+|.||+|+.|.++..   ...||||++....   . ...+..|++|+.+|.+|+|+|+|+|||+..+ ..
T Consensus       110 e~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~---l-~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp  184 (1039)
T KOG0199|consen  110 EQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDS---L-NAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QP  184 (1039)
T ss_pred             HHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCc---c-chhHHHHHHHHHHHHhccCcceeEEeeeecc-ch
Confidence            4567889999999999999987743   3568999986322   2 2267899999999999999999999999776 77


Q ss_pred             EEEEEeeccCCCHHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCC
Q 004959          417 FYIYLEYVHPGSINKYVRE-HCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTG  495 (721)
Q Consensus       417 ~yLVmEy~~gGsL~~~L~~-~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~  495 (721)
                      +.+|||++.+|+|.+.|++ ....|.......|+.||+.||.||..+++|||||...|||+-....||||||||.+.+..
T Consensus       185 ~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~DFGLmRaLg~  264 (1039)
T KOG0199|consen  185 AMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICDFGLMRALGE  264 (1039)
T ss_pred             hhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceeeeecccceeccCC
Confidence            8999999999999999987 567788999999999999999999999999999999999999889999999999999877


Q ss_pred             CcccccCC----CCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhh-CCCCCCchhhHHHHHHHhhc-CCCCC
Q 004959          496 QKADLSMK----GSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFKVMRD-TPAIP  569 (721)
Q Consensus       496 ~~~~~s~~----GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLt-G~~PF~~~~~~~~~~ki~~~-~~~~p  569 (721)
                      .+.++.+.    --..|+|||.|       +...++-++|||+|||+||||++ |..||.+.....++.++-.+ ...-|
T Consensus       265 ned~Yvm~p~rkvPfAWCaPEsL-------rh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~~erLpRP  337 (1039)
T KOG0199|consen  265 NEDMYVMAPQRKVPFAWCAPESL-------RHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDAGERLPRP  337 (1039)
T ss_pred             CCcceEecCCCcCcccccCHhHh-------ccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhccccccCCCC
Confidence            66655433    23569999999       45667789999999999999998 89999999888888777533 34567


Q ss_pred             CCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccc
Q 004959          570 DSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFL  603 (721)
Q Consensus       570 ~~lS~el~dLI~~cL~~DP~kRPSa~eLL~Hp~f  603 (721)
                      ..++++++++++.||..+|++|||+..|.+.-++
T Consensus       338 k~csedIY~imk~cWah~paDRptFsair~~~~l  371 (1039)
T KOG0199|consen  338 KYCSEDIYQIMKNCWAHNPADRPTFSAIREDLVL  371 (1039)
T ss_pred             CCChHHHHHHHHHhccCCccccccHHHHHHhHHH
Confidence            8899999999999999999999999998654343

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-37  Score=316.60  Aligned_cols=257  Identities=29%  Similarity=0.465  Sum_probs=214.1

Q ss_pred             CeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHH-HHhCCCCCeeeeeeeEEecCeEEE
Q 004959          341 QWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKV-LSHLKHPNIVQYYGSEIVEDKFYI  419 (721)
Q Consensus       341 ~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~i-L~~L~HPnIV~l~g~~~~~~~~yL  419 (721)
                      ..+-+..||.|+||+|++-.++.+|+..|||.|+....    ....++++.|... |+.-++||||++||....++..||
T Consensus        65 ~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~----~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWi  140 (361)
T KOG1006|consen   65 NLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNI----EKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWI  140 (361)
T ss_pred             hHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccc----hHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceee
Confidence            45667789999999999999999999999999975322    3345677777765 455579999999999999999999


Q ss_pred             EEeeccCCCHHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHhhC-CeeccCCCCCcEEEcCCCceEEeecCCccccC
Q 004959          420 YLEYVHPGSINKYVRE----HCGAITESVVRNFTRHILSGLAYLHSK-KTIHRDIKGANLLVDASGVVKLADFGMAKHLT  494 (721)
Q Consensus       420 VmEy~~gGsL~~~L~~----~~~~Lse~~i~~i~~QIl~AL~yLHs~-gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~  494 (721)
                      .||+|+ .+|..+.+.    ....++|+.+-.|....+.||.||.+. .||||||||+|||++..|.|||||||++-.+.
T Consensus       141 CMELMd-~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv  219 (361)
T KOG1006|consen  141 CMELMD-ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLV  219 (361)
T ss_pred             eHHHHh-hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeeecccchHhHH
Confidence            999996 676554321    236799999999999999999999764 89999999999999999999999999998877


Q ss_pred             CCcccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchh-hHHHHHHHhhcCCCCC----
Q 004959          495 GQKADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYE-GAAAMFKVMRDTPAIP----  569 (721)
Q Consensus       495 ~~~~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~-~~~~~~ki~~~~~~~p----  569 (721)
                      +.-......|...|||||.+..     ....|+.++||||||++|||+.||..|+.+-+ ..+++..+..+.+.+.    
T Consensus       220 ~SiAkT~daGCrpYmAPERi~p-----~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdpp~l~~~~  294 (361)
T KOG1006|consen  220 DSIAKTVDAGCRPYMAPERIDP-----SDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDPPILLFDK  294 (361)
T ss_pred             HHHHhhhccCCccccChhccCC-----ccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCCCCeecCcc
Confidence            6665556679999999999953     33358889999999999999999999998744 4566666666554432    


Q ss_pred             --CCCCHHHHHHHHHhcccCCCCCCCHHHHHhccccccCC
Q 004959          570 --DSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQ  607 (721)
Q Consensus       570 --~~lS~el~dLI~~cL~~DP~kRPSa~eLL~Hp~f~~~~  607 (721)
                        -.++..+..||..||.+|-..||.+.+|+++||+....
T Consensus       295 ~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr~y~  334 (361)
T KOG1006|consen  295 ECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKFPFYRMYA  334 (361)
T ss_pred             cccccCHHHHHHHHHHhhcccccCcchhhhhcCchhhhhh
Confidence              23789999999999999999999999999999998644

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=100.00  E-value=8.6e-35  Score=329.99  Aligned_cols=267  Identities=19%  Similarity=0.259  Sum_probs=190.4

Q ss_pred             CCCeeEeeEEeecCCeEEEEEEEC----------------CCCcEEEEEEeecCCCCccc---------HHHHHHHHHHH
Q 004959          339 NSQWQKGKLIGRGTFGSVYVASNR----------------ETGALCAMKEVDIFPDDPKS---------AESIKQLEQEI  393 (721)
Q Consensus       339 ~~~y~~~k~LG~G~fG~VY~a~~~----------------~tg~~vAIK~i~~~~~~~~~---------~~~~k~~~~Ei  393 (721)
                      .++|++.++||+|+||+||+|...                ..++.||||.+.........         ....+....|+
T Consensus       144 ~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~  223 (507)
T PLN03224        144 SDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEA  223 (507)
T ss_pred             ccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHH
Confidence            568999999999999999999642                34568999998532110000         00112334577


Q ss_pred             HHHHhCCCCCe-----eeeeeeEEe--------cCeEEEEEeeccCCCHHHHHHHhcC----------------------
Q 004959          394 KVLSHLKHPNI-----VQYYGSEIV--------EDKFYIYLEYVHPGSINKYVREHCG----------------------  438 (721)
Q Consensus       394 ~iL~~L~HPnI-----V~l~g~~~~--------~~~~yLVmEy~~gGsL~~~L~~~~~----------------------  438 (721)
                      .++.+++|.++     +++++++..        ++..+|||||+.+++|.+++....+                      
T Consensus       224 ~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~  303 (507)
T PLN03224        224 YMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQ  303 (507)
T ss_pred             HHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhccc
Confidence            77788876654     566666543        3568999999999999999864321                      


Q ss_pred             -CCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCCccccc--CCCCCccCChhhHH
Q 004959          439 -AITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLS--MKGSPYWMAPELMM  515 (721)
Q Consensus       439 -~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~~~~~s--~~GT~~Y~APEvl~  515 (721)
                       .+.+..++.++.||+.||.|||+++|+||||||+|||++.++.+||+|||++..+........  ..+|+.|+|||++.
T Consensus       304 ~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~l~  383 (507)
T PLN03224        304 DKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEELV  383 (507)
T ss_pred             ccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChhhhc
Confidence             235677889999999999999999999999999999999999999999999976544322222  23589999999985


Q ss_pred             HHhhcCCC---------------CCCcchhhHHHHHHHHHHHhhCCC-CCCchhhHHHH-----------HHHhhcC--C
Q 004959          516 AVMQKGKS---------------SDSALAVDIWSLGCTIIEMYTGKP-PWSEYEGAAAM-----------FKVMRDT--P  566 (721)
Q Consensus       516 ~~~~~~k~---------------~~~s~asDVWSLGVILyELLtG~~-PF~~~~~~~~~-----------~ki~~~~--~  566 (721)
                      ........               .......||||+|||||+|++|.. ||.........           ..+....  .
T Consensus       384 ~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~~~~~  463 (507)
T PLN03224        384 MPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQKYDF  463 (507)
T ss_pred             CCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcccCCCc
Confidence            32111100               111224799999999999999986 77542211111           1111111  2


Q ss_pred             CCCCCCCHHHHHHHHHhcccCC---CCCCCHHHHHhcccccc
Q 004959          567 AIPDSLSPEGKDFLRCCFQRNP---ADRPPASLLLEHRFLKN  605 (721)
Q Consensus       567 ~~p~~lS~el~dLI~~cL~~DP---~kRPSa~eLL~Hp~f~~  605 (721)
                      ...+.++++++|||.+||..+|   .+|+|++|+|+||||..
T Consensus       464 ~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~~  505 (507)
T PLN03224        464 SLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFLP  505 (507)
T ss_pred             ccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcCC
Confidence            2345678999999999999876   68999999999999964

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=8.3e-36  Score=328.86  Aligned_cols=244  Identities=26%  Similarity=0.503  Sum_probs=208.3

Q ss_pred             eEeeEEeecCCeEEEEEEECC--CC--cEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeEE
Q 004959          343 QKGKLIGRGTFGSVYVASNRE--TG--ALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFY  418 (721)
Q Consensus       343 ~~~k~LG~G~fG~VY~a~~~~--tg--~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~y  418 (721)
                      .+.++||+|-||.||+|....  .|  -.||||....    ....+..+.|..|..+|+.++|||||+++|++. +..++
T Consensus       392 tl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~----d~t~d~tekflqEa~iMrnfdHphIikLIGv~~-e~P~W  466 (974)
T KOG4257|consen  392 TLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKT----DCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCV-EQPMW  466 (974)
T ss_pred             cHHHhhcCCcccceeeeEecccccCcceeeeeehhcc----CCChhhHHHHHHHHHHHHhCCCcchhheeeeee-cccee
Confidence            345789999999999997543  23  3578886542    123344688999999999999999999999865 56899


Q ss_pred             EEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCCcc
Q 004959          419 IYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKA  498 (721)
Q Consensus       419 LVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~~~  498 (721)
                      ||||++.-|.|..||+.++..|+......|+.||+.||.|||+..+|||||...||||.....|||+||||++.+..+..
T Consensus       467 ivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~y  546 (974)
T KOG4257|consen  467 IVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQCVKLADFGLSRYLEDDAY  546 (974)
T ss_pred             EEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcceeeecccchhhhccccch
Confidence            99999999999999998888999999999999999999999999999999999999999999999999999998876654


Q ss_pred             cccCCCC--CccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhh-CCCCCCchhhHHHHHHHhhc-CCCCCCCCCH
Q 004959          499 DLSMKGS--PYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFKVMRD-TPAIPDSLSP  574 (721)
Q Consensus       499 ~~s~~GT--~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLt-G~~PF~~~~~~~~~~ki~~~-~~~~p~~lS~  574 (721)
                      ...-.|-  .-|||||.+       ....++.++|||-|||++||++. |..||.+..+.+.+..+-++ ....|+.+++
T Consensus       547 YkaS~~kLPIKWmaPESI-------NfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnGeRlP~P~nCPp  619 (974)
T KOG4257|consen  547 YKASRGKLPIKWMAPESI-------NFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENGERLPCPPNCPP  619 (974)
T ss_pred             hhccccccceeecCcccc-------chhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEecCCCCCCCCCCCCh
Confidence            3333333  349999998       45678889999999999999886 99999998887777776654 4678899999


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHH
Q 004959          575 EGKDFLRCCFQRNPADRPPASLLL  598 (721)
Q Consensus       575 el~dLI~~cL~~DP~kRPSa~eLL  598 (721)
                      .+..|+.+||.+||.+||++.||.
T Consensus       620 ~LYslmskcWayeP~kRPrftei~  643 (974)
T KOG4257|consen  620 ALYSLMSKCWAYEPSKRPRFTEIK  643 (974)
T ss_pred             HHHHHHHHHhccCcccCCcHHHHH
Confidence            999999999999999999998863

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-35  Score=324.58  Aligned_cols=243  Identities=27%  Similarity=0.500  Sum_probs=208.0

Q ss_pred             EeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeEEEEEee
Q 004959          344 KGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYIYLEY  423 (721)
Q Consensus       344 ~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~yLVmEy  423 (721)
                      ....||.|-||.||.+.++.-.-.||||.+.      .+...+++|+.|..+|+.++|||+|+|+|+|..+-.+|||.||
T Consensus       271 MkhKLGGGQYGeVYeGvWKkyslTvAVKtLK------EDtMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEf  344 (1157)
T KOG4278|consen  271 MKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK------EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEF  344 (1157)
T ss_pred             eeeccCCCcccceeeeeeeccceeeehhhhh------hcchhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEec
Confidence            4467999999999999999988999999874      3345678999999999999999999999999999999999999


Q ss_pred             ccCCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCCcccc--
Q 004959          424 VHPGSINKYVREH-CGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADL--  500 (721)
Q Consensus       424 ~~gGsL~~~L~~~-~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~~~~~--  500 (721)
                      |..|+|.+||++. ...++.-...+++.||..||+||..+++|||||...|+||.++..||++||||++.+.++....  
T Consensus       345 M~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTYTAHA  424 (1157)
T KOG4278|consen  345 MCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTYTAHA  424 (1157)
T ss_pred             ccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccceEEeeccchhhhhcCCceeccc
Confidence            9999999999875 3456777788999999999999999999999999999999999999999999999887664322  


Q ss_pred             cCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhh-CCCCCCchhhHHHHHHHhhcC-CCCCCCCCHHHHH
Q 004959          501 SMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFKVMRDT-PAIPDSLSPEGKD  578 (721)
Q Consensus       501 s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLt-G~~PF~~~~~~~~~~ki~~~~-~~~p~~lS~el~d  578 (721)
                      ...--.-|.|||-|.       ...++.++|||+|||+|||+.| |-.||.+.+....+..+-++. -.-|+.+++.+.+
T Consensus       425 GAKFPIKWTAPEsLA-------yNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkgyRM~~PeGCPpkVYe  497 (1157)
T KOG4278|consen  425 GAKFPIKWTAPESLA-------YNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKGYRMDGPEGCPPKVYE  497 (1157)
T ss_pred             CccCcccccCccccc-------ccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhccccccCCCCCCHHHHH
Confidence            222345699999994       4567788999999999999988 999999876554444333332 3457899999999


Q ss_pred             HHHHhcccCCCCCCCHHHHHh
Q 004959          579 FLRCCFQRNPADRPPASLLLE  599 (721)
Q Consensus       579 LI~~cL~~DP~kRPSa~eLL~  599 (721)
                      ||+.||+++|.+||++.|+-+
T Consensus       498 LMraCW~WsPsDRPsFaeiHq  518 (1157)
T KOG4278|consen  498 LMRACWNWSPSDRPSFAEIHQ  518 (1157)
T ss_pred             HHHHHhcCCcccCccHHHHHH
Confidence            999999999999999999853

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=100.00  E-value=5.7e-36  Score=299.11  Aligned_cols=251  Identities=24%  Similarity=0.438  Sum_probs=209.3

Q ss_pred             CCCCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCC-CCCeeeeeeeEEec--
Q 004959          338 MNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLK-HPNIVQYYGSEIVE--  414 (721)
Q Consensus       338 l~~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~-HPnIV~l~g~~~~~--  414 (721)
                      -.++|++.+.+|+|-|+.||.|.+..+++.++||++.-        -..+.+.+||.||+.|. |||||+++++..+.  
T Consensus        36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKP--------VkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~S  107 (338)
T KOG0668|consen   36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKP--------VKKKKIKREIKILQNLRGGPNIIKLLDIVKDPES  107 (338)
T ss_pred             ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeech--------HHHHHHHHHHHHHHhccCCCCeeehhhhhcCccc
Confidence            34689999999999999999999999999999998752        22468999999999997 99999999987764  


Q ss_pred             CeEEEEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCC-CceEEeecCCcccc
Q 004959          415 DKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDAS-GVVKLADFGMAKHL  493 (721)
Q Consensus       415 ~~~yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~-g~VKL~DFGlA~~l  493 (721)
                      ....||+||+...+...+.    ..|+..+++.++.||+.||.|||++||+|||+||.|++||.. ..++|+|+|||..+
T Consensus       108 ktpaLiFE~v~n~Dfk~ly----~tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFY  183 (338)
T KOG0668|consen  108 KTPSLIFEYVNNTDFKQLY----PTLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY  183 (338)
T ss_pred             cCchhHhhhhccccHHHHh----hhhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecchHhhc
Confidence            3578999999887765543    468889999999999999999999999999999999999864 58999999999998


Q ss_pred             CCCcccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCC-CchhhHHHHHHHhhc--------
Q 004959          494 TGQKADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPW-SEYEGAAAMFKVMRD--------  564 (721)
Q Consensus       494 ~~~~~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF-~~~~~~~~~~ki~~~--------  564 (721)
                      ..+......+.+.+|--||+|..      ...|+..-|+|||||+|..|+..+-|| .+.++.+++.+|.+-        
T Consensus       184 Hp~~eYnVRVASRyfKGPELLVd------y~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~  257 (338)
T KOG0668|consen  184 HPGKEYNVRVASRYFKGPELLVD------YQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYA  257 (338)
T ss_pred             CCCceeeeeeehhhcCCchheee------chhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHH
Confidence            88777777778999999999964      345566789999999999999999887 444555555443210        


Q ss_pred             ---------CCC--------------------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhccccccC
Q 004959          565 ---------TPA--------------------IPDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNS  606 (721)
Q Consensus       565 ---------~~~--------------------~p~~lS~el~dLI~~cL~~DP~kRPSa~eLL~Hp~f~~~  606 (721)
                               .+.                    .-..+++++.|||.++|..|-.+|+|+.|+|.||||...
T Consensus       258 Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~~~  328 (338)
T KOG0668|consen  258 YLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAPV  328 (338)
T ss_pred             HHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHHHH
Confidence                     000                    011257999999999999999999999999999999754

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-35  Score=334.79  Aligned_cols=249  Identities=24%  Similarity=0.445  Sum_probs=218.0

Q ss_pred             CeeEeeEEeecCCeEEEEEEECCCC---cEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeE
Q 004959          341 QWQKGKLIGRGTFGSVYVASNRETG---ALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKF  417 (721)
Q Consensus       341 ~y~~~k~LG~G~fG~VY~a~~~~tg---~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~  417 (721)
                      ...+.++||.|.||.||+|+.+..|   ..||||.++    ......+...|+.|..||.+++||||++|.|+......+
T Consensus       630 ~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK----~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~Pv  705 (996)
T KOG0196|consen  630 CVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLK----AGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPV  705 (996)
T ss_pred             heEEEEEEecccccceecccccCCCCcceeEEEeeec----cCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCcee
Confidence            4568899999999999999988665   569999885    344566778999999999999999999999999999999


Q ss_pred             EEEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCCc
Q 004959          418 YIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQK  497 (721)
Q Consensus       418 yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~~  497 (721)
                      .||.|||+.|+|..+|+++.+.|+..++..+++.|+.||+||-++|+|||||...||||+.+-.+|++||||++.+.++.
T Consensus       706 MIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~  785 (996)
T KOG0196|consen  706 MIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP  785 (996)
T ss_pred             EEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceEEEeccccceeecccCC
Confidence            99999999999999999998999999999999999999999999999999999999999999999999999999876554


Q ss_pred             c-cccCCC---CCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhh-CCCCCCchhhHHHHHHHhhcCC-CCCCC
Q 004959          498 A-DLSMKG---SPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFKVMRDTP-AIPDS  571 (721)
Q Consensus       498 ~-~~s~~G---T~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLt-G~~PF~~~~~~~~~~ki~~~~~-~~p~~  571 (721)
                      . ..+..|   -..|.|||.+.       ...++.++||||+||+|||.+. |..||-+..+++.+..|.++.. ..|-.
T Consensus       786 ~~~ytt~GGKIPiRWTAPEAIa-------~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gyRLPpPmD  858 (996)
T KOG0196|consen  786 EAAYTTLGGKIPIRWTAPEAIA-------YRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGYRLPPPMD  858 (996)
T ss_pred             CccccccCCccceeecChhHhh-------hcccCchhhccccceEEEEecccCCCcccccchHHHHHHHHhccCCCCCCC
Confidence            2 222222   26799999994       4567789999999999999775 9999999888888888877643 34567


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q 004959          572 LSPEGKDFLRCCFQRNPADRPPASLLLEH  600 (721)
Q Consensus       572 lS~el~dLI~~cL~~DP~kRPSa~eLL~H  600 (721)
                      ++..+..|+..||++|-.+||.+.||+.+
T Consensus       859 CP~aL~qLMldCWqkdR~~RP~F~qiV~~  887 (996)
T KOG0196|consen  859 CPAALYQLMLDCWQKDRNRRPKFAQIVST  887 (996)
T ss_pred             CcHHHHHHHHHHHHHHhhcCCCHHHHHHH
Confidence            89999999999999999999999999865

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-36  Score=306.78  Aligned_cols=257  Identities=29%  Similarity=0.486  Sum_probs=208.6

Q ss_pred             CeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEec-----C
Q 004959          341 QWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVE-----D  415 (721)
Q Consensus       341 ~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~-----~  415 (721)
                      +.+..+.||.|+||+||.+++..+|+.||+|++-.   -.......+++.+|+++|...+|.||+..+++..-.     .
T Consensus        54 Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pn---vfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFq  130 (449)
T KOG0664|consen   54 DIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPN---VFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQ  130 (449)
T ss_pred             cCCCCCcccccceeEEEeccCCCCccchhHhhcch---HHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHH
Confidence            44556789999999999999999999999997632   223344568899999999999999999988875543     3


Q ss_pred             eEEEEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCC
Q 004959          416 KFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTG  495 (721)
Q Consensus       416 ~~yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~  495 (721)
                      ++|+|.|+|. .+|.++|... +.++...++-+++||++||+|||+.||.||||||.|+|++.++.+||||||+++....
T Consensus       131 EiYV~TELmQ-SDLHKIIVSP-Q~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~  208 (449)
T KOG0664|consen  131 ELYVLTELMQ-SDLHKIIVSP-QALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLARTWDQ  208 (449)
T ss_pred             HHHHHHHHHH-hhhhheeccC-CCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEecccccccccch
Confidence            6889999995 7888888654 7899999999999999999999999999999999999999999999999999987544


Q ss_pred             Ccc-c-ccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhh----------
Q 004959          496 QKA-D-LSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMR----------  563 (721)
Q Consensus       496 ~~~-~-~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~----------  563 (721)
                      ... + ...+-|.+|+|||+++|.      ..|+.++||||+|||+.||+-.+..|......+++..|..          
T Consensus       209 d~~~hMTqEVVTQYYRAPEiLMGa------RhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaM  282 (449)
T KOG0664|consen  209 RDRLNMTHEVVTQYYRAPELLMGA------RRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAM  282 (449)
T ss_pred             hhhhhhHHHHHHHHhccHHHhhcc------hhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHH
Confidence            332 2 224568999999999973      5677789999999999999999999976655554443321          


Q ss_pred             -------------cCCCCC-----------CCCCHHHHHHHHHhcccCCCCCCCHHHHHhccccccCCC
Q 004959          564 -------------DTPAIP-----------DSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQ  608 (721)
Q Consensus       564 -------------~~~~~p-----------~~lS~el~dLI~~cL~~DP~kRPSa~eLL~Hp~f~~~~~  608 (721)
                                   .....|           ..-..+..+++.++|..||++|++.++.+.|+|+.....
T Consensus       283 r~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e~R~  351 (449)
T KOG0664|consen  283 KYACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEEGRL  351 (449)
T ss_pred             HHHhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccccccccce
Confidence                         111111           123457788999999999999999999999999876543

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=100.00  E-value=1.2e-35  Score=322.78  Aligned_cols=253  Identities=23%  Similarity=0.407  Sum_probs=208.2

Q ss_pred             CCCCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCC------CCCeeeeeeeE
Q 004959          338 MNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLK------HPNIVQYYGSE  411 (721)
Q Consensus       338 l~~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~------HPnIV~l~g~~  411 (721)
                      +...|.+....|+|-|+.|..|.+..-|..||||+|.      ......+.=+.|+.||++|+      .-|+|+|+-.|
T Consensus       430 LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIR------nNE~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F  503 (752)
T KOG0670|consen  430 LDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIR------NNEVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHF  503 (752)
T ss_pred             hcceeEEEeccccceeeeeeeccccCCCCeeEEEEee------cchHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHh
Confidence            4567888889999999999999999999999999996      23344566788999999996      34899999999


Q ss_pred             EecCeEEEEEeeccCCCHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCC-ceEEeecC
Q 004959          412 IVEDKFYIYLEYVHPGSINKYVREHCG--AITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASG-VVKLADFG  488 (721)
Q Consensus       412 ~~~~~~yLVmEy~~gGsL~~~L~~~~~--~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g-~VKL~DFG  488 (721)
                      .+.+++|||||-+. .+|.++|++.+.  .|....++.|+.||+-||..|...||+|.||||.||||++.. .+||||||
T Consensus       504 ~hknHLClVFE~Ls-lNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~iLKLCDfG  582 (752)
T KOG0670|consen  504 KHKNHLCLVFEPLS-LNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNILKLCDFG  582 (752)
T ss_pred             hhcceeEEEehhhh-chHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcceeeeccCc
Confidence            99999999999995 799999987643  477889999999999999999999999999999999999765 67999999


Q ss_pred             CccccCCCcccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhcCCCC
Q 004959          489 MAKHLTGQKADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAI  568 (721)
Q Consensus       489 lA~~l~~~~~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~~~~~  568 (721)
                      .|.....+.. ..+.-+..|.|||++.|.       .|+...|+||+||+||||.||+..|.+..+..++...+.....+
T Consensus       583 SA~~~~enei-tPYLVSRFYRaPEIiLG~-------~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~  654 (752)
T KOG0670|consen  583 SASFASENEI-TPYLVSRFYRAPEIILGL-------PYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKF  654 (752)
T ss_pred             cccccccccc-cHHHHHHhccCcceeecC-------cccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCC
Confidence            9987655443 345567889999999764       45556899999999999999999999876665554333211111


Q ss_pred             CC-----------------------------------------------------CC-------CHHHHHHHHHhcccCC
Q 004959          569 PD-----------------------------------------------------SL-------SPEGKDFLRCCFQRNP  588 (721)
Q Consensus       569 p~-----------------------------------------------------~l-------S~el~dLI~~cL~~DP  588 (721)
                      |.                                                     .+       -..+++||.+||.+||
T Consensus       655 p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP  734 (752)
T KOG0670|consen  655 PNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDP  734 (752)
T ss_pred             cHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccCh
Confidence            10                                                     01       1457899999999999


Q ss_pred             CCCCCHHHHHhcccccc
Q 004959          589 ADRPPASLLLEHRFLKN  605 (721)
Q Consensus       589 ~kRPSa~eLL~Hp~f~~  605 (721)
                      ++|.|+.|+|.||||+.
T Consensus       735 ~KRit~nqAL~HpFi~~  751 (752)
T KOG0670|consen  735 EKRITVNQALKHPFITE  751 (752)
T ss_pred             hhcCCHHHHhcCCcccC
Confidence            99999999999999974

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=3.3e-35  Score=327.20  Aligned_cols=257  Identities=37%  Similarity=0.641  Sum_probs=223.7

Q ss_pred             CCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeEEE
Q 004959          340 SQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYI  419 (721)
Q Consensus       340 ~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~yL  419 (721)
                      ++|+++..+|.|+||.||+|+++.+++..|+|+|+..+.+     .+.-+.+||-+++.++|||||.++|.|...+.++|
T Consensus        15 ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~d-----d~~~iqqei~~~~dc~h~nivay~gsylr~dklwi   89 (829)
T KOG0576|consen   15 DDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGD-----DFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWI   89 (829)
T ss_pred             cchhheeeecCCcccchhhhcccccCchhhheeeeccCCc-----cccccccceeeeecCCCcChHHHHhhhhhhcCcEE
Confidence            5899999999999999999999999999999999865433     35678899999999999999999999999999999


Q ss_pred             EEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCCc-c
Q 004959          420 YLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQK-A  498 (721)
Q Consensus       420 VmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~~-~  498 (721)
                      +||||.||+|+++-.- .+.++|.++.++++..+.||+|||++|-+|||||..|||++++|.|||+|||.+..+.... .
T Consensus        90 cMEycgggslQdiy~~-TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsaqitati~K  168 (829)
T KOG0576|consen   90 CMEYCGGGSLQDIYHV-TGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSAQITATIAK  168 (829)
T ss_pred             EEEecCCCcccceeee-cccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCchhhhhhhhhh
Confidence            9999999999987654 3789999999999999999999999999999999999999999999999999998775433 3


Q ss_pred             cccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhcCCCC-----CCCCC
Q 004959          499 DLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAI-----PDSLS  573 (721)
Q Consensus       499 ~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~~~~~-----p~~lS  573 (721)
                      ...+.||++|||||+..-.    +...|...+|||++|+...|+---.+|.........++...+..+..     +..++
T Consensus       169 rksfiGtpywmapEvaave----rkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~lkDk~kws  244 (829)
T KOG0576|consen  169 RKSFIGTPYWMAPEVAAVE----RKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTLKDKTKWS  244 (829)
T ss_pred             hhcccCCccccchhHHHHH----hcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCcccCCccch
Confidence            4578899999999997533    45678889999999999999998888876666666555544433322     34688


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHHhccccccC
Q 004959          574 PEGKDFLRCCFQRNPADRPPASLLLEHRFLKNS  606 (721)
Q Consensus       574 ~el~dLI~~cL~~DP~kRPSa~eLL~Hp~f~~~  606 (721)
                      +.+.+|++.+|.++|++||+++.+|.|||+...
T Consensus       245 ~~fh~fvK~altknpKkRptaeklL~h~fvs~~  277 (829)
T KOG0576|consen  245 EFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT  277 (829)
T ss_pred             HHHHHHHHHHhcCCCccCCChhhheeceeeccc
Confidence            999999999999999999999999999998754

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=8.4e-34  Score=345.65  Aligned_cols=236  Identities=24%  Similarity=0.359  Sum_probs=185.6

Q ss_pred             CeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeEEEE
Q 004959          341 QWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYIY  420 (721)
Q Consensus       341 ~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~yLV  420 (721)
                      .|...++||+|+||.||+|++..+|..||||.+....  .       ....|+++|++++|||||++++++.+.+..|+|
T Consensus       691 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~-------~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv  761 (968)
T PLN00113        691 SLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVN--S-------IPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLI  761 (968)
T ss_pred             hCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCc--c-------ccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEE
Confidence            4566789999999999999999999999999875211  1       123468889999999999999999999999999


Q ss_pred             EeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHh---hCCeeccCCCCCcEEEcCCCceEEeecCCccccCCCc
Q 004959          421 LEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLH---SKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQK  497 (721)
Q Consensus       421 mEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLH---s~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~~  497 (721)
                      ||||++|+|.++++    .+++..+..++.||+.||+|||   +.+|+||||||+|||++.++..++. ||........ 
T Consensus       762 ~Ey~~~g~L~~~l~----~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~-  835 (968)
T PLN00113        762 HEYIEGKNLSEVLR----NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD-  835 (968)
T ss_pred             EeCCCCCcHHHHHh----cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC-
Confidence            99999999999995    3889999999999999999999   6799999999999999998887775 6665443222 


Q ss_pred             ccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhh----HHHHHHH-hhc-------C
Q 004959          498 ADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEG----AAAMFKV-MRD-------T  565 (721)
Q Consensus       498 ~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~----~~~~~ki-~~~-------~  565 (721)
                        ....||+.|||||++.       ...++.++|||||||++|||++|+.||.....    .....+. ...       .
T Consensus       836 --~~~~~t~~y~aPE~~~-------~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  906 (968)
T PLN00113        836 --TKCFISSAYVAPETRE-------TKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWID  906 (968)
T ss_pred             --CCccccccccCccccc-------CCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeC
Confidence              2346899999999984       34577789999999999999999999854211    1111110 000       0


Q ss_pred             CCCC------CCCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q 004959          566 PAIP------DSLSPEGKDFLRCCFQRNPADRPPASLLLEH  600 (721)
Q Consensus       566 ~~~p------~~lS~el~dLI~~cL~~DP~kRPSa~eLL~H  600 (721)
                      +.+.      .....++.+++.+||+.||++||++.|+++.
T Consensus       907 ~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  947 (968)
T PLN00113        907 PSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKT  947 (968)
T ss_pred             ccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHH
Confidence            1111      1112356789999999999999999999875

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-32  Score=320.20  Aligned_cols=246  Identities=30%  Similarity=0.537  Sum_probs=204.3

Q ss_pred             eeEeeEEeecCCeEEEEEEEC---C----CCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCC-CCCeeeeeeeEEe
Q 004959          342 WQKGKLIGRGTFGSVYVASNR---E----TGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLK-HPNIVQYYGSEIV  413 (721)
Q Consensus       342 y~~~k~LG~G~fG~VY~a~~~---~----tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~-HPnIV~l~g~~~~  413 (721)
                      .++.+.||+|.||+|++|.-.   .    ....||||.+..   . ......+.+..|+++|+.+. |+|||.++|++..
T Consensus       298 l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~---~-~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~  373 (609)
T KOG0200|consen  298 LKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKE---N-ASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQ  373 (609)
T ss_pred             ccccceeecccccceEeEEEeecccccccceEEEEEEeccc---c-cCcHHHHHHHHHHHHHHHhcCCcchhhheeeecc
Confidence            356679999999999999633   1    146789997642   2 22366789999999999995 9999999999999


Q ss_pred             cCeEEEEEeeccCCCHHHHHHHhc---------------CCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcC
Q 004959          414 EDKFYIYLEYVHPGSINKYVREHC---------------GAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDA  478 (721)
Q Consensus       414 ~~~~yLVmEy~~gGsL~~~L~~~~---------------~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~  478 (721)
                      .+.+++|+||+..|+|.++++..+               ..++..+...++.||+.|++||++.++|||||-..||||..
T Consensus       374 ~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNVLi~~  453 (609)
T KOG0200|consen  374 DGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNVLITK  453 (609)
T ss_pred             CCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhEEecC
Confidence            999999999999999999998775               34889999999999999999999999999999999999999


Q ss_pred             CCceEEeecCCccccCCCccccc--CCCCC--ccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhh-CCCCCCchh
Q 004959          479 SGVVKLADFGMAKHLTGQKADLS--MKGSP--YWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYE  553 (721)
Q Consensus       479 ~g~VKL~DFGlA~~l~~~~~~~s--~~GT~--~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLt-G~~PF~~~~  553 (721)
                      +..+||+|||+|+..........  ..|+.  .|||||.+.       ...++.++|||||||+||||++ |..||.+..
T Consensus       454 ~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~-------~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~  526 (609)
T KOG0200|consen  454 NKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLF-------DRVFTSKSDVWSFGILLWEIFTLGGTPYPGIP  526 (609)
T ss_pred             CCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhc-------cCcccccchhhHHHHHHHHHhhCCCCCCCCCC
Confidence            99999999999997554433221  12223  399999994       4677888999999999999998 999999855


Q ss_pred             -hHHHHHHHhhc--CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHh
Q 004959          554 -GAAAMFKVMRD--TPAIPDSLSPEGKDFLRCCFQRNPADRPPASLLLE  599 (721)
Q Consensus       554 -~~~~~~ki~~~--~~~~p~~lS~el~dLI~~cL~~DP~kRPSa~eLL~  599 (721)
                       ..+. .+.++.  ....|..+++++.++++.||+.+|++||++.++.+
T Consensus       527 ~~~~l-~~~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~  574 (609)
T KOG0200|consen  527 PTEEL-LEFLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVE  574 (609)
T ss_pred             cHHHH-HHHHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence             3344 334433  34678889999999999999999999999999975

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-32  Score=298.09  Aligned_cols=130  Identities=24%  Similarity=0.419  Sum_probs=114.2

Q ss_pred             CCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCC-----C---CCeeeeeeeE
Q 004959          340 SQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLK-----H---PNIVQYYGSE  411 (721)
Q Consensus       340 ~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~-----H---PnIV~l~g~~  411 (721)
                      .+|.+.+.||+|-|++||+|.+.++.+.||+|++.      ..+...+....||++|++++     |   .+||+|++.|
T Consensus        78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvK------SAqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~F  151 (590)
T KOG1290|consen   78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVK------SAQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHF  151 (590)
T ss_pred             ceEEEEEeccccccceeEEEeeccCCeEEEEEEEe------hhhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccc
Confidence            78999999999999999999999999999999985      22334567789999999984     2   4799999999


Q ss_pred             Eec----CeEEEEEeeccCCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhC-CeeccCCCCCcEEE
Q 004959          412 IVE----DKFYIYLEYVHPGSINKYVREH-CGAITESVVRNFTRHILSGLAYLHSK-KTIHRDIKGANLLV  476 (721)
Q Consensus       412 ~~~----~~~yLVmEy~~gGsL~~~L~~~-~~~Lse~~i~~i~~QIl~AL~yLHs~-gIIHrDLKPeNILl  476 (721)
                      ...    .++++|+|++ |..|..+|... ...++...+++|++|||.||.|||.. ||||-||||||||+
T Consensus       152 khsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl  221 (590)
T KOG1290|consen  152 KHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLL  221 (590)
T ss_pred             eecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeee
Confidence            864    5799999999 78888888654 56799999999999999999999975 99999999999998

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-33  Score=320.83  Aligned_cols=243  Identities=30%  Similarity=0.481  Sum_probs=193.5

Q ss_pred             eeEEeecCCeE-EEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCC-CCCeeeeeeeEEecCeEEEEEe
Q 004959          345 GKLIGRGTFGS-VYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLK-HPNIVQYYGSEIVEDKFYIYLE  422 (721)
Q Consensus       345 ~k~LG~G~fG~-VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~-HPnIV~l~g~~~~~~~~yLVmE  422 (721)
                      .+++|.|+-|+ ||+|...  |+.||||.+-        .+......+||.+|+.-+ |||||++|+...+....||.+|
T Consensus       514 ~eilG~Gs~Gt~Vf~G~ye--~R~VAVKrll--------~e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalE  583 (903)
T KOG1027|consen  514 KEILGYGSNGTVVFRGVYE--GREVAVKRLL--------EEFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALE  583 (903)
T ss_pred             HHHcccCCCCcEEEEEeeC--CceehHHHHh--------hHhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEeh
Confidence            35789999974 7999765  8899999763        345667899999999885 9999999999999999999999


Q ss_pred             eccCCCHHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcC---CC--ceEEeecCCccccC
Q 004959          423 YVHPGSINKYVREHCG---AITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDA---SG--VVKLADFGMAKHLT  494 (721)
Q Consensus       423 y~~gGsL~~~L~~~~~---~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~---~g--~VKL~DFGlA~~l~  494 (721)
                      .|. -+|.+++.....   .......+.++.|++.||++||+.+||||||||+||||+.   ++  .++|+|||+++.+.
T Consensus       584 LC~-~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~  662 (903)
T KOG1027|consen  584 LCA-CSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLA  662 (903)
T ss_pred             Hhh-hhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccccccC
Confidence            996 799999976311   1111456789999999999999999999999999999975   34  68999999999987


Q ss_pred             CCccc----ccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhC-CCCCCchhhHHHHHHHhhcCCCC-
Q 004959          495 GQKAD----LSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTG-KPPWSEYEGAAAMFKVMRDTPAI-  568 (721)
Q Consensus       495 ~~~~~----~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG-~~PF~~~~~~~~~~ki~~~~~~~-  568 (721)
                      .+...    ....||-.|+|||++...       ..+.++|||||||++|+.++| ..||......  ...|+.+...+ 
T Consensus       663 ~~~sS~~r~s~~sGt~GW~APE~L~~~-------~~~~avDiFslGCvfyYvltgG~HpFGd~~~R--~~NIl~~~~~L~  733 (903)
T KOG1027|consen  663 GGKSSFSRLSGGSGTSGWQAPEQLRED-------RKTQAVDIFSLGCVFYYVLTGGSHPFGDSLER--QANILTGNYTLV  733 (903)
T ss_pred             CCcchhhcccCCCCcccccCHHHHhcc-------ccCcccchhhcCceEEEEecCCccCCCchHHh--hhhhhcCcccee
Confidence            66543    345699999999999643       234489999999999999985 9999764332  22333333221 


Q ss_pred             --CCCCCHHHHHHHHHhcccCCCCCCCHHHHHhccccccCC
Q 004959          569 --PDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQ  607 (721)
Q Consensus       569 --p~~lS~el~dLI~~cL~~DP~kRPSa~eLL~Hp~f~~~~  607 (721)
                        ......++.+||.+||..+|..||++.++|.||||-+..
T Consensus       734 ~L~~~~d~eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW~~e  774 (903)
T KOG1027|consen  734 HLEPLPDCEAKDLISRMLNPDPQLRPSATDVLNHPLFWDSE  774 (903)
T ss_pred             eeccCchHHHHHHHHHhcCCCcccCCCHHHHhCCCccCChH
Confidence              122222899999999999999999999999999997653

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.98  E-value=5.4e-31  Score=255.49  Aligned_cols=213  Identities=40%  Similarity=0.709  Sum_probs=185.6

Q ss_pred             EeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeEEEEEeeccCC
Q 004959          348 IGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYIYLEYVHPG  427 (721)
Q Consensus       348 LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~yLVmEy~~gG  427 (721)
                      ||+|.+|.||++....+|+.+++|++......    ...+.+.+|+.+++.+.|++|+++++++......+++|||+.|+
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~----~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~   76 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSS----SLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGG   76 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccch----hHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCC
Confidence            68999999999999888999999988632111    14568999999999999999999999999999999999999999


Q ss_pred             CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcC-CCceEEeecCCccccCCCc-ccccCCCC
Q 004959          428 SINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDA-SGVVKLADFGMAKHLTGQK-ADLSMKGS  505 (721)
Q Consensus       428 sL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~-~g~VKL~DFGlA~~l~~~~-~~~s~~GT  505 (721)
                      +|.+++......+++..+..++.||+.+|.|||+.|++|+||+|.||+++. ++.++|+|||.+....... ......+.
T Consensus        77 ~l~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~  156 (215)
T cd00180          77 SLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGT  156 (215)
T ss_pred             cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchhhcccCC
Confidence            999999765457899999999999999999999999999999999999998 8999999999998665432 12335578


Q ss_pred             CccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhcCCCCCCCCCHHHHHHHHHhcc
Q 004959          506 PYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDSLSPEGKDFLRCCFQ  585 (721)
Q Consensus       506 ~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~~~~~p~~lS~el~dLI~~cL~  585 (721)
                      ..|++||.+...      ..++.+.|+|+||+++|+|                               ..+.++|..||+
T Consensus       157 ~~~~~pe~~~~~------~~~~~~~D~~~lg~~~~~l-------------------------------~~~~~~l~~~l~  199 (215)
T cd00180         157 PAYMAPEVLLGK------GYYSEKSDIWSLGVILYEL-------------------------------PELKDLIRKMLQ  199 (215)
T ss_pred             CCccChhHhccc------CCCCchhhhHHHHHHHHHH-------------------------------HHHHHHHHHHhh
Confidence            899999998431      2566789999999999999                               778999999999


Q ss_pred             cCCCCCCCHHHHHhcc
Q 004959          586 RNPADRPPASLLLEHR  601 (721)
Q Consensus       586 ~DP~kRPSa~eLL~Hp  601 (721)
                      .||++||++.++++|+
T Consensus       200 ~~p~~R~~~~~l~~~~  215 (215)
T cd00180         200 KDPEKRPSAKEILEHL  215 (215)
T ss_pred             CCcccCcCHHHHhhCC
Confidence            9999999999999874

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=99.98  E-value=1.8e-32  Score=309.93  Aligned_cols=248  Identities=27%  Similarity=0.439  Sum_probs=208.7

Q ss_pred             CCeeEeeEEeecCCeEEEEEEECCCCc----EEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecC
Q 004959          340 SQWQKGKLIGRGTFGSVYVASNRETGA----LCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVED  415 (721)
Q Consensus       340 ~~y~~~k~LG~G~fG~VY~a~~~~tg~----~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~  415 (721)
                      ...+.+++||.|+||.||+|.+...|+    +||||++..    ........++..|+-+|..|+|||+++|++++....
T Consensus       696 telkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~----~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~  771 (1177)
T KOG1025|consen  696 TELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIE----FTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST  771 (1177)
T ss_pred             hhhhhhceeccccceeEEeeeEecCCceecceeEEEEeec----cCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch
Confidence            356778999999999999998776665    467776642    333445578899999999999999999999987765


Q ss_pred             eEEEEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCC
Q 004959          416 KFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTG  495 (721)
Q Consensus       416 ~~yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~  495 (721)
                       +-||++||++|.|.++++.+++.+..+....|..||+.||.|||+++++||||-..||||..-..|||.|||+++.+..
T Consensus       772 -~qlvtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~  850 (1177)
T KOG1025|consen  772 -LQLVTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAP  850 (1177)
T ss_pred             -HHHHHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchhhccCc
Confidence             8899999999999999999999999999999999999999999999999999999999999999999999999998876


Q ss_pred             CcccccCCC---CCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhh-CCCCCCchhhHHHHHHHhh-cCCCCCC
Q 004959          496 QKADLSMKG---SPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFKVMR-DTPAIPD  570 (721)
Q Consensus       496 ~~~~~s~~G---T~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLt-G~~PF~~~~~~~~~~ki~~-~~~~~p~  570 (721)
                      ........|   -+-|||-|.+.       ...++.++|||||||++||++| |..|+.+....+.-.-+.. +....|+
T Consensus       851 d~~ey~~~~gK~pikwmale~i~-------~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~geRLsqPp  923 (1177)
T KOG1025|consen  851 DEKEYSAPGGKVPIKWMALESIR-------IRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKGERLSQPP  923 (1177)
T ss_pred             ccccccccccccCcHHHHHHHhh-------ccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhccccCCCCC
Confidence            665444332   34589999884       4567788999999999999999 9999988765544333222 2345678


Q ss_pred             CCCHHHHHHHHHhcccCCCCCCCHHHHHh
Q 004959          571 SLSPEGKDFLRCCFQRNPADRPPASLLLE  599 (721)
Q Consensus       571 ~lS~el~dLI~~cL~~DP~kRPSa~eLL~  599 (721)
                      ..+.++.-+|.+||..|++.||++.++..
T Consensus       924 iCtiDVy~~mvkCwmid~~~rp~fkel~~  952 (1177)
T KOG1025|consen  924 ICTIDVYMVMVKCWMIDADSRPTFKELAE  952 (1177)
T ss_pred             CccHHHHHHHHHHhccCcccCccHHHHHH
Confidence            89999999999999999999999999864

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=99.98  E-value=1.8e-32  Score=270.81  Aligned_cols=218  Identities=28%  Similarity=0.490  Sum_probs=183.7

Q ss_pred             CeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhC-CCCCeeeeeeeEEecCeEEE
Q 004959          341 QWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHL-KHPNIVQYYGSEIVEDKFYI  419 (721)
Q Consensus       341 ~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L-~HPnIV~l~g~~~~~~~~yL  419 (721)
                      ....+..||+|+||+|-+.++..+|...|+|.+...    ...+..+++.+|+.+..+. .+|++|.+||.+..+..++|
T Consensus        47 ~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~t----vn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwI  122 (282)
T KOG0984|consen   47 DLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRAT----VNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWI  122 (282)
T ss_pred             hhhhhhhhcCCccchhhheeeccCCeEEEEeeehhh----cChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEE
Confidence            445567899999999999999999999999998642    2345567788898886554 69999999999999999999


Q ss_pred             EEeeccCCCHHHHHH---HhcCCCCHHHHHHHHHHHHHHHHHHhhC-CeeccCCCCCcEEEcCCCceEEeecCCccccCC
Q 004959          420 YLEYVHPGSINKYVR---EHCGAITESVVRNFTRHILSGLAYLHSK-KTIHRDIKGANLLVDASGVVKLADFGMAKHLTG  495 (721)
Q Consensus       420 VmEy~~gGsL~~~L~---~~~~~Lse~~i~~i~~QIl~AL~yLHs~-gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~  495 (721)
                      .||.|+ .+|..+-+   ..++.++|..+-+|+..|+.||.|||++ .|||||+||.||||+.+|+||+||||.+-.+.+
T Consensus       123 cME~M~-tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~d  201 (282)
T KOG0984|consen  123 CMELMD-TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGISGYLVD  201 (282)
T ss_pred             eHHHhh-hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEcccccceeehh
Confidence            999996 67776643   3467899999999999999999999987 899999999999999999999999999988876


Q ss_pred             CcccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCc-hhhHHHHHHHhhcCC
Q 004959          496 QKADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSE-YEGAAAMFKVMRDTP  566 (721)
Q Consensus       496 ~~~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~-~~~~~~~~ki~~~~~  566 (721)
                      ........|...|||||.+....   +...|+.++||||||+++.||.+++.||.. ....+++.+++.+..
T Consensus       202 SiAkt~daGCkpYmaPEri~~e~---n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVeep~  270 (282)
T KOG0984|consen  202 SIAKTMDAGCKPYMAPERINPEL---NQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVEEPS  270 (282)
T ss_pred             hhHHHHhcCCCccCChhhcCccc---CcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhcCCC
Confidence            65554466889999999996532   334789999999999999999999999975 456677777776543

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.97  E-value=1.6e-32  Score=301.74  Aligned_cols=204  Identities=25%  Similarity=0.383  Sum_probs=175.2

Q ss_pred             CCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCccc---HHHHHHHHHHHHHHHhCC---CCCeeeeeeeEEe
Q 004959          340 SQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKS---AESIKQLEQEIKVLSHLK---HPNIVQYYGSEIV  413 (721)
Q Consensus       340 ~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~---~~~~k~~~~Ei~iL~~L~---HPnIV~l~g~~~~  413 (721)
                      ..|...+.||+|+||+|++|+++.....|+||.|.+.+--...   ...+-.+-.||+||..|+   |+||++++++|++
T Consensus       561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd  640 (772)
T KOG1152|consen  561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED  640 (772)
T ss_pred             ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence            4688999999999999999999999999999998642100000   001224567999999997   9999999999999


Q ss_pred             cCeEEEEEeecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccc
Q 004959          414 EDKFYIYLEYVH-PGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKH  492 (721)
Q Consensus       414 ~~~~yLVmEy~~-gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~  492 (721)
                      ++++||+||--. |.+|+++|..+ ..+.|.+++.|++||+.|+++||++||||||||-|||.++.+|-+||+|||.|..
T Consensus       641 dd~yyl~te~hg~gIDLFd~IE~k-p~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~~klidfgsaa~  719 (772)
T KOG1152|consen  641 DDYYYLETEVHGEGIDLFDFIEFK-PRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGFVKLIDFGSAAY  719 (772)
T ss_pred             CCeeEEEecCCCCCcchhhhhhcc-CccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCeEEEeeccchhh
Confidence            999999999664 45999999765 7899999999999999999999999999999999999999999999999999986


Q ss_pred             cCCCcccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCc
Q 004959          493 LTGQKADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSE  551 (721)
Q Consensus       493 l~~~~~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~  551 (721)
                      ...+ ....++||..|.|||+|.|..|.++.      -|||+||++||.+++...||.+
T Consensus       720 ~ksg-pfd~f~gtv~~aapevl~g~~y~gk~------qdiwalgillytivykenpyyn  771 (772)
T KOG1152|consen  720 TKSG-PFDVFVGTVDYAAPEVLGGEKYLGKP------QDIWALGILLYTIVYKENPYYN  771 (772)
T ss_pred             hcCC-CcceeeeeccccchhhhCCCccCCCc------chhhhhhheeeEEEeccCCCcC
Confidence            5544 44568899999999999988877764      5999999999999999999864

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=99.97  E-value=2.8e-31  Score=287.48  Aligned_cols=246  Identities=26%  Similarity=0.426  Sum_probs=191.9

Q ss_pred             CCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHh--CCCCCeeeeeeeEEecC--
Q 004959          340 SQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSH--LKHPNIVQYYGSEIVED--  415 (721)
Q Consensus       340 ~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~--L~HPnIV~l~g~~~~~~--  415 (721)
                      ...++..+||+|.||.||+|...  ++.||||++..        +..+.+..|-+|...  ++|+||+++++......  
T Consensus       210 ~pl~l~eli~~Grfg~V~KaqL~--~~~VAVKifp~--------~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~  279 (534)
T KOG3653|consen  210 DPLQLLELIGRGRFGCVWKAQLD--NRLVAVKIFPE--------QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTAD  279 (534)
T ss_pred             CchhhHHHhhcCccceeehhhcc--CceeEEEecCH--------HHHHHHHhHHHHHhccCccchhHHHhhchhccCCcc
Confidence            45677889999999999999765  69999998752        344567777666554  57999999999876655  


Q ss_pred             --eEEEEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhC---------CeeccCCCCCcEEEcCCCceEE
Q 004959          416 --KFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSK---------KTIHRDIKGANLLVDASGVVKL  484 (721)
Q Consensus       416 --~~yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~---------gIIHrDLKPeNILld~~g~VKL  484 (721)
                        .++||+||.+.|+|.+||..+  .+++....+++.-|++||+|||+.         .|+|||||..||||..+++..|
T Consensus       280 ~~eywLVt~fh~kGsL~dyL~~n--tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccI  357 (534)
T KOG3653|consen  280 RMEYWLVTEFHPKGSLCDYLKAN--TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCI  357 (534)
T ss_pred             ccceeEEeeeccCCcHHHHHHhc--cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEe
Confidence              899999999999999999875  899999999999999999999963         6999999999999999999999


Q ss_pred             eecCCccccCCCcc---cccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCC------------CCC
Q 004959          485 ADFGMAKHLTGQKA---DLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGK------------PPW  549 (721)
Q Consensus       485 ~DFGlA~~l~~~~~---~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~------------~PF  549 (721)
                      +|||||..+.....   ....+||..|||||+|.+...-.. ...-.++||||+|.+||||++..            +||
T Consensus       358 aDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d-~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpf  436 (534)
T KOG3653|consen  358 ADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQD-RDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPF  436 (534)
T ss_pred             eccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhccccc-HHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCch
Confidence            99999998865432   234789999999999987543322 23345789999999999999743            233


Q ss_pred             Cch----hhHHHHHHH---hhcCCCCCCC-----CCHHHHHHHHHhcccCCCCCCCHHHHH
Q 004959          550 SEY----EGAAAMFKV---MRDTPAIPDS-----LSPEGKDFLRCCFQRNPADRPPASLLL  598 (721)
Q Consensus       550 ~~~----~~~~~~~ki---~~~~~~~p~~-----lS~el~dLI~~cL~~DP~kRPSa~eLL  598 (721)
                      ...    ...+.+...   .+..+.+|+.     --.-+++.|..||..|++.|.|+.=+.
T Consensus       437 e~evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~  497 (534)
T KOG3653|consen  437 EAEVGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVE  497 (534)
T ss_pred             hHHhcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHH
Confidence            311    112223222   2334555543     235678999999999999999986443

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.97  E-value=5.2e-30  Score=255.00  Aligned_cols=214  Identities=36%  Similarity=0.630  Sum_probs=180.7

Q ss_pred             eeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeEEEEE
Q 004959          342 WQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYIYL  421 (721)
Q Consensus       342 y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~yLVm  421 (721)
                      |.+++.||.|++|.||+|.+..+++.+|||.+......    ...+.+.+|+..++.++|+||+++++++...+..++++
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~----~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~   76 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE----KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVM   76 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch----HHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEE
Confidence            56788999999999999999988999999998642111    35678999999999999999999999999999999999


Q ss_pred             eeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCCc--cc
Q 004959          422 EYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQK--AD  499 (721)
Q Consensus       422 Ey~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~~--~~  499 (721)
                      ||+.+++|.+++......+++..+..++.|++.+|.|||+++++|+||++.||+++.++.++|+|||++..+....  ..
T Consensus        77 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~  156 (225)
T smart00221       77 EYCEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAALL  156 (225)
T ss_pred             eccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccccc
Confidence            9999999999997653338999999999999999999999999999999999999999999999999998775543  33


Q ss_pred             ccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCc-hhhH-HHHHHHhhcC
Q 004959          500 LSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSE-YEGA-AAMFKVMRDT  565 (721)
Q Consensus       500 ~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~-~~~~-~~~~ki~~~~  565 (721)
                      ....++..|++||.+.      ....++.++|||+||+++|+|++|+.||.. .... .....+..+.
T Consensus       157 ~~~~~~~~~~~pe~~~------~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~  218 (225)
T smart00221      157 KTVKGTPFYLAPEVLL------GGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVWSFGV  218 (225)
T ss_pred             cceeccCCcCCHhHhc------CCCCCCchhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHHhcCC
Confidence            4456888999999984      234455689999999999999999999977 4444 4444444443

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.97  E-value=2.6e-31  Score=285.15  Aligned_cols=252  Identities=27%  Similarity=0.452  Sum_probs=200.1

Q ss_pred             CCCCeeEeeEEeecCCeEEEEEEECC---CCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCC-CCCeeeeeeeEEe
Q 004959          338 MNSQWQKGKLIGRGTFGSVYVASNRE---TGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLK-HPNIVQYYGSEIV  413 (721)
Q Consensus       338 l~~~y~~~k~LG~G~fG~VY~a~~~~---tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~-HPnIV~l~g~~~~  413 (721)
                      +...|.++..||+|.|++||+|++..   ..+.||+|.+....       ...++..|+++|..+. +.||+.+.+++..
T Consensus        34 ~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts-------~p~ri~~El~~L~~~gG~~ni~~~~~~~rn  106 (418)
T KOG1167|consen   34 ISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS-------SPSRILNELEMLYRLGGSDNIIKLNGCFRN  106 (418)
T ss_pred             hhhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc-------CchHHHHHHHHHHHhccchhhhcchhhhcc
Confidence            34578999999999999999998877   78999999886431       1347999999999996 9999999999999


Q ss_pred             cCeEEEEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcC-CCceEEeecCCccc
Q 004959          414 EDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDA-SGVVKLADFGMAKH  492 (721)
Q Consensus       414 ~~~~yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~-~g~VKL~DFGlA~~  492 (721)
                      .+...+||||++..+..+++.    .++..+++.|++.++.||.++|.+|||||||||.|+|.+. .+.-.|+|||||..
T Consensus       107 nd~v~ivlp~~~H~~f~~l~~----~l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~  182 (418)
T KOG1167|consen  107 NDQVAIVLPYFEHDRFRDLYR----SLSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQR  182 (418)
T ss_pred             CCeeEEEecccCccCHHHHHh----cCCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhHHH
Confidence            999999999999888777765    4778999999999999999999999999999999999975 56789999999872


Q ss_pred             cCCCc--------------c-------------------------------cccCCCCCccCChhhHHHHhhcCCCCCCc
Q 004959          493 LTGQK--------------A-------------------------------DLSMKGSPYWMAPELMMAVMQKGKSSDSA  527 (721)
Q Consensus       493 l~~~~--------------~-------------------------------~~s~~GT~~Y~APEvl~~~~~~~k~~~~s  527 (721)
                      .....              .                               .....||++|+|||++..      ....+
T Consensus       183 ~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k------~~~Qt  256 (418)
T KOG1167|consen  183 YDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFR------CPRQT  256 (418)
T ss_pred             HHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhh------ccCcC
Confidence            11000              0                               001239999999999974      45566


Q ss_pred             chhhHHHHHHHHHHHhhCCCCCCc-hhhHHHHHHHhh--------------cC-------------------C-------
Q 004959          528 LAVDIWSLGCTIIEMYTGKPPWSE-YEGAAAMFKVMR--------------DT-------------------P-------  566 (721)
Q Consensus       528 ~asDVWSLGVILyELLtG~~PF~~-~~~~~~~~ki~~--------------~~-------------------~-------  566 (721)
                      .++||||.|||++-+++++.||-. .++.+.+..+..              +.                   .       
T Consensus       257 taiDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~  336 (418)
T KOG1167|consen  257 TAIDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESI  336 (418)
T ss_pred             CccceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhc
Confidence            789999999999999999999842 121111111100              00                   0       


Q ss_pred             -----------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhccccccC
Q 004959          567 -----------AIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNS  606 (721)
Q Consensus       567 -----------~~p~~lS~el~dLI~~cL~~DP~kRPSa~eLL~Hp~f~~~  606 (721)
                                 ..-+.++..+.+|+.+||..||.+|+|++++|+||||...
T Consensus       337 ~~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~~  387 (418)
T KOG1167|consen  337 YKSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFDEA  387 (418)
T ss_pred             ccccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCcch
Confidence                       0012245688999999999999999999999999999854

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=3.8e-30  Score=277.06  Aligned_cols=248  Identities=26%  Similarity=0.436  Sum_probs=191.9

Q ss_pred             CCCCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHh--CCCCCeeeeeeeEEec-
Q 004959          338 MNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSH--LKHPNIVQYYGSEIVE-  414 (721)
Q Consensus       338 l~~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~--L~HPnIV~l~g~~~~~-  414 (721)
                      +..+.++.+.||+|-||+||+|.++  |+.||||++...  +      .+.+.+|.+|.+.  |+|+||+.+++.-..+ 
T Consensus       209 iarqI~L~e~IGkGRyGEVwrG~wr--Ge~VAVKiF~sr--d------E~SWfrEtEIYqTvmLRHENILgFIaaD~~~~  278 (513)
T KOG2052|consen  209 IARQIVLQEIIGKGRFGEVWRGRWR--GEDVAVKIFSSR--D------ERSWFRETEIYQTVMLRHENILGFIAADNKDN  278 (513)
T ss_pred             hhheeEEEEEecCccccceeecccc--CCceEEEEeccc--c------hhhhhhHHHHHHHHHhccchhhhhhhccccCC
Confidence            3457899999999999999999988  899999998631  1      1345566666554  5899999999875443 


Q ss_pred             ---CeEEEEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhC--------CeeccCCCCCcEEEcCCCceE
Q 004959          415 ---DKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSK--------KTIHRDIKGANLLVDASGVVK  483 (721)
Q Consensus       415 ---~~~yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~--------gIIHrDLKPeNILld~~g~VK  483 (721)
                         .++|||.+|-+.|+|+|||..  ..++.+...+++.-++.||+|||..        .|.|||||..||||..+|...
T Consensus       279 gs~TQLwLvTdYHe~GSL~DyL~r--~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~  356 (513)
T KOG2052|consen  279 GSWTQLWLVTDYHEHGSLYDYLNR--NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCC  356 (513)
T ss_pred             CceEEEEEeeecccCCcHHHHHhh--ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEE
Confidence               369999999999999999986  5899999999999999999999953        599999999999999999999


Q ss_pred             EeecCCccccCCCc-----ccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhC----------CCC
Q 004959          484 LADFGMAKHLTGQK-----ADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTG----------KPP  548 (721)
Q Consensus       484 L~DFGlA~~l~~~~-----~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG----------~~P  548 (721)
                      |+|+|||.......     .....+||-.|||||+|.......-...| ..+||||||.+|||++..          ++|
T Consensus       357 IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesy-k~ADIYafgLVlWEiarRc~~ggi~eey~~P  435 (513)
T KOG2052|consen  357 IADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESY-KRADIYAFGLVLWEIARRCESGGIVEEYQLP  435 (513)
T ss_pred             EeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhh-hHHHHHHHHHHHHHHHHHhhcCCEehhhcCC
Confidence            99999998765432     22456899999999999765443322222 258999999999999852          478


Q ss_pred             CCch----hhHHHHHHHh---hcCCCCCCCC-C-H---HHHHHHHHhcccCCCCCCCHHHHH
Q 004959          549 WSEY----EGAAAMFKVM---RDTPAIPDSL-S-P---EGKDFLRCCFQRNPADRPPASLLL  598 (721)
Q Consensus       549 F~~~----~~~~~~~ki~---~~~~~~p~~l-S-~---el~dLI~~cL~~DP~kRPSa~eLL  598 (721)
                      |.+.    ...+.+.+++   +..+.+|..+ + +   .+-.+|+.||..||.-|.|+--|-
T Consensus       436 yyd~Vp~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriK  497 (513)
T KOG2052|consen  436 YYDVVPSDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIK  497 (513)
T ss_pred             cccCCCCCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHH
Confidence            8653    3345555543   2234455433 2 2   335689999999999999987764

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.97  E-value=3.9e-31  Score=269.97  Aligned_cols=258  Identities=22%  Similarity=0.359  Sum_probs=202.3

Q ss_pred             CCCCCCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCC-CCCeeeeeee-EEe
Q 004959          336 LPMNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLK-HPNIVQYYGS-EIV  413 (721)
Q Consensus       336 ~~l~~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~-HPnIV~l~g~-~~~  413 (721)
                      ..+.+.|.+.+.||+|.||.+.+|.++.+++.+++|.+..      .....+.|.+|...--.|. |.|||.-|++ |+.
T Consensus        20 v~l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~------p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt   93 (378)
T KOG1345|consen   20 VDLEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPR------PQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQT   93 (378)
T ss_pred             cchhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCc------chhhHHHHHHHhccceeeccchhhhHHHHHHhhc
Confidence            4566789999999999999999999999999999998752      2345678999988766664 8999998875 778


Q ss_pred             cCeEEEEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcC--CCceEEeecCCcc
Q 004959          414 EDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDA--SGVVKLADFGMAK  491 (721)
Q Consensus       414 ~~~~yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~--~g~VKL~DFGlA~  491 (721)
                      .+.++++|||++.|+|..-+..  ..+.|...+.++.|+++||.|+|++++||||||.+||||-.  ...|||||||+.+
T Consensus        94 ~d~YvF~qE~aP~gdL~snv~~--~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~  171 (378)
T KOG1345|consen   94 SDAYVFVQEFAPRGDLRSNVEA--AGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTR  171 (378)
T ss_pred             CceEEEeeccCccchhhhhcCc--ccccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeeccccc
Confidence            8899999999999999888765  46899999999999999999999999999999999999942  3489999999987


Q ss_pred             ccCCCcccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHH----HHHHHhh----
Q 004959          492 HLTGQKADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAA----AMFKVMR----  563 (721)
Q Consensus       492 ~l~~~~~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~----~~~ki~~----  563 (721)
                      .......  ...-+..|.+||++.... + ......+..|||.||+|+|.+|+|.+||......+    .+.+...    
T Consensus       172 k~g~tV~--~~~~~~~y~~pe~~~~~~-n-e~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~  247 (378)
T KOG1345|consen  172 KVGTTVK--YLEYVNNYHAPELCDTVV-N-EKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNP  247 (378)
T ss_pred             ccCceeh--hhhhhcccCCcHHHhhcc-c-cceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCc
Confidence            5432221  122467799999986542 1 22344567899999999999999999997432111    1111111    


Q ss_pred             cCCCCCCCCCHHHHHHHHHhcccCCCCC---CCHHHHHhcccccc
Q 004959          564 DTPAIPDSLSPEGKDFLRCCFQRNPADR---PPASLLLEHRFLKN  605 (721)
Q Consensus       564 ~~~~~p~~lS~el~dLI~~cL~~DP~kR---PSa~eLL~Hp~f~~  605 (721)
                      ..+.....+++.+..+.++-|..++++|   .++.......|...
T Consensus       248 ~~P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~E~  292 (378)
T KOG1345|consen  248 ALPKKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLWKEK  292 (378)
T ss_pred             cCchhhcccCHHHHHHHHHhcCCcccccchhHHHHHHHHHHHHHh
Confidence            2233445689999999999999999999   66666666677654

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.96  E-value=2.1e-30  Score=310.34  Aligned_cols=198  Identities=18%  Similarity=0.253  Sum_probs=146.6

Q ss_pred             CCC-CCeeeeeeeE-------EecCeEEEEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCC
Q 004959          399 LKH-PNIVQYYGSE-------IVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIK  470 (721)
Q Consensus       399 L~H-PnIV~l~g~~-------~~~~~~yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLK  470 (721)
                      +.| .||+.+++.|       ...+.++++|||+ +++|.++|......+++.+++.|++||+.||.|||++||||||||
T Consensus        29 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDlK  107 (793)
T PLN00181         29 LSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNVR  107 (793)
T ss_pred             hhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccCC
Confidence            344 5777777765       2334678889988 579999997655679999999999999999999999999999999


Q ss_pred             CCcEEEcC-------------------CCceEEeecCCccccCCCc-----------------ccccCCCCCccCChhhH
Q 004959          471 GANLLVDA-------------------SGVVKLADFGMAKHLTGQK-----------------ADLSMKGSPYWMAPELM  514 (721)
Q Consensus       471 PeNILld~-------------------~g~VKL~DFGlA~~l~~~~-----------------~~~s~~GT~~Y~APEvl  514 (721)
                      |+||||+.                   ++.+||+|||+++......                 .....+||++|||||++
T Consensus       108 P~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~  187 (793)
T PLN00181        108 PSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEED  187 (793)
T ss_pred             chhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhhh
Confidence            99999954                   3456666777665421100                 01124689999999998


Q ss_pred             HHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhc-CCCCCCCCCHHHHHHHHHhcccCCCCCCC
Q 004959          515 MAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRD-TPAIPDSLSPEGKDFLRCCFQRNPADRPP  593 (721)
Q Consensus       515 ~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~-~~~~p~~lS~el~dLI~~cL~~DP~kRPS  593 (721)
                      .+       ..++.++|||||||+||||++|..|+.....  .+..+... .+........+..+++.+||+.||.+||+
T Consensus       188 ~~-------~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~~P~~Rps  258 (793)
T PLN00181        188 NG-------SSSNCASDVYRLGVLLFELFCPVSSREEKSR--TMSSLRHRVLPPQILLNWPKEASFCLWLLHPEPSCRPS  258 (793)
T ss_pred             cc-------CCCCchhhhhhHHHHHHHHhhCCCchhhHHH--HHHHHHHhhcChhhhhcCHHHHHHHHHhCCCChhhCcC
Confidence            53       4467789999999999999999998764321  11111111 11111112456778999999999999999


Q ss_pred             HHHHHhccccccC
Q 004959          594 ASLLLEHRFLKNS  606 (721)
Q Consensus       594 a~eLL~Hp~f~~~  606 (721)
                      +.|+|+||||...
T Consensus       259 ~~eil~h~~~~~~  271 (793)
T PLN00181        259 MSELLQSEFINEP  271 (793)
T ss_pred             hHHHhhchhhhhh
Confidence            9999999999764

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=99.96  E-value=2.8e-28  Score=258.68  Aligned_cols=249  Identities=24%  Similarity=0.352  Sum_probs=204.0

Q ss_pred             CCeeEeeEEeecCCeEEEEEEECCC-----CcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEec
Q 004959          340 SQWQKGKLIGRGTFGSVYVASNRET-----GALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVE  414 (721)
Q Consensus       340 ~~y~~~k~LG~G~fG~VY~a~~~~t-----g~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~  414 (721)
                      .++++..++.+|.||.||.|.+++.     .+.|-+|.+.    +.-+..++..+..|--+|..+.|||+..+.++...+
T Consensus       284 ~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk----~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~  359 (563)
T KOG1024|consen  284 CRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVK----QHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIED  359 (563)
T ss_pred             hheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHH----hcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeec
Confidence            4678888999999999999976642     3445566553    334556778899999999999999999999987654


Q ss_pred             -CeEEEEEeeccCCCHHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEee
Q 004959          415 -DKFYIYLEYVHPGSINKYVREHC-------GAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLAD  486 (721)
Q Consensus       415 -~~~yLVmEy~~gGsL~~~L~~~~-------~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~D  486 (721)
                       +..++++.++.-|+|..+|...+       +.++-.++..++.||+.|++|||+.||||-||...|.+||+.-+|||+|
T Consensus       360 ~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~LqVkltD  439 (563)
T KOG1024|consen  360 YATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQLQVKLTD  439 (563)
T ss_pred             cCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhheeEEecc
Confidence             56788899999999999997321       3467778889999999999999999999999999999999999999999


Q ss_pred             cCCccccCCCccccc---CCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhh-CCCCCCchhhHHHHHHHh
Q 004959          487 FGMAKHLTGQKADLS---MKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFKVM  562 (721)
Q Consensus       487 FGlA~~l~~~~~~~s---~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLt-G~~PF~~~~~~~~~~ki~  562 (721)
                      =.+++.+.....+.-   .-....||++|.+..       ..|+.++|||||||+||||+| |+.|+.+.+..++...+.
T Consensus       440 saLSRDLFP~DYhcLGDnEnRPvkWMslEal~n-------~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylk  512 (563)
T KOG1024|consen  440 SALSRDLFPGDYHCLGDNENRPVKWMSLEALQN-------SHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLK  512 (563)
T ss_pred             chhccccCcccccccCCCCCCcccccCHHHHhh-------hhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHh
Confidence            999998765543321   112355999999964       456778999999999999998 999999988877665555


Q ss_pred             hcC-CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHh
Q 004959          563 RDT-PAIPDSLSPEGKDFLRCCFQRNPADRPPASLLLE  599 (721)
Q Consensus       563 ~~~-~~~p~~lS~el~dLI~~cL~~DP~kRPSa~eLL~  599 (721)
                      .+. ...|-++++++..++..||...|++||+++|+..
T Consensus       513 dGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~  550 (563)
T KOG1024|consen  513 DGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVI  550 (563)
T ss_pred             ccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHH
Confidence            443 3557889999999999999999999999999864

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.95  E-value=2.2e-26  Score=233.42  Aligned_cols=258  Identities=34%  Similarity=0.585  Sum_probs=206.5

Q ss_pred             eeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCC-CeeeeeeeEEecCeEEEE
Q 004959          342 WQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHP-NIVQYYGSEIVEDKFYIY  420 (721)
Q Consensus       342 y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HP-nIV~l~g~~~~~~~~yLV  420 (721)
                      |.+.+.||.|+||.||++.+.   ..+++|.+.....  ........+.+|+.++..+.|+ +|+.+++++......+++
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~--~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~   76 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLE--SKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLV   76 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhc--cchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEE
Confidence            788899999999999999887   7899998864221  1113567899999999999988 799999999777788999


Q ss_pred             EeeccCCCHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCC-ceEEeecCCccccCCCc
Q 004959          421 LEYVHPGSINKYVREHC--GAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASG-VVKLADFGMAKHLTGQK  497 (721)
Q Consensus       421 mEy~~gGsL~~~L~~~~--~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g-~VKL~DFGlA~~l~~~~  497 (721)
                      ++|+.+++|.+++....  ..+.+..+..++.||+.+|.|+|+.|++||||||+|||++..+ .++++|||++..+....
T Consensus        77 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~  156 (384)
T COG0515          77 MEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG  156 (384)
T ss_pred             EecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence            99999999997776543  2799999999999999999999999999999999999999988 79999999998655433


Q ss_pred             -------ccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhh---HHHHH-HHhhcCC
Q 004959          498 -------ADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEG---AAAMF-KVMRDTP  566 (721)
Q Consensus       498 -------~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~---~~~~~-ki~~~~~  566 (721)
                             ......||..|+|||.+.+..    ...+....|+|++|++++++++|..||.....   ..... .+.....
T Consensus       157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~----~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~  232 (384)
T COG0515         157 STSSIPALPSTSVGTPGYMAPEVLLGLS----LAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPT  232 (384)
T ss_pred             ccccccccccccccccccCCHHHhcCCC----CCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCC
Confidence                   235577999999999995310    14566789999999999999999999877653   23333 3322222


Q ss_pred             C-CCCCC--------CHHHHHHHHHhcccCCCCCCCHHHHHhccccccCCC
Q 004959          567 A-IPDSL--------SPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQ  608 (721)
Q Consensus       567 ~-~p~~l--------S~el~dLI~~cL~~DP~kRPSa~eLL~Hp~f~~~~~  608 (721)
                      . .....        ...+.+++..|+..+|..|.+..+...+.|......
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~~~~  283 (384)
T COG0515         233 PSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLKL  283 (384)
T ss_pred             cccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhchHhhCccc
Confidence            2 22111        147899999999999999999999998877665443

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.95  E-value=5.6e-28  Score=235.03  Aligned_cols=160  Identities=27%  Similarity=0.370  Sum_probs=129.3

Q ss_pred             CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCCcccccCCCCC
Q 004959          427 GSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSP  506 (721)
Q Consensus       427 GsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~~~~~s~~GT~  506 (721)
                      |+|.+++...+..+++.+++.|+.||+.||.|||+++      ||+|||++.++.+|+  ||++......    ...||+
T Consensus         1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~----~~~g~~   68 (176)
T smart00750        1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTPE----QSRVDP   68 (176)
T ss_pred             CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeeccc----cCCCcc
Confidence            6899999876677999999999999999999999999      999999999999999  9999865432    236899


Q ss_pred             ccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHH-HHHHHhhcCCC-------CCCCCCH--HH
Q 004959          507 YWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAA-AMFKVMRDTPA-------IPDSLSP--EG  576 (721)
Q Consensus       507 ~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~-~~~ki~~~~~~-------~p~~lS~--el  576 (721)
                      .|||||++.       ...++.++|||||||++|||++|+.||....... .+..+......       .+..++.  ++
T Consensus        69 ~y~aPE~~~-------~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  141 (176)
T smart00750       69 YFMAPEVIQ-------GQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSF  141 (176)
T ss_pred             cccChHHhc-------CCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhH
Confidence            999999994       3456778999999999999999999997644322 22222221111       1223344  69


Q ss_pred             HHHHHHhcccCCCCCCCHHHHHhcccccc
Q 004959          577 KDFLRCCFQRNPADRPPASLLLEHRFLKN  605 (721)
Q Consensus       577 ~dLI~~cL~~DP~kRPSa~eLL~Hp~f~~  605 (721)
                      .+||.+||..||++||++.|+++|+|+..
T Consensus       142 ~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~  170 (176)
T smart00750      142 ADFMRVCASRLPQRREAANHYLAHCRALF  170 (176)
T ss_pred             HHHHHHHHhcccccccCHHHHHHHHHHHH
Confidence            99999999999999999999999999763

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.94  E-value=4.3e-28  Score=280.64  Aligned_cols=260  Identities=26%  Similarity=0.419  Sum_probs=205.6

Q ss_pred             CCe-eEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCC-CCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeE
Q 004959          340 SQW-QKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFP-DDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKF  417 (721)
Q Consensus       340 ~~y-~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~-~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~  417 (721)
                      ..| ..+.++|.|+||.|+.+......+.++.|...... ......+....+..|+-+-..+.|+||+..+..+.+...+
T Consensus       317 ~~y~~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~  396 (601)
T KOG0590|consen  317 EKYGKPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGI  396 (601)
T ss_pred             cccCCccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccc
Confidence            445 45679999999999999888777778877654210 1112222333377888888999999999888877776667


Q ss_pred             EEEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCCc
Q 004959          418 YIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQK  497 (721)
Q Consensus       418 yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~~  497 (721)
                      +-+||||++ +|+.++... +.+...++..+++||+.||.|||+.||.|||||++|||+..+|.+||+|||.+..+....
T Consensus       397 ~~~mE~~~~-Dlf~~~~~~-~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~  474 (601)
T KOG0590|consen  397 LQSMEYCPY-DLFSLVMSN-GKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPW  474 (601)
T ss_pred             hhhhhcccH-HHHHHHhcc-cccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecCcceeeccCc
Confidence            777999998 999999764 579999999999999999999999999999999999999999999999999997754322


Q ss_pred             -----ccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHH---------Hhh
Q 004959          498 -----ADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFK---------VMR  563 (721)
Q Consensus       498 -----~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~k---------i~~  563 (721)
                           .....+|+..|+|||++.+..|...      .+||||.|++++.|++|+.||......+..+.         +..
T Consensus       475 e~~~~~~~g~~gS~pY~apE~~~~~~ydpr------~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~  548 (601)
T KOG0590|consen  475 EKNIHESSGIVGSDPYLAPEVLTGKEYDPR------AVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFE  548 (601)
T ss_pred             chhhhhhcCcccCCcCcCcccccccccCcc------hhhhhhccceEEEEecCCCccccccccccchhhhcccccccccc
Confidence                 2245789999999999976555443      68999999999999999999976443332211         111


Q ss_pred             cCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhccccccCC
Q 004959          564 DTPAIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQ  607 (721)
Q Consensus       564 ~~~~~p~~lS~el~dLI~~cL~~DP~kRPSa~eLL~Hp~f~~~~  607 (721)
                      +...+...++.+.+.+|.+||+.||.+|.|+++|++.+||+...
T Consensus       549 ~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i~  592 (601)
T KOG0590|consen  549 GPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRSIE  592 (601)
T ss_pred             ChHHHHHhchhhHHHHHHHHccCChhheecHHHHhhChHhhhcc
Confidence            12233345788899999999999999999999999999998654

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.94  E-value=2.4e-25  Score=240.09  Aligned_cols=247  Identities=26%  Similarity=0.332  Sum_probs=193.9

Q ss_pred             CeeEeeEEeecCCeEEEEEEECCCC-cEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCC----CCeeeeeeeE-Eec
Q 004959          341 QWQKGKLIGRGTFGSVYVASNRETG-ALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKH----PNIVQYYGSE-IVE  414 (721)
Q Consensus       341 ~y~~~k~LG~G~fG~VY~a~~~~tg-~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~H----PnIV~l~g~~-~~~  414 (721)
                      .|++++.||+|+||.||+|.+..++ ..+|+|.........     ...+..|+.+|..+..    .++..+++.+ ..+
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~-----~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~   93 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSK-----PSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTE   93 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCC-----CccchhHHHHHHHHhhhcCCCCCCEEEEeccCCC
Confidence            8999999999999999999988775 689999875421111     0146678888888863    6899999988 477


Q ss_pred             CeEEEEEeeccCCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCC-----CceEEeecC
Q 004959          415 DKFYIYLEYVHPGSINKYVREHC-GAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDAS-----GVVKLADFG  488 (721)
Q Consensus       415 ~~~yLVmEy~~gGsL~~~L~~~~-~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~-----g~VKL~DFG  488 (721)
                      ...|+||+.+ |.+|.++..... +.++...+..++.|++.+|++||+.|+|||||||.|+++...     ..+.|+|||
T Consensus        94 ~~~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfG  172 (322)
T KOG1164|consen   94 DFNFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFG  172 (322)
T ss_pred             ceeEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecC
Confidence            8899999999 789999886664 789999999999999999999999999999999999999754     369999999


Q ss_pred             Ccc--ccCCCc--------c-cccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHH
Q 004959          489 MAK--HLTGQK--------A-DLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAA  557 (721)
Q Consensus       489 lA~--~l~~~~--------~-~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~  557 (721)
                      +++  .+....        . ...+.||..|+++..+.       ....+++.|+||+++++.+|+.|.+||........
T Consensus       173 lar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~-------~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~  245 (322)
T KOG1164|consen  173 LARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHL-------GIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDL  245 (322)
T ss_pred             CCccccccCCCCcccccCCCCccCCCCccccccHHHhC-------CCccCCchhhhhHHHHHHHHhcCCCCCccccccch
Confidence            998  432111        1 12355999999999884       45566678999999999999999999976553222


Q ss_pred             HHHH---hhcCCC--CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q 004959          558 MFKV---MRDTPA--IPDSLSPEGKDFLRCCFQRNPADRPPASLLLEH  600 (721)
Q Consensus       558 ~~ki---~~~~~~--~p~~lS~el~dLI~~cL~~DP~kRPSa~eLL~H  600 (721)
                      ..+.   ......  .....+.++.+++..+-..+...+|.+..+...
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~  293 (322)
T KOG1164|consen  246 KSKFEKDPRKLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAEL  293 (322)
T ss_pred             HHHHHHHhhhhccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHH
Confidence            2222   221111  234456788888888888999999999988754

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.93  E-value=1.1e-25  Score=246.29  Aligned_cols=184  Identities=17%  Similarity=0.175  Sum_probs=138.6

Q ss_pred             CCCCCeeEeeEEeecCCeEEEEEEECC-CCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeee-eeeeEEec
Q 004959          337 PMNSQWQKGKLIGRGTFGSVYVASNRE-TGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQ-YYGSEIVE  414 (721)
Q Consensus       337 ~l~~~y~~~k~LG~G~fG~VY~a~~~~-tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~-l~g~~~~~  414 (721)
                      .+...|++++.||+|+||+||+|.++. +|+.||||++.............+.+.+|+++|+++.|+|||. +++.    
T Consensus        15 ~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~----   90 (365)
T PRK09188         15 ALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT----   90 (365)
T ss_pred             cccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc----
Confidence            455789999999999999999998876 6788899986421100012334567999999999999999985 4432    


Q ss_pred             CeEEEEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCC-CCCcEEEcCCCceEEeecCCcccc
Q 004959          415 DKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDI-KGANLLVDASGVVKLADFGMAKHL  493 (721)
Q Consensus       415 ~~~yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDL-KPeNILld~~g~VKL~DFGlA~~l  493 (721)
                      +..|||||||+|++|.. +.    ...   ...++.||+.||.|||++||+|||| ||+|||++.++.+||+|||+|+.+
T Consensus        91 ~~~~LVmE~~~G~~L~~-~~----~~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~~  162 (365)
T PRK09188         91 GKDGLVRGWTEGVPLHL-AR----PHG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDFQLASVF  162 (365)
T ss_pred             CCcEEEEEccCCCCHHH-hC----ccc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEEEECccceec
Confidence            46899999999999963 21    111   1467899999999999999999999 999999999999999999999876


Q ss_pred             CCCccc---------ccCCCCCccCChhhHHHHhhcCCCCCCcchhhHH
Q 004959          494 TGQKAD---------LSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIW  533 (721)
Q Consensus       494 ~~~~~~---------~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVW  533 (721)
                      ......         ...++++.|+|||.+....... ....+...|-|
T Consensus       163 ~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~~~~-~~~~~~~~dgW  210 (365)
T PRK09188        163 RRRGALYRIAAYEDLRHLLKHKRTYAPDALTPRERKI-LARKSLPSRIW  210 (365)
T ss_pred             ccCcchhhhhhhhhhhhhhccCccCCcccCChhhhcc-ccccccccCcE
Confidence            543211         2456889999999986543322 22333345666

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.93  E-value=5e-27  Score=262.85  Aligned_cols=241  Identities=26%  Similarity=0.449  Sum_probs=206.8

Q ss_pred             EEeecCCeEEEEEE---ECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCC-CCCeeeeeeeEEecCeEEEEEe
Q 004959          347 LIGRGTFGSVYVAS---NRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLK-HPNIVQYYGSEIVEDKFYIYLE  422 (721)
Q Consensus       347 ~LG~G~fG~VY~a~---~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~-HPnIV~l~g~~~~~~~~yLVmE  422 (721)
                      .+|+|+||.|+++.   ....|..||+|+..+.........   ....|..++..++ ||.+|+++..++.+...|++++
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~---~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld   77 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRT---HTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILD   77 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhccccccccccccc---ccccHHHHHhhccCCCceeeeeeeeccccchhHhhh
Confidence            37999999999763   446788999998865432222221   4456777888887 9999999999999999999999


Q ss_pred             eccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCCcccccC
Q 004959          423 YVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSM  502 (721)
Q Consensus       423 y~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~~~~~s~  502 (721)
                      |..||+|+..+.+. ..+.+...+.+...++-+++++|+.||+|||+|++||+++.+|.+++.|||+++..-..+..   
T Consensus        78 ~~rgg~lft~l~~~-~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~---  153 (612)
T KOG0603|consen   78 FLRGGDLFTRLSKE-VMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA---  153 (612)
T ss_pred             hcccchhhhccccC-CchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhHhhhhc---
Confidence            99999998887654 67888999999999999999999999999999999999999999999999999876554443   


Q ss_pred             CCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhcCCCCCCCCCHHHHHHHHH
Q 004959          503 KGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDSLSPEGKDFLRC  582 (721)
Q Consensus       503 ~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~~~~~p~~lS~el~dLI~~  582 (721)
                      |||..|||||++.         ....++|.||||++++||++|..||..    +.+..|++.....|..++.++++++..
T Consensus       154 cgt~eymApEI~~---------gh~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~~~~~~p~~l~~~a~~~~~~  220 (612)
T KOG0603|consen  154 CGTYEYRAPEIIN---------GHLSAADWWSFGVLAFELLTGTLPFGG----DTMKRILKAELEMPRELSAEARSLFRQ  220 (612)
T ss_pred             ccchhhhhhHhhh---------ccCCcccchhhhhhHHHHhhCCCCCch----HHHHHHhhhccCCchhhhHHHHHHHHH
Confidence            9999999999995         234478999999999999999999987    677788888889999999999999999


Q ss_pred             hcccCCCCCCC-----HHHHHhccccccCC
Q 004959          583 CFQRNPADRPP-----ASLLLEHRFLKNSQ  607 (721)
Q Consensus       583 cL~~DP~kRPS-----a~eLL~Hp~f~~~~  607 (721)
                      ++..+|..|.-     +.|+++|+||+...
T Consensus       221 l~~r~p~nrLg~~~~~~~eik~h~f~~~i~  250 (612)
T KOG0603|consen  221 LFKRNPENRLGAGPDGVDEIKQHEFFQSID  250 (612)
T ss_pred             HHhhCHHHHhccCcchhHHHhccchheeee
Confidence            99999999974     57999999998654

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.92  E-value=3.9e-24  Score=223.94  Aligned_cols=243  Identities=21%  Similarity=0.327  Sum_probs=196.4

Q ss_pred             CCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCC-CCCeeeeeeeEEecCeEE
Q 004959          340 SQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLK-HPNIVQYYGSEIVEDKFY  418 (721)
Q Consensus       340 ~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~-HPnIV~l~g~~~~~~~~y  418 (721)
                      -.|++++.||+|.||++++|++.-+++.||||.-....+.       -++..|.+..+.|. .++|...|-+..+..+-.
T Consensus        28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~A-------PQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~Ni  100 (449)
T KOG1165|consen   28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSEA-------PQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNI  100 (449)
T ss_pred             ccceeccccccCcceeeecccccccCceEEEEeccccCCc-------chHHHHHHHHHHHcCCCCCCceeeeccccchhh
Confidence            3799999999999999999999999999999965432222       36777888888875 789999998888888889


Q ss_pred             EEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCC-----CceEEeecCCcccc
Q 004959          419 IYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDAS-----GVVKLADFGMAKHL  493 (721)
Q Consensus       419 LVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~-----g~VKL~DFGlA~~l  493 (721)
                      ||||++ |-+|+|+..-.+..|+...+..++.|++.-++|+|++.+|+|||||+|+||..-     ..|.|+|||+|+.+
T Consensus       101 LVidLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Y  179 (449)
T KOG1165|consen  101 LVIDLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEY  179 (449)
T ss_pred             hhhhhh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhhh
Confidence            999999 789999988777889999999999999999999999999999999999999643     36899999999987


Q ss_pred             CCCcc--------cccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhh---HHHHHHHh
Q 004959          494 TGQKA--------DLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEG---AAAMFKVM  562 (721)
Q Consensus       494 ~~~~~--------~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~---~~~~~ki~  562 (721)
                      .+...        +.+..||..||+-....|..       .++..|+-|||-++.+.|-|.+||.+...   .+.+.+|-
T Consensus       180 rDp~TkqHIPYrE~KSLsGTARYMSINTHlGrE-------QSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIG  252 (449)
T KOG1165|consen  180 RDPKTKQHIPYREHKSLSGTARYMSINTHLGRE-------QSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIG  252 (449)
T ss_pred             cCccccccCccccccccccceeeeEeeccccch-------hhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhc
Confidence            65432        23467999999988886543       34457999999999999999999987533   33444443


Q ss_pred             hcCC-----CCCCCCCHHHHHHHHHhcccCCCCCCCHHHH
Q 004959          563 RDTP-----AIPDSLSPEGKDFLRCCFQRNPADRPPASLL  597 (721)
Q Consensus       563 ~~~~-----~~p~~lS~el~dLI~~cL~~DP~kRPSa~eL  597 (721)
                      ....     .+-..++.++...|+..=.++-++-|..+-+
T Consensus       253 e~Kr~T~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdyl  292 (449)
T KOG1165|consen  253 ETKRSTPIEVLCEGFPEEFATYLRYVRRLDFFETPDYDYL  292 (449)
T ss_pred             cccccCCHHHHHhcCHHHHHHHHHHHHhcCcccCCCHHHH
Confidence            2221     2235678888888888877788888877654

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.91  E-value=7.7e-24  Score=213.78  Aligned_cols=246  Identities=22%  Similarity=0.332  Sum_probs=196.9

Q ss_pred             CCCCCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCC-CCeeeeeeeEEecC
Q 004959          337 PMNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKH-PNIVQYYGSEIVED  415 (721)
Q Consensus       337 ~l~~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~H-PnIV~l~g~~~~~~  415 (721)
                      ...+.|++++.||.|+||.+|+|.+..+|+.||||+-......+       ++..|.++.+.|++ ..|..+..++.+..
T Consensus        12 iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~hp-------qL~yEskvY~iL~~g~GiP~i~~y~~e~~   84 (341)
T KOG1163|consen   12 IVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKHP-------QLLYESKVYRILQGGVGIPHIRHYGTEKD   84 (341)
T ss_pred             eeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCCc-------chhHHHHHHHHhccCCCCchhhhhccccc
Confidence            34578999999999999999999999999999999765332222       57788888888874 56777777778888


Q ss_pred             eEEEEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcC---CCceEEeecCCccc
Q 004959          416 KFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDA---SGVVKLADFGMAKH  492 (721)
Q Consensus       416 ~~yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~---~g~VKL~DFGlA~~  492 (721)
                      +-.+|||++ |-+|+++..-....++...+.-++.|++.-|+|+|.+++|||||||+|+|+.-   ...+.|+|||+|+.
T Consensus        85 ynvlVMdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKk  163 (341)
T KOG1163|consen   85 YNVLVMDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKK  163 (341)
T ss_pred             cceeeeecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhh
Confidence            899999999 78999888665578999999999999999999999999999999999999953   34799999999998


Q ss_pred             cCCCcc--------cccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhH---HHHHHH
Q 004959          493 LTGQKA--------DLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGA---AAMFKV  561 (721)
Q Consensus       493 l~~~~~--------~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~---~~~~ki  561 (721)
                      +.+...        .....||..|.+-..+.+..+.       ...|+-|+|.+|..+.-|.+||.+....   ....+|
T Consensus       164 y~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqS-------RRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI  236 (341)
T KOG1163|consen  164 YRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQS-------RRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKI  236 (341)
T ss_pred             hccccccccCccccCCccceeeeehhhhhhhhhhhh-------hhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHH
Confidence            754322        2345699999998777654443       3569999999999999999999885433   333344


Q ss_pred             hhcCCC-----CCCCCCHHHHHHHHHhcccCCCCCCCHHHH
Q 004959          562 MRDTPA-----IPDSLSPEGKDFLRCCFQRNPADRPPASLL  597 (721)
Q Consensus       562 ~~~~~~-----~p~~lS~el~dLI~~cL~~DP~kRPSa~eL  597 (721)
                      ......     +-..++.|+.-+|..|=..--++-|...-|
T Consensus       237 ~EkK~s~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~yl  277 (341)
T KOG1163|consen  237 SEKKMSTPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYL  277 (341)
T ss_pred             HHhhcCCCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHH
Confidence            433222     235688999999999988888888886654

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.89  E-value=2.4e-23  Score=242.84  Aligned_cols=225  Identities=28%  Similarity=0.493  Sum_probs=175.5

Q ss_pred             CCCCCCCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEec
Q 004959          335 PLPMNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVE  414 (721)
Q Consensus       335 ~~~l~~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~  414 (721)
                      ..+...+|..+|+|-.|+||-||.++|+.+.+.+|+| +++.          ..+.+-  ||.....|.+|         
T Consensus        78 ~~p~e~df~~IklisngAygavylvrh~~trqrfa~k-iNkq----------~lilRn--ilt~a~npfvv---------  135 (1205)
T KOG0606|consen   78 RAPSESDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQ----------NLILRN--ILTFAGNPFVV---------  135 (1205)
T ss_pred             cCCCccccceeEeeccCCCCceeeeeccccccchhhc-cccc----------chhhhc--cccccCCccee---------
Confidence            3455678999999999999999999999999999995 4321          011111  44444555555         


Q ss_pred             CeEEEEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccC
Q 004959          415 DKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLT  494 (721)
Q Consensus       415 ~~~yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~  494 (721)
                                  |+-...++.. +.++...        +.+++|||+.||+|||+||+|+||+.-|.+||.|||+.+...
T Consensus       136 ------------gDc~tllk~~-g~lPvdm--------vla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GL  194 (1205)
T KOG0606|consen  136 ------------GDCATLLKNI-GPLPVDM--------VLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGL  194 (1205)
T ss_pred             ------------chhhhhcccC-CCCcchh--------hHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhh
Confidence                        3444444332 4555433        789999999999999999999999999999999999987531


Q ss_pred             C----------------CcccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHH
Q 004959          495 G----------------QKADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAM  558 (721)
Q Consensus       495 ~----------------~~~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~  558 (721)
                      .                +-.....||||+|+|||++..       ..|...+|+|++|+|+||.+.|..||.+....+.+
T Consensus       195 ms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilr-------qgygkpvdwwamGiIlyeFLVgcvpffGdtpeelf  267 (1205)
T KOG0606|consen  195 MSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILR-------QGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELF  267 (1205)
T ss_pred             hhccchhhhcchHHHHHHhhhccccCCccccChhhhhh-------hccCCCccHHHHHHHHHHHheeeeeccCCCHHHHH
Confidence            1                011234689999999999964       34555799999999999999999999999888888


Q ss_pred             HHHhhcCCCCCC---CCCHHHHHHHHHhcccCCCCC---CCHHHHHhccccccCCCC
Q 004959          559 FKVMRDTPAIPD---SLSPEGKDFLRCCFQRNPADR---PPASLLLEHRFLKNSQQP  609 (721)
Q Consensus       559 ~ki~~~~~~~p~---~lS~el~dLI~~cL~~DP~kR---PSa~eLL~Hp~f~~~~~~  609 (721)
                      ..++.+...+|+   .+.+|++++|.++|+.+|..|   ..+.++.+|.||+.....
T Consensus       268 g~visd~i~wpE~dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~LDw~  324 (1205)
T KOG0606|consen  268 GQVISDDIEWPEEDEALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQLLDWK  324 (1205)
T ss_pred             hhhhhhhccccccCcCCCHHHHHHHHHHHHhChHhhcccchhhhhhhccceeecccc
Confidence            888877665554   578999999999999999999   467889999999876544

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.88  E-value=3e-22  Score=211.91  Aligned_cols=242  Identities=23%  Similarity=0.309  Sum_probs=155.1

Q ss_pred             CeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCC----------CCeeeeeee
Q 004959          341 QWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKH----------PNIVQYYGS  410 (721)
Q Consensus       341 ~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~H----------PnIV~l~g~  410 (721)
                      .+..++.||.|+|+.||.+++.+||+.+|+|+..... + .....++.+.+|.-....+.+          -.++-.++.
T Consensus        13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~-~-~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~   90 (288)
T PF14531_consen   13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPA-D-ASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDL   90 (288)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESS-T-THTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEE
T ss_pred             EEEEccccccCCceEEEEEEEccCCceEEEEEEeccc-c-cchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEE
Confidence            5678899999999999999999999999999986544 2 223356777777655444322          122222222


Q ss_pred             EE---------ec---C-----eEEEEEeeccCCCHHHHHHH---hcCC---CCHHHHHHHHHHHHHHHHHHhhCCeecc
Q 004959          411 EI---------VE---D-----KFYIYLEYVHPGSINKYVRE---HCGA---ITESVVRNFTRHILSGLAYLHSKKTIHR  467 (721)
Q Consensus       411 ~~---------~~---~-----~~yLVmEy~~gGsL~~~L~~---~~~~---Lse~~i~~i~~QIl~AL~yLHs~gIIHr  467 (721)
                      ..         ..   .     ..+++|+-+. ++|.+++..   ....   +.......+..|++..+++||..||+|+
T Consensus        91 ~~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~-~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHg  169 (288)
T PF14531_consen   91 LRIPGKPPFFERGPGQSIYWVLNRFLLMPRAQ-GDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHG  169 (288)
T ss_dssp             EEETTS-SEEEECETTEEEEEESEEEEEE--S-EEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEES
T ss_pred             EEEcCCCcceecCCCCccceeehhhhccchhh-hcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEec
Confidence            11         11   1     2367788774 788877642   2111   1122234556899999999999999999


Q ss_pred             CCCCCcEEEcCCCceEEeecCCccccCCCcccccCCCCCccCChhhHHHHh-hcCCCCCCcchhhHHHHHHHHHHHhhCC
Q 004959          468 DIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPYWMAPELMMAVM-QKGKSSDSALAVDIWSLGCTIIEMYTGK  546 (721)
Q Consensus       468 DLKPeNILld~~g~VKL~DFGlA~~l~~~~~~~s~~GT~~Y~APEvl~~~~-~~~k~~~~s~asDVWSLGVILyELLtG~  546 (721)
                      ||||+|+|++.+|.++|+||+...........  ...+..|.+||...... +......++.+.|.|+||+++|.|.||.
T Consensus       170 di~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~--~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~  247 (288)
T PF14531_consen  170 DIKPENFLLDQDGGVFLGDFSSLVRAGTRYRC--SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGR  247 (288)
T ss_dssp             T-SGGGEEE-TTS-EEE--GGGEEETTEEEEG--GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS
T ss_pred             ccceeeEEEcCCCCEEEcChHHHeecCceeec--cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHcc
Confidence            99999999999999999999877654322111  33567899999875431 1113345778999999999999999999


Q ss_pred             CCCCchhhHHHHHHHhhcCCCCCCCCCHHHHHHHHHhcccCCCCC
Q 004959          547 PPWSEYEGAAAMFKVMRDTPAIPDSLSPEGKDFLRCCFQRNPADR  591 (721)
Q Consensus       547 ~PF~~~~~~~~~~ki~~~~~~~p~~lS~el~dLI~~cL~~DP~kR  591 (721)
                      .||...........   ....+. .+++.+++||+.+|++||++|
T Consensus       248 lPf~~~~~~~~~~~---~f~~C~-~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  248 LPFGLSSPEADPEW---DFSRCR-DMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             -STCCCGGGSTSGG---GGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred             CCCCCCCccccccc---cchhcC-CcCHHHHHHHHHHccCCcccC
Confidence            99975432211111   222344 789999999999999999987

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.88  E-value=5.3e-23  Score=219.30  Aligned_cols=252  Identities=23%  Similarity=0.391  Sum_probs=181.0

Q ss_pred             CCeeEeeEEeecCCeEEEEEEECCCCc-----------------------------------EEEEEEeecCCCCcccHH
Q 004959          340 SQWQKGKLIGRGTFGSVYVASNRETGA-----------------------------------LCAMKEVDIFPDDPKSAE  384 (721)
Q Consensus       340 ~~y~~~k~LG~G~fG~VY~a~~~~tg~-----------------------------------~vAIK~i~~~~~~~~~~~  384 (721)
                      ++|+++..||+|+-+.||.|....+|.                                   +.|||.+..+..+..+..
T Consensus       157 ddyeiG~~igkGC~AaVY~A~~~~dg~~le~~~~t~~~pgf~p~ts~p~e~~q~~~p~~~aFPLAiKmMfN~~~~s~~~~  236 (598)
T KOG4158|consen  157 DDYEIGEFIGKGCNAAVYSARLANDGSDLESSGNTHYGPGFNPVTSIPAEIPQVSKPAQKAFPLAIKMMFNFEHDSGDAH  236 (598)
T ss_pred             hhhcccchhhccchhhhhhhhcCCCcccccccCCCCcCCCcCCCcCCcccCCcccCccccccchHHHHhcccccCCchHH
Confidence            579999999999999999986554221                                   245665543333333333


Q ss_pred             HHHHHHHHHH------HH--------Hh--------CCCCCeeeeeeeEEec---------------------------C
Q 004959          385 SIKQLEQEIK------VL--------SH--------LKHPNIVQYYGSEIVE---------------------------D  415 (721)
Q Consensus       385 ~~k~~~~Ei~------iL--------~~--------L~HPnIV~l~g~~~~~---------------------------~  415 (721)
                      .++.+.+|..      .+        +.        ..|||||++.++|++.                           .
T Consensus       237 iL~sM~~ElvPa~~~a~~~e~~~~t~R~l~nqtvhLa~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~  316 (598)
T KOG4158|consen  237 ILKSMGNELVPAPNAAKLLEGQMGTFRPLPNQTVHLAKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPK  316 (598)
T ss_pred             HHHHhhhhccCcchhhhhcccccceeeeCCCCCcccCCCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCc
Confidence            3444444431      01        11        2599999999887652                           1


Q ss_pred             eEEEEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEc--CCC--ceEEeecCCcc
Q 004959          416 KFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVD--ASG--VVKLADFGMAK  491 (721)
Q Consensus       416 ~~yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld--~~g--~VKL~DFGlA~  491 (721)
                      .+|+||.-+. -+|..|+..  ...+....+-++.|+++|+.|||++||.|||||.+||||.  +++  .+.|+|||++-
T Consensus       317 tlylvMkrY~-~tLr~yl~~--~~~s~r~~~~~laQlLEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcL  393 (598)
T KOG4158|consen  317 TLYLVMKRYR-QTLREYLWT--RHRSYRTGRVILAQLLEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCL  393 (598)
T ss_pred             eEEEehhcch-hhHHHHHhc--CCCchHHHHHHHHHHHHHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceee
Confidence            4799999885 689999875  3677888889999999999999999999999999999993  343  67999999875


Q ss_pred             ccCCCc-------ccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhH--HHHHHHh
Q 004959          492 HLTGQK-------ADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGA--AAMFKVM  562 (721)
Q Consensus       492 ~l~~~~-------~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~--~~~~ki~  562 (721)
                      .-....       ......|....||||+....+.......|. ++|.|+.|.+.||++....||......  +......
T Consensus       394 Ad~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~avvny~-kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe  472 (598)
T KOG4158|consen  394 ADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNAVVNYE-KADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQE  472 (598)
T ss_pred             eccccccccccccccccCCCcceecchhhhhcCCCCceeeccc-hhhhhhhhhhHHHHhccCCcccccchheechhhhhh
Confidence            432211       122345788899999996544322222333 689999999999999999999873221  1111222


Q ss_pred             hcCCCCCCCCCHHHHHHHHHhcccCCCCCCCHH
Q 004959          563 RDTPAIPDSLSPEGKDFLRCCFQRNPADRPPAS  595 (721)
Q Consensus       563 ~~~~~~p~~lS~el~dLI~~cL~~DP~kRPSa~  595 (721)
                      ...+.+|+.+++.+++++..+|+.||.+|++..
T Consensus       473 ~qLPalp~~vpp~~rqlV~~lL~r~pskRvsp~  505 (598)
T KOG4158|consen  473 SQLPALPSRVPPVARQLVFDLLKRDPSKRVSPN  505 (598)
T ss_pred             hhCCCCcccCChHHHHHHHHHhcCCccccCCcc
Confidence            346788999999999999999999999999854

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.88  E-value=2.3e-22  Score=201.58  Aligned_cols=144  Identities=18%  Similarity=0.164  Sum_probs=110.9

Q ss_pred             eeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccH---------------------HHHHHHHHHHHHHHhCCCCC
Q 004959          345 GKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSA---------------------ESIKQLEQEIKVLSHLKHPN  403 (721)
Q Consensus       345 ~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~---------------------~~~k~~~~Ei~iL~~L~HPn  403 (721)
                      ...||+|+||.||+|.+. +|+.||||++..........                     ........|+++|.++.+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~   80 (190)
T cd05147           2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG   80 (190)
T ss_pred             CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence            458999999999999987 89999999986432111110                     01123456999999998777


Q ss_pred             eeeeeeeEEecCeEEEEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHH-hhCCeeccCCCCCcEEEcCCCce
Q 004959          404 IVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYL-HSKKTIHRDIKGANLLVDASGVV  482 (721)
Q Consensus       404 IV~l~g~~~~~~~~yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yL-Hs~gIIHrDLKPeNILld~~g~V  482 (721)
                      |.....+..  ...+|||||+.|++|...+.. .+.+++..+..++.||+.+|.|| |+.||+||||||+|||++ ++.+
T Consensus        81 v~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~-~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~-~~~v  156 (190)
T cd05147          81 IPCPEPILL--KSHVLVMEFIGDDGWAAPRLK-DAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH-DGKL  156 (190)
T ss_pred             CCCCcEEEe--cCCEEEEEEeCCCCCcchhhh-cCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE-CCcE
Confidence            643332222  234899999998877655433 36799999999999999999999 799999999999999998 5789


Q ss_pred             EEeecCCcccc
Q 004959          483 KLADFGMAKHL  493 (721)
Q Consensus       483 KL~DFGlA~~l  493 (721)
                      +|+|||+|...
T Consensus       157 ~LiDFG~a~~~  167 (190)
T cd05147         157 YIIDVSQSVEH  167 (190)
T ss_pred             EEEEccccccC
Confidence            99999999754

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.87  E-value=9.1e-22  Score=196.59  Aligned_cols=146  Identities=17%  Similarity=0.138  Sum_probs=113.6

Q ss_pred             eeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCccc---------------------HHHHHHHHHHHHHHHhCCCCC
Q 004959          345 GKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKS---------------------AESIKQLEQEIKVLSHLKHPN  403 (721)
Q Consensus       345 ~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~---------------------~~~~k~~~~Ei~iL~~L~HPn  403 (721)
                      .+.||+|+||+||+|.+. +|+.||||++.........                     ......+.+|+..+.++.|++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~   80 (190)
T cd05145           2 NGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG   80 (190)
T ss_pred             CceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence            468999999999999987 8999999998753211100                     011233468999999999998


Q ss_pred             eeeeeeeEEecCeEEEEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhh-CCeeccCCCCCcEEEcCCCce
Q 004959          404 IVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHS-KKTIHRDIKGANLLVDASGVV  482 (721)
Q Consensus       404 IV~l~g~~~~~~~~yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs-~gIIHrDLKPeNILld~~g~V  482 (721)
                      |.....+...  ..||||||++|+++...+.. ...+++..+..++.||+.+|.+||. +||+||||||+|||++ ++.+
T Consensus        81 i~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~-~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~~~~  156 (190)
T cd05145          81 VPVPEPILLK--KNVLVMEFIGDDGSPAPRLK-DVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-DGKP  156 (190)
T ss_pred             CCCceEEEec--CCEEEEEEecCCCchhhhhh-hccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-CCCE
Confidence            7544433322  34899999998865443222 2568889999999999999999999 9999999999999998 8999


Q ss_pred             EEeecCCccccCC
Q 004959          483 KLADFGMAKHLTG  495 (721)
Q Consensus       483 KL~DFGlA~~l~~  495 (721)
                      +|+|||++..+..
T Consensus       157 ~liDFG~a~~~~~  169 (190)
T cd05145         157 YIIDVSQAVELDH  169 (190)
T ss_pred             EEEEcccceecCC
Confidence            9999999986643

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.87  E-value=1.9e-22  Score=207.55  Aligned_cols=174  Identities=14%  Similarity=0.196  Sum_probs=132.3

Q ss_pred             CCCCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHH------HHHHHHHHHhCCCCCeeeeeeeE
Q 004959          338 MNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQ------LEQEIKVLSHLKHPNIVQYYGSE  411 (721)
Q Consensus       338 l~~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~------~~~Ei~iL~~L~HPnIV~l~g~~  411 (721)
                      +.++|++.++||.|+||.||++..  ++..+|||++...  ..........      +++|++.+.++.|++|..+.+++
T Consensus        29 l~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~--~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~  104 (232)
T PRK10359         29 LSYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPK--VKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFY  104 (232)
T ss_pred             hhCceEEEEEecCCCceEEEEEec--CCCcEEEEEechh--cCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEee
Confidence            457899999999999999999755  4778999988522  2222333333      68999999999999999998886


Q ss_pred             Eec--------CeEEEEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceE
Q 004959          412 IVE--------DKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVK  483 (721)
Q Consensus       412 ~~~--------~~~yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VK  483 (721)
                      ...        ...+|||||++|.+|.++..     +++    ..+.+|+.+|..||+.|++||||||.||+++.+| ++
T Consensus       105 ~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~-----~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g-i~  174 (232)
T PRK10359        105 LLAERKTLRYAHTYIMLIEYIEGVELNDMPE-----ISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG-LR  174 (232)
T ss_pred             eecccccccccCCeEEEEEEECCccHHHhhh-----ccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC-EE
Confidence            643        35899999999999987732     333    2456999999999999999999999999999988 99


Q ss_pred             EeecCCccccCCCcccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHh
Q 004959          484 LADFGMAKHLTGQKADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMY  543 (721)
Q Consensus       484 L~DFGlA~~l~~~~~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELL  543 (721)
                      |+|||............           .++..       ..+..++|+|+|||++..+.
T Consensus       175 liDfg~~~~~~e~~a~d-----------~~vle-------r~y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        175 IIDLSGKRCTAQRKAKD-----------RIDLE-------RHYGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             EEECCCcccccchhhHH-----------HHHHH-------hHhcccccccceeEeehHHH
Confidence            99999887553222110           02222       12335789999999987654

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.87  E-value=8.9e-23  Score=238.03  Aligned_cols=250  Identities=23%  Similarity=0.342  Sum_probs=187.2

Q ss_pred             CeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeEEEE
Q 004959          341 QWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYIY  420 (721)
Q Consensus       341 ~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~yLV  420 (721)
                      +|...+.||.+-|=+|.+|++.+ |. |+||++.+ +++...-...++...|++ ...+++||++.+..+.+.....|||
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~e-G~-vVvKVFvk-~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylv   99 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDRE-GL-VVVKVFVK-QDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLV   99 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCCC-ce-EEEEEEec-cCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHH
Confidence            67888999999999999998764 44 99998754 333444555666667777 7778999999999888888889999


Q ss_pred             EeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCcccc--CCC-c
Q 004959          421 LEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHL--TGQ-K  497 (721)
Q Consensus       421 mEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l--~~~-~  497 (721)
                      -+|+. -+|+|.|..+ ..+.+-+.+.|+.||+.||.-||..||+|||||.|||||+..+-+.|+||..-+-.  ..+ .
T Consensus       100 Rqyvk-hnLyDRlSTR-PFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNP  177 (1431)
T KOG1240|consen  100 RQYVK-HNLYDRLSTR-PFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNP  177 (1431)
T ss_pred             HHHHh-hhhhhhhccc-hHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccCCccCCCCCc
Confidence            99995 7899988654 56788899999999999999999999999999999999999999999999755432  111 1


Q ss_pred             cccc-----CCCCCccCChhhHHHHh---hcCCCCC-CcchhhHHHHHHHHHHHhh-CCCCCCchhhHHHHHHHhhcCCC
Q 004959          498 ADLS-----MKGSPYWMAPELMMAVM---QKGKSSD-SALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFKVMRDTPA  567 (721)
Q Consensus       498 ~~~s-----~~GT~~Y~APEvl~~~~---~~~k~~~-~s~asDVWSLGVILyELLt-G~~PF~~~~~~~~~~ki~~~~~~  567 (721)
                      ...+     -..-..|+|||.+....   ....... .+++.||||+||+++||++ |++||.-.    ++..+......
T Consensus       178 adf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS----QL~aYr~~~~~  253 (1431)
T KOG1240|consen  178 ADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS----QLLAYRSGNAD  253 (1431)
T ss_pred             ccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH----HHHhHhccCcc
Confidence            1111     11234599999997522   1111222 6789999999999999998 89999531    11111111000


Q ss_pred             CC-----CCCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q 004959          568 IP-----DSLSPEGKDFLRCCFQRNPADRPPASLLLEH  600 (721)
Q Consensus       568 ~p-----~~lS~el~dLI~~cL~~DP~kRPSa~eLL~H  600 (721)
                      .+     .--+..++.+|..|++.||.+|.++++.|+.
T Consensus       254 ~~e~~Le~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~  291 (1431)
T KOG1240|consen  254 DPEQLLEKIEDVSLRNLILSMIQRDPSKRLSAEDYLQK  291 (1431)
T ss_pred             CHHHHHHhCcCccHHHHHHHHHccCchhccCHHHHHHh
Confidence            00     1113468999999999999999999999865

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.86  E-value=4.3e-21  Score=194.62  Aligned_cols=189  Identities=16%  Similarity=0.110  Sum_probs=139.4

Q ss_pred             eEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCC-CCCeeeeeeeEEecCeEEEEE
Q 004959          343 QKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLK-HPNIVQYYGSEIVEDKFYIYL  421 (721)
Q Consensus       343 ~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~-HPnIV~l~g~~~~~~~~yLVm  421 (721)
                      .++..|++|+||+||.+..  .+..++.+.+...+-.. ..-....+.+|+++|++|. |++|++++++    +..|++|
T Consensus         5 ~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~-~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvm   77 (218)
T PRK12274          5 AVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWL-RGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDR   77 (218)
T ss_pred             ccceeecCCCcceEEEeec--CCceeeecccccchhhh-hhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEE
Confidence            3456999999999998765  57788877654211100 1111236789999999995 5789999885    4579999


Q ss_pred             eeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCC-CCCcEEEcCCCceEEeecCCccccCCCccc-
Q 004959          422 EYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDI-KGANLLVDASGVVKLADFGMAKHLTGQKAD-  499 (721)
Q Consensus       422 Ey~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDL-KPeNILld~~g~VKL~DFGlA~~l~~~~~~-  499 (721)
                      ||+.|.+|.+.+..       . ...++.||+.+|.+||++||+|||| ||+|||++.+|.++|+|||+|......... 
T Consensus        78 eyI~G~~L~~~~~~-------~-~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~  149 (218)
T PRK12274         78 SYLAGAAMYQRPPR-------G-DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWM  149 (218)
T ss_pred             eeecCccHHhhhhh-------h-hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHH
Confidence            99999998754321       1 1357889999999999999999999 799999999999999999999855433210 


Q ss_pred             ---c----------cCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCc
Q 004959          500 ---L----------SMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSE  551 (721)
Q Consensus       500 ---~----------s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~  551 (721)
                         .          -...++.|++|+...-..     ..--.+.+.++.|+-+|.++|+..++-+
T Consensus       150 r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~-----~~~~~~~~w~~~g~~~~~~~~~~~~~~~  209 (218)
T PRK12274        150 RLLAREDLRHLLKHKRMYCPAALTPVERRVLK-----RTSWIRELWFATGKPVYRFVTRRVLHWE  209 (218)
T ss_pred             HHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhc-----cchhHHHHHHHhcchHHHHHhccCCccc
Confidence               0          122688999998764321     1111356899999999999999887643

>PRK10345 hypothetical protein; Provisional

Probab=99.83  E-value=3.7e-20  Score=188.73  Aligned_cols=135  Identities=19%  Similarity=0.299  Sum_probs=107.1

Q ss_pred             EeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhC-----CCCCeeeeeeeEEecC---
Q 004959          344 KGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHL-----KHPNIVQYYGSEIVED---  415 (721)
Q Consensus       344 ~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L-----~HPnIV~l~g~~~~~~---  415 (721)
                      -.++||+|+||.||.  +..++.. +||++....     ....+.+.+|+.+++.+     .||||++++|+++++.   
T Consensus         6 ~~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~-----~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g   77 (210)
T PRK10345          6 EQSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRG-----DGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTG   77 (210)
T ss_pred             CcceecCCCceEEEE--CCCCcCe-EEEEEeccc-----cchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCe
Confidence            346899999999995  7777666 699875421     12346789999999999     5799999999998863   


Q ss_pred             eEE-EEEee--ccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHH-HHHhhCCeeccCCCCCcEEEcCC----CceEEeec
Q 004959          416 KFY-IYLEY--VHPGSINKYVREHCGAITESVVRNFTRHILSGL-AYLHSKKTIHRDIKGANLLVDAS----GVVKLADF  487 (721)
Q Consensus       416 ~~y-LVmEy--~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL-~yLHs~gIIHrDLKPeNILld~~----g~VKL~DF  487 (721)
                      .++ +||||  +.+++|.+++.+  +.+++.  ..++.|++.++ +|||+++|+||||||+|||++..    +.++|+||
T Consensus        78 ~v~~~I~e~~G~~~~tL~~~l~~--~~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg  153 (210)
T PRK10345         78 YVYDVIADFDGKPSITLTEFAEQ--CRYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDN  153 (210)
T ss_pred             EEEEEEecCCCCcchhHHHHHHc--ccccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEEC
Confidence            434 78999  557999999965  346666  35688888888 99999999999999999999743    37999995


Q ss_pred             CCc
Q 004959          488 GMA  490 (721)
Q Consensus       488 GlA  490 (721)
                      +.+
T Consensus       154 ~G~  156 (210)
T PRK10345        154 IGE  156 (210)
T ss_pred             CCC
Confidence            434

>smart00090 RIO RIO-like kinase

Probab=99.81  E-value=1.1e-19  Score=188.36  Aligned_cols=147  Identities=19%  Similarity=0.143  Sum_probs=114.7

Q ss_pred             CeeEeeEEeecCCeEEEEEE-ECCCCcEEEEEEeecCCCCccc-------------------HHHHHHHHHHHHHHHhCC
Q 004959          341 QWQKGKLIGRGTFGSVYVAS-NRETGALCAMKEVDIFPDDPKS-------------------AESIKQLEQEIKVLSHLK  400 (721)
Q Consensus       341 ~y~~~k~LG~G~fG~VY~a~-~~~tg~~vAIK~i~~~~~~~~~-------------------~~~~k~~~~Ei~iL~~L~  400 (721)
                      .|++.+.||+|+||.||+|. +..+|+.||||++.........                   ......+.+|+.++.++.
T Consensus        29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~  108 (237)
T smart00090       29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY  108 (237)
T ss_pred             hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            58899999999999999998 7778999999998643211100                   011234678999999997


Q ss_pred             CCC--eeeeeeeEEecCeEEEEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCC-eeccCCCCCcEEEc
Q 004959          401 HPN--IVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKK-TIHRDIKGANLLVD  477 (721)
Q Consensus       401 HPn--IV~l~g~~~~~~~~yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~g-IIHrDLKPeNILld  477 (721)
                      +..  +.++++.    ...||||||+.|++|..++... ..+.+..+..++.||+.+|.+||.+| |+||||||+|||++
T Consensus       109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli~  183 (237)
T smart00090      109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKD-VEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILVH  183 (237)
T ss_pred             hcCCCCCeeeEe----cCceEEEEEecCCccccccccc-CCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEEE
Confidence            532  3344432    2458999999998887655332 45667778899999999999999999 99999999999999


Q ss_pred             CCCceEEeecCCcccc
Q 004959          478 ASGVVKLADFGMAKHL  493 (721)
Q Consensus       478 ~~g~VKL~DFGlA~~l  493 (721)
                       ++.++|+|||++...
T Consensus       184 -~~~i~LiDFg~a~~~  198 (237)
T smart00090      184 -DGKVVIIDVSQSVEL  198 (237)
T ss_pred             -CCCEEEEEChhhhcc
Confidence             889999999998754

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.80  E-value=3.4e-20  Score=189.92  Aligned_cols=242  Identities=20%  Similarity=0.349  Sum_probs=190.0

Q ss_pred             eeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeEEEEE
Q 004959          342 WQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYIYL  421 (721)
Q Consensus       342 y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~yLVm  421 (721)
                      ..+...|.+...|+.|++++.  |..++.|++...   ......-+.|..|.-.|+.+.||||+.+++.+...-.+.++.
T Consensus       192 lnl~tkl~e~hsgelwrgrwq--gndivakil~vr---~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~is  266 (448)
T KOG0195|consen  192 LNLITKLAESHSGELWRGRWQ--GNDIVAKILNVR---EVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIIS  266 (448)
T ss_pred             hhhhhhhccCCCccccccccc--Ccchhhhhhhhh---hcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEee
Confidence            344556788888999999887  455677766432   222333457888888899999999999999999999999999


Q ss_pred             eeccCCCHHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHhhCC--eeccCCCCCcEEEcCCCceEE--eecCCccccCCC
Q 004959          422 EYVHPGSINKYVREHCG-AITESVVRNFTRHILSGLAYLHSKK--TIHRDIKGANLLVDASGVVKL--ADFGMAKHLTGQ  496 (721)
Q Consensus       422 Ey~~gGsL~~~L~~~~~-~Lse~~i~~i~~QIl~AL~yLHs~g--IIHrDLKPeNILld~~g~VKL--~DFGlA~~l~~~  496 (721)
                      .||+.|+|+.+|.+..+ .+...++..++..|++|++|||+..  |.---|....++||++-+.+|  +|--++...   
T Consensus       267 q~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kfsfqe---  343 (448)
T KOG0195|consen  267 QYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKFSFQE---  343 (448)
T ss_pred             eeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccceeeeec---
Confidence            99999999999976532 3577889999999999999999985  334458888999999876554  453333221   


Q ss_pred             cccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhc--CCCCCCCCCH
Q 004959          497 KADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRD--TPAIPDSLSP  574 (721)
Q Consensus       497 ~~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~--~~~~p~~lS~  574 (721)
                         ....-.|.||+||.+....    ....-.++|+|||.++||||.|...||.+....+.-.++..+  ...+|+.++.
T Consensus       344 ---~gr~y~pawmspealqrkp----ed~n~raadmwsfaillwel~trevpfadlspmecgmkialeglrv~ippgis~  416 (448)
T KOG0195|consen  344 ---VGRAYSPAWMSPEALQRKP----EDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEGLRVHIPPGISR  416 (448)
T ss_pred             ---cccccCcccCCHHHHhcCc----hhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhccccccCCCCccH
Confidence               1123478899999997532    222345799999999999999999999998888777666443  3578999999


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHH
Q 004959          575 EGKDFLRCCFQRNPADRPPASLLL  598 (721)
Q Consensus       575 el~dLI~~cL~~DP~kRPSa~eLL  598 (721)
                      .+..|+.-|+..||.+||.+.+++
T Consensus       417 hm~klm~icmnedpgkrpkfdmiv  440 (448)
T KOG0195|consen  417 HMNKLMNICMNEDPGKRPKFDMIV  440 (448)
T ss_pred             HHHHHHHHHhcCCCCcCCCcceeh
Confidence            999999999999999999998875

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.80  E-value=1.4e-18  Score=174.62  Aligned_cols=139  Identities=21%  Similarity=0.295  Sum_probs=114.1

Q ss_pred             eEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCc---ccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeEEEEEe
Q 004959          346 KLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDP---KSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYIYLE  422 (721)
Q Consensus       346 k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~---~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~yLVmE  422 (721)
                      +.||+|++|.||+|..  .|..+++|+........   ........+.+|+.++..+.|++|+....++...+..++|||
T Consensus         2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e   79 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVME   79 (211)
T ss_pred             cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEE
Confidence            5799999999999987  57889999754211111   111123567889999999999998877777777788999999


Q ss_pred             eccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccc
Q 004959          423 YVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKH  492 (721)
Q Consensus       423 y~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~  492 (721)
                      |++|++|.+++...    .. ....++.+|+.+|.+||..|++|||++|.|||++ ++.++|+|||++..
T Consensus        80 ~~~G~~L~~~~~~~----~~-~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879         80 YIEGEPLKDLINSN----GM-EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             EeCCcCHHHHHHhc----cH-HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence            99999999998653    12 7889999999999999999999999999999998 78999999998864

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.78  E-value=7.1e-21  Score=220.73  Aligned_cols=257  Identities=30%  Similarity=0.470  Sum_probs=210.1

Q ss_pred             CCeeEeeEEeecCCeEEEEEEEC-CCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCC-CCCeeeeeeeEEecCeE
Q 004959          340 SQWQKGKLIGRGTFGSVYVASNR-ETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLK-HPNIVQYYGSEIVEDKF  417 (721)
Q Consensus       340 ~~y~~~k~LG~G~fG~VY~a~~~-~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~-HPnIV~l~g~~~~~~~~  417 (721)
                      ..|.+.+.||+|+|+.|-.+... .....+|+|.+....   +.....+.+..|+.+-..+. |.|++.+++.....+..
T Consensus        20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~---~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~   96 (601)
T KOG0590|consen   20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPP---KSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSY   96 (601)
T ss_pred             ccccccccccccccchhhhhhhcCCCcceeeccCCCCCC---CccchhhhcCccccccccccccccccccCCccCCCccc
Confidence            36788888999999999998764 445667788776433   44555677778888888887 99999999999999999


Q ss_pred             EEEEeeccCCCHHHHH-HHhcCCCCHHHHHHHHHHHHHHHHHHh-hCCeeccCCCCCcEEEcCCC-ceEEeecCCccccC
Q 004959          418 YIYLEYVHPGSINKYV-REHCGAITESVVRNFTRHILSGLAYLH-SKKTIHRDIKGANLLVDASG-VVKLADFGMAKHLT  494 (721)
Q Consensus       418 yLVmEy~~gGsL~~~L-~~~~~~Lse~~i~~i~~QIl~AL~yLH-s~gIIHrDLKPeNILld~~g-~VKL~DFGlA~~l~  494 (721)
                      ++++||..|++++..+ ......++...+..++.|+..+|.|+| ..++.|+||||+|.+++..+ .++++|||+|..+.
T Consensus        97 ~~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~  176 (601)
T KOG0590|consen   97 LLSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLATAYR  176 (601)
T ss_pred             ccccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhcccc
Confidence            9999999999999988 544336788899999999999999999 99999999999999999999 99999999998876


Q ss_pred             C-Ccc---cccCCC-CCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHH-Hhhc----
Q 004959          495 G-QKA---DLSMKG-SPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFK-VMRD----  564 (721)
Q Consensus       495 ~-~~~---~~s~~G-T~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~k-i~~~----  564 (721)
                      . ...   ....+| ++.|+|||.+.+..+.      ....|+||+|+++.-|++|..||.........+. ....    
T Consensus       177 ~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~------~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~  250 (601)
T KOG0590|consen  177 NKNGAERSLKDRCGSSPPYGAPEHLSGKAYR------GPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGRF  250 (601)
T ss_pred             ccCCcceeeecccCCCCCCCCcccccchhhc------CCCcccccccccccccccCCCCccccccccccceeeccccccc
Confidence            5 322   234678 9999999999764332      3358999999999999999999976544332211 1111    


Q ss_pred             CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccccc
Q 004959          565 TPAIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKN  605 (721)
Q Consensus       565 ~~~~p~~lS~el~dLI~~cL~~DP~kRPSa~eLL~Hp~f~~  605 (721)
                      .......++....+++.++|..+|..|.+.+++..++|+..
T Consensus       251 ~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~  291 (601)
T KOG0590|consen  251 TQLPWNSISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS  291 (601)
T ss_pred             ccCccccCChhhhhcccccccCCchhccccccccccccccc
Confidence            23445678899999999999999999999999999999987

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.77  E-value=2.3e-18  Score=171.70  Aligned_cols=135  Identities=21%  Similarity=0.288  Sum_probs=108.4

Q ss_pred             EEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcc---cHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeEEEEEee
Q 004959          347 LIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPK---SAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYIYLEY  423 (721)
Q Consensus       347 ~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~---~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~yLVmEy  423 (721)
                      +||+|+||.||+|..  +|..|++|+.........   .....+++.+|++++..+.|++|.....++...+..++||||
T Consensus         1 ~ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~   78 (199)
T TIGR03724         1 LIAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEY   78 (199)
T ss_pred             CCCCCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEE
Confidence            489999999999984  578899998542211111   122346788999999999988765555555567778999999


Q ss_pred             ccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccc
Q 004959          424 VHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKH  492 (721)
Q Consensus       424 ~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~  492 (721)
                      ++|++|.+++.....        .++.||+.+|.+||+.|++|+|++|.|||++ ++.++|+|||++..
T Consensus        79 ~~g~~l~~~~~~~~~--------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~  138 (199)
T TIGR03724        79 IEGKPLKDVIEEGND--------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY  138 (199)
T ss_pred             ECCccHHHHHhhcHH--------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence            999999988754311        7899999999999999999999999999998 88999999999865

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.76  E-value=2e-18  Score=205.33  Aligned_cols=190  Identities=26%  Similarity=0.388  Sum_probs=150.8

Q ss_pred             CCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCC---CCCeeeeeeeEEecCe
Q 004959          340 SQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLK---HPNIVQYYGSEIVEDK  416 (721)
Q Consensus       340 ~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~---HPnIV~l~g~~~~~~~  416 (721)
                      ..|.+-++||+|+||+||.|.+.+ |+.||||+-.  +....      +|.--.+++.+|+   -+-|+.+...+.-.+.
T Consensus       698 ~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~--P~~~W------EfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~  768 (974)
T KOG1166|consen  698 EKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEK--PPNPW------EFYICLQVMERLKPQMLPSIMHISSAHVFQNA  768 (974)
T ss_pred             eeEEEEeeeccccceEEEEeecCC-CcEEEEEeec--CCCce------eeeehHHHHHhhchhhhcchHHHHHHHccCCc
Confidence            468889999999999999999887 9999999743  11221      1122233445554   3445555566666778


Q ss_pred             EEEEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcC-------CCceEEeecCC
Q 004959          417 FYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDA-------SGVVKLADFGM  489 (721)
Q Consensus       417 ~yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~-------~g~VKL~DFGl  489 (721)
                      -+||+||.+.|+|.+++. ..+.++|..+..+..|++..|++||..||||+||||+|+||..       +--++|+|||.
T Consensus       769 S~lv~ey~~~Gtlld~~N-~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~  847 (974)
T KOG1166|consen  769 SVLVSEYSPYGTLLDLIN-TNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFGR  847 (974)
T ss_pred             ceeeeeccccccHHHhhc-cCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEeccc
Confidence            899999999999999997 4578999999999999999999999999999999999999942       23689999999


Q ss_pred             ccccC---CCcccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCC
Q 004959          490 AKHLT---GQKADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGK  546 (721)
Q Consensus       490 A~~l~---~~~~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~  546 (721)
                      +-.+.   .+......++|-.+--+|..       .+..++..+|.|.|.-++|.||.|+
T Consensus       848 siDm~lfp~~~~F~~~~~td~f~C~EM~-------~grpWtYq~DyfGlAa~~h~mLFG~  900 (974)
T KOG1166|consen  848 SIDMKLFPDGTKFKAVWHTDLFDCIEMR-------EGRPWTYQIDYFGLAATVHVMLFGK  900 (974)
T ss_pred             ceeeeEcCCCcEEeeeeccccchhHHHh-------cCCCCchhhhhHHHHHHHHHHHHHH
Confidence            87653   23233456788888889988       4567888999999999999999997

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.76  E-value=2.5e-18  Score=172.32  Aligned_cols=143  Identities=18%  Similarity=0.172  Sum_probs=110.3

Q ss_pred             CeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCccc-----------------HHHHHHHHHHHHHHHhCCCCC
Q 004959          341 QWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKS-----------------AESIKQLEQEIKVLSHLKHPN  403 (721)
Q Consensus       341 ~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~-----------------~~~~k~~~~Ei~iL~~L~HPn  403 (721)
                      .|.+++.||+|+||.||+|... +|+.||||++.........                 ........+|+.++..+.|.+
T Consensus        16 ~~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~   94 (198)
T cd05144          16 VESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEG   94 (198)
T ss_pred             hhhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcC
Confidence            3778899999999999999875 7999999987532110000                 001123678899999998774


Q ss_pred             --eeeeeeeEEecCeEEEEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCc
Q 004959          404 --IVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGV  481 (721)
Q Consensus       404 --IV~l~g~~~~~~~~yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~  481 (721)
                        ++..++    ....++||||++|++|..++..       .....++.||+.+|.++|..||+||||||+||||+.++.
T Consensus        95 i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~-------~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~~  163 (198)
T cd05144          95 FPVPKPID----WNRHAVVMEYIDGVELYRVRVL-------EDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDEK  163 (198)
T ss_pred             CCCCceee----cCCceEEEEEeCCcchhhcccc-------ccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCCc
Confidence              444443    3456899999999998765421       346678899999999999999999999999999999999


Q ss_pred             eEEeecCCccccCC
Q 004959          482 VKLADFGMAKHLTG  495 (721)
Q Consensus       482 VKL~DFGlA~~l~~  495 (721)
                      ++|+|||++..+..
T Consensus       164 ~~liDfg~~~~~~~  177 (198)
T cd05144         164 IYIIDWPQMVSTDH  177 (198)
T ss_pred             EEEEECCccccCCC
Confidence            99999999965543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.76  E-value=1.8e-17  Score=190.80  Aligned_cols=140  Identities=18%  Similarity=0.211  Sum_probs=112.7

Q ss_pred             CeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCc---ccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeE
Q 004959          341 QWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDP---KSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKF  417 (721)
Q Consensus       341 ~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~---~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~  417 (721)
                      .|...+.||+|+||+||++....  ..+++|+........   ......+++.+|+++|+.++|++|+..+.++......
T Consensus       334 ~~~~~~~iG~G~~g~Vy~~~~~~--~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~  411 (535)
T PRK09605        334 RKIPDHLIGKGAEADIKKGEYLG--RDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEK  411 (535)
T ss_pred             ccCccceeccCCcEEEEEEeecC--ccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCC
Confidence            34667899999999999998653  345555432111111   1122346788999999999999998887777777788


Q ss_pred             EEEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccc
Q 004959          418 YIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKH  492 (721)
Q Consensus       418 yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~  492 (721)
                      ++||||++|++|.+++.         ....++.||+.+|.|||+.||+||||||+|||+ .++.++|+|||+++.
T Consensus       412 ~lv~E~~~g~~L~~~l~---------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl-~~~~~~liDFGla~~  476 (535)
T PRK09605        412 TIVMEYIGGKDLKDVLE---------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKY  476 (535)
T ss_pred             EEEEEecCCCcHHHHHH---------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE-ECCcEEEEeCccccc
Confidence            99999999999998885         356789999999999999999999999999999 678999999999975

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.76  E-value=4.9e-19  Score=195.84  Aligned_cols=242  Identities=23%  Similarity=0.345  Sum_probs=164.3

Q ss_pred             eeEeeEEeecCCeEEEEEEECCC---CcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeee-------eE
Q 004959          342 WQKGKLIGRGTFGSVYVASNRET---GALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYG-------SE  411 (721)
Q Consensus       342 y~~~k~LG~G~fG~VY~a~~~~t---g~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g-------~~  411 (721)
                      +.+.+.++..+++.+........   .+.+.-|...     ...........+++-.+....|-+..-+.+       .+
T Consensus       246 ~~~~k~~~~~~~~~~~~~q~~~~~s~~E~~~s~~~~-----~d~~~~~~~~~r~~~~l~~~~~~~~s~~~d~~~s~~~~~  320 (516)
T KOG1033|consen  246 SSISKSSERVSSGIVFEKQGKNNSSLREWLKSKRAD-----VDSLCACKYTFRQLGVLVDSSHSNRSILEDLRPSLFESS  320 (516)
T ss_pred             ccccccccccccCCchhhhhcccchhhhhccchhhh-----ccchhhhhhhhhhhhheeccccCCcccccCCCCchhhhc
Confidence            34445566666666665433222   2333333221     122123445556666665555444333332       11


Q ss_pred             E-----ecCeEEEEEeeccCCCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEE
Q 004959          412 I-----VEDKFYIYLEYVHPGSINKYVREH--CGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKL  484 (721)
Q Consensus       412 ~-----~~~~~yLVmEy~~gGsL~~~L~~~--~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL  484 (721)
                      .     ...++||.|++|.-.+|.+||...  ....+....+.++.||+.|++|   +|.+|+|+||.||++..++.+||
T Consensus       321 ~~~~v~~~~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~kI  397 (516)
T KOG1033|consen  321 KRNKVGKKVYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLKI  397 (516)
T ss_pred             cccccccccchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchhhhh
Confidence            1     123689999999999999999643  3456778899999999999999   99999999999999999999999


Q ss_pred             eecCCccccCCCc-------ccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhh-CCCCCCchhhHH
Q 004959          485 ADFGMAKHLTGQK-------ADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAA  556 (721)
Q Consensus       485 ~DFGlA~~l~~~~-------~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLt-G~~PF~~~~~~~  556 (721)
                      .|||+........       .+....||.+||+||.+.       +..|+.++|||+||+||+||+. =...|.-    .
T Consensus       398 gDFgl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~-------g~~y~~kvdIyaLGlil~EL~~~f~T~~er----~  466 (516)
T KOG1033|consen  398 GDFGLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIR-------GQQYSEKVDIYALGLILAELLIQFSTQFER----I  466 (516)
T ss_pred             hhhhheeecccCCcccchhhhhhhcccccccCCHHHHh-------hhhhhhhcchhhHHHHHHHHHHHhccHHHH----H
Confidence            9999998766554       445577999999999995       4567778999999999999997 2222221    1


Q ss_pred             HHHHHhhcCCCCC-CCC--CHHHHHHHHHhcccCCCCCCCHHHHHhcccc
Q 004959          557 AMFKVMRDTPAIP-DSL--SPEGKDFLRCCFQRNPADRPPASLLLEHRFL  603 (721)
Q Consensus       557 ~~~ki~~~~~~~p-~~l--S~el~dLI~~cL~~DP~kRPSa~eLL~Hp~f  603 (721)
                      .....+++. .+| ..+  -++-.+|+.+||...|.+||++.+.-.|.|.
T Consensus       467 ~t~~d~r~g-~ip~~~~~d~p~e~~ll~~lls~~p~~RP~~~~~~~~~~~  515 (516)
T KOG1033|consen  467 ATLTDIRDG-IIPPEFLQDYPEEYTLLQQLLSPSPEERPSAIEVALHEFL  515 (516)
T ss_pred             HhhhhhhcC-CCChHHhhcCcHHHHHHHHhcCCCcccCchHHHHhhhhhc
Confidence            112222221 222 111  2344689999999999999988888777775

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.74  E-value=7e-18  Score=189.18  Aligned_cols=204  Identities=26%  Similarity=0.462  Sum_probs=161.4

Q ss_pred             HHhCCCCCeeeeeeeEEecCeEEEEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCe-eccCCCCCcE
Q 004959          396 LSHLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKT-IHRDIKGANL  474 (721)
Q Consensus       396 L~~L~HPnIV~l~g~~~~~~~~yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gI-IHrDLKPeNI  474 (721)
                      |+.+.|.|+.+++|.+.+...+++|.+||..|+|.+.+......+++--...+++.|+.||.|||.-.| +|+.|+..|.
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nC   80 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNC   80 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccccc
Confidence            457889999999999999999999999999999999998876778888899999999999999998866 9999999999


Q ss_pred             EEcCCCceEEeecCCccccCC---CcccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCc
Q 004959          475 LVDASGVVKLADFGMAKHLTG---QKADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSE  551 (721)
Q Consensus       475 Lld~~g~VKL~DFGlA~~l~~---~~~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~  551 (721)
                      ++|....+||.|||+......   ........-..-|.|||.+............+.+.||||||+++||+++...||..
T Consensus        81 lvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~~~  160 (484)
T KOG1023|consen   81 LVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPFDL  160 (484)
T ss_pred             eeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCcccc
Confidence            999999999999999876642   11111222345699999997643333223356779999999999999999999975


Q ss_pred             h----hhHHHHHHHhh-cCCCC-C-----CCCCHHHHHHHHHhcccCCCCCCCHHHHHh
Q 004959          552 Y----EGAAAMFKVMR-DTPAI-P-----DSLSPEGKDFLRCCFQRNPADRPPASLLLE  599 (721)
Q Consensus       552 ~----~~~~~~~ki~~-~~~~~-p-----~~lS~el~dLI~~cL~~DP~kRPSa~eLL~  599 (721)
                      .    ...+.+.++.. ....+ |     ..+.+++..+++.||..+|++||+++++-.
T Consensus       161 ~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~  219 (484)
T KOG1023|consen  161 RNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRS  219 (484)
T ss_pred             ccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHh
Confidence            2    22344444444 21111 1     134557899999999999999999999753

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.71  E-value=5.5e-17  Score=159.94  Aligned_cols=142  Identities=21%  Similarity=0.255  Sum_probs=100.4

Q ss_pred             eeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHH-------------------HHHHHHHHHHHhCCCCC--
Q 004959          345 GKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESI-------------------KQLEQEIKVLSHLKHPN--  403 (721)
Q Consensus       345 ~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~-------------------k~~~~Ei~iL~~L~HPn--  403 (721)
                      ++.||+|+||.||+|.+. +|+.||||++.............                   .....|...+..+.+..  
T Consensus         2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~   80 (187)
T cd05119           2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP   80 (187)
T ss_pred             CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence            468999999999999876 79999999876422111111000                   11145666666665433  


Q ss_pred             eeeeeeeEEecCeEEEEEeeccCCCHHH-HHHHhcCCCCHHHHHHHHHHHHHHHHHHhh-CCeeccCCCCCcEEEcCCCc
Q 004959          404 IVQYYGSEIVEDKFYIYLEYVHPGSINK-YVREHCGAITESVVRNFTRHILSGLAYLHS-KKTIHRDIKGANLLVDASGV  481 (721)
Q Consensus       404 IV~l~g~~~~~~~~yLVmEy~~gGsL~~-~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs-~gIIHrDLKPeNILld~~g~  481 (721)
                      +.+++++    ...++||||+.|+.+.. .+....  . ...+..++.|++.++.++|. .||+|+||||+||+++ ++.
T Consensus        81 ~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~--~-~~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~~~  152 (187)
T cd05119          81 VPKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR--L-LEDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-DGK  152 (187)
T ss_pred             CCceEec----CCCEEEEEEeCCCCccChhhhhhh--h-cccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-CCc
Confidence            4444443    34689999999854321 122110  1 16788999999999999999 9999999999999999 899


Q ss_pred             eEEeecCCccccCC
Q 004959          482 VKLADFGMAKHLTG  495 (721)
Q Consensus       482 VKL~DFGlA~~l~~  495 (721)
                      ++|+|||.+.....
T Consensus       153 ~~liDfg~a~~~~~  166 (187)
T cd05119         153 VYIIDVPQAVEIDH  166 (187)
T ss_pred             EEEEECcccccccC
Confidence            99999999976543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.68  E-value=3.7e-16  Score=162.36  Aligned_cols=140  Identities=17%  Similarity=0.260  Sum_probs=106.6

Q ss_pred             eeEEe-ecCCeEEEEEEECCCCcEEEEEEeecCC------CC--cccHHHHHHHHHHHHHHHhCCCCCe--eeeeeeEEe
Q 004959          345 GKLIG-RGTFGSVYVASNRETGALCAMKEVDIFP------DD--PKSAESIKQLEQEIKVLSHLKHPNI--VQYYGSEIV  413 (721)
Q Consensus       345 ~k~LG-~G~fG~VY~a~~~~tg~~vAIK~i~~~~------~~--~~~~~~~k~~~~Ei~iL~~L~HPnI--V~l~g~~~~  413 (721)
                      +..|| .|+.|.||.+...  +..++||.+....      .+  ........++.+|+.++.+|.|++|  +..+++...
T Consensus        36 ~~~lg~~~g~gtv~~v~~~--~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~  113 (239)
T PRK01723         36 ARVVGSAKGRGTTWFVQTP--GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVV  113 (239)
T ss_pred             CceeecCCCCccEEEEEeC--CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeee
Confidence            45687 8888888888764  7889999875311      00  0112234678899999999998775  666665443


Q ss_pred             cC----eEEEEEeeccC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecC
Q 004959          414 ED----KFYIYLEYVHP-GSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFG  488 (721)
Q Consensus       414 ~~----~~yLVmEy~~g-GsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFG  488 (721)
                      ..    ..++||||++| .+|.+++..  ..+++..    +.||+.+|.+||++||+||||||+|||++.++.++|+|||
T Consensus       114 ~~~~~~~~~lV~e~l~G~~~L~~~l~~--~~l~~~~----~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~v~LIDfg  187 (239)
T PRK01723        114 RHGLFYRADILIERIEGARDLVALLQE--APLSEEQ----WQAIGQLIARFHDAGVYHADLNAHNILLDPDGKFWLIDFD  187 (239)
T ss_pred             ecCcceeeeEEEEecCCCCCHHHHHhc--CCCCHHH----HHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCCEEEEECC
Confidence            22    23599999997 689888864  3566543    5789999999999999999999999999998999999999


Q ss_pred             Cccc
Q 004959          489 MAKH  492 (721)
Q Consensus       489 lA~~  492 (721)
                      .+..
T Consensus       188 ~~~~  191 (239)
T PRK01723        188 RGEL  191 (239)
T ss_pred             Cccc
Confidence            8864

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.66  E-value=5.8e-16  Score=143.80  Aligned_cols=131  Identities=21%  Similarity=0.288  Sum_probs=110.1

Q ss_pred             EeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCC--CCeeeeeeeEEecCeEEEEE
Q 004959          344 KGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKH--PNIVQYYGSEIVEDKFYIYL  421 (721)
Q Consensus       344 ~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~H--PnIV~l~g~~~~~~~~yLVm  421 (721)
                      +.+.||.|.++.||++....  ..+++|.+....   .    ...+.+|+.+++.+.|  .+++++++++...+..|++|
T Consensus         2 ~~~~i~~g~~~~v~~~~~~~--~~~~iK~~~~~~---~----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~   72 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTKD--EDYVLKINPSRE---K----GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLM   72 (155)
T ss_pred             cceecccccccceEEEEecC--CeEEEEecCCCC---c----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEE
Confidence            35789999999999998753  789999875321   1    3568889999999976  58899998888888999999


Q ss_pred             eeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhC---CeeccCCCCCcEEEcCCCceEEeecCCcc
Q 004959          422 EYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSK---KTIHRDIKGANLLVDASGVVKLADFGMAK  491 (721)
Q Consensus       422 Ey~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~---gIIHrDLKPeNILld~~g~VKL~DFGlA~  491 (721)
                      ||+.|+.+..+        +......++.+++.+|.+||..   +++|+||+|+|||++..+.++|+|||++.
T Consensus        73 e~~~g~~~~~~--------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~  137 (155)
T cd05120          73 EWIEGETLDEV--------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAG  137 (155)
T ss_pred             EecCCeecccC--------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEeccccc
Confidence            99998877543        4456677889999999999985   79999999999999998999999999886

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.63  E-value=9.3e-16  Score=172.50  Aligned_cols=254  Identities=22%  Similarity=0.270  Sum_probs=199.1

Q ss_pred             CCeeEeeEEee--cCCeEEEEEEE--CCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCC-CCCeeeeeeeEEec
Q 004959          340 SQWQKGKLIGR--GTFGSVYVASN--RETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLK-HPNIVQYYGSEIVE  414 (721)
Q Consensus       340 ~~y~~~k~LG~--G~fG~VY~a~~--~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~-HPnIV~l~g~~~~~  414 (721)
                      ..+...+.+|.  |.+|.||.+..  ..++..+|+|.-.+....+.   .-..-.+|+.-.+.++ |+|.|+.+..++..
T Consensus       114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~---~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~  190 (524)
T KOG0601|consen  114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPL---DSKRKLREFLSHHKIDSHENPVRDSPAWEGS  190 (524)
T ss_pred             hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCcc---ccccccchhhcccccCccccccccCcccccC
Confidence            35667788999  99999999988  88999999997433222111   1123345666666664 99999999999999


Q ss_pred             CeEEEEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHH----HHHHHhhCCeeccCCCCCcEEEcCC-CceEEeecCC
Q 004959          415 DKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILS----GLAYLHSKKTIHRDIKGANLLVDAS-GVVKLADFGM  489 (721)
Q Consensus       415 ~~~yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~----AL~yLHs~gIIHrDLKPeNILld~~-g~VKL~DFGl  489 (721)
                      +..|+-+|+|. .+|..+....+..+++..++.++.+...    ||.++|..+++|-|+||.||++..+ ...+++|||+
T Consensus       191 ~~lfiqtE~~~-~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~df~~  269 (524)
T KOG0601|consen  191 GILFIQTELCG-ESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLTDFGL  269 (524)
T ss_pred             Ccceeeecccc-chhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecCCcce
Confidence            99999999995 8999998877677999999999999999    9999999999999999999999988 7899999999


Q ss_pred             ccccCCCcccc------cCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCch--hhHHHHHHH
Q 004959          490 AKHLTGQKADL------SMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEY--EGAAAMFKV  561 (721)
Q Consensus       490 A~~l~~~~~~~------s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~--~~~~~~~ki  561 (721)
                      ...+..+....      ...|...|++||++.+        -++.+.|||+||.++.+-.+|..++...  ..-..+...
T Consensus       270 v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~--------l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~  341 (524)
T KOG0601|consen  270 VSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG--------LATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQG  341 (524)
T ss_pred             eEEccCCccccceeeeecCCCCceEeChhhhcc--------ccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccc
Confidence            98886654322      1258889999999843        4566789999999999999987766432  211111111


Q ss_pred             hhcCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhccccccC
Q 004959          562 MRDTPAIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNS  606 (721)
Q Consensus       562 ~~~~~~~p~~lS~el~dLI~~cL~~DP~kRPSa~eLL~Hp~f~~~  606 (721)
                      . ...++-...+.++...+..|++.+|-.|++++.++.|+++...
T Consensus       342 ~-ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~  385 (524)
T KOG0601|consen  342 Y-IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSK  385 (524)
T ss_pred             c-CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccch
Confidence            1 2223444567777789999999999999999999999998743

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.53  E-value=2e-15  Score=177.22  Aligned_cols=262  Identities=21%  Similarity=0.344  Sum_probs=205.8

Q ss_pred             CCCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeEE
Q 004959          339 NSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFY  418 (721)
Q Consensus       339 ~~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~y  418 (721)
                      .+.+.+.+-+-.|.|+.++.+.-..+|...++|+..+...  ......+.+..+-+++-...+|.++...--+......+
T Consensus       803 ~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~--i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~  880 (1205)
T KOG0606|consen  803 PDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPK--IRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLP  880 (1205)
T ss_pred             CccceecccccCCCCcccccCCccccccccchhhhccchh--hccccccccCCccCccccCCCCceecccCCCCCCCCcc
Confidence            3567788899999999999998888888888886643211  11112344455555555556677776665566678899


Q ss_pred             EEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccC----
Q 004959          419 IYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLT----  494 (721)
Q Consensus       419 LVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~----  494 (721)
                      |||+|+.|++|...|+.. +..+++.++.++..+..+++|||...++|+|++|.|+|+..+|..++.|||+.....    
T Consensus       881 L~~~~~~~~~~~Skl~~~-~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p  959 (1205)
T KOG0606|consen  881 LVGHYLNGGDLPSKLHNS-GCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPP  959 (1205)
T ss_pred             hhhHHhccCCchhhhhcC-CCcccccccchhHHHHhhhhccccchhhcccccccchhhcccCCcccCccccccccccccC
Confidence            999999999999999875 568888899999999999999999999999999999999999999999998432210    


Q ss_pred             --CC--------------------------cccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCC
Q 004959          495 --GQ--------------------------KADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGK  546 (721)
Q Consensus       495 --~~--------------------------~~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~  546 (721)
                        +.                          .......||+.|.+||.+.+.       ....++|+|++|++++|.++|.
T Consensus       960 ~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~-------~hgs~ad~~~~g~~l~e~l~g~ 1032 (1205)
T KOG0606|consen  960 TTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGR-------RHGSAADWWSSGVCLFEVLTGI 1032 (1205)
T ss_pred             cCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccc-------cCCCcchhhhhhhhhhhhhcCC
Confidence              00                          001234599999999999653       2334689999999999999999


Q ss_pred             CCCCchhhHHHHHHHhhcCCC---CCCCCCHHHHHHHHHhcccCCCCCCCHH---HHHhccccccCCCCC
Q 004959          547 PPWSEYEGAAAMFKVMRDTPA---IPDSLSPEGKDFLRCCFQRNPADRPPAS---LLLEHRFLKNSQQPD  610 (721)
Q Consensus       547 ~PF~~~~~~~~~~ki~~~~~~---~p~~lS~el~dLI~~cL~~DP~kRPSa~---eLL~Hp~f~~~~~~~  610 (721)
                      +||........+..+......   .+...+.++++++.++|..++.+|..+.   ++-.|+||+......
T Consensus      1033 pp~na~tpq~~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~~~~e~k~~~~~~~~~~~~ 1102 (1205)
T KOG0606|consen 1033 PPFNAETPQQIFENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAKGAAEVKGHPFFQDVDWEN 1102 (1205)
T ss_pred             CCCCCcchhhhhhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcccccccccCCccCCCCccc
Confidence            999998888888777765443   4456899999999999999999999888   899999999765543

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.50  E-value=1.1e-13  Score=155.82  Aligned_cols=146  Identities=17%  Similarity=0.160  Sum_probs=98.7

Q ss_pred             eEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcc-------------------------cHHHH----H------HHH
Q 004959          346 KLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPK-------------------------SAESI----K------QLE  390 (721)
Q Consensus       346 k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~-------------------------~~~~~----k------~~~  390 (721)
                      +.||.|++|+||+|+.+ +|+.||||+....-....                         ....+    +      .+.
T Consensus       123 ~plasaSigQVh~A~l~-~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~  201 (437)
T TIGR01982       123 KPLAAASIAQVHRARLV-DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR  201 (437)
T ss_pred             cceeeeehhheEEEEec-CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence            57999999999999875 699999998742100000                         00000    1      233


Q ss_pred             HHHHHHHhC----CCCCeeeeeeeEE-ecCeEEEEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHH-HHHHHhhCCe
Q 004959          391 QEIKVLSHL----KHPNIVQYYGSEI-VEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILS-GLAYLHSKKT  464 (721)
Q Consensus       391 ~Ei~iL~~L----~HPnIV~l~g~~~-~~~~~yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~-AL~yLHs~gI  464 (721)
                      +|...+.++    .|.+-|.+-.++. ..+..+|||||++|++|.++.......+   ....++.+++. .+..+|..|+
T Consensus       202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~---~~~~ia~~~~~~~l~ql~~~g~  278 (437)
T TIGR01982       202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGL---DRKALAENLARSFLNQVLRDGF  278 (437)
T ss_pred             HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCC---CHHHHHHHHHHHHHHHHHhCCc
Confidence            455544444    2333333333332 2456799999999999988775432222   23456666665 4788999999


Q ss_pred             eccCCCCCcEEEcCCCceEEeecCCccccCC
Q 004959          465 IHRDIKGANLLVDASGVVKLADFGMAKHLTG  495 (721)
Q Consensus       465 IHrDLKPeNILld~~g~VKL~DFGlA~~l~~  495 (721)
                      +|+|+||.||+++.+|.++|+|||++..+..
T Consensus       279 ~H~D~hPgNilv~~~g~i~liDfG~~~~l~~  309 (437)
T TIGR01982       279 FHADLHPGNIFVLKDGKIIALDFGIVGRLSE  309 (437)
T ss_pred             eeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence            9999999999999999999999999987754

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.47  E-value=6.1e-14  Score=160.72  Aligned_cols=148  Identities=18%  Similarity=0.187  Sum_probs=99.7

Q ss_pred             CeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCC----------------------C---cccH----HHHHHHHH
Q 004959          341 QWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPD----------------------D---PKSA----ESIKQLEQ  391 (721)
Q Consensus       341 ~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~----------------------~---~~~~----~~~k~~~~  391 (721)
                      .|.. +.||.|++|+||+|+.+.+|+.||||++...-.                      +   ..-.    +..+.+.+
T Consensus       121 ~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~  199 (537)
T PRK04750        121 DFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHD  199 (537)
T ss_pred             hcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHH
Confidence            4555 789999999999999998899999999852100                      0   0000    11223333


Q ss_pred             HHHH------HHhC----CCCCeeeeeeeEEe-cCeEEEEEeeccCCCHHHHH--HHhc---CCCCHHHHHHHHHHHHHH
Q 004959          392 EIKV------LSHL----KHPNIVQYYGSEIV-EDKFYIYLEYVHPGSINKYV--REHC---GAITESVVRNFTRHILSG  455 (721)
Q Consensus       392 Ei~i------L~~L----~HPnIV~l~g~~~~-~~~~yLVmEy~~gGsL~~~L--~~~~---~~Lse~~i~~i~~QIl~A  455 (721)
                      |+.+      +.++    .+.+.|.+-.++.+ ....+|||||+.|+.|.++.  ...+   ..+.+..+..++.||+  
T Consensus       200 ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qif--  277 (537)
T PRK04750        200 ELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQVF--  277 (537)
T ss_pred             hhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHHH--
Confidence            3333      3333    23333443343332 45678999999999998753  2221   1355566666777765  


Q ss_pred             HHHHhhCCeeccCCCCCcEEEcCCC----ceEEeecCCccccCCC
Q 004959          456 LAYLHSKKTIHRDIKGANLLVDASG----VVKLADFGMAKHLTGQ  496 (721)
Q Consensus       456 L~yLHs~gIIHrDLKPeNILld~~g----~VKL~DFGlA~~l~~~  496 (721)
                           ..|++|+|+||.||+|+.+|    .++++|||++..+...
T Consensus       278 -----~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~~  317 (537)
T PRK04750        278 -----RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNKE  317 (537)
T ss_pred             -----hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCHH
Confidence                 58999999999999999888    9999999999877543

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.41  E-value=3e-14  Score=150.12  Aligned_cols=238  Identities=22%  Similarity=0.357  Sum_probs=158.5

Q ss_pred             EEEEEEECCCCcEEEEEEeecC-CCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecC-----eEEEEEeeccCCC
Q 004959          355 SVYVASNRETGALCAMKEVDIF-PDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVED-----KFYIYLEYVHPGS  428 (721)
Q Consensus       355 ~VY~a~~~~tg~~vAIK~i~~~-~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~-----~~yLVmEy~~gGs  428 (721)
                      .||++-++..|..|.-..+..- .++.+.+  .+..+.-..-|-++.|-|||+++.++.+..     +..++.|||.-|+
T Consensus        81 ~v~lamd~e~g~evvwneVq~~~rK~~~~q--eek~~~vFdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs  158 (458)
T KOG1266|consen   81 DVYLAMDTEEGVEVVWNEVQFSERKNPKEQ--EEKRRAVFDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGS  158 (458)
T ss_pred             HHHHHhhhccCchhhHHHHHHHHhcChhhC--HHHHHHHHHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchh
Confidence            4677777777766654444211 1111111  111111222344556999999998876543     5789999999999


Q ss_pred             HHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHhhCC--eeccCCCCCcEEEcCCCceEEeecCCccc-----cCCCcc
Q 004959          429 INKYVREH---CGAITESVVRNFTRHILSGLAYLHSKK--TIHRDIKGANLLVDASGVVKLADFGMAKH-----LTGQKA  498 (721)
Q Consensus       429 L~~~L~~~---~~~Lse~~i~~i~~QIl~AL~yLHs~g--IIHrDLKPeNILld~~g~VKL~DFGlA~~-----l~~~~~  498 (721)
                      |.++|++.   ...+.....++|+-||+.||.|||+..  |+|+++...-|++..+|-||+.---....     ......
T Consensus       159 ~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~E  238 (458)
T KOG1266|consen  159 LKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAE  238 (458)
T ss_pred             HHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCccccCCcchhheeecCCceEEecccCccccchhhhhhhHhh
Confidence            99999653   346888899999999999999999985  99999999999999999888853211110     000111


Q ss_pred             cccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCC-Cchh---hHHHHHHHhhcCCCCCCCCCH
Q 004959          499 DLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPW-SEYE---GAAAMFKVMRDTPAIPDSLSP  574 (721)
Q Consensus       499 ~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF-~~~~---~~~~~~ki~~~~~~~p~~lS~  574 (721)
                      .....|-++|.|||.=       .....+-++|||+||.+.++|..|..-- ....   ..+.+...+.   .+...   
T Consensus       239 k~~~~~~~g~~a~~sg-------~~tn~~~a~dIy~fgmcAlemailEiq~tnseS~~~~ee~ia~~i~---~len~---  305 (458)
T KOG1266|consen  239 KSVNTSLPGFSAPESG-------TTTNTTGASDIYKFGMCALEMAILEIQSTNSESKVEVEENIANVII---GLENG---  305 (458)
T ss_pred             hhccccCCccccCCcC-------cccccccchhhhhhhHHHHHHHHheeccCCCcceeehhhhhhhhee---eccCc---
Confidence            1123477889999964       3344555799999999999999877532 2211   1122222111   11111   


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHHhccccccCC
Q 004959          575 EGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQ  607 (721)
Q Consensus       575 el~dLI~~cL~~DP~kRPSa~eLL~Hp~f~~~~  607 (721)
                      --+++|.+||+-.|..||++.+++.||.+-+..
T Consensus       306 lqr~~i~kcl~~eP~~rp~ar~llfHpllfeVh  338 (458)
T KOG1266|consen  306 LQRGSITKCLEGEPNGRPDARLLLFHPLLFEVH  338 (458)
T ss_pred             cccCcCcccccCCCCCCcchhhhhcCceeeecc
Confidence            125799999999999999999999999876544

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.41  E-value=4.8e-13  Score=129.29  Aligned_cols=127  Identities=17%  Similarity=0.118  Sum_probs=95.1

Q ss_pred             eeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCee-eeeeeEEecCeEEEEEee
Q 004959          345 GKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIV-QYYGSEIVEDKFYIYLEY  423 (721)
Q Consensus       345 ~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV-~l~g~~~~~~~~yLVmEy  423 (721)
                      .+.|+.|.++.||++...  |+.|++|+.....   .   ....+.+|+.+++.+.+.+++ +++.+.  .+..++||||
T Consensus         3 ~~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~---~---~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~   72 (170)
T cd05151           3 ISPLKGGMTNKNYRVEVA--NKKYVVRIPGNGT---E---LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEF   72 (170)
T ss_pred             eeecCCcccCceEEEEEC--CeEEEEEeCCCCc---c---cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEe
Confidence            357899999999999865  7889999764211   1   122457889999988655544 444432  3345899999


Q ss_pred             ccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCe-----eccCCCCCcEEEcCCCceEEeecCCcc
Q 004959          424 VHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKT-----IHRDIKGANLLVDASGVVKLADFGMAK  491 (721)
Q Consensus       424 ~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gI-----IHrDLKPeNILld~~g~VKL~DFGlA~  491 (721)
                      ++|.++...         ......++.+|+.+|..||..++     +|+|++|.||+++ ++.++|+|||.+.
T Consensus        73 i~G~~l~~~---------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~  135 (170)
T cd05151          73 IEGSELLTE---------DFSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG  135 (170)
T ss_pred             cCCCccccc---------cccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence            999887543         01123467899999999999985     9999999999998 6789999999875

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.41  E-value=2e-12  Score=130.59  Aligned_cols=142  Identities=18%  Similarity=0.235  Sum_probs=102.3

Q ss_pred             eEEeecCCeEEEEEEECC------CCcEEEEEEeecCCCCccc-----------------HHHHHHH----HHHHHHHHh
Q 004959          346 KLIGRGTFGSVYVASNRE------TGALCAMKEVDIFPDDPKS-----------------AESIKQL----EQEIKVLSH  398 (721)
Q Consensus       346 k~LG~G~fG~VY~a~~~~------tg~~vAIK~i~~~~~~~~~-----------------~~~~k~~----~~Ei~iL~~  398 (721)
                      ..||.|--+.||.|....      .+..+|||+.......-+.                 ....+.+    ++|++.|++
T Consensus         3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r   82 (197)
T cd05146           3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR   82 (197)
T ss_pred             CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence            478999999999997553      3579999987532110000                 0112233    389999999


Q ss_pred             CCC--CCeeeeeeeEEecCeEEEEEeeccCCCHHH-HHHHhcCCCCHHHHHHHHHHHHHHHHHH-hhCCeeccCCCCCcE
Q 004959          399 LKH--PNIVQYYGSEIVEDKFYIYLEYVHPGSINK-YVREHCGAITESVVRNFTRHILSGLAYL-HSKKTIHRDIKGANL  474 (721)
Q Consensus       399 L~H--PnIV~l~g~~~~~~~~yLVmEy~~gGsL~~-~L~~~~~~Lse~~i~~i~~QIl~AL~yL-Hs~gIIHrDLKPeNI  474 (721)
                      |..  -++...+++    ..-+|||||+.++.+.. .+++  ..+++..+..++.|++.+|..| |+.||||+||++.||
T Consensus        83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd--~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~NI  156 (197)
T cd05146          83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD--AKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYNM  156 (197)
T ss_pred             HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc--cccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHE
Confidence            853  344555543    56789999997654432 2322  3456667788899999999999 899999999999999


Q ss_pred             EEcCCCceEEeecCCccccC
Q 004959          475 LVDASGVVKLADFGMAKHLT  494 (721)
Q Consensus       475 Lld~~g~VKL~DFGlA~~l~  494 (721)
                      |++ ++.+.|+|||.+....
T Consensus       157 L~~-~~~v~iIDF~qav~~~  175 (197)
T cd05146         157 LWH-DGKVWFIDVSQSVEPT  175 (197)
T ss_pred             EEE-CCcEEEEECCCceeCC
Confidence            996 5789999999887553

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.39  E-value=6.4e-12  Score=143.24  Aligned_cols=169  Identities=24%  Similarity=0.378  Sum_probs=131.0

Q ss_pred             EEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeEEEEEeeccCCCHHHHHHHhc
Q 004959          358 VASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHC  437 (721)
Q Consensus       358 ~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~yLVmEy~~gGsL~~~L~~~~  437 (721)
                      .|..+.++..|.|........     .....+.+-++.|+.++||||+++++.++.++.+|||+|-+.  -|..++.+. 
T Consensus        30 ~~t~k~~~~~vsVF~~~~~~~-----~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l-  101 (690)
T KOG1243|consen   30 DGTRKADGGPVSVFVYKRSNG-----EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKEL-  101 (690)
T ss_pred             ccceeccCCceEEEEEeCCCc-----hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHh-
Confidence            466677888888888753221     445567788889999999999999999999999999999996  577777654 


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHh-hCCeeccCCCCCcEEEcCCCceEEeecCCccccCCCccc-ccCCCCCccCChhhHH
Q 004959          438 GAITESVVRNFTRHILSGLAYLH-SKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKAD-LSMKGSPYWMAPELMM  515 (721)
Q Consensus       438 ~~Lse~~i~~i~~QIl~AL~yLH-s~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~~~~-~s~~GT~~Y~APEvl~  515 (721)
                         .+..+...+.||+.||.||| +.+++|++|.-.-|+|++.|..||++|.++....+-... ....---.|..|+.+.
T Consensus       102 ---~~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~~~  178 (690)
T KOG1243|consen  102 ---GKEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPAKSLYLIESFDDPEEID  178 (690)
T ss_pred             ---HHHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcccccchhhhcccChhhcC
Confidence               37778888999999999997 668999999999999999999999999988655433221 1111122366777652


Q ss_pred             HHhhcCCCCCCcchhhHHHHHHHHHHHhhCC
Q 004959          516 AVMQKGKSSDSALAVDIWSLGCTIIEMYTGK  546 (721)
Q Consensus       516 ~~~~~~k~~~~s~asDVWSLGVILyELLtG~  546 (721)
                      .       .  ....|.|-|||++++++.|.
T Consensus       179 ~-------s--~~s~D~~~Lg~li~el~ng~  200 (690)
T KOG1243|consen  179 P-------S--EWSIDSWGLGCLIEELFNGS  200 (690)
T ss_pred             c-------c--ccchhhhhHHHHHHHHhCcc
Confidence            1       1  13579999999999999993

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.39  E-value=2.7e-13  Score=152.81  Aligned_cols=249  Identities=24%  Similarity=0.229  Sum_probs=183.8

Q ss_pred             CCeeEeeEEeecCCeEEEEEEEC-CCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhC-CCCCeeeeeeeEEecCeE
Q 004959          340 SQWQKGKLIGRGTFGSVYVASNR-ETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHL-KHPNIVQYYGSEIVEDKF  417 (721)
Q Consensus       340 ~~y~~~k~LG~G~fG~VY~a~~~-~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L-~HPnIV~l~g~~~~~~~~  417 (721)
                      .+|.++..||.|.|+.|+.+... .++..|++|.+...  -....+.+ .-..|+.+...+ .|.+++.++..+......
T Consensus       265 ~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~--l~~~~~di-~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~  341 (524)
T KOG0601|consen  265 TDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG--LATFASDI-FSLGEVILEAILGSHLPSVGKNSSWSQLRQG  341 (524)
T ss_pred             CCcceeEEccCCccccceeeeecCCCCceEeChhhhcc--ccchHhhh-cchhhhhHhhHhhcccccCCCCCCccccccc
Confidence            47888999999999999998755 78889999976421  11111112 224566666665 499999998888888888


Q ss_pred             EEEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCC-CceEEeecCCccccCCC
Q 004959          418 YIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDAS-GVVKLADFGMAKHLTGQ  496 (721)
Q Consensus       418 yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~-g~VKL~DFGlA~~l~~~  496 (721)
                      ||-.|||+++++...+.- ...+.+...+.+..|++.++.++|++.++|+|+||.||++..+ +..++.|||+...+.-.
T Consensus       342 ~ip~e~~~~~s~~l~~~~-~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~~  420 (524)
T KOG0601|consen  342 YIPLEFCEGGSSSLRSVT-SQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAFS  420 (524)
T ss_pred             cCchhhhcCcchhhhhHH-HHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhcccccccccccee
Confidence            999999999988766632 3678899999999999999999999999999999999999876 78899999998753211


Q ss_pred             cccccCCCCCccC-ChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCC-CCchhhHHHHHHHhhcCCCCCCCCCH
Q 004959          497 KADLSMKGSPYWM-APELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPP-WSEYEGAAAMFKVMRDTPAIPDSLSP  574 (721)
Q Consensus       497 ~~~~s~~GT~~Y~-APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~P-F~~~~~~~~~~ki~~~~~~~p~~lS~  574 (721)
                        .....++-+++ ..|++.      ....+..++|+++||.-+++.++|... +...    ....+..+..........
T Consensus       421 --~~~~~~~~r~~p~~~~~~------e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~----~~~~i~~~~~p~~~~~~~  488 (524)
T KOG0601|consen  421 --SGVFHHIDRLYPIAEILL------EDYPHLSKADIFSLGLSVDEAITGSPLSESGV----QSLTIRSGDTPNLPGLKL  488 (524)
T ss_pred             --cccccccccccccchhhc------cccccccccccccccccccccccCcccCcccc----cceeeecccccCCCchHH
Confidence              11222334444 355554      344556689999999999999998753 3322    222333333333344448


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHHhccccc
Q 004959          575 EGKDFLRCCFQRNPADRPPASLLLEHRFLK  604 (721)
Q Consensus       575 el~dLI~~cL~~DP~kRPSa~eLL~Hp~f~  604 (721)
                      +++.+.+.++..++..|+.+.++..|.-|.
T Consensus       489 ~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~  518 (524)
T KOG0601|consen  489 QLQVLLKVMINPDRKRRPSAVELSLHSEFY  518 (524)
T ss_pred             hhhhhhhhhcCCccccchhhhhhcccchhh
Confidence            899999999999999999999998886553

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.22  E-value=1.1e-10  Score=115.47  Aligned_cols=147  Identities=22%  Similarity=0.255  Sum_probs=110.1

Q ss_pred             EeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCC-Cc--ccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeEEEE
Q 004959          344 KGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPD-DP--KSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYIY  420 (721)
Q Consensus       344 ~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~-~~--~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~yLV  420 (721)
                      ...+|-+|+-+.|+++...  |+.+.||.-....- .+  ...-..++..+|+++|.++.--.|.--.=++.+...-.|+
T Consensus        11 ~l~likQGAEArv~~~~~~--Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~   88 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSFS--GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIY   88 (229)
T ss_pred             cceeeeccceeeEeeeccC--CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEE
Confidence            4568899999999999765  89999997542211 11  1223456788999999988644443322345666777899


Q ss_pred             EeeccC-CCHHHHHHHhcCCCCHHHH-HHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCC---ceEEeecCCccc
Q 004959          421 LEYVHP-GSINKYVREHCGAITESVV-RNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASG---VVKLADFGMAKH  492 (721)
Q Consensus       421 mEy~~g-GsL~~~L~~~~~~Lse~~i-~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g---~VKL~DFGlA~~  492 (721)
                      |||++| -++.+++......-.+++. ..++.+|-+.|.-||.++|||+||..+||++..+|   .+.|+|||++..
T Consensus        89 ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~  165 (229)
T KOG3087|consen   89 MEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSV  165 (229)
T ss_pred             EEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchhc
Confidence            999986 4788888776444444444 78999999999999999999999999999997665   458999999864

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.19  E-value=1.7e-10  Score=114.49  Aligned_cols=136  Identities=18%  Similarity=0.283  Sum_probs=99.4

Q ss_pred             eEEeecCCeEEEEEEECCCCcEEEEEEeecCCC-Ccc--cHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeEEEEEe
Q 004959          346 KLIGRGTFGSVYVASNRETGALCAMKEVDIFPD-DPK--SAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYIYLE  422 (721)
Q Consensus       346 k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~-~~~--~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~yLVmE  422 (721)
                      .++++|+-+.+|.+...  |..+++|.-....- .+.  ..-..++..+|..+|.++.--.|..-+=++.+.+...|+||
T Consensus         2 ~~i~~GAEa~i~~~~~~--g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me   79 (204)
T COG3642           2 DLIKQGAEAIIYLTDFL--GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVME   79 (204)
T ss_pred             chhhCCcceeEEeeecc--CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEE
Confidence            36789999999999653  55677775422111 111  11234566789999998864444333333456778899999


Q ss_pred             eccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccc
Q 004959          423 YVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKH  492 (721)
Q Consensus       423 y~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~  492 (721)
                      |++|..|.+++...        ...++..|-.-+.-||..||||+||.+.||++... .+.++||||+..
T Consensus        80 ~I~G~~lkd~l~~~--------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~-~i~~IDfGLg~~  140 (204)
T COG3642          80 YIEGELLKDALEEA--------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGG-RIYFIDFGLGEF  140 (204)
T ss_pred             EeCChhHHHHHHhc--------chHHHHHHHHHHHHHHhcCeecCCCccceEEEeCC-cEEEEECCcccc
Confidence            99998888888754        24677788888889999999999999999999654 499999999873

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.19  E-value=7.3e-11  Score=118.37  Aligned_cols=139  Identities=18%  Similarity=0.204  Sum_probs=103.5

Q ss_pred             eEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCC--CeeeeeeeEEec---CeEEEE
Q 004959          346 KLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHP--NIVQYYGSEIVE---DKFYIY  420 (721)
Q Consensus       346 k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HP--nIV~l~g~~~~~---~~~yLV  420 (721)
                      +.||.|.++.||++.... |+.|++|+.......    .....+.+|+.+++.+.+.  ++.+++.+....   +..++|
T Consensus         4 ~~l~~G~~n~~~~v~~~~-g~~~ilK~~~~~~~~----~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v   78 (223)
T cd05154           4 RQLSGGQSNLTYLLTAGG-GRRLVLRRPPPGALL----PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYV   78 (223)
T ss_pred             eecCCCccceEEEEEecC-CcceEEEeCCCcccC----cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEE
Confidence            578999999999998753 689999986532110    1234678999999999753  456666665543   367899


Q ss_pred             EeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhh---------------------------------------
Q 004959          421 LEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHS---------------------------------------  461 (721)
Q Consensus       421 mEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs---------------------------------------  461 (721)
                      |||++|.+|.+.+..  ..+++.....++.+|+.+|.+||+                                       
T Consensus        79 ~e~i~G~~l~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (223)
T cd05154          79 MERVDGRVLRDRLLR--PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPA  156 (223)
T ss_pred             EEEeCCEecCCCCCC--CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHH
Confidence            999999888665421  346667777777777777777773                                       


Q ss_pred             -----------------CCeeccCCCCCcEEEcC--CCceEEeecCCcc
Q 004959          462 -----------------KKTIHRDIKGANLLVDA--SGVVKLADFGMAK  491 (721)
Q Consensus       462 -----------------~gIIHrDLKPeNILld~--~g~VKL~DFGlA~  491 (721)
                                       ..++|+|+++.|||++.  ++.+.|+||+.+.
T Consensus       157 ~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~  205 (223)
T cd05154         157 MERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELAT  205 (223)
T ss_pred             HHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccc
Confidence                             24699999999999988  5678999999775

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=99.07  E-value=5.1e-09  Score=116.80  Aligned_cols=212  Identities=14%  Similarity=0.183  Sum_probs=156.3

Q ss_pred             eEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEe----cCeEEEEEeeccC-CC
Q 004959          354 GSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIV----EDKFYIYLEYVHP-GS  428 (721)
Q Consensus       354 G~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~----~~~~yLVmEy~~g-Gs  428 (721)
                      .+.|+|+...+|..|++|.+........     .....-++.++++.|.|||.+.++|..    +..++||++|.++ ++
T Consensus       290 ~Ttyk~~s~~DG~~YvLkRlhg~r~~~~-----nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~T  364 (655)
T KOG3741|consen  290 ITTYKATSNVDGNAYVLKRLHGDRDQST-----NKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPT  364 (655)
T ss_pred             ceeEeeeeccCCceeeeeeeccccccCc-----ccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCch
Confidence            5789999999999999999843222111     122344677899999999999998873    4568999999986 46


Q ss_pred             HHHHHHHh--------------cCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccC
Q 004959          429 INKYVREH--------------CGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLT  494 (721)
Q Consensus       429 L~~~L~~~--------------~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~  494 (721)
                      |.++....              +..++|..+|.|+.||..||.++|+.|+..+-|.+.+||++.+..|+|...|....+.
T Consensus       365 L~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~  444 (655)
T KOG3741|consen  365 LYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQ  444 (655)
T ss_pred             HHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcceEEEecccceeeec
Confidence            76654211              2347899999999999999999999999999999999999988889988888776654


Q ss_pred             CCcccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCC-CCchhhHHHHHHHhhcCCCCCCCCC
Q 004959          495 GQKADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPP-WSEYEGAAAMFKVMRDTPAIPDSLS  573 (721)
Q Consensus       495 ~~~~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~P-F~~~~~~~~~~ki~~~~~~~p~~lS  573 (721)
                      .+..             |-+.+.          .+-|.=.||.+++.|.||..- |..........      ..+...++
T Consensus       445 ~d~~-------------~~le~~----------Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~~------~~I~~~yS  495 (655)
T KOG3741|consen  445 EDPT-------------EPLESQ----------QQNDLRDLGLLLLALATGTENSNRTDSTQSSHL------TRITTTYS  495 (655)
T ss_pred             CCCC-------------cchhHH----------hhhhHHHHHHHHHHHhhcccccccccchHHHHH------HHhhhhhh
Confidence            4430             112110          134889999999999999632 22221111111      13345689


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHHhc
Q 004959          574 PEGKDFLRCCFQRNPADRPPASLLLEH  600 (721)
Q Consensus       574 ~el~dLI~~cL~~DP~kRPSa~eLL~H  600 (721)
                      .+++++|..+...++++ -+..++|.|
T Consensus       496 ~D~rn~v~yl~s~~~~~-ksI~~llp~  521 (655)
T KOG3741|consen  496 TDLRNVVEYLESLNFRE-KSIQDLLPM  521 (655)
T ss_pred             HHHHHHHHHHHhcCccc-ccHHHHHHH
Confidence            99999999999999987 788888866

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=99.03  E-value=1.6e-09  Score=108.91  Aligned_cols=131  Identities=21%  Similarity=0.264  Sum_probs=86.2

Q ss_pred             EEEEEEECCCCcEEEEEEeecCCC-------------C--------cccHHHHHHHHHHHHHHHhCCCC--CeeeeeeeE
Q 004959          355 SVYVASNRETGALCAMKEVDIFPD-------------D--------PKSAESIKQLEQEIKVLSHLKHP--NIVQYYGSE  411 (721)
Q Consensus       355 ~VY~a~~~~tg~~vAIK~i~~~~~-------------~--------~~~~~~~k~~~~Ei~iL~~L~HP--nIV~l~g~~  411 (721)
                      .||.|... .|..+|||+......             .        ...........+|.+.|.++..-  ++.+.+++ 
T Consensus         1 ~Vy~~~~~-~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~-   78 (188)
T PF01163_consen    1 DVYHAIDP-DGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDY-   78 (188)
T ss_dssp             EEEEEEEC-TTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEE-
T ss_pred             CEEEEECC-CCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEE-
Confidence            48999864 478999998753110             0        11122345678899999999865  45566544 


Q ss_pred             EecCeEEEEEeecc--CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHH-HhhCCeeccCCCCCcEEEcCCCceEEeecC
Q 004959          412 IVEDKFYIYLEYVH--PGSINKYVREHCGAITESVVRNFTRHILSGLAY-LHSKKTIHRDIKGANLLVDASGVVKLADFG  488 (721)
Q Consensus       412 ~~~~~~yLVmEy~~--gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~y-LHs~gIIHrDLKPeNILld~~g~VKL~DFG  488 (721)
                         +.-+|||||++  |..+..+...   .++......++.+++..+.. +|+.||||+||.+.|||++++ .+.|+|||
T Consensus        79 ---~~~~ivME~I~~~G~~~~~l~~~---~~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~-~~~iIDf~  151 (188)
T PF01163_consen   79 ---NRNVIVMEYIGEDGVPLPRLKDV---DLSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG-KVYIIDFG  151 (188)
T ss_dssp             ---ETTEEEEE--EETTEEGGCHHHC---GGGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT-CEEE--GT
T ss_pred             ---eCCEEEEEecCCCccchhhHHhc---cccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc-eEEEEecC
Confidence               24579999998  6566544332   22245677788888886655 579999999999999999876 99999999


Q ss_pred             CccccC
Q 004959          489 MAKHLT  494 (721)
Q Consensus       489 lA~~l~  494 (721)
                      .+....
T Consensus       152 qav~~~  157 (188)
T PF01163_consen  152 QAVDSS  157 (188)
T ss_dssp             TEEETT
T ss_pred             cceecC
Confidence            887543

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=98.98  E-value=9.6e-09  Score=108.85  Aligned_cols=139  Identities=13%  Similarity=0.092  Sum_probs=95.9

Q ss_pred             EEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHH----------HHHHHHHHHHHhCCCCCe--eeeeeeEEe-
Q 004959          347 LIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESI----------KQLEQEIKVLSHLKHPNI--VQYYGSEIV-  413 (721)
Q Consensus       347 ~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~----------k~~~~Ei~iL~~L~HPnI--V~l~g~~~~-  413 (721)
                      ++-......|+.+..  .|+.|.||.....    ......          ..+.+|...+.+|..-+|  ...+.+++. 
T Consensus        29 ~v~~~~~rrvvr~~~--~g~~~~vKr~~~~----~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~  102 (268)
T PRK15123         29 VFRELEGRRTLRFEL--AGKSYFLKWHRGT----GWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERG  102 (268)
T ss_pred             EEecCCCceEEEEEE--CCEEEEEEEecCC----cHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEec
Confidence            333333334555543  4778999965311    000111          136788888888753333  233333332 


Q ss_pred             ----cCeEEEEEeeccCC-CHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcC-------CC
Q 004959          414 ----EDKFYIYLEYVHPG-SINKYVREH-CGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDA-------SG  480 (721)
Q Consensus       414 ----~~~~yLVmEy~~gG-sL~~~L~~~-~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~-------~g  480 (721)
                          ...-+||||++++. +|.+++... .....+.....++.+|+..+.-||..||+|+||++.||||+.       ++
T Consensus       103 ~~~~~~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~  182 (268)
T PRK15123        103 SNPATRTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDL  182 (268)
T ss_pred             CCCccceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCc
Confidence                23578999999875 799888642 245667788899999999999999999999999999999975       45


Q ss_pred             ceEEeecCCcc
Q 004959          481 VVKLADFGMAK  491 (721)
Q Consensus       481 ~VKL~DFGlA~  491 (721)
                      .+.|+||+.+.
T Consensus       183 ~~~LIDl~r~~  193 (268)
T PRK15123        183 KLSVIDLHRAQ  193 (268)
T ss_pred             eEEEEECCccc
Confidence            89999999875

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.92  E-value=4.6e-10  Score=128.69  Aligned_cols=151  Identities=26%  Similarity=0.432  Sum_probs=113.6

Q ss_pred             HHHHHHHHHhhC-CeeccCCCCCcEEEcCCCceEEeecCCccccCCCccc--------c--cCCCCCccCChhhHHHHhh
Q 004959          451 HILSGLAYLHSK-KTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKAD--------L--SMKGSPYWMAPELMMAVMQ  519 (721)
Q Consensus       451 QIl~AL~yLHs~-gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~~~~--------~--s~~GT~~Y~APEvl~~~~~  519 (721)
                      ++++||.|+|.. ++||+.|.|++|.++.+|.+||+.|+++....+....        .  ...-...|.|||++.+   
T Consensus       107 ~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~---  183 (700)
T KOG2137|consen  107 NVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG---  183 (700)
T ss_pred             cccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc---
Confidence            455999999975 8999999999999999999999999998765442110        0  1124677999999953   


Q ss_pred             cCCCCCCcchhhHHHHHHHHHHHh-hCCCCCCchhhHHHHHHH--hh--cCCCCCCCCCHHHHHHHHHhcccCCCCCCCH
Q 004959          520 KGKSSDSALAVDIWSLGCTIIEMY-TGKPPWSEYEGAAAMFKV--MR--DTPAIPDSLSPEGKDFLRCCFQRNPADRPPA  594 (721)
Q Consensus       520 ~~k~~~~s~asDVWSLGVILyELL-tG~~PF~~~~~~~~~~ki--~~--~~~~~p~~lS~el~dLI~~cL~~DP~kRPSa  594 (721)
                          ...+.++|+|||||++|.+. .|+.-+............  ..  ........++.|+++=|.++|..+...||++
T Consensus       184 ----~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~~  259 (700)
T KOG2137|consen  184 ----TTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNAGAFGYSNNLPSELRESLKKLLNGDSAVRPTL  259 (700)
T ss_pred             ----ccccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcccccccccccccCcHHHHHHHHHHhcCCcccCcch
Confidence                45566899999999999998 566666543222221111  11  1123346789999999999999999999999


Q ss_pred             HHHHhccccccCCC
Q 004959          595 SLLLEHRFLKNSQQ  608 (721)
Q Consensus       595 ~eLL~Hp~f~~~~~  608 (721)
                      .+++.-+||.+...
T Consensus       260 ~~l~~~~ff~D~~~  273 (700)
T KOG2137|consen  260 DLLLSIPFFSDPGL  273 (700)
T ss_pred             hhhhcccccCCchh
Confidence            99999999987654

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.86  E-value=1.7e-08  Score=105.73  Aligned_cols=140  Identities=21%  Similarity=0.236  Sum_probs=103.4

Q ss_pred             eeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCC---------------CCccc--HHHHHHHHHHHHHHHhCCCC--
Q 004959          342 WQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFP---------------DDPKS--AESIKQLEQEIKVLSHLKHP--  402 (721)
Q Consensus       342 y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~---------------~~~~~--~~~~k~~~~Ei~iL~~L~HP--  402 (721)
                      +.++..||-|--+.||.|.+. .|.++|||.-+.-.               ....+  .......++|..+|.+|.-.  
T Consensus        93 e~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~  171 (304)
T COG0478          93 EAIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV  171 (304)
T ss_pred             HhhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence            346789999999999999876 58999999753210               01111  11234567899999998744  


Q ss_pred             CeeeeeeeEEecCeEEEEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCce
Q 004959          403 NIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVV  482 (721)
Q Consensus       403 nIV~l~g~~~~~~~~yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~V  482 (721)
                      .|.+-+++    ++..+||||++|..|...      .+..+....++..|++-+.-+-..||||+|+..-||||+++|.+
T Consensus       172 ~VP~P~~~----nRHaVvMe~ieG~eL~~~------r~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~dg~~  241 (304)
T COG0478         172 KVPKPIAW----NRHAVVMEYIEGVELYRL------RLDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDGDI  241 (304)
T ss_pred             CCCCcccc----ccceeeeehcccceeecc------cCcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecCCCE
Confidence            55555543    567899999998766533      22345566677777777777779999999999999999999999


Q ss_pred             EEeecCCccc
Q 004959          483 KLADFGMAKH  492 (721)
Q Consensus       483 KL~DFGlA~~  492 (721)
                      .++||-.+..
T Consensus       242 ~vIDwPQ~v~  251 (304)
T COG0478         242 VVIDWPQAVP  251 (304)
T ss_pred             EEEeCccccc
Confidence            9999976643

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.72  E-value=7.5e-08  Score=97.88  Aligned_cols=105  Identities=18%  Similarity=0.250  Sum_probs=82.0

Q ss_pred             HHHHHHHHHHHhCCCCC--eeeeeeeEEec----CeEEEEEeeccCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHH
Q 004959          387 KQLEQEIKVLSHLKHPN--IVQYYGSEIVE----DKFYIYLEYVHPG-SINKYVREHCGAITESVVRNFTRHILSGLAYL  459 (721)
Q Consensus       387 k~~~~Ei~iL~~L~HPn--IV~l~g~~~~~----~~~yLVmEy~~gG-sL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yL  459 (721)
                      .+..+|...+.+|..-.  +...+.+.+..    ...+||+|++++. +|.+++... ..++......++.+|+..+.-|
T Consensus        56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~-~~~~~~~~~~ll~~l~~~i~~l  134 (206)
T PF06293_consen   56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQW-EQLDPSQRRELLRALARLIAKL  134 (206)
T ss_pred             hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhh-cccchhhHHHHHHHHHHHHHHH
Confidence            35677888777775332  33444444432    2468999999874 799998764 2377778899999999999999


Q ss_pred             hhCCeeccCCCCCcEEEcCCC---ceEEeecCCccc
Q 004959          460 HSKKTIHRDIKGANLLVDASG---VVKLADFGMAKH  492 (721)
Q Consensus       460 Hs~gIIHrDLKPeNILld~~g---~VKL~DFGlA~~  492 (721)
                      |.+||+|+|+++.||||+.++   .+.|+||+-++.
T Consensus       135 H~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~  170 (206)
T PF06293_consen  135 HDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF  170 (206)
T ss_pred             HHCcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence            999999999999999999887   899999997764

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=98.60  E-value=3.1e-07  Score=100.66  Aligned_cols=239  Identities=18%  Similarity=0.229  Sum_probs=151.5

Q ss_pred             EeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhC-CCCCeee--------eeeeEEec
Q 004959          344 KGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHL-KHPNIVQ--------YYGSEIVE  414 (721)
Q Consensus       344 ~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L-~HPnIV~--------l~g~~~~~  414 (721)
                      .++.||+|+-+.+|..-...  . .+.|++..-+....     .   +-+..|... .||-+-.        ++|-- ..
T Consensus        15 ~gr~LgqGgea~ly~l~e~~--d-~VAKIYh~Pppa~~-----a---qk~a~la~~p~~p~~~~rvaWPqa~L~G~~-~~   82 (637)
T COG4248          15 PGRPLGQGGEADLYTLGEVR--D-QVAKIYHAPPPAAQ-----A---QKVAELAATPDAPLLNYRVAWPQATLHGGR-RG   82 (637)
T ss_pred             CCccccCCccceeeecchhh--c-hhheeecCCCchHH-----H---HHHHHhccCCCCcchhhhhcccHHHhhCCC-cc
Confidence            45689999999999764332  2 23465543221111     1   112222222 3553321        22221 12


Q ss_pred             CeEEEEEeeccCCC-HHHHH-----HHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecC
Q 004959          415 DKFYIYLEYVHPGS-INKYV-----REHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFG  488 (721)
Q Consensus       415 ~~~yLVmEy~~gGs-L~~~L-----~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFG  488 (721)
                      ..+-+.|..+.|.. +..++     +..+....++.+.++++.|+.+.+.||..|.+-+|+.++||||.+++.|.|+|=.
T Consensus        83 ~~iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVdsD  162 (637)
T COG4248          83 KVIGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDSD  162 (637)
T ss_pred             ceeEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEccc
Confidence            23778888887642 22222     1223457788999999999999999999999999999999999999999999855


Q ss_pred             CccccCCCcccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhC-CCCCCchh-------hHH-HHH
Q 004959          489 MAKHLTGQKADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTG-KPPWSEYE-------GAA-AMF  559 (721)
Q Consensus       489 lA~~l~~~~~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG-~~PF~~~~-------~~~-~~~  559 (721)
                      .-....++..+...+|...|.+||.-.-....  +.+-+...|.|.|||++++||.| +.||.+..       ..+ .+.
T Consensus       163 sfqi~~ng~~~~cpVg~~eftPPElQ~~~sf~--g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia  240 (637)
T COG4248         163 SFQINANGTLHLCPVGVSEFTPPELQTLPSFV--GFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIA  240 (637)
T ss_pred             ceeeccCCceEecccCccccCCHHHhcccccc--ccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhh
Confidence            43333344444556799999999986422222  23344567999999999999986 99997532       111 110


Q ss_pred             H----H--hhcCC--C----CC-CCCCHHHHHHHHHhccc--CCCCCCCHHH
Q 004959          560 K----V--MRDTP--A----IP-DSLSPEGKDFLRCCFQR--NPADRPPASL  596 (721)
Q Consensus       560 k----i--~~~~~--~----~p-~~lS~el~dLI~~cL~~--DP~kRPSa~e  596 (721)
                      .    .  .....  .    +| .-++++++.|+.+|+..  ++.-|||++.
T Consensus       241 ~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~a  292 (637)
T COG4248         241 HGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKA  292 (637)
T ss_pred             cceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHH
Confidence            0    0  01111  1    11 24788999999999975  3567999865

>PRK09902 hypothetical protein; Provisional

Probab=98.59  E-value=4.5e-07  Score=92.74  Aligned_cols=144  Identities=15%  Similarity=0.166  Sum_probs=101.7

Q ss_pred             EEeecCCeEEEEEEECCCCcEEEEEEee-cCCCCcccHHHHHHHHHHHHHHHhCCCCC--eeeeeeeEEe----cCeEEE
Q 004959          347 LIGRGTFGSVYVASNRETGALCAMKEVD-IFPDDPKSAESIKQLEQEIKVLSHLKHPN--IVQYYGSEIV----EDKFYI  419 (721)
Q Consensus       347 ~LG~G~fG~VY~a~~~~tg~~vAIK~i~-~~~~~~~~~~~~k~~~~Ei~iL~~L~HPn--IV~l~g~~~~----~~~~yL  419 (721)
                      --|+||-+-|+.....  |+.|-+|.-. .....-...-....|.+|+..|++|..-+  +.+.+.....    .-+-+|
T Consensus        25 N~~rgG~SgV~r~~~~--g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~L  102 (216)
T PRK09902         25 NYRRNGMSGVQCVERN--GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALL  102 (216)
T ss_pred             CcCCCCcceEEEEEeC--CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEE
Confidence            3477888899987644  4578888764 11111110113457889999988886322  3444421111    124689


Q ss_pred             EEeeccC-CCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCc--eEEeecCCccc
Q 004959          420 YLEYVHP-GSINKYVREH-CGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGV--VKLADFGMAKH  492 (721)
Q Consensus       420 VmEy~~g-GsL~~~L~~~-~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~--VKL~DFGlA~~  492 (721)
                      |+|-+.| .+|.+++.+. ....++.....++.+|+..|.-||+.|+.|+|+-+.|||++.+|.  |+++||.-++.
T Consensus       103 VTe~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~  179 (216)
T PRK09902        103 VTEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR  179 (216)
T ss_pred             EEEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence            9998864 5898888653 235677788899999999999999999999999999999987776  99999986653

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=98.51  E-value=1.2e-08  Score=116.25  Aligned_cols=243  Identities=23%  Similarity=0.210  Sum_probs=170.8

Q ss_pred             CeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCC-eeeeeeeEEecCeEEE
Q 004959          341 QWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPN-IVQYYGSEIVEDKFYI  419 (721)
Q Consensus       341 ~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPn-IV~l~g~~~~~~~~yL  419 (721)
                      .+.....+++|+++++|+.+...+...+ .+.+...          ..+.-++++|.+++||| .+..++-++.++..++
T Consensus       243 ws~~fh~fvK~altknpKkRptaeklL~-h~fvs~~----------l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i  311 (829)
T KOG0576|consen  243 WSEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT----------LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWI  311 (829)
T ss_pred             chHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc----------hhhHHHHHHHHHccCCCCcccccccCCcccccch
Confidence            3455677899999999999877665555 6665421          34556888999999999 7888888888889999


Q ss_pred             EEeeccCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCCcc
Q 004959          420 YLEYVHPG-SINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKA  498 (721)
Q Consensus       420 VmEy~~gG-sL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~~~  498 (721)
                      +|+++.++ +....+....-.+.+-+...+.+.-+++|++||+.--+|+|    |||..+ +.+|+.||+....+.....
T Consensus       312 ~~~i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~~  386 (829)
T KOG0576|consen  312 PMRICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGSE-EEVKLLDFAVPPQLTRTMK  386 (829)
T ss_pred             hhhhhcCCccccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----cccccc-cccccccccCCcccCcccc
Confidence            99999877 22111111112244445666777888999999998778999    888754 7899999999988876666


Q ss_pred             cccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhcC--CCCC--CCCCH
Q 004959          499 DLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDT--PAIP--DSLSP  574 (721)
Q Consensus       499 ~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~~--~~~p--~~lS~  574 (721)
                      ..+..+++.|+|||+...       ..+....|+|++|+-..+|.-|.+|-....  .....+-...  +.+.  ...+.
T Consensus       387 ~~t~~~~~~~~~pev~~~-------~~~~~~p~~~~~~~~~~~~ap~~pPr~~P~--~~~~~~g~~p~s~~L~~~~aw~~  457 (829)
T KOG0576|consen  387 PRTAIGTPEPLAPEVIQE-------NTIDGCPDSGSLAVSAIQMAPGLPPRSSPP--AVLPMIGNGPNSPMLTDKSAWSP  457 (829)
T ss_pred             cccCCCCCCCCCchhhcc-------cccccCCCccCCCcchhhcCCCCCCCCCCc--cccCCCCCCCCccccchhhhcCc
Confidence            677889999999999854       344446799999998888888887754311  0000000000  0000  01111


Q ss_pred             HH-HHHHHHhcccCCCCCCCHHHHHhccccccCCC
Q 004959          575 EG-KDFLRCCFQRNPADRPPASLLLEHRFLKNSQQ  608 (721)
Q Consensus       575 el-~dLI~~cL~~DP~kRPSa~eLL~Hp~f~~~~~  608 (721)
                      -. .++...|+..-|..|+...+++.|.+|.....
T Consensus       458 ~~~~~~~~~~~~g~P~~pkv~mgacfsKvfngCpl  492 (829)
T KOG0576|consen  458 VFHRDFPAPCLNGLPPTPKVHMGACFSKVFNGCPL  492 (829)
T ss_pred             ccccCCcccccCCCCCCCcchhhHHHHHHhccCcc
Confidence            11 24778899999999999999999999986543

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.47  E-value=3.2e-06  Score=84.92  Aligned_cols=138  Identities=19%  Similarity=0.282  Sum_probs=81.7

Q ss_pred             eeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCC--CeeeeeeeEE---ecCeEEE
Q 004959          345 GKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHP--NIVQYYGSEI---VEDKFYI  419 (721)
Q Consensus       345 ~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HP--nIV~l~g~~~---~~~~~yL  419 (721)
                      ++.|+.|..+.||++....  ..+++|....       ......+.+|..+++.|...  .+.+++....   .....++
T Consensus         2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~-------~~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~   72 (239)
T PF01636_consen    2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRP-------PDAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYL   72 (239)
T ss_dssp             EEEEEESSSSEEEEEEETT--SEEEEEEESS-------HHHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEE
T ss_pred             CccCCCCCeeeEEEEEECC--cEEEEEEeCC-------CCCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceE
Confidence            4689999999999998765  4899998641       14556788899888888533  2445555332   2335799


Q ss_pred             EEeeccCCCHHH----------------HHH---Hhc---CCCCHHH------HHHH---------------HHHHHH-H
Q 004959          420 YLEYVHPGSINK----------------YVR---EHC---GAITESV------VRNF---------------TRHILS-G  455 (721)
Q Consensus       420 VmEy~~gGsL~~----------------~L~---~~~---~~Lse~~------i~~i---------------~~QIl~-A  455 (721)
                      +|++++|..+..                .+.   ...   ..+....      ...+               ...+.. .
T Consensus        73 ~~~~i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  152 (239)
T PF01636_consen   73 LMEYIPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERL  152 (239)
T ss_dssp             EEEEESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHH
T ss_pred             EEEEeccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHH
Confidence            999999987776                111   110   0011000      0000               111222 2


Q ss_pred             HHHHh-------hCCeeccCCCCCcEEEc-CCCceEEeecCCcc
Q 004959          456 LAYLH-------SKKTIHRDIKGANLLVD-ASGVVKLADFGMAK  491 (721)
Q Consensus       456 L~yLH-------s~gIIHrDLKPeNILld-~~g~VKL~DFGlA~  491 (721)
                      +..++       ...++|+|+.+.|||++ .++.|-|+||+.+.
T Consensus       153 ~~~~~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~  196 (239)
T PF01636_consen  153 LQELEALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG  196 (239)
T ss_dssp             HHHHHHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred             HHHHHhhhccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence            33333       24699999999999999 66777899998775

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=98.47  E-value=1.2e-06  Score=105.80  Aligned_cols=210  Identities=23%  Similarity=0.336  Sum_probs=149.7

Q ss_pred             HHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCe----EEEEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHH
Q 004959          384 ESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDK----FYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYL  459 (721)
Q Consensus       384 ~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~----~yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yL  459 (721)
                      ..+...+.|+..+..+.|+|++.++.+......    +.+..|+|.+.++...+... +.++...++.+..++++||.|+
T Consensus       224 ~~i~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v-~~i~~~~~r~~~~~~~~GL~~~  302 (1351)
T KOG1035|consen  224 KEIQTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSV-GSIPLETLRILHQKLLEGLAYL  302 (1351)
T ss_pred             HHHHHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhc-cccCHHHHHHHHHHHhhhHHHH
Confidence            455566777888888999999999887554332    23445788888888888654 7889999999999999999999


Q ss_pred             hhCCeeccCCCCC---cEEEcCCCceEEe--ecCCccccCCCcccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHH
Q 004959          460 HSKKTIHRDIKGA---NLLVDASGVVKLA--DFGMAKHLTGQKADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWS  534 (721)
Q Consensus       460 Hs~gIIHrDLKPe---NILld~~g~VKL~--DFGlA~~l~~~~~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWS  534 (721)
                      |+....|.-|...   +-.++.++.+.+.  ||+....+..........-...|.++|....     +........|+|.
T Consensus       303 h~~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~~~~~~~~~~~e~~~~-----~~~~~~r~~dL~~  377 (1351)
T KOG1035|consen  303 HSLSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFSDLLAEIRNADEDLKE-----NTAKKSRLTDLWC  377 (1351)
T ss_pred             HHhccceeEEecccccccccCccceeecchhhhcccccCCCcccchhhcCcccccccccccc-----ccchhhhhhHHHH
Confidence            9996555544444   3344555666666  9998887766555555555677888887742     3334445579999


Q ss_pred             HHHHHHHHhhCCCCCCchhhHHHHHHHhhcCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhccccccCCC
Q 004959          535 LGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQ  608 (721)
Q Consensus       535 LGVILyELLtG~~PF~~~~~~~~~~ki~~~~~~~p~~lS~el~dLI~~cL~~DP~kRPSa~eLL~Hp~f~~~~~  608 (721)
                      +|.++..+..|..+-....   ....+      .+.....+..+++.+|+.-+.++|+++.+++.|+|......
T Consensus       378 lgll~~~~~~~~~i~~~~~---~~~~~------l~~~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~f~~~~~~  442 (1351)
T KOG1035|consen  378 LGLLLLQLSQGEDISEKSA---VPVSL------LDVLSTSELLDALPKCLDEDSEERLSALELLTHPFLRFPTD  442 (1351)
T ss_pred             HHHHHhhhhhcCccccccc---chhhh------hccccchhhhhhhhhhcchhhhhccchhhhhhchhcccccc
Confidence            9999999998865422111   11111      11112227789999999999999999999999999875443

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.46  E-value=6.6e-07  Score=102.68  Aligned_cols=147  Identities=19%  Similarity=0.234  Sum_probs=91.9

Q ss_pred             eEEeecCCeEEEEEEECCCCcEEEEEEeecC----------------------CCC---cccHHHH----HHH------H
Q 004959          346 KLIGRGTFGSVYVASNRETGALCAMKEVDIF----------------------PDD---PKSAESI----KQL------E  390 (721)
Q Consensus       346 k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~----------------------~~~---~~~~~~~----k~~------~  390 (721)
                      .-|+.++-|+||+|+.+. |+.||||+.+-.                      ...   -.-.+.+    +.+      .
T Consensus       131 ~PiAsASIaQVH~A~L~s-G~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~  209 (517)
T COG0661         131 EPIASASIAQVHRAVLKS-GEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR  209 (517)
T ss_pred             CchhhhhHhhheeEEecC-CCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence            468899999999999875 999999986410                      000   0111111    222      2


Q ss_pred             HHHHHHHhCC-----CCCeeeeeeeE-EecCeEEEEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCe
Q 004959          391 QEIKVLSHLK-----HPNIVQYYGSE-IVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKT  464 (721)
Q Consensus       391 ~Ei~iL~~L~-----HPnIV~l~g~~-~~~~~~yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gI  464 (721)
                      +|..-+.++.     .++| .+=.+| +-.+...|+|||++|..+.++.......++...+...+.++.  +..+=..|+
T Consensus       210 ~EA~n~~~~~~nf~~~~~v-~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~ia~~~~~~f--~~q~~~dgf  286 (517)
T COG0661         210 REAANAERFRENFKDDPDV-YVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAGIDRKELAELLVRAF--LRQLLRDGF  286 (517)
T ss_pred             HHHHHHHHHHHHcCCCCCe-EeceeehhccCCcEEEEEeeCCEecccHHHHHhcCCCHHHHHHHHHHHH--HHHHHhcCc
Confidence            3333343332     2332 222222 235677899999999988888543334555333332222221  122224799


Q ss_pred             eccCCCCCcEEEcCCCceEEeecCCccccCCC
Q 004959          465 IHRDIKGANLLVDASGVVKLADFGMAKHLTGQ  496 (721)
Q Consensus       465 IHrDLKPeNILld~~g~VKL~DFGlA~~l~~~  496 (721)
                      +|.|.+|.||+|+.+|.+.+.|||+...+...
T Consensus       287 fHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~~  318 (517)
T COG0661         287 FHADPHPGNILVRSDGRIVLLDFGIVGRLDPK  318 (517)
T ss_pred             cccCCCccceEEecCCcEEEEcCcceecCCHH
Confidence            99999999999999999999999998876543

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.42  E-value=3.8e-06  Score=86.39  Aligned_cols=139  Identities=16%  Similarity=0.248  Sum_probs=87.8

Q ss_pred             CCCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHH------HHHHHHHHHhCC---CCCeeeeee
Q 004959          339 NSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQ------LEQEIKVLSHLK---HPNIVQYYG  409 (721)
Q Consensus       339 ~~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~------~~~Ei~iL~~L~---HPnIV~l~g  409 (721)
                      ..+|...+++-......|.+..-  +|+.+++|...-  .....+.....      ..+++..+.++.   .-.+..++-
T Consensus        30 ~~~~~~~kv~k~~~r~~ValIei--~~~kyIlK~pr~--~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl  105 (229)
T PF06176_consen   30 DNNYKIIKVFKNTKRNYVALIEI--DGKKYILKEPRE--ENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYL  105 (229)
T ss_pred             hCCceEEEeecCCCccEEEEEEE--CCcEEEEeccch--hhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCcccccccee
Confidence            45777888887777766766543  478999997642  11111111111      123344333332   222222222


Q ss_pred             eE-----EecCeEEEEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEE
Q 004959          410 SE-----IVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKL  484 (721)
Q Consensus       410 ~~-----~~~~~~yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL  484 (721)
                      +.     ......+|||||++|..|.++..     +++    .+...|.++|.-||+.|++|+|.+|.|++++.+ .+++
T Consensus       106 ~~ekk~~~~~~~~~ll~EYIeG~~l~d~~~-----i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~-~i~i  175 (229)
T PF06176_consen  106 AAEKKIFRYTSSYVLLMEYIEGVELNDIED-----IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNN-GIRI  175 (229)
T ss_pred             eeeeeeccceeEEEEEEEEecCeecccchh-----cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEECC-cEEE
Confidence            21     12345678999999988866532     333    244567788999999999999999999999854 5999


Q ss_pred             eecCCcc
Q 004959          485 ADFGMAK  491 (721)
Q Consensus       485 ~DFGlA~  491 (721)
                      +||+..+
T Consensus       176 ID~~~k~  182 (229)
T PF06176_consen  176 IDTQGKR  182 (229)
T ss_pred             EECcccc
Confidence            9998664

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.34  E-value=4.5e-06  Score=86.31  Aligned_cols=134  Identities=14%  Similarity=0.169  Sum_probs=81.7

Q ss_pred             eEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCC--eeeeeeeEEecCeEEEEEee
Q 004959          346 KLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPN--IVQYYGSEIVEDKFYIYLEY  423 (721)
Q Consensus       346 k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPn--IV~l~g~~~~~~~~yLVmEy  423 (721)
                      ..||.|..+.||++    .|..+++|....   . .   ....+.+|.++|+.+..-.  +.+.+++....+...+|||+
T Consensus         7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~---~-~---~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~   75 (226)
T TIGR02172         7 TQTGEGGNGESYTH----KTGKWMLKLYNP---G-F---DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYEL   75 (226)
T ss_pred             eeecCCCCcceeEe----cCCCEEEEeCCC---C-C---CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeee
Confidence            47899999999984    255688887642   1 1   1235688999998886333  45667776777778899999


Q ss_pred             ccCCC-HH--------------HHHHH-----hc---CCCCHHH-HHHHHH----------HHHHH-HHHHh----hCCe
Q 004959          424 VHPGS-IN--------------KYVRE-----HC---GAITESV-VRNFTR----------HILSG-LAYLH----SKKT  464 (721)
Q Consensus       424 ~~gGs-L~--------------~~L~~-----~~---~~Lse~~-i~~i~~----------QIl~A-L~yLH----s~gI  464 (721)
                      ++|.+ +.              ..+.+     +.   ....... ...+..          .+... ..+|.    ...+
T Consensus        76 i~G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~  155 (226)
T TIGR02172        76 IVGKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTC  155 (226)
T ss_pred             cCCccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCce
Confidence            99863 11              11111     10   0111111 001100          01111 12222    1247


Q ss_pred             eccCCCCCcEEEcCCCceEEeecCCcc
Q 004959          465 IHRDIKGANLLVDASGVVKLADFGMAK  491 (721)
Q Consensus       465 IHrDLKPeNILld~~g~VKL~DFGlA~  491 (721)
                      +|+|+.|.||++++++ +.|+||+.+.
T Consensus       156 ~HgD~~~~Nii~~~~~-~~iIDwe~a~  181 (226)
T TIGR02172       156 LHGDFQIGNLITSGKG-TYWIDLGDFG  181 (226)
T ss_pred             EecCCCCCcEEEcCCC-cEEEechhcC
Confidence            8999999999999888 9999999775

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.29  E-value=5e-06  Score=86.60  Aligned_cols=141  Identities=15%  Similarity=0.190  Sum_probs=93.4

Q ss_pred             eEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCccc-----------------H--HHHHHHHHHHHHHHhCCC--CCe
Q 004959          346 KLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKS-----------------A--ESIKQLEQEIKVLSHLKH--PNI  404 (721)
Q Consensus       346 k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~-----------------~--~~~k~~~~Ei~iL~~L~H--PnI  404 (721)
                      ..|..|--+.||+|.. .++..+|+|+........+.                 .  ....-...|+.-|+++..  =.+
T Consensus        54 g~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrv  132 (268)
T COG1718          54 GCISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRV  132 (268)
T ss_pred             eeecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCC
Confidence            3677788889999975 45899999998542211111                 0  011223557777777642  223


Q ss_pred             eeeeeeEEecCeEEEEEeeccCCCH-HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhh-CCeeccCCCCCcEEEcCCCce
Q 004959          405 VQYYGSEIVEDKFYIYLEYVHPGSI-NKYVREHCGAITESVVRNFTRHILSGLAYLHS-KKTIHRDIKGANLLVDASGVV  482 (721)
Q Consensus       405 V~l~g~~~~~~~~yLVmEy~~gGsL-~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs-~gIIHrDLKPeNILld~~g~V  482 (721)
                      .+-+.+    ..-.|||||+....+ .-.|..  -.+...++..+..++++.+.-|-. .|+||+||..-|||+. ++.+
T Consensus       133 P~Pi~~----~~nVLvMEfIg~~g~pAP~LkD--v~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~-~~~p  205 (268)
T COG1718         133 PEPIAF----RNNVLVMEFIGDDGLPAPRLKD--VPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH-DGEP  205 (268)
T ss_pred             CCceee----cCCeEEEEeccCCCCCCCCccc--CCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE-CCeE
Confidence            333332    234799999954311 111211  233444788889999999998876 8999999999999998 8899


Q ss_pred             EEeecCCccccC
Q 004959          483 KLADFGMAKHLT  494 (721)
Q Consensus       483 KL~DFGlA~~l~  494 (721)
                      .|+|||-|....
T Consensus       206 ~iID~~QaV~~~  217 (268)
T COG1718         206 YIIDVSQAVTID  217 (268)
T ss_pred             EEEECccccccC
Confidence            999999887554

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.18  E-value=1.3e-05  Score=82.90  Aligned_cols=134  Identities=16%  Similarity=0.155  Sum_probs=80.5

Q ss_pred             EeecCC-eEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCC-CCCeeeeeeeEEecCeEEEEEeecc
Q 004959          348 IGRGTF-GSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLK-HPNIVQYYGSEIVEDKFYIYLEYVH  425 (721)
Q Consensus       348 LG~G~f-G~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~-HPnIV~l~g~~~~~~~~yLVmEy~~  425 (721)
                      |-.|.. ..||++...  +..+.+|.....   .     ...+.+|+.+++.+. +--+.+++++....+..++|||+++
T Consensus         6 ~~~g~~~~~v~~~~~~--~~~~~vk~~~~~---~-----~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~   75 (244)
T cd05150           6 VTEGQSGATVYRLDGK--NPGLYLKIAPSG---P-----TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVP   75 (244)
T ss_pred             cCCCCCcCeEEEEcCC--CCcEEEEecCCC---c-----ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeC
Confidence            334444 789998653  467888875421   1     235677888888874 3345577777666677899999999


Q ss_pred             CCCHHHHH----------------HH-hcC-----CCCHH------HHHHH-------------------HHHHHHHHHH
Q 004959          426 PGSINKYV----------------RE-HCG-----AITES------VVRNF-------------------TRHILSGLAY  458 (721)
Q Consensus       426 gGsL~~~L----------------~~-~~~-----~Lse~------~i~~i-------------------~~QIl~AL~y  458 (721)
                      |..|....                .. +.-     .+...      .....                   ..++...|..
T Consensus        76 G~~l~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  155 (244)
T cd05150          76 GVPAAALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEA  155 (244)
T ss_pred             CccHhHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHh
Confidence            87765331                10 000     11100      00000                   1111111111


Q ss_pred             H----hhCCeeccCCCCCcEEEcCCCceEEeecCCcc
Q 004959          459 L----HSKKTIHRDIKGANLLVDASGVVKLADFGMAK  491 (721)
Q Consensus       459 L----Hs~gIIHrDLKPeNILld~~g~VKL~DFGlA~  491 (721)
                      .    ....++|+|+.|.|||++.++.+.|+||+.+.
T Consensus       156 ~~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~  192 (244)
T cd05150         156 TRPAEEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLG  192 (244)
T ss_pred             hCCCcCceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence            1    12358999999999999987778899999774

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=98.16  E-value=1e-05  Score=92.91  Aligned_cols=147  Identities=20%  Similarity=0.144  Sum_probs=90.9

Q ss_pred             eEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCc--------------------------ccHHHHHHHHHHHHH----
Q 004959          346 KLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDP--------------------------KSAESIKQLEQEIKV----  395 (721)
Q Consensus       346 k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~--------------------------~~~~~~k~~~~Ei~i----  395 (721)
                      +.||.-+.|+||+|+.+. |+.||||+-.-.-.+.                          .-.+..+.+..|+.+    
T Consensus       167 ~piaaASlaQVhrA~L~~-G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA  245 (538)
T KOG1235|consen  167 EPIAAASLAQVHRARLKN-GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA  245 (538)
T ss_pred             chhhhcchhheEEEEecC-CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence            578999999999999887 9999999853100000                          000111223333322    


Q ss_pred             ------HHhCCCCCe---eeeeeeEE-ecCeEEEEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCee
Q 004959          396 ------LSHLKHPNI---VQYYGSEI-VEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTI  465 (721)
Q Consensus       396 ------L~~L~HPnI---V~l~g~~~-~~~~~yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gII  465 (721)
                            .+.+.|-+.   |.+=.++. ......|+||||+|..+.++-.-....++...+...+.++..-+-+  ..|++
T Consensus       246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i~~~gi~~~~i~~~l~~~~~~qIf--~~Gff  323 (538)
T KOG1235|consen  246 KNAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAIDKRGISPHDILNKLVEAYLEQIF--KTGFF  323 (538)
T ss_pred             HhHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHHHHcCCCHHHHHHHHHHHHHHHHH--hcCCc
Confidence                  222334441   11222222 2456799999999987765543223456666555544444333333  45799


Q ss_pred             ccCCCCCcEEEcC----CCceEEeecCCccccCC
Q 004959          466 HRDIKGANLLVDA----SGVVKLADFGMAKHLTG  495 (721)
Q Consensus       466 HrDLKPeNILld~----~g~VKL~DFGlA~~l~~  495 (721)
                      |+|-+|.||||..    ++.+.|.|||+...+..
T Consensus       324 HaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~  357 (538)
T KOG1235|consen  324 HADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH  357 (538)
T ss_pred             cCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence            9999999999984    56899999999887643

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=98.14  E-value=7.4e-05  Score=76.11  Aligned_cols=130  Identities=22%  Similarity=0.297  Sum_probs=92.3

Q ss_pred             CCeeEeeEEeecCC-eEEEEEEECCCCcEEEEEEeecCC---CC-----cc--c------HHHHHHHHHHHHHHHhCC--
Q 004959          340 SQWQKGKLIGRGTF-GSVYVASNRETGALCAMKEVDIFP---DD-----PK--S------AESIKQLEQEIKVLSHLK--  400 (721)
Q Consensus       340 ~~y~~~k~LG~G~f-G~VY~a~~~~tg~~vAIK~i~~~~---~~-----~~--~------~~~~k~~~~Ei~iL~~L~--  400 (721)
                      ..++.++.||.|.- |.||++...  |+.||||+.....   .+     ..  .      .....-|..|-+...+|+  
T Consensus        37 ~~I~flefLg~g~~~~~V~kv~I~--g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~  114 (207)
T PF13095_consen   37 DDIEFLEFLGHGSHDGYVFKVEID--GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEA  114 (207)
T ss_pred             CcEeeeeecCCCCceeEEEEEEEC--CeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhc
Confidence            68999999999999 999999765  8899999933211   00     00  0      022345677888777764  


Q ss_pred             -CCCe--eeeeeeEEecC------------------eEEEEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHH
Q 004959          401 -HPNI--VQYYGSEIVED------------------KFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYL  459 (721)
Q Consensus       401 -HPnI--V~l~g~~~~~~------------------~~yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yL  459 (721)
                       +.++  |+|+|+..-..                  ...||.||+....          .+    ...-+.+|++-|..+
T Consensus       115 ~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~----------~~----~~~~~~~~~~dl~~~  180 (207)
T PF13095_consen  115 GREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP----------PL----QIRDIPQMLRDLKIL  180 (207)
T ss_pred             cccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc----------cc----chhHHHHHHHHHHHH
Confidence             4566  99999864321                  2467888887543          12    223356788889999


Q ss_pred             hhCCeeccCCCCCcEEEcCCCceEEeecCCc
Q 004959          460 HSKKTIHRDIKGANLLVDASGVVKLADFGMA  490 (721)
Q Consensus       460 Hs~gIIHrDLKPeNILld~~g~VKL~DFGlA  490 (721)
                      |..||+-+|+++.|..     .-||+|||.+
T Consensus       181 ~k~gI~~~Dv~~~ny~-----~G~lvDfs~~  206 (207)
T PF13095_consen  181 HKLGIVPRDVKPRNYR-----GGKLVDFSSS  206 (207)
T ss_pred             HHCCeeeccCcccccc-----CCEEEecccC
Confidence            9999999999999986     4589999864

>PLN02876 acyl-CoA dehydrogenase

Probab=98.01  E-value=3.3e-05  Score=94.13  Aligned_cols=80  Identities=16%  Similarity=0.239  Sum_probs=54.7

Q ss_pred             eeEEeecCCeEEEEEEECCCC--cEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCC-CCCe--eeeeeeEEec---Ce
Q 004959          345 GKLIGRGTFGSVYVASNRETG--ALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLK-HPNI--VQYYGSEIVE---DK  416 (721)
Q Consensus       345 ~k~LG~G~fG~VY~a~~~~tg--~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~-HPnI--V~l~g~~~~~---~~  416 (721)
                      .+.|+.|.+..+|+......+  ..+++|+...   ... ......+.+|+.+|+.+. |.+|  .+++.++.+.   +.
T Consensus        43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~---~~~-~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~  118 (822)
T PLN02876         43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPP---GKL-LQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGT  118 (822)
T ss_pred             EEEeCCCCcCceEEEEECCCCcceeEEEEeCCC---Ccc-CccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCC
Confidence            567899999999998765432  4677775421   110 011246789999999995 6654  6777766553   46


Q ss_pred             EEEEEeeccCCC
Q 004959          417 FYIYLEYVHPGS  428 (721)
Q Consensus       417 ~yLVmEy~~gGs  428 (721)
                      .|+||||++|..
T Consensus       119 ~flVME~v~G~~  130 (822)
T PLN02876        119 AFYIMEYLEGRI  130 (822)
T ss_pred             ceEEEEecCCcc
Confidence            799999999864

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=97.94  E-value=4e-05  Score=76.32  Aligned_cols=131  Identities=22%  Similarity=0.263  Sum_probs=92.7

Q ss_pred             CeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCee-eeeeeEEecCeEEE
Q 004959          341 QWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIV-QYYGSEIVEDKFYI  419 (721)
Q Consensus       341 ~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV-~l~g~~~~~~~~yL  419 (721)
                      ..+..+.||+|.+|.||+|...  |..+|+|+-+.  +.     ....++.|.++|..+.--++- ++|.+.    ..++
T Consensus        23 ~~~v~~~L~KG~~s~Vyl~~~~--~~~~a~Kvrr~--ds-----~r~~l~kEakiLeil~g~~~~p~vy~yg----~~~i   89 (201)
T COG2112          23 ELRVEKELAKGTTSVVYLGEWR--GGEVALKVRRR--DS-----PRRNLEKEAKILEILAGEGVTPEVYFYG----EDFI   89 (201)
T ss_pred             hhhhhhhhhcccccEEEEeecc--CceEEEEEecC--Cc-----chhhHHHHHHHHHHhhhcCCCceEEEec----hhhh
Confidence            3455688999999999999876  67999997642  11     245788999999998866553 344442    3345


Q ss_pred             EEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCC-CCcEEEcCCCceEEeecCCccc
Q 004959          420 YLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIK-GANLLVDASGVVKLADFGMAKH  492 (721)
Q Consensus       420 VmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLK-PeNILld~~g~VKL~DFGlA~~  492 (721)
                      .|||+.|..|.++-...    .    ++-+..++++---|-..||-|+.|. |..++|-.++.+.|+||.-|+.
T Consensus        90 ~me~i~G~~L~~~~~~~----~----rk~l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~  155 (201)
T COG2112          90 RMEYIDGRPLGKLEIGG----D----RKHLLRVLEKAYKLDRLGIEHGELSRPWKNVLVNDRDVYIIDFDSATF  155 (201)
T ss_pred             hhhhhcCcchhhhhhcc----c----HHHHHHHHHHHHHHHHhccchhhhcCCceeEEecCCcEEEEEccchhh
Confidence            69999998887665321    1    2233455666555677899999996 6655555666999999998873

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=97.88  E-value=5.5e-05  Score=78.06  Aligned_cols=30  Identities=30%  Similarity=0.422  Sum_probs=25.4

Q ss_pred             CCeeccCCCCCcEEEcCCCceEEeecCCcc
Q 004959          462 KKTIHRDIKGANLLVDASGVVKLADFGMAK  491 (721)
Q Consensus       462 ~gIIHrDLKPeNILld~~g~VKL~DFGlA~  491 (721)
                      .+++|+|+.+.|||++.++..-|+||+.+.
T Consensus       164 ~~l~HGD~~~~Nvlv~~~~i~giIDw~~a~  193 (235)
T cd05155         164 PVWFHGDLAPGNLLVQDGRLSAVIDFGCLG  193 (235)
T ss_pred             ceEEeCCCCCCcEEEECCCEEEEEeCcccC
Confidence            358999999999999876556799999774

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=97.86  E-value=5.8e-06  Score=101.67  Aligned_cols=213  Identities=14%  Similarity=-0.000  Sum_probs=148.5

Q ss_pred             HHHHHHHHHHHhCCCCCeeeeeeeEEe--cCeEEEEEeeccCCCHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHhh
Q 004959          387 KQLEQEIKVLSHLKHPNIVQYYGSEIV--EDKFYIYLEYVHPGSINKYVREHC---GAITESVVRNFTRHILSGLAYLHS  461 (721)
Q Consensus       387 k~~~~Ei~iL~~L~HPnIV~l~g~~~~--~~~~yLVmEy~~gGsL~~~L~~~~---~~Lse~~i~~i~~QIl~AL~yLHs  461 (721)
                      +....|...++...|++++..+.-...  ....|.+++|+.+|.+++.|.+..   ..+.+.-+.....+.+.+..-+|+
T Consensus      1274 emll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls 1353 (2724)
T KOG1826|consen 1274 EMLLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILS 1353 (2724)
T ss_pred             HhhhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhh
Confidence            344555556666789998876654332  346789999999999999997542   334555565666665778888776


Q ss_pred             C-----CeeccCCCCCcEEEcCCCceEEeecCCccccCCCc-ccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHH
Q 004959          462 K-----KTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQK-ADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSL  535 (721)
Q Consensus       462 ~-----gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~~-~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSL  535 (721)
                      .     -.+|++||+-|.+|..+..||+.++|+.+...... ......+++.|+++++.....+       +.+.|+|..
T Consensus      1354 ~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~N~ik~-------t~rsdilr~ 1426 (2724)
T KOG1826|consen 1354 LTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVLSFFGLELCSPIYVLQLIKNEIKF-------TKRSDILRR 1426 (2724)
T ss_pred             cccCCccchhhhhhhhccceecCCcccccccccccccCchHhhhhhhhCCHHHHHHHHHHHHhh-------hhHHHHHHH
Confidence            5     26999999999999999999999999998433322 2234568899999999876443       334799999


Q ss_pred             HHHHHHHhhCCCCCCchhhHHHHHHHhhc--CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhccccccCC
Q 004959          536 GCTIIEMYTGKPPWSEYEGAAAMFKVMRD--TPAIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQ  607 (721)
Q Consensus       536 GVILyELLtG~~PF~~~~~~~~~~ki~~~--~~~~p~~lS~el~dLI~~cL~~DP~kRPSa~eLL~Hp~f~~~~  607 (721)
                      |+.+|++..|..+|........ ..++.+  ...++...+.++-.....+|-.....||.-...+.-+.+....
T Consensus      1427 s~~ly~rs~~n~~fi~flq~~L-kgiidn~tf~sIe~l~pgdaNve~~~~Ll~K~~~rp~q~isls~d~~a~~~ 1499 (2724)
T KOG1826|consen 1427 SLSLYLRSDGNAYFIFFLQPAL-KGIIDNHTFFSIEKLKPGDANVEALHRLLWKYMERPGQYISLSRDHFAVGL 1499 (2724)
T ss_pred             HHHHHHHhcccHHHHHHHHHHH-cCcccccccccccccCCCcccHHHHHHHHHHhhhcchhhhhcccccccccc
Confidence            9999999999888754332222 112211  2234444455666666666667777889888888777765443

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=97.80  E-value=0.0003  Score=71.60  Aligned_cols=134  Identities=20%  Similarity=0.337  Sum_probs=93.2

Q ss_pred             eEEeecCCeEEEEEEECCCCcEEEEEEeecCCCC-----------cccHHHHHHHHHHHHHHHhCC------CCCeeeee
Q 004959          346 KLIGRGTFGSVYVASNRETGALCAMKEVDIFPDD-----------PKSAESIKQLEQEIKVLSHLK------HPNIVQYY  408 (721)
Q Consensus       346 k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~-----------~~~~~~~k~~~~Ei~iL~~L~------HPnIV~l~  408 (721)
                      .+||+|+.=.||.--   .....+||++......           .......++..+|+.....+.      +.+|.+++
T Consensus         7 ~~i~~G~~R~cy~HP---~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~   83 (199)
T PF10707_consen    7 DLIAQGGERDCYQHP---DDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY   83 (199)
T ss_pred             cccccCCCceEEECC---CCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence            489999999999743   3456788887532200           000112456667776666655      78899999


Q ss_pred             eeEEecCeEEEEEeeccC------CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCC--C
Q 004959          409 GSEIVEDKFYIYLEYVHP------GSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDAS--G  480 (721)
Q Consensus       409 g~~~~~~~~yLVmEy~~g------GsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~--g  480 (721)
                      |+.++....-+|+|.+..      -+|.+++.+  +.+++ .+   ...|-+-..||-+.+|+.+||+|.||++...  +
T Consensus        84 G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~--~~~~~-~~---~~~L~~f~~~l~~~~Iv~~dl~~~NIv~~~~~~~  157 (199)
T PF10707_consen   84 GFVETNLGLGLVVELIRDADGNISPTLEDYLKE--GGLTE-EL---RQALDEFKRYLLDHHIVIRDLNPHNIVVQRRDSG  157 (199)
T ss_pred             EEEecCCceEEEEEEEECCCCCcCccHHHHHHc--CCccH-HH---HHHHHHHHHHHHHcCCeecCCCcccEEEEecCCC
Confidence            999999999999998754      368888854  35665 33   3344455578889999999999999999643  2


Q ss_pred             --ceEEee-cC
Q 004959          481 --VVKLAD-FG  488 (721)
Q Consensus       481 --~VKL~D-FG  488 (721)
                        .+.|+| ||
T Consensus       158 ~~~lvlIDG~G  168 (199)
T PF10707_consen  158 EFRLVLIDGLG  168 (199)
T ss_pred             ceEEEEEeCCC
Confidence              578888 44

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=97.74  E-value=0.00022  Score=73.11  Aligned_cols=75  Identities=15%  Similarity=0.143  Sum_probs=47.0

Q ss_pred             eeEEeecCCeEEEEEEECC-CCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCC-eeeeeeeEEecCeEEEEEe
Q 004959          345 GKLIGRGTFGSVYVASNRE-TGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPN-IVQYYGSEIVEDKFYIYLE  422 (721)
Q Consensus       345 ~k~LG~G~fG~VY~a~~~~-tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPn-IV~l~g~~~~~~~~yLVmE  422 (721)
                      .+.|..|-...+|++.... .++.|++|+......      ..-...+|+.+++.+.... +.++++.+.    -.+|||
T Consensus         3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~------~~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e   72 (235)
T cd05157           3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTE------LIIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYE   72 (235)
T ss_pred             EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCcc------ceecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEE
Confidence            4567888889999987543 357899996542111      1113357888888885333 334444322    247999


Q ss_pred             eccCCCH
Q 004959          423 YVHPGSI  429 (721)
Q Consensus       423 y~~gGsL  429 (721)
                      |++|.++
T Consensus        73 ~i~G~~l   79 (235)
T cd05157          73 FIPGRTL   79 (235)
T ss_pred             eeCCCcC
Confidence            9998665

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=97.57  E-value=0.00068  Score=76.02  Aligned_cols=82  Identities=17%  Similarity=0.175  Sum_probs=55.0

Q ss_pred             eeEEeecCCeEEEEEEECCCCcEEEEEEeecCCC-Cccc-HHHHHHHHHHHHHHHhCC---CCCeeeeeeeEEecCeEEE
Q 004959          345 GKLIGRGTFGSVYVASNRETGALCAMKEVDIFPD-DPKS-AESIKQLEQEIKVLSHLK---HPNIVQYYGSEIVEDKFYI  419 (721)
Q Consensus       345 ~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~-~~~~-~~~~k~~~~Ei~iL~~L~---HPnIV~l~g~~~~~~~~yL  419 (721)
                      .+.||.|.+..||++.....++.|+||+..-... .... ....++...|...|+.+.   ..++.+++.+  +.+..++
T Consensus        31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~l  108 (401)
T PRK09550         31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVT  108 (401)
T ss_pred             eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEE
Confidence            3689999999999999865446899998531100 0111 123456777888888763   3456777765  4466789


Q ss_pred             EEeeccCCC
Q 004959          420 YLEYVHPGS  428 (721)
Q Consensus       420 VmEy~~gGs  428 (721)
                      ||||+++..
T Consensus       109 VME~L~~~~  117 (401)
T PRK09550        109 VMEDLSDHK  117 (401)
T ss_pred             EEecCCCcc
Confidence            999998643

>PRK10593 hypothetical protein; Provisional

Probab=97.54  E-value=0.001  Score=71.72  Aligned_cols=78  Identities=14%  Similarity=0.057  Sum_probs=54.0

Q ss_pred             eEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCC---CCeeeeeeeEEe---cCe
Q 004959          343 QKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKH---PNIVQYYGSEIV---EDK  416 (721)
Q Consensus       343 ~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~H---PnIV~l~g~~~~---~~~  416 (721)
                      ...+.||.|..+.||.....  +..+.+|....  ..     ....+..|...|+.|..   -.|.++++++..   .+.
T Consensus        17 ~~~~~i~~G~~~~vy~~~~~--~~~~~~k~~~~--~~-----~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~   87 (297)
T PRK10593         17 SRVECISEQPYAALWALYDS--QGNPMPLMARS--FS-----TPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGP   87 (297)
T ss_pred             heeeecCCccceeEEEEEcC--CCCEEEEEecc--cc-----cchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCC
Confidence            34568999999999998643  23577776421  00     12477889998888853   356677776644   467


Q ss_pred             EEEEEeeccCCCH
Q 004959          417 FYIYLEYVHPGSI  429 (721)
Q Consensus       417 ~yLVmEy~~gGsL  429 (721)
                      .+||||+++|+++
T Consensus        88 ~~LVmE~i~G~~~  100 (297)
T PRK10593         88 DVLLLERLRGVSV  100 (297)
T ss_pred             eEEEEeccCCEec
Confidence            8999999998754

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=97.52  E-value=4.6e-05  Score=82.04  Aligned_cols=140  Identities=15%  Similarity=0.176  Sum_probs=97.0

Q ss_pred             eeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCC---------------CCcccHHHH--HHHHHHHHHHHhCC-CC-
Q 004959          342 WQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFP---------------DDPKSAESI--KQLEQEIKVLSHLK-HP-  402 (721)
Q Consensus       342 y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~---------------~~~~~~~~~--k~~~~Ei~iL~~L~-HP-  402 (721)
                      +.++..||-|--+-||.+-+. .|.+.++|.-++-.               ....+...+  -...+|..+|+.|. |- 
T Consensus        94 ~svGnqIGVGKESDIY~v~d~-~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gf  172 (465)
T KOG2268|consen   94 ESVGNQIGVGKESDIYVVADE-EGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGF  172 (465)
T ss_pred             hhhccccccccccceEEEecC-CCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCC
Confidence            456889999999999999765 48899999643210               000011111  22357888898885 32 


Q ss_pred             CeeeeeeeEEecCeEEEEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCce
Q 004959          403 NIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVV  482 (721)
Q Consensus       403 nIV~l~g~~~~~~~~yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~V  482 (721)
                      -|.+-++    -++.++|||++.|..|.+.-.       ...+..+...|..-+.-|-.+|+||+|..--||+|++++.+
T Consensus       173 pVPkpiD----~~RH~Vvmelv~g~Pl~~v~~-------v~d~~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~dd~~i  241 (465)
T KOG2268|consen  173 PVPKPID----HNRHCVVMELVDGYPLRQVRH-------VEDPPTLYDDLMGLIVRLANHGLIHGDFNEFNIMVKDDDKI  241 (465)
T ss_pred             CCCCccc----ccceeeHHHhhcccceeeeee-------cCChHHHHHHHHHHHHHHHHcCceecccchheeEEecCCCE
Confidence            2333333    467789999999988765431       11234455566666777889999999999999999999999


Q ss_pred             EEeecCCcccc
Q 004959          483 KLADFGMAKHL  493 (721)
Q Consensus       483 KL~DFGlA~~l  493 (721)
                      +++||--+...
T Consensus       242 ~vIDFPQmvS~  252 (465)
T KOG2268|consen  242 VVIDFPQMVST  252 (465)
T ss_pred             EEeechHhhcc
Confidence            99999765543

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=97.49  E-value=0.00032  Score=70.72  Aligned_cols=98  Identities=20%  Similarity=0.152  Sum_probs=78.4

Q ss_pred             HHHHHHHHhCCC-CCeeeeeeeEEecCeEEEEEeeccCCCHHHH---HHHhcCCCCHHHHHHHHHHHHHHHHHHhh---C
Q 004959          390 EQEIKVLSHLKH-PNIVQYYGSEIVEDKFYIYLEYVHPGSINKY---VREHCGAITESVVRNFTRHILSGLAYLHS---K  462 (721)
Q Consensus       390 ~~Ei~iL~~L~H-PnIV~l~g~~~~~~~~yLVmEy~~gGsL~~~---L~~~~~~Lse~~i~~i~~QIl~AL~yLHs---~  462 (721)
                      ..|.-+|+.+.+ +++.+++|.+-    .++|.||...+++...   +.. ....++....+|+.|+++.+++|+.   .
T Consensus         7 ~~E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~~l~~-~~~~~w~~R~~iA~~lL~~l~~l~~~~~~   81 (188)
T PF12260_consen    7 NNEPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIYRPLSQ-FLQSPWEQRAKIALQLLELLEELDHGPLG   81 (188)
T ss_pred             ccHHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCcccccccccccc-ccccCHHHHHHHHHHHHHHHHHHhcCCCC
Confidence            458888999976 69999999873    3668899987765421   111 1246889999999999999999987   3


Q ss_pred             CeeccCCCCCcEEEcCCCceEEeecCCccc
Q 004959          463 KTIHRDIKGANLLVDASGVVKLADFGMAKH  492 (721)
Q Consensus       463 gIIHrDLKPeNILld~~g~VKL~DFGlA~~  492 (721)
                      .+.-.|++++|+-|+++|.+|++|...+..
T Consensus        82 ~~~lcDv~~~nfgv~~~~~lk~iDld~v~~  111 (188)
T PF12260_consen   82 FFYLCDVSPDNFGVNDDGRLKLIDLDDVFV  111 (188)
T ss_pred             cEEEeecchHHeEEeCCCcEEEEechhcch
Confidence            588899999999999999999999987654

Proteins in this uncharacterised family are described as transmembrane proteins.

>TIGR02721 ycfN_thiK thiamine kinase

Probab=97.44  E-value=0.00034  Score=73.08  Aligned_cols=132  Identities=17%  Similarity=0.250  Sum_probs=74.2

Q ss_pred             EeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCe-eeeeeeEEecCeEEEEEeeccC
Q 004959          348 IGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNI-VQYYGSEIVEDKFYIYLEYVHP  426 (721)
Q Consensus       348 LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnI-V~l~g~~~~~~~~yLVmEy~~g  426 (721)
                      +..|-.+.+|+..  .+|+.+++|.....   ..  ...-...+|..+|+.+..-.+ .+++...  .  -++||||++|
T Consensus         4 ~~~G~tn~~y~~~--~~~~~~vlR~~~~~---~~--~~~~~r~~E~~~l~~l~~~g~~P~~i~~~--~--~~~v~e~i~G   72 (256)
T TIGR02721         4 LSGGLTNRSWRIE--HPGISFVWRPQSPV---CK--ALGVDRQREYQILQALSALGLAPKPILVN--E--HWLLVEWLEG   72 (256)
T ss_pred             CCCcCcCCeEEEE--eCCccEEEeeCCcc---cc--cccCcHHHHHHHHHHHHhcCCCCceEEEe--C--CEEEEEeccC
Confidence            4567778899886  34678888864311   10  000124678888888864333 2333332  2  3689999998


Q ss_pred             CCHHH--------------HHHH-hcC-----CCCH-HHHHHHHHHH---------HHHHHHHhh--------CCeeccC
Q 004959          427 GSINK--------------YVRE-HCG-----AITE-SVVRNFTRHI---------LSGLAYLHS--------KKTIHRD  468 (721)
Q Consensus       427 GsL~~--------------~L~~-~~~-----~Lse-~~i~~i~~QI---------l~AL~yLHs--------~gIIHrD  468 (721)
                      ..+..              .+.+ +..     .+.. ..+..+..++         ...+..+-.        ..++|+|
T Consensus        73 ~~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~D  152 (256)
T TIGR02721        73 EVITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMD  152 (256)
T ss_pred             cccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCC
Confidence            65431              1111 111     1111 1222222222         111222211        2589999


Q ss_pred             CCCCcEEEcCCCceEEeecCCcc
Q 004959          469 IKGANLLVDASGVVKLADFGMAK  491 (721)
Q Consensus       469 LKPeNILld~~g~VKL~DFGlA~  491 (721)
                      +.+.|||++.++ +.|+||+.+.
T Consensus       153 l~~~Nil~~~~~-~~lIDwE~a~  174 (256)
T TIGR02721       153 VHAYNLVVTPQG-LKLIDWEYAS  174 (256)
T ss_pred             CCcCcEEEeCCC-CEEEeccccC
Confidence            999999998877 8899999775

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=97.39  E-value=0.0013  Score=72.13  Aligned_cols=145  Identities=18%  Similarity=0.242  Sum_probs=95.0

Q ss_pred             EeeEEeecCCeEEEEEEECCCCcEEEEEEeec----CCCC----------------cccHHHH-HHHHHHHHHHHhCCCC
Q 004959          344 KGKLIGRGTFGSVYVASNRETGALCAMKEVDI----FPDD----------------PKSAESI-KQLEQEIKVLSHLKHP  402 (721)
Q Consensus       344 ~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~----~~~~----------------~~~~~~~-k~~~~Ei~iL~~L~HP  402 (721)
                      +...|..|--+.||.|... +|..+|||++..    +++.                ......+ -..+.|++-|.+|..-
T Consensus       148 inGCiSTGKEANVYHat~~-dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~a  226 (520)
T KOG2270|consen  148 INGCISTGKEANVYHATEE-DGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNA  226 (520)
T ss_pred             cccccccCccceeEeeecC-CCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhc
Confidence            4457889999999999864 588899998642    1110                0011111 1235677778887643


Q ss_pred             CeeeeeeeEEecCeEEEEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHH-hhCCeeccCCCCCcEEEcCCCc
Q 004959          403 NIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYL-HSKKTIHRDIKGANLLVDASGV  481 (721)
Q Consensus       403 nIV~l~g~~~~~~~~yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yL-Hs~gIIHrDLKPeNILld~~g~  481 (721)
                      .|. +=.-... ....|||+|+. ++=+..-.-....++...+..+-.|++.-|.-| |..++||.||.--|+|+ .+|.
T Consensus       227 GIP-~PePIlL-k~hVLVM~FlG-rdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Ly-hdG~  302 (520)
T KOG2270|consen  227 GIP-CPEPILL-KNHVLVMEFLG-RDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLY-HDGK  302 (520)
T ss_pred             CCC-CCCceee-ecceEeeeecc-CCCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheE-ECCE
Confidence            321 1111001 23479999995 332222111224678888888888999888887 56799999999999999 5689


Q ss_pred             eEEeecCCcccc
Q 004959          482 VKLADFGMAKHL  493 (721)
Q Consensus       482 VKL~DFGlA~~l  493 (721)
                      +.|+|-+.+...
T Consensus       303 lyiIDVSQSVE~  314 (520)
T KOG2270|consen  303 LYIIDVSQSVEH  314 (520)
T ss_pred             EEEEEccccccC
Confidence            999999877643

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=97.28  E-value=0.001  Score=71.03  Aligned_cols=75  Identities=19%  Similarity=0.192  Sum_probs=46.4

Q ss_pred             eEEeecCCeEEEEEEECC------CCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCe-eeeeeeEEecCeEE
Q 004959          346 KLIGRGTFGSVYVASNRE------TGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNI-VQYYGSEIVEDKFY  418 (721)
Q Consensus       346 k~LG~G~fG~VY~a~~~~------tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnI-V~l~g~~~~~~~~y  418 (721)
                      +.|..|--..||++....      .++.|++|+.....      .......+|+.++..+....+ .++++++.    -.
T Consensus         4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~------~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~----~~   73 (302)
T cd05156           4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV------ELLIDRERELVVFARLSERNLGPKLYGIFP----NG   73 (302)
T ss_pred             EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC------cceechHHHHHHHHHHHhCCCCCceEEEeC----CC
Confidence            456667777899887543      36789999864211      112345778888888753333 34444432    23


Q ss_pred             EEEeeccCCCHH
Q 004959          419 IYLEYVHPGSIN  430 (721)
Q Consensus       419 LVmEy~~gGsL~  430 (721)
                      +||||++|..+.
T Consensus        74 ~v~e~i~G~~l~   85 (302)
T cd05156          74 RIEEFIPSRTLT   85 (302)
T ss_pred             chhheeCCCcCC
Confidence            689999886653

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=97.24  E-value=0.0029  Score=68.08  Aligned_cols=140  Identities=18%  Similarity=0.188  Sum_probs=79.8

Q ss_pred             eEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCC--eeeeee------eEEec
Q 004959          343 QKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPN--IVQYYG------SEIVE  414 (721)
Q Consensus       343 ~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPn--IV~l~g------~~~~~  414 (721)
                      ...+.|+.|....+|++.. . +..+++|+....    ...   ..+..|++++..|....  |.+++.      +....
T Consensus        25 ~~i~~~~~G~~n~~y~v~t-~-~~~~vLK~~~~~----~~~---~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~   95 (307)
T TIGR00938        25 LSLKGIAEGVENSNYLLTT-D-VGRYILTLYEKR----VKA---EELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLA   95 (307)
T ss_pred             eeccccCCccccceEEEEe-C-CCcEEEEEecCC----CCH---HHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcC
Confidence            3456778887789998864 3 346888976421    111   23455667776664211  333332      11234


Q ss_pred             CeEEEEEeeccCCCHH-----------HHH---HHhcCCCC--------HH---H--HH----------HHHHHHHHHHH
Q 004959          415 DKFYIYLEYVHPGSIN-----------KYV---REHCGAIT--------ES---V--VR----------NFTRHILSGLA  457 (721)
Q Consensus       415 ~~~yLVmEy~~gGsL~-----------~~L---~~~~~~Ls--------e~---~--i~----------~i~~QIl~AL~  457 (721)
                      +..+++|||++|..+.           ..+   +.....+.        ..   .  ..          .....+...++
T Consensus        96 g~~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~  175 (307)
T TIGR00938        96 GKPACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELD  175 (307)
T ss_pred             CeEEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHH
Confidence            6789999999985431           111   11001110        00   0  00          01112334455


Q ss_pred             HHh-------hCCeeccCCCCCcEEEcCCCceEEeecCCcc
Q 004959          458 YLH-------SKKTIHRDIKGANLLVDASGVVKLADFGMAK  491 (721)
Q Consensus       458 yLH-------s~gIIHrDLKPeNILld~~g~VKL~DFGlA~  491 (721)
                      ++.       ..++||+|+++.||+++.++.+.|+||+.+.
T Consensus       176 ~l~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~  216 (307)
T TIGR00938       176 YLDKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC  216 (307)
T ss_pred             HHHhhhhhcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence            553       2589999999999999988877899999764

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=97.22  E-value=0.0032  Score=66.89  Aligned_cols=138  Identities=15%  Similarity=0.166  Sum_probs=82.0

Q ss_pred             EeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCC--eeeeee------eEEecC
Q 004959          344 KGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPN--IVQYYG------SEIVED  415 (721)
Q Consensus       344 ~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPn--IV~l~g------~~~~~~  415 (721)
                      ..+.|..|.-..+|+....  +..+++|+...     ..   ...+..|+.++..|.+-.  +.+++.      +....+
T Consensus        18 ~i~~i~~G~~n~~y~v~~~--~~~~vLr~~~~-----~~---~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~   87 (296)
T cd05153          18 SFEGISAGIENTNYFVTTD--SGRYVLTLFEK-----VS---AEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAG   87 (296)
T ss_pred             heecccCccccceEEEEeC--CCcEEEEEcCC-----CC---hHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCC
Confidence            3557778888899998643  45788997642     11   235667777777774322  334332      123356


Q ss_pred             eEEEEEeeccCCCHHH-----------HH---HHhcCCCCH--------HHH------------HHHHHHHHHHHHHHhh
Q 004959          416 KFYIYLEYVHPGSINK-----------YV---REHCGAITE--------SVV------------RNFTRHILSGLAYLHS  461 (721)
Q Consensus       416 ~~yLVmEy~~gGsL~~-----------~L---~~~~~~Lse--------~~i------------~~i~~QIl~AL~yLHs  461 (721)
                      ..++||+|++|..+..           .+   +.....+..        ...            ......+..++.++..
T Consensus        88 ~~~~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~  167 (296)
T cd05153          88 KPAALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDA  167 (296)
T ss_pred             ceEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHh
Confidence            6789999999866421           11   110000100        000            0111123344445443


Q ss_pred             -------CCeeccCCCCCcEEEcCCCceEEeecCCcc
Q 004959          462 -------KKTIHRDIKGANLLVDASGVVKLADFGMAK  491 (721)
Q Consensus       462 -------~gIIHrDLKPeNILld~~g~VKL~DFGlA~  491 (721)
                             .++||+|+.|.|||++.++.+.|+||+.+.
T Consensus       168 ~~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~  204 (296)
T cd05153         168 FDPSDLPRGVIHADLFRDNVLFDGDELSGVIDFYFAC  204 (296)
T ss_pred             hhhhcCCCcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence                   479999999999999987777999998764

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>PRK05231 homoserine kinase; Provisional

Probab=97.20  E-value=0.0076  Score=64.90  Aligned_cols=30  Identities=27%  Similarity=0.402  Sum_probs=25.7

Q ss_pred             CCeeccCCCCCcEEEcCCCceEEeecCCcc
Q 004959          462 KKTIHRDIKGANLLVDASGVVKLADFGMAK  491 (721)
Q Consensus       462 ~gIIHrDLKPeNILld~~g~VKL~DFGlA~  491 (721)
                      .|+||+|+++.|||++.+..+-|+||+.+.
T Consensus       187 ~~liHgD~~~~Nil~~~~~~~~iIDf~~~~  216 (319)
T PRK05231        187 RGVIHADLFRDNVLFEGDRLSGFIDFYFAC  216 (319)
T ss_pred             cccCCCCCCCCcEEEECCceEEEEeccccc
Confidence            389999999999999866556899999774

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=96.99  E-value=0.0034  Score=69.43  Aligned_cols=78  Identities=12%  Similarity=0.123  Sum_probs=49.8

Q ss_pred             EEeecCCeEEEEEEECCCCcEEEEEEeecCCC--CcccHHHHHHHHHHHHHHHhCC--CC-CeeeeeeeEEecCeEEEEE
Q 004959          347 LIGRGTFGSVYVASNRETGALCAMKEVDIFPD--DPKSAESIKQLEQEIKVLSHLK--HP-NIVQYYGSEIVEDKFYIYL  421 (721)
Q Consensus       347 ~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~--~~~~~~~~k~~~~Ei~iL~~L~--HP-nIV~l~g~~~~~~~~yLVm  421 (721)
                      .||.|....||++.....++.|+||+-.-.-.  .....-..++..-|...|+...  .| .+.++|.+  +++...+||
T Consensus         2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~vM   79 (370)
T TIGR01767         2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTVM   79 (370)
T ss_pred             cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceehH
Confidence            57999999999999764447899997531100  0011122445667777777664  34 45556543  566677999


Q ss_pred             eeccC
Q 004959          422 EYVHP  426 (721)
Q Consensus       422 Ey~~g  426 (721)
                      |++..
T Consensus        80 EdL~~   84 (370)
T TIGR01767        80 EDLSH   84 (370)
T ss_pred             hhCcc
Confidence            99954

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only]

Probab=96.87  E-value=0.0035  Score=71.28  Aligned_cols=161  Identities=19%  Similarity=0.285  Sum_probs=104.6

Q ss_pred             HHHHHHHHHHhCCCCCeeeeeeeEEe-cCeEEEEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeec
Q 004959          388 QLEQEIKVLSHLKHPNIVQYYGSEIV-EDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIH  466 (721)
Q Consensus       388 ~~~~Ei~iL~~L~HPnIV~l~g~~~~-~~~~yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIH  466 (721)
                      ++.--..+++.+.|+|...++++... ..+..+|||++ +.+|++++..+.  +-..       +++       .+|+.|
T Consensus        28 ~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~~--l~~~-------s~~-------~~~~~~   90 (725)
T KOG1093|consen   28 QILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTGN--LKDE-------SLL-------AHGVLH   90 (725)
T ss_pred             HHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHhcc--cchh-------hhc-------ccccce
Confidence            34445677889999999999987654 34588999999 589999987652  2111       111       222222


Q ss_pred             cCCCCCcEEEcCCCceEEeecCCccccCCCcccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCC
Q 004959          467 RDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGK  546 (721)
Q Consensus       467 rDLKPeNILld~~g~VKL~DFGlA~~l~~~~~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~  546 (721)
                           .||       ++.+| -++..   .   ....                       .+++|||++|.++.++..|.
T Consensus        91 -----~~~-------~~~td-~~~t~---~---~~~~-----------------------~pKsdVwsl~~i~~el~L~~  128 (725)
T KOG1093|consen   91 -----LNI-------IYITD-HFLTK---Y---PSPI-----------------------GPKSDVWSLGFIILELYLGI  128 (725)
T ss_pred             -----ehh-------hhccc-ccccc---C---CCCC-----------------------CcchhhhhHHHHHHHHHHhh
Confidence                 122       23333 01100   0   0001                       13689999999999999999


Q ss_pred             CCCCchhhHHHHHHHhhcCC------------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhccccccCC
Q 004959          547 PPWSEYEGAAAMFKVMRDTP------------AIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQ  607 (721)
Q Consensus       547 ~PF~~~~~~~~~~ki~~~~~------------~~p~~lS~el~dLI~~cL~~DP~kRPSa~eLL~Hp~f~~~~  607 (721)
                      ..|......+....+..-..            .+-..++..+.+++..|+-..|..||...++++++-|....
T Consensus       129 ~l~~~~~~s~~l~~i~k~~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~~k~~i~~ev~  201 (725)
T KOG1093|consen  129 SLEAELTESEYLEILLKYYTDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRPLPMELSKRCSFTEVY  201 (725)
T ss_pred             HHHHHHHHHHHHHHHHHhccCchhHHHHHHHHHHHHhhhHhHHHHhccCCccccccccchhHHhcCccHHHHH
Confidence            88877665555544433211            11123566678899999999999999999999999988763

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=96.71  E-value=0.039  Score=58.89  Aligned_cols=29  Identities=24%  Similarity=0.348  Sum_probs=25.5

Q ss_pred             CCeeccCCCCCcEEEcCCCceEEeecCCcc
Q 004959          462 KKTIHRDIKGANLLVDASGVVKLADFGMAK  491 (721)
Q Consensus       462 ~gIIHrDLKPeNILld~~g~VKL~DFGlA~  491 (721)
                      .++||+|+.+.|||++. +.+.|+||+.+.
T Consensus       187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~  215 (313)
T TIGR02906       187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT  215 (313)
T ss_pred             CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence            57999999999999987 678999998653

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=96.68  E-value=0.0075  Score=64.39  Aligned_cols=29  Identities=28%  Similarity=0.459  Sum_probs=24.8

Q ss_pred             CeeccCCCCCcEEEcCCCc-eEEeecCCcc
Q 004959          463 KTIHRDIKGANLLVDASGV-VKLADFGMAK  491 (721)
Q Consensus       463 gIIHrDLKPeNILld~~g~-VKL~DFGlA~  491 (721)
                      .++|+|+++.|||++.++. +-|+||+.+.
T Consensus       186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~  215 (276)
T cd05152         186 VLVHGDLHPGHILIDEDARVTGLIDWTEAK  215 (276)
T ss_pred             eeEeCCCCCCcEEEeCCCCEEEEECcHhcc
Confidence            4899999999999987565 4699999875

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=96.66  E-value=0.013  Score=63.96  Aligned_cols=144  Identities=15%  Similarity=0.204  Sum_probs=79.9

Q ss_pred             eEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCC--CCeeeeeeeEEecC--eEE
Q 004959          343 QKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKH--PNIVQYYGSEIVED--KFY  418 (721)
Q Consensus       343 ~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~H--PnIV~l~g~~~~~~--~~y  418 (721)
                      .+++.+-.|.--.+|.....  ++.+++. ..   .............+|+.+|+.+.-  --+...++++..+.  ..|
T Consensus        28 ~~v~~~~~G~sn~t~~~~~~--~~~~vlR-~P---~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf  101 (321)
T COG3173          28 LIVEEISGGWSNDTFRLGDT--GQKYVLR-KP---PRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPF  101 (321)
T ss_pred             ceeeeccCCcccceEEEecC--CceEEEe-cC---CccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCce
Confidence            34444433333344554433  7778777 21   122333445667788888888753  22334555555544  679


Q ss_pred             EEEeeccCCCHH------------------HHHHHhc----------C---CCCHHHHHHHHH--------------HHH
Q 004959          419 IYLEYVHPGSIN------------------KYVREHC----------G---AITESVVRNFTR--------------HIL  453 (721)
Q Consensus       419 LVmEy~~gGsL~------------------~~L~~~~----------~---~Lse~~i~~i~~--------------QIl  453 (721)
                      .||+|++|..+.                  ++|..-.          +   .+...++..+..              ++.
T Consensus       102 ~v~~~veGe~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~  181 (321)
T COG3173         102 YVMEWVEGEVVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLAD  181 (321)
T ss_pred             EEEEEecceeccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHH
Confidence            999999983221                  1121100          0   001111111111              112


Q ss_pred             HHHHHHhhC--------CeeccCCCCCcEEEcCCCceEEeecCCccc
Q 004959          454 SGLAYLHSK--------KTIHRDIKGANLLVDASGVVKLADFGMAKH  492 (721)
Q Consensus       454 ~AL~yLHs~--------gIIHrDLKPeNILld~~g~VKL~DFGlA~~  492 (721)
                      .-..+|+.+        .++|+|+.+.||+|+.++.+=|+||+++..
T Consensus       182 ~~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~l  228 (321)
T COG3173         182 RLIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATL  228 (321)
T ss_pred             HHHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEecccccc
Confidence            223444432        589999999999999998899999999864

>PLN02236 choline kinase

Probab=96.49  E-value=0.015  Score=63.92  Aligned_cols=137  Identities=14%  Similarity=0.177  Sum_probs=77.6

Q ss_pred             eeEEeecCCeEEEEEEECC----CCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCe-eeeeeeEEecCeEEE
Q 004959          345 GKLIGRGTFGSVYVASNRE----TGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNI-VQYYGSEIVEDKFYI  419 (721)
Q Consensus       345 ~k~LG~G~fG~VY~a~~~~----tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnI-V~l~g~~~~~~~~yL  419 (721)
                      .+.|-.|-.-.+|++....    .++.|++|+.....     ...+. ..+|+.+++.+..-++ .++++.+.. +   .
T Consensus        41 i~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t-----~~~id-R~~E~~~~~~l~~~gl~P~~~~~~~~-g---~  110 (344)
T PLN02236         41 VIPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGV-----ELFFD-RDDEIRTFECMSRHGQGPRLLGRFPN-G---R  110 (344)
T ss_pred             EEEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCC-----Ceeec-hHHHHHHHHHHHHcCCCCceEEEECC-c---e
Confidence            3455558888999986432    34688999764211     11122 3678888888864333 345555432 2   5


Q ss_pred             EEeeccCCCHHHH--------------HHH-hcCC-------CCHHHHHHHHHHH-----------------HHHHHHH-
Q 004959          420 YLEYVHPGSINKY--------------VRE-HCGA-------ITESVVRNFTRHI-----------------LSGLAYL-  459 (721)
Q Consensus       420 VmEy~~gGsL~~~--------------L~~-~~~~-------Lse~~i~~i~~QI-----------------l~AL~yL-  459 (721)
                      |.||++|.+|...              +.+ +...       .....+..++.++                 ...+..| 
T Consensus       111 v~efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~  190 (344)
T PLN02236        111 VEEFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLE  190 (344)
T ss_pred             EEEeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHH
Confidence            7899987665311              110 1001       1122233333221                 1111111 


Q ss_pred             -------hhCCeeccCCCCCcEEEcC-CCceEEeecCCcc
Q 004959          460 -------HSKKTIHRDIKGANLLVDA-SGVVKLADFGMAK  491 (721)
Q Consensus       460 -------Hs~gIIHrDLKPeNILld~-~g~VKL~DFGlA~  491 (721)
                             +...++|+|+++.|||+++ ++.+.|+||..+.
T Consensus       191 ~~~~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~  230 (344)
T PLN02236        191 KELSGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYAS  230 (344)
T ss_pred             HHhcccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence                   1236899999999999986 4689999998774

>PRK12396 5-methylribose kinase; Reviewed

Probab=96.21  E-value=0.015  Score=65.16  Aligned_cols=80  Identities=16%  Similarity=0.090  Sum_probs=53.4

Q ss_pred             eeEEeecCCeEEEEEEECCCCcEEEEEEeecC-CCCcccHHHHHHHHHHHHHHHhCC--CC-CeeeeeeeEEecCeEEEE
Q 004959          345 GKLIGRGTFGSVYVASNRETGALCAMKEVDIF-PDDPKSAESIKQLEQEIKVLSHLK--HP-NIVQYYGSEIVEDKFYIY  420 (721)
Q Consensus       345 ~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~-~~~~~~~~~~k~~~~Ei~iL~~L~--HP-nIV~l~g~~~~~~~~yLV  420 (721)
                      .+.||.|.-.-||++.+...++.|+||+---. .......-..++..-|..+|+.+.  .| .+.++|.+  +++...+|
T Consensus        34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~v  111 (409)
T PRK12396         34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCV  111 (409)
T ss_pred             eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHH
Confidence            67889999999999988544678999975311 111111223566777888888764  34 45566643  56677889


Q ss_pred             EeeccC
Q 004959          421 LEYVHP  426 (721)
Q Consensus       421 mEy~~g  426 (721)
                      ||++..
T Consensus       112 MEdL~~  117 (409)
T PRK12396        112 MEDLSD  117 (409)
T ss_pred             HHhCcc
Confidence            999854

>PLN02756 S-methyl-5-thioribose kinase

Probab=96.19  E-value=0.066  Score=60.36  Aligned_cols=79  Identities=16%  Similarity=0.188  Sum_probs=50.6

Q ss_pred             EeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCccc--HHHHHHHHHHHHHHHhCC---CCCeeeeeeeEEecCeEE
Q 004959          344 KGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKS--AESIKQLEQEIKVLSHLK---HPNIVQYYGSEIVEDKFY  418 (721)
Q Consensus       344 ~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~--~~~~k~~~~Ei~iL~~L~---HPnIV~l~g~~~~~~~~y  418 (721)
                      ..+.||.|.-..||+..+.  +..|+||+-.....-...  .-...+...|...|+.+.   ..++.+++.++.  +..+
T Consensus        36 ~~~eiggGn~N~VyrV~~~--~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~v  111 (418)
T PLN02756         36 KIKEVGDGNLNFVYIVVSS--SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMAL  111 (418)
T ss_pred             eEEEcCCCceeeEEEEEcC--CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCE
Confidence            3668899999999998863  567999975411110000  012344555667676654   246777887654  5578


Q ss_pred             EEEeeccC
Q 004959          419 IYLEYVHP  426 (721)
Q Consensus       419 LVmEy~~g  426 (721)
                      ++|||+++
T Consensus       112 lvME~L~~  119 (418)
T PLN02756        112 IGMRYLEP  119 (418)
T ss_pred             EEEeecCC
Confidence            89999976

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=96.18  E-value=0.022  Score=62.25  Aligned_cols=136  Identities=15%  Similarity=0.199  Sum_probs=75.7

Q ss_pred             eEEeecCCeEEEEEEECCC---CcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCe-eeeeeeEEecCeEEEEE
Q 004959          346 KLIGRGTFGSVYVASNRET---GALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNI-VQYYGSEIVEDKFYIYL  421 (721)
Q Consensus       346 k~LG~G~fG~VY~a~~~~t---g~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnI-V~l~g~~~~~~~~yLVm  421 (721)
                      +.|..|-...+|++.....   +..|++|+......      ..-.-.+|+.+++.+..-++ .++++++. .+   +|.
T Consensus        20 ~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~------~~IdR~~E~~il~~l~~~gl~P~~l~~~~-~G---~i~   89 (330)
T PLN02421         20 ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTD------YVIDRERELQAIKYLSAAGFGAKLLGVFG-NG---MIQ   89 (330)
T ss_pred             EEeCCcccceEEEEEecCCCCCCceEEEEEecCCcC------eEechHHHHHHHHHHHhcCCCCceeEEeC-Cc---Eee
Confidence            4455588888998865432   34788997642111      11123578888888865444 34555542 22   488


Q ss_pred             eeccCCCHHH--------------HHHH-hcCC------C-CHHHHHHHHHHH----------------------HHHHH
Q 004959          422 EYVHPGSINK--------------YVRE-HCGA------I-TESVVRNFTRHI----------------------LSGLA  457 (721)
Q Consensus       422 Ey~~gGsL~~--------------~L~~-~~~~------L-se~~i~~i~~QI----------------------l~AL~  457 (721)
                      +|++|..|..              .+++ +...      . -...+..++.++                      ..-+.
T Consensus        90 ~fi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~  169 (330)
T PLN02421         90 SFINARTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIV  169 (330)
T ss_pred             hhhcCCCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHH
Confidence            9998765421              1111 1111      1 122222232221                      11122


Q ss_pred             H---H-hhC----CeeccCCCCCcEEEcC-CCceEEeecCCcc
Q 004959          458 Y---L-HSK----KTIHRDIKGANLLVDA-SGVVKLADFGMAK  491 (721)
Q Consensus       458 y---L-Hs~----gIIHrDLKPeNILld~-~g~VKL~DFGlA~  491 (721)
                      .   + ...    -++|.||.+.|||+++ ++.++|+||..|.
T Consensus       170 ~l~~~~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag  212 (330)
T PLN02421        170 ELKEITDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGS  212 (330)
T ss_pred             HHHHHhccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccC
Confidence            2   2 122    2799999999999975 5789999998774

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=96.16  E-value=0.079  Score=57.12  Aligned_cols=29  Identities=17%  Similarity=0.214  Sum_probs=27.0

Q ss_pred             CeeccCCCCCcEEEcCCCceEEeecCCcc
Q 004959          463 KTIHRDIKGANLLVDASGVVKLADFGMAK  491 (721)
Q Consensus       463 gIIHrDLKPeNILld~~g~VKL~DFGlA~  491 (721)
                      ++||+|+.+.|||++.++.+.|+||..+.
T Consensus       197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~  225 (309)
T TIGR02904       197 VLVHGKLSLSHFLYDETRGGYFINFEKAS  225 (309)
T ss_pred             eeeCCCCcHHhEEEcCCCCEEEEEhhhcc
Confidence            79999999999999999999999998775

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=95.99  E-value=0.017  Score=63.55  Aligned_cols=72  Identities=25%  Similarity=0.282  Sum_probs=56.1

Q ss_pred             CeEEEEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhC-CeeccCCCCCcEEEcCCCceEEeecCCcccc
Q 004959          415 DKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSK-KTIHRDIKGANLLVDASGVVKLADFGMAKHL  493 (721)
Q Consensus       415 ~~~yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~-gIIHrDLKPeNILld~~g~VKL~DFGlA~~l  493 (721)
                      .+.|++|++- |+.|.- +    .....+++..|+++.+..|.-+..+ .+-||||...||||+ +|+|.|+||-+++.-
T Consensus       299 ~y~yl~~kdh-gt~is~-i----k~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~GnvtLIDfklsRl~  371 (488)
T COG5072         299 LYLYLHFKDH-GTPISI-I----KADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-EGNVTLIDFKLSRLS  371 (488)
T ss_pred             eEEEEEEecC-Cceeee-e----ecccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-cCceEEEEeeeeecc
Confidence            4567778776 555532 1    2345678888999988888777665 689999999999999 999999999999843

>PRK06148 hypothetical protein; Provisional

Probab=95.47  E-value=0.23  Score=62.43  Aligned_cols=30  Identities=43%  Similarity=0.624  Sum_probs=25.8

Q ss_pred             CCeeccCCCCCcEEEcCCC--ceE-EeecCCcc
Q 004959          462 KKTIHRDIKGANLLVDASG--VVK-LADFGMAK  491 (721)
Q Consensus       462 ~gIIHrDLKPeNILld~~g--~VK-L~DFGlA~  491 (721)
                      .++||+|+.+.|||++.++  .+. |+|||.+.
T Consensus       203 ~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~  235 (1013)
T PRK06148        203 AQVIHNDANDYNILVDADDGERISGLIDFGDAV  235 (1013)
T ss_pred             cceECCCCCcccEEEcCCCCcceEEEEECcccc
Confidence            4799999999999998775  565 99999875

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=95.30  E-value=0.1  Score=56.22  Aligned_cols=76  Identities=16%  Similarity=0.173  Sum_probs=47.2

Q ss_pred             eeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCC---CCCeeeeeeeEEecCeEE
Q 004959          342 WQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLK---HPNIVQYYGSEIVEDKFY  418 (721)
Q Consensus       342 y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~---HPnIV~l~g~~~~~~~~y  418 (721)
                      .+..+.|+.|....+|...  .+++.+.||+-...        ....+..|..-|+.|.   --.+.+.+++....+.-|
T Consensus        19 i~~~~~v~GG~i~~a~~~~--~~~~~~FvK~~~~~--------~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~f   88 (288)
T PF03881_consen   19 ITSIEPVSGGDINEAYRLD--TDGGSYFVKVNSES--------GRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAF   88 (288)
T ss_dssp             --EEEEE--SSSSEEEEEE--TTS-EEEEEEEEGG--------GCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCE
T ss_pred             eeeeEecCCCChhheEEEE--CCCccEEEEecChh--------hHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCce
Confidence            3456789999999999987  66889999976411        1236777888777773   345678888877777789


Q ss_pred             EEEeeccCC
Q 004959          419 IYLEYVHPG  427 (721)
Q Consensus       419 LVmEy~~gG  427 (721)
                      |||||++.+
T Consensus        89 Llle~l~~~   97 (288)
T PF03881_consen   89 LLLEFLEMG   97 (288)
T ss_dssp             EEEE-----
T ss_pred             EEEEeecCC
Confidence            999999876

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>PRK11768 serine/threonine protein kinase; Provisional

Probab=94.93  E-value=0.27  Score=53.64  Aligned_cols=28  Identities=21%  Similarity=0.254  Sum_probs=23.8

Q ss_pred             CCeeccCCCCCcEEEcCCCceEEeecCCcc
Q 004959          462 KKTIHRDIKGANLLVDASGVVKLADFGMAK  491 (721)
Q Consensus       462 ~gIIHrDLKPeNILld~~g~VKL~DFGlA~  491 (721)
                      .++||+|+.+.|||++ + .+.|+||+.+.
T Consensus       196 ~~liHgD~h~~NvL~~-d-~~~iIDFDd~~  223 (325)
T PRK11768        196 LLRLHGDCHPGNILWR-D-GPHFVDLDDAR  223 (325)
T ss_pred             ccceecCCCchhcccc-C-CcEEEeCCCCC
Confidence            4789999999999995 4 57899999764

>PTZ00384 choline kinase; Provisional

Probab=94.82  E-value=0.12  Score=57.82  Aligned_cols=81  Identities=16%  Similarity=0.135  Sum_probs=44.7

Q ss_pred             EeeEEeecCCeEEEEEEECCC-CcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCe-eeeeeeEEecCeEEEEE
Q 004959          344 KGKLIGRGTFGSVYVASNRET-GALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNI-VQYYGSEIVEDKFYIYL  421 (721)
Q Consensus       344 ~~k~LG~G~fG~VY~a~~~~t-g~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnI-V~l~g~~~~~~~~yLVm  421 (721)
                      ..+.|..|--..+|++..... +..+.+|.+-... .....+..-.-.+|+++++.|...++ .++++.+.    -++|.
T Consensus        54 ~i~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~-~g~~~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~----~g~l~  128 (383)
T PTZ00384         54 EIKKMNNGITNQVYQATLVDGDKDRYPIKSVCIKK-SSTYNSLVIDNDLQYNIAKLLGDNNFGPKIIGRFG----DFTIQ  128 (383)
T ss_pred             EEEEeCCcccceEEEEEecCCCCCccccceEEEEe-ccCCCceEeccHHHHHHHHHHHhCCCCCeEEEecC----CEEEE
Confidence            344555588899999975432 2233233211000 00111111133578899999875544 45566553    26899


Q ss_pred             eeccCCCH
Q 004959          422 EYVHPGSI  429 (721)
Q Consensus       422 Ey~~gGsL  429 (721)
                      ||++|..|
T Consensus       129 efIeGr~l  136 (383)
T PTZ00384        129 EWVEGNTM  136 (383)
T ss_pred             EEeccccC
Confidence            99998765

>PF02958 EcKinase: Ecdysteroid kinase; InterPro: IPR004119 This family includes proteins of unknown function

Probab=94.36  E-value=0.29  Score=52.04  Aligned_cols=77  Identities=14%  Similarity=0.131  Sum_probs=44.1

Q ss_pred             eecCCeEEEEEEECC----CC----cEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCC-------------CCCeeee
Q 004959          349 GRGTFGSVYVASNRE----TG----ALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLK-------------HPNIVQY  407 (721)
Q Consensus       349 G~G~fG~VY~a~~~~----tg----~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~-------------HPnIV~l  407 (721)
                      |.|-.|.+|++.-.-    ++    ..++||.................+.+|+.+.+.+-             ...+.++
T Consensus         2 Gd~y~s~~~rv~v~~~~~~~~~~~~~s~ivK~~p~~~~~~~~~~~~~~f~~E~~fY~~~~p~l~~~~~~~~~~~~~~P~~   81 (294)
T PF02958_consen    2 GDNYLSDMYRVTVTYELKGDGKNEPLSLIVKSPPTNPSRREFLREMGSFRREIFFYRELLPELEELQKEAGDPFKFFPKC   81 (294)
T ss_pred             CCcceeEEEEEEEEEEEccCCCceEEEEEEEeCCCchhhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHhccccceeeceE
Confidence            677788888875422    22    35777765311111122234566778887766541             1234566


Q ss_pred             eeeEEecCeEEEEEeecc
Q 004959          408 YGSEIVEDKFYIYLEYVH  425 (721)
Q Consensus       408 ~g~~~~~~~~yLVmEy~~  425 (721)
                      +.........+||||-+.
T Consensus        82 ~~~~~~~~~~~lvlEDL~   99 (294)
T PF02958_consen   82 YYADEDPGDEVLVLEDLS   99 (294)
T ss_pred             EEeccCCCceeeehhhhh
Confidence            666555556789998663

All known members of this group are proteins from drosophila and Caenorhabditis elegans.

>KOG1236 consensus Predicted unusual protein kinase [General function prediction only]

Probab=93.96  E-value=0.11  Score=58.14  Aligned_cols=61  Identities=16%  Similarity=0.283  Sum_probs=44.5

Q ss_pred             EEEEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHH-hhCCeeccCCCCCcEEEcCC
Q 004959          417 FYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYL-HSKKTIHRDIKGANLLVDAS  479 (721)
Q Consensus       417 ~yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yL-Hs~gIIHrDLKPeNILld~~  479 (721)
                      ..||=+|+.|..+..++...  ..+|...+.++.-.++||.-+ --.+++|.|+.|.||+|..+
T Consensus       320 ~vl~E~~~~Gl~v~~~v~~~--~~pe~l~kkva~lg~~AllkMl~vDNFvHaDlHPGNVlirf~  381 (565)
T KOG1236|consen  320 LVLVETYERGLSVLRFVKWK--SQPEALVKKVAKLGVNALLKMLIVDNFVHADLHPGNVLIRFN  381 (565)
T ss_pred             ceeeeeccccccHHhhhhcc--cChHHHHHHHHHHHHHHHHHHHHhhcceecccCCCcEEEEec
Confidence            45667899999999988754  455666666666666665443 34589999999999999543

>PTZ00296 choline kinase; Provisional

Probab=93.83  E-value=0.31  Score=55.64  Aligned_cols=76  Identities=13%  Similarity=0.033  Sum_probs=45.5

Q ss_pred             EeeEEeecCCeEEEEEEECC--------CCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCee-eeeeeEEec
Q 004959          344 KGKLIGRGTFGSVYVASNRE--------TGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIV-QYYGSEIVE  414 (721)
Q Consensus       344 ~~k~LG~G~fG~VY~a~~~~--------tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV-~l~g~~~~~  414 (721)
                      ..+.|..|-.-.+|++....        .++.|.+++......      .+-...+|..+++.+..-+|- ++++.+.  
T Consensus       109 ~i~~l~gGlTN~~f~v~~~~~~~~~~~~~~~~~lvRiyG~~te------~lIdR~~E~~v~~~ls~~gi~P~l~~~f~--  180 (442)
T PTZ00296        109 RVNQILSGLTNQLFEVSLKEETANNYPSIRRRVLFRIYGKDVD------ELYNPISEFEVYKTMSKYRIAPQLLNTFS--  180 (442)
T ss_pred             EEEEecCcccCceEEEEecCCCCccccCcCceEEEEecCCCcc------ceeCHHHHHHHHHHHHHCCCCCceEEEeC--
Confidence            55677778888999987542        256788887642111      111335677777777644442 3444432  


Q ss_pred             CeEEEEEeeccCCCH
Q 004959          415 DKFYIYLEYVHPGSI  429 (721)
Q Consensus       415 ~~~yLVmEy~~gGsL  429 (721)
                        -+.|.||++|..|
T Consensus       181 --gg~I~efi~g~~l  193 (442)
T PTZ00296        181 --GGRIEEWLYGDPL  193 (442)
T ss_pred             --CCEEEEeeCCccC
Confidence              3457899987633

>PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length

Probab=93.05  E-value=0.36  Score=50.37  Aligned_cols=85  Identities=22%  Similarity=0.266  Sum_probs=58.5

Q ss_pred             HHHHHHHHHHHhCCCCCeeeeeeeEEecCeEEEEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhh--CCe
Q 004959          387 KQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHS--KKT  464 (721)
Q Consensus       387 k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs--~gI  464 (721)
                      ..+..+..++.++.  .|+++..-  ..-.+-+++|+|-....          +.    ..++.-=+.+|.-.|+  .+.
T Consensus       103 ~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~i----------~~----~N~i~agi~~L~~fH~~~~~~  164 (308)
T PF07387_consen  103 ALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIKI----------NF----SNFITAGIKDLMDFHSENQHC  164 (308)
T ss_pred             hhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCccc----------ch----hHHHHHhHHHHHHhhccCCCe
Confidence            45677888888765  47777632  34457789999953211          00    1111122466777884  369


Q ss_pred             eccCCCCCcEEEcCCCceEEeecCC
Q 004959          465 IHRDIKGANLLVDASGVVKLADFGM  489 (721)
Q Consensus       465 IHrDLKPeNILld~~g~VKL~DFGl  489 (721)
                      +|+|..|+||+-|..|.+||.|=+.
T Consensus       165 lHGD~np~NiM~D~~G~lKlVDP~~  189 (308)
T PF07387_consen  165 LHGDCNPDNIMCDKFGYLKLVDPVC  189 (308)
T ss_pred             ecCCCChhheeecCCCCEEecChhh
Confidence            9999999999999999999999764

The function of this family is unknown.

>COG3001 Uncharacterized protein conserved in bacteria [Function unknown]

Probab=91.64  E-value=0.89  Score=47.75  Aligned_cols=69  Identities=19%  Similarity=0.230  Sum_probs=46.8

Q ss_pred             eEEEEEEECCC-CcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCC---CCeeeeeeeEEecCeEEEEEeeccCCCH
Q 004959          354 GSVYVASNRET-GALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKH---PNIVQYYGSEIVEDKFYIYLEYVHPGSI  429 (721)
Q Consensus       354 G~VY~a~~~~t-g~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~H---PnIV~l~g~~~~~~~~yLVmEy~~gGsL  429 (721)
                      |.|..|....+ ...|.+|+=        .......+..|+.-|+.|.-   -.|.+++.+....+..|+||||++.+.+
T Consensus        27 G~inea~~v~dg~~~~FvK~n--------~~~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~~~~~   98 (286)
T COG3001          27 GDINEAWRLRDGTDPFFVKCN--------QREQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLPTGPL   98 (286)
T ss_pred             ccccceeEeecCCcceEEEec--------chhhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeeccCCCC
Confidence            44555544433 356888852        23445677888877777653   4566778888888999999999987655


Q ss_pred             H
Q 004959          430 N  430 (721)
Q Consensus       430 ~  430 (721)
                      .
T Consensus        99 d   99 (286)
T COG3001          99 D   99 (286)
T ss_pred             C
Confidence            3

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	721
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		4e-45
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		4e-45
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		1e-43
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		3e-43
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		6e-43
3a7f_A	303	Human Mst3 Kinase Length = 303		8e-42
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		8e-42
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		1e-41
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		1e-41
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		1e-41
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		1e-41
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		4e-41
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		5e-41
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		1e-40
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		1e-40
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		9e-40
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		1e-39
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		4e-39
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		6e-39
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		7e-39
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		7e-39
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		1e-38
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		3e-38
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		2e-37
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		2e-35
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		3e-35
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		1e-33
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		1e-33
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		2e-33
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		2e-33
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		2e-33
4fie_A	423	Full-Length Human Pak4 Length = 423		3e-33
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		3e-33
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		5e-33
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		5e-33
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		5e-33
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		6e-33
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		6e-33
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		8e-33
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		9e-33
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		9e-33
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		9e-33
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		9e-33
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		1e-32
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		1e-32
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		1e-32
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		1e-32
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		1e-32
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		1e-32
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		1e-32
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		2e-32
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		2e-32
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		2e-32
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		2e-32
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		2e-32
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		2e-32
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		2e-32
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		2e-32
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		3e-32
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		3e-32
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		4e-32
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		4e-32
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		4e-32
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		4e-32
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		8e-32
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		9e-32
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		2e-31
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		2e-31
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		5e-31
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		6e-31
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-30
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		1e-30
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		1e-30
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-30
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		2e-30
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		6e-30
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		6e-30
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		1e-29
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		2e-29
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		6e-29
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		6e-29
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		6e-29
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		7e-29
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		7e-29
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		8e-29
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		1e-28
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		1e-28
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		1e-28
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		1e-28
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		2e-28
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		2e-28
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-28
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		3e-28
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		3e-28
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		3e-28
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		4e-28
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		4e-28
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		4e-28
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		4e-28
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		5e-28
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		5e-28
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		5e-28
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		6e-28
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		6e-28
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		6e-28
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		6e-28
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		8e-28
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		8e-28
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		9e-28
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		1e-27
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		1e-27
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		1e-27
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		1e-27
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		1e-27
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		1e-27
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		1e-27
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		1e-27
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		1e-27
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		1e-27
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		1e-27
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		1e-27
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		2e-27
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		2e-27
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		2e-27
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		2e-27
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		2e-27
3g51_A	325	Structural Diversity Of The Active Conformation Of		3e-27
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		3e-27
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		3e-27
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		3e-27
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		3e-27
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		3e-27
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		3e-27
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		3e-27
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		3e-27
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		4e-27
4ae6_A	343	Structure And Function Of The Human Sperm-specific		5e-27
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		6e-27
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		6e-27
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		6e-27
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		6e-27
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		7e-27
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		7e-27
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		7e-27
4ae9_A	343	Structure And Function Of The Human Sperm-specific		8e-27
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		8e-27
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		9e-27
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		1e-26
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		1e-26
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		1e-26
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		1e-26
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		1e-26
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		1e-26
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		1e-26
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		1e-26
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		1e-26
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		1e-26
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		2e-26
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		2e-26
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		2e-26
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		2e-26
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		2e-26
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		2e-26
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		2e-26
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		2e-26
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		2e-26
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		2e-26
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		2e-26
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		2e-26
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		2e-26
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		2e-26
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		2e-26
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		2e-26
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		2e-26
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		3e-26
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		3e-26
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		3e-26
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		3e-26
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		3e-26
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		3e-26
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		3e-26
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		3e-26
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		4e-26
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		4e-26
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		4e-26
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		5e-26
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		5e-26
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		5e-26
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		5e-26
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		6e-26
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		8e-26
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		8e-26
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		8e-26
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		1e-25
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		1e-25
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		1e-25
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		1e-25
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		1e-25
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		1e-25
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		1e-25
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		1e-25
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		1e-25
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		2e-25
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		2e-25
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		2e-25
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		3e-25
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		4e-25
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		5e-25
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		7e-25
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		8e-25
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		9e-25
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		9e-25
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		9e-25
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		9e-25
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		9e-25
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		1e-24
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		1e-24
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		1e-24
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		1e-24
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		1e-24
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		1e-24
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		1e-24
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		1e-24
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		1e-24
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		1e-24
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		1e-24
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		2e-24
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		2e-24
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		2e-24
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		2e-24
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		2e-24
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		2e-24
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		2e-24
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		2e-24
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		2e-24
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		2e-24
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		2e-24
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		2e-24
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		2e-24
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		2e-24
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		2e-24
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		2e-24
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		2e-24
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		2e-24
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		3e-24
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		3e-24
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		3e-24
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		3e-24
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		3e-24
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		3e-24
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		3e-24
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		3e-24
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		3e-24
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		4e-24
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		4e-24
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		4e-24
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		5e-24
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		5e-24
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		5e-24
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		5e-24
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		5e-24
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		5e-24
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		5e-24
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		8e-24
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		9e-24
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-23
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		1e-23
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		1e-23
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		1e-23
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		1e-23
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		1e-23
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		1e-23
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		1e-23
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		1e-23
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		2e-23
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		2e-23
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		2e-23
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		2e-23
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		2e-23
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		2e-23
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		2e-23
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		2e-23
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		2e-23
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		2e-23
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		2e-23
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		3e-23
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		3e-23
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		3e-23
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		3e-23
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		3e-23
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		4e-23
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		4e-23
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		4e-23
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		4e-23
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		4e-23
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		4e-23
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		5e-23
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		5e-23
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		5e-23
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		5e-23
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		5e-23
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		5e-23
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		5e-23
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		5e-23
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		6e-23
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		6e-23
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		7e-23
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		7e-23
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		7e-23
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		7e-23
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		7e-23
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		7e-23
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		7e-23
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		7e-23
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		7e-23
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		8e-23
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		8e-23
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		8e-23
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		9e-23
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		9e-23
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		1e-22
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		1e-22
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		1e-22
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		1e-22
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		1e-22
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		1e-22
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		1e-22
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		2e-22
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		2e-22
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		2e-22
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		2e-22
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		2e-22
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		2e-22
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		2e-22
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		2e-22
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		2e-22
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		2e-22
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		2e-22
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		2e-22
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		2e-22
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		2e-22
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		2e-22
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		2e-22
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		2e-22
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		3e-22
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		3e-22
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		3e-22
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		3e-22
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		3e-22
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		4e-22
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		4e-22
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		4e-22
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		5e-22
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		6e-22
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		7e-22
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		7e-22
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		7e-22
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		7e-22
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		7e-22
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		7e-22
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		8e-22
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		8e-22
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		9e-22
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		9e-22
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		9e-22
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		9e-22
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		9e-22
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		1e-21
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		1e-21
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		1e-21
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		1e-21
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		1e-21
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		1e-21
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		1e-21
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		1e-21
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		1e-21
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		1e-21
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		2e-21
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		2e-21
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		2e-21
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		2e-21
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		2e-21
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		2e-21
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		2e-21
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		2e-21
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		2e-21
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		2e-21
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		2e-21
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		2e-21
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		2e-21
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		2e-21
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		2e-21
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		2e-21
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		2e-21
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		2e-21
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		2e-21
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		2e-21
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		2e-21
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		2e-21
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		2e-21
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		2e-21
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		2e-21
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		2e-21
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		2e-21
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		2e-21
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		2e-21
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		2e-21
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		2e-21
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		2e-21
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		2e-21
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		2e-21
3hec_A	348	P38 In Complex With Imatinib Length = 348		2e-21
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		2e-21
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		2e-21
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		2e-21
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		2e-21
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		2e-21
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		2e-21
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		2e-21
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		2e-21
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		2e-21
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		2e-21
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		2e-21
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		2e-21
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		2e-21
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		2e-21
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		2e-21
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		3e-21
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		3e-21
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		3e-21
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		3e-21
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		3e-21
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		3e-21
2oza_B	366	Structure Of P38alpha Complex Length = 366		3e-21
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		3e-21
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		3e-21
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		3e-21
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		3e-21
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		3e-21
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		3e-21
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		4e-21
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		4e-21
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		4e-21
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		4e-21
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		4e-21
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		5e-21
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		5e-21
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		5e-21
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		7e-21
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		1e-20
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		1e-20
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		1e-20
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		1e-20
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		1e-20
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		1e-20
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		1e-20
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		1e-20
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		1e-20
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		1e-20
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		1e-20
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		1e-20
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		1e-20
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		2e-20
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		2e-20
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		2e-20
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		2e-20
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		2e-20
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		2e-20
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		2e-20
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		2e-20
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		2e-20
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		2e-20
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		3e-20
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		3e-20
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		3e-20
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		3e-20
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		3e-20
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		3e-20
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		3e-20
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		3e-20
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		3e-20
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		3e-20
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		3e-20
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		4e-20
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		4e-20
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		4e-20
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		4e-20
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		4e-20
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		5e-20
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		5e-20
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		7e-20
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		7e-20
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		7e-20
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		7e-20
3kk9_A	282	Camkii Substrate Complex B Length = 282		7e-20
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		7e-20
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		7e-20
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		8e-20
3kk8_A	284	Camkii Substrate Complex A Length = 284		8e-20
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		8e-20
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		8e-20
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		9e-20
2vd5_A	412	Structure Of Human Myotonic Dystrophy Protein Kinas		9e-20
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		9e-20
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		1e-19
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		1e-19
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		1e-19
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		1e-19
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		1e-19
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		1e-19
3soa_A	444	Full-Length Human Camkii Length = 444		2e-19
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		2e-19
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		2e-19
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		2e-19
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		2e-19
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		2e-19
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		2e-19
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		2e-19
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		2e-19
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		2e-19
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		3e-19
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		3e-19
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		3e-19
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		3e-19
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		3e-19
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		3e-19
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		3e-19
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		3e-19
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		3e-19
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		3e-19
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		4e-19
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		4e-19
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		4e-19
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		5e-19
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		5e-19
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		5e-19
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		5e-19
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		5e-19
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		5e-19
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		5e-19
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		6e-19
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		6e-19
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		6e-19
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		6e-19
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		7e-19
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		7e-19
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		8e-19
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		8e-19
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		8e-19
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		9e-19
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		9e-19
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		1e-18
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		1e-18
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		1e-18
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		1e-18
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		1e-18
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		1e-18
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		1e-18
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		1e-18
2wtk_B	373	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		1e-18
4exu_A	371	Mapk13, Inactive Form Length = 371		1e-18
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		2e-18
3gni_B	389	Structure Of Strad And Mo25 Length = 389		2e-18
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		2e-18
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		2e-18
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		2e-18
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		2e-18
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		2e-18
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		2e-18
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		2e-18
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		2e-18
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		3e-18
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		3e-18
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		3e-18
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		3e-18
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		3e-18
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		3e-18
3b2t_A	311	Structure Of Phosphotransferase Length = 311		3e-18
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		3e-18
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-18
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		3e-18
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-18
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		3e-18
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		3e-18
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		3e-18
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		4e-18
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		4e-18
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-18
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		4e-18
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		4e-18
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		5e-18
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		5e-18
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		5e-18
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		5e-18
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		5e-18
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		5e-18
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		5e-18
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		5e-18
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		5e-18
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		6e-18
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		6e-18
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		6e-18
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		6e-18
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		6e-18
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		6e-18
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		6e-18
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		6e-18
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		7e-18
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		7e-18
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		7e-18
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		7e-18
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		7e-18
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		7e-18
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		8e-18
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		8e-18
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		8e-18
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		8e-18
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		9e-18
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		9e-18
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		1e-17
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		1e-17
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		1e-17
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		1e-17
3a4o_X	286	Lyn Kinase Domain Length = 286		1e-17
2pl0_A	289	Lck Bound To Imatinib Length = 289		1e-17
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		1e-17
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-17
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-17
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		1e-17
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		1e-17
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		1e-17
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		1e-17
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		1e-17
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		1e-17
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		1e-17
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		1e-17
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		1e-17
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		2e-17
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		2e-17
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		2e-17
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-17
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-17
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		2e-17
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		2e-17
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-17
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		2e-17
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		2e-17
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		2e-17
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-17
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		2e-17
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		2e-17
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		2e-17
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		3e-17
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-17
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-17
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		3e-17
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		3e-17
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		3e-17
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		3e-17
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		3e-17
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		4e-17
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		4e-17
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		4e-17
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		4e-17
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		4e-17
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		4e-17
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		4e-17
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		4e-17
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		4e-17
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		4e-17
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		4e-17
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		4e-17
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		5e-17
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		5e-17
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		5e-17
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		6e-17
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		6e-17
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		6e-17
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		6e-17
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		8e-17
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		8e-17
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		8e-17
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		8e-17
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		8e-17
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		8e-17
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		8e-17
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		8e-17
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		9e-17
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		9e-17
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		9e-17
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		9e-17
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-16
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		1e-16
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		1e-16
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		1e-16
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		1e-16
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		1e-16
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		1e-16
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		1e-16
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		1e-16
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		1e-16
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		1e-16
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		1e-16
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		1e-16
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		1e-16
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		1e-16
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		1e-16
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		1e-16
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		1e-16
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		1e-16
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		1e-16
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		1e-16
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		1e-16
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		1e-16
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		1e-16
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-16
2zmd_A	390	Crystal Structure Of Human Mps1 Catalytic Domain T6		2e-16
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		2e-16
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		2e-16
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		2e-16
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		2e-16
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		2e-16
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		2e-16
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		2e-16
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		2e-16
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		2e-16
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		2e-16
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		2e-16
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		2e-16
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		2e-16
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		2e-16
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		2e-16
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		2e-16
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		2e-16
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		2e-16
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		3e-16
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		3e-16
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		3e-16
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		3e-16
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		3e-16
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		4e-16
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		4e-16
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		4e-16
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		4e-16
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		4e-16
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		4e-16
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		4e-16
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		4e-16
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		4e-16
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		5e-16
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		5e-16
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		5e-16
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		5e-16
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		5e-16
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		6e-16
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		6e-16
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		6e-16
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		6e-16
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		6e-16
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		6e-16
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		6e-16
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		6e-16
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		6e-16
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		6e-16
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		6e-16
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		6e-16
4h58_A	275	Braf In Complex With Compound 3 Length = 275		7e-16
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		7e-16
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		7e-16
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		7e-16
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		7e-16
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		7e-16
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		7e-16
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		8e-16
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		1e-15
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		1e-15
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		1e-15
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		1e-15
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-15
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-15
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		1e-15
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		1e-15
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		1e-15
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		1e-15
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		1e-15
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		1e-15
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		1e-15
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		1e-15
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		1e-15
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		1e-15
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		1e-15
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		1e-15
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		2e-15
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		2e-15
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		2e-15
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-15
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		2e-15
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		2e-15
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		2e-15
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		2e-15
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		2e-15
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		2e-15
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		2e-15
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		2e-15
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		2e-15
3eb0_A	383	Crystal Structure Of Cgd4_240 From Cryptosporidium		2e-15
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-15
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		2e-15
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		2e-15
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-15
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		2e-15
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		3e-15
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		3e-15
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		3e-15
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		3e-15
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		3e-15
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		3e-15
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		3e-15
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		3e-15
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		3e-15
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		3e-15
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		3e-15
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		3e-15
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		3e-15
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		4e-15
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		4e-15
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		4e-15
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		4e-15
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		4e-15
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		5e-15
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		5e-15
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		5e-15
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		6e-15
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		6e-15
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		6e-15
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		6e-15
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		6e-15
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		6e-15
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		6e-15
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		6e-15
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		6e-15
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		7e-15
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		7e-15
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		7e-15
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		7e-15
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		7e-15
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		7e-15
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		7e-15
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		7e-15
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		7e-15
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		7e-15
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		7e-15
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		7e-15
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		7e-15
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		7e-15
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		7e-15
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		8e-15
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		8e-15
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		8e-15
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		8e-15
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		8e-15
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		8e-15
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		9e-15
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		9e-15
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		9e-15
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		9e-15
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		9e-15
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		9e-15
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		9e-15
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		9e-15
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		1e-14
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		1e-14
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		1e-14
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		1e-14
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		1e-14
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		1e-14
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		1e-14
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		1e-14
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		1e-14
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		1e-14
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		1e-14
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		1e-14
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		2e-14
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		2e-14
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		2e-14
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		2e-14
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		2e-14
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		3e-14
3lj0_A	434	Ire1 Complexed With Adp And Quercetin Length = 434		3e-14
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		3e-14
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		4e-14
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		5e-14
1fvr_A	327	Tie2 Kinase Domain Length = 327		5e-14
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		6e-14
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		6e-14
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		8e-14
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		8e-14
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		8e-14
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		9e-14
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		9e-14
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		1e-13
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		1e-13
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		1e-13
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		1e-13
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		1e-13
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		1e-13
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		1e-13
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		1e-13
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		2e-13
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-13
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		2e-13
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		2e-13
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		2e-13
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		3e-13
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		3e-13
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		3e-13
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		4e-13
4alu_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		5e-13
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		6e-13
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		6e-13
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		8e-13
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		8e-13
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		8e-13
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		8e-13
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		1e-12
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		1e-12
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		1e-12
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		2e-12
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-12
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		2e-12
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		2e-12
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		2e-12
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		3e-12
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		3e-12
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		3e-12
3kvw_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		3e-12
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		3e-12
4azf_A	417	Human Dyrk2 In Complex With Leucettine L41 Length =		4e-12
3k2l_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		4e-12
4fl3_A	635	Structural And Biophysical Characterization Of The		6e-12
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		7e-12
4fl2_A	636	Structural And Biophysical Characterization Of The		7e-12
3anq_A	368	Human Dyrk1aINHIBITOR COMPLEX Length = 368		8e-12
2vx3_A	382	Crystal Structure Of The Human Dual Specificity Tyr		8e-12
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		9e-12
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		9e-12
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		1e-11
4aze_A	382	Human Dyrk1a In Complex With Leucettine L41 Length		1e-11
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		1e-11
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		1e-11
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		1e-11
1kwp_A	400	Crystal Structure Of Mapkap2 Length = 400		1e-11
1na7_A	329	Crystal Structure Of The Catalytic Subunit Of Human		1e-11
3r2b_A	318	Mk2 Kinase Bound To Compound 5b Length = 318		1e-11
3r2y_A	319	Mk2 Kinase Bound To Compound 1 Length = 319		1e-11
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		1e-11
3gok_A	334	Binding Site Mapping Of Protein Ligands Length = 33		1e-11
2oza_A	356	Structure Of P38alpha Complex Length = 356		1e-11
2onl_C	406	Crystal Structure Of The P38a-Mapkap Kinase 2 Heter		2e-11
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		2e-11
2p3g_X	327	Crystal Structure Of A Pyrrolopyridine Inhibitor Bo		2e-11
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		2e-11
3ka0_A	320	Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4		2e-11
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		3e-11
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		3e-11
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		3e-11
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		3e-11
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		4e-11
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		4e-11
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		4e-11
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		4e-11
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		4e-11
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		4e-11
2z2w_A	285	Humand Wee1 Kinase Complexed With Inhibitor Pf03357		4e-11
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		5e-11
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		5e-11
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		5e-11
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		5e-11
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		5e-11
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		6e-11
3bi6_A	287	Wee1 Kinase Complex With Inhibitor Pd352396 Length		1e-10
2in6_A	287	Wee1 Kinase Complex With Inhibitor Pd311839 Length		1e-10
1x8b_A	289	Structure Of Human Wee1a Kinase: Kinase Domain Comp		1e-10
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		1e-10
1nxk_A	400	Crystal Structure Of Staurosporine Bound To Map Kap		1e-10
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		2e-10
1tki_A	321	Autoinhibited Serine Kinase Domain Of The Giant Mus		3e-10
4fvp_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain (		4e-10
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		5e-10
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		6e-10
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		6e-10
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		6e-10
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		7e-10
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		7e-10
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		9e-10
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		9e-10
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		1e-09
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		1e-09
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		1e-09
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		2e-09

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score =  179 bits (455), Expect = 4e-45,   Method: Compositional matrix adjust.
 Identities = 105/270 (38%), Positives = 151/270 (55%), Gaps = 13/270 (4%)
Query: 339 NSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSH 398
           N  W+    +G G FG VY A N+ETGAL A K ++      KS E ++    EI++L+ 
Sbjct: 10  NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIE-----TKSEEELEDYIVEIEILAT 64
Query: 399 LKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAY 458
             HP IV+  G+   + K +I +E+   G+++  + E    +TE  ++   R +L  L +
Sbjct: 65  CDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNF 124
Query: 459 LHSKKTIHRDIKGANLLVDASGVVKLADFGM-AKHL-TGQKADLSMKGSPYWMAPELMMA 516
           LHSK+ IHRD+K  N+L+   G ++LADFG+ AK+L T QK D S  G+PYWMAPE++M 
Sbjct: 125 LHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRD-SFIGTPYWMAPEVVMC 183
Query: 517 VMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTP---AIPDSLS 573
              K    D     DIWSLG T+IEM   +PP  E      + K+ +  P     P   S
Sbjct: 184 ETMKDTPYD--YKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTPSKWS 241
Query: 574 PEGKDFLRCCFQRNPADRPPASLLLEHRFL 603
            E +DFL+    +NP  RP A+ LLEH F+
Sbjct: 242 VEFRDFLKIALDKNPETRPSAAQLLEHPFV 271

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score =  179 bits (455), Expect = 4e-45,   Method: Compositional matrix adjust.
 Identities = 105/270 (38%), Positives = 151/270 (55%), Gaps = 13/270 (4%)
Query: 339 NSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSH 398
           N  W+    +G G FG VY A N+ETGAL A K ++      KS E ++    EI++L+ 
Sbjct: 18  NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIE-----TKSEEELEDYIVEIEILAT 72
Query: 399 LKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAY 458
             HP IV+  G+   + K +I +E+   G+++  + E    +TE  ++   R +L  L +
Sbjct: 73  CDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNF 132
Query: 459 LHSKKTIHRDIKGANLLVDASGVVKLADFGM-AKHL-TGQKADLSMKGSPYWMAPELMMA 516
           LHSK+ IHRD+K  N+L+   G ++LADFG+ AK+L T QK D S  G+PYWMAPE++M 
Sbjct: 133 LHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRD-SFIGTPYWMAPEVVMC 191
Query: 517 VMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTP---AIPDSLS 573
              K    D     DIWSLG T+IEM   +PP  E      + K+ +  P     P   S
Sbjct: 192 ETMKDTPYD--YKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTPSKWS 249
Query: 574 PEGKDFLRCCFQRNPADRPPASLLLEHRFL 603
            E +DFL+    +NP  RP A+ LLEH F+
Sbjct: 250 VEFRDFLKIALDKNPETRPSAAQLLEHPFV 279

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score =  174 bits (442), Expect = 1e-43,   Method: Compositional matrix adjust.
 Identities = 113/271 (41%), Positives = 156/271 (57%), Gaps = 21/271 (7%)
Query: 347 LIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQ-LEQEIKVLSHLKHPNIV 405
           ++G+GT+G VY   +       A+KE+      P+      Q L +EI +  HLKH NIV
Sbjct: 29  VLGKGTYGIVYAGRDLSNQVRIAIKEI------PERDSRYSQPLHEEIALHKHLKHKNIV 82
Query: 406 QYYGSEIVEDKFY-IYLEYVHPGSINKYVREHCGAI--TESVVRNFTRHILSGLAYLHSK 462
           QY GS   E+ F  I++E V  GS++  +R   G +   E  +  +T+ IL GL YLH  
Sbjct: 83  QYLGS-FSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN 141
Query: 463 KTIHRDIKGANLLVDA-SGVVKLADFGMAKHLTG-QKADLSMKGSPYWMAPELMMAVMQK 520
           + +HRDIKG N+L++  SGV+K++DFG +K L G      +  G+  +MAPE    ++ K
Sbjct: 142 QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPE----IIDK 197
Query: 521 GKSSDSALAVDIWSLGCTIIEMYTGKPPWSEY-EGAAAMFKV--MRDTPAIPDSLSPEGK 577
           G       A DIWSLGCTIIEM TGKPP+ E  E  AAMFKV   +  P IP+S+S E K
Sbjct: 198 GPRG-YGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSAEAK 256
Query: 578 DFLRCCFQRNPADRPPASLLLEHRFLKNSQQ 608
            F+  CF+ +P  R  A+ LL   FLK S +
Sbjct: 257 AFILKCFEPDPDKRACANDLLVDEFLKVSSK 287

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score =  173 bits (438), Expect = 3e-43,   Method: Compositional matrix adjust.
 Identities = 112/267 (41%), Positives = 154/267 (57%), Gaps = 21/267 (7%)
Query: 347 LIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQ-LEQEIKVLSHLKHPNIV 405
           ++G+GT+G VY   +       A+KE+      P+      Q L +EI +  HLKH NIV
Sbjct: 15  VLGKGTYGIVYAGRDLSNQVRIAIKEI------PERDSRYSQPLHEEIALHKHLKHKNIV 68
Query: 406 QYYGSEIVEDKFY-IYLEYVHPGSINKYVREHCGAI--TESVVRNFTRHILSGLAYLHSK 462
           QY GS   E+ F  I++E V  GS++  +R   G +   E  +  +T+ IL GL YLH  
Sbjct: 69  QYLGS-FSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN 127
Query: 463 KTIHRDIKGANLLVDA-SGVVKLADFGMAKHLTG-QKADLSMKGSPYWMAPELMMAVMQK 520
           + +HRDIKG N+L++  SGV+K++DFG +K L G      +  G+  +MAPE    ++ K
Sbjct: 128 QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPE----IIDK 183
Query: 521 GKSSDSALAVDIWSLGCTIIEMYTGKPPWSEY-EGAAAMFKV--MRDTPAIPDSLSPEGK 577
           G       A DIWSLGCTIIEM TGKPP+ E  E  AAMFKV   +  P IP+S+S E K
Sbjct: 184 GPRG-YGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSAEAK 242
Query: 578 DFLRCCFQRNPADRPPASLLLEHRFLK 604
            F+  CF+ +P  R  A+ LL   FLK
Sbjct: 243 AFILKCFEPDPDKRACANDLLVDEFLK 269

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score =  172 bits (436), Expect = 6e-43,   Method: Compositional matrix adjust.
 Identities = 91/264 (34%), Positives = 148/264 (56%), Gaps = 18/264 (6%)
Query: 348 IGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQY 407
           +G G++GSVY A ++ETG + A+K+V +  D       ++++ +EI ++     P++V+Y
Sbjct: 37  LGEGSYGSVYKAIHKETGQIVAIKQVPVESD-------LQEIIKEISIMQQCDSPHVVKY 89
Query: 408 YGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHR 467
           YGS       +I +EY   GS++  +R     +TE  +    +  L GL YLH  + IHR
Sbjct: 90  YGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHR 149
Query: 468 DIKGANLLVDASGVVKLADFGMAKHLTGQKADLS-MKGSPYWMAPELMMAVMQKGKSSDS 526
           DIK  N+L++  G  KLADFG+A  LT   A  + + G+P+WMAPE++  +         
Sbjct: 150 DIKAGNILLNTEGHAKLADFGVAGQLTDXMAKRNXVIGTPFWMAPEVIQEI-------GY 202
Query: 527 ALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAI---PDSLSPEGKDFLRCC 583
               DIWSLG T IEM  GKPP+++     A+F +  + P     P+  S    DF++ C
Sbjct: 203 NCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPELWSDNFTDFVKQC 262
Query: 584 FQRNPADRPPASLLLEHRFLKNSQ 607
             ++P  R  A+ LL+H F+++++
Sbjct: 263 LVKSPEQRATATQLLQHPFVRSAK 286

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score =  168 bits (426), Expect = 8e-42,   Method: Compositional matrix adjust.
 Identities = 107/287 (37%), Positives = 163/287 (56%), Gaps = 29/287 (10%)
Query: 329 VAAKPEPLPMNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQ 388
           + A PE L     + K + IG+G+FG V+   +  T  + A+K +D+     ++ + I+ 
Sbjct: 16  LKADPEEL-----FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDL----EEAEDEIED 66
Query: 389 LEQEIKVLSHLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNF 448
           ++QEI VLS    P + +YYGS + + K +I +EY+  GS    +    G + E+ +   
Sbjct: 67  IQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEP--GPLDETQIATI 124
Query: 449 TRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMK----- 503
            R IL GL YLHS+K IHRDIK AN+L+   G VKLADFG+A    GQ  D  +K     
Sbjct: 125 LREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVA----GQLTDTQIKRNXFV 180
Query: 504 GSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMR 563
           G+P+WMAPE++     K  + DS    DIWSLG T IE+  G+PP SE      +F + +
Sbjct: 181 GTPFWMAPEVI-----KQSAYDS--KADIWSLGITAIELARGEPPHSELHPMKVLFLIPK 233
Query: 564 DT-PAIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRF-LKNSQQ 608
           +  P +  + S   K+F+  C  + P+ RP A  LL+H+F L+N+++
Sbjct: 234 NNPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILRNAKK 280

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score =  168 bits (426), Expect = 8e-42,   Method: Compositional matrix adjust.
 Identities = 102/274 (37%), Positives = 147/274 (53%), Gaps = 14/274 (5%)
Query: 342 WQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKH 401
           W+    +G G FG VY A N+ET  L A K +D      KS E ++    EI +L+   H
Sbjct: 39  WEIIGELGDGAFGKVYKAQNKETSVLAAAKVID-----TKSEEELEDYMVEIDILASCDH 93
Query: 402 PNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHS 461
           PNIV+   +   E+  +I +E+   G+++  + E    +TES ++   +  L  L YLH 
Sbjct: 94  PNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHD 153
Query: 462 KKTIHRDIKGANLLVDASGVVKLADFGM-AKHL-TGQKADLSMKGSPYWMAPELMMAVMQ 519
            K IHRD+K  N+L    G +KLADFG+ AK+  T Q+ D S  G+PYWMAPE++M    
Sbjct: 154 NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRD-SFIGTPYWMAPEVVMCETS 212
Query: 520 KGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTP---AIPDSLSPEG 576
           K +  D     D+WSLG T+IEM   +PP  E      + K+ +  P   A P   S   
Sbjct: 213 KDRPYD--YKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNF 270
Query: 577 KDFLRCCFQRNPADRPPASLLLEHRFLK-NSQQP 609
           KDFL+ C ++N   R   S LL+H F+  +S +P
Sbjct: 271 KDFLKKCLEKNVDARWTTSQLLQHPFVTVDSNKP 304

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score =  168 bits (425), Expect = 1e-41,   Method: Compositional matrix adjust.
 Identities = 101/264 (38%), Positives = 154/264 (58%), Gaps = 16/264 (6%)
Query: 348 IGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQY 407
           IG+G+FG V+   +  T  + A+K +D+     ++ + I+ ++QEI VLS    P + +Y
Sbjct: 35  IGKGSFGEVFKGIDNRTQKVVAIKIIDL----EEAEDEIEDIQQEITVLSQCDSPYVTKY 90
Query: 408 YGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHR 467
           YGS + + K +I +EY+  GS    +    G + E+ +    R IL GL YLHS+K IHR
Sbjct: 91  YGSYLKDTKLWIIMEYLGGGSALDLLEP--GPLDETQIATILREILKGLDYLHSEKKIHR 148
Query: 468 DIKGANLLVDASGVVKLADFGMAKHLTG-QKADLSMKGSPYWMAPELMMAVMQKGKSSDS 526
           DIK AN+L+   G VKLADFG+A  LT  Q    +  G+P+WMAPE++     K  + DS
Sbjct: 149 DIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVI-----KQSAYDS 203
Query: 527 ALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDT-PAIPDSLSPEGKDFLRCCFQ 585
               DIWSLG T IE+  G+PP SE      +F + ++  P +  + S   K+F+  C  
Sbjct: 204 --KADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACLN 261
Query: 586 RNPADRPPASLLLEHRF-LKNSQQ 608
           + P+ RP A  LL+H+F L+N+++
Sbjct: 262 KEPSFRPTAKELLKHKFILRNAKK 285

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score =  168 bits (425), Expect = 1e-41,   Method: Compositional matrix adjust.
 Identities = 101/264 (38%), Positives = 154/264 (58%), Gaps = 16/264 (6%)
Query: 348 IGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQY 407
           IG+G+FG V+   +  T  + A+K +D+     ++ + I+ ++QEI VLS    P + +Y
Sbjct: 15  IGKGSFGEVFKGIDNRTQKVVAIKIIDL----EEAEDEIEDIQQEITVLSQCDSPYVTKY 70
Query: 408 YGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHR 467
           YGS + + K +I +EY+  GS    +    G + E+ +    R IL GL YLHS+K IHR
Sbjct: 71  YGSYLKDTKLWIIMEYLGGGSALDLLEP--GPLDETQIATILREILKGLDYLHSEKKIHR 128
Query: 468 DIKGANLLVDASGVVKLADFGMAKHLTG-QKADLSMKGSPYWMAPELMMAVMQKGKSSDS 526
           DIK AN+L+   G VKLADFG+A  LT  Q    +  G+P+WMAPE++     K  + DS
Sbjct: 129 DIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVI-----KQSAYDS 183
Query: 527 ALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDT-PAIPDSLSPEGKDFLRCCFQ 585
               DIWSLG T IE+  G+PP SE      +F + ++  P +  + S   K+F+  C  
Sbjct: 184 --KADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACLN 241
Query: 586 RNPADRPPASLLLEHRF-LKNSQQ 608
           + P+ RP A  LL+H+F L+N+++
Sbjct: 242 KEPSFRPTAKELLKHKFILRNAKK 265

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score =  167 bits (424), Expect = 1e-41,   Method: Compositional matrix adjust.
 Identities = 102/268 (38%), Positives = 155/268 (57%), Gaps = 24/268 (8%)
Query: 348 IGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQY 407
           IG+G+FG V+   +  T  + A+K +D+     ++ + I+ ++QEI VLS    P + +Y
Sbjct: 15  IGKGSFGEVFKGIDNRTQKVVAIKIIDL----EEAEDEIEDIQQEITVLSQCDSPYVTKY 70
Query: 408 YGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHR 467
           YGS + + K +I +EY+  GS    +    G + E+ +    R IL GL YLHS+K IHR
Sbjct: 71  YGSYLKDTKLWIIMEYLGGGSALDLLEP--GPLDETQIATILREILKGLDYLHSEKKIHR 128
Query: 468 DIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMK-----GSPYWMAPELMMAVMQKGK 522
           DIK AN+L+   G VKLADFG+A    GQ  D  +K     G+P+WMAPE++     K  
Sbjct: 129 DIKAANVLLSEHGEVKLADFGVA----GQLTDTQIKRNXFVGTPFWMAPEVI-----KQS 179
Query: 523 SSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDT-PAIPDSLSPEGKDFLR 581
           + DS    DIWSLG T IE+  G+PP SE      +F + ++  P +  + S   K+F+ 
Sbjct: 180 AYDS--KADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVE 237
Query: 582 CCFQRNPADRPPASLLLEHRF-LKNSQQ 608
            C  + P+ RP A  LL+H+F L+N+++
Sbjct: 238 ACLNKEPSFRPTAKELLKHKFILRNAKK 265

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score =  167 bits (424), Expect = 1e-41,   Method: Compositional matrix adjust.
 Identities = 100/274 (36%), Positives = 145/274 (52%), Gaps = 14/274 (5%)
Query: 342 WQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKH 401
           W+    +G G FG VY A N+ET  L A K +D      KS E ++    EI +L+   H
Sbjct: 39  WEIIGELGDGAFGKVYKAQNKETSVLAAAKVID-----TKSEEELEDYMVEIDILASCDH 93
Query: 402 PNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHS 461
           PNIV+   +   E+  +I +E+   G+++  + E    +TES ++   +  L  L YLH 
Sbjct: 94  PNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHD 153
Query: 462 KKTIHRDIKGANLLVDASGVVKLADFGMAKHLTG--QKADLSMKGSPYWMAPELMMAVMQ 519
            K IHRD+K  N+L    G +KLADFG++   T   Q+ D S  G+PYWMAPE++M    
Sbjct: 154 NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRXIQRRD-SFIGTPYWMAPEVVMCETS 212
Query: 520 KGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTP---AIPDSLSPEG 576
           K +  D     D+WSLG T+IEM   +PP  E      + K+ +  P   A P   S   
Sbjct: 213 KDRPYD--YKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNF 270
Query: 577 KDFLRCCFQRNPADRPPASLLLEHRFLK-NSQQP 609
           KDFL+ C ++N   R   S LL+H F+  +S +P
Sbjct: 271 KDFLKKCLEKNVDARWTTSQLLQHPFVTVDSNKP 304

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score =  166 bits (420), Expect = 4e-41,   Method: Compositional matrix adjust.
 Identities = 99/274 (36%), Positives = 145/274 (52%), Gaps = 14/274 (5%)
Query: 342 WQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKH 401
           W+    +G G FG VY A N+ET  L A K +D      KS E ++    EI +L+   H
Sbjct: 39  WEIIGELGDGAFGKVYKAQNKETSVLAAAKVID-----TKSEEELEDYMVEIDILASCDH 93
Query: 402 PNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHS 461
           PNIV+   +   E+  +I +E+   G+++  + E    +TES ++   +  L  L YLH 
Sbjct: 94  PNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHD 153
Query: 462 KKTIHRDIKGANLLVDASGVVKLADFGMAKHLTG--QKADLSMKGSPYWMAPELMMAVMQ 519
            K IHRD+K  N+L    G +KLADFG++   T   Q+ D  + G+PYWMAPE++M    
Sbjct: 154 NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRXIQRRDXFI-GTPYWMAPEVVMCETS 212
Query: 520 KGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTP---AIPDSLSPEG 576
           K +  D     D+WSLG T+IEM   +PP  E      + K+ +  P   A P   S   
Sbjct: 213 KDRPYD--YKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNF 270
Query: 577 KDFLRCCFQRNPADRPPASLLLEHRFLK-NSQQP 609
           KDFL+ C ++N   R   S LL+H F+  +S +P
Sbjct: 271 KDFLKKCLEKNVDARWTTSQLLQHPFVTVDSNKP 304

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score =  166 bits (419), Expect = 5e-41,   Method: Compositional matrix adjust.
 Identities = 96/258 (37%), Positives = 147/258 (56%), Gaps = 15/258 (5%)
Query: 348 IGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQY 407
           IG+G+FG VY   +  T  + A+K +D+     ++ + I+ ++QEI VLS    P I +Y
Sbjct: 27  IGKGSFGEVYKGIDNHTKEVVAIKIIDL----EEAEDEIEDIQQEITVLSQCDSPYITRY 82
Query: 408 YGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHR 467
           +GS +   K +I +EY+  GS    ++   G + E+ +    R IL GL YLHS++ IHR
Sbjct: 83  FGSYLKSTKLWIIMEYLGGGSALDLLKP--GPLEETYIATILREILKGLDYLHSERKIHR 140
Query: 468 DIKGANLLVDASGVVKLADFGMAKHLTGQKADLS-MKGSPYWMAPELMMAVMQKGKSSDS 526
           DIK AN+L+   G VKLADFG+A  LT  +   +   G+P+WMAPE++       K S  
Sbjct: 141 DIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEVI-------KQSAY 193
Query: 527 ALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDT-PAIPDSLSPEGKDFLRCCFQ 585
               DIWSLG T IE+  G+PP S+      +F + +++ P +    S   K+F+  C  
Sbjct: 194 DFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPPTLEGQHSKPFKEFVEACLN 253
Query: 586 RNPADRPPASLLLEHRFL 603
           ++P  RP A  LL+H+F+
Sbjct: 254 KDPRFRPTAKELLKHKFI 271

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score =  164 bits (416), Expect = 1e-40,   Method: Compositional matrix adjust.
 Identities = 104/281 (37%), Positives = 157/281 (55%), Gaps = 21/281 (7%)
Query: 331 AKPEPLPMNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLE 390
           A PE L     + K + IG+G+FG V+   +  T  + A+K +D+     ++ + I+ ++
Sbjct: 19  ADPEEL-----FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDL----EEAEDEIEDIQ 69
Query: 391 QEIKVLSHLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTR 450
           QEI VLS      + +YYGS +   K +I +EY+  GS    +R   G   E  +    +
Sbjct: 70  QEITVLSQCDSSYVTKYYGSYLKGSKLWIIMEYLGGGSALDLLR--AGPFDEFQIATMLK 127
Query: 451 HILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTG-QKADLSMKGSPYWM 509
            IL GL YLHS+K IHRDIK AN+L+   G VKLADFG+A  LT  Q    +  G+P+WM
Sbjct: 128 EILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWM 187
Query: 510 APELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDT-PAI 568
           APE    V+Q+      A   DIWSLG T IE+  G+PP S+      +F + ++  P +
Sbjct: 188 APE----VIQQSAYDSKA---DIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNPPTL 240
Query: 569 PDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFL-KNSQQ 608
               +   K+F+  C  ++P+ RP A  LL+H+F+ KNS++
Sbjct: 241 VGDFTKSFKEFIDACLNKDPSFRPTAKELLKHKFIVKNSKK 281

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score =  162 bits (409), Expect = 9e-40,   Method: Compositional matrix adjust.
 Identities = 93/266 (34%), Positives = 146/266 (54%), Gaps = 12/266 (4%)
Query: 348 IGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQY 407
           IG G+FG+VY A +     + A+K++       +S E  + + +E++ L  L+HPN +QY
Sbjct: 62  IGHGSFGAVYFARDVRNSEVVAIKKMSY--SGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 119
Query: 408 YGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHR 467
            G  + E   ++ +EY   GS +  +  H   + E  +   T   L GLAYLHS   IHR
Sbjct: 120 RGCYLREHTAWLVMEYC-LGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHR 178
Query: 468 DIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPYWMAPELMMAVMQKGKSSDSA 527
           D+K  N+L+   G+VKL DFG A  +          G+PYWMAPE+++A M +G+     
Sbjct: 179 DVKAGNILLSEPGLVKLGDFGSASIMAPAN---XFVGTPYWMAPEVILA-MDEGQYDGK- 233
Query: 528 LAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMR-DTPAIPDS-LSPEGKDFLRCCFQ 585
             VD+WSLG T IE+   KPP       +A++ + + ++PA+     S   ++F+  C Q
Sbjct: 234 --VDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQ 291
Query: 586 RNPADRPPASLLLEHRFLKNSQQPDV 611
           + P DRP + +LL+HRF+   + P V
Sbjct: 292 KIPQDRPTSEVLLKHRFVLRERPPTV 317

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score =  161 bits (408), Expect = 1e-39,   Method: Compositional matrix adjust.
 Identities = 93/266 (34%), Positives = 146/266 (54%), Gaps = 12/266 (4%)
Query: 348 IGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQY 407
           IG G+FG+VY A +     + A+K++       +S E  + + +E++ L  L+HPN +QY
Sbjct: 23  IGHGSFGAVYFARDVRNSEVVAIKKMSY--SGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 80
Query: 408 YGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHR 467
            G  + E   ++ +EY   GS +  +  H   + E  +   T   L GLAYLHS   IHR
Sbjct: 81  RGCYLREHTAWLVMEYC-LGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHR 139
Query: 468 DIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPYWMAPELMMAVMQKGKSSDSA 527
           D+K  N+L+   G+VKL DFG A  +          G+PYWMAPE+++A M +G+     
Sbjct: 140 DVKAGNILLSEPGLVKLGDFGSASIMAPAN---XFVGTPYWMAPEVILA-MDEGQYDGK- 194
Query: 528 LAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMR-DTPAIPDS-LSPEGKDFLRCCFQ 585
             VD+WSLG T IE+   KPP       +A++ + + ++PA+     S   ++F+  C Q
Sbjct: 195 --VDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQ 252
Query: 586 RNPADRPPASLLLEHRFLKNSQQPDV 611
           + P DRP + +LL+HRF+   + P V
Sbjct: 253 KIPQDRPTSEVLLKHRFVLRERPPTV 278

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score =  159 bits (403), Expect = 4e-39,   Method: Compositional matrix adjust.
 Identities = 98/261 (37%), Positives = 142/261 (54%), Gaps = 18/261 (6%)
Query: 348 IGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQY 407
           IG+G  G+VY A +  TG   A++++++    PK    I     EI V+   K+PNIV Y
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNL-QQQPKKELIIN----EILVMRENKNPNIVNY 82
Query: 408 YGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHR 467
             S +V D+ ++ +EY+  GS+   V E C  + E  +    R  L  L +LHS + IHR
Sbjct: 83  LDSYLVGDELWVVMEYLAGGSLTDVVTETC--MDEGQIAAVCRECLQALEFLHSNQVIHR 140
Query: 468 DIKGANLLVDASGVVKLADFGMAKHLTGQKADLS-MKGSPYWMAPELMMAVMQKGKSSDS 526
           DIK  N+L+   G VKL DFG    +T +++  S M G+PYWMAPE+   V +K      
Sbjct: 141 DIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSXMVGTPYWMAPEV---VTRKAYGP-- 195
Query: 527 ALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRD-TPAI--PDSLSPEGKDFLRCC 583
              VDIWSLG   IEM  G+PP+       A++ +  + TP +  P+ LS   +DFL  C
Sbjct: 196 --KVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRC 253
Query: 584 FQRNPADRPPASLLLEHRFLK 604
            + +   R  A  LL+H+FLK
Sbjct: 254 LEMDVEKRGSAKELLQHQFLK 274

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score =  159 bits (401), Expect = 6e-39,   Method: Compositional matrix adjust.
 Identities = 98/261 (37%), Positives = 141/261 (54%), Gaps = 18/261 (6%)
Query: 348 IGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQY 407
           IG+G  G+VY A +  TG   A++++++    PK    I     EI V+   K+PNIV Y
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNL-QQQPKKELIIN----EILVMRENKNPNIVNY 82
Query: 408 YGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHR 467
             S +V D+ ++ +EY+  GS+   V E C  + E  +    R  L  L +LHS + IHR
Sbjct: 83  LDSYLVGDELWVVMEYLAGGSLTDVVTETC--MDEGQIAAVCRECLQALEFLHSNQVIHR 140
Query: 468 DIKGANLLVDASGVVKLADFGMAKHLTGQKADLS-MKGSPYWMAPELMMAVMQKGKSSDS 526
           DIK  N+L+   G VKL DFG    +T +++  S M G+PYWMAPE+   V +K      
Sbjct: 141 DIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEV---VTRKAYGP-- 195
Query: 527 ALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRD-TPAI--PDSLSPEGKDFLRCC 583
              VDIWSLG   IEM  G+PP+       A++ +  + TP +  P+ LS   +DFL  C
Sbjct: 196 --KVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRC 253
Query: 584 FQRNPADRPPASLLLEHRFLK 604
              +   R  A  LL+H+FLK
Sbjct: 254 LDMDVEKRGSAKELLQHQFLK 274

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score =  159 bits (401), Expect = 7e-39,   Method: Compositional matrix adjust.
 Identities = 98/261 (37%), Positives = 141/261 (54%), Gaps = 18/261 (6%)
Query: 348 IGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQY 407
           IG+G  G+VY A +  TG   A++++++    PK    I     EI V+   K+PNIV Y
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNL-QQQPKKELIIN----EILVMRENKNPNIVNY 82
Query: 408 YGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHR 467
             S +V D+ ++ +EY+  GS+   V E C  + E  +    R  L  L +LHS + IHR
Sbjct: 83  LDSYLVGDELWVVMEYLAGGSLTDVVTETC--MDEGQIAAVCRECLQALEFLHSNQVIHR 140
Query: 468 DIKGANLLVDASGVVKLADFGMAKHLTGQKADLS-MKGSPYWMAPELMMAVMQKGKSSDS 526
           DIK  N+L+   G VKL DFG    +T +++  S M G+PYWMAPE+   V +K      
Sbjct: 141 DIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSEMVGTPYWMAPEV---VTRKAYGP-- 195
Query: 527 ALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRD-TPAI--PDSLSPEGKDFLRCC 583
              VDIWSLG   IEM  G+PP+       A++ +  + TP +  P+ LS   +DFL  C
Sbjct: 196 --KVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRC 253
Query: 584 FQRNPADRPPASLLLEHRFLK 604
              +   R  A  LL+H+FLK
Sbjct: 254 LDMDVEKRGSAKELLQHQFLK 274

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score =  159 bits (401), Expect = 7e-39,   Method: Compositional matrix adjust.
 Identities = 97/261 (37%), Positives = 142/261 (54%), Gaps = 18/261 (6%)
Query: 348 IGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQY 407
           IG+G  G+VY A +  TG   A++++++    PK    I     EI V+   K+PNIV Y
Sbjct: 29  IGQGASGTVYTAMDVATGQEVAIRQMNL-QQQPKKELIIN----EILVMRENKNPNIVNY 83
Query: 408 YGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHR 467
             S +V D+ ++ +EY+  GS+   V E C  + E  +    R  L  L +LHS + IHR
Sbjct: 84  LDSYLVGDELWVVMEYLAGGSLTDVVTETC--MDEGQIAAVCRECLQALEFLHSNQVIHR 141
Query: 468 DIKGANLLVDASGVVKLADFGMAKHLTGQKADLS-MKGSPYWMAPELMMAVMQKGKSSDS 526
           DIK  N+L+   G VKL DFG    +T +++  S M G+PYWMAPE+   V +K      
Sbjct: 142 DIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSXMVGTPYWMAPEV---VTRKAYGP-- 196
Query: 527 ALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRD-TPAI--PDSLSPEGKDFLRCC 583
              VDIWSLG   IEM  G+PP+       A++ +  + TP +  P+ LS   +DFL  C
Sbjct: 197 --KVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRC 254
Query: 584 FQRNPADRPPASLLLEHRFLK 604
            + +   R  A  L++H+FLK
Sbjct: 255 LEMDVEKRGSAKELIQHQFLK 275

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score =  158 bits (399), Expect = 1e-38,   Method: Compositional matrix adjust.
 Identities = 87/265 (32%), Positives = 144/265 (54%), Gaps = 14/265 (5%)
Query: 342 WQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKH 401
           ++ G L+G+G+F  VY A +  TG   A+K +D        A  +++++ E+K+   LKH
Sbjct: 13  FKVGNLLGKGSFAGVYRAESIHTGLEVAIKMID--KKAMYKAGMVQRVQNEVKIHCQLKH 70
Query: 402 PNIVQYYGSEIVEDKFYIYL--EYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYL 459
           P+I++ Y     ED  Y+YL  E  H G +N+Y++      +E+  R+F   I++G+ YL
Sbjct: 71  PSILELYN--YFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYL 128
Query: 460 HSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTG-QKADLSMKGSPYWMAPELMMAVM 518
           HS   +HRD+  +NLL+  +  +K+ADFG+A  L    +   ++ G+P +++PE+     
Sbjct: 129 HSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYISPEI----- 183
Query: 519 QKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDSLSPEGKD 578
                S   L  D+WSLGC    +  G+PP+        + KV+     +P  LS E KD
Sbjct: 184 --ATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMPSFLSIEAKD 241
Query: 579 FLRCCFQRNPADRPPASLLLEHRFL 603
            +    +RNPADR   S +L+H F+
Sbjct: 242 LIHQLLRRNPADRLSLSSVLDHPFM 266

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score =  157 bits (396), Expect = 3e-38,   Method: Compositional matrix adjust.
 Identities = 96/261 (36%), Positives = 142/261 (54%), Gaps = 18/261 (6%)
Query: 348 IGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQY 407
           IG+G  G+VY A +  TG   A++++++    PK    I     EI V+   K+PNIV Y
Sbjct: 29  IGQGASGTVYTAMDVATGQEVAIRQMNL-QQQPKKELIIN----EILVMRENKNPNIVNY 83
Query: 408 YGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHR 467
             S +V D+ ++ +EY+  GS+   V E C  + E  +    R  L  L +LHS + IHR
Sbjct: 84  LDSYLVGDELWVVMEYLAGGSLTDVVTETC--MDEGQIAAVCRECLQALEFLHSNQVIHR 141
Query: 468 DIKGANLLVDASGVVKLADFGMAKHLTGQKADLS-MKGSPYWMAPELMMAVMQKGKSSDS 526
           +IK  N+L+   G VKL DFG    +T +++  S M G+PYWMAPE+   V +K      
Sbjct: 142 NIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEV---VTRKAYGPK- 197
Query: 527 ALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRD-TPAI--PDSLSPEGKDFLRCC 583
              VDIWSLG   IEM  G+PP+       A++ +  + TP +  P+ LS   +DFL  C
Sbjct: 198 ---VDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRC 254
Query: 584 FQRNPADRPPASLLLEHRFLK 604
            + +   R  A  L++H+FLK
Sbjct: 255 LEMDVEKRGSAKELIQHQFLK 275

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score =  154 bits (389), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 98/306 (32%), Positives = 160/306 (52%), Gaps = 24/306 (7%)
Query: 346 KLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIV 405
           +L+G GT+G VY   + +TG L A+K +D+  D+    E IKQ    +K  SH  H NI 
Sbjct: 30  ELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE---EEEIKQEINMLKKYSH--HRNIA 84
Query: 406 QYYGSEI------VEDKFYIYLEYVHPGSINKYVREHCG-AITESVVRNFTRHILSGLAY 458
            YYG+ I      ++D+ ++ +E+   GS+   ++   G  + E  +    R IL GL++
Sbjct: 85  TYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSH 144
Query: 459 LHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHL---TGQKADLSMKGSPYWMAPELMM 515
           LH  K IHRDIKG N+L+  +  VKL DFG++  L    G++   +  G+PYWMAPE++ 
Sbjct: 145 LHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRN--TFIGTPYWMAPEVIA 202
Query: 516 AVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRD-TPAIPD-SLS 573
                  + D     D+WSLG T IEM  G PP  +     A+F + R+  P +     S
Sbjct: 203 CDENPDATYD--FKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKSKKWS 260
Query: 574 PEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQPDVPSCSLSFSG-MQLTEKPHSPRE 632
            + + F+  C  +N + RP    L++H F+++  QP+     +     +  T+K    ++
Sbjct: 261 KKFQSFIESCLVKNHSQRPATEQLMKHPFIRD--QPNERQVRIQLKDHIDRTKKKRGEKD 318
Query: 633 KADAKY 638
           + + +Y
Sbjct: 319 ETEYEY 324

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score =  147 bits (372), Expect = 2e-35,   Method: Compositional matrix adjust.
 Identities = 92/288 (31%), Positives = 145/288 (50%), Gaps = 33/288 (11%)
Query: 346 KLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIV 405
           ++IG G    V  A         A+K +++     K   S+ +L +EI+ +S   HPNIV
Sbjct: 21  EVIGSGATAVVQAAYCAPKKEKVAIKRINL----EKCQTSMDELLKEIQAMSQCHHPNIV 76
Query: 406 QYYGSEIVEDKFYIYLEYVHPGSINKYVR------EH-CGAITESVVRNFTRHILSGLAY 458
            YY S +V+D+ ++ ++ +  GS+   ++      EH  G + ES +    R +L GL Y
Sbjct: 77  SYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEY 136
Query: 459 LHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHL------TGQKADLSMKGSPYWMAPE 512
           LH    IHRD+K  N+L+   G V++ADFG++  L      T  K   +  G+P WMAPE
Sbjct: 137 LHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPE 196
Query: 513 LMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEY-EGAAAMFKVMRDTPAIP-- 569
               VM++ +  D     DIWS G T IE+ TG  P+ +Y      M  +  D P++   
Sbjct: 197 ----VMEQVRGYD--FKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLETG 250
Query: 570 ----DSLSPEGKDF---LRCCFQRNPADRPPASLLLEHRFLKNSQQPD 610
               + L   GK F   +  C Q++P  RP A+ LL H+F + ++  +
Sbjct: 251 VQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAKNKE 298

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score =  147 bits (370), Expect = 3e-35,   Method: Compositional matrix adjust.
 Identities = 92/285 (32%), Positives = 144/285 (50%), Gaps = 33/285 (11%)
Query: 346 KLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIV 405
           ++IG G    V  A         A+K +++     K   S+ +L +EI+ +S   HPNIV
Sbjct: 16  EVIGSGATAVVQAAYCAPKKEKVAIKRINL----EKCQTSMDELLKEIQAMSQCHHPNIV 71
Query: 406 QYYGSEIVEDKFYIYLEYVHPGSINKYVR------EH-CGAITESVVRNFTRHILSGLAY 458
            YY S +V+D+ ++ ++ +  GS+   ++      EH  G + ES +    R +L GL Y
Sbjct: 72  SYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEY 131
Query: 459 LHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHL------TGQKADLSMKGSPYWMAPE 512
           LH    IHRD+K  N+L+   G V++ADFG++  L      T  K   +  G+P WMAPE
Sbjct: 132 LHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPE 191
Query: 513 LMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEY-EGAAAMFKVMRDTPAIP-- 569
               VM++ +  D     DIWS G T IE+ TG  P+ +Y      M  +  D P++   
Sbjct: 192 ----VMEQVRGYD--FKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLETG 245
Query: 570 ----DSLSPEGKDF---LRCCFQRNPADRPPASLLLEHRFLKNSQ 607
               + L   GK F   +  C Q++P  RP A+ LL H+F + ++
Sbjct: 246 VQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAK 290

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score =  141 bits (355), Expect = 1e-33,   Method: Compositional matrix adjust.
 Identities = 82/266 (30%), Positives = 141/266 (53%), Gaps = 12/266 (4%)
Query: 345 GKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNI 404
           G+ +G+G FG+VY+A  +++  + A+K   +F    + A    QL +E+++ SHL+HPNI
Sbjct: 39  GRPLGKGKFGNVYLAREKQSKFILALKV--LFKAQLEKAGVEHQLRREVEIQSHLRHPNI 96
Query: 405 VQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKT 464
           ++ YG      + Y+ LEY   G++ + +++      E     +   + + L+Y HSK+ 
Sbjct: 97  LRLYGYFHDATRVYLILEYAPLGTVYRELQK-LSKFDEQRTATYITELANALSYCHSKRV 155
Query: 465 IHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPYWMAPELMMAVMQKGKSS 524
           IHRDIK  NLL+ ++G +K+ADFG + H    + D  + G+  ++ PE++   M   K  
Sbjct: 156 IHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRD-DLCGTLDYLPPEMIEGRMHDEK-- 212
Query: 525 DSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDSLSPEGKDFLRCCF 584
                VD+WSLG    E   GKPP+          ++ R     PD ++   +D +    
Sbjct: 213 -----VDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLL 267
Query: 585 QRNPADRPPASLLLEHRFLK-NSQQP 609
           + NP+ RP    +LEH ++  NS +P
Sbjct: 268 KHNPSQRPMLREVLEHPWITANSSKP 293

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score =  141 bits (355), Expect = 1e-33,   Method: Compositional matrix adjust.
 Identities = 86/279 (30%), Positives = 147/279 (52%), Gaps = 19/279 (6%)
Query: 338 MNSQW-----QKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQE 392
           M  QW     + G+ +G+G FG+VY+A  +++  + A+K   +F    + A    QL +E
Sbjct: 1   MKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKV--LFKAQLEKAGVEHQLRRE 58
Query: 393 IKVLSHLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHI 452
           +++ SHL+HPNI++ YG      + Y+ LEY   G++ + +++      E     +   +
Sbjct: 59  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK-LSKFDEQRTATYITEL 117
Query: 453 LSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHL-TGQKADLSMKGSPYWMAP 511
            + L+Y HSK+ IHRDIK  NLL+ ++G +K+ADFG + H  + ++ DL   G+  ++ P
Sbjct: 118 ANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLC--GTLDYLPP 175
Query: 512 ELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDS 571
           E++   M   K       VD+WSLG    E   GKPP+          ++ R     PD 
Sbjct: 176 EMIEGRMHDEK-------VDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDF 228
Query: 572 LSPEGKDFLRCCFQRNPADRPPASLLLEHRFLK-NSQQP 609
           ++   +D +    + NP+ RP    +LEH ++  NS +P
Sbjct: 229 VTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKP 267

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score =  140 bits (354), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 82/269 (30%), Positives = 144/269 (53%), Gaps = 12/269 (4%)
Query: 342 WQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKH 401
           ++ G+ +G+G FG+VY+A  +++  + A+K   +F    + A    QL +E+++ SHL+H
Sbjct: 11  FEIGRPLGKGKFGNVYLAREKQSKFILALKV--LFKAQLEKAGVEHQLRREVEIQSHLRH 68
Query: 402 PNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHS 461
           PNI++ YG      + Y+ LEY   G++ + +++      E     +   + + L+Y HS
Sbjct: 69  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQK-LSKFDEQRTATYITELANALSYCHS 127
Query: 462 KKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPYWMAPELMMAVMQKG 521
           K+ IHRDIK  NLL+ ++G +K+ADFG + H    + D ++ G+  ++ PE++   M   
Sbjct: 128 KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRD-TLCGTLDYLPPEMIEGRMHDE 186
Query: 522 KSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDSLSPEGKDFLR 581
           K       VD+WSLG    E   GKPP+          ++ R     PD ++   +D + 
Sbjct: 187 K-------VDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLIS 239
Query: 582 CCFQRNPADRPPASLLLEHRFLK-NSQQP 609
              + NP+ RP    +LEH ++  NS +P
Sbjct: 240 RLLKHNPSQRPMLREVLEHPWITANSSKP 268

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score =  140 bits (354), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 89/272 (32%), Positives = 144/272 (52%), Gaps = 23/272 (8%)
Query: 348 IGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQY 407
           IG G+ G V +A  + +G   A+K +D+     +  +  + L  E+ ++   +H N+V+ 
Sbjct: 53  IGEGSTGIVCLAREKHSGRQVAVKMMDL-----RKQQRRELLFNEVVIMRDYQHFNVVEM 107
Query: 408 YGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHR 467
           Y S +V ++ ++ +E++  G++   V +    + E  +      +L  LAYLH++  IHR
Sbjct: 108 YKSYLVGEELWVLMEFLQGGALTDIVSQ--VRLNEEQIATVCEAVLQALAYLHAQGVIHR 165
Query: 468 DIKGANLLVDASGVVKLADFGMAKHLTGQKADLS-MKGSPYWMAPELMMAVMQKGKSSDS 526
           DIK  ++L+   G VKL+DFG    ++        + G+PYWMAPE++         S  
Sbjct: 166 DIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKXLVGTPYWMAPEVI-------SRSLY 218
Query: 527 ALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDT--PAIPDS--LSPEGKDFLRC 582
           A  VDIWSLG  +IEM  G+PP+       AM K +RD+  P + +S  +SP  +DFL  
Sbjct: 219 ATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAM-KRLRDSPPPKLKNSHKVSPVLRDFLER 277
Query: 583 CFQRNPADRPPASLLLEHRFLKNSQQPDVPSC 614
              R+P +R  A  LL+H FL    Q  +P C
Sbjct: 278 MLVRDPQERATAQELLDHPFLL---QTGLPEC 306

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score =  140 bits (353), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 86/280 (30%), Positives = 147/280 (52%), Gaps = 18/280 (6%)
Query: 337 PMNS-QW-----QKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLE 390
           P+ S QW     + G+ +G+G FG+VY+A  +++  + A+K   +F    + A    QL 
Sbjct: 2   PLGSRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKV--LFKAQLEKAGVEHQLR 59
Query: 391 QEIKVLSHLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTR 450
           +E+++ SHL+HPNI++ YG      + Y+ LEY   G++ + +++      E     +  
Sbjct: 60  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK-LSKFDEQRTATYIT 118
Query: 451 HILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPYWMA 510
            + + L+Y HSK+ IHRDIK  NLL+ ++G +K+ADFG + H    + D  + G+  ++ 
Sbjct: 119 ELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRD-DLCGTLDYLP 177
Query: 511 PELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPD 570
           PE++   M   K       VD+WSLG    E   GKPP+          ++ R     PD
Sbjct: 178 PEMIEGRMHDEK-------VDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD 230
Query: 571 SLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLK-NSQQP 609
            ++   +D +    + NP+ RP    +LEH ++  NS +P
Sbjct: 231 FVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKP 270

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score =  140 bits (352), Expect = 3e-33,   Method: Compositional matrix adjust.
 Identities = 87/267 (32%), Positives = 142/267 (53%), Gaps = 20/267 (7%)
Query: 348 IGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQY 407
           IG G+ G V +A+ R +G L A+K++D+     +  +  + L  E+ ++   +H N+V+ 
Sbjct: 159 IGEGSTGIVCIATVRSSGKLVAVKKMDL-----RKQQRRELLFNEVVIMRDYQHENVVEM 213
Query: 408 YGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHR 467
           Y S +V D+ ++ +E++  G++   V      + E  +      +L  L+ LH++  IHR
Sbjct: 214 YNSYLVGDELWVVMEFLEGGALTDIVTH--TRMNEEQIAAVCLAVLQALSVLHAQGVIHR 271
Query: 468 DIKGANLLVDASGVVKLADFGMAKHLTGQKADLS-MKGSPYWMAPELMMAVMQKGKSSDS 526
           DIK  ++L+   G VKL+DFG    ++ +      + G+PYWMAPEL+  +         
Sbjct: 272 DIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRL-------PY 324
Query: 527 ALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDT--PAIPD--SLSPEGKDFLRC 582
              VDIWSLG  +IEM  G+PP+       AM K++RD   P + +   +SP  K FL  
Sbjct: 325 GPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAM-KMIRDNLPPRLKNLHKVSPSLKGFLDR 383
Query: 583 CFQRNPADRPPASLLLEHRFLKNSQQP 609
              R+PA R  A+ LL+H FL  +  P
Sbjct: 384 LLVRDPAQRATAAELLKHPFLAKAGPP 410

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score =  140 bits (352), Expect = 3e-33,   Method: Compositional matrix adjust.
 Identities = 85/281 (30%), Positives = 146/281 (51%), Gaps = 17/281 (6%)
Query: 335 PLPMNSQW-----QKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQL 389
           PL    QW       G+ +G+G FG+VY+A  R++  + A+K   +F    + A    QL
Sbjct: 2   PLGSKRQWTLEDFDIGRPLGKGKFGNVYLARERQSKFILALKV--LFKTQLEKAGVEHQL 59
Query: 390 EQEIKVLSHLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFT 449
            +E+++ SHL+HPNI++ YG      + Y+ LEY   G++ + +++      E     + 
Sbjct: 60  RREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK-LSRFDEQRTATYI 118
Query: 450 RHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPYWM 509
             + + L+Y HSK+ IHRDIK  NLL+ ++G +K+ADFG + H    + D ++ G+  ++
Sbjct: 119 TELANALSYCHSKRVIHRDIKPENLLLGSNGELKIADFGWSVHAPSSRRD-TLCGTLDYL 177
Query: 510 APELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIP 569
            PE++   M   K       VD+WSLG    E   G PP+  +       ++ R     P
Sbjct: 178 PPEMIEGRMHDEK-------VDLWSLGVLCYEFLVGMPPFEAHTYQETYRRISRVEFTFP 230
Query: 570 DSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLK-NSQQP 609
           D ++   +D +    + N + R   + +LEH ++K NS +P
Sbjct: 231 DFVTEGARDLISRLLKHNASQRLTLAEVLEHPWIKANSSKP 271

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score =  139 bits (351), Expect = 5e-33,   Method: Compositional matrix adjust.
 Identities = 83/270 (30%), Positives = 145/270 (53%), Gaps = 14/270 (5%)
Query: 342 WQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKH 401
           ++ G+ +G+G FG+VY+A  +++  + A+K   +F    + A    QL +E+++ SHL+H
Sbjct: 15  FEIGRPLGKGKFGNVYLAREKQSKFILALKV--LFKAQLEKAGVEHQLRREVEIQSHLRH 72
Query: 402 PNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHS 461
           PNI++ YG      + Y+ LEY   G++ + +++      E     +   + + L+Y HS
Sbjct: 73  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQK-LSKFDEQRTATYITELANALSYCHS 131
Query: 462 KKTIHRDIKGANLLVDASGVVKLADFGMAKHL-TGQKADLSMKGSPYWMAPELMMAVMQK 520
           K+ IHRDIK  NLL+ ++G +K+ADFG + H  + ++ DL   G+  ++ PE++   M  
Sbjct: 132 KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLC--GTLDYLPPEMIEGRMHD 189
Query: 521 GKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDSLSPEGKDFL 580
            K       VD+WSLG    E   GKPP+          ++ R     PD ++   +D +
Sbjct: 190 EK-------VDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLI 242
Query: 581 RCCFQRNPADRPPASLLLEHRFLK-NSQQP 609
               + NP+ RP    +LEH ++  NS +P
Sbjct: 243 SRLLKHNPSQRPMLREVLEHPWITANSSKP 272

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score =  139 bits (350), Expect = 5e-33,   Method: Compositional matrix adjust.
 Identities = 83/270 (30%), Positives = 145/270 (53%), Gaps = 14/270 (5%)
Query: 342 WQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKH 401
           ++ G+ +G+G FG+VY+A  +++  + A+K   +F    + A    QL +E+++ SHL+H
Sbjct: 11  FEIGRPLGKGKFGNVYLAREKQSKFILALKV--LFKAQLEKAGVEHQLRREVEIQSHLRH 68
Query: 402 PNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHS 461
           PNI++ YG      + Y+ LEY   G++ + +++      E     +   + + L+Y HS
Sbjct: 69  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQK-LSKFDEQRTATYITELANALSYCHS 127
Query: 462 KKTIHRDIKGANLLVDASGVVKLADFGMAKHL-TGQKADLSMKGSPYWMAPELMMAVMQK 520
           K+ IHRDIK  NLL+ ++G +K+ADFG + H  + ++ DL   G+  ++ PE++   M  
Sbjct: 128 KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLC--GTLDYLPPEMIEGRMHD 185
Query: 521 GKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDSLSPEGKDFL 580
            K       VD+WSLG    E   GKPP+          ++ R     PD ++   +D +
Sbjct: 186 EK-------VDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLI 238
Query: 581 RCCFQRNPADRPPASLLLEHRFLK-NSQQP 609
               + NP+ RP    +LEH ++  NS +P
Sbjct: 239 SRLLKHNPSQRPMLREVLEHPWITANSSKP 268

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score =  139 bits (350), Expect = 5e-33,   Method: Compositional matrix adjust.
 Identities = 83/270 (30%), Positives = 145/270 (53%), Gaps = 14/270 (5%)
Query: 342 WQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKH 401
           ++ G+ +G+G FG+VY+A  +++  + A+K   +F    + A    QL +E+++ SHL+H
Sbjct: 10  FEIGRPLGKGKFGNVYLAREKQSKFILALKV--LFKAQLEKAGVEHQLRREVEIQSHLRH 67
Query: 402 PNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHS 461
           PNI++ YG      + Y+ LEY   G++ + +++      E     +   + + L+Y HS
Sbjct: 68  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQK-LSKFDEQRTATYITELANALSYCHS 126
Query: 462 KKTIHRDIKGANLLVDASGVVKLADFGMAKHL-TGQKADLSMKGSPYWMAPELMMAVMQK 520
           K+ IHRDIK  NLL+ ++G +K+ADFG + H  + ++ DL   G+  ++ PE++   M  
Sbjct: 127 KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLC--GTLDYLPPEMIEGRMHD 184
Query: 521 GKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDSLSPEGKDFL 580
            K       VD+WSLG    E   GKPP+          ++ R     PD ++   +D +
Sbjct: 185 EK-------VDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLI 237
Query: 581 RCCFQRNPADRPPASLLLEHRFLK-NSQQP 609
               + NP+ RP    +LEH ++  NS +P
Sbjct: 238 SRLLKHNPSQRPMLREVLEHPWITANSSKP 267

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score =  139 bits (350), Expect = 6e-33,   Method: Compositional matrix adjust.
 Identities = 81/266 (30%), Positives = 141/266 (53%), Gaps = 12/266 (4%)
Query: 345 GKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNI 404
           G+ +G+G FG+VY+A  +++  + A+K   +F    + A    QL +E+++ SHL+HPNI
Sbjct: 39  GRPLGKGKFGNVYLAREKQSKFILALK--VLFKAQLEKAGVEHQLRREVEIQSHLRHPNI 96
Query: 405 VQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKT 464
           ++ YG      + Y+ LEY   G++ + +++      E     +   + + L+Y HSK+ 
Sbjct: 97  LRLYGYFHDATRVYLILEYAPLGTVYRELQK-LSKFDEQRTATYITELANALSYCHSKRV 155
Query: 465 IHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPYWMAPELMMAVMQKGKSS 524
           IHRDIK  NLL+ ++G +K+ADFG + H    +   ++ G+  ++ PE++   M   K  
Sbjct: 156 IHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT-TLCGTLDYLPPEMIEGRMHDEK-- 212
Query: 525 DSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDSLSPEGKDFLRCCF 584
                VD+WSLG    E   GKPP+          ++ R     PD ++   +D +    
Sbjct: 213 -----VDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLL 267
Query: 585 QRNPADRPPASLLLEHRFLK-NSQQP 609
           + NP+ RP    +LEH ++  NS +P
Sbjct: 268 KHNPSQRPMLREVLEHPWITANSSKP 293

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score =  139 bits (350), Expect = 6e-33,   Method: Compositional matrix adjust.
 Identities = 81/266 (30%), Positives = 141/266 (53%), Gaps = 12/266 (4%)
Query: 345 GKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNI 404
           G+ +G+G FG+VY+A  +++  + A+K   +F    + A    QL +E+++ SHL+HPNI
Sbjct: 14  GRPLGKGKFGNVYLAREKQSKFILALKV--LFKAQLEKAGVEHQLRREVEIQSHLRHPNI 71
Query: 405 VQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKT 464
           ++ YG      + Y+ LEY   G++ + +++      E     +   + + L+Y HSK+ 
Sbjct: 72  LRLYGYFHDATRVYLILEYAPLGTVYRELQK-LSKFDEQRTATYITELANALSYCHSKRV 130
Query: 465 IHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPYWMAPELMMAVMQKGKSS 524
           IHRDIK  NLL+ ++G +K+ADFG + H    +   ++ G+  ++ PE++   M   K  
Sbjct: 131 IHRDIKPENLLLGSAGELKIADFGWSCHAPSSRRT-TLSGTLDYLPPEMIEGRMHDEK-- 187
Query: 525 DSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDSLSPEGKDFLRCCF 584
                VD+WSLG    E   GKPP+          ++ R     PD ++   +D +    
Sbjct: 188 -----VDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLL 242
Query: 585 QRNPADRPPASLLLEHRFLK-NSQQP 609
           + NP+ RP    +LEH ++  NS +P
Sbjct: 243 KHNPSQRPMLREVLEHPWITANSSKP 268

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score =  138 bits (348), Expect = 8e-33,   Method: Compositional matrix adjust.
 Identities = 82/266 (30%), Positives = 139/266 (52%), Gaps = 12/266 (4%)
Query: 345 GKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNI 404
           G+ +G+G FG+VY+A  +++  + A+K   +F    + A    QL +E+++ SHL+HPNI
Sbjct: 18  GRPLGKGKFGNVYLAREKQSKFILALK--VLFKAQLEKAGVEHQLRREVEIQSHLRHPNI 75
Query: 405 VQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKT 464
           ++ YG      + Y+ LEY   G + K +++      E     +   + + L+Y HSK+ 
Sbjct: 76  LRLYGYFHDATRVYLILEYAPRGEVYKELQK-LSKFDEQRTATYITELANALSYCHSKRV 134
Query: 465 IHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPYWMAPELMMAVMQKGKSS 524
           IHRDIK  NLL+ ++G +K+ADFG + H    +    + G+  ++ PE++   M   K  
Sbjct: 135 IHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRX-XLXGTLDYLPPEMIEGRMHDEK-- 191
Query: 525 DSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDSLSPEGKDFLRCCF 584
                VD+WSLG    E   GKPP+          ++ R     PD ++   +D +    
Sbjct: 192 -----VDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLL 246
Query: 585 QRNPADRPPASLLLEHRFLK-NSQQP 609
           + NP+ RP    +LEH ++  NS +P
Sbjct: 247 KHNPSQRPMLREVLEHPWITANSSKP 272

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score =  138 bits (348), Expect = 9e-33,   Method: Compositional matrix adjust.
 Identities = 82/266 (30%), Positives = 140/266 (52%), Gaps = 12/266 (4%)
Query: 345 GKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNI 404
           G+ +G+G FG+VY+A  +++  + A+K   +F    + A    QL +E+++ SHL+HPNI
Sbjct: 18  GRPLGKGKFGNVYLAREKQSKFILALK--VLFKAQLEKAGVEHQLRREVEIQSHLRHPNI 75
Query: 405 VQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKT 464
           ++ YG      + Y+ LEY   G + K +++      E     +   + + L+Y HSK+ 
Sbjct: 76  LRLYGYFHDATRVYLILEYAPRGEVYKELQK-LSKFDEQRTATYITELANALSYCHSKRV 134
Query: 465 IHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPYWMAPELMMAVMQKGKSS 524
           IHRDIK  NLL+ ++G +K+ADFG + H    +   ++ G+  ++ PE++   M   K  
Sbjct: 135 IHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT-TLCGTLDYLPPEMIEGRMHDEK-- 191
Query: 525 DSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDSLSPEGKDFLRCCF 584
                VD+WSLG    E   GKPP+          ++ R     PD ++   +D +    
Sbjct: 192 -----VDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLL 246
Query: 585 QRNPADRPPASLLLEHRFLK-NSQQP 609
           + NP+ RP    +LEH ++  NS +P
Sbjct: 247 KHNPSQRPMLREVLEHPWITANSSKP 272

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score =  138 bits (348), Expect = 9e-33,   Method: Compositional matrix adjust.
 Identities = 81/266 (30%), Positives = 141/266 (53%), Gaps = 12/266 (4%)
Query: 345 GKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNI 404
           G+ +G+G FG+VY+A  +++  + A+K   +F    + A    QL +E+++ SHL+HPNI
Sbjct: 30  GRPLGKGKFGNVYLAREKQSKFILALK--VLFKAQLEKAGVEHQLRREVEIQSHLRHPNI 87
Query: 405 VQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKT 464
           ++ YG      + Y+ LEY   G++ + +++      E     +   + + L+Y HSK+ 
Sbjct: 88  LRLYGYFHDATRVYLILEYAPLGTVYRELQK-LSKFDEQRTATYITELANALSYCHSKRV 146
Query: 465 IHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPYWMAPELMMAVMQKGKSS 524
           IHRDIK  NLL+ ++G +K+ADFG + H    +   ++ G+  ++ PE++   M   K  
Sbjct: 147 IHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT-TLCGTLDYLPPEMIEGRMHDEK-- 203
Query: 525 DSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDSLSPEGKDFLRCCF 584
                VD+WSLG    E   GKPP+          ++ R     PD ++   +D +    
Sbjct: 204 -----VDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLL 258
Query: 585 QRNPADRPPASLLLEHRFLK-NSQQP 609
           + NP+ RP    +LEH ++  NS +P
Sbjct: 259 KHNPSQRPMLREVLEHPWITANSSKP 284

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score =  138 bits (348), Expect = 9e-33,   Method: Compositional matrix adjust.
 Identities = 88/267 (32%), Positives = 144/267 (53%), Gaps = 20/267 (7%)
Query: 348 IGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQY 407
           IG G+ G V +A+ R +G L A+K++D+     +  +  + L  E+ ++   +H N+V+ 
Sbjct: 37  IGEGSTGIVCIATVRSSGKLVAVKKMDL-----RKQQRRELLFNEVVIMRDYQHENVVEM 91
Query: 408 YGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHR 467
           Y S +V D+ ++ +E++  G++   V      + E  +      +L  L+ LH++  IHR
Sbjct: 92  YNSYLVGDELWVVMEFLEGGALTDIVTH--TRMNEEQIAAVCLAVLQALSVLHAQGVIHR 149
Query: 468 DIKGANLLVDASGVVKLADFGMAKHLTGQKADLS-MKGSPYWMAPELMMAVMQKGKSSDS 526
           DIK  ++L+   G VKL+DFG    ++ +      + G+PYWMAPEL ++ +  G     
Sbjct: 150 DIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPEL-ISRLPYGPE--- 205
Query: 527 ALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDT--PAIPD--SLSPEGKDFLRC 582
              VDIWSLG  +IEM  G+PP+       AM K++RD   P + +   +SP  K FL  
Sbjct: 206 ---VDIWSLGIMVIEMVDGEPPYFNEPPLKAM-KMIRDNLPPRLKNLHKVSPSLKGFLDR 261
Query: 583 CFQRNPADRPPASLLLEHRFLKNSQQP 609
              R+PA R  A+ LL+H FL  +  P
Sbjct: 262 LLVRDPAQRATAAELLKHPFLAKAGPP 288

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score =  138 bits (348), Expect = 9e-33,   Method: Compositional matrix adjust.
 Identities = 88/267 (32%), Positives = 144/267 (53%), Gaps = 20/267 (7%)
Query: 348 IGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQY 407
           IG G+ G V +A+ R +G L A+K++D+     +  +  + L  E+ ++   +H N+V+ 
Sbjct: 82  IGEGSTGIVCIATVRSSGKLVAVKKMDL-----RKQQRRELLFNEVVIMRDYQHENVVEM 136
Query: 408 YGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHR 467
           Y S +V D+ ++ +E++  G++   V      + E  +      +L  L+ LH++  IHR
Sbjct: 137 YNSYLVGDELWVVMEFLEGGALTDIVTH--TRMNEEQIAAVCLAVLQALSVLHAQGVIHR 194
Query: 468 DIKGANLLVDASGVVKLADFGMAKHLTGQKADLS-MKGSPYWMAPELMMAVMQKGKSSDS 526
           DIK  ++L+   G VKL+DFG    ++ +      + G+PYWMAPEL ++ +  G     
Sbjct: 195 DIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPEL-ISRLPYGPE--- 250
Query: 527 ALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDT--PAIPD--SLSPEGKDFLRC 582
              VDIWSLG  +IEM  G+PP+       AM K++RD   P + +   +SP  K FL  
Sbjct: 251 ---VDIWSLGIMVIEMVDGEPPYFNEPPLKAM-KMIRDNLPPRLKNLHKVSPSLKGFLDR 306
Query: 583 CFQRNPADRPPASLLLEHRFLKNSQQP 609
              R+PA R  A+ LL+H FL  +  P
Sbjct: 307 LLVRDPAQRATAAELLKHPFLAKAGPP 333

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score =  138 bits (348), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 88/267 (32%), Positives = 144/267 (53%), Gaps = 20/267 (7%)
Query: 348 IGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQY 407
           IG G+ G V +A+ R +G L A+K++D+     +  +  + L  E+ ++   +H N+V+ 
Sbjct: 39  IGEGSTGIVCIATVRSSGKLVAVKKMDL-----RKQQRRELLFNEVVIMRDYQHENVVEM 93
Query: 408 YGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHR 467
           Y S +V D+ ++ +E++  G++   V      + E  +      +L  L+ LH++  IHR
Sbjct: 94  YNSYLVGDELWVVMEFLEGGALTDIVTH--TRMNEEQIAAVCLAVLQALSVLHAQGVIHR 151
Query: 468 DIKGANLLVDASGVVKLADFGMAKHLTGQKADLS-MKGSPYWMAPELMMAVMQKGKSSDS 526
           DIK  ++L+   G VKL+DFG    ++ +      + G+PYWMAPEL ++ +  G     
Sbjct: 152 DIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPEL-ISRLPYGPE--- 207
Query: 527 ALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDT--PAIPD--SLSPEGKDFLRC 582
              VDIWSLG  +IEM  G+PP+       AM K++RD   P + +   +SP  K FL  
Sbjct: 208 ---VDIWSLGIMVIEMVDGEPPYFNEPPLKAM-KMIRDNLPPRLKNLHKVSPSLKGFLDR 263
Query: 583 CFQRNPADRPPASLLLEHRFLKNSQQP 609
              R+PA R  A+ LL+H FL  +  P
Sbjct: 264 LLVRDPAQRATAAELLKHPFLAKAGPP 290

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score =  138 bits (347), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 81/269 (30%), Positives = 143/269 (53%), Gaps = 12/269 (4%)
Query: 342 WQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKH 401
           ++ G+ +G+G FG+VY+A  +++  + A+K   +F    + A    QL +E+++ SHL+H
Sbjct: 10  FEIGRPLGKGKFGNVYLAREKQSKFILALKV--LFKAQLEKAGVEHQLRREVEIQSHLRH 67
Query: 402 PNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHS 461
           PNI++ YG      + Y+ LEY   G++ + +++      E     +   + + L+Y HS
Sbjct: 68  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQK-LSKFDEQRTATYITELANALSYCHS 126
Query: 462 KKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPYWMAPELMMAVMQKG 521
           K+ IHRDIK  NLL+ ++G +K+ADFG + H    +   ++ G+  ++ PE++   M   
Sbjct: 127 KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT-TLCGTLDYLPPEMIEGRMHDE 185
Query: 522 KSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDSLSPEGKDFLR 581
           K       VD+WSLG    E   GKPP+          ++ R     PD ++   +D + 
Sbjct: 186 K-------VDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLIS 238
Query: 582 CCFQRNPADRPPASLLLEHRFLK-NSQQP 609
              + NP+ RP    +LEH ++  NS +P
Sbjct: 239 RLLKHNPSQRPMLREVLEHPWITANSSKP 267

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score =  138 bits (347), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 81/266 (30%), Positives = 141/266 (53%), Gaps = 12/266 (4%)
Query: 345 GKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNI 404
           G+ +G+G FG+VY+A  +++  + A+K   +F    + A    QL +E+++ SHL+HPNI
Sbjct: 16  GRPLGKGKFGNVYLAREKQSKFILALK--VLFKAQLEKAGVEHQLRREVEIQSHLRHPNI 73
Query: 405 VQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKT 464
           ++ YG      + Y+ LEY   G++ + +++      E     +   + + L+Y HSK+ 
Sbjct: 74  LRLYGYFHDATRVYLILEYAPLGTVYRELQK-LSKFDEQRTATYITELANALSYCHSKRV 132
Query: 465 IHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPYWMAPELMMAVMQKGKSS 524
           IHRDIK  NLL+ ++G +K+ADFG + H    +   ++ G+  ++ PE++   M   K  
Sbjct: 133 IHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT-TLCGTLDYLPPEMIEGRMHDEK-- 189
Query: 525 DSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDSLSPEGKDFLRCCF 584
                VD+WSLG    E   GKPP+          ++ R     PD ++   +D +    
Sbjct: 190 -----VDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLL 244
Query: 585 QRNPADRPPASLLLEHRFLK-NSQQP 609
           + NP+ RP    +LEH ++  NS +P
Sbjct: 245 KHNPSQRPMLREVLEHPWITANSSKP 270

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score =  138 bits (347), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 81/269 (30%), Positives = 143/269 (53%), Gaps = 12/269 (4%)
Query: 342 WQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKH 401
           ++ G+ +G+G FG+VY+A  +++  + A+K   +F    + A    QL +E+++ SHL+H
Sbjct: 15  FEIGRPLGKGKFGNVYLAREKQSKFILALK--VLFKAQLEKAGVEHQLRREVEIQSHLRH 72
Query: 402 PNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHS 461
           PNI++ YG      + Y+ LEY   G++ + +++      E     +   + + L+Y HS
Sbjct: 73  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQK-LSKFDEQRTATYITELANALSYCHS 131
Query: 462 KKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPYWMAPELMMAVMQKG 521
           K+ IHRDIK  NLL+ ++G +K+ADFG + H    +   ++ G+  ++ PE++   M   
Sbjct: 132 KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT-TLCGTLDYLPPEMIEGRMHDE 190
Query: 522 KSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDSLSPEGKDFLR 581
           K       VD+WSLG    E   GKPP+          ++ R     PD ++   +D + 
Sbjct: 191 K-------VDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLIS 243
Query: 582 CCFQRNPADRPPASLLLEHRFLK-NSQQP 609
              + NP+ RP    +LEH ++  NS +P
Sbjct: 244 RLLKHNPSQRPMLREVLEHPWITANSSKP 272

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score =  138 bits (347), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 81/269 (30%), Positives = 143/269 (53%), Gaps = 12/269 (4%)
Query: 342 WQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKH 401
           ++ G+ +G+G FG+VY+A  +++  + A+K   +F    + A    QL +E+++ SHL+H
Sbjct: 9   FEIGRPLGKGKFGNVYLAREKQSKFILALKV--LFKAQLEKAGVEHQLRREVEIQSHLRH 66
Query: 402 PNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHS 461
           PNI++ YG      + Y+ LEY   G++ + +++      E     +   + + L+Y HS
Sbjct: 67  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQK-LSKFDEQRTATYITELANALSYCHS 125
Query: 462 KKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPYWMAPELMMAVMQKG 521
           K+ IHRDIK  NLL+ ++G +K+ADFG + H    +   ++ G+  ++ PE++   M   
Sbjct: 126 KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT-TLCGTLDYLPPEMIEGRMHDE 184
Query: 522 KSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDSLSPEGKDFLR 581
           K       VD+WSLG    E   GKPP+          ++ R     PD ++   +D + 
Sbjct: 185 K-------VDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLIS 237
Query: 582 CCFQRNPADRPPASLLLEHRFLK-NSQQP 609
              + NP+ RP    +LEH ++  NS +P
Sbjct: 238 RLLKHNPSQRPMLREVLEHPWITANSSKP 266

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score =  138 bits (347), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 81/269 (30%), Positives = 143/269 (53%), Gaps = 12/269 (4%)
Query: 342 WQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKH 401
           ++ G+ +G+G FG+VY+A  +++  + A+K   +F    + A    QL +E+++ SHL+H
Sbjct: 14  FEIGRPLGKGKFGNVYLAREKQSKFILALKV--LFKAQLEKAGVEHQLRREVEIQSHLRH 71
Query: 402 PNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHS 461
           PNI++ YG      + Y+ LEY   G++ + +++      E     +   + + L+Y HS
Sbjct: 72  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQK-LSKFDEQRTATYITELANALSYCHS 130
Query: 462 KKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPYWMAPELMMAVMQKG 521
           K+ IHRDIK  NLL+ ++G +K+ADFG + H    +   ++ G+  ++ PE++   M   
Sbjct: 131 KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT-TLCGTLDYLPPEMIEGRMHDE 189
Query: 522 KSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDSLSPEGKDFLR 581
           K       VD+WSLG    E   GKPP+          ++ R     PD ++   +D + 
Sbjct: 190 K-------VDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLIS 242
Query: 582 CCFQRNPADRPPASLLLEHRFLK-NSQQP 609
              + NP+ RP    +LEH ++  NS +P
Sbjct: 243 RLLKHNPSQRPMLREVLEHPWITANSSKP 271

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score =  137 bits (346), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 88/267 (32%), Positives = 144/267 (53%), Gaps = 20/267 (7%)
Query: 348 IGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQY 407
           IG G+ G V +A+ R +G L A+K++D+     +  +  + L  E+ ++   +H N+V+ 
Sbjct: 28  IGEGSTGIVCIATVRSSGKLVAVKKMDL-----RKQQRRELLFNEVVIMRDYQHENVVEM 82
Query: 408 YGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHR 467
           Y S +V D+ ++ +E++  G++   V      + E  +      +L  L+ LH++  IHR
Sbjct: 83  YNSYLVGDELWVVMEFLEGGALTDIVTH--TRMNEEQIAAVCLAVLQALSVLHAQGVIHR 140
Query: 468 DIKGANLLVDASGVVKLADFGMAKHLTGQKADLS-MKGSPYWMAPELMMAVMQKGKSSDS 526
           DIK  ++L+   G VKL+DFG    ++ +      + G+PYWMAPEL ++ +  G     
Sbjct: 141 DIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPEL-ISRLPYGPE--- 196
Query: 527 ALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDT--PAIPD--SLSPEGKDFLRC 582
              VDIWSLG  +IEM  G+PP+       AM K++RD   P + +   +SP  K FL  
Sbjct: 197 ---VDIWSLGIMVIEMVDGEPPYFNEPPLKAM-KMIRDNLPPRLKNLHKVSPSLKGFLDR 252
Query: 583 CFQRNPADRPPASLLLEHRFLKNSQQP 609
              R+PA R  A+ LL+H FL  +  P
Sbjct: 253 LLVRDPAQRATAAELLKHPFLAKAGPP 279

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score =  137 bits (346), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 82/270 (30%), Positives = 145/270 (53%), Gaps = 14/270 (5%)
Query: 342 WQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKH 401
           ++ G+ +G+G FG+VY+A  +++  + A+K   +F    + A    QL +E+++ SHL+H
Sbjct: 10  FEIGRPLGKGKFGNVYLAREKQSKFILALKV--LFKAQLEKAGVEHQLRREVEIQSHLRH 67
Query: 402 PNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHS 461
           PNI++ YG      + Y+ LEY   G++ + +++      E     +   + + L+Y HS
Sbjct: 68  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQK-LSKFDEQRTATYITELANALSYCHS 126
Query: 462 KKTIHRDIKGANLLVDASGVVKLADFGMAKHL-TGQKADLSMKGSPYWMAPELMMAVMQK 520
           K+ IHRDIK  NLL+ ++G +K+ADFG + H  + ++ +L   G+  ++ PE++   M  
Sbjct: 127 KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTELC--GTLDYLPPEMIEGRMHD 184
Query: 521 GKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDSLSPEGKDFL 580
            K       VD+WSLG    E   GKPP+          ++ R     PD ++   +D +
Sbjct: 185 EK-------VDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLI 237
Query: 581 RCCFQRNPADRPPASLLLEHRFLK-NSQQP 609
               + NP+ RP    +LEH ++  NS +P
Sbjct: 238 SRLLKHNPSQRPMLREVLEHPWITANSSKP 267

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score =  137 bits (346), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 83/270 (30%), Positives = 145/270 (53%), Gaps = 14/270 (5%)
Query: 342 WQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKH 401
           ++ G+ +G+G FG+VY+A  +++  + A+K   +F    + A    QL +E+++ SHL+H
Sbjct: 13  FEIGRPLGKGKFGNVYLAREKQSKFILALKV--LFKAQLEKAGVEHQLRREVEIQSHLRH 70
Query: 402 PNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHS 461
           PNI++ YG      + Y+ LEY   G++ + +++      E     +   + + L+Y HS
Sbjct: 71  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQK-LSKFDEQRTATYITELANALSYCHS 129
Query: 462 KKTIHRDIKGANLLVDASGVVKLADFGMAKHL-TGQKADLSMKGSPYWMAPELMMAVMQK 520
           K+ IHRDIK  NLL+ ++G +K+ADFG + H  + ++A L   G+  ++ PE++   M  
Sbjct: 130 KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRAALC--GTLDYLPPEMIEGRMHD 187
Query: 521 GKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDSLSPEGKDFL 580
            K       VD+WSLG    E   GKPP+          ++ R     PD ++   +D +
Sbjct: 188 EK-------VDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLI 240
Query: 581 RCCFQRNPADRPPASLLLEHRFLK-NSQQP 609
               + NP+ RP    +LEH ++  NS +P
Sbjct: 241 SRLLKHNPSQRPMLREVLEHPWITANSSKP 270

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score =  137 bits (346), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 91/285 (31%), Positives = 150/285 (52%), Gaps = 24/285 (8%)
Query: 327 PQVAAKPEPLPMNS--QWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAE 384
           PQ A +P+ +  N+   ++  K IGRG F  VY A+    G   A+K+V IF  D   A+
Sbjct: 18  PQKALRPD-MGYNTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIF--DLMDAK 74
Query: 385 SIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSIN---KYVREHCGAIT 441
           +     +EI +L  L HPN+++YY S I +++  I LE    G ++   K+ ++    I 
Sbjct: 75  ARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIP 134
Query: 442 ESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQ-KADL 500
           E  V  +   + S L ++HS++ +HRDIK AN+ + A+GVVKL D G+ +  + +  A  
Sbjct: 135 ERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAH 194
Query: 501 SMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFK 560
           S+ G+PY+M+PE    + + G +  S    DIWSLGC + EM   + P+  Y     ++ 
Sbjct: 195 SLVGTPYYMSPE---RIHENGYNFKS----DIWSLGCLLYEMAALQSPF--YGDKMNLYS 245
Query: 561 VMR-----DTPAIP-DSLSPEGKDFLRCCFQRNPADRPPASLLLE 599
           + +     D P +P D  S E +  +  C   +P  RP  + + +
Sbjct: 246 LCKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYD 290

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score =  137 bits (346), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 88/267 (32%), Positives = 144/267 (53%), Gaps = 20/267 (7%)
Query: 348 IGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQY 407
           IG G+ G V +A+ R +G L A+K++D+     +  +  + L  E+ ++   +H N+V+ 
Sbjct: 32  IGEGSTGIVCIATVRSSGKLVAVKKMDL-----RKQQRRELLFNEVVIMRDYQHENVVEM 86
Query: 408 YGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHR 467
           Y S +V D+ ++ +E++  G++   V      + E  +      +L  L+ LH++  IHR
Sbjct: 87  YNSYLVGDELWVVMEFLEGGALTDIVTH--TRMNEEQIAAVCLAVLQALSVLHAQGVIHR 144
Query: 468 DIKGANLLVDASGVVKLADFGMAKHLTGQKADLS-MKGSPYWMAPELMMAVMQKGKSSDS 526
           DIK  ++L+   G VKL+DFG    ++ +      + G+PYWMAPEL ++ +  G     
Sbjct: 145 DIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPEL-ISRLPYGPE--- 200
Query: 527 ALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDT--PAIPD--SLSPEGKDFLRC 582
              VDIWSLG  +IEM  G+PP+       AM K++RD   P + +   +SP  K FL  
Sbjct: 201 ---VDIWSLGIMVIEMVDGEPPYFNEPPLKAM-KMIRDNLPPRLKNLHKVSPSLKGFLDR 256
Query: 583 CFQRNPADRPPASLLLEHRFLKNSQQP 609
              R+PA R  A+ LL+H FL  +  P
Sbjct: 257 LLVRDPAQRATAAELLKHPFLAKAGPP 283

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score =  137 bits (346), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 86/276 (31%), Positives = 145/276 (52%), Gaps = 19/276 (6%)
Query: 341 QW-----QKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKV 395
           QW     + G+ +G+G FG+VY+A  + +  + A+K   +F    + A    QL +E+++
Sbjct: 4   QWALEDFEIGRPLGKGKFGNVYLAREKNSKFILALKV--LFKAQLEKAGVEHQLRREVEI 61
Query: 396 LSHLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSG 455
            SHL+HPNI++ YG      + Y+ LEY   G++ + +++      E     +   + + 
Sbjct: 62  QSHLRHPNILRLYGYFHDSTRVYLILEYAPLGTVYRELQK-LSKFDEQRTATYITELANA 120
Query: 456 LAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHL-TGQKADLSMKGSPYWMAPELM 514
           L+Y HSKK IHRDIK  NLL+ ++G +K+ADFG + H  + ++A L   G+  ++ PE++
Sbjct: 121 LSYCHSKKVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRAALC--GTLDYLPPEMI 178
Query: 515 MAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDSLSP 574
              M   K       VD+WSLG    E   GKPP+          ++ R     PD ++ 
Sbjct: 179 EGRMHDEK-------VDLWSLGVLCYEFLVGKPPFEANTYQDTYKRISRVEFTFPDFVTE 231
Query: 575 EGKDFLRCCFQRNPADRPPASLLLEHRFLK-NSQQP 609
             +D +    + NP+ RP    +LEH ++  NS +P
Sbjct: 232 GARDLISRLLKHNPSQRPMLREVLEHPWITANSSKP 267

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score =  137 bits (346), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 83/270 (30%), Positives = 145/270 (53%), Gaps = 14/270 (5%)
Query: 342 WQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKH 401
           ++ G+ +G+G FG+VY+A  +++  + A+K   +F    + A    QL +E+++ SHL+H
Sbjct: 10  FEIGRPLGKGKFGNVYLAREKQSKFILALKV--LFKAQLEKAGVEHQLRREVEIQSHLRH 67
Query: 402 PNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHS 461
           PNI++ YG      + Y+ LEY   G++ + +++      E     +   + + L+Y HS
Sbjct: 68  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQK-LSKFDEQRTATYITELANALSYCHS 126
Query: 462 KKTIHRDIKGANLLVDASGVVKLADFGMAKHL-TGQKADLSMKGSPYWMAPELMMAVMQK 520
           K+ IHRDIK  NLL+ ++G +K+ADFG + H  + ++A L   G+  ++ PE++   M  
Sbjct: 127 KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRAALC--GTLDYLPPEMIEGRMHD 184
Query: 521 GKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDSLSPEGKDFL 580
            K       VD+WSLG    E   GKPP+          ++ R     PD ++   +D +
Sbjct: 185 EK-------VDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLI 237
Query: 581 RCCFQRNPADRPPASLLLEHRFLK-NSQQP 609
               + NP+ RP    +LEH ++  NS +P
Sbjct: 238 SRLLKHNPSQRPMLREVLEHPWITANSSKP 267

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score =  137 bits (345), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 81/266 (30%), Positives = 140/266 (52%), Gaps = 12/266 (4%)
Query: 345 GKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNI 404
           G+ +G+G FG+VY+A  +++  + A+K   +F    + A    QL +E+++ SHL+HPNI
Sbjct: 15  GRPLGKGKFGNVYLAREKQSKFILALK--VLFKAQLEKAGVEHQLRREVEIQSHLRHPNI 72
Query: 405 VQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKT 464
           ++ YG      + Y+ LEY   G++ + +++      E     +   + + L+Y HSK+ 
Sbjct: 73  LRLYGYFHDATRVYLILEYAPLGTVYRELQK-LSKFDEQRTATYITELANALSYCHSKRV 131
Query: 465 IHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPYWMAPELMMAVMQKGKSS 524
           IHRDIK  NLL+ ++G +K+ADFG + H    +    + G+  ++ PE++   M   K  
Sbjct: 132 IHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRX-XLCGTLDYLPPEMIEGRMHDEK-- 188
Query: 525 DSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDSLSPEGKDFLRCCF 584
                VD+WSLG    E   GKPP+          ++ R     PD ++   +D +    
Sbjct: 189 -----VDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLL 243
Query: 585 QRNPADRPPASLLLEHRFLK-NSQQP 609
           + NP+ RP    +LEH ++  NS +P
Sbjct: 244 KHNPSQRPMLREVLEHPWITANSSKP 269

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score =  137 bits (345), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 84/281 (29%), Positives = 145/281 (51%), Gaps = 17/281 (6%)
Query: 335 PLPMNSQW-----QKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQL 389
           PL    QW       G+ +G+G FG+VY+A  R++  + A+K   +F    + A    QL
Sbjct: 2   PLGSKRQWTLEDFDIGRPLGKGKFGNVYLARERQSKFILALKV--LFKTQLEKAGVEHQL 59
Query: 390 EQEIKVLSHLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFT 449
            +E+++ SHL+HPNI++ YG      + Y+ LEY   G++ + +++      E     + 
Sbjct: 60  RREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK-LSRFDEQRTATYI 118
Query: 450 RHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPYWM 509
             + + L+Y HSK+ IHRDIK  NLL+ ++G +K+ADFG + H    +   ++ G+  ++
Sbjct: 119 TELANALSYCHSKRVIHRDIKPENLLLGSNGELKIADFGWSVHAPSSRRT-TLCGTLDYL 177
Query: 510 APELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIP 569
            PE++   M   K       VD+WSLG    E   G PP+  +       ++ R     P
Sbjct: 178 PPEMIEGRMHDEK-------VDLWSLGVLCYEFLVGMPPFEAHTYQETYRRISRVEFTFP 230
Query: 570 DSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLK-NSQQP 609
           D ++   +D +    + N + R   + +LEH ++K NS +P
Sbjct: 231 DFVTEGARDLISRLLKHNASQRLTLAEVLEHPWIKANSSKP 271

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score =  137 bits (344), Expect = 3e-32,   Method: Compositional matrix adjust.
 Identities = 81/269 (30%), Positives = 142/269 (52%), Gaps = 12/269 (4%)
Query: 342 WQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKH 401
           ++ G+ +G+G FG+VY+A  +++  + A+K   +F    + A    QL +E+++ SHL+H
Sbjct: 10  FEIGRPLGKGKFGNVYLAREKQSKFILALKV--LFKAQLEKAGVEHQLRREVEIQSHLRH 67
Query: 402 PNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHS 461
           PNI++ YG      + Y+ LEY   G++ + +++      E     +   + + L+Y HS
Sbjct: 68  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQK-LSKFDEQRTATYITELANALSYCHS 126
Query: 462 KKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPYWMAPELMMAVMQKG 521
           K+ IHRDIK  NLL+ ++G +K+ADFG + H    +    + G+  ++ PE++   M   
Sbjct: 127 KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT-XLCGTLDYLPPEMIEGRMHDE 185
Query: 522 KSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDSLSPEGKDFLR 581
           K       VD+WSLG    E   GKPP+          ++ R     PD ++   +D + 
Sbjct: 186 K-------VDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLIS 238
Query: 582 CCFQRNPADRPPASLLLEHRFLK-NSQQP 609
              + NP+ RP    +LEH ++  NS +P
Sbjct: 239 RLLKHNPSQRPMLREVLEHPWITANSSKP 267

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score =  137 bits (344), Expect = 3e-32,   Method: Compositional matrix adjust.
 Identities = 81/269 (30%), Positives = 142/269 (52%), Gaps = 12/269 (4%)
Query: 342 WQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKH 401
           ++ G+ +G+G FG+VY+A  +++  + A+K   +F    + A    QL +E+++ SHL+H
Sbjct: 10  FEIGRPLGKGKFGNVYLAREKQSKFILALKV--LFKAQLEKAGVEHQLRREVEIQSHLRH 67
Query: 402 PNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHS 461
           PNI++ YG      + Y+ LEY   G++ + +++      E     +   + + L+Y HS
Sbjct: 68  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQK-LSKFDEQRTATYITELANALSYCHS 126
Query: 462 KKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPYWMAPELMMAVMQKG 521
           K+ IHRDIK  NLL+ ++G +K+ADFG + H    +    + G+  ++ PE++   M   
Sbjct: 127 KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRX-XLCGTLDYLPPEMIEGRMHDE 185
Query: 522 KSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDSLSPEGKDFLR 581
           K       VD+WSLG    E   GKPP+          ++ R     PD ++   +D + 
Sbjct: 186 K-------VDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLIS 238
Query: 582 CCFQRNPADRPPASLLLEHRFLK-NSQQP 609
              + NP+ RP    +LEH ++  NS +P
Sbjct: 239 RLLKHNPSQRPMLREVLEHPWITANSSKP 267

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score =  136 bits (343), Expect = 4e-32,   Method: Compositional matrix adjust.
 Identities = 80/266 (30%), Positives = 141/266 (53%), Gaps = 12/266 (4%)
Query: 345 GKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNI 404
           G+ +G+G FG+VY+A  +++  + A+K   +F    + A    QL +E+++ SHL+HPNI
Sbjct: 15  GRPLGKGKFGNVYLAREKQSKFILALK--VLFKAQLEKAGVEHQLRREVEIQSHLRHPNI 72
Query: 405 VQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKT 464
           ++ YG      + Y+ LEY   G++ + +++      E     +   + + L+Y HSK+ 
Sbjct: 73  LRLYGYFHDATRVYLILEYAPLGTVYRELQK-LSKFDEQRTATYITELANALSYCHSKRV 131
Query: 465 IHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPYWMAPELMMAVMQKGKSS 524
           IHRDIK  NLL+ ++G +K+A+FG + H    +   ++ G+  ++ PE++   M   K  
Sbjct: 132 IHRDIKPENLLLGSAGELKIANFGWSVHAPSSRRT-TLCGTLDYLPPEMIEGRMHDEK-- 188
Query: 525 DSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDSLSPEGKDFLRCCF 584
                VD+WSLG    E   GKPP+          ++ R     PD ++   +D +    
Sbjct: 189 -----VDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLL 243
Query: 585 QRNPADRPPASLLLEHRFLK-NSQQP 609
           + NP+ RP    +LEH ++  NS +P
Sbjct: 244 KHNPSQRPMLREVLEHPWITANSSKP 269

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score =  136 bits (343), Expect = 4e-32,   Method: Compositional matrix adjust.
 Identities = 80/269 (29%), Positives = 143/269 (53%), Gaps = 12/269 (4%)
Query: 342 WQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKH 401
           ++ G+ +G+G FG+VY+A  +++  + A+K   +F    + A    QL +E+++ SHL+H
Sbjct: 13  FEIGRPLGKGKFGNVYLAREKQSKFILALK--VLFKAQLEKAGVEHQLRREVEIQSHLRH 70
Query: 402 PNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHS 461
           PNI++ YG      + Y+ LEY   G++ + +++      E     +   + + L+Y HS
Sbjct: 71  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQK-LSKFDEQRTATYITELANALSYCHS 129
Query: 462 KKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPYWMAPELMMAVMQKG 521
           K+ IHRDIK  NLL+ ++G +K+A+FG + H    +   ++ G+  ++ PE++   M   
Sbjct: 130 KRVIHRDIKPENLLLGSAGELKIANFGWSVHAPSSRRT-TLCGTLDYLPPEMIEGRMHDE 188
Query: 522 KSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDSLSPEGKDFLR 581
           K       VD+WSLG    E   GKPP+          ++ R     PD ++   +D + 
Sbjct: 189 K-------VDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLIS 241
Query: 582 CCFQRNPADRPPASLLLEHRFLK-NSQQP 609
              + NP+ RP    +LEH ++  NS +P
Sbjct: 242 RLLKHNPSQRPMLREVLEHPWITANSSKP 270

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score =  136 bits (343), Expect = 4e-32,   Method: Compositional matrix adjust.
 Identities = 81/266 (30%), Positives = 142/266 (53%), Gaps = 12/266 (4%)
Query: 345 GKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNI 404
           G+ +G+G FG+VY+A  +++  + A+K   +F    + A    QL +E+++ SHL+HPNI
Sbjct: 18  GRPLGKGKFGNVYLAREKQSKFILALK--VLFKAQLEKAGVEHQLRREVEIQSHLRHPNI 75
Query: 405 VQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKT 464
           ++ YG      + Y+ LEY   G++ + +++      E     +   + + L+Y HSK+ 
Sbjct: 76  LRLYGYFHDATRVYLILEYAPLGTVYRELQK-LSKFDEQRTATYITELANALSYCHSKRV 134
Query: 465 IHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPYWMAPELMMAVMQKGKSS 524
           IHRDIK  NLL+ ++G +K+ADFG + H    +   ++ G+  ++ PE +     +G+  
Sbjct: 135 IHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT-TLCGTLDYLPPEXI-----EGRXH 188
Query: 525 DSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDSLSPEGKDFLRCCF 584
           D    VD+WSLG    E   GKPP+          ++ R     PD ++   +D +    
Sbjct: 189 DE--KVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLL 246
Query: 585 QRNPADRPPASLLLEHRFLK-NSQQP 609
           + NP+ RP    +LEH ++  NS +P
Sbjct: 247 KHNPSQRPXLREVLEHPWITANSSKP 272

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score =  136 bits (342), Expect = 4e-32,   Method: Compositional matrix adjust.
 Identities = 80/265 (30%), Positives = 138/265 (52%), Gaps = 16/265 (6%)
Query: 341 QW-----QKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKV 395
           QW     + G+ +G+G FG+VY+A  +++  + A+K   +F    + A    QL +E+++
Sbjct: 7   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALK--VLFKAQLEKAGVEHQLRREVEI 64
Query: 396 LSHLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSG 455
            SHL+HPNI++ YG      + Y+ LEY   G++ + +++      E     +   + + 
Sbjct: 65  QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK-LSKFDEQRTATYITELANA 123
Query: 456 LAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPYWMAPELMM 515
           L+Y HSK+ IHRDIK  NLL+ ++G +K+ADFG + H    +   ++ G+  ++ PE++ 
Sbjct: 124 LSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT-TLCGTLDYLPPEMIE 182
Query: 516 AVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDSLSPE 575
             M   K       VD+WSLG    E   GKPP+          ++ R     PD ++  
Sbjct: 183 GRMHDEK-------VDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEG 235
Query: 576 GKDFLRCCFQRNPADRPPASLLLEH 600
            +D +    + NP+ RP    +LEH
Sbjct: 236 ARDLISRLLKHNPSQRPMLREVLEH 260

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score =  135 bits (340), Expect = 8e-32,   Method: Compositional matrix adjust.
 Identities = 78/259 (30%), Positives = 136/259 (52%), Gaps = 11/259 (4%)
Query: 342 WQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKH 401
           ++ G+ +G+G FG+VY+A  ++   + A+K   +F    + A    QL +E+++ SHL+H
Sbjct: 7   FEIGRPLGKGKFGNVYLAREKQRKFILALKV--LFKAQLEKAGVEHQLRREVEIQSHLRH 64
Query: 402 PNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHS 461
           PNI++ YG      + Y+ LEY   G++ + +++      E     +   + + L+Y HS
Sbjct: 65  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQK-LSKFDEQRTATYITELANALSYCHS 123
Query: 462 KKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPYWMAPELMMAVMQKG 521
           K+ IHRDIK  NLL+ ++G +K+ADFG + H    +   ++ G+  ++ PE++   M   
Sbjct: 124 KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT-TLCGTLDYLPPEMIEGRMHDE 182
Query: 522 KSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDSLSPEGKDFLR 581
           K       VD+WSLG    E   GKPP+          ++ R     PD ++   +D + 
Sbjct: 183 K-------VDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLIS 235
Query: 582 CCFQRNPADRPPASLLLEH 600
              + NP+ RP    +LEH
Sbjct: 236 RLLKHNPSQRPMLREVLEH 254

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score =  135 bits (339), Expect = 9e-32,   Method: Compositional matrix adjust.
 Identities = 80/265 (30%), Positives = 137/265 (51%), Gaps = 16/265 (6%)
Query: 341 QW-----QKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKV 395
           QW     + G+ +G+G FG+VY+A  +++  + A+K   +F    + A    QL +E+++
Sbjct: 7   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALK--VLFKAQLEKAGVEHQLRREVEI 64
Query: 396 LSHLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSG 455
            SHL+HPNI++ YG      + Y+ LEY   G++ + +++      E     +   + + 
Sbjct: 65  QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK-LSKFDEQRTATYITELANA 123
Query: 456 LAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPYWMAPELMM 515
           L+Y HSK+ IHRDIK  NLL+ ++G +K+ADFG + H    +    + G+  ++ PE++ 
Sbjct: 124 LSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRX-XLCGTLDYLPPEMIE 182
Query: 516 AVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDSLSPE 575
             M   K       VD+WSLG    E   GKPP+          ++ R     PD ++  
Sbjct: 183 GRMHDEK-------VDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEG 235
Query: 576 GKDFLRCCFQRNPADRPPASLLLEH 600
            +D +    + NP+ RP    +LEH
Sbjct: 236 ARDLISRLLKHNPSQRPMLREVLEH 260

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score =  134 bits (337), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 85/266 (31%), Positives = 137/266 (51%), Gaps = 12/266 (4%)
Query: 346 KLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIV 405
           K IG+G F  V +A +  TG   A+K +D    +P S   +++L +E++++  L HPNIV
Sbjct: 18  KTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTS---LQKLFREVRIMKILNHPNIV 74
Query: 406 QYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTI 465
           + +     E   Y+ +EY   G +  Y+  H G + E   R+  R I+S + Y H K+ +
Sbjct: 75  KLFEVIETEKTLYLIMEYASGGEVFDYLVAH-GRMKEKEARSKFRQIVSAVQYCHQKRIV 133
Query: 466 HRDIKGANLLVDASGVVKLADFGMAKHLT-GQKADLSMKGSPYWMAPELMMAVMQKGKSS 524
           HRD+K  NLL+DA   +K+ADFG +   T G K D +  GSP + APEL      +GK  
Sbjct: 134 HRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLD-TFCGSPPYAAPELF-----QGKKY 187
Query: 525 DSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDSLSPEGKDFLRCCF 584
           D    VD+WSLG  +  + +G  P+          +V+R    IP  +S + ++ L+   
Sbjct: 188 DGP-EVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCENLLKRFL 246
Query: 585 QRNPADRPPASLLLEHRFLKNSQQPD 610
             NP  R     +++ R++    + D
Sbjct: 247 VLNPIKRGTLEQIMKDRWINAGHEED 272

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score =  134 bits (336), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 86/283 (30%), Positives = 144/283 (50%), Gaps = 12/283 (4%)
Query: 329 VAAKPEPLPMNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQ 388
           +A+  +  P    ++  K IG+G F  V +A +  TG   A+K +D    +P S   +++
Sbjct: 4   IASCADEQPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTS---LQK 60
Query: 389 LEQEIKVLSHLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNF 448
           L +E++++  L HPNIV+ +     E   Y+ +EY   G +  Y+  H G + E   R+ 
Sbjct: 61  LFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAH-GRMKEKEARSK 119
Query: 449 TRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLT-GQKADLSMKGSPY 507
            R I+S + Y H K+ +HRD+K  NLL+DA   +K+ADFG +   T G K D +  G+P 
Sbjct: 120 FRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLD-AFCGAPP 178
Query: 508 WMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPA 567
           + APEL      +GK  D    VD+WSLG  +  + +G  P+          +V+R    
Sbjct: 179 YAAPELF-----QGKKYDGP-EVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYR 232
Query: 568 IPDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQPD 610
           IP  +S + ++ L+     NP  R     +++ R++    + D
Sbjct: 233 IPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKDRWINAGHEED 275

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score =  132 bits (333), Expect = 5e-31,   Method: Compositional matrix adjust.
 Identities = 86/282 (30%), Positives = 141/282 (50%), Gaps = 12/282 (4%)
Query: 330 AAKPEPLPMNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQL 389
           A   +  P    ++  K IG+G F  V +A +  TG   A+K +D       ++ S+++L
Sbjct: 4   ATSADEQPHIGNYRLLKTIGKGNFAKVKLARHILTGKEVAVKIID---KTQLNSSSLQKL 60
Query: 390 EQEIKVLSHLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFT 449
            +E++++  L HPNIV+ +     E   Y+ +EY   G +  Y+  H G + E   R   
Sbjct: 61  FREVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAH-GRMKEKEARAKF 119
Query: 450 RHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLT-GQKADLSMKGSPYW 508
           R I+S + Y H K  +HRD+K  NLL+DA   +K+ADFG +   T G K D +  GSP +
Sbjct: 120 RQIVSAVQYCHQKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLD-TFCGSPPY 178
Query: 509 MAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAI 568
            APEL      +GK  D    VD+WSLG  +  + +G  P+          +V+R    I
Sbjct: 179 AAPELF-----QGKKYDGP-EVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRI 232
Query: 569 PDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQPD 610
           P  +S + ++ L+     NP+ R     +++ R++    + D
Sbjct: 233 PFYMSTDCENLLKKFLILNPSKRGTLEQIMKDRWMNVGHEDD 274

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score =  132 bits (333), Expect = 6e-31,   Method: Compositional matrix adjust.
 Identities = 86/282 (30%), Positives = 141/282 (50%), Gaps = 12/282 (4%)
Query: 330 AAKPEPLPMNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQL 389
           A   +  P    ++  K IG+G F  V +A +  TG   A+K +D       ++ S+++L
Sbjct: 4   ATSADEQPHIGNYRLLKTIGKGNFAKVKLARHILTGKEVAVKIID---KTQLNSSSLQKL 60
Query: 390 EQEIKVLSHLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFT 449
            +E++++  L HPNIV+ +     E   Y+ +EY   G +  Y+  H G + E   R   
Sbjct: 61  FREVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAH-GRMKEKEARAKF 119
Query: 450 RHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLT-GQKADLSMKGSPYW 508
           R I+S + Y H K  +HRD+K  NLL+DA   +K+ADFG +   T G K D +  GSP +
Sbjct: 120 RQIVSAVQYCHQKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLD-TFCGSPPY 178
Query: 509 MAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAI 568
            APEL      +GK  D    VD+WSLG  +  + +G  P+          +V+R    I
Sbjct: 179 AAPELF-----QGKKYDGP-EVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRI 232
Query: 569 PDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQPD 610
           P  +S + ++ L+     NP+ R     +++ R++    + D
Sbjct: 233 PFYMSTDCENLLKKFLILNPSKRGTLEQIMKDRWMNVGHEDD 274

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score =  132 bits (331), Expect = 1e-30,   Method: Compositional matrix adjust.
 Identities = 85/282 (30%), Positives = 141/282 (50%), Gaps = 12/282 (4%)
Query: 330 AAKPEPLPMNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQL 389
           A   +  P    ++  K IG+G F  V +A +  TG   A++ +D       ++ S+++L
Sbjct: 4   ATSADEQPHIGNYRLLKTIGKGNFAKVKLARHILTGKEVAVRIID---KTQLNSSSLQKL 60
Query: 390 EQEIKVLSHLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFT 449
            +E++++  L HPNIV+ +     E   Y+ +EY   G +  Y+  H G + E   R   
Sbjct: 61  FREVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAH-GRMKEKEARAKF 119
Query: 450 RHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLT-GQKADLSMKGSPYW 508
           R I+S + Y H K  +HRD+K  NLL+DA   +K+ADFG +   T G K D +  GSP +
Sbjct: 120 RQIVSAVQYCHQKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLD-TFCGSPPY 178
Query: 509 MAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAI 568
            APEL      +GK  D    VD+WSLG  +  + +G  P+          +V+R    I
Sbjct: 179 AAPELF-----QGKKYDGP-EVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRI 232
Query: 569 PDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQPD 610
           P  +S + ++ L+     NP+ R     +++ R++    + D
Sbjct: 233 PFYMSTDCENLLKKFLILNPSKRGTLEQIMKDRWMNVGHEDD 274

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score =  131 bits (330), Expect = 1e-30,   Method: Compositional matrix adjust.
 Identities = 87/278 (31%), Positives = 137/278 (49%), Gaps = 35/278 (12%)
Query: 348 IGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQY 407
           IG G+ G V +A+ + TG   A+K++D+     +  +  + L  E+ ++    H N+V  
Sbjct: 53  IGEGSTGIVCIATEKHTGKQVAVKKMDL-----RKQQRRELLFNEVVIMRDYHHDNVVDM 107
Query: 408 YGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHR 467
           Y S +V D+ ++ +E++  G++   V      + E  +      +L  L+YLH++  IHR
Sbjct: 108 YSSYLVGDELWVVMEFLEGGALTDIVTH--TRMNEEQIATVCLSVLRALSYLHNQGVIHR 165
Query: 468 DIKGANLLVDASGVVKLADFGMAKHLTGQKADLS-MKGSPYWMAPELMMAVMQKGKSSDS 526
           DIK  ++L+ + G +KL+DFG    ++ +      + G+PYWMAPE++  +         
Sbjct: 166 DIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKXLVGTPYWMAPEVISRL-------PY 218
Query: 527 ALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDSLSPEGKD-------- 578
              VDIWSLG  +IEM  G+PP+       AM +       I DSL P  KD        
Sbjct: 219 GTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRR-------IRDSLPPRVKDLHKVSSVL 271
Query: 579 --FLRCCFQRNPADRPPASLLLEHRFLKNSQQPDVPSC 614
             FL     R P+ R  A  LL H FLK +     PSC
Sbjct: 272 RGFLDLMLVREPSQRATAQELLGHPFLKLAGP---PSC 306

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score =  131 bits (330), Expect = 1e-30,   Method: Compositional matrix adjust.
 Identities = 84/266 (31%), Positives = 136/266 (51%), Gaps = 12/266 (4%)
Query: 346 KLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIV 405
           K IG+G F  V +A +  TG   A+K +D       ++ S+++L +E++++  L HPNIV
Sbjct: 13  KTIGKGNFAKVKLARHILTGKEVAVKIID---KTQLNSSSLQKLFREVRIMKVLNHPNIV 69
Query: 406 QYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTI 465
           + +     E   Y+ +EY   G +  Y+  H G + E   R   R I+S + Y H K  +
Sbjct: 70  KLFEVIETEKTLYLVMEYASGGEVFDYLVAH-GWMKEKEARAKFRQIVSAVQYCHQKFIV 128
Query: 466 HRDIKGANLLVDASGVVKLADFGMAKHLT-GQKADLSMKGSPYWMAPELMMAVMQKGKSS 524
           HRD+K  NLL+DA   +K+ADFG +   T G K D +  GSP + APEL      +GK  
Sbjct: 129 HRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLD-TFCGSPPYAAPELF-----QGKKY 182
Query: 525 DSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDSLSPEGKDFLRCCF 584
           D    VD+WSLG  +  + +G  P+          +V+R    IP  +S + ++ L+   
Sbjct: 183 DGP-EVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCENLLKKFL 241
Query: 585 QRNPADRPPASLLLEHRFLKNSQQPD 610
             NP+ R     +++ R++    + D
Sbjct: 242 ILNPSKRGTLEQIMKDRWMNVGHEDD 267

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score =  131 bits (329), Expect = 1e-30,   Method: Compositional matrix adjust.
 Identities = 85/282 (30%), Positives = 141/282 (50%), Gaps = 12/282 (4%)
Query: 330 AAKPEPLPMNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQL 389
           A   +  P    ++  K IG+G F  V +A +  TG   A+K +D       ++ S+++L
Sbjct: 4   ATSADEQPHIGNYRLLKTIGKGNFAKVKLARHILTGKEVAVKIID---KTQLNSSSLQKL 60
Query: 390 EQEIKVLSHLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFT 449
            +E++++  L HPNIV+ +     E   Y+ +EY   G +  Y+  H G + E   R   
Sbjct: 61  FREVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAH-GRMKEKEARAKF 119
Query: 450 RHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLT-GQKADLSMKGSPYW 508
           R I+S + Y H K  +HRD+K  NLL+DA   +K+ADFG +   T G K D +  G+P +
Sbjct: 120 RQIVSAVQYCHQKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLD-AFCGAPPY 178
Query: 509 MAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAI 568
            APEL      +GK  D    VD+WSLG  +  + +G  P+          +V+R    I
Sbjct: 179 AAPELF-----QGKKYDGP-EVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRI 232
Query: 569 PDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQPD 610
           P  +S + ++ L+     NP+ R     +++ R++    + D
Sbjct: 233 PFYMSTDCENLLKKFLILNPSKRGTLEQIMKDRWMNVGHEDD 274

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score =  131 bits (329), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 85/282 (30%), Positives = 140/282 (49%), Gaps = 12/282 (4%)
Query: 330 AAKPEPLPMNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQL 389
           A   +  P    ++  K IG+G F  V +A +  TG   A++ +D       ++ S+++L
Sbjct: 4   ATSADEQPHIGNYRLLKTIGKGNFAKVKLARHILTGKEVAVRIID---KTQLNSSSLQKL 60
Query: 390 EQEIKVLSHLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFT 449
            +E++++  L HPNIV+ +     E   Y+ +EY   G +  Y+  H G + E   R   
Sbjct: 61  FREVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAH-GRMKEKEARAKF 119
Query: 450 RHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLT-GQKADLSMKGSPYW 508
           R I+S + Y H K  +HRD+K  NLL+DA   +K+ADFG +   T G K D    GSP +
Sbjct: 120 RQIVSAVQYCHQKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLD-EFCGSPPY 178
Query: 509 MAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAI 568
            APEL      +GK  D    VD+WSLG  +  + +G  P+          +V+R    I
Sbjct: 179 AAPELF-----QGKKYDGP-EVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRI 232
Query: 569 PDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQPD 610
           P  +S + ++ L+     NP+ R     +++ R++    + D
Sbjct: 233 PFYMSTDCENLLKKFLILNPSKRGTLEQIMKDRWMNVGHEDD 274

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score =  129 bits (324), Expect = 6e-30,   Method: Compositional matrix adjust.
 Identities = 84/296 (28%), Positives = 144/296 (48%), Gaps = 26/296 (8%)
Query: 321 SPSATIPQVAAKPEPLPMNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDP 380
           +P   IP V   P  +    ++ +G+ +G+G F   Y  ++ +T  + A K V      P
Sbjct: 26  APLKEIPDVLVDPRTM---KRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVV------P 76
Query: 381 KSA----ESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREH 436
           KS        +++  EI +   L +P++V ++G    +D  Y+ LE     S+ + + + 
Sbjct: 77  KSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLE-LHKR 135
Query: 437 CGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLT-- 494
             A+TE   R F R  + G+ YLH+ + IHRD+K  NL ++    VK+ DFG+A  +   
Sbjct: 136 RKAVTEPEARYFMRQTIQGVQYLHNNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFD 195
Query: 495 -GQKADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYE 553
             +K DL   G+P ++APE++    +KG S      VDIWSLGC +  +  GKPP+    
Sbjct: 196 GERKKDLC--GTPNYIAPEVL---CKKGHS----FEVDIWSLGCILYTLLVGKPPFETSC 246
Query: 554 GAAAMFKVMRDTPAIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQP 609
                 ++ ++  ++P  ++P     +R     +P  RP  + LL   F  +   P
Sbjct: 247 LKETYIRIKKNEYSVPRHINPVASALIRRMLHADPTLRPSVAELLTDEFFTSGYAP 302

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score =  129 bits (324), Expect = 6e-30,   Method: Compositional matrix adjust.
 Identities = 84/296 (28%), Positives = 144/296 (48%), Gaps = 26/296 (8%)
Query: 321 SPSATIPQVAAKPEPLPMNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDP 380
           +P   IP V   P  +    ++ +G+ +G+G F   Y  ++ +T  + A K V      P
Sbjct: 10  APLKEIPDVLVDPRTM---KRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVV------P 60
Query: 381 KSA----ESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREH 436
           KS        +++  EI +   L +P++V ++G    +D  Y+ LE     S+ + + + 
Sbjct: 61  KSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLE-LHKR 119
Query: 437 CGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLT-- 494
             A+TE   R F R  + G+ YLH+ + IHRD+K  NL ++    VK+ DFG+A  +   
Sbjct: 120 RKAVTEPEARYFMRQTIQGVQYLHNNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFD 179
Query: 495 -GQKADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYE 553
             +K DL   G+P ++APE++    +KG S      VDIWSLGC +  +  GKPP+    
Sbjct: 180 GERKKDLC--GTPNYIAPEVL---CKKGHS----FEVDIWSLGCILYTLLVGKPPFETSC 230
Query: 554 GAAAMFKVMRDTPAIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQP 609
                 ++ ++  ++P  ++P     +R     +P  RP  + LL   F  +   P
Sbjct: 231 LKETYIRIKKNEYSVPRHINPVASALIRRMLHADPTLRPSVAELLTDEFFTSGYAP 286

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score =  128 bits (322), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 82/295 (27%), Positives = 145/295 (49%), Gaps = 24/295 (8%)
Query: 321 SPSATIPQVAAKPEPLPMNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDP 380
           +P   IP V   P  +    ++ +G+ +G+G F   Y  ++ +T  + A K V      P
Sbjct: 26  APLKEIPDVLVDPRTM---KRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVV------P 76
Query: 381 KSA----ESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREH 436
           KS        +++  EI +   L +P++V ++G    +D  Y+ LE     S+ + + + 
Sbjct: 77  KSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLE-LHKR 135
Query: 437 CGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLT-- 494
             A+TE   R F R  + G+ YLH+ + IHRD+K  NL ++    VK+ DFG+A  +   
Sbjct: 136 RKAVTEPEARYFMRQTIQGVQYLHNNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFD 195
Query: 495 GQKADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEG 554
           G++   ++ G+P ++APE++    +KG S      VDIWSLGC +  +  GKPP+     
Sbjct: 196 GERKK-TLCGTPNYIAPEVL---CKKGHS----FEVDIWSLGCILYTLLVGKPPFETSCL 247
Query: 555 AAAMFKVMRDTPAIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQP 609
                ++ ++  ++P  ++P     +R     +P  RP  + LL   F  +   P
Sbjct: 248 KETYIRIKKNEYSVPRHINPVASALIRRMLHADPTLRPSVAELLTDEFFTSGYAP 302

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score =  127 bits (320), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 82/295 (27%), Positives = 144/295 (48%), Gaps = 24/295 (8%)
Query: 321 SPSATIPQVAAKPEPLPMNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDP 380
           +P   IP V   P  +    ++ +G+ +G+G F   Y  ++ +T  + A K V      P
Sbjct: 26  APLKEIPDVLVDPRTM---KRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVV------P 76
Query: 381 KSA----ESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREH 436
           KS        +++  EI +   L +P++V ++G    +D  Y+ LE     S+ + + + 
Sbjct: 77  KSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLE-LHKR 135
Query: 437 CGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLT-- 494
             A+TE   R F R  + G+ YLH+ + IHRD+K  NL ++    VK+ DFG+A  +   
Sbjct: 136 RKAVTEPEARYFMRQTIQGVQYLHNNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFD 195
Query: 495 GQKADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEG 554
           G++    + G+P ++APE++    +KG S      VDIWSLGC +  +  GKPP+     
Sbjct: 196 GERKK-XLCGTPNYIAPEVL---CKKGHS----FEVDIWSLGCILYTLLVGKPPFETSCL 247
Query: 555 AAAMFKVMRDTPAIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQP 609
                ++ ++  ++P  ++P     +R     +P  RP  + LL   F  +   P
Sbjct: 248 KETYIRIKKNEYSVPRHINPVASALIRRMLHADPTLRPSVAELLTDEFFTSGYAP 302

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score =  125 bits (315), Expect = 6e-29,   Method: Compositional matrix adjust.
 Identities = 84/277 (30%), Positives = 134/277 (48%), Gaps = 26/277 (9%)
Query: 346 KLIGRGTFGSVYVASNRETGALCAMK----EVDIFPDDPKSAESIKQLEQEIKVLSHLKH 401
           KL+G+GTFG V +   + TG   AMK    EV I  D+      +     E +VL + +H
Sbjct: 14  KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDE------VAHTVTESRVLQNTRH 67
Query: 402 PNIVQYYGSEIVEDKFYIYLEYVHPGSINKYV-REHCGAITESVVRNFTRHILSGLAYLH 460
           P +     +    D+    +EY + G +  ++ RE     TE   R +   I+S L YLH
Sbjct: 68  PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRER--VFTEERARFYGAEIVSALEYLH 125
Query: 461 SKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADL-SMKGSPYWMAPELMMAVMQ 519
           S+  ++RDIK  NL++D  G +K+ DFG+ K      A + +  G+P ++APE++     
Sbjct: 126 SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVL----- 180
Query: 520 KGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDSLSPEGKDF 579
             + +D   AVD W LG  + EM  G+ P+   +       ++ +    P +LSPE K  
Sbjct: 181 --EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSL 238
Query: 580 LRCCFQRNPADR-----PPASLLLEHRFLKNSQQPDV 611
           L    +++P  R       A  ++EHRF  +    DV
Sbjct: 239 LAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDV 275

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score =  125 bits (315), Expect = 6e-29,   Method: Compositional matrix adjust.
 Identities = 82/280 (29%), Positives = 153/280 (54%), Gaps = 20/280 (7%)
Query: 339 NSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSH 398
           +  ++K   +G G  G V+  S++ +G + A K + +   + K A    Q+ +E++VL  
Sbjct: 24  DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHL---EIKPAIR-NQIIRELQVLHE 79
Query: 399 LKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAY 458
              P IV +YG+   + +  I +E++  GS+++ +++  G I E ++   +  ++ GL Y
Sbjct: 80  CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK-AGRIPEQILGKVSIAVIKGLTY 138
Query: 459 LHSK-KTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPYWMAPELMMAV 517
           L  K K +HRD+K +N+LV++ G +KL DFG++  L    A+ S  G+  +M+PE +   
Sbjct: 139 LREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN-SFVGTRSYMSPERL--- 194
Query: 518 MQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDT-----PAIPDSL 572
               + +  ++  DIWS+G +++EM  G+ P     G+ A+F+++        P +P  +
Sbjct: 195 ----QGTHYSVQSDIWSMGLSLVEMAVGRYPIGSGSGSMAIFELLDYIVNEPPPKLPSGV 250
Query: 573 -SPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQPDV 611
            S E +DF+  C  +NPA+R     L+ H F+K S   +V
Sbjct: 251 FSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDAEEV 290

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score =  125 bits (315), Expect = 6e-29,   Method: Compositional matrix adjust.
 Identities = 78/259 (30%), Positives = 130/259 (50%), Gaps = 13/259 (5%)
Query: 348 IGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQY 407
           IG G+FG   +  + E G    +KE++I     K  E  ++   E+ VL+++KHPNIVQY
Sbjct: 32  IGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRR---EVAVLANMKHPNIVQY 88
Query: 408 YGSEIVEDKFYIYLEYVHPGSINKYVREHCGAI-TESVVRNFTRHILSGLAYLHSKKTIH 466
             S       YI ++Y   G + K +    G +  E  + ++   I   L ++H +K +H
Sbjct: 89  RESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILH 148
Query: 467 RDIKGANLLVDASGVVKLADFGMAKHLTGQ-KADLSMKGSPYWMAPELMMAVMQKGKSSD 525
           RDIK  N+ +   G V+L DFG+A+ L    +   +  G+PY+++PE+        KS  
Sbjct: 149 RDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICENKPYNNKS-- 206
Query: 526 SALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDT-PAIPDSLSPEGKDFLRCCF 584
                DIW+LGC + E+ T K  +        + K++  + P +    S + +  +   F
Sbjct: 207 -----DIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPPVSLHYSYDLRSLVSQLF 261
Query: 585 QRNPADRPPASLLLEHRFL 603
           +RNP DRP  + +LE  F+
Sbjct: 262 KRNPRDRPSVNSILEKGFI 280

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score =  125 bits (315), Expect = 7e-29,   Method: Compositional matrix adjust.
 Identities = 84/277 (30%), Positives = 134/277 (48%), Gaps = 26/277 (9%)
Query: 346 KLIGRGTFGSVYVASNRETGALCAMK----EVDIFPDDPKSAESIKQLEQEIKVLSHLKH 401
           KL+G+GTFG V +   + TG   AMK    EV I  D+      +     E +VL + +H
Sbjct: 11  KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDE------VAHTVTESRVLQNTRH 64
Query: 402 PNIVQYYGSEIVEDKFYIYLEYVHPGSINKYV-REHCGAITESVVRNFTRHILSGLAYLH 460
           P +     +    D+    +EY + G +  ++ RE     TE   R +   I+S L YLH
Sbjct: 65  PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRER--VFTEERARFYGAEIVSALEYLH 122
Query: 461 SKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADL-SMKGSPYWMAPELMMAVMQ 519
           S+  ++RDIK  NL++D  G +K+ DFG+ K      A + +  G+P ++APE++     
Sbjct: 123 SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVL----- 177
Query: 520 KGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDSLSPEGKDF 579
             + +D   AVD W LG  + EM  G+ P+   +       ++ +    P +LSPE K  
Sbjct: 178 --EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSL 235
Query: 580 LRCCFQRNPADR-----PPASLLLEHRFLKNSQQPDV 611
           L    +++P  R       A  ++EHRF  +    DV
Sbjct: 236 LAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDV 272

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score =  125 bits (314), Expect = 7e-29,   Method: Compositional matrix adjust.
 Identities = 93/325 (28%), Positives = 149/325 (45%), Gaps = 50/325 (15%)
Query: 335 PLPMNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIK 394
           PL     +QK + IG GT+G VY A N+ TG + A+K++ +   D ++        +EI 
Sbjct: 2   PLVDMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL---DTETEGVPSTAIREIS 58
Query: 395 VLSHLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHC-GAITESVVRNFTRHIL 453
           +L  L HPNIV+       E+K Y+  E++H   + K++       I   +++++   +L
Sbjct: 59  LLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLL 117
Query: 454 SGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPYWM-APE 512
            GLA+ HS + +HRD+K  NLL++  G +KLADFG+A+         + +    W  APE
Sbjct: 118 QGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPE 177
Query: 513 LMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRD--TP---- 566
           +++           + AVDIWSLGC   EM T +  +        +F++ R   TP    
Sbjct: 178 ILLG------CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVV 231
Query: 567 -----AIPDS------------------LSPEGKDFLRCCFQRNPADRPPASLLLEHRFL 603
                ++PD                   L  +G+  L      +P  R  A   L H F 
Sbjct: 232 WPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 291
Query: 604 KNSQQPDVPSCSLSFSGMQLTEKPH 628
           ++  +P VP   L        E+PH
Sbjct: 292 QDVTKP-VPHLRL--------ERPH 307

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score =  125 bits (314), Expect = 8e-29,   Method: Compositional matrix adjust.
 Identities = 84/277 (30%), Positives = 134/277 (48%), Gaps = 26/277 (9%)
Query: 346 KLIGRGTFGSVYVASNRETGALCAMK----EVDIFPDDPKSAESIKQLEQEIKVLSHLKH 401
           KL+G+GTFG V +   + TG   AMK    EV I  D+      +     E +VL + +H
Sbjct: 11  KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDE------VAHTVTESRVLQNTRH 64
Query: 402 PNIVQYYGSEIVEDKFYIYLEYVHPGSINKYV-REHCGAITESVVRNFTRHILSGLAYLH 460
           P +     +    D+    +EY + G +  ++ RE     TE   R +   I+S L YLH
Sbjct: 65  PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRER--VFTEERARFYGAEIVSALEYLH 122
Query: 461 SKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADL-SMKGSPYWMAPELMMAVMQ 519
           S+  ++RDIK  NL++D  G +K+ DFG+ K      A + +  G+P ++APE++     
Sbjct: 123 SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVL----- 177
Query: 520 KGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDSLSPEGKDF 579
             + +D   AVD W LG  + EM  G+ P+   +       ++ +    P +LSPE K  
Sbjct: 178 --EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSL 235
Query: 580 LRCCFQRNPADR-----PPASLLLEHRFLKNSQQPDV 611
           L    +++P  R       A  ++EHRF  +    DV
Sbjct: 236 LAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDV 272

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score =  125 bits (313), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 79/268 (29%), Positives = 132/268 (49%), Gaps = 11/268 (4%)
Query: 345 GKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNI 404
           G+ +G+G FG+VY+A  ++   + A+K   +F    +      QL +EI++ SHL+HPNI
Sbjct: 20  GRPLGKGKFGNVYLAREKQNKFIMALKV--LFKSQLEKEGVEHQLRREIEIQSHLRHPNI 77
Query: 405 VQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKT 464
           ++ Y       + Y+ LE+   G + K +++H G   E     F   +   L Y H +K 
Sbjct: 78  LRMYNYFHDRKRIYLMLEFAPRGELYKELQKH-GRFDEQRSATFMEELADALHYCHERKV 136
Query: 465 IHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPYWMAPELMMAVMQKGKSS 524
           IHRDIK  NLL+   G +K+ADFG + H    +    M G+  ++ PE++     +GK+ 
Sbjct: 137 IHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRR-XMCGTLDYLPPEMI-----EGKTH 190
Query: 525 DSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDSLSPEGKDFLRCCF 584
           D    VD+W  G    E   G PP+          +++      P  LS   KD +    
Sbjct: 191 DE--KVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPPFLSDGSKDLISKLL 248
Query: 585 QRNPADRPPASLLLEHRFLKNSQQPDVP 612
           + +P  R P   ++EH ++K + +  +P
Sbjct: 249 RYHPPQRLPLKGVMEHPWVKANSRRVLP 276

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score =  125 bits (313), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 84/277 (30%), Positives = 133/277 (48%), Gaps = 26/277 (9%)
Query: 346 KLIGRGTFGSVYVASNRETGALCAMK----EVDIFPDDPKSAESIKQLEQEIKVLSHLKH 401
           KL+G+GTFG V +   + TG   AMK    EV I  D+      +     E +VL + +H
Sbjct: 11  KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDE------VAHTVTESRVLQNTRH 64
Query: 402 PNIVQYYGSEIVEDKFYIYLEYVHPGSINKYV-REHCGAITESVVRNFTRHILSGLAYLH 460
           P +     +    D+    +EY + G +  ++ RE     TE   R +   I+S L YLH
Sbjct: 65  PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRER--VFTEERARFYGAEIVSALEYLH 122
Query: 461 SKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLS-MKGSPYWMAPELMMAVMQ 519
           S+  ++RDIK  NL++D  G +K+ DFG+ K      A +    G+P ++APE++     
Sbjct: 123 SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVL----- 177
Query: 520 KGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDSLSPEGKDF 579
             + +D   AVD W LG  + EM  G+ P+   +       ++ +    P +LSPE K  
Sbjct: 178 --EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSL 235
Query: 580 LRCCFQRNPADR-----PPASLLLEHRFLKNSQQPDV 611
           L    +++P  R       A  ++EHRF  +    DV
Sbjct: 236 LAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDV 272

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score =  124 bits (312), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 84/277 (30%), Positives = 133/277 (48%), Gaps = 26/277 (9%)
Query: 346 KLIGRGTFGSVYVASNRETGALCAMK----EVDIFPDDPKSAESIKQLEQEIKVLSHLKH 401
           KL+G+GTFG V +   + TG   AMK    EV I  D+      +     E +VL + +H
Sbjct: 11  KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDE------VAHTVTESRVLQNTRH 64
Query: 402 PNIVQYYGSEIVEDKFYIYLEYVHPGSINKYV-REHCGAITESVVRNFTRHILSGLAYLH 460
           P +     +    D+    +EY + G +  ++ RE     TE   R +   I+S L YLH
Sbjct: 65  PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRER--VFTEERARFYGAEIVSALEYLH 122
Query: 461 SKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLS-MKGSPYWMAPELMMAVMQ 519
           S+  ++RDIK  NL++D  G +K+ DFG+ K      A +    G+P ++APE++     
Sbjct: 123 SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVL----- 177
Query: 520 KGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDSLSPEGKDF 579
             + +D   AVD W LG  + EM  G+ P+   +       ++ +    P +LSPE K  
Sbjct: 178 --EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSL 235
Query: 580 LRCCFQRNPADR-----PPASLLLEHRFLKNSQQPDV 611
           L    +++P  R       A  ++EHRF  +    DV
Sbjct: 236 LAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDV 272

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score =  124 bits (311), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 85/282 (30%), Positives = 134/282 (47%), Gaps = 26/282 (9%)
Query: 346 KLIGRGTFGSVYVASNRETGALCAMK----EVDIFPDDPKSAESIKQLEQEIKVLSHLKH 401
           KL+G+GTFG V +   + TG   AMK    EV I  D+      +     E +VL + +H
Sbjct: 11  KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDE------VAHTVTESRVLQNTRH 64
Query: 402 PNIVQYYGSEIVEDKFYIYLEYVHPGSINKYV-REHCGAITESVVRNFTRHILSGLAYLH 460
           P +     +    D+    +EY + G +  ++ RE     TE   R +   I+S L YLH
Sbjct: 65  PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRER--VFTEERARFYGAEIVSALEYLH 122
Query: 461 SKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLS-MKGSPYWMAPELMMAVMQ 519
           S+  ++RDIK  NL++D  G +K+ DFG+ K      A +    G+P ++APE++     
Sbjct: 123 SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVL----- 177
Query: 520 KGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDSLSPEGKDF 579
             + +D   AVD W LG  + EM  G+ P+   +       ++ +    P +LSPE K  
Sbjct: 178 --EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSL 235
Query: 580 LRCCFQRNPADR-----PPASLLLEHRFLKNSQQPDVPSCSL 616
           L    +++P  R       A  ++EHRF  +    DV    L
Sbjct: 236 LAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKL 277

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score =  124 bits (311), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 85/282 (30%), Positives = 134/282 (47%), Gaps = 26/282 (9%)
Query: 346 KLIGRGTFGSVYVASNRETGALCAMK----EVDIFPDDPKSAESIKQLEQEIKVLSHLKH 401
           KL+G+GTFG V +   + TG   AMK    EV I  D+      +     E +VL + +H
Sbjct: 16  KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDE------VAHTVTESRVLQNTRH 69
Query: 402 PNIVQYYGSEIVEDKFYIYLEYVHPGSINKYV-REHCGAITESVVRNFTRHILSGLAYLH 460
           P +     +    D+    +EY + G +  ++ RE     TE   R +   I+S L YLH
Sbjct: 70  PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRER--VFTEERARFYGAEIVSALEYLH 127
Query: 461 SKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLS-MKGSPYWMAPELMMAVMQ 519
           S+  ++RDIK  NL++D  G +K+ DFG+ K      A +    G+P ++APE++     
Sbjct: 128 SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVL----- 182
Query: 520 KGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDSLSPEGKDF 579
             + +D   AVD W LG  + EM  G+ P+   +       ++ +    P +LSPE K  
Sbjct: 183 --EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSL 240
Query: 580 LRCCFQRNPADR-----PPASLLLEHRFLKNSQQPDVPSCSL 616
           L    +++P  R       A  ++EHRF  +    DV    L
Sbjct: 241 LAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKL 282

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score =  124 bits (311), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 85/282 (30%), Positives = 135/282 (47%), Gaps = 12/282 (4%)
Query: 330 AAKPEPLPMNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQL 389
           A   +  P    ++  K IG+G F  V +A +  TG   A+K +D       ++ S+++L
Sbjct: 4   ATSADEQPHIGNYRLLKTIGKGNFAKVKLARHILTGKEVAVKIID---KTQLNSSSLQKL 60
Query: 390 EQEIKVLSHLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFT 449
            +E+++   L HPNIV+ +     E   Y+  EY   G +  Y+  H G   E   R   
Sbjct: 61  FREVRIXKVLNHPNIVKLFEVIETEKTLYLVXEYASGGEVFDYLVAH-GRXKEKEARAKF 119
Query: 450 RHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLT-GQKADLSMKGSPYW 508
           R I+S + Y H K  +HRD+K  NLL+DA   +K+ADFG +   T G K D +  G+P +
Sbjct: 120 RQIVSAVQYCHQKFIVHRDLKAENLLLDADXNIKIADFGFSNEFTFGNKLD-AFCGAPPY 178
Query: 509 MAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAI 568
            APEL      +GK  D    VD+WSLG  +  + +G  P+          +V+R    I
Sbjct: 179 AAPELF-----QGKKYDGP-EVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRI 232
Query: 569 PDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQPD 610
           P   S + ++ L+     NP+ R     + + R+     + D
Sbjct: 233 PFYXSTDCENLLKKFLILNPSKRGTLEQIXKDRWXNVGHEDD 274

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score =  124 bits (310), Expect = 3e-28,   Method: Compositional matrix adjust.
 Identities = 90/313 (28%), Positives = 144/313 (46%), Gaps = 42/313 (13%)
Query: 335 PLPMNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIK 394
           PL     +QK + IG GT+G VY A N+ TG + A+K++ +   D ++        +EI 
Sbjct: 2   PLGSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL---DTETEGVPSTAIREIS 58
Query: 395 VLSHLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHC-GAITESVVRNFTRHIL 453
           +L  L HPNIV+       E+K Y+  E++H   + K++       I   +++++   +L
Sbjct: 59  LLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLL 117
Query: 454 SGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPYWM-APE 512
            GLA+ HS + +HRD+K  NLL++  G +KLADFG+A+           +    W  APE
Sbjct: 118 QGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPE 177
Query: 513 LMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRD--TP---- 566
           +++           + AVDIWSLGC   EM T +  +        +F++ R   TP    
Sbjct: 178 ILLG------CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVV 231
Query: 567 -----AIPDS------------------LSPEGKDFLRCCFQRNPADRPPASLLLEHRFL 603
                ++PD                   L  +G+  L      +P  R  A   L H F 
Sbjct: 232 WPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 291
Query: 604 KNSQQPDVPSCSL 616
           ++  +P VP   L
Sbjct: 292 QDVTKP-VPHLRL 303

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score =  123 bits (309), Expect = 3e-28,   Method: Compositional matrix adjust.
 Identities = 78/265 (29%), Positives = 130/265 (49%), Gaps = 11/265 (4%)
Query: 348 IGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQY 407
           +G+G FG+VY+A  ++   + A+K   +F    +      QL +EI++ SHL+HPNI++ 
Sbjct: 22  LGKGKFGNVYLAREKQNKFIMALKV--LFKSQLEKEGVEHQLRREIEIQSHLRHPNILRM 79
Query: 408 YGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHR 467
           Y       + Y+ LE+   G + K +++H G   E     F   +   L Y H +K IHR
Sbjct: 80  YNYFHDRKRIYLMLEFAPRGELYKELQKH-GRFDEQRSATFMEELADALHYCHERKVIHR 138
Query: 468 DIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPYWMAPELMMAVMQKGKSSDSA 527
           DIK  NLL+   G +K+ADFG + H    +    M G+  ++ PE++     +GK+ D  
Sbjct: 139 DIKPENLLMGYKGELKIADFGWSVHAPSLRRR-XMCGTLDYLPPEMI-----EGKTHDE- 191
Query: 528 LAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDSLSPEGKDFLRCCFQRN 587
             VD+W  G    E   G PP+          +++      P  LS   KD +    + +
Sbjct: 192 -KVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPPFLSDGSKDLISKLLRYH 250
Query: 588 PADRPPASLLLEHRFLKNSQQPDVP 612
           P  R P   ++EH ++K + +  +P
Sbjct: 251 PPQRLPLKGVMEHPWVKANSRRVLP 275

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score =  123 bits (309), Expect = 3e-28,   Method: Compositional matrix adjust.
 Identities = 87/306 (28%), Positives = 141/306 (46%), Gaps = 41/306 (13%)
Query: 335 PLPMNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIK 394
           PL     +QK + IG GT+G VY A N+ TG + A+K++ +   D ++        +EI 
Sbjct: 1   PLGSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL---DTETEGVPSTAIREIS 57
Query: 395 VLSHLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHC-GAITESVVRNFTRHIL 453
           +L  L HPNIV+       E+K Y+  E++H   + K++       I   +++++   +L
Sbjct: 58  LLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLL 116
Query: 454 SGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPYWM-APE 512
            GLA+ HS + +HRD+K  NLL++  G +KLADFG+A+           +    W  APE
Sbjct: 117 QGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPE 176
Query: 513 LMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRD--TP---- 566
           +++           + AVDIWSLGC   EM T +  +        +F++ R   TP    
Sbjct: 177 ILLG------CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVV 230
Query: 567 -----AIPDS------------------LSPEGKDFLRCCFQRNPADRPPASLLLEHRFL 603
                ++PD                   L  +G+  L      +P  R  A   L H F 
Sbjct: 231 WPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 290
Query: 604 KNSQQP 609
           ++  +P
Sbjct: 291 QDVTKP 296

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score =  123 bits (308), Expect = 4e-28,   Method: Compositional matrix adjust.
 Identities = 88/306 (28%), Positives = 139/306 (45%), Gaps = 40/306 (13%)
Query: 341 QWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLK 400
            +QK + IG GT+G VY A N+ TG + A+K++ +   D ++        +EI +L  L 
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL---DTETEGVPSTAIREISLLKELN 59
Query: 401 HPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLH 460
           HPNIV+       E+K Y+  E+VH              I   +++++   +L GLA+ H
Sbjct: 60  HPNIVKLLDVIHTENKLYLVFEHVHQDLKTFMDASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 461 SKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPYWM-APELMMAVMQ 519
           S + +HRD+K  NLL++  G +KLADFG+A+         + +    W  APE+++    
Sbjct: 120 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG--- 176
Query: 520 KGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRD--TP---------AI 568
                  + AVDIWSLGC   EM T +  +        +F++ R   TP         ++
Sbjct: 177 ---CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSM 233
Query: 569 PDS------------------LSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQPD 610
           PD                   L  +G+  L      +P  R  A   L H F ++  +P 
Sbjct: 234 PDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP- 292
Query: 611 VPSCSL 616
           VP   L
Sbjct: 293 VPHLRL 298

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score =  123 bits (308), Expect = 4e-28,   Method: Compositional matrix adjust.
 Identities = 90/307 (29%), Positives = 145/307 (47%), Gaps = 42/307 (13%)
Query: 341 QWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLK 400
            +QK + IG GT+G VY A N+ TG + A+K++ +   D ++        +EI +L  L 
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL---DTETEGVPSTAIREISLLKELN 60
Query: 401 HPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHC-GAITESVVRNFTRHILSGLAYL 459
           HPNIV+       E+K Y+  E++H   + K++       I   +++++   +L GLA+ 
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 119
Query: 460 HSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPYWM-APELMMAVM 518
           HS + +HRD+K  NLL++  G +KLADFG+A+         + +    W  APE+++   
Sbjct: 120 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG-- 177
Query: 519 QKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRD--TP---------A 567
            K  S+    AVDIWSLGC   EM T +  +        +F++ R   TP         +
Sbjct: 178 XKYYST----AVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS 233
Query: 568 IPDS------------------LSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQP 609
           +PD                   L  +G+  L      +P  R  A   L H F ++  +P
Sbjct: 234 MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 293
Query: 610 DVPSCSL 616
            VP   L
Sbjct: 294 -VPHLRL 299

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score =  123 bits (308), Expect = 4e-28,   Method: Compositional matrix adjust.
 Identities = 88/307 (28%), Positives = 143/307 (46%), Gaps = 42/307 (13%)
Query: 341 QWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLK 400
            +QK + IG GT+G VY A N+ TG + A+K++ +   D ++        +EI +L  L 
Sbjct: 11  NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL---DTETEGVPSTAIREISLLKELN 67
Query: 401 HPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHC-GAITESVVRNFTRHILSGLAYL 459
           HPNIV+       E+K Y+  E++H   + K++       I   +++++   +L GLA+ 
Sbjct: 68  HPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 126
Query: 460 HSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPYWM-APELMMAVM 518
           HS + +HRD+K  NLL++  G +KLADFG+A+         + +    W  APE+++   
Sbjct: 127 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG-- 184
Query: 519 QKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRD--TP---------A 567
                   + AVDIWSLGC   EM T +  +        +F++ R   TP         +
Sbjct: 185 ----XKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS 240
Query: 568 IPDS------------------LSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQP 609
           +PD                   L  +G+  L      +P  R  A   L H F ++  +P
Sbjct: 241 MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 300
Query: 610 DVPSCSL 616
            VP   L
Sbjct: 301 -VPHLRL 306

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score =  123 bits (308), Expect = 4e-28,   Method: Compositional matrix adjust.
 Identities = 88/307 (28%), Positives = 143/307 (46%), Gaps = 42/307 (13%)
Query: 341 QWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLK 400
            +QK + IG GT+G VY A N+ TG + A+K++ +   D ++        +EI +L  L 
Sbjct: 11  NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL---DTETEGVPSTAIREISLLKELN 67
Query: 401 HPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHC-GAITESVVRNFTRHILSGLAYL 459
           HPNIV+       E+K Y+  E++H   + K++       I   +++++   +L GLA+ 
Sbjct: 68  HPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 126
Query: 460 HSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPYWM-APELMMAVM 518
           HS + +HRD+K  NLL++  G +KLADFG+A+         + +    W  APE+++   
Sbjct: 127 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG-- 184
Query: 519 QKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRD--TP---------A 567
                   + AVDIWSLGC   EM T +  +        +F++ R   TP         +
Sbjct: 185 ----CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS 240
Query: 568 IPDS------------------LSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQP 609
           +PD                   L  +G+  L      +P  R  A   L H F ++  +P
Sbjct: 241 MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 300
Query: 610 DVPSCSL 616
            VP   L
Sbjct: 301 -VPHLRL 306

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score =  122 bits (307), Expect = 5e-28,   Method: Compositional matrix adjust.
 Identities = 88/307 (28%), Positives = 143/307 (46%), Gaps = 42/307 (13%)
Query: 341 QWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLK 400
            +QK + IG GT+G VY A N+ TG + A+K++ +   D ++        +EI +L  L 
Sbjct: 5   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL---DTETEGVPSTAIREISLLKELN 61
Query: 401 HPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHC-GAITESVVRNFTRHILSGLAYL 459
           HPNIV+       E+K Y+  E++H   + K++       I   +++++   +L GLA+ 
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 120
Query: 460 HSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPYWM-APELMMAVM 518
           HS + +HRD+K  NLL++  G +KLADFG+A+         + +    W  APE+++   
Sbjct: 121 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG-- 178
Query: 519 QKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRD--TP---------A 567
                   + AVDIWSLGC   EM T +  +        +F++ R   TP         +
Sbjct: 179 ----CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS 234
Query: 568 IPDS------------------LSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQP 609
           +PD                   L  +G+  L      +P  R  A   L H F ++  +P
Sbjct: 235 MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 294
Query: 610 DVPSCSL 616
            VP   L
Sbjct: 295 -VPHLRL 300

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score =  122 bits (307), Expect = 5e-28,   Method: Compositional matrix adjust.
 Identities = 84/276 (30%), Positives = 138/276 (50%), Gaps = 12/276 (4%)
Query: 329 VAAKPEPLPMNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQ 388
           + +  +  P    ++  K IG+G F  V +A +  TG   A+K +D    +P S   +++
Sbjct: 4   ITSATDEQPHIGNYRLQKTIGKGNFAKVKLARHVLTGREVAVKIIDKTQLNPTS---LQK 60
Query: 389 LEQEIKVLSHLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNF 448
           L +E++++  L HPNIV+ +     E   Y+ +EY   G +  Y+  H G + E   R  
Sbjct: 61  LFREVRIMKILNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAH-GRMKEKEARAK 119
Query: 449 TRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLT-GQKADLSMKGSPY 507
            R I+S + Y H K  +HRD+K  NLL+D    +K+ADFG +   T G K D +  GSP 
Sbjct: 120 FRQIVSAVQYCHQKYIVHRDLKAENLLLDGDMNIKIADFGFSNEFTVGNKLD-TFCGSPP 178
Query: 508 WMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPA 567
           + APEL      +GK  D    VD+WSLG  +  + +G  P+          +V+R    
Sbjct: 179 YAAPELF-----QGKKYDGP-EVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYR 232
Query: 568 IPDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFL 603
           IP  +S + ++ L+     NP  R     +++ R++
Sbjct: 233 IPFYMSTDCENLLKKLLVLNPIKRGSLEQIMKDRWM 268

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score =  122 bits (307), Expect = 5e-28,   Method: Compositional matrix adjust.
 Identities = 88/307 (28%), Positives = 143/307 (46%), Gaps = 42/307 (13%)
Query: 341 QWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLK 400
            +QK + IG GT+G VY A N+ TG + A+K++ +   D ++        +EI +L  L 
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL---DTETEGVPSTAIREISLLKELN 59
Query: 401 HPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHC-GAITESVVRNFTRHILSGLAYL 459
           HPNIV+       E+K Y+  E++H   + K++       I   +++++   +L GLA+ 
Sbjct: 60  HPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 118
Query: 460 HSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPYWM-APELMMAVM 518
           HS + +HRD+K  NLL++  G +KLADFG+A+         + +    W  APE+++   
Sbjct: 119 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG-- 176
Query: 519 QKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRD--TP---------A 567
                   + AVDIWSLGC   EM T +  +        +F++ R   TP         +
Sbjct: 177 ----CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS 232
Query: 568 IPDS------------------LSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQP 609
           +PD                   L  +G+  L      +P  R  A   L H F ++  +P
Sbjct: 233 MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 292
Query: 610 DVPSCSL 616
            VP   L
Sbjct: 293 -VPHLRL 298

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score =  122 bits (307), Expect = 6e-28,   Method: Compositional matrix adjust.
 Identities = 88/307 (28%), Positives = 143/307 (46%), Gaps = 42/307 (13%)
Query: 341 QWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLK 400
            +QK + IG GT+G VY A N+ TG + A+K++ +   D ++        +EI +L  L 
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL---DTETEGVPSTAIREISLLKELN 60
Query: 401 HPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHC-GAITESVVRNFTRHILSGLAYL 459
           HPNIV+       E+K Y+  E++H   + K++       I   +++++   +L GLA+ 
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 119
Query: 460 HSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPYWM-APELMMAVM 518
           HS + +HRD+K  NLL++  G +KLADFG+A+         + +    W  APE+++   
Sbjct: 120 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG-- 177
Query: 519 QKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRD--TP---------A 567
                   + AVDIWSLGC   EM T +  +        +F++ R   TP         +
Sbjct: 178 ----CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS 233
Query: 568 IPDS------------------LSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQP 609
           +PD                   L  +G+  L      +P  R  A   L H F ++  +P
Sbjct: 234 MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 293
Query: 610 DVPSCSL 616
            VP   L
Sbjct: 294 -VPHLRL 299

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score =  122 bits (307), Expect = 6e-28,   Method: Compositional matrix adjust.
 Identities = 88/307 (28%), Positives = 143/307 (46%), Gaps = 42/307 (13%)
Query: 341 QWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLK 400
            +QK + IG GT+G VY A N+ TG + A+K++ +   D ++        +EI +L  L 
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL---DTETEGVPSTAIREISLLKELN 59
Query: 401 HPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHC-GAITESVVRNFTRHILSGLAYL 459
           HPNIV+       E+K Y+  E++H   + K++       I   +++++   +L GLA+ 
Sbjct: 60  HPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 118
Query: 460 HSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPYWM-APELMMAVM 518
           HS + +HRD+K  NLL++  G +KLADFG+A+         + +    W  APE+++   
Sbjct: 119 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG-- 176
Query: 519 QKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRD--TP---------A 567
                   + AVDIWSLGC   EM T +  +        +F++ R   TP         +
Sbjct: 177 ----CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS 232
Query: 568 IPDS------------------LSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQP 609
           +PD                   L  +G+  L      +P  R  A   L H F ++  +P
Sbjct: 233 MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 292
Query: 610 DVPSCSL 616
            VP   L
Sbjct: 293 -VPHLRL 298

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score =  122 bits (307), Expect = 6e-28,   Method: Compositional matrix adjust.
 Identities = 88/307 (28%), Positives = 143/307 (46%), Gaps = 42/307 (13%)
Query: 341 QWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLK 400
            +QK + IG GT+G VY A N+ TG + A+K++ +   D ++        +EI +L  L 
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL---DTETEGVPSTAIREISLLKELN 60
Query: 401 HPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHC-GAITESVVRNFTRHILSGLAYL 459
           HPNIV+       E+K Y+  E++H   + K++       I   +++++   +L GLA+ 
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 119
Query: 460 HSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPYWM-APELMMAVM 518
           HS + +HRD+K  NLL++  G +KLADFG+A+         + +    W  APE+++   
Sbjct: 120 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG-- 177
Query: 519 QKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRD--TP---------A 567
                   + AVDIWSLGC   EM T +  +        +F++ R   TP         +
Sbjct: 178 ----CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS 233
Query: 568 IPDS------------------LSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQP 609
           +PD                   L  +G+  L      +P  R  A   L H F ++  +P
Sbjct: 234 MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 293
Query: 610 DVPSCSL 616
            VP   L
Sbjct: 294 -VPHLRL 299

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score =  122 bits (306), Expect = 6e-28,   Method: Compositional matrix adjust.
 Identities = 89/306 (29%), Positives = 141/306 (46%), Gaps = 40/306 (13%)
Query: 341 QWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLK 400
            +QK + IG GT+G VY A N+ TG + A+K++ +   D ++        +EI +L  L 
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL---DTETEGVPSTAIREISLLKELN 60
Query: 401 HPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLH 460
           HPNIV+       E+K Y+  E++H    +         I   +++++   +L GLA+ H
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQDLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCH 120
Query: 461 SKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPYWM-APELMMAVMQ 519
           S + +HRD+K  NLL++  G +KLADFG+A+           +    W  APE+++    
Sbjct: 121 SHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGC-- 178
Query: 520 KGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRD--TP---------AI 568
           K  S+    AVDIWSLGC   EM T +  +        +F++ R   TP         ++
Sbjct: 179 KYYST----AVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSM 234
Query: 569 PDS------------------LSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQPD 610
           PD                   L  +G+  L      +P  R  A   L H F ++  +P 
Sbjct: 235 PDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP- 293
Query: 611 VPSCSL 616
           VP   L
Sbjct: 294 VPHLRL 299

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score =  122 bits (305), Expect = 8e-28,   Method: Compositional matrix adjust.
 Identities = 88/307 (28%), Positives = 142/307 (46%), Gaps = 42/307 (13%)
Query: 341 QWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLK 400
            +QK + IG GT+G VY A N+ TG + A+K++ +   D ++        +EI +L  L 
Sbjct: 6   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL---DTETEGVPSTAIREISLLKELN 62
Query: 401 HPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHC-GAITESVVRNFTRHILSGLAYL 459
           HPNIV+       E+K Y+  E++H   + K++       I   +++++   +L GLA+ 
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 121
Query: 460 HSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPYWM-APELMMAVM 518
           HS + +HRD+K  NLL++  G +KLADFG+A+           +    W  APE+++   
Sbjct: 122 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG-- 179
Query: 519 QKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRD--TP---------A 567
                   + AVDIWSLGC   EM T +  +        +F++ R   TP         +
Sbjct: 180 ----CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS 235
Query: 568 IPDS------------------LSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQP 609
           +PD                   L  +G+  L      +P  R  A   L H F ++  +P
Sbjct: 236 MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 295
Query: 610 DVPSCSL 616
            VP   L
Sbjct: 296 -VPHLRL 301

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score =  122 bits (305), Expect = 8e-28,   Method: Compositional matrix adjust.
 Identities = 87/306 (28%), Positives = 138/306 (45%), Gaps = 40/306 (13%)
Query: 341 QWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLK 400
            +QK + IG GT+G VY A N+ TG + A+K++ +   D ++        +EI +L  L 
Sbjct: 7   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL---DTETEGVPSTAIREISLLKELN 63
Query: 401 HPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLH 460
           HPNIV+       E+K Y+  E++H              I   +++++   +L GLA+ H
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFLHQDLKTFMDASALTGIPLPLIKSYLFQLLQGLAFCH 123
Query: 461 SKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPYWM-APELMMAVMQ 519
           S + +HRD+K  NLL++  G +KLADFG+A+           +    W  APE+++    
Sbjct: 124 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG--- 180
Query: 520 KGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRD--TP---------AI 568
                  + AVDIWSLGC   EM T +  +        +F++ R   TP         ++
Sbjct: 181 ---CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSM 237
Query: 569 PDS------------------LSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQPD 610
           PD                   L  +G+  L      +P  R  A   L H F ++  +P 
Sbjct: 238 PDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP- 296
Query: 611 VPSCSL 616
           VP   L
Sbjct: 297 VPHLRL 302

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score =  122 bits (305), Expect = 9e-28,   Method: Compositional matrix adjust.
 Identities = 88/307 (28%), Positives = 142/307 (46%), Gaps = 42/307 (13%)
Query: 341 QWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLK 400
            +QK + IG GT+G VY A N+ TG + A+K++ +   D ++        +EI +L  L 
Sbjct: 7   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL---DTETEGVPSTAIREISLLKELN 63
Query: 401 HPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHC-GAITESVVRNFTRHILSGLAYL 459
           HPNIV+       E+K Y+  E++H   + K++       I   +++++   +L GLA+ 
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 122
Query: 460 HSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPYWM-APELMMAVM 518
           HS + +HRD+K  NLL++  G +KLADFG+A+           +    W  APE+++   
Sbjct: 123 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG-- 180
Query: 519 QKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRD--TP---------A 567
                   + AVDIWSLGC   EM T +  +        +F++ R   TP         +
Sbjct: 181 ----CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS 236
Query: 568 IPDS------------------LSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQP 609
           +PD                   L  +G+  L      +P  R  A   L H F ++  +P
Sbjct: 237 MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 296
Query: 610 DVPSCSL 616
            VP   L
Sbjct: 297 -VPHLRL 302

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score =  122 bits (305), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 88/307 (28%), Positives = 142/307 (46%), Gaps = 42/307 (13%)
Query: 341 QWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLK 400
            +QK + IG GT+G VY A N+ TG + A+K++ +   D ++        +EI +L  L 
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL---DTETEGVPSTAIREISLLKELN 60
Query: 401 HPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHC-GAITESVVRNFTRHILSGLAYL 459
           HPNIV+       E+K Y+  E++H   + K++       I   +++++   +L GLA+ 
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 119
Query: 460 HSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPYWM-APELMMAVM 518
           HS + +HRD+K  NLL++  G +KLADFG+A+           +    W  APE+++   
Sbjct: 120 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG-- 177
Query: 519 QKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRD--TP---------A 567
                   + AVDIWSLGC   EM T +  +        +F++ R   TP         +
Sbjct: 178 ----CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS 233
Query: 568 IPDS------------------LSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQP 609
           +PD                   L  +G+  L      +P  R  A   L H F ++  +P
Sbjct: 234 MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 293
Query: 610 DVPSCSL 616
            VP   L
Sbjct: 294 -VPHLRL 299

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score =  122 bits (305), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 88/307 (28%), Positives = 142/307 (46%), Gaps = 42/307 (13%)
Query: 341 QWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLK 400
            +QK + IG GT+G VY A N+ TG + A+K++ +   D ++        +EI +L  L 
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL---DTETEGVPSTAIREISLLKELN 59
Query: 401 HPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHC-GAITESVVRNFTRHILSGLAYL 459
           HPNIV+       E+K Y+  E++H   + K++       I   +++++   +L GLA+ 
Sbjct: 60  HPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 118
Query: 460 HSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPYWM-APELMMAVM 518
           HS + +HRD+K  NLL++  G +KLADFG+A+           +    W  APE+++   
Sbjct: 119 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG-- 176
Query: 519 QKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRD--TP---------A 567
                   + AVDIWSLGC   EM T +  +        +F++ R   TP         +
Sbjct: 177 ----CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS 232
Query: 568 IPDS------------------LSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQP 609
           +PD                   L  +G+  L      +P  R  A   L H F ++  +P
Sbjct: 233 MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 292
Query: 610 DVPSCSL 616
            VP   L
Sbjct: 293 -VPHLRL 298

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score =  122 bits (305), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 88/307 (28%), Positives = 142/307 (46%), Gaps = 42/307 (13%)
Query: 341 QWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLK 400
            +QK + IG GT+G VY A N+ TG + A+K++ +   D ++        +EI +L  L 
Sbjct: 5   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL---DTETEGVPSTAIREISLLKELN 61
Query: 401 HPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHC-GAITESVVRNFTRHILSGLAYL 459
           HPNIV+       E+K Y+  E++H   + K++       I   +++++   +L GLA+ 
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 120
Query: 460 HSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPYWM-APELMMAVM 518
           HS + +HRD+K  NLL++  G +KLADFG+A+           +    W  APE+++   
Sbjct: 121 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG-- 178
Query: 519 QKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRD--TP---------A 567
                   + AVDIWSLGC   EM T +  +        +F++ R   TP         +
Sbjct: 179 ----CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS 234
Query: 568 IPDS------------------LSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQP 609
           +PD                   L  +G+  L      +P  R  A   L H F ++  +P
Sbjct: 235 MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 294
Query: 610 DVPSCSL 616
            VP   L
Sbjct: 295 -VPHLRL 300

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score =  121 bits (304), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 83/254 (32%), Positives = 128/254 (50%), Gaps = 18/254 (7%)
Query: 341 QWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQ---EIKVLS 397
           Q+++ K IG G+FG V +  + ETG   AMK +D      +    +KQ+E    E ++L 
Sbjct: 42  QFERIKTIGTGSFGRVMLVKHMETGNHYAMKILD-----KQKVVKLKQIEHTLNEKRILQ 96
Query: 398 HLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLA 457
            +  P +V+   S       Y+ +EYV  G +  ++R   G  +E   R +   I+    
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLR-RIGRFSEPHARFYAAQIVLTFE 155
Query: 458 YLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPYWMAPELMMAV 517
           YLHS   I+RD+K  NLL+D  G +K+ADFG AK + G+   L   G+P ++APE++++ 
Sbjct: 156 YLHSLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXLC--GTPEYLAPEIILS- 212
Query: 518 MQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDSLSPEGK 577
             KG +     AVD W+LG  I EM  G PP+   +      K++      P   S + K
Sbjct: 213 --KGYNK----AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLK 266
Query: 578 DFLRCCFQRNPADR 591
           D LR   Q +   R
Sbjct: 267 DLLRNLLQVDLTKR 280

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score =  121 bits (304), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 85/300 (28%), Positives = 139/300 (46%), Gaps = 41/300 (13%)
Query: 341 QWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLK 400
            +QK + IG GT+G VY A N+ TG + A+K++ +   D ++        +EI +L  L 
Sbjct: 6   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL---DTETEGVPSTAIREISLLKELN 62
Query: 401 HPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHC-GAITESVVRNFTRHILSGLAYL 459
           HPNIV+       E+K Y+  E++H   + K++       I   +++++   +L GLA+ 
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 121
Query: 460 HSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPYWM-APELMMAVM 518
           HS + +HRD+K  NLL++  G +KLADFG+A+           +    W  APE+++   
Sbjct: 122 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG-- 179
Query: 519 QKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRD--TP---------A 567
                   + AVDIWSLGC   EM T +  +        +F++ R   TP         +
Sbjct: 180 ----CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS 235
Query: 568 IPDS------------------LSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQP 609
           +PD                   L  +G+  L      +P  R  A   L H F ++  +P
Sbjct: 236 MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 295

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score =  121 bits (304), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 85/300 (28%), Positives = 139/300 (46%), Gaps = 41/300 (13%)
Query: 341 QWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLK 400
            +QK + IG GT+G VY A N+ TG + A+K++ +   D ++        +EI +L  L 
Sbjct: 6   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL---DTETEGVPSTAIREISLLKELN 62
Query: 401 HPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHC-GAITESVVRNFTRHILSGLAYL 459
           HPNIV+       E+K Y+  E++H   + K++       I   +++++   +L GLA+ 
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 121
Query: 460 HSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPYWM-APELMMAVM 518
           HS + +HRD+K  NLL++  G +KLADFG+A+           +    W  APE+++   
Sbjct: 122 HSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG-- 179
Query: 519 QKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRD--TP---------A 567
                   + AVDIWSLGC   EM T +  +        +F++ R   TP         +
Sbjct: 180 ----CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS 235
Query: 568 IPDS------------------LSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQP 609
           +PD                   L  +G+  L      +P  R  A   L H F ++  +P
Sbjct: 236 MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 295

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score =  121 bits (304), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 85/300 (28%), Positives = 139/300 (46%), Gaps = 41/300 (13%)
Query: 341 QWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLK 400
            +QK + IG GT+G VY A N+ TG + A+K++ +   D ++        +EI +L  L 
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL---DTETEGVPSTAIREISLLKELN 60
Query: 401 HPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHC-GAITESVVRNFTRHILSGLAYL 459
           HPNIV+       E+K Y+  E++H   + K++       I   +++++   +L GLA+ 
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 119
Query: 460 HSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPYWM-APELMMAVM 518
           HS + +HRD+K  NLL++  G +KLADFG+A+           +    W  APE+++   
Sbjct: 120 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG-- 177
Query: 519 QKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRD--TP---------A 567
                   + AVDIWSLGC   EM T +  +        +F++ R   TP         +
Sbjct: 178 ----CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS 233
Query: 568 IPDS------------------LSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQP 609
           +PD                   L  +G+  L      +P  R  A   L H F ++  +P
Sbjct: 234 MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 293

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score =  121 bits (304), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 85/300 (28%), Positives = 139/300 (46%), Gaps = 41/300 (13%)
Query: 341 QWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLK 400
            +QK + IG GT+G VY A N+ TG + A+K++ +   D ++        +EI +L  L 
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL---DTETEGVPSTAIREISLLKELN 60
Query: 401 HPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHC-GAITESVVRNFTRHILSGLAYL 459
           HPNIV+       E+K Y+  E++H   + K++       I   +++++   +L GLA+ 
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 119
Query: 460 HSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPYWM-APELMMAVM 518
           HS + +HRD+K  NLL++  G +KLADFG+A+           +    W  APE+++   
Sbjct: 120 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG-- 177
Query: 519 QKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRD--TP---------A 567
                   + AVDIWSLGC   EM T +  +        +F++ R   TP         +
Sbjct: 178 ----CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS 233
Query: 568 IPDS------------------LSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQP 609
           +PD                   L  +G+  L      +P  R  A   L H F ++  +P
Sbjct: 234 MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 293

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score =  121 bits (304), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 87/307 (28%), Positives = 143/307 (46%), Gaps = 42/307 (13%)
Query: 341 QWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLK 400
            +QK + IG GT+G VY A N+ TG + A+K++ +   D ++        +EI +L  L 
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL---DTETEGVPSTAIREISLLKELN 60
Query: 401 HPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHC-GAITESVVRNFTRHILSGLAYL 459
           HPNIV+       E+K Y+  E++H   + K++       I   +++++   +L GL++ 
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLSFC 119
Query: 460 HSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPYWM-APELMMAVM 518
           HS + +HRD+K  NLL++  G +KLADFG+A+         + +    W  APE+++   
Sbjct: 120 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG-- 177
Query: 519 QKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRD--TP---------A 567
                   + AVDIWSLGC   EM T +  +        +F++ R   TP         +
Sbjct: 178 ----CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS 233
Query: 568 IPDS------------------LSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQP 609
           +PD                   L  +G+  L      +P  R  A   L H F ++  +P
Sbjct: 234 MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 293
Query: 610 DVPSCSL 616
            VP   L
Sbjct: 294 -VPHLRL 299

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score =  121 bits (304), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 85/300 (28%), Positives = 139/300 (46%), Gaps = 41/300 (13%)
Query: 341 QWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLK 400
            +QK + IG GT+G VY A N+ TG + A+K++ +   D ++        +EI +L  L 
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL---DTETEGVPSTAIREISLLKELN 59
Query: 401 HPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHC-GAITESVVRNFTRHILSGLAYL 459
           HPNIV+       E+K Y+  E++H   + K++       I   +++++   +L GLA+ 
Sbjct: 60  HPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 118
Query: 460 HSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPYWM-APELMMAVM 518
           HS + +HRD+K  NLL++  G +KLADFG+A+           +    W  APE+++   
Sbjct: 119 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG-- 176
Query: 519 QKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRD--TP---------A 567
                   + AVDIWSLGC   EM T +  +        +F++ R   TP         +
Sbjct: 177 ----CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS 232
Query: 568 IPDS------------------LSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQP 609
           +PD                   L  +G+  L      +P  R  A   L H F ++  +P
Sbjct: 233 MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 292

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score =  121 bits (304), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 85/300 (28%), Positives = 139/300 (46%), Gaps = 41/300 (13%)
Query: 341 QWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLK 400
            +QK + IG GT+G VY A N+ TG + A+K++ +   D ++        +EI +L  L 
Sbjct: 5   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL---DTETEGVPSTAIREISLLKELN 61
Query: 401 HPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHC-GAITESVVRNFTRHILSGLAYL 459
           HPNIV+       E+K Y+  E++H   + K++       I   +++++   +L GLA+ 
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 120
Query: 460 HSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPYWM-APELMMAVM 518
           HS + +HRD+K  NLL++  G +KLADFG+A+           +    W  APE+++   
Sbjct: 121 HSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG-- 178
Query: 519 QKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRD--TP---------A 567
                   + AVDIWSLGC   EM T +  +        +F++ R   TP         +
Sbjct: 179 ----CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS 234
Query: 568 IPDS------------------LSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQP 609
           +PD                   L  +G+  L      +P  R  A   L H F ++  +P
Sbjct: 235 MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 294

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score =  121 bits (303), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 85/300 (28%), Positives = 139/300 (46%), Gaps = 41/300 (13%)
Query: 341 QWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLK 400
            +QK + IG GT+G VY A N+ TG + A+K++ +   D ++        +EI +L  L 
Sbjct: 5   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL---DTETEGVPSTAIREISLLKELN 61
Query: 401 HPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHC-GAITESVVRNFTRHILSGLAYL 459
           HPNIV+       E+K Y+  E++H   + K++       I   +++++   +L GLA+ 
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 120
Query: 460 HSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPYWM-APELMMAVM 518
           HS + +HRD+K  NLL++  G +KLADFG+A+           +    W  APE+++   
Sbjct: 121 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG-- 178
Query: 519 QKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRD--TP---------A 567
                   + AVDIWSLGC   EM T +  +        +F++ R   TP         +
Sbjct: 179 ----CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS 234
Query: 568 IPDS------------------LSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQP 609
           +PD                   L  +G+  L      +P  R  A   L H F ++  +P
Sbjct: 235 MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 294

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score =  120 bits (302), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 86/301 (28%), Positives = 160/301 (53%), Gaps = 21/301 (6%)
Query: 339 NSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSH 398
           +  ++K   +G G  G V+  S++ +G + A K + +   + K A    Q+ +E++VL  
Sbjct: 8   DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHL---EIKPAIR-NQIIRELQVLHE 63
Query: 399 LKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAY 458
              P IV +YG+   + +  I +E++  GS+++ +++  G I E ++   +  ++ GL Y
Sbjct: 64  CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK-AGRIPEQILGKVSIAVIKGLTY 122
Query: 459 LHSK-KTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPYWMAPELMMAV 517
           L  K K +HRD+K +N+LV++ G +KL DFG++  L  + A+    G+  +M+PE +   
Sbjct: 123 LREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDEMAN-EFVGTRSYMSPERL--- 178
Query: 518 MQKGKSSDSALAVDIWSLGCTIIEMYTG---KPPWSEYEGAAAMFKVMRDTPAIPDSL-S 573
               + +  ++  DIWS+G +++EM  G   +PP + +E     + V    P +P ++ S
Sbjct: 179 ----QGTHYSVQSDIWSMGLSLVEMAVGRYPRPPMAIFE--LLDYIVNEPPPKLPSAVFS 232
Query: 574 PEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQPDVPSCSLSFSGMQLTEKPHSPREK 633
            E +DF+  C  +NPA+R     L+ H F+K S   +V       S + L + P +P   
Sbjct: 233 LEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDAEEVDFAGWLCSTIGLNQ-PSTPTHA 291
Query: 634 A 634
           A
Sbjct: 292 A 292

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score =  120 bits (301), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 90/312 (28%), Positives = 142/312 (45%), Gaps = 40/312 (12%)
Query: 335 PLPMNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIK 394
           PL     +QK + IG GT+G VY A N+ TG + A+K++ +   D ++        +EI 
Sbjct: 1   PLGSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL---DTETEGVPSTAIREIS 57
Query: 395 VLSHLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILS 454
           +L  L HPNIV+       E+K Y+  E++     +         I   +++++   +L 
Sbjct: 58  LLKELNHPNIVKLLDVIHTENKLYLVFEFLSMDLKDFMDASALTGIPLPLIKSYLFQLLQ 117
Query: 455 GLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPYWM-APEL 513
           GLA+ HS + +HRD+K  NLL++  G +KLADFG+A+           +    W  APE+
Sbjct: 118 GLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEI 177
Query: 514 MMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRD--TP----- 566
           ++    K  S+    AVDIWSLGC   EM T +  +        +F++ R   TP     
Sbjct: 178 LLGC--KYYST----AVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVW 231
Query: 567 ----AIPDS------------------LSPEGKDFLRCCFQRNPADRPPASLLLEHRFLK 604
               ++PD                   L  +G+  L      +P  R  A   L H F +
Sbjct: 232 PGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 291
Query: 605 NSQQPDVPSCSL 616
           +  +P VP   L
Sbjct: 292 DVTKP-VPHLRL 302

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score =  120 bits (301), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 83/266 (31%), Positives = 135/266 (50%), Gaps = 25/266 (9%)
Query: 340 SQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHL 399
           SQ+++ + +G GT+ +VY   N+ TG   A+KEV +  ++   + +I+    EI ++  L
Sbjct: 5   SQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIR----EISLMKEL 60
Query: 400 KHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITE-----SVVRNFTRHILS 454
           KH NIV+ Y     E+K  +  E++    + KY+       T      ++V+ F   +L 
Sbjct: 61  KHENIVRLYDVIHTENKLTLVFEFM-DNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQ 119
Query: 455 GLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPYWM-APEL 513
           GLA+ H  K +HRD+K  NLL++  G +KL DFG+A+         S +    W  AP++
Sbjct: 120 GLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVVTLWYRAPDV 179
Query: 514 MMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPW---SEYEGAAAMFKVMRDTPAIPD 570
           +M       S   + ++DIWS GC + EM TGKP +   ++ E    +F +M  TP   +
Sbjct: 180 LMG------SRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIM-GTPN--E 230
Query: 571 SLSPEGKDFLRCCFQRNPADRPPASL 596
           SL P      +  +  N   RPP  L
Sbjct: 231 SLWPSVTKLPK--YNPNIQQRPPRDL 254

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score =  120 bits (301), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 87/307 (28%), Positives = 142/307 (46%), Gaps = 42/307 (13%)
Query: 341 QWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLK 400
            +QK + IG GT+G VY A N+ TG + A+ ++ +   D ++        +EI +L  L 
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRL---DTETEGVPSTAIREISLLKELN 60
Query: 401 HPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHC-GAITESVVRNFTRHILSGLAYL 459
           HPNIV+       E+K Y+  E++H   + K++       I   +++++   +L GLA+ 
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 119
Query: 460 HSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPYWM-APELMMAVM 518
           HS + +HRD+K  NLL++  G +KLADFG+A+         + +    W  APE+++   
Sbjct: 120 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG-- 177
Query: 519 QKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRD--TP---------A 567
                   + AVDIWSLGC   EM T +  +        +F++ R   TP         +
Sbjct: 178 ----CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS 233
Query: 568 IPDS------------------LSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQP 609
           +PD                   L  +G+  L      +P  R  A   L H F ++  +P
Sbjct: 234 MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 293
Query: 610 DVPSCSL 616
            VP   L
Sbjct: 294 -VPHLRL 299

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score =  120 bits (301), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 87/307 (28%), Positives = 142/307 (46%), Gaps = 42/307 (13%)
Query: 341 QWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLK 400
            +QK + IG GT+G VY A N+ TG + A+ ++ +   D ++        +EI +L  L 
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRL---DTETEGVPSTAIREISLLKELN 59
Query: 401 HPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHC-GAITESVVRNFTRHILSGLAYL 459
           HPNIV+       E+K Y+  E++H   + K++       I   +++++   +L GLA+ 
Sbjct: 60  HPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 118
Query: 460 HSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPYWM-APELMMAVM 518
           HS + +HRD+K  NLL++  G +KLADFG+A+         + +    W  APE+++   
Sbjct: 119 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG-- 176
Query: 519 QKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRD--TP---------A 567
                   + AVDIWSLGC   EM T +  +        +F++ R   TP         +
Sbjct: 177 ----CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS 232
Query: 568 IPDS------------------LSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQP 609
           +PD                   L  +G+  L      +P  R  A   L H F ++  +P
Sbjct: 233 MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 292
Query: 610 DVPSCSL 616
            VP   L
Sbjct: 293 -VPHLRL 298

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score =  120 bits (301), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 78/260 (30%), Positives = 132/260 (50%), Gaps = 15/260 (5%)
Query: 340 SQWQKGKLIGRGTFGSVYVA---SNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVL 396
           SQ++  K++G+G+FG V++    S  +   L AMK   +            + + E  +L
Sbjct: 24  SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMK---VLKKATLKVRDRVRTKMERDIL 80
Query: 397 SHLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGL 456
             + HP IV+ + +   E K Y+ L+++  G +   + +     TE  V+ +   +   L
Sbjct: 81  VEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEV-MFTEEDVKFYLAELALAL 139
Query: 457 AYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKH-LTGQKADLSMKGSPYWMAPELMM 515
            +LHS   I+RD+K  N+L+D  G +KL DFG++K  +  +K   S  G+  +MAPE+  
Sbjct: 140 DHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEV-- 197
Query: 516 AVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDSLSPE 575
            V ++G +     + D WS G  + EM TG  P+   +    M  +++    +P  LSPE
Sbjct: 198 -VNRRGHTQ----SADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQFLSPE 252
Query: 576 GKDFLRCCFQRNPADRPPAS 595
            +  LR  F+RNPA+R  A 
Sbjct: 253 AQSLLRMLFKRNPANRLGAG 272

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score =  120 bits (301), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 83/298 (27%), Positives = 140/298 (46%), Gaps = 44/298 (14%)
Query: 340 SQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHL 399
            +++   L+G G++G V    N++TG + A+K+  +  DD K  + I    +EIK+L  L
Sbjct: 25  EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKF-LESDDDKMVKKIAM--REIKLLKQL 81
Query: 400 KHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYL 459
           +H N+V        + ++Y+  E+V    ++  +      +   VV+ +   I++G+ + 
Sbjct: 82  RHENLVNLLEVCKKKKRWYLVFEFVDHTILDD-LELFPNGLDYQVVQKYLFQIINGIGFC 140
Query: 460 HSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLT--GQKADLSMKGSPYWMAPELMMAV 517
           HS   IHRDIK  N+LV  SGVVKL DFG A+ L   G+  D  +  + ++ APEL++  
Sbjct: 141 HSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEV-ATRWYRAPELLVGD 199
Query: 518 MQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVM--------------R 563
           ++ GK      AVD+W++GC + EM+ G+P +        ++ +M               
Sbjct: 200 VKYGK------AVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFN 253
Query: 564 DTPAIPDSLSPEGK-----------------DFLRCCFQRNPADRPPASLLLEHRFLK 604
             P       PE K                 D  + C   +P  RP  + LL H F +
Sbjct: 254 KNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQ 311

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score =  120 bits (301), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 74/234 (31%), Positives = 121/234 (51%), Gaps = 13/234 (5%)
Query: 341 QWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLK 400
            +QK + IG GT+G VY A N+ TG + A+K++ +   D ++        +EI +L  L 
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL---DTETEGVPSTAIREISLLKELN 60
Query: 401 HPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHC-GAITESVVRNFTRHILSGLAYL 459
           HPNIV+       E+K Y+  E++H   + K++       I   +++++   +L GLA+ 
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 119
Query: 460 HSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPYWM-APELMMAVM 518
           HS + +HRD+K  NLL++  G +KLADFG+A+           +    W  APE+++   
Sbjct: 120 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG-- 177
Query: 519 QKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDSL 572
                   + AVDIWSLGC   EM T +  +        +F++ R T   PD +
Sbjct: 178 ----CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFR-TLGTPDEV 226

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score =  120 bits (301), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 85/287 (29%), Positives = 141/287 (49%), Gaps = 31/287 (10%)
Query: 331 AKPEPLPMNSQWQKGKLIGRGTFGSVYVASNRETGALCAMK----EVDIFPDDPKSAESI 386
           AKP+     ++++  KL+G+GTFG V +   + TG   AMK    EV +  D+      +
Sbjct: 139 AKPKHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDE------V 192
Query: 387 KQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYV-REHCGAITESVV 445
                E +VL + +HP +     S    D+    +EY + G +  ++ RE     +E   
Sbjct: 193 AHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRER--VFSEDRA 250
Query: 446 RNFTRHILSGLAYLHSKK-TIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMK- 503
           R +   I+S L YLHS+K  ++RD+K  NL++D  G +K+ DFG+ K   G K   +MK 
Sbjct: 251 RFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKE--GIKDGATMKT 308
Query: 504 --GSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKV 561
             G+P ++APE++       + +D   AVD W LG  + EM  G+ P+   +       +
Sbjct: 309 FCGTPEYLAPEVL-------EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI 361
Query: 562 MRDTPAIPDSLSPEGKDFLRCCFQRNPADR-----PPASLLLEHRFL 603
           + +    P +L PE K  L    +++P  R       A  +++HRF 
Sbjct: 362 LMEEIRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFF 408

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score =  120 bits (301), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 85/287 (29%), Positives = 141/287 (49%), Gaps = 31/287 (10%)
Query: 331 AKPEPLPMNSQWQKGKLIGRGTFGSVYVASNRETGALCAMK----EVDIFPDDPKSAESI 386
           AKP+     ++++  KL+G+GTFG V +   + TG   AMK    EV +  D+      +
Sbjct: 142 AKPKHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDE------V 195
Query: 387 KQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYV-REHCGAITESVV 445
                E +VL + +HP +     S    D+    +EY + G +  ++ RE     +E   
Sbjct: 196 AHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRER--VFSEDRA 253
Query: 446 RNFTRHILSGLAYLHSKK-TIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMK- 503
           R +   I+S L YLHS+K  ++RD+K  NL++D  G +K+ DFG+ K   G K   +MK 
Sbjct: 254 RFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKE--GIKDGATMKT 311
Query: 504 --GSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKV 561
             G+P ++APE++       + +D   AVD W LG  + EM  G+ P+   +       +
Sbjct: 312 FCGTPEYLAPEVL-------EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI 364
Query: 562 MRDTPAIPDSLSPEGKDFLRCCFQRNPADR-----PPASLLLEHRFL 603
           + +    P +L PE K  L    +++P  R       A  +++HRF 
Sbjct: 365 LMEEIRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFF 411

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score =  120 bits (301), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 82/254 (32%), Positives = 127/254 (50%), Gaps = 18/254 (7%)
Query: 341 QWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQ---EIKVLS 397
           Q+++ K IG G+FG V +  + ETG   AMK +D      +    +KQ+E    E ++L 
Sbjct: 42  QFERIKTIGTGSFGRVMLVKHMETGNHYAMKILD-----KQKVVKLKQIEHTLNEKRILQ 96
Query: 398 HLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLA 457
            +  P +V+   S       Y+ +EY+  G +  ++R   G  +E   R +   I+    
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLR-RIGRFSEPHARFYAAQIVLTFE 155
Query: 458 YLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPYWMAPELMMAV 517
           YLHS   I+RD+K  NLL+D  G +K+ADFG AK + G+   L   G+P ++APE+   +
Sbjct: 156 YLHSLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXLC--GTPEYLAPEI---I 210
Query: 518 MQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDSLSPEGK 577
           + KG +     AVD W+LG  I EM  G PP+   +      K++      P   S + K
Sbjct: 211 LSKGYNK----AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLK 266
Query: 578 DFLRCCFQRNPADR 591
           D LR   Q +   R
Sbjct: 267 DLLRNLLQVDLTKR 280

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score =  120 bits (300), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 78/260 (30%), Positives = 132/260 (50%), Gaps = 15/260 (5%)
Query: 340 SQWQKGKLIGRGTFGSVYVA---SNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVL 396
           SQ++  K++G+G+FG V++    S  +   L AMK   +            + + E  +L
Sbjct: 24  SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMK---VLKKATLKVRDRVRTKMERDIL 80
Query: 397 SHLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGL 456
             + HP IV+ + +   E K Y+ L+++  G +   + +     TE  V+ +   +   L
Sbjct: 81  VEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEV-MFTEEDVKFYLAELALAL 139
Query: 457 AYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKH-LTGQKADLSMKGSPYWMAPELMM 515
            +LHS   I+RD+K  N+L+D  G +KL DFG++K  +  +K   S  G+  +MAPE+  
Sbjct: 140 DHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEV-- 197
Query: 516 AVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDSLSPE 575
            V ++G +     + D WS G  + EM TG  P+   +    M  +++    +P  LSPE
Sbjct: 198 -VNRRGHTQ----SADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQFLSPE 252
Query: 576 GKDFLRCCFQRNPADRPPAS 595
            +  LR  F+RNPA+R  A 
Sbjct: 253 AQSLLRMLFKRNPANRLGAG 272

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score =  120 bits (300), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 82/254 (32%), Positives = 127/254 (50%), Gaps = 18/254 (7%)
Query: 341 QWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQ---EIKVLS 397
           Q+++ K IG G+FG V +  + ETG   AMK +D      +    +KQ+E    E ++L 
Sbjct: 42  QFERIKTIGTGSFGRVMLVKHMETGNHYAMKILD-----KQKVVKLKQIEHTLNEKRILQ 96
Query: 398 HLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLA 457
            +  P +V+   S       Y+ +EY+  G +  ++R   G  +E   R +   I+    
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLR-RIGRFSEPHARFYAAQIVLTFE 155
Query: 458 YLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPYWMAPELMMAV 517
           YLHS   I+RD+K  NLL+D  G +K+ADFG AK + G+   L   G+P ++APE+   +
Sbjct: 156 YLHSLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXLC--GTPEYLAPEI---I 210
Query: 518 MQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDSLSPEGK 577
           + KG +     AVD W+LG  I EM  G PP+   +      K++      P   S + K
Sbjct: 211 LSKGYNK----AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLK 266
Query: 578 DFLRCCFQRNPADR 591
           D LR   Q +   R
Sbjct: 267 DLLRNLLQVDLTKR 280

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score =  120 bits (300), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 78/260 (30%), Positives = 132/260 (50%), Gaps = 15/260 (5%)
Query: 340 SQWQKGKLIGRGTFGSVYVA---SNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVL 396
           SQ++  K++G+G+FG V++    S  +   L AMK   +            + + E  +L
Sbjct: 25  SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMK---VLKKATLKVRDRVRTKMERDIL 81
Query: 397 SHLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGL 456
             + HP IV+ + +   E K Y+ L+++  G +   + +     TE  V+ +   +   L
Sbjct: 82  VEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEV-MFTEEDVKFYLAELALAL 140
Query: 457 AYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKH-LTGQKADLSMKGSPYWMAPELMM 515
            +LHS   I+RD+K  N+L+D  G +KL DFG++K  +  +K   S  G+  +MAPE+  
Sbjct: 141 DHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEV-- 198
Query: 516 AVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDSLSPE 575
            V ++G +     + D WS G  + EM TG  P+   +    M  +++    +P  LSPE
Sbjct: 199 -VNRRGHTQ----SADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQFLSPE 253
Query: 576 GKDFLRCCFQRNPADRPPAS 595
            +  LR  F+RNPA+R  A 
Sbjct: 254 AQSLLRMLFKRNPANRLGAG 273

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score =  119 bits (299), Expect = 4e-27,   Method: Compositional matrix adjust.
 Identities = 86/306 (28%), Positives = 140/306 (45%), Gaps = 41/306 (13%)
Query: 335 PLPMNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIK 394
           PL     +QK + IG GT+G VY A N+ TG + A+K++ +   D ++        +EI 
Sbjct: 1   PLGSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL---DTETEGVPSTAIREIS 57
Query: 395 VLSHLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHC-GAITESVVRNFTRHIL 453
           +L  L HPNIV+       E+K Y+  E++    + K++       I   +++++   +L
Sbjct: 58  LLKELNHPNIVKLLDVIHTENKLYLVFEFLS-MDLKKFMDASALTGIPLPLIKSYLFQLL 116
Query: 454 SGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPYWM-APE 512
            GLA+ HS + +HRD+K  NLL++  G +KLADFG+A+           +    W  APE
Sbjct: 117 QGLAFCHSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPE 176
Query: 513 LMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRD--TP---- 566
           +++           + AVDIWSLGC   EM T +  +        +F++ R   TP    
Sbjct: 177 ILLG------CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVV 230
Query: 567 -----AIPDS------------------LSPEGKDFLRCCFQRNPADRPPASLLLEHRFL 603
                ++PD                   L  +G+  L      +P  R  A   L H F 
Sbjct: 231 WPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 290
Query: 604 KNSQQP 609
           ++  +P
Sbjct: 291 QDVTKP 296

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score =  119 bits (299), Expect = 5e-27,   Method: Compositional matrix adjust.
 Identities = 80/254 (31%), Positives = 128/254 (50%), Gaps = 18/254 (7%)
Query: 341 QWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQ---EIKVLS 397
           Q+++ K +G G+FG V +  ++ETG   AMK +D      +    +KQ+E    E ++L 
Sbjct: 35  QFERIKTLGTGSFGRVMLVKHKETGNHYAMKILD-----KQKVVKLKQIEHTLNEKRILQ 89
Query: 398 HLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLA 457
            +  P +V+   S       Y+ +EYV  G +  ++R   G  +E   R +   I+    
Sbjct: 90  AVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLR-RIGRFSEPHARFYAAQIVLTFE 148
Query: 458 YLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPYWMAPELMMAV 517
           YLHS   I+RD+K  NLL+D  G +++ DFG AK + G+   L   G+P ++APE++++ 
Sbjct: 149 YLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC--GTPEYLAPEIILS- 205
Query: 518 MQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDSLSPEGK 577
             KG +     AVD W+LG  I EM  G PP+   +      K++      P   S + K
Sbjct: 206 --KGYNK----AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLK 259
Query: 578 DFLRCCFQRNPADR 591
           D LR   Q +   R
Sbjct: 260 DLLRNLLQVDLTKR 273

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score =  119 bits (298), Expect = 6e-27,   Method: Compositional matrix adjust.
 Identities = 80/254 (31%), Positives = 128/254 (50%), Gaps = 18/254 (7%)
Query: 341 QWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQ---EIKVLS 397
           Q+++ K +G G+FG V +  ++ETG   AMK +D      +    +KQ+E    E ++L 
Sbjct: 42  QFERIKTLGTGSFGRVMLVKHKETGNHFAMKILD-----KQKVVKLKQIEHTLNEKRILQ 96
Query: 398 HLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLA 457
            +  P +V+   S       Y+ +EYV  G +  ++R   G  +E   R +   I+    
Sbjct: 97  AVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLR-RIGRFSEPHARFYAAQIVLTFE 155
Query: 458 YLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPYWMAPELMMAV 517
           YLHS   I+RD+K  NLL+D  G +++ DFG AK + G+   L   G+P ++APE++++ 
Sbjct: 156 YLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC--GTPEYLAPEIILS- 212
Query: 518 MQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDSLSPEGK 577
             KG +     AVD W+LG  I EM  G PP+   +      K++      P   S + K
Sbjct: 213 --KGYNK----AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLK 266
Query: 578 DFLRCCFQRNPADR 591
           D LR   Q +   R
Sbjct: 267 DLLRNLLQVDLTKR 280

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score =  119 bits (298), Expect = 6e-27,   Method: Compositional matrix adjust.
 Identities = 80/254 (31%), Positives = 128/254 (50%), Gaps = 18/254 (7%)
Query: 341 QWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQ---EIKVLS 397
           Q+++ K +G G+FG V +  ++ETG   AMK +D      +    +KQ+E    E ++L 
Sbjct: 63  QFERIKTLGTGSFGRVMLVKHKETGNHYAMKILD-----KQKVVKLKQIEHTLNEKRILQ 117
Query: 398 HLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLA 457
            +  P +V+   S       Y+ +EYV  G +  ++R   G  +E   R +   I+    
Sbjct: 118 AVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRR-IGRFSEPHARFYAAQIVLTFE 176
Query: 458 YLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPYWMAPELMMAV 517
           YLHS   I+RD+K  NLL+D  G +++ DFG AK + G+   L   G+P ++APE++++ 
Sbjct: 177 YLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC--GTPEYLAPEIILS- 233
Query: 518 MQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDSLSPEGK 577
             KG +     AVD W+LG  I EM  G PP+   +      K++      P   S + K
Sbjct: 234 --KGYNK----AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLK 287
Query: 578 DFLRCCFQRNPADR 591
           D LR   Q +   R
Sbjct: 288 DLLRNLLQVDLTKR 301

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score =  119 bits (298), Expect = 6e-27,   Method: Compositional matrix adjust.
 Identities = 80/254 (31%), Positives = 128/254 (50%), Gaps = 18/254 (7%)
Query: 341 QWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQ---EIKVLS 397
           Q+++ K +G G+FG V +  ++ETG   AMK +D      +    +KQ+E    E ++L 
Sbjct: 42  QFERIKTLGTGSFGRVMLVKHKETGNHFAMKILD-----KQKVVKLKQIEHTLNEKRILQ 96
Query: 398 HLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLA 457
            +  P +V+   S       Y+ +EYV  G +  ++R   G  +E   R +   I+    
Sbjct: 97  AVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLR-RIGRFSEPHARFYAAQIVLTFE 155
Query: 458 YLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPYWMAPELMMAV 517
           YLHS   I+RD+K  NLL+D  G +++ DFG AK + G+   L   G+P ++APE++++ 
Sbjct: 156 YLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC--GTPEYLAPEIILS- 212
Query: 518 MQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDSLSPEGK 577
             KG +     AVD W+LG  I EM  G PP+   +      K++      P   S + K
Sbjct: 213 --KGYNK----AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLK 266
Query: 578 DFLRCCFQRNPADR 591
           D LR   Q +   R
Sbjct: 267 DLLRNLLQVDLTKR 280

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score =  119 bits (298), Expect = 6e-27,   Method: Compositional matrix adjust.
 Identities = 80/254 (31%), Positives = 128/254 (50%), Gaps = 18/254 (7%)
Query: 341 QWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQ---EIKVLS 397
           Q+++ K +G G+FG V +  ++ETG   AMK +D      +    +KQ+E    E ++L 
Sbjct: 43  QFERIKTLGTGSFGRVMLVKHKETGNHYAMKILD-----KQKVVKLKQIEHTLNEKRILQ 97
Query: 398 HLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLA 457
            +  P +V+   S       Y+ +EYV  G +  ++R   G  +E   R +   I+    
Sbjct: 98  AVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLR-RIGRFSEPHARFYAAQIVLTFE 156
Query: 458 YLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPYWMAPELMMAV 517
           YLHS   I+RD+K  NLL+D  G +++ DFG AK + G+   L   G+P ++APE++++ 
Sbjct: 157 YLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC--GTPEYLAPEIILS- 213
Query: 518 MQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDSLSPEGK 577
             KG +     AVD W+LG  I EM  G PP+   +      K++      P   S + K
Sbjct: 214 --KGYNK----AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLK 267
Query: 578 DFLRCCFQRNPADR 591
           D LR   Q +   R
Sbjct: 268 DLLRNLLQVDLTKR 281

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score =  119 bits (298), Expect = 7e-27,   Method: Compositional matrix adjust.
 Identities = 80/254 (31%), Positives = 128/254 (50%), Gaps = 18/254 (7%)
Query: 341 QWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQ---EIKVLS 397
           Q+++ K +G G+FG V +  ++ETG   AMK +D      +    +KQ+E    E ++L 
Sbjct: 42  QFERIKTLGTGSFGRVMLVKHKETGNHFAMKILD-----KQKVVKLKQIEHTLNEKRILQ 96
Query: 398 HLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLA 457
            +  P +V+   S       Y+ +EYV  G +  ++R   G  +E   R +   I+    
Sbjct: 97  AVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLR-RIGRFSEPHARFYAAQIVLTFE 155
Query: 458 YLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPYWMAPELMMAV 517
           YLHS   I+RD+K  NLL+D  G +++ DFG AK + G+   L   G+P ++APE++++ 
Sbjct: 156 YLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC--GTPEYLAPEIILS- 212
Query: 518 MQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDSLSPEGK 577
             KG +     AVD W+LG  I EM  G PP+   +      K++      P   S + K
Sbjct: 213 --KGYNK----AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLK 266
Query: 578 DFLRCCFQRNPADR 591
           D LR   Q +   R
Sbjct: 267 DLLRNLLQVDLTKR 280

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score =  119 bits (298), Expect = 7e-27,   Method: Compositional matrix adjust.
 Identities = 80/254 (31%), Positives = 128/254 (50%), Gaps = 18/254 (7%)
Query: 341 QWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQ---EIKVLS 397
           Q+++ K +G G+FG V +  ++ETG   AMK +D      +    +KQ+E    E ++L 
Sbjct: 43  QFERIKTLGTGSFGRVMLVKHKETGNHYAMKILD-----KQKVVKLKQIEHTLNEKRILQ 97
Query: 398 HLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLA 457
            +  P +V+   S       Y+ +EYV  G +  ++R   G  +E   R +   I+    
Sbjct: 98  AVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLR-RIGRFSEPHARFYAAQIVLTFE 156
Query: 458 YLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPYWMAPELMMAV 517
           YLHS   I+RD+K  NLL+D  G +++ DFG AK + G+   L   G+P ++APE++++ 
Sbjct: 157 YLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC--GTPEYLAPEIILS- 213
Query: 518 MQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDSLSPEGK 577
             KG +     AVD W+LG  I EM  G PP+   +      K++      P   S + K
Sbjct: 214 --KGYNK----AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLK 267
Query: 578 DFLRCCFQRNPADR 591
           D LR   Q +   R
Sbjct: 268 DLLRNLLQVDLTKR 281

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score =  119 bits (297), Expect = 7e-27,   Method: Compositional matrix adjust.
 Identities = 80/254 (31%), Positives = 128/254 (50%), Gaps = 18/254 (7%)
Query: 341 QWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQ---EIKVLS 397
           Q+++ K +G G+FG V +  ++ETG   AMK +D      +    +KQ+E    E ++L 
Sbjct: 43  QFERIKTLGTGSFGRVMLVKHKETGNHYAMKILD-----KQKVVKLKQIEHTLNEKRILQ 97
Query: 398 HLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLA 457
            +  P +V+   S       Y+ +EYV  G +  ++R   G  +E   R +   I+    
Sbjct: 98  AVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLR-RIGRFSEPHARFYAAQIVLTFE 156
Query: 458 YLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPYWMAPELMMAV 517
           YLHS   I+RD+K  NLL+D  G +++ DFG AK + G+   L   G+P ++APE++++ 
Sbjct: 157 YLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC--GTPEYLAPEIILS- 213
Query: 518 MQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDSLSPEGK 577
             KG +     AVD W+LG  I EM  G PP+   +      K++      P   S + K
Sbjct: 214 --KGYNK----AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLK 267
Query: 578 DFLRCCFQRNPADR 591
           D LR   Q +   R
Sbjct: 268 DLLRNLLQVDLTKR 281

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score =  119 bits (297), Expect = 8e-27,   Method: Compositional matrix adjust.
 Identities = 80/254 (31%), Positives = 127/254 (50%), Gaps = 18/254 (7%)
Query: 341 QWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQ---EIKVLS 397
           Q+++ K +G G+FG V +  ++ETG   AMK +D      +    +KQ+E    E ++L 
Sbjct: 35  QFERIKTLGTGSFGRVMLVKHKETGNHYAMKILD-----KQKVVKLKQIEHTLNEKRILQ 89
Query: 398 HLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLA 457
            +  P +V+   S       Y+ +EYV  G +  ++R   G   E   R +   I+    
Sbjct: 90  AVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLR-RIGRFXEPHARFYAAQIVLTFE 148
Query: 458 YLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPYWMAPELMMAV 517
           YLHS   I+RD+K  NLL+D  G +++ DFG AK + G+   L   G+P ++APE++++ 
Sbjct: 149 YLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC--GTPEYLAPEIILS- 205
Query: 518 MQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDSLSPEGK 577
             KG +     AVD W+LG  I EM  G PP+   +      K++      P   S + K
Sbjct: 206 --KGYNK----AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLK 259
Query: 578 DFLRCCFQRNPADR 591
           D LR   Q +   R
Sbjct: 260 DLLRNLLQVDLTKR 273

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score =  119 bits (297), Expect = 8e-27,   Method: Compositional matrix adjust.
 Identities = 88/307 (28%), Positives = 141/307 (45%), Gaps = 42/307 (13%)
Query: 341 QWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLK 400
            +QK + IG GT+G VY A N+ TG + A+K++ +   D ++        +EI +L  L 
Sbjct: 7   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL---DTETEGVPSTAIREISLLKELN 63
Query: 401 HPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHC-GAITESVVRNFTRHILSGLAYL 459
           HPNIV+       E+K Y+  E+V    + K++       I   +++++   +L GLA+ 
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEHVD-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 122
Query: 460 HSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPYWM-APELMMAVM 518
           HS + +HRD+K  NLL++  G +KLADFG+A+           +    W  APE+++   
Sbjct: 123 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG-- 180
Query: 519 QKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRD--TP---------A 567
                   + AVDIWSLGC   EM T +  +        +F++ R   TP         +
Sbjct: 181 ----CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS 236
Query: 568 IPDS------------------LSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQP 609
           +PD                   L  +G+  L      +P  R  A   L H F ++  +P
Sbjct: 237 MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 296
Query: 610 DVPSCSL 616
            VP   L
Sbjct: 297 -VPHLRL 302

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score =  118 bits (296), Expect = 9e-27,   Method: Compositional matrix adjust.
 Identities = 73/251 (29%), Positives = 125/251 (49%), Gaps = 18/251 (7%)
Query: 346 KLIGRGTFGSVYVASNRETGALCAMKEVD---IFPDDPKSAESIKQLEQEIKVLS-HLKH 401
           K++G+G+FG V++A  ++T    A+K +    +  DD      +++     +VLS   +H
Sbjct: 24  KMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEK-----RVLSLAWEH 78
Query: 402 PNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHS 461
           P +   + +   ++  +  +EY++ G +  +++  C     S    +   I+ GL +LHS
Sbjct: 79  PFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQS-CHKFDLSRATFYAAEIILGLQFLHS 137
Query: 462 KKTIHRDIKGANLLVDASGVVKLADFGMAK-HLTGQKADLSMKGSPYWMAPELMMAVMQK 520
           K  ++RD+K  N+L+D  G +K+ADFGM K ++ G        G+P ++APE+++   QK
Sbjct: 138 KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNEFCGTPDYIAPEILLG--QK 195
Query: 521 GKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDSLSPEGKDFL 580
              S     VD WS G  + EM  G+ P+   +       +  D P  P  L  E KD L
Sbjct: 196 YNHS-----VDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDLL 250
Query: 581 RCCFQRNPADR 591
              F R P  R
Sbjct: 251 VKLFVREPEKR 261

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score =  118 bits (296), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 76/256 (29%), Positives = 133/256 (51%), Gaps = 15/256 (5%)
Query: 340 SQWQKGKLIGRGTFGSVYVA---SNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVL 396
           S ++  K++G+G+FG V++    +  ++G L AMK   +            + + E  +L
Sbjct: 28  SHFELLKVLGQGSFGKVFLVRKVTRPDSGHLYAMK---VLKKATLKVRDRVRTKMERDIL 84
Query: 397 SHLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGL 456
           + + HP +V+ + +   E K Y+ L+++  G +   + +     TE  V+ +   +  GL
Sbjct: 85  ADVNHPFVVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEV-MFTEEDVKFYLAELALGL 143
Query: 457 AYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKH-LTGQKADLSMKGSPYWMAPELMM 515
            +LHS   I+RD+K  N+L+D  G +KL DFG++K  +  +K   S  G+  +MAPE+  
Sbjct: 144 DHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKEAIDHEKKAYSFCGTVEYMAPEV-- 201
Query: 516 AVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDSLSPE 575
            V ++G S     + D WS G  + EM TG  P+   +    M  +++    +P  LS E
Sbjct: 202 -VNRQGHSH----SADWWSYGVLMFEMLTGSLPFQGKDRKETMTLILKAKLGMPQFLSTE 256
Query: 576 GKDFLRCCFQRNPADR 591
            +  LR  F+RNPA+R
Sbjct: 257 AQSLLRALFKRNPANR 272

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score =  118 bits (296), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 80/254 (31%), Positives = 127/254 (50%), Gaps = 18/254 (7%)
Query: 341 QWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQ---EIKVLS 397
           Q+ + K +G G+FG V +  ++E+G   AMK +D      +    +KQ+E    E ++L 
Sbjct: 42  QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILD-----KQKVVKLKQIEHTLNEKRILQ 96
Query: 398 HLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLA 457
            +  P +V+   S       Y+ +EYV  G +  ++R   G  +E   R +   I+    
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR-RIGRFSEPHARFYAAQIVLTFE 155
Query: 458 YLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPYWMAPELMMAV 517
           YLHS   I+RD+K  NLL+D  G +++ DFG AK + G+   L   G+P ++APE++++ 
Sbjct: 156 YLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC--GTPEYLAPEIILS- 212
Query: 518 MQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDSLSPEGK 577
             KG +     AVD W+LG  I EM  G PP+   E      K++      P   S + K
Sbjct: 213 --KGYNK----AVDWWALGVLIYEMAAGYPPFFADEPIQIYEKIVSGKVRFPSHFSSDLK 266
Query: 578 DFLRCCFQRNPADR 591
           D LR   Q +   R
Sbjct: 267 DLLRNLLQVDLTKR 280

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score =  118 bits (296), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 73/251 (29%), Positives = 125/251 (49%), Gaps = 18/251 (7%)
Query: 346 KLIGRGTFGSVYVASNRETGALCAMKEVD---IFPDDPKSAESIKQLEQEIKVLS-HLKH 401
           K++G+G+FG V++A  ++T    A+K +    +  DD      +++     +VLS   +H
Sbjct: 23  KMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEK-----RVLSLAWEH 77
Query: 402 PNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHS 461
           P +   + +   ++  +  +EY++ G +  +++  C     S    +   I+ GL +LHS
Sbjct: 78  PFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQS-CHKFDLSRATFYAAEIILGLQFLHS 136
Query: 462 KKTIHRDIKGANLLVDASGVVKLADFGMAK-HLTGQKADLSMKGSPYWMAPELMMAVMQK 520
           K  ++RD+K  N+L+D  G +K+ADFGM K ++ G        G+P ++APE+++   QK
Sbjct: 137 KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNXFCGTPDYIAPEILLG--QK 194
Query: 521 GKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDSLSPEGKDFL 580
              S     VD WS G  + EM  G+ P+   +       +  D P  P  L  E KD L
Sbjct: 195 YNHS-----VDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDLL 249
Query: 581 RCCFQRNPADR 591
              F R P  R
Sbjct: 250 VKLFVREPEKR 260

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score =  118 bits (296), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 88/309 (28%), Positives = 162/309 (52%), Gaps = 27/309 (8%)
Query: 339 NSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSH 398
           +  ++K   +G G  G V+  S++ +G + A K + +   + K A    Q+ +E++VL  
Sbjct: 5   DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHL---EIKPAIR-NQIIRELQVLHE 60
Query: 399 LKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAY 458
              P IV +YG+   + +  I +E++  GS+++ +++  G I E ++   +  ++ GL Y
Sbjct: 61  CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK-AGRIPEQILGKVSIAVIKGLTY 119
Query: 459 LHSK-KTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPYWMAPELMMAV 517
           L  K K +HRD+K +N+LV++ G +KL DFG++  L    A+ S  G+  +M+PE +   
Sbjct: 120 LREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN-SFVGTRSYMSPERL--- 175
Query: 518 MQKGKSSDSALAVDIWSLGCTIIEMYTGK---PPWSEYEGA---AAMFKVMRDT-----P 566
               + +  ++  DIWS+G +++EM  G+   PP    E +    A+F+++        P
Sbjct: 176 ----QGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKEDSRPPMAIFELLDYIVNEPPP 231
Query: 567 AIPDSL-SPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQPDVPSCSLSFSGMQLTE 625
            +P  + S E +DF+  C  +NPA+R     L+ H F+K S   +V       S + L +
Sbjct: 232 KLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDAEEVDFAGWLCSTIGLNQ 291
Query: 626 KPHSPREKA 634
            P +P   A
Sbjct: 292 -PSTPTHAA 299

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score =  118 bits (296), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 83/299 (27%), Positives = 135/299 (45%), Gaps = 39/299 (13%)
Query: 341 QWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLK 400
            +QK + IG GT+G VY A N+ TG + A+K++ +   D ++        +EI +L  L 
Sbjct: 6   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL---DTETEGVPSTAIREISLLKELN 62
Query: 401 HPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLH 460
           HPNIV+       E+K Y+  E++     +         I   +++++   +L GLA+ H
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFLSMDLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCH 122
Query: 461 SKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPYWM-APELMMAVMQ 519
           S + +HRD+K  NLL++  G +KLADFG+A+           +    W  APE+++    
Sbjct: 123 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG--- 179
Query: 520 KGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRD--TP---------AI 568
                  + AVDIWSLGC   EM T +  +        +F++ R   TP         ++
Sbjct: 180 ---CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSM 236
Query: 569 PDS------------------LSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQP 609
           PD                   L  +G+  L      +P  R  A   L H F ++  +P
Sbjct: 237 PDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 295

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score =  118 bits (296), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 80/254 (31%), Positives = 127/254 (50%), Gaps = 18/254 (7%)
Query: 341 QWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQ---EIKVLS 397
           Q+++ K +G G+FG V +  + ETG   AMK +D      +    +KQ+E    E ++L 
Sbjct: 42  QFERIKTLGTGSFGRVMLVKHMETGNHYAMKILD-----KQKVVKLKQIEHTLNEKRILQ 96
Query: 398 HLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLA 457
            +  P +V+   S       Y+ +EYV  G +  ++R   G  +E   R +   I+    
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR-RIGRFSEPHARFYAAQIVLTFE 155
Query: 458 YLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPYWMAPELMMAV 517
           YLHS   I+RD+K  NLL+D  G +++ DFG AK + G+   L   G+P ++APE++++ 
Sbjct: 156 YLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC--GTPEYLAPEIILS- 212
Query: 518 MQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDSLSPEGK 577
             KG +     AVD W+LG  I EM  G PP+   +      K++      P   S + K
Sbjct: 213 --KGYNK----AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLK 266
Query: 578 DFLRCCFQRNPADR 591
           D LR   Q +   R
Sbjct: 267 DLLRNLLQVDLTKR 280

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score =  118 bits (296), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 79/254 (31%), Positives = 128/254 (50%), Gaps = 18/254 (7%)
Query: 341 QWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQ---EIKVLS 397
           Q+ + K +G G+FG V +  ++E+G   AMK +D      +    +KQ+E    E ++L 
Sbjct: 42  QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILD-----KQKVVKLKQIEHTLNEKRILQ 96
Query: 398 HLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLA 457
            +  P +V+   S       Y+ +EYV  G +  ++R   G  +E   R +   I+    
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR-RIGRFSEPHARFYAAQIVLTFE 155
Query: 458 YLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPYWMAPELMMAV 517
           YLHS   I+RD+K  NLL+D  G +++ DFG AK + G+   L+  G+P ++APE++++ 
Sbjct: 156 YLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLA--GTPEYLAPEIILS- 212
Query: 518 MQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDSLSPEGK 577
             KG +     AVD W+LG  I EM  G PP+   +      K++      P   S + K
Sbjct: 213 --KGYNK----AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLK 266
Query: 578 DFLRCCFQRNPADR 591
           D LR   Q +   R
Sbjct: 267 DLLRNLLQVDLTKR 280

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score =  118 bits (295), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 87/307 (28%), Positives = 141/307 (45%), Gaps = 42/307 (13%)
Query: 341 QWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLK 400
            +QK + IG GT+G VY A N+ TG + A+K++ +   D ++        +EI +L  L 
Sbjct: 5   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL---DTETEGVPSTAIREISLLKELN 61
Query: 401 HPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHC-GAITESVVRNFTRHILSGLAYL 459
           HPNIV+       E+K Y+  E++    + K++       I   +++++   +L GLA+ 
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFL-SMDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 120
Query: 460 HSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPYWM-APELMMAVM 518
           HS + +HRD+K  NLL++  G +KLADFG+A+           +    W  APE+++   
Sbjct: 121 HSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG-- 178
Query: 519 QKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRD--TP---------A 567
                   + AVDIWSLGC   EM T +  +        +F++ R   TP         +
Sbjct: 179 ----CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS 234
Query: 568 IPDS------------------LSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQP 609
           +PD                   L  +G+  L      +P  R  A   L H F ++  +P
Sbjct: 235 MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 294
Query: 610 DVPSCSL 616
            VP   L
Sbjct: 295 -VPHLRL 300

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score =  118 bits (295), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 79/254 (31%), Positives = 128/254 (50%), Gaps = 18/254 (7%)
Query: 341 QWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQ---EIKVLS 397
           Q+ + K +G G+FG V +  ++E+G   AMK +D      +    +KQ+E    E ++L 
Sbjct: 63  QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILD-----KQKVVKLKQIEHTLNEKRILQ 117
Query: 398 HLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLA 457
            +  P +V+   S       Y+ +EYV  G +  ++R   G  +E   R +   I+    
Sbjct: 118 AVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR-RIGRFSEPHARFYAAQIVLTFE 176
Query: 458 YLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPYWMAPELMMAV 517
           YLHS   I+RD+K  NLL+D  G +++ DFG AK + G  A  ++ G+P ++APE++++ 
Sbjct: 177 YLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG--ATWTLCGTPEYLAPEIILS- 233
Query: 518 MQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDSLSPEGK 577
             KG +     AVD W+LG  I EM  G PP+   +      K++      P   S + K
Sbjct: 234 --KGYNK----AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLK 287
Query: 578 DFLRCCFQRNPADR 591
           D LR   Q +   R
Sbjct: 288 DLLRNLLQVDLTKR 301

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score =  118 bits (295), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 80/254 (31%), Positives = 127/254 (50%), Gaps = 18/254 (7%)
Query: 341 QWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQ---EIKVLS 397
           Q+++ K +G G+FG V +  + ETG   AMK +D      +    +KQ+E    E ++L 
Sbjct: 28  QFERIKTLGTGSFGRVMLVKHMETGNHYAMKILD-----KQKVVKLKQIEHTLNEKRILQ 82
Query: 398 HLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLA 457
            +  P +V+   S       Y+ +EYV  G +  ++R   G  +E   R +   I+    
Sbjct: 83  AVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLR-RIGRFSEPHARFYAAQIVLTFE 141
Query: 458 YLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPYWMAPELMMAV 517
           YLHS   I+RD+K  NLL+D  G +++ DFG AK + G+   L   G+P ++APE++++ 
Sbjct: 142 YLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLC--GTPEYLAPEIILS- 198
Query: 518 MQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDSLSPEGK 577
             KG +     AVD W+LG  I EM  G PP+   +      K++      P   S + K
Sbjct: 199 --KGYNK----AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLK 252
Query: 578 DFLRCCFQRNPADR 591
           D LR   Q +   R
Sbjct: 253 DLLRNLLQVDLTKR 266

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score =  117 bits (294), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 80/254 (31%), Positives = 127/254 (50%), Gaps = 18/254 (7%)
Query: 341 QWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQ---EIKVLS 397
           Q+++ K +G G+FG V +  + ETG   AMK +D      +    +KQ+E    E ++L 
Sbjct: 42  QFERIKTLGTGSFGRVMLVKHMETGNHYAMKILD-----KQKVVKLKQIEHTLNEKRILQ 96
Query: 398 HLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLA 457
            +  P +V+   S       Y+ +EYV  G +  ++R   G  +E   R +   I+    
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLR-RIGRFSEPHARFYAAQIVLTFE 155
Query: 458 YLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPYWMAPELMMAV 517
           YLHS   I+RD+K  NLL+D  G +++ DFG AK + G+   L   G+P ++APE++++ 
Sbjct: 156 YLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC--GTPEYLAPEIILS- 212
Query: 518 MQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDSLSPEGK 577
             KG +     AVD W+LG  I EM  G PP+   +      K++      P   S + K
Sbjct: 213 --KGYNK----AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLK 266
Query: 578 DFLRCCFQRNPADR 591
           D LR   Q +   R
Sbjct: 267 DLLRNLLQVDLTKR 280

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score =  117 bits (294), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 83/284 (29%), Positives = 139/284 (48%), Gaps = 31/284 (10%)
Query: 334 EPLPMNSQWQKGKLIGRGTFGSVYVASNRETGALCAMK----EVDIFPDDPKSAESIKQL 389
           +P    ++++  KL+G+GTFG V +   + TG   AMK    EV +  D+      +   
Sbjct: 4   DPRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDE------VAHT 57
Query: 390 EQEIKVLSHLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYV-REHCGAITESVVRNF 448
             E +VL + +HP +     S    D+    +EY + G +  ++ RE     +E   R +
Sbjct: 58  LTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRER--VFSEDRARFY 115
Query: 449 TRHILSGLAYLHSKK-TIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMK---G 504
              I+S L YLHS+K  ++RD+K  NL++D  G +K+ DFG+ K   G K   +MK   G
Sbjct: 116 GAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKE--GIKDGATMKXFCG 173
Query: 505 SPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRD 564
           +P ++APE++       + +D   AVD W LG  + EM  G+ P+   +       ++ +
Sbjct: 174 TPEYLAPEVL-------EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME 226
Query: 565 TPAIPDSLSPEGKDFLRCCFQRNPADR-----PPASLLLEHRFL 603
               P +L PE K  L    +++P  R       A  +++HRF 
Sbjct: 227 EIRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFF 270

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score =  117 bits (294), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 80/254 (31%), Positives = 127/254 (50%), Gaps = 18/254 (7%)
Query: 341 QWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQ---EIKVLS 397
           Q+++ K +G G+FG V +  + ETG   AMK +D      +    +KQ+E    E ++L 
Sbjct: 42  QFERIKTLGTGSFGRVMLVKHMETGNHYAMKILD-----KQKVVKLKQIEHTLNEKRILQ 96
Query: 398 HLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLA 457
            +  P +V+   S       Y+ +EYV  G +  ++R   G  +E   R +   I+    
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLR-RIGRFSEPHARFYAAQIVLTFE 155
Query: 458 YLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPYWMAPELMMAV 517
           YLHS   I+RD+K  NLL+D  G +++ DFG AK + G+   L   G+P ++APE++++ 
Sbjct: 156 YLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC--GTPEYLAPEIILS- 212
Query: 518 MQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDSLSPEGK 577
             KG +     AVD W+LG  I EM  G PP+   +      K++      P   S + K
Sbjct: 213 --KGYNK----AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLK 266
Query: 578 DFLRCCFQRNPADR 591
           D LR   Q +   R
Sbjct: 267 DLLRNLLQVDLTKR 280

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score =  117 bits (294), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 80/254 (31%), Positives = 127/254 (50%), Gaps = 18/254 (7%)
Query: 341 QWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQ---EIKVLS 397
           Q+++ K +G G+FG V +  + ETG   AMK +D      +    +KQ+E    E ++L 
Sbjct: 43  QFERIKTLGTGSFGRVMLVKHMETGNHYAMKILD-----KQKVVKLKQIEHTLNEKRILQ 97
Query: 398 HLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLA 457
            +  P +V+   S       Y+ +EYV  G +  ++R   G  +E   R +   I+    
Sbjct: 98  AVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLR-RIGRFSEPHARFYAAQIVLTFE 156
Query: 458 YLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPYWMAPELMMAV 517
           YLHS   I+RD+K  NLL+D  G +++ DFG AK + G+   L   G+P ++APE++++ 
Sbjct: 157 YLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLC--GTPEYLAPEIILS- 213
Query: 518 MQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDSLSPEGK 577
             KG +     AVD W+LG  I EM  G PP+   +      K++      P   S + K
Sbjct: 214 --KGYNK----AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLK 267
Query: 578 DFLRCCFQRNPADR 591
           D LR   Q +   R
Sbjct: 268 DLLRNLLQVDLTKR 281

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score =  117 bits (294), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 79/254 (31%), Positives = 127/254 (50%), Gaps = 18/254 (7%)
Query: 341 QWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQ---EIKVLS 397
           Q+ + K +G G+FG V +  ++E+G   AMK +D      +    +KQ+E    E ++L 
Sbjct: 29  QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILD-----KQKVVKLKQIEHTLNEKRILQ 83
Query: 398 HLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLA 457
            +  P +V+   S       Y+ +EYV  G +  ++R   G  +E   R +   I+    
Sbjct: 84  AVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR-RIGRFSEPHARFYAAQIVLTFE 142
Query: 458 YLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPYWMAPELMMAV 517
           YLHS   I+RD+K  NLL+D  G +++ DFG AK + G+   L   G+P ++APE++++ 
Sbjct: 143 YLHSLDLIYRDLKPENLLIDEQGYIQVTDFGFAKRVKGRTWXLC--GTPEYLAPEIILS- 199
Query: 518 MQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDSLSPEGK 577
             KG +     AVD W+LG  I EM  G PP+   +      K++      P   S + K
Sbjct: 200 --KGYNK----AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLK 253
Query: 578 DFLRCCFQRNPADR 591
           D LR   Q +   R
Sbjct: 254 DLLRNLLQVDLTKR 267

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score =  117 bits (294), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 79/275 (28%), Positives = 135/275 (49%), Gaps = 15/275 (5%)
Query: 340 SQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHL 399
             +  G  +G GTFG V +  ++ TG   A+K ++      +S + + ++++EI+ L   
Sbjct: 11  GHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILN--RQKIRSLDVVGKIKREIQNLKLF 68
Query: 400 KHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYL 459
           +HP+I++ Y        F++ +EYV  G +  Y+ +H G + E   R   + ILS + Y 
Sbjct: 69  RHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKH-GRVEEMEARRLFQQILSAVDYC 127
Query: 460 HSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPYWMAPELMMAVMQ 519
           H    +HRD+K  N+L+DA    K+ADFG++  ++  +   +  GSP + APE++   + 
Sbjct: 128 HRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLY 187
Query: 520 KGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMR-DTPAIPDSLSPEGKD 578
            G        VDIWS G  +  +  G  P+ + E    +FK +R     IP+ L+     
Sbjct: 188 AGPE------VDIWSCGVILYALLCGTLPFDD-EHVPTLFKKIRGGVFYIPEYLNRSVAT 240
Query: 579 FLRCCFQRNPADRPPASLLLEHRFLKNSQQPDVPS 613
            L    Q +P  R     + EH + K     D+PS
Sbjct: 241 LLMHMLQVDPLKRATIKDIREHEWFKQ----DLPS 271

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score =  117 bits (294), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 79/254 (31%), Positives = 127/254 (50%), Gaps = 18/254 (7%)
Query: 341 QWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQ---EIKVLS 397
           Q+ + K +G G+FG V +  ++E+G   AMK +D      +    +KQ+E    E ++L 
Sbjct: 42  QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILD-----KQKVVKLKQIEHTLNEKRILQ 96
Query: 398 HLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLA 457
            +  P +V+   S       Y+ +EYV  G +  ++R   G  +E   R +   I+    
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR-RIGRFSEPHARFYAAQIVLTFE 155
Query: 458 YLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPYWMAPELMMAV 517
           YLHS   I+RD+K  NLL+D  G +++ DFG AK + G+   L   G+P ++APE++++ 
Sbjct: 156 YLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLX--GTPEYLAPEIILS- 212
Query: 518 MQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDSLSPEGK 577
             KG +     AVD W+LG  I EM  G PP+   +      K++      P   S + K
Sbjct: 213 --KGYNK----AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLK 266
Query: 578 DFLRCCFQRNPADR 591
           D LR   Q +   R
Sbjct: 267 DLLRNLLQVDLTKR 280

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score =  117 bits (294), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 80/254 (31%), Positives = 127/254 (50%), Gaps = 18/254 (7%)
Query: 341 QWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQ---EIKVLS 397
           Q+++ K +G G+FG V +  + ETG   AMK +D      +    +KQ+E    E ++L 
Sbjct: 43  QFERIKTLGTGSFGRVMLVKHMETGNHYAMKILD-----KQKVVKLKQIEHTLNEKRILQ 97
Query: 398 HLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLA 457
            +  P +V+   S       Y+ +EYV  G +  ++R   G  +E   R +   I+    
Sbjct: 98  AVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLR-RIGRFSEPHARFYAAQIVLTFE 156
Query: 458 YLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPYWMAPELMMAV 517
           YLHS   I+RD+K  NLL+D  G +++ DFG AK + G+   L   G+P ++APE++++ 
Sbjct: 157 YLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC--GTPEYLAPEIILS- 213
Query: 518 MQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDSLSPEGK 577
             KG +     AVD W+LG  I EM  G PP+   +      K++      P   S + K
Sbjct: 214 --KGYNK----AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLK 267
Query: 578 DFLRCCFQRNPADR 591
           D LR   Q +   R
Sbjct: 268 DLLRNLLQVDLTKR 281

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score =  117 bits (294), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 80/254 (31%), Positives = 127/254 (50%), Gaps = 18/254 (7%)
Query: 341 QWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQ---EIKVLS 397
           Q+++ K +G G+FG V +  + ETG   AMK +D      +    +KQ+E    E ++L 
Sbjct: 42  QFERIKTLGTGSFGRVMLVKHMETGNHYAMKILD-----KQKVVKLKQIEHTLNEKRILQ 96
Query: 398 HLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLA 457
            +  P +V+   S       Y+ +EYV  G +  ++R   G  +E   R +   I+    
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLR-RIGRFSEPHARFYAAQIVLTFE 155
Query: 458 YLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPYWMAPELMMAV 517
           YLHS   I+RD+K  NLL+D  G +++ DFG AK + G+   L   G+P ++APE++++ 
Sbjct: 156 YLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC--GTPEYLAPEIILS- 212
Query: 518 MQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDSLSPEGK 577
             KG +     AVD W+LG  I EM  G PP+   +      K++      P   S + K
Sbjct: 213 --KGYNK----AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLK 266
Query: 578 DFLRCCFQRNPADR 591
           D LR   Q +   R
Sbjct: 267 DLLRNLLQVDLTKR 280

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score =  117 bits (294), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 79/254 (31%), Positives = 126/254 (49%), Gaps = 18/254 (7%)
Query: 341 QWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQ---EIKVLS 397
           Q+++ K +G G+FG V +  ++ETG   AMK +D      +    +KQ+E    E ++L 
Sbjct: 43  QFERIKTLGTGSFGRVMLVKHKETGNHYAMKILD-----KQKVVKLKQIEHTLNEKRILQ 97
Query: 398 HLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLA 457
            +  P +V+   S       Y+ +EY   G +  ++R   G  +E   R +   I+    
Sbjct: 98  AVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLR-RIGRFSEPHARFYAAQIVLTFE 156
Query: 458 YLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPYWMAPELMMAV 517
           YLHS   I+RD+K  NL++D  G +K+ DFG AK + G+   L   G+P ++APE+   +
Sbjct: 157 YLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLC--GTPEYLAPEI---I 211
Query: 518 MQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDSLSPEGK 577
           + KG +     AVD W+LG  I EM  G PP+   +      K++      P   S + K
Sbjct: 212 LSKGYNK----AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLK 267
Query: 578 DFLRCCFQRNPADR 591
           D LR   Q +   R
Sbjct: 268 DLLRNLLQVDLTKR 281

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score =  117 bits (294), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 82/278 (29%), Positives = 137/278 (49%), Gaps = 31/278 (11%)
Query: 340 SQWQKGKLIGRGTFGSVYVASNRETGALCAMK----EVDIFPDDPKSAESIKQLEQEIKV 395
           ++++  KL+G+GTFG V +   + TG   AMK    EV +  D+      +     E +V
Sbjct: 8   NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDE------VAHTLTENRV 61
Query: 396 LSHLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYV-REHCGAITESVVRNFTRHILS 454
           L + +HP +     S    D+    +EY + G +  ++ RE     +E   R +   I+S
Sbjct: 62  LQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRER--VFSEDRARFYGAEIVS 119
Query: 455 GLAYLHSKK-TIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMK---GSPYWMA 510
            L YLHS+K  ++RD+K  NL++D  G +K+ DFG+ K   G K   +MK   G+P ++A
Sbjct: 120 ALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKE--GIKDGATMKXFCGTPEYLA 177
Query: 511 PELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPD 570
           PE++       + +D   AVD W LG  + EM  G+ P+   +       ++ +    P 
Sbjct: 178 PEVL-------EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPR 230
Query: 571 SLSPEGKDFLRCCFQRNPADR-----PPASLLLEHRFL 603
           +L PE K  L    +++P  R       A  +++HRF 
Sbjct: 231 TLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFF 268

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  117 bits (294), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 79/254 (31%), Positives = 127/254 (50%), Gaps = 18/254 (7%)
Query: 341 QWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQ---EIKVLS 397
           Q+ + K +G G+FG V +  ++E+G   AMK +D      +    +KQ+E    E ++L 
Sbjct: 42  QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILD-----KQKVVKLKQIEHTLNEKRILQ 96
Query: 398 HLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLA 457
            +  P +V+   S       Y+ +EYV  G +  ++R   G  +E   R +   I+    
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR-RIGRFSEPHARFYAAQIVLTFE 155
Query: 458 YLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPYWMAPELMMAV 517
           YLHS   I+RD+K  NLL+D  G +++ DFG AK + G+   L   G+P ++APE++++ 
Sbjct: 156 YLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC--GTPEYLAPEIILS- 212
Query: 518 MQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDSLSPEGK 577
             KG +     AVD W+LG  I EM  G PP+   +      K++      P   S + K
Sbjct: 213 --KGYNK----AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLK 266
Query: 578 DFLRCCFQRNPADR 591
           D LR   Q +   R
Sbjct: 267 DLLRNLLQVDLTKR 280

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score =  117 bits (293), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 82/278 (29%), Positives = 137/278 (49%), Gaps = 31/278 (11%)
Query: 340 SQWQKGKLIGRGTFGSVYVASNRETGALCAMK----EVDIFPDDPKSAESIKQLEQEIKV 395
           ++++  KL+G+GTFG V +   + TG   AMK    EV +  D+      +     E +V
Sbjct: 9   NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDE------VAHTLTENRV 62
Query: 396 LSHLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYV-REHCGAITESVVRNFTRHILS 454
           L + +HP +     S    D+    +EY + G +  ++ RE     +E   R +   I+S
Sbjct: 63  LQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRER--VFSEDRARFYGAEIVS 120
Query: 455 GLAYLHSKK-TIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMK---GSPYWMA 510
            L YLHS+K  ++RD+K  NL++D  G +K+ DFG+ K   G K   +MK   G+P ++A
Sbjct: 121 ALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKE--GIKDGATMKXFCGTPEYLA 178
Query: 511 PELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPD 570
           PE++       + +D   AVD W LG  + EM  G+ P+   +       ++ +    P 
Sbjct: 179 PEVL-------EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPR 231
Query: 571 SLSPEGKDFLRCCFQRNPADR-----PPASLLLEHRFL 603
           +L PE K  L    +++P  R       A  +++HRF 
Sbjct: 232 TLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFF 269

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score =  117 bits (293), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 79/254 (31%), Positives = 127/254 (50%), Gaps = 18/254 (7%)
Query: 341 QWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQ---EIKVLS 397
           Q+ + K +G G+FG V +  ++E+G   AMK +D      +    +KQ+E    E ++L 
Sbjct: 43  QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILD-----KQKVVKLKQIEHTLNEKRILQ 97
Query: 398 HLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLA 457
            +  P +V+   S       Y+ +EYV  G +  ++R   G  +E   R +   I+    
Sbjct: 98  AVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR-RIGRFSEPHARFYAAQIVLTFE 156
Query: 458 YLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPYWMAPELMMAV 517
           YLHS   I+RD+K  NLL+D  G +++ DFG AK + G+   L   G+P ++APE++++ 
Sbjct: 157 YLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC--GTPEYLAPEIILS- 213
Query: 518 MQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDSLSPEGK 577
             KG +     AVD W+LG  I EM  G PP+   +      K++      P   S + K
Sbjct: 214 --KGYNK----AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLK 267
Query: 578 DFLRCCFQRNPADR 591
           D LR   Q +   R
Sbjct: 268 DLLRNLLQVDLTKR 281

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score =  117 bits (293), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 79/254 (31%), Positives = 127/254 (50%), Gaps = 18/254 (7%)
Query: 341 QWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQ---EIKVLS 397
           Q+ + K +G G+FG V +  ++E+G   AMK +D      +    +KQ+E    E ++L 
Sbjct: 42  QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILD-----KQKVVKLKQIEHTLNEKRILQ 96
Query: 398 HLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLA 457
            +  P +V+   S       Y+ +EYV  G +  ++R   G  +E   R +   I+    
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR-RIGRFSEPHARFYAAQIVLTFE 155
Query: 458 YLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPYWMAPELMMAV 517
           YLHS   I+RD+K  NLL+D  G +++ DFG AK + G+   L   G+P ++APE++++ 
Sbjct: 156 YLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC--GTPEYLAPEIILS- 212
Query: 518 MQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDSLSPEGK 577
             KG +     AVD W+LG  I EM  G PP+   +      K++      P   S + K
Sbjct: 213 --KGYNK----AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLK 266
Query: 578 DFLRCCFQRNPADR 591
           D LR   Q +   R
Sbjct: 267 DLLRNLLQVDLTKR 280

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score =  117 bits (293), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 79/254 (31%), Positives = 127/254 (50%), Gaps = 18/254 (7%)
Query: 341 QWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQ---EIKVLS 397
           Q+ + K +G G+FG V +  ++E+G   AMK +D      +    +KQ+E    E ++L 
Sbjct: 42  QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILD-----KQKVVKLKQIEHTLNEKRILQ 96
Query: 398 HLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLA 457
            +  P +V+   S       Y+ +EYV  G +  ++R   G  +E   R +   I+    
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR-RIGRFSEPHARFYAAQIVLTFE 155
Query: 458 YLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPYWMAPELMMAV 517
           YLHS   I+RD+K  NLL+D  G +++ DFG AK + G+   L   G+P ++APE++++ 
Sbjct: 156 YLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC--GTPEYLAPEIILS- 212
Query: 518 MQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDSLSPEGK 577
             KG +     AVD W+LG  I EM  G PP+   +      K++      P   S + K
Sbjct: 213 --KGYNK----AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLK 266
Query: 578 DFLRCCFQRNPADR 591
           D LR   Q +   R
Sbjct: 267 DLLRNLLQVDLTKR 280

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score =  117 bits (293), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 80/254 (31%), Positives = 127/254 (50%), Gaps = 18/254 (7%)
Query: 341 QWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQ---EIKVLS 397
           Q+++ + +G G+FG V +  ++ETG   AMK +D      +    +KQ+E    E ++  
Sbjct: 43  QFERIRTLGTGSFGRVMLVKHKETGNHYAMKILD-----KQKVVKLKQIEHTLNEKRIQQ 97
Query: 398 HLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLA 457
            +  P +V+   S       Y+ LEY   G +  ++R   G  +E   R +   I+    
Sbjct: 98  AVNFPFLVKLEFSFKDNSNLYMVLEYAPGGEMFSHLR-RIGRFSEPHARFYAAQIVLTFE 156
Query: 458 YLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPYWMAPELMMAV 517
           YLHS   I+RD+K  NLL+D  G +K+ADFG AK + G+   L   G+P ++APE++++ 
Sbjct: 157 YLHSLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXLC--GTPEYLAPEIILS- 213
Query: 518 MQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDSLSPEGK 577
             KG +     AVD W+LG  I EM  G PP+   +      K++      P   S + K
Sbjct: 214 --KGYNK----AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLK 267
Query: 578 DFLRCCFQRNPADR 591
           D LR   Q +   R
Sbjct: 268 DLLRNLLQVDLTKR 281

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score =  117 bits (292), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 80/254 (31%), Positives = 126/254 (49%), Gaps = 18/254 (7%)
Query: 341 QWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQ---EIKVLS 397
           Q+++ K +G G+FG V +  + ETG   AMK +D      +    +KQ+E    E ++L 
Sbjct: 42  QFERIKTLGTGSFGRVMLVKHMETGNHYAMKILD-----KQKVVKLKQIEHTLNEKRILQ 96
Query: 398 HLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLA 457
            +  P +V+   S       Y+ +EYV  G +  ++R   G   E   R +   I+    
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLR-RIGRFXEPHARFYAAQIVLTFE 155
Query: 458 YLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPYWMAPELMMAV 517
           YLHS   I+RD+K  NLL+D  G +++ DFG AK + G+   L   G+P ++APE++++ 
Sbjct: 156 YLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC--GTPEYLAPEIILS- 212
Query: 518 MQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDSLSPEGK 577
             KG +     AVD W+LG  I EM  G PP+   +      K++      P   S + K
Sbjct: 213 --KGYNK----AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLK 266
Query: 578 DFLRCCFQRNPADR 591
           D LR   Q +   R
Sbjct: 267 DLLRNLLQVDLTKR 280

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score =  117 bits (292), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 80/254 (31%), Positives = 126/254 (49%), Gaps = 18/254 (7%)
Query: 341 QWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQ---EIKVLS 397
           Q+++ K +G G+FG V +  + ETG   AMK +D      +    +KQ+E    E ++L 
Sbjct: 43  QFERIKTLGTGSFGRVMLVKHMETGNHYAMKILD-----KQKVVKLKQIEHTLNEKRILQ 97
Query: 398 HLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLA 457
            +  P +V+   S       Y+ +EYV  G +  ++R   G   E   R +   I+    
Sbjct: 98  AVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLR-RIGRFXEPHARFYAAQIVLTFE 156
Query: 458 YLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPYWMAPELMMAV 517
           YLHS   I+RD+K  NLL+D  G +++ DFG AK + G+   L   G+P ++APE++++ 
Sbjct: 157 YLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC--GTPEYLAPEIILS- 213
Query: 518 MQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDSLSPEGK 577
             KG +     AVD W+LG  I EM  G PP+   +      K++      P   S + K
Sbjct: 214 --KGYNK----AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLK 267
Query: 578 DFLRCCFQRNPADR 591
           D LR   Q +   R
Sbjct: 268 DLLRNLLQVDLTKR 281

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score =  117 bits (292), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 80/254 (31%), Positives = 126/254 (49%), Gaps = 18/254 (7%)
Query: 341 QWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQ---EIKVLS 397
           Q+++ K +G G+FG V +  + ETG   AMK +D      +    +KQ+E    E ++L 
Sbjct: 42  QFERIKTLGTGSFGRVMLVKHMETGNHYAMKILD-----KQKVVKLKQIEHTLNEKRILQ 96
Query: 398 HLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLA 457
            +  P +V+   S       Y+ +EYV  G +  ++R   G   E   R +   I+    
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLR-RIGRFXEPHARFYAAQIVLTFE 155
Query: 458 YLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPYWMAPELMMAV 517
           YLHS   I+RD+K  NLL+D  G +++ DFG AK + G+   L   G+P ++APE++++ 
Sbjct: 156 YLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC--GTPEYLAPEIILS- 212
Query: 518 MQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDSLSPEGK 577
             KG +     AVD W+LG  I EM  G PP+   +      K++      P   S + K
Sbjct: 213 --KGYNK----AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLK 266
Query: 578 DFLRCCFQRNPADR 591
           D LR   Q +   R
Sbjct: 267 DLLRNLLQVDLTKR 280

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score =  117 bits (292), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 79/275 (28%), Positives = 134/275 (48%), Gaps = 15/275 (5%)
Query: 340 SQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHL 399
             +  G  +G GTFG V +  ++ TG   A+K ++      +S + + ++++EI+ L   
Sbjct: 11  GHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILN--RQKIRSLDVVGKIKREIQNLKLF 68
Query: 400 KHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYL 459
           +HP+I++ Y        F++ +EYV  G +  Y+ +H G + E   R   + ILS + Y 
Sbjct: 69  RHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKH-GRVEEMEARRLFQQILSAVDYC 127
Query: 460 HSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPYWMAPELMMAVMQ 519
           H    +HRD+K  N+L+DA    K+ADFG++  ++  +      GSP + APE++   + 
Sbjct: 128 HRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRDSCGSPNYAAPEVISGRLY 187
Query: 520 KGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMR-DTPAIPDSLSPEGKD 578
            G        VDIWS G  +  +  G  P+ + E    +FK +R     IP+ L+     
Sbjct: 188 AGPE------VDIWSCGVILYALLCGTLPFDD-EHVPTLFKKIRGGVFYIPEYLNRSVAT 240
Query: 579 FLRCCFQRNPADRPPASLLLEHRFLKNSQQPDVPS 613
            L    Q +P  R     + EH + K     D+PS
Sbjct: 241 LLMHMLQVDPLKRATIKDIREHEWFKQ----DLPS 271

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score =  117 bits (292), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 79/254 (31%), Positives = 126/254 (49%), Gaps = 18/254 (7%)
Query: 341 QWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQ---EIKVLS 397
           Q+ + K +G G+FG V +  ++E+G   AMK +D      +    +KQ+E    E ++L 
Sbjct: 37  QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILD-----KQKVVKLKQIEHTLNEKRILQ 91
Query: 398 HLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLA 457
            +  P +V+   S       Y+ +EYV  G +  ++R   G   E   R +   I+    
Sbjct: 92  AVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR-RIGRFXEPHARFYAAQIVLTFE 150
Query: 458 YLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPYWMAPELMMAV 517
           YLHS   I+RD+K  NLL+D  G +++ DFG AK + G+   L   G+P ++APE++++ 
Sbjct: 151 YLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC--GTPEYLAPEIILS- 207
Query: 518 MQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDSLSPEGK 577
             KG +     AVD W+LG  I EM  G PP+   +      K++      P   S + K
Sbjct: 208 --KGYNK----AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLK 261
Query: 578 DFLRCCFQRNPADR 591
           D LR   Q +   R
Sbjct: 262 DLLRNLLQVDLTKR 275

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score =  117 bits (292), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 79/254 (31%), Positives = 126/254 (49%), Gaps = 18/254 (7%)
Query: 341 QWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQ---EIKVLS 397
           Q+ + K +G G+FG V +  ++E+G   AMK +D      +    +KQ+E    E ++L 
Sbjct: 42  QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILD-----KQKVVKLKQIEHTLNEKRILQ 96
Query: 398 HLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLA 457
            +  P +V+   S       Y+ +EYV  G +  ++R   G   E   R +   I+    
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR-RIGRFAEPHARFYAAQIVLTFE 155
Query: 458 YLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPYWMAPELMMAV 517
           YLHS   I+RD+K  NLL+D  G +++ DFG AK + G+   L   G+P ++APE++++ 
Sbjct: 156 YLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC--GTPEYLAPEIILS- 212
Query: 518 MQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDSLSPEGK 577
             KG +     AVD W+LG  I EM  G PP+   +      K++      P   S + K
Sbjct: 213 --KGYNK----AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLK 266
Query: 578 DFLRCCFQRNPADR 591
           D LR   Q +   R
Sbjct: 267 DLLRNLLQVDLTKR 280

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score =  116 bits (291), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 79/254 (31%), Positives = 126/254 (49%), Gaps = 18/254 (7%)
Query: 341 QWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQ---EIKVLS 397
           Q+ + K +G G+FG V +  ++E+G   AMK +D      +    +KQ+E    E ++L 
Sbjct: 63  QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILD-----KQKVVKLKQIEHTLNEKRILQ 117
Query: 398 HLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLA 457
            +  P +V+   S       Y+ +EYV  G +  ++R   G   E   R +   I+    
Sbjct: 118 AVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR-RIGRFXEPHARFYAAQIVLTFE 176
Query: 458 YLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPYWMAPELMMAV 517
           YLHS   I+RD+K  NLL+D  G +++ DFG AK + G+   L   G+P ++APE++++ 
Sbjct: 177 YLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC--GTPEYLAPEIILS- 233
Query: 518 MQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDSLSPEGK 577
             KG +     AVD W+LG  I EM  G PP+   +      K++      P   S + K
Sbjct: 234 --KGYNK----AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLK 287
Query: 578 DFLRCCFQRNPADR 591
           D LR   Q +   R
Sbjct: 288 DLLRNLLQVDLTKR 301

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  116 bits (291), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 79/254 (31%), Positives = 126/254 (49%), Gaps = 18/254 (7%)
Query: 341 QWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQ---EIKVLS 397
           Q+ + K +G G+FG V +  ++E+G   AMK +D      +    +KQ+E    E ++L 
Sbjct: 42  QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILD-----KQKVVKLKQIEHTLNEKRILQ 96
Query: 398 HLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLA 457
            +  P +V+   S       Y+ +EYV  G +  ++R   G   E   R +   I+    
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR-RIGRFXEPHARFYAAQIVLTFE 155
Query: 458 YLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPYWMAPELMMAV 517
           YLHS   I+RD+K  NLL+D  G +++ DFG AK + G+   L   G+P ++APE++++ 
Sbjct: 156 YLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC--GTPEYLAPEIILS- 212
Query: 518 MQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDSLSPEGK 577
             KG +     AVD W+LG  I EM  G PP+   +      K++      P   S + K
Sbjct: 213 --KGYNK----AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLK 266
Query: 578 DFLRCCFQRNPADR 591
           D LR   Q +   R
Sbjct: 267 DLLRNLLQVDLTKR 280

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score =  116 bits (291), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 79/254 (31%), Positives = 126/254 (49%), Gaps = 18/254 (7%)
Query: 341 QWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQ---EIKVLS 397
           Q+ + K +G G+FG V +  ++E+G   AMK +D      +    +KQ+E    E ++L 
Sbjct: 42  QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILD-----KQKVVKLKQIEHTLNEKRILQ 96
Query: 398 HLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLA 457
            +  P +V+   S       Y+ +EYV  G +  ++R   G   E   R +   I+    
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR-RIGRFXEPHARFYAAQIVLTFE 155
Query: 458 YLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPYWMAPELMMAV 517
           YLHS   I+RD+K  NLL+D  G +++ DFG AK + G+   L   G+P ++APE++++ 
Sbjct: 156 YLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC--GTPEYLAPEIILS- 212
Query: 518 MQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDSLSPEGK 577
             KG +     AVD W+LG  I EM  G PP+   +      K++      P   S + K
Sbjct: 213 --KGYNK----AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLK 266
Query: 578 DFLRCCFQRNPADR 591
           D LR   Q +   R
Sbjct: 267 DLLRNLLQVDLTKR 280

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  116 bits (291), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 78/248 (31%), Positives = 125/248 (50%), Gaps = 18/248 (7%)
Query: 341 QWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQ---EIKVLS 397
           Q+ + K +G G+FG V +  ++E+G   AMK +D      +    +KQ+E    E ++L 
Sbjct: 42  QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILD-----KQKVVKLKQIEHTLNEKRILQ 96
Query: 398 HLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLA 457
            +  P +V+   S       Y+ +EYV  G +  ++R   G  +E   R +   I+    
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR-RIGRFSEPHARFYAAQIVLTFE 155
Query: 458 YLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPYWMAPELMMAV 517
           YLHS   I+RD+K  NLL+D  G +++ DFG AK + G+   L   G+P ++APE++++ 
Sbjct: 156 YLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC--GTPEYLAPEIILS- 212
Query: 518 MQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDSLSPEGK 577
             KG +     AVD W+LG  I EM  G PP+   +      K++      P   S + K
Sbjct: 213 --KGYNK----AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLK 266
Query: 578 DFLRCCFQ 585
           D LR   Q
Sbjct: 267 DLLRNLLQ 274

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score =  116 bits (291), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 79/254 (31%), Positives = 126/254 (49%), Gaps = 18/254 (7%)
Query: 341 QWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQ---EIKVLS 397
           Q+ + K +G G+FG V +  ++E+G   AMK +D      +    +KQ+E    E ++L 
Sbjct: 42  QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILD-----KQKVVKLKQIEHTLNEKRILQ 96
Query: 398 HLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLA 457
            +  P +V+   S       Y+ +EYV  G +  ++R   G   E   R +   I+    
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR-RIGRFXEPHARFYAAQIVLTFE 155
Query: 458 YLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPYWMAPELMMAV 517
           YLHS   I+RD+K  NLL+D  G +++ DFG AK + G+   L   G+P ++APE++++ 
Sbjct: 156 YLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC--GTPEYLAPEIILS- 212
Query: 518 MQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDSLSPEGK 577
             KG +     AVD W+LG  I EM  G PP+   +      K++      P   S + K
Sbjct: 213 --KGYNK----AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLK 266
Query: 578 DFLRCCFQRNPADR 591
           D LR   Q +   R
Sbjct: 267 DLLRNLLQVDLTKR 280

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score =  116 bits (290), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 79/254 (31%), Positives = 125/254 (49%), Gaps = 18/254 (7%)
Query: 341 QWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQ---EIKVLS 397
           Q+++ K +G G+FG V +  + ETG   AMK +D      +    +KQ+E    E ++L 
Sbjct: 42  QFERIKTLGTGSFGRVMLVKHMETGNHYAMKILD-----KQKVVKLKQIEHTLNEKRILQ 96
Query: 398 HLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLA 457
            +  P +V+   S       Y+ +EY   G +  ++R   G  +E   R +   I+    
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLR-RIGRFSEPHARFYAAQIVLTFE 155
Query: 458 YLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPYWMAPELMMAV 517
           YLHS   I+RD+K  NL++D  G +K+ DFG AK + G+   L   G+P ++APE+   +
Sbjct: 156 YLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLC--GTPEYLAPEI---I 210
Query: 518 MQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDSLSPEGK 577
           + KG +     AVD W+LG  I EM  G PP+   +      K++      P   S + K
Sbjct: 211 LSKGYNK----AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLK 266
Query: 578 DFLRCCFQRNPADR 591
           D LR   Q +   R
Sbjct: 267 DLLRNLLQVDLTKR 280

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score =  116 bits (290), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 87/322 (27%), Positives = 147/322 (45%), Gaps = 51/322 (15%)
Query: 338 MNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLE-QEIKVL 396
           M  +++K   IG G++G V+   NR+TG + A+K+     DDP     IK++  +EI++L
Sbjct: 1   MMEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDP----VIKKIALREIRML 56
Query: 397 SHLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGL 456
             LKHPN+V        + + ++  EY     +++  R   G + E +V++ T   L  +
Sbjct: 57  KQLKHPNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDRYQRG-VPEHLVKSITWQTLQAV 115
Query: 457 AYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPYWM-APELMM 515
            + H    IHRD+K  N+L+    V+KL DFG A+ LTG       + +  W  +PEL++
Sbjct: 116 NFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLV 175
Query: 516 AVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPW---SEYEGAAAMFKVMRDT------- 565
              Q G        VD+W++GC   E+ +G P W   S+ +    + K + D        
Sbjct: 176 GDTQYGP------PVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQV 229
Query: 566 ---------PAIPD------------SLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLK 604
                      IPD            ++S      L+ C   +P +R     LL H + +
Sbjct: 230 FSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFE 289
Query: 605 N-------SQQPDVPSCSLSFS 619
           N       +++ D P+ +L F 
Sbjct: 290 NIREIEDLAKEHDKPAENLYFQ 311

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score =  116 bits (290), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 75/276 (27%), Positives = 136/276 (49%), Gaps = 11/276 (3%)
Query: 342 WQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKH 401
           ++ G+ +G+G FG+VY+A  +++  + A+K   +F    +      QL +EI++ +HL H
Sbjct: 25  FEIGRPLGKGKFGNVYLAREKKSHFIVALKV--LFKSQIEKEGVEHQLRREIEIQAHLHH 82
Query: 402 PNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHS 461
           PNI++ Y       + Y+ LEY   G + K +++ C    E         +   L Y H 
Sbjct: 83  PNILRLYNYFYDRRRIYLILEYAPRGELYKELQKSC-TFDEQRTATIMEELADALMYCHG 141
Query: 462 KKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPYWMAPELMMAVMQKG 521
           KK IHRDIK  NLL+   G +K+ADFG + H    +   +M G+  ++ PE++   M   
Sbjct: 142 KKVIHRDIKPENLLLGLKGELKIADFGWSVHAPSLRRK-TMCGTLDYLPPEMIEGRMHNE 200
Query: 522 KSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDSLSPEGKDFLR 581
           K       VD+W +G    E+  G PP+          ++++     P S+    +D + 
Sbjct: 201 K-------VDLWCIGVLCYELLVGNPPFESASHNETYRRIVKVDLKFPASVPTGAQDLIS 253
Query: 582 CCFQRNPADRPPASLLLEHRFLKNSQQPDVPSCSLS 617
              + NP++R P + +  H +++ + +  +P  +L 
Sbjct: 254 KLLRHNPSERLPLAQVSAHPWVRANSRRVLPPSALQ 289

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score =  116 bits (290), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 78/254 (30%), Positives = 127/254 (50%), Gaps = 18/254 (7%)
Query: 341 QWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQ---EIKVLS 397
           Q+ + K +G G+FG V +  ++E+G   AMK +D      +    +KQ+E    E ++L 
Sbjct: 42  QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILD-----KQKVVKLKQIEHTLNEKRILQ 96
Query: 398 HLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLA 457
            +  P +V+   S       Y+ +EYV  G +  ++R   G  +E   R +   I+    
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR-RIGRFSEPHARFYAAQIVLTFE 155
Query: 458 YLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPYWMAPELMMAV 517
           YLHS   I+RD+K  NL++D  G +++ DFG AK + G+   L   G+P ++APE++++ 
Sbjct: 156 YLHSLDLIYRDLKPENLIIDQQGYIQVTDFGFAKRVKGRTWXLC--GTPEYLAPEIIIS- 212
Query: 518 MQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDSLSPEGK 577
             KG +     AVD W+LG  I EM  G PP+   +      K++      P   S + K
Sbjct: 213 --KGYNK----AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLK 266
Query: 578 DFLRCCFQRNPADR 591
           D LR   Q +   R
Sbjct: 267 DLLRNLLQVDLTKR 280

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score =  115 bits (289), Expect = 6e-26,   Method: Compositional matrix adjust.
 Identities = 78/254 (30%), Positives = 127/254 (50%), Gaps = 18/254 (7%)
Query: 341 QWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQ---EIKVLS 397
           Q+ + K +G G+FG V +  ++E+G   AMK +D      +    +KQ+E    E ++L 
Sbjct: 42  QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILD-----KQKVVKLKQIEHTLNEKRILQ 96
Query: 398 HLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLA 457
            +  P +V+   S       Y+ +EYV  G +  ++R   G  +E   R +   I+    
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR-RIGRFSEPHARFYAAQIVLTFE 155
Query: 458 YLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPYWMAPELMMAV 517
           YLHS   I+RD+K  NLL+D  G +++ DFG AK + G+   L   G+P ++APE++++ 
Sbjct: 156 YLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC--GTPEYLAPEIILS- 212
Query: 518 MQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDSLSPEGK 577
             KG +     AVD W+LG  I +M  G PP+   +      K++      P   S + K
Sbjct: 213 --KGYNK----AVDWWALGVLIYQMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLK 266
Query: 578 DFLRCCFQRNPADR 591
           D LR   Q +   R
Sbjct: 267 DLLRNLLQVDLTKR 280

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score =  115 bits (288), Expect = 8e-26,   Method: Compositional matrix adjust.
 Identities = 78/254 (30%), Positives = 126/254 (49%), Gaps = 18/254 (7%)
Query: 341 QWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQ---EIKVLS 397
           Q+++ K +G G+FG V +  + ETG   AMK +D      +    +K++E    E ++L 
Sbjct: 42  QFERIKTLGTGSFGRVMLVKHMETGNHYAMKILD-----KQKVVKLKEIEHTLNEKRILQ 96
Query: 398 HLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLA 457
            +  P +V+   S       Y+ +EY   G +  ++R   G  +E   R +   I+    
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLR-RIGRFSEPHARFYAAQIVLTFE 155
Query: 458 YLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPYWMAPELMMAV 517
           YLHS   I+RD+K  NL++D  G +K+ DFG+AK + G+   L   G+P ++APE+   +
Sbjct: 156 YLHSLDLIYRDLKPENLMIDQQGYIKVTDFGLAKRVKGRTWXLC--GTPEYLAPEI---I 210
Query: 518 MQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDSLSPEGK 577
           + KG +     AVD W+LG  I EM  G PP+   +      K++      P   S + K
Sbjct: 211 LSKGYNK----AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLK 266
Query: 578 DFLRCCFQRNPADR 591
           D LR   Q +   R
Sbjct: 267 DLLRNLLQVDLTKR 280

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score =  115 bits (288), Expect = 8e-26,   Method: Compositional matrix adjust.
 Identities = 70/244 (28%), Positives = 131/244 (53%), Gaps = 14/244 (5%)
Query: 338 MNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLS 397
           +N +++    +G G   +VY+A +       A+K + I P + +  E++K+ E+E+   S
Sbjct: 9   INERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKE--ETLKRFEREVHNSS 66
Query: 398 HLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLA 457
            L H NIV     +  +D +Y+ +EY+   ++++Y+  H G ++     NFT  IL G+ 
Sbjct: 67  QLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESH-GPLSVDTAINFTNQILDGIK 125
Query: 458 YLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHL--TGQKADLSMKGSPYWMAPELMM 515
           + H  + +HRDIK  N+L+D++  +K+ DFG+AK L  T       + G+  + +PE   
Sbjct: 126 HAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPE--- 182
Query: 516 AVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDSLSPE 575
               KG+++D     DI+S+G  + EM  G+PP++     +   K ++D  ++P+  +  
Sbjct: 183 --QAKGEATDE--CTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQD--SVPNVTTDV 236
Query: 576 GKDF 579
            KD 
Sbjct: 237 RKDI 240

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score =  115 bits (288), Expect = 8e-26,   Method: Compositional matrix adjust.
 Identities = 79/254 (31%), Positives = 124/254 (48%), Gaps = 18/254 (7%)
Query: 341 QWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQ---EIKVLS 397
           Q+++ K +G G+FG V +  + ETG   AMK +D      +    +KQ+E    E ++L 
Sbjct: 42  QFERIKTLGTGSFGRVMLVKHMETGNHYAMKILD-----KQKVVKLKQIEHTLNEKRILQ 96
Query: 398 HLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLA 457
            +  P +V+   S       Y+ +EY   G +  ++R   G   E   R +   I+    
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLR-RIGRFXEPHARFYAAQIVLTFE 155
Query: 458 YLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPYWMAPELMMAV 517
           YLHS   I+RD+K  NL++D  G +K+ DFG AK + G+   L   G+P ++APE+   +
Sbjct: 156 YLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLC--GTPEYLAPEI---I 210
Query: 518 MQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDSLSPEGK 577
           + KG +     AVD W+LG  I EM  G PP+   +      K++      P   S + K
Sbjct: 211 LSKGYNK----AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLK 266
Query: 578 DFLRCCFQRNPADR 591
           D LR   Q +   R
Sbjct: 267 DLLRNLLQVDLTKR 280

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score =  115 bits (287), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 78/254 (30%), Positives = 125/254 (49%), Gaps = 18/254 (7%)
Query: 341 QWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQ---EIKVLS 397
           Q+++ K +G G+FG V +  + ETG   AMK +D      +    +KQ+E    E ++L 
Sbjct: 42  QFERIKTLGTGSFGRVMLVKHMETGNHYAMKILD-----KQKVVKLKQIEHTLNEKRILQ 96
Query: 398 HLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLA 457
            +  P +V+   S       Y+ +EY   G +  ++R   G  +E   R +   I+    
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLR-RIGRFSEPHARFYAAQIVLTFE 155
Query: 458 YLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPYWMAPELMMAV 517
           YLHS   I+RD+K  NL++D  G +++ DFG AK + G+   L   G+P ++APE+   +
Sbjct: 156 YLHSLDLIYRDLKPENLMIDQQGYIQVTDFGFAKRVKGRTWXLC--GTPEYLAPEI---I 210
Query: 518 MQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDSLSPEGK 577
           + KG +     AVD W+LG  I EM  G PP+   +      K++      P   S + K
Sbjct: 211 LSKGYNK----AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLK 266
Query: 578 DFLRCCFQRNPADR 591
           D LR   Q +   R
Sbjct: 267 DLLRNLLQVDLTKR 280

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  115 bits (287), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 79/254 (31%), Positives = 126/254 (49%), Gaps = 18/254 (7%)
Query: 341 QWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQ---EIKVLS 397
           Q+ + K +G G+FG V +  ++E+G   AMK +D      +    +KQ+E    E ++L 
Sbjct: 42  QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILD-----KQKVVKLKQIEHTLNEKRILQ 96
Query: 398 HLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLA 457
            +  P +V+   S       Y+ +EYV  G +  ++R   G  +E   R +   I+    
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR-RIGRFSEPHARFYAAQIVLTFE 155
Query: 458 YLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPYWMAPELMMAV 517
           YLHS   I+RD+K  NLL+D  G +++ DFG AK + G+   L   G+P  +APE++++ 
Sbjct: 156 YLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC--GTPEALAPEIILS- 212
Query: 518 MQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDSLSPEGK 577
             KG +     AVD W+LG  I EM  G PP+   +      K++      P   S + K
Sbjct: 213 --KGYNK----AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLK 266
Query: 578 DFLRCCFQRNPADR 591
           D LR   Q +   R
Sbjct: 267 DLLRNLLQVDLTKR 280

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score =  115 bits (287), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 80/294 (27%), Positives = 144/294 (48%), Gaps = 24/294 (8%)
Query: 322 PSATIPQVAAKPEPLPMNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPK 381
           P+  IP+V   P       ++ +G+ +G+G F   +  S+ +T  + A K V      PK
Sbjct: 6   PAKEIPEVLVDPR---SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIV------PK 56
Query: 382 SA----ESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHC 437
           S        +++  EI +   L H ++V ++G     D  ++ LE     S+ + + +  
Sbjct: 57  SLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLE-LHKRR 115
Query: 438 GAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLT--G 495
            A+TE   R + R I+ G  YLH  + IHRD+K  NL ++    VK+ DFG+A  +   G
Sbjct: 116 KALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG 175
Query: 496 QKADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGA 555
           ++   ++ G+P ++APE++    +KG S +    VD+WS+GC +  +  GKPP+      
Sbjct: 176 ERKK-TLCGTPNYIAPEVL---SKKGHSFE----VDVWSIGCIMYTLLVGKPPFETSCLK 227
Query: 556 AAMFKVMRDTPAIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQP 609
               ++ ++  +IP  ++P     ++   Q +P  RP  + LL   F  +   P
Sbjct: 228 ETYLRIKKNEYSIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIP 281

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  115 bits (287), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 78/254 (30%), Positives = 126/254 (49%), Gaps = 18/254 (7%)
Query: 341 QWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQ---EIKVLS 397
           Q+ + K +G G+FG V +  ++E+G   AMK +D      +    +KQ+E    E ++L 
Sbjct: 42  QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILD-----KQKVVKLKQIEHTLNEKRILQ 96
Query: 398 HLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLA 457
            +  P +V+   S       Y+ +EYV  G +  ++R   G  +E   R +   I+    
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR-RIGRFSEPHARFYAAQIVLTFE 155
Query: 458 YLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPYWMAPELMMAV 517
           YLHS   I+RD+K  NLL+D  G +++ DFG AK + G+   L   G+P ++AP ++++ 
Sbjct: 156 YLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC--GTPEYLAPAIILS- 212
Query: 518 MQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDSLSPEGK 577
             KG +     AVD W+LG  I EM  G PP+   +      K++      P   S + K
Sbjct: 213 --KGYNK----AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLK 266
Query: 578 DFLRCCFQRNPADR 591
           D LR   Q +   R
Sbjct: 267 DLLRNLLQVDLTKR 280

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score =  114 bits (286), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 78/254 (30%), Positives = 124/254 (48%), Gaps = 18/254 (7%)
Query: 341 QWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQ---EIKVLS 397
           Q+++ K +G G+FG V +  + ETG   AMK +D      +    +KQ+E    E ++L 
Sbjct: 43  QFERIKTLGTGSFGRVMLVKHMETGNHYAMKILD-----KQKVVKLKQIEHTLNEKRILQ 97
Query: 398 HLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLA 457
            +  P + +   S       Y+ +EY   G +  ++R   G  +E   R +   I+    
Sbjct: 98  AVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLR-RIGRFSEPHARFYAAQIVLTFE 156
Query: 458 YLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPYWMAPELMMAV 517
           YLHS   I+RD+K  NL++D  G +K+ DFG AK + G+   L   G+P ++APE+   +
Sbjct: 157 YLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLC--GTPEYLAPEI---I 211
Query: 518 MQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDSLSPEGK 577
           + KG +     AVD W+LG  I EM  G PP+   +      K++      P   S + K
Sbjct: 212 LSKGYNK----AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLK 267
Query: 578 DFLRCCFQRNPADR 591
           D LR   Q +   R
Sbjct: 268 DLLRNLLQVDLTKR 281

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score =  114 bits (286), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 82/278 (29%), Positives = 133/278 (47%), Gaps = 39/278 (14%)
Query: 345 GKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNI 404
           G+++G+G FG     ++RETG +  MKE+  F +     E+ +   +E+KV+  L+HPN+
Sbjct: 15  GEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDE-----ETQRTFLKEVKVMRCLEHPNV 69
Query: 405 VQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKT 464
           +++ G    + +     EY+  G++   ++        S   +F + I SG+AYLHS   
Sbjct: 70  LKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNI 129
Query: 465 IHRDIKGANLLVDASGVVKLADFGMAKHLTGQKAD---------------LSMKGSPYWM 509
           IHRD+   N LV  +  V +ADFG+A+ +  +K                  ++ G+PYWM
Sbjct: 130 IHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWM 189
Query: 510 APELMMAVMQKGKSSDSALAVDIWSLG---CTIIEMYTGKPPW----SEYEGAAAMFKVM 562
           APE++      G+S D    VD++S G   C II      P +     ++      F   
Sbjct: 190 APEMI-----NGRSYDE--KVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDR 242
Query: 563 RDTPAIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEH 600
              P  P S  P     +RCC   +P  R P+ + LEH
Sbjct: 243 YCPPNCPPSFFPIT---VRCC-DLDPEKR-PSFVKLEH 275

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score =  114 bits (286), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 78/254 (30%), Positives = 124/254 (48%), Gaps = 18/254 (7%)
Query: 341 QWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQ---EIKVLS 397
           Q+++ K +G G+FG V +  + ETG   AMK +D      +    +KQ+E    E ++L 
Sbjct: 43  QFERIKTLGTGSFGRVMLVKHMETGNHYAMKILD-----KQKVVKLKQIEHTLNEKRILQ 97
Query: 398 HLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLA 457
            +  P + +   S       Y+ +EY   G +  ++R   G  +E   R +   I+    
Sbjct: 98  AVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLR-RIGRFSEPHARFYAAQIVLTFE 156
Query: 458 YLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPYWMAPELMMAV 517
           YLHS   I+RD+K  NL++D  G +K+ DFG AK + G+   L   G+P ++APE+   +
Sbjct: 157 YLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLC--GTPEYLAPEI---I 211
Query: 518 MQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDSLSPEGK 577
           + KG +     AVD W+LG  I EM  G PP+   +      K++      P   S + K
Sbjct: 212 LSKGYNK----AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLK 267
Query: 578 DFLRCCFQRNPADR 591
           D LR   Q +   R
Sbjct: 268 DLLRNLLQVDLTKR 281

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score =  114 bits (286), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 80/294 (27%), Positives = 144/294 (48%), Gaps = 24/294 (8%)
Query: 322 PSATIPQVAAKPEPLPMNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPK 381
           P+  IP+V   P       ++ +G+ +G+G F   +  S+ +T  + A K V      PK
Sbjct: 2   PAKEIPEVLVDPR---SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIV------PK 52
Query: 382 SA----ESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHC 437
           S        +++  EI +   L H ++V ++G     D  ++ LE     S+ + + +  
Sbjct: 53  SLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLE-LHKRR 111
Query: 438 GAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLT--G 495
            A+TE   R + R I+ G  YLH  + IHRD+K  NL ++    VK+ DFG+A  +   G
Sbjct: 112 KALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG 171
Query: 496 QKADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGA 555
           ++   ++ G+P ++APE++    +KG S +    VD+WS+GC +  +  GKPP+      
Sbjct: 172 ERKK-TLCGTPNYIAPEVL---SKKGHSFE----VDVWSIGCIMYTLLVGKPPFETSCLK 223
Query: 556 AAMFKVMRDTPAIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQP 609
               ++ ++  +IP  ++P     ++   Q +P  RP  + LL   F  +   P
Sbjct: 224 ETYLRIKKNEYSIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIP 277

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score =  114 bits (286), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 80/294 (27%), Positives = 144/294 (48%), Gaps = 24/294 (8%)
Query: 322 PSATIPQVAAKPEPLPMNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPK 381
           P+  IP+V   P       ++ +G+ +G+G F   +  S+ +T  + A K V      PK
Sbjct: 2   PAKEIPEVLVDPR---SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIV------PK 52
Query: 382 SA----ESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHC 437
           S        +++  EI +   L H ++V ++G     D  ++ LE     S+ + + +  
Sbjct: 53  SLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLE-LHKRR 111
Query: 438 GAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLT--G 495
            A+TE   R + R I+ G  YLH  + IHRD+K  NL ++    VK+ DFG+A  +   G
Sbjct: 112 KALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG 171
Query: 496 QKADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGA 555
           ++   ++ G+P ++APE++    +KG S +    VD+WS+GC +  +  GKPP+      
Sbjct: 172 ERKK-TLCGTPNYIAPEVL---SKKGHSFE----VDVWSIGCIMYTLLVGKPPFETSCLK 223
Query: 556 AAMFKVMRDTPAIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQP 609
               ++ ++  +IP  ++P     ++   Q +P  RP  + LL   F  +   P
Sbjct: 224 ETYLRIKKNEYSIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIP 277

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score =  114 bits (285), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 77/254 (30%), Positives = 126/254 (49%), Gaps = 18/254 (7%)
Query: 341 QWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQ---EIKVLS 397
           Q+++ K +G G+FG V +  + ETG   AMK +D      +    +K++E    E ++L 
Sbjct: 42  QFERIKTLGTGSFGRVMLVKHMETGNHYAMKILD-----KQKVVKLKEIEHTLNEKRILQ 96
Query: 398 HLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLA 457
            +  P +V+   S       Y+ +EY   G +  ++R   G  +E   R +   I+    
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLR-RIGRFSEPHARFYAAQIVLTFE 155
Query: 458 YLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPYWMAPELMMAV 517
           YLHS   I+RD+K  NL++D  G +++ DFG+AK + G+   L   G+P ++APE+   +
Sbjct: 156 YLHSLDLIYRDLKPENLMIDQQGYIQVTDFGLAKRVKGRTWXLC--GTPEYLAPEI---I 210
Query: 518 MQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDSLSPEGK 577
           + KG +     AVD W+LG  I EM  G PP+   +      K++      P   S + K
Sbjct: 211 LSKGYNK----AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLK 266
Query: 578 DFLRCCFQRNPADR 591
           D LR   Q +   R
Sbjct: 267 DLLRNLLQVDLTKR 280

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score =  114 bits (285), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 78/254 (30%), Positives = 123/254 (48%), Gaps = 18/254 (7%)
Query: 341 QWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQ---EIKVLS 397
           Q+++ K +G G+FG V +  + ETG   AMK +D      +    +KQ+E    E ++L 
Sbjct: 43  QFERIKTLGTGSFGRVMLVKHMETGNHYAMKILD-----KQKVVKLKQIEHTLNEKRILQ 97
Query: 398 HLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLA 457
            +  P + +   S       Y+ +EY   G +  ++R   G   E   R +   I+    
Sbjct: 98  AVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLR-RIGRFXEPHARFYAAQIVLTFE 156
Query: 458 YLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPYWMAPELMMAV 517
           YLHS   I+RD+K  NL++D  G +K+ DFG AK + G+   L   G+P ++APE+   +
Sbjct: 157 YLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLC--GTPEYLAPEI---I 211
Query: 518 MQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDSLSPEGK 577
           + KG +     AVD W+LG  I EM  G PP+   +      K++      P   S + K
Sbjct: 212 LSKGYNK----AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLK 267
Query: 578 DFLRCCFQRNPADR 591
           D LR   Q +   R
Sbjct: 268 DLLRNLLQVDLTKR 281

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score =  114 bits (284), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 77/258 (29%), Positives = 130/258 (50%), Gaps = 26/258 (10%)
Query: 316 GAAVLSPSATIPQVAAKPEPLPMNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDI 375
           GA  LS   T+     +    P    +   K+IG G+FG VY A   ++G L A+K+V  
Sbjct: 1   GAMSLSKVTTVVATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-- 58
Query: 376 FPDDPKSAESIKQLEQEIKVLSHLKHPNIVQ----YYGSEIVEDKFY--IYLEYVHPGSI 429
                   +  +   +E++++  L H NIV+    +Y S   +D+ Y  + L+YV P ++
Sbjct: 59  -------LQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYV-PETV 110
Query: 430 NKYVREHCGA---ITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDA-SGVVKLA 485
            +  R +  A   +    V+ +   +   LAY+HS    HRDIK  NLL+D  + V+KL 
Sbjct: 111 YRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLC 170
Query: 486 DFGMAKHLTGQKADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTG 545
           DFG AK L   + ++S   S Y+ APEL+        ++D   ++D+WS GC + E+  G
Sbjct: 171 DFGSAKQLVRGEPNVSYICSRYYRAPELIFG------ATDYTSSIDVWSAGCVLAELLLG 224
Query: 546 KPPWSEYEGAAAMFKVMR 563
           +P +    G   + ++++
Sbjct: 225 QPIFPGDSGVDQLVEIIK 242

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score =  113 bits (283), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 73/245 (29%), Positives = 126/245 (51%), Gaps = 19/245 (7%)
Query: 342 WQKGKLIGRGTFGSVYVASNRETGALCAMKEVD---IFPDDPKSAESIKQLEQEIKVLSH 398
           ++ GK++G G+F +V +A    T    A+K ++   I  ++      +  + +E  V+S 
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKEN-----KVPYVTRERDVMSR 88
Query: 399 LKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAY 458
           L HP  V+ Y +   ++K Y  L Y   G + KY+R+  G+  E+  R +T  I+S L Y
Sbjct: 89  LDHPFFVKLYFTFQDDEKLYFGLSYAKNGCLLKYIRK-IGSFDETCTRFYTAEIVSALEY 147
Query: 459 LHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHL---TGQKADLSMKGSPYWMAPELMM 515
           LH K  IHRD+K  N+L++    +++ DFG AK L   + Q    S  G+  +++PEL+ 
Sbjct: 148 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELL- 206
Query: 516 AVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDSLSPE 575
              +K  S  S    D+W+LGC I ++  G PP+          K+++     P+   P+
Sbjct: 207 --TEKSASKSS----DLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPK 260
Query: 576 GKDFL 580
            +D +
Sbjct: 261 ARDLV 265

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score =  113 bits (282), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 73/261 (27%), Positives = 123/261 (47%), Gaps = 9/261 (3%)
Query: 345 GKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNI 404
           G  +G GTFG V V  +  TG   A+K ++      +S + + ++ +EI+ L   +HP+I
Sbjct: 21  GDTLGVGTFGKVKVGKHELTGHKVAVKILN--RQKIRSLDVVGKIRREIQNLKLFRHPHI 78
Query: 405 VQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKT 464
           ++ Y         ++ +EYV  G +  Y+ ++ G + E   R   + ILSG+ Y H    
Sbjct: 79  IKLYQVISTPSDIFMVMEYVSGGELFDYICKN-GRLDEKESRRLFQQILSGVDYCHRHMV 137
Query: 465 IHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPYWMAPELMMAVMQKGKSS 524
           +HRD+K  N+L+DA    K+ADFG++  ++  +      GSP + APE++   +  G   
Sbjct: 138 VHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRXSCGSPNYAAPEVISGRLYAGPE- 196
Query: 525 DSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDSLSPEGKDFLRCCF 584
                VDIWS G  +  +  G  P+ +        K+       P  L+P     L+   
Sbjct: 197 -----VDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYTPQYLNPSVISLLKHML 251
Query: 585 QRNPADRPPASLLLEHRFLKN 605
           Q +P  R     + EH + K 
Sbjct: 252 QVDPMKRATIKDIREHEWFKQ 272

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score =  112 bits (281), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 87/290 (30%), Positives = 141/290 (48%), Gaps = 17/290 (5%)
Query: 348 IGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQY 407
           +G GT G V+    R+TG + A+K++    +  ++   +  L+  +K  SH   P IVQ 
Sbjct: 33  MGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLK--SH-DCPYIVQC 89
Query: 408 YGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKK-TIH 466
           +G+ I     +I +E +   +  K  +   G I E ++   T  I+  L YL  K   IH
Sbjct: 90  FGTFITNTDVFIAMELMGTCA-EKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIH 148
Query: 467 RDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPYWMAPELMMAVMQKGKSSDS 526
           RD+K +N+L+D  G +KL DFG++  L   KA     G   +MAPE +          D 
Sbjct: 149 RDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRSAGCAAYMAPERIDP--PDPTKPDY 206
Query: 527 ALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVM-----RDTPAIPDSLSPEG--KDF 579
            +  D+WSLG +++E+ TG+ P   Y+     F+V+      + P +P  +   G  + F
Sbjct: 207 DIRADVWSLGISLVELATGQFP---YKNCKTDFEVLTKVLQEEPPLLPGHMGFSGDFQSF 263
Query: 580 LRCCFQRNPADRPPASLLLEHRFLKNSQQPDVPSCSLSFSGMQLTEKPHS 629
           ++ C  ++   RP  + LLEH F+K  +  +V   S     M  TE P S
Sbjct: 264 VKDCLTKDHRKRPKYNKLLEHSFIKRYETLEVDVASWFKDVMAKTESPRS 313

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score =  112 bits (280), Expect = 7e-25,   Method: Compositional matrix adjust.
 Identities = 87/328 (26%), Positives = 153/328 (46%), Gaps = 30/328 (9%)
Query: 315 PGAAVLSPSATIPQVAAKPEPLPMNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVD 374
           PG+ +    AT P +  +      + +++  +++G+G+FG V +  ++ TG  CA+K + 
Sbjct: 2   PGSMMDHLHAT-PGMFVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVIS 60
Query: 375 IFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYIYL--EYVHPGSINKY 432
                 K     + L +E+++L  L HPNI++ Y  E  EDK Y YL  E    G +   
Sbjct: 61  --KRQVKQKTDKESLLREVQLLKQLDHPNIMKLY--EFFEDKGYFYLVGEVYTGGELFDE 116
Query: 433 VREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDA---SGVVKLADFGM 489
           +       +E       R +LSG+ Y+H  K +HRD+K  NLL+++      +++ DFG+
Sbjct: 117 IISR-KRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGL 175
Query: 490 AKHLTGQKADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPW 549
           + H    K      G+ Y++APE++     +          D+WS G  +  + +G PP+
Sbjct: 176 STHFEASKKMKDKIGTAYYIAPEVLHGTYDE--------KCDVWSTGVILYILLSGCPPF 227
Query: 550 SEYEGAAAMFKVMRD--TPAIPD--SLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKN 605
           +       + KV +   T  +P    +S   KD +R      P+ R  A   L+H +++ 
Sbjct: 228 NGANEYDILKKVEKGKYTFELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQT 287
Query: 606 SQQP----DVPSCS---LSFSGMQLTEK 626
             +     DVPS     L+    Q T+K
Sbjct: 288 YTKEQISVDVPSLDNAILNIRQFQGTQK 315

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score =  112 bits (279), Expect = 8e-25,   Method: Compositional matrix adjust.
 Identities = 72/245 (29%), Positives = 125/245 (51%), Gaps = 19/245 (7%)
Query: 342 WQKGKLIGRGTFGSVYVASNRETGALCAMKEVD---IFPDDPKSAESIKQLEQEIKVLSH 398
           ++ GK++G G+F +V +A    T    A+K ++   I  ++      +  + +E  V+S 
Sbjct: 35  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKEN-----KVPYVTRERDVMSR 89
Query: 399 LKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAY 458
           L HP  V+ Y +   ++K Y  L Y   G + KY+R+  G+  E+  R +T  I+S L Y
Sbjct: 90  LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRK-IGSFDETCTRFYTAEIVSALEY 148
Query: 459 LHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHL---TGQKADLSMKGSPYWMAPELMM 515
           LH K  IHRD+K  N+L++    +++ DFG AK L   + Q    S  G+  +++PEL+ 
Sbjct: 149 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELL- 207
Query: 516 AVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDSLSPE 575
              +K     S    D+W+LGC I ++  G PP+          K+++     P+   P+
Sbjct: 208 --TEKSACKSS----DLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPK 261
Query: 576 GKDFL 580
            +D +
Sbjct: 262 ARDLV 266

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score =  112 bits (279), Expect = 9e-25,   Method: Compositional matrix adjust.
 Identities = 79/290 (27%), Positives = 142/290 (48%), Gaps = 24/290 (8%)
Query: 326 IPQVAAKPEPLPMNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSA-- 383
           IP+V   P       ++ +G+ +G+G F   +  S+ +T  + A K V      PKS   
Sbjct: 28  IPEVLVDPR---SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIV------PKSLLL 78
Query: 384 --ESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAIT 441
                +++  EI +   L H ++V ++G     D  ++ LE     S+ + + +   A+T
Sbjct: 79  KPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLE-LHKRRKALT 137
Query: 442 ESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLT--GQKAD 499
           E   R + R I+ G  YLH  + IHRD+K  NL ++    VK+ DFG+A  +   G++  
Sbjct: 138 EPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKK 197
Query: 500 LSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMF 559
           + + G+P ++APE++    +KG S +    VD+WS+GC +  +  GKPP+          
Sbjct: 198 V-LCGTPNYIAPEVL---SKKGHSFE----VDVWSIGCIMYTLLVGKPPFETSCLKETYL 249
Query: 560 KVMRDTPAIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQP 609
           ++ ++  +IP  ++P     ++   Q +P  RP  + LL   F  +   P
Sbjct: 250 RIKKNEYSIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIP 299

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score =  112 bits (279), Expect = 9e-25,   Method: Compositional matrix adjust.
 Identities = 79/290 (27%), Positives = 142/290 (48%), Gaps = 24/290 (8%)
Query: 326 IPQVAAKPEPLPMNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSA-- 383
           IP+V   P       ++ +G+ +G+G F   +  S+ +T  + A K V      PKS   
Sbjct: 30  IPEVLVDPR---SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIV------PKSLLL 80
Query: 384 --ESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAIT 441
                +++  EI +   L H ++V ++G     D  ++ LE     S+ + + +   A+T
Sbjct: 81  KPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLE-LHKRRKALT 139
Query: 442 ESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLT--GQKAD 499
           E   R + R I+ G  YLH  + IHRD+K  NL ++    VK+ DFG+A  +   G++  
Sbjct: 140 EPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKK 199
Query: 500 LSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMF 559
           + + G+P ++APE++    +KG S +    VD+WS+GC +  +  GKPP+          
Sbjct: 200 V-LCGTPNYIAPEVL---SKKGHSFE----VDVWSIGCIMYTLLVGKPPFETSCLKETYL 251
Query: 560 KVMRDTPAIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQP 609
           ++ ++  +IP  ++P     ++   Q +P  RP  + LL   F  +   P
Sbjct: 252 RIKKNEYSIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIP 301

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score =  112 bits (279), Expect = 9e-25,   Method: Compositional matrix adjust.
 Identities = 72/237 (30%), Positives = 123/237 (51%), Gaps = 26/237 (10%)
Query: 337 PMNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVL 396
           P    +   K+IG G+FG VY A   ++G L A+K+V          +  +   +E++++
Sbjct: 53  PQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV---------LQDKRFKNRELQIM 103
Query: 397 SHLKHPNIVQ----YYGSEIVEDKFYI--YLEYVHPGSINKYVREHCGA---ITESVVRN 447
             L H NIV+    +Y S   +D+ Y+   L+YV P ++ +  R +  A   +    V+ 
Sbjct: 104 RKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYV-PETVYRVARHYSRAKQTLPVIYVKL 162
Query: 448 FTRHILSGLAYLHSKKTIHRDIKGANLLVDA-SGVVKLADFGMAKHLTGQKADLSMKGSP 506
           +   +   LAY+HS    HRDIK  NLL+D  + V+KL DFG AK L   + ++S   S 
Sbjct: 163 YMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSR 222
Query: 507 YWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMR 563
           Y+ APEL+        ++D   ++D+WS GC + E+  G+P +    G   + ++++
Sbjct: 223 YYRAPELIFG------ATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIK 273

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score =  112 bits (279), Expect = 9e-25,   Method: Compositional matrix adjust.
 Identities = 72/237 (30%), Positives = 123/237 (51%), Gaps = 26/237 (10%)
Query: 337 PMNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVL 396
           P    +   K+IG G+FG VY A   ++G L A+K+V          +  +   +E++++
Sbjct: 51  PQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV---------LQDKRFKNRELQIM 101
Query: 397 SHLKHPNIVQ----YYGSEIVEDKFYI--YLEYVHPGSINKYVREHCGA---ITESVVRN 447
             L H NIV+    +Y S   +D+ Y+   L+YV P ++ +  R +  A   +    V+ 
Sbjct: 102 RKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYV-PETVYRVARHYSRAKQTLPVIYVKL 160
Query: 448 FTRHILSGLAYLHSKKTIHRDIKGANLLVDA-SGVVKLADFGMAKHLTGQKADLSMKGSP 506
           +   +   LAY+HS    HRDIK  NLL+D  + V+KL DFG AK L   + ++S   S 
Sbjct: 161 YMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSR 220
Query: 507 YWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMR 563
           Y+ APEL+        ++D   ++D+WS GC + E+  G+P +    G   + ++++
Sbjct: 221 YYRAPELIFG------ATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIK 271

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score =  112 bits (279), Expect = 9e-25,   Method: Compositional matrix adjust.
 Identities = 72/237 (30%), Positives = 123/237 (51%), Gaps = 26/237 (10%)
Query: 337 PMNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVL 396
           P    +   K+IG G+FG VY A   ++G L A+K+V          +  +   +E++++
Sbjct: 55  PQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV---------LQDKRFKNRELQIM 105
Query: 397 SHLKHPNIVQ----YYGSEIVEDKFYI--YLEYVHPGSINKYVREHCGA---ITESVVRN 447
             L H NIV+    +Y S   +D+ Y+   L+YV P ++ +  R +  A   +    V+ 
Sbjct: 106 RKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYV-PETVYRVARHYSRAKQTLPVIYVKL 164
Query: 448 FTRHILSGLAYLHSKKTIHRDIKGANLLVDA-SGVVKLADFGMAKHLTGQKADLSMKGSP 506
           +   +   LAY+HS    HRDIK  NLL+D  + V+KL DFG AK L   + ++S   S 
Sbjct: 165 YMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSR 224
Query: 507 YWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMR 563
           Y+ APEL+        ++D   ++D+WS GC + E+  G+P +    G   + ++++
Sbjct: 225 YYRAPELIFG------ATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIK 275

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score =  112 bits (279), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 72/237 (30%), Positives = 123/237 (51%), Gaps = 26/237 (10%)
Query: 337 PMNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVL 396
           P    +   K+IG G+FG VY A   ++G L A+K+V          +  +   +E++++
Sbjct: 45  PQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV---------LQDKRFKNRELQIM 95
Query: 397 SHLKHPNIVQ----YYGSEIVEDKFYI--YLEYVHPGSINKYVREHCGA---ITESVVRN 447
             L H NIV+    +Y S   +D+ Y+   L+YV P ++ +  R +  A   +    V+ 
Sbjct: 96  RKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYV-PETVYRVARHYSRAKQTLPVIYVKL 154
Query: 448 FTRHILSGLAYLHSKKTIHRDIKGANLLVDA-SGVVKLADFGMAKHLTGQKADLSMKGSP 506
           +   +   LAY+HS    HRDIK  NLL+D  + V+KL DFG AK L   + ++S   S 
Sbjct: 155 YMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSR 214
Query: 507 YWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMR 563
           Y+ APEL+        ++D   ++D+WS GC + E+  G+P +    G   + ++++
Sbjct: 215 YYRAPELIFG------ATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIK 265

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score =  112 bits (279), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 73/237 (30%), Positives = 124/237 (52%), Gaps = 26/237 (10%)
Query: 337 PMNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVL 396
           P    +   K+IG G+FG VY A   ++G L A+K+V          ++ K   +E++++
Sbjct: 17  PQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-------LQGKAFKN--RELQIM 67
Query: 397 SHLKHPNIVQ----YYGSEIVEDKFYI--YLEYVHPGSINKYVREHCGA---ITESVVRN 447
             L H NIV+    +Y S   +D+ Y+   L+YV P ++ +  R +  A   +    V+ 
Sbjct: 68  RKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYV-PATVYRVARHYSRAKQTLPVIYVKL 126
Query: 448 FTRHILSGLAYLHSKKTIHRDIKGANLLVDA-SGVVKLADFGMAKHLTGQKADLSMKGSP 506
           +   +   LAY+HS    HRDIK  NLL+D  + V+KL DFG AK L   + ++S   S 
Sbjct: 127 YMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSR 186
Query: 507 YWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMR 563
           Y+ APEL+        ++D   ++D+WS GC + E+  G+P +    G   + ++++
Sbjct: 187 YYRAPELIFG------ATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIK 237

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score =  111 bits (278), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 72/237 (30%), Positives = 123/237 (51%), Gaps = 26/237 (10%)
Query: 337 PMNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVL 396
           P    +   K+IG G+FG VY A   ++G L A+K+V          +  +   +E++++
Sbjct: 51  PQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV---------LQDKRFKNRELQIM 101
Query: 397 SHLKHPNIVQ----YYGSEIVEDKFYI--YLEYVHPGSINKYVREHCGA---ITESVVRN 447
             L H NIV+    +Y S   +D+ Y+   L+YV P ++ +  R +  A   +    V+ 
Sbjct: 102 RKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYV-PETVYRVARHYSRAKQTLPVIYVKL 160
Query: 448 FTRHILSGLAYLHSKKTIHRDIKGANLLVDA-SGVVKLADFGMAKHLTGQKADLSMKGSP 506
           +   +   LAY+HS    HRDIK  NLL+D  + V+KL DFG AK L   + ++S   S 
Sbjct: 161 YMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSR 220
Query: 507 YWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMR 563
           Y+ APEL+        ++D   ++D+WS GC + E+  G+P +    G   + ++++
Sbjct: 221 YYRAPELIFG------ATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIK 271

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score =  111 bits (278), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 72/237 (30%), Positives = 123/237 (51%), Gaps = 26/237 (10%)
Query: 337 PMNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVL 396
           P    +   K+IG G+FG VY A   ++G L A+K+V          +  +   +E++++
Sbjct: 29  PQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV---------LQDKRFKNRELQIM 79
Query: 397 SHLKHPNIVQ----YYGSEIVEDKFYI--YLEYVHPGSINKYVREHCGA---ITESVVRN 447
             L H NIV+    +Y S   +D+ Y+   L+YV P ++ +  R +  A   +    V+ 
Sbjct: 80  RKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYV-PETVYRVARHYSRAKQTLPVIYVKL 138
Query: 448 FTRHILSGLAYLHSKKTIHRDIKGANLLVDA-SGVVKLADFGMAKHLTGQKADLSMKGSP 506
           +   +   LAY+HS    HRDIK  NLL+D  + V+KL DFG AK L   + ++S   S 
Sbjct: 139 YMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSR 198
Query: 507 YWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMR 563
           Y+ APEL+        ++D   ++D+WS GC + E+  G+P +    G   + ++++
Sbjct: 199 YYRAPELIFG------ATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIK 249

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score =  111 bits (278), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 72/237 (30%), Positives = 123/237 (51%), Gaps = 26/237 (10%)
Query: 337 PMNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVL 396
           P    +   K+IG G+FG VY A   ++G L A+K+V          +  +   +E++++
Sbjct: 25  PQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV---------LQDKRFKNRELQIM 75
Query: 397 SHLKHPNIVQ----YYGSEIVEDKFYI--YLEYVHPGSINKYVREHCGA---ITESVVRN 447
             L H NIV+    +Y S   +D+ Y+   L+YV P ++ +  R +  A   +    V+ 
Sbjct: 76  RKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYV-PETVYRVARHYSRAKQTLPVIYVKL 134
Query: 448 FTRHILSGLAYLHSKKTIHRDIKGANLLVDA-SGVVKLADFGMAKHLTGQKADLSMKGSP 506
           +   +   LAY+HS    HRDIK  NLL+D  + V+KL DFG AK L   + ++S   S 
Sbjct: 135 YMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSR 194
Query: 507 YWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMR 563
           Y+ APEL+        ++D   ++D+WS GC + E+  G+P +    G   + ++++
Sbjct: 195 YYRAPELIFG------ATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIK 245

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score =  111 bits (278), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 71/242 (29%), Positives = 122/242 (50%), Gaps = 13/242 (5%)
Query: 342 WQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKH 401
           ++ GK++G G+F +V +A    T    A+K ++           +  + +E  V+S L H
Sbjct: 31  FKFGKILGEGSFSTVVLARELATSREYAIKILE--KRHIIKENKVPYVTRERDVMSRLDH 88
Query: 402 PNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHS 461
           P  V+ Y +   ++K Y  L Y   G + KY+R+  G+  E+  R +T  I+S L YLH 
Sbjct: 89  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRK-IGSFDETCTRFYTAEIVSALEYLHG 147
Query: 462 KKTIHRDIKGANLLVDASGVVKLADFGMAKHL---TGQKADLSMKGSPYWMAPELMMAVM 518
           K  IHRD+K  N+L++    +++ DFG AK L   + Q    S  G+  +++PEL+    
Sbjct: 148 KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELL---T 204
Query: 519 QKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDSLSPEGKD 578
           +K     S    D+W+LGC I ++  G PP+          K+++     P+   P+ +D
Sbjct: 205 EKSACKSS----DLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARD 260
Query: 579 FL 580
            +
Sbjct: 261 LV 262

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score =  111 bits (278), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 72/237 (30%), Positives = 123/237 (51%), Gaps = 26/237 (10%)
Query: 337 PMNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVL 396
           P    +   K+IG G+FG VY A   ++G L A+K+V          +  +   +E++++
Sbjct: 30  PQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV---------LQDKRFKNRELQIM 80
Query: 397 SHLKHPNIVQ----YYGSEIVEDKFYI--YLEYVHPGSINKYVREHCGA---ITESVVRN 447
             L H NIV+    +Y S   +D+ Y+   L+YV P ++ +  R +  A   +    V+ 
Sbjct: 81  RKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYV-PETVYRVARHYSRAKQTLPVIYVKL 139
Query: 448 FTRHILSGLAYLHSKKTIHRDIKGANLLVDA-SGVVKLADFGMAKHLTGQKADLSMKGSP 506
           +   +   LAY+HS    HRDIK  NLL+D  + V+KL DFG AK L   + ++S   S 
Sbjct: 140 YMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSR 199
Query: 507 YWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMR 563
           Y+ APEL+        ++D   ++D+WS GC + E+  G+P +    G   + ++++
Sbjct: 200 YYRAPELIFG------ATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIK 250

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score =  111 bits (278), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 72/237 (30%), Positives = 123/237 (51%), Gaps = 26/237 (10%)
Query: 337 PMNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVL 396
           P    +   K+IG G+FG VY A   ++G L A+K+V          +  +   +E++++
Sbjct: 36  PQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV---------LQDKRFKNRELQIM 86
Query: 397 SHLKHPNIVQ----YYGSEIVEDKFYI--YLEYVHPGSINKYVREHCGA---ITESVVRN 447
             L H NIV+    +Y S   +D+ Y+   L+YV P ++ +  R +  A   +    V+ 
Sbjct: 87  RKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYV-PETVYRVARHYSRAKQTLPVIYVKL 145
Query: 448 FTRHILSGLAYLHSKKTIHRDIKGANLLVDA-SGVVKLADFGMAKHLTGQKADLSMKGSP 506
           +   +   LAY+HS    HRDIK  NLL+D  + V+KL DFG AK L   + ++S   S 
Sbjct: 146 YMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSR 205
Query: 507 YWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMR 563
           Y+ APEL+        ++D   ++D+WS GC + E+  G+P +    G   + ++++
Sbjct: 206 YYRAPELIFG------ATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIK 256

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score =  111 bits (277), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 72/237 (30%), Positives = 123/237 (51%), Gaps = 26/237 (10%)
Query: 337 PMNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVL 396
           P    +   K+IG G+FG VY A   ++G L A+K+V          +  +   +E++++
Sbjct: 96  PQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV---------LQDKRFKNRELQIM 146
Query: 397 SHLKHPNIVQ----YYGSEIVEDKFYI--YLEYVHPGSINKYVREHCGA---ITESVVRN 447
             L H NIV+    +Y S   +D+ Y+   L+YV P ++ +  R +  A   +    V+ 
Sbjct: 147 RKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYV-PETVYRVARHYSRAKQTLPVIYVKL 205
Query: 448 FTRHILSGLAYLHSKKTIHRDIKGANLLVDA-SGVVKLADFGMAKHLTGQKADLSMKGSP 506
           +   +   LAY+HS    HRDIK  NLL+D  + V+KL DFG AK L   + ++S   S 
Sbjct: 206 YMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSR 265
Query: 507 YWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMR 563
           Y+ APEL+        ++D   ++D+WS GC + E+  G+P +    G   + ++++
Sbjct: 266 YYRAPELIFG------ATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIK 316

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score =  111 bits (277), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 72/237 (30%), Positives = 123/237 (51%), Gaps = 26/237 (10%)
Query: 337 PMNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVL 396
           P    +   K+IG G+FG VY A   ++G L A+K+V          +  +   +E++++
Sbjct: 29  PQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV---------LQDKRFKNRELQIM 79
Query: 397 SHLKHPNIVQ----YYGSEIVEDKFYI--YLEYVHPGSINKYVREHCGA---ITESVVRN 447
             L H NIV+    +Y S   +D+ Y+   L+YV P ++ +  R +  A   +    V+ 
Sbjct: 80  RKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYV-PETVYRVARHYSRAKQTLPVIYVKL 138
Query: 448 FTRHILSGLAYLHSKKTIHRDIKGANLLVDA-SGVVKLADFGMAKHLTGQKADLSMKGSP 506
           +   +   LAY+HS    HRDIK  NLL+D  + V+KL DFG AK L   + ++S   S 
Sbjct: 139 YMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSR 198
Query: 507 YWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMR 563
           Y+ APEL+        ++D   ++D+WS GC + E+  G+P +    G   + ++++
Sbjct: 199 YYRAPELIFG------ATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIK 249

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score =  111 bits (277), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 79/290 (27%), Positives = 142/290 (48%), Gaps = 24/290 (8%)
Query: 326 IPQVAAKPEPLPMNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSA-- 383
           IP+V   P       ++ +G+ +G+G F   +  S+ +T  + A K V      PKS   
Sbjct: 4   IPEVLVDPR---SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIV------PKSLLL 54
Query: 384 --ESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAIT 441
                +++  EI +   L H ++V ++G     D  ++ LE     S+ + + +   A+T
Sbjct: 55  KPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLE-LHKRRKALT 113
Query: 442 ESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLT--GQKAD 499
           E   R + R I+ G  YLH  + IHRD+K  NL ++    VK+ DFG+A  +   G++  
Sbjct: 114 EPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKK 173
Query: 500 LSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMF 559
           + + G+P ++APE++    +KG S +    VD+WS+GC +  +  GKPP+          
Sbjct: 174 V-LCGTPNYIAPEVL---SKKGHSFE----VDVWSIGCIMYTLLVGKPPFETSCLKETYL 225
Query: 560 KVMRDTPAIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQP 609
           ++ ++  +IP  ++P     ++   Q +P  RP  + LL   F  +   P
Sbjct: 226 RIKKNEYSIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIP 275

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score =  111 bits (277), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 69/245 (28%), Positives = 123/245 (50%), Gaps = 19/245 (7%)
Query: 342 WQKGKLIGRGTFGSVYVASNRETGALCAMKEVD---IFPDDPKSAESIKQLEQEIKVLSH 398
           ++ GK++G G+F +V +A    T    A+K ++   I  ++      +  + +E  V+S 
Sbjct: 12  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKEN-----KVPYVTRERDVMSR 66
Query: 399 LKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAY 458
           L HP  V+ Y +   ++K Y  L Y   G + KY+R+  G+  E+  R +T  I+S L Y
Sbjct: 67  LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRK-IGSFDETCTRFYTAEIVSALEY 125
Query: 459 LHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHL---TGQKADLSMKGSPYWMAPELMM 515
           LH K  IHRD+K  N+L++    +++ DFG AK L   + Q       G+  +++PEL+ 
Sbjct: 126 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 185
Query: 516 AVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDSLSPE 575
                     +  + D+W+LGC I ++  G PP+          K+++     P+   P+
Sbjct: 186 -------EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPK 238
Query: 576 GKDFL 580
            +D +
Sbjct: 239 ARDLV 243

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score =  111 bits (277), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 84/311 (27%), Positives = 144/311 (46%), Gaps = 41/311 (13%)
Query: 338 MNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQ------LEQ 391
            + +++  +++G+G+FG V +  ++ TG  CA+K +        S   +KQ      L +
Sbjct: 24  FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVI--------SKRQVKQKTDKESLLR 75
Query: 392 EIKVLSHLKHPNIVQYYGSEIVEDKFYIYL--EYVHPGSINKYVREHCGAITESVVRNFT 449
           E+++L  L HPNI + Y  E  EDK Y YL  E    G +   +       +E       
Sbjct: 76  EVQLLKQLDHPNIXKLY--EFFEDKGYFYLVGEVYTGGELFDEIISR-KRFSEVDAARII 132
Query: 450 RHILSGLAYLHSKKTIHRDIKGANLLVDA---SGVVKLADFGMAKHLTGQKADLSMKGSP 506
           R +LSG+ Y H  K +HRD+K  NLL+++      +++ DFG++ H    K      G+ 
Sbjct: 133 RQVLSGITYXHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKXKDKIGTA 192
Query: 507 YWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRD-- 564
           Y++APE++     +          D+WS G  +  + +G PP++       + KV +   
Sbjct: 193 YYIAPEVLHGTYDE--------KCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKY 244
Query: 565 TPAIPD--SLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQP----DVPSCS--- 615
           T  +P    +S   KD +R      P+ R  A   L+H +++   +     DVPS     
Sbjct: 245 TFELPQWKKVSESAKDLIRKXLTYVPSXRISARDALDHEWIQTYTKEQISVDVPSLDNAI 304
Query: 616 LSFSGMQLTEK 626
           L+    Q T+K
Sbjct: 305 LNIRQFQGTQK 315

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score =  111 bits (277), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 72/270 (26%), Positives = 127/270 (47%), Gaps = 25/270 (9%)
Query: 348 IGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQY 407
           +G G FG V++   R +G    +K ++      +S   ++Q+E EI+VL  L HPNI++ 
Sbjct: 30  LGSGAFGDVHLVEERSSGLERVIKTIN----KDRSQVPMEQIEAEIEVLKSLDHPNIIKI 85
Query: 408 YGSEIVED--KFYIYLEYVHPGSINKYV---REHCGAITESVVRNFTRHILSGLAYLHSK 462
           +  E+ ED    YI +E    G + + +   +    A++E  V    + +++ LAY HS+
Sbjct: 86  F--EVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ 143
Query: 463 KTIHRDIKGANLLVDAS---GVVKLADFGMAKHLTGQKADLSMKGSPYWMAPELMMAVMQ 519
             +H+D+K  N+L   +     +K+ DFG+A+     +   +  G+  +MAPE+      
Sbjct: 144 HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPEVF----- 198
Query: 520 KGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDS---LSPEG 576
                D     DIWS G  +  + TG  P++         K     P        L+P+ 
Sbjct: 199 ---KRDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVECRPLTPQA 255
Query: 577 KDFLRCCFQRNPADRPPASLLLEHRFLKNS 606
            D L+    ++P  RP A+ +L H + K +
Sbjct: 256 VDLLKQMLTKDPERRPSAAQVLHHEWFKQA 285

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score =  111 bits (277), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 72/237 (30%), Positives = 123/237 (51%), Gaps = 26/237 (10%)
Query: 337 PMNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVL 396
           P    +   K+IG G+FG VY A   ++G L A+K+V          +  +   +E++++
Sbjct: 18  PQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV---------LQDKRFKNRELQIM 68
Query: 397 SHLKHPNIVQ----YYGSEIVEDKFYI--YLEYVHPGSINKYVREHCGA---ITESVVRN 447
             L H NIV+    +Y S   +D+ Y+   L+YV P ++ +  R +  A   +    V+ 
Sbjct: 69  RKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYV-PETVYRVARHYSRAKQTLPVIYVKL 127
Query: 448 FTRHILSGLAYLHSKKTIHRDIKGANLLVDA-SGVVKLADFGMAKHLTGQKADLSMKGSP 506
           +   +   LAY+HS    HRDIK  NLL+D  + V+KL DFG AK L   + ++S   S 
Sbjct: 128 YMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSR 187
Query: 507 YWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMR 563
           Y+ APEL+        ++D   ++D+WS GC + E+  G+P +    G   + ++++
Sbjct: 188 YYRAPELIFG------ATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIK 238

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score =  111 bits (277), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 72/237 (30%), Positives = 123/237 (51%), Gaps = 26/237 (10%)
Query: 337 PMNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVL 396
           P    +   K+IG G+FG VY A   ++G L A+K+V          +  +   +E++++
Sbjct: 17  PQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV---------LQDKRFKNRELQIM 67
Query: 397 SHLKHPNIVQ----YYGSEIVEDKFYI--YLEYVHPGSINKYVREHCGA---ITESVVRN 447
             L H NIV+    +Y S   +D+ Y+   L+YV P ++ +  R +  A   +    V+ 
Sbjct: 68  RKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYV-PETVYRVARHYSRAKQTLPVIYVKL 126
Query: 448 FTRHILSGLAYLHSKKTIHRDIKGANLLVDA-SGVVKLADFGMAKHLTGQKADLSMKGSP 506
           +   +   LAY+HS    HRDIK  NLL+D  + V+KL DFG AK L   + ++S   S 
Sbjct: 127 YMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSR 186
Query: 507 YWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMR 563
           Y+ APEL+        ++D   ++D+WS GC + E+  G+P +    G   + ++++
Sbjct: 187 YYRAPELIFG------ATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIK 237

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score =  111 bits (277), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 71/245 (28%), Positives = 124/245 (50%), Gaps = 19/245 (7%)
Query: 342 WQKGKLIGRGTFGSVYVASNRETGALCAMKEVD---IFPDDPKSAESIKQLEQEIKVLSH 398
           ++ GK++G G+F +V +A    T    A+K ++   I  ++      +  + +E  V+S 
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKEN-----KVPYVTRERDVMSR 88
Query: 399 LKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAY 458
           L HP  V+ Y +   ++K Y  L Y   G + KY+R+  G+  E+  R +T  I+S L Y
Sbjct: 89  LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRK-IGSFDETCTRFYTAEIVSALEY 147
Query: 459 LHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHL---TGQKADLSMKGSPYWMAPELMM 515
           LH K  IHRD+K  N+L++    +++ DFG AK L   + Q       G+  +++PEL+ 
Sbjct: 148 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL- 206
Query: 516 AVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDSLSPE 575
              +K     S    D+W+LGC I ++  G PP+          K+++     P+   P+
Sbjct: 207 --TEKSAXKSS----DLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDFPEKFFPK 260
Query: 576 GKDFL 580
            +D +
Sbjct: 261 ARDLV 265

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score =  111 bits (277), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 82/305 (26%), Positives = 144/305 (47%), Gaps = 29/305 (9%)
Query: 338 MNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLS 397
            + +++  +++G+G+FG V +  ++ TG  CA+K +       K     + L +E+++L 
Sbjct: 47  FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVIS--KRQVKQKTDKESLLREVQLLK 104
Query: 398 HLKHPNIVQYYGSEIVEDKFYIYL--EYVHPGSINKYVREHCGAITESVVRNFTRHILSG 455
            L HPNI++ Y  E  EDK Y YL  E    G +   +       +E       R +LSG
Sbjct: 105 QLDHPNIMKLY--EFFEDKGYFYLVGEVYTGGELFDEIISR-KRFSEVDAARIIRQVLSG 161
Query: 456 LAYLHSKKTIHRDIKGANLLVDA---SGVVKLADFGMAKHLTGQKADLSMKGSPYWMAPE 512
           + Y+H  K +HRD+K  NLL+++      +++ DFG++ H    K      G+ Y++APE
Sbjct: 162 ITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPE 221
Query: 513 LMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRD--TPAIPD 570
           ++     +          D+WS G  +  + +G PP++       + KV +   T  +P 
Sbjct: 222 VLHGTYDE--------KCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQ 273
Query: 571 --SLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQP----DVPSCS---LSFSGM 621
              +S   KD +R      P+ R  A   L+H +++   +     DVPS     L+    
Sbjct: 274 WKKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQTYTKEQISVDVPSLDNAILNIRQF 333
Query: 622 QLTEK 626
           Q T+K
Sbjct: 334 QGTQK 338

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score =  111 bits (277), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 82/305 (26%), Positives = 144/305 (47%), Gaps = 29/305 (9%)
Query: 338 MNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLS 397
            + +++  +++G+G+FG V +  ++ TG  CA+K +       K     + L +E+++L 
Sbjct: 48  FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVIS--KRQVKQKTDKESLLREVQLLK 105
Query: 398 HLKHPNIVQYYGSEIVEDKFYIYL--EYVHPGSINKYVREHCGAITESVVRNFTRHILSG 455
            L HPNI++ Y  E  EDK Y YL  E    G +   +       +E       R +LSG
Sbjct: 106 QLDHPNIMKLY--EFFEDKGYFYLVGEVYTGGELFDEIISR-KRFSEVDAARIIRQVLSG 162
Query: 456 LAYLHSKKTIHRDIKGANLLVDA---SGVVKLADFGMAKHLTGQKADLSMKGSPYWMAPE 512
           + Y+H  K +HRD+K  NLL+++      +++ DFG++ H    K      G+ Y++APE
Sbjct: 163 ITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPE 222
Query: 513 LMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRD--TPAIPD 570
           ++     +          D+WS G  +  + +G PP++       + KV +   T  +P 
Sbjct: 223 VLHGTYDE--------KCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQ 274
Query: 571 --SLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQP----DVPSCS---LSFSGM 621
              +S   KD +R      P+ R  A   L+H +++   +     DVPS     L+    
Sbjct: 275 WKKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQTYTKEQISVDVPSLDNAILNIRQF 334
Query: 622 QLTEK 626
           Q T+K
Sbjct: 335 QGTQK 339

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score =  111 bits (277), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 72/237 (30%), Positives = 123/237 (51%), Gaps = 26/237 (10%)
Query: 337 PMNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVL 396
           P    +   K+IG G+FG VY A   ++G L A+K+V          +  +   +E++++
Sbjct: 17  PQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV---------LQDKRFKNRELQIM 67
Query: 397 SHLKHPNIVQ----YYGSEIVEDKFYI--YLEYVHPGSINKYVREHCGA---ITESVVRN 447
             L H NIV+    +Y S   +D+ Y+   L+YV P ++ +  R +  A   +    V+ 
Sbjct: 68  RKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYV-PETVYRVARHYSRAKQTLPVIYVKL 126
Query: 448 FTRHILSGLAYLHSKKTIHRDIKGANLLVDA-SGVVKLADFGMAKHLTGQKADLSMKGSP 506
           +   +   LAY+HS    HRDIK  NLL+D  + V+KL DFG AK L   + ++S   S 
Sbjct: 127 YMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSR 186
Query: 507 YWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMR 563
           Y+ APEL+        ++D   ++D+WS GC + E+  G+P +    G   + ++++
Sbjct: 187 YYRAPELIFG------ATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIK 237

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score =  111 bits (277), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 73/237 (30%), Positives = 124/237 (52%), Gaps = 26/237 (10%)
Query: 337 PMNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVL 396
           P    +   K+IG G+FG VY A   ++G L A+K+V          ++ K   +E++++
Sbjct: 17  PQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-------LQGKAFKN--RELQIM 67
Query: 397 SHLKHPNIVQ----YYGSEIVEDKFYI--YLEYVHPGSINKYVREHCGA---ITESVVRN 447
             L H NIV+    +Y S   +D+ Y+   L+YV P ++ +  R +  A   +    V+ 
Sbjct: 68  RKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYV-PETVYRVARHYSRAKQTLPVIYVKL 126
Query: 448 FTRHILSGLAYLHSKKTIHRDIKGANLLVDA-SGVVKLADFGMAKHLTGQKADLSMKGSP 506
           +   +   LAY+HS    HRDIK  NLL+D  + V+KL DFG AK L   + ++S   S 
Sbjct: 127 YMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSR 186
Query: 507 YWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMR 563
           Y+ APEL+        ++D   ++D+WS GC + E+  G+P +    G   + ++++
Sbjct: 187 YYRAPELIFG------ATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIK 237

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score =  111 bits (277), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 71/245 (28%), Positives = 124/245 (50%), Gaps = 19/245 (7%)
Query: 342 WQKGKLIGRGTFGSVYVASNRETGALCAMKEVD---IFPDDPKSAESIKQLEQEIKVLSH 398
           ++ GK++G G+F +V +A    T    A+K ++   I  ++      +  + +E  V+S 
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKEN-----KVPYVTRERDVMSR 88
Query: 399 LKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAY 458
           L HP  V+ Y +   ++K Y  L Y   G + KY+R+  G+  E+  R +T  I+S L Y
Sbjct: 89  LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRK-IGSFDETCTRFYTAEIVSALEY 147
Query: 459 LHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHL---TGQKADLSMKGSPYWMAPELMM 515
           LH K  IHRD+K  N+L++    +++ DFG AK L   + Q       G+  +++PEL+ 
Sbjct: 148 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL- 206
Query: 516 AVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDSLSPE 575
              +K     S    D+W+LGC I ++  G PP+          K+++     P+   P+
Sbjct: 207 --TEKSACKSS----DLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDFPEKFFPK 260
Query: 576 GKDFL 580
            +D +
Sbjct: 261 ARDLV 265

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score =  111 bits (277), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 73/237 (30%), Positives = 124/237 (52%), Gaps = 26/237 (10%)
Query: 337 PMNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVL 396
           P    +   K+IG G+FG VY A   ++G L A+K+V          ++ K   +E++++
Sbjct: 17  PQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-------LQGKAFKN--RELQIM 67
Query: 397 SHLKHPNIVQ----YYGSEIVEDKFYI--YLEYVHPGSINKYVREHCGA---ITESVVRN 447
             L H NIV+    +Y S   +D+ Y+   L+YV P ++ +  R +  A   +    V+ 
Sbjct: 68  RKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYV-PETVYRVARHYSRAKQTLPVIYVKL 126
Query: 448 FTRHILSGLAYLHSKKTIHRDIKGANLLVDA-SGVVKLADFGMAKHLTGQKADLSMKGSP 506
           +   +   LAY+HS    HRDIK  NLL+D  + V+KL DFG AK L   + ++S   S 
Sbjct: 127 YMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSR 186
Query: 507 YWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMR 563
           Y+ APEL+        ++D   ++D+WS GC + E+  G+P +    G   + ++++
Sbjct: 187 YYRAPELIFG------ATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIK 237

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score =  111 bits (277), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 71/245 (28%), Positives = 125/245 (51%), Gaps = 19/245 (7%)
Query: 342 WQKGKLIGRGTFGSVYVASNRETGALCAMKEVD---IFPDDPKSAESIKQLEQEIKVLSH 398
           ++ GK++G G+F +V +A    T    A+K ++   I  ++      +  + +E  V+S 
Sbjct: 32  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKEN-----KVPYVTRERDVMSR 86
Query: 399 LKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAY 458
           L HP  V+ Y +   ++K Y  L Y   G + KY+R+  G+  E+  R +T  I+S L Y
Sbjct: 87  LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRK-IGSFDETCTRFYTAEIVSALEY 145
Query: 459 LHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHL---TGQKADLSMKGSPYWMAPELMM 515
           LH K  IHRD+K  N+L++    +++ DFG AK L   + Q    +  G+  +++PEL+ 
Sbjct: 146 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAFVGTAQYVSPELL- 204
Query: 516 AVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDSLSPE 575
              +K     S    D+W+LGC I ++  G PP+          K+++     P+   P+
Sbjct: 205 --TEKSACKSS----DLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPK 258
Query: 576 GKDFL 580
            +D +
Sbjct: 259 ARDLV 263

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score =  111 bits (277), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 69/245 (28%), Positives = 123/245 (50%), Gaps = 19/245 (7%)
Query: 342 WQKGKLIGRGTFGSVYVASNRETGALCAMKEVD---IFPDDPKSAESIKQLEQEIKVLSH 398
           ++ GK++G G+F +V +A    T    A+K ++   I  ++      +  + +E  V+S 
Sbjct: 11  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKEN-----KVPYVTRERDVMSR 65
Query: 399 LKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAY 458
           L HP  V+ Y +   ++K Y  L Y   G + KY+R+  G+  E+  R +T  I+S L Y
Sbjct: 66  LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRK-IGSFDETCTRFYTAEIVSALEY 124
Query: 459 LHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHL---TGQKADLSMKGSPYWMAPELMM 515
           LH K  IHRD+K  N+L++    +++ DFG AK L   + Q       G+  +++PEL+ 
Sbjct: 125 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 184
Query: 516 AVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDSLSPE 575
                     +  + D+W+LGC I ++  G PP+          K+++     P+   P+
Sbjct: 185 -------EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPK 237
Query: 576 GKDFL 580
            +D +
Sbjct: 238 ARDLV 242

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score =  111 bits (277), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 72/237 (30%), Positives = 123/237 (51%), Gaps = 26/237 (10%)
Query: 337 PMNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVL 396
           P    +   K+IG G+FG VY A   ++G L A+K+V          +  +   +E++++
Sbjct: 17  PQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV---------LQDKRFKNRELQIM 67
Query: 397 SHLKHPNIVQ----YYGSEIVEDKFYI--YLEYVHPGSINKYVREHCGA---ITESVVRN 447
             L H NIV+    +Y S   +D+ Y+   L+YV P ++ +  R +  A   +    V+ 
Sbjct: 68  RKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYV-PETVYRVARHYSRAKQTLPVIYVKL 126
Query: 448 FTRHILSGLAYLHSKKTIHRDIKGANLLVDA-SGVVKLADFGMAKHLTGQKADLSMKGSP 506
           +   +   LAY+HS    HRDIK  NLL+D  + V+KL DFG AK L   + ++S   S 
Sbjct: 127 YMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSR 186
Query: 507 YWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMR 563
           Y+ APEL+        ++D   ++D+WS GC + E+  G+P +    G   + ++++
Sbjct: 187 YYRAPELIFG------ATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIK 237

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score =  110 bits (276), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 68/242 (28%), Positives = 120/242 (49%), Gaps = 13/242 (5%)
Query: 342 WQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKH 401
           ++ GK++G G+F +V +A    T    A+K ++           +  + +E  V+S L H
Sbjct: 10  FKFGKILGEGSFSTVVLARELATSREYAIKILE--KRHIIKENKVPYVTRERDVMSRLDH 67
Query: 402 PNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHS 461
           P  V+ Y +   ++K Y  L Y   G + KY+R+  G+  E+  R +T  I+S L YLH 
Sbjct: 68  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRK-IGSFDETCTRFYTAEIVSALEYLHG 126
Query: 462 KKTIHRDIKGANLLVDASGVVKLADFGMAKHL---TGQKADLSMKGSPYWMAPELMMAVM 518
           K  IHRD+K  N+L++    +++ DFG AK L   + Q       G+  +++PEL+    
Sbjct: 127 KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT--- 183
Query: 519 QKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDSLSPEGKD 578
                  +  + D+W+LGC I ++  G PP+          K+++     P+   P+ +D
Sbjct: 184 ----EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARD 239
Query: 579 FL 580
            +
Sbjct: 240 LV 241

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score =  110 bits (276), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 72/237 (30%), Positives = 123/237 (51%), Gaps = 26/237 (10%)
Query: 337 PMNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVL 396
           P    +   K+IG G+FG VY A   ++G L A+K+V          +  +   +E++++
Sbjct: 21  PQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV---------LQDKRFKNRELQIM 71
Query: 397 SHLKHPNIVQ----YYGSEIVEDKFYI--YLEYVHPGSINKYVREHCGA---ITESVVRN 447
             L H NIV+    +Y S   +D+ Y+   L+YV P ++ +  R +  A   +    V+ 
Sbjct: 72  RKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYV-PETVYRVARHYSRAKQTLPVIYVKL 130
Query: 448 FTRHILSGLAYLHSKKTIHRDIKGANLLVDA-SGVVKLADFGMAKHLTGQKADLSMKGSP 506
           +   +   LAY+HS    HRDIK  NLL+D  + V+KL DFG AK L   + ++S   S 
Sbjct: 131 YMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSR 190
Query: 507 YWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMR 563
           Y+ APEL+        ++D   ++D+WS GC + E+  G+P +    G   + ++++
Sbjct: 191 YYRAPELIFG------ATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIK 241

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score =  110 bits (276), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 70/242 (28%), Positives = 121/242 (50%), Gaps = 13/242 (5%)
Query: 342 WQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKH 401
           ++ GK++G G+F +V +A    T    A+K ++           +  + +E  V+S L H
Sbjct: 9   FKFGKILGEGSFSTVVLARELATSREYAIKILE--KRHIIKENKVPYVTRERDVMSRLDH 66
Query: 402 PNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHS 461
           P  V+ Y +   ++K Y  L Y   G + KY+R+  G+  E+  R +T  I+S L YLH 
Sbjct: 67  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRK-IGSFDETCTRFYTAEIVSALEYLHG 125
Query: 462 KKTIHRDIKGANLLVDASGVVKLADFGMAKHL---TGQKADLSMKGSPYWMAPELMMAVM 518
           K  IHRD+K  N+L++    +++ DFG AK L   + Q       G+  +++PEL+    
Sbjct: 126 KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL---T 182
Query: 519 QKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDSLSPEGKD 578
           +K     S    D+W+LGC I ++  G PP+          K+++     P+   P+ +D
Sbjct: 183 EKSACKSS----DLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARD 238
Query: 579 FL 580
            +
Sbjct: 239 LV 240

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score =  110 bits (275), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 71/245 (28%), Positives = 124/245 (50%), Gaps = 19/245 (7%)
Query: 342 WQKGKLIGRGTFGSVYVASNRETGALCAMKEVD---IFPDDPKSAESIKQLEQEIKVLSH 398
           ++ GK++G G+F +V +A    T    A+K ++   I  ++      +  + +E  V+S 
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKEN-----KVPYVTRERDVMSR 88
Query: 399 LKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAY 458
           L HP  V+ Y +   ++K Y  L Y   G + KY+R+  G+  E+  R +T  I+S L Y
Sbjct: 89  LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRK-IGSFDETCTRFYTAEIVSALEY 147
Query: 459 LHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHL---TGQKADLSMKGSPYWMAPELMM 515
           LH K  IHRD+K  N+L++    +++ DFG AK L   + Q       G+  +++PEL+ 
Sbjct: 148 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL- 206
Query: 516 AVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDSLSPE 575
              +K     S    D+W+LGC I ++  G PP+          K+++     P+   P+
Sbjct: 207 --TEKSACKSS----DLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPK 260
Query: 576 GKDFL 580
            +D +
Sbjct: 261 ARDLV 265

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score =  110 bits (275), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 71/245 (28%), Positives = 124/245 (50%), Gaps = 19/245 (7%)
Query: 342 WQKGKLIGRGTFGSVYVASNRETGALCAMKEVD---IFPDDPKSAESIKQLEQEIKVLSH 398
           ++ GK++G G+F +V +A    T    A+K ++   I  ++      +  + +E  V+S 
Sbjct: 32  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKEN-----KVPYVTRERDVMSR 86
Query: 399 LKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAY 458
           L HP  V+ Y +   ++K Y  L Y   G + KY+R+  G+  E+  R +T  I+S L Y
Sbjct: 87  LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRK-IGSFDETCTRFYTAEIVSALEY 145
Query: 459 LHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHL---TGQKADLSMKGSPYWMAPELMM 515
           LH K  IHRD+K  N+L++    +++ DFG AK L   + Q       G+  +++PEL+ 
Sbjct: 146 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL- 204
Query: 516 AVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDSLSPE 575
              +K     S    D+W+LGC I ++  G PP+          K+++     P+   P+
Sbjct: 205 --TEKSACKSS----DLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPK 258
Query: 576 GKDFL 580
            +D +
Sbjct: 259 ARDLV 263

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score =  110 bits (275), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 72/237 (30%), Positives = 122/237 (51%), Gaps = 26/237 (10%)
Query: 337 PMNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVL 396
           P    +   K+IG G+FG VY A   ++G L A+K+V          +  +   +E++++
Sbjct: 17  PQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV---------LQDKRFKNRELQIM 67
Query: 397 SHLKHPNIVQ----YYGSEIVEDKFYI--YLEYVHPGSINKYVREHCGA---ITESVVRN 447
             L H NIV+    +Y S   +D  Y+   L+YV P ++ +  R +  A   +    V+ 
Sbjct: 68  RKLDHCNIVRLRYFFYSSGEKKDVVYLNLVLDYV-PETVYRVARHYSRAKQTLPVIYVKL 126
Query: 448 FTRHILSGLAYLHSKKTIHRDIKGANLLVDA-SGVVKLADFGMAKHLTGQKADLSMKGSP 506
           +   +   LAY+HS    HRDIK  NLL+D  + V+KL DFG AK L   + ++S   S 
Sbjct: 127 YMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSR 186
Query: 507 YWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMR 563
           Y+ APEL+        ++D   ++D+WS GC + E+  G+P +    G   + ++++
Sbjct: 187 YYRAPELIFG------ATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIK 237

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score =  110 bits (275), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 71/245 (28%), Positives = 124/245 (50%), Gaps = 19/245 (7%)
Query: 342 WQKGKLIGRGTFGSVYVASNRETGALCAMKEVD---IFPDDPKSAESIKQLEQEIKVLSH 398
           ++ GK++G G+F +V +A    T    A+K ++   I  ++      +  + +E  V+S 
Sbjct: 35  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKEN-----KVPYVTRERDVMSR 89
Query: 399 LKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAY 458
           L HP  V+ Y +   ++K Y  L Y   G + KY+R+  G+  E+  R +T  I+S L Y
Sbjct: 90  LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRK-IGSFDETCTRFYTAEIVSALEY 148
Query: 459 LHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHL---TGQKADLSMKGSPYWMAPELMM 515
           LH K  IHRD+K  N+L++    +++ DFG AK L   + Q       G+  +++PEL+ 
Sbjct: 149 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL- 207
Query: 516 AVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDSLSPE 575
              +K     S    D+W+LGC I ++  G PP+          K+++     P+   P+
Sbjct: 208 --TEKSACKSS----DLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPK 261
Query: 576 GKDFL 580
            +D +
Sbjct: 262 ARDLV 266

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score =  110 bits (275), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 71/245 (28%), Positives = 124/245 (50%), Gaps = 19/245 (7%)
Query: 342 WQKGKLIGRGTFGSVYVASNRETGALCAMKEVD---IFPDDPKSAESIKQLEQEIKVLSH 398
           ++ GK++G G+F +V +A    T    A+K ++   I  ++      +  + +E  V+S 
Sbjct: 32  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKEN-----KVPYVTRERDVMSR 86
Query: 399 LKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAY 458
           L HP  V+ Y +   ++K Y  L Y   G + KY+R+  G+  E+  R +T  I+S L Y
Sbjct: 87  LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRK-IGSFDETCTRFYTAEIVSALEY 145
Query: 459 LHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHL---TGQKADLSMKGSPYWMAPELMM 515
           LH K  IHRD+K  N+L++    +++ DFG AK L   + Q       G+  +++PEL+ 
Sbjct: 146 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL- 204
Query: 516 AVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDSLSPE 575
              +K     S    D+W+LGC I ++  G PP+          K+++     P+   P+
Sbjct: 205 --TEKSACKSS----DLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPK 258
Query: 576 GKDFL 580
            +D +
Sbjct: 259 ARDLV 263

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score =  110 bits (274), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 81/291 (27%), Positives = 135/291 (46%), Gaps = 43/291 (14%)
Query: 348 IGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQY 407
           IG GT+G VY A N   G   A+K++ +  +D     +  +   EI +L  LKH NIV+ 
Sbjct: 10  IGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIR---EISILKELKHSNIVKL 65
Query: 408 YGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVV-RNFTRHILSGLAYLHSKKTIH 466
           Y  +++  K  + L + H     K + + C    ESV  ++F   +L+G+AY H ++ +H
Sbjct: 66  Y--DVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLH 123
Query: 467 RDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPYWM-APELMMAVMQKGKSSD 525
           RD+K  NLL++  G +K+ADFG+A+         + +    W  AP+++M       S  
Sbjct: 124 RDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVVTLWYRAPDVLMG------SKK 177
Query: 526 SALAVDIWSLGCTIIEMYTGKPPW---SEYEGAAAMFKVM-----RDTPAIPD------- 570
            +  +DIWS+GC   EM  G P +   SE +    +F+++     ++ P + +       
Sbjct: 178 YSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPN 237
Query: 571 --------------SLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQ 607
                          L   G D L    + +P  R  A   LEH + K + 
Sbjct: 238 FTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKENN 288

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score =  110 bits (274), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 71/245 (28%), Positives = 124/245 (50%), Gaps = 19/245 (7%)
Query: 342 WQKGKLIGRGTFGSVYVASNRETGALCAMKEVD---IFPDDPKSAESIKQLEQEIKVLSH 398
           ++ GK++G G+F +V +A    T    A+K ++   I  ++      +  + +E  V+S 
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKEN-----KVPYVTRERDVMSR 88
Query: 399 LKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAY 458
           L HP  V+ Y +   ++K Y  L Y   G + KY+R+  G+  E+  R +T  I+S L Y
Sbjct: 89  LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRK-IGSFDETCTRFYTAEIVSALEY 147
Query: 459 LHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHL---TGQKADLSMKGSPYWMAPELMM 515
           LH K  IHRD+K  N+L++    +++ DFG AK L   + Q       G+  +++PEL+ 
Sbjct: 148 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL- 206
Query: 516 AVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDSLSPE 575
              +K     S    D+W+LGC I ++  G PP+          K+++     P+   P+
Sbjct: 207 --TEKSACKSS----DLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPK 260
Query: 576 GKDFL 580
            +D +
Sbjct: 261 ARDLV 265

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score =  110 bits (274), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 71/245 (28%), Positives = 124/245 (50%), Gaps = 19/245 (7%)
Query: 342 WQKGKLIGRGTFGSVYVASNRETGALCAMKEVD---IFPDDPKSAESIKQLEQEIKVLSH 398
           ++ GK++G G+F +V +A    T    A+K ++   I  ++      +  + +E  V+S 
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKEN-----KVPYVTRERDVMSR 88
Query: 399 LKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAY 458
           L HP  V+ Y +   ++K Y  L Y   G + KY+R+  G+  E+  R +T  I+S L Y
Sbjct: 89  LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRK-IGSFDETCTRFYTAEIVSALEY 147
Query: 459 LHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHL---TGQKADLSMKGSPYWMAPELMM 515
           LH K  IHRD+K  N+L++    +++ DFG AK L   + Q       G+  +++PEL+ 
Sbjct: 148 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL- 206
Query: 516 AVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDSLSPE 575
              +K     S    D+W+LGC I ++  G PP+          K+++     P+   P+
Sbjct: 207 --TEKSACKSS----DLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPK 260
Query: 576 GKDFL 580
            +D +
Sbjct: 261 ARDLV 265

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score =  110 bits (274), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 70/242 (28%), Positives = 121/242 (50%), Gaps = 13/242 (5%)
Query: 342 WQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKH 401
           ++ GK++G G+F +V +A    T    A+K ++           +  + +E  V+S L H
Sbjct: 16  FKFGKILGEGSFSTVVLARELATSREYAIKILE--KRHIIKENKVPYVTRERDVMSRLDH 73
Query: 402 PNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHS 461
           P  V+ Y +   ++K Y  L Y   G + KY+R+  G+  E+  R +T  I+S L YLH 
Sbjct: 74  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRK-IGSFDETCTRFYTAEIVSALEYLHG 132
Query: 462 KKTIHRDIKGANLLVDASGVVKLADFGMAKHL---TGQKADLSMKGSPYWMAPELMMAVM 518
           K  IHRD+K  N+L++    +++ DFG AK L   + Q       G+  +++PEL+    
Sbjct: 133 KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL---T 189
Query: 519 QKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDSLSPEGKD 578
           +K     S    D+W+LGC I ++  G PP+          K+++     P+   P+ +D
Sbjct: 190 EKSACKSS----DLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARD 245
Query: 579 FL 580
            +
Sbjct: 246 LV 247

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score =  110 bits (274), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 81/291 (27%), Positives = 135/291 (46%), Gaps = 43/291 (14%)
Query: 348 IGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQY 407
           IG GT+G VY A N   G   A+K++ +  +D     +  +   EI +L  LKH NIV+ 
Sbjct: 10  IGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIR---EISILKELKHSNIVKL 65
Query: 408 YGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVV-RNFTRHILSGLAYLHSKKTIH 466
           Y  +++  K  + L + H     K + + C    ESV  ++F   +L+G+AY H ++ +H
Sbjct: 66  Y--DVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLH 123
Query: 467 RDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPYWM-APELMMAVMQKGKSSD 525
           RD+K  NLL++  G +K+ADFG+A+         + +    W  AP+++M       S  
Sbjct: 124 RDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVVTLWYRAPDVLMG------SKK 177
Query: 526 SALAVDIWSLGCTIIEMYTGKPPW---SEYEGAAAMFKVM-----RDTPAIPD------- 570
            +  +DIWS+GC   EM  G P +   SE +    +F+++     ++ P + +       
Sbjct: 178 YSTTIDIWSVGCIFAEMVNGAPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPN 237
Query: 571 --------------SLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQ 607
                          L   G D L    + +P  R  A   LEH + K + 
Sbjct: 238 FTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKENN 288

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score =  110 bits (274), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 75/248 (30%), Positives = 128/248 (51%), Gaps = 25/248 (10%)
Query: 342 WQKGKLIGRGTFGSVYVASNRETGALCAMKEVD---IFPDDPKSAESIKQLEQEIKVLSH 398
           ++ GK++G G+F +V +A    T    A+K ++   I  ++      +  + +E  V+S 
Sbjct: 37  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKEN-----KVPYVTRERDVMSR 91
Query: 399 LKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAY 458
           L HP  V+ Y +   ++K Y  L Y   G + KY+R+  G+  E+  R +T  I+S L Y
Sbjct: 92  LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRK-IGSFDETCTRFYTAEIVSALEY 150
Query: 459 LHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHL---TGQKADLSMKGSPYWMAPELMM 515
           LH K  IHRD+K  N+L++    +++ DFG AK L   + Q       G+  +++PEL+ 
Sbjct: 151 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL- 209
Query: 516 AVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPW---SEYEGAAAMFKVMRDTPAIPDSL 572
              +K     S    D+W+LGC I ++  G PP+   +EY     + K+  D PA   + 
Sbjct: 210 --TEKSACKSS----DLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPA---AF 260
Query: 573 SPEGKDFL 580
            P+ +D +
Sbjct: 261 FPKARDLV 268

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score =  110 bits (274), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 81/291 (27%), Positives = 135/291 (46%), Gaps = 43/291 (14%)
Query: 348 IGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQY 407
           IG GT+G VY A N   G   A+K++ +  +D     +  +   EI +L  LKH NIV+ 
Sbjct: 10  IGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIR---EISILKELKHSNIVKL 65
Query: 408 YGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVV-RNFTRHILSGLAYLHSKKTIH 466
           Y  +++  K  + L + H     K + + C    ESV  ++F   +L+G+AY H ++ +H
Sbjct: 66  Y--DVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLH 123
Query: 467 RDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPYWM-APELMMAVMQKGKSSD 525
           RD+K  NLL++  G +K+ADFG+A+         + +    W  AP+++M       S  
Sbjct: 124 RDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMG------SKK 177
Query: 526 SALAVDIWSLGCTIIEMYTGKPPW---SEYEGAAAMFKVM-----RDTPAIPD------- 570
            +  +DIWS+GC   EM  G P +   SE +    +F+++     ++ P + +       
Sbjct: 178 YSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPN 237
Query: 571 --------------SLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQ 607
                          L   G D L    + +P  R  A   LEH + K + 
Sbjct: 238 FTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKENN 288

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score =  109 bits (273), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 78/250 (31%), Positives = 135/250 (54%), Gaps = 12/250 (4%)
Query: 346 KLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQ-EIKVLSHLKHPNI 404
           ++IGRG FG VY     +TG + AMK +D      K  E++   E+  + ++S    P I
Sbjct: 194 RIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFI 253
Query: 405 VQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKT 464
           V    +    DK    L+ ++ G ++ ++ +H G  +E+ +R +   I+ GL ++H++  
Sbjct: 254 VCMSYAFHTPDKLSFILDLMNGGDLHYHLSQH-GVFSEADMRFYAAEIILGLEHMHNRFV 312
Query: 465 IHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPYWMAPELMMAVMQKGKSS 524
           ++RD+K AN+L+D  G V+++D G+A   + +K   S+ G+  +MAPE    V+QKG + 
Sbjct: 313 VYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV-GTHGYMAPE----VLQKGVAY 367
Query: 525 DSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAM-FKVMRDTPAI--PDSLSPEGKDFLR 581
           DS  + D +SLGC + ++  G  P+ +++         M  T A+  PDS SPE +  L 
Sbjct: 368 DS--SADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLE 425
Query: 582 CCFQRNPADR 591
              QR+   R
Sbjct: 426 GLLQRDVNRR 435

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score =  109 bits (273), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 78/250 (31%), Positives = 135/250 (54%), Gaps = 12/250 (4%)
Query: 346 KLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQ-EIKVLSHLKHPNI 404
           ++IGRG FG VY     +TG + AMK +D      K  E++   E+  + ++S    P I
Sbjct: 195 RIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFI 254
Query: 405 VQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKT 464
           V    +    DK    L+ ++ G ++ ++ +H G  +E+ +R +   I+ GL ++H++  
Sbjct: 255 VCMSYAFHTPDKLSFILDLMNGGDLHYHLSQH-GVFSEADMRFYAAEIILGLEHMHNRFV 313
Query: 465 IHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPYWMAPELMMAVMQKGKSS 524
           ++RD+K AN+L+D  G V+++D G+A   + +K   S+ G+  +MAPE    V+QKG + 
Sbjct: 314 VYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV-GTHGYMAPE----VLQKGVAY 368
Query: 525 DSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAM-FKVMRDTPAI--PDSLSPEGKDFLR 581
           DS  + D +SLGC + ++  G  P+ +++         M  T A+  PDS SPE +  L 
Sbjct: 369 DS--SADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLE 426
Query: 582 CCFQRNPADR 591
              QR+   R
Sbjct: 427 GLLQRDVNRR 436

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score =  109 bits (273), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 70/242 (28%), Positives = 121/242 (50%), Gaps = 13/242 (5%)
Query: 342 WQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKH 401
           ++ GK++G G+F +V +A    T    A+K ++           +  + +E  V+S L H
Sbjct: 31  FKFGKILGEGSFSTVVLARELATSREYAIKILE--KRHIIKENKVPYVTRERDVMSRLDH 88
Query: 402 PNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHS 461
           P  V+ Y +   ++K Y  L Y   G + KY+R+  G+  E+  R +T  I+S L YLH 
Sbjct: 89  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRK-IGSFDETCTRFYTAEIVSALEYLHG 147
Query: 462 KKTIHRDIKGANLLVDASGVVKLADFGMAKHL---TGQKADLSMKGSPYWMAPELMMAVM 518
           K  IHRD+K  N+L++    +++ DFG AK L   + Q       G+  +++PEL+    
Sbjct: 148 KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL---T 204
Query: 519 QKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDSLSPEGKD 578
           +K     S    D+W+LGC I ++  G PP+          K+++     P+   P+ +D
Sbjct: 205 EKSACKSS----DLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARD 260
Query: 579 FL 580
            +
Sbjct: 261 LV 262

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score =  109 bits (273), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 89/341 (26%), Positives = 164/341 (48%), Gaps = 59/341 (17%)
Query: 339 NSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSH 398
           +  ++K   +G G  G V+  S++ +G + A K + +   + K A    Q+ +E++VL  
Sbjct: 67  DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHL---EIKPAIR-NQIIRELQVLHE 122
Query: 399 LKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAY 458
              P IV +YG+   + +  I +E++  GS+++ +++  G I E ++   +  ++ GL Y
Sbjct: 123 CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK-AGRIPEQILGKVSIAVIKGLTY 181
Query: 459 LHSK-KTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPYWMAPELMMAV 517
           L  K K +HRD+K +N+LV++ G +KL DFG++  L    A+ S  G+  +M+PE +   
Sbjct: 182 LREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN-SFVGTRSYMSPERL--- 237
Query: 518 MQKGKSSDSALAVDIWSLGCTIIEMYTGKPPW-------------SEYEGAA-------- 556
               + +  ++  DIWS+G +++EM  G+ P               + EG A        
Sbjct: 238 ----QGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPR 293
Query: 557 -----------------AMFKVM-----RDTPAIPDSL-SPEGKDFLRCCFQRNPADRPP 593
                            A+F+++        P +P ++ S E +DF+  C  +NPA+R  
Sbjct: 294 TPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSAVFSLEFQDFVNKCLIKNPAERAD 353
Query: 594 ASLLLEHRFLKNSQQPDVPSCSLSFSGMQLTEKPHSPREKA 634
              L+ H F+K S   +V       S + L + P +P   A
Sbjct: 354 LKQLMVHAFIKRSDAEEVDFAGWLCSTIGLNQ-PSTPTHAA 393

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score =  109 bits (273), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 81/260 (31%), Positives = 139/260 (53%), Gaps = 13/260 (5%)
Query: 336 LPMNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQ-EIK 394
           L MN  +   ++IGRG FG VY     +TG + AMK +D      K  E++   E+  + 
Sbjct: 186 LTMND-FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLS 244
Query: 395 VLSHLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILS 454
           ++S    P IV    +    DK    L+ ++ G ++ ++ +H G  +E+ +R +   I+ 
Sbjct: 245 LVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQH-GVFSEADMRFYAAEIIL 303
Query: 455 GLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPYWMAPELM 514
           GL ++H++  ++RD+K AN+L+D  G V+++D G+A   + +K   S+ G+  +MAPE  
Sbjct: 304 GLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV-GTHGYMAPE-- 360
Query: 515 MAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAM-FKVMRDTPAI--PDS 571
             V+QKG + DS  + D +SLGC + ++  G  P+ +++         M  T A+  PDS
Sbjct: 361 --VLQKGVAYDS--SADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDS 416
Query: 572 LSPEGKDFLRCCFQRNPADR 591
            SPE +  L    QR+   R
Sbjct: 417 FSPELRSLLEGLLQRDVNRR 436

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score =  109 bits (273), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 81/260 (31%), Positives = 139/260 (53%), Gaps = 13/260 (5%)
Query: 336 LPMNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQ-EIK 394
           L MN  +   ++IGRG FG VY     +TG + AMK +D      K  E++   E+  + 
Sbjct: 186 LTMND-FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLS 244
Query: 395 VLSHLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILS 454
           ++S    P IV    +    DK    L+ ++ G ++ ++ +H G  +E+ +R +   I+ 
Sbjct: 245 LVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQH-GVFSEADMRFYAAEIIL 303
Query: 455 GLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPYWMAPELM 514
           GL ++H++  ++RD+K AN+L+D  G V+++D G+A   + +K   S+ G+  +MAPE  
Sbjct: 304 GLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV-GTHGYMAPE-- 360
Query: 515 MAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAM-FKVMRDTPAI--PDS 571
             V+QKG + DS  + D +SLGC + ++  G  P+ +++         M  T A+  PDS
Sbjct: 361 --VLQKGVAYDS--SADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDS 416
Query: 572 LSPEGKDFLRCCFQRNPADR 591
            SPE +  L    QR+   R
Sbjct: 417 FSPELRSLLEGLLQRDVNRR 436

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score =  109 bits (272), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 71/246 (28%), Positives = 123/246 (50%), Gaps = 19/246 (7%)
Query: 342 WQKGKLIGRGTFGSVYVASNRETGALCAMKEVD---IFPDDPKSAESIKQLEQEIKVLSH 398
           ++ GK++G G+F +V +A    T    A+K ++   I  ++      +  + +E  V+S 
Sbjct: 39  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKEN-----KVPYVTRERDVMSR 93
Query: 399 LKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAY 458
           L HP  V+ Y     ++K Y  L Y   G + KY+R+  G+  E+  R +T  I+S L Y
Sbjct: 94  LDHPFFVKLYFCFQDDEKLYFGLSYAKNGELLKYIRK-IGSFDETCTRFYTAEIVSALEY 152
Query: 459 LHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHL---TGQKADLSMKGSPYWMAPELMM 515
           LH K  IHRD+K  N+L++    +++ DFG AK L   + Q       G+  +++PEL+ 
Sbjct: 153 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL- 211
Query: 516 AVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDSLSPE 575
              +K     S    D+W+LGC I ++  G PP+          K+++     P+   P+
Sbjct: 212 --TEKSACKSS----DLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPK 265
Query: 576 GKDFLR 581
            +D + 
Sbjct: 266 ARDLVE 271

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score =  108 bits (271), Expect = 8e-24,   Method: Compositional matrix adjust.
 Identities = 89/341 (26%), Positives = 163/341 (47%), Gaps = 59/341 (17%)
Query: 339 NSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSH 398
           +  ++K   +G G  G V+  S++ +G + A K + +   + K A    Q+ +E++VL  
Sbjct: 5   DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHL---EIKPAIR-NQIIRELQVLHE 60
Query: 399 LKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAY 458
              P IV +YG+   + +  I +E++  GS+++ +++  G I E ++   +  ++ GL Y
Sbjct: 61  CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK-AGRIPEQILGKVSIAVIKGLTY 119
Query: 459 LHSK-KTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPYWMAPELMMAV 517
           L  K K +HRD+K +N+LV++ G +KL DFG++  L    A+ S  G+  +M+PE +   
Sbjct: 120 LREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN-SFVGTRSYMSPERL--- 175
Query: 518 MQKGKSSDSALAVDIWSLGCTIIEMYTGKPPW-------------SEYEGAA-------- 556
               + +  ++  DIWS+G +++EM  G+ P               + EG A        
Sbjct: 176 ----QGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPR 231
Query: 557 -----------------AMFKVMRDT-----PAIPDSL-SPEGKDFLRCCFQRNPADRPP 593
                            A+F+++        P +P  + S E +DF+  C  +NPA+R  
Sbjct: 232 TPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERAD 291
Query: 594 ASLLLEHRFLKNSQQPDVPSCSLSFSGMQLTEKPHSPREKA 634
              L+ H F+K S   +V       S + L + P +P   A
Sbjct: 292 LKQLMVHAFIKRSDAEEVDFAGWLCSTIGLNQ-PSTPTHAA 331

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score =  108 bits (271), Expect = 9e-24,   Method: Compositional matrix adjust.
 Identities = 89/341 (26%), Positives = 163/341 (47%), Gaps = 59/341 (17%)
Query: 339 NSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSH 398
           +  ++K   +G G  G V+  S++ +G + A K + +   + K A    Q+ +E++VL  
Sbjct: 5   DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHL---EIKPAIR-NQIIRELQVLHE 60
Query: 399 LKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAY 458
              P IV +YG+   + +  I +E++  GS+++ +++  G I E ++   +  ++ GL Y
Sbjct: 61  CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK-AGRIPEQILGKVSIAVIKGLTY 119
Query: 459 LHSK-KTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPYWMAPELMMAV 517
           L  K K +HRD+K +N+LV++ G +KL DFG++  L    A+ S  G+  +M+PE +   
Sbjct: 120 LREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN-SFVGTRSYMSPERL--- 175
Query: 518 MQKGKSSDSALAVDIWSLGCTIIEMYTGKPPW-------------SEYEGAA-------- 556
               + +  ++  DIWS+G +++EM  G+ P               + EG A        
Sbjct: 176 ----QGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPR 231
Query: 557 -----------------AMFKVMRDT-----PAIPDSL-SPEGKDFLRCCFQRNPADRPP 593
                            A+F+++        P +P  + S E +DF+  C  +NPA+R  
Sbjct: 232 TPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERAD 291
Query: 594 ASLLLEHRFLKNSQQPDVPSCSLSFSGMQLTEKPHSPREKA 634
              L+ H F+K S   +V       S + L + P +P   A
Sbjct: 292 LKQLMVHAFIKRSDAEEVDFAGWLCSTIGLNQ-PSTPTHAA 331

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score =  108 bits (270), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 89/341 (26%), Positives = 163/341 (47%), Gaps = 59/341 (17%)
Query: 339 NSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSH 398
           +  ++K   +G G  G V+  S++ +G + A K + +   + K A    Q+ +E++VL  
Sbjct: 32  DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHL---EIKPAIR-NQIIRELQVLHE 87
Query: 399 LKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAY 458
              P IV +YG+   + +  I +E++  GS+++ +++  G I E ++   +  ++ GL Y
Sbjct: 88  CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK-AGRIPEQILGKVSIAVIKGLTY 146
Query: 459 LHSK-KTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPYWMAPELMMAV 517
           L  K K +HRD+K +N+LV++ G +KL DFG++  L    A+ S  G+  +M+PE +   
Sbjct: 147 LREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN-SFVGTRSYMSPERL--- 202
Query: 518 MQKGKSSDSALAVDIWSLGCTIIEMYTGKPPW-------------SEYEGAA-------- 556
               + +  ++  DIWS+G +++EM  G+ P               + EG A        
Sbjct: 203 ----QGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPR 258
Query: 557 -----------------AMFKVMRDT-----PAIPDSL-SPEGKDFLRCCFQRNPADRPP 593
                            A+F+++        P +P  + S E +DF+  C  +NPA+R  
Sbjct: 259 TPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERAD 318
Query: 594 ASLLLEHRFLKNSQQPDVPSCSLSFSGMQLTEKPHSPREKA 634
              L+ H F+K S   +V       S + L + P +P   A
Sbjct: 319 LKQLMVHAFIKRSDAEEVDFAGWLCSTIGLNQ-PSTPTHAA 358

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score =  108 bits (270), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 70/245 (28%), Positives = 123/245 (50%), Gaps = 19/245 (7%)
Query: 342 WQKGKLIGRGTFGSVYVASNRETGALCAMKEVD---IFPDDPKSAESIKQLEQEIKVLSH 398
           ++ GK++G G+F +  +A    T    A+K ++   I  ++      +  + +E  V+S 
Sbjct: 32  FKFGKILGEGSFSTTVLARELATSREYAIKILEKRHIIKEN-----KVPYVTRERDVMSR 86
Query: 399 LKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAY 458
           L HP  V+ Y +   ++K Y  L Y   G + KY+R+  G+  E+  R +T  I+S L Y
Sbjct: 87  LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRK-IGSFDETCTRFYTAEIVSALEY 145
Query: 459 LHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHL---TGQKADLSMKGSPYWMAPELMM 515
           LH K  IHRD+K  N+L++    +++ DFG AK L   + Q       G+  +++PEL+ 
Sbjct: 146 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL- 204
Query: 516 AVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDSLSPE 575
              +K     S    D+W+LGC I ++  G PP+          K+++     P+   P+
Sbjct: 205 --TEKSACKSS----DLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPK 258
Query: 576 GKDFL 580
            +D +
Sbjct: 259 ARDLV 263

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score =  108 bits (270), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 74/277 (26%), Positives = 133/277 (48%), Gaps = 22/277 (7%)
Query: 338 MNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLS 397
            + +++  +++G+G+FG V +  ++ TG  CA+K +       K     + L +E+++L 
Sbjct: 30  FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVIS--KRQVKQKTDKESLLREVQLLK 87
Query: 398 HLKHPNIVQYYGSEIVEDKFYIYL--EYVHPGSINKYVREHCGAITESVVRNFTRHILSG 455
            L HPNI++ Y  E  EDK Y YL  E    G +   +       +E       R +LSG
Sbjct: 88  QLDHPNIMKLY--EFFEDKGYFYLVGEVYTGGELFDEIISR-KRFSEVDAARIIRQVLSG 144
Query: 456 LAYLHSKKTIHRDIKGANLLVDA---SGVVKLADFGMAKHLTGQKADLSMKGSPYWMAPE 512
           + Y+H  K +HRD+K  NLL+++      +++ DFG++ H    K      G+ Y++APE
Sbjct: 145 ITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPE 204
Query: 513 LMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRD--TPAIPD 570
           ++     +          D+WS G  +  + +G PP++       + KV +   T  +P 
Sbjct: 205 VLHGTYDE--------KCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQ 256
Query: 571 --SLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKN 605
              +S   KD +R      P+ R  A   L+H +++ 
Sbjct: 257 WKKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQT 293

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score =  108 bits (269), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 67/212 (31%), Positives = 108/212 (50%), Gaps = 15/212 (7%)
Query: 340 SQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDD---PKSAESIKQLEQEIKVL 396
            +++K + IG GT+G+V+ A NRET  + A+K V +  DD   P SA       +EI +L
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSAL------REICLL 55
Query: 397 SHLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGL 456
             LKH NIV+ +     + K  +  E+     + KY     G +   +V++F   +L GL
Sbjct: 56  KELKHKNIVRLHDVLHSDKKLTLVFEFCD-QDLKKYFDSCNGDLDPEIVKSFLFQLLKGL 114
Query: 457 AYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPYWMAPELMMA 516
            + HS+  +HRD+K  NLL++ +G +KLADFG+A+         S +    W  P  ++ 
Sbjct: 115 GFCHSRNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLF 174
Query: 517 VMQKGKSSDSALAVDIWSLGCTIIEMYTGKPP 548
             +   +S     +D+WS GC   E+     P
Sbjct: 175 GAKLYSTS-----IDMWSAGCIFAELANAARP 201

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score =  108 bits (269), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 83/303 (27%), Positives = 139/303 (45%), Gaps = 45/303 (14%)
Query: 340 SQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDD---PKSAESIKQLEQEIKVL 396
            +++K + IG GT+G+V+ A NRET  + A+K V +  DD   P SA       +EI +L
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSAL------REICLL 55
Query: 397 SHLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGL 456
             LKH NIV+ +     + K  +  E+     + KY     G +   +V++F   +L GL
Sbjct: 56  KELKHKNIVRLHDVLHSDKKLTLVFEFCD-QDLKKYFDSCNGDLDPEIVKSFLFQLLKGL 114
Query: 457 AYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPYWMAPELMMA 516
            + HS+  +HRD+K  NLL++ +G +KLA+FG+A+         S +    W  P  ++ 
Sbjct: 115 GFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLF 174
Query: 517 VMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFKVMR--DTPA------ 567
             +   +S     +D+WS GC   E+   G+P +   +    + ++ R   TP       
Sbjct: 175 GAKLYSTS-----IDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPS 229
Query: 568 ---IPD------------------SLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNS 606
              +PD                   L+  G+D L+   + NP  R  A   L+H +  + 
Sbjct: 230 MTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDF 289
Query: 607 QQP 609
             P
Sbjct: 290 CPP 292

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score =  108 bits (269), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 100/362 (27%), Positives = 155/362 (42%), Gaps = 72/362 (19%)
Query: 314 PPGAAVLSPSATIPQVAAKPEPL----------PMNSQWQKGKLIGRGTFGSVYVASNRE 363
           PPG     P+ T   VAAK   L           +  +++  + IG G +G V  A  R 
Sbjct: 18  PPGPVKAEPAHTAASVAAKNLALLKARSFDVTFDVGDEYEIIETIGNGAYGVVSSARRRL 77
Query: 364 TGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQY---------YGSEIVE 414
           TG   A+K++   P+      + K+  +E+K+L H KH NI+           YG     
Sbjct: 78  TGQQVAIKKI---PNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEF--- 131
Query: 415 DKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANL 474
              Y+ L+ +    +++ +      +T   VR F   +L GL Y+HS + IHRD+K +NL
Sbjct: 132 KSVYVVLDLME-SDLHQIIHS-SQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNL 189
Query: 475 LVDASGVVKLADFGMAKHLTGQKADLSMKGSPY-----WMAPELMMAVMQKGKSSDSALA 529
           LV+ +  +K+ DFGMA+ L    A+     + Y     + APELM+++ +  +      A
Sbjct: 190 LVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQ------A 243
Query: 530 VDIWSLGCTIIEMYTGKP--PWSEYEGAAAMFKVMRDTPAIPDSLSPEGKDFLRCCFQRN 587
           +D+WS+GC   EM   +   P   Y     +  ++  TP+ P  +   G + +R   Q  
Sbjct: 244 IDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPS-PAVIQAVGAERVRAYIQSL 302
Query: 588 P-------------ADRPPASLL-----------------LEHRFLKNSQQP-DVPSCSL 616
           P             ADR   SLL                 L H FL     P D P C+ 
Sbjct: 303 PPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKYHDPDDEPDCAP 362
Query: 617 SF 618
            F
Sbjct: 363 PF 364

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score =  108 bits (269), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 72/251 (28%), Positives = 128/251 (50%), Gaps = 18/251 (7%)
Query: 346 KLIGRGTFGSVYVASNRETGALCAMKEV--DIFPDDPKSAESIKQLEQEIKVLSHLK-HP 402
           +++G+G+FG V +A  +ETG L A+K +  D+   D    + ++    E ++LS  + HP
Sbjct: 29  RVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQD----DDVECTMTEKRILSLARNHP 84
Query: 403 NIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSK 462
            + Q +      D+ +  +E+V+ G +  ++++      E+  R +   I+S L +LH K
Sbjct: 85  FLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQK-SRRFDEARARFYAAEIISALMFLHDK 143
Query: 463 KTIHRDIKGANLLVDASGVVKLADFGMAKH-LTGQKADLSMKGSPYWMAPELMMAVMQKG 521
             I+RD+K  N+L+D  G  KLADFGM K  +       +  G+P ++APE++  ++   
Sbjct: 144 GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATFCGTPDYIAPEILQEMLY-- 201
Query: 522 KSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFK-VMRDTPAIPDSLSPEGKDFL 580
                  AVD W++G  + EM  G  P+ E E    +F+ ++ D    P  L  +    L
Sbjct: 202 -----GPAVDWWAMGVLLYEMLCGHAPF-EAENEDDLFEAILNDEVVYPTWLHEDATGIL 255
Query: 581 RCCFQRNPADR 591
           +    +NP  R
Sbjct: 256 KSFMTKNPTMR 266

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score =  108 bits (269), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 74/254 (29%), Positives = 122/254 (48%), Gaps = 13/254 (5%)
Query: 346 KLIGRGTFGSVYVA---SNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHP 402
           +++G+G +G V+     +   TG + AMK +       ++A+     + E  +L  +KHP
Sbjct: 23  RVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKK-AMIVRNAKDTAHTKAERNILEEVKHP 81
Query: 403 NIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSK 462
            IV    +     K Y+ LEY+  G +   + E  G   E     +   I   L +LH K
Sbjct: 82  FIVDLIYAFQTGGKLYLILEYLSGGELFMQL-EREGIFMEDTACFYLAEISMALGHLHQK 140
Query: 463 KTIHRDIKGANLLVDASGVVKLADFGMAKH-LTGQKADLSMKGSPYWMAPELMMAVMQKG 521
             I+RD+K  N++++  G VKL DFG+ K  +       +  G+  +MAPE++M      
Sbjct: 141 GIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEILM------ 194
Query: 522 KSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDSLSPEGKDFLR 581
             S    AVD WSLG  + +M TG PP++       + K+++    +P  L+ E +D L+
Sbjct: 195 -RSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPYLTQEARDLLK 253
Query: 582 CCFQRNPADRPPAS 595
              +RN A R  A 
Sbjct: 254 KLLKRNAASRLGAG 267

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score =  108 bits (269), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 88/310 (28%), Positives = 146/310 (47%), Gaps = 54/310 (17%)
Query: 339 NSQWQKGKLIGRGTFGSVYVASNRETGA-LCAMKEVDIFPDDPKSAESIKQLE--QEIKV 395
           + Q++    IG G +G V+ A + + G    A+K V +     ++ E    L   +E+ V
Sbjct: 10  DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRV-----QTGEEGMPLSTIREVAV 64
Query: 396 LSHLK---HPNIVQYYGSEIV-----EDKFYIYLEYVHPGSINKYVRE--HCGAITESVV 445
           L HL+   HPN+V+ +    V     E K  +  E+V    +  Y+ +    G  TE++ 
Sbjct: 65  LRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETI- 122
Query: 446 RNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGS 505
           ++    +L GL +LHS + +HRD+K  N+LV +SG +KLADFG+A+  + Q A  S+  +
Sbjct: 123 KDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVT 182
Query: 506 PYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVM--- 562
            ++ APE+++        S  A  VD+WS+GC   EM+  KP +        + K++   
Sbjct: 183 LWYRAPEVLL-------QSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVI 235
Query: 563 -----RDTP---AIP----------------DSLSPEGKDFLRCCFQRNPADRPPASLLL 598
                 D P   A+P                  +   GKD L  C   NPA R  A   L
Sbjct: 236 GLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSAL 295
Query: 599 EHRFLKNSQQ 608
            H + ++ ++
Sbjct: 296 SHPYFQDLER 305

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  107 bits (268), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 64/219 (29%), Positives = 111/219 (50%), Gaps = 14/219 (6%)
Query: 336 LPMNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKV 395
           +P    W   + +G G +G V +A NR T    A+K VD+     ++ +  + +++EI +
Sbjct: 2   VPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDM----KRAVDCPENIKKEIXI 57
Query: 396 LSHLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSG 455
              L H N+V++YG     +  Y++LEY   G +   +    G + E   + F   +++G
Sbjct: 58  NKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG-MPEPDAQRFFHQLMAG 116
Query: 456 LAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMA---KHLTGQKADLSMKGSPYWMAPE 512
           + YLH     HRDIK  NLL+D    +K++DFG+A   ++   ++    M G+  ++APE
Sbjct: 117 VVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPE 176
Query: 513 LMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSE 551
           L+       +    A  VD+WS G  +  M  G+ PW +
Sbjct: 177 LL------KRREFHAEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score =  107 bits (268), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 84/276 (30%), Positives = 136/276 (49%), Gaps = 18/276 (6%)
Query: 348 IGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQY 407
           +GRG +G V    +  +G + A+K +    +  +    +  L+  ++ +     P  V +
Sbjct: 59  LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDC---PFTVTF 115
Query: 408 YGSEIVEDKFYIYLEYVHPGSINKY---VREHCGAITESVVRNFTRHILSGLAYLHSK-K 463
           YG+   E   +I +E +   S++K+   V +    I E ++      I+  L +LHSK  
Sbjct: 116 YGALFREGDVWICMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS 174
Query: 464 TIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPYWMAPELMM-AVMQKGK 522
            IHRD+K +N+L++A G VK+ DFG++ +L    A     G   +MAPE +   + QKG 
Sbjct: 175 VIHRDVKPSNVLINALGQVKMCDFGISGYLVDSVAKTIDAGCKPYMAPERINPELNQKGY 234
Query: 523 SSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFK--VMRDTPAIP-DSLSPEGKDF 579
           S  S    DIWSLG T+IE+   + P+  +       K  V   +P +P D  S E  DF
Sbjct: 235 SVKS----DIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPADKFSAEFVDF 290
Query: 580 LRCCFQRNPADRPPASLLLEHRF--LKNSQQPDVPS 613
              C ++N  +RP    L++H F  L  S+  DV S
Sbjct: 291 TSQCLKKNSKERPTYPELMQHPFFTLHESKGTDVAS 326

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score =  107 bits (268), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 84/318 (26%), Positives = 155/318 (48%), Gaps = 58/318 (18%)
Query: 339 NSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSH 398
           +  ++K   +G G  G V+  S++ +G + A K + +   + K A    Q+ +E++VL  
Sbjct: 5   DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHL---EIKPAIR-NQIIRELQVLHE 60
Query: 399 LKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAY 458
              P IV +YG+   + +  I +E++  GS+++ +++  G I E ++   +  ++ GL Y
Sbjct: 61  CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK-AGRIPEQILGKVSIAVIKGLTY 119
Query: 459 LHSK-KTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPYWMAPELMMAV 517
           L  K K +HRD+K +N+LV++ G +KL DFG++  L    A+ S  G+  +M+PE +   
Sbjct: 120 LREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN-SFVGTRSYMSPERL--- 175
Query: 518 MQKGKSSDSALAVDIWSLGCTIIEMYTGKPPW-------------SEYEGAA-------- 556
               + +  ++  DIWS+G +++EM  G+ P               + EG A        
Sbjct: 176 ----QGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPR 231
Query: 557 -----------------AMFKVMRDT-----PAIPDSL-SPEGKDFLRCCFQRNPADRPP 593
                            A+F+++        P +P  + S E +DF+  C  +NPA+R  
Sbjct: 232 TPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERAD 291
Query: 594 ASLLLEHRFLKNSQQPDV 611
              L+ H F+K S   +V
Sbjct: 292 LKQLMVHAFIKRSDAEEV 309

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score =  107 bits (268), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 84/318 (26%), Positives = 155/318 (48%), Gaps = 58/318 (18%)
Query: 339 NSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSH 398
           +  ++K   +G G  G V+  S++ +G + A K + +   + K A    Q+ +E++VL  
Sbjct: 5   DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHL---EIKPAIR-NQIIRELQVLHE 60
Query: 399 LKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAY 458
              P IV +YG+   + +  I +E++  GS+++ +++  G I E ++   +  ++ GL Y
Sbjct: 61  CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK-AGRIPEQILGKVSIAVIKGLTY 119
Query: 459 LHSK-KTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPYWMAPELMMAV 517
           L  K K +HRD+K +N+LV++ G +KL DFG++  L    A+ S  G+  +M+PE +   
Sbjct: 120 LREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN-SFVGTRSYMSPERL--- 175
Query: 518 MQKGKSSDSALAVDIWSLGCTIIEMYTGKPPW-------------SEYEGAA-------- 556
               + +  ++  DIWS+G +++EM  G+ P               + EG A        
Sbjct: 176 ----QGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPR 231
Query: 557 -----------------AMFKVMRDT-----PAIPDSL-SPEGKDFLRCCFQRNPADRPP 593
                            A+F+++        P +P  + S E +DF+  C  +NPA+R  
Sbjct: 232 TPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERAD 291
Query: 594 ASLLLEHRFLKNSQQPDV 611
              L+ H F+K S   +V
Sbjct: 292 LKQLMVHAFIKRSDAEEV 309

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score =  107 bits (268), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 64/219 (29%), Positives = 111/219 (50%), Gaps = 14/219 (6%)
Query: 336 LPMNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKV 395
           +P    W   + +G G +G V +A NR T    A+K VD+     ++ +  + +++EI +
Sbjct: 3   VPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDM----KRAVDCPENIKKEIXI 58
Query: 396 LSHLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSG 455
              L H N+V++YG     +  Y++LEY   G +   +    G + E   + F   +++G
Sbjct: 59  NKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG-MPEPDAQRFFHQLMAG 117
Query: 456 LAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMA---KHLTGQKADLSMKGSPYWMAPE 512
           + YLH     HRDIK  NLL+D    +K++DFG+A   ++   ++    M G+  ++APE
Sbjct: 118 VVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPE 177
Query: 513 LMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSE 551
           L+       +    A  VD+WS G  +  M  G+ PW +
Sbjct: 178 LL------KRREFHAEPVDVWSCGIVLTAMLAGELPWDQ 210

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score =  107 bits (267), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 74/250 (29%), Positives = 123/250 (49%), Gaps = 18/250 (7%)
Query: 347 LIGRGTFGSVYVASNRETGALCAMKEVD---IFPDDPKSAESIKQLEQEIKVLSHL-KHP 402
           ++G+G+FG V +A  + T  L A+K +    +  DD      +     E +VL+ L K P
Sbjct: 26  VLGKGSFGKVMLADRKGTEELYAIKILKKDVVIQDDDVECTMV-----EKRVLALLDKPP 80
Query: 403 NIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSK 462
            + Q +      D+ Y  +EYV+ G +  ++++  G   E     +   I  GL +LH +
Sbjct: 81  FLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQ-VGKFKEPQAVFYAAEISIGLFFLHKR 139
Query: 463 KTIHRDIKGANLLVDASGVVKLADFGMAK-HLTGQKADLSMKGSPYWMAPELMMAVMQKG 521
             I+RD+K  N+++D+ G +K+ADFGM K H+          G+P ++APE+ +A    G
Sbjct: 140 GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMMDGVTTREFCGTPDYIAPEI-IAYQPYG 198
Query: 522 KSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDSLSPEGKDFLR 581
           KS      VD W+ G  + EM  G+PP+   +       +M    + P SLS E     +
Sbjct: 199 KS------VDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSICK 252
Query: 582 CCFQRNPADR 591
               ++PA R
Sbjct: 253 GLMTKHPAKR 262

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score =  107 bits (267), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 81/268 (30%), Positives = 133/268 (49%), Gaps = 26/268 (9%)
Query: 346 KLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIV 405
           ++IG G FG VY A     G   A+K     PD+  S ++I+ + QE K+ + LKHPNI+
Sbjct: 13  EIIGIGGFGKVYRAF--WIGDEVAVKAARHDPDEDIS-QTIENVRQEAKLFAMLKHPNII 69
Query: 406 QYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKK-- 463
              G  + E    + +E+   G +N+ +      I   ++ N+   I  G+ YLH +   
Sbjct: 70  ALRGVCLKEPNLCLVMEFARGGPLNRVLSGK--RIPPDILVNWAVQIARGMNYLHDEAIV 127
Query: 464 -TIHRDIKGANLLV-------DASG-VVKLADFGMAKHLTGQKADLSMKGSPYWMAPELM 514
             IHRD+K +N+L+       D S  ++K+ DFG+A+    +   +S  G+  WMAPE++
Sbjct: 128 PIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWH-RTTKMSAAGAYAWMAPEVI 186
Query: 515 MAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPD-SLS 573
            A M    S       D+WS G  + E+ TG+ P+   +G A  + V  +  A+P  S  
Sbjct: 187 RASMFSKGS-------DVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPIPSTC 239
Query: 574 PE-GKDFLRCCFQRNPADRPPASLLLEH 600
           PE     +  C+  +P  RP  + +L+ 
Sbjct: 240 PEPFAKLMEDCWNPDPHSRPSFTNILDQ 267

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score =  107 bits (267), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 101/362 (27%), Positives = 153/362 (42%), Gaps = 72/362 (19%)
Query: 314 PPGAAVLSPSATIPQVAAKPEPL----------PMNSQWQKGKLIGRGTFGSVYVASNRE 363
           PPG     P+ T   VAAK   L           +  +++  + IG G +G V  A  R 
Sbjct: 19  PPGPVKAEPAHTAASVAAKNLALLKARSFDVTFDVGDEYEIIETIGNGAYGVVSSARRRL 78
Query: 364 TGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQY---------YGSEIVE 414
           TG   A+K++   P+      + K+  +E+K+L H KH NI+           YG     
Sbjct: 79  TGQQVAIKKI---PNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEF--- 132
Query: 415 DKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANL 474
              Y+ L+ +   S    +      +T   VR F   +L GL Y+HS + IHRD+K +NL
Sbjct: 133 KSVYVVLDLME--SDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNL 190
Query: 475 LVDASGVVKLADFGMAKHLTGQKADLSMKGSPY-----WMAPELMMAVMQKGKSSDSALA 529
           LV+ +  +K+ DFGMA+ L    A+     + Y     + APELM+++ +  +      A
Sbjct: 191 LVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQ------A 244
Query: 530 VDIWSLGCTIIEMYTGKP--PWSEYEGAAAMFKVMRDTPAIPDSLSPEGKDFLRCCFQRN 587
           +D+WS+GC   EM   +   P   Y     +  ++  TP+ P  +   G + +R   Q  
Sbjct: 245 IDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPS-PAVIQAVGAERVRAYIQSL 303
Query: 588 P-------------ADRPPASLL-----------------LEHRFLKNSQQP-DVPSCSL 616
           P             ADR   SLL                 L H FL     P D P C+ 
Sbjct: 304 PPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKYHDPDDEPDCAP 363
Query: 617 SF 618
            F
Sbjct: 364 PF 365

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score =  107 bits (267), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 88/310 (28%), Positives = 146/310 (47%), Gaps = 54/310 (17%)
Query: 339 NSQWQKGKLIGRGTFGSVYVASNRETGA-LCAMKEVDIFPDDPKSAESIKQLE--QEIKV 395
           + Q++    IG G +G V+ A + + G    A+K V +     ++ E    L   +E+ V
Sbjct: 10  DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRV-----QTGEEGMPLSTIREVAV 64
Query: 396 LSHLK---HPNIVQYYGSEIV-----EDKFYIYLEYVHPGSINKYVRE--HCGAITESVV 445
           L HL+   HPN+V+ +    V     E K  +  E+V    +  Y+ +    G  TE++ 
Sbjct: 65  LRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETI- 122
Query: 446 RNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGS 505
           ++    +L GL +LHS + +HRD+K  N+LV +SG +KLADFG+A+  + Q A  S+  +
Sbjct: 123 KDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVT 182
Query: 506 PYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVM--- 562
            ++ APE+++        S  A  VD+WS+GC   EM+  KP +        + K++   
Sbjct: 183 LWYRAPEVLL-------QSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVI 235
Query: 563 -----RDTP---AIP----------------DSLSPEGKDFLRCCFQRNPADRPPASLLL 598
                 D P   A+P                  +   GKD L  C   NPA R  A   L
Sbjct: 236 GLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSAL 295
Query: 599 EHRFLKNSQQ 608
            H + ++ ++
Sbjct: 296 SHPYFQDLER 305

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score =  107 bits (267), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 82/290 (28%), Positives = 143/290 (49%), Gaps = 29/290 (10%)
Query: 330 AAKPEPLPM---NSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESI 386
            A P  LP+   + +++  K IG G FG   +  +++   L A+K ++      K  E++
Sbjct: 6   VAGPMDLPIMHDSDRYELVKDIGAGNFGVARLMRDKQANELVAVKYIE---RGEKIDENV 62
Query: 387 KQLEQEIKVLSH--LKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESV 444
           K+     ++++H  L+HPNIV++    +      I +EY   G + + +  + G  +E  
Sbjct: 63  KR-----EIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERIC-NAGRFSEDE 116
Query: 445 VRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGV--VKLADFGMAKHLTGQKADLSM 502
            R F + ++SG++Y H+ +  HRD+K  N L+D S    +K+ADFG +K         S 
Sbjct: 117 ARFFFQQLISGVSYAHAMQVAHRDLKLENTLLDGSPAPRLKIADFGYSKASVLHSQPKSA 176
Query: 503 KGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEG----AAAM 558
            G+P ++APE+++     GK +      D+WS G T+  M  G  P+ + E        +
Sbjct: 177 VGTPAYIAPEVLLKKEYDGKVA------DVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 230
Query: 559 FKVMRDTPAIPD--SLSPEGKDFLRCCFQRNPADRPPASLLLEHR-FLKN 605
            +++    AIPD   +SPE +  +   F  +PA R     +  H  FLKN
Sbjct: 231 HRILNVQYAIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKN 280

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  107 bits (266), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 64/219 (29%), Positives = 111/219 (50%), Gaps = 14/219 (6%)
Query: 336 LPMNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKV 395
           +P    W   + +G G +G V +A NR T    A+K VD+     ++ +  + +++EI +
Sbjct: 2   VPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDM----KRAVDCPENIKKEIXI 57
Query: 396 LSHLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSG 455
              L H N+V++YG     +  Y++LEY   G +   +    G + E   + F   +++G
Sbjct: 58  NKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG-MPEPDAQRFFHQLMAG 116
Query: 456 LAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMA---KHLTGQKADLSMKGSPYWMAPE 512
           + YLH     HRDIK  NLL+D    +K++DFG+A   ++   ++    M G+  ++APE
Sbjct: 117 VVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 176
Query: 513 LMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSE 551
           L+       +    A  VD+WS G  +  M  G+ PW +
Sbjct: 177 LL------KRREFHAEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  107 bits (266), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 64/219 (29%), Positives = 111/219 (50%), Gaps = 14/219 (6%)
Query: 336 LPMNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKV 395
           +P    W   + +G G +G V +A NR T    A+K VD+     ++ +  + +++EI +
Sbjct: 2   VPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDM----KRAVDCPENIKKEICI 57
Query: 396 LSHLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSG 455
              L H N+V++YG     +  Y++LEY   G +   +    G + E   + F   +++G
Sbjct: 58  NKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG-MPEPDAQRFFHQLMAG 116
Query: 456 LAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMA---KHLTGQKADLSMKGSPYWMAPE 512
           + YLH     HRDIK  NLL+D    +K++DFG+A   ++   ++    M G+  ++APE
Sbjct: 117 VVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPE 176
Query: 513 LMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSE 551
           L+       +    A  VD+WS G  +  M  G+ PW +
Sbjct: 177 LL------KRREFHAEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  107 bits (266), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 64/219 (29%), Positives = 111/219 (50%), Gaps = 14/219 (6%)
Query: 336 LPMNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKV 395
           +P    W   + +G G +G V +A NR T    A+K VD+     ++ +  + +++EI +
Sbjct: 2   VPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDM----KRAVDCPENIKKEICI 57
Query: 396 LSHLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSG 455
              L H N+V++YG     +  Y++LEY   G +   +    G + E   + F   +++G
Sbjct: 58  NKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG-MPEPDAQRFFHQLMAG 116
Query: 456 LAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMA---KHLTGQKADLSMKGSPYWMAPE 512
           + YLH     HRDIK  NLL+D    +K++DFG+A   ++   ++    M G+  ++APE
Sbjct: 117 VVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPE 176
Query: 513 LMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSE 551
           L+       +    A  VD+WS G  +  M  G+ PW +
Sbjct: 177 LL------KRREFHAEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score =  107 bits (266), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 74/254 (29%), Positives = 121/254 (47%), Gaps = 13/254 (5%)
Query: 346 KLIGRGTFGSVYVA---SNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHP 402
           +++G+G +G V+     +   TG + AMK +       ++A+     + E  +L  +KHP
Sbjct: 23  RVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKK-AMIVRNAKDTAHTKAERNILEEVKHP 81
Query: 403 NIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSK 462
            IV    +     K Y+ LEY+  G +   + E  G   E     +   I   L +LH K
Sbjct: 82  FIVDLIYAFQTGGKLYLILEYLSGGELFMQL-EREGIFMEDTACFYLAEISMALGHLHQK 140
Query: 463 KTIHRDIKGANLLVDASGVVKLADFGMAKH-LTGQKADLSMKGSPYWMAPELMMAVMQKG 521
             I+RD+K  N++++  G VKL DFG+ K  +          G+  +MAPE++M      
Sbjct: 141 GIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHXFCGTIEYMAPEILM------ 194
Query: 522 KSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDSLSPEGKDFLR 581
             S    AVD WSLG  + +M TG PP++       + K+++    +P  L+ E +D L+
Sbjct: 195 -RSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPYLTQEARDLLK 253
Query: 582 CCFQRNPADRPPAS 595
              +RN A R  A 
Sbjct: 254 KLLKRNAASRLGAG 267

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score =  107 bits (266), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 81/285 (28%), Positives = 131/285 (45%), Gaps = 46/285 (16%)
Query: 340 SQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVD------------------------- 374
           +Q+     IG+G++G V +A N       AMK +                          
Sbjct: 13  NQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGG 72
Query: 375 -IFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIV----EDKFYIYLEYVHPGSI 429
            I P  P     I+Q+ QEI +L  L HPN+V+    E++    ED  Y+  E V+ G +
Sbjct: 73  CIQPRGP-----IEQVYQEIAILKKLDHPNVVKLV--EVLDDPNEDHLYMVFELVNQGPV 125
Query: 430 NKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGM 489
            +        ++E   R + + ++ G+ YLH +K IHRDIK +NLLV   G +K+ADFG+
Sbjct: 126 MEV--PTLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGV 183
Query: 490 AKHLTGQKADLS-MKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPP 548
           +    G  A LS   G+P +MAPE     + + +   S  A+D+W++G T+     G+ P
Sbjct: 184 SNEFKGSDALLSNTVGTPAFMAPE----SLSETRKIFSGKALDVWAMGVTLYCFVFGQCP 239
Query: 549 WSEYEGAAAMFKVMRDTPAIPDS--LSPEGKDFLRCCFQRNPADR 591
           + +        K+       PD   ++ + KD +     +NP  R
Sbjct: 240 FMDERIMCLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESR 284

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score =  106 bits (265), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 77/305 (25%), Positives = 136/305 (44%), Gaps = 37/305 (12%)
Query: 341 QWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLK 400
           +++K   +G G F +VY A ++ T  + A+K++ +           +   +EIK+L  L 
Sbjct: 11  RYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELS 70
Query: 401 HPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLH 460
           HPNI+    +   +    +  +++    +   ++++   +T S ++ +    L GL YLH
Sbjct: 71  HPNIIGLLDAFGHKSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLH 129
Query: 461 SKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTG-QKADLSMKGSPYWMAPELMMAVMQ 519
               +HRD+K  NLL+D +GV+KLADFG+AK      +A      + ++ APEL+     
Sbjct: 130 QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYXHQVVTRWYRAPELLFGARM 189
Query: 520 KGKSSDSALAVDIWSLGCTIIEMY---------------------TGKPPWSEYEGAAAM 558
            G      + VD+W++GC + E+                       G P   ++    ++
Sbjct: 190 YG------VGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSL 243
Query: 559 --FKVMRDTPAIP--DSLSPEGKDFL---RCCFQRNPADRPPASLLLEHRFLKNSQQPDV 611
             +   +  P IP     S  G D L   +  F  NP  R  A+  L+ ++  N   P  
Sbjct: 244 PDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGP-T 302
Query: 612 PSCSL 616
           P C L
Sbjct: 303 PGCQL 307

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score =  106 bits (265), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 88/306 (28%), Positives = 143/306 (46%), Gaps = 54/306 (17%)
Query: 339 NSQWQKGKLIGRGTFGSVYVASNRETGA-LCAMKEVDIFPDDPKSAESIKQLE--QEIKV 395
           + Q++    IG G +G V+ A + + G    A+K V +     ++ E    L   +E+ V
Sbjct: 10  DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRV-----QTGEEGMPLSTIREVAV 64
Query: 396 LSHLK---HPNIVQYYGSEIV-----EDKFYIYLEYVHPGSINKYVRE--HCGAITESVV 445
           L HL+   HPN+V+ +    V     E K  +  E+V    +  Y+ +    G  TE++ 
Sbjct: 65  LRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETI- 122
Query: 446 RNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGS 505
           ++    +L GL +LHS + +HRD+K  N+LV +SG +KLADFG+A+  + Q A  S+  +
Sbjct: 123 KDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVT 182
Query: 506 PYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVM--- 562
            ++ APE+++        S  A  VD+WS+GC   EM+  KP +        + K++   
Sbjct: 183 LWYRAPEVLL-------QSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVI 235
Query: 563 -----RDTP---AIP----------------DSLSPEGKDFLRCCFQRNPADRPPASLLL 598
                 D P   A+P                  +   GKD L  C   NPA R  A   L
Sbjct: 236 GLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSAL 295
Query: 599 EHRFLK 604
            H + +
Sbjct: 296 SHPYFQ 301

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score =  106 bits (265), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 64/219 (29%), Positives = 111/219 (50%), Gaps = 14/219 (6%)
Query: 336 LPMNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKV 395
           +P    W   + +G G +G V +A NR T    A+K VD+     ++ +  + +++EI +
Sbjct: 2   VPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDM----KRAVDCPENIKKEICI 57
Query: 396 LSHLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSG 455
              L H N+V++YG     +  Y++LEY   G +   +    G + E   + F   +++G
Sbjct: 58  NKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG-MPEPDAQRFFHQLMAG 116
Query: 456 LAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMA---KHLTGQKADLSMKGSPYWMAPE 512
           + YLH     HRDIK  NLL+D    +K++DFG+A   ++   ++    M G+  ++APE
Sbjct: 117 VVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 176
Query: 513 LMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSE 551
           L+       +    A  VD+WS G  +  M  G+ PW +
Sbjct: 177 LLK------RREFHAEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score =  106 bits (265), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 64/219 (29%), Positives = 111/219 (50%), Gaps = 14/219 (6%)
Query: 336 LPMNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKV 395
           +P    W   + +G G +G V +A NR T    A+K VD+     ++ +  + +++EI +
Sbjct: 2   VPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDM----KRAVDCPENIKKEICI 57
Query: 396 LSHLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSG 455
              L H N+V++YG     +  Y++LEY   G +   +    G + E   + F   +++G
Sbjct: 58  NKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG-MPEPDAQRFFHQLMAG 116
Query: 456 LAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMA---KHLTGQKADLSMKGSPYWMAPE 512
           + YLH     HRDIK  NLL+D    +K++DFG+A   ++   ++    M G+  ++APE
Sbjct: 117 VVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPE 176
Query: 513 LMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSE 551
           L+       +    A  VD+WS G  +  M  G+ PW +
Sbjct: 177 LL------KRREFHAEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score =  106 bits (265), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 66/214 (30%), Positives = 113/214 (52%), Gaps = 18/214 (8%)
Query: 338 MNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDD---PKSAESIKQLEQEIK 394
           +  ++QK + +G GT+G VY A + + G + A+K + +  +D   P +A       +EI 
Sbjct: 19  LMEKYQKLEKVGEGTYGVVYKAKDSQ-GRIVALKRIRLDAEDEGIPSTAI------REIS 71
Query: 395 VLSHLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILS 454
           +L  L HPNIV        E    +  E++    + K + E+   + +S ++ +   +L 
Sbjct: 72  LLKELHHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLR 130
Query: 455 GLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPYWM-APEL 513
           G+A+ H  + +HRD+K  NLL+++ G +KLADFG+A+         + +    W  AP++
Sbjct: 131 GVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDV 190
Query: 514 MMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKP 547
           +M       S   + +VDIWS+GC   EM TGKP
Sbjct: 191 LMG------SKKYSTSVDIWSIGCIFAEMITGKP 218

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score =  106 bits (265), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 64/219 (29%), Positives = 111/219 (50%), Gaps = 14/219 (6%)
Query: 336 LPMNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKV 395
           +P    W   + +G G +G V +A NR T    A+K VD+     ++ +  + +++EI +
Sbjct: 3   VPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDM----KRAVDCPENIKKEICI 58
Query: 396 LSHLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSG 455
              L H N+V++YG     +  Y++LEY   G +   +    G + E   + F   +++G
Sbjct: 59  NKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG-MPEPDAQRFFHQLMAG 117
Query: 456 LAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMA---KHLTGQKADLSMKGSPYWMAPE 512
           + YLH     HRDIK  NLL+D    +K++DFG+A   ++   ++    M G+  ++APE
Sbjct: 118 VVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 177
Query: 513 LMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSE 551
           L+       +    A  VD+WS G  +  M  G+ PW +
Sbjct: 178 LLK------RREFHAEPVDVWSCGIVLTAMLAGELPWDQ 210

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score =  106 bits (264), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 83/313 (26%), Positives = 150/313 (47%), Gaps = 62/313 (19%)
Query: 348 IGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQY 407
           +G G  G V    +R +G + A K + +   + K A    Q+ +E++VL     P IV +
Sbjct: 24  LGAGNGGVVTKVQHRPSGLIMARKLIHL---EIKPAIR-NQIIRELQVLHECNSPYIVGF 79
Query: 408 YGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTI-H 466
           YG+   + +  I +E++  GS+++ ++E    I E ++   +  +L GLAYL  K  I H
Sbjct: 80  YGAFYSDGEISICMEHMDGGSLDQVLKE-AKRIPEEILGKVSIAVLRGLAYLREKHQIMH 138
Query: 467 RDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPYWMAPELMMAVMQKGKSSDS 526
           RD+K +N+LV++ G +KL DFG++  L    A+ S  G+  +MAPE +       + +  
Sbjct: 139 RDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN-SFVGTRSYMAPERL-------QGTHY 190
Query: 527 ALAVDIWSLGCTIIEMYTGK-----PPWSEYEG--------------------------- 554
           ++  DIWS+G +++E+  G+     P   E E                            
Sbjct: 191 SVQSDIWSMGLSLVELAVGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRPPGRP 250
Query: 555 ----------AAAMFKVMRDT-----PAIPDSL-SPEGKDFLRCCFQRNPADRPPASLLL 598
                     A A+F+++        P +P+ + +P+ ++F+  C  +NPA+R    +L 
Sbjct: 251 VSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLT 310
Query: 599 EHRFLKNSQQPDV 611
            H F+K S+  +V
Sbjct: 311 NHTFIKRSEVEEV 323

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  106 bits (264), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 64/219 (29%), Positives = 111/219 (50%), Gaps = 14/219 (6%)
Query: 336 LPMNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKV 395
           +P    W   + +G G +G V +A NR T    A+K VD+     ++ +  + +++EI +
Sbjct: 2   VPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDM----KRAVDCPENIKKEICI 57
Query: 396 LSHLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSG 455
              L H N+V++YG     +  Y++LEY   G +   +    G + E   + F   +++G
Sbjct: 58  NKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG-MPEPDAQRFFHQLMAG 116
Query: 456 LAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMA---KHLTGQKADLSMKGSPYWMAPE 512
           + YLH     HRDIK  NLL+D    +K++DFG+A   ++   ++    M G+  ++APE
Sbjct: 117 VVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 176
Query: 513 LMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSE 551
           L+       +    A  VD+WS G  +  M  G+ PW +
Sbjct: 177 LL------KRREFHAEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score =  106 bits (264), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 64/219 (29%), Positives = 112/219 (51%), Gaps = 14/219 (6%)
Query: 336 LPMNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKV 395
           +P    W   + +G G +G V +A NR T    A+K VD+     ++ +  + +++EI +
Sbjct: 3   VPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDM----KRAVDCPENIKKEICI 58
Query: 396 LSHLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSG 455
            + L H N+V++YG     +  Y++LEY   G +   +    G + E   + F   +++G
Sbjct: 59  NAMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG-MPEPDAQRFFHQLMAG 117
Query: 456 LAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMA---KHLTGQKADLSMKGSPYWMAPE 512
           + YLH     HRDIK  NLL+D    +K++DFG+A   ++   ++    M G+  ++APE
Sbjct: 118 VVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 177
Query: 513 LMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSE 551
           L+       +    A  VD+WS G  +  M  G+ PW +
Sbjct: 178 LL------KRREFHAEPVDVWSCGIVLTAMLAGELPWDQ 210

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score =  106 bits (264), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 64/219 (29%), Positives = 111/219 (50%), Gaps = 14/219 (6%)
Query: 336 LPMNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKV 395
           +P    W   + +G G +G V +A NR T    A+K VD+     ++ +  + +++EI +
Sbjct: 3   VPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDM----KRAVDCPENIKKEICI 58
Query: 396 LSHLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSG 455
              L H N+V++YG     +  Y++LEY   G +   +    G + E   + F   +++G
Sbjct: 59  NKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG-MPEPDAQRFFHQLMAG 117
Query: 456 LAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMA---KHLTGQKADLSMKGSPYWMAPE 512
           + YLH     HRDIK  NLL+D    +K++DFG+A   ++   ++    M G+  ++APE
Sbjct: 118 VVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 177
Query: 513 LMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSE 551
           L+       +    A  VD+WS G  +  M  G+ PW +
Sbjct: 178 LL------KRREFHAEPVDVWSCGIVLTAMLAGELPWDQ 210

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score =  106 bits (264), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 64/219 (29%), Positives = 111/219 (50%), Gaps = 14/219 (6%)
Query: 336 LPMNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKV 395
           +P    W   + +G G +G V +A NR T    A+K VD+     ++ +  + +++EI +
Sbjct: 3   VPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDM----KRAVDCPENIKKEICI 58
Query: 396 LSHLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSG 455
              L H N+V++YG     +  Y++LEY   G +   +    G + E   + F   +++G
Sbjct: 59  NKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG-MPEPDAQRFFHQLMAG 117
Query: 456 LAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMA---KHLTGQKADLSMKGSPYWMAPE 512
           + YLH     HRDIK  NLL+D    +K++DFG+A   ++   ++    M G+  ++APE
Sbjct: 118 VVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 177
Query: 513 LMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSE 551
           L+       +    A  VD+WS G  +  M  G+ PW +
Sbjct: 178 LL------KRREFHAEPVDVWSCGIVLTAMLAGELPWDQ 210

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score =  106 bits (264), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 64/219 (29%), Positives = 111/219 (50%), Gaps = 14/219 (6%)
Query: 336 LPMNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKV 395
           +P    W   + +G G +G V +A NR T    A+K VD+     ++ +  + +++EI +
Sbjct: 3   VPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDM----KRAVDCPENIKKEICI 58
Query: 396 LSHLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSG 455
              L H N+V++YG     +  Y++LEY   G +   +    G + E   + F   +++G
Sbjct: 59  NKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG-MPEPDAQRFFHQLMAG 117
Query: 456 LAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMA---KHLTGQKADLSMKGSPYWMAPE 512
           + YLH     HRDIK  NLL+D    +K++DFG+A   ++   ++    M G+  ++APE
Sbjct: 118 VVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 177
Query: 513 LMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSE 551
           L+       +    A  VD+WS G  +  M  G+ PW +
Sbjct: 178 LL------KRREFHAEPVDVWSCGIVLTAMLAGELPWDQ 210

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score =  106 bits (264), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 64/218 (29%), Positives = 110/218 (50%), Gaps = 14/218 (6%)
Query: 337 PMNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVL 396
           P    W   + +G G +G V +A NR T    A+K VD+     ++ +  + +++EI + 
Sbjct: 2   PFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDM----KRAVDCPENIKKEICIN 57
Query: 397 SHLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGL 456
             L H N+V++YG     +  Y++LEY   G +   +    G + E   + F   +++G+
Sbjct: 58  KMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG-MPEPDAQRFFHQLMAGV 116
Query: 457 AYLHSKKTIHRDIKGANLLVDASGVVKLADFGMA---KHLTGQKADLSMKGSPYWMAPEL 513
            YLH     HRDIK  NLL+D    +K++DFG+A   ++   ++    M G+  ++APEL
Sbjct: 117 VYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 176
Query: 514 MMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSE 551
           +       +    A  VD+WS G  +  M  G+ PW +
Sbjct: 177 L------KRREFHAEPVDVWSCGIVLTAMLAGELPWDQ 208

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score =  106 bits (264), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 66/214 (30%), Positives = 113/214 (52%), Gaps = 18/214 (8%)
Query: 338 MNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDD---PKSAESIKQLEQEIK 394
           +  ++QK + +G GT+G VY A + + G + A+K + +  +D   P +A       +EI 
Sbjct: 19  LMEKYQKLEKVGEGTYGVVYKAKDSQ-GRIVALKRIRLDAEDEGIPSTAI------REIS 71
Query: 395 VLSHLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILS 454
           +L  L HPNIV        E    +  E++    + K + E+   + +S ++ +   +L 
Sbjct: 72  LLKELHHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLR 130
Query: 455 GLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPYWM-APEL 513
           G+A+ H  + +HRD+K  NLL+++ G +KLADFG+A+         + +    W  AP++
Sbjct: 131 GVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDV 190
Query: 514 MMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKP 547
           +M       S   + +VDIWS+GC   EM TGKP
Sbjct: 191 LMG------SKKYSTSVDIWSIGCIFAEMITGKP 218

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score =  106 bits (264), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 64/219 (29%), Positives = 111/219 (50%), Gaps = 14/219 (6%)
Query: 336 LPMNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKV 395
           +P    W   + +G G +G V +A NR T    A+K VD+     ++ +  + +++EI +
Sbjct: 3   VPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDM----KRAVDCPENIKKEICI 58
Query: 396 LSHLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSG 455
              L H N+V++YG     +  Y++LEY   G +   +    G + E   + F   +++G
Sbjct: 59  NKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG-MPEPDAQRFFHQLMAG 117
Query: 456 LAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMA---KHLTGQKADLSMKGSPYWMAPE 512
           + YLH     HRDIK  NLL+D    +K++DFG+A   ++   ++    M G+  ++APE
Sbjct: 118 VVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 177
Query: 513 LMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSE 551
           L+       +    A  VD+WS G  +  M  G+ PW +
Sbjct: 178 LL------KRREFHAEPVDVWSCGIVLTAMLAGELPWDQ 210

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score =  105 bits (263), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 74/249 (29%), Positives = 119/249 (47%), Gaps = 16/249 (6%)
Query: 348 IGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQY 407
           +G G +G VYV   ++     A+K +       +    +++  +E  V+  +KHPN+VQ 
Sbjct: 40  LGGGQYGEVYVGVWKKYSLTVAVKTLK------EDTMEVEEFLKEAAVMKEIKHPNLVQL 93
Query: 408 YGSEIVEDKFYIYLEYVHPGSINKYVREHCG--AITESVVRNFTRHILSGLAYLHSKKTI 465
            G   +E  FYI  EY+  G++  Y+RE C    +T  V+      I S + YL  K  I
Sbjct: 94  LGVCTLEPPFYIVTEYMPYGNLLDYLRE-CNREEVTAVVLLYMATQISSAMEYLEKKNFI 152
Query: 466 HRDIKGANLLVDASGVVKLADFGMAKHLTGQ--KADLSMKGSPYWMAPELMMAVMQKGKS 523
           HRD+   N LV  + VVK+ADFG+++ +TG    A    K    W APE +       KS
Sbjct: 153 HRDLAARNCLVGENHVVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKS 212
Query: 524 SDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDSLSPEGKDFLRCC 583
              A  V +W +    +  Y G      Y+     +++ +     P+   P+  + +R C
Sbjct: 213 DVWAFGVLLWEIATYGMSPYPGIDLSQVYDLLEKGYRMEQ-----PEGCPPKVYELMRAC 267
Query: 584 FQRNPADRP 592
           ++ +PADRP
Sbjct: 268 WKWSPADRP 276

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score =  105 bits (263), Expect = 7e-23,   Method: Compositional matrix adjust.
 Identities = 64/219 (29%), Positives = 111/219 (50%), Gaps = 14/219 (6%)
Query: 336 LPMNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKV 395
           +P    W   + +G G +G V +A NR T    A+K VD+     ++ +  + +++EI +
Sbjct: 3   VPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDM----KRAVDCPENIKKEICI 58
Query: 396 LSHLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSG 455
              L H N+V++YG     +  Y++LEY   G +   +    G + E   + F   +++G
Sbjct: 59  NKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG-MPEPDAQRFFHQLMAG 117
Query: 456 LAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMA---KHLTGQKADLSMKGSPYWMAPE 512
           + YLH     HRDIK  NLL+D    +K++DFG+A   ++   ++    M G+  ++APE
Sbjct: 118 VVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 177
Query: 513 LMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSE 551
           L+       +    A  VD+WS G  +  M  G+ PW +
Sbjct: 178 LL------KRREFHAEPVDVWSCGIVLTAMLAGELPWDQ 210

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score =  105 bits (263), Expect = 7e-23,   Method: Compositional matrix adjust.
 Identities = 74/249 (29%), Positives = 117/249 (46%), Gaps = 16/249 (6%)
Query: 348 IGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQY 407
           +G G FG VY    ++     A+K +       +    +++  +E  V+  +KHPN+VQ 
Sbjct: 19  LGGGQFGEVYEGVWKKYSLTVAVKTL------KEDTMEVEEFLKEAAVMKEIKHPNLVQL 72
Query: 408 YGSEIVEDKFYIYLEYVHPGSINKYVREHCG--AITESVVRNFTRHILSGLAYLHSKKTI 465
            G    E  FYI  E++  G++  Y+RE C    ++  V+      I S + YL  K  I
Sbjct: 73  LGVCTREPPFYIITEFMTYGNLLDYLRE-CNRQEVSAVVLLYMATQISSAMEYLEKKNFI 131
Query: 466 HRDIKGANLLVDASGVVKLADFGMAKHLTGQ--KADLSMKGSPYWMAPELMMAVMQKGKS 523
           HRD+   N LV  + +VK+ADFG+++ +TG    A    K    W APE +       KS
Sbjct: 132 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESLAYNKFSIKS 191
Query: 524 SDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDSLSPEGKDFLRCC 583
              A  V +W +    +  Y G  P   YE     +++ R     P+    +  + +R C
Sbjct: 192 DVWAFGVLLWEIATYGMSPYPGIDPSQVYELLEKDYRMER-----PEGCPEKVYELMRAC 246
Query: 584 FQRNPADRP 592
           +Q NP+DRP
Sbjct: 247 WQWNPSDRP 255

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score =  105 bits (263), Expect = 7e-23,   Method: Compositional matrix adjust.
 Identities = 64/219 (29%), Positives = 111/219 (50%), Gaps = 14/219 (6%)
Query: 336 LPMNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKV 395
           +P    W   + +G G +G V +A NR T    A+K VD+     ++ +  + +++EI +
Sbjct: 2   VPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDM----KRAVDCPENIKKEICI 57
Query: 396 LSHLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSG 455
              L H N+V++YG     +  Y++LEY   G +   +    G + E   + F   +++G
Sbjct: 58  NKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG-MPEPDAQRFFHQLMAG 116
Query: 456 LAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMA---KHLTGQKADLSMKGSPYWMAPE 512
           + YLH     HRDIK  NLL+D    +K++DFG+A   ++   ++    M G+  ++APE
Sbjct: 117 VVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 176
Query: 513 LMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSE 551
           L+       +    A  VD+WS G  +  M  G+ PW +
Sbjct: 177 LL------KRREFHAEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score =  105 bits (263), Expect = 7e-23,   Method: Compositional matrix adjust.
 Identities = 85/277 (30%), Positives = 138/277 (49%), Gaps = 20/277 (7%)
Query: 348 IGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQY 407
           +GRG +G V    +  +G + A+K +    +  +    +  L+  ++ +     P  V +
Sbjct: 15  LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDC---PFTVTF 71
Query: 408 YGSEIVEDKFYIYLEYVHPGSINKYVREHCG---AITESVVRNFTRHILSGLAYLHSK-K 463
           YG+   E   +I +E +   S++K+ ++       I E ++      I+  L +LHSK  
Sbjct: 72  YGALFREGDVWICMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS 130
Query: 464 TIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKA-DLSMKGSPYWMAPELMM-AVMQKG 521
            IHRD+K +N+L++A G VK+ DFG++ +L    A D+     PY MAPE +   + QKG
Sbjct: 131 VIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDIDAGCKPY-MAPERINPELNQKG 189
Query: 522 KSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFK--VMRDTPAIP-DSLSPEGKD 578
            S  S    DIWSLG T+IE+   + P+  +       K  V   +P +P D  S E  D
Sbjct: 190 YSVKS----DIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPADKFSAEFVD 245
Query: 579 FLRCCFQRNPADRPPASLLLEHRF--LKNSQQPDVPS 613
           F   C ++N  +RP    L++H F  L  S+  DV S
Sbjct: 246 FTSQCLKKNSKERPTYPELMQHPFFTLHESKGTDVAS 282

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score =  105 bits (263), Expect = 7e-23,   Method: Compositional matrix adjust.
 Identities = 64/219 (29%), Positives = 111/219 (50%), Gaps = 14/219 (6%)
Query: 336 LPMNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKV 395
           +P    W   + +G G +G V +A NR T    A+K VD+     ++ +  + +++EI +
Sbjct: 2   VPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDM----KRAVDCPENIKKEICI 57
Query: 396 LSHLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSG 455
              L H N+V++YG     +  Y++LEY   G +   +    G + E   + F   +++G
Sbjct: 58  NKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG-MPEPDAQRFFHQLMAG 116
Query: 456 LAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMA---KHLTGQKADLSMKGSPYWMAPE 512
           + YLH     HRDIK  NLL+D    +K++DFG+A   ++   ++    M G+  ++APE
Sbjct: 117 VVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 176
Query: 513 LMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSE 551
           L+       +    A  VD+WS G  +  M  G+ PW +
Sbjct: 177 LL------KRREFHAEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score =  105 bits (263), Expect = 7e-23,   Method: Compositional matrix adjust.
 Identities = 64/219 (29%), Positives = 111/219 (50%), Gaps = 14/219 (6%)
Query: 336 LPMNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKV 395
           +P    W   + +G G +G V +A NR T    A+K VD+     ++ +  + +++EI +
Sbjct: 2   VPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDM----KRAVDCPENIKKEICI 57
Query: 396 LSHLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSG 455
              L H N+V++YG     +  Y++LEY   G +   +    G + E   + F   +++G
Sbjct: 58  NKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG-MPEPDAQRFFHQLMAG 116
Query: 456 LAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMA---KHLTGQKADLSMKGSPYWMAPE 512
           + YLH     HRDIK  NLL+D    +K++DFG+A   ++   ++    M G+  ++APE
Sbjct: 117 VVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 176
Query: 513 LMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSE 551
           L+       +    A  VD+WS G  +  M  G+ PW +
Sbjct: 177 LL------KRREFHAEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score =  105 bits (263), Expect = 7e-23,   Method: Compositional matrix adjust.
 Identities = 80/287 (27%), Positives = 141/287 (49%), Gaps = 29/287 (10%)
Query: 333 PEPLPM---NSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQL 389
           P  LP+   + +++  K IG G FG   +  ++++  L A+K ++      K A ++K+ 
Sbjct: 9   PMDLPIMHDSDRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIE---RGEKIAANVKR- 64
Query: 390 EQEIKVLSH--LKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRN 447
               ++++H  L+HPNIV++    +      I +EY   G + + +  + G  +E   R 
Sbjct: 65  ----EIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERIC-NAGRFSEDEARF 119
Query: 448 FTRHILSGLAYLHSKKTIHRDIKGANLLVDASGV--VKLADFGMAKHLTGQKADLSMKGS 505
           F + ++SG++Y H+ +  HRD+K  N L+D S    +K+ DFG +K         S  G+
Sbjct: 120 FFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGT 179
Query: 506 PYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEG----AAAMFKV 561
           P ++APE+++     GK        D+WS G T+  M  G  P+ + E        + ++
Sbjct: 180 PAYIAPEVLLKKEYDGK------VADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRI 233
Query: 562 MRDTPAIPD--SLSPEGKDFLRCCFQRNPADRPPASLLLEHR-FLKN 605
           +    AIPD   +SPE +  +   F  +PA R     +  H  FLKN
Sbjct: 234 LNVQYAIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKN 280

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score =  105 bits (263), Expect = 7e-23,   Method: Compositional matrix adjust.
 Identities = 64/219 (29%), Positives = 111/219 (50%), Gaps = 14/219 (6%)
Query: 336 LPMNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKV 395
           +P    W   + +G G +G V +A NR T    A+K VD+     ++ +  + +++EI +
Sbjct: 2   VPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDM----KRAVDCPENIKKEICI 57
Query: 396 LSHLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSG 455
              L H N+V++YG     +  Y++LEY   G +   +    G + E   + F   +++G
Sbjct: 58  NKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG-MPEPDAQRFFHQLMAG 116
Query: 456 LAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMA---KHLTGQKADLSMKGSPYWMAPE 512
           + YLH     HRDIK  NLL+D    +K++DFG+A   ++   ++    M G+  ++APE
Sbjct: 117 VVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 176
Query: 513 LMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSE 551
           L+       +    A  VD+WS G  +  M  G+ PW +
Sbjct: 177 LL------KRREFHAEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score =  105 bits (263), Expect = 7e-23,   Method: Compositional matrix adjust.
 Identities = 74/245 (30%), Positives = 122/245 (49%), Gaps = 12/245 (4%)
Query: 348 IGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQY 407
           +G G+FG V +A++ +T    A+K +       K ++   ++E+EI  L  L+HP+I++ 
Sbjct: 17  LGEGSFGKVKLATHYKTQQKVALKFIS--RQLLKKSDMHMRVEREISYLKLLRHPHIIKL 74
Query: 408 YGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHR 467
           Y          + +EY   G +  Y+ E    +TE   R F + I+  + Y H  K +HR
Sbjct: 75  YDVITTPTDIVMVIEYA-GGELFDYIVEK-KRMTEDEGRRFFQQIICAIEYCHRHKIVHR 132
Query: 468 DIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPYWMAPELMMAVMQKGKSSDSA 527
           D+K  NLL+D +  VK+ADFG++  +T      +  GSP + APE++   +  G      
Sbjct: 133 DLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVINGKLYAGPE---- 188
Query: 528 LAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMF-KVMRDTPAIPDSLSPEGKDFLRCCFQR 586
             VD+WS G  +  M  G+ P+ + E    +F KV      +PD LSP  +  +R     
Sbjct: 189 --VDVWSCGIVLYVMLVGRLPFDD-EFIPNLFKKVNSCVYVMPDFLSPGAQSLIRRMIVA 245
Query: 587 NPADR 591
           +P  R
Sbjct: 246 DPMQR 250

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score =  105 bits (262), Expect = 8e-23,   Method: Compositional matrix adjust.
 Identities = 73/249 (29%), Positives = 118/249 (47%), Gaps = 16/249 (6%)
Query: 348 IGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQY 407
           +G G +G VY    ++     A+K +       +    +++  +E  V+  +KHPN+VQ 
Sbjct: 19  LGGGQYGEVYEGVWKKYSLTVAVKTL------KEDTMEVEEFLKEAAVMKEIKHPNLVQL 72
Query: 408 YGSEIVEDKFYIYLEYVHPGSINKYVREHCG--AITESVVRNFTRHILSGLAYLHSKKTI 465
            G    E  FYI +E++  G++  Y+RE C    ++  V+      I S + YL  K  I
Sbjct: 73  LGVCTREPPFYIIIEFMTYGNLLDYLRE-CNRQEVSAVVLLYMATQISSAMEYLEKKNFI 131
Query: 466 HRDIKGANLLVDASGVVKLADFGMAKHLTGQ--KADLSMKGSPYWMAPELMMAVMQKGKS 523
           HRD+   N LV  + +VK+ADFG+++ +TG    A    K    W APE +       KS
Sbjct: 132 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESLAYNKFSIKS 191
Query: 524 SDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDSLSPEGKDFLRCC 583
              A  V +W +    +  Y G  P   YE     +++ R     P+    +  + +R C
Sbjct: 192 DVWAFGVLLWEIATYGMSPYPGIDPSQVYELLEKDYRMER-----PEGCPEKVYELMRAC 246
Query: 584 FQRNPADRP 592
           +Q NP+DRP
Sbjct: 247 WQWNPSDRP 255

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score =  105 bits (262), Expect = 8e-23,   Method: Compositional matrix adjust.
 Identities = 79/268 (29%), Positives = 130/268 (48%), Gaps = 29/268 (10%)
Query: 341 QWQKGKL-IGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHL 399
            W   +L +GRG+FG V+   +++TG  CA+K+V +        E  +   +E+   + L
Sbjct: 74  HWATHQLRLGRGSFGEVHRMEDKQTGFQCAVKKVRL--------EVFRA--EELMACAGL 123
Query: 400 KHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYL 459
             P IV  YG+        I++E +  GS+ + V+E  G + E     +    L GL YL
Sbjct: 124 TSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLVKEQ-GCLPEDRALYYLGQALEGLEYL 182
Query: 460 HSKKTIHRDIKGANLLVDASGV-VKLADFGMAKHLT--GQKADL----SMKGSPYWMAPE 512
           HS++ +H D+K  N+L+ + G    L DFG A  L   G   DL     + G+   MAPE
Sbjct: 183 HSRRILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKDLLTGDYIPGTETHMAPE 242
Query: 513 LMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTP---AIP 569
           +++     G+S D+   VD+WS  C ++ M  G  PW+++       K+  + P    IP
Sbjct: 243 VVL-----GRSCDA--KVDVWSSCCMMLHMLNGCHPWTQFFRGPLCLKIASEPPPVREIP 295
Query: 570 DSLSPEGKDFLRCCFQRNPADRPPASLL 597
            S +P     ++   ++ P  R  A+ L
Sbjct: 296 PSCAPLTAQAIQEGLRKEPIHRVSAAEL 323

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score =  105 bits (262), Expect = 8e-23,   Method: Compositional matrix adjust.
 Identities = 73/265 (27%), Positives = 128/265 (48%), Gaps = 12/265 (4%)
Query: 341 QWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLK 400
            +Q  K +G G+FG V +A +  TG   A+K ++        ++   ++E+EI  L  L+
Sbjct: 5   NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIIN--KKVLAKSDMQGRIEREISYLRLLR 62
Query: 401 HPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLH 460
           HP+I++ Y     +D+  + +EY      +  V+     ++E   R F + I+S + Y H
Sbjct: 63  HPHIIKLYDVIKSKDEIIMVIEYAGNELFDYIVQR--DKMSEQEARRFFQQIISAVEYCH 120
Query: 461 SKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPYWMAPELMMAVMQK 520
             K +HRD+K  NLL+D    VK+ADFG++  +T      +  GSP + APE++   +  
Sbjct: 121 RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYA 180
Query: 521 GKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFK-VMRDTPAIPDSLSPEGKDF 579
           G        VD+WS G  +  M   + P+ + E    +FK +      +P  LSP     
Sbjct: 181 GPE------VDVWSCGVILYVMLCRRLPFDD-ESIPVLFKNISNGVYTLPKFLSPGAAGL 233
Query: 580 LRCCFQRNPADRPPASLLLEHRFLK 604
           ++     NP +R     +++  + K
Sbjct: 234 IKRMLIVNPLNRISIHEIMQDDWFK 258

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score =  105 bits (262), Expect = 9e-23,   Method: Compositional matrix adjust.
 Identities = 73/265 (27%), Positives = 128/265 (48%), Gaps = 12/265 (4%)
Query: 341 QWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLK 400
            +Q  K +G G+FG V +A +  TG   A+K ++        ++   ++E+EI  L  L+
Sbjct: 14  NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIIN--KKVLAKSDMQGRIEREISYLRLLR 71
Query: 401 HPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLH 460
           HP+I++ Y     +D+  + +EY      +  V+     ++E   R F + I+S + Y H
Sbjct: 72  HPHIIKLYDVIKSKDEIIMVIEYAGNELFDYIVQR--DKMSEQEARRFFQQIISAVEYCH 129
Query: 461 SKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPYWMAPELMMAVMQK 520
             K +HRD+K  NLL+D    VK+ADFG++  +T      +  GSP + APE++   +  
Sbjct: 130 RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYA 189
Query: 521 GKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFK-VMRDTPAIPDSLSPEGKDF 579
           G        VD+WS G  +  M   + P+ + E    +FK +      +P  LSP     
Sbjct: 190 GPE------VDVWSCGVILYVMLCRRLPFDD-ESIPVLFKNISNGVYTLPKFLSPGAAGL 242
Query: 580 LRCCFQRNPADRPPASLLLEHRFLK 604
           ++     NP +R     +++  + K
Sbjct: 243 IKRMLIVNPLNRISIHEIMQDDWFK 267

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score =  105 bits (262), Expect = 9e-23,   Method: Compositional matrix adjust.
 Identities = 73/265 (27%), Positives = 128/265 (48%), Gaps = 12/265 (4%)
Query: 341 QWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLK 400
            +Q  K +G G+FG V +A +  TG   A+K ++        ++   ++E+EI  L  L+
Sbjct: 15  NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIIN--KKVLAKSDMQGRIEREISYLRLLR 72
Query: 401 HPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLH 460
           HP+I++ Y     +D+  + +EY      +  V+     ++E   R F + I+S + Y H
Sbjct: 73  HPHIIKLYDVIKSKDEIIMVIEYAGNELFDYIVQR--DKMSEQEARRFFQQIISAVEYCH 130
Query: 461 SKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPYWMAPELMMAVMQK 520
             K +HRD+K  NLL+D    VK+ADFG++  +T      +  GSP + APE++   +  
Sbjct: 131 RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYA 190
Query: 521 GKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFK-VMRDTPAIPDSLSPEGKDF 579
           G        VD+WS G  +  M   + P+ + E    +FK +      +P  LSP     
Sbjct: 191 GPE------VDVWSCGVILYVMLCRRLPFDD-ESIPVLFKNISNGVYTLPKFLSPGAAGL 243
Query: 580 LRCCFQRNPADRPPASLLLEHRFLK 604
           ++     NP +R     +++  + K
Sbjct: 244 IKRMLIVNPLNRISIHEIMQDDWFK 268

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score =  105 bits (262), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 73/265 (27%), Positives = 128/265 (48%), Gaps = 12/265 (4%)
Query: 341 QWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLK 400
            +Q  K +G G+FG V +A +  TG   A+K ++        ++   ++E+EI  L  L+
Sbjct: 9   NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIIN--KKVLAKSDMQGRIEREISYLRLLR 66
Query: 401 HPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLH 460
           HP+I++ Y     +D+  + +EY      +  V+     ++E   R F + I+S + Y H
Sbjct: 67  HPHIIKLYDVIKSKDEIIMVIEYAGNELFDYIVQR--DKMSEQEARRFFQQIISAVEYCH 124
Query: 461 SKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPYWMAPELMMAVMQK 520
             K +HRD+K  NLL+D    VK+ADFG++  +T      +  GSP + APE++   +  
Sbjct: 125 RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYA 184
Query: 521 GKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFK-VMRDTPAIPDSLSPEGKDF 579
           G        VD+WS G  +  M   + P+ + E    +FK +      +P  LSP     
Sbjct: 185 GPE------VDVWSCGVILYVMLCRRLPFDD-ESIPVLFKNISNGVYTLPKFLSPGAAGL 237
Query: 580 LRCCFQRNPADRPPASLLLEHRFLK 604
           ++     NP +R     +++  + K
Sbjct: 238 IKRMLIVNPLNRISIHEIMQDDWFK 262

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score =  105 bits (261), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 61/201 (30%), Positives = 104/201 (51%), Gaps = 12/201 (5%)
Query: 348 IGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQY 407
           +G GT+ +VY   ++ T  L A+KE+ +  ++     +I+    E+ +L  LKH NIV  
Sbjct: 10  LGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIR----EVSLLKDLKHANIVTL 65
Query: 408 YGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHR 467
           +     E    +  EY+    + +Y+ +    I    V+ F   +L GLAY H +K +HR
Sbjct: 66  HDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHR 124
Query: 468 DIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPYWMA-PELMMAVMQKGKSSDS 526
           D+K  NLL++  G +KLADFG+A+  +        +    W   P++++       S+D 
Sbjct: 125 DLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVVTLWYRPPDILLG------STDY 178
Query: 527 ALAVDIWSLGCTIIEMYTGKP 547
           +  +D+W +GC   EM TG+P
Sbjct: 179 STQIDMWGVGCIFYEMATGRP 199

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score =  105 bits (261), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 76/283 (26%), Positives = 140/283 (49%), Gaps = 22/283 (7%)
Query: 346 KLIGRGTFGSVYVA---SNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKH- 401
           K++G G +G V++    S  +TG L AMK +       + A++ +    E +VL H++  
Sbjct: 60  KVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKK-ATIVQKAKTTEHTRTERQVLEHIRQS 118
Query: 402 PNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHS 461
           P +V  + +   E K ++ L+Y++ G +  ++ +     TE  V+ +   I+  L +LH 
Sbjct: 119 PFLVTLHYAFQTETKLHLILDYINGGELFTHLSQR-ERFTEHEVQIYVGEIVLALEHLHK 177
Query: 462 KKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMK--GSPYWMAPELMMAVMQ 519
              I+RDIK  N+L+D++G V L DFG++K     + + +    G+  +MAP+++     
Sbjct: 178 LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIV----- 232
Query: 520 KGKSSDSALAVDIWSLGCTIIEMYTGKPPWS----EYEGAAAMFKVMRDTPAIPDSLSPE 575
           +G  S    AVD WSLG  + E+ TG  P++    +   A    ++++  P  P  +S  
Sbjct: 233 RGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSAL 292
Query: 576 GKDFLRCCFQRNPADR-----PPASLLLEHRFLKNSQQPDVPS 613
            KD ++    ++P  R       A  + EH F +     D+ +
Sbjct: 293 AKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWDDLAA 335

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score =  105 bits (261), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 83/271 (30%), Positives = 139/271 (51%), Gaps = 29/271 (10%)
Query: 348 IGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQ-LEQEIKVLSHLKHPNIVQ 406
           IGRG+F +VY   + ET    A  E+     D K  +S +Q  ++E + L  L+HPNIV+
Sbjct: 34  IGRGSFKTVYKGLDTETTVEVAWCELQ----DRKLTKSERQRFKEEAEXLKGLQHPNIVR 89
Query: 407 YYGS--EIVEDKFYIYL--EYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSK 462
           +Y S    V+ K  I L  E    G++  Y++         V+R++ R IL GL +LH++
Sbjct: 90  FYDSWESTVKGKKCIVLVTELXTSGTLKTYLKRF-KVXKIKVLRSWCRQILKGLQFLHTR 148
Query: 463 K--TIHRDIKGANLLVDA-SGVVKLADFGMAKHLTGQKADL--SMKGSPYWMAPELMMAV 517
               IHRD+K  N+ +   +G VK+ D G+A   T ++A    ++ G+P + APE     
Sbjct: 149 TPPIIHRDLKCDNIFITGPTGSVKIGDLGLA---TLKRASFAKAVIGTPEFXAPEXYEEK 205
Query: 518 MQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRD--TPAIPDSLS-P 574
             +        +VD+++ G   +E  T + P+SE + AA +++ +     PA  D ++ P
Sbjct: 206 YDE--------SVDVYAFGXCXLEXATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIP 257
Query: 575 EGKDFLRCCFQRNPADRPPASLLLEHRFLKN 605
           E K+ +  C ++N  +R     LL H F + 
Sbjct: 258 EVKEIIEGCIRQNKDERYSIKDLLNHAFFQE 288

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score =  105 bits (261), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 77/278 (27%), Positives = 138/278 (49%), Gaps = 26/278 (9%)
Query: 339 NSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSH 398
           + +++  K IG G FG   +  ++++  L A+K ++      K  E++K+     ++++H
Sbjct: 17  SDRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIE---RGEKIDENVKR-----EIINH 68
Query: 399 --LKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGL 456
             L+HPNIV++    +      I +EY   G + + +  + G  +E   R F + ++SG+
Sbjct: 69  RSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERIC-NAGRFSEDEARFFFQQLISGV 127
Query: 457 AYLHSKKTIHRDIKGANLLVDASGV--VKLADFGMAKHLTGQKADLSMKGSPYWMAPELM 514
           +Y H+ +  HRD+K  N L+D S    +K+ DFG +K         S  G+P ++APE++
Sbjct: 128 SYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL 187
Query: 515 MAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEG----AAAMFKVMRDTPAIPD 570
           +     GK +      D+WS G T+  M  G  P+ + E        + +++    AIPD
Sbjct: 188 LKKEYDGKVA------DVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPD 241
Query: 571 --SLSPEGKDFLRCCFQRNPADRPPASLLLEHR-FLKN 605
              +SPE +  +   F  +PA R     +  H  FLKN
Sbjct: 242 YVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKN 279

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score =  104 bits (260), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 77/236 (32%), Positives = 123/236 (52%), Gaps = 26/236 (11%)
Query: 341 QWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLK 400
           ++Q  ++ G+GTFG+V +   + TG   A+K+V     DP+      Q+ Q++ VL    
Sbjct: 24  RFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKV---IQDPRFRNRELQIMQDLAVL---H 77
Query: 401 HPNIVQ---YYGSEIVEDKFYIYL----EYVHPGSINKYVREHCG---AITESVVRNFTR 450
           HPNIVQ   Y+ +    D+  IYL    EYV P ++++  R +     A    +++ F  
Sbjct: 78  HPNIVQLQSYFYTLGERDRRDIYLNVVMEYV-PDTLHRCCRNYYRRQVAPPPILIKVFLF 136
Query: 451 HILSGLAYLH--SKKTIHRDIKGANLLV-DASGVVKLADFGMAKHLTGQKADLSMKGSPY 507
            ++  +  LH  S    HRDIK  N+LV +A G +KL DFG AK L+  + +++   S Y
Sbjct: 137 QLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYICSRY 196
Query: 508 WMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMR 563
           + APEL+        +     AVDIWS+GC   EM  G+P +     A  + +++R
Sbjct: 197 YRAPELIFG------NQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVR 246

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score =  104 bits (260), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 82/298 (27%), Positives = 141/298 (47%), Gaps = 36/298 (12%)
Query: 338 MNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLS 397
           ++  +Q+ K +G G +G V +  ++ T    A+K   I      S  S  +L +E+ VL 
Sbjct: 35  LSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIK---IIRKTSVSTSSNSKLLEEVAVLK 91
Query: 398 HLKHPNIVQYYGSEIVEDK--FYIYLEYVHPGSINKYV--REHCGAITESVVRNFTRHIL 453
            L HPNI++ Y  +  EDK  +Y+ +E    G +   +  R     +  +V+    + +L
Sbjct: 92  LLDHPNIMKLY--DFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVI---IKQVL 146
Query: 454 SGLAYLHSKKTIHRDIKGANLLVDA---SGVVKLADFGMAKHLTGQKADLSMKGSPYWMA 510
           SG+ YLH    +HRD+K  NLL+++     ++K+ DFG++     QK      G+ Y++A
Sbjct: 147 SGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIA 206
Query: 511 PELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMR-----DT 565
           PE++       K  D     D+WS+G  +  +  G PP+        + KV +     D+
Sbjct: 207 PEVLR------KKYDE--KCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDS 258
Query: 566 PAIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQPDVPSCSLSFSGMQL 623
           P   + +S   KD ++   Q +   R  A   LEH ++K         CS   SG++L
Sbjct: 259 PEWKN-VSEGAKDLIKQMLQFDSQRRISAQQALEHPWIK-------EMCSKKESGIEL 308

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score =  104 bits (259), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 78/272 (28%), Positives = 130/272 (47%), Gaps = 39/272 (14%)
Query: 348 IGRGTFGSV----YVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPN 403
           +G+G FGSV    Y      TG + A+K++        + E ++  E+EI++L  L+H N
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-----HSTEEHLRDFEREIEILKSLQHDN 75
Query: 404 IVQYYGSEIVEDK--FYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHS 461
           IV+Y G      +    + +EY+  GS+  Y++ H   I    +  +T  I  G+ YL +
Sbjct: 76  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQAHAERIDHIKLLQYTSQICKGMEYLGT 135
Query: 462 KKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMK---GSP-YWMAPELMMAV 517
           K+ IHRD+   N+LV+    VK+ DFG+ K L   K    +K    SP +W APE +   
Sbjct: 136 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT-- 193
Query: 518 MQKGKSSDSALAVDIWSLGCTIIEMYT----GKPPWSEY--------EGAAAMF---KVM 562
                 S  ++A D+WS G  + E++T     K P +E+        +G   +F   +++
Sbjct: 194 -----ESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELL 248
Query: 563 RDTPAI--PDSLSPEGKDFLRCCFQRNPADRP 592
           ++   +  PD    E    +  C+  N   RP
Sbjct: 249 KNNGRLPRPDGCPDEIYMIMTECWNNNVNQRP 280

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score =  104 bits (259), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 78/272 (28%), Positives = 131/272 (48%), Gaps = 39/272 (14%)
Query: 348 IGRGTFGSV----YVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPN 403
           +G+G FGSV    Y      TG + A+K++        + E ++  E+EI++L  L+H N
Sbjct: 23  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-----HSTEEHLRDFEREIEILKSLQHDN 77
Query: 404 IVQYYGSEIVEDK--FYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHS 461
           IV+Y G      +    + +EY+  GS+  Y+++H   I    +  +T  I  G+ YL +
Sbjct: 78  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT 137
Query: 462 KKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMK---GSP-YWMAPELMMAV 517
           K+ IHRD+   N+LV+    VK+ DFG+ K L   K    +K    SP +W APE +   
Sbjct: 138 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT-- 195
Query: 518 MQKGKSSDSALAVDIWSLGCTIIEMYT----GKPPWSEY--------EGAAAMF---KVM 562
                 S  ++A D+WS G  + E++T     K P +E+        +G   +F   +++
Sbjct: 196 -----ESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELL 250
Query: 563 RDTPAI--PDSLSPEGKDFLRCCFQRNPADRP 592
           ++   +  PD    E    +  C+  N   RP
Sbjct: 251 KNNGRLPRPDGCPDEIYMIMTECWNNNVNQRP 282

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  104 bits (259), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 64/219 (29%), Positives = 110/219 (50%), Gaps = 14/219 (6%)
Query: 336 LPMNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKV 395
           +P    W   + +G G  G V +A NR T    A+K VD+     ++ +  + +++EI +
Sbjct: 2   VPFVEDWDLVQTLGEGAAGEVQLAVNRVTEEAVAVKIVDM----KRAVDCPENIKKEICI 57
Query: 396 LSHLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSG 455
              L H N+V++YG     +  Y++LEY   G +   +    G + E   + F   +++G
Sbjct: 58  NKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG-MPEPDAQRFFHQLMAG 116
Query: 456 LAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMA---KHLTGQKADLSMKGSPYWMAPE 512
           + YLH     HRDIK  NLL+D    +K++DFG+A   ++   ++    M G+  ++APE
Sbjct: 117 VVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 176
Query: 513 LMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSE 551
           L+       +    A  VD+WS G  +  M  G+ PW +
Sbjct: 177 LL------KRREFHAEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score =  104 bits (259), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 78/272 (28%), Positives = 131/272 (48%), Gaps = 39/272 (14%)
Query: 348 IGRGTFGSV----YVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPN 403
           +G+G FGSV    Y      TG + A+K++        + E ++  E+EI++L  L+H N
Sbjct: 25  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-----HSTEEHLRDFEREIEILKSLQHDN 79
Query: 404 IVQYYGSEIVEDK--FYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHS 461
           IV+Y G      +    + +EY+  GS+  Y+++H   I    +  +T  I  G+ YL +
Sbjct: 80  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT 139
Query: 462 KKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMK---GSP-YWMAPELMMAV 517
           K+ IHRD+   N+LV+    VK+ DFG+ K L   K    +K    SP +W APE +   
Sbjct: 140 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT-- 197
Query: 518 MQKGKSSDSALAVDIWSLGCTIIEMYT----GKPPWSEY--------EGAAAMF---KVM 562
                 S  ++A D+WS G  + E++T     K P +E+        +G   +F   +++
Sbjct: 198 -----ESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELL 252
Query: 563 RDTPAI--PDSLSPEGKDFLRCCFQRNPADRP 592
           ++   +  PD    E    +  C+  N   RP
Sbjct: 253 KNNGRLPRPDGCPDEIYMIMTECWNNNVNQRP 284

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score =  104 bits (259), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 86/295 (29%), Positives = 140/295 (47%), Gaps = 19/295 (6%)
Query: 348 IGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQY 407
           IGRG +GSV    ++ +G + A+K +    D+ +  + +  L+    V+     P IVQ+
Sbjct: 30  IGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDV---VMRSSDCPYIVQF 86
Query: 408 YGSEIVEDKFYIYLEYVHPG--SINKYVREHCG-AITESVVRNFTRHILSGLAYLHSK-K 463
           YG+   E   +I +E +        KYV       I E ++   T   +  L +L    K
Sbjct: 87  YGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK 146
Query: 464 TIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPYWMAPELMM-AVMQKGK 522
            IHRDIK +N+L+D SG +KL DFG++  L    A     G   +MAPE +  +  ++G 
Sbjct: 147 IIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSASRQGY 206
Query: 523 SSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFK--VMRDTPAIPDS----LSPEG 576
              S    D+WSLG T+ E+ TG+ P+ ++          V  D P + +S     SP  
Sbjct: 207 DVRS----DVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQLSNSEEREFSPSF 262
Query: 577 KDFLRCCFQRNPADRPPASLLLEHRFLKNSQQPDVP-SCSLSFSGMQLTEKPHSP 630
            +F+  C  ++ + RP    LL+H F+   ++  V  +C +     Q+   P SP
Sbjct: 263 INFVNLCLTKDESKRPKYKELLKHPFILMYEERAVEVACYVCKILDQMPATPSSP 317

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score =  104 bits (259), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 78/272 (28%), Positives = 131/272 (48%), Gaps = 39/272 (14%)
Query: 348 IGRGTFGSV----YVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPN 403
           +G+G FGSV    Y      TG + A+K++        + E ++  E+EI++L  L+H N
Sbjct: 22  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-----HSTEEHLRDFEREIEILKSLQHDN 76
Query: 404 IVQYYGSEIVEDK--FYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHS 461
           IV+Y G      +    + +EY+  GS+  Y+++H   I    +  +T  I  G+ YL +
Sbjct: 77  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT 136
Query: 462 KKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMK---GSP-YWMAPELMMAV 517
           K+ IHRD+   N+LV+    VK+ DFG+ K L   K    +K    SP +W APE +   
Sbjct: 137 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT-- 194
Query: 518 MQKGKSSDSALAVDIWSLGCTIIEMYT----GKPPWSEY--------EGAAAMF---KVM 562
                 S  ++A D+WS G  + E++T     K P +E+        +G   +F   +++
Sbjct: 195 -----ESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELL 249
Query: 563 RDTPAI--PDSLSPEGKDFLRCCFQRNPADRP 592
           ++   +  PD    E    +  C+  N   RP
Sbjct: 250 KNNGRLPRPDGCPDEIYMIMTECWNNNVNQRP 281

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score =  104 bits (259), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 78/272 (28%), Positives = 131/272 (48%), Gaps = 39/272 (14%)
Query: 348 IGRGTFGSV----YVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPN 403
           +G+G FGSV    Y      TG + A+K++        + E ++  E+EI++L  L+H N
Sbjct: 17  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-----HSTEEHLRDFEREIEILKSLQHDN 71
Query: 404 IVQYYGSEIVEDK--FYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHS 461
           IV+Y G      +    + +EY+  GS+  Y+++H   I    +  +T  I  G+ YL +
Sbjct: 72  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT 131
Query: 462 KKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMK---GSP-YWMAPELMMAV 517
           K+ IHRD+   N+LV+    VK+ DFG+ K L   K    +K    SP +W APE +   
Sbjct: 132 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT-- 189
Query: 518 MQKGKSSDSALAVDIWSLGCTIIEMYT----GKPPWSEY--------EGAAAMF---KVM 562
                 S  ++A D+WS G  + E++T     K P +E+        +G   +F   +++
Sbjct: 190 -----ESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELL 244
Query: 563 RDTPAI--PDSLSPEGKDFLRCCFQRNPADRP 592
           ++   +  PD    E    +  C+  N   RP
Sbjct: 245 KNNGRLPRPDGCPDEIYMIMTECWNNNVNQRP 276

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score =  104 bits (259), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 78/272 (28%), Positives = 131/272 (48%), Gaps = 39/272 (14%)
Query: 348 IGRGTFGSV----YVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPN 403
           +G+G FGSV    Y      TG + A+K++        + E ++  E+EI++L  L+H N
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-----HSTEEHLRDFEREIEILKSLQHDN 75
Query: 404 IVQYYGSEIVEDK--FYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHS 461
           IV+Y G      +    + +EY+  GS+  Y+++H   I    +  +T  I  G+ YL +
Sbjct: 76  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT 135
Query: 462 KKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMK---GSP-YWMAPELMMAV 517
           K+ IHRD+   N+LV+    VK+ DFG+ K L   K    +K    SP +W APE +   
Sbjct: 136 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT-- 193
Query: 518 MQKGKSSDSALAVDIWSLGCTIIEMYT----GKPPWSEY--------EGAAAMF---KVM 562
                 S  ++A D+WS G  + E++T     K P +E+        +G   +F   +++
Sbjct: 194 -----ESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELL 248
Query: 563 RDTPAI--PDSLSPEGKDFLRCCFQRNPADRP 592
           ++   +  PD    E    +  C+  N   RP
Sbjct: 249 KNNGRLPRPDGCPDEIYMIMTECWNNNVNQRP 280

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score =  104 bits (259), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 73/249 (29%), Positives = 117/249 (46%), Gaps = 16/249 (6%)
Query: 348 IGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQY 407
           +G G +G VY    ++     A+K +       +    +++  +E  V+  +KHPN+VQ 
Sbjct: 19  LGGGQYGEVYEGVWKKYSLTVAVKTL------KEDTMEVEEFLKEAAVMKEIKHPNLVQL 72
Query: 408 YGSEIVEDKFYIYLEYVHPGSINKYVREHCG--AITESVVRNFTRHILSGLAYLHSKKTI 465
            G    E  FYI  E++  G++  Y+RE C    ++  V+      I S + YL  K  I
Sbjct: 73  LGVCTREPPFYIITEFMTYGNLLDYLRE-CNRQEVSAVVLLYMATQISSAMEYLEKKNFI 131
Query: 466 HRDIKGANLLVDASGVVKLADFGMAKHLTGQ--KADLSMKGSPYWMAPELMMAVMQKGKS 523
           HRD+   N LV  + +VK+ADFG+++ +TG    A    K    W APE +       KS
Sbjct: 132 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTFTAHAGAKFPIKWTAPESLAYNKFSIKS 191
Query: 524 SDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDSLSPEGKDFLRCC 583
              A  V +W +    +  Y G  P   YE     +++ R     P+    +  + +R C
Sbjct: 192 DVWAFGVLLWEIATYGMSPYPGIDPSQVYELLEKDYRMER-----PEGCPEKVYELMRAC 246
Query: 584 FQRNPADRP 592
           +Q NP+DRP
Sbjct: 247 WQWNPSDRP 255

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score =  104 bits (259), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 78/272 (28%), Positives = 131/272 (48%), Gaps = 39/272 (14%)
Query: 348 IGRGTFGSV----YVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPN 403
           +G+G FGSV    Y      TG + A+K++        + E ++  E+EI++L  L+H N
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-----HSTEEHLRDFEREIEILKSLQHDN 72
Query: 404 IVQYYGSEIVEDK--FYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHS 461
           IV+Y G      +    + +EY+  GS+  Y+++H   I    +  +T  I  G+ YL +
Sbjct: 73  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT 132
Query: 462 KKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMK---GSP-YWMAPELMMAV 517
           K+ IHRD+   N+LV+    VK+ DFG+ K L   K    +K    SP +W APE +   
Sbjct: 133 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT-- 190
Query: 518 MQKGKSSDSALAVDIWSLGCTIIEMYT----GKPPWSEY--------EGAAAMF---KVM 562
                 S  ++A D+WS G  + E++T     K P +E+        +G   +F   +++
Sbjct: 191 -----ESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELL 245
Query: 563 RDTPAI--PDSLSPEGKDFLRCCFQRNPADRP 592
           ++   +  PD    E    +  C+  N   RP
Sbjct: 246 KNNGRLPRPDGCPDEIYMIMTECWNNNVNQRP 277

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score =  104 bits (259), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 78/272 (28%), Positives = 131/272 (48%), Gaps = 39/272 (14%)
Query: 348 IGRGTFGSV----YVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPN 403
           +G+G FGSV    Y      TG + A+K++        + E ++  E+EI++L  L+H N
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-----HSTEEHLRDFEREIEILKSLQHDN 72
Query: 404 IVQYYGSEIVEDK--FYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHS 461
           IV+Y G      +    + +EY+  GS+  Y+++H   I    +  +T  I  G+ YL +
Sbjct: 73  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT 132
Query: 462 KKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMK---GSP-YWMAPELMMAV 517
           K+ IHRD+   N+LV+    VK+ DFG+ K L   K    +K    SP +W APE +   
Sbjct: 133 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLT-- 190
Query: 518 MQKGKSSDSALAVDIWSLGCTIIEMYT----GKPPWSEY--------EGAAAMF---KVM 562
                 S  ++A D+WS G  + E++T     K P +E+        +G   +F   +++
Sbjct: 191 -----ESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELL 245
Query: 563 RDTPAI--PDSLSPEGKDFLRCCFQRNPADRP 592
           ++   +  PD    E    +  C+  N   RP
Sbjct: 246 KNNGRLPRPDGCPDEIYMIMTECWNNNVNQRP 277

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score =  104 bits (259), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 78/272 (28%), Positives = 131/272 (48%), Gaps = 39/272 (14%)
Query: 348 IGRGTFGSV----YVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPN 403
           +G+G FGSV    Y      TG + A+K++        + E ++  E+EI++L  L+H N
Sbjct: 24  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-----HSTEEHLRDFEREIEILKSLQHDN 78
Query: 404 IVQYYGSEIVEDK--FYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHS 461
           IV+Y G      +    + +EY+  GS+  Y+++H   I    +  +T  I  G+ YL +
Sbjct: 79  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT 138
Query: 462 KKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMK---GSP-YWMAPELMMAV 517
           K+ IHRD+   N+LV+    VK+ DFG+ K L   K    +K    SP +W APE +   
Sbjct: 139 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT-- 196
Query: 518 MQKGKSSDSALAVDIWSLGCTIIEMYT----GKPPWSEY--------EGAAAMF---KVM 562
                 S  ++A D+WS G  + E++T     K P +E+        +G   +F   +++
Sbjct: 197 -----ESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELL 251
Query: 563 RDTPAI--PDSLSPEGKDFLRCCFQRNPADRP 592
           ++   +  PD    E    +  C+  N   RP
Sbjct: 252 KNNGRLPRPDGCPDEIYMIMTECWNNNVNQRP 283

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score =  104 bits (259), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 78/272 (28%), Positives = 131/272 (48%), Gaps = 39/272 (14%)
Query: 348 IGRGTFGSV----YVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPN 403
           +G+G FGSV    Y      TG + A+K++        + E ++  E+EI++L  L+H N
Sbjct: 49  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-----HSTEEHLRDFEREIEILKSLQHDN 103
Query: 404 IVQYYGSEIVEDK--FYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHS 461
           IV+Y G      +    + +EY+  GS+  Y+++H   I    +  +T  I  G+ YL +
Sbjct: 104 IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT 163
Query: 462 KKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMK---GSP-YWMAPELMMAV 517
           K+ IHRD+   N+LV+    VK+ DFG+ K L   K    +K    SP +W APE +   
Sbjct: 164 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT-- 221
Query: 518 MQKGKSSDSALAVDIWSLGCTIIEMYT----GKPPWSEY--------EGAAAMF---KVM 562
                 S  ++A D+WS G  + E++T     K P +E+        +G   +F   +++
Sbjct: 222 -----ESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELL 276
Query: 563 RDTPAI--PDSLSPEGKDFLRCCFQRNPADRP 592
           ++   +  PD    E    +  C+  N   RP
Sbjct: 277 KNNGRLPRPDGCPDEIYMIMTECWNNNVNQRP 308

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score =  104 bits (259), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 78/272 (28%), Positives = 131/272 (48%), Gaps = 39/272 (14%)
Query: 348 IGRGTFGSV----YVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPN 403
           +G+G FGSV    Y      TG + A+K++        + E ++  E+EI++L  L+H N
Sbjct: 16  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-----HSTEEHLRDFEREIEILKSLQHDN 70
Query: 404 IVQYYGSEIVEDK--FYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHS 461
           IV+Y G      +    + +EY+  GS+  Y+++H   I    +  +T  I  G+ YL +
Sbjct: 71  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT 130
Query: 462 KKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMK---GSP-YWMAPELMMAV 517
           K+ IHRD+   N+LV+    VK+ DFG+ K L   K    +K    SP +W APE +   
Sbjct: 131 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT-- 188
Query: 518 MQKGKSSDSALAVDIWSLGCTIIEMYT----GKPPWSEY--------EGAAAMF---KVM 562
                 S  ++A D+WS G  + E++T     K P +E+        +G   +F   +++
Sbjct: 189 -----ESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELL 243
Query: 563 RDTPAI--PDSLSPEGKDFLRCCFQRNPADRP 592
           ++   +  PD    E    +  C+  N   RP
Sbjct: 244 KNNGRLPRPDGCPDEIYMIMTECWNNNVNQRP 275

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score =  103 bits (258), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 78/272 (28%), Positives = 131/272 (48%), Gaps = 39/272 (14%)
Query: 348 IGRGTFGSV----YVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPN 403
           +G+G FGSV    Y      TG + A+K++        + E ++  E+EI++L  L+H N
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-----HSTEEHLRDFEREIEILKSLQHDN 72
Query: 404 IVQYYGSEIVEDK--FYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHS 461
           IV+Y G      +    + +EY+  GS+  Y+++H   I    +  +T  I  G+ YL +
Sbjct: 73  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT 132
Query: 462 KKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMK---GSP-YWMAPELMMAV 517
           K+ IHRD+   N+LV+    VK+ DFG+ K L   K    +K    SP +W APE +   
Sbjct: 133 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT-- 190
Query: 518 MQKGKSSDSALAVDIWSLGCTIIEMYT----GKPPWSEY--------EGAAAMF---KVM 562
                 S  ++A D+WS G  + E++T     K P +E+        +G   +F   +++
Sbjct: 191 -----ESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELL 245
Query: 563 RDTPAI--PDSLSPEGKDFLRCCFQRNPADRP 592
           ++   +  PD    E    +  C+  N   RP
Sbjct: 246 KNNGRLPRPDGCPDEIYMIMTECWNNNVNQRP 277

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score =  103 bits (258), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 77/268 (28%), Positives = 128/268 (47%), Gaps = 29/268 (10%)
Query: 341 QWQKGKL-IGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHL 399
            W   +L +GRG+FG V+   +++TG  CA+K+V +        E  +   +E+   + L
Sbjct: 93  HWATHQLRLGRGSFGEVHRMEDKQTGFQCAVKKVRL--------EVFRA--EELMACAGL 142
Query: 400 KHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYL 459
             P IV  YG+        I++E +  GS+ + V+E  G + E     +    L GL YL
Sbjct: 143 TSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLVKEQ-GCLPEDRALYYLGQALEGLEYL 201
Query: 460 HSKKTIHRDIKGANLLVDASGV-VKLADFGMAKHLTGQKADLSM------KGSPYWMAPE 512
           HS++ +H D+K  N+L+ + G    L DFG A  L       S+       G+   MAPE
Sbjct: 202 HSRRILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKSLLTGDYIPGTETHMAPE 261
Query: 513 LMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTP---AIP 569
           +++     G+S D+   VD+WS  C ++ M  G  PW+++       K+  + P    IP
Sbjct: 262 VVL-----GRSCDA--KVDVWSSCCMMLHMLNGCHPWTQFFRGPLCLKIASEPPPVREIP 314
Query: 570 DSLSPEGKDFLRCCFQRNPADRPPASLL 597
            S +P     ++   ++ P  R  A+ L
Sbjct: 315 PSCAPLTAQAIQEGLRKEPIHRVSAAEL 342

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score =  103 bits (258), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 78/272 (28%), Positives = 131/272 (48%), Gaps = 39/272 (14%)
Query: 348 IGRGTFGSV----YVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPN 403
           +G+G FGSV    Y      TG + A+K++        + E ++  E+EI++L  L+H N
Sbjct: 36  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-----HSTEEHLRDFEREIEILKSLQHDN 90
Query: 404 IVQYYGSEIVEDK--FYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHS 461
           IV+Y G      +    + +EY+  GS+  Y+++H   I    +  +T  I  G+ YL +
Sbjct: 91  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT 150
Query: 462 KKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMK---GSP-YWMAPELMMAV 517
           K+ IHRD+   N+LV+    VK+ DFG+ K L   K    +K    SP +W APE +   
Sbjct: 151 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT-- 208
Query: 518 MQKGKSSDSALAVDIWSLGCTIIEMYT----GKPPWSEY--------EGAAAMF---KVM 562
                 S  ++A D+WS G  + E++T     K P +E+        +G   +F   +++
Sbjct: 209 -----ESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELL 263
Query: 563 RDTPAI--PDSLSPEGKDFLRCCFQRNPADRP 592
           ++   +  PD    E    +  C+  N   RP
Sbjct: 264 KNNGRLPRPDGCPDEIYMIMTECWNNNVNQRP 295

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score =  103 bits (258), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 80/321 (24%), Positives = 154/321 (47%), Gaps = 61/321 (19%)
Query: 338 MNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLS 397
           ++S +Q   L+G G +G V  A+++ TG + A+K+++ F D P  A  ++ L +EIK+L 
Sbjct: 9   ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPF-DKPLFA--LRTL-REIKILK 64
Query: 398 HLKHPNIVQYYGSEIVE-----DKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHI 452
           H KH NI+  +  +  +     ++ YI  E +    +++ +      +++  ++ F    
Sbjct: 65  HFKHENIITIFNIQRPDSFENFNEVYIIQELMQ-TDLHRVISTQ--MLSDDHIQYFIYQT 121
Query: 453 LSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHL----------TGQKADLSM 502
           L  +  LH    IHRD+K +NLL++++  +K+ DFG+A+ +          TGQ++ ++ 
Sbjct: 122 LRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTE 181
Query: 503 KGSPYWM-APELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKP--PWSEYEGAAAMF 559
             +  W  APE+M+       S+  + A+D+WS GC + E++  +P  P  +Y     + 
Sbjct: 182 XVATRWYRAPEVMLT------SAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLI 235
Query: 560 ----------------------KVMRDTPAIPDS--------LSPEGKDFLRCCFQRNPA 589
                                 + ++  P  P +        ++P+G D L+     +PA
Sbjct: 236 FGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPA 295
Query: 590 DRPPASLLLEHRFLKNSQQPD 610
            R  A   LEH +L+    P+
Sbjct: 296 KRITAKEALEHPYLQTYHDPN 316

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score =  103 bits (257), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 77/272 (28%), Positives = 132/272 (48%), Gaps = 39/272 (14%)
Query: 348 IGRGTFGSV----YVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPN 403
           +G+G FGSV    Y      TG + A+K++        + E ++  E+EI++L  L+H N
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-----HSTEEHLRDFEREIEILKSLQHDN 75
Query: 404 IVQYYGSEIVEDK--FYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHS 461
           IV+Y G      +    + +E++  GS+ +Y+++H   I    +  +T  I  G+ YL +
Sbjct: 76  IVKYKGVCYSAGRRNLKLIMEFLPYGSLREYLQKHKERIDHIKLLQYTSQICKGMEYLGT 135
Query: 462 KKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMK---GSP-YWMAPELMMAV 517
           K+ IHRD+   N+LV+    VK+ DFG+ K L   K    +K    SP +W APE +   
Sbjct: 136 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT-- 193
Query: 518 MQKGKSSDSALAVDIWSLGCTIIEMYT----GKPPWSEY--------EGAAAMF---KVM 562
                 S  ++A D+WS G  + E++T     K P +E+        +G   +F   +++
Sbjct: 194 -----ESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELL 248
Query: 563 RDTPAI--PDSLSPEGKDFLRCCFQRNPADRP 592
           ++   +  PD    E    +  C+  N   RP
Sbjct: 249 KNNGRLPRPDGCPDEIYMIMTECWNNNVNQRP 280

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  103 bits (257), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 78/266 (29%), Positives = 128/266 (48%), Gaps = 33/266 (12%)
Query: 348 IGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQY 407
           IG G+FG+V+ A     G+  A+K   I  +    AE + +  +E+ ++  L+HPNIV +
Sbjct: 45  IGAGSFGTVHRAEWH--GSDVAVK---ILMEQDFHAERVNEFLREVAIMKRLRHPNIVLF 99
Query: 408 YGSEIVEDKFYIYLEYVHPGSINKYVREHCGA---ITESVVRNFTRHILSGLAYLHSKK- 463
            G+        I  EY+  GS+ + + +  GA   + E    +    +  G+ YLH++  
Sbjct: 100 MGAVTQPPNLSIVTEYLSRGSLYRLLHK-SGAREQLDERRRLSMAYDVAKGMNYLHNRNP 158
Query: 464 -TIHRDIKGANLLVDASGVVKLADFGMAK-----HLTGQKADLSMKGSPYWMAPELMMAV 517
             +HRD+K  NLLVD    VK+ DFG+++      L  + A     G+P WMAPE++   
Sbjct: 159 PIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKASXFLXSKXA----AGTPEWMAPEVLRDE 214
Query: 518 MQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYE----GAAAMFKVMRDTPAIPDSLS 573
               KS       D++S G  + E+ T + PW         AA  FK  R    IP +L+
Sbjct: 215 PSNEKS-------DVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKR--LEIPRNLN 265
Query: 574 PEGKDFLRCCFQRNPADRPPASLLLE 599
           P+    +  C+   P  RP  + +++
Sbjct: 266 PQVAAIIEGCWTNEPWKRPSFATIMD 291

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score =  103 bits (257), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 80/321 (24%), Positives = 154/321 (47%), Gaps = 61/321 (19%)
Query: 338 MNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLS 397
           ++S +Q   L+G G +G V  A+++ TG + A+K+++ F D P  A  ++ L +EIK+L 
Sbjct: 9   ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPF-DKPLFA--LRTL-REIKILK 64
Query: 398 HLKHPNIVQYYGSEIVE-----DKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHI 452
           H KH NI+  +  +  +     ++ YI  E +    +++ +      +++  ++ F    
Sbjct: 65  HFKHENIITIFNIQRPDSFENFNEVYIIQELMQ-TDLHRVISTQ--MLSDDHIQYFIYQT 121
Query: 453 LSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHL----------TGQKADLSM 502
           L  +  LH    IHRD+K +NLL++++  +K+ DFG+A+ +          TGQ++ ++ 
Sbjct: 122 LRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTE 181
Query: 503 KGSPYWM-APELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKP--PWSEYEGAAAMF 559
             +  W  APE+M+       S+  + A+D+WS GC + E++  +P  P  +Y     + 
Sbjct: 182 YVATRWYRAPEVMLT------SAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLI 235
Query: 560 ----------------------KVMRDTPAIPDS--------LSPEGKDFLRCCFQRNPA 589
                                 + ++  P  P +        ++P+G D L+     +PA
Sbjct: 236 FGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPA 295
Query: 590 DRPPASLLLEHRFLKNSQQPD 610
            R  A   LEH +L+    P+
Sbjct: 296 KRITAKEALEHPYLQTYHDPN 316

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score =  103 bits (257), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 78/272 (28%), Positives = 131/272 (48%), Gaps = 39/272 (14%)
Query: 348 IGRGTFGSV----YVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPN 403
           +G+G FGSV    Y      TG + A+K++        + E ++  E+EI++L  L+H N
Sbjct: 36  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-----HSTEEHLRDFEREIEILKSLQHDN 90
Query: 404 IVQYYGSEIVEDK--FYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHS 461
           IV+Y G      +    + +EY+  GS+  Y+++H   I    +  +T  I  G+ YL +
Sbjct: 91  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT 150
Query: 462 KKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMK---GSP-YWMAPELMMAV 517
           K+ IHRD+   N+LV+    VK+ DFG+ K L   K    +K    SP +W APE +   
Sbjct: 151 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESL--- 207
Query: 518 MQKGKSSDSALAVDIWSLGCTIIEMYT----GKPPWSEY--------EGAAAMF---KVM 562
                 S  ++A D+WS G  + E++T     K P +E+        +G   +F   +++
Sbjct: 208 ----TESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELL 263
Query: 563 RDTPAI--PDSLSPEGKDFLRCCFQRNPADRP 592
           ++   +  PD    E    +  C+  N   RP
Sbjct: 264 KNNGRLPRPDGCPDEIYMIMTECWNNNVNQRP 295

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score =  103 bits (257), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 81/289 (28%), Positives = 137/289 (47%), Gaps = 25/289 (8%)
Query: 329 VAAKPEPLPM---NSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAES 385
           V   P  +P+   + ++   K IG G FG   +  ++ T  L A+K ++      + A  
Sbjct: 6   VTTGPLDMPIMHDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIE------RGAAI 59
Query: 386 IKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVV 445
            + +++EI     L+HPNIV++    +      I +EY   G + + +  + G  +E   
Sbjct: 60  DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERIC-NAGRFSEDEA 118
Query: 446 RNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGV--VKLADFGMAKHLTGQKADLSMK 503
           R F + +LSG++Y HS +  HRD+K  N L+D S    +K+ DFG +K         S  
Sbjct: 119 RFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV 178
Query: 504 GSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEG----AAAMF 559
           G+P ++APE+++     GK +      D+WS G T+  M  G  P+ + E        + 
Sbjct: 179 GTPAYIAPEVLLRQEYDGKIA------DVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQ 232
Query: 560 KVMRDTPAIPDS--LSPEGKDFLRCCFQRNPADRPPASLLLEHR-FLKN 605
           +++    +IPD   +SPE    +   F  +PA R     +  H  FLKN
Sbjct: 233 RILSVKYSIPDDIRISPECCHLISRIFVADPATRISIPEIKTHSWFLKN 281

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  103 bits (256), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 76/262 (29%), Positives = 128/262 (48%), Gaps = 25/262 (9%)
Query: 348 IGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQY 407
           IG G+FG+V+ A     G+  A+K   I  +    AE + +  +E+ ++  L+HPNIV +
Sbjct: 45  IGAGSFGTVHRAEWH--GSDVAVK---ILMEQDFHAERVNEFLREVAIMKRLRHPNIVLF 99
Query: 408 YGSEIVEDKFYIYLEYVHPGSINKYVREHCGA---ITESVVRNFTRHILSGLAYLHSKK- 463
            G+        I  EY+  GS+ + + +  GA   + E    +    +  G+ YLH++  
Sbjct: 100 MGAVTQPPNLSIVTEYLSRGSLYRLLHK-SGAREQLDERRRLSMAYDVAKGMNYLHNRNP 158
Query: 464 -TIHRDIKGANLLVDASGVVKLADFGMAK-HLTGQKADLSMKGSPYWMAPELMMAVMQKG 521
             +HR++K  NLLVD    VK+ DFG+++   +   +  S  G+P WMAPE++       
Sbjct: 159 PIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNE 218
Query: 522 KSSDSALAVDIWSLGCTIIEMYTGKPPWSEYE----GAAAMFKVMRDTPAIPDSLSPEGK 577
           KS       D++S G  + E+ T + PW         AA  FK  R    IP +L+P+  
Sbjct: 219 KS-------DVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKR--LEIPRNLNPQVA 269
Query: 578 DFLRCCFQRNPADRPPASLLLE 599
             +  C+   P  RP  + +++
Sbjct: 270 AIIEGCWTNEPWKRPSFATIMD 291

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score =  103 bits (256), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 70/233 (30%), Positives = 125/233 (53%), Gaps = 29/233 (12%)
Query: 342 WQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKH 401
           +   K+IG G+FG V+ A   E+  + A+K+V          +  +   +E++++  +KH
Sbjct: 42  YTNCKVIGNGSFGVVFQAKLVESDEV-AIKKV---------LQDKRFKNRELQIMRIVKH 91
Query: 402 PNIVQ----YYGSEIVEDKFYI--YLEYVHPGSINKYVREHCGAITES----VVRNFTRH 451
           PN+V     +Y +   +D+ ++   LEYV P ++ +  R H   + ++    +++ +   
Sbjct: 92  PNVVDLKAFFYSNGDKKDEVFLNLVLEYV-PETVYRASR-HYAKLKQTMPMLLIKLYMYQ 149
Query: 452 ILSGLAYLHSKKTIHRDIKGANLLVDA-SGVVKLADFGMAKHLTGQKADLSMKGSPYWMA 510
           +L  LAY+HS    HRDIK  NLL+D  SGV+KL DFG AK L   + ++S   S Y+ A
Sbjct: 150 LLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSXICSRYYRA 209
Query: 511 PELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMR 563
           PEL+        +++    +DIWS GC + E+  G+P +    G   + ++++
Sbjct: 210 PELIFG------ATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIK 256

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score =  102 bits (255), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 73/259 (28%), Positives = 123/259 (47%), Gaps = 22/259 (8%)
Query: 340 SQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIK----- 394
           S +   K+IG+G+FG V +A ++      A+K +       K A   K+ E+ I      
Sbjct: 38  SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQ------KKAILKKKEEKHIMSERNV 91
Query: 395 VLSHLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYV-REHCGAITESVVRNFTRHIL 453
           +L ++KHP +V  + S    DK Y  L+Y++ G +  ++ RE C    E   R +   I 
Sbjct: 92  LLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERC--FLEPRARFYAAEIA 149
Query: 454 SGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAK-HLTGQKADLSMKGSPYWMAPE 512
           S L YLHS   ++RD+K  N+L+D+ G + L DFG+ K ++       +  G+P ++APE
Sbjct: 150 SALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTFCGTPEYLAPE 209
Query: 513 LMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDSL 572
               V+ K     +   VD W LG  + EM  G PP+     A     ++     +  ++
Sbjct: 210 ----VLHKQPYDRT---VDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNI 262
Query: 573 SPEGKDFLRCCFQRNPADR 591
           +   +  L    Q++   R
Sbjct: 263 TNSARHLLEGLLQKDRTKR 281

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score =  102 bits (255), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 65/214 (30%), Positives = 116/214 (54%), Gaps = 24/214 (11%)
Query: 341 QWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESI---KQLEQEIKVLS 397
           ++Q    +G G +GSV  A + +TG   A+K++       +  +SI   K+  +E+++L 
Sbjct: 19  RYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKL------SRPFQSIIHAKRTYRELRLLK 72
Query: 398 HLKHPNIV----QYYGSEIVEDKFYIYL-EYVHPGSINKYVREHCGAITESVVRNFTRHI 452
           H+KH N++     +  +  +E+   +YL  ++    +N  V+  C  +T+  V+     I
Sbjct: 73  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQI 130
Query: 453 LSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPYWMAPE 512
           L GL Y+HS   IHRD+K +NL V+    +K+ DFG+A+H   + A      + ++ APE
Sbjct: 131 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMA--GFVATRWYRAPE 188
Query: 513 LMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGK 546
           +M+  M   ++      VDIWS+GC + E+ TG+
Sbjct: 189 IMLNWMHYNQT------VDIWSVGCIMAELLTGR 216

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score =  102 bits (254), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 79/287 (27%), Positives = 140/287 (48%), Gaps = 29/287 (10%)
Query: 333 PEPLPM---NSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQL 389
           P  LP+   + +++  K IG G FG   +  ++++  L A+K ++      K  E++K+ 
Sbjct: 9   PMDLPIMHDSDRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIE---RGEKIDENVKR- 64
Query: 390 EQEIKVLSH--LKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRN 447
               ++++H  L+HPNIV++    +      I +EY   G + + +  + G  +E   R 
Sbjct: 65  ----EIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERIC-NAGRFSEDEARF 119
Query: 448 FTRHILSGLAYLHSKKTIHRDIKGANLLVDASGV--VKLADFGMAKHLTGQKADLSMKGS 505
           F + ++SG++Y H+ +  HRD+K  N L+D S    +K+  FG +K         S  G+
Sbjct: 120 FFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQPKSTVGT 179
Query: 506 PYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEG----AAAMFKV 561
           P ++APE+++     GK        D+WS G T+  M  G  P+ + E        + ++
Sbjct: 180 PAYIAPEVLLKKEYDGK------VADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRI 233
Query: 562 MRDTPAIPD--SLSPEGKDFLRCCFQRNPADRPPASLLLEHR-FLKN 605
           +    AIPD   +SPE +  +   F  +PA R     +  H  FLKN
Sbjct: 234 LNVQYAIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKN 280

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score =  102 bits (254), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 79/321 (24%), Positives = 154/321 (47%), Gaps = 61/321 (19%)
Query: 338 MNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLS 397
           ++S +Q   L+G G +G V  A+++ TG + A+K+++ F D P  A  ++ L +EIK+L 
Sbjct: 9   ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPF-DKPLFA--LRTL-REIKILK 64
Query: 398 HLKHPNIVQYYGSEIVE-----DKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHI 452
           H KH NI+  +  +  +     ++ YI  E +    +++ +      +++  ++ F    
Sbjct: 65  HFKHENIITIFNIQRPDSFENFNEVYIIQELMQ-TDLHRVISTQ--MLSDDHIQYFIYQT 121
Query: 453 LSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHL----------TGQKADL-S 501
           L  +  LH    IHRD+K +NLL++++  +K+ DFG+A+ +          TGQ++ +  
Sbjct: 122 LRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVE 181
Query: 502 MKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKP--PWSEYEGAAAMF 559
              + ++ APE+M+       S+  + A+D+WS GC + E++  +P  P  +Y     + 
Sbjct: 182 FVATRWYRAPEVMLT------SAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLI 235
Query: 560 ----------------------KVMRDTPAIPDS--------LSPEGKDFLRCCFQRNPA 589
                                 + ++  P  P +        ++P+G D L+     +PA
Sbjct: 236 FGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPA 295
Query: 590 DRPPASLLLEHRFLKNSQQPD 610
            R  A   LEH +L+    P+
Sbjct: 296 KRITAKEALEHPYLQTYHDPN 316

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score =  102 bits (254), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 110/204 (53%), Gaps = 11/204 (5%)
Query: 348 IGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAE--SIKQLEQEIKVLSHLKHPNIV 405
           IG+G+FG V +    +T  + AMK    + +  K  E   ++ + +E++++  L+HP +V
Sbjct: 23  IGKGSFGKVCIVQKNDTKKMYAMK----YMNKQKCVERNEVRNVFKELQIMQGLEHPFLV 78
Query: 406 QYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTI 465
             + S   E+  ++ ++ +  G +  +++++     E  V+ F   ++  L YL +++ I
Sbjct: 79  NLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNV-HFKEETVKLFICELVMALDYLQNQRII 137
Query: 466 HRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPYWMAPELMMAVMQKGKSSD 525
           HRD+K  N+L+D  G V + DF +A  L  +    +M G+  +MAPE+  +     K + 
Sbjct: 138 HRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTMAGTKPYMAPEMFSS----RKGAG 193
Query: 526 SALAVDIWSLGCTIIEMYTGKPPW 549
            + AVD WSLG T  E+  G+ P+
Sbjct: 194 YSFAVDWWSLGVTAYELLRGRRPY 217

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score =  102 bits (254), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 64/207 (30%), Positives = 113/207 (54%), Gaps = 24/207 (11%)
Query: 348 IGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESI---KQLEQEIKVLSHLKHPNI 404
           +G G +GSV  A + +TG   A+K++       +  +SI   K+  +E+++L H+KH N+
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKL------SRPFQSIIHAKRTYRELRLLKHMKHENV 83
Query: 405 V----QYYGSEIVEDKFYIYL-EYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYL 459
           +     +  +  +E+   +YL  ++    +N  V+  C  +T+  V+     IL GL Y+
Sbjct: 84  IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILRGLKYI 141
Query: 460 HSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPYWMAPELMMAVMQ 519
           HS   IHRD+K +NL V+    +K+ DFG+A+H   + A      + ++ APE+M+  M 
Sbjct: 142 HSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMA--GFVATRWYRAPEIMLNWMH 199
Query: 520 KGKSSDSALAVDIWSLGCTIIEMYTGK 546
             ++      VDIWS+GC + E+ TG+
Sbjct: 200 YNQT------VDIWSVGCIMAELLTGR 220

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score =  102 bits (254), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 64/207 (30%), Positives = 113/207 (54%), Gaps = 24/207 (11%)
Query: 348 IGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESI---KQLEQEIKVLSHLKHPNI 404
           +G G +GSV  A + +TG   A+K++       +  +SI   K+  +E+++L H+KH N+
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKL------SRPFQSIIHAKRTYRELRLLKHMKHENV 83
Query: 405 V----QYYGSEIVEDKFYIYL-EYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYL 459
           +     +  +  +E+   +YL  ++    +N  V+  C  +T+  V+     IL GL Y+
Sbjct: 84  IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILRGLKYI 141
Query: 460 HSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPYWMAPELMMAVMQ 519
           HS   IHRD+K +NL V+    +K+ DFG+A+H   + A      + ++ APE+M+  M 
Sbjct: 142 HSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMA--GFVATRWYRAPEIMLNWMH 199
Query: 520 KGKSSDSALAVDIWSLGCTIIEMYTGK 546
             ++      VDIWS+GC + E+ TG+
Sbjct: 200 YNQT------VDIWSVGCIMAELLTGR 220

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score =  102 bits (254), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 77/284 (27%), Positives = 135/284 (47%), Gaps = 44/284 (15%)
Query: 348 IGRGTFGSVYVASNRETGALC-----AMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHP 402
           +G G FG V++A   E   LC      +  V    D   +A   K   +E ++L++L+H 
Sbjct: 21  LGEGAFGKVFLA---ECYNLCPEQDKILVAVKTLKDASDNAR--KDFHREAELLTNLQHE 75
Query: 403 NIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHC------------GAITESVVRNFTR 450
           +IV++YG  +  D   +  EY+  G +NK++R H               +T+S + +  +
Sbjct: 76  HIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQ 135
Query: 451 HILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHL-------TGQKADLSMK 503
            I +G+ YL S+  +HRD+   N LV  + +VK+ DFGM++ +        G    L ++
Sbjct: 136 QIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIR 195
Query: 504 GSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFKVM 562
               WM PE   ++M +  +++S    D+WSLG  + E++T GK PW +      +  + 
Sbjct: 196 ----WMPPE---SIMYRKFTTES----DVWSLGVVLWEIFTYGKQPWYQLSNNEVIECIT 244
Query: 563 RD-TPAIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKN 605
           +      P +   E  + +  C+QR P  R     +  H  L+N
Sbjct: 245 QGRVLQRPRTCPQEVYELMLGCWQREPHMRKNIKGI--HTLLQN 286

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score =  102 bits (254), Expect = 8e-22,   Method: Compositional matrix adjust.
 Identities = 76/277 (27%), Positives = 126/277 (45%), Gaps = 27/277 (9%)
Query: 338 MNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKS-AESIKQLEQEIKVL 396
           +N  +     IGRG++G V +A  + T    A K++      PK   E + + +QEI+++
Sbjct: 24  INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKI------PKYFVEDVDRFKQEIEIM 77
Query: 397 SHLKHPNIVQYYGSEIVEDK--FYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILS 454
             L HPNI++ Y  E  ED    Y+ +E    G + + V  H     ES      + +LS
Sbjct: 78  KSLDHPNIIRLY--ETFEDNTDIYLVMELCTGGELFERVV-HKRVFRESDAARIMKDVLS 134
Query: 455 GLAYLHSKKTIHRDIKGANLLV---DASGVVKLADFGMAKHLTGQKADLSMKGSPYWMAP 511
            +AY H     HRD+K  N L         +KL DFG+A      K   +  G+PY+++P
Sbjct: 135 AVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSP 194
Query: 512 ELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPD- 570
           +++  +   G   D       WS G  +  +  G PP+S       M K+   T   P+ 
Sbjct: 195 QVLEGLY--GPECDE------WSAGVMMYVLLCGYPPFSAPTDXEVMLKIREGTFTFPEK 246
Query: 571 ---SLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLK 604
              ++SP+ +  +R    ++P  R  +   LEH + +
Sbjct: 247 DWLNVSPQAESLIRRLLTKSPKQRITSLQALEHEWFE 283

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score =  102 bits (254), Expect = 8e-22,   Method: Compositional matrix adjust.
 Identities = 72/249 (28%), Positives = 116/249 (46%), Gaps = 16/249 (6%)
Query: 348 IGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQY 407
           +G G +G VY    ++     A+K +       +    +++  +E  V+  +KHPN+VQ 
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLK------EDTMEVEEFLKEAAVMKEIKHPNLVQL 79
Query: 408 YGSEIVEDKFYIYLEYVHPGSINKYVREHCG--AITESVVRNFTRHILSGLAYLHSKKTI 465
            G    E  FYI +E++  G++  Y+RE C    +   V+      I S + YL  K  I
Sbjct: 80  LGVCTREPPFYIIIEFMTYGNLLDYLRE-CNRQEVNAVVLLYMATQISSAMEYLEKKNFI 138
Query: 466 HRDIKGANLLVDASGVVKLADFGMAKHLTGQ--KADLSMKGSPYWMAPELMMAVMQKGKS 523
           HRD+   N LV  + +VK+ADFG+++ +TG    A    K    W APE +       KS
Sbjct: 139 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKS 198
Query: 524 SDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDSLSPEGKDFLRCC 583
              A  V +W +    +  Y G      YE     +++ R     P+    +  + +R C
Sbjct: 199 DVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMER-----PEGCPEKVYELMRAC 253
Query: 584 FQRNPADRP 592
           +Q NP+DRP
Sbjct: 254 WQWNPSDRP 262

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score =  102 bits (253), Expect = 9e-22,   Method: Compositional matrix adjust.
 Identities = 76/277 (27%), Positives = 126/277 (45%), Gaps = 27/277 (9%)
Query: 338 MNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKS-AESIKQLEQEIKVL 396
           +N  +     IGRG++G V +A  + T    A K++      PK   E + + +QEI+++
Sbjct: 7   INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKI------PKYFVEDVDRFKQEIEIM 60
Query: 397 SHLKHPNIVQYYGSEIVEDK--FYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILS 454
             L HPNI++ Y  E  ED    Y+ +E    G + + V  H     ES      + +LS
Sbjct: 61  KSLDHPNIIRLY--ETFEDNTDIYLVMELCTGGELFERVV-HKRVFRESDAARIMKDVLS 117
Query: 455 GLAYLHSKKTIHRDIKGANLLV---DASGVVKLADFGMAKHLTGQKADLSMKGSPYWMAP 511
            +AY H     HRD+K  N L         +KL DFG+A      K   +  G+PY+++P
Sbjct: 118 AVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSP 177
Query: 512 ELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPD- 570
           +++  +   G   D       WS G  +  +  G PP+S       M K+   T   P+ 
Sbjct: 178 QVLEGLY--GPECDE------WSAGVMMYVLLCGYPPFSAPTDXEVMLKIREGTFTFPEK 229
Query: 571 ---SLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLK 604
              ++SP+ +  +R    ++P  R  +   LEH + +
Sbjct: 230 DWLNVSPQAESLIRRLLTKSPKQRITSLQALEHEWFE 266

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score =  102 bits (253), Expect = 9e-22,   Method: Compositional matrix adjust.
 Identities = 89/325 (27%), Positives = 162/325 (49%), Gaps = 47/325 (14%)
Query: 341 QWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESI---KQLEQEIKVLS 397
           ++Q    +G G +GSV  + + ++G   A+K++       +  +SI   K+  +E+++L 
Sbjct: 52  RYQTLSPVGSGAYGSVCSSYDVKSGLKIAVKKLS------RPFQSIIHAKRTYRELRLLK 105
Query: 398 HLKHPNIVQ----YYGSEIVEDKFYIYL-EYVHPGSINKYVREHCGAITESVVRNFTRHI 452
           H+KH N++     +  +  +E+   +YL  ++    +N  V+  C  +T+  V+     I
Sbjct: 106 HMKHENVIGLLDVFTPATSLEEFNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQI 163
Query: 453 LSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKG---SPYWM 509
           L GL Y+HS   IHRD+K +NL V+    +K+ DFG+A+H      D  M G   + ++ 
Sbjct: 164 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARH-----TDDEMTGYVATRWYR 218
Query: 510 APELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIP 569
           APE+M+  M         + VDIWS+GC + E+ TG+  +   +    + ++MR T   P
Sbjct: 219 APEIMLNWMHYN------MTVDIWSVGCIMAELLTGRTLFPGTDHINQLQQIMRLTGTPP 272
Query: 570 DSL-----SPEGKDFLRCCFQ---RNPAD-----RPPASLLLEHRFLKNSQQPDVPSCSL 616
            S+     S E ++++    Q   RN AD      P A  LLE   + ++ +    S +L
Sbjct: 273 ASVISRMPSHEARNYINSLPQMPKRNFADVFIGANPLAVDLLEKMLVLDTDKRITASEAL 332
Query: 617 SFSGMQLTEKPHSPREKADAK-YDQ 640
           +        + H P ++ +++ YDQ
Sbjct: 333 AHPYFS---QYHDPDDEPESEPYDQ 354

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score =  102 bits (253), Expect = 9e-22,   Method: Compositional matrix adjust.
 Identities = 67/210 (31%), Positives = 114/210 (54%), Gaps = 30/210 (14%)
Query: 348 IGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESI---KQLEQEIKVLSHLKHPNI 404
           IG G +GSV  A + +TG   A+K++       +  +SI   K+  +E+++L H+KH N+
Sbjct: 35  IGSGAYGSVCAAFDTKTGLRVAVKKL------SRPFQSIIHAKRTYRELRLLKHMKHENV 88
Query: 405 V----QYYGSEIVEDKFYIYL-EYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYL 459
           +     +  +  +E+   +YL  ++    +N  V+  C  +T+  V+     IL GL Y+
Sbjct: 89  IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILRGLKYI 146
Query: 460 HSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKG---SPYWMAPELMMA 516
           HS   IHRD+K +NL V+    +K+ DFG+A+H      D  M G   + ++ APE+M+ 
Sbjct: 147 HSADIIHRDLKPSNLAVNEDXELKILDFGLARH-----TDDEMTGYVATRWYRAPEIMLN 201
Query: 517 VMQKGKSSDSALAVDIWSLGCTIIEMYTGK 546
            M   ++      VDIWS+GC + E+ TG+
Sbjct: 202 WMHYNQT------VDIWSVGCIMAELLTGR 225

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score =  102 bits (253), Expect = 9e-22,   Method: Compositional matrix adjust.
 Identities = 72/249 (28%), Positives = 116/249 (46%), Gaps = 16/249 (6%)
Query: 348 IGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQY 407
           +G G +G VY    ++     A+K +       +    +++  +E  V+  +KHPN+VQ 
Sbjct: 22  LGGGQYGEVYEGVWKKYSLTVAVKTLK------EDTMEVEEFLKEAAVMKEIKHPNLVQL 75
Query: 408 YGSEIVEDKFYIYLEYVHPGSINKYVREHCG--AITESVVRNFTRHILSGLAYLHSKKTI 465
            G    E  FYI +E++  G++  Y+RE C    +   V+      I S + YL  K  I
Sbjct: 76  LGVCTREPPFYIIIEFMTYGNLLDYLRE-CNRQEVNAVVLLYMATQISSAMEYLEKKNFI 134
Query: 466 HRDIKGANLLVDASGVVKLADFGMAKHLTGQ--KADLSMKGSPYWMAPELMMAVMQKGKS 523
           HRD+   N LV  + +VK+ADFG+++ +TG    A    K    W APE +       KS
Sbjct: 135 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESLAYNKFSIKS 194
Query: 524 SDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDSLSPEGKDFLRCC 583
              A  V +W +    +  Y G      YE     +++ R     P+    +  + +R C
Sbjct: 195 DVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMER-----PEGCPEKVYELMRAC 249
Query: 584 FQRNPADRP 592
           +Q NP+DRP
Sbjct: 250 WQWNPSDRP 258

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score =  102 bits (253), Expect = 9e-22,   Method: Compositional matrix adjust.
 Identities = 67/210 (31%), Positives = 114/210 (54%), Gaps = 30/210 (14%)
Query: 348 IGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESI---KQLEQEIKVLSHLKHPNI 404
           +G G +GSV  A + +TG   A+K++       K  +SI   K+  +E+++L H+KH N+
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKL------SKPFQSIIHAKRTYRELRLLKHMKHENV 95
Query: 405 VQ----YYGSEIVEDKFYIYL-EYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYL 459
           +     +  +  +E+   +YL  ++    +N  V+  C  +T+  V+     IL GL Y+
Sbjct: 96  IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILRGLKYI 153
Query: 460 HSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKG---SPYWMAPELMMA 516
           HS   IHRD+K +NL V+    +K+ DFG+A+H      D  M G   + ++ APE+M+ 
Sbjct: 154 HSADIIHRDLKPSNLAVNEDCELKILDFGLARH-----TDDEMTGYVATRWYRAPEIMLN 208
Query: 517 VMQKGKSSDSALAVDIWSLGCTIIEMYTGK 546
            M   ++      VDIWS+GC + E+ TG+
Sbjct: 209 WMHYNQT------VDIWSVGCIMAELLTGR 232

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score =  102 bits (253), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 67/217 (30%), Positives = 117/217 (53%), Gaps = 30/217 (13%)
Query: 341 QWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESI---KQLEQEIKVLS 397
           ++Q    +G G +GSV  A + +TG   A+K++       +  +SI   K+  +E+++L 
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL------SRPFQSIIHAKRTYRELRLLK 76
Query: 398 HLKHPNIV----QYYGSEIVEDKFYIYL-EYVHPGSINKYVREHCGAITESVVRNFTRHI 452
           H+KH N++     +  +  +E+   +YL  ++    +N  V+  C  +T+  V+     I
Sbjct: 77  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQI 134
Query: 453 LSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKG---SPYWM 509
           L GL Y+HS   IHRD+K +NL V+    +K+ DFG+A+H      D  M G   + ++ 
Sbjct: 135 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARH-----TDDEMTGYVATRWYR 189
Query: 510 APELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGK 546
           APE+M+  M   ++      VDIWS+GC + E+ TG+
Sbjct: 190 APEIMLNAMHYNQT------VDIWSVGCIMAELLTGR 220

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score =  102 bits (253), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 72/249 (28%), Positives = 117/249 (46%), Gaps = 16/249 (6%)
Query: 348 IGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQY 407
           +G G +G VY    ++     A+K +       +    +++  +E  V+  +KHPN+VQ 
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTL------KEDTMEVEEFLKEAAVMKEIKHPNLVQL 74
Query: 408 YGSEIVEDKFYIYLEYVHPGSINKYVREHCG--AITESVVRNFTRHILSGLAYLHSKKTI 465
            G    E  FYI +E++  G++  Y+RE C    ++  V+      I S + YL  K  I
Sbjct: 75  LGVCTREPPFYIIIEFMTYGNLLDYLRE-CNRQEVSAVVLLYMATQISSAMEYLEKKNFI 133
Query: 466 HRDIKGANLLVDASGVVKLADFGMAKHLTGQ--KADLSMKGSPYWMAPELMMAVMQKGKS 523
           HRD+   N LV  + +VK+ADFG+++ +TG    A    K    W APE +       KS
Sbjct: 134 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKS 193
Query: 524 SDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDSLSPEGKDFLRCC 583
              A  V +W +    +  Y G      YE     +++ R     P+    +  + +R C
Sbjct: 194 DVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMER-----PEGCPEKVYELMRAC 248
Query: 584 FQRNPADRP 592
           +Q NP+DRP
Sbjct: 249 WQWNPSDRP 257

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score =  102 bits (253), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 72/249 (28%), Positives = 117/249 (46%), Gaps = 16/249 (6%)
Query: 348 IGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQY 407
           +G G +G VY    ++     A+K +       +    +++  +E  V+  +KHPN+VQ 
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTL------KEDTMEVEEFLKEAAVMKEIKHPNLVQL 74
Query: 408 YGSEIVEDKFYIYLEYVHPGSINKYVREHCG--AITESVVRNFTRHILSGLAYLHSKKTI 465
            G    E  FYI +E++  G++  Y+RE C    ++  V+      I S + YL  K  I
Sbjct: 75  LGVCTREPPFYIIIEFMTYGNLLDYLRE-CNRQEVSAVVLLYMATQISSAMEYLEKKNFI 133
Query: 466 HRDIKGANLLVDASGVVKLADFGMAKHLTGQ--KADLSMKGSPYWMAPELMMAVMQKGKS 523
           HRD+   N LV  + +VK+ADFG+++ +TG    A    K    W APE +       KS
Sbjct: 134 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKS 193
Query: 524 SDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDSLSPEGKDFLRCC 583
              A  V +W +    +  Y G      YE     +++ R     P+    +  + +R C
Sbjct: 194 DVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMER-----PEGCPEKVYELMRAC 248
Query: 584 FQRNPADRP 592
           +Q NP+DRP
Sbjct: 249 WQWNPSDRP 257

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score =  102 bits (253), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 77/272 (28%), Positives = 131/272 (48%), Gaps = 39/272 (14%)
Query: 348 IGRGTFGSV----YVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPN 403
           +G+G FGSV    Y      TG + A+K++        + E ++  E+EI++L  L+H N
Sbjct: 19  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-----HSTEEHLRDFEREIEILKSLQHDN 73
Query: 404 IVQYYGSEIVEDK--FYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHS 461
           IV+Y G      +    + +EY+  GS+  Y+++H   I    +  +T  I  G+ YL +
Sbjct: 74  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT 133
Query: 462 KKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMK---GSP-YWMAPELMMAV 517
           K+ IHR++   N+LV+    VK+ DFG+ K L   K    +K    SP +W APE +   
Sbjct: 134 KRYIHRNLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLT-- 191
Query: 518 MQKGKSSDSALAVDIWSLGCTIIEMYT----GKPPWSEY--------EGAAAMF---KVM 562
                 S  ++A D+WS G  + E++T     K P +E+        +G   +F   +++
Sbjct: 192 -----ESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELL 246
Query: 563 RDTPAI--PDSLSPEGKDFLRCCFQRNPADRP 592
           ++   +  PD    E    +  C+  N   RP
Sbjct: 247 KNNGRLPRPDGCPDEIYMIMTECWNNNVNQRP 278

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score =  102 bits (253), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 69/223 (30%), Positives = 112/223 (50%), Gaps = 27/223 (12%)
Query: 340 SQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHL 399
           S+++K   IG+GTFG V+ A +R+TG   A+K+V    ++ K    I  L +EIK+L  L
Sbjct: 18  SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKV--LMENEKEGFPITAL-REIKILQLL 74
Query: 400 KHPNIVQYYGSEIVEDK----------FYIYLEYVHPGSINKYVREHCGAITESVVRNFT 449
           KH N+V     EI   K           Y+  ++     +   +       T S ++   
Sbjct: 75  KHENVVNLI--EICRTKASPYNRCKGSIYLVFDFCE-HDLAGLLSNVLVKFTLSEIKRVM 131
Query: 450 RHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKAD-----LSMKG 504
           + +L+GL Y+H  K +HRD+K AN+L+   GV+KLADFG+A+  +  K        +   
Sbjct: 132 QMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVV 191
Query: 505 SPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKP 547
           + ++  PEL++         D    +D+W  GC + EM+T  P
Sbjct: 192 TLWYRPPELLLG------ERDYGPPIDLWGAGCIMAEMWTRSP 228

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score =  101 bits (252), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 66/210 (31%), Positives = 114/210 (54%), Gaps = 30/210 (14%)
Query: 348 IGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESI---KQLEQEIKVLSHLKHPNI 404
           +G G +GSV  A + +TG   A+K++       +  +SI   K+  +E+++L H+KH N+
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKL------SRPFQSIIHAKRTYRELRLLKHMKHENV 85
Query: 405 V----QYYGSEIVEDKFYIYL-EYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYL 459
           +     +  +  +E+   +YL  ++    +N  V+  C  +T+  V+     IL GL Y+
Sbjct: 86  IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILRGLKYI 143
Query: 460 HSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKG---SPYWMAPELMMA 516
           HS   IHRD+K +NL V+    +K+ DFG+A+H      D  M G   + ++ APE+M+ 
Sbjct: 144 HSADIIHRDLKPSNLAVNEDSELKILDFGLARH-----TDDEMTGYVATRWYRAPEIMLN 198
Query: 517 VMQKGKSSDSALAVDIWSLGCTIIEMYTGK 546
            M   ++      VDIWS+GC + E+ TG+
Sbjct: 199 WMHYNQT------VDIWSVGCIMAELLTGR 222

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score =  101 bits (252), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 66/210 (31%), Positives = 114/210 (54%), Gaps = 30/210 (14%)
Query: 348 IGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESI---KQLEQEIKVLSHLKHPNI 404
           +G G +GSV  A + +TG   A+K++       +  +SI   K+  +E+++L H+KH N+
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKL------SRPFQSIIHAKRTYRELRLLKHMKHENV 89
Query: 405 V----QYYGSEIVEDKFYIYL-EYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYL 459
           +     +  +  +E+   +YL  ++    +N  V+  C  +T+  V+     IL GL Y+
Sbjct: 90  IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILRGLKYI 147
Query: 460 HSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKG---SPYWMAPELMMA 516
           HS   IHRD+K +NL V+    +K+ DFG+A+H      D  M G   + ++ APE+M+ 
Sbjct: 148 HSADIIHRDLKPSNLAVNEDSELKILDFGLARH-----TDDEMTGYVATRWYRAPEIMLN 202
Query: 517 VMQKGKSSDSALAVDIWSLGCTIIEMYTGK 546
            M   ++      VDIWS+GC + E+ TG+
Sbjct: 203 WMHYNQT------VDIWSVGCIMAELLTGR 226

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score =  101 bits (252), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 66/210 (31%), Positives = 114/210 (54%), Gaps = 30/210 (14%)
Query: 348 IGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESI---KQLEQEIKVLSHLKHPNI 404
           +G G +GSV  A + +TG   A+K++       +  +SI   K+  +E+++L H+KH N+
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKL------SRPFQSIIHAKRTYRELRLLKHMKHENV 83
Query: 405 V----QYYGSEIVEDKFYIYL-EYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYL 459
           +     +  +  +E+   +YL  ++    +N  V+  C  +T+  V+     IL GL Y+
Sbjct: 84  IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILRGLKYI 141
Query: 460 HSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKG---SPYWMAPELMMA 516
           HS   IHRD+K +NL V+    +K+ DFG+A+H      D  M G   + ++ APE+M+ 
Sbjct: 142 HSADIIHRDLKPSNLAVNEDCELKILDFGLARH-----TDDEMTGYVATRWYRAPEIMLN 196
Query: 517 VMQKGKSSDSALAVDIWSLGCTIIEMYTGK 546
            M   ++      VDIWS+GC + E+ TG+
Sbjct: 197 WMHYNQT------VDIWSVGCIMAELLTGR 220

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score =  101 bits (251), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 66/210 (31%), Positives = 114/210 (54%), Gaps = 30/210 (14%)
Query: 348 IGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESI---KQLEQEIKVLSHLKHPNI 404
           +G G +GSV  A + +TG   A+K++       +  +SI   K+  +E+++L H+KH N+
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKL------SRPFQSIIHAKRTYRELRLLKHMKHENV 88
Query: 405 V----QYYGSEIVEDKFYIYL-EYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYL 459
           +     +  +  +E+   +YL  ++    +N  V+  C  +T+  V+     IL GL Y+
Sbjct: 89  IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILRGLKYI 146
Query: 460 HSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKG---SPYWMAPELMMA 516
           HS   IHRD+K +NL V+    +K+ DFG+A+H      D  M G   + ++ APE+M+ 
Sbjct: 147 HSADIIHRDLKPSNLAVNEDXELKILDFGLARH-----TDDEMTGYVATRWYRAPEIMLN 201
Query: 517 VMQKGKSSDSALAVDIWSLGCTIIEMYTGK 546
            M   ++      VDIWS+GC + E+ TG+
Sbjct: 202 WMHYNQT------VDIWSVGCIMAELLTGR 225

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score =  101 bits (251), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 67/217 (30%), Positives = 117/217 (53%), Gaps = 30/217 (13%)
Query: 341 QWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESI---KQLEQEIKVLS 397
           ++Q    +G G +GSV  A + +TG   A+K++       +  +SI   K+  +E+++L 
Sbjct: 19  RYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKL------SRPFQSIIHAKRTYRELRLLK 72
Query: 398 HLKHPNIV----QYYGSEIVEDKFYIYL-EYVHPGSINKYVREHCGAITESVVRNFTRHI 452
           H+KH N++     +  +  +E+   +YL  ++    +N  V+  C  +T+  V+     I
Sbjct: 73  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK--CAKLTDDHVQFLIYQI 130
Query: 453 LSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKG---SPYWM 509
           L GL Y+HS   IHRD+K +NL V+    +K+ DFG+A+H      D  M G   + ++ 
Sbjct: 131 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARH-----TDDEMTGYVATRWYR 185
Query: 510 APELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGK 546
           APE+M+  M   ++      VDIWS+GC + E+ TG+
Sbjct: 186 APEIMLNWMHYNQT------VDIWSVGCIMAELLTGR 216

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score =  101 bits (251), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 71/293 (24%), Positives = 133/293 (45%), Gaps = 13/293 (4%)
Query: 320 LSPSATIPQVAAKPEPLPMNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPD- 378
           + P   +P  AA  E      ++    +IGRG    V    +R TG   A+K +++  + 
Sbjct: 77  MGPEDELPDWAAAKE---FYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAER 133
Query: 379 -DPKSAESIKQ-LEQEIKVLSHLK-HPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVRE 435
             P+  E +++   +E  +L  +  HP+I+    S       ++  + +  G +  Y+ E
Sbjct: 134 LSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTE 193
Query: 436 HCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTG 495
              A++E   R+  R +L  +++LH+   +HRD+K  N+L+D +  ++L+DFG + HL  
Sbjct: 194 KV-ALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEP 252
Query: 496 QKADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGA 555
            +    + G+P ++APE++   M +         VD+W+ G  +  +  G PP+      
Sbjct: 253 GEKLRELCGTPGYLAPEILKCSMDETHPG-YGKEVDLWACGVILFTLLAGSPPFWHRRQI 311
Query: 556 AAMFKVMRDTPAIP----DSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLK 604
             +  +M           D  S   KD +    Q +P  R  A   L+H F +
Sbjct: 312 LMLRMIMEGQYQFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFE 364

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score =  101 bits (251), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 66/210 (31%), Positives = 114/210 (54%), Gaps = 30/210 (14%)
Query: 348 IGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESI---KQLEQEIKVLSHLKHPNI 404
           +G G +GSV  A + +TG   A+K++       +  +SI   K+  +E+++L H+KH N+
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKL------SRPFQSIIHAKRTYRELRLLKHMKHENV 83
Query: 405 V----QYYGSEIVEDKFYIYL-EYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYL 459
           +     +  +  +E+   +YL  ++    +N  V+  C  +T+  V+     IL GL Y+
Sbjct: 84  IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILRGLKYI 141
Query: 460 HSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKG---SPYWMAPELMMA 516
           HS   IHRD+K +NL V+    +K+ DFG+A+H      D  M G   + ++ APE+M+ 
Sbjct: 142 HSADIIHRDLKPSNLAVNEDCELKILDFGLARH-----TDDEMTGYVATRWYRAPEIMLN 196
Query: 517 VMQKGKSSDSALAVDIWSLGCTIIEMYTGK 546
            M   ++      VDIWS+GC + E+ TG+
Sbjct: 197 WMHYNQT------VDIWSVGCIMAELLTGR 220

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score =  101 bits (251), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 66/210 (31%), Positives = 114/210 (54%), Gaps = 30/210 (14%)
Query: 348 IGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESI---KQLEQEIKVLSHLKHPNI 404
           +G G +GSV  A + +TG   A+K++       +  +SI   K+  +E+++L H+KH N+
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKL------SRPFQSIIHAKRTYRELRLLKHMKHENV 83
Query: 405 V----QYYGSEIVEDKFYIYL-EYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYL 459
           +     +  +  +E+   +YL  ++    +N  V+  C  +T+  V+     IL GL Y+
Sbjct: 84  IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILRGLKYI 141
Query: 460 HSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKG---SPYWMAPELMMA 516
           HS   IHRD+K +NL V+    +K+ DFG+A+H      D  M G   + ++ APE+M+ 
Sbjct: 142 HSADIIHRDLKPSNLAVNEDCELKILDFGLARH-----TDDEMTGYVATRWYRAPEIMLN 196
Query: 517 VMQKGKSSDSALAVDIWSLGCTIIEMYTGK 546
            M   ++      VDIWS+GC + E+ TG+
Sbjct: 197 WMHYNQT------VDIWSVGCIMAELLTGR 220

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score =  101 bits (251), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 66/210 (31%), Positives = 114/210 (54%), Gaps = 30/210 (14%)
Query: 348 IGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESI---KQLEQEIKVLSHLKHPNI 404
           +G G +GSV  A + +TG   A+K++       +  +SI   K+  +E+++L H+KH N+
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKL------SRPFQSIIHAKRTYRELRLLKHMKHENV 83
Query: 405 V----QYYGSEIVEDKFYIYL-EYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYL 459
           +     +  +  +E+   +YL  ++    +N  V+  C  +T+  V+     IL GL Y+
Sbjct: 84  IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILRGLKYI 141
Query: 460 HSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKG---SPYWMAPELMMA 516
           HS   IHRD+K +NL V+    +K+ DFG+A+H      D  M G   + ++ APE+M+ 
Sbjct: 142 HSADIIHRDLKPSNLAVNEDCELKILDFGLARH-----TDDEMTGYVATRWYRAPEIMLN 196
Query: 517 VMQKGKSSDSALAVDIWSLGCTIIEMYTGK 546
            M   ++      VDIWS+GC + E+ TG+
Sbjct: 197 WMHYNQT------VDIWSVGCIMAELLTGR 220

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score =  101 bits (251), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 67/217 (30%), Positives = 117/217 (53%), Gaps = 30/217 (13%)
Query: 341 QWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESI---KQLEQEIKVLS 397
           ++Q    +G G +GSV  A + +TG   A+K++       +  +SI   K+  +E+++L 
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL------SRPFQSIIHAKRTYRELRLLK 76
Query: 398 HLKHPNIV----QYYGSEIVEDKFYIYL-EYVHPGSINKYVREHCGAITESVVRNFTRHI 452
           H+KH N++     +  +  +E+   +YL  ++    +N  V+  C  +T+  V+     I
Sbjct: 77  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQI 134
Query: 453 LSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKG---SPYWM 509
           L GL Y+HS   IHRD+K +NL V+    +K+ DFG+A+H      D  M G   + ++ 
Sbjct: 135 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARH-----TDDEMTGXVATRWYR 189
Query: 510 APELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGK 546
           APE+M+  M   ++      VDIWS+GC + E+ TG+
Sbjct: 190 APEIMLNWMHYNQT------VDIWSVGCIMAELLTGR 220

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score =  101 bits (251), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 78/287 (27%), Positives = 140/287 (48%), Gaps = 29/287 (10%)
Query: 333 PEPLPM---NSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQL 389
           P  LP+   + +++  K IG G FG   +  ++++  L A+K ++      K  E++K+ 
Sbjct: 9   PMDLPIMHDSDRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIE---RGEKIDENVKR- 64
Query: 390 EQEIKVLSH--LKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRN 447
               ++++H  L+HPNIV++    +      I +EY   G + + +  + G  +E   R 
Sbjct: 65  ----EIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERIC-NAGRFSEDEARF 119
Query: 448 FTRHILSGLAYLHSKKTIHRDIKGANLLVDASGV--VKLADFGMAKHLTGQKADLSMKGS 505
           F + ++SG++Y H+ +  HRD+K  N L+D S    +K+  FG +K            G+
Sbjct: 120 FFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQPKDTVGT 179
Query: 506 PYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEG----AAAMFKV 561
           P ++APE+++     GK +      D+WS G T+  M  G  P+ + E        + ++
Sbjct: 180 PAYIAPEVLLKKEYDGKVA------DVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRI 233
Query: 562 MRDTPAIPD--SLSPEGKDFLRCCFQRNPADRPPASLLLEHR-FLKN 605
           +    AIPD   +SPE +  +   F  +PA R     +  H  FLKN
Sbjct: 234 LNVQYAIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKN 280

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score =  101 bits (251), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 67/217 (30%), Positives = 117/217 (53%), Gaps = 30/217 (13%)
Query: 341 QWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESI---KQLEQEIKVLS 397
           ++Q    +G G +GSV  A + +TG   A+K++       +  +SI   K+  +E+++L 
Sbjct: 25  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL------SRPFQSIIHAKRTYRELRLLK 78
Query: 398 HLKHPNIVQ----YYGSEIVEDKFYIYL-EYVHPGSINKYVREHCGAITESVVRNFTRHI 452
           H+KH N++     +  +  +E+   +YL  ++    +N  V+  C  +T+  V+     I
Sbjct: 79  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQI 136
Query: 453 LSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKG---SPYWM 509
           L GL Y+HS   IHRD+K +NL V+    +K+ DFG+A+H      D  M G   + ++ 
Sbjct: 137 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARH-----TDDEMTGYVATRWYR 191
Query: 510 APELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGK 546
           APE+M+  M   ++      VDIWS+GC + E+ TG+
Sbjct: 192 APEIMLNWMHYNQT------VDIWSVGCIMAELLTGR 222

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score =  101 bits (251), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 66/210 (31%), Positives = 114/210 (54%), Gaps = 30/210 (14%)
Query: 348 IGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESI---KQLEQEIKVLSHLKHPNI 404
           +G G +GSV  A + +TG   A+K++       +  +SI   K+  +E+++L H+KH N+
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKL------SRPFQSIIHAKRTYRELRLLKHMKHENV 83
Query: 405 V----QYYGSEIVEDKFYIYL-EYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYL 459
           +     +  +  +E+   +YL  ++    +N  V+  C  +T+  V+     IL GL Y+
Sbjct: 84  IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILRGLKYI 141
Query: 460 HSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKG---SPYWMAPELMMA 516
           HS   IHRD+K +NL V+    +K+ DFG+A+H      D  M G   + ++ APE+M+ 
Sbjct: 142 HSADIIHRDLKPSNLAVNEDCELKILDFGLARH-----TDDEMTGYVATRWYRAPEIMLN 196
Query: 517 VMQKGKSSDSALAVDIWSLGCTIIEMYTGK 546
            M   ++      VDIWS+GC + E+ TG+
Sbjct: 197 WMHYNQT------VDIWSVGCIMAELLTGR 220

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score =  101 bits (251), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 66/210 (31%), Positives = 114/210 (54%), Gaps = 30/210 (14%)
Query: 348 IGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESI---KQLEQEIKVLSHLKHPNI 404
           +G G +GSV  A + +TG   A+K++       +  +SI   K+  +E+++L H+KH N+
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKL------SRPFQSIIHAKRTYRELRLLKHMKHENV 88
Query: 405 V----QYYGSEIVEDKFYIYL-EYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYL 459
           +     +  +  +E+   +YL  ++    +N  V+  C  +T+  V+     IL GL Y+
Sbjct: 89  IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILRGLKYI 146
Query: 460 HSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKG---SPYWMAPELMMA 516
           HS   IHRD+K +NL V+    +K+ DFG+A+H      D  M G   + ++ APE+M+ 
Sbjct: 147 HSADIIHRDLKPSNLAVNEDCELKILDFGLARH-----TDDEMTGYVATRWYRAPEIMLN 201
Query: 517 VMQKGKSSDSALAVDIWSLGCTIIEMYTGK 546
            M   ++      VDIWS+GC + E+ TG+
Sbjct: 202 WMHYNQT------VDIWSVGCIMAELLTGR 225

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score =  101 bits (251), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 66/210 (31%), Positives = 114/210 (54%), Gaps = 30/210 (14%)
Query: 348 IGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESI---KQLEQEIKVLSHLKHPNI 404
           +G G +GSV  A + +TG   A+K++       +  +SI   K+  +E+++L H+KH N+
Sbjct: 29  VGSGAYGSVCAAFDTKTGLRVAVKKL------SRPFQSIIHAKRTYRELRLLKHMKHENV 82
Query: 405 V----QYYGSEIVEDKFYIYL-EYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYL 459
           +     +  +  +E+   +YL  ++    +N  V+  C  +T+  V+     IL GL Y+
Sbjct: 83  IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILRGLKYI 140
Query: 460 HSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKG---SPYWMAPELMMA 516
           HS   IHRD+K +NL V+    +K+ DFG+A+H      D  M G   + ++ APE+M+ 
Sbjct: 141 HSADIIHRDLKPSNLAVNEDCELKILDFGLARH-----TDDEMTGYVATRWYRAPEIMLN 195
Query: 517 VMQKGKSSDSALAVDIWSLGCTIIEMYTGK 546
            M   ++      VDIWS+GC + E+ TG+
Sbjct: 196 WMHYNQT------VDIWSVGCIMAELLTGR 219

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score =  101 bits (251), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 72/249 (28%), Positives = 115/249 (46%), Gaps = 16/249 (6%)
Query: 348 IGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQY 407
           +G G +G VY    ++     A+K +       +    +++  +E  V+  +KHPN+VQ 
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLK------EDTMEVEEFLKEAAVMKEIKHPNLVQL 79
Query: 408 YGSEIVEDKFYIYLEYVHPGSINKYVREHCG--AITESVVRNFTRHILSGLAYLHSKKTI 465
            G    E  FYI  E++  G++  Y+RE C    +   V+      I S + YL  K  I
Sbjct: 80  LGVCTREPPFYIITEFMTYGNLLDYLRE-CNRQEVNAVVLLYMATQISSAMEYLEKKNFI 138
Query: 466 HRDIKGANLLVDASGVVKLADFGMAKHLTGQ--KADLSMKGSPYWMAPELMMAVMQKGKS 523
           HRD+   N LV  + +VK+ADFG+++ +TG    A    K    W APE +       KS
Sbjct: 139 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKS 198
Query: 524 SDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDSLSPEGKDFLRCC 583
              A  V +W +    +  Y G      YE     +++ R     P+    +  + +R C
Sbjct: 199 DVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMER-----PEGCPEKVYELMRAC 253
Query: 584 FQRNPADRP 592
           +Q NP+DRP
Sbjct: 254 WQWNPSDRP 262

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score =  101 bits (251), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 76/267 (28%), Positives = 125/267 (46%), Gaps = 18/267 (6%)
Query: 334 EPLPMNSQW-QKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQE 392
           E  PM   W    +++GRG FG V+    + TG L A K+++      +       +E+ 
Sbjct: 178 EAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEK- 236
Query: 393 IKVLSHLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKY---VREHCGAITESVVRNFT 449
            K+L+ +    IV    +   +    + +  ++ G I  +   V E      E     +T
Sbjct: 237 -KILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYT 295
Query: 450 RHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHL-TGQKADLSMKGSPYW 508
             I+SGL +LH +  I+RD+K  N+L+D  G V+++D G+A  L  GQ       G+P +
Sbjct: 296 AQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGF 355
Query: 509 MAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPW----SEYEGAAAMFKVMRD 564
           MAPEL++     G+  D   +VD ++LG T+ EM   + P+     + E      +V+  
Sbjct: 356 MAPELLL-----GEEYD--FSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQ 408
Query: 565 TPAIPDSLSPEGKDFLRCCFQRNPADR 591
               PD  SP  KDF     Q++P  R
Sbjct: 409 AVTYPDKFSPASKDFCEALLQKDPEKR 435

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score =  101 bits (251), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 66/210 (31%), Positives = 114/210 (54%), Gaps = 30/210 (14%)
Query: 348 IGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESI---KQLEQEIKVLSHLKHPNI 404
           +G G +GSV  A + +TG   A+K++       +  +SI   K+  +E+++L H+KH N+
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKL------SRPFQSIIHAKRTYRELRLLKHMKHENV 85
Query: 405 V----QYYGSEIVEDKFYIYL-EYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYL 459
           +     +  +  +E+   +YL  ++    +N  V+  C  +T+  V+     IL GL Y+
Sbjct: 86  IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILRGLKYI 143
Query: 460 HSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKG---SPYWMAPELMMA 516
           HS   IHRD+K +NL V+    +K+ DFG+A+H      D  M G   + ++ APE+M+ 
Sbjct: 144 HSADIIHRDLKPSNLAVNEDCELKILDFGLARH-----TDDEMTGYVATRWYRAPEIMLN 198
Query: 517 VMQKGKSSDSALAVDIWSLGCTIIEMYTGK 546
            M   ++      VDIWS+GC + E+ TG+
Sbjct: 199 WMHYNQT------VDIWSVGCIMAELLTGR 222

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score =  101 bits (251), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 66/210 (31%), Positives = 114/210 (54%), Gaps = 30/210 (14%)
Query: 348 IGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESI---KQLEQEIKVLSHLKHPNI 404
           +G G +GSV  A + +TG   A+K++       +  +SI   K+  +E+++L H+KH N+
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKL------SRPFQSIIHAKRTYRELRLLKHMKHENV 83
Query: 405 V----QYYGSEIVEDKFYIYL-EYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYL 459
           +     +  +  +E+   +YL  ++    +N  V+  C  +T+  V+     IL GL Y+
Sbjct: 84  IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILRGLKYI 141
Query: 460 HSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKG---SPYWMAPELMMA 516
           HS   IHRD+K +NL V+    +K+ DFG+A+H      D  M G   + ++ APE+M+ 
Sbjct: 142 HSADIIHRDLKPSNLAVNEDCELKILDFGLARH-----TDDEMTGYVATRWYRAPEIMLN 196
Query: 517 VMQKGKSSDSALAVDIWSLGCTIIEMYTGK 546
            M   ++      VDIWS+GC + E+ TG+
Sbjct: 197 WMHYNQT------VDIWSVGCIMAELLTGR 220

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score =  101 bits (251), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 66/210 (31%), Positives = 114/210 (54%), Gaps = 30/210 (14%)
Query: 348 IGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESI---KQLEQEIKVLSHLKHPNI 404
           +G G +GSV  A + +TG   A+K++       +  +SI   K+  +E+++L H+KH N+
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKL------SRPFQSIIHAKRTYRELRLLKHMKHENV 95
Query: 405 VQ----YYGSEIVEDKFYIYL-EYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYL 459
           +     +  +  +E+   +YL  ++    +N  V+  C  +T+  V+     IL GL Y+
Sbjct: 96  IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILRGLKYI 153
Query: 460 HSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKG---SPYWMAPELMMA 516
           HS   IHRD+K +NL V+    +K+ DFG+A+H      D  M G   + ++ APE+M+ 
Sbjct: 154 HSADIIHRDLKPSNLAVNEDCELKILDFGLARH-----TDDEMTGYVATRWYRAPEIMLN 208
Query: 517 VMQKGKSSDSALAVDIWSLGCTIIEMYTGK 546
            M   ++      VDIWS+GC + E+ TG+
Sbjct: 209 WMHYNQT------VDIWSVGCIMAELLTGR 232

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score =  101 bits (251), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 66/210 (31%), Positives = 114/210 (54%), Gaps = 30/210 (14%)
Query: 348 IGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESI---KQLEQEIKVLSHLKHPNI 404
           +G G +GSV  A + +TG   A+K++       +  +SI   K+  +E+++L H+KH N+
Sbjct: 53  VGSGAYGSVCAAFDTKTGLRVAVKKL------SRPFQSIIHAKRTYRELRLLKHMKHENV 106
Query: 405 VQ----YYGSEIVEDKFYIYL-EYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYL 459
           +     +  +  +E+   +YL  ++    +N  V+  C  +T+  V+     IL GL Y+
Sbjct: 107 IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILRGLKYI 164
Query: 460 HSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKG---SPYWMAPELMMA 516
           HS   IHRD+K +NL V+    +K+ DFG+A+H      D  M G   + ++ APE+M+ 
Sbjct: 165 HSADIIHRDLKPSNLAVNEDCELKILDFGLARH-----TDDEMXGYVATRWYRAPEIMLN 219
Query: 517 VMQKGKSSDSALAVDIWSLGCTIIEMYTGK 546
            M   ++      VDIWS+GC + E+ TG+
Sbjct: 220 WMHYNQT------VDIWSVGCIMAELLTGR 243

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score =  101 bits (251), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 76/267 (28%), Positives = 125/267 (46%), Gaps = 18/267 (6%)
Query: 334 EPLPMNSQW-QKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQE 392
           E  PM   W    +++GRG FG V+    + TG L A K+++      +       +E+ 
Sbjct: 178 EAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEK- 236
Query: 393 IKVLSHLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKY---VREHCGAITESVVRNFT 449
            K+L+ +    IV    +   +    + +  ++ G I  +   V E      E     +T
Sbjct: 237 -KILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYT 295
Query: 450 RHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHL-TGQKADLSMKGSPYW 508
             I+SGL +LH +  I+RD+K  N+L+D  G V+++D G+A  L  GQ       G+P +
Sbjct: 296 AQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGF 355
Query: 509 MAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPW----SEYEGAAAMFKVMRD 564
           MAPEL++     G+  D   +VD ++LG T+ EM   + P+     + E      +V+  
Sbjct: 356 MAPELLL-----GEEYD--FSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQ 408
Query: 565 TPAIPDSLSPEGKDFLRCCFQRNPADR 591
               PD  SP  KDF     Q++P  R
Sbjct: 409 AVTYPDKFSPASKDFCEALLQKDPEKR 435

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score =  101 bits (251), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 66/210 (31%), Positives = 114/210 (54%), Gaps = 30/210 (14%)
Query: 348 IGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESI---KQLEQEIKVLSHLKHPNI 404
           +G G +GSV  A + +TG   A+K++       +  +SI   K+  +E+++L H+KH N+
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKL------SRPFQSIIHAKRTYRELRLLKHMKHENV 85
Query: 405 V----QYYGSEIVEDKFYIYL-EYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYL 459
           +     +  +  +E+   +YL  ++    +N  V+  C  +T+  V+     IL GL Y+
Sbjct: 86  IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILRGLKYI 143
Query: 460 HSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKG---SPYWMAPELMMA 516
           HS   IHRD+K +NL V+    +K+ DFG+A+H      D  M G   + ++ APE+M+ 
Sbjct: 144 HSADIIHRDLKPSNLAVNEDCELKILDFGLARH-----TDDEMTGYVATRWYRAPEIMLN 198
Query: 517 VMQKGKSSDSALAVDIWSLGCTIIEMYTGK 546
            M   ++      VDIWS+GC + E+ TG+
Sbjct: 199 WMHYNQT------VDIWSVGCIMAELLTGR 222

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score =  101 bits (251), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 76/267 (28%), Positives = 125/267 (46%), Gaps = 18/267 (6%)
Query: 334 EPLPMNSQW-QKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQE 392
           E  PM   W    +++GRG FG V+    + TG L A K+++      +       +E+ 
Sbjct: 178 EAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEK- 236
Query: 393 IKVLSHLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKY---VREHCGAITESVVRNFT 449
            K+L+ +    IV    +   +    + +  ++ G I  +   V E      E     +T
Sbjct: 237 -KILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYT 295
Query: 450 RHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHL-TGQKADLSMKGSPYW 508
             I+SGL +LH +  I+RD+K  N+L+D  G V+++D G+A  L  GQ       G+P +
Sbjct: 296 AQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGF 355
Query: 509 MAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPW----SEYEGAAAMFKVMRD 564
           MAPEL++     G+  D   +VD ++LG T+ EM   + P+     + E      +V+  
Sbjct: 356 MAPELLL-----GEEYD--FSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQ 408
Query: 565 TPAIPDSLSPEGKDFLRCCFQRNPADR 591
               PD  SP  KDF     Q++P  R
Sbjct: 409 AVTYPDKFSPASKDFCEALLQKDPEKR 435

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score =  101 bits (251), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 72/249 (28%), Positives = 115/249 (46%), Gaps = 16/249 (6%)
Query: 348 IGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQY 407
           +G G +G VY    ++     A+K +       +    +++  +E  V+  +KHPN+VQ 
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLK------EDTMEVEEFLKEAAVMKEIKHPNLVQL 79
Query: 408 YGSEIVEDKFYIYLEYVHPGSINKYVREHCG--AITESVVRNFTRHILSGLAYLHSKKTI 465
            G    E  FYI  E++  G++  Y+RE C    +   V+      I S + YL  K  I
Sbjct: 80  LGVCTREPPFYIITEFMTYGNLLDYLRE-CNRQEVNAVVLLYMATQISSAMEYLEKKNFI 138
Query: 466 HRDIKGANLLVDASGVVKLADFGMAKHLTGQ--KADLSMKGSPYWMAPELMMAVMQKGKS 523
           HRD+   N LV  + +VK+ADFG+++ +TG    A    K    W APE +       KS
Sbjct: 139 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESLAYNKFSIKS 198
Query: 524 SDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDSLSPEGKDFLRCC 583
              A  V +W +    +  Y G      YE     +++ R     P+    +  + +R C
Sbjct: 199 DVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMER-----PEGCPEKVYELMRAC 253
Query: 584 FQRNPADRP 592
           +Q NP+DRP
Sbjct: 254 WQWNPSDRP 262

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score =  101 bits (251), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 66/210 (31%), Positives = 114/210 (54%), Gaps = 30/210 (14%)
Query: 348 IGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESI---KQLEQEIKVLSHLKHPNI 404
           +G G +GSV  A + +TG   A+K++       +  +SI   K+  +E+++L H+KH N+
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKL------SRPFQSIIHAKRTYRELRLLKHMKHENV 95
Query: 405 VQ----YYGSEIVEDKFYIYL-EYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYL 459
           +     +  +  +E+   +YL  ++    +N  V+  C  +T+  V+     IL GL Y+
Sbjct: 96  IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILRGLKYI 153
Query: 460 HSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKG---SPYWMAPELMMA 516
           HS   IHRD+K +NL V+    +K+ DFG+A+H      D  M G   + ++ APE+M+ 
Sbjct: 154 HSADIIHRDLKPSNLAVNEDCELKILDFGLARH-----TDDEMTGYVATRWYRAPEIMLN 208
Query: 517 VMQKGKSSDSALAVDIWSLGCTIIEMYTGK 546
            M   ++      VDIWS+GC + E+ TG+
Sbjct: 209 WMHYNQT------VDIWSVGCIMAELLTGR 232

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score =  101 bits (251), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 72/249 (28%), Positives = 116/249 (46%), Gaps = 16/249 (6%)
Query: 348 IGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQY 407
           +G G +G VY    ++     A+K +       +    +++  +E  V+  +KHPN+VQ 
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTL------KEDTMEVEEFLKEAAVMKEIKHPNLVQL 79
Query: 408 YGSEIVEDKFYIYLEYVHPGSINKYVREHCG--AITESVVRNFTRHILSGLAYLHSKKTI 465
            G    E  FYI  E++  G++  Y+RE C    ++  V+      I S + YL  K  I
Sbjct: 80  LGVCTREPPFYIITEFMTYGNLLDYLRE-CNRQEVSAVVLLYMATQISSAMEYLEKKNFI 138
Query: 466 HRDIKGANLLVDASGVVKLADFGMAKHLTGQ--KADLSMKGSPYWMAPELMMAVMQKGKS 523
           HRD+   N LV  + +VK+ADFG+++ +TG    A    K    W APE +       KS
Sbjct: 139 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKS 198
Query: 524 SDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDSLSPEGKDFLRCC 583
              A  V +W +    +  Y G      YE     +++ R     P+    +  + +R C
Sbjct: 199 DVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMER-----PEGCPEKVYELMRAC 253
Query: 584 FQRNPADRP 592
           +Q NP+DRP
Sbjct: 254 WQWNPSDRP 262

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score =  100 bits (250), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 66/210 (31%), Positives = 114/210 (54%), Gaps = 30/210 (14%)
Query: 348 IGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESI---KQLEQEIKVLSHLKHPNI 404
           +G G +GSV  A + +TG   A+K++       +  +SI   K+  +E+++L H+KH N+
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKL------SRPFQSIIHAKRTYRELRLLKHMKHENV 90
Query: 405 V----QYYGSEIVEDKFYIYL-EYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYL 459
           +     +  +  +E+   +YL  ++    +N  V+  C  +T+  V+     IL GL Y+
Sbjct: 91  IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILRGLKYI 148
Query: 460 HSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKG---SPYWMAPELMMA 516
           HS   IHRD+K +NL V+    +K+ DFG+A+H      D  M G   + ++ APE+M+ 
Sbjct: 149 HSADIIHRDLKPSNLAVNEDCELKILDFGLARH-----TDDEMTGYVATRWYRAPEIMLN 203
Query: 517 VMQKGKSSDSALAVDIWSLGCTIIEMYTGK 546
            M   ++      VDIWS+GC + E+ TG+
Sbjct: 204 WMHYNQT------VDIWSVGCIMAELLTGR 227

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score =  100 bits (250), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 66/210 (31%), Positives = 114/210 (54%), Gaps = 30/210 (14%)
Query: 348 IGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESI---KQLEQEIKVLSHLKHPNI 404
           +G G +GSV  A + +TG   A+K++       +  +SI   K+  +E+++L H+KH N+
Sbjct: 41  VGSGAYGSVCAAFDTKTGLRVAVKKL------SRPFQSIIHAKRTYRELRLLKHMKHENV 94
Query: 405 VQ----YYGSEIVEDKFYIYL-EYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYL 459
           +     +  +  +E+   +YL  ++    +N  V+  C  +T+  V+     IL GL Y+
Sbjct: 95  IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILRGLKYI 152
Query: 460 HSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKG---SPYWMAPELMMA 516
           HS   IHRD+K +NL V+    +K+ DFG+A+H      D  M G   + ++ APE+M+ 
Sbjct: 153 HSADIIHRDLKPSNLAVNEDXELKILDFGLARH-----TDDEMTGYVATRWYRAPEIMLN 207
Query: 517 VMQKGKSSDSALAVDIWSLGCTIIEMYTGK 546
            M   ++      VDIWS+GC + E+ TG+
Sbjct: 208 WMHYNQT------VDIWSVGCIMAELLTGR 231

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score =  100 bits (250), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 76/267 (28%), Positives = 125/267 (46%), Gaps = 18/267 (6%)
Query: 334 EPLPMNSQW-QKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQE 392
           E  PM   W    +++GRG FG V+    + TG L A K+++      +       +E+ 
Sbjct: 178 EAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEK- 236
Query: 393 IKVLSHLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKY---VREHCGAITESVVRNFT 449
            K+L+ +    IV    +   +    + +  ++ G I  +   V E      E     +T
Sbjct: 237 -KILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYT 295
Query: 450 RHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHL-TGQKADLSMKGSPYW 508
             I+SGL +LH +  I+RD+K  N+L+D  G V+++D G+A  L  GQ       G+P +
Sbjct: 296 AQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGF 355
Query: 509 MAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPW----SEYEGAAAMFKVMRD 564
           MAPEL++     G+  D   +VD ++LG T+ EM   + P+     + E      +V+  
Sbjct: 356 MAPELLL-----GEEYD--FSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQ 408
Query: 565 TPAIPDSLSPEGKDFLRCCFQRNPADR 591
               PD  SP  KDF     Q++P  R
Sbjct: 409 AVTYPDKFSPASKDFCEALLQKDPEKR 435

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score =  100 bits (250), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 67/217 (30%), Positives = 117/217 (53%), Gaps = 30/217 (13%)
Query: 341 QWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESI---KQLEQEIKVLS 397
           ++Q    +G G +GSV  A + +TG   A+K++       +  +SI   K+  +E+++L 
Sbjct: 42  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL------SRPFQSIIHAKRTYRELRLLK 95
Query: 398 HLKHPNIVQ----YYGSEIVEDKFYIYL-EYVHPGSINKYVREHCGAITESVVRNFTRHI 452
           H+KH N++     +  +  +E+   +YL  ++    +N  V+  C  +T+  V+     I
Sbjct: 96  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQI 153
Query: 453 LSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKG---SPYWM 509
           L GL Y+HS   IHRD+K +NL V+    +K+ DFG+A+H      D  M G   + ++ 
Sbjct: 154 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARH-----TDDEMTGYVATRWYR 208
Query: 510 APELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGK 546
           APE+M+  M   ++      VDIWS+GC + E+ TG+
Sbjct: 209 APEIMLNWMHYNQT------VDIWSVGCIMAELLTGR 239

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score =  100 bits (250), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 67/217 (30%), Positives = 117/217 (53%), Gaps = 30/217 (13%)
Query: 341 QWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESI---KQLEQEIKVLS 397
           ++Q    +G G +GSV  A + +TG   A+K++       +  +SI   K+  +E+++L 
Sbjct: 20  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL------SRPFQSIIHAKRTYRELRLLK 73
Query: 398 HLKHPNIV----QYYGSEIVEDKFYIYL-EYVHPGSINKYVREHCGAITESVVRNFTRHI 452
           H+KH N++     +  +  +E+   +YL  ++    +N  V+  C  +T+  V+     I
Sbjct: 74  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQI 131
Query: 453 LSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKG---SPYWM 509
           L GL Y+HS   IHRD+K +NL V+    +K+ DFG+A+H      D  M G   + ++ 
Sbjct: 132 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARH-----TDDEMTGYVATRWYR 186
Query: 510 APELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGK 546
           APE+M+  M   ++      VDIWS+GC + E+ TG+
Sbjct: 187 APEIMLNWMHYNQT------VDIWSVGCIMAELLTGR 217

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score =  100 bits (250), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 72/249 (28%), Positives = 115/249 (46%), Gaps = 16/249 (6%)
Query: 348 IGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQY 407
           +G G +G VY    ++     A+K +       +    +++  +E  V+  +KHPN+VQ 
Sbjct: 25  LGGGQYGEVYEGVWKKYSLTVAVKTLK------EDTMEVEEFLKEAAVMKEIKHPNLVQL 78
Query: 408 YGSEIVEDKFYIYLEYVHPGSINKYVREHCG--AITESVVRNFTRHILSGLAYLHSKKTI 465
            G    E  FYI  E++  G++  Y+RE C    +   V+      I S + YL  K  I
Sbjct: 79  LGVCTREPPFYIITEFMTYGNLLDYLRE-CNRQEVNAVVLLYMATQISSAMEYLEKKNFI 137
Query: 466 HRDIKGANLLVDASGVVKLADFGMAKHLTGQ--KADLSMKGSPYWMAPELMMAVMQKGKS 523
           HRD+   N LV  + +VK+ADFG+++ +TG    A    K    W APE +       KS
Sbjct: 138 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKS 197
Query: 524 SDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDSLSPEGKDFLRCC 583
              A  V +W +    +  Y G      YE     +++ R     P+    +  + +R C
Sbjct: 198 DVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMER-----PEGCPEKVYELMRAC 252
Query: 584 FQRNPADRP 592
           +Q NP+DRP
Sbjct: 253 WQWNPSDRP 261

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score =  100 bits (250), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 67/217 (30%), Positives = 117/217 (53%), Gaps = 30/217 (13%)
Query: 341 QWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESI---KQLEQEIKVLS 397
           ++Q    +G G +GSV  A + +TG   A+K++       +  +SI   K+  +E+++L 
Sbjct: 20  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL------SRPFQSIIHAKRTYRELRLLK 73
Query: 398 HLKHPNIV----QYYGSEIVEDKFYIYL-EYVHPGSINKYVREHCGAITESVVRNFTRHI 452
           H+KH N++     +  +  +E+   +YL  ++    +N  V+  C  +T+  V+     I
Sbjct: 74  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQI 131
Query: 453 LSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKG---SPYWM 509
           L GL Y+HS   IHRD+K +NL V+    +K+ DFG+A+H      D  M G   + ++ 
Sbjct: 132 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARH-----TDDEMTGYVATRWYR 186
Query: 510 APELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGK 546
           APE+M+  M   ++      VDIWS+GC + E+ TG+
Sbjct: 187 APEIMLNWMHYNQT------VDIWSVGCIMAELLTGR 217

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score =  100 bits (250), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 69/223 (30%), Positives = 112/223 (50%), Gaps = 27/223 (12%)
Query: 340 SQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHL 399
           S+++K   IG+GTFG V+ A +R+TG   A+K+V    ++ K    I  L +EIK+L  L
Sbjct: 17  SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKV--LMENEKEGFPITAL-REIKILQLL 73
Query: 400 KHPNIVQYYGSEIVEDK----------FYIYLEYVHPGSINKYVREHCGAITESVVRNFT 449
           KH N+V     EI   K           Y+  ++     +   +       T S ++   
Sbjct: 74  KHENVVNLI--EICRTKASPYNRCKGSIYLVFDFCE-HDLAGLLSNVLVKFTLSEIKRVM 130
Query: 450 RHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKAD-----LSMKG 504
           + +L+GL Y+H  K +HRD+K AN+L+   GV+KLADFG+A+  +  K        +   
Sbjct: 131 QMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVV 190
Query: 505 SPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKP 547
           + ++  PEL++         D    +D+W  GC + EM+T  P
Sbjct: 191 TLWYRPPELLLG------ERDYGPPIDLWGAGCIMAEMWTRSP 227

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score =  100 bits (250), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 67/217 (30%), Positives = 117/217 (53%), Gaps = 30/217 (13%)
Query: 341 QWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESI---KQLEQEIKVLS 397
           ++Q    +G G +GSV  A + +TG   A+K++       +  +SI   K+  +E+++L 
Sbjct: 21  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL------SRPFQSIIHAKRTYRELRLLK 74
Query: 398 HLKHPNIVQ----YYGSEIVEDKFYIYL-EYVHPGSINKYVREHCGAITESVVRNFTRHI 452
           H+KH N++     +  +  +E+   +YL  ++    +N  V+  C  +T+  V+     I
Sbjct: 75  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQI 132
Query: 453 LSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKG---SPYWM 509
           L GL Y+HS   IHRD+K +NL V+    +K+ DFG+A+H      D  M G   + ++ 
Sbjct: 133 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARH-----TDDEMTGYVATRWYR 187
Query: 510 APELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGK 546
           APE+M+  M   ++      VDIWS+GC + E+ TG+
Sbjct: 188 APEIMLNWMHYNQT------VDIWSVGCIMAELLTGR 218

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score =  100 bits (250), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 66/210 (31%), Positives = 114/210 (54%), Gaps = 30/210 (14%)
Query: 348 IGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESI---KQLEQEIKVLSHLKHPNI 404
           +G G +GSV  A + +TG   A+K++       +  +SI   K+  +E+++L H+KH N+
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKL------SRPFQSIIHAKRTYRELRLLKHMKHENV 89
Query: 405 V----QYYGSEIVEDKFYIYL-EYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYL 459
           +     +  +  +E+   +YL  ++    +N  V+  C  +T+  V+     IL GL Y+
Sbjct: 90  IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILRGLKYI 147
Query: 460 HSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKG---SPYWMAPELMMA 516
           HS   IHRD+K +NL V+    +K+ DFG+A+H      D  M G   + ++ APE+M+ 
Sbjct: 148 HSADIIHRDLKPSNLAVNEDCELKILDFGLARH-----TDDEMTGYVATRWYRAPEIMLN 202
Query: 517 VMQKGKSSDSALAVDIWSLGCTIIEMYTGK 546
            M   ++      VDIWS+GC + E+ TG+
Sbjct: 203 WMHYNQT------VDIWSVGCIMAELLTGR 226

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score =  100 bits (250), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 67/217 (30%), Positives = 117/217 (53%), Gaps = 30/217 (13%)
Query: 341 QWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESI---KQLEQEIKVLS 397
           ++Q    +G G +GSV  A + +TG   A+K++       +  +SI   K+  +E+++L 
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL------SRPFQSIIHAKRTYRELRLLK 76
Query: 398 HLKHPNIV----QYYGSEIVEDKFYIYL-EYVHPGSINKYVREHCGAITESVVRNFTRHI 452
           H+KH N++     +  +  +E+   +YL  ++    +N  V+  C  +T+  V+     I
Sbjct: 77  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQI 134
Query: 453 LSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKG---SPYWM 509
           L GL Y+HS   IHRD+K +NL V+    +K+ DFG+A+H      D  M G   + ++ 
Sbjct: 135 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARH-----TDDEMTGYVATRWYR 189
Query: 510 APELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGK 546
           APE+M+  M   ++      VDIWS+GC + E+ TG+
Sbjct: 190 APEIMLNWMHYNQT------VDIWSVGCIMAELLTGR 220

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score =  100 bits (250), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 67/217 (30%), Positives = 117/217 (53%), Gaps = 30/217 (13%)
Query: 341 QWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESI---KQLEQEIKVLS 397
           ++Q    +G G +GSV  A + +TG   A+K++       +  +SI   K+  +E+++L 
Sbjct: 28  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL------SRPFQSIIHAKRTYRELRLLK 81
Query: 398 HLKHPNIV----QYYGSEIVEDKFYIYL-EYVHPGSINKYVREHCGAITESVVRNFTRHI 452
           H+KH N++     +  +  +E+   +YL  ++    +N  V+  C  +T+  V+     I
Sbjct: 82  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQI 139
Query: 453 LSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKG---SPYWM 509
           L GL Y+HS   IHRD+K +NL V+    +K+ DFG+A+H      D  M G   + ++ 
Sbjct: 140 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARH-----TDDEMTGYVATRWYR 194
Query: 510 APELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGK 546
           APE+M+  M   ++      VDIWS+GC + E+ TG+
Sbjct: 195 APEIMLNWMHYNQT------VDIWSVGCIMAELLTGR 225

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score =  100 bits (250), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 67/217 (30%), Positives = 117/217 (53%), Gaps = 30/217 (13%)
Query: 341 QWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESI---KQLEQEIKVLS 397
           ++Q    +G G +GSV  A + +TG   A+K++       +  +SI   K+  +E+++L 
Sbjct: 19  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL------SRPFQSIIHAKRTYRELRLLK 72
Query: 398 HLKHPNIV----QYYGSEIVEDKFYIYL-EYVHPGSINKYVREHCGAITESVVRNFTRHI 452
           H+KH N++     +  +  +E+   +YL  ++    +N  V+  C  +T+  V+     I
Sbjct: 73  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQI 130
Query: 453 LSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKG---SPYWM 509
           L GL Y+HS   IHRD+K +NL V+    +K+ DFG+A+H      D  M G   + ++ 
Sbjct: 131 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARH-----TDDEMTGYVATRWYR 185
Query: 510 APELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGK 546
           APE+M+  M   ++      VDIWS+GC + E+ TG+
Sbjct: 186 APEIMLNWMHYNQT------VDIWSVGCIMAELLTGR 216

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score =  100 bits (250), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 112/207 (54%), Gaps = 24/207 (11%)
Query: 348 IGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESI---KQLEQEIKVLSHLKHPNI 404
           +G G +GSV  A + +TG   A+K++       +  +SI   K+  +E+++L H+KH N+
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKL------SRPFQSIIHAKRTYRELRLLKHMKHENV 90
Query: 405 V----QYYGSEIVEDKFYIYL-EYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYL 459
           +     +  +  +E+   +YL  ++    +N  V+  C  +T+  V+     IL GL Y+
Sbjct: 91  IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILRGLKYI 148
Query: 460 HSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPYWMAPELMMAVMQ 519
           HS   IHRD+K +NL V+    +K+ DFG+A+H   +        + ++ APE+M+  M 
Sbjct: 149 HSADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMT--GYVATRWYRAPEIMLNWMH 206
Query: 520 KGKSSDSALAVDIWSLGCTIIEMYTGK 546
             ++      VDIWS+GC + E+ TG+
Sbjct: 207 YNQT------VDIWSVGCIMAELLTGR 227

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score =  100 bits (250), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 67/217 (30%), Positives = 117/217 (53%), Gaps = 30/217 (13%)
Query: 341 QWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESI---KQLEQEIKVLS 397
           ++Q    +G G +GSV  A + +TG   A+K++       +  +SI   K+  +E+++L 
Sbjct: 43  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL------SRPFQSIIHAKRTYRELRLLK 96
Query: 398 HLKHPNIVQ----YYGSEIVEDKFYIYL-EYVHPGSINKYVREHCGAITESVVRNFTRHI 452
           H+KH N++     +  +  +E+   +YL  ++    +N  V+  C  +T+  V+     I
Sbjct: 97  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQI 154
Query: 453 LSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKG---SPYWM 509
           L GL Y+HS   IHRD+K +NL V+    +K+ DFG+A+H      D  M G   + ++ 
Sbjct: 155 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARH-----TDDEMTGYVATRWYR 209
Query: 510 APELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGK 546
           APE+M+  M   ++      VDIWS+GC + E+ TG+
Sbjct: 210 APEIMLNWMHYNQT------VDIWSVGCIMAELLTGR 240

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score =  100 bits (250), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 71/249 (28%), Positives = 116/249 (46%), Gaps = 16/249 (6%)
Query: 348 IGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQY 407
           +G G +G VY    ++     A+K +       +    +++  +E  V+  +KHPN+VQ 
Sbjct: 228 LGGGQYGEVYEGVWKKYSLTVAVKTLK------EDTMEVEEFLKEAAVMKEIKHPNLVQL 281
Query: 408 YGSEIVEDKFYIYLEYVHPGSINKYVREHCG--AITESVVRNFTRHILSGLAYLHSKKTI 465
            G    E  FYI  E++  G++  Y+RE C    ++  V+      I S + YL  K  I
Sbjct: 282 LGVCTREPPFYIITEFMTYGNLLDYLRE-CNRQEVSAVVLLYMATQISSAMEYLEKKNFI 340
Query: 466 HRDIKGANLLVDASGVVKLADFGMAKHLTGQ--KADLSMKGSPYWMAPELMMAVMQKGKS 523
           HR++   N LV  + +VK+ADFG+++ +TG    A    K    W APE +       KS
Sbjct: 341 HRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKS 400
Query: 524 SDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDSLSPEGKDFLRCC 583
              A  V +W +    +  Y G      YE     +++ R     P+    +  + +R C
Sbjct: 401 DVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMER-----PEGCPEKVYELMRAC 455
Query: 584 FQRNPADRP 592
           +Q NP+DRP
Sbjct: 456 WQWNPSDRP 464

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score =  100 bits (250), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 66/210 (31%), Positives = 114/210 (54%), Gaps = 30/210 (14%)
Query: 348 IGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESI---KQLEQEIKVLSHLKHPNI 404
           +G G +GSV  A + +TG   A+K++       +  +SI   K+  +E+++L H+KH N+
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKL------SRPFQSIIHAKRTYRELRLLKHMKHENV 83
Query: 405 V----QYYGSEIVEDKFYIYL-EYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYL 459
           +     +  +  +E+   +YL  ++    +N  V+  C  +T+  V+     IL GL Y+
Sbjct: 84  IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILRGLKYI 141
Query: 460 HSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKG---SPYWMAPELMMA 516
           HS   IHRD+K +NL V+    +K+ DFG+A+H      D  M G   + ++ APE+M+ 
Sbjct: 142 HSADIIHRDLKPSNLAVNEDCELKILDFGLARH-----TDDEMTGYVATRWYRAPEIMLN 196
Query: 517 VMQKGKSSDSALAVDIWSLGCTIIEMYTGK 546
            M   ++      VDIWS+GC + E+ TG+
Sbjct: 197 WMHYNQT------VDIWSVGCIMAELLTGR 220

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score =  100 bits (250), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 66/210 (31%), Positives = 114/210 (54%), Gaps = 30/210 (14%)
Query: 348 IGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESI---KQLEQEIKVLSHLKHPNI 404
           +G G +GSV  A + +TG   A+K++       +  +SI   K+  +E+++L H+KH N+
Sbjct: 40  VGSGAYGSVCAAFDTKTGHRVAVKKL------SRPFQSIIHAKRTYRELRLLKHMKHENV 93
Query: 405 V----QYYGSEIVEDKFYIYL-EYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYL 459
           +     +  +  +E+   +YL  ++    +N  V+  C  +T+  V+     IL GL Y+
Sbjct: 94  IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILRGLKYI 151
Query: 460 HSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKG---SPYWMAPELMMA 516
           HS   IHRD+K +NL V+    +K+ DFG+A+H      D  M G   + ++ APE+M+ 
Sbjct: 152 HSADIIHRDLKPSNLAVNEDCELKILDFGLARH-----TDDEMTGYVATRWYRAPEIMLN 206
Query: 517 VMQKGKSSDSALAVDIWSLGCTIIEMYTGK 546
            M   ++      VDIWS+GC + E+ TG+
Sbjct: 207 WMHYNQT------VDIWSVGCIMAELLTGR 230

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score =  100 bits (250), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 69/223 (30%), Positives = 112/223 (50%), Gaps = 27/223 (12%)
Query: 340 SQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHL 399
           S+++K   IG+GTFG V+ A +R+TG   A+K+V    ++ K    I  L +EIK+L  L
Sbjct: 18  SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKV--LMENEKEGFPITAL-REIKILQLL 74
Query: 400 KHPNIVQYYGSEIVEDK----------FYIYLEYVHPGSINKYVREHCGAITESVVRNFT 449
           KH N+V     EI   K           Y+  ++     +   +       T S ++   
Sbjct: 75  KHENVVNLI--EICRTKASPYNRCKASIYLVFDFCE-HDLAGLLSNVLVKFTLSEIKRVM 131
Query: 450 RHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKAD-----LSMKG 504
           + +L+GL Y+H  K +HRD+K AN+L+   GV+KLADFG+A+  +  K        +   
Sbjct: 132 QMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVV 191
Query: 505 SPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKP 547
           + ++  PEL++         D    +D+W  GC + EM+T  P
Sbjct: 192 TLWYRPPELLLG------ERDYGPPIDLWGAGCIMAEMWTRSP 228

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score =  100 bits (250), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 67/217 (30%), Positives = 117/217 (53%), Gaps = 30/217 (13%)
Query: 341 QWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESI---KQLEQEIKVLS 397
           ++Q    +G G +GSV  A + +TG   A+K++       +  +SI   K+  +E+++L 
Sbjct: 29  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL------SRPFQSIIHAKRTYRELRLLK 82
Query: 398 HLKHPNIV----QYYGSEIVEDKFYIYL-EYVHPGSINKYVREHCGAITESVVRNFTRHI 452
           H+KH N++     +  +  +E+   +YL  ++    +N  V+  C  +T+  V+     I
Sbjct: 83  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQI 140
Query: 453 LSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKG---SPYWM 509
           L GL Y+HS   IHRD+K +NL V+    +K+ DFG+A+H      D  M G   + ++ 
Sbjct: 141 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARH-----TDDEMTGYVATRWYR 195
Query: 510 APELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGK 546
           APE+M+  M   ++      VDIWS+GC + E+ TG+
Sbjct: 196 APEIMLNWMHYNQT------VDIWSVGCIMAELLTGR 226

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score =  100 bits (250), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 67/217 (30%), Positives = 117/217 (53%), Gaps = 30/217 (13%)
Query: 341 QWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESI---KQLEQEIKVLS 397
           ++Q    +G G +GSV  A + +TG   A+K++       +  +SI   K+  +E+++L 
Sbjct: 19  RYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKL------SRPFQSIIHAKRTYRELRLLK 72
Query: 398 HLKHPNIV----QYYGSEIVEDKFYIYL-EYVHPGSINKYVREHCGAITESVVRNFTRHI 452
           H+KH N++     +  +  +E+   +YL  ++    +N  V+  C  +T+  V+     I
Sbjct: 73  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQI 130
Query: 453 LSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKG---SPYWM 509
           L GL Y+HS   IHRD+K +NL V+    +K+ DFG+A+H      D  M G   + ++ 
Sbjct: 131 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARH-----TDDEMTGYVATRWYR 185
Query: 510 APELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGK 546
           APE+M+  M   ++      VDIWS+GC + E+ TG+
Sbjct: 186 APEIMLNWMHYNQT------VDIWSVGCIMAELLTGR 216

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score =  100 bits (250), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 66/210 (31%), Positives = 114/210 (54%), Gaps = 30/210 (14%)
Query: 348 IGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESI---KQLEQEIKVLSHLKHPNI 404
           +G G +GSV  A + +TG   A+K++       +  +SI   K+  +E+++L H+KH N+
Sbjct: 53  VGSGAYGSVCAAFDTKTGLRVAVKKL------SRPFQSIIHAKRTYRELRLLKHMKHENV 106
Query: 405 VQ----YYGSEIVEDKFYIYL-EYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYL 459
           +     +  +  +E+   +YL  ++    +N  V+  C  +T+  V+     IL GL Y+
Sbjct: 107 IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILRGLKYI 164
Query: 460 HSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKG---SPYWMAPELMMA 516
           HS   IHRD+K +NL V+    +K+ DFG+A+H      D  M G   + ++ APE+M+ 
Sbjct: 165 HSADIIHRDLKPSNLAVNEDCELKILDFGLARH-----TDDEMTGYVATRWYRAPEIMLN 219
Query: 517 VMQKGKSSDSALAVDIWSLGCTIIEMYTGK 546
            M   ++      VDIWS+GC + E+ TG+
Sbjct: 220 WMHYNQT------VDIWSVGCIMAELLTGR 243

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score =  100 bits (250), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 112/207 (54%), Gaps = 24/207 (11%)
Query: 348 IGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESI---KQLEQEIKVLSHLKHPNI 404
           +G G +GSV  A + +TG   A+K++       +  +SI   K+  +E+++L H+KH N+
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKL------SRPFQSIIHAKRTYRELRLLKHMKHENV 90
Query: 405 V----QYYGSEIVEDKFYIYL-EYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYL 459
           +     +  +  +E+   +YL  ++    +N  V+  C  +T+  V+     IL GL Y+
Sbjct: 91  IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILRGLKYI 148
Query: 460 HSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPYWMAPELMMAVMQ 519
           HS   IHRD+K +NL V+    +K+ DFG+A+H   +        + ++ APE+M+  M 
Sbjct: 149 HSADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMT--GYVATRWYRAPEIMLNWMH 206
Query: 520 KGKSSDSALAVDIWSLGCTIIEMYTGK 546
             ++      VDIWS+GC + E+ TG+
Sbjct: 207 YNQT------VDIWSVGCIMAELLTGR 227

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score =  100 bits (250), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 66/210 (31%), Positives = 114/210 (54%), Gaps = 30/210 (14%)
Query: 348 IGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESI---KQLEQEIKVLSHLKHPNI 404
           +G G +GSV  A + +TG   A+K++       +  +SI   K+  +E+++L H+KH N+
Sbjct: 41  VGSGAYGSVCAAFDTKTGLRVAVKKL------SRPFQSIIHAKRTYRELRLLKHMKHENV 94
Query: 405 VQ----YYGSEIVEDKFYIYL-EYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYL 459
           +     +  +  +E+   +YL  ++    +N  V+  C  +T+  V+     IL GL Y+
Sbjct: 95  IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILRGLKYI 152
Query: 460 HSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKG---SPYWMAPELMMA 516
           HS   IHRD+K +NL V+    +K+ DFG+A+H      D  M G   + ++ APE+M+ 
Sbjct: 153 HSADIIHRDLKPSNLAVNEDCELKILDFGLARH-----TDDEMTGYVATRWYRAPEIMLN 207
Query: 517 VMQKGKSSDSALAVDIWSLGCTIIEMYTGK 546
            M   ++      VDIWS+GC + E+ TG+
Sbjct: 208 WMHYNQT------VDIWSVGCIMAELLTGR 231

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score =  100 bits (250), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 79/277 (28%), Positives = 131/277 (47%), Gaps = 23/277 (8%)
Query: 342 WQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKH 401
           ++  ++IG+G F  V    NRETG   A+K VD+         S + L++E  +   LKH
Sbjct: 26  YELCEVIGKGAFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKH 85
Query: 402 PNIVQYYGSEIVEDKFYIYLEYVHPGSINKYV--REHCGAI-TESVVRNFTRHILSGLAY 458
           P+IV+   +   +   Y+  E++    +   +  R   G + +E+V  ++ R IL  L Y
Sbjct: 86  PHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRY 145
Query: 459 LHSKKTIHRDIKGANLLV---DASGVVKLADFGMAKHLTGQKADLS--MKGSPYWMAPEL 513
            H    IHRD+K  N+L+   + S  VKL DFG+A  L G+   ++    G+P++MAPE+
Sbjct: 146 CHDNNIIHRDVKPENVLLASKENSAPVKLGDFGVAIQL-GESGLVAGGRVGTPHFMAPEV 204
Query: 514 MMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVM-----RDTPAI 568
           +       K       VD+W  G  +  + +G  P+  Y     +F+ +     +  P  
Sbjct: 205 V-------KREPYGKPVDVWGCGVILFILLSGCLPF--YGTKERLFEGIIKGKYKMNPRQ 255
Query: 569 PDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKN 605
              +S   KD +R     +PA+R      L H +LK 
Sbjct: 256 WSHISESAKDLVRRMLMLDPAERITVYEALNHPWLKE 292

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score =  100 bits (250), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 112/207 (54%), Gaps = 24/207 (11%)
Query: 348 IGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESI---KQLEQEIKVLSHLKHPNI 404
           +G G +GSV  A + +TG   A+K++       +  +SI   K+  +E+++L H+KH N+
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKL------SRPFQSIIHAKRTYRELRLLKHMKHENV 90
Query: 405 V----QYYGSEIVEDKFYIYL-EYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYL 459
           +     +  +  +E+   +YL  ++    +N  V+  C  +T+  V+     IL GL Y+
Sbjct: 91  IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILRGLKYI 148
Query: 460 HSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPYWMAPELMMAVMQ 519
           HS   IHRD+K +NL V+    +K+ DFG+A+H   +        + ++ APE+M+  M 
Sbjct: 149 HSADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMT--GYVATRWYRAPEIMLNWMH 206
Query: 520 KGKSSDSALAVDIWSLGCTIIEMYTGK 546
             ++      VDIWS+GC + E+ TG+
Sbjct: 207 YNQT------VDIWSVGCIMAELLTGR 227

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score =  100 bits (250), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 72/249 (28%), Positives = 116/249 (46%), Gaps = 16/249 (6%)
Query: 348 IGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQY 407
           +G G +G VY    ++     A+K +       +    +++  +E  V+  +KHPN+VQ 
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTL------KEDTMEVEEFLKEAAVMKEIKHPNLVQL 74
Query: 408 YGSEIVEDKFYIYLEYVHPGSINKYVREHCG--AITESVVRNFTRHILSGLAYLHSKKTI 465
            G    E  FYI  E++  G++  Y+RE C    ++  V+      I S + YL  K  I
Sbjct: 75  LGVCTREPPFYIITEFMTYGNLLDYLRE-CNRQEVSAVVLLYMATQISSAMEYLEKKNFI 133
Query: 466 HRDIKGANLLVDASGVVKLADFGMAKHLTGQ--KADLSMKGSPYWMAPELMMAVMQKGKS 523
           HRD+   N LV  + +VK+ADFG+++ +TG    A    K    W APE +       KS
Sbjct: 134 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKS 193
Query: 524 SDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDSLSPEGKDFLRCC 583
              A  V +W +    +  Y G      YE     +++ R     P+    +  + +R C
Sbjct: 194 DVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMER-----PEGCPEKVYELMRAC 248
Query: 584 FQRNPADRP 592
           +Q NP+DRP
Sbjct: 249 WQWNPSDRP 257

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score =  100 bits (249), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 71/249 (28%), Positives = 115/249 (46%), Gaps = 16/249 (6%)
Query: 348 IGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQY 407
           +G G +G VY    ++     A+K +       +    +++  +E  V+  +KHPN+VQ 
Sbjct: 267 LGGGQYGEVYEGVWKKYSLTVAVKTLK------EDTMEVEEFLKEAAVMKEIKHPNLVQL 320
Query: 408 YGSEIVEDKFYIYLEYVHPGSINKYVREHCG--AITESVVRNFTRHILSGLAYLHSKKTI 465
            G    E  FYI  E++  G++  Y+RE C    +   V+      I S + YL  K  I
Sbjct: 321 LGVCTREPPFYIITEFMTYGNLLDYLRE-CNRQEVNAVVLLYMATQISSAMEYLEKKNFI 379
Query: 466 HRDIKGANLLVDASGVVKLADFGMAKHLTGQ--KADLSMKGSPYWMAPELMMAVMQKGKS 523
           HR++   N LV  + +VK+ADFG+++ +TG    A    K    W APE +       KS
Sbjct: 380 HRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKS 439
Query: 524 SDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDSLSPEGKDFLRCC 583
              A  V +W +    +  Y G      YE     +++ R     P+    +  + +R C
Sbjct: 440 DVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMER-----PEGCPEKVYELMRAC 494
Query: 584 FQRNPADRP 592
           +Q NP+DRP
Sbjct: 495 WQWNPSDRP 503

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score =  100 bits (249), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 67/217 (30%), Positives = 117/217 (53%), Gaps = 30/217 (13%)
Query: 341 QWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESI---KQLEQEIKVLS 397
           ++Q    +G G +GSV  A + +TG   A+K++       +  +SI   K+  +E+++L 
Sbjct: 43  RYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKL------SRPFQSIIHAKRTYRELRLLK 96
Query: 398 HLKHPNIVQ----YYGSEIVEDKFYIYL-EYVHPGSINKYVREHCGAITESVVRNFTRHI 452
           H+KH N++     +  +  +E+   +YL  ++    +N  V+  C  +T+  V+     I
Sbjct: 97  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQI 154
Query: 453 LSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKG---SPYWM 509
           L GL Y+HS   IHRD+K +NL V+    +K+ DFG+A+H      D  M G   + ++ 
Sbjct: 155 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARH-----TDDEMXGXVATRWYR 209
Query: 510 APELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGK 546
           APE+M+  M   ++      VDIWS+GC + E+ TG+
Sbjct: 210 APEIMLNWMHYNQT------VDIWSVGCIMAELLTGR 240

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score =  100 bits (249), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 67/217 (30%), Positives = 117/217 (53%), Gaps = 30/217 (13%)
Query: 341 QWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESI---KQLEQEIKVLS 397
           ++Q    +G G +GSV  A + +TG   A+K++       +  +SI   K+  +E+++L 
Sbjct: 43  RYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKL------SRPFQSIIHAKRTYRELRLLK 96
Query: 398 HLKHPNIVQ----YYGSEIVEDKFYIYL-EYVHPGSINKYVREHCGAITESVVRNFTRHI 452
           H+KH N++     +  +  +E+   +YL  ++    +N  V+  C  +T+  V+     I
Sbjct: 97  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQI 154
Query: 453 LSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKG---SPYWM 509
           L GL Y+HS   IHRD+K +NL V+    +K+ DFG+A+H      D  M G   + ++ 
Sbjct: 155 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARH-----TDDEMTGYVATRWYR 209
Query: 510 APELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGK 546
           APE+M+  M   ++      VDIWS+GC + E+ TG+
Sbjct: 210 APEIMLNWMHYNQT------VDIWSVGCIMAELLTGR 240

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score =  100 bits (249), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 69/223 (30%), Positives = 112/223 (50%), Gaps = 27/223 (12%)
Query: 340 SQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHL 399
           S+++K   IG+GTFG V+ A +R+TG   A+K+V    ++ K    I  L +EIK+L  L
Sbjct: 18  SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKV--LMENEKEGFPITAL-REIKILQLL 74
Query: 400 KHPNIVQYYGSEIVEDK----------FYIYLEYVHPGSINKYVREHCGAITESVVRNFT 449
           KH N+V     EI   K           Y+  ++     +   +       T S ++   
Sbjct: 75  KHENVVNLI--EICRTKASPYNRCKGSIYLVFDFCE-HDLAGLLSNVLVKFTLSEIKRVM 131
Query: 450 RHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKAD-----LSMKG 504
           + +L+GL Y+H  K +HRD+K AN+L+   GV+KLADFG+A+  +  K        +   
Sbjct: 132 QMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVV 191
Query: 505 SPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKP 547
           + ++  PEL++         D    +D+W  GC + EM+T  P
Sbjct: 192 TLWYRPPELLLG------ERDYGPPIDLWGAGCIMAEMWTRSP 228

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score =  100 bits (249), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 67/217 (30%), Positives = 117/217 (53%), Gaps = 30/217 (13%)
Query: 341 QWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESI---KQLEQEIKVLS 397
           ++Q    +G G +GSV  A + +TG   A+K++       +  +SI   K+  +E+++L 
Sbjct: 42  RYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKL------SRPFQSIIHAKRTYRELRLLK 95
Query: 398 HLKHPNIVQ----YYGSEIVEDKFYIYL-EYVHPGSINKYVREHCGAITESVVRNFTRHI 452
           H+KH N++     +  +  +E+   +YL  ++    +N  V+  C  +T+  V+     I
Sbjct: 96  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQI 153
Query: 453 LSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKG---SPYWM 509
           L GL Y+HS   IHRD+K +NL V+    +K+ DFG+A+H      D  M G   + ++ 
Sbjct: 154 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARH-----TDDEMTGYVATRWYR 208
Query: 510 APELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGK 546
           APE+M+  M   ++      VDIWS+GC + E+ TG+
Sbjct: 209 APEIMLNWMHYNQT------VDIWSVGCIMAELLTGR 239

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score =  100 bits (249), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 72/249 (28%), Positives = 116/249 (46%), Gaps = 16/249 (6%)
Query: 348 IGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQY 407
           +G G +G VY    ++     A+K +       +    +++  +E  V+  +KHPN+VQ 
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTL------KEDTMEVEEFLKEAAVMKEIKHPNLVQL 74
Query: 408 YGSEIVEDKFYIYLEYVHPGSINKYVREHCG--AITESVVRNFTRHILSGLAYLHSKKTI 465
            G    E  FYI  E++  G++  Y+RE C    ++  V+      I S + YL  K  I
Sbjct: 75  LGVCTREPPFYIITEFMTYGNLLDYLRE-CNRQEVSAVVLLYMATQISSAMEYLEKKNFI 133
Query: 466 HRDIKGANLLVDASGVVKLADFGMAKHLTGQ--KADLSMKGSPYWMAPELMMAVMQKGKS 523
           HRD+   N LV  + +VK+ADFG+++ +TG    A    K    W APE +       KS
Sbjct: 134 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKS 193
Query: 524 SDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDSLSPEGKDFLRCC 583
              A  V +W +    +  Y G      YE     +++ R     P+    +  + +R C
Sbjct: 194 DVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMER-----PEGCPEKVYELMRAC 248
Query: 584 FQRNPADRP 592
           +Q NP+DRP
Sbjct: 249 WQWNPSDRP 257

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score =  100 bits (249), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 72/249 (28%), Positives = 115/249 (46%), Gaps = 16/249 (6%)
Query: 348 IGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQY 407
           +G G +G VY    ++     A+K +       +    +++  +E  V+  +KHPN+VQ 
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTL------KEDTMEVEEFLKEAAVMKEIKHPNLVQL 79
Query: 408 YGSEIVEDKFYIYLEYVHPGSINKYVREHCG--AITESVVRNFTRHILSGLAYLHSKKTI 465
            G    E  FYI  E++  G++  Y+RE C    +   V+      I S + YL  K  I
Sbjct: 80  LGVCTREPPFYIITEFMTYGNLLDYLRE-CNRQEVNAVVLLYMATQISSAMEYLEKKNFI 138
Query: 466 HRDIKGANLLVDASGVVKLADFGMAKHLTGQ--KADLSMKGSPYWMAPELMMAVMQKGKS 523
           HRD+   N LV  + +VK+ADFG+++ +TG    A    K    W APE +       KS
Sbjct: 139 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKS 198
Query: 524 SDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDSLSPEGKDFLRCC 583
              A  V +W +    +  Y G      YE     +++ R     P+    +  + +R C
Sbjct: 199 DVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMER-----PEGCPEKVYELMRAC 253
Query: 584 FQRNPADRP 592
           +Q NP+DRP
Sbjct: 254 WQWNPSDRP 262

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score =  100 bits (249), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 67/217 (30%), Positives = 117/217 (53%), Gaps = 30/217 (13%)
Query: 341 QWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESI---KQLEQEIKVLS 397
           ++Q    +G G +GSV  A + +TG   A+K++       +  +SI   K+  +E+++L 
Sbjct: 29  RYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKL------SRPFQSIIHAKRTYRELRLLK 82
Query: 398 HLKHPNIV----QYYGSEIVEDKFYIYL-EYVHPGSINKYVREHCGAITESVVRNFTRHI 452
           H+KH N++     +  +  +E+   +YL  ++    +N  V+  C  +T+  V+     I
Sbjct: 83  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQI 140
Query: 453 LSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKG---SPYWM 509
           L GL Y+HS   IHRD+K +NL V+    +K+ DFG+A+H      D  M G   + ++ 
Sbjct: 141 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARH-----TDDEMTGYVATRWYR 195
Query: 510 APELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGK 546
           APE+M+  M   ++      VDIWS+GC + E+ TG+
Sbjct: 196 APEIMLNWMHYNQT------VDIWSVGCIMAELLTGR 226

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score =  100 bits (249), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 72/249 (28%), Positives = 115/249 (46%), Gaps = 16/249 (6%)
Query: 348 IGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQY 407
           +G G +G VY    ++     A+K +       +    +++  +E  V+  +KHPN+VQ 
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLK------EDTMEVEEFLKEAAVMKEIKHPNLVQL 74
Query: 408 YGSEIVEDKFYIYLEYVHPGSINKYVREHCG--AITESVVRNFTRHILSGLAYLHSKKTI 465
            G    E  FYI  E++  G++  Y+RE C    +   V+      I S + YL  K  I
Sbjct: 75  LGVCTREPPFYIITEFMTYGNLLDYLRE-CNRQEVNAVVLLYMATQISSAMEYLEKKNFI 133
Query: 466 HRDIKGANLLVDASGVVKLADFGMAKHLTGQ--KADLSMKGSPYWMAPELMMAVMQKGKS 523
           HRD+   N LV  + +VK+ADFG+++ +TG    A    K    W APE +       KS
Sbjct: 134 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKS 193
Query: 524 SDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDSLSPEGKDFLRCC 583
              A  V +W +    +  Y G      YE     +++ R     P+    +  + +R C
Sbjct: 194 DVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMER-----PEGCPEKVYELMRAC 248
Query: 584 FQRNPADRP 592
           +Q NP+DRP
Sbjct: 249 WQWNPSDRP 257

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score =  100 bits (249), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 72/249 (28%), Positives = 115/249 (46%), Gaps = 16/249 (6%)
Query: 348 IGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQY 407
           +G G +G VY    ++     A+K +       +    +++  +E  V+  +KHPN+VQ 
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLK------EDTMEVEEFLKEAAVMKEIKHPNLVQL 74
Query: 408 YGSEIVEDKFYIYLEYVHPGSINKYVREHCG--AITESVVRNFTRHILSGLAYLHSKKTI 465
            G    E  FYI  E++  G++  Y+RE C    +   V+      I S + YL  K  I
Sbjct: 75  LGVCTREPPFYIITEFMTYGNLLDYLRE-CNRQEVNAVVLLYMATQISSAMEYLEKKNFI 133
Query: 466 HRDIKGANLLVDASGVVKLADFGMAKHLTGQ--KADLSMKGSPYWMAPELMMAVMQKGKS 523
           HRD+   N LV  + +VK+ADFG+++ +TG    A    K    W APE +       KS
Sbjct: 134 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKS 193
Query: 524 SDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDSLSPEGKDFLRCC 583
              A  V +W +    +  Y G      YE     +++ R     P+    +  + +R C
Sbjct: 194 DVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMER-----PEGCPEKVYELMRAC 248
Query: 584 FQRNPADRP 592
           +Q NP+DRP
Sbjct: 249 WQWNPSDRP 257

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score =  100 bits (249), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 72/249 (28%), Positives = 115/249 (46%), Gaps = 16/249 (6%)
Query: 348 IGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQY 407
           +G G +G VY    ++     A+K +       +    +++  +E  V+  +KHPN+VQ 
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTL------KEDTMEVEEFLKEAAVMKEIKHPNLVQL 76
Query: 408 YGSEIVEDKFYIYLEYVHPGSINKYVREHCG--AITESVVRNFTRHILSGLAYLHSKKTI 465
            G    E  FYI  E++  G++  Y+RE C    +   V+      I S + YL  K  I
Sbjct: 77  LGVCTREPPFYIITEFMTYGNLLDYLRE-CNRQEVNAVVLLYMATQISSAMEYLEKKNFI 135
Query: 466 HRDIKGANLLVDASGVVKLADFGMAKHLTGQ--KADLSMKGSPYWMAPELMMAVMQKGKS 523
           HRD+   N LV  + +VK+ADFG+++ +TG    A    K    W APE +       KS
Sbjct: 136 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKS 195
Query: 524 SDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDSLSPEGKDFLRCC 583
              A  V +W +    +  Y G      YE     +++ R     P+    +  + +R C
Sbjct: 196 DVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMER-----PEGCPEKVYELMRAC 250
Query: 584 FQRNPADRP 592
           +Q NP+DRP
Sbjct: 251 WQWNPSDRP 259

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score =  100 bits (248), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 71/259 (27%), Positives = 125/259 (48%), Gaps = 25/259 (9%)
Query: 346 KLIGRGTFGSVYVASNRETGALCAMKEV--DIFPDDPKSAESIKQLEQEIKVLSHL-KHP 402
           ++IGRG++  V +   ++T  + AMK V  ++  DD    E I  ++ E  V      HP
Sbjct: 15  RVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDD----EDIDWVQTEKHVFEQASNHP 70
Query: 403 NIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSK 462
            +V  +     E + +  +EYV+ G +  +++     + E   R ++  I   L YLH +
Sbjct: 71  FLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQ-RKLPEEHARFYSAEISLALNYLHER 129
Query: 463 KTIHRDIKGANLLVDASGVVKLADFGMAKH-LTGQKADLSMKGSPYWMAPELMMAVMQKG 521
             I+RD+K  N+L+D+ G +KL D+GM K  L          G+P ++APE++       
Sbjct: 130 GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPEIL------- 182
Query: 522 KSSDSALAVDIWSLGCTIIEMYTGKPPWS--------EYEGAAAMFKVMRDTPA-IPDSL 572
           +  D   +VD W+LG  + EM  G+ P+         +      +F+V+ +    IP SL
Sbjct: 183 RGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSL 242
Query: 573 SPEGKDFLRCCFQRNPADR 591
           S +    L+    ++P +R
Sbjct: 243 SVKAASVLKSFLNKDPKER 261

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score =  100 bits (248), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 72/249 (28%), Positives = 115/249 (46%), Gaps = 16/249 (6%)
Query: 348 IGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQY 407
           +G G +G VY    ++     A+K +       +    +++  +E  V+  +KHPN+VQ 
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTL------KEDTMEVEEFLKEAAVMKEIKHPNLVQL 76
Query: 408 YGSEIVEDKFYIYLEYVHPGSINKYVREHCG--AITESVVRNFTRHILSGLAYLHSKKTI 465
            G    E  FYI  E++  G++  Y+RE C    +   V+      I S + YL  K  I
Sbjct: 77  LGVCTREPPFYIITEFMTYGNLLDYLRE-CNRQEVNAVVLLYMATQISSAMEYLEKKNFI 135
Query: 466 HRDIKGANLLVDASGVVKLADFGMAKHLTGQ--KADLSMKGSPYWMAPELMMAVMQKGKS 523
           HRD+   N LV  + +VK+ADFG+++ +TG    A    K    W APE +       KS
Sbjct: 136 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKS 195
Query: 524 SDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDSLSPEGKDFLRCC 583
              A  V +W +    +  Y G      YE     +++ R     P+    +  + +R C
Sbjct: 196 DVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMER-----PEGCPEKVYELMRAC 250
Query: 584 FQRNPADRP 592
           +Q NP+DRP
Sbjct: 251 WQWNPSDRP 259

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score =  100 bits (248), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 70/259 (27%), Positives = 126/259 (48%), Gaps = 25/259 (9%)
Query: 346 KLIGRGTFGSVYVASNRETGALCAMKEV--DIFPDDPKSAESIKQLEQEIKVLSHL-KHP 402
           ++IGRG++  V +   ++T  + AM+ V  ++  DD    E I  ++ E  V      HP
Sbjct: 58  RVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDD----EDIDWVQTEKHVFEQASNHP 113
Query: 403 NIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSK 462
            +V  +     E + +  +EYV+ G +  +++     + E   R ++  I   L YLH +
Sbjct: 114 FLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQ-RKLPEEHARFYSAEISLALNYLHER 172
Query: 463 KTIHRDIKGANLLVDASGVVKLADFGMAKH-LTGQKADLSMKGSPYWMAPELMMAVMQKG 521
             I+RD+K  N+L+D+ G +KL D+GM K  L       +  G+P ++APE++       
Sbjct: 173 GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEIL------- 225
Query: 522 KSSDSALAVDIWSLGCTIIEMYTGKPPWS--------EYEGAAAMFKVMRDTPA-IPDSL 572
           +  D   +VD W+LG  + EM  G+ P+         +      +F+V+ +    IP SL
Sbjct: 226 RGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSL 285
Query: 573 SPEGKDFLRCCFQRNPADR 591
           S +    L+    ++P +R
Sbjct: 286 SVKAASVLKSFLNKDPKER 304

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score =  100 bits (248), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 71/259 (27%), Positives = 125/259 (48%), Gaps = 25/259 (9%)
Query: 346 KLIGRGTFGSVYVASNRETGALCAMKEV--DIFPDDPKSAESIKQLEQEIKVLSHL-KHP 402
           ++IGRG++  V +   ++T  + AMK V  ++  DD    E I  ++ E  V      HP
Sbjct: 11  RVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDD----EDIDWVQTEKHVFEQASNHP 66
Query: 403 NIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSK 462
            +V  +     E + +  +EYV+ G +  +++     + E   R ++  I   L YLH +
Sbjct: 67  FLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQ-RKLPEEHARFYSAEISLALNYLHER 125
Query: 463 KTIHRDIKGANLLVDASGVVKLADFGMAKH-LTGQKADLSMKGSPYWMAPELMMAVMQKG 521
             I+RD+K  N+L+D+ G +KL D+GM K  L          G+P ++APE++       
Sbjct: 126 GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPEIL------- 178
Query: 522 KSSDSALAVDIWSLGCTIIEMYTGKPPWS--------EYEGAAAMFKVMRDTPA-IPDSL 572
           +  D   +VD W+LG  + EM  G+ P+         +      +F+V+ +    IP SL
Sbjct: 179 RGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSL 238
Query: 573 SPEGKDFLRCCFQRNPADR 591
           S +    L+    ++P +R
Sbjct: 239 SVKAASVLKSFLNKDPKER 257

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score =  100 bits (248), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 72/249 (28%), Positives = 115/249 (46%), Gaps = 16/249 (6%)
Query: 348 IGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQY 407
           +G G +G VY    ++     A+K +       +    +++  +E  V+  +KHPN+VQ 
Sbjct: 34  LGGGQYGEVYEGVWKKYSLTVAVKTL------KEDTMEVEEFLKEAAVMKEIKHPNLVQL 87
Query: 408 YGSEIVEDKFYIYLEYVHPGSINKYVREHCG--AITESVVRNFTRHILSGLAYLHSKKTI 465
            G    E  FYI  E++  G++  Y+RE C    +   V+      I S + YL  K  I
Sbjct: 88  LGVCTREPPFYIITEFMTYGNLLDYLRE-CNRQEVNAVVLLYMATQISSAMEYLEKKNFI 146
Query: 466 HRDIKGANLLVDASGVVKLADFGMAKHLTGQ--KADLSMKGSPYWMAPELMMAVMQKGKS 523
           HRD+   N LV  + +VK+ADFG+++ +TG    A    K    W APE +       KS
Sbjct: 147 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKS 206
Query: 524 SDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDSLSPEGKDFLRCC 583
              A  V +W +    +  Y G      YE     +++ R     P+    +  + +R C
Sbjct: 207 DVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMER-----PEGCPEKVYELMRAC 261
Query: 584 FQRNPADRP 592
           +Q NP+DRP
Sbjct: 262 WQWNPSDRP 270

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score =  100 bits (248), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 72/249 (28%), Positives = 115/249 (46%), Gaps = 16/249 (6%)
Query: 348 IGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQY 407
           +G G +G VY    ++     A+K +       +    +++  +E  V+  +KHPN+VQ 
Sbjct: 22  LGGGQYGEVYEGVWKKYSLTVAVKTLK------EDTMEVEEFLKEAAVMKEIKHPNLVQL 75
Query: 408 YGSEIVEDKFYIYLEYVHPGSINKYVREHCG--AITESVVRNFTRHILSGLAYLHSKKTI 465
            G    E  FYI  E++  G++  Y+RE C    +   V+      I S + YL  K  I
Sbjct: 76  LGVCTREPPFYIITEFMTYGNLLDYLRE-CNRQEVNAVVLLYMATQISSAMEYLEKKNFI 134
Query: 466 HRDIKGANLLVDASGVVKLADFGMAKHLTGQ--KADLSMKGSPYWMAPELMMAVMQKGKS 523
           HRD+   N LV  + +VK+ADFG+++ +TG    A    K    W APE +       KS
Sbjct: 135 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFPIKWTAPESLAYNKFSIKS 194
Query: 524 SDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDSLSPEGKDFLRCC 583
              A  V +W +    +  Y G      YE     +++ R     P+    +  + +R C
Sbjct: 195 DVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMER-----PEGCPEKVYELMRAC 249
Query: 584 FQRNPADRP 592
           +Q NP+DRP
Sbjct: 250 WQWNPSDRP 258

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score =  100 bits (248), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 72/249 (28%), Positives = 115/249 (46%), Gaps = 16/249 (6%)
Query: 348 IGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQY 407
           +G G +G VY    ++     A+K +       +    +++  +E  V+  +KHPN+VQ 
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTLK------EDTMEVEEFLKEAAVMKEIKHPNLVQL 76
Query: 408 YGSEIVEDKFYIYLEYVHPGSINKYVREHCG--AITESVVRNFTRHILSGLAYLHSKKTI 465
            G    E  FYI  E++  G++  Y+RE C    +   V+      I S + YL  K  I
Sbjct: 77  LGVCTREPPFYIITEFMTYGNLLDYLRE-CNRQEVNAVVLLYMATQISSAMEYLEKKNFI 135
Query: 466 HRDIKGANLLVDASGVVKLADFGMAKHLTGQ--KADLSMKGSPYWMAPELMMAVMQKGKS 523
           HRD+   N LV  + +VK+ADFG+++ +TG    A    K    W APE +       KS
Sbjct: 136 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFPIKWTAPESLAYNKFSIKS 195
Query: 524 SDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDSLSPEGKDFLRCC 583
              A  V +W +    +  Y G      YE     +++ R     P+    +  + +R C
Sbjct: 196 DVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMER-----PEGCPEKVYELMRAC 250
Query: 584 FQRNPADRP 592
           +Q NP+DRP
Sbjct: 251 WQWNPSDRP 259

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 99.8 bits (247), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 114/210 (54%), Gaps = 30/210 (14%)
Query: 348 IGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESI---KQLEQEIKVLSHLKHPNI 404
           +G G +GSV  A + +TG   A+K++       +  +SI   K+  +E+++L H+KH N+
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKL------SRPFQSIIHAKRTYRELRLLKHMKHENV 83
Query: 405 V----QYYGSEIVEDKFYIYL-EYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYL 459
           +     +  +  +E+   +YL  ++    +N  V+  C  +T+  V+     IL GL Y+
Sbjct: 84  IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILRGLKYI 141
Query: 460 HSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKG---SPYWMAPELMMA 516
           HS   IHRD+K +NL V+    +K+ D+G+A+H      D  M G   + ++ APE+M+ 
Sbjct: 142 HSADIIHRDLKPSNLAVNEDCELKILDYGLARH-----TDDEMTGYVATRWYRAPEIMLN 196
Query: 517 VMQKGKSSDSALAVDIWSLGCTIIEMYTGK 546
            M   ++      VDIWS+GC + E+ TG+
Sbjct: 197 WMHYNQT------VDIWSVGCIMAELLTGR 220

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 99.8 bits (247), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 70/259 (27%), Positives = 125/259 (48%), Gaps = 25/259 (9%)
Query: 346 KLIGRGTFGSVYVASNRETGALCAMKEV--DIFPDDPKSAESIKQLEQEIKVLSHL-KHP 402
           ++IGRG++  V +   ++T  + AMK V  ++  DD    E I  ++ E  V      HP
Sbjct: 26  RVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDD----EDIDWVQTEKHVFEQASNHP 81
Query: 403 NIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSK 462
            +V  +     E + +  +EYV+ G +  +++     + E   R ++  I   L YLH +
Sbjct: 82  FLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQ-RKLPEEHARFYSAEISLALNYLHER 140
Query: 463 KTIHRDIKGANLLVDASGVVKLADFGMAKH-LTGQKADLSMKGSPYWMAPELMMAVMQKG 521
             I+RD+K  N+L+D+ G +KL D+GM K  L          G+P ++APE++       
Sbjct: 141 GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPEIL------- 193
Query: 522 KSSDSALAVDIWSLGCTIIEMYTGKPPWS--------EYEGAAAMFKVMRDTPA-IPDSL 572
           +  D   +VD W+LG  + EM  G+ P+         +      +F+V+ +    IP S+
Sbjct: 194 RGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSM 253
Query: 573 SPEGKDFLRCCFQRNPADR 591
           S +    L+    ++P +R
Sbjct: 254 SVKAASVLKSFLNKDPKER 272

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 99.8 bits (247), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 77/273 (28%), Positives = 130/273 (47%), Gaps = 45/273 (16%)
Query: 348 IGRGTFGSVYVA-----SNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHP 402
           +G G FG V++A     S  +   L A+K +     DP  A   K  ++E ++L++L+H 
Sbjct: 23  LGEGAFGKVFLAECYNLSPTKDKMLVAVKALK----DPTLAAR-KDFQREAELLTNLQHE 77
Query: 403 NIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHC---------------GAITESVVRN 447
           +IV++YG     D   +  EY+  G +NK++R H                G +  S + +
Sbjct: 78  HIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLH 137
Query: 448 FTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHL-------TGQKADL 500
               I SG+ YL S+  +HRD+   N LV A+ +VK+ DFGM++ +        G    L
Sbjct: 138 IASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTML 197
Query: 501 SMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMF 559
            ++    WM PE   ++M +  +++S    D+WS G  + E++T GK PW +      + 
Sbjct: 198 PIR----WMPPE---SIMYRKFTTES----DVWSFGVILWEIFTYGKQPWFQLSNTEVIE 246
Query: 560 KVMRDTPAIPDSLSP-EGKDFLRCCFQRNPADR 591
            + +        + P E  D +  C+QR P  R
Sbjct: 247 CITQGRVLERPRVCPKEVYDVMLGCWQREPQQR 279

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 99.4 bits (246), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 75/275 (27%), Positives = 131/275 (47%), Gaps = 28/275 (10%)
Query: 338 MNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLS 397
           ++ ++Q+ K +G G +G V +  ++ TGA  A+K +        +  +   L  E+ VL 
Sbjct: 19  LSDRYQRVKKLGSGAYGEVLLCKDKLTGAERAIKIIK--KSSVTTTSNSGALLDEVAVLK 76
Query: 398 HLKHPNIVQYYGSEIVEDK--FYIYLEYVHPGSI--NKYVREHCGAITESVVRNFTRHIL 453
            L HPNI++ Y  E  EDK  +Y+ +E    G +     +R+    +  +V+    + +L
Sbjct: 77  QLDHPNIMKLY--EFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAVI---MKQVL 131
Query: 454 SGLAYLHSKKTIHRDIKGANLLVDA---SGVVKLADFGMAKHL-TGQKADLSMKGSPYWM 509
           SG  YLH    +HRD+K  NLL+++     ++K+ DFG++ H   G K    + G+ Y++
Sbjct: 132 SGTTYLHKHNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKERL-GTAYYI 190
Query: 510 APELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAI- 568
           APE++       K  D     D+WS G  +  +  G PP+        + +V +   +  
Sbjct: 191 APEVLR------KKYDE--KCDVWSCGVILYILLCGYPPFGGQTDQEILKRVEKGKFSFD 242
Query: 569 -PD--SLSPEGKDFLRCCFQRNPADRPPASLLLEH 600
            PD   +S E K  ++      P+ R  A   L H
Sbjct: 243 PPDWTQVSDEAKQLVKLMLTYEPSKRISAEEALNH 277

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 98.6 bits (244), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 75/275 (27%), Positives = 131/275 (47%), Gaps = 28/275 (10%)
Query: 338 MNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLS 397
           ++ ++Q+ K +G G +G V +  ++ TGA  A+K +        +  +   L  E+ VL 
Sbjct: 2   LSDRYQRVKKLGSGAYGEVLLCKDKLTGAERAIKIIK--KSSVTTTSNSGALLDEVAVLK 59
Query: 398 HLKHPNIVQYYGSEIVEDK--FYIYLEYVHPGSINKYV--REHCGAITESVVRNFTRHIL 453
            L HPNI++ Y  E  EDK  +Y+ +E    G +   +  R+    +  +V+    + +L
Sbjct: 60  QLDHPNIMKLY--EFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAVI---MKQVL 114
Query: 454 SGLAYLHSKKTIHRDIKGANLLVDA---SGVVKLADFGMAKHL-TGQKADLSMKGSPYWM 509
           SG  YLH    +HRD+K  NLL+++     ++K+ DFG++ H   G K    + G+ Y++
Sbjct: 115 SGTTYLHKHNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKERL-GTAYYI 173
Query: 510 APELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAI- 568
           APE++       K  D     D+WS G  +  +  G PP+        + +V +   +  
Sbjct: 174 APEVLR------KKYDE--KCDVWSCGVILYILLCGYPPFGGQTDQEILKRVEKGKFSFD 225
Query: 569 -PD--SLSPEGKDFLRCCFQRNPADRPPASLLLEH 600
            PD   +S E K  ++      P+ R  A   L H
Sbjct: 226 PPDWTQVSDEAKQLVKLMLTYEPSKRISAEEALNH 260

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 98.6 bits (244), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 80/291 (27%), Positives = 136/291 (46%), Gaps = 25/291 (8%)
Query: 334 EPLPMNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEI 393
           E L   S +Q  + +G+G F  V        G   A K   I      SA   ++LE+E 
Sbjct: 16  ENLYFQSMYQLFEELGKGAFSVVRRCVKVLAGQEYAAK---IINTKKLSARDHQKLEREA 72
Query: 394 KVLSHLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYV--REHCGAITESVVRNFTRH 451
           ++   LKHPNIV+ + S   E   Y+  + V  G + + +  RE+    +E+   +  + 
Sbjct: 73  RICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREY---YSEADASHCIQQ 129
Query: 452 ILSGLAYLHSKKTIHRDIKGANLLVDA---SGVVKLADFGMAKHLTG-QKADLSMKGSPY 507
           IL  + + H    +HRD+K  NLL+ +      VKLADFG+A  + G Q+A     G+P 
Sbjct: 130 ILEAVLHCHQMGVVHRDLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPG 189
Query: 508 WMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPA 567
           +++PE++       +       VD+W+ G  +  +  G PP+ + +      ++      
Sbjct: 190 YLSPEVL-------RKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYD 242
Query: 568 IP----DSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQPDVPSC 614
            P    D+++PE KD +      NP+ R  A+  L+H ++  S +  V SC
Sbjct: 243 FPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALKHPWI--SHRSTVASC 291

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 98.6 bits (244), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 83/268 (30%), Positives = 120/268 (44%), Gaps = 28/268 (10%)
Query: 348 IGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQ-LEQEIKVLSHLKHPNIVQ 406
           IG G++G       +  G +   KE+D         E+ KQ L  E+ +L  LKHPNIV+
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDY----GSMTEAEKQMLVSEVNLLRELKHPNIVR 69
Query: 407 YYGSEI--VEDKFYIYLEYVHPGS----INKYVREHCGAITESVVRNFTRHILSGLAYLH 460
           YY   I       YI +EY   G     I K  +E      E V+R  T+  L+ L   H
Sbjct: 70  YYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLA-LKECH 128
Query: 461 SKK-----TIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMK--GSPYWMAPEL 513
            +       +HRD+K AN+ +D    VKL DFG+A+ L     D + +  G+PY+M+PE 
Sbjct: 129 RRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILN-HDEDFAKEFVGTPYYMSPEQ 187
Query: 514 MMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDT-PAIPDSL 572
           M  +    KS       DIWSLGC + E+    PP++ +       K+       IP   
Sbjct: 188 MNRMSYNEKS-------DIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRY 240
Query: 573 SPEGKDFLRCCFQRNPADRPPASLLLEH 600
           S E  + +          RP    +LE+
Sbjct: 241 SDELNEIITRMLNLKDYHRPSVEEILEN 268

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 98.6 bits (244), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 67/253 (26%), Positives = 121/253 (47%), Gaps = 18/253 (7%)
Query: 342 WQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQ---EIKVLSH 398
           +Q  + +G G+FG V++  +R  G   AMK +       +    +KQ+E    E  +LS 
Sbjct: 8   FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLK-----KEIVVRLKQVEHTNDERLMLSI 62
Query: 399 LKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAY 458
           + HP I++ +G+     + ++ ++Y+  G +   +R+        V + +   +   L Y
Sbjct: 63  VTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRK-SQRFPNPVAKFYAAEVCLALEY 121
Query: 459 LHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPYWMAPELMMAVM 518
           LHSK  I+RD+K  N+L+D +G +K+ DFG AK++      L   G+P ++APE++    
Sbjct: 122 LHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYXLC--GTPDYIAPEVV---- 175
Query: 519 QKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDSLSPEGKD 578
               +     ++D WS G  I EM  G  P+ +        K++      P   + + KD
Sbjct: 176 ---STKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKD 232
Query: 579 FLRCCFQRNPADR 591
            L     R+ + R
Sbjct: 233 LLSRLITRDLSQR 245

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 98.6 bits (244), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 82/267 (30%), Positives = 119/267 (44%), Gaps = 26/267 (9%)
Query: 348 IGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQ-LEQEIKVLSHLKHPNIVQ 406
           IG G++G       +  G +   KE+D         E+ KQ L  E+ +L  LKHPNIV+
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDY----GSMTEAEKQMLVSEVNLLRELKHPNIVR 69
Query: 407 YYGSEI--VEDKFYIYLEYVHPGS----INKYVREHCGAITESVVRNFTRHILSGLAYLH 460
           YY   I       YI +EY   G     I K  +E      E V+R  T+  L+ L   H
Sbjct: 70  YYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLA-LKECH 128
Query: 461 SKK-----TIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKA-DLSMKGSPYWMAPELM 514
            +       +HRD+K AN+ +D    VKL DFG+A+ L    +   +  G+PY+M+PE M
Sbjct: 129 RRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQM 188
Query: 515 MAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDT-PAIPDSLS 573
             +    KS       DIWSLGC + E+    PP++ +       K+       IP   S
Sbjct: 189 NRMSYNEKS-------DIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYS 241
Query: 574 PEGKDFLRCCFQRNPADRPPASLLLEH 600
            E  + +          RP    +LE+
Sbjct: 242 DELNEIITRMLNLKDYHRPSVEEILEN 268

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 98.6 bits (244), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 79/257 (30%), Positives = 126/257 (49%), Gaps = 31/257 (12%)
Query: 348 IGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQ--LEQEIKVLSHLKHPNIV 405
           +G G F  V +A  + TG L A+K +      PK A   K+  +E EI VL  +KH NIV
Sbjct: 30  LGTGAFSEVVLAEEKATGKLFAVKCI------PKKALKGKESSIENEIAVLRKIKHENIV 83
Query: 406 QYYGSEIVE--DKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKK 463
                +I E  +  Y+ ++ V  G +   + E  G  TE       R +L  + YLH   
Sbjct: 84  AL--EDIYESPNHLYLVMQLVSGGELFDRIVEK-GFYTEKDASTLIRQVLDAVYYLHRMG 140
Query: 464 TIHRDIKGANLLV---DASGVVKLADFGMAKHLTGQKADLSMK-GSPYWMAPELMMAVMQ 519
            +HRD+K  NLL    D    + ++DFG++K + G+   +S   G+P ++APE++    Q
Sbjct: 141 IVHRDLKPENLLYYSQDEESKIMISDFGLSK-MEGKGDVMSTACGTPGYVAPEVL---AQ 196
Query: 520 KGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMR-----DTPAIPDSLSP 574
           K  S     AVD WS+G     +  G PP+ +   +    ++++     D+P   D +S 
Sbjct: 197 KPYSK----AVDCWSIGVIAYILLCGYPPFYDENDSKLFEQILKAEYEFDSP-YWDDISD 251
Query: 575 EGKDFLRCCFQRNPADR 591
             KDF+R   +++P  R
Sbjct: 252 SAKDFIRNLMEKDPNKR 268

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 98.2 bits (243), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 77/276 (27%), Positives = 131/276 (47%), Gaps = 23/276 (8%)
Query: 338 MNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLS 397
           M  ++Q  + +G+G F  V       TG   A K   I      SA   ++LE+E ++  
Sbjct: 2   MTDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAK---IINTKKLSARDHQKLEREARICR 58
Query: 398 HLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYV--REHCGAITESVVRNFTRHILSG 455
            LKHPNIV+ + S   E   Y+  + V  G + + +  RE+    +E+   +  + IL  
Sbjct: 59  LLKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREY---YSEADASHCIQQILES 115
Query: 456 LAYLHSKKTIHRDIKGANLLVDA---SGVVKLADFGMAKHLTG-QKADLSMKGSPYWMAP 511
           + + H    +HRD+K  NLL+ +      VKLADFG+A  + G Q+A     G+P +++P
Sbjct: 116 VNHCHLNGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSP 175
Query: 512 ELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIP-- 569
           E++       +       VD+W+ G  +  +  G PP+ + +      ++       P  
Sbjct: 176 EVL-------RKDPYGKPVDMWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSP 228
Query: 570 --DSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFL 603
             D+++PE KD +      NPA R  AS  L+H ++
Sbjct: 229 EWDTVTPEAKDLINKMLTINPAKRITASEALKHPWI 264

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 98.2 bits (243), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 82/267 (30%), Positives = 119/267 (44%), Gaps = 26/267 (9%)
Query: 348 IGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQ-LEQEIKVLSHLKHPNIVQ 406
           IG G++G       +  G +   KE+D         E+ KQ L  E+ +L  LKHPNIV+
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDY----GSMTEAEKQMLVSEVNLLRELKHPNIVR 69
Query: 407 YYGSEI--VEDKFYIYLEYVHPGS----INKYVREHCGAITESVVRNFTRHILSGLAYLH 460
           YY   I       YI +EY   G     I K  +E      E V+R  T+  L+ L   H
Sbjct: 70  YYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLA-LKECH 128
Query: 461 SKK-----TIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKA-DLSMKGSPYWMAPELM 514
            +       +HRD+K AN+ +D    VKL DFG+A+ L    +   +  G+PY+M+PE M
Sbjct: 129 RRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQM 188
Query: 515 MAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDT-PAIPDSLS 573
             +    KS       DIWSLGC + E+    PP++ +       K+       IP   S
Sbjct: 189 NRMSYNEKS-------DIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYS 241
Query: 574 PEGKDFLRCCFQRNPADRPPASLLLEH 600
            E  + +          RP    +LE+
Sbjct: 242 DELNEIITRMLNLKDYHRPSVEEILEN 268

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 98.2 bits (243), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 81/276 (29%), Positives = 129/276 (46%), Gaps = 18/276 (6%)
Query: 348 IGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQY 407
           +GRG +G V    +  +G + A+K +    +  +    +  L+   + +     P  V +
Sbjct: 42  LGRGAYGVVEKXRHVPSGQIXAVKRIRATVNSQEQKRLLXDLDISXRTVDC---PFTVTF 98
Query: 408 YGSEIVEDKFYIYLEYVHPGSINKYVREHCG---AITESVVRNFTRHILSGLAYLHSK-K 463
           YG+   E   +I  E +   S++K+ ++       I E ++      I+  L +LHSK  
Sbjct: 99  YGALFREGDVWICXE-LXDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS 157
Query: 464 TIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKA-DLSMKGSPYWMAPELMMAVMQKGK 522
            IHRD+K +N+L++A G VK  DFG++ +L    A D+     PY     +   + QKG 
Sbjct: 158 VIHRDVKPSNVLINALGQVKXCDFGISGYLVDDVAKDIDAGCKPYXAPERINPELNQKGY 217
Query: 523 SSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFK--VMRDTPAIP-DSLSPEGKDF 579
           S  S    DIWSLG T IE+   + P+  +       K  V   +P +P D  S E  DF
Sbjct: 218 SVKS----DIWSLGITXIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPADKFSAEFVDF 273
Query: 580 LRCCFQRNPADRPPASLLLEHRF--LKNSQQPDVPS 613
              C ++N  +RP    L +H F  L  S+  DV S
Sbjct: 274 TSQCLKKNSKERPTYPELXQHPFFTLHESKGTDVAS 309

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 98.2 bits (243), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 77/279 (27%), Positives = 130/279 (46%), Gaps = 44/279 (15%)
Query: 348 IGRGTFGSV----YVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPN 403
           +G+G FGSV    Y      TGAL A+K++     D +     +  ++EI++L  L    
Sbjct: 15  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQ-----RDFQREIQILKALHSDF 69
Query: 404 IVQYYGSEIVEDK--FYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHS 461
           IV+Y G      +    + +EY+  G +  +++ H   +  S +  ++  I  G+ YL S
Sbjct: 70  IVKYRGVSYGPGRPELRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGS 129
Query: 462 KKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMK---GSP-YWMAPELMMAV 517
           ++ +HRD+   N+LV++   VK+ADFG+AK L   K    ++    SP +W APE +   
Sbjct: 130 RRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDXXVVREPGQSPIFWYAPESLSDN 189
Query: 518 MQKGKSSDSALAVDIWSLGCTIIEMYT----GKPPWSEYEGAAAMFKVMRDTPAI----- 568
           +   +S       D+WS G  + E++T       P +E+     M    RD PA+     
Sbjct: 190 IFSRQS-------DVWSFGVVLYELFTYCDKSCSPSAEF---LRMMGCERDVPALCRLLE 239
Query: 569 ----------PDSLSPEGKDFLRCCFQRNPADRPPASLL 597
                     P +   E  + ++ C+  +P DRP  S L
Sbjct: 240 LLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSAL 278

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 98.2 bits (243), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 63/221 (28%), Positives = 112/221 (50%), Gaps = 26/221 (11%)
Query: 339 NSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIK-QLEQEIKVLS 397
            S+++    IG G +G+VY A +  +G   A+K V +    P   E +     +E+ +L 
Sbjct: 3   TSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRV----PNGEEGLPISTVREVALLR 58
Query: 398 HLK---HPNIVQYY---GSEIVEDKFYIYLEYVHPGSINKYVREHCG-----AITESVVR 446
            L+   HPN+V+      +   + +  + L + H   +++ +R +        +    ++
Sbjct: 59  RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEH---VDQDLRTYLDKAPPPGLPAETIK 115
Query: 447 NFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSP 506
           +  R  L GL +LH+   +HRD+K  N+LV + G VKLADFG+A+  + Q A   +  + 
Sbjct: 116 DLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALFPVVVTL 175
Query: 507 YWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKP 547
           ++ APE+++        S  A  VD+WS+GC   EM+  KP
Sbjct: 176 WYRAPEVLL-------QSTYATPVDMWSVGCIFAEMFRRKP 209

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 98.2 bits (243), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 77/264 (29%), Positives = 124/264 (46%), Gaps = 25/264 (9%)
Query: 346 KLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIV 405
           +++G G F  V++   R TG L A+K +   P    S+     LE EI VL  +KH NIV
Sbjct: 15  EVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSS-----LENEIAVLKKIKHENIV 69
Query: 406 QYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTI 465
                      +Y+ ++ V  G +   + E  G  TE       + +LS + YLH    +
Sbjct: 70  TLEDIYESTTHYYLVMQLVSGGELFDRILER-GVYTEKDASLVIQQVLSAVKYLHENGIV 128
Query: 466 HRDIKGANLLV---DASGVVKLADFGMAKHLTGQKADLSMK-GSPYWMAPELMMAVMQKG 521
           HRD+K  NLL    + +  + + DFG++K    Q   +S   G+P ++APE++    QK 
Sbjct: 129 HRDLKPENLLYLTPEENSKIMITDFGLSK--MEQNGIMSTACGTPGYVAPEVL---AQKP 183
Query: 522 KSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRD-----TPAIPDSLSPEG 576
            S     AVD WS+G     +  G PP+ E E  + +F+ +++          D +S   
Sbjct: 184 YSK----AVDCWSIGVITYILLCGYPPFYE-ETESKLFEKIKEGYYEFESPFWDDISESA 238
Query: 577 KDFLRCCFQRNPADRPPASLLLEH 600
           KDF+    +++P +R      L H
Sbjct: 239 KDFICHLLEKDPNERYTCEKALSH 262

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 98.2 bits (243), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 74/251 (29%), Positives = 125/251 (49%), Gaps = 20/251 (7%)
Query: 347 LIGRGTFGSVYVASNRETGALCAMK----EVDIFPDDPKSAESIKQLEQEIKVLSHLKHP 402
           ++G+G+FG V ++  + T  L A+K    +V I  DD +       +E+ +  L   K P
Sbjct: 348 VLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECT----MVEKRVLALPG-KPP 402
Query: 403 NIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSK 462
            + Q +      D+ Y  +EYV+ G +  ++++  G   E     +   I  GL +L SK
Sbjct: 403 FLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQ-VGRFKEPHAVFYAAEIAIGLFFLQSK 461
Query: 463 KTIHRDIKGANLLVDASGVVKLADFGMAK-HLTGQKADLSMKGSPYWMAPELMMAVMQKG 521
             I+RD+K  N+++D+ G +K+ADFGM K ++          G+P ++APE+ +A    G
Sbjct: 462 GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKXFCGTPDYIAPEI-IAYQPYG 520
Query: 522 KSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFK-VMRDTPAIPDSLSPEGKDFL 580
           KS      VD W+ G  + EM  G+ P+ E E    +F+ +M    A P S+S E     
Sbjct: 521 KS------VDWWAFGVLLYEMLAGQAPF-EGEDEDELFQSIMEHNVAYPKSMSKEAVAIC 573
Query: 581 RCCFQRNPADR 591
           +    ++P  R
Sbjct: 574 KGLMTKHPGKR 584

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 98.2 bits (243), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 113/210 (53%), Gaps = 30/210 (14%)
Query: 348 IGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESI---KQLEQEIKVLSHLKHPNI 404
           +G G +GSV  A + +TG   A+K++       +  +SI   K+  +E+++L H+KH N+
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKL------SRPFQSIIHAKRTYRELRLLKHMKHENV 83
Query: 405 V----QYYGSEIVEDKFYIYL-EYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYL 459
           +     +  +  +E+   +YL  ++    +N  V+  C  +T+  V+     IL GL Y+
Sbjct: 84  IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILRGLKYI 141
Query: 460 HSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKG---SPYWMAPELMMA 516
           HS   IHRD+K +NL V+    +K+  FG+A+H      D  M G   + ++ APE+M+ 
Sbjct: 142 HSADIIHRDLKPSNLAVNEDCELKILGFGLARH-----TDDEMTGYVATRWYRAPEIMLN 196
Query: 517 VMQKGKSSDSALAVDIWSLGCTIIEMYTGK 546
            M   ++      VDIWS+GC + E+ TG+
Sbjct: 197 WMHYNQT------VDIWSVGCIMAELLTGR 220

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 97.8 bits (242), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 77/276 (27%), Positives = 131/276 (47%), Gaps = 23/276 (8%)
Query: 338 MNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLS 397
           M  ++Q  + +G+G F  V       TG   A K   I      SA   ++LE+E ++  
Sbjct: 2   MTDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAK---IINTKKLSARDHQKLEREARICR 58
Query: 398 HLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYV--REHCGAITESVVRNFTRHILSG 455
            LKHPNIV+ + S   E   Y+  + V  G + + +  RE+    +E+   +  + IL  
Sbjct: 59  LLKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREY---YSEADASHCIQQILES 115
Query: 456 LAYLHSKKTIHRDIKGANLLVDA---SGVVKLADFGMAKHLTG-QKADLSMKGSPYWMAP 511
           + + H    +HRD+K  NLL+ +      VKLADFG+A  + G Q+A     G+P +++P
Sbjct: 116 VNHCHLNGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSP 175
Query: 512 ELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIP-- 569
           E++       +       VD+W+ G  +  +  G PP+ + +      ++       P  
Sbjct: 176 EVL-------RKDPYGKPVDMWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSP 228
Query: 570 --DSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFL 603
             D+++PE KD +      NPA R  AS  L+H ++
Sbjct: 229 EWDTVTPEAKDLINKMLTINPAKRITASEALKHPWI 264

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 97.8 bits (242), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 73/282 (25%), Positives = 132/282 (46%), Gaps = 17/282 (6%)
Query: 335 PLPMNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVD---IFPDDPKSAESIKQLEQ 391
           P  +  ++   K +G G  G V +A  R+T    A+K +          + A+    +E 
Sbjct: 5   PKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVET 64
Query: 392 EIKVLSHLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRH 451
           EI++L  L HP I++       ED +YI LE +  G +   V  +   + E+  + +   
Sbjct: 65  EIEILKKLNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGN-KRLKEATCKLYFYQ 122
Query: 452 ILSGLAYLHSKKTIHRDIKGANLLV---DASGVVKLADFGMAKHLTGQKADLSMKGSPYW 508
           +L  + YLH    IHRD+K  N+L+   +   ++K+ DFG +K L       ++ G+P +
Sbjct: 123 MLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTY 182
Query: 509 MAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRD---- 564
           +APE++++V   G +     AVD WSLG  +    +G PP+SE+    ++   +      
Sbjct: 183 LAPEVLVSVGTAGYNR----AVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYN 238
Query: 565 -TPAIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKN 605
             P +   +S +  D ++     +P  R      L H +L++
Sbjct: 239 FIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD 280

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 97.8 bits (242), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 73/282 (25%), Positives = 132/282 (46%), Gaps = 17/282 (6%)
Query: 335 PLPMNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVD---IFPDDPKSAESIKQLEQ 391
           P  +  ++   K +G G  G V +A  R+T    A+K +          + A+    +E 
Sbjct: 4   PKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVET 63
Query: 392 EIKVLSHLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRH 451
           EI++L  L HP I++       ED +YI LE +  G +   V  +   + E+  + +   
Sbjct: 64  EIEILKKLNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGN-KRLKEATCKLYFYQ 121
Query: 452 ILSGLAYLHSKKTIHRDIKGANLLV---DASGVVKLADFGMAKHLTGQKADLSMKGSPYW 508
           +L  + YLH    IHRD+K  N+L+   +   ++K+ DFG +K L       ++ G+P +
Sbjct: 122 MLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTY 181
Query: 509 MAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRD---- 564
           +APE++++V   G +     AVD WSLG  +    +G PP+SE+    ++   +      
Sbjct: 182 LAPEVLVSVGTAGYNR----AVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYN 237
Query: 565 -TPAIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKN 605
             P +   +S +  D ++     +P  R      L H +L++
Sbjct: 238 FIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD 279

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 97.8 bits (242), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 73/282 (25%), Positives = 132/282 (46%), Gaps = 17/282 (6%)
Query: 335 PLPMNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVD---IFPDDPKSAESIKQLEQ 391
           P  +  ++   K +G G  G V +A  R+T    A+K +          + A+    +E 
Sbjct: 11  PKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVET 70
Query: 392 EIKVLSHLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRH 451
           EI++L  L HP I++       ED +YI LE +  G +   V  +   + E+  + +   
Sbjct: 71  EIEILKKLNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGN-KRLKEATCKLYFYQ 128
Query: 452 ILSGLAYLHSKKTIHRDIKGANLLV---DASGVVKLADFGMAKHLTGQKADLSMKGSPYW 508
           +L  + YLH    IHRD+K  N+L+   +   ++K+ DFG +K L       ++ G+P +
Sbjct: 129 MLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTY 188
Query: 509 MAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRD---- 564
           +APE++++V   G +     AVD WSLG  +    +G PP+SE+    ++   +      
Sbjct: 189 LAPEVLVSVGTAGYNR----AVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYN 244
Query: 565 -TPAIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKN 605
             P +   +S +  D ++     +P  R      L H +L++
Sbjct: 245 FIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD 286

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 73/282 (25%), Positives = 132/282 (46%), Gaps = 17/282 (6%)
Query: 335 PLPMNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVD---IFPDDPKSAESIKQLEQ 391
           P  +  ++   K +G G  G V +A  R+T    A+K +          + A+    +E 
Sbjct: 5   PKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVET 64
Query: 392 EIKVLSHLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRH 451
           EI++L  L HP I++       ED +YI LE +  G +   V  +   + E+  + +   
Sbjct: 65  EIEILKKLNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGN-KRLKEATCKLYFYQ 122
Query: 452 ILSGLAYLHSKKTIHRDIKGANLLV---DASGVVKLADFGMAKHLTGQKADLSMKGSPYW 508
           +L  + YLH    IHRD+K  N+L+   +   ++K+ DFG +K L       ++ G+P +
Sbjct: 123 MLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTY 182
Query: 509 MAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRD---- 564
           +APE++++V   G +     AVD WSLG  +    +G PP+SE+    ++   +      
Sbjct: 183 LAPEVLVSVGTAGYNR----AVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYN 238
Query: 565 -TPAIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKN 605
             P +   +S +  D ++     +P  R      L H +L++
Sbjct: 239 FIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD 280

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 73/282 (25%), Positives = 132/282 (46%), Gaps = 17/282 (6%)
Query: 335 PLPMNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVD---IFPDDPKSAESIKQLEQ 391
           P  +  ++   K +G G  G V +A  R+T    A+K +          + A+    +E 
Sbjct: 5   PKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVET 64
Query: 392 EIKVLSHLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRH 451
           EI++L  L HP I++       ED +YI LE +  G +   V  +   + E+  + +   
Sbjct: 65  EIEILKKLNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGN-KRLKEATCKLYFYQ 122
Query: 452 ILSGLAYLHSKKTIHRDIKGANLLV---DASGVVKLADFGMAKHLTGQKADLSMKGSPYW 508
           +L  + YLH    IHRD+K  N+L+   +   ++K+ DFG +K L       ++ G+P +
Sbjct: 123 MLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTY 182
Query: 509 MAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRD---- 564
           +APE++++V   G +     AVD WSLG  +    +G PP+SE+    ++   +      
Sbjct: 183 LAPEVLVSVGTAGYNR----AVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYN 238
Query: 565 -TPAIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKN 605
             P +   +S +  D ++     +P  R      L H +L++
Sbjct: 239 FIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD 280

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 66/217 (30%), Positives = 116/217 (53%), Gaps = 30/217 (13%)
Query: 341 QWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESI---KQLEQEIKVLS 397
           ++Q    +G G +GSV  A + +TG   A+K++       +  +SI   K+  +E+++L 
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKL------SRPFQSIIHAKRTYRELRLLK 76
Query: 398 HLKHPNIV----QYYGSEIVEDKFYIYL-EYVHPGSINKYVREHCGAITESVVRNFTRHI 452
           H+KH N++     +  +  +E+   +YL  ++    +N  V+  C  +T+  V+     I
Sbjct: 77  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQI 134
Query: 453 LSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKG---SPYWM 509
           L GL Y+HS   IHRD+K +NL V+    +K+ DF +A+H      D  M G   + ++ 
Sbjct: 135 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFYLARH-----TDDEMTGYVATRWYR 189
Query: 510 APELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGK 546
           APE+M+  M   ++      VDIWS+GC + E+ TG+
Sbjct: 190 APEIMLNWMHYNQT------VDIWSVGCIMAELLTGR 220

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 77/279 (27%), Positives = 130/279 (46%), Gaps = 44/279 (15%)
Query: 348 IGRGTFGSV----YVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPN 403
           +G+G FGSV    Y      TGAL A+K++     D +     +  ++EI++L  L    
Sbjct: 19  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQ-----RDFQREIQILKALHSDF 73
Query: 404 IVQYYGSEIVEDK--FYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHS 461
           IV+Y G      +    + +EY+  G +  +++ H   +  S +  ++  I  G+ YL S
Sbjct: 74  IVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGS 133
Query: 462 KKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMK---GSP-YWMAPELMMAV 517
           ++ +HRD+   N+LV++   VK+ADFG+AK L   K    ++    SP +W APE +   
Sbjct: 134 RRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDN 193
Query: 518 MQKGKSSDSALAVDIWSLGCTIIEMYT----GKPPWSEYEGAAAMFKVMRDTPAI----- 568
           +   +S       D+WS G  + E++T       P +E+     M    RD PA+     
Sbjct: 194 IFSRQS-------DVWSFGVVLYELFTYCDKSCSPSAEF---LRMMGCERDVPALCRLLE 243
Query: 569 ----------PDSLSPEGKDFLRCCFQRNPADRPPASLL 597
                     P +   E  + ++ C+  +P DRP  S L
Sbjct: 244 LLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSAL 282

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 113/210 (53%), Gaps = 30/210 (14%)
Query: 348 IGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESI---KQLEQEIKVLSHLKHPNI 404
           +G G +GSV  A + +TG   A+K++       +  +SI   K+  +E+++L H+KH N+
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKL------SRPFQSIIHAKRTYRELRLLKHMKHENV 83
Query: 405 V----QYYGSEIVEDKFYIYL-EYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYL 459
           +     +  +  +E+   +YL  ++    +N  V+     +T+  V+     IL GL Y+
Sbjct: 84  IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKXQ--KLTDDHVQFLIYQILRGLKYI 141
Query: 460 HSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKG---SPYWMAPELMMA 516
           HS   IHRD+K +NL V+    +K+ DFG+A+H      D  M G   + ++ APE+M+ 
Sbjct: 142 HSADIIHRDLKPSNLAVNEDXELKILDFGLARH-----TDDEMTGYVATRWYRAPEIMLN 196
Query: 517 VMQKGKSSDSALAVDIWSLGCTIIEMYTGK 546
            M   ++      VDIWS+GC + E+ TG+
Sbjct: 197 WMHYNQT------VDIWSVGCIMAELLTGR 220

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 97.4 bits (241), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 113/210 (53%), Gaps = 30/210 (14%)
Query: 348 IGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESI---KQLEQEIKVLSHLKHPNI 404
           +G G +GSV  A + +TG   A+K++       +  +SI   K+  +E+++L H+KH N+
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKL------SRPFQSIIHAKRTYRELRLLKHMKHENV 83
Query: 405 V----QYYGSEIVEDKFYIYL-EYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYL 459
           +     +  +  +E+   +YL  ++    +N  V+  C  +T+  V+     IL GL Y+
Sbjct: 84  IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILRGLKYI 141
Query: 460 HSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKG---SPYWMAPELMMA 516
           HS   IHRD+K +NL V+    +K+ D G+A+H      D  M G   + ++ APE+M+ 
Sbjct: 142 HSADIIHRDLKPSNLAVNEDCELKILDAGLARH-----TDDEMTGYVATRWYRAPEIMLN 196
Query: 517 VMQKGKSSDSALAVDIWSLGCTIIEMYTGK 546
            M   ++      VDIWS+GC + E+ TG+
Sbjct: 197 WMHYNQT------VDIWSVGCIMAELLTGR 220

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 97.4 bits (241), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 87/320 (27%), Positives = 136/320 (42%), Gaps = 65/320 (20%)
Query: 336 LPMNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVD---IFPDDPKSAESIKQLEQE 392
           L +  ++     IG+G++G V VA   +T A+ A+K ++   I   +PK  E IK    E
Sbjct: 22  LELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKT---E 78
Query: 393 IKVLSHLKHPNIVQYYGSEIVEDKFYIYL--EYVHPG----SINKYVREHCGAITESVVR 446
           ++++  L HPNI + Y  E+ ED+ YI L  E  H G     +N ++ +  G     VV+
Sbjct: 79  VRLMKKLHHPNIARLY--EVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVK 136
Query: 447 -----------------------------------NFTRHILSGLAYLHSKKTIHRDIKG 471
                                              N  R I S L YLH++   HRDIK 
Sbjct: 137 TQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKP 196
Query: 472 ANLL--VDASGVVKLADFGMAKHL----TGQKADLSMK-GSPYWMAPELMMAVMQKGKSS 524
            N L   + S  +KL DFG++K       G+   ++ K G+PY++APE++        + 
Sbjct: 197 ENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTT-----NE 251
Query: 525 DSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIP----DSLSPEGKDFL 580
                 D WS G  +  +  G  P+     A  + +V+           + LSP  +D L
Sbjct: 252 SYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLL 311
Query: 581 RCCFQRNPADRPPASLLLEH 600
                RN  +R  A   L+H
Sbjct: 312 SNLLNRNVDERFDAMRALQH 331

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 97.1 bits (240), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 113/210 (53%), Gaps = 30/210 (14%)
Query: 348 IGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESI---KQLEQEIKVLSHLKHPNI 404
           +G G +GSV  A + +TG   A+K++       +  +SI   K+  +E+++L H+KH N+
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKL------SRPFQSIIHAKRTYRELRLLKHMKHENV 83
Query: 405 V----QYYGSEIVEDKFYIYL-EYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYL 459
           +     +  +  +E+   +YL  ++    +N  V+  C  +T+  V+     IL GL Y+
Sbjct: 84  IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILRGLKYI 141
Query: 460 HSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKG---SPYWMAPELMMA 516
           HS   IHRD+K +NL V+    +K+ D G+A+H      D  M G   + ++ APE+M+ 
Sbjct: 142 HSADIIHRDLKPSNLAVNEDCELKILDRGLARH-----TDDEMTGYVATRWYRAPEIMLN 196
Query: 517 VMQKGKSSDSALAVDIWSLGCTIIEMYTGK 546
            M   ++      VDIWS+GC + E+ TG+
Sbjct: 197 WMHYNQT------VDIWSVGCIMAELLTGR 220

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 97.1 bits (240), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 78/282 (27%), Positives = 129/282 (45%), Gaps = 50/282 (17%)
Query: 348 IGRGTFGSV----YVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPN 403
           +G+G FGSV    Y      TGAL A+K++     D +     +  ++EI++L  L    
Sbjct: 31  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQ-----RDFQREIQILKALHSDF 85
Query: 404 IVQYYGSEIV--EDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHS 461
           IV+Y G           + +EY+  G +  +++ H   +  S +  ++  I  G+ YL S
Sbjct: 86  IVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGS 145
Query: 462 KKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSP-----YWMAPELMMA 516
           ++ +HRD+   N+LV++   VK+ADFG+AK L   K D  +   P     +W APE +  
Sbjct: 146 RRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDK-DYYVVREPGQSPIFWYAPESL-- 202
Query: 517 VMQKGKSSDSALA--VDIWSLGCTIIEMYT----GKPPWSEYEGAAAMFKVMRDTPAI-- 568
                  SD+  +   D+WS G  + E++T       P +E+     M    RD PA+  
Sbjct: 203 -------SDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEF---LRMMGCERDVPALSR 252
Query: 569 -------------PDSLSPEGKDFLRCCFQRNPADRPPASLL 597
                        P +   E  + ++ C+  +P DRP  S L
Sbjct: 253 LLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSAL 294

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 97.1 bits (240), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 63/221 (28%), Positives = 112/221 (50%), Gaps = 26/221 (11%)
Query: 339 NSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIK-QLEQEIKVLS 397
            S+++    IG G +G+VY A +  +G   A+K V +    P   E +     +E+ +L 
Sbjct: 3   TSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRV----PNGEEGLPISTVREVALLR 58
Query: 398 HLK---HPNIVQYY---GSEIVEDKFYIYLEYVHPGSINKYVREHCG-----AITESVVR 446
            L+   HPN+V+      +   + +  + L + H   +++ +R +        +    ++
Sbjct: 59  RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEH---VDQDLRTYLDKAPPPGLPAETIK 115
Query: 447 NFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSP 506
           +  R  L GL +LH+   +HRD+K  N+LV + G VKLADFG+A+  + Q A   +  + 
Sbjct: 116 DLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALAPVVVTL 175
Query: 507 YWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKP 547
           ++ APE+++        S  A  VD+WS+GC   EM+  KP
Sbjct: 176 WYRAPEVLL-------QSTYATPVDMWSVGCIFAEMFRRKP 209

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 97.1 bits (240), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 113/210 (53%), Gaps = 30/210 (14%)
Query: 348 IGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESI---KQLEQEIKVLSHLKHPNI 404
           +G G +GSV  A + +TG   A+K++       +  +SI   K+  +E+++L H+KH N+
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKL------SRPFQSIIHAKRTYRELRLLKHMKHENV 83
Query: 405 V----QYYGSEIVEDKFYIYL-EYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYL 459
           +     +  +  +E+   +YL  ++    +N  V+     +T+  V+     IL GL Y+
Sbjct: 84  IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKXQ--KLTDDHVQFLIYQILRGLKYI 141
Query: 460 HSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKG---SPYWMAPELMMA 516
           HS   IHRD+K +NL V+    +K+ DFG+A+H      D  M G   + ++ APE+M+ 
Sbjct: 142 HSADIIHRDLKPSNLAVNEDCELKILDFGLARH-----TDDEMTGYVATRWYRAPEIMLN 196
Query: 517 VMQKGKSSDSALAVDIWSLGCTIIEMYTGK 546
            M   ++      VDIWS+GC + E+ TG+
Sbjct: 197 WMHYNQT------VDIWSVGCIMAELLTGR 220

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 97.1 bits (240), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 80/276 (28%), Positives = 129/276 (46%), Gaps = 29/276 (10%)
Query: 347 LIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQ--LEQEIKVLSHLKHPNI 404
           ++G G F  V +A ++ T  L A+K +       K A   K+  +E EI VL  +KHPNI
Sbjct: 25  VLGTGAFSEVILAEDKRTQKLVAIKCI------AKKALEGKEGSMENEIAVLHKIKHPNI 78
Query: 405 VQYYGSEIVEDKFYIYL--EYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSK 462
           V     +I E   ++YL  + V  G +   + E  G  TE         +L  + YLH  
Sbjct: 79  VAL--DDIYESGGHLYLIMQLVSGGELFDRIVEK-GFYTERDASRLIFQVLDAVKYLHDL 135
Query: 463 KTIHRDIKGANLL---VDASGVVKLADFGMAKHLTGQKADLSMKGSPYWMAPELMMAVMQ 519
             +HRD+K  NLL   +D    + ++DFG++K         +  G+P ++APE++    Q
Sbjct: 136 GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVL---AQ 192
Query: 520 KGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMR-----DTPAIPDSLSP 574
           K  S     AVD WS+G     +  G PP+ +   A    ++++     D+P   D +S 
Sbjct: 193 KPYSK----AVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYW-DDISD 247
Query: 575 EGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQPD 610
             KDF+R   +++P  R      L+H ++      D
Sbjct: 248 SAKDFIRHLMEKDPEKRFTCEQALQHPWIAGDTALD 283

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 97.1 bits (240), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 74/251 (29%), Positives = 125/251 (49%), Gaps = 20/251 (7%)
Query: 347 LIGRGTFGSVYVASNRETGALCAMK----EVDIFPDDPKSAESIKQLEQEIKVLSHLKHP 402
           ++G+G+FG V ++  + T  L A+K    +V I  DD +       +E+ +  L   K P
Sbjct: 27  VLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECT----MVEKRVLALPG-KPP 81
Query: 403 NIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSK 462
            + Q +      D+ Y  +EYV+ G +  ++++  G   E     +   I  GL +L SK
Sbjct: 82  FLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQ-VGRFKEPHAVFYAAEIAIGLFFLQSK 140
Query: 463 KTIHRDIKGANLLVDASGVVKLADFGMAK-HLTGQKADLSMKGSPYWMAPELMMAVMQKG 521
             I+RD+K  N+++D+ G +K+ADFGM K ++          G+P ++APE+ +A    G
Sbjct: 141 GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKXFCGTPDYIAPEI-IAYQPYG 199
Query: 522 KSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFK-VMRDTPAIPDSLSPEGKDFL 580
           KS      VD W+ G  + EM  G+ P+ E E    +F+ +M    A P S+S E     
Sbjct: 200 KS------VDWWAFGVLLYEMLAGQAPF-EGEDEDELFQSIMEHNVAYPKSMSKEAVAIC 252
Query: 581 RCCFQRNPADR 591
           +    ++P  R
Sbjct: 253 KGLMTKHPGKR 263

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 97.1 bits (240), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 113/210 (53%), Gaps = 30/210 (14%)
Query: 348 IGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESI---KQLEQEIKVLSHLKHPNI 404
           +G G +GSV  A + +TG   A+K++       +  +SI   K+  +E+++L H+KH N+
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKL------SRPFQSIIHAKRTYRELRLLKHMKHENV 83
Query: 405 V----QYYGSEIVEDKFYIYL-EYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYL 459
           +     +  +  +E+   +YL  ++    +N  V+  C  +T+  V+     IL GL Y+
Sbjct: 84  IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILRGLKYI 141
Query: 460 HSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKG---SPYWMAPELMMA 516
           HS   IHRD+K +NL V+    +K+ D G+A+H      D  M G   + ++ APE+M+ 
Sbjct: 142 HSADIIHRDLKPSNLAVNEDCELKILDGGLARH-----TDDEMTGYVATRWYRAPEIMLN 196
Query: 517 VMQKGKSSDSALAVDIWSLGCTIIEMYTGK 546
            M   ++      VDIWS+GC + E+ TG+
Sbjct: 197 WMHYNQT------VDIWSVGCIMAELLTGR 220

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 97.1 bits (240), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 80/276 (28%), Positives = 129/276 (46%), Gaps = 29/276 (10%)
Query: 347 LIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQ--LEQEIKVLSHLKHPNI 404
           ++G G F  V +A ++ T  L A+K +       K A   K+  +E EI VL  +KHPNI
Sbjct: 25  VLGTGAFSEVILAEDKRTQKLVAIKCI------AKEALEGKEGSMENEIAVLHKIKHPNI 78
Query: 405 VQYYGSEIVEDKFYIYL--EYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSK 462
           V     +I E   ++YL  + V  G +   + E  G  TE         +L  + YLH  
Sbjct: 79  VAL--DDIYESGGHLYLIMQLVSGGELFDRIVEK-GFYTERDASRLIFQVLDAVKYLHDL 135
Query: 463 KTIHRDIKGANLL---VDASGVVKLADFGMAKHLTGQKADLSMKGSPYWMAPELMMAVMQ 519
             +HRD+K  NLL   +D    + ++DFG++K         +  G+P ++APE++    Q
Sbjct: 136 GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVL---AQ 192
Query: 520 KGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMR-----DTPAIPDSLSP 574
           K  S     AVD WS+G     +  G PP+ +   A    ++++     D+P   D +S 
Sbjct: 193 KPYSK----AVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYW-DDISD 247
Query: 575 EGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQPD 610
             KDF+R   +++P  R      L+H ++      D
Sbjct: 248 SAKDFIRHLMEKDPEKRFTCEQALQHPWIAGDTALD 283

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 97.1 bits (240), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 77/270 (28%), Positives = 129/270 (47%), Gaps = 22/270 (8%)
Query: 348 IGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQY 407
           +G+G F  V    ++ TG   A K   I      SA   ++LE+E ++   L+HPNIV+ 
Sbjct: 37  LGKGAFSVVRRCVHKTTGLEFAAK---IINTKKLSARDFQKLEREARICRKLQHPNIVRL 93
Query: 408 YGSEIVEDKFYIYLEYVHPGSINKYV--REHCGAITESVVRNFTRHILSGLAYLHSKKTI 465
           + S   E   Y+  + V  G + + +  RE     +E+   +  + IL  +AY HS   +
Sbjct: 94  HDSIQEESFHYLVFDLVTGGELFEDIVAREF---YSEADASHCIQQILESIAYCHSNGIV 150
Query: 466 HRDIKGANLLVDA---SGVVKLADFGMAKHLTGQKADLSMKGSPYWMAPELMMAVMQKGK 522
           HR++K  NLL+ +      VKLADFG+A  +   +A     G+P +++PE++       K
Sbjct: 151 HRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVL-------K 203
Query: 523 SSDSALAVDIWSLGCTIIEMYTGKPP-WSE--YEGAAAMFKVMRDTPAIP-DSLSPEGKD 578
               +  VDIW+ G  +  +  G PP W E  +   A +     D P+   D+++PE K 
Sbjct: 204 KDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKS 263
Query: 579 FLRCCFQRNPADRPPASLLLEHRFLKNSQQ 608
            +      NP  R  A   L+  ++ N ++
Sbjct: 264 LIDSMLTVNPKKRITADQALKVPWICNRER 293

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 97.1 bits (240), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 81/328 (24%), Positives = 145/328 (44%), Gaps = 42/328 (12%)
Query: 324 ATIPQVAAKPEPLPMNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDI-------F 376
           A  P +  + +   +   + K + +G G +G V +   +   +  A+K +         +
Sbjct: 20  AINPGMYVRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRY 79
Query: 377 PDDPKSAESI-KQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYIYL--EYVHPGS----- 428
            DD K+ E   +++  EI +L  L HPNI++ +  ++ EDK Y YL  E+   G      
Sbjct: 80  SDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLF--DVFEDKKYFYLVTEFYEGGELFEQI 137
Query: 429 INKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGV---VKLA 485
           IN++  + C A       N  + ILSG+ YLH    +HRDIK  N+L++       +K+ 
Sbjct: 138 INRHKFDECDA------ANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIV 191
Query: 486 DFGMAKHLTGQKADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTG 545
           DFG++   +         G+ Y++APE++     K K ++     D+WS G  +  +  G
Sbjct: 192 DFGLSSFFSKDYKLRDRLGTAYYIAPEVL-----KKKYNEKC---DVWSCGVIMYILLCG 243
Query: 546 KPPWSEYEGAAAMFKVMRDTPAIP----DSLSPEGKDFLRCCFQRNPADRPPASLLLEHR 601
            PP+        + KV +           ++S E K+ ++     +   R  A   L  R
Sbjct: 244 YPPFGGQNDQDIIKKVEKGKYYFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSR 303
Query: 602 FLK----NSQQPDVPSCSLSFSGMQLTE 625
           ++K    N  + D  +   + S M+  E
Sbjct: 304 WIKKYANNINKSDQKTLCGALSNMRKFE 331

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 96.7 bits (239), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 77/279 (27%), Positives = 129/279 (46%), Gaps = 44/279 (15%)
Query: 348 IGRGTFGSV----YVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPN 403
           +G+G FGSV    Y      TGAL A+K++     D +     +  ++EI++L  L    
Sbjct: 18  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQ-----RDFQREIQILKALHSDF 72
Query: 404 IVQYYGSEIV--EDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHS 461
           IV+Y G           + +EY+  G +  +++ H   +  S +  ++  I  G+ YL S
Sbjct: 73  IVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGS 132
Query: 462 KKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMK---GSP-YWMAPELMMAV 517
           ++ +HRD+   N+LV++   VK+ADFG+AK L   K    ++    SP +W APE +   
Sbjct: 133 RRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDN 192
Query: 518 MQKGKSSDSALAVDIWSLGCTIIEMYT----GKPPWSEYEGAAAMFKVMRDTPAI----- 568
           +   +S       D+WS G  + E++T       P +E+     M    RD PA+     
Sbjct: 193 IFSRQS-------DVWSFGVVLYELFTYCDKSCSPSAEF---LRMMGSERDVPALSRLLE 242
Query: 569 ----------PDSLSPEGKDFLRCCFQRNPADRPPASLL 597
                     P +   E  + ++ C+  +P DRP  S L
Sbjct: 243 LLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSAL 281

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 96.7 bits (239), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 79/296 (26%), Positives = 136/296 (45%), Gaps = 23/296 (7%)
Query: 323 SATIPQVAAKPEPLPMNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKS 382
           S  +P+ +   + +     ++  ++IG+G F  V    NRETG   A+K VD+       
Sbjct: 9   SGLVPRGSMADDDVLFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSP 68
Query: 383 AESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYV--REHCGAI 440
             S + L++E  +   LKHP+IV+   +   +   Y+  E++    +   +  R   G +
Sbjct: 69  GLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFV 128
Query: 441 -TESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLV---DASGVVKLADFGMAKHLTGQ 496
            +E+V  ++ R IL  L Y H    IHRD+K   +L+   + S  VKL  FG+A  L G+
Sbjct: 129 YSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQL-GE 187
Query: 497 KADLS--MKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEG 554
              ++    G+P++MAPE++       K       VD+W  G  +  + +G  P+  Y  
Sbjct: 188 SGLVAGGRVGTPHFMAPEVV-------KREPYGKPVDVWGCGVILFILLSGCLPF--YGT 238
Query: 555 AAAMFKVM-----RDTPAIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKN 605
              +F+ +     +  P     +S   KD +R     +PA+R      L H +LK 
Sbjct: 239 KERLFEGIIKGKYKMNPRQWSHISESAKDLVRRMLMLDPAERITVYEALNHPWLKE 294

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 96.7 bits (239), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 80/276 (28%), Positives = 129/276 (46%), Gaps = 29/276 (10%)
Query: 347 LIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQ--LEQEIKVLSHLKHPNI 404
           ++G G F  V +A ++ T  L A+K +       K A   K+  +E EI VL  +KHPNI
Sbjct: 25  VLGTGAFSEVILAEDKRTQKLVAIKCI------AKEALEGKEGSMENEIAVLHKIKHPNI 78
Query: 405 VQYYGSEIVEDKFYIYL--EYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSK 462
           V     +I E   ++YL  + V  G +   + E  G  TE         +L  + YLH  
Sbjct: 79  VAL--DDIYESGGHLYLIMQLVSGGELFDRIVEK-GFYTERDASRLIFQVLDAVKYLHDL 135
Query: 463 KTIHRDIKGANLL---VDASGVVKLADFGMAKHLTGQKADLSMKGSPYWMAPELMMAVMQ 519
             +HRD+K  NLL   +D    + ++DFG++K         +  G+P ++APE++    Q
Sbjct: 136 GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVL---AQ 192
Query: 520 KGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMR-----DTPAIPDSLSP 574
           K  S     AVD WS+G     +  G PP+ +   A    ++++     D+P   D +S 
Sbjct: 193 KPYSK----AVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSP-YWDDISD 247
Query: 575 EGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQPD 610
             KDF+R   +++P  R      L+H ++      D
Sbjct: 248 SAKDFIRHLMEKDPEKRFTCEQALQHPWIAGDTALD 283

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 96.7 bits (239), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 80/276 (28%), Positives = 129/276 (46%), Gaps = 29/276 (10%)
Query: 347 LIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQ--LEQEIKVLSHLKHPNI 404
           ++G G F  V +A ++ T  L A+K +       K A   K+  +E EI VL  +KHPNI
Sbjct: 25  VLGTGAFSEVILAEDKRTQKLVAIKCI------AKEALEGKEGSMENEIAVLHKIKHPNI 78
Query: 405 VQYYGSEIVEDKFYIYL--EYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSK 462
           V     +I E   ++YL  + V  G +   + E  G  TE         +L  + YLH  
Sbjct: 79  VAL--DDIYESGGHLYLIMQLVSGGELFDRIVEK-GFYTERDASRLIFQVLDAVKYLHDL 135
Query: 463 KTIHRDIKGANLL---VDASGVVKLADFGMAKHLTGQKADLSMKGSPYWMAPELMMAVMQ 519
             +HRD+K  NLL   +D    + ++DFG++K         +  G+P ++APE++    Q
Sbjct: 136 GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVL---AQ 192
Query: 520 KGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMR-----DTPAIPDSLSP 574
           K  S     AVD WS+G     +  G PP+ +   A    ++++     D+P   D +S 
Sbjct: 193 KPYSK----AVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSP-YWDDISD 247
Query: 575 EGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQPD 610
             KDF+R   +++P  R      L+H ++      D
Sbjct: 248 SAKDFIRHLMEKDPEKRFTCEQALQHPWIAGDTALD 283

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 96.3 bits (238), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 63/221 (28%), Positives = 112/221 (50%), Gaps = 26/221 (11%)
Query: 339 NSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIK-QLEQEIKVLS 397
            S+++    IG G +G+VY A +  +G   A+K V +    P   E +     +E+ +L 
Sbjct: 3   TSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRV----PNGEEGLPISTVREVALLR 58
Query: 398 HLK---HPNIVQYY---GSEIVEDKFYIYLEYVHPGSINKYVREHCG-----AITESVVR 446
            L+   HPN+V+      +   + +  + L + H   +++ +R +        +    ++
Sbjct: 59  RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEH---VDQDLRTYLDKAPPPGLPAETIK 115
Query: 447 NFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSP 506
           +  R  L GL +LH+   +HRD+K  N+LV + G VKLADFG+A+  + Q A   +  + 
Sbjct: 116 DLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALDPVVVTL 175
Query: 507 YWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKP 547
           ++ APE+++        S  A  VD+WS+GC   EM+  KP
Sbjct: 176 WYRAPEVLL-------QSTYATPVDMWSVGCIFAEMFRRKP 209

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 96.3 bits (238), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 64/210 (30%), Positives = 112/210 (53%), Gaps = 30/210 (14%)
Query: 348 IGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESI---KQLEQEIKVLSHLKHPNI 404
           +G G +GSV  A + +TG   A+K++       +  +SI   K+  +E+++L H+KH N+
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKL------SRPFQSIIHAKRTYRELRLLKHMKHENV 83
Query: 405 VQ----YYGSEIVEDKFYIYL-EYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYL 459
           +     +  +  +E+   +YL  ++    +N  V+     +T+  V+     IL GL Y+
Sbjct: 84  IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKSQ--KLTDDHVQFLIYQILRGLKYI 141
Query: 460 HSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKG---SPYWMAPELMMA 516
           HS   IHRD+K +NL V+    +K+ DFG+ +H      D  M G   + ++ APE+M+ 
Sbjct: 142 HSADIIHRDLKPSNLAVNEDSELKILDFGLCRH-----TDDEMTGYVATRWYRAPEIMLN 196
Query: 517 VMQKGKSSDSALAVDIWSLGCTIIEMYTGK 546
            M   ++      VDIWS+GC + E+ TG+
Sbjct: 197 WMHYNQT------VDIWSVGCIMAELLTGR 220

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 95.9 bits (237), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 72/282 (25%), Positives = 132/282 (46%), Gaps = 17/282 (6%)
Query: 335 PLPMNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVD---IFPDDPKSAESIKQLEQ 391
           P  +  ++   K +G G  G V +A  R+T    A++ +          + A+    +E 
Sbjct: 130 PKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVET 189
Query: 392 EIKVLSHLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRH 451
           EI++L  L HP I++       ED +YI LE +  G +   V  +   + E+  + +   
Sbjct: 190 EIEILKKLNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGN-KRLKEATCKLYFYQ 247
Query: 452 ILSGLAYLHSKKTIHRDIKGANLLV---DASGVVKLADFGMAKHLTGQKADLSMKGSPYW 508
           +L  + YLH    IHRD+K  N+L+   +   ++K+ DFG +K L       ++ G+P +
Sbjct: 248 MLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTY 307
Query: 509 MAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRD---- 564
           +APE++++V   G +     AVD WSLG  +    +G PP+SE+    ++   +      
Sbjct: 308 LAPEVLVSVGTAGYNR----AVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYN 363
Query: 565 -TPAIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKN 605
             P +   +S +  D ++     +P  R      L H +L++
Sbjct: 364 FIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD 405

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 95.9 bits (237), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 78/287 (27%), Positives = 133/287 (46%), Gaps = 35/287 (12%)
Query: 340 SQWQKGKLIGRGTFGSVYVASNRETGALC----AMKEVDIFPDDPKSAESIKQLEQEIKV 395
            ++  G L+G G++G V    + ET  LC     + +       P    ++K+   EI++
Sbjct: 5   GKYLMGDLLGEGSYGKVKEVLDSET--LCRRAVKILKKKKLRRIPNGEANVKK---EIQL 59
Query: 396 LSHLKHPNIVQY----YGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITE-----SVVR 446
           L  L+H N++Q     Y  E  + K Y+ +EY   G     ++E   ++ E         
Sbjct: 60  LRRLRHKNVIQLVDVLYNEE--KQKMYMVMEYCVCG-----MQEMLDSVPEKRFPVCQAH 112
Query: 447 NFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMK--- 503
            +   ++ GL YLHS+  +H+DIK  NLL+   G +K++  G+A+ L    AD + +   
Sbjct: 113 GYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQ 172
Query: 504 GSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFK-VM 562
           GSP +  PE+       G  + S   VDIWS G T+  + TG  P+ E +    +F+ + 
Sbjct: 173 GSPAFQPPEI-----ANGLDTFSGFKVDIWSAGVTLYNITTGLYPF-EGDNIYKLFENIG 226
Query: 563 RDTPAIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQP 609
           + + AIP    P   D L+   +  PA R     + +H + +    P
Sbjct: 227 KGSYAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHPP 273

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 95.9 bits (237), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 86/325 (26%), Positives = 149/325 (45%), Gaps = 49/325 (15%)
Query: 312 PLPPGAAVLSPSATIPQVAAKPE-PLPMNSQWQ-------KGKLIGRGTFGSVYVAS--- 360
           PL      LS +A  P +A   E  LP + +W+        GK +G G FG V +A    
Sbjct: 45  PLVRITTRLSSTADTPMLAGVSEYELPEDPKWEFPRDKLTLGKPLGEGCFGQVVMAEAVG 104
Query: 361 -NRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHL-KHPNIVQYYGSEIVEDKFY 418
            +++         V +  DD  + + +  L  E++++  + KH NI+   G+   +   Y
Sbjct: 105 IDKDKPKEAVTVAVKMLKDD-ATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLY 163
Query: 419 IYLEYVHPGSINKYVR-------EHCGAI--------TESVVRNFTRHILSGLAYLHSKK 463
           + +EY   G++ +Y+R       E+   I        T   + + T  +  G+ YL S+K
Sbjct: 164 VIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK 223
Query: 464 TIHRDIKGANLLVDASGVVKLADFGMAKHLTG---QKADLSMKGSPYWMAPELMMAVMQK 520
            IHRD+   N+LV  + V+K+ADFG+A+ +      K   + +    WMAPE +   +  
Sbjct: 224 CIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYT 283
Query: 521 GKSSDSALAVDIWSLGCTIIEMYT--GKPPWSEYEG--AAAMFKVMRDTPAI--PDSLSP 574
            +S       D+WS G  + E++T  G P    Y G     +FK++++   +  P + + 
Sbjct: 284 HQS-------DVWSFGVLMWEIFTLGGSP----YPGIPVEELFKLLKEGHRMDKPANCTN 332
Query: 575 EGKDFLRCCFQRNPADRPPASLLLE 599
           E    +R C+   P+ RP    L+E
Sbjct: 333 ELYMMMRDCWHAVPSQRPTFKQLVE 357

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 95.9 bits (237), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 75/272 (27%), Positives = 132/272 (48%), Gaps = 19/272 (6%)
Query: 346 KLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIV 405
           K+IGRG FG V +  ++ T  + AMK +  F    +S  +    E++I   ++   P +V
Sbjct: 80  KVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFAN--SPWVV 137
Query: 406 QYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTI 465
           Q + +   +   Y+ +EY+  G +   +  +   + E   R +T  ++  L  +HS   I
Sbjct: 138 QLFYAFQDDRYLYMVMEYMPGGDLVNLMSNY--DVPEKWARFYTAEVVLALDAIHSMGFI 195
Query: 466 HRDIKGANLLVDASGVVKLADFGMAKHLTGQ---KADLSMKGSPYWMAPELMMAVMQKGK 522
           HRD+K  N+L+D SG +KLADFG    +  +   + D ++ G+P +++PE++ +   +G 
Sbjct: 196 HRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-GTPDYISPEVLKS---QGG 251
Query: 523 SSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVM--RDTPAIPD--SLSPEGKD 578
                   D WS+G  + EM  G  P+          K+M  +++   PD   +S E K+
Sbjct: 252 DGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAKN 311
Query: 579 FLRCCFQRNPADRPPASLLLE---HRFLKNSQ 607
            + C F  +   R   + + E   H F KN Q
Sbjct: 312 LI-CAFLTDREVRLGRNGVEEIKRHLFFKNDQ 342

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 95.9 bits (237), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 77/270 (28%), Positives = 129/270 (47%), Gaps = 22/270 (8%)
Query: 348 IGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQY 407
           +G+G F  V    ++ TG   A K   I      SA   ++LE+E ++   L+HPNIV+ 
Sbjct: 13  LGKGAFSVVRRCVHKTTGLEFAAK---IINTKKLSARDFQKLEREARICRKLQHPNIVRL 69
Query: 408 YGSEIVEDKFYIYLEYVHPGSINKYV--REHCGAITESVVRNFTRHILSGLAYLHSKKTI 465
           + S   E   Y+  + V  G + + +  RE     +E+   +  + IL  +AY HS   +
Sbjct: 70  HDSIQEESFHYLVFDLVTGGELFEDIVAREF---YSEADASHCIQQILESIAYCHSNGIV 126
Query: 466 HRDIKGANLLVDA---SGVVKLADFGMAKHLTGQKADLSMKGSPYWMAPELMMAVMQKGK 522
           HR++K  NLL+ +      VKLADFG+A  +   +A     G+P +++PE++       K
Sbjct: 127 HRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVL-------K 179
Query: 523 SSDSALAVDIWSLGCTIIEMYTGKPP-WSE--YEGAAAMFKVMRDTPAIP-DSLSPEGKD 578
               +  VDIW+ G  +  +  G PP W E  +   A +     D P+   D+++PE K 
Sbjct: 180 KDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKS 239
Query: 579 FLRCCFQRNPADRPPASLLLEHRFLKNSQQ 608
            +      NP  R  A   L+  ++ N ++
Sbjct: 240 LIDSMLTVNPKKRITADQALKVPWICNRER 269

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 95.9 bits (237), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 72/282 (25%), Positives = 132/282 (46%), Gaps = 17/282 (6%)
Query: 335 PLPMNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVD---IFPDDPKSAESIKQLEQ 391
           P  +  ++   K +G G  G V +A  R+T    A++ +          + A+    +E 
Sbjct: 144 PKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVET 203
Query: 392 EIKVLSHLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRH 451
           EI++L  L HP I++       ED +YI LE +  G +   V  +   + E+  + +   
Sbjct: 204 EIEILKKLNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGN-KRLKEATCKLYFYQ 261
Query: 452 ILSGLAYLHSKKTIHRDIKGANLLV---DASGVVKLADFGMAKHLTGQKADLSMKGSPYW 508
           +L  + YLH    IHRD+K  N+L+   +   ++K+ DFG +K L       ++ G+P +
Sbjct: 262 MLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTY 321
Query: 509 MAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRD---- 564
           +APE++++V   G +     AVD WSLG  +    +G PP+SE+    ++   +      
Sbjct: 322 LAPEVLVSVGTAGYNR----AVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYN 377
Query: 565 -TPAIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKN 605
             P +   +S +  D ++     +P  R      L H +L++
Sbjct: 378 FIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD 419

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 95.9 bits (237), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 75/272 (27%), Positives = 132/272 (48%), Gaps = 19/272 (6%)
Query: 346 KLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIV 405
           K+IGRG FG V +  ++ T  + AMK +  F    +S  +    E++I   ++   P +V
Sbjct: 75  KVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFAN--SPWVV 132
Query: 406 QYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTI 465
           Q + +   +   Y+ +EY+  G +   +  +   + E   R +T  ++  L  +HS   I
Sbjct: 133 QLFYAFQDDRYLYMVMEYMPGGDLVNLMSNY--DVPEKWARFYTAEVVLALDAIHSMGFI 190
Query: 466 HRDIKGANLLVDASGVVKLADFGMAKHLTGQ---KADLSMKGSPYWMAPELMMAVMQKGK 522
           HRD+K  N+L+D SG +KLADFG    +  +   + D ++ G+P +++PE++ +   +G 
Sbjct: 191 HRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-GTPDYISPEVLKS---QGG 246
Query: 523 SSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVM--RDTPAIPD--SLSPEGKD 578
                   D WS+G  + EM  G  P+          K+M  +++   PD   +S E K+
Sbjct: 247 DGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAKN 306
Query: 579 FLRCCFQRNPADRPPASLLLE---HRFLKNSQ 607
            + C F  +   R   + + E   H F KN Q
Sbjct: 307 LI-CAFLTDREVRLGRNGVEEIKRHLFFKNDQ 337

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 95.9 bits (237), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 65/212 (30%), Positives = 107/212 (50%), Gaps = 25/212 (11%)
Query: 348 IGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQY 407
           +GRG+FG V+   +++TG  CA+K+V +          + ++E E+   + L  P IV  
Sbjct: 66  VGRGSFGEVHRMKDKQTGFQCAVKKVRL---------EVFRVE-ELVACAGLSSPRIVPL 115
Query: 408 YGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHR 467
           YG+        I++E +  GS+ + +++  G + E     +    L GL YLH+++ +H 
Sbjct: 116 YGAVREGPWVNIFMELLEGGSLGQLIKQM-GCLPEDRALYYLGQALEGLEYLHTRRILHG 174
Query: 468 DIKGANLLVDASGV-VKLADFGMAKHLTGQKADLSMK------GSPYWMAPELMMAVMQK 520
           D+K  N+L+ + G    L DFG A  L       S+       G+   MAPE++M     
Sbjct: 175 DVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVM----- 229
Query: 521 GKSSDSALAVDIWSLGCTIIEMYTGKPPWSEY 552
           GK  D+   VDIWS  C ++ M  G  PW++Y
Sbjct: 230 GKPCDA--KVDIWSSCCMMLHMLNGCHPWTQY 259

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 95.9 bits (237), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 77/270 (28%), Positives = 129/270 (47%), Gaps = 22/270 (8%)
Query: 348 IGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQY 407
           +G+G F  V    ++ TG   A K   I      SA   ++LE+E ++   L+HPNIV+ 
Sbjct: 14  LGKGAFSVVRRCVHKTTGLEFAAK---IINTKKLSARDFQKLEREARICRKLQHPNIVRL 70
Query: 408 YGSEIVEDKFYIYLEYVHPGSINKYV--REHCGAITESVVRNFTRHILSGLAYLHSKKTI 465
           + S   E   Y+  + V  G + + +  RE     +E+   +  + IL  +AY HS   +
Sbjct: 71  HDSIQEESFHYLVFDLVTGGELFEDIVAREF---YSEADASHCIQQILESIAYCHSNGIV 127
Query: 466 HRDIKGANLLVDA---SGVVKLADFGMAKHLTGQKADLSMKGSPYWMAPELMMAVMQKGK 522
           HR++K  NLL+ +      VKLADFG+A  +   +A     G+P +++PE++       K
Sbjct: 128 HRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVL-------K 180
Query: 523 SSDSALAVDIWSLGCTIIEMYTGKPP-WSE--YEGAAAMFKVMRDTPAIP-DSLSPEGKD 578
               +  VDIW+ G  +  +  G PP W E  +   A +     D P+   D+++PE K 
Sbjct: 181 KDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKS 240
Query: 579 FLRCCFQRNPADRPPASLLLEHRFLKNSQQ 608
            +      NP  R  A   L+  ++ N ++
Sbjct: 241 LIDSMLTVNPKKRITADQALKVPWICNRER 270

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 95.9 bits (237), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 72/280 (25%), Positives = 127/280 (45%), Gaps = 25/280 (8%)
Query: 348 IGRGTFGSVYVAS-NRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQ 406
           +G G+FG V     +  +G   ++    + PD     E++    +E+  +  L H N+++
Sbjct: 20  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 79
Query: 407 YYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIH 466
            YG  ++     +  E    GS+   +R+H G      +  +   +  G+ YL SK+ IH
Sbjct: 80  LYGV-VLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIH 138
Query: 467 RDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSM---KGSPY-WMAPELMMAVMQKGK 522
           RD+   NLL+    +VK+ DFG+ + L        M   +  P+ W APE +       K
Sbjct: 139 RDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESL-------K 191
Query: 523 SSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFKVMRDTPAI--PDSLSPEGKDF 579
           +   + A D W  G T+ EM+T G+ PW    G+  + K+ ++   +  P+    +  + 
Sbjct: 192 TRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDIYNV 251
Query: 580 LRCCFQRNPADRPP----ASLLLE-----HRFLKNSQQPD 610
           +  C+   P DRP        LLE      R L++ ++PD
Sbjct: 252 MVQCWAHKPEDRPTFVALRDFLLEAQPTDMRALQDFEEPD 291

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 95.5 bits (236), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 70/272 (25%), Positives = 124/272 (45%), Gaps = 18/272 (6%)
Query: 348 IGRGTFGSVYVAS-NRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQ 406
           +G G+FG V     +  +G   ++    + PD     E++    +E+  +  L H N+++
Sbjct: 26  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 407 YYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIH 466
            YG  ++     +  E    GS+   +R+H G      +  +   +  G+ YL SK+ IH
Sbjct: 86  LYGV-VLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIH 144
Query: 467 RDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSM---KGSPY-WMAPELMMAVMQKGK 522
           RD+   NLL+    +VK+ DFG+ + L        M   +  P+ W APE +       K
Sbjct: 145 RDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESL-------K 197
Query: 523 SSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFKVMRDTPAI--PDSLSPEGKDF 579
           +   + A D W  G T+ EM+T G+ PW    G+  + K+ ++   +  P+    +  + 
Sbjct: 198 TRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDIYNV 257
Query: 580 LRCCFQRNPADRPPASLLLEHRFLKNSQQPDV 611
           +  C+   P DRP    L +  FL  +Q  D+
Sbjct: 258 MVQCWAHKPEDRPTFVALRD--FLLEAQPTDM 287

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 95.5 bits (236), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 70/272 (25%), Positives = 124/272 (45%), Gaps = 18/272 (6%)
Query: 348 IGRGTFGSVYVAS-NRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQ 406
           +G G+FG V     +  +G   ++    + PD     E++    +E+  +  L H N+++
Sbjct: 26  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 407 YYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIH 466
            YG  ++     +  E    GS+   +R+H G      +  +   +  G+ YL SK+ IH
Sbjct: 86  LYGV-VLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIH 144
Query: 467 RDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSM---KGSPY-WMAPELMMAVMQKGK 522
           RD+   NLL+    +VK+ DFG+ + L        M   +  P+ W APE +       K
Sbjct: 145 RDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAPESL-------K 197
Query: 523 SSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFKVMRDTPAI--PDSLSPEGKDF 579
           +   + A D W  G T+ EM+T G+ PW    G+  + K+ ++   +  P+    +  + 
Sbjct: 198 TRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDIYNV 257
Query: 580 LRCCFQRNPADRPPASLLLEHRFLKNSQQPDV 611
           +  C+   P DRP    L +  FL  +Q  D+
Sbjct: 258 MVQCWAHKPEDRPTFVALRD--FLLEAQPTDM 287

>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412

Iteration: 1
 Score = 95.5 bits (236), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 68/243 (27%), Positives = 115/243 (47%), Gaps = 9/243 (3%)
Query: 346 KLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIV 405
           K+IGRG F  V V   ++TG + AMK ++ + D  K  E +    +E  VL +     I 
Sbjct: 67  KVIGRGAFSEVAVVKMKQTGQVYAMKIMNKW-DMLKRGE-VSCFREERDVLVNGDRRWIT 124
Query: 406 QYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTI 465
           Q + +   E+  Y+ +EY   G +   + +    I   + R +   I+  +  +H    +
Sbjct: 125 QLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYV 184
Query: 466 HRDIKGANLLVDASGVVKLADFGMAKHL--TGQKADLSMKGSPYWMAPELMMAVMQKGKS 523
           HRDIK  N+L+D  G ++LADFG    L   G    L   G+P +++PE++ AV     +
Sbjct: 185 HRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGT 244
Query: 524 SDSALAVDIWSLGCTIIEMYTGKPPW-----SEYEGAAAMFKVMRDTPAIPDSLSPEGKD 578
                  D W+LG    EM+ G+ P+     +E  G    +K     P + + +  E +D
Sbjct: 245 GSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPLVDEGVPEEARD 304
Query: 579 FLR 581
           F++
Sbjct: 305 FIQ 307

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 95.5 bits (236), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 77/269 (28%), Positives = 128/269 (47%), Gaps = 22/269 (8%)
Query: 348 IGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQY 407
           +G+G F  V    ++ TG   A K   I      SA   ++LE+E ++   L+HPNIV+ 
Sbjct: 14  LGKGAFSVVRRCVHKTTGLEFAAK---IINTKKLSARDFQKLEREARICRKLQHPNIVRL 70
Query: 408 YGSEIVEDKFYIYLEYVHPGSINKYV--REHCGAITESVVRNFTRHILSGLAYLHSKKTI 465
           + S   E   Y+  + V  G + + +  RE     +E+   +  + IL  +AY HS   +
Sbjct: 71  HDSIQEESFHYLVFDLVTGGELFEDIVAREF---YSEADASHCIQQILESIAYCHSNGIV 127
Query: 466 HRDIKGANLLVDA---SGVVKLADFGMAKHLTGQKADLSMKGSPYWMAPELMMAVMQKGK 522
           HR++K  NLL+ +      VKLADFG+A  +   +A     G+P +++PE++       K
Sbjct: 128 HRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVL-------K 180
Query: 523 SSDSALAVDIWSLGCTIIEMYTGKPP-WSE--YEGAAAMFKVMRDTPAIP-DSLSPEGKD 578
               +  VDIW+ G  +  +  G PP W E  +   A +     D P+   D+++PE K 
Sbjct: 181 KDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKS 240
Query: 579 FLRCCFQRNPADRPPASLLLEHRFLKNSQ 607
            +      NP  R  A   L+  ++ N +
Sbjct: 241 LIDSMLTVNPKKRITADQALKVPWICNRE 269

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 95.5 bits (236), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 65/212 (30%), Positives = 107/212 (50%), Gaps = 25/212 (11%)
Query: 348 IGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQY 407
           +GRG+FG V+   +++TG  CA+K+V +          + ++E E+   + L  P IV  
Sbjct: 82  VGRGSFGEVHRMKDKQTGFQCAVKKVRL---------EVFRVE-ELVACAGLSSPRIVPL 131
Query: 408 YGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHR 467
           YG+        I++E +  GS+ + +++  G + E     +    L GL YLH+++ +H 
Sbjct: 132 YGAVREGPWVNIFMELLEGGSLGQLIKQM-GCLPEDRALYYLGQALEGLEYLHTRRILHG 190
Query: 468 DIKGANLLVDASGV-VKLADFGMAKHLTGQKADLSMK------GSPYWMAPELMMAVMQK 520
           D+K  N+L+ + G    L DFG A  L       S+       G+   MAPE++M     
Sbjct: 191 DVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVM----- 245
Query: 521 GKSSDSALAVDIWSLGCTIIEMYTGKPPWSEY 552
           GK  D+   VDIWS  C ++ M  G  PW++Y
Sbjct: 246 GKPCDA--KVDIWSSCCMMLHMLNGCHPWTQY 275

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 95.5 bits (236), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 63/224 (28%), Positives = 111/224 (49%), Gaps = 29/224 (12%)
Query: 339 NSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLE----QEIK 394
            S+++    IG G +G+VY A +  +G   A+K V +    P        L     +E+ 
Sbjct: 8   TSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRV----PNGGGGGGGLPISTVREVA 63
Query: 395 VLSHLK---HPNIVQYY---GSEIVEDKFYIYLEYVHPGSINKYVREHCG-----AITES 443
           +L  L+   HPN+V+      +   + +  + L + H   +++ +R +        +   
Sbjct: 64  LLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEH---VDQDLRTYLDKAPPPGLPAE 120
Query: 444 VVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMK 503
            +++  R  L GL +LH+   +HRD+K  N+LV + G VKLADFG+A+  + Q A   + 
Sbjct: 121 TIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPVV 180
Query: 504 GSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKP 547
            + ++ APE+++        S  A  VD+WS+GC   EM+  KP
Sbjct: 181 VTLWYRAPEVLL-------QSTYATPVDMWSVGCIFAEMFRRKP 217

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 95.1 bits (235), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 75/272 (27%), Positives = 132/272 (48%), Gaps = 19/272 (6%)
Query: 346 KLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIV 405
           K+IGRG FG V +  ++ T  + AMK +  F    +S  +    E++I   ++   P +V
Sbjct: 80  KVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFAN--SPWVV 137
Query: 406 QYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTI 465
           Q + +   +   Y+ +EY+  G +   +  +   + E   R +T  ++  L  +HS   I
Sbjct: 138 QLFYAFQDDRYLYMVMEYMPGGDLVNLMSNY--DVPEKWARFYTAEVVLALDAIHSMGFI 195
Query: 466 HRDIKGANLLVDASGVVKLADFGMAKHLTGQ---KADLSMKGSPYWMAPELMMAVMQKGK 522
           HRD+K  N+L+D SG +KLADFG    +  +   + D ++ G+P +++PE++ +   +G 
Sbjct: 196 HRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-GTPDYISPEVLKS---QGG 251
Query: 523 SSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVM--RDTPAIPD--SLSPEGKD 578
                   D WS+G  + EM  G  P+          K+M  +++   PD   +S E K+
Sbjct: 252 DGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAKN 311
Query: 579 FLRCCFQRNPADRPPASLLLE---HRFLKNSQ 607
            + C F  +   R   + + E   H F KN Q
Sbjct: 312 LI-CAFLTDREVRLGRNGVEEIKRHLFFKNDQ 342

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 95.1 bits (235), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 65/212 (30%), Positives = 107/212 (50%), Gaps = 25/212 (11%)
Query: 348 IGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQY 407
           +GRG+FG V+   +++TG  CA+K+V +          + ++E E+   + L  P IV  
Sbjct: 80  LGRGSFGEVHRMKDKQTGFQCAVKKVRL---------EVFRVE-ELVACAGLSSPRIVPL 129
Query: 408 YGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHR 467
           YG+        I++E +  GS+ + +++  G + E     +    L GL YLH+++ +H 
Sbjct: 130 YGAVREGPWVNIFMELLEGGSLGQLIKQM-GCLPEDRALYYLGQALEGLEYLHTRRILHG 188
Query: 468 DIKGANLLVDASGV-VKLADFGMAKHLTGQKADLSMK------GSPYWMAPELMMAVMQK 520
           D+K  N+L+ + G    L DFG A  L       S+       G+   MAPE++M     
Sbjct: 189 DVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVM----- 243
Query: 521 GKSSDSALAVDIWSLGCTIIEMYTGKPPWSEY 552
           GK  D+   VDIWS  C ++ M  G  PW++Y
Sbjct: 244 GKPCDA--KVDIWSSCCMMLHMLNGCHPWTQY 273

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 95.1 bits (235), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 73/270 (27%), Positives = 119/270 (44%), Gaps = 37/270 (13%)
Query: 346 KLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIV 405
           +LIG G FG V+ A +R  G    +K V           + ++ E+E+K L+ L H NIV
Sbjct: 17  ELIGSGGFGQVFKAKHRIDGKTYVIKRVKY---------NNEKAEREVKALAKLDHVNIV 67
Query: 406 QYYG----------------SEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVR-NF 448
            Y G                S       +I +E+   G++ +++ +  G   + V+    
Sbjct: 68  HYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALEL 127
Query: 449 TRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPYW 508
              I  G+ Y+HSKK I+RD+K +N+ +  +  VK+ DFG+   L         KG+  +
Sbjct: 128 FEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRXRSKGTLRY 187
Query: 509 MAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAI 568
           M+PE +        S D    VD+++LG  + E+        E    +  F  +RD   I
Sbjct: 188 MSPEQI-------SSQDYGKEVDLYALGLILAELLHVCDTAFE---TSKFFTDLRD-GII 236
Query: 569 PDSLSPEGKDFLRCCFQRNPADRPPASLLL 598
            D    + K  L+    + P DRP  S +L
Sbjct: 237 SDIFDKKEKTLLQKLLSKKPEDRPNTSEIL 266

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 95.1 bits (235), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 70/271 (25%), Positives = 123/271 (45%), Gaps = 18/271 (6%)
Query: 348 IGRGTFGSVYVAS-NRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQ 406
           +G G+FG V     +  +G   ++    + PD     E++    +E+  +  L H N+++
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 407 YYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIH 466
            YG  ++     +  E    GS+   +R+H G      +  +   +  G+ YL SK+ IH
Sbjct: 76  LYGV-VLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIH 134
Query: 467 RDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSM---KGSPY-WMAPELMMAVMQKGK 522
           RD+   NLL+    +VK+ DFG+ + L        M   +  P+ W APE +       K
Sbjct: 135 RDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESL-------K 187
Query: 523 SSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFKVMRDTPAI--PDSLSPEGKDF 579
           +   + A D W  G T+ EM+T G+ PW    G+  + K+ ++   +  P+    +  + 
Sbjct: 188 TRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDIYNV 247
Query: 580 LRCCFQRNPADRPPASLLLEHRFLKNSQQPD 610
           +  C+   P DRP    L +  FL  +Q  D
Sbjct: 248 MVQCWAHKPEDRPTFVALRD--FLLEAQPTD 276

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 94.7 bits (234), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 76/291 (26%), Positives = 137/291 (47%), Gaps = 33/291 (11%)
Query: 338 MNSQWQKGKLIGRGTFG----SVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEI 393
              ++Q  + +G+G F      V V + +E  A+       I      SA   ++LE+E 
Sbjct: 9   FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAM-------IINTKKLSARDHQKLEREA 61
Query: 394 KVLSHLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYV--REHCGAITESVVRNFTRH 451
           ++   LKHPNIV+ + S   E   Y+  + V  G + + +  RE+    +E+   +  + 
Sbjct: 62  RICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREY---YSEADASHCIQQ 118
Query: 452 ILSGLAYLHSKKTIHRDIKGANLLVDA---SGVVKLADFGMAKHLTG-QKADLSMKGSPY 507
           IL  + + H    +HR++K  NLL+ +      VKLADFG+A  + G Q+A     G+P 
Sbjct: 119 ILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPG 178
Query: 508 WMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPA 567
           +++PE++       +       VD+W+ G  +  +  G PP+ + +      ++      
Sbjct: 179 YLSPEVL-------RKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYD 231
Query: 568 IP----DSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQPDVPSC 614
            P    D+++PE KD +      NP+ R  A+  L+H ++  S +  V SC
Sbjct: 232 FPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALKHPWI--SHRSTVASC 280

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 94.7 bits (234), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 72/260 (27%), Positives = 116/260 (44%), Gaps = 24/260 (9%)
Query: 346 KLIGRGTFGSVYVAS--NRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPN 403
           K +G G FG V +     +   A+  +KE  +  D+           QE + +  L HP 
Sbjct: 14  KELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDE---------FFQEAQTMMKLSHPK 64
Query: 404 IVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKK 463
           +V++YG    E   YI  EY+  G +  Y+R H   +  S +      +  G+A+L S +
Sbjct: 65  LVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQ 124
Query: 464 TIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPY---WMAPELMMAVMQK 520
            IHRD+   N LVD    VK++DFGM +++   +  +S  G+ +   W APE+       
Sbjct: 125 FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQY-VSSVGTKFPVKWSAPEVFHYFKYS 183
Query: 521 GKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFKVMRDTPAI-PDSLSPEGKD 578
            KS       D+W+ G  + E+++ GK P+  Y  +  + KV +      P   S     
Sbjct: 184 SKS-------DVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYRPHLASDTIYQ 236
Query: 579 FLRCCFQRNPADRPPASLLL 598
            +  C+   P  RP    LL
Sbjct: 237 IMYSCWHELPEKRPTFQQLL 256

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 85/323 (26%), Positives = 157/323 (48%), Gaps = 51/323 (15%)
Query: 348 IGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESI-KQLEQEIKVLSHLKHPNIVQ 406
           +G G +G+V  A +  TGA  A+K++      P  +E   K+  +E+++L H++H N++ 
Sbjct: 33  VGSGAYGAVCSAVDGRTGAKVAIKKLY----RPFQSELFAKRAYRELRLLKHMRHENVIG 88
Query: 407 ----YYGSEIVED--KFYIYLEYVHP--GSINKYVREHCGAITESVVRNFTRHILSGLAY 458
               +   E ++D   FY+ + ++    G + K+ +     + E  ++     +L GL Y
Sbjct: 89  LLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEK-----LGEDRIQFLVYQMLKGLRY 143
Query: 459 LHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKG---SPYWMAPELMM 515
           +H+   IHRD+K  NL V+    +K+ DFG+A+     +AD  M G   + ++ APE+++
Sbjct: 144 IHAAGIIHRDLKPGNLAVNEDCELKILDFGLAR-----QADSEMXGXVVTRWYRAPEVIL 198
Query: 516 AVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDSL--- 572
             M+  ++      VDIWS+GC + EM TGK  +   +    + ++M+ T   P      
Sbjct: 199 NWMRYTQT------VDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQR 252
Query: 573 --SPEGKDFLRCCFQRNPAD--------RPPASLLLEHRFLKNSQQPDVPSCSLS---FS 619
             S E K++++   +    D         P A  LLE   + +++Q      +L+   F 
Sbjct: 253 LQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFE 312
Query: 620 GMQLTEKPHSPR-EKADAKYDQV 641
            +  TE    P+ +K D  +D V
Sbjct: 313 SLHDTED--EPQVQKYDDSFDDV 333

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 65/253 (25%), Positives = 116/253 (45%), Gaps = 16/253 (6%)
Query: 348 IGRGTFGSVYVAS-NRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQ 406
           +G G+FG V     +  +G   ++    + PD     E++    +E+  +  L H N+++
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 407 YYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIH 466
            YG  ++     +  E    GS+   +R+H G      +  +   +  G+ YL SK+ IH
Sbjct: 76  LYGV-VLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIH 134
Query: 467 RDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSM---KGSPY-WMAPELMMAVMQKGK 522
           RD+   NLL+    +VK+ DFG+ + L        M   +  P+ W APE +       K
Sbjct: 135 RDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAPESL-------K 187
Query: 523 SSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFKVMRDTPAI--PDSLSPEGKDF 579
           +   + A D W  G T+ EM+T G+ PW    G+  + K+ ++   +  P+    +  + 
Sbjct: 188 TRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDIYNV 247
Query: 580 LRCCFQRNPADRP 592
           +  C+   P DRP
Sbjct: 248 MVQCWAHKPEDRP 260

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 72/251 (28%), Positives = 126/251 (50%), Gaps = 27/251 (10%)
Query: 348 IGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQ- 406
           +G G +GSV  A +       A+K++       +S    ++  +E+++L HLKH N++  
Sbjct: 36  VGSGAYGSVCSAYDARLRQKVAVKKLS---RPFQSLIHARRTYRELRLLKHLKHENVIGL 92
Query: 407 ---YYGSEIVEDKFYIYLEYVHPGS-INKYVREHCGAITESVVRNFTRHILSGLAYLHSK 462
              +  +  +ED   +YL     G+ +N  V+  C A+++  V+     +L GL Y+HS 
Sbjct: 93  LDVFTPATSIEDFSEVYLVTTLMGADLNNIVK--CQALSDEHVQFLVYQLLRGLKYIHSA 150
Query: 463 KTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKG---SPYWMAPELMMAVMQ 519
             IHRD+K +N+ V+    +++ DFG+A+     +AD  M G   + ++ APE+M+  M 
Sbjct: 151 GIIHRDLKPSNVAVNEDSELRILDFGLAR-----QADEEMTGYVATRWYRAPEIMLNWMH 205
Query: 520 KGKSSDSALAVDIWSLGCTIIEMYTGKP--PWSEYEGAAAMFKVMRDTPAIPDSLSPEGK 577
             ++      VDIWS+GC + E+  GK   P S+Y         +  TP+ P+ L+    
Sbjct: 206 YNQT------VDIWSVGCIMAELLQGKALFPGSDYIDQLKRIMEVVGTPS-PEVLAKISS 258
Query: 578 DFLRCCFQRNP 588
           +  R   Q  P
Sbjct: 259 EHARTYIQSLP 269

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 106/208 (50%), Gaps = 23/208 (11%)
Query: 348 IGRGTFGSV----YVASNRETGALCAMKEVDIFPDDPKSA-ESIKQLEQEIKVLSHLKHP 402
           +G G FG V    Y      TG   A+K +      P+S    I  L++EI++L +L H 
Sbjct: 29  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLK-----PESGGNHIADLKKEIEILRNLYHE 83
Query: 403 NIVQYYG--SEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLH 460
           NIV+Y G  +E   +   + +E++  GS+ +Y+ ++   I       +   I  G+ YL 
Sbjct: 84  NIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLG 143
Query: 461 SKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMK---GSP-YWMAPELMMA 516
           S++ +HRD+   N+LV++   VK+ DFG+ K +   K   ++K    SP +W APE +M 
Sbjct: 144 SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPECLM- 202
Query: 517 VMQKGKSSDSALAVDIWSLGCTIIEMYT 544
                  S   +A D+WS G T+ E+ T
Sbjct: 203 ------QSKFYIASDVWSFGVTLHELLT 224

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 75/285 (26%), Positives = 136/285 (47%), Gaps = 21/285 (7%)
Query: 338 MNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFP-DDPKSAESIKQLEQEIKVL 396
           +   ++ G+ +G G F  V     + TG   A K +        +   S +++E+E+ +L
Sbjct: 3   VEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNIL 62
Query: 397 SHLKHPNIVQYYGSEIVEDK--FYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILS 454
             ++HPNI+  +  +I E+K    + LE V  G +  ++ E   ++TE     F + IL 
Sbjct: 63  REIRHPNIITLH--DIFENKTDVVLILELVSGGELFDFLAEK-ESLTEDEATQFLKQILD 119
Query: 455 GLAYLHSKKTIHRDIKGANLLVDASGV----VKLADFGMAKHLTGQKADLSMKGSPYWMA 510
           G+ YLHSK+  H D+K  N+++    V    +KL DFG+A  +       ++ G+P ++A
Sbjct: 120 GVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVA 179
Query: 511 PELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPW---SEYEGAAAMFKVMRDTPA 567
           PE++             L  D+WS+G     + +G  P+   ++ E    +  V  D   
Sbjct: 180 PEIV-------NYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDE 232
Query: 568 IPDSLSPE-GKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQPDV 611
              S + E  KDF+R    ++P  R   +  LEH ++K  ++ +V
Sbjct: 233 EYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRRRNV 277

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 76/275 (27%), Positives = 127/275 (46%), Gaps = 27/275 (9%)
Query: 338 MNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKE--VDIFPDDPKSAESIKQLEQEIKV 395
           M  ++Q  + IG+G F  V     R    LC   E    I      SA   ++LE+E ++
Sbjct: 2   MTDEYQLYEDIGKGAFSVV-----RRCVKLCTGHEYAAKIINTKKLSARDHQKLEREARI 56
Query: 396 LSHLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYV--REHCGAITESVVRNFTRHIL 453
              LKH NIV+ + S   E   Y+  + V  G + + +  RE+    +E+   +  + IL
Sbjct: 57  CRLLKHSNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREY---YSEADASHCIQQIL 113
Query: 454 SGLAYLHSKKTIHRDIKGANLLVDA---SGVVKLADFGMAKHLTG-QKADLSMKGSPYWM 509
             + + H    +HRD+K  NLL+ +      VKLADFG+A  + G Q+A     G+P ++
Sbjct: 114 EAVLHCHQMGVVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYL 173
Query: 510 APELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIP 569
           +PE++       +       VDIW+ G  +  +  G PP+ + +      ++       P
Sbjct: 174 SPEVL-------RKEAYGKPVDIWACGVILYILLVGYPPFWDEDQHKLYQQIKAGAYDFP 226
Query: 570 ----DSLSPEGKDFLRCCFQRNPADRPPASLLLEH 600
               D+++PE K+ +      NPA R  A   L+H
Sbjct: 227 SPEWDTVTPEAKNLINQMLTINPAKRITAHEALKH 261

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 65/253 (25%), Positives = 116/253 (45%), Gaps = 16/253 (6%)
Query: 348 IGRGTFGSVYVAS-NRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQ 406
           +G G+FG V     +  +G   ++    + PD     E++    +E+  +  L H N+++
Sbjct: 20  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 79
Query: 407 YYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIH 466
            YG  ++     +  E    GS+   +R+H G      +  +   +  G+ YL SK+ IH
Sbjct: 80  LYGV-VLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIH 138
Query: 467 RDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSM---KGSPY-WMAPELMMAVMQKGK 522
           RD+   NLL+    +VK+ DFG+ + L        M   +  P+ W APE +       K
Sbjct: 139 RDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESL-------K 191
Query: 523 SSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFKVMRDTPAI--PDSLSPEGKDF 579
           +   + A D W  G T+ EM+T G+ PW    G+  + K+ ++   +  P+    +  + 
Sbjct: 192 TRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDIYNV 251
Query: 580 LRCCFQRNPADRP 592
           +  C+   P DRP
Sbjct: 252 MVQCWAHKPEDRP 264

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 70/263 (26%), Positives = 117/263 (44%), Gaps = 34/263 (12%)
Query: 348 IGRGTFGSVYVAS--NRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIV 405
           IG G FG V++    N++  A+  +KE  +  DD           +E +V+  L HP +V
Sbjct: 35  IGSGQFGLVHLGYWLNKDKVAIKTIKEGSMSEDD---------FIEEAEVMMKLSHPKLV 85
Query: 406 QYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTI 465
           Q YG  + +    +  E++  G ++ Y+R   G      +      +  G+AYL     I
Sbjct: 86  QLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVI 145
Query: 466 HRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPY---WMAPELMMAVMQKGK 522
           HRD+   N LV  + V+K++DFGM + +   +   S  G+ +   W +PE+        K
Sbjct: 146 HRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT-SSTGTKFPVKWASPEVFSFSRYSSK 204
Query: 523 SSDSALAVDIWSLGCTIIEMYT-GKPPWSE------YEGAAAMFKVMRDTPAIPDSLSPE 575
           S       D+WS G  + E+++ GK P+         E  +  F++ +     P   S  
Sbjct: 205 S-------DVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYK-----PRLASTH 252
Query: 576 GKDFLRCCFQRNPADRPPASLLL 598
               +  C++  P DRP  S LL
Sbjct: 253 VYQIMNHCWKERPEDRPAFSRLL 275

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 94.0 bits (232), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 66/251 (26%), Positives = 122/251 (48%), Gaps = 34/251 (13%)
Query: 389 LEQEIKVLSHLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYV-------REHCGAIT 441
            + E+++++ +K+   +   G     D+ YI  EY+   SI K+        + +   I 
Sbjct: 90  FKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIP 149
Query: 442 ESVVRNFTRHILSGLAYLHSKKTI-HRDIKGANLLVDASGVVKLADFGMAKHLTGQKADL 500
             V++   + +L+  +Y+H++K I HRD+K +N+L+D +G VKL+DFG ++++  +K   
Sbjct: 150 IQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIKG 209
Query: 501 SMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFK 560
           S +G+  +M PE         +SS +   VDIWSLG  +  M+    P+S       +F 
Sbjct: 210 S-RGTYEFMPPEFF-----SNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFN 263
Query: 561 VMR--------------------DTPAIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEH 600
            +R                     +    + LS E  DFL+   ++NPA+R  +   L+H
Sbjct: 264 NIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKH 323
Query: 601 RFLKNSQQPDV 611
            +L ++   D+
Sbjct: 324 EWLADTNIEDL 334

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 94.0 bits (232), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 83/315 (26%), Positives = 136/315 (43%), Gaps = 63/315 (20%)
Query: 338 MNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLS 397
           + S++   K +G G  G V+ A + +     A+K++ +   DP   +S+K   +EIK++ 
Sbjct: 9   LGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVL--TDP---QSVKHALREIKIIR 63
Query: 398 HLKHPNIVQYY------GSEIVED--------KFYIYLEYVHPGSINKYVREHCGAITES 443
            L H NIV+ +      GS++ +D          YI  EY+     N  V E  G + E 
Sbjct: 64  RLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLAN--VLEQ-GPLLEE 120
Query: 444 VVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASG-VVKLADFGMAKHLT---GQKAD 499
             R F   +L GL Y+HS   +HRD+K ANL ++    V+K+ DFG+A+ +      K  
Sbjct: 121 HARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGH 180
Query: 500 LSMKGSPYWM-APELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAM 558
           LS      W  +P L+++       ++   A+D+W+ GC   EM TGK  ++       M
Sbjct: 181 LSEGLVTKWYRSPRLLLS------PNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQM 234
Query: 559 FKVMRDTPAIPDS------------------------------LSPEGKDFLRCCFQRNP 588
             ++   P + +                               +S E  DFL      +P
Sbjct: 235 QLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSP 294
Query: 589 ADRPPASLLLEHRFL 603
            DR  A   L H ++
Sbjct: 295 MDRLTAEEALSHPYM 309

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 94.0 bits (232), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 106/208 (50%), Gaps = 23/208 (11%)
Query: 348 IGRGTFGSV----YVASNRETGALCAMKEVDIFPDDPKSA-ESIKQLEQEIKVLSHLKHP 402
           +G G FG V    Y      TG   A+K +      P+S    I  L++EI++L +L H 
Sbjct: 17  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLK-----PESGGNHIADLKKEIEILRNLYHE 71
Query: 403 NIVQYYG--SEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLH 460
           NIV+Y G  +E   +   + +E++  GS+ +Y+ ++   I       +   I  G+ YL 
Sbjct: 72  NIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLG 131
Query: 461 SKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMK---GSP-YWMAPELMMA 516
           S++ +HRD+   N+LV++   VK+ DFG+ K +   K   ++K    SP +W APE +M 
Sbjct: 132 SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPECLM- 190
Query: 517 VMQKGKSSDSALAVDIWSLGCTIIEMYT 544
                  S   +A D+WS G T+ E+ T
Sbjct: 191 ------QSKFYIASDVWSFGVTLHELLT 212

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 94.0 bits (232), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 72/251 (28%), Positives = 126/251 (50%), Gaps = 27/251 (10%)
Query: 348 IGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQ- 406
           +G G +GSV  A +       A+K++       +S    ++  +E+++L HLKH N++  
Sbjct: 28  VGSGAYGSVCSAYDARLRQKVAVKKLS---RPFQSLIHARRTYRELRLLKHLKHENVIGL 84
Query: 407 ---YYGSEIVEDKFYIYLEYVHPGS-INKYVREHCGAITESVVRNFTRHILSGLAYLHSK 462
              +  +  +ED   +YL     G+ +N  V+  C A+++  V+     +L GL Y+HS 
Sbjct: 85  LDVFTPATSIEDFSEVYLVTTLMGADLNNIVK--CQALSDEHVQFLVYQLLRGLKYIHSA 142
Query: 463 KTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKG---SPYWMAPELMMAVMQ 519
             IHRD+K +N+ V+    +++ DFG+A+     +AD  M G   + ++ APE+M+  M 
Sbjct: 143 GIIHRDLKPSNVAVNEDCELRILDFGLAR-----QADEEMTGYVATRWYRAPEIMLNWMH 197
Query: 520 KGKSSDSALAVDIWSLGCTIIEMYTGKP--PWSEYEGAAAMFKVMRDTPAIPDSLSPEGK 577
             ++      VDIWS+GC + E+  GK   P S+Y         +  TP+ P+ L+    
Sbjct: 198 YNQT------VDIWSVGCIMAELLQGKALFPGSDYIDQLKRIMEVVGTPS-PEVLAKISS 250
Query: 578 DFLRCCFQRNP 588
           +  R   Q  P
Sbjct: 251 EHARTYIQSLP 261

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 94.0 bits (232), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 74/283 (26%), Positives = 121/283 (42%), Gaps = 50/283 (17%)
Query: 346 KLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIV 405
           +LIG G FG V+ A +R  G    ++ V           + ++ E+E+K L+ L H NIV
Sbjct: 18  ELIGSGGFGQVFKAKHRIDGKTYVIRRVKY---------NNEKAEREVKALAKLDHVNIV 68
Query: 406 QYYGS--------EIVEDKF---------------------YIYLEYVHPGSINKYVREH 436
            Y G         E  +D                       +I +E+   G++ +++ + 
Sbjct: 69  HYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKR 128
Query: 437 CGAITESVVR-NFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTG 495
            G   + V+       I  G+ Y+HSKK IHRD+K +N+ +  +  VK+ DFG+   L  
Sbjct: 129 RGEKLDKVLALELFEQITKGVDYIHSKKLIHRDLKPSNIFLVDTKQVKIGDFGLVTSLKN 188
Query: 496 QKADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGA 555
                  KG+  +M+PE +        S D    VD+++LG  + E+        E    
Sbjct: 189 DGKRTRSKGTLRYMSPEQI-------SSQDYGKEVDLYALGLILAELLHVCDTAFE---T 238
Query: 556 AAMFKVMRDTPAIPDSLSPEGKDFLRCCFQRNPADRPPASLLL 598
           +  F  +RD   I D    + K  L+    + P DRP  S +L
Sbjct: 239 SKFFTDLRD-GIISDIFDKKEKTLLQKLLSKKPEDRPNTSEIL 280

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 94.0 bits (232), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 77/277 (27%), Positives = 129/277 (46%), Gaps = 23/277 (8%)
Query: 342 WQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKH 401
           ++  ++IG+G F  V    NRETG   A+K VD+         S + L++E  +   LKH
Sbjct: 26  YELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKH 85
Query: 402 PNIVQYYGSEIVEDKFYIYLEYVHPGSINKYV--REHCGAI-TESVVRNFTRHILSGLAY 458
           P+IV+   +   +   Y+  E++    +   +  R   G + +E+V  ++ R IL  L Y
Sbjct: 86  PHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRY 145
Query: 459 LHSKKTIHRDIKGANLLV---DASGVVKLADFGMAKHLTGQKADLS--MKGSPYWMAPEL 513
            H    IHRD+K   +L+   + S  VKL  FG+A  L G+   ++    G+P++MAPE+
Sbjct: 146 CHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQL-GESGLVAGGRVGTPHFMAPEV 204
Query: 514 MMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVM-----RDTPAI 568
           +       K       VD+W  G  +  + +G  P+  Y     +F+ +     +  P  
Sbjct: 205 V-------KREPYGKPVDVWGCGVILFILLSGCLPF--YGTKERLFEGIIKGKYKMNPRQ 255
Query: 569 PDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKN 605
              +S   KD +R     +PA+R      L H +LK 
Sbjct: 256 WSHISESAKDLVRRMLMLDPAERITVYEALNHPWLKE 292

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 94.0 bits (232), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 80/305 (26%), Positives = 137/305 (44%), Gaps = 58/305 (19%)
Query: 336 LPMNSQWQK-------GKLIGRGTFGSVYVAS---------NRETGALCAMKEVDIFPDD 379
           LP + +W+        GK +G G FG V +A          NR T     M + D    D
Sbjct: 2   LPEDPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKD 61
Query: 380 PKSAESIKQLEQEIKVLSHL-KHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVR---- 434
                 +  L  E++++  + KH NI+   G+   +   Y+ +EY   G++ +Y++    
Sbjct: 62  ------LSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRP 115
Query: 435 ---EHC--------GAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVK 483
              E+C          ++   + +    +  G+ YL SKK IHRD+   N+LV    V+K
Sbjct: 116 PGLEYCYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMK 175
Query: 484 LADFGMAK---HLTGQKADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTII 540
           +ADFG+A+   H+   K   + +    WMAPE +   +   +S       D+WS G  + 
Sbjct: 176 IADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQS-------DVWSFGVLLW 228
Query: 541 EMYT--GKPPWSEYEG--AAAMFKVMRDTPAI--PDSLSPEGKDFLRCCFQRNPADRPPA 594
           E++T  G P    Y G     +FK++++   +  P + + E    +R C+   P+ RP  
Sbjct: 229 EIFTLGGSP----YPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTF 284
Query: 595 SLLLE 599
             L+E
Sbjct: 285 KQLVE 289

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 93.6 bits (231), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 65/253 (25%), Positives = 116/253 (45%), Gaps = 16/253 (6%)
Query: 348 IGRGTFGSVYVAS-NRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQ 406
           +G G+FG V     +  +G   ++    + PD     E++    +E+  +  L H N+++
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 407 YYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIH 466
            YG  ++     +  E    GS+   +R+H G      +  +   +  G+ YL SK+ IH
Sbjct: 76  LYGV-VLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIH 134
Query: 467 RDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSM---KGSPY-WMAPELMMAVMQKGK 522
           RD+   NLL+    +VK+ DFG+ + L        M   +  P+ W APE +       K
Sbjct: 135 RDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESL-------K 187
Query: 523 SSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFKVMRDTPAI--PDSLSPEGKDF 579
           +   + A D W  G T+ EM+T G+ PW    G+  + K+ ++   +  P+    +  + 
Sbjct: 188 TRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDIYNV 247
Query: 580 LRCCFQRNPADRP 592
           +  C+   P DRP
Sbjct: 248 MVQCWAHKPEDRP 260

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 93.6 bits (231), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 79/256 (30%), Positives = 126/256 (49%), Gaps = 29/256 (11%)
Query: 346 KLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIV 405
           +++GRG FG V  A  R      A+K+++       S    K    E++ LS + HPNIV
Sbjct: 15  EVVGRGAFGVVCKAKWRAKDV--AIKQIE-------SESERKAFIVELRQLSRVNHPNIV 65
Query: 406 QYYGSEIVEDKFYIYLEYVHPGSINKYVR--EHCGAITESVVRNFTRHILSGLAYLHS-- 461
           + YG+ +  +   + +EY   GS+   +   E     T +   ++      G+AYLHS  
Sbjct: 66  KLYGACL--NPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQ 123
Query: 462 -KKTIHRDIKGANLLVDASG-VVKLADFGMAKHLTGQKADLSMKGSPYWMAPELMMAVMQ 519
            K  IHRD+K  NLL+ A G V+K+ DFG A  +  Q    + KGS  WMAPE+      
Sbjct: 124 PKALIHRDLKPPNLLLVAGGTVLKICDFGTACDI--QTHMTNNKGSAAWMAPEVF----- 176
Query: 520 KGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAA--AMFKVMRDT-PAIPDSLSPEG 576
             + S+ +   D++S G  + E+ T + P+ E  G A   M+ V   T P +  +L    
Sbjct: 177 --EGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLPKPI 234
Query: 577 KDFLRCCFQRNPADRP 592
           +  +  C+ ++P+ RP
Sbjct: 235 ESLMTRCWSKDPSQRP 250

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 93.6 bits (231), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 75/285 (26%), Positives = 136/285 (47%), Gaps = 21/285 (7%)
Query: 338 MNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFP-DDPKSAESIKQLEQEIKVL 396
           +   ++ G+ +G G F  V     + TG   A K +        +   S +++E+E+ +L
Sbjct: 24  VEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLXSSRRGVSREEIEREVNIL 83
Query: 397 SHLKHPNIVQYYGSEIVEDK--FYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILS 454
             ++HPNI+  +  +I E+K    + LE V  G +  ++ E   ++TE     F + IL 
Sbjct: 84  REIRHPNIITLH--DIFENKTDVVLILELVSGGELFDFLAEK-ESLTEDEATQFLKQILD 140
Query: 455 GLAYLHSKKTIHRDIKGANLLVDASGV----VKLADFGMAKHLTGQKADLSMKGSPYWMA 510
           G+ YLHSK+  H D+K  N+++    V    +KL DFG+A  +       ++ G+P ++A
Sbjct: 141 GVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVA 200
Query: 511 PELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPW---SEYEGAAAMFKVMRDTPA 567
           PE++             L  D+WS+G     + +G  P+   ++ E    +  V  D   
Sbjct: 201 PEIV-------NYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDE 253
Query: 568 IPDSLSPE-GKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQPDV 611
              S + E  KDF+R    ++P  R   +  LEH ++K  ++ +V
Sbjct: 254 EYFSNTSELAKDFIRRLLVKDPKRRMXIAQSLEHSWIKAIRRRNV 298

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 93.6 bits (231), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 79/256 (30%), Positives = 126/256 (49%), Gaps = 29/256 (11%)
Query: 346 KLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIV 405
           +++GRG FG V  A  R      A+K+++       S    K    E++ LS + HPNIV
Sbjct: 14  EVVGRGAFGVVCKAKWRAKDV--AIKQIE-------SESERKAFIVELRQLSRVNHPNIV 64
Query: 406 QYYGSEIVEDKFYIYLEYVHPGSINKYVR--EHCGAITESVVRNFTRHILSGLAYLHS-- 461
           + YG+ +  +   + +EY   GS+   +   E     T +   ++      G+AYLHS  
Sbjct: 65  KLYGACL--NPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQ 122
Query: 462 -KKTIHRDIKGANLLVDASG-VVKLADFGMAKHLTGQKADLSMKGSPYWMAPELMMAVMQ 519
            K  IHRD+K  NLL+ A G V+K+ DFG A  +  Q    + KGS  WMAPE+      
Sbjct: 123 PKALIHRDLKPPNLLLVAGGTVLKICDFGTACDI--QTHMTNNKGSAAWMAPEVF----- 175
Query: 520 KGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAA--AMFKVMRDT-PAIPDSLSPEG 576
             + S+ +   D++S G  + E+ T + P+ E  G A   M+ V   T P +  +L    
Sbjct: 176 --EGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLPKPI 233
Query: 577 KDFLRCCFQRNPADRP 592
           +  +  C+ ++P+ RP
Sbjct: 234 ESLMTRCWSKDPSQRP 249

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 93.2 bits (230), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 69/273 (25%), Positives = 127/273 (46%), Gaps = 46/273 (16%)
Query: 348 IGRGTFGSVYVASN-----RETGALCAMKEVDIFPDDPKSAESIKQ-LEQEIKVLSHLKH 401
           +G G FG V++A        +   L A+K +       +++ES +Q  ++E ++L+ L+H
Sbjct: 26  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALK------EASESARQDFQREAELLTMLQH 79
Query: 402 PNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHC--------------GAITESVVRN 447
            +IV+++G         +  EY+  G +N+++R H               G +    +  
Sbjct: 80  QHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLA 139
Query: 448 FTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHL-------TGQKADL 500
               + +G+ YL     +HRD+   N LV    VVK+ DFGM++ +        G +  L
Sbjct: 140 VASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTML 199
Query: 501 SMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMF 559
            ++    WM PE   +++ +  +++S    D+WS G  + E++T GK PW +     A+ 
Sbjct: 200 PIR----WMPPE---SILYRKFTTES----DVWSFGVVLWEIFTYGKQPWYQLSNTEAID 248
Query: 560 KVMRDTP-AIPDSLSPEGKDFLRCCFQRNPADR 591
            + +      P +  PE    +R C+QR P  R
Sbjct: 249 CITQGRELERPRACPPEVYAIMRGCWQREPQQR 281

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 93.2 bits (230), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 81/273 (29%), Positives = 125/273 (45%), Gaps = 43/273 (15%)
Query: 348 IGRGTFGSV----YVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPN 403
           +G G FG V    Y  +N  TG + A+K +      P+     KQ   EI +L  L H +
Sbjct: 39  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKA-DAGPQHRSGWKQ---EIDILRTLYHEH 94
Query: 404 IVQYYGSEIVED----KFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYL 459
           I++Y G    ED       + +EYV  GS+  Y+  H   + + ++  F + I  G+AYL
Sbjct: 95  IIKYKGC--CEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQLLL--FAQQICEGMAYL 150
Query: 460 HSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMK---GSP-YWMAPELMM 515
           H++  IHRD+   N+L+D   +VK+ DFG+AK +        ++    SP +W APE + 
Sbjct: 151 HAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEXYRVREDGDSPVFWYAPECL- 209
Query: 516 AVMQKGKSSDSALAVDIWSLGCTIIEMYT-----GKPP--WSEYEG-AAAMFKVMRDTPA 567
                 K      A D+WS G T+ E+ T       PP  + E  G A     V+R T  
Sbjct: 210 ------KEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTEL 263
Query: 568 I--------PDSLSPEGKDFLRCCFQRNPADRP 592
           +        PD    E    ++ C++   + RP
Sbjct: 264 LERGERLPRPDKCPAEVYHLMKNCWETEASFRP 296

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 93.2 bits (230), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 69/273 (25%), Positives = 127/273 (46%), Gaps = 46/273 (16%)
Query: 348 IGRGTFGSVYVASN-----RETGALCAMKEVDIFPDDPKSAESIKQ-LEQEIKVLSHLKH 401
           +G G FG V++A        +   L A+K +       +++ES +Q  ++E ++L+ L+H
Sbjct: 49  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALK------EASESARQDFQREAELLTMLQH 102
Query: 402 PNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHC--------------GAITESVVRN 447
            +IV+++G         +  EY+  G +N+++R H               G +    +  
Sbjct: 103 QHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLA 162
Query: 448 FTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHL-------TGQKADL 500
               + +G+ YL     +HRD+   N LV    VVK+ DFGM++ +        G +  L
Sbjct: 163 VASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTML 222
Query: 501 SMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMF 559
            ++    WM PE   +++ +  +++S    D+WS G  + E++T GK PW +     A+ 
Sbjct: 223 PIR----WMPPE---SILYRKFTTES----DVWSFGVVLWEIFTYGKQPWYQLSNTEAID 271
Query: 560 KVMRDTP-AIPDSLSPEGKDFLRCCFQRNPADR 591
            + +      P +  PE    +R C+QR P  R
Sbjct: 272 CITQGRELERPRACPPEVYAIMRGCWQREPQQR 304

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 93.2 bits (230), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 71/261 (27%), Positives = 110/261 (42%), Gaps = 18/261 (6%)
Query: 345 GKLIGRGTFGSVYVASNRETGALCAMKEV-DIFPDDPKSAESIKQLEQEIKVLSHLKHPN 403
           G+ IGRG FG V+    R    L A+K   +  P D K+     +  QE ++L    HPN
Sbjct: 119 GEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKA-----KFLQEARILKQYSHPN 173
Query: 404 IVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKK 463
           IV+  G    +   YI +E V  G    ++R     +    +        +G+ YL SK 
Sbjct: 174 IVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKC 233
Query: 464 TIHRDIKGANLLVDASGVVKLADFGMAKHLTG--QKADLSMKGSPY-WMAPELMMAVMQK 520
            IHRD+   N LV    V+K++DFGM++        A   ++  P  W APE     +  
Sbjct: 234 CIHRDLAARNCLVTEKNVLKISDFGMSREEADGVXAASGGLRQVPVKWTAPE----ALNY 289
Query: 521 GKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFKVMRDTPAIPDSLSPEGK-D 578
           G+ S  +   D+WS G  + E ++ G  P+           V +        L P+    
Sbjct: 290 GRYSSES---DVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRLPCPELCPDAVFR 346
Query: 579 FLRCCFQRNPADRPPASLLLE 599
            +  C+   P  RP  S + +
Sbjct: 347 LMEQCWAYEPGQRPSFSTIYQ 367

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 93.2 bits (230), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 79/305 (25%), Positives = 138/305 (45%), Gaps = 58/305 (19%)
Query: 336 LPMNSQWQK-------GKLIGRGTFGSVYVAS---------NRETGALCAMKEVDIFPDD 379
           LP + +W+        GK +G G FG V +A          NR T     M + D     
Sbjct: 17  LPEDPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD----- 71
Query: 380 PKSAESIKQLEQEIKVLSHL-KHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVR---- 434
             + + +  L  E++++  + KH NI+   G+   +   Y+ +EY   G++ +Y++    
Sbjct: 72  -ATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRP 130
Query: 435 ---EHC--------GAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVK 483
              E+C          ++   + +    +  G+ YL SKK IHRD+   N+LV    V+K
Sbjct: 131 PGLEYCYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMK 190
Query: 484 LADFGMAK---HLTGQKADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTII 540
           +ADFG+A+   H+   K   + +    WMAPE +   +   +S       D+WS G  + 
Sbjct: 191 IADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQS-------DVWSFGVLLW 243
Query: 541 EMYT--GKPPWSEYEG--AAAMFKVMRDTPAI--PDSLSPEGKDFLRCCFQRNPADRPPA 594
           E++T  G P    Y G     +FK++++   +  P + + E    +R C+   P+ RP  
Sbjct: 244 EIFTLGGSP----YPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTF 299
Query: 595 SLLLE 599
             L+E
Sbjct: 300 KQLVE 304

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 93.2 bits (230), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 69/273 (25%), Positives = 127/273 (46%), Gaps = 46/273 (16%)
Query: 348 IGRGTFGSVYVASN-----RETGALCAMKEVDIFPDDPKSAESIKQ-LEQEIKVLSHLKH 401
           +G G FG V++A        +   L A+K +       +++ES +Q  ++E ++L+ L+H
Sbjct: 20  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALK------EASESARQDFQREAELLTMLQH 73
Query: 402 PNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHC--------------GAITESVVRN 447
            +IV+++G         +  EY+  G +N+++R H               G +    +  
Sbjct: 74  QHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLA 133
Query: 448 FTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHL-------TGQKADL 500
               + +G+ YL     +HRD+   N LV    VVK+ DFGM++ +        G +  L
Sbjct: 134 VASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTML 193
Query: 501 SMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMF 559
            ++    WM PE   +++ +  +++S    D+WS G  + E++T GK PW +     A+ 
Sbjct: 194 PIR----WMPPE---SILYRKFTTES----DVWSFGVVLWEIFTYGKQPWYQLSNTEAID 242
Query: 560 KVMRDTP-AIPDSLSPEGKDFLRCCFQRNPADR 591
            + +      P +  PE    +R C+QR P  R
Sbjct: 243 CITQGRELERPRACPPEVYAIMRGCWQREPQQR 275

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 93.2 bits (230), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 74/278 (26%), Positives = 132/278 (47%), Gaps = 21/278 (7%)
Query: 338 MNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFP-DDPKSAESIKQLEQEIKVL 396
           +   ++ G+ +G G F  V     + TG   A K +        +   S +++E+E+ +L
Sbjct: 10  VEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNIL 69
Query: 397 SHLKHPNIVQYYGSEIVEDK--FYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILS 454
             ++HPNI+  +  +I E+K    + LE V  G +  ++ E   ++TE     F + IL 
Sbjct: 70  REIRHPNIITLH--DIFENKTDVVLILELVSGGELFDFLAEK-ESLTEDEATQFLKQILD 126
Query: 455 GLAYLHSKKTIHRDIKGANLLVDASGV----VKLADFGMAKHLTGQKADLSMKGSPYWMA 510
           G+ YLHSK+  H D+K  N+++    V    +KL DFG+A  +       ++ G+P ++A
Sbjct: 127 GVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVA 186
Query: 511 PELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPW---SEYEGAAAMFKVMRDTPA 567
           PE++             L  D+WS+G     + +G  P+   ++ E    +  V  D   
Sbjct: 187 PEIV-------NYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDE 239
Query: 568 IPDSLSPE-GKDFLRCCFQRNPADRPPASLLLEHRFLK 604
              S + E  KDF+R    ++P  R   +  LEH ++K
Sbjct: 240 EYFSNTSELAKDFIRRLLVKDPKRRMXIAQSLEHSWIK 277

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 93.2 bits (230), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 80/307 (26%), Positives = 137/307 (44%), Gaps = 39/307 (12%)
Query: 333 PEPLPMNSQW-------QKGKLIGRGTFGSVYVASNRETGALCAMKEVDI-FPDDPKSAE 384
           P  LP N +W       Q GK +G G FG V  A+    G   A+ +V +        A+
Sbjct: 32  PTQLPYNEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHAD 91
Query: 385 SIKQLEQEIKVLSHL-KHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREH------- 436
             + L  E+K++SHL +H NIV   G+        +  EY   G +  ++R         
Sbjct: 92  EKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETD 151
Query: 437 -CGAITESVVR-----NFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMA 490
              AI  S +      +F+  +  G+A+L SK  IHRD+   N+L+    V K+ DFG+A
Sbjct: 152 PAFAIANSTLSTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLA 211
Query: 491 KHLTGQKADLSMKGSP----YWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-G 545
           + +    ++  +KG+      WMAPE +   +   +S       D+WS G  + E+++ G
Sbjct: 212 RDIMND-SNYIVKGNARLPVKWMAPESIFDCVYTVQS-------DVWSYGILLWEIFSLG 263
Query: 546 KPPWSEYEGAAAMFKVMRDTPAIPD-SLSPEG-KDFLRCCFQRNPADRPPASLLLEHRFL 603
             P+      +  +K+++D   +   + +P+     ++ C+   P  RP    +    FL
Sbjct: 264 LNPYPGILVNSKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICS--FL 321
Query: 604 KNSQQPD 610
           +   Q D
Sbjct: 322 QEQAQED 328

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 92.8 bits (229), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 69/263 (26%), Positives = 117/263 (44%), Gaps = 34/263 (12%)
Query: 348 IGRGTFGSVYVAS--NRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIV 405
           IG G FG V++    N++  A+  ++E          A S +   +E +V+  L HP +V
Sbjct: 15  IGSGQFGLVHLGYWLNKDKVAIKTIRE---------GAMSEEDFIEEAEVMMKLSHPKLV 65
Query: 406 QYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTI 465
           Q YG  + +    +  E++  G ++ Y+R   G      +      +  G+AYL     I
Sbjct: 66  QLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEASVI 125
Query: 466 HRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPY---WMAPELMMAVMQKGK 522
           HRD+   N LV  + V+K++DFGM + +   +   S  G+ +   W +PE+        K
Sbjct: 126 HRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT-SSTGTKFPVKWASPEVFSFSRYSSK 184
Query: 523 SSDSALAVDIWSLGCTIIEMYT-GKPPWSE------YEGAAAMFKVMRDTPAIPDSLSPE 575
           S       D+WS G  + E+++ GK P+         E  +  F++ +     P   S  
Sbjct: 185 S-------DVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYK-----PRLASTH 232
Query: 576 GKDFLRCCFQRNPADRPPASLLL 598
               +  C++  P DRP  S LL
Sbjct: 233 VYQIMNHCWKERPEDRPAFSRLL 255

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 92.8 bits (229), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 78/303 (25%), Positives = 136/303 (44%), Gaps = 35/303 (11%)
Query: 333 PEPLPMNSQW-------QKGKLIGRGTFGSVYVASNRETGALCAMKEVDI-FPDDPKSAE 384
           P  LP N +W       Q GK +G G FG V  A+    G   A+ +V +        A+
Sbjct: 24  PTQLPYNEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHAD 83
Query: 385 SIKQLEQEIKVLSHL-KHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITES 443
             + L  E+K++SHL +H NIV   G+        +  EY   G +  ++R    A  + 
Sbjct: 84  EKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDK 143
Query: 444 V---------VRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLT 494
                     + +F+  +  G+A+L SK  IHRD+   N+L+    V K+ DFG+A+ + 
Sbjct: 144 EDGRPLELRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIM 203
Query: 495 GQKADLSMKGSP----YWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPW 549
              ++  +KG+      WMAPE +   +   +S       D+WS G  + E+++ G  P+
Sbjct: 204 -NDSNYIVKGNARLPVKWMAPESIFDCVYTVQS-------DVWSYGILLWEIFSLGLNPY 255
Query: 550 SEYEGAAAMFKVMRDTPAIPD-SLSPEG-KDFLRCCFQRNPADRPPASLLLEHRFLKNSQ 607
                 +  +K+++D   +   + +P+     ++ C+   P  RP    +    FL+   
Sbjct: 256 PGILVNSKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICS--FLQEQA 313
Query: 608 QPD 610
           Q D
Sbjct: 314 QED 316

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 92.8 bits (229), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 71/261 (27%), Positives = 110/261 (42%), Gaps = 18/261 (6%)
Query: 345 GKLIGRGTFGSVYVASNRETGALCAMKEV-DIFPDDPKSAESIKQLEQEIKVLSHLKHPN 403
           G+ IGRG FG V+    R    L A+K   +  P D K+     +  QE ++L    HPN
Sbjct: 119 GEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKA-----KFLQEARILKQYSHPN 173
Query: 404 IVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKK 463
           IV+  G    +   YI +E V  G    ++R     +    +        +G+ YL SK 
Sbjct: 174 IVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKC 233
Query: 464 TIHRDIKGANLLVDASGVVKLADFGMAKHLTG--QKADLSMKGSPY-WMAPELMMAVMQK 520
            IHRD+   N LV    V+K++DFGM++        A   ++  P  W APE     +  
Sbjct: 234 CIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPE----ALNY 289
Query: 521 GKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFKVMRDTPAIPDSLSPEGK-D 578
           G+ S  +   D+WS G  + E ++ G  P+           V +        L P+    
Sbjct: 290 GRYSSES---DVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRLPCPELCPDAVFR 346
Query: 579 FLRCCFQRNPADRPPASLLLE 599
            +  C+   P  RP  S + +
Sbjct: 347 LMEQCWAYEPGQRPSFSTIYQ 367

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 92.8 bits (229), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 80/307 (26%), Positives = 137/307 (44%), Gaps = 39/307 (12%)
Query: 333 PEPLPMNSQW-------QKGKLIGRGTFGSVYVASNRETGALCAMKEVDI-FPDDPKSAE 384
           P  LP N +W       Q GK +G G FG V  A+    G   A+ +V +        A+
Sbjct: 32  PTQLPYNEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHAD 91
Query: 385 SIKQLEQEIKVLSHL-KHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREH------- 436
             + L  E+K++SHL +H NIV   G+        +  EY   G +  ++R         
Sbjct: 92  EKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETD 151
Query: 437 -CGAITESV-----VRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMA 490
              AI  S      + +F+  +  G+A+L SK  IHRD+   N+L+    V K+ DFG+A
Sbjct: 152 PAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLA 211
Query: 491 KHLTGQKADLSMKGSP----YWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-G 545
           + +    ++  +KG+      WMAPE +   +   +S       D+WS G  + E+++ G
Sbjct: 212 RDIMND-SNYIVKGNARLPVKWMAPESIFDCVYTVQS-------DVWSYGILLWEIFSLG 263
Query: 546 KPPWSEYEGAAAMFKVMRDTPAIPD-SLSPEG-KDFLRCCFQRNPADRPPASLLLEHRFL 603
             P+      +  +K+++D   +   + +P+     ++ C+   P  RP    +    FL
Sbjct: 264 LNPYPGILVNSKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICS--FL 321
Query: 604 KNSQQPD 610
           +   Q D
Sbjct: 322 QEQAQED 328

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 92.8 bits (229), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 80/300 (26%), Positives = 144/300 (48%), Gaps = 48/300 (16%)
Query: 347 LIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQ 406
           ++G+G+FG V    +R T    A+K ++      K   +I +   E+++L  L HPNI++
Sbjct: 29  MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILR---EVELLKKLDHPNIMK 85
Query: 407 YYGSEIVEDK--FYIYLEYVHPGSI------NKYVREHCGAITESVVRNFTRHILSGLAY 458
            +  EI+ED   FYI  E    G +       K   EH  A          + + SG+ Y
Sbjct: 86  LF--EILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAA-------RIIKQVFSGITY 136
Query: 459 LHSKKTIHRDIKGANLLVDASGV---VKLADFGMAKHLTGQKADLSMK---GSPYWMAPE 512
           +H    +HRD+K  N+L+++      +K+ DFG++   T  + +  MK   G+ Y++APE
Sbjct: 137 MHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLS---TCFQQNTKMKDRIGTAYYIAPE 193
Query: 513 LMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPW---SEYE--GAAAMFKVMRDTPA 567
           ++     +          D+WS G  +  + +G PP+   +EY+        K   D P 
Sbjct: 194 VLRGTYDE--------KCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQ 245
Query: 568 IPDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLK--NSQQP---DVPSCSLSFSGMQ 622
              ++S + KD +R     +P+ R  A+  LEH +++  +S+ P   D+PS   + + ++
Sbjct: 246 WR-TISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYSSETPTISDLPSLESAMTNIR 304

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 92.8 bits (229), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 78/303 (25%), Positives = 136/303 (44%), Gaps = 35/303 (11%)
Query: 333 PEPLPMNSQW-------QKGKLIGRGTFGSVYVASNRETGALCAMKEVDI-FPDDPKSAE 384
           P  LP N +W       Q GK +G G FG V  A+    G   A+ +V +        A+
Sbjct: 32  PTQLPYNEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHAD 91
Query: 385 SIKQLEQEIKVLSHL-KHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITES 443
             + L  E+K++SHL +H NIV   G+        +  EY   G +  ++R    A  + 
Sbjct: 92  EKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDK 151
Query: 444 V---------VRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLT 494
                     + +F+  +  G+A+L SK  IHRD+   N+L+    V K+ DFG+A+ + 
Sbjct: 152 EDGRPLELRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIM 211
Query: 495 GQKADLSMKGSP----YWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPW 549
              ++  +KG+      WMAPE +   +   +S       D+WS G  + E+++ G  P+
Sbjct: 212 ND-SNYIVKGNARLPVKWMAPESIFDCVYTVQS-------DVWSYGILLWEIFSLGLNPY 263
Query: 550 SEYEGAAAMFKVMRDTPAIPD-SLSPEG-KDFLRCCFQRNPADRPPASLLLEHRFLKNSQ 607
                 +  +K+++D   +   + +P+     ++ C+   P  RP    +    FL+   
Sbjct: 264 PGILVNSKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICS--FLQEQA 321
Query: 608 QPD 610
           Q D
Sbjct: 322 QED 324

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 92.4 bits (228), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 75/274 (27%), Positives = 132/274 (48%), Gaps = 33/274 (12%)
Query: 348 IGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQY 407
           +G+G FG V++ +   T  + A+K +      P++        QE +V+  L+H  +VQ 
Sbjct: 26  LGQGCFGEVWMGTWNGTTRV-AIKTLKPGTMSPEA------FLQEAQVMKKLRHEKLVQL 78
Query: 408 YGSEIVEDKFYIYLEYVHPGSINKYVREHCGA-ITESVVRNFTRHILSGLAYLHSKKTIH 466
           Y   + E+  YI +EY+  GS+  +++   G  +    + +    I SG+AY+     +H
Sbjct: 79  YAV-VSEEPIYIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVH 137
Query: 467 RDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPY---WMAPELMMAVMQKGKS 523
           RD++ AN+LV  + V K+ADFG+A+ L       + +G+ +   W APE  +     G+ 
Sbjct: 138 RDLRAANILVGENLVCKVADFGLAR-LIEDNEXTARQGAKFPIKWTAPEAALY----GRF 192
Query: 524 SDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFKVMRDT-----PAIPDSLSPEGK 577
           +   +  D+WS G  + E+ T G+ P+        + +V R       P  P+SL     
Sbjct: 193 T---IKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLH---- 245
Query: 578 DFLRCCFQRNPADRPPASLL---LEHRFLKNSQQ 608
           D +  C++++P +RP    L   LE  F     Q
Sbjct: 246 DLMCQCWRKDPEERPTFEYLQAFLEDYFTSTEPQ 279

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 92.4 bits (228), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 64/207 (30%), Positives = 104/207 (50%), Gaps = 23/207 (11%)
Query: 348 IGRGTFGSV----YVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPN 403
           +G G FG V    Y  +N  TG + A+K +     +    +     ++EI++L  L H +
Sbjct: 17  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALK----EGCGPQLRSGWQREIEILRTLYHEH 72
Query: 404 IVQYYGS--EIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHS 461
           IV+Y G   +  E    + +EYV  GS+  Y+  HC  + + ++  F + I  G+AYLH+
Sbjct: 73  IVKYKGCCEDQGEKSVQLVMEYVPLGSLRDYLPRHCVGLAQLLL--FAQQICEGMAYLHA 130
Query: 462 KKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMK---GSP-YWMAPELMMAV 517
           +  IHR +   N+L+D   +VK+ DFG+AK +        ++    SP +W APE +   
Sbjct: 131 QHYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECL--- 187
Query: 518 MQKGKSSDSALAVDIWSLGCTIIEMYT 544
               K      A D+WS G T+ E+ T
Sbjct: 188 ----KECKFYYASDVWSFGVTLYELLT 210

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 92.4 bits (228), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 80/273 (29%), Positives = 125/273 (45%), Gaps = 43/273 (15%)
Query: 348 IGRGTFGSV----YVASNRETGALCAMK--EVDIFPDDPKSAESIKQLEQEIKVLSHLKH 401
           +G G FG V    Y  +N  TG + A+K  + D  P            +QEI +L  L H
Sbjct: 22  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSG------WKQEIDILRTLYH 75
Query: 402 PNIVQYYGS--EIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYL 459
            +I++Y G   +  E    + +EYV  GS+  Y+  H   + + ++  F + I  G+AYL
Sbjct: 76  EHIIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHSIGLAQLLL--FAQQICEGMAYL 133
Query: 460 HSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMK---GSP-YWMAPELMM 515
           HS+  IHR++   N+L+D   +VK+ DFG+AK +        ++    SP +W APE + 
Sbjct: 134 HSQHYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECL- 192
Query: 516 AVMQKGKSSDSALAVDIWSLGCTIIEMYT-----GKPP--WSEYEG-AAAMFKVMRDTPA 567
                 K      A D+WS G T+ E+ T       PP  + E  G A     V+R T  
Sbjct: 193 ------KEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTEL 246
Query: 568 I--------PDSLSPEGKDFLRCCFQRNPADRP 592
           +        PD    E    ++ C++   + RP
Sbjct: 247 LERGERLPRPDKCPCEVYHLMKNCWETEASFRP 279

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 92.4 bits (228), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 82/310 (26%), Positives = 143/310 (46%), Gaps = 49/310 (15%)
Query: 327 PQVAAKPE-PLPMNSQWQ-------KGKLIGRGTFGSVYVAS----NRETGALCAMKEVD 374
           P +A   E  LP + +W+        GK +G G FG V +A     +++         V 
Sbjct: 14  PMLAGVSEYELPEDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVK 73
Query: 375 IFPDDPKSAESIKQLEQEIKVLSHL-KHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYV 433
           +  DD  + E +  L  E++++  + KH NI+   G+   +   Y+ +EY   G++ +Y+
Sbjct: 74  MLKDDA-TEEDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYL 132
Query: 434 R-------EHCGAI--------TESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDA 478
           R       E+   I        T   + + T  +  G+ YL S+K IHRD+   N+LV  
Sbjct: 133 RARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTE 192
Query: 479 SGVVKLADFGMAKHLTG---QKADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSL 535
           + V+K+ADFG+A+ +      K   + +    WMAPE +   +   +S       D+WS 
Sbjct: 193 NNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQS-------DVWSF 245
Query: 536 GCTIIEMYT--GKPPWSEYEG--AAAMFKVMRDTPAI--PDSLSPEGKDFLRCCFQRNPA 589
           G  + E++T  G P    Y G     +FK++++   +  P + + E    +R C+   P+
Sbjct: 246 GVLMWEIFTLGGSP----YPGIPVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPS 301
Query: 590 DRPPASLLLE 599
            RP    L+E
Sbjct: 302 QRPTFKQLVE 311

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 92.0 bits (227), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 77/274 (28%), Positives = 126/274 (45%), Gaps = 33/274 (12%)
Query: 348 IGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQY 407
           +G+G FG V++      G       V I    P +  S +   QE +V+  L+H  +VQ 
Sbjct: 275 LGQGCFGEVWM------GTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQL 327
Query: 408 YGSEIVEDKFYIYLEYVHPGSINKYVREHCGA-ITESVVRNFTRHILSGLAYLHSKKTIH 466
           Y + + E+  YI  EY+  GS+  +++   G  +    + +    I SG+AY+     +H
Sbjct: 328 Y-AVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVH 386
Query: 467 RDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPY---WMAPELMMAVMQKGKS 523
           RD++ AN+LV  + V K+ADFG+A+ L       + +G+ +   W APE  +      KS
Sbjct: 387 RDLRAANILVGENLVCKVADFGLAR-LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 445
Query: 524 SDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFKVMRDT-----PAIPDSLSPEGK 577
                  D+WS G  + E+ T G+ P+        + +V R       P  P+SL     
Sbjct: 446 -------DVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESL----H 494
Query: 578 DFLRCCFQRNPADRPPASLL---LEHRFLKNSQQ 608
           D +  C+++ P +RP    L   LE  F     Q
Sbjct: 495 DLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQ 528

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 92.0 bits (227), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 64/207 (30%), Positives = 104/207 (50%), Gaps = 23/207 (11%)
Query: 348 IGRGTFGSV----YVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPN 403
           +G G FG V    Y  +N  TG + A+K +     +    +     ++EI++L  L H +
Sbjct: 16  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALK----EGCGPQLRSGWQREIEILRTLYHEH 71
Query: 404 IVQYYGS--EIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHS 461
           IV+Y G   +  E    + +EYV  GS+  Y+  HC  + + ++  F + I  G+AYLH+
Sbjct: 72  IVKYKGCCEDQGEKSVQLVMEYVPLGSLRDYLPRHCVGLAQLLL--FAQQICEGMAYLHA 129
Query: 462 KKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMK---GSP-YWMAPELMMAV 517
           +  IHR +   N+L+D   +VK+ DFG+AK +        ++    SP +W APE +   
Sbjct: 130 QHYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECL--- 186
Query: 518 MQKGKSSDSALAVDIWSLGCTIIEMYT 544
               K      A D+WS G T+ E+ T
Sbjct: 187 ----KECKFYYASDVWSFGVTLYELLT 209

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 92.0 bits (227), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 79/290 (27%), Positives = 134/290 (46%), Gaps = 46/290 (15%)
Query: 348 IGRGTFGSVYVASNRETGAL----CAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPN 403
           IG G FG V+ A  R  G L      M  V +  ++  SA+     ++E  +++   +PN
Sbjct: 55  IGEGAFGRVFQA--RAPGLLPYEPFTMVAVKMLKEE-ASADMQADFQREAALMAEFDNPN 111
Query: 404 IVQYYGSEIVEDKFYIYLEYVHPGSINKYVRE----------HCGAITESVVRN------ 447
           IV+  G   V     +  EY+  G +N+++R           H    T + V +      
Sbjct: 112 IVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPL 171
Query: 448 -------FTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQ---K 497
                    R + +G+AYL  +K +HRD+   N LV  + VVK+ADFG+++++      K
Sbjct: 172 SCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYK 231
Query: 498 ADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAA 556
           AD +      WM PE   ++     +++S    D+W+ G  + E+++ G  P+       
Sbjct: 232 ADGNDAIPIRWMPPE---SIFYNRYTTES----DVWAYGVVLWEIFSYGLQPYYGMAHEE 284
Query: 557 AMFKVMRD--TPAIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLK 604
            ++ V RD    A P++   E  + +R C+ + PADRP  S    HR L+
Sbjct: 285 VIYYV-RDGNILACPENCPLELYNLMRLCWSKLPADRP--SFCSIHRILQ 331

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 92.0 bits (227), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 69/263 (26%), Positives = 117/263 (44%), Gaps = 34/263 (12%)
Query: 348 IGRGTFGSVYVAS--NRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIV 405
           IG G FG V++    N++  A+  ++E          A S +   +E +V+  L HP +V
Sbjct: 15  IGSGQFGLVHLGYWLNKDKVAIKTIRE---------GAMSEEDFIEEAEVMMKLSHPKLV 65
Query: 406 QYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTI 465
           Q YG  + +    +  E++  G ++ Y+R   G      +      +  G+AYL     I
Sbjct: 66  QLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVI 125
Query: 466 HRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPY---WMAPELMMAVMQKGK 522
           HRD+   N LV  + V+K++DFGM + +   +   S  G+ +   W +PE+        K
Sbjct: 126 HRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT-SSTGTKFPVKWASPEVFSFSRYSSK 184
Query: 523 SSDSALAVDIWSLGCTIIEMYT-GKPPWSE------YEGAAAMFKVMRDTPAIPDSLSPE 575
           S       D+WS G  + E+++ GK P+         E  +  F++ +     P   S  
Sbjct: 185 S-------DVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYK-----PRLASTH 232
Query: 576 GKDFLRCCFQRNPADRPPASLLL 598
               +  C++  P DRP  S LL
Sbjct: 233 VYQIMNHCWKERPEDRPAFSRLL 255

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 92.0 bits (227), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 76/274 (27%), Positives = 130/274 (47%), Gaps = 33/274 (12%)
Query: 348 IGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQY 407
           +G+G FG V++ +   T  + A+K +      P++        QE +V+  L+H  +VQ 
Sbjct: 23  LGQGCFGEVWMGTWNGTTRV-AIKTLKPGTMSPEA------FLQEAQVMKKLRHEKLVQL 75
Query: 408 YGSEIVEDKFYIYLEYVHPGSINKYVREHCGA-ITESVVRNFTRHILSGLAYLHSKKTIH 466
           Y   + E+  YI  EY++ GS+  +++   G  +    + + +  I SG+AY+     +H
Sbjct: 76  YAV-VSEEPIYIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAYVERMNYVH 134
Query: 467 RDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPY---WMAPELMMAVMQKGKS 523
           RD++ AN+LV  + V K+ADFG+A+ L       + +G+ +   W APE  +      KS
Sbjct: 135 RDLRAANILVGENLVCKVADFGLAR-LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 193
Query: 524 SDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFKVMRDT-----PAIPDSLSPEGK 577
                  D+WS G  + E+ T G+ P+        + +V R       P  P+SL     
Sbjct: 194 -------DVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLH---- 242
Query: 578 DFLRCCFQRNPADRPPASLL---LEHRFLKNSQQ 608
           D +  C+++ P +RP    L   LE  F     Q
Sbjct: 243 DLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQ 276

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 92.0 bits (227), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 75/274 (27%), Positives = 131/274 (47%), Gaps = 33/274 (12%)
Query: 348 IGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQY 407
           +G+G FG V++ +   T  + A+K +      P++        QE +V+  L+H  +VQ 
Sbjct: 23  LGQGCFGEVWMGTWNGTTRV-AIKTLKPGTMSPEA------FLQEAQVMKKLRHEKLVQL 75
Query: 408 YGSEIVEDKFYIYLEYVHPGSINKYVREHCGA-ITESVVRNFTRHILSGLAYLHSKKTIH 466
           Y   + E+  YI  EY++ GS+  +++   G  +    + + +  I SG+AY+     +H
Sbjct: 76  YAV-VSEEPIYIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAYVERMNYVH 134
Query: 467 RDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPY---WMAPELMMAVMQKGKS 523
           RD++ AN+LV  + V K+ADFG+A+ +   +   + +G+ +   W APE  +      KS
Sbjct: 135 RDLRAANILVGENLVCKVADFGLARLIEDNEWT-ARQGAKFPIKWTAPEAALYGRFTIKS 193
Query: 524 SDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFKVMRDT-----PAIPDSLSPEGK 577
                  D+WS G  + E+ T G+ P+        + +V R       P  P+SL     
Sbjct: 194 -------DVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLH---- 242
Query: 578 DFLRCCFQRNPADRPPASLL---LEHRFLKNSQQ 608
           D +  C+++ P +RP    L   LE  F     Q
Sbjct: 243 DLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQ 276

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 76/274 (27%), Positives = 130/274 (47%), Gaps = 33/274 (12%)
Query: 348 IGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQY 407
           +G+G FG V++ +   T  + A+K +      P++        QE +V+  L+H  +VQ 
Sbjct: 26  LGQGCFGEVWMGTWNGTTRV-AIKTLKPGTMSPEA------FLQEAQVMKKLRHEKLVQL 78
Query: 408 YGSEIVEDKFYIYLEYVHPGSINKYVREHCGA-ITESVVRNFTRHILSGLAYLHSKKTIH 466
           Y   + E+  YI +EY+  GS+  +++   G  +    + +    I SG+AY+     +H
Sbjct: 79  YAV-VSEEPIYIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVH 137
Query: 467 RDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPY---WMAPELMMAVMQKGKS 523
           RD++ AN+LV  + V K+ADFG+A+ L       + +G+ +   W APE  +      KS
Sbjct: 138 RDLRAANILVGENLVCKVADFGLAR-LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 196
Query: 524 SDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFKVMRDT-----PAIPDSLSPEGK 577
                  D+WS G  + E+ T G+ P+        + +V R       P  P+SL     
Sbjct: 197 -------DVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLH---- 245
Query: 578 DFLRCCFQRNPADRPPASLL---LEHRFLKNSQQ 608
           D +  C++++P +RP    L   LE  F     Q
Sbjct: 246 DLMCQCWRKDPEERPTFEYLQAFLEDYFTSTEPQ 279

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 69/263 (26%), Positives = 117/263 (44%), Gaps = 34/263 (12%)
Query: 348 IGRGTFGSVYVAS--NRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIV 405
           IG G FG V++    N++  A+  ++E          A S +   +E +V+  L HP +V
Sbjct: 18  IGSGQFGLVHLGYWLNKDKVAIKTIRE---------GAMSEEDFIEEAEVMMKLSHPKLV 68
Query: 406 QYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTI 465
           Q YG  + +    +  E++  G ++ Y+R   G      +      +  G+AYL     I
Sbjct: 69  QLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVI 128
Query: 466 HRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPY---WMAPELMMAVMQKGK 522
           HRD+   N LV  + V+K++DFGM + +   +   S  G+ +   W +PE+        K
Sbjct: 129 HRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT-SSTGTKFPVKWASPEVFSFSRYSSK 187
Query: 523 SSDSALAVDIWSLGCTIIEMYT-GKPPWSE------YEGAAAMFKVMRDTPAIPDSLSPE 575
           S       D+WS G  + E+++ GK P+         E  +  F++ +     P   S  
Sbjct: 188 S-------DVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYK-----PRLASTH 235
Query: 576 GKDFLRCCFQRNPADRPPASLLL 598
               +  C++  P DRP  S LL
Sbjct: 236 VYQIMNHCWRERPEDRPAFSRLL 258

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 69/263 (26%), Positives = 117/263 (44%), Gaps = 34/263 (12%)
Query: 348 IGRGTFGSVYVAS--NRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIV 405
           IG G FG V++    N++  A+  ++E          A S +   +E +V+  L HP +V
Sbjct: 13  IGSGQFGLVHLGYWLNKDKVAIKTIRE---------GAMSEEDFIEEAEVMMKLSHPKLV 63
Query: 406 QYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTI 465
           Q YG  + +    +  E++  G ++ Y+R   G      +      +  G+AYL     I
Sbjct: 64  QLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVI 123
Query: 466 HRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPY---WMAPELMMAVMQKGK 522
           HRD+   N LV  + V+K++DFGM + +   +   S  G+ +   W +PE+        K
Sbjct: 124 HRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT-SSTGTKFPVKWASPEVFSFSRYSSK 182
Query: 523 SSDSALAVDIWSLGCTIIEMYT-GKPPWSE------YEGAAAMFKVMRDTPAIPDSLSPE 575
           S       D+WS G  + E+++ GK P+         E  +  F++ +     P   S  
Sbjct: 183 S-------DVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYK-----PRLASTH 230
Query: 576 GKDFLRCCFQRNPADRPPASLLL 598
               +  C++  P DRP  S LL
Sbjct: 231 VYQIMNHCWKERPEDRPAFSRLL 253

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 73/269 (27%), Positives = 125/269 (46%), Gaps = 23/269 (8%)
Query: 342 WQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKH 401
           +Q  + +G+G F  V     +      A K   I      SA   ++LE+E ++   LKH
Sbjct: 33  YQLFEELGKGAFSVVRRCVKKTPTQEYAAK---IINTKKLSARDHQKLEREARICRLLKH 89
Query: 402 PNIVQYYGSEIVEDKFYIYLEYVHPGSINKYV--REHCGAITESVVRNFTRHILSGLAYL 459
           PNIV+ + S   E   Y+  + V  G + + +  RE+    +E+   +    IL  + ++
Sbjct: 90  PNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREY---YSEADASHCIHQILESVNHI 146
Query: 460 HSKKTIHRDIKGANLLVDA---SGVVKLADFGMAKHLTG-QKADLSMKGSPYWMAPELMM 515
           H    +HRD+K  NLL+ +      VKLADFG+A  + G Q+A     G+P +++PE++ 
Sbjct: 147 HQHDIVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGEQQAWFGFAGTPGYLSPEVL- 205
Query: 516 AVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIP----DS 571
                 +       VDIW+ G  +  +  G PP+ + +      ++       P    D+
Sbjct: 206 ------RKDPYGKPVDIWACGVILYILLVGYPPFWDEDQHKLYQQIKAGAYDFPSPEWDT 259
Query: 572 LSPEGKDFLRCCFQRNPADRPPASLLLEH 600
           ++PE K+ +      NPA R  A   L+H
Sbjct: 260 VTPEAKNLINQMLTINPAKRITADQALKH 288

>pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 80/327 (24%), Positives = 135/327 (41%), Gaps = 67/327 (20%)
Query: 336 LPMNSQWQKGKLIGRG--TFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEI 393
           LP    ++   +IG+G     +V +A  + TG    ++ +++   +  S E +  L+ E+
Sbjct: 5   LPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINL---EACSNEMVTFLQGEL 61
Query: 394 KVLSHLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREH-CGAITESVVRNFTRHI 452
            V     HPNIV Y  + I +++ ++   ++  GS    +  H    + E  +    + +
Sbjct: 62  HVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGV 121
Query: 453 LSGLAYLHSKKTIHRDIKGANLLVDASGVVKL----ADFGMAKHLTGQKA-----DLSMK 503
           L  L Y+H    +HR +K +++L+   G V L    ++  M  H   Q+        S+K
Sbjct: 122 LKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVK 181
Query: 504 GSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFK--- 560
             P W++PE++   +Q G  + S    DI+S+G T  E+  G  P+ +      + +   
Sbjct: 182 VLP-WLSPEVLQQNLQ-GYDAKS----DIYSVGITACELANGHVPFKDMPATQMLLEKLN 235
Query: 561 ----VMRDTPAIP------------------DSL---------------------SPEGK 577
                + DT  IP                  DSL                     SP   
Sbjct: 236 GTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFH 295
Query: 578 DFLRCCFQRNPADRPPASLLLEHRFLK 604
            F+  C QRNP  RP AS LL H F K
Sbjct: 296 HFVEQCLQRNPDARPSASTLLNHSFFK 322

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 107/207 (51%), Gaps = 25/207 (12%)
Query: 348 IGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESI-KQLEQEIKVLSHLKHPNIVQ 406
           +G G +GSV  A ++ +G   A+K++      P  +E   K+  +E+ +L H++H N++ 
Sbjct: 50  VGSGAYGSVCSAIDKRSGEKVAIKKLS----RPFQSEIFAKRAYRELLLLKHMQHENVIG 105
Query: 407 ----YYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSK 462
               +  +  + + +  YL  V P       +      +E  ++     +L GL Y+HS 
Sbjct: 106 LLDVFTPASSLRNFYDFYL--VMPFMQTDLQKIMGMEFSEEKIQYLVYQMLKGLKYIHSA 163
Query: 463 KTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKG---SPYWMAPELMMAVMQ 519
             +HRD+K  NL V+    +K+ DFG+A+H     AD  M G   + ++ APE++++ M 
Sbjct: 164 GVVHRDLKPGNLAVNEDCELKILDFGLARH-----ADAEMTGYVVTRWYRAPEVILSWMH 218
Query: 520 KGKSSDSALAVDIWSLGCTIIEMYTGK 546
             ++      VDIWS+GC + EM TGK
Sbjct: 219 YNQT------VDIWSVGCIMAEMLTGK 239

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 91.3 bits (225), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 68/274 (24%), Positives = 119/274 (43%), Gaps = 11/274 (4%)
Query: 341 QWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQ----EIKVL 396
            ++  +++GRG    V    ++ T    A+K +D+      SAE +++L +    E+ +L
Sbjct: 18  NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 77
Query: 397 SHLK-HPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSG 455
             +  HPNI+Q   +      F++  + +  G +  Y+ E    ++E   R   R +L  
Sbjct: 78  RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKV-TLSEKETRKIMRALLEV 136
Query: 456 LAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPYWMAPELMM 515
           +  LH    +HRD+K  N+L+D    +KL DFG +  L   +   S+ G+P ++APE++ 
Sbjct: 137 ICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLRSVCGTPSYLAPEIIE 196
Query: 516 AVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIP----DS 571
             M           VD+WS G  +  +  G PP+   +    +  +M           D 
Sbjct: 197 CSMNDNHPG-YGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDD 255
Query: 572 LSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKN 605
            S   KD +       P  R  A   L H F + 
Sbjct: 256 YSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ 289

>pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389

Iteration: 1
 Score = 91.3 bits (225), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 80/327 (24%), Positives = 135/327 (41%), Gaps = 67/327 (20%)
Query: 336 LPMNSQWQKGKLIGRG--TFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEI 393
           LP    ++   +IG+G     +V +A  + TG    ++ +++   +  S E +  L+ E+
Sbjct: 21  LPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINL---EACSNEMVTFLQGEL 77
Query: 394 KVLSHLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREH-CGAITESVVRNFTRHI 452
            V     HPNIV Y  + I +++ ++   ++  GS    +  H    + E  +    + +
Sbjct: 78  HVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGV 137
Query: 453 LSGLAYLHSKKTIHRDIKGANLLVDASGVVKL----ADFGMAKHLTGQKA-----DLSMK 503
           L  L Y+H    +HR +K +++L+   G V L    ++  M  H   Q+        S+K
Sbjct: 138 LKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVK 197
Query: 504 GSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFK--- 560
             P W++PE++   +Q G  + S    DI+S+G T  E+  G  P+ +      + +   
Sbjct: 198 VLP-WLSPEVLQQNLQ-GYDAKS----DIYSVGITACELANGHVPFKDMPATQMLLEKLN 251
Query: 561 ----VMRDTPAIP------------------DSL---------------------SPEGK 577
                + DT  IP                  DSL                     SP   
Sbjct: 252 GTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFH 311
Query: 578 DFLRCCFQRNPADRPPASLLLEHRFLK 604
            F+  C QRNP  RP AS LL H F K
Sbjct: 312 HFVEQCLQRNPDARPSASTLLNHSFFK 338

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 91.3 bits (225), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 107/207 (51%), Gaps = 25/207 (12%)
Query: 348 IGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESI-KQLEQEIKVLSHLKHPNIVQ 406
           +G G +GSV  A ++ +G   A+K++      P  +E   K+  +E+ +L H++H N++ 
Sbjct: 32  VGSGAYGSVCSAIDKRSGEKVAIKKLS----RPFQSEIFAKRAYRELLLLKHMQHENVIG 87
Query: 407 ----YYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSK 462
               +  +  + + +  YL  V P       +      +E  ++     +L GL Y+HS 
Sbjct: 88  LLDVFTPASSLRNFYDFYL--VMPFMQTDLQKIMGLKFSEEKIQYLVYQMLKGLKYIHSA 145
Query: 463 KTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKG---SPYWMAPELMMAVMQ 519
             +HRD+K  NL V+    +K+ DFG+A+H     AD  M G   + ++ APE++++ M 
Sbjct: 146 GVVHRDLKPGNLAVNEDCELKILDFGLARH-----ADAEMTGYVVTRWYRAPEVILSWMH 200
Query: 520 KGKSSDSALAVDIWSLGCTIIEMYTGK 546
             ++      VDIWS+GC + EM TGK
Sbjct: 201 YNQT------VDIWSVGCIMAEMLTGK 221

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 91.3 bits (225), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 79/273 (28%), Positives = 125/273 (45%), Gaps = 43/273 (15%)
Query: 348 IGRGTFGSV----YVASNRETGALCAMK--EVDIFPDDPKSAESIKQLEQEIKVLSHLKH 401
           +G G FG V    Y  +N  TG + A+K  + D  P            +QEI +L  L H
Sbjct: 22  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSG------WKQEIDILRTLYH 75
Query: 402 PNIVQYYGS--EIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYL 459
            +I++Y G   +  E    + +EYV  GS+  Y+  H   + + ++  F + I  G+AYL
Sbjct: 76  EHIIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHSIGLAQLLL--FAQQICEGMAYL 133
Query: 460 HSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMK---GSP-YWMAPELMM 515
           H++  IHR++   N+L+D   +VK+ DFG+AK +        ++    SP +W APE + 
Sbjct: 134 HAQHYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECL- 192
Query: 516 AVMQKGKSSDSALAVDIWSLGCTIIEMYT-----GKPP--WSEYEG-AAAMFKVMRDTPA 567
                 K      A D+WS G T+ E+ T       PP  + E  G A     V+R T  
Sbjct: 193 ------KEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTEL 246
Query: 568 I--------PDSLSPEGKDFLRCCFQRNPADRP 592
           +        PD    E    ++ C++   + RP
Sbjct: 247 LERGERLPRPDKCPCEVYHLMKNCWETEASFRP 279

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 69/263 (26%), Positives = 117/263 (44%), Gaps = 34/263 (12%)
Query: 348 IGRGTFGSVYVAS--NRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIV 405
           IG G FG V++    N++  A+  ++E          A S +   +E +V+  L HP +V
Sbjct: 16  IGSGQFGLVHLGYWLNKDKVAIKTIRE---------GAMSEEDFIEEAEVMMKLSHPKLV 66
Query: 406 QYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTI 465
           Q YG  + +    +  E++  G ++ Y+R   G      +      +  G+AYL     I
Sbjct: 67  QLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVI 126
Query: 466 HRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPY---WMAPELMMAVMQKGK 522
           HRD+   N LV  + V+K++DFGM + +   +   S  G+ +   W +PE+        K
Sbjct: 127 HRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT-SSTGTKFPVKWASPEVFSFSRYSSK 185
Query: 523 SSDSALAVDIWSLGCTIIEMYT-GKPPWSE------YEGAAAMFKVMRDTPAIPDSLSPE 575
           S       D+WS G  + E+++ GK P+         E  +  F++ +     P   S  
Sbjct: 186 S-------DVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYK-----PRLASTH 233
Query: 576 GKDFLRCCFQRNPADRPPASLLL 598
               +  C++  P DRP  S LL
Sbjct: 234 VYQIMNHCWRERPEDRPAFSRLL 256

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 81/310 (26%), Positives = 143/310 (46%), Gaps = 49/310 (15%)
Query: 327 PQVAAKPE-PLPMNSQWQ-------KGKLIGRGTFGSVYVAS----NRETGALCAMKEVD 374
           P +A   E  LP + +W+        GK +G G FG V +A     +++         V 
Sbjct: 14  PMLAGVSEYELPEDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVK 73
Query: 375 IFPDDPKSAESIKQLEQEIKVLSHL-KHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYV 433
           +  DD  + + +  L  E++++  + KH NI+   G+   +   Y+ +EY   G++ +Y+
Sbjct: 74  MLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYL 132
Query: 434 R-------EHCGAI--------TESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDA 478
           R       E+   I        T   + + T  +  G+ YL S+K IHRD+   N+LV  
Sbjct: 133 RARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTE 192
Query: 479 SGVVKLADFGMAKHLTG---QKADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSL 535
           + V+K+ADFG+A+ +      K   + +    WMAPE +   +   +S       D+WS 
Sbjct: 193 NNVMKIADFGLARDINNIDXXKKTTNGRLPVKWMAPEALFDRVYTHQS-------DVWSF 245
Query: 536 GCTIIEMYT--GKPPWSEYEG--AAAMFKVMRDTPAI--PDSLSPEGKDFLRCCFQRNPA 589
           G  + E++T  G P    Y G     +FK++++   +  P + + E    +R C+   P+
Sbjct: 246 GVLMWEIFTLGGSP----YPGIPVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPS 301
Query: 590 DRPPASLLLE 599
            RP    L+E
Sbjct: 302 QRPTFKQLVE 311

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 76/274 (27%), Positives = 129/274 (47%), Gaps = 33/274 (12%)
Query: 348 IGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQY 407
           +G+G FG V++ +   T  + A+K +      P++        QE +V+  L+H  +VQ 
Sbjct: 15  LGQGCFGEVWMGTWNGTTRV-AIKTLKPGTMSPEA------FLQEAQVMKKLRHEKLVQL 67
Query: 408 YGSEIVEDKFYIYLEYVHPGSINKYVREHCGA-ITESVVRNFTRHILSGLAYLHSKKTIH 466
           Y   + E+  YI  EY+  GS+  +++   G  +    + +    I SG+AY+     +H
Sbjct: 68  YAV-VSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVH 126
Query: 467 RDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPY---WMAPELMMAVMQKGKS 523
           RD++ AN+LV  + V K+ADFG+A+ L       + +G+ +   W APE  +      KS
Sbjct: 127 RDLRAANILVGENLVCKVADFGLAR-LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 185
Query: 524 SDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFKVMRDT-----PAIPDSLSPEGK 577
                  D+WS G  + E+ T G+ P+        + +V R       P  P+SL     
Sbjct: 186 -------DVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLH---- 234
Query: 578 DFLRCCFQRNPADRPPASLL---LEHRFLKNSQQ 608
           D +  C++++P +RP    L   LE  F     Q
Sbjct: 235 DLMCQCWRKDPEERPTFEYLQAFLEDYFTSTEPQ 268

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 71/251 (28%), Positives = 125/251 (49%), Gaps = 27/251 (10%)
Query: 348 IGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQ- 406
           +G G +GSV  A +       A+K++       +S    ++  +E+++L HLKH N++  
Sbjct: 36  VGSGAYGSVCSAYDARLRQKVAVKKLS---RPFQSLIHARRTYRELRLLKHLKHENVIGL 92
Query: 407 ---YYGSEIVEDKFYIYLEYVHPGS-INKYVREHCGAITESVVRNFTRHILSGLAYLHSK 462
              +  +  +ED   +YL     G+ +N  V+    A+++  V+     +L GL Y+HS 
Sbjct: 93  LDVFTPATSIEDFSEVYLVTTLMGADLNNIVKSQ--ALSDEHVQFLVYQLLRGLKYIHSA 150
Query: 463 KTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKG---SPYWMAPELMMAVMQ 519
             IHRD+K +N+ V+    +++ DFG+A+     +AD  M G   + ++ APE+M+  M 
Sbjct: 151 GIIHRDLKPSNVAVNEDSELRILDFGLAR-----QADEEMTGYVATRWYRAPEIMLNWMH 205
Query: 520 KGKSSDSALAVDIWSLGCTIIEMYTGKP--PWSEYEGAAAMFKVMRDTPAIPDSLSPEGK 577
             ++      VDIWS+GC + E+  GK   P S+Y         +  TP+ P+ L+    
Sbjct: 206 YNQT------VDIWSVGCIMAELLQGKALFPGSDYIDQLKRIMEVVGTPS-PEVLAKISS 258
Query: 578 DFLRCCFQRNP 588
           +  R   Q  P
Sbjct: 259 EHARTYIQSLP 269

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 76/274 (27%), Positives = 129/274 (47%), Gaps = 33/274 (12%)
Query: 348 IGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQY 407
           +G+G FG V++ +   T  + A+K +      P++        QE +V+  L+H  +VQ 
Sbjct: 17  LGQGCFGEVWMGTWNGTTRV-AIKTLKPGTMSPEA------FLQEAQVMKKLRHEKLVQL 69
Query: 408 YGSEIVEDKFYIYLEYVHPGSINKYVREHCGA-ITESVVRNFTRHILSGLAYLHSKKTIH 466
           Y   + E+  YI  EY+  GS+  +++   G  +    + +    I SG+AY+     +H
Sbjct: 70  YAV-VSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVH 128
Query: 467 RDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPY---WMAPELMMAVMQKGKS 523
           RD++ AN+LV  + V K+ADFG+A+ L       + +G+ +   W APE  +      KS
Sbjct: 129 RDLRAANILVGENLVCKVADFGLAR-LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 187
Query: 524 SDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFKVMRDT-----PAIPDSLSPEGK 577
                  D+WS G  + E+ T G+ P+        + +V R       P  P+SL     
Sbjct: 188 -------DVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLH---- 236
Query: 578 DFLRCCFQRNPADRPPASLL---LEHRFLKNSQQ 608
           D +  C++++P +RP    L   LE  F     Q
Sbjct: 237 DLMCQCWRKDPEERPTFEYLQAFLEDYFTSTEPQ 270

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 76/274 (27%), Positives = 129/274 (47%), Gaps = 33/274 (12%)
Query: 348 IGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQY 407
           +G+G FG V++ +   T  + A+K +      P++        QE +V+  L+H  +VQ 
Sbjct: 26  LGQGCFGEVWMGTWNGTTRV-AIKTLKPGTMSPEA------FLQEAQVMKKLRHEKLVQL 78
Query: 408 YGSEIVEDKFYIYLEYVHPGSINKYVREHCGA-ITESVVRNFTRHILSGLAYLHSKKTIH 466
           Y   + E+  YI  EY+  GS+  +++   G  +    + +    I SG+AY+     +H
Sbjct: 79  YAV-VSEEPIYIVCEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVH 137
Query: 467 RDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPY---WMAPELMMAVMQKGKS 523
           RD++ AN+LV  + V K+ADFG+A+ L       + +G+ +   W APE  +      KS
Sbjct: 138 RDLRAANILVGENLVCKVADFGLAR-LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 196
Query: 524 SDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFKVMRDT-----PAIPDSLSPEGK 577
                  D+WS G  + E+ T G+ P+        + +V R       P  P+SL     
Sbjct: 197 -------DVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLH---- 245
Query: 578 DFLRCCFQRNPADRPPASLL---LEHRFLKNSQQ 608
           D +  C++++P +RP    L   LE  F     Q
Sbjct: 246 DLMCQCWRKDPEERPTFEYLQAFLEDYFTSTEPQ 279

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 90.9 bits (224), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 76/274 (27%), Positives = 128/274 (46%), Gaps = 33/274 (12%)
Query: 348 IGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQY 407
           +G+G FG V++ +   T  + A+K +      P++        QE +V+  L+H  +VQ 
Sbjct: 192 LGQGCFGEVWMGTWNGTTRV-AIKTLKPGTMSPEA------FLQEAQVMKKLRHEKLVQL 244
Query: 408 YGSEIVEDKFYIYLEYVHPGSINKYVREHCGA-ITESVVRNFTRHILSGLAYLHSKKTIH 466
           Y   + E+  YI  EY+  GS+  +++   G  +    + +    I SG+AY+     +H
Sbjct: 245 YAV-VSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVH 303
Query: 467 RDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPY---WMAPELMMAVMQKGKS 523
           RD++ AN+LV  + V K+ADFG+A+ L       + +G+ +   W APE  +      KS
Sbjct: 304 RDLRAANILVGENLVCKVADFGLAR-LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 362
Query: 524 SDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFKVMRDT-----PAIPDSLSPEGK 577
                  D+WS G  + E+ T G+ P+        + +V R       P  P+SL     
Sbjct: 363 -------DVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESL----H 411
Query: 578 DFLRCCFQRNPADRPPASLL---LEHRFLKNSQQ 608
           D +  C+++ P +RP    L   LE  F     Q
Sbjct: 412 DLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQ 445

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 90.5 bits (223), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 81/305 (26%), Positives = 136/305 (44%), Gaps = 58/305 (19%)
Query: 336 LPMNSQWQK-------GKLIGRGTFGSVYVAS---------NRETGALCAMKEVDIFPDD 379
           LP + +W+        GK +G G FG V +A          NR T     M + D    D
Sbjct: 17  LPEDPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKD 76
Query: 380 PKSAESIKQLEQEIKVLSHL-KHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYV--REH 436
                 +  L  E++++  + KH NI+   G+   +   Y+ +EY   G++ +Y+  RE 
Sbjct: 77  ------LSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQAREP 130
Query: 437 CG-------------AITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVK 483
            G              ++   + +    +  G+ YL SKK IHRD+   N+LV    V+K
Sbjct: 131 PGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMK 190
Query: 484 LADFGMAK---HLTGQKADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTII 540
           +ADFG+A+   H+   K   + +    WMAPE +   +   +S       D+WS G  + 
Sbjct: 191 IADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQS-------DVWSFGVLLW 243
Query: 541 EMYT--GKPPWSEYEG--AAAMFKVMRDTPAI--PDSLSPEGKDFLRCCFQRNPADRPPA 594
           E++T  G P    Y G     +FK++++   +  P + + E    +R C+   P+ RP  
Sbjct: 244 EIFTLGGSP----YPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTF 299
Query: 595 SLLLE 599
             L+E
Sbjct: 300 KQLVE 304

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 90.5 bits (223), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 76/274 (27%), Positives = 129/274 (47%), Gaps = 33/274 (12%)
Query: 348 IGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQY 407
           +G+G FG V++ +   T  + A+K +      P++        QE +V+  L+H  +VQ 
Sbjct: 26  LGQGCFGEVWMGTWNGTTRV-AIKTLKPGTMSPEA------FLQEAQVMKKLRHEKLVQL 78
Query: 408 YGSEIVEDKFYIYLEYVHPGSINKYVREHCGA-ITESVVRNFTRHILSGLAYLHSKKTIH 466
           Y   + E+  YI  EY+  GS+  +++   G  +    + +    I SG+AY+     +H
Sbjct: 79  YAV-VSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVH 137
Query: 467 RDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPY---WMAPELMMAVMQKGKS 523
           RD++ AN+LV  + V K+ADFG+A+ L       + +G+ +   W APE  +      KS
Sbjct: 138 RDLRAANILVGENLVCKVADFGLAR-LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 196
Query: 524 SDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFKVMRDT-----PAIPDSLSPEGK 577
                  D+WS G  + E+ T G+ P+        + +V R       P  P+SL     
Sbjct: 197 -------DVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLH---- 245
Query: 578 DFLRCCFQRNPADRPPASLL---LEHRFLKNSQQ 608
           D +  C++++P +RP    L   LE  F     Q
Sbjct: 246 DLMCQCWRKDPEERPTFEYLQAFLEDYFTSTEPQ 279

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 90.5 bits (223), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 76/274 (27%), Positives = 128/274 (46%), Gaps = 33/274 (12%)
Query: 348 IGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQY 407
           +G+G FG V++ +   T  + A+K +      P++        QE +V+  L+H  +VQ 
Sbjct: 192 LGQGCFGEVWMGTWNGTTRV-AIKTLKPGTMSPEA------FLQEAQVMKKLRHEKLVQL 244
Query: 408 YGSEIVEDKFYIYLEYVHPGSINKYVREHCGA-ITESVVRNFTRHILSGLAYLHSKKTIH 466
           Y   + E+  YI  EY+  GS+  +++   G  +    + +    I SG+AY+     +H
Sbjct: 245 YAV-VSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVH 303
Query: 467 RDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPY---WMAPELMMAVMQKGKS 523
           RD++ AN+LV  + V K+ADFG+A+ L       + +G+ +   W APE  +      KS
Sbjct: 304 RDLRAANILVGENLVCKVADFGLAR-LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 362
Query: 524 SDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFKVMRDT-----PAIPDSLSPEGK 577
                  D+WS G  + E+ T G+ P+        + +V R       P  P+SL     
Sbjct: 363 -------DVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESL----H 411
Query: 578 DFLRCCFQRNPADRPPASLL---LEHRFLKNSQQ 608
           D +  C+++ P +RP    L   LE  F     Q
Sbjct: 412 DLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQ 445

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 90.5 bits (223), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 76/274 (27%), Positives = 128/274 (46%), Gaps = 33/274 (12%)
Query: 348 IGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQY 407
           +G+G FG V++ +   T  + A+K +      P++        QE +V+  L+H  +VQ 
Sbjct: 19  LGQGCFGEVWMGTWNGTTRV-AIKTLKPGTMSPEA------FLQEAQVMKKLRHEKLVQL 71
Query: 408 YGSEIVEDKFYIYLEYVHPGSINKYVREHCGA-ITESVVRNFTRHILSGLAYLHSKKTIH 466
           Y   + E+  YI  EY+  GS+  +++   G  +    + +    I SG+AY+     +H
Sbjct: 72  YAV-VSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVH 130
Query: 467 RDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPY---WMAPELMMAVMQKGKS 523
           RD++ AN+LV  + V K+ADFG+A+ L       + +G+ +   W APE  +      KS
Sbjct: 131 RDLRAANILVGENLVCKVADFGLAR-LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 189
Query: 524 SDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFKVMRDT-----PAIPDSLSPEGK 577
                  D+WS G  + E+ T G+ P+        + +V R       P  P+SL     
Sbjct: 190 -------DVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLH---- 238
Query: 578 DFLRCCFQRNPADRPPASLL---LEHRFLKNSQQ 608
           D +  C+++ P +RP    L   LE  F     Q
Sbjct: 239 DLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQ 272

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score = 90.5 bits (223), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 72/269 (26%), Positives = 123/269 (45%), Gaps = 26/269 (9%)
Query: 338 MNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESI------KQLEQ 391
           M S +   + I  G++G+V    + E G   A+K V     D ++   +      K++ +
Sbjct: 20  MQSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLR 78
Query: 392 EIKVLSHLKHPNI-----VQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVR 446
           EI++L+H  HPNI     +  +  E    K Y+  E +    + + + +    I+   ++
Sbjct: 79  EIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIHDQRIVISPQHIQ 137
Query: 447 NFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSP 506
            F  HIL GL  LH    +HRD+   N+L+  +  + + DF +A+  T            
Sbjct: 138 YFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVTHR 197
Query: 507 YWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPW---SEYEGAAAMFKVMR 563
           ++ APEL+M    KG +      VD+WS GC + EM+  K  +   + Y     + +V+ 
Sbjct: 198 WYRAPELVMQF--KGFTK----LVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVV- 250
Query: 564 DTPAIPDSL---SPEGKDFLRCCFQRNPA 589
            TP I D +   SP  +D+LR      PA
Sbjct: 251 GTPKIEDVVMFSSPSARDYLRNSLSNVPA 279

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 90.5 bits (223), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 81/310 (26%), Positives = 143/310 (46%), Gaps = 49/310 (15%)
Query: 327 PQVAAKPE-PLPMNSQWQ-------KGKLIGRGTFGSVYVAS----NRETGALCAMKEVD 374
           P +A   E  LP + +W+        GK +G G FG V +A     +++         V 
Sbjct: 1   PMLAGVSEYELPEDPKWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVK 60
Query: 375 IFPDDPKSAESIKQLEQEIKVLSHL-KHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYV 433
           +  DD  + + +  L  E++++  + KH NI+   G+   +   Y+ +EY   G++ +Y+
Sbjct: 61  MLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYL 119
Query: 434 R-------EHCGAI--------TESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDA 478
           R       E+   I        T   + + T  +  G+ YL S+K IHRD+   N+LV  
Sbjct: 120 RARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLTARNVLVTE 179
Query: 479 SGVVKLADFGMAKHLTG---QKADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSL 535
           + V+K+ADFG+A+ +      K   + +    WMAPE +   +   +S       D+WS 
Sbjct: 180 NNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQS-------DVWSF 232
Query: 536 GCTIIEMYT--GKPPWSEYEG--AAAMFKVMRDTPAI--PDSLSPEGKDFLRCCFQRNPA 589
           G  + E++T  G P    Y G     +FK++++   +  P + + E    +R C+   P+
Sbjct: 233 GVLMWEIFTLGGSP----YPGIPVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPS 288
Query: 590 DRPPASLLLE 599
            RP    L+E
Sbjct: 289 QRPTFKQLVE 298

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 90.5 bits (223), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 77/305 (25%), Positives = 135/305 (44%), Gaps = 58/305 (19%)
Query: 336 LPMNSQWQK-------GKLIGRGTFGSVYVAS---------NRETGALCAMKEVDIFPDD 379
           LP + +W+        GK +G G FG V +A          NR T     M + D     
Sbjct: 17  LPEDPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD----- 71
Query: 380 PKSAESIKQLEQEIKVLSHL-KHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREH-- 436
             + + +  L  E++++  + KH NI+   G+   +   Y+ +EY   G++ +Y++    
Sbjct: 72  -ATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRP 130
Query: 437 -------------CGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVK 483
                           ++   + +    +  G+ YL SKK IHRD+   N+LV    V+K
Sbjct: 131 PGLEFSFNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMK 190
Query: 484 LADFGMAK---HLTGQKADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTII 540
           +ADFG+A+   H+   K   + +    WMAPE +   +   +S       D+WS G  + 
Sbjct: 191 IADFGLARDIHHIDXXKKTTNGRLPVKWMAPEALFDRIYTHQS-------DVWSFGVLLW 243
Query: 541 EMYT--GKPPWSEYEG--AAAMFKVMRDTPAI--PDSLSPEGKDFLRCCFQRNPADRPPA 594
           E++T  G P    Y G     +FK++++   +  P + + E    +R C+   P+ RP  
Sbjct: 244 EIFTLGGSP----YPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTF 299
Query: 595 SLLLE 599
             L+E
Sbjct: 300 KQLVE 304

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 90.5 bits (223), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 81/310 (26%), Positives = 143/310 (46%), Gaps = 49/310 (15%)
Query: 327 PQVAAKPE-PLPMNSQWQ-------KGKLIGRGTFGSVYVAS----NRETGALCAMKEVD 374
           P +A   E  LP + +W+        GK +G G FG V +A     +++         V 
Sbjct: 14  PMLAGVSEYELPEDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVK 73
Query: 375 IFPDDPKSAESIKQLEQEIKVLSHL-KHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYV 433
           +  DD  + + +  L  E++++  + KH NI+   G+   +   Y+ +EY   G++ +Y+
Sbjct: 74  MLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIIHLLGACTQDGPLYVIVEYASKGNLREYL 132
Query: 434 R-------EHCGAI--------TESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDA 478
           R       E+   I        T   + + T  +  G+ YL S+K IHRD+   N+LV  
Sbjct: 133 RARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTE 192
Query: 479 SGVVKLADFGMAKHLTG---QKADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSL 535
           + V+K+ADFG+A+ +      K   + +    WMAPE +   +   +S       D+WS 
Sbjct: 193 NNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQS-------DVWSF 245
Query: 536 GCTIIEMYT--GKPPWSEYEG--AAAMFKVMRDTPAI--PDSLSPEGKDFLRCCFQRNPA 589
           G  + E++T  G P    Y G     +FK++++   +  P + + E    +R C+   P+
Sbjct: 246 GVLMWEIFTLGGSP----YPGIPVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPS 301
Query: 590 DRPPASLLLE 599
            RP    L+E
Sbjct: 302 QRPTFKQLVE 311

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 90.5 bits (223), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 81/310 (26%), Positives = 143/310 (46%), Gaps = 49/310 (15%)
Query: 327 PQVAAKPE-PLPMNSQWQ-------KGKLIGRGTFGSVYVAS----NRETGALCAMKEVD 374
           P +A   E  LP + +W+        GK +G G FG V +A     +++         V 
Sbjct: 3   PMLAGVSEYELPEDPKWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVK 62
Query: 375 IFPDDPKSAESIKQLEQEIKVLSHL-KHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYV 433
           +  DD  + + +  L  E++++  + KH NI+   G+   +   Y+ +EY   G++ +Y+
Sbjct: 63  MLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYL 121
Query: 434 R-------EHCGAI--------TESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDA 478
           R       E+   I        T   + + T  +  G+ YL S+K IHRD+   N+LV  
Sbjct: 122 RARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTE 181
Query: 479 SGVVKLADFGMAKHLTG---QKADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSL 535
           + V+K+ADFG+A+ +      K   + +    WMAPE +   +   +S       D+WS 
Sbjct: 182 NNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQS-------DVWSF 234
Query: 536 GCTIIEMYT--GKPPWSEYEG--AAAMFKVMRDTPAI--PDSLSPEGKDFLRCCFQRNPA 589
           G  + E++T  G P    Y G     +FK++++   +  P + + E    +R C+   P+
Sbjct: 235 GVLMWEIFTLGGSP----YPGIPVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPS 290
Query: 590 DRPPASLLLE 599
            RP    L+E
Sbjct: 291 QRPTFKQLVE 300

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 90.5 bits (223), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 81/310 (26%), Positives = 143/310 (46%), Gaps = 49/310 (15%)
Query: 327 PQVAAKPE-PLPMNSQWQ-------KGKLIGRGTFGSVYVAS----NRETGALCAMKEVD 374
           P +A   E  LP + +W+        GK +G G FG V +A     +++         V 
Sbjct: 14  PMLAGVSEYELPEDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVK 73
Query: 375 IFPDDPKSAESIKQLEQEIKVLSHL-KHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYV 433
           +  DD  + + +  L  E++++  + KH NI+   G+   +   Y+ +EY   G++ +Y+
Sbjct: 74  MLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYL 132
Query: 434 R-------EHCGAI--------TESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDA 478
           R       E+   I        T   + + T  +  G+ YL S+K IHRD+   N+LV  
Sbjct: 133 RARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTE 192
Query: 479 SGVVKLADFGMAKHLTG---QKADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSL 535
           + V+K+ADFG+A+ +      K   + +    WMAPE +   +   +S       D+WS 
Sbjct: 193 NNVMKIADFGLARDINNIDYYKNTTNGRLPVKWMAPEALFDRVYTHQS-------DVWSF 245
Query: 536 GCTIIEMYT--GKPPWSEYEG--AAAMFKVMRDTPAI--PDSLSPEGKDFLRCCFQRNPA 589
           G  + E++T  G P    Y G     +FK++++   +  P + + E    +R C+   P+
Sbjct: 246 GVLMWEIFTLGGSP----YPGIPVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPS 301
Query: 590 DRPPASLLLE 599
            RP    L+E
Sbjct: 302 QRPTFKQLVE 311

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 90.5 bits (223), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 75/276 (27%), Positives = 128/276 (46%), Gaps = 37/276 (13%)
Query: 348 IGRGTFGSVYVASNRETG--ALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIV 405
           +G+G FG V++ +   T   A+  +K  ++ P+            QE +V+  L+H  +V
Sbjct: 193 LGQGCFGEVWMGTWNGTTRVAIKTLKPGNMSPE---------AFLQEAQVMKKLRHEKLV 243
Query: 406 QYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGA-ITESVVRNFTRHILSGLAYLHSKKT 464
           Q Y   + E+  YI  EY+  GS+  +++   G  +    + +    I SG+AY+     
Sbjct: 244 QLYAV-VSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNY 302
Query: 465 IHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPY---WMAPELMMAVMQKG 521
           +HRD++ AN+LV  + V K+ADFG+ + L       + +G+ +   W APE  +      
Sbjct: 303 VHRDLRAANILVGENLVCKVADFGLGR-LIEDNEYTARQGAKFPIKWTAPEAALYGRFTI 361
Query: 522 KSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFKVMRDT-----PAIPDSLSPE 575
           KS       D+WS G  + E+ T G+ P+        + +V R       P  P+SL   
Sbjct: 362 KS-------DVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESL--- 411
Query: 576 GKDFLRCCFQRNPADRPPASLL---LEHRFLKNSQQ 608
             D +  C++++P +RP    L   LE  F     Q
Sbjct: 412 -HDLMCQCWRKDPEERPTFEYLQAFLEDYFTSTEPQ 446

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 90.5 bits (223), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 81/310 (26%), Positives = 143/310 (46%), Gaps = 49/310 (15%)
Query: 327 PQVAAKPE-PLPMNSQWQ-------KGKLIGRGTFGSVYVAS----NRETGALCAMKEVD 374
           P +A   E  LP + +W+        GK +G G FG V +A     +++         V 
Sbjct: 6   PMLAGVSEYELPEDPKWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVK 65
Query: 375 IFPDDPKSAESIKQLEQEIKVLSHL-KHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYV 433
           +  DD  + + +  L  E++++  + KH NI+   G+   +   Y+ +EY   G++ +Y+
Sbjct: 66  MLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYL 124
Query: 434 R-------EHCGAI--------TESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDA 478
           R       E+   I        T   + + T  +  G+ YL S+K IHRD+   N+LV  
Sbjct: 125 RARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTE 184
Query: 479 SGVVKLADFGMAKHLTG---QKADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSL 535
           + V+K+ADFG+A+ +      K   + +    WMAPE +   +   +S       D+WS 
Sbjct: 185 NNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQS-------DVWSF 237
Query: 536 GCTIIEMYT--GKPPWSEYEG--AAAMFKVMRDTPAI--PDSLSPEGKDFLRCCFQRNPA 589
           G  + E++T  G P    Y G     +FK++++   +  P + + E    +R C+   P+
Sbjct: 238 GVLMWEIFTLGGSP----YPGIPVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPS 293
Query: 590 DRPPASLLLE 599
            RP    L+E
Sbjct: 294 QRPTFKQLVE 303

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 90.1 bits (222), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 78/263 (29%), Positives = 122/263 (46%), Gaps = 31/263 (11%)
Query: 348 IGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQY 407
           IG+G FG V +   R  G   A+K +       K+  + +    E  V++ L+H N+VQ 
Sbjct: 201 IGKGEFGDVMLGDYR--GNKVAVKCI-------KNDATAQAFLAEASVMTQLRHSNLVQL 251
Query: 408 YGSEIVEDK--FYIYLEYVHPGSINKYVREHCGAITES-VVRNFTRHILSGLAYLHSKKT 464
            G  IVE+K   YI  EY+  GS+  Y+R    ++     +  F+  +   + YL     
Sbjct: 252 LGV-IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNF 310
Query: 465 IHRDIKGANLLVDASGVVKLADFGMAKHL--TGQKADLSMKGSPYWMAPELMMAVMQKGK 522
           +HRD+   N+LV    V K++DFG+ K    T     L +K    W APE   A+ +K  
Sbjct: 311 VHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVK----WTAPE---ALREKKF 363
Query: 523 SSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFKVMRDTPA-IPDSLSPEGKDFL 580
           S+ S    D+WS G  + E+Y+ G+ P+        + +V +      PD   P   D +
Sbjct: 364 STKS----DVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYDVM 419
Query: 581 RCCFQRNPADRPPASLL---LEH 600
           + C+  + A RP    L   LEH
Sbjct: 420 KNCWHLDAATRPTFLQLREQLEH 442

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 90.1 bits (222), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 74/274 (27%), Positives = 131/274 (47%), Gaps = 33/274 (12%)
Query: 348 IGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQY 407
           +G+G FG V++ +   T  + A+K +      P++        QE +V+  L+H  +VQ 
Sbjct: 26  LGQGCFGEVWMGTWNGTTRV-AIKTLKPGTMSPEA------FLQEAQVMKKLRHEKLVQL 78
Query: 408 YGSEIVEDKFYIYLEYVHPGSINKYVREHCGA-ITESVVRNFTRHILSGLAYLHSKKTIH 466
           Y   + E+  YI +EY+  G +  +++   G  +    + +    I SG+AY+     +H
Sbjct: 79  YAV-VSEEPIYIVMEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVH 137
Query: 467 RDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPY---WMAPELMMAVMQKGKS 523
           RD++ AN+LV  + V K+ADFG+A+ L       + +G+ +   W APE  +     G+ 
Sbjct: 138 RDLRAANILVGENLVCKVADFGLAR-LIEDNEYTARQGAKFPIKWTAPEAALY----GRF 192
Query: 524 SDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFKVMRDT-----PAIPDSLSPEGK 577
           +   +  D+WS G  + E+ T G+ P+        + +V R       P  P+SL     
Sbjct: 193 T---IKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLH---- 245
Query: 578 DFLRCCFQRNPADRPPASLL---LEHRFLKNSQQ 608
           D +  C++++P +RP    L   LE  F     Q
Sbjct: 246 DLMCQCWRKDPEERPTFEYLQAFLEDYFTSTEPQ 279

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score = 90.1 bits (222), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 72/269 (26%), Positives = 123/269 (45%), Gaps = 26/269 (9%)
Query: 338 MNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESI------KQLEQ 391
           M S +   + I  G++G+V    + E G   A+K V     D ++   +      K++ +
Sbjct: 20  MQSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLR 78
Query: 392 EIKVLSHLKHPNI-----VQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVR 446
           EI++L+H  HPNI     +  +  E    K Y+  E +    + + + +    I+   ++
Sbjct: 79  EIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIHDQRIVISPQHIQ 137
Query: 447 NFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSP 506
            F  HIL GL  LH    +HRD+   N+L+  +  + + DF +A+  T            
Sbjct: 138 YFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVTHR 197
Query: 507 YWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPW---SEYEGAAAMFKVMR 563
           ++ APEL+M    KG +      VD+WS GC + EM+  K  +   + Y     + +V+ 
Sbjct: 198 WYRAPELVMQF--KGFTK----LVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVV- 250
Query: 564 DTPAIPDSL---SPEGKDFLRCCFQRNPA 589
            TP I D +   SP  +D+LR      PA
Sbjct: 251 GTPKIEDVVMFSSPSARDYLRNSLSNVPA 279

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 90.1 bits (222), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 81/310 (26%), Positives = 143/310 (46%), Gaps = 49/310 (15%)
Query: 327 PQVAAKPE-PLPMNSQWQ-------KGKLIGRGTFGSVYVAS----NRETGALCAMKEVD 374
           P +A   E  LP + +W+        GK +G G FG V +A     +++         V 
Sbjct: 14  PMLAGVSEYELPEDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVK 73
Query: 375 IFPDDPKSAESIKQLEQEIKVLSHL-KHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYV 433
           +  DD  + + +  L  E++++  + KH NI+   G+   +   Y+ +EY   G++ +Y+
Sbjct: 74  MLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIITLLGACTQDGPLYVIVEYASKGNLREYL 132
Query: 434 R-------EHCGAI--------TESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDA 478
           R       E+   I        T   + + T  +  G+ YL S+K IHRD+   N+LV  
Sbjct: 133 RARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTE 192
Query: 479 SGVVKLADFGMAKHLTG---QKADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSL 535
           + V+K+ADFG+A+ +      K   + +    WMAPE +   +   +S       D+WS 
Sbjct: 193 NNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQS-------DVWSF 245
Query: 536 GCTIIEMYT--GKPPWSEYEG--AAAMFKVMRDTPAI--PDSLSPEGKDFLRCCFQRNPA 589
           G  + E++T  G P    Y G     +FK++++   +  P + + E    +R C+   P+
Sbjct: 246 GVLMWEIFTLGGSP----YPGIPVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPS 301
Query: 590 DRPPASLLLE 599
            RP    L+E
Sbjct: 302 QRPTFKQLVE 311

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 90.1 bits (222), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 79/310 (25%), Positives = 141/310 (45%), Gaps = 49/310 (15%)
Query: 327 PQVAAKPE-PLPMNSQWQ-------KGKLIGRGTFGSVYVAS----NRETGALCAMKEVD 374
           P +A   E  LP + +W+        GK +G G FG V +A     +++         V 
Sbjct: 14  PMLAGVSEYELPEDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVK 73
Query: 375 IFPDDPKSAESIKQLEQEIKVLSHL-KHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYV 433
           +  DD  + + +  L  E++++  + KH NI+   G+   +   Y+ +EY   G++ +Y+
Sbjct: 74  MLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYL 132
Query: 434 REH---------------CGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDA 478
           R                    +T   + + T  +  G+ YL S+K IHRD+   N+LV  
Sbjct: 133 RARRPPGMEXSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTE 192
Query: 479 SGVVKLADFGMAKHLTG---QKADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSL 535
           + V+K+ADFG+A+ +      K   + +    WMAPE +   +   +S       D+WS 
Sbjct: 193 NNVMKIADFGLARDINNIDXXKKTTNGRLPVKWMAPEALFDRVYTHQS-------DVWSF 245
Query: 536 GCTIIEMYT--GKPPWSEYEG--AAAMFKVMRDTPAI--PDSLSPEGKDFLRCCFQRNPA 589
           G  + E++T  G P    Y G     +FK++++   +  P + + E    +R C+   P+
Sbjct: 246 GVLMWEIFTLGGSP----YPGIPVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPS 301
Query: 590 DRPPASLLLE 599
            RP    L+E
Sbjct: 302 QRPTFKQLVE 311

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 89.7 bits (221), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 72/267 (26%), Positives = 129/267 (48%), Gaps = 31/267 (11%)
Query: 347 LIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQ 406
           ++G+G+FG V    +R T    A+K ++      K   +I +   E+++L  L HPNI++
Sbjct: 29  MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILR---EVELLKKLDHPNIMK 85
Query: 407 YYGSEIVEDK--FYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKT 464
            +  EI+ED   FYI  E    G +   + +     +E       + + SG+ Y+H    
Sbjct: 86  LF--EILEDSSSFYIVGELYTGGELFDEIIKR-KRFSEHDAARIIKQVFSGITYMHKHNI 142
Query: 465 IHRDIKGANLLVDASGV---VKLADFGMAKHLTGQKADLSMK---GSPYWMAPELMMAVM 518
           +HRD+K  N+L+++      +K+ DFG++   T  + +  MK   G+ Y++APE++    
Sbjct: 143 VHRDLKPENILLESKEKDCDIKIIDFGLS---TCFQQNTKMKDRIGTAYYIAPEVLRGTY 199
Query: 519 QKGKSSDSALAVDIWSLGCTIIEMYTGKPPW---SEYE--GAAAMFKVMRDTPAIPDSLS 573
            +          D+WS G  +  + +G PP+   +EY+        K   D P    ++S
Sbjct: 200 DE--------KCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWR-TIS 250
Query: 574 PEGKDFLRCCFQRNPADRPPASLLLEH 600
            + KD +R     +P+ R  A+  LEH
Sbjct: 251 DDAKDLIRKMLTFHPSLRITATQCLEH 277

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 89.7 bits (221), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 69/279 (24%), Positives = 133/279 (47%), Gaps = 24/279 (8%)
Query: 335 PLPMNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQ--- 391
           P   +++ +  K IG+G FG V+     +  ++ A+K + I  D     E I++ ++   
Sbjct: 14  PTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSL-ILGDSEGETEMIEKFQEFQR 72
Query: 392 EIKVLSHLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRH 451
           E+ ++S+L HPNIV+ YG  ++ +   + +E+V  G +   + +    I  SV       
Sbjct: 73  EVFIMSNLNHPNIVKLYG--LMHNPPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLD 130
Query: 452 ILSGLAYLHSKK--TIHRDIKGANLLV-----DASGVVKLADFGMAKHLTGQKADLSMKG 504
           I  G+ Y+ ++    +HRD++  N+ +     +A    K+ADFG+++      + L   G
Sbjct: 131 IALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHSVSGLL--G 188
Query: 505 SPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYE-GAAAMFKVMR 563
           +  WMAPE + A     +        D +S    +  + TG+ P+ EY  G      ++R
Sbjct: 189 NFQWMAPETIGA-----EEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIR 243
Query: 564 DT---PAIPDSLSPEGKDFLRCCFQRNPADRPPASLLLE 599
           +    P IP+   P  ++ +  C+  +P  RP  S +++
Sbjct: 244 EEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVK 282

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 89.7 bits (221), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 76/274 (27%), Positives = 128/274 (46%), Gaps = 33/274 (12%)
Query: 348 IGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQY 407
           +G+G FG V++ +   T  + A+K +      P++        QE +V+  L+H  +VQ 
Sbjct: 192 LGQGCFGEVWMGTWNGTTRV-AIKTLKPGTMSPEA------FLQEAQVMKKLRHEKLVQL 244
Query: 408 YGSEIVEDKFYIYLEYVHPGSINKYVREHCGA-ITESVVRNFTRHILSGLAYLHSKKTIH 466
           Y   + E+  YI  EY+  GS+  +++   G  +    + +    I SG+AY+     +H
Sbjct: 245 YAV-VSEEPIYIVGEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVH 303
Query: 467 RDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPY---WMAPELMMAVMQKGKS 523
           RD++ AN+LV  + V K+ADFG+A+ L       + +G+ +   W APE  +      KS
Sbjct: 304 RDLRAANILVGENLVCKVADFGLAR-LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 362
Query: 524 SDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFKVMRDT-----PAIPDSLSPEGK 577
                  D+WS G  + E+ T G+ P+        + +V R       P  P+SL     
Sbjct: 363 -------DVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESL----H 411
Query: 578 DFLRCCFQRNPADRPPASLL---LEHRFLKNSQQ 608
           D +  C+++ P +RP    L   LE  F     Q
Sbjct: 412 DLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQ 445

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 89.7 bits (221), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 75/273 (27%), Positives = 129/273 (47%), Gaps = 43/273 (15%)
Query: 347 LIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQ 406
           ++G+G+FG V    +R T    A+K ++      K   +I +   E+++L  L HPNI++
Sbjct: 29  MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILR---EVELLKKLDHPNIMK 85
Query: 407 YYGSEIVEDK--FYIYLEYVHPGSI------NKYVREHCGAITESVVRNFTRHILSGLAY 458
            +  EI+ED   FYI  E    G +       K   EH  A          + + SG+ Y
Sbjct: 86  LF--EILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAA-------RIIKQVFSGITY 136
Query: 459 LHSKKTIHRDIKGANLLVDASGV---VKLADFGMAKHLTGQKADLSMK---GSPYWMAPE 512
           +H    +HRD+K  N+L+++      +K+ DFG++   T  + +  MK   G+ Y++APE
Sbjct: 137 MHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLS---TCFQQNTKMKDRIGTAYYIAPE 193
Query: 513 LMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPW---SEYE--GAAAMFKVMRDTPA 567
           ++     +          D+WS G  +  + +G PP+   +EY+        K   D P 
Sbjct: 194 VLRGTYDE--------KCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQ 245
Query: 568 IPDSLSPEGKDFLRCCFQRNPADRPPASLLLEH 600
              ++S + KD +R     +P+ R  A+  LEH
Sbjct: 246 WR-TISDDAKDLIRKMLTFHPSLRITATQCLEH 277

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 89.7 bits (221), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 62/226 (27%), Positives = 103/226 (45%), Gaps = 14/226 (6%)
Query: 348 IGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQY 407
           IG G+FG+VY        A+  +K VD  P      E  +    E+ VL   +H NI+ +
Sbjct: 44  IGSGSFGTVYKGKWHGDVAVKILKVVDPTP------EQFQAFRNEVAVLRKTRHVNILLF 97
Query: 408 YGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHR 467
            G  + +D   I  ++    S+ K++           + +  R    G+ YLH+K  IHR
Sbjct: 98  MGY-MTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHR 156
Query: 468 DIKGANLLVDASGVVKLADFGMA---KHLTGQKADLSMKGSPYWMAPELMMAVMQKGKSS 524
           D+K  N+ +     VK+ DFG+A      +G +      GS  WMAPE    V++   ++
Sbjct: 157 DMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPE----VIRMQDNN 212
Query: 525 DSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPD 570
             +   D++S G  + E+ TG+ P+S       +  ++    A PD
Sbjct: 213 PFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPD 258

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 89.7 bits (221), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 71/263 (26%), Positives = 120/263 (45%), Gaps = 30/263 (11%)
Query: 346 KLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIV 405
           K +G G FG V     R    + A+K +       + + S  +  +E KV+ +L H  +V
Sbjct: 15  KELGTGQFGVVKYGKWRGQYDV-AIKMI------KEGSMSEDEFIEEAKVMMNLSHEKLV 67
Query: 406 QYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTI 465
           Q YG    +   +I  EY+  G +  Y+RE         +    + +   + YL SK+ +
Sbjct: 68  QLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFL 127
Query: 466 HRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPY---WMAPELMMAVMQKGK 522
           HRD+   N LV+  GVVK++DFG+++++   +   S +GS +   W  PE++M      K
Sbjct: 128 HRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT-SSRGSKFPVRWSPPEVLMYSKFSSK 186
Query: 523 SSDSALAVDIWSLGCTIIEMYT-GKPPWSEY------EGAAAMFKVMRDTPAIPDSLSPE 575
           S       DIW+ G  + E+Y+ GK P+  +      E  A   ++ R     P   S +
Sbjct: 187 S-------DIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYR-----PHLASEK 234
Query: 576 GKDFLRCCFQRNPADRPPASLLL 598
               +  C+     +RP   +LL
Sbjct: 235 VYTIMYSCWHEKADERPTFKILL 257

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 89.7 bits (221), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 67/274 (24%), Positives = 118/274 (43%), Gaps = 11/274 (4%)
Query: 341 QWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQ----EIKVL 396
            ++  +++GRG    V    ++ T    A+K +D+      SAE +++L +    E+ +L
Sbjct: 18  NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 77
Query: 397 SHLK-HPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSG 455
             +  HPNI+Q   +      F++  + +  G +  Y+ E    ++E   R   R +L  
Sbjct: 78  RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKV-TLSEKETRKIMRALLEV 136
Query: 456 LAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPYWMAPELMM 515
           +  LH    +HRD+K  N+L+D    +KL DFG +  L   +    + G+P ++APE++ 
Sbjct: 137 ICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIE 196
Query: 516 AVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIP----DS 571
             M           VD+WS G  +  +  G PP+   +    +  +M           D 
Sbjct: 197 CSMNDNHPG-YGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDD 255
Query: 572 LSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKN 605
            S   KD +       P  R  A   L H F + 
Sbjct: 256 YSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ 289

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 89.7 bits (221), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 72/265 (27%), Positives = 119/265 (44%), Gaps = 34/265 (12%)
Query: 346 KLIGRGTFGSVYVASNRETG--ALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPN 403
           K +G G FG V     R     A+  +KE  +  D         +  +E KV+ +L H  
Sbjct: 30  KELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED---------EFIEEAKVMMNLSHEK 80
Query: 404 IVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKK 463
           +VQ YG    +   +I  EY+  G +  Y+RE         +    + +   + YL SK+
Sbjct: 81  LVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ 140
Query: 464 TIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPY---WMAPELMMAVMQK 520
            +HRD+   N LV+  GVVK++DFG+++++   +   S+ GS +   W  PE++M     
Sbjct: 141 FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEETSSV-GSKFPVRWSPPEVLMYSKFS 199
Query: 521 GKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEY------EGAAAMFKVMRDTPAIPDSLS 573
            KS       DIW+ G  + E+Y+ GK P+  +      E  A   ++ R     P   S
Sbjct: 200 SKS-------DIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYR-----PHLAS 247
Query: 574 PEGKDFLRCCFQRNPADRPPASLLL 598
            +    +  C+     +RP   +LL
Sbjct: 248 EKVYTIMYSCWHEKADERPTFKILL 272

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 89.7 bits (221), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 75/274 (27%), Positives = 129/274 (47%), Gaps = 33/274 (12%)
Query: 348 IGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQY 407
           +G+G FG V++ +   T  + A+K +      P++        QE +V+  ++H  +VQ 
Sbjct: 26  LGQGCFGEVWMGTWNGTTRV-AIKTLKPGTMSPEA------FLQEAQVMKKIRHEKLVQL 78
Query: 408 YGSEIVEDKFYIYLEYVHPGSINKYVREHCGA-ITESVVRNFTRHILSGLAYLHSKKTIH 466
           Y   + E+  YI  EY+  GS+  +++   G  +    + +    I SG+AY+     +H
Sbjct: 79  YAV-VSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVH 137
Query: 467 RDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPY---WMAPELMMAVMQKGKS 523
           RD++ AN+LV  + V K+ADFG+A+ L       + +G+ +   W APE  +      KS
Sbjct: 138 RDLRAANILVGENLVCKVADFGLAR-LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 196
Query: 524 SDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFKVMRDT-----PAIPDSLSPEGK 577
                  D+WS G  + E+ T G+ P+        + +V R       P  P+SL     
Sbjct: 197 -------DVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLH---- 245
Query: 578 DFLRCCFQRNPADRPPASLL---LEHRFLKNSQQ 608
           D +  C++++P +RP    L   LE  F     Q
Sbjct: 246 DLMCQCWRKDPEERPTFEYLQAFLEDYFTSTEPQ 279

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 89.7 bits (221), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 79/305 (25%), Positives = 136/305 (44%), Gaps = 58/305 (19%)
Query: 336 LPMNSQWQK-------GKLIGRGTFGSVYVAS---------NRETGALCAMKEVDIFPDD 379
           LP + +W+        GK +G G FG V +A          NR T     M + D    D
Sbjct: 6   LPEDPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKD 65
Query: 380 PKSAESIKQLEQEIKVLSHL-KHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVR---- 434
                 +  L  E++++  + KH NI+   G+   +   Y+ +EY   G++ +Y++    
Sbjct: 66  ------LSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRP 119
Query: 435 ---EHC--------GAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVK 483
              E+           ++   + +    +  G+ YL SKK IHRD+   N+LV    V+K
Sbjct: 120 PGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMK 179
Query: 484 LADFGMAK---HLTGQKADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTII 540
           +ADFG+A+   H+   K   + +    WMAPE +   +   +S       D+WS G  + 
Sbjct: 180 IADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQS-------DVWSFGVLLW 232
Query: 541 EMYT--GKPPWSEYEG--AAAMFKVMRDTPAI--PDSLSPEGKDFLRCCFQRNPADRPPA 594
           E++T  G P    Y G     +FK++++   +  P + + E    +R C+   P+ RP  
Sbjct: 233 EIFTLGGSP----YPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTF 288
Query: 595 SLLLE 599
             L+E
Sbjct: 289 KQLVE 293

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 89.7 bits (221), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 74/290 (25%), Positives = 135/290 (46%), Gaps = 18/290 (6%)
Query: 328 QVAAKPEPLPMNSQ-WQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESI 386
           ++  K   L M ++ +   K+IGRG FG V +  ++ +  + AMK +  F    +S  + 
Sbjct: 62  KIVKKIRGLQMKAEDYDVVKVIGRGAFGEVQLVRHKASQKVYAMKLLSKFEMIKRSDSAF 121
Query: 387 KQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVR 446
              E++I   ++   P +VQ + +   +   Y+ +EY+  G +   +  +   + E   +
Sbjct: 122 FWEERDIMAFAN--SPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNY--DVPEKWAK 177
Query: 447 NFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFG--MAKHLTGQKADLSMKG 504
            +T  ++  L  +HS   IHRD+K  N+L+D  G +KLADFG  M    TG     +  G
Sbjct: 178 FYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVHCDTAVG 237
Query: 505 SPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVM-- 562
           +P +++PE++ +   +G         D WS+G  + EM  G  P+          K+M  
Sbjct: 238 TPDYISPEVLKS---QGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDH 294
Query: 563 RDTPAIPDS--LSPEGKDFLRCCFQRNPA---DRPPASLLLEHRFLKNSQ 607
           +++   P+   +S   K+ + C F  +      R     + +H F KN Q
Sbjct: 295 KNSLCFPEDAEISKHAKNLI-CAFLTDREVRLGRNGVEEIKQHPFFKNDQ 343

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 89.4 bits (220), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 74/297 (24%), Positives = 134/297 (45%), Gaps = 41/297 (13%)
Query: 329 VAAKPEPLPMNSQWQK-------GKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPK 381
           V   P  LP + +W+        GK +G G FG V  A+        A   V +    P 
Sbjct: 28  VYIDPTQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPS 87
Query: 382 SAESIKQ-LEQEIKVLSHL-KHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREH--- 436
           +  + ++ L  E+KVLS+L  H NIV   G+  +     +  EY   G +  ++R     
Sbjct: 88  AHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDS 147
Query: 437 --CGAITESVVR------------NFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVV 482
             C   + +++             +F+  +  G+A+L SK  IHRD+   N+L+    + 
Sbjct: 148 FICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRIT 207
Query: 483 KLADFGMAKHLTGQKADLSMKGSP----YWMAPELMMAVMQKGKSSDSALAVDIWSLGCT 538
           K+ DFG+A+H+    ++  +KG+      WMAPE +   +   +S       D+WS G  
Sbjct: 208 KICDFGLARHIKND-SNYVVKGNARLPVKWMAPESIFNCVYTFES-------DVWSYGIF 259
Query: 539 IIEMYT-GKPPWSEYEGAAAMFKVMRDTPAI--PDSLSPEGKDFLRCCFQRNPADRP 592
           + E+++ G  P+      +  +K++++   +  P+    E  D ++ C+  +P  RP
Sbjct: 260 LWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRP 316

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 89.4 bits (220), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 80/310 (25%), Positives = 143/310 (46%), Gaps = 49/310 (15%)
Query: 327 PQVAAKPE-PLPMNSQWQ-------KGKLIGRGTFGSVYVAS----NRETGALCAMKEVD 374
           P +A   E  LP + +W+        GK +G G FG V +A     +++         V 
Sbjct: 14  PMLAGVSEYELPEDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVK 73
Query: 375 IFPDDPKSAESIKQLEQEIKVLSHL-KHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYV 433
           +  DD  + + +  L  E++++  + KH NI+   G+   +   Y+ +EY   G++ +Y+
Sbjct: 74  MLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYL 132
Query: 434 R-------EHCGAI--------TESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDA 478
           R       E+   I        T   + + T  +  G+ YL S+K IHRD+   N+LV  
Sbjct: 133 RARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTE 192
Query: 479 SGVVKLADFGMAKHLTG---QKADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSL 535
           + V+++ADFG+A+ +      K   + +    WMAPE +   +   +S       D+WS 
Sbjct: 193 NNVMRIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQS-------DVWSF 245
Query: 536 GCTIIEMYT--GKPPWSEYEG--AAAMFKVMRDTPAI--PDSLSPEGKDFLRCCFQRNPA 589
           G  + E++T  G P    Y G     +FK++++   +  P + + E    +R C+   P+
Sbjct: 246 GVLMWEIFTLGGSP----YPGIPVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPS 301
Query: 590 DRPPASLLLE 599
            RP    L+E
Sbjct: 302 QRPTFKQLVE 311

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 89.4 bits (220), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 72/265 (27%), Positives = 119/265 (44%), Gaps = 34/265 (12%)
Query: 346 KLIGRGTFGSVYVASNRETG--ALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPN 403
           K +G G FG V     R     A+  +KE  +  D         +  +E KV+ +L H  
Sbjct: 30  KELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED---------EFIEEAKVMMNLSHEK 80
Query: 404 IVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKK 463
           +VQ YG    +   +I  EY+  G +  Y+RE         +    + +   + YL SK+
Sbjct: 81  LVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ 140
Query: 464 TIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPY---WMAPELMMAVMQK 520
            +HRD+   N LV+  GVVK++DFG+++++   +   S+ GS +   W  PE++M     
Sbjct: 141 FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSV-GSKFPVRWSPPEVLMYSKFS 199
Query: 521 GKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEY------EGAAAMFKVMRDTPAIPDSLS 573
            KS       DIW+ G  + E+Y+ GK P+  +      E  A   ++ R     P   S
Sbjct: 200 SKS-------DIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYR-----PHLAS 247
Query: 574 PEGKDFLRCCFQRNPADRPPASLLL 598
            +    +  C+     +RP   +LL
Sbjct: 248 EKVYTIMYSCWHEKADERPTFKILL 272

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 89.4 bits (220), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 76/274 (27%), Positives = 128/274 (46%), Gaps = 33/274 (12%)
Query: 348 IGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQY 407
           +G+G FG V++ +   T  + A+K +      P++        QE +V+  L+H  +VQ 
Sbjct: 26  LGQGCFGEVWMGTWNGTTRV-AIKTLKPGTMSPEA------FLQEAQVMKKLRHEKLVQL 78
Query: 408 YGSEIVEDKFYIYLEYVHPGSINKYVREHCGA-ITESVVRNFTRHILSGLAYLHSKKTIH 466
           Y   + E+  YI  EY+  GS+  +++   G  +    + +    I SG+AY+     +H
Sbjct: 79  YAV-VSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVH 137
Query: 467 RDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPY---WMAPELMMAVMQKGKS 523
           RD+  AN+LV  + V K+ADFG+A+ L       + +G+ +   W APE  +      KS
Sbjct: 138 RDLAAANILVGENLVCKVADFGLAR-LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 196
Query: 524 SDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFKVMRDT-----PAIPDSLSPEGK 577
                  D+WS G  + E+ T G+ P+        + +V R       P  P+SL     
Sbjct: 197 -------DVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLH---- 245
Query: 578 DFLRCCFQRNPADRPPASLL---LEHRFLKNSQQ 608
           D +  C++++P +RP    L   LE  F     Q
Sbjct: 246 DLMCQCWRKDPEERPTFEYLQAFLEDYFTSTEPQ 279

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 89.4 bits (220), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 64/258 (24%), Positives = 119/258 (46%), Gaps = 26/258 (10%)
Query: 348 IGRGTFGSVYVA--SNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIV 405
           +G G FG V++   +     A+ ++K+  + PD             E  ++  L+H  +V
Sbjct: 29  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD---------AFLAEANLMKQLQHQRLV 79
Query: 406 QYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGA-ITESVVRNFTRHILSGLAYLHSKKT 464
           + Y   + ++  YI  EY+  GS+  +++   G  +T + + +    I  G+A++  +  
Sbjct: 80  RLYAV-VTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNY 138
Query: 465 IHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPY---WMAPELMMAVMQKG 521
           IHRD++ AN+LV  +   K+ADFG+A+ L       + +G+ +   W APE +       
Sbjct: 139 IHRDLRAANILVSDTLSCKIADFGLAR-LIEDNEXTAREGAKFPIKWTAPEAI------- 190
Query: 522 KSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFKVMRDTPAI-PDSLSPEGKDF 579
                 +  D+WS G  + E+ T G+ P+        +  + R    + PD+   E    
Sbjct: 191 NYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQL 250
Query: 580 LRCCFQRNPADRPPASLL 597
           +R C++  P DRP    L
Sbjct: 251 MRLCWKERPEDRPTFDYL 268

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 89.4 bits (220), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 79/305 (25%), Positives = 136/305 (44%), Gaps = 58/305 (19%)
Query: 336 LPMNSQWQK-------GKLIGRGTFGSVYVAS---------NRETGALCAMKEVDIFPDD 379
           LP + +W+        GK +G G FG V +A          NR T     M + D    D
Sbjct: 9   LPEDPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKD 68
Query: 380 PKSAESIKQLEQEIKVLSHL-KHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVR---- 434
                 +  L  E++++  + KH NI+   G+   +   Y+ +EY   G++ +Y++    
Sbjct: 69  ------LSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRP 122
Query: 435 ---EHC--------GAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVK 483
              E+           ++   + +    +  G+ YL SKK IHRD+   N+LV    V+K
Sbjct: 123 PGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMK 182
Query: 484 LADFGMAK---HLTGQKADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTII 540
           +ADFG+A+   H+   K   + +    WMAPE +   +   +S       D+WS G  + 
Sbjct: 183 IADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQS-------DVWSFGVLLW 235
Query: 541 EMYT--GKPPWSEYEG--AAAMFKVMRDTPAI--PDSLSPEGKDFLRCCFQRNPADRPPA 594
           E++T  G P    Y G     +FK++++   +  P + + E    +R C+   P+ RP  
Sbjct: 236 EIFTLGGSP----YPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTF 291
Query: 595 SLLLE 599
             L+E
Sbjct: 292 KQLVE 296

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 89.4 bits (220), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 79/305 (25%), Positives = 136/305 (44%), Gaps = 58/305 (19%)
Query: 336 LPMNSQWQK-------GKLIGRGTFGSVYVAS---------NRETGALCAMKEVDIFPDD 379
           LP + +W+        GK +G G FG V +A          NR T     M + D    D
Sbjct: 10  LPEDPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKD 69
Query: 380 PKSAESIKQLEQEIKVLSHL-KHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVR---- 434
                 +  L  E++++  + KH NI+   G+   +   Y+ +EY   G++ +Y++    
Sbjct: 70  ------LSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRP 123
Query: 435 ---EHC--------GAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVK 483
              E+           ++   + +    +  G+ YL SKK IHRD+   N+LV    V+K
Sbjct: 124 PGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMK 183
Query: 484 LADFGMAK---HLTGQKADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTII 540
           +ADFG+A+   H+   K   + +    WMAPE +   +   +S       D+WS G  + 
Sbjct: 184 IADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQS-------DVWSFGVLLW 236
Query: 541 EMYT--GKPPWSEYEG--AAAMFKVMRDTPAI--PDSLSPEGKDFLRCCFQRNPADRPPA 594
           E++T  G P    Y G     +FK++++   +  P + + E    +R C+   P+ RP  
Sbjct: 237 EIFTLGGSP----YPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTF 292
Query: 595 SLLLE 599
             L+E
Sbjct: 293 KQLVE 297

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 89.4 bits (220), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 64/258 (24%), Positives = 119/258 (46%), Gaps = 26/258 (10%)
Query: 348 IGRGTFGSVYVA--SNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIV 405
           +G G FG V++   +     A+ ++K+  + PD             E  ++  L+H  +V
Sbjct: 30  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD---------AFLAEANLMKQLQHQRLV 80
Query: 406 QYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGA-ITESVVRNFTRHILSGLAYLHSKKT 464
           + Y   + ++  YI  EY+  GS+  +++   G  +T + + +    I  G+A++  +  
Sbjct: 81  RLYAV-VTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNY 139
Query: 465 IHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPY---WMAPELMMAVMQKG 521
           IHRD++ AN+LV  +   K+ADFG+A+ L       + +G+ +   W APE +       
Sbjct: 140 IHRDLRAANILVSDTLSCKIADFGLAR-LIEDNEXTAREGAKFPIKWTAPEAI------- 191
Query: 522 KSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFKVMRDTPAI-PDSLSPEGKDF 579
                 +  D+WS G  + E+ T G+ P+        +  + R    + PD+   E    
Sbjct: 192 NYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQL 251
Query: 580 LRCCFQRNPADRPPASLL 597
           +R C++  P DRP    L
Sbjct: 252 MRLCWKERPEDRPTFDYL 269

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 89.4 bits (220), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 67/275 (24%), Positives = 118/275 (42%), Gaps = 11/275 (4%)
Query: 340 SQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQ----EIKV 395
             ++  +++GRG    V    ++ T    A+K +D+      SAE +++L +    E+ +
Sbjct: 4   ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 63
Query: 396 LSHLK-HPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILS 454
           L  +  HPNI+Q   +      F++  + +  G +  Y+ E    ++E   R   R +L 
Sbjct: 64  LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKV-TLSEKETRKIMRALLE 122
Query: 455 GLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPYWMAPELM 514
            +  LH    +HRD+K  N+L+D    +KL DFG +  L   +    + G+P ++APE++
Sbjct: 123 VICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEII 182
Query: 515 MAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIP----D 570
              M           VD+WS G  +  +  G PP+   +    +  +M           D
Sbjct: 183 ECSMNDNHPG-YGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWD 241
Query: 571 SLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKN 605
             S   KD +       P  R  A   L H F + 
Sbjct: 242 DYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ 276

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 89.4 bits (220), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 71/263 (26%), Positives = 120/263 (45%), Gaps = 30/263 (11%)
Query: 346 KLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIV 405
           K +G G FG V     R    + A+K +       + + S  +  +E KV+ +L H  +V
Sbjct: 10  KELGTGQFGVVKYGKWRGQYDV-AIKMI------KEGSMSEDEFIEEAKVMMNLSHEKLV 62
Query: 406 QYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTI 465
           Q YG    +   +I  EY+  G +  Y+RE         +    + +   + YL SK+ +
Sbjct: 63  QLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFL 122
Query: 466 HRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPY---WMAPELMMAVMQKGK 522
           HRD+   N LV+  GVVK++DFG+++++   +   S+ GS +   W  PE++M      K
Sbjct: 123 HRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSV-GSKFPVRWSPPEVLMYSKFSSK 181
Query: 523 SSDSALAVDIWSLGCTIIEMYT-GKPPWSEY------EGAAAMFKVMRDTPAIPDSLSPE 575
           S       DIW+ G  + E+Y+ GK P+  +      E  A   ++ R     P   S +
Sbjct: 182 S-------DIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYR-----PHLASEK 229
Query: 576 GKDFLRCCFQRNPADRPPASLLL 598
               +  C+     +RP   +LL
Sbjct: 230 VYTIMYSCWHEKADERPTFKILL 252

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 89.4 bits (220), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 67/270 (24%), Positives = 122/270 (45%), Gaps = 26/270 (9%)
Query: 348 IGRGTFGSVYVASNRETGALCAMKEVDI-FPDDPKSAESIKQLEQEIKVLSHLKHPNIVQ 406
           +G G FG V+    + TG +   K ++  +P D  +      ++ EI +++ L HP ++ 
Sbjct: 59  LGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYT------VKNEISIMNQLHHPKLIN 112
Query: 407 YYGSEIVEDKF--YIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKT 464
            + +   EDK+   + LE++  G +   +      ++E+ V N+ R    GL ++H    
Sbjct: 113 LHDA--FEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSI 170
Query: 465 IHRDIKGANLLVDA--SGVVKLADFGMAKHLTGQKADLSMKGSPYWMAPELMMAVMQKGK 522
           +H DIK  N++ +   +  VK+ DFG+A  L   +       +  + APE++        
Sbjct: 171 VHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIV-------D 223
Query: 523 SSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMR-----DTPAIPDSLSPEGK 577
                   D+W++G     + +G  P++  +    +  V R     D  A   S+SPE K
Sbjct: 224 REPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAF-SSVSPEAK 282
Query: 578 DFLRCCFQRNPADRPPASLLLEHRFLKNSQ 607
           DF++   Q+ P  R      LEH +LK   
Sbjct: 283 DFIKNLLQKEPRKRLTVHDALEHPWLKGDH 312

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 89.4 bits (220), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 72/265 (27%), Positives = 119/265 (44%), Gaps = 34/265 (12%)
Query: 346 KLIGRGTFGSVYVASNRETG--ALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPN 403
           K +G G FG V     R     A+  +KE  +  D         +  +E KV+ +L H  
Sbjct: 14  KELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED---------EFIEEAKVMMNLSHEK 64
Query: 404 IVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKK 463
           +VQ YG    +   +I  EY+  G +  Y+RE         +    + +   + YL SK+
Sbjct: 65  LVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ 124
Query: 464 TIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPY---WMAPELMMAVMQK 520
            +HRD+   N LV+  GVVK++DFG+++++   +   S+ GS +   W  PE++M     
Sbjct: 125 FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSV-GSKFPVRWSPPEVLMYSKFS 183
Query: 521 GKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEY------EGAAAMFKVMRDTPAIPDSLS 573
            KS       DIW+ G  + E+Y+ GK P+  +      E  A   ++ R     P   S
Sbjct: 184 SKS-------DIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYR-----PHLAS 231
Query: 574 PEGKDFLRCCFQRNPADRPPASLLL 598
            +    +  C+     +RP   +LL
Sbjct: 232 EKVYTIMYSCWHEKADERPTFKILL 256

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 89.4 bits (220), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 64/258 (24%), Positives = 119/258 (46%), Gaps = 26/258 (10%)
Query: 348 IGRGTFGSVYVA--SNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIV 405
           +G G FG V++   +     A+ ++K+  + PD             E  ++  L+H  +V
Sbjct: 27  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD---------AFLAEANLMKQLQHQRLV 77
Query: 406 QYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGA-ITESVVRNFTRHILSGLAYLHSKKT 464
           + Y   + ++  YI  EY+  GS+  +++   G  +T + + +    I  G+A++  +  
Sbjct: 78  RLYAV-VTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNY 136
Query: 465 IHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPY---WMAPELMMAVMQKG 521
           IHRD++ AN+LV  +   K+ADFG+A+ L       + +G+ +   W APE +       
Sbjct: 137 IHRDLRAANILVSDTLSCKIADFGLAR-LIEDNEXTAREGAKFPIKWTAPEAI------- 188
Query: 522 KSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFKVMRDTPAI-PDSLSPEGKDF 579
                 +  D+WS G  + E+ T G+ P+        +  + R    + PD+   E    
Sbjct: 189 NYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQL 248
Query: 580 LRCCFQRNPADRPPASLL 597
           +R C++  P DRP    L
Sbjct: 249 MRLCWKERPEDRPTFDYL 266

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 89.0 bits (219), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 79/305 (25%), Positives = 136/305 (44%), Gaps = 58/305 (19%)
Query: 336 LPMNSQWQK-------GKLIGRGTFGSVYVAS---------NRETGALCAMKEVDIFPDD 379
           LP + +W+        GK +G G FG V +A          NR T     M + D    D
Sbjct: 17  LPEDPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKD 76
Query: 380 PKSAESIKQLEQEIKVLSHL-KHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVR---- 434
                 +  L  E++++  + KH NI+   G+   +   Y+ +EY   G++ +Y++    
Sbjct: 77  ------LSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRP 130
Query: 435 ---EHC--------GAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVK 483
              E+           ++   + +    +  G+ YL SKK IHRD+   N+LV    V+K
Sbjct: 131 PGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMK 190
Query: 484 LADFGMAK---HLTGQKADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTII 540
           +ADFG+A+   H+   K   + +    WMAPE +   +   +S       D+WS G  + 
Sbjct: 191 IADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQS-------DVWSFGVLLW 243
Query: 541 EMYT--GKPPWSEYEG--AAAMFKVMRDTPAI--PDSLSPEGKDFLRCCFQRNPADRPPA 594
           E++T  G P    Y G     +FK++++   +  P + + E    +R C+   P+ RP  
Sbjct: 244 EIFTLGGSP----YPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTF 299
Query: 595 SLLLE 599
             L+E
Sbjct: 300 KQLVE 304

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 89.0 bits (219), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 82/312 (26%), Positives = 141/312 (45%), Gaps = 44/312 (14%)
Query: 334 EPLPMN-SQWQ-------KGKLIGRGTFGSVYVAS--NRETGALCAMKEVDIFPDDPKSA 383
           E LP + S+W+        GK +GRG FG V  A     +  A C    V +  +    +
Sbjct: 14  ERLPYDASKWEFPRDRLNLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS 73
Query: 384 ESIKQLEQEIKVLSHL-KHPNIVQYYGSEIVEDK-FYIYLEYVHPGSINKYVREHCGAIT 441
           E  + L  E+K+L H+  H N+V   G+         + +E+   G+++ Y+R       
Sbjct: 74  EH-RALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFV 132
Query: 442 -----ESVVRNFT--RHILS-------GLAYLHSKKTIHRDIKGANLLVDASGVVKLADF 487
                E + ++F    H++        G+ +L S+K IHRD+   N+L+    VVK+ DF
Sbjct: 133 PYKTPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDF 192
Query: 488 GMAKHLTGQKADLSMKGSP----YWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMY 543
           G+A+ +  +  D   KG       WMAPE +   +   +S       D+WS G  + E++
Sbjct: 193 GLARDIX-KDPDXVRKGDARLPLKWMAPETIFDRVYTIQS-------DVWSFGVLLWEIF 244
Query: 544 T-GKPPWSEYEGAAAMFKVMRDTPAI--PDSLSPEGKDFLRCCFQRNPADRPPASLLLEH 600
           + G  P+   +      + +++   +  PD  +PE    +  C+   P+ RP  S L+EH
Sbjct: 245 SLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 304
Query: 601 --RFLKNSQQPD 610
               L+ + Q D
Sbjct: 305 LGNLLQANAQQD 316

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 89.0 bits (219), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 78/309 (25%), Positives = 138/309 (44%), Gaps = 41/309 (13%)
Query: 333 PEPLPMNSQW-------QKGKLIGRGTFGSVYVASNRETGALCAMKEVDI-FPDDPKSAE 384
           P  LP N +W       Q GK +G G FG V  A+    G   A+ +V +        A+
Sbjct: 32  PTQLPYNEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHAD 91
Query: 385 SIKQLEQEIKVLSHL-KHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVR-------EH 436
             + L  E+K++SHL +H NIV   G+        +  EY   G +  ++R       E+
Sbjct: 92  EKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKRPPGLEY 151
Query: 437 C--------GAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFG 488
                      ++   + +F+  +  G+A+L SK  IHRD+   N+L+    V K+ DFG
Sbjct: 152 SYNPSHNPEEQLSSRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFG 211
Query: 489 MAKHLTGQKADLSMKGSP----YWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT 544
           +A+ +    ++  +KG+      WMAPE +   +   +S       D+WS G  + E+++
Sbjct: 212 LARDIM-NDSNYIVKGNARLPVKWMAPESIFDCVYTVQS-------DVWSYGILLWEIFS 263
Query: 545 -GKPPWSEYEGAAAMFKVMRDTPAIPD-SLSPEG-KDFLRCCFQRNPADRPPASLLLEHR 601
            G  P+      +  +K+++D   +   + +P+     ++ C+   P  RP    +    
Sbjct: 264 LGLNPYPGILVNSKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICS-- 321
Query: 602 FLKNSQQPD 610
           FL+   Q D
Sbjct: 322 FLQEQAQED 330

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 89.0 bits (219), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 75/274 (27%), Positives = 128/274 (46%), Gaps = 33/274 (12%)
Query: 348 IGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQY 407
           +G+G FG V++ +   T  + A+K +      P++        QE +V+  L+H  +VQ 
Sbjct: 26  LGQGCFGEVWMGTWNGTTRV-AIKTLKPGTMSPEA------FLQEAQVMKKLRHEKLVQL 78
Query: 408 YGSEIVEDKFYIYLEYVHPGSINKYVREHCGA-ITESVVRNFTRHILSGLAYLHSKKTIH 466
           Y   + E+  YI  EY+  G +  +++   G  +    + +    I SG+AY+     +H
Sbjct: 79  YAV-VSEEPIYIVTEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVH 137
Query: 467 RDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPY---WMAPELMMAVMQKGKS 523
           RD++ AN+LV  + V K+ADFG+A+ L       + +G+ +   W APE  +      KS
Sbjct: 138 RDLRAANILVGENLVCKVADFGLAR-LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 196
Query: 524 SDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFKVMRDT-----PAIPDSLSPEGK 577
                  D+WS G  + E+ T G+ P+        + +V R       P  P+SL     
Sbjct: 197 -------DVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLH---- 245
Query: 578 DFLRCCFQRNPADRPPASLL---LEHRFLKNSQQ 608
           D +  C++++P +RP    L   LE  F     Q
Sbjct: 246 DLMCQCWRKDPEERPTFEYLQAFLEDYFTSTEPQ 279

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 89.0 bits (219), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 64/258 (24%), Positives = 119/258 (46%), Gaps = 26/258 (10%)
Query: 348 IGRGTFGSVYVA--SNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIV 405
           +G G FG V++   +     A+ ++K+  + PD             E  ++  L+H  +V
Sbjct: 21  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD---------AFLAEANLMKQLQHQRLV 71
Query: 406 QYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGA-ITESVVRNFTRHILSGLAYLHSKKT 464
           + Y   + ++  YI  EY+  GS+  +++   G  +T + + +    I  G+A++  +  
Sbjct: 72  RLYAV-VTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNY 130
Query: 465 IHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPY---WMAPELMMAVMQKG 521
           IHRD++ AN+LV  +   K+ADFG+A+ L       + +G+ +   W APE +       
Sbjct: 131 IHRDLRAANILVSDTLSCKIADFGLAR-LIEDNEXTAREGAKFPIKWTAPEAI------- 182
Query: 522 KSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFKVMRDTPAI-PDSLSPEGKDF 579
                 +  D+WS G  + E+ T G+ P+        +  + R    + PD+   E    
Sbjct: 183 NYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQL 242
Query: 580 LRCCFQRNPADRPPASLL 597
           +R C++  P DRP    L
Sbjct: 243 MRLCWKERPEDRPTFDYL 260

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 89.0 bits (219), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 64/258 (24%), Positives = 119/258 (46%), Gaps = 26/258 (10%)
Query: 348 IGRGTFGSVYVA--SNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIV 405
           +G G FG V++   +     A+ ++K+  + PD             E  ++  L+H  +V
Sbjct: 23  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD---------AFLAEANLMKQLQHQRLV 73
Query: 406 QYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGA-ITESVVRNFTRHILSGLAYLHSKKT 464
           + Y   + ++  YI  EY+  GS+  +++   G  +T + + +    I  G+A++  +  
Sbjct: 74  RLYAV-VTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNY 132
Query: 465 IHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPY---WMAPELMMAVMQKG 521
           IHRD++ AN+LV  +   K+ADFG+A+ L       + +G+ +   W APE +       
Sbjct: 133 IHRDLRAANILVSDTLSCKIADFGLAR-LIEDNEXTAREGAKFPIKWTAPEAI------- 184
Query: 522 KSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFKVMRDTPAI-PDSLSPEGKDF 579
                 +  D+WS G  + E+ T G+ P+        +  + R    + PD+   E    
Sbjct: 185 NYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQL 244
Query: 580 LRCCFQRNPADRPPASLL 597
           +R C++  P DRP    L
Sbjct: 245 MRLCWKERPEDRPTFDYL 262

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 78/305 (25%), Positives = 137/305 (44%), Gaps = 58/305 (19%)
Query: 336 LPMNSQWQK-------GKLIGRGTFGSVYVAS---------NRETGALCAMKEVDIFPDD 379
           LP + +W+        GK +G G FG V +A          NR T     M + D     
Sbjct: 58  LPEDPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD----- 112
Query: 380 PKSAESIKQLEQEIKVLSHL-KHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVR---- 434
             + + +  L  E++++  + KH NI+   G+   +   Y+ +EY   G++ +Y++    
Sbjct: 113 -ATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRP 171
Query: 435 ---EHC--------GAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVK 483
              E+           ++   + +    +  G+ YL SKK IHRD+   N+LV    V+K
Sbjct: 172 PGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMK 231
Query: 484 LADFGMAK---HLTGQKADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTII 540
           +ADFG+A+   H+   K   + +    WMAPE +   +   +S       D+WS G  + 
Sbjct: 232 IADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQS-------DVWSFGVLLW 284
Query: 541 EMYT--GKPPWSEYEG--AAAMFKVMRDTPAI--PDSLSPEGKDFLRCCFQRNPADRPPA 594
           E++T  G P    Y G     +FK++++   +  P + + E    +R C+   P+ RP  
Sbjct: 285 EIFTLGGSP----YPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTF 340
Query: 595 SLLLE 599
             L+E
Sbjct: 341 KQLVE 345

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 72/265 (27%), Positives = 119/265 (44%), Gaps = 34/265 (12%)
Query: 346 KLIGRGTFGSVYVASNRETG--ALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPN 403
           K +G G FG V     R     A+  +KE  +  D         +  +E KV+ +L H  
Sbjct: 21  KELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED---------EFIEEAKVMMNLSHEK 71
Query: 404 IVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKK 463
           +VQ YG    +   +I  EY+  G +  Y+RE         +    + +   + YL SK+
Sbjct: 72  LVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ 131
Query: 464 TIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPY---WMAPELMMAVMQK 520
            +HRD+   N LV+  GVVK++DFG+++++   +   S+ GS +   W  PE++M     
Sbjct: 132 FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSV-GSKFPVRWSPPEVLMYSKFS 190
Query: 521 GKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEY------EGAAAMFKVMRDTPAIPDSLS 573
            KS       DIW+ G  + E+Y+ GK P+  +      E  A   ++ R     P   S
Sbjct: 191 SKS-------DIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYR-----PHLAS 238
Query: 574 PEGKDFLRCCFQRNPADRPPASLLL 598
            +    +  C+     +RP   +LL
Sbjct: 239 EKVYTIMYSCWHEKADERPTFKILL 263

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 71/263 (26%), Positives = 120/263 (45%), Gaps = 30/263 (11%)
Query: 346 KLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIV 405
           K +G G FG V     R    + A+K +       + + S  +  +E KV+ +L H  +V
Sbjct: 15  KELGTGQFGVVKYGKWRGQYDV-AIKMI------KEGSMSEDEFIEEAKVMMNLSHEKLV 67
Query: 406 QYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTI 465
           Q YG    +   +I  EY+  G +  Y+RE         +    + +   + YL SK+ +
Sbjct: 68  QLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFL 127
Query: 466 HRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPY---WMAPELMMAVMQKGK 522
           HRD+   N LV+  GVVK++DFG+++++   +   S+ GS +   W  PE++M      K
Sbjct: 128 HRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSV-GSKFPVRWSPPEVLMYSKFSSK 186
Query: 523 SSDSALAVDIWSLGCTIIEMYT-GKPPWSEY------EGAAAMFKVMRDTPAIPDSLSPE 575
           S       DIW+ G  + E+Y+ GK P+  +      E  A   ++ R     P   S +
Sbjct: 187 S-------DIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYR-----PHLASEK 234
Query: 576 GKDFLRCCFQRNPADRPPASLLL 598
               +  C+     +RP   +LL
Sbjct: 235 VYTIMYSCWHEKADERPTFKILL 257

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 69/279 (24%), Positives = 132/279 (47%), Gaps = 24/279 (8%)
Query: 335 PLPMNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQ--- 391
           P   +++ +  K IG+G FG V+     +  ++ A+K + I  D     E I++ ++   
Sbjct: 14  PTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSL-ILGDSEGETEMIEKFQEFQR 72
Query: 392 EIKVLSHLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRH 451
           E+ ++S+L HPNIV+ YG  ++ +   + +E+V  G +   + +    I  SV       
Sbjct: 73  EVFIMSNLNHPNIVKLYG--LMHNPPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLD 130
Query: 452 ILSGLAYLHSKK--TIHRDIKGANLLV-----DASGVVKLADFGMAKHLTGQKADLSMKG 504
           I  G+ Y+ ++    +HRD++  N+ +     +A    K+ADFG ++      + L   G
Sbjct: 131 IALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGTSQQSVHSVSGLL--G 188
Query: 505 SPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYE-GAAAMFKVMR 563
           +  WMAPE + A     +        D +S    +  + TG+ P+ EY  G      ++R
Sbjct: 189 NFQWMAPETIGA-----EEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIR 243
Query: 564 DT---PAIPDSLSPEGKDFLRCCFQRNPADRPPASLLLE 599
           +    P IP+   P  ++ +  C+  +P  RP  S +++
Sbjct: 244 EEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVK 282

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 72/264 (27%), Positives = 124/264 (46%), Gaps = 33/264 (12%)
Query: 346 KLIGRGTFGSVYVA--SNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPN 403
           K +G G FG V++   +N    A+  +K        P +  S++   +E  ++  L+H  
Sbjct: 19  KRLGAGQFGEVWMGYYNNSTKVAVKTLK--------PGTM-SVQAFLEEANLMKTLQHDK 69
Query: 404 IVQYYGSEIVEDKFYIYLEYVHPGSINKYVR-EHCGAITESVVRNFTRHILSGLAYLHSK 462
           +V+ Y     E+  YI  EY+  GS+  +++ +  G +    + +F+  I  G+AY+  K
Sbjct: 70  LVRLYAVVTREEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERK 129
Query: 463 KTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPY---WMAPELMMAVMQ 519
             IHRD++ AN+LV  S + K+ADFG+A+ +   +   + +G+ +   W APE +     
Sbjct: 130 NYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYT-AREGAKFPIKWTAPEAINFGCF 188
Query: 520 KGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFKV-----MRDTPAIPDSLS 573
             KS       D+WS G  + E+ T GK P+     A  M  +     M      PD L 
Sbjct: 189 TIKS-------DVWSFGILLYEIVTYGKIPYPGRTNADVMTALSQGYRMPRVENCPDELY 241
Query: 574 PEGKDFLRCCFQRNPADRPPASLL 597
               D ++ C++    +RP    L
Sbjct: 242 ----DIMKMCWKEKAEERPTFDYL 261

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 64/258 (24%), Positives = 119/258 (46%), Gaps = 26/258 (10%)
Query: 348 IGRGTFGSVYVA--SNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIV 405
           +G G FG V++   +     A+ ++K+  + PD             E  ++  L+H  +V
Sbjct: 31  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD---------AFLAEANLMKQLQHQRLV 81
Query: 406 QYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGA-ITESVVRNFTRHILSGLAYLHSKKT 464
           + Y   + ++  YI  EY+  GS+  +++   G  +T + + +    I  G+A++  +  
Sbjct: 82  RLYAV-VTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNY 140
Query: 465 IHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPY---WMAPELMMAVMQKG 521
           IHRD++ AN+LV  +   K+ADFG+A+ L       + +G+ +   W APE +       
Sbjct: 141 IHRDLRAANILVSDTLSCKIADFGLAR-LIEDNEYTAREGAKFPIKWTAPEAI------- 192
Query: 522 KSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFKVMRDTPAI-PDSLSPEGKDF 579
                 +  D+WS G  + E+ T G+ P+        +  + R    + PD+   E    
Sbjct: 193 NYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQL 252
Query: 580 LRCCFQRNPADRPPASLL 597
           +R C++  P DRP    L
Sbjct: 253 MRLCWKERPEDRPTFDYL 270

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 64/258 (24%), Positives = 119/258 (46%), Gaps = 26/258 (10%)
Query: 348 IGRGTFGSVYVA--SNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIV 405
           +G G FG V++   +     A+ ++K+  + PD             E  ++  L+H  +V
Sbjct: 22  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD---------AFLAEANLMKQLQHQRLV 72
Query: 406 QYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGA-ITESVVRNFTRHILSGLAYLHSKKT 464
           + Y   + ++  YI  EY+  GS+  +++   G  +T + + +    I  G+A++  +  
Sbjct: 73  RLYAV-VTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNY 131
Query: 465 IHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPY---WMAPELMMAVMQKG 521
           IHRD++ AN+LV  +   K+ADFG+A+ L       + +G+ +   W APE +       
Sbjct: 132 IHRDLRAANILVSDTLSCKIADFGLAR-LIEDNEXTAREGAKFPIKWTAPEAI------- 183
Query: 522 KSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFKVMRDTPAI-PDSLSPEGKDF 579
                 +  D+WS G  + E+ T G+ P+        +  + R    + PD+   E    
Sbjct: 184 NYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQL 243
Query: 580 LRCCFQRNPADRPPASLL 597
           +R C++  P DRP    L
Sbjct: 244 MRLCWKERPEDRPTFDYL 261

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 81/313 (25%), Positives = 140/313 (44%), Gaps = 45/313 (14%)
Query: 334 EPLPMN-SQWQ-------KGKLIGRGTFGSVYVAS--NRETGALCAMKEVDIFPDDPKSA 383
           E LP + S+W+        GK +GRG FG V  A     +  A C    V +  +    +
Sbjct: 4   ERLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS 63
Query: 384 ESIKQLEQEIKVLSHL-KHPNIVQYYGSEIVEDK-FYIYLEYVHPGSINKYVREHCGAIT 441
           E  + L  E+K+L H+  H N+V   G+         + +E+   G+++ Y+R       
Sbjct: 64  EH-RALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFV 122
Query: 442 ------ESVVRNF---------TRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLAD 486
                 E + ++F         +  +  G+ +L S+K IHRD+   N+L+    VVK+ D
Sbjct: 123 PYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICD 182
Query: 487 FGMAKHLTGQKADLSMKGSPY----WMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEM 542
           FG+A+ +  +  D   KG       WMAPE +   +   +S       D+WS G  + E+
Sbjct: 183 FGLARDIX-KDPDXVRKGDARLPLKWMAPETIFDRVYTIQS-------DVWSFGVLLWEI 234
Query: 543 YT-GKPPWSEYEGAAAMFKVMRDTPAI--PDSLSPEGKDFLRCCFQRNPADRPPASLLLE 599
           ++ G  P+   +      + +++   +  PD  +PE    +  C+   P+ RP  S L+E
Sbjct: 235 FSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVE 294
Query: 600 H--RFLKNSQQPD 610
           H    L+ + Q D
Sbjct: 295 HLGNLLQANAQQD 307

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 79/311 (25%), Positives = 133/311 (42%), Gaps = 50/311 (16%)
Query: 340 SQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHL 399
           S +++  ++G+G FG V  A N       A+K++        + E +  +  E+ +L+ L
Sbjct: 6   SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKI------RHTEEKLSTILSEVMLLASL 59
Query: 400 KHPNIVQYYGSEIVEDKF-------------YIYLEYVHPGSINKYVR-EHCGAITESVV 445
            H  +V+YY + +    F             +I +EY   G++   +  E+     +   
Sbjct: 60  NHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYW 119
Query: 446 RNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAK-------------- 491
           R F R IL  L+Y+HS+  IHRD+K  N+ +D S  VK+ DFG+AK              
Sbjct: 120 RLF-RQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQ 178
Query: 492 HLTGQKADL-SMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWS 550
           +L G   +L S  G+  ++A E++       +       +D++SLG    EM     P+S
Sbjct: 179 NLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEK------IDMYSLGIIFFEMIY---PFS 229
Query: 551 EYEGAAAMFKVMRDT-----PAIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKN 605
                  + K +R       P   D+     K  +R     +P  RP A  LL   +L  
Sbjct: 230 TGMERVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPV 289
Query: 606 SQQPDVPSCSL 616
             Q +V   +L
Sbjct: 290 KHQDEVIKEAL 300

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 64/242 (26%), Positives = 114/242 (47%), Gaps = 17/242 (7%)
Query: 339 NSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSH 398
           N  W    ++G+G   +V+   +++TG L A+K   +F ++      +    +E +VL  
Sbjct: 8   NHLWLLSDILGQGATANVFRGRHKKTGDLFAIK---VF-NNISFLRPVDVQMREFEVLKK 63
Query: 399 LKHPNIVQYYG--SEIVEDKFYIYLEYVHPGSINKYVREHCGA--ITESVVRNFTRHILS 454
           L H NIV+ +    E       + +E+   GS+   + E   A  + ES      R ++ 
Sbjct: 64  LNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVG 123
Query: 455 GLAYLHSKKTIHRDIKGANLL----VDASGVVKLADFGMAKHLTGQKADLSMKGSPYWMA 510
           G+ +L     +HR+IK  N++     D   V KL DFG A+ L   +  +S+ G+  ++ 
Sbjct: 124 GMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLH 183
Query: 511 PELM-MAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEG----AAAMFKVMRDT 565
           P++   AV++K         VD+WS+G T     TG  P+  +EG       M+K++   
Sbjct: 184 PDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGK 243
Query: 566 PA 567
           P+
Sbjct: 244 PS 245

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 82/326 (25%), Positives = 143/326 (43%), Gaps = 54/326 (16%)
Query: 330 AAKPEPLPMN----------SQWQ-------KGKLIGRGTFGSVYVAS--NRETGALCAM 370
           A  P+ LP++          S+W+        GK +GRG FG V  A     +  A C  
Sbjct: 2   AMDPDELPLDEHCERLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRT 61
Query: 371 KEVDIFPDDPKSAESIKQLEQEIKVLSHL-KHPNIVQYYGSEIVEDK-FYIYLEYVHPGS 428
             V +  +    +E  + L  E+K+L H+  H N+V   G+         + +E+   G+
Sbjct: 62  VAVKMLKEGATHSEH-RALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGN 120
Query: 429 INKYVREHCGAIT------ESVVRNF---------TRHILSGLAYLHSKKTIHRDIKGAN 473
           ++ Y+R             E + ++F         +  +  G+ +L S+K IHRD+   N
Sbjct: 121 LSTYLRSKRNEFVPYKEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARN 180
Query: 474 LLVDASGVVKLADFGMAKHLTGQKADLSMKGSP----YWMAPELMMAVMQKGKSSDSALA 529
           +L+    VVK+ DFG+A+ +  +  D   KG       WMAPE +   +   +S      
Sbjct: 181 ILLSEKNVVKICDFGLARDIY-KDPDYVRKGDARLPLKWMAPETIFDRVYTIQS------ 233
Query: 530 VDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFKVMRDTPAI--PDSLSPEGKDFLRCCFQR 586
            D+WS G  + E+++ G  P+   +      + +++   +  PD  +PE    +  C+  
Sbjct: 234 -DVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHG 292
Query: 587 NPADRPPASLLLEH--RFLKNSQQPD 610
            P+ RP  S L+EH    L+ + Q D
Sbjct: 293 EPSQRPTFSELVEHLGNLLQANAQQD 318

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 64/258 (24%), Positives = 119/258 (46%), Gaps = 26/258 (10%)
Query: 348 IGRGTFGSVYVA--SNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIV 405
           +G G FG V++   +     A+ ++K+  + PD             E  ++  L+H  +V
Sbjct: 21  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD---------AFLAEANLMKQLQHQRLV 71
Query: 406 QYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGA-ITESVVRNFTRHILSGLAYLHSKKT 464
           + Y   + ++  YI  EY+  GS+  +++   G  +T + + +    I  G+A++  +  
Sbjct: 72  RLYAV-VTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNY 130
Query: 465 IHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPY---WMAPELMMAVMQKG 521
           IHRD++ AN+LV  +   K+ADFG+A+ L       + +G+ +   W APE +       
Sbjct: 131 IHRDLRAANILVSDTLSCKIADFGLAR-LIEDNEXTAREGAKFPIKWTAPEAI------- 182
Query: 522 KSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFKVMRDTPAI-PDSLSPEGKDF 579
                 +  D+WS G  + E+ T G+ P+        +  + R    + PD+   E    
Sbjct: 183 NYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQL 242
Query: 580 LRCCFQRNPADRPPASLL 597
           +R C++  P DRP    L
Sbjct: 243 MRLCWKERPEDRPTFDYL 260

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 79/316 (25%), Positives = 138/316 (43%), Gaps = 48/316 (15%)
Query: 333 PEPLPMNSQW-------QKGKLIGRGTFGSVYVASNRETGALCAMKEVDI-FPDDPKSAE 384
           P  LP N +W       Q GK +G G FG V  A+    G   A+ +V +        A+
Sbjct: 17  PTQLPYNEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHAD 76
Query: 385 SIKQLEQEIKVLSHL-KHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAIT-- 441
             + L  E+K++SHL +H NIV   G+        +  EY   G +  ++R    A+   
Sbjct: 77  EKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEAMLGP 136
Query: 442 --------ESV------------VRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGV 481
                   E +            + +F+  +  G+A+L SK  IHRD+   N+L+    V
Sbjct: 137 SLAPGQDPEGLDKEDGRPLELRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHV 196
Query: 482 VKLADFGMAKHLTGQKADLSMKGSP----YWMAPELMMAVMQKGKSSDSALAVDIWSLGC 537
            K+ DFG+A+ +    ++  +KG+      WMAPE +   +   +S       D+WS G 
Sbjct: 197 AKIGDFGLARDIM-NDSNYIVKGNARLPVKWMAPESIFDCVYTVQS-------DVWSYGI 248
Query: 538 TIIEMYT-GKPPWSEYEGAAAMFKVMRDTPAIPD-SLSPEG-KDFLRCCFQRNPADRPPA 594
            + E+++ G  P+      +  +K+++D   +   + +P+     ++ C+   P  RP  
Sbjct: 249 LLWEIFSLGLNPYPGILVNSKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTF 308
Query: 595 SLLLEHRFLKNSQQPD 610
             +    FL+   Q D
Sbjct: 309 QQICS--FLQEQAQED 322

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 67/268 (25%), Positives = 121/268 (45%), Gaps = 18/268 (6%)
Query: 348 IGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQY 407
           +G G FG V+  + R TG   A K    F   P  ++  + + +EI+ +S L+HP +V  
Sbjct: 59  LGTGAFGVVHRVTERATGNNFAAK----FVMTPHESDK-ETVRKEIQTMSVLRHPTLVNL 113
Query: 408 YGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHR 467
           + +   +++  +  E++  G + + V +    ++E     + R +  GL ++H    +H 
Sbjct: 114 HDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHL 173
Query: 468 DIKGANLLVDA--SGVVKLADFGMAKHLTGQKADLSMKGSPYWMAPELMMAVMQKGKSSD 525
           D+K  N++     S  +KL DFG+  HL  +++     G+  + APE+      +GK   
Sbjct: 174 DLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVA-----EGKP-- 226
Query: 526 SALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDS----LSPEGKDFLR 581
                D+WS+G     + +G  P+        +  V      + DS    +S +GKDF+R
Sbjct: 227 VGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIR 286
Query: 582 CCFQRNPADRPPASLLLEHRFLKNSQQP 609
                +P  R      LEH +L     P
Sbjct: 287 KLLLADPNTRMTIHQALEHPWLTPGNAP 314

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 82/313 (26%), Positives = 141/313 (45%), Gaps = 45/313 (14%)
Query: 334 EPLPMN-SQWQ-------KGKLIGRGTFGSVYVAS--NRETGALCAMKEVDIFPDDPKSA 383
           E LP + S+W+        GK +GRG FG V  A     +  A C    V +  +    +
Sbjct: 13  ERLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS 72
Query: 384 ESIKQLEQEIKVLSHL-KHPNIVQYYGSEIVEDK-FYIYLEYVHPGSINKYVREHCGAIT 441
           E  + L  E+K+L H+  H N+V   G+         + +E+   G+++ Y+R       
Sbjct: 73  EH-RALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFV 131
Query: 442 ------ESVVRNFT--RHILS-------GLAYLHSKKTIHRDIKGANLLVDASGVVKLAD 486
                 E + ++F    H++        G+ +L S+K IHRD+   N+L+    VVK+ D
Sbjct: 132 PYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICD 191
Query: 487 FGMAKHLTGQKADLSMKGSP----YWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEM 542
           FG+A+ +  +  D   KG       WMAPE +   +   +S       D+WS G  + E+
Sbjct: 192 FGLARDIX-KDPDXVRKGDARLPLKWMAPETIFDRVYTIQS-------DVWSFGVLLWEI 243
Query: 543 YT-GKPPWSEYEGAAAMFKVMRDTPAI--PDSLSPEGKDFLRCCFQRNPADRPPASLLLE 599
           ++ G  P+   +      + +++   +  PD  +PE    +  C+   P+ RP  S L+E
Sbjct: 244 FSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVE 303
Query: 600 H--RFLKNSQQPD 610
           H    L+ + Q D
Sbjct: 304 HLGNLLQANAQQD 316

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 81/327 (24%), Positives = 143/327 (43%), Gaps = 54/327 (16%)
Query: 329 VAAKPEPLPMN----------SQWQ-------KGKLIGRGTFGSVYVAS--NRETGALCA 369
           +   P+ LP++          S+W+        GK +GRG FG V  A     +  A C 
Sbjct: 36  IVMDPDELPLDEHCERLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCR 95
Query: 370 MKEVDIFPDDPKSAESIKQLEQEIKVLSHL-KHPNIVQYYGSEIVEDK-FYIYLEYVHPG 427
              V +  +    +E  + L  E+K+L H+  H N+V   G+         + +E+   G
Sbjct: 96  TVAVKMLKEGATHSEH-RALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFG 154
Query: 428 SINKYVREHCGAIT------ESVVRNF---------TRHILSGLAYLHSKKTIHRDIKGA 472
           +++ Y+R             E + ++F         +  +  G+ +L S+K IHRD+   
Sbjct: 155 NLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAAR 214
Query: 473 NLLVDASGVVKLADFGMAKHLTGQKADLSMKGSP----YWMAPELMMAVMQKGKSSDSAL 528
           N+L+    VVK+ DFG+A+ +  +  D   KG       WMAPE +   +   +S     
Sbjct: 215 NILLSEKNVVKICDFGLARDIY-KDPDYVRKGDARLPLKWMAPETIFDRVYTIQS----- 268
Query: 529 AVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFKVMRDTPAI--PDSLSPEGKDFLRCCFQ 585
             D+WS G  + E+++ G  P+   +      + +++   +  PD  +PE    +  C+ 
Sbjct: 269 --DVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWH 326
Query: 586 RNPADRPPASLLLEH--RFLKNSQQPD 610
             P+ RP  S L+EH    L+ + Q D
Sbjct: 327 GEPSQRPTFSELVEHLGNLLQANAQQD 353

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 64/258 (24%), Positives = 119/258 (46%), Gaps = 26/258 (10%)
Query: 348 IGRGTFGSVYVA--SNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIV 405
           +G G FG V++   +     A+ ++K+  + PD             E  ++  L+H  +V
Sbjct: 27  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD---------AFLAEANLMKQLQHQRLV 77
Query: 406 QYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGA-ITESVVRNFTRHILSGLAYLHSKKT 464
           + Y   + ++  YI  EY+  GS+  +++   G  +T + + +    I  G+A++  +  
Sbjct: 78  RLYAV-VTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNY 136
Query: 465 IHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPY---WMAPELMMAVMQKG 521
           IHRD++ AN+LV  +   K+ADFG+A+ L       + +G+ +   W APE +       
Sbjct: 137 IHRDLRAANILVSDTLSCKIADFGLAR-LIEDNEYTAREGAKFPIKWTAPEAI------- 188
Query: 522 KSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFKVMRDTPAI-PDSLSPEGKDF 579
                 +  D+WS G  + E+ T G+ P+        +  + R    + PD+   E    
Sbjct: 189 NYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQL 248
Query: 580 LRCCFQRNPADRPPASLL 597
           +R C++  P DRP    L
Sbjct: 249 MRLCWKERPEDRPTFDYL 266

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 64/258 (24%), Positives = 119/258 (46%), Gaps = 26/258 (10%)
Query: 348 IGRGTFGSVYVA--SNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIV 405
           +G G FG V++   +     A+ ++K+  + PD             E  ++  L+H  +V
Sbjct: 26  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD---------AFLAEANLMKQLQHQRLV 76
Query: 406 QYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGA-ITESVVRNFTRHILSGLAYLHSKKT 464
           + Y   + ++  YI  EY+  GS+  +++   G  +T + + +    I  G+A++  +  
Sbjct: 77  RLYAV-VTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNY 135
Query: 465 IHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPY---WMAPELMMAVMQKG 521
           IHRD++ AN+LV  +   K+ADFG+A+ L       + +G+ +   W APE +       
Sbjct: 136 IHRDLRAANILVSDTLSCKIADFGLAR-LIEDNEYTAREGAKFPIKWTAPEAI------- 187
Query: 522 KSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFKVMRDTPAI-PDSLSPEGKDF 579
                 +  D+WS G  + E+ T G+ P+        +  + R    + PD+   E    
Sbjct: 188 NYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQL 247
Query: 580 LRCCFQRNPADRPPASLL 597
           +R C++  P DRP    L
Sbjct: 248 MRLCWKERPEDRPTFDYL 265

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 81/313 (25%), Positives = 140/313 (44%), Gaps = 45/313 (14%)
Query: 334 EPLPMN-SQWQ-------KGKLIGRGTFGSVYVAS--NRETGALCAMKEVDIFPDDPKSA 383
           E LP + S+W+        GK +GRG FG V  A     +  A C    V +  +    +
Sbjct: 13  ERLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS 72
Query: 384 ESIKQLEQEIKVLSHL-KHPNIVQYYGSEIVEDK-FYIYLEYVHPGSINKYVREHCGAIT 441
           E  + L  E+K+L H+  H N+V   G+         + +E+   G+++ Y+R       
Sbjct: 73  EH-RALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFV 131
Query: 442 ------ESVVRNF---------TRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLAD 486
                 E + ++F         +  +  G+ +L S+K IHRD+   N+L+    VVK+ D
Sbjct: 132 PYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICD 191
Query: 487 FGMAKHLTGQKADLSMKGSP----YWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEM 542
           FG+A+ +  +  D   KG       WMAPE +   +   +S       D+WS G  + E+
Sbjct: 192 FGLARDIY-KDPDXVRKGDARLPLKWMAPETIFDRVYTIQS-------DVWSFGVLLWEI 243
Query: 543 YT-GKPPWSEYEGAAAMFKVMRDTPAI--PDSLSPEGKDFLRCCFQRNPADRPPASLLLE 599
           ++ G  P+   +      + +++   +  PD  +PE    +  C+   P+ RP  S L+E
Sbjct: 244 FSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVE 303
Query: 600 H--RFLKNSQQPD 610
           H    L+ + Q D
Sbjct: 304 HLGNLLQANAQQD 316

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 67/268 (25%), Positives = 121/268 (45%), Gaps = 18/268 (6%)
Query: 348 IGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQY 407
           +G G FG V+  + R TG   A K    F   P  ++  + + +EI+ +S L+HP +V  
Sbjct: 165 LGTGAFGVVHRVTERATGNNFAAK----FVMTPHESDK-ETVRKEIQTMSVLRHPTLVNL 219
Query: 408 YGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHR 467
           + +   +++  +  E++  G + + V +    ++E     + R +  GL ++H    +H 
Sbjct: 220 HDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHL 279
Query: 468 DIKGANLLVDA--SGVVKLADFGMAKHLTGQKADLSMKGSPYWMAPELMMAVMQKGKSSD 525
           D+K  N++     S  +KL DFG+  HL  +++     G+  + APE+      +GK   
Sbjct: 280 DLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVA-----EGKP-- 332
Query: 526 SALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDS----LSPEGKDFLR 581
                D+WS+G     + +G  P+        +  V      + DS    +S +GKDF+R
Sbjct: 333 VGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIR 392
Query: 582 CCFQRNPADRPPASLLLEHRFLKNSQQP 609
                +P  R      LEH +L     P
Sbjct: 393 KLLLADPNTRMTIHQALEHPWLTPGNAP 420

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 75/274 (27%), Positives = 127/274 (46%), Gaps = 33/274 (12%)
Query: 348 IGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQY 407
           +G+G FG V++ +   T  + A+K +      P++        QE +V+  L+H  +VQ 
Sbjct: 16  LGQGCFGEVWMGTWNGTTRV-AIKTLKPGTMSPEA------FLQEAQVMKKLRHEKLVQL 68
Query: 408 YGSEIVEDKFYIYLEYVHPGSINKYVREHCGA-ITESVVRNFTRHILSGLAYLHSKKTIH 466
           Y   + E+   I  EY+  GS+  +++   G  +    + +    I SG+AY+     +H
Sbjct: 69  YAV-VSEEPIXIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVH 127
Query: 467 RDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPY---WMAPELMMAVMQKGKS 523
           RD++ AN+LV  + V K+ADFG+A+ L       + +G+ +   W APE  +      KS
Sbjct: 128 RDLRAANILVGENLVCKVADFGLAR-LIEDNEXTARQGAKFPIKWTAPEAALYGRFTIKS 186
Query: 524 SDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFKVMRDT-----PAIPDSLSPEGK 577
                  D+WS G  + E+ T G+ P+        + +V R       P  P+SL     
Sbjct: 187 -------DVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLH---- 235
Query: 578 DFLRCCFQRNPADRPPASLL---LEHRFLKNSQQ 608
           D +  C+++ P +RP    L   LE  F     Q
Sbjct: 236 DLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQ 269

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 81/313 (25%), Positives = 140/313 (44%), Gaps = 45/313 (14%)
Query: 334 EPLPMN-SQWQ-------KGKLIGRGTFGSVYVAS--NRETGALCAMKEVDIFPDDPKSA 383
           E LP + S+W+        GK +GRG FG V  A     +  A C    V +  +    +
Sbjct: 13  ERLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS 72
Query: 384 ESIKQLEQEIKVLSHL-KHPNIVQYYGSEIVEDK-FYIYLEYVHPGSINKYVREHCGAIT 441
           E  + L  E+K+L H+  H N+V   G+         + +E+   G+++ Y+R       
Sbjct: 73  EH-RALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFV 131
Query: 442 ------ESVVRNF---------TRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLAD 486
                 E + ++F         +  +  G+ +L S+K IHRD+   N+L+    VVK+ D
Sbjct: 132 PYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICD 191
Query: 487 FGMAKHLTGQKADLSMKGSP----YWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEM 542
           FG+A+ +  +  D   KG       WMAPE +   +   +S       D+WS G  + E+
Sbjct: 192 FGLARDIY-KDPDYVRKGDARLPLKWMAPETIFDRVYTIQS-------DVWSFGVLLWEI 243
Query: 543 YT-GKPPWSEYEGAAAMFKVMRDTPAI--PDSLSPEGKDFLRCCFQRNPADRPPASLLLE 599
           ++ G  P+   +      + +++   +  PD  +PE    +  C+   P+ RP  S L+E
Sbjct: 244 FSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVE 303
Query: 600 H--RFLKNSQQPD 610
           H    L+ + Q D
Sbjct: 304 HLGNLLQANAQQD 316

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 80/310 (25%), Positives = 142/310 (45%), Gaps = 49/310 (15%)
Query: 327 PQVAAKPE-PLPMNSQWQ-------KGKLIGRGTFGSVYVAS----NRETGALCAMKEVD 374
           P +A   E  LP + +W+        GK +G G FG V +A     +++         V 
Sbjct: 14  PMLAGVSEYELPEDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVK 73
Query: 375 IFPDDPKSAESIKQLEQEIKVLSHL-KHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYV 433
           +  DD  + + +  L  E++++  + KH NI+   G+   +   Y+ + Y   G++ +Y+
Sbjct: 74  MLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVAYASKGNLREYL 132
Query: 434 R-------EHCGAI--------TESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDA 478
           R       E+   I        T   + + T  +  G+ YL S+K IHRD+   N+LV  
Sbjct: 133 RARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTE 192
Query: 479 SGVVKLADFGMAKHLTG---QKADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSL 535
           + V+K+ADFG+A+ +      K   + +    WMAPE +   +   +S       D+WS 
Sbjct: 193 NNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQS-------DVWSF 245
Query: 536 GCTIIEMYT--GKPPWSEYEG--AAAMFKVMRDTPAI--PDSLSPEGKDFLRCCFQRNPA 589
           G  + E++T  G P    Y G     +FK++++   +  P + + E    +R C+   P+
Sbjct: 246 GVLMWEIFTLGGSP----YPGIPVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPS 301
Query: 590 DRPPASLLLE 599
            RP    L+E
Sbjct: 302 QRPTFKQLVE 311

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 64/258 (24%), Positives = 119/258 (46%), Gaps = 26/258 (10%)
Query: 348 IGRGTFGSVYVA--SNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIV 405
           +G G FG V++   +     A+ ++K+  + PD             E  ++  L+H  +V
Sbjct: 16  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD---------AFLAEANLMKQLQHQRLV 66
Query: 406 QYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGA-ITESVVRNFTRHILSGLAYLHSKKT 464
           + Y   + ++  YI  EY+  GS+  +++   G  +T + + +    I  G+A++  +  
Sbjct: 67  RLYAV-VTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNY 125
Query: 465 IHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPY---WMAPELMMAVMQKG 521
           IHRD++ AN+LV  +   K+ADFG+A+ L       + +G+ +   W APE +       
Sbjct: 126 IHRDLRAANILVSDTLSCKIADFGLAR-LIEDNEYTAREGAKFPIKWTAPEAI------- 177
Query: 522 KSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFKVMRDTPAI-PDSLSPEGKDF 579
                 +  D+WS G  + E+ T G+ P+        +  + R    + PD+   E    
Sbjct: 178 NYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQL 237
Query: 580 LRCCFQRNPADRPPASLL 597
           +R C++  P DRP    L
Sbjct: 238 MRLCWKERPEDRPTFDYL 255

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 77/263 (29%), Positives = 122/263 (46%), Gaps = 31/263 (11%)
Query: 348 IGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQY 407
           IG+G FG V +   R  G   A+K +       K+  + +    E  V++ L+H N+VQ 
Sbjct: 14  IGKGEFGDVMLGDYR--GNKVAVKCI-------KNDATAQAFLAEASVMTQLRHSNLVQL 64
Query: 408 YGSEIVEDK--FYIYLEYVHPGSINKYVREHCGAITES-VVRNFTRHILSGLAYLHSKKT 464
            G  IVE+K   YI  EY+  GS+  Y+R    ++     +  F+  +   + YL     
Sbjct: 65  LGV-IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNF 123
Query: 465 IHRDIKGANLLVDASGVVKLADFGMAKHL--TGQKADLSMKGSPYWMAPELMMAVMQKGK 522
           +HRD+   N+LV    V K++DFG+ K    T     L +K    W APE   A+ +K  
Sbjct: 124 VHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVK----WTAPE---ALREKKF 176
Query: 523 SSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFKVMRDTPA-IPDSLSPEGKDFL 580
           S+ S    D+WS G  + E+Y+ G+ P+        + +V +      PD   P   + +
Sbjct: 177 STKS----DVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYEVM 232
Query: 581 RCCFQRNPADRPPASLL---LEH 600
           + C+  + A RP    L   LEH
Sbjct: 233 KNCWHLDAAMRPSFLQLREQLEH 255

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 81/313 (25%), Positives = 139/313 (44%), Gaps = 45/313 (14%)
Query: 334 EPLPMN-SQWQ-------KGKLIGRGTFGSVYVAS--NRETGALCAMKEVDIFPDDPKSA 383
           E LP + S+W+        GK +GRG FG V  A     +  A C    V +  +    +
Sbjct: 4   ERLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS 63
Query: 384 ESIKQLEQEIKVLSHL-KHPNIVQYYGSEIVEDK-FYIYLEYVHPGSINKYVREHCGAIT 441
           E  + L  E+K+L H+  H N+V   G+         +  E+   G+++ Y+R       
Sbjct: 64  EH-RALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFV 122
Query: 442 ------ESVVRNF---------TRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLAD 486
                 E + ++F         +  +  G+ +L S+K IHRD+   N+L+    VVK+ D
Sbjct: 123 PYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICD 182
Query: 487 FGMAKHLTGQKADLSMKGSP----YWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEM 542
           FG+A+ +  +  D   KG       WMAPE +   +   +S       D+WS G  + E+
Sbjct: 183 FGLARDIX-KDPDXVRKGDARLPLKWMAPETIFDRVYTIQS-------DVWSFGVLLWEI 234
Query: 543 YT-GKPPWSEYEGAAAMFKVMRDTPAI--PDSLSPEGKDFLRCCFQRNPADRPPASLLLE 599
           ++ G  P+   +      + +++   +  PD  +PE    +  C+   P+ RP  S L+E
Sbjct: 235 FSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVE 294
Query: 600 H--RFLKNSQQPD 610
           H    L+ + Q D
Sbjct: 295 HLGNLLQANAQQD 307

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 77/263 (29%), Positives = 122/263 (46%), Gaps = 31/263 (11%)
Query: 348 IGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQY 407
           IG+G FG V +   R  G   A+K +       K+  + +    E  V++ L+H N+VQ 
Sbjct: 29  IGKGEFGDVMLGDYR--GNKVAVKCI-------KNDATAQAFLAEASVMTQLRHSNLVQL 79
Query: 408 YGSEIVEDK--FYIYLEYVHPGSINKYVREHCGAITES-VVRNFTRHILSGLAYLHSKKT 464
            G  IVE+K   YI  EY+  GS+  Y+R    ++     +  F+  +   + YL     
Sbjct: 80  LGV-IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNF 138
Query: 465 IHRDIKGANLLVDASGVVKLADFGMAKHL--TGQKADLSMKGSPYWMAPELMMAVMQKGK 522
           +HRD+   N+LV    V K++DFG+ K    T     L +K    W APE   A+ +K  
Sbjct: 139 VHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVK----WTAPE---ALREKKF 191
Query: 523 SSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFKVMRDTPA-IPDSLSPEGKDFL 580
           S+ S    D+WS G  + E+Y+ G+ P+        + +V +      PD   P   + +
Sbjct: 192 STKS----DVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYEVM 247
Query: 581 RCCFQRNPADRPPASLL---LEH 600
           + C+  + A RP    L   LEH
Sbjct: 248 KNCWHLDAAMRPSFLQLREQLEH 270

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 64/258 (24%), Positives = 119/258 (46%), Gaps = 26/258 (10%)
Query: 348 IGRGTFGSVYVA--SNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIV 405
           +G G FG V++   +     A+ ++K+  + PD             E  ++  L+H  +V
Sbjct: 21  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD---------AFLAEANLMKQLQHQRLV 71
Query: 406 QYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGA-ITESVVRNFTRHILSGLAYLHSKKT 464
           + Y   + ++  YI  EY+  GS+  +++   G  +T + + +    I  G+A++  +  
Sbjct: 72  RLYAV-VTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNY 130
Query: 465 IHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPY---WMAPELMMAVMQKG 521
           IHRD++ AN+LV  +   K+ADFG+A+ L       + +G+ +   W APE +       
Sbjct: 131 IHRDLRAANILVSDTLSCKIADFGLAR-LIEDNEYTAREGAKFPIKWTAPEAI------- 182
Query: 522 KSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFKVMRDTPAI-PDSLSPEGKDF 579
                 +  D+WS G  + E+ T G+ P+        +  + R    + PD+   E    
Sbjct: 183 NYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQL 242
Query: 580 LRCCFQRNPADRPPASLL 597
           +R C++  P DRP    L
Sbjct: 243 MRLCWKERPEDRPTFDYL 260

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 65/257 (25%), Positives = 119/257 (46%), Gaps = 20/257 (7%)
Query: 345 GKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNI 404
           G+ IG G+FG+VY    +  G + A+K +++    P+  ++ K    E+ VL   +H NI
Sbjct: 17  GQRIGSGSFGTVY--KGKWHGDV-AVKMLNVTAPTPQQLQAFKN---EVGVLRKTRHVNI 70
Query: 405 VQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKT 464
           + + G    + +  I  ++    S+  ++           + +  R    G+ YLH+K  
Sbjct: 71  LLFMGYS-TKPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSI 129
Query: 465 IHRDIKGANLLVDASGVVKLADFGMA---KHLTGQKADLSMKGSPYWMAPELMMAVMQKG 521
           IHRD+K  N+ +     VK+ DFG+A      +G      + GS  WMAPE    V++  
Sbjct: 130 IHRDLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPE----VIRMQ 185
Query: 522 KSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPD-----SLSPE- 575
            S+  +   D+++ G  + E+ TG+ P+S       + +++      PD     S  P+ 
Sbjct: 186 DSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPKR 245
Query: 576 GKDFLRCCFQRNPADRP 592
            K  +  C ++   +RP
Sbjct: 246 MKRLMAECLKKKRDERP 262

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 80/310 (25%), Positives = 142/310 (45%), Gaps = 49/310 (15%)
Query: 327 PQVAAKPE-PLPMNSQWQ-------KGKLIGRGTFGSVYVAS----NRETGALCAMKEVD 374
           P +A   E  LP + +W+        GK +G G FG V +A     +++         V 
Sbjct: 14  PMLAGVSEYELPEDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVK 73
Query: 375 IFPDDPKSAESIKQLEQEIKVLSHL-KHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYV 433
           +  DD  + + +  L  E++++  + KH NI+   G+   +   Y+ + Y   G++ +Y+
Sbjct: 74  MLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVGYASKGNLREYL 132
Query: 434 R-------EHCGAI--------TESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDA 478
           R       E+   I        T   + + T  +  G+ YL S+K IHRD+   N+LV  
Sbjct: 133 RARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTE 192
Query: 479 SGVVKLADFGMAKHLTG---QKADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSL 535
           + V+K+ADFG+A+ +      K   + +    WMAPE +   +   +S       D+WS 
Sbjct: 193 NNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQS-------DVWSF 245
Query: 536 GCTIIEMYT--GKPPWSEYEG--AAAMFKVMRDTPAI--PDSLSPEGKDFLRCCFQRNPA 589
           G  + E++T  G P    Y G     +FK++++   +  P + + E    +R C+   P+
Sbjct: 246 GVLMWEIFTLGGSP----YPGIPVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPS 301
Query: 590 DRPPASLLLE 599
            RP    L+E
Sbjct: 302 QRPTFKQLVE 311

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 69/292 (23%), Positives = 133/292 (45%), Gaps = 24/292 (8%)
Query: 335 PLPMNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIK 394
           P  ++ +++ G+++G G    V++A +       A+K   +  D  +      +  +E +
Sbjct: 7   PSHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKV--LRADLARDPSFYLRFRREAQ 64
Query: 395 VLSHLKHPNIVQYYGSEIVEDKF----YIYLEYVHPGSINKYVREHCGAITESVVRNFTR 450
             + L HP IV  Y +   E       YI +EYV   ++   V    G +T         
Sbjct: 65  NAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTE-GPMTPKRAIEVIA 123
Query: 451 HILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADL----SMKGSP 506
                L + H    IHRD+K AN+L+ A+  VK+ DFG+A+ +      +    ++ G+ 
Sbjct: 124 DACQALNFSHQNGIIHRDVKPANILISATNAVKVVDFGIARAIADSGNSVXQTAAVIGTA 183
Query: 507 YWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTP 566
            +++PE       +G S D+    D++SLGC + E+ TG+PP++     +  ++ +R+ P
Sbjct: 184 QYLSPE-----QARGDSVDA--RSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDP 236
Query: 567 AIP----DSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLK--NSQQPDVP 612
             P    + LS +    +     +NP +R   +  +    ++  N + P+ P
Sbjct: 237 IPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHNGEPPEAP 288

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 64/257 (24%), Positives = 117/257 (45%), Gaps = 20/257 (7%)
Query: 345 GKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNI 404
           G+ IG G+FG+VY     +     A+K +++    P+  ++ K    E+ VL   +H NI
Sbjct: 29  GQRIGSGSFGTVYKG---KWHGDVAVKMLNVTAPTPQQLQAFKN---EVGVLRKTRHVNI 82
Query: 405 VQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKT 464
           + + G    + +  I  ++    S+  ++           + +  R    G+ YLH+K  
Sbjct: 83  LLFMGYS-TKPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSI 141
Query: 465 IHRDIKGANLLVDASGVVKLADFGMAKH---LTGQKADLSMKGSPYWMAPELMMAVMQKG 521
           IHRD+K  N+ +     VK+ DFG+A      +G      + GS  WMAPE    V++  
Sbjct: 142 IHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPE----VIRMQ 197
Query: 522 KSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPD-----SLSPE- 575
            S+  +   D+++ G  + E+ TG+ P+S       + +++      PD     S  P+ 
Sbjct: 198 DSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPKR 257
Query: 576 GKDFLRCCFQRNPADRP 592
            K  +  C ++   +RP
Sbjct: 258 MKRLMAECLKKKRDERP 274

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 69/279 (24%), Positives = 136/279 (48%), Gaps = 24/279 (8%)
Query: 335 PLPMNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQ--- 391
           P   +++ +  K IG+G FG V+     +  ++ A+K + I  D     E I++ ++   
Sbjct: 14  PTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSL-ILGDSEGETEMIEKFQEFQR 72
Query: 392 EIKVLSHLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRH 451
           E+ ++S+L HPNIV+ YG  ++ +   + +E+V  G +   + +    I  SV       
Sbjct: 73  EVFIMSNLNHPNIVKLYG--LMHNPPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLD 130
Query: 452 ILSGLAYLHSKK--TIHRDIKGANLLV-----DASGVVKLADFGMAKHLTGQKADLSMKG 504
           I  G+ Y+ ++    +HRD++  N+ +     +A    K+ADF +++      + L   G
Sbjct: 131 IALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQQSVHSVSGLL--G 188
Query: 505 SPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYE-GAAAMFKVMR 563
           +  WMAPE + A  ++   ++ A   D +S    +  + TG+ P+ EY  G      ++R
Sbjct: 189 NFQWMAPETIGA--EEESYTEKA---DTYSFAMILYTILTGEGPFDEYSYGKIKFINMIR 243
Query: 564 DT---PAIPDSLSPEGKDFLRCCFQRNPADRPPASLLLE 599
           +    P IP+   P  ++ +  C+  +P  RP  S +++
Sbjct: 244 EEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVK 282

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 87.4 bits (215), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 74/293 (25%), Positives = 125/293 (42%), Gaps = 43/293 (14%)
Query: 334 EPLPMNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDI--------FPDDPKSAES 385
           E  P+ SQ+Q G L+G G FGSVY           A+K V+          P+  +    
Sbjct: 2   EKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPME 61
Query: 386 IKQLEQE-------IKVLSHLKHPNIVQYYGSEIVEDKFYIYLEYVHP-GSINKYVREHC 437
           +  L++        I++L   + P            D F + LE + P   +  ++ E  
Sbjct: 62  VVLLKKVSSGFSGVIRLLDWFERP------------DSFVLILERMEPVQDLFDFITER- 108
Query: 438 GAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDAS-GVVKLADFGMAKHLTGQ 496
           GA+ E + R+F   +L  + + H+   +HRDIK  N+L+D + G +KL DFG    L   
Sbjct: 109 GALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGA-LLKD 167
Query: 497 KADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAA 556
                  G+  +  PE +      G+S+       +WSLG  + +M  G  P+   E   
Sbjct: 168 TVYTDFDGTRVYSPPEWIRYHRYHGRSA------AVWSLGILLYDMVCGDIPFEHDE--- 218
Query: 557 AMFKVMRDTPAIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQP 609
              +++R        +S E +  +R C    P+DRP    +  H ++++   P
Sbjct: 219 ---EIIRGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLP 268

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 87.0 bits (214), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 81/313 (25%), Positives = 139/313 (44%), Gaps = 45/313 (14%)
Query: 334 EPLPMN-SQWQ-------KGKLIGRGTFGSVYVAS--NRETGALCAMKEVDIFPDDPKSA 383
           E LP + S+W+        GK +GRG FG V  A     +  A C    V +  +    +
Sbjct: 4   ERLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS 63
Query: 384 ESIKQLEQEIKVLSHL-KHPNIVQYYGSEIVEDK-FYIYLEYVHPGSINKYVREHCGAIT 441
           E  + L  E+K+L H+  H N+V   G+         +  E+   G+++ Y+R       
Sbjct: 64  EH-RALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFV 122
Query: 442 ------ESVVRNF---------TRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLAD 486
                 E + ++F         +  +  G+ +L S+K IHRD+   N+L+    VVK+ D
Sbjct: 123 PYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICD 182
Query: 487 FGMAKHLTGQKADLSMKGSPY----WMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEM 542
           FG+A+ +  +  D   KG       WMAPE +   +   +S       D+WS G  + E+
Sbjct: 183 FGLARDIY-KDPDYVRKGDARLPLKWMAPETIFDRVYTIQS-------DVWSFGVLLWEI 234
Query: 543 YT-GKPPWSEYEGAAAMFKVMRDTPAI--PDSLSPEGKDFLRCCFQRNPADRPPASLLLE 599
           ++ G  P+   +      + +++   +  PD  +PE    +  C+   P+ RP  S L+E
Sbjct: 235 FSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVE 294
Query: 600 H--RFLKNSQQPD 610
           H    L+ + Q D
Sbjct: 295 HLGNLLQANAQQD 307

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 87.0 bits (214), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 81/313 (25%), Positives = 139/313 (44%), Gaps = 45/313 (14%)
Query: 334 EPLPMN-SQWQ-------KGKLIGRGTFGSVYVAS--NRETGALCAMKEVDIFPDDPKSA 383
           E LP + S+W+        GK +GRG FG V  A     +  A C    V +  +    +
Sbjct: 4   ERLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS 63
Query: 384 ESIKQLEQEIKVLSHL-KHPNIVQYYGSEIVEDK-FYIYLEYVHPGSINKYVREHCGAIT 441
           E  + L  E+K+L H+  H N+V   G+         +  E+   G+++ Y+R       
Sbjct: 64  EH-RALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFV 122
Query: 442 ------ESVVRNF---------TRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLAD 486
                 E + ++F         +  +  G+ +L S+K IHRD+   N+L+    VVK+ D
Sbjct: 123 PYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICD 182
Query: 487 FGMAKHLTGQKADLSMKGSPY----WMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEM 542
           FG+A+ +  +  D   KG       WMAPE +   +   +S       D+WS G  + E+
Sbjct: 183 FGLARDIY-KDPDYVRKGDARLPLKWMAPETIFDRVYTIQS-------DVWSFGVLLWEI 234
Query: 543 YT-GKPPWSEYEGAAAMFKVMRDTPAI--PDSLSPEGKDFLRCCFQRNPADRPPASLLLE 599
           ++ G  P+   +      + +++   +  PD  +PE    +  C+   P+ RP  S L+E
Sbjct: 235 FSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVE 294
Query: 600 H--RFLKNSQQPD 610
           H    L+ + Q D
Sbjct: 295 HLGNLLQANAQQD 307

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score = 87.0 bits (214), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 63/242 (26%), Positives = 113/242 (46%), Gaps = 17/242 (7%)
Query: 339 NSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSH 398
           N  W    ++G+G   +V+   +++TG L A+K   +F ++      +    +E +VL  
Sbjct: 8   NHLWLLSDILGQGATANVFRGRHKKTGDLFAIK---VF-NNISFLRPVDVQMREFEVLKK 63
Query: 399 LKHPNIVQYYG--SEIVEDKFYIYLEYVHPGSINKYVREHCGA--ITESVVRNFTRHILS 454
           L H NIV+ +    E       + +E+   GS+   + E   A  + ES      R ++ 
Sbjct: 64  LNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVG 123
Query: 455 GLAYLHSKKTIHRDIKGANLL----VDASGVVKLADFGMAKHLTGQKADLSMKGSPYWMA 510
           G+ +L     +HR+IK  N++     D   V KL DFG A+ L   +  + + G+  ++ 
Sbjct: 124 GMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVXLYGTEEYLH 183
Query: 511 PELM-MAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEG----AAAMFKVMRDT 565
           P++   AV++K         VD+WS+G T     TG  P+  +EG       M+K++   
Sbjct: 184 PDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGK 243
Query: 566 PA 567
           P+
Sbjct: 244 PS 245

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 87.0 bits (214), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 75/299 (25%), Positives = 127/299 (42%), Gaps = 43/299 (14%)
Query: 328 QVAAKPEPLPMNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDI--------FPDD 379
           ++A   E  P+ SQ+Q G L+G G FGSVY           A+K V+          P+ 
Sbjct: 12  KLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNG 71
Query: 380 PKSAESIKQLEQE-------IKVLSHLKHPNIVQYYGSEIVEDKFYIYLEYVHP-GSINK 431
            +    +  L++        I++L   + P            D F + LE   P   +  
Sbjct: 72  TRVPMEVVLLKKVSSGFSGVIRLLDWFERP------------DSFVLILERPEPVQDLFD 119
Query: 432 YVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDAS-GVVKLADFGMA 490
           ++ E  GA+ E + R+F   +L  + + H+   +HRDIK  N+L+D + G +KL DFG  
Sbjct: 120 FITER-GALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSG 178
Query: 491 KHLTGQKADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWS 550
             L          G+  +  PE +      G+S+       +WSLG  + +M  G  P+ 
Sbjct: 179 A-LLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSA------AVWSLGILLYDMVCGDIPFE 231
Query: 551 EYEGAAAMFKVMRDTPAIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQP 609
             E      +++R        +S E +  +R C    P+DRP    +  H ++++   P
Sbjct: 232 HDE------EIIRGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLP 284

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 87.0 bits (214), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 69/272 (25%), Positives = 124/272 (45%), Gaps = 21/272 (7%)
Query: 330 AAKPEPLPMNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQL 389
           AA    +P + Q   G+ IG G+FG+VY    +  G + A+K +++    P+  ++ K  
Sbjct: 15  AADDWEIP-DGQITVGQRIGSGSFGTVY--KGKWHGDV-AVKMLNVTAPTPQQLQAFKN- 69
Query: 390 EQEIKVLSHLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFT 449
             E+ VL   +H NI+ + G      +  I  ++    S+  ++           + +  
Sbjct: 70  --EVGVLRKTRHVNILLFMGYSTAP-QLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIA 126
Query: 450 RHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKH---LTGQKADLSMKGSP 506
           R    G+ YLH+K  IHRD+K  N+ +     VK+ DFG+A      +G      + GS 
Sbjct: 127 RQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSI 186
Query: 507 YWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTP 566
            WMAPE    V++   S+  +   D+++ G  + E+ TG+ P+S       + +++    
Sbjct: 187 LWMAPE----VIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGS 242
Query: 567 AIPD-----SLSPE-GKDFLRCCFQRNPADRP 592
             PD     S  P+  K  +  C ++   +RP
Sbjct: 243 LSPDLSKVRSNCPKRMKRLMAECLKKKRDERP 274

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 87.0 bits (214), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 75/299 (25%), Positives = 127/299 (42%), Gaps = 43/299 (14%)
Query: 328 QVAAKPEPLPMNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDI--------FPDD 379
           ++A   E  P+ SQ+Q G L+G G FGSVY           A+K V+          P+ 
Sbjct: 24  KLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNG 83
Query: 380 PKSAESIKQLEQE-------IKVLSHLKHPNIVQYYGSEIVEDKFYIYLEYVHP-GSINK 431
            +    +  L++        I++L   + P            D F + LE   P   +  
Sbjct: 84  TRVPMEVVLLKKVSSGFSGVIRLLDWFERP------------DSFVLILERPEPVQDLFD 131
Query: 432 YVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDAS-GVVKLADFGMA 490
           ++ E  GA+ E + R+F   +L  + + H+   +HRDIK  N+L+D + G +KL DFG  
Sbjct: 132 FITER-GALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSG 190
Query: 491 KHLTGQKADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWS 550
             L          G+  +  PE +      G+S+       +WSLG  + +M  G  P+ 
Sbjct: 191 A-LLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSA------AVWSLGILLYDMVCGDIPFE 243
Query: 551 EYEGAAAMFKVMRDTPAIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQP 609
             E      +++R        +S E +  +R C    P+DRP    +  H ++++   P
Sbjct: 244 HDE------EIIRGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLP 296

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 87.0 bits (214), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 75/299 (25%), Positives = 127/299 (42%), Gaps = 43/299 (14%)
Query: 328 QVAAKPEPLPMNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDI--------FPDD 379
           ++A   E  P+ SQ+Q G L+G G FGSVY           A+K V+          P+ 
Sbjct: 11  KLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNG 70
Query: 380 PKSAESIKQLEQE-------IKVLSHLKHPNIVQYYGSEIVEDKFYIYLEYVHP-GSINK 431
            +    +  L++        I++L   + P            D F + LE   P   +  
Sbjct: 71  TRVPMEVVLLKKVSSGFSGVIRLLDWFERP------------DSFVLILERPEPVQDLFD 118
Query: 432 YVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDAS-GVVKLADFGMA 490
           ++ E  GA+ E + R+F   +L  + + H+   +HRDIK  N+L+D + G +KL DFG  
Sbjct: 119 FITER-GALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSG 177
Query: 491 KHLTGQKADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWS 550
             L          G+  +  PE +      G+S+       +WSLG  + +M  G  P+ 
Sbjct: 178 A-LLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSA------AVWSLGILLYDMVCGDIPFE 230
Query: 551 EYEGAAAMFKVMRDTPAIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQP 609
             E      +++R        +S E +  +R C    P+DRP    +  H ++++   P
Sbjct: 231 HDE------EIIRGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLP 283

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 87.0 bits (214), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 81/281 (28%), Positives = 129/281 (45%), Gaps = 38/281 (13%)
Query: 337 PMNSQW----QKGKL---IGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQL 389
           P+ S W    ++ KL   IG+G FG V +   R  G   A+K +       K+  + +  
Sbjct: 2   PLGSGWALNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCI-------KNDATAQAF 52
Query: 390 EQEIKVLSHLKHPNIVQYYGSEIVEDK--FYIYLEYVHPGSINKYVREHCGAITES-VVR 446
             E  V++ L+H N+VQ  G  IVE+K   YI  EY+  GS+  Y+R    ++     + 
Sbjct: 53  LAEASVMTQLRHSNLVQLLGV-IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLL 111
Query: 447 NFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHL--TGQKADLSMKG 504
            F+  +   + YL     +HRD+   N+LV    V K++DFG+ K    T     L +K 
Sbjct: 112 KFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVK- 170
Query: 505 SPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFKVMR 563
              W APE   A+ +   S+ S    D+WS G  + E+Y+ G+ P+        + +V +
Sbjct: 171 ---WTAPE---ALREAAFSTKS----DVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK 220
Query: 564 DTPA-IPDSLSPEGKDFLRCCFQRNPADRPPASLL---LEH 600
                 PD   P   + ++ C+  + A RP    L   LEH
Sbjct: 221 GYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEH 261

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 87.0 bits (214), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 75/299 (25%), Positives = 127/299 (42%), Gaps = 43/299 (14%)
Query: 328 QVAAKPEPLPMNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDI--------FPDD 379
           ++A   E  P+ SQ+Q G L+G G FGSVY           A+K V+          P+ 
Sbjct: 11  KLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNG 70
Query: 380 PKSAESIKQLEQE-------IKVLSHLKHPNIVQYYGSEIVEDKFYIYLEYVHP-GSINK 431
            +    +  L++        I++L   + P            D F + LE   P   +  
Sbjct: 71  TRVPMEVVLLKKVSSGFSGVIRLLDWFERP------------DSFVLILERPEPVQDLFD 118
Query: 432 YVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDAS-GVVKLADFGMA 490
           ++ E  GA+ E + R+F   +L  + + H+   +HRDIK  N+L+D + G +KL DFG  
Sbjct: 119 FITER-GALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSG 177
Query: 491 KHLTGQKADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWS 550
             L          G+  +  PE +      G+S+       +WSLG  + +M  G  P+ 
Sbjct: 178 A-LLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSA------AVWSLGILLYDMVCGDIPFE 230
Query: 551 EYEGAAAMFKVMRDTPAIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQP 609
             E      +++R        +S E +  +R C    P+DRP    +  H ++++   P
Sbjct: 231 HDE------EIIRGQVFFRQRVSXECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLP 283

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 87.0 bits (214), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 75/299 (25%), Positives = 127/299 (42%), Gaps = 43/299 (14%)
Query: 328 QVAAKPEPLPMNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDI--------FPDD 379
           ++A   E  P+ SQ+Q G L+G G FGSVY           A+K V+          P+ 
Sbjct: 31  KLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNG 90
Query: 380 PKSAESIKQLEQE-------IKVLSHLKHPNIVQYYGSEIVEDKFYIYLEYVHP-GSINK 431
            +    +  L++        I++L   + P            D F + LE   P   +  
Sbjct: 91  TRVPMEVVLLKKVSSGFSGVIRLLDWFERP------------DSFVLILERPEPVQDLFD 138
Query: 432 YVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDAS-GVVKLADFGMA 490
           ++ E  GA+ E + R+F   +L  + + H+   +HRDIK  N+L+D + G +KL DFG  
Sbjct: 139 FITER-GALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSG 197
Query: 491 KHLTGQKADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWS 550
             L          G+  +  PE +      G+S+       +WSLG  + +M  G  P+ 
Sbjct: 198 A-LLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSA------AVWSLGILLYDMVCGDIPFE 250
Query: 551 EYEGAAAMFKVMRDTPAIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQP 609
             E      +++R        +S E +  +R C    P+DRP    +  H ++++   P
Sbjct: 251 HDE------EIIRGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLP 303

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score = 87.0 bits (214), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 65/224 (29%), Positives = 107/224 (47%), Gaps = 39/224 (17%)
Query: 347 LIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQ 406
           LIGRG++G VY+A ++ T    A+K+V+   +D       K++ +EI +L+ LK   I++
Sbjct: 33  LIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDC---KRILREITILNRLKSDYIIR 89
Query: 407 YYGSEIVED-----KFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHS 461
            Y   I +D     + YI LE +    + K  +     +TE  ++    ++L G  ++H 
Sbjct: 90  LYDLIIPDDLLKFDELYIVLE-IADSDLKKLFKTPI-FLTEEHIKTILYNLLLGENFIHE 147
Query: 462 KKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQK-----ADLSMKGSP---------- 506
              IHRD+K AN L++    VK+ DFG+A+ +  +K      DL     P          
Sbjct: 148 SGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQ 207
Query: 507 --------YWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEM 542
                   ++ APEL++      KS      +DIWS GC   E+
Sbjct: 208 LTSHVVTRWYRAPELILLQENYTKS------IDIWSTGCIFAEL 245

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 87.0 bits (214), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 75/299 (25%), Positives = 127/299 (42%), Gaps = 43/299 (14%)
Query: 328 QVAAKPEPLPMNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDI--------FPDD 379
           ++A   E  P+ SQ+Q G L+G G FGSVY           A+K V+          P+ 
Sbjct: 39  KLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNG 98
Query: 380 PKSAESIKQLEQE-------IKVLSHLKHPNIVQYYGSEIVEDKFYIYLEYVHP-GSINK 431
            +    +  L++        I++L   + P            D F + LE   P   +  
Sbjct: 99  TRVPMEVVLLKKVSSGFSGVIRLLDWFERP------------DSFVLILERPEPVQDLFD 146
Query: 432 YVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDAS-GVVKLADFGMA 490
           ++ E  GA+ E + R+F   +L  + + H+   +HRDIK  N+L+D + G +KL DFG  
Sbjct: 147 FITER-GALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSG 205
Query: 491 KHLTGQKADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWS 550
             L          G+  +  PE +      G+S+       +WSLG  + +M  G  P+ 
Sbjct: 206 A-LLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSA------AVWSLGILLYDMVCGDIPFE 258
Query: 551 EYEGAAAMFKVMRDTPAIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQP 609
             E      +++R        +S E +  +R C    P+DRP    +  H ++++   P
Sbjct: 259 HDE------EIIRGQVFFRQRVSXECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLP 311

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 87.0 bits (214), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 68/292 (23%), Positives = 132/292 (45%), Gaps = 24/292 (8%)
Query: 335 PLPMNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIK 394
           P  ++ +++ G+++G G    V++A +       A+K   +  D  +      +  +E +
Sbjct: 7   PSHLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKV--LRADLARDPSFYLRFRREAQ 64
Query: 395 VLSHLKHPNIVQYYGSEIVEDKF----YIYLEYVHPGSINKYVREHCGAITESVVRNFTR 450
             + L HP IV  Y +   E       YI +EYV   ++   V    G +T         
Sbjct: 65  NAAALNHPAIVAVYATGEAETPAGPLPYIVMEYVDGVTLRDIVHTE-GPMTPKRAIEVIA 123
Query: 451 HILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMK----GSP 506
                L + H    IHRD+K AN+++ A+  VK+ DFG+A+ +      ++      G+ 
Sbjct: 124 DACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTA 183
Query: 507 YWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTP 566
            +++PE       +G S D+    D++SLGC + E+ TG+PP++     +  ++ +R+ P
Sbjct: 184 QYLSPE-----QARGDSVDA--RSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDP 236
Query: 567 AIP----DSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLK--NSQQPDVP 612
             P    + LS +    +     +NP +R   +  +    ++  N + P+ P
Sbjct: 237 IPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHNGEPPEAP 288

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 86.7 bits (213), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 75/299 (25%), Positives = 127/299 (42%), Gaps = 43/299 (14%)
Query: 328 QVAAKPEPLPMNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDI--------FPDD 379
           ++A   E  P+ SQ+Q G L+G G FGSVY           A+K V+          P+ 
Sbjct: 12  KLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNG 71
Query: 380 PKSAESIKQLEQE-------IKVLSHLKHPNIVQYYGSEIVEDKFYIYLEYVHP-GSINK 431
            +    +  L++        I++L   + P            D F + LE   P   +  
Sbjct: 72  TRVPMEVVLLKKVSSGFSGVIRLLDWFERP------------DSFVLILERPEPVQDLFD 119
Query: 432 YVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDAS-GVVKLADFGMA 490
           ++ E  GA+ E + R+F   +L  + + H+   +HRDIK  N+L+D + G +KL DFG  
Sbjct: 120 FITER-GALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSG 178
Query: 491 KHLTGQKADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWS 550
             L          G+  +  PE +      G+S+       +WSLG  + +M  G  P+ 
Sbjct: 179 A-LLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSA------AVWSLGILLYDMVCGDIPFE 231
Query: 551 EYEGAAAMFKVMRDTPAIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQP 609
             E      +++R        +S E +  +R C    P+DRP    +  H ++++   P
Sbjct: 232 HDE------EIIRGQVFFRQRVSXECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLP 284

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 86.7 bits (213), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 75/299 (25%), Positives = 127/299 (42%), Gaps = 43/299 (14%)
Query: 328 QVAAKPEPLPMNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDI--------FPDD 379
           ++A   E  P+ SQ+Q G L+G G FGSVY           A+K V+          P+ 
Sbjct: 39  KLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNG 98
Query: 380 PKSAESIKQLEQE-------IKVLSHLKHPNIVQYYGSEIVEDKFYIYLEYVHP-GSINK 431
            +    +  L++        I++L   + P            D F + LE   P   +  
Sbjct: 99  TRVPMEVVLLKKVSSGFSGVIRLLDWFERP------------DSFVLILERPEPVQDLFD 146
Query: 432 YVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDAS-GVVKLADFGMA 490
           ++ E  GA+ E + R+F   +L  + + H+   +HRDIK  N+L+D + G +KL DFG  
Sbjct: 147 FITER-GALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSG 205
Query: 491 KHLTGQKADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWS 550
             L          G+  +  PE +      G+S+       +WSLG  + +M  G  P+ 
Sbjct: 206 A-LLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSA------AVWSLGILLYDMVCGDIPFE 258
Query: 551 EYEGAAAMFKVMRDTPAIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQP 609
             E      +++R        +S E +  +R C    P+DRP    +  H ++++   P
Sbjct: 259 HDE------EIIRGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLP 311

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 86.7 bits (213), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 75/299 (25%), Positives = 127/299 (42%), Gaps = 43/299 (14%)
Query: 328 QVAAKPEPLPMNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDI--------FPDD 379
           ++A   E  P+ SQ+Q G L+G G FGSVY           A+K V+          P+ 
Sbjct: 44  KLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNG 103
Query: 380 PKSAESIKQLEQE-------IKVLSHLKHPNIVQYYGSEIVEDKFYIYLEYVHP-GSINK 431
            +    +  L++        I++L   + P            D F + LE   P   +  
Sbjct: 104 TRVPMEVVLLKKVSSGFSGVIRLLDWFERP------------DSFVLILERPEPVQDLFD 151
Query: 432 YVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDAS-GVVKLADFGMA 490
           ++ E  GA+ E + R+F   +L  + + H+   +HRDIK  N+L+D + G +KL DFG  
Sbjct: 152 FITER-GALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSG 210
Query: 491 KHLTGQKADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWS 550
             L          G+  +  PE +      G+S+       +WSLG  + +M  G  P+ 
Sbjct: 211 A-LLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSA------AVWSLGILLYDMVCGDIPFE 263
Query: 551 EYEGAAAMFKVMRDTPAIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQP 609
             E      +++R        +S E +  +R C    P+DRP    +  H ++++   P
Sbjct: 264 HDE------EIIRGQVFFRQRVSXECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLP 316

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 86.7 bits (213), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 76/287 (26%), Positives = 130/287 (45%), Gaps = 25/287 (8%)
Query: 316 GAAVLSPSATIPQVAAKPEPLPMNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDI 375
           GA    P+  + +   +  P  +  Q    K+IG G FG VY    + +      KEV +
Sbjct: 24  GAMGSDPNQAVLKFTTEIHPSCVTRQ----KVIGAGEFGEVYKGMLKTS---SGKKEVPV 76
Query: 376 FPDDPKSAESIKQ---LEQEIKVLSHLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKY 432
                K+  + KQ      E  ++    H NI++  G         I  EY+  G+++K+
Sbjct: 77  AIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKF 136
Query: 433 VREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKH 492
           +RE  G  +   +    R I +G+ YL +   +HRD+   N+LV+++ V K++DFG+++ 
Sbjct: 137 LREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRV 196
Query: 493 LTGQ-KADLSMKGSPY---WMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKP 547
           L    +A  +  G      W APE   A+  +  +S S    D+WS G  + E+ T G+ 
Sbjct: 197 LEDDPEATYTTSGGKIPIRWTAPE---AISYRKFTSAS----DVWSFGIVMWEVMTYGER 249
Query: 548 PWSEYEGAAAMFKVMRDTPAIPDSLSPEGKDF--LRCCFQRNPADRP 592
           P+ E      M K + D   +P  +      +  +  C+Q+  A RP
Sbjct: 250 PYWELSNHEVM-KAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRP 295

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 86.7 bits (213), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 73/297 (24%), Positives = 133/297 (44%), Gaps = 41/297 (13%)
Query: 329 VAAKPEPLPMNSQWQK-------GKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPK 381
           V   P  LP + +W+        GK +G G FG V  A+        A   V +    P 
Sbjct: 5   VYIDPTQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPS 64
Query: 382 SAESIKQ-LEQEIKVLSHL-KHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREH--- 436
           +  + ++ L  E+KVLS+L  H NIV   G+  +     +  EY   G +  ++R     
Sbjct: 65  AHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDS 124
Query: 437 --CGAITESVVR------------NFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVV 482
             C   + +++             +F+  +  G+A+L SK  IHRD+   N+L+    + 
Sbjct: 125 FICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRIT 184
Query: 483 KLADFGMAKHLTGQKADLSMKGSP----YWMAPELMMAVMQKGKSSDSALAVDIWSLGCT 538
           K+ DFG+A+ +    ++  +KG+      WMAPE +   +   +S       D+WS G  
Sbjct: 185 KICDFGLARDIKND-SNYVVKGNARLPVKWMAPESIFNCVYTFES-------DVWSYGIF 236
Query: 539 IIEMYT-GKPPWSEYEGAAAMFKVMRDTPAI--PDSLSPEGKDFLRCCFQRNPADRP 592
           + E+++ G  P+      +  +K++++   +  P+    E  D ++ C+  +P  RP
Sbjct: 237 LWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRP 293

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 86.7 bits (213), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 73/297 (24%), Positives = 133/297 (44%), Gaps = 41/297 (13%)
Query: 329 VAAKPEPLPMNSQWQK-------GKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPK 381
           V   P  LP + +W+        GK +G G FG V  A+        A   V +    P 
Sbjct: 21  VXIDPTQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPS 80
Query: 382 SAESIKQ-LEQEIKVLSHL-KHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREH--- 436
           +  + ++ L  E+KVLS+L  H NIV   G+  +     +  EY   G +  ++R     
Sbjct: 81  AHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDS 140
Query: 437 --CGAITESVVR------------NFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVV 482
             C   + +++             +F+  +  G+A+L SK  IHRD+   N+L+    + 
Sbjct: 141 FICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRIT 200
Query: 483 KLADFGMAKHLTGQKADLSMKGSP----YWMAPELMMAVMQKGKSSDSALAVDIWSLGCT 538
           K+ DFG+A+ +    ++  +KG+      WMAPE +   +   +S       D+WS G  
Sbjct: 201 KICDFGLARDIKND-SNYVVKGNARLPVKWMAPESIFNCVYTFES-------DVWSYGIF 252
Query: 539 IIEMYT-GKPPWSEYEGAAAMFKVMRDTPAI--PDSLSPEGKDFLRCCFQRNPADRP 592
           + E+++ G  P+      +  +K++++   +  P+    E  D ++ C+  +P  RP
Sbjct: 253 LWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRP 309

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 86.3 bits (212), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 63/258 (24%), Positives = 119/258 (46%), Gaps = 26/258 (10%)
Query: 348 IGRGTFGSVYVA--SNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIV 405
           +G G FG V++   +     A+ ++K+  + PD             E  ++  L+H  +V
Sbjct: 17  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD---------AFLAEANLMKQLQHQRLV 67
Query: 406 QYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGA-ITESVVRNFTRHILSGLAYLHSKKT 464
           + Y   + ++  YI  EY+  GS+  +++   G  +T + + +    I  G+A++  +  
Sbjct: 68  RLYAV-VTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNY 126
Query: 465 IHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPY---WMAPELMMAVMQKG 521
           IHR+++ AN+LV  +   K+ADFG+A+ L       + +G+ +   W APE +       
Sbjct: 127 IHRNLRAANILVSDTLSCKIADFGLAR-LIEDNEYTAREGAKFPIKWTAPEAI------- 178
Query: 522 KSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFKVMRDTPAI-PDSLSPEGKDF 579
                 +  D+WS G  + E+ T G+ P+        +  + R    + PD+   E    
Sbjct: 179 NYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQL 238
Query: 580 LRCCFQRNPADRPPASLL 597
           +R C++  P DRP    L
Sbjct: 239 MRLCWKERPEDRPTFDYL 256

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 86.3 bits (212), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 68/292 (23%), Positives = 132/292 (45%), Gaps = 24/292 (8%)
Query: 335 PLPMNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIK 394
           P  ++ +++ G+++G G    V++A +       A+K   +  D  +      +  +E +
Sbjct: 7   PSHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKV--LRADLARDPSFYLRFRREAQ 64
Query: 395 VLSHLKHPNIVQYYGSEIVEDKF----YIYLEYVHPGSINKYVREHCGAITESVVRNFTR 450
             + L HP IV  Y +   E       YI +EYV   ++   V    G +T         
Sbjct: 65  NAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTE-GPMTPKRAIEVIA 123
Query: 451 HILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMK----GSP 506
                L + H    IHRD+K AN+++ A+  VK+ DFG+A+ +      ++      G+ 
Sbjct: 124 DACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTA 183
Query: 507 YWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTP 566
            +++PE       +G S D+    D++SLGC + E+ TG+PP++     +  ++ +R+ P
Sbjct: 184 QYLSPE-----QARGDSVDA--RSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDP 236
Query: 567 AIP----DSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLK--NSQQPDVP 612
             P    + LS +    +     +NP +R   +  +    ++  N + P+ P
Sbjct: 237 IPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHNGEPPEAP 288

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 86.3 bits (212), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 68/292 (23%), Positives = 132/292 (45%), Gaps = 24/292 (8%)
Query: 335 PLPMNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIK 394
           P  ++ +++ G+++G G    V++A +       A+K   +  D  +      +  +E +
Sbjct: 7   PSHLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKV--LRADLARDPSFYLRFRREAQ 64
Query: 395 VLSHLKHPNIVQYYGSEIVEDKF----YIYLEYVHPGSINKYVREHCGAITESVVRNFTR 450
             + L HP IV  Y +   E       YI +EYV   ++   V    G +T         
Sbjct: 65  NAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTE-GPMTPKRAIEVIA 123
Query: 451 HILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMK----GSP 506
                L + H    IHRD+K AN+++ A+  VK+ DFG+A+ +      ++      G+ 
Sbjct: 124 DACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTA 183
Query: 507 YWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTP 566
            +++PE       +G S D+    D++SLGC + E+ TG+PP++     +  ++ +R+ P
Sbjct: 184 QYLSPE-----QARGDSVDA--RSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDP 236
Query: 567 AIP----DSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLK--NSQQPDVP 612
             P    + LS +    +     +NP +R   +  +    ++  N + P+ P
Sbjct: 237 IPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHNGEPPEAP 288

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 86.3 bits (212), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 75/299 (25%), Positives = 126/299 (42%), Gaps = 43/299 (14%)
Query: 328 QVAAKPEPLPMNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDI--------FPDD 379
           ++A   E  P+ SQ+Q G L+G G FGSVY           A+K V+          P+ 
Sbjct: 12  KLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNG 71
Query: 380 PKSAESIKQLEQE-------IKVLSHLKHPNIVQYYGSEIVEDKFYIYLEYVHP-GSINK 431
            +    +  L++        I++L   + P            D F + LE   P   +  
Sbjct: 72  TRVPMEVVLLKKVSSGFSGVIRLLDWFERP------------DSFVLILERPEPVQDLFD 119
Query: 432 YVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDAS-GVVKLADFGMA 490
           ++ E  GA+ E + R+F   +L  + + H+   +HRDIK  N+L+D + G +KL DFG  
Sbjct: 120 FITER-GALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSG 178
Query: 491 KHLTGQKADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWS 550
             L          G+  +  PE +      G+S+       +WSLG  + +M  G  P+ 
Sbjct: 179 A-LLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSA------AVWSLGILLYDMVCGDIPFE 231
Query: 551 EYEGAAAMFKVMRDTPAIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQP 609
             E      +++R        +S E +  +R C    P DRP    +  H ++++   P
Sbjct: 232 HDE------EIIRGQVFFRQRVSXECQHLIRWCLALRPXDRPTFEEIQNHPWMQDVLLP 284

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 86.3 bits (212), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 72/272 (26%), Positives = 125/272 (45%), Gaps = 25/272 (9%)
Query: 346 KLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIV 405
           K +G G FG V++      G      +V I    P +  S +   +E +++  LKH  +V
Sbjct: 15  KRLGNGQFGEVWM------GTWNGNTKVAIKTLKPGTM-SPESFLEEAQIMKKLKHDKLV 67
Query: 406 QYYGSEIVEDKFYIYLEYVHPGSINKYVREHCG-AITESVVRNFTRHILSGLAYLHSKKT 464
           Q Y   + E+  YI  EY++ GS+  ++++  G A+    + +    + +G+AY+     
Sbjct: 68  QLYAV-VSEEPIYIVTEYMNKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNY 126
Query: 465 IHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPY---WMAPELMMAVMQKG 521
           IHRD++ AN+LV    + K+ADFG+A+ L       + +G+ +   W APE  +      
Sbjct: 127 IHRDLRSANILVGNGLICKIADFGLAR-LIEDNEXTARQGAKFPIKWTAPEAALYGRFTI 185
Query: 522 KSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFKVMRDTPA-IPDSLSPEGKDF 579
           KS       D+WS G  + E+ T G+ P+        + +V R      P        + 
Sbjct: 186 KS-------DVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMPCPQDCPISLHEL 238
Query: 580 LRCCFQRNPADRPPASLL---LEHRFLKNSQQ 608
           +  C++++P +RP    L   LE  F     Q
Sbjct: 239 MIHCWKKDPEERPTFEYLQSFLEDYFTATEPQ 270

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score = 86.3 bits (212), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 73/290 (25%), Positives = 123/290 (42%), Gaps = 43/290 (14%)
Query: 337 PMNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDI--------FPDDPKSAESIKQ 388
           P+ SQ+Q G L+G G FGSVY           A+K V+          P+  +    +  
Sbjct: 1   PLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVL 60
Query: 389 LEQE-------IKVLSHLKHPNIVQYYGSEIVEDKFYIYLEYVHP-GSINKYVREHCGAI 440
           L++        I++L   + P            D F + LE   P   +  ++ E  GA+
Sbjct: 61  LKKVSSGFSGVIRLLDWFERP------------DSFVLILERPEPVQDLFDFITER-GAL 107
Query: 441 TESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDAS-GVVKLADFGMAKHLTGQKAD 499
            E + R+F   +L  + + H+   +HRDIK  N+L+D + G +KL DFG    L      
Sbjct: 108 QEELARSFFWQVLEAVRHCHNXGVLHRDIKDENILIDLNRGELKLIDFGSGA-LLKDTVY 166
Query: 500 LSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMF 559
               G+  +  PE +      G+S+       +WSLG  + +M  G  P+   E      
Sbjct: 167 TDFDGTRVYSPPEWIRYHRYHGRSA------AVWSLGILLYDMVCGDIPFEHDE------ 214
Query: 560 KVMRDTPAIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQP 609
           +++R        +S E +  +R C    P+DRP    +  H ++++   P
Sbjct: 215 EIIRGQVFFRQRVSXECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLP 264

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 86.3 bits (212), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 73/297 (24%), Positives = 133/297 (44%), Gaps = 41/297 (13%)
Query: 329 VAAKPEPLPMNSQWQK-------GKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPK 381
           V   P  LP + +W+        GK +G G FG V  A+        A   V +    P 
Sbjct: 28  VYIDPTQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPS 87
Query: 382 SAESIKQ-LEQEIKVLSHL-KHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREH--- 436
           +  + ++ L  E+KVLS+L  H NIV   G+  +     +  EY   G +  ++R     
Sbjct: 88  AHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDS 147
Query: 437 --CGAITESVVR------------NFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVV 482
             C   + +++             +F+  +  G+A+L SK  IHRD+   N+L+    + 
Sbjct: 148 FICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRIT 207
Query: 483 KLADFGMAKHLTGQKADLSMKGSP----YWMAPELMMAVMQKGKSSDSALAVDIWSLGCT 538
           K+ DFG+A+ +    ++  +KG+      WMAPE +   +   +S       D+WS G  
Sbjct: 208 KICDFGLARDIKND-SNYVVKGNARLPVKWMAPESIFNCVYTFES-------DVWSYGIF 259
Query: 539 IIEMYT-GKPPWSEYEGAAAMFKVMRDTPAI--PDSLSPEGKDFLRCCFQRNPADRP 592
           + E+++ G  P+      +  +K++++   +  P+    E  D ++ C+  +P  RP
Sbjct: 260 LWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRP 316

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 85.9 bits (211), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 74/293 (25%), Positives = 124/293 (42%), Gaps = 43/293 (14%)
Query: 334 EPLPMNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDI--------FPDDPKSAES 385
           E  P+ SQ+Q G L+G G FGSVY           A+K V+          P+  +    
Sbjct: 2   EKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPME 61
Query: 386 IKQLEQE-------IKVLSHLKHPNIVQYYGSEIVEDKFYIYLEYVHP-GSINKYVREHC 437
           +  L++        I++L   + P            D F + LE   P   +  ++ E  
Sbjct: 62  VVLLKKVSSGFSGVIRLLDWFERP------------DSFVLILERPEPVQDLFDFITER- 108
Query: 438 GAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDAS-GVVKLADFGMAKHLTGQ 496
           GA+ E + R+F   +L  + + H+   +HRDIK  N+L+D + G +KL DFG    L   
Sbjct: 109 GALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGA-LLKD 167
Query: 497 KADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAA 556
                  G+  +  PE +      G+S+       +WSLG  + +M  G  P+   E   
Sbjct: 168 TVYTDFDGTRVYSPPEWIRYHRYHGRSA------AVWSLGILLYDMVCGDIPFEHDE--- 218
Query: 557 AMFKVMRDTPAIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQP 609
              +++R        +S E +  +R C    P+DRP    +  H ++++   P
Sbjct: 219 ---EIIRGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLP 268

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 85.9 bits (211), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 73/297 (24%), Positives = 133/297 (44%), Gaps = 41/297 (13%)
Query: 329 VAAKPEPLPMNSQWQK-------GKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPK 381
           V   P  LP + +W+        GK +G G FG V  A+        A   V +    P 
Sbjct: 23  VYIDPTQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPS 82
Query: 382 SAESIKQ-LEQEIKVLSHL-KHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREH--- 436
           +  + ++ L  E+KVLS+L  H NIV   G+  +     +  EY   G +  ++R     
Sbjct: 83  AHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDS 142
Query: 437 --CGAITESVVR------------NFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVV 482
             C   + +++             +F+  +  G+A+L SK  IHRD+   N+L+    + 
Sbjct: 143 FICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRIT 202
Query: 483 KLADFGMAKHLTGQKADLSMKGSP----YWMAPELMMAVMQKGKSSDSALAVDIWSLGCT 538
           K+ DFG+A+ +    ++  +KG+      WMAPE +   +   +S       D+WS G  
Sbjct: 203 KICDFGLARDIKND-SNYVVKGNARLPVKWMAPESIFNCVYTFES-------DVWSYGIF 254
Query: 539 IIEMYT-GKPPWSEYEGAAAMFKVMRDTPAI--PDSLSPEGKDFLRCCFQRNPADRP 592
           + E+++ G  P+      +  +K++++   +  P+    E  D ++ C+  +P  RP
Sbjct: 255 LWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRP 311

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 85.9 bits (211), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 66/278 (23%), Positives = 127/278 (45%), Gaps = 22/278 (7%)
Query: 326 IPQVAAKPEPLPMNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAES 385
           +P+ +    P  ++ +++ G+++G G    V++A +       A+K   +  D  +    
Sbjct: 15  VPRGSHMTTPSHLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKV--LRADLARDPSF 72
Query: 386 IKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKF----YIYLEYVHPGSINKYVREHCGAIT 441
             +  +E +  + L HP IV  Y +   E       YI +EYV   ++   V    G +T
Sbjct: 73  YLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTE-GPMT 131
Query: 442 ESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLS 501
                         L + H    IHRD+K AN+++ A+  VK+ DFG+A+ +      ++
Sbjct: 132 PKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVT 191
Query: 502 MK----GSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAA 557
                 G+  +++PE       +G S D+    D++SLGC + E+ TG+PP++     + 
Sbjct: 192 QTAAVIGTAQYLSPE-----QARGDSVDA--RSDVYSLGCVLYEVLTGEPPFTGDSPVSV 244
Query: 558 MFKVMRDTPAIP----DSLSPEGKDFLRCCFQRNPADR 591
            ++ +R+ P  P    + LS +    +     +NP +R
Sbjct: 245 AYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENR 282

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 85.9 bits (211), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 74/293 (25%), Positives = 124/293 (42%), Gaps = 43/293 (14%)
Query: 334 EPLPMNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDI--------FPDDPKSAES 385
           E  P+ SQ+Q G L+G G FGSVY           A+K V+          P+  +    
Sbjct: 3   EKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPME 62
Query: 386 IKQLEQE-------IKVLSHLKHPNIVQYYGSEIVEDKFYIYLEYVHP-GSINKYVREHC 437
           +  L++        I++L   + P            D F + LE   P   +  ++ E  
Sbjct: 63  VVLLKKVSSGFSGVIRLLDWFERP------------DSFVLILERPEPVQDLFDFITER- 109
Query: 438 GAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDAS-GVVKLADFGMAKHLTGQ 496
           GA+ E + R+F   +L  + + H+   +HRDIK  N+L+D + G +KL DFG    L   
Sbjct: 110 GALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGA-LLKD 168
Query: 497 KADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAA 556
                  G+  +  PE +      G+S+       +WSLG  + +M  G  P+   E   
Sbjct: 169 TVYTDFDGTRVYSPPEWIRYHRYHGRSA------AVWSLGILLYDMVCGDIPFEHDE--- 219
Query: 557 AMFKVMRDTPAIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQP 609
              +++R        +S E +  +R C    P+DRP    +  H ++++   P
Sbjct: 220 ---EIIRGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLP 269

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 85.9 bits (211), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 74/293 (25%), Positives = 124/293 (42%), Gaps = 43/293 (14%)
Query: 334 EPLPMNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDI--------FPDDPKSAES 385
           E  P+ SQ+Q G L+G G FGSVY           A+K V+          P+  +    
Sbjct: 3   EKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPME 62
Query: 386 IKQLEQE-------IKVLSHLKHPNIVQYYGSEIVEDKFYIYLEYVHP-GSINKYVREHC 437
           +  L++        I++L   + P            D F + LE   P   +  ++ E  
Sbjct: 63  VVLLKKVSSGFSGVIRLLDWFERP------------DSFVLILERPEPVQDLFDFITER- 109
Query: 438 GAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDAS-GVVKLADFGMAKHLTGQ 496
           GA+ E + R+F   +L  + + H+   +HRDIK  N+L+D + G +KL DFG    L   
Sbjct: 110 GALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGA-LLKD 168
Query: 497 KADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAA 556
                  G+  +  PE +      G+S+       +WSLG  + +M  G  P+   E   
Sbjct: 169 TVYTDFDGTRVYSPPEWIRYHRYHGRSA------AVWSLGILLYDMVCGDIPFEHDE--- 219
Query: 557 AMFKVMRDTPAIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQP 609
              +++R        +S E +  +R C    P+DRP    +  H ++++   P
Sbjct: 220 ---EIIRGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLP 269

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 85.5 bits (210), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 74/293 (25%), Positives = 124/293 (42%), Gaps = 43/293 (14%)
Query: 334 EPLPMNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDI--------FPDDPKSAES 385
           E  P+ SQ+Q G L+G G FGSVY           A+K V+          P+  +    
Sbjct: 3   EKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPME 62
Query: 386 IKQLEQE-------IKVLSHLKHPNIVQYYGSEIVEDKFYIYLEYVHP-GSINKYVREHC 437
           +  L++        I++L   + P            D F + LE   P   +  ++ E  
Sbjct: 63  VVLLKKVSSGFSGVIRLLDWFERP------------DSFVLILERPEPVQDLFDFITER- 109
Query: 438 GAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDAS-GVVKLADFGMAKHLTGQ 496
           GA+ E + R+F   +L  + + H+   +HRDIK  N+L+D + G +KL DFG    L   
Sbjct: 110 GALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGA-LLKD 168
Query: 497 KADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAA 556
                  G+  +  PE +      G+S+       +WSLG  + +M  G  P+   E   
Sbjct: 169 TVYTDFDGTRVYSPPEWIRYHRYHGRSA------AVWSLGILLYDMVCGDIPFEHDE--- 219
Query: 557 AMFKVMRDTPAIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQP 609
              +++R        +S E +  +R C    P+DRP    +  H ++++   P
Sbjct: 220 ---EIIRGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLP 269

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 85.5 bits (210), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 72/286 (25%), Positives = 132/286 (46%), Gaps = 27/286 (9%)
Query: 338 MNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAE---SIKQLEQEIK 394
           ++  +  G+ +G G F  V     + TG   A K +       KS+    S + +E+E+ 
Sbjct: 9   VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIK--KRRTKSSRRGVSREDIEREVS 66
Query: 395 VLSHLKHPNIVQYYGSEIVEDK--FYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHI 452
           +L  ++HPN++  +  E+ E+K    + LE V  G +  ++ E   ++TE     F + I
Sbjct: 67  ILKEIQHPNVITLH--EVYENKTDVILILELVAGGELFDFLAEK-ESLTEEEATEFLKQI 123
Query: 453 LSGLAYLHSKKTIHRDIKGANLLVDASGV----VKLADFGMAKHLTGQKADLSMKGSPYW 508
           L+G+ YLHS +  H D+K  N+++    V    +K+ DFG+A  +       ++ G+P +
Sbjct: 124 LNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPAF 183
Query: 509 MAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAI 568
           +APE++             L  D+WS+G     + +G  P+        +  V       
Sbjct: 184 VAPEIV-------NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEF 236
Query: 569 PD----SLSPEGKDFLRCCFQRNPADRPPASLLLEHRFL--KNSQQ 608
            D    + S   KDF+R    ++P  R      L+H ++  K++QQ
Sbjct: 237 EDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQ 282

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 85.5 bits (210), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 68/292 (23%), Positives = 132/292 (45%), Gaps = 24/292 (8%)
Query: 335 PLPMNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIK 394
           P  ++ +++ G+++G G    V++A +       A+K   +  D  +      +  +E +
Sbjct: 7   PSHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKV--LRADLARDPSFYLRFRREAQ 64
Query: 395 VLSHLKHPNIVQYYGSEIVEDKF----YIYLEYVHPGSINKYVREHCGAITESVVRNFTR 450
             + L HP IV  Y +   E       YI +EYV   ++   V    G +T         
Sbjct: 65  NAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTE-GPMTPKRAIEVIA 123
Query: 451 HILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMK----GSP 506
                L + H    IHRD+K AN+++ A+  VK+ DFG+A+ +      ++      G+ 
Sbjct: 124 DACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTA 183
Query: 507 YWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTP 566
            +++PE       +G S D+    D++SLGC + E+ TG+PP++     +  ++ +R+ P
Sbjct: 184 QYLSPE-----QARGDSVDA--RSDVYSLGCVLYEVLTGEPPFTGDSPDSVAYQHVREDP 236
Query: 567 AIP----DSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLK--NSQQPDVP 612
             P    + LS +    +     +NP +R   +  +    ++  N + P+ P
Sbjct: 237 IPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHNGEPPEAP 288

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 85.5 bits (210), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 61/233 (26%), Positives = 110/233 (47%), Gaps = 15/233 (6%)
Query: 320 LSPSATIPQVAAKPEPLPMNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDD 379
           L+PS T P  A     +   ++ ++ K++G G FG+VY       G    +       ++
Sbjct: 20  LTPSGTAPNQAQLR--ILKETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNE 77
Query: 380 PKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGA 439
               ++  +   E  +++ + HP++V+  G   +     +  + +  G + +YV EH   
Sbjct: 78  TTGPKANVEFMDEALIMASMDHPHLVRLLGV-CLSPTIQLVTQLMPHGCLLEYVHEHKDN 136
Query: 440 ITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKAD 499
           I   ++ N+   I  G+ YL  ++ +HRD+   N+LV +   VK+ DFG+A+ L G + +
Sbjct: 137 IGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKE 196
Query: 500 LSMKGSPY---WMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT--GKP 547
            +  G      WMA E    +  +  +  S    D+WS G TI E+ T  GKP
Sbjct: 197 YNADGGKMPIKWMALE---CIHYRKFTHQS----DVWSYGVTIWELMTFGGKP 242

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 85.5 bits (210), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 72/286 (25%), Positives = 132/286 (46%), Gaps = 27/286 (9%)
Query: 338 MNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAE---SIKQLEQEIK 394
           ++  +  G+ +G G F  V     + TG   A K +       KS+    S + +E+E+ 
Sbjct: 9   VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIK--KRRTKSSRRGVSREDIEREVS 66
Query: 395 VLSHLKHPNIVQYYGSEIVEDK--FYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHI 452
           +L  ++HPN++  +  E+ E+K    + LE V  G +  ++ E   ++TE     F + I
Sbjct: 67  ILKEIQHPNVITLH--EVYENKTDVILILELVAGGELFDFLAEK-ESLTEEEATEFLKQI 123
Query: 453 LSGLAYLHSKKTIHRDIKGANLLVDASGV----VKLADFGMAKHLTGQKADLSMKGSPYW 508
           L+G+ YLHS +  H D+K  N+++    V    +K+ DFG+A  +       ++ G+P +
Sbjct: 124 LNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEF 183
Query: 509 MAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAI 568
           +APE++             L  D+WS+G     + +G  P+        +  V       
Sbjct: 184 VAPEIV-------NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEF 236
Query: 569 PD----SLSPEGKDFLRCCFQRNPADRPPASLLLEHRFL--KNSQQ 608
            D    + S   KDF+R    ++P  R      L+H ++  K++QQ
Sbjct: 237 EDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQ 282

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 85.5 bits (210), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 72/286 (25%), Positives = 132/286 (46%), Gaps = 27/286 (9%)
Query: 338 MNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAE---SIKQLEQEIK 394
           ++  +  G+ +G G F  V     + TG   A K +       KS+    S + +E+E+ 
Sbjct: 9   VDDYYDTGEELGSGVFAVVKKCREKSTGLQYAAKFIK--KRRTKSSRRGVSREDIEREVS 66
Query: 395 VLSHLKHPNIVQYYGSEIVEDK--FYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHI 452
           +L  ++HPN++  +  E+ E+K    + LE V  G +  ++ E   ++TE     F + I
Sbjct: 67  ILKEIQHPNVITLH--EVYENKTDVILILELVAGGELFDFLAEK-ESLTEEEATEFLKQI 123
Query: 453 LSGLAYLHSKKTIHRDIKGANLLVDASGV----VKLADFGMAKHLTGQKADLSMKGSPYW 508
           L+G+ YLHS +  H D+K  N+++    V    +K+ DFG+A  +       ++ G+P +
Sbjct: 124 LNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEF 183
Query: 509 MAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAI 568
           +APE++             L  D+WS+G     + +G  P+        +  V       
Sbjct: 184 VAPEIV-------NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEF 236
Query: 569 PD----SLSPEGKDFLRCCFQRNPADRPPASLLLEHRFL--KNSQQ 608
            D    + S   KDF+R    ++P  R      L+H ++  K++QQ
Sbjct: 237 EDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQ 282

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score = 85.5 bits (210), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 73/290 (25%), Positives = 123/290 (42%), Gaps = 43/290 (14%)
Query: 337 PMNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDI--------FPDDPKSAESIKQ 388
           P+ SQ+Q G L+G G FGSVY           A+K V+          P+  +    +  
Sbjct: 1   PLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVL 60
Query: 389 LEQE-------IKVLSHLKHPNIVQYYGSEIVEDKFYIYLEYVHP-GSINKYVREHCGAI 440
           L++        I++L   + P            D F + LE   P   +  ++ E  GA+
Sbjct: 61  LKKVSSGFSGVIRLLDWFERP------------DSFVLILERPEPVQDLFDFITER-GAL 107
Query: 441 TESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDAS-GVVKLADFGMAKHLTGQKAD 499
            E + R+F   +L  + + H+   +HRDIK  N+L+D + G +KL DFG    L      
Sbjct: 108 QEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGA-LLKDTVY 166
Query: 500 LSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMF 559
               G+  +  PE +      G+S+       +WSLG  + +M  G  P+   E      
Sbjct: 167 TDFDGTRVYSPPEWIRYHRYHGRSA------AVWSLGILLYDMVCGDIPFEHDE------ 214
Query: 560 KVMRDTPAIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQP 609
           +++R        +S E +  +R C    P+DRP    +  H ++++   P
Sbjct: 215 EIIRGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLP 264

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 78/311 (25%), Positives = 132/311 (42%), Gaps = 50/311 (16%)
Query: 340 SQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHL 399
           S +++  ++G+G FG V  A N       A+K++        + E +  +  E+ +L+ L
Sbjct: 6   SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKI------RHTEEKLSTILSEVMLLASL 59
Query: 400 KHPNIVQYYGSEIVEDKF-------------YIYLEYVHPGSINKYVR-EHCGAITESVV 445
            H  +V+YY + +    F             +I +EY    ++   +  E+     +   
Sbjct: 60  NHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENLNQQRDEYW 119
Query: 446 RNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAK-------------- 491
           R F R IL  L+Y+HS+  IHRD+K  N+ +D S  VK+ DFG+AK              
Sbjct: 120 RLF-RQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQ 178
Query: 492 HLTGQKADL-SMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWS 550
           +L G   +L S  G+  ++A E++       +       +D++SLG    EM     P+S
Sbjct: 179 NLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEK------IDMYSLGIIFFEMIY---PFS 229
Query: 551 EYEGAAAMFKVMRDT-----PAIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKN 605
                  + K +R       P   D+     K  +R     +P  RP A  LL   +L  
Sbjct: 230 TGMERVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPV 289
Query: 606 SQQPDVPSCSL 616
             Q +V   +L
Sbjct: 290 KHQDEVIKEAL 300

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 72/286 (25%), Positives = 132/286 (46%), Gaps = 27/286 (9%)
Query: 338 MNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAE---SIKQLEQEIK 394
           ++  +  G+ +G G F  V     + TG   A K +       KS+    S + +E+E+ 
Sbjct: 9   VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIK--KRRTKSSRRGVSREDIEREVS 66
Query: 395 VLSHLKHPNIVQYYGSEIVEDK--FYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHI 452
           +L  ++HPN++  +  E+ E+K    + LE V  G +  ++ E   ++TE     F + I
Sbjct: 67  ILKEIQHPNVITLH--EVYENKTDVILILELVAGGELFDFLAEK-ESLTEEEATEFLKQI 123
Query: 453 LSGLAYLHSKKTIHRDIKGANLLVDASGV----VKLADFGMAKHLTGQKADLSMKGSPYW 508
           L+G+ YLHS +  H D+K  N+++    V    +K+ DFG+A  +       ++ G+P +
Sbjct: 124 LNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEF 183
Query: 509 MAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAI 568
           +APE++             L  D+WS+G     + +G  P+        +  V       
Sbjct: 184 VAPEIV-------NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEF 236
Query: 569 PD----SLSPEGKDFLRCCFQRNPADRPPASLLLEHRFL--KNSQQ 608
            D    + S   KDF+R    ++P  R      L+H ++  K++QQ
Sbjct: 237 EDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQ 282

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 75/278 (26%), Positives = 130/278 (46%), Gaps = 23/278 (8%)
Query: 346 KLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKH--PN 403
           K IG G    V+   N E   + A+K V++   D ++ +S +    EI  L+ L+     
Sbjct: 62  KQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRN---EIAYLNKLQQHSDK 117
Query: 404 IVQYYGSEIVEDKFYIYLEYVHPGSI--NKYVREHCGAITESVVRNFTRHILSGLAYLHS 461
           I++ Y  EI +   Y+ +E    G+I  N ++++   +I     +++ +++L  +  +H 
Sbjct: 118 IIRLYDYEITDQYIYMVME---CGNIDLNSWLKKK-KSIDPWERKSYWKNMLEAVHTIHQ 173
Query: 462 KKTIHRDIKGANLLVDASGVVKLADFGMAKHL---TGQKADLSMKGSPYWMAPEL---MM 515
              +H D+K AN L+   G++KL DFG+A  +   T      S  G+  +M PE    M 
Sbjct: 174 HGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMS 232
Query: 516 AVMQKGKSSDSALAV-DIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRD---TPAIPDS 571
           +  + GKS        D+WSLGC +  M  GK P+ +     +    + D       PD 
Sbjct: 233 SSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDI 292
Query: 572 LSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQP 609
              + +D L+CC +R+P  R     LL H +++    P
Sbjct: 293 PEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHP 330

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 77/312 (24%), Positives = 147/312 (47%), Gaps = 37/312 (11%)
Query: 320 LSPSATIPQVAAKPEPLPMNSQWQ-------KGKLIGRGTFGSVYVAS-NRETG-ALCAM 370
           L    ++P +++KP+       W+         K +G G FG V++A+ N+ T  A+  M
Sbjct: 161 LCQKLSVPCMSSKPQKPWEKDAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTM 220
Query: 371 KEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSIN 430
           K        P S  S++    E  V+  L+H  +V+ +   + ++  YI  E++  GS+ 
Sbjct: 221 K--------PGSM-SVEAFLAEANVMKTLQHDKLVKLHAV-VTKEPIYIITEFMAKGSLL 270
Query: 431 KYVREHCGAITE-SVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGM 489
            +++   G+      + +F+  I  G+A++  +  IHRD++ AN+LV AS V K+ADFG+
Sbjct: 271 DFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGL 330
Query: 490 AKHLTGQKADLSMKGSPY---WMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-G 545
           A+ +   +   + +G+ +   W APE +             +  D+WS G  ++E+ T G
Sbjct: 331 ARVIEDNEYT-AREGAKFPIKWTAPEAI-------NFGSFTIKSDVWSFGILLMEIVTYG 382
Query: 546 KPPWSEYEGAAAMFKVMRDTPA-IPDSLSPEGKDFLRCCFQRNPADRPP----ASLLLEH 600
           + P+        +  + R      P++   E  + +  C++  P +RP      S+L + 
Sbjct: 383 RIPYPGMSNPEVIRALERGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDF 442
Query: 601 RFLKNSQQPDVP 612
                SQ  ++P
Sbjct: 443 YTATESQXEEIP 454

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 74/293 (25%), Positives = 124/293 (42%), Gaps = 43/293 (14%)
Query: 334 EPLPMNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDI--------FPDDPKSAES 385
           E  P+ SQ+Q G L+G G FGSVY           A+K V+          P+  +    
Sbjct: 1   EKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPME 60
Query: 386 IKQLEQE-------IKVLSHLKHPNIVQYYGSEIVEDKFYIYLEYVHP-GSINKYVREHC 437
           +  L++        I++L   + P            D F + LE   P   +  ++ E  
Sbjct: 61  VVLLKKVSSGFSGVIRLLDWFERP------------DSFVLILERPEPVQDLFDFITER- 107
Query: 438 GAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDAS-GVVKLADFGMAKHLTGQ 496
           GA+ E + R+F   +L  + + H+   +HRDIK  N+L+D + G +KL DFG    L   
Sbjct: 108 GALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGA-LLKD 166
Query: 497 KADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAA 556
                  G+  +  PE +      G+S+       +WSLG  + +M  G  P+   E   
Sbjct: 167 TVYTDFDGTRVYSPPEWIRYHRYHGRSA------AVWSLGILLYDMVCGDIPFEHDE--- 217
Query: 557 AMFKVMRDTPAIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQP 609
              +++R        +S E +  +R C    P+DRP    +  H ++++   P
Sbjct: 218 ---EIIRGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLP 267

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 62/264 (23%), Positives = 127/264 (48%), Gaps = 17/264 (6%)
Query: 334 EPLPMNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEI 393
           +P+  N+ +++ +++G+G FG V     R TG + A K+++      +  E++   E++I
Sbjct: 179 QPVTKNT-FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQI 237
Query: 394 KVLSHLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCG--AITESVVRNFTRH 451
             L  +    +V    +   +D   + L  ++ G +  ++  H G     E+    +   
Sbjct: 238 --LEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIY-HMGQAGFPEARAVFYAAE 294
Query: 452 ILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPYWMAP 511
           I  GL  LH ++ ++RD+K  N+L+D  G ++++D G+A H+   +      G+  +MAP
Sbjct: 295 ICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAP 354
Query: 512 ELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDS 571
           E++       K+     + D W+LGC + EM  G+ P+ + +      +V R    +P+ 
Sbjct: 355 EVV-------KNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEE 407
Query: 572 ----LSPEGKDFLRCCFQRNPADR 591
                SP+ +        ++PA+R
Sbjct: 408 YSERFSPQARSLCSQLLCKDPAER 431

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 72/286 (25%), Positives = 132/286 (46%), Gaps = 27/286 (9%)
Query: 338 MNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAE---SIKQLEQEIK 394
           ++  +  G+ +G G F  V     + TG   A K +       KS+    S + +E+E+ 
Sbjct: 8   VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIK--KRRTKSSRRGVSREDIEREVS 65
Query: 395 VLSHLKHPNIVQYYGSEIVEDK--FYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHI 452
           +L  ++HPN++  +  E+ E+K    + LE V  G +  ++ E   ++TE     F + I
Sbjct: 66  ILKEIQHPNVITLH--EVYENKTDVILILELVAGGELFDFLAEK-ESLTEEEATEFLKQI 122
Query: 453 LSGLAYLHSKKTIHRDIKGANLLVDASGV----VKLADFGMAKHLTGQKADLSMKGSPYW 508
           L+G+ YLHS +  H D+K  N+++    V    +K+ DFG+A  +       ++ G+P +
Sbjct: 123 LNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEF 182
Query: 509 MAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAI 568
           +APE++             L  D+WS+G     + +G  P+        +  V       
Sbjct: 183 VAPEIV-------NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEF 235
Query: 569 PD----SLSPEGKDFLRCCFQRNPADRPPASLLLEHRFL--KNSQQ 608
            D    + S   KDF+R    ++P  R      L+H ++  K++QQ
Sbjct: 236 EDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQ 281

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 72/286 (25%), Positives = 132/286 (46%), Gaps = 27/286 (9%)
Query: 338 MNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAE---SIKQLEQEIK 394
           ++  +  G+ +G G F  V     + TG   A K +       KS+    S + +E+E+ 
Sbjct: 9   VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIK--KRRTKSSRRGVSREDIEREVS 66
Query: 395 VLSHLKHPNIVQYYGSEIVEDK--FYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHI 452
           +L  ++HPN++  +  E+ E+K    + LE V  G +  ++ E   ++TE     F + I
Sbjct: 67  ILKEIQHPNVITLH--EVYENKTDVILILELVAGGELFDFLAEK-ESLTEEEATEFLKQI 123
Query: 453 LSGLAYLHSKKTIHRDIKGANLLVDASGV----VKLADFGMAKHLTGQKADLSMKGSPYW 508
           L+G+ YLHS +  H D+K  N+++    V    +K+ DFG+A  +       ++ G+P +
Sbjct: 124 LNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEF 183
Query: 509 MAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAI 568
           +APE++             L  D+WS+G     + +G  P+        +  V       
Sbjct: 184 VAPEIV-------NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEF 236
Query: 569 PD----SLSPEGKDFLRCCFQRNPADRPPASLLLEHRFL--KNSQQ 608
            D    + S   KDF+R    ++P  R      L+H ++  K++QQ
Sbjct: 237 EDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQ 282

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 74/293 (25%), Positives = 124/293 (42%), Gaps = 43/293 (14%)
Query: 334 EPLPMNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDI--------FPDDPKSAES 385
           E  P+ SQ+Q G L+G G FGSVY           A+K V+          P+  +    
Sbjct: 25  EKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPME 84
Query: 386 IKQLEQE-------IKVLSHLKHPNIVQYYGSEIVEDKFYIYLEYVHP-GSINKYVREHC 437
           +  L++        I++L   + P            D F + LE   P   +  ++ E  
Sbjct: 85  VVLLKKVSSGFSGVIRLLDWFERP------------DSFVLILERPEPVQDLFDFITER- 131
Query: 438 GAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDAS-GVVKLADFGMAKHLTGQ 496
           GA+ E + R+F   +L  + + H+   +HRDIK  N+L+D + G +KL DFG    L   
Sbjct: 132 GALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGA-LLKD 190
Query: 497 KADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAA 556
                  G+  +  PE +      G+S+       +WSLG  + +M  G  P+   E   
Sbjct: 191 TVYTDFDGTRVYSPPEWIRYHRYHGRSA------AVWSLGILLYDMVCGDIPFEHDE--- 241
Query: 557 AMFKVMRDTPAIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQP 609
              +++R        +S E +  +R C    P+DRP    +  H ++++   P
Sbjct: 242 ---EIIRGQVFFRQRVSXECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLP 291

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 62/264 (23%), Positives = 127/264 (48%), Gaps = 17/264 (6%)
Query: 334 EPLPMNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEI 393
           +P+  N+ +++ +++G+G FG V     R TG + A K+++      +  E++   E++I
Sbjct: 179 QPVTKNT-FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQI 237
Query: 394 KVLSHLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCG--AITESVVRNFTRH 451
             L  +    +V    +   +D   + L  ++ G +  ++  H G     E+    +   
Sbjct: 238 --LEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIY-HMGQAGFPEARAVFYAAE 294
Query: 452 ILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPYWMAP 511
           I  GL  LH ++ ++RD+K  N+L+D  G ++++D G+A H+   +      G+  +MAP
Sbjct: 295 ICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAP 354
Query: 512 ELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDS 571
           E++       K+     + D W+LGC + EM  G+ P+ + +      +V R    +P+ 
Sbjct: 355 EVV-------KNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEE 407
Query: 572 ----LSPEGKDFLRCCFQRNPADR 591
                SP+ +        ++PA+R
Sbjct: 408 YSERFSPQARSLCSQLLCKDPAER 431

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 75/278 (26%), Positives = 130/278 (46%), Gaps = 23/278 (8%)
Query: 346 KLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKH--PN 403
           K IG G    V+   N E   + A+K V++   D ++ +S +    EI  L+ L+     
Sbjct: 62  KQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRN---EIAYLNKLQQHSDK 117
Query: 404 IVQYYGSEIVEDKFYIYLEYVHPGSI--NKYVREHCGAITESVVRNFTRHILSGLAYLHS 461
           I++ Y  EI +   Y+ +E    G+I  N ++++   +I     +++ +++L  +  +H 
Sbjct: 118 IIRLYDYEITDQYIYMVME---CGNIDLNSWLKKK-KSIDPWERKSYWKNMLEAVHTIHQ 173
Query: 462 KKTIHRDIKGANLLVDASGVVKLADFGMAKHL---TGQKADLSMKGSPYWMAPEL---MM 515
              +H D+K AN L+   G++KL DFG+A  +   T      S  G+  +M PE    M 
Sbjct: 174 HGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMS 232
Query: 516 AVMQKGKSSDSALAV-DIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRD---TPAIPDS 571
           +  + GKS        D+WSLGC +  M  GK P+ +     +    + D       PD 
Sbjct: 233 SSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDI 292
Query: 572 LSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQP 609
              + +D L+CC +R+P  R     LL H +++    P
Sbjct: 293 PEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHP 330

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 72/286 (25%), Positives = 132/286 (46%), Gaps = 27/286 (9%)
Query: 338 MNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAE---SIKQLEQEIK 394
           ++  +  G+ +G G F  V     + TG   A K +       KS+    S + +E+E+ 
Sbjct: 9   VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIK--KRRTKSSRRGVSREDIEREVS 66
Query: 395 VLSHLKHPNIVQYYGSEIVEDK--FYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHI 452
           +L  ++HPN++  +  E+ E+K    + LE V  G +  ++ E   ++TE     F + I
Sbjct: 67  ILKEIQHPNVITLH--EVYENKTDVILILELVAGGELFDFLAEK-ESLTEEEATEFLKQI 123
Query: 453 LSGLAYLHSKKTIHRDIKGANLLVDASGV----VKLADFGMAKHLTGQKADLSMKGSPYW 508
           L+G+ YLHS +  H D+K  N+++    V    +K+ DFG+A  +       ++ G+P +
Sbjct: 124 LNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEF 183
Query: 509 MAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAI 568
           +APE++             L  D+WS+G     + +G  P+        +  V       
Sbjct: 184 VAPEIV-------NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEF 236
Query: 569 PD----SLSPEGKDFLRCCFQRNPADRPPASLLLEHRFL--KNSQQ 608
            D    + S   KDF+R    ++P  R      L+H ++  K++QQ
Sbjct: 237 EDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQ 282

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 72/286 (25%), Positives = 132/286 (46%), Gaps = 27/286 (9%)
Query: 338 MNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAE---SIKQLEQEIK 394
           ++  +  G+ +G G F  V     + TG   A K +       KS+    S + +E+E+ 
Sbjct: 8   VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIK--KRRTKSSRRGVSREDIEREVS 65
Query: 395 VLSHLKHPNIVQYYGSEIVEDK--FYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHI 452
           +L  ++HPN++  +  E+ E+K    + LE V  G +  ++ E   ++TE     F + I
Sbjct: 66  ILKEIQHPNVITLH--EVYENKTDVILILELVAGGELFDFLAEK-ESLTEEEATEFLKQI 122
Query: 453 LSGLAYLHSKKTIHRDIKGANLLVDASGV----VKLADFGMAKHLTGQKADLSMKGSPYW 508
           L+G+ YLHS +  H D+K  N+++    V    +K+ DFG+A  +       ++ G+P +
Sbjct: 123 LNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEF 182
Query: 509 MAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAI 568
           +APE++             L  D+WS+G     + +G  P+        +  V       
Sbjct: 183 VAPEIV-------NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEF 235
Query: 569 PD----SLSPEGKDFLRCCFQRNPADRPPASLLLEHRFL--KNSQQ 608
            D    + S   KDF+R    ++P  R      L+H ++  K++QQ
Sbjct: 236 EDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQ 281

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 67/272 (24%), Positives = 122/272 (44%), Gaps = 29/272 (10%)
Query: 348 IGRGTFGSVYVA--SNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIV 405
           +G G  G V++   +     A+ ++K+  + PD             E  ++  L+H  +V
Sbjct: 21  LGAGQAGEVWMGYYNGHTKVAVKSLKQGSMSPD---------AFLAEANLMKQLQHQRLV 71
Query: 406 QYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGA-ITESVVRNFTRHILSGLAYLHSKKT 464
           + Y   + ++  YI  EY+  GS+  +++   G  +T + + +    I  G+A++  +  
Sbjct: 72  RLYAV-VTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNY 130
Query: 465 IHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPY---WMAPELMMAVMQKG 521
           IHRD++ AN+LV  +   K+ADFG+A+ L       + +G+ +   W APE +       
Sbjct: 131 IHRDLRAANILVSDTLSCKIADFGLAR-LIEDAEXTAREGAKFPIKWTAPEAI------- 182
Query: 522 KSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFKVMRDTPAI-PDSLSPEGKDF 579
                 +  D+WS G  + E+ T G+ P+        +  + R    + PD+   E    
Sbjct: 183 NYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQL 242
Query: 580 LRCCFQRNPADRPPASLL---LEHRFLKNSQQ 608
           +R C++  P DRP    L   LE  F     Q
Sbjct: 243 MRLCWKERPEDRPTFDYLRSVLEDFFTATEGQ 274

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 78/310 (25%), Positives = 137/310 (44%), Gaps = 41/310 (13%)
Query: 334 EPLPMN-SQWQ-------KGKLIGRGTFGSVYVASNRETGALCAMKEVDI-FPDDPKSAE 384
           E LP + S+W+        GK +GRG FG V  A           + V +    +  +  
Sbjct: 15  ERLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHS 74
Query: 385 SIKQLEQEIKVLSHL-KHPNIVQYYGSEIVEDK-FYIYLEYVHPGSINKYVREHCGAIT- 441
             + L  E+K+L H+  H N+V   G+         + +E+   G+++ Y+R        
Sbjct: 75  EHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVP 134
Query: 442 ---ESVVRNF---------TRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGM 489
              E + ++F         +  +  G+ +L S+K IHRD+   N+L+    VVK+ DFG+
Sbjct: 135 YKPEDLYKDFLTLEHLIXYSFQVAKGMEFLASRKXIHRDLAARNILLSEKNVVKICDFGL 194
Query: 490 AKHLTGQKADLSMKGSP----YWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT- 544
           A+ +  +  D   KG       WMAPE +   +   +S       D+WS G  + E+++ 
Sbjct: 195 ARDIX-KDPDXVRKGDARLPLKWMAPETIFDRVYTIQS-------DVWSFGVLLWEIFSL 246
Query: 545 GKPPWSEYEGAAAMFKVMRDTPAI--PDSLSPEGKDFLRCCFQRNPADRPPASLLLEH-- 600
           G  P+   +      + +++   +  PD  +PE    +  C+   P+ RP  S L+EH  
Sbjct: 247 GASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLG 306
Query: 601 RFLKNSQQPD 610
             L+ + Q D
Sbjct: 307 NLLQANAQQD 316

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 70/284 (24%), Positives = 130/284 (45%), Gaps = 23/284 (8%)
Query: 338 MNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIF-PDDPKSAESIKQLEQEIKVL 396
           ++  +  G+ +G G F  V     + TG   A K +        +   S + +E+E+ +L
Sbjct: 9   VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSIL 68
Query: 397 SHLKHPNIVQYYGSEIVEDK--FYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILS 454
             ++HPN++  +  E+ E+K    + LE V  G +  ++ E   ++TE     F + IL+
Sbjct: 69  KEIQHPNVITLH--EVYENKTDVILILELVAGGELFDFLAEK-ESLTEEEATEFLKQILN 125
Query: 455 GLAYLHSKKTIHRDIKGANLLVDASGV----VKLADFGMAKHLTGQKADLSMKGSPYWMA 510
           G+ YLHS +  H D+K  N+++    V    +K+ DFG+A  +       ++ G+P ++A
Sbjct: 126 GVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVA 185
Query: 511 PELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPD 570
           PE++             L  D+WS+G     + +G  P+        +  V        D
Sbjct: 186 PEIV-------NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFED 238
Query: 571 ----SLSPEGKDFLRCCFQRNPADRPPASLLLEHRFL--KNSQQ 608
               + S   KDF+R    ++P  R      L+H ++  K++QQ
Sbjct: 239 EYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQ 282

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 76/302 (25%), Positives = 126/302 (41%), Gaps = 49/302 (16%)
Query: 328 QVAAKPEPLPMNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDI--------FPDD 379
           ++A   E  P+ SQ+Q G L+G G FGSVY           A+K V+          P+ 
Sbjct: 24  KLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNG 83
Query: 380 PKSAESIKQLEQE-------IKVLSHLKHPNIVQYYGSEIVEDKFYIYLEYVHP-GSINK 431
            +    +  L++        I++L   + P            D F + LE   P   +  
Sbjct: 84  TRVPMEVVLLKKVSSGFSGVIRLLDWFERP------------DSFVLILERPEPVQDLFD 131
Query: 432 YVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDAS-GVVKLADFGMA 490
           ++ E  GA+ E + R+F   +L  + + H+   +HRDIK  N+L+D + G +KL DFG  
Sbjct: 132 FITER-GALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSG 190
Query: 491 KHLTGQKADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWS 550
             L          G+  +  PE +      G+S+       +WSLG  + +M  G  P+ 
Sbjct: 191 A-LLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSA------AVWSLGILLYDMVCGDIPFE 243
Query: 551 EYE---GAAAMFKVMRDTPAIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQ 607
             E   G    F+           +S E +  +R C    P+DRP    +  H ++++  
Sbjct: 244 HDEEIIGGQVFFR---------QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVL 294
Query: 608 QP 609
            P
Sbjct: 295 LP 296

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 72/286 (25%), Positives = 132/286 (46%), Gaps = 27/286 (9%)
Query: 338 MNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAE---SIKQLEQEIK 394
           ++  +  G+ +G G F  V     + TG   A K +       KS+    S + +E+E+ 
Sbjct: 9   VDDYYDTGEELGSGKFAVVKKCREKSTGLQYAAKFIK--KRRTKSSRRGVSREDIEREVS 66
Query: 395 VLSHLKHPNIVQYYGSEIVEDK--FYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHI 452
           +L  ++HPN++  +  E+ E+K    + LE V  G +  ++ E   ++TE     F + I
Sbjct: 67  ILKEIQHPNVITLH--EVYENKTDVILILELVAGGELFDFLAEK-ESLTEEEATEFLKQI 123
Query: 453 LSGLAYLHSKKTIHRDIKGANLLVDASGV----VKLADFGMAKHLTGQKADLSMKGSPYW 508
           L+G+ YLHS +  H D+K  N+++    V    +K+ DFG+A  +       ++ G+P +
Sbjct: 124 LNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEF 183
Query: 509 MAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAI 568
           +APE++             L  D+WS+G     + +G  P+        +  V       
Sbjct: 184 VAPEIV-------NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEF 236
Query: 569 PD----SLSPEGKDFLRCCFQRNPADRPPASLLLEHRFL--KNSQQ 608
            D    + S   KDF+R    ++P  R      L+H ++  K++QQ
Sbjct: 237 EDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQ 282

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 106/216 (49%), Gaps = 23/216 (10%)
Query: 348 IGRGTFGSVYVASNRETGALCAMKEV-------DIFPDDPKSAESIKQLEQEIKVLSHLK 400
           +G G FG V+ A ++E      +K +       D + +DPK    + ++  EI +LS ++
Sbjct: 32  LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPK----LGKVTLEIAILSRVE 87
Query: 401 HPNIVQYYGSEIVEDKFYIYLEYVHPGS---INKYVREHCGAITESVVRNFTRHILSGLA 457
           H NI++    +I E++ +  L     GS   +  ++  H   + E +     R ++S + 
Sbjct: 88  HANIIKVL--DIFENQGFFQLVMEKHGSGLDLFAFIDRH-PRLDEPLASYIFRQLVSAVG 144
Query: 458 YLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPYWMAPELMMAV 517
           YL  K  IHRDIK  N+++     +KL DFG A +L   K   +  G+  + APE++M  
Sbjct: 145 YLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFCGTIEYCAPEVLMGN 204
Query: 518 MQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYE 553
             +G        +++WSLG T+  +   + P+ E E
Sbjct: 205 PYRGPE------LEMWSLGVTLYTLVFEENPFCELE 234

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 76/302 (25%), Positives = 126/302 (41%), Gaps = 49/302 (16%)
Query: 328 QVAAKPEPLPMNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDI--------FPDD 379
           ++A   E  P+ SQ+Q G L+G G FGSVY           A+K V+          P+ 
Sbjct: 25  KLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNG 84
Query: 380 PKSAESIKQLEQE-------IKVLSHLKHPNIVQYYGSEIVEDKFYIYLEYVHP-GSINK 431
            +    +  L++        I++L   + P            D F + LE   P   +  
Sbjct: 85  TRVPMEVVLLKKVSSGFSGVIRLLDWFERP------------DSFVLILERPEPVQDLFD 132
Query: 432 YVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDAS-GVVKLADFGMA 490
           ++ E  GA+ E + R+F   +L  + + H+   +HRDIK  N+L+D + G +KL DFG  
Sbjct: 133 FITER-GALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSG 191
Query: 491 KHLTGQKADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWS 550
             L          G+  +  PE +      G+S+       +WSLG  + +M  G  P+ 
Sbjct: 192 A-LLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSA------AVWSLGILLYDMVCGDIPFE 244
Query: 551 EYE---GAAAMFKVMRDTPAIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQ 607
             E   G    F+           +S E +  +R C    P+DRP    +  H ++++  
Sbjct: 245 HDEEIIGGQVFFR---------QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVL 295
Query: 608 QP 609
            P
Sbjct: 296 LP 297

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 76/302 (25%), Positives = 126/302 (41%), Gaps = 49/302 (16%)
Query: 328 QVAAKPEPLPMNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDI--------FPDD 379
           ++A   E  P+ SQ+Q G L+G G FGSVY           A+K V+          P+ 
Sbjct: 25  KLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNG 84
Query: 380 PKSAESIKQLEQE-------IKVLSHLKHPNIVQYYGSEIVEDKFYIYLEYVHP-GSINK 431
            +    +  L++        I++L   + P            D F + LE   P   +  
Sbjct: 85  TRVPMEVVLLKKVSSGFSGVIRLLDWFERP------------DSFVLILERPEPVQDLFD 132
Query: 432 YVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDAS-GVVKLADFGMA 490
           ++ E  GA+ E + R+F   +L  + + H+   +HRDIK  N+L+D + G +KL DFG  
Sbjct: 133 FITER-GALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSG 191
Query: 491 KHLTGQKADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWS 550
             L          G+  +  PE +      G+S+       +WSLG  + +M  G  P+ 
Sbjct: 192 A-LLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSA------AVWSLGILLYDMVCGDIPFE 244
Query: 551 EYE---GAAAMFKVMRDTPAIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQ 607
             E   G    F+           +S E +  +R C    P+DRP    +  H ++++  
Sbjct: 245 HDEEIIGGQVFFR---------QRVSXECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVL 295
Query: 608 QP 609
            P
Sbjct: 296 LP 297

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 76/302 (25%), Positives = 126/302 (41%), Gaps = 49/302 (16%)
Query: 328 QVAAKPEPLPMNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDI--------FPDD 379
           ++A   E  P+ SQ+Q G L+G G FGSVY           A+K V+          P+ 
Sbjct: 25  KLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNG 84
Query: 380 PKSAESIKQLEQE-------IKVLSHLKHPNIVQYYGSEIVEDKFYIYLEYVHP-GSINK 431
            +    +  L++        I++L   + P            D F + LE   P   +  
Sbjct: 85  TRVPMEVVLLKKVSSGFSGVIRLLDWFERP------------DSFVLILERPEPVQDLFD 132
Query: 432 YVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDAS-GVVKLADFGMA 490
           ++ E  GA+ E + R+F   +L  + + H+   +HRDIK  N+L+D + G +KL DFG  
Sbjct: 133 FITER-GALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSG 191
Query: 491 KHLTGQKADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWS 550
             L          G+  +  PE +      G+S+       +WSLG  + +M  G  P+ 
Sbjct: 192 A-LLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSA------AVWSLGILLYDMVCGDIPFE 244
Query: 551 EYE---GAAAMFKVMRDTPAIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQ 607
             E   G    F+           +S E +  +R C    P+DRP    +  H ++++  
Sbjct: 245 HDEEIIGGQVFFR---------QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVL 295
Query: 608 QP 609
            P
Sbjct: 296 LP 297

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 76/302 (25%), Positives = 126/302 (41%), Gaps = 49/302 (16%)
Query: 328 QVAAKPEPLPMNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDI--------FPDD 379
           ++A   E  P+ SQ+Q G L+G G FGSVY           A+K V+          P+ 
Sbjct: 24  KLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNG 83
Query: 380 PKSAESIKQLEQE-------IKVLSHLKHPNIVQYYGSEIVEDKFYIYLEYVHP-GSINK 431
            +    +  L++        I++L   + P            D F + LE   P   +  
Sbjct: 84  TRVPMEVVLLKKVSSGFSGVIRLLDWFERP------------DSFVLILERPEPVQDLFD 131
Query: 432 YVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDAS-GVVKLADFGMA 490
           ++ E  GA+ E + R+F   +L  + + H+   +HRDIK  N+L+D + G +KL DFG  
Sbjct: 132 FITER-GALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSG 190
Query: 491 KHLTGQKADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWS 550
             L          G+  +  PE +      G+S+       +WSLG  + +M  G  P+ 
Sbjct: 191 A-LLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSA------AVWSLGILLYDMVCGDIPFE 243
Query: 551 EYE---GAAAMFKVMRDTPAIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQ 607
             E   G    F+           +S E +  +R C    P+DRP    +  H ++++  
Sbjct: 244 HDEEIIGGQVFFR---------QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVL 294
Query: 608 QP 609
            P
Sbjct: 295 LP 296

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 76/302 (25%), Positives = 126/302 (41%), Gaps = 49/302 (16%)
Query: 328 QVAAKPEPLPMNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDI--------FPDD 379
           ++A   E  P+ SQ+Q G L+G G FGSVY           A+K V+          P+ 
Sbjct: 24  KLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNG 83
Query: 380 PKSAESIKQLEQE-------IKVLSHLKHPNIVQYYGSEIVEDKFYIYLEYVHP-GSINK 431
            +    +  L++        I++L   + P            D F + LE   P   +  
Sbjct: 84  TRVPMEVVLLKKVSSGFSGVIRLLDWFERP------------DSFVLILERPEPVQDLFD 131
Query: 432 YVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDAS-GVVKLADFGMA 490
           ++ E  GA+ E + R+F   +L  + + H+   +HRDIK  N+L+D + G +KL DFG  
Sbjct: 132 FITER-GALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSG 190
Query: 491 KHLTGQKADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWS 550
             L          G+  +  PE +      G+S+       +WSLG  + +M  G  P+ 
Sbjct: 191 A-LLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSA------AVWSLGILLYDMVCGDIPFE 243
Query: 551 EYE---GAAAMFKVMRDTPAIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQ 607
             E   G    F+           +S E +  +R C    P+DRP    +  H ++++  
Sbjct: 244 HDEEIIGGQVFFR---------QRVSXECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVL 294
Query: 608 QP 609
            P
Sbjct: 295 LP 296

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 76/302 (25%), Positives = 126/302 (41%), Gaps = 49/302 (16%)
Query: 328 QVAAKPEPLPMNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDI--------FPDD 379
           ++A   E  P+ SQ+Q G L+G G FGSVY           A+K V+          P+ 
Sbjct: 25  KLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNG 84
Query: 380 PKSAESIKQLEQE-------IKVLSHLKHPNIVQYYGSEIVEDKFYIYLEYVHP-GSINK 431
            +    +  L++        I++L   + P            D F + LE   P   +  
Sbjct: 85  TRVPMEVVLLKKVSSGFSGVIRLLDWFERP------------DSFVLILERPEPVQDLFD 132
Query: 432 YVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDAS-GVVKLADFGMA 490
           ++ E  GA+ E + R+F   +L  + + H+   +HRDIK  N+L+D + G +KL DFG  
Sbjct: 133 FITER-GALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSG 191
Query: 491 KHLTGQKADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWS 550
             L          G+  +  PE +      G+S+       +WSLG  + +M  G  P+ 
Sbjct: 192 A-LLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSA------AVWSLGILLYDMVCGDIPFE 244
Query: 551 EYE---GAAAMFKVMRDTPAIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQ 607
             E   G    F+           +S E +  +R C    P+DRP    +  H ++++  
Sbjct: 245 HDEEIIGGQVFFR---------QRVSXECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVL 295
Query: 608 QP 609
            P
Sbjct: 296 LP 297

>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 75/278 (26%), Positives = 130/278 (46%), Gaps = 23/278 (8%)
Query: 346 KLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKH--PN 403
           K IG G    V+   N E   + A+K V++   D ++ +S +    EI  L+ L+     
Sbjct: 62  KQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRN---EIAYLNKLQQHSDK 117
Query: 404 IVQYYGSEIVEDKFYIYLEYVHPGSI--NKYVREHCGAITESVVRNFTRHILSGLAYLHS 461
           I++ Y  EI +   Y+ +E    G+I  N ++++   +I     +++ +++L  +  +H 
Sbjct: 118 IIRLYDYEITDQYIYMVME---CGNIDLNSWLKKK-KSIDPWERKSYWKNMLEAVHTIHQ 173
Query: 462 KKTIHRDIKGANLLVDASGVVKLADFGMAKHL---TGQKADLSMKGSPYWMAPEL---MM 515
              +H D+K AN L+   G++KL DFG+A  +   T      S  G+  +M PE    M 
Sbjct: 174 HGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMS 232
Query: 516 AVMQKGKSSDSALAV-DIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRD---TPAIPDS 571
           +  + GKS        D+WSLGC +  M  GK P+ +     +    + D       PD 
Sbjct: 233 SSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDI 292
Query: 572 LSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQP 609
              + +D L+CC +R+P  R     LL H +++    P
Sbjct: 293 PEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHP 330

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 75/278 (26%), Positives = 130/278 (46%), Gaps = 23/278 (8%)
Query: 346 KLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKH--PN 403
           K IG G    V+   N E   + A+K V++   D ++ +S +    EI  L+ L+     
Sbjct: 18  KQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRN---EIAYLNKLQQHSDK 73
Query: 404 IVQYYGSEIVEDKFYIYLEYVHPGSI--NKYVREHCGAITESVVRNFTRHILSGLAYLHS 461
           I++ Y  EI +   Y+ +E    G+I  N ++++   +I     +++ +++L  +  +H 
Sbjct: 74  IIRLYDYEITDQYIYMVME---CGNIDLNSWLKKK-KSIDPWERKSYWKNMLEAVHTIHQ 129
Query: 462 KKTIHRDIKGANLLVDASGVVKLADFGMAKHL---TGQKADLSMKGSPYWMAPEL---MM 515
              +H D+K AN L+   G++KL DFG+A  +   T      S  G+  +M PE    M 
Sbjct: 130 HGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMS 188
Query: 516 AVMQKGKSSDSALAV-DIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRD---TPAIPDS 571
           +  + GKS        D+WSLGC +  M  GK P+ +     +    + D       PD 
Sbjct: 189 SSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDI 248
Query: 572 LSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQP 609
              + +D L+CC +R+P  R     LL H +++    P
Sbjct: 249 PEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHP 286

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 70/280 (25%), Positives = 128/280 (45%), Gaps = 25/280 (8%)
Query: 338 MNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAE---SIKQLEQEIK 394
           ++  +  G+ +G G F  V     + TG   A K +       KS+    S + +E+E+ 
Sbjct: 9   VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIK--KRRTKSSRRGVSREDIEREVS 66
Query: 395 VLSHLKHPNIVQYYGSEIVEDK--FYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHI 452
           +L  ++HPN++  +  E+ E+K    + LE V  G +  ++ E   ++TE     F + I
Sbjct: 67  ILKEIQHPNVITLH--EVYENKTDVILILELVAGGELFDFLAEK-ESLTEEEATEFLKQI 123
Query: 453 LSGLAYLHSKKTIHRDIKGANLLVDASGV----VKLADFGMAKHLTGQKADLSMKGSPYW 508
           L+G+ YLHS +  H D+K  N+++    V    +K+ DFG+A  +       ++ G+P +
Sbjct: 124 LNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEF 183
Query: 509 MAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAI 568
           +APE++             L  D+WS+G     + +G  P+        +  V       
Sbjct: 184 VAPEIV-------NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEF 236
Query: 569 PD----SLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLK 604
            D    + S   KDF+R    ++P  R      L+H ++K
Sbjct: 237 EDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 70/284 (24%), Positives = 130/284 (45%), Gaps = 23/284 (8%)
Query: 338 MNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIF-PDDPKSAESIKQLEQEIKVL 396
           ++  +  G+ +G G F  V     + TG   A K +        +   S + +E+E+ +L
Sbjct: 9   VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSIL 68
Query: 397 SHLKHPNIVQYYGSEIVEDK--FYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILS 454
             ++HPN++  +  E+ E+K    + LE V  G +  ++ E   ++TE     F + IL+
Sbjct: 69  KEIQHPNVITLH--EVYENKTDVILILELVAGGELFDFLAEK-ESLTEEEATEFLKQILN 125
Query: 455 GLAYLHSKKTIHRDIKGANLLVDASGV----VKLADFGMAKHLTGQKADLSMKGSPYWMA 510
           G+ YLHS +  H D+K  N+++    V    +K+ DFG+A  +       ++ G+P ++A
Sbjct: 126 GVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVA 185
Query: 511 PELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPD 570
           PE++             L  D+WS+G     + +G  P+        +  V        D
Sbjct: 186 PEIV-------NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFED 238
Query: 571 ----SLSPEGKDFLRCCFQRNPADRPPASLLLEHRFL--KNSQQ 608
               + S   KDF+R    ++P  R      L+H ++  K++QQ
Sbjct: 239 EYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQ 282

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 101/221 (45%), Gaps = 26/221 (11%)
Query: 342 WQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKH 401
           W+  + +G G FG V    +++TG   A+K+         S ++ ++   EI+++  L H
Sbjct: 17  WEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCR----QELSPKNRERWCLEIQIMKKLNH 72
Query: 402 PNIVQYYGSEIVE--------DKFYIYLEYVHPGSINKYVR--EHCGAITESVVRNFTRH 451
           PN+V     E+ +        D   + +EY   G + KY+   E+C  + E  +R     
Sbjct: 73  PNVVS--AREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSD 130
Query: 452 ILSGLAYLHSKKTIHRDIKGANLLVD---ASGVVKLADFGMAKHLTGQKADLSMKGSPYW 508
           I S L YLH  + IHRD+K  N+++       + K+ D G AK L   +      G+  +
Sbjct: 131 ISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQY 190
Query: 509 MAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPW 549
           +APEL+       +     + VD WS G    E  TG  P+
Sbjct: 191 LAPELL-------EQKKYTVTVDYWSFGTLAFECITGFRPF 224

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 70/280 (25%), Positives = 128/280 (45%), Gaps = 25/280 (8%)
Query: 338 MNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAE---SIKQLEQEIK 394
           ++  +  G+ +G G F  V     + TG   A K +       KS+    S + +E+E+ 
Sbjct: 9   VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIK--KRRTKSSRRGVSREDIEREVS 66
Query: 395 VLSHLKHPNIVQYYGSEIVEDK--FYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHI 452
           +L  ++HPN++  +  E+ E+K    + LE V  G +  ++ E   ++TE     F + I
Sbjct: 67  ILKEIQHPNVITLH--EVYENKTDVILILELVAGGELFDFLAEK-ESLTEEEATEFLKQI 123
Query: 453 LSGLAYLHSKKTIHRDIKGANLLVDASGV----VKLADFGMAKHLTGQKADLSMKGSPYW 508
           L+G+ YLHS +  H D+K  N+++    V    +K+ DFG+A  +       ++ G+P +
Sbjct: 124 LNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEF 183
Query: 509 MAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAI 568
           +APE++             L  D+WS+G     + +G  P+        +  V       
Sbjct: 184 VAPEIV-------NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEF 236
Query: 569 PD----SLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLK 604
            D    + S   KDF+R    ++P  R      L+H ++K
Sbjct: 237 EDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 70/264 (26%), Positives = 124/264 (46%), Gaps = 33/264 (12%)
Query: 346 KLIGRGTFGSVYVA--SNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPN 403
           K +G G FG V++   +N    A+  +K        P +  S++   +E  ++  L+H  
Sbjct: 18  KKLGAGQFGEVWMGYYNNSTKVAVKTLK--------PGTM-SVQAFLEEANLMKTLQHDK 68
Query: 404 IVQYYGSEIVEDKFYIYLEYVHPGSINKYVR-EHCGAITESVVRNFTRHILSGLAYLHSK 462
           +V+ Y     E+  YI  E++  GS+  +++ +  G +    + +F+  I  G+AY+  K
Sbjct: 69  LVRLYAVVTKEEPIYIITEFMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERK 128
Query: 463 KTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPY---WMAPELMMAVMQ 519
             IHRD++ AN+LV  S + K+ADFG+A+ +   +   + +G+ +   W APE +     
Sbjct: 129 NYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYT-AREGAKFPIKWTAPEAINFGCF 187
Query: 520 KGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFKV-----MRDTPAIPDSLS 573
             KS       ++WS G  + E+ T GK P+     A  M  +     M      PD L 
Sbjct: 188 TIKS-------NVWSFGILLYEIVTYGKIPYPGRTNADVMSALSQGYRMPRMENCPDELY 240
Query: 574 PEGKDFLRCCFQRNPADRPPASLL 597
               D ++ C++    +RP    L
Sbjct: 241 ----DIMKMCWKEKAEERPTFDYL 260

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 101/221 (45%), Gaps = 26/221 (11%)
Query: 342 WQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKH 401
           W+  + +G G FG V    +++TG   A+K+         S ++ ++   EI+++  L H
Sbjct: 16  WEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCR----QELSPKNRERWCLEIQIMKKLNH 71
Query: 402 PNIVQYYGSEIVE--------DKFYIYLEYVHPGSINKYVR--EHCGAITESVVRNFTRH 451
           PN+V     E+ +        D   + +EY   G + KY+   E+C  + E  +R     
Sbjct: 72  PNVVS--AREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSD 129
Query: 452 ILSGLAYLHSKKTIHRDIKGANLLVD---ASGVVKLADFGMAKHLTGQKADLSMKGSPYW 508
           I S L YLH  + IHRD+K  N+++       + K+ D G AK L   +      G+  +
Sbjct: 130 ISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQY 189
Query: 509 MAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPW 549
           +APEL+       +     + VD WS G    E  TG  P+
Sbjct: 190 LAPELL-------EQKKYTVTVDYWSFGTLAFECITGFRPF 223

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 75/278 (26%), Positives = 130/278 (46%), Gaps = 23/278 (8%)
Query: 346 KLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKH--PN 403
           K IG G    V+   N E   + A+K V++   D ++ +S +    EI  L+ L+     
Sbjct: 15  KQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRN---EIAYLNKLQQHSDK 70
Query: 404 IVQYYGSEIVEDKFYIYLEYVHPGSI--NKYVREHCGAITESVVRNFTRHILSGLAYLHS 461
           I++ Y  EI +   Y+ +E    G+I  N ++++   +I     +++ +++L  +  +H 
Sbjct: 71  IIRLYDYEITDQYIYMVME---CGNIDLNSWLKKK-KSIDPWERKSYWKNMLEAVHTIHQ 126
Query: 462 KKTIHRDIKGANLLVDASGVVKLADFGMAKHL---TGQKADLSMKGSPYWMAPEL---MM 515
              +H D+K AN L+   G++KL DFG+A  +   T      S  G+  +M PE    M 
Sbjct: 127 HGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMS 185
Query: 516 AVMQKGKSSDSALAV-DIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRD---TPAIPDS 571
           +  + GKS        D+WSLGC +  M  GK P+ +     +    + D       PD 
Sbjct: 186 SSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDI 245
Query: 572 LSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQP 609
              + +D L+CC +R+P  R     LL H +++    P
Sbjct: 246 PEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHP 283

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 75/278 (26%), Positives = 130/278 (46%), Gaps = 23/278 (8%)
Query: 346 KLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKH--PN 403
           K IG G    V+   N E   + A+K V++   D ++ +S +    EI  L+ L+     
Sbjct: 34  KQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRN---EIAYLNKLQQHSDK 89
Query: 404 IVQYYGSEIVEDKFYIYLEYVHPGSI--NKYVREHCGAITESVVRNFTRHILSGLAYLHS 461
           I++ Y  EI +   Y+ +E    G+I  N ++++   +I     +++ +++L  +  +H 
Sbjct: 90  IIRLYDYEITDQYIYMVME---CGNIDLNSWLKKK-KSIDPWERKSYWKNMLEAVHTIHQ 145
Query: 462 KKTIHRDIKGANLLVDASGVVKLADFGMAKHL---TGQKADLSMKGSPYWMAPEL---MM 515
              +H D+K AN L+   G++KL DFG+A  +   T      S  G+  +M PE    M 
Sbjct: 146 HGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMS 204
Query: 516 AVMQKGKSSDSALAV-DIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRD---TPAIPDS 571
           +  + GKS        D+WSLGC +  M  GK P+ +     +    + D       PD 
Sbjct: 205 SSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDI 264
Query: 572 LSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQP 609
              + +D L+CC +R+P  R     LL H +++    P
Sbjct: 265 PEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHP 302

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 112/227 (49%), Gaps = 23/227 (10%)
Query: 339 NSQWQKGKLIGRGTFGSVY----VASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIK 394
            ++++K K++G G FG+VY    +    +     A+KE+     +  S ++ K++  E  
Sbjct: 18  ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR----EATSPKANKEILDEAY 73
Query: 395 VLSHLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILS 454
           V++ + +P++ +  G   +     + ++ +  G +  YVREH   I    + N+   I  
Sbjct: 74  VMASVDNPHVCRLLGI-CLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAK 132
Query: 455 GLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPY---WMAP 511
           G+ YL  ++ +HRD+   N+LV     VK+ DFG+AK L  ++ +   +G      WMA 
Sbjct: 133 GMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 192
Query: 512 ELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAA 557
           E ++  +   +S       D+WS G T+ E+ T G  P   Y+G  A
Sbjct: 193 ESILHRIYTHQS-------DVWSYGVTVWELMTFGSKP---YDGIPA 229

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 71/258 (27%), Positives = 120/258 (46%), Gaps = 24/258 (9%)
Query: 346 KLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQ---LEQEIKVLSHLKHP 402
           K+IG G FG V     +  G     +E+ +     K+  + KQ      E  ++    HP
Sbjct: 35  KVIGVGEFGEVCSGRLKVPGK----REICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHP 90
Query: 403 NIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSK 462
           NI+   G         I  EY+  GS++ ++R++ G  T   +    R I SG+ YL   
Sbjct: 91  NIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLRGIGSGMKYLSDM 150
Query: 463 KTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQ-KADLSMKGSPY---WMAPELMMAVM 518
             +HRD+   N+LV+++ V K++DFGM++ L    +A  + +G      W APE   A+ 
Sbjct: 151 SAVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPE---AIA 207
Query: 519 QKGKSSDSALAVDIWSLGCTIIEM--YTGKPPW--SEYEGAAAMFKVMRDTPAIPDSLSP 574
            +  +S    A D+WS G  + E+  Y  +P W  S  +   A+ +  R  P +   ++ 
Sbjct: 208 YRKFTS----ASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEEGYRLPPPMDCPIAL 263
Query: 575 EGKDFLRCCFQRNPADRP 592
                +  C+Q+  +DRP
Sbjct: 264 H--QLMLDCWQKERSDRP 279

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 75/278 (26%), Positives = 130/278 (46%), Gaps = 23/278 (8%)
Query: 346 KLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKH--PN 403
           K IG G    V+   N E   + A+K V++   D ++ +S +    EI  L+ L+     
Sbjct: 14  KQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRN---EIAYLNKLQQHSDK 69
Query: 404 IVQYYGSEIVEDKFYIYLEYVHPGSI--NKYVREHCGAITESVVRNFTRHILSGLAYLHS 461
           I++ Y  EI +   Y+ +E    G+I  N ++++   +I     +++ +++L  +  +H 
Sbjct: 70  IIRLYDYEITDQYIYMVME---CGNIDLNSWLKKK-KSIDPWERKSYWKNMLEAVHTIHQ 125
Query: 462 KKTIHRDIKGANLLVDASGVVKLADFGMAKHL---TGQKADLSMKGSPYWMAPEL---MM 515
              +H D+K AN L+   G++KL DFG+A  +   T      S  G+  +M PE    M 
Sbjct: 126 HGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMS 184
Query: 516 AVMQKGKSSDSALAV-DIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRD---TPAIPDS 571
           +  + GKS        D+WSLGC +  M  GK P+ +     +    + D       PD 
Sbjct: 185 SSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDI 244
Query: 572 LSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQP 609
              + +D L+CC +R+P  R     LL H +++    P
Sbjct: 245 PEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHP 282

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 112/227 (49%), Gaps = 23/227 (10%)
Query: 339 NSQWQKGKLIGRGTFGSVY----VASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIK 394
            ++++K K++G G FG+VY    +    +     A+KE+     +  S ++ K++  E  
Sbjct: 15  ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR----EATSPKANKEILDEAY 70
Query: 395 VLSHLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILS 454
           V++ + +P++ +  G   +     + ++ +  G +  YVREH   I    + N+   I  
Sbjct: 71  VMASVDNPHVCRLLGI-CLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAK 129
Query: 455 GLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPY---WMAP 511
           G+ YL  ++ +HRD+   N+LV     VK+ DFG+AK L  ++ +   +G      WMA 
Sbjct: 130 GMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 189
Query: 512 ELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAA 557
           E ++  +   +S       D+WS G T+ E+ T G  P   Y+G  A
Sbjct: 190 ESILHRIYTHQS-------DVWSYGVTVWELMTFGSKP---YDGIPA 226

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 112/227 (49%), Gaps = 23/227 (10%)
Query: 339 NSQWQKGKLIGRGTFGSVY----VASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIK 394
            ++++K K++G G FG+VY    +    +     A+KE+     +  S ++ K++  E  
Sbjct: 14  ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR----EATSPKANKEILDEAY 69
Query: 395 VLSHLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILS 454
           V++ + +P++ +  G   +     + ++ +  G +  YVREH   I    + N+   I  
Sbjct: 70  VMASVDNPHVCRLLGI-CLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAK 128
Query: 455 GLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPY---WMAP 511
           G+ YL  ++ +HRD+   N+LV     VK+ DFG+AK L  ++ +   +G      WMA 
Sbjct: 129 GMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 188
Query: 512 ELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAA 557
           E ++  +   +S       D+WS G T+ E+ T G  P   Y+G  A
Sbjct: 189 ESILHRIYTHQS-------DVWSYGVTVWELMTFGSKP---YDGIPA 225

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 112/227 (49%), Gaps = 23/227 (10%)
Query: 339 NSQWQKGKLIGRGTFGSVY----VASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIK 394
            ++++K K++G G FG+VY    +    +     A+KE+     +  S ++ K++  E  
Sbjct: 15  ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR----EATSPKANKEILDEAY 70
Query: 395 VLSHLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILS 454
           V++ + +P++ +  G   +     + ++ +  G +  YVREH   I    + N+   I  
Sbjct: 71  VMASVDNPHVCRLLGI-CLTSTVQLIMQLMPFGXLLDYVREHKDNIGSQYLLNWCVQIAK 129
Query: 455 GLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPY---WMAP 511
           G+ YL  ++ +HRD+   N+LV     VK+ DFG+AK L  ++ +   +G      WMA 
Sbjct: 130 GMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 189
Query: 512 ELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAA 557
           E ++  +   +S       D+WS G T+ E+ T G  P   Y+G  A
Sbjct: 190 ESILHRIYTHQS-------DVWSYGVTVWELMTFGSKP---YDGIPA 226

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 74/296 (25%), Positives = 132/296 (44%), Gaps = 37/296 (12%)
Query: 334 EPLPMN-SQWQ-------KGKLIGRGTFGSVYVASNRETGALCAMKEVDI-FPDDPKSAE 384
           E LP + S+W+        GK +GRG FG V  A           + V +    +  +  
Sbjct: 13  ERLPYDASKWEFPRDRLNLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHS 72
Query: 385 SIKQLEQEIKVLSHL-KHPNIVQYYGSEIVEDK-FYIYLEYVHPGSINKYVRE------- 435
             + L  E+K+L H+  H N+V   G+         + +E+   G+++ Y+R        
Sbjct: 73  EHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVP 132
Query: 436 ----HCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAK 491
               +   +T   +  ++  +  G+ +L S+K IHRD+   N+L+    VVK+ DFG+A+
Sbjct: 133 YKDLYKDFLTLEHLIXYSFQVAKGMEFLASRKXIHRDLAARNILLSEKNVVKIXDFGLAR 192
Query: 492 HLTGQKADLSMKGSP----YWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GK 546
            +  +  D   KG       WMAPE +   +   +S       D+WS G  + E+++ G 
Sbjct: 193 DIY-KDPDYVRKGDARLPLKWMAPETIFDRVYTIQS-------DVWSFGVLLWEIFSLGA 244
Query: 547 PPWSEYEGAAAMFKVMRDTPAI--PDSLSPEGKDFLRCCFQRNPADRPPASLLLEH 600
            P+   +      + +++   +  PD  +PE    +  C+   P+ RP  S L+EH
Sbjct: 245 SPYPGVKIDEEFXRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 300

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 112/227 (49%), Gaps = 23/227 (10%)
Query: 339 NSQWQKGKLIGRGTFGSVY----VASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIK 394
            ++++K K++G G FG+VY    +    +     A+KE+     +  S ++ K++  E  
Sbjct: 16  ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR----EATSPKANKEILDEAY 71
Query: 395 VLSHLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILS 454
           V++ + +P++ +  G   +     + ++ +  G +  YVREH   I    + N+   I  
Sbjct: 72  VMASVDNPHVCRLLGI-CLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAK 130
Query: 455 GLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPY---WMAP 511
           G+ YL  ++ +HRD+   N+LV     VK+ DFG+AK L  ++ +   +G      WMA 
Sbjct: 131 GMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 190
Query: 512 ELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAA 557
           E ++  +   +S       D+WS G T+ E+ T G  P   Y+G  A
Sbjct: 191 ESILHRIYTHQS-------DVWSYGVTVWELMTFGSKP---YDGIPA 227

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 112/227 (49%), Gaps = 23/227 (10%)
Query: 339 NSQWQKGKLIGRGTFGSVY----VASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIK 394
            ++++K K++G G FG+VY    +    +     A+KE+     +  S ++ K++  E  
Sbjct: 17  ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR----EATSPKANKEILDEAY 72
Query: 395 VLSHLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILS 454
           V++ + +P++ +  G   +     + ++ +  G +  YVREH   I    + N+   I  
Sbjct: 73  VMASVDNPHVCRLLGI-CLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAK 131
Query: 455 GLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPY---WMAP 511
           G+ YL  ++ +HRD+   N+LV     VK+ DFG+AK L  ++ +   +G      WMA 
Sbjct: 132 GMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 191
Query: 512 ELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAA 557
           E ++  +   +S       D+WS G T+ E+ T G  P   Y+G  A
Sbjct: 192 ESILHRIYTHQS-------DVWSYGVTVWELMTFGSKP---YDGIPA 228

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 70/284 (24%), Positives = 130/284 (45%), Gaps = 23/284 (8%)
Query: 338 MNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIF-PDDPKSAESIKQLEQEIKVL 396
           ++  +  G+ +G G F  V     + TG   A K +        +   S + +E+E+ +L
Sbjct: 9   VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSIL 68
Query: 397 SHLKHPNIVQYYGSEIVEDKFYIYL--EYVHPGSINKYVREHCGAITESVVRNFTRHILS 454
             ++HPN++  +  E+ E+K  + L  E V  G +  ++ E   ++TE     F + IL+
Sbjct: 69  KEIQHPNVITLH--EVYENKTDVILIGELVAGGELFDFLAEK-ESLTEEEATEFLKQILN 125
Query: 455 GLAYLHSKKTIHRDIKGANLLVDASGV----VKLADFGMAKHLTGQKADLSMKGSPYWMA 510
           G+ YLHS +  H D+K  N+++    V    +K+ DFG+A  +       ++ G+P ++A
Sbjct: 126 GVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVA 185
Query: 511 PELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPD 570
           PE++             L  D+WS+G     + +G  P+        +  V        D
Sbjct: 186 PEIV-------NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFED 238
Query: 571 ----SLSPEGKDFLRCCFQRNPADRPPASLLLEHRFL--KNSQQ 608
               + S   KDF+R    ++P  R      L+H ++  K++QQ
Sbjct: 239 EYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQ 282

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 66/258 (25%), Positives = 115/258 (44%), Gaps = 22/258 (8%)
Query: 346 KLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQ---LEQEIKVLSHLKHP 402
           ++IG G FG V     +  G     +E+ +     KS  + KQ      E  ++    HP
Sbjct: 39  QVIGAGEFGEVCSGHLKLPGK----REIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHP 94
Query: 403 NIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSK 462
           N++   G         I  E++  GS++ ++R++ G  T   +    R I +G+ YL   
Sbjct: 95  NVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADM 154
Query: 463 KTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKAD------LSMKGSPYWMAPELMMA 516
             +HRD+   N+LV+++ V K++DFG+++ L    +D      L  K    W APE   A
Sbjct: 155 NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPE---A 211
Query: 517 VMQKGKSSDSALAVDIWSLGCTIIE-MYTGKPPWSEYEGAAAMFKVMRDTPAIPDSLSPE 575
           +  +  +S    A D+WS G  + E M  G+ P+ +      +  + +D    P    P 
Sbjct: 212 IQYRKFTS----ASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPPPMDCPS 267
Query: 576 G-KDFLRCCFQRNPADRP 592
                +  C+Q++   RP
Sbjct: 268 ALHQLMLDCWQKDRNHRP 285

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 101/213 (47%), Gaps = 14/213 (6%)
Query: 331 AKPEPLPMNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKE-VDIFPDDPKSAESIKQL 389
           ++PE     S +Q+   +G G++G V+   ++E G L A+K  +  F      A  + ++
Sbjct: 49  SRPESFFQQS-FQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEV 107
Query: 390 EQEIKVLSHLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFT 449
               KV    +HP  V+   +       Y+  E   P S+ ++      ++ E+ V  + 
Sbjct: 108 GSHEKVG---QHPCCVRLEQAWEEGGILYLQTELCGP-SLQQHCEAWGASLPEAQVWGYL 163
Query: 450 RHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPYWM 509
           R  L  LA+LHS+  +H D+K AN+ +   G  KL DFG+   L    A    +G P +M
Sbjct: 164 RDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQEGDPRYM 223
Query: 510 APELMMAVMQKGKSSDSALAVDIWSLGCTIIEM 542
           APEL+              A D++SLG TI+E+
Sbjct: 224 APELLQG--------SYGTAADVFSLGLTILEV 248

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 71/258 (27%), Positives = 120/258 (46%), Gaps = 24/258 (9%)
Query: 346 KLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQ---LEQEIKVLSHLKHP 402
           K+IG G FG V     +  G     +E+ +     K+  + KQ      E  ++    HP
Sbjct: 20  KVIGVGEFGEVCSGRLKVPGK----REICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHP 75
Query: 403 NIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSK 462
           NI+   G         I  EY+  GS++ ++R++ G  T   +    R I SG+ YL   
Sbjct: 76  NIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLRGIGSGMKYLSDM 135
Query: 463 KTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQ-KADLSMKGSPY---WMAPELMMAVM 518
             +HRD+   N+LV+++ V K++DFGM++ L    +A  + +G      W APE   A+ 
Sbjct: 136 SYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPE---AIA 192
Query: 519 QKGKSSDSALAVDIWSLGCTIIEM--YTGKPPW--SEYEGAAAMFKVMRDTPAIPDSLSP 574
            +  +S    A D+WS G  + E+  Y  +P W  S  +   A+ +  R  P +   ++ 
Sbjct: 193 YRKFTS----ASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEEGYRLPPPMDCPIAL 248
Query: 575 EGKDFLRCCFQRNPADRP 592
                +  C+Q+  +DRP
Sbjct: 249 H--QLMLDCWQKERSDRP 264

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 67/265 (25%), Positives = 120/265 (45%), Gaps = 24/265 (9%)
Query: 339 NSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSH 398
           + Q   G+ IG G+FG+VY    +  G + A+K +++    P+  ++ K    E+ VL  
Sbjct: 27  DGQITVGQRIGSGSFGTVY--KGKWHGDV-AVKMLNVTAPTPQQLQAFKN---EVGVLRK 80
Query: 399 LKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVR--NFTRHILSGL 456
            +H NI+ + G    + +  I  ++    S+  Y   H       +++  +  R    G+
Sbjct: 81  TRHVNILLFMGYS-TKPQLAIVTQWCEGSSL--YHHLHIIETKFEMIKLIDIARQTAQGM 137
Query: 457 AYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKH---LTGQKADLSMKGSPYWMAPEL 513
            YLH+K  IHRD+K  N+ +     VK+ DFG+A      +G      + GS  WMAPE 
Sbjct: 138 DYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPE- 196
Query: 514 MMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGA-AAMFKVMR-----DTPA 567
              V++    +  +   D+++ G  + E+ TG+ P+S        +F V R     D   
Sbjct: 197 ---VIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSK 253
Query: 568 IPDSLSPEGKDFLRCCFQRNPADRP 592
           +  +     K  +  C ++   +RP
Sbjct: 254 VRSNCPKAMKRLMAECLKKKRDERP 278

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 83.6 bits (205), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 74/296 (25%), Positives = 132/296 (44%), Gaps = 37/296 (12%)
Query: 334 EPLPMN-SQWQ-------KGKLIGRGTFGSVYVASNRETGALCAMKEVDI-FPDDPKSAE 384
           E LP + S+W+        GK +GRG FG V  A           + V +    +  +  
Sbjct: 13  ERLPYDASKWEFPRDRLNLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHS 72
Query: 385 SIKQLEQEIKVLSHL-KHPNIVQYYGSEIVEDK-FYIYLEYVHPGSINKYVRE------- 435
             + L  E+K+L H+  H N+V   G+         + +E+   G+++ Y+R        
Sbjct: 73  EHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVP 132
Query: 436 ----HCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAK 491
               +   +T   +  ++  +  G+ +L S+K IHRD+   N+L+    VVK+ DFG+A+
Sbjct: 133 YKDLYKDFLTLEHLICYSFQVAKGMEFLASRKXIHRDLAARNILLSEKNVVKICDFGLAR 192
Query: 492 HLTGQKADLSMKGSP----YWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GK 546
            +  +  D   KG       WMAPE +   +   +S       D+WS G  + E+++ G 
Sbjct: 193 DIY-KDPDYVRKGDARLPLKWMAPETIFDRVYTIQS-------DVWSFGVLLWEIFSLGA 244
Query: 547 PPWSEYEGAAAMFKVMRDTPAI--PDSLSPEGKDFLRCCFQRNPADRPPASLLLEH 600
            P+   +      + +++   +  PD  +PE    +  C+   P+ RP  S L+EH
Sbjct: 245 SPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 300

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score = 83.6 bits (205), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 74/293 (25%), Positives = 122/293 (41%), Gaps = 49/293 (16%)
Query: 337 PMNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDI--------FPDDPKSAESIKQ 388
           P+ SQ+Q G L+G G FGSVY           A+K V+          P+  +    +  
Sbjct: 1   PLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVL 60
Query: 389 LEQE-------IKVLSHLKHPNIVQYYGSEIVEDKFYIYLEYVHP-GSINKYVREHCGAI 440
           L++        I++L   + P            D F + LE   P   +  ++ E  GA+
Sbjct: 61  LKKVSSGFSGVIRLLDWFERP------------DSFVLILERPEPVQDLFDFITER-GAL 107
Query: 441 TESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDAS-GVVKLADFGMAKHLTGQKAD 499
            E + R+F   +L  + + H+   +HRDIK  N+L+D + G +KL DFG    L      
Sbjct: 108 QEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGA-LLKDTVY 166
Query: 500 LSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYE---GAA 556
               G+  +  PE +      G+S+       +WSLG  + +M  G  P+   E   G  
Sbjct: 167 TDFDGTRVYSPPEWIRYHRYHGRSA------AVWSLGILLYDMVCGDIPFEHDEEIIGGQ 220
Query: 557 AMFKVMRDTPAIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQP 609
             F+           +S E +  +R C    P+DRP    +  H ++++   P
Sbjct: 221 VFFR---------QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLP 264

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 83.6 bits (205), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 71/257 (27%), Positives = 130/257 (50%), Gaps = 30/257 (11%)
Query: 346 KLIGRGTFGSVYVAS-NRETG-ALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPN 403
           K +G G FG V++A+ N+ T  A+  MK        P S  S++    E  V+  L+H  
Sbjct: 21  KKLGAGQFGEVWMATYNKHTKVAVKTMK--------PGSM-SVEAFLAEANVMKTLQHDK 71
Query: 404 IVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITE-SVVRNFTRHILSGLAYLHSK 462
           +V+ +   + ++  YI  E++  GS+  +++   G+      + +F+  I  G+A++  +
Sbjct: 72  LVKLHAV-VTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR 130
Query: 463 KTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPY---WMAPELMMAVMQ 519
             IHRD++ AN+LV AS V K+ADFG+A+ +   +   + +G+ +   W APE +     
Sbjct: 131 NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYT-AREGAKFPIKWTAPEAI----- 184
Query: 520 KGKSSDSALAVDIWSLGCTIIEMYT-GKPPW---SEYEGAAAMFKVMRDTPAIPDSLSPE 575
                   +  D+WS G  ++E+ T G+ P+   S  E   A+ +  R  P  P++   E
Sbjct: 185 --NFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYR-MPR-PENCPEE 240
Query: 576 GKDFLRCCFQRNPADRP 592
             + +  C++  P +RP
Sbjct: 241 LYNIMMRCWKNRPEERP 257

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 83.6 bits (205), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 77/287 (26%), Positives = 138/287 (48%), Gaps = 41/287 (14%)
Query: 320 LSPSATIPQVAAKPEPLPMNSQWQ-------KGKLIGRGTFGSVYVAS-NRETG-ALCAM 370
           L    ++P +++KP+       W+         K +G G FG V++A+ N+ T  A+  M
Sbjct: 155 LCQKLSVPCMSSKPQKPWEKDAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTM 214
Query: 371 KEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSIN 430
           K        P S  S++    E  V+  L+H  +V+ +   + ++  YI  E++  GS+ 
Sbjct: 215 K--------PGSM-SVEAFLAEANVMKTLQHDKLVKLHAV-VTKEPIYIITEFMAKGSLL 264
Query: 431 KYVREHCGAITE-SVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGM 489
            +++   G+      + +F+  I  G+A++  +  IHRD++ AN+LV AS V K+ADFG+
Sbjct: 265 DFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGL 324
Query: 490 AKHLTGQKADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPP 548
           A+   G K  +       W APE +             +  D+WS G  ++E+ T G+ P
Sbjct: 325 AR--VGAKFPIK------WTAPEAI-------NFGSFTIKSDVWSFGILLMEIVTYGRIP 369
Query: 549 W---SEYEGAAAMFKVMRDTPAIPDSLSPEGKDFLRCCFQRNPADRP 592
           +   S  E   A+ +  R  P  P++   E  + +  C++  P +RP
Sbjct: 370 YPGMSNPEVIRALERGYR-MPR-PENCPEELYNIMMRCWKNRPEERP 414

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 83.6 bits (205), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 72/281 (25%), Positives = 130/281 (46%), Gaps = 29/281 (10%)
Query: 346 KLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKH--PN 403
           K IG G    V+   N E   + A+K V++   D ++ +S +    EI  L+ L+     
Sbjct: 34  KQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRN---EIAYLNKLQQHSDK 89
Query: 404 IVQYYGSEIVEDKFYIYLEYVHPGSI--NKYVREHCGAITESVVRNFTRHILSGLAYLHS 461
           I++ Y  EI +   Y+ +E    G+I  N ++++   +I     +++ +++L  +  +H 
Sbjct: 90  IIRLYDYEITDQYIYMVME---CGNIDLNSWLKKK-KSIDPWERKSYWKNMLEAVHTIHQ 145
Query: 462 KKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADL---SMKGSPYWMAPELMMAVM 518
              +H D+K AN L+   G++KL DFG+A  +      +   S  G+  +M PE   A+ 
Sbjct: 146 HGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDXXXVVKDSQVGTVNYMPPE---AIK 201
Query: 519 QKGKSSDSALAV-------DIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRD---TPAI 568
               S ++  +        D+WSLGC +  M  GK P+ +     +    + D       
Sbjct: 202 DMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEF 261
Query: 569 PDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQP 609
           PD    + +D L+CC +R+P  R     LL H +++    P
Sbjct: 262 PDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHP 302

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 83.6 bits (205), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 67/265 (25%), Positives = 120/265 (45%), Gaps = 24/265 (9%)
Query: 339 NSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSH 398
           + Q   G+ IG G+FG+VY    +  G + A+K +++    P+  ++ K    E+ VL  
Sbjct: 35  DGQITVGQRIGSGSFGTVY--KGKWHGDV-AVKMLNVTAPTPQQLQAFKN---EVGVLRK 88
Query: 399 LKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVR--NFTRHILSGL 456
            +H NI+ + G    + +  I  ++    S+  Y   H       +++  +  R    G+
Sbjct: 89  TRHVNILLFMGYS-TKPQLAIVTQWCEGSSL--YHHLHIIETKFEMIKLIDIARQTAQGM 145
Query: 457 AYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKH---LTGQKADLSMKGSPYWMAPEL 513
            YLH+K  IHRD+K  N+ +     VK+ DFG+A      +G      + GS  WMAPE 
Sbjct: 146 DYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPE- 204
Query: 514 MMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGA-AAMFKVMR-----DTPA 567
              V++    +  +   D+++ G  + E+ TG+ P+S        +F V R     D   
Sbjct: 205 ---VIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSK 261
Query: 568 IPDSLSPEGKDFLRCCFQRNPADRP 592
           +  +     K  +  C ++   +RP
Sbjct: 262 VRSNCPKAMKRLMAECLKKKRDERP 286

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 83.6 bits (205), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 67/265 (25%), Positives = 120/265 (45%), Gaps = 24/265 (9%)
Query: 339 NSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSH 398
           + Q   G+ IG G+FG+VY    +  G + A+K +++    P+  ++ K    E+ VL  
Sbjct: 35  DGQITVGQRIGSGSFGTVY--KGKWHGDV-AVKMLNVTAPTPQQLQAFKN---EVGVLRK 88
Query: 399 LKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVR--NFTRHILSGL 456
            +H NI+ + G    + +  I  ++    S+  Y   H       +++  +  R    G+
Sbjct: 89  TRHVNILLFMGYS-TKPQLAIVTQWCEGSSL--YHHLHIIETKFEMIKLIDIARQTAQGM 145
Query: 457 AYLHSKKTIHRDIKGANLLVDASGVVKLADFGMA---KHLTGQKADLSMKGSPYWMAPEL 513
            YLH+K  IHRD+K  N+ +     VK+ DFG+A      +G      + GS  WMAPE 
Sbjct: 146 DYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPE- 204
Query: 514 MMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGA-AAMFKVMR-----DTPA 567
              V++    +  +   D+++ G  + E+ TG+ P+S        +F V R     D   
Sbjct: 205 ---VIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSK 261
Query: 568 IPDSLSPEGKDFLRCCFQRNPADRP 592
           +  +     K  +  C ++   +RP
Sbjct: 262 VRSNCPKAMKRLMAECLKKKRDERP 286

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 83.2 bits (204), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 67/265 (25%), Positives = 120/265 (45%), Gaps = 24/265 (9%)
Query: 339 NSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSH 398
           + Q   G+ IG G+FG+VY    +  G + A+K +++    P+  ++ K    E+ VL  
Sbjct: 34  DGQITVGQRIGSGSFGTVY--KGKWHGDV-AVKMLNVTAPTPQQLQAFKN---EVGVLRK 87
Query: 399 LKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVR--NFTRHILSGL 456
            +H NI+ + G    + +  I  ++    S+  Y   H       +++  +  R    G+
Sbjct: 88  TRHVNILLFMGYS-TKPQLAIVTQWCEGSSL--YHHLHIIETKFEMIKLIDIARQTAQGM 144
Query: 457 AYLHSKKTIHRDIKGANLLVDASGVVKLADFGMA---KHLTGQKADLSMKGSPYWMAPEL 513
            YLH+K  IHRD+K  N+ +     VK+ DFG+A      +G      + GS  WMAPE 
Sbjct: 145 DYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPE- 203
Query: 514 MMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGA-AAMFKVMR-----DTPA 567
              V++    +  +   D+++ G  + E+ TG+ P+S        +F V R     D   
Sbjct: 204 ---VIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSK 260
Query: 568 IPDSLSPEGKDFLRCCFQRNPADRP 592
           +  +     K  +  C ++   +RP
Sbjct: 261 VRSNCPKAMKRLMAECLKKKRDERP 285

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 83.2 bits (204), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 71/258 (27%), Positives = 120/258 (46%), Gaps = 24/258 (9%)
Query: 346 KLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQ---LEQEIKVLSHLKHP 402
           K+IG G FG V     +  G     +E+ +     K+  + KQ      E  ++    HP
Sbjct: 14  KVIGVGEFGEVCSGRLKVPGK----REICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHP 69
Query: 403 NIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSK 462
           NI+   G         I  EY+  GS++ ++R++ G  T   +    R I SG+ YL   
Sbjct: 70  NIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLRGIGSGMKYLSDM 129
Query: 463 KTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQ-KADLSMKGSPY---WMAPELMMAVM 518
             +HRD+   N+LV+++ V K++DFGM++ L    +A  + +G      W APE   A+ 
Sbjct: 130 SYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPE---AIA 186
Query: 519 QKGKSSDSALAVDIWSLGCTIIEM--YTGKPPW--SEYEGAAAMFKVMRDTPAIPDSLSP 574
            +  +S    A D+WS G  + E+  Y  +P W  S  +   A+ +  R  P +   ++ 
Sbjct: 187 YRKFTS----ASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEEGYRLPPPMDCPIAL 242
Query: 575 EGKDFLRCCFQRNPADRP 592
                +  C+Q+  +DRP
Sbjct: 243 H--QLMLDCWQKERSDRP 258

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 83.2 bits (204), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 102/213 (47%), Gaps = 20/213 (9%)
Query: 346 KLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQ---LEQEIKVLSHLKHP 402
           K++G G FG V   S R    L + KE+ +     K   + KQ      E  ++    HP
Sbjct: 51  KVVGAGEFGEV--CSGRL--KLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHP 106
Query: 403 NIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSK 462
           NI++  G         I  EY+  GS++ ++R+H    T   +    R I SG+ YL   
Sbjct: 107 NIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDM 166
Query: 463 KTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQ-KADLSMKGSPY---WMAPELMMAVM 518
             +HRD+   N+L++++ V K++DFG+A+ L    +A  + +G      W +PE   A+ 
Sbjct: 167 GYVHRDLAARNILINSNLVCKVSDFGLARVLEDDPEAAYTTRGGKIPIRWTSPE---AIA 223
Query: 519 QKGKSSDSALAVDIWSLGCTIIEM--YTGKPPW 549
            +  +S    A D+WS G  + E+  Y  +P W
Sbjct: 224 YRKFTS----ASDVWSYGIVLWEVMSYGERPYW 252

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 83.2 bits (204), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 67/265 (25%), Positives = 120/265 (45%), Gaps = 24/265 (9%)
Query: 339 NSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSH 398
           + Q   G+ IG G+FG+VY    +  G + A+K +++    P+  ++ K    E+ VL  
Sbjct: 7   DGQITVGQRIGSGSFGTVY--KGKWHGDV-AVKMLNVTAPTPQQLQAFKN---EVGVLRK 60
Query: 399 LKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVR--NFTRHILSGL 456
            +H NI+ + G    + +  I  ++    S+  Y   H       +++  +  R    G+
Sbjct: 61  TRHVNILLFMGYS-TKPQLAIVTQWCEGSSL--YHHLHIIETKFEMIKLIDIARQTAQGM 117
Query: 457 AYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKH---LTGQKADLSMKGSPYWMAPEL 513
            YLH+K  IHRD+K  N+ +     VK+ DFG+A      +G      + GS  WMAPE 
Sbjct: 118 DYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPE- 176
Query: 514 MMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGA-AAMFKVMR-----DTPA 567
              V++    +  +   D+++ G  + E+ TG+ P+S        +F V R     D   
Sbjct: 177 ---VIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSK 233
Query: 568 IPDSLSPEGKDFLRCCFQRNPADRP 592
           +  +     K  +  C ++   +RP
Sbjct: 234 VRSNCPKAMKRLMAECLKKKRDERP 258

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 83.2 bits (204), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 111/227 (48%), Gaps = 23/227 (10%)
Query: 339 NSQWQKGKLIGRGTFGSVY----VASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIK 394
            ++++K K++G G FG+VY    +    +     A+KE+     +  S ++ K++  E  
Sbjct: 24  ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR----EATSPKANKEILDEAY 79
Query: 395 VLSHLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILS 454
           V++ + +P++ +  G   +     +  + +  G +  YVREH   I    + N+   I  
Sbjct: 80  VMASVDNPHVCRLLGI-CLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAK 138
Query: 455 GLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPY---WMAP 511
           G+ YL  ++ +HRD+   N+LV     VK+ DFG+AK L  ++ +   +G      WMA 
Sbjct: 139 GMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 198
Query: 512 ELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAA 557
           E ++  +   +S       D+WS G T+ E+ T G  P   Y+G  A
Sbjct: 199 ESILHRIYTHQS-------DVWSYGVTVWELMTFGSKP---YDGIPA 235

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 83.2 bits (204), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 63/269 (23%), Positives = 123/269 (45%), Gaps = 20/269 (7%)
Query: 344 KGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPN 403
           K +++G G FG V+      TG   A K +       +  +  ++++ EI V++ L H N
Sbjct: 93  KTEILGGGRFGQVHKCEETATGLKLAAKIIK-----TRGMKDKEEVKNEISVMNQLDHAN 147
Query: 404 IVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKK 463
           ++Q Y +   ++   + +EYV  G +   + +    +TE     F + I  G+ ++H   
Sbjct: 148 LIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMY 207
Query: 464 TIHRDIKGANLLV---DASGVVKLADFGMAKHLTGQKADLSMKGSPYWMAPELMMAVMQK 520
            +H D+K  N+L    DA   +K+ DFG+A+    ++      G+P ++APE++      
Sbjct: 208 ILHLDLKPENILCVNRDAKQ-IKIIDFGLARRYKPREKLKVNFGTPEFLAPEVV------ 260
Query: 521 GKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPD----SLSPEG 576
                 +   D+WS+G     + +G  P+     A  +  ++     + D     +S E 
Sbjct: 261 -NYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEEA 319
Query: 577 KDFLRCCFQRNPADRPPASLLLEHRFLKN 605
           K+F+     +  + R  AS  L+H +L +
Sbjct: 320 KEFISKLLIKEKSWRISASEALKHPWLSD 348

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 83.2 bits (204), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 111/227 (48%), Gaps = 23/227 (10%)
Query: 339 NSQWQKGKLIGRGTFGSVY----VASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIK 394
            ++++K K++G G FG+VY    +    +     A+KE+     +  S ++ K++  E  
Sbjct: 14  ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR----EATSPKANKEILDEAY 69
Query: 395 VLSHLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILS 454
           V++ + +P++ +  G   +     +  + +  G +  YVREH   I    + N+   I  
Sbjct: 70  VMASVDNPHVCRLLGI-CLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAK 128
Query: 455 GLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPY---WMAP 511
           G+ YL  ++ +HRD+   N+LV     VK+ DFG+AK L  ++ +   +G      WMA 
Sbjct: 129 GMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 188
Query: 512 ELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAA 557
           E ++  +   +S       D+WS G T+ E+ T G  P   Y+G  A
Sbjct: 189 ESILHRIYTHQS-------DVWSYGVTVWELMTFGSKP---YDGIPA 225

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 82.8 bits (203), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 111/227 (48%), Gaps = 23/227 (10%)
Query: 339 NSQWQKGKLIGRGTFGSVY----VASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIK 394
            ++++K K++G G FG+VY    +    +     A+KE+     +  S ++ K++  E  
Sbjct: 18  ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR----EATSPKANKEILDEAY 73
Query: 395 VLSHLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILS 454
           V++ + +P++ +  G   +     + ++ +  G +  YVREH   I    + N+   I  
Sbjct: 74  VMASVDNPHVCRLLGI-CLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAK 132
Query: 455 GLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPY---WMAP 511
           G+ YL  ++ +HRD+   N+LV     VK+ DFG AK L  ++ +   +G      WMA 
Sbjct: 133 GMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMAL 192
Query: 512 ELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAA 557
           E ++  +   +S       D+WS G T+ E+ T G  P   Y+G  A
Sbjct: 193 ESILHRIYTHQS-------DVWSYGVTVWELMTFGSKP---YDGIPA 229

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 82.8 bits (203), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 111/227 (48%), Gaps = 23/227 (10%)
Query: 339 NSQWQKGKLIGRGTFGSVY----VASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIK 394
            ++++K K++G G FG+VY    +    +     A+KE+     +  S ++ K++  E  
Sbjct: 17  ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR----EATSPKANKEILDEAY 72
Query: 395 VLSHLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILS 454
           V++ + +P++ +  G   +     +  + +  G +  YVREH   I    + N+   I  
Sbjct: 73  VMASVDNPHVCRLLGI-CLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAK 131
Query: 455 GLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPY---WMAP 511
           G+ YL  ++ +HRD+   N+LV     VK+ DFG+AK L  ++ +   +G      WMA 
Sbjct: 132 GMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 191
Query: 512 ELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAA 557
           E ++  +   +S       D+WS G T+ E+ T G  P   Y+G  A
Sbjct: 192 ESILHRIYTHQS-------DVWSYGVTVWELMTFGSKP---YDGIPA 228

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 82.8 bits (203), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 111/227 (48%), Gaps = 23/227 (10%)
Query: 339 NSQWQKGKLIGRGTFGSVY----VASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIK 394
            ++++K K++G G FG+VY    +    +     A+KE+     +  S ++ K++  E  
Sbjct: 16  ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR----EATSPKANKEILDEAY 71
Query: 395 VLSHLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILS 454
           V++ + +P++ +  G   +     +  + +  G +  YVREH   I    + N+   I  
Sbjct: 72  VMASVDNPHVCRLLGI-CLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAK 130
Query: 455 GLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPY---WMAP 511
           G+ YL  ++ +HRD+   N+LV     VK+ DFG+AK L  ++ +   +G      WMA 
Sbjct: 131 GMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 190
Query: 512 ELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAA 557
           E ++  +   +S       D+WS G T+ E+ T G  P   Y+G  A
Sbjct: 191 ESILHRIYTHQS-------DVWSYGVTVWELMTFGSKP---YDGIPA 227

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 82.8 bits (203), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 111/227 (48%), Gaps = 23/227 (10%)
Query: 339 NSQWQKGKLIGRGTFGSVY----VASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIK 394
            ++++K K++G G FG+VY    +    +     A+KE+     +  S ++ K++  E  
Sbjct: 16  ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR----EATSPKANKEILDEAY 71
Query: 395 VLSHLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILS 454
           V++ + +P++ +  G   +     + ++ +  G +  YVREH   I    + N+   I  
Sbjct: 72  VMASVDNPHVCRLLGI-CLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAK 130
Query: 455 GLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPY---WMAP 511
           G+ YL  ++ +HRD+   N+LV     VK+ DFG AK L  ++ +   +G      WMA 
Sbjct: 131 GMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMAL 190
Query: 512 ELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAA 557
           E ++  +   +S       D+WS G T+ E+ T G  P   Y+G  A
Sbjct: 191 ESILHRIYTHQS-------DVWSYGVTVWELMTFGSKP---YDGIPA 227

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 82.8 bits (203), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 111/227 (48%), Gaps = 23/227 (10%)
Query: 339 NSQWQKGKLIGRGTFGSVY----VASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIK 394
            ++++K K++G G FG+VY    +    +     A+KE+     +  S ++ K++  E  
Sbjct: 39  ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR----EATSPKANKEILDEAY 94
Query: 395 VLSHLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILS 454
           V++ + +P++ +  G   +     +  + +  G +  YVREH   I    + N+   I  
Sbjct: 95  VMASVDNPHVCRLLGI-CLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAK 153
Query: 455 GLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPY---WMAP 511
           G+ YL  ++ +HRD+   N+LV     VK+ DFG+AK L  ++ +   +G      WMA 
Sbjct: 154 GMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 213
Query: 512 ELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAA 557
           E ++  +   +S       D+WS G T+ E+ T G  P   Y+G  A
Sbjct: 214 ESILHRIYTHQS-------DVWSYGVTVWELMTFGSKP---YDGIPA 250

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 82.8 bits (203), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 111/227 (48%), Gaps = 23/227 (10%)
Query: 339 NSQWQKGKLIGRGTFGSVY----VASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIK 394
            ++++K K++G G FG+VY    +    +     A+KE+     +  S ++ K++  E  
Sbjct: 20  ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR----EATSPKANKEILDEAY 75
Query: 395 VLSHLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILS 454
           V++ + +P++ +  G   +     +  + +  G +  YVREH   I    + N+   I  
Sbjct: 76  VMASVDNPHVCRLLGI-CLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAK 134
Query: 455 GLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPY---WMAP 511
           G+ YL  ++ +HRD+   N+LV     VK+ DFG+AK L  ++ +   +G      WMA 
Sbjct: 135 GMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 194
Query: 512 ELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAA 557
           E ++  +   +S       D+WS G T+ E+ T G  P   Y+G  A
Sbjct: 195 ESILHRIYTHQS-------DVWSYGVTVWELMTFGSKP---YDGIPA 231

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 82.8 bits (203), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 67/265 (25%), Positives = 120/265 (45%), Gaps = 24/265 (9%)
Query: 339 NSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSH 398
           + Q   G+ IG G+FG+VY    +  G + A+K +++    P+  ++ K    E+ VL  
Sbjct: 12  DGQITVGQRIGSGSFGTVY--KGKWHGDV-AVKMLNVTAPTPQQLQAFKN---EVGVLRK 65
Query: 399 LKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVR--NFTRHILSGL 456
            +H NI+ + G    + +  I  ++    S+  Y   H       +++  +  R    G+
Sbjct: 66  TRHVNILLFMGYS-TKPQLAIVTQWCEGSSL--YHHLHIIETKFEMIKLIDIARQTAQGM 122
Query: 457 AYLHSKKTIHRDIKGANLLVDASGVVKLADFGMA---KHLTGQKADLSMKGSPYWMAPEL 513
            YLH+K  IHRD+K  N+ +     VK+ DFG+A      +G      + GS  WMAPE 
Sbjct: 123 DYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPE- 181
Query: 514 MMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGA-AAMFKVMR-----DTPA 567
              V++    +  +   D+++ G  + E+ TG+ P+S        +F V R     D   
Sbjct: 182 ---VIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSK 238
Query: 568 IPDSLSPEGKDFLRCCFQRNPADRP 592
           +  +     K  +  C ++   +RP
Sbjct: 239 VRSNCPKAMKRLMAECLKKKRDERP 263

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 82.8 bits (203), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 111/227 (48%), Gaps = 23/227 (10%)
Query: 339 NSQWQKGKLIGRGTFGSVY----VASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIK 394
            ++++K K++G G FG+VY    +    +     A+KE+     +  S ++ K++  E  
Sbjct: 17  ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR----EATSPKANKEILDEAY 72
Query: 395 VLSHLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILS 454
           V++ + +P++ +  G   +     +  + +  G +  YVREH   I    + N+   I  
Sbjct: 73  VMASVDNPHVCRLLGI-CLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAK 131
Query: 455 GLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPY---WMAP 511
           G+ YL  ++ +HRD+   N+LV     VK+ DFG+AK L  ++ +   +G      WMA 
Sbjct: 132 GMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 191
Query: 512 ELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAA 557
           E ++  +   +S       D+WS G T+ E+ T G  P   Y+G  A
Sbjct: 192 ESILHRIYTHQS-------DVWSYGVTVWELMTFGSKP---YDGIPA 228

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 82.8 bits (203), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 111/227 (48%), Gaps = 23/227 (10%)
Query: 339 NSQWQKGKLIGRGTFGSVY----VASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIK 394
            ++++K K++G G FG+VY    +    +     A+KE+     +  S ++ K++  E  
Sbjct: 14  ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR----EATSPKANKEILDEAY 69
Query: 395 VLSHLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILS 454
           V++ + +P++ +  G   +     +  + +  G +  YVREH   I    + N+   I  
Sbjct: 70  VMASVDNPHVCRLLGI-CLTSTVQLITQLMPFGXLLDYVREHKDNIGSQYLLNWCVQIAK 128
Query: 455 GLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPY---WMAP 511
           G+ YL  ++ +HRD+   N+LV     VK+ DFG+AK L  ++ +   +G      WMA 
Sbjct: 129 GMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 188
Query: 512 ELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAA 557
           E ++  +   +S       D+WS G T+ E+ T G  P   Y+G  A
Sbjct: 189 ESILHRIYTHQS-------DVWSYGVTVWELMTFGSKP---YDGIPA 225

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 82.8 bits (203), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 67/265 (25%), Positives = 120/265 (45%), Gaps = 24/265 (9%)
Query: 339 NSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSH 398
           + Q   G+ IG G+FG+VY    +  G + A+K +++    P+  ++ K    E+ VL  
Sbjct: 9   DGQITVGQRIGSGSFGTVY--KGKWHGDV-AVKMLNVTAPTPQQLQAFKN---EVGVLRK 62
Query: 399 LKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVR--NFTRHILSGL 456
            +H NI+ + G    + +  I  ++    S+  Y   H       +++  +  R    G+
Sbjct: 63  TRHVNILLFMGYS-TKPQLAIVTQWCEGSSL--YHHLHIIETKFEMIKLIDIARQTAQGM 119
Query: 457 AYLHSKKTIHRDIKGANLLVDASGVVKLADFGMA---KHLTGQKADLSMKGSPYWMAPEL 513
            YLH+K  IHRD+K  N+ +     VK+ DFG+A      +G      + GS  WMAPE 
Sbjct: 120 DYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPE- 178
Query: 514 MMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGA-AAMFKVMR-----DTPA 567
              V++    +  +   D+++ G  + E+ TG+ P+S        +F V R     D   
Sbjct: 179 ---VIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSK 235
Query: 568 IPDSLSPEGKDFLRCCFQRNPADRP 592
           +  +     K  +  C ++   +RP
Sbjct: 236 VRSNCPKAMKRLMAECLKKKRDERP 260

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 82.8 bits (203), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 102/213 (47%), Gaps = 13/213 (6%)
Query: 340 SQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHL 399
           ++ ++ K++G G FG+VY       G    +       ++    ++  +   E  +++ +
Sbjct: 15  TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASM 74
Query: 400 KHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYL 459
            HP++V+  G   +     +  + +  G + +YV EH   I   ++ N+   I  G+ YL
Sbjct: 75  DHPHLVRLLGV-CLSPTIQLVTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQIAKGMMYL 133
Query: 460 HSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPY---WMAPELMMA 516
             ++ +HRD+   N+LV +   VK+ DFG+A+ L G + + +  G      WMA E    
Sbjct: 134 EERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALE---C 190
Query: 517 VMQKGKSSDSALAVDIWSLGCTIIEMYT--GKP 547
           +  +  +  S    D+WS G TI E+ T  GKP
Sbjct: 191 IHYRKFTHQS----DVWSYGVTIWELMTFGGKP 219

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 82.8 bits (203), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 111/227 (48%), Gaps = 23/227 (10%)
Query: 339 NSQWQKGKLIGRGTFGSVY----VASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIK 394
            ++++K K++G G FG+VY    +    +     A+KE+     +  S ++ K++  E  
Sbjct: 11  ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR----EATSPKANKEILDEAY 66
Query: 395 VLSHLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILS 454
           V++ + +P++ +  G   +     +  + +  G +  YVREH   I    + N+   I  
Sbjct: 67  VMASVDNPHVCRLLGI-CLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAE 125
Query: 455 GLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPY---WMAP 511
           G+ YL  ++ +HRD+   N+LV     VK+ DFG+AK L  ++ +   +G      WMA 
Sbjct: 126 GMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 185
Query: 512 ELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAA 557
           E ++  +   +S       D+WS G T+ E+ T G  P   Y+G  A
Sbjct: 186 ESILHRIYTHQS-------DVWSYGVTVWELMTFGSKP---YDGIPA 222

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 82.8 bits (203), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 67/265 (25%), Positives = 120/265 (45%), Gaps = 24/265 (9%)
Query: 339 NSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSH 398
           + Q   G+ IG G+FG+VY    +  G + A+K +++    P+  ++ K    E+ VL  
Sbjct: 7   DGQITVGQRIGSGSFGTVY--KGKWHGDV-AVKMLNVTAPTPQQLQAFKN---EVGVLRK 60
Query: 399 LKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVR--NFTRHILSGL 456
            +H NI+ + G    + +  I  ++    S+  Y   H       +++  +  R    G+
Sbjct: 61  TRHVNILLFMGYS-TKPQLAIVTQWCEGSSL--YHHLHIIETKFEMIKLIDIARQTAQGM 117
Query: 457 AYLHSKKTIHRDIKGANLLVDASGVVKLADFGMA---KHLTGQKADLSMKGSPYWMAPEL 513
            YLH+K  IHRD+K  N+ +     VK+ DFG+A      +G      + GS  WMAPE 
Sbjct: 118 DYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPE- 176
Query: 514 MMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGA-AAMFKVMR-----DTPA 567
              V++    +  +   D+++ G  + E+ TG+ P+S        +F V R     D   
Sbjct: 177 ---VIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSK 233
Query: 568 IPDSLSPEGKDFLRCCFQRNPADRP 592
           +  +     K  +  C ++   +RP
Sbjct: 234 VRSNCPKAMKRLMAECLKKKRDERP 258

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 82.8 bits (203), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 111/227 (48%), Gaps = 23/227 (10%)
Query: 339 NSQWQKGKLIGRGTFGSVY----VASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIK 394
            ++++K K++G G FG+VY    +    +     A+KE+     +  S ++ K++  E  
Sbjct: 21  ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR----EATSPKANKEILDEAY 76
Query: 395 VLSHLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILS 454
           V++ + +P++ +  G   +     +  + +  G +  YVREH   I    + N+   I  
Sbjct: 77  VMASVDNPHVCRLLGI-CLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAK 135
Query: 455 GLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPY---WMAP 511
           G+ YL  ++ +HRD+   N+LV     VK+ DFG+AK L  ++ +   +G      WMA 
Sbjct: 136 GMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 195
Query: 512 ELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAA 557
           E ++  +   +S       D+WS G T+ E+ T G  P   Y+G  A
Sbjct: 196 ESILHRIYTHQS-------DVWSYGVTVWELMTFGSKP---YDGIPA 232

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 82.8 bits (203), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 111/227 (48%), Gaps = 23/227 (10%)
Query: 339 NSQWQKGKLIGRGTFGSVY----VASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIK 394
            ++++K K++G G FG+VY    +    +     A+KE+     +  S ++ K++  E  
Sbjct: 17  ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR----EATSPKANKEILDEAY 72
Query: 395 VLSHLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILS 454
           V++ + +P++ +  G   +     +  + +  G +  YVREH   I    + N+   I  
Sbjct: 73  VMASVDNPHVCRLLGI-CLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAK 131
Query: 455 GLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPY---WMAP 511
           G+ YL  ++ +HRD+   N+LV     VK+ DFG+AK L  ++ +   +G      WMA 
Sbjct: 132 GMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 191
Query: 512 ELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAA 557
           E ++  +   +S       D+WS G T+ E+ T G  P   Y+G  A
Sbjct: 192 ESILHRIYTHQS-------DVWSYGVTVWELMTFGSKP---YDGIPA 228

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 82.8 bits (203), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 111/227 (48%), Gaps = 23/227 (10%)
Query: 339 NSQWQKGKLIGRGTFGSVY----VASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIK 394
            ++++K K++G G FG+VY    +    +     A+KE+     +  S ++ K++  E  
Sbjct: 8   ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR----EATSPKANKEILDEAY 63
Query: 395 VLSHLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILS 454
           V++ + +P++ +  G   +     +  + +  G +  YVREH   I    + N+   I  
Sbjct: 64  VMASVDNPHVCRLLGI-CLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAK 122
Query: 455 GLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPY---WMAP 511
           G+ YL  ++ +HRD+   N+LV     VK+ DFG+AK L  ++ +   +G      WMA 
Sbjct: 123 GMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 182
Query: 512 ELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAA 557
           E ++  +   +S       D+WS G T+ E+ T G  P   Y+G  A
Sbjct: 183 ESILHRIYTHQS-------DVWSYGVTVWELMTFGSKP---YDGIPA 219

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 82.8 bits (203), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 111/227 (48%), Gaps = 23/227 (10%)
Query: 339 NSQWQKGKLIGRGTFGSVY----VASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIK 394
            ++++K K++G G FG+VY    +    +     A+KE+     +  S ++ K++  E  
Sbjct: 16  ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR----EATSPKANKEILDEAY 71
Query: 395 VLSHLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILS 454
           V++ + +P++ +  G   +     + ++ +  G +  YVREH   I    + N+   I  
Sbjct: 72  VMASVDNPHVCRLLGI-CLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAK 130
Query: 455 GLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPY---WMAP 511
           G+ YL  ++ +HRD+   N+LV     VK+ DFG AK L  ++ +   +G      WMA 
Sbjct: 131 GMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMAL 190
Query: 512 ELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAA 557
           E ++  +   +S       D+WS G T+ E+ T G  P   Y+G  A
Sbjct: 191 ESILHRIYTHQS-------DVWSYGVTVWELMTFGSKP---YDGIPA 227

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 82.8 bits (203), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 67/265 (25%), Positives = 120/265 (45%), Gaps = 24/265 (9%)
Query: 339 NSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSH 398
           + Q   G+ IG G+FG+VY    +  G + A+K +++    P+  ++ K    E+ VL  
Sbjct: 12  DGQITVGQRIGSGSFGTVY--KGKWHGDV-AVKMLNVTAPTPQQLQAFKN---EVGVLRK 65
Query: 399 LKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVR--NFTRHILSGL 456
            +H NI+ + G    + +  I  ++    S+  Y   H       +++  +  R    G+
Sbjct: 66  TRHVNILLFMGYS-TKPQLAIVTQWCEGSSL--YHHLHIIETKFEMIKLIDIARQTAQGM 122
Query: 457 AYLHSKKTIHRDIKGANLLVDASGVVKLADFGMA---KHLTGQKADLSMKGSPYWMAPEL 513
            YLH+K  IHRD+K  N+ +     VK+ DFG+A      +G      + GS  WMAPE 
Sbjct: 123 DYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPE- 181
Query: 514 MMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEG-AAAMFKVMR-----DTPA 567
              V++    +  +   D+++ G  + E+ TG+ P+S        +F V R     D   
Sbjct: 182 ---VIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSK 238
Query: 568 IPDSLSPEGKDFLRCCFQRNPADRP 592
           +  +     K  +  C ++   +RP
Sbjct: 239 VRSNCPKAMKRLMAECLKKKRDERP 263

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 82.4 bits (202), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 64/242 (26%), Positives = 114/242 (47%), Gaps = 17/242 (7%)
Query: 320 LSPSATIPQVAAKPEPLPMNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDD 379
           L+PS   P  A     +   ++++K K++G G FG+VY       G    +    +   +
Sbjct: 31  LTPSGEAPNQALLR--ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIMELRE 88
Query: 380 PKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGA 439
             S ++ K++  E  V++ + +P++ +  G   +     +  + +  G +  YVREH   
Sbjct: 89  ATSPKANKEILDEAYVMASVDNPHVCRLLGI-CLTSTVQLITQLMPFGCLLDYVREHKDN 147
Query: 440 ITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKAD 499
           I    + N+   I  G+ YL  ++ +HRD+   N+LV     VK+ DFG+AK L  ++ +
Sbjct: 148 IGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE 207
Query: 500 LSMKGSPY---WMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGA 555
              +G      WMA E ++  +   +S       D+WS G T+ E+ T G  P   Y+G 
Sbjct: 208 YHAEGGKVPIKWMALESILHRIYTHQS-------DVWSYGVTVWELMTFGSKP---YDGI 257
Query: 556 AA 557
            A
Sbjct: 258 PA 259

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 82.4 bits (202), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 73/263 (27%), Positives = 114/263 (43%), Gaps = 27/263 (10%)
Query: 348 IGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQY 407
           +GRG    VY    + T    A+K +       K     K +  EI VL  L HPNI++ 
Sbjct: 61  LGRGATSIVYRCKQKGTQKPYALKVL-------KKTVDKKIVRTEIGVLLRLSHPNIIKL 113
Query: 408 YGSEIVED--KFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTI 465
              EI E   +  + LE V  G +   + E  G  +E    +  + IL  +AYLH    +
Sbjct: 114 --KEIFETPTEISLVLELVTGGELFDRIVEK-GYYSERDAADAVKQILEAVAYLHENGIV 170
Query: 466 HRDIKGANLLVDA---SGVVKLADFGMAKHLTGQKADLSMKGSPYWMAPELMMAVMQKGK 522
           HRD+K  NLL         +K+ADFG++K +  Q    ++ G+P + APE++       +
Sbjct: 171 HRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPEIL-------R 223
Query: 523 SSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAI-----PDSLSPEGK 577
                  VD+WS+G     +  G  P+ +  G   MF+ + +          D +S   K
Sbjct: 224 GCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSLNAK 283
Query: 578 DFLRCCFQRNPADRPPASLLLEH 600
           D +R     +P  R      L+H
Sbjct: 284 DLVRKLIVLDPKKRLTTFQALQH 306

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 66/248 (26%), Positives = 108/248 (43%), Gaps = 24/248 (9%)
Query: 315 PGAAVLSPSATIPQVAAKPEPL---PMNSQWQKGKLIGRGTFGSVY---VASNRETGALC 368
           PG   +  SA  P++    + +   P +      ++IGRG FG VY   +  N      C
Sbjct: 2   PGTVHIDLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHC 61
Query: 369 AMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEI-VEDKFYIYLEYVHPG 427
           A+K ++   D       + Q   E  ++    HPN++   G  +  E    + L Y+  G
Sbjct: 62  AVKSLNRITD----IGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHG 117
Query: 428 SINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADF 487
            +  ++R      T   +  F   +  G+ +L SKK +HRD+   N ++D    VK+ADF
Sbjct: 118 DLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADF 177
Query: 488 GMAKHLTGQKAD-----LSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEM 542
           G+A+ +  ++ D        K    WMA E +       KS       D+WS G  + E+
Sbjct: 178 GLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKS-------DVWSFGVLLWEL 230
Query: 543 YT-GKPPW 549
            T G PP+
Sbjct: 231 MTRGAPPY 238

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 111/227 (48%), Gaps = 23/227 (10%)
Query: 339 NSQWQKGKLIGRGTFGSVY----VASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIK 394
            ++++K K++G G FG+VY    +    +     A+KE+     +  S ++ K++  E  
Sbjct: 14  ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR----EATSPKANKEILDEAY 69
Query: 395 VLSHLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILS 454
           V++ + +P++ +  G   +     +  + +  G +  YVREH   I    + N+   I  
Sbjct: 70  VMASVDNPHVCRLLGI-CLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAK 128
Query: 455 GLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPY---WMAP 511
           G+ YL  ++ +HRD+   N+LV     VK+ DFG+AK L  ++ +   +G      WMA 
Sbjct: 129 GMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 188
Query: 512 ELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAA 557
           E ++  +   +S       D+WS G T+ E+ T G  P   Y+G  A
Sbjct: 189 ESILHRIYTHQS-------DVWSYGVTVWELMTFGSKP---YDGIPA 225

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 67/265 (25%), Positives = 119/265 (44%), Gaps = 24/265 (9%)
Query: 339 NSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSH 398
           + Q   G+ IG G+FG+VY    +  G + A+K +++    P+  ++ K    E+ VL  
Sbjct: 7   DGQITVGQRIGSGSFGTVY--KGKWHGDV-AVKMLNVTAPTPQQLQAFKN---EVGVLRK 60
Query: 399 LKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVR--NFTRHILSGL 456
            +H NI+ + G      +  I  ++    S+  Y   H       +++  +  R    G+
Sbjct: 61  TRHVNILLFMGYS-TAPQLAIVTQWCEGSSL--YHHLHIIETKFEMIKLIDIARQTAQGM 117
Query: 457 AYLHSKKTIHRDIKGANLLVDASGVVKLADFGMA---KHLTGQKADLSMKGSPYWMAPEL 513
            YLH+K  IHRD+K  N+ +     VK+ DFG+A      +G      + GS  WMAPE 
Sbjct: 118 DYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPE- 176
Query: 514 MMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGA-AAMFKVMR-----DTPA 567
              V++    +  +   D+++ G  + E+ TG+ P+S        +F V R     D   
Sbjct: 177 ---VIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSK 233
Query: 568 IPDSLSPEGKDFLRCCFQRNPADRP 592
           +  +     K  +  C ++   +RP
Sbjct: 234 VRSNCPKAMKRLMAECLKKKRDERP 258

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 62/257 (24%), Positives = 124/257 (48%), Gaps = 25/257 (9%)
Query: 329 VAAKPEPLPMNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDD---PKSAES 385
           V+A P    ++ ++++   +G GT+G VY A +  T    A+K + +  ++   P +A  
Sbjct: 24  VSAAPSATSID-RYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAI- 81
Query: 386 IKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVV 445
                +E+ +L  L+H NI++         + ++  EY     + KY+ ++   ++  V+
Sbjct: 82  -----REVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAE-NDLKKYMDKNPD-VSMRVI 134
Query: 446 RNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASG-----VVKLADFGMAKHLTGQKADL 500
           ++F   +++G+ + HS++ +HRD+K  NLL+  S      V+K+ DFG+A+         
Sbjct: 135 KSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQF 194
Query: 501 SMKGSPYWMA-PELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMF 559
           + +    W   PE+++       S   + +VDIWS+ C   EM    P +        +F
Sbjct: 195 THEIITLWYRPPEILLG------SRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLF 248
Query: 560 KVMRDTPAIPDSLSPEG 576
           K+  +   +PD  +  G
Sbjct: 249 KIF-EVLGLPDDTTWPG 264

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 102/213 (47%), Gaps = 20/213 (9%)
Query: 346 KLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQ---LEQEIKVLSHLKHP 402
           K++G G FG V   S R    L + KE+ +     K   + KQ      E  ++    HP
Sbjct: 51  KVVGAGEFGEV--CSGRL--KLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHP 106
Query: 403 NIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSK 462
           NI++  G         I  EY+  GS++ ++R+H    T   +    R I SG+ YL   
Sbjct: 107 NIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDM 166
Query: 463 KTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQ-KADLSMKGSPY---WMAPELMMAVM 518
             +HRD+   N+L++++ V K++DFG+++ L    +A  + +G      W +PE   A+ 
Sbjct: 167 GFVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPE---AIA 223
Query: 519 QKGKSSDSALAVDIWSLGCTIIEM--YTGKPPW 549
            +  +S    A D+WS G  + E+  Y  +P W
Sbjct: 224 YRKFTS----ASDVWSYGIVLWEVMSYGERPYW 252

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 102/213 (47%), Gaps = 20/213 (9%)
Query: 346 KLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQ---LEQEIKVLSHLKHP 402
           K++G G FG V   S R    L + KE+ +     K   + KQ      E  ++    HP
Sbjct: 51  KVVGAGEFGEV--CSGRL--KLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHP 106
Query: 403 NIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSK 462
           NI++  G         I  EY+  GS++ ++R+H    T   +    R I SG+ YL   
Sbjct: 107 NIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDM 166
Query: 463 KTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQ-KADLSMKGSPY---WMAPELMMAVM 518
             +HRD+   N+L++++ V K++DFG+++ L    +A  + +G      W +PE   A+ 
Sbjct: 167 GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPE---AIA 223
Query: 519 QKGKSSDSALAVDIWSLGCTIIEM--YTGKPPW 549
            +  +S    A D+WS G  + E+  Y  +P W
Sbjct: 224 YRKFTS----ASDVWSYGIVLWEVMSYGERPYW 252

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 62/243 (25%), Positives = 111/243 (45%), Gaps = 11/243 (4%)
Query: 346 KLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIV 405
           K+IGRG FG V V   +    + AMK ++ +    ++  +  + E+++ V    K    +
Sbjct: 80  KVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTL 139
Query: 406 QYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTI 465
            Y   +  ++  Y+ ++Y   G +   + +    + E + R +   ++  +  +H    +
Sbjct: 140 HYAFQD--DNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYV 197
Query: 466 HRDIKGANLLVDASGVVKLADFGMAKHLT--GQKADLSMKGSPYWMAPELMMAVMQKGKS 523
           HRDIK  N+L+D +G ++LADFG    L   G        G+P +++PE++ A M+ GK 
Sbjct: 198 HRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQA-MEGGKG 256
Query: 524 SDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMR-----DTPAIPDSLSPEGKD 578
                  D WSLG  + EM  G+ P+          K+M        P     +S   KD
Sbjct: 257 R-YGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQVTDVSENAKD 315
Query: 579 FLR 581
            +R
Sbjct: 316 LIR 318

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 102/213 (47%), Gaps = 20/213 (9%)
Query: 346 KLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQ---LEQEIKVLSHLKHP 402
           K++G G FG V   S R    L + KE+ +     K   + KQ      E  ++    HP
Sbjct: 49  KVVGAGEFGEV--CSGRL--KLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHP 104
Query: 403 NIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSK 462
           NI++  G         I  EY+  GS++ ++R+H    T   +    R I SG+ YL   
Sbjct: 105 NIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDM 164
Query: 463 KTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQ-KADLSMKGSPY---WMAPELMMAVM 518
             +HRD+   N+L++++ V K++DFG+++ L    +A  + +G      W +PE   A+ 
Sbjct: 165 GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPE---AIA 221
Query: 519 QKGKSSDSALAVDIWSLGCTIIEM--YTGKPPW 549
            +  +S    A D+WS G  + E+  Y  +P W
Sbjct: 222 YRKFTS----ASDVWSYGIVLWEVMSYGERPYW 250

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 101/213 (47%), Gaps = 20/213 (9%)
Query: 346 KLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQ---LEQEIKVLSHLKHP 402
           K++G G FG V   S R    L + KE+ +     K   + KQ      E  ++    HP
Sbjct: 51  KVVGAGEFGEV--CSGRL--KLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHP 106
Query: 403 NIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSK 462
           NI++  G         I  EY+  GS++ ++R+H    T   +    R I SG+ YL   
Sbjct: 107 NIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDM 166
Query: 463 KTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQ-KADLSMKGSPY---WMAPELMMAVM 518
             +HRD+   N+L++++ V K++DFG+ + L    +A  + +G      W +PE   A+ 
Sbjct: 167 GYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPE---AIA 223
Query: 519 QKGKSSDSALAVDIWSLGCTIIEM--YTGKPPW 549
            +  +S    A D+WS G  + E+  Y  +P W
Sbjct: 224 YRKFTS----ASDVWSYGIVLWEVMSYGERPYW 252

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 102/213 (47%), Gaps = 20/213 (9%)
Query: 346 KLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQ---LEQEIKVLSHLKHP 402
           K++G G FG V   S R    L + KE+ +     K   + KQ      E  ++    HP
Sbjct: 39  KVVGAGEFGEV--CSGRL--KLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHP 94
Query: 403 NIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSK 462
           NI++  G         I  EY+  GS++ ++R+H    T   +    R I SG+ YL   
Sbjct: 95  NIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDM 154
Query: 463 KTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQ-KADLSMKGSPY---WMAPELMMAVM 518
             +HRD+   N+L++++ V K++DFG+++ L    +A  + +G      W +PE   A+ 
Sbjct: 155 GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPE---AIA 211
Query: 519 QKGKSSDSALAVDIWSLGCTIIEM--YTGKPPW 549
            +  +S    A D+WS G  + E+  Y  +P W
Sbjct: 212 YRKFTS----ASDVWSYGIVLWEVMSYGERPYW 240

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 102/213 (47%), Gaps = 20/213 (9%)
Query: 346 KLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQ---LEQEIKVLSHLKHP 402
           K++G G FG V   S R    L + KE+ +     K   + KQ      E  ++    HP
Sbjct: 51  KVVGAGEFGEV--CSGRL--KLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHP 106
Query: 403 NIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSK 462
           NI++  G         I  EY+  GS++ ++R+H    T   +    R I SG+ YL   
Sbjct: 107 NIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDM 166
Query: 463 KTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQ-KADLSMKGSPY---WMAPELMMAVM 518
             +HRD+   N+L++++ V K++DFG+++ L    +A  + +G      W +PE   A+ 
Sbjct: 167 GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPE---AIA 223
Query: 519 QKGKSSDSALAVDIWSLGCTIIEM--YTGKPPW 549
            +  +S    A D+WS G  + E+  Y  +P W
Sbjct: 224 YRKFTS----ASDVWSYGIVLWEVMSYGERPYW 252

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 102/213 (47%), Gaps = 20/213 (9%)
Query: 346 KLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQ---LEQEIKVLSHLKHP 402
           K++G G FG V   S R    L + KE+ +     K   + KQ      E  ++    HP
Sbjct: 51  KVVGAGEFGEV--CSGRL--KLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHP 106
Query: 403 NIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSK 462
           NI++  G         I  EY+  GS++ ++R+H    T   +    R I SG+ YL   
Sbjct: 107 NIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDM 166
Query: 463 KTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQ-KADLSMKGSPY---WMAPELMMAVM 518
             +HRD+   N+L++++ V K++DFG+++ L    +A  + +G      W +PE   A+ 
Sbjct: 167 GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPE---AIA 223
Query: 519 QKGKSSDSALAVDIWSLGCTIIEM--YTGKPPW 549
            +  +S    A D+WS G  + E+  Y  +P W
Sbjct: 224 YRKFTS----ASDVWSYGIVLWEVMSYGERPYW 252

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 60/227 (26%), Positives = 111/227 (48%), Gaps = 23/227 (10%)
Query: 339 NSQWQKGKLIGRGTFGSVY----VASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIK 394
            ++++K K++  G FG+VY    +    +     A+KE+     +  S ++ K++  E  
Sbjct: 21  ETEFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELR----EATSPKANKEILDEAY 76
Query: 395 VLSHLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILS 454
           V++ + +P++ +  G   +     + ++ +  G +  YVREH   I    + N+   I  
Sbjct: 77  VMASVDNPHVCRLLGI-CLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAK 135
Query: 455 GLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPY---WMAP 511
           G+ YL  ++ +HRD+   N+LV     VK+ DFG+AK L  ++ +   +G      WMA 
Sbjct: 136 GMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 195
Query: 512 ELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAA 557
           E ++  +   +S       D+WS G T+ E+ T G  P   Y+G  A
Sbjct: 196 ESILHRIYTHQS-------DVWSYGVTVWELMTFGSKP---YDGIPA 232

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 102/213 (47%), Gaps = 20/213 (9%)
Query: 346 KLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQ---LEQEIKVLSHLKHP 402
           K++G G FG V   S R    L + KE+ +     K   + KQ      E  ++    HP
Sbjct: 51  KVVGAGEFGEV--CSGRL--KLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHP 106
Query: 403 NIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSK 462
           NI++  G         I  EY+  GS++ ++R+H    T   +    R I SG+ YL   
Sbjct: 107 NIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDM 166
Query: 463 KTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQ-KADLSMKGSPY---WMAPELMMAVM 518
             +HRD+   N+L++++ V K++DFG+++ L    +A  + +G      W +PE   A+ 
Sbjct: 167 GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPE---AIA 223
Query: 519 QKGKSSDSALAVDIWSLGCTIIEM--YTGKPPW 549
            +  +S    A D+WS G  + E+  Y  +P W
Sbjct: 224 YRKFTS----ASDVWSYGIVLWEVMSYGERPYW 252

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 61/243 (25%), Positives = 113/243 (46%), Gaps = 11/243 (4%)
Query: 346 KLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIV 405
           K+IGRG FG V V   + T  + AMK ++ +    ++  +  + E+++ V    +    +
Sbjct: 96  KVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREERDVLVNGDCQWITAL 155
Query: 406 QYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTI 465
            Y   +  E+  Y+ ++Y   G +   + +    + E + R +   ++  +  +H    +
Sbjct: 156 HYAFQD--ENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEMVLAIDSIHQLHYV 213
Query: 466 HRDIKGANLLVDASGVVKLADFGMAKHLT--GQKADLSMKGSPYWMAPELMMAVMQKGKS 523
           HRDIK  N+L+D +G ++LADFG    +   G        G+P +++PE++ A M+ G  
Sbjct: 214 HRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQSSVAVGTPDYISPEILQA-MEDGMG 272
Query: 524 SDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMR-----DTPAIPDSLSPEGKD 578
                  D WSLG  + EM  G+ P+          K+M        P+    +S E KD
Sbjct: 273 KYGP-ECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHVTDVSEEAKD 331
Query: 579 FLR 581
            ++
Sbjct: 332 LIQ 334

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 102/213 (47%), Gaps = 20/213 (9%)
Query: 346 KLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQ---LEQEIKVLSHLKHP 402
           K++G G FG V   S R    L + KE+ +     K   + KQ      E  ++    HP
Sbjct: 22  KVVGAGEFGEV--CSGRL--KLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHP 77
Query: 403 NIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSK 462
           NI++  G         I  EY+  GS++ ++R+H    T   +    R I SG+ YL   
Sbjct: 78  NIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDM 137
Query: 463 KTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQ-KADLSMKGSPY---WMAPELMMAVM 518
             +HRD+   N+L++++ V K++DFG+++ L    +A  + +G      W +PE   A+ 
Sbjct: 138 GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPE---AIA 194
Query: 519 QKGKSSDSALAVDIWSLGCTIIEM--YTGKPPW 549
            +  +S    A D+WS G  + E+  Y  +P W
Sbjct: 195 YRKFTS----ASDVWSYGIVLWEVMSYGERPYW 223

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 61/243 (25%), Positives = 113/243 (46%), Gaps = 11/243 (4%)
Query: 346 KLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIV 405
           K+IGRG FG V V   + T  + AMK ++ +    ++  +  + E+++ V    +    +
Sbjct: 80  KVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREERDVLVNGDCQWITAL 139
Query: 406 QYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTI 465
            Y   +  E+  Y+ ++Y   G +   + +    + E + R +   ++  +  +H    +
Sbjct: 140 HYAFQD--ENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEMVLAIDSIHQLHYV 197
Query: 466 HRDIKGANLLVDASGVVKLADFGMAKHLT--GQKADLSMKGSPYWMAPELMMAVMQKGKS 523
           HRDIK  N+L+D +G ++LADFG    +   G        G+P +++PE++ A M+ G  
Sbjct: 198 HRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQSSVAVGTPDYISPEILQA-MEDGMG 256
Query: 524 SDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMR-----DTPAIPDSLSPEGKD 578
                  D WSLG  + EM  G+ P+          K+M        P+    +S E KD
Sbjct: 257 KYGP-ECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHVTDVSEEAKD 315
Query: 579 FLR 581
            ++
Sbjct: 316 LIQ 318

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 110/227 (48%), Gaps = 23/227 (10%)
Query: 339 NSQWQKGKLIGRGTFGSVY----VASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIK 394
            ++++K K++G G FG+VY    +    +     A+KE+     +  S ++ K++  E  
Sbjct: 16  ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR----EATSPKANKEILDEAY 71
Query: 395 VLSHLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILS 454
           V++ + +P++ +  G   +     +  + +  G +  YVREH   I    + N+   I  
Sbjct: 72  VMASVDNPHVCRLLGI-CLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAK 130
Query: 455 GLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPY---WMAP 511
           G+ YL  ++ +HRD+   N+LV     VK+ DFG AK L  ++ +   +G      WMA 
Sbjct: 131 GMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMAL 190
Query: 512 ELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAA 557
           E ++  +   +S       D+WS G T+ E+ T G  P   Y+G  A
Sbjct: 191 ESILHRIYTHQS-------DVWSYGVTVWELMTFGSKP---YDGIPA 227

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 81.6 bits (200), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 110/227 (48%), Gaps = 23/227 (10%)
Query: 339 NSQWQKGKLIGRGTFGSVY----VASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIK 394
            ++++K K++G G FG+VY    +    +     A+KE+     +  S ++ K++  E  
Sbjct: 14  ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR----EATSPKANKEILDEAY 69
Query: 395 VLSHLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILS 454
           V++ + +P++ +  G   +     +  + +  G +  YVREH   I    + N+   I  
Sbjct: 70  VMASVDNPHVCRLLGI-CLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAK 128
Query: 455 GLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPY---WMAP 511
           G+ YL  ++ +HRD+   N+LV     VK+ DFG AK L  ++ +   +G      WMA 
Sbjct: 129 GMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMAL 188
Query: 512 ELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAA 557
           E ++  +   +S       D+WS G T+ E+ T G  P   Y+G  A
Sbjct: 189 ESILHRIYTHQS-------DVWSYGVTVWELMTFGSKP---YDGIPA 225

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/264 (24%), Positives = 120/264 (45%), Gaps = 37/264 (14%)
Query: 345 GKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIK------------QLEQE 392
           G+ IG G FG V+             + + + P++P  A +IK            +  QE
Sbjct: 15  GRCIGEGQFGDVH-------------QGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQE 61
Query: 393 IKVLSHLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHI 452
              +    HP+IV+  G  I E+  +I +E    G +  +++    ++  + +  +   +
Sbjct: 62  ALTMRQFDHPHIVKLIGV-ITENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQL 120
Query: 453 LSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGS--PYWMA 510
            + LAYL SK+ +HRDI   N+LV A+  VKL DFG+++++       + KG     WMA
Sbjct: 121 STALAYLESKRFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMA 180
Query: 511 PELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFKVMR-DTPAI 568
           PE   ++  +  +S S    D+W  G  + E+   G  P+   +    + ++   +   +
Sbjct: 181 PE---SINFRRFTSAS----DVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPM 233
Query: 569 PDSLSPEGKDFLRCCFQRNPADRP 592
           P +  P     +  C+  +P+ RP
Sbjct: 234 PPNCPPTLYSLMTKCWAYDPSRRP 257

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 104/210 (49%), Gaps = 24/210 (11%)
Query: 348 IGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIV-- 405
           IG G +G V  A +       A+K++  F        +++    EIK+L   +H NI+  
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR----EIKILLRFRHENIIGI 90
Query: 406 -QYYGSEIVEDKFYIYL-EYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKK 463
                +  +E    +Y+ + +    + K ++  C  ++   +  F   IL GL Y+HS  
Sbjct: 91  NDIIRAPTIEQMKDVYIVQDLMETDLYKLLK--CQHLSNDHICYFLYQILRGLKYIHSAN 148
Query: 464 TIHRDIKGANLLVDASGVVKLADFGMAK------HLTGQKADLSMKGSPYWMAPELMMAV 517
            +HRD+K +NLL++ +  +K+ DFG+A+        TG   +     + ++ APE+M+  
Sbjct: 149 VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYV--ATRWYRAPEIMLN- 205
Query: 518 MQKGKSSDSALAVDIWSLGCTIIEMYTGKP 547
             KG +     ++DIWS+GC + EM + +P
Sbjct: 206 -SKGYTK----SIDIWSVGCILAEMLSNRP 230

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 96/214 (44%), Gaps = 21/214 (9%)
Query: 346 KLIGRGTFGSVY---VASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHP 402
           ++IGRG FG VY   +  N      CA+K ++   D       + Q   E  ++    HP
Sbjct: 95  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITD----IGEVSQFLTEGIIMKDFSHP 150
Query: 403 NIVQYYGSEI-VEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHS 461
           N++   G  +  E    + L Y+  G +  ++R      T   +  F   +  G+ +L S
Sbjct: 151 NVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLAS 210
Query: 462 KKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKAD-----LSMKGSPYWMAPELMMA 516
           KK +HRD+   N ++D    VK+ADFG+A+ +  ++ D        K    WMA E +  
Sbjct: 211 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT 270
Query: 517 VMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPW 549
                KS       D+WS G  + E+ T G PP+
Sbjct: 271 QKFTTKS-------DVWSFGVLLWELMTRGAPPY 297

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 100/209 (47%), Gaps = 22/209 (10%)
Query: 348 IGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIV-- 405
           IG G +G V  A +       A+K++  F        +++    EIK+L   +H NI+  
Sbjct: 51  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR----EIKILLRFRHENIIGI 106
Query: 406 -QYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKT 464
                +  +E    +YL   H    + Y       ++   +  F   IL GL Y+HS   
Sbjct: 107 NDIIRAPTIEQMKDVYL-VTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANV 165
Query: 465 IHRDIKGANLLVDASGVVKLADFGMAK------HLTGQKADLSMKGSPYWMAPELMMAVM 518
           +HRD+K +NLL++ +  +K+ DFG+A+        TG   +     + ++ APE+M+   
Sbjct: 166 LHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYV--ATRWYRAPEIMLN-- 221
Query: 519 QKGKSSDSALAVDIWSLGCTIIEMYTGKP 547
            KG +     ++DIWS+GC + EM + +P
Sbjct: 222 SKGYTK----SIDIWSVGCILAEMLSNRP 246

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 96/214 (44%), Gaps = 21/214 (9%)
Query: 346 KLIGRGTFGSVY---VASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHP 402
           ++IGRG FG VY   +  N      CA+K ++   D       + Q   E  ++    HP
Sbjct: 37  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITD----IGEVSQFLTEGIIMKDFSHP 92
Query: 403 NIVQYYGSEI-VEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHS 461
           N++   G  +  E    + L Y+  G +  ++R      T   +  F   +  G+ +L S
Sbjct: 93  NVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLAS 152
Query: 462 KKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKAD-----LSMKGSPYWMAPELMMA 516
           KK +HRD+   N ++D    VK+ADFG+A+ +  ++ D        K    WMA E +  
Sbjct: 153 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMLDKEFDSVHNKTGAKLPVKWMALESLQT 212
Query: 517 VMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPW 549
                KS       D+WS G  + E+ T G PP+
Sbjct: 213 QKFTTKS-------DVWSFGVLLWELMTRGAPPY 239

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 110/227 (48%), Gaps = 23/227 (10%)
Query: 339 NSQWQKGKLIGRGTFGSVY----VASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIK 394
            ++++K K++G G FG+VY    +    +     A+KE+     +  S ++ K++  E  
Sbjct: 21  ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR----EATSPKANKEILDEAY 76
Query: 395 VLSHLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILS 454
           V++ + +P++ +  G   +     +  + +  G +  YVREH   I    + N+   I  
Sbjct: 77  VMASVDNPHVCRLLGI-CLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAK 135
Query: 455 GLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPY---WMAP 511
           G+ YL  ++ +HRD+   N+LV     VK+ DFG AK L  ++ +   +G      WMA 
Sbjct: 136 GMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMAL 195
Query: 512 ELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAA 557
           E ++  +   +S       D+WS G T+ E+ T G  P   Y+G  A
Sbjct: 196 ESILHRIYTHQS-------DVWSYGVTVWELMTFGSKP---YDGIPA 232

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 64/264 (24%), Positives = 120/264 (45%), Gaps = 37/264 (14%)
Query: 345 GKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIK------------QLEQE 392
           G+ IG G FG V+             + + + P++P  A +IK            +  QE
Sbjct: 15  GRCIGEGQFGDVH-------------QGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQE 61
Query: 393 IKVLSHLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHI 452
              +    HP+IV+  G  I E+  +I +E    G +  +++    ++  + +  +   +
Sbjct: 62  ALTMRQFDHPHIVKLIGV-ITENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQL 120
Query: 453 LSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGS--PYWMA 510
            + LAYL SK+ +HRDI   N+LV ++  VKL DFG+++++       + KG     WMA
Sbjct: 121 STALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTXXKASKGKLPIKWMA 180
Query: 511 PELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFKVMR-DTPAI 568
           PE   ++  +  +S S    D+W  G  + E+   G  P+   +    + ++   +   +
Sbjct: 181 PE---SINFRRFTSAS----DVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPM 233
Query: 569 PDSLSPEGKDFLRCCFQRNPADRP 592
           P +  P     +  C+  +P+ RP
Sbjct: 234 PPNCPPTLYSLMTKCWAYDPSRRP 257

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 98/218 (44%), Gaps = 29/218 (13%)
Query: 346 KLIGRGTFGSVY---VASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHP 402
           ++IGRG FG VY   +  N      CA+K ++   D       + Q   E  ++    HP
Sbjct: 35  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITD----IGEVSQFLTEGIIMKDFSHP 90
Query: 403 NIVQYYGSEI-VEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHS 461
           N++   G  +  E    + L Y+  G +  ++R      T   +  F   +  G+ YL S
Sbjct: 91  NVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLAS 150
Query: 462 KKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQK---------ADLSMKGSPYWMAPE 512
           KK +HRD+   N ++D    VK+ADFG+A+ +  ++         A L +K    WMA E
Sbjct: 151 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEXXSVHNKTGAKLPVK----WMALE 206
Query: 513 LMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPW 549
            +       KS       D+WS G  + E+ T G PP+
Sbjct: 207 SLQTQKFTTKS-------DVWSFGVLLWELMTRGAPPY 237

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 68/271 (25%), Positives = 120/271 (44%), Gaps = 25/271 (9%)
Query: 346 KLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKH-PNI 404
           K +GRG F  V    ++ TG   A K         +  +   ++  EI VL   K  P +
Sbjct: 35  KELGRGKFAVVRQCISKSTGQEYAAK---FLKKRRRGQDCRAEILHEIAVLELAKSCPRV 91
Query: 405 VQYYGSEIVED--KFYIYLEYVHPGSINKYVR-EHCGAITESVVRNFTRHILSGLAYLHS 461
           +  +  E+ E+  +  + LEY   G I      E    ++E+ V    + IL G+ YLH 
Sbjct: 92  INLH--EVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQ 149
Query: 462 KKTIHRDIKGANLLVDAS---GVVKLADFGMAKHLTGQKADL-SMKGSPYWMAPELMMAV 517
              +H D+K  N+L+ +    G +K+ DFGM++ + G   +L  + G+P ++APE++   
Sbjct: 150 NNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKI-GHACELREIMGTPEYLAPEIL--- 205
Query: 518 MQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPD----SLS 573
                      A D+W++G     + T   P+   +       + +      +    S+S
Sbjct: 206 ----NYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFSSVS 261
Query: 574 PEGKDFLRCCFQRNPADRPPASLLLEHRFLK 604
               DF++    +NP  RP A + L H +L+
Sbjct: 262 QLATDFIQSLLVKNPEKRPTAEICLSHSWLQ 292

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 64/233 (27%), Positives = 112/233 (48%), Gaps = 42/233 (18%)
Query: 341 QWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLK 400
            ++   LIGRG++G VY+A ++      A+K+V+   +D       K++ +EI +L+ LK
Sbjct: 29  NYEIKHLIGRGSYGYVYLAYDKNANKNVAIKKVNRMFEDLIDC---KRILREITILNRLK 85
Query: 401 HPNIVQYYGSEIVED-----KFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSG 455
              I++ +   I ED     + YI LE +    + K  +     +TE  V+    ++L G
Sbjct: 86  SDYIIRLHDLIIPEDLLKFDELYIVLE-IADSDLKKLFKTPI-FLTEQHVKTILYNLLLG 143
Query: 456 LAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQK-----ADL---------- 500
             ++H    IHRD+K AN L++    VK+ DFG+A+ +   K      DL          
Sbjct: 144 EKFIHESGIIHRDLKPANCLLNQDCSVKICDFGLARTINSDKDIHIVNDLEEKEENEEPG 203
Query: 501 -----------SMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEM 542
                      S   + ++ APEL++  +Q+  ++    ++DIWS GC   E+
Sbjct: 204 PHNKNLKKQLTSHVVTRWYRAPELIL--LQENYTN----SIDIWSTGCIFAEL 250

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 98/218 (44%), Gaps = 29/218 (13%)
Query: 346 KLIGRGTFGSVY---VASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHP 402
           ++IGRG FG VY   +  N      CA+K ++   D       + Q   E  ++    HP
Sbjct: 54  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITD----IGEVSQFLTEGIIMKDFSHP 109
Query: 403 NIVQYYGSEI-VEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHS 461
           N++   G  +  E    + L Y+  G +  ++R      T   +  F   +  G+ YL S
Sbjct: 110 NVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLAS 169
Query: 462 KKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQK---------ADLSMKGSPYWMAPE 512
           KK +HRD+   N ++D    VK+ADFG+A+ +  ++         A L +K    WMA E
Sbjct: 170 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVK----WMALE 225
Query: 513 LMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPW 549
            +       KS       D+WS G  + E+ T G PP+
Sbjct: 226 SLQTQKFTTKS-------DVWSFGVLLWELMTRGAPPY 256

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 96/214 (44%), Gaps = 21/214 (9%)
Query: 346 KLIGRGTFGSVY---VASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHP 402
           ++IGRG FG VY   +  N      CA+K ++   D       + Q   E  ++    HP
Sbjct: 41  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITD----IGEVSQFLTEGIIMKDFSHP 96
Query: 403 NIVQYYGSEI-VEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHS 461
           N++   G  +  E    + L Y+  G +  ++R      T   +  F   +  G+ +L S
Sbjct: 97  NVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLAS 156
Query: 462 KKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKAD-----LSMKGSPYWMAPELMMA 516
           KK +HRD+   N ++D    VK+ADFG+A+ +  ++ D        K    WMA E +  
Sbjct: 157 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT 216
Query: 517 VMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPW 549
                KS       D+WS G  + E+ T G PP+
Sbjct: 217 QKFTTKS-------DVWSFGVLLWELMTRGAPPY 243

>pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 69/263 (26%), Positives = 124/263 (47%), Gaps = 54/263 (20%)
Query: 341 QWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEI-KVLSHL 399
           ++  GK +G G+FG V    + E+G   A+K+V     DP+     K  E +I KVL H+
Sbjct: 8   KYSLGKTLGTGSFGIVCEVFDIESGKRFALKKV---LQDPR----YKNRELDIMKVLDHV 60
Query: 400 KHPNIVQYY---GSE----------------------------IV---EDKFY-IYLEYV 424
               +V Y+   G E                            IV   ++K+  + +EYV
Sbjct: 61  NIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYV 120
Query: 425 HPGSINKYVREHCGA---ITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDA-SG 480
            P +++K ++    +   I  +++  +   +   + ++HS    HRDIK  NLLV++   
Sbjct: 121 -PDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDN 179
Query: 481 VVKLADFGMAKHLTGQKADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTII 540
            +KL DFG AK L   +  ++   S ++ APELM+       +++   ++D+WS+GC   
Sbjct: 180 TLKLCDFGSAKKLIPSEPSVAXICSRFYRAPELMLG------ATEYTPSIDLWSIGCVFG 233
Query: 541 EMYTGKPPWSEYEGAAAMFKVMR 563
           E+  GKP +S       + ++++
Sbjct: 234 ELILGKPLFSGETSIDQLVRIIQ 256

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 96/214 (44%), Gaps = 21/214 (9%)
Query: 346 KLIGRGTFGSVY---VASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHP 402
           ++IGRG FG VY   +  N      CA+K ++   D       + Q   E  ++    HP
Sbjct: 34  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITD----IGEVSQFLTEGIIMKDFSHP 89
Query: 403 NIVQYYGSEI-VEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHS 461
           N++   G  +  E    + L Y+  G +  ++R      T   +  F   +  G+ +L S
Sbjct: 90  NVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLAS 149
Query: 462 KKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKAD-----LSMKGSPYWMAPELMMA 516
           KK +HRD+   N ++D    VK+ADFG+A+ +  ++ D        K    WMA E +  
Sbjct: 150 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT 209
Query: 517 VMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPW 549
                KS       D+WS G  + E+ T G PP+
Sbjct: 210 QKFTTKS-------DVWSFGVLLWELMTRGAPPY 236

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 96/214 (44%), Gaps = 21/214 (9%)
Query: 346 KLIGRGTFGSVY---VASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHP 402
           ++IGRG FG VY   +  N      CA+K ++   D       + Q   E  ++    HP
Sbjct: 37  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITD----IGEVSQFLTEGIIMKDFSHP 92
Query: 403 NIVQYYGSEI-VEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHS 461
           N++   G  +  E    + L Y+  G +  ++R      T   +  F   +  G+ +L S
Sbjct: 93  NVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLAS 152
Query: 462 KKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKAD-----LSMKGSPYWMAPELMMA 516
           KK +HRD+   N ++D    VK+ADFG+A+ +  ++ D        K    WMA E +  
Sbjct: 153 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT 212
Query: 517 VMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPW 549
                KS       D+WS G  + E+ T G PP+
Sbjct: 213 QKFTTKS-------DVWSFGVLLWELMTRGAPPY 239

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 98/218 (44%), Gaps = 29/218 (13%)
Query: 346 KLIGRGTFGSVY---VASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHP 402
           ++IGRG FG VY   +  N      CA+K ++   D       + Q   E  ++    HP
Sbjct: 28  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITD----IGEVSQFLTEGIIMKDFSHP 83
Query: 403 NIVQYYGSEI-VEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHS 461
           N++   G  +  E    + L Y+  G +  ++R      T   +  F   +  G+ YL S
Sbjct: 84  NVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLAS 143
Query: 462 KKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQK---------ADLSMKGSPYWMAPE 512
           KK +HRD+   N ++D    VK+ADFG+A+ +  ++         A L +K    WMA E
Sbjct: 144 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVK----WMALE 199
Query: 513 LMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPW 549
            +       KS       D+WS G  + E+ T G PP+
Sbjct: 200 SLQTQKFTTKS-------DVWSFGVLLWELMTRGAPPY 230

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 96/214 (44%), Gaps = 21/214 (9%)
Query: 346 KLIGRGTFGSVY---VASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHP 402
           ++IGRG FG VY   +  N      CA+K ++   D       + Q   E  ++    HP
Sbjct: 36  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITD----IGEVSQFLTEGIIMKDFSHP 91
Query: 403 NIVQYYGSEI-VEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHS 461
           N++   G  +  E    + L Y+  G +  ++R      T   +  F   +  G+ +L S
Sbjct: 92  NVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLAS 151
Query: 462 KKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKAD-----LSMKGSPYWMAPELMMA 516
           KK +HRD+   N ++D    VK+ADFG+A+ +  ++ D        K    WMA E +  
Sbjct: 152 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT 211
Query: 517 VMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPW 549
                KS       D+WS G  + E+ T G PP+
Sbjct: 212 QKFTTKS-------DVWSFGVLLWELMTRGAPPY 238

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 98/218 (44%), Gaps = 29/218 (13%)
Query: 346 KLIGRGTFGSVY---VASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHP 402
           ++IGRG FG VY   +  N      CA+K ++   D       + Q   E  ++    HP
Sbjct: 55  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITD----IGEVSQFLTEGIIMKDFSHP 110
Query: 403 NIVQYYGSEI-VEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHS 461
           N++   G  +  E    + L Y+  G +  ++R      T   +  F   +  G+ YL S
Sbjct: 111 NVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLAS 170
Query: 462 KKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQK---------ADLSMKGSPYWMAPE 512
           KK +HRD+   N ++D    VK+ADFG+A+ +  ++         A L +K    WMA E
Sbjct: 171 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVK----WMALE 226
Query: 513 LMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPW 549
            +       KS       D+WS G  + E+ T G PP+
Sbjct: 227 SLQTQKFTTKS-------DVWSFGVLLWELMTRGAPPY 257

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 80.9 bits (198), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 65/264 (24%), Positives = 120/264 (45%), Gaps = 37/264 (14%)
Query: 345 GKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIK------------QLEQE 392
           G+ IG G FG V+             + + + P++P  A +IK            +  QE
Sbjct: 395 GRCIGEGQFGDVH-------------QGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQE 441
Query: 393 IKVLSHLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHI 452
              +    HP+IV+  G  I E+  +I +E    G +  +++    ++  + +  +   +
Sbjct: 442 ALTMRQFDHPHIVKLIGV-ITENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQL 500
Query: 453 LSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGS--PYWMA 510
            + LAYL SK+ +HRDI   N+LV A+  VKL DFG+++++       + KG     WMA
Sbjct: 501 STALAYLESKRFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMA 560
Query: 511 PELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFKVMR-DTPAI 568
           PE   ++  +  +S    A D+W  G  + E+   G  P+   +    + ++   +   +
Sbjct: 561 PE---SINFRRFTS----ASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPM 613
Query: 569 PDSLSPEGKDFLRCCFQRNPADRP 592
           P +  P     +  C+  +P+ RP
Sbjct: 614 PPNCPPTLYSLMTKCWAYDPSRRP 637

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 65/217 (29%), Positives = 106/217 (48%), Gaps = 24/217 (11%)
Query: 345 GKLIGRGTFGSVYVA-SNRETGA---LCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLK 400
           G  +G G FG VY    N  T A   L AM  VDI  ++ K     +Q +QEIKV++  +
Sbjct: 36  GNKMGEGGFGVVYKGYVNNTTVAVKKLAAM--VDITTEELK-----QQFDQEIKVMAKCQ 88
Query: 401 HPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGA--ITESVVRNFTRHILSGLAY 458
           H N+V+  G     D   +   Y+  GS+   +    G   ++  +     +   +G+ +
Sbjct: 89  HENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINF 148
Query: 459 LHSKKTIHRDIKGANLLVDASGVVKLADFGMAK---HLTGQKADLSMKGSPYWMAPELMM 515
           LH    IHRDIK AN+L+D +   K++DFG+A+             + G+  +MAPE + 
Sbjct: 149 LHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMXXRIVGTTAYMAPEAL- 207
Query: 516 AVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEY 552
               +G+ +  +   DI+S G  ++E+ TG P   E+
Sbjct: 208 ----RGEITPKS---DIYSFGVVLLEIITGLPAVDEH 237

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 98/218 (44%), Gaps = 29/218 (13%)
Query: 346 KLIGRGTFGSVY---VASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHP 402
           ++IGRG FG VY   +  N      CA+K ++   D       + Q   E  ++    HP
Sbjct: 36  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITD----IGEVSQFLTEGIIMKDFSHP 91
Query: 403 NIVQYYGSEI-VEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHS 461
           N++   G  +  E    + L Y+  G +  ++R      T   +  F   +  G+ YL S
Sbjct: 92  NVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLAS 151
Query: 462 KKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQK---------ADLSMKGSPYWMAPE 512
           KK +HRD+   N ++D    VK+ADFG+A+ +  ++         A L +K    WMA E
Sbjct: 152 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVK----WMALE 207
Query: 513 LMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPW 549
            +       KS       D+WS G  + E+ T G PP+
Sbjct: 208 SLQTQKFTTKS-------DVWSFGVLLWELMTRGAPPY 238

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 65/217 (29%), Positives = 106/217 (48%), Gaps = 24/217 (11%)
Query: 345 GKLIGRGTFGSVYVA-SNRETGA---LCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLK 400
           G  +G G FG VY    N  T A   L AM  VDI  ++ K     +Q +QEIKV++  +
Sbjct: 30  GNKMGEGGFGVVYKGYVNNTTVAVKKLAAM--VDITTEELK-----QQFDQEIKVMAKCQ 82
Query: 401 HPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGA--ITESVVRNFTRHILSGLAY 458
           H N+V+  G     D   +   Y+  GS+   +    G   ++  +     +   +G+ +
Sbjct: 83  HENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINF 142
Query: 459 LHSKKTIHRDIKGANLLVDASGVVKLADFGMAK---HLTGQKADLSMKGSPYWMAPELMM 515
           LH    IHRDIK AN+L+D +   K++DFG+A+             + G+  +MAPE + 
Sbjct: 143 LHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQXVMXXRIVGTTAYMAPEAL- 201
Query: 516 AVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEY 552
               +G+ +  +   DI+S G  ++E+ TG P   E+
Sbjct: 202 ----RGEITPKS---DIYSFGVVLLEIITGLPAVDEH 231

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 83/311 (26%), Positives = 126/311 (40%), Gaps = 57/311 (18%)
Query: 348 IGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAE-SIKQLEQ------------EIK 394
           +G G FG VY              +V   P+DP   + ++K L +            E  
Sbjct: 39  LGHGAFGEVYEG------------QVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEAL 86
Query: 395 VLSHLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVRE------HCGAITESVVRNF 448
           ++S L H NIV+  G  +     +I LE +  G +  ++RE         ++    + + 
Sbjct: 87  IISKLNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHV 146
Query: 449 TRHILSGLAYLHSKKTIHRDIKGANLLVDASG---VVKLADFGMAKHL-------TGQKA 498
            R I  G  YL     IHRDI   N L+   G   V K+ DFGMA+ +        G  A
Sbjct: 147 ARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCA 206
Query: 499 DLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAA 557
            L +K    WM PE  M  +   K+       D WS G  + E+++ G  P+        
Sbjct: 207 MLPVK----WMPPEAFMEGIFTSKT-------DTWSFGVLLWEIFSLGYMPYPSKSNQEV 255
Query: 558 MFKVMRDTPAIPDSLSPEGKDF--LRCCFQRNPADRPPASLLLEHRFLKNSQQPDVPSCS 615
           +  V       P    P G  +  +  C+Q  P DRP  +++LE R    +Q PDV + +
Sbjct: 256 LEFVTSGGRMDPPKNCP-GPVYRIMTQCWQHQPEDRPNFAIILE-RIEYCTQDPDVINTA 313
Query: 616 LSFSGMQLTEK 626
           L      L E+
Sbjct: 314 LPIEYGPLVEE 324

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 60/227 (26%), Positives = 110/227 (48%), Gaps = 23/227 (10%)
Query: 339 NSQWQKGKLIGRGTFGSVY----VASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIK 394
            ++++K K++  G FG+VY    +    +     A+KE+     +  S ++ K++  E  
Sbjct: 14  ETEFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELR----EATSPKANKEILDEAY 69
Query: 395 VLSHLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILS 454
           V++ + +P++ +  G   +     +  + +  G +  YVREH   I    + N+   I  
Sbjct: 70  VMASVDNPHVCRLLGI-CLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAK 128
Query: 455 GLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPY---WMAP 511
           G+ YL  ++ +HRD+   N+LV     VK+ DFG+AK L  ++ +   +G      WMA 
Sbjct: 129 GMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 188
Query: 512 ELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAA 557
           E ++  +   +S       D+WS G T+ E+ T G  P   Y+G  A
Sbjct: 189 ESILHRIYTHQS-------DVWSYGVTVWELMTFGSKP---YDGIPA 225

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 67/218 (30%), Positives = 109/218 (50%), Gaps = 26/218 (11%)
Query: 345 GKLIGRGTFGSVYVA-SNRETGA---LCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLK 400
           G  +G G FG VY    N  T A   L AM  VDI  ++ K     +Q +QEIKV++  +
Sbjct: 36  GNKMGEGGFGVVYKGYVNNTTVAVKKLAAM--VDITTEELK-----QQFDQEIKVMAKCQ 88
Query: 401 HPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGA--ITESVVRNFTRHILSGLAY 458
           H N+V+  G     D   +   Y+  GS+   +    G   ++  +     +   +G+ +
Sbjct: 89  HENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINF 148
Query: 459 LHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMK----GSPYWMAPELM 514
           LH    IHRDIK AN+L+D +   K++DFG+A+  + + A   M     G+  +MAPE +
Sbjct: 149 LHENHHIHRDIKSANILLDEAFTAKISDFGLAR-ASEKFAQTVMXSRIVGTTAYMAPEAL 207
Query: 515 MAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEY 552
                +G+ +  +   DI+S G  ++E+ TG P   E+
Sbjct: 208 -----RGEITPKS---DIYSFGVVLLEIITGLPAVDEH 237

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 98/218 (44%), Gaps = 29/218 (13%)
Query: 346 KLIGRGTFGSVY---VASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHP 402
           ++IGRG FG VY   +  N      CA+K ++   D       + Q   E  ++    HP
Sbjct: 34  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITD----IGEVSQFLTEGIIMKDFSHP 89
Query: 403 NIVQYYGSEI-VEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHS 461
           N++   G  +  E    + L Y+  G +  ++R      T   +  F   +  G+ YL S
Sbjct: 90  NVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLAS 149
Query: 462 KKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQK---------ADLSMKGSPYWMAPE 512
           KK +HRD+   N ++D    VK+ADFG+A+ +  ++         A L +K    WMA E
Sbjct: 150 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVK----WMALE 205
Query: 513 LMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPW 549
            +       KS       D+WS G  + E+ T G PP+
Sbjct: 206 SLQTQKFTTKS-------DVWSFGVLLWELMTRGAPPY 236

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 55/226 (24%), Positives = 111/226 (49%), Gaps = 22/226 (9%)
Query: 331 AKPEPLPMNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLE 390
            K +P  +  ++ + + IG G +G V  A +       A+K++  F        +++   
Sbjct: 34  VKGQPFDVGPRYTQLQYIGEGAYGMVSSAYDHVRKTRVAIKKISPFEHQTYCQRTLR--- 90
Query: 391 QEIKVLSHLKHPNIV---QYYGSEIVEDKFYIYL-EYVHPGSINKYVREHCGAITESVVR 446
            EI++L   +H N++       +  +E    +Y+ + +    + K ++     ++   + 
Sbjct: 91  -EIQILLRFRHENVIGIRDILRASTLEAMRDVYIVQDLMETDLYKLLKSQ--QLSNDHIC 147
Query: 447 NFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKAD-----LS 501
            F   IL GL Y+HS   +HRD+K +NLL++ +  +K+ DFG+A+ +   + D       
Sbjct: 148 YFLYQILRGLKYIHSANVLHRDLKPSNLLINTTCDLKICDFGLAR-IADPEHDHTGFLTE 206
Query: 502 MKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKP 547
              + ++ APE+M+    KG +     ++DIWS+GC + EM + +P
Sbjct: 207 XVATRWYRAPEIMLN--SKGYTK----SIDIWSVGCILAEMLSNRP 246

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 98/218 (44%), Gaps = 29/218 (13%)
Query: 346 KLIGRGTFGSVY---VASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHP 402
           ++IGRG FG VY   +  N      CA+K ++   D       + Q   E  ++    HP
Sbjct: 33  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITD----IGEVSQFLTEGIIMKDFSHP 88
Query: 403 NIVQYYGSEI-VEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHS 461
           N++   G  +  E    + L Y+  G +  ++R      T   +  F   +  G+ YL S
Sbjct: 89  NVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLAS 148
Query: 462 KKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQK---------ADLSMKGSPYWMAPE 512
           KK +HRD+   N ++D    VK+ADFG+A+ +  ++         A L +K    WMA E
Sbjct: 149 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVK----WMALE 204
Query: 513 LMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPW 549
            +       KS       D+WS G  + E+ T G PP+
Sbjct: 205 SLQTQKFTTKS-------DVWSFGVLLWELMTRGAPPY 235

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 60/227 (26%), Positives = 110/227 (48%), Gaps = 23/227 (10%)
Query: 339 NSQWQKGKLIGRGTFGSVY----VASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIK 394
            ++++K K++  G FG+VY    +    +     A+KE+     +  S ++ K++  E  
Sbjct: 21  ETEFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELR----EATSPKANKEILDEAY 76
Query: 395 VLSHLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILS 454
           V++ + +P++ +  G   +     +  + +  G +  YVREH   I    + N+   I  
Sbjct: 77  VMASVDNPHVCRLLGI-CLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAK 135
Query: 455 GLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPY---WMAP 511
           G+ YL  ++ +HRD+   N+LV     VK+ DFG+AK L  ++ +   +G      WMA 
Sbjct: 136 GMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 195
Query: 512 ELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAA 557
           E ++  +   +S       D+WS G T+ E+ T G  P   Y+G  A
Sbjct: 196 ESILHRIYTHQS-------DVWSYGVTVWELMTFGSKP---YDGIPA 232

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 65/258 (25%), Positives = 114/258 (44%), Gaps = 22/258 (8%)
Query: 346 KLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQ---LEQEIKVLSHLKHP 402
           ++IG G FG V     +  G     +E+ +     KS  + KQ      E  ++    HP
Sbjct: 13  QVIGAGEFGEVCSGHLKLPGK----REIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHP 68
Query: 403 NIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSK 462
           N++   G         I  E++  GS++ ++R++ G  T   +    R I +G+ YL   
Sbjct: 69  NVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADM 128
Query: 463 KTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKAD------LSMKGSPYWMAPELMMA 516
             +HR +   N+LV+++ V K++DFG+++ L    +D      L  K    W APE   A
Sbjct: 129 NYVHRALAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPE---A 185
Query: 517 VMQKGKSSDSALAVDIWSLGCTIIE-MYTGKPPWSEYEGAAAMFKVMRDTPAIPDSLSPE 575
           +  +  +S    A D+WS G  + E M  G+ P+ +      +  + +D    P    P 
Sbjct: 186 IQYRKFTS----ASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPPPMDCPS 241
Query: 576 G-KDFLRCCFQRNPADRP 592
                +  C+Q++   RP
Sbjct: 242 ALHQLMLDCWQKDRNHRP 259

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 98/218 (44%), Gaps = 29/218 (13%)
Query: 346 KLIGRGTFGSVY---VASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHP 402
           ++IGRG FG VY   +  N      CA+K ++   D       + Q   E  ++    HP
Sbjct: 31  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITD----IGEVSQFLTEGIIMKDFSHP 86
Query: 403 NIVQYYGSEI-VEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHS 461
           N++   G  +  E    + L Y+  G +  ++R      T   +  F   +  G+ YL S
Sbjct: 87  NVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLAS 146
Query: 462 KKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQK---------ADLSMKGSPYWMAPE 512
           KK +HRD+   N ++D    VK+ADFG+A+ +  ++         A L +K    WMA E
Sbjct: 147 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVK----WMALE 202
Query: 513 LMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPW 549
            +       KS       D+WS G  + E+ T G PP+
Sbjct: 203 SLQTQKFTTKS-------DVWSFGVLLWELMTRGAPPY 233

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 80.1 bits (196), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 68/269 (25%), Positives = 119/269 (44%), Gaps = 25/269 (9%)
Query: 345 GKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIK-----QLEQEIKVLSHL 399
           G+ +G G F  V     + TG   A K    F    +S  S +     ++E+E+ +L  +
Sbjct: 17  GEELGSGQFAIVKKCREKSTGLEYAAK----FIKKRQSRASRRGVCREEIEREVSILRQV 72
Query: 400 KHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYL 459
            HPNI+  +          + LE V  G +  ++ +   +++E    +F + IL G+ YL
Sbjct: 73  LHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQK-ESLSEEEATSFIKQILDGVNYL 131
Query: 460 HSKKTIHRDIKGANLLVDASGV----VKLADFGMAKHLTGQKADLSMKGSPYWMAPELMM 515
           H+KK  H D+K  N+++    +    +KL DFG+A  +       ++ G+P ++APE++ 
Sbjct: 132 HTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIV- 190
Query: 516 AVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPW---SEYEGAAAMFKVMRDTPAIPDSL 572
                       L  D+WS+G     + +G  P+   ++ E  A +  V  D      S 
Sbjct: 191 ------NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQ 244
Query: 573 SPE-GKDFLRCCFQRNPADRPPASLLLEH 600
           + E  KDF+R    +    R      L H
Sbjct: 245 TSELAKDFIRKLLVKETRKRLTIQEALRH 273

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 80.1 bits (196), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 83/311 (26%), Positives = 126/311 (40%), Gaps = 57/311 (18%)
Query: 348 IGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAE-SIKQLEQ------------EIK 394
           +G G FG VY              +V   P+DP   + ++K L +            E  
Sbjct: 53  LGHGAFGEVYEG------------QVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEAL 100
Query: 395 VLSHLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVRE------HCGAITESVVRNF 448
           ++S L H NIV+  G  +     +I LE +  G +  ++RE         ++    + + 
Sbjct: 101 IISKLNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHV 160
Query: 449 TRHILSGLAYLHSKKTIHRDIKGANLLVDASG---VVKLADFGMAKHL-------TGQKA 498
            R I  G  YL     IHRDI   N L+   G   V K+ DFGMA+ +        G  A
Sbjct: 161 ARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCA 220
Query: 499 DLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAA 557
            L +K    WM PE  M  +   K+       D WS G  + E+++ G  P+        
Sbjct: 221 MLPVK----WMPPEAFMEGIFTSKT-------DTWSFGVLLWEIFSLGYMPYPSKSNQEV 269
Query: 558 MFKVMRDTPAIPDSLSPEGKDF--LRCCFQRNPADRPPASLLLEHRFLKNSQQPDVPSCS 615
           +  V       P    P G  +  +  C+Q  P DRP  +++LE R    +Q PDV + +
Sbjct: 270 LEFVTSGGRMDPPKNCP-GPVYRIMTQCWQHQPEDRPNFAIILE-RIEYCTQDPDVINTA 327
Query: 616 LSFSGMQLTEK 626
           L      L E+
Sbjct: 328 LPIEYGPLVEE 338

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 80.1 bits (196), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 98/218 (44%), Gaps = 29/218 (13%)
Query: 346 KLIGRGTFGSVY---VASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHP 402
           ++IGRG FG VY   +  N      CA+K ++   D       + Q   E  ++    HP
Sbjct: 35  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITD----IGEVSQFLTEGIIMKDFSHP 90
Query: 403 NIVQYYGSEI-VEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHS 461
           N++   G  +  E    + L Y+  G +  ++R      T   +  F   +  G+ YL S
Sbjct: 91  NVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLAS 150
Query: 462 KKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQK---------ADLSMKGSPYWMAPE 512
           KK +HRD+   N ++D    VK+ADFG+A+ +  ++         A L +K    WMA E
Sbjct: 151 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVK----WMALE 206
Query: 513 LMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPW 549
            +       KS       D+WS G  + E+ T G PP+
Sbjct: 207 SLQTQKFTTKS-------DVWSFGVLLWELMTRGAPPY 237

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 80.1 bits (196), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 98/218 (44%), Gaps = 29/218 (13%)
Query: 346 KLIGRGTFGSVY---VASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHP 402
           ++IGRG FG VY   +  N      CA+K ++   D       + Q   E  ++    HP
Sbjct: 36  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITD----IGEVSQFLTEGIIMKDFSHP 91
Query: 403 NIVQYYGSEI-VEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHS 461
           N++   G  +  E    + L Y+  G +  ++R      T   +  F   +  G+ YL S
Sbjct: 92  NVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLAS 151
Query: 462 KKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQK---------ADLSMKGSPYWMAPE 512
           KK +HRD+   N ++D    VK+ADFG+A+ +  ++         A L +K    WMA E
Sbjct: 152 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVK----WMALE 207
Query: 513 LMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPW 549
            +       KS       D+WS G  + E+ T G PP+
Sbjct: 208 SLQTQKFTTKS-------DVWSFGVLLWELMTRGAPPY 238

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 80.1 bits (196), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 76/311 (24%), Positives = 129/311 (41%), Gaps = 50/311 (16%)
Query: 340 SQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHL 399
           S +++  ++G+G FG V  A N       A+K++        + E +  +  E+ +L+ L
Sbjct: 6   SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKI------RHTEEKLSTILSEVXLLASL 59
Query: 400 KHPNIVQYYGSEIVEDKF-------------YIYLEYVHPGSINKYVR-EHCGAITESVV 445
            H  +V+YY + +    F             +I  EY    ++   +  E+     +   
Sbjct: 60  NHQYVVRYYAAWLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENLNQQRDEYW 119
Query: 446 RNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAK-------------- 491
           R F R IL  L+Y+HS+  IHR++K  N+ +D S  VK+ DFG+AK              
Sbjct: 120 RLF-RQILEALSYIHSQGIIHRNLKPXNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQ 178
Query: 492 HLTGQKADL-SMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWS 550
           +L G   +L S  G+  ++A E++       +       +D +SLG    E      P+S
Sbjct: 179 NLPGSSDNLTSAIGTAXYVATEVLDGTGHYNEK------IDXYSLGIIFFEXIY---PFS 229
Query: 551 EYEGAAAMFKVMRDT-----PAIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKN 605
                  + K +R       P   D+     K  +R     +P  RP A  LL   +L  
Sbjct: 230 TGXERVNILKKLRSVSIEFPPDFDDNKXKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPV 289
Query: 606 SQQPDVPSCSL 616
             Q +V   +L
Sbjct: 290 KHQDEVIKEAL 300

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 79.7 bits (195), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 68/282 (24%), Positives = 123/282 (43%), Gaps = 22/282 (7%)
Query: 338 MNSQWQKGKLIGRGTFGSVYVA---SNRETGALCAMKEVDIFPDDPKSAESIKQLEQEI- 393
             ++++ G L+G+G FG+V+     ++R   A+  +    +    P S      LE  + 
Sbjct: 29  FEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALL 88
Query: 394 -KVLSHLKHPNIVQYYGSEIVEDKFYIYLEYVHPGS-INKYVREHCGAITESVVRNFTRH 451
            KV +   HP +++       ++ F + LE   P   +  Y+ E  G + E   R F   
Sbjct: 89  WKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEK-GPLGEGPSRCFFGQ 147
Query: 452 ILSGLAYLHSKKTIHRDIKGANLLVDA-SGVVKLADFGMAKHLTGQKADLSMKGSPYWMA 510
           +++ + + HS+  +HRDIK  N+L+D   G  KL DFG    L  +       G+  +  
Sbjct: 148 VVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYT-DFDGTRVYSP 206
Query: 511 PELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPD 570
           PE +       +    AL   +WSLG  + +M  G  P+   +      +++      P 
Sbjct: 207 PEWI------SRHQYHALPATVWSLGILLYDMVCGDIPFERDQ------EILEAELHFPA 254
Query: 571 SLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQPDVP 612
            +SP+    +R C    P+ RP    +L   +++   + DVP
Sbjct: 255 HVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPAE-DVP 295

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 79.7 bits (195), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 64/264 (24%), Positives = 120/264 (45%), Gaps = 37/264 (14%)
Query: 345 GKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIK------------QLEQE 392
           G+ IG G FG V+             + + + P++P  A +IK            +  QE
Sbjct: 15  GRCIGEGQFGDVH-------------QGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQE 61
Query: 393 IKVLSHLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHI 452
              +    HP+IV+  G  I E+  +I +E    G +  +++    ++  + +  +   +
Sbjct: 62  ALTMRQFDHPHIVKLIGV-ITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQL 120
Query: 453 LSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGS--PYWMA 510
            + LAYL SK+ +HRDI   N+LV ++  VKL DFG+++++       + KG     WMA
Sbjct: 121 STALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMA 180
Query: 511 PELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFKVMR-DTPAI 568
           PE   ++  +  +S S    D+W  G  + E+   G  P+   +    + ++   +   +
Sbjct: 181 PE---SINFRRFTSAS----DVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPM 233
Query: 569 PDSLSPEGKDFLRCCFQRNPADRP 592
           P +  P     +  C+  +P+ RP
Sbjct: 234 PPNCPPTLYSLMTKCWAYDPSRRP 257

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 79.7 bits (195), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 99/214 (46%), Gaps = 20/214 (9%)
Query: 346 KLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQ---LEQEIKVLSHLKHP 402
           K+IG G  G V     R  G     ++V +     K+  + +Q      E  ++    HP
Sbjct: 55  KIIGSGDSGEVCYGRLRVPG----QRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHP 110
Query: 403 NIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSK 462
           NI++  G         I  EY+  GS++ ++R H G  T   +    R + +G+ YL   
Sbjct: 111 NIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDL 170
Query: 463 KTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQ-KADLSMKGSPY---WMAPELMMAVM 518
             +HRD+   N+LVD++ V K++DFG+++ L     A  +  G      W APE   A+ 
Sbjct: 171 GYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAXTTTGGKIPIRWTAPE---AIA 227
Query: 519 QKGKSSDSALAVDIWSLGCTIIEM--YTGKPPWS 550
            +  SS    A D+WS G  + E+  Y  +P W+
Sbjct: 228 FRTFSS----ASDVWSFGVVMWEVLAYGERPYWN 257

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 79.7 bits (195), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 99/214 (46%), Gaps = 20/214 (9%)
Query: 346 KLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQ---LEQEIKVLSHLKHP 402
           K+IG G  G V     R  G     ++V +     K+  + +Q      E  ++    HP
Sbjct: 55  KIIGSGDSGEVCYGRLRVPG----QRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHP 110
Query: 403 NIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSK 462
           NI++  G         I  EY+  GS++ ++R H G  T   +    R + +G+ YL   
Sbjct: 111 NIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDL 170
Query: 463 KTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQ-KADLSMKGSPY---WMAPELMMAVM 518
             +HRD+   N+LVD++ V K++DFG+++ L     A  +  G      W APE   A+ 
Sbjct: 171 GYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPE---AIA 227
Query: 519 QKGKSSDSALAVDIWSLGCTIIEM--YTGKPPWS 550
            +  SS    A D+WS G  + E+  Y  +P W+
Sbjct: 228 FRTFSS----ASDVWSFGVVMWEVLAYGERPYWN 257

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 79.7 bits (195), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 100/222 (45%), Gaps = 48/222 (21%)
Query: 348 IGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIV-- 405
           IG G +G V  A +       A+K++  F        +++    EIK+L   +H NI+  
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR----EIKILLRFRHENIIGI 86
Query: 406 --------------QYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRH 451
                          Y   +++E   Y  L+  H              ++   +  F   
Sbjct: 87  NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH--------------LSNDHICYFLYQ 132
Query: 452 ILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAK------HLTGQKADLSMKGS 505
           IL GL Y+HS   +HRD+K +NLL++ +  +K+ DFG+A+        TG   +     +
Sbjct: 133 ILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYV--AT 190
Query: 506 PYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKP 547
            ++ APE+M+    KG +     ++DIWS+GC + EM + +P
Sbjct: 191 RWYRAPEIMLN--SKGYTK----SIDIWSVGCILAEMLSNRP 226

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 79.7 bits (195), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 64/264 (24%), Positives = 120/264 (45%), Gaps = 37/264 (14%)
Query: 345 GKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIK------------QLEQE 392
           G+ IG G FG V+             + + + P++P  A +IK            +  QE
Sbjct: 15  GRCIGEGQFGDVH-------------QGIYMSPENPALAVAIKTCKNCTSDSVREKFLQE 61
Query: 393 IKVLSHLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHI 452
              +    HP+IV+  G  I E+  +I +E    G +  +++    ++  + +  +   +
Sbjct: 62  ALTMRQFDHPHIVKLIGV-ITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQL 120
Query: 453 LSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGS--PYWMA 510
            + LAYL SK+ +HRDI   N+LV ++  VKL DFG+++++       + KG     WMA
Sbjct: 121 STALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMA 180
Query: 511 PELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFKVMR-DTPAI 568
           PE   ++  +  +S S    D+W  G  + E+   G  P+   +    + ++   +   +
Sbjct: 181 PE---SINFRRFTSAS----DVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPM 233
Query: 569 PDSLSPEGKDFLRCCFQRNPADRP 592
           P +  P     +  C+  +P+ RP
Sbjct: 234 PPNCPPTLYSLMTKCWAYDPSRRP 257

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 79.3 bits (194), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 62/249 (24%), Positives = 122/249 (48%), Gaps = 42/249 (16%)
Query: 341 QWQKGKLIGRGTFGSVYVASNRETGALCAMKEV-DIFPDDPKSAESIKQLEQEIKVLSHL 399
           +++  K +G+G +G V+ + +R TG + A+K++ D F +   +  + +    EI +L+ L
Sbjct: 10  KYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFR----EIMILTEL 65
Query: 400 K-HPNIVQYYGSEIVEDKFYIYLEYVH-PGSINKYVREHCGAITESVVRNFTRH-ILSGL 456
             H NIV        ++   +YL + +    ++  +R     I E V + +  + ++  +
Sbjct: 66  SGHENIVNLLNVLRADNDRDVYLVFDYMETDLHAVIR---ANILEPVHKQYVVYQLIKVI 122
Query: 457 AYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTG-----QKADLSMK-------- 503
            YLHS   +HRD+K +N+L++A   VK+ADFG+++             LS+         
Sbjct: 123 KYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDD 182
Query: 504 ---------GSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEG 554
                     + ++ APE+++       S+     +D+WSLGC + E+  GKP    + G
Sbjct: 183 DQPILTDYVATRWYRAPEILLG------STKYTKGIDMWSLGCILGEILCGKPI---FPG 233
Query: 555 AAAMFKVMR 563
           ++ M ++ R
Sbjct: 234 SSTMNQLER 242

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 79.3 bits (194), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 100/222 (45%), Gaps = 48/222 (21%)
Query: 348 IGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIV-- 405
           IG G +G V  A +       A+K++  F        +++    EIK+L   +H NI+  
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR----EIKILLRFRHENIIGI 86
Query: 406 --------------QYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRH 451
                          Y   +++E   Y  L+  H              ++   +  F   
Sbjct: 87  NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH--------------LSNDHICYFLYQ 132
Query: 452 ILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAK------HLTGQKADLSMKGS 505
           IL GL Y+HS   +HRD+K +NLL++ +  +K+ DFG+A+        TG   +     +
Sbjct: 133 ILRGLKYIHSANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYV--AT 190
Query: 506 PYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKP 547
            ++ APE+M+    KG +     ++DIWS+GC + EM + +P
Sbjct: 191 RWYRAPEIMLN--SKGYTK----SIDIWSVGCILAEMLSNRP 226

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 79.3 bits (194), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 100/222 (45%), Gaps = 48/222 (21%)
Query: 348 IGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIV-- 405
           IG G +G V  A +       A+K++  F        +++    EIK+L   +H NI+  
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR----EIKILLRFRHENIIGI 86
Query: 406 --------------QYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRH 451
                          Y   +++E   Y  L+  H              ++   +  F   
Sbjct: 87  NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH--------------LSNDHICYFLYQ 132
Query: 452 ILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAK------HLTGQKADLSMKGS 505
           IL GL Y+HS   +HRD+K +NLL++ +  +K+ DFG+A+        TG   +     +
Sbjct: 133 ILRGLKYIHSANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYV--AT 190
Query: 506 PYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKP 547
            ++ APE+M+    KG +     ++DIWS+GC + EM + +P
Sbjct: 191 RWYRAPEIMLN--SKGYTK----SIDIWSVGCILAEMLSNRP 226

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 79.3 bits (194), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 64/264 (24%), Positives = 120/264 (45%), Gaps = 37/264 (14%)
Query: 345 GKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIK------------QLEQE 392
           G+ IG G FG V+             + + + P++P  A +IK            +  QE
Sbjct: 43  GRCIGEGQFGDVH-------------QGIYMSPENPALAVAIKTCKNCTSDSVREKFLQE 89
Query: 393 IKVLSHLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHI 452
              +    HP+IV+  G  I E+  +I +E    G +  +++    ++  + +  +   +
Sbjct: 90  ALTMRQFDHPHIVKLIGV-ITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQL 148
Query: 453 LSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGS--PYWMA 510
            + LAYL SK+ +HRDI   N+LV ++  VKL DFG+++++       + KG     WMA
Sbjct: 149 STALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMA 208
Query: 511 PELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFKVMR-DTPAI 568
           PE   ++  +  +S S    D+W  G  + E+   G  P+   +    + ++   +   +
Sbjct: 209 PE---SINFRRFTSAS----DVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPM 261
Query: 569 PDSLSPEGKDFLRCCFQRNPADRP 592
           P +  P     +  C+  +P+ RP
Sbjct: 262 PPNCPPTLYSLMTKCWAYDPSRRP 285

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 79.3 bits (194), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 100/222 (45%), Gaps = 48/222 (21%)
Query: 348 IGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIV-- 405
           IG G +G V  A +       A+K++  F        +++    EIK+L   +H NI+  
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR----EIKILLRFRHENIIGI 90
Query: 406 --------------QYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRH 451
                          Y   +++E   Y  L+  H              ++   +  F   
Sbjct: 91  NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH--------------LSNDHICYFLYQ 136
Query: 452 ILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAK------HLTGQKADLSMKGS 505
           IL GL Y+HS   +HRD+K +NLL++ +  +K+ DFG+A+        TG   +     +
Sbjct: 137 ILRGLKYIHSANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYV--AT 194
Query: 506 PYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKP 547
            ++ APE+M+    KG +     ++DIWS+GC + EM + +P
Sbjct: 195 RWYRAPEIMLN--SKGYTK----SIDIWSVGCILAEMLSNRP 230

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 79.3 bits (194), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 100/222 (45%), Gaps = 48/222 (21%)
Query: 348 IGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQ- 406
           IG G +G V  A +       A+K++  F        +++    EIK+L   +H NI+  
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR----EIKILLRFRHENIIGI 88
Query: 407 ---------------YYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRH 451
                          Y   +++E   Y  L+  H              ++   +  F   
Sbjct: 89  NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH--------------LSNDHICYFLYQ 134
Query: 452 ILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAK------HLTGQKADLSMKGS 505
           IL GL Y+HS   +HRD+K +NLL++ +  +K+ DFG+A+        TG   +     +
Sbjct: 135 ILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYV--AT 192
Query: 506 PYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKP 547
            ++ APE+M+    KG +     ++DIWS+GC + EM + +P
Sbjct: 193 RWYRAPEIMLN--SKGYTK----SIDIWSVGCILAEMLSNRP 228

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 79.3 bits (194), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 64/264 (24%), Positives = 120/264 (45%), Gaps = 37/264 (14%)
Query: 345 GKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIK------------QLEQE 392
           G+ IG G FG V+             + + + P++P  A +IK            +  QE
Sbjct: 17  GRCIGEGQFGDVH-------------QGIYMSPENPALAVAIKTCKNCTSDSVREKFLQE 63
Query: 393 IKVLSHLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHI 452
              +    HP+IV+  G  I E+  +I +E    G +  +++    ++  + +  +   +
Sbjct: 64  ALTMRQFDHPHIVKLIGV-ITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQL 122
Query: 453 LSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGS--PYWMA 510
            + LAYL SK+ +HRDI   N+LV ++  VKL DFG+++++       + KG     WMA
Sbjct: 123 STALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMA 182
Query: 511 PELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFKVMR-DTPAI 568
           PE   ++  +  +S    A D+W  G  + E+   G  P+   +    + ++   +   +
Sbjct: 183 PE---SINFRRFTS----ASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPM 235
Query: 569 PDSLSPEGKDFLRCCFQRNPADRP 592
           P +  P     +  C+  +P+ RP
Sbjct: 236 PPNCPPTLYSLMTKCWAYDPSRRP 259

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 79.3 bits (194), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 100/222 (45%), Gaps = 48/222 (21%)
Query: 348 IGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQ- 406
           IG G +G V  A +       A+K++  F        +++    EIK+L   +H NI+  
Sbjct: 51  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR----EIKILLRFRHENIIGI 106
Query: 407 ---------------YYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRH 451
                          Y   +++E   Y  L+  H              ++   +  F   
Sbjct: 107 NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH--------------LSNDHICYFLYQ 152
Query: 452 ILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAK------HLTGQKADLSMKGS 505
           IL GL Y+HS   +HRD+K +NLL++ +  +K+ DFG+A+        TG   +     +
Sbjct: 153 ILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYV--AT 210
Query: 506 PYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKP 547
            ++ APE+M+    KG +     ++DIWS+GC + EM + +P
Sbjct: 211 RWYRAPEIMLN--SKGYTK----SIDIWSVGCILAEMLSNRP 246

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 79.3 bits (194), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 101/213 (47%), Gaps = 20/213 (9%)
Query: 346 KLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQ---LEQEIKVLSHLKHP 402
           K++G G FG V   S R    L + KE+ +     K   + KQ      E  ++    HP
Sbjct: 51  KVVGAGEFGEV--CSGRL--KLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHP 106
Query: 403 NIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSK 462
           NI++  G         I  E +  GS++ ++R+H    T   +    R I SG+ YL   
Sbjct: 107 NIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDM 166
Query: 463 KTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQ-KADLSMKGSPY---WMAPELMMAVM 518
             +HRD+   N+L++++ V K++DFG+++ L    +A  + +G      W +PE   A+ 
Sbjct: 167 GAVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPE---AIA 223
Query: 519 QKGKSSDSALAVDIWSLGCTIIEM--YTGKPPW 549
            +  +S    A D+WS G  + E+  Y  +P W
Sbjct: 224 YRKFTS----ASDVWSYGIVLWEVMSYGERPYW 252

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 79.3 bits (194), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 100/222 (45%), Gaps = 48/222 (21%)
Query: 348 IGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQ- 406
           IG G +G V  A +       A+K++  F        +++    EIK+L   +H NI+  
Sbjct: 39  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR----EIKILLRFRHENIIGI 94
Query: 407 ---------------YYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRH 451
                          Y   +++E   Y  L+  H              ++   +  F   
Sbjct: 95  NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH--------------LSNDHICYFLYQ 140
Query: 452 ILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAK------HLTGQKADLSMKGS 505
           IL GL Y+HS   +HRD+K +NLL++ +  +K+ DFG+A+        TG   +     +
Sbjct: 141 ILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYV--AT 198
Query: 506 PYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKP 547
            ++ APE+M+    KG +     ++DIWS+GC + EM + +P
Sbjct: 199 RWYRAPEIMLN--SKGYTK----SIDIWSVGCILAEMLSNRP 234

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 79.3 bits (194), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 100/222 (45%), Gaps = 48/222 (21%)
Query: 348 IGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQ- 406
           IG G +G V  A +       A+K++  F        +++    EIK+L   +H NI+  
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR----EIKILLRFRHENIIGI 86
Query: 407 ---------------YYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRH 451
                          Y   +++E   Y  L+  H              ++   +  F   
Sbjct: 87  NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH--------------LSNDHICYFLYQ 132
Query: 452 ILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAK------HLTGQKADLSMKGS 505
           IL GL Y+HS   +HRD+K +NLL++ +  +K+ DFG+A+        TG   +     +
Sbjct: 133 ILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYV--AT 190
Query: 506 PYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKP 547
            ++ APE+M+    KG +     ++DIWS+GC + EM + +P
Sbjct: 191 RWYRAPEIMLN--SKGYTK----SIDIWSVGCILAEMLSNRP 226

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 79.3 bits (194), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 100/222 (45%), Gaps = 48/222 (21%)
Query: 348 IGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQ- 406
           IG G +G V  A +       A+K++  F        +++    EIK+L   +H NI+  
Sbjct: 36  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR----EIKILLRFRHENIIGI 91
Query: 407 ---------------YYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRH 451
                          Y   +++E   Y  L+  H              ++   +  F   
Sbjct: 92  NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH--------------LSNDHICYFLYQ 137
Query: 452 ILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAK------HLTGQKADLSMKGS 505
           IL GL Y+HS   +HRD+K +NLL++ +  +K+ DFG+A+        TG   +     +
Sbjct: 138 ILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYV--AT 195
Query: 506 PYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKP 547
            ++ APE+M+    KG +     ++DIWS+GC + EM + +P
Sbjct: 196 RWYRAPEIMLN--SKGYTK----SIDIWSVGCILAEMLSNRP 231

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 79.3 bits (194), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 100/222 (45%), Gaps = 48/222 (21%)
Query: 348 IGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQ- 406
           IG G +G V  A +       A+K++  F        +++    EIK+L   +H NI+  
Sbjct: 37  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR----EIKILLRFRHENIIGI 92
Query: 407 ---------------YYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRH 451
                          Y   +++E   Y  L+  H              ++   +  F   
Sbjct: 93  NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH--------------LSNDHICYFLYQ 138
Query: 452 ILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAK------HLTGQKADLSMKGS 505
           IL GL Y+HS   +HRD+K +NLL++ +  +K+ DFG+A+        TG   +     +
Sbjct: 139 ILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYV--AT 196
Query: 506 PYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKP 547
            ++ APE+M+    KG +     ++DIWS+GC + EM + +P
Sbjct: 197 RWYRAPEIMLN--SKGYTK----SIDIWSVGCILAEMLSNRP 232

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 79.3 bits (194), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 100/222 (45%), Gaps = 48/222 (21%)
Query: 348 IGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQ- 406
           IG G +G V  A +       A+K++  F        +++    EIK+L   +H NI+  
Sbjct: 28  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR----EIKILLRFRHENIIGI 83
Query: 407 ---------------YYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRH 451
                          Y   +++E   Y  L+  H              ++   +  F   
Sbjct: 84  NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH--------------LSNDHICYFLYQ 129
Query: 452 ILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAK------HLTGQKADLSMKGS 505
           IL GL Y+HS   +HRD+K +NLL++ +  +K+ DFG+A+        TG   +     +
Sbjct: 130 ILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYV--AT 187
Query: 506 PYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKP 547
            ++ APE+M+    KG +     ++DIWS+GC + EM + +P
Sbjct: 188 RWYRAPEIMLN--SKGYTK----SIDIWSVGCILAEMLSNRP 223

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 79.3 bits (194), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 100/222 (45%), Gaps = 48/222 (21%)
Query: 348 IGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQ- 406
           IG G +G V  A +       A+K++  F        +++    EIK+L   +H NI+  
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR----EIKILLRFRHENIIGI 90
Query: 407 ---------------YYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRH 451
                          Y   +++E   Y  L+  H              ++   +  F   
Sbjct: 91  NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH--------------LSNDHICYFLYQ 136
Query: 452 ILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAK------HLTGQKADLSMKGS 505
           IL GL Y+HS   +HRD+K +NLL++ +  +K+ DFG+A+        TG   +     +
Sbjct: 137 ILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYV--AT 194
Query: 506 PYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKP 547
            ++ APE+M+    KG +     ++DIWS+GC + EM + +P
Sbjct: 195 RWYRAPEIMLN--SKGYTK----SIDIWSVGCILAEMLSNRP 230

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 79.3 bits (194), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 100/222 (45%), Gaps = 48/222 (21%)
Query: 348 IGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIV-- 405
           IG G +G V  A +       A+K++  F        +++    EIK+L   +H NI+  
Sbjct: 29  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR----EIKILLRFRHENIIGI 84
Query: 406 --------------QYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRH 451
                          Y   +++E   Y  L+  H              ++   +  F   
Sbjct: 85  NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH--------------LSNDHICYFLYQ 130
Query: 452 ILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAK------HLTGQKADLSMKGS 505
           IL GL Y+HS   +HRD+K +NLL++ +  +K+ DFG+A+        TG   +     +
Sbjct: 131 ILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYV--AT 188
Query: 506 PYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKP 547
            ++ APE+M+    KG +     ++DIWS+GC + EM + +P
Sbjct: 189 RWYRAPEIMLN--SKGYTK----SIDIWSVGCILAEMLSNRP 224

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 79.3 bits (194), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 100/222 (45%), Gaps = 48/222 (21%)
Query: 348 IGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIV-- 405
           IG G +G V  A +       A+K++  F        +++    EIK+L   +H NI+  
Sbjct: 29  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR----EIKILLRFRHENIIGI 84
Query: 406 --------------QYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRH 451
                          Y   +++E   Y  L+  H              ++   +  F   
Sbjct: 85  NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH--------------LSNDHICYFLYQ 130
Query: 452 ILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAK------HLTGQKADLSMKGS 505
           IL GL Y+HS   +HRD+K +NLL++ +  +K+ DFG+A+        TG   +     +
Sbjct: 131 ILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYV--AT 188
Query: 506 PYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKP 547
            ++ APE+M+    KG +     ++DIWS+GC + EM + +P
Sbjct: 189 RWYRAPEIMLN--SKGYTK----SIDIWSVGCILAEMLSNRP 224

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 79.3 bits (194), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 82/311 (26%), Positives = 125/311 (40%), Gaps = 57/311 (18%)
Query: 348 IGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAE-SIKQLEQ------------EIK 394
           +G G FG VY              +V   P+DP   + ++K L +            E  
Sbjct: 39  LGHGAFGEVYEG------------QVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEAL 86
Query: 395 VLSHLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVRE------HCGAITESVVRNF 448
           ++S   H NIV+  G  +     +I LE +  G +  ++RE         ++    + + 
Sbjct: 87  IISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHV 146
Query: 449 TRHILSGLAYLHSKKTIHRDIKGANLLVDASG---VVKLADFGMAKHL-------TGQKA 498
            R I  G  YL     IHRDI   N L+   G   V K+ DFGMA+ +        G  A
Sbjct: 147 ARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCA 206
Query: 499 DLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAA 557
            L +K    WM PE  M  +   K+       D WS G  + E+++ G  P+        
Sbjct: 207 MLPVK----WMPPEAFMEGIFTSKT-------DTWSFGVLLWEIFSLGYMPYPSKSNQEV 255
Query: 558 MFKVMRDTPAIPDSLSPEGKDF--LRCCFQRNPADRPPASLLLEHRFLKNSQQPDVPSCS 615
           +  V       P    P G  +  +  C+Q  P DRP  +++LE R    +Q PDV + +
Sbjct: 256 LEFVTSGGRMDPPKNCP-GPVYRIMTQCWQHQPEDRPNFAIILE-RIEYCTQDPDVINTA 313
Query: 616 LSFSGMQLTEK 626
           L      L E+
Sbjct: 314 LPIEYGPLVEE 324

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 79.3 bits (194), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 64/264 (24%), Positives = 120/264 (45%), Gaps = 37/264 (14%)
Query: 345 GKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIK------------QLEQE 392
           G+ IG G FG V+             + + + P++P  A +IK            +  QE
Sbjct: 20  GRCIGEGQFGDVH-------------QGIYMSPENPALAVAIKTCKNCTSDSVREKFLQE 66
Query: 393 IKVLSHLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHI 452
              +    HP+IV+  G  I E+  +I +E    G +  +++    ++  + +  +   +
Sbjct: 67  ALTMRQFDHPHIVKLIGV-ITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQL 125
Query: 453 LSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGS--PYWMA 510
            + LAYL SK+ +HRDI   N+LV ++  VKL DFG+++++       + KG     WMA
Sbjct: 126 STALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMA 185
Query: 511 PELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFKVMR-DTPAI 568
           PE   ++  +  +S S    D+W  G  + E+   G  P+   +    + ++   +   +
Sbjct: 186 PE---SINFRRFTSAS----DVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPM 238
Query: 569 PDSLSPEGKDFLRCCFQRNPADRP 592
           P +  P     +  C+  +P+ RP
Sbjct: 239 PPNCPPTLYSLMTKCWAYDPSRRP 262

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 79.3 bits (194), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 100/222 (45%), Gaps = 48/222 (21%)
Query: 348 IGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQ- 406
           IG G +G V  A +       A+K++  F        +++    EIK+L   +H NI+  
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYXQRTLR----EIKILLRFRHENIIGI 90
Query: 407 ---------------YYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRH 451
                          Y   +++E   Y  L+  H              ++   +  F   
Sbjct: 91  NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH--------------LSNDHICYFLYQ 136
Query: 452 ILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAK------HLTGQKADLSMKGS 505
           IL GL Y+HS   +HRD+K +NLL++ +  +K+ DFG+A+        TG   +     +
Sbjct: 137 ILRGLKYIHSANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYV--AT 194
Query: 506 PYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKP 547
            ++ APE+M+    KG +     ++DIWS+GC + EM + +P
Sbjct: 195 RWYRAPEIMLN--SKGYTK----SIDIWSVGCILAEMLSNRP 230

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 79.3 bits (194), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 64/264 (24%), Positives = 120/264 (45%), Gaps = 37/264 (14%)
Query: 345 GKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIK------------QLEQE 392
           G+ IG G FG V+             + + + P++P  A +IK            +  QE
Sbjct: 12  GRCIGEGQFGDVH-------------QGIYMSPENPALAVAIKTCKNCTSDSVREKFLQE 58
Query: 393 IKVLSHLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHI 452
              +    HP+IV+  G  I E+  +I +E    G +  +++    ++  + +  +   +
Sbjct: 59  ALTMRQFDHPHIVKLIGV-ITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQL 117
Query: 453 LSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGS--PYWMA 510
            + LAYL SK+ +HRDI   N+LV ++  VKL DFG+++++       + KG     WMA
Sbjct: 118 STALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMA 177
Query: 511 PELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFKVMR-DTPAI 568
           PE   ++  +  +S    A D+W  G  + E+   G  P+   +    + ++   +   +
Sbjct: 178 PE---SINFRRFTS----ASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPM 230
Query: 569 PDSLSPEGKDFLRCCFQRNPADRP 592
           P +  P     +  C+  +P+ RP
Sbjct: 231 PPNCPPTLYSLMTKCWAYDPSRRP 254

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 79.3 bits (194), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 64/264 (24%), Positives = 120/264 (45%), Gaps = 37/264 (14%)
Query: 345 GKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIK------------QLEQE 392
           G+ IG G FG V+             + + + P++P  A +IK            +  QE
Sbjct: 18  GRCIGEGQFGDVH-------------QGIYMSPENPALAVAIKTCKNCTSDSVREKFLQE 64
Query: 393 IKVLSHLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHI 452
              +    HP+IV+  G  I E+  +I +E    G +  +++    ++  + +  +   +
Sbjct: 65  ALTMRQFDHPHIVKLIGV-ITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQL 123
Query: 453 LSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGS--PYWMA 510
            + LAYL SK+ +HRDI   N+LV ++  VKL DFG+++++       + KG     WMA
Sbjct: 124 STALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMA 183
Query: 511 PELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFKVMR-DTPAI 568
           PE   ++  +  +S    A D+W  G  + E+   G  P+   +    + ++   +   +
Sbjct: 184 PE---SINFRRFTS----ASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPM 236
Query: 569 PDSLSPEGKDFLRCCFQRNPADRP 592
           P +  P     +  C+  +P+ RP
Sbjct: 237 PPNCPPTLYSLMTKCWAYDPSRRP 260

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 79.3 bits (194), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 64/264 (24%), Positives = 120/264 (45%), Gaps = 37/264 (14%)
Query: 345 GKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIK------------QLEQE 392
           G+ IG G FG V+             + + + P++P  A +IK            +  QE
Sbjct: 395 GRCIGEGQFGDVH-------------QGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQE 441
Query: 393 IKVLSHLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHI 452
              +    HP+IV+  G  I E+  +I +E    G +  +++    ++  + +  +   +
Sbjct: 442 ALTMRQFDHPHIVKLIGV-ITENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQL 500
Query: 453 LSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGS--PYWMA 510
            + LAYL SK+ +HRDI   N+LV ++  VKL DFG+++++       + KG     WMA
Sbjct: 501 STALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMA 560
Query: 511 PELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFKVMR-DTPAI 568
           PE   ++  +  +S    A D+W  G  + E+   G  P+   +    + ++   +   +
Sbjct: 561 PE---SINFRRFTS----ASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPM 613
Query: 569 PDSLSPEGKDFLRCCFQRNPADRP 592
           P +  P     +  C+  +P+ RP
Sbjct: 614 PPNCPPTLYSLMTKCWAYDPSRRP 637

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 79.3 bits (194), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 82/311 (26%), Positives = 125/311 (40%), Gaps = 57/311 (18%)
Query: 348 IGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAE-SIKQLEQ------------EIK 394
           +G G FG VY              +V   P+DP   + ++K L +            E  
Sbjct: 30  LGHGAFGEVYEG------------QVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEAL 77
Query: 395 VLSHLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVRE------HCGAITESVVRNF 448
           ++S   H NIV+  G  +     +I LE +  G +  ++RE         ++    + + 
Sbjct: 78  IISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHV 137
Query: 449 TRHILSGLAYLHSKKTIHRDIKGANLLVDASG---VVKLADFGMAKHL-------TGQKA 498
            R I  G  YL     IHRDI   N L+   G   V K+ DFGMA+ +        G  A
Sbjct: 138 ARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCA 197
Query: 499 DLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAA 557
            L +K    WM PE  M  +   K+       D WS G  + E+++ G  P+        
Sbjct: 198 MLPVK----WMPPEAFMEGIFTSKT-------DTWSFGVLLWEIFSLGYMPYPSKSNQEV 246
Query: 558 MFKVMRDTPAIPDSLSPEGKDF--LRCCFQRNPADRPPASLLLEHRFLKNSQQPDVPSCS 615
           +  V       P    P G  +  +  C+Q  P DRP  +++LE R    +Q PDV + +
Sbjct: 247 LEFVTSGGRMDPPKNCP-GPVYRIMTQCWQHQPEDRPNFAIILE-RIEYCTQDPDVINTA 304
Query: 616 LSFSGMQLTEK 626
           L      L E+
Sbjct: 305 LPIEYGPLVEE 315

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 79.0 bits (193), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 100/222 (45%), Gaps = 48/222 (21%)
Query: 348 IGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQ- 406
           IG G +G V  A +       A+K++  F        +++    EIK+L   +H NI+  
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR----EIKILLAFRHENIIGI 88
Query: 407 ---------------YYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRH 451
                          Y   +++E   Y  L+  H              ++   +  F   
Sbjct: 89  NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH--------------LSNDHICYFLYQ 134
Query: 452 ILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAK------HLTGQKADLSMKGS 505
           IL GL Y+HS   +HRD+K +NLL++ +  +K+ DFG+A+        TG   +     +
Sbjct: 135 ILRGLKYIHSANVLHRDLKPSNLLLNTTSDLKICDFGLARVADPDHDHTGFLTEYV--AT 192
Query: 506 PYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKP 547
            ++ APE+M+    KG +     ++DIWS+GC + EM + +P
Sbjct: 193 RWYRAPEIMLN--SKGYTK----SIDIWSVGCILAEMLSNRP 228

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 79.0 bits (193), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 82/311 (26%), Positives = 125/311 (40%), Gaps = 57/311 (18%)
Query: 348 IGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAE-SIKQLEQ------------EIK 394
           +G G FG VY              +V   P+DP   + ++K L +            E  
Sbjct: 38  LGHGAFGEVYEG------------QVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEAL 85
Query: 395 VLSHLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVRE------HCGAITESVVRNF 448
           ++S   H NIV+  G  +     +I LE +  G +  ++RE         ++    + + 
Sbjct: 86  IISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHV 145
Query: 449 TRHILSGLAYLHSKKTIHRDIKGANLLVDASG---VVKLADFGMAKHL-------TGQKA 498
            R I  G  YL     IHRDI   N L+   G   V K+ DFGMA+ +        G  A
Sbjct: 146 ARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCA 205
Query: 499 DLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAA 557
            L +K    WM PE  M  +   K+       D WS G  + E+++ G  P+        
Sbjct: 206 MLPVK----WMPPEAFMEGIFTSKT-------DTWSFGVLLWEIFSLGYMPYPSKSNQEV 254
Query: 558 MFKVMRDTPAIPDSLSPEGKDF--LRCCFQRNPADRPPASLLLEHRFLKNSQQPDVPSCS 615
           +  V       P    P G  +  +  C+Q  P DRP  +++LE R    +Q PDV + +
Sbjct: 255 LEFVTSGGRMDPPKNCP-GPVYRIMTQCWQHQPEDRPNFAIILE-RIEYCTQDPDVINTA 312
Query: 616 LSFSGMQLTEK 626
           L      L E+
Sbjct: 313 LPIEYGPLVEE 323

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 79.0 bits (193), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 82/311 (26%), Positives = 125/311 (40%), Gaps = 57/311 (18%)
Query: 348 IGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAE-SIKQLEQ------------EIK 394
           +G G FG VY              +V   P+DP   + ++K L +            E  
Sbjct: 45  LGHGAFGEVYEG------------QVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEAL 92
Query: 395 VLSHLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVRE------HCGAITESVVRNF 448
           ++S   H NIV+  G  +     +I LE +  G +  ++RE         ++    + + 
Sbjct: 93  IISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHV 152
Query: 449 TRHILSGLAYLHSKKTIHRDIKGANLLVDASG---VVKLADFGMAKHL-------TGQKA 498
            R I  G  YL     IHRDI   N L+   G   V K+ DFGMA+ +        G  A
Sbjct: 153 ARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCA 212
Query: 499 DLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAA 557
            L +K    WM PE  M  +   K+       D WS G  + E+++ G  P+        
Sbjct: 213 MLPVK----WMPPEAFMEGIFTSKT-------DTWSFGVLLWEIFSLGYMPYPSKSNQEV 261
Query: 558 MFKVMRDTPAIPDSLSPEGKDF--LRCCFQRNPADRPPASLLLEHRFLKNSQQPDVPSCS 615
           +  V       P    P G  +  +  C+Q  P DRP  +++LE R    +Q PDV + +
Sbjct: 262 LEFVTSGGRMDPPKNCP-GPVYRIMTQCWQHQPEDRPNFAIILE-RIEYCTQDPDVINTA 319
Query: 616 LSFSGMQLTEK 626
           L      L E+
Sbjct: 320 LPIEYGPLVEE 330

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 79.0 bits (193), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 100/222 (45%), Gaps = 48/222 (21%)
Query: 348 IGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQ- 406
           IG G +G V  A +       A+K++  F        +++    EIK+L   +H NI+  
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR----EIKILLRFRHENIIGI 90
Query: 407 ---------------YYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRH 451
                          Y   +++E   Y  L+  H              ++   +  F   
Sbjct: 91  NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH--------------LSNDHICYFLYQ 136
Query: 452 ILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAK------HLTGQKADLSMKGS 505
           IL GL Y+HS   +HRD+K +NLL++ +  +K+ DFG+A+        TG   +     +
Sbjct: 137 ILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXV--AT 194
Query: 506 PYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKP 547
            ++ APE+M+    KG +     ++DIWS+GC + EM + +P
Sbjct: 195 RWYRAPEIMLN--SKGYTK----SIDIWSVGCILAEMLSNRP 230

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 79.0 bits (193), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 100/222 (45%), Gaps = 48/222 (21%)
Query: 348 IGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIV-- 405
           IG G +G V  A +       A+K++  F        +++    EIK+L   +H NI+  
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR----EIKILLRFRHENIIGI 86
Query: 406 --------------QYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRH 451
                          Y   +++E   Y  L+  H              ++   +  F   
Sbjct: 87  NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH--------------LSNDHICYFLYQ 132
Query: 452 ILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAK------HLTGQKADLSMKGS 505
           IL GL Y+HS   +HRD+K +NLL++ +  +K+ DFG+A+        TG   +     +
Sbjct: 133 ILRGLKYIHSANVLHRDLKPSNLLLNTTXDLKIXDFGLARVADPDHDHTGFLTEYV--AT 190
Query: 506 PYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKP 547
            ++ APE+M+    KG +     ++DIWS+GC + EM + +P
Sbjct: 191 RWYRAPEIMLN--SKGYTK----SIDIWSVGCILAEMLSNRP 226

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 79.0 bits (193), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 100/222 (45%), Gaps = 48/222 (21%)
Query: 348 IGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQ- 406
           IG G +G V  A +       A+K++  F        +++    EIK+L   +H NI+  
Sbjct: 36  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR----EIKILLRFRHENIIGI 91
Query: 407 ---------------YYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRH 451
                          Y   +++E   Y  L+  H              ++   +  F   
Sbjct: 92  NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH--------------LSNDHICYFLYQ 137
Query: 452 ILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAK------HLTGQKADLSMKGS 505
           IL GL Y+HS   +HRD+K +NLL++ +  +K+ DFG+A+        TG   +     +
Sbjct: 138 ILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXV--AT 195
Query: 506 PYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKP 547
            ++ APE+M+    KG +     ++DIWS+GC + EM + +P
Sbjct: 196 RWYRAPEIMLN--SKGYTK----SIDIWSVGCILAEMLSNRP 231

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 79.0 bits (193), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 82/311 (26%), Positives = 125/311 (40%), Gaps = 57/311 (18%)
Query: 348 IGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAE-SIKQLEQ------------EIK 394
           +G G FG VY              +V   P+DP   + ++K L +            E  
Sbjct: 56  LGHGAFGEVYEG------------QVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEAL 103
Query: 395 VLSHLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVRE------HCGAITESVVRNF 448
           ++S   H NIV+  G  +     +I LE +  G +  ++RE         ++    + + 
Sbjct: 104 IISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHV 163
Query: 449 TRHILSGLAYLHSKKTIHRDIKGANLLVDASG---VVKLADFGMAKHL-------TGQKA 498
            R I  G  YL     IHRDI   N L+   G   V K+ DFGMA+ +        G  A
Sbjct: 164 ARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCA 223
Query: 499 DLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAA 557
            L +K    WM PE  M  +   K+       D WS G  + E+++ G  P+        
Sbjct: 224 MLPVK----WMPPEAFMEGIFTSKT-------DTWSFGVLLWEIFSLGYMPYPSKSNQEV 272
Query: 558 MFKVMRDTPAIPDSLSPEGKDF--LRCCFQRNPADRPPASLLLEHRFLKNSQQPDVPSCS 615
           +  V       P    P G  +  +  C+Q  P DRP  +++LE R    +Q PDV + +
Sbjct: 273 LEFVTSGGRMDPPKNCP-GPVYRIMTQCWQHQPEDRPNFAIILE-RIEYCTQDPDVINTA 330
Query: 616 LSFSGMQLTEK 626
           L      L E+
Sbjct: 331 LPIEYGPLVEE 341

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 79.0 bits (193), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 82/311 (26%), Positives = 125/311 (40%), Gaps = 57/311 (18%)
Query: 348 IGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAE-SIKQLEQ------------EIK 394
           +G G FG VY              +V   P+DP   + ++K L +            E  
Sbjct: 39  LGHGAFGEVYEG------------QVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEAL 86
Query: 395 VLSHLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVRE------HCGAITESVVRNF 448
           ++S   H NIV+  G  +     +I LE +  G +  ++RE         ++    + + 
Sbjct: 87  IISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHV 146
Query: 449 TRHILSGLAYLHSKKTIHRDIKGANLLVDASG---VVKLADFGMAKHL-------TGQKA 498
            R I  G  YL     IHRDI   N L+   G   V K+ DFGMA+ +        G  A
Sbjct: 147 ARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAQDIYRASYYRKGGCA 206
Query: 499 DLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAA 557
            L +K    WM PE  M  +   K+       D WS G  + E+++ G  P+        
Sbjct: 207 MLPVK----WMPPEAFMEGIFTSKT-------DTWSFGVLLWEIFSLGYMPYPSKSNQEV 255
Query: 558 MFKVMRDTPAIPDSLSPEGKDF--LRCCFQRNPADRPPASLLLEHRFLKNSQQPDVPSCS 615
           +  V       P    P G  +  +  C+Q  P DRP  +++LE R    +Q PDV + +
Sbjct: 256 LEFVTSGGRMDPPKNCP-GPVYRIMTQCWQHQPEDRPNFAIILE-RIEYCTQDPDVINTA 313
Query: 616 LSFSGMQLTEK 626
           L      L E+
Sbjct: 314 LPIEYGPLVEE 324

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 79.0 bits (193), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 82/311 (26%), Positives = 125/311 (40%), Gaps = 57/311 (18%)
Query: 348 IGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAE-SIKQLEQ------------EIK 394
           +G G FG VY              +V   P+DP   + ++K L +            E  
Sbjct: 53  LGHGAFGEVYEG------------QVSGMPNDPSPLQVAVKTLPEVYSEQDELDFLMEAL 100
Query: 395 VLSHLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVRE------HCGAITESVVRNF 448
           ++S   H NIV+  G  +     +I LE +  G +  ++RE         ++    + + 
Sbjct: 101 IISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHV 160
Query: 449 TRHILSGLAYLHSKKTIHRDIKGANLLVDASG---VVKLADFGMAKHL-------TGQKA 498
            R I  G  YL     IHRDI   N L+   G   V K+ DFGMA+ +        G  A
Sbjct: 161 ARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCA 220
Query: 499 DLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAA 557
            L +K    WM PE  M  +   K+       D WS G  + E+++ G  P+        
Sbjct: 221 MLPVK----WMPPEAFMEGIFTSKT-------DTWSFGVLLWEIFSLGYMPYPSKSNQEV 269
Query: 558 MFKVMRDTPAIPDSLSPEGKDF--LRCCFQRNPADRPPASLLLEHRFLKNSQQPDVPSCS 615
           +  V       P    P G  +  +  C+Q  P DRP  +++LE R    +Q PDV + +
Sbjct: 270 LEFVTSGGRMDPPKNCP-GPVYRIMTQCWQHQPEDRPNFAIILE-RIEYCTQDPDVINTA 327
Query: 616 LSFSGMQLTEK 626
           L      L E+
Sbjct: 328 LPIEYGPLVEE 338

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 79.0 bits (193), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 82/311 (26%), Positives = 125/311 (40%), Gaps = 57/311 (18%)
Query: 348 IGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAE-SIKQLEQ------------EIK 394
           +G G FG VY              +V   P+DP   + ++K L +            E  
Sbjct: 65  LGHGAFGEVYEG------------QVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEAL 112
Query: 395 VLSHLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVRE------HCGAITESVVRNF 448
           ++S   H NIV+  G  +     +I LE +  G +  ++RE         ++    + + 
Sbjct: 113 IISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHV 172
Query: 449 TRHILSGLAYLHSKKTIHRDIKGANLLVDASG---VVKLADFGMAKHL-------TGQKA 498
            R I  G  YL     IHRDI   N L+   G   V K+ DFGMA+ +        G  A
Sbjct: 173 ARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCA 232
Query: 499 DLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAA 557
            L +K    WM PE  M  +   K+       D WS G  + E+++ G  P+        
Sbjct: 233 MLPVK----WMPPEAFMEGIFTSKT-------DTWSFGVLLWEIFSLGYMPYPSKSNQEV 281
Query: 558 MFKVMRDTPAIPDSLSPEGKDF--LRCCFQRNPADRPPASLLLEHRFLKNSQQPDVPSCS 615
           +  V       P    P G  +  +  C+Q  P DRP  +++LE R    +Q PDV + +
Sbjct: 282 LEFVTSGGRMDPPKNCP-GPVYRIMTQCWQHQPEDRPNFAIILE-RIEYCTQDPDVINTA 339
Query: 616 LSFSGMQLTEK 626
           L      L E+
Sbjct: 340 LPIEYGPLVEE 350

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 79.0 bits (193), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 82/311 (26%), Positives = 125/311 (40%), Gaps = 57/311 (18%)
Query: 348 IGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAE-SIKQLEQ------------EIK 394
           +G G FG VY              +V   P+DP   + ++K L +            E  
Sbjct: 55  LGHGAFGEVYEG------------QVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEAL 102
Query: 395 VLSHLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVRE------HCGAITESVVRNF 448
           ++S   H NIV+  G  +     +I LE +  G +  ++RE         ++    + + 
Sbjct: 103 IISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHV 162
Query: 449 TRHILSGLAYLHSKKTIHRDIKGANLLVDASG---VVKLADFGMAKHL-------TGQKA 498
            R I  G  YL     IHRDI   N L+   G   V K+ DFGMA+ +        G  A
Sbjct: 163 ARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCA 222
Query: 499 DLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAA 557
            L +K    WM PE  M  +   K+       D WS G  + E+++ G  P+        
Sbjct: 223 MLPVK----WMPPEAFMEGIFTSKT-------DTWSFGVLLWEIFSLGYMPYPSKSNQEV 271
Query: 558 MFKVMRDTPAIPDSLSPEGKDF--LRCCFQRNPADRPPASLLLEHRFLKNSQQPDVPSCS 615
           +  V       P    P G  +  +  C+Q  P DRP  +++LE R    +Q PDV + +
Sbjct: 272 LEFVTSGGRMDPPKNCP-GPVYRIMTQCWQHQPEDRPNFAIILE-RIEYCTQDPDVINTA 329
Query: 616 LSFSGMQLTEK 626
           L      L E+
Sbjct: 330 LPIEYGPLVEE 340

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 82/311 (26%), Positives = 125/311 (40%), Gaps = 57/311 (18%)
Query: 348 IGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAE-SIKQLEQ------------EIK 394
           +G G FG VY              +V   P+DP   + ++K L +            E  
Sbjct: 79  LGHGAFGEVYEG------------QVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEAL 126
Query: 395 VLSHLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVRE------HCGAITESVVRNF 448
           ++S   H NIV+  G  +     +I LE +  G +  ++RE         ++    + + 
Sbjct: 127 IISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHV 186
Query: 449 TRHILSGLAYLHSKKTIHRDIKGANLLVDASG---VVKLADFGMAKHL-------TGQKA 498
            R I  G  YL     IHRDI   N L+   G   V K+ DFGMA+ +        G  A
Sbjct: 187 ARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCA 246
Query: 499 DLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAA 557
            L +K    WM PE  M  +   K+       D WS G  + E+++ G  P+        
Sbjct: 247 MLPVK----WMPPEAFMEGIFTSKT-------DTWSFGVLLWEIFSLGYMPYPSKSNQEV 295
Query: 558 MFKVMRDTPAIPDSLSPEGKDF--LRCCFQRNPADRPPASLLLEHRFLKNSQQPDVPSCS 615
           +  V       P    P G  +  +  C+Q  P DRP  +++LE R    +Q PDV + +
Sbjct: 296 LEFVTSGGRMDPPKNCP-GPVYRIMTQCWQHQPEDRPNFAIILE-RIEYCTQDPDVINTA 353
Query: 616 LSFSGMQLTEK 626
           L      L E+
Sbjct: 354 LPIEYGPLVEE 364

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 68/258 (26%), Positives = 119/258 (46%), Gaps = 24/258 (9%)
Query: 346 KLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQ---EIKVLSHLKHP 402
           ++IG G FG V   S R    L   ++V +     K   + KQ      E  ++    HP
Sbjct: 49  RVIGAGEFGEV--CSGRLK--LPGKRDVAVAIKTLKVGYTEKQRRDFLCEASIMGQFDHP 104
Query: 403 NIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSK 462
           N+V   G         I +E++  G+++ ++R+H G  T   +    R I +G+ YL   
Sbjct: 105 NVVHLEGVVTRGKPVMIVIEFMENGALDAFLRKHDGQFTVIQLVGMLRGIAAGMRYLADM 164
Query: 463 KTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQ-KADLSMKGSPY---WMAPELMMAVM 518
             +HRD+   N+LV+++ V K++DFG+++ +    +A  +  G      W APE   A+ 
Sbjct: 165 GYVHRDLAARNILVNSNLVCKVSDFGLSRVIEDDPEAVYTTTGGKIPVRWTAPE---AIQ 221
Query: 519 QKGKSSDSALAVDIWSLGCTIIEM--YTGKPPWSEYEGAAAMFKVMRDTPAIPDSLS-PE 575
            +  +S S    D+WS G  + E+  Y  +P W        + K + +   +P  +  P 
Sbjct: 222 YRKFTSAS----DVWSYGIVMWEVMSYGERPYWD--MSNQDVIKAIEEGYRLPAPMDCPA 275
Query: 576 G-KDFLRCCFQRNPADRP 592
           G    +  C+Q+  A+RP
Sbjct: 276 GLHQLMLDCWQKERAERP 293

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 100/222 (45%), Gaps = 48/222 (21%)
Query: 348 IGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIV-- 405
           IG G +G V  A +       A+K++  F        +++    EIK+L   +H NI+  
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR----EIKILLAFRHENIIGI 88
Query: 406 --------------QYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRH 451
                          Y   +++E   Y  L+  H              ++   +  F   
Sbjct: 89  NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH--------------LSNDHICYFLYQ 134
Query: 452 ILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAK------HLTGQKADLSMKGS 505
           IL GL Y+HS   +HRD+K +NLL++ +  +K+ DFG+A+        TG   +     +
Sbjct: 135 ILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYV--AT 192
Query: 506 PYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKP 547
            ++ APE+M+    KG +     ++DIWS+GC + EM + +P
Sbjct: 193 RWYRAPEIMLN--SKGYTK----SIDIWSVGCILAEMLSNRP 228

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 68/253 (26%), Positives = 121/253 (47%), Gaps = 55/253 (21%)
Query: 330 AAKPEPLPMNSQWQK------GKLIGRGTFGSVYVASNRETGALCAMKEV-DIFPDDPKS 382
           A+ P P   +S WQ         LIG G++G V  A ++    + A+K++  +F D    
Sbjct: 40  ASMPRP---HSDWQIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFED---- 92
Query: 383 AESIKQLEQEIKVLSHLKHPNIVQYYGSEI---VE--DKFYIYLEYVHPGSINKYVREHC 437
               K++ +EI +L+ L H ++V+     I   VE  D+ Y+ LE +      K  R   
Sbjct: 93  LIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLE-IADSDFKKLFRTPV 151
Query: 438 GAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKH----- 492
             +TE  ++    ++L G+ Y+HS   +HRD+K AN LV+    VK+ DFG+A+      
Sbjct: 152 -YLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPE 210
Query: 493 -------LTGQKADLSMKGSP----------------YWMAPELMMAVMQKGKSSDSALA 529
                  ++ ++ D+++   P                ++ APEL++  +Q+  +     A
Sbjct: 211 NGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELIL--LQENYTE----A 264
Query: 530 VDIWSLGCTIIEM 542
           +D+WS+GC   E+
Sbjct: 265 IDVWSIGCIFAEL 277

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 68/262 (25%), Positives = 116/262 (44%), Gaps = 30/262 (11%)
Query: 346 KLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQ---EIKVLSHLKHP 402
           ++IG G FG V     +  G     KE  +     K   + +Q  +   E  ++   +HP
Sbjct: 22  EVIGAGEFGEVCRGRLKAPGK----KESCVAIKTLKGGYTERQRREFLSEASIMGQFEHP 77
Query: 403 NIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSK 462
           NI++  G         I  E++  G+++ ++R + G  T   +    R I SG+ YL   
Sbjct: 78  NIIRLEGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVIQLVGMLRGIASGMRYLAEM 137
Query: 463 KTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKAD------LSMKGSPYWMAPELMMA 516
             +HRD+   N+LV+++ V K++DFG+++ L    +D      L  K    W APE   A
Sbjct: 138 SYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSSLGGKIPIRWTAPE---A 194
Query: 517 VMQKGKSSDSALAVDIWSLGCTIIE-MYTGKPPWSEYEGAAAMFKVMRDT-----PAIPD 570
           +  +  +S    A D WS G  + E M  G+ P+ +      +  + +D      P  P 
Sbjct: 195 IAFRKFTS----ASDAWSYGIVMWEVMSFGERPYWDMSNQDVINAIEQDYRLPPPPDCPT 250
Query: 571 SLSPEGKDFLRCCFQRNPADRP 592
           SL       +  C+Q++   RP
Sbjct: 251 SL----HQLMLDCWQKDRNARP 268

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 101/213 (47%), Gaps = 20/213 (9%)
Query: 346 KLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQ---LEQEIKVLSHLKHP 402
           K++G G FG V   S R    L + KE+ +     K   + KQ      E  ++    HP
Sbjct: 51  KVVGAGEFGEV--CSGRL--KLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHP 106
Query: 403 NIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSK 462
           NI++  G         I  E +  GS++ ++R+H    T   +    R I SG+ YL   
Sbjct: 107 NIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDM 166
Query: 463 KTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQ-KADLSMKGSPY---WMAPELMMAVM 518
             +HRD+   N+L++++ V K++DFG+++ L    +A  + +G      W +PE   A+ 
Sbjct: 167 GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPE---AIA 223
Query: 519 QKGKSSDSALAVDIWSLGCTIIEM--YTGKPPW 549
            +  +S    A D+WS G  + E+  Y  +P W
Sbjct: 224 YRKFTS----ASDVWSYGIVLWEVMSYGERPYW 252

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 89/336 (26%), Positives = 140/336 (41%), Gaps = 45/336 (13%)
Query: 332 KPEPLPMNSQWQKGK-LIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLE 390
           +P+   +   +Q  K ++G G  G V    +R TG  CA+K   +  D PK+ + +    
Sbjct: 1   EPKKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALK---LLYDSPKARQEVDHHW 57
Query: 391 QEIKVLSHLKHPNIV----QYYGSEIVEDKFYIYLEYVHPGSINKYVREHCG-AITESVV 445
           Q          P+IV     Y      +    I +E +  G +   ++E    A TE   
Sbjct: 58  QASG------GPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREA 111
Query: 446 RNFTRHILSGLAYLHSKKTIHRDIKGANLLV---DASGVVKLADFGMAKHLTGQKADLSM 502
               R I + + +LHS    HRD+K  NLL    +   V+KL DFG AK  T Q A  + 
Sbjct: 112 AEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKE-TTQNALQTP 170
Query: 503 KGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAA---AMF 559
             +PY++APE    V+   K   S    D+WSLG  +  +  G PP+    G A    M 
Sbjct: 171 CYTPYYVAPE----VLGPEKYDKSC---DMWSLGVIMYILLCGFPPFYSNTGQAISPGMK 223
Query: 560 KVMR-DTPAIPD----SLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQPDVPSC 614
           + +R      P+     +S + K  +R   + +P +R   +  + H ++  S    VP  
Sbjct: 224 RRIRLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSMV--VPQT 281
Query: 615 SLSFSGMQLTEKPHSPREKAD---------AKYDQV 641
            L  + +   +K H    K +           YDQV
Sbjct: 282 PLHTARVLQEDKDHWDEVKEEMTSALATMRVDYDQV 317

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 101/213 (47%), Gaps = 20/213 (9%)
Query: 346 KLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQ---LEQEIKVLSHLKHP 402
           K++G G FG V   S R    L + KE+ +     K   + KQ      E  ++    HP
Sbjct: 22  KVVGAGEFGEV--CSGRL--KLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHP 77
Query: 403 NIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSK 462
           NI++  G         I  E +  GS++ ++R+H    T   +    R I SG+ YL   
Sbjct: 78  NIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDM 137
Query: 463 KTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQ-KADLSMKGSPY---WMAPELMMAVM 518
             +HRD+   N+L++++ V K++DFG+++ L    +A  + +G      W +PE   A+ 
Sbjct: 138 GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPE---AIA 194
Query: 519 QKGKSSDSALAVDIWSLGCTIIEM--YTGKPPW 549
            +  +S    A D+WS G  + E+  Y  +P W
Sbjct: 195 YRKFTS----ASDVWSYGIVLWEVMSYGERPYW 223

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 66/284 (23%), Positives = 117/284 (41%), Gaps = 50/284 (17%)
Query: 345 GKLIGRGTFGSVYVASNRETGALCAMKEVDI-FPDDPKSAESIKQLEQEIKVLSHLKHPN 403
           GK +G G FG V  A+            V +    +  S   ++ L  E  VL  + HP+
Sbjct: 28  GKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPH 87
Query: 404 IVQYYGSEIVEDKFYIYLEYVHPGSINKYVRE--HCG---------------------AI 440
           +++ YG+   +    + +EY   GS+  ++RE    G                     A+
Sbjct: 88  VIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERAL 147
Query: 441 TESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADL 500
           T   + +F   I  G+ YL   K +HRD+   N+LV     +K++DFG+++ +  + + +
Sbjct: 148 TMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSXV 207
Query: 501 SMKGSPY---WMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEM-------YTGKPPWS 550
                     WMA E +   +   +S       D+WS G  + E+       Y G PP  
Sbjct: 208 KRSQGRIPVKWMAIESLFDHIYTTQS-------DVWSFGVLLWEIVTLGGNPYPGIPP-- 258
Query: 551 EYEGAAAMFKVMRDTPAI--PDSLSPEGKDFLRCCFQRNPADRP 592
                  +F +++    +  PD+ S E    +  C+++ P  RP
Sbjct: 259 -----ERLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRP 297

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 81/311 (26%), Positives = 125/311 (40%), Gaps = 57/311 (18%)
Query: 348 IGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAE-SIKQLEQ------------EIK 394
           +G G FG VY              +V   P+DP   + ++K L +            E  
Sbjct: 38  LGHGAFGEVYEG------------QVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEAL 85
Query: 395 VLSHLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVRE------HCGAITESVVRNF 448
           ++S   H NIV+  G  +     +I +E +  G +  ++RE         ++    + + 
Sbjct: 86  IISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHV 145
Query: 449 TRHILSGLAYLHSKKTIHRDIKGANLLVDASG---VVKLADFGMAKHL-------TGQKA 498
            R I  G  YL     IHRDI   N L+   G   V K+ DFGMA+ +        G  A
Sbjct: 146 ARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCA 205
Query: 499 DLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAA 557
            L +K    WM PE  M  +   K+       D WS G  + E+++ G  P+        
Sbjct: 206 MLPVK----WMPPEAFMEGIFTSKT-------DTWSFGVLLWEIFSLGYMPYPSKSNQEV 254
Query: 558 MFKVMRDTPAIPDSLSPEGKDF--LRCCFQRNPADRPPASLLLEHRFLKNSQQPDVPSCS 615
           +  V       P    P G  +  +  C+Q  P DRP  +++LE R    +Q PDV + +
Sbjct: 255 LEFVTSGGRMDPPKNCP-GPVYRIMTQCWQHQPEDRPNFAIILE-RIEYCTQDPDVINTA 312
Query: 616 LSFSGMQLTEK 626
           L      L E+
Sbjct: 313 LPIEYGPLVEE 323

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 89/336 (26%), Positives = 140/336 (41%), Gaps = 45/336 (13%)
Query: 332 KPEPLPMNSQWQKGK-LIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLE 390
           +P+   +   +Q  K ++G G  G V    +R TG  CA+K   +  D PK+ + +    
Sbjct: 20  EPKKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALK---LLYDSPKARQEVDHHW 76
Query: 391 QEIKVLSHLKHPNIV----QYYGSEIVEDKFYIYLEYVHPGSINKYVREHCG-AITESVV 445
           Q          P+IV     Y      +    I +E +  G +   ++E    A TE   
Sbjct: 77  QASG------GPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREA 130
Query: 446 RNFTRHILSGLAYLHSKKTIHRDIKGANLLV---DASGVVKLADFGMAKHLTGQKADLSM 502
               R I + + +LHS    HRD+K  NLL    +   V+KL DFG AK  T Q A  + 
Sbjct: 131 AEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETT-QNALQTP 189
Query: 503 KGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAA---AMF 559
             +PY++APE    V+   K   S    D+WSLG  +  +  G PP+    G A    M 
Sbjct: 190 CYTPYYVAPE----VLGPEKYDKSC---DMWSLGVIMYILLCGFPPFYSNTGQAISPGMK 242
Query: 560 KVMR-DTPAIPD----SLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQPDVPSC 614
           + +R      P+     +S + K  +R   + +P +R   +  + H ++  S    VP  
Sbjct: 243 RRIRLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSMV--VPQT 300
Query: 615 SLSFSGMQLTEKPHSPREKAD---------AKYDQV 641
            L  + +   +K H    K +           YDQV
Sbjct: 301 PLHTARVLQEDKDHWDEVKEEMTSALATMRVDYDQV 336

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 57/222 (25%), Positives = 100/222 (45%), Gaps = 48/222 (21%)
Query: 348 IGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQ- 406
           IG G +G V  A +       A++++  F        +++    EIK+L   +H NI+  
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIRKISPFEHQTYCQRTLR----EIKILLRFRHENIIGI 90
Query: 407 ---------------YYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRH 451
                          Y   +++E   Y  L+  H              ++   +  F   
Sbjct: 91  NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH--------------LSNDHICYFLYQ 136
Query: 452 ILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAK------HLTGQKADLSMKGS 505
           IL GL Y+HS   +HRD+K +NLL++ +  +K+ DFG+A+        TG   +     +
Sbjct: 137 ILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYV--AT 194
Query: 506 PYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKP 547
            ++ APE+M+    KG +     ++DIWS+GC + EM + +P
Sbjct: 195 RWYRAPEIMLN--SKGYTK----SIDIWSVGCILAEMLSNRP 230

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 81/311 (26%), Positives = 125/311 (40%), Gaps = 57/311 (18%)
Query: 348 IGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAE-SIKQLEQ------------EIK 394
           +G G FG VY              +V   P+DP   + ++K L +            E  
Sbjct: 53  LGHGAFGEVYEG------------QVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEAL 100
Query: 395 VLSHLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVRE------HCGAITESVVRNF 448
           ++S   H NIV+  G  +     +I +E +  G +  ++RE         ++    + + 
Sbjct: 101 IISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHV 160
Query: 449 TRHILSGLAYLHSKKTIHRDIKGANLLVDASG---VVKLADFGMAKHL-------TGQKA 498
            R I  G  YL     IHRDI   N L+   G   V K+ DFGMA+ +        G  A
Sbjct: 161 ARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCA 220
Query: 499 DLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAA 557
            L +K    WM PE  M  +   K+       D WS G  + E+++ G  P+        
Sbjct: 221 MLPVK----WMPPEAFMEGIFTSKT-------DTWSFGVLLWEIFSLGYMPYPSKSNQEV 269
Query: 558 MFKVMRDTPAIPDSLSPEGKDF--LRCCFQRNPADRPPASLLLEHRFLKNSQQPDVPSCS 615
           +  V       P    P G  +  +  C+Q  P DRP  +++LE R    +Q PDV + +
Sbjct: 270 LEFVTSGGRMDPPKNCP-GPVYRIMTQCWQHQPEDRPNFAIILE-RIEYCTQDPDVINTA 327
Query: 616 LSFSGMQLTEK 626
           L      L E+
Sbjct: 328 LPIEYGPLVEE 338

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 66/223 (29%), Positives = 105/223 (47%), Gaps = 32/223 (14%)
Query: 344 KGKLIGRGTFGSVYVASNRETGAL--CAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKH 401
           +G  +GRGT+G VY A  ++       A+K+++       +  S+    +EI +L  LKH
Sbjct: 25  EGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIE------GTGISMSAC-REIALLRELKH 77
Query: 402 PNIV--QYYGSEIVEDKFYIYLEYVHPG--SINKYVREHCG-----AITESVVRNFTRHI 452
           PN++  Q       + K ++  +Y       I K+ R          +   +V++    I
Sbjct: 78  PNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQI 137
Query: 453 LSGLAYLHSKKTIHRDIKGANLLVDAS----GVVKLADFGMAKHLTG---QKADLSMKGS 505
           L G+ YLH+   +HRD+K AN+LV       G VK+AD G A+         ADL     
Sbjct: 138 LDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV 197
Query: 506 PYWM-APELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKP 547
            +W  APEL++      K      A+DIW++GC   E+ T +P
Sbjct: 198 TFWYRAPELLLGARHYTK------AIDIWAIGCIFAELLTSEP 234

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 68/262 (25%), Positives = 116/262 (44%), Gaps = 30/262 (11%)
Query: 346 KLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQ---EIKVLSHLKHP 402
           ++IG G FG V     +  G     KE  +     K   + +Q  +   E  ++   +HP
Sbjct: 20  EVIGAGEFGEVCRGRLKAPGK----KESCVAIKTLKGGYTERQRREFLSEASIMGQFEHP 75
Query: 403 NIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSK 462
           NI++  G         I  E++  G+++ ++R + G  T   +    R I SG+ YL   
Sbjct: 76  NIIRLEGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVIQLVGMLRGIASGMRYLAEM 135
Query: 463 KTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKAD------LSMKGSPYWMAPELMMA 516
             +HRD+   N+LV+++ V K++DFG+++ L    +D      L  K    W APE   A
Sbjct: 136 SYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTYTSSLGGKIPIRWTAPE---A 192
Query: 517 VMQKGKSSDSALAVDIWSLGCTIIE-MYTGKPPWSEYEGAAAMFKVMRDT-----PAIPD 570
           +  +  +S    A D WS G  + E M  G+ P+ +      +  + +D      P  P 
Sbjct: 193 IAFRKFTS----ASDAWSYGIVMWEVMSFGERPYWDMSNQDVINAIEQDYRLPPPPDCPT 248
Query: 571 SLSPEGKDFLRCCFQRNPADRP 592
           SL       +  C+Q++   RP
Sbjct: 249 SL----HQLMLDCWQKDRNARP 266

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 64/239 (26%), Positives = 106/239 (44%), Gaps = 30/239 (12%)
Query: 392 EIKVLSHLK-HPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFT- 449
           EIK+L+    HPN+++YY SE  +   YI LE  +    +    ++       + + +  
Sbjct: 58  EIKLLTESDDHPNVIRYYCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNP 117
Query: 450 ----RHILSGLAYLHSKKTIHRDIKGANLLVDASG-------------VVKLADFGMAKH 492
               R I SG+A+LHS K IHRD+K  N+LV  S               + ++DFG+ K 
Sbjct: 118 ISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKK 177
Query: 493 LTGQKADLSMK-----GSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GK 546
           L   ++          G+  W APEL+              ++DI+S+GC    + + GK
Sbjct: 178 LDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGK 237
Query: 547 PPWSE-YEGAAAMFK---VMRDTPAIPD-SLSPEGKDFLRCCFQRNPADRPPASLLLEH 600
            P+ + Y   + + +    + +   + D SL  E  D +      +P  RP A  +L H
Sbjct: 238 HPFGDKYSRESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRH 296

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 69/286 (24%), Positives = 119/286 (41%), Gaps = 54/286 (18%)
Query: 345 GKLIGRGTFGSVYVASNRETGALCAMKEVDI-FPDDPKSAESIKQLEQEIKVLSHLKHPN 403
           GK +G G FG V  A+            V +    +  S   ++ L  E  VL  + HP+
Sbjct: 28  GKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPH 87
Query: 404 IVQYYGSEIVEDKFYIYLEYVHPGSINKYVRE--HCG---------------------AI 440
           +++ YG+   +    + +EY   GS+  ++RE    G                     A+
Sbjct: 88  VIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERAL 147
Query: 441 TESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADL 500
           T   + +F   I  G+ YL   K +HRD+   N+LV     +K++DFG+++ +   + D 
Sbjct: 148 TMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVY--EEDS 205
Query: 501 SMKGSP-----YWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEM-------YTGKPP 548
            +K S       WMA E +   +   +S       D+WS G  + E+       Y G PP
Sbjct: 206 YVKRSQGRIPVKWMAIESLFDHIYTTQS-------DVWSFGVLLWEIVTLGGNPYPGIPP 258
Query: 549 WSEYEGAAAMFKVMRDTPAI--PDSLSPEGKDFLRCCFQRNPADRP 592
                    +F +++    +  PD+ S E    +  C+++ P  RP
Sbjct: 259 -------ERLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRP 297

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 67/239 (28%), Positives = 114/239 (47%), Gaps = 34/239 (14%)
Query: 392 EIKVLSHLK-HPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFT- 449
           EIK+L+    HPN+++YY SE  +   YI LE  +    +    ++       + + +  
Sbjct: 76  EIKLLTESDDHPNVIRYYCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNP 135
Query: 450 ----RHILSGLAYLHSKKTIHRDIKGANLLVDASG-------------VVKLADFGMAKH 492
               R I SG+A+LHS K IHRD+K  N+LV  S               + ++DFG+ K 
Sbjct: 136 ISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKK 195
Query: 493 L-TGQ---KADLSM-KGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GK 546
           L +GQ   + +L+   G+  W APEL+    ++  +     ++DI+S+GC    + + GK
Sbjct: 196 LDSGQXXFRXNLNNPSGTSGWRAPELLEESTKRRLTR----SIDIFSMGCVFYYILSKGK 251
Query: 547 PPWSE-YEGAAAMFK---VMRDTPAIPD-SLSPEGKDFLRCCFQRNPADRPPASLLLEH 600
            P+ + Y   + + +    + +   + D SL  E  D +      +P  RP A  +L H
Sbjct: 252 HPFGDKYSRESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRH 310

>pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 67/239 (28%), Positives = 111/239 (46%), Gaps = 30/239 (12%)
Query: 392 EIKVLSHLK-HPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFT- 449
           EIK+L+    HPN+++YY SE  +   YI LE  +    +    ++       + + +  
Sbjct: 58  EIKLLTESDDHPNVIRYYCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNP 117
Query: 450 ----RHILSGLAYLHSKKTIHRDIKGANLLVDASG-------------VVKLADFGMAKH 492
               R I SG+A+LHS K IHRD+K  N+LV  S               + ++DFG+ K 
Sbjct: 118 ISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKK 177
Query: 493 L-TGQ---KADLSM-KGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GK 546
           L +GQ   + +L+   G+  W APEL+              ++DI+S+GC    + + GK
Sbjct: 178 LDSGQXXFRXNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGK 237
Query: 547 PPWSE-YEGAAAMFK---VMRDTPAIPD-SLSPEGKDFLRCCFQRNPADRPPASLLLEH 600
            P+ + Y   + + +    + +   + D SL  E  D +      +P  RP A  +L H
Sbjct: 238 HPFGDKYSRESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRH 296

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 67/239 (28%), Positives = 114/239 (47%), Gaps = 34/239 (14%)
Query: 392 EIKVLSHLK-HPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFT- 449
           EIK+L+    HPN+++YY SE  +   YI LE  +    +    ++       + + +  
Sbjct: 76  EIKLLTESDDHPNVIRYYCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNP 135
Query: 450 ----RHILSGLAYLHSKKTIHRDIKGANLLVDASG-------------VVKLADFGMAKH 492
               R I SG+A+LHS K IHRD+K  N+LV  S               + ++DFG+ K 
Sbjct: 136 ISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKK 195
Query: 493 L-TGQ---KADLSM-KGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GK 546
           L +GQ   + +L+   G+  W APEL+    ++  +     ++DI+S+GC    + + GK
Sbjct: 196 LDSGQXXFRXNLNNPSGTSGWRAPELLEESTKRRLTR----SIDIFSMGCVFYYILSKGK 251
Query: 547 PPWSE-YEGAAAMFK---VMRDTPAIPD-SLSPEGKDFLRCCFQRNPADRPPASLLLEH 600
            P+ + Y   + + +    + +   + D SL  E  D +      +P  RP A  +L H
Sbjct: 252 HPFGDKYSRESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRH 310

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 75/285 (26%), Positives = 125/285 (43%), Gaps = 57/285 (20%)
Query: 347 LIGRGTFGSVYVASNRETG-----ALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHL-K 400
           +IG G FG V  A  ++ G     A+  MKE         S +  +    E++VL  L  
Sbjct: 22  VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-------ASKDDHRDFAGELEVLCKLGH 74
Query: 401 HPNIVQYYGSEIVEDKFYIYL--EYVHPGSINKYVREH---------------CGAITES 443
           HPNI+   G+   E + Y+YL  EY   G++  ++R+                   ++  
Sbjct: 75  HPNIINLLGA--CEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQ 132
Query: 444 VVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADL--S 501
            + +F   +  G+ YL  K+ IHRD+   N+LV  + V K+ADFG+++   GQ+  +  +
Sbjct: 133 QLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKKT 189
Query: 502 MKGSPY-WMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEM-------YTGKPPWSEYE 553
           M   P  WMA E +   +    S       D+WS G  + E+       Y G      YE
Sbjct: 190 MGRLPVRWMAIESLNYSVYTTNS-------DVWSYGVLLWEIVSLGGTPYCGMTCAELYE 242
Query: 554 GAAAMFKVMRDTPAIPDSLSPEGKDFLRCCFQRNPADRPPASLLL 598
                +++ +     P +   E  D +R C++  P +RP  + +L
Sbjct: 243 KLPQGYRLEK-----PLNCDDEVYDLMRQCWREKPYERPSFAQIL 282

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 76.6 bits (187), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 65/284 (22%), Positives = 116/284 (40%), Gaps = 50/284 (17%)
Query: 345 GKLIGRGTFGSVYVASNRETGALCAMKEVDI-FPDDPKSAESIKQLEQEIKVLSHLKHPN 403
           GK +G G FG V  A+            V +    +  S   ++ L  E  VL  + HP+
Sbjct: 28  GKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPH 87
Query: 404 IVQYYGSEIVEDKFYIYLEYVHPGSINKYVRE--HCG---------------------AI 440
           +++ YG+   +    + +EY   GS+  ++RE    G                     A+
Sbjct: 88  VIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERAL 147
Query: 441 TESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADL 500
           T   + +F   I  G+ YL     +HRD+   N+LV     +K++DFG+++ +  + + +
Sbjct: 148 TMGDLISFAWQISQGMQYLAEMSLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSXV 207
Query: 501 SMKGSPY---WMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEM-------YTGKPPWS 550
                     WMA E +   +   +S       D+WS G  + E+       Y G PP  
Sbjct: 208 KRSQGRIPVKWMAIESLFDHIYTTQS-------DVWSFGVLLWEIVTLGGNPYPGIPP-- 258
Query: 551 EYEGAAAMFKVMRDTPAI--PDSLSPEGKDFLRCCFQRNPADRP 592
                  +F +++    +  PD+ S E    +  C+++ P  RP
Sbjct: 259 -----ERLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRP 297

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 75/285 (26%), Positives = 125/285 (43%), Gaps = 57/285 (20%)
Query: 347 LIGRGTFGSVYVASNRETG-----ALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHL-K 400
           +IG G FG V  A  ++ G     A+  MKE         S +  +    E++VL  L  
Sbjct: 32  VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-------ASKDDHRDFAGELEVLCKLGH 84
Query: 401 HPNIVQYYGSEIVEDKFYIYL--EYVHPGSINKYVREH---------------CGAITES 443
           HPNI+   G+   E + Y+YL  EY   G++  ++R+                   ++  
Sbjct: 85  HPNIINLLGA--CEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQ 142
Query: 444 VVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADL--S 501
            + +F   +  G+ YL  K+ IHRD+   N+LV  + V K+ADFG+++   GQ+  +  +
Sbjct: 143 QLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKKT 199
Query: 502 MKGSPY-WMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEM-------YTGKPPWSEYE 553
           M   P  WMA E +   +    S       D+WS G  + E+       Y G      YE
Sbjct: 200 MGRLPVRWMAIESLNYSVYTTNS-------DVWSYGVLLWEIVSLGGTPYCGMTCAELYE 252
Query: 554 GAAAMFKVMRDTPAIPDSLSPEGKDFLRCCFQRNPADRPPASLLL 598
                +++ +     P +   E  D +R C++  P +RP  + +L
Sbjct: 253 KLPQGYRLEK-----PLNCDDEVYDLMRQCWREKPYERPSFAQIL 292

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 76.3 bits (186), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 69/277 (24%), Positives = 126/277 (45%), Gaps = 33/277 (11%)
Query: 327 PQVAAKPEPLPMNSQWQKGKLIGRGTFGSVY--VASNRETGALCAMKEVDIFPDDPKSAE 384
           PQ     E + +N      +++G G FG VY  V +N +       +++++     K   
Sbjct: 17  PQYGIAREDVVLN------RILGEGFFGEVYEGVYTNHKG------EKINVAVKTCKKDC 64
Query: 385 SIKQLEQ---EIKVLSHLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAIT 441
           ++   E+   E  ++ +L HP+IV+  G  I E+  +I +E    G +  Y+  +  ++ 
Sbjct: 65  TLDNKEKFMSEAVIMKNLDHPHIVKLIGI-IEEEPTWIIMELYPYGELGHYLERNKNSLK 123
Query: 442 ESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQ---KA 498
              +  ++  I   +AYL S   +HRDI   N+LV +   VKL DFG+++++  +   KA
Sbjct: 124 VLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKA 183
Query: 499 DLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPP--WSEYEGA 555
            ++ +    WM+PE +              A D+W     + E+ + GK P  W E +  
Sbjct: 184 SVT-RLPIKWMSPESI-------NFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDV 235
Query: 556 AAMFKVMRDTPAIPDSLSPEGKDFLRCCFQRNPADRP 592
             + +     P  PD   P     +  C+  +P+DRP
Sbjct: 236 IGVLEKGDRLPK-PDLCPPVLYTLMTRCWDYDPSDRP 271

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 76.3 bits (186), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 68/272 (25%), Positives = 121/272 (44%), Gaps = 38/272 (13%)
Query: 346 KLIGRGTFGSVY---VASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHP 402
           ++IG+G FG VY        +    CA+K +    +     + ++   +E  ++  L HP
Sbjct: 27  RVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITE----MQQVEAFLREGLLMRGLNHP 82
Query: 403 NIVQYYGSEIVEDKF-YIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHS 461
           N++   G  +  +   ++ L Y+  G + +++R      T   + +F   +  G+ YL  
Sbjct: 83  NVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAE 142
Query: 462 KKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQK---------ADLSMKGSPYWMAPE 512
           +K +HRD+   N ++D S  VK+ADFG+A+ +  ++         A L +K    W A E
Sbjct: 143 QKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVK----WTALE 198
Query: 513 LMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYE--GAAAMFKVMRDTPA-- 567
            +       KS       D+WS G  + E+ T G PP+   +           R  P   
Sbjct: 199 SLQTYRFTTKS-------DVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRLPQPE 251
Query: 568 -IPDSLSPEGKDFLRCCFQRNPADRPPASLLL 598
             PDSL       ++ C++ +PA RP   +L+
Sbjct: 252 YCPDSLY----QVMQQCWEADPAVRPTFRVLV 279

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 75.9 bits (185), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 69/277 (24%), Positives = 126/277 (45%), Gaps = 33/277 (11%)
Query: 327 PQVAAKPEPLPMNSQWQKGKLIGRGTFGSVY--VASNRETGALCAMKEVDIFPDDPKSAE 384
           PQ     E + +N      +++G G FG VY  V +N +       +++++     K   
Sbjct: 1   PQYGIAREDVVLN------RILGEGFFGEVYEGVYTNHKG------EKINVAVKTCKKDC 48
Query: 385 SIKQLEQ---EIKVLSHLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAIT 441
           ++   E+   E  ++ +L HP+IV+  G  I E+  +I +E    G +  Y+  +  ++ 
Sbjct: 49  TLDNKEKFMSEAVIMKNLDHPHIVKLIGI-IEEEPTWIIMELYPYGELGHYLERNKNSLK 107
Query: 442 ESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQ---KA 498
              +  ++  I   +AYL S   +HRDI   N+LV +   VKL DFG+++++  +   KA
Sbjct: 108 VLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKA 167
Query: 499 DLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPP--WSEYEGA 555
            ++ +    WM+PE +              A D+W     + E+ + GK P  W E +  
Sbjct: 168 SVT-RLPIKWMSPESI-------NFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDV 219
Query: 556 AAMFKVMRDTPAIPDSLSPEGKDFLRCCFQRNPADRP 592
             + +     P  PD   P     +  C+  +P+DRP
Sbjct: 220 IGVLEKGDRLPK-PDLCPPVLYTLMTRCWDYDPSDRP 255

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 75.9 bits (185), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 64/268 (23%), Positives = 118/268 (44%), Gaps = 17/268 (6%)
Query: 342 WQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDP-KSAESIKQLEQEIKVLSHLK 400
           +  G+ +G G F  V     + TG   A K +        +   S +++E+E+ +L  + 
Sbjct: 14  YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL 73
Query: 401 HPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLH 460
           H N++  +          + LE V  G +  ++ +   +++E    +F + IL G+ YLH
Sbjct: 74  HHNVITLHDVYENRTDVVLILELVSGGELFDFLAQK-ESLSEEEATSFIKQILDGVNYLH 132
Query: 461 SKKTIHRDIKGANLLVDASGV----VKLADFGMAKHLTGQKADLSMKGSPYWMAPELMMA 516
           +KK  H D+K  N+++    +    +KL DFG+A  +       ++ G+P ++APE++  
Sbjct: 133 TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIV-- 190
Query: 517 VMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPW---SEYEGAAAMFKVMRDTPAIPDSLS 573
                      L  D+WS+G     + +G  P+   ++ E  A +  V  D      S +
Sbjct: 191 -----NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQT 245
Query: 574 PE-GKDFLRCCFQRNPADRPPASLLLEH 600
            E  KDF+R    +    R      L H
Sbjct: 246 SELAKDFIRKLLVKETRKRLTIQEALRH 273

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 75.9 bits (185), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 69/277 (24%), Positives = 126/277 (45%), Gaps = 33/277 (11%)
Query: 327 PQVAAKPEPLPMNSQWQKGKLIGRGTFGSVY--VASNRETGALCAMKEVDIFPDDPKSAE 384
           PQ     E + +N      +++G G FG VY  V +N +       +++++     K   
Sbjct: 5   PQYGIAREDVVLN------RILGEGFFGEVYEGVYTNHKG------EKINVAVKTCKKDC 52
Query: 385 SIKQLEQ---EIKVLSHLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAIT 441
           ++   E+   E  ++ +L HP+IV+  G  I E+  +I +E    G +  Y+  +  ++ 
Sbjct: 53  TLDNKEKFMSEAVIMKNLDHPHIVKLIGI-IEEEPTWIIMELYPYGELGHYLERNKNSLK 111
Query: 442 ESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQ---KA 498
              +  ++  I   +AYL S   +HRDI   N+LV +   VKL DFG+++++  +   KA
Sbjct: 112 VLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKA 171
Query: 499 DLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPP--WSEYEGA 555
            ++ +    WM+PE +              A D+W     + E+ + GK P  W E +  
Sbjct: 172 SVT-RLPIKWMSPESI-------NFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDV 223
Query: 556 AAMFKVMRDTPAIPDSLSPEGKDFLRCCFQRNPADRP 592
             + +     P  PD   P     +  C+  +P+DRP
Sbjct: 224 IGVLEKGDRLPK-PDLCPPVLYTLMTRCWDYDPSDRP 259

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 75.5 bits (184), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 64/268 (23%), Positives = 118/268 (44%), Gaps = 17/268 (6%)
Query: 342 WQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDP-KSAESIKQLEQEIKVLSHLK 400
           +  G+ +G G F  V     + TG   A K +        +   S +++E+E+ +L  + 
Sbjct: 14  YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL 73
Query: 401 HPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLH 460
           H N++  +          + LE V  G +  ++ +   +++E    +F + IL G+ YLH
Sbjct: 74  HHNVITLHDVYENRTDVVLILELVSGGELFDFLAQK-ESLSEEEATSFIKQILDGVNYLH 132
Query: 461 SKKTIHRDIKGANLLVDASGV----VKLADFGMAKHLTGQKADLSMKGSPYWMAPELMMA 516
           +KK  H D+K  N+++    +    +KL DFG+A  +       ++ G+P ++APE++  
Sbjct: 133 TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIV-- 190
Query: 517 VMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPW---SEYEGAAAMFKVMRDTPAIPDSLS 573
                      L  D+WS+G     + +G  P+   ++ E  A +  V  D      S +
Sbjct: 191 -----NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHT 245
Query: 574 PE-GKDFLRCCFQRNPADRPPASLLLEH 600
            E  KDF+R    +    R      L H
Sbjct: 246 SELAKDFIRKLLVKETRKRLTIQEALRH 273

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 75.5 bits (184), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 69/281 (24%), Positives = 123/281 (43%), Gaps = 43/281 (15%)
Query: 345 GKLIGRGTFGSVYVASNR---ETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHL-K 400
           GK++G G FG V  A+     +TG    +  V +  +   S+E  + L  E+K+++ L  
Sbjct: 50  GKVLGSGAFGKVMNATAYGISKTGVSIQVA-VKMLKEKADSSER-EALMSELKMMTQLGS 107
Query: 401 HPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVR----------------------EHCG 438
           H NIV   G+  +    Y+  EY   G +  Y+R                      E   
Sbjct: 108 HENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLN 167
Query: 439 AITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKA 498
            +T   +  F   +  G+ +L  K  +HRD+   N+LV    VVK+ DFG+A+ +    +
Sbjct: 168 VLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSD-S 226
Query: 499 DLSMKGSP----YWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYE 553
           +  ++G+      WMAPE +   +   KS       D+WS G  + E+++ G  P+    
Sbjct: 227 NYVVRGNARLPVKWMAPESLFEGIYTIKS-------DVWSYGILLWEIFSLGVNPYPGIP 279
Query: 554 GAAAMFKVMRDTPAI--PDSLSPEGKDFLRCCFQRNPADRP 592
             A  +K++++   +  P   + E    ++ C+  +   RP
Sbjct: 280 VDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRP 320

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 78/298 (26%), Positives = 127/298 (42%), Gaps = 46/298 (15%)
Query: 348 IGRGTFGSVYVASNR-----ETGALCAMKEVDIFPDDPKSAESIKQLE--QEIKVLSHLK 400
           +G+G+FG VY  + R     E     A+K V+      +SA   +++E   E  V+    
Sbjct: 22  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVN------ESASLRERIEFLNEASVMKGFT 75
Query: 401 HPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVR---------NFTRH 451
             ++V+  G         + +E +  G +  Y+R        +  R              
Sbjct: 76  CHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAE 135
Query: 452 ILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSP----- 506
           I  G+AYL++KK +HRD+   N +V     VK+ DFGM + +   + D   KG       
Sbjct: 136 IADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIX--ETDXXRKGGKGLLPV 193
Query: 507 YWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAA--AMFKVMR 563
            WMAPE     ++ G  + S+   D+WS G  + E+ +  + P   Y+G +   + K + 
Sbjct: 194 RWMAPE----SLKDGVFTTSS---DMWSFGVVLWEITSLAEQP---YQGLSNEQVLKFVM 243
Query: 564 DTPAI--PDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQPDVPSCSLSFS 619
           D   +  PD+      D +R C+Q NP  RP  + L     LK+   P  P  S   S
Sbjct: 244 DGGYLDQPDNCPERVTDLMRMCWQFNPKMRP--TFLEIVNLLKDDLHPSFPEVSFFHS 299

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 78/298 (26%), Positives = 127/298 (42%), Gaps = 46/298 (15%)
Query: 348 IGRGTFGSVYVASNR-----ETGALCAMKEVDIFPDDPKSAESIKQLE--QEIKVLSHLK 400
           +G+G+FG VY  + R     E     A+K V+      +SA   +++E   E  V+    
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVN------ESASLRERIEFLNEASVMKGFT 78
Query: 401 HPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVR---------NFTRH 451
             ++V+  G         + +E +  G +  Y+R        +  R              
Sbjct: 79  CHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAE 138
Query: 452 ILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSP----- 506
           I  G+AYL++KK +HRD+   N +V     VK+ DFGM + +   + D   KG       
Sbjct: 139 IADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIX--ETDXXRKGGKGLLPV 196
Query: 507 YWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAA--AMFKVMR 563
            WMAPE     ++ G  + S+   D+WS G  + E+ +  + P   Y+G +   + K + 
Sbjct: 197 RWMAPE----SLKDGVFTTSS---DMWSFGVVLWEITSLAEQP---YQGLSNEQVLKFVM 246
Query: 564 DTPAI--PDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQPDVPSCSLSFS 619
           D   +  PD+      D +R C+Q NP  RP  + L     LK+   P  P  S   S
Sbjct: 247 DGGYLDQPDNCPERVTDLMRMCWQFNPKMRP--TFLEIVNLLKDDLHPSFPEVSFFHS 302

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 54/225 (24%), Positives = 104/225 (46%), Gaps = 40/225 (17%)
Query: 346 KLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIV 405
           + +GRG FG V+ A N+      A+K + +    P    + +++ +E+K L+ L+HP IV
Sbjct: 11  QCLGRGGFGVVFEAKNKVDDCNYAIKRIRL----PNRELAREKVMREVKALAKLEHPGIV 66
Query: 406 QYYGSEIVEDK------------FYIYLEYVHPGSINKYVREHCGAITE---SVVRNFTR 450
           +Y+ + + ++              YI ++     ++  ++   C  I E   SV  +   
Sbjct: 67  RYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRC-TIEERERSVCLHIFL 125
Query: 451 HILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSM-------- 502
            I   + +LHSK  +HRD+K +N+      VVK+ DFG+   +   + + ++        
Sbjct: 126 QIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYA 185
Query: 503 -----KGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEM 542
                 G+  +M+PE +         +  +  VDI+SLG  + E+
Sbjct: 186 RHTGQVGTKLYMSPEQI-------HGNSYSHKVDIFSLGLILFEL 223

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 64/265 (24%), Positives = 117/265 (44%), Gaps = 17/265 (6%)
Query: 345 GKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDP-KSAESIKQLEQEIKVLSHLKHPN 403
           G+ +G G F  V     + TG   A K +        +   S +++E+E+ +L  + H N
Sbjct: 17  GEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHN 76
Query: 404 IVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKK 463
           ++  +          + LE V  G +  ++ +   +++E    +F + IL G+ YLH+KK
Sbjct: 77  VITLHDVYENRTDVVLILELVSGGELFDFLAQK-ESLSEEEATSFIKQILDGVNYLHTKK 135
Query: 464 TIHRDIKGANLLVDASGV----VKLADFGMAKHLTGQKADLSMKGSPYWMAPELMMAVMQ 519
             H D+K  N+++    +    +KL DFG+A  +       ++ G+P ++APE++     
Sbjct: 136 IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIV----- 190
Query: 520 KGKSSDSALAVDIWSLGCTIIEMYTGKPPW---SEYEGAAAMFKVMRDTPAIPDSLSPE- 575
                   L  D+WS+G     + +G  P+   ++ E  A +  V  D      S + E 
Sbjct: 191 --NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQTSEL 248
Query: 576 GKDFLRCCFQRNPADRPPASLLLEH 600
            KDF+R    +    R      L H
Sbjct: 249 AKDFIRKLLVKETRKRLTIQEALRH 273

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 100/213 (46%), Gaps = 20/213 (9%)
Query: 346 KLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQ---LEQEIKVLSHLKHP 402
           ++IG G FG V     +  G     +E+ +     K   + KQ      E  ++    HP
Sbjct: 28  RVIGAGEFGEVCSGRLKLPGK----RELPVAIKTLKVGYTEKQRRDFLGEASIMGQFDHP 83
Query: 403 NIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSK 462
           NI+   G         I  EY+  GS++ +++++ G  T   +    R I +G+ YL   
Sbjct: 84  NIIHLEGVVTKSKPVMIVTEYMENGSLDTFLKKNDGQFTVIQLVGMLRGISAGMKYLSDM 143
Query: 463 KTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQ-KADLSMKGSPY---WMAPELMMAVM 518
             +HRD+   N+L++++ V K++DFG+++ L    +A  + +G      W APE   A+ 
Sbjct: 144 GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPE---AIA 200
Query: 519 QKGKSSDSALAVDIWSLGCTIIEM--YTGKPPW 549
            +  +S    A D+WS G  + E+  Y  +P W
Sbjct: 201 FRKFTS----ASDVWSYGIVMWEVVSYGERPYW 229

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 78/298 (26%), Positives = 127/298 (42%), Gaps = 46/298 (15%)
Query: 348 IGRGTFGSVYVASNR-----ETGALCAMKEVDIFPDDPKSAESIKQLE--QEIKVLSHLK 400
           +G+G+FG VY  + R     E     A+K V+      +SA   +++E   E  V+    
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVN------ESASLRERIEFLNEASVMKGFT 78
Query: 401 HPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVR---------NFTRH 451
             ++V+  G         + +E +  G +  Y+R        +  R              
Sbjct: 79  CHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAE 138
Query: 452 ILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSP----- 506
           I  G+AYL++KK +HRD+   N +V     VK+ DFGM + +   + D   KG       
Sbjct: 139 IADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIX--ETDXXRKGGKGLLPV 196
Query: 507 YWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAA--AMFKVMR 563
            WMAPE     ++ G  + S+   D+WS G  + E+ +  + P   Y+G +   + K + 
Sbjct: 197 RWMAPE----SLKDGVFTTSS---DMWSFGVVLWEITSLAEQP---YQGLSNEQVLKFVM 246
Query: 564 DTPAI--PDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQPDVPSCSLSFS 619
           D   +  PD+      D +R C+Q NP  RP  + L     LK+   P  P  S   S
Sbjct: 247 DGGYLDQPDNCPERVTDLMRMCWQFNPNMRP--TFLEIVNLLKDDLHPSFPEVSFFHS 302

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 64/265 (24%), Positives = 117/265 (44%), Gaps = 17/265 (6%)
Query: 345 GKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDP-KSAESIKQLEQEIKVLSHLKHPN 403
           G+ +G G F  V     + TG   A K +        +   S +++E+E+ +L  + H N
Sbjct: 17  GEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHN 76
Query: 404 IVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKK 463
           ++  +          + LE V  G +  ++ +   +++E    +F + IL G+ YLH+KK
Sbjct: 77  VITLHDVYENRTDVVLILELVSGGELFDFLAQK-ESLSEEEATSFIKQILDGVNYLHTKK 135
Query: 464 TIHRDIKGANLLVDASGV----VKLADFGMAKHLTGQKADLSMKGSPYWMAPELMMAVMQ 519
             H D+K  N+++    +    +KL DFG+A  +       ++ G+P ++APE++     
Sbjct: 136 IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIV----- 190
Query: 520 KGKSSDSALAVDIWSLGCTIIEMYTGKPPW---SEYEGAAAMFKVMRDTPAIPDSLSPE- 575
                   L  D+WS+G     + +G  P+   ++ E  A +  V  D      S + E 
Sbjct: 191 --NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHTSEL 248
Query: 576 GKDFLRCCFQRNPADRPPASLLLEH 600
            KDF+R    +    R      L H
Sbjct: 249 AKDFIRKLLVKETRKRLTIQEALRH 273

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 74/285 (25%), Positives = 125/285 (43%), Gaps = 57/285 (20%)
Query: 347 LIGRGTFGSVYVASNRETG-----ALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHL-K 400
           +IG G FG V  A  ++ G     A+  MKE         S +  +    E++VL  L  
Sbjct: 29  VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-------ASKDDHRDFAGELEVLCKLGH 81
Query: 401 HPNIVQYYGSEIVEDKFYIYL--EYVHPGSINKYVREH---------------CGAITES 443
           HPNI+   G+   E + Y+YL  EY   G++  ++R+                   ++  
Sbjct: 82  HPNIINLLGA--CEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQ 139
Query: 444 VVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADL--S 501
            + +F   +  G+ YL  K+ IHR++   N+LV  + V K+ADFG+++   GQ+  +  +
Sbjct: 140 QLLHFAADVARGMDYLSQKQFIHRNLAARNILVGENYVAKIADFGLSR---GQEVYVKKT 196
Query: 502 MKGSPY-WMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEM-------YTGKPPWSEYE 553
           M   P  WMA E +   +    S       D+WS G  + E+       Y G      YE
Sbjct: 197 MGRLPVRWMAIESLNYSVYTTNS-------DVWSYGVLLWEIVSLGGTPYCGMTCAELYE 249
Query: 554 GAAAMFKVMRDTPAIPDSLSPEGKDFLRCCFQRNPADRPPASLLL 598
                +++ +     P +   E  D +R C++  P +RP  + +L
Sbjct: 250 KLPQGYRLEK-----PLNCDDEVYDLMRQCWREKPYERPSFAQIL 289

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 64/268 (23%), Positives = 118/268 (44%), Gaps = 17/268 (6%)
Query: 342 WQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDP-KSAESIKQLEQEIKVLSHLK 400
           +  G+ +G G F  V     + TG   A K +        +   S +++E+E+ +L  + 
Sbjct: 14  YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL 73
Query: 401 HPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLH 460
           H N++  +          + LE V  G +  ++ +   +++E    +F + IL G+ YLH
Sbjct: 74  HHNVITLHDVYENRTDVVLILELVSGGELFDFLAQK-ESLSEEEATSFIKQILDGVNYLH 132
Query: 461 SKKTIHRDIKGANLLVDASGV----VKLADFGMAKHLTGQKADLSMKGSPYWMAPELMMA 516
           +KK  H D+K  N+++    +    +KL DFG+A  +       ++ G+P ++APE++  
Sbjct: 133 TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIV-- 190
Query: 517 VMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPW---SEYEGAAAMFKVMRDTPAIPDSLS 573
                      L  D+WS+G     + +G  P+   ++ E  A +  V  D      S +
Sbjct: 191 -----NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHT 245
Query: 574 PE-GKDFLRCCFQRNPADRPPASLLLEH 600
            E  KDF+R    +    R      L H
Sbjct: 246 SELAKDFIRKLLVKETRKRLTIQEALRH 273

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 78/298 (26%), Positives = 127/298 (42%), Gaps = 46/298 (15%)
Query: 348 IGRGTFGSVYVASNR-----ETGALCAMKEVDIFPDDPKSAESIKQLE--QEIKVLSHLK 400
           +G+G+FG VY  + R     E     A+K V+      +SA   +++E   E  V+    
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVN------ESASLRERIEFLNEASVMKGFT 78
Query: 401 HPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVR---------NFTRH 451
             ++V+  G         + +E +  G +  Y+R        +  R              
Sbjct: 79  CHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAE 138
Query: 452 ILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSP----- 506
           I  G+AYL++KK +HRD+   N +V     VK+ DFGM + +   + D   KG       
Sbjct: 139 IADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDI--YETDYYRKGGKGLLPV 196
Query: 507 YWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAA--AMFKVMR 563
            WMAPE     ++ G  + S+   D+WS G  + E+ +  + P   Y+G +   + K + 
Sbjct: 197 RWMAPE----SLKDGVFTTSS---DMWSFGVVLWEITSLAEQP---YQGLSNEQVLKFVM 246
Query: 564 DTPAI--PDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQPDVPSCSLSFS 619
           D   +  PD+      D +R C+Q NP  RP  + L     LK+   P  P  S   S
Sbjct: 247 DGGYLDQPDNCPERVTDLMRMCWQFNPKMRP--TFLEIVNLLKDDLHPSFPEVSFFHS 302

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 74/279 (26%), Positives = 134/279 (48%), Gaps = 40/279 (14%)
Query: 348 IGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVL-SHLKHPNIVQ 406
           IG G++       ++ T    A+K +D    DP          +EI++L  + +HPNI+ 
Sbjct: 30  IGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPT---------EEIEILLRYGQHPNIIT 80
Query: 407 YYGSEIVEDKFYIYL--EYVHPGSI-NKYVREHCGAITESVVRNFTRHILSGLAYLHSKK 463
               ++ +D  Y+Y+  E +  G + +K +R+   +  E+    FT  I   + YLH++ 
Sbjct: 81  L--KDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFT--ITKTVEYLHAQG 136
Query: 464 TIHRDIKGANLL-VDASG---VVKLADFGMAKHLTGQKADLSMKGSPYWMAPELMMAVMQ 519
            +HRD+K +N+L VD SG    +++ DFG AK L   +A+  +  +P + A  +   V++
Sbjct: 137 VVHRDLKPSNILYVDESGNPESIRICDFGFAKQL---RAENGLLMTPCYTANFVAPEVLE 193
Query: 520 KGKSSDSALAVDIWSLGCTIIEMYTGKPPWSE----------YEGAAAMFKVMRDTPAIP 569
           + +  D+  A DIWSLG  +  M TG  P++               +  F +   +    
Sbjct: 194 R-QGYDA--ACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSL---SGGYW 247
Query: 570 DSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQ 608
           +S+S   KD +      +P  R  A+L+L H ++ +  Q
Sbjct: 248 NSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHWDQ 286

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 78/298 (26%), Positives = 127/298 (42%), Gaps = 46/298 (15%)
Query: 348 IGRGTFGSVYVASNR-----ETGALCAMKEVDIFPDDPKSAESIKQLE--QEIKVLSHLK 400
           +G+G+FG VY  + R     E     A+K V+      +SA   +++E   E  V+    
Sbjct: 24  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVN------ESASLRERIEFLNEASVMKGFT 77
Query: 401 HPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVR---------NFTRH 451
             ++V+  G         + +E +  G +  Y+R        +  R              
Sbjct: 78  CHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAE 137
Query: 452 ILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSP----- 506
           I  G+AYL++KK +HRD+   N +V     VK+ DFGM + +   + D   KG       
Sbjct: 138 IADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDI--YETDYYRKGGKGLLPV 195
Query: 507 YWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAA--AMFKVMR 563
            WMAPE     ++ G  + S+   D+WS G  + E+ +  + P   Y+G +   + K + 
Sbjct: 196 RWMAPE----SLKDGVFTTSS---DMWSFGVVLWEITSLAEQP---YQGLSNEQVLKFVM 245
Query: 564 DTPAI--PDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQPDVPSCSLSFS 619
           D   +  PD+      D +R C+Q NP  RP  + L     LK+   P  P  S   S
Sbjct: 246 DGGYLDQPDNCPERVTDLMRMCWQFNPKMRP--TFLEIVNLLKDDLHPSFPEVSFFHS 301

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 66/217 (30%), Positives = 103/217 (47%), Gaps = 24/217 (11%)
Query: 345 GKLIGRGTFGSVYVA-SNRETGA---LCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLK 400
           G   G G FG VY    N  T A   L AM  VDI  ++ K     +Q +QEIKV +  +
Sbjct: 27  GNKXGEGGFGVVYKGYVNNTTVAVKKLAAM--VDITTEELK-----QQFDQEIKVXAKCQ 79
Query: 401 HPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGA--ITESVVRNFTRHILSGLAY 458
           H N+V+  G     D   +   Y   GS+   +    G   ++        +   +G+ +
Sbjct: 80  HENLVELLGFSSDGDDLCLVYVYXPNGSLLDRLSCLDGTPPLSWHXRCKIAQGAANGINF 139
Query: 459 LHSKKTIHRDIKGANLLVDASGVVKLADFGMAK--HLTGQKADLS-MKGSPYWMAPELMM 515
           LH    IHRDIK AN+L+D +   K++DFG+A+      Q    S + G+  + APE + 
Sbjct: 140 LHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQXVXXSRIVGTTAYXAPEAL- 198
Query: 516 AVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEY 552
               +G+ +  +   DI+S G  ++E+ TG P   E+
Sbjct: 199 ----RGEITPKS---DIYSFGVVLLEIITGLPAVDEH 228

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 62/239 (25%), Positives = 111/239 (46%), Gaps = 23/239 (9%)
Query: 320 LSPSATIPQVAAKPEPLPMNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDD 379
           L PS    +V A+   +   ++ +K K++G G FG+V+       G    +       +D
Sbjct: 14  LDPSEKANKVLAR---IFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIED 70
Query: 380 PKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGA 439
               +S + +   +  +  L H +IV+  G         +  +Y+  GS+  +VR+H GA
Sbjct: 71  KSGRQSFQAVTDHMLAIGSLDHAHIVRLLGL-CPGSSLQLVTQYLPLGSLLDHVRQHRGA 129
Query: 440 ITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMA-------KH 492
           +   ++ N+   I  G+ YL     +HR++   N+L+ +   V++ADFG+A       K 
Sbjct: 130 LGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQ 189
Query: 493 LTGQKADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWS 550
           L   +A   +K    WMA E     +  GK +  +   D+WS G T+ E+ T G  P++
Sbjct: 190 LLYSEAKTPIK----WMALE----SIHFGKYTHQS---DVWSYGVTVWELMTFGAEPYA 237

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 75/293 (25%), Positives = 131/293 (44%), Gaps = 43/293 (14%)
Query: 347 LIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLK-HPNIV 405
           ++G G    V    N  T    A+K ++  P   +S     ++ +E+++L   + H N++
Sbjct: 20  VLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRS-----RVFREVEMLYQCQGHRNVL 74
Query: 406 QYYGSEIVEDKFYIYLEYVHPGSINKYV--REHCGAITESVVRNFTRHILSGLAYLHSKK 463
           +       ED+FY+  E +  GSI  ++  R H   +  SVV    + + S L +LH+K 
Sbjct: 75  ELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVV---VQDVASALDFLHNKG 131
Query: 464 TIHRDIKGANLLVDASGV---VKLADFGMAK--HLTGQKADLSM------KGSPYWMAPE 512
             HRD+K  N+L +       VK+ DFG+     L G  + +S        GS  +MAPE
Sbjct: 132 IAHRDLKPENILCEHPNQVSPVKICDFGLGSGIKLNGDCSPISTPELLTPCGSAEYMAPE 191
Query: 513 LMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPP----------WSEYEGAAA----M 558
           ++ A  ++    D     D+WSLG  +  + +G PP          W   E   A    +
Sbjct: 192 VVEAFSEEASIYDK--RCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNML 249
Query: 559 FKVMRDTP-AIPDS----LSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNS 606
           F+ +++     PD     +S   KD +     R+   R  A+ +L+H +++  
Sbjct: 250 FESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGC 302

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 73/280 (26%), Positives = 128/280 (45%), Gaps = 49/280 (17%)
Query: 344 KGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPN 403
           +G ++ RG F +  VA  R            I P+    A+   QL +E       +HPN
Sbjct: 37  EGTIVYRGMFDNRDVAVKR------------ILPECFSFADREVQLLRESD-----EHPN 79
Query: 404 IVQYYGSEIVEDKFYIYLEYVHPGSINKYVRE----HCGAITESVVRNFTRHILSGLAYL 459
           +++Y+ +E      YI +E     ++ +YV +    H G    ++++  T    SGLA+L
Sbjct: 80  VIRYFCTEKDRQFQYIAIELC-AATLQEYVEQKDFAHLGLEPITLLQQTT----SGLAHL 134
Query: 460 HSKKTIHRDIKGANLLV---DASGVVK--LADFGMAKHLTGQKADLSMK----GSPYWMA 510
           HS   +HRD+K  N+L+   +A G +K  ++DFG+ K L   +   S +    G+  W+A
Sbjct: 135 HSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIA 194
Query: 511 PELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFKVMRDTPAIP 569
           PE+    + +    +    VDI+S GC    + + G  P+ +     A   ++    ++ 
Sbjct: 195 PEM----LSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQA--NILLGACSL- 247
Query: 570 DSLSPE------GKDFLRCCFQRNPADRPPASLLLEHRFL 603
           D L PE       ++ +      +P  RP A  +L+H F 
Sbjct: 248 DCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFF 287

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 78/300 (26%), Positives = 128/300 (42%), Gaps = 50/300 (16%)
Query: 348 IGRGTFGSVYVASNR-----ETGALCAMKEVDIFPDDPKSAESIKQLE--QEIKVLSHLK 400
           +G+G+FG VY  + R     E     A+K V+      +SA   +++E   E  V+    
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVN------ESASLRERIEFLNEASVMKGFT 78
Query: 401 HPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVR---------NFTRH 451
             ++V+  G         + +E +  G +  Y+R        +  R              
Sbjct: 79  CHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAE 138
Query: 452 ILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHL-------TGQKADLSMKG 504
           I  G+AYL++KK +HRD+   N +V     VK+ DFGM + +        G K  L ++ 
Sbjct: 139 IADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETAYYRKGGKGLLPVR- 197
Query: 505 SPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAA--AMFKV 561
              WMAPE     ++ G  + S+   D+WS G  + E+ +  + P   Y+G +   + K 
Sbjct: 198 ---WMAPE----SLKDGVFTTSS---DMWSFGVVLWEITSLAEQP---YQGLSNEQVLKF 244
Query: 562 MRDTPAI--PDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQPDVPSCSLSFS 619
           + D   +  PD+      D +R C+Q NP  RP  + L     LK+   P  P  S   S
Sbjct: 245 VMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRP--TFLEIVNLLKDDLHPSFPEVSFFHS 302

>pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 73.2 bits (178), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 52/197 (26%), Positives = 89/197 (45%), Gaps = 16/197 (8%)
Query: 415 DKFYIYLEYVHP-GSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGAN 473
           D F + LE   P   +  ++ E  GA+ E + R+F   +L  + + H+   +HRDIK  N
Sbjct: 129 DSFVLILERPEPVQDLFDFITER-GALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDEN 187
Query: 474 LLVDAS-GVVKLADFGMAKHLTGQKADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDI 532
           +L+D + G +KL DFG    L          G+  +  PE +      G+S+       +
Sbjct: 188 ILIDLNRGELKLIDFGSGA-LLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSA------AV 240
Query: 533 WSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDSLSPEGKDFLRCCFQRNPADRP 592
           WSLG  + +M  G  P+   E      +++R        +S E +  +R C    P+DRP
Sbjct: 241 WSLGILLYDMVCGDIPFEHDE------EIIRGQVFFRQRVSSECQHLIRWCLALRPSDRP 294
Query: 593 PASLLLEHRFLKNSQQP 609
               +  H ++++   P
Sbjct: 295 TFEEIQNHPWMQDVLLP 311

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 72.8 bits (177), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 75/293 (25%), Positives = 138/293 (47%), Gaps = 36/293 (12%)
Query: 348 IGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQY 407
           IG G++       ++ T    A+K +D    DP  +E I+ L      L + +HPNI+  
Sbjct: 35  IGVGSYSECKRCVHKATNMEYAVKVIDKSKRDP--SEEIEIL------LRYGQHPNIITL 86
Query: 408 YGSEIVEDKFYIYL--EYVHPGSI-NKYVREHCGAITESVVRNFTRHILS-GLAYLHSKK 463
              ++ +D  ++YL  E +  G + +K +R+   +  E+   +F  H +   + YLHS+ 
Sbjct: 87  --KDVYDDGKHVYLVTELMRGGELLDKILRQKFFSEREA---SFVLHTIGKTVEYLHSQG 141
Query: 464 TIHRDIKGANLL-VDASG---VVKLADFGMAKHLTGQKADLSMKGSPYWMAPELMMAVMQ 519
            +HRD+K +N+L VD SG    +++ DFG AK L   +A+  +  +P + A  +   V++
Sbjct: 142 VVHRDLKPSNILYVDESGNPECLRICDFGFAKQL---RAENGLLMTPCYTANFVAPEVLK 198
Query: 520 KGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRD-------TPAIPDSL 572
           +    +     DIWSLG  +  M  G  P++          + R        +    +++
Sbjct: 199 RQGYDE---GCDIWSLGILLYTMLAGYTPFANGPSDTPEEILTRIGSGKFTLSGGNWNTV 255
Query: 573 SPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQPDVPSCSLSFSGMQLTE 625
           S   KD +      +P  R  A  +L+H ++  +Q+  +P   LS   +QL +
Sbjct: 256 SETAKDLVSKMLHVDPHQRLTAKQVLQHPWV--TQKDKLPQSQLSHQDLQLVK 306

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 72.8 bits (177), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 103/220 (46%), Gaps = 20/220 (9%)
Query: 339 NSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSH 398
            ++ +K K++G G FG+V+       G    +       +D    +S + +   +  +  
Sbjct: 12  ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGS 71
Query: 399 LKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAY 458
           L H +IV+  G         +  +Y+  GS+  +VR+H GA+   ++ N+   I  G+ Y
Sbjct: 72  LDHAHIVRLLGL-CPGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYY 130
Query: 459 LHSKKTIHRDIKGANLLVDASGVVKLADFGMA-------KHLTGQKADLSMKGSPYWMAP 511
           L     +HR++   N+L+ +   V++ADFG+A       K L   +A   +K    WMA 
Sbjct: 131 LEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIK----WMAL 186
Query: 512 ELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWS 550
           E     +  GK +  +   D+WS G T+ E+ T G  P++
Sbjct: 187 E----SIHFGKYTHQS---DVWSYGVTVWELMTFGAEPYA 219

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 72.4 bits (176), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 77/298 (25%), Positives = 127/298 (42%), Gaps = 46/298 (15%)
Query: 348 IGRGTFGSVYVASNR-----ETGALCAMKEVDIFPDDPKSAESIKQLE--QEIKVLSHLK 400
           +G+G+FG VY  + R     E     A+K V+      +SA   +++E   E  V+    
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVN------ESASLRERIEFLNEASVMKGFT 78
Query: 401 HPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVR---------NFTRH 451
             ++V+  G         + +E +  G +  Y+R        +  R              
Sbjct: 79  CHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAE 138
Query: 452 ILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSP----- 506
           I  G+AYL++KK +HR++   N +V     VK+ DFGM + +   + D   KG       
Sbjct: 139 IADGMAYLNAKKFVHRNLAARNCMVAHDFTVKIGDFGMTRDI--YETDYYRKGGKGLLPV 196
Query: 507 YWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAA--AMFKVMR 563
            WMAPE     ++ G  + S+   D+WS G  + E+ +  + P   Y+G +   + K + 
Sbjct: 197 RWMAPE----SLKDGVFTTSS---DMWSFGVVLWEITSLAEQP---YQGLSNEQVLKFVM 246
Query: 564 DTPAI--PDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQPDVPSCSLSFS 619
           D   +  PD+      D +R C+Q NP  RP  + L     LK+   P  P  S   S
Sbjct: 247 DGGYLDQPDNCPERVTDLMRMCWQFNPNMRP--TFLEIVNLLKDDLHPSFPEVSFFHS 302

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 72.4 bits (176), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 77/298 (25%), Positives = 127/298 (42%), Gaps = 46/298 (15%)
Query: 348 IGRGTFGSVYVASNR-----ETGALCAMKEVDIFPDDPKSAESIKQLE--QEIKVLSHLK 400
           +G+G+FG VY  + R     E     A+K V+      +SA   +++E   E  V+    
Sbjct: 26  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVN------ESASLRERIEFLNEASVMKGFT 79
Query: 401 HPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVR---------NFTRH 451
             ++V+  G         + +E +  G +  Y+R        +  R              
Sbjct: 80  CHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAE 139
Query: 452 ILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSP----- 506
           I  G+AYL++KK +HR++   N +V     VK+ DFGM + +   + D   KG       
Sbjct: 140 IADGMAYLNAKKFVHRNLAARNCMVAHDFTVKIGDFGMTRDI--YETDYYRKGGKGLLPV 197
Query: 507 YWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAA--AMFKVMR 563
            WMAPE     ++ G  + S+   D+WS G  + E+ +  + P   Y+G +   + K + 
Sbjct: 198 RWMAPE----SLKDGVFTTSS---DMWSFGVVLWEITSLAEQP---YQGLSNEQVLKFVM 247
Query: 564 DTPAI--PDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQPDVPSCSLSFS 619
           D   +  PD+      D +R C+Q NP  RP  + L     LK+   P  P  S   S
Sbjct: 248 DGGYLDQPDNCPERVTDLMRMCWQFNPNMRP--TFLEIVNLLKDDLHPSFPEVSFFHS 303

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 72.4 bits (176), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 73/301 (24%), Positives = 135/301 (44%), Gaps = 50/301 (16%)
Query: 346 KLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLK-HPNI 404
           +L+G G +  V  A + + G   A+K ++      ++  S  ++ +E++ L   + + NI
Sbjct: 19  ELLGEGAYAKVQGAVSLQNGKEYAVKIIE-----KQAGHSRSRVFREVETLYQCQGNKNI 73
Query: 405 VQYYGSEIVED--KFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSK 462
           ++    E  ED  +FY+  E +  GSI  ++++      E       R + + L +LH+K
Sbjct: 74  LELI--EFFEDDTRFYLVFEKLQGGSILAHIQKQ-KHFNEREASRVVRDVAAALDFLHTK 130
Query: 463 KTIHRDIKGANLLVDA---SGVVKLADFGMAKHLTGQKADLSMK-----------GSPYW 508
              HRD+K  N+L ++      VK+ DF +    +G K + S             GS  +
Sbjct: 131 GIAHRDLKPENILCESPEKVSPVKICDFDLG---SGMKLNNSCTPITTPELTTPCGSAEY 187
Query: 509 MAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAA----------- 557
           MAPE++     +    D     D+WSLG  +  M +G PP+  + GA             
Sbjct: 188 MAPEVVEVFTDQATFYDK--RCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVC 245
Query: 558 ---MFKVMRDTP-AIPDS----LSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQP 609
              +F+ +++     PD     +S E KD +     R+   R  A+ +L+H +++  Q P
Sbjct: 246 QNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQG-QAP 304
Query: 610 D 610
           +
Sbjct: 305 E 305

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 72.4 bits (176), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 62/272 (22%), Positives = 125/272 (45%), Gaps = 21/272 (7%)
Query: 340 SQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHL 399
            Q + G+LIG+G FG VY    R  G + A++ +DI  D+    + +K  ++E+      
Sbjct: 33  EQLEIGELIGKGRFGQVY--HGRWHGEV-AIRLIDIERDNE---DQLKAFKREVMAYRQT 86
Query: 400 KHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYL 459
           +H N+V + G+ +      I        ++   VR+    +  +  R   + I+ G+ YL
Sbjct: 87  RHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYL 146
Query: 460 HSKKTIHRDIKGANLLVDASGVVKLADFGM---AKHLTGQKADLSMKGSPYW---MAPEL 513
           H+K  +H+D+K  N+  D +G V + DFG+   +  L   + +  ++    W   +APE+
Sbjct: 147 HAKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEI 205
Query: 514 MMAVMQKGKSSDSALA--VDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPD- 570
           +  +    +      +   D+++LG    E++  + P+      A ++++   T   P+ 
Sbjct: 206 IRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQM--GTGMKPNL 263
Query: 571 ---SLSPEGKDFLRCCFQRNPADRPPASLLLE 599
               +  E  D L  C+     +RP  + L++
Sbjct: 264 SQIGMGKEISDILLFCWAFEQEERPTFTKLMD 295

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 73/279 (26%), Positives = 132/279 (47%), Gaps = 40/279 (14%)
Query: 348 IGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVL-SHLKHPNIVQ 406
           IG G++       ++ T    A+K +D    DP          +EI++L  + +HPNI+ 
Sbjct: 30  IGVGSYSVCKRCIHKATNXEFAVKIIDKSKRDPT---------EEIEILLRYGQHPNIIT 80
Query: 407 YYGSEIVEDKFYIYL--EYVHPGSI-NKYVREHCGAITESVVRNFTRHILSGLAYLHSKK 463
               ++ +D  Y+Y+  E    G + +K +R+   +  E+    FT  I   + YLH++ 
Sbjct: 81  L--KDVYDDGKYVYVVTELXKGGELLDKILRQKFFSEREASAVLFT--ITKTVEYLHAQG 136
Query: 464 TIHRDIKGANLL-VDASG---VVKLADFGMAKHLTGQKADLSMKGSPYWMAPELMMAVMQ 519
            +HRD+K +N+L VD SG    +++ DFG AK L   +A+  +  +P + A  +   V++
Sbjct: 137 VVHRDLKPSNILYVDESGNPESIRICDFGFAKQL---RAENGLLXTPCYTANFVAPEVLE 193
Query: 520 KGKSSDSALAVDIWSLGCTIIEMYTGKPPWSE----------YEGAAAMFKVMRDTPAIP 569
           + +  D+  A DIWSLG  +    TG  P++               +  F +   +    
Sbjct: 194 R-QGYDA--ACDIWSLGVLLYTXLTGYTPFANGPDDTPEEILARIGSGKFSL---SGGYW 247
Query: 570 DSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQ 608
           +S+S   KD +      +P  R  A+L+L H ++ +  Q
Sbjct: 248 NSVSDTAKDLVSKXLHVDPHQRLTAALVLRHPWIVHWDQ 286

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 75/296 (25%), Positives = 139/296 (46%), Gaps = 42/296 (14%)
Query: 348 IGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQY 407
           IG G++       ++ T    A+K +D    DP  +E I+ L      L + +HPNI+  
Sbjct: 35  IGVGSYSECKRCVHKATNMEYAVKVIDKSKRDP--SEEIEIL------LRYGQHPNIITL 86
Query: 408 YGSEIVEDKFYIYL--EYVHPGSI-NKYVREHCGAITESVVRNFTRHILS-GLAYLHSKK 463
              ++ +D  ++YL  E +  G + +K +R+   +  E+   +F  H +   + YLHS+ 
Sbjct: 87  --KDVYDDGKHVYLVTELMRGGELLDKILRQKFFSEREA---SFVLHTIGKTVEYLHSQG 141
Query: 464 TIHRDIKGANLL-VDASG---VVKLADFGMAKHLTGQKADLSMKGSPYWMAPELMMAVMQ 519
            +HRD+K +N+L VD SG    +++ DFG AK L   +A+  +  +P + A  +   V++
Sbjct: 142 VVHRDLKPSNILYVDESGNPECLRICDFGFAKQL---RAENGLLMTPCYTANFVAPEVLK 198
Query: 520 KGKSSDSALAVDIWSLGCTIIEMYTGKPPWSE----------YEGAAAMFKVMRDTPAIP 569
           +    +     DIWSLG  +  M  G  P++               +  F +   +    
Sbjct: 199 RQGYDE---GCDIWSLGILLYTMLAGYTPFANGPSDTPEEILTRIGSGKFTL---SGGNW 252
Query: 570 DSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQPDVPSCSLSFSGMQLTE 625
           +++S   KD +      +P  R  A  +L+H ++  +Q+  +P   LS   +QL +
Sbjct: 253 NTVSETAKDLVSKMLHVDPHQRLTAKQVLQHPWV--TQKDKLPQSQLSHQDLQLVK 306

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 75/293 (25%), Positives = 130/293 (44%), Gaps = 43/293 (14%)
Query: 347 LIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLK-HPNIV 405
           ++G G    V    N  T    A+K ++  P   +S     ++ +E+++L   + H N++
Sbjct: 20  VLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRS-----RVFREVEMLYQCQGHRNVL 74
Query: 406 QYYGSEIVEDKFYIYLEYVHPGSINKYV--REHCGAITESVVRNFTRHILSGLAYLHSKK 463
           +       ED+FY+  E +  GSI  ++  R H   +  SVV    + + S L +LH+K 
Sbjct: 75  ELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVV---VQDVASALDFLHNKG 131
Query: 464 TIHRDIKGANLLVDASGV---VKLADF--GMAKHLTGQKADLSM------KGSPYWMAPE 512
             HRD+K  N+L +       VK+ DF  G    L G  + +S        GS  +MAPE
Sbjct: 132 IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPE 191
Query: 513 LMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPP----------WSEYEGAAA----M 558
           ++ A  ++    D     D+WSLG  +  + +G PP          W   E   A    +
Sbjct: 192 VVEAFSEEASIYDK--RCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNML 249
Query: 559 FKVMRDTP-AIPDS----LSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNS 606
           F+ +++     PD     +S   KD +     R+   R  A+ +L+H +++  
Sbjct: 250 FESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGC 302

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 47/167 (28%), Positives = 84/167 (50%), Gaps = 15/167 (8%)
Query: 440 ITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKAD 499
           IT   + +++  +  G+ +L S+K IHRD+   N+L+  + VVK+ DFG+A+ +  +  D
Sbjct: 196 ITMEDLISYSFQVARGMEFLSSRKCIHRDLAARNILLSENNVVKICDFGLARDIY-KNPD 254
Query: 500 LSMKGSP----YWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEG 554
              KG       WMAPE +   +   KS       D+WS G  + E+++ G  P+   + 
Sbjct: 255 YVRKGDTRLPLKWMAPESIFDKIYSTKS-------DVWSYGVLLWEIFSLGGSPYPGVQM 307
Query: 555 AAAMFKVMRDTPAI--PDSLSPEGKDFLRCCFQRNPADRPPASLLLE 599
                  +R+   +  P+  +PE    +  C+ R+P +RP  + L+E
Sbjct: 308 DEDFCSRLREGMRMRAPEYSTPEIYQIMLDCWHRDPKERPRFAELVE 354

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 48/172 (27%), Positives = 84/172 (48%), Gaps = 17/172 (9%)
Query: 448 FTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSP- 506
           ++  +  G+ +L S+K IHRD+   N+L+    VVK+ DFG+A+ +  +  D   KG   
Sbjct: 205 YSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIY-KDPDYVRKGDAR 263
Query: 507 ---YWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFKVM 562
               WMAPE +   +   +S       D+WS G  + E+++ G  P+   +      + +
Sbjct: 264 LPLKWMAPETIFDRVYTIQS-------DVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL 316
Query: 563 RDTPAI--PDSLSPEGKDFLRCCFQRNPADRPPASLLLEH--RFLKNSQQPD 610
           ++   +  PD  +PE    +  C+   P+ RP  S L+EH    L+ + Q D
Sbjct: 317 KEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANAQQD 368

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 66/273 (24%), Positives = 117/273 (42%), Gaps = 32/273 (11%)
Query: 345 GKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNI 404
           GK++G G FGSV   + ++         V     D  S   I++   E   +    HPN+
Sbjct: 39  GKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNV 98
Query: 405 VQYYGSEIVED-----KFYIYLEYVHPGSINKYV---REHCG--AITESVVRNFTRHILS 454
           ++  G  I        K  + L ++  G ++ Y+   R   G   I    +  F   I  
Sbjct: 99  IRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIAL 158
Query: 455 GLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHL-------TGQKADLSMKGSPY 507
           G+ YL ++  +HRD+   N ++     V +ADFG++K +        G+ A + +K    
Sbjct: 159 GMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVK---- 214
Query: 508 WMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFKVMRDTP 566
           W+A E +   +   KS       D+W+ G T+ E+ T G  P+   +    M+  +    
Sbjct: 215 WIAIESLADRVYTSKS-------DVWAFGVTMWEIATRGMTPYPGVQN-HEMYDYLLHGH 266
Query: 567 AI--PDSLSPEGKDFLRCCFQRNPADRPPASLL 597
            +  P+    E  + +  C++ +P DRP  S+L
Sbjct: 267 RLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVL 299

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 48/172 (27%), Positives = 84/172 (48%), Gaps = 17/172 (9%)
Query: 448 FTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSP- 506
           ++  +  G+ +L S+K IHRD+   N+L+    VVK+ DFG+A+ +  +  D   KG   
Sbjct: 203 YSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIY-KDPDYVRKGDAR 261
Query: 507 ---YWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFKVM 562
               WMAPE +   +   +S       D+WS G  + E+++ G  P+   +      + +
Sbjct: 262 LPLKWMAPETIFDRVYTIQS-------DVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL 314
Query: 563 RDTPAI--PDSLSPEGKDFLRCCFQRNPADRPPASLLLEH--RFLKNSQQPD 610
           ++   +  PD  +PE    +  C+   P+ RP  S L+EH    L+ + Q D
Sbjct: 315 KEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANAQQD 366

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 56/223 (25%), Positives = 105/223 (47%), Gaps = 15/223 (6%)
Query: 339 NSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSH 398
            ++ +K K++G G FG+VY       G    +        +  S ++ K++  E  V++ 
Sbjct: 16  ETELRKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAG 75
Query: 399 LKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAY 458
           +  P + +  G   +     +  + +  G +  +VRE+ G +    + N+   I  G++Y
Sbjct: 76  VGSPYVSRLLGI-CLTSTVQLVTQLMPYGCLLDHVRENRGRLGSQDLLNWCMQIAKGMSY 134
Query: 459 LHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPY---WMAPELMM 515
           L   + +HRD+   N+LV +   VK+ DFG+A+ L   + +    G      WMA E   
Sbjct: 135 LEDVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALE--- 191
Query: 516 AVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAA 557
           +++++  +  S    D+WS G T+ E+ T G  P   Y+G  A
Sbjct: 192 SILRRRFTHQS----DVWSYGVTVWELMTFGAKP---YDGIPA 227

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 45/160 (28%), Positives = 79/160 (49%), Gaps = 15/160 (9%)
Query: 448 FTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSP- 506
           ++  +  G+ +L S+K IHRD+   N+L+    VVK+ DFG+A+ +  +  D   KG   
Sbjct: 198 YSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIY-KDPDYVRKGDAR 256
Query: 507 ---YWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFKVM 562
               WMAPE +   +   +S       D+WS G  + E+++ G  P+   +      + +
Sbjct: 257 LPLKWMAPETIFDRVYTIQS-------DVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL 309
Query: 563 RDTPAI--PDSLSPEGKDFLRCCFQRNPADRPPASLLLEH 600
           ++   +  PD  +PE    +  C+   P+ RP  S L+EH
Sbjct: 310 KEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 349

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 45/160 (28%), Positives = 79/160 (49%), Gaps = 15/160 (9%)
Query: 448 FTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSP- 506
           ++  +  G+ +L S+K IHRD+   N+L+    VVK+ DFG+A+ +  +  D   KG   
Sbjct: 196 YSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIY-KDPDYVRKGDAR 254
Query: 507 ---YWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFKVM 562
               WMAPE +   +   +S       D+WS G  + E+++ G  P+   +      + +
Sbjct: 255 LPLKWMAPETIFDRVYTIQS-------DVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL 307
Query: 563 RDTPAI--PDSLSPEGKDFLRCCFQRNPADRPPASLLLEH 600
           ++   +  PD  +PE    +  C+   P+ RP  S L+EH
Sbjct: 308 KEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 347

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 111/209 (53%), Gaps = 25/209 (11%)
Query: 347 LIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQ 406
           LIG G FG VY    R+ GA  A+K        P+S++ I++ E EI+ LS  +HP++V 
Sbjct: 46  LIGHGVFGKVYKGVLRD-GAKVALKR-----RTPESSQGIEEFETEIETLSFCRHPHLVS 99
Query: 407 YYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHI------LSGLAYLH 460
             G     ++  +  +Y+  G++ +++    G+   ++  ++ + +        GL YLH
Sbjct: 100 LIGFCDERNEMILIYKYMENGNLKRHLY---GSDLPTMSMSWEQRLEICIGAARGLHYLH 156
Query: 461 SKKTIHRDIKGANLLVDASGVVKLADFGMAKHLT--GQK-ADLSMKGSPYWMAPELMMAV 517
           ++  IHRD+K  N+L+D + V K+ DFG++K  T  GQ      +KG+  ++ PE  +  
Sbjct: 157 TRAIIHRDVKSINILLDENFVPKITDFGISKKGTELGQTHLXXVVKGTLGYIDPEYFI-- 214
Query: 518 MQKGKSSDSALAVDIWSLGCTIIEMYTGK 546
             KG+ ++ +   D++S G  + E+   +
Sbjct: 215 --KGRLTEKS---DVYSFGVVLFEVLCAR 238

>pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 95/210 (45%), Gaps = 23/210 (10%)
Query: 346 KLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHP--- 402
           K+IG+G+FG V  A + +     A+K V             +Q  +EI++L HL+     
Sbjct: 103 KVIGKGSFGQVVKAYDHKVHQHVALKMVR------NEKRFHRQAAEEIRILEHLRKQDKD 156
Query: 403 ---NIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYL 459
              N++    +    +   +  E +         +      +  +VR F   IL  L  L
Sbjct: 157 NTMNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDAL 216
Query: 460 HSKKTIHRDIKGANLLVDASGV--VKLADFGMAKHLTGQKADLSMKGSPYWMAPELMMAV 517
           H  + IH D+K  N+L+   G   +K+ DFG + +   Q+    ++ S ++ APE+++  
Sbjct: 217 HKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCY-EHQRVYTXIQ-SRFYRAPEVILG- 273
Query: 518 MQKGKSSDSALAVDIWSLGCTIIEMYTGKP 547
                 +   + +D+WSLGC + E+ TG P
Sbjct: 274 ------ARYGMPIDMWSLGCILAELLTGYP 297

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 112/211 (53%), Gaps = 29/211 (13%)
Query: 347 LIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQ 406
           LIG G FG VY    R+ GA  A+K        P+S++ I++ E EI+ LS  +HP++V 
Sbjct: 46  LIGHGVFGKVYKGVLRD-GAKVALKR-----RTPESSQGIEEFETEIETLSFCRHPHLVS 99
Query: 407 YYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHI------LSGLAYLH 460
             G     ++  +  +Y+  G++ +++    G+   ++  ++ + +        GL YLH
Sbjct: 100 LIGFCDERNEMILIYKYMENGNLKRHLY---GSDLPTMSMSWEQRLEICIGAARGLHYLH 156
Query: 461 SKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLS-----MKGSPYWMAPELMM 515
           ++  IHRD+K  N+L+D + V K+ DFG++K   G + D +     +KG+  ++ PE  +
Sbjct: 157 TRAIIHRDVKSINILLDENFVPKITDFGISK--KGTELDQTHLXXVVKGTLGYIDPEYFI 214
Query: 516 AVMQKGKSSDSALAVDIWSLGCTIIEMYTGK 546
               KG+ ++ +   D++S G  + E+   +
Sbjct: 215 ----KGRLTEKS---DVYSFGVVLFEVLCAR 238

>pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 95/210 (45%), Gaps = 23/210 (10%)
Query: 346 KLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHP--- 402
           K+IG+G+FG V  A + +     A+K V             +Q  +EI++L HL+     
Sbjct: 103 KVIGKGSFGQVVKAYDHKVHQHVALKMVR------NEKRFHRQAAEEIRILEHLRKQDKD 156
Query: 403 ---NIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYL 459
              N++    +    +   +  E +         +      +  +VR F   IL  L  L
Sbjct: 157 NTMNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDAL 216
Query: 460 HSKKTIHRDIKGANLLVDASGV--VKLADFGMAKHLTGQKADLSMKGSPYWMAPELMMAV 517
           H  + IH D+K  N+L+   G   +K+ DFG + +   Q+    ++ S ++ APE+++  
Sbjct: 217 HKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCY-EHQRVYTXIQ-SRFYRAPEVILG- 273
Query: 518 MQKGKSSDSALAVDIWSLGCTIIEMYTGKP 547
                 +   + +D+WSLGC + E+ TG P
Sbjct: 274 ------ARYGMPIDMWSLGCILAELLTGYP 297

>pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 94/210 (44%), Gaps = 23/210 (10%)
Query: 346 KLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHP--- 402
           K+IG+G FG V  A + +     A+K V             +Q  +EI++L HL+     
Sbjct: 103 KVIGKGXFGQVVKAYDHKVHQHVALKMVR------NEKRFHRQAAEEIRILEHLRKQDKD 156
Query: 403 ---NIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYL 459
              N++    +    +   +  E +         +      +  +VR F   IL  L  L
Sbjct: 157 NTMNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDAL 216
Query: 460 HSKKTIHRDIKGANLLVDASGV--VKLADFGMAKHLTGQKADLSMKGSPYWMAPELMMAV 517
           H  + IH D+K  N+L+   G   +K+ DFG + +   Q+    ++ S ++ APE+++  
Sbjct: 217 HKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCY-EHQRVYXXIQ-SRFYRAPEVILG- 273
Query: 518 MQKGKSSDSALAVDIWSLGCTIIEMYTGKP 547
                 +   + +D+WSLGC + E+ TG P
Sbjct: 274 ------ARYGMPIDMWSLGCILAELLTGYP 297

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 60/254 (23%), Positives = 109/254 (42%), Gaps = 18/254 (7%)
Query: 346 KLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIV 405
           K +G G FG+V      +   +     V I  ++        +L  E  V+  L +P IV
Sbjct: 375 KELGSGNFGTV-KKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 433
Query: 406 QYYGSEIVE-DKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKT 464
           +  G  I E + + + +E    G +NKY++++     ++++      +  G+ YL     
Sbjct: 434 RMIG--ICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIE-LVHQVSMGMKYLEESNF 490
Query: 465 IHRDIKGANLLVDASGVVKLADFGMAKHLTGQ----KADLSMKGSPYWMAPELMMAVMQK 520
           +HRD+   N+L+      K++DFG++K L       KA    K    W APE +      
Sbjct: 491 VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFS 550
Query: 521 GKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFKVMR-DTPAIPDSLSPEGKD 578
            KS       D+WS G  + E ++ G+ P+   +G+     + + +    P     E  D
Sbjct: 551 SKS-------DVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYD 603
Query: 579 FLRCCFQRNPADRP 592
            +  C+  +  +RP
Sbjct: 604 LMNLCWTYDVENRP 617

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 69.3 bits (168), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 100/221 (45%), Gaps = 33/221 (14%)
Query: 346 KLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIV 405
           +LIGRG +G+VY  S  E     A+K V  F +           E+ I  +  ++H NI 
Sbjct: 19  ELIGRGRYGAVYKGSLDERP--VAVK-VFSFANRQNFIN-----EKNIYRVPLMEHDNIA 70
Query: 406 QYY-GSEIVED----KFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLH 460
           ++  G E V      ++ + +EY   GS+ KY+  H      S        +  GLAYLH
Sbjct: 71  RFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTSDWVSSC--RLAHSVTRGLAYLH 128
Query: 461 SK---------KTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQK---------ADLSM 502
           ++            HRD+   N+LV   G   ++DFG++  LTG +         A +S 
Sbjct: 129 TELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISE 188
Query: 503 KGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMY 543
            G+  +MAPE++   +       +   VD+++LG    E++
Sbjct: 189 VGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIF 229

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 69.3 bits (168), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 60/254 (23%), Positives = 109/254 (42%), Gaps = 18/254 (7%)
Query: 346 KLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIV 405
           K +G G FG+V      +   +     V I  ++        +L  E  V+  L +P IV
Sbjct: 376 KELGSGNFGTV-KKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 434
Query: 406 QYYGSEIVE-DKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKT 464
           +  G  I E + + + +E    G +NKY++++     ++++      +  G+ YL     
Sbjct: 435 RMIG--ICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIE-LVHQVSMGMKYLEESNF 491
Query: 465 IHRDIKGANLLVDASGVVKLADFGMAKHLTGQ----KADLSMKGSPYWMAPELMMAVMQK 520
           +HRD+   N+L+      K++DFG++K L       KA    K    W APE +      
Sbjct: 492 VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFS 551
Query: 521 GKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFKVMR-DTPAIPDSLSPEGKD 578
            KS       D+WS G  + E ++ G+ P+   +G+     + + +    P     E  D
Sbjct: 552 SKS-------DVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYD 604
Query: 579 FLRCCFQRNPADRP 592
            +  C+  +  +RP
Sbjct: 605 LMNLCWTYDVENRP 618

>pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368

Iteration: 1
 Score = 69.3 bits (168), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 61/247 (24%), Positives = 119/247 (48%), Gaps = 28/247 (11%)
Query: 347 LIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHL-KHPNIV 405
           LIG+G+FG V  A +R      A+K +            + Q + E+++L  + KH   +
Sbjct: 42  LIGKGSFGQVVKAYDRVEQEWVAIKII------KNKKAFLNQAQIEVRLLELMNKHDTEM 95
Query: 406 QYYGSEI-----VEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLH 460
           +YY   +       +   +  E +     +     +   ++ ++ R F + + + L +L 
Sbjct: 96  KYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLA 155
Query: 461 SKK--TIHRDIKGANLLVD--ASGVVKLADFGMAKHLTGQKADLSMKGSPYWMAPELMMA 516
           + +   IH D+K  N+L+       +K+ DFG +  L GQ+    ++ S ++ +PE+++ 
Sbjct: 156 TPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQL-GQRIYQXIQ-SRFYRSPEVLL- 212
Query: 517 VMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWS---EYEGAAAMFKVMRDTPAIPDSLS 573
               G   D  LA+D+WSLGC ++EM+TG+P +S   E +    + +V+   PA     +
Sbjct: 213 ----GMPYD--LAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQA 266
Query: 574 PEGKDFL 580
           P+ + F 
Sbjct: 267 PKARKFF 273

>pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382

Iteration: 1
 Score = 69.3 bits (168), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 61/247 (24%), Positives = 119/247 (48%), Gaps = 28/247 (11%)
Query: 347 LIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHL-KHPNIV 405
           LIG+G+FG V  A +R      A+K +            + Q + E+++L  + KH   +
Sbjct: 61  LIGKGSFGQVVKAYDRVEQEWVAIKII------KNKKAFLNQAQIEVRLLELMNKHDTEM 114
Query: 406 QYYGSEI-----VEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLH 460
           +YY   +       +   +  E +     +     +   ++ ++ R F + + + L +L 
Sbjct: 115 KYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLA 174
Query: 461 SKK--TIHRDIKGANLLVD--ASGVVKLADFGMAKHLTGQKADLSMKGSPYWMAPELMMA 516
           + +   IH D+K  N+L+       +K+ DFG +  L GQ+    ++ S ++ +PE+++ 
Sbjct: 175 TPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQL-GQRIYQXIQ-SRFYRSPEVLL- 231
Query: 517 VMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWS---EYEGAAAMFKVMRDTPAIPDSLS 573
               G   D  LA+D+WSLGC ++EM+TG+P +S   E +    + +V+   PA     +
Sbjct: 232 ----GMPYD--LAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQA 285
Query: 574 PEGKDFL 580
           P+ + F 
Sbjct: 286 PKARKFF 292

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 68.9 bits (167), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 61/279 (21%), Positives = 121/279 (43%), Gaps = 35/279 (12%)
Query: 341 QWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLK 400
           Q+  G+++G+G FGSV  A  ++         V +   D  ++  I++  +E   +    
Sbjct: 24  QFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFD 83
Query: 401 HPNIVQYYGSEI---VEDKF---YIYLEYVHPGSINKY-----VREHCGAITESVVRNFT 449
           HP++ +  G  +    + +     + L ++  G ++ +     + E+   +    +  F 
Sbjct: 84  HPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFM 143
Query: 450 RHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHL-------TGQKADLSM 502
             I  G+ YL S+  IHRD+   N ++     V +ADFG+++ +        G  + L +
Sbjct: 144 VDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPV 203
Query: 503 KGSPYWMAPELMMAVMQKGKSSDSALAV--DIWSLGCTIIEMYT-GKPPWSEYEGAAAM- 558
           K    W+A E +         +D+   V  D+W+ G T+ E+ T G+ P++  E A    
Sbjct: 204 K----WLALESL---------ADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYN 250
Query: 559 FKVMRDTPAIPDSLSPEGKDFLRCCFQRNPADRPPASLL 597
           + +  +    P     E  D +  C+  +P  RP  + L
Sbjct: 251 YLIGGNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCL 289

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 68.9 bits (167), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 72/304 (23%), Positives = 118/304 (38%), Gaps = 58/304 (19%)
Query: 348 IGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQ------------EIKV 395
           +G+G+FG VY    +            +  D+P++  +IK + +            E  V
Sbjct: 33  LGQGSFGMVYEGVAK-----------GVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 81
Query: 396 LSHLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVR--------- 446
           +      ++V+  G         + +E +  G +  Y+R    A+  + V          
Sbjct: 82  MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMI 141
Query: 447 NFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSP 506
                I  G+AYL++ K +HRD+   N +V     VK+ DFGM + +   + D   KG  
Sbjct: 142 QMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDI--YETDYYRKGGK 199
Query: 507 -----YWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFK 560
                 WM+PE +       K        D+WS G  + E+ T  + P+        +  
Sbjct: 200 GLLPVRWMSPESL-------KDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRF 252
Query: 561 VMR----DTP-AIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQPDVPSCS 615
           VM     D P   PD L     + +R C+Q NP  RP  S L     +K   +P     S
Sbjct: 253 VMEGGLLDKPDNCPDMLF----ELMRMCWQYNPKMRP--SFLEIISSIKEEMEPGFREVS 306
Query: 616 LSFS 619
             +S
Sbjct: 307 FYYS 310

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 72/304 (23%), Positives = 118/304 (38%), Gaps = 58/304 (19%)
Query: 348 IGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQ------------EIKV 395
           +G+G+FG VY    +            +  D+P++  +IK + +            E  V
Sbjct: 23  LGQGSFGMVYEGVAK-----------GVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 71
Query: 396 LSHLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITE---------SVVR 446
           +      ++V+  G         + +E +  G +  Y+R    A+           S + 
Sbjct: 72  MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMI 131
Query: 447 NFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSP 506
                I  G+AYL++ K +HRD+   N +V     VK+ DFGM + +   + D   KG  
Sbjct: 132 QMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDI--YETDYYRKGGK 189
Query: 507 -----YWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFK 560
                 WM+PE +       K        D+WS G  + E+ T  + P+        +  
Sbjct: 190 GLLPVRWMSPESL-------KDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRF 242
Query: 561 VMR----DTP-AIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQPDVPSCS 615
           VM     D P   PD L     + +R C+Q NP  RP  S L     +K   +P     S
Sbjct: 243 VMEGGLLDKPDNCPDMLF----ELMRMCWQYNPKMRP--SFLEIISSIKEEMEPGFREVS 296
Query: 616 LSFS 619
             +S
Sbjct: 297 FYYS 300

>pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/247 (24%), Positives = 119/247 (48%), Gaps = 28/247 (11%)
Query: 347 LIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHL-KHPNIV 405
           LIG+G+FG V  A +R      A+K +            + Q + E+++L  + KH   +
Sbjct: 61  LIGKGSFGQVVKAYDRVEQEWVAIKII------KNKKAFLNQAQIEVRLLELMNKHDTEM 114
Query: 406 QYYGSEI-----VEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLH 460
           +YY   +       +   +  E +     +     +   ++ ++ R F + + + L +L 
Sbjct: 115 KYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLA 174
Query: 461 SKK--TIHRDIKGANLLVD--ASGVVKLADFGMAKHLTGQKADLSMKGSPYWMAPELMMA 516
           + +   IH D+K  N+L+       +K+ DFG +  L GQ+    ++ S ++ +PE+++ 
Sbjct: 175 TPELSIIHCDLKPENILLCNPKRXAIKIVDFGSSCQL-GQRIYQXIQ-SRFYRSPEVLL- 231
Query: 517 VMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWS---EYEGAAAMFKVMRDTPAIPDSLS 573
               G   D  LA+D+WSLGC ++EM+TG+P +S   E +    + +V+   PA     +
Sbjct: 232 ----GMPYD--LAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQA 285
Query: 574 PEGKDFL 580
           P+ + F 
Sbjct: 286 PKARKFF 292

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 72/281 (25%), Positives = 117/281 (41%), Gaps = 27/281 (9%)
Query: 346 KLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIV 405
           +++G G  G V    N+ T    A+K   +  D PK+   + +L        H+    IV
Sbjct: 30  QVLGLGINGKVLQIFNKRTQEKFALK---MLQDCPKARREV-ELHWRASQCPHI--VRIV 83
Query: 406 QYYGSEIVEDK-FYIYLEYVHPGSINKYVREHCG-AITESVVRNFTRHILSGLAYLHSKK 463
             Y +     K   I +E +  G +   +++    A TE       + I   + YLHS  
Sbjct: 84  DVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN 143
Query: 464 TIHRDIKGANLLVDA---SGVVKLADFGMAKHLTGQKADLSMKGSPYWMAPELMMAVMQK 520
             HRD+K  NLL  +   + ++KL DFG AK  T   +  +   +PY++APE    V+  
Sbjct: 144 IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPE----VLGP 199
Query: 521 GKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAA----AMFKVMRDTPAIPD----SL 572
            K   S    D+WSLG  +  +  G PP+    G A       ++       P+     +
Sbjct: 200 EKYDKSC---DMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEV 256
Query: 573 SPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQ-PDVP 612
           S E K  +R   +  P  R   +  + H ++  S + P  P
Sbjct: 257 SEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTP 297

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 72/281 (25%), Positives = 117/281 (41%), Gaps = 27/281 (9%)
Query: 346 KLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIV 405
           +++G G  G V    N+ T    A+K   +  D PK+   + +L        H+    IV
Sbjct: 29  QVLGLGINGKVLQIFNKRTQEKFALK---MLQDCPKARREV-ELHWRASQCPHI--VRIV 82
Query: 406 QYYGSEIVEDK-FYIYLEYVHPGSINKYVREHCG-AITESVVRNFTRHILSGLAYLHSKK 463
             Y +     K   I +E +  G +   +++    A TE       + I   + YLHS  
Sbjct: 83  DVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN 142
Query: 464 TIHRDIKGANLLVDA---SGVVKLADFGMAKHLTGQKADLSMKGSPYWMAPELMMAVMQK 520
             HRD+K  NLL  +   + ++KL DFG AK  T   +  +   +PY++APE    V+  
Sbjct: 143 IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPE----VLGP 198
Query: 521 GKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAA----AMFKVMRDTPAIPD----SL 572
            K   S    D+WSLG  +  +  G PP+    G A       ++       P+     +
Sbjct: 199 EKYDKSC---DMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEV 255
Query: 573 SPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQ-PDVP 612
           S E K  +R   +  P  R   +  + H ++  S + P  P
Sbjct: 256 SEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTP 296

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 72/281 (25%), Positives = 117/281 (41%), Gaps = 27/281 (9%)
Query: 346 KLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIV 405
           +++G G  G V    N+ T    A+K   +  D PK+   + +L        H+    IV
Sbjct: 28  QVLGLGINGKVLQIFNKRTQEKFALK---MLQDCPKARREV-ELHWRASQCPHI--VRIV 81
Query: 406 QYYGSEIVEDK-FYIYLEYVHPGSINKYVREHCG-AITESVVRNFTRHILSGLAYLHSKK 463
             Y +     K   I +E +  G +   +++    A TE       + I   + YLHS  
Sbjct: 82  DVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN 141
Query: 464 TIHRDIKGANLLVDA---SGVVKLADFGMAKHLTGQKADLSMKGSPYWMAPELMMAVMQK 520
             HRD+K  NLL  +   + ++KL DFG AK  T   +  +   +PY++APE    V+  
Sbjct: 142 IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPE----VLGP 197
Query: 521 GKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAA----AMFKVMRDTPAIPD----SL 572
            K   S    D+WSLG  +  +  G PP+    G A       ++       P+     +
Sbjct: 198 EKYDKSC---DMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEV 254
Query: 573 SPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQ-PDVP 612
           S E K  +R   +  P  R   +  + H ++  S + P  P
Sbjct: 255 SEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTP 295

>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 72/281 (25%), Positives = 117/281 (41%), Gaps = 27/281 (9%)
Query: 346 KLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIV 405
           +++G G  G V    N+ T    A+K   +  D PK+   + +L        H+    IV
Sbjct: 68  QVLGLGINGKVLQIFNKRTQEKFALK---MLQDCPKARREV-ELHWRASQCPHI--VRIV 121
Query: 406 QYYGSEIVEDK-FYIYLEYVHPGSINKYVREHCG-AITESVVRNFTRHILSGLAYLHSKK 463
             Y +     K   I +E +  G +   +++    A TE       + I   + YLHS  
Sbjct: 122 DVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN 181
Query: 464 TIHRDIKGANLLVDA---SGVVKLADFGMAKHLTGQKADLSMKGSPYWMAPELMMAVMQK 520
             HRD+K  NLL  +   + ++KL DFG AK  T   +  +   +PY++APE    V+  
Sbjct: 182 IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPE----VLGP 237
Query: 521 GKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAA----AMFKVMRDTPAIPD----SL 572
            K   S    D+WSLG  +  +  G PP+    G A       ++       P+     +
Sbjct: 238 EKYDKSC---DMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEV 294
Query: 573 SPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQ-PDVP 612
           S E K  +R   +  P  R   +  + H ++  S + P  P
Sbjct: 295 SEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTP 335

>pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 101/211 (47%), Gaps = 20/211 (9%)
Query: 342 WQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKH 401
           +Q  + +GRG +  V+ A N        +K +      P     IK+   EIK+L +L+ 
Sbjct: 39  YQLVRKLGRGKYSEVFEAINITNNEKVVVKILK-----PVKKNKIKR---EIKILENLRG 90
Query: 402 -PNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLH 460
            PNI+    ++IV+D        V     N   ++    +T+  +R +   IL  L Y H
Sbjct: 91  GPNIITL--ADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCH 148
Query: 461 SKKTIHRDIKGANLLVDASG-VVKLADFGMAKHLT-GQKADLSMKGSPYWMAPELMMAVM 518
           S   +HRD+K  N+++D     ++L D+G+A+    GQ+ ++ +  S Y+  PEL++   
Sbjct: 149 SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRV-ASRYFKGPELLVDYQ 207
Query: 519 QKGKSSDSALAVDIWSLGCTIIEMYTGKPPW 549
               S      +D+WSLGC +  M   K P+
Sbjct: 208 MYDYS------LDMWSLGCMLASMIFRKEPF 232

>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 72/281 (25%), Positives = 117/281 (41%), Gaps = 27/281 (9%)
Query: 346 KLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIV 405
           +++G G  G V    N+ T    A+K   +  D PK+   + +L        H+    IV
Sbjct: 22  QVLGLGINGKVLQIFNKRTQEKFALK---MLQDCPKARREV-ELHWRASQCPHI--VRIV 75
Query: 406 QYYGSEIVEDK-FYIYLEYVHPGSINKYVREHCG-AITESVVRNFTRHILSGLAYLHSKK 463
             Y +     K   I +E +  G +   +++    A TE       + I   + YLHS  
Sbjct: 76  DVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN 135
Query: 464 TIHRDIKGANLLVDA---SGVVKLADFGMAKHLTGQKADLSMKGSPYWMAPELMMAVMQK 520
             HRD+K  NLL  +   + ++KL DFG AK  T   +  +   +PY++APE    V+  
Sbjct: 136 IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPE----VLGP 191
Query: 521 GKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAA----AMFKVMRDTPAIPD----SL 572
            K   S    D+WSLG  +  +  G PP+    G A       ++       P+     +
Sbjct: 192 EKYDKSC---DMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEV 248
Query: 573 SPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQ-PDVP 612
           S E K  +R   +  P  R   +  + H ++  S + P  P
Sbjct: 249 SEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTP 289

>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 72/281 (25%), Positives = 117/281 (41%), Gaps = 27/281 (9%)
Query: 346 KLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIV 405
           +++G G  G V    N+ T    A+K   +  D PK+   + +L        H+    IV
Sbjct: 23  QVLGLGINGKVLQIFNKRTQEKFALK---MLQDCPKARREV-ELHWRASQCPHI--VRIV 76
Query: 406 QYYGSEIVEDK-FYIYLEYVHPGSINKYVREHCG-AITESVVRNFTRHILSGLAYLHSKK 463
             Y +     K   I +E +  G +   +++    A TE       + I   + YLHS  
Sbjct: 77  DVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN 136
Query: 464 TIHRDIKGANLLVDA---SGVVKLADFGMAKHLTGQKADLSMKGSPYWMAPELMMAVMQK 520
             HRD+K  NLL  +   + ++KL DFG AK  T   +  +   +PY++APE    V+  
Sbjct: 137 IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPE----VLGP 192
Query: 521 GKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAA----AMFKVMRDTPAIPD----SL 572
            K   S    D+WSLG  +  +  G PP+    G A       ++       P+     +
Sbjct: 193 EKYDKSC---DMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEV 249
Query: 573 SPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQ-PDVP 612
           S E K  +R   +  P  R   +  + H ++  S + P  P
Sbjct: 250 SEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTP 290

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 100/208 (48%), Gaps = 20/208 (9%)
Query: 347 LIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQ 406
           ++GRG FG VY       G L A+K +     + +      Q + E++++S   H N+++
Sbjct: 45  ILGRGGFGKVY-KGRLADGTLVAVKRLK----EERXQGGELQFQTEVEMISMAVHRNLLR 99
Query: 407 YYGSEIVEDKFYIYLEYVHPGSINKYVREHCGA---ITESVVRNFTRHILSGLAYLHSK- 462
             G  +   +  +   Y+  GS+   +RE   +   +     +        GLAYLH   
Sbjct: 100 LRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHC 159
Query: 463 --KTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADL--SMKGSPYWMAPELMMAVM 518
             K IHRD+K AN+L+D      + DFG+AK +  +   +  +++G+   +APE     +
Sbjct: 160 DPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXXAVRGTIGHIAPE----YL 215
Query: 519 QKGKSSDSALAVDIWSLGCTIIEMYTGK 546
             GKSS+     D++  G  ++E+ TG+
Sbjct: 216 STGKSSEKT---DVFGYGVMLLELITGQ 240

>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 72/281 (25%), Positives = 117/281 (41%), Gaps = 27/281 (9%)
Query: 346 KLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIV 405
           +++G G  G V    N+ T    A+K   +  D PK+   + +L        H+    IV
Sbjct: 38  QVLGLGINGKVLQIFNKRTQEKFALK---MLQDCPKARREV-ELHWRASQCPHI--VRIV 91
Query: 406 QYYGSEIVEDK-FYIYLEYVHPGSINKYVREHCG-AITESVVRNFTRHILSGLAYLHSKK 463
             Y +     K   I +E +  G +   +++    A TE       + I   + YLHS  
Sbjct: 92  DVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN 151
Query: 464 TIHRDIKGANLLVDA---SGVVKLADFGMAKHLTGQKADLSMKGSPYWMAPELMMAVMQK 520
             HRD+K  NLL  +   + ++KL DFG AK  T   +  +   +PY++APE    V+  
Sbjct: 152 IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPE----VLGP 207
Query: 521 GKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAA----AMFKVMRDTPAIPD----SL 572
            K   S    D+WSLG  +  +  G PP+    G A       ++       P+     +
Sbjct: 208 EKYDKSC---DMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEV 264
Query: 573 SPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQ-PDVP 612
           S E K  +R   +  P  R   +  + H ++  S + P  P
Sbjct: 265 SEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTP 305

>pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 72/281 (25%), Positives = 117/281 (41%), Gaps = 27/281 (9%)
Query: 346 KLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIV 405
           +++G G  G V    N+ T    A+K   +  D PK+   + +L        H+    IV
Sbjct: 24  QVLGLGINGKVLQIFNKRTQEKFALK---MLQDCPKARREV-ELHWRASQCPHI--VRIV 77
Query: 406 QYYGSEIVEDK-FYIYLEYVHPGSINKYVREHCG-AITESVVRNFTRHILSGLAYLHSKK 463
             Y +     K   I +E +  G +   +++    A TE       + I   + YLHS  
Sbjct: 78  DVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN 137
Query: 464 TIHRDIKGANLLVDA---SGVVKLADFGMAKHLTGQKADLSMKGSPYWMAPELMMAVMQK 520
             HRD+K  NLL  +   + ++KL DFG AK  T   +  +   +PY++APE    V+  
Sbjct: 138 IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPE----VLGP 193
Query: 521 GKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAA----AMFKVMRDTPAIPD----SL 572
            K   S    D+WSLG  +  +  G PP+    G A       ++       P+     +
Sbjct: 194 EKYDKSC---DMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEV 250
Query: 573 SPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQ-PDVP 612
           S E K  +R   +  P  R   +  + H ++  S + P  P
Sbjct: 251 SEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTP 291

>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 72/281 (25%), Positives = 117/281 (41%), Gaps = 27/281 (9%)
Query: 346 KLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIV 405
           +++G G  G V    N+ T    A+K   +  D PK+   + +L        H+    IV
Sbjct: 74  QVLGLGINGKVLQIFNKRTQEKFALK---MLQDCPKARREV-ELHWRASQCPHI--VRIV 127
Query: 406 QYYGSEIVEDK-FYIYLEYVHPGSINKYVREHCG-AITESVVRNFTRHILSGLAYLHSKK 463
             Y +     K   I +E +  G +   +++    A TE       + I   + YLHS  
Sbjct: 128 DVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN 187
Query: 464 TIHRDIKGANLLVDA---SGVVKLADFGMAKHLTGQKADLSMKGSPYWMAPELMMAVMQK 520
             HRD+K  NLL  +   + ++KL DFG AK  T   +  +   +PY++APE    V+  
Sbjct: 188 IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPE----VLGP 243
Query: 521 GKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAA----AMFKVMRDTPAIPD----SL 572
            K   S    D+WSLG  +  +  G PP+    G A       ++       P+     +
Sbjct: 244 EKYDKSC---DMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEV 300
Query: 573 SPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQ-PDVP 612
           S E K  +R   +  P  R   +  + H ++  S + P  P
Sbjct: 301 SEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTP 341

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 72/304 (23%), Positives = 120/304 (39%), Gaps = 58/304 (19%)
Query: 348 IGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQ------------EIKV 395
           +G+G+FG VY    +            +  D+P++  +IK + +            E  V
Sbjct: 18  LGQGSFGMVYEGVAK-----------GVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 66
Query: 396 LSHLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVR------EHCGAI---TESVVR 446
           +      ++V+  G         + +E +  G +  Y+R      E+   +   + S + 
Sbjct: 67  MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMI 126
Query: 447 NFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSP 506
                I  G+AYL++ K +HRD+   N +V     VK+ DFGM + +   + D   KG  
Sbjct: 127 QMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIX--ETDXXRKGGK 184
Query: 507 -----YWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFK 560
                 WM+PE +       K        D+WS G  + E+ T  + P+        +  
Sbjct: 185 GLLPVRWMSPESL-------KDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRF 237
Query: 561 VMR----DTP-AIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQPDVPSCS 615
           VM     D P   PD L     + +R C+Q NP  RP  S L     +K   +P     S
Sbjct: 238 VMEGGLLDKPDNCPDMLL----ELMRMCWQYNPKMRP--SFLEIISSIKEEMEPGFREVS 291
Query: 616 LSFS 619
             +S
Sbjct: 292 FYYS 295

>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 72/281 (25%), Positives = 117/281 (41%), Gaps = 27/281 (9%)
Query: 346 KLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIV 405
           +++G G  G V    N+ T    A+K   +  D PK+   + +L        H+    IV
Sbjct: 24  QVLGLGINGKVLQIFNKRTQEKFALK---MLQDCPKARREV-ELHWRASQCPHI--VRIV 77
Query: 406 QYYGSEIVEDK-FYIYLEYVHPGSINKYVREHCG-AITESVVRNFTRHILSGLAYLHSKK 463
             Y +     K   I +E +  G +   +++    A TE       + I   + YLHS  
Sbjct: 78  DVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN 137
Query: 464 TIHRDIKGANLLVDA---SGVVKLADFGMAKHLTGQKADLSMKGSPYWMAPELMMAVMQK 520
             HRD+K  NLL  +   + ++KL DFG AK  T   +  +   +PY++APE    V+  
Sbjct: 138 IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPE----VLGP 193
Query: 521 GKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAA----AMFKVMRDTPAIPD----SL 572
            K   S    D+WSLG  +  +  G PP+    G A       ++       P+     +
Sbjct: 194 EKYDKSC---DMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEV 250
Query: 573 SPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQ-PDVP 612
           S E K  +R   +  P  R   +  + H ++  S + P  P
Sbjct: 251 SEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTP 291

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 72/304 (23%), Positives = 120/304 (39%), Gaps = 58/304 (19%)
Query: 348 IGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQ------------EIKV 395
           +G+G+FG VY    +            +  D+P++  +IK + +            E  V
Sbjct: 27  LGQGSFGMVYEGVAK-----------GVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 75
Query: 396 LSHLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVR------EHCGAI---TESVVR 446
           +      ++V+  G         + +E +  G +  Y+R      E+   +   + S + 
Sbjct: 76  MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMI 135
Query: 447 NFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSP 506
                I  G+AYL++ K +HRD+   N +V     VK+ DFGM + +   + D   KG  
Sbjct: 136 QMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIX--ETDXXRKGGK 193
Query: 507 -----YWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFK 560
                 WM+PE +       K        D+WS G  + E+ T  + P+        +  
Sbjct: 194 GLLPVRWMSPESL-------KDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRF 246
Query: 561 VMR----DTP-AIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQPDVPSCS 615
           VM     D P   PD L     + +R C+Q NP  RP  S L     +K   +P     S
Sbjct: 247 VMEGGLLDKPDNCPDMLF----ELMRMCWQYNPKMRP--SFLEIISSIKEEMEPGFREVS 300
Query: 616 LSFS 619
             +S
Sbjct: 301 FYYS 304

>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 72/281 (25%), Positives = 116/281 (41%), Gaps = 27/281 (9%)
Query: 346 KLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIV 405
           +++G G  G V    N+ T    A+K   +  D PK+   + +L        H+    IV
Sbjct: 22  QVLGLGINGKVLQIFNKRTQEKFALK---MLQDCPKARREV-ELHWRASQCPHI--VRIV 75
Query: 406 QYYGSEIVEDK-FYIYLEYVHPGSINKYVREHCG-AITESVVRNFTRHILSGLAYLHSKK 463
             Y +     K   I +E +  G +   +++    A TE       + I   + YLHS  
Sbjct: 76  DVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN 135
Query: 464 TIHRDIKGANLLVDA---SGVVKLADFGMAKHLTGQKADLSMKGSPYWMAPELMMAVMQK 520
             HRD+K  NLL  +   + ++KL DFG AK  T   +      +PY++APE    V+  
Sbjct: 136 IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTEPCYTPYYVAPE----VLGP 191
Query: 521 GKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAA----AMFKVMRDTPAIPD----SL 572
            K   S    D+WSLG  +  +  G PP+    G A       ++       P+     +
Sbjct: 192 EKYDKSC---DMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEV 248
Query: 573 SPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQ-PDVP 612
           S E K  +R   +  P  R   +  + H ++  S + P  P
Sbjct: 249 SEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTP 289

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 100/208 (48%), Gaps = 20/208 (9%)
Query: 347 LIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQ 406
           ++GRG FG VY       G L A+K +     + ++     Q + E++++S   H N+++
Sbjct: 37  ILGRGGFGKVY-KGRLADGXLVAVKRLK----EERTQGGELQFQTEVEMISMAVHRNLLR 91
Query: 407 YYGSEIVEDKFYIYLEYVHPGSINKYVREHCGA---ITESVVRNFTRHILSGLAYLHSK- 462
             G  +   +  +   Y+  GS+   +RE   +   +     +        GLAYLH   
Sbjct: 92  LRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHC 151
Query: 463 --KTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADL--SMKGSPYWMAPELMMAVM 518
             K IHRD+K AN+L+D      + DFG+AK +  +   +  +++G    +APE     +
Sbjct: 152 DPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXXAVRGXIGHIAPE----YL 207
Query: 519 QKGKSSDSALAVDIWSLGCTIIEMYTGK 546
             GKSS+     D++  G  ++E+ TG+
Sbjct: 208 STGKSSEKT---DVFGYGVMLLELITGQ 232

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 60/254 (23%), Positives = 109/254 (42%), Gaps = 18/254 (7%)
Query: 346 KLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIV 405
           K +G G FG+V      +   +     V I  ++        +L  E  V+  L +P IV
Sbjct: 31  KELGSGNFGTV-KKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 89
Query: 406 QYYGSEIVE-DKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKT 464
           +  G  I E + + + +E    G +NKY++++     ++++      +  G+ YL     
Sbjct: 90  RMIG--ICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIE-LVHQVSMGMKYLEESNF 146
Query: 465 IHRDIKGANLLVDASGVVKLADFGMAKHLTGQ----KADLSMKGSPYWMAPELMMAVMQK 520
           +HRD+   N+L+      K++DFG++K L       KA    K    W APE +      
Sbjct: 147 VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFS 206
Query: 521 GKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFKVMR-DTPAIPDSLSPEGKD 578
            KS       D+WS G  + E ++ G+ P+   +G+     + + +    P     E  D
Sbjct: 207 SKS-------DVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYD 259
Query: 579 FLRCCFQRNPADRP 592
            +  C+  +  +RP
Sbjct: 260 LMNLCWTYDVENRP 273

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 60/254 (23%), Positives = 109/254 (42%), Gaps = 18/254 (7%)
Query: 346 KLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIV 405
           K +G G FG+V      +   +     V I  ++        +L  E  V+  L +P IV
Sbjct: 33  KELGSGNFGTV-KKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 91
Query: 406 QYYGSEIVE-DKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKT 464
           +  G  I E + + + +E    G +NKY++++     ++++      +  G+ YL     
Sbjct: 92  RMIG--ICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIE-LVHQVSMGMKYLEESNF 148
Query: 465 IHRDIKGANLLVDASGVVKLADFGMAKHLTGQ----KADLSMKGSPYWMAPELMMAVMQK 520
           +HRD+   N+L+      K++DFG++K L       KA    K    W APE +      
Sbjct: 149 VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFS 208
Query: 521 GKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFKVMR-DTPAIPDSLSPEGKD 578
            KS       D+WS G  + E ++ G+ P+   +G+     + + +    P     E  D
Sbjct: 209 SKS-------DVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYD 261
Query: 579 FLRCCFQRNPADRP 592
            +  C+  +  +RP
Sbjct: 262 LMNLCWTYDVENRP 275

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 60/254 (23%), Positives = 109/254 (42%), Gaps = 18/254 (7%)
Query: 346 KLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIV 405
           K +G G FG+V      +   +     V I  ++        +L  E  V+  L +P IV
Sbjct: 33  KELGSGNFGTV-KKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 91
Query: 406 QYYGSEIVE-DKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKT 464
           +  G  I E + + + +E    G +NKY++++     ++++      +  G+ YL     
Sbjct: 92  RMIG--ICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIE-LVHQVSMGMKYLEESNF 148
Query: 465 IHRDIKGANLLVDASGVVKLADFGMAKHLTGQ----KADLSMKGSPYWMAPELMMAVMQK 520
           +HRD+   N+L+      K++DFG++K L       KA    K    W APE +      
Sbjct: 149 VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFS 208
Query: 521 GKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFKVMR-DTPAIPDSLSPEGKD 578
            KS       D+WS G  + E ++ G+ P+   +G+     + + +    P     E  D
Sbjct: 209 SKS-------DVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYD 261
Query: 579 FLRCCFQRNPADRP 592
            +  C+  +  +RP
Sbjct: 262 LMNLCWTYDVENRP 275

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 72/304 (23%), Positives = 120/304 (39%), Gaps = 58/304 (19%)
Query: 348 IGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQ------------EIKV 395
           +G+G+FG VY    +            +  D+P++  +IK + +            E  V
Sbjct: 26  LGQGSFGMVYEGVAK-----------GVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 74
Query: 396 LSHLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVR------EHCGAI---TESVVR 446
           +      ++V+  G         + +E +  G +  Y+R      E+   +   + S + 
Sbjct: 75  MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMI 134
Query: 447 NFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSP 506
                I  G+AYL++ K +HRD+   N +V     VK+ DFGM + +   + D   KG  
Sbjct: 135 QMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDI--YETDYYRKGGK 192
Query: 507 -----YWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFK 560
                 WM+PE +       K        D+WS G  + E+ T  + P+        +  
Sbjct: 193 GLLPVRWMSPESL-------KDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRF 245
Query: 561 VMR----DTP-AIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQPDVPSCS 615
           VM     D P   PD L     + +R C+Q NP  RP  S L     +K   +P     S
Sbjct: 246 VMEGGLLDKPDNCPDMLF----ELMRMCWQYNPKMRP--SFLEIISSIKEEMEPGFREVS 299
Query: 616 LSFS 619
             +S
Sbjct: 300 FYYS 303

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 72/304 (23%), Positives = 120/304 (39%), Gaps = 58/304 (19%)
Query: 348 IGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQ------------EIKV 395
           +G+G+FG VY    +            +  D+P++  +IK + +            E  V
Sbjct: 20  LGQGSFGMVYEGVAK-----------GVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 68
Query: 396 LSHLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVR------EHCGAI---TESVVR 446
           +      ++V+  G         + +E +  G +  Y+R      E+   +   + S + 
Sbjct: 69  MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMI 128
Query: 447 NFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSP 506
                I  G+AYL++ K +HRD+   N +V     VK+ DFGM + +   + D   KG  
Sbjct: 129 QMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDI--YETDYYRKGGK 186
Query: 507 -----YWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFK 560
                 WM+PE +       K        D+WS G  + E+ T  + P+        +  
Sbjct: 187 GLLPVRWMSPESL-------KDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRF 239
Query: 561 VMR----DTP-AIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQPDVPSCS 615
           VM     D P   PD L     + +R C+Q NP  RP  S L     +K   +P     S
Sbjct: 240 VMEGGLLDKPDNCPDMLF----ELMRMCWQYNPKMRP--SFLEIISSIKEEMEPGFREVS 293
Query: 616 LSFS 619
             +S
Sbjct: 294 FYYS 297

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 72/304 (23%), Positives = 120/304 (39%), Gaps = 58/304 (19%)
Query: 348 IGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQ------------EIKV 395
           +G+G+FG VY    +            +  D+P++  +IK + +            E  V
Sbjct: 24  LGQGSFGMVYEGVAK-----------GVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 72
Query: 396 LSHLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVR------EHCGAI---TESVVR 446
           +      ++V+  G         + +E +  G +  Y+R      E+   +   + S + 
Sbjct: 73  MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMI 132
Query: 447 NFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSP 506
                I  G+AYL++ K +HRD+   N +V     VK+ DFGM + +   + D   KG  
Sbjct: 133 QMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDI--YETDYYRKGGK 190
Query: 507 -----YWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFK 560
                 WM+PE +       K        D+WS G  + E+ T  + P+        +  
Sbjct: 191 GLLPVRWMSPESL-------KDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRF 243
Query: 561 VMR----DTP-AIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQPDVPSCS 615
           VM     D P   PD L     + +R C+Q NP  RP  S L     +K   +P     S
Sbjct: 244 VMEGGLLDKPDNCPDMLF----ELMRMCWQYNPKMRP--SFLEIISSIKEEMEPGFREVS 297
Query: 616 LSFS 619
             +S
Sbjct: 298 FYYS 301

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 72/304 (23%), Positives = 120/304 (39%), Gaps = 58/304 (19%)
Query: 348 IGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQ------------EIKV 395
           +G+G+FG VY    +            +  D+P++  +IK + +            E  V
Sbjct: 33  LGQGSFGMVYEGVAK-----------GVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 81
Query: 396 LSHLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVR------EHCGAI---TESVVR 446
           +      ++V+  G         + +E +  G +  Y+R      E+   +   + S + 
Sbjct: 82  MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMI 141
Query: 447 NFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSP 506
                I  G+AYL++ K +HRD+   N +V     VK+ DFGM + +   + D   KG  
Sbjct: 142 QMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDI--YETDYYRKGGK 199
Query: 507 -----YWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFK 560
                 WM+PE +       K        D+WS G  + E+ T  + P+        +  
Sbjct: 200 GLLPVRWMSPESL-------KDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRF 252
Query: 561 VMR----DTP-AIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQPDVPSCS 615
           VM     D P   PD L     + +R C+Q NP  RP  S L     +K   +P     S
Sbjct: 253 VMEGGLLDKPDNCPDMLF----ELMRMCWQYNPKMRP--SFLEIISSIKEEMEPGFREVS 306
Query: 616 LSFS 619
             +S
Sbjct: 307 FYYS 310

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 60/254 (23%), Positives = 109/254 (42%), Gaps = 18/254 (7%)
Query: 346 KLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIV 405
           K +G G FG+V      +   +     V I  ++        +L  E  V+  L +P IV
Sbjct: 23  KELGSGNFGTV-KKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 81
Query: 406 QYYGSEIVE-DKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKT 464
           +  G  I E + + + +E    G +NKY++++     ++++      +  G+ YL     
Sbjct: 82  RMIG--ICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIE-LVHQVSMGMKYLEESNF 138
Query: 465 IHRDIKGANLLVDASGVVKLADFGMAKHLTGQ----KADLSMKGSPYWMAPELMMAVMQK 520
           +HRD+   N+L+      K++DFG++K L       KA    K    W APE +      
Sbjct: 139 VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFS 198
Query: 521 GKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFKVMR-DTPAIPDSLSPEGKD 578
            KS       D+WS G  + E ++ G+ P+   +G+     + + +    P     E  D
Sbjct: 199 SKS-------DVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYD 251
Query: 579 FLRCCFQRNPADRP 592
            +  C+  +  +RP
Sbjct: 252 LMNLCWTYDVENRP 265

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 72/304 (23%), Positives = 120/304 (39%), Gaps = 58/304 (19%)
Query: 348 IGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQ------------EIKV 395
           +G+G+FG VY    +            +  D+P++  +IK + +            E  V
Sbjct: 27  LGQGSFGMVYEGVAK-----------GVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 75
Query: 396 LSHLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVR------EHCGAI---TESVVR 446
           +      ++V+  G         + +E +  G +  Y+R      E+   +   + S + 
Sbjct: 76  MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMI 135
Query: 447 NFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSP 506
                I  G+AYL++ K +HRD+   N +V     VK+ DFGM + +   + D   KG  
Sbjct: 136 QMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDI--YETDYYRKGGK 193
Query: 507 -----YWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFK 560
                 WM+PE +       K        D+WS G  + E+ T  + P+        +  
Sbjct: 194 GLLPVRWMSPESL-------KDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRF 246
Query: 561 VMR----DTP-AIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQPDVPSCS 615
           VM     D P   PD L     + +R C+Q NP  RP  S L     +K   +P     S
Sbjct: 247 VMEGGLLDKPDNCPDMLF----ELMRMCWQYNPKMRP--SFLEIISSIKEEMEPGFREVS 300
Query: 616 LSFS 619
             +S
Sbjct: 301 FYYS 304

>pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 67/295 (22%), Positives = 123/295 (41%), Gaps = 53/295 (17%)
Query: 340 SQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHL 399
           +++ + + IG G FGSV+    R  G + A+K           A S+ +     +V +H 
Sbjct: 7   TEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKR-----SKKPLAGSVDEQNALREVYAHA 61
Query: 400 ---KHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAIT---ESVVRNFTRHIL 453
              +H ++V+Y+ +   +D   I  EY + GS+   + E+   ++   E+ +++    + 
Sbjct: 62  VLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVG 121
Query: 454 SGLAYLHSKKTIHRDIKGANLLVDASGV-------------------VKLADFGMAKHLT 494
            GL Y+HS   +H DIK +N+ +  + +                    K+ D G   H+T
Sbjct: 122 RGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLG---HVT 178
Query: 495 GQKADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKP------P 548
              +    +G   ++A E    V+Q+  +       DI++L  T++     +P       
Sbjct: 179 RISSPQVEEGDSRFLANE----VLQENYT--HLPKADIFALALTVVXAAGAEPLPRNGDQ 232
Query: 549 WSEYEGAAAMFKVMRDTPAIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFL 603
           W E              P IP  LS E  + L+     +P  RP A  L++H  L
Sbjct: 233 WHEIRQGR--------LPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVL 279

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 60/254 (23%), Positives = 109/254 (42%), Gaps = 18/254 (7%)
Query: 346 KLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIV 405
           K +G G FG+V      +   +     V I  ++        +L  E  V+  L +P IV
Sbjct: 17  KELGSGNFGTV-KKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 75
Query: 406 QYYGSEIVE-DKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKT 464
           +  G  I E + + + +E    G +NKY++++     ++++      +  G+ YL     
Sbjct: 76  RMIG--ICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIE-LVHQVSMGMKYLEESNF 132
Query: 465 IHRDIKGANLLVDASGVVKLADFGMAKHLTGQ----KADLSMKGSPYWMAPELMMAVMQK 520
           +HRD+   N+L+      K++DFG++K L       KA    K    W APE +      
Sbjct: 133 VHRDLAARNVLLVTQHYAKISDFGLSKALRADENXYKAQTHGKWPVKWYAPECINYYKFS 192
Query: 521 GKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFKVMR-DTPAIPDSLSPEGKD 578
            KS       D+WS G  + E ++ G+ P+   +G+     + + +    P     E  D
Sbjct: 193 SKS-------DVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYD 245
Query: 579 FLRCCFQRNPADRP 592
            +  C+  +  +RP
Sbjct: 246 LMNLCWTYDVENRP 259

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 60/254 (23%), Positives = 109/254 (42%), Gaps = 18/254 (7%)
Query: 346 KLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIV 405
           K +G G FG+V      +   +     V I  ++        +L  E  V+  L +P IV
Sbjct: 17  KELGSGNFGTV-KKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 75
Query: 406 QYYGSEIVE-DKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKT 464
           +  G  I E + + + +E    G +NKY++++     ++++      +  G+ YL     
Sbjct: 76  RMIG--ICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIE-LVHQVSMGMKYLEESNF 132
Query: 465 IHRDIKGANLLVDASGVVKLADFGMAKHLTGQ----KADLSMKGSPYWMAPELMMAVMQK 520
           +HRD+   N+L+      K++DFG++K L       KA    K    W APE +      
Sbjct: 133 VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFS 192
Query: 521 GKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFKVMR-DTPAIPDSLSPEGKD 578
            KS       D+WS G  + E ++ G+ P+   +G+     + + +    P     E  D
Sbjct: 193 SKS-------DVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYD 245
Query: 579 FLRCCFQRNPADRP 592
            +  C+  +  +RP
Sbjct: 246 LMNLCWTYDVENRP 259

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 72/304 (23%), Positives = 120/304 (39%), Gaps = 58/304 (19%)
Query: 348 IGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQ------------EIKV 395
           +G+G+FG VY    +            +  D+P++  +IK + +            E  V
Sbjct: 26  LGQGSFGMVYEGVAK-----------GVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 74
Query: 396 LSHLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVR------EHCGAI---TESVVR 446
           +      ++V+  G         + +E +  G +  Y+R      E+   +   + S + 
Sbjct: 75  MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMI 134
Query: 447 NFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSP 506
                I  G+AYL++ K +HRD+   N +V     VK+ DFGM + +   + D   KG  
Sbjct: 135 QMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDI--YETDYYRKGGK 192
Query: 507 -----YWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFK 560
                 WM+PE +       K        D+WS G  + E+ T  + P+        +  
Sbjct: 193 GLLPVRWMSPESL-------KDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRF 245
Query: 561 VMR----DTP-AIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQPDVPSCS 615
           VM     D P   PD L     + +R C+Q NP  RP  S L     +K   +P     S
Sbjct: 246 VMEGGLLDKPDNCPDMLF----ELMRMCWQYNPKMRP--SFLEIISSIKEEMEPGFREVS 299
Query: 616 LSFS 619
             +S
Sbjct: 300 FYYS 303

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 72/304 (23%), Positives = 120/304 (39%), Gaps = 58/304 (19%)
Query: 348 IGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQ------------EIKV 395
           +G+G+FG VY    +            +  D+P++  +IK + +            E  V
Sbjct: 55  LGQGSFGMVYEGVAK-----------GVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 103
Query: 396 LSHLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVR------EHCGAI---TESVVR 446
           +      ++V+  G         + +E +  G +  Y+R      E+   +   + S + 
Sbjct: 104 MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMI 163
Query: 447 NFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSP 506
                I  G+AYL++ K +HRD+   N +V     VK+ DFGM + +   + D   KG  
Sbjct: 164 QMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDI--YETDYYRKGGK 221
Query: 507 -----YWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFK 560
                 WM+PE +       K        D+WS G  + E+ T  + P+        +  
Sbjct: 222 GLLPVRWMSPESL-------KDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRF 274
Query: 561 VMR----DTP-AIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQPDVPSCS 615
           VM     D P   PD L     + +R C+Q NP  RP  S L     +K   +P     S
Sbjct: 275 VMEGGLLDKPDNCPDMLF----ELMRMCWQYNPKMRP--SFLEIISSIKEEMEPGFREVS 328
Query: 616 LSFS 619
             +S
Sbjct: 329 FYYS 332

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 60/254 (23%), Positives = 109/254 (42%), Gaps = 18/254 (7%)
Query: 346 KLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIV 405
           K +G G FG+V      +   +     V I  ++        +L  E  V+  L +P IV
Sbjct: 11  KELGSGNFGTV-KKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 69
Query: 406 QYYGSEIVE-DKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKT 464
           +  G  I E + + + +E    G +NKY++++     ++++      +  G+ YL     
Sbjct: 70  RMIG--ICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIE-LVHQVSMGMKYLEESNF 126
Query: 465 IHRDIKGANLLVDASGVVKLADFGMAKHLTGQ----KADLSMKGSPYWMAPELMMAVMQK 520
           +HRD+   N+L+      K++DFG++K L       KA    K    W APE +      
Sbjct: 127 VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFS 186
Query: 521 GKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFKVMR-DTPAIPDSLSPEGKD 578
            KS       D+WS G  + E ++ G+ P+   +G+     + + +    P     E  D
Sbjct: 187 SKS-------DVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYD 239
Query: 579 FLRCCFQRNPADRP 592
            +  C+  +  +RP
Sbjct: 240 LMNLCWTYDVENRP 253

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 66.2 bits (160), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 60/254 (23%), Positives = 109/254 (42%), Gaps = 18/254 (7%)
Query: 346 KLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIV 405
           K +G G FG+V      +   +     V I  ++        +L  E  V+  L +P IV
Sbjct: 13  KELGSGNFGTV-KKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 71
Query: 406 QYYGSEIVE-DKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKT 464
           +  G  I E + + + +E    G +NKY++++     ++++      +  G+ YL     
Sbjct: 72  RMIG--ICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIE-LVHQVSMGMKYLEESNF 128
Query: 465 IHRDIKGANLLVDASGVVKLADFGMAKHLTGQ----KADLSMKGSPYWMAPELMMAVMQK 520
           +HRD+   N+L+      K++DFG++K L       KA    K    W APE +      
Sbjct: 129 VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFS 188
Query: 521 GKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFKVMR-DTPAIPDSLSPEGKD 578
            KS       D+WS G  + E ++ G+ P+   +G+     + + +    P     E  D
Sbjct: 189 SKS-------DVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYD 241
Query: 579 FLRCCFQRNPADRP 592
            +  C+  +  +RP
Sbjct: 242 LMNLCWTYDVENRP 255

>pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 65/296 (21%), Positives = 122/296 (41%), Gaps = 53/296 (17%)
Query: 339 NSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSH 398
            +++ + + IG G FGSV+    R  G + A+K           A S+ +     +V +H
Sbjct: 8   TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKR-----SKKPLAGSVDEQNALREVYAH 62
Query: 399 L---KHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAIT---ESVVRNFTRHI 452
               +H ++V+Y+ +   +D   I  EY + GS+   + E+   ++   E+ +++    +
Sbjct: 63  AVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQV 122
Query: 453 LSGLAYLHSKKTIHRDIKGANLLVDASGV-------------------VKLADFGMAKHL 493
             GL Y+HS   +H DIK +N+ +  + +                    K+ D G   H+
Sbjct: 123 GRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLG---HV 179
Query: 494 TGQKADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKP------ 547
           T   +    +G   ++A E++       ++       DI++L  T++     +P      
Sbjct: 180 TRISSPQVEEGDSRFLANEVLQ------ENYTHLPKADIFALALTVVCAAGAEPLPRNGD 233
Query: 548 PWSEYEGAAAMFKVMRDTPAIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFL 603
            W E              P IP  LS E  + L+     +P  RP A  L++H  L
Sbjct: 234 QWHEIRQGR--------LPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVL 281

>pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 67/296 (22%), Positives = 123/296 (41%), Gaps = 53/296 (17%)
Query: 339 NSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSH 398
            +++ + + IG G FGSV+    R  G + A+K           A S+ +     +V +H
Sbjct: 8   TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKR-----SKKPLAGSVDEQNALREVYAH 62
Query: 399 L---KHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAIT---ESVVRNFTRHI 452
               +H ++V+Y+ +   +D   I  EY + GS+   + E+   ++   E+ +++    +
Sbjct: 63  AVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQV 122
Query: 453 LSGLAYLHSKKTIHRDIKGANLLVDASGV-------------------VKLADFGMAKHL 493
             GL Y+HS   +H DIK +N+ +  + +                    K+ D G   H+
Sbjct: 123 GRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLG---HV 179
Query: 494 TGQKADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKP------ 547
           T   +    +G   ++A E    V+Q+  +       DI++L  T++     +P      
Sbjct: 180 TRISSPQVEEGDSRFLANE----VLQENYT--HLPKADIFALALTVVCAAGAEPLPRNGD 233
Query: 548 PWSEYEGAAAMFKVMRDTPAIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFL 603
            W E              P IP  LS E  + L+     +P  RP A  L++H  L
Sbjct: 234 QWHEIRQGR--------LPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVL 281

>pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 65/296 (21%), Positives = 122/296 (41%), Gaps = 53/296 (17%)
Query: 339 NSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSH 398
            +++ + + IG G FGSV+    R  G + A+K           A S+ +     +V +H
Sbjct: 10  TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKR-----SKKPLAGSVDEQNALREVYAH 64
Query: 399 L---KHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAIT---ESVVRNFTRHI 452
               +H ++V+Y+ +   +D   I  EY + GS+   + E+   ++   E+ +++    +
Sbjct: 65  AVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQV 124
Query: 453 LSGLAYLHSKKTIHRDIKGANLLVDASGV-------------------VKLADFGMAKHL 493
             GL Y+HS   +H DIK +N+ +  + +                    K+ D G   H+
Sbjct: 125 GRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLG---HV 181
Query: 494 TGQKADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKP------ 547
           T   +    +G   ++A E++       ++       DI++L  T++     +P      
Sbjct: 182 TRISSPQVEEGDSRFLANEVLQ------ENYTHLPKADIFALALTVVCAAGAEPLPRNGD 235
Query: 548 PWSEYEGAAAMFKVMRDTPAIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFL 603
            W E              P IP  LS E  + L+     +P  RP A  L++H  L
Sbjct: 236 QWHEIRQGR--------LPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVL 283

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 72/304 (23%), Positives = 119/304 (39%), Gaps = 58/304 (19%)
Query: 348 IGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQ------------EIKV 395
           +G+G+FG VY    +            +  D+P++  +IK + +            E  V
Sbjct: 20  LGQGSFGMVYEGVAK-----------GVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 68
Query: 396 LSHLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVR------EHCGAI---TESVVR 446
           +      ++V+  G         + +E +  G +  Y+R      E+   +   + S + 
Sbjct: 69  MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMI 128
Query: 447 NFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSP 506
                I  G+AYL++ K +HRD+   N  V     VK+ DFGM + +   + D   KG  
Sbjct: 129 QMAGEIADGMAYLNANKFVHRDLAARNCXVAEDFTVKIGDFGMTRDI--YETDYYRKGGK 186
Query: 507 -----YWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFK 560
                 WM+PE +       K        D+WS G  + E+ T  + P+        +  
Sbjct: 187 GLLPVRWMSPESL-------KDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRF 239
Query: 561 VMR----DTP-AIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQPDVPSCS 615
           VM     D P   PD L     + +R C+Q NP  RP  S L     +K   +P     S
Sbjct: 240 VMEGGLLDKPDNCPDMLL----ELMRMCWQYNPKMRP--SFLEIISSIKEEMEPGFREVS 293
Query: 616 LSFS 619
             +S
Sbjct: 294 FYYS 297

>pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 72/281 (25%), Positives = 113/281 (40%), Gaps = 27/281 (9%)
Query: 346 KLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIV 405
           +++G G  G V    N+ T    A+K +    D PK+   + +L        H+    IV
Sbjct: 68  QVLGLGINGKVLQIFNKRTQEKFALKXLQ---DCPKARREV-ELHWRASQCPHI--VRIV 121
Query: 406 QYYGSEIVEDK-FYIYLEYVHPGSINKYVREHCG-AITESVVRNFTRHILSGLAYLHSKK 463
             Y +     K   I  E +  G +   +++    A TE       + I   + YLHS  
Sbjct: 122 DVYENLYAGRKCLLIVXECLDGGELFSRIQDRGDQAFTEREASEIXKSIGEAIQYLHSIN 181
Query: 464 TIHRDIKGANLLVDA---SGVVKLADFGMAKHLTGQKADLSMKGSPYWMAPELMMAVMQK 520
             HRD+K  NLL  +   + ++KL DFG AK  T   +  +   +PY++APE    V+  
Sbjct: 182 IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPE----VLGP 237
Query: 521 GKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAA----AMFKVMRDTPAIPD----SL 572
            K   S    D WSLG     +  G PP+    G A       ++       P+     +
Sbjct: 238 EKYDKSC---DXWSLGVIXYILLCGYPPFYSNHGLAISPGXKTRIRXGQYEFPNPEWSEV 294
Query: 573 SPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQ-PDVP 612
           S E K  +R   +  P  R   +    H ++  S + P  P
Sbjct: 295 SEEVKXLIRNLLKTEPTQRXTITEFXNHPWIXQSTKVPQTP 335

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 103/210 (49%), Gaps = 29/210 (13%)
Query: 350 RGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYG 409
           RG FG V+ A       L     V IFP   K +    Q E E+  L  +KH NI+Q+ G
Sbjct: 34  RGRFGCVWKAQ-----LLNEYVAVKIFPIQDKQS---WQNEYEVYSLPGMKHENILQFIG 85
Query: 410 SE----IVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHS---- 461
           +E     V+   ++   +   GS++ +++ +   ++ + + +    +  GLAYLH     
Sbjct: 86  AEKRGTSVDVDLWLITAFHEKGSLSDFLKAN--VVSWNELCHIAETMARGLAYLHEDIPG 143
Query: 462 -----KKTI-HRDIKGANLLVDASGVVKLADFGMA-KHLTGQKADLS--MKGSPYWMAPE 512
                K  I HRDIK  N+L+  +    +ADFG+A K   G+ A  +    G+  +MAPE
Sbjct: 144 LKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPE 203
Query: 513 LMMAVMQKGKSSDSALAVDIWSLGCTIIEM 542
           ++   +   +  D+ L +D++++G  + E+
Sbjct: 204 VLEGAINFQR--DAFLRIDMYAMGLVLWEL 231

>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 61/266 (22%), Positives = 112/266 (42%), Gaps = 23/266 (8%)
Query: 348 IGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQY 407
           +GRG FG V+      +      K V +   D         +++EI +L+  +H NI+  
Sbjct: 13  LGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQV------LVKKEISILNIARHRNILHL 66
Query: 408 YGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHR 467
           + S    ++  +  E++    I + +      + E  + ++   +   L +LHS    H 
Sbjct: 67  HESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHF 126
Query: 468 DIKGANLLVDA--SGVVKLADFGMAKHLT-GQKADLSMKGSPYWMAPELMMAVMQKGKSS 524
           DI+  N++     S  +K+ +FG A+ L  G    L +  +P + APE+        +  
Sbjct: 127 DIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL-LFTAPEYYAPEV-------HQHD 178
Query: 525 DSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMR-----DTPAIPDSLSPEGKDF 579
             + A D+WSLG  +  + +G  P+        +  +M      D  A  + +S E  DF
Sbjct: 179 VVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKE-ISIEAMDF 237
Query: 580 LRCCFQRNPADRPPASLLLEHRFLKN 605
           +     +    R  AS  L+H +LK 
Sbjct: 238 VDRLLVKERKSRMTASEALQHPWLKQ 263

>pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 56/256 (21%), Positives = 109/256 (42%), Gaps = 21/256 (8%)
Query: 348 IGRGTFGSVYVASNRETGALCAMKEVDIFPD--DPKSAESIKQLEQEIKVLSHLKHPNIV 405
           +G+GTF  ++    RE G    + E ++     D       +   +   ++S L H ++V
Sbjct: 16  LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLV 75
Query: 406 QYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTI 465
             YG  +  D+  +  E+V  GS++ Y++++   I         + + + + +L     I
Sbjct: 76  LNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLI 135
Query: 466 HRDIKGANLLV-----DASG---VVKLADFGMAKHLTGQKADLSMKGSPYWMAPELMMAV 517
           H ++   N+L+       +G    +KL+D G++  +T    D+  +  P W+ PE +   
Sbjct: 136 HGNVCAKNILLIREEDRKTGNPPFIKLSDPGIS--ITVLPKDILQERIP-WVPPECI--- 189
Query: 518 MQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFKVMRDTPAIPDSLSPEG 576
                  +  LA D WS G T+ E+ + G  P S  +    + +   D   +P   + E 
Sbjct: 190 ---ENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKL-QFYEDRHQLPAPKAAEL 245
Query: 577 KDFLRCCFQRNPADRP 592
            + +  C    P  RP
Sbjct: 246 ANLINNCMDYEPDHRP 261

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 62/254 (24%), Positives = 108/254 (42%), Gaps = 22/254 (8%)
Query: 348 IGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAES---IKQLEQEIKVLSHLKHPNI 404
           +G G FGSV     R+       K++D+     K        +++ +E +++  L +P I
Sbjct: 344 LGCGNFGSV-----RQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYI 398
Query: 405 VQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKT 464
           V+  G    E    + +E    G ++K++      I  S V      +  G+ YL  K  
Sbjct: 399 VRLIGVCQAE-ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNF 457
Query: 465 IHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSP----YWMAPELMMAVMQK 520
           +HR++   N+L+      K++DFG++K L    +  + + +      W APE    +  +
Sbjct: 458 VHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPE---CINFR 514
Query: 521 GKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAM-FKVMRDTPAIPDSLSPEGKD 578
             SS S    D+WS G T+ E  + G+ P+ + +G   M F         P    PE   
Sbjct: 515 KFSSRS----DVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPELYA 570
Query: 579 FLRCCFQRNPADRP 592
            +  C+     DRP
Sbjct: 571 LMSDCWIYKWEDRP 584

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 78/292 (26%), Positives = 127/292 (43%), Gaps = 58/292 (19%)
Query: 346 KLIGRGTFGSVYVASNRETGALCAMKEVDIFPD-DPKSAESIKQLEQEIKVLSHLKHPNI 404
           + +G+G +G V+  S +  G   A+K   IF   D KS       E E+     L+H NI
Sbjct: 43  ECVGKGRYGEVWRGSWQ--GENVAVK---IFSSRDEKSWFR----ETELYNTVMLRHENI 93
Query: 405 VQYYGSEIVE----DKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLH 460
           + +  S++       + ++   Y   GS+  Y+ +     T S +R     I SGLA+LH
Sbjct: 94  LGFIASDMTSRHSSTQLWLITHYHEMGSLYDYL-QLTTLDTVSCLR-IVLSIASGLAHLH 151
Query: 461 SK--------KTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSP-----Y 507
            +           HRD+K  N+LV  +G   +AD G+A   +     L +  +P      
Sbjct: 152 IEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKR 211
Query: 508 WMAPELMMAVMQKGKSSDSALAVDIWSLGCT------------IIEMYTGKPPWSE---- 551
           +MAPE++   +Q     DS   VDIW+ G              I+E Y  KPP+ +    
Sbjct: 212 YMAPEVLDETIQV-DCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDY--KPPFYDVVPN 268
Query: 552 ---YEGAAAMFKVMRDTPAIPD------SLSPEGKDFLRCCFQRNPADRPPA 594
              +E    +  V +  P IP+      +L+   K  ++ C+ +NP+ R  A
Sbjct: 269 DPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAK-LMKECWYQNPSARLTA 319

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 78/290 (26%), Positives = 126/290 (43%), Gaps = 58/290 (20%)
Query: 348 IGRGTFGSVYVASNRETGALCAMKEVDIFPD-DPKSAESIKQLEQEIKVLSHLKHPNIVQ 406
           +G+G +G V+  S +  G   A+K   IF   D KS       E E+     L+H NI+ 
Sbjct: 16  VGKGRYGEVWRGSWQ--GENVAVK---IFSSRDEKSWFR----ETELYNTVMLRHENILG 66
Query: 407 YYGSEIVE----DKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSK 462
           +  S++       + ++   Y   GS+  Y+ +     T S +R     I SGLA+LH +
Sbjct: 67  FIASDMTSRHSSTQLWLITHYHEMGSLYDYL-QLTTLDTVSCLR-IVLSIASGLAHLHIE 124
Query: 463 --------KTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSP-----YWM 509
                      HRD+K  N+LV  +G   +AD G+A   +     L +  +P      +M
Sbjct: 125 IFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYM 184
Query: 510 APELMMAVMQKGKSSDSALAVDIWSLGCT------------IIEMYTGKPPWSE------ 551
           APE++   +Q     DS   VDIW+ G              I+E Y  KPP+ +      
Sbjct: 185 APEVLDETIQV-DCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDY--KPPFYDVVPNDP 241
Query: 552 -YEGAAAMFKVMRDTPAIPD------SLSPEGKDFLRCCFQRNPADRPPA 594
            +E    +  V +  P IP+      +L+   K  ++ C+ +NP+ R  A
Sbjct: 242 SFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAK-LMKECWYQNPSARLTA 290

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 32/95 (33%), Positives = 53/95 (55%), Gaps = 7/95 (7%)
Query: 451 HILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPYWMA 510
            +L G+ +LHS   IHRD+K +N++V +   +K+ DFG+A+        +    + Y+ A
Sbjct: 136 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMVPFVVTRYYRA 195
Query: 511 PELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTG 545
           PE+++ +  K         VDIWS+GC + EM  G
Sbjct: 196 PEVILGMGYKEN-------VDIWSVGCIMGEMIKG 223

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 62.8 bits (151), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 66/264 (25%), Positives = 112/264 (42%), Gaps = 23/264 (8%)
Query: 348 IGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAES---IKQLEQEIKVLSHLKHPNI 404
           +G G FGSV     R+       K++D+     K        +++ +E +++  L +P I
Sbjct: 18  LGCGNFGSV-----RQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYI 72
Query: 405 VQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKT 464
           V+  G    E    + +E    G ++K++      I  S V      +  G+ YL  K  
Sbjct: 73  VRLIGVCQAE-ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNF 131
Query: 465 IHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSP----YWMAPELMMAVMQK 520
           +HRD+   N+L+      K++DFG++K L    +  + + +      W APE    +  +
Sbjct: 132 VHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPE---CINFR 188
Query: 521 GKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAM-FKVMRDTPAIPDSLSPEGKD 578
             SS S    D+WS G T+ E  + G+ P+ + +G   M F         P    PE   
Sbjct: 189 KFSSRS----DVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPELYA 244
Query: 579 FLRCCFQRNPADRPPASLLLEHRF 602
            +  C+     DRP   L +E R 
Sbjct: 245 LMSDCWIYKWEDRPDF-LTVEQRM 267

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 62.8 bits (151), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 78/290 (26%), Positives = 126/290 (43%), Gaps = 58/290 (20%)
Query: 348 IGRGTFGSVYVASNRETGALCAMKEVDIFPD-DPKSAESIKQLEQEIKVLSHLKHPNIVQ 406
           +G+G +G V+  S +  G   A+K   IF   D KS       E E+     L+H NI+ 
Sbjct: 16  VGKGRYGEVWRGSWQ--GENVAVK---IFSSRDEKSWFR----ETELYNTVMLRHENILG 66
Query: 407 YYGSEIVE----DKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSK 462
           +  S++       + ++   Y   GS+  Y+ +     T S +R     I SGLA+LH +
Sbjct: 67  FIASDMTSRHSSTQLWLITHYHEMGSLYDYL-QLTTLDTVSCLR-IVLSIASGLAHLHIE 124
Query: 463 --------KTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSP-----YWM 509
                      HRD+K  N+LV  +G   +AD G+A   +     L +  +P      +M
Sbjct: 125 IFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYM 184
Query: 510 APELMMAVMQKGKSSDSALAVDIWSLGCT------------IIEMYTGKPPWSE------ 551
           APE++   +Q     DS   VDIW+ G              I+E Y  KPP+ +      
Sbjct: 185 APEVLDETIQV-DCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDY--KPPFYDVVPNDP 241
Query: 552 -YEGAAAMFKVMRDTPAIPD------SLSPEGKDFLRCCFQRNPADRPPA 594
            +E    +  V +  P IP+      +L+   K  ++ C+ +NP+ R  A
Sbjct: 242 SFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAK-LMKECWYQNPSARLTA 290

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 62.4 bits (150), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 35/100 (35%), Positives = 55/100 (55%), Gaps = 17/100 (17%)
Query: 451 HILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSP---- 506
            +L G+ +LHS   IHRD+K +N++V +   +K+ DFG+A+      A  S   +P    
Sbjct: 134 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLAR-----TAGTSFMMTPYVVT 188
Query: 507 -YWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTG 545
            Y+ APE+++ +  K         VDIWS+GC + EM  G
Sbjct: 189 RYYRAPEVILGMGYKEN-------VDIWSVGCIMGEMIKG 221

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 62.4 bits (150), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 35/100 (35%), Positives = 55/100 (55%), Gaps = 17/100 (17%)
Query: 451 HILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSP---- 506
            +L G+ +LHS   IHRD+K +N++V +   +K+ DFG+A+      A  S   +P    
Sbjct: 134 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLAR-----TAGTSFMMTPYVVT 188
Query: 507 -YWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTG 545
            Y+ APE+++ +  K         VDIWS+GC + EM  G
Sbjct: 189 RYYRAPEVILGMGYKEN-------VDIWSVGCIMGEMIKG 221

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 35/100 (35%), Positives = 55/100 (55%), Gaps = 17/100 (17%)
Query: 451 HILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSP---- 506
            +L G+ +LHS   IHRD+K +N++V +   +K+ DFG+A+      A  S   +P    
Sbjct: 134 QMLVGIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLAR-----TAGTSFMMTPYVVT 188
Query: 507 -YWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTG 545
            Y+ APE+++ +  K         VDIWS+GC + EM  G
Sbjct: 189 RYYRAPEVILGMGYKEN-------VDIWSVGCIMGEMIKG 221

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 61/274 (22%), Positives = 119/274 (43%), Gaps = 42/274 (15%)
Query: 346 KLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIV 405
           +++  G F  VY A +  +G   A+K   +  ++ +   +I Q    +K LS   HPNIV
Sbjct: 34  RVLAEGGFAFVYEAQDVGSGREYALKR--LLSNEEEKNRAIIQEVCFMKKLS--GHPNIV 89
Query: 406 QYYGSEIVEDKF-------YIYLEYVHPGSINKYVR--EHCGAITESVVRNFTRHILSGL 456
           Q+  +  +  +        ++ L  +  G + ++++  E  G ++   V          +
Sbjct: 90  QFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAV 149
Query: 457 AYLHSKK--TIHRDIKGANLLVDASGVVKLADFGMAKHLTGQ-------------KADLS 501
            ++H +K   IHRD+K  NLL+   G +KL DFG A  ++               + +++
Sbjct: 150 QHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEIT 209
Query: 502 MKGSPYWMAPEL--MMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMF 559
              +P +  PE+  + +    G+        DIW+LGC +  +   + P+ +     A  
Sbjct: 210 RNTTPMYRTPEIIDLYSNFPIGEKQ------DIWALGCILYLLCFRQHPFED----GAKL 259
Query: 560 KVMRDTPAIP--DSLSPEGKDFLRCCFQRNPADR 591
           +++    +IP  D+        +R   Q NP +R
Sbjct: 260 RIVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEER 293

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 35/100 (35%), Positives = 55/100 (55%), Gaps = 17/100 (17%)
Query: 451 HILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSP---- 506
            +L G+ +LHS   IHRD+K +N++V +   +K+ DFG+A+      A  S   +P    
Sbjct: 134 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR-----TAGTSFMMTPEVVT 188
Query: 507 -YWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTG 545
            Y+ APE+++ +  K         VDIWS+GC + EM  G
Sbjct: 189 RYYRAPEVILGMGYKEN-------VDIWSVGCIMGEMIKG 221

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 35/100 (35%), Positives = 55/100 (55%), Gaps = 17/100 (17%)
Query: 451 HILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSP---- 506
            +L G+ +LHS   IHRD+K +N++V +   +K+ DFG+A+      A  S   +P    
Sbjct: 134 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR-----TAGTSFMMTPYVVT 188
Query: 507 -YWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTG 545
            Y+ APE+++ +  K         VDIWS+GC + EM  G
Sbjct: 189 RYYRAPEVILGMGYKEN-------VDIWSVGCIMGEMIKG 221
  Database: pdbaa

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	721
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	1e-142
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	1e-129
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	1e-118
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	1e-102
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	1e-101
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	1e-100
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	2e-98
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	4e-97
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	3e-95
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	2e-90
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	3e-87
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	1e-86
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	2e-85
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	6e-85
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	8e-85
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	7e-84
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	8e-83
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	2e-82
3fme_A	290	Dual specificity mitogen-activated protein kinase;	8e-78
3aln_A	327	Dual specificity mitogen-activated protein kinase;	5e-77
2a19_B	284	Interferon-induced, double-stranded RNA-activated	7e-77
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	2e-76
3an0_A	340	Dual specificity mitogen-activated protein kinase;	6e-76
2dyl_A	318	Dual specificity mitogen-activated protein kinase	7e-76
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	1e-74
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	2e-74
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	1e-72
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	6e-72
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	2e-71
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	5e-71
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	4e-68
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	4e-67
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	2e-66
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	1e-65
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	3e-64
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	4e-64
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	5e-63
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	5e-63
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	3e-62
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	5e-59
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	4e-57
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	9e-57
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	3e-56
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	4e-56
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	6e-56
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	6e-56
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	7e-56
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	7e-56
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	9e-56
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	2e-55
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	2e-55
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	3e-55
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	3e-55
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	8e-55
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	9e-55
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	3e-54
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	3e-54
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	3e-54
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	3e-54
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	3e-54
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	7e-54
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	9e-54
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	9e-54
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	1e-53
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	2e-53
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	2e-53
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	5e-53
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	6e-53
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	6e-53
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	8e-53
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	9e-53
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	2e-52
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	1e-51
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	1e-51
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	1e-51
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	2e-51
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	3e-51
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	3e-51
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	3e-51
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	4e-51
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	5e-51
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	6e-51
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	8e-51
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	3e-50
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	4e-50
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	4e-50
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	4e-50
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	6e-50
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	7e-50
3bhy_A	283	Death-associated protein kinase 3; death associate	8e-50
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	1e-49
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	1e-49
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	1e-49
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	2e-49
3o0g_A	292	Cell division protein kinase 5; kinase activator c	2e-49
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	2e-49
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	2e-49
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	3e-49
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	5e-49
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	9e-49
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	1e-48
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	5e-48
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	1e-47
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	2e-47
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	3e-47
3niz_A	311	Rhodanese family protein; structural genomics, str	3e-47
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	3e-47
3q4u_A	301	Activin receptor type-1; structural genomics conso	1e-46
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	2e-46
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	2e-46
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	1e-45
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	1e-45
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	4e-45
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	5e-45
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	2e-44
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	2e-44
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	2e-44
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	2e-44
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	2e-44
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	3e-44
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	3e-44
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	4e-44
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	7e-44
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	1e-43
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	2e-43
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	2e-43
3soc_A	322	Activin receptor type-2A; structural genomics cons	5e-43
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	6e-43
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	8e-43
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	1e-42
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	1e-42
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	2e-42
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	5e-42
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	6e-42
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	9e-42
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	9e-42
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	1e-41
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	1e-41
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	1e-41
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	3e-41
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	3e-41
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	5e-41
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	5e-41
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	2e-40
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	2e-40
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	4e-40
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	4e-40
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	1e-39
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	1e-39
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	3e-39
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	4e-39
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	5e-39
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	6e-39
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	1e-38
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	2e-38
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	5e-38
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	5e-38
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	6e-38
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	1e-37
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	1e-37
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	4e-37
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	4e-37
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	5e-37
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	7e-37
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	8e-37
3ork_A	311	Serine/threonine protein kinase; structural genomi	1e-36
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	2e-36
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	2e-36
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	3e-36
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	5e-36
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	9e-36
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	1e-35
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	1e-35
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	1e-35
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	1e-35
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	1e-35
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	1e-35
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	1e-35
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	2e-35
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	3e-35
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	4e-35
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	5e-35
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	8e-35
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	1e-34
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	1e-34
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	1e-34
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	2e-34
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	2e-34
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	2e-34
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	3e-34
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	4e-34
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	5e-34
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	6e-34
3pls_A	298	Macrophage-stimulating protein receptor; protein k	9e-34
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	1e-33
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	1e-33
3rp9_A	458	Mitogen-activated protein kinase; structural genom	3e-33
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	5e-33
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	6e-33
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	7e-33
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	3e-32
4aoj_A	329	High affinity nerve growth factor receptor; transf	3e-32
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	5e-32
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	6e-32
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	8e-32
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	9e-32
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	1e-31
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	3e-31
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	3e-31
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	3e-31
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	4e-31
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	5e-31
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	1e-30
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	9e-30
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	3e-28
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	3e-28
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	5e-27
3uqc_A	286	Probable conserved transmembrane protein; structur	3e-24
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	4e-22
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	6e-22
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	9e-22
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	1e-21
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	5e-21
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	8e-21
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	3e-20
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	6e-20
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	1e-19
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	2e-19
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	7e-19
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	8e-18
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	1e-17
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	2e-17
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	7e-08
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	2e-17
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	2e-16
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	2e-16
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	5e-15
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	7e-04

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  416 bits (1072), Expect = e-142
 Identities = 109/281 (38%), Positives = 154/281 (54%), Gaps = 17/281 (6%)

Query: 340 SQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHL 399
            +     ++G+GT+G VY   +       A+KE+       + +   + L +EI +  HL
Sbjct: 22  DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPE-----RDSRYSQPLHEEIALHKHL 76

Query: 400 KHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAI--TESVVRNFTRHILSGLA 457
           KH NIVQY GS        I++E V  GS++  +R   G +   E  +  +T+ IL GL 
Sbjct: 77  KHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLK 136

Query: 458 YLHSKKTIHRDIKGANLLVDA-SGVVKLADFGMAKHLTG-QKADLSMKGSPYWMAPELMM 515
           YLH  + +HRDIKG N+L++  SGV+K++DFG +K L G      +  G+  +MAPE   
Sbjct: 137 YLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPE--- 193

Query: 516 AVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEY-EGAAAMFKV--MRDTPAIPDSL 572
            ++ KG       A DIWSLGCTIIEM TGKPP+ E  E  AAMFKV   +  P IP+S+
Sbjct: 194 -IIDKGPRGYGK-AADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESM 251

Query: 573 SPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQPDVPS 613
           S E K F+  CF+ +P  R  A+ LL   FLK S +     
Sbjct: 252 SAEAKAFILKCFEPDPDKRACANDLLVDEFLKVSSKKKKTQ 292

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  386 bits (993), Expect = e-129
 Identities = 83/340 (24%), Positives = 132/340 (38%), Gaps = 30/340 (8%)

Query: 286 SPSGPSSPIHSKLSRESTVR-IEVHPLPLPPGAAVLSPSATIPQVA-AKPEPLPMNSQWQ 343
           S S  S   HS  S   T          L P            ++     E         
Sbjct: 2   SGSVSSGQAHSLASLAKTWSSGSAKLQRLGPETEDNEGVLLTEKLKPVDYEYREEVHWMT 61

Query: 344 KGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPN 403
               +GRG+FG V+   +++TG  CA+K+V +               +E+   + L  P 
Sbjct: 62  HQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRL----------EVFRVEELVACAGLSSPR 111

Query: 404 IVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKK 463
           IV  YG+        I++E +  GS+ + ++   G + E     +    L GL YLH+++
Sbjct: 112 IVPLYGAVREGPWVNIFMELLEGGSLGQLIK-QMGCLPEDRALYYLGQALEGLEYLHTRR 170

Query: 464 TIHRDIKGANLLVDASGV-VKLADFGMAKHLTGQKADL------SMKGSPYWMAPELMMA 516
            +H D+K  N+L+ + G    L DFG A  L              + G+   MAPE+   
Sbjct: 171 ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEV--- 227

Query: 517 VMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTP---AIPDSLS 573
           VM K   +     VDIWS  C ++ M  G  PW++Y       K+  + P    IP S +
Sbjct: 228 VMGKPCDA----KVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSCA 283

Query: 574 PEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQPDVPS 613
           P     ++   ++ P  R  A  L         +   + S
Sbjct: 284 PLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKS 323

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  356 bits (916), Expect = e-118
 Identities = 76/278 (27%), Positives = 139/278 (50%), Gaps = 24/278 (8%)

Query: 339 NSQWQK-GKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLS 397
           + ++ K    IGRG+F +VY   + ET    A  E+    D   +    ++ ++E ++L 
Sbjct: 24  DGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQ---DRKLTKSERQRFKEEAEMLK 80

Query: 398 HLKHPNIVQYYGSEIV----EDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHIL 453
            L+HPNIV++Y S       +    +  E +  G++  Y++     +   V+R++ R IL
Sbjct: 81  GLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRF-KVMKIKVLRSWCRQIL 139

Query: 454 SGLAYLHSKKT--IHRDIKGANLLVDA-SGVVKLADFGMAKHLTGQKADLSMKGSPYWMA 510
            GL +LH++    IHRD+K  N+ +   +G VK+ D G+A       A  ++ G+P +MA
Sbjct: 140 KGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFA-KAVIGTPEFMA 198

Query: 511 PELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFK-VMRDTP--A 567
           PE    + ++        +VD+++ G  ++EM T + P+SE + AA +++ V       +
Sbjct: 199 PE----MYEEKYD----ESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPAS 250

Query: 568 IPDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKN 605
                 PE K+ +  C ++N  +R     LL H F + 
Sbjct: 251 FDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE 288

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  313 bits (804), Expect = e-102
 Identities = 61/295 (20%), Positives = 124/295 (42%), Gaps = 39/295 (13%)

Query: 338 MNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLS 397
             +++ + + IG G FGSV+    R  G + A+K            ++     +E+   +
Sbjct: 9   YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNA---LREVYAHA 65

Query: 398 HL-KHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHC---GAITESVVRNFTRHIL 453
            L +H ++V+Y+ +   +D   I  EY + GS+   + E+        E+ +++    + 
Sbjct: 66  VLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVG 125

Query: 454 SGLAYLHSKKTIHRDIKGANLLVDASGV-------------------VKLADFGMAKHLT 494
            GL Y+HS   +H DIK +N+ +  + +                    K+ D G    ++
Sbjct: 126 RGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRIS 185

Query: 495 GQKADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEG 554
             +     +G   ++A E    V+Q+  +       DI++L  T++     +P     + 
Sbjct: 186 SPQ---VEEGDSRFLANE----VLQENYTHLP--KADIFALALTVVCAAGAEPLPRNGD- 235

Query: 555 AAAMFKVMR-DTPAIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQ 608
                ++ +   P IP  LS E  + L+     +P  RP A  L++H  L ++ +
Sbjct: 236 --QWHEIRQGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSASR 288

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  314 bits (806), Expect = e-101
 Identities = 77/343 (22%), Positives = 149/343 (43%), Gaps = 26/343 (7%)

Query: 339 NSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSH 398
              +   K IG G    V+   N E   + A+K V++   +    +++     EI  L+ 
Sbjct: 8   GRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNL---EEADNQTLDSYRNEIAYLNK 63

Query: 399 LKHPN--IVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGL 456
           L+  +  I++ Y  EI +   Y+ +E  +   +N ++++   +I     +++ +++L  +
Sbjct: 64  LQQHSDKIIRLYDYEITDQYIYMVMECGN-IDLNSWLKKK-KSIDPWERKSYWKNMLEAV 121

Query: 457 AYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADL---SMKGSPYWMAPEL 513
             +H    +H D+K AN L+   G++KL DFG+A  +      +   S  G+  +M PE 
Sbjct: 122 HTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEA 180

Query: 514 MMAVMQKGKSSDSAL----AVDIWSLGCTIIEMYTGKPPWSEYEGA-AAMFKVMRD--TP 566
           +  +    ++  S        D+WSLGC +  M  GK P+ +     + +  ++      
Sbjct: 181 IKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEI 240

Query: 567 AIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQPDVPSCSLSFSGMQLT-- 624
             PD    + +D L+CC +R+P  R     LL H +++    P       +   M+    
Sbjct: 241 EFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAKGTTEEMKYVLG 300

Query: 625 -----EKPHSPREKADAKYDQVAALSSSRSSRKATLESENGRR 662
                  P+S  + A   Y+  +   S  SS   T E + G++
Sbjct: 301 QLVGLNSPNSILKAAKTLYEHYSGGESHNSSSSKTFEKKRGKK 343

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  311 bits (799), Expect = e-100
 Identities = 83/394 (21%), Positives = 160/394 (40%), Gaps = 29/394 (7%)

Query: 288 SGPSSPIHSKLSRESTVRIEVHPLPLPPGAAVLSPSATIPQVAAKPEPLPMNSQWQKGKL 347
           S    P  S +   +  + E   +  P         A+                +   K 
Sbjct: 7   SSGLVPRGSGMKETAAAKFERQHMDSPDLGTDDDDKASSSA---NECISVKGRIYSILKQ 63

Query: 348 IGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPN--IV 405
           IG G    V+   N E   + A+K V++   +    +++     EI  L+ L+  +  I+
Sbjct: 64  IGSGGSSKVFQVLN-EKKQIYAIKYVNL---EEADNQTLDSYRNEIAYLNKLQQHSDKII 119

Query: 406 QYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTI 465
           + Y  EI +   Y+ +E  +   +N ++++   +I     +++ +++L  +  +H    +
Sbjct: 120 RLYDYEITDQYIYMVMECGN-IDLNSWLKKK-KSIDPWERKSYWKNMLEAVHTIHQHGIV 177

Query: 466 HRDIKGANLLVDASGVVKLADFGMAKHLTGQKADL---SMKGSPYWMAPELMMAVMQKGK 522
           H D+K AN L+   G++KL DFG+A  +      +   S  G+  +M PE +  +    +
Sbjct: 178 HSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRE 236

Query: 523 SSDSAL----AVDIWSLGCTIIEMYTGKPPWSEYEGA-AAMFKVMRD--TPAIPDSLSPE 575
           +  S        D+WSLGC +  M  GK P+ +     + +  ++        PD    +
Sbjct: 237 NGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKD 296

Query: 576 GKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQPDVPSCSLSFSGMQLT-------EKPH 628
            +D L+CC +R+P  R     LL H +++    P       +   M+           P+
Sbjct: 297 LQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAKGTTEEMKYVLGQLVGLNSPN 356

Query: 629 SPREKADAKYDQVAALSSSRSSRKATLESENGRR 662
           S  + A   Y+  +   S  SS   T E + G++
Sbjct: 357 SILKAAKTLYEHYSGGESHNSSSSKTFEKKRGKK 390

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  305 bits (782), Expect = 2e-98
 Identities = 74/323 (22%), Positives = 129/323 (39%), Gaps = 16/323 (4%)

Query: 282 RNAISPSGPSSPIHSKLSRESTVRIEVHPLPLPPGAAVLSPSATIPQVAAKPEPLPMNSQ 341
            +    SG      +   +      ++ P  +           +     ++PE       
Sbjct: 3   HHHHHSSGVDLGTENLYFQSMH---QLQPRRVSFRGEASETLQSPGYDPSRPESFFQ-QS 58

Query: 342 WQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKH 401
           +Q+   +G G++G V+   ++E G L A+K        PK  +  ++L +        +H
Sbjct: 59  FQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPK--DRARKLAEVGSHEKVGQH 116

Query: 402 PNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHS 461
           P  V+   +       Y+  E     S+ ++      ++ E+ V  + R  L  LA+LHS
Sbjct: 117 PCCVRLEQAWEEGGILYLQTELCG-PSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHS 175

Query: 462 KKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPYWMAPELMMAVMQKG 521
           +  +H D+K AN+ +   G  KL DFG+   L    A    +G P +MAPE    ++Q  
Sbjct: 176 QGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQEGDPRYMAPE----LLQGS 231

Query: 522 KSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDSLSPEGKDFLR 581
             +    A D++SLG TI+E+          EG   + +     P     LS E +  L 
Sbjct: 232 YGT----AADVFSLGLTILEVACNMELPHGGEGWQQLRQ-GYLPPEFTAGLSSELRSVLV 286

Query: 582 CCFQRNPADRPPASLLLEHRFLK 604
              + +P  R  A  LL    L+
Sbjct: 287 MMLEPDPKLRATAEALLALPVLR 309

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  301 bits (773), Expect = 4e-97
 Identities = 66/283 (23%), Positives = 129/283 (45%), Gaps = 19/283 (6%)

Query: 339 NSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSH 398
              +   K IG G    V+   N E   + A+K V++   +    +++     EI  L+ 
Sbjct: 27  GRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNL---EEADNQTLDSYRNEIAYLNK 82

Query: 399 LKHPN--IVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGL 456
           L+  +  I++ Y  EI +   Y+ +E  +   +N ++++   +I     +++ +++L  +
Sbjct: 83  LQQHSDKIIRLYDYEITDQYIYMVMECGN-IDLNSWLKKK-KSIDPWERKSYWKNMLEAV 140

Query: 457 AYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADL---SMKGSPYWMAPEL 513
             +H    +H D+K AN L+   G++KL DFG+A  +      +   S  G+  +M PE 
Sbjct: 141 HTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEA 199

Query: 514 MMAVMQKGKSSDSAL----AVDIWSLGCTIIEMYTGKPPWSEYEG-AAAMFKVMRD--TP 566
           +  +    ++  S        D+WSLGC +  M  GK P+ +     + +  ++      
Sbjct: 200 IKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEI 259

Query: 567 AIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQP 609
             PD    + +D L+CC +R+P  R     LL H +++    P
Sbjct: 260 EFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHP 302

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  296 bits (761), Expect = 3e-95
 Identities = 89/302 (29%), Positives = 150/302 (49%), Gaps = 18/302 (5%)

Query: 314 PPGAAVLSPSATIPQVAAKPE-PLPMNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKE 372
             G          PQ A +P+      + ++  K IGRG F  VY A+    G   A+K+
Sbjct: 5   SQGMQGPPVPQFQPQKALRPDMGYNTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKK 64

Query: 373 VDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKY 432
           V IF  D   A++     +EI +L  L HPN+++YY S I +++  I LE    G +++ 
Sbjct: 65  VQIF--DLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRM 122

Query: 433 V---REHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGM 489
           +   ++    I E  V  +   + S L ++HS++ +HRDIK AN+ + A+GVVKL D G+
Sbjct: 123 IKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGL 182

Query: 490 AKHLTGQKADL-SMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPP 548
            +  + +     S+ G+PY+M+PE    + + G +  S    DIWSLGC + EM   + P
Sbjct: 183 GRFFSSKTTAAHSLVGTPYYMSPER---IHENGYNFKS----DIWSLGCLLYEMAALQSP 235

Query: 549 WSEYEG--AAAMFKVMR-DTPAIP-DSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLK 604
           +   +    +   K+ + D P +P D  S E +  +  C   +P  RP  + + +     
Sbjct: 236 FYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRM 295

Query: 605 NS 606
           ++
Sbjct: 296 HA 297

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  283 bits (727), Expect = 2e-90
 Identities = 103/273 (37%), Positives = 151/273 (55%), Gaps = 13/273 (4%)

Query: 339 NSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSH 398
           N  W+    +G G FG VY A N+ETGAL A K ++      KS E ++    EI++L+ 
Sbjct: 18  NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIET-----KSEEELEDYIVEIEILAT 72

Query: 399 LKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAY 458
             HP IV+  G+   + K +I +E+   G+++  + E    +TE  ++   R +L  L +
Sbjct: 73  CDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNF 132

Query: 459 LHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHL--TGQKADLSMKGSPYWMAPELMMA 516
           LHSK+ IHRD+K  N+L+   G ++LADFG++     T QK D S  G+PYWMAPE++M 
Sbjct: 133 LHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRD-SFIGTPYWMAPEVVMC 191

Query: 517 VMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMR-DTPAI--PDSLS 573
              K    D     DIWSLG T+IEM   +PP  E      + K+ + D P +  P   S
Sbjct: 192 ETMKDTPYDY--KADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTPSKWS 249

Query: 574 PEGKDFLRCCFQRNPADRPPASLLLEHRFLKNS 606
            E +DFL+    +NP  RP A+ LLEH F+ + 
Sbjct: 250 VEFRDFLKIALDKNPETRPSAAQLLEHPFVSSI 282

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  275 bits (706), Expect = 3e-87
 Identities = 99/274 (36%), Positives = 153/274 (55%), Gaps = 17/274 (6%)

Query: 339 NSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSH 398
              + K + IG+G+FG V+   +  T  + A+K +D+   + +    I+ ++QEI VLS 
Sbjct: 21  EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDE----IEDIQQEITVLSQ 76

Query: 399 LKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAY 458
              P + +YYGS + + K +I +EY+  GS    +    G + E+ +    R IL GL Y
Sbjct: 77  CDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEP--GPLDETQIATILREILKGLDY 134

Query: 459 LHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHL--TGQKADLSMKGSPYWMAPELMMA 516
           LHS+K IHRDIK AN+L+   G VKLADFG+A  L  T  K + +  G+P+WMAPE    
Sbjct: 135 LHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRN-TFVGTPFWMAPE---- 189

Query: 517 VMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMR-DTPAIPDSLSPE 575
           V+++      A   DIWSLG T IE+  G+PP SE      +F + + + P +  + S  
Sbjct: 190 VIKQSAYDSKA---DIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKP 246

Query: 576 GKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQP 609
            K+F+  C  + P+ RP A  LL+H+F+  + + 
Sbjct: 247 LKEFVEACLNKEPSFRPTAKELLKHKFILRNAKK 280

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  275 bits (706), Expect = 1e-86
 Identities = 99/322 (30%), Positives = 156/322 (48%), Gaps = 12/322 (3%)

Query: 292 SPIHSKLSRESTVRIEVHPLPLPPGAAVLSPSATIPQVAAKPEPLPMNSQWQKGKLIGRG 351
              H      +T  +       P  A   + S   P VA           +   + IG G
Sbjct: 6   HHHHHDYDIPTTENLYFQGAMDPMPAGGRAGSLKDPDVAELFFKDDPEKLFSDLREIGHG 65

Query: 352 TFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSE 411
           +FG+VY A +     + A+K++          E  + + +E++ L  L+HPN +QY G  
Sbjct: 66  SFGAVYFARDVRNSEVVAIKKMSYSGKQSN--EKWQDIIKEVRFLQKLRHPNTIQYRGCY 123

Query: 412 IVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKG 471
           + E   ++ +EY   GS +  +  H   + E  +   T   L GLAYLHS   IHRD+K 
Sbjct: 124 LREHTAWLVMEYC-LGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKA 182

Query: 472 ANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVD 531
            N+L+   G+VKL DFG A  +       S  G+PYWMAPE+++A+ +          VD
Sbjct: 183 GNILLSEPGLVKLGDFGSASIMAPAN---SFVGTPYWMAPEVILAMDEGQYDG----KVD 235

Query: 532 IWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMR-DTPAI-PDSLSPEGKDFLRCCFQRNPA 589
           +WSLG T IE+   KPP       +A++ + + ++PA+     S   ++F+  C Q+ P 
Sbjct: 236 VWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQ 295

Query: 590 DRPPASLLLEHRFLKNSQQPDV 611
           DRP + +LL+HRF+   + P V
Sbjct: 296 DRPTSEVLLKHRFVLRERPPTV 317

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  271 bits (694), Expect = 2e-85
 Identities = 91/277 (32%), Positives = 151/277 (54%), Gaps = 18/277 (6%)

Query: 339 NSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSH 398
              +   + +G G++GSVY A ++ETG + A+K+V +          ++++ +EI ++  
Sbjct: 28  EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPV-------ESDLQEIIKEISIMQQ 80

Query: 399 LKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAY 458
              P++V+YYGS       +I +EY   GS++  +R     +TE  +    +  L GL Y
Sbjct: 81  CDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEY 140

Query: 459 LHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKAD-LSMKGSPYWMAPELMMAV 517
           LH  + IHRDIK  N+L++  G  KLADFG+A  LT   A   ++ G+P+WMAPE+   +
Sbjct: 141 LHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEV---I 197

Query: 518 MQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKV-MRDTPAI--PDSLSP 574
            + G +       DIWSLG T IEM  GKPP+++     A+F +     P    P+  S 
Sbjct: 198 QEIGYNC----VADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPELWSD 253

Query: 575 EGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQPDV 611
              DF++ C  ++P  R  A+ LL+H F+++++   +
Sbjct: 254 NFTDFVKQCLVKSPEQRATATQLLQHPFVRSAKGVSI 290

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  269 bits (690), Expect = 6e-85
 Identities = 83/305 (27%), Positives = 139/305 (45%), Gaps = 34/305 (11%)

Query: 330 AAKPEPLPMNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQL 389
           +A P  +     ++  ++IG G    V  A         A+K +++          + +L
Sbjct: 6   SALPWSINR-DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTS----MDEL 60

Query: 390 EQEIKVLSHLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSI-------NKYVREHCGAITE 442
            +EI+ +S   HPNIV YY S +V+D+ ++ ++ +  GS+               G + E
Sbjct: 61  LKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDE 120

Query: 443 SVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSM 502
           S +    R +L GL YLH    IHRD+K  N+L+   G V++ADFG++  L         
Sbjct: 121 STIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRN 180

Query: 503 K------GSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAA 556
           K      G+P WMAPE    VM++ +  D     DIWS G T IE+ TG  P+ +Y    
Sbjct: 181 KVRKTFVGTPCWMAPE----VMEQVRGYDF--KADIWSFGITAIELATGAAPYHKYPPMK 234

Query: 557 AMFKVMRDTP----------AIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNS 606
            +   +++ P           +        +  +  C Q++P  RP A+ LL H+F + +
Sbjct: 235 VLMLTLQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKA 294

Query: 607 QQPDV 611
           +  + 
Sbjct: 295 KNKEF 299

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  270 bits (693), Expect = 8e-85
 Identities = 80/326 (24%), Positives = 148/326 (45%), Gaps = 21/326 (6%)

Query: 341 QWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLK 400
           ++ + + IG G+FG   +  + E G    +KE++I      S++  ++  +E+ VL+++K
Sbjct: 25  KYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINI---SRMSSKEREESRREVAVLANMK 81

Query: 401 HPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGA-ITESVVRNFTRHILSGLAYL 459
           HPNIVQY  S       YI ++Y   G + K +    G    E  + ++   I   L ++
Sbjct: 82  HPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHV 141

Query: 460 HSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADL-SMKGSPYWMAPELMMAVM 518
           H +K +HRDIK  N+ +   G V+L DFG+A+ L        +  G+PY+++PE+     
Sbjct: 142 HDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEIC---- 197

Query: 519 QKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDT-PAIPDSLSPEGK 577
            + K  ++    DIW+LGC + E+ T K  +        + K++  + P +    S + +
Sbjct: 198 -ENKPYNN--KSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPPVSLHYSYDLR 254

Query: 578 DFLRCCFQRNPADRPPASLLLEHRFLKNSQQPDVPSCSLSFSGMQLTEKPHSPREKADAK 637
             +   F+RNP DRP  + +LE  F+    +         F   QL  +    +  +   
Sbjct: 255 SLVSQLFKRNPRDRPSVNSILEKGFIAKRIE--------KFLSPQLIAEEFCLKTFSKFG 306

Query: 638 YDQVAALSSSRSSRKATLESENGRRS 663
              + A   +      ++        
Sbjct: 307 SQPIPAKRPASGQNSISVMPAQKITK 332

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  266 bits (682), Expect = 7e-84
 Identities = 93/275 (33%), Positives = 146/275 (53%), Gaps = 18/275 (6%)

Query: 339 NSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSH 398
             ++ + + IG+G  G+VY A +  TG   A++++++     +     + +  EI V+  
Sbjct: 19  KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNL-----QQQPKKELIINEILVMRE 73

Query: 399 LKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAY 458
            K+PNIV Y  S +V D+ ++ +EY+  GS+   V E    + E  +    R  L  L +
Sbjct: 74  NKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEF 131

Query: 459 LHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKAD-LSMKGSPYWMAPELMMAV 517
           LHS + IHRDIK  N+L+   G VKL DFG    +T +++   +M G+PYWMAPE+   V
Sbjct: 132 LHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEV---V 188

Query: 518 MQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKV-MRDTPAI--PDSLSP 574
            +K         VDIWSLG   IEM  G+PP+       A++ +    TP +  P+ LS 
Sbjct: 189 TRKAYGP----KVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSA 244

Query: 575 EGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQP 609
             +DFL  C + +   R  A  LL+H+FLK ++  
Sbjct: 245 IFRDFLNRCLEMDVEKRGSAKELLQHQFLKIAKPL 279

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  265 bits (678), Expect = 8e-83
 Identities = 89/302 (29%), Positives = 150/302 (49%), Gaps = 24/302 (7%)

Query: 327 PQVAAKPEPLPMNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESI 386
             ++A  +P      ++  +L+G GT+G VY   + +TG L A+K +D+  D+       
Sbjct: 14  IDLSALRDP---AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE------E 64

Query: 387 KQLEQEIKVLSHL-KHPNIVQYYGS------EIVEDKFYIYLEYVHPGSINKYVREH-CG 438
           ++++QEI +L     H NI  YYG+        ++D+ ++ +E+   GS+   ++     
Sbjct: 65  EEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGN 124

Query: 439 AITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTG--Q 496
            + E  +    R IL GL++LH  K IHRDIKG N+L+  +  VKL DFG++  L     
Sbjct: 125 TLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVG 184

Query: 497 KADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAA 556
           + + +  G+PYWMAPE++        + D     D+WSLG T IEM  G PP  +     
Sbjct: 185 RRN-TFIGTPYWMAPEVIACDENPDATYDF--KSDLWSLGITAIEMAEGAPPLCDMHPMR 241

Query: 557 AMFKVMRDTPAI--PDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQPDVPSC 614
           A+F + R+          S + + F+  C  +N + RP    L++H F+++         
Sbjct: 242 ALFLIPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQPNERQVRI 301

Query: 615 SL 616
            L
Sbjct: 302 QL 303

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  263 bits (675), Expect = 2e-82
 Identities = 82/275 (29%), Positives = 137/275 (49%), Gaps = 18/275 (6%)

Query: 339 NSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSH 398
                    IG G+ G V +A  + +G   A+K +D+     +  +  + L  E+ ++  
Sbjct: 44  RLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDL-----RKQQRRELLFNEVVIMRD 98

Query: 399 LKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAY 458
            +H N+V+ Y S +V ++ ++ +E++  G++   V +    + E  +      +L  LAY
Sbjct: 99  YQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ--VRLNEEQIATVCEAVLQALAY 156

Query: 459 LHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKAD-LSMKGSPYWMAPELMMAV 517
           LH++  IHRDIK  ++L+   G VKL+DFG    ++       S+ G+PYWMAPE++   
Sbjct: 157 LHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVI--- 213

Query: 518 MQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKV-MRDTPAI--PDSLSP 574
                   +   VDIWSLG  +IEM  G+PP+       AM ++     P +     +SP
Sbjct: 214 --SRSLYAT--EVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNSHKVSP 269

Query: 575 EGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQP 609
             +DFL     R+P +R  A  LL+H FL  +  P
Sbjct: 270 VLRDFLERMLVRDPQERATAQELLDHPFLLQTGLP 304

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  250 bits (640), Expect = 8e-78
 Identities = 73/280 (26%), Positives = 126/280 (45%), Gaps = 16/280 (5%)

Query: 340 SQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHL 399
              +    +GRG +G V    +  +G + A+K +    +     +  K+L  ++ +    
Sbjct: 7   DDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNS----QEQKRLLMDLDISMRT 62

Query: 400 -KHPNIVQYYGSEIVEDKFYIYLEYVHPGS---INKYVREHCGAITESVVRNFTRHILSG 455
              P  V +YG+   E   +I +E +   S     K V +    I E ++      I+  
Sbjct: 63  VDCPFTVTFYGALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKA 121

Query: 456 LAYLHSK-KTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPYWMAPELM 514
           L +LHSK   IHRD+K +N+L++A G VK+ DFG++ +L    A     G   +MAPE +
Sbjct: 122 LEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDIDAGCKPYMAPERI 181

Query: 515 MAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGA-AAMFKVMRDTP--AIPDS 571
              + +   S  +   DIWSLG T+IE+   + P+  +      + +V+ +       D 
Sbjct: 182 NPELNQKGYSVKS---DIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPADK 238

Query: 572 LSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQPDV 611
            S E  DF   C ++N  +RP    L++H F    +    
Sbjct: 239 FSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTLHESKGT 278

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  249 bits (638), Expect = 5e-77
 Identities = 78/276 (28%), Positives = 133/276 (48%), Gaps = 20/276 (7%)

Query: 348 IGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHL-KHPNIVQ 406
           IGRG +GSV    ++ +G + A+K +    D+    +  KQL  ++ V+      P IVQ
Sbjct: 30  IGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDE----KEQKQLLMDLDVVMRSSDCPYIVQ 85

Query: 407 YYGSEIVEDKFYIYLEYVHPGSINKYVRE----HCGAITESVVRNFTRHILSGLAYLHSK 462
           +YG+   E   +I +E +   S +K+ +         I E ++   T   +  L +L   
Sbjct: 86  FYGALFREGDCWICMELM-STSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKEN 144

Query: 463 -KTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPYWMAPELMMAVMQKG 521
            K IHRDIK +N+L+D SG +KL DFG++  L    A     G   +MAPE +     + 
Sbjct: 145 LKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSASRQ 204

Query: 522 KSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEG-AAAMFKVMRDTP-----AIPDSLSPE 575
                +   D+WSLG T+ E+ TG+ P+ ++      + +V++  P     +     SP 
Sbjct: 205 GYDVRS---DVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQLSNSEEREFSPS 261

Query: 576 GKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQPDV 611
             +F+  C  ++ + RP    LL+H F+   ++  V
Sbjct: 262 FINFVNLCLTKDESKRPKYKELLKHPFILMYEERAV 297

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  247 bits (633), Expect = 7e-77
 Identities = 66/280 (23%), Positives = 118/280 (42%), Gaps = 37/280 (13%)

Query: 343 QKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHP 402
           ++ +LIG G FG V+ A +R  G    +K V           + ++ E+E+K L+ L H 
Sbjct: 14  KEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKY---------NNEKAEREVKALAKLDHV 64

Query: 403 NIVQYYGS----------------EIVEDKFYIYLEYVHPGSINKYVREHCGA-ITESVV 445
           NIV Y G                        +I +E+   G++ +++ +  G  + + + 
Sbjct: 65  NIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLA 124

Query: 446 RNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGS 505
                 I  G+ Y+HSKK I+RD+K +N+ +  +  VK+ DFG+   L         KG+
Sbjct: 125 LELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGT 184

Query: 506 PYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDT 565
             +M+PE +       +       VD+++LG  + E+         +E +     +    
Sbjct: 185 LRYMSPEQI-----SSQDYGK--EVDLYALGLILAELLHVCDT--AFETSKFFTDLRD-- 233

Query: 566 PAIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKN 605
             I D    + K  L+    + P DRP  S +L    +  
Sbjct: 234 GIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWK 273

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  247 bits (632), Expect = 2e-76
 Identities = 72/305 (23%), Positives = 122/305 (40%), Gaps = 48/305 (15%)

Query: 340 SQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHL 399
           S +++  ++G+G FG V  A N       A+K++        + E +  +  E+ +L+ L
Sbjct: 6   SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIR------HTEEKLSTILSEVMLLASL 59

Query: 400 KHPNIVQYYGS-------------EIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVR 446
            H  +V+YY +                +   +I +EY   G++   +             
Sbjct: 60  NHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYW 119

Query: 447 NFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADL------ 500
              R IL  L+Y+HS+  IHRD+K  N+ +D S  VK+ DFG+AK++      L      
Sbjct: 120 RLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQN 179

Query: 501 ---------SMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSE 551
                    S  G+  ++A E++      G    +   +D++SLG    EM        E
Sbjct: 180 LPGSSDNLTSAIGTAMYVATEVL-----DGTGHYNE-KIDMYSLGIIFFEMIYPFSTGME 233

Query: 552 YEGAAAMFKVMRD-----TPAIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNS 606
                 + K +R       P   D+     K  +R     +P  RP A  LL   +L   
Sbjct: 234 R---VNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVK 290

Query: 607 QQPDV 611
            Q +V
Sbjct: 291 HQDEV 295

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  246 bits (630), Expect = 7e-76
 Identities = 78/270 (28%), Positives = 131/270 (48%), Gaps = 13/270 (4%)

Query: 348 IGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVL-SHLKHPNIVQ 406
           +G GT G V+    R+TG + A+K++    +     E  K++  ++ V+      P IVQ
Sbjct: 33  MGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNK----EENKRILMDLDVVLKSHDCPYIVQ 88

Query: 407 YYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSK-KTI 465
            +G+ I     +I +E +      K  +   G I E ++   T  I+  L YL  K   I
Sbjct: 89  CFGTFITNTDVFIAMELMG-TCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVI 147

Query: 466 HRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPYWMAPELMMAVMQKGKSSD 525
           HRD+K +N+L+D  G +KL DFG++  L   KA     G   +MAPE +          D
Sbjct: 148 HRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYD 207

Query: 526 SALAVDIWSLGCTIIEMYTGKPPWSEYEGA-AAMFKVMRDTP---AIPDSLSPEGKDFLR 581
                D+WSLG +++E+ TG+ P+   +     + KV+++ P         S + + F++
Sbjct: 208 I--RADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGHMGFSGDFQSFVK 265

Query: 582 CCFQRNPADRPPASLLLEHRFLKNSQQPDV 611
            C  ++   RP  + LLEH F+K  +  +V
Sbjct: 266 DCLTKDHRKRPKYNKLLEHSFIKRYETLEV 295

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  241 bits (617), Expect = 1e-74
 Identities = 74/286 (25%), Positives = 116/286 (40%), Gaps = 25/286 (8%)

Query: 338 MNSQWQK---GKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIK 394
           M S+ +       IG G++G       +  G +   KE+D       +    + L  E+ 
Sbjct: 1   MPSRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDY---GSMTEAEKQMLVSEVN 57

Query: 395 VLSHLKHPNIVQYYGSEIVE--DKFYIYLEYVHPGSINKYVREHCGA---ITESVVRNFT 449
           +L  LKHPNIV+YY   I       YI +EY   G +   + +       + E  V    
Sbjct: 58  LLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVM 117

Query: 450 RHILSGLAYLHSKKT-----IHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADL-SMK 503
             +   L   H +       +HRD+K AN+ +D    VKL DFG+A+ L    +   +  
Sbjct: 118 TQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFV 177

Query: 504 GSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMR 563
           G+PY+M+PE M        S +     DIWSLGC + E+    PP++ +       K+  
Sbjct: 178 GTPYYMSPEQM-----NRMSYNE--KSDIWSLGCLLYELCALMPPFTAFSQKELAGKIRE 230

Query: 564 DT-PAIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQ 608
                IP   S E  + +          RP    +LE+  +     
Sbjct: 231 GKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILEHHH 276

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  244 bits (625), Expect = 2e-74
 Identities = 70/377 (18%), Positives = 135/377 (35%), Gaps = 72/377 (19%)

Query: 340 SQWQKGKLIGRG--TFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLS 397
             ++   +IG+G     +V +A  + TG    ++ +++   +  S E +  L+ E+ V  
Sbjct: 25  GCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINL---EACSNEMVTFLQGELHVSK 81

Query: 398 HLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHC-GAITESVVRNFTRHILSGL 456
              HPNIV Y  + I +++ ++   ++  GS    +  H    + E  +    + +L  L
Sbjct: 82  LFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKAL 141

Query: 457 AYLHSKKTIHRDIKGANLLVDASGVVKLADFG--------MAKHLTGQKADLSMKGSPYW 508
            Y+H    +HR +K +++L+   G V L+             +                W
Sbjct: 142 DYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPW 201

Query: 509 MAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTP-- 566
           ++PE++    Q  +  D+    DI+S+G T  E+  G  P+ +      + + +  T   
Sbjct: 202 LSPEVLQ---QNLQGYDAK--SDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPC 256

Query: 567 --------------------------------------------AIPDSLSPEGKDFLRC 582
                                                           + SP    F+  
Sbjct: 257 LLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQ 316

Query: 583 CFQRNPADRPPASLLLEHRFLKNSQQPDVPSCSLSFSGMQLTEKPHSPREKADAKYDQVA 642
           C QRNP  RP AS LL H F K  ++        +   +    +P +P    +    Q  
Sbjct: 317 CLQRNPDARPSASTLLNHSFFKQIKR-------RASEALPELLRPVTPITNFEGSQSQDH 369

Query: 643 ALSSSRSSRKATLESEN 659
           +      +    LE ++
Sbjct: 370 SGIFGLVTNLEELEVDD 386

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  237 bits (606), Expect = 1e-72
 Identities = 65/296 (21%), Positives = 125/296 (42%), Gaps = 41/296 (13%)

Query: 343 QKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHP 402
           +  + +GRG FG V+ A N+      A+K + +    P    + +++ +E+K L+ L+HP
Sbjct: 8   EPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRL----PNRELAREKVMREVKALAKLEHP 63

Query: 403 NIVQYYGSEIVEDKF------------YIYLEYVHPGSINKYVREHCGA--ITESVVRNF 448
            IV+Y+ + + ++              YI ++     ++  ++   C       SV  + 
Sbjct: 64  GIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHI 123

Query: 449 TRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKAD--------- 499
              I   + +LHSK  +HRD+K +N+      VVK+ DFG+   +   + +         
Sbjct: 124 FLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPA 183

Query: 500 ----LSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGA 555
                   G+  +M+PE +      G S      VDI+SLG  + E+    P  ++ E  
Sbjct: 184 YARHTGQVGTKLYMSPEQI-----HGNSYSH--KVDIFSLGLILFELLY--PFSTQMERV 234

Query: 556 AAMFKVMR-DTPAIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQPD 610
             +  V     P +     P     ++     +P +RP A  ++E+   ++   P 
Sbjct: 235 RTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFPG 290

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  239 bits (612), Expect = 6e-72
 Identities = 61/282 (21%), Positives = 117/282 (41%), Gaps = 28/282 (9%)

Query: 341 QWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHL- 399
            +    ++G G  G++ V          A+K +          E     ++E+++L    
Sbjct: 25  SFCPKDVLGHGAEGTI-VYRGMFDNRDVAVKRILP--------ECFSFADREVQLLRESD 75

Query: 400 KHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYL 459
           +HPN+++Y+ +E      YI +E     ++ +YV +   A          +   SGLA+L
Sbjct: 76  EHPNVIRYFCTEKDRQFQYIAIELC-AATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHL 134

Query: 460 HSKKTIHRDIKGANLLV-----DASGVVKLADFGMAKHLT-GQKADLSMK---GSPYWMA 510
           HS   +HRD+K  N+L+            ++DFG+ K L  G+ +        G+  W+A
Sbjct: 135 HSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIA 194

Query: 511 PELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFKVMR---DTP 566
           PE++    ++  +      VDI+S GC    + + G  P+ +     A   +     D  
Sbjct: 195 PEMLSEDCKENPTY----TVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCL 250

Query: 567 AIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQ 608
                     ++ +      +P  RP A  +L+H F  + ++
Sbjct: 251 HPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWSLEK 292

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  235 bits (602), Expect = 2e-71
 Identities = 78/318 (24%), Positives = 143/318 (44%), Gaps = 58/318 (18%)

Query: 339 NSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSH 398
           +  ++K   +G G  G V+  S++ +G + A K + +            Q+ +E++VL  
Sbjct: 32  DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKP----AIRNQIIRELQVLHE 87

Query: 399 LKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAY 458
              P IV +YG+   + +  I +E++  GS+++ +++  G I E ++   +  ++ GL Y
Sbjct: 88  CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKA-GRIPEQILGKVSIAVIKGLTY 146

Query: 459 LHSK-KTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPYWMAPELMMAV 517
           L  K K +HRD+K +N+LV++ G +KL DFG++  L    A+ S  G+  +M+PE     
Sbjct: 147 LREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN-SFVGTRSYMSPE----R 201

Query: 518 MQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAA-------------------- 557
           +Q    S  +   DIWS+G +++EM  G+ P    +                        
Sbjct: 202 LQGTHYSVQS---DIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPR 258

Query: 558 ----------------------MFKVMRDTPAI--PDSLSPEGKDFLRCCFQRNPADRPP 593
                                 +  ++ + P        S E +DF+  C  +NPA+R  
Sbjct: 259 TPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERAD 318

Query: 594 ASLLLEHRFLKNSQQPDV 611
              L+ H F+K S   +V
Sbjct: 319 LKQLMVHAFIKRSDAEEV 336

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  232 bits (593), Expect = 5e-71
 Identities = 87/280 (31%), Positives = 144/280 (51%), Gaps = 30/280 (10%)

Query: 341 QWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKS----AESIKQLEQEIKVL 396
            ++ G L+G+G+F  VY A +  TG   A+K +D      K     A  +++++ E+K+ 
Sbjct: 12  DFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMID------KKAMYKAGMVQRVQNEVKIH 65

Query: 397 SHLKHPNIVQYYGSEIVEDKFYIY--LEYVHPGSINKYVREHCGAITESVVRNFTRHILS 454
             LKHP+I++ Y     ED  Y+Y  LE  H G +N+Y++      +E+  R+F   I++
Sbjct: 66  CQLKHPSILELY--NYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIIT 123

Query: 455 GLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMK----GSPYWMA 510
           G+ YLHS   +HRD+  +NLL+  +  +K+ADFG+A  L   K          G+P +++
Sbjct: 124 GMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQL---KMPHEKHYTLCGTPNYIS 180

Query: 511 PELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMF-KVMRDTPAIP 569
           PE     +    +       D+WSLGC    +  G+PP+ + +       KV+     +P
Sbjct: 181 PE-----IATRSAHGL--ESDVWSLGCMFYTLLIGRPPF-DTDTVKNTLNKVVLADYEMP 232

Query: 570 DSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQP 609
             LS E KD +    +RNPADR   S +L+H F+  +   
Sbjct: 233 SFLSIEAKDLIHQLLRRNPADRLSLSSVLDHPFMSRNSST 272

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  224 bits (573), Expect = 4e-68
 Identities = 84/269 (31%), Positives = 141/269 (52%), Gaps = 18/269 (6%)

Query: 345 GKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNI 404
           G+ +G+G FG+VY+A  +++  + A+K   +F    + A    QL +E+++ SHL+HPNI
Sbjct: 14  GRPLGKGKFGNVYLAREKQSKFILALKV--LFKAQLEKAGVEHQLRREVEIQSHLRHPNI 71

Query: 405 VQYYGSEIVEDKFYIY--LEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSK 462
           ++ YG     D   +Y  LEY   G++ + +++      E     +   + + L+Y HSK
Sbjct: 72  LRLYG--YFHDATRVYLILEYAPLGTVYRELQKL-SKFDEQRTATYITELANALSYCHSK 128

Query: 463 KTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPYWMAPELMMAVMQKGK 522
           + IHRDIK  NLL+ ++G +K+ADFG + H    +    + G+  ++ PE     M +G+
Sbjct: 129 RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT-DLCGTLDYLPPE-----MIEGR 182

Query: 523 SSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMF-KVMRDTPAIPDSLSPEGKDFLR 581
             D    VD+WSLG    E   GKPP+ E       + ++ R     PD ++   +D + 
Sbjct: 183 MHDE--KVDLWSLGVLCYEFLVGKPPF-EANTYQETYKRISRVEFTFPDFVTEGARDLIS 239

Query: 582 CCFQRNPADRPPASLLLEHR-FLKNSQQP 609
              + NP+ RP    +LEH     NS +P
Sbjct: 240 RLLKHNPSQRPMLREVLEHPWITANSSKP 268

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  222 bits (567), Expect = 4e-67
 Identities = 79/305 (25%), Positives = 139/305 (45%), Gaps = 36/305 (11%)

Query: 323 SATIPQVAAKPEPLPMNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKS 382
           +  IP+V   P       ++ +G+ +G+G F   +  S+ +T  + A K V       KS
Sbjct: 1   AKEIPEVLVDPRSR---RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVP------KS 51

Query: 383 ----AESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYIY--LEYVHPGSINKYVREH 436
                   +++  EI +   L H ++V ++     ED  +++  LE     S+ +  +  
Sbjct: 52  LLLKPHQREKMSMEISIHRSLAHQHVVGFH--GFFEDNDFVFVVLELCRRRSLLELHKRR 109

Query: 437 CGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQ 496
             A+TE   R + R I+ G  YLH  + IHRD+K  NL ++    VK+ DFG+A  +   
Sbjct: 110 -KALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKV--- 165

Query: 497 KADLSMK----GSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEY 552
           + D   K    G+P ++APE     +   K       VD+WS+GC +  +  GKPP+ E 
Sbjct: 166 EYDGERKKVLCGTPNYIAPE-----VLSKKGHS--FEVDVWSIGCIMYTLLVGKPPF-ET 217

Query: 553 EGAAAMF-KVMRDTPAIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQPDV 611
                 + ++ ++  +IP  ++P     ++   Q +P  RP  + LL   F  +   P  
Sbjct: 218 SCLKETYLRIKKNEYSIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIPAR 277

Query: 612 --PSC 614
              +C
Sbjct: 278 LPITC 282

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  222 bits (567), Expect = 2e-66
 Identities = 80/317 (25%), Positives = 141/317 (44%), Gaps = 26/317 (8%)

Query: 301 ESTVRIEVHPLPLPPGAAVLSPSATIPQVAAKPEPLPMNSQWQKGKLIGRGTFGSVYVAS 360
               +  V  +  P   A   P+  IP+V   P       ++ +G+ +G+G F   +  S
Sbjct: 5   ADPGKAGVPGVAAPGAPAAAPPAKEIPEVLVDPRSR---RRYVRGRFLGKGGFAKCFEIS 61

Query: 361 NRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYIY 420
           + +T  + A K V             +++  EI +   L H ++V ++     ED  +++
Sbjct: 62  DADTKEVFAGKIVPK--SLLLKPHQREKMSMEISIHRSLAHQHVVGFH--GFFEDNDFVF 117

Query: 421 --LEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDA 478
             LE     S+ +  +    A+TE   R + R I+ G  YLH  + IHRD+K  NL ++ 
Sbjct: 118 VVLELCRRRSLLELHKRR-KALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNE 176

Query: 479 SGVVKLADFGMAKHLTGQKADLSMK----GSPYWMAPELMMAVMQKGKSSDSALAVDIWS 534
              VK+ DFG+A  +   + D   K    G+P ++APE     +   K       VD+WS
Sbjct: 177 DLEVKIGDFGLATKV---EYDGERKKVLCGTPNYIAPE-----VLSKKGHS--FEVDVWS 226

Query: 535 LGCTIIEMYTGKPPWSEYEGAAAMF-KVMRDTPAIPDSLSPEGKDFLRCCFQRNPADRPP 593
           +GC +  +  GKPP+ E       + ++ ++  +IP  ++P     ++   Q +P  RP 
Sbjct: 227 IGCIMYTLLVGKPPF-ETSCLKETYLRIKKNEYSIPKHINPVAASLIQKMLQTDPTARPT 285

Query: 594 ASLLLEHRFLKNSQQPD 610
            + LL   F  +   P 
Sbjct: 286 INELLNDEFFTSGYIPA 302

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  218 bits (558), Expect = 1e-65
 Identities = 62/311 (19%), Positives = 116/311 (37%), Gaps = 46/311 (14%)

Query: 339 NSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSH 398
           N  W    ++G+G   +V+   +++TG L A+K  +    +      +    +E +VL  
Sbjct: 8   NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFN----NISFLRPVDVQMREFEVLKK 63

Query: 399 LKHPNIVQYYGSEIVEDK----FYIYLEYVHPGSINKYVREH--CGAITESVVRNFTRHI 452
           L H NIV+ +   I E+       + +E+   GS+   + E      + ES      R +
Sbjct: 64  LNHKNIVKLF--AIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDV 121

Query: 453 LSGLAYLHSKKTIHRDIKGANLLV----DASGVVKLADFGMAKHLTGQKADLSMKGSPYW 508
           + G+ +L     +HR+IK  N++     D   V KL DFG A+ L   +  +S+ G+  +
Sbjct: 122 VGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEY 181

Query: 509 MAPELMMAVMQKGKSSDS-ALAVDIWSLGCTIIEMYTGKPPWSEYEGAAA----MFKVMR 563
           + P++    + +          VD+WS+G T     TG  P+  +EG       M+K++ 
Sbjct: 182 LHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT 241

Query: 564 DTPA-------------------------IPDSLSPEGKDFLRCCFQRNPADRPPASLLL 598
             P+                         +   L       L    + +           
Sbjct: 242 GKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFF 301

Query: 599 EHRFLKNSQQP 609
                   +  
Sbjct: 302 AETSDILHRGN 312

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  214 bits (547), Expect = 3e-64
 Identities = 80/269 (29%), Positives = 133/269 (49%), Gaps = 13/269 (4%)

Query: 345 GKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNI 404
           G+ +G+G FG+VY+A  ++   + A+K   +F    +      QL +EI++ SHL+HPNI
Sbjct: 19  GRPLGKGKFGNVYLAREKQNKFIMALKV--LFKSQLEKEGVEHQLRREIEIQSHLRHPNI 76

Query: 405 VQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKT 464
           ++ Y       + Y+ LE+   G + K +++H G   E     F   +   L Y H +K 
Sbjct: 77  LRMYNYFHDRKRIYLMLEFAPRGELYKELQKH-GRFDEQRSATFMEELADALHYCHERKV 135

Query: 465 IHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPYWMAPELMMAVMQKGKSS 524
           IHRDIK  NLL+   G +K+ADFG + H    +   +M G+  ++ PE     M +GK+ 
Sbjct: 136 IHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRR-TMCGTLDYLPPE-----MIEGKTH 189

Query: 525 DSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMF-KVMRDTPAIPDSLSPEGKDFLRCC 583
           D    VD+W  G    E   G PP+ +         +++      P  LS   KD +   
Sbjct: 190 DE--KVDLWCAGVLCYEFLVGMPPF-DSPSHTETHRRIVNVDLKFPPFLSDGSKDLISKL 246

Query: 584 FQRNPADRPPASLLLEHRFLKNSQQPDVP 612
            + +P  R P   ++EH ++K + +  +P
Sbjct: 247 LRYHPPQRLPLKGVMEHPWVKANSRRVLP 275

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  214 bits (548), Expect = 4e-64
 Identities = 58/296 (19%), Positives = 103/296 (34%), Gaps = 30/296 (10%)

Query: 339 NSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSH 398
           N  +   + +G G F  V +      G   A+K +          +  ++ ++E  +   
Sbjct: 28  NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILC-----HEQQDREEAQREADMHRL 82

Query: 399 LKHPNIVQYYGSEIVED----KFYIYLEYVHPGSINKYVREH---CGAITESVVRNFTRH 451
             HPNI++     + E     + ++ L +   G++   +         +TE  +      
Sbjct: 83  FNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLG 142

Query: 452 ILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQ----------KADLS 501
           I  GL  +H+K   HRD+K  N+L+   G   L D G                  +   +
Sbjct: 143 ICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAA 202

Query: 502 MKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPP--WSEYEGAAAMF 559
            + +  + APE  +  +Q     D     D+WSLGC +  M  G+ P      +G +   
Sbjct: 203 QRCTISYRAPE--LFSVQSHCVIDE--RTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVAL 258

Query: 560 KVMRD-TPAIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEH-RFLKNSQQPDVPS 613
            V    +       S      L      +P  RP   LLL     L+        +
Sbjct: 259 AVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPAPGQHTT 314

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  214 bits (547), Expect = 5e-63
 Identities = 67/345 (19%), Positives = 125/345 (36%), Gaps = 51/345 (14%)

Query: 339 NSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSH 398
           N  W    ++G+G   +V+   +++TG L A+K  +    +      +    +E +VL  
Sbjct: 8   NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFN----NISFLRPVDVQMREFEVLKK 63

Query: 399 LKHPNIVQYYGSEIVEDK----FYIYLEYVHPGSINKYVREH--CGAITESVVRNFTRHI 452
           L H NIV+ +   I E+       + +E+   GS+   + E      + ES      R +
Sbjct: 64  LNHKNIVKLF--AIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDV 121

Query: 453 LSGLAYLHSKKTIHRDIKGANLLV----DASGVVKLADFGMAKHLTGQKADLSMKGSPYW 508
           + G+ +L     +HR+IK  N++     D   V KL DFG A+ L   +  +S+ G+  +
Sbjct: 122 VGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEY 181

Query: 509 MAPELMMAVMQKGKSSDS-ALAVDIWSLGCTIIEMYTGKPPWSEYEGAAA----MFKVMR 563
           + P++    + +          VD+WS+G T     TG  P+  +EG       M+K++ 
Sbjct: 182 LHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT 241

Query: 564 DTPA-------------------------IPDSLSPEGKDFLRCCFQRNPADRPPASLLL 598
             P+                         +   L       L    + +           
Sbjct: 242 GKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFF 301

Query: 599 EH-RFLKNSQQPDVPSCSLSFSGMQLTEKPHSPREKADAKYDQVA 642
                + +     V     S   M   +        A   ++ V 
Sbjct: 302 AETSDILHRMVIHV----FSLQQMTAHKIYIHSYNTATIFHELVY 342

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  215 bits (550), Expect = 5e-63
 Identities = 75/302 (24%), Positives = 122/302 (40%), Gaps = 41/302 (13%)

Query: 338 MNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLS 397
           + +     K++G G+ G+V        G   A+K + I        +       EIK+L+
Sbjct: 13  LKNLVVSEKILGYGSSGTVVFQ-GSFQGRPVAVKRMLI--------DFCDIALMEIKLLT 63

Query: 398 HLK-HPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYV------REHCGAITESVVRNFTR 450
               HPN+++YY SE  +   YI LE     ++   V       E+     E    +  R
Sbjct: 64  ESDDHPNVIRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLR 122

Query: 451 HILSGLAYLHSKKTIHRDIKGANLLVDASGV-------------VKLADFGMAKHLTGQK 497
            I SG+A+LHS K IHRD+K  N+LV  S               + ++DFG+ K L   +
Sbjct: 123 QIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQ 182

Query: 498 ADLSMK-----GSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPP-WS 550
           +          G+  W APEL+              ++DI+S+GC    + + GK P   
Sbjct: 183 SSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGD 242

Query: 551 EYEGAAAMFKVMRDTPAIP----DSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNS 606
           +Y   + + + +     +      SL  E  D +      +P  RP A  +L H      
Sbjct: 243 KYSRESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWPK 302

Query: 607 QQ 608
            +
Sbjct: 303 SK 304

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  210 bits (537), Expect = 3e-62
 Identities = 72/345 (20%), Positives = 145/345 (42%), Gaps = 53/345 (15%)

Query: 312 PLPPGAAVLSPSATIPQVAAKPEPLPMN-SQWQKGKLIGRGTFGSVYVASNRETGALCAM 370
           PL     +LS  + +  +    +      + ++  + + +G F  + +    +     A+
Sbjct: 2   PLGSMKDILSNYSNLIYLNKYVKEKDKYINDYRIIRTLNQGKFNKIILC--EKDNKFYAL 59

Query: 371 KEVD------------IFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFY 418
           K+ +               D           + E+++++ +K+   +      I+ +   
Sbjct: 60  KKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCE--GIITNYDE 117

Query: 419 IYL--EYVHPGSINKYVREH-------CGAITESVVRNFTRHILSGLAYLHSKKTI-HRD 468
           +Y+  EY+   SI K+              I   V++   + +L+  +Y+H++K I HRD
Sbjct: 118 VYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRD 177

Query: 469 IKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPYWMAPELMMAVMQKGKSSDSAL 528
           +K +N+L+D +G VKL+DFG ++++  +K     +G+  +M PE         +SS +  
Sbjct: 178 VKPSNILMDKNGRVKLSDFGESEYMVDKKIK-GSRGTYEFMPPE-----FFSNESSYNGA 231

Query: 529 AVDIWSLGCTIIEMYTGKPPWSEYEGAAAMF-KVMRDTPAIP------------------ 569
            VDIWSLG  +  M+    P+S       +F  +       P                  
Sbjct: 232 KVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCS 291

Query: 570 -DSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQPDVPS 613
            + LS E  DFL+   ++NPA+R  +   L+H +L ++   D+  
Sbjct: 292 NNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLADTNIEDLRE 336

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score =  200 bits (511), Expect = 5e-59
 Identities = 80/295 (27%), Positives = 134/295 (45%), Gaps = 42/295 (14%)

Query: 341 QWQKGKLIGRGTFGSVYVASNRETGALCAMKEVD---------------------IFPDD 379
           Q+     IG+G++G V +A N       AMK +                           
Sbjct: 14  QYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGC 73

Query: 380 PKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVE----DKFYIYLEYVHPGSINKYVRE 435
            +    I+Q+ QEI +L  L HPN+V+    E+++    D  Y+  E V+ G + +    
Sbjct: 74  IQPRGPIEQVYQEIAILKKLDHPNVVKLV--EVLDDPNEDHLYMVFELVNQGPVMEVPTL 131

Query: 436 HCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTG 495
               ++E   R + + ++ G+ YLH +K IHRDIK +NLLV   G +K+ADFG++    G
Sbjct: 132 --KPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKG 189

Query: 496 QKADLSMK-GSPYWMAPELMMAVMQK--GKSSDSALAVDIWSLGCTIIEMYTGKPPWSEY 552
             A LS   G+P +MAPE +    +   GK      A+D+W++G T+     G+ P+ + 
Sbjct: 190 SDALLSNTVGTPAFMAPESLSETRKIFSGK------ALDVWAMGVTLYCFVFGQCPFMD- 242

Query: 553 EGAAAMF-KVMRDTPAIPD--SLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLK 604
           E    +  K+       PD   ++ + KD +     +NP  R     +  H ++ 
Sbjct: 243 ERIMCLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVT 297

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  195 bits (497), Expect = 4e-57
 Identities = 61/280 (21%), Positives = 124/280 (44%), Gaps = 33/280 (11%)

Query: 335 PLPMNSQW-------QKGKLIGRGTFGSVYVASNRETGALCAMKEVDI--FPDDPKSAES 385
             P +          +  K IG+G FG V+     +  ++ A+K + +     + +  E 
Sbjct: 7   EFPKSRLPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEK 66

Query: 386 IKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVV 445
            ++ ++E+ ++S+L HPNIV+ YG  ++ +   + +E+V  G +   + +    I  SV 
Sbjct: 67  FQEFQREVFIMSNLNHPNIVKLYG--LMHNPPRMVMEFVPCGDLYHRLLDKAHPIKWSVK 124

Query: 446 RNFTRHILSGLAYLHSKKT--IHRDIKGANLLVDASG-----VVKLADFGMAKHLTGQKA 498
                 I  G+ Y+ ++    +HRD++  N+ + +         K+ADFG+++      +
Sbjct: 125 LRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHSVS 184

Query: 499 DLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTII--EMYTGKPPWSEYEG-- 554
              + G+  WMAPE +       +        D +S    +I   + TG+ P+ EY    
Sbjct: 185 --GLLGNFQWMAPETI-----GAEEESYTEKADTYSFA--MILYTILTGEGPFDEYSYGK 235

Query: 555 AAAMFKVMRDT--PAIPDSLSPEGKDFLRCCFQRNPADRP 592
              +  +  +   P IP+   P  ++ +  C+  +P  RP
Sbjct: 236 IKFINMIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRP 275

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  198 bits (505), Expect = 9e-57
 Identities = 70/285 (24%), Positives = 130/285 (45%), Gaps = 19/285 (6%)

Query: 345 GKLIGRGTFGSVYVASNRETGALCAMKEVD---IFPDDPKSAESIKQLEQEIKVLSHLKH 401
            K +G G  G V +A  R+T    A++ +          + A+    +E EI++L  L H
Sbjct: 140 SKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNH 199

Query: 402 PNIVQYYGSEIVEDK-FYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLH 460
           P I++       + + +YI LE +  G +   V  +   + E+  + +   +L  + YLH
Sbjct: 200 PCIIKIK--NFFDAEDYYIVLELMEGGELFDKVVGN-KRLKEATCKLYFYQMLLAVQYLH 256

Query: 461 SKKTIHRDIKGANLLV---DASGVVKLADFGMAKHLTGQKADLSMKGSPYWMAPELMMAV 517
               IHRD+K  N+L+   +   ++K+ DFG +K L       ++ G+P ++APE++++V
Sbjct: 257 ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSV 316

Query: 518 MQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMF-KVMR---DTPAIP-DSL 572
              G +     AVD WSLG  +    +G PP+SE+    ++  ++     +        +
Sbjct: 317 GTAGYNR----AVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEV 372

Query: 573 SPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQPDVPSCSLS 617
           S +  D ++     +P  R      L H +L++          LS
Sbjct: 373 SEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMKRKFQDLLS 417

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  193 bits (492), Expect = 3e-56
 Identities = 74/289 (25%), Positives = 126/289 (43%), Gaps = 31/289 (10%)

Query: 321 SPSATIPQVAAKPEPLPMNSQ-W-------QKGKLIGRGTFGSVYVASNRETGALCAMKE 372
                IP          M+              + IG G+FG+V+ A     G+  A+K 
Sbjct: 10  MSDYDIPTTENLYFQGAMDGDDMDIPWCDLNIKEKIGAGSFGTVHRAEWH--GSDVAVK- 66

Query: 373 VDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKY 432
             I  +    AE + +  +E+ ++  L+HPNIV + G+        I  EY+  GS+ + 
Sbjct: 67  --ILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRL 124

Query: 433 VREHCGA--ITESVVRNFTRHILSGLAYLHSKKT--IHRDIKGANLLVDASGVVKLADFG 488
           + +      + E    +    +  G+ YLH++    +HR++K  NLLVD    VK+ DFG
Sbjct: 125 LHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFG 184

Query: 489 MAKHLTGQKADL-SMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTII--EMYTG 545
           +++          S  G+P WMAPE++     + + S+     D++S G  +I  E+ T 
Sbjct: 185 LSRLKASTFLSSKSAAGTPEWMAPEVL-----RDEPSNE--KSDVYSFG--VILWELATL 235

Query: 546 KPPWSEYEGAAAMFKVMRDT--PAIPDSLSPEGKDFLRCCFQRNPADRP 592
           + PW     A  +  V        IP +L+P+    +  C+   P  RP
Sbjct: 236 QQPWGNLNPAQVVAAVGFKCKRLEIPRNLNPQVAAIIEGCWTNEPWKRP 284

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  194 bits (494), Expect = 4e-56
 Identities = 62/323 (19%), Positives = 126/323 (39%), Gaps = 40/323 (12%)

Query: 339 NSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSH 398
             + +  +++  G F  VY A +  +G   A+K +          E  + + QE+  +  
Sbjct: 27  ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLS-----NEEEKNRAIIQEVCFMKK 81

Query: 399 LK-HPNIVQYYGSEIV-------EDKFYIYLEYVHPGSINKYV--REHCGAITESVVRNF 448
           L  HPNIVQ+  +  +           ++ L  +  G + +++   E  G ++   V   
Sbjct: 82  LSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKI 141

Query: 449 TRHILSGLAYLHSKKT--IHRDIKGANLLVDASGVVKLADFGMAKHLTGQ---------- 496
                  + ++H +K   IHRD+K  NLL+   G +KL DFG A  ++            
Sbjct: 142 FYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRR 201

Query: 497 ---KADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYE 553
              + +++   +P +  PE  +  +            DIW+LGC +  +   + P   +E
Sbjct: 202 ALVEEEITRNTTPMYRTPE--IIDLYSNFPIGE--KQDIWALGCILYLLCFRQHP---FE 254

Query: 554 GAAAMFKVMRDTPAIP--DSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQPDV 611
             A + +++    +IP  D+        +R   Q NP +R   + ++       + +   
Sbjct: 255 DGAKL-RIVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARNVN 313

Query: 612 PSCSLSFSGMQLTEKPHSPREKA 634
           P   ++    Q      +   + 
Sbjct: 314 PKSPITELLEQNGGYGSATLSRG 336

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  197 bits (504), Expect = 6e-56
 Identities = 81/322 (25%), Positives = 140/322 (43%), Gaps = 36/322 (11%)

Query: 322 PSATIPQVAAKPEPL------PMNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDI 375
           P + +  + A P           + +++  +++G+G+FG V +  ++ TG  CA+K +  
Sbjct: 2   PGSMMDHLHATPGMFVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISK 61

Query: 376 FPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYIYL--EYVHPGSINKYV 433
                K     + L +E+++L  L HPNI++ Y  E  EDK Y YL  E    G +   +
Sbjct: 62  --RQVKQKTDKESLLREVQLLKQLDHPNIMKLY--EFFEDKGYFYLVGEVYTGGELFDEI 117

Query: 434 REHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLV---DASGVVKLADFGMA 490
                  +E       R +LSG+ Y+H  K +HRD+K  NLL+        +++ DFG++
Sbjct: 118 ISR-KRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLS 176

Query: 491 KHLTGQKADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPP-W 549
            H    K      G+ Y++APE    V+            D+WS G  +  + +G PP  
Sbjct: 177 THFEASKKMKDKIGTAYYIAPE----VLHGTYDE----KCDVWSTGVILYILLSGCPPFN 228

Query: 550 SEYEGAAAMF-KVMR---DTPAIP-DSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLK 604
              E    +  KV +            +S   KD +R      P+ R  A   L+H +++
Sbjct: 229 GANE--YDILKKVEKGKYTFELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQ 286

Query: 605 NSQQ----PDVPSCSLSFSGMQ 622
              +     DVPS   +   ++
Sbjct: 287 TYTKEQISVDVPSLDNAILNIR 308

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score =  193 bits (492), Expect = 6e-56
 Identities = 71/354 (20%), Positives = 138/354 (38%), Gaps = 29/354 (8%)

Query: 318 AVLSPSATIPQVAAKPEPLPMNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVD--- 374
           A+  P   +            + ++     +G G FG V+ A ++E      +K +    
Sbjct: 2   ALEEPPKAVELEGLAACEGEYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEK 61

Query: 375 IFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYIYLE---YVHPGSINK 431
           +  D       + ++  EI +LS ++H NI++    +I E++ +  L    +     +  
Sbjct: 62  VLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVL--DIFENQGFFQLVMEKHGSGLDLFA 119

Query: 432 YVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAK 491
           ++  H   + E +     R ++S + YL  K  IHRDIK  N+++     +KL DFG A 
Sbjct: 120 FIDRH-PRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAA 178

Query: 492 HLT-GQKADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWS 550
           +L  G+       G+  + APE++M     G        +++WSLG T+  +   + P+ 
Sbjct: 179 YLERGKLFYTFC-GTIEYCAPEVLM-----GNPYRGP-ELEMWSLGVTLYTLVFEENPFC 231

Query: 551 EYEGAAAMFKVMRDTPAIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQPD 610
           E E      + +      P  +S E    +    Q  P  R     L+   ++   Q  +
Sbjct: 232 ELE------ETVEAAIHPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTDPWVT--QPVN 283

Query: 611 VPSCSLSFSGMQLTEKPHSPREKADAKYDQVAALSSSRSSRKATLESENGRRSH 664
           +      ++  ++            A   ++   S S  ++   L    G   H
Sbjct: 284 LA----DYTWEEVFRVNKPESGVLSAASLEMGNRSLSDVAQAQELCGGEGHHHH 333

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score =  193 bits (492), Expect = 7e-56
 Identities = 86/293 (29%), Positives = 147/293 (50%), Gaps = 18/293 (6%)

Query: 328 QVAAKPEPLPMNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIK 387
            +A+  +  P    ++  K IG+G F  V +A +  TG   A+K   I      +  S++
Sbjct: 3   SIASCADEQPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIK---IIDKTQLNPTSLQ 59

Query: 388 QLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYIYL--EYVHPGSINKYVREHCGAITESVV 445
           +L +E++++  L HPNIV+ +  E++E +  +YL  EY   G +  Y+  H G + E   
Sbjct: 60  KLFREVRIMKILNHPNIVKLF--EVIETEKTLYLIMEYASGGEVFDYLVAH-GRMKEKEA 116

Query: 446 RNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGM-AKHLTGQKADLSMKG 504
           R+  R I+S + Y H K+ +HRD+K  NLL+DA   +K+ADFG   +   G K D    G
Sbjct: 117 RSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFC-G 175

Query: 505 SPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMF-KVMR 563
           +P + APEL      +GK  D    VD+WSLG  +  + +G  P+   +    +  +V+R
Sbjct: 176 APPYAAPELF-----QGKKYDGP-EVDVWSLGVILYTLVSGSLPFDG-QNLKELRERVLR 228

Query: 564 DTPAIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQPDVPSCSL 616
               IP  +S + ++ L+     NP  R     +++ R++    + D     +
Sbjct: 229 GKYRIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKDRWINAGHEEDELKPFV 281

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score =  192 bits (490), Expect = 7e-56
 Identities = 78/333 (23%), Positives = 138/333 (41%), Gaps = 66/333 (19%)

Query: 338 MNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDD---PKSAESIKQLEQEIK 394
           M  +++K   IG G++G V+   NR+TG + A+K+     DD    K A  ++    EI+
Sbjct: 1   MMEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIA--LR----EIR 54

Query: 395 VLSHLKHPNIVQYYGSEIV--EDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHI 452
           +L  LKHPN+V     E+   + + ++  EY    ++   +  +   + E +V++ T   
Sbjct: 55  MLKQLKHPNLVNLL--EVFRRKRRLHLVFEYCD-HTVLHELDRYQRGVPEHLVKSITWQT 111

Query: 453 LSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPY----- 507
           L  + + H    IHRD+K  N+L+    V+KL DFG A+        L+     Y     
Sbjct: 112 LQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFAR-------LLTGPSDYYDDEVA 164

Query: 508 --WM-APELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPW---SEYEGAAAMFKV 561
             W  +PEL++   Q G        VD+W++GC   E+ +G P W   S+ +    + K 
Sbjct: 165 TRWYRSPELLVGDTQYGP------PVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKT 218

Query: 562 M-----RDTPAI---PD--------------------SLSPEGKDFLRCCFQRNPADRPP 593
           +     R                              ++S      L+ C   +P +R  
Sbjct: 219 LGDLIPRHQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLT 278

Query: 594 ASLLLEHRFLKNSQQPDVPSCSLSFSGMQLTEK 626
              LL H + +N ++ +  +         L  +
Sbjct: 279 CEQLLHHPYFENIREIEDLAKEHDKPAENLYFQ 311

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  190 bits (486), Expect = 9e-56
 Identities = 72/263 (27%), Positives = 123/263 (46%), Gaps = 30/263 (11%)

Query: 345 GKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNI 404
            ++IG G FG VY A     G   A+K     PD+  S ++I+ + QE K+ + LKHPNI
Sbjct: 12  EEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDIS-QTIENVRQEAKLFAMLKHPNI 68

Query: 405 VQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKT 464
           +   G  + E    + +E+   G +N+ +      I   ++ N+   I  G+ YLH +  
Sbjct: 69  IALRGVCLKEPNLCLVMEFARGGPLNRVLSGK--RIPPDILVNWAVQIARGMNYLHDEAI 126

Query: 465 ---IHRDIKGANLLVDASG--------VVKLADFGMAKHLTGQKADLSMKGSPYWMAPEL 513
              IHRD+K +N+L+            ++K+ DFG+A+    +   +S  G+  WMAPE+
Sbjct: 127 VPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWH-RTTKMSAAGAYAWMAPEV 185

Query: 514 MMAVMQKGKSSDSALAVDIWSLGCTII--EMYTGKPPWSEYEGAAAMFKVMRD--TPAIP 569
           +     +          D+WS G  ++  E+ TG+ P+   +G A  + V  +     IP
Sbjct: 186 I-----RASMFSK--GSDVWSYG--VLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPIP 236

Query: 570 DSLSPEGKDFLRCCFQRNPADRP 592
            +        +  C+  +P  RP
Sbjct: 237 STCPEPFAKLMEDCWNPDPHSRP 259

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score =  190 bits (485), Expect = 2e-55
 Identities = 72/279 (25%), Positives = 126/279 (45%), Gaps = 37/279 (13%)

Query: 345 GKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNI 404
            + +G G FG V++   R +G    +K ++      +S   ++Q+E EI+VL  L HPNI
Sbjct: 27  KRKLGSGAFGDVHLVEERSSGLERVIKTINK----DRSQVPMEQIEAEIEVLKSLDHPNI 82

Query: 405 VQYYGSEIVEDKFYIYL--EYVHPG----SINKYVREHCGAITESVVRNFTRHILSGLAY 458
           ++ +  E+ ED   +Y+  E    G     I         A++E  V    + +++ LAY
Sbjct: 83  IKIF--EVFEDYHNMYIVMETCEGGELLERIVSAQARG-KALSEGYVAELMKQMMNALAY 139

Query: 459 LHSKKTIHRDIKGANLLV---DASGVVKLADFGMAKHLTGQKADLSMKGSPYWMAPELMM 515
            HS+  +H+D+K  N+L         +K+ DFG+A+     +   +  G+  +MAPE   
Sbjct: 140 FHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPE--- 196

Query: 516 AVMQKGKSSDSALAVDIWSLGCTIIEMYT---GKPP-WSEYEGAAAMF-KVMR---DTPA 567
            V ++  +       DIWS G  ++ MY    G  P          +  K      +   
Sbjct: 197 -VFKRDVT----FKCDIWSAG--VV-MYFLLTGCLPFTGTSL--EEVQQKATYKEPNYAV 246

Query: 568 IPDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNS 606
               L+P+  D L+    ++P  RP A+ +L H + K +
Sbjct: 247 ECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQA 285

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  193 bits (491), Expect = 2e-55
 Identities = 52/381 (13%), Positives = 112/381 (29%), Gaps = 57/381 (14%)

Query: 272 FHSPRSRSPCRNAISPSGPSSPIHSKLSRESTVRIEVHPLPLPPGAAVLSPSATIPQVAA 331
            H     S  R  +   GP   +  +L        + +           + S     +  
Sbjct: 1   MHHHHHHSSGRENLYFQGPGDVVIEELFNRIP---QANVRTTSEYMQSAADSLVSTSLWN 57

Query: 332 KPEPLPMNS-------QWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAE 384
             +P  + S          +G ++G+    +   A+++ETG    +     +  +   + 
Sbjct: 58  TGQPFRVESELGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHV--PYFTERPPSN 115

Query: 385 SIKQLEQEIKVLSHLK-------------------------HPNIVQYYGSEIVEDKFYI 419
           +IKQ+++E+  L  L+                            +++    E        
Sbjct: 116 AIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSR 175

Query: 420 YLEYVHP--------GSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKG 471
           +  Y             +  +   H  ++        T  ++  LA LH    +H  ++ 
Sbjct: 176 FFLYPRMQSNLQTFGEVLLSHSSTH-KSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRP 234

Query: 472 ANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPYWMAPELMMAVMQKGKSSDSAL--- 528
            ++++D  G V L  F          A +    S  +  PEL           D      
Sbjct: 235 VDIVLDQRGGVFLTGFEHLVRDG---ARVVSSVSRGFEPPELEARRATISYHRDRRTLMT 291

Query: 529 -AVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDSLSPEGKDFLRCCFQRN 587
            + D W+LG  I  ++    P ++         + R       ++    +  L    +  
Sbjct: 292 FSFDAWALGLVIYWIWCADLPITKDAALGGSEWIFRS----CKNIPQPVRALLEGFLRYP 347

Query: 588 PADRPPASLLLEHRFLKNSQQ 608
             DR      +E    +  + 
Sbjct: 348 KEDRLLPLQAMETPEYEQLRT 368

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  200 bits (509), Expect = 3e-55
 Identities = 66/294 (22%), Positives = 113/294 (38%), Gaps = 27/294 (9%)

Query: 331 AKPEPLPMNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLE 390
           +   P      W+  + +G G FG V    +++TG   A+K+         S ++ ++  
Sbjct: 5   SPSLPTQTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCR----QELSPKNRERWC 60

Query: 391 QEIKVLSHLKHPNIVQYYGSEIVEDK--------FYIYLEYVHPGSINKYV--REHCGAI 440
            EI+++  L HPN+V     E+ +            + +EY   G + KY+   E+C  +
Sbjct: 61  LEIQIMKKLNHPNVVSAR--EVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGL 118

Query: 441 TESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASG---VVKLADFGMAKHLTGQK 497
            E  +R     I S L YLH  + IHRD+K  N+++       + K+ D G AK L   +
Sbjct: 119 KEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGE 178

Query: 498 ADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAA 557
                 G+  ++APEL+       K       VD WS G    E  TG  P+        
Sbjct: 179 LCTEFVGTLQYLAPELLE-----QKKYTV--TVDYWSFGTLAFECITGFRPFLPNWQPVQ 231

Query: 558 MFKVMRDTPAIPDSLSPEGKDFLRCCFQ-RNPADRPPASLLLEHRFLKNSQQPD 610
               +R+       +  +    ++       P            R+L+      
Sbjct: 232 WHGKVREKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWH 285

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  190 bits (485), Expect = 3e-55
 Identities = 79/298 (26%), Positives = 132/298 (44%), Gaps = 31/298 (10%)

Query: 340 SQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHL 399
            + +  +++GRG FG V  A  R      A+K++       +S    K    E++ LS +
Sbjct: 8   KEIEVEEVVGRGAFGVVCKAKWR--AKDVAIKQI-------ESESERKAFIVELRQLSRV 58

Query: 400 KHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVR--EHCGAITESVVRNFTRHILSGLA 457
            HPNIV+ YG     +   + +EY   GS+   +   E     T +   ++      G+A
Sbjct: 59  NHPNIVKLYG--ACLNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVA 116

Query: 458 YLHSKKT---IHRDIKGANLLVDASG-VVKLADFGMAKHLTGQKADLSMKGSPYWMAPEL 513
           YLHS +    IHRD+K  NLL+ A G V+K+ DFG A  +       + KGS  WMAPE+
Sbjct: 117 YLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHM--TNNKGSAAWMAPEV 174

Query: 514 MMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGA--AAMFKVMRDT-PAIPD 570
                 +G +       D++S G  + E+ T + P+ E  G     M+ V   T P +  
Sbjct: 175 F-----EGSNYSE--KCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIK 227

Query: 571 SLSPEGKDFLRCCFQRNPADRPPASLLLEH--RFLKNSQQPDVPSCSLSFSGMQLTEK 626
           +L    +  +  C+ ++P+ RP    +++     ++     D P        +   E 
Sbjct: 228 NLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEPLQYPCQHSLPPGED 285

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =  190 bits (485), Expect = 8e-55
 Identities = 76/320 (23%), Positives = 126/320 (39%), Gaps = 65/320 (20%)

Query: 345 GKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNI 404
              IG+G++G V VA   +T A+ A+K ++       + + +++++ E++++  L HPNI
Sbjct: 31  KGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNI 90

Query: 405 VQYYGSEIVEDKFYIYL--EYVHPGSI--------------------------------- 429
            + Y  E+ ED+ YI L  E  H G +                                 
Sbjct: 91  ARLY--EVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEE 148

Query: 430 ------NKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLV--DASGV 481
                 + +         E ++ N  R I S L YLH++   HRDIK  N L   + S  
Sbjct: 149 AINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNKSFE 208

Query: 482 VKLADFGMAKHLTGQKADLSMK-----GSPYWMAPELMMAVMQK-GKSSDSALAVDIWSL 535
           +KL DFG++K                 G+PY++APE++    +  G         D WS 
Sbjct: 209 IKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGP------KCDAWSA 262

Query: 536 GCTIIEMYTGKPP-WSEYEGAAAMF-KVMRDTPAIP----DSLSPEGKDFLRCCFQRNPA 589
           G  +  +  G  P     +  A    +V+           + LSP  +D L     RN  
Sbjct: 263 GVLLHLLLMGAVPFPGVND--ADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVD 320

Query: 590 DRPPASLLLEHRFLKNSQQP 609
           +R  A   L+H ++      
Sbjct: 321 ERFDAMRALQHPWISQFSDK 340

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score =  189 bits (483), Expect = 9e-55
 Identities = 77/312 (24%), Positives = 133/312 (42%), Gaps = 29/312 (9%)

Query: 309 HPLPLPPGAAVLSPSATIP--QVAAKPEPLPMNSQWQKGKLIGRGTFGSVYVASNRETGA 366
           H   L P  + ++P   +   ++A   E  P+ SQ+Q G L+G G FGSVY         
Sbjct: 10  HSSGLVPRGSHMAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNL 69

Query: 367 LCAMKEVD---IFPDDPKSAESIKQLEQEIKVLSHLKH--PNIVQYYGSEIVE--DKFYI 419
             A+K V+   I   D     +  ++  E+ +L  +      +++    +  E  D F +
Sbjct: 70  PVAIKHVEKDRI--SDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLL--DWFERPDSFVL 125

Query: 420 YLEYVHP-GSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDA 478
            LE   P   +  ++ E  GA+ E + R+F   +L  + + H+   +HRDIK  N+L+D 
Sbjct: 126 ILERPEPVQDLFDFITER-GALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDL 184

Query: 479 -SGVVKLADFGMAKHLTGQKADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGC 537
             G +KL DFG    L          G+  +  PE +              +  +WSLG 
Sbjct: 185 NRGELKLIDFGSGALLKDTVYTDFD-GTRVYSPPEWIR-----YHRYH-GRSAAVWSLGI 237

Query: 538 TIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDSLSPEGKDFLRCCFQRNPADRPPASLL 597
            + +M  G  P+   E      +++R        +S E +  +R C    P+DRP    +
Sbjct: 238 LLYDMVCGDIPFEHDE------EIIRGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEI 291

Query: 598 LEHRFLKNSQQP 609
             H ++++   P
Sbjct: 292 QNHPWMQDVLLP 303

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score =  187 bits (476), Expect = 3e-54
 Identities = 75/285 (26%), Positives = 122/285 (42%), Gaps = 40/285 (14%)

Query: 345 GKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNI 404
              IGRG++G V +A  + T    A K++          E + + +QEI+++  L HPNI
Sbjct: 14  ENTIGRGSWGEVKIAVQKGTRIRRAAKKIP-----KYFVEDVDRFKQEIEIMKSLDHPNI 68

Query: 405 VQYYGSEIVEDKFYIYL--EYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSK 462
           ++ Y  E  ED   IYL  E    G + + V        ES      + +LS +AY H  
Sbjct: 69  IRLY--ETFEDNTDIYLVMELCTGGELFERVVHK-RVFRESDAARIMKDVLSAVAYCHKL 125

Query: 463 KTIHRDIKGANLLV---DASGVVKLADFGMAKHLTGQKADLSMKGSPYWMAPELMMAVMQ 519
              HRD+K  N L         +KL DFG+A      K   +  G+PY+++P+    V++
Sbjct: 126 NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQ----VLE 181

Query: 520 K--GKSSDSALAVDIWSLGCTIIEMYT---GKPP-WSEYEGAAAMF-KVMRDTPAIP--- 569
              G         D WS G  ++ MY    G PP  +  +  + +  K+   T   P   
Sbjct: 182 GLYGP------ECDEWSAG--VM-MYVLLCGYPPFSAPTD--SEVMLKIREGTFTFPEKD 230

Query: 570 -DSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLK-NSQQPDVP 612
             ++SP+ +  +R    ++P  R  +   LEH + +         
Sbjct: 231 WLNVSPQAESLIRRLLTKSPKQRITSLQALEHEWFEKQLSSSPRN 275

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  193 bits (492), Expect = 3e-54
 Identities = 77/294 (26%), Positives = 129/294 (43%), Gaps = 32/294 (10%)

Query: 345 GKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNI 404
            K +G G +G V +  ++ T    A+K   I      S  S  +L +E+ VL  L HPNI
Sbjct: 42  VKKLGSGAYGEVLLCRDKVTHVERAIK---IIRKTSVSTSSNSKLLEEVAVLKLLDHPNI 98

Query: 405 VQYYGSEIVEDKFYIYL--EYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSK 462
           ++ Y  +  EDK   YL  E    G +   +        E       + +LSG+ YLH  
Sbjct: 99  MKLY--DFFEDKRNYYLVMECYKGGELFDEIIHR-MKFNEVDAAVIIKQVLSGVTYLHKH 155

Query: 463 KTIHRDIKGANLLV---DASGVVKLADFGMAKHLTGQKADLSMKGSPYWMAPELMMAVMQ 519
             +HRD+K  NLL+   +   ++K+ DFG++     QK      G+ Y++APE    V++
Sbjct: 156 NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPE----VLR 211

Query: 520 KGKSSDSALAVDIWSLGCTIIEMYTGKPP-WSEYEGAAAMF-KVMR---DTPAIP-DSLS 573
           K          D+WS+G  +  +  G PP   + +    +  KV +      +    ++S
Sbjct: 212 KKYDE----KCDVWSIGVILFILLAGYPPFGGQTD--QEILRKVEKGKYTFDSPEWKNVS 265

Query: 574 PEGKDFLRCCFQRNPADRPPASLLLEHRFLKN-----SQQPDVPSCSLSFSGMQ 622
              KD ++   Q +   R  A   LEH ++K          ++PS + +   M+
Sbjct: 266 EGAKDLIKQMLQFDSQRRISAQQALEHPWIKEMCSKKESGIELPSLANAIENMR 319

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score =  188 bits (479), Expect = 3e-54
 Identities = 80/330 (24%), Positives = 141/330 (42%), Gaps = 38/330 (11%)

Query: 345 GKLIGRGTFGSVYVASNRETGALCAMKEVD---IFPDDPKSAESIKQLEQEIKVLSHLKH 401
            K +G G  G V +A  R+T    A+K +          + A+    +E EI++L  L H
Sbjct: 15  SKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNH 74

Query: 402 PNIVQYYGSEIVEDK-FYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLH 460
           P I++       + + +YI LE +  G +   V  +   + E+  + +   +L  + YLH
Sbjct: 75  PCIIKIK--NFFDAEDYYIVLELMEGGELFDKVVGN-KRLKEATCKLYFYQMLLAVQYLH 131

Query: 461 SKKTIHRDIKGANLLVDASG---VVKLADFGMAKHLTGQKADLSMKGSPYWMAPELMMAV 517
               IHRD+K  N+L+ +     ++K+ DFG +K L       ++ G+P ++APE++++V
Sbjct: 132 ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSV 191

Query: 518 MQKGKSSDSALAVDIWSLGCTIIEMYT---GKPPWSEYEGAAAMF-KVMR---DTPAIP- 569
              G +     AVD WSLG  I  ++    G PP+SE+    ++  ++     +      
Sbjct: 192 GTAGYNR----AVDCWSLGV-I--LFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVW 244

Query: 570 DSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQPDVPSCSLSFSGMQLTEKPHS 629
             +S +  D ++     +P  R      L H +L++          LS            
Sbjct: 245 AEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMKRKFQDLLS------------ 292

Query: 630 PREKADAKYDQVAALSSSRSSRKATLESEN 659
             E       QV A  S+   R    E+E 
Sbjct: 293 -EENESTALPQVLAQPSTSRKRPREGEAEG 321

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  193 bits (492), Expect = 3e-54
 Identities = 66/296 (22%), Positives = 130/296 (43%), Gaps = 36/296 (12%)

Query: 345 GKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNI 404
             ++G+G+FG V    +R T    A+K   +        +    + +E+++L  L HPNI
Sbjct: 27  VCMLGKGSFGEVLKCKDRITQQEYAVK---VINKASAKNKDTSTILREVELLKKLDHPNI 83

Query: 405 VQYYGSEIVEDKFYIYL--EYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSK 462
           ++ +  EI+ED    Y+  E    G +   + +     +E       + + SG+ Y+H  
Sbjct: 84  MKLF--EILEDSSSFYIVGELYTGGELFDEIIKR-KRFSEHDAARIIKQVFSGITYMHKH 140

Query: 463 KTIHRDIKGANLLV---DASGVVKLADFGMAKHLTGQKADLSMKGSPYWMAPELMMAVMQ 519
             +HRD+K  N+L+   +    +K+ DFG++             G+ Y++APE    V++
Sbjct: 141 NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPE----VLR 196

Query: 520 K--GKSSDSALAVDIWSLGCTIIEMYTGKPP-WSEYEGAAAMF-KVMR---DTPAIP-DS 571
               +        D+WS G  +  + +G PP + + E    +  +V             +
Sbjct: 197 GTYDE------KCDVWSAGVILYILLSGTPPFYGKNE--YDILKRVETGKYAFDLPQWRT 248

Query: 572 LSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQ-----PDVPSCSLSFSGMQ 622
           +S + KD +R     +P+ R  A+  LEH +++          D+PS   + + ++
Sbjct: 249 ISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYSSETPTISDLPSLESAMTNIR 304

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score =  188 bits (479), Expect = 3e-54
 Identities = 71/318 (22%), Positives = 133/318 (41%), Gaps = 21/318 (6%)

Query: 341 QWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLK 400
            W   + +G G +G V +A NR T    A+K VD+     ++ +  + +++EI +   L 
Sbjct: 8   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDM----KRAVDCPENIKKEICINKMLN 63

Query: 401 HPNIVQYYGSEIVEDKFYIYL--EYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAY 458
           H N+V++Y      +    YL  EY   G +   +      + E   + F   +++G+ Y
Sbjct: 64  HENVVKFY--GHRREGNIQYLFLEYCSGGELFDRIEPD-IGMPEPDAQRFFHQLMAGVVY 120

Query: 459 LHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMK---GSPYWMAPELMM 515
           LH     HRDIK  NLL+D    +K++DFG+A        +  +    G+  ++APEL+ 
Sbjct: 121 LHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 180

Query: 516 AVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMF--KVMRDTPAIP-DSL 572
                 +   +   VD+WS G  +  M  G+ PW +   +   +     + T   P   +
Sbjct: 181 -----RREFHAE-PVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKI 234

Query: 573 SPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQPDVPSCSLSFSGMQLTEKPHSPRE 632
                  L      NP+ R     + + R+     +       ++  G+  +    S   
Sbjct: 235 DSAPLALLHKILVENPSARITIPDIKKDRWYNKPLKKGAKRPRVTSGGVSESPSGFSKHI 294

Query: 633 KADAKYDQVAALSSSRSS 650
           +++  +  V + S +  S
Sbjct: 295 QSNLDFSPVNSASRTPGS 312

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score =  185 bits (473), Expect = 7e-54
 Identities = 67/274 (24%), Positives = 118/274 (43%), Gaps = 22/274 (8%)

Query: 341 QWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLK 400
            W   + +G G +G V +A NR T    A+K VD+     ++ +  + +++EI +   L 
Sbjct: 8   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDM----KRAVDCPENIKKEICINKMLN 63

Query: 401 HPNIVQYYGSEIVEDKFYIY--LEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAY 458
           H N+V++Y      +    Y  LEY   G +   +      + E   + F   +++G+ Y
Sbjct: 64  HENVVKFY--GHRREGNIQYLFLEYCSGGELFDRIEPD-IGMPEPDAQRFFHQLMAGVVY 120

Query: 459 LHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMK---GSPYWMAPELMM 515
           LH     HRDIK  NLL+D    +K++DFG+A        +  +    G+  ++APEL+ 
Sbjct: 121 LHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 180

Query: 516 AVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMF--KVMRDTPAIP-DSL 572
                 +   +   VD+WS G  +  M  G+ PW +   +   +     + T   P   +
Sbjct: 181 -----RREFHAE-PVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKI 234

Query: 573 SPEGKDFLRCCFQRNPADRPPASLLLEHR-FLKN 605
                  L      NP+ R     + + R + K 
Sbjct: 235 DSAPLALLHKILVENPSARITIPDIKKDRWYNKP 268

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  186 bits (475), Expect = 9e-54
 Identities = 73/266 (27%), Positives = 122/266 (45%), Gaps = 30/266 (11%)

Query: 345 GKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNI 404
           G+++G+G FG     ++RETG +  MKE+  F       E+ +   +E+KV+  L+HPN+
Sbjct: 15  GEVLGKGCFGQAIKVTHRETGEVMVMKELIRF-----DEETQRTFLKEVKVMRCLEHPNV 69

Query: 405 VQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKT 464
           +++ G    + +     EY+  G++   ++        S   +F + I SG+AYLHS   
Sbjct: 70  LKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNI 129

Query: 465 IHRDIKGANLLVDASGVVKLADFGMAKHLTG---------------QKADLSMKGSPYWM 509
           IHRD+   N LV  +  V +ADFG+A+ +                 +K   ++ G+PYWM
Sbjct: 130 IHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWM 189

Query: 510 APELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDT---P 566
           APE++      G+S D    VD++S G  + E+        +Y      F +        
Sbjct: 190 APEMI-----NGRSYDE--KVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDR 242

Query: 567 AIPDSLSPEGKDFLRCCFQRNPADRP 592
             P +  P        C   +P  RP
Sbjct: 243 YCPPNCPPSFFPITVRCCDLDPEKRP 268

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score =  187 bits (477), Expect = 9e-54
 Identities = 87/317 (27%), Positives = 142/317 (44%), Gaps = 66/317 (20%)

Query: 341 QWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDD---PKSAESIKQLEQEIKVLS 397
           +++   L+G G++G V    N++TG + A+K+     DD    K A  ++    EIK+L 
Sbjct: 26  KYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIA--MR----EIKLLK 79

Query: 398 HLKHPNIVQYYGSEIV--EDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSG 455
            L+H N+V     E+   + ++Y+  E+V   +I   +      +   VV+ +   I++G
Sbjct: 80  QLRHENLVNLL--EVCKKKKRWYLVFEFVD-HTILDDLELFPNGLDYQVVQKYLFQIING 136

Query: 456 LAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPY-------W 508
           + + HS   IHRDIK  N+LV  SGVVKL DFG A+        L+  G  Y       W
Sbjct: 137 IGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFAR-------TLAAPGEVYDDEVATRW 189

Query: 509 M-APELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPW---SEYEGAAAMFKVMRD 564
             APEL++  ++ GK      AVD+W++GC + EM+ G+P +   S+ +    +   + +
Sbjct: 190 YRAPELLVGDVKYGK------AVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGN 243

Query: 565 -TPAI-------PD--------------------SLSPEGKDFLRCCFQRNPADRPPASL 596
             P         P                      LS    D  + C   +P  RP  + 
Sbjct: 244 LIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAE 303

Query: 597 LLEHRFLKNSQQPDVPS 613
           LL H F +     +  S
Sbjct: 304 LLHHDFFQMDGFAERFS 320

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  185 bits (471), Expect = 1e-53
 Identities = 45/257 (17%), Positives = 94/257 (36%), Gaps = 24/257 (9%)

Query: 345 GKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNI 404
              +     G ++    +  G    +K   +      S    +   +E   L    HPN+
Sbjct: 15  LTKLNENHSGELWKGRWQ--GNDIVVK---VLKVRDWSTRKSRDFNEECPRLRIFSHPNV 69

Query: 405 VQYYG--SEIVEDKFYIYLEYVHPGSINKYVREHCG-AITESVVRNFTRHILSGLAYLHS 461
           +   G           +   ++  GS+   + E     + +S    F   +  G+A+LH+
Sbjct: 70  LPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHT 129

Query: 462 KKT--IHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPYWMAPELMMAVMQ 519
            +       +   ++++D     +++   +               +P W+APE     +Q
Sbjct: 130 LEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQSP----GRMYAPAWVAPE----ALQ 181

Query: 520 KGKSSDSALAVDIWSLGCTII--EMYTGKPPWSEYEGAAAMFKVMRDT--PAIPDSLSPE 575
           K     +  + D+WS    ++  E+ T + P+++        KV  +   P IP  +SP 
Sbjct: 182 KKPEDTNRRSADMWSFA--VLLWELVTREVPFADLSNMEIGMKVALEGLRPTIPPGISPH 239

Query: 576 GKDFLRCCFQRNPADRP 592
               ++ C   +PA RP
Sbjct: 240 VSKLMKICMNEDPAKRP 256

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  191 bits (487), Expect = 2e-53
 Identities = 71/301 (23%), Positives = 131/301 (43%), Gaps = 36/301 (11%)

Query: 345 GKLIGRGTFGSVYVASNRETGALCAMK--------EVDIFPDDPKSAESIKQLEQEIKVL 396
            + +G G +G V +   +   +  A+K        +     D+    +  +++  EI +L
Sbjct: 41  VRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLL 100

Query: 397 SHLKHPNIVQYYGSEIVEDKFYIYL--EYVHPGSINKYVREHCGAITESVVRNFTRHILS 454
             L HPNI++ +  ++ EDK Y YL  E+   G + + +        E    N  + ILS
Sbjct: 101 KSLDHPNIIKLF--DVFEDKKYFYLVTEFYEGGELFEQIINR-HKFDECDAANIMKQILS 157

Query: 455 GLAYLHSKKTIHRDIKGANLLV---DASGVVKLADFGMAKHLTGQKADLSMKGSPYWMAP 511
           G+ YLH    +HRDIK  N+L+   ++   +K+ DFG++   +         G+ Y++AP
Sbjct: 158 GICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYIAP 217

Query: 512 ELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPP-WSEYEGAAAMF-KVMR---DTP 566
           E    V++K  +       D+WS G  +  +  G PP   + +    +  KV +      
Sbjct: 218 E----VLKKKYNE----KCDVWSCGVIMYILLCGYPPFGGQND--QDIIKKVEKGKYYFD 267

Query: 567 AIP-DSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLK----NSQQPDVPSCSLSFSGM 621
                ++S E K+ ++     +   R  A   L  R++K    N  + D  +   + S M
Sbjct: 268 FNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYANNINKSDQKTLCGALSNM 327

Query: 622 Q 622
           +
Sbjct: 328 R 328

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  184 bits (470), Expect = 2e-53
 Identities = 65/282 (23%), Positives = 124/282 (43%), Gaps = 37/282 (13%)

Query: 345 GKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNI 404
             ++G+G+FG V    +R T    A+K   +        +    + +E+++L  L HPNI
Sbjct: 27  VCMLGKGSFGEVLKCKDRITQQEYAVK---VINKASAKNKDTSTILREVELLKKLDHPNI 83

Query: 405 VQYYGSEIVEDKFYIYL--EYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSK 462
           ++ +  EI+ED    Y+  E    G +   + +     +E       + + SG+ Y+H  
Sbjct: 84  MKLF--EILEDSSSFYIVGELYTGGELFDEIIKR-KRFSEHDAARIIKQVFSGITYMHKH 140

Query: 463 KTIHRDIKGANLLV---DASGVVKLADFGMAKHLTGQKADLSMKGSPYWMAPELMMAVMQ 519
             +HRD+K  N+L+   +    +K+ DFG++             G+ Y++APE    V++
Sbjct: 141 NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPE----VLR 196

Query: 520 K--GKSSDSALAVDIWSLGCTIIEMYT---GKPP-WSEYEGAAAMF-KVMR---DTPAIP 569
               +        D+WS G  +I +Y    G PP + + E    +  +V           
Sbjct: 197 GTYDE------KCDVWSAG--VI-LYILLSGTPPFYGKNE--YDILKRVETGKYAFDLPQ 245

Query: 570 -DSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQPD 610
             ++S + KD +R     +P+ R  A+  LEH +++     +
Sbjct: 246 WRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYSSEE 287

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  184 bits (470), Expect = 5e-53
 Identities = 56/281 (19%), Positives = 118/281 (41%), Gaps = 19/281 (6%)

Query: 345 GKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNI 404
           G+LIG+G FG VY        A      + +   +  + + +K  ++E+      +H N+
Sbjct: 38  GELIGKGRFGQVYHGRWHGEVA------IRLIDIERDNEDQLKAFKREVMAYRQTRHENV 91

Query: 405 VQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKT 464
           V + G+ +      I        ++   VR+    +  +  R   + I+ G+ YLH+K  
Sbjct: 92  VLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGI 151

Query: 465 IHRDIKGANLLVDASGVVKLADFGMAK---HLTGQKADLSMK---GSPYWMAPELMMAVM 518
           +H+D+K  N+  D +G V + DFG+      L   + +  ++   G    +APE++  + 
Sbjct: 152 LHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLS 210

Query: 519 QKGKSSDSAL--AVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDT--PAIPDSLSP 574
              +          D+++LG    E++  + P+      A ++++            +  
Sbjct: 211 PDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKPNLSQIGMGK 270

Query: 575 EGKDFLRCCFQRNPADRPPASLLLEH--RFLKNSQQPDVPS 613
           E  D L  C+     +RP  + L++   +  K +++   P 
Sbjct: 271 EISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNRRLSHPG 311

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score =  184 bits (470), Expect = 6e-53
 Identities = 67/311 (21%), Positives = 122/311 (39%), Gaps = 25/311 (8%)

Query: 314 PPGAAVLSPSATIPQVAAKPEPLPMNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEV 373
            P     +P  T        +     ++++ G L+G+G FG+V+           A+K +
Sbjct: 5   KPLQGPPAPPGTPTPPPGGKDREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVI 64

Query: 374 DIFPDDPKSA-ESIKQLEQEIKVLSHL----KHPNIVQYYGSEIVE--DKFYIYLEYVHP 426
                   S          E+ +L  +     HP +++    +  E  + F + LE   P
Sbjct: 65  PRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLL--DWFETQEGFMLVLERPLP 122

Query: 427 GS-INKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDA-SGVVKL 484
              +  Y+ E  G + E   R F   +++ + + HS+  +HRDIK  N+L+D   G  KL
Sbjct: 123 AQDLFDYITEK-GPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKL 181

Query: 485 ADFGMAKHLTGQKADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT 544
            DFG    L  +       G+  +  PE +            AL   +WSLG  + +M  
Sbjct: 182 IDFGSGALLHDEPYTDFD-GTRVYSPPEWIS-----RHQYH-ALPATVWSLGILLYDMVC 234

Query: 545 GKPPWSEYEGAAAMFKVMRDTPAIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLK 604
           G  P+   +      +++      P  +SP+    +R C    P+ RP    +L   +++
Sbjct: 235 GDIPFERDQ------EILEAELHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQ 288

Query: 605 NSQQPDVPSCS 615
              +    + S
Sbjct: 289 TPAEDVPLNPS 299

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score =  184 bits (468), Expect = 6e-53
 Identities = 74/284 (26%), Positives = 120/284 (42%), Gaps = 25/284 (8%)

Query: 345 GKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIK----QLEQEIKVLSHLK 400
            +++GRG    V    ++ T    A+K +D+      SAE ++       +E+ +L  + 
Sbjct: 22  KEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVS 81

Query: 401 -HPNIVQYYGSEIVEDKFYIYL--EYVHPGSINKYVREHCGAITESVVRNFTRHILSGLA 457
            HPNI+Q    +  E   + +L  + +  G +  Y+ E    ++E   R   R +L  + 
Sbjct: 82  GHPNIIQLK--DTYETNTFFFLVFDLMKKGELFDYLTEK-VTLSEKETRKIMRALLEVIC 138

Query: 458 YLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPYWMAPELMMAV 517
            LH    +HRD+K  N+L+D    +KL DFG +  L   +    + G+P ++APE++   
Sbjct: 139 ALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECS 198

Query: 518 MQKGKSSDSALAVDIWSLGCTIIEMYT---GKPP-WSEYEGAAAMF-KVMRDTPAIP--- 569
           M           VD+WS G  +I MYT   G PP W   +    M   +M          
Sbjct: 199 MNDNHPGYG-KEVDMWSTG--VI-MYTLLAGSPPFWHRKQ--MLMLRMIMSGNYQFGSPE 252

Query: 570 -DSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQPDVP 612
            D  S   KD +       P  R  A   L H F +     +V 
Sbjct: 253 WDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYVVEEVR 296

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  185 bits (472), Expect = 8e-53
 Identities = 79/299 (26%), Positives = 129/299 (43%), Gaps = 38/299 (12%)

Query: 345 GKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNI 404
            ++IG+G F  V    NRETG   A+K VD+         S + L++E  +   LKHP+I
Sbjct: 29  CEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHI 88

Query: 405 VQYYGSEIVEDKFYIYL--EYVHPG----SINKYVREHCGAI-TESVVRNFTRHILSGLA 457
           V+    E       +Y+  E++        I K  R   G + +E+V  ++ R IL  L 
Sbjct: 89  VELL--ETYSSDGMLYMVFEFMDGADLCFEIVK--RADAGFVYSEAVASHYMRQILEALR 144

Query: 458 YLHSKKTIHRDIKGANLLV---DASGVVKLADFGMAKHLTGQKADLSMK-GSPYWMAPEL 513
           Y H    IHRD+K   +L+   + S  VKL  FG+A  L         + G+P++MAPE+
Sbjct: 145 YCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEV 204

Query: 514 MMAVMQKGKSSDSALAVDIWSLGCTIIEMYT---GKPP-WSEYEGAAAMF-KVMR---DT 565
           +     K +       VD+W  G  +I ++    G  P +   E    +F  +++     
Sbjct: 205 V-----KREPYG--KPVDVWGCG--VI-LFILLSGCLPFYGTKER---LFEGIIKGKYKM 251

Query: 566 PAIP-DSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKN-SQQPDVPSCSLSFSGMQ 622
                  +S   KD +R     +PA+R      L H +LK   +         +   ++
Sbjct: 252 NPRQWSHISESAKDLVRRMLMLDPAERITVYEALNHPWLKERDRYAYKIHLPETVEQLR 310

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  183 bits (466), Expect = 9e-53
 Identities = 60/257 (23%), Positives = 108/257 (42%), Gaps = 20/257 (7%)

Query: 345 GKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNI 404
           G+ IG G+FG+VY        A      V +      + + ++  + E+ VL   +H NI
Sbjct: 29  GQRIGSGSFGTVYKGKWHGDVA------VKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNI 82

Query: 405 VQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKT 464
           + + G      +  I  ++    S+  ++           + +  R    G+ YLH+K  
Sbjct: 83  LLFMGY-STAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSI 141

Query: 465 IHRDIKGANLLVDASGVVKLADFGMAK---HLTGQKADLSMKGSPYWMAPELMMAVMQKG 521
           IHRD+K  N+ +     VK+ DFG+A      +G      + GS  WMAPE    V++  
Sbjct: 142 IHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPE----VIRMQ 197

Query: 522 KSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGA-AAMFKV-----MRDTPAIPDSLSPE 575
            S+  +   D+++ G  + E+ TG+ P+S        +  V       D   +  +    
Sbjct: 198 DSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPKR 257

Query: 576 GKDFLRCCFQRNPADRP 592
            K  +  C ++   +RP
Sbjct: 258 MKRLMAECLKKKRDERP 274

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score =  182 bits (464), Expect = 2e-52
 Identities = 77/283 (27%), Positives = 136/283 (48%), Gaps = 38/283 (13%)

Query: 345 GKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNI 404
            + +G+G F  V    ++ TG   A K   I      SA   ++LE+E ++   L+HPNI
Sbjct: 11  KEELGKGAFSVVRRCVHKTTGLEFAAK---IINTKKLSARDFQKLEREARICRKLQHPNI 67

Query: 405 VQYYGSEIVEDKFYIYL--EYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSK 462
           V+ +  + ++++ + YL  + V  G + + +       +E+   +  + IL  +AY HS 
Sbjct: 68  VRLH--DSIQEESFHYLVFDLVTGGELFEDIVAR-EFYSEADASHCIQQILESIAYCHSN 124

Query: 463 KTIHRDIKGANLLV---DASGVVKLADFGMAKHLTGQKADLSMKGSPYWMAPELMMAVMQ 519
             +HR++K  NLL+        VKLADFG+A  +   +A     G+P +++PE    V++
Sbjct: 125 GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPE----VLK 180

Query: 520 K---GKSSDSALAVDIWSLGCTIIEMYT---GKPP-WSEYEGAAAMF-KVMR---DTPAI 568
           K    K       VDIW+ G  +I +Y    G PP W E +    ++ ++     D P+ 
Sbjct: 181 KDPYSK------PVDIWACG--VI-LYILLVGYPPFWDEDQ--HRLYAQIKAGAYDYPSP 229

Query: 569 P-DSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQPD 610
             D+++PE K  +      NP  R  A   L+  ++ N ++  
Sbjct: 230 EWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNRERVA 272

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score =  182 bits (464), Expect = 1e-51
 Identities = 82/342 (23%), Positives = 139/342 (40%), Gaps = 35/342 (10%)

Query: 295 HSKLSRESTVRIEVHPLPLPPGAAVLSPSATIPQVAAKPEPLP-MNSQWQKGKLIGRGTF 353
           HS      T  +    +     +A    ++ +P           ++  ++    +GRG  
Sbjct: 7   HSSGVDLGTENLYFQSMSSVTASAAPGTASLVPDYWIDGSNRDALSDFFEVESELGRGAT 66

Query: 354 GSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIV 413
             VY    + T    A+K +       K+ +  K +  EI VL  L HPNI++    EI 
Sbjct: 67  SIVYRCKQKGTQKPYALKVLK------KTVD-KKIVRTEIGVLLRLSHPNIIKLK--EIF 117

Query: 414 EDKFYIYL--EYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKG 471
           E    I L  E V  G +   + E  G  +E    +  + IL  +AYLH    +HRD+K 
Sbjct: 118 ETPTEISLVLELVTGGELFDRIVEK-GYYSERDAADAVKQILEAVAYLHENGIVHRDLKP 176

Query: 472 ANLLV---DASGVVKLADFGMAKHLTGQKADLSMKGSPYWMAPELMMAVMQKGKSSDSAL 528
            NLL         +K+ADFG++K +  Q    ++ G+P + APE++     +G +     
Sbjct: 177 ENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPEIL-----RGCAYG--P 229

Query: 529 AVDIWSLGCTIIEMYT---GKPP-WSEYEGAAAMFKVMR---DTPAIP-DSLSPEGKDFL 580
            VD+WS+G  II  Y    G  P + E        +++       +   D +S   KD +
Sbjct: 230 EVDMWSVG--II-TYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSLNAKDLV 286

Query: 581 RCCFQRNPADRPPASLLLEHRFLKNSQQPDVPSCSLSFSGMQ 622
           R     +P  R      L+H ++   +  +      +   +Q
Sbjct: 287 RKLIVLDPKKRLTTFQALQHPWVTG-KAANFVHMDTAQKKLQ 327

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score =  182 bits (464), Expect = 1e-51
 Identities = 78/359 (21%), Positives = 143/359 (39%), Gaps = 28/359 (7%)

Query: 265 FSAESSPFHSPRSRSPCRNAISPSGPSSPIHSKLSRESTVRIEVHPL----PLPPGAAVL 320
           F+ E           P  N          +    S+ + +  E   L    P        
Sbjct: 15  FNKERRRARREIRHLPNLNREQRRAFIRSLRDDPSQSANLLAEAKKLNDAQPKGTENLYF 74

Query: 321 SPSATIPQVAAKPEPLPMNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVD---IFP 377
                  ++           ++    +IGRG    V    +R TG   A+K ++      
Sbjct: 75  QSMGPEDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERL 134

Query: 378 DDPKSAESIKQLEQEIKVLSHLK-HPNIVQYYGSEIVEDKFYIYL--EYVHPGSINKYVR 434
              +  E  +   +E  +L  +  HP+I+     +  E   +++L  + +  G +  Y+ 
Sbjct: 135 SPEQLEEVREATRRETHILRQVAGHPHIITLI--DSYESSSFMFLVFDLMRKGELFDYLT 192

Query: 435 EHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLT 494
           E   A++E   R+  R +L  +++LH+   +HRD+K  N+L+D +  ++L+DFG + HL 
Sbjct: 193 EK-VALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLE 251

Query: 495 GQKADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT---GKPP-WS 550
             +    + G+P ++APE++   M +         VD+W+ G  +I ++T   G PP W 
Sbjct: 252 PGEKLRELCGTPGYLAPEILKCSMDETHPGYG-KEVDLWACG--VI-LFTLLAGSPPFWH 307

Query: 551 EYEGAAAMF-KVMRDTPAIP----DSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLK 604
             +    M   +M           D  S   KD +    Q +P  R  A   L+H F +
Sbjct: 308 RRQ--ILMLRMIMEGQYQFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFE 364

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score =  185 bits (471), Expect = 1e-51
 Identities = 75/297 (25%), Positives = 136/297 (45%), Gaps = 40/297 (13%)

Query: 345 GKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNI 404
            + +G+G F  V        G   A     I      SA   ++LE+E ++   LKHPNI
Sbjct: 16  FEELGKGAFSVVRRCVKVLAGQEYAAM---IINTKKLSARDHQKLEREARICRLLKHPNI 72

Query: 405 VQYYGSEIVEDKFYIYL--EYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSK 462
           V+ +  + + ++ + YL  + V  G + + +       +E+   +  + IL  + + H  
Sbjct: 73  VRLH--DSISEEGHHYLIFDLVTGGELFEDIVAR-EYYSEADASHCIQQILEAVLHCHQM 129

Query: 463 KTIHRDIKGANLLV---DASGVVKLADFGMAKHLTGQKADLS-MKGSPYWMAPELMMAVM 518
             +HR++K  NLL+        VKLADFG+A  + G++       G+P +++PE    V+
Sbjct: 130 GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPE----VL 185

Query: 519 QK---GKSSDSALAVDIWSLGCTIIEMYT---GKPP-WSEYEGAAAMF-KVMR---DTPA 567
           +K   GK       VD+W+ G  +I +Y    G PP W E +    ++ ++     D P+
Sbjct: 186 RKDPYGK------PVDLWACG--VI-LYILLVGYPPFWDEDQ--HRLYQQIKAGAYDFPS 234

Query: 568 IP-DSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLK-NSQQPDVPSCSLSFSGMQ 622
              D+++PE KD +      NP+ R  A+  L+H ++   S          +   ++
Sbjct: 235 PEWDTVTPEAKDLINKMLTINPSKRITAAEALKHPWISHRSTVASCMHRQETVDCLK 291

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  181 bits (460), Expect = 2e-51
 Identities = 58/339 (17%), Positives = 113/339 (33%), Gaps = 86/339 (25%)

Query: 340 SQWQKGKLIGRGTFGSVYVASNRETGALCAMK----------------EVDI-------- 375
           + ++  + +GRG FG V+ A N+      A+K                EV          
Sbjct: 6   TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 65

Query: 376 -----------------------------FPDDPKSAESIKQLEQEIKVLSHLKHPNIVQ 406
                                              S   +     +I+ +      N V 
Sbjct: 66  IVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVG 125

Query: 407 YYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAIT--ESVVRNFTRHILSGLAYLHSKKT 464
                  +   YI ++     ++  ++   C        V  +    I   + +LHSK  
Sbjct: 126 QLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGL 185

Query: 465 IHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMK-------------GSPYWMAP 511
           +HRD+K +N+      VVK+ DFG+   +   + + ++              G+  +M+P
Sbjct: 186 MHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSP 245

Query: 512 ELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRD-----TP 566
           E +      G +      VDI+SLG  + E+        E        +++ D      P
Sbjct: 246 EQI-----HGNNYSH--KVDIFSLGLILFELLYSFSTQME------RVRIITDVRNLKFP 292

Query: 567 AIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKN 605
            +     P+    ++     +P +RP A+ ++E+   +N
Sbjct: 293 LLFTQKYPQEHMMVQDMLSPSPTERPEATDIIENAIFEN 331

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score =  180 bits (459), Expect = 3e-51
 Identities = 71/292 (24%), Positives = 129/292 (44%), Gaps = 29/292 (9%)

Query: 345 GKLIGRGTFGSVYVASNRETGALCAMKEVDI-FPDDPKSAESIKQLEQEIKVLSHLKHPN 403
           G+ +G G F  V     + TG   A K +        +   S + +E+E+ +L  ++HPN
Sbjct: 16  GEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPN 75

Query: 404 IVQYYGSEIVEDKFYIYL--EYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHS 461
           ++  +  E+ E+K  + L  E V  G +  ++ E   ++TE     F + IL+G+ YLHS
Sbjct: 76  VITLH--EVYENKTDVILILELVAGGELFDFLAEK-ESLTEEEATEFLKQILNGVYYLHS 132

Query: 462 KKTIHRDIKGANLLV----DASGVVKLADFGMAKHLTGQKADLSMKGSPYWMAPELMMAV 517
            +  H D+K  N+++         +K+ DFG+A  +       ++ G+P ++APE++   
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIV--- 189

Query: 518 MQKGKSSDSALAVDIWSLGCTIIEMY---TGKPP-WSEYEGAAAMFKVMR---DTPAIP- 569
               +     L  D+WS+G  +I  Y   +G  P   + +    +  V     +      
Sbjct: 190 --NYEPLG--LEADMWSIG--VI-TYILLSGASPFLGDTK-QETLANVSAVNYEFEDEYF 241

Query: 570 DSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQPDVPSCSLSFSGM 621
            + S   KDF+R    ++P  R      L+H ++K        S   S   M
Sbjct: 242 SNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQALSRKASAVNM 293

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  181 bits (461), Expect = 3e-51
 Identities = 41/308 (13%), Positives = 77/308 (25%), Gaps = 49/308 (15%)

Query: 341 QWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLK 400
           + +  + +  G    V++  + E     A+K          S   +++L +     + L 
Sbjct: 63  KLKLVEPLRVGDRSVVFLVRDVERLEDFALKV--FTMGAENSRSELERLHEATFAAARLL 120

Query: 401 HPNIVQYYGSEIVEDKFYIYLEYVHP-------------------------------GSI 429
             +  +      +            P                                S 
Sbjct: 121 GESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFST 180

Query: 430 NKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGM 489
             +V    G      +   T  ++   A L SK  +H      NL +   G + L D   
Sbjct: 181 LDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGRLMLGDVSA 240

Query: 490 AKHLTGQKADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPW 549
              +            P   AP           ++    A++ W LG +I  ++    P+
Sbjct: 241 LWKVG---TRGPASSVPVTYAPR----EFLNASTATFTHALNAWQLGLSIYRVWCLFLPF 293

Query: 550 SEY-EGAAAMFKVMRDTPAIPDSL--------SPEGKDFLRCCFQRNPADRPPASLLLEH 600
                G    +K         DSL            K  +      +   R      +E 
Sbjct: 294 GLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMET 353

Query: 601 RFLKNSQQ 608
                 Q 
Sbjct: 354 PEFLQLQN 361

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score =  181 bits (461), Expect = 3e-51
 Identities = 83/349 (23%), Positives = 153/349 (43%), Gaps = 43/349 (12%)

Query: 345 GKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNI 404
            + +G+G F  V    ++ TG   A K   I      SA   ++LE+E ++   L+HPNI
Sbjct: 34  KEELGKGAFSVVRRCVHKTTGLEFAAK---IINTKKLSARDFQKLEREARICRKLQHPNI 90

Query: 405 VQYYGSEIVEDKFYIYL--EYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSK 462
           V+ +  + ++++ + YL  + V  G + + +       +E+   +  + IL  +AY HS 
Sbjct: 91  VRLH--DSIQEESFHYLVFDLVTGGELFEDIVAR-EFYSEADASHCIQQILESIAYCHSN 147

Query: 463 KTIHRDIKGANLLV---DASGVVKLADFGMAKHLTGQKADLSMKGSPYWMAPELMMAVMQ 519
             +HR++K  NLL+        VKLADFG+A  +   +A     G+P +++PE    V++
Sbjct: 148 GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPE----VLK 203

Query: 520 K---GKSSDSALAVDIWSLGCTIIEMYT---GKPP-WSEYEGAAAMF-KVMR---DTPAI 568
           K    K       VDIW+ G  +I +Y    G PP W E +    ++ ++     D P+ 
Sbjct: 204 KDPYSK------PVDIWACG--VI-LYILLVGYPPFWDEDQ--HRLYAQIKAGAYDYPSP 252

Query: 569 P-DSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKN-SQQPDVPSCSLSFSGMQLTEK 626
             D+++PE K  +      NP  R  A   L+  ++ N  +         +   +    K
Sbjct: 253 EWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNRERVASAIHRQDTVDCL----K 308

Query: 627 PHSPREKADAKYDQVAALSSSRSSRKATLESENGRRSHLETSDLTVAST 675
             + R K           + + S+    L ++  +       + + +S 
Sbjct: 309 KFNARRKLKGAILTTMIATRNLSNLGRNLLNKKEQGPPSTIKESSESSQ 357

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score =  178 bits (453), Expect = 4e-51
 Identities = 76/268 (28%), Positives = 129/268 (48%), Gaps = 17/268 (6%)

Query: 341 QWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLK 400
            +  G  +G GTFG V +  ++ TG   A+K ++      +S + + ++++EI+ L   +
Sbjct: 12  HYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILN--RQKIRSLDVVGKIKREIQNLKLFR 69

Query: 401 HPNIVQYYGSEIVEDKFYIYL--EYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAY 458
           HP+I++ Y  +++      ++  EYV  G +  Y+ +H G + E   R   + ILS + Y
Sbjct: 70  HPHIIKLY--QVISTPTDFFMVMEYVSGGELFDYICKH-GRVEEMEARRLFQQILSAVDY 126

Query: 459 LHSKKTIHRDIKGANLLVDASGVVKLADFGM-AKHLTGQKADLSMKGSPYWMAPELMMAV 517
            H    +HRD+K  N+L+DA    K+ADFG+      G+    S  GSP + APE++   
Sbjct: 127 CHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC-GSPNYAAPEVI--- 182

Query: 518 MQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMF-KVMRDTPAIPDSLSPEG 576
              G+       VDIWS G  +  +  G  P+ + E    +F K+      IP+ L+   
Sbjct: 183 --SGRLYAGP-EVDIWSCGVILYALLCGTLPFDD-EHVPTLFKKIRGGVFYIPEYLNRSV 238

Query: 577 KDFLRCCFQRNPADRPPASLLLEHRFLK 604
              L    Q +P  R     + EH + K
Sbjct: 239 ATLLMHMLQVDPLKRATIKDIREHEWFK 266

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score =  179 bits (457), Expect = 5e-51
 Identities = 66/329 (20%), Positives = 122/329 (37%), Gaps = 41/329 (12%)

Query: 345 GKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNI 404
            + +GRG FG V+      +      K V               +++EI +L+  +H NI
Sbjct: 10  AEDLGRGEFGIVHRCVETSSKKTYMAKFV------KVKGTDQVLVKKEISILNIARHRNI 63

Query: 405 VQYYGSEIVEDKFYIYL--EYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSK 462
           +  +  E  E    + +  E++    I + +      + E  + ++   +   L +LHS 
Sbjct: 64  LHLH--ESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSH 121

Query: 463 KTIHRDIKGANLLV--DASGVVKLADFGMAKHLTGQKADLSMKGSPYWMAPELMMAVMQK 520
              H DI+  N++     S  +K+ +FG A+ L        +  +P + APE+       
Sbjct: 122 NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEV---HQHD 178

Query: 521 GKSSDSALAVDIWSLGCTIIEMY---TGKPP-WSEYEGAAAMF-KVMR-----DTPAIPD 570
             S     A D+WSLG   + +Y   +G  P  +E      +   +M      D  A  +
Sbjct: 179 VVS----TATDMWSLG--TL-VYVLLSGINPFLAETN--QQIIENIMNAEYTFDEEAFKE 229

Query: 571 SLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQP---DVPSCSLSFSGMQLTEKP 627
            +S E  DF+     +    R  AS  L+H +LK   +     V              K 
Sbjct: 230 -ISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQKIERVSTKVIRTLKHRRYYHTLIKK 288

Query: 628 HSPREKADAKYDQVAALSSSRSSRKATLE 656
                       +++   + RS +  ++ 
Sbjct: 289 DL---NMVVSAARISCGGAIRSQKGVSVA 314

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score =  178 bits (455), Expect = 6e-51
 Identities = 79/295 (26%), Positives = 125/295 (42%), Gaps = 49/295 (16%)

Query: 339 NSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSH 398
              +   +++G G F  V++   R TG L A+K +         A     LE EI VL  
Sbjct: 8   RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKK-----SPAFRDSSLENEIAVLKK 62

Query: 399 LKHPNIVQYYGSEIVEDKFYIYL--EYVHPG----SINKYVREHCGAITESVVRNFTRHI 452
           +KH NIV     +I E   + YL  + V  G     I +      G  TE       + +
Sbjct: 63  IKHENIVTLE--DIYESTTHYYLVMQLVSGGELFDRILER-----GVYTEKDASLVIQQV 115

Query: 453 LSGLAYLHSKKTIHRDIKGANLLV---DASGVVKLADFGMAKHLTGQKADLSMK---GSP 506
           LS + YLH    +HRD+K  NLL    + +  + + DFG++K          M    G+P
Sbjct: 116 LSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGI----MSTACGTP 171

Query: 507 YWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT---GKPP-WSEYEGAAAMF-KV 561
            ++APE++       K      AVD WS+G  +I  Y    G PP + E E  + +F K+
Sbjct: 172 GYVAPEVL-----AQKPYS--KAVDCWSIG--VI-TYILLCGYPPFYEETE--SKLFEKI 219

Query: 562 MR---DTPAIP-DSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQPDVP 612
                +  +   D +S   KDF+    +++P +R      L H ++  +      
Sbjct: 220 KEGYYEFESPFWDDISESAKDFICHLLEKDPNERYTCEKALSHPWIDGNTALHRD 274

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score =  178 bits (453), Expect = 3e-50
 Identities = 78/268 (29%), Positives = 130/268 (48%), Gaps = 18/268 (6%)

Query: 341 QWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLK 400
            +   + +G G+FG V +A++ +T    A+K +       K ++   ++E+EI  L  L+
Sbjct: 10  PYIIRETLGEGSFGKVKLATHYKTQQKVALKFIS--RQLLKKSDMHMRVEREISYLKLLR 67

Query: 401 HPNIVQYYGSEIVEDKFYIYL--EYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAY 458
           HP+I++ Y  +++     I +  EY   G +  Y+ E    +TE   R F + I+  + Y
Sbjct: 68  HPHIIKLY--DVITTPTDIVMVIEYAG-GELFDYIVEK-KRMTEDEGRRFFQQIICAIEY 123

Query: 459 LHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLT-GQKADLSMKGSPYWMAPELMMAV 517
            H  K +HRD+K  NLL+D +  VK+ADFG++  +T G     S  GSP + APE++   
Sbjct: 124 CHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSC-GSPNYAAPEVI--- 179

Query: 518 MQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMF-KVMRDTPAIPDSLSPEG 576
              GK       VD+WS G  +  M  G+ P+ + E    +F KV      +PD LSP  
Sbjct: 180 --NGKLYAGP-EVDVWSCGIVLYVMLVGRLPFDD-EFIPNLFKKVNSCVYVMPDFLSPGA 235

Query: 577 KDFLRCCFQRNPADRPPASLLLEHRFLK 604
           +  +R     +P  R     +    +  
Sbjct: 236 QSLIRRMIVADPMQRITIQEIRRDPWFN 263

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score =  177 bits (450), Expect = 4e-50
 Identities = 68/317 (21%), Positives = 131/317 (41%), Gaps = 32/317 (10%)

Query: 345 GKLIGRGTFGSVYVASNRETGALCAMKEVDIFP-DDPKSAESIKQLEQEIKVLSHLKHPN 403
           G+ +G G F  V     + TG   A K +        +   S +++E+E+ +L  + H N
Sbjct: 17  GEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHN 76

Query: 404 IVQYYGSEIVEDKFYIYL--EYVHPGSI-NKYVREHCGAITESVVRNFTRHILSGLAYLH 460
           ++  +  ++ E++  + L  E V  G + +   ++   +++E    +F + IL G+ YLH
Sbjct: 77  VITLH--DVYENRTDVVLILELVSGGELFDFLAQK--ESLSEEEATSFIKQILDGVNYLH 132

Query: 461 SKKTIHRDIKGANLLV----DASGVVKLADFGMAKHLTGQKADLSMKGSPYWMAPELMMA 516
           +KK  H D+K  N+++         +KL DFG+A  +       ++ G+P ++APE+   
Sbjct: 133 TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEI--- 189

Query: 517 VMQKGKSSDSALAVDIWSLGCTIIEMY---TGKPP-WSEYEGAAAMFKVMR---DTPAIP 569
           V  +       L  D+WS+G  +I  Y   +G  P   + +    +  +     D     
Sbjct: 190 VNYEPLG----LEADMWSIG--VI-TYILLSGASPFLGDTK-QETLANITSVSYDFDEEF 241

Query: 570 -DSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQPDVPSCSLSFSGMQLTEKPH 628
               S   KDF+R    +    R      L H ++             S   ++   K  
Sbjct: 242 FSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDNQQAMVRRESVVNLENFRK-Q 300

Query: 629 SPREKADAKYDQVAALS 645
             R +    +  V+  +
Sbjct: 301 YVRRRWKLSFSIVSLCN 317

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score =  178 bits (454), Expect = 4e-50
 Identities = 81/375 (21%), Positives = 150/375 (40%), Gaps = 41/375 (10%)

Query: 266 SAESSPFHSPRSRSPCRNAISPSGPSSPIHSKLSRESTVRIEVHPLPLPPGAAVLSPSAT 325
           S ++S     RS       +  +   +      S+ ++      P P  P    +     
Sbjct: 23  SMKNSGDQDSRSGHNEAKEVWSNADLTERMPVKSKRTSALAVDIPAPPAPFDHRI----- 77

Query: 326 IPQVAAKPEPLPMNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAES 385
              V AK   +       K +++G G FG V+      TG   A K +       +  + 
Sbjct: 78  ---VTAKQGAVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKT-----RGMKD 129

Query: 386 IKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYIYL--EYVHPGSINKYVREHCGAITES 443
            ++++ EI V++ L H N++Q Y  +  E K  I L  EYV  G +   + +    +TE 
Sbjct: 130 KEEVKNEISVMNQLDHANLIQLY--DAFESKNDIVLVMEYVDGGELFDRIIDESYNLTEL 187

Query: 444 VVRNFTRHILSGLAYLHSKKTIHRDIKGANLLV--DASGVVKLADFGMAKHLTGQKADLS 501
               F + I  G+ ++H    +H D+K  N+L     +  +K+ DFG+A+    ++    
Sbjct: 188 DTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKV 247

Query: 502 MKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMY---TGKPP-WSEYEGAAA 557
             G+P ++APE+   V     S       D+WS+G  +I  Y   +G  P   + + A  
Sbjct: 248 NFGTPEFLAPEV---VNYDFVS----FPTDMWSVG--VI-AYMLLSGLSPFLGDND-AET 296

Query: 558 MFKVMR-----DTPAIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKN-SQQPDV 611
           +  ++      +     D +S E K+F+     +  + R  AS  L+H +L +      +
Sbjct: 297 LNNILACRWDLEDEEFQD-ISEEAKEFISKLLIKEKSWRISASEALKHPWLSDHKLHSRL 355

Query: 612 PSCSLSFSGMQLTEK 626
            +      G    + 
Sbjct: 356 SAQKKKNRGSDAQDF 370

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score =  178 bits (454), Expect = 6e-50
 Identities = 67/258 (25%), Positives = 117/258 (45%), Gaps = 28/258 (10%)

Query: 346 KLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQ------EIKVLSHL 399
           + IG+G+FG V +    +T  + AMK ++      K  +   +  +      E++++  L
Sbjct: 21  RAIGKGSFGKVCIVQKNDTKKMYAMKYMN------K--QKCVERNEVRNVFKELQIMQGL 72

Query: 400 KHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREH---CGAITESVVRNFTRHILSGL 456
           +HP +V  + S   E+  ++ ++ +  G +    R H        E  V+ F   ++  L
Sbjct: 73  EHPFLVNLWYSFQDEEDMFMVVDLLLGGDL----RYHLQQNVHFKEETVKLFICELVMAL 128

Query: 457 AYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPYWMAPELMMA 516
            YL +++ IHRD+K  N+L+D  G V + DF +A  L  +    +M G+  +MAPE+  +
Sbjct: 129 DYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTMAGTKPYMAPEMFSS 188

Query: 517 VMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPW--SEYEGAAAMF-KVMRDTPAIPDSLS 573
               G S     AVD WSLG T  E+  G+ P+       +  +           P + S
Sbjct: 189 RKGAGYSF----AVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYPSAWS 244

Query: 574 PEGKDFLRCCFQRNPADR 591
            E    L+   + NP  R
Sbjct: 245 QEMVSLLKKLLEPNPDQR 262

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score =  176 bits (449), Expect = 7e-50
 Identities = 76/310 (24%), Positives = 128/310 (41%), Gaps = 33/310 (10%)

Query: 344 KGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKH-P 402
             K +GRG F  V    ++ TG   A K         +  +   ++  EI VL   K  P
Sbjct: 33  TSKELGRGKFAVVRQCISKSTGQEYAAK---FLKKRRRGQDCRAEILHEIAVLELAKSCP 89

Query: 403 NIVQYYGSEIVEDKFYIYL--EYVHPGSI-NKYVREHCGAITESVVRNFTRHILSGLAYL 459
            ++  +  E+ E+   I L  EY   G I +  + E    ++E+ V    + IL G+ YL
Sbjct: 90  RVINLH--EVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYL 147

Query: 460 HSKKTIHRDIKGANLLV---DASGVVKLADFGMAKHLTGQKADLSMKGSPYWMAPELMMA 516
           H    +H D+K  N+L+      G +K+ DFGM++ +        + G+P ++APE++  
Sbjct: 148 HQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAPEIL-- 205

Query: 517 VMQKGKSSDSALAVDIWSLGCTIIEMY---TGKPP-WSEYEGAAAMF-KVMR---DTPAI 568
                       A D+W++G  II  Y   T   P   E       +  + +   D    
Sbjct: 206 ---NYDPIT--TATDMWNIG--II-AYMLLTHTSPFVGEDN--QETYLNISQVNVDYSEE 255

Query: 569 P-DSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQPDVPSCSLSFSGMQLTEKP 627
              S+S    DF++    +NP  RP A + L H +L+     ++     + S  Q  +  
Sbjct: 256 TFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDFENLFHPEETSSSSQTQDHS 315

Query: 628 HSPREKADAK 637
               E   +K
Sbjct: 316 VRSSEDKTSK 325

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score =  175 bits (445), Expect = 8e-50
 Identities = 73/286 (25%), Positives = 131/286 (45%), Gaps = 33/286 (11%)

Query: 345 GKLIGRGTFGSVYVASNRETGALCAMKEVDIFP-DDPKSAESIKQLEQEIKVLSHLKHPN 403
           G+ +G G F  V     + TG   A K +        +   S +++E+E+ +L  ++HPN
Sbjct: 10  GEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPN 69

Query: 404 IVQYYGSEIVEDKFYIYL--EYVHPGSI-NKYVREHCGAITESVVRNFTRHILSGLAYLH 460
           I+  +  +I E+K  + L  E V  G + +    +   ++TE     F + IL G+ YLH
Sbjct: 70  IITLH--DIFENKTDVVLILELVSGGELFDFLAEK--ESLTEDEATQFLKQILDGVHYLH 125

Query: 461 SKKTIHRDIKGANLLV----DASGVVKLADFGMAKHLTGQKADLSMKGSPYWMAPELMMA 516
           SK+  H D+K  N+++      +  +KL DFG+A  +       ++ G+P ++APE++  
Sbjct: 126 SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIV-- 183

Query: 517 VMQKGKSSDSALAVDIWSLGCTIIEMY---TGKPP-WSEYEGAAAMF-KVMR---DTPAI 568
                +     L  D+WS+G  +I  Y   +G  P   E +        +     D    
Sbjct: 184 ---NYEPLG--LEADMWSIG--VI-TYILLSGASPFLGETK--QETLTNISAVNYDFDEE 233

Query: 569 P-DSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQPDVPS 613
              + S   KDF+R    ++P  R   +  LEH ++K  ++ +V  
Sbjct: 234 YFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRRRNVRG 279

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  177 bits (452), Expect = 1e-49
 Identities = 73/340 (21%), Positives = 140/340 (41%), Gaps = 35/340 (10%)

Query: 345 GKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNI 404
            + +G G FG V+    + TG +   K ++              ++ EI +++ L HP +
Sbjct: 56  LEELGSGAFGVVHRCVEKATGRVFVAKFINT-----PYPLDKYTVKNEISIMNQLHHPKL 110

Query: 405 VQYYGSEIVEDKFYIYL--EYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSK 462
           +  +  +  EDK+ + L  E++  G +   +      ++E+ V N+ R    GL ++H  
Sbjct: 111 INLH--DAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEH 168

Query: 463 KTIHRDIKGANLLV--DASGVVKLADFGMAKHLTGQKADLSMKGSPYWMAPELMMAVMQK 520
             +H DIK  N++     +  VK+ DFG+A  L   +       +  + APE++      
Sbjct: 169 SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIV-----D 223

Query: 521 GKSSDSALAVDIWSLGCTIIEMY---TGKPP-WSEYEGAAAMFKVMR-----DTPAIPDS 571
            +        D+W++G  ++  Y   +G  P   E +    +  V R     D  A    
Sbjct: 224 REPVG--FYTDMWAIG--VL-GYVLLSGLSPFAGEDD-LETLQNVKRCDWEFDEDAFSS- 276

Query: 572 LSPEGKDFLRCCFQRNPADRPPASLLLEHRFLK-NSQQPDVPSCSLSFSGMQLTEKPHSP 630
           +SPE KDF++   Q+ P  R      LEH +LK +         S  ++  ++ +K    
Sbjct: 277 VSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSNLTSRIPSSRYN--KIRQKIKEK 334

Query: 631 REKADAKYDQVAALSSSRSSRKATLESENGRRSHLETSDL 670
                A    +  +++  S RK   +      S+ +  + 
Sbjct: 335 YADWPAPQPAIGRIANFSSLRKHRPQEYQIYDSYFDRKEA 374

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score =  176 bits (449), Expect = 1e-49
 Identities = 75/344 (21%), Positives = 142/344 (41%), Gaps = 33/344 (9%)

Query: 345 GKLIGRGTFGSVYVASNRETGALCAMKEVDIFP-DDPKSAESIKQLEQEIKVLSHLKHPN 403
           G+ +G G F  V     + TG   A K +        +     +++E+E+ +L  + HPN
Sbjct: 17  GEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPN 76

Query: 404 IVQYYGSEIVEDKFYIYL--EYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHS 461
           I+  +  ++ E++  + L  E V  G +  ++ +   +++E    +F + IL G+ YLH+
Sbjct: 77  IITLH--DVYENRTDVVLILELVSGGELFDFLAQK-ESLSEEEATSFIKQILDGVNYLHT 133

Query: 462 KKTIHRDIKGANLLV----DASGVVKLADFGMAKHLTGQKADLSMKGSPYWMAPELMMAV 517
           KK  H D+K  N+++         +KL DFG+A  +       ++ G+P ++APE+   V
Sbjct: 134 KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEI---V 190

Query: 518 MQKGKSSDSALAVDIWSLGCTIIEMY---TGKPP-WSEYEGAAAMFKVMR---DTPAIP- 569
             +       L  D+WS+G  +I  Y   +G  P   + +    +  +     D      
Sbjct: 191 NYEPLG----LEADMWSIG--VI-TYILLSGASPFLGDTK-QETLANITAVSYDFDEEFF 242

Query: 570 DSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQPDVPSCSLSFSGMQLTEKPHS 629
              S   KDF+R    +    R      L H ++             S   ++  +K   
Sbjct: 243 SQTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDTQQAMVRRESVVNLENFKK-QY 301

Query: 630 PREKADAKYDQVAA---LSSSRSSRKATLESENGRRSHLETSDL 670
            R +    +  V+    L+ S   +     SE+ R    +T + 
Sbjct: 302 VRRRWKLSFSIVSLCNHLTRSLMKKVHLRTSEDLRNCESDTEEN 345

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score =  174 bits (444), Expect = 2e-49
 Identities = 71/285 (24%), Positives = 126/285 (44%), Gaps = 27/285 (9%)

Query: 341 QWQKGKLIGRGTFGSVYVASNRETGALCAMKEVD---IFPDDPKSAESIKQLEQEIKVLS 397
           ++  G L+G G++G V    + ET    A+K +    +     +       +++EI++L 
Sbjct: 6   KYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLR----RIPNGEANVKKEIQLLR 61

Query: 398 HLKHPNIVQYYGSEIV----EDKFYIYLEYVHPGSIN--KYVREHCGAITESVVRNFTRH 451
            L+H N++Q    +++    + K Y+ +EY   G       V E            +   
Sbjct: 62  RLRHKNVIQLV--DVLYNEEKQKMYMVMEYCVCGMQEMLDSVPE--KRFPVCQAHGYFCQ 117

Query: 452 ILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMK---GSPYW 508
           ++ GL YLHS+  +H+DIK  NLL+   G +K++  G+A+ L    AD + +   GSP +
Sbjct: 118 LIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAF 177

Query: 509 MAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMF-KVMRDTPA 567
             PE    +     +      VDIWS G T+  + TG  P+   +    +F  + + + A
Sbjct: 178 QPPE----IANGLDTFSGF-KVDIWSAGVTLYNITTGLYPFEG-DNIYKLFENIGKGSYA 231

Query: 568 IPDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQPDVP 612
           IP    P   D L+   +  PA R     + +H + +    P   
Sbjct: 232 IPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHPPAEA 276

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score =  174 bits (443), Expect = 2e-49
 Identities = 82/316 (25%), Positives = 142/316 (44%), Gaps = 73/316 (23%)

Query: 341 QWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDD---PKSAESIKQLEQEIKVLS 397
           +++K + IG GT+G+V+ A NRET  + A+K V +  DD   P SA  ++    EI +L 
Sbjct: 3   KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSA--LR----EICLLK 56

Query: 398 HLKHPNIVQYYGSEIV--EDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSG 455
            LKH NIV+ +  +++  + K  +  E+     + KY     G +   +V++F   +L G
Sbjct: 57  ELKHKNIVRLH--DVLHSDKKLTLVFEFCD-QDLKKYFDSCNGDLDPEIVKSFLFQLLKG 113

Query: 456 LAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPY-------- 507
           L + HS+  +HRD+K  NLL++ +G +KLA+FG+A+            G P         
Sbjct: 114 LGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLAR----------AFGIPVRCYSAEVV 163

Query: 508 --WM-APELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPW----SEYEGAAAMFK 560
             W   P+++        +   + ++D+WS GC   E+     P        +    +F+
Sbjct: 164 TLWYRPPDVLFG------AKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFR 217

Query: 561 VMRDTP---------AIPD------------------SLSPEGKDFLRCCFQRNPADRPP 593
           ++  TP          +PD                   L+  G+D L+   + NP  R  
Sbjct: 218 LLG-TPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRIS 276

Query: 594 ASLLLEHRFLKNSQQP 609
           A   L+H +  +   P
Sbjct: 277 AEEALQHPYFSDFCPP 292

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score =  174 bits (444), Expect = 2e-49
 Identities = 80/304 (26%), Positives = 138/304 (45%), Gaps = 40/304 (13%)

Query: 321 SPSATIPQVAAKPEPLPMNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDP 380
           + S    Q   +P        ++ GK++G G+F +V +A    T    A+K ++      
Sbjct: 12  AGSLQHAQPPPQPRKKRPED-FKFGKILGEGSFSTVVLARELATSREYAIKILEK----- 65

Query: 381 KSAESIKQLEQ------EIKVLSHLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVR 434
                I +  +      E  V+S L HP  V+ Y +   ++K Y  L Y   G + KY+R
Sbjct: 66  ---RHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR 122

Query: 435 EHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLT 494
              G+  E+  R +T  I+S L YLH K  IHRD+K  N+L++    +++ DFG AK L+
Sbjct: 123 -KIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLS 181

Query: 495 GQKADL---SMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPW-- 549
            +       S  G+  +++PEL   + +K        + D+W+LGC I ++  G PP+  
Sbjct: 182 PESKQARANSFVGTAQYVSPEL---LTEKSACK----SSDLWALGCIIYQLVAGLPPFRA 234

Query: 550 -SEYEGAAAMF-KVMRDTPAIPDSLSPEGKDFLRCCFQRNPADRPPASL------LLEHR 601
            +EY     +F K+++     P+   P+ +D +      +   R           L  H 
Sbjct: 235 GNEYL----IFQKIIKLEYDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHP 290

Query: 602 FLKN 605
           F ++
Sbjct: 291 FFES 294

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score =  175 bits (445), Expect = 2e-49
 Identities = 82/340 (24%), Positives = 145/340 (42%), Gaps = 70/340 (20%)

Query: 341 QWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDD--PKSAESIKQLEQEIKVLSH 398
            + K   +G GT+ +VY   ++ T  L A+KE+ +  ++  P +A  I+    E+ +L  
Sbjct: 3   TYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTA--IR----EVSLLKD 56

Query: 399 LKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAY 458
           LKH NIV  +     E    +  EY+    + +Y+ +    I    V+ F   +L GLAY
Sbjct: 57  LKHANIVTLHDIIHTEKSLTLVFEYLD-KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAY 115

Query: 459 LHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPY----------W 508
            H +K +HRD+K  NLL++  G +KLADFG+A+           K  P           W
Sbjct: 116 CHRQKVLHRDLKPQNLLINERGELKLADFGLAR----------AKSIPTKTYDNEVVTLW 165

Query: 509 M-APELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPW---SEYEGAAAMFKVMRD 564
              P++++       S+D +  +D+W +GC   EM TG+P +   +  E    +F+++  
Sbjct: 166 YRPPDILLG------STDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILG- 218

Query: 565 TP---------AIPD-------------------SLSPEGKDFLRCCFQRNPADRPPASL 596
           TP         +  +                    L  +G D L    Q    +R  A  
Sbjct: 219 TPTEETWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAED 278

Query: 597 LLEHRFLKN--SQQPDVPSCSLSFSGMQLTEKPHSPREKA 634
            ++H F  +   +   +P  +  F+  ++  +  +    A
Sbjct: 279 AMKHPFFLSLGERIHKLPDTTSIFALKEIQLQKEASLRSA 318

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score =  175 bits (446), Expect = 3e-49
 Identities = 84/369 (22%), Positives = 151/369 (40%), Gaps = 81/369 (21%)

Query: 340 SQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDD------PKSAESIKQLEQEI 393
            +++K   +G G F +VY A ++ T  + A+K++ +           ++A  ++    EI
Sbjct: 10  KRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTA--LR----EI 63

Query: 394 KVLSHLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHIL 453
           K+L  L HPNI+    +   +    +  +++    +   ++++   +T S ++ +    L
Sbjct: 64  KLLQELSHPNIIGLLDAFGHKSNISLVFDFM-ETDLEVIIKDNSLVLTPSHIKAYMLMTL 122

Query: 454 SGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPY------ 507
            GL YLH    +HRD+K  NLL+D +GV+KLADFG+AK            GSP       
Sbjct: 123 QGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKS----------FGSPNRAYTHQ 172

Query: 508 ----WM-APELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPW---SEYEGAAAMF 559
               W  APEL+        +    + VD+W++GC + E+    P     S+ +    +F
Sbjct: 173 VVTRWYRAPELLFG------ARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIF 226

Query: 560 KVMRDTP---------AIPD-----------------SLSPEGKDFLRCCFQRNPADRPP 593
           + +  TP         ++PD                 +   +  D ++  F  NP  R  
Sbjct: 227 ETLG-TPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARIT 285

Query: 594 ASLLLEHRFLKNSQQPDVPSCSLSFSGMQLTEKPHSPREKADAKYDQVAALSSSRSSRKA 653
           A+  L+ ++  N   P            QL   P         K     AL+  R   +A
Sbjct: 286 ATQALKMKYFSNRPGPTPGC--------QL---PRPNCPVETLKEQSNPALAIKRKRTEA 334

Query: 654 TLESENGRR 662
             +    ++
Sbjct: 335 LEQGGLPKK 343

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  180 bits (458), Expect = 5e-49
 Identities = 89/436 (20%), Positives = 159/436 (36%), Gaps = 40/436 (9%)

Query: 270 SPFHSPRSRSPCRNAISPSGPSSPIHSKLSRESTVRIEVHPLPLPPGAAV-------LSP 322
                   R    N    S P  P    L      +          G  V        + 
Sbjct: 73  RAGKQYEFRIIAENKHGQSKPCEPTAPVLIPGDERKRRRGYDVDEQGKIVRGKGTVSSNY 132

Query: 323 SATIPQVAAKPEPLPMNSQWQK-------GKLIGRGTFGSVYVASNRETGALCAMKEVDI 375
              +  +  +  P P+  +           + +G G FG V+  + R TG   A K V  
Sbjct: 133 DNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMT 192

Query: 376 FPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYIYL--EYVHPGSINKYV 433
                      + + +EI+ +S L+HP +V  +  +  ED   + +  E++  G + + V
Sbjct: 193 -----PHESDKETVRKEIQTMSVLRHPTLVNLH--DAFEDDNEMVMIYEFMSGGELFEKV 245

Query: 434 REHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLV--DASGVVKLADFGMAK 491
            +    ++E     + R +  GL ++H    +H D+K  N++     S  +KL DFG+  
Sbjct: 246 ADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTA 305

Query: 492 HLTGQKADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPP-WS 550
           HL  +++     G+  + APE+      +GK        D+WS+G     + +G  P   
Sbjct: 306 HLDPKQSVKVTTGTAEFAAPEVA-----EGKPVG--YYTDMWSVGVLSYILLSGLSPFGG 358

Query: 551 EYEGAAAMFKVMR-----DTPAIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKN 605
           E +    +  V       D  A    +S +GKDF+R     +P  R      LEH +L  
Sbjct: 359 END-DETLRNVKSCDWNMDDSAFSG-ISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTP 416

Query: 606 SQQPDVPSCSLSFSGMQLTEKPHSPREKADAKYDQVAALSSSRSSRKATLESENGRRSHL 665
              P   S   S    ++ +   +  +        +  +S+  S RK   +  + R +  
Sbjct: 417 GNAPGRDSQIPSSRYTKIRDSIKTKYDAWPEPLPPLGRISNYSSLRKHRPQEYSIRDAFW 476

Query: 666 ETSDLTVASTCSPRST 681
           + S+        P  T
Sbjct: 477 DRSEAQPRFIVKPYGT 492

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score =  172 bits (438), Expect = 9e-49
 Identities = 82/310 (26%), Positives = 135/310 (43%), Gaps = 69/310 (22%)

Query: 341 QWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDD---PKSAESIKQLEQEIKVLS 397
           ++   + IG GT+G VY A N   G   A+K++ +  +D   P +   I+    EI +L 
Sbjct: 3   KYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTT--IR----EISILK 55

Query: 398 HLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLA 457
            LKH NIV+ Y     + +  +  E++    + K +    G +     ++F   +L+G+A
Sbjct: 56  ELKHSNIVKLYDVIHTKKRLVLVFEHLD-QDLKKLLDVCEGGLESVTAKSFLLQLLNGIA 114

Query: 458 YLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPY---------- 507
           Y H ++ +HRD+K  NLL++  G +K+ADFG+A+            G P           
Sbjct: 115 YCHDRRVLHRDLKPQNLLINREGELKIADFGLAR----------AFGIPVRKYTHEIVTL 164

Query: 508 WM-APELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPW---SEYEGAAAMFKVMR 563
           W  AP+++M       S   +  +DIWS+GC   EM  G P +   SE +    +F+++ 
Sbjct: 165 WYRAPDVLMG------SKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILG 218

Query: 564 DTP---------AIPD------------------SLSPEGKDFLRCCFQRNPADRPPASL 596
            TP          +P                    L   G D L    + +P  R  A  
Sbjct: 219 -TPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQ 277

Query: 597 LLEHRFLKNS 606
            LEH + K +
Sbjct: 278 ALEHAYFKEN 287

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score =  173 bits (440), Expect = 1e-48
 Identities = 75/349 (21%), Positives = 141/349 (40%), Gaps = 87/349 (24%)

Query: 321 SPSATIPQVAAKPEPLPMNSQW--------QKGKLIGRGTFGSVYVASNRETGALCAMKE 372
               T+      P  + +++          ++   +G GT+G VY A +  T    A+K 
Sbjct: 7   HHMGTLEAQTQGPGSMSVSAAPSATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKR 66

Query: 373 VDIFPDD---PKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIV--EDKFYIYLEYVHPG 427
           + +  ++   P +A  I+    E+ +L  L+H NI++     ++    + ++  EY    
Sbjct: 67  IRLEHEEEGVPGTA--IR----EVSLLKELQHRNIIELK--SVIHHNHRLHLIFEYAE-N 117

Query: 428 SINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDAS-----GVV 482
            + KY+ +    ++  V+++F   +++G+ + HS++ +HRD+K  NLL+  S      V+
Sbjct: 118 DLKKYM-DKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVL 176

Query: 483 KLADFGMAKHLTGQKADLSMKGSPY----------WM-APELMMAVMQKGKSSDSALAVD 531
           K+ DFG+A+            G P           W   PE+++       S   + +VD
Sbjct: 177 KIGDFGLAR----------AFGIPIRQFTHEIITLWYRPPEILLG------SRHYSTSVD 220

Query: 532 IWSLGCTIIEMYTGKPPW---SEYEGAAAMFKVMRDTP---------------------- 566
           IWS+ C   EM    P +   SE +    +F+V+   P                      
Sbjct: 221 IWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLG-LPDDTTWPGVTALPDWKQSFPKFR 279

Query: 567 ------AIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQP 609
                  +   L  EG D L    + +P  R  A   LEH +  ++   
Sbjct: 280 GKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHNDFD 328

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  172 bits (437), Expect = 5e-48
 Identities = 59/354 (16%), Positives = 112/354 (31%), Gaps = 34/354 (9%)

Query: 274 SPRSRSPCRNAISPSGPSSPIHSKLSRESTVRIEVHPLPLPPGAAVLSPSATIPQVAAKP 333
           SP+  S            +P   KL  +    +     P+            +P +  K 
Sbjct: 2   SPQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGL---SKPVSSYPNTFEWQCKLPAIKPKT 58

Query: 334 EPLPMNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEI 393
           E    +       L+G G F  VY A+  +       ++  +    P +        Q +
Sbjct: 59  EFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLM 118

Query: 394 KVLSHLKHPNIVQYYGSEIVEDKFYIYLEYVHPGS----INKYVREHCGAITESVVRNFT 449
           + L        +++Y + + ++   +  E    G+    IN Y       + + +V +F 
Sbjct: 119 ERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFA 178

Query: 450 RHILSGLAYLHSKKTIHRDIKGANLLV-----------DASGVVKLADFGMAKHLTGQKA 498
             +L  +  +H  + IH DIK  N ++           D S  + L D G +  +     
Sbjct: 179 MRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPK 238

Query: 499 DLSMK---GSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGA 555
                    +  +   E     M   K  +    +D + +  T+  M  G     + EG 
Sbjct: 239 GTIFTAKCETSGFQCVE-----MLSNKPWN--YQIDYFGVAATVYCMLFGTYMKVKNEGG 291

Query: 556 AAMFK-VMRDTPAIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQ 608
               + + R  P +         +F             P+  LL  +  K  QQ
Sbjct: 292 ECKPEGLFRRLPHLDMW-----NEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQ 340

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score =  171 bits (435), Expect = 1e-47
 Identities = 77/294 (26%), Positives = 135/294 (45%), Gaps = 28/294 (9%)

Query: 324 ATIPQVAAKPEPLPMNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSA 383
           A +         +  + ++   K IG G FG   +  ++ T  L A+K ++      + A
Sbjct: 4   APVTTGPLDMPIMHDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIE------RGA 57

Query: 384 ESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYIYL--EYVHPGSINKYVREHCGAIT 441
              + +++EI     L+HPNIV++   E++    ++ +  EY   G + + +    G  +
Sbjct: 58  AIDENVQREIINHRSLRHPNIVRFK--EVILTPTHLAIIMEYASGGELYERICNA-GRFS 114

Query: 442 ESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGV--VKLADFGMAKHLTGQKAD 499
           E   R F + +LSG++Y HS +  HRD+K  N L+D S    +K+ DFG +K        
Sbjct: 115 EDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 174

Query: 500 LSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMF 559
            S  G+P ++APE+++      +  D     D+WS G T+  M  G  P+ +       +
Sbjct: 175 KSTVGTPAYIAPEVLL-----RQEYDGK-IADVWSCGVTLYVMLVGAYPFED-PEEPRDY 227

Query: 560 K-----VMRDTPAIPDS--LSPEGKDFLRCCFQRNPADRPPASLLLEHR-FLKN 605
           +     ++    +IPD   +SPE    +   F  +PA R     +  H  FLKN
Sbjct: 228 RKTIQRILSVKYSIPDDIRISPECCHLISRIFVADPATRISIPEIKTHSWFLKN 281

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score =  173 bits (441), Expect = 2e-47
 Identities = 88/385 (22%), Positives = 154/385 (40%), Gaps = 38/385 (9%)

Query: 341 QWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLK 400
            +  G  +G GTFG V V  +  TG   A+K ++      +S + + ++ +EI+ L   +
Sbjct: 17  HYILGDTLGVGTFGKVKVGKHELTGHKVAVKILN--RQKIRSLDVVGKIRREIQNLKLFR 74

Query: 401 HPNIVQYYGSEIVEDKFYIYL--EYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAY 458
           HP+I++ Y  +++     I++  EYV  G +  Y+ ++ G + E   R   + ILSG+ Y
Sbjct: 75  HPHIIKLY--QVISTPSDIFMVMEYVSGGELFDYICKN-GRLDEKESRRLFQQILSGVDY 131

Query: 459 LHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMK---GSPYWMAPELMM 515
            H    +HRD+K  N+L+DA    K+ADFG++           ++   GSP + APE++ 
Sbjct: 132 CHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNM---MSDGEFLRTSCGSPNYAAPEVI- 187

Query: 516 AVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMF-KVMRDTPAIPDSLSP 574
                G+       VDIWS G  +  +  G  P+ + +    +F K+       P  L+P
Sbjct: 188 ----SGRLYAGP-EVDIWSSGVILYALLCGTLPFDD-DHVPTLFKKICDGIFYTPQYLNP 241

Query: 575 EGKDFLRCCFQRNPADRPPASLLLEHR-FLKNSQQPDVPSCSLSFSGM-------QLTEK 626
                L+   Q +P  R     + EH  F ++  +   P      S M       ++ EK
Sbjct: 242 SVISLLKHMLQVDPMKRATIKDIREHEWFKQDLPKYLFPEDPSYSSTMIDDEALKEVCEK 301

Query: 627 PHSPREK------ADAKYDQVAA---LSSSRSSRKATLESENGRRSHLETSDLTVASTCS 677
                E+           D +A    L           +      S  ++       T  
Sbjct: 302 FECSEEEVLSCLYNRNHQDPLAVAYHLIIDNRRIMNEAKDFYLATSPPDSFLDDHHLTRP 361

Query: 678 PRSTLEALPCLSPLHSGPSTRHSSA 702
               +  L   +P         +  
Sbjct: 362 HPERVPFLVAETPRARHTLDELNPQ 386

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score =  168 bits (429), Expect = 3e-47
 Identities = 91/334 (27%), Positives = 143/334 (42%), Gaps = 81/334 (24%)

Query: 340 SQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDD--PKSAESIKQLEQEIKVLS 397
           SQ+++ + +G GT+ +VY   N+ TG   A+KEV +  ++  P +A  I+    EI ++ 
Sbjct: 5   SQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTA--IR----EISLMK 58

Query: 398 HLKHPNIVQYYGSEIV--EDKFYIYLEYVHPGSINKY-----VREHCGAITESVVRNFTR 450
            LKH NIV+ Y  +++  E+K  +  E++    + KY     V      +  ++V+ F  
Sbjct: 59  ELKHENIVRLY--DVIHTENKLTLVFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQW 115

Query: 451 HILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPY--- 507
            +L GLA+ H  K +HRD+K  NLL++  G +KL DFG+A+            G P    
Sbjct: 116 QLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLAR----------AFGIPVNTF 165

Query: 508 -------WM-APELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPW---SEYEGAA 556
                  W  AP+++M       S   + ++DIWS GC + EM TGKP +   ++ E   
Sbjct: 166 SSEVVTLWYRAPDVLMG------SRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLK 219

Query: 557 AMFKVMRDTP--------------------------------AIPDSLSPEGKDFLRCCF 584
            +F +M  TP                                   + L     DFL    
Sbjct: 220 LIFDIMG-TPNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLL 278

Query: 585 QRNPADRPPASLLLEHRFLKNSQQPDVPSCSLSF 618
           Q NP  R  A   L H +            S S 
Sbjct: 279 QLNPDMRLSAKQALHHPWFAEYYHHASMGGSRSH 312

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score =  168 bits (429), Expect = 3e-47
 Identities = 81/330 (24%), Positives = 140/330 (42%), Gaps = 82/330 (24%)

Query: 331 AKPEPLPMNSQWQKGKL--------IGRGTFGSVYVASNRETGALCAMKEVDIFPDD--- 379
                    + + +G +        +G GT+G VY A +   G + A+K + +  +D   
Sbjct: 4   HHHHSSGRENLYFQGLMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAEDEGI 62

Query: 380 PKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIV--EDKFYIYLEYVHPGSINKYVREHC 437
           P +A  I+    EI +L  L HPNIV     +++  E    +  E++    + K + E+ 
Sbjct: 63  PSTA--IR----EISLLKELHHPNIVSLI--DVIHSERCLTLVFEFME-KDLKKVLDENK 113

Query: 438 GAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQK 497
             + +S ++ +   +L G+A+ H  + +HRD+K  NLL+++ G +KLADFG+A+      
Sbjct: 114 TGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLAR------ 167

Query: 498 ADLSMKGSPY----------WM-APELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGK 546
                 G P           W  AP+++M       S   + +VDIWS+GC   EM TGK
Sbjct: 168 ----AFGIPVRSYTHEVVTLWYRAPDVLMG------SKKYSTSVDIWSIGCIFAEMITGK 217

Query: 547 PPW---SEYEGAAAMFKVMRDTP---------AIPD-------------------SLSPE 575
           P +   ++ +    +F ++  TP          +P                        E
Sbjct: 218 PLFPGVTDDDQLPKIFSILG-TPNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQE 276

Query: 576 GKDFLRCCFQRNPADRPPASLLLEHRFLKN 605
           G D L      +P  R  A   + H + K+
Sbjct: 277 GIDLLSNMLCFDPNKRISARDAMNHPYFKD 306

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score =  169 bits (429), Expect = 3e-47
 Identities = 67/291 (23%), Positives = 128/291 (43%), Gaps = 43/291 (14%)

Query: 344 KGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLK-HP 402
           K K +G G+F       ++++    A+K +       K  E+    ++EI  L   + HP
Sbjct: 15  KDKPLGEGSFSICRKCVHKKSNQAFAVKIIS------KRMEA--NTQKEITALKLCEGHP 66

Query: 403 NIVQYYGSEIVEDKFYIYL--EYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLH 460
           NIV+ +  E+  D+ + +L  E ++ G + + +++     +E+      R ++S ++++H
Sbjct: 67  NIVKLH--EVFHDQLHTFLVMELLNGGELFERIKKK-KHFSETEASYIMRKLVSAVSHMH 123

Query: 461 SKKTIHRDIKGANLLV---DASGVVKLADFGMAKHLTGQKADLSMK-GSPYWMAPELMMA 516
               +HRD+K  NLL    + +  +K+ DFG A+        L     + ++ APEL+  
Sbjct: 124 DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELL-- 181

Query: 517 VMQKGKSSDSALAVDIWSLGCTIIEMYT---GKPP-WSEYEGAAA-----MF-KVMR--- 563
                   D   + D+WSLG  +I +YT   G+ P  S            +  K+ +   
Sbjct: 182 ---NQNGYD--ESCDLWSLG--VI-LYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDF 233

Query: 564 DTPAIP-DSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQ-PDVP 612
                   ++S E KD ++     +P  R   S L  + +L++  Q    P
Sbjct: 234 SFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGSQLSSNP 284

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  167 bits (424), Expect = 1e-46
 Identities = 69/296 (23%), Positives = 121/296 (40%), Gaps = 50/296 (16%)

Query: 343 QKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHP 402
              + +G+G +G V+  S +  G   A+K   IF    + +      E E+     L+H 
Sbjct: 11  TLLECVGKGRYGEVWRGSWQ--GENVAVK---IFSSRDEKSW---FRETELYNTVMLRHE 62

Query: 403 NIVQYYGSEIVED----KFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAY 458
           NI+ +  S++       + ++   Y   GS+  Y++     +           I SGLA+
Sbjct: 63  NILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLT--TLDTVSCLRIVLSIASGLAH 120

Query: 459 LHSKKT--------IHRDIKGANLLVDASGVVKLADFGMA--KHLTGQKADLSMK---GS 505
           LH +           HRD+K  N+LV  +G   +AD G+A     +  + D+      G+
Sbjct: 121 LHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGT 180

Query: 506 PYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTG----------KPPWSEYEGA 555
             +MAPE++   +Q     DS   VDIW+ G  + E+             KPP+ +    
Sbjct: 181 KRYMAPEVLDETIQ-VDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPN 239

Query: 556 AAMFKVMRDT-------PAIPDSLSPEG-----KDFLRCCFQRNPADRPPASLLLE 599
              F+ MR         P IP+    +         ++ C+ +NP+ R  A  + +
Sbjct: 240 DPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKK 295

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score =  167 bits (426), Expect = 2e-46
 Identities = 66/287 (22%), Positives = 122/287 (42%), Gaps = 41/287 (14%)

Query: 345 GKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHL-KHPN 403
            + IG G++       ++ T    A+K +D      KS     +   EI++L    +HPN
Sbjct: 27  KEDIGVGSYSVCKRCIHKATNMEFAVKIID------KSKRDPTE---EIEILLRYGQHPN 77

Query: 404 IVQYYGSEIVEDKFYIYL--EYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHS 461
           I+     ++ +D  Y+Y+  E +  G +   +       +E         I   + YLH+
Sbjct: 78  IITLK--DVYDDGKYVYVVTELMKGGELLDKILRQ-KFFSEREASAVLFTITKTVEYLHA 134

Query: 462 KKTIHRDIKGANLLV----DASGVVKLADFGMAKHLTGQKADLSMK-GSPYWMAPELMMA 516
           +  +HRD+K +N+L          +++ DFG AK L  +   L     +  ++APE++  
Sbjct: 135 QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPEVL-- 192

Query: 517 VMQKGKSSDSALAVDIWSLGCTIIEMYT---GKPP-WSEY-EGAAAMF-KVMR---DTPA 567
              + +  D   A DIWSLG  ++ +YT   G  P  +   +    +  ++         
Sbjct: 193 ---ERQGYD--AACDIWSLG--VL-LYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSG 244

Query: 568 IP-DSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKN-SQQPDVP 612
              +S+S   KD +      +P  R  A+L+L H ++ +  Q P   
Sbjct: 245 GYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHWDQLPQYQ 291

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score =  169 bits (430), Expect = 2e-46
 Identities = 92/432 (21%), Positives = 164/432 (37%), Gaps = 63/432 (14%)

Query: 290 PSSPIHSKLSRESTVRIEVHPLPLPPGAAVLSPSATIPQVAAKPEPLPMNSQWQKGKLIG 349
           P +   ++  +          + +         +  +      P+  P    +   K+IG
Sbjct: 5   PRTTSFAESCKPVQQPSAFGSMKVSRDKDGSKVTTVVATPGQGPDR-PQEVSYTDTKVIG 63

Query: 350 RGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQ--- 406
            G+FG VY A   ++G L A+K+V     D +         +E++++  L H NIV+   
Sbjct: 64  NGSFGVVYQAKLCDSGELVAIKKV---LQDKRFKN------RELQIMRKLDHCNIVRLRY 114

Query: 407 -YYGSEIVEDKFYIYL--EYVHPGSINKYVREHCGA---ITESVVRNFTRHILSGLAYLH 460
            +Y S   +D+ Y+ L  +YV P ++ +  R +  A   +    V+ +   +   LAY+H
Sbjct: 115 FFYSSGEKKDEVYLNLVLDYV-PETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH 173

Query: 461 SKKTIHRDIKGANLLVDA-SGVVKLADFGMAKHLTGQKADLSMKGSPYWMAPELMMAVMQ 519
           S    HRDIK  NLL+D  + V+KL DFG AK L   + ++S   S Y+ APEL+     
Sbjct: 174 SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFG--- 230

Query: 520 KGKSSDSALAVDIWSLGCTIIEMYTGKP--------------------------PWSEYE 553
              ++D   ++D+WS GC + E+  G+P                                
Sbjct: 231 ---ATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPN 287

Query: 554 GAAAMFKVMRDTP---AIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLK-----N 605
                F  ++  P          PE         +  P  R        H F       N
Sbjct: 288 YTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPN 347

Query: 606 SQQPDVPSC--SLSFSGMQLTEKPHSPREKADAKYDQVAALSSSRSSRKATLESENGRRS 663
            + P+        +F+  +L+  P              AA S+  ++  A+  +   R  
Sbjct: 348 VKLPNGRDTPALFNFTTQELSSNPPLATILIPPHARIQAAASTPTNATAASDANTGDRGQ 407

Query: 664 HLETSDLTVAST 675
               +  + +++
Sbjct: 408 TNNAASASASNS 419

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  165 bits (419), Expect = 1e-45
 Identities = 66/305 (21%), Positives = 124/305 (40%), Gaps = 56/305 (18%)

Query: 336 LPMNSQW------QKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQL 389
           LP+  Q       Q  K IG+G +G V++   R  G   A+K   +F    +++      
Sbjct: 27  LPLLVQRTIAKQIQMVKQIGKGRYGEVWMGKWR--GEKVAVK---VFFTTEEASW---FR 78

Query: 390 EQEIKVLSHLKHPNIVQYYGSEIVED----KFYIYLEYVHPGSINKYVREHCGAITESVV 445
           E EI     ++H NI+ +  ++I       + Y+  +Y   GS+  Y++     +    +
Sbjct: 79  ETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKST--TLDAKSM 136

Query: 446 RNFTRHILSGLAYLHSKKT--------IHRDIKGANLLVDASGVVKLADFGMA--KHLTG 495
                  +SGL +LH++           HRD+K  N+LV  +G   +AD G+A       
Sbjct: 137 LKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDT 196

Query: 496 QKADLSMK---GSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTG------- 545
            + D+      G+  +M PE++   + +     S +  D++S G  + E+          
Sbjct: 197 NEVDIPPNTRVGTKRYMPPEVLDESLNR-NHFQSYIMADMYSFGLILWEVARRCVSGGIV 255

Query: 546 ---KPPWSEYEGAAAMFKVMRDT-------PAIPDSLSPEG-----KDFLRCCFQRNPAD 590
              + P+ +   +   ++ MR+        P+ P+  S +         +  C+  NPA 
Sbjct: 256 EEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPAS 315

Query: 591 RPPAS 595
           R  A 
Sbjct: 316 RLTAL 320

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  167 bits (424), Expect = 1e-45
 Identities = 46/328 (14%), Positives = 103/328 (31%), Gaps = 44/328 (13%)

Query: 344 KGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHL---- 399
           +G ++G+    +   A+++ETG    +     +  +   + +IKQ+++E+  L  L    
Sbjct: 82  RGTVLGQEDPYAYLEATDQETGESFEVHV--PYFTERPPSNAIKQMKEEVLRLRLLRGIK 139

Query: 400 ------------------KHPNIVQYYGSEIVEDKFYIYLEYV-----------HPGSIN 430
                             K P   +     + E   ++   +                + 
Sbjct: 140 NQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLL 199

Query: 431 KYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMA 490
            +   H  ++        T  ++  LA LH    +H  ++  ++++D  G V L  F   
Sbjct: 200 SHSSTH-KSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHL 258

Query: 491 KHL--TGQKADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPP 548
                +           P   A  ++     +   +    A D W+LG  I  ++    P
Sbjct: 259 VRDGASAVSPIGRGFAPPETTAERMLP--FGQHHPTLMTFAFDTWTLGLAIYWIWCADLP 316

Query: 549 WSEYEGAAAMFKVMRDTPAIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQ 608
            ++         + R    IP  +    +  L    +    DR      +E    +  + 
Sbjct: 317 NTDDAALGGSEWIFRSCKNIPQPV----RALLEGFLRYPKEDRLLPLQAMETPEYEQLRT 372

Query: 609 PDVPSCSLSFSGMQLTEKPHSPREKADA 636
               +  L  +  + T +  +P      
Sbjct: 373 ELSAALPLYQTDGEPTREGGAPPSGTSQ 400

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score =  162 bits (413), Expect = 5e-45
 Identities = 62/305 (20%), Positives = 115/305 (37%), Gaps = 50/305 (16%)

Query: 344 KGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLK-HP 402
           +  ++G G    V    N  T    A+K ++      +      ++ +E+++L   + H 
Sbjct: 17  QEDVLGEGAHARVQTCINLITSQEYAVKIIEK-----QPGHIRSRVFREVEMLYQCQGHR 71

Query: 403 NIVQYYGSEIVEDKFYIYL--EYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLH 460
           N+++    E  E++   YL  E +  GSI  ++ +      E       + + S L +LH
Sbjct: 72  NVLELI--EFFEEEDRFYLVFEKMRGGSILSHIHKR-RHFNELEASVVVQDVASALDFLH 128

Query: 461 SKKTIHRDIKGANLLV---DASGVVKLADFGMAKHLTGQKADLSMK--------GSPYWM 509
           +K   HRD+K  N+L    +    VK+ DF +   +        +         GS  +M
Sbjct: 129 NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYM 188

Query: 510 APELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT---GKPP-WSEYEGAAAMFKVMRDT 565
           APE++ A  ++    D     D+WSLG  +I +Y    G PP            +     
Sbjct: 189 APEVVEAFSEEASIYD--KRCDLWSLG--VI-LYILLSGYPPFVGRCGSDCGWDRGEACP 243

Query: 566 PAIP------------------DSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQ 607
                                   +S   KD +     R+   R  A+ +L+H +++   
Sbjct: 244 ACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGC- 302

Query: 608 QPDVP 612
            P+  
Sbjct: 303 APENT 307

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score =  167 bits (424), Expect = 2e-44
 Identities = 71/261 (27%), Positives = 121/261 (46%), Gaps = 31/261 (11%)

Query: 346 KLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQ------EIKVLSHL 399
           +++GRG FG V+    + TG L A K+++      K  + +K+ +       E K+L+ +
Sbjct: 191 RVLGRGGFGEVFACQMKATGKLYACKKLN------K--KRLKKRKGYQGAMVEKKILAKV 242

Query: 400 KHPNIVQYYGSEIVEDKFYIYLEYVHPGS----INKYVREHCGAITESVVRNFTRHILSG 455
               IV    +   +    + +  ++ G     I     ++     E     +T  I+SG
Sbjct: 243 HSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDN-PGFQEPRAIFYTAQIVSG 301

Query: 456 LAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAK-HLTGQKADLSMKGSPYWMAPELM 514
           L +LH +  I+RD+K  N+L+D  G V+++D G+A     GQ       G+P +MAPEL+
Sbjct: 302 LEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELL 361

Query: 515 MAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPW---SEYEGAAAMF-KVMRDTPAIPD 570
                 G+  D   +VD ++LG T+ EM   + P+    E      +  +V+      PD
Sbjct: 362 -----LGEEYDF--SVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPD 414

Query: 571 SLSPEGKDFLRCCFQRNPADR 591
             SP  KDF     Q++P  R
Sbjct: 415 KFSPASKDFCEALLQKDPEKR 435

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score =  162 bits (412), Expect = 2e-44
 Identities = 84/347 (24%), Positives = 139/347 (40%), Gaps = 78/347 (22%)

Query: 340 SQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDD---PKSAESIKQLEQEIKVL 396
           S+++K   IG+GTFG V+ A +R+TG   A+K+V +  +    P +A       +EIK+L
Sbjct: 17  SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITAL------REIKIL 70

Query: 397 SHLKHPNIVQYYGSEIV----------EDKFYIYLEYV-HPGSINKYVREHCGAITESVV 445
             LKH N+V     EI           +   Y+  ++  H   +   +       T S +
Sbjct: 71  QLLKHENVVNLI--EICRTKASPYNRCKGSIYLVFDFCEH--DLAGLLSNVLVKFTLSEI 126

Query: 446 RNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGS 505
           +   + +L+GL Y+H  K +HRD+K AN+L+   GV+KLADFG+A+  +      + + +
Sbjct: 127 KRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFS---LAKNSQPN 183

Query: 506 PY-------WM-APELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPW---SEYEG 554
            Y       W   PEL++     G+       +D+W  GC + EM+T  P     +E   
Sbjct: 184 RYTNRVVTLWYRPPELLL-----GERDYGP-PIDLWGAGCIMAEMWTRSPIMQGNTEQHQ 237

Query: 555 AAAMFKVMRDTP---------AIPD---------------------SLSPEGKDFLRCCF 584
            A + ++   +                                      P   D +    
Sbjct: 238 LALISQLCG-SITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLL 296

Query: 585 QRNPADRPPASLLLEHRFLKNSQQPDVPSCSLSF---SGMQLTEKPH 628
             +PA R  +   L H F  +   P      LS    S  +    P 
Sbjct: 297 VLDPAQRIDSDDALNHDFFWSDPMPSDLKGMLSTHLTSMFEYLAPPR 343

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score =  161 bits (410), Expect = 2e-44
 Identities = 74/252 (29%), Positives = 120/252 (47%), Gaps = 21/252 (8%)

Query: 346 KLIGRGTFGSVYVASNRETGALCAMK----EVDIFPDDPKSAESIKQLEQEIKVLSHLKH 401
           KL+G+GTFG V +   + TG   AMK    EV I  D+            E +VL + +H
Sbjct: 11  KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDE---VAHTVT---ESRVLQNTRH 64

Query: 402 PNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHS 461
           P +     +    D+    +EY + G +  ++       TE   R +   I+S L YLHS
Sbjct: 65  PFLTALKYAFQTHDRLCFVMEYANGGELFFHLS-RERVFTEERARFYGAEIVSALEYLHS 123

Query: 462 KKTIHRDIKGANLLVDASGVVKLADFGMAK-HLTGQKADLSMKGSPYWMAPELMMAVMQK 520
           +  ++RDIK  NL++D  G +K+ DFG+ K  ++      +  G+P ++APE+   +   
Sbjct: 124 RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEV---LEDN 180

Query: 521 GKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMF-KVMRDTPAIPDSLSPEGKDF 579
                   AVD W LG  + EM  G+ P+   +    +F  ++ +    P +LSPE K  
Sbjct: 181 DYGR----AVDWWGLGVVMYEMMCGRLPFYN-QDHERLFELILMEEIRFPRTLSPEAKSL 235

Query: 580 LRCCFQRNPADR 591
           L    +++P  R
Sbjct: 236 LAGLLKKDPKQR 247

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score =  161 bits (409), Expect = 2e-44
 Identities = 74/257 (28%), Positives = 121/257 (47%), Gaps = 27/257 (10%)

Query: 346 KLIGRGTFGSVYVA---SNRETGALCAMKEV--DIFPDDPKSAESIKQLEQEIKVLSHLK 400
           +++G+G +G V+     +   TG + AMK +   +   + K     K    E  +L  +K
Sbjct: 23  RVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKA---ERNILEEVK 79

Query: 401 HPNIVQYYGSEIVEDKFYIYLEYVHPGS----INKYVREHCGAITESVVRNFTRHILSGL 456
           HP IV    +     K Y+ LEY+  G     + +      G   E     +   I   L
Sbjct: 80  HPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLER-----EGIFMEDTACFYLAEISMAL 134

Query: 457 AYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAK-HLTGQKADLSMKGSPYWMAPELMM 515
            +LH K  I+RD+K  N++++  G VKL DFG+ K  +       +  G+  +MAPE+  
Sbjct: 135 GHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEI-- 192

Query: 516 AVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMF-KVMRDTPAIPDSLSP 574
            +M+ G +     AVD WSLG  + +M TG PP++  E       K+++    +P  L+ 
Sbjct: 193 -LMRSGHNR----AVDWWSLGALMYDMLTGAPPFTG-ENRKKTIDKILKCKLNLPPYLTQ 246

Query: 575 EGKDFLRCCFQRNPADR 591
           E +D L+   +RN A R
Sbjct: 247 EARDLLKKLLKRNAASR 263

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score =  161 bits (410), Expect = 2e-44
 Identities = 80/326 (24%), Positives = 133/326 (40%), Gaps = 53/326 (16%)

Query: 346 KLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHL-KHPNI 404
           +++G G  G V    +R TG  CA+K +        S     +  QE+         P+I
Sbjct: 35  QVLGLGVNGKVLECFHRRTGQKCALKLLY------DS----PKARQEVDHHWQASGGPHI 84

Query: 405 VQYYG----SEIVEDKFYIYLEYVHPGSI-NKYVREHCGAITESVVRNFTRHILSGLAYL 459
           V            +    I +E +  G + ++       A TE       R I + + +L
Sbjct: 85  VCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFL 144

Query: 460 HSKKTIHRDIKGANLLV---DASGVVKLADFGMAKHLTGQKADLSMK---GSPYWMAPEL 513
           HS    HRD+K  NLL    +   V+KL DFG AK  T       ++    +PY++APE+
Sbjct: 145 HSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA----LQTPCYTPYYVAPEV 200

Query: 514 MMAVMQKGKSSDSALAVDIWSLGCTIIEMYT---GKPP-WSE--YEGAAAMFKVMR---- 563
           +       +  D   + D+WSLG  +I MY    G PP +S      +  M + +R    
Sbjct: 201 L-----GPEKYD--KSCDMWSLG--VI-MYILLCGFPPFYSNTGQAISPGMKRRIRLGQY 250

Query: 564 DTPAIP-DSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQPDVPSCSLSFSGMQ 622
             P      +S + K  +R   + +P +R   +  + H ++  S    VP   L  + + 
Sbjct: 251 GFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSMV--VPQTPLHTARVL 308

Query: 623 LTEKPHSPREKADAKYDQVAALSSSR 648
             +K H    K +      +AL++ R
Sbjct: 309 QEDKDHWDEVKEEMT----SALATMR 330

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score =  162 bits (413), Expect = 3e-44
 Identities = 87/389 (22%), Positives = 142/389 (36%), Gaps = 48/389 (12%)

Query: 285 ISPSGPSSPIHSKLSRESTVRIEVHPLPLPPGAAVLSPSATIPQVAAKPEPLPMNSQWQK 344
           +S S   SP     +     +     LP PP      P    PQ   K       +    
Sbjct: 2   LSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIID 61

Query: 345 -----GKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHL 399
                 +++G G  G V    N+ T    A+K   +  D         +  +E+++    
Sbjct: 62  DYKVTSQVLGLGINGKVLQIFNKRTQEKFALK---MLQD-------CPKARREVELHWRA 111

Query: 400 -KHPNIVQYYG----SEIVEDKFYIYLEYVHPGSI-NKYVREHCGAITESVVRNFTRHIL 453
            + P+IV+                I +E +  G + ++       A TE       + I 
Sbjct: 112 SQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIG 171

Query: 454 SGLAYLHSKKTIHRDIKGANLLV---DASGVVKLADFGMAKHLTGQKADLSMKGSPYWMA 510
             + YLHS    HRD+K  NLL      + ++KL DFG AK  T   +  +   +PY++A
Sbjct: 172 EAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVA 231

Query: 511 PELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT---GKPP-WSEYEGA--AAMF-KVMR 563
           PE    V+   K      + D+WSLG  +I MY    G PP +S +  A    M  ++  
Sbjct: 232 PE----VLGPEKYD---KSCDMWSLG--VI-MYILLCGYPPFYSNHGLAISPGMKTRIRM 281

Query: 564 DTPAIP----DSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQPDVPSCSLSFS 619
                P      +S E K  +R   +  P  R   +  + H ++  S +  VP   L  +
Sbjct: 282 GQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTK--VPQTPLH-T 338

Query: 620 GMQLTEKPHSPREKADAKYDQVAALSSSR 648
              L E      +  +     +A +    
Sbjct: 339 SRVLKEDKERWEDVKEEMTSALATMRVDY 367

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score =  162 bits (413), Expect = 3e-44
 Identities = 87/356 (24%), Positives = 148/356 (41%), Gaps = 68/356 (19%)

Query: 314 PPGAAVLSPSA-----TIPQVAAKPEPLPMNSQWQKGKLIGRGTFGSVYVASNRETGALC 368
           P     L+P            +           +   K+IG G+FG V+ A   E+  + 
Sbjct: 9   PLNGVKLNPLDDPNKVIKVLASDGKTGEQREIAYTNCKVIGNGSFGVVFQAKLVESDEV- 67

Query: 369 AMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQ----YYGSEIVEDKFYIYL--E 422
           A+K+V       K+        +E++++  +KHPN+V     +Y +   +D+ ++ L  E
Sbjct: 68  AIKKVLQDKRF-KN--------RELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLE 118

Query: 423 YVHPGSINKYVREHCGA---ITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDA- 478
           YV P ++ +  R +      +   +++ +   +L  LAY+HS    HRDIK  NLL+D  
Sbjct: 119 YV-PETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPP 177

Query: 479 SGVVKLADFGMAKHLTGQKADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCT 538
           SGV+KL DFG AK L   + ++S   S Y+ APEL+        +++    +DIWS GC 
Sbjct: 178 SGVLKLIDFGSAKILIAGEPNVSYICSRYYRAPELIFG------ATNYTTNIDIWSTGCV 231

Query: 539 IIEMYTGKPPW---SEYEGAAAMFKVMRDTP---------------------------AI 568
           + E+  G+P +   S  +    + KV+  TP                             
Sbjct: 232 MAELMQGQPLFPGESGIDQLVEIIKVL-GTPSREQIKTMNPNYMEHKFPQIRPHPFSKVF 290

Query: 569 PDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLK-----NSQQPDVPSCSLSFS 619
                P+  D +    +  P+ R  A   L H F        ++ P+       F+
Sbjct: 291 RPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELRTGEARMPNGRELPPLFN 346

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score =  160 bits (407), Expect = 4e-44
 Identities = 67/253 (26%), Positives = 121/253 (47%), Gaps = 26/253 (10%)

Query: 346 KLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQ------EIKVLSHL 399
           + +G G+FG V++  +R  G   AMK +          E + +L+Q      E  +LS +
Sbjct: 12  RTLGTGSFGRVHLIRSRHNGRYYAMKVLKK--------EIVVRLKQVEHTNDERLMLSIV 63

Query: 400 KHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYL 459
            HP I++ +G+     + ++ ++Y+  G +   +R         V + +   +   L YL
Sbjct: 64  THPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLR-KSQRFPNPVAKFYAAEVCLALEYL 122

Query: 460 HSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPYWMAPELMMAVMQ 519
           HSK  I+RD+K  N+L+D +G +K+ DFG AK++       ++ G+P ++APE+   V  
Sbjct: 123 HSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTY--TLCGTPDYIAPEV---VST 177

Query: 520 KGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMF-KVMRDTPAIPDSLSPEGKD 578
           K  +     ++D WS G  I EM  G  P+ +       + K++      P   + + KD
Sbjct: 178 KPYNK----SIDWWSFGILIYEMLAGYTPFYD-SNTMKTYEKILNAELRFPPFFNEDVKD 232

Query: 579 FLRCCFQRNPADR 591
            L     R+ + R
Sbjct: 233 LLSRLITRDLSQR 245

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score =  165 bits (420), Expect = 7e-44
 Identities = 55/251 (21%), Positives = 110/251 (43%), Gaps = 14/251 (5%)

Query: 346 KLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIV 405
           +++G+G FG V     R TG + A K+++      K  +       E ++L  +    +V
Sbjct: 190 RVLGKGGFGEVCACQVRATGKMYACKKLE--KKRIKKRKGEAMALNEKQILEKVNSRFVV 247

Query: 406 QYYGSEIVEDKFYIYLEYVHPGSINKYV-REHCGAITESVVRNFTRHILSGLAYLHSKKT 464
               +   +D   + L  ++ G +  ++         E+    +   I  GL  LH ++ 
Sbjct: 248 SLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERI 307

Query: 465 IHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPYWMAPELMMAVMQKGKSS 524
           ++RD+K  N+L+D  G ++++D G+A H+   +      G+  +MAPE++     K +  
Sbjct: 308 VYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVV-----KNERY 362

Query: 525 DSALAVDIWSLGCTIIEMYTGKPPW---SEYEGAAAMF-KVMRDTPAIPDSLSPEGKDFL 580
               + D W+LGC + EM  G+ P+    +      +   V        +  SP+ +   
Sbjct: 363 TF--SPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSERFSPQARSLC 420

Query: 581 RCCFQRNPADR 591
                ++PA+R
Sbjct: 421 SQLLCKDPAER 431

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score =  159 bits (405), Expect = 1e-43
 Identities = 76/253 (30%), Positives = 125/253 (49%), Gaps = 26/253 (10%)

Query: 346 KLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQ------EIKVLSHL 399
           K +G G+FG V +  ++E+G   AMK +D         + + +L+Q      E ++L  +
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDK--------QKVVKLKQIEHTLNEKRILQAV 98

Query: 400 KHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYL 459
             P +V+   S       Y+ +EYV  G +  ++R   G  +E   R +   I+    YL
Sbjct: 99  NFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR-RIGRFSEPHARFYAAQIVLTFEYL 157

Query: 460 HSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPYWMAPELMMAVMQ 519
           HS   I+RD+K  NLL+D  G +++ DFG AK + G+    ++ G+P  +APE+   ++ 
Sbjct: 158 HSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR--TWTLCGTPEALAPEI---ILS 212

Query: 520 KGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMF-KVMRDTPAIPDSLSPEGKD 578
           KG +     AVD W+LG  I EM  G PP+   +    ++ K++      P   S + KD
Sbjct: 213 KGYNK----AVDWWALGVLIYEMAAGYPPFFA-DQPIQIYEKIVSGKVRFPSHFSSDLKD 267

Query: 579 FLRCCFQRNPADR 591
            LR   Q +   R
Sbjct: 268 LLRNLLQVDLTKR 280

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score =  158 bits (403), Expect = 2e-43
 Identities = 76/260 (29%), Positives = 129/260 (49%), Gaps = 35/260 (13%)

Query: 346 KLIGRGTFGSVYVA---SNRETGALCAMKEVDIFPDDPKSAESIKQLEQ-----EIKVLS 397
           K++G+G+FG V++    S  +   L AMK +           ++K  ++     E  +L 
Sbjct: 30  KVLGQGSFGKVFLVKKISGSDARQLYAMKVL--------KKATLKVRDRVRTKMERDILV 81

Query: 398 HLKHPNIVQYYGSEIVEDKFYIYLEYVHPGS----INKYVREHCGAITESVVRNFTRHIL 453
            + HP IV+ + +   E K Y+ L+++  G     ++K         TE  V+ +   + 
Sbjct: 82  EVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSK-----EVMFTEEDVKFYLAELA 136

Query: 454 SGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAK-HLTGQKADLSMKGSPYWMAPE 512
             L +LHS   I+RD+K  N+L+D  G +KL DFG++K  +  +K   S  G+  +MAPE
Sbjct: 137 LALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPE 196

Query: 513 LMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMF-KVMRDTPAIPDS 571
           +   V ++G +     + D WS G  + EM TG  P+   +        +++    +P  
Sbjct: 197 V---VNRRGHTQ----SADWWSFGVLMFEMLTGTLPFQG-KDRKETMTMILKAKLGMPQF 248

Query: 572 LSPEGKDFLRCCFQRNPADR 591
           LSPE +  LR  F+RNPA+R
Sbjct: 249 LSPEAQSLLRMLFKRNPANR 268

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score =  158 bits (401), Expect = 2e-43
 Identities = 77/321 (23%), Positives = 130/321 (40%), Gaps = 82/321 (25%)

Query: 340 SQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDD------PKSAESIKQLEQEI 393
           S+++    IG G +G+VY A +  +G   A+K V +          P S   ++    E+
Sbjct: 9   SRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPIST--VR----EV 62

Query: 394 KVLSHLK---HPNIVQYYGSEIV-------EDKFYIYLEYVHPGSINKYVREH-CGAITE 442
            +L  L+   HPN+V+    ++        E K  +  E+V    +  Y+ +     +  
Sbjct: 63  ALLRRLEAFEHPNVVRLM--DVCATSRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPA 119

Query: 443 SVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSM 502
             +++  R  L GL +LH+   +HRD+K  N+LV + G VKLADFG+A+          +
Sbjct: 120 ETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLAR----------I 169

Query: 503 KGSPYWM----------APELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPW--- 549
                 +          APE+++        S  A  VD+WS+GC   EM+  KP +   
Sbjct: 170 YSYQMALTPVVVTLWYRAPEVLLQ-------STYATPVDMWSVGCIFAEMFRRKPLFCGN 222

Query: 550 SEYEGAAAMFKVMRDTP---------AIPDS----------------LSPEGKDFLRCCF 584
           SE +    +F ++   P         ++P                  +   G   L    
Sbjct: 223 SEADQLGKIFDLIG-LPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEML 281

Query: 585 QRNPADRPPASLLLEHRFLKN 605
             NP  R  A   L+H +L  
Sbjct: 282 TFNPHKRISAFRALQHSYLHK 302

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  157 bits (399), Expect = 5e-43
 Identities = 64/303 (21%), Positives = 119/303 (39%), Gaps = 52/303 (17%)

Query: 333 PEPLPMNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQE 392
                 +   Q  ++  RG FG V+ A         A+K   IFP      +   Q E E
Sbjct: 17  ENLYFQSMPLQLLEVKARGRFGCVWKAQLLNEYV--AVK---IFP---IQDKQSWQNEYE 68

Query: 393 IKVLSHLKHPNIVQYYGSEI----VEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNF 448
           +  L  +KH NI+Q+ G+E     V+   ++   +   GS++ +++ +   ++ + + + 
Sbjct: 69  VYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKAN--VVSWNELCHI 126

Query: 449 TRHILSGLAYLHSKKT----------IHRDIKGANLLVDASGVVKLADFGMAKHLTGQKA 498
              +  GLAYLH               HRDIK  N+L+  +    +ADFG+A      K+
Sbjct: 127 AETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKS 186

Query: 499 DLSMK---GSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWS----E 551
                   G+  +MAPE++   +      D+ L +D++++G  + E+ +          E
Sbjct: 187 AGDTHGQVGTRRYMAPEVLEGAIN--FQRDAFLRIDMYAMGLVLWELASRCTAADGPVDE 244

Query: 552 YE-------GAAAMFKVMRDT-------PAIPDSLSPEG-----KDFLRCCFQRNPADRP 592
           Y        G     + M++        P + D            + +  C+  +   R 
Sbjct: 245 YMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARL 304

Query: 593 PAS 595
            A 
Sbjct: 305 SAG 307

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score =  160 bits (407), Expect = 6e-43
 Identities = 76/271 (28%), Positives = 128/271 (47%), Gaps = 25/271 (9%)

Query: 346 KLIGRGTFGSVYVASNRETGALCAMKEV---DIFPDDPKSAESIKQLEQEIKVLSHLKHP 402
           KL+G+GTFG V +   + TG   AMK +    I   D      +     E +VL + +HP
Sbjct: 154 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKD-----EVAHTLTENRVLQNSRHP 208

Query: 403 NIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSK 462
            +     S    D+    +EY + G +  ++       +E   R +   I+S L YLHS+
Sbjct: 209 FLTALKYSFQTHDRLCFVMEYANGGELFFHLS-RERVFSEDRARFYGAEIVSALDYLHSE 267

Query: 463 KTI-HRDIKGANLLVDASGVVKLADFGMAK-HLTGQKADLSMKGSPYWMAPELMMAVMQK 520
           K + +RD+K  NL++D  G +K+ DFG+ K  +       +  G+P ++APE++      
Sbjct: 268 KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVL------ 321

Query: 521 GKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMF-KVMRDTPAIPDSLSPEGKDF 579
            + +D   AVD W LG  + EM  G+ P+   +    +F  ++ +    P +L PE K  
Sbjct: 322 -EDNDYGRAVDWWGLGVVMYEMMCGRLPFYN-QDHEKLFELILMEEIRFPRTLGPEAKSL 379

Query: 580 LRCCFQRNPADR-----PPASLLLEHRFLKN 605
           L    +++P  R       A  +++HRF   
Sbjct: 380 LSGLLKKDPKQRLGGGSEDAKEIMQHRFFAG 410

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score =  157 bits (399), Expect = 8e-43
 Identities = 67/260 (25%), Positives = 121/260 (46%), Gaps = 27/260 (10%)

Query: 346 KLIGRGTFGSVYVASNRETGALCAMKEV---DIFPDDPKSAESIKQLEQEIKVLSH-LKH 401
           ++IGRG++  V +   ++T  + AMK V    +  D+      I  ++ E  V      H
Sbjct: 15  RVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDE-----DIDWVQTEKHVFEQASNH 69

Query: 402 PNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHS 461
           P +V  +     E + +  +EYV+ G +  +++     + E   R ++  I   L YLH 
Sbjct: 70  PFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQ-RQRKLPEEHARFYSAEISLALNYLHE 128

Query: 462 KKTIHRDIKGANLLVDASGVVKLADFGMAK-HLTGQKADLSMKGSPYWMAPELMMAVMQK 520
           +  I+RD+K  N+L+D+ G +KL D+GM K  L       +  G+P ++APE+   +  +
Sbjct: 129 RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEI---LRGE 185

Query: 521 GKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAA--------MF-KVMRDTPAIPDS 571
                   +VD W+LG  + EM  G+ P+     +          +F  ++     IP S
Sbjct: 186 DYG----FSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRS 241

Query: 572 LSPEGKDFLRCCFQRNPADR 591
           LS +    L+    ++P +R
Sbjct: 242 LSVKAASVLKSFLNKDPKER 261

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  156 bits (397), Expect = 1e-42
 Identities = 66/292 (22%), Positives = 115/292 (39%), Gaps = 50/292 (17%)

Query: 343 QKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHP 402
              + IG+G FG V+    R  G   A+K   IF    + +      E EI     L+H 
Sbjct: 45  VLQESIGKGRFGEVWRGKWR--GEEVAVK---IFSSREERSW---FREAEIYQTVMLRHE 96

Query: 403 NIVQYYGSEIVED----KFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAY 458
           NI+ +  ++  ++    + ++  +Y   GS+  Y+  +   +T   +        SGLA+
Sbjct: 97  NILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAH 154

Query: 459 LHSKKT--------IHRDIKGANLLVDASGVVKLADFGMA--KHLTGQKADLSMK---GS 505
           LH +           HRD+K  N+LV  +G   +AD G+A          D++     G+
Sbjct: 155 LHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGT 214

Query: 506 PYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTG----------KPPWSEYEGA 555
             +MAPE++   +   K  +S    DI+++G    E+             + P+ +   +
Sbjct: 215 KRYMAPEVLDDSINM-KHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPS 273

Query: 556 AAMFKVMRDT-------PAIPDSLS-----PEGKDFLRCCFQRNPADRPPAS 595
               + MR         P IP+              +R C+  N A R  A 
Sbjct: 274 DPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTAL 325

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score =  163 bits (415), Expect = 1e-42
 Identities = 76/258 (29%), Positives = 128/258 (49%), Gaps = 28/258 (10%)

Query: 346 KLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQ------EIKVL--- 396
           ++IGRG FG VY     +TG + AMK +D      K  + IK  +       E  +L   
Sbjct: 195 RIIGRGGFGEVYGCRKADTGKMYAMKCLD------K--KRIKMKQGETLALNERIMLSLV 246

Query: 397 SHLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGL 456
           S    P IV    +    DK    L+ ++ G +  Y     G  +E+ +R +   I+ GL
Sbjct: 247 STGDCPFIVCMSYAFHTPDKLSFILDLMNGGDL-HYHLSQHGVFSEADMRFYAAEIILGL 305

Query: 457 AYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPYWMAPELMMA 516
            ++H++  ++RD+K AN+L+D  G V+++D G+A   + +K   +  G+  +MAPE    
Sbjct: 306 EHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH-ASVGTHGYMAPE---- 360

Query: 517 VMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGA--AAMF-KVMRDTPAIPDSLS 573
           V+QKG + DS  + D +SLGC + ++  G  P+ +++      +    +     +PDS S
Sbjct: 361 VLQKGVAYDS--SADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFS 418

Query: 574 PEGKDFLRCCFQRNPADR 591
           PE +  L    QR+   R
Sbjct: 419 PELRSLLEGLLQRDVNRR 436

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score =  155 bits (395), Expect = 2e-42
 Identities = 83/329 (25%), Positives = 139/329 (42%), Gaps = 80/329 (24%)

Query: 340 SQWQKGKLIGRGTFGSVYVASN-RETGALCAMKEVDIFPDD---PKSAESIKQLEQEIKV 395
            Q++    IG G +G V+ A + +  G   A+K V +   +   P S   I+    E+ V
Sbjct: 11  QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLST--IR----EVAV 64

Query: 396 LSHLK---HPNIVQYYGSEIV-------EDKFYIYLEYVHPGSINKYVREH-CGAITESV 444
           L HL+   HPN+V+ +  ++        E K  +  E+V    +  Y+ +     +    
Sbjct: 65  LRHLETFEHPNVVRLF--DVCTVSRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTET 121

Query: 445 VRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKG 504
           +++    +L GL +LHS + +HRD+K  N+LV +SG +KLADFG+A+          +  
Sbjct: 122 IKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLAR----------IYS 171

Query: 505 SPYWM----------APELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPW---SE 551
               +          APE+++        S  A  VD+WS+GC   EM+  KP +   S+
Sbjct: 172 FQMALTSVVVTLWYRAPEVLL-------QSSYATPVDLWSVGCIFAEMFRRKPLFRGSSD 224

Query: 552 YEGAAAMFKVMRDTP---------AIPDS----------------LSPEGKDFLRCCFQR 586
            +    +  V+   P         A+P                  +   GKD L  C   
Sbjct: 225 VDQLGKILDVIG-LPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTF 283

Query: 587 NPADRPPASLLLEHRFLKNSQQPDVPSCS 615
           NPA R  A   L H + ++ ++      S
Sbjct: 284 NPAKRISAYSALSHPYFQDLERCKENLDS 312

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score =  156 bits (397), Expect = 5e-42
 Identities = 70/310 (22%), Positives = 131/310 (42%), Gaps = 38/310 (12%)

Query: 307 EVHPLPLPPGAAVLSPSATIPQVAAKPEPLPMNSQWQKG-----------KLIGRGTFGS 355
             H   +P    +    A    +  + E +      +             ++IGRG++  
Sbjct: 8   HHHDYDIPTTENLYFQGAMGSGIEEEKEAMNTRESGKASSSLGLQDFDLLRVIGRGSYAK 67

Query: 356 VYVASNRETGALCAMKEV---DIFPDDPKSAESIKQLEQEIKVLSH-LKHPNIVQYYGSE 411
           V +   ++T  + AM+ V    +  D+      I  ++ E  V      HP +V  +   
Sbjct: 68  VLLVRLKKTDRIYAMRVVKKELVNDDE-----DIDWVQTEKHVFEQASNHPFLVGLHSCF 122

Query: 412 IVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKG 471
             E + +  +EYV+ G +  +++     + E   R ++  I   L YLH +  I+RD+K 
Sbjct: 123 QTESRLFFVIEYVNGGDLMFHMQ-RQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKL 181

Query: 472 ANLLVDASGVVKLADFGMAK-HLTGQKADLSMKGSPYWMAPELMMAVMQKGKSSDSALAV 530
            N+L+D+ G +KL D+GM K  L       +  G+P ++APE+   +  +        +V
Sbjct: 182 DNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEI---LRGEDYGF----SV 234

Query: 531 DIWSLGCTIIEMYTGKPPWSEYEGAAA--------MF-KVMRDTPAIPDSLSPEGKDFLR 581
           D W+LG  + EM  G+ P+     +          +F  ++     IP SLS +    L+
Sbjct: 235 DWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVLK 294

Query: 582 CCFQRNPADR 591
               ++P +R
Sbjct: 295 SFLNKDPKER 304

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score =  155 bits (394), Expect = 6e-42
 Identities = 90/349 (25%), Positives = 146/349 (41%), Gaps = 70/349 (20%)

Query: 340 SQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLE-QEIKVLSH 398
            ++Q  ++ G+GTFG+V +   + TG   A+K+V     DP      +  E Q ++ L+ 
Sbjct: 23  DRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKV---IQDP----RFRNRELQIMQDLAV 75

Query: 399 LKHPNIVQ---YYGSEIVEDKFYIYL----EYVHPGSINKYVREHCGA---ITESVVRNF 448
           L HPNIVQ   Y+ +    D+  IYL    EYV P ++++  R +          +++ F
Sbjct: 76  LHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYV-PDTLHRCCRNYYRRQVAPPPILIKVF 134

Query: 449 TRHILSGLAYLH--SKKTIHRDIKGANLLVD-ASGVVKLADFGMAKHLTGQKADLSMKGS 505
              ++  +  LH  S    HRDIK  N+LV+ A G +KL DFG AK L+  + +++   S
Sbjct: 135 LFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYICS 194

Query: 506 PYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKP------------------ 547
            Y+ APEL+        +     AVDIWS+GC   EM  G+P                  
Sbjct: 195 RYYRAPELIF------GNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVL 248

Query: 548 --P----WSEYEGAAAMFKVMRDTPAIP---------DSLSPEGKDFLRCCFQRNPADRP 592
             P      +   +      + ++  IP            + E  D L    Q  P +R 
Sbjct: 249 GCPSREVLRKLNPSHTDVD-LYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERM 307

Query: 593 PASLLLEHRFLK-----NSQQP---DVPSCSLSFSGMQLTEKPHSPREK 633
                L H +        ++ P   D+P     F   ++     + + K
Sbjct: 308 KPYEALCHPYFDELHDPATKLPNNKDLPEDLFRFLPNEIEVMSEAQKAK 356

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score =  154 bits (392), Expect = 9e-42
 Identities = 73/252 (28%), Positives = 127/252 (50%), Gaps = 20/252 (7%)

Query: 346 KLIGRGTFGSVYVASNRETGALCAMKEV---DIFPDDPKSAESIKQLEQEIKVLSH-LKH 401
           K++G+G+FG V++A  ++T    A+K +    +  DD    E       E +VLS   +H
Sbjct: 23  KMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDD--DVECTMV---EKRVLSLAWEH 77

Query: 402 PNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHS 461
           P +   + +   ++  +  +EY++ G +  +++  C     S    +   I+ GL +LHS
Sbjct: 78  PFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQS-CHKFDLSRATFYAAEIILGLQFLHS 136

Query: 462 KKTIHRDIKGANLLVDASGVVKLADFGMAK-HLTGQKADLSMKGSPYWMAPELMMAVMQK 520
           K  ++RD+K  N+L+D  G +K+ADFGM K ++ G     +  G+P ++APE+   ++ +
Sbjct: 137 KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEI---LLGQ 193

Query: 521 GKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMF-KVMRDTPAIPDSLSPEGKDF 579
             +     +VD WS G  + EM  G+ P+   +    +F  +  D P  P  L  E KD 
Sbjct: 194 KYNH----SVDWWSFGVLLYEMLIGQSPFHG-QDEEELFHSIRMDNPFYPRWLEKEAKDL 248

Query: 580 LRCCFQRNPADR 591
           L   F R P  R
Sbjct: 249 LVKLFVREPEKR 260

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score =  156 bits (396), Expect = 9e-42
 Identities = 73/289 (25%), Positives = 124/289 (42%), Gaps = 23/289 (7%)

Query: 346 KLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIV 405
           K+IGRG F  V V   ++TG + AMK ++    D      +    +E  VL +     I 
Sbjct: 67  KVIGRGAFSEVAVVKMKQTGQVYAMKIMN--KWDMLKRGEVSCFREERDVLVNGDRRWIT 124

Query: 406 QYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTI 465
           Q + +   E+  Y+ +EY   G +   + +    I   + R +   I+  +  +H    +
Sbjct: 125 QLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYV 184

Query: 466 HRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMK--GSPYWMAPELMMAVMQKGKS 523
           HRDIK  N+L+D  G ++LADFG    L       S+   G+P +++PE++ AV     +
Sbjct: 185 HRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGT 244

Query: 524 SDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMF-KVMRDT-----PAIPDSLSPEGK 577
                  D W+LG    EM+ G+ P+   +  A  + K++        P + + +  E +
Sbjct: 245 GSYGPECDWWALGVFAYEMFYGQTPFYA-DSTAETYGKIVHYKEHLSLPLVDEGVPEEAR 303

Query: 578 DFLRCCFQRNPADR---PPASLLLEHRF--------LKNSQQPDVPSCS 615
           DF++      P  R     A     H F        L++S  P  P   
Sbjct: 304 DFIQ-RLLCPPETRLGRGGAGDFRTHPFFFGLDWDGLRDSVPPFTPDFE 351

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score =  154 bits (392), Expect = 1e-41
 Identities = 73/252 (28%), Positives = 121/252 (48%), Gaps = 20/252 (7%)

Query: 346 KLIGRGTFGSVYVASNRETGALCAMKEV---DIFPDDPKSAESIKQLEQEIKVLSH-LKH 401
           +++G+G+FG V +A  +ETG L A+K +    I  DD    E       E ++LS    H
Sbjct: 29  RVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDD--DVECTMT---EKRILSLARNH 83

Query: 402 PNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHS 461
           P + Q +      D+ +  +E+V+ G +  +++       E+  R +   I+S L +LH 
Sbjct: 84  PFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQ-KSRRFDEARARFYAAEIISALMFLHD 142

Query: 462 KKTIHRDIKGANLLVDASGVVKLADFGMAK-HLTGQKADLSMKGSPYWMAPELMMAVMQK 520
           K  I+RD+K  N+L+D  G  KLADFGM K  +       +  G+P ++APE+   + + 
Sbjct: 143 KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATFCGTPDYIAPEI---LQEM 199

Query: 521 GKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMF-KVMRDTPAIPDSLSPEGKDF 579
                   AVD W++G  + EM  G  P+   E    +F  ++ D    P  L  +    
Sbjct: 200 LYG----PAVDWWAMGVLLYEMLCGHAPFEA-ENEDDLFEAILNDEVVYPTWLHEDATGI 254

Query: 580 LRCCFQRNPADR 591
           L+    +NP  R
Sbjct: 255 LKSFMTKNPTMR 266

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score =  154 bits (392), Expect = 1e-41
 Identities = 69/252 (27%), Positives = 120/252 (47%), Gaps = 20/252 (7%)

Query: 346 KLIGRGTFGSVYVASNRETGALCAMKEV---DIFPDDPKSAESIKQLEQEIKVLSH-LKH 401
            ++G+G+FG V ++  + T  L A+K +    +  DD    E       E +VL+   K 
Sbjct: 26  MVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDD--DVECTMV---EKRVLALPGKP 80

Query: 402 PNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHS 461
           P + Q +      D+ Y  +EYV+ G +  ++ +  G   E     +   I  GL +L S
Sbjct: 81  PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHI-QQVGRFKEPHAVFYAAEIAIGLFFLQS 139

Query: 462 KKTIHRDIKGANLLVDASGVVKLADFGMAK-HLTGQKADLSMKGSPYWMAPELMMAVMQK 520
           K  I+RD+K  N+++D+ G +K+ADFGM K ++       +  G+P ++APE+   +  +
Sbjct: 140 KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEI---IAYQ 196

Query: 521 GKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMF-KVMRDTPAIPDSLSPEGKDF 579
                   +VD W+ G  + EM  G+ P+   E    +F  +M    A P S+S E    
Sbjct: 197 PYGK----SVDWWAFGVLLYEMLAGQAPFEG-EDEDELFQSIMEHNVAYPKSMSKEAVAI 251

Query: 580 LRCCFQRNPADR 591
            +    ++P  R
Sbjct: 252 CKGLMTKHPGKR 263

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score =  154 bits (391), Expect = 1e-41
 Identities = 72/258 (27%), Positives = 126/258 (48%), Gaps = 21/258 (8%)

Query: 346 KLIGRGTFGSVYVA---SNRETGALCAMKEV--DIFPDDPKSAESIKQLEQEIKVLSHLK 400
           K++G G +G V++    S  +TG L AMK +         K+ E  +    E +VL H++
Sbjct: 60  KVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRT---ERQVLEHIR 116

Query: 401 H-PNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYL 459
             P +V  + +   E K ++ L+Y++ G +  ++       TE  V+ +   I+  L +L
Sbjct: 117 QSPFLVTLHYAFQTETKLHLILDYINGGELFTHLS-QRERFTEHEVQIYVGEIVLALEHL 175

Query: 460 HSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADL--SMKGSPYWMAPELMMAV 517
           H    I+RDIK  N+L+D++G V L DFG++K     + +      G+  +MAP+++   
Sbjct: 176 HKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRG- 234

Query: 518 MQKGKSSDSALAVDIWSLGCTIIEMYTGKPPW---SEYEGAAAMF-KVMRDTPAIPDSLS 573
              G       AVD WSLG  + E+ TG  P+    E    A +  ++++  P  P  +S
Sbjct: 235 GDSGHDK----AVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMS 290

Query: 574 PEGKDFLRCCFQRNPADR 591
              KD ++    ++P  R
Sbjct: 291 ALAKDLIQRLLMKDPKKR 308

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  152 bits (386), Expect = 3e-41
 Identities = 70/319 (21%), Positives = 124/319 (38%), Gaps = 59/319 (18%)

Query: 330 AAKPEPLPMNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQL 389
           AA  EP       +  +LIGRG +G+VY  S  E     A+K   +F     + ++    
Sbjct: 3   AAASEPSLDLDNLKLLELIGRGRYGAVYKGSLDERPV--AVK---VFS--FANRQNFIN- 54

Query: 390 EQEIKVLSHLKHPNIVQYYGSEI-----VEDKFYIYLEYVHPGSINKYVREHCGAITESV 444
           E+ I  +  ++H NI ++   +         ++ + +EY   GS+ KY+  H        
Sbjct: 55  EKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLH--TSDWVS 112

Query: 445 VRNFTRHILSGLAYLHSKKT---------IHRDIKGANLLVDASGVVKLADFGMAKHLTG 495
                  +  GLAYLH++            HRD+   N+LV   G   ++DFG++  LTG
Sbjct: 113 SCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTG 172

Query: 496 ------QKADLSMK---GSPYWMAPELMMAVMQKGKSSDSALAVDIWSLG---------C 537
                  + D +     G+  +MAPE++   +       +   VD+++LG         C
Sbjct: 173 NRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRC 232

Query: 538 TIIEMYTG----KPPWSEYEGAAAMFKVMRDT-------PAIPDSLSPEG------KDFL 580
           T +         +  +    G    F+ M+         P  P++           K+ +
Sbjct: 233 TDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETI 292

Query: 581 RCCFQRNPADRPPASLLLE 599
             C+ ++   R  A    E
Sbjct: 293 EDCWDQDAEARLTAQXAEE 311

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score =  153 bits (390), Expect = 3e-41
 Identities = 67/252 (26%), Positives = 118/252 (46%), Gaps = 20/252 (7%)

Query: 346 KLIGRGTFGSVYVASNRETGALCAMKEV---DIFPDDPKSAESIKQLEQEIKVLS-HLKH 401
           K+IG+G+FG V +A ++      A+K +    I        + I     E  VL  ++KH
Sbjct: 44  KVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKK--EEKHIMS---ERNVLLKNVKH 98

Query: 402 PNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHS 461
           P +V  + S    DK Y  L+Y++ G +  +++       E   R +   I S L YLHS
Sbjct: 99  PFLVGLHFSFQTADKLYFVLDYINGGELFYHLQ-RERCFLEPRARFYAAEIASALGYLHS 157

Query: 462 KKTIHRDIKGANLLVDASGVVKLADFGMAK-HLTGQKADLSMKGSPYWMAPELMMAVMQK 520
              ++RD+K  N+L+D+ G + L DFG+ K ++       +  G+P ++APE+   + ++
Sbjct: 158 LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEV---LHKQ 214

Query: 521 GKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMF-KVMRDTPAIPDSLSPEGKDF 579
                    VD W LG  + EM  G PP+      A M+  ++     +  +++   +  
Sbjct: 215 PYDR----TVDWWCLGAVLYEMLYGLPPFYS-RNTAEMYDNILNKPLQLKPNITNSARHL 269

Query: 580 LRCCFQRNPADR 591
           L    Q++   R
Sbjct: 270 LEGLLQKDRTKR 281

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  153 bits (389), Expect = 5e-41
 Identities = 70/262 (26%), Positives = 109/262 (41%), Gaps = 20/262 (7%)

Query: 345 GKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNI 404
           G+ IGRG FG V+    R    L A+K       +    +   +  QE ++L    HPNI
Sbjct: 119 GEQIGRGNFGEVFSGRLRADNTLVAVKSCR----ETLPPDLKAKFLQEARILKQYSHPNI 174

Query: 405 VQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKT 464
           V+  G    +   YI +E V  G    ++R     +    +        +G+ YL SK  
Sbjct: 175 VRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCC 234

Query: 465 IHRDIKGANLLVDASGVVKLADFGMAKHLTGQ--KADLSMKGSPY-WMAPELMMAVMQKG 521
           IHRD+   N LV    V+K++DFGM++        A   ++  P  W APE     +  G
Sbjct: 235 IHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPE----ALNYG 290

Query: 522 K-SSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFKVMRDT--PAIPDSLSPEGK 577
           + SS+S    D+WS G  + E ++ G  P+           V +    P  P+       
Sbjct: 291 RYSSES----DVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRLPC-PELCPDAVF 345

Query: 578 DFLRCCFQRNPADRPPASLLLE 599
             +  C+   P  RP  S + +
Sbjct: 346 RLMEQCWAYEPGQRPSFSTIYQ 367

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score =  151 bits (383), Expect = 5e-41
 Identities = 73/331 (22%), Positives = 116/331 (35%), Gaps = 78/331 (23%)

Query: 345 GKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHL-KHPN 403
            +++G G  G V    N+ T    A+K +              +  +E+++     + P+
Sbjct: 23  SQVLGLGINGKVLQIFNKRTQEKFALKMLQ----------DCPKARREVELHWRASQCPH 72

Query: 404 IVQYYG----SEIVEDKFYIYLEYVHPG----SINKYVREHCGAITESVVRNFTRHILSG 455
           IV+                I +E +  G     I    R    A TE       + I   
Sbjct: 73  IVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQD--RGD-QAFTEREASEIMKSIGEA 129

Query: 456 LAYLHSKKTIHRDIKGANLLV---DASGVVKLADFGMAKHLTGQKADLSMKGSPYWMAPE 512
           + YLHS    HRD+K  NLL      + ++KL DFG AK  TG+K         Y     
Sbjct: 130 IQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTGEK---------Y----- 175

Query: 513 LMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT---GKPP-WSEYEGA--AAMF-KVMRDT 565
                    KS       D+WSLG  +I MY    G PP +S +  A    M  ++    
Sbjct: 176 --------DKS------CDMWSLG--VI-MYILLCGYPPFYSNHGLAISPGMKTRIRMGQ 218

Query: 566 PAIP----DSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQ-PDVPSCSLSFSG 620
              P      +S E K  +R   +  P  R   +  + H ++  S + P  P  +     
Sbjct: 219 YEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLK 278

Query: 621 MQLTEKPHSPREKADAKYDQVAALSSSRSSR 651
                      +K   +  +    S+  + R
Sbjct: 279 E----------DKERWEDVKEEMTSALATMR 299

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  150 bits (380), Expect = 2e-40
 Identities = 70/281 (24%), Positives = 119/281 (42%), Gaps = 48/281 (17%)

Query: 343 QKGKLIGRGTFGSVYVA----SNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSH 398
           +    +G+G FGSV +         TGAL A+K++          +  +  ++EI++L  
Sbjct: 26  KYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQ-----HSGPDQQRDFQREIQILKA 80

Query: 399 LKHPNIVQYYG--SEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGL 456
           L    IV+Y G           + +EY+  G +  +++ H   +  S +  ++  I  G+
Sbjct: 81  LHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGM 140

Query: 457 AYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHL--------TGQKADLSMKGSPYW 508
            YL S++ +HRD+   N+LV++   VK+ADFG+AK L          +     +     W
Sbjct: 141 EYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIF----W 196

Query: 509 MAPELMMAVMQKGK-SSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFKVMRDTP 566
            APE     +     S  S    D+WS G  + E++T      S       M    RD P
Sbjct: 197 YAPE----SLSDNIFSRQS----DVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVP 248

Query: 567 AI---------------PDSLSPEGKDFLRCCFQRNPADRP 592
           A+               P +   E  + ++ C+  +P DRP
Sbjct: 249 ALSRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRP 289

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score =  152 bits (387), Expect = 2e-40
 Identities = 64/256 (25%), Positives = 109/256 (42%), Gaps = 23/256 (8%)

Query: 346 KLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLE-----QEIKVLSHLK 400
           K+IGRG FG V V   +    + AMK +          E +K+ E     +E  VL +  
Sbjct: 80  KVIGRGAFGEVAVVKLKNADKVFAMKIL-------NKWEMLKRAETACFREERDVLVNGD 132

Query: 401 HPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLH 460
              I   + +   ++  Y+ ++Y   G +   + +    + E + R +   ++  +  +H
Sbjct: 133 SKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVH 192

Query: 461 SKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMK--GSPYWMAPELMMAVM 518
               +HRDIK  N+L+D +G ++LADFG    L       S    G+P +++PE++ A  
Sbjct: 193 QLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQA-- 250

Query: 519 QKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMF-KVMRDT-----PAIPDSL 572
            +G         D WSLG  + EM  G+ P+   E     + K+M        P     +
Sbjct: 251 MEGGKGRYGPECDWWSLGVCMYEMLYGETPFYA-ESLVETYGKIMNHKERFQFPTQVTDV 309

Query: 573 SPEGKDFLRCCFQRNP 588
           S   KD +R       
Sbjct: 310 SENAKDLIRRLICSRE 325

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score =  151 bits (384), Expect = 4e-40
 Identities = 67/258 (25%), Positives = 120/258 (46%), Gaps = 26/258 (10%)

Query: 346 KLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLE-----QEIKVLSHLK 400
           K+IGRG FG V +  ++ T  + AMK +          E IK+ +     +E  +++   
Sbjct: 75  KVIGRGAFGEVQLVRHKSTRKVYAMKLL-------SKFEMIKRSDSAFFWEERDIMAFAN 127

Query: 401 HPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLH 460
            P +VQ + +   +   Y+ +EY+  G +   +  +   + E   R +T  ++  L  +H
Sbjct: 128 SPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYD--VPEKWARFYTAEVVLALDAIH 185

Query: 461 SKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLS--MKGSPYWMAPELMMAVM 518
           S   IHRD+K  N+L+D SG +KLADFG    +  +         G+P +++PE+   + 
Sbjct: 186 SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEV---LK 242

Query: 519 QKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMF-KVM--RDTPAIPDS--LS 573
            +G         D WS+G  + EM  G  P+   +     + K+M  +++   PD   +S
Sbjct: 243 SQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYA-DSLVGTYSKIMNHKNSLTFPDDNDIS 301

Query: 574 PEGKDFLRCCFQRNPADR 591
            E K+ +   F  +   R
Sbjct: 302 KEAKNLIC-AFLTDREVR 318

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  148 bits (376), Expect = 4e-40
 Identities = 70/301 (23%), Positives = 121/301 (40%), Gaps = 52/301 (17%)

Query: 329 VAAKPEPLPMNSQWQ-------KGKLIGRGTFGSVYVA----SNRETGALCAMKEVDIFP 377
           + ++ +P               + + +G G FG V +         TG   A+K +    
Sbjct: 3   IVSEKKPATEVDPTHFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLK--- 59

Query: 378 DDPKSAESIKQLEQEIKVLSHLKHPNIVQYYG--SEIVEDKFYIYLEYVHPGSINKYVRE 435
                   I  L++EI++L +L H NIV+Y G  +E   +   + +E++  GS+ +Y+ +
Sbjct: 60  -PESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPK 118

Query: 436 HCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHL-- 493
           +   I       +   I  G+ YL S++ +HRD+   N+LV++   VK+ DFG+ K +  
Sbjct: 119 NKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIET 178

Query: 494 ------TGQKADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GK 546
                      D  +     W APE    +MQ      S    D+WS G T+ E+ T   
Sbjct: 179 DKEYYTVKDDRDSPVF----WYAPE---CLMQSKFYIAS----DVWSFGVTLHELLTYCD 227

Query: 547 PPWSEYEGAAAMFKV----MRDTPAI-----------PDSLSPEGKDFLRCCFQRNPADR 591
              S       M       M  T  +           P +   E    +R C++  P++R
Sbjct: 228 SDSSPMALFLKMIGPTHGQMTVTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNR 287

Query: 592 P 592
            
Sbjct: 288 T 288

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score =  154 bits (391), Expect = 1e-39
 Identities = 78/446 (17%), Positives = 156/446 (34%), Gaps = 25/446 (5%)

Query: 157 SSSNSPIASVFSRRVGRKMPEFFDTKSSRSVNLALNYVERSRDNFRLNIPAKSAPTSPFT 216
            + ++        +                  + ++    S    +L +       S   
Sbjct: 153 GTDHTERRGRIYIQAHIDREVLIVVVRDAKNLVPMDPNGLSDPYVKLKLIPDPKSESKQK 212

Query: 217 SPVRSPQRSVGGMFQYKVPNGNQGWSAPEMPTLDIPGLPPPAFFDYTVFSAESSPFHSPR 276
           +       +      ++               +    L     F  ++    S    +  
Sbjct: 213 TKTIKSSLNPEWNETFRFQLKESDKDRRLSVEIWDWDLTSRNDFMGSLSFGISELQKAGV 272

Query: 277 SRSPCRNAISPSGPSSPIHSKLSRESTVRIEVHPLPLPPGAAVLSPSATIPQVAAKPEPL 336
                  +       +        E    +         G    +P        +K +  
Sbjct: 273 DGWFKLLSQEEGEYFNVPVPPEGSEGNEELRQKFERAKIGQGTKAPEEKTANTISKFDNN 332

Query: 337 PMNSQWQKG-----KLIGRGTFGSVYVASNRETGALCAMKEV---DIFPDDPKSAESIKQ 388
               + +        ++G+G+FG V ++  + T  L A+K +    +  DD      ++ 
Sbjct: 333 GNRDRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDD-----DVEC 387

Query: 389 LEQEIKVLSH-LKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRN 447
              E +VL+   K P + Q +      D+ Y  +EYV+ G +  ++ +  G   E     
Sbjct: 388 TMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHI-QQVGRFKEPHAVF 446

Query: 448 FTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAK-HLTGQKADLSMKGSP 506
           +   I  GL +L SK  I+RD+K  N+++D+ G +K+ADFGM K ++       +  G+P
Sbjct: 447 YAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFCGTP 506

Query: 507 YWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMF-KVMRDT 565
            ++APE+   +  +        +VD W+ G  + EM  G+ P+   E    +F  +M   
Sbjct: 507 DYIAPEI---IAYQPYGK----SVDWWAFGVLLYEMLAGQAPFEG-EDEDELFQSIMEHN 558

Query: 566 PAIPDSLSPEGKDFLRCCFQRNPADR 591
            A P S+S E     +    ++P  R
Sbjct: 559 VAYPKSMSKEAVAICKGLMTKHPGKR 584

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score =  148 bits (376), Expect = 1e-39
 Identities = 80/319 (25%), Positives = 138/319 (43%), Gaps = 62/319 (19%)

Query: 346 KLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIV 405
            L+G G +G V  A+++ TG + A+K+++ F D P  A    +  +EIK+L H KH NI+
Sbjct: 17  SLLGEGAYGVVCSATHKPTGEIVAIKKIEPF-DKPLFA---LRTLREIKILKHFKHENII 72

Query: 406 Q----YYGSEIVEDK-FYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLH 460
                            YI  E +    +++ +      +++  ++ F    L  +  LH
Sbjct: 73  TIFNIQRPDSFENFNEVYIIQELM-QTDLHRVIS--TQMLSDDHIQYFIYQTLRAVKVLH 129

Query: 461 SKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSP-----------YWM 509
               IHRD+K +NLL++++  +K+ DFG+A+ +    AD S                ++ 
Sbjct: 130 GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYR 189

Query: 510 APELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKP--------------------PW 549
           APE+M+   +  +      A+D+WS GC + E++  +P                    P 
Sbjct: 190 APEVMLTSAKYSR------AMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPH 243

Query: 550 SEY-------EGAAAMFKVMRDTPAIP-DSL----SPEGKDFLRCCFQRNPADRPPASLL 597
           S+          A    K +   PA P + +    +P+G D L+     +PA R  A   
Sbjct: 244 SDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEA 303

Query: 598 LEHRFLKNSQQP-DVPSCS 615
           LEH +L+    P D P   
Sbjct: 304 LEHPYLQTYHDPNDEPEGE 322

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score =  148 bits (375), Expect = 3e-39
 Identities = 68/335 (20%), Positives = 120/335 (35%), Gaps = 87/335 (25%)

Query: 340 SQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHL 399
            ++  GK +G G+FG V    + E+G   A+K+V     DP+         +E+ ++  L
Sbjct: 7   KKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKV---LQDPRYKN------RELDIMKVL 57

Query: 400 KHPNIVQ------------------------------------YYGSEIVEDKFYIYL-- 421
            H NI++                                               Y+ +  
Sbjct: 58  DHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIM 117

Query: 422 EYVHPGSINKYVREHCGA---ITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDA 478
           EYV P +++K ++    +   I  +++  +   +   + ++HS    HRDIK  NLLV++
Sbjct: 118 EYV-PDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNS 176

Query: 479 -SGVVKLADFGMAKHLTGQKADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGC 537
               +KL DFG AK L   +  ++   S ++ APELM+   +         ++D+WS+GC
Sbjct: 177 KDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTP------SIDLWSIGC 230

Query: 538 TIIEMYTGKP--PWSEY------------------------EGAAAMFKVMRDTP---AI 568
              E+  GKP                                     F  ++       +
Sbjct: 231 VFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKIL 290

Query: 569 PDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFL 603
           P+       D L    +  P  R      + H F 
Sbjct: 291 PEGTPSLAIDLLEQILRYEPDLRINPYEAMAHPFF 325

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  145 bits (368), Expect = 4e-39
 Identities = 71/283 (25%), Positives = 120/283 (42%), Gaps = 51/283 (18%)

Query: 343 QKGKLIGRGTFGSVYVA----SNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSH 398
           +  + +G+G FGSV +         TG + A+K++        + E ++  E+EI++L  
Sbjct: 13  KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-----HSTEEHLRDFEREIEILKS 67

Query: 399 LKHPNIVQYYG--SEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGL 456
           L+H NIV+Y G           + +EY+  GS+  Y+++H   I    +  +T  I  G+
Sbjct: 68  LQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGM 127

Query: 457 AYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHL--------TGQKADLSMKGSPYW 508
            YL +K+ IHRD+   N+LV+    VK+ DFG+ K L          +  +  +     W
Sbjct: 128 EYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIF----W 183

Query: 509 MAPELMMAVMQKGK-SSDSALAVDIWSLGCTIIEMYT----------------GKPPWSE 551
            APE     + + K S  S    D+WS G  + E++T                G     +
Sbjct: 184 YAPE----SLTESKFSVAS----DVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQ 235

Query: 552 YEGAAAMFKVMRDT--PAIPDSLSPEGKDFLRCCFQRNPADRP 592
                 +  +  +   P  PD    E    +  C+  N   RP
Sbjct: 236 MIVFHLIELLKNNGRLPR-PDGCPDEIYMIMTECWNNNVNQRP 277

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score =  147 bits (372), Expect = 5e-39
 Identities = 77/321 (23%), Positives = 135/321 (42%), Gaps = 61/321 (19%)

Query: 340 SQWQKGKLIGRGTFGSVYVASNRETGALCAMKEV-DIFPDDPKSAESIKQLEQEIKVLSH 398
             +     +G G +GSV  A ++ +G   A+K++   F      A   K+  +E+ +L H
Sbjct: 24  KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF-QSEIFA---KRAYRELLLLKH 79

Query: 399 LKHPNIVQYY-----GSEIVEDK-FYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHI 452
           ++H N++         S +     FY+ + ++    + K +       +E  ++     +
Sbjct: 80  MQHENVIGLLDVFTPASSLRNFYDFYLVMPFM-QTDLQKIMGLK---FSEEKIQYLVYQM 135

Query: 453 LSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKG---SPYWM 509
           L GL Y+HS   +HRD+K  NL V+    +K+ DFG+A+H     AD  M G   + ++ 
Sbjct: 136 LKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARH-----ADAEMTGYVVTRWYR 190

Query: 510 APELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKP--PWSEY--------------- 552
           APE++++ M   +       VDIWS+GC + EM TGK      +Y               
Sbjct: 191 APEVILSWMHYNQ------TVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPG 244

Query: 553 ---------EGAAAMFKVMRDTPAIP-DSL----SPEGKDFLRCCFQRNPADRPPASLLL 598
                    + A +  + +  TP      L    SP+  D L    + +   R  A+  L
Sbjct: 245 TEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQAL 304

Query: 599 EHRFLKNSQQP-DVPSCSLSF 618
            H F +  + P +       F
Sbjct: 305 THPFFEPFRDPEEETEAQQPF 325

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  145 bits (369), Expect = 6e-39
 Identities = 73/318 (22%), Positives = 124/318 (38%), Gaps = 59/318 (18%)

Query: 315 PGAAVLSPSATIPQVAAKPEPLPMNSQW-------QKGKLIGRGTFGSVYVA----SNRE 363
               + +      Q  A                  +  + +G+G FGSV +         
Sbjct: 10  HDYDIPTTENLYFQ-GAMGSAFEDRDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDN 68

Query: 364 TGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYG--SEIVEDKFYIYL 421
           TG + A+K++        + E ++  E+EI++L  L+H NIV+Y G           + +
Sbjct: 69  TGEVVAVKKLQ-----HSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIM 123

Query: 422 EYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGV 481
           EY+  GS+  Y+++H   I    +  +T  I  G+ YL +K+ IHRD+   N+LV+    
Sbjct: 124 EYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENR 183

Query: 482 VKLADFGMAKHL--------TGQKADLSMKGSPYWMAPELMMAVMQKGK-SSDSALAVDI 532
           VK+ DFG+ K L          +  +  +     W APE     + + K S  S    D+
Sbjct: 184 VKIGDFGLTKVLPQDKEYYKVKEPGESPIF----WYAPE----SLTESKFSVAS----DV 231

Query: 533 WSLGCTIIEMYT----------------GKPPWSEYEGAAAMFKVMRDT--PAIPDSLSP 574
           WS G  + E++T                G     +      +  +  +   P  PD    
Sbjct: 232 WSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPR-PDGCPD 290

Query: 575 EGKDFLRCCFQRNPADRP 592
           E    +  C+  N   RP
Sbjct: 291 EIYMIMTECWNNNVNQRP 308

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  145 bits (368), Expect = 1e-38
 Identities = 69/285 (24%), Positives = 121/285 (42%), Gaps = 41/285 (14%)

Query: 343 QKGKLIGRGTFGSVY----VASNRETGALCAMKEVDIFPDDPKSAESIKQLE---QEIKV 395
           +K K++G G FG+VY    +    +     A+KE+       + A S K  +    E  V
Sbjct: 18  KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL-------REATSPKANKEILDEAYV 70

Query: 396 LSHLKHPNIVQYYGSEIV-EDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILS 454
           ++ + +P++ +  G  I       +  + +  G +  YVREH   I    + N+   I  
Sbjct: 71  MASVDNPHVCRLLG--ICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAK 128

Query: 455 GLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGS--PY-WMAP 511
           G+ YL  ++ +HRD+   N+LV     VK+ DFG+AK L  ++ +   +G   P  WMA 
Sbjct: 129 GMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 188

Query: 512 ELMMAVMQKGK-SSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFKVMR----DT 565
           E     +     +  S    D+WS G T+ E+ T G  P+     +     + +      
Sbjct: 189 E----SILHRIYTHQS----DVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQ 240

Query: 566 PAI-PDSLSPEGKDFLRCCFQRNPADRPPASLLLEH--RFLKNSQ 607
           P I    +       +R C+  +   RP    L+    +  ++ Q
Sbjct: 241 PPICTIDVY----MIMRKCWMIDADSRPKFRELIIEFSKMARDPQ 281

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  142 bits (361), Expect = 2e-38
 Identities = 63/268 (23%), Positives = 118/268 (44%), Gaps = 45/268 (16%)

Query: 345 GKLIGRGTFGSVYVA---SNRETGALCAMKEVDIFPDDPKSAESIKQLE---QEIKVLSH 398
            +++G G FG VY     +++      A+K         K   ++   E    E  ++ +
Sbjct: 17  NRILGEGFFGEVYEGVYTNHKGEKINVAVKTC-------KKDCTLDNKEKFMSEAVIMKN 69

Query: 399 LKHPNIVQYYGSEIVEDK-FYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLA 457
           L HP+IV+  G  I+E++  +I +E    G +  Y+  +  ++    +  ++  I   +A
Sbjct: 70  LDHPHIVKLIG--IIEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMA 127

Query: 458 YLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHL------TGQKADLSMKGSPYWMAP 511
           YL S   +HRDI   N+LV +   VKL DFG+++++            L +K    WM+P
Sbjct: 128 YLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIK----WMSP 183

Query: 512 ELMMAVMQKGK-SSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFKVMR----DT 565
           E     +   + ++ S    D+W     + E+ + GK P+   E    +  + +      
Sbjct: 184 E----SINFRRFTTAS----DVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLPK 235

Query: 566 PAI-PDSLSPEGKDFLRCCFQRNPADRP 592
           P + P  L       +  C+  +P+DRP
Sbjct: 236 PDLCPPVLY----TLMTRCWDYDPSDRP 259

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score =  144 bits (365), Expect = 5e-38
 Identities = 74/321 (23%), Positives = 123/321 (38%), Gaps = 56/321 (17%)

Query: 340 SQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHL 399
            ++     IG G +G V  A +       A+K++  F +        ++  +EIK+L   
Sbjct: 27  PRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPF-EHQTYC---QRTLREIKILLRF 82

Query: 400 KHPNIVQ----YYGSEIVEDK-FYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILS 454
           +H NI+          I + K  YI  + +    + K ++     ++   +  F   IL 
Sbjct: 83  RHENIIGINDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLK--TQHLSNDHICYFLYQILR 139

Query: 455 GLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPY----WM- 509
           GL Y+HS   +HRD+K +NLL++ +  +K+ DFG+A+             + Y    W  
Sbjct: 140 GLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFL-TEYVATRWYR 198

Query: 510 APELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKP--PWSEY--------------- 552
           APE+M+      K      ++DIWS+GC + EM + +P  P   Y               
Sbjct: 199 APEIMLNSKGYTK------SIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPS 252

Query: 553 ---------EGAAAMFKVMRDTPAIP-DSL----SPEGKDFLRCCFQRNPADRPPASLLL 598
                      A      +     +P + L      +  D L      NP  R      L
Sbjct: 253 QEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQAL 312

Query: 599 EHRFLKNSQQP-DVPSCSLSF 618
            H +L+    P D P     F
Sbjct: 313 AHPYLEQYYDPSDEPIAEAPF 333

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score =  145 bits (367), Expect = 5e-38
 Identities = 73/387 (18%), Positives = 130/387 (33%), Gaps = 96/387 (24%)

Query: 348 IGRGTFGSVYVASNRE--TGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIV 405
           +GRGT+G VY A  ++       A+K+++       S  + +    EI +L  LKHPN++
Sbjct: 29  VGRGTYGHVYKAKRKDGKDDKDYALKQIE---GTGISMSACR----EIALLRELKHPNVI 81

Query: 406 QYYGSEIV----EDKFYIYLEYV----------HPGSINKYVREHCGAITESVVRNFTRH 451
                ++     + K ++  +Y           H  S           +   +V++    
Sbjct: 82  SLQ--KVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQ---LPRGMVKSLLYQ 136

Query: 452 ILSGLAYLHSKKTIHRDIKGANLLVDAS----GVVKLADFGMAKHLTGQKADLSMKGSP- 506
           IL G+ YLH+   +HRD+K AN+LV       G VK+AD G A+        L+      
Sbjct: 137 ILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVV 196

Query: 507 --YWM-APELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKP---------------- 547
             +W  APEL++      K      A+DIW++GC   E+ T +P                
Sbjct: 197 VTFWYRAPELLLGARHYTK------AIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYH 250

Query: 548 -------------P----W---SEYEGAAAMFKVMRDTPAIPDS-----------LSPEG 576
                        P    W    +    + + K  R       S              + 
Sbjct: 251 HDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKA 310

Query: 577 KDFLRCCFQRNPADRPPASLLLEHRFLKNSQQPDVPSCSLSFSGMQLTEKPHSPREKADA 636
              L+     +P  R  +   ++  +      P               + P+  RE    
Sbjct: 311 FHLLQKLLTMDPIKRITSEQAMQDPYFLEDPLPTSDV-------FAGCQIPYPKREFLTE 363

Query: 637 KYDQVAALSSSRSSRKATLESENGRRS 663
           +         ++  ++    +      
Sbjct: 364 EEPDDKGDKKNQQQQQGNNHTNGTGHP 390

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  141 bits (359), Expect = 6e-38
 Identities = 68/261 (26%), Positives = 128/261 (49%), Gaps = 27/261 (10%)

Query: 345 GKLIGRGTFGSVYVASNRETGALCAMKEVDI-FPDDPKSAESIKQLEQEIKVLSHLKHPN 403
              +G G   +VY+A +       A+K + I   +     E++K+ E+E+   S L H N
Sbjct: 16  VDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKE---ETLKRFEREVHNSSQLSHQN 72

Query: 404 IVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKK 463
           IV     +  +D +Y+ +EY+   ++++Y+  H G ++     NFT  IL G+ + H  +
Sbjct: 73  IVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESH-GPLSVDTAINFTNQILDGIKHAHDMR 131

Query: 464 TIHRDIKGANLLVDASGVVKLADFGMAKHLTGQK--ADLSMKGSPYWMAPELMMAVMQ-K 520
            +HRDIK  N+L+D++  +K+ DFG+AK L+         + G+  + +PE      Q K
Sbjct: 132 IVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPE------QAK 185

Query: 521 GKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEG----AAAMFKVMRDTPAIP----DSL 572
           G+++D     DI+S+G  + EM  G+PP   + G    + A+  +    P +       +
Sbjct: 186 GEATDE--CTDIYSIGIVLYEMLVGEPP---FNGETAVSIAIKHIQDSVPNVTTDVRKDI 240

Query: 573 SPEGKDFLRCCFQRNPADRPP 593
                + +    +++ A+R  
Sbjct: 241 PQSLSNVILRATEKDKANRYK 261

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  142 bits (359), Expect = 1e-37
 Identities = 75/303 (24%), Positives = 127/303 (41%), Gaps = 50/303 (16%)

Query: 343 QKGKLIGRGTFGSVYVA----SNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSH 398
           +K + +G G FG V +     +N  TG + A+K +          +     +QEI +L  
Sbjct: 34  KKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALK----ADAGPQHRSGWKQEIDILRT 89

Query: 399 LKHPNIVQYYG--SEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGL 456
           L H +I++Y G   +       + +EYV  GS+  Y+  H  +I  + +  F + I  G+
Sbjct: 90  LYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRH--SIGLAQLLLFAQQICEGM 147

Query: 457 AYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHL--------TGQKADLSMKGSPYW 508
           AYLH++  IHRD+   N+L+D   +VK+ DFG+AK +          +  D  +     W
Sbjct: 148 AYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVF----W 203

Query: 509 MAPELMMAVMQKGK-SSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFKV----M 562
            APE     +++ K    S    D+WS G T+ E+ T      S       +  +    M
Sbjct: 204 YAPE----CLKEYKFYYAS----DVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQM 255

Query: 563 RDTPAI-----------PDSLSPEGKDFLRCCFQRNPADRPP-ASLLLEHRFLKNSQQPD 610
                            PD    E    ++ C++   + RP   +L+   + +    Q  
Sbjct: 256 TVLRLTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQGQ 315

Query: 611 VPS 613
            PS
Sbjct: 316 APS 318

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  140 bits (356), Expect = 1e-37
 Identities = 69/263 (26%), Positives = 118/263 (44%), Gaps = 26/263 (9%)

Query: 343 QKGKLIGRGTFGSVYVAS-NRETGAL--CAMKEVDIFPDDPKSAESIKQLEQEIKVLSHL 399
           +  + +G G+FG V     +  +G     A+K   + PD     E++    +E+  +  L
Sbjct: 21  RLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKC--LKPDVLSQPEAMDDFIREVNAMHSL 78

Query: 400 KHPNIVQYYGSEIV-EDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAY 458
            H N+++ YG  +V      +  E    GS+   +R+H G      +  +   +  G+ Y
Sbjct: 79  DHRNLIRLYG--VVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGY 136

Query: 459 LHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGS---PY-WMAPELM 514
           L SK+ IHRD+   NLL+    +VK+ DFG+ + L        M+     P+ W APE  
Sbjct: 137 LESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPE-- 194

Query: 515 MAVMQKGK-SSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFKVMRDT---PAIP 569
              ++    S  S    D W  G T+ EM+T G+ PW    G+  + K+ ++    P  P
Sbjct: 195 --SLKTRTFSHAS----DTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPR-P 247

Query: 570 DSLSPEGKDFLRCCFQRNPADRP 592
           +    +  + +  C+   P DRP
Sbjct: 248 EDCPQDIYNVMVQCWAHKPEDRP 270

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  139 bits (353), Expect = 4e-37
 Identities = 66/270 (24%), Positives = 116/270 (42%), Gaps = 49/270 (18%)

Query: 345 GKLIGRGTFGSVY-----VASNRETGALCAMKEVDIFPDDPKSAESIKQLE---QEIKVL 396
           G+ IG G FG V+        N       A+K         K+  S    E   QE   +
Sbjct: 20  GRCIGEGQFGDVHQGIYMSPENPAL--AVAIKTC-------KNCTSDSVREKFLQEALTM 70

Query: 397 SHLKHPNIVQYYGSEIV-EDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSG 455
               HP+IV+  G  ++ E+  +I +E    G +  +++    ++  + +  +   + + 
Sbjct: 71  RQFDHPHIVKLIG--VITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTA 128

Query: 456 LAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHL------TGQKADLSMKGSPYWM 509
           LAYL SK+ +HRDI   N+LV ++  VKL DFG+++++         K  L +K    WM
Sbjct: 129 LAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIK----WM 184

Query: 510 APELMMAVMQKGK-SSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFKVMR---- 563
           APE     +   + +S S    D+W  G  + E+   G  P+   +    + ++      
Sbjct: 185 APE----SINFRRFTSAS----DVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERL 236

Query: 564 DTPAI-PDSLSPEGKDFLRCCFQRNPADRP 592
             P   P +L       +  C+  +P+ RP
Sbjct: 237 PMPPNCPPTLY----SLMTKCWAYDPSRRP 262

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  138 bits (351), Expect = 4e-37
 Identities = 72/255 (28%), Positives = 114/255 (44%), Gaps = 24/255 (9%)

Query: 345 GKLIGRGTFGSVYVAS-NRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPN 403
            K +G G FG V +     +     A+K +       + + S  +  QE + +  L HP 
Sbjct: 13  LKELGSGQFGVVKLGKWKGQY--DVAVKMI------KEGSMSEDEFFQEAQTMMKLSHPK 64

Query: 404 IVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKK 463
           +V++YG    E   YI  EY+  G +  Y+R H   +  S +      +  G+A+L S +
Sbjct: 65  LVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQ 124

Query: 464 TIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGS-PY-WMAPELMMAVMQKG 521
            IHRD+   N LVD    VK++DFGM +++   +   S+    P  W APE    V    
Sbjct: 125 FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPE----VFHYF 180

Query: 522 K-SSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFKVMRDT--PAIPDSLSPEGK 577
           K SS S    D+W+ G  + E+++ GK P+  Y  +  + KV +       P   S    
Sbjct: 181 KYSSKS----DVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYR-PHLASDTIY 235

Query: 578 DFLRCCFQRNPADRP 592
             +  C+   P  RP
Sbjct: 236 QIMYSCWHELPEKRP 250

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  138 bits (351), Expect = 5e-37
 Identities = 64/256 (25%), Positives = 109/256 (42%), Gaps = 26/256 (10%)

Query: 345 GKLIGRGTFGSVYVASNRETG--ALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHP 402
            + IG G FG V++         A+  ++E  +  +D           +E +V+  L HP
Sbjct: 13  VQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEED---------FIEEAEVMMKLSHP 63

Query: 403 NIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSK 462
            +VQ YG  + +    +  E++  G ++ Y+R   G      +      +  G+AYL   
Sbjct: 64  KLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA 123

Query: 463 KTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGS-PY-WMAPELMMAVMQK 520
             IHRD+   N LV  + V+K++DFGM + +   +   S     P  W +PE    V   
Sbjct: 124 CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPE----VFSF 179

Query: 521 GK-SSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFKVMRDT--PAIPDSLSPEG 576
            + SS S    D+WS G  + E+++ GK P+     +  +  +         P   S   
Sbjct: 180 SRYSSKS----DVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYK-PRLASTHV 234

Query: 577 KDFLRCCFQRNPADRP 592
              +  C++  P DRP
Sbjct: 235 YQIMNHCWRERPEDRP 250

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  140 bits (354), Expect = 7e-37
 Identities = 67/290 (23%), Positives = 112/290 (38%), Gaps = 43/290 (14%)

Query: 327 PQVAAKPEPLPMNSQW-------QKGKLIGRGTFGSVY-----VASNRETGALCAMKEVD 374
           P    +P     +             K+IG G  G V      V   R+     A+K + 
Sbjct: 29  PHTYEEPGRAGRSFTREIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDV--PVAIKALK 86

Query: 375 IFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVR 434
                  +    +    E  ++    HPNI++  G         I  EY+  GS++ ++R
Sbjct: 87  ----AGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLR 142

Query: 435 EHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHL- 493
            H G  T   +    R + +G+ YL     +HRD+   N+LVD++ V K++DFG+++ L 
Sbjct: 143 THDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLE 202

Query: 494 -------TGQKADLSMKGSPYWMAPELMMAVMQKGK-SSDSALAVDIWSLGCTIIEMYT- 544
                  T     + ++    W APE     +     SS S    D+WS G  + E+   
Sbjct: 203 DDPDAAYTTTGGKIPIR----WTAPE----AIAFRTFSSAS----DVWSFGVVMWEVLAY 250

Query: 545 GKPPWSEYEGAAAMFKVMRDT--PAIPDSLSPEGKDFLRCCFQRNPADRP 592
           G+ P+        +  V      PA P          +  C+ ++ A RP
Sbjct: 251 GERPYWNMTNRDVISSVEEGYRLPA-PMGCPHALHQLMLDCWHKDRAQRP 299

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  142 bits (361), Expect = 8e-37
 Identities = 68/256 (26%), Positives = 117/256 (45%), Gaps = 26/256 (10%)

Query: 345 GKLIGRGTFGSVYVASNRETG--ALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHP 402
              +G+G FG V++ +   T   A+  +K   + P+            QE +V+  L+H 
Sbjct: 189 EVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA---------FLQEAQVMKKLRHE 239

Query: 403 NIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCG-AITESVVRNFTRHILSGLAYLHS 461
            +VQ Y   + E+  YI  EY+  GS+  +++   G  +    + +    I SG+AY+  
Sbjct: 240 KLVQLYAV-VSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER 298

Query: 462 KKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGS-PY-WMAPELMMAVMQ 519
              +HRD++ AN+LV  + V K+ADFG+A+ +   +         P  W APE   A + 
Sbjct: 299 MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPE---AALY 355

Query: 520 KGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFKVMRD--TPAIPDSLSPEG 576
              +  S    D+WS G  + E+ T G+ P+        + +V R    P  P       
Sbjct: 356 GRFTIKS----DVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPC-PPECPESL 410

Query: 577 KDFLRCCFQRNPADRP 592
            D +  C+++ P +RP
Sbjct: 411 HDLMCQCWRKEPEERP 426

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  138 bits (351), Expect = 1e-36
 Identities = 70/288 (24%), Positives = 127/288 (44%), Gaps = 34/288 (11%)

Query: 345 GKLIGRGTFGSVYVASNRETGALCAMKEVDI-FPDDPKSAESIKQLEQEIKVLSHLKHPN 403
           G+++G G    V++A +       A+K +      DP       +  +E +  + L HP 
Sbjct: 17  GEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDP---SFYLRFRREAQNAAALNHPA 73

Query: 404 IVQYY--GSEIVEDKFYIYL--EYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYL 459
           IV  Y  G          Y+  EYV   ++   V    G +T              L + 
Sbjct: 74  IVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTE-GPMTPKRAIEVIADACQALNFS 132

Query: 460 HSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADL----SMKGSPYWMAPELMM 515
           H    IHRD+K AN+++ A+  VK+ DFG+A+ +      +    ++ G+  +++PE   
Sbjct: 133 HQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPE--- 189

Query: 516 AVMQ-KGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAM---FKVMRDTPAIP-- 569
              Q +G S D+    D++SLGC + E+ TG+PP   + G + +   ++ +R+ P  P  
Sbjct: 190 ---QARGDSVDA--RSDVYSLGCVLYEVLTGEPP---FTGDSPVSVAYQHVREDPIPPSA 241

Query: 570 --DSLSPEGKDFLRCCFQRNPADRPP--ASLLLEHRFLKNSQQPDVPS 613
             + LS +    +     +NP +R    A +  +   + N + P+ P 
Sbjct: 242 RHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHNGEPPEAPK 289

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score =  140 bits (354), Expect = 2e-36
 Identities = 82/332 (24%), Positives = 137/332 (41%), Gaps = 65/332 (19%)

Query: 340 SQWQKGKLIGRGTFGSVYVASNRETGALCAMKEV-DIFPDDPKSAESIKQLEQEIKVLSH 398
            ++Q    +G G +GSV  A + +TG   A+K++   F      A   K+  +E+++L H
Sbjct: 29  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHA---KRTYRELRLLKH 84

Query: 399 LKHPNIVQYY-------GSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRH 451
           +KH N++            E   D  Y+    +    +N  V+  C  +T+  V+     
Sbjct: 85  MKHENVIGLLDVFTPARSLEEFND-VYLVTHLM-GADLNNIVK--CQKLTDDHVQFLIYQ 140

Query: 452 ILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKG---SPYW 508
           IL GL Y+HS   IHRD+K +NL V+    +K+ DFG+A+H   +     M G   + ++
Sbjct: 141 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTADE-----MTGYVATRWY 195

Query: 509 MAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKP--PWSEY-------------- 552
            APE+M+  M   +       VDIWS+GC + E+ TG+   P +++              
Sbjct: 196 RAPEIMLNWMHYNQ------TVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTP 249

Query: 553 ----------EGAAAMFKVMRDTPAIP-DSL----SPEGKDFLRCCFQRNPADRPPASLL 597
                     E A    + +   P +   ++    +P   D L      +   R  A+  
Sbjct: 250 GAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQA 309

Query: 598 LEHRFLKNSQQP-DVPSC---SLSFSGMQLTE 625
           L H +      P D P       S     L  
Sbjct: 310 LAHAYFAQYHDPDDEPVADPYDQSLESRDLLI 341

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  137 bits (348), Expect = 2e-36
 Identities = 61/256 (23%), Positives = 109/256 (42%), Gaps = 26/256 (10%)

Query: 348 IGRGTFGSVYVAS-NRETGALC-AMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIV 405
           +G G FGSV           +  A+K   +           +++ +E +++  L +P IV
Sbjct: 18  LGCGNFGSVRQGVYRMRKKQIDVAIKV--LKQGT--EKADTEEMMREAQIMHQLDNPYIV 73

Query: 406 QYYGSEIVEDK-FYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKT 464
           +  G  + + +   + +E    G ++K++      I  S V      +  G+ YL  K  
Sbjct: 74  RLIG--VCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNF 131

Query: 465 IHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGS---PY-WMAPELMMAVMQK 520
           +HRD+   N+L+      K++DFG++K L    +  + + +   P  W APE     +  
Sbjct: 132 VHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPE----CINF 187

Query: 521 GK-SSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFKVMRDT--PAIPDSLSPEG 576
            K SS S    D+WS G T+ E  + G+ P+ + +G   M  + +       P    PE 
Sbjct: 188 RKFSSRS----DVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMEC-PPECPPEL 242

Query: 577 KDFLRCCFQRNPADRP 592
              +  C+     DRP
Sbjct: 243 YALMSDCWIYKWEDRP 258

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  136 bits (346), Expect = 3e-36
 Identities = 65/260 (25%), Positives = 112/260 (43%), Gaps = 34/260 (13%)

Query: 345 GKLIGRGTFGSVY--VASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHP 402
            K +G G FG V       +   A+  +KE          + S  +  +E KV+ +L H 
Sbjct: 29  LKELGTGQFGVVKYGKWRGQYDVAIKMIKE---------GSMSEDEFIEEAKVMMNLSHE 79

Query: 403 NIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSK 462
            +VQ YG    +   +I  EY+  G +  Y+RE         +    + +   + YL SK
Sbjct: 80  KLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESK 139

Query: 463 KTIHRDIKGANLLVDASGVVKLADFGMAKHLTG------QKADLSMKGSPYWMAPELMMA 516
           + +HRD+   N LV+  GVVK++DFG+++++          +   ++    W  PE    
Sbjct: 140 QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVR----WSPPE---- 191

Query: 517 VMQKGK-SSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFKVMRDT--PAIPDSL 572
           V+   K SS S    DIW+ G  + E+Y+ GK P+  +  +     + +       P   
Sbjct: 192 VLMYSKFSSKS----DIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYR-PHLA 246

Query: 573 SPEGKDFLRCCFQRNPADRP 592
           S +    +  C+     +RP
Sbjct: 247 SEKVYTIMYSCWHEKADERP 266

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  136 bits (345), Expect = 5e-36
 Identities = 61/264 (23%), Positives = 111/264 (42%), Gaps = 34/264 (12%)

Query: 344 KGKLIGRGTFGSVYVA--SNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKH 401
           + K +G G FG+V       ++     A+K   I  ++        +L  E  V+  L +
Sbjct: 21  EDKELGSGNFGTVKKGYYQMKKVVKTVAVK---ILKNEANDPALKDELLAEANVMQQLDN 77

Query: 402 PNIVQYYGSEIVEDK-FYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLH 460
           P IV+  G  I E + + + +E    G +NKY++++   + +  +      +  G+ YL 
Sbjct: 78  PYIVRMIG--ICEAESWMLVMEMAELGPLNKYLQQN-RHVKDKNIIELVHQVSMGMKYLE 134

Query: 461 SKKTIHRDIKGANLLVDASGVVKLADFGMAKHL--------TGQKADLSMKGSPYWMAPE 512
               +HRD+   N+L+      K++DFG++K L                +K    W APE
Sbjct: 135 ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVK----WYAPE 190

Query: 513 LMMAVMQKGK-SSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFKVMRDT--PAI 568
                +   K SS S    D+WS G  + E ++ G+ P+   +G+     + +       
Sbjct: 191 ----CINYYKFSSKS----DVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGC- 241

Query: 569 PDSLSPEGKDFLRCCFQRNPADRP 592
           P     E  D +  C+  +  +RP
Sbjct: 242 PAGCPREMYDLMNLCWTYDVENRP 265

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  142 bits (360), Expect = 9e-36
 Identities = 75/344 (21%), Positives = 137/344 (39%), Gaps = 56/344 (16%)

Query: 281 CRNAISPSGPSSPIHSKLSRESTVRIEVHPLPLPPGAAVLSPSATIPQVAAKPEPL---- 336
           CR  +      S I             +  L       V S + ++ +     E +    
Sbjct: 318 CR--LVNGATQSFIIRPQKEGERALPSIPKLANNEKQGVRSHTVSVSETDDYAEIIDEED 375

Query: 337 ----PMNSQWQ-------KGKLIGRGTFGSVY--VASNRETGAL-CAMKEVDIFPDDPKS 382
               P    ++        G+ IG G FG V+  +  + E  A+  A+K         K+
Sbjct: 376 TYTMPSTRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTC-------KN 428

Query: 383 AESIKQLE---QEIKVLSHLKHPNIVQYYGSEIVEDK-FYIYLEYVHPGSINKYVREHCG 438
             S    E   QE   +    HP+IV+  G  ++ +   +I +E    G +  +++    
Sbjct: 429 CTSDSVREKFLQEALTMRQFDHPHIVKLIG--VITENPVWIIMELCTLGELRSFLQVRKF 486

Query: 439 AITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHL----- 493
           ++  + +  +   + + LAYL SK+ +HRDI   N+LV ++  VKL DFG+++++     
Sbjct: 487 SLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTY 546

Query: 494 -TGQKADLSMKGSPYWMAPELMMAVMQKGK-SSDSALAVDIWSLGCTIIEMYT-GKPPWS 550
               K  L +K    WMAPE     +   + +S S    D+W  G  + E+   G  P+ 
Sbjct: 547 YKASKGKLPIK----WMAPE----SINFRRFTSAS----DVWMFGVCMWEILMHGVKPFQ 594

Query: 551 EYEGAAAMFKVMRDT--PAIPDSLSPEGKDFLRCCFQRNPADRP 592
             +    + ++      P  P +  P     +  C+  +P+ RP
Sbjct: 595 GVKNNDVIGRIENGERLPM-PPNCPPTLYSLMTKCWAYDPSRRP 637

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  140 bits (355), Expect = 1e-35
 Identities = 75/276 (27%), Positives = 127/276 (46%), Gaps = 23/276 (8%)

Query: 345 GKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNI 404
              +G G +G VY    ++     A+K   +  D  +  E +    +E  V+  +KHPN+
Sbjct: 225 KHKLGGGQYGEVYEGVWKKYSLTVAVK--TLKEDTMEVEEFL----KEAAVMKEIKHPNL 278

Query: 405 VQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCG-AITESVVRNFTRHILSGLAYLHSKK 463
           VQ  G    E  FYI  E++  G++  Y+RE     ++  V+      I S + YL  K 
Sbjct: 279 VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN 338

Query: 464 TIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGS-PY-WMAPELMMAVMQKG 521
            IHR++   N LV  + +VK+ADFG+++ +TG           P  W APE   ++    
Sbjct: 339 FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE---SLAYNK 395

Query: 522 KSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFKVMRD--TPAIPDSLSPEGKD 578
            S  S    D+W+ G  + E+ T G  P+   + +     + +D      P+    +  +
Sbjct: 396 FSIKS----DVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMER-PEGCPEKVYE 450

Query: 579 FLRCCFQRNPADRPPASLL---LEHRFLKNSQQPDV 611
            +R C+Q NP+DRP  + +    E  F ++S   +V
Sbjct: 451 LMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEV 486

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score =  137 bits (348), Expect = 1e-35
 Identities = 63/331 (19%), Positives = 120/331 (36%), Gaps = 77/331 (23%)

Query: 340 SQWQKGKLIGRGTFGSVYVASNRETGALCAMKEV-DIFPDDPKSAESIKQLEQEIKVLSH 398
            ++Q  K IG G  G V  A +       A+K++   F  +   A   K+  +E+ ++  
Sbjct: 25  KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPF-QNQTHA---KRAYRELVLMKC 80

Query: 399 LKHPNIVQ-------YYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRH 451
           + H NI+            E  +D  YI +E +   ++ + ++     +    +      
Sbjct: 81  VNHKNIIGLLNVFTPQKSLEEFQD-VYIVMELM-DANLCQVIQME---LDHERMSYLLYQ 135

Query: 452 ILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPYWM-- 509
           +L G+ +LHS   IHRD+K +N++V +   +K+ DFG+A+      A  S   +PY +  
Sbjct: 136 MLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART-----AGTSFMMTPYVVTR 190

Query: 510 ---APELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKP--PWSEY------------ 552
              APE+++              VDIWS+GC + EM  G    P +++            
Sbjct: 191 YYRAPEVIL-------GMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLG 243

Query: 553 -----------EGAAAMFKVMRDTPAIP-----------------DSLSPEGKDFLRCCF 584
                             +                             + + +D L    
Sbjct: 244 TPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKML 303

Query: 585 QRNPADRPPASLLLEHRFLKNSQQP-DVPSC 614
             + + R      L+H ++     P +  + 
Sbjct: 304 VIDASKRISVDEALQHPYINVWYDPSEAEAP 334

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score =  136 bits (345), Expect = 1e-35
 Identities = 71/313 (22%), Positives = 117/313 (37%), Gaps = 72/313 (23%)

Query: 340 SQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHL 399
             +Q  + +GRG +  V+ A N        +K   + P   K  +      +EIK+L +L
Sbjct: 36  DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKI--LKPVKKKKIK------REIKILENL 87

Query: 400 K-HPNIVQYYGSEIVEDKFYIYL--EYVHPGSINKYVREHCGAITESVVRNFTRHILSGL 456
           +  PNI+               L  E+V+     +  +     +T+  +R +   IL  L
Sbjct: 88  RGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ----TLTDYDIRFYMYEILKAL 143

Query: 457 AYLHSKKTIHRDIKGANLLVDAS-GVVKLADFGMA------KHLTGQKADLSMKGSPYWM 509
            Y HS   +HRD+K  N+++D     ++L D+G+A      +    + A      S Y+ 
Sbjct: 144 DYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVA------SRYFK 197

Query: 510 APELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPW----SEYEGAAAMFKV---- 561
            PEL++       S      +D+WSLGC +  M   K P+      Y+    + KV    
Sbjct: 198 GPELLVDYQMYDYS------LDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTE 251

Query: 562 ----------MRDTPAIPDSL--------------------SPEGKDFLRCCFQRNPADR 591
                     +   P   D L                    SPE  DFL    + +   R
Sbjct: 252 DLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSR 311

Query: 592 PPASLLLEHRFLK 604
             A   +EH +  
Sbjct: 312 LTAREAMEHPYFY 324

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score =  137 bits (347), Expect = 1e-35
 Identities = 69/337 (20%), Positives = 125/337 (37%), Gaps = 61/337 (18%)

Query: 340 SQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESI------KQLEQEI 393
           S +   + I  G++G+V    +   G   A+K V     D ++   +      K++ +EI
Sbjct: 22  SPYTVQRFISSGSYGAVCAGVDS-EGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREI 80

Query: 394 KVLSHLKHPNIVQYYGSEIVEDK-----FYIYLEYVHPGSINKYVREHCGAITESVVRNF 448
           ++L+H  HPNI+      +  ++      Y+  E +    + + + +    I+   ++ F
Sbjct: 81  RLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELM-RTDLAQVIHDQRIVISPQHIQYF 139

Query: 449 TRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKG---S 505
             HIL GL  LH    +HRD+   N+L+  +  + + DF +A+      AD +       
Sbjct: 140 MYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAR---EDTADANKTHYVTH 196

Query: 506 PYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKP--PWSEY----------- 552
            ++ APEL+M      K       VD+WS GC + EM+  K     S +           
Sbjct: 197 RWYRAPELVMQFKGFTK------LVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVV 250

Query: 553 -------------EGAAAMFKVMR-DTPAIP-DSL----SPEGKDFLRCCFQRNPADRPP 593
                          A    +    + PA    ++     P   D +    + NP  R  
Sbjct: 251 GTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRIS 310

Query: 594 ASLLLEHRFLKNSQQP-DVPSC---SLSFSGMQLTEK 626
               L H + ++   P D+         F        
Sbjct: 311 TEQALRHPYFESLFDPLDLTEGLSERFHFDESVTDVY 347

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score =  137 bits (348), Expect = 1e-35
 Identities = 77/326 (23%), Positives = 137/326 (42%), Gaps = 65/326 (19%)

Query: 346 KLIGRGTFGSVYVASNRETGALCAMKEV-DIFPDDPKSAESIKQLEQEIKVLSHLKHPNI 404
           + +G G +G+V  A +  TGA  A+K++   F      A   K+  +E+++L H++H N+
Sbjct: 31  QPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPF-QSELFA---KRAYRELRLLKHMRHENV 86

Query: 405 VQYY-------GSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLA 457
           +            +   D FY+ + ++    + K ++     + E  ++     +L GL 
Sbjct: 87  IGLLDVFTPDETLDDFTD-FYLVMPFM-GTDLGKLMK--HEKLGEDRIQFLVYQMLKGLR 142

Query: 458 YLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKG---SPYWMAPELM 514
           Y+H+   IHRD+K  NL V+    +K+ DFG+A+      AD  M G   + ++ APE++
Sbjct: 143 YIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQ-----ADSEMTGYVVTRWYRAPEVI 197

Query: 515 MAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKP--PWSEY-------------------- 552
           +  M+  +       VDIWS+GC + EM TGK     S++                    
Sbjct: 198 LNWMRYTQ------TVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQ 251

Query: 553 ----EGAAAMFKVMRDTPAIP-DSL----SPEGKDFLRCCFQRNPADRPPASLLLEHRFL 603
               + A    K + +       S+    SP   + L      +   R  A   L H + 
Sbjct: 252 RLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYF 311

Query: 604 KN----SQQPDVPSCSLSFSGMQLTE 625
           ++      +P V     SF  +  T 
Sbjct: 312 ESLHDTEDEPQVQKYDDSFDDVDRTL 337

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  135 bits (343), Expect = 1e-35
 Identities = 61/258 (23%), Positives = 105/258 (40%), Gaps = 23/258 (8%)

Query: 345 GKLIGRGTFGSVYVASNRETGALCAMKEVDI-FPDDPKSAESIKQLEQEIKVLSHLKHPN 403
            +L+GRG  G VY A +     + A+K +      DP       ++++E +    L+ P+
Sbjct: 39  RRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDP---VFRTRMQREARTAGRLQEPH 95

Query: 404 IVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKK 463
           +V  +    ++ + Y+ +  ++   +   +R   G +         R I S L   H+  
Sbjct: 96  VVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQ-GPLAPPRAVAIVRQIGSALDAAHAAG 154

Query: 464 TIHRDIKGANLLVDASGVVKLADFGMAKHLTGQK--ADLSMKGSPYWMAPELMMAVMQKG 521
             HRD+K  N+LV A     L DFG+A   T +K     +  G+ Y+MAPE         
Sbjct: 155 ATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERF-----SE 209

Query: 522 KSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEG--AAAMFKVMRDTP----AIPDSLSPE 575
             +      DI++L C + E  TG PP   Y+G   + M   +         +   +   
Sbjct: 210 SHATY--RADIYALTCVLYECLTGSPP---YQGDQLSVMGAHINQAIPRPSTVRPGIPVA 264

Query: 576 GKDFLRCCFQRNPADRPP 593
               +     +NP DR  
Sbjct: 265 FDAVIARGMAKNPEDRYV 282

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score =  137 bits (348), Expect = 1e-35
 Identities = 76/349 (21%), Positives = 136/349 (38%), Gaps = 89/349 (25%)

Query: 346 KLIGRGTFGSVYVASNRETGALCAMKEV-DIFPDDPKSAESIKQLEQEIKVLSHLK-HPN 403
           K +G+G +G V+ + +R TG + A+K++ D F  +   A   ++  +EI +L+ L  H N
Sbjct: 15  KKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAF-QNSTDA---QRTFREIMILTELSGHEN 70

Query: 404 IVQYYGSEIVEDKF---YIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLH 460
           IV    + +  D     Y+  +Y+    ++  +R     +     +     ++  + YLH
Sbjct: 71  IVNLL-NVLRADNDRDVYLVFDYM-ETDLHAVIR--ANILEPVHKQYVVYQLIKVIKYLH 126

Query: 461 SKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPYWM----------- 509
           S   +HRD+K +N+L++A   VK+ADFG+++     +   +                   
Sbjct: 127 SGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPI 186

Query: 510 -----------APELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKP--PWSEY---- 552
                      APE+++   +  K       +D+WSLGC + E+  GKP  P S      
Sbjct: 187 LTDYVATRWYRAPEILLGSTKYTK------GIDMWSLGCILGEILCGKPIFPGSSTMNQL 240

Query: 553 --------------------EGAAAMFKVMRDTPAIPDS--------------------- 571
                                 A  M + +++   I  S                     
Sbjct: 241 ERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKAD 300

Query: 572 LSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQP-DVPSCSLSFS 619
            + E  D L    Q NP  R  A+  L+H F+     P + P+C    +
Sbjct: 301 CNEEALDLLDKLLQFNPNKRISANDALKHPFVSIFHNPNEEPNCDHIIT 349

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  135 bits (343), Expect = 2e-35
 Identities = 72/288 (25%), Positives = 122/288 (42%), Gaps = 38/288 (13%)

Query: 327 PQVAAKPEPLPMNSQW-------QKGKLIGRGTFGSVYVA----SNRETGALCAMKEVDI 375
             + + P    +            + K+IG G FG VY      S+ +     A+K +  
Sbjct: 24  GAMGSDPNQAVLKFTTEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTL-- 81

Query: 376 FPDDPKSAESIKQLE---QEIKVLSHLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKY 432
                K+  + KQ      E  ++    H NI++  G         I  EY+  G+++K+
Sbjct: 82  -----KAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKF 136

Query: 433 VREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKH 492
           +RE  G  +   +    R I +G+ YL +   +HRD+   N+LV+++ V K++DFG+++ 
Sbjct: 137 LREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRV 196

Query: 493 LT-GQKADLSMKGS--PY-WMAPELMMAVMQKGK-SSDSALAVDIWSLGCTIIEMYT-GK 546
           L    +A  +  G   P  W APE     +   K +S S    D+WS G  + E+ T G+
Sbjct: 197 LEDDPEATYTTSGGKIPIRWTAPE----AISYRKFTSAS----DVWSFGIVMWEVMTYGE 248

Query: 547 PPWSEYEGAAAMFKVMRDT--PAIPDSLSPEGKDFLRCCFQRNPADRP 592
            P+ E      M  +      P  P          +  C+Q+  A RP
Sbjct: 249 RPYWELSNHEVMKAINDGFRLPT-PMDCPSAIYQLMMQCWQQERARRP 295

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score =  135 bits (342), Expect = 3e-35
 Identities = 78/315 (24%), Positives = 121/315 (38%), Gaps = 65/315 (20%)

Query: 340 SQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHL 399
           S++   K +G G  G V+ A + +     A+K++ +   DP+S    K   +EIK++  L
Sbjct: 11  SRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKI-VL-TDPQSV---KHALREIKIIRRL 65

Query: 400 KHPNIV-----------QYYGSEIVEDKF---YIYLEYVHPGSINKYVREHCGAITESVV 445
            H NIV           Q         +    YI  EY+    +   +    G + E   
Sbjct: 66  DHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYM-ETDLANVLE--QGPLLEEHA 122

Query: 446 RNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASG-VVKLADFGMAKHLTGQKADLSMKG 504
           R F   +L GL Y+HS   +HRD+K ANL ++    V+K+ DFG+A+ +    +      
Sbjct: 123 RLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHL- 181

Query: 505 SPY----WM-APELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKP--PWSEY----- 552
           S      W  +P L+++     K      A+D+W+ GC   EM TGK     +       
Sbjct: 182 SEGLVTKWYRSPRLLLSPNNYTK------AIDMWAAGCIFAEMLTGKTLFAGAHELEQMQ 235

Query: 553 ------------------EGAAAMFKVMRDTPAIP-DSL----SPEGKDFLRCCFQRNPA 589
                                    +     P  P   L    S E  DFL      +P 
Sbjct: 236 LILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPM 295

Query: 590 DRPPASLLLEHRFLK 604
           DR  A   L H ++ 
Sbjct: 296 DRLTAEEALSHPYMS 310

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  135 bits (341), Expect = 4e-35
 Identities = 65/266 (24%), Positives = 117/266 (43%), Gaps = 35/266 (13%)

Query: 343 QKGKLIGRGTFGSVY----VASNRETGALCAMKEVDIFPDDPKSAESIKQLE---QEIKV 395
           +K K++G G FG+VY    +    +     A+KE+       + A S K  +    E  V
Sbjct: 18  KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL-------REATSPKANKEILDEAYV 70

Query: 396 LSHLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSG 455
           ++ + +P++ +  G   +     +  + +  G +  YVREH   I    + N+   I  G
Sbjct: 71  MASVDNPHVCRLLGI-CLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKG 129

Query: 456 LAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGS--PY-WMAPE 512
           + YL  ++ +HRD+   N+LV     VK+ DFG+AK L  ++ +   +G   P  WMA E
Sbjct: 130 MNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 189

Query: 513 LMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFKVMR----DTPA 567
              +++ +  +  S    D+WS G T+ E+ T G  P+     +     + +      P 
Sbjct: 190 ---SILHRIYTHQS----DVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPP 242

Query: 568 I-PDSLSPEGKDFLRCCFQRNPADRP 592
           I    +       +  C+  +   RP
Sbjct: 243 ICTIDVY----MIMVKCWMIDADSRP 264

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  133 bits (337), Expect = 5e-35
 Identities = 73/275 (26%), Positives = 122/275 (44%), Gaps = 37/275 (13%)

Query: 336 LPMNSQW-------QKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQ 388
            P   +W            +G G +G VY    ++     A+K +       +    +++
Sbjct: 2   SPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL------KEDTMEVEE 55

Query: 389 LEQEIKVLSHLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCG-AITESVVRN 447
             +E  V+  +KHPN+VQ  G    E  FYI  E++  G++  Y+RE     ++  V+  
Sbjct: 56  FLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLY 115

Query: 448 FTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLT------GQKADLS 501
               I S + YL  K  IHRD+   N LV  + +VK+ADFG+++ +T         A   
Sbjct: 116 MATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFP 175

Query: 502 MKGSPYWMAPELMMAVMQKGK-SSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMF 559
           +K    W APE     +   K S  S    D+W+ G  + E+ T G  P+   + +    
Sbjct: 176 IK----WTAPE----SLAYNKFSIKS----DVWAFGVLLWEIATYGMSPYPGIDLSQVYE 223

Query: 560 KVMRDT--PAIPDSLSPEGKDFLRCCFQRNPADRP 592
            + +D      P+    +  + +R C+Q NP+DRP
Sbjct: 224 LLEKDYRMER-PEGCPEKVYELMRACWQWNPSDRP 257

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  137 bits (346), Expect = 8e-35
 Identities = 70/293 (23%), Positives = 130/293 (44%), Gaps = 35/293 (11%)

Query: 316 GAAVLSPSATIPQVAAKPEPLPMNSQW-------QKGKLIGRGTFGSVY--VASNRETGA 366
           G   L    ++P +++KP+       W       +  K +G G FG V+    +     A
Sbjct: 157 GNDGLCQKLSVPCMSSKPQKPWEKDAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVA 216

Query: 367 LCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYIYLEYVHP 426
           +  MK   +  +             E  V+  L+H  +V+ +   + ++  YI  E++  
Sbjct: 217 VKTMKPGSMSVEA---------FLAEANVMKTLQHDKLVKLHAV-VTKEPIYIITEFMAK 266

Query: 427 GSINKYVREHCGA-ITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLA 485
           GS+  +++   G+      + +F+  I  G+A++  +  IHRD++ AN+LV AS V K+A
Sbjct: 267 GSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIA 326

Query: 486 DFGMAKHLTGQKADLSMKGS-PY-WMAPELMMAVMQKGK-SSDSALAVDIWSLGCTIIEM 542
           DFG+A+ +   +         P  W APE     +  G  +  S    D+WS G  ++E+
Sbjct: 327 DFGLARVIEDNEYTAREGAKFPIKWTAPE----AINFGSFTIKS----DVWSFGILLMEI 378

Query: 543 YT-GKPPWSEYEGAAAMFKVMRD--TPAIPDSLSPEGKDFLRCCFQRNPADRP 592
            T G+ P+        +  + R    P  P++   E  + +  C++  P +RP
Sbjct: 379 VTYGRIPYPGMSNPEVIRALERGYRMPR-PENCPEELYNIMMRCWKNRPEERP 430

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  139 bits (351), Expect = 1e-34
 Identities = 72/342 (21%), Positives = 135/342 (39%), Gaps = 35/342 (10%)

Query: 268 ESSPFHSPRSRSPCRNAISPSGPSSPIHSKLSRESTVRIEVHP--LPLPPGAAVLSPSAT 325
            +S   +P   +       P      ++S        RI       P+P   +V     +
Sbjct: 261 NASGAAAPTLPAHPSTLTHPQRRIDTLNSDGYTPEPARITSPDKPRPMPMDTSVFESPFS 320

Query: 326 IP-QVAAKPEPLPMNSQWQKGKLIGRGTFGSVY----VASNRETG-ALCAMKEVDIFPDD 379
            P ++  K   L  ++       +G G FGSV         ++   A+  +K+       
Sbjct: 321 DPEELKDKKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQ------- 373

Query: 380 PKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDK-FYIYLEYVHPGSINKYVREHCG 438
                  +++ +E +++  L +P IV+  G  + + +   + +E    G ++K++     
Sbjct: 374 GTEKADTEEMMREAQIMHQLDNPYIVRLIG--VCQAEALMLVMEMAGGGPLHKFLVGKRE 431

Query: 439 AITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKA 498
            I  S V      +  G+ YL  K  +HR++   N+L+      K++DFG++K L    +
Sbjct: 432 EIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDS 491

Query: 499 DLSMKGS---PY-WMAPELMMAVMQKGK-SSDSALAVDIWSLGCTIIEMYT-GKPPWSEY 552
             + + +   P  W APE     +   K SS S    D+WS G T+ E  + G+ P+ + 
Sbjct: 492 YYTARSAGKWPLKWYAPE----CINFRKFSSRS----DVWSYGVTMWEALSYGQKPYKKM 543

Query: 553 EGAAAMFKVMRDT--PAIPDSLSPEGKDFLRCCFQRNPADRP 592
           +G   M  + +       P    PE    +  C+     DRP
Sbjct: 544 KGPEVMAFIEQGKRMEC-PPECPPELYALMSDCWIYKWEDRP 584

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  132 bits (334), Expect = 1e-34
 Identities = 64/257 (24%), Positives = 116/257 (45%), Gaps = 28/257 (10%)

Query: 345 GKLIGRGTFGSVY--VASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHP 402
            + +G G FG V+    +     A+ ++K+  + PD             E  ++  L+H 
Sbjct: 18  VERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA---------FLAEANLMKQLQHQ 68

Query: 403 NIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGA-ITESVVRNFTRHILSGLAYLHS 461
            +V+ Y   + ++  YI  EY+  GS+  +++   G  +T + + +    I  G+A++  
Sbjct: 69  RLVRLYA-VVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE 127

Query: 462 KKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGS-PY-WMAPELMMAVMQ 519
           +  IHRD++ AN+LV  +   K+ADFG+A+ +   +         P  W APE     + 
Sbjct: 128 RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPE----AIN 183

Query: 520 KGK-SSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFKVMRDT--PAIPDSLSPE 575
            G  +  S    D+WS G  + E+ T G+ P+        +  + R       PD+   E
Sbjct: 184 YGTFTIKS----DVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVR-PDNCPEE 238

Query: 576 GKDFLRCCFQRNPADRP 592
               +R C++  P DRP
Sbjct: 239 LYQLMRLCWKERPEDRP 255

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  132 bits (334), Expect = 1e-34
 Identities = 68/258 (26%), Positives = 116/258 (44%), Gaps = 34/258 (13%)

Query: 345 GKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNI 404
            + IG+G FG V +   R      A+K +       K+  + +    E  V++ L+H N+
Sbjct: 26  LQTIGKGEFGDVMLGDYRGNK--VAVKCI-------KNDATAQAFLAEASVMTQLRHSNL 76

Query: 405 VQYYGSEIV---EDKFYIYLEYVHPGSINKYVREHCG-AITESVVRNFTRHILSGLAYLH 460
           VQ  G  ++   +   YI  EY+  GS+  Y+R      +    +  F+  +   + YL 
Sbjct: 77  VQLLG--VIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE 134

Query: 461 SKKTIHRDIKGANLLVDASGVVKLADFGMAK--HLTGQKADLSMKGSPYWMAPELMMAVM 518
               +HRD+   N+LV    V K++DFG+ K    T     L +K    W APE     +
Sbjct: 135 GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVK----WTAPE----AL 186

Query: 519 QKGK-SSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFKVMRDT--PAIPDSLSP 574
           ++ K S+ S    D+WS G  + E+Y+ G+ P+        + +V +     A PD   P
Sbjct: 187 REKKFSTKS----DVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDA-PDGCPP 241

Query: 575 EGKDFLRCCFQRNPADRP 592
              + ++ C+  + A RP
Sbjct: 242 AVYEVMKNCWHLDAAMRP 259

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  132 bits (333), Expect = 2e-34
 Identities = 54/290 (18%), Positives = 107/290 (36%), Gaps = 47/290 (16%)

Query: 345 GKLIGRGTFGSVYVASNRETGAL-------CAMKEVDIFPDDPKSAESIKQLEQEIKVLS 397
            + +G+GTF  ++    RE G           +K +D            +   +   ++S
Sbjct: 13  NESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLD-----KAHRNYSESFFEAASMMS 67

Query: 398 HLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLA 457
            L H ++V  YG  +  D+  +  E+V  GS++ Y++++   I         + + + + 
Sbjct: 68  KLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMH 127

Query: 458 YLHSKKTIHRDIKGANLLVDASG--------VVKLADFGMAKHLTGQKADLSMKGSPY-W 508
           +L     IH ++   N+L+             +KL+D G++  +        +      W
Sbjct: 128 FLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITV----LPKDILQERIPW 183

Query: 509 MAPELMMAVMQKGK-SSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFKVMRDT- 565
           + PE    +      +  +    D WS G T+ E+ + G  P S  +    +        
Sbjct: 184 VPPE---CIENPKNLNLAT----DKWSFGTTLWEICSGGDKPLSALDSQRKLQFYEDRHQ 236

Query: 566 -PAIPDSLSPEGK---DFLRCCFQRNPADRPPASLLLEHRFLKNSQQPDV 611
            PA      P+     + +  C    P  RP    +   R L +   PD+
Sbjct: 237 LPA------PKAAELANLINNCMDYEPDHRPSFRAI--IRDLNSLFTPDL 278

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  132 bits (335), Expect = 2e-34
 Identities = 63/269 (23%), Positives = 114/269 (42%), Gaps = 41/269 (15%)

Query: 343 QKGKLIGRGTFGSVY----VASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSH 398
           +K K++G G FG+V+    +           +K   +  D     +S + +   +  +  
Sbjct: 16  RKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIK---VIEDKS-GRQSFQAVTDHMLAIGS 71

Query: 399 LKHPNIVQYYGSEIV-EDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLA 457
           L H +IV+  G  +       +  +Y+  GS+  +VR+H GA+   ++ N+   I  G+ 
Sbjct: 72  LDHAHIVRLLG--LCPGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMY 129

Query: 458 YLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHL-------TGQKADLSMKGSPYWMA 510
           YL     +HR++   N+L+ +   V++ADFG+A  L          +A   +K    WMA
Sbjct: 130 YLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIK----WMA 185

Query: 511 PELMMAVMQKGK-SSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFKVMR----D 564
            E     +  GK +  S    D+WS G T+ E+ T G  P++    A     + +     
Sbjct: 186 LE----SIHFGKYTHQS----DVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGERLA 237

Query: 565 TPAI-PDSLSPEGKDFLRCCFQRNPADRP 592
            P I    +       +  C+  +   RP
Sbjct: 238 QPQICTIDVY----MVMVKCWMIDENIRP 262

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  134 bits (338), Expect = 2e-34
 Identities = 68/287 (23%), Positives = 114/287 (39%), Gaps = 37/287 (12%)

Query: 327 PQVAAKPEPLPMNSQW-------QKGKLIGRGTFGSVYVASNRETGA---LCAMKEVDIF 376
           P     P                   K++G G FG V     +         A+K +   
Sbjct: 25  PHTFEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTL--- 81

Query: 377 PDDPKSAESIKQLE---QEIKVLSHLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYV 433
               K   + KQ      E  ++    HPNI++  G         I  EY+  GS++ ++
Sbjct: 82  ----KVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL 137

Query: 434 REHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHL 493
           R+H    T   +    R I SG+ YL     +HRD+   N+L++++ V K++DFG+ + L
Sbjct: 138 RKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVL 197

Query: 494 TGQK-ADLSMKGS--PY-WMAPELMMAVMQKGK-SSDSALAVDIWSLGCTIIEMYT-GKP 547
                A  + +G   P  W +PE     +   K +S S    D+WS G  + E+ + G+ 
Sbjct: 198 EDDPEAAYTTRGGKIPIRWTSPE----AIAYRKFTSAS----DVWSYGIVLWEVMSYGER 249

Query: 548 PWSEYEGAAAMFKVMRDT--PAIPDSLSPEGKDFLRCCFQRNPADRP 592
           P+ E      +  V      P  P          +  C+Q++  +RP
Sbjct: 250 PYWEMSNQDVIKAVDEGYRLPP-PMDCPAALYQLMLDCWQKDRNNRP 295

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  132 bits (334), Expect = 3e-34
 Identities = 59/298 (19%), Positives = 117/298 (39%), Gaps = 44/298 (14%)

Query: 333 PEPLPMNSQW-------QKGKLIGRGTFGSVY--VASNRETGAL-CAMKEVDIFPDDPKS 382
            E                 G+++G+G FGSV        +   +  A+K +     D  +
Sbjct: 9   DELKEKLEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKML---KADIIA 65

Query: 383 AESIKQLEQEIKVLSHLKHPNIVQYYG------SEIVEDKFYIYLEYVHPGSINKYVREH 436
           +  I++  +E   +    HP++ +  G      ++       + L ++  G ++ ++   
Sbjct: 66  SSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLAS 125

Query: 437 -----CGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAK 491
                   +    +  F   I  G+ YL S+  IHRD+   N ++     V +ADFG+++
Sbjct: 126 RIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSR 185

Query: 492 HL-------TGQKADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT 544
            +        G  + L +K    W+A E   ++     +  S    D+W+ G T+ E+ T
Sbjct: 186 KIYSGDYYRQGCASKLPVK----WLALE---SLADNLYTVHS----DVWAFGVTMWEIMT 234

Query: 545 -GKPPWSEYEGAAAMFKVMR-DTPAIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEH 600
            G+ P++  E A     ++  +    P     E  D +  C+  +P  RP  + L   
Sbjct: 235 RGQTPYAGIENAEIYNYLIGGNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRME 292

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  136 bits (344), Expect = 4e-34
 Identities = 68/256 (26%), Positives = 117/256 (45%), Gaps = 26/256 (10%)

Query: 345 GKLIGRGTFGSVYVASNRETG--ALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHP 402
              +G+G FG V++ +   T   A+  +K   + P+            QE +V+  L+H 
Sbjct: 272 EVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA---------FLQEAQVMKKLRHE 322

Query: 403 NIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCG-AITESVVRNFTRHILSGLAYLHS 461
            +VQ Y   + E+  YI  EY+  GS+  +++   G  +    + +    I SG+AY+  
Sbjct: 323 KLVQLYAV-VSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER 381

Query: 462 KKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGS-PY-WMAPELMMAVMQ 519
              +HRD++ AN+LV  + V K+ADFG+A+ +   +         P  W APE   A + 
Sbjct: 382 MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPE---AALY 438

Query: 520 KGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFKVMRD--TPAIPDSLSPEG 576
              +  S    D+WS G  + E+ T G+ P+        + +V R    P  P       
Sbjct: 439 GRFTIKS----DVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPC-PPECPESL 493

Query: 577 KDFLRCCFQRNPADRP 592
            D +  C+++ P +RP
Sbjct: 494 HDLMCQCWRKEPEERP 509

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  132 bits (333), Expect = 5e-34
 Identities = 69/309 (22%), Positives = 119/309 (38%), Gaps = 40/309 (12%)

Query: 345 GKLIGRGTFGSVYVA-----SNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHL 399
            + +G+G+FG VY          E     A+K V    +     E   +   E  V+   
Sbjct: 30  SRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTV---NEAASMRE-RIEFLNEASVMKEF 85

Query: 400 KHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRN---------FTR 450
              ++V+  G         + +E +  G +  Y+R    A+  + V              
Sbjct: 86  NCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAG 145

Query: 451 HILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHL-------TGQKADLSMK 503
            I  G+AYL++ K +HRD+   N +V     VK+ DFGM + +        G K  L ++
Sbjct: 146 EIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 205

Query: 504 GSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFKVM 562
               WM+PE   ++     ++ S    D+WS G  + E+ T  + P+        +  VM
Sbjct: 206 ----WMSPE---SLKDGVFTTYS----DVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVM 254

Query: 563 R-DTPAIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQPDVPSCSLSFSGM 621
                  PD+      + +R C+Q NP  RP    ++    +K   +P     S  +S  
Sbjct: 255 EGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS--IKEEMEPGFREVSFYYSEE 312

Query: 622 QLTEKPHSP 630
               +P   
Sbjct: 313 NKLPEPEEL 321

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  134 bits (339), Expect = 6e-34
 Identities = 71/283 (25%), Positives = 123/283 (43%), Gaps = 41/283 (14%)

Query: 327 PQVAAKPEPLPMNSQW-------QKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDD 379
            +     +     S W       +  + IG+G FG V +   R  G   A+K +      
Sbjct: 173 MEGTVAAQDEFYRSGWALNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCI------ 224

Query: 380 PKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIV---EDKFYIYLEYVHPGSINKYVREH 436
            K+  + +    E  V++ L+H N+VQ  G  ++   +   YI  EY+  GS+  Y+R  
Sbjct: 225 -KNDATAQAFLAEASVMTQLRHSNLVQLLG--VIVEEKGGLYIVTEYMAKGSLVDYLRSR 281

Query: 437 CG-AITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTG 495
               +    +  F+  +   + YL     +HRD+   N+LV    V K++DFG+ K  + 
Sbjct: 282 GRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 341

Query: 496 QKAD--LSMKGSPYWMAPELMMAVMQKGK-SSDSALAVDIWSLGCTIIEMYT-GKPPWSE 551
            +    L +K    W APE     +++ K S+ S    D+WS G  + E+Y+ G+ P+  
Sbjct: 342 TQDTGKLPVK----WTAPE----ALREKKFSTKS----DVWSFGILLWEIYSFGRVPYPR 389

Query: 552 YEGAAAMFKVMRD--TPAIPDSLSPEGKDFLRCCFQRNPADRP 592
                 + +V +     A PD   P   D ++ C+  + A RP
Sbjct: 390 IPLKDVVPRVEKGYKMDA-PDGCPPAVYDVMKNCWHLDAATRP 431

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  130 bits (329), Expect = 9e-34
 Identities = 67/270 (24%), Positives = 121/270 (44%), Gaps = 40/270 (14%)

Query: 343 QKGKLIGRGTFGSVY--VASNRETGAL-CAMKEVDIFPDDPKSAESIKQLEQEIKVLSHL 399
              ++IG+G FG VY     ++    + CA+K +          + ++   +E  ++  L
Sbjct: 24  HSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLS----RITEMQQVEAFLREGLLMRGL 79

Query: 400 KHPNIVQYYG-SEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAY 458
            HPN++   G     E   ++ L Y+  G + +++R      T   + +F   +  G+ Y
Sbjct: 80  NHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEY 139

Query: 459 LHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHL---------TGQKADLSMKGSPYWM 509
           L  +K +HRD+   N ++D S  VK+ADFG+A+ +           + A L +K    W 
Sbjct: 140 LAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVK----WT 195

Query: 510 APELMMAVMQKGK-SSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFKVMR---- 563
           A E     +Q  + ++ S    D+WS G  + E+ T G PP+   +       + +    
Sbjct: 196 ALE----SLQTYRFTTKS----DVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRL 247

Query: 564 DTPAI-PDSLSPEGKDFLRCCFQRNPADRP 592
             P   PDSL       ++ C++ +PA RP
Sbjct: 248 PQPEYCPDSLY----QVMQQCWEADPAVRP 273

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score =  130 bits (329), Expect = 1e-33
 Identities = 74/319 (23%), Positives = 124/319 (38%), Gaps = 59/319 (18%)

Query: 333 PEPLPMNSQW-------QKGKLIGRGTFGSVYVA-----SNRETGALCAMKEVDIFPDDP 380
           P  LP + +W         GK +G G FG V  A        +     A+K +       
Sbjct: 9   PTQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKML---KPSA 65

Query: 381 KSAESIKQLEQEIKVLSHL-KHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGA 439
              E  + L  E+KVLS+L  H NIV   G+  +     +  EY   G +  ++R    +
Sbjct: 66  HLTE-REALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDS 124

Query: 440 ITESVVRN-----------------FTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVV 482
              S                     F+  +  G+A+L SK  IHRD+   N+L+    + 
Sbjct: 125 FICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRIT 184

Query: 483 KLADFGMAKHLTGQKADLSMKGS----PY-WMAPELMMAVMQKGKSSDSALAVDIWSLGC 537
           K+ DFG+A+ +  +     +       P  WMAPE   ++     + +S    D+WS G 
Sbjct: 185 KICDFGLARDI--KNDSNYVVKGNARLPVKWMAPE---SIFNCVYTFES----DVWSYGI 235

Query: 538 TIIEMYT-GKPPWSEYEGAAAMFKVMRDTPA-----IPDSLSPEGKDFLRCCFQRNPADR 591
            + E+++ G  P   Y G     K  +          P+    E  D ++ C+  +P  R
Sbjct: 236 FLWELFSLGSSP---YPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKR 292

Query: 592 PPASLLLEH--RFLKNSQQ 608
           P    +++   + +  S  
Sbjct: 293 PTFKQIVQLIEKQISESTN 311

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  131 bits (332), Expect = 1e-33
 Identities = 77/377 (20%), Positives = 137/377 (36%), Gaps = 44/377 (11%)

Query: 273 HSPRSRSPCRNAISP-SGPSSPIHSKLSRESTVRIEVHPLPLPPGAAVLSPSATIPQVAA 331
           H  R  S     + P   P       +   ST   +             + +  I   A 
Sbjct: 14  HGRRRASVAAGILVPRGSPGLDGICSIEELSTSLYKKAGSENLYFQG--ANTVHIDLSAL 71

Query: 332 KPEPLPMNSQWQK---------GKLIGRGTFGSVYVASNRETGA---LCAMKEVDIFPDD 379
            PE +                  ++IGRG FG VY  +  +       CA+K ++     
Sbjct: 72  NPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLN----R 127

Query: 380 PKSAESIKQLEQEIKVLSHLKHPNIVQYYG-SEIVEDKFYIYLEYVHPGSINKYVREHCG 438
                 + Q   E  ++    HPN++   G     E    + L Y+  G +  ++R    
Sbjct: 128 ITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH 187

Query: 439 AITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKA 498
             T   +  F   +  G+ +L SKK +HRD+   N ++D    VK+ADFG+A+ +  ++ 
Sbjct: 188 NPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF 247

Query: 499 DLSMKGS----PY-WMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEY 552
           D     +    P  WMA E   ++  +  ++ S    D+WS G  + E+ T G PP+ + 
Sbjct: 248 DSVHNKTGAKLPVKWMALE---SLQTQKFTTKS----DVWSFGVLLWELMTRGAPPYPDV 300

Query: 553 EGAAAMFKVMR----DTPAI-PDSLSPEGKDFLRCCFQRNPADRPPASLLLEH--RFLKN 605
                   +++      P   PD L     + +  C+      RP  S L+         
Sbjct: 301 NTFDITVYLLQGRRLLQPEYCPDPLY----EVMLKCWHPKAEMRPSFSELVSRISAIFST 356

Query: 606 SQQPDVPSCSLSFSGMQ 622
                    + ++  ++
Sbjct: 357 FIGEHYVHVNATYVNVK 373

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score =  132 bits (334), Expect = 3e-33
 Identities = 64/302 (21%), Positives = 119/302 (39%), Gaps = 49/302 (16%)

Query: 286 SPSGPSSPIHSKLSRESTVRIEVHPLPLPPGAAVLSPSATIPQVAAKPEPLPMNSQWQKG 345
           S    ++        + TV                 P+A++P+  +  +   +  +++  
Sbjct: 2   SSHEAAAAQQHNSGTQHTVSGSQQEGQQRKQHHSSKPTASMPRPHSDWQ---IPDRYEIR 58

Query: 346 KLIGRGTFGSVYVASNRETGALCAMKEV-DIFPDDPKSAESIKQLEQEIKVLSHLKHPNI 404
            LIG G++G V  A ++    + A+K++  +F +D       K++ +EI +L+ L H ++
Sbjct: 59  HLIGTGSYGHVCEAYDKLEKRVVAIKKILRVF-EDLIDC---KRILREIAILNRLNHDHV 114

Query: 405 VQYY-----GSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYL 459
           V+             D+ Y+ LE        K  R     +TE  ++    ++L G+ Y+
Sbjct: 115 VKVLDIVIPKDVEKFDELYVVLEIAD-SDFKKLFRTP-VYLTELHIKTLLYNLLVGVKYV 172

Query: 460 HSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPYWM---------- 509
           HS   +HRD+K AN LV+    VK+ DFG+A+ +   +   S                  
Sbjct: 173 HSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPH 232

Query: 510 ------------------APELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSE 551
                             APEL++      +      A+D+WS+GC   E+         
Sbjct: 233 TKNLKRQLTGHVVTRWYRAPELILLQENYTE------AIDVWSIGCIFAELLNMIKENVA 286

Query: 552 YE 553
           Y 
Sbjct: 287 YH 288

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score =  129 bits (326), Expect = 5e-33
 Identities = 76/320 (23%), Positives = 122/320 (38%), Gaps = 60/320 (18%)

Query: 333 PEPLPMNSQW-------QKGKLIGRGTFGSVYVA-----SNRETGALCAMKEVDIFPDDP 380
           P  LP N +W       Q GK +G G FG V  A        +     A+K +       
Sbjct: 32  PTQLPYNEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKML---KSTA 88

Query: 381 KSAESIKQLEQEIKVLSHL-KHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGA 439
            + E  + L  E+K++SHL +H NIV   G+        +  EY   G +  ++R     
Sbjct: 89  HADE-KEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRV 147

Query: 440 ITESVVRNFTRHILS-------------GLAYLHSKKTIHRDIKGANLLVDASGVVKLAD 486
           +             S             G+A+L SK  IHRD+   N+L+    V K+ D
Sbjct: 148 LETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGD 207

Query: 487 FGMAKHL-------TGQKADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTI 539
           FG+A+ +           A L +K    WMAPE   ++     +  S    D+WS G  +
Sbjct: 208 FGLARDIMNDSNYIVKGNARLPVK----WMAPE---SIFDCVYTVQS----DVWSYGILL 256

Query: 540 IEMYT-GKPPWSEYEGAAAMFKVMRDTPA-----IPDSLSPEGKDFLRCCFQRNPADRPP 593
            E+++ G  P   Y G     K  +          P          ++ C+   P  RP 
Sbjct: 257 WEIFSLGLNP---YPGILVNSKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPT 313

Query: 594 ASLL---LEHRFLKNSQQPD 610
              +   L+ +  ++ ++ D
Sbjct: 314 FQQICSFLQEQAQEDRRERD 333

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  128 bits (324), Expect = 6e-33
 Identities = 70/296 (23%), Positives = 121/296 (40%), Gaps = 50/296 (16%)

Query: 345 GKLIGRGTFGSVYVA---SNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKH 401
           GK++G G FGSV          T    A+K +     D  S   I++   E   +    H
Sbjct: 39  GKILGEGEFGSVMEGNLKQEDGTSLKVAVKTM---KLDNSSQREIEEFLSEAACMKDFSH 95

Query: 402 PNIVQYYG-----SEIVEDKFYIYLEYVHPGSINKYVREH-----CGAITESVVRNFTRH 451
           PN+++  G     S     K  + L ++  G ++ Y+           I    +  F   
Sbjct: 96  PNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVD 155

Query: 452 ILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHL-------TGQKADLSMKG 504
           I  G+ YL ++  +HRD+   N ++     V +ADFG++K +        G+ A + +K 
Sbjct: 156 IALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVK- 214

Query: 505 SPYWMAPELMMAVMQKGK-SSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFKVM 562
              W+A E     +     +S S    D+W+ G T+ E+ T G  P+   +       ++
Sbjct: 215 ---WIAIE----SLADRVYTSKS----DVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLL 263

Query: 563 R----DTPAI-PDSLSPEGKDFLRCCFQRNPADRPPASLLLEH--RFLKNSQQPDV 611
                  P    D L     + +  C++ +P DRP  S+L     + L++   PDV
Sbjct: 264 HGHRLKQPEDCLDELY----EIMYSCWRTDPLDRPTFSVLRLQLEKLLESL--PDV 313

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  127 bits (322), Expect = 7e-33
 Identities = 64/264 (24%), Positives = 106/264 (40%), Gaps = 32/264 (12%)

Query: 345 GKLIGRGTFGSVYVA---SNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKH 401
            ++IGRG FG VY      N      CA+K ++           + Q   E  ++    H
Sbjct: 30  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLN----RITDIGEVSQFLTEGIIMKDFSH 85

Query: 402 PNIVQYYG-SEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLH 460
           PN++   G     E    + L Y+  G +  ++R      T   +  F   +  G+ YL 
Sbjct: 86  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLA 145

Query: 461 SKKTIHRDIKGANLLVDASGVVKLADFGMA---------KHLTGQKADLSMKGSPYWMAP 511
           SKK +HRD+   N ++D    VK+ADFG+A                A L +K    WMA 
Sbjct: 146 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVK----WMAL 201

Query: 512 ELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFKVMRDT--PAI 568
           E   ++  +  ++ S    D+WS G  + E+ T G PP+ +         +++       
Sbjct: 202 E---SLQTQKFTTKS----DVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQ- 253

Query: 569 PDSLSPEGKDFLRCCFQRNPADRP 592
           P+       + +  C+      RP
Sbjct: 254 PEYCPDPLYEVMLKCWHPKAEMRP 277

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score =  129 bits (326), Expect = 3e-32
 Identities = 63/245 (25%), Positives = 106/245 (43%), Gaps = 42/245 (17%)

Query: 346 KLIGRGTFGSVYVASNRETGALCAMKEV-DIFPDDPKSAESIKQLEQEIKVLSHLKHPNI 404
            LIGRG++G VY+A ++ T    A+K+V  +F +D       K++ +EI +L+ LK   I
Sbjct: 32  HLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMF-EDLIDC---KRILREITILNRLKSDYI 87

Query: 405 VQYYGSEIVEDK-----FYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYL 459
           ++ Y   I +D       YI LE      + K  +     +TE  ++    ++L G  ++
Sbjct: 88  IRLYDLIIPDDLLKFDELYIVLEIA-DSDLKKLFKTP-IFLTEEHIKTILYNLLLGENFI 145

Query: 460 HSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPYWM---------- 509
           H    IHRD+K AN L++    VK+ DFG+A+ +  +K    +                 
Sbjct: 146 HESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLK 205

Query: 510 -------------APELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPW-SEYEGA 555
                        APEL++      K      ++DIWS GC   E+        ++    
Sbjct: 206 KQLTSHVVTRWYRAPELILLQENYTK------SIDIWSTGCIFAELLNMLQSHINDPTNR 259

Query: 556 AAMFK 560
             +F 
Sbjct: 260 FPLFP 264

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score =  126 bits (319), Expect = 3e-32
 Identities = 70/325 (21%), Positives = 127/325 (39%), Gaps = 55/325 (16%)

Query: 321 SPSATIPQVAAKPEPLPMNSQW-------QKGKLIGRGTFGSVYVA-----SNRETGALC 368
             S     +   P+                    +G G FG V++A        +   L 
Sbjct: 15  KGSGLQGHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLV 74

Query: 369 AMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYIYLEYVHPGS 428
           A+K +        S  + +  ++E ++L+ L+H +IV+++G         +  EY+  G 
Sbjct: 75  AVKALK-----EASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGD 129

Query: 429 INKYVREH--------------CGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANL 474
           +N+++R H               G +    +      + +G+ YL     +HRD+   N 
Sbjct: 130 LNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNC 189

Query: 475 LVDASGVVKLADFGMAKHL-------TGQKADLSMKGSPYWMAPELMMAVMQKGK-SSDS 526
           LV    VVK+ DFGM++ +        G +  L ++    WM PE     +   K +++S
Sbjct: 190 LVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR----WMPPE----SILYRKFTTES 241

Query: 527 ALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFKVMRD-TPAIPDSLSPEGKDFLRCCF 584
               D+WS G  + E++T GK PW +     A+  + +      P +  PE    +R C+
Sbjct: 242 ----DVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRACPPEVYAIMRGCW 297

Query: 585 QRNPADRPPASLLLEH--RFLKNSQ 607
           QR P  R     +        +   
Sbjct: 298 QREPQQRHSIKDVHARLQALAQAPP 322

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score =  126 bits (318), Expect = 5e-32
 Identities = 77/305 (25%), Positives = 121/305 (39%), Gaps = 41/305 (13%)

Query: 345 GKLIGRGTFGSVYVA-----SNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHL 399
            + +G G FG VY        N  +    A+K +     +  S +       E  ++S  
Sbjct: 35  IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLP----EVCSEQDELDFLMEALIISKF 90

Query: 400 KHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHC------GAITESVVRNFTRHIL 453
            H NIV+  G  +     +I +E +  G +  ++RE         ++    + +  R I 
Sbjct: 91  NHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIA 150

Query: 454 SGLAYLHSKKTIHRDIKGANLLVDASG---VVKLADFGMAKHL-------TGQKADLSMK 503
            G  YL     IHRDI   N L+   G   V K+ DFGMA+ +        G  A L +K
Sbjct: 151 CGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVK 210

Query: 504 GSPYWMAPELMMAVMQKGK-SSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFKV 561
               WM PE       +G  +S +    D WS G  + E+++ G  P+        +  V
Sbjct: 211 ----WMPPE----AFMEGIFTSKT----DTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFV 258

Query: 562 MRD-TPAIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQPDVPSCSLSFSG 620
                   P +        +  C+Q  P DRP  +++LE R    +Q PDV + +L    
Sbjct: 259 TSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILE-RIEYCTQDPDVINTALPIEY 317

Query: 621 MQLTE 625
             L E
Sbjct: 318 GPLVE 322

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score =  126 bits (319), Expect = 6e-32
 Identities = 90/372 (24%), Positives = 145/372 (38%), Gaps = 63/372 (16%)

Query: 278 RSPCRNAISPSGPSSPIHSKLSRESTVRIEVHPLPLPPGAAVLSPSATIPQVAAKPEPLP 337
           R P R  ++ S  SS   S  S    VRI            +   S            LP
Sbjct: 23  RIPLRRQVTVSAESS--SSMNSNTPLVRITTRLSSTADTPMLAGVS---------EYELP 71

Query: 338 MNSQW-------QKGKLIGRGTFGSVYVA-------SNRETGALCAMKEVDIFPDDPKSA 383
            + +W         GK +G G FG V +A          +     A+K +    DD    
Sbjct: 72  EDPKWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKML---KDDATEK 128

Query: 384 ESIKQLEQEIKVLSHL-KHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITE 442
           + +  L  E++++  + KH NI+   G+   +   Y+ +EY   G++ +Y+R       E
Sbjct: 129 D-LSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGME 187

Query: 443 SVVRN---------------FTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADF 487
                                T  +  G+ YL S+K IHRD+   N+LV  + V+K+ADF
Sbjct: 188 YSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADF 247

Query: 488 GMAKHLTGQKADLSMKGS----PY-WMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEM 542
           G+A+ +     D   K +    P  WMAPE   A+  +  +  S    D+WS G  + E+
Sbjct: 248 GLARDI--NNIDYYKKTTNGRLPVKWMAPE---ALFDRVYTHQS----DVWSFGVLMWEI 298

Query: 543 YT-GKPPWSEYEGAAAMFKVMR-DTPAIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEH 600
           +T G  P+           +        P + + E    +R C+   P+ RP    L+E 
Sbjct: 299 FTLGGSPYPGIPVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 358

Query: 601 --RFLKNSQQPD 610
             R L  +   +
Sbjct: 359 LDRILTLTTNEE 370

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score =  125 bits (316), Expect = 8e-32
 Identities = 80/330 (24%), Positives = 134/330 (40%), Gaps = 68/330 (20%)

Query: 333 PEPLPMNSQWQK-----------------GKLIGRGTFGSVYVA-----SNRETGALCAM 370
           P+ LP++   ++                 GK +GRG FG V  A         T    A+
Sbjct: 3   PDELPLDEHCERLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAV 62

Query: 371 KEVDIFPDDPKSAESIKQLEQEIKVLSHL-KHPNIVQYYGSEIVEDK-FYIYLEYVHPGS 428
           K +    +    +E  + L  E+K+L H+  H N+V   G+         + +E+   G+
Sbjct: 63  KML---KEGATHSE-HRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGN 118

Query: 429 INKYVREHCGAITESVVRN---------------FTRHILSGLAYLHSKKTIHRDIKGAN 473
           ++ Y+R          V                 ++  +  G+ +L S+K IHRD+   N
Sbjct: 119 LSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARN 178

Query: 474 LLVDASGVVKLADFGMAKHLTGQKADLSMKGS----PY-WMAPELMMAVMQKGKSSDSAL 528
           +L+    VVK+ DFG+A+ +   K    ++      P  WMAPE    +  +  +  S  
Sbjct: 179 ILLSEKNVVKICDFGLARDI--YKDPDYVRKGDARLPLKWMAPE---TIFDRVYTIQS-- 231

Query: 529 AVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFKVMRDTPA-----IPDSLSPEGKDFLRC 582
             D+WS G  + E+++ G  P   Y G     +  R          PD  +PE    +  
Sbjct: 232 --DVWSFGVLLWEIFSLGASP---YPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLD 286

Query: 583 CFQRNPADRPPASLLLEH--RFLKNSQQPD 610
           C+   P+ RP  S L+EH    L+ + Q D
Sbjct: 287 CWHGEPSQRPTFSELVEHLGNLLQANAQQD 316

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score =  126 bits (318), Expect = 9e-32
 Identities = 78/305 (25%), Positives = 121/305 (39%), Gaps = 41/305 (13%)

Query: 345 GKLIGRGTFGSVYVA-----SNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHL 399
            + +G G FG VY        N  +    A+K +     +  S +       E  ++S  
Sbjct: 76  IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLP----EVCSEQDELDFLMEALIISKF 131

Query: 400 KHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHC------GAITESVVRNFTRHIL 453
            H NIV+  G  +     +I LE +  G +  ++RE         ++    + +  R I 
Sbjct: 132 NHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIA 191

Query: 454 SGLAYLHSKKTIHRDIKGANLLVDASG---VVKLADFGMAKHL-------TGQKADLSMK 503
            G  YL     IHRDI   N L+   G   V K+ DFGMA+ +        G  A L +K
Sbjct: 192 CGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVK 251

Query: 504 GSPYWMAPELMMAVMQKGK-SSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFKV 561
               WM PE       +G  +S +    D WS G  + E+++ G  P+        +  V
Sbjct: 252 ----WMPPE----AFMEGIFTSKT----DTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFV 299

Query: 562 MRD-TPAIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQPDVPSCSLSFSG 620
                   P +        +  C+Q  P DRP  +++LE R    +Q PDV + +L    
Sbjct: 300 TSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILE-RIEYCTQDPDVINTALPIEY 358

Query: 621 MQLTE 625
             L E
Sbjct: 359 GPLVE 363

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score =  125 bits (316), Expect = 1e-31
 Identities = 81/324 (25%), Positives = 134/324 (41%), Gaps = 53/324 (16%)

Query: 327 PQVAAKPEP-LPMNSQW-------QKGKLIGRGTFGSVYVA-------SNRETGALCAMK 371
           P +A   E  LP + +W         GK +G G FG V +A          +     A+K
Sbjct: 14  PMLAGVSEYELPEDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVK 73

Query: 372 EVDIFPDDPKSAESIKQLEQEIKVLSHL-KHPNIVQYYGSEIVEDKFYIYLEYVHPGSIN 430
            +    DD    + +  L  E++++  + KH NI+   G+   +   Y+ +EY   G++ 
Sbjct: 74  ML---KDDATEKD-LSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 129

Query: 431 KYVREHCGAITESVVRN---------------FTRHILSGLAYLHSKKTIHRDIKGANLL 475
           +Y+R       E                     T  +  G+ YL S+K IHRD+   N+L
Sbjct: 130 EYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVL 189

Query: 476 VDASGVVKLADFGMAKHLTGQKADLSMKGS----PY-WMAPELMMAVMQKGKSSDSALAV 530
           V  + V+K+ADFG+A+ +     D   K +    P  WMAPE   A+  +  +  S    
Sbjct: 190 VTENNVMKIADFGLARDI--NNIDYYKKTTNGRLPVKWMAPE---ALFDRVYTHQS---- 240

Query: 531 DIWSLGCTIIEMYT-GKPPWSEYEGAAAMFKVMR-DTPAIPDSLSPEGKDFLRCCFQRNP 588
           D+WS G  + E++T G  P+           +        P + + E    +R C+   P
Sbjct: 241 DVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVP 300

Query: 589 ADRPPASLLLEH--RFLKNSQQPD 610
           + RP    L+E   R L  +   +
Sbjct: 301 SQRPTFKQLVEDLDRILTLTTNEE 324

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score =  123 bits (310), Expect = 3e-31
 Identities = 74/285 (25%), Positives = 129/285 (45%), Gaps = 47/285 (16%)

Query: 345 GKLIGRGTFGSVYVA-----SNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHL 399
            + +G G FG V++A     S  +   L A+K +        +  + K  ++E ++L++L
Sbjct: 20  KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALK-----DPTLAARKDFQREAELLTNL 74

Query: 400 KHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREH---------------CGAITESV 444
           +H +IV++YG     D   +  EY+  G +NK++R H                G +  S 
Sbjct: 75  QHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQ 134

Query: 445 VRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHL-------TGQK 497
           + +    I SG+ YL S+  +HRD+   N LV A+ +VK+ DFGM++ +        G  
Sbjct: 135 MLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGH 194

Query: 498 ADLSMKGSPYWMAPELMMAVMQKGK-SSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGA 555
             L ++    WM PE     +   K +++S    D+WS G  + E++T GK PW +    
Sbjct: 195 TMLPIR----WMPPE----SIMYRKFTTES----DVWSFGVILWEIFTYGKQPWFQLSNT 242

Query: 556 AAMFKVMRD-TPAIPDSLSPEGKDFLRCCFQRNPADRPPASLLLE 599
             +  + +      P     E  D +  C+QR P  R     + +
Sbjct: 243 EVIECITQGRVLERPRVCPKEVYDVMLGCWQREPQQRLNIKEIYK 287

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score =  122 bits (309), Expect = 3e-31
 Identities = 60/278 (21%), Positives = 105/278 (37%), Gaps = 46/278 (16%)

Query: 345 GKLIGRGTFGSVYVA-----SNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHL 399
            + +G   FG VY       +  E     A+K +     D       ++   E  + + L
Sbjct: 14  MEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLK----DKAEGPLREEFRHEAMLRARL 69

Query: 400 KHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHC---------------GAITESV 444
           +HPN+V   G    +    +   Y   G +++++                    A+    
Sbjct: 70  QHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPD 129

Query: 445 VRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHL-------TGQK 497
             +    I +G+ YL S   +H+D+   N+LV     VK++D G+ + +           
Sbjct: 130 FVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGN 189

Query: 498 ADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAA 556
           + L ++    WMAPE   A+M    S DS    DIWS G  + E+++ G  P+  Y    
Sbjct: 190 SLLPIR----WMAPE---AIMYGKFSIDS----DIWSYGVVLWEVFSYGLQPYCGYSNQD 238

Query: 557 AMFKVMRDT--PAIPDSLSPEGKDFLRCCFQRNPADRP 592
            +  +      P  PD         +  C+   P+ RP
Sbjct: 239 VVEMIRNRQVLPC-PDDCPAWVYALMIECWNEFPSRRP 275

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score =  123 bits (311), Expect = 3e-31
 Identities = 69/327 (21%), Positives = 128/327 (39%), Gaps = 65/327 (19%)

Query: 329 VAAKPEPLPMNSQW-------QKGKLIGRGTFGSVYVA-----SNRETGALCAMKEVDIF 376
           ++     +  + +W         GK +G G FG V  A       R      A+K +   
Sbjct: 5   LSVDAFKILEDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKML--- 61

Query: 377 PDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREH 436
            ++   +E ++ L  E  VL  + HP++++ YG+   +    + +EY   GS+  ++RE 
Sbjct: 62  KENASPSE-LRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRES 120

Query: 437 CGAITESVVRN-----------------------FTRHILSGLAYLHSKKTIHRDIKGAN 473
                  +                          F   I  G+ YL   K +HRD+   N
Sbjct: 121 RKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARN 180

Query: 474 LLVDASGVVKLADFGMAKHLTGQKADLSMKGS----PY-WMAPELMMAVMQKGKSSDSAL 528
           +LV     +K++DFG+++ +   + D  +K S    P  WMA E   ++     ++ S  
Sbjct: 181 ILVAEGRKMKISDFGLSRDV--YEEDSYVKRSQGRIPVKWMAIE---SLFDHIYTTQS-- 233

Query: 529 AVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFKV-----MRDTPAIPDSLSPEGKDFLRC 582
             D+WS G  + E+ T G  P+           +     M      PD+ S E    +  
Sbjct: 234 --DVWSFGVLLWEIVTLGGNPYPGIPPERLFNLLKTGHRM----ERPDNCSEEMYRLMLQ 287

Query: 583 CFQRNPADRPPASLLLEH--RFLKNSQ 607
           C+++ P  RP  + + +   + +   +
Sbjct: 288 CWKQEPDKRPVFADISKDLEKMMVKRR 314

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score =  123 bits (312), Expect = 4e-31
 Identities = 71/340 (20%), Positives = 125/340 (36%), Gaps = 64/340 (18%)

Query: 319 VLSPSATIPQVAAKPEPLPMNSQW-------QKGKLIGRGTFGSVYVA-----SNRETGA 366
            ++ S+              + +W       + GK++G G FG V  A     S      
Sbjct: 17  QVTGSSDNEYFYVDFREYEYDLKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSI 76

Query: 367 LCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHL-KHPNIVQYYGSEIVEDKFYIYLEYVH 425
             A+K +    +   S+E  + L  E+K+++ L  H NIV   G+  +    Y+  EY  
Sbjct: 77  QVAVKML---KEKADSSE-REALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCC 132

Query: 426 PGSINKYVREHCGAITESVVR----------------------NFTRHILSGLAYLHSKK 463
            G +  Y+R      +E  +                        F   +  G+ +L  K 
Sbjct: 133 YGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS 192

Query: 464 TIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGS----PY-WMAPELMMAVM 518
            +HRD+   N+LV    VVK+ DFG+A+ +        +       P  WMAPE   ++ 
Sbjct: 193 CVHRDLAARNVLVTHGKVVKICDFGLARDI--MSDSNYVVRGNARLPVKWMAPE---SLF 247

Query: 519 QKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFKVMRDTPA-----IPDSL 572
           +   +  S    D+WS G  + E+++ G  P   Y G        +          P   
Sbjct: 248 EGIYTIKS----DVWSYGILLWEIFSLGVNP---YPGIPVDANFYKLIQNGFKMDQPFYA 300

Query: 573 SPEGKDFLRCCFQRNPADRPPASLLLEH--RFLKNSQQPD 610
           + E    ++ C+  +   RP    L       L ++++  
Sbjct: 301 TEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADAEEAM 340

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score =  126 bits (317), Expect = 5e-31
 Identities = 64/320 (20%), Positives = 118/320 (36%), Gaps = 76/320 (23%)

Query: 340 SQWQKGKLIGRGTFGSVYVASNRETGALCAMKEV-DIFPDDPKSAESIKQLEQEIKVLSH 398
            ++Q  K IG G  G V  A +       A+K++   F  +   A   K+  +E+ ++  
Sbjct: 62  KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF-QNQTHA---KRAYRELVLMKC 117

Query: 399 LKHPNIVQ-------YYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRH 451
           + H NI+            E  +D  Y+ +E +   ++ + ++     +    +      
Sbjct: 118 VNHKNIISLLNVFTPQKTLEEFQD-VYLVMELM-DANLCQVIQME---LDHERMSYLLYQ 172

Query: 452 ILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPYWM-- 509
           +L G+ +LHS   IHRD+K +N++V +   +K+ DFG+A+      A  S   +PY +  
Sbjct: 173 MLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART-----AGTSFMMTPYVVTR 227

Query: 510 ---APELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKP--PWSEY------------ 552
              APE+++              VDIWS+GC + EM   K   P  +Y            
Sbjct: 228 YYRAPEVIL-------GMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLG 280

Query: 553 -----------EGAAAMFKVMRDTPAIP-----------------DSLSPEGKDFLRCCF 584
                             +       +                     + + +D L    
Sbjct: 281 TPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKML 340

Query: 585 QRNPADRPPASLLLEHRFLK 604
             +PA R      L+H ++ 
Sbjct: 341 VIDPAKRISVDDALQHPYIN 360

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score =  123 bits (311), Expect = 1e-30
 Identities = 75/319 (23%), Positives = 127/319 (39%), Gaps = 52/319 (16%)

Query: 332 KPEPLPMNSQW-------QKGKLIGRGTFGSVYVA-------SNRETGALCAMKEVDIFP 377
               LP + +W         GK +G G FG V +A                A+K +    
Sbjct: 54  SEYELPEDPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKML---K 110

Query: 378 DDPKSAESIKQLEQEIKVLSHL-KHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREH 436
            D    + +  L  E++++  + KH NI+   G+   +   Y+ +EY   G++ +Y++  
Sbjct: 111 SDATEKD-LSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQAR 169

Query: 437 CGAITESVVRN---------------FTRHILSGLAYLHSKKTIHRDIKGANLLVDASGV 481
                E                        +  G+ YL SKK IHRD+   N+LV    V
Sbjct: 170 RPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNV 229

Query: 482 VKLADFGMAKHLTGQKADLSMKGS----PY-WMAPELMMAVMQKGKSSDSALAVDIWSLG 536
           +K+ADFG+A+ +     D   K +    P  WMAPE   A+  +  +  S    D+WS G
Sbjct: 230 MKIADFGLARDI--HHIDYYKKTTNGRLPVKWMAPE---ALFDRIYTHQS----DVWSFG 280

Query: 537 CTIIEMYT-GKPPWSEYEGAAAMFKVMRD-TPAIPDSLSPEGKDFLRCCFQRNPADRPPA 594
             + E++T G  P+           +        P + + E    +R C+   P+ RP  
Sbjct: 281 VLLWEIFTLGGSPYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTF 340

Query: 595 SLLLEH--RFLKNSQQPDV 611
             L+E   R +  +   ++
Sbjct: 341 KQLVEDLDRIVALTSNQEM 359

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score =  120 bits (302), Expect = 9e-30
 Identities = 70/300 (23%), Positives = 131/300 (43%), Gaps = 50/300 (16%)

Query: 345 GKLIGRGTFGSVYVA-----SNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHL 399
            + IG G FG V+ A        E   + A+K +    ++  SA+     ++E  +++  
Sbjct: 52  VRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKML---KEEA-SADMQADFQREAALMAEF 107

Query: 400 KHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRN------------ 447
            +PNIV+  G   V     +  EY+  G +N+++R        S+  +            
Sbjct: 108 DNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPG 167

Query: 448 -----------FTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQ 496
                        R + +G+AYL  +K +HRD+   N LV  + VVK+ADFG+++++   
Sbjct: 168 PPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNI--Y 225

Query: 497 KADLSMKGS----PY-WMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWS 550
            AD          P  WM PE   ++     +++S    D+W+ G  + E+++ G  P+ 
Sbjct: 226 SADYYKADGNDAIPIRWMPPE---SIFYNRYTTES----DVWAYGVVLWEIFSYGLQPYY 278

Query: 551 EYEGAAAMFKVM-RDTPAIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEH--RFLKNSQ 607
                  ++ V   +  A P++   E  + +R C+ + PADRP    +     R  + ++
Sbjct: 279 GMAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCERAE 338

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  119 bits (301), Expect = 3e-28
 Identities = 52/253 (20%), Positives = 93/253 (36%), Gaps = 31/253 (12%)

Query: 347 LIGRGTFGSVYVAS-NRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIV 405
            I  G  G +Y+A      G    +K   +   D    E+      E + L+ + HP+IV
Sbjct: 87  CIAHGGLGWIYLALDRNVNGRPVVLK-GLVHSGDA---EAQAMAMAERQFLAEVVHPSIV 142

Query: 406 QYY-----GSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLH 460
           Q +          +   YI +EYV   S+ +        +  +    +   IL  L+YLH
Sbjct: 143 QIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKG---QKLPVAEAIAYLLEILPALSYLH 199

Query: 461 SKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPYWMAPELMMAVMQK 520
           S   ++ D+K  N+++     +KL D G    +          G+P + APE++     +
Sbjct: 200 SIGLVYNDLKPENIMLTEEQ-LKLIDLGAVSRINSFGYLY---GTPGFQAPEIV-----R 250

Query: 521 GKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDSLSPEGKDFL 580
              +    A DI+++G T+  +    P      G       + +   +           L
Sbjct: 251 TGPTV---ATDIYTVGRTLAALTLDLPT---RNGRYV--DGLPEDDPVLK-TYDSYGRLL 301

Query: 581 RCCFQRNPADRPP 593
           R     +P  R  
Sbjct: 302 RRAIDPDPRQRFT 314

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score =  115 bits (289), Expect = 3e-28
 Identities = 68/290 (23%), Positives = 121/290 (41%), Gaps = 43/290 (14%)

Query: 345 GKLIGRGTFGSVYVA--SNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHL-KH 401
             +IG G FG V  A           A+K +    +     +  +    E++VL  L  H
Sbjct: 30  QDVIGEGNFGQVLKARIKKDGLRMDAAIKRM---KEYASKDD-HRDFAGELEVLCKLGHH 85

Query: 402 PNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRN-------------- 447
           PNI+   G+       Y+ +EY   G++  ++R+     T+                   
Sbjct: 86  PNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLL 145

Query: 448 -FTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAK----HLTGQKADLSM 502
            F   +  G+ YL  K+ IHRD+   N+LV  + V K+ADFG+++    ++      L +
Sbjct: 146 HFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPV 205

Query: 503 KGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFKV 561
           +    WMA E   ++     +++S    D+WS G  + E+ + G  P+     A    K+
Sbjct: 206 R----WMAIE---SLNYSVYTTNS----DVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL 254

Query: 562 MRDT--PAIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEH--RFLKNSQ 607
            +       P +   E  D +R C++  P +RP  + +L    R L+  +
Sbjct: 255 PQGYRLEK-PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK 303

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score =  112 bits (282), Expect = 5e-27
 Identities = 71/355 (20%), Positives = 118/355 (33%), Gaps = 102/355 (28%)

Query: 346 KLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAES-IKQLEQEIKVLSHLK---- 400
           + +G G F +V++A +       AMK V       +  +   +  E EIK+L  +     
Sbjct: 25  RKLGWGHFSTVWLAKDMVNNTHVAMKIV-------RGDKVYTEAAEDEIKLLQRVNDADN 77

Query: 401 -------HPNIVQYYGSEIVEDKFYIY-LEYVH------PGSINKYV---REHCGAITES 443
                    +I++        D F       VH          N      +     I   
Sbjct: 78  TKEDSMGANHILKLL------DHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLI 131

Query: 444 VVRNFTRHILSGLAYLHSK-KTIHRDIKGANLLVDAS------GVVKLADFGMAKHLTGQ 496
            V+  ++ +L GL Y+H +   IH DIK  N+L++          +K+AD G A      
Sbjct: 132 YVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEH 191

Query: 497 KADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKP--------- 547
             +     +  + +PE+++     G         DIWS  C I E+ TG           
Sbjct: 192 YTNSIQ--TREYRSPEVLL-----GAPWGCG--ADIWSTACLIFELITGDFLFEPDEGHS 242

Query: 548 PWSEYEGAAAM---------------------F------------------KVMRDTPAI 568
              + +  A +                     F                   V+ +    
Sbjct: 243 YTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKF 302

Query: 569 PDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNS---QQPDVPSCSLSFSG 620
               + E  DFL    Q +P  R  A  L+ H +LK++   ++  VP   L  SG
Sbjct: 303 SKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLKDTLGMEEIRVPDRELYGSG 357

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score =  102 bits (255), Expect = 3e-24
 Identities = 33/258 (12%), Positives = 67/258 (25%), Gaps = 45/258 (17%)

Query: 347 LIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQ 406
             G       + A +       A+  VD  P      + +++       LS +  P + +
Sbjct: 38  FHGGVPPLQFWQALDTALDRQVALTFVD--PQGVLPDDVLQETLSRTLRLSRIDKPGVAR 95

Query: 407 YYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIH 466
                       +  E++  GS+ +             +R   + + +     H      
Sbjct: 96  VLDVVHTRAGGLVVAEWIRGGSLQEVADT--SPSPVGAIR-AMQSLAAAADAAHRAGVAL 152

Query: 467 RDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPYWMAPELMMAVMQKGKSSDS 526
                + + V   G V LA                                       D+
Sbjct: 153 SIDHPSRVRVSIDGDVVLAYPATM---------------------------------PDA 179

Query: 527 ALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIP-------DSLSPEGKDF 579
               DI  +G ++  +   + P  E    + +    RDT   P         +  +    
Sbjct: 180 NPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQISAV 239

Query: 580 LRCCFQRNPADRPPASLL 597
                Q +   R  ++LL
Sbjct: 240 AARSVQGDGGIRSASTLL 257

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 99.0 bits (247), Expect = 4e-22
 Identities = 55/227 (24%), Positives = 96/227 (42%), Gaps = 57/227 (25%)

Query: 346 KLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESI-KQLEQEIKVLSHLKH--- 401
           K+IG+G+FG V  A + +     A+K V       ++ +   +Q  +EI++L HL+    
Sbjct: 103 KVIGKGSFGQVVKAYDHKVHQHVALKMV-------RNEKRFHRQAAEEIRILEHLRKQDK 155

Query: 402 ---PNIVQYYGS-----------EIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRN 447
               N++    +           E++    Y  ++       NK+        +  +VR 
Sbjct: 156 DNTMNVIHMLENFTFRNHICMTFELLSMNLYELIKK------NKFQG-----FSLPLVRK 204

Query: 448 FTRHILSGLAYLHSKKTIHRDIKGANLLV--DASGVVKLADFGMAKHLTGQKADLSMKGS 505
           F   IL  L  LH  + IH D+K  N+L+       +K+ DFG + +   +         
Sbjct: 205 FAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRV-------Y 257

Query: 506 PY-----WMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKP 547
            Y     + APE+++     G        +D+WSLGC + E+ TG P
Sbjct: 258 TYIQSRFYRAPEVIL-----GARYGMP--IDMWSLGCILAELLTGYP 297

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score = 96.1 bits (240), Expect = 6e-22
 Identities = 66/274 (24%), Positives = 112/274 (40%), Gaps = 47/274 (17%)

Query: 347 LIGRGTFGSVY--VASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNI 404
            +G G FG VY    +N       A+K++     D  + E  +Q +QEIKV++  +H N+
Sbjct: 38  KMGEGGFGVVYKGYVNNTTV----AVKKLAA-MVDITTEELKQQFDQEIKVMAKCQHENL 92

Query: 405 VQYYGSEIVED-KFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRH-----ILSGLAY 458
           V+  G     D    +Y  Y+  GS+   +    G    S      R        +G+ +
Sbjct: 93  VELLGFSSDGDDLCLVY-VYMPNGSLLDRLSCLDGTPPLSW---HMRCKIAQGAANGINF 148

Query: 459 LHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHL-TGQKADLS---MKGSPYWMAPELM 514
           LH    IHRDIK AN+L+D +   K++DFG+A+      +  ++   + G+  +MAPE +
Sbjct: 149 LHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIV-GTTAYMAPEAL 207

Query: 515 MAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEG-------AAAMFKVMRDTPA 567
                +G+ +  +   DI+S G  ++E+ TG P   E+            +    +    
Sbjct: 208 -----RGEITPKS---DIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIED 259

Query: 568 IPDSL---SPEGKDFLRC------CFQRNPADRP 592
             D     +               C       RP
Sbjct: 260 YIDKKMNDADS-TSVEAMYSVASQCLHEKKNKRP 292

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score = 95.7 bits (239), Expect = 9e-22
 Identities = 61/230 (26%), Positives = 101/230 (43%), Gaps = 63/230 (27%)

Query: 347 LIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQ 406
           LIG G FG VY       G L    +V +    P+S++ I++ E EI+ LS  +HP++V 
Sbjct: 46  LIGHGVFGKVY------KGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVS 99

Query: 407 YYGSEIVEDKFY---------IYLEYVHPGSINKYVREHC-GAITESVVRNFTRHILS-- 454
             G        +         IY +Y+  G+    ++ H  G        +     +S  
Sbjct: 100 LIG--------FCDERNEMILIY-KYMENGN----LKRHLYG-------SDLPTMSMSWE 139

Query: 455 -----------GLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLS-- 501
                      GL YLH++  IHRD+K  N+L+D + V K+ DFG++K   G + D +  
Sbjct: 140 QRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISK--KGTELDQTHL 197

Query: 502 ---MKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPP 548
              +KG+  ++ PE  +      KS       D++S G  + E+   +  
Sbjct: 198 STVVKGTLGYIDPEYFIKGRLTEKS-------DVYSFGVVLFEVLCARSA 240

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 96.7 bits (241), Expect = 1e-21
 Identities = 53/225 (23%), Positives = 100/225 (44%), Gaps = 51/225 (22%)

Query: 346 KLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAES-IKQLEQEIKVLSHL----- 399
            LIG+G+FG V  A +R      A+K +       K+ ++ + Q + E+++L  +     
Sbjct: 60  SLIGKGSFGQVVKAYDRVEQEWVAIKII-------KNKKAFLNQAQIEVRLLELMNKHDT 112

Query: 400 --KHPNIVQYYGS-----------EIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVR 446
             K+  IV                E++    Y  L          +       ++ ++ R
Sbjct: 113 EMKY-YIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRN------TNFR-----GVSLNLTR 160

Query: 447 NFTRHILSGLAYLHSKKT--IHRDIKGANLLV--DASGVVKLADFGMAKHLTGQKADLSM 502
            F + + + L +L + +   IH D+K  N+L+       +K+ DFG +  L  +      
Sbjct: 161 KFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIY--QY 218

Query: 503 KGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKP 547
             S ++ +PE+++     G   D A  +D+WSLGC ++EM+TG+P
Sbjct: 219 IQSRFYRSPEVLL-----GMPYDLA--IDMWSLGCILVEMHTGEP 256

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 93.2 bits (232), Expect = 5e-21
 Identities = 69/303 (22%), Positives = 120/303 (39%), Gaps = 54/303 (17%)

Query: 339 NSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIK----QLEQEIK 394
            ++++ G+ IG G+FG +Y+ ++   G   A+K            E +K    QL  E K
Sbjct: 8   GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIK-----------LECVKTKHPQLHIESK 56

Query: 395 VLSHLKH-PNI--VQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRH 451
           +   ++    I  +++ G+E   D   + +E + P S+           +   V      
Sbjct: 57  IYKMMQGGVGIPTIRWCGAE--GDYNVMVMELLGP-SLEDLFNFCSRKFSLKTVLLLADQ 113

Query: 452 ILSGLAYLHSKKTIHRDIKGANLLV---DASGVVKLADFGMAK----HLTGQ----KADL 500
           ++S + Y+HSK  IHRD+K  N L+       +V + DFG+AK      T Q    + + 
Sbjct: 114 MISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENK 173

Query: 501 SMKGSPYWMAPELMMAVMQKGKSS--DSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAM 558
           ++ G+  + +    + + Q    S  D     D+ SLG  ++    G  PW   + A   
Sbjct: 174 NLTGTARYASINTHLGIEQ----SRRD-----DLESLGYVLMYFNLGSLPWQGLKAATKR 224

Query: 559 FKVMR------DTP--AIPDSLSPEGKDFLRCCFQRNPADRPPASL---LLEHRFLKNSQ 607
            K  R       TP   +      E   +L  C      D+P  S    L  + F +   
Sbjct: 225 QKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGF 284

Query: 608 QPD 610
             D
Sbjct: 285 SYD 287

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 93.9 bits (234), Expect = 8e-21
 Identities = 67/351 (19%), Positives = 113/351 (32%), Gaps = 123/351 (35%)

Query: 346 KLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAES-IKQLEQEIKVLSHLKH--- 401
           + +G GTFG V +  + +     A+K V       ++ +   +  + E  +L  +++   
Sbjct: 41  RKMGDGTFGRVLLCQHIDNKKYYAVKVV-------RNIKKYTRSAKIEADILKKIQNDDI 93

Query: 402 --PNIVQYYGS-----------EIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNF 448
              NIV+Y+G            E +    Y  +        N Y            ++ +
Sbjct: 94  NNNNIVKYHGKFMYYDHMCLIFEPLGPSLYEIITR------NNYN-----GFHIEDIKLY 142

Query: 449 TRHILSGLAYLHSKKTIHRDIKGAN-LLVDASGV------------------------VK 483
              IL  L YL      H D+K  N LL D                            +K
Sbjct: 143 CIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIK 202

Query: 484 LADFGMA----KHLTGQKADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTI 539
           L DFG A     +     + ++   +  + APE+++ +   G       + D+WS GC +
Sbjct: 203 LIDFGCATFKSDYHG---SIIN---TRQYRAPEVILNL---GWDV----SSDMWSFGCVL 249

Query: 540 IEMYTGK---PPWSEYEGAAAMFKVM---------------------------------- 562
            E+YTG          E  A M  ++                                  
Sbjct: 250 AELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENAS 309

Query: 563 --RDTPAIPDSLS-------PEGKDFLRCCFQRNPADRPPASLLLEHRFLK 604
                  +   L            DFL    Q +P  RP  + LL+H+FL+
Sbjct: 310 SINSIKHVKKCLPLYKIIKHELFCDFLYSILQIDPTLRPSPAELLKHKFLE 360

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 92.1 bits (229), Expect = 3e-20
 Identities = 53/280 (18%), Positives = 90/280 (32%), Gaps = 64/280 (22%)

Query: 327 PQVAAKPEPLP--------MNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPD 378
             +  +  P P          +QW  GK IG G FG +Y+A         A   V +   
Sbjct: 16  ENLYFQSMPFPEGKVLDDMEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQ 75

Query: 379 DPKSAESIKQLEQEIKVLSHLKHPNIVQ-----------------YYGSEIVEDKFYIYL 421
           +         L  E+K    +   + ++                   G    + + Y ++
Sbjct: 76  ENG------PLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFM 129

Query: 422 --EYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDA- 478
             E +    + K      G   +S V      +L  L Y+H  + +H DIK ANLL+   
Sbjct: 130 VMERLGI-DLQKI-SGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYK 187

Query: 479 -SGVVKLADFGMAKHLTG--------QKADLSMKGSPYWMAPELMMAVMQKGKSSDSALA 529
               V LAD+G++             +       G+  +              S D+   
Sbjct: 188 NPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFT-------------SLDAHKG 234

Query: 530 V------DIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMR 563
           V      D+  LG  ++    GK PW +        +  +
Sbjct: 235 VALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQTAK 274

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score = 90.7 bits (226), Expect = 6e-20
 Identities = 59/225 (26%), Positives = 102/225 (45%), Gaps = 50/225 (22%)

Query: 347 LIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQ------------EIK 394
           ++GRG FG VY       G L          D    A  +K+L++            E++
Sbjct: 37  ILGRGGFGKVY------KGRL---------ADGTLVA--VKRLKEERTQGGELQFQTEVE 79

Query: 395 VLSHLKHPNIVQYYGSEIVED-KFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRH-- 451
           ++S   H N+++  G  +    +  +Y  Y+  GS+   +RE   +  +  +    R   
Sbjct: 80  MISMAVHRNLLRLRGFCMTPTERLLVY-PYMANGSVASCLRERPES--QPPLDWPKRQRI 136

Query: 452 ---ILSGLAYLHSK---KTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLS--MK 503
                 GLAYLH     K IHRD+K AN+L+D      + DFG+AK +  +   ++  ++
Sbjct: 137 ALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVR 196

Query: 504 GSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPP 548
           G+   +APE +      GKSS+     D++  G  ++E+ TG+  
Sbjct: 197 GTIGHIAPEYLST----GKSSEKT---DVFGYGVMLLELITGQRA 234

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 90.0 bits (224), Expect = 1e-19
 Identities = 66/351 (18%), Positives = 107/351 (30%), Gaps = 119/351 (33%)

Query: 346 KLIGRGTFGSVYVASNRETGA-LCAMKEVDIFPDDPKSAES-IKQLEQEIKVLSHLKHP- 402
             +G G FG V    + + G    A+K V       K+ +   +    EI+VL HL    
Sbjct: 20  DTLGEGAFGKVVECIDHKAGGRHVAVKIV-------KNVDRYCEAARSEIQVLEHLNTTD 72

Query: 403 -----NIVQYYGS-----------EIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVR 446
                  VQ               E++    Y +++       N ++           +R
Sbjct: 73  PNSTFRCVQMLEWFEHHGHICIVFELLGLSTYDFIKE------NGFLP-----FRLDHIR 121

Query: 447 NFTRHILSGLAYLHSKKTIHRDIKGAN-LLVDASGV------------------VKLADF 487
                I   + +LHS K  H D+K  N L V +                     +K+ DF
Sbjct: 122 KMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDF 181

Query: 488 GMAKHLTGQKADLSMKGSPY-----WMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEM 542
           G A              S       + APE+++A+   G S       D+WS+GC +IE 
Sbjct: 182 GSA-------TYDDEHHSTLVSTRHYRAPEVILAL---GWSQ----PCDVWSIGCILIEY 227

Query: 543 YTGKP----------------------------------------PWSEYEGAAAMF--- 559
           Y G                                           W E+  A       
Sbjct: 228 YLGFTVFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRA 287

Query: 560 -KVMRDTPAIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQP 609
            K +++     D       D ++   + +PA R      L+H F    ++ 
Sbjct: 288 CKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLREALKHPFFDLLKKS 338

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 88.2 bits (219), Expect = 2e-19
 Identities = 50/239 (20%), Positives = 91/239 (38%), Gaps = 45/239 (18%)

Query: 339 NSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIK----QLEQEIK 394
              ++ G+ IG G+FG ++  +N       A+K            E  +    QL  E +
Sbjct: 9   GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIK-----------FEPRRSDAPQLRDEYR 57

Query: 395 VLSHLKH-PNI--VQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRH 451
               L     I  V Y+G E       + ++ + P S+   +       +   V    + 
Sbjct: 58  TYKLLAGCTGIPNVYYFGQE--GLHNVLVIDLLGP-SLEDLLDLCGRKFSVKTVAMAAKQ 114

Query: 452 ILSGLAYLHSKKTIHRDIKGANLLVDASG-----VVKLADFGMAK----HLTGQ----KA 498
           +L+ +  +H K  ++RDIK  N L+         ++ + DFGM K     +T Q    + 
Sbjct: 115 MLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYRE 174

Query: 499 DLSMKGSPYWMAPELMMAVMQKGKSS--DSALAVDIWSLGCTIIEMYTGKPPWSEYEGA 555
             ++ G+  +M+    +   Q    S  D     D+ +LG   +    G  PW   + A
Sbjct: 175 KKNLSGTARYMSINTHLGREQ----SRRD-----DLEALGHVFMYFLRGSLPWQGLKAA 224

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 87.8 bits (218), Expect = 7e-19
 Identities = 62/364 (17%), Positives = 110/364 (30%), Gaps = 120/364 (32%)

Query: 346 KLIGRGTFGSVYVASNRETG-ALCAMKEVDIFPDDPKSAES-IKQLEQEIKVLSHLKHP- 402
             +G GTFG V    +   G +  A+K +       ++     +    EI VL  +K   
Sbjct: 25  GNLGEGTFGKVVECLDHARGKSQVALKII-------RNVGKYREAARLEINVLKKIKEKD 77

Query: 403 -----NIVQYYGS-----------EIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVR 446
                  V                E++    + +L+       N +            VR
Sbjct: 78  KENKFLCVLMSDWFNFHGHMCIAFELLGKNTFEFLKE------NNFQP-----YPLPHVR 126

Query: 447 NFTRHILSGLAYLHSKKTIHRDIKGAN-LLVDASGV------------------VKLADF 487
           +    +   L +LH  +  H D+K  N L V++                     +++ADF
Sbjct: 127 HMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADF 186

Query: 488 GMAKHLTGQKADLSMKGSPY-----WMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEM 542
           G A              +       +  PE+++ +   G +       D+WS+GC + E 
Sbjct: 187 GSA-------TFDHEHHTTIVATRHYRPPEVILEL---GWAQ----PCDVWSIGCILFEY 232

Query: 543 YTGKPPW---SEYEGAAAMFKVM-----------------RDTPAIPDSLSPEGK----- 577
           Y G   +      E    M K++                      + D  S +G+     
Sbjct: 233 YRGFTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKEN 292

Query: 578 -------------------DFLRCCFQRNPADRPPASLLLEHRFLKNSQQPDVPSCSLSF 618
                              D +R   + +PA R   +  L H F      P+  S   S 
Sbjct: 293 CKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALLHPFFAG-LTPEERSFHTSR 351

Query: 619 SGMQ 622
           +  +
Sbjct: 352 NPSR 355

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 85.3 bits (211), Expect = 8e-18
 Identities = 68/384 (17%), Positives = 120/384 (31%), Gaps = 137/384 (35%)

Query: 338 MNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLS 397
            N ++   + +G G F +V+++ + +     AMK   +        E+      EI++L 
Sbjct: 35  FNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMK---VVKSAEHYTET---ALDEIRLLK 88

Query: 398 HLK-----HPN---IVQYYGSEIVEDKFYIYLE------YVHP---GSINKYVRE-HCGA 439
            ++      PN   +VQ        D F I          V       + K++ + +   
Sbjct: 89  SVRNSDPNDPNREMVVQLL------DDFKISGVNGTHICMVFEVLGHHLLKWIIKSNYQG 142

Query: 440 ITESVVRNFTRHILSGLAYLHSK-KTIHRDIKGANLLVDAS------------------- 479
           +    V+   + +L GL YLH+K + IH DIK  N+L+  +                   
Sbjct: 143 LPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGA 202

Query: 480 ------------------------------GVVKLADFGMAKHLTGQKADLSMKGSPYWM 509
                                           VK+AD G A  +     +     +  + 
Sbjct: 203 PPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQ--TRQYR 260

Query: 510 APELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGA---------AAMFK 560
           + E    ++  G ++      DIWS  C   E+ TG   +  + G          A + +
Sbjct: 261 SLE---VLIGSGYNT----PADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIE 313

Query: 561 VM-------------------------RDTPAIPDSL----------SPEGK----DFLR 581
           ++                           T   P  L          S E      DFL 
Sbjct: 314 LLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLL 373

Query: 582 CCFQRNPADRPPASLLLEHRFLKN 605
              +  P  R  A+  L H +L +
Sbjct: 374 PMLELIPEKRATAAECLRHPWLNS 397

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 84.4 bits (209), Expect = 1e-17
 Identities = 48/297 (16%), Positives = 87/297 (29%), Gaps = 56/297 (18%)

Query: 308 VHPLPLPPGAAVLSPS-ATIPQVAAKPEPLPMNS--------QWQKGKLIGRGTFGSVYV 358
           +H          L         +    E LP  +        QW+      R   G +Y 
Sbjct: 1   MHHHHHHSSGVDLGTENLYFQSMTTSLEALPTGTVLTDKSGRQWKLKSFQTRDNQGILYE 60

Query: 359 ASNRETGALCAMKEVDIF-----PDDPKSAESIKQLEQEIKV--------LSHLKHPNIV 405
           A+   T    +  +   F       D +        ++  K         L       I 
Sbjct: 61  AAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLAIP 120

Query: 406 QYYGSEIVEDKFYIY-LEYVHPGSINKYVREHCG--AITESVVRNFTRHILSGLAYLHSK 462
              G  + +DK+    L  +   S+     +      ++E  V      +L  L +LH  
Sbjct: 121 TCMGFGVHQDKYRFLVLPSLGR-SLQS-ALDVSPKHVLSERSVLQVACRLLDALEFLHEN 178

Query: 463 KTIHRDIKGANLLVDAS--GVVKLADFGMAKH--LTGQ------KADLSMKGSPYWMAPE 512
           + +H ++   N+ VD      V LA +G A     +G+       +    +G   ++   
Sbjct: 179 EYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFI--- 235

Query: 513 LMMAVMQKGKSSDSALAV------DIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMR 563
                     S D           D+ SLG  +++   G  PW+            +
Sbjct: 236 ----------SMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCLPNTEDIMKQK 282

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 83.8 bits (207), Expect = 2e-17
 Identities = 55/212 (25%), Positives = 91/212 (42%), Gaps = 30/212 (14%)

Query: 410 SEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDI 469
           S  VE+K    +E             +   +T   +  ++  +  G+ +L S+K IHRD+
Sbjct: 165 SGFVEEKSLSDVEEE-----EAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDL 219

Query: 470 KGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGS----PY-WMAPELMMAVMQKGKSS 524
              N+L+    VVK+ DFG+A+ +   K    ++      P  WMAPE    +  +  + 
Sbjct: 220 AARNILLSEKNVVKICDFGLARDI--YKDPDYVRKGDARLPLKWMAPE---TIFDRVYTI 274

Query: 525 DSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFKVMRDTPA-----IPDSLSPEGKD 578
            S    D+WS G  + E+++ G  P   Y G     +  R          PD  +PE   
Sbjct: 275 QS----DVWSFGVLLWEIFSLGASP---YPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQ 327

Query: 579 FLRCCFQRNPADRPPASLLLEH--RFLKNSQQ 608
            +  C+   P+ RP  S L+EH    L+ + Q
Sbjct: 328 TMLDCWHGEPSQRPTFSELVEHLGNLLQANAQ 359

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 54.2 bits (130), Expect = 7e-08
 Identities = 40/176 (22%), Positives = 68/176 (38%), Gaps = 24/176 (13%)

Query: 334 EPLPMN-SQW-------QKGKLIGRGTFGSVYVA-----SNRETGALCAMKEVDIFPDDP 380
           E LP + S+W       + GK +GRG FG V  A         T    A+K +    +  
Sbjct: 8   ERLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKML---KEGA 64

Query: 381 KSAESIKQLEQEIKVLSHL-KHPNIVQYYG-SEIVEDKFYIYLEYVHPGSINKYVREHCG 438
             +E  + L  E+K+L H+  H N+V   G          + +E+   G+++ Y+R    
Sbjct: 65  THSE-HRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRN 123

Query: 439 AITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLT 494
                  +        G  Y+ +   I  D+K     + +S     + F   K L+
Sbjct: 124 EFVPYKTKGA--RFRQGKDYVGA---IPVDLKRRLDSITSSQSSASSGFVEEKSLS 174

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 83.2 bits (206), Expect = 2e-17
 Identities = 56/239 (23%), Positives = 89/239 (37%), Gaps = 45/239 (18%)

Query: 339 NSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIK----QLEQEIK 394
              ++ GK IG G FG + +  N  T    A+K            E +K    QL  E +
Sbjct: 8   GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIK-----------LEPMKSRAPQLHLEYR 56

Query: 395 VLSHLKH-PNI--VQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRH 451
               L     I  V Y+G         + LE + P S+           +   V      
Sbjct: 57  FYKQLGSGDGIPQVYYFGPC--GKYNAMVLELLGP-SLEDLFDLCDRTFSLKTVLMIAIQ 113

Query: 452 ILSGLAYLHSKKTIHRDIKGANLLVDASG-----VVKLADFGMAK----HLTGQ----KA 498
           ++S + Y+HSK  I+RD+K  N L+   G     V+ + DF +AK      T +    + 
Sbjct: 114 LISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYRE 173

Query: 499 DLSMKGSPYWMAPELMMAVMQKGKSS--DSALAVDIWSLGCTIIEMYTGKPPWSEYEGA 555
             S+ G+  +M+    +   Q    S  D     D+ +LG   +    G  PW   +  
Sbjct: 174 HKSLTGTARYMSINTHLGKEQ----SRRD-----DLEALGHMFMYFLRGSLPWQGLKAD 223

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 80.6 bits (199), Expect = 2e-16
 Identities = 48/269 (17%), Positives = 87/269 (32%), Gaps = 51/269 (18%)

Query: 333 PEPLP--------MNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAE 384
            E             + W+ G  IG+G FG +Y+A    + ++ +     +   +P    
Sbjct: 20  AEQFAVGEIITDMAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVV-KVEPSDN- 77

Query: 385 SIKQLEQEIKVLSHLKHPNIVQ-----------------YYGSEIVEDKFYIYL--EYVH 425
               L  E+K       P  +Q                   G      K Y ++  +   
Sbjct: 78  --GPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFG 135

Query: 426 PGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDA--SGVVK 483
              + K    +    +   V   +  IL  L Y+H  + +H DIK +NLL++      V 
Sbjct: 136 S-DLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVY 194

Query: 484 LADFGMAK---------HLTGQKADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWS 534
           L D+G+A                      G+  + + +    V    +        D+  
Sbjct: 195 LVDYGLAYRYCPEGVHKAYA-ADPKRCHDGTIEFTSIDAHNGVAPSRRG-------DLEI 246

Query: 535 LGCTIIEMYTGKPPWSEYEGAAAMFKVMR 563
           LG  +I+  TG  PW +        +  +
Sbjct: 247 LGYCMIQWLTGHLPWEDNLKDPKYVRDSK 275

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 81.6 bits (201), Expect = 2e-16
 Identities = 52/231 (22%), Positives = 102/231 (44%), Gaps = 31/231 (13%)

Query: 339 NSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSH 398
            ++++ G+ IG G+FG +Y+ +N +T    A+K  ++    P       QL  E K+   
Sbjct: 6   GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHP-------QLLYESKIYRI 58

Query: 399 LK-HPNI--VQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSG 455
           L+    I  V+++G E   D   + ++ + P S+          ++   V      +++ 
Sbjct: 59  LQGGTGIPNVRWFGVE--GDYNVLVMDLLGP-SLEDLFNFCSRKLSLKTVLMLADQMINR 115

Query: 456 LAYLHSKKTIHRDIKGANLLV---DASGVVKLADFGMAK----HLTGQ----KADLSMKG 504
           + ++HSK  +HRDIK  N L+     +  V + DFG+AK      T Q    + + ++ G
Sbjct: 116 VEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTG 175

Query: 505 SPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGA 555
           +  + +    + + Q  +        D+ SLG  ++    G  PW   +  
Sbjct: 176 TARYASVNTHLGIEQSRRD-------DLESLGYVLMYFLRGSLPWQGLKAG 219

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 76.1 bits (186), Expect = 5e-15
 Identities = 37/209 (17%), Positives = 69/209 (33%), Gaps = 52/209 (24%)

Query: 334 EPLPMN-----SQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQ 388
            P+P +      + Q+ + IG G FG V+      T    A+K + I   D  +    K 
Sbjct: 9   GPVPFSHCLPTEKLQRCEKIGEGVFGEVFQTIADHTPV--AIKIIAIEGPDLVNGSHQKT 66

Query: 389 LEQ---EIKVLSHL---------KHPNIVQYYGSEIV----------------------- 413
            E+   EI +   L         +    +       V                       
Sbjct: 67  FEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSAN 126

Query: 414 -------EDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSK-KTI 465
                  +D+ +I LE+   G   + +R      + +  ++    + + LA   +  +  
Sbjct: 127 DRPDFFKDDQLFIVLEFEFGGIDLEQMRTKL--SSLATAKSILHQLTASLAVAEASLRFE 184

Query: 466 HRDIKGANLLVDASGVVKLADFGMAKHLT 494
           HRD+   N+L+  + + KL      K  T
Sbjct: 185 HRDLHWGNVLLKKTSLKKLHYTLNGKSST 213

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 42.1 bits (98), Expect = 7e-04
 Identities = 34/228 (14%), Positives = 63/228 (27%), Gaps = 48/228 (21%)

Query: 306 IEVHPLPLPPGAAVLSPSATIPQVAAKPEPLPMNSQWQKGKLIGRGTFGSVYVAS--NRE 363
           ++  P  LP      +P   +  +A         + W   K +      ++  +S    E
Sbjct: 311 LDCRPQDLPREVLTTNPRR-LSIIAESIRD--GLATWDNWKHVNCDKLTTIIESSLNVLE 367

Query: 364 TGALCAM-KEVDIFPDD---PKS------AESIKQLEQEIKVLSH-----LKHPNIVQYY 408
                 M   + +FP     P         + IK     +    H      K P      
Sbjct: 368 PAEYRKMFDRLSVFPPSAHIPTILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTIS 427

Query: 409 GSEIVEDKFYIYLEY---------VHPGSINKY--VREHCG-AITESVVRN-FTRHILSG 455
               +     IYLE          +H   ++ Y   +      +    +   F  HI   
Sbjct: 428 ----IPS---IYLELKVKLENEYALHRSIVDHYNIPKTFDSDDLIPPYLDQYFYSHI--- 477

Query: 456 LAYLHSKKT--IHRDIKGANLLVDASGV-VKLADFGMAKHLTGQKADL 500
             + H K      R      + +D   +  K+     A + +G   + 
Sbjct: 478 -GH-HLKNIEHPERMTLFRMVFLDFRFLEQKIRHDSTAWNASGSILNT 523

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	721
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.98
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.95
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.91
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.85
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.72
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.36
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.24
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.14
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	99.13
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.99
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.66
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.57
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.37
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	98.31
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.27
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	98.25
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.19
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	97.63
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	97.63
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.61
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.59
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.47
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.35
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.27
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	97.2
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	97.17
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	97.04
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	97.04
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	96.96
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	96.57
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	96.36
3mes_A	424	Choline kinase; malaria, structural genomics, stru	95.0
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	93.87
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	83.22
4ano_A	219	ESSB; membrane protein, membrane secretion, ESS ty	81.61

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=1.3e-61  Score=518.33  Aligned_cols=258  Identities=28%  Similarity=0.516  Sum_probs=233.4

Q ss_pred             CCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeEEE
Q 004959          340 SQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYI  419 (721)
Q Consensus       340 ~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~yL  419 (721)
                      ++|++++.||+|+||+||+|+++.+|+.||||++.+..  .......+.+.+|+++|++|+|||||+++++|++++.+||
T Consensus        32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~--~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yi  109 (311)
T 4aw0_A           32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRH--IIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYF  109 (311)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHH--HHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred             cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHH--CCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence            47999999999999999999999999999999986421  0111235678999999999999999999999999999999


Q ss_pred             EEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCCc--
Q 004959          420 YLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQK--  497 (721)
Q Consensus       420 VmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~~--  497 (721)
                      |||||+||+|.++|.+. +.++|.+++.|+.||+.||+|||++|||||||||+||||+.+|.|||+|||+|+.+....  
T Consensus       110 vmEy~~gG~L~~~i~~~-~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~~  188 (311)
T 4aw0_A          110 GLSYAKNGELLKYIRKI-GSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQ  188 (311)
T ss_dssp             EECCCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTTC
T ss_pred             EEecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCCc
Confidence            99999999999999875 789999999999999999999999999999999999999999999999999999875432  


Q ss_pred             -ccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhcCCCCCCCCCHHH
Q 004959          498 -ADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDSLSPEG  576 (721)
Q Consensus       498 -~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~~~~~p~~lS~el  576 (721)
                       ...+.+||+.|||||++.+       ..|+.++|||||||+||||++|+.||.+.+..+.+.++......+|..+++++
T Consensus       189 ~~~~~~~GTp~YmAPEvl~~-------~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~  261 (311)
T 4aw0_A          189 ARANSFVGTAQYVSPELLTE-------KSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDFPEKFFPKA  261 (311)
T ss_dssp             CCBCCCCSCGGGCCHHHHHH-------SCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTCCHHH
T ss_pred             ccccCcccCcccCCHHHHcC-------CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCcccCHHH
Confidence             2356899999999999965       35678999999999999999999999998888889999999889999999999


Q ss_pred             HHHHHHhcccCCCCCCCHHH------HHhccccccCC
Q 004959          577 KDFLRCCFQRNPADRPPASL------LLEHRFLKNSQ  607 (721)
Q Consensus       577 ~dLI~~cL~~DP~kRPSa~e------LL~Hp~f~~~~  607 (721)
                      ++||++||++||++|||++|      |++||||++..
T Consensus       262 ~dli~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~id  298 (311)
T 4aw0_A          262 RDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVT  298 (311)
T ss_dssp             HHHHHHHSCSSGGGSTTSGGGTCHHHHHTSGGGTTCC
T ss_pred             HHHHHHHccCCHhHCcChHHHcCCHHHHCCCCcCCCC
Confidence            99999999999999999987      68999998754

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=1.2e-60  Score=502.93  Aligned_cols=256  Identities=27%  Similarity=0.464  Sum_probs=215.5

Q ss_pred             CCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeEEE
Q 004959          340 SQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYI  419 (721)
Q Consensus       340 ~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~yL  419 (721)
                      ++|++++.||+|+||+||+|+++.+|+.||||++.+..  .......+.+.+|+.+|++++|||||++++++.+++.+||
T Consensus        13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~--~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~i   90 (275)
T 3hyh_A           13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKV--LAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIM   90 (275)
T ss_dssp             -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHH--cCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence            58999999999999999999999999999999987422  1223345679999999999999999999999999999999


Q ss_pred             EEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCCccc
Q 004959          420 YLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKAD  499 (721)
Q Consensus       420 VmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~~~~  499 (721)
                      ||||| +|+|.+++.+. +.+++.+++.++.||+.||+|||++||+||||||+||||+.+|.+||+|||+|+........
T Consensus        91 vmEy~-~g~L~~~l~~~-~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~~~  168 (275)
T 3hyh_A           91 VIEYA-GNELFDYIVQR-DKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFL  168 (275)
T ss_dssp             EEECC-CEEHHHHHHHS-CSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEEECCSSCC---------
T ss_pred             EEeCC-CCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEEEeecCCCeecCCCCcc
Confidence            99999 68999999765 78999999999999999999999999999999999999999999999999999887666666


Q ss_pred             ccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhcCCCCCCCCCHHHHHH
Q 004959          500 LSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDSLSPEGKDF  579 (721)
Q Consensus       500 ~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~~~~~p~~lS~el~dL  579 (721)
                      .+.+||+.|||||++.+      ...++.++|||||||+||+|++|+.||.+....+.+..+......+|..+|+++++|
T Consensus       169 ~~~~GT~~Y~APE~~~~------~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~~l  242 (275)
T 3hyh_A          169 KTSCGSPNYAAPEVISG------KLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPKFLSPGAAGL  242 (275)
T ss_dssp             ------CTTSCHHHHSS------SSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTSCHHHHHH
T ss_pred             CCeeECcccCChhhhcC------CCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence            67899999999999953      122356899999999999999999999988888888888888888999999999999


Q ss_pred             HHHhcccCCCCCCCHHHHHhcccccc
Q 004959          580 LRCCFQRNPADRPPASLLLEHRFLKN  605 (721)
Q Consensus       580 I~~cL~~DP~kRPSa~eLL~Hp~f~~  605 (721)
                      |++||++||++|||++|+|+||||+.
T Consensus       243 i~~~L~~dP~~R~s~~eil~hpw~k~  268 (275)
T 3hyh_A          243 IKRMLIVNPLNRISIHEIMQDDWFKV  268 (275)
T ss_dssp             HHHHSCSSGGGSCCHHHHHHCHHHHT
T ss_pred             HHHHccCChhHCcCHHHHHcCccccc
Confidence            99999999999999999999999975

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=1.4e-60  Score=518.16  Aligned_cols=257  Identities=29%  Similarity=0.531  Sum_probs=225.8

Q ss_pred             CCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeEEE
Q 004959          340 SQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYI  419 (721)
Q Consensus       340 ~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~yL  419 (721)
                      ++|++++.||+|+||+||+|+++.+|+.||||++.+..   ......+.+.+|+.+|++|+|||||++++++++++.+||
T Consensus        24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yi  100 (350)
T 4b9d_A           24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISR---MSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYI  100 (350)
T ss_dssp             CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTT---SCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHH---CCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEE
Confidence            58999999999999999999999999999999997432   334567889999999999999999999999999999999


Q ss_pred             EEeeccCCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCCcc
Q 004959          420 YLEYVHPGSINKYVREH-CGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKA  498 (721)
Q Consensus       420 VmEy~~gGsL~~~L~~~-~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~~~  498 (721)
                      |||||+||+|.++|... ...++|.+++.|+.||+.||+|||++|||||||||+||||+.+|.|||+|||+|+.+.....
T Consensus       101 VmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~  180 (350)
T 4b9d_A          101 VMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVE  180 (350)
T ss_dssp             EEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCCEEECSTTEESCCCHHHH
T ss_pred             EEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCCEEEcccccceeecCCcc
Confidence            99999999999999765 34679999999999999999999999999999999999999999999999999997754332


Q ss_pred             -cccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhcC-CCCCCCCCHHH
Q 004959          499 -DLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDT-PAIPDSLSPEG  576 (721)
Q Consensus       499 -~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~~-~~~p~~lS~el  576 (721)
                       ..+.+||+.|||||++.       +..|+.++||||||||||||++|+.||.+.+..+.+.++.... +.++..+|+++
T Consensus       181 ~~~~~~GT~~YmAPE~l~-------~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~s~~~  253 (350)
T 4b9d_A          181 LARACIGTPYYLSPEICE-------NKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPPVSLHYSYDL  253 (350)
T ss_dssp             HHHHHHSCCTTCCHHHHT-------TCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCCTTSCHHH
T ss_pred             cccccCCCccccCHHHHC-------CCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCCccCCHHH
Confidence             34578999999999994       4568889999999999999999999999988888888887764 45678899999


Q ss_pred             HHHHHHhcccCCCCCCCHHHHHhccccccC
Q 004959          577 KDFLRCCFQRNPADRPPASLLLEHRFLKNS  606 (721)
Q Consensus       577 ~dLI~~cL~~DP~kRPSa~eLL~Hp~f~~~  606 (721)
                      ++||.+||++||++|||++|||+||||+..
T Consensus       254 ~~li~~~L~~dP~~R~s~~e~l~hp~~~~~  283 (350)
T 4b9d_A          254 RSLVSQLFKRNPRDRPSVNSILEKGFIAKR  283 (350)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHTSHHHHTT
T ss_pred             HHHHHHHccCChhHCcCHHHHhcCHHhhcC
Confidence            999999999999999999999999999753

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=3.6e-60  Score=514.07  Aligned_cols=255  Identities=33%  Similarity=0.568  Sum_probs=228.0

Q ss_pred             CCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeEEE
Q 004959          340 SQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYI  419 (721)
Q Consensus       340 ~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~yL  419 (721)
                      ..|++++.||+|+||+||+|+++.+|+.||||++.+.....     .+.+.+|+.+|+.++|||||+++++|.+++.+||
T Consensus        74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~-----~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~i  148 (346)
T 4fih_A           74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR-----RELLFNEVVIMRDYQHENVVEMYNSYLVGDELWV  148 (346)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSS-----GGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhH-----HHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence            47999999999999999999999999999999997532221     3468899999999999999999999999999999


Q ss_pred             EEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCCc-c
Q 004959          420 YLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQK-A  498 (721)
Q Consensus       420 VmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~~-~  498 (721)
                      |||||+||+|.+++.+  +.++|.+++.|+.||+.||+|||++|||||||||+||||+.+|.|||+|||+|+.+.... .
T Consensus       149 vmEy~~gg~L~~~l~~--~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~  226 (346)
T 4fih_A          149 VMEFLEGGALTDIVTH--TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR  226 (346)
T ss_dssp             EECCCTTEEHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCC
T ss_pred             EEeCCCCCcHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCEEEecCcCceecCCCCCc
Confidence            9999999999999975  579999999999999999999999999999999999999999999999999999876543 3


Q ss_pred             cccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhcCC---CCCCCCCHH
Q 004959          499 DLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTP---AIPDSLSPE  575 (721)
Q Consensus       499 ~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~~~---~~p~~lS~e  575 (721)
                      ..+.+||+.|||||++.       ...|+.++||||||||||||++|++||.+.+..+.+..+.....   ..+..+|++
T Consensus       227 ~~~~~GTp~YmAPEvl~-------~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~  299 (346)
T 4fih_A          227 RKSLVGTPYWMAPELIS-------RLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPS  299 (346)
T ss_dssp             BCCCCSCGGGCCHHHHT-------TCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCSCGGGSCHH
T ss_pred             ccccccCcCcCCHHHHC-------CCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCCccccCCHH
Confidence            45789999999999994       45678899999999999999999999998887777777766533   233568999


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHHhccccccCCC
Q 004959          576 GKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQ  608 (721)
Q Consensus       576 l~dLI~~cL~~DP~kRPSa~eLL~Hp~f~~~~~  608 (721)
                      +++||.+||++||++|||++|||+||||++...
T Consensus       300 ~~dli~~~L~~dP~~R~ta~e~l~Hp~~~~~~~  332 (346)
T 4fih_A          300 LKGFLDRLLVRDPAQRATAAELLKHPFLAKAGP  332 (346)
T ss_dssp             HHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCCC
T ss_pred             HHHHHHHHcCCChhHCcCHHHHhcCHhhcCCCC
Confidence            999999999999999999999999999987543

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=4.5e-59  Score=517.53  Aligned_cols=255  Identities=33%  Similarity=0.568  Sum_probs=228.5

Q ss_pred             CCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeEEE
Q 004959          340 SQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYI  419 (721)
Q Consensus       340 ~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~yL  419 (721)
                      ..|++++.||+|+||+||+|+++.+|+.||||++.+.....     .+.+.+|+.+|+.|+|||||+++++|.+++.+||
T Consensus       151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~-----~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~i  225 (423)
T 4fie_A          151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR-----RELLFNEVVIMRDYQHENVVEMYNSYLVGDELWV  225 (423)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSS-----GGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhH-----HHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEE
Confidence            57999999999999999999999999999999997543221     3468899999999999999999999999999999


Q ss_pred             EEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCCc-c
Q 004959          420 YLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQK-A  498 (721)
Q Consensus       420 VmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~~-~  498 (721)
                      |||||+||+|.+++..  +.++|.+++.|+.||+.||+|||++|||||||||+||||+.+|.|||+|||+|+.+.... .
T Consensus       226 VmEy~~gG~L~~~i~~--~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~~  303 (423)
T 4fie_A          226 VMEFLEGGALTDIVTH--TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR  303 (423)
T ss_dssp             EEECCTTEEHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCCC
T ss_pred             EEeCCCCCcHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEecCccceECCCCCcc
Confidence            9999999999999965  579999999999999999999999999999999999999999999999999999876543 3


Q ss_pred             cccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhcCC---CCCCCCCHH
Q 004959          499 DLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTP---AIPDSLSPE  575 (721)
Q Consensus       499 ~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~~~---~~p~~lS~e  575 (721)
                      ..+.+||++|||||++.       ...|+.++||||||||||||++|+.||.+....+.+..+.....   ..+..+|++
T Consensus       304 ~~~~~GTp~YmAPEvl~-------~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~  376 (423)
T 4fie_A          304 RKSLVGTPYWMAPELIS-------RLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPS  376 (423)
T ss_dssp             BCCCEECTTTCCHHHHT-------TCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSSCHH
T ss_pred             ccccccCcCcCCHHHHC-------CCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCcccccCCHH
Confidence            45688999999999994       45678899999999999999999999998887777777766532   344678999


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHHhccccccCCC
Q 004959          576 GKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQ  608 (721)
Q Consensus       576 l~dLI~~cL~~DP~kRPSa~eLL~Hp~f~~~~~  608 (721)
                      +++||.+||++||++|||++|||+||||+....
T Consensus       377 ~~dli~~~L~~dP~~R~ta~ell~Hp~~~~~~~  409 (423)
T 4fie_A          377 LKGFLDRLLVRDPAQRATAAELLKHPFLAKAGP  409 (423)
T ss_dssp             HHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCCC
T ss_pred             HHHHHHHHcCCChhHCcCHHHHhcCHHhcCCCC
Confidence            999999999999999999999999999987543

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=7.4e-60  Score=503.48  Aligned_cols=256  Identities=30%  Similarity=0.490  Sum_probs=222.8

Q ss_pred             CCeeEeeEEeecCCeEEEEEEEC---CCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCe
Q 004959          340 SQWQKGKLIGRGTFGSVYVASNR---ETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDK  416 (721)
Q Consensus       340 ~~y~~~k~LG~G~fG~VY~a~~~---~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~  416 (721)
                      ++|++++.||+|+||+||+|++.   .+++.||||++.+......   ...++.+|+.+|++++|||||++++++.+++.
T Consensus        24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~---~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~  100 (304)
T 3ubd_A           24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVR---DRVRTKMERDILVEVNHPFIVKLHYAFQTEGK  100 (304)
T ss_dssp             GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEE---ECC------CCCCCCCCTTEECEEEEEEETTE
T ss_pred             cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChH---HHHHHHHHHHHHHHCCCCCCCeEEEEEEECCE
Confidence            57999999999999999999874   5789999999864221111   12357889999999999999999999999999


Q ss_pred             EEEEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCC
Q 004959          417 FYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQ  496 (721)
Q Consensus       417 ~yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~  496 (721)
                      +|||||||+||+|.++|.+. +.++|.+++.|+.||+.||+|||++|||||||||+|||++.+|.+||+|||+|+.....
T Consensus       101 ~~ivmEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~  179 (304)
T 3ubd_A          101 LYLILDFLRGGDLFTRLSKE-VMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDH  179 (304)
T ss_dssp             EEEEECCCTTCEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCEEEESSEEEEC----
T ss_pred             EEEEEEcCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCEEecccccceeccCC
Confidence            99999999999999999875 78999999999999999999999999999999999999999999999999999875443


Q ss_pred             -cccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhcCCCCCCCCCHH
Q 004959          497 -KADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDSLSPE  575 (721)
Q Consensus       497 -~~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~~~~~p~~lS~e  575 (721)
                       ....+.+||+.|||||++.+       ..|+.++|||||||+||||++|+.||.+.+..+.+.++......+|..+|++
T Consensus       180 ~~~~~~~~GT~~YmAPE~~~~-------~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~  252 (304)
T 3ubd_A          180 EKKAYSFCGTVEYMAPEVVNR-------RGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQFLSPE  252 (304)
T ss_dssp             -CCCCSCCCCGGGCCHHHHHT-------SCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHH
T ss_pred             CccccccccCcccCCHHHhcc-------CCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCCCcCCHH
Confidence             34456889999999999953       4577899999999999999999999999888888999999888999999999


Q ss_pred             HHHHHHHhcccCCCCCCC-----HHHHHhccccccC
Q 004959          576 GKDFLRCCFQRNPADRPP-----ASLLLEHRFLKNS  606 (721)
Q Consensus       576 l~dLI~~cL~~DP~kRPS-----a~eLL~Hp~f~~~  606 (721)
                      +++||++||++||++|||     ++||++||||++.
T Consensus       253 ~~~li~~~L~~dP~~R~ta~~~~~~eil~Hp~f~~i  288 (304)
T 3ubd_A          253 AQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFSTI  288 (304)
T ss_dssp             HHHHHHHHTCSSGGGSTTCSTTTHHHHHTSGGGTTC
T ss_pred             HHHHHHHHcccCHHHCCCCCcCCHHHHHcCccccCC
Confidence            999999999999999998     5899999999864

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=2.9e-58  Score=488.13  Aligned_cols=253  Identities=28%  Similarity=0.525  Sum_probs=217.6

Q ss_pred             CCe-eEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEe----c
Q 004959          340 SQW-QKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIV----E  414 (721)
Q Consensus       340 ~~y-~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~----~  414 (721)
                      ++| ++.+.||+|+||+||+|.++.+|+.||||++...   .......+.+.+|+.+|++|+|||||+++++|.+    +
T Consensus        25 gr~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~---~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~  101 (290)
T 3fpq_A           25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDR---KLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGK  101 (290)
T ss_dssp             SSEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGG---GSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTE
T ss_pred             CceEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchh---hCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCC
Confidence            345 7888999999999999999999999999998642   2334556789999999999999999999999875    3


Q ss_pred             CeEEEEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCC--eeccCCCCCcEEEcC-CCceEEeecCCcc
Q 004959          415 DKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKK--TIHRDIKGANLLVDA-SGVVKLADFGMAK  491 (721)
Q Consensus       415 ~~~yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~g--IIHrDLKPeNILld~-~g~VKL~DFGlA~  491 (721)
                      +.+|||||||+||+|.++|.+. +.+++..++.|+.||+.||+|||++|  ||||||||+||||+. +|.+||+|||+|+
T Consensus       102 ~~~~lvmEy~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~  180 (290)
T 3fpq_A          102 KCIVLVTELMTSGTLKTYLKRF-KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT  180 (290)
T ss_dssp             EEEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred             cEEEEEEeCCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCE
Confidence            5689999999999999999875 78999999999999999999999999  999999999999974 7999999999998


Q ss_pred             ccCCCcccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhcC---CCC
Q 004959          492 HLTGQKADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDT---PAI  568 (721)
Q Consensus       492 ~l~~~~~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~~---~~~  568 (721)
                      .... ....+.+||+.|||||++.+        .|+.++|||||||+||||+||+.||.+......+.+.+...   ..+
T Consensus       181 ~~~~-~~~~~~~GTp~YmAPE~~~~--------~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~~~~~  251 (290)
T 3fpq_A          181 LKRA-SFAKAVIGTPEFMAPEMYEE--------KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASF  251 (290)
T ss_dssp             GCCT-TSBEESCSSCCCCCGGGGGT--------CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGG
T ss_pred             eCCC-CccCCcccCccccCHHHcCC--------CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCCCCCC
Confidence            5433 33456789999999998842        37789999999999999999999998765555554444332   234


Q ss_pred             CCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccccc
Q 004959          569 PDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKN  605 (721)
Q Consensus       569 p~~lS~el~dLI~~cL~~DP~kRPSa~eLL~Hp~f~~  605 (721)
                      +..+++++++||.+||++||++|||++|+|+||||++
T Consensus       252 ~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~Hp~~~~  288 (290)
T 3fpq_A          252 DKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE  288 (290)
T ss_dssp             GGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred             CccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccC
Confidence            5678899999999999999999999999999999985

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.9e-57  Score=501.65  Aligned_cols=263  Identities=27%  Similarity=0.443  Sum_probs=224.7

Q ss_pred             CCCCCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEe---
Q 004959          337 PMNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIV---  413 (721)
Q Consensus       337 ~l~~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~---  413 (721)
                      .+.++|++++.||+|+||+||+|+++.+|+.||||++..   ........+.+.+|+.+|+.|+|||||++++++..   
T Consensus        51 ~i~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~---~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~  127 (398)
T 4b99_A           51 DVGDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPN---AFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVP  127 (398)
T ss_dssp             CCCSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETT---TTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSC
T ss_pred             CCCCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECc---cccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccc
Confidence            355789999999999999999999999999999999863   23344556788999999999999999999998764   


Q ss_pred             ---cCeEEEEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCc
Q 004959          414 ---EDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMA  490 (721)
Q Consensus       414 ---~~~~yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA  490 (721)
                         .+.+|||||||. |+|.++|... +.+++.+++.|+.||+.||.|||++|||||||||+||||+.+|.+||+|||+|
T Consensus       128 ~~~~~~~~ivmE~~~-g~L~~~i~~~-~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla  205 (398)
T 4b99_A          128 YGEFKSVYVVLDLME-SDLHQIIHSS-QPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMA  205 (398)
T ss_dssp             TTTCCCEEEEEECCS-EEHHHHHTSS-SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             cccCCEEEEEEeCCC-CCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCCEEEeeccee
Confidence               367999999996 6899999764 78999999999999999999999999999999999999999999999999999


Q ss_pred             cccCCC-----cccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhcC
Q 004959          491 KHLTGQ-----KADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDT  565 (721)
Q Consensus       491 ~~l~~~-----~~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~~  565 (721)
                      +.+...     ....+.+||++|||||++.+      ...++.++||||||||||||++|++||.+.+..+++..+....
T Consensus       206 ~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~------~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~  279 (398)
T 4b99_A          206 RGLCTSPAEHQYFMTEYVATRWYRAPELMLS------LHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVL  279 (398)
T ss_dssp             BCC-------CCCCCSSCCCCTTCCHHHHTT------CSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHH
T ss_pred             eecccCccccccccccceeChHhcCHHHhcC------CCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhc
Confidence            876432     23346789999999999853      2346789999999999999999999999887777777665321


Q ss_pred             CC-------------------------------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhccccccCCCCC
Q 004959          566 PA-------------------------------IPDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQPD  610 (721)
Q Consensus       566 ~~-------------------------------~p~~lS~el~dLI~~cL~~DP~kRPSa~eLL~Hp~f~~~~~~~  610 (721)
                      ..                               +...+++++++||.+||++||++|||++|+|+||||+....+.
T Consensus       280 g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~p~  355 (398)
T 4b99_A          280 GTPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKYHDPD  355 (398)
T ss_dssp             CCCCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTTCCGG
T ss_pred             CCCChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcCCCCc
Confidence            11                               1135789999999999999999999999999999999876553

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=4.9e-58  Score=495.65  Aligned_cols=252  Identities=28%  Similarity=0.512  Sum_probs=220.1

Q ss_pred             CCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeEEE
Q 004959          340 SQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYI  419 (721)
Q Consensus       340 ~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~yL  419 (721)
                      ..|++.+.||+|+||+||+|+++.+|+.||||++.+..          ...+|+.+|+.|+|||||++++++.+++.+||
T Consensus        58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~----------~~~~E~~il~~l~HpnIV~l~~~~~~~~~~~i  127 (336)
T 4g3f_A           58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEV----------FRVEELVACAGLSSPRIVPLYGAVREGPWVNI  127 (336)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT----------CCTHHHHTTTTCCCTTBCCEEEEEEETTEEEE
T ss_pred             hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHH----------hHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence            46899999999999999999999999999999997421          12469999999999999999999999999999


Q ss_pred             EEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCC-ceEEeecCCccccCCCcc
Q 004959          420 YLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASG-VVKLADFGMAKHLTGQKA  498 (721)
Q Consensus       420 VmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g-~VKL~DFGlA~~l~~~~~  498 (721)
                      |||||+||+|.++|.+. +.+++.+++.|+.||+.||+|||++|||||||||+||||+.+| .+||+|||+|+.+.....
T Consensus       128 vmEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~  206 (336)
T 4g3f_A          128 FMELLEGGSLGQLIKQM-GCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGL  206 (336)
T ss_dssp             EECCCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC-----
T ss_pred             EEeccCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCc
Confidence            99999999999999875 7899999999999999999999999999999999999999988 699999999987754321


Q ss_pred             ------cccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhcCC---CCC
Q 004959          499 ------DLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTP---AIP  569 (721)
Q Consensus       499 ------~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~~~---~~p  569 (721)
                            ....+||+.|||||++.       +..|+.++|||||||+||||++|+.||.+....+.+.++....+   .++
T Consensus       207 ~~~~~~~~~~~GT~~YmAPE~~~-------~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~  279 (336)
T 4g3f_A          207 GKSLLTGDYIPGTETHMAPEVVM-------GKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIP  279 (336)
T ss_dssp             -------CCCCCCGGGCCHHHHT-------TCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSCCGGGGSC
T ss_pred             ccceecCCccccCccccCHHHHC-------CCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCCCCchhcC
Confidence                  12468999999999994       35678899999999999999999999988776666777766543   467


Q ss_pred             CCCCHHHHHHHHHhcccCCCCCCCHHHHH-------------hccccccCCCC
Q 004959          570 DSLSPEGKDFLRCCFQRNPADRPPASLLL-------------EHRFLKNSQQP  609 (721)
Q Consensus       570 ~~lS~el~dLI~~cL~~DP~kRPSa~eLL-------------~Hp~f~~~~~~  609 (721)
                      ..+++++.+||.+||++||++|||+.||+             +|||+.....|
T Consensus       280 ~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~~~~P  332 (336)
T 4g3f_A          280 PSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGEYKEP  332 (336)
T ss_dssp             TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSSCCCC
T ss_pred             ccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCCCCCC
Confidence            88999999999999999999999999984             68888765544

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=2.9e-55  Score=466.59  Aligned_cols=254  Identities=24%  Similarity=0.449  Sum_probs=201.4

Q ss_pred             CeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecC-----
Q 004959          341 QWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVED-----  415 (721)
Q Consensus       341 ~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~-----  415 (721)
                      +|++++.||+|+||+||+|+++.+|+.||||++...    ......+.+.+|+.+|++|+|||||++++++.+.+     
T Consensus         6 dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~----~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~   81 (299)
T 4g31_A            6 DFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLP----NRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKL   81 (299)
T ss_dssp             HEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEEC----SSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC-----
T ss_pred             hCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEecc----CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccc
Confidence            699999999999999999999999999999998742    23445678999999999999999999999987654     


Q ss_pred             -------eEEEEEeeccCCCHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEee
Q 004959          416 -------KFYIYLEYVHPGSINKYVREHC--GAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLAD  486 (721)
Q Consensus       416 -------~~yLVmEy~~gGsL~~~L~~~~--~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~D  486 (721)
                             .+|||||||.||+|.+++....  ....+..++.|+.||+.||+|||++|||||||||+||||+.+|.+||+|
T Consensus        82 ~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~vKl~D  161 (299)
T 4g31_A           82 QPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGD  161 (299)
T ss_dssp             -----CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC
T ss_pred             cccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCcEEEcc
Confidence                   3799999999999999997642  2345677899999999999999999999999999999999999999999


Q ss_pred             cCCccccCCCcc-------------cccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchh
Q 004959          487 FGMAKHLTGQKA-------------DLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYE  553 (721)
Q Consensus       487 FGlA~~l~~~~~-------------~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~  553 (721)
                      ||+|+.+.....             ..+.+||+.|||||++.       +..|+.++|||||||+||||++   ||....
T Consensus       162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~-------~~~y~~~~DiwSlGvilyell~---Pf~~~~  231 (299)
T 4g31_A          162 FGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIH-------GNSYSHKVDIFSLGLILFELLY---PFSTQM  231 (299)
T ss_dssp             CCCC--------------------------CCCTTSCHHHHT-------TCCCCTHHHHHHHHHHHHHHHS---CCSSHH
T ss_pred             CccceecCCCccccccccccccccccCCcccCccccCHHHHc-------CCCCCCHHHHHHHHHHHHHHcc---CCCCcc
Confidence            999987654321             23467999999999994       4567889999999999999996   787643


Q ss_pred             hH-HHHHHHhhcC-CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhccccccCCC
Q 004959          554 GA-AAMFKVMRDT-PAIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQ  608 (721)
Q Consensus       554 ~~-~~~~ki~~~~-~~~p~~lS~el~dLI~~cL~~DP~kRPSa~eLL~Hp~f~~~~~  608 (721)
                      .. ..+..+.... +..+...++++.+||++||++||++|||+.|+|+||||++...
T Consensus       232 ~~~~~~~~~~~~~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~~~~  288 (299)
T 4g31_A          232 ERVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDF  288 (299)
T ss_dssp             HHHHHHHHHHTTCCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCCC--
T ss_pred             HHHHHHHHHhcCCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCCCCC
Confidence            32 2333332221 1222345678899999999999999999999999999987543

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=7e-55  Score=501.92  Aligned_cols=260  Identities=23%  Similarity=0.412  Sum_probs=234.9

Q ss_pred             CCCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeEE
Q 004959          339 NSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFY  418 (721)
Q Consensus       339 ~~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~y  418 (721)
                      .++|++++.||+|+||+||+|+++.+|+.||||++..     ......+.+.+|+.+|+.|+|||||+++++|.+.+.+|
T Consensus       156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~-----~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~  230 (573)
T 3uto_A          156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMT-----PHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMV  230 (573)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----CSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEE
T ss_pred             ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEec-----cchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEE
Confidence            3689999999999999999999999999999999863     22344567899999999999999999999999999999


Q ss_pred             EEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCC--CceEEeecCCccccCCC
Q 004959          419 IYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDAS--GVVKLADFGMAKHLTGQ  496 (721)
Q Consensus       419 LVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~--g~VKL~DFGlA~~l~~~  496 (721)
                      ||||||.||+|.++|....+.|+|.+++.|+.||+.||+|||++||+||||||+||||+.+  |.+||+|||+|+.+...
T Consensus       231 iv~E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~  310 (573)
T 3uto_A          231 MIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK  310 (573)
T ss_dssp             EEEECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTT
T ss_pred             EEEeecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEccCC
Confidence            9999999999999997666789999999999999999999999999999999999999854  89999999999988777


Q ss_pred             cccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhcCCCCC----CCC
Q 004959          497 KADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIP----DSL  572 (721)
Q Consensus       497 ~~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~~~~~p----~~l  572 (721)
                      ......+||+.|||||++.       +..|+.++||||||||||||++|..||.+....+.+..+......++    ..+
T Consensus       311 ~~~~~~~GT~~y~APEv~~-------~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  383 (573)
T 3uto_A          311 QSVKVTTGTAEFAAPEVAE-------GKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGI  383 (573)
T ss_dssp             SEEEEECSSGGGCCHHHHT-------TCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCSGGGTTS
T ss_pred             CceeeeEECccccCHHHhC-------CCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCCcccccCC
Confidence            6667789999999999994       45678899999999999999999999999888888888877655443    568


Q ss_pred             CHHHHHHHHHhcccCCCCCCCHHHHHhccccccCCCCC
Q 004959          573 SPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQPD  610 (721)
Q Consensus       573 S~el~dLI~~cL~~DP~kRPSa~eLL~Hp~f~~~~~~~  610 (721)
                      |+++++||++||++||++|||+.|+|+||||+....+.
T Consensus       384 s~~~~dli~~~L~~dp~~R~t~~e~l~Hpw~~~~~~~~  421 (573)
T 3uto_A          384 SEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPG  421 (573)
T ss_dssp             CHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTSCCCCTT
T ss_pred             CHHHHHHHHHHccCChhHCcCHHHHhcCcCcCCCCCCC
Confidence            99999999999999999999999999999999766543

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=4.8e-55  Score=465.17  Aligned_cols=252  Identities=28%  Similarity=0.515  Sum_probs=218.7

Q ss_pred             CCeeEeeEEeecCCeEEEEEEEC-----CCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEec
Q 004959          340 SQWQKGKLIGRGTFGSVYVASNR-----ETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVE  414 (721)
Q Consensus       340 ~~y~~~k~LG~G~fG~VY~a~~~-----~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~  414 (721)
                      ++|.+++.||+|+||+||+|++.     .+|..||||++..     ......++|.+|+++|++|+|||||+++|++.++
T Consensus        13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~-----~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~   87 (299)
T 4asz_A           13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKD-----ASDNARKDFHREAELLTNLQHEHIVKFYGVCVEG   87 (299)
T ss_dssp             GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECS-----CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred             HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCC-----CChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeC
Confidence            57999999999999999999865     4688999999852     2345677899999999999999999999999999


Q ss_pred             CeEEEEEeeccCCCHHHHHHHhc------------CCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCce
Q 004959          415 DKFYIYLEYVHPGSINKYVREHC------------GAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVV  482 (721)
Q Consensus       415 ~~~yLVmEy~~gGsL~~~L~~~~------------~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~V  482 (721)
                      +.+|||||||++|+|.++|...+            ..+++.++..|+.||+.||.|||+++||||||||+||||+.++.+
T Consensus        88 ~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~~~~  167 (299)
T 4asz_A           88 DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLV  167 (299)
T ss_dssp             SSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCE
T ss_pred             CEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCCCcE
Confidence            99999999999999999997642            469999999999999999999999999999999999999999999


Q ss_pred             EEeecCCccccCCCccc---ccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhh-CCCCCCchhhHHHH
Q 004959          483 KLADFGMAKHLTGQKAD---LSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAM  558 (721)
Q Consensus       483 KL~DFGlA~~l~~~~~~---~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLt-G~~PF~~~~~~~~~  558 (721)
                      ||+|||+|+.+......   ...+||+.|||||++.+       ..|+.++|||||||+||||+| |+.||.+....+.+
T Consensus       168 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~-------~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~  240 (299)
T 4asz_A          168 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMY-------RKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVI  240 (299)
T ss_dssp             EECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHH-------CCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHH
T ss_pred             EECCcccceecCCCCceeecCceecChhhcCHHHHcC-------CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHH
Confidence            99999999876543322   23469999999999964       457889999999999999998 99999998877777


Q ss_pred             HHHhhcC-CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccccc
Q 004959          559 FKVMRDT-PAIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKN  605 (721)
Q Consensus       559 ~ki~~~~-~~~p~~lS~el~dLI~~cL~~DP~kRPSa~eLL~Hp~f~~  605 (721)
                      ..+..+. ...|..+++++.+||.+||+.||++|||+.||+  .|+++
T Consensus       241 ~~i~~~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~--~~L~~  286 (299)
T 4asz_A          241 ECITQGRVLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIH--TLLQN  286 (299)
T ss_dssp             HHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH--HHHHH
T ss_pred             HHHHcCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHH--HHHHH
Confidence            7776654 567889999999999999999999999999994  56654

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=2e-54  Score=471.65  Aligned_cols=252  Identities=24%  Similarity=0.375  Sum_probs=208.4

Q ss_pred             CCCCeeEeeEEeecCCeEEEEEEEC---CCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhC-CCCCeeeeeeeEEe
Q 004959          338 MNSQWQKGKLIGRGTFGSVYVASNR---ETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHL-KHPNIVQYYGSEIV  413 (721)
Q Consensus       338 l~~~y~~~k~LG~G~fG~VY~a~~~---~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L-~HPnIV~l~g~~~~  413 (721)
                      +.+.|++++.||+|+||+||+|+++   .+++.||||++...    .   ...++.+|+++|+.+ +|||||+++++|.+
T Consensus        19 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~----~---~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~   91 (361)
T 4f9c_A           19 LSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPT----S---HPIRIAAELQCLTVAGGQDNVMGVKYCFRK   91 (361)
T ss_dssp             GGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTT----S---CHHHHHHHHHHHHHTCSBTTBCCCSEEEEE
T ss_pred             ccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccc----c---CHHHHHHHHHHHHHhcCCCCCceEEEEEEE
Confidence            4568999999999999999999875   46889999988531    1   124678999999998 69999999999999


Q ss_pred             cCeEEEEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCC-CceEEeecCCccc
Q 004959          414 EDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDAS-GVVKLADFGMAKH  492 (721)
Q Consensus       414 ~~~~yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~-g~VKL~DFGlA~~  492 (721)
                      .+.+|||||||+||+|.+++    +.+++.+++.|+.||+.||+|||++|||||||||+||||+.+ +.+||+|||+|+.
T Consensus        92 ~~~~~lvmE~~~g~~L~~~~----~~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~  167 (361)
T 4f9c_A           92 NDHVVIAMPYLEHESFLDIL----NSLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQG  167 (361)
T ss_dssp             TTEEEEEEECCCCCCHHHHH----TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred             CCEEEEEEeCCCcccHHHHH----cCCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcc
Confidence            99999999999999999988    359999999999999999999999999999999999999876 7999999999986


Q ss_pred             cCCCc-----------------------------ccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHh
Q 004959          493 LTGQK-----------------------------ADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMY  543 (721)
Q Consensus       493 l~~~~-----------------------------~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELL  543 (721)
                      .....                             ...+.+||+.|||||++.+      ...|+.++||||+|||||||+
T Consensus       168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~------~~~y~~~~DiWSlG~il~ell  241 (361)
T 4f9c_A          168 THDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTK------CPNQTTAIDMWSAGVIFLSLL  241 (361)
T ss_dssp             CTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTT------CSCCCTHHHHHHHHHHHHHHH
T ss_pred             cCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcC------CCCCCCccchhhhHHHHHHHH
Confidence            54321                             1234679999999999953      345778999999999999999


Q ss_pred             hCCCCCCc-hhhHHHHHHHhhc------------------------------------------------------CCCC
Q 004959          544 TGKPPWSE-YEGAAAMFKVMRD------------------------------------------------------TPAI  568 (721)
Q Consensus       544 tG~~PF~~-~~~~~~~~ki~~~------------------------------------------------------~~~~  568 (721)
                      +|+.||.. .+..+++.++...                                                      ....
T Consensus       242 ~G~~Pf~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~  321 (361)
T 4f9c_A          242 SGRYPFYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEG  321 (361)
T ss_dssp             HTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------
T ss_pred             HCCCCCCCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccc
Confidence            99999954 3333333332110                                                      0012


Q ss_pred             CCCCCHHHHHHHHHhcccCCCCCCCHHHHHhccccccC
Q 004959          569 PDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNS  606 (721)
Q Consensus       569 p~~lS~el~dLI~~cL~~DP~kRPSa~eLL~Hp~f~~~  606 (721)
                      ...+|++++|||++||++||++|+|++|+|+||||++.
T Consensus       322 ~~~is~~a~DLl~~lL~~dP~~R~ta~eaL~Hp~f~~i  359 (361)
T 4f9c_A          322 WNEVPDEAYDLLDKLLDLNPASRITAEEALLHPFFKDM  359 (361)
T ss_dssp             CTTCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGTTC
T ss_pred             cccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCC
Confidence            24589999999999999999999999999999999864

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=3.9e-54  Score=463.93  Aligned_cols=249  Identities=26%  Similarity=0.496  Sum_probs=212.7

Q ss_pred             CCeeEeeEEeecCCeEEEEEEEC-----CCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEec
Q 004959          340 SQWQKGKLIGRGTFGSVYVASNR-----ETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVE  414 (721)
Q Consensus       340 ~~y~~~k~LG~G~fG~VY~a~~~-----~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~  414 (721)
                      .+|.+.+.||+|+||+||+|+.+     .+|+.||||++..     ......+.|.+|+.+|++|+|||||+++|++.+.
T Consensus        41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~-----~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~  115 (329)
T 4aoj_A           41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKE-----ASESARQDFQREAELLTMLQHQHIVRFFGVCTEG  115 (329)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESC-----CSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred             HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECc-----CCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC
Confidence            57899999999999999999865     4689999999852     2445678899999999999999999999999999


Q ss_pred             CeEEEEEeeccCCCHHHHHHHhc--------------CCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCC
Q 004959          415 DKFYIYLEYVHPGSINKYVREHC--------------GAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASG  480 (721)
Q Consensus       415 ~~~yLVmEy~~gGsL~~~L~~~~--------------~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g  480 (721)
                      +.+|||||||++|+|.++|....              +.+++.++..|+.||+.||+|||+++||||||||+||||+.++
T Consensus       116 ~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~~~~  195 (329)
T 4aoj_A          116 RPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGL  195 (329)
T ss_dssp             SSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTT
T ss_pred             CEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEECCCC
Confidence            99999999999999999997532              4589999999999999999999999999999999999999999


Q ss_pred             ceEEeecCCccccCCCcc---cccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhh-CCCCCCchhhHH
Q 004959          481 VVKLADFGMAKHLTGQKA---DLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAA  556 (721)
Q Consensus       481 ~VKL~DFGlA~~l~~~~~---~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLt-G~~PF~~~~~~~  556 (721)
                      .+||+|||+|+.+.....   ....+||+.|||||++.       ...++.++|||||||+||||+| |+.||.+....+
T Consensus       196 ~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~-------~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~  268 (329)
T 4aoj_A          196 VVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESIL-------YRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTE  268 (329)
T ss_dssp             EEEECCCC----------------CCCCGGGCCHHHHT-------TCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHH
T ss_pred             cEEEcccccceeccCCCcceecCcccccccccChhhhc-------CCCCCccccccchHHHHHHHHcCCCCCCCCCCHHH
Confidence            999999999987654332   23467999999999994       4668899999999999999998 999999888777


Q ss_pred             HHHHHhhc-CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q 004959          557 AMFKVMRD-TPAIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEH  600 (721)
Q Consensus       557 ~~~ki~~~-~~~~p~~lS~el~dLI~~cL~~DP~kRPSa~eLL~H  600 (721)
                      .+..+..+ ....|..+++++.+||.+||+.||++|||+.||+++
T Consensus       269 ~~~~i~~g~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~  313 (329)
T 4aoj_A          269 AIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHAR  313 (329)
T ss_dssp             HHHHHHHTCCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHH
T ss_pred             HHHHHHcCCCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence            77777664 456788999999999999999999999999999875

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=2.5e-54  Score=461.46  Aligned_cols=251  Identities=24%  Similarity=0.403  Sum_probs=210.5

Q ss_pred             CCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeEEE
Q 004959          340 SQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYI  419 (721)
Q Consensus       340 ~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~yL  419 (721)
                      +++++++.||+|+||+||+|++..   .||||++...   ....+..+.|.+|+.+|++++|||||++++++. ++.+||
T Consensus        36 ~~l~l~~~iG~G~fG~Vy~~~~~~---~vAvK~~~~~---~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~-~~~~~i  108 (307)
T 3omv_A           36 SEVMLSTRIGSGSFGTVYKGKWHG---DVAVKILKVV---DPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMT-KDNLAI  108 (307)
T ss_dssp             TSCCEEEECCCCSSSEEEEEESSS---EEEEEECCCS---SCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEE
T ss_pred             HHeEEeeEEeeCCCcEEEEEEECC---cEEEEEEEec---CCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE-CCeEEE
Confidence            578899999999999999998653   5999988632   234566788999999999999999999999865 567899


Q ss_pred             EEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCCc--
Q 004959          420 YLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQK--  497 (721)
Q Consensus       420 VmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~~--  497 (721)
                      |||||+||+|.++|......+++.++..|+.||+.||+|||+++||||||||+||||+.++.+||+|||+|+......  
T Consensus       109 VmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~  188 (307)
T 3omv_A          109 VTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGS  188 (307)
T ss_dssp             EEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEEEEECCCSSCBC-------
T ss_pred             EEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCcEEEeeccCceecccCCcc
Confidence            999999999999998776789999999999999999999999999999999999999999999999999998764322  


Q ss_pred             -ccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhcC------CCCCC
Q 004959          498 -ADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDT------PAIPD  570 (721)
Q Consensus       498 -~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~~------~~~p~  570 (721)
                       .....+||+.|||||++.+.    ....|+.++|||||||+||||+||+.||.+......+..++...      ..++.
T Consensus       189 ~~~~~~~GT~~ymAPE~l~~~----~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~  264 (307)
T 3omv_A          189 QQVEQPTGSVLWMAPEVIRMQ----DNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYK  264 (307)
T ss_dssp             -----CCCCTTSCCHHHHHCC----SSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCCCSTTSCT
T ss_pred             eeecccccCCCccCHHHhhcc----CCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCCcccccc
Confidence             23456899999999999631    23458899999999999999999999998866555555444322      23456


Q ss_pred             CCCHHHHHHHHHhcccCCCCCCCHHHHHhcc
Q 004959          571 SLSPEGKDFLRCCFQRNPADRPPASLLLEHR  601 (721)
Q Consensus       571 ~lS~el~dLI~~cL~~DP~kRPSa~eLL~Hp  601 (721)
                      .+++++.+||.+||+.||++|||+.||+++.
T Consensus       265 ~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L  295 (307)
T 3omv_A          265 NCPKAMKRLVADCVKKVKEERPLFPQILSSI  295 (307)
T ss_dssp             TSCHHHHHHHHHHTCSSSTTSCCHHHHHHHH
T ss_pred             cchHHHHHHHHHHcCCCHhHCcCHHHHHHHH
Confidence            7899999999999999999999999987664

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=2.7e-54  Score=501.21  Aligned_cols=260  Identities=27%  Similarity=0.423  Sum_probs=225.9

Q ss_pred             CCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCC-CcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeEE
Q 004959          340 SQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPD-DPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFY  418 (721)
Q Consensus       340 ~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~-~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~y  418 (721)
                      ++|+++++||+|+||+||+|+++.+|+.||||++.+... .............++.+++.++|||||+++++|.+.+.+|
T Consensus       189 ddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~ly  268 (689)
T 3v5w_A          189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS  268 (689)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred             HHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEE
Confidence            579999999999999999999999999999999864211 1122233334455677788889999999999999999999


Q ss_pred             EEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCCcc
Q 004959          419 IYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKA  498 (721)
Q Consensus       419 LVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~~~  498 (721)
                      ||||||.||+|.++|.+. +.++|..++.|+.||+.||+|||++|||||||||+||||+.+|.|||+|||+|+.+.... 
T Consensus       269 lVmEy~~GGdL~~~l~~~-~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~~~~-  346 (689)
T 3v5w_A          269 FILDLMNGGDLHYHLSQH-GVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-  346 (689)
T ss_dssp             EEECCCCSCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSCC-
T ss_pred             EEEecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCCEEecccceeeecCCCC-
Confidence            999999999999999875 789999999999999999999999999999999999999999999999999998775443 


Q ss_pred             cccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchh---hHHHHHHHhhcCCCCCCCCCHH
Q 004959          499 DLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYE---GAAAMFKVMRDTPAIPDSLSPE  575 (721)
Q Consensus       499 ~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~---~~~~~~ki~~~~~~~p~~lS~e  575 (721)
                      ..+.|||+.|||||++.      .+..|+.++||||||||||||++|++||.+..   ..+....+......+|..+|++
T Consensus       347 ~~t~~GTp~YmAPEvl~------~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~~~~~p~~~S~~  420 (689)
T 3v5w_A          347 PHASVGTHGYMAPEVLQ------KGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPE  420 (689)
T ss_dssp             CCSCCSCGGGCCHHHHS------TTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHCCCCCCTTSCHH
T ss_pred             CCCccCCcCccCHHHHh------CCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCCCCCccCCHH
Confidence            45689999999999994      23467889999999999999999999997643   2344556677778899999999


Q ss_pred             HHHHHHHhcccCCCCCCC-----HHHHHhccccccCC
Q 004959          576 GKDFLRCCFQRNPADRPP-----ASLLLEHRFLKNSQ  607 (721)
Q Consensus       576 l~dLI~~cL~~DP~kRPS-----a~eLL~Hp~f~~~~  607 (721)
                      +++||.+||++||++|++     ++||++||||++..
T Consensus       421 a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~id  457 (689)
T 3v5w_A          421 LRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLD  457 (689)
T ss_dssp             HHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTTCC
T ss_pred             HHHHHHHHccCCHhHCCCCCCCCHHHHhcCccccCCC
Confidence            999999999999999998     79999999998753

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=6.3e-54  Score=458.35  Aligned_cols=250  Identities=22%  Similarity=0.364  Sum_probs=216.6

Q ss_pred             CCeeEeeEEeecCCeEEEEEEEC-----CCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEec
Q 004959          340 SQWQKGKLIGRGTFGSVYVASNR-----ETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVE  414 (721)
Q Consensus       340 ~~y~~~k~LG~G~fG~VY~a~~~-----~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~  414 (721)
                      +++++.+.||+|+||+||+|...     .+++.||||++....    .....+.|.+|+.+|++++|||||+++|++.+.
T Consensus        26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~----~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~  101 (308)
T 4gt4_A           26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA----EGPLREEFRHEAMLRARLQHPNVVCLLGVVTKD  101 (308)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-C----CC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECccc----ChHHHHHHHHHHHHHHhCCCCCCCCcceEEEEC
Confidence            47899999999999999999853     467899999985321    223356899999999999999999999999999


Q ss_pred             CeEEEEEeeccCCCHHHHHHHh---------------cCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCC
Q 004959          415 DKFYIYLEYVHPGSINKYVREH---------------CGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDAS  479 (721)
Q Consensus       415 ~~~yLVmEy~~gGsL~~~L~~~---------------~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~  479 (721)
                      +.+|||||||++|+|.++|...               ...+++.++..|+.||+.||+|||+++||||||||+||||+++
T Consensus       102 ~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl~~~  181 (308)
T 4gt4_A          102 QPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDK  181 (308)
T ss_dssp             SSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGG
T ss_pred             CEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEECCC
Confidence            9999999999999999999653               2468999999999999999999999999999999999999999


Q ss_pred             CceEEeecCCccccCCCcc---cccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhh-CCCCCCchhhH
Q 004959          480 GVVKLADFGMAKHLTGQKA---DLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGA  555 (721)
Q Consensus       480 g~VKL~DFGlA~~l~~~~~---~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLt-G~~PF~~~~~~  555 (721)
                      +.+||+|||+|+.+.....   ....+||+.|||||++.+       ..|+.++|||||||+||||+| |..||.+....
T Consensus       182 ~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~-------~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~  254 (308)
T 4gt4_A          182 LNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMY-------GKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ  254 (308)
T ss_dssp             GCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHH-------CCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHH
T ss_pred             CCEEECCcccceeccCCCceeEecccccCCcccCHHHHhC-------CCCCccchhhhHHHHHHHHHhCCCCCCCCCCHH
Confidence            9999999999987654322   234679999999999964       457889999999999999998 89999988877


Q ss_pred             HHHHHHhhcC-CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q 004959          556 AAMFKVMRDT-PAIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEH  600 (721)
Q Consensus       556 ~~~~ki~~~~-~~~p~~lS~el~dLI~~cL~~DP~kRPSa~eLL~H  600 (721)
                      +.+..+.... ...|..++.++.+||.+||+.||++|||+.||+++
T Consensus       255 ~~~~~i~~~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~  300 (308)
T 4gt4_A          255 DVVEMIRNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSR  300 (308)
T ss_dssp             HHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHcCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            7777766543 46788899999999999999999999999999876

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=1.9e-51  Score=440.57  Aligned_cols=262  Identities=29%  Similarity=0.496  Sum_probs=238.0

Q ss_pred             CCCCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeE
Q 004959          338 MNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKF  417 (721)
Q Consensus       338 l~~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~  417 (721)
                      ..++|++++.||+|+||.||+|.+..+|+.||||++...   .......+.+.+|+.+|+.++||||+++++++...+.+
T Consensus        13 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~---~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~   89 (328)
T 3fe3_A           13 HIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKT---QLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTL   89 (328)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGG---GSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             ccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhh---cCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEE
Confidence            346899999999999999999999999999999998642   23445677899999999999999999999999999999


Q ss_pred             EEEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCCc
Q 004959          418 YIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQK  497 (721)
Q Consensus       418 yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~~  497 (721)
                      |+||||+.||+|.+++... +.+++.+++.++.||+.||+|||++||+||||||+||||+.++.+||+|||++..+....
T Consensus        90 ~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~  168 (328)
T 3fe3_A           90 YLIMEYASGGEVFDYLVAH-GRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG  168 (328)
T ss_dssp             EEEECCCTTCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSC
T ss_pred             EEEEECCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCCEEEeeccCceecCCCC
Confidence            9999999999999999775 789999999999999999999999999999999999999999999999999998877666


Q ss_pred             ccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhcCCCCCCCCCHHHH
Q 004959          498 ADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDSLSPEGK  577 (721)
Q Consensus       498 ~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~~~~~p~~lS~el~  577 (721)
                      .....+||+.|+|||++.+      ....+.++|||||||+||+|++|+.||.+....+...++......+|..+++++.
T Consensus       169 ~~~~~~gt~~y~aPE~~~~------~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~  242 (328)
T 3fe3_A          169 KLDAFCGAPPYAAPELFQG------KKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCE  242 (328)
T ss_dssp             GGGTTSSSGGGCCHHHHHT------CCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHH
T ss_pred             ccccccCCcceeCcccccC------CCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHH
Confidence            6667889999999999964      2223478999999999999999999999988888888888888889999999999


Q ss_pred             HHHHHhcccCCCCCCCHHHHHhccccccCCCC
Q 004959          578 DFLRCCFQRNPADRPPASLLLEHRFLKNSQQP  609 (721)
Q Consensus       578 dLI~~cL~~DP~kRPSa~eLL~Hp~f~~~~~~  609 (721)
                      +||++||+.||++|||++|+|+||||+.....
T Consensus       243 ~li~~~L~~dP~~R~t~~eil~h~~~~~~~~~  274 (328)
T 3fe3_A          243 NLLKRFLVLNPIKRGTLEQIMKDRWINAGHEE  274 (328)
T ss_dssp             HHHHHHCCSSTTTSCCHHHHTTCTTTTTTCTT
T ss_pred             HHHHHHCCCChhHCcCHHHHhcCHhhcCCCcc
Confidence            99999999999999999999999999876543

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=1.4e-52  Score=455.94  Aligned_cols=250  Identities=26%  Similarity=0.495  Sum_probs=213.9

Q ss_pred             CCeeEeeEEeecCCeEEEEEEECCC-----CcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCC-CCeeeeeeeEEe
Q 004959          340 SQWQKGKLIGRGTFGSVYVASNRET-----GALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKH-PNIVQYYGSEIV  413 (721)
Q Consensus       340 ~~y~~~k~LG~G~fG~VY~a~~~~t-----g~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~H-PnIV~l~g~~~~  413 (721)
                      ++|++++.||+|+||+||+|.+..+     ++.||||.+..    .......+.+.+|+.+|.++.| ||||+++|+|..
T Consensus        64 ~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~----~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~  139 (353)
T 4ase_A           64 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKE----GATHSEHRALMSELKILIHIGHHLNVVNLLGACTK  139 (353)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECT----TCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECC
T ss_pred             HHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEcc----ccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEe
Confidence            5799999999999999999987654     46899998852    2334556789999999999965 899999999876


Q ss_pred             c-CeEEEEEeeccCCCHHHHHHHhc---------------CCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEc
Q 004959          414 E-DKFYIYLEYVHPGSINKYVREHC---------------GAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVD  477 (721)
Q Consensus       414 ~-~~~yLVmEy~~gGsL~~~L~~~~---------------~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld  477 (721)
                      . +.+|||||||++|+|.++|+...               ..+++..+..|+.||+.||+|||+++||||||||+||||+
T Consensus       140 ~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NILl~  219 (353)
T 4ase_A          140 PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS  219 (353)
T ss_dssp             TTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC
T ss_pred             cCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccceeeC
Confidence            4 57999999999999999997542               3489999999999999999999999999999999999999


Q ss_pred             CCCceEEeecCCccccCCCcc---cccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhh-CCCCCCchh
Q 004959          478 ASGVVKLADFGMAKHLTGQKA---DLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYE  553 (721)
Q Consensus       478 ~~g~VKL~DFGlA~~l~~~~~---~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLt-G~~PF~~~~  553 (721)
                      .++.+||+|||+|+.+.....   ....+||+.|||||++.+       ..|+.++|||||||+||||+| |+.||.+..
T Consensus       220 ~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~-------~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~  292 (353)
T 4ase_A          220 EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD-------RVYTIQSDVWSFGVLLWEIFSLGASPYPGVK  292 (353)
T ss_dssp             GGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHH-------CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred             CCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhc-------CCCCCcccEeehHHHHHHHHhCCCCCCCCCC
Confidence            999999999999997754432   234679999999999964       457889999999999999998 999998865


Q ss_pred             hHHHHHHHhhc--CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q 004959          554 GAAAMFKVMRD--TPAIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEH  600 (721)
Q Consensus       554 ~~~~~~ki~~~--~~~~p~~lS~el~dLI~~cL~~DP~kRPSa~eLL~H  600 (721)
                      ..+.+.+++..  .+..|..+++++.+||.+||+.||++|||+.||++|
T Consensus       293 ~~~~~~~~i~~g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~  341 (353)
T 4ase_A          293 IDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  341 (353)
T ss_dssp             CSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence            54444444433  356788899999999999999999999999999998

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=2.2e-50  Score=434.61  Aligned_cols=258  Identities=29%  Similarity=0.491  Sum_probs=230.2

Q ss_pred             CCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeEEE
Q 004959          340 SQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYI  419 (721)
Q Consensus       340 ~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~yL  419 (721)
                      ++|++++.||+|+||+||+|+++.+|+.||||++....  .......+.+.+|+.+|+.++||||+++++++.+.+.+|+
T Consensus         5 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~l   82 (337)
T 1o6l_A            5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEV--IIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCF   82 (337)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHH--HHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEE
T ss_pred             HHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHH--hhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEE
Confidence            57999999999999999999999999999999986311  0011234678899999999999999999999999999999


Q ss_pred             EEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCC-Ccc
Q 004959          420 YLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTG-QKA  498 (721)
Q Consensus       420 VmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~-~~~  498 (721)
                      ||||+.||+|..++... +.+++..++.++.||+.||+|||++||+||||||+||||+.+|.+||+|||+++.... ...
T Consensus        83 v~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~~  161 (337)
T 1o6l_A           83 VMEYANGGELFFHLSRE-RVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT  161 (337)
T ss_dssp             EEECCTTCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTCC
T ss_pred             EEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCEEEeeccchhhcccCCCc
Confidence            99999999999999765 6899999999999999999999999999999999999999999999999999986433 334


Q ss_pred             cccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhcCCCCCCCCCHHHHH
Q 004959          499 DLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDSLSPEGKD  578 (721)
Q Consensus       499 ~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~~~~~p~~lS~el~d  578 (721)
                      ....+||+.|+|||++.       ...++.++|||||||++|||++|+.||.+.+.......+......+|..+++++++
T Consensus       162 ~~~~~gt~~y~aPE~~~-------~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~  234 (337)
T 1o6l_A          162 MKTFCGTPEYLAPEVLE-------DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKS  234 (337)
T ss_dssp             BCCCEECGGGCCGGGGS-------SSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHH
T ss_pred             ccccccChhhCChhhhc-------CCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHH
Confidence            45678999999999984       34577899999999999999999999998887778888888888889999999999


Q ss_pred             HHHHhcccCCCCCC-----CHHHHHhccccccCC
Q 004959          579 FLRCCFQRNPADRP-----PASLLLEHRFLKNSQ  607 (721)
Q Consensus       579 LI~~cL~~DP~kRP-----Sa~eLL~Hp~f~~~~  607 (721)
                      ||++||+.||++||     +++|+++||||....
T Consensus       235 li~~lL~~dP~~R~g~~~~~~~ei~~h~~f~~~~  268 (337)
T 1o6l_A          235 LLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSIN  268 (337)
T ss_dssp             HHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCC
T ss_pred             HHHHHhhcCHHHhcCCCCCCHHHHHcCCCcCCCC
Confidence            99999999999999     999999999998643

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=4.8e-50  Score=436.04  Aligned_cols=262  Identities=23%  Similarity=0.399  Sum_probs=231.2

Q ss_pred             CCCCCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcc-cHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecC
Q 004959          337 PMNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPK-SAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVED  415 (721)
Q Consensus       337 ~l~~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~-~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~  415 (721)
                      .+.+.|++++.||+|+||+||+|.++.+|+.||||++........ .....+.+.+|+.+|+.++|||||++++++.+.+
T Consensus         9 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~   88 (361)
T 2yab_A            9 KVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRT   88 (361)
T ss_dssp             CGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred             ChhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCC
Confidence            455789999999999999999999999999999999975432211 1113467889999999999999999999999999


Q ss_pred             eEEEEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCC----ceEEeecCCcc
Q 004959          416 KFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASG----VVKLADFGMAK  491 (721)
Q Consensus       416 ~~yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g----~VKL~DFGlA~  491 (721)
                      .+|+||||+.||+|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++.++    .+||+|||++.
T Consensus        89 ~~~lv~e~~~gg~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~  167 (361)
T 2yab_A           89 DVVLILELVSGGELFDFLAQK-ESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH  167 (361)
T ss_dssp             EEEEEEECCCSCBHHHHHTTC-SCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSCE
T ss_pred             EEEEEEEcCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCce
Confidence            999999999999999999654 6899999999999999999999999999999999999998776    79999999999


Q ss_pred             ccCCCcccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhcCCCCC--
Q 004959          492 HLTGQKADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIP--  569 (721)
Q Consensus       492 ~l~~~~~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~~~~~p--  569 (721)
                      .+.........+||+.|+|||++.       ...++.++|||||||++|+|++|..||.+....+.+..+......++  
T Consensus       168 ~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~  240 (361)
T 2yab_A          168 EIEDGVEFKNIFGTPEFVAPEIVN-------YEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEE  240 (361)
T ss_dssp             ECCTTCCCCCCCSCGGGCCHHHHT-------TCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHH
T ss_pred             EcCCCCccccCCCCccEECchHHc-------CCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCch
Confidence            877665556778999999999984       34577899999999999999999999998887777777777655544  


Q ss_pred             --CCCCHHHHHHHHHhcccCCCCCCCHHHHHhccccccC
Q 004959          570 --DSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNS  606 (721)
Q Consensus       570 --~~lS~el~dLI~~cL~~DP~kRPSa~eLL~Hp~f~~~  606 (721)
                        ..+++++++||++||+.||++|||+.|+|+||||+..
T Consensus       241 ~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~  279 (361)
T 2yab_A          241 FFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPV  279 (361)
T ss_dssp             HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTSCS
T ss_pred             hccCCCHHHHHHHHHHCCCChhHCcCHHHHhcCcCcCCC
Confidence              5789999999999999999999999999999999853

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=1e-50  Score=439.84  Aligned_cols=257  Identities=28%  Similarity=0.481  Sum_probs=226.4

Q ss_pred             CCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhC-CCCCeeeeeeeEEecCeEE
Q 004959          340 SQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHL-KHPNIVQYYGSEIVEDKFY  418 (721)
Q Consensus       340 ~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L-~HPnIV~l~g~~~~~~~~y  418 (721)
                      ++|++++.||+|+||+||+|+++.+|+.||||++...  ........+.+.+|+.+|..+ +|||||++++++.+.+.+|
T Consensus        23 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~--~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~  100 (353)
T 3txo_A           23 DNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKD--VILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLF  100 (353)
T ss_dssp             CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHH--HHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred             hheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHH--HhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEE
Confidence            5899999999999999999999999999999998631  011222356788999999988 6999999999999999999


Q ss_pred             EEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCC-Cc
Q 004959          419 IYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTG-QK  497 (721)
Q Consensus       419 LVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~-~~  497 (721)
                      ||||||.||+|.+++... +.+++..++.|+.||+.||+|||++||+||||||+||||+.+|.+||+|||+++.... ..
T Consensus       101 lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~~~  179 (353)
T 3txo_A          101 FVMEFVNGGDLMFHIQKS-RRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGV  179 (353)
T ss_dssp             EEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC---
T ss_pred             EEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCEEEccccceeecccCCc
Confidence            999999999999999775 7899999999999999999999999999999999999999999999999999986433 33


Q ss_pred             ccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhcCCCCCCCCCHHHH
Q 004959          498 ADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDSLSPEGK  577 (721)
Q Consensus       498 ~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~~~~~p~~lS~el~  577 (721)
                      .....+||+.|+|||++.+..       ++.++|||||||++|||++|+.||.+....+.+.++......+|..++.++.
T Consensus       180 ~~~~~~gt~~y~aPE~~~~~~-------~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~  252 (353)
T 3txo_A          180 TTATFCGTPDYIAPEILQEML-------YGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLHEDAT  252 (353)
T ss_dssp             ------CCGGGCCHHHHHHHH-------CTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHH
T ss_pred             cccccCCCcCeEChhhcCCCC-------cCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHH
Confidence            445678999999999997643       4568999999999999999999999988888889999988899999999999


Q ss_pred             HHHHHhcccCCCCCCCH------HHHHhccccccC
Q 004959          578 DFLRCCFQRNPADRPPA------SLLLEHRFLKNS  606 (721)
Q Consensus       578 dLI~~cL~~DP~kRPSa------~eLL~Hp~f~~~  606 (721)
                      +||++||++||++||++      +|+++||||++.
T Consensus       253 ~li~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~~  287 (353)
T 3txo_A          253 GILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKEI  287 (353)
T ss_dssp             HHHHHHTCSSGGGSTTSGGGTCTHHHHTSGGGTTC
T ss_pred             HHHHHHhhhCHHHccCCcccCCHHHHhhCCcccCC
Confidence            99999999999999999      999999999865

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.5e-50  Score=428.53  Aligned_cols=256  Identities=22%  Similarity=0.345  Sum_probs=229.5

Q ss_pred             CCCCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeE
Q 004959          338 MNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKF  417 (721)
Q Consensus       338 l~~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~  417 (721)
                      +.++|++++.||+|+||.||+|.+..+|+.||+|++...      ......+.+|+.+|+.++|||||++++++.+.+.+
T Consensus         3 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~------~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~   76 (321)
T 1tki_A            3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK------GTDQVLVKKEISILNIARHRNILHLHESFESMEEL   76 (321)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC------THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEE
T ss_pred             hhhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC------cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEE
Confidence            457899999999999999999999999999999998531      23345788999999999999999999999999999


Q ss_pred             EEEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcC--CCceEEeecCCccccCC
Q 004959          418 YIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDA--SGVVKLADFGMAKHLTG  495 (721)
Q Consensus       418 yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~--~g~VKL~DFGlA~~l~~  495 (721)
                      |+|||||.||+|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.  ++.+||+|||++..+..
T Consensus        77 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~  156 (321)
T 1tki_A           77 VMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP  156 (321)
T ss_dssp             EEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCT
T ss_pred             EEEEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCC
Confidence            9999999999999999766567999999999999999999999999999999999999987  78999999999988766


Q ss_pred             CcccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhcCCCCC----CC
Q 004959          496 QKADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIP----DS  571 (721)
Q Consensus       496 ~~~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~~~~~p----~~  571 (721)
                      ........||+.|+|||++.       ...++.++|||||||++|+|++|..||.+....+.+..+......++    ..
T Consensus       157 ~~~~~~~~gt~~y~aPE~~~-------~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  229 (321)
T 1tki_A          157 GDNFRLLFTAPEYYAPEVHQ-------HDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKE  229 (321)
T ss_dssp             TCEEEEEESCGGGSCHHHHT-------TCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTT
T ss_pred             CCccccccCChhhcCcHHhc-------CCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCChhhhcc
Confidence            55555677999999999994       34567899999999999999999999998887777777777665554    47


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHHHHhccccccC
Q 004959          572 LSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNS  606 (721)
Q Consensus       572 lS~el~dLI~~cL~~DP~kRPSa~eLL~Hp~f~~~  606 (721)
                      ++.++.+||.+||+.||++|||+.|+|+||||++.
T Consensus       230 ~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~  264 (321)
T 1tki_A          230 ISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQK  264 (321)
T ss_dssp             SCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred             CCHHHHHHHHHHcCCChhHCcCHHHHhcChhhccC
Confidence            89999999999999999999999999999999864

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=8.9e-50  Score=425.92  Aligned_cols=256  Identities=25%  Similarity=0.463  Sum_probs=229.7

Q ss_pred             CCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeEEE
Q 004959          340 SQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYI  419 (721)
Q Consensus       340 ~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~yL  419 (721)
                      ++|++++.||+|+||.||+|+++.+|+.||||++....  .......+.+.+|+.+|+.++|||||++++++.+.+.+|+
T Consensus         6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l   83 (318)
T 1fot_A            6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEI--VVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFM   83 (318)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHH--HHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEE
T ss_pred             HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHH--hhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEE
Confidence            57999999999999999999999999999999986310  0011234677899999999999999999999999999999


Q ss_pred             EEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCCccc
Q 004959          420 YLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKAD  499 (721)
Q Consensus       420 VmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~~~~  499 (721)
                      ||||+.||+|.+++... +.+++..++.++.||+.||.|||++||+||||||+||||+.+|.+||+|||+++....  ..
T Consensus        84 v~e~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~--~~  160 (318)
T 1fot_A           84 IMDYIEGGELFSLLRKS-QRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD--VT  160 (318)
T ss_dssp             EECCCCSCBHHHHHHHT-SSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSS--CB
T ss_pred             EEeCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCCEEEeecCcceecCC--cc
Confidence            99999999999999765 6799999999999999999999999999999999999999999999999999987643  23


Q ss_pred             ccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhcCCCCCCCCCHHHHHH
Q 004959          500 LSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDSLSPEGKDF  579 (721)
Q Consensus       500 ~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~~~~~p~~lS~el~dL  579 (721)
                      ...+||+.|+|||++.       ...++.++|||||||++|||++|..||.+....+.+.++......+|..++.++++|
T Consensus       161 ~~~~gt~~y~aPE~~~-------~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~l  233 (318)
T 1fot_A          161 YTLCGTPDYIAPEVVS-------TKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDL  233 (318)
T ss_dssp             CCCCSCTTTCCHHHHT-------TCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCCTTSCHHHHHH
T ss_pred             ccccCCccccCHhHhc-------CCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence            4578999999999984       345778899999999999999999999988888888888888888899999999999


Q ss_pred             HHHhcccCCCCCC-----CHHHHHhccccccCC
Q 004959          580 LRCCFQRNPADRP-----PASLLLEHRFLKNSQ  607 (721)
Q Consensus       580 I~~cL~~DP~kRP-----Sa~eLL~Hp~f~~~~  607 (721)
                      |++||+.||++|+     +++++++||||++..
T Consensus       234 i~~lL~~dp~~R~~~~~~~~~~i~~hp~f~~~~  266 (318)
T 1fot_A          234 LSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVV  266 (318)
T ss_dssp             HHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCC
T ss_pred             HHHHhccCHHHcCCCcCCCHHHHhcCccccCCC
Confidence            9999999999999     999999999998643

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=2.9e-49  Score=426.55  Aligned_cols=258  Identities=27%  Similarity=0.477  Sum_probs=226.4

Q ss_pred             CCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhC-CCCCeeeeeeeEEecCeEE
Q 004959          340 SQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHL-KHPNIVQYYGSEIVEDKFY  418 (721)
Q Consensus       340 ~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L-~HPnIV~l~g~~~~~~~~y  418 (721)
                      .+|++++.||+|+||.||+|+++.+|+.||||++...  ........+.+.+|+.+|.++ +|||||++++++.+.+.+|
T Consensus         9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~   86 (345)
T 3a8x_A            9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKE--LVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLF   86 (345)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGG--GSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred             hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhH--HhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEE
Confidence            5799999999999999999999999999999998743  223445677889999999988 8999999999999999999


Q ss_pred             EEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccC-CCc
Q 004959          419 IYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLT-GQK  497 (721)
Q Consensus       419 LVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~-~~~  497 (721)
                      +||||+.||+|.+++... +.+++..++.++.||+.||.|||++||+||||||+||||+.+|.+||+|||+++... ...
T Consensus        87 lv~e~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~~~  165 (345)
T 3a8x_A           87 FVIEYVNGGDLMFHMQRQ-RKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD  165 (345)
T ss_dssp             EEECCCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCTTC
T ss_pred             EEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEEeccccccccCCCC
Confidence            999999999999999765 679999999999999999999999999999999999999999999999999998643 333


Q ss_pred             ccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCch---------hhHHHHHHHhhcCCCC
Q 004959          498 ADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEY---------EGAAAMFKVMRDTPAI  568 (721)
Q Consensus       498 ~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~---------~~~~~~~ki~~~~~~~  568 (721)
                      .....+||+.|+|||++.       ...++.++|||||||+||||++|+.||...         ........+......+
T Consensus       166 ~~~~~~gt~~y~aPE~~~-------~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~  238 (345)
T 3a8x_A          166 TTSTFCGTPNYIAPEILR-------GEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRI  238 (345)
T ss_dssp             CBCCCCSCGGGCCHHHHT-------TCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCCCC
T ss_pred             cccccCCCccccCccccC-------CCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCCCC
Confidence            445678999999999994       346788999999999999999999999642         2233445566667788


Q ss_pred             CCCCCHHHHHHHHHhcccCCCCCCCH------HHHHhccccccCC
Q 004959          569 PDSLSPEGKDFLRCCFQRNPADRPPA------SLLLEHRFLKNSQ  607 (721)
Q Consensus       569 p~~lS~el~dLI~~cL~~DP~kRPSa------~eLL~Hp~f~~~~  607 (721)
                      |..++.++++||++||+.||++||++      +|+++||||++..
T Consensus       239 p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~~~  283 (345)
T 3a8x_A          239 PRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVD  283 (345)
T ss_dssp             CTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTTCC
T ss_pred             CCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCCCC
Confidence            89999999999999999999999995      8999999998643

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=1.7e-49  Score=437.72  Aligned_cols=258  Identities=26%  Similarity=0.480  Sum_probs=224.1

Q ss_pred             CCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhC-CCCCeeeeeeeEEecCeEE
Q 004959          340 SQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHL-KHPNIVQYYGSEIVEDKFY  418 (721)
Q Consensus       340 ~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L-~HPnIV~l~g~~~~~~~~y  418 (721)
                      .+|+++++||+|+||+||+|+++.+|+.||||++.+..  .......+.+.+|+.+|.++ +|||||++++++.+.+.+|
T Consensus        52 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~--~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~  129 (396)
T 4dc2_A           52 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKEL--VNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLF  129 (396)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGG--TC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEE
T ss_pred             hHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhh--ccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEE
Confidence            58999999999999999999999999999999987432  12233455688899999887 8999999999999999999


Q ss_pred             EEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCcccc-CCCc
Q 004959          419 IYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHL-TGQK  497 (721)
Q Consensus       419 LVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l-~~~~  497 (721)
                      ||||||.||+|..++... +.+++..++.|+.||+.||.|||++||+||||||+||||+.+|.+||+|||+++.. ....
T Consensus       130 lV~E~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~~  208 (396)
T 4dc2_A          130 FVIEYVNGGDLMFHMQRQ-RKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD  208 (396)
T ss_dssp             EEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTC
T ss_pred             EEEEcCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCEEEeecceeeecccCCC
Confidence            999999999999999765 68999999999999999999999999999999999999999999999999999863 3344


Q ss_pred             ccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCch---------hhHHHHHHHhhcCCCC
Q 004959          498 ADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEY---------EGAAAMFKVMRDTPAI  568 (721)
Q Consensus       498 ~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~---------~~~~~~~ki~~~~~~~  568 (721)
                      .....+||+.|+|||++.       ...++.++|||||||+||||++|+.||...         ........+......+
T Consensus       209 ~~~~~~gt~~Y~aPE~l~-------~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~  281 (396)
T 4dc2_A          209 TTSTFCGTPNYIAPEILR-------GEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRI  281 (396)
T ss_dssp             CBCCCCBCGGGCCHHHHT-------TCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCCCC
T ss_pred             ccccccCCcccCCchhhc-------CCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccccCC
Confidence            456788999999999994       356788999999999999999999999632         1223455566777888


Q ss_pred             CCCCCHHHHHHHHHhcccCCCCCCCH------HHHHhccccccCC
Q 004959          569 PDSLSPEGKDFLRCCFQRNPADRPPA------SLLLEHRFLKNSQ  607 (721)
Q Consensus       569 p~~lS~el~dLI~~cL~~DP~kRPSa------~eLL~Hp~f~~~~  607 (721)
                      |..++.++++||++||++||++|+++      +||++||||++..
T Consensus       282 p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~i~  326 (396)
T 4dc2_A          282 PRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVD  326 (396)
T ss_dssp             CTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTTCC
T ss_pred             CCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccCCC
Confidence            99999999999999999999999984      8999999998653

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=3.9e-49  Score=414.82  Aligned_cols=254  Identities=35%  Similarity=0.627  Sum_probs=223.0

Q ss_pred             CCCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeEE
Q 004959          339 NSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFY  418 (721)
Q Consensus       339 ~~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~y  418 (721)
                      ..+|++++.||+|+||.||+|.+..+|+.||||++......     ..+.+.+|+.+|+.++|||||++++++...+.+|
T Consensus        19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~   93 (297)
T 3fxz_A           19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP-----KKELIINEILVMRENKNPNIVNYLDSYLVGDELW   93 (297)
T ss_dssp             GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCS-----CHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred             hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeeccccc-----HHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEE
Confidence            45899999999999999999999999999999998643221     1356889999999999999999999999999999


Q ss_pred             EEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCCcc
Q 004959          419 IYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKA  498 (721)
Q Consensus       419 LVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~~~  498 (721)
                      +||||+.||+|.+++...  .+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+.....
T Consensus        94 lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  171 (297)
T 3fxz_A           94 VVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS  171 (297)
T ss_dssp             EEEECCTTCBHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred             EEEECCCCCCHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCccc
Confidence            999999999999999763  699999999999999999999999999999999999999999999999999987654433


Q ss_pred             -cccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhc---CCCCCCCCCH
Q 004959          499 -DLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRD---TPAIPDSLSP  574 (721)
Q Consensus       499 -~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~---~~~~p~~lS~  574 (721)
                       ....+||+.|+|||++.+       ..++.++|||||||++|+|++|..||.+.........+...   ....+..++.
T Consensus       172 ~~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (297)
T 3fxz_A          172 KRSTMVGTPYWMAPEVVTR-------KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSA  244 (297)
T ss_dssp             CBCCCCSCGGGCCHHHHHC-------SCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSCGGGSCH
T ss_pred             ccCCccCCcCccChhhhcC-------CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCH
Confidence             345679999999999953       45678999999999999999999999887666655555433   2334667899


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHHhccccccC
Q 004959          575 EGKDFLRCCFQRNPADRPPASLLLEHRFLKNS  606 (721)
Q Consensus       575 el~dLI~~cL~~DP~kRPSa~eLL~Hp~f~~~  606 (721)
                      ++.+||.+||+.||++|||+.|+|+||||+..
T Consensus       245 ~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~  276 (297)
T 3fxz_A          245 IFRDFLNRCLEMDVEKRGSAKELLQHQFLKIA  276 (297)
T ss_dssp             HHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGC
T ss_pred             HHHHHHHHHccCChhHCcCHHHHhhChhhccc
Confidence            99999999999999999999999999999864

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=7.5e-50  Score=431.98  Aligned_cols=259  Identities=26%  Similarity=0.465  Sum_probs=230.1

Q ss_pred             CCCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhC-CCCCeeeeeeeEEecCeE
Q 004959          339 NSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHL-KHPNIVQYYGSEIVEDKF  417 (721)
Q Consensus       339 ~~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L-~HPnIV~l~g~~~~~~~~  417 (721)
                      .++|++++.||+|+||.||+|+++.+|+.||||++....  .......+.+..|..+|..+ +||||+++++++.+.+.+
T Consensus        16 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~   93 (345)
T 1xjd_A           16 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDV--VLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENL   93 (345)
T ss_dssp             CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHH--HHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred             hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHH--hhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEE
Confidence            368999999999999999999999999999999986311  00011245678899999876 899999999999999999


Q ss_pred             EEEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCC-C
Q 004959          418 YIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTG-Q  496 (721)
Q Consensus       418 yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~-~  496 (721)
                      |+||||+.||+|.+++... +.+++..++.++.||+.||+|||++||+||||||+||||+.+|.+||+|||+++.... .
T Consensus        94 ~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~  172 (345)
T 1xjd_A           94 FFVMEYLNGGDLMYHIQSC-HKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD  172 (345)
T ss_dssp             EEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT
T ss_pred             EEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCEEEeEChhhhhcccCC
Confidence            9999999999999999765 6899999999999999999999999999999999999999999999999999986533 3


Q ss_pred             cccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhcCCCCCCCCCHHH
Q 004959          497 KADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDSLSPEG  576 (721)
Q Consensus       497 ~~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~~~~~p~~lS~el  576 (721)
                      ......+||+.|+|||++.       ...++.++|||||||++|||++|..||.+.+..+.+..+......++..++.++
T Consensus       173 ~~~~~~~gt~~y~aPE~~~-------~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~  245 (345)
T 1xjd_A          173 AKTNTFCGTPDYIAPEILL-------GQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEA  245 (345)
T ss_dssp             CCBCCCCSCGGGCCHHHHT-------TCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHH
T ss_pred             CcccCCCCCcccCChhhhc-------CCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhCCCCCCcccCHHH
Confidence            3445678999999999994       345788999999999999999999999988888888888888888899999999


Q ss_pred             HHHHHHhcccCCCCCCCHH-HHHhccccccCC
Q 004959          577 KDFLRCCFQRNPADRPPAS-LLLEHRFLKNSQ  607 (721)
Q Consensus       577 ~dLI~~cL~~DP~kRPSa~-eLL~Hp~f~~~~  607 (721)
                      ++||++||+.||++||++. +|++||||+...
T Consensus       246 ~~li~~lL~~dp~~R~~~~~~i~~hp~f~~~~  277 (345)
T 1xjd_A          246 KDLLVKLFVREPEKRLGVRGDIRQHPLFREIN  277 (345)
T ss_dssp             HHHHHHHSCSSGGGSBTTBSCGGGSGGGTTCC
T ss_pred             HHHHHHHhcCCHhHcCCChHHHHcCccccCCC
Confidence            9999999999999999998 999999998653

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=4.5e-49  Score=427.47  Aligned_cols=257  Identities=27%  Similarity=0.460  Sum_probs=228.0

Q ss_pred             CCCCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeE
Q 004959          338 MNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKF  417 (721)
Q Consensus       338 l~~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~  417 (721)
                      +.++|++++.||+|+||.||+|.++.+|+.||||++...   .......+.+.+|+.+|+.++|||||++++++.+.+..
T Consensus        27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~---~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~  103 (362)
T 2bdw_A           27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTK---KLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFH  103 (362)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETT---TCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             cccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcc---cCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEE
Confidence            345799999999999999999999999999999998742   22345667899999999999999999999999999999


Q ss_pred             EEEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCC---ceEEeecCCccccC
Q 004959          418 YIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASG---VVKLADFGMAKHLT  494 (721)
Q Consensus       418 yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g---~VKL~DFGlA~~l~  494 (721)
                      |+||||+.||+|.+++... ..+++..++.++.||+.||.|||++||+||||||+||||+.++   .+||+|||++..+.
T Consensus       104 ~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~  182 (362)
T 2bdw_A          104 YLVFDLVTGGELFEDIVAR-EFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN  182 (362)
T ss_dssp             EEEECCCCSCBHHHHHTTC-SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCT
T ss_pred             EEEEecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEec
Confidence            9999999999999998754 6799999999999999999999999999999999999998654   59999999998876


Q ss_pred             CCcccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhcCCCCC----C
Q 004959          495 GQKADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIP----D  570 (721)
Q Consensus       495 ~~~~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~~~~~p----~  570 (721)
                      ........+||+.|+|||++.       ...++.++|||||||++|+|++|..||.+.+..+.+..+......++    .
T Consensus       183 ~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~  255 (362)
T 2bdw_A          183 DSEAWHGFAGTPGYLSPEVLK-------KDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWD  255 (362)
T ss_dssp             TCCSCCCSCSCTTTCCHHHHT-------TCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTGGG
T ss_pred             CCcccccCCCCccccCHHHHc-------cCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCccccc
Confidence            655555678999999999984       34577899999999999999999999988777777777766655444    3


Q ss_pred             CCCHHHHHHHHHhcccCCCCCCCHHHHHhcccccc
Q 004959          571 SLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKN  605 (721)
Q Consensus       571 ~lS~el~dLI~~cL~~DP~kRPSa~eLL~Hp~f~~  605 (721)
                      .+++++++||.+||+.||++||++.|+|+||||..
T Consensus       256 ~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~  290 (362)
T 2bdw_A          256 TVTPEAKSLIDSMLTVNPKKRITADQALKVPWICN  290 (362)
T ss_dssp             GSCHHHHHHHHHHSCSSGGGSCCHHHHTTSHHHHT
T ss_pred             CCCHHHHHHHHHHcCCChhhCcCHHHHhcCcccCC
Confidence            57999999999999999999999999999999975

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=1.9e-49  Score=430.15  Aligned_cols=258  Identities=26%  Similarity=0.423  Sum_probs=229.8

Q ss_pred             CCCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhC-CCCCeeeeeeeEEecCeE
Q 004959          339 NSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHL-KHPNIVQYYGSEIVEDKF  417 (721)
Q Consensus       339 ~~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L-~HPnIV~l~g~~~~~~~~  417 (721)
                      .++|++++.||+|+||.||+|+++.+|+.||||++....  .......+.+..|..+|..+ +||||+++++++.+.+.+
T Consensus        19 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~--~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~   96 (353)
T 2i0e_A           19 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDV--VIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRL   96 (353)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHH--HHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEE
T ss_pred             hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHH--hhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEE
Confidence            368999999999999999999999999999999986321  00112346778999999988 799999999999999999


Q ss_pred             EEEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCC-C
Q 004959          418 YIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTG-Q  496 (721)
Q Consensus       418 yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~-~  496 (721)
                      ||||||+.||+|.+++... +.+++..++.++.||+.||.|||++||+||||||+||||+.+|.+||+|||+++.... .
T Consensus        97 ~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~  175 (353)
T 2i0e_A           97 YFVMEYVNGGDLMYHIQQV-GRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDG  175 (353)
T ss_dssp             EEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT
T ss_pred             EEEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcEEEEeCCcccccccCC
Confidence            9999999999999999765 6799999999999999999999999999999999999999999999999999986432 3


Q ss_pred             cccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhcCCCCCCCCCHHH
Q 004959          497 KADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDSLSPEG  576 (721)
Q Consensus       497 ~~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~~~~~p~~lS~el  576 (721)
                      ......+||+.|+|||++.       ...++.++|||||||++|||++|+.||.+.+..+.+.++......+|..++.++
T Consensus       176 ~~~~~~~gt~~y~aPE~~~-------~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~  248 (353)
T 2i0e_A          176 VTTKTFCGTPDYIAPEIIA-------YQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEA  248 (353)
T ss_dssp             CCBCCCCSCGGGCCHHHHT-------TCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHH
T ss_pred             cccccccCCccccChhhhc-------CCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHH
Confidence            3445678999999999994       345788999999999999999999999988888888888888888999999999


Q ss_pred             HHHHHHhcccCCCCCCC-----HHHHHhccccccC
Q 004959          577 KDFLRCCFQRNPADRPP-----ASLLLEHRFLKNS  606 (721)
Q Consensus       577 ~dLI~~cL~~DP~kRPS-----a~eLL~Hp~f~~~  606 (721)
                      ++||++||+.||++||+     +++|++||||+..
T Consensus       249 ~~li~~lL~~dP~~R~~~~~~~~~~i~~h~~f~~~  283 (353)
T 2i0e_A          249 VAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYI  283 (353)
T ss_dssp             HHHHHHHTCSCTTSCTTCSTTHHHHHHTSGGGTTC
T ss_pred             HHHHHHHhhcCHHHcCCCCCCCHHHHhcCccccCC
Confidence            99999999999999994     7999999999864

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=2.1e-49  Score=428.76  Aligned_cols=256  Identities=30%  Similarity=0.485  Sum_probs=230.5

Q ss_pred             CCCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeEE
Q 004959          339 NSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFY  418 (721)
Q Consensus       339 ~~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~y  418 (721)
                      .++|++++.||+|+||.||+|+++.+|+.||||++....  .......+.+.+|+.+|+.++||||+++++++.+.+.+|
T Consensus        40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~  117 (350)
T 1rdq_E           40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQK--VVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLY  117 (350)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHH--HHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred             HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHH--hccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEE
Confidence            368999999999999999999999999999999986311  011123467889999999999999999999999999999


Q ss_pred             EEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCCcc
Q 004959          419 IYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKA  498 (721)
Q Consensus       419 LVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~~~  498 (721)
                      +||||+.||+|.+++... +.+++..++.++.||+.||+|||++||+||||||+||||+.+|.+||+|||+++.+...  
T Consensus       118 lv~e~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~--  194 (350)
T 1rdq_E          118 MVMEYVAGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR--  194 (350)
T ss_dssp             EEEECCTTCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC--
T ss_pred             EEEcCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCCEEEcccccceeccCC--
Confidence            999999999999999875 67999999999999999999999999999999999999999999999999999876543  


Q ss_pred             cccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhcCCCCCCCCCHHHHH
Q 004959          499 DLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDSLSPEGKD  578 (721)
Q Consensus       499 ~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~~~~~p~~lS~el~d  578 (721)
                      ....+||+.|+|||++.       ...++.++|||||||+||||++|..||.+....+.+.++......+|..++.++.+
T Consensus       195 ~~~~~gt~~y~aPE~~~-------~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~  267 (350)
T 1rdq_E          195 TWTLCGTPEALAPEIIL-------SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKD  267 (350)
T ss_dssp             BCCCEECGGGCCHHHHT-------TCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTCCHHHHH
T ss_pred             cccccCCccccCHHHhc-------CCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHH
Confidence            34568999999999994       34577899999999999999999999998888888888888888889999999999


Q ss_pred             HHHHhcccCCCCCCC-----HHHHHhccccccC
Q 004959          579 FLRCCFQRNPADRPP-----ASLLLEHRFLKNS  606 (721)
Q Consensus       579 LI~~cL~~DP~kRPS-----a~eLL~Hp~f~~~  606 (721)
                      ||++||+.||++||+     +++|++||||...
T Consensus       268 li~~lL~~dp~~R~~~~~~~~~ei~~h~~f~~~  300 (350)
T 1rdq_E          268 LLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATT  300 (350)
T ss_dssp             HHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTC
T ss_pred             HHHHHhhcCHHhccCCccCCHHHHHhCcCcCCC
Confidence            999999999999998     9999999999864

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=8.1e-49  Score=418.12  Aligned_cols=261  Identities=24%  Similarity=0.419  Sum_probs=227.7

Q ss_pred             CCCCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcc-cHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCe
Q 004959          338 MNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPK-SAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDK  416 (721)
Q Consensus       338 l~~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~-~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~  416 (721)
                      +.+.|++++.||+|+||.||+|.+..+|+.||||++........ .....+.+.+|+.+|+.++|||||++++++.+.+.
T Consensus         9 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~   88 (326)
T 2y0a_A            9 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTD   88 (326)
T ss_dssp             HHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred             cccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCE
Confidence            44679999999999999999999999999999999875432211 11124678899999999999999999999999999


Q ss_pred             EEEEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCC----ceEEeecCCccc
Q 004959          417 FYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASG----VVKLADFGMAKH  492 (721)
Q Consensus       417 ~yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g----~VKL~DFGlA~~  492 (721)
                      +|+||||+.|++|.+++... +.+++..++.++.||+.||.|||++||+||||||+||||+.++    .+||+|||++..
T Consensus        89 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~  167 (326)
T 2y0a_A           89 VILILELVAGGELFDFLAEK-ESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK  167 (326)
T ss_dssp             EEEEEECCCSCBHHHHHTTS-SCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCEE
T ss_pred             EEEEEEcCCCCCHHHHHHhc-CCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCeE
Confidence            99999999999999999654 6799999999999999999999999999999999999998877    899999999988


Q ss_pred             cCCCcccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhcCCCCC---
Q 004959          493 LTGQKADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIP---  569 (721)
Q Consensus       493 l~~~~~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~~~~~p---  569 (721)
                      +.........+||+.|+|||++.       ...++.++|||||||++|+|++|..||.+....+.+..+......++   
T Consensus       168 ~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  240 (326)
T 2y0a_A          168 IDFGNEFKNIFGTPEFVAPEIVN-------YEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEY  240 (326)
T ss_dssp             CCTTSCCCCCCSCTTTCCHHHHT-------TCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCCCHHH
T ss_pred             CCCCCccccccCCcCcCCceeec-------CCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCcCccc
Confidence            76555555678999999999983       34577899999999999999999999988777777666665544443   


Q ss_pred             -CCCCHHHHHHHHHhcccCCCCCCCHHHHHhccccccC
Q 004959          570 -DSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNS  606 (721)
Q Consensus       570 -~~lS~el~dLI~~cL~~DP~kRPSa~eLL~Hp~f~~~  606 (721)
                       ..++.++.+||++||+.||++|||+.|+|+||||+..
T Consensus       241 ~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~  278 (326)
T 2y0a_A          241 FSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPK  278 (326)
T ss_dssp             HTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTSCC
T ss_pred             cccCCHHHHHHHHHHccCChhhCCCHHHHhcCCCccCC
Confidence             5689999999999999999999999999999999753

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=3.7e-49  Score=431.08  Aligned_cols=259  Identities=27%  Similarity=0.440  Sum_probs=221.8

Q ss_pred             CCCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHH-HHhCCCCCeeeeeeeEEecCeE
Q 004959          339 NSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKV-LSHLKHPNIVQYYGSEIVEDKF  417 (721)
Q Consensus       339 ~~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~i-L~~L~HPnIV~l~g~~~~~~~~  417 (721)
                      .++|++++.||+|+||+||+|+++.+++.||||++.+..  .......+.+.+|..+ ++.++|||||++++++.+.+.+
T Consensus        37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~--~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~  114 (373)
T 2r5t_A           37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKA--ILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKL  114 (373)
T ss_dssp             GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGG--BC-------------CCBCCCCCTTBCCEEEEEECSSEE
T ss_pred             hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHH--hhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEE
Confidence            468999999999999999999999999999999986432  1222344566777776 5778999999999999999999


Q ss_pred             EEEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCC-C
Q 004959          418 YIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTG-Q  496 (721)
Q Consensus       418 yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~-~  496 (721)
                      ||||||+.||+|.+++... +.+++..++.++.||+.||+|||++||+||||||+||||+.+|.+||+|||+++.... .
T Consensus       115 ~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~~  193 (373)
T 2r5t_A          115 YFVLDYINGGELFYHLQRE-RCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN  193 (373)
T ss_dssp             EEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCCC
T ss_pred             EEEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEeeCccccccccCC
Confidence            9999999999999999765 6799999999999999999999999999999999999999999999999999986433 3


Q ss_pred             cccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhcCCCCCCCCCHHH
Q 004959          497 KADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDSLSPEG  576 (721)
Q Consensus       497 ~~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~~~~~p~~lS~el  576 (721)
                      ......+||+.|+|||++.       ...++.++|||||||++|||++|..||.+.+..+.+.+++.....++..++.++
T Consensus       194 ~~~~~~~gt~~y~aPE~~~-------~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  266 (373)
T 2r5t_A          194 STTSTFCGTPEYLAPEVLH-------KQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSA  266 (373)
T ss_dssp             CCCCSBSCCCCCCCHHHHT-------TCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHSCCCCCSSSCHHH
T ss_pred             CccccccCCccccCHHHhC-------CCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHH
Confidence            3445678999999999994       345778999999999999999999999988888888888888888889999999


Q ss_pred             HHHHHHhcccCCCCCCCH----HHHHhccccccCC
Q 004959          577 KDFLRCCFQRNPADRPPA----SLLLEHRFLKNSQ  607 (721)
Q Consensus       577 ~dLI~~cL~~DP~kRPSa----~eLL~Hp~f~~~~  607 (721)
                      ++||++||+.||++|+++    +++++||||+...
T Consensus       267 ~~li~~lL~~dp~~R~~~~~~~~~i~~h~~f~~~~  301 (373)
T 2r5t_A          267 RHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSLIN  301 (373)
T ss_dssp             HHHHHHHTCSSGGGSTTTTTTHHHHHTSGGGTTCC
T ss_pred             HHHHHHHcccCHHhCCCCCCCHHHHhCCccccCCC
Confidence            999999999999999986    7999999998643

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=6.8e-49  Score=427.56  Aligned_cols=292  Identities=23%  Similarity=0.417  Sum_probs=222.6

Q ss_pred             CCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCC-CCCeeeeeeeEEecC--e
Q 004959          340 SQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLK-HPNIVQYYGSEIVED--K  416 (721)
Q Consensus       340 ~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~-HPnIV~l~g~~~~~~--~  416 (721)
                      .+|++++.||+|+||.||+|.+..+|+.||||++..   ........+.+.+|+.+|+.+. |||||++++++...+  .
T Consensus         9 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~---~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~   85 (388)
T 3oz6_A            9 RKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFD---AFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRD   85 (388)
T ss_dssp             TTEEEEEC-------CEEEEEETTTCCEEEEEEECC-----CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSC
T ss_pred             CceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecc---cccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCE
Confidence            589999999999999999999999999999998853   2334556678889999999997 999999999987654  7


Q ss_pred             EEEEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCC
Q 004959          417 FYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQ  496 (721)
Q Consensus       417 ~yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~  496 (721)
                      +|+|||||. ++|..++..  +.+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+++.+...
T Consensus        86 ~~lv~e~~~-~~L~~~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~  162 (388)
T 3oz6_A           86 VYLVFDYME-TDLHAVIRA--NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNI  162 (388)
T ss_dssp             EEEEEECCS-EEHHHHHHH--TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEESSSC
T ss_pred             EEEEecccC-cCHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEecCCccccccccc
Confidence            899999997 689999875  57999999999999999999999999999999999999999999999999999865321


Q ss_pred             ----------------------cccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhh
Q 004959          497 ----------------------KADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEG  554 (721)
Q Consensus       497 ----------------------~~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~  554 (721)
                                            ......+||++|+|||++.+      ...++.++||||||||||||++|++||.+.+.
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~  236 (388)
T 3oz6_A          163 RRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLG------STKYTKGIDMWSLGCILGEILCGKPIFPGSST  236 (388)
T ss_dssp             CCCCCCGGGCCC---------------CCCGGGGCCHHHHTT------CCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred             ccccccccccccccccccccccccccCCcccCCcCCHHHhcC------CCCCCChhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence                                  11234679999999999953      35678899999999999999999999988777


Q ss_pred             HHHHHHHhhcCC-----------------------------------------------CCCCCCCHHHHHHHHHhcccC
Q 004959          555 AAAMFKVMRDTP-----------------------------------------------AIPDSLSPEGKDFLRCCFQRN  587 (721)
Q Consensus       555 ~~~~~ki~~~~~-----------------------------------------------~~p~~lS~el~dLI~~cL~~D  587 (721)
                      .+.+.+++....                                               ..+..+++++.+||++||+.|
T Consensus       237 ~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~d  316 (388)
T 3oz6_A          237 MNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFN  316 (388)
T ss_dssp             HHHHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSS
T ss_pred             HHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccC
Confidence            666665542110                                               011267899999999999999


Q ss_pred             CCCCCCHHHHHhccccccCCCCCCCCcccccCCCCCC-CCCCChhHHHhhhHHHHHh
Q 004959          588 PADRPPASLLLEHRFLKNSQQPDVPSCSLSFSGMQLT-EKPHSPREKADAKYDQVAA  643 (721)
Q Consensus       588 P~kRPSa~eLL~Hp~f~~~~~~~~~~~~~~~~~~~l~-~~~~~~~~~~~~~~d~~~~  643 (721)
                      |++|||++|+|+||||+....+.............+. .......+.++..|+++..
T Consensus       317 P~~R~t~~e~l~Hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  373 (388)
T 3oz6_A          317 PNKRISANDALKHPFVSIFHNPNEEPNCDHIITIPINDNVKHSIDDYRNLVYSEISR  373 (388)
T ss_dssp             GGGSCCHHHHTTSTTTTTTCCGGGCCCCSSCCCCC------CCHHHHHHHHHHHHHH
T ss_pred             cccCCCHHHHhCCHHHHHhcCCccCCCCCCCCCCCccccccCCHHHHHHHHHHHHHH
Confidence            9999999999999999876655332211111111222 1223344455566666544

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=1.1e-48  Score=407.96  Aligned_cols=258  Identities=27%  Similarity=0.482  Sum_probs=216.4

Q ss_pred             CCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeEEE
Q 004959          340 SQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYI  419 (721)
Q Consensus       340 ~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~yL  419 (721)
                      ++|++++.||+|+||+||+|.++.+|+.||||++....   ......+.+.+|+.+|++++||||+++++++.+.+.+|+
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   78 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDD---DDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTL   78 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSC---SSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEE
T ss_pred             CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccC---CcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEE
Confidence            47999999999999999999999999999999987432   223345678899999999999999999999999999999


Q ss_pred             EEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCCc-c
Q 004959          420 YLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQK-A  498 (721)
Q Consensus       420 VmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~~-~  498 (721)
                      ||||+.+ +|.+++....+.+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+.... .
T Consensus        79 v~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  157 (292)
T 3o0g_A           79 VFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRC  157 (292)
T ss_dssp             EEECCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCCSC
T ss_pred             EEecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecCCcccc
Confidence            9999975 6767776656789999999999999999999999999999999999999999999999999998765332 2


Q ss_pred             cccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCC-CchhhHHHHHHHhhcC------------
Q 004959          499 DLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPW-SEYEGAAAMFKVMRDT------------  565 (721)
Q Consensus       499 ~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF-~~~~~~~~~~ki~~~~------------  565 (721)
                      .....||+.|+|||++.+      ...++.++|||||||++|+|++|..|| .+....+.+..+....            
T Consensus       158 ~~~~~~t~~y~aPE~~~~------~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~  231 (292)
T 3o0g_A          158 YSAEVVTLWYRPPDVLFG------AKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMT  231 (292)
T ss_dssp             CCSCCSCGGGCCHHHHTT------CSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGG
T ss_pred             ccCCccccCCcChHHHcC------CCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhc
Confidence            344679999999999853      234678999999999999999988774 5544444444443210            


Q ss_pred             -----------------CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhccccccCC
Q 004959          566 -----------------PAIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQ  607 (721)
Q Consensus       566 -----------------~~~p~~lS~el~dLI~~cL~~DP~kRPSa~eLL~Hp~f~~~~  607 (721)
                                       ......++.++++||++||+.||++|||++|+|+||||++..
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  290 (292)
T 3o0g_A          232 KLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFC  290 (292)
T ss_dssp             GSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTC-
T ss_pred             ccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCcccccCC
Confidence                             011235789999999999999999999999999999998753

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=1.6e-49  Score=422.58  Aligned_cols=250  Identities=25%  Similarity=0.330  Sum_probs=194.8

Q ss_pred             CCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecC----
Q 004959          340 SQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVED----  415 (721)
Q Consensus       340 ~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~----  415 (721)
                      .+|.+.+.||+|+||+||+|++  +|+.||||++...     . .....++.|+..+.+++|||||++++++.+++    
T Consensus         3 r~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~-----~-~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~   74 (303)
T 3hmm_A            3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSR-----E-ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWT   74 (303)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGG-----G-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECcc-----c-hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCce
Confidence            4689999999999999999987  4899999998531     1 12223456777778899999999999988764    


Q ss_pred             eEEEEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhC--------CeeccCCCCCcEEEcCCCceEEeec
Q 004959          416 KFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSK--------KTIHRDIKGANLLVDASGVVKLADF  487 (721)
Q Consensus       416 ~~yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~--------gIIHrDLKPeNILld~~g~VKL~DF  487 (721)
                      .+|||||||++|+|.++|..  ..++++.+..++.||+.||+|||++        +||||||||+||||+.++.+||+||
T Consensus        75 ~~~lV~Ey~~~gsL~~~l~~--~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DF  152 (303)
T 3hmm_A           75 QLWLVSDYHEHGSLFDYLNR--YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL  152 (303)
T ss_dssp             EEEEEEECCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCC
T ss_pred             EEEEEecCCCCCcHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeC
Confidence            68999999999999999975  4799999999999999999999987        9999999999999999999999999


Q ss_pred             CCccccCCCccc-----ccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCch----------
Q 004959          488 GMAKHLTGQKAD-----LSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEY----------  552 (721)
Q Consensus       488 GlA~~l~~~~~~-----~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~----------  552 (721)
                      |+|+........     ...+||+.|||||++.+... .+...++.++|||||||+||||+||..||...          
T Consensus       153 Gla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~-~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~  231 (303)
T 3hmm_A          153 GLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSIN-MKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDL  231 (303)
T ss_dssp             TTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSC-TTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTT
T ss_pred             CCCccccCCCCceeeecccccccccccCHHHhccccc-ccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhc
Confidence            999876543321     23579999999999954211 11224677999999999999999998765321          


Q ss_pred             ----hhHHHHHHHhh-c--CCCCCCC-----CCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q 004959          553 ----EGAAAMFKVMR-D--TPAIPDS-----LSPEGKDFLRCCFQRNPADRPPASLLLEH  600 (721)
Q Consensus       553 ----~~~~~~~ki~~-~--~~~~p~~-----lS~el~dLI~~cL~~DP~kRPSa~eLL~H  600 (721)
                          ...+.+.+... .  .+.+|..     ....+.+||.+||+.||++|||+.||++.
T Consensus       232 ~~~~~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~  291 (303)
T 3hmm_A          232 VPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT  291 (303)
T ss_dssp             SCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred             ccccchHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence                11223333222 2  2233332     23468899999999999999999999875

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=3.2e-48  Score=401.13  Aligned_cols=261  Identities=26%  Similarity=0.454  Sum_probs=230.5

Q ss_pred             CCCCCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCe
Q 004959          337 PMNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDK  416 (721)
Q Consensus       337 ~l~~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~  416 (721)
                      .+.++|++++.||+|+||.||+|.+..+|+.||+|++...   .......+.+.+|+.++++++||||+++++++...+.
T Consensus         3 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   79 (284)
T 3kk8_A            3 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTK---KLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESF   79 (284)
T ss_dssp             TTTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGG---GCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred             hhhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecc---cCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCE
Confidence            3567999999999999999999999999999999998642   2345566788999999999999999999999999999


Q ss_pred             EEEEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCc---eEEeecCCcccc
Q 004959          417 FYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGV---VKLADFGMAKHL  493 (721)
Q Consensus       417 ~yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~---VKL~DFGlA~~l  493 (721)
                      .|+||||+.|++|.+++... ..+++..++.++.||+.||.|||++||+||||||+||||+.++.   +||+|||++...
T Consensus        80 ~~~v~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~  158 (284)
T 3kk8_A           80 HYLVFDLVTGGELFEDIVAR-EFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEV  158 (284)
T ss_dssp             EEEEECCCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred             EEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEc
Confidence            99999999999999998765 67999999999999999999999999999999999999987655   999999999877


Q ss_pred             CCCcccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhcCCCCC----
Q 004959          494 TGQKADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIP----  569 (721)
Q Consensus       494 ~~~~~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~~~~~p----  569 (721)
                      ..........||+.|+|||++.       ...++.++|||||||++|+|++|..||...........+.......+    
T Consensus       159 ~~~~~~~~~~~~~~y~aPE~~~-------~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  231 (284)
T 3kk8_A          159 NDSEAWHGFAGTPGYLSPEVLK-------KDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEW  231 (284)
T ss_dssp             CSSCBCCCSCSCGGGCCHHHHT-------TCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTT
T ss_pred             ccCccccCCCCCcCCcCchhhc-------CCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCCchhh
Confidence            6665556678999999999984       34577899999999999999999999988777776666665544333    


Q ss_pred             CCCCHHHHHHHHHhcccCCCCCCCHHHHHhccccccCCC
Q 004959          570 DSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQ  608 (721)
Q Consensus       570 ~~lS~el~dLI~~cL~~DP~kRPSa~eLL~Hp~f~~~~~  608 (721)
                      ..+++++.+||.+||+.||++|||++|+|+||||++...
T Consensus       232 ~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~  270 (284)
T 3kk8_A          232 DTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNRER  270 (284)
T ss_dssp             TTSCHHHHHHHHHHSCSSTTTSCCHHHHTTSHHHHSCCC
T ss_pred             cccCHHHHHHHHHHcccChhhCCCHHHHhcCccccCChh
Confidence            468999999999999999999999999999999987543

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=9.8e-49  Score=417.62  Aligned_cols=259  Identities=29%  Similarity=0.478  Sum_probs=218.9

Q ss_pred             CCCeeEeeEEeecCCeEEEEEEEC---CCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecC
Q 004959          339 NSQWQKGKLIGRGTFGSVYVASNR---ETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVED  415 (721)
Q Consensus       339 ~~~y~~~k~LG~G~fG~VY~a~~~---~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~  415 (721)
                      .++|++++.||+|+||.||+|++.   .+|+.||||++..... .........+.+|+.+|+.++|||||++++++...+
T Consensus        16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~   94 (327)
T 3a62_A           16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMI-VRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGG   94 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC---------------HHHHHHHCCCTTBCCEEEEEECSS
T ss_pred             HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHh-hhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCC
Confidence            358999999999999999999985   6899999999864211 112234566889999999999999999999999999


Q ss_pred             eEEEEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCC
Q 004959          416 KFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTG  495 (721)
Q Consensus       416 ~~yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~  495 (721)
                      .+|+||||+.|++|.+++... +.+++..++.++.||+.||.|||++||+||||||+||||+.+|.+||+|||+++....
T Consensus        95 ~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~  173 (327)
T 3a62_A           95 KLYLILEYLSGGELFMQLERE-GIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIH  173 (327)
T ss_dssp             CEEEEEECCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSCEEECCCSCC-----
T ss_pred             EEEEEEeCCCCCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCcEEEEeCCccccccc
Confidence            999999999999999999765 6799999999999999999999999999999999999999999999999999986433


Q ss_pred             C-cccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhcCCCCCCCCCH
Q 004959          496 Q-KADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDSLSP  574 (721)
Q Consensus       496 ~-~~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~~~~~p~~lS~  574 (721)
                      . ......+||+.|+|||++.       ...++.++|||||||++|+|++|+.||.+....+.+.++......++..++.
T Consensus       174 ~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~  246 (327)
T 3a62_A          174 DGTVTHTFCGTIEYMAPEILM-------RSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPYLTQ  246 (327)
T ss_dssp             -----CTTSSCCTTSCHHHHT-------TSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTSCH
T ss_pred             CCccccccCCCcCccCHhhCc-------CCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCCCCH
Confidence            2 2334568999999999984       3456789999999999999999999999888888888888888888999999


Q ss_pred             HHHHHHHHhcccCCCCCC-----CHHHHHhccccccC
Q 004959          575 EGKDFLRCCFQRNPADRP-----PASLLLEHRFLKNS  606 (721)
Q Consensus       575 el~dLI~~cL~~DP~kRP-----Sa~eLL~Hp~f~~~  606 (721)
                      ++++||++||+.||++||     +++|+++||||+..
T Consensus       247 ~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~~  283 (327)
T 3a62_A          247 EARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHI  283 (327)
T ss_dssp             HHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSSC
T ss_pred             HHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCcccCC
Confidence            999999999999999999     89999999999864

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=1.7e-48  Score=433.90  Aligned_cols=265  Identities=25%  Similarity=0.408  Sum_probs=204.8

Q ss_pred             CCCCCCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEec-
Q 004959          336 LPMNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVE-  414 (721)
Q Consensus       336 ~~l~~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~-  414 (721)
                      ..+.++|++++.||+|+||+||+|+++.+|+.||||++..   ........+++.+|+.+|+.++|||||++++++... 
T Consensus        49 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~---~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  125 (458)
T 3rp9_A           49 WQIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILR---VFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKD  125 (458)
T ss_dssp             CCSCTTEEECCC-------CEEEEEECC--CEEEEEEECS---TTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSC
T ss_pred             CccCCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEech---hhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCC
Confidence            4456799999999999999999999999999999999853   233455678899999999999999999999998543 


Q ss_pred             ----CeEEEEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCc
Q 004959          415 ----DKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMA  490 (721)
Q Consensus       415 ----~~~yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA  490 (721)
                          ..+|+||||+ +++|.+++... ..+++..++.|+.||+.||+|||++|||||||||+||||+.++.+||+|||++
T Consensus       126 ~~~~~~~~lv~e~~-~~~L~~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl~DFGla  203 (458)
T 3rp9_A          126 VEKFDELYVVLEIA-DSDFKKLFRTP-VYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLA  203 (458)
T ss_dssp             TTTCCCEEEEECCC-SEEHHHHHHSS-CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             cccCceEEEEEecc-ccchhhhcccC-CCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEeecccccc
Confidence                5799999998 57999998754 67999999999999999999999999999999999999999999999999999


Q ss_pred             cccCCCc----------------------------ccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHH
Q 004959          491 KHLTGQK----------------------------ADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEM  542 (721)
Q Consensus       491 ~~l~~~~----------------------------~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyEL  542 (721)
                      +.+....                            .....+||++|+|||++.      ....++.++||||||||||||
T Consensus       204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~------~~~~~~~~~DiwSlG~il~el  277 (458)
T 3rp9_A          204 RTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELIL------LQENYTEAIDVWSIGCIFAEL  277 (458)
T ss_dssp             BCTTSCTTCCCCCC---------------------------CCCTTCCHHHHT------TCCCCCTHHHHHHHHHHHHHH
T ss_pred             hhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhh------CCCCCCcHhHHHHHHHHHHHH
Confidence            8764221                            123467999999999874      234578899999999999999


Q ss_pred             hh-----------CCCCCCchhh--------------------HHHHHHHhh-----------------------cC---
Q 004959          543 YT-----------GKPPWSEYEG--------------------AAAMFKVMR-----------------------DT---  565 (721)
Q Consensus       543 Lt-----------G~~PF~~~~~--------------------~~~~~ki~~-----------------------~~---  565 (721)
                      ++           |+++|.+...                    .+.+..+..                       ..   
T Consensus       278 ltg~~~~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~  357 (458)
T 3rp9_A          278 LNMIKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKR  357 (458)
T ss_dssp             HTTSTTTCSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCC
T ss_pred             HHhccccccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCC
Confidence            99           6777755321                    122221111                       00   


Q ss_pred             -----CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhccccccCCCCCC
Q 004959          566 -----PAIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQPDV  611 (721)
Q Consensus       566 -----~~~p~~lS~el~dLI~~cL~~DP~kRPSa~eLL~Hp~f~~~~~~~~  611 (721)
                           ......+++++.+||++||+.||++|||++|+|+||||+....+..
T Consensus       358 ~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~~~~~~  408 (458)
T 3rp9_A          358 EGTDLAERFPASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEVRIAEV  408 (458)
T ss_dssp             CCCCGGGGSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTCCGGG
T ss_pred             CCCCHHHHCCCCCHHHHHHHHHHhccCccccCCHHHHhcCHhhhhcCCCcc
Confidence                 0112456999999999999999999999999999999998765543

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=5.6e-49  Score=423.91  Aligned_cols=261  Identities=26%  Similarity=0.426  Sum_probs=220.1

Q ss_pred             CCCCCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCe
Q 004959          337 PMNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDK  416 (721)
Q Consensus       337 ~l~~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~  416 (721)
                      .+.+.|++++.||+|+||+||+|.++.+|+.||||++.............+.+.+|+.+|+.++|||||++++++.+.+.
T Consensus        21 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~  100 (351)
T 3c0i_A           21 LFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGM  100 (351)
T ss_dssp             CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTE
T ss_pred             ccccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCE
Confidence            34568999999999999999999999999999999986321100111124678899999999999999999999999999


Q ss_pred             EEEEEeeccCCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCc---eEEeecCCc
Q 004959          417 FYIYLEYVHPGSINKYVREH---CGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGV---VKLADFGMA  490 (721)
Q Consensus       417 ~yLVmEy~~gGsL~~~L~~~---~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~---VKL~DFGlA  490 (721)
                      +|+|||||.|++|.+++...   ...+++..++.++.||+.||.|||++||+||||||+||||+.++.   +||+|||++
T Consensus       101 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a  180 (351)
T 3c0i_A          101 LYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVA  180 (351)
T ss_dssp             EEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCTTC
T ss_pred             EEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCcce
Confidence            99999999999999888653   235899999999999999999999999999999999999987654   999999999


Q ss_pred             cccCCCcc-cccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhcCCCCC
Q 004959          491 KHLTGQKA-DLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIP  569 (721)
Q Consensus       491 ~~l~~~~~-~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~~~~~p  569 (721)
                      ..+..... ....+||+.|+|||++.       ...++.++|||||||+||+|++|..||.+.. .+.+..+.......+
T Consensus       181 ~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~~DiwslG~il~~ll~g~~pf~~~~-~~~~~~i~~~~~~~~  252 (351)
T 3c0i_A          181 IQLGESGLVAGGRVGTPHFMAPEVVK-------REPYGKPVDVWGCGVILFILLSGCLPFYGTK-ERLFEGIIKGKYKMN  252 (351)
T ss_dssp             EECCTTSCBCCCCCSCGGGCCHHHHT-------TCCBCTHHHHHHHHHHHHHHHHSSCSSCSSH-HHHHHHHHHTCCCCC
T ss_pred             eEecCCCeeecCCcCCcCccCHHHHc-------CCCCCchHhhHHHHHHHHHHHHCCCCCCCcH-HHHHHHHHcCCCCCC
Confidence            87755433 34567999999999994       3457789999999999999999999998754 344445555443333


Q ss_pred             ----CCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccccc
Q 004959          570 ----DSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKN  605 (721)
Q Consensus       570 ----~~lS~el~dLI~~cL~~DP~kRPSa~eLL~Hp~f~~  605 (721)
                          ..++.++++||++||+.||++|||+.|+|+||||+.
T Consensus       253 ~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~  292 (351)
T 3c0i_A          253 PRQWSHISESAKDLVRRMLMLDPAERITVYEALNHPWLKE  292 (351)
T ss_dssp             HHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHT
T ss_pred             ccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcChhhcC
Confidence                568999999999999999999999999999999985

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=1e-48  Score=414.18  Aligned_cols=260  Identities=28%  Similarity=0.486  Sum_probs=216.7

Q ss_pred             CCCCCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCe
Q 004959          337 PMNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDK  416 (721)
Q Consensus       337 ~l~~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~  416 (721)
                      .+.++|++++.||+|+||+||+|.+. +|+.||||++....   ......+.+.+|+.+|++++|||||++++++.+.+.
T Consensus        18 ~l~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~   93 (311)
T 3niz_A           18 GLMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDA---EDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERC   93 (311)
T ss_dssp             CSSCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC---------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSC
T ss_pred             chHhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEeccc---ccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCE
Confidence            45679999999999999999999985 49999999986422   223345678899999999999999999999999999


Q ss_pred             EEEEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCC
Q 004959          417 FYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQ  496 (721)
Q Consensus       417 ~yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~  496 (721)
                      +|+||||+. ++|.+++......+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+...
T Consensus        94 ~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~  172 (311)
T 3niz_A           94 LTLVFEFME-KDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIP  172 (311)
T ss_dssp             EEEEEECCS-EEHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEETTSC
T ss_pred             EEEEEcCCC-CCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCCEEEccCcCceecCCC
Confidence            999999997 5888888776677999999999999999999999999999999999999999999999999999876533


Q ss_pred             c-ccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhc---CC------
Q 004959          497 K-ADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRD---TP------  566 (721)
Q Consensus       497 ~-~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~---~~------  566 (721)
                      . .....+||+.|+|||++.+      ...++.++|||||||++|+|++|+.||.+....+.+..+...   ..      
T Consensus       173 ~~~~~~~~~t~~y~aPE~~~~------~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  246 (311)
T 3niz_A          173 VRSYTHEVVTLWYRAPDVLMG------SKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQ  246 (311)
T ss_dssp             CC---CCCCCCTTCCHHHHTT------CCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGG
T ss_pred             cccccCCcccCCcCCHHHhcC------CCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhh
Confidence            2 2334579999999999853      245678999999999999999999999876555444443321   00      


Q ss_pred             ---------------------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhccccccCC
Q 004959          567 ---------------------AIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQ  607 (721)
Q Consensus       567 ---------------------~~p~~lS~el~dLI~~cL~~DP~kRPSa~eLL~Hp~f~~~~  607 (721)
                                           .+...+++++.+||++||+.||++|||++|+|+||||++..
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~  308 (311)
T 3niz_A          247 VQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDLD  308 (311)
T ss_dssp             GTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTSC
T ss_pred             hhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCcccccCC
Confidence                                 01234788999999999999999999999999999998753

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=5.3e-50  Score=431.63  Aligned_cols=258  Identities=28%  Similarity=0.438  Sum_probs=224.6

Q ss_pred             CCCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeEE
Q 004959          339 NSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFY  418 (721)
Q Consensus       339 ~~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~y  418 (721)
                      .++|++++.||+|+||+||+|.+..+|+.||||++....  ....+..+.+.+|+.+|+.++||||+++++++.+.+.+|
T Consensus         8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~   85 (336)
T 3h4j_B            8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQL--LKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIV   85 (336)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHH--HHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHH--ccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEE
Confidence            368999999999999999999999999999999986310  000112357889999999999999999999999999999


Q ss_pred             EEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCCcc
Q 004959          419 IYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKA  498 (721)
Q Consensus       419 LVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~~~  498 (721)
                      +||||+ +|+|.+++... +.+++.+++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++........
T Consensus        86 lv~E~~-~g~l~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~~  163 (336)
T 3h4j_B           86 MVIEYA-GGELFDYIVEK-KRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNF  163 (336)
T ss_dssp             EEECCC-CEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSBT
T ss_pred             EEEECC-CCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCEEEEEeccceeccCCcc
Confidence            999999 68999998765 6899999999999999999999999999999999999999999999999999988776666


Q ss_pred             cccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhcCCCCCCCCCHHHHH
Q 004959          499 DLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDSLSPEGKD  578 (721)
Q Consensus       499 ~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~~~~~p~~lS~el~d  578 (721)
                      ....+||+.|+|||++.+.      ...+.++|||||||++|+|++|..||.+........++......+|..+++++.+
T Consensus       164 ~~~~~gt~~y~aPE~~~~~------~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~  237 (336)
T 3h4j_B          164 LKTSCGSPNYAAPEVINGK------LYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVYVMPDFLSPGAQS  237 (336)
T ss_dssp             TCCCTTSTTTSCGGGSCCS------GGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCCCSSCCCCCTTSCHHHHH
T ss_pred             cccccCCcCcCCHHHHcCC------CCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCCCcccCCHHHHH
Confidence            6678899999999998431      1225789999999999999999999987654444444455556778889999999


Q ss_pred             HHHHhcccCCCCCCCHHHHHhccccccC
Q 004959          579 FLRCCFQRNPADRPPASLLLEHRFLKNS  606 (721)
Q Consensus       579 LI~~cL~~DP~kRPSa~eLL~Hp~f~~~  606 (721)
                      ||++||+.||++|||++|+++||||+..
T Consensus       238 li~~~L~~dP~~Rpt~~eil~hp~~~~~  265 (336)
T 3h4j_B          238 LIRRMIVADPMQRITIQEIRRDPWFNVN  265 (336)
T ss_dssp             HHHTTSCSSGGGSCCHHHHTTCHHHHTT
T ss_pred             HHHHHcCCChhHCcCHHHHHhChhhccC
Confidence            9999999999999999999999999864

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=2.2e-48  Score=434.60  Aligned_cols=258  Identities=26%  Similarity=0.438  Sum_probs=226.7

Q ss_pred             CCCCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeE
Q 004959          338 MNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKF  417 (721)
Q Consensus       338 l~~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~  417 (721)
                      +.++|++++.||+|+||+||+|.++.+|+.||+|++...   .......+.+.+|+.+|+.++|||||++++++.+.+..
T Consensus         9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~---~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~   85 (444)
T 3soa_A            9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTK---KLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHH   85 (444)
T ss_dssp             HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESC---SCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEE
T ss_pred             ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcc---cCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEE
Confidence            346899999999999999999999999999999998742   23344567899999999999999999999999999999


Q ss_pred             EEEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEc---CCCceEEeecCCccccC
Q 004959          418 YIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVD---ASGVVKLADFGMAKHLT  494 (721)
Q Consensus       418 yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld---~~g~VKL~DFGlA~~l~  494 (721)
                      |+|||||.||+|.+++... +.+++..+..++.||+.||.|||++||+||||||+||||+   .++.+||+|||++..+.
T Consensus        86 ~lv~E~~~gg~L~~~i~~~-~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~  164 (444)
T 3soa_A           86 YLIFDLVTGGELFEDIVAR-EYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVE  164 (444)
T ss_dssp             EEEECCCBCCBHHHHHHHC-SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCC
T ss_pred             EEEEEeCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEec
Confidence            9999999999999999765 6799999999999999999999999999999999999998   45789999999998776


Q ss_pred             CCcc-cccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhcCCCCC----
Q 004959          495 GQKA-DLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIP----  569 (721)
Q Consensus       495 ~~~~-~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~~~~~p----  569 (721)
                      .... ....+||+.|+|||++.       ...++.++||||||||||+|++|..||.+....+.+..+......++    
T Consensus       165 ~~~~~~~~~~gt~~Y~APE~l~-------~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~  237 (444)
T 3soa_A          165 GEQQAWFGFAGTPGYLSPEVLR-------KDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEW  237 (444)
T ss_dssp             TTCCBCCCSCSCGGGCCHHHHT-------TCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTTT
T ss_pred             CCCceeecccCCcccCCHHHhc-------CCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCcccc
Confidence            5433 34578999999999994       34678899999999999999999999998887777777776655444    


Q ss_pred             CCCCHHHHHHHHHhcccCCCCCCCHHHHHhccccccC
Q 004959          570 DSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNS  606 (721)
Q Consensus       570 ~~lS~el~dLI~~cL~~DP~kRPSa~eLL~Hp~f~~~  606 (721)
                      ..+++++++||.+||+.||++|||+.|+|+||||+..
T Consensus       238 ~~~s~~~~~li~~~L~~dP~~Rpta~e~L~hp~~~~~  274 (444)
T 3soa_A          238 DTVTPEAKDLINKMLTINPSKRITAAEALKHPWISHR  274 (444)
T ss_dssp             TTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSCTTHHH
T ss_pred             ccCCHHHHHHHHHHcCCChhHCCCHHHHhcCccccCC
Confidence            4689999999999999999999999999999999753

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=9.2e-49  Score=417.56  Aligned_cols=262  Identities=26%  Similarity=0.458  Sum_probs=218.4

Q ss_pred             CCCCCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCe
Q 004959          337 PMNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDK  416 (721)
Q Consensus       337 ~l~~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~  416 (721)
                      ++.++|++++.||+|+||+||+|.+..+|+.||||++....    .....+.+.+|+.+++.++|||||++++++.+.+.
T Consensus         4 ~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~   79 (323)
T 3tki_A            4 PFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKR----AVDCPENIKKEICINKMLNHENVVKFYGHRREGNI   79 (323)
T ss_dssp             TTTTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-----------CHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred             cHhhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEccc----ccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCe
Confidence            45679999999999999999999999999999999986421    12234578899999999999999999999999999


Q ss_pred             EEEEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCC
Q 004959          417 FYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQ  496 (721)
Q Consensus       417 ~yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~  496 (721)
                      .|+|||||.||+|.+++... ..+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+...
T Consensus        80 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  158 (323)
T 3tki_A           80 QYLFLEYCSGGELFDRIEPD-IGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYN  158 (323)
T ss_dssp             EEEEEECCTTEEGGGGSBTT-TBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEET
T ss_pred             EEEEEEcCCCCcHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCCEEEEEeeccceeccC
Confidence            99999999999999998654 57999999999999999999999999999999999999999999999999999865432


Q ss_pred             c---ccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHH-HHhhcCC--CCCC
Q 004959          497 K---ADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMF-KVMRDTP--AIPD  570 (721)
Q Consensus       497 ~---~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~-ki~~~~~--~~p~  570 (721)
                      .   .....+||+.|+|||++.+      ...++.++|||||||+||+|++|+.||.......... .......  ....
T Consensus       159 ~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  232 (323)
T 3tki_A          159 NRERLLNKMCGTLPYVAPELLKR------REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWK  232 (323)
T ss_dssp             TEECCBCSCCSCGGGSCHHHHHC------SSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTTSTTGG
T ss_pred             CcccccCCCccCcCccCcHHhcc------CCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccccCCccc
Confidence            2   2235679999999999953      2234678999999999999999999997654432222 2222221  2235


Q ss_pred             CCCHHHHHHHHHhcccCCCCCCCHHHHHhccccccCCCC
Q 004959          571 SLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQP  609 (721)
Q Consensus       571 ~lS~el~dLI~~cL~~DP~kRPSa~eLL~Hp~f~~~~~~  609 (721)
                      .++.++.+||.+||+.||++|||++|+++||||+.....
T Consensus       233 ~~~~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~~~~  271 (323)
T 3tki_A          233 KIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLKK  271 (323)
T ss_dssp             GSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCCCC
T ss_pred             cCCHHHHHHHHHHccCChhhCcCHHHHhhChhhcccccc
Confidence            689999999999999999999999999999999875443

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=3.7e-49  Score=442.64  Aligned_cols=292  Identities=23%  Similarity=0.346  Sum_probs=223.3

Q ss_pred             CCCCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEec---
Q 004959          338 MNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVE---  414 (721)
Q Consensus       338 l~~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~---  414 (721)
                      +.++|++++.||+|+||+||+|.+..+|+.||||++...   .......+++.+|+.+|+.++|||||++++++...   
T Consensus        60 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~---~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~  136 (464)
T 3ttj_A           60 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRP---FQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTL  136 (464)
T ss_dssp             EETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESG---GGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCST
T ss_pred             ecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECcc---ccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCcc
Confidence            346899999999999999999999999999999998632   33456677899999999999999999999998654   


Q ss_pred             ---CeEEEEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCcc
Q 004959          415 ---DKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAK  491 (721)
Q Consensus       415 ---~~~yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~  491 (721)
                         ..+|||||||.+ +|.+.+.   ..+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+++
T Consensus       137 ~~~~~~~lv~E~~~~-~l~~~~~---~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~  212 (464)
T 3ttj_A          137 EEFQDVYLVMELMDA-NLCQVIQ---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR  212 (464)
T ss_dssp             TTCCEEEEEEECCSE-EHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCCC-
T ss_pred             ccCCeEEEEEeCCCC-CHHHHHh---hcCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCCEEEEEEEeee
Confidence               467999999975 5666663   359999999999999999999999999999999999999999999999999998


Q ss_pred             ccCCCcccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhcCC-----
Q 004959          492 HLTGQKADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTP-----  566 (721)
Q Consensus       492 ~l~~~~~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~~~-----  566 (721)
                      ...........+||+.|+|||++.+       ..++.++||||||||||||++|+.||.+.+..+.+.+++....     
T Consensus       213 ~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~  285 (464)
T 3ttj_A          213 TAGTSFMMTPYVVTRYYRAPEVILG-------MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPE  285 (464)
T ss_dssp             ----CCCC----CCCTTCCHHHHTT-------CCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHH
T ss_pred             ecCCCcccCCCcccccccCHHHHcC-------CCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHH
Confidence            7766555566889999999999953       4577899999999999999999999998777666665543211     


Q ss_pred             -----------------CC---------CCC-----------CCHHHHHHHHHhcccCCCCCCCHHHHHhccccccCCCC
Q 004959          567 -----------------AI---------PDS-----------LSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQP  609 (721)
Q Consensus       567 -----------------~~---------p~~-----------lS~el~dLI~~cL~~DP~kRPSa~eLL~Hp~f~~~~~~  609 (721)
                                       ..         +..           .++++++||++||+.||++|||++|+|+||||+....+
T Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~~~~~~  365 (464)
T 3ttj_A          286 FMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDP  365 (464)
T ss_dssp             HHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGCCH
T ss_pred             HHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhhhccCc
Confidence                             00         000           15679999999999999999999999999999876543


Q ss_pred             CC-CCcccccCCCCCCCCCCChhHHHhhhHHHHHh
Q 004959          610 DV-PSCSLSFSGMQLTEKPHSPREKADAKYDQVAA  643 (721)
Q Consensus       610 ~~-~~~~~~~~~~~l~~~~~~~~~~~~~~~d~~~~  643 (721)
                      .. ...........+.+......+.++..++++..
T Consensus       366 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~  400 (464)
T 3ttj_A          366 AEVEAPPPQIYDKQLDEREHTIEEWKELIYKEVMN  400 (464)
T ss_dssp             HHHSCCC-----------CCCHHHHHHHHHHHHHC
T ss_pred             ccccCCCCccCCcchhhccCCHHHHHHHHHHHHHH
Confidence            21 11111112233444445555666666666544

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=7.5e-48  Score=427.03  Aligned_cols=298  Identities=26%  Similarity=0.414  Sum_probs=228.9

Q ss_pred             CCCCCCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEec-
Q 004959          336 LPMNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVE-  414 (721)
Q Consensus       336 ~~l~~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~-  414 (721)
                      ..+.++|++++.||+|+||.||+|.++.+|+.||||++..   ........+++.+|+.+|+.++|||||++++++... 
T Consensus        22 ~~i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~---~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~   98 (432)
T 3n9x_A           22 VHVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNR---MFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDD   98 (432)
T ss_dssp             CCCCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECS---TTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSC
T ss_pred             ceecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCc---hhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCC
Confidence            4566799999999999999999999999999999999863   233455678899999999999999999999998776 


Q ss_pred             ----CeEEEEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCc
Q 004959          415 ----DKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMA  490 (721)
Q Consensus       415 ----~~~yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA  490 (721)
                          +.+||||||+. ++|.+++... ..+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++
T Consensus        99 ~~~~~~~~lv~e~~~-~~L~~~~~~~-~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~kL~DFGla  176 (432)
T 3n9x_A           99 LLKFDELYIVLEIAD-SDLKKLFKTP-IFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLA  176 (432)
T ss_dssp             TTTCCCEEEEEECCS-EEHHHHHHSS-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             CCcCCeEEEEEecCC-cCHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCEEEccCCCc
Confidence                57999999996 6999999764 67999999999999999999999999999999999999999999999999999


Q ss_pred             cccCCCc-----------------------ccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCC-
Q 004959          491 KHLTGQK-----------------------ADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGK-  546 (721)
Q Consensus       491 ~~l~~~~-----------------------~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~-  546 (721)
                      +.+....                       .....+||++|+|||++.      ....++.++||||||||||||++|. 
T Consensus       177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~------~~~~~~~~~DiwSlG~il~ell~g~~  250 (432)
T 3n9x_A          177 RTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELIL------LQENYTKSIDIWSTGCIFAELLNMLQ  250 (432)
T ss_dssp             EEC-------------------------------CCCCCTTCCHHHHT------TCSCCCTHHHHHHHHHHHHHHHTTCT
T ss_pred             ccccccccccccccccccccccccccchhccccCCCCCccccCHHHHh------cCCCCCcccccchHHHHHHHHHhccc
Confidence            8765432                       124578999999999974      2345788999999999999999854 


Q ss_pred             ----------CCCCchh-----------------hHHHHHHHhh-----------------------cCC-C-------C
Q 004959          547 ----------PPWSEYE-----------------GAAAMFKVMR-----------------------DTP-A-------I  568 (721)
Q Consensus       547 ----------~PF~~~~-----------------~~~~~~ki~~-----------------------~~~-~-------~  568 (721)
                                ++|.+..                 ..+++..+..                       ..+ .       .
T Consensus       251 p~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  330 (432)
T 3n9x_A          251 SHINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQK  330 (432)
T ss_dssp             TTCSSGGGCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHH
T ss_pred             ccccccccccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHH
Confidence                      4443321                 1122211111                       100 0       1


Q ss_pred             CCCCCHHHHHHHHHhcccCCCCCCCHHHHHhccccccCCCCCCCCcccccCCCCCCC-CCCChhHHHhhhHHHHHhh
Q 004959          569 PDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQPDVPSCSLSFSGMQLTE-KPHSPREKADAKYDQVAAL  644 (721)
Q Consensus       569 p~~lS~el~dLI~~cL~~DP~kRPSa~eLL~Hp~f~~~~~~~~~~~~~~~~~~~l~~-~~~~~~~~~~~~~d~~~~l  644 (721)
                      ...+++++.+||++||+.||++|||++|+|+||||+....+........-....+.+ ......+.++..++++...
T Consensus       331 ~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~  407 (432)
T 3n9x_A          331 YPSISDDGINLLESMLKFNPNKRITIDQALDHPYLKDVRKKKLENFSTKKIILPFDDWMVLSETQLRYIFLKEVQSF  407 (432)
T ss_dssp             STTSCHHHHHHHHHHSCSSTTTSCCHHHHHTCGGGTTTCCTTTC---CCCCCCSSCTTCCCCHHHHHHHHHHHHHHH
T ss_pred             CCCCCHHHHHHHHHHhcCCcccCCCHHHHhcChhhhhccCcccCcCCCCCCCCChhhcccCCHHHHHHHHHHHHHHh
Confidence            145899999999999999999999999999999999877664432111111111222 2344555566777777665

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=4.7e-48  Score=418.99  Aligned_cols=259  Identities=27%  Similarity=0.452  Sum_probs=209.0

Q ss_pred             CCCCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeE
Q 004959          338 MNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKF  417 (721)
Q Consensus       338 l~~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~  417 (721)
                      ..++|++++.||+|+||+||+|+++.+|+.||||++.....  .    .+.+.+|+.+++.++|||||++++++.+.+.+
T Consensus        18 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~----~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~   91 (361)
T 3uc3_A           18 DSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA--I----DENVQREIINHRSLRHPNIVRFKEVILTPTHL   91 (361)
T ss_dssp             CTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT--S----CHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             CCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc--c----cHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEE
Confidence            34689999999999999999999999999999999864221  1    24678999999999999999999999999999


Q ss_pred             EEEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCc--eEEeecCCccccCC
Q 004959          418 YIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGV--VKLADFGMAKHLTG  495 (721)
Q Consensus       418 yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~--VKL~DFGlA~~l~~  495 (721)
                      |+||||+.||+|.+++... +.+++..++.++.||+.||.|||++||+||||||+||||+.++.  +||+|||+++....
T Consensus        92 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~  170 (361)
T 3uc3_A           92 AIIMEYASGGELYERICNA-GRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL  170 (361)
T ss_dssp             EEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC-----
T ss_pred             EEEEEeCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCccccccc
Confidence            9999999999999999765 67999999999999999999999999999999999999987765  99999999986544


Q ss_pred             CcccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhh----HHHHHHHhhcCCCCCC-
Q 004959          496 QKADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEG----AAAMFKVMRDTPAIPD-  570 (721)
Q Consensus       496 ~~~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~----~~~~~ki~~~~~~~p~-  570 (721)
                      .......+||+.|+|||++.+      ....+.++|||||||++|+|++|+.||.+...    ...+..+......++. 
T Consensus       171 ~~~~~~~~gt~~y~aPE~~~~------~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (361)
T 3uc3_A          171 HSQPKSTVGTPAYIAPEVLLR------QEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDD  244 (361)
T ss_dssp             ----------CTTSCHHHHHC------SSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCCCTT
T ss_pred             cCCCCCCcCCCCcCChhhhcC------CCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCCCCc
Confidence            444456779999999999953      22234458999999999999999999976433    3334444444444444 


Q ss_pred             -CCCHHHHHHHHHhcccCCCCCCCHHHHHhccccccCCCC
Q 004959          571 -SLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQP  609 (721)
Q Consensus       571 -~lS~el~dLI~~cL~~DP~kRPSa~eLL~Hp~f~~~~~~  609 (721)
                       .+++++++||.+||+.||++|||+.||++||||......
T Consensus       245 ~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~~  284 (361)
T 3uc3_A          245 IRISPECCHLISRIFVADPATRISIPEIKTHSWFLKNLPA  284 (361)
T ss_dssp             SCCCHHHHHHHHHHSCSCTTTSCCHHHHHTSHHHHTTCCC
T ss_pred             CCCCHHHHHHHHHHccCChhHCcCHHHHHhCcchhcCCch
Confidence             589999999999999999999999999999999765433

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=5.1e-49  Score=437.41  Aligned_cols=258  Identities=28%  Similarity=0.487  Sum_probs=220.9

Q ss_pred             CCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeEEE
Q 004959          340 SQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYI  419 (721)
Q Consensus       340 ~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~yL  419 (721)
                      ++|++++.||+|+||.||+|.+..+|+.||||++....  .........+.+|+.+|+.++||||+++++++...+.+||
T Consensus       148 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~l  225 (446)
T 4ejn_A          148 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEV--IVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCF  225 (446)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHH--HC-------------CCCCCSCTTSCCEEEEEEETTEEEE
T ss_pred             HHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhh--hhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEE
Confidence            57999999999999999999999999999999986311  1122345677899999999999999999999999999999


Q ss_pred             EEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhh-CCeeccCCCCCcEEEcCCCceEEeecCCccccCCC-c
Q 004959          420 YLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHS-KKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQ-K  497 (721)
Q Consensus       420 VmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs-~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~-~  497 (721)
                      |||||.||+|.+++... +.+++..++.++.||+.||+|||+ +|||||||||+||||+.++.+||+|||+++..... .
T Consensus       226 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~  304 (446)
T 4ejn_A          226 VMEYANGGELFFHLSRE-RVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA  304 (446)
T ss_dssp             EECCCSSCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC---
T ss_pred             EEeeCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEccCCCceeccCCCc
Confidence            99999999999999765 689999999999999999999998 99999999999999999999999999999864332 3


Q ss_pred             ccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhcCCCCCCCCCHHHH
Q 004959          498 ADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDSLSPEGK  577 (721)
Q Consensus       498 ~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~~~~~p~~lS~el~  577 (721)
                      .....+||+.|+|||++.+       ..++.++|||||||+||||++|+.||.+.........+......+|..+++++.
T Consensus       305 ~~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~  377 (446)
T 4ejn_A          305 TMKTFCGTPEYLAPEVLED-------NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAK  377 (446)
T ss_dssp             --CCSSSCGGGCCHHHHHT-------SCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHH
T ss_pred             ccccccCCccccCHhhcCC-------CCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHH
Confidence            3456789999999999953       457789999999999999999999999888888888888888888999999999


Q ss_pred             HHHHHhcccCCCCCC-----CHHHHHhccccccCC
Q 004959          578 DFLRCCFQRNPADRP-----PASLLLEHRFLKNSQ  607 (721)
Q Consensus       578 dLI~~cL~~DP~kRP-----Sa~eLL~Hp~f~~~~  607 (721)
                      +||.+||+.||++||     +++|+|+||||++..
T Consensus       378 ~li~~~L~~dP~~R~~~~~~t~~ell~hp~f~~~~  412 (446)
T 4ejn_A          378 SLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIV  412 (446)
T ss_dssp             HHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCC
T ss_pred             HHHHHHcccCHHHhCCCCCCCHHHHHhCccccCCC
Confidence            999999999999999     999999999998753

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=6.9e-49  Score=431.04  Aligned_cols=262  Identities=24%  Similarity=0.442  Sum_probs=229.6

Q ss_pred             CCCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeEE
Q 004959          339 NSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFY  418 (721)
Q Consensus       339 ~~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~y  418 (721)
                      .++|++++.||+|+||.||+|.+..+|+.||||++....  .......+.+.+|+.+|+.++|||||++++++.+.+.+|
T Consensus        14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~--~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~   91 (384)
T 4fr4_A           14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQK--CVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMF   91 (384)
T ss_dssp             GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHH--HHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred             hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhh--cccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence            368999999999999999999999999999999986311  011123467889999999999999999999999999999


Q ss_pred             EEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCCcc
Q 004959          419 IYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKA  498 (721)
Q Consensus       419 LVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~~~  498 (721)
                      +||||+.||+|..++... +.+++..++.|+.||+.||.|||++||+||||||+||||+.+|.+||+|||++..+.....
T Consensus        92 lv~e~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~  170 (384)
T 4fr4_A           92 MVVDLLLGGDLRYHLQQN-VHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQ  170 (384)
T ss_dssp             EEECCCTTEEHHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTCC
T ss_pred             EEEecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCCEEEeccceeeeccCCCc
Confidence            999999999999999764 6799999999999999999999999999999999999999999999999999998776666


Q ss_pred             cccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCch---hhHHHHHHHhhcCCCCCCCCCHH
Q 004959          499 DLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEY---EGAAAMFKVMRDTPAIPDSLSPE  575 (721)
Q Consensus       499 ~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~---~~~~~~~ki~~~~~~~p~~lS~e  575 (721)
                      ....+||+.|+|||++.+    .....++.++|||||||+||+|++|+.||...   ...+.+..+......+|..++.+
T Consensus       171 ~~~~~gt~~Y~aPE~~~~----~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~p~~~s~~  246 (384)
T 4fr4_A          171 ITTMAGTKPYMAPEMFSS----RKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYPSAWSQE  246 (384)
T ss_dssp             BCCCCSCGGGCCGGGTCC----CSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHCCCCCCTTSCHH
T ss_pred             eeccCCCccccCCeeecc----CCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhcccCCCCcCCHH
Confidence            677899999999999842    12345788999999999999999999999742   33445555566677888999999


Q ss_pred             HHHHHHHhcccCCCCCCC-HHHHHhccccccCC
Q 004959          576 GKDFLRCCFQRNPADRPP-ASLLLEHRFLKNSQ  607 (721)
Q Consensus       576 l~dLI~~cL~~DP~kRPS-a~eLL~Hp~f~~~~  607 (721)
                      +.+||++||+.||++||+ ++++++||||.+..
T Consensus       247 ~~~li~~lL~~dP~~R~s~~~~l~~hp~f~~~~  279 (384)
T 4fr4_A          247 MVSLLKKLLEPNPDQRFSQLSDVQNFPYMNDIN  279 (384)
T ss_dssp             HHHHHHHHSCSSGGGSCCSHHHHHTSGGGTTCC
T ss_pred             HHHHHHHHhcCCHhHhcccHHHHHcChhhhcCC
Confidence            999999999999999998 99999999998653

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=6.7e-49  Score=434.93  Aligned_cols=267  Identities=26%  Similarity=0.404  Sum_probs=226.8

Q ss_pred             CCCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeEE
Q 004959          339 NSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFY  418 (721)
Q Consensus       339 ~~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~y  418 (721)
                      .++|++++.||+|+||+||+|+++.+|+.||||++.+.  ........+.+.+|+.+|..++|||||++++++.+.+.+|
T Consensus        60 ~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~--~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~  137 (412)
T 2vd5_A           60 RDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKW--DMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLY  137 (412)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHH--HHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEE
T ss_pred             hhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHH--HhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEE
Confidence            46899999999999999999999999999999998631  0111122345788999999999999999999999999999


Q ss_pred             EEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCCcc
Q 004959          419 IYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKA  498 (721)
Q Consensus       419 LVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~~~  498 (721)
                      ||||||.||+|.+++.+.+..+++..++.++.||+.||+|||++|||||||||+||||+.+|.+||+|||+++.+.....
T Consensus       138 lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~vkL~DFGla~~~~~~~~  217 (412)
T 2vd5_A          138 LVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGT  217 (412)
T ss_dssp             EEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSC
T ss_pred             EEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCCEEEeechhheeccCCCc
Confidence            99999999999999987656899999999999999999999999999999999999999999999999999987755433


Q ss_pred             --cccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhc-----CCCCCCC
Q 004959          499 --DLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRD-----TPAIPDS  571 (721)
Q Consensus       499 --~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~-----~~~~p~~  571 (721)
                        ....+||+.|+|||++...........++.++|||||||++|||++|+.||.+....+.+.+++..     .+..+..
T Consensus       218 ~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~  297 (412)
T 2vd5_A          218 VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPLVDEG  297 (412)
T ss_dssp             EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCC----C
T ss_pred             cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCcCCCccccC
Confidence              235689999999999975433222446788999999999999999999999988777777776642     2233467


Q ss_pred             CCHHHHHHHHHhcccCCCCC---CCHHHHHhccccccCCC
Q 004959          572 LSPEGKDFLRCCFQRNPADR---PPASLLLEHRFLKNSQQ  608 (721)
Q Consensus       572 lS~el~dLI~~cL~~DP~kR---PSa~eLL~Hp~f~~~~~  608 (721)
                      ++.++++||++||+ +|++|   ++++|+++||||++...
T Consensus       298 ~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~i~w  336 (412)
T 2vd5_A          298 VPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFGLDW  336 (412)
T ss_dssp             CCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTTCCS
T ss_pred             CCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCCCCH
Confidence            99999999999999 99998   59999999999987543

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=2.3e-48  Score=423.09  Aligned_cols=264  Identities=24%  Similarity=0.457  Sum_probs=220.0

Q ss_pred             CCCCCeeEeeEEeec--CCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEec
Q 004959          337 PMNSQWQKGKLIGRG--TFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVE  414 (721)
Q Consensus       337 ~l~~~y~~~k~LG~G--~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~  414 (721)
                      ...++|++++.||+|  +||.||+|+++.+|+.||||++...   .......+.+.+|+.+|+.++|||||++++++.+.
T Consensus        22 ~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~   98 (389)
T 3gni_B           22 PEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLE---ACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIAD   98 (389)
T ss_dssp             CCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGG---GSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred             CCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEeccc---ccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEEC
Confidence            345689999999999  9999999999999999999998742   23345678899999999999999999999999999


Q ss_pred             CeEEEEEeeccCCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCcccc
Q 004959          415 DKFYIYLEYVHPGSINKYVREH-CGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHL  493 (721)
Q Consensus       415 ~~~yLVmEy~~gGsL~~~L~~~-~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l  493 (721)
                      +.+|+|||||.+|+|.+++... ...+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+
T Consensus        99 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~  178 (389)
T 3gni_B           99 NELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSM  178 (389)
T ss_dssp             TEEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred             CEEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccccceee
Confidence            9999999999999999999765 357999999999999999999999999999999999999999999999999998654


Q ss_pred             CCCc--------ccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhcC
Q 004959          494 TGQK--------ADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDT  565 (721)
Q Consensus       494 ~~~~--------~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~~  565 (721)
                      ....        .....+||+.|+|||++.+     ....++.++|||||||++|+|++|+.||.+......+..+....
T Consensus       179 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~  253 (389)
T 3gni_B          179 ISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQ-----NLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGT  253 (389)
T ss_dssp             EETTEECSCBCCCCTTCTTTGGGSCHHHHST-----TSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC----
T ss_pred             ccccccccccccccccccccccccCHHHHhc-----cCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCC
Confidence            3211        1123479999999999953     22457889999999999999999999998755444443332211


Q ss_pred             ----------------------------------------------CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHh
Q 004959          566 ----------------------------------------------PAIPDSLSPEGKDFLRCCFQRNPADRPPASLLLE  599 (721)
Q Consensus       566 ----------------------------------------------~~~p~~lS~el~dLI~~cL~~DP~kRPSa~eLL~  599 (721)
                                                                    ...+..+++++.+||++||+.||++|||+.|+|+
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~  333 (389)
T 3gni_B          254 VPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLN  333 (389)
T ss_dssp             ----------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             CCccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence                                                          1134568899999999999999999999999999


Q ss_pred             ccccccCCC
Q 004959          600 HRFLKNSQQ  608 (721)
Q Consensus       600 Hp~f~~~~~  608 (721)
                      ||||+....
T Consensus       334 hp~f~~~~~  342 (389)
T 3gni_B          334 HSFFKQIKR  342 (389)
T ss_dssp             SGGGGGC--
T ss_pred             CHHHHHHhh
Confidence            999987654

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=8.5e-49  Score=411.86  Aligned_cols=262  Identities=28%  Similarity=0.473  Sum_probs=214.0

Q ss_pred             CCCCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhC---CCCCeeeeeeeEEec
Q 004959          338 MNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHL---KHPNIVQYYGSEIVE  414 (721)
Q Consensus       338 l~~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L---~HPnIV~l~g~~~~~  414 (721)
                      +.++|++++.||+|+||+||+|++..+|+.||||++...............+.+|+.+++++   .||||+++++++...
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~   86 (308)
T 3g33_A            7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS   86 (308)
T ss_dssp             ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred             cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence            45689999999999999999999999999999999875332211111123556677777666   499999999998875


Q ss_pred             C-----eEEEEEeeccCCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecC
Q 004959          415 D-----KFYIYLEYVHPGSINKYVREHC-GAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFG  488 (721)
Q Consensus       415 ~-----~~yLVmEy~~gGsL~~~L~~~~-~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFG  488 (721)
                      .     .+++||||+. ++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||
T Consensus        87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg  165 (308)
T 3g33_A           87 RTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFG  165 (308)
T ss_dssp             CSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSCEEECSCS
T ss_pred             CCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEEeeCc
Confidence            5     5899999997 69999997653 349999999999999999999999999999999999999999999999999


Q ss_pred             CccccCCCcccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhcCCC-
Q 004959          489 MAKHLTGQKADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPA-  567 (721)
Q Consensus       489 lA~~l~~~~~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~~~~-  567 (721)
                      ++..+.........+||+.|+|||++.+       ..++.++|||||||++|+|++|+.||.+....+.+.++...... 
T Consensus       166 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~  238 (308)
T 3g33_A          166 LARIYSYQMALTPVVVTLWYRAPEVLLQ-------STYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLP  238 (308)
T ss_dssp             CTTTSTTCCCSGGGGCCCSSCCHHHHHT-------SCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred             cccccCCCcccCCccccccccCchHHcC-------CCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence            9987766555566789999999999953       34677899999999999999999999887776666665432100 


Q ss_pred             --------------------------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhccccccCC
Q 004959          568 --------------------------IPDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQ  607 (721)
Q Consensus       568 --------------------------~p~~lS~el~dLI~~cL~~DP~kRPSa~eLL~Hp~f~~~~  607 (721)
                                                ....+++++.+||.+||+.||++|||+.|+|+||||++..
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~~~  304 (308)
T 3g33_A          239 PEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKDE  304 (308)
T ss_dssp             CTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC----
T ss_pred             ChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccCCC
Confidence                                      1135789999999999999999999999999999998643

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=3e-48  Score=425.85  Aligned_cols=258  Identities=23%  Similarity=0.397  Sum_probs=227.6

Q ss_pred             CCCCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeE
Q 004959          338 MNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKF  417 (721)
Q Consensus       338 l~~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~  417 (721)
                      +.+.|++++.||+|+||.||+|.++.+|+.||+|++...     .......+.+|+.+|+.++|||||++++++.+.+.+
T Consensus        49 ~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~-----~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~  123 (387)
T 1kob_A           49 VYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTP-----YPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEM  123 (387)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-----SHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEE
T ss_pred             cccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEeccc-----chhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEE
Confidence            456899999999999999999999999999999998631     233456788999999999999999999999999999


Q ss_pred             EEEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcC--CCceEEeecCCccccCC
Q 004959          418 YIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDA--SGVVKLADFGMAKHLTG  495 (721)
Q Consensus       418 yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~--~g~VKL~DFGlA~~l~~  495 (721)
                      |+|||||.||+|.+++......+++..++.++.||+.||.|||++||+||||||+||||+.  ++.+||+|||++..+..
T Consensus       124 ~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~  203 (387)
T 1kob_A          124 VLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP  203 (387)
T ss_dssp             EEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCT
T ss_pred             EEEEEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecCC
Confidence            9999999999999999766567999999999999999999999999999999999999974  46899999999998766


Q ss_pred             CcccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhcCCCC----CCC
Q 004959          496 QKADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAI----PDS  571 (721)
Q Consensus       496 ~~~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~~~~~----p~~  571 (721)
                      .......+||+.|+|||++.       ...++.++|||||||+||+|++|..||.+....+.+..+......+    ...
T Consensus       204 ~~~~~~~~gt~~y~aPE~~~-------~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~  276 (387)
T 1kob_A          204 DEIVKVTTATAEFAAPEIVD-------REPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSS  276 (387)
T ss_dssp             TSCEEEECSSGGGCCHHHHT-------TCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTT
T ss_pred             CcceeeeccCCCccCchhcc-------CCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccc
Confidence            55545568999999999984       3557889999999999999999999999877777777666554333    356


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHHHHhccccccCC
Q 004959          572 LSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQ  607 (721)
Q Consensus       572 lS~el~dLI~~cL~~DP~kRPSa~eLL~Hp~f~~~~  607 (721)
                      +++++++||.+||+.||++|||+.|+|+||||+...
T Consensus       277 ~s~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~  312 (387)
T 1kob_A          277 VSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDH  312 (387)
T ss_dssp             SCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSCC
T ss_pred             CCHHHHHHHHHHcCCChhHCcCHHHHhhCccccCCc
Confidence            899999999999999999999999999999998754

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=1.2e-48  Score=407.30  Aligned_cols=256  Identities=29%  Similarity=0.535  Sum_probs=213.9

Q ss_pred             CCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeEEE
Q 004959          340 SQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYI  419 (721)
Q Consensus       340 ~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~yL  419 (721)
                      ++|++++.||+|+||.||+|.+ .+|+.||||++......   ....+.+.+|+.+|+.++||||+++++++...+.+|+
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   77 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKED---EGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVL   77 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGG---GCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEE
T ss_pred             ccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccc---cccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEE
Confidence            4799999999999999999998 67999999998643211   1223567899999999999999999999999999999


Q ss_pred             EEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCCc-c
Q 004959          420 YLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQK-A  498 (721)
Q Consensus       420 VmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~~-~  498 (721)
                      ||||+.+ +|.+++....+.+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+.... .
T Consensus        78 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  156 (288)
T 1ob3_A           78 VFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRK  156 (288)
T ss_dssp             EEECCSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC----
T ss_pred             EEEecCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEeECccccccCccccc
Confidence            9999974 9999998766789999999999999999999999999999999999999999999999999998764332 2


Q ss_pred             cccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhcC-------------
Q 004959          499 DLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDT-------------  565 (721)
Q Consensus       499 ~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~~-------------  565 (721)
                      .....||+.|+|||++.+      ...++.++|||||||++|+|++|+.||.+....+.+..+....             
T Consensus       157 ~~~~~~t~~y~aPE~~~~------~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (288)
T 1ob3_A          157 YTHEIVTLWYRAPDVLMG------SKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTE  230 (288)
T ss_dssp             -----CCCTTCCHHHHTT------CCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGG
T ss_pred             cccccccccccCchheeC------CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhc
Confidence            234579999999999852      2356789999999999999999999998876666555543210             


Q ss_pred             -C---------------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhccccccC
Q 004959          566 -P---------------AIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNS  606 (721)
Q Consensus       566 -~---------------~~p~~lS~el~dLI~~cL~~DP~kRPSa~eLL~Hp~f~~~  606 (721)
                       +               .+...+++++.+||++||+.||++|||++|+|+||||++.
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~  287 (288)
T 1ob3_A          231 LPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKEN  287 (288)
T ss_dssp             STTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC-
T ss_pred             ccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhc
Confidence             0               1124578999999999999999999999999999999853

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=7.9e-48  Score=403.93  Aligned_cols=260  Identities=27%  Similarity=0.517  Sum_probs=215.6

Q ss_pred             CCCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeEE
Q 004959          339 NSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFY  418 (721)
Q Consensus       339 ~~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~y  418 (721)
                      .++|++++.||+|+||.||+|.+..+|+.||||++..   ........+.+.+|+.+|++++||||+++++++...+..+
T Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~---~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   78 (311)
T 4agu_A            2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLE---SEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLH   78 (311)
T ss_dssp             -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC---CCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred             cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeec---cccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEE
Confidence            3689999999999999999999999999999998853   2334455678889999999999999999999999999999


Q ss_pred             EEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCCcc
Q 004959          419 IYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKA  498 (721)
Q Consensus       419 LVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~~~  498 (721)
                      +||||+.+++|.+++... ..+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+.....
T Consensus        79 lv~e~~~~~~l~~~~~~~-~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  157 (311)
T 4agu_A           79 LVFEYCDHTVLHELDRYQ-RGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSD  157 (311)
T ss_dssp             EEEECCSEEHHHHHHHTS-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC----
T ss_pred             EEEEeCCCchHHHHHhhh-cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCccc
Confidence            999999999998887654 6799999999999999999999999999999999999999999999999999987654332


Q ss_pred             -cccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhcC------------
Q 004959          499 -DLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDT------------  565 (721)
Q Consensus       499 -~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~~------------  565 (721)
                       ....+||+.|+|||++.+      ...++.++|||||||++|+|++|..||.+....+....+....            
T Consensus       158 ~~~~~~~~~~y~aPE~~~~------~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (311)
T 4agu_A          158 YYDDEVATRWYRSPELLVG------DTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFS  231 (311)
T ss_dssp             --------GGGCCHHHHHT------CSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHH
T ss_pred             ccCCCcCCccccChHHHhc------CCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccc
Confidence             234679999999999953      2456789999999999999999999998876655544332210            


Q ss_pred             -------CCC------------CCCCCHHHHHHHHHhcccCCCCCCCHHHHHhccccccCCC
Q 004959          566 -------PAI------------PDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQ  608 (721)
Q Consensus       566 -------~~~------------p~~lS~el~dLI~~cL~~DP~kRPSa~eLL~Hp~f~~~~~  608 (721)
                             ...            ...++.++.+||.+||+.||++|||++|+|+||||++...
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~  293 (311)
T 4agu_A          232 TNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIRE  293 (311)
T ss_dssp             TCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTTCC-
T ss_pred             cccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHhccC
Confidence                   001            1357899999999999999999999999999999997643

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.3e-48  Score=408.51  Aligned_cols=260  Identities=29%  Similarity=0.471  Sum_probs=215.3

Q ss_pred             CCCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCc---------------------ccHHHHHHHHHHHHHHH
Q 004959          339 NSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDP---------------------KSAESIKQLEQEIKVLS  397 (721)
Q Consensus       339 ~~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~---------------------~~~~~~k~~~~Ei~iL~  397 (721)
                      .++|++++.||+|+||.||+|++..+|+.||||++.......                     ......+.+.+|+.+|+
T Consensus        12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~   91 (298)
T 2zv2_A           12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK   91 (298)
T ss_dssp             ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred             ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence            368999999999999999999999999999999986432110                     01123467899999999


Q ss_pred             hCCCCCeeeeeeeEEe--cCeEEEEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEE
Q 004959          398 HLKHPNIVQYYGSEIV--EDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLL  475 (721)
Q Consensus       398 ~L~HPnIV~l~g~~~~--~~~~yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNIL  475 (721)
                      +++||||+++++++.+  .+.+|+||||+.+++|.+++.  ...+++..++.++.||+.||.|||++||+||||||+|||
T Consensus        92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil  169 (298)
T 2zv2_A           92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT--LKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLL  169 (298)
T ss_dssp             TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC--SSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEE
T ss_pred             hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEE
Confidence            9999999999999887  568999999999999987653  357999999999999999999999999999999999999


Q ss_pred             EcCCCceEEeecCCccccCCCcc-cccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhh
Q 004959          476 VDASGVVKLADFGMAKHLTGQKA-DLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEG  554 (721)
Q Consensus       476 ld~~g~VKL~DFGlA~~l~~~~~-~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~  554 (721)
                      |+.++.+||+|||++..+..... .....||+.|+|||++.+.    ....++.++|||||||++|+|++|..||.....
T Consensus       170 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~  245 (298)
T 2zv2_A          170 VGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSET----RKIFSGKALDVWAMGVTLYCFVFGQCPFMDERI  245 (298)
T ss_dssp             ECTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTT----CCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred             ECCCCCEEEecCCCccccccccccccCCcCCccccChhhhccC----CCCCCCchhhhHhHHHHHHHHHHCCCCCCCccH
Confidence            99999999999999987654432 2446799999999998431    111246789999999999999999999988766


Q ss_pred             HHHHHHHhhcCCCCC--CCCCHHHHHHHHHhcccCCCCCCCHHHHHhccccc
Q 004959          555 AAAMFKVMRDTPAIP--DSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLK  604 (721)
Q Consensus       555 ~~~~~ki~~~~~~~p--~~lS~el~dLI~~cL~~DP~kRPSa~eLL~Hp~f~  604 (721)
                      ......+......++  ..+++++.+||.+||+.||++||++.|+++||||+
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~~~  297 (298)
T 2zv2_A          246 MCLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVT  297 (298)
T ss_dssp             HHHHHHHHHCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCHHHH
T ss_pred             HHHHHHHhcccCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhcCcccc
Confidence            666666555544444  46899999999999999999999999999999996

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=2.9e-48  Score=422.98  Aligned_cols=254  Identities=23%  Similarity=0.405  Sum_probs=220.5

Q ss_pred             CeeE--eeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeEE
Q 004959          341 QWQK--GKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFY  418 (721)
Q Consensus       341 ~y~~--~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~y  418 (721)
                      .|++  .+.||+|+||.||+|.+..+|+.||+|++..     ......+.+.+|+.+|++++|||||++++++...+.+|
T Consensus        88 ~~~~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~-----~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  162 (373)
T 2x4f_A           88 FYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKT-----RGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIV  162 (373)
T ss_dssp             TEEEEEEEECC-----CEEEEEETTTCCEEEEEEEEC-----CSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred             ceeeecceEEecCcCEEEEEEEEcCCCcEEEEEEEcc-----cccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEE
Confidence            4544  6789999999999999999999999999863     22345678899999999999999999999999999999


Q ss_pred             EEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEE--cCCCceEEeecCCccccCCC
Q 004959          419 IYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLV--DASGVVKLADFGMAKHLTGQ  496 (721)
Q Consensus       419 LVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILl--d~~g~VKL~DFGlA~~l~~~  496 (721)
                      |||||++|++|.+++......+++..++.++.||+.||.|||++||+||||||+||||  +.++.+||+|||+++.+...
T Consensus       163 lv~E~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~  242 (373)
T 2x4f_A          163 LVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPR  242 (373)
T ss_dssp             EEEECCTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTT
T ss_pred             EEEeCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCc
Confidence            9999999999999997766679999999999999999999999999999999999999  56779999999999987666


Q ss_pred             cccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhcCCCCC----CCC
Q 004959          497 KADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIP----DSL  572 (721)
Q Consensus       497 ~~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~~~~~p----~~l  572 (721)
                      ......+||+.|+|||++.       ...++.++|||||||+||||++|..||.+....+.+..+......++    ..+
T Consensus       243 ~~~~~~~gt~~y~aPE~~~-------~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  315 (373)
T 2x4f_A          243 EKLKVNFGTPEFLAPEVVN-------YDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDI  315 (373)
T ss_dssp             CBCCCCCSSCTTCCHHHHT-------TCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSCSGGGTTS
T ss_pred             cccccccCCCcEeChhhcc-------CCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCChhhhccC
Confidence            5555678999999999983       35678899999999999999999999998887777777776554433    468


Q ss_pred             CHHHHHHHHHhcccCCCCCCCHHHHHhccccccC
Q 004959          573 SPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNS  606 (721)
Q Consensus       573 S~el~dLI~~cL~~DP~kRPSa~eLL~Hp~f~~~  606 (721)
                      ++++++||.+||+.||++||++.|+|+||||.+.
T Consensus       316 ~~~~~~li~~~L~~dp~~Rps~~e~l~hp~~~~~  349 (373)
T 2x4f_A          316 SEEAKEFISKLLIKEKSWRISASEALKHPWLSDH  349 (373)
T ss_dssp             CHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHCH
T ss_pred             CHHHHHHHHHHcCCChhhCCCHHHHhcCcCcCCC
Confidence            9999999999999999999999999999999853

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=3e-48  Score=411.33  Aligned_cols=260  Identities=30%  Similarity=0.521  Sum_probs=206.5

Q ss_pred             CCCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeEE
Q 004959          339 NSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFY  418 (721)
Q Consensus       339 ~~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~y  418 (721)
                      .++|++++.||+|+||.||+|.++.+|+.||||++.......    ..+.+.+|+.+|++++|||||++++++..++.+|
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~----~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~   79 (317)
T 2pmi_A            4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEG----TPSTAIREISLMKELKHENIVRLYDVIHTENKLT   79 (317)
T ss_dssp             ---------------CEEEEEECSSSCCEEEEEEEECCSTTC----SCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEE
T ss_pred             ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccc----cHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEE
Confidence            358999999999999999999999999999999987432221    2346788999999999999999999999999999


Q ss_pred             EEEeeccCCCHHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCcccc
Q 004959          419 IYLEYVHPGSINKYVREHC-----GAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHL  493 (721)
Q Consensus       419 LVmEy~~gGsL~~~L~~~~-----~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l  493 (721)
                      |||||+. |+|.+++....     ..+++..++.++.||+.||.|||++||+||||||+||||+.+|.+||+|||++..+
T Consensus        80 lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~  158 (317)
T 2pmi_A           80 LVFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAF  158 (317)
T ss_dssp             EEEECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCSSCEET
T ss_pred             EEEEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCCEEECcCccceec
Confidence            9999998 69999987643     45899999999999999999999999999999999999999999999999999876


Q ss_pred             CCCc-ccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhcC-------
Q 004959          494 TGQK-ADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDT-------  565 (721)
Q Consensus       494 ~~~~-~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~~-------  565 (721)
                      .... .....+||+.|+|||++.+      ...++.++|||||||++|+|++|+.||.+....+.+..+....       
T Consensus       159 ~~~~~~~~~~~~t~~y~aPE~~~~------~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  232 (317)
T 2pmi_A          159 GIPVNTFSSEVVTLWYRAPDVLMG------SRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESL  232 (317)
T ss_dssp             TSCCCCCCCCCSCCTTCCHHHHTT------CCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTT
T ss_pred             CCCcccCCCCcccccccCchHhhC------CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhH
Confidence            5332 2345679999999999852      2356789999999999999999999998876666555443210       


Q ss_pred             ---------------------------CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhccccccCCCC
Q 004959          566 ---------------------------PAIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQP  609 (721)
Q Consensus       566 ---------------------------~~~p~~lS~el~dLI~~cL~~DP~kRPSa~eLL~Hp~f~~~~~~  609 (721)
                                                 ...+..++.++.+||.+||+.||++|||+.|+|+||||++....
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~  303 (317)
T 2pmi_A          233 WPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEYYHH  303 (317)
T ss_dssp             CGGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCC-
T ss_pred             hhhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhcccch
Confidence                                       01123578999999999999999999999999999999976543

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=8.4e-48  Score=417.88  Aligned_cols=293  Identities=23%  Similarity=0.413  Sum_probs=226.5

Q ss_pred             CCCCCCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecC
Q 004959          336 LPMNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVED  415 (721)
Q Consensus       336 ~~l~~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~  415 (721)
                      ..+...|++++.||+|+||.||+|.+..+|+.||||++..   ........+++.+|+.+|+.++||||+++++++...+
T Consensus        21 ~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~---~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~   97 (367)
T 1cm8_A           21 WEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYR---PFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDE   97 (367)
T ss_dssp             ECCBSSEEEEEEC------CEEEEEETTTCCEEEEEECSS---TTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCS
T ss_pred             eeecceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCc---cccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCC
Confidence            3455789999999999999999999999999999998853   2234556778999999999999999999999987653


Q ss_pred             ------eEEEEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCC
Q 004959          416 ------KFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGM  489 (721)
Q Consensus       416 ------~~yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGl  489 (721)
                            .+|+||||+ +++|.+++..  +.+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+
T Consensus        98 ~~~~~~~~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~  174 (367)
T 1cm8_A           98 TLDDFTDFYLVMPFM-GTDLGKLMKH--EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGL  174 (367)
T ss_dssp             STTTCCCCEEEEECC-SEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred             ccccCceEEEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCCEEEEeeec
Confidence                  469999999 8899999875  5799999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCCcccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhcC----
Q 004959          490 AKHLTGQKADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDT----  565 (721)
Q Consensus       490 A~~l~~~~~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~~----  565 (721)
                      ++.....  ....+||+.|+|||++.+      ...++.++||||||||+|||++|+.||.+.+..+.+..+....    
T Consensus       175 a~~~~~~--~~~~~~t~~y~aPE~~~~------~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~  246 (367)
T 1cm8_A          175 ARQADSE--MTGYVVTRWYRAPEVILN------WMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPP  246 (367)
T ss_dssp             CEECCSS--CCSSCSCGGGCCTHHHHT------TTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCC
T ss_pred             ccccccc--cCcCcCCCCcCCHHHHhC------CCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence            9876432  345679999999999863      2457778999999999999999999998876666555543211    


Q ss_pred             ---------------------------CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhccccccCCCCCCCCccccc
Q 004959          566 ---------------------------PAIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQPDVPSCSLSF  618 (721)
Q Consensus       566 ---------------------------~~~p~~lS~el~dLI~~cL~~DP~kRPSa~eLL~Hp~f~~~~~~~~~~~~~~~  618 (721)
                                                 ..+...+++++.+||.+||+.||++|||++|+|+||||+....+........+
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~~~~~~~~~~~~  326 (367)
T 1cm8_A          247 AEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTEDEPQVQKY  326 (367)
T ss_dssp             HHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC------CCCCC
T ss_pred             HHHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhcCCccCCCCCCC
Confidence                                       11234679999999999999999999999999999999987655433221111


Q ss_pred             CCCCCCCCCCChhHHHhhhHHHHHh
Q 004959          619 SGMQLTEKPHSPREKADAKYDQVAA  643 (721)
Q Consensus       619 ~~~~l~~~~~~~~~~~~~~~d~~~~  643 (721)
                       ...+.+......+..+..++++..
T Consensus       327 -~~~~~~~~~~~~~~~~~~~~~~~~  350 (367)
T 1cm8_A          327 -DDSFDDVDRTLDEWKRVTYKEVLS  350 (367)
T ss_dssp             -CCC-----CCHHHHHHHHHHHHHT
T ss_pred             -CCChhhhcCCHHHHHHHHHHHHHH
Confidence             122233333444555566666554

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=1.2e-47  Score=395.95  Aligned_cols=255  Identities=27%  Similarity=0.499  Sum_probs=228.2

Q ss_pred             CCCCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeE
Q 004959          338 MNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKF  417 (721)
Q Consensus       338 l~~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~  417 (721)
                      +.++|++.+.||+|+||.||+|.+..++..||+|++......     ..+.+.+|+.+|+.++||||+++++++.+.+..
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~-----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   81 (277)
T 3f3z_A            7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVE-----DVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDI   81 (277)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCS-----CHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred             hhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccc-----hHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeE
Confidence            446799999999999999999999999999999998643211     246788999999999999999999999999999


Q ss_pred             EEEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEE---cCCCceEEeecCCccccC
Q 004959          418 YIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLV---DASGVVKLADFGMAKHLT  494 (721)
Q Consensus       418 yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILl---d~~g~VKL~DFGlA~~l~  494 (721)
                      |+||||+.|++|.+++... ..+++..++.++.||+.||.|||++||+||||||+||||   +.++.+||+|||++..+.
T Consensus        82 ~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~  160 (277)
T 3f3z_A           82 YLVMELCTGGELFERVVHK-RVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK  160 (277)
T ss_dssp             EEEEECCCSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred             EEEEeccCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceecc
Confidence            9999999999999999765 679999999999999999999999999999999999999   778899999999998877


Q ss_pred             CCcccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhcCCCCCC----
Q 004959          495 GQKADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPD----  570 (721)
Q Consensus       495 ~~~~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~~~~~p~----  570 (721)
                      .........||+.|+|||++.+        .++.++|||||||++|+|++|+.||......+....+.......+.    
T Consensus       161 ~~~~~~~~~~t~~y~aPE~~~~--------~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (277)
T 3f3z_A          161 PGKMMRTKVGTPYYVSPQVLEG--------LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWL  232 (277)
T ss_dssp             TTSCBCCCCSCTTTCCHHHHTT--------CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHHT
T ss_pred             CccchhccCCCCCccChHHhcc--------cCCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCchhhh
Confidence            6666666789999999999842        2677899999999999999999999988777777777777666554    


Q ss_pred             CCCHHHHHHHHHhcccCCCCCCCHHHHHhccccccC
Q 004959          571 SLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNS  606 (721)
Q Consensus       571 ~lS~el~dLI~~cL~~DP~kRPSa~eLL~Hp~f~~~  606 (721)
                      .+++++.+||.+||+.||++||++.++|+||||++.
T Consensus       233 ~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~  268 (277)
T 3f3z_A          233 NVSPQAESLIRRLLTKSPKQRITSLQALEHEWFEKQ  268 (277)
T ss_dssp             TSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHHH
T ss_pred             cCCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhcc
Confidence            689999999999999999999999999999999864

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=2e-48  Score=438.81  Aligned_cols=260  Identities=28%  Similarity=0.480  Sum_probs=232.3

Q ss_pred             CCCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeEE
Q 004959          339 NSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFY  418 (721)
Q Consensus       339 ~~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~y  418 (721)
                      .++|++++.||+|+||.||+|++..+|+.||||++....  ....+..+.+.+|+.+|+.++||||+++++++.+.+.+|
T Consensus        15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~--~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~   92 (476)
T 2y94_A           15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQK--IRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIF   92 (476)
T ss_dssp             ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHH--HHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred             ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhh--ccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence            468999999999999999999999999999999986311  011123567899999999999999999999999999999


Q ss_pred             EEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCCcc
Q 004959          419 IYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKA  498 (721)
Q Consensus       419 LVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~~~  498 (721)
                      +||||+.||+|.+++... +.+++.+++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+.....
T Consensus        93 lv~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~~  171 (476)
T 2y94_A           93 MVMEYVSGGELFDYICKN-GRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF  171 (476)
T ss_dssp             EEEECCSSEEHHHHTTSS-SSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCEEECCCSSCEECCTTCC
T ss_pred             EEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCCeEEEeccchhhcccccc
Confidence            999999999999999754 6799999999999999999999999999999999999999999999999999998766655


Q ss_pred             cccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhcCCCCCCCCCHHHHH
Q 004959          499 DLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDSLSPEGKD  578 (721)
Q Consensus       499 ~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~~~~~p~~lS~el~d  578 (721)
                      ....+||+.|+|||++.+      ....+.++|||||||++|+|++|..||.+......+.++.......|..+++++.+
T Consensus       172 ~~~~~gt~~y~aPE~~~~------~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~  245 (476)
T 2y94_A          172 LRTSCGSPNYAAPEVISG------RLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYTPQYLNPSVIS  245 (476)
T ss_dssp             BCCCCSCSTTCCHHHHTT------CCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTCCCCCTTCCHHHHH
T ss_pred             ccccCCCcCeEChhhccC------CCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCcCCCccCCHHHHH
Confidence            567889999999999953      12236789999999999999999999998877778888888877888899999999


Q ss_pred             HHHHhcccCCCCCCCHHHHHhccccccCC
Q 004959          579 FLRCCFQRNPADRPPASLLLEHRFLKNSQ  607 (721)
Q Consensus       579 LI~~cL~~DP~kRPSa~eLL~Hp~f~~~~  607 (721)
                      ||++||+.||++|||+.|+++||||+...
T Consensus       246 Li~~~L~~dP~~Rpt~~eil~hp~~~~~~  274 (476)
T 2y94_A          246 LLKHMLQVDPMKRATIKDIREHEWFKQDL  274 (476)
T ss_dssp             HHHHHTCSSTTTSCCHHHHHTCHHHHTTC
T ss_pred             HHHHHcCCCchhCcCHHHHHhCHHhhhcC
Confidence            99999999999999999999999998653

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=2.2e-48  Score=402.46  Aligned_cols=258  Identities=29%  Similarity=0.543  Sum_probs=225.3

Q ss_pred             CCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeEEE
Q 004959          340 SQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYI  419 (721)
Q Consensus       340 ~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~yL  419 (721)
                      ++|++++.||+|+||.||+|.+..+++.||||++....  .......+.+.+|+.++++++||||+++++++.+.+..|+
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   86 (279)
T 3fdn_A            9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQ--LEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL   86 (279)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHH--HHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred             ccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccc--cchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEE
Confidence            58999999999999999999999999999999985311  1111224678899999999999999999999999999999


Q ss_pred             EEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCCccc
Q 004959          420 YLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKAD  499 (721)
Q Consensus       420 VmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~~~~  499 (721)
                      ||||+.+++|.+++... ..+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++...... ..
T Consensus        87 v~e~~~~~~l~~~l~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~-~~  164 (279)
T 3fdn_A           87 ILEYAPLGTVYRELQKL-SKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS-RR  164 (279)
T ss_dssp             EECCCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCEEECSCCEESCC------
T ss_pred             EEecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCCEEEEeccccccCCcc-cc
Confidence            99999999999999765 67999999999999999999999999999999999999999999999999998654433 23


Q ss_pred             ccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhcCCCCCCCCCHHHHHH
Q 004959          500 LSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDSLSPEGKDF  579 (721)
Q Consensus       500 ~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~~~~~p~~lS~el~dL  579 (721)
                      ....||+.|+|||++.       ...++.++|||||||++|+|++|..||......+....+......++..+++++.+|
T Consensus       165 ~~~~~~~~y~aPE~~~-------~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  237 (279)
T 3fdn_A          165 TDLCGTLDYLPPEMIE-------GRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDL  237 (279)
T ss_dssp             ---CCCCTTCCHHHHT-------TCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCTTSCHHHHHH
T ss_pred             cccCCCCCccCHhHhc-------cCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCCCCCCCcCCHHHHHH
Confidence            4567999999999984       345677899999999999999999999988877777777777778889999999999


Q ss_pred             HHHhcccCCCCCCCHHHHHhccccccCCC
Q 004959          580 LRCCFQRNPADRPPASLLLEHRFLKNSQQ  608 (721)
Q Consensus       580 I~~cL~~DP~kRPSa~eLL~Hp~f~~~~~  608 (721)
                      |.+||+.||++||++.|+|+||||+....
T Consensus       238 i~~~l~~~p~~Rps~~e~l~h~~~~~~~~  266 (279)
T 3fdn_A          238 ISRLLKHNPSQRPMLREVLEHPWITANSS  266 (279)
T ss_dssp             HHHHCCSSGGGSCCHHHHHHCHHHHHHCS
T ss_pred             HHHHhccChhhCCCHHHHhhCccccCCcc
Confidence            99999999999999999999999987543

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=1.8e-47  Score=398.61  Aligned_cols=263  Identities=26%  Similarity=0.497  Sum_probs=234.1

Q ss_pred             CCCCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeE
Q 004959          338 MNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKF  417 (721)
Q Consensus       338 l~~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~  417 (721)
                      ...+|++++.||+|+||.||+|.+..+|+.||+|++...  ........+.+.+|+.+++.+.||||+++++++.+.+..
T Consensus        13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~--~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~   90 (294)
T 2rku_A           13 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKS--LLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFV   90 (294)
T ss_dssp             TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGG--GCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred             cccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechh--hccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEE
Confidence            346899999999999999999999999999999998642  122345667889999999999999999999999999999


Q ss_pred             EEEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCCc
Q 004959          418 YIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQK  497 (721)
Q Consensus       418 yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~~  497 (721)
                      |+||||+.+++|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus        91 ~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~  169 (294)
T 2rku_A           91 FVVLELCRRRSLLELHKRR-KALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG  169 (294)
T ss_dssp             EEEEECCTTCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred             EEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCCEEEEeccCceecccCc
Confidence            9999999999999998765 689999999999999999999999999999999999999999999999999998765332


Q ss_pred             -ccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhcCCCCCCCCCHHH
Q 004959          498 -ADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDSLSPEG  576 (721)
Q Consensus       498 -~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~~~~~p~~lS~el  576 (721)
                       ......||+.|+|||++.       ...++.++|||||||++|+|++|+.||......+....+......++..++.++
T Consensus       170 ~~~~~~~~~~~y~aPE~~~-------~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (294)
T 2rku_A          170 ERKKVLCGTPNYIAPEVLS-------KKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVA  242 (294)
T ss_dssp             CCBCCCCSCCSSCCHHHHT-------TSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCTTSCHHH
T ss_pred             cccccccCCCCcCCcchhc-------cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhccCCCccccCHHH
Confidence             234467999999999984       345677999999999999999999999987777777777777778888999999


Q ss_pred             HHHHHHhcccCCCCCCCHHHHHhccccccCCCCC
Q 004959          577 KDFLRCCFQRNPADRPPASLLLEHRFLKNSQQPD  610 (721)
Q Consensus       577 ~dLI~~cL~~DP~kRPSa~eLL~Hp~f~~~~~~~  610 (721)
                      .+||.+||+.||++||+++|+++||||.....+.
T Consensus       243 ~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~~~~  276 (294)
T 2rku_A          243 ASLIQKMLQTDPTARPTINELLNDEFFTSGYIPA  276 (294)
T ss_dssp             HHHHHHHTCSSGGGSCCGGGGGGSHHHHTSCCCS
T ss_pred             HHHHHHHcccChhhCcCHHHHhhChheecCCcCC
Confidence            9999999999999999999999999999876654

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=3.4e-48  Score=426.30  Aligned_cols=254  Identities=24%  Similarity=0.407  Sum_probs=206.6

Q ss_pred             CCCCCeeEe-eEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHH-HhCCCCCeeeeeeeEEe-
Q 004959          337 PMNSQWQKG-KLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVL-SHLKHPNIVQYYGSEIV-  413 (721)
Q Consensus       337 ~l~~~y~~~-k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL-~~L~HPnIV~l~g~~~~-  413 (721)
                      .+.++|.+. ++||+|+||+||+|.++.+|+.||||++..      .    ..+.+|+.++ +.++|||||++++++.. 
T Consensus        58 ~~~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~------~----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~  127 (400)
T 1nxk_A           58 AIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD------C----PKARREVELHWRASQCPHIVRIVDVYENL  127 (400)
T ss_dssp             CGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC------S----HHHHHHHHHHHHHTTSTTBCCEEEEEEEE
T ss_pred             cccccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCc------c----hhHHHHHHHHHHhcCCCCcceEeEEEeec
Confidence            344578876 799999999999999999999999999852      1    3567888887 45589999999999876 


Q ss_pred             ---cCeEEEEEeeccCCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcC---CCceEEee
Q 004959          414 ---EDKFYIYLEYVHPGSINKYVREHC-GAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDA---SGVVKLAD  486 (721)
Q Consensus       414 ---~~~~yLVmEy~~gGsL~~~L~~~~-~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~---~g~VKL~D  486 (721)
                         .+.+|||||||.||+|.+++.... ..+++.+++.|+.||+.||.|||++||+||||||+||||+.   ++.+||+|
T Consensus       128 ~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~D  207 (400)
T 1nxk_A          128 YAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTD  207 (400)
T ss_dssp             ETTEEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECC
T ss_pred             ccCCcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEe
Confidence               667999999999999999997642 46999999999999999999999999999999999999987   78999999


Q ss_pred             cCCccccCCCcccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHH----HHHHHh
Q 004959          487 FGMAKHLTGQKADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAA----AMFKVM  562 (721)
Q Consensus       487 FGlA~~l~~~~~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~----~~~ki~  562 (721)
                      ||+++...........+||+.|+|||++       ....++.++||||||||||+|++|+.||.+.....    ....+.
T Consensus       208 FG~a~~~~~~~~~~~~~gt~~y~aPE~~-------~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~  280 (400)
T 1nxk_A          208 FGFAKETTSHNSLTTPCYTPYYVAPEVL-------GPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIR  280 (400)
T ss_dssp             CTTCEECC-----------CTTCCGGGS-------CCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHH
T ss_pred             cccccccCCCCccccCCCCCCccCHhhc-------CCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHH
Confidence            9999877655555677899999999998       34567889999999999999999999997644321    233333


Q ss_pred             hcCCCCC----CCCCHHHHHHHHHhcccCCCCCCCHHHHHhccccccCC
Q 004959          563 RDTPAIP----DSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQ  607 (721)
Q Consensus       563 ~~~~~~p----~~lS~el~dLI~~cL~~DP~kRPSa~eLL~Hp~f~~~~  607 (721)
                      .....++    ..++.++++||++||+.||++|||+.|+|+||||....
T Consensus       281 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~  329 (400)
T 1nxk_A          281 MGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST  329 (400)
T ss_dssp             HTCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHTTT
T ss_pred             cCcccCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccCCC
Confidence            3333333    56899999999999999999999999999999998654

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=1.4e-47  Score=409.26  Aligned_cols=263  Identities=26%  Similarity=0.497  Sum_probs=234.1

Q ss_pred             CCCCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeE
Q 004959          338 MNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKF  417 (721)
Q Consensus       338 l~~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~  417 (721)
                      ...+|++++.||+|+||.||+|.+..+++.||+|++...  ........+.+.+|+.+++.++||||+++++++.+.+.+
T Consensus        39 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~--~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  116 (335)
T 2owb_A           39 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKS--LLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFV  116 (335)
T ss_dssp             TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGG--GCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred             cCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechh--hhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeE
Confidence            346899999999999999999999999999999998642  122345667889999999999999999999999999999


Q ss_pred             EEEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCCc
Q 004959          418 YIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQK  497 (721)
Q Consensus       418 yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~~  497 (721)
                      |+||||+.+++|.+++... ..+++.+++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+....
T Consensus       117 ~lv~e~~~~~~L~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~  195 (335)
T 2owb_A          117 FVVLELCRRRSLLELHKRR-KALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG  195 (335)
T ss_dssp             EEEECCCTTCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred             EEEEecCCCCCHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCEEEeeccCceecccCc
Confidence            9999999999999998765 689999999999999999999999999999999999999999999999999998765332


Q ss_pred             -ccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhcCCCCCCCCCHHH
Q 004959          498 -ADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDSLSPEG  576 (721)
Q Consensus       498 -~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~~~~~p~~lS~el  576 (721)
                       ......||+.|+|||++.+       ..++.++|||||||++|+|++|+.||......+.+..+......++..++.++
T Consensus       196 ~~~~~~~gt~~y~aPE~~~~-------~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  268 (335)
T 2owb_A          196 ERKKVLCGTPNYIAPEVLSK-------KGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVA  268 (335)
T ss_dssp             CCBCCCCSCCSSCCHHHHHT-------SCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCTTSCHHH
T ss_pred             ccccccCCCccccCHHHhcc-------CCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcCCCCCCccCCHHH
Confidence             3345679999999999953       34677899999999999999999999987777777777777778888999999


Q ss_pred             HHHHHHhcccCCCCCCCHHHHHhccccccCCCCC
Q 004959          577 KDFLRCCFQRNPADRPPASLLLEHRFLKNSQQPD  610 (721)
Q Consensus       577 ~dLI~~cL~~DP~kRPSa~eLL~Hp~f~~~~~~~  610 (721)
                      .+||++||+.||++||++.|+|+|+||.....+.
T Consensus       269 ~~li~~~l~~dp~~Rps~~ell~~~~~~~~~~~~  302 (335)
T 2owb_A          269 ASLIQKMLQTDPTARPTINELLNDEFFTSGYIPA  302 (335)
T ss_dssp             HHHHHHHTCSSGGGSCCGGGGGGSHHHHTSCCCS
T ss_pred             HHHHHHHccCChhHCcCHHHHhcCccccCCCccc
Confidence            9999999999999999999999999999876553

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=2.6e-48  Score=413.88  Aligned_cols=259  Identities=24%  Similarity=0.457  Sum_probs=210.5

Q ss_pred             CCCCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeE
Q 004959          338 MNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKF  417 (721)
Q Consensus       338 l~~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~  417 (721)
                      ..++|++++.||+|+||.||+|.+..+|+.||||++...   .......+.+.+|+.+|++++|||||++++++.+.+.+
T Consensus        32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  108 (329)
T 3gbz_A           32 SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLE---HEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRL  108 (329)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCC---C--------CHHHHHHGGGCCCTTBCCEEEEEEETTEE
T ss_pred             chhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEccc---ccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEE
Confidence            346899999999999999999999999999999998642   22333456778999999999999999999999999999


Q ss_pred             EEEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEc-----CCCceEEeecCCccc
Q 004959          418 YIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVD-----ASGVVKLADFGMAKH  492 (721)
Q Consensus       418 yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld-----~~g~VKL~DFGlA~~  492 (721)
                      ||||||+. |+|.+++... ..+++..++.++.||+.||.|||++||+||||||+||||+     .++.+||+|||++..
T Consensus       109 ~lv~e~~~-~~L~~~~~~~-~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~  186 (329)
T 3gbz_A          109 HLIFEYAE-NDLKKYMDKN-PDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARA  186 (329)
T ss_dssp             EEEEECCS-EEHHHHHHHC-TTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHH
T ss_pred             EEEEecCC-CCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCccc
Confidence            99999997 5999999765 6799999999999999999999999999999999999994     445699999999987


Q ss_pred             cCCCc-ccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhcCCC----
Q 004959          493 LTGQK-ADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPA----  567 (721)
Q Consensus       493 l~~~~-~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~~~~----  567 (721)
                      +.... .....+||+.|+|||++.+      ...++.++|||||||++|+|++|..||.+....+.+.++......    
T Consensus       187 ~~~~~~~~~~~~~t~~y~aPE~~~~------~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~  260 (329)
T 3gbz_A          187 FGIPIRQFTHEIITLWYRPPEILLG------SRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDT  260 (329)
T ss_dssp             HC-----------CCTTCCHHHHTT------CCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTT
T ss_pred             cCCcccccCCCcCCccccCHHHhcC------CCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchh
Confidence            65332 2334578999999999953      234788999999999999999999999887776666665432110    


Q ss_pred             --------------C------------CCCCCHHHHHHHHHhcccCCCCCCCHHHHHhccccccCC
Q 004959          568 --------------I------------PDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQ  607 (721)
Q Consensus       568 --------------~------------p~~lS~el~dLI~~cL~~DP~kRPSa~eLL~Hp~f~~~~  607 (721)
                                    +            +..+++++.+||.+||+.||++|||++|+|+||||++..
T Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  326 (329)
T 3gbz_A          261 TWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHND  326 (329)
T ss_dssp             TSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSSC
T ss_pred             hhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccCCCC
Confidence                          0            011789999999999999999999999999999998753

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=1e-47  Score=400.29  Aligned_cols=256  Identities=27%  Similarity=0.510  Sum_probs=216.3

Q ss_pred             CCCCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeE
Q 004959          338 MNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKF  417 (721)
Q Consensus       338 l~~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~  417 (721)
                      +.+.|++.+.||+|+||.||+|.+..+|+.||+|++......    ...+.+.+|+.+|++++||||+++++++.+.+..
T Consensus        20 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~----~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~   95 (285)
T 3is5_A           20 IDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQ----VPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNM   95 (285)
T ss_dssp             HHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCC----SCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred             hhhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccc----hhHHHHHHHHHHHHhCCCchHHhHHHheecCCeE
Confidence            456899999999999999999999999999999998753211    1246788999999999999999999999999999


Q ss_pred             EEEEeeccCCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEE---cCCCceEEeecCCcc
Q 004959          418 YIYLEYVHPGSINKYVREH---CGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLV---DASGVVKLADFGMAK  491 (721)
Q Consensus       418 yLVmEy~~gGsL~~~L~~~---~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILl---d~~g~VKL~DFGlA~  491 (721)
                      |+||||+.+|+|.+++...   ...+++..++.++.||+.||.|||++||+||||||+||||   +.++.+||+|||++.
T Consensus        96 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~  175 (285)
T 3is5_A           96 YIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAE  175 (285)
T ss_dssp             EEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCC
T ss_pred             EEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeecce
Confidence            9999999999999998543   3679999999999999999999999999999999999999   446789999999998


Q ss_pred             ccCCCcccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhcCCCCC--
Q 004959          492 HLTGQKADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIP--  569 (721)
Q Consensus       492 ~l~~~~~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~~~~~p--  569 (721)
                      .+..........||+.|+|||++.        ..++.++|||||||++|+|++|+.||.+....+....+........  
T Consensus       176 ~~~~~~~~~~~~~t~~y~aPE~~~--------~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~  247 (285)
T 3is5_A          176 LFKSDEHSTNAAGTALYMAPEVFK--------RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVE  247 (285)
T ss_dssp             C----------CTTGGGCCHHHHT--------TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCC-
T ss_pred             ecCCcccCcCcccccCcCChHHhc--------cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCcccccc
Confidence            776655555678999999999983        2467899999999999999999999988776666555554433332  


Q ss_pred             -CCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccccc
Q 004959          570 -DSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKN  605 (721)
Q Consensus       570 -~~lS~el~dLI~~cL~~DP~kRPSa~eLL~Hp~f~~  605 (721)
                       ..+++++.+||.+||+.||++|||+.|+|+||||++
T Consensus       248 ~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~f~~  284 (285)
T 3is5_A          248 CRPLTPQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQ  284 (285)
T ss_dssp             -CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGGC
T ss_pred             cCcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHhhc
Confidence             347999999999999999999999999999999985

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=8.6e-49  Score=437.33  Aligned_cols=266  Identities=23%  Similarity=0.361  Sum_probs=227.0

Q ss_pred             CCCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeEE
Q 004959          339 NSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFY  418 (721)
Q Consensus       339 ~~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~y  418 (721)
                      .++|++++.||+|+||+||+|+++.+|+.||||++.+..  .......+.+.+|+.+|..++|||||++++++.+.+.+|
T Consensus        73 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~  150 (437)
T 4aw2_A           73 REDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWE--MLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLY  150 (437)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHH--HHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEE
T ss_pred             hhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHH--hhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEE
Confidence            468999999999999999999999999999999986310  000011234788999999999999999999999999999


Q ss_pred             EEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCCcc
Q 004959          419 IYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKA  498 (721)
Q Consensus       419 LVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~~~  498 (721)
                      ||||||.||+|.+++....+.+++..++.|+.||+.||.|||++|||||||||+||||+.+|.+||+|||+++.+.....
T Consensus       151 lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~  230 (437)
T 4aw2_A          151 LVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT  230 (437)
T ss_dssp             EEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSC
T ss_pred             EEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCCEEEcchhhhhhcccCCC
Confidence            99999999999999987667899999999999999999999999999999999999999999999999999987654433


Q ss_pred             --cccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhc--CCCCC---CC
Q 004959          499 --DLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRD--TPAIP---DS  571 (721)
Q Consensus       499 --~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~--~~~~p---~~  571 (721)
                        ....+||+.|||||++.....  ....++.++|||||||+||||++|+.||.+....+.+.+++..  ...+|   ..
T Consensus       231 ~~~~~~~GT~~Y~APE~l~~~~~--~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~  308 (437)
T 4aw2_A          231 VQSSVAVGTPDYISPEILQAMEG--GKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQVTD  308 (437)
T ss_dssp             EECCSCCSCGGGCCHHHHHHHHT--SCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCSSCCC
T ss_pred             cccccccCCcCeeChHHHhhccc--CCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccccccCCccccc
Confidence              234689999999999974321  1345778999999999999999999999988777777777542  22333   45


Q ss_pred             CCHHHHHHHHHhcccCCCC--CCCHHHHHhccccccCCC
Q 004959          572 LSPEGKDFLRCCFQRNPAD--RPPASLLLEHRFLKNSQQ  608 (721)
Q Consensus       572 lS~el~dLI~~cL~~DP~k--RPSa~eLL~Hp~f~~~~~  608 (721)
                      +++++++||++||+.+|++  |++++|+++||||++...
T Consensus       309 ~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~i~w  347 (437)
T 4aw2_A          309 VSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSGIDW  347 (437)
T ss_dssp             SCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTTCCT
T ss_pred             CCHHHHHHHHHHhcccccccCCCCHHHHhCCCccCCCCH
Confidence            8999999999999999988  999999999999987543

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=1.3e-47  Score=406.20  Aligned_cols=261  Identities=23%  Similarity=0.391  Sum_probs=228.1

Q ss_pred             CCCCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcc-cHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCe
Q 004959          338 MNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPK-SAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDK  416 (721)
Q Consensus       338 l~~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~-~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~  416 (721)
                      +.+.|++++.||+|+||.||+|.+..+|+.||||++........ .....+.+.+|+.+|+.+.||||+++++++.+.+.
T Consensus        10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   89 (321)
T 2a2a_A           10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTD   89 (321)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred             hhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCE
Confidence            34679999999999999999999999999999999875322211 11124678899999999999999999999999999


Q ss_pred             EEEEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCC----ceEEeecCCccc
Q 004959          417 FYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASG----VVKLADFGMAKH  492 (721)
Q Consensus       417 ~yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g----~VKL~DFGlA~~  492 (721)
                      .|+||||+.|++|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++.++    .+||+|||++..
T Consensus        90 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~  168 (321)
T 2a2a_A           90 VVLILELVSGGELFDFLAQK-ESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE  168 (321)
T ss_dssp             EEEEECCCCSCBHHHHHHTC-SCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTCEE
T ss_pred             EEEEEEcCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCcccee
Confidence            99999999999999999764 6799999999999999999999999999999999999999887    799999999988


Q ss_pred             cCCCcccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhcCCCCC---
Q 004959          493 LTGQKADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIP---  569 (721)
Q Consensus       493 l~~~~~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~~~~~p---  569 (721)
                      +..........||+.|+|||++.       ...++.++|||||||++|+|++|..||.+....+.+..+......++   
T Consensus       169 ~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  241 (321)
T 2a2a_A          169 IEDGVEFKNIFGTPEFVAPEIVN-------YEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEF  241 (321)
T ss_dssp             CCTTCCCCCCCSCGGGCCHHHHT-------TCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHH
T ss_pred             cCccccccccCCCCCccCccccc-------CCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccccChhh
Confidence            76655555677999999999984       34577899999999999999999999988777777777666554443   


Q ss_pred             -CCCCHHHHHHHHHhcccCCCCCCCHHHHHhccccccC
Q 004959          570 -DSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNS  606 (721)
Q Consensus       570 -~~lS~el~dLI~~cL~~DP~kRPSa~eLL~Hp~f~~~  606 (721)
                       ..++.++.+||.+||+.||++|||+.|+|+||||...
T Consensus       242 ~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~hp~~~~~  279 (321)
T 2a2a_A          242 FSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPV  279 (321)
T ss_dssp             HTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHSTTTSCS
T ss_pred             hcccCHHHHHHHHHHcCCChhhCcCHHHHhcCccccCC
Confidence             5689999999999999999999999999999999754

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=3.5e-47  Score=410.61  Aligned_cols=262  Identities=23%  Similarity=0.412  Sum_probs=221.1

Q ss_pred             CCCCCCCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEec
Q 004959          335 PLPMNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVE  414 (721)
Q Consensus       335 ~~~l~~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~  414 (721)
                      ...+..+|++++.||+|+||.||+|.+..+|+.||||++..    .......+.+.+|+.+|++++||||+++++++...
T Consensus        22 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~----~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~   97 (364)
T 3qyz_A           22 VFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISP----FEHQTYCQRTLREIKILLRFRHENIIGINDIIRAP   97 (364)
T ss_dssp             BCCCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC----TTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCS
T ss_pred             eccccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEecc----ccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecC
Confidence            34556799999999999999999999999999999999853    23445567889999999999999999999998765


Q ss_pred             -----CeEEEEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCC
Q 004959          415 -----DKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGM  489 (721)
Q Consensus       415 -----~~~yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGl  489 (721)
                           ...|+||||+. |+|.+++..  +.+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+
T Consensus        98 ~~~~~~~~~iv~e~~~-~~L~~~l~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~  174 (364)
T 3qyz_A           98 TIEQMKDVYIVQDLME-TDLYKLLKT--QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGL  174 (364)
T ss_dssp             STTTCCCEEEEEECCS-EEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred             CccccceEEEEEcccC-cCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCCEEEEeCcc
Confidence                 36899999997 699999865  5799999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCCcc----cccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhcC
Q 004959          490 AKHLTGQKA----DLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDT  565 (721)
Q Consensus       490 A~~l~~~~~----~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~~  565 (721)
                      +........    ....+||+.|+|||++.+      ...++.++|||||||++|+|++|+.||.+....+.+..+....
T Consensus       175 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~  248 (364)
T 3qyz_A          175 ARVADPDHDHTGFLTEYVATRWYRAPEIMLN------SKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGIL  248 (364)
T ss_dssp             CEECCGGGCBCCTTCCCCSCGGGCCHHHHHT------BCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHH
T ss_pred             eEecCCCCCccccccccccccCCCCCHHhcC------CCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHh
Confidence            987654322    234579999999999853      3446789999999999999999999998766555544443210


Q ss_pred             --------------------------C-----CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhccccccCCCC
Q 004959          566 --------------------------P-----AIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQP  609 (721)
Q Consensus       566 --------------------------~-----~~p~~lS~el~dLI~~cL~~DP~kRPSa~eLL~Hp~f~~~~~~  609 (721)
                                                .     .+...++.++.+||.+||+.||++|||+.|+|+||||+....+
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~~~  323 (364)
T 3qyz_A          249 GSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDP  323 (364)
T ss_dssp             CSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTTCCG
T ss_pred             CCCCHHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhccCc
Confidence                                      0     0124578999999999999999999999999999999987544

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=1.1e-48  Score=432.91  Aligned_cols=262  Identities=26%  Similarity=0.417  Sum_probs=224.3

Q ss_pred             CCCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeEE
Q 004959          339 NSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFY  418 (721)
Q Consensus       339 ~~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~y  418 (721)
                      .++|++++.||+|+||+||+|+++.+|+.||||++.+...  ......+.+.+|+.+|+.++|||||++++++.+.+.+|
T Consensus        68 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~--~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~  145 (410)
T 3v8s_A           68 AEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEM--IKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLY  145 (410)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHH--HHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             ccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhh--hhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEE
Confidence            3589999999999999999999999999999999863100  00001234778999999999999999999999999999


Q ss_pred             EEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCCcc
Q 004959          419 IYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKA  498 (721)
Q Consensus       419 LVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~~~  498 (721)
                      ||||||.||+|.+++..  ..+++..++.++.||+.||+|||++||+||||||+||||+.+|.+||+|||+++.+.....
T Consensus       146 lV~E~~~gg~L~~~l~~--~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~~~  223 (410)
T 3v8s_A          146 MVMEYMPGGDLVNLMSN--YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGM  223 (410)
T ss_dssp             EEECCCTTEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSE
T ss_pred             EEEeCCCCCcHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCCEEEeccceeEeeccCCc
Confidence            99999999999999975  4799999999999999999999999999999999999999999999999999987654432


Q ss_pred             --cccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhcC--CCCC--CCC
Q 004959          499 --DLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDT--PAIP--DSL  572 (721)
Q Consensus       499 --~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~~--~~~p--~~l  572 (721)
                        ..+.+||+.|+|||++.+..   ....++.++|||||||+||||++|+.||.+.+..+.+.+++...  ..+|  ..+
T Consensus       224 ~~~~~~~gt~~Y~APE~l~~~~---~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~  300 (410)
T 3v8s_A          224 VRCDTAVGTPDYISPEVLKSQG---GDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDI  300 (410)
T ss_dssp             EECCSCCSCGGGCCHHHHHTTT---TTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCTTCCC
T ss_pred             ccccCCcCCccccCHHHhhccC---CCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccccccCCCcccc
Confidence              34678999999999996421   11226789999999999999999999999888777777776532  2333  479


Q ss_pred             CHHHHHHHHHhcccCCCC--CCCHHHHHhccccccCC
Q 004959          573 SPEGKDFLRCCFQRNPAD--RPPASLLLEHRFLKNSQ  607 (721)
Q Consensus       573 S~el~dLI~~cL~~DP~k--RPSa~eLL~Hp~f~~~~  607 (721)
                      +.++++||++||+.+|++  |++++||++||||++..
T Consensus       301 s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~~~  337 (410)
T 3v8s_A          301 SKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQ  337 (410)
T ss_dssp             CHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCCSS
T ss_pred             cHHHHHHHHHHccChhhhCCCCCHHHHhcCccccCCC
Confidence            999999999999999988  99999999999998753

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=7.2e-48  Score=399.67  Aligned_cols=263  Identities=29%  Similarity=0.512  Sum_probs=230.6

Q ss_pred             CCCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeEE
Q 004959          339 NSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFY  418 (721)
Q Consensus       339 ~~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~y  418 (721)
                      .++|++++.||+|+||.||+|.+..+++.||||++....  .......+.+.+|+.+++.++||||+++++++.+.+..|
T Consensus        13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   90 (284)
T 2vgo_A           13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQ--LEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIY   90 (284)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHH--HHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred             hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccc--cchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEE
Confidence            368999999999999999999999999999999985311  001112357889999999999999999999999999999


Q ss_pred             EEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCCcc
Q 004959          419 IYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKA  498 (721)
Q Consensus       419 LVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~~~  498 (721)
                      +||||+.+++|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... .
T Consensus        91 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~-~  168 (284)
T 2vgo_A           91 LMLEFAPRGELYKELQKH-GRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSL-R  168 (284)
T ss_dssp             EEECCCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCCEEECCCTTCEECSSS-C
T ss_pred             EEEEeCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCCEEEecccccccCccc-c
Confidence            999999999999999775 67999999999999999999999999999999999999999999999999999765433 2


Q ss_pred             cccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhcCCCCCCCCCHHHHH
Q 004959          499 DLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDSLSPEGKD  578 (721)
Q Consensus       499 ~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~~~~~p~~lS~el~d  578 (721)
                      .....|++.|+|||++.       ...++.++|||||||++|+|++|..||......+....+......++..++.++++
T Consensus       169 ~~~~~~~~~y~aPE~~~-------~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (284)
T 2vgo_A          169 RRTMCGTLDYLPPEMIE-------GKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPPFLSDGSKD  241 (284)
T ss_dssp             BCCCCSCGGGCCHHHHT-------TCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCTTSCHHHHH
T ss_pred             cccccCCCCcCCHHHhc-------cCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhccccCCCCcCCHHHHH
Confidence            34567999999999984       34567789999999999999999999988777777777777777888899999999


Q ss_pred             HHHHhcccCCCCCCCHHHHHhccccccCCCCCCC
Q 004959          579 FLRCCFQRNPADRPPASLLLEHRFLKNSQQPDVP  612 (721)
Q Consensus       579 LI~~cL~~DP~kRPSa~eLL~Hp~f~~~~~~~~~  612 (721)
                      ||.+||+.||++||++.++++||||+.......+
T Consensus       242 li~~~l~~~p~~Rps~~~ll~h~~~~~~~~~~~p  275 (284)
T 2vgo_A          242 LISKLLRYHPPQRLPLKGVMEHPWVKANSRRVLP  275 (284)
T ss_dssp             HHHHHSCSSGGGSCCHHHHHTCHHHHHHCCCCCC
T ss_pred             HHHHHhhcCHhhCCCHHHHhhCHHHHhhccccCC
Confidence            9999999999999999999999999876554433

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=7.9e-48  Score=414.98  Aligned_cols=256  Identities=26%  Similarity=0.392  Sum_probs=205.6

Q ss_pred             CCCCCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCe
Q 004959          337 PMNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDK  416 (721)
Q Consensus       337 ~l~~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~  416 (721)
                      .+.+.|++.+.||+|+||.||+|.+..+++.||||++...       ...+.+.+|+.+|++++||||+++++++...+.
T Consensus        50 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~-------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  122 (349)
T 2w4o_A           50 ALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKT-------VDKKIVRTEIGVLLRLSHPNIIKLKEIFETPTE  122 (349)
T ss_dssp             CGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC-----------------CHHHHHCCCTTBCCEEEEEECSSE
T ss_pred             cccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccc-------hhHHHHHHHHHHHHhCCCCCCcceeeeEecCCe
Confidence            3456899999999999999999999999999999998632       123567899999999999999999999999999


Q ss_pred             EEEEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcC---CCceEEeecCCcccc
Q 004959          417 FYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDA---SGVVKLADFGMAKHL  493 (721)
Q Consensus       417 ~yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~---~g~VKL~DFGlA~~l  493 (721)
                      +|+||||+.||+|.+++... +.+++.+++.++.||+.||.|||++||+||||||+||||+.   ++.+||+|||+++..
T Consensus       123 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~  201 (349)
T 2w4o_A          123 ISLVLELVTGGELFDRIVEK-GYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIV  201 (349)
T ss_dssp             EEEEECCCCSCBHHHHHTTC-SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC-----
T ss_pred             EEEEEEeCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCcccccc
Confidence            99999999999999999764 67999999999999999999999999999999999999975   789999999999877


Q ss_pred             CCCcccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHH-HHHHHhhcCCC----C
Q 004959          494 TGQKADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAA-AMFKVMRDTPA----I  568 (721)
Q Consensus       494 ~~~~~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~-~~~ki~~~~~~----~  568 (721)
                      .........+||+.|+|||++.       ...++.++|||||||+||||++|..||....... .+..+......    .
T Consensus       202 ~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~  274 (349)
T 2w4o_A          202 EHQVLMKTVCGTPGYCAPEILR-------GCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPW  274 (349)
T ss_dssp             -----------CGGGSCHHHHT-------TCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCCTTT
T ss_pred             CcccccccccCCCCccCHHHhc-------CCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccCCch
Confidence            6554445678999999999984       3457789999999999999999999997765544 34444443332    2


Q ss_pred             CCCCCHHHHHHHHHhcccCCCCCCCHHHHHhccccccCC
Q 004959          569 PDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQ  607 (721)
Q Consensus       569 p~~lS~el~dLI~~cL~~DP~kRPSa~eLL~Hp~f~~~~  607 (721)
                      ...++.++.+||++||+.||++|||+.|+|+||||....
T Consensus       275 ~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~  313 (349)
T 2w4o_A          275 WDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPWVTGKA  313 (349)
T ss_dssp             TTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTTSTT
T ss_pred             hhhCCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCCc
Confidence            356899999999999999999999999999999998654

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=1.4e-47  Score=415.64  Aligned_cols=292  Identities=22%  Similarity=0.334  Sum_probs=224.8

Q ss_pred             CCCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecC---
Q 004959          339 NSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVED---  415 (721)
Q Consensus       339 ~~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~---  415 (721)
                      .++|++++.||+|+||.||+|.+..+|+.||||++...   .......+.+.+|+.+|+.++||||+++++++...+   
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~  100 (371)
T 2xrw_A           24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRP---FQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLE  100 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECT---TSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTT
T ss_pred             hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccc---cCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccc
Confidence            46899999999999999999999999999999998632   234556678899999999999999999999987655   


Q ss_pred             ---eEEEEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccc
Q 004959          416 ---KFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKH  492 (721)
Q Consensus       416 ---~~yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~  492 (721)
                         .+|+||||+. ++|.+++.   ..+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.
T Consensus       101 ~~~~~~lv~e~~~-~~l~~~~~---~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~  176 (371)
T 2xrw_A          101 EFQDVYIVMELMD-ANLCQVIQ---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART  176 (371)
T ss_dssp             TCCEEEEEEECCS-EEHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC---
T ss_pred             cccceEEEEEcCC-CCHHHHHh---hccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEEEeecccc
Confidence               7899999997 57888875   4699999999999999999999999999999999999999999999999999987


Q ss_pred             cCCCcccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhcCCC-----
Q 004959          493 LTGQKADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPA-----  567 (721)
Q Consensus       493 l~~~~~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~~~~-----  567 (721)
                      ..........+||+.|+|||++.       ...++.++|||||||++|+|++|..||.+.+..+.+.++......     
T Consensus       177 ~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  249 (371)
T 2xrw_A          177 AGTSFMMTPYVVTRYYRAPEVIL-------GMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEF  249 (371)
T ss_dssp             -------------CTTCCHHHHT-------TCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHH
T ss_pred             cccccccCCceecCCccCHHHhc-------CCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence            65544445678999999999994       345777899999999999999999999887776666655442111     


Q ss_pred             -----------------CC--------------C------CCCHHHHHHHHHhcccCCCCCCCHHHHHhccccccCCCCC
Q 004959          568 -----------------IP--------------D------SLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQPD  610 (721)
Q Consensus       568 -----------------~p--------------~------~lS~el~dLI~~cL~~DP~kRPSa~eLL~Hp~f~~~~~~~  610 (721)
                                       +.              .      ..+.++++||++||+.||++|||++|+|+||||+....+.
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~~~~  329 (371)
T 2xrw_A          250 MKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYDPS  329 (371)
T ss_dssp             HTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTTCCHH
T ss_pred             HHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchhhhcCcc
Confidence                             00              0      0156889999999999999999999999999998765432


Q ss_pred             CC-CcccccCCCCCCCCCCChhHHHhhhHHHHHhh
Q 004959          611 VP-SCSLSFSGMQLTEKPHSPREKADAKYDQVAAL  644 (721)
Q Consensus       611 ~~-~~~~~~~~~~l~~~~~~~~~~~~~~~d~~~~l  644 (721)
                      .. .........++.+......+..+..++++..+
T Consensus       330 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  364 (371)
T 2xrw_A          330 EAEAPPPKIPDKQLDEREHTIEEWKELIYKEVMDL  364 (371)
T ss_dssp             HHTCCCCCCCTTTTCCCCCCHHHHHHHHHHHHHHH
T ss_pred             ccCCCCCCCCChhhccccCcHHHHHHHHHHHHHHH
Confidence            11 11112233445555556666667777776554

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=3.7e-47  Score=395.91  Aligned_cols=270  Identities=24%  Similarity=0.400  Sum_probs=232.1

Q ss_pred             CCCCCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcc----cHHHHHHHHHHHHHHHhCC-CCCeeeeeeeE
Q 004959          337 PMNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPK----SAESIKQLEQEIKVLSHLK-HPNIVQYYGSE  411 (721)
Q Consensus       337 ~l~~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~----~~~~~k~~~~Ei~iL~~L~-HPnIV~l~g~~  411 (721)
                      .+.++|++.+.||+|+||.||+|.++.+|+.||||++........    .....+.+.+|+.+|+++. ||||+++++++
T Consensus        14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~   93 (298)
T 1phk_A           14 GFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY   93 (298)
T ss_dssp             -CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred             chhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeee
Confidence            456799999999999999999999999999999999875332111    1234567889999999996 99999999999


Q ss_pred             EecCeEEEEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCcc
Q 004959          412 IVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAK  491 (721)
Q Consensus       412 ~~~~~~yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~  491 (721)
                      ...+..|+||||+.+++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus        94 ~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~  172 (298)
T 1phk_A           94 ETNTFFFLVFDLMKKGELFDYLTEK-VTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSC  172 (298)
T ss_dssp             ECSSEEEEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred             ccCCeEEEEEeccCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCcEEEecccchh
Confidence            9999999999999999999999765 689999999999999999999999999999999999999999999999999998


Q ss_pred             ccCCCcccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhcCCCCC--
Q 004959          492 HLTGQKADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIP--  569 (721)
Q Consensus       492 ~l~~~~~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~~~~~p--  569 (721)
                      .+..........||+.|+|||++.+.... ....++.++|||||||++|+|++|..||...........+.......+  
T Consensus       173 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  251 (298)
T 1phk_A          173 QLDPGEKLREVCGTPSYLAPEIIECSMND-NHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSP  251 (298)
T ss_dssp             ECCTTCCBCCCCSCGGGCCHHHHHHHHCT-TSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTT
T ss_pred             hcCCCcccccccCCccccCHHHhcccccc-ccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcCCcccCcc
Confidence            87665555667899999999999754332 234577899999999999999999999988776666666665544333  


Q ss_pred             --CCCCHHHHHHHHHhcccCCCCCCCHHHHHhccccccCCC
Q 004959          570 --DSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQ  608 (721)
Q Consensus       570 --~~lS~el~dLI~~cL~~DP~kRPSa~eLL~Hp~f~~~~~  608 (721)
                        ..++.++.+||.+||+.||++||++.|+|+||||++...
T Consensus       252 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~  292 (298)
T 1phk_A          252 EWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYVV  292 (298)
T ss_dssp             TGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTTC-
T ss_pred             cccccCHHHHHHHHHHccCCcccCCCHHHHHhChHhhhccc
Confidence              358999999999999999999999999999999987543

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=1.8e-48  Score=402.44  Aligned_cols=259  Identities=32%  Similarity=0.610  Sum_probs=203.2

Q ss_pred             CCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeEEE
Q 004959          340 SQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYI  419 (721)
Q Consensus       340 ~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~yL  419 (721)
                      ++|++++.||+|+||.||+|++..+|+.||||++....  .......+.+.+|+.++++++||||+++++++.+.+..|+
T Consensus        11 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   88 (278)
T 3cok_A           11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKA--MYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYL   88 (278)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHH--HHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEE
T ss_pred             ccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhh--hhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEE
Confidence            57999999999999999999999999999999985311  0011124678999999999999999999999999999999


Q ss_pred             EEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCCc-c
Q 004959          420 YLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQK-A  498 (721)
Q Consensus       420 VmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~~-~  498 (721)
                      ||||+.+++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+.... .
T Consensus        89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~  168 (278)
T 3cok_A           89 VLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEK  168 (278)
T ss_dssp             EEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCEEECCCTTCEECC-----
T ss_pred             EEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEEeecceeeccCCCCc
Confidence            999999999999998766789999999999999999999999999999999999999999999999999998765332 2


Q ss_pred             cccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhcCCCCCCCCCHHHHH
Q 004959          499 DLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDSLSPEGKD  578 (721)
Q Consensus       499 ~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~~~~~p~~lS~el~d  578 (721)
                      .....||+.|+|||++.+       ..++.++|||||||++|+|++|+.||......+.+.++.......+..++.++.+
T Consensus       169 ~~~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (278)
T 3cok_A          169 HYTLCGTPNYISPEIATR-------SAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMPSFLSIEAKD  241 (278)
T ss_dssp             ------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CCSSCCCCCTTSCHHHHH
T ss_pred             ceeccCCCCcCCcchhcC-------CCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHhhcccCCccccCHHHHH
Confidence            345679999999999853       3456689999999999999999999987666566666655566778889999999


Q ss_pred             HHHHhcccCCCCCCCHHHHHhccccccCC
Q 004959          579 FLRCCFQRNPADRPPASLLLEHRFLKNSQ  607 (721)
Q Consensus       579 LI~~cL~~DP~kRPSa~eLL~Hp~f~~~~  607 (721)
                      ||.+||+.||++||++.++|+||||....
T Consensus       242 li~~~l~~dp~~Rps~~~~l~h~~~~~~~  270 (278)
T 3cok_A          242 LIHQLLRRNPADRLSLSSVLDHPFMSRNS  270 (278)
T ss_dssp             HHHHHSCSSGGGSCCHHHHTTSTTTC---
T ss_pred             HHHHHcccCHhhCCCHHHHhcCccccCCC
Confidence            99999999999999999999999998643

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=7.8e-48  Score=396.62  Aligned_cols=259  Identities=28%  Similarity=0.484  Sum_probs=219.3

Q ss_pred             CCCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeEE
Q 004959          339 NSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFY  418 (721)
Q Consensus       339 ~~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~y  418 (721)
                      .++|++++.||+|+||.||+|.+..+|+.||||++....  .......+.+.+|+.+++.++||||+++++++...+..|
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   87 (276)
T 2h6d_A           10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQK--IRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFF   87 (276)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHH--HHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred             eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEecccc--ccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEE
Confidence            368999999999999999999999999999999986311  011123467889999999999999999999999999999


Q ss_pred             EEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCCcc
Q 004959          419 IYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKA  498 (721)
Q Consensus       419 LVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~~~  498 (721)
                      +||||+.+++|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++........
T Consensus        88 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~  166 (276)
T 2h6d_A           88 MVMEYVSGGELFDYICKH-GRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF  166 (276)
T ss_dssp             EEEECCCSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC---
T ss_pred             EEEeccCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEEEeecccccccCCCcc
Confidence            999999999999999775 6799999999999999999999999999999999999999999999999999987765544


Q ss_pred             cccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhcCCCCCCCCCHHHHH
Q 004959          499 DLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDSLSPEGKD  578 (721)
Q Consensus       499 ~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~~~~~p~~lS~el~d  578 (721)
                      .....||+.|+|||++.+      ....+.++|||||||++|+|++|..||...........+......++..++.++.+
T Consensus       167 ~~~~~~~~~y~aPE~~~~------~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  240 (276)
T 2h6d_A          167 LRTSCGSPNYAAPEVISG------RLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPEYLNRSVAT  240 (276)
T ss_dssp             ----------CCTGGGTT------SCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHH
T ss_pred             eecccCCccccCHHHHcC------CCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcccCchhcCHHHHH
Confidence            455679999999999843      12236789999999999999999999988777777777777777788889999999


Q ss_pred             HHHHhcccCCCCCCCHHHHHhccccccC
Q 004959          579 FLRCCFQRNPADRPPASLLLEHRFLKNS  606 (721)
Q Consensus       579 LI~~cL~~DP~kRPSa~eLL~Hp~f~~~  606 (721)
                      ||.+||+.||++|||+.|+++||||++.
T Consensus       241 li~~~l~~~p~~Rps~~~~l~h~~~~~~  268 (276)
T 2h6d_A          241 LLMHMLQVDPLKRATIKDIREHEWFKQD  268 (276)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHHSHHHHTT
T ss_pred             HHHHHccCChhhCCCHHHHHhChhhccC
Confidence            9999999999999999999999999864

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=8.2e-48  Score=412.80  Aligned_cols=264  Identities=25%  Similarity=0.466  Sum_probs=217.1

Q ss_pred             CCCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeEE
Q 004959          339 NSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFY  418 (721)
Q Consensus       339 ~~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~y  418 (721)
                      .++|++++.||+|+||.||+|.+..+|+.||||++.............+.+.+|+.+|+.++||||+++++++.+.+..|
T Consensus         9 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   88 (346)
T 1ua2_A            9 AKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNIS   88 (346)
T ss_dssp             ----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCE
T ss_pred             hcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCceE
Confidence            46899999999999999999999999999999998643222111222356889999999999999999999999999999


Q ss_pred             EEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCCc-
Q 004959          419 IYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQK-  497 (721)
Q Consensus       419 LVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~~-  497 (721)
                      +||||+.+ +|.+++......+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.+.... 
T Consensus        89 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~  167 (346)
T 1ua2_A           89 LVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR  167 (346)
T ss_dssp             EEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC
T ss_pred             EEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCCEEEEecccceeccCCcc
Confidence            99999975 8998887766679999999999999999999999999999999999999999999999999998765433 


Q ss_pred             ccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhcCC-----C-----
Q 004959          498 ADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTP-----A-----  567 (721)
Q Consensus       498 ~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~~~-----~-----  567 (721)
                      .....+||+.|+|||++.+      ...++.++|||||||++|+|++|.+||.+....+.+.++.....     .     
T Consensus       168 ~~~~~~~t~~y~aPE~~~~------~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~  241 (346)
T 1ua2_A          168 AYTHQVVTRWYRAPELLFG------ARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMC  241 (346)
T ss_dssp             CCCCSCCCCTTCCHHHHTT------CSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTT
T ss_pred             cCCcccccccccCchHhhC------CCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhhc
Confidence            3345679999999999842      23477899999999999999999999988777666666543210     0     


Q ss_pred             ------------------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhccccccCCCC
Q 004959          568 ------------------IPDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQP  609 (721)
Q Consensus       568 ------------------~p~~lS~el~dLI~~cL~~DP~kRPSa~eLL~Hp~f~~~~~~  609 (721)
                                        +...++.++++||++||+.||++|||+.|+|+||||.+...+
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~~~~~  301 (346)
T 1ua2_A          242 SLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGP  301 (346)
T ss_dssp             SSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSCC
T ss_pred             cCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhcCCCC
Confidence                              014567999999999999999999999999999999876544

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=2.4e-47  Score=409.39  Aligned_cols=252  Identities=26%  Similarity=0.408  Sum_probs=214.8

Q ss_pred             CCCCCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCC-----CCCeeeeeeeE
Q 004959          337 PMNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLK-----HPNIVQYYGSE  411 (721)
Q Consensus       337 ~l~~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~-----HPnIV~l~g~~  411 (721)
                      .+.++|++++.||+|+||.||+|++..+|+.||||++..      .....+.+..|+.+|+.+.     |||||++++++
T Consensus        32 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~------~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~  105 (360)
T 3llt_A           32 LLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRN------IKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKF  105 (360)
T ss_dssp             EETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS------CHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEE
T ss_pred             EecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEecc------chhhhhhhHHHHHHHHHhcccCCCCCCeeccccee
Confidence            346799999999999999999999999999999999852      2345567788999999997     99999999999


Q ss_pred             EecCeEEEEEeeccCCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcC------------
Q 004959          412 IVEDKFYIYLEYVHPGSINKYVREHC-GAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDA------------  478 (721)
Q Consensus       412 ~~~~~~yLVmEy~~gGsL~~~L~~~~-~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~------------  478 (721)
                      ...+.+|+||||+ +++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+||||+.            
T Consensus       106 ~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~~~  184 (360)
T 3llt_A          106 MYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRR  184 (360)
T ss_dssp             EETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEEEEC
T ss_pred             eECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccchhc
Confidence            9999999999999 899999997653 45999999999999999999999999999999999999975            


Q ss_pred             -------------CCceEEeecCCccccCCCcccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhC
Q 004959          479 -------------SGVVKLADFGMAKHLTGQKADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTG  545 (721)
Q Consensus       479 -------------~g~VKL~DFGlA~~l~~~~~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG  545 (721)
                                   ++.+||+|||++......  ....+||+.|+|||++.       ...++.++|||||||+||+|++|
T Consensus       185 ~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~--~~~~~gt~~y~aPE~~~-------~~~~~~~~DiwslG~il~ell~g  255 (360)
T 3llt_A          185 VTDGKKIQIYRTKSTGIKLIDFGCATFKSDY--HGSIINTRQYRAPEVIL-------NLGWDVSSDMWSFGCVLAELYTG  255 (360)
T ss_dssp             TTTCCEEEEEEESCCCEEECCCTTCEETTSC--CCSCCSCGGGCCHHHHT-------TCCCCTTHHHHHHHHHHHHHHHS
T ss_pred             ccccccccccccCCCCEEEEeccCceecCCC--CcCccCcccccCcHHHc-------CCCCCCccchHHHHHHHHHHHHC
Confidence                         789999999999865432  34567999999999994       34577899999999999999999


Q ss_pred             CCCCCchhhHHHHHHHhhcCCCCC----------------------------------------------CCCCHHHHHH
Q 004959          546 KPPWSEYEGAAAMFKVMRDTPAIP----------------------------------------------DSLSPEGKDF  579 (721)
Q Consensus       546 ~~PF~~~~~~~~~~ki~~~~~~~p----------------------------------------------~~lS~el~dL  579 (721)
                      +.||......+.+..+.......+                                              ...++++.+|
T Consensus       256 ~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  335 (360)
T 3llt_A          256 SLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDF  335 (360)
T ss_dssp             SCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHH
T ss_pred             CCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHH
Confidence            999987665555544433222111                                              1124778899


Q ss_pred             HHHhcccCCCCCCCHHHHHhccccc
Q 004959          580 LRCCFQRNPADRPPASLLLEHRFLK  604 (721)
Q Consensus       580 I~~cL~~DP~kRPSa~eLL~Hp~f~  604 (721)
                      |.+||+.||++|||+.|+|+||||+
T Consensus       336 i~~~L~~dP~~Rpta~elL~hp~f~  360 (360)
T 3llt_A          336 LYSILQIDPTLRPSPAELLKHKFLE  360 (360)
T ss_dssp             HHHHCCSSGGGSCCHHHHTTSGGGC
T ss_pred             HHHHhcCChhhCCCHHHHhcCcccC
Confidence            9999999999999999999999995

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=7.5e-47  Score=409.78  Aligned_cols=263  Identities=25%  Similarity=0.461  Sum_probs=228.2

Q ss_pred             CCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcc---cHHHHHHHHHHHHHHHhC-CCCCeeeeeeeEEecC
Q 004959          340 SQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPK---SAESIKQLEQEIKVLSHL-KHPNIVQYYGSEIVED  415 (721)
Q Consensus       340 ~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~---~~~~~k~~~~Ei~iL~~L-~HPnIV~l~g~~~~~~  415 (721)
                      .+|++.+.||+|+||+||+|.+..+|+.||||++........   .....+.+.+|+.+|+++ .||||+++++++...+
T Consensus        94 ~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~  173 (365)
T 2y7j_A           94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSS  173 (365)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSS
T ss_pred             hhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCC
Confidence            579999999999999999999999999999999875322211   123356788999999999 7999999999999999


Q ss_pred             eEEEEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCC
Q 004959          416 KFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTG  495 (721)
Q Consensus       416 ~~yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~  495 (721)
                      ..|+||||+.|++|.+++... ..+++..++.++.||+.||.|||++||+||||||+||||+.+|.+||+|||++..+..
T Consensus       174 ~~~lv~e~~~g~~L~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~~~  252 (365)
T 2y7j_A          174 FMFLVFDLMRKGELFDYLTEK-VALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEP  252 (365)
T ss_dssp             EEEEEECCCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCT
T ss_pred             EEEEEEEeCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEecCcccccCC
Confidence            999999999999999999765 6799999999999999999999999999999999999999999999999999988776


Q ss_pred             CcccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhcCCCCC----CC
Q 004959          496 QKADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIP----DS  571 (721)
Q Consensus       496 ~~~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~~~~~p----~~  571 (721)
                      .......+||+.|+|||++.+.... ....++.++|||||||+||+|++|..||........+..+.......+    ..
T Consensus       253 ~~~~~~~~gt~~y~aPE~~~~~~~~-~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  331 (365)
T 2y7j_A          253 GEKLRELCGTPGYLAPEILKCSMDE-THPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPEWDD  331 (365)
T ss_dssp             TCCBCCCCSCGGGCCHHHHHHTTCT-TSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCHHHHSS
T ss_pred             CcccccCCCCCCccChhhccccccc-cCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCccccc
Confidence            6555667899999999999753221 233577899999999999999999999988776666666665544333    46


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHHHHhccccc
Q 004959          572 LSPEGKDFLRCCFQRNPADRPPASLLLEHRFLK  604 (721)
Q Consensus       572 lS~el~dLI~~cL~~DP~kRPSa~eLL~Hp~f~  604 (721)
                      ++.++.+||++||+.||++||++.|+|+||||+
T Consensus       332 ~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f~  364 (365)
T 2y7j_A          332 RSSTVKDLISRLLQVDPEARLTAEQALQHPFFE  364 (365)
T ss_dssp             SCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGC
T ss_pred             CCHHHHHHHHHHcCCChhHCcCHHHHhcCcccC
Confidence            889999999999999999999999999999996

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=1.9e-47  Score=404.11  Aligned_cols=253  Identities=26%  Similarity=0.359  Sum_probs=208.6

Q ss_pred             CCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhC-CCCCeeeeeeeEEecCeEE
Q 004959          340 SQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHL-KHPNIVQYYGSEIVEDKFY  418 (721)
Q Consensus       340 ~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L-~HPnIV~l~g~~~~~~~~y  418 (721)
                      ++|++++.||+|+||+||+|.+..+|+.||||++...   .........+..|+..+..+ .|||||++++++.+.+.+|
T Consensus        57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~  133 (311)
T 3p1a_A           57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSP---FRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILY  133 (311)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSS---CCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred             hheeeeheeccCCCeEEEEEEECCCCeEEEEEEeccc---ccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEE
Confidence            5799999999999999999999999999999987532   22233344555566555554 8999999999999999999


Q ss_pred             EEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCCcc
Q 004959          419 IYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKA  498 (721)
Q Consensus       419 LVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~~~  498 (721)
                      |||||+ +++|.+++......+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++........
T Consensus       134 lv~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~~  212 (311)
T 3p1a_A          134 LQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGA  212 (311)
T ss_dssp             EEEECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGCEEECCCTTCEECC----
T ss_pred             EEEecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEccceeeeecccCCC
Confidence            999999 6799999987777899999999999999999999999999999999999999999999999999987765555


Q ss_pred             cccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhcCCCCCCCCCHHHHH
Q 004959          499 DLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDSLSPEGKD  578 (721)
Q Consensus       499 ~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~~~~~p~~lS~el~d  578 (721)
                      .....||+.|+|||++.+        .++.++|||||||++|||++|..||........+... .....++..+++++.+
T Consensus       213 ~~~~~gt~~y~aPE~~~~--------~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~  283 (311)
T 3p1a_A          213 GEVQEGDPRYMAPELLQG--------SYGTAADVFSLGLTILEVACNMELPHGGEGWQQLRQG-YLPPEFTAGLSSELRS  283 (311)
T ss_dssp             --CCCCCGGGCCGGGGGT--------CCSTHHHHHHHHHHHHHHHHTCCCCSSHHHHHHHTTT-CCCHHHHTTSCHHHHH
T ss_pred             CcccCCCccccCHhHhcC--------CCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHhcc-CCCcccccCCCHHHHH
Confidence            556779999999999842        4677999999999999999997766554433222111 0112234678999999


Q ss_pred             HHHHhcccCCCCCCCHHHHHhcccccc
Q 004959          579 FLRCCFQRNPADRPPASLLLEHRFLKN  605 (721)
Q Consensus       579 LI~~cL~~DP~kRPSa~eLL~Hp~f~~  605 (721)
                      ||.+||+.||++|||++|+|+||||++
T Consensus       284 li~~~L~~dP~~Rpt~~ell~hp~~~~  310 (311)
T 3p1a_A          284 VLVMMLEPDPKLRATAEALLALPVLRQ  310 (311)
T ss_dssp             HHHHHSCSSTTTSCCHHHHHTSGGGSC
T ss_pred             HHHHHcCCChhhCcCHHHHHhCccccC
Confidence            999999999999999999999999975

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=2.8e-47  Score=430.05  Aligned_cols=263  Identities=24%  Similarity=0.430  Sum_probs=228.3

Q ss_pred             CCCCCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcc--------cHHHHHHHHHHHHHHHhCCCCCeeeee
Q 004959          337 PMNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPK--------SAESIKQLEQEIKVLSHLKHPNIVQYY  408 (721)
Q Consensus       337 ~l~~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~--------~~~~~k~~~~Ei~iL~~L~HPnIV~l~  408 (721)
                      .+.+.|++++.||+|+||+||+|.++.+++.||||++........        .....+.+.+|+.+|++++|||||+++
T Consensus        33 ~i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~  112 (504)
T 3q5i_A           33 KIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLF  112 (504)
T ss_dssp             CGGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred             CcccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEE
Confidence            456789999999999999999999999999999999864321110        012356789999999999999999999


Q ss_pred             eeEEecCeEEEEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCC---ceEEe
Q 004959          409 GSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASG---VVKLA  485 (721)
Q Consensus       409 g~~~~~~~~yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g---~VKL~  485 (721)
                      +++.+.+.+|||||||.||+|.+++... +.+++..++.++.||+.||.|||++||+||||||+||||+.++   .+||+
T Consensus       113 ~~~~~~~~~~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~  191 (504)
T 3q5i_A          113 DVFEDKKYFYLVTEFYEGGELFEQIINR-HKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIV  191 (504)
T ss_dssp             EEEECSSEEEEEEECCTTCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEEEC
T ss_pred             EEEEcCCEEEEEEecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEEEE
Confidence            9999999999999999999999999765 6799999999999999999999999999999999999998776   69999


Q ss_pred             ecCCccccCCCcccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhcC
Q 004959          486 DFGMAKHLTGQKADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDT  565 (721)
Q Consensus       486 DFGlA~~l~~~~~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~~  565 (721)
                      |||++..+.........+||+.|+|||++.        ..++.++|||||||++|+|++|..||.+....+.+..+....
T Consensus       192 Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~  263 (504)
T 3q5i_A          192 DFGLSSFFSKDYKLRDRLGTAYYIAPEVLK--------KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGK  263 (504)
T ss_dssp             CCTTCEECCTTSCBCCCCSCTTTCCHHHHT--------TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC
T ss_pred             ECCCCEEcCCCCccccccCCcCCCCHHHhc--------cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC
Confidence            999999877665556678999999999983        247789999999999999999999999988888888877766


Q ss_pred             CCCC----CCCCHHHHHHHHHhcccCCCCCCCHHHHHhccccccCCC
Q 004959          566 PAIP----DSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQ  608 (721)
Q Consensus       566 ~~~p----~~lS~el~dLI~~cL~~DP~kRPSa~eLL~Hp~f~~~~~  608 (721)
                      ..++    ..+++++++||++||+.||++|||++|+|+||||+....
T Consensus       264 ~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~~  310 (504)
T 3q5i_A          264 YYFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYAN  310 (504)
T ss_dssp             CCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHTCC
T ss_pred             CCCCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhchh
Confidence            5544    578999999999999999999999999999999987543

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=5.8e-48  Score=410.72  Aligned_cols=266  Identities=26%  Similarity=0.448  Sum_probs=221.5

Q ss_pred             CCCCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeE
Q 004959          338 MNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKF  417 (721)
Q Consensus       338 l~~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~  417 (721)
                      +.++|++++.||+|+||.||+|.+..+++.||||++.............+.+.+|+.+|++++|||||++++++.+.+..
T Consensus        24 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~  103 (345)
T 3hko_A           24 LQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYI  103 (345)
T ss_dssp             HHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             hhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeE
Confidence            45689999999999999999999999999999999864211111234567899999999999999999999999999999


Q ss_pred             EEEEeeccCCCHHHHHHHh---------------------------------------cCCCCHHHHHHHHHHHHHHHHH
Q 004959          418 YIYLEYVHPGSINKYVREH---------------------------------------CGAITESVVRNFTRHILSGLAY  458 (721)
Q Consensus       418 yLVmEy~~gGsL~~~L~~~---------------------------------------~~~Lse~~i~~i~~QIl~AL~y  458 (721)
                      |+|||||+||+|.+++...                                       ...+++..++.++.||+.||.|
T Consensus       104 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~  183 (345)
T 3hko_A          104 CLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHY  183 (345)
T ss_dssp             EEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHH
T ss_pred             EEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHH
Confidence            9999999999999988421                                       0124678899999999999999


Q ss_pred             HhhCCeeccCCCCCcEEEcCCC--ceEEeecCCccccCCCc-----ccccCCCCCccCChhhHHHHhhcCCCCCCcchhh
Q 004959          459 LHSKKTIHRDIKGANLLVDASG--VVKLADFGMAKHLTGQK-----ADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVD  531 (721)
Q Consensus       459 LHs~gIIHrDLKPeNILld~~g--~VKL~DFGlA~~l~~~~-----~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asD  531 (721)
                      ||++||+||||||+||||+.++  .+||+|||++..+....     ......||+.|+|||++.+     ....++.++|
T Consensus       184 LH~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~~~D  258 (345)
T 3hko_A          184 LHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNT-----TNESYGPKCD  258 (345)
T ss_dssp             HHHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTC-----SSSCCCTHHH
T ss_pred             HHHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhcc-----CCCCCCcHHH
Confidence            9999999999999999998776  89999999998754321     1234679999999999842     2356778999


Q ss_pred             HHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhcCCCCCC----CCCHHHHHHHHHhcccCCCCCCCHHHHHhccccccCC
Q 004959          532 IWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPD----SLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQ  607 (721)
Q Consensus       532 VWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~~~~~p~----~lS~el~dLI~~cL~~DP~kRPSa~eLL~Hp~f~~~~  607 (721)
                      ||||||+||||++|+.||.+....+....+......++.    .+++++.+||.+||+.||++||++.|+|+||||++..
T Consensus       259 iwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~hp~~~~~~  338 (345)
T 3hko_A          259 AWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQHPWISQFS  338 (345)
T ss_dssp             HHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHHSHHHHTTS
T ss_pred             HHHHHHHHHHHHHCCCCCCCCChHHHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhHCCCHHHHhcChhhccCh
Confidence            999999999999999999988777777777766544332    4799999999999999999999999999999998754


Q ss_pred             C
Q 004959          608 Q  608 (721)
Q Consensus       608 ~  608 (721)
                      .
T Consensus       339 ~  339 (345)
T 3hko_A          339 D  339 (345)
T ss_dssp             S
T ss_pred             H
Confidence            3

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=2.3e-47  Score=408.71  Aligned_cols=262  Identities=27%  Similarity=0.450  Sum_probs=217.7

Q ss_pred             CCCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEe-----
Q 004959          339 NSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIV-----  413 (721)
Q Consensus       339 ~~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~-----  413 (721)
                      .++|++++.||+|+||.||+|++..+|+.||||++.......   .....+.+|+.+|+.++||||+++++++..     
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   92 (351)
T 3mi9_A           16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKE---GFPITALREIKILQLLKHENVVNLIEICRTKASPY   92 (351)
T ss_dssp             GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSS---SSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC----
T ss_pred             ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccc---cchHHHHHHHHHHHhccCCCcccHhheeecccccc
Confidence            368999999999999999999999999999999886432221   123467789999999999999999999887     


Q ss_pred             ---cCeEEEEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCc
Q 004959          414 ---EDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMA  490 (721)
Q Consensus       414 ---~~~~yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA  490 (721)
                         .+.+|+||||+. ++|.+.+......+++.+++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++
T Consensus        93 ~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a  171 (351)
T 3mi9_A           93 NRCKGSIYLVFDFCE-HDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLA  171 (351)
T ss_dssp             ----CEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred             ccCCceEEEEEeccC-CCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCCEEEccchhc
Confidence               456899999997 5888888776678999999999999999999999999999999999999999999999999999


Q ss_pred             cccCCC-----cccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhcC
Q 004959          491 KHLTGQ-----KADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDT  565 (721)
Q Consensus       491 ~~l~~~-----~~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~~  565 (721)
                      ..+...     ......+||+.|+|||++.+      ...++.++|||||||++|+|++|..||.+....+.+..+....
T Consensus       172 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~  245 (351)
T 3mi9_A          172 RAFSLAKNSQPNRYTNRVVTLWYRPPELLLG------ERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLC  245 (351)
T ss_dssp             EECCCCSSSSCCCCCSSCSCGGGCCHHHHTT------CCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHH
T ss_pred             ccccccccccccccCCcccccCccCchhhcC------CCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh
Confidence            876422     12234678999999999843      2446789999999999999999999999877666655554321


Q ss_pred             CCCCCC--------------------------------CCHHHHHHHHHhcccCCCCCCCHHHHHhccccccCCCCC
Q 004959          566 PAIPDS--------------------------------LSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQPD  610 (721)
Q Consensus       566 ~~~p~~--------------------------------lS~el~dLI~~cL~~DP~kRPSa~eLL~Hp~f~~~~~~~  610 (721)
                      ...+..                                .++++.+||.+||+.||++|||++|+|+||||.....+.
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~  322 (351)
T 3mi9_A          246 GSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDPMPS  322 (351)
T ss_dssp             CCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGSSSCCC
T ss_pred             CCCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCCCCCcc
Confidence            111111                                277899999999999999999999999999998765543

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=8.6e-47  Score=401.61  Aligned_cols=253  Identities=33%  Similarity=0.583  Sum_probs=220.4

Q ss_pred             CeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeEEEE
Q 004959          341 QWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYIY  420 (721)
Q Consensus       341 ~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~yLV  420 (721)
                      .|...+.||+|+||.||+|++..+|+.||||++.....     ...+.+.+|+.+|+.++||||+++++++...+..|+|
T Consensus        46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  120 (321)
T 2c30_A           46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQ-----QRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVL  120 (321)
T ss_dssp             HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccch-----hHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEE
Confidence            48888999999999999999999999999999864321     1245688999999999999999999999999999999


Q ss_pred             EeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCCc-cc
Q 004959          421 LEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQK-AD  499 (721)
Q Consensus       421 mEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~~-~~  499 (721)
                      |||+.|++|.+++..  ..+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+.... ..
T Consensus       121 ~e~~~~~~L~~~l~~--~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~  198 (321)
T 2c30_A          121 MEFLQGGALTDIVSQ--VRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKR  198 (321)
T ss_dssp             ECCCCSCBHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCB
T ss_pred             EecCCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCcEEEeeeeeeeecccCcccc
Confidence            999999999999864  479999999999999999999999999999999999999999999999999998765433 23


Q ss_pred             ccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhcCC---CCCCCCCHHH
Q 004959          500 LSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTP---AIPDSLSPEG  576 (721)
Q Consensus       500 ~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~~~---~~p~~lS~el  576 (721)
                      ....||+.|+|||++.       ...++.++|||||||++|+|++|+.||......+.+..+.....   ..+..+++++
T Consensus       199 ~~~~gt~~y~aPE~~~-------~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  271 (321)
T 2c30_A          199 KSLVGTPYWMAPEVIS-------RSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNSHKVSPVL  271 (321)
T ss_dssp             CCCCSCGGGCCHHHHT-------TCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCTTGGGSCHHH
T ss_pred             ccccCCccccCHhhhc-------CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCcCccccCCHHH
Confidence            4567999999999994       34577899999999999999999999988766666655554432   2234589999


Q ss_pred             HHHHHHhcccCCCCCCCHHHHHhccccccCC
Q 004959          577 KDFLRCCFQRNPADRPPASLLLEHRFLKNSQ  607 (721)
Q Consensus       577 ~dLI~~cL~~DP~kRPSa~eLL~Hp~f~~~~  607 (721)
                      .+||.+||+.||++|||+.|+++||||....
T Consensus       272 ~~li~~~l~~dp~~Rps~~ell~hp~~~~~~  302 (321)
T 2c30_A          272 RDFLERMLVRDPQERATAQELLDHPFLLQTG  302 (321)
T ss_dssp             HHHHHHHSCSSTTTSCCHHHHHTSGGGGGCC
T ss_pred             HHHHHHHccCChhhCcCHHHHhcChhhccCC
Confidence            9999999999999999999999999998654

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=6.8e-48  Score=409.76  Aligned_cols=259  Identities=27%  Similarity=0.456  Sum_probs=213.0

Q ss_pred             CCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeEEE
Q 004959          340 SQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYI  419 (721)
Q Consensus       340 ~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~yL  419 (721)
                      ++|++++.||+|+||.||+|.+..+|+.||||++.....    ......+.+|+.+|+.++||||+++++++...+.+|+
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   77 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHE----EGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTL   77 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC----------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEE
T ss_pred             CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccc----cccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEE
Confidence            479999999999999999999999999999999863211    1112245579999999999999999999999999999


Q ss_pred             EEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCCc-c
Q 004959          420 YLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQK-A  498 (721)
Q Consensus       420 VmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~~-~  498 (721)
                      ||||+. |+|.+++......+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++....... .
T Consensus        78 v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~  156 (324)
T 3mtl_A           78 VFEYLD-KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKT  156 (324)
T ss_dssp             EEECCS-EEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCCEEECSSSEEECC------
T ss_pred             Eecccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCCEEEccCcccccccCCccc
Confidence            999997 69999998776779999999999999999999999999999999999999999999999999998654332 2


Q ss_pred             cccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhcCC-----C------
Q 004959          499 DLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTP-----A------  567 (721)
Q Consensus       499 ~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~~~-----~------  567 (721)
                      ....+||+.|+|||++.+      ...++.++|||||||++|+|++|+.||.+....+.+..+.....     .      
T Consensus       157 ~~~~~~t~~y~aPE~~~~------~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  230 (324)
T 3mtl_A          157 YDNEVVTLWYRPPDILLG------STDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILS  230 (324)
T ss_dssp             ------CGGGCCHHHHTT------CCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGG
T ss_pred             cccccCcccccChhhhcC------CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhc
Confidence            234578999999999852      24577899999999999999999999988766665555433110     0      


Q ss_pred             -------------------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhccccccCCCC
Q 004959          568 -------------------IPDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQP  609 (721)
Q Consensus       568 -------------------~p~~lS~el~dLI~~cL~~DP~kRPSa~eLL~Hp~f~~~~~~  609 (721)
                                         ....++.++.+||.+||+.||++|||++|+|+||||......
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~  291 (324)
T 3mtl_A          231 NEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGER  291 (324)
T ss_dssp             CHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCST
T ss_pred             chhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhcccc
Confidence                               113478999999999999999999999999999999876543

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=2.9e-47  Score=428.97  Aligned_cols=257  Identities=26%  Similarity=0.468  Sum_probs=222.8

Q ss_pred             CCCCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeE
Q 004959          338 MNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKF  417 (721)
Q Consensus       338 l~~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~  417 (721)
                      +.+.|++++.||+|+||+||+|+++.+|..||||++.......   .....+.+|+.+|+.++|||||++++++.+...+
T Consensus        35 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~  111 (494)
T 3lij_A           35 LSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVST---SSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNY  111 (494)
T ss_dssp             HHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC--------CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred             hhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCc---hHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEE
Confidence            4457999999999999999999999999999999987432111   1245788999999999999999999999999999


Q ss_pred             EEEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCC---CceEEeecCCccccC
Q 004959          418 YIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDAS---GVVKLADFGMAKHLT  494 (721)
Q Consensus       418 yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~---g~VKL~DFGlA~~l~  494 (721)
                      |+|||||.||+|.+++... ..+++..++.++.||+.||.|||++||+||||||+||||+..   +.+||+|||++..+.
T Consensus       112 ~lv~e~~~~g~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~  190 (494)
T 3lij_A          112 YLVMECYKGGELFDEIIHR-MKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFE  190 (494)
T ss_dssp             EEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECB
T ss_pred             EEEEecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECC
Confidence            9999999999999998765 679999999999999999999999999999999999999764   459999999998877


Q ss_pred             CCcccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhcCCCCC----C
Q 004959          495 GQKADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIP----D  570 (721)
Q Consensus       495 ~~~~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~~~~~p----~  570 (721)
                      ........+||+.|+|||++.        ..++.++|||||||++|+|++|..||.+....+.+..+......++    .
T Consensus       191 ~~~~~~~~~gt~~y~aPE~l~--------~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  262 (494)
T 3lij_A          191 NQKKMKERLGTAYYIAPEVLR--------KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWK  262 (494)
T ss_dssp             TTBCBCCCCSCTTTCCHHHHT--------TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCSGGGT
T ss_pred             CCccccccCCCcCeeCHHHHc--------ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCchhcc
Confidence            666666778999999999983        2477899999999999999999999998888777777776654433    4


Q ss_pred             CCCHHHHHHHHHhcccCCCCCCCHHHHHhccccccC
Q 004959          571 SLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNS  606 (721)
Q Consensus       571 ~lS~el~dLI~~cL~~DP~kRPSa~eLL~Hp~f~~~  606 (721)
                      .+++++++||++||+.||++|||+.|+|+||||+..
T Consensus       263 ~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~  298 (494)
T 3lij_A          263 NVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKEM  298 (494)
T ss_dssp             TSCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHHH
T ss_pred             cCCHHHHHHHHHHCCCChhhCccHHHHhcCcccccC
Confidence            689999999999999999999999999999999763

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=5.3e-47  Score=391.80  Aligned_cols=260  Identities=25%  Similarity=0.437  Sum_probs=221.5

Q ss_pred             CCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcc-cHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeEE
Q 004959          340 SQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPK-SAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFY  418 (721)
Q Consensus       340 ~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~-~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~y  418 (721)
                      ++|++++.||+|+||.||+|.+..+|+.||+|++........ .....+.+.+|+.+|++++||||+++++++.+.+..|
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   84 (283)
T 3bhy_A            5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV   84 (283)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence            479999999999999999999999999999999875322211 1112467899999999999999999999999999999


Q ss_pred             EEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCC----ceEEeecCCccccC
Q 004959          419 IYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASG----VVKLADFGMAKHLT  494 (721)
Q Consensus       419 LVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g----~VKL~DFGlA~~l~  494 (721)
                      +||||+.+++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++    .+||+|||++..+.
T Consensus        85 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~~  163 (283)
T 3bhy_A           85 LILELVSGGELFDFLAEK-ESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIE  163 (283)
T ss_dssp             EEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEECC
T ss_pred             EEEeecCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEecccceecc
Confidence            999999999999999765 6799999999999999999999999999999999999998877    89999999998776


Q ss_pred             CCcccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhcCCCCC----C
Q 004959          495 GQKADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIP----D  570 (721)
Q Consensus       495 ~~~~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~~~~~p----~  570 (721)
                      .........||+.|+|||++.       ...++.++|||||||++|+|++|..||......+.+..+.......+    .
T Consensus       164 ~~~~~~~~~~~~~y~aPE~~~-------~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (283)
T 3bhy_A          164 AGNEFKNIFGTPEFVAPEIVN-------YEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFS  236 (283)
T ss_dssp             --------CCCGGGCCHHHHT-------TCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCHHHHT
T ss_pred             CCCcccccCCCcCccCcceec-------CCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCcchhcc
Confidence            555445567999999999984       34577899999999999999999999988777666666655444333    5


Q ss_pred             CCCHHHHHHHHHhcccCCCCCCCHHHHHhccccccCC
Q 004959          571 SLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQ  607 (721)
Q Consensus       571 ~lS~el~dLI~~cL~~DP~kRPSa~eLL~Hp~f~~~~  607 (721)
                      .++.++.+||++||+.||++||++.|+|+||||+...
T Consensus       237 ~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~  273 (283)
T 3bhy_A          237 NTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIR  273 (283)
T ss_dssp             TCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHH
T ss_pred             cCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHH
Confidence            6899999999999999999999999999999998643

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=9.2e-47  Score=396.71  Aligned_cols=263  Identities=24%  Similarity=0.372  Sum_probs=212.1

Q ss_pred             CCCCCeeEe-eEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhC-CCCCeeeeeeeEEec
Q 004959          337 PMNSQWQKG-KLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHL-KHPNIVQYYGSEIVE  414 (721)
Q Consensus       337 ~l~~~y~~~-k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L-~HPnIV~l~g~~~~~  414 (721)
                      .+.+.|++. +.||+|+||.||+|.+..+|+.||||++.....     ...+.+.+|+.+|.++ .||||+++++++.+.
T Consensus         9 ~~~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~   83 (316)
T 2ac3_A            9 RFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPG-----HIRSRVFREVEMLYQCQGHRNVLELIEFFEEE   83 (316)
T ss_dssp             CTTTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSS-----CCHHHHHHHHHHHHHTCCCTTBCCEEEEEEET
T ss_pred             ccceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcc-----hhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeC
Confidence            456789995 889999999999999999999999999864321     1245788999999985 799999999999999


Q ss_pred             CeEEEEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCc---eEEeecCCcc
Q 004959          415 DKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGV---VKLADFGMAK  491 (721)
Q Consensus       415 ~~~yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~---VKL~DFGlA~  491 (721)
                      +.+|+||||+.||+|.+++... ..+++..++.++.||+.||.|||++||+||||||+||||+.++.   +||+|||++.
T Consensus        84 ~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~  162 (316)
T 2ac3_A           84 DRFYLVFEKMRGGSILSHIHKR-RHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGS  162 (316)
T ss_dssp             TEEEEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC
T ss_pred             CEEEEEEEcCCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCcc
Confidence            9999999999999999999775 67999999999999999999999999999999999999988775   9999999997


Q ss_pred             ccCCCc--------ccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchh----------
Q 004959          492 HLTGQK--------ADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYE----------  553 (721)
Q Consensus       492 ~l~~~~--------~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~----------  553 (721)
                      .+....        .....+||+.|+|||++.+....  ...++.++|||||||++|+|++|+.||.+..          
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~--~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~  240 (316)
T 2ac3_A          163 GIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEE--ASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGE  240 (316)
T ss_dssp             -------------------CCSGGGCCHHHHHHTSHH--HHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----
T ss_pred             ccccCCccccccccccccccCCcCccChHHhhccccc--ccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccc
Confidence            654221        12245699999999999641100  0124557999999999999999999997642          


Q ss_pred             -----hHHHHHHHhhcCCCCC----CCCCHHHHHHHHHhcccCCCCCCCHHHHHhccccccCC
Q 004959          554 -----GAAAMFKVMRDTPAIP----DSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQ  607 (721)
Q Consensus       554 -----~~~~~~ki~~~~~~~p----~~lS~el~dLI~~cL~~DP~kRPSa~eLL~Hp~f~~~~  607 (721)
                           .......+......++    ..++.++++||++||+.||++|||+.|+|+||||+...
T Consensus       241 ~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~  303 (316)
T 2ac3_A          241 ACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCA  303 (316)
T ss_dssp             CCHHHHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC---
T ss_pred             cchhHHHHHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhhcCCC
Confidence                 1223344444444444    46899999999999999999999999999999998653

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=1.3e-46  Score=387.03  Aligned_cols=255  Identities=23%  Similarity=0.400  Sum_probs=214.4

Q ss_pred             CCCCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhC-CCCCeeeeeeeEEecCe
Q 004959          338 MNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHL-KHPNIVQYYGSEIVEDK  416 (721)
Q Consensus       338 l~~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L-~HPnIV~l~g~~~~~~~  416 (721)
                      +.++|++++.||+|+||.||+|.+..+|+.||||++....   ........+.+|+.++..+ +||||+++++++.+.+.
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~   85 (289)
T 1x8b_A            9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPL---AGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDH   85 (289)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCC---TTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTE
T ss_pred             ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccc---cccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCe
Confidence            3468999999999999999999999999999999986422   2223456788999999999 89999999999999999


Q ss_pred             EEEEEeeccCCCHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCC--------------
Q 004959          417 FYIYLEYVHPGSINKYVREHC---GAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDAS--------------  479 (721)
Q Consensus       417 ~yLVmEy~~gGsL~~~L~~~~---~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~--------------  479 (721)
                      .|+||||++|++|.+++....   +.+++..++.++.||+.||.|||++||+||||||+||||+.+              
T Consensus        86 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~  165 (289)
T 1x8b_A           86 MLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDD  165 (289)
T ss_dssp             EEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC----------------
T ss_pred             EEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCccccccccccc
Confidence            999999999999999997642   679999999999999999999999999999999999999844              


Q ss_pred             -----CceEEeecCCccccCCCcccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhh
Q 004959          480 -----GVVKLADFGMAKHLTGQKADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEG  554 (721)
Q Consensus       480 -----g~VKL~DFGlA~~l~~~~~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~  554 (721)
                           ..+||+|||++.......   ...||+.|+|||++.+      ...++.++|||||||++|+|++|..++.....
T Consensus       166 ~~~~~~~~kl~Dfg~~~~~~~~~---~~~gt~~y~aPE~~~~------~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~  236 (289)
T 1x8b_A          166 WASNKVMFKIGDLGHVTRISSPQ---VEEGDSRFLANEVLQE------NYTHLPKADIFALALTVVCAAGAEPLPRNGDQ  236 (289)
T ss_dssp             ----CCCEEECCCTTCEETTCSC---CCCCCGGGCCHHHHTT------CCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHH
T ss_pred             ccCCceEEEEcccccccccCCcc---ccCCCccccChhHhcC------CCCCCchhhHHHHHHHHHHHhcCCCCCcchhH
Confidence                 479999999998765432   3469999999999852      23566799999999999999999988765443


Q ss_pred             HHHHHHHhhcCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhccccccC
Q 004959          555 AAAMFKVMRDTPAIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNS  606 (721)
Q Consensus       555 ~~~~~ki~~~~~~~p~~lS~el~dLI~~cL~~DP~kRPSa~eLL~Hp~f~~~  606 (721)
                      ...+.  ....+.++..+++++.+||.+||+.||++|||+.|+++||||...
T Consensus       237 ~~~~~--~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  286 (289)
T 1x8b_A          237 WHEIR--QGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSA  286 (289)
T ss_dssp             HHHHH--TTCCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC---
T ss_pred             HHHHH--cCCCCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChHhhhh
Confidence            32222  123456778899999999999999999999999999999999864

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=1e-47  Score=405.24  Aligned_cols=262  Identities=23%  Similarity=0.416  Sum_probs=219.6

Q ss_pred             CCCCCCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecC
Q 004959          336 LPMNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVED  415 (721)
Q Consensus       336 ~~l~~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~  415 (721)
                      ..+.++|++++.||+|+||.||+|.+..+|+.||||++...  ........+.+.+|+.++++++|||||++++++....
T Consensus         8 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~   85 (311)
T 3ork_A            8 SHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRAD--LARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAET   85 (311)
T ss_dssp             SEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTT--TTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEE
T ss_pred             ceecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCcc--ccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccC
Confidence            34567999999999999999999999999999999998642  2334566778999999999999999999999987754


Q ss_pred             e----EEEEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCcc
Q 004959          416 K----FYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAK  491 (721)
Q Consensus       416 ~----~yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~  491 (721)
                      .    .|+||||++|++|.+++... +.+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++.
T Consensus        86 ~~~~~~~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~  164 (311)
T 3ork_A           86 PAGPLPYIVMEYVDGVTLRDIVHTE-GPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIAR  164 (311)
T ss_dssp             TTEEEEEEEEECCCEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSCEEECCCSCC-
T ss_pred             CCCcccEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCCEEEeeccCcc
Confidence            3    49999999999999999765 679999999999999999999999999999999999999999999999999998


Q ss_pred             ccCCCcc----cccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhcCCC
Q 004959          492 HLTGQKA----DLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPA  567 (721)
Q Consensus       492 ~l~~~~~----~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~~~~  567 (721)
                      .+.....    ....+||+.|+|||++.+       ..++.++|||||||++|+|++|+.||.+....+...........
T Consensus       165 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~  237 (311)
T 3ork_A          165 AIADSGNSVTQTAAVIGTAQYLSPEQARG-------DSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPI  237 (311)
T ss_dssp             -----------------CCTTCCHHHHHT-------CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCC
T ss_pred             cccccccccccccccCcCcccCCHHHhcC-------CCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCC
Confidence            7654322    223569999999999953       45778999999999999999999999987777766666655433


Q ss_pred             C----CCCCCHHHHHHHHHhcccCCCCCCCHHHHHhccccccCC
Q 004959          568 I----PDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQ  607 (721)
Q Consensus       568 ~----p~~lS~el~dLI~~cL~~DP~kRPSa~eLL~Hp~f~~~~  607 (721)
                      .    ...++.++.+||.+||+.||++||++.++|.|+|++...
T Consensus       238 ~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~  281 (311)
T 3ork_A          238 PPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHN  281 (311)
T ss_dssp             CHHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHT
T ss_pred             CcccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHhc
Confidence            2    246899999999999999999999999999999997543

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=1.2e-47  Score=403.73  Aligned_cols=253  Identities=24%  Similarity=0.442  Sum_probs=207.1

Q ss_pred             CCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecC----
Q 004959          340 SQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVED----  415 (721)
Q Consensus       340 ~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~----  415 (721)
                      ++|++++.||+|+||+||+|+++.+|+.||||++....    .....+.+.+|+.+|++++|||||++++++.+..    
T Consensus         6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~   81 (332)
T 3qd2_B            6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPN----RELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKW   81 (332)
T ss_dssp             HHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCS----TTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHH
T ss_pred             hcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCC----chhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchh
Confidence            47999999999999999999999999999999986432    2234577899999999999999999999886543    


Q ss_pred             -----------------------------------------------------eEEEEEeeccCCCHHHHHHHhc--CCC
Q 004959          416 -----------------------------------------------------KFYIYLEYVHPGSINKYVREHC--GAI  440 (721)
Q Consensus       416 -----------------------------------------------------~~yLVmEy~~gGsL~~~L~~~~--~~L  440 (721)
                                                                           .+|+|||||.|++|.+++....  ...
T Consensus        82 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~  161 (332)
T 3qd2_B           82 QEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDR  161 (332)
T ss_dssp             HHHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGS
T ss_pred             hhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccch
Confidence                                                                 3899999999999999997642  235


Q ss_pred             CHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCCc-------------ccccCCCCCc
Q 004959          441 TESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQK-------------ADLSMKGSPY  507 (721)
Q Consensus       441 se~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~~-------------~~~s~~GT~~  507 (721)
                      .+..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.+....             .....+||+.
T Consensus       162 ~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~  241 (332)
T 3qd2_B          162 EHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL  241 (332)
T ss_dssp             CHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGG
T ss_pred             hhHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcC
Confidence            667799999999999999999999999999999999999999999999998775432             2234579999


Q ss_pred             cCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhc-CCCCCCCCCHHHHHHHHHhccc
Q 004959          508 WMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRD-TPAIPDSLSPEGKDFLRCCFQR  586 (721)
Q Consensus       508 Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~-~~~~p~~lS~el~dLI~~cL~~  586 (721)
                      |+|||++.+       ..++.++|||||||++|+|++|..|+....  .....+... .+..+...++++.+||.+||+.
T Consensus       242 y~aPE~~~~-------~~~~~~~Di~slG~il~el~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~  312 (332)
T 3qd2_B          242 YMSPEQIHG-------NNYSHKVDIFSLGLILFELLYSFSTQMERV--RIITDVRNLKFPLLFTQKYPQEHMMVQDMLSP  312 (332)
T ss_dssp             GSCHHHHHC-------CCCCTHHHHHHHHHHHHHHHSCCCCHHHHH--HHHHHHHTTCCCHHHHHHCHHHHHHHHHHHCS
T ss_pred             ccChHHhcC-------CCCcchhhHHHHHHHHHHHHHcCCChhHHH--HHHHHhhccCCCcccccCChhHHHHHHHHccC
Confidence            999999953       457789999999999999999987764322  222222221 1112234678899999999999


Q ss_pred             CCCCCCCHHHHHhcccccc
Q 004959          587 NPADRPPASLLLEHRFLKN  605 (721)
Q Consensus       587 DP~kRPSa~eLL~Hp~f~~  605 (721)
                      ||++|||+.|+|+||||++
T Consensus       313 ~p~~Rps~~~~l~~~~f~~  331 (332)
T 3qd2_B          313 SPTERPEATDIIENAIFEN  331 (332)
T ss_dssp             SGGGSCCHHHHHHSTTCCC
T ss_pred             CCCcCCCHHHHhhchhhhc
Confidence            9999999999999999975

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=9e-47  Score=407.27  Aligned_cols=258  Identities=34%  Similarity=0.637  Sum_probs=224.8

Q ss_pred             CCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeEEE
Q 004959          340 SQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYI  419 (721)
Q Consensus       340 ~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~yL  419 (721)
                      ..|++++.||+|+||.||+|++..+|+.||||++...  ........+.+.+|+.+|+.++|||||++++++...+..||
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~--~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l  131 (348)
T 1u5q_A           54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYS--GKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWL  131 (348)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESC--SSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccc--cccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEE
Confidence            4699999999999999999999999999999998642  22344556789999999999999999999999999999999


Q ss_pred             EEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCCccc
Q 004959          420 YLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKAD  499 (721)
Q Consensus       420 VmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~~~~  499 (721)
                      ||||+. |+|.+++......+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+...   
T Consensus       132 v~e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~---  207 (348)
T 1u5q_A          132 VMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA---  207 (348)
T ss_dssp             EEECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB---
T ss_pred             EEecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEeeccCceecCCC---
Confidence            999997 6888888766678999999999999999999999999999999999999999999999999999866432   


Q ss_pred             ccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhcCC--CCCCCCCHHHH
Q 004959          500 LSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTP--AIPDSLSPEGK  577 (721)
Q Consensus       500 ~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~~~--~~p~~lS~el~  577 (721)
                      ...+||+.|+|||++.+.    ....++.++|||||||+||||++|+.||.+......+..+.....  ..+..+++++.
T Consensus       208 ~~~~gt~~y~aPE~~~~~----~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  283 (348)
T 1u5q_A          208 NSFVGTPYWMAPEVILAM----DEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFR  283 (348)
T ss_dssp             CCCCSCGGGCCHHHHHTT----SSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCCCTTSCHHHH
T ss_pred             CcccCCcceeCHhhhccc----cCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHH
Confidence            346799999999998532    234577899999999999999999999988776666666655432  23457899999


Q ss_pred             HHHHHhcccCCCCCCCHHHHHhccccccCC
Q 004959          578 DFLRCCFQRNPADRPPASLLLEHRFLKNSQ  607 (721)
Q Consensus       578 dLI~~cL~~DP~kRPSa~eLL~Hp~f~~~~  607 (721)
                      +||.+||+.||++|||++++|+||||....
T Consensus       284 ~li~~~l~~dP~~Rps~~~ll~h~~~~~~~  313 (348)
T 1u5q_A          284 NFVDSCLQKIPQDRPTSEVLLKHRFVLRER  313 (348)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHTTCHHHHSCC
T ss_pred             HHHHHHcccChhhCcCHHHHhhChhhhccC
Confidence            999999999999999999999999997643

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=2.9e-47  Score=410.45  Aligned_cols=253  Identities=23%  Similarity=0.367  Sum_probs=215.5

Q ss_pred             CCCCCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhC-CCCCeeeeeeeEEecC
Q 004959          337 PMNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHL-KHPNIVQYYGSEIVED  415 (721)
Q Consensus       337 ~l~~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L-~HPnIV~l~g~~~~~~  415 (721)
                      .+.++|++++.||+|+||+||+|.++.+|+.||||++.....         ...+|+.+|.++ .|||||++++++.+.+
T Consensus        19 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~---------~~~~E~~~l~~~~~hp~iv~~~~~~~~~~   89 (342)
T 2qr7_A           19 QFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR---------DPTEEIEILLRYGQHPNIITLKDVYDDGK   89 (342)
T ss_dssp             CHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC---------CCHHHHHHHHHHTTSTTBCCEEEEEECSS
T ss_pred             CccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC---------ChHHHHHHHHHhcCCCCcCeEEEEEEcCC
Confidence            455689999999999999999999999999999999864321         234678888877 7999999999999999


Q ss_pred             eEEEEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCC-C---ceEEeecCCcc
Q 004959          416 KFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDAS-G---VVKLADFGMAK  491 (721)
Q Consensus       416 ~~yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~-g---~VKL~DFGlA~  491 (721)
                      .+|+|||||.||+|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||+..+ +   .+||+|||++.
T Consensus        90 ~~~lv~E~~~gg~L~~~i~~~-~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~  168 (342)
T 2qr7_A           90 YVYVVTELMKGGELLDKILRQ-KFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAK  168 (342)
T ss_dssp             EEEEEECCCCSCBHHHHHHTC-TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCE
T ss_pred             EEEEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcc
Confidence            999999999999999999764 679999999999999999999999999999999999998543 3   59999999998


Q ss_pred             ccCCCc-ccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCch---hhHHHHHHHhhcCCC
Q 004959          492 HLTGQK-ADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEY---EGAAAMFKVMRDTPA  567 (721)
Q Consensus       492 ~l~~~~-~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~---~~~~~~~ki~~~~~~  567 (721)
                      .+.... .....+||+.|+|||++.+..       ++.++|||||||++|+|++|..||.+.   ...+.+..+......
T Consensus       169 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~-------~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~  241 (342)
T 2qr7_A          169 QLRAENGLLMTPCYTANFVAPEVLERQG-------YDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFS  241 (342)
T ss_dssp             ECBCTTCCBCCSSCCSSCCCHHHHHHHH-------HHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCC
T ss_pred             cCcCCCCceeccCCCccccCHHHhcCCC-------CCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcc
Confidence            765433 345678999999999997543       456899999999999999999999752   334455555554443


Q ss_pred             C----CCCCCHHHHHHHHHhcccCCCCCCCHHHHHhccccccC
Q 004959          568 I----PDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNS  606 (721)
Q Consensus       568 ~----p~~lS~el~dLI~~cL~~DP~kRPSa~eLL~Hp~f~~~  606 (721)
                      +    +..+++++++||++||+.||++||++.|+|+||||.+.
T Consensus       242 ~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~  284 (342)
T 2qr7_A          242 LSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHW  284 (342)
T ss_dssp             CCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHTG
T ss_pred             cCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCeecCc
Confidence            3    35689999999999999999999999999999999764

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=1.5e-47  Score=448.71  Aligned_cols=259  Identities=26%  Similarity=0.429  Sum_probs=231.9

Q ss_pred             CCCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhC-CCCCeeeeeeeEEecCeE
Q 004959          339 NSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHL-KHPNIVQYYGSEIVEDKF  417 (721)
Q Consensus       339 ~~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L-~HPnIV~l~g~~~~~~~~  417 (721)
                      .++|+++++||+|+||+||+|+++.+|+.||||++.+..  .......+.+..|+.+|..+ +||+|+.+++++.+.+.+
T Consensus       340 ~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~--~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~  417 (674)
T 3pfq_A          340 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDV--VIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRL  417 (674)
T ss_dssp             CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHH--HHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEE
T ss_pred             ccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccc--cccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEE
Confidence            358999999999999999999999999999999986311  00112345778899999988 699999999999999999


Q ss_pred             EEEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccC-CC
Q 004959          418 YIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLT-GQ  496 (721)
Q Consensus       418 yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~-~~  496 (721)
                      ||||||+.||+|.+++... +.+++..++.|+.||+.||+|||++|||||||||+||||+.+|.+||+|||+++... ..
T Consensus       418 ~lV~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~  496 (674)
T 3pfq_A          418 YFVMEYVNGGDLMYHIQQV-GRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDG  496 (674)
T ss_dssp             EEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEEECCCTTCEECCCTT
T ss_pred             EEEEeCcCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEEEeecceeeccccCC
Confidence            9999999999999999875 689999999999999999999999999999999999999999999999999998643 33


Q ss_pred             cccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhcCCCCCCCCCHHH
Q 004959          497 KADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDSLSPEG  576 (721)
Q Consensus       497 ~~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~~~~~p~~lS~el  576 (721)
                      ......+||+.|||||++.       ...++.++||||||||||||++|..||.+.+..+.+..++.....+|..++.++
T Consensus       497 ~~~~~~~GT~~Y~APE~l~-------~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~  569 (674)
T 3pfq_A          497 VTTKTFCGTPDYIAPEIIA-------YQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEA  569 (674)
T ss_dssp             CCBCCCCSCSSSCCHHHHT-------CCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSSCCCCCTTSCHHH
T ss_pred             cccccccCCCcccCHhhhc-------CCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHH
Confidence            3445688999999999993       456788999999999999999999999998888899999999889999999999


Q ss_pred             HHHHHHhcccCCCCCCCH-----HHHHhccccccCC
Q 004959          577 KDFLRCCFQRNPADRPPA-----SLLLEHRFLKNSQ  607 (721)
Q Consensus       577 ~dLI~~cL~~DP~kRPSa-----~eLL~Hp~f~~~~  607 (721)
                      ++||++||++||++|+++     +||++||||+...
T Consensus       570 ~~li~~lL~~dP~~R~~~~~~~~~ei~~h~ff~~i~  605 (674)
T 3pfq_A          570 VAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYID  605 (674)
T ss_dssp             HHHHHHHSCSSSTTCTTCSTTHHHHHHSSGGGSSCC
T ss_pred             HHHHHHHccCCHHHCCCCCCCcHHHHhcCccccCCC
Confidence            999999999999999997     9999999998753

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=4.1e-46  Score=397.69  Aligned_cols=262  Identities=26%  Similarity=0.520  Sum_probs=219.1

Q ss_pred             CCCCCCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEec-
Q 004959          336 LPMNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVE-  414 (721)
Q Consensus       336 ~~l~~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~-  414 (721)
                      ..+.++|++++.||+|+||.||+|.+..+|+.||||++..    .........+.+|+.+|+.++||||+++++++... 
T Consensus         7 ~~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~----~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   82 (353)
T 2b9h_A            7 YNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEP----FDKPLFALRTLREIKILKHFKHENIITIFNIQRPDS   82 (353)
T ss_dssp             CCSCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC----CSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSC
T ss_pred             cccccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecc----cccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccc
Confidence            3456799999999999999999999999999999999852    23345567788999999999999999999987654 


Q ss_pred             ----CeEEEEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCc
Q 004959          415 ----DKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMA  490 (721)
Q Consensus       415 ----~~~yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA  490 (721)
                          ...|+||||+. ++|.+++..  +.+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++
T Consensus        83 ~~~~~~~~lv~e~~~-~~L~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a  159 (353)
T 2b9h_A           83 FENFNEVYIIQELMQ-TDLHRVIST--QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLA  159 (353)
T ss_dssp             STTCCCEEEEECCCS-EEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTC
T ss_pred             cCccceEEEEEeccC-ccHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcEEEEecccc
Confidence                67999999997 689999875  57999999999999999999999999999999999999999999999999999


Q ss_pred             cccCCCcc-----------cccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHH
Q 004959          491 KHLTGQKA-----------DLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMF  559 (721)
Q Consensus       491 ~~l~~~~~-----------~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~  559 (721)
                      ..+.....           ....+||+.|+|||++.+      ...++.++|||||||++|+|++|+.||.+....+.+.
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~  233 (353)
T 2b9h_A          160 RIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLT------SAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLL  233 (353)
T ss_dssp             EECC----------------CCCCCCGGGCCHHHHHS------CCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH
T ss_pred             cccccccccccCccccccchhhccccccccCCeeecc------CCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHH
Confidence            87643221           123579999999999852      3567889999999999999999999998866554443


Q ss_pred             HHhhc------------------------CCC--------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhccccccCC
Q 004959          560 KVMRD------------------------TPA--------IPDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQ  607 (721)
Q Consensus       560 ki~~~------------------------~~~--------~p~~lS~el~dLI~~cL~~DP~kRPSa~eLL~Hp~f~~~~  607 (721)
                      .+...                        .+.        .+..+++++.+||.+||+.||++|||+.|+|+||||+...
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~  313 (353)
T 2b9h_A          234 LIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYH  313 (353)
T ss_dssp             HHHHHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred             HHHHHhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccccC
Confidence            33210                        011        1246899999999999999999999999999999999766


Q ss_pred             CCC
Q 004959          608 QPD  610 (721)
Q Consensus       608 ~~~  610 (721)
                      .+.
T Consensus       314 ~~~  316 (353)
T 2b9h_A          314 DPN  316 (353)
T ss_dssp             CTT
T ss_pred             Ccc
Confidence            543

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=1.5e-47  Score=429.25  Aligned_cols=261  Identities=25%  Similarity=0.480  Sum_probs=229.3

Q ss_pred             CCCCCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCe
Q 004959          337 PMNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDK  416 (721)
Q Consensus       337 ~l~~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~  416 (721)
                      .+.++|++++.||+|+||.||+|.++.+|+.||||++......  .....+.+.+|+.+|++++|||||++++++.+.+.
T Consensus        23 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~  100 (484)
T 3nyv_A           23 IFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVK--QKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGY  100 (484)
T ss_dssp             CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC--BSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred             cccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcc--cchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCE
Confidence            3456899999999999999999999999999999998643221  12235678999999999999999999999999999


Q ss_pred             EEEEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEE---cCCCceEEeecCCcccc
Q 004959          417 FYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLV---DASGVVKLADFGMAKHL  493 (721)
Q Consensus       417 ~yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILl---d~~g~VKL~DFGlA~~l  493 (721)
                      +|+|||||.||+|.+++... +.+++..++.++.||+.||.|||++||+||||||+||||   +.++.+||+|||++..+
T Consensus       101 ~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~  179 (484)
T 3nyv_A          101 FYLVGEVYTGGELFDEIISR-KRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF  179 (484)
T ss_dssp             EEEEECCCCSCBHHHHHHTC-SCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHB
T ss_pred             EEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEc
Confidence            99999999999999999765 679999999999999999999999999999999999999   46789999999999887


Q ss_pred             CCCcccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhcCCCCC----
Q 004959          494 TGQKADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIP----  569 (721)
Q Consensus       494 ~~~~~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~~~~~p----  569 (721)
                      .........+||+.|+|||++.+        .++.++|||||||++|+|++|..||.+....+.+..+......++    
T Consensus       180 ~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  251 (484)
T 3nyv_A          180 EASKKMKDKIGTAYYIAPEVLHG--------TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQW  251 (484)
T ss_dssp             CCCCSHHHHTTGGGTCCHHHHHT--------CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGG
T ss_pred             ccccccccCCCCccccCceeecC--------CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCccc
Confidence            66655556789999999999853        367799999999999999999999999888777777776654433    


Q ss_pred             CCCCHHHHHHHHHhcccCCCCCCCHHHHHhccccccCCC
Q 004959          570 DSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQ  608 (721)
Q Consensus       570 ~~lS~el~dLI~~cL~~DP~kRPSa~eLL~Hp~f~~~~~  608 (721)
                      ..+++++++||++||+.||++|||+.|+|+||||+....
T Consensus       252 ~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~~~~~~~~  290 (484)
T 3nyv_A          252 KKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQTYTK  290 (484)
T ss_dssp             GGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHHHTC
T ss_pred             ccCCHHHHHHHHHHCCCChhHCcCHHHHhhChhhccccc
Confidence            468999999999999999999999999999999986543

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=7.1e-47  Score=411.41  Aligned_cols=252  Identities=26%  Similarity=0.468  Sum_probs=214.6

Q ss_pred             CCCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEec----
Q 004959          339 NSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVE----  414 (721)
Q Consensus       339 ~~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~----  414 (721)
                      ..+|++++.||+|+||+||+|.+..+|+.||||++.....         ...+|+.+|+.++|||||++++++...    
T Consensus         6 ~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~---------~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~   76 (383)
T 3eb0_A            6 SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR---------YKNRELDIMKVLDHVNIIKLVDYFYTTGDEE   76 (383)
T ss_dssp             CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT---------SCCHHHHHHTTCCCTTBCCEEEEEEEC----
T ss_pred             cceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc---------hHHHHHHHHHHcCCCCccchhheeeecCccc
Confidence            4689999999999999999999999999999999863221         224799999999999999999998543    


Q ss_pred             ----------------------------------CeEEEEEeeccCCCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHH
Q 004959          415 ----------------------------------DKFYIYLEYVHPGSINKYVRE---HCGAITESVVRNFTRHILSGLA  457 (721)
Q Consensus       415 ----------------------------------~~~yLVmEy~~gGsL~~~L~~---~~~~Lse~~i~~i~~QIl~AL~  457 (721)
                                                        ..+++||||+. |+|.+.+..   ....+++..++.++.||+.||.
T Consensus        77 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~  155 (383)
T 3eb0_A           77 PKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVG  155 (383)
T ss_dssp             ---------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHH
T ss_pred             ccccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHH
Confidence                                              34899999997 588777753   3467999999999999999999


Q ss_pred             HHhhCCeeccCCCCCcEEEc-CCCceEEeecCCccccCCCcccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHH
Q 004959          458 YLHSKKTIHRDIKGANLLVD-ASGVVKLADFGMAKHLTGQKADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLG  536 (721)
Q Consensus       458 yLHs~gIIHrDLKPeNILld-~~g~VKL~DFGlA~~l~~~~~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLG  536 (721)
                      |||++||+||||||+||||+ .++.+||+|||+++.+..........||+.|+|||++.+      ...++.++||||||
T Consensus       156 ~LH~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~------~~~~~~~~DiwslG  229 (383)
T 3eb0_A          156 FIHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLG------ATEYTPSIDLWSIG  229 (383)
T ss_dssp             HHHTTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHTT------CSSCCTHHHHHHHH
T ss_pred             HHHHCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCCcCcccCCCccCHHHhcC------CCCCCcchhhhhHH
Confidence            99999999999999999998 688999999999998776666667889999999999853      23477899999999


Q ss_pred             HHHHHHhhCCCCCCchhhHHHHHHHhhcCC-----------------------------CCCCCCCHHHHHHHHHhcccC
Q 004959          537 CTIIEMYTGKPPWSEYEGAAAMFKVMRDTP-----------------------------AIPDSLSPEGKDFLRCCFQRN  587 (721)
Q Consensus       537 VILyELLtG~~PF~~~~~~~~~~ki~~~~~-----------------------------~~p~~lS~el~dLI~~cL~~D  587 (721)
                      |++|||++|+.||.+....+.+..++....                             .++..++.++.+||.+||+.|
T Consensus       230 ~il~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d  309 (383)
T 3eb0_A          230 CVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYE  309 (383)
T ss_dssp             HHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSS
T ss_pred             HHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCC
Confidence            999999999999998777666665543100                             134568999999999999999


Q ss_pred             CCCCCCHHHHHhccccccC
Q 004959          588 PADRPPASLLLEHRFLKNS  606 (721)
Q Consensus       588 P~kRPSa~eLL~Hp~f~~~  606 (721)
                      |++|||+.|+|+||||+..
T Consensus       310 P~~R~t~~e~l~hp~f~~~  328 (383)
T 3eb0_A          310 PDLRINPYEAMAHPFFDHL  328 (383)
T ss_dssp             GGGSCCHHHHHTSGGGHHH
T ss_pred             hhhCCCHHHHhcCHHHHHH
Confidence            9999999999999999864

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=4.6e-47  Score=412.72  Aligned_cols=293  Identities=25%  Similarity=0.419  Sum_probs=218.7

Q ss_pred             CCCCCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEec--
Q 004959          337 PMNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVE--  414 (721)
Q Consensus       337 ~l~~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~--  414 (721)
                      .+.++|++++.||+|+||.||+|.+..+|+.||||++..   ........+.+.+|+.+|+.++||||+++++++...  
T Consensus        26 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~---~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~  102 (367)
T 2fst_X           26 EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR---PFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARS  102 (367)
T ss_dssp             EEETTEEEEEECC----CCEEEEEETTTTEEEEEEECSS---TTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSS
T ss_pred             CCCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCc---cccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCc
Confidence            344789999999999999999999999999999998853   223445667889999999999999999999998654  


Q ss_pred             ----CeEEEEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCc
Q 004959          415 ----DKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMA  490 (721)
Q Consensus       415 ----~~~yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA  490 (721)
                          ..+|+||||+ +++|.+++..  +.+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++
T Consensus       103 ~~~~~~~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kL~DFG~a  179 (367)
T 2fst_X          103 LEEFNDVYLVTHLM-GADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA  179 (367)
T ss_dssp             GGGCCCCEEEEECC-CEECC-------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC----
T ss_pred             cccCCeEEEEeccc-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCCEEEeecccc
Confidence                5689999999 7899999865  57999999999999999999999999999999999999999999999999999


Q ss_pred             cccCCCcccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhc------
Q 004959          491 KHLTGQKADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRD------  564 (721)
Q Consensus       491 ~~l~~~~~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~------  564 (721)
                      +.....  ....+||+.|+|||++.+      ...++.++||||||||+|||++|+.||.+.+..+.+..+...      
T Consensus       180 ~~~~~~--~~~~~~t~~y~aPE~~~~------~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~  251 (367)
T 2fst_X          180 RHTADE--MTGYVATRWYRAPEIMLN------WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGA  251 (367)
T ss_dssp             -------------CCCTTCCHHHHTT------CCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCH
T ss_pred             cccccc--CCCcCcCcCccChHHHcC------CcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCH
Confidence            865432  344679999999999853      245778899999999999999999999887766655544321      


Q ss_pred             -----------------CCCC--------CCCCCHHHHHHHHHhcccCCCCCCCHHHHHhccccccCCCCCCCCcccccC
Q 004959          565 -----------------TPAI--------PDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQPDVPSCSLSFS  619 (721)
Q Consensus       565 -----------------~~~~--------p~~lS~el~dLI~~cL~~DP~kRPSa~eLL~Hp~f~~~~~~~~~~~~~~~~  619 (721)
                                       ....        ...+++++.+||.+||+.||++|||+.|+|+||||.....+........+ 
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~~~~~~~~~~~~~-  330 (367)
T 2fst_X          252 ELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPY-  330 (367)
T ss_dssp             HHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCGGGCCCCCCC-
T ss_pred             HHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhhccCCCCCCCCCCC-
Confidence                             0111        13568999999999999999999999999999999987665432211111 


Q ss_pred             CCCCCCCCCChhHHHhhhHHHHHhh
Q 004959          620 GMQLTEKPHSPREKADAKYDQVAAL  644 (721)
Q Consensus       620 ~~~l~~~~~~~~~~~~~~~d~~~~l  644 (721)
                      ...+........+..+..|+++...
T Consensus       331 ~~~~~~~~~~~~~~~~~~~~e~~~~  355 (367)
T 2fst_X          331 DQSLESRDLLIDEWKSLTYDEVISF  355 (367)
T ss_dssp             CGGGSSCCCCHHHHHHHHHHHHHHC
T ss_pred             CcchhhccCCHHHHHHHHHHHHHHh
Confidence            1223333444556667777777653

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=4.2e-47  Score=426.45  Aligned_cols=259  Identities=24%  Similarity=0.444  Sum_probs=224.7

Q ss_pred             CCCCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeE
Q 004959          338 MNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKF  417 (721)
Q Consensus       338 l~~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~  417 (721)
                      +.++|++++.||+|+||+||+|.++.+|+.||||++........   ....+.+|+.+|++++|||||++++++.+.+.+
T Consensus        20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~---~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~   96 (486)
T 3mwu_A           20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNK---DTSTILREVELLKKLDHPNIMKLFEILEDSSSF   96 (486)
T ss_dssp             HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCS---CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccch---HHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEE
Confidence            44689999999999999999999999999999999863211111   246788999999999999999999999999999


Q ss_pred             EEEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEc---CCCceEEeecCCccccC
Q 004959          418 YIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVD---ASGVVKLADFGMAKHLT  494 (721)
Q Consensus       418 yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld---~~g~VKL~DFGlA~~l~  494 (721)
                      |+|||||.||+|.+++... +.+++..++.++.||+.||.|||++||+||||||+||||+   .++.+||+|||++..+.
T Consensus        97 ~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~  175 (486)
T 3mwu_A           97 YIVGELYTGGELFDEIIKR-KRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ  175 (486)
T ss_dssp             EEEECCCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBC
T ss_pred             EEEEEcCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECC
Confidence            9999999999999999765 6899999999999999999999999999999999999995   45679999999998776


Q ss_pred             CCcccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhcCCCCC----C
Q 004959          495 GQKADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIP----D  570 (721)
Q Consensus       495 ~~~~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~~~~~p----~  570 (721)
                      ........+||+.|+|||++.+        .++.++||||||||+|+|++|..||.+....+.+..+......++    .
T Consensus       176 ~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  247 (486)
T 3mwu_A          176 QNTKMKDRIGTAYYIAPEVLRG--------TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWR  247 (486)
T ss_dssp             CC----CCTTGGGGCCGGGGGS--------CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCSGGGG
T ss_pred             CCCccCCCcCCCCCCCHHHhCC--------CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcccC
Confidence            6655566789999999999842        377899999999999999999999998887777777766544332    4


Q ss_pred             CCCHHHHHHHHHhcccCCCCCCCHHHHHhccccccCCC
Q 004959          571 SLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQ  608 (721)
Q Consensus       571 ~lS~el~dLI~~cL~~DP~kRPSa~eLL~Hp~f~~~~~  608 (721)
                      .+++++++||++||+.||++|||+.|+|+||||+....
T Consensus       248 ~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~~~  285 (486)
T 3mwu_A          248 TISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYSS  285 (486)
T ss_dssp             GSCHHHHHHHHHHTCSSTTTSCCHHHHHHCHHHHHTCC
T ss_pred             CCCHHHHHHHHHHcCCChhhCcCHHHHhcCHhhccCcc
Confidence            68999999999999999999999999999999987644

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=1.8e-46  Score=406.86  Aligned_cols=294  Identities=23%  Similarity=0.413  Sum_probs=230.7

Q ss_pred             CCCCCCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecC
Q 004959          336 LPMNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVED  415 (721)
Q Consensus       336 ~~l~~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~  415 (721)
                      ..+..+|++++.||+|+||.||+|.+..+|+.||||++..   ........+.+.+|+.+|+.++||||+++++++...+
T Consensus        38 ~~l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~---~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~  114 (371)
T 4exu_A           38 WELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSR---PFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPAS  114 (371)
T ss_dssp             EEEETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS---TTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCS
T ss_pred             ecccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecc---cccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccC
Confidence            3456799999999999999999999999999999999863   2234556788999999999999999999999998776


Q ss_pred             eE------EEEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCC
Q 004959          416 KF------YIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGM  489 (721)
Q Consensus       416 ~~------yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGl  489 (721)
                      ..      |+||||+. ++|.+++.   ..+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+
T Consensus       115 ~~~~~~~~~lv~e~~~-~~l~~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~  190 (371)
T 4exu_A          115 SLRNFYDFYLVMPFMQ-TDLQKIMG---MEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGL  190 (371)
T ss_dssp             SSTTCCCCEEEEECCC-EEHHHHTT---SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSTTC
T ss_pred             CcccceeEEEEEcccc-ccHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCCEEEEecCc
Confidence            54      99999997 68887763   4599999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCCcccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhcC----
Q 004959          490 AKHLTGQKADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDT----  565 (721)
Q Consensus       490 A~~l~~~~~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~~----  565 (721)
                      ++.....  ....+||+.|+|||++.+      ...++.++|||||||++|+|++|+.||.+....+.+..+....    
T Consensus       191 a~~~~~~--~~~~~~t~~y~aPE~~~~------~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~  262 (371)
T 4exu_A          191 ARHADAE--MTGYVVTRWYRAPEVILS------WMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPG  262 (371)
T ss_dssp             C----------CTTCCCTTSCHHHHSC------CSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred             ccccccC--cCCcccCccccCHHHhcC------CCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCc
Confidence            9865432  345679999999999842      2457788999999999999999999998876665555543210    


Q ss_pred             -------------------C--------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhccccccCCCCCCCCccccc
Q 004959          566 -------------------P--------AIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQPDVPSCSLSF  618 (721)
Q Consensus       566 -------------------~--------~~p~~lS~el~dLI~~cL~~DP~kRPSa~eLL~Hp~f~~~~~~~~~~~~~~~  618 (721)
                                         .        .++..+++++.+||.+||+.||++|||+.|+|+||||+....+.........
T Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~~~~~~~~  342 (371)
T 4exu_A          263 TEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRDPEEETEAQQP  342 (371)
T ss_dssp             HHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTCCGGGCCCCSSC
T ss_pred             HHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcccccCCCcccccccccC
Confidence                               0        1124579999999999999999999999999999999976554332222111


Q ss_pred             CCCCCCCCCCChhHHHhhhHHHHHhh
Q 004959          619 SGMQLTEKPHSPREKADAKYDQVAAL  644 (721)
Q Consensus       619 ~~~~l~~~~~~~~~~~~~~~d~~~~l  644 (721)
                      ....+........+.++..++++..+
T Consensus       343 ~~~~~~~~~~~~~~~~~~~~~~~~~~  368 (371)
T 4exu_A          343 FDDSLEHEKLTVDEWKQHIYKEIVNF  368 (371)
T ss_dssp             CCCTTSSCCCCHHHHHHHHHHHHHHC
T ss_pred             cCcchhhcccchHHHHHHHHHHHHhc
Confidence            11223333444555566666665543

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=2e-47  Score=439.43  Aligned_cols=259  Identities=22%  Similarity=0.396  Sum_probs=225.6

Q ss_pred             CCCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeEE
Q 004959          339 NSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFY  418 (721)
Q Consensus       339 ~~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~y  418 (721)
                      .++|+++++||+|+||.||+|+++.+|+.||||++....  .........+.+|+.+|+.++|||||++++++.+.+.+|
T Consensus       183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~--~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~  260 (576)
T 2acx_A          183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKR--IKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALC  260 (576)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHH--HHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHh--hhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEE
Confidence            357999999999999999999999999999999986321  011112456789999999999999999999999999999


Q ss_pred             EEEeeccCCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCCc
Q 004959          419 IYLEYVHPGSINKYVREHC-GAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQK  497 (721)
Q Consensus       419 LVmEy~~gGsL~~~L~~~~-~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~~  497 (721)
                      ||||||.||+|.+++.... ..+++..++.|+.||+.||.|||++|||||||||+||||+.+|.+||+|||+++.+....
T Consensus       261 lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~~  340 (576)
T 2acx_A          261 LVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ  340 (576)
T ss_dssp             EEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCTTC
T ss_pred             EEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCCeEEEecccceecccCc
Confidence            9999999999999997642 349999999999999999999999999999999999999999999999999998876655


Q ss_pred             ccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchh----hHHHHHHHhhcCCCCCCCCC
Q 004959          498 ADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYE----GAAAMFKVMRDTPAIPDSLS  573 (721)
Q Consensus       498 ~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~----~~~~~~ki~~~~~~~p~~lS  573 (721)
                      .....+||+.|+|||++.       ...++.++|||||||+||||++|..||....    .......+......++..++
T Consensus       341 ~~~~~~GT~~Y~APEvl~-------~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~~~~~p~~~s  413 (576)
T 2acx_A          341 TIKGRVGTVGYMAPEVVK-------NERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSERFS  413 (576)
T ss_dssp             CEECCCSCGGGCCHHHHT-------TCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHCCCCCCTTSC
T ss_pred             cccccCCCccccCHHHHc-------CCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcccccCCccCC
Confidence            555678999999999994       3457789999999999999999999997642    23344455555667788999


Q ss_pred             HHHHHHHHHhcccCCCCCC-----CHHHHHhccccccC
Q 004959          574 PEGKDFLRCCFQRNPADRP-----PASLLLEHRFLKNS  606 (721)
Q Consensus       574 ~el~dLI~~cL~~DP~kRP-----Sa~eLL~Hp~f~~~  606 (721)
                      .++++||++||+.||++||     +++|+++||||++.
T Consensus       414 ~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~i  451 (576)
T 2acx_A          414 PQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKL  451 (576)
T ss_dssp             HHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTTC
T ss_pred             HHHHHHHHHhccCCHHHcCCCCCCCHHHHHhChhhccC
Confidence            9999999999999999999     89999999999874

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=1.1e-46  Score=416.42  Aligned_cols=255  Identities=28%  Similarity=0.477  Sum_probs=213.6

Q ss_pred             CCCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEec----
Q 004959          339 NSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVE----  414 (721)
Q Consensus       339 ~~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~----  414 (721)
                      ...|++++.||+|+||+||+|++..+|+.||||++....         ..+.+|+.+|+.++|||||++++++...    
T Consensus        53 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~---------~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~  123 (420)
T 1j1b_A           53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK---------RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKK  123 (420)
T ss_dssp             EEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT---------TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTT
T ss_pred             cceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc---------hhHHHHHHHHHHcCCCCccceeeEEeccCCCC
Confidence            457999999999999999999999999999999986321         1234799999999999999999988542    


Q ss_pred             --CeEEEEEeeccCCCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCC-CceEEeecC
Q 004959          415 --DKFYIYLEYVHPGSINKYVRE---HCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDAS-GVVKLADFG  488 (721)
Q Consensus       415 --~~~yLVmEy~~gGsL~~~L~~---~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~-g~VKL~DFG  488 (721)
                        ..+++||||+.+ +|.+++..   ....+++..++.|+.||+.||.|||++||+||||||+||||+.+ +.+||+|||
T Consensus       124 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DFG  202 (420)
T 1j1b_A          124 DEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFG  202 (420)
T ss_dssp             TEEEEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCCT
T ss_pred             cceeEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccch
Confidence              247899999975 66666543   34679999999999999999999999999999999999999965 578999999


Q ss_pred             CccccCCCcccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhc----
Q 004959          489 MAKHLTGQKADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRD----  564 (721)
Q Consensus       489 lA~~l~~~~~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~----  564 (721)
                      +++.+.........+||+.|+|||++.+      ...++.++||||||||||||++|+.||.+....+.+.+++..    
T Consensus       203 ~a~~~~~~~~~~~~~~t~~y~aPE~~~~------~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p  276 (420)
T 1j1b_A          203 SAKQLVRGEPNVSYICSRYYRAPELIFG------ATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTP  276 (420)
T ss_dssp             TCEECCTTCCCCSCCSCTTSCCHHHHTT------CSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSC
T ss_pred             hhhhcccCCCceeeeeCCCcCCHHHHcC------CCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence            9998766666667789999999999853      235778999999999999999999999887766666555431    


Q ss_pred             -------------CCC------------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhccccccCCCC
Q 004959          565 -------------TPA------------IPDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQP  609 (721)
Q Consensus       565 -------------~~~------------~p~~lS~el~dLI~~cL~~DP~kRPSa~eLL~Hp~f~~~~~~  609 (721)
                                   ...            ++..++.++++||++||+.||++||++.|+|+||||.....+
T Consensus       277 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~  346 (420)
T 1j1b_A          277 TREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDP  346 (420)
T ss_dssp             CHHHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGCT
T ss_pred             CHHHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhcccccc
Confidence                         001            234578999999999999999999999999999999876544

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=5.2e-47  Score=400.70  Aligned_cols=261  Identities=23%  Similarity=0.394  Sum_probs=217.0

Q ss_pred             CCCCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecC--
Q 004959          338 MNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVED--  415 (721)
Q Consensus       338 l~~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~--  415 (721)
                      +..+|++++.||+|+||.||+|.+..+|+.||||++....    .....+.+.+|+.+|++++||||+++++++...+  
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   82 (319)
T 4euu_A            7 SNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNIS----FLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTR   82 (319)
T ss_dssp             SSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGG----GGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTC
T ss_pred             CCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEecccc----ccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCc
Confidence            4568999999999999999999999999999999986321    1122456789999999999999999999988765  


Q ss_pred             eEEEEEeeccCCCHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEE----cCCCceEEeecCC
Q 004959          416 KFYIYLEYVHPGSINKYVREHC--GAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLV----DASGVVKLADFGM  489 (721)
Q Consensus       416 ~~yLVmEy~~gGsL~~~L~~~~--~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILl----d~~g~VKL~DFGl  489 (721)
                      ..|+||||+.|++|.+++....  ..+++..++.++.||+.||.|||++||+||||||+||||    +.++.+||+|||+
T Consensus        83 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~  162 (319)
T 4euu_A           83 HKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGA  162 (319)
T ss_dssp             CEEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCCTT
T ss_pred             eEEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccCCC
Confidence            7899999999999999997653  239999999999999999999999999999999999999    7778899999999


Q ss_pred             ccccCCCcccccCCCCCccCChhhHHHHhhcC-CCCCCcchhhHHHHHHHHHHHhhCCCCCCc----hhhHHHHHHHhhc
Q 004959          490 AKHLTGQKADLSMKGSPYWMAPELMMAVMQKG-KSSDSALAVDIWSLGCTIIEMYTGKPPWSE----YEGAAAMFKVMRD  564 (721)
Q Consensus       490 A~~l~~~~~~~s~~GT~~Y~APEvl~~~~~~~-k~~~~s~asDVWSLGVILyELLtG~~PF~~----~~~~~~~~ki~~~  564 (721)
                      ++.+.........+||+.|+|||++....... ....++.++|||||||++|||++|+.||..    ....+.+.++...
T Consensus       163 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~  242 (319)
T 4euu_A          163 ARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG  242 (319)
T ss_dssp             CEECCTTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHH
T ss_pred             ceecCCCCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcC
Confidence            99877666666678999999999996532221 235678899999999999999999999964    2334455555443


Q ss_pred             CC-------------------------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhccc
Q 004959          565 TP-------------------------AIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRF  602 (721)
Q Consensus       565 ~~-------------------------~~p~~lS~el~dLI~~cL~~DP~kRPSa~eLL~Hp~  602 (721)
                      .+                         .+...++..+.+||++||+.||++|||++|+|+||-
T Consensus       243 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~  305 (319)
T 4euu_A          243 KPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETS  305 (319)
T ss_dssp             CCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHH
T ss_pred             CCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccH
Confidence            32                         111234567899999999999999999999999974

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=4.1e-47  Score=405.20  Aligned_cols=253  Identities=22%  Similarity=0.361  Sum_probs=198.9

Q ss_pred             CCeeEe---eEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCC-CCCeeeeeeeEEecC
Q 004959          340 SQWQKG---KLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLK-HPNIVQYYGSEIVED  415 (721)
Q Consensus       340 ~~y~~~---k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~-HPnIV~l~g~~~~~~  415 (721)
                      .+|++.   +.||+|+||.||+|.++.+|+.||||++...        ....+.+|+.+|+.+. |||||++++++.+.+
T Consensus         8 ~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~--------~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~   79 (325)
T 3kn6_A            8 QHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR--------MEANTQKEITALKLCEGHPNIVKLHEVFHDQL   79 (325)
T ss_dssp             HHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGG--------GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred             hccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChh--------hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCC
Confidence            356664   7899999999999999999999999998631        2356788999999997 999999999999999


Q ss_pred             eEEEEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCC---ceEEeecCCccc
Q 004959          416 KFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASG---VVKLADFGMAKH  492 (721)
Q Consensus       416 ~~yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g---~VKL~DFGlA~~  492 (721)
                      ..||||||+.||+|.+++... +.+++.+++.++.||+.||.|||++||+||||||+||||+.++   .+||+|||+++.
T Consensus        80 ~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~  158 (325)
T 3kn6_A           80 HTFLVMELLNGGELFERIKKK-KHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARL  158 (325)
T ss_dssp             EEEEEECCCCSCBHHHHHHHC-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEE
T ss_pred             EEEEEEEccCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEecccccee
Confidence            999999999999999999775 6899999999999999999999999999999999999998766   899999999986


Q ss_pred             cCCCc-ccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhh-------HHHHHHHhhc
Q 004959          493 LTGQK-ADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEG-------AAAMFKVMRD  564 (721)
Q Consensus       493 l~~~~-~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~-------~~~~~ki~~~  564 (721)
                      ..... .....+||+.|+|||++.       ...++.++|||||||++|+|++|..||.....       .+.+..+...
T Consensus       159 ~~~~~~~~~~~~~t~~y~aPE~~~-------~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~  231 (325)
T 3kn6_A          159 KPPDNQPLKTPCFTLHYAAPELLN-------QNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKG  231 (325)
T ss_dssp             CCC-----------------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTT
T ss_pred             cCCCCCcccccCCCcCccCHHHhc-------CCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcC
Confidence            65433 234567999999999984       34578899999999999999999999976432       3444555555


Q ss_pred             CCCCC----CCCCHHHHHHHHHhcccCCCCCCCHHHHHhccccccCCC
Q 004959          565 TPAIP----DSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQ  608 (721)
Q Consensus       565 ~~~~p----~~lS~el~dLI~~cL~~DP~kRPSa~eLL~Hp~f~~~~~  608 (721)
                      ...++    ..+++++++||.+||+.||++|||+.|+++||||++...
T Consensus       232 ~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~~~~  279 (325)
T 3kn6_A          232 DFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGSQ  279 (325)
T ss_dssp             CCCCCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCTTCC
T ss_pred             CCCCCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChhhccCcc
Confidence            44443    358999999999999999999999999999999987543

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=1.9e-47  Score=409.82  Aligned_cols=256  Identities=23%  Similarity=0.375  Sum_probs=220.5

Q ss_pred             CCCCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcc---cHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEec
Q 004959          338 MNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPK---SAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVE  414 (721)
Q Consensus       338 l~~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~---~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~  414 (721)
                      +.++|++++.||+|+||.||+|.+..+|+.||||++........   .....+.+.+|+.+|++++||||+++++++.+.
T Consensus        22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~  101 (335)
T 3dls_A           22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ  101 (335)
T ss_dssp             HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred             cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence            34689999999999999999999999999999999875321111   011234577899999999999999999999999


Q ss_pred             CeEEEEEeeccCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCcccc
Q 004959          415 DKFYIYLEYVHPG-SINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHL  493 (721)
Q Consensus       415 ~~~yLVmEy~~gG-sL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l  493 (721)
                      +.+|+||||+.+| +|.+++... ..+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+
T Consensus       102 ~~~~lv~e~~~~g~~l~~~~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~  180 (335)
T 3dls_A          102 GFFQLVMEKHGSGLDLFAFIDRH-PRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYL  180 (335)
T ss_dssp             SEEEEEEECCTTSCBHHHHHHTC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             CEEEEEEEeCCCCccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCcEEEeecccceEC
Confidence            9999999999776 999999764 67999999999999999999999999999999999999999999999999999987


Q ss_pred             CCCcccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhcCCCCCCCCC
Q 004959          494 TGQKADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDSLS  573 (721)
Q Consensus       494 ~~~~~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~~~~~p~~lS  573 (721)
                      .........+||+.|+|||++.+      ...++.++|||||||++|+|++|..||.....      ........+..++
T Consensus       181 ~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~~DiwslG~il~el~~g~~pf~~~~~------~~~~~~~~~~~~~  248 (335)
T 3dls_A          181 ERGKLFYTFCGTIEYCAPEVLMG------NPYRGPELEMWSLGVTLYTLVFEENPFCELEE------TVEAAIHPPYLVS  248 (335)
T ss_dssp             CTTCCBCEECSCGGGCCHHHHTT------CCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG------GTTTCCCCSSCCC
T ss_pred             CCCCceeccCCCccccChhhhcC------CCCCCCcccchhHHHHHHHHHhCCCchhhHHH------HHhhccCCCcccC
Confidence            76665566789999999999953      22237789999999999999999999976432      2334445667799


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHHhccccccC
Q 004959          574 PEGKDFLRCCFQRNPADRPPASLLLEHRFLKNS  606 (721)
Q Consensus       574 ~el~dLI~~cL~~DP~kRPSa~eLL~Hp~f~~~  606 (721)
                      +++.+||.+||+.||++|||++++++||||+..
T Consensus       249 ~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~~  281 (335)
T 3dls_A          249 KELMSLVSGLLQPVPERRTTLEKLVTDPWVTQP  281 (335)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHHCTTTTCC
T ss_pred             HHHHHHHHHHccCChhhCcCHHHHhcCccccCC
Confidence            999999999999999999999999999999864

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=5.6e-47  Score=433.51  Aligned_cols=258  Identities=27%  Similarity=0.446  Sum_probs=225.7

Q ss_pred             CCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeEEE
Q 004959          340 SQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYI  419 (721)
Q Consensus       340 ~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~yL  419 (721)
                      +.|++.++||+|+||+||+|+++.+|+.||||++.+..  .......+.+.+|+.+|++++|||||++++++.+.+.+||
T Consensus       185 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~--~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~l  262 (543)
T 3c4z_A          185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKR--LKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCL  262 (543)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHH--HHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             hheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHH--hhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEE
Confidence            58999999999999999999999999999999986321  0111224678899999999999999999999999999999


Q ss_pred             EEeeccCCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCC
Q 004959          420 YLEYVHPGSINKYVREH---CGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQ  496 (721)
Q Consensus       420 VmEy~~gGsL~~~L~~~---~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~  496 (721)
                      ||||+.||+|.+++...   ...+++..++.|+.||+.||.|||++||+||||||+||||+.+|.+||+|||+++.+...
T Consensus       263 VmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~~  342 (543)
T 3c4z_A          263 VMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAG  342 (543)
T ss_dssp             EECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred             EEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCCEEEeecceeeeccCC
Confidence            99999999999999764   246999999999999999999999999999999999999999999999999999877554


Q ss_pred             cc-cccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCch----hhHHHHHHHhhcCCCCCCC
Q 004959          497 KA-DLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEY----EGAAAMFKVMRDTPAIPDS  571 (721)
Q Consensus       497 ~~-~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~----~~~~~~~ki~~~~~~~p~~  571 (721)
                      .. ....+||+.|+|||++.       +..++.++|||||||+||||++|+.||...    ...+....+......+|..
T Consensus       343 ~~~~~~~~GT~~Y~APE~l~-------~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~~~~p~~  415 (543)
T 3c4z_A          343 QTKTKGYAGTPGFMAPELLL-------GEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDK  415 (543)
T ss_dssp             CCCBCCCCSCTTTSCHHHHT-------TCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCCCCCCTT
T ss_pred             CcccccccCCccccChhhhc-------CCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhcccCCCcc
Confidence            43 34468999999999994       346788999999999999999999999764    2345556667777788899


Q ss_pred             CCHHHHHHHHHhcccCCCCCCC-----HHHHHhccccccC
Q 004959          572 LSPEGKDFLRCCFQRNPADRPP-----ASLLLEHRFLKNS  606 (721)
Q Consensus       572 lS~el~dLI~~cL~~DP~kRPS-----a~eLL~Hp~f~~~  606 (721)
                      ++.++++||++||+.||++||+     +++|++||||++.
T Consensus       416 ~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~i  455 (543)
T 3c4z_A          416 FSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDI  455 (543)
T ss_dssp             SCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTTC
T ss_pred             cCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcCccccCC
Confidence            9999999999999999999996     5899999999874

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=1.1e-46  Score=390.26  Aligned_cols=261  Identities=28%  Similarity=0.466  Sum_probs=204.0

Q ss_pred             CCCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeEE
Q 004959          339 NSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFY  418 (721)
Q Consensus       339 ~~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~y  418 (721)
                      .++|++++.||+|+||.||+|.+..+|+.||||++...   .......+.+.++..+++.+.||||+++++++.+.+..|
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~   82 (290)
T 3fme_A            6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRAT---VNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVW   82 (290)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC------CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEE
T ss_pred             HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecc---cCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEE
Confidence            35899999999999999999999999999999998532   223334445555666688899999999999999999999


Q ss_pred             EEEeeccCCCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHhhC-CeeccCCCCCcEEEcCCCceEEeecCCccccC
Q 004959          419 IYLEYVHPGSINKYVRE---HCGAITESVVRNFTRHILSGLAYLHSK-KTIHRDIKGANLLVDASGVVKLADFGMAKHLT  494 (721)
Q Consensus       419 LVmEy~~gGsL~~~L~~---~~~~Lse~~i~~i~~QIl~AL~yLHs~-gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~  494 (721)
                      +||||++ |+|.+++..   ....+++..++.++.||+.||.|||++ ||+||||||+||||+.++.+||+|||++..+.
T Consensus        83 lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  161 (290)
T 3fme_A           83 ICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLV  161 (290)
T ss_dssp             EEEECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEBCCC-------
T ss_pred             EEEehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecCCccccc
Confidence            9999997 588777754   346899999999999999999999998 99999999999999999999999999998776


Q ss_pred             CCcccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCch-hhHHHHHHHhhc-CCCC-CCC
Q 004959          495 GQKADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEY-EGAAAMFKVMRD-TPAI-PDS  571 (721)
Q Consensus       495 ~~~~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~-~~~~~~~ki~~~-~~~~-p~~  571 (721)
                      .........||+.|+|||++...   .....++.++|||||||++|+|++|..||... .....+...... .... +..
T Consensus       162 ~~~~~~~~~~t~~y~aPE~~~~~---~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (290)
T 3fme_A          162 DDVAKDIDAGCKPYMAPERINPE---LNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPADK  238 (290)
T ss_dssp             --------CCCCCCSCHHHHSCC---TTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCCCCCCTTT
T ss_pred             ccccccccCCCccccChhhcChh---hcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCCCCccccc
Confidence            65555556799999999997321   12345788999999999999999999999753 333333333333 2222 356


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHHHHhccccccC
Q 004959          572 LSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNS  606 (721)
Q Consensus       572 lS~el~dLI~~cL~~DP~kRPSa~eLL~Hp~f~~~  606 (721)
                      ++.++.+||.+||+.||++|||+.|+++||||+..
T Consensus       239 ~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~~  273 (290)
T 3fme_A          239 FSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTLH  273 (290)
T ss_dssp             SCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred             CCHHHHHHHHHHhhcChhhCcCHHHHHhCcccccC
Confidence            89999999999999999999999999999999853

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=2.8e-46  Score=392.06  Aligned_cols=259  Identities=25%  Similarity=0.456  Sum_probs=218.0

Q ss_pred             CCCCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeE
Q 004959          338 MNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKF  417 (721)
Q Consensus       338 l~~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~  417 (721)
                      +.++|++++.||+|+||.||+|.+..+|+.||||++...  ........+.+.+|+.++++++||||+++++++...+.+
T Consensus         9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~   86 (294)
T 4eqm_A            9 INERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIP--PREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCY   86 (294)
T ss_dssp             EETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECC--SSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEE
T ss_pred             hhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccC--ccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeE
Confidence            456899999999999999999999999999999998643  234456678899999999999999999999999999999


Q ss_pred             EEEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCCc
Q 004959          418 YIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQK  497 (721)
Q Consensus       418 yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~~  497 (721)
                      |+||||++|++|.+++... +.+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+....
T Consensus        87 ~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  165 (294)
T 4eqm_A           87 YLVMEYIEGPTLSEYIESH-GPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETS  165 (294)
T ss_dssp             EEEEECCCSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC----
T ss_pred             EEEEeCCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEEeCCCcccccccc
Confidence            9999999999999999775 689999999999999999999999999999999999999999999999999998765432


Q ss_pred             c--cccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhcCC-----CCCC
Q 004959          498 A--DLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTP-----AIPD  570 (721)
Q Consensus       498 ~--~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~~~-----~~p~  570 (721)
                      .  ....+||+.|+|||++.+       ..++.++|||||||++|+|++|+.||.+........+......     ..+.
T Consensus       166 ~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (294)
T 4eqm_A          166 LTQTNHVLGTVQYFSPEQAKG-------EATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRK  238 (294)
T ss_dssp             ---------CCSSCCHHHHHT-------CCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCCCCHHHHSCT
T ss_pred             ccccCccccCccccCHhHhcC-------CCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccCCCcchhccc
Confidence            2  234579999999999953       3456789999999999999999999998776666655554432     2346


Q ss_pred             CCCHHHHHHHHHhcccCCCCCCCHHHHHhccccccC
Q 004959          571 SLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNS  606 (721)
Q Consensus       571 ~lS~el~dLI~~cL~~DP~kRPSa~eLL~Hp~f~~~  606 (721)
                      .+++++.++|.+||+.||++||+..+.+.+.|..-.
T Consensus       239 ~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~  274 (294)
T 4eqm_A          239 DIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVL  274 (294)
T ss_dssp             TSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSS
T ss_pred             CCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHH
Confidence            789999999999999999999966666667775543

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=1.3e-46  Score=400.45  Aligned_cols=261  Identities=25%  Similarity=0.408  Sum_probs=219.4

Q ss_pred             CCCeeEe-eEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCC-CCCeeeeeeeEEecCe
Q 004959          339 NSQWQKG-KLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLK-HPNIVQYYGSEIVEDK  416 (721)
Q Consensus       339 ~~~y~~~-k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~-HPnIV~l~g~~~~~~~  416 (721)
                      .+.|.+. +.||+|+||.||+|.+..+|+.||||++.......   .....+.+|+.+|+.+. ||||+++++++...+.
T Consensus        27 ~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~  103 (327)
T 3lm5_A           27 NNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQ---DCRAEILHEIAVLELAKSCPRVINLHEVYENTSE  103 (327)
T ss_dssp             HHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTE---ECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred             hhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcch---HHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCe
Confidence            4568887 89999999999999999999999999986432222   23467889999999995 6999999999999999


Q ss_pred             EEEEEeeccCCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcC---CCceEEeecCCccc
Q 004959          417 FYIYLEYVHPGSINKYVREH-CGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDA---SGVVKLADFGMAKH  492 (721)
Q Consensus       417 ~yLVmEy~~gGsL~~~L~~~-~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~---~g~VKL~DFGlA~~  492 (721)
                      +|+||||+.||+|.+++... ...+++..++.++.||+.||+|||++||+||||||+||||+.   ++.+||+|||++..
T Consensus       104 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~  183 (327)
T 3lm5_A          104 IILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRK  183 (327)
T ss_dssp             EEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGGCEE
T ss_pred             EEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCccccc
Confidence            99999999999999988543 367999999999999999999999999999999999999987   78999999999988


Q ss_pred             cCCCcccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhcCCC----C
Q 004959          493 LTGQKADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPA----I  568 (721)
Q Consensus       493 l~~~~~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~~~~----~  568 (721)
                      +.........+||+.|+|||++.       ...++.++|||||||++|+|++|+.||......+....+......    .
T Consensus       184 ~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  256 (327)
T 3lm5_A          184 IGHACELREIMGTPEYLAPEILN-------YDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEET  256 (327)
T ss_dssp             C---------CCCGGGCCHHHHT-------TCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTT
T ss_pred             cCCccccccccCCcCccCCeeec-------CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccCchh
Confidence            76555555678999999999983       456778999999999999999999999887777766666554332    3


Q ss_pred             CCCCCHHHHHHHHHhcccCCCCCCCHHHHHhccccccCCCC
Q 004959          569 PDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQP  609 (721)
Q Consensus       569 p~~lS~el~dLI~~cL~~DP~kRPSa~eLL~Hp~f~~~~~~  609 (721)
                      +..++.++.+||.+||+.||++|||++|+|+||||++....
T Consensus       257 ~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~~~~~~~  297 (327)
T 3lm5_A          257 FSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDFE  297 (327)
T ss_dssp             TTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTCGGGCCCCTT
T ss_pred             hcccCHHHHHHHHHHcCCChhhCcCHHHHhCCHhhcccccc
Confidence            35689999999999999999999999999999999876543

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.9e-46  Score=401.66  Aligned_cols=263  Identities=24%  Similarity=0.473  Sum_probs=214.6

Q ss_pred             CCCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCC--CCeeeeeeeEEecCe
Q 004959          339 NSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKH--PNIVQYYGSEIVEDK  416 (721)
Q Consensus       339 ~~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~H--PnIV~l~g~~~~~~~  416 (721)
                      ...|++++.||+|+||.||+|.+. +++.||||++...   .......+.+.+|+.+|+.+.|  +||+++++++...+.
T Consensus         8 ~~~y~i~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~   83 (343)
T 3dbq_A            8 GRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLE---EADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQY   83 (343)
T ss_dssp             SCEEEEEEEESCCSSEEEEEEECT-TSCEEEEEEEECT---TCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred             cCEEEEEEEEecCCCeEEEEEEeC-CCCEEEEEEeecc---ccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCE
Confidence            457999999999999999999874 6899999998643   2345567889999999999986  999999999999999


Q ss_pred             EEEEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCC
Q 004959          417 FYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQ  496 (721)
Q Consensus       417 ~yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~  496 (721)
                      +|||||+ .+++|.+++... +.+++.+++.++.||+.||.|||++||+||||||+||||+ ++.+||+|||+++.+...
T Consensus        84 ~~lv~e~-~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~  160 (343)
T 3dbq_A           84 IYMVMEC-GNIDLNSWLKKK-KSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD  160 (343)
T ss_dssp             EEEEECC-CSEEHHHHHHHS-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC---
T ss_pred             EEEEEeC-CCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CCcEEEeecccccccCcc
Confidence            9999995 578999999875 7899999999999999999999999999999999999996 688999999999876543


Q ss_pred             cc---cccCCCCCccCChhhHHHHhhcC----CCCCCcchhhHHHHHHHHHHHhhCCCCCCchhh-HHHHHHHhh--cCC
Q 004959          497 KA---DLSMKGSPYWMAPELMMAVMQKG----KSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEG-AAAMFKVMR--DTP  566 (721)
Q Consensus       497 ~~---~~s~~GT~~Y~APEvl~~~~~~~----k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~-~~~~~ki~~--~~~  566 (721)
                      ..   ....+||+.|+|||++.+.....    ....++.++|||||||+||+|++|+.||..... ...+..+..  ...
T Consensus       161 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~  240 (343)
T 3dbq_A          161 TTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEI  240 (343)
T ss_dssp             ---------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSCC
T ss_pred             cccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhcCCccc
Confidence            32   23467999999999996521111    124678899999999999999999999976433 233333332  234


Q ss_pred             CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhccccccCCC
Q 004959          567 AIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQ  608 (721)
Q Consensus       567 ~~p~~lS~el~dLI~~cL~~DP~kRPSa~eLL~Hp~f~~~~~  608 (721)
                      .++...+.++.+||.+||+.||++|||+.|+|+||||+....
T Consensus       241 ~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~  282 (343)
T 3dbq_A          241 EFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTH  282 (343)
T ss_dssp             CCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCCC
T ss_pred             CCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCccccccCC
Confidence            567778899999999999999999999999999999986544

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=4.6e-47  Score=403.60  Aligned_cols=260  Identities=28%  Similarity=0.505  Sum_probs=216.5

Q ss_pred             CCCCCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCe
Q 004959          337 PMNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDK  416 (721)
Q Consensus       337 ~l~~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~  416 (721)
                      ...++|++++.||+|+||.||+|++..+|+.||||++...   .......+.+.+|+.+|+.++||||+++++++...+.
T Consensus        22 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   98 (331)
T 4aaa_A           22 QSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLES---DDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKR   98 (331)
T ss_dssp             BCGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESC---SSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTE
T ss_pred             hhhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecC---CCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCE
Confidence            3456899999999999999999999999999999988632   3344556778899999999999999999999999999


Q ss_pred             EEEEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCC
Q 004959          417 FYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQ  496 (721)
Q Consensus       417 ~yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~  496 (721)
                      .|+||||+.+++|.+++... ..+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+...
T Consensus        99 ~~lv~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  177 (331)
T 4aaa_A           99 WYLVFEFVDHTILDDLELFP-NGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAP  177 (331)
T ss_dssp             EEEEEECCSEEHHHHHHHST-TCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCTTC------
T ss_pred             EEEEEecCCcchHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCcEEEEeCCCceeecCC
Confidence            99999999998888876543 67999999999999999999999999999999999999999999999999999876543


Q ss_pred             c-ccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhcC----------
Q 004959          497 K-ADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDT----------  565 (721)
Q Consensus       497 ~-~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~~----------  565 (721)
                      . ......||+.|+|||++.+      ...++.++|||||||++|+|++|+.||.+....+.+..+....          
T Consensus       178 ~~~~~~~~~t~~y~aPE~~~~------~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (331)
T 4aaa_A          178 GEVYDDEVATRWYRAPELLVG------DVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQEL  251 (331)
T ss_dssp             ------CCCCCTTCCHHHHTT------CTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHH
T ss_pred             ccccCCCcCCccccCcccccC------CCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhH
Confidence            2 2334679999999999842      2356789999999999999999999998876665554443210          


Q ss_pred             ---------CCC------------CCCCCHHHHHHHHHhcccCCCCCCCHHHHHhccccccC
Q 004959          566 ---------PAI------------PDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNS  606 (721)
Q Consensus       566 ---------~~~------------p~~lS~el~dLI~~cL~~DP~kRPSa~eLL~Hp~f~~~  606 (721)
                               ...            ...+++++.+||.+||+.||++|||+.|+|+||||+..
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~~  313 (331)
T 4aaa_A          252 FNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMD  313 (331)
T ss_dssp             HHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHGG
T ss_pred             hhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhccC
Confidence                     001            13578999999999999999999999999999999753

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=3.3e-47  Score=420.61  Aligned_cols=262  Identities=26%  Similarity=0.440  Sum_probs=206.9

Q ss_pred             CCCCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCC---cccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEec
Q 004959          338 MNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDD---PKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVE  414 (721)
Q Consensus       338 l~~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~---~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~  414 (721)
                      +.++|++++.||+|+||.||+|.+..+|+.||||++......   .........+.+|+.+|++++|||||++++++. .
T Consensus       133 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-~  211 (419)
T 3i6u_A          133 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD-A  211 (419)
T ss_dssp             HHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-S
T ss_pred             hhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-c
Confidence            356899999999999999999999999999999998643211   112223446889999999999999999999875 4


Q ss_pred             CeEEEEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCC---ceEEeecCCcc
Q 004959          415 DKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASG---VVKLADFGMAK  491 (721)
Q Consensus       415 ~~~yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g---~VKL~DFGlA~  491 (721)
                      +.+|+|||||.+|+|.+++... +.+++..++.++.||+.||.|||++||+||||||+||||+.++   .+||+|||+++
T Consensus       212 ~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~  290 (419)
T 3i6u_A          212 EDYYIVLELMEGGELFDKVVGN-KRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK  290 (419)
T ss_dssp             SEEEEEEECCTTCBGGGGTSSS-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTTT
T ss_pred             CceEEEEEcCCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeecccce
Confidence            5689999999999999988654 6799999999999999999999999999999999999997554   59999999999


Q ss_pred             ccCCCcccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHH-HHhhcCCCC--
Q 004959          492 HLTGQKADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMF-KVMRDTPAI--  568 (721)
Q Consensus       492 ~l~~~~~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~-ki~~~~~~~--  568 (721)
                      .+.........+||+.|+|||++.+.    ....++.++|||||||+||+|++|..||........+. .+.......  
T Consensus       291 ~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~~~~~  366 (419)
T 3i6u_A          291 ILGETSLMRTLCGTPTYLAPEVLVSV----GTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIP  366 (419)
T ss_dssp             SCC-----------CTTCCTTTTC--------CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCCCCCH
T ss_pred             ecCCCccccccCCCCCccCceeeecC----CCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCCCCCc
Confidence            87665555667899999999998431    23457889999999999999999999997654332222 222222222  


Q ss_pred             --CCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccccc
Q 004959          569 --PDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKN  605 (721)
Q Consensus       569 --p~~lS~el~dLI~~cL~~DP~kRPSa~eLL~Hp~f~~  605 (721)
                        ...+++++.+||++||+.||++||+++|+|+||||++
T Consensus       367 ~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~  405 (419)
T 3i6u_A          367 EVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD  405 (419)
T ss_dssp             HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred             hhhcccCHHHHHHHHHHccCChhHCcCHHHHhCCcccCC
Confidence              2468999999999999999999999999999999975

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=2.3e-46  Score=392.68  Aligned_cols=255  Identities=28%  Similarity=0.461  Sum_probs=220.6

Q ss_pred             CCCCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeE
Q 004959          338 MNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKF  417 (721)
Q Consensus       338 l~~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~  417 (721)
                      +.++|++++.||+|+||.||+|++..+|+.||||++....     ....+.+.+|+.+|+.++||||+++++++.+.+..
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   81 (304)
T 2jam_A            7 IRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSP-----AFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHY   81 (304)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC-----------HHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             hhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEeccc-----ccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEE
Confidence            3468999999999999999999999999999999986421     12235688999999999999999999999999999


Q ss_pred             EEEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEE---cCCCceEEeecCCccccC
Q 004959          418 YIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLV---DASGVVKLADFGMAKHLT  494 (721)
Q Consensus       418 yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILl---d~~g~VKL~DFGlA~~l~  494 (721)
                      |+||||+.|++|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++....
T Consensus        82 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~  160 (304)
T 2jam_A           82 YLVMQLVSGGELFDRILER-GVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ  160 (304)
T ss_dssp             EEEECCCCSCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCC
T ss_pred             EEEEEcCCCccHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceecC
Confidence            9999999999999999765 679999999999999999999999999999999999999   778899999999997544


Q ss_pred             CCcccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhcCCC----CCC
Q 004959          495 GQKADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPA----IPD  570 (721)
Q Consensus       495 ~~~~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~~~~----~p~  570 (721)
                      .. .....+||+.|+|||++.       ...++.++|||||||++|+|++|..||...........+......    .+.
T Consensus       161 ~~-~~~~~~~~~~y~aPE~~~-------~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  232 (304)
T 2jam_A          161 NG-IMSTACGTPGYVAPEVLA-------QKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWD  232 (304)
T ss_dssp             CB-TTHHHHSCCCBCCTTTBS-------SCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCCCTTTTT
T ss_pred             CC-ccccccCCCCccChHHhc-------cCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccc
Confidence            32 223456999999999983       456788999999999999999999999887766666666655433    335


Q ss_pred             CCCHHHHHHHHHhcccCCCCCCCHHHHHhccccccC
Q 004959          571 SLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNS  606 (721)
Q Consensus       571 ~lS~el~dLI~~cL~~DP~kRPSa~eLL~Hp~f~~~  606 (721)
                      .++.++.+||.+||+.||++||+++|+|+||||...
T Consensus       233 ~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~  268 (304)
T 2jam_A          233 DISESAKDFICHLLEKDPNERYTCEKALSHPWIDGN  268 (304)
T ss_dssp             TSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHSS
T ss_pred             cCCHHHHHHHHHHcCCChhHCcCHHHHhcCccccCC
Confidence            789999999999999999999999999999999864

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=9.4e-47  Score=394.09  Aligned_cols=265  Identities=25%  Similarity=0.430  Sum_probs=223.1

Q ss_pred             CCCCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEE--ecC
Q 004959          338 MNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEI--VED  415 (721)
Q Consensus       338 l~~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~--~~~  415 (721)
                      +.++|++++.||+|+||.||+|.+..+|+.||||++..... .......+.+.+|+.+|+.++||||+++++++.  ..+
T Consensus         3 l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   81 (305)
T 2wtk_C            3 LIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKL-RRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQ   81 (305)
T ss_dssp             --CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHH-HHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---
T ss_pred             cccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccc-cccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCC
Confidence            34689999999999999999999999999999999853210 001123567899999999999999999999984  456


Q ss_pred             eEEEEEeeccCCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccC
Q 004959          416 KFYIYLEYVHPGSINKYVREH-CGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLT  494 (721)
Q Consensus       416 ~~yLVmEy~~gGsL~~~L~~~-~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~  494 (721)
                      ..|+||||+.++ |.+++... ...+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+.
T Consensus        82 ~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~  160 (305)
T 2wtk_C           82 KMYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALH  160 (305)
T ss_dssp             CEEEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred             eEEEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCcEEeeccccccccC
Confidence            899999999876 77777653 4679999999999999999999999999999999999999999999999999998764


Q ss_pred             CC---cccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhcCCCCCCC
Q 004959          495 GQ---KADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDS  571 (721)
Q Consensus       495 ~~---~~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~~~~~p~~  571 (721)
                      ..   .......||+.|+|||++.+     ....++.++|||||||++|+|++|..||.+....+....+......++..
T Consensus       161 ~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~  235 (305)
T 2wtk_C          161 PFAADDTCRTSQGSPAFQPPEIANG-----LDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYAIPGD  235 (305)
T ss_dssp             TTCSSCEECCCCSCGGGCCHHHHTC-----CSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCCSS
T ss_pred             ccccccccccCCCCCCCcChhhccC-----cccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcCCCCCCCc
Confidence            32   22234669999999999842     22234678999999999999999999999887777777777777788889


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHHHHhccccccCCCC
Q 004959          572 LSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQP  609 (721)
Q Consensus       572 lS~el~dLI~~cL~~DP~kRPSa~eLL~Hp~f~~~~~~  609 (721)
                      +++++.+||.+||+.||++||++.|+++||||+....+
T Consensus       236 ~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~~  273 (305)
T 2wtk_C          236 CGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHPP  273 (305)
T ss_dssp             SCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSCCCC
T ss_pred             cCHHHHHHHHHHccCChhhCCCHHHHhcCcccccCCCC
Confidence            99999999999999999999999999999999876544

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=3.9e-46  Score=387.80  Aligned_cols=254  Identities=28%  Similarity=0.512  Sum_probs=216.4

Q ss_pred             CCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEe----cC
Q 004959          340 SQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIV----ED  415 (721)
Q Consensus       340 ~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~----~~  415 (721)
                      ..|++.+.||+|+||.||+|.+..++..||+|++...   .......+.+.+|+.+|+.++||||+++++++..    ..
T Consensus        26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~---~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~  102 (290)
T 1t4h_A           26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDR---KLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKK  102 (290)
T ss_dssp             CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGG---GSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCE
T ss_pred             eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecch---hhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCc
Confidence            4689999999999999999999999999999998642   2344567789999999999999999999998876    35


Q ss_pred             eEEEEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCC--eeccCCCCCcEEEc-CCCceEEeecCCccc
Q 004959          416 KFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKK--TIHRDIKGANLLVD-ASGVVKLADFGMAKH  492 (721)
Q Consensus       416 ~~yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~g--IIHrDLKPeNILld-~~g~VKL~DFGlA~~  492 (721)
                      .+|+||||+.+++|.+++... ..+++..++.++.||+.||.|||++|  |+||||||+||||+ .++.+||+|||++..
T Consensus       103 ~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~  181 (290)
T 1t4h_A          103 CIVLVTELMTSGTLKTYLKRF-KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL  181 (290)
T ss_dssp             EEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred             eEEEEEEecCCCCHHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCccc
Confidence            689999999999999999765 67999999999999999999999999  99999999999997 788999999999975


Q ss_pred             cCCCcccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhcC---CCCC
Q 004959          493 LTGQKADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDT---PAIP  569 (721)
Q Consensus       493 l~~~~~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~~---~~~p  569 (721)
                      .... ......||+.|+|||++.        ..++.++|||||||++|+|++|+.||................   ..++
T Consensus       182 ~~~~-~~~~~~~t~~y~aPE~~~--------~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  252 (290)
T 1t4h_A          182 KRAS-FAKAVIGTPEFMAPEMYE--------EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFD  252 (290)
T ss_dssp             CCTT-SBEESCSSCCCCCGGGGG--------TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGG
T ss_pred             cccc-ccccccCCcCcCCHHHHh--------ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCCccccC
Confidence            4433 234467999999999884        236779999999999999999999998755544444433322   2344


Q ss_pred             CCCCHHHHHHHHHhcccCCCCCCCHHHHHhccccccC
Q 004959          570 DSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNS  606 (721)
Q Consensus       570 ~~lS~el~dLI~~cL~~DP~kRPSa~eLL~Hp~f~~~  606 (721)
                      ...++++.+||.+||+.||++|||+.|+|+||||++.
T Consensus       253 ~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~f~~~  289 (290)
T 1t4h_A          253 KVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQEE  289 (290)
T ss_dssp             GCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC--
T ss_pred             CCCCHHHHHHHHHHccCChhhCCCHHHHhhCcccccC
Confidence            5678999999999999999999999999999999863

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=1e-46  Score=398.97  Aligned_cols=261  Identities=27%  Similarity=0.439  Sum_probs=212.4

Q ss_pred             CCCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCC---cccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecC
Q 004959          339 NSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDD---PKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVED  415 (721)
Q Consensus       339 ~~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~---~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~  415 (721)
                      .++|++++.||+|+||.||+|.+..+|+.||||++......   .........+.+|+.+|+.++||||+++++++...+
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   88 (322)
T 2ycf_A            9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED   88 (322)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS
T ss_pred             hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc
Confidence            45799999999999999999999999999999998642211   112233456889999999999999999999987655


Q ss_pred             eEEEEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCc---eEEeecCCccc
Q 004959          416 KFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGV---VKLADFGMAKH  492 (721)
Q Consensus       416 ~~yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~---VKL~DFGlA~~  492 (721)
                       .|+||||+.+++|.+++... ..+++..++.++.||+.||.|||++||+||||||+||||+.++.   +||+|||++..
T Consensus        89 -~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~  166 (322)
T 2ycf_A           89 -YYIVLELMEGGELFDKVVGN-KRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI  166 (322)
T ss_dssp             -EEEEEECCTTEETHHHHSTT-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTTCEE
T ss_pred             -eEEEEecCCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCcccee
Confidence             89999999999999998654 68999999999999999999999999999999999999987664   99999999987


Q ss_pred             cCCCcccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHH-HHHhhcCCCC---
Q 004959          493 LTGQKADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAM-FKVMRDTPAI---  568 (721)
Q Consensus       493 l~~~~~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~-~ki~~~~~~~---  568 (721)
                      +..........||+.|+|||++.+.    ....++.++|||||||++|+|++|..||........+ ..+.......   
T Consensus       167 ~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  242 (322)
T 2ycf_A          167 LGETSLMRTLCGTPTYLAPEVLVSV----GTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPE  242 (322)
T ss_dssp             CCCCHHHHHHHSCCTTCCHHHHHHT----TTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCCCCCHH
T ss_pred             cccccccccccCCcCccCchhhccC----CCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCccccCch
Confidence            7554433456799999999998542    2345678999999999999999999999765433222 2222222222   


Q ss_pred             -CCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccccc
Q 004959          569 -PDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKN  605 (721)
Q Consensus       569 -p~~lS~el~dLI~~cL~~DP~kRPSa~eLL~Hp~f~~  605 (721)
                       +..++.++.+||.+||+.||++||+++++|+||||++
T Consensus       243 ~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~~  280 (322)
T 2ycf_A          243 VWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD  280 (322)
T ss_dssp             HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGCC
T ss_pred             hhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhCcCcCC
Confidence             2568999999999999999999999999999999974

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=1.8e-46  Score=403.08  Aligned_cols=256  Identities=29%  Similarity=0.547  Sum_probs=217.1

Q ss_pred             CCCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeEE
Q 004959          339 NSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFY  418 (721)
Q Consensus       339 ~~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~y  418 (721)
                      .++|++++.||+|+||.||+|.+..+|+.||+|++...    ......+.+.+|+.+|+.++||||+++++++...+.+|
T Consensus        32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~----~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  107 (360)
T 3eqc_A           32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLE----IKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS  107 (360)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECC----CCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEE
T ss_pred             cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccc----cCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEE
Confidence            46899999999999999999999999999999998642    23456678999999999999999999999999999999


Q ss_pred             EEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhC-CeeccCCCCCcEEEcCCCceEEeecCCccccCCCc
Q 004959          419 IYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSK-KTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQK  497 (721)
Q Consensus       419 LVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~-gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~~  497 (721)
                      +||||++|++|.+++... +.+++..+..++.||+.||.|||++ ||+||||||+||||+.++.+||+|||++..+... 
T Consensus       108 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-  185 (360)
T 3eqc_A          108 ICMEHMDGGSLDQVLKKA-GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-  185 (360)
T ss_dssp             EEECCCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH-
T ss_pred             EEEECCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCEEEEECCCCcccccc-
Confidence            999999999999999775 6799999999999999999999996 9999999999999999999999999999765332 


Q ss_pred             ccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHH------------------
Q 004959          498 ADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMF------------------  559 (721)
Q Consensus       498 ~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~------------------  559 (721)
                      ......||+.|+|||++.       ...++.++|||||||++|+|++|+.||......+...                  
T Consensus       186 ~~~~~~gt~~y~aPE~~~-------~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (360)
T 3eqc_A          186 MANSFVGTRSYMSPERLQ-------GTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPR  258 (360)
T ss_dssp             C----CCCCTTCCHHHHT-------TCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC---------------
T ss_pred             cccCCCCCCCeECHHHHc-------CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcc
Confidence            223467999999999994       4567889999999999999999999997644332211                  


Q ss_pred             ------------------------HHhhcC-CCC-CCCCCHHHHHHHHHhcccCCCCCCCHHHHHhccccccCC
Q 004959          560 ------------------------KVMRDT-PAI-PDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQ  607 (721)
Q Consensus       560 ------------------------ki~~~~-~~~-p~~lS~el~dLI~~cL~~DP~kRPSa~eLL~Hp~f~~~~  607 (721)
                                              .+.... ... ...++.++.+||.+||+.||++|||++|+|+||||+...
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~  332 (360)
T 3eqc_A          259 TPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSD  332 (360)
T ss_dssp             ---------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHHHH
T ss_pred             cCCCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhcch
Confidence                                    111111 111 234789999999999999999999999999999998643

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=3.2e-46  Score=409.14  Aligned_cols=255  Identities=29%  Similarity=0.474  Sum_probs=212.0

Q ss_pred             CCCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCe--
Q 004959          339 NSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDK--  416 (721)
Q Consensus       339 ~~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~--  416 (721)
                      ..+|++++.||+|+||+||+|++..+++ ||+|++.....         ...+|+.+|+.++|||||++++++...+.  
T Consensus        39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~---------~~~~E~~il~~l~h~niv~l~~~~~~~~~~~  108 (394)
T 4e7w_A           39 EIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKR---------FKNRELQIMRIVKHPNVVDLKAFFYSNGDKK  108 (394)
T ss_dssp             EEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTT---------SCCHHHHHHHTCCCTTBCCEEEEEEEESSSS
T ss_pred             cceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcc---------hHHHHHHHHHhCCCCCcceEEEEEEecCCCC
Confidence            3579999999999999999999987766 88888753211         12369999999999999999999866543  


Q ss_pred             ----EEEEEeeccCCCHHHHHH--HhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEc-CCCceEEeecCC
Q 004959          417 ----FYIYLEYVHPGSINKYVR--EHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVD-ASGVVKLADFGM  489 (721)
Q Consensus       417 ----~yLVmEy~~gGsL~~~L~--~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld-~~g~VKL~DFGl  489 (721)
                          +|+||||+.++.+..+..  .....+++..++.++.||+.||+|||++||+||||||+||||+ .++.+||+|||+
T Consensus       109 ~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL~DFG~  188 (394)
T 4e7w_A          109 DEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGS  188 (394)
T ss_dssp             SCEEEEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred             CceEEEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEEeeCCC
Confidence                889999998654333322  2246899999999999999999999999999999999999999 789999999999


Q ss_pred             ccccCCCcccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhcC----
Q 004959          490 AKHLTGQKADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDT----  565 (721)
Q Consensus       490 A~~l~~~~~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~~----  565 (721)
                      ++.+..........||+.|+|||++.+      ...++.++|||||||+||||++|+.||.+....+.+..+....    
T Consensus       189 a~~~~~~~~~~~~~~t~~y~aPE~~~~------~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~  262 (394)
T 4e7w_A          189 AKILIAGEPNVSYICSRYYRAPELIFG------ATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPS  262 (394)
T ss_dssp             CEECCTTCCCCSSCSCGGGCCHHHHTT------CSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCC
T ss_pred             cccccCCCCCcccccCcCccCHHHHcC------CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence            998776666667889999999999853      2357889999999999999999999999877666665554310    


Q ss_pred             -------------C------------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhccccccCCCC
Q 004959          566 -------------P------------AIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQP  609 (721)
Q Consensus       566 -------------~------------~~p~~lS~el~dLI~~cL~~DP~kRPSa~eLL~Hp~f~~~~~~  609 (721)
                                   .            .++..+++++.+||.+||+.||++|||+.|+|+||||+.....
T Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~  331 (394)
T 4e7w_A          263 REQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELRTG  331 (394)
T ss_dssp             HHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTTSS
T ss_pred             HHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhccc
Confidence                         0            1234588999999999999999999999999999999976554

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=8.8e-46  Score=397.17  Aligned_cols=257  Identities=25%  Similarity=0.457  Sum_probs=214.4

Q ss_pred             CCCCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCe-
Q 004959          338 MNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDK-  416 (721)
Q Consensus       338 l~~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~-  416 (721)
                      +..+|++.+.||+|+||.||+|.+..+|+.||||++..   ........+.+.+|+.+|+.++||||+++++++...+. 
T Consensus        22 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~---~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   98 (353)
T 3coi_A           22 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSR---PFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSL   98 (353)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESS---TTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSG
T ss_pred             cCceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecc---cccchHHHHHHHHHHHHHHhcCCCCcccHhheEeccccc
Confidence            44689999999999999999999999999999999863   22345566788999999999999999999999887654 


Q ss_pred             -----EEEEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCcc
Q 004959          417 -----FYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAK  491 (721)
Q Consensus       417 -----~yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~  491 (721)
                           +|+||||+. ++|.+++.   ..+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++.
T Consensus        99 ~~~~~~~lv~e~~~-~~l~~~~~---~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~  174 (353)
T 3coi_A           99 RNFYDFYLVMPFMQ-TDLQKIMG---LKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLAR  174 (353)
T ss_dssp             GGCCCCEEEEECCS-EEGGGTTT---SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCCEEECSTTCTT
T ss_pred             ccceeEEEEecccc-CCHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCcEEEeeccccc
Confidence                 599999997 68887763   459999999999999999999999999999999999999999999999999998


Q ss_pred             ccCCCcccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhc-------
Q 004959          492 HLTGQKADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRD-------  564 (721)
Q Consensus       492 ~l~~~~~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~-------  564 (721)
                      .....  .....||+.|+|||++.+      ...++.++|||||||++|+|++|..||.+....+.+..+...       
T Consensus       175 ~~~~~--~~~~~~t~~y~aPE~~~~------~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~  246 (353)
T 3coi_A          175 HADAE--MTGYVVTRWYRAPEVILS------WMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTE  246 (353)
T ss_dssp             C----------CCSBCCSCHHHHSC------CSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHH
T ss_pred             CCCCC--ccccccCcCcCCHHHHhC------cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHH
Confidence            65432  234679999999999842      245677899999999999999999999876655544443221       


Q ss_pred             ------------------------CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhccccccCCCC
Q 004959          565 ------------------------TPAIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQP  609 (721)
Q Consensus       565 ------------------------~~~~p~~lS~el~dLI~~cL~~DP~kRPSa~eLL~Hp~f~~~~~~  609 (721)
                                              .......++.++.+||.+||+.||++|||+.|+|+||||+....+
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~~~  315 (353)
T 3coi_A          247 FVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRDP  315 (353)
T ss_dssp             HHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTCCG
T ss_pred             HHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhccCc
Confidence                                    112335679999999999999999999999999999999876554

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=1.7e-46  Score=386.00  Aligned_cols=259  Identities=26%  Similarity=0.445  Sum_probs=217.8

Q ss_pred             CCCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeEE
Q 004959          339 NSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFY  418 (721)
Q Consensus       339 ~~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~y  418 (721)
                      .++|++++.||+|+||.||+|.+..+|+.||||++....    .....+.+.+|+.+++.++||||+++++++.+.+..|
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   81 (276)
T 2yex_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKR----AVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQY   81 (276)
T ss_dssp             HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGG----CTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred             ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeecc----chhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEE
Confidence            357999999999999999999999999999999986422    1234567899999999999999999999999999999


Q ss_pred             EEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCCc-
Q 004959          419 IYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQK-  497 (721)
Q Consensus       419 LVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~~-  497 (721)
                      +||||+.+++|.+++... ..+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+.... 
T Consensus        82 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~  160 (276)
T 2yex_A           82 LFLEYCSGGELFDRIEPD-IGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR  160 (276)
T ss_dssp             EEEECCTTEEGGGGSBTT-TBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred             EEEEecCCCcHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcc
Confidence            999999999999998653 579999999999999999999999999999999999999999999999999998654322 


Q ss_pred             --ccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHH-HHHHHhhcCC--CCCCCC
Q 004959          498 --ADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAA-AMFKVMRDTP--AIPDSL  572 (721)
Q Consensus       498 --~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~-~~~ki~~~~~--~~p~~l  572 (721)
                        .....+||+.|+|||++.+      ...++.++|||||||++|+|++|..||....... .+........  .....+
T Consensus       161 ~~~~~~~~~~~~y~aPE~~~~------~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (276)
T 2yex_A          161 ERLLNKMCGTLPYVAPELLKR------REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKI  234 (276)
T ss_dssp             ECCBCCCCSCGGGCCGGGGTC------SSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTTSTTGGGS
T ss_pred             hhcccCCccccCccChHHHhc------CCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcccccCchhhc
Confidence              2234679999999999842      1223678999999999999999999997654332 2222222222  223468


Q ss_pred             CHHHHHHHHHhcccCCCCCCCHHHHHhccccccCCC
Q 004959          573 SPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQ  608 (721)
Q Consensus       573 S~el~dLI~~cL~~DP~kRPSa~eLL~Hp~f~~~~~  608 (721)
                      +.++.+||.+||+.||++|||+.|+++||||++...
T Consensus       235 ~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~  270 (276)
T 2yex_A          235 DSAPLALLHKILVENPSARITIPDIKKDRWYNKPLK  270 (276)
T ss_dssp             CHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCCC
T ss_pred             CHHHHHHHHHHCCCCchhCCCHHHHhcCccccChhh
Confidence            999999999999999999999999999999986543

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=3.4e-46  Score=394.67  Aligned_cols=251  Identities=24%  Similarity=0.400  Sum_probs=211.7

Q ss_pred             CCCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCC-CCCeeeeeeeEEe--cC
Q 004959          339 NSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLK-HPNIVQYYGSEIV--ED  415 (721)
Q Consensus       339 ~~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~-HPnIV~l~g~~~~--~~  415 (721)
                      .++|++++.||+|+||.||+|.+..+|+.||||++...     .   .+.+.+|+.+|+++. ||||+++++++..  ..
T Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-----~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~  106 (330)
T 3nsz_A           35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV-----K---KKKIKREIKILENLRGGPNIITLADIVKDPVSR  106 (330)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-----C---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTC
T ss_pred             CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc-----c---hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCC
Confidence            46899999999999999999999999999999998521     1   357889999999997 9999999999987  66


Q ss_pred             eEEEEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCC-ceEEeecCCccccC
Q 004959          416 KFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASG-VVKLADFGMAKHLT  494 (721)
Q Consensus       416 ~~yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g-~VKL~DFGlA~~l~  494 (721)
                      ..++||||+.+++|.+++.    .+++..++.++.||+.||.|||++||+||||||+||||+.++ .+||+|||+++.+.
T Consensus       107 ~~~lv~e~~~~~~l~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~  182 (330)
T 3nsz_A          107 TPALVFEHVNNTDFKQLYQ----TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH  182 (330)
T ss_dssp             CEEEEEECCCCCCHHHHGG----GCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred             ceEEEEeccCchhHHHHHH----hCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcC
Confidence            7999999999999998874    489999999999999999999999999999999999999777 89999999998876


Q ss_pred             CCcccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCch-hhHHHHHHHhh----------
Q 004959          495 GQKADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEY-EGAAAMFKVMR----------  563 (721)
Q Consensus       495 ~~~~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~-~~~~~~~ki~~----------  563 (721)
                      .........||+.|+|||++.+      ...++.++|||||||+||+|++|+.||... ...+.+..+..          
T Consensus       183 ~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~  256 (330)
T 3nsz_A          183 PGQEYNVRVASRYFKGPELLVD------YQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDY  256 (330)
T ss_dssp             TTCCCCSCCSCGGGCCHHHHTT------CCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHH
T ss_pred             CCCccccccccccccChhhhcC------CCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhH
Confidence            6655566789999999999842      245778999999999999999999999432 22222211110          


Q ss_pred             ---cCC------------------------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhccccccCC
Q 004959          564 ---DTP------------------------AIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQ  607 (721)
Q Consensus       564 ---~~~------------------------~~p~~lS~el~dLI~~cL~~DP~kRPSa~eLL~Hp~f~~~~  607 (721)
                         ...                        ..+..+++++.+||.+||+.||++|||++|+|+||||++..
T Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~  327 (330)
T 3nsz_A          257 IDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVV  327 (330)
T ss_dssp             HHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTTCC
T ss_pred             HHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHhhhc
Confidence               000                        11123799999999999999999999999999999998754

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=6.1e-46  Score=390.11  Aligned_cols=256  Identities=35%  Similarity=0.672  Sum_probs=217.9

Q ss_pred             CCCCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeE
Q 004959          338 MNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKF  417 (721)
Q Consensus       338 l~~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~  417 (721)
                      ..+.|++++.||+|+||.||+|.+..+|+.||||++....       ..+.+.+|+.+|+.++||||+++++++...+.+
T Consensus        27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   99 (314)
T 3com_A           27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES-------DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDL   99 (314)
T ss_dssp             ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS-------CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEE
T ss_pred             chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH-------HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEE
Confidence            4568999999999999999999999999999999986421       135688999999999999999999999999999


Q ss_pred             EEEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCCc
Q 004959          418 YIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQK  497 (721)
Q Consensus       418 yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~~  497 (721)
                      |+||||+.+++|.+++......+++..++.++.||+.||.|||++||+|+||||+||||+.++.+||+|||++..+....
T Consensus       100 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~  179 (314)
T 3com_A          100 WIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTM  179 (314)
T ss_dssp             EEEEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECBTTB
T ss_pred             EEEeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCCEEEeecccchhhhhhc
Confidence            99999999999999998666789999999999999999999999999999999999999999999999999998765432


Q ss_pred             -ccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhcCC---CCCCCCC
Q 004959          498 -ADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTP---AIPDSLS  573 (721)
Q Consensus       498 -~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~~~---~~p~~lS  573 (721)
                       ......||+.|+|||++.       ...++.++|||||||++|+|++|..||...........+.....   ..+..++
T Consensus       180 ~~~~~~~~~~~y~aPE~~~-------~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (314)
T 3com_A          180 AKRNTVIGTPFWMAPEVIQ-------EIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPELWS  252 (314)
T ss_dssp             SCBCCCCSCGGGCCHHHHS-------SSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGGSC
T ss_pred             cccCccCCCCCccChhhcC-------CCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCcccCCcccCC
Confidence             234567999999999984       34577789999999999999999999987666555554444322   2345689


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHHhccccccCC
Q 004959          574 PEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQ  607 (721)
Q Consensus       574 ~el~dLI~~cL~~DP~kRPSa~eLL~Hp~f~~~~  607 (721)
                      .++.+||.+||+.||++|||+.++|+||||+...
T Consensus       253 ~~l~~li~~~l~~dp~~Rpt~~~ll~~~~~~~~~  286 (314)
T 3com_A          253 DNFTDFVKQCLVKSPEQRATATQLLQHPFVRSAK  286 (314)
T ss_dssp             HHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHTCC
T ss_pred             HHHHHHHHHHccCChhhCcCHHHHHhCHHHhcCC
Confidence            9999999999999999999999999999998653

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=1.4e-46  Score=392.17  Aligned_cols=263  Identities=37%  Similarity=0.636  Sum_probs=221.4

Q ss_pred             CCCCCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCe
Q 004959          337 PMNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDK  416 (721)
Q Consensus       337 ~l~~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~  416 (721)
                      ...+.|++++.||+|+||.||+|.+..+|+.||+|++...     .....+.+.+|+.+|+.++||||+++++++...+.
T Consensus        16 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~-----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   90 (302)
T 2j7t_A           16 DPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETK-----SEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGK   90 (302)
T ss_dssp             CGGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC---------CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-C
T ss_pred             CCccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCC-----CHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCe
Confidence            3456899999999999999999999999999999998532     12235678899999999999999999999999999


Q ss_pred             EEEEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCC
Q 004959          417 FYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQ  496 (721)
Q Consensus       417 ~yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~  496 (721)
                      .|+||||+++++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus        91 ~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  170 (302)
T 2j7t_A           91 LWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKT  170 (302)
T ss_dssp             EEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHH
T ss_pred             EEEEEEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCCEEEEECCCCcccccc
Confidence            99999999999999999876678999999999999999999999999999999999999999999999999987643221


Q ss_pred             -cccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhcCC---CCCCCC
Q 004959          497 -KADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTP---AIPDSL  572 (721)
Q Consensus       497 -~~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~~~---~~p~~l  572 (721)
                       .......||+.|+|||++.....  ....++.++|||||||++|+|++|..||........+..+.....   ..+..+
T Consensus       171 ~~~~~~~~~~~~y~aPE~~~~~~~--~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (302)
T 2j7t_A          171 LQKRDSFIGTPYWMAPEVVMCETM--KDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTPSKW  248 (302)
T ss_dssp             HHC-----CCGGGCCHHHHHHHHT--TSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGGS
T ss_pred             ccccccccCChhhcCCeeeccccC--CCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCCcccCCcccc
Confidence             12234579999999999964332  234567899999999999999999999988776666666555432   234668


Q ss_pred             CHHHHHHHHHhcccCCCCCCCHHHHHhccccccC
Q 004959          573 SPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNS  606 (721)
Q Consensus       573 S~el~dLI~~cL~~DP~kRPSa~eLL~Hp~f~~~  606 (721)
                      +.++.+||.+||+.||++|||+.++++||||...
T Consensus       249 ~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  282 (302)
T 2j7t_A          249 SVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSI  282 (302)
T ss_dssp             CHHHHHHHHHHSCSCTTTSCCHHHHTTSTTTTTC
T ss_pred             CHHHHHHHHHHcccChhhCCCHHHHhcChHHhhh
Confidence            9999999999999999999999999999999864

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=3e-46  Score=391.12  Aligned_cols=260  Identities=28%  Similarity=0.479  Sum_probs=212.3

Q ss_pred             CCCCCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEE----
Q 004959          337 PMNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEI----  412 (721)
Q Consensus       337 ~l~~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~----  412 (721)
                      .+.++|++++.||+|+||.||+|.+..+|+.||||++..     ......+.+.+|+.+|++++||||+++++++.    
T Consensus         8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-----~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~   82 (320)
T 2i6l_A            8 DLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVL-----TDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGS   82 (320)
T ss_dssp             EETTTEEEEEECC-----CEEEEEETTTTEEEEEEEEEC-----CSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSC
T ss_pred             ccCCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEec-----CChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccc
Confidence            345789999999999999999999999999999998863     23456778999999999999999999999873    


Q ss_pred             ----------ecCeEEEEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEc-CCCc
Q 004959          413 ----------VEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVD-ASGV  481 (721)
Q Consensus       413 ----------~~~~~yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld-~~g~  481 (721)
                                ..+..|+||||+. |+|.+++..  +.+++..++.++.||+.||+|||++||+||||||+||||+ .++.
T Consensus        83 ~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~  159 (320)
T 2i6l_A           83 QLTDDVGSLTELNSVYIVQEYME-TDLANVLEQ--GPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLV  159 (320)
T ss_dssp             BCCC----CCSCSEEEEEEECCS-EEHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTE
T ss_pred             ccccccccccccCceeEEeeccC-CCHHHHhhc--CCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCe
Confidence                      3467899999997 699999864  5799999999999999999999999999999999999997 5679


Q ss_pred             eEEeecCCccccCCCc----ccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHH
Q 004959          482 VKLADFGMAKHLTGQK----ADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAA  557 (721)
Q Consensus       482 VKL~DFGlA~~l~~~~----~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~  557 (721)
                      +||+|||++..+....    ......||+.|+|||++.+      ...++.++|||||||++|+|++|+.||.+....+.
T Consensus       160 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~  233 (320)
T 2i6l_A          160 LKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLS------PNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQ  233 (320)
T ss_dssp             EEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHC------TTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred             EEEccCccccccCCCcccccccccccccccccCcHHhcC------cccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHH
Confidence            9999999998764321    1233458999999999852      34578899999999999999999999988766665


Q ss_pred             HHHHhhcCCC------------------------------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhccccccCC
Q 004959          558 MFKVMRDTPA------------------------------IPDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQ  607 (721)
Q Consensus       558 ~~ki~~~~~~------------------------------~p~~lS~el~dLI~~cL~~DP~kRPSa~eLL~Hp~f~~~~  607 (721)
                      +..+....+.                              .+..++.++++||++||+.||++|||++|+|+||||+...
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~  313 (320)
T 2i6l_A          234 MQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIYS  313 (320)
T ss_dssp             HHHHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTTC
T ss_pred             HHHHHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCccccccc
Confidence            5554432211                              1246899999999999999999999999999999999765


Q ss_pred             CCC
Q 004959          608 QPD  610 (721)
Q Consensus       608 ~~~  610 (721)
                      .+.
T Consensus       314 ~p~  316 (320)
T 2i6l_A          314 FPM  316 (320)
T ss_dssp             C--
T ss_pred             Ccc
Confidence            543

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=8.9e-46  Score=397.50  Aligned_cols=264  Identities=25%  Similarity=0.422  Sum_probs=211.6

Q ss_pred             CCCCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCc------ccHHHHHHHHHHHHHHHhCCCCCeeeeeeeE
Q 004959          338 MNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDP------KSAESIKQLEQEIKVLSHLKHPNIVQYYGSE  411 (721)
Q Consensus       338 l~~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~------~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~  411 (721)
                      +.++|++++.||+|+||.||+|.+.. |+.||||++.......      ......+.+.+|+.+|++++||||+++++++
T Consensus        20 ~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~   98 (362)
T 3pg1_A           20 MQSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIF   98 (362)
T ss_dssp             TTCSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEE
T ss_pred             hccceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeE
Confidence            45789999999999999999999865 9999999986432221      2344567899999999999999999999998


Q ss_pred             Eec-----CeEEEEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEee
Q 004959          412 IVE-----DKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLAD  486 (721)
Q Consensus       412 ~~~-----~~~yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~D  486 (721)
                      ...     ..+|+||||+. |+|.+++......+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|
T Consensus        99 ~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~D  177 (362)
T 3pg1_A           99 VHFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICD  177 (362)
T ss_dssp             EECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC
T ss_pred             EeccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCCCEEEEe
Confidence            553     36899999997 688888877666899999999999999999999999999999999999999999999999


Q ss_pred             cCCccccCCCcccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhcC-
Q 004959          487 FGMAKHLTGQKADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDT-  565 (721)
Q Consensus       487 FGlA~~l~~~~~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~~-  565 (721)
                      ||++.............||+.|+|||++.+      ...++.++|||||||++|+|++|+.||.+....+.+..+.... 
T Consensus       178 fg~~~~~~~~~~~~~~~~t~~y~aPE~~~~------~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~  251 (362)
T 3pg1_A          178 FNLAREDTADANKTHYVTHRWYRAPELVMQ------FKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVG  251 (362)
T ss_dssp             TTC---------------CGGGCCHHHHTT------CTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC
T ss_pred             cCcccccccccccceecccceecCcHHhcC------CCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcC
Confidence            999987655555556789999999999852      2457789999999999999999999998866555554443210 


Q ss_pred             -----------------------C--------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhccccccCCCC
Q 004959          566 -----------------------P--------AIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQP  609 (721)
Q Consensus       566 -----------------------~--------~~p~~lS~el~dLI~~cL~~DP~kRPSa~eLL~Hp~f~~~~~~  609 (721)
                                             .        ..+..+++++.+||.+||+.||++|||+.|+|+||||+....+
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~  326 (362)
T 3pg1_A          252 TPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESLFDP  326 (362)
T ss_dssp             CCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTTCCG
T ss_pred             CCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhhccCc
Confidence                                   0        1123568999999999999999999999999999999987544

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=3e-46  Score=414.44  Aligned_cols=254  Identities=25%  Similarity=0.441  Sum_probs=213.5

Q ss_pred             CCCCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhC------CCCCeeeeeeeE
Q 004959          338 MNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHL------KHPNIVQYYGSE  411 (721)
Q Consensus       338 l~~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L------~HPnIV~l~g~~  411 (721)
                      +..+|++++.||+|+||+||+|.+..+|+.||||++..      .....+.+.+|+.+|+.+      .|+||+++++++
T Consensus        95 ~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~------~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~  168 (429)
T 3kvw_A           95 VAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRN------EKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENF  168 (429)
T ss_dssp             ETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECS------CHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEE
T ss_pred             ccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECC------ccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeec
Confidence            45689999999999999999999999999999999852      234456778888888877      577999999999


Q ss_pred             EecCeEEEEEeeccCCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCc--eEEeecC
Q 004959          412 IVEDKFYIYLEYVHPGSINKYVREHC-GAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGV--VKLADFG  488 (721)
Q Consensus       412 ~~~~~~yLVmEy~~gGsL~~~L~~~~-~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~--VKL~DFG  488 (721)
                      ...+.+|+||||+. ++|.+++.... ..+++..++.|+.||+.||.|||++|||||||||+||||+.++.  +||+|||
T Consensus       169 ~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DFG  247 (429)
T 3kvw_A          169 TFRNHICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFG  247 (429)
T ss_dssp             EETTEEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCCT
T ss_pred             ccCCeEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeecc
Confidence            99999999999996 69999987653 45999999999999999999999999999999999999999887  9999999


Q ss_pred             CccccCCCcccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhcCC--
Q 004959          489 MAKHLTGQKADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTP--  566 (721)
Q Consensus       489 lA~~l~~~~~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~~~--  566 (721)
                      ++.....  .....+||+.|+|||++.+       ..++.++|||||||+||||++|..||.+....+.+..+.....  
T Consensus       248 ~a~~~~~--~~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p  318 (429)
T 3kvw_A          248 SSCYEHQ--RVYTYIQSRFYRAPEVILG-------ARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMP  318 (429)
T ss_dssp             TCEETTC--CCCSSCSCGGGCCHHHHHT-------BCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCC
T ss_pred             cceecCC--cccccCCCCCccChHHHhC-------CCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCC
Confidence            9976433  2345689999999999964       3467899999999999999999999988766665554432100  


Q ss_pred             ---------------------------------------------------------CCCCCCCHHHHHHHHHhcccCCC
Q 004959          567 ---------------------------------------------------------AIPDSLSPEGKDFLRCCFQRNPA  589 (721)
Q Consensus       567 ---------------------------------------------------------~~p~~lS~el~dLI~~cL~~DP~  589 (721)
                                                                               .++...++++.+||++||+.||+
T Consensus       319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~  398 (429)
T 3kvw_A          319 SQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPA  398 (429)
T ss_dssp             CHHHHHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTT
T ss_pred             CHHHHHhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChh
Confidence                                                                     01123478899999999999999


Q ss_pred             CCCCHHHHHhccccccCC
Q 004959          590 DRPPASLLLEHRFLKNSQ  607 (721)
Q Consensus       590 kRPSa~eLL~Hp~f~~~~  607 (721)
                      +|||++|+|+||||+...
T Consensus       399 ~Rpta~e~L~Hpw~~~~~  416 (429)
T 3kvw_A          399 VRMTPGQALRHPWLRRRL  416 (429)
T ss_dssp             TSCCHHHHHTSTTTC---
T ss_pred             hCCCHHHHhCChhhccCC
Confidence            999999999999998653

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.1e-45  Score=390.31  Aligned_cols=262  Identities=33%  Similarity=0.631  Sum_probs=214.6

Q ss_pred             CCCCCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhC-CCCCeeeeeeeEEe--
Q 004959          337 PMNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHL-KHPNIVQYYGSEIV--  413 (721)
Q Consensus       337 ~l~~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L-~HPnIV~l~g~~~~--  413 (721)
                      ...++|++++.||+|+||.||+|.+..+|+.||||++.....      ..+.+.+|+.+|+++ +||||+++++++..  
T Consensus        21 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~------~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~   94 (326)
T 2x7f_A           21 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD------EEEEIKQEINMLKKYSHHRNIATYYGAFIKKN   94 (326)
T ss_dssp             CCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS------TTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC
T ss_pred             CCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcc------cHHHHHHHHHHHHhccCCCCeeeeeeEEeecc
Confidence            456789999999999999999999999999999999864321      135788999999998 79999999999887  


Q ss_pred             ----cCeEEEEEeeccCCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecC
Q 004959          414 ----EDKFYIYLEYVHPGSINKYVREH-CGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFG  488 (721)
Q Consensus       414 ----~~~~yLVmEy~~gGsL~~~L~~~-~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFG  488 (721)
                          .+.+|+||||+.+++|.+++... ...+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||
T Consensus        95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg  174 (326)
T 2x7f_A           95 PPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFG  174 (326)
T ss_dssp             --CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCT
T ss_pred             CccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCCEEEeeCc
Confidence                46899999999999999999764 3579999999999999999999999999999999999999999999999999


Q ss_pred             CccccCCCc-ccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhcCC-
Q 004959          489 MAKHLTGQK-ADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTP-  566 (721)
Q Consensus       489 lA~~l~~~~-~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~~~-  566 (721)
                      ++..+.... ......||+.|+|||++.....  ....++.++|||||||++|+|++|..||........+..+..... 
T Consensus       175 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~--~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~  252 (326)
T 2x7f_A          175 VSAQLDRTVGRRNTFIGTPYWMAPEVIACDEN--PDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAP  252 (326)
T ss_dssp             TTC-------------CCGGGCCHHHHC----------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCC
T ss_pred             CceecCcCccccccccCCccccChhhhccccc--cCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccc
Confidence            998764332 2334679999999999853211  134567789999999999999999999988766666655554432 


Q ss_pred             -CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhccccccC
Q 004959          567 -AIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNS  606 (721)
Q Consensus       567 -~~p~~lS~el~dLI~~cL~~DP~kRPSa~eLL~Hp~f~~~  606 (721)
                       ..+..++.++.+||.+||..||++||++.++++||||++.
T Consensus       253 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~~  293 (326)
T 2x7f_A          253 RLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQ  293 (326)
T ss_dssp             CCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHCC
T ss_pred             cCCccccCHHHHHHHHHHhccChhhCCCHHHHhhChHHhhC
Confidence             2345689999999999999999999999999999999864

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=9.8e-47  Score=406.99  Aligned_cols=260  Identities=28%  Similarity=0.474  Sum_probs=219.2

Q ss_pred             CCeeEeeEEeecCCeEEEEEEEC---CCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhC-CCCCeeeeeeeEEecC
Q 004959          340 SQWQKGKLIGRGTFGSVYVASNR---ETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHL-KHPNIVQYYGSEIVED  415 (721)
Q Consensus       340 ~~y~~~k~LG~G~fG~VY~a~~~---~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L-~HPnIV~l~g~~~~~~  415 (721)
                      ++|++++.||+|+||.||+|++.   .+|+.||||++...... ......+.+.+|+.+|+.+ +||||+++++++...+
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~  132 (355)
T 1vzo_A           54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIV-QKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET  132 (355)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEE-EEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred             cceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhh-hhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence            58999999999999999999984   58999999998532100 0111234567899999999 6999999999999999


Q ss_pred             eEEEEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCC
Q 004959          416 KFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTG  495 (721)
Q Consensus       416 ~~yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~  495 (721)
                      .+||||||+.+|+|.+++... ..+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.+..
T Consensus       133 ~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~  211 (355)
T 1vzo_A          133 KLHLILDYINGGELFTHLSQR-ERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVA  211 (355)
T ss_dssp             EEEEEECCCCSCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEECCG
T ss_pred             eEEEEeecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCcEEEeeCCCCeeccc
Confidence            999999999999999999765 6799999999999999999999999999999999999999999999999999987643


Q ss_pred             Cc--ccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCch----hhHHHHHHHhhcCCCCC
Q 004959          496 QK--ADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEY----EGAAAMFKVMRDTPAIP  569 (721)
Q Consensus       496 ~~--~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~----~~~~~~~ki~~~~~~~p  569 (721)
                      ..  .....+||+.|+|||++.+     ....++.++|||||||+||||++|+.||...    ........+....+.++
T Consensus       212 ~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  286 (355)
T 1vzo_A          212 DETERAYDFCGTIEYMAPDIVRG-----GDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYP  286 (355)
T ss_dssp             GGGGGGCGGGSCCTTCCHHHHTT-----CC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCC
T ss_pred             CCCCcccCcccCcCccChhhhcC-----CCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhccCCCCC
Confidence            32  2234679999999999953     2234677899999999999999999999643    22344445566677788


Q ss_pred             CCCCHHHHHHHHHhcccCCCCCC-----CHHHHHhccccccC
Q 004959          570 DSLSPEGKDFLRCCFQRNPADRP-----PASLLLEHRFLKNS  606 (721)
Q Consensus       570 ~~lS~el~dLI~~cL~~DP~kRP-----Sa~eLL~Hp~f~~~  606 (721)
                      ..++..+.+||.+||+.||++||     +++|+++|+||+..
T Consensus       287 ~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~~  328 (355)
T 1vzo_A          287 QEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKI  328 (355)
T ss_dssp             TTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTC
T ss_pred             cccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhcC
Confidence            89999999999999999999999     99999999999864

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=3.7e-46  Score=384.75  Aligned_cols=259  Identities=27%  Similarity=0.481  Sum_probs=221.3

Q ss_pred             CCCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEe--cCe
Q 004959          339 NSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIV--EDK  416 (721)
Q Consensus       339 ~~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~--~~~  416 (721)
                      .++|++++.||+|+||.||+|.+..+|+.||+|++...   .......+.+.+|+.+|++++||||+++++++..  ...
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   81 (279)
T 2w5a_A            5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYG---SMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTT   81 (279)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECT---TCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTE
T ss_pred             hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcc---cCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCce
Confidence            35899999999999999999999999999999998642   2334567789999999999999999999998754  568


Q ss_pred             EEEEEeeccCCCHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHhhCC-----eeccCCCCCcEEEcCCCceEEeecC
Q 004959          417 FYIYLEYVHPGSINKYVREHC---GAITESVVRNFTRHILSGLAYLHSKK-----TIHRDIKGANLLVDASGVVKLADFG  488 (721)
Q Consensus       417 ~yLVmEy~~gGsL~~~L~~~~---~~Lse~~i~~i~~QIl~AL~yLHs~g-----IIHrDLKPeNILld~~g~VKL~DFG  488 (721)
                      +|+||||+++++|.+++....   ..+++..++.++.||+.||.|||++|     |+||||||+|||++.++.+||+|||
T Consensus        82 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg  161 (279)
T 2w5a_A           82 LYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFG  161 (279)
T ss_dssp             EEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCC
T ss_pred             EEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCc
Confidence            999999999999999997542   35999999999999999999999999     9999999999999999999999999


Q ss_pred             CccccCCCcc-cccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhcC-C
Q 004959          489 MAKHLTGQKA-DLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDT-P  566 (721)
Q Consensus       489 lA~~l~~~~~-~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~~-~  566 (721)
                      ++..+..... .....||+.|+|||++.+       ..++.++|||||||++|+|++|..||......+....+.... .
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~  234 (279)
T 2w5a_A          162 LARILNHDTSFAKTFVGTPYYMSPEQMNR-------MSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFR  234 (279)
T ss_dssp             HHHHC---CHHHHHHHSCCTTCCHHHHHC-------C-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC
T ss_pred             hheeeccccccccccCCCccccChHHhcc-------CCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhcccc
Confidence            9987654322 223569999999999853       356789999999999999999999998877666665555543 3


Q ss_pred             CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhccccccCC
Q 004959          567 AIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQ  607 (721)
Q Consensus       567 ~~p~~lS~el~dLI~~cL~~DP~kRPSa~eLL~Hp~f~~~~  607 (721)
                      .++..++.++.+||.+||+.||++||++.|||+|+|+....
T Consensus       235 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~  275 (279)
T 2w5a_A          235 RIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILEHH  275 (279)
T ss_dssp             CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCGGG
T ss_pred             cCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhhhc
Confidence            66778999999999999999999999999999999998643

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=7.4e-46  Score=406.06  Aligned_cols=262  Identities=24%  Similarity=0.473  Sum_probs=214.8

Q ss_pred             CCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCC--CCCeeeeeeeEEecCeE
Q 004959          340 SQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLK--HPNIVQYYGSEIVEDKF  417 (721)
Q Consensus       340 ~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~--HPnIV~l~g~~~~~~~~  417 (721)
                      ..|++++.||+|+||.||+|.+.. |+.||||++...   .......+.+.+|+.+|+.+.  |||||++++++...+.+
T Consensus        56 ~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~---~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~  131 (390)
T 2zmd_A           56 RIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLE---EADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYI  131 (390)
T ss_dssp             EEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECT---TCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred             CceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecc---cccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEE
Confidence            469999999999999999999865 999999998743   234556788999999999996  59999999999999999


Q ss_pred             EEEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCCc
Q 004959          418 YIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQK  497 (721)
Q Consensus       418 yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~~  497 (721)
                      ||||| +.+++|.+++... ..+++.+++.++.||+.||.|||++||+||||||+||||+ ++.+||+|||+++.+....
T Consensus       132 ~lv~E-~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~  208 (390)
T 2zmd_A          132 YMVME-CGNIDLNSWLKKK-KSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDT  208 (390)
T ss_dssp             EEEEE-CCSEEHHHHHHHC-SSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC----
T ss_pred             EEEEe-cCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-CCeEEEEecCccccccCCC
Confidence            99999 5578999999875 6899999999999999999999999999999999999995 5899999999998765433


Q ss_pred             c---cccCCCCCccCChhhHHHHhhc----CCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhh-HHHHHHHhhc--CCC
Q 004959          498 A---DLSMKGSPYWMAPELMMAVMQK----GKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEG-AAAMFKVMRD--TPA  567 (721)
Q Consensus       498 ~---~~s~~GT~~Y~APEvl~~~~~~----~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~-~~~~~ki~~~--~~~  567 (721)
                      .   ....+||+.|+|||++.+....    .....++.++||||||||||||++|+.||..... ...+..+...  ...
T Consensus       209 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~  288 (390)
T 2zmd_A          209 TSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIE  288 (390)
T ss_dssp             -----CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHCTTSCCC
T ss_pred             ccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhCccccCC
Confidence            2   2356799999999999642111    0123578899999999999999999999976432 3344444433  234


Q ss_pred             CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhccccccCCC
Q 004959          568 IPDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQ  608 (721)
Q Consensus       568 ~p~~lS~el~dLI~~cL~~DP~kRPSa~eLL~Hp~f~~~~~  608 (721)
                      ++...+.++.+||.+||+.||++||++.|+|+||||+....
T Consensus       289 ~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~~~  329 (390)
T 2zmd_A          289 FPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTH  329 (390)
T ss_dssp             CCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCC-
T ss_pred             CCccchHHHHHHHHHHcccChhhCCCHHHHhhCcCccccCc
Confidence            56778899999999999999999999999999999986543

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=1.7e-46  Score=405.21  Aligned_cols=252  Identities=22%  Similarity=0.347  Sum_probs=206.0

Q ss_pred             CCCCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCC--------CCCeeeeee
Q 004959          338 MNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLK--------HPNIVQYYG  409 (721)
Q Consensus       338 l~~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~--------HPnIV~l~g  409 (721)
                      +.++|++++.||+|+||+||+|++..+|+.||||++..      .....+.+.+|+.+|+.+.        |+||+++++
T Consensus        35 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~------~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~  108 (397)
T 1wak_A           35 FNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKS------AEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLD  108 (397)
T ss_dssp             ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS------CHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEE
T ss_pred             cCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEec------CCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeec
Confidence            35789999999999999999999999999999999852      2345677889999999985        788999999


Q ss_pred             eEE----ecCeEEEEEeeccCCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhC-CeeccCCCCCcEEEcCCC---
Q 004959          410 SEI----VEDKFYIYLEYVHPGSINKYVREH-CGAITESVVRNFTRHILSGLAYLHSK-KTIHRDIKGANLLVDASG---  480 (721)
Q Consensus       410 ~~~----~~~~~yLVmEy~~gGsL~~~L~~~-~~~Lse~~i~~i~~QIl~AL~yLHs~-gIIHrDLKPeNILld~~g---  480 (721)
                      ++.    ....+||||||+ +++|.+++... .+.+++..++.|+.||+.||.|||++ ||+||||||+||||+.++   
T Consensus       109 ~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~~  187 (397)
T 1wak_A          109 DFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYI  187 (397)
T ss_dssp             EEEEEETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHHH
T ss_pred             ceeecCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchhh
Confidence            987    456899999999 56666666543 36799999999999999999999998 999999999999998775   


Q ss_pred             ----------------------------------------------ceEEeecCCccccCCCcccccCCCCCccCChhhH
Q 004959          481 ----------------------------------------------VVKLADFGMAKHLTGQKADLSMKGSPYWMAPELM  514 (721)
Q Consensus       481 ----------------------------------------------~VKL~DFGlA~~l~~~~~~~s~~GT~~Y~APEvl  514 (721)
                                                                    .+||+|||++......  ....+||+.|+|||++
T Consensus       188 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~--~~~~~gt~~y~aPE~~  265 (397)
T 1wak_A          188 RRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH--FTEDIQTRQYRSLEVL  265 (397)
T ss_dssp             HHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC--SCSCCSCGGGCCHHHH
T ss_pred             hhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc--CccCCCCCcccCChhh
Confidence                                                          7999999999876433  3446799999999999


Q ss_pred             HHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchh------hHHHHHHHhh---c---------------------
Q 004959          515 MAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYE------GAAAMFKVMR---D---------------------  564 (721)
Q Consensus       515 ~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~------~~~~~~ki~~---~---------------------  564 (721)
                      .+       ..++.++|||||||+||||++|+.||....      ....+..+..   .                     
T Consensus       266 ~~-------~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~  338 (397)
T 1wak_A          266 IG-------SGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGD  338 (397)
T ss_dssp             HT-------SCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSS
T ss_pred             cC-------CCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccc
Confidence            63       346779999999999999999999997432      1222222111   0                     


Q ss_pred             ------------------CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccccc
Q 004959          565 ------------------TPAIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKN  605 (721)
Q Consensus       565 ------------------~~~~p~~lS~el~dLI~~cL~~DP~kRPSa~eLL~Hp~f~~  605 (721)
                                        ....+...+.++.+||.+||+.||++|||++|+|+||||+.
T Consensus       339 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~  397 (397)
T 1wak_A          339 LKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLNS  397 (397)
T ss_dssp             BSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGGGC
T ss_pred             cccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCccccC
Confidence                              00112233567899999999999999999999999999973

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=1e-45  Score=387.00  Aligned_cols=255  Identities=38%  Similarity=0.698  Sum_probs=223.5

Q ss_pred             CCCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeEE
Q 004959          339 NSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFY  418 (721)
Q Consensus       339 ~~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~y  418 (721)
                      ...|++++.||+|+||.||+|.+..+|+.||||++.....    ....+.+.+|+.+|+.+.||||+++++++...+..|
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   96 (303)
T 3a7i_A           21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA----EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLW   96 (303)
T ss_dssp             GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTC----STTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred             HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEeccccc----HHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEE
Confidence            3579999999999999999999999999999999864321    123567899999999999999999999999999999


Q ss_pred             EEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCCc-
Q 004959          419 IYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQK-  497 (721)
Q Consensus       419 LVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~~-  497 (721)
                      +||||+.+++|.+++..  +.+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+.... 
T Consensus        97 lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~  174 (303)
T 3a7i_A           97 IIMEYLGGGSALDLLEP--GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI  174 (303)
T ss_dssp             EEEECCTTEEHHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTBC
T ss_pred             EEEEeCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCCEEEeecccceecCcccc
Confidence            99999999999999864  579999999999999999999999999999999999999999999999999998765433 


Q ss_pred             ccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhc-CCCCCCCCCHHH
Q 004959          498 ADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRD-TPAIPDSLSPEG  576 (721)
Q Consensus       498 ~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~-~~~~p~~lS~el  576 (721)
                      ......||+.|+|||++.       ...++.++|||||||++|+|++|..||...........+... ...++..++.++
T Consensus       175 ~~~~~~~~~~y~aPE~~~-------~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  247 (303)
T 3a7i_A          175 KRNTFVGTPFWMAPEVIK-------QSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPL  247 (303)
T ss_dssp             CBCCCCSCGGGCCHHHHT-------TCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCCSSCCHHH
T ss_pred             ccCccCCCcCccCHHHHh-------cCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcCCCCCCccccCHHH
Confidence            234567999999999994       345677999999999999999999999887666555554443 345667899999


Q ss_pred             HHHHHHhcccCCCCCCCHHHHHhccccccC
Q 004959          577 KDFLRCCFQRNPADRPPASLLLEHRFLKNS  606 (721)
Q Consensus       577 ~dLI~~cL~~DP~kRPSa~eLL~Hp~f~~~  606 (721)
                      .+||.+||+.||++|||+.++++||||...
T Consensus       248 ~~li~~~l~~dp~~Rps~~~ll~~~~~~~~  277 (303)
T 3a7i_A          248 KEFVEACLNKEPSFRPTAKELLKHKFILRN  277 (303)
T ss_dssp             HHHHHHHCCSSGGGSCCHHHHTTCHHHHHH
T ss_pred             HHHHHHHcCCChhhCcCHHHHhhChhhhcC
Confidence            999999999999999999999999999764

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=1.6e-45  Score=388.35  Aligned_cols=260  Identities=30%  Similarity=0.523  Sum_probs=216.2

Q ss_pred             CCCCeeEeeEEeecCCeEEEEEEEC-CCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhC---CCCCeeeeeeeEE-
Q 004959          338 MNSQWQKGKLIGRGTFGSVYVASNR-ETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHL---KHPNIVQYYGSEI-  412 (721)
Q Consensus       338 l~~~y~~~k~LG~G~fG~VY~a~~~-~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L---~HPnIV~l~g~~~-  412 (721)
                      ..++|++++.||+|+||.||+|.+. .+|+.||||++.........   ...+.+|+.+++.+   .||||+++++++. 
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~---~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~   85 (326)
T 1blx_A            9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGM---PLSTIREVAVLRHLETFEHPNVVRLFDVCTV   85 (326)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSC---BCTHHHHHHHHHHHHHTCCTTBCCEEEEEEE
T ss_pred             chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccC---CchhhHHHHHHHhhhccCCCCeEeeeeeeee
Confidence            4568999999999999999999995 67899999998643222111   12455677666665   8999999999987 


Q ss_pred             ----ecCeEEEEEeeccCCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeec
Q 004959          413 ----VEDKFYIYLEYVHPGSINKYVREHC-GAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADF  487 (721)
Q Consensus       413 ----~~~~~yLVmEy~~gGsL~~~L~~~~-~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DF  487 (721)
                          .....++||||+. |+|.+++.... ..+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+||
T Consensus        86 ~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~~kl~Df  164 (326)
T 1blx_A           86 SRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADF  164 (326)
T ss_dssp             EECSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSC
T ss_pred             cccCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCCEEEecC
Confidence                5677999999997 69999997653 45999999999999999999999999999999999999999999999999


Q ss_pred             CCccccCCCcccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhcC--
Q 004959          488 GMAKHLTGQKADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDT--  565 (721)
Q Consensus       488 GlA~~l~~~~~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~~--  565 (721)
                      |++..+..........||+.|+|||++.       ...++.++|||||||++|+|++|+.||.+....+.+.++....  
T Consensus       165 g~~~~~~~~~~~~~~~~~~~y~aPE~~~-------~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~  237 (326)
T 1blx_A          165 GLARIYSFQMALTSVVVTLWYRAPEVLL-------QSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGL  237 (326)
T ss_dssp             CSCCCCCGGGGGCCCCCCCTTCCHHHHT-------TCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred             cccccccCCCCccccccccceeCHHHHh-------cCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCC
Confidence            9998776555555678999999999994       3457789999999999999999999998877666655554210  


Q ss_pred             -------------------------CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhccccccCCC
Q 004959          566 -------------------------PAIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQ  608 (721)
Q Consensus       566 -------------------------~~~p~~lS~el~dLI~~cL~~DP~kRPSa~eLL~Hp~f~~~~~  608 (721)
                                               ..+...++.++++||.+||+.||++||++.|+|+||||++...
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~  305 (326)
T 1blx_A          238 PGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLER  305 (326)
T ss_dssp             CCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCC
T ss_pred             CCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCccccccch
Confidence                                     0123568999999999999999999999999999999987543

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=1.4e-45  Score=382.79  Aligned_cols=257  Identities=40%  Similarity=0.667  Sum_probs=212.9

Q ss_pred             eeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeEEEEE
Q 004959          342 WQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYIYL  421 (721)
Q Consensus       342 y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~yLVm  421 (721)
                      |....+||+|+||.||+|.+..+++.||||++...     .....+.+.+|+.+++.++||||+++++++...+..++||
T Consensus        24 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~-----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   98 (295)
T 2clq_A           24 NGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPER-----DSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFM   98 (295)
T ss_dssp             TSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECC-----CC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             CCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCC-----chHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEE
Confidence            34445999999999999999999999999998642     1233467889999999999999999999999999999999


Q ss_pred             eeccCCCHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcC-CCceEEeecCCccccCCCc-
Q 004959          422 EYVHPGSINKYVREHCG--AITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDA-SGVVKLADFGMAKHLTGQK-  497 (721)
Q Consensus       422 Ey~~gGsL~~~L~~~~~--~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~-~g~VKL~DFGlA~~l~~~~-  497 (721)
                      ||+.+++|.+++....+  .+++..++.++.||+.||.|||++||+||||||+||||+. ++.+||+|||++..+.... 
T Consensus        99 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~  178 (295)
T 2clq_A           99 EQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINP  178 (295)
T ss_dssp             ECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC---
T ss_pred             EeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeecccccccCCCCC
Confidence            99999999999986533  4679999999999999999999999999999999999987 8999999999998765432 


Q ss_pred             ccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHH-HHHH--HhhcCCCCCCCCCH
Q 004959          498 ADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAA-AMFK--VMRDTPAIPDSLSP  574 (721)
Q Consensus       498 ~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~-~~~k--i~~~~~~~p~~lS~  574 (721)
                      ......||+.|+|||++.+..     ..++.++|||||||++|+|++|+.||....... ....  .....+.++..++.
T Consensus       179 ~~~~~~~~~~y~aPE~~~~~~-----~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (295)
T 2clq_A          179 CTETFTGTLQYMAPEIIDKGP-----RGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSA  253 (295)
T ss_dssp             --CCCCCCGGGCCHHHHHHGG-----GGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCCCCCCCTTSCH
T ss_pred             cccccCCCccccChhhhcCCC-----CCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhccccccccccccCCH
Confidence            234567999999999996521     235678999999999999999999997643222 1221  22345567888999


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHHhccccccCCC
Q 004959          575 EGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQ  608 (721)
Q Consensus       575 el~dLI~~cL~~DP~kRPSa~eLL~Hp~f~~~~~  608 (721)
                      ++.+||.+||+.||++||+++++|+|+||+....
T Consensus       254 ~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~  287 (295)
T 2clq_A          254 EAKAFILKCFEPDPDKRACANDLLVDEFLKVSSK  287 (295)
T ss_dssp             HHHHHHHHTTCSSTTTSCCHHHHHTSGGGCC---
T ss_pred             HHHHHHHHHccCChhhCCCHHHHhcChhhhhccc
Confidence            9999999999999999999999999999986543

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=3.9e-46  Score=391.94  Aligned_cols=247  Identities=28%  Similarity=0.495  Sum_probs=211.8

Q ss_pred             CCCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeEE
Q 004959          339 NSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFY  418 (721)
Q Consensus       339 ~~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~y  418 (721)
                      .++|++++.||+|+||+||+|.+..+|+.||+|++..     ......+.+.+|+.+|++++||||+++++++.+.+..|
T Consensus         9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~-----~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~   83 (310)
T 3s95_A            9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIR-----FDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLN   83 (310)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESC-----CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEE
T ss_pred             hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEecc-----CCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeE
Confidence            3589999999999999999999999999999998742     34556788999999999999999999999999999999


Q ss_pred             EEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCCcc
Q 004959          419 IYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKA  498 (721)
Q Consensus       419 LVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~~~  498 (721)
                      +||||+.||+|.+++......+++..+..++.||+.||+|||++||+||||||+||||+.++.+||+|||++..+.....
T Consensus        84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  163 (310)
T 3s95_A           84 FITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKT  163 (310)
T ss_dssp             EEEECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEEECCCTTCEECC----
T ss_pred             EEEEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEEEeecccceecccccc
Confidence            99999999999999988667899999999999999999999999999999999999999999999999999987643322


Q ss_pred             c---------------ccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHH-----HH
Q 004959          499 D---------------LSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAA-----AM  558 (721)
Q Consensus       499 ~---------------~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~-----~~  558 (721)
                      .               ...+||+.|+|||++.       ...++.++|||||||++|+|++|..||.......     ..
T Consensus       164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~  236 (310)
T 3s95_A          164 QPEGLRSLKKPDRKKRYTVVGNPYWMAPEMIN-------GRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNV  236 (310)
T ss_dssp             ----------------CCCCSCGGGCCHHHHT-------TCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCH
T ss_pred             cccccccccccccccccccCCCcceeCHHHhc-------CCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhh
Confidence            1               1467999999999994       4567789999999999999999999986532111     01


Q ss_pred             HHHhhcCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHh
Q 004959          559 FKVMRDTPAIPDSLSPEGKDFLRCCFQRNPADRPPASLLLE  599 (721)
Q Consensus       559 ~ki~~~~~~~p~~lS~el~dLI~~cL~~DP~kRPSa~eLL~  599 (721)
                      .....  ...+..+++++.+||.+||+.||++|||+.++++
T Consensus       237 ~~~~~--~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~  275 (310)
T 3s95_A          237 RGFLD--RYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEH  275 (310)
T ss_dssp             HHHHH--HTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             hcccc--ccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence            11111  1346778899999999999999999999999986

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=6.4e-46  Score=391.09  Aligned_cols=253  Identities=23%  Similarity=0.343  Sum_probs=211.4

Q ss_pred             CCCCeeEeeEEeecCCeEEEEEEE-CCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCC------Ceeeeeee
Q 004959          338 MNSQWQKGKLIGRGTFGSVYVASN-RETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHP------NIVQYYGS  410 (721)
Q Consensus       338 l~~~y~~~k~LG~G~fG~VY~a~~-~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HP------nIV~l~g~  410 (721)
                      +.++|++++.||+|+||.||+|.+ ..+|+.||||++..      .....+.+.+|+.+++.+.|+      +|++++++
T Consensus        12 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~------~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~   85 (339)
T 1z57_A           12 LSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKN------VDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEW   85 (339)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECS------SHHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEE
T ss_pred             ccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEec------CCchhHHHHHHHHHHHHhhhcCCCCceeeEeeecc
Confidence            456899999999999999999998 56889999999852      234567788999999988765      49999999


Q ss_pred             EEecCeEEEEEeeccCCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcC-----------
Q 004959          411 EIVEDKFYIYLEYVHPGSINKYVREHC-GAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDA-----------  478 (721)
Q Consensus       411 ~~~~~~~yLVmEy~~gGsL~~~L~~~~-~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~-----------  478 (721)
                      +...+.+|+||||+ +++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+||||+.           
T Consensus        86 ~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~  164 (339)
T 1z57_A           86 FEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKI  164 (339)
T ss_dssp             EEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC---
T ss_pred             cccCCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCCcc
Confidence            99999999999999 899999997653 36899999999999999999999999999999999999987           


Q ss_pred             --------CCceEEeecCCccccCCCcccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCC
Q 004959          479 --------SGVVKLADFGMAKHLTGQKADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWS  550 (721)
Q Consensus       479 --------~g~VKL~DFGlA~~l~~~~~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~  550 (721)
                              ++.+||+|||++......  ....+||+.|+|||++.       ...++.++|||||||++|||++|..||.
T Consensus       165 ~~~~~~~~~~~~kl~Dfg~~~~~~~~--~~~~~gt~~y~aPE~~~-------~~~~~~~~Di~slG~il~el~~g~~pf~  235 (339)
T 1z57_A          165 KRDERTLINPDIKVVDFGSATYDDEH--HSTLVSTRHYRAPEVIL-------ALGWSQPCDVWSIGCILIEYYLGFTVFP  235 (339)
T ss_dssp             -CEEEEESCCCEEECCCSSCEETTSC--CCSSCSCGGGCCHHHHT-------TSCCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred             ccccccccCCCceEeeCcccccCccc--cccccCCccccChHHhh-------CCCCCcchhhHHHHHHHHHHHhCCCCCC
Confidence                    668999999999865432  34567999999999994       3457789999999999999999999998


Q ss_pred             chhhHHHHHHHhhcCCC--------------------------------------------CCCCCCHHHHHHHHHhccc
Q 004959          551 EYEGAAAMFKVMRDTPA--------------------------------------------IPDSLSPEGKDFLRCCFQR  586 (721)
Q Consensus       551 ~~~~~~~~~ki~~~~~~--------------------------------------------~p~~lS~el~dLI~~cL~~  586 (721)
                      ..+..+....+......                                            .....++++.+||.+||+.
T Consensus       236 ~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~  315 (339)
T 1z57_A          236 THDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEY  315 (339)
T ss_dssp             CSCHHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCS
T ss_pred             CCChHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCc
Confidence            76554443332211111                                            1122357789999999999


Q ss_pred             CCCCCCCHHHHHhccccccC
Q 004959          587 NPADRPPASLLLEHRFLKNS  606 (721)
Q Consensus       587 DP~kRPSa~eLL~Hp~f~~~  606 (721)
                      ||++|||+.|+|+||||+..
T Consensus       316 dP~~Rpt~~ell~hp~f~~~  335 (339)
T 1z57_A          316 DPAKRITLREALKHPFFDLL  335 (339)
T ss_dssp             STTTSCCHHHHTTSGGGGGG
T ss_pred             CcccccCHHHHhcCHHHHHH
Confidence            99999999999999999864

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=2.3e-45  Score=380.83  Aligned_cols=253  Identities=27%  Similarity=0.455  Sum_probs=207.9

Q ss_pred             CCCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEe-----
Q 004959          339 NSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIV-----  413 (721)
Q Consensus       339 ~~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~-----  413 (721)
                      .++|++++.||+|+||.||+|++..+|+.||||++..      .....+.+.+|+.+|+.++||||+++++++.+     
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~------~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   78 (303)
T 1zy4_A            5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH------TEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFV   78 (303)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEE------EHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCC
T ss_pred             cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEec------cHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchh
Confidence            3579999999999999999999999999999999852      34556789999999999999999999998765     


Q ss_pred             --------cCeEEEEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEe
Q 004959          414 --------EDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLA  485 (721)
Q Consensus       414 --------~~~~yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~  485 (721)
                              .+..|+||||+++|+|.+++......+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+
T Consensus        79 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~~kl~  158 (303)
T 1zy4_A           79 KPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIG  158 (303)
T ss_dssp             C------CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEEC
T ss_pred             hhhcccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCCEEEe
Confidence                    467899999999999999998765678999999999999999999999999999999999999999999999


Q ss_pred             ecCCccccCCC---------------cccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCC
Q 004959          486 DFGMAKHLTGQ---------------KADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWS  550 (721)
Q Consensus       486 DFGlA~~l~~~---------------~~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~  550 (721)
                      |||++..+...               .......||+.|+|||++.+      ...++.++|||||||++|+|++   ||.
T Consensus       159 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~~Di~slG~il~~l~~---p~~  229 (303)
T 1zy4_A          159 DFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDG------TGHYNEKIDMYSLGIIFFEMIY---PFS  229 (303)
T ss_dssp             CCCCCSCTTC-------------------------CTTSCHHHHTS------CSCCCTHHHHHHHHHHHHHHHS---CCS
T ss_pred             eCcchhhcccccchhccccccccccccccccCCCcccccCcccccC------CCCCcchhhHHHHHHHHHHHHh---ccC
Confidence            99999865422               11234569999999999842      2357789999999999999998   665


Q ss_pred             ch-hhHHHHHHHhhcCC----CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhccccccC
Q 004959          551 EY-EGAAAMFKVMRDTP----AIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNS  606 (721)
Q Consensus       551 ~~-~~~~~~~ki~~~~~----~~p~~lS~el~dLI~~cL~~DP~kRPSa~eLL~Hp~f~~~  606 (721)
                      .. ...+....+.....    .++...+.++.+||++||+.||++|||+.++++||||+..
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  290 (303)
T 1zy4_A          230 TGMERVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVK  290 (303)
T ss_dssp             SHHHHHHHHHHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCSCCC
T ss_pred             CchhHHHHHHhccccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCcCCC
Confidence            43 33333333333322    3345567889999999999999999999999999999753

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=1e-45  Score=395.75  Aligned_cols=259  Identities=30%  Similarity=0.468  Sum_probs=205.2

Q ss_pred             CCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCe---
Q 004959          340 SQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDK---  416 (721)
Q Consensus       340 ~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~---  416 (721)
                      ++|++++.||+|+||.||+|++..+|+.||||++......      .....+|+..+..++|||||++++++...+.   
T Consensus        23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~   96 (360)
T 3e3p_A           23 DRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRF------RNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDR   96 (360)
T ss_dssp             TTEEEC----------CEEEEETTTCCEEEEEEEECCTTC------CCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCT
T ss_pred             cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccc------cHHHHHHHHHHHhcCCCCcccHHHhhhccccccc
Confidence            5899999999999999999999999999999988542211      1245677888889999999999999876443   


Q ss_pred             ----EEEEEeeccCCCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHh--hCCeeccCCCCCcEEEcC-CCceEEee
Q 004959          417 ----FYIYLEYVHPGSINKYVRE---HCGAITESVVRNFTRHILSGLAYLH--SKKTIHRDIKGANLLVDA-SGVVKLAD  486 (721)
Q Consensus       417 ----~yLVmEy~~gGsL~~~L~~---~~~~Lse~~i~~i~~QIl~AL~yLH--s~gIIHrDLKPeNILld~-~g~VKL~D  486 (721)
                          +|+||||+.+ +|...+..   ....+++..++.++.||+.||.|||  ++||+||||||+||||+. ++.+||+|
T Consensus        97 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~kl~D  175 (360)
T 3e3p_A           97 RDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCD  175 (360)
T ss_dssp             TCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEEEECC
T ss_pred             cceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcEEEee
Confidence                8999999985 55554432   3467899999999999999999999  999999999999999996 89999999


Q ss_pred             cCCccccCCCcccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhcC-
Q 004959          487 FGMAKHLTGQKADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDT-  565 (721)
Q Consensus       487 FGlA~~l~~~~~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~~-  565 (721)
                      ||++..+..........||+.|+|||++.+      ...++.++|||||||++|+|++|+.||.+......+..+.... 
T Consensus       176 fg~a~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~  249 (360)
T 3e3p_A          176 FGSAKKLSPSEPNVAYICSRYYRAPELIFG------NQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLG  249 (360)
T ss_dssp             CTTCBCCCTTSCCCSTTSCGGGCCHHHHTT------CSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHC
T ss_pred             CCCceecCCCCCcccccCCcceeCHHHHcC------CCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcC
Confidence            999998776666667789999999999842      2346789999999999999999999998876666555554310 


Q ss_pred             -------------------------------CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhccccccCCCCCC
Q 004959          566 -------------------------------PAIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQPDV  611 (721)
Q Consensus       566 -------------------------------~~~p~~lS~el~dLI~~cL~~DP~kRPSa~eLL~Hp~f~~~~~~~~  611 (721)
                                                     .......++++.+||.+||+.||++|||+.|+|+||||+....+..
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~~~  326 (360)
T 3e3p_A          250 CPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELHDPAT  326 (360)
T ss_dssp             CCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGGCTTC
T ss_pred             CCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccCCccc
Confidence                                           1122236789999999999999999999999999999998765543

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=1.3e-45  Score=383.85  Aligned_cols=256  Identities=23%  Similarity=0.445  Sum_probs=222.0

Q ss_pred             CCCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeEE
Q 004959          339 NSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFY  418 (721)
Q Consensus       339 ~~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~y  418 (721)
                      .++|++++.||+|+||.||+|.+..+|+.||||++.......   ...+.+.+|+.++++++||||+++++++...+..|
T Consensus        21 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   97 (287)
T 2wei_A           21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKN---KDTSTILREVELLKKLDHPNIMKLFEILEDSSSFY   97 (287)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSS---SCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred             hhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccch---HHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEE
Confidence            458999999999999999999999999999999986432222   23467889999999999999999999999999999


Q ss_pred             EEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCC---CceEEeecCCccccCC
Q 004959          419 IYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDAS---GVVKLADFGMAKHLTG  495 (721)
Q Consensus       419 LVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~---g~VKL~DFGlA~~l~~  495 (721)
                      +||||+.+++|.+++... ..+++..++.++.||+.||.|||++||+||||||+||||+.+   +.+||+|||++..+..
T Consensus        98 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~  176 (287)
T 2wei_A           98 IVGELYTGGELFDEIIKR-KRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ  176 (287)
T ss_dssp             EEECCCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCC
T ss_pred             EEEEccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeecC
Confidence            999999999999998765 679999999999999999999999999999999999999764   4799999999987655


Q ss_pred             CcccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhcCCCCC----CC
Q 004959          496 QKADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIP----DS  571 (721)
Q Consensus       496 ~~~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~~~~~p----~~  571 (721)
                      ........||+.|+|||++.+        .++.++|||||||++|+|++|..||.+....+....+.......+    ..
T Consensus       177 ~~~~~~~~~~~~y~aPE~~~~--------~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (287)
T 2wei_A          177 NTKMKDRIGTAYYIAPEVLRG--------TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRT  248 (287)
T ss_dssp             CSSCSCHHHHHTTCCHHHHTT--------CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGTT
T ss_pred             CCccccccCcccccChHHhcC--------CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCchhhhh
Confidence            544445568999999999842        367789999999999999999999988777666666655543322    56


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHHHHhccccccC
Q 004959          572 LSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNS  606 (721)
Q Consensus       572 lS~el~dLI~~cL~~DP~kRPSa~eLL~Hp~f~~~  606 (721)
                      ++.++.+||.+||+.||++|||+.|+|+||||++.
T Consensus       249 ~~~~~~~li~~~l~~dp~~Rps~~ell~hp~~~~~  283 (287)
T 2wei_A          249 ISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKY  283 (287)
T ss_dssp             SCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHHH
T ss_pred             cCHHHHHHHHHHcccChhhCcCHHHHhcCHHHhcc
Confidence            89999999999999999999999999999999864

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=1.3e-46  Score=391.39  Aligned_cols=260  Identities=31%  Similarity=0.625  Sum_probs=197.5

Q ss_pred             CCCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeEE
Q 004959          339 NSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFY  418 (721)
Q Consensus       339 ~~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~y  418 (721)
                      .++|++++.||+|+||.||+|.+..+|+.||||++...    ......+.+.+|+.+|++++||||+++++++...+..|
T Consensus        14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   89 (303)
T 2vwi_A           14 RDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLE----KCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELW   89 (303)
T ss_dssp             CCCCEEEEECC---CCCEEEEEC----CEEEEECCC--------------------CCCCCCCTTBCCEEEEEESSSCEE
T ss_pred             hhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhh----hcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcE
Confidence            46899999999999999999999999999999987532    11234567889999999999999999999999999999


Q ss_pred             EEEeeccCCCHHHHHHH-------hcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCcc
Q 004959          419 IYLEYVHPGSINKYVRE-------HCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAK  491 (721)
Q Consensus       419 LVmEy~~gGsL~~~L~~-------~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~  491 (721)
                      +||||+.|++|.+++..       ..+.+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++.
T Consensus        90 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~  169 (303)
T 2vwi_A           90 LVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSA  169 (303)
T ss_dssp             EEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCHHHH
T ss_pred             EEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCCEEEEeccchh
Confidence            99999999999999974       23569999999999999999999999999999999999999999999999999997


Q ss_pred             ccCCCc------ccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhcC
Q 004959          492 HLTGQK------ADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDT  565 (721)
Q Consensus       492 ~l~~~~------~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~~  565 (721)
                      .+....      ......||+.|+|||++.+.      ..++.++|||||||++|+|++|..||................
T Consensus       170 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~------~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~  243 (303)
T 2vwi_A          170 FLATGGDITRNKVRKTFVGTPCWMAPEVMEQV------RGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQND  243 (303)
T ss_dssp             HCC---------------CCCTTCCHHHHHHH------HCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSS
T ss_pred             eeccCCCccchhhhcccCCCccccCHHHhccc------cCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccC
Confidence            654322      12345799999999998642      235668999999999999999999998765554444443322


Q ss_pred             C----------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhccccccCCC
Q 004959          566 P----------AIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQ  608 (721)
Q Consensus       566 ~----------~~p~~lS~el~dLI~~cL~~DP~kRPSa~eLL~Hp~f~~~~~  608 (721)
                      .          .....++.++.+||.+||+.||++||++.++++||||+....
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~  296 (303)
T 2vwi_A          244 PPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAKN  296 (303)
T ss_dssp             CCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC-----
T ss_pred             CCccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhhcCCC
Confidence            1          223567899999999999999999999999999999987543

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=1e-45  Score=394.02  Aligned_cols=251  Identities=25%  Similarity=0.417  Sum_probs=216.0

Q ss_pred             CCCeeEeeEEeecCCeEEEEEEECCCCc---EEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecC
Q 004959          339 NSQWQKGKLIGRGTFGSVYVASNRETGA---LCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVED  415 (721)
Q Consensus       339 ~~~y~~~k~LG~G~fG~VY~a~~~~tg~---~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~  415 (721)
                      .++|++++.||+|+||.||+|.+..+|+   .||||++..    .......+.+.+|+.+|+.++||||+++++++.+.+
T Consensus        48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~----~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~  123 (325)
T 3kul_A           48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKA----GYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGR  123 (325)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECT----TCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGG
T ss_pred             hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCC----CCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCC
Confidence            4689999999999999999999986555   499999853    224456678999999999999999999999999999


Q ss_pred             eEEEEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCC
Q 004959          416 KFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTG  495 (721)
Q Consensus       416 ~~yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~  495 (721)
                      ..||||||+.||+|.+++....+.+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.+..
T Consensus       124 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  203 (325)
T 3kul_A          124 LAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLED  203 (325)
T ss_dssp             CCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCSSCEECC-
T ss_pred             ccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCCEEECCCCccccccc
Confidence            99999999999999999987767899999999999999999999999999999999999999999999999999987654


Q ss_pred             Cccc----ccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhh-CCCCCCchhhHHHHHHHhhc-CCCCC
Q 004959          496 QKAD----LSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFKVMRD-TPAIP  569 (721)
Q Consensus       496 ~~~~----~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLt-G~~PF~~~~~~~~~~ki~~~-~~~~p  569 (721)
                      ....    ....||+.|+|||++.+       ..++.++|||||||++|+|++ |..||.+....+....+... ....+
T Consensus       204 ~~~~~~~~~~~~~t~~y~aPE~~~~-------~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~  276 (325)
T 3kul_A          204 DPDAAYTTTGGKIPIRWTAPEAIAF-------RTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRLPAP  276 (325)
T ss_dssp             ---CCEECC---CCGGGSCHHHHHH-------CEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCCC
T ss_pred             CccceeeccCCCCcccccCHhHhcC-------CCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCCCCCC
Confidence            3221    22346788999999964       346778999999999999999 99999887777666666554 34566


Q ss_pred             CCCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q 004959          570 DSLSPEGKDFLRCCFQRNPADRPPASLLLEH  600 (721)
Q Consensus       570 ~~lS~el~dLI~~cL~~DP~kRPSa~eLL~H  600 (721)
                      ..+++++.+||.+||+.||++||++.++++.
T Consensus       277 ~~~~~~l~~li~~~l~~dp~~Rps~~eil~~  307 (325)
T 3kul_A          277 MGCPHALHQLMLDCWHKDRAQRPRFSQIVSV  307 (325)
T ss_dssp             TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCcCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            7899999999999999999999999999864

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=2.9e-47  Score=413.63  Aligned_cols=256  Identities=14%  Similarity=0.176  Sum_probs=203.0

Q ss_pred             CCCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHH---HHHhCCCCCeeeee-------
Q 004959          339 NSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIK---VLSHLKHPNIVQYY-------  408 (721)
Q Consensus       339 ~~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~---iL~~L~HPnIV~l~-------  408 (721)
                      .++|++++.||+|+||+||+|++..+|+.||||++.....  ......+.+.+|+.   +|+.++|||||+++       
T Consensus        72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~--~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~  149 (377)
T 3byv_A           72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTER--PPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPF  149 (377)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC---CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCS
T ss_pred             CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccc--cchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhh
Confidence            4689999999999999999999999999999999874321  22234678899994   55555799999998       


Q ss_pred             eeEEecC-----------------eEEEEEeeccCCCHHHHHHHhcCCCCH-------HHHHHHHHHHHHHHHHHhhCCe
Q 004959          409 GSEIVED-----------------KFYIYLEYVHPGSINKYVREHCGAITE-------SVVRNFTRHILSGLAYLHSKKT  464 (721)
Q Consensus       409 g~~~~~~-----------------~~yLVmEy~~gGsL~~~L~~~~~~Lse-------~~i~~i~~QIl~AL~yLHs~gI  464 (721)
                      +++...+                 ..||||||+ +|+|.+++... +.+++       ..++.|+.||+.||+|||++||
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~-~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i  227 (377)
T 3byv_A          150 DLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVL-LSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGL  227 (377)
T ss_dssp             EEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHH-HHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred             hhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhc-cccccccccccHHHHHHHHHHHHHHHHHHHhCCe
Confidence            6655543                 289999999 68999999765 33444       7888899999999999999999


Q ss_pred             eccCCCCCcEEEcCCCceEEeecCCccccCCCcccccCCCCCccCChhhHHHH----hhcCCCCCCcchhhHHHHHHHHH
Q 004959          465 IHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPYWMAPELMMAV----MQKGKSSDSALAVDIWSLGCTII  540 (721)
Q Consensus       465 IHrDLKPeNILld~~g~VKL~DFGlA~~l~~~~~~~s~~GT~~Y~APEvl~~~----~~~~k~~~~s~asDVWSLGVILy  540 (721)
                      +||||||+||||+.++.+||+|||+++....  .....+| +.|+|||++.+.    ........++.++|||||||+||
T Consensus       228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~--~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~  304 (377)
T 3byv_A          228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA--RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIY  304 (377)
T ss_dssp             ECSCCCGGGEEECTTCCEEECCGGGCEETTC--EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHH
T ss_pred             ecCCCCHHHEEEcCCCCEEEEechhheecCC--cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHH
Confidence            9999999999999999999999999986432  3345678 999999999764    00111124678999999999999


Q ss_pred             HHhhCCCCCCchhhHHHHHHHhhcCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccccc
Q 004959          541 EMYTGKPPWSEYEGAAAMFKVMRDTPAIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKN  605 (721)
Q Consensus       541 ELLtG~~PF~~~~~~~~~~ki~~~~~~~p~~lS~el~dLI~~cL~~DP~kRPSa~eLL~Hp~f~~  605 (721)
                      ||++|+.||.+.........+.    ..+..+++++.+||.+||+.||++||++.|+|+||||+.
T Consensus       305 elltg~~Pf~~~~~~~~~~~~~----~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~  365 (377)
T 3byv_A          305 WIWCADLPITKDAALGGSEWIF----RSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQ  365 (377)
T ss_dssp             HHHHSSCCC------CCSGGGG----SSCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTSHHHHH
T ss_pred             HHHHCCCCCcccccccchhhhh----hhccCCCHHHHHHHHHHcCCCchhCCCHHHHhhChHHHH
Confidence            9999999997755433333322    234678999999999999999999999999999999975

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=1.2e-45  Score=391.07  Aligned_cols=255  Identities=27%  Similarity=0.498  Sum_probs=210.6

Q ss_pred             CCCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeEE
Q 004959          339 NSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFY  418 (721)
Q Consensus       339 ~~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~y  418 (721)
                      ..+|++++.||+|+||.||+|.+  +|+.||||++..   ........+.+.+|+.+|++++|||||++++++...+.+|
T Consensus        36 ~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~---~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~  110 (309)
T 3p86_A           36 WCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILME---QDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLS  110 (309)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECC---CCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCE
T ss_pred             hhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecC---CCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceE
Confidence            46899999999999999999987  488999999863   2334556778999999999999999999999999999999


Q ss_pred             EEEeeccCCCHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhCC--eeccCCCCCcEEEcCCCceEEeecCCccccC
Q 004959          419 IYLEYVHPGSINKYVREHC--GAITESVVRNFTRHILSGLAYLHSKK--TIHRDIKGANLLVDASGVVKLADFGMAKHLT  494 (721)
Q Consensus       419 LVmEy~~gGsL~~~L~~~~--~~Lse~~i~~i~~QIl~AL~yLHs~g--IIHrDLKPeNILld~~g~VKL~DFGlA~~l~  494 (721)
                      +||||+.+|+|.+++....  ..+++..++.++.||+.||.|||++|  |+||||||+||||+.++.+||+|||+++...
T Consensus       111 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~  190 (309)
T 3p86_A          111 IVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKA  190 (309)
T ss_dssp             EEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCCC------
T ss_pred             EEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCCCCCcccc
Confidence            9999999999999997642  23999999999999999999999999  9999999999999999999999999997654


Q ss_pred             CCc-ccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHh--hcCCCCCCC
Q 004959          495 GQK-ADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVM--RDTPAIPDS  571 (721)
Q Consensus       495 ~~~-~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~--~~~~~~p~~  571 (721)
                      ... ......||+.|+|||++.       ...++.++|||||||++|+|++|..||......+....+.  .....++..
T Consensus       191 ~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  263 (309)
T 3p86_A          191 STFLSSKSAAGTPEWMAPEVLR-------DEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRN  263 (309)
T ss_dssp             -----------CCTTSCHHHHT-------TCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCCCCCCTT
T ss_pred             ccccccccCCCCccccChhhhc-------CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCcc
Confidence            332 223467999999999994       3456778999999999999999999998877666555543  334567788


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHHHHh--cccccc
Q 004959          572 LSPEGKDFLRCCFQRNPADRPPASLLLE--HRFLKN  605 (721)
Q Consensus       572 lS~el~dLI~~cL~~DP~kRPSa~eLL~--Hp~f~~  605 (721)
                      +++++.+||.+||+.||++|||+.++++  +.+++.
T Consensus       264 ~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~  299 (309)
T 3p86_A          264 LNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKS  299 (309)
T ss_dssp             SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-
T ss_pred             CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence            9999999999999999999999999987  456654

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=1.2e-45  Score=401.26  Aligned_cols=251  Identities=26%  Similarity=0.480  Sum_probs=216.4

Q ss_pred             CCCeeEeeEEeecCCeEEEEEEEC-------CCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhC-CCCCeeeeeee
Q 004959          339 NSQWQKGKLIGRGTFGSVYVASNR-------ETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHL-KHPNIVQYYGS  410 (721)
Q Consensus       339 ~~~y~~~k~LG~G~fG~VY~a~~~-------~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L-~HPnIV~l~g~  410 (721)
                      .++|++++.||+|+||.||+|.+.       .++..||||++..    .......+.+.+|+.+|+++ +|||||+++++
T Consensus        80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~----~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~  155 (370)
T 2psq_A           80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKD----DATEKDLSDLVSEMEMMKMIGKHKNIINLLGA  155 (370)
T ss_dssp             GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCT----TCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEE
T ss_pred             HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecC----CcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEE
Confidence            368999999999999999999864       3567899998853    23455677899999999999 89999999999


Q ss_pred             EEecCeEEEEEeeccCCCHHHHHHHhc---------------CCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEE
Q 004959          411 EIVEDKFYIYLEYVHPGSINKYVREHC---------------GAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLL  475 (721)
Q Consensus       411 ~~~~~~~yLVmEy~~gGsL~~~L~~~~---------------~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNIL  475 (721)
                      +...+.+|+||||+.||+|.+++....               ..+++.+++.++.||+.||.|||++||+||||||+|||
T Consensus       156 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIl  235 (370)
T 2psq_A          156 CTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVL  235 (370)
T ss_dssp             ECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEE
T ss_pred             EccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhhEE
Confidence            999999999999999999999998653               34899999999999999999999999999999999999


Q ss_pred             EcCCCceEEeecCCccccCCCcc---cccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhh-CCCCCCc
Q 004959          476 VDASGVVKLADFGMAKHLTGQKA---DLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSE  551 (721)
Q Consensus       476 ld~~g~VKL~DFGlA~~l~~~~~---~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLt-G~~PF~~  551 (721)
                      |+.++.+||+|||+++.+.....   .....||+.|+|||++.+       ..++.++|||||||+||||++ |..||.+
T Consensus       236 l~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-------~~~~~~~DvwslG~il~ellt~g~~p~~~  308 (370)
T 2psq_A          236 VTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFD-------RVYTHQSDVWSFGVLMWEIFTLGGSPYPG  308 (370)
T ss_dssp             ECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHT-------CCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred             ECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcC-------CCCCcHHHHHHHHHHHHHHHcCCCCCCCC
Confidence            99999999999999987654322   233457889999999953       457889999999999999999 9999988


Q ss_pred             hhhHHHHHHHhhc-CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q 004959          552 YEGAAAMFKVMRD-TPAIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEH  600 (721)
Q Consensus       552 ~~~~~~~~ki~~~-~~~~p~~lS~el~dLI~~cL~~DP~kRPSa~eLL~H  600 (721)
                      ....+.+..+... ....+..++.++.+||.+||+.||++||++.|++++
T Consensus       309 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~  358 (370)
T 2psq_A          309 IPVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED  358 (370)
T ss_dssp             CCGGGHHHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            7666555555443 345677899999999999999999999999999976

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=1.5e-45  Score=379.32  Aligned_cols=247  Identities=26%  Similarity=0.459  Sum_probs=216.2

Q ss_pred             CCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeEEE
Q 004959          340 SQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYI  419 (721)
Q Consensus       340 ~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~yL  419 (721)
                      ++|++++.||+|+||.||+|.+. +++.||+|++...   ...   .+.+.+|+.+|++++||||+++++++.+.+..|+
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l   82 (269)
T 4hcu_A           10 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREG---AMS---EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICL   82 (269)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTT---SBC---HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred             hhceeeheecCCCccEEEEEEec-CCCeEEEEEeccc---ccC---HHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEE
Confidence            58999999999999999999987 4778999998632   112   2568899999999999999999999999999999


Q ss_pred             EEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCCc--
Q 004959          420 YLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQK--  497 (721)
Q Consensus       420 VmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~~--  497 (721)
                      ||||+++++|.+++....+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......  
T Consensus        83 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  162 (269)
T 4hcu_A           83 VFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT  162 (269)
T ss_dssp             EEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHH
T ss_pred             EEEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCCEEeccccccccccccccc
Confidence            999999999999998776789999999999999999999999999999999999999999999999999998664432  


Q ss_pred             ccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhh-CCCCCCchhhHHHHHHHhhc-CCCCCCCCCHH
Q 004959          498 ADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFKVMRD-TPAIPDSLSPE  575 (721)
Q Consensus       498 ~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLt-G~~PF~~~~~~~~~~ki~~~-~~~~p~~lS~e  575 (721)
                      ......||+.|+|||++.+       ..++.++|||||||++|+|++ |..||......+....+... ....+..++++
T Consensus       163 ~~~~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (269)
T 4hcu_A          163 SSTGTKFPVKWASPEVFSF-------SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTH  235 (269)
T ss_dssp             STTSTTCCGGGCCHHHHHH-------CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTSCHH
T ss_pred             cccCcccccccCCHHHhcC-------CCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCccCCCCCcCCHH
Confidence            2233557889999999954       346789999999999999999 99999987777766666554 34556778999


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHHhc
Q 004959          576 GKDFLRCCFQRNPADRPPASLLLEH  600 (721)
Q Consensus       576 l~dLI~~cL~~DP~kRPSa~eLL~H  600 (721)
                      +.+||.+||+.||++||++.++++|
T Consensus       236 ~~~li~~~l~~~p~~Rps~~~ll~~  260 (269)
T 4hcu_A          236 VYQIMNHCWRERPEDRPAFSRLLRQ  260 (269)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHccCCcccCcCHHHHHHH
Confidence            9999999999999999999999987

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=1.7e-45  Score=388.71  Aligned_cols=262  Identities=22%  Similarity=0.403  Sum_probs=199.7

Q ss_pred             CCCCeeEeeEEeecCCeEEEEEEECCCCc---EEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEec
Q 004959          338 MNSQWQKGKLIGRGTFGSVYVASNRETGA---LCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVE  414 (721)
Q Consensus       338 l~~~y~~~k~LG~G~fG~VY~a~~~~tg~---~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~  414 (721)
                      ..++|++++.||+|+||.||+|.+..++.   .||||++...   .......+.+.+|+.+|++++||||+++++++...
T Consensus        21 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   97 (323)
T 3qup_A           21 PEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKAD---IIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRS   97 (323)
T ss_dssp             C---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC---------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC
T ss_pred             ChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEeccc---ccCHHHHHHHHHHHHHHHHCCCCceehhhceeecc
Confidence            34689999999999999999999887765   8999988532   12234567899999999999999999999999877


Q ss_pred             CeE------EEEEeeccCCCHHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceE
Q 004959          415 DKF------YIYLEYVHPGSINKYVREHC-----GAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVK  483 (721)
Q Consensus       415 ~~~------yLVmEy~~gGsL~~~L~~~~-----~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VK  483 (721)
                      +..      |+||||+.+|+|.+++....     ..+++..++.++.||+.||.|||++||+||||||+||||+.++.+|
T Consensus        98 ~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~~~k  177 (323)
T 3qup_A           98 RAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVC  177 (323)
T ss_dssp             -------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEE
T ss_pred             ccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCCCCEE
Confidence            655      99999999999999996542     1599999999999999999999999999999999999999999999


Q ss_pred             EeecCCccccCCCccc---ccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhh-CCCCCCchhhHHHHH
Q 004959          484 LADFGMAKHLTGQKAD---LSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMF  559 (721)
Q Consensus       484 L~DFGlA~~l~~~~~~---~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLt-G~~PF~~~~~~~~~~  559 (721)
                      |+|||+++.+......   ....+++.|+|||++.+       ..++.++|||||||++|+|++ |..||.+....+...
T Consensus       178 l~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~  250 (323)
T 3qup_A          178 VADFGLSRKIYSGDYYRQGCASKLPVKWLALESLAD-------NLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYN  250 (323)
T ss_dssp             ECCCCC-----------------CCGGGCCHHHHHH-------CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHH
T ss_pred             EeeccccccccccccccccccccCcccccCchhhcC-------CCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHH
Confidence            9999999876443322   23457889999999964       346789999999999999999 999998877666666


Q ss_pred             HHhhc-CCCCCCCCCHHHHHHHHHhcccCCCCCCC-------HHHHHhccccccCCCC
Q 004959          560 KVMRD-TPAIPDSLSPEGKDFLRCCFQRNPADRPP-------ASLLLEHRFLKNSQQP  609 (721)
Q Consensus       560 ki~~~-~~~~p~~lS~el~dLI~~cL~~DP~kRPS-------a~eLL~Hp~f~~~~~~  609 (721)
                      .+... ....+..+++++.+||.+||+.||++|||       +++++.|+|+....+.
T Consensus       251 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~~~~  308 (323)
T 3qup_A          251 YLIGGNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLSTSQD  308 (323)
T ss_dssp             HHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC---------
T ss_pred             HHhcCCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCCCCC
Confidence            65544 34667789999999999999999999999       7778899999875443

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=3e-46  Score=404.34  Aligned_cols=257  Identities=13%  Similarity=0.103  Sum_probs=195.0

Q ss_pred             CCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhC--CCCCeeeee-------ee
Q 004959          340 SQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHL--KHPNIVQYY-------GS  410 (721)
Q Consensus       340 ~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L--~HPnIV~l~-------g~  410 (721)
                      ..|++++.||+|+||.||+|.+..+|+.||||++...  ........+.+.+|+.+++.|  +|||||+++       ++
T Consensus        62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~  139 (371)
T 3q60_A           62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMG--AENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDA  139 (371)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECC--STTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEE
T ss_pred             eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEec--ccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehh
Confidence            3599999999999999999999999999999998743  222445567788885544444  699988755       44


Q ss_pred             EEec-----------------CeEEEEEeeccCCCHHHHHHHhcCCCCHHHH------HHHHHHHHHHHHHHhhCCeecc
Q 004959          411 EIVE-----------------DKFYIYLEYVHPGSINKYVREHCGAITESVV------RNFTRHILSGLAYLHSKKTIHR  467 (721)
Q Consensus       411 ~~~~-----------------~~~yLVmEy~~gGsL~~~L~~~~~~Lse~~i------~~i~~QIl~AL~yLHs~gIIHr  467 (721)
                      +...                 ..+|||||||. |+|.+++......+.+...      ..++.||+.||+|||++||+||
T Consensus       140 ~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHr  218 (371)
T 3q60_A          140 VAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHG  218 (371)
T ss_dssp             EEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEET
T ss_pred             eecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccC
Confidence            4332                 34899999998 8999999876455655555      6777999999999999999999


Q ss_pred             CCCCCcEEEcCCCceEEeecCCccccCCCcccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCC
Q 004959          468 DIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKP  547 (721)
Q Consensus       468 DLKPeNILld~~g~VKL~DFGlA~~l~~~~~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~  547 (721)
                      ||||+||||+.+|.+||+|||+++......  ....||+.|+|||++.+     ....++.++|||||||+||||++|+.
T Consensus       219 Dikp~NIll~~~~~~kL~DFG~a~~~~~~~--~~~~~t~~y~aPE~~~~-----~~~~~~~~~DiwSlG~il~elltg~~  291 (371)
T 3q60_A          219 HFTPDNLFIMPDGRLMLGDVSALWKVGTRG--PASSVPVTYAPREFLNA-----STATFTHALNAWQLGLSIYRVWCLFL  291 (371)
T ss_dssp             TCSGGGEEECTTSCEEECCGGGEEETTCEE--EGGGSCGGGCCHHHHTC-----SEEECCHHHHHHHHHHHHHHHHHSSC
T ss_pred             cCCHHHEEECCCCCEEEEecceeeecCCCc--cCccCCcCCcChhhccC-----CCCCcCccccHHHHHHHHHHHHhCCC
Confidence            999999999999999999999998664322  13457799999999932     12457889999999999999999999


Q ss_pred             CCCchhhHHH--HHH-----HhhcCC--CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhccccccC
Q 004959          548 PWSEYEGAAA--MFK-----VMRDTP--AIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNS  606 (721)
Q Consensus       548 PF~~~~~~~~--~~k-----i~~~~~--~~p~~lS~el~dLI~~cL~~DP~kRPSa~eLL~Hp~f~~~  606 (721)
                      ||.+......  +..     ......  ..+..+++++.+||.+||+.||++|||+.++|+||||++.
T Consensus       292 Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~  359 (371)
T 3q60_A          292 PFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQL  359 (371)
T ss_dssp             STTBCCTTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHHHH
T ss_pred             CCCCcCcccccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHHHH
Confidence            9977532110  000     001111  1224789999999999999999999999999999999753

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=1.9e-45  Score=390.55  Aligned_cols=253  Identities=22%  Similarity=0.348  Sum_probs=209.8

Q ss_pred             CCCCeeEeeEEeecCCeEEEEEEECCCC-cEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCC------eeeeeee
Q 004959          338 MNSQWQKGKLIGRGTFGSVYVASNRETG-ALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPN------IVQYYGS  410 (721)
Q Consensus       338 l~~~y~~~k~LG~G~fG~VY~a~~~~tg-~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPn------IV~l~g~  410 (721)
                      +.++|++++.||+|+||.||+|.+..++ +.||||++..      .....+.+.+|+.+|+.+.|++      |+.++++
T Consensus        17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~------~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~   90 (355)
T 2eu9_A           17 LQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRN------VGKYREAARLEINVLKKIKEKDKENKFLCVLMSDW   90 (355)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECS------CHHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEE
T ss_pred             ecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcc------cccchhHHHHHHHHHHHHhhcCCCCceeEEEeeee
Confidence            4579999999999999999999998877 6899999852      2345567888999999997665      8999999


Q ss_pred             EEecCeEEEEEeeccCCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEE-------------
Q 004959          411 EIVEDKFYIYLEYVHPGSINKYVREH-CGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLV-------------  476 (721)
Q Consensus       411 ~~~~~~~yLVmEy~~gGsL~~~L~~~-~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILl-------------  476 (721)
                      +...+.+||||||+ +++|.+++... ...+++..++.++.||+.||.|||++||+||||||+||||             
T Consensus        91 ~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~  169 (355)
T 2eu9_A           91 FNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHK  169 (355)
T ss_dssp             EEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC-
T ss_pred             eeeCCeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecccccccccccc
Confidence            99999999999999 56777777654 3579999999999999999999999999999999999999             


Q ss_pred             ------cCCCceEEeecCCccccCCCcccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCC
Q 004959          477 ------DASGVVKLADFGMAKHLTGQKADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWS  550 (721)
Q Consensus       477 ------d~~g~VKL~DFGlA~~l~~~~~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~  550 (721)
                            +.++.+||+|||++......  ....+||+.|+|||++.       ...++.++|||||||+||||++|..||.
T Consensus       170 ~~~~~~~~~~~~kl~Dfg~~~~~~~~--~~~~~gt~~y~aPE~~~-------~~~~~~~~Di~slG~il~el~~g~~pf~  240 (355)
T 2eu9_A          170 SCEEKSVKNTSIRVADFGSATFDHEH--HTTIVATRHYRPPEVIL-------ELGWAQPCDVWSIGCILFEYYRGFTLFQ  240 (355)
T ss_dssp             CCCEEEESCCCEEECCCTTCEETTSC--CCSSCSCGGGCCHHHHT-------TCCCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred             cccccccCCCcEEEeecCcccccccc--ccCCcCCCcccCCeeee-------cCCCCCccchHHHHHHHHHHHhCCCCCC
Confidence                  56789999999999864432  34567999999999994       3457789999999999999999999998


Q ss_pred             chhhHHHHHHHhhcCCCCC--------------------------------------------CCCCHHHHHHHHHhccc
Q 004959          551 EYEGAAAMFKVMRDTPAIP--------------------------------------------DSLSPEGKDFLRCCFQR  586 (721)
Q Consensus       551 ~~~~~~~~~ki~~~~~~~p--------------------------------------------~~lS~el~dLI~~cL~~  586 (721)
                      .....+.+..+......+|                                            ...+.++.+||++||+.
T Consensus       241 ~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~  320 (355)
T 2eu9_A          241 THENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEF  320 (355)
T ss_dssp             CSSHHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCS
T ss_pred             CCCHHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcC
Confidence            7655544433322111111                                            11245789999999999


Q ss_pred             CCCCCCCHHHHHhccccccC
Q 004959          587 NPADRPPASLLLEHRFLKNS  606 (721)
Q Consensus       587 DP~kRPSa~eLL~Hp~f~~~  606 (721)
                      ||++|||+.|+|+||||+..
T Consensus       321 dP~~Rpt~~e~l~hp~f~~~  340 (355)
T 2eu9_A          321 DPAQRITLAEALLHPFFAGL  340 (355)
T ss_dssp             STTTSCCHHHHTTSGGGGGC
T ss_pred             ChhhCcCHHHHhcChhhcCC
Confidence            99999999999999999865

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.7e-45  Score=386.90  Aligned_cols=259  Identities=23%  Similarity=0.446  Sum_probs=208.9

Q ss_pred             CCCCCCCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCc-ccHHHHHHHHHHHHHHHhC----CCCCeeeeee
Q 004959          335 PLPMNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDP-KSAESIKQLEQEIKVLSHL----KHPNIVQYYG  409 (721)
Q Consensus       335 ~~~l~~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~-~~~~~~k~~~~Ei~iL~~L----~HPnIV~l~g  409 (721)
                      ...+.++|++++.||+|+||.||+|.+..+|+.||||++....... ........+.+|+.++.++    .|+||+++++
T Consensus        26 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~  105 (312)
T 2iwi_A           26 REAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLD  105 (312)
T ss_dssp             -------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEE
T ss_pred             hhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEE
Confidence            3445678999999999999999999999999999999986432111 1112234566799999998    8999999999


Q ss_pred             eEEecCeEEEEEee-ccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEc-CCCceEEeec
Q 004959          410 SEIVEDKFYIYLEY-VHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVD-ASGVVKLADF  487 (721)
Q Consensus       410 ~~~~~~~~yLVmEy-~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld-~~g~VKL~DF  487 (721)
                      ++...+..++|||| +.+++|.+++... +.+++..++.++.||+.||.|||++||+||||||+||||+ .++.+||+||
T Consensus       106 ~~~~~~~~~~v~e~~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~df  184 (312)
T 2iwi_A          106 WFETQEGFMLVLERPLPAQDLFDYITEK-GPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDF  184 (312)
T ss_dssp             EC-----CEEEEECCSSEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEEEECCC
T ss_pred             EEecCCeEEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeEEEEEc
Confidence            99999999999999 7899999999875 6799999999999999999999999999999999999999 7899999999


Q ss_pred             CCccccCCCcccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhcCCC
Q 004959          488 GMAKHLTGQKADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPA  567 (721)
Q Consensus       488 GlA~~l~~~~~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~~~~  567 (721)
                      |++..+.... .....||+.|+|||++.+.      ...+.++|||||||++|+|++|+.||....      .+......
T Consensus       185 g~~~~~~~~~-~~~~~~~~~y~aPE~~~~~------~~~~~~~Di~slG~il~~l~~g~~pf~~~~------~~~~~~~~  251 (312)
T 2iwi_A          185 GSGALLHDEP-YTDFDGTRVYSPPEWISRH------QYHALPATVWSLGILLYDMVCGDIPFERDQ------EILEAELH  251 (312)
T ss_dssp             SSCEECCSSC-BCCCCSCTTTSCHHHHHHS------CBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHTCCC
T ss_pred             chhhhcccCc-ccccCCcccccCceeeecC------CCCCccchHHHHHHHHHHHHHCCCCCCChH------HHhhhccC
Confidence            9998765432 3456799999999998642      223458999999999999999999997643      23344556


Q ss_pred             CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhccccccCC
Q 004959          568 IPDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQ  607 (721)
Q Consensus       568 ~p~~lS~el~dLI~~cL~~DP~kRPSa~eLL~Hp~f~~~~  607 (721)
                      ++..++.++.+||.+||+.||++||+++|+++||||+...
T Consensus       252 ~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~~~~  291 (312)
T 2iwi_A          252 FPAHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPA  291 (312)
T ss_dssp             CCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTTTCC--
T ss_pred             CcccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhcCch
Confidence            7788999999999999999999999999999999998654

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=1e-45  Score=395.57  Aligned_cols=251  Identities=27%  Similarity=0.507  Sum_probs=212.8

Q ss_pred             CCCeeEeeEEeecCCeEEEEEE-----ECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhC-CCCCeeeeeeeEE
Q 004959          339 NSQWQKGKLIGRGTFGSVYVAS-----NRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHL-KHPNIVQYYGSEI  412 (721)
Q Consensus       339 ~~~y~~~k~LG~G~fG~VY~a~-----~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L-~HPnIV~l~g~~~  412 (721)
                      .++|++++.||+|+||.||+|.     +..+++.||||++..    .......+.+.+|+.+|.++ +|||||++++++.
T Consensus        21 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~----~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~   96 (359)
T 3vhe_A           21 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKE----GATHSEHRALMSELKILIHIGHHLNVVNLLGACT   96 (359)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECT----TCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             ccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecC----cCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeee
Confidence            3689999999999999999998     566789999999853    23345567899999999999 7999999999988


Q ss_pred             ecC-eEEEEEeeccCCCHHHHHHHhcC-----------------------------------------------------
Q 004959          413 VED-KFYIYLEYVHPGSINKYVREHCG-----------------------------------------------------  438 (721)
Q Consensus       413 ~~~-~~yLVmEy~~gGsL~~~L~~~~~-----------------------------------------------------  438 (721)
                      ..+ .+|+|||||.||+|.+++.....                                                     
T Consensus        97 ~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  176 (359)
T 3vhe_A           97 KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDV  176 (359)
T ss_dssp             STTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-----------------------------------------------
T ss_pred             cCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchh
Confidence            755 49999999999999999976422                                                     


Q ss_pred             ------------CCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCCcc---cccCC
Q 004959          439 ------------AITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKA---DLSMK  503 (721)
Q Consensus       439 ------------~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~~~---~~s~~  503 (721)
                                  .+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+.....   .....
T Consensus       177 ~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~  256 (359)
T 3vhe_A          177 EEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR  256 (359)
T ss_dssp             -------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--CE
T ss_pred             hhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhccccC
Confidence                        189999999999999999999999999999999999999999999999999987643322   23356


Q ss_pred             CCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhh-CCCCCCchhhHHHHHHHhhc--CCCCCCCCCHHHHHHH
Q 004959          504 GSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFKVMRD--TPAIPDSLSPEGKDFL  580 (721)
Q Consensus       504 GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLt-G~~PF~~~~~~~~~~ki~~~--~~~~p~~lS~el~dLI  580 (721)
                      ||+.|+|||++.+       ..++.++|||||||++|||++ |..||.+....+.+...+..  ....+..+++++.+||
T Consensus       257 ~t~~y~aPE~~~~-------~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  329 (359)
T 3vhe_A          257 LPLKWMAPETIFD-------RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTM  329 (359)
T ss_dssp             ECGGGCCHHHHHH-------CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHH
T ss_pred             CCceeEChhhhcC-------CCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCCCCCCCCCHHHHHHH
Confidence            8999999999964       356789999999999999998 99999876544444443332  4566778999999999


Q ss_pred             HHhcccCCCCCCCHHHHHhc
Q 004959          581 RCCFQRNPADRPPASLLLEH  600 (721)
Q Consensus       581 ~~cL~~DP~kRPSa~eLL~H  600 (721)
                      .+||+.||++|||+.|+++|
T Consensus       330 ~~~l~~dP~~Rps~~ell~~  349 (359)
T 3vhe_A          330 LDCWHGEPSQRPTFSELVEH  349 (359)
T ss_dssp             HHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHccCChhhCCCHHHHHHH
Confidence            99999999999999999987

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=2.3e-45  Score=389.81  Aligned_cols=251  Identities=26%  Similarity=0.480  Sum_probs=217.0

Q ss_pred             CCCeeEeeEEeecCCeEEEEEEEC-----CCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEe
Q 004959          339 NSQWQKGKLIGRGTFGSVYVASNR-----ETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIV  413 (721)
Q Consensus       339 ~~~y~~~k~LG~G~fG~VY~a~~~-----~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~  413 (721)
                      .++|++++.||+|+||.||+|.+.     .+++.||||++..    .......+.+.+|+.+|+.++||||+++++++.+
T Consensus        46 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~----~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~  121 (343)
T 1luf_A           46 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKE----EASADMQADFQREAALMAEFDNPNIVKLLGVCAV  121 (343)
T ss_dssp             GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCT----TCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred             HHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEecc----ccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcc
Confidence            368999999999999999999987     4568999998853    2234566789999999999999999999999999


Q ss_pred             cCeEEEEEeeccCCCHHHHHHHhc-----------------------CCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCC
Q 004959          414 EDKFYIYLEYVHPGSINKYVREHC-----------------------GAITESVVRNFTRHILSGLAYLHSKKTIHRDIK  470 (721)
Q Consensus       414 ~~~~yLVmEy~~gGsL~~~L~~~~-----------------------~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLK  470 (721)
                      .+..|+||||+.+|+|.+++....                       ..+++.+++.++.||+.||.|||++||+|||||
T Consensus       122 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlk  201 (343)
T 1luf_A          122 GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLA  201 (343)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCS
T ss_pred             CCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCC
Confidence            999999999999999999997642                       579999999999999999999999999999999


Q ss_pred             CCcEEEcCCCceEEeecCCccccCCCc---ccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhh-CC
Q 004959          471 GANLLVDASGVVKLADFGMAKHLTGQK---ADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GK  546 (721)
Q Consensus       471 PeNILld~~g~VKL~DFGlA~~l~~~~---~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLt-G~  546 (721)
                      |+||||+.++.+||+|||++..+....   ......||+.|+|||++.+       ..++.++|||||||++|+|++ |.
T Consensus       202 p~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-------~~~~~~~Di~slG~il~el~t~g~  274 (343)
T 1luf_A          202 TRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFY-------NRYTTESDVWAYGVVLWEIFSYGL  274 (343)
T ss_dssp             GGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHH-------CCCCHHHHHHHHHHHHHHHHTTTC
T ss_pred             cceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhcc-------CCcCcccccHHHHHHHHHHHhcCC
Confidence            999999999999999999998764332   1234568899999999964       346789999999999999999 99


Q ss_pred             CCCCchhhHHHHHHHhhcC-CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q 004959          547 PPWSEYEGAAAMFKVMRDT-PAIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEH  600 (721)
Q Consensus       547 ~PF~~~~~~~~~~ki~~~~-~~~p~~lS~el~dLI~~cL~~DP~kRPSa~eLL~H  600 (721)
                      .||.+....+....+.... ..++..++.++.+||++||+.||++||++.+++++
T Consensus       275 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~  329 (343)
T 1luf_A          275 QPYYGMAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRI  329 (343)
T ss_dssp             CTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CcCCCCChHHHHHHHhCCCcCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHH
Confidence            9998877666666655543 45678899999999999999999999999999875

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=3.3e-45  Score=398.14  Aligned_cols=253  Identities=25%  Similarity=0.434  Sum_probs=211.0

Q ss_pred             CCCCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCC-CC-----CeeeeeeeE
Q 004959          338 MNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLK-HP-----NIVQYYGSE  411 (721)
Q Consensus       338 l~~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~-HP-----nIV~l~g~~  411 (721)
                      +.++|++++.||+|+||+||+|.+..+|+.||||++..      .....+.+..|+.+++.+. |+     +|+.+++++
T Consensus        52 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~------~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~  125 (382)
T 2vx3_A           52 WMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKN------KKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHF  125 (382)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECS------SHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEE
T ss_pred             eeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEec------cHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeee
Confidence            45789999999999999999999999999999999852      2345567888999988885 54     499999999


Q ss_pred             EecCeEEEEEeeccCCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHh--hCCeeccCCCCCcEEEc--CCCceEEee
Q 004959          412 IVEDKFYIYLEYVHPGSINKYVREHC-GAITESVVRNFTRHILSGLAYLH--SKKTIHRDIKGANLLVD--ASGVVKLAD  486 (721)
Q Consensus       412 ~~~~~~yLVmEy~~gGsL~~~L~~~~-~~Lse~~i~~i~~QIl~AL~yLH--s~gIIHrDLKPeNILld--~~g~VKL~D  486 (721)
                      ...+.+||||||+. ++|.+++.... ..+++..++.++.||+.||.|||  +.|||||||||+||||+  .++.+||+|
T Consensus       126 ~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~D  204 (382)
T 2vx3_A          126 MFRNHLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVD  204 (382)
T ss_dssp             EETTEEEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECC
T ss_pred             ccCCceEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEe
Confidence            99999999999996 59999997653 56999999999999999999999  57999999999999995  477899999


Q ss_pred             cCCccccCCCcccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhcCC
Q 004959          487 FGMAKHLTGQKADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTP  566 (721)
Q Consensus       487 FGlA~~l~~~~~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~~~  566 (721)
                      ||+++.+...  ....+||+.|+|||++.       ...++.++|||||||+||||++|+.||.+....+.+.++.....
T Consensus       205 FG~a~~~~~~--~~~~~~t~~y~aPE~~~-------~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~  275 (382)
T 2vx3_A          205 FGSSCQLGQR--IYQYIQSRFYRSPEVLL-------GMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLG  275 (382)
T ss_dssp             CTTCEETTCC--CCSSCSCGGGCCHHHHT-------TCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHC
T ss_pred             ccCceecccc--cccccCCccccChHHHc-------CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence            9999876432  34567999999999994       34577899999999999999999999998776666655543111


Q ss_pred             CC------------------CC------------------C----------------------------CCHHHHHHHHH
Q 004959          567 AI------------------PD------------------S----------------------------LSPEGKDFLRC  582 (721)
Q Consensus       567 ~~------------------p~------------------~----------------------------lS~el~dLI~~  582 (721)
                      ..                  +.                  .                            .++++++||++
T Consensus       276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~  355 (382)
T 2vx3_A          276 IPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILR  355 (382)
T ss_dssp             SCCHHHHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHH
T ss_pred             CCCHHHHHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHH
Confidence            00                  00                  0                            01378999999


Q ss_pred             hcccCCCCCCCHHHHHhccccccC
Q 004959          583 CFQRNPADRPPASLLLEHRFLKNS  606 (721)
Q Consensus       583 cL~~DP~kRPSa~eLL~Hp~f~~~  606 (721)
                      ||+.||++|||++|+|+||||+..
T Consensus       356 mL~~dP~~Rpta~e~L~hp~f~~~  379 (382)
T 2vx3_A          356 MLDYDPKTRIQPYYALQHSFFKKT  379 (382)
T ss_dssp             HTCSCTTTSCCHHHHTTSGGGCC-
T ss_pred             hcCCChhhCCCHHHHhcCcccccC
Confidence            999999999999999999999864

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=1.3e-45  Score=404.37  Aligned_cols=256  Identities=25%  Similarity=0.450  Sum_probs=193.9

Q ss_pred             CCeeE-eeEEeecCCeEEEEEEEC--CCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEe--c
Q 004959          340 SQWQK-GKLIGRGTFGSVYVASNR--ETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIV--E  414 (721)
Q Consensus       340 ~~y~~-~k~LG~G~fG~VY~a~~~--~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~--~  414 (721)
                      +.|++ +++||+|+||.||+|+++  .+++.||||++...   ..    .+.+.+|+.+|+.++|||||++++++..  .
T Consensus        20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~---~~----~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~   92 (405)
T 3rgf_A           20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGT---GI----SMSACREIALLRELKHPNVISLQKVFLSHAD   92 (405)
T ss_dssp             HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSS---SC----CHHHHHHHHHHHHCCCTTBCCCCEEEEETTT
T ss_pred             hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCC---CC----CHHHHHHHHHHHhcCCCCeeeEeeEEecCCC
Confidence            45776 668999999999999966  57899999998532   11    1367889999999999999999999865  6


Q ss_pred             CeEEEEEeeccCCCHHHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEE----cCCCce
Q 004959          415 DKFYIYLEYVHPGSINKYVREHC--------GAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLV----DASGVV  482 (721)
Q Consensus       415 ~~~yLVmEy~~gGsL~~~L~~~~--------~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILl----d~~g~V  482 (721)
                      ..+||||||+. ++|.+++....        ..+++..++.|+.||+.||.|||++||+||||||+||||    +.++.+
T Consensus        93 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~  171 (405)
T 3rgf_A           93 RKVWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRV  171 (405)
T ss_dssp             TEEEEEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTCE
T ss_pred             CeEEEEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCcE
Confidence            78999999996 58888875321        249999999999999999999999999999999999999    677899


Q ss_pred             EEeecCCccccCCCc----ccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhh----
Q 004959          483 KLADFGMAKHLTGQK----ADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEG----  554 (721)
Q Consensus       483 KL~DFGlA~~l~~~~----~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~----  554 (721)
                      ||+|||+++.+....    .....+||+.|+|||++.+      ...++.++||||||||||+|++|+.||.+...    
T Consensus       172 kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~  245 (405)
T 3rgf_A          172 KIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLG------ARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKT  245 (405)
T ss_dssp             EECCTTCCC----------------CCCTTCCHHHHTT------CCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC-----
T ss_pred             EEEECCCceecCCCCcccccCCCceecCcccCchhhcC------CCcccchhhhHHHHHHHHHHHhCCCCCCCccccccc
Confidence            999999998765432    2234679999999999953      23578899999999999999999999965332    


Q ss_pred             -----HHHHHHHhhcC--CC------------------------------------CCCCCCHHHHHHHHHhcccCCCCC
Q 004959          555 -----AAAMFKVMRDT--PA------------------------------------IPDSLSPEGKDFLRCCFQRNPADR  591 (721)
Q Consensus       555 -----~~~~~ki~~~~--~~------------------------------------~p~~lS~el~dLI~~cL~~DP~kR  591 (721)
                           .+.+..+....  +.                                    .....+.++.+||.+||+.||++|
T Consensus       246 ~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R  325 (405)
T 3rgf_A          246 SNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKR  325 (405)
T ss_dssp             -CCCCHHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGS
T ss_pred             cccchHHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccC
Confidence                 12222222110  00                                    011237889999999999999999


Q ss_pred             CCHHHHHhccccccCCCC
Q 004959          592 PPASLLLEHRFLKNSQQP  609 (721)
Q Consensus       592 PSa~eLL~Hp~f~~~~~~  609 (721)
                      ||++|+|+||||.....+
T Consensus       326 ~ta~e~L~hp~f~~~~~~  343 (405)
T 3rgf_A          326 ITSEQAMQDPYFLEDPLP  343 (405)
T ss_dssp             CCHHHHHTSGGGTSSSCC
T ss_pred             CCHHHHhcChhhccCCCC
Confidence            999999999999876554

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=1.4e-45  Score=400.19  Aligned_cols=256  Identities=25%  Similarity=0.404  Sum_probs=218.1

Q ss_pred             CCCeeEeeEEeecCCeEEEEEE-----ECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEe
Q 004959          339 NSQWQKGKLIGRGTFGSVYVAS-----NRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIV  413 (721)
Q Consensus       339 ~~~y~~~k~LG~G~fG~VY~a~-----~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~  413 (721)
                      ..+|++++.||+|+||.||+|.     +..+++.||||++..    .........+.+|+.+|++++|||||++++++..
T Consensus        70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~----~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~  145 (367)
T 3l9p_A           70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPE----VCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQ  145 (367)
T ss_dssp             GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCS----SCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEeccc----ccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEec
Confidence            3589999999999999999999     556788999998852    2344556678899999999999999999999999


Q ss_pred             cCeEEEEEeeccCCCHHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCC---ceEE
Q 004959          414 EDKFYIYLEYVHPGSINKYVREHC------GAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASG---VVKL  484 (721)
Q Consensus       414 ~~~~yLVmEy~~gGsL~~~L~~~~------~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g---~VKL  484 (721)
                      .+..|+|||||.||+|.+++....      ..+++..++.++.||+.||.|||++||+||||||+||||+.+|   .+||
T Consensus       146 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~kL  225 (367)
T 3l9p_A          146 SLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKI  225 (367)
T ss_dssp             SSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEE
T ss_pred             CCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceEEE
Confidence            999999999999999999998753      3589999999999999999999999999999999999999655   5999


Q ss_pred             eecCCccccCCC---cccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhh-CCCCCCchhhHHHHHH
Q 004959          485 ADFGMAKHLTGQ---KADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFK  560 (721)
Q Consensus       485 ~DFGlA~~l~~~---~~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLt-G~~PF~~~~~~~~~~k  560 (721)
                      +|||+++.+...   .......||+.|+|||++.+       ..++.++|||||||+||||++ |..||......+.+..
T Consensus       226 ~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-------~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~  298 (367)
T 3l9p_A          226 GDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFME-------GIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEF  298 (367)
T ss_dssp             CCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHH-------CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHH
T ss_pred             CCCccccccccccccccCCCcCCcccEECHHHhcC-------CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence            999999865322   12234568999999999964       357789999999999999998 9999998777776666


Q ss_pred             HhhcC-CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccccc
Q 004959          561 VMRDT-PAIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKN  605 (721)
Q Consensus       561 i~~~~-~~~p~~lS~el~dLI~~cL~~DP~kRPSa~eLL~Hp~f~~  605 (721)
                      +.... ...+..++.++.+||.+||+.||++||++.+|++|.++..
T Consensus       299 i~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~  344 (367)
T 3l9p_A          299 VTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT  344 (367)
T ss_dssp             HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHcCCCCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence            65543 4566789999999999999999999999999999987653

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=2.1e-45  Score=391.46  Aligned_cols=259  Identities=25%  Similarity=0.441  Sum_probs=219.4

Q ss_pred             CCCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcc------------cHHHHHHHHHHHHHHHhCCCCCeee
Q 004959          339 NSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPK------------SAESIKQLEQEIKVLSHLKHPNIVQ  406 (721)
Q Consensus       339 ~~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~------------~~~~~k~~~~Ei~iL~~L~HPnIV~  406 (721)
                      .++|++++.||+|+||.||+|.+  +|+.||||++........            .....+.+.+|+.+|++++||||++
T Consensus        30 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~  107 (348)
T 2pml_X           30 INDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLT  107 (348)
T ss_dssp             ETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCC
T ss_pred             cCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcce
Confidence            46899999999999999999998  899999999863211100            0011267899999999999999999


Q ss_pred             eeeeEEecCeEEEEEeeccCCCHHHH------HHHh-cCCCCHHHHHHHHHHHHHHHHHHhh-CCeeccCCCCCcEEEcC
Q 004959          407 YYGSEIVEDKFYIYLEYVHPGSINKY------VREH-CGAITESVVRNFTRHILSGLAYLHS-KKTIHRDIKGANLLVDA  478 (721)
Q Consensus       407 l~g~~~~~~~~yLVmEy~~gGsL~~~------L~~~-~~~Lse~~i~~i~~QIl~AL~yLHs-~gIIHrDLKPeNILld~  478 (721)
                      +++++.+.+..|+||||+++|+|.++      +... ...+++..++.++.||+.||.|||+ +||+||||||+||||+.
T Consensus       108 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Nil~~~  187 (348)
T 2pml_X          108 CEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDK  187 (348)
T ss_dssp             CSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGEEECT
T ss_pred             EEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhEEEcC
Confidence            99999999999999999999999988      5442 4679999999999999999999999 99999999999999999


Q ss_pred             CCceEEeecCCccccCCCcccccCCCCCccCChhhHHHHhhcCCCCCCcc-hhhHHHHHHHHHHHhhCCCCCCchhh-HH
Q 004959          479 SGVVKLADFGMAKHLTGQKADLSMKGSPYWMAPELMMAVMQKGKSSDSAL-AVDIWSLGCTIIEMYTGKPPWSEYEG-AA  556 (721)
Q Consensus       479 ~g~VKL~DFGlA~~l~~~~~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~-asDVWSLGVILyELLtG~~PF~~~~~-~~  556 (721)
                      ++.+||+|||++..+... ......||+.|+|||++.+      ...++. ++|||||||++|+|++|..||..... .+
T Consensus       188 ~~~~kl~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~------~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~  260 (348)
T 2pml_X          188 NGRVKLSDFGESEYMVDK-KIKGSRGTYEFMPPEFFSN------ESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVE  260 (348)
T ss_dssp             TSCEEECCCTTCEECBTT-EECSSCSCGGGCCGGGGSS------CCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHH
T ss_pred             CCcEEEeccccccccccc-cccCCCCCcCccCchhhcC------CCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHH
Confidence            999999999999876443 3345679999999999842      114444 89999999999999999999987665 55


Q ss_pred             HHHHHhhcCCCCC-------------------CCCCHHHHHHHHHhcccCCCCCCCHHHHHhccccccC
Q 004959          557 AMFKVMRDTPAIP-------------------DSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNS  606 (721)
Q Consensus       557 ~~~ki~~~~~~~p-------------------~~lS~el~dLI~~cL~~DP~kRPSa~eLL~Hp~f~~~  606 (721)
                      ....+......++                   ..++.++.+||.+||+.||++||++.|+|+||||++.
T Consensus       261 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f~~~  329 (348)
T 2pml_X          261 LFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLADT  329 (348)
T ss_dssp             HHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGTTC
T ss_pred             HHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCccccCC
Confidence            5556655555555                   5689999999999999999999999999999999864

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=4.5e-45  Score=382.39  Aligned_cols=251  Identities=25%  Similarity=0.448  Sum_probs=215.9

Q ss_pred             CCCeeEeeEEeecCCeEEEEEEE-----CCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEe
Q 004959          339 NSQWQKGKLIGRGTFGSVYVASN-----RETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIV  413 (721)
Q Consensus       339 ~~~y~~~k~LG~G~fG~VY~a~~-----~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~  413 (721)
                      ..+|++++.||+|+||.||+|.+     ..+++.||||++..    .......+.+.+|+.+|+.++||||+++++++.+
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~----~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~   97 (314)
T 2ivs_A           22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKE----NASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQ   97 (314)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCT----TCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS
T ss_pred             hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccC----CCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEec
Confidence            46899999999999999999987     34568999998852    2345567889999999999999999999999999


Q ss_pred             cCeEEEEEeeccCCCHHHHHHHhc-----------------------CCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCC
Q 004959          414 EDKFYIYLEYVHPGSINKYVREHC-----------------------GAITESVVRNFTRHILSGLAYLHSKKTIHRDIK  470 (721)
Q Consensus       414 ~~~~yLVmEy~~gGsL~~~L~~~~-----------------------~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLK  470 (721)
                      .+..|+||||+.|++|.+++....                       ..+++..++.++.||+.||.|||++||+|||||
T Consensus        98 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dik  177 (314)
T 2ivs_A           98 DGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLA  177 (314)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECCCCS
T ss_pred             CCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCcccccc
Confidence            999999999999999999997642                       238999999999999999999999999999999


Q ss_pred             CCcEEEcCCCceEEeecCCccccCCCcc---cccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhh-CC
Q 004959          471 GANLLVDASGVVKLADFGMAKHLTGQKA---DLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GK  546 (721)
Q Consensus       471 PeNILld~~g~VKL~DFGlA~~l~~~~~---~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLt-G~  546 (721)
                      |+||||+.++.+||+|||++..+.....   .....||+.|+|||++.+       ..++.++|||||||++|+|++ |.
T Consensus       178 p~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~il~el~t~g~  250 (314)
T 2ivs_A          178 ARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFD-------HIYTTQSDVWSFGVLLWEIVTLGG  250 (314)
T ss_dssp             GGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHH-------CEECHHHHHHHHHHHHHHHHTTSC
T ss_pred             hheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcC-------CCcCchhhHHHHHHHHHHHHhCCC
Confidence            9999999999999999999987654332   233457889999999964       346778999999999999999 99


Q ss_pred             CCCCchhhHHHHHHHhhc-CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q 004959          547 PPWSEYEGAAAMFKVMRD-TPAIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEH  600 (721)
Q Consensus       547 ~PF~~~~~~~~~~ki~~~-~~~~p~~lS~el~dLI~~cL~~DP~kRPSa~eLL~H  600 (721)
                      .||.+.........+... ....+..+++++.+||.+||+.||++||++.+++++
T Consensus       251 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~  305 (314)
T 2ivs_A          251 NPYPGIPPERLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKD  305 (314)
T ss_dssp             CSSTTCCGGGHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCCCCCHHHHHHHhhcCCcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            999876655555444433 345677899999999999999999999999999976

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=5.9e-45  Score=382.13  Aligned_cols=261  Identities=30%  Similarity=0.504  Sum_probs=199.7

Q ss_pred             CCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeEEE
Q 004959          340 SQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYI  419 (721)
Q Consensus       340 ~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~yL  419 (721)
                      ++|++++.||+|+||.||+|.+..+|+.||||++...   .......+.+..+..+++.++||||+++++++...+.+|+
T Consensus        25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~l  101 (318)
T 2dyl_A           25 NDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRS---GNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFI  101 (318)
T ss_dssp             GGEEEEEEC------CEEEEEETTTCCEEEEEEEETT---SCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             ccccccceeeecCCeeEEEEEEecCCeEEEEEEeccc---ccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEE
Confidence            5899999999999999999999999999999998642   2223334445556667888899999999999999999999


Q ss_pred             EEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhC-CeeccCCCCCcEEEcCCCceEEeecCCccccCCCcc
Q 004959          420 YLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSK-KTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKA  498 (721)
Q Consensus       420 VmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~-gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~~~  498 (721)
                      ||||+ ++.+..++....+.+++..++.++.||+.||.|||++ ||+||||||+||||+.++.+||+|||++..+.....
T Consensus       102 v~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~  180 (318)
T 2dyl_A          102 AMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKA  180 (318)
T ss_dssp             EECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCEEECCCTTC--------
T ss_pred             EEecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCEEEEECCCchhccCCcc
Confidence            99999 5677776665567899999999999999999999995 999999999999999999999999999987765554


Q ss_pred             cccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCch-hhHHHHHHHhhcCC-CCC--CCCCH
Q 004959          499 DLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEY-EGAAAMFKVMRDTP-AIP--DSLSP  574 (721)
Q Consensus       499 ~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~-~~~~~~~ki~~~~~-~~p--~~lS~  574 (721)
                      .....||+.|+|||++.....  ....++.++|||||||++|+|++|+.||... ...+.+..+..... .++  ..++.
T Consensus       181 ~~~~~~~~~y~aPE~~~~~~~--~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (318)
T 2dyl_A          181 KDRSAGCAAYMAPERIDPPDP--TKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGHMGFSG  258 (318)
T ss_dssp             ------CCTTCCHHHHC----------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCCCCCCSSSCCCH
T ss_pred             ccccCCCccccChhhcccccc--cccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCCCCCCccCCCCH
Confidence            455679999999999853211  2345677999999999999999999999763 34444555544432 222  35899


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHHhccccccC
Q 004959          575 EGKDFLRCCFQRNPADRPPASLLLEHRFLKNS  606 (721)
Q Consensus       575 el~dLI~~cL~~DP~kRPSa~eLL~Hp~f~~~  606 (721)
                      ++.+||.+||+.||++||++.++++||||+..
T Consensus       259 ~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  290 (318)
T 2dyl_A          259 DFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRY  290 (318)
T ss_dssp             HHHHHHHHHTCSCTTTSCCHHHHTTSHHHHHH
T ss_pred             HHHHHHHHHccCChhHCcCHHHHhhCHHHHhc
Confidence            99999999999999999999999999999854

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=7e-45  Score=376.47  Aligned_cols=249  Identities=26%  Similarity=0.447  Sum_probs=213.6

Q ss_pred             CCCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeEE
Q 004959          339 NSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFY  418 (721)
Q Consensus       339 ~~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~y  418 (721)
                      .++|++++.||+|+||.||+|.+. ++..||||++....   ..   .+.+.+|+.+|+.++||||+++++++.+.+.+|
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   95 (283)
T 3gen_A           23 PKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGS---MS---EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIF   95 (283)
T ss_dssp             GGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTS---BC---HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred             HHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCC---CC---HHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeE
Confidence            358999999999999999999876 57789999986321   12   256889999999999999999999999999999


Q ss_pred             EEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCCcc
Q 004959          419 IYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKA  498 (721)
Q Consensus       419 LVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~~~  498 (721)
                      +||||+.+++|.+++......+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+.....
T Consensus        96 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~  175 (283)
T 3gen_A           96 IITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY  175 (283)
T ss_dssp             EEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHH
T ss_pred             EEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCCEEEcccccccccccccc
Confidence            99999999999999987667899999999999999999999999999999999999999999999999999987654322


Q ss_pred             --cccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhh-CCCCCCchhhHHHHHHHhhcC-CCCCCCCCH
Q 004959          499 --DLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFKVMRDT-PAIPDSLSP  574 (721)
Q Consensus       499 --~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLt-G~~PF~~~~~~~~~~ki~~~~-~~~p~~lS~  574 (721)
                        .....||+.|+|||++.+       ..++.++|||||||++|+|++ |+.||......+....+.... ...+..+++
T Consensus       176 ~~~~~~~~~~~y~aPE~~~~-------~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (283)
T 3gen_A          176 TSSVGSKFPVRWSPPEVLMY-------SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASE  248 (283)
T ss_dssp             HSTTSTTSCGGGCCHHHHHH-------CCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCTTCCH
T ss_pred             ccccCCccCcccCCHHHhcc-------CCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcccCCCCCCcCCH
Confidence              233457889999999964       346789999999999999998 999999877777666666553 445677899


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHHhcc
Q 004959          575 EGKDFLRCCFQRNPADRPPASLLLEHR  601 (721)
Q Consensus       575 el~dLI~~cL~~DP~kRPSa~eLL~Hp  601 (721)
                      ++.+||.+||+.||++|||+.++++|-
T Consensus       249 ~l~~li~~~l~~~p~~Rps~~~ll~~L  275 (283)
T 3gen_A          249 KVYTIMYSCWHEKADERPTFKILLSNI  275 (283)
T ss_dssp             HHHHHHHHTTCSSGGGSCCHHHHHHHH
T ss_pred             HHHHHHHHHccCChhHCcCHHHHHHHH
Confidence            999999999999999999999999873

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=5.6e-45  Score=374.29  Aligned_cols=248  Identities=27%  Similarity=0.452  Sum_probs=215.0

Q ss_pred             CCCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeEE
Q 004959          339 NSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFY  418 (721)
Q Consensus       339 ~~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~y  418 (721)
                      .++|++++.||+|+||.||+|.+. ++..||+|++....   ..   .+.+.+|+.+|++++||||+++++++...+..|
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   79 (268)
T 3sxs_A            7 REEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGS---MS---EDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIY   79 (268)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTT---BC---HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEE
T ss_pred             hhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCC---Cc---HHHHHHHHHHHHhCCCCCEeeEEEEEccCCceE
Confidence            358999999999999999999876 47789999986321   11   256889999999999999999999999999999


Q ss_pred             EEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCCcc
Q 004959          419 IYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKA  498 (721)
Q Consensus       419 LVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~~~  498 (721)
                      +||||+++++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++........
T Consensus        80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~  159 (268)
T 3sxs_A           80 IVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQY  159 (268)
T ss_dssp             EEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCE
T ss_pred             EEEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCCEEEccCccceecchhhh
Confidence            99999999999999987766799999999999999999999999999999999999999999999999999987654432


Q ss_pred             --cccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhh-CCCCCCchhhHHHHHHHhhcC-CCCCCCCCH
Q 004959          499 --DLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFKVMRDT-PAIPDSLSP  574 (721)
Q Consensus       499 --~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLt-G~~PF~~~~~~~~~~ki~~~~-~~~p~~lS~  574 (721)
                        .....||+.|+|||++.+       ..++.++|||||||++|+|++ |..||......+....+.... ...+..+++
T Consensus       160 ~~~~~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (268)
T 3sxs_A          160 VSSVGTKFPVKWSAPEVFHY-------FKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYRPHLASD  232 (268)
T ss_dssp             EECCSCCCCGGGCCHHHHHH-------SEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCTTSCH
T ss_pred             hcccCCCcCcccCCHHHHhc-------cCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCCCCCCCCcChH
Confidence              223457788999999965       235668999999999999999 999998877777666665543 345667899


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHHhc
Q 004959          575 EGKDFLRCCFQRNPADRPPASLLLEH  600 (721)
Q Consensus       575 el~dLI~~cL~~DP~kRPSa~eLL~H  600 (721)
                      ++.+||.+||+.||++|||+.|+++|
T Consensus       233 ~l~~li~~~l~~~p~~Rps~~~ll~~  258 (268)
T 3sxs_A          233 TIYQIMYSCWHELPEKRPTFQQLLSS  258 (268)
T ss_dssp             HHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            99999999999999999999999987

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=2.6e-45  Score=389.20  Aligned_cols=258  Identities=26%  Similarity=0.456  Sum_probs=218.9

Q ss_pred             CCCCCCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcc-cHHHHHHHHHHHHHHHhCC--CCCeeeeeeeEE
Q 004959          336 LPMNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPK-SAESIKQLEQEIKVLSHLK--HPNIVQYYGSEI  412 (721)
Q Consensus       336 ~~l~~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~-~~~~~k~~~~Ei~iL~~L~--HPnIV~l~g~~~  412 (721)
                      ..+.++|++++.||+|+||.||+|.+..+|+.||||++........ .....+.+.+|+.+|+++.  |+||+++++++.
T Consensus        39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~  118 (320)
T 3a99_A           39 EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFE  118 (320)
T ss_dssp             -CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEE
T ss_pred             CCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEe
Confidence            4466799999999999999999999999999999999864321110 0011235678999999996  599999999999


Q ss_pred             ecCeEEEEEeeccC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEc-CCCceEEeecCCc
Q 004959          413 VEDKFYIYLEYVHP-GSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVD-ASGVVKLADFGMA  490 (721)
Q Consensus       413 ~~~~~yLVmEy~~g-GsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld-~~g~VKL~DFGlA  490 (721)
                      ..+..++||||+.+ ++|.+++... +.+++..++.++.||+.||.|||++||+||||||+||||+ .++.+||+|||++
T Consensus       119 ~~~~~~lv~e~~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~kL~Dfg~~  197 (320)
T 3a99_A          119 RPDSFVLILERPEPVQDLFDFITER-GALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSG  197 (320)
T ss_dssp             CSSEEEEEEECCSSEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTC
T ss_pred             cCCcEEEEEEcCCCCccHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEEEeeCccc
Confidence            99999999999986 8999999775 7899999999999999999999999999999999999999 7789999999999


Q ss_pred             cccCCCcccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhcCCCCCC
Q 004959          491 KHLTGQKADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPD  570 (721)
Q Consensus       491 ~~l~~~~~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~~~~~p~  570 (721)
                      ..+... ......||+.|+|||++.+.      ..++.++|||||||++|||++|+.||....      .+......++.
T Consensus       198 ~~~~~~-~~~~~~gt~~y~aPE~~~~~------~~~~~~~Di~slG~il~el~~g~~pf~~~~------~~~~~~~~~~~  264 (320)
T 3a99_A          198 ALLKDT-VYTDFDGTRVYSPPEWIRYH------RYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQVFFRQ  264 (320)
T ss_dssp             EECCSS-CBCCCCSCGGGSCHHHHHHS------CBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHCCCCCSS
T ss_pred             cccccc-cccCCCCCccCCChHHhccC------CCCCccchHHhHHHHHHHHHHCCCCCCChh------hhhcccccccc
Confidence            876543 23456799999999999642      234678999999999999999999998653      23344556678


Q ss_pred             CCCHHHHHHHHHhcccCCCCCCCHHHHHhccccccCC
Q 004959          571 SLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQ  607 (721)
Q Consensus       571 ~lS~el~dLI~~cL~~DP~kRPSa~eLL~Hp~f~~~~  607 (721)
                      .+++++.+||.+||+.||++||+++||++||||++..
T Consensus       265 ~~~~~~~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~  301 (320)
T 3a99_A          265 RVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVL  301 (320)
T ss_dssp             CCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCC
T ss_pred             cCCHHHHHHHHHHccCChhhCcCHHHHhcCHhhcCcc
Confidence            8999999999999999999999999999999998653

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=3.3e-45  Score=389.13  Aligned_cols=246  Identities=22%  Similarity=0.312  Sum_probs=207.2

Q ss_pred             CCCCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhC-CCCCeeeeeeeEEecCe
Q 004959          338 MNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHL-KHPNIVQYYGSEIVEDK  416 (721)
Q Consensus       338 l~~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L-~HPnIV~l~g~~~~~~~  416 (721)
                      +..+|++++.||+|+||.||+|.+..+|+.||||++.....       .+.+.+|+.+|+.+ +||||+++++++...+.
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-------~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~   79 (330)
T 2izr_A            7 VGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR-------APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKY   79 (330)
T ss_dssp             ETTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS-------SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTE
T ss_pred             EcCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc-------hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCc
Confidence            45789999999999999999999999999999999864321       12578899999999 89999999999999999


Q ss_pred             EEEEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCc-----eEEeecCCcc
Q 004959          417 FYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGV-----VKLADFGMAK  491 (721)
Q Consensus       417 ~yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~-----VKL~DFGlA~  491 (721)
                      .|+||||+ +++|.+++....+.+++..++.++.||+.||+|||++||+||||||+||||+.++.     +||+|||+++
T Consensus        80 ~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~  158 (330)
T 2izr_A           80 NAMVLELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK  158 (330)
T ss_dssp             EEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCE
T ss_pred             cEEEEEeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEcccce
Confidence            99999999 89999999876678999999999999999999999999999999999999998887     9999999998


Q ss_pred             ccCCCcc--------cccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchh---hHHHHHH
Q 004959          492 HLTGQKA--------DLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYE---GAAAMFK  560 (721)
Q Consensus       492 ~l~~~~~--------~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~---~~~~~~k  560 (721)
                      .+.....        ....+||+.|+|||++.       ...++.++|||||||+||||++|+.||.+..   ..+.+..
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~  231 (330)
T 2izr_A          159 EYIDPETKKHIPYREHKSLTGTARYMSINTHL-------GKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQK  231 (330)
T ss_dssp             ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHT-------TCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHH
T ss_pred             eeecCCCCccccccccCCcCCCccccChHHHc-------CCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHH
Confidence            7644322        23567999999999984       4567889999999999999999999998632   2233333


Q ss_pred             HhhcCCCC-----CCCCCHHHHHHHHHhcccCCCCCCCHHHHHh
Q 004959          561 VMRDTPAI-----PDSLSPEGKDFLRCCFQRNPADRPPASLLLE  599 (721)
Q Consensus       561 i~~~~~~~-----p~~lS~el~dLI~~cL~~DP~kRPSa~eLL~  599 (721)
                      +.......     ...++ ++.+||.+||+.||.+||++.+|++
T Consensus       232 i~~~~~~~~~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~  274 (330)
T 2izr_A          232 IGDTKRATPIEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRK  274 (330)
T ss_dssp             HHHHHHHSCHHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred             HHhhhccCCHHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHH
Confidence            32221111     12344 9999999999999999999999876

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=2.2e-44  Score=374.38  Aligned_cols=248  Identities=17%  Similarity=0.261  Sum_probs=209.7

Q ss_pred             CCCCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhC-CCCCeeeeeeeEEecCe
Q 004959          338 MNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHL-KHPNIVQYYGSEIVEDK  416 (721)
Q Consensus       338 l~~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L-~HPnIV~l~g~~~~~~~  416 (721)
                      +.++|++++.||+|+||.||+|.+..+|+.||||++.....       .+.+.+|+.+++.+ +|+||+++++++.....
T Consensus         8 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-------~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~   80 (298)
T 1csn_A            8 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD-------APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLH   80 (298)
T ss_dssp             ETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT-------SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTE
T ss_pred             cccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCc-------cHHHHHHHHHHHHHhcCCCCCeEEeecCCCce
Confidence            45689999999999999999999999999999998863221       13578899999999 79999999999999999


Q ss_pred             EEEEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCc-----eEEeecCCcc
Q 004959          417 FYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGV-----VKLADFGMAK  491 (721)
Q Consensus       417 ~yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~-----VKL~DFGlA~  491 (721)
                      .|+||||+ +++|.+++......+++..++.++.||+.||.|||++||+||||||+||||+.++.     +||+|||++.
T Consensus        81 ~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~  159 (298)
T 1csn_A           81 NVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK  159 (298)
T ss_dssp             EEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCE
T ss_pred             eEEEEEec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECcccc
Confidence            99999999 99999999876667999999999999999999999999999999999999987775     9999999998


Q ss_pred             ccCCCcc--------cccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchh---hHHHHHH
Q 004959          492 HLTGQKA--------DLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYE---GAAAMFK  560 (721)
Q Consensus       492 ~l~~~~~--------~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~---~~~~~~k  560 (721)
                      .+.....        .....||+.|+|||++.       ...++.++|||||||++|+|++|+.||.+..   ....+..
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~  232 (298)
T 1csn_A          160 FYRDPVTKQHIPYREKKNLSGTARYMSINTHL-------GREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYER  232 (298)
T ss_dssp             ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHT-------TCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHH
T ss_pred             ccccccccccccccCccCCCCCcccCCchhhc-------CCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHH
Confidence            7654322        23467999999999984       4557889999999999999999999997632   2233333


Q ss_pred             Hhhc-----CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q 004959          561 VMRD-----TPAIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEH  600 (721)
Q Consensus       561 i~~~-----~~~~p~~lS~el~dLI~~cL~~DP~kRPSa~eLL~H  600 (721)
                      +...     .......+++++.+||.+||+.||++||++.+|++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~  277 (298)
T 1csn_A          233 IGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGL  277 (298)
T ss_dssp             HHHHHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHH
T ss_pred             HHhhccCccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence            2221     112335789999999999999999999999999864

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=3e-45  Score=398.47  Aligned_cols=251  Identities=25%  Similarity=0.441  Sum_probs=216.7

Q ss_pred             CCCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeEE
Q 004959          339 NSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFY  418 (721)
Q Consensus       339 ~~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~y  418 (721)
                      .++|++++.||+|+||.||+|.+..+|+.||||++..    .......+.+.+|+.+|++++|||||++++++...+.+|
T Consensus       113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~----~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~  188 (377)
T 3cbl_A          113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRE----TLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIY  188 (377)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCT----TSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCE
T ss_pred             hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccc----cCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcE
Confidence            3589999999999999999999999999999998752    223455667899999999999999999999999999999


Q ss_pred             EEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCCcc
Q 004959          419 IYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKA  498 (721)
Q Consensus       419 LVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~~~  498 (721)
                      +||||+++|+|.+++......+++..+..++.||+.||+|||++||+||||||+||||+.++.+||+|||+++.......
T Consensus       189 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~  268 (377)
T 3cbl_A          189 IVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVY  268 (377)
T ss_dssp             EEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEE
T ss_pred             EEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCcEEECcCCCceecCCCce
Confidence            99999999999999987766799999999999999999999999999999999999999999999999999986543321


Q ss_pred             cc---cCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhh-CCCCCCchhhHHHHHHHhhc-CCCCCCCCC
Q 004959          499 DL---SMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFKVMRD-TPAIPDSLS  573 (721)
Q Consensus       499 ~~---s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLt-G~~PF~~~~~~~~~~ki~~~-~~~~p~~lS  573 (721)
                      ..   ...+++.|+|||++.+       ..++.++|||||||+||||++ |..||.+....+....+... ....+..++
T Consensus       269 ~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  341 (377)
T 3cbl_A          269 AASGGLRQVPVKWTAPEALNY-------GRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRLPCPELCP  341 (377)
T ss_dssp             ECCSSCCEEEGGGSCHHHHHH-------CEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTTCCCCCCTTCC
T ss_pred             eecCCCCCCCcCcCCHhHhcc-------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCC
Confidence            11   1235678999999964       346779999999999999998 99999887666555544443 345677899


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHHhc
Q 004959          574 PEGKDFLRCCFQRNPADRPPASLLLEH  600 (721)
Q Consensus       574 ~el~dLI~~cL~~DP~kRPSa~eLL~H  600 (721)
                      +++.+||.+||+.||++|||+.+|++.
T Consensus       342 ~~l~~li~~cl~~dP~~Rps~~~i~~~  368 (377)
T 3cbl_A          342 DAVFRLMEQCWAYEPGQRPSFSTIYQE  368 (377)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence            999999999999999999999999863

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=2.1e-45  Score=381.04  Aligned_cols=248  Identities=21%  Similarity=0.374  Sum_probs=211.4

Q ss_pred             CCCeeEeeEEeecCCeEEEEEEECCCC-------cEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeE
Q 004959          339 NSQWQKGKLIGRGTFGSVYVASNRETG-------ALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSE  411 (721)
Q Consensus       339 ~~~y~~~k~LG~G~fG~VY~a~~~~tg-------~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~  411 (721)
                      .++|++++.||+|+||.||+|.+..++       ..||+|++...     .....+.+.+|+.+|++++||||+++++++
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~-----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~   81 (289)
T 4fvq_A            7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKA-----HRNYSESFFEAASMMSKLSHKHLVLNYGVC   81 (289)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGG-----GGGGHHHHHHHHHHHHTSCCTTBCCEEEEE
T ss_pred             hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccc-----cHHHHHHHHHHHHHHHhCCCCCEeEEEEEE
Confidence            358999999999999999999988877       47999988531     223456789999999999999999999999


Q ss_pred             EecCeEEEEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCc--------eE
Q 004959          412 IVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGV--------VK  483 (721)
Q Consensus       412 ~~~~~~yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~--------VK  483 (721)
                      .+.+..|+||||+.||+|.+++......+++..++.++.||+.||.|||++||+||||||+||||+.++.        +|
T Consensus        82 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~k  161 (289)
T 4fvq_A           82 VCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIK  161 (289)
T ss_dssp             CCTTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCEEE
T ss_pred             EeCCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCcccccccceee
Confidence            9999999999999999999999877666999999999999999999999999999999999999998886        99


Q ss_pred             EeecCCccccCCCcccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhh
Q 004959          484 LADFGMAKHLTGQKADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMR  563 (721)
Q Consensus       484 L~DFGlA~~l~~~~~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~  563 (721)
                      |+|||++......   ....||+.|+|||++.+      ...++.++|||||||++|+|++|..|+..............
T Consensus       162 l~Dfg~~~~~~~~---~~~~~~~~y~aPE~~~~------~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~~  232 (289)
T 4fvq_A          162 LSDPGISITVLPK---DILQERIPWVPPECIEN------PKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYE  232 (289)
T ss_dssp             ECCCCSCTTTSCH---HHHHHTTTTSCHHHHHC------GGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHH
T ss_pred             eccCcccccccCc---cccCCcCcccCHHHhCC------CCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHhh
Confidence            9999999765432   23458899999999963      13467799999999999999995544443333444445555


Q ss_pred             cCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q 004959          564 DTPAIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEH  600 (721)
Q Consensus       564 ~~~~~p~~lS~el~dLI~~cL~~DP~kRPSa~eLL~H  600 (721)
                      ....++..++.++.+||.+||+.||++|||+.++++|
T Consensus       233 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  269 (289)
T 4fvq_A          233 DRHQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRD  269 (289)
T ss_dssp             TTCCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred             ccCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            6667788889999999999999999999999999987

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=6.3e-45  Score=377.52  Aligned_cols=251  Identities=24%  Similarity=0.409  Sum_probs=204.9

Q ss_pred             CCCCeeEeeEEeecCCeEEEEEEECCC---CcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEec
Q 004959          338 MNSQWQKGKLIGRGTFGSVYVASNRET---GALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVE  414 (721)
Q Consensus       338 l~~~y~~~k~LG~G~fG~VY~a~~~~t---g~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~  414 (721)
                      ..++|++++.||+|+||.||+|.+..+   +..||+|.+..    .......+.+.+|+.+|++++||||+++++++ .+
T Consensus        13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~----~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-~~   87 (281)
T 1mp8_A           13 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKN----CTSDSVREKFLQEALTMRQFDHPHIVKLIGVI-TE   87 (281)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTT----TTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-CS
T ss_pred             ehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccc----cCCHHHHHHHHHHHHHHHhCCCCccceEEEEE-cc
Confidence            346899999999999999999998654   55799998752    23445667899999999999999999999987 45


Q ss_pred             CeEEEEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccC
Q 004959          415 DKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLT  494 (721)
Q Consensus       415 ~~~yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~  494 (721)
                      +..|+||||+.+++|.+++......+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+.
T Consensus        88 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  167 (281)
T 1mp8_A           88 NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME  167 (281)
T ss_dssp             SSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC--------
T ss_pred             CccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCCEEECccccccccC
Confidence            67899999999999999998766679999999999999999999999999999999999999999999999999998765


Q ss_pred             CCccc--ccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhh-CCCCCCchhhHHHHHHHhhc-CCCCCC
Q 004959          495 GQKAD--LSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFKVMRD-TPAIPD  570 (721)
Q Consensus       495 ~~~~~--~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLt-G~~PF~~~~~~~~~~ki~~~-~~~~p~  570 (721)
                      .....  ....+|+.|+|||++.+       ..++.++|||||||++|||++ |..||.+....+....+... ...++.
T Consensus       168 ~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~~~~~~~  240 (281)
T 1mp8_A          168 DSTYYKASKGKLPIKWMAPESINF-------RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPP  240 (281)
T ss_dssp             -----------CCGGGCCHHHHHH-------CCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCT
T ss_pred             cccccccccCCCcccccChhhccc-------CCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCCCCCCCC
Confidence            43321  23457889999999964       346779999999999999996 99999887666666555543 345678


Q ss_pred             CCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q 004959          571 SLSPEGKDFLRCCFQRNPADRPPASLLLEH  600 (721)
Q Consensus       571 ~lS~el~dLI~~cL~~DP~kRPSa~eLL~H  600 (721)
                      .+++++.+||.+||+.||++||++.|++++
T Consensus       241 ~~~~~l~~li~~~l~~~p~~Rps~~~l~~~  270 (281)
T 1mp8_A          241 NCPPTLYSLMTKCWAYDPSRRPRFTELKAQ  270 (281)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            899999999999999999999999999875

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=7.4e-45  Score=379.05  Aligned_cols=250  Identities=28%  Similarity=0.496  Sum_probs=207.2

Q ss_pred             CCCeeEeeEEeecCCeEEEEEE----ECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEec
Q 004959          339 NSQWQKGKLIGRGTFGSVYVAS----NRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVE  414 (721)
Q Consensus       339 ~~~y~~~k~LG~G~fG~VY~a~----~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~  414 (721)
                      ..+|++++.||+|+||.||+|+    +..+|+.||||++..     ......+.+.+|+.+|++++||||+++++++...
T Consensus         9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~-----~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   83 (295)
T 3ugc_A            9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQH-----STEEHLRDFEREIEILKSLQHDNIVKYKGVCYSA   83 (295)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESC-----CCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHH
T ss_pred             HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEccc-----CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC
Confidence            4689999999999999999998    667899999998852     2345667899999999999999999999988654


Q ss_pred             --CeEEEEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccc
Q 004959          415 --DKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKH  492 (721)
Q Consensus       415 --~~~yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~  492 (721)
                        ..+|+||||+.+|+|.+++......+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||++..
T Consensus        84 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~  163 (295)
T 3ugc_A           84 GRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKV  163 (295)
T ss_dssp             HHTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCSCC-
T ss_pred             CCCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeEEEccCccccc
Confidence              558999999999999999987766799999999999999999999999999999999999999999999999999987


Q ss_pred             cCCCcc----cccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHH------------
Q 004959          493 LTGQKA----DLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAA------------  556 (721)
Q Consensus       493 l~~~~~----~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~------------  556 (721)
                      +.....    .....|+..|+|||++.+       ..++.++|||||||++|+|++|..||.......            
T Consensus       164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~  236 (295)
T 3ugc_A          164 LPQDKEFFKVKEPGESPIFWYAPESLTE-------SKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQM  236 (295)
T ss_dssp             ------------CTTCGGGGCCHHHHHH-------CCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHH
T ss_pred             ccCCcceeeeccCCCCccceeCcHHhcC-------CCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccch
Confidence            654322    123457788999999964       346789999999999999999999987543211            


Q ss_pred             ---HHHHHh--hcCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q 004959          557 ---AMFKVM--RDTPAIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEH  600 (721)
Q Consensus       557 ---~~~ki~--~~~~~~p~~lS~el~dLI~~cL~~DP~kRPSa~eLL~H  600 (721)
                         ......  ......+..+++++.+||.+||+.||++|||+.|+++.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~  285 (295)
T 3ugc_A          237 IVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALR  285 (295)
T ss_dssp             HHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred             hHHHHHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence               111111  12345677899999999999999999999999999864

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=8.7e-45  Score=389.78  Aligned_cols=254  Identities=24%  Similarity=0.373  Sum_probs=207.9

Q ss_pred             CCCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCC-----------CCCeeee
Q 004959          339 NSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLK-----------HPNIVQY  407 (721)
Q Consensus       339 ~~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~-----------HPnIV~l  407 (721)
                      ..+|++++.||+|+||.||+|.+..+|+.||||++..      .....+.+.+|+.+|+++.           |+||+++
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~------~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~   91 (373)
T 1q8y_A           18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRG------DKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKL   91 (373)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS------CHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCC
T ss_pred             CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecC------CccchhhhhHHHHHHHHhhcccccchhccccchHHHH
Confidence            4689999999999999999999999999999999852      2344567889999999886           8999999


Q ss_pred             eeeEEecC----eEEEEEeeccCCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhC-CeeccCCCCCcEEEcC---
Q 004959          408 YGSEIVED----KFYIYLEYVHPGSINKYVREH-CGAITESVVRNFTRHILSGLAYLHSK-KTIHRDIKGANLLVDA---  478 (721)
Q Consensus       408 ~g~~~~~~----~~yLVmEy~~gGsL~~~L~~~-~~~Lse~~i~~i~~QIl~AL~yLHs~-gIIHrDLKPeNILld~---  478 (721)
                      ++++...+    .+++||||+ +++|.+++... ...+++..++.++.||+.||.|||++ ||+||||||+||||+.   
T Consensus        92 ~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~  170 (373)
T 1q8y_A           92 LDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDS  170 (373)
T ss_dssp             CEEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEET
T ss_pred             HHHhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCC
Confidence            99988755    799999999 89999999764 35699999999999999999999998 9999999999999953   


Q ss_pred             ---CCceEEeecCCccccCCCcccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhh-
Q 004959          479 ---SGVVKLADFGMAKHLTGQKADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEG-  554 (721)
Q Consensus       479 ---~g~VKL~DFGlA~~l~~~~~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~-  554 (721)
                         .+.+||+|||++..+...  .....||+.|+|||++.+       ..++.++|||||||+||||++|..||..... 
T Consensus       171 ~~~~~~~kl~Dfg~a~~~~~~--~~~~~~t~~y~aPE~~~~-------~~~~~~~Di~slG~il~el~~g~~pf~~~~~~  241 (373)
T 1q8y_A          171 PENLIQIKIADLGNACWYDEH--YTNSIQTREYRSPEVLLG-------APWGCGADIWSTACLIFELITGDFLFEPDEGH  241 (373)
T ss_dssp             TTTEEEEEECCCTTCEETTBC--CCSCCSCGGGCCHHHHHT-------CCCCTHHHHHHHHHHHHHHHHSSCCC------
T ss_pred             CcCcceEEEcccccccccCCC--CCCCCCCccccCcHHHhC-------CCCCchHhHHHHHHHHHHHHhCCCCCCCCccc
Confidence               348999999999876433  234579999999999953       3467899999999999999999999975431 


Q ss_pred             -----HHHHHHHhh------------------------------------------cCCCCCCCCCHHHHHHHHHhcccC
Q 004959          555 -----AAAMFKVMR------------------------------------------DTPAIPDSLSPEGKDFLRCCFQRN  587 (721)
Q Consensus       555 -----~~~~~ki~~------------------------------------------~~~~~p~~lS~el~dLI~~cL~~D  587 (721)
                           .+.+..+..                                          ....++..++.++.+||.+||+.|
T Consensus       242 ~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d  321 (373)
T 1q8y_A          242 SYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLD  321 (373)
T ss_dssp             ---CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSS
T ss_pred             ccCChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccC
Confidence                 122222111                                          112233445678999999999999


Q ss_pred             CCCCCCHHHHHhccccccCCC
Q 004959          588 PADRPPASLLLEHRFLKNSQQ  608 (721)
Q Consensus       588 P~kRPSa~eLL~Hp~f~~~~~  608 (721)
                      |++|||++|+|+||||++...
T Consensus       322 P~~Rpt~~ell~hp~f~~~~~  342 (373)
T 1q8y_A          322 PRKRADAGGLVNHPWLKDTLG  342 (373)
T ss_dssp             TTTCBCHHHHHTCGGGTTCTT
T ss_pred             ccccCCHHHHhhChhhhcccC
Confidence            999999999999999997543

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=3.9e-45  Score=388.98  Aligned_cols=250  Identities=25%  Similarity=0.424  Sum_probs=205.9

Q ss_pred             CCCeeEeeEEeecCCeEEEEEEECCCCcEE----EEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEec
Q 004959          339 NSQWQKGKLIGRGTFGSVYVASNRETGALC----AMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVE  414 (721)
Q Consensus       339 ~~~y~~~k~LG~G~fG~VY~a~~~~tg~~v----AIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~  414 (721)
                      ..+|++++.||+|+||.||+|++..+|+.+    |+|.+..    .......+.+.+|+.+|++++|||||++++++...
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~----~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   89 (327)
T 3poz_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELRE----ATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS   89 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-----------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS
T ss_pred             HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeeccc----ccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC
Confidence            468999999999999999999998888766    6665532    22233457889999999999999999999998865


Q ss_pred             CeEEEEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccC
Q 004959          415 DKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLT  494 (721)
Q Consensus       415 ~~~yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~  494 (721)
                      . .++||||+.+|+|.+++......+++..++.|+.||+.||.|||++||+||||||+||||+.++.+||+|||+++.+.
T Consensus        90 ~-~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~  168 (327)
T 3poz_A           90 T-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG  168 (327)
T ss_dssp             S-EEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTHHHHHT
T ss_pred             C-eEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCCEEEccCcceeEcc
Confidence            4 789999999999999998877889999999999999999999999999999999999999999999999999998765


Q ss_pred             CCccc---ccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhh-CCCCCCchhhHHHHHHHhhc-CCCCC
Q 004959          495 GQKAD---LSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFKVMRD-TPAIP  569 (721)
Q Consensus       495 ~~~~~---~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLt-G~~PF~~~~~~~~~~ki~~~-~~~~p  569 (721)
                      .....   ....||+.|+|||++.+       ..++.++|||||||++|||++ |+.||.+....+....+... ....+
T Consensus       169 ~~~~~~~~~~~~~t~~y~aPE~~~~-------~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~  241 (327)
T 3poz_A          169 AEEKEYHAEGGKVPIKWMALESILH-------RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQP  241 (327)
T ss_dssp             TTCC-------CCCGGGSCHHHHHH-------CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCC
T ss_pred             CCcccccccCCCccccccChHHhcc-------CCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCCCCCCC
Confidence            43322   23457889999999964       456789999999999999999 99999876555544444333 34566


Q ss_pred             CCCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q 004959          570 DSLSPEGKDFLRCCFQRNPADRPPASLLLEH  600 (721)
Q Consensus       570 ~~lS~el~dLI~~cL~~DP~kRPSa~eLL~H  600 (721)
                      ..++.++.+||.+||+.||++||++.|++++
T Consensus       242 ~~~~~~~~~li~~~l~~~p~~Rps~~ell~~  272 (327)
T 3poz_A          242 PICTIDVYMIMVKCWMIDADSRPKFRELIIE  272 (327)
T ss_dssp             TTBCHHHHHHHHHHTCSCGGGSCCHHHHHHH
T ss_pred             ccCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence            7789999999999999999999999999987

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.6e-44  Score=391.50  Aligned_cols=251  Identities=25%  Similarity=0.472  Sum_probs=217.2

Q ss_pred             CCCeeEeeEEeecCCeEEEEEEECC-------CCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhC-CCCCeeeeeee
Q 004959          339 NSQWQKGKLIGRGTFGSVYVASNRE-------TGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHL-KHPNIVQYYGS  410 (721)
Q Consensus       339 ~~~y~~~k~LG~G~fG~VY~a~~~~-------tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L-~HPnIV~l~g~  410 (721)
                      .++|++++.||+|+||.||+|.+..       .+..||||++..    .......+.+.+|+.+|+++ +|||||+++++
T Consensus        68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~----~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~  143 (382)
T 3tt0_A           68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKS----DATEKDLSDLISEMEMMKMIGKHKNIINLLGA  143 (382)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECT----TCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeecc----ccCHHHHHHHHHHHHHHHHhcCCchhhhheee
Confidence            4689999999999999999998753       346899998853    23455677899999999999 89999999999


Q ss_pred             EEecCeEEEEEeeccCCCHHHHHHHhc---------------CCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEE
Q 004959          411 EIVEDKFYIYLEYVHPGSINKYVREHC---------------GAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLL  475 (721)
Q Consensus       411 ~~~~~~~yLVmEy~~gGsL~~~L~~~~---------------~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNIL  475 (721)
                      +...+..|+||||+.+|+|.+++....               ..+++..++.++.||+.||.|||++||+||||||+|||
T Consensus       144 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIl  223 (382)
T 3tt0_A          144 CTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVL  223 (382)
T ss_dssp             ECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEE
T ss_pred             eccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcceEE
Confidence            999999999999999999999998753               35999999999999999999999999999999999999


Q ss_pred             EcCCCceEEeecCCccccCCCc---ccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhh-CCCCCCc
Q 004959          476 VDASGVVKLADFGMAKHLTGQK---ADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSE  551 (721)
Q Consensus       476 ld~~g~VKL~DFGlA~~l~~~~---~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLt-G~~PF~~  551 (721)
                      |+.++.+||+|||+++.+....   ......||+.|+|||++.       ...++.++|||||||++|+|++ |..||.+
T Consensus       224 l~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~-------~~~~~~~~DiwslG~il~ellt~g~~p~~~  296 (382)
T 3tt0_A          224 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALF-------DRIYTHQSDVWSFGVLLWEIFTLGGSPYPG  296 (382)
T ss_dssp             ECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHH-------SCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred             EcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhc-------CCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Confidence            9999999999999998765432   223345788999999995       3457889999999999999999 9999988


Q ss_pred             hhhHHHHHHHhhc-CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q 004959          552 YEGAAAMFKVMRD-TPAIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEH  600 (721)
Q Consensus       552 ~~~~~~~~ki~~~-~~~~p~~lS~el~dLI~~cL~~DP~kRPSa~eLL~H  600 (721)
                      ....+....+... ....+..+++++.+||.+||+.||++||++.|++++
T Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  346 (382)
T 3tt0_A          297 VPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED  346 (382)
T ss_dssp             CCHHHHHHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            7766665555444 345677899999999999999999999999999987

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=6.7e-45  Score=389.41  Aligned_cols=256  Identities=26%  Similarity=0.405  Sum_probs=186.2

Q ss_pred             CCCCCCCCeeEe-eEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEE
Q 004959          334 EPLPMNSQWQKG-KLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEI  412 (721)
Q Consensus       334 ~~~~l~~~y~~~-k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~  412 (721)
                      ....+.++|++. ++||+|+||.||+|.++.+|+.||||++..      ....   .......++.+.||||+++++++.
T Consensus        22 ~~~~~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~------~~~~---~~e~~~~~~~~~h~~i~~~~~~~~   92 (336)
T 3fhr_A           22 KKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYD------SPKA---RQEVDHHWQASGGPHIVCILDVYE   92 (336)
T ss_dssp             BCSCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEES------SHHH---HHHHHHHHHHTTSTTBCCEEEEEE
T ss_pred             CCccccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecC------cHHH---HHHHHHHHHhcCCCChHHHHHHHh
Confidence            344567899995 479999999999999999999999999852      1111   222233466779999999999987


Q ss_pred             e----cCeEEEEEeeccCCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcC---CCceEE
Q 004959          413 V----EDKFYIYLEYVHPGSINKYVREHC-GAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDA---SGVVKL  484 (721)
Q Consensus       413 ~----~~~~yLVmEy~~gGsL~~~L~~~~-~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~---~g~VKL  484 (721)
                      .    ...+|||||||.||+|.+++.... ..+++..++.++.||+.||.|||++||+||||||+||||+.   ++.+||
T Consensus        93 ~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl  172 (336)
T 3fhr_A           93 NMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKL  172 (336)
T ss_dssp             EEETTEEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEE
T ss_pred             hccCCCceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEE
Confidence            6    556899999999999999998653 46999999999999999999999999999999999999976   445999


Q ss_pred             eecCCccccCCCcccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHH----HH
Q 004959          485 ADFGMAKHLTGQKADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAM----FK  560 (721)
Q Consensus       485 ~DFGlA~~l~~~~~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~----~k  560 (721)
                      +|||++...... .....+||+.|+|||++.+       ..++.++|||||||++|+|++|..||.........    ..
T Consensus       173 ~Dfg~~~~~~~~-~~~~~~~t~~y~aPE~~~~-------~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~  244 (336)
T 3fhr_A          173 TDFGFAKETTQN-ALQTPCYTPYYVAPEVLGP-------EKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRR  244 (336)
T ss_dssp             CCCTTCEEC------------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---------------
T ss_pred             eccccceecccc-ccccCCCCcCccChhhhCC-------CCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHh
Confidence            999999866433 2345678999999999843       45667899999999999999999999765443321    11


Q ss_pred             HhhcCC----CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhccccccC
Q 004959          561 VMRDTP----AIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNS  606 (721)
Q Consensus       561 i~~~~~----~~p~~lS~el~dLI~~cL~~DP~kRPSa~eLL~Hp~f~~~  606 (721)
                      +.....    .....++.++.+||.+||+.||++|||+.|+|+||||++.
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~  294 (336)
T 3fhr_A          245 IRLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQS  294 (336)
T ss_dssp             ------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTG
T ss_pred             hhccccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCcccccc
Confidence            111211    2225689999999999999999999999999999999864

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=1.2e-45  Score=392.21  Aligned_cols=250  Identities=24%  Similarity=0.375  Sum_probs=209.8

Q ss_pred             CCCeeEeeEEeecCCeEEEEEEECCCCcE----EEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEec
Q 004959          339 NSQWQKGKLIGRGTFGSVYVASNRETGAL----CAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVE  414 (721)
Q Consensus       339 ~~~y~~~k~LG~G~fG~VY~a~~~~tg~~----vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~  414 (721)
                      ..+|++++.||+|+||.||+|.+..+|+.    ||+|.+....    .....+.+.+|+.+++.++|||||++++++. .
T Consensus        12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~   86 (325)
T 3kex_A           12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKS----GRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-G   86 (325)
T ss_dssp             TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTT----SCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-B
T ss_pred             HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccc----cHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-C
Confidence            46899999999999999999999988887    6666653211    1112346778999999999999999999875 5


Q ss_pred             CeEEEEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccC
Q 004959          415 DKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLT  494 (721)
Q Consensus       415 ~~~yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~  494 (721)
                      +..++||||+.+|+|.+++....+.+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.+.
T Consensus        87 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~  166 (325)
T 3kex_A           87 SSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLP  166 (325)
T ss_dssp             SSEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSCEEECSCSGGGGSC
T ss_pred             CccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCeEEECCCCcccccC
Confidence            67999999999999999998766789999999999999999999999999999999999999999999999999998765


Q ss_pred             CCcc---cccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhh-CCCCCCchhhHHHHHHHhhc-CCCCC
Q 004959          495 GQKA---DLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFKVMRD-TPAIP  569 (721)
Q Consensus       495 ~~~~---~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLt-G~~PF~~~~~~~~~~ki~~~-~~~~p  569 (721)
                      ....   .....||+.|+|||++.+       ..++.++|||||||++|+|++ |..||.+....+....+... ....+
T Consensus       167 ~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~  239 (325)
T 3kex_A          167 PDDKQLLYSEAKTPIKWMALESIHF-------GKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGERLAQP  239 (325)
T ss_dssp             CCTTCCC-----CCTTTSCHHHHHH-------CCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTCBCCCC
T ss_pred             cccccccccCCCCcccccChHHhcc-------CCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCCC
Confidence            4332   233568889999999964       347789999999999999999 99999886655555554443 34566


Q ss_pred             CCCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q 004959          570 DSLSPEGKDFLRCCFQRNPADRPPASLLLEH  600 (721)
Q Consensus       570 ~~lS~el~dLI~~cL~~DP~kRPSa~eLL~H  600 (721)
                      ..++.++.+||.+||+.||++||++.++++|
T Consensus       240 ~~~~~~~~~li~~~l~~dp~~Rps~~el~~~  270 (325)
T 3kex_A          240 QICTIDVYMVMVKCWMIDENIRPTFKELANE  270 (325)
T ss_dssp             TTBCTTTTHHHHHHTCSCTTTSCCHHHHHHH
T ss_pred             CcCcHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            7788999999999999999999999999987

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=1.9e-44  Score=374.03  Aligned_cols=254  Identities=24%  Similarity=0.450  Sum_probs=212.2

Q ss_pred             CCCCCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHH---HHHHHHHHHHHHhCCCCCeeeeeeeEEe
Q 004959          337 PMNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAES---IKQLEQEIKVLSHLKHPNIVQYYGSEIV  413 (721)
Q Consensus       337 ~l~~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~---~k~~~~Ei~iL~~L~HPnIV~l~g~~~~  413 (721)
                      ...++|++.+.||+|+||.||+|++..+++.||||++....... ....   .+.+.+|+.+|++++||||+++++++.+
T Consensus        16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~   94 (287)
T 4f0f_A           16 LADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEG-ETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHN   94 (287)
T ss_dssp             CCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTC-CHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETT
T ss_pred             hhhccceehhccccCCceeEEEEEEcCCceEEEEEEeecccccc-chhHHHHHHHHHHHHHHHHhCCCCCchhhheeecC
Confidence            44578999999999999999999999999999999986432221 2222   2678999999999999999999998865


Q ss_pred             cCeEEEEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCC--eeccCCCCCcEEEcCCCc-----eEEee
Q 004959          414 EDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKK--TIHRDIKGANLLVDASGV-----VKLAD  486 (721)
Q Consensus       414 ~~~~yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~g--IIHrDLKPeNILld~~g~-----VKL~D  486 (721)
                      ..  ++||||+.+|+|.+++......+++..++.++.||+.||+|||++|  |+||||||+||||+.++.     +||+|
T Consensus        95 ~~--~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~D  172 (287)
T 4f0f_A           95 PP--RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVAD  172 (287)
T ss_dssp             TT--EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEECC
T ss_pred             CC--eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeCC
Confidence            54  7999999999999999877678999999999999999999999999  999999999999988776     99999


Q ss_pred             cCCccccCCCcccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHH--HHHHh--
Q 004959          487 FGMAKHLTGQKADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAA--MFKVM--  562 (721)
Q Consensus       487 FGlA~~l~~~~~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~--~~ki~--  562 (721)
                      ||+++....  ......||+.|+|||++.+     ....++.++|||||||++|+|++|+.||........  ...+.  
T Consensus       173 fg~~~~~~~--~~~~~~g~~~y~aPE~~~~-----~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~  245 (287)
T 4f0f_A          173 FGLSQQSVH--SVSGLLGNFQWMAPETIGA-----EEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREE  245 (287)
T ss_dssp             CTTCBCCSS--CEECCCCCCTTSCGGGSSC-----SSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHS
T ss_pred             CCccccccc--cccccCCCccccCchhhcc-----CCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhcc
Confidence            999985433  2344679999999999832     234567899999999999999999999976433222  22222  


Q ss_pred             hcCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q 004959          563 RDTPAIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEH  600 (721)
Q Consensus       563 ~~~~~~p~~lS~el~dLI~~cL~~DP~kRPSa~eLL~H  600 (721)
                      .....++..+++++.+||.+||+.||++|||+.|+++.
T Consensus       246 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  283 (287)
T 4f0f_A          246 GLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKE  283 (287)
T ss_dssp             CCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence            22346678899999999999999999999999999864

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=1e-44  Score=384.39  Aligned_cols=251  Identities=26%  Similarity=0.454  Sum_probs=213.1

Q ss_pred             CCCeeEeeEEeecCCeEEEEEEECCCCcEE--EEEEeecCCCCcccHHHHHHHHHHHHHHHhC-CCCCeeeeeeeEEecC
Q 004959          339 NSQWQKGKLIGRGTFGSVYVASNRETGALC--AMKEVDIFPDDPKSAESIKQLEQEIKVLSHL-KHPNIVQYYGSEIVED  415 (721)
Q Consensus       339 ~~~y~~~k~LG~G~fG~VY~a~~~~tg~~v--AIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L-~HPnIV~l~g~~~~~~  415 (721)
                      .++|++++.||+|+||.||+|++..+|..+  |+|.+...    ......+.+.+|+.+|+++ +||||+++++++.+.+
T Consensus        24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~----~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~   99 (327)
T 1fvr_A           24 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY----ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG   99 (327)
T ss_dssp             GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC----------CHHHHHHHHHTTCCCCTTBCCEEEEEEETT
T ss_pred             HHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccc----cchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCC
Confidence            368999999999999999999999888866  99987632    2233456789999999999 8999999999999999


Q ss_pred             eEEEEEeeccCCCHHHHHHHhc---------------CCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCC
Q 004959          416 KFYIYLEYVHPGSINKYVREHC---------------GAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASG  480 (721)
Q Consensus       416 ~~yLVmEy~~gGsL~~~L~~~~---------------~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g  480 (721)
                      ..|+||||+++++|.+++....               ..+++..++.++.||+.||.|||++||+||||||+||||+.++
T Consensus       100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~  179 (327)
T 1fvr_A          100 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY  179 (327)
T ss_dssp             EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGG
T ss_pred             ceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcCCC
Confidence            9999999999999999997642               4699999999999999999999999999999999999999999


Q ss_pred             ceEEeecCCccccCCCcccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhh-CCCCCCchhhHHHHH
Q 004959          481 VVKLADFGMAKHLTGQKADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMF  559 (721)
Q Consensus       481 ~VKL~DFGlA~~l~~~~~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLt-G~~PF~~~~~~~~~~  559 (721)
                      .+||+|||++.............+++.|+|||++.+       ..++.++|||||||++|+|++ |..||.+....+...
T Consensus       180 ~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~  252 (327)
T 1fvr_A          180 VAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNY-------SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYE  252 (327)
T ss_dssp             CEEECCTTCEESSCEECCC----CCTTTCCHHHHHH-------CEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHH
T ss_pred             eEEEcccCcCccccccccccCCCCCccccChhhhcc-------ccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHH
Confidence            999999999975443333344567899999999954       346678999999999999998 999998877666666


Q ss_pred             HHhhc-CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q 004959          560 KVMRD-TPAIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEH  600 (721)
Q Consensus       560 ki~~~-~~~~p~~lS~el~dLI~~cL~~DP~kRPSa~eLL~H  600 (721)
                      .+... ....+..+++++.+||.+||+.||++||++.|++++
T Consensus       253 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  294 (327)
T 1fvr_A          253 KLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS  294 (327)
T ss_dssp             HGGGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HhhcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            65554 345667889999999999999999999999999987

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=1.2e-44  Score=378.88  Aligned_cols=250  Identities=26%  Similarity=0.491  Sum_probs=214.1

Q ss_pred             CCeeEeeEEeecCCeEEEEEEE-----CCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhC-CCCCeeeeeeeEEe
Q 004959          340 SQWQKGKLIGRGTFGSVYVASN-----RETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHL-KHPNIVQYYGSEIV  413 (721)
Q Consensus       340 ~~y~~~k~LG~G~fG~VY~a~~-----~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L-~HPnIV~l~g~~~~  413 (721)
                      ++|++++.||+|+||.||+|.+     ..+++.||||++...    ......+.+.+|+.+|+++ +||||+++++++..
T Consensus        23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~   98 (313)
T 1t46_A           23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPS----AHLTEREALMSELKVLSYLGNHMNIVNLLGACTI   98 (313)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTT----CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             hhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcc----hhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEec
Confidence            5899999999999999999984     567899999998531    2344567899999999999 89999999999999


Q ss_pred             cCeEEEEEeeccCCCHHHHHHHhcC-----------------CCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEE
Q 004959          414 EDKFYIYLEYVHPGSINKYVREHCG-----------------AITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLV  476 (721)
Q Consensus       414 ~~~~yLVmEy~~gGsL~~~L~~~~~-----------------~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILl  476 (721)
                      .+..|+||||+.+|+|.+++.....                 .+++..++.++.||+.||.|||++||+||||||+||||
T Consensus        99 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~  178 (313)
T 1t46_A           99 GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILL  178 (313)
T ss_dssp             SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred             CCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEE
Confidence            9999999999999999999976532                 48999999999999999999999999999999999999


Q ss_pred             cCCCceEEeecCCccccCCCcc---cccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhh-CCCCCCch
Q 004959          477 DASGVVKLADFGMAKHLTGQKA---DLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEY  552 (721)
Q Consensus       477 d~~g~VKL~DFGlA~~l~~~~~---~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLt-G~~PF~~~  552 (721)
                      +.++.+||+|||++..+.....   .....||+.|+|||++.+       ..++.++|||||||++|+|++ |..||.+.
T Consensus       179 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~il~ellt~g~~p~~~~  251 (313)
T 1t46_A          179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFN-------CVYTFESDVWSYGIFLWELFSLGSSPYPGM  251 (313)
T ss_dssp             ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHH-------CCCCHHHHHHHHHHHHHHHHTTTCCSSTTC
T ss_pred             cCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcC-------CCCChHHHHHHHHHHHHHHHhCCCCCCCcc
Confidence            9999999999999987654432   123457889999999964       346789999999999999999 99999876


Q ss_pred             hhHHHHHHHhhc--CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q 004959          553 EGAAAMFKVMRD--TPAIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEH  600 (721)
Q Consensus       553 ~~~~~~~ki~~~--~~~~p~~lS~el~dLI~~cL~~DP~kRPSa~eLL~H  600 (721)
                      .....+......  ....+..++.++.+||.+||+.||++|||+.|++++
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  301 (313)
T 1t46_A          252 PVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL  301 (313)
T ss_dssp             CSSHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             cchhHHHHHhccCCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence            554444444333  234467789999999999999999999999999976

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=9.5e-45  Score=386.35  Aligned_cols=252  Identities=25%  Similarity=0.445  Sum_probs=212.3

Q ss_pred             CCeeEeeEEeecCCeEEEEEEE-----CCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhC-CCCCeeeeeeeEEe
Q 004959          340 SQWQKGKLIGRGTFGSVYVASN-----RETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHL-KHPNIVQYYGSEIV  413 (721)
Q Consensus       340 ~~y~~~k~LG~G~fG~VY~a~~-----~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L-~HPnIV~l~g~~~~  413 (721)
                      ++|++++.||+|+||.||+|.+     ..++..||||++...    ......+.+.+|+.+|+++ .||||+++++++..
T Consensus        45 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~  120 (344)
T 1rjb_A           45 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEK----ADSSEREALMSELKMMTQLGSHENIVNLLGACTL  120 (344)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             HHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccc----cCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEee
Confidence            5899999999999999999997     346778999998632    1233456889999999999 89999999999999


Q ss_pred             cCeEEEEEeeccCCCHHHHHHHhcC----------------------CCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCC
Q 004959          414 EDKFYIYLEYVHPGSINKYVREHCG----------------------AITESVVRNFTRHILSGLAYLHSKKTIHRDIKG  471 (721)
Q Consensus       414 ~~~~yLVmEy~~gGsL~~~L~~~~~----------------------~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKP  471 (721)
                      .+..|+||||+++|+|.+++.....                      .+++..++.++.||+.||.|||++||+||||||
T Consensus       121 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp  200 (344)
T 1rjb_A          121 SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAA  200 (344)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSG
T ss_pred             CCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCh
Confidence            9999999999999999999976532                      378999999999999999999999999999999


Q ss_pred             CcEEEcCCCceEEeecCCccccCCCcc---cccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhh-CCC
Q 004959          472 ANLLVDASGVVKLADFGMAKHLTGQKA---DLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKP  547 (721)
Q Consensus       472 eNILld~~g~VKL~DFGlA~~l~~~~~---~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLt-G~~  547 (721)
                      +||||+.++.+||+|||++..+.....   .....||+.|+|||++.+       ..++.++|||||||+||+|++ |..
T Consensus       201 ~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-------~~~~~~~Di~slG~il~el~t~g~~  273 (344)
T 1rjb_A          201 RNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFE-------GIYTIKSDVWSYGILLWEIFSLGVN  273 (344)
T ss_dssp             GGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHH-------CCCCHHHHHHHHHHHHHHHTTTSCC
T ss_pred             hhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhcc-------CCCChhHhHHHHHHHHHHHHcCCCC
Confidence            999999999999999999987644322   123457889999999964       346789999999999999998 999


Q ss_pred             CCCchhhHHHHHHHhhc--CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhccc
Q 004959          548 PWSEYEGAAAMFKVMRD--TPAIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRF  602 (721)
Q Consensus       548 PF~~~~~~~~~~ki~~~--~~~~p~~lS~el~dLI~~cL~~DP~kRPSa~eLL~Hp~  602 (721)
                      ||.+......+...+..  ....+..+++++.+||.+||+.||++||++.++++|..
T Consensus       274 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~  330 (344)
T 1rjb_A          274 PYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG  330 (344)
T ss_dssp             SSTTCCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             CcccCCcHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHH
Confidence            99876655555554443  33456778999999999999999999999999998754

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=1.9e-44  Score=370.37  Aligned_cols=249  Identities=30%  Similarity=0.552  Sum_probs=202.4

Q ss_pred             CCCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeEE
Q 004959          339 NSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFY  418 (721)
Q Consensus       339 ~~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~y  418 (721)
                      .++|++.+.||+|+||.||+|.+.  |+.||||++..... .......+.+.+|+.+++.++||||+++++++.+.+..|
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~-~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   82 (271)
T 3dtc_A            6 FAELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPD-EDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLC   82 (271)
T ss_dssp             TTSEEEEEEEEEETTEEEEEEEET--TEEEEEEEC-----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CE
T ss_pred             hhheeeeeeeccCCCeEEEEEEEc--CCeEEEEEEecCCc-ccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceE
Confidence            358999999999999999999975  88999998864221 122334578899999999999999999999999999999


Q ss_pred             EEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCC---eeccCCCCCcEEEcC--------CCceEEeec
Q 004959          419 IYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKK---TIHRDIKGANLLVDA--------SGVVKLADF  487 (721)
Q Consensus       419 LVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~g---IIHrDLKPeNILld~--------~g~VKL~DF  487 (721)
                      +||||+.|++|.+++..  ..+++..++.++.||+.||.|||++|   |+||||||+||||+.        ++.+||+||
T Consensus        83 lv~e~~~~~~L~~~~~~--~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Df  160 (271)
T 3dtc_A           83 LVMEFARGGPLNRVLSG--KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDF  160 (271)
T ss_dssp             EEEECCTTEEHHHHHTS--SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCC
T ss_pred             EEEEcCCCCCHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccC
Confidence            99999999999999853  58999999999999999999999999   999999999999986        678999999


Q ss_pred             CCccccCCCcccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhcC--
Q 004959          488 GMAKHLTGQKADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDT--  565 (721)
Q Consensus       488 GlA~~l~~~~~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~~--  565 (721)
                      |++..+..... ....||+.|+|||++.+       ..++.++|||||||++|+|++|+.||.+.........+....  
T Consensus       161 g~~~~~~~~~~-~~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~  232 (271)
T 3dtc_A          161 GLAREWHRTTK-MSAAGAYAWMAPEVIRA-------SMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLA  232 (271)
T ss_dssp             CC--------------CCGGGSCHHHHHH-------CCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSCCC
T ss_pred             Ccccccccccc-cCCCCccceeCHHHhcc-------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCCCC
Confidence            99986644332 34579999999999964       346789999999999999999999998877666665554443  


Q ss_pred             CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q 004959          566 PAIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEH  600 (721)
Q Consensus       566 ~~~p~~lS~el~dLI~~cL~~DP~kRPSa~eLL~H  600 (721)
                      ...+..+++++.+||.+||+.||++|||+.|+++|
T Consensus       233 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~  267 (271)
T 3dtc_A          233 LPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQ  267 (271)
T ss_dssp             CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHH
Confidence            45667899999999999999999999999999986

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=1.9e-44  Score=368.57  Aligned_cols=249  Identities=18%  Similarity=0.339  Sum_probs=213.7

Q ss_pred             CCCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEec--Ce
Q 004959          339 NSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVE--DK  416 (721)
Q Consensus       339 ~~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~--~~  416 (721)
                      .++|++++.||+|+||.||+|++.  |+.||||++...   .......+.+.+|+.+|++++||||+++++++.+.  +.
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~---~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   83 (271)
T 3kmu_A            9 FKQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVR---DWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPH   83 (271)
T ss_dssp             GGGCEEEEEEEEETTEEEEEEEET--TEEEEEEEECCT---TCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSS
T ss_pred             HHHhHHHHHhcCCCcceEEEEEEC--CeeEEEEEeccc---ccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCC
Confidence            358999999999999999999985  889999998642   23445667899999999999999999999999877  78


Q ss_pred             EEEEEeeccCCCHHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHhhCC--eeccCCCCCcEEEcCCCceEEeecCCcccc
Q 004959          417 FYIYLEYVHPGSINKYVREHCG-AITESVVRNFTRHILSGLAYLHSKK--TIHRDIKGANLLVDASGVVKLADFGMAKHL  493 (721)
Q Consensus       417 ~yLVmEy~~gGsL~~~L~~~~~-~Lse~~i~~i~~QIl~AL~yLHs~g--IIHrDLKPeNILld~~g~VKL~DFGlA~~l  493 (721)
                      .++||||+++|+|.+++..... .+++..++.++.||+.||.|||++|  |+||||||+|||++.++.++|+|||++...
T Consensus        84 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~  163 (271)
T 3kmu_A           84 PTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSF  163 (271)
T ss_dssp             CEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTT
T ss_pred             eEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEeccceeee
Confidence            8999999999999999986533 5899999999999999999999999  999999999999999999999999887643


Q ss_pred             CCCcccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhc--CCCCCCC
Q 004959          494 TGQKADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRD--TPAIPDS  571 (721)
Q Consensus       494 ~~~~~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~--~~~~p~~  571 (721)
                      ..    ....||+.|+|||++.+..    ...++.++|||||||++|+|++|+.||.+....+....+...  .+.++..
T Consensus       164 ~~----~~~~~t~~y~aPE~~~~~~----~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  235 (271)
T 3kmu_A          164 QS----PGRMYAPAWVAPEALQKKP----EDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIPPG  235 (271)
T ss_dssp             SC----TTCBSCGGGSCHHHHHSCG----GGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCCCCCCTT
T ss_pred             cc----cCccCCccccChhhhccCC----CCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCCCCCCCC
Confidence            22    2356899999999996422    223445799999999999999999999887766666655543  4566788


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q 004959          572 LSPEGKDFLRCCFQRNPADRPPASLLLEH  600 (721)
Q Consensus       572 lS~el~dLI~~cL~~DP~kRPSa~eLL~H  600 (721)
                      +++++.+||.+||+.||++|||+.++++.
T Consensus       236 ~~~~~~~li~~~l~~~p~~Rps~~~il~~  264 (271)
T 3kmu_A          236 ISPHVSKLMKICMNEDPAKRPKFDMIVPI  264 (271)
T ss_dssp             CCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            99999999999999999999999999864

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=3e-44  Score=370.21  Aligned_cols=247  Identities=27%  Similarity=0.449  Sum_probs=213.0

Q ss_pred             CCCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEe-----
Q 004959          339 NSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIV-----  413 (721)
Q Consensus       339 ~~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~-----  413 (721)
                      ..+|++++.||+|+||.||+|.+..+|+.||||++....         +.+.+|+.+|+.++||||+++++++..     
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   80 (284)
T 2a19_B           10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN---------EKAEREVKALAKLDHVNIVHYNGCWDGFDYDP   80 (284)
T ss_dssp             HHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS---------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-
T ss_pred             ccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc---------HHHHHHHHHHHhCCCCCEEEEeeeEeccccCc
Confidence            457999999999999999999999999999999986321         256789999999999999999998765     


Q ss_pred             -----------cCeEEEEEeeccCCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCc
Q 004959          414 -----------EDKFYIYLEYVHPGSINKYVREH-CGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGV  481 (721)
Q Consensus       414 -----------~~~~yLVmEy~~gGsL~~~L~~~-~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~  481 (721)
                                 ...+|+||||+.+++|.+++... ...+++..++.++.||+.||.|||++||+||||||+||||+.++.
T Consensus        81 ~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~  160 (284)
T 2a19_B           81 ETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQ  160 (284)
T ss_dssp             --------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTE
T ss_pred             ccccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCCC
Confidence                       45689999999999999999764 367999999999999999999999999999999999999999999


Q ss_pred             eEEeecCCccccCCCcccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHH
Q 004959          482 VKLADFGMAKHLTGQKADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKV  561 (721)
Q Consensus       482 VKL~DFGlA~~l~~~~~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki  561 (721)
                      +||+|||++..+..........||+.|+|||++.+       ..++.++|||||||++|+|++|..||.....  ....+
T Consensus       161 ~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~il~~l~~~~~~~~~~~~--~~~~~  231 (284)
T 2a19_B          161 VKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISS-------QDYGKEVDLYALGLILAELLHVCDTAFETSK--FFTDL  231 (284)
T ss_dssp             EEECCCTTCEESSCCSCCCCCCSCCTTSCHHHHHC-------SCCCTHHHHHHHHHHHHHHHSCCSSHHHHHH--HHHHH
T ss_pred             EEECcchhheeccccccccccCCcccccChhhhcc-------CCCcchhhhHHHHHHHHHHHhcCCcchhHHH--HHHHh
Confidence            99999999988766555556779999999999853       4567799999999999999999998854322  22222


Q ss_pred             hhcCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccccc
Q 004959          562 MRDTPAIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKN  605 (721)
Q Consensus       562 ~~~~~~~p~~lS~el~dLI~~cL~~DP~kRPSa~eLL~Hp~f~~  605 (721)
                      .  ...++..++.++.+||.+||+.||++||++.|+++|.+.-.
T Consensus       232 ~--~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~  273 (284)
T 2a19_B          232 R--DGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWK  273 (284)
T ss_dssp             H--TTCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHT
T ss_pred             h--cccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence            2  23456788999999999999999999999999999987653

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=8.6e-45  Score=387.17  Aligned_cols=254  Identities=24%  Similarity=0.400  Sum_probs=205.6

Q ss_pred             CCCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeEE
Q 004959          339 NSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFY  418 (721)
Q Consensus       339 ~~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~y  418 (721)
                      ..+|++++.||+|+||.||+|.+..+|+.|++|++.+...........+.+.+|+.+|++++||||+++++++.... .+
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~   92 (327)
T 3lzb_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ   92 (327)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EE
T ss_pred             HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ce
Confidence            46899999999999999999999988887644433211111112223567889999999999999999999988654 88


Q ss_pred             EEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCCcc
Q 004959          419 IYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKA  498 (721)
Q Consensus       419 LVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~~~  498 (721)
                      +||||+.+|+|.+++....+.+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.+.....
T Consensus        93 ~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~~~~  172 (327)
T 3lzb_A           93 LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK  172 (327)
T ss_dssp             EEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTC---------
T ss_pred             EEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEEEccCcceeEccCccc
Confidence            99999999999999988778899999999999999999999999999999999999999999999999999987644332


Q ss_pred             c---ccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhh-CCCCCCchhhHHHHHHHhhc-CCCCCCCCC
Q 004959          499 D---LSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFKVMRD-TPAIPDSLS  573 (721)
Q Consensus       499 ~---~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLt-G~~PF~~~~~~~~~~ki~~~-~~~~p~~lS  573 (721)
                      .   ....||+.|+|||++.+       ..++.++|||||||++|+|++ |..||.+....+....+... ....+..++
T Consensus       173 ~~~~~~~~~t~~y~aPE~~~~-------~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (327)
T 3lzb_A          173 EYHAEGGKVPIKWMALESILH-------RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICT  245 (327)
T ss_dssp             -------CCCGGGSCHHHHHH-------CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTBC
T ss_pred             cccccCCCccccccCHHHHcC-------CCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCccCC
Confidence            2   23457889999999964       356789999999999999999 99999886655555444433 345667899


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHHhc
Q 004959          574 PEGKDFLRCCFQRNPADRPPASLLLEH  600 (721)
Q Consensus       574 ~el~dLI~~cL~~DP~kRPSa~eLL~H  600 (721)
                      .++.+||++||+.||++||++.|+++.
T Consensus       246 ~~l~~li~~~l~~dp~~Rps~~ell~~  272 (327)
T 3lzb_A          246 IDVYMIMRKCWMIDADSRPKFRELIIE  272 (327)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            999999999999999999999999974

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=2.3e-44  Score=368.44  Aligned_cols=247  Identities=26%  Similarity=0.451  Sum_probs=215.1

Q ss_pred             CCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeEEE
Q 004959          340 SQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYI  419 (721)
Q Consensus       340 ~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~yL  419 (721)
                      ++|++.+.||+|+||.||+|.+. +++.||+|++....   ..   .+.+.+|+.+++.++||||+++++++.+.+..|+
T Consensus         8 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~---~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   80 (267)
T 3t9t_A            8 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGA---MS---EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICL   80 (267)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTT---BC---HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEE
T ss_pred             hheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccC---CC---HHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEE
Confidence            57999999999999999999986 57899999986321   11   2578899999999999999999999999999999


Q ss_pred             EEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCCc--
Q 004959          420 YLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQK--  497 (721)
Q Consensus       420 VmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~~--  497 (721)
                      ||||+++++|.+++....+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......  
T Consensus        81 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~  160 (267)
T 3t9t_A           81 VTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT  160 (267)
T ss_dssp             EECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHH
T ss_pred             EEeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCCEEEccccccccccccccc
Confidence            999999999999998776789999999999999999999999999999999999999999999999999998764432  


Q ss_pred             ccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhh-CCCCCCchhhHHHHHHHhhcC-CCCCCCCCHH
Q 004959          498 ADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFKVMRDT-PAIPDSLSPE  575 (721)
Q Consensus       498 ~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLt-G~~PF~~~~~~~~~~ki~~~~-~~~p~~lS~e  575 (721)
                      ......|++.|+|||++.+       ..++.++|||||||++|+|++ |..||......+....+.... ...+..++.+
T Consensus       161 ~~~~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~  233 (267)
T 3t9t_A          161 SSTGTKFPVKWASPEVFSF-------SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTH  233 (267)
T ss_dssp             STTSTTCCGGGCCHHHHHH-------CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTSCHH
T ss_pred             ccccccccccccChhhhcC-------CCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCcCCCCccCcHH
Confidence            1223457889999999954       346779999999999999999 999998877666666665543 3456778999


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHHhc
Q 004959          576 GKDFLRCCFQRNPADRPPASLLLEH  600 (721)
Q Consensus       576 l~dLI~~cL~~DP~kRPSa~eLL~H  600 (721)
                      +.+||.+||+.||++||++.+++++
T Consensus       234 l~~li~~~l~~~p~~Rps~~~ll~~  258 (267)
T 3t9t_A          234 VYQIMNHCWRERPEDRPAFSRLLRQ  258 (267)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHccCChhhCcCHHHHHHH
Confidence            9999999999999999999999976

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=1.3e-44  Score=383.24  Aligned_cols=260  Identities=29%  Similarity=0.506  Sum_probs=192.0

Q ss_pred             CCCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHH-HHHhCCCCCeeeeeeeEEecCeE
Q 004959          339 NSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIK-VLSHLKHPNIVQYYGSEIVEDKF  417 (721)
Q Consensus       339 ~~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~-iL~~L~HPnIV~l~g~~~~~~~~  417 (721)
                      .++|++++.||+|+||.||+|.+..+|+.||||++...    ........+..|+. +++.++||||+++++++...+..
T Consensus        21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~----~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~   96 (327)
T 3aln_A           21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRST----VDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDC   96 (327)
T ss_dssp             SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECC----CCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEE
T ss_pred             HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecc----cCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCce
Confidence            36899999999999999999999999999999998632    22334455666666 77788999999999999999999


Q ss_pred             EEEEeeccCCCHHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHhhC-CeeccCCCCCcEEEcCCCceEEeecCCccc
Q 004959          418 YIYLEYVHPGSINKYVRE----HCGAITESVVRNFTRHILSGLAYLHSK-KTIHRDIKGANLLVDASGVVKLADFGMAKH  492 (721)
Q Consensus       418 yLVmEy~~gGsL~~~L~~----~~~~Lse~~i~~i~~QIl~AL~yLHs~-gIIHrDLKPeNILld~~g~VKL~DFGlA~~  492 (721)
                      |+||||+.+ +|.+++..    ....+++..+..++.||+.||.|||++ ||+||||||+||||+.++.+||+|||++..
T Consensus        97 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~  175 (327)
T 3aln_A           97 WICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQ  175 (327)
T ss_dssp             EEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTEEEECCCSSSCC
T ss_pred             EEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCCEEEccCCCcee
Confidence            999999974 88877753    246799999999999999999999999 999999999999999999999999999987


Q ss_pred             cCCCcccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhH-HHHHHHhhcC-CCC--
Q 004959          493 LTGQKADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGA-AAMFKVMRDT-PAI--  568 (721)
Q Consensus       493 l~~~~~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~-~~~~ki~~~~-~~~--  568 (721)
                      +..........||+.|+|||++....   ....++.++|||||||++|+|++|..||...... +.+..+.... +.+  
T Consensus       176 ~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  252 (327)
T 3aln_A          176 LVDSIAKTRDAGCRPYMAPERIDPSA---SRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQLSN  252 (327)
T ss_dssp             ---------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCCCSCCCCCCC
T ss_pred             cccccccccCCCCccccCceeecccc---CcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHhcCCCCCCCC
Confidence            76554444557999999999984321   1234677999999999999999999999874332 2222222222 112  


Q ss_pred             --CCCCCHHHHHHHHHhcccCCCCCCCHHHHHhccccccC
Q 004959          569 --PDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNS  606 (721)
Q Consensus       569 --p~~lS~el~dLI~~cL~~DP~kRPSa~eLL~Hp~f~~~  606 (721)
                        ...++.++.+||.+||+.||++||++.++++||||...
T Consensus       253 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~  292 (327)
T 3aln_A          253 SEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMY  292 (327)
T ss_dssp             CSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred             cccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHHh
Confidence              23589999999999999999999999999999999754

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=5.7e-44  Score=375.95  Aligned_cols=263  Identities=24%  Similarity=0.471  Sum_probs=211.1

Q ss_pred             CCCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCC--CCCeeeeeeeEEecCe
Q 004959          339 NSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLK--HPNIVQYYGSEIVEDK  416 (721)
Q Consensus       339 ~~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~--HPnIV~l~g~~~~~~~  416 (721)
                      ..+|++++.||+|+||.||+|.+. +|+.||||++...   .......+.+.+|+.+|+++.  |+||+++++++...+.
T Consensus        27 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~  102 (313)
T 3cek_A           27 GRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLE---EADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQY  102 (313)
T ss_dssp             TEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECS---SCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSE
T ss_pred             cceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEeccc---cccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCE
Confidence            357999999999999999999985 4899999998642   234556788999999999997  5999999999999999


Q ss_pred             EEEEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCC
Q 004959          417 FYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQ  496 (721)
Q Consensus       417 ~yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~  496 (721)
                      .|+||| +.+++|.+++... ..+++..++.++.||+.||.|||++||+||||||+||||+ ++.+||+|||++..+...
T Consensus       103 ~~lv~e-~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~-~~~~kL~Dfg~~~~~~~~  179 (313)
T 3cek_A          103 IYMVME-CGNIDLNSWLKKK-KSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD  179 (313)
T ss_dssp             EEEEEC-CCSEEHHHHHHHC-SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCC----
T ss_pred             EEEEEe-cCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEE-CCeEEEeeccccccccCc
Confidence            999999 5578999999865 6899999999999999999999999999999999999996 489999999999876543


Q ss_pred             cc---cccCCCCCccCChhhHHHHhhc----CCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhh-HHHHHHHhhc--CC
Q 004959          497 KA---DLSMKGSPYWMAPELMMAVMQK----GKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEG-AAAMFKVMRD--TP  566 (721)
Q Consensus       497 ~~---~~s~~GT~~Y~APEvl~~~~~~----~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~-~~~~~ki~~~--~~  566 (721)
                      ..   .....||+.|+|||++.+....    .....++.++|||||||++|+|++|..||..... ...+..+...  ..
T Consensus       180 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~  259 (313)
T 3cek_A          180 TTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEI  259 (313)
T ss_dssp             ----------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSCC
T ss_pred             cccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHHhccccc
Confidence            32   2345699999999998532110    0124578899999999999999999999976432 2333333332  23


Q ss_pred             CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhccccccCCC
Q 004959          567 AIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQ  608 (721)
Q Consensus       567 ~~p~~lS~el~dLI~~cL~~DP~kRPSa~eLL~Hp~f~~~~~  608 (721)
                      .++...+.++.+||.+||+.||++||++.|+|+||||+....
T Consensus       260 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~~~~  301 (313)
T 3cek_A          260 EFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTH  301 (313)
T ss_dssp             CCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHCC--
T ss_pred             CCcccchHHHHHHHHHHccCCcccCcCHHHHhcCccccCCCC
Confidence            456778999999999999999999999999999999986543

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=2.5e-44  Score=379.10  Aligned_cols=251  Identities=24%  Similarity=0.389  Sum_probs=216.4

Q ss_pred             CCCeeEeeEEeecCCeEEEEEEEC-----CCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEe
Q 004959          339 NSQWQKGKLIGRGTFGSVYVASNR-----ETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIV  413 (721)
Q Consensus       339 ~~~y~~~k~LG~G~fG~VY~a~~~-----~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~  413 (721)
                      .++|++++.||+|+||.||+|.+.     .+++.||||++..    .........+.+|+.+|+.++||||+++++++.+
T Consensus        24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~----~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~   99 (322)
T 1p4o_A           24 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNE----AASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ   99 (322)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCT----TSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECS
T ss_pred             hhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEeccc----ccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEcc
Confidence            468999999999999999999876     4678999998852    2334556678999999999999999999999999


Q ss_pred             cCeEEEEEeeccCCCHHHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEE
Q 004959          414 EDKFYIYLEYVHPGSINKYVREHC---------GAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKL  484 (721)
Q Consensus       414 ~~~~yLVmEy~~gGsL~~~L~~~~---------~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL  484 (721)
                      .+..|+||||+.+|+|.+++....         ..+++..++.++.||+.||.|||++||+||||||+||||+.++.+||
T Consensus       100 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~kl  179 (322)
T 1p4o_A          100 GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKI  179 (322)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCEEE
T ss_pred             CCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCCCeEEE
Confidence            999999999999999999997542         45799999999999999999999999999999999999999999999


Q ss_pred             eecCCccccCCCcc---cccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhh-CCCCCCchhhHHHHHH
Q 004959          485 ADFGMAKHLTGQKA---DLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFK  560 (721)
Q Consensus       485 ~DFGlA~~l~~~~~---~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLt-G~~PF~~~~~~~~~~k  560 (721)
                      +|||++..+.....   .....||+.|+|||++.+       ..++.++|||||||++|+|++ |..||.+....+....
T Consensus       180 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~  252 (322)
T 1p4o_A          180 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKD-------GVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRF  252 (322)
T ss_dssp             CCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHH-------CCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHH
T ss_pred             CcCccccccccccccccccCCCCCCCccChhhhcc-------CCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHH
Confidence            99999986644321   123457899999999964       346789999999999999999 8999988766666655


Q ss_pred             Hhhc-CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q 004959          561 VMRD-TPAIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEH  600 (721)
Q Consensus       561 i~~~-~~~~p~~lS~el~dLI~~cL~~DP~kRPSa~eLL~H  600 (721)
                      +... ....+..++.++.+||.+||+.||++||++.|+++|
T Consensus       253 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~  293 (322)
T 1p4o_A          253 VMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS  293 (322)
T ss_dssp             HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            5543 345677899999999999999999999999999987

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.6e-44  Score=372.14  Aligned_cols=251  Identities=23%  Similarity=0.373  Sum_probs=214.7

Q ss_pred             CCeeEee-EEeecCCeEEEEEEEC--CCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCe
Q 004959          340 SQWQKGK-LIGRGTFGSVYVASNR--ETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDK  416 (721)
Q Consensus       340 ~~y~~~k-~LG~G~fG~VY~a~~~--~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~  416 (721)
                      ++|.+.+ .||+|+||.||+|.+.  .++..||||++...    ......+.+.+|+.+|+.++||||+++++++ ..+.
T Consensus         9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~   83 (287)
T 1u59_A            9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG----TEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEA   83 (287)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSS----CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSS
T ss_pred             HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCc----cchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCC
Confidence            4677766 9999999999999854  56889999998632    3455677899999999999999999999998 5567


Q ss_pred             EEEEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCC
Q 004959          417 FYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQ  496 (721)
Q Consensus       417 ~yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~  496 (721)
                      .|+||||+.+++|.+++......+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+...
T Consensus        84 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~  163 (287)
T 1u59_A           84 LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGAD  163 (287)
T ss_dssp             EEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTC
T ss_pred             cEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCEEECcccceeeeccC
Confidence            99999999999999999766677999999999999999999999999999999999999999999999999999876543


Q ss_pred             ccc----ccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhh-CCCCCCchhhHHHHHHHhhc-CCCCCC
Q 004959          497 KAD----LSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFKVMRD-TPAIPD  570 (721)
Q Consensus       497 ~~~----~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLt-G~~PF~~~~~~~~~~ki~~~-~~~~p~  570 (721)
                      ...    ....||+.|+|||++.+       ..++.++|||||||++|+|++ |+.||......+....+... ...++.
T Consensus       164 ~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~~~~~~~~  236 (287)
T 1u59_A          164 DSYYTARSAGKWPLKWYAPECINF-------RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPP  236 (287)
T ss_dssp             SCEECCCCSSCCCGGGCCHHHHHH-------CEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCCCCT
T ss_pred             cceeeccccccccccccCHHHhcc-------CCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcCCcCCCCC
Confidence            321    23457899999999954       346778999999999999998 99999887666666555544 356678


Q ss_pred             CCCHHHHHHHHHhcccCCCCCCCHHHHHhccc
Q 004959          571 SLSPEGKDFLRCCFQRNPADRPPASLLLEHRF  602 (721)
Q Consensus       571 ~lS~el~dLI~~cL~~DP~kRPSa~eLL~Hp~  602 (721)
                      .+++++.+||.+||+.||++||++.++++|.+
T Consensus       237 ~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~  268 (287)
T 1u59_A          237 ECPPELYALMSDCWIYKWEDRPDFLTVEQRMR  268 (287)
T ss_dssp             TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred             CcCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence            89999999999999999999999999998854

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=8.2e-44  Score=369.74  Aligned_cols=249  Identities=20%  Similarity=0.333  Sum_probs=206.1

Q ss_pred             CCCCCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeE-EecC
Q 004959          337 PMNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSE-IVED  415 (721)
Q Consensus       337 ~l~~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~-~~~~  415 (721)
                      .+.++|++++.||+|+||.||+|++..+|+.||||++......       +.+.+|+.+++.+.|++++..+..+ ...+
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-------~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~   78 (296)
T 3uzp_A            6 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH-------PQLHIESKIYKMMQGGVGIPTIRWCGAEGD   78 (296)
T ss_dssp             EETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSC-------CHHHHHHHHHHHHTTSTTCCCEEEEEEETT
T ss_pred             eeccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcch-------hHHHHHHHHHHHhhcCCCCCccccccCCCC
Confidence            3457899999999999999999999999999999998642211       2578999999999988876666554 5677


Q ss_pred             eEEEEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEE---cCCCceEEeecCCccc
Q 004959          416 KFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLV---DASGVVKLADFGMAKH  492 (721)
Q Consensus       416 ~~yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILl---d~~g~VKL~DFGlA~~  492 (721)
                      ..|+||||+ +++|.+++......+++..++.++.||+.||.|||++||+||||||+||||   +.++.+||+|||++..
T Consensus        79 ~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~  157 (296)
T 3uzp_A           79 YNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK  157 (296)
T ss_dssp             EEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEE
T ss_pred             ceEEEEEec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCccc
Confidence            889999999 899999998666789999999999999999999999999999999999999   4788999999999987


Q ss_pred             cCCCcc--------cccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchh---hHHHHHHH
Q 004959          493 LTGQKA--------DLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYE---GAAAMFKV  561 (721)
Q Consensus       493 l~~~~~--------~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~---~~~~~~ki  561 (721)
                      +.....        .....||+.|+|||++.       ...++.++|||||||+||+|++|+.||.+..   ..+.+..+
T Consensus       158 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~  230 (296)
T 3uzp_A          158 YRDARTHQHIPYRENKNLTGTARYASINTHL-------GIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERI  230 (296)
T ss_dssp             CBCTTTCCBCCCCCSCCCCSCTTTCCHHHHT-------TCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHH
T ss_pred             ccccccccccccccccccccccccCChhhhc-------CCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhh
Confidence            654332        23467999999999984       4557889999999999999999999997632   11222222


Q ss_pred             hhcCC-----CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q 004959          562 MRDTP-----AIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEH  600 (721)
Q Consensus       562 ~~~~~-----~~p~~lS~el~dLI~~cL~~DP~kRPSa~eLL~H  600 (721)
                      .....     .++..+++++.+||.+||+.||++||++.++++.
T Consensus       231 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~  274 (296)
T 3uzp_A          231 SEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQL  274 (296)
T ss_dssp             HHHHHHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHH
T ss_pred             cccccCCchHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHH
Confidence            22111     2236789999999999999999999999998764

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=5.5e-44  Score=372.40  Aligned_cols=252  Identities=23%  Similarity=0.452  Sum_probs=200.6

Q ss_pred             CCCCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeE
Q 004959          338 MNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKF  417 (721)
Q Consensus       338 l~~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~  417 (721)
                      ..++|++++.||+|+||.||+|.+.   ..||||++...   .......+.+.+|+.+|++++||||++++++ ......
T Consensus        22 ~~~~y~~~~~lG~G~~g~Vy~~~~~---~~vavK~~~~~---~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~-~~~~~~   94 (289)
T 3og7_A           22 PDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVT---APTPQQLQAFKNEVGVLRKTRHVNILLFMGY-STAPQL   94 (289)
T ss_dssp             CTTSCEEEEEEEECSSEEEEEEESS---SEEEEEEESCS---SCCHHHHHHHHHHHHHHTTCCCTTBCCEEEE-ECSSSC
T ss_pred             CccceeeeeEecCCCCeEEEEEEEc---CceEEEEEecc---CCCHHHHHHHHHHHHHHHhCCCCcEEEEEee-ccCCcc
Confidence            3568999999999999999999864   35999998643   3345667889999999999999999999995 456678


Q ss_pred             EEEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCC-
Q 004959          418 YIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQ-  496 (721)
Q Consensus       418 yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~-  496 (721)
                      ++||||+.|++|.+++......+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++...... 
T Consensus        95 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  174 (289)
T 3og7_A           95 AIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWS  174 (289)
T ss_dssp             EEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC---------
T ss_pred             EEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEEccceecccccccc
Confidence            9999999999999999766678999999999999999999999999999999999999999999999999999765432 


Q ss_pred             --cccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhcC------CCC
Q 004959          497 --KADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDT------PAI  568 (721)
Q Consensus       497 --~~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~~------~~~  568 (721)
                        .......||+.|+|||++...    ....++.++|||||||++|+|++|+.||......+.+.......      ..+
T Consensus       175 ~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (289)
T 3og7_A          175 GSHQFEQLSGSILWMAPEVIRMQ----DSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKV  250 (289)
T ss_dssp             ---------CCCTTCCHHHHC--------CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCCTTSS
T ss_pred             ccccccccCCCccccCchhhccc----CCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCcchhhc
Confidence              222345799999999998421    24557789999999999999999999998765555554443322      223


Q ss_pred             CCCCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q 004959          569 PDSLSPEGKDFLRCCFQRNPADRPPASLLLEH  600 (721)
Q Consensus       569 p~~lS~el~dLI~~cL~~DP~kRPSa~eLL~H  600 (721)
                      ...+++++.+||.+||+.||++||++.++++.
T Consensus       251 ~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~  282 (289)
T 3og7_A          251 RSNCPKRMKRLMAECLKKKRDERPSFPRILAE  282 (289)
T ss_dssp             CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             cccCCHHHHHHHHHHccCChhhCCCHHHHHHH
Confidence            45789999999999999999999999999864

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=7.1e-44  Score=379.52  Aligned_cols=251  Identities=26%  Similarity=0.481  Sum_probs=214.3

Q ss_pred             CCCeeEeeEEeecCCeEEEEEEEC-------CCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhC-CCCCeeeeeee
Q 004959          339 NSQWQKGKLIGRGTFGSVYVASNR-------ETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHL-KHPNIVQYYGS  410 (721)
Q Consensus       339 ~~~y~~~k~LG~G~fG~VY~a~~~-------~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L-~HPnIV~l~g~  410 (721)
                      .++|++++.||+|+||.||+|.+.       .++..||||++..    .......+.+.+|+.+|+++ +||||++++++
T Consensus        34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~----~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~  109 (334)
T 2pvf_A           34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKD----DATEKDLSDLVSEMEMMKMIGKHKNIINLLGA  109 (334)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCT----TCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeecc----CCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEE
Confidence            368999999999999999999875       4678899998853    22445677899999999999 89999999999


Q ss_pred             EEecCeEEEEEeeccCCCHHHHHHHhc---------------CCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEE
Q 004959          411 EIVEDKFYIYLEYVHPGSINKYVREHC---------------GAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLL  475 (721)
Q Consensus       411 ~~~~~~~yLVmEy~~gGsL~~~L~~~~---------------~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNIL  475 (721)
                      +...+.+|+||||+.+|+|.+++....               ..+++..++.++.||+.||.|||++||+||||||+|||
T Consensus       110 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIl  189 (334)
T 2pvf_A          110 CTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVL  189 (334)
T ss_dssp             ECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEE
T ss_pred             EccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccceEE
Confidence            999999999999999999999997653               24899999999999999999999999999999999999


Q ss_pred             EcCCCceEEeecCCccccCCCcc---cccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhh-CCCCCCc
Q 004959          476 VDASGVVKLADFGMAKHLTGQKA---DLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSE  551 (721)
Q Consensus       476 ld~~g~VKL~DFGlA~~l~~~~~---~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLt-G~~PF~~  551 (721)
                      |+.++.+||+|||++..+.....   .....||+.|+|||++.+       ..++.++|||||||++|+|++ |..||.+
T Consensus       190 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~il~ellt~g~~p~~~  262 (334)
T 2pvf_A          190 VTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFD-------RVYTHQSDVWSFGVLMWEIFTLGGSPYPG  262 (334)
T ss_dssp             ECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHH-------CEECHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred             EcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcC-------CCcChHHHHHHHHHHHHHHHhCCCCCcCc
Confidence            99999999999999987654322   233457889999999964       346778999999999999999 9999988


Q ss_pred             hhhHHHHHHHhhc-CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q 004959          552 YEGAAAMFKVMRD-TPAIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEH  600 (721)
Q Consensus       552 ~~~~~~~~ki~~~-~~~~p~~lS~el~dLI~~cL~~DP~kRPSa~eLL~H  600 (721)
                      ....+....+... ....+..++.++.+||.+||+.||++||++.|++++
T Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  312 (334)
T 2pvf_A          263 IPVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED  312 (334)
T ss_dssp             CCHHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            7666655555443 345677899999999999999999999999999976

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.1e-43  Score=379.33  Aligned_cols=251  Identities=25%  Similarity=0.415  Sum_probs=209.3

Q ss_pred             CCCeeEeeEEeecCCeEEEEEEECCCC----cEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEec
Q 004959          339 NSQWQKGKLIGRGTFGSVYVASNRETG----ALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVE  414 (721)
Q Consensus       339 ~~~y~~~k~LG~G~fG~VY~a~~~~tg----~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~  414 (721)
                      ...|++.+.||+|+||.||+|.+..++    ..||||++..    .........+.+|+.+|++++||||+++++++...
T Consensus        43 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~----~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~  118 (333)
T 1mqb_A           43 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKA----GYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKY  118 (333)
T ss_dssp             TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECT----TCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred             hHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCC----CCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecC
Confidence            468999999999999999999876543    4599998853    12344566889999999999999999999999999


Q ss_pred             CeEEEEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccC
Q 004959          415 DKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLT  494 (721)
Q Consensus       415 ~~~yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~  494 (721)
                      +..||||||+.+|+|.+++....+.+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+.
T Consensus       119 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~  198 (333)
T 1mqb_A          119 KPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLE  198 (333)
T ss_dssp             SSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred             CCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCcEEECCCCcchhhc
Confidence            99999999999999999998776789999999999999999999999999999999999999999999999999998765


Q ss_pred             CCccc----ccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhh-CCCCCCchhhHHHHHHHhhc-CCCC
Q 004959          495 GQKAD----LSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFKVMRD-TPAI  568 (721)
Q Consensus       495 ~~~~~----~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLt-G~~PF~~~~~~~~~~ki~~~-~~~~  568 (721)
                      .....    ....+|+.|+|||++.       ...++.++|||||||++|||++ |..||.+....+.+..+... ....
T Consensus       199 ~~~~~~~~~~~~~~~~~y~aPE~~~-------~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~~  271 (333)
T 1mqb_A          199 DDPEATYTTSGGKIPIRWTAPEAIS-------YRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPT  271 (333)
T ss_dssp             ------------CCCGGGSCHHHHH-------SCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCC
T ss_pred             cccccccccCCCCccccccCchhcc-------cCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCCCcCCC
Confidence            43211    1234688999999984       3457789999999999999998 99999887666666555544 3445


Q ss_pred             CCCCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q 004959          569 PDSLSPEGKDFLRCCFQRNPADRPPASLLLEH  600 (721)
Q Consensus       569 p~~lS~el~dLI~~cL~~DP~kRPSa~eLL~H  600 (721)
                      +..++.++.+||.+||+.||++||++.+++++
T Consensus       272 ~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~  303 (333)
T 1mqb_A          272 PMDCPSAIYQLMMQCWQQERARRPKFADIVSI  303 (333)
T ss_dssp             CTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             cccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            67789999999999999999999999999876

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=9.1e-44  Score=375.14  Aligned_cols=253  Identities=23%  Similarity=0.372  Sum_probs=205.8

Q ss_pred             CCCCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeE
Q 004959          338 MNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKF  417 (721)
Q Consensus       338 l~~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~  417 (721)
                      ..++|++++.||+|+||.||+|.+..+|+.||||++...  ........+.+.+|+.++++++||||+++++++...+.+
T Consensus        32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~  109 (309)
T 2h34_A           32 QFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSET--LSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQL  109 (309)
T ss_dssp             --CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGG--GGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEE
T ss_pred             EeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcc--cccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeE
Confidence            446899999999999999999999999999999998632  223445567899999999999999999999999999999


Q ss_pred             EEEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCCc
Q 004959          418 YIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQK  497 (721)
Q Consensus       418 yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~~  497 (721)
                      |+||||++|++|.+++... +.+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++.......
T Consensus       110 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~  188 (309)
T 2h34_A          110 YVDMRLINGVDLAAMLRRQ-GPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDEK  188 (309)
T ss_dssp             EEEEECCCCEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSCCC--------
T ss_pred             EEEEEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCEEEecCccCccccccc
Confidence            9999999999999999865 679999999999999999999999999999999999999999999999999998765432


Q ss_pred             c--cccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhcC---CCCCCCC
Q 004959          498 A--DLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDT---PAIPDSL  572 (721)
Q Consensus       498 ~--~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~~---~~~p~~l  572 (721)
                      .  .....||+.|+|||++.       ...++.++|||||||++|+|++|+.||...........+....   ...+..+
T Consensus       189 ~~~~~~~~~~~~y~aPE~~~-------~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  261 (309)
T 2h34_A          189 LTQLGNTVGTLYYMAPERFS-------ESHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHINQAIPRPSTVRPGI  261 (309)
T ss_dssp             --------CCGGGCCGGGTC-------C----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHHHSCCCCGGGTSTTC
T ss_pred             cccccccCCCcCccCHHHHc-------CCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHhccCCCCccccCCCC
Confidence            2  23457999999999984       3456678999999999999999999998866543333333222   1345678


Q ss_pred             CHHHHHHHHHhcccCCCCCC-CHHHHHhc
Q 004959          573 SPEGKDFLRCCFQRNPADRP-PASLLLEH  600 (721)
Q Consensus       573 S~el~dLI~~cL~~DP~kRP-Sa~eLL~H  600 (721)
                      +.++.+||.+||+.||++|| +++++++.
T Consensus       262 ~~~l~~li~~~l~~dP~~Rp~s~~~l~~~  290 (309)
T 2h34_A          262 PVAFDAVIARGMAKNPEDRYVTCGDLSAA  290 (309)
T ss_dssp             CTHHHHHHHHHTCSSGGGSCSSHHHHHHH
T ss_pred             CHHHHHHHHHhccCCHHHHHHhHHHHHHH
Confidence            99999999999999999999 88888753

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=1.8e-44  Score=373.83  Aligned_cols=249  Identities=27%  Similarity=0.485  Sum_probs=215.8

Q ss_pred             CCCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeEE
Q 004959          339 NSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFY  418 (721)
Q Consensus       339 ~~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~y  418 (721)
                      ..+|++.+.||+|+||.||+|.+..+++.||||++...      ....+.+.+|+.+|++++||||+++++++.+.+.+|
T Consensus        12 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   85 (288)
T 3kfa_A           12 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED------TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY   85 (288)
T ss_dssp             GGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC------STHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEE
T ss_pred             ccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC------HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEE
Confidence            46899999999999999999999999999999998531      123567889999999999999999999999999999


Q ss_pred             EEEeeccCCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCCc
Q 004959          419 IYLEYVHPGSINKYVREH-CGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQK  497 (721)
Q Consensus       419 LVmEy~~gGsL~~~L~~~-~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~~  497 (721)
                      +||||+.|++|.+++... ...+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++.......
T Consensus        86 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~  165 (288)
T 3kfa_A           86 IITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT  165 (288)
T ss_dssp             EEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSS
T ss_pred             EEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCCEEEccCccceeccCCc
Confidence            999999999999999764 3569999999999999999999999999999999999999999999999999998765443


Q ss_pred             c--cccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhh-CCCCCCchhhHHHHHHHhhc-CCCCCCCCC
Q 004959          498 A--DLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFKVMRD-TPAIPDSLS  573 (721)
Q Consensus       498 ~--~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLt-G~~PF~~~~~~~~~~ki~~~-~~~~p~~lS  573 (721)
                      .  .....||+.|+|||++.+       ..++.++|||||||++|+|++ |..||...........+... ....+..++
T Consensus       166 ~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (288)
T 3kfa_A          166 YTAHAGAKFPIKWTAPESLAY-------NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCP  238 (288)
T ss_dssp             SEEETTEEECGGGCCHHHHHH-------CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCCTTCC
T ss_pred             cccccCCccccCcCChhhhcc-------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhccCCCCCCCCCC
Confidence            2  223457889999999964       346789999999999999999 99999876655555444443 345677899


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHHhc
Q 004959          574 PEGKDFLRCCFQRNPADRPPASLLLEH  600 (721)
Q Consensus       574 ~el~dLI~~cL~~DP~kRPSa~eLL~H  600 (721)
                      +++.+||.+||+.||++||++.++++.
T Consensus       239 ~~l~~li~~~l~~dp~~Rps~~~~~~~  265 (288)
T 3kfa_A          239 EKVYELMRACWQWNPSDRPSFAEIHQA  265 (288)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHHHhCCChhhCcCHHHHHHH
Confidence            999999999999999999999999864

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=2.4e-44  Score=388.47  Aligned_cols=252  Identities=19%  Similarity=0.306  Sum_probs=200.7

Q ss_pred             CCCeeEeeEEeecCCeEEEEEEECCC-----CcEEEEEEeecCCCCcccHHHH--------HHHHHHHHHHHhCCCCCee
Q 004959          339 NSQWQKGKLIGRGTFGSVYVASNRET-----GALCAMKEVDIFPDDPKSAESI--------KQLEQEIKVLSHLKHPNIV  405 (721)
Q Consensus       339 ~~~y~~~k~LG~G~fG~VY~a~~~~t-----g~~vAIK~i~~~~~~~~~~~~~--------k~~~~Ei~iL~~L~HPnIV  405 (721)
                      ..+|++++.||+|+||.||+|.+..+     ++.||||++....  .......        ..+..|+..+..+.||||+
T Consensus        34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv  111 (364)
T 3op5_A           34 AAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDN--GPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVP  111 (364)
T ss_dssp             CCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTC--HHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSC
T ss_pred             CCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccc--hhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCC
Confidence            45899999999999999999998764     6889999986321  1001111        2234566677888999999


Q ss_pred             eeeeeEEec----CeEEEEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEc--CC
Q 004959          406 QYYGSEIVE----DKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVD--AS  479 (721)
Q Consensus       406 ~l~g~~~~~----~~~yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld--~~  479 (721)
                      ++++++...    ...||||||| |++|.+++....+.+++..++.|+.||+.||.|||++||+||||||+||||+  .+
T Consensus       112 ~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~~  190 (364)
T 3op5_A          112 KYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNP  190 (364)
T ss_dssp             CEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSCT
T ss_pred             eEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCCC
Confidence            999998775    5589999999 9999999987767899999999999999999999999999999999999999  88


Q ss_pred             CceEEeecCCccccCCCccc--------ccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCc
Q 004959          480 GVVKLADFGMAKHLTGQKAD--------LSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSE  551 (721)
Q Consensus       480 g~VKL~DFGlA~~l~~~~~~--------~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~  551 (721)
                      +.+||+|||+++.+......        ...+||+.|+|||++.       ...++.++|||||||+||||++|+.||.+
T Consensus       191 ~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~~Di~slG~~l~el~~g~~Pf~~  263 (364)
T 3op5_A          191 DQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHN-------GVAPSRRGDLEILGYCMIQWLTGHLPWED  263 (364)
T ss_dssp             TCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHT-------TCCCCHHHHHHHHHHHHHHHHHSCCTTGG
T ss_pred             CeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhC-------CCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence            99999999999876543222        2345999999999994       44578899999999999999999999986


Q ss_pred             hhhHHHHHHHhh-----c------CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q 004959          552 YEGAAAMFKVMR-----D------TPAIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEH  600 (721)
Q Consensus       552 ~~~~~~~~ki~~-----~------~~~~p~~lS~el~dLI~~cL~~DP~kRPSa~eLL~H  600 (721)
                      ............     .      .......++.++.+||..||+.||++||++.+|++.
T Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~  323 (364)
T 3op5_A          264 NLKDPKYVRDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRDI  323 (364)
T ss_dssp             GTTCHHHHHHHHHHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHH
T ss_pred             cccCHHHHHHHHHHhhhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHHH
Confidence            422221111110     0      001125689999999999999999999999998763

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=7.9e-44  Score=369.29  Aligned_cols=248  Identities=21%  Similarity=0.335  Sum_probs=201.7

Q ss_pred             CCCCCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeE-EecC
Q 004959          337 PMNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSE-IVED  415 (721)
Q Consensus       337 ~l~~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~-~~~~  415 (721)
                      .+.++|++++.||+|+||.||+|++..+|+.||||++.....       .+.+.+|+.+++.+.|++++..+..+ ...+
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-------~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~   78 (296)
T 4hgt_A            6 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-------HPQLHIESKIYKMMQGGVGIPTIRWCGAEGD   78 (296)
T ss_dssp             -----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC----------CCCHHHHHHHHHHHTTSTTCCCEEEEEEETT
T ss_pred             ccCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc-------chHHHHHHHHHHHhcCCCCCCeeeeecCCCC
Confidence            456789999999999999999999999999999998753221       13578899999999988877666654 6678


Q ss_pred             eEEEEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEE---cCCCceEEeecCCccc
Q 004959          416 KFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLV---DASGVVKLADFGMAKH  492 (721)
Q Consensus       416 ~~yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILl---d~~g~VKL~DFGlA~~  492 (721)
                      ..++||||+ +++|.+++......+++..++.++.||+.||.|||++||+||||||+||||   +.++.+||+|||++..
T Consensus        79 ~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~  157 (296)
T 4hgt_A           79 YNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK  157 (296)
T ss_dssp             EEEEEEECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEE
T ss_pred             ceEEEEEcc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCcccee
Confidence            899999999 899999998766789999999999999999999999999999999999999   7889999999999987


Q ss_pred             cCCCcc--------cccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhh---HHHHHHH
Q 004959          493 LTGQKA--------DLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEG---AAAMFKV  561 (721)
Q Consensus       493 l~~~~~--------~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~---~~~~~ki  561 (721)
                      +.....        .....||+.|+|||++.       ...++.++|||||||++|+|++|+.||.+...   ...+..+
T Consensus       158 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~  230 (296)
T 4hgt_A          158 YRDARTHQHIPYRENKNLTGTARYASINTHL-------GIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERI  230 (296)
T ss_dssp             CBCTTTCCBCCCCCSCCCCSCGGGCCHHHHT-------TCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHH
T ss_pred             ccCcccCccCCCCcccccCCCccccchHHhc-------CCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhh
Confidence            654322        22467999999999984       44578899999999999999999999976322   1222222


Q ss_pred             hhcCC-----CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHh
Q 004959          562 MRDTP-----AIPDSLSPEGKDFLRCCFQRNPADRPPASLLLE  599 (721)
Q Consensus       562 ~~~~~-----~~p~~lS~el~dLI~~cL~~DP~kRPSa~eLL~  599 (721)
                      .....     .....+++++.+||.+||+.||++||++.++++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~  273 (296)
T 4hgt_A          231 SEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ  273 (296)
T ss_dssp             HHHHHHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred             hcccccchhhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHH
Confidence            22111     123668999999999999999999999999986

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=2.5e-44  Score=391.69  Aligned_cols=250  Identities=23%  Similarity=0.416  Sum_probs=204.1

Q ss_pred             CCeeEeeEEeecCCeEEEEEEEC---CCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCe
Q 004959          340 SQWQKGKLIGRGTFGSVYVASNR---ETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDK  416 (721)
Q Consensus       340 ~~y~~~k~LG~G~fG~VY~a~~~---~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~  416 (721)
                      .+|++++.||+|+||.||+|+++   .++..||||++...    ......+.+.+|+.+|++++|||||++++++...+.
T Consensus        45 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  120 (373)
T 2qol_A           45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVG----YTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKP  120 (373)
T ss_dssp             GGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTT----CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred             hhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCc----cCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCc
Confidence            57999999999999999999876   56788999988532    234556789999999999999999999999999999


Q ss_pred             EEEEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCC
Q 004959          417 FYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQ  496 (721)
Q Consensus       417 ~yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~  496 (721)
                      .||||||+++|+|.+++......+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.+...
T Consensus       121 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  200 (373)
T 2qol_A          121 VMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDD  200 (373)
T ss_dssp             CEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred             eEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCCEEECcCccccccccC
Confidence            99999999999999999877678999999999999999999999999999999999999999999999999999876543


Q ss_pred             ccc----ccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhh-CCCCCCchhhHHHHHHHhhc-CCCCCC
Q 004959          497 KAD----LSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFKVMRD-TPAIPD  570 (721)
Q Consensus       497 ~~~----~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLt-G~~PF~~~~~~~~~~ki~~~-~~~~p~  570 (721)
                      ...    ....+++.|+|||++.+       ..++.++|||||||+||||++ |+.||......+....+... ....+.
T Consensus       201 ~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~~~~~~~~  273 (373)
T 2qol_A          201 PEAAYTTRGGKIPIRWTSPEAIAY-------RKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPM  273 (373)
T ss_dssp             -------------CTTSCHHHHHH-------CCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTTEECCCCT
T ss_pred             CccceeccCCCcCCCccChhhhcc-------CCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCc
Confidence            221    12335788999999964       346789999999999999998 99999887666655555443 234566


Q ss_pred             CCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q 004959          571 SLSPEGKDFLRCCFQRNPADRPPASLLLEH  600 (721)
Q Consensus       571 ~lS~el~dLI~~cL~~DP~kRPSa~eLL~H  600 (721)
                      .++.++.+||.+||+.||++||++.++++.
T Consensus       274 ~~~~~l~~li~~cl~~dp~~RPs~~~i~~~  303 (373)
T 2qol_A          274 DCPAALYQLMLDCWQKDRNNRPKFEQIVSI  303 (373)
T ss_dssp             TCBHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             cccHHHHHHHHHHhCcChhhCcCHHHHHHH
Confidence            789999999999999999999999999864

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=8.6e-44  Score=368.45  Aligned_cols=251  Identities=23%  Similarity=0.393  Sum_probs=209.7

Q ss_pred             CCCCeeEeeEEeecCCeEEEEEEECC---CCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEec
Q 004959          338 MNSQWQKGKLIGRGTFGSVYVASNRE---TGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVE  414 (721)
Q Consensus       338 l~~~y~~~k~LG~G~fG~VY~a~~~~---tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~  414 (721)
                      ..++|++.+.||+|+||.||+|.+..   ++..||+|++...    ......+.+.+|+.+|+.++||||+++++++.. 
T Consensus        10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-   84 (281)
T 3cc6_A           10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKD----CTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-   84 (281)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTT----SCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-
T ss_pred             cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccc----cCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-
Confidence            34689999999999999999998653   3456999987531    234556789999999999999999999998764 


Q ss_pred             CeEEEEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccC
Q 004959          415 DKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLT  494 (721)
Q Consensus       415 ~~~yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~  494 (721)
                      +..|+||||+.+++|.+++......+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+.
T Consensus        85 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  164 (281)
T 3cc6_A           85 EPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIE  164 (281)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTEEEECCCCGGGCC-
T ss_pred             CCCEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCcEEeCccCCCcccc
Confidence            56789999999999999998776779999999999999999999999999999999999999999999999999998765


Q ss_pred             CCcc--cccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhh-CCCCCCchhhHHHHHHHhhc-CCCCCC
Q 004959          495 GQKA--DLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFKVMRD-TPAIPD  570 (721)
Q Consensus       495 ~~~~--~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLt-G~~PF~~~~~~~~~~ki~~~-~~~~p~  570 (721)
                      ....  .....||+.|+|||++.+       ..++.++|||||||++|+|++ |+.||......+....+... ....+.
T Consensus       165 ~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~~~~~~~  237 (281)
T 3cc6_A          165 DEDYYKASVTRLPIKWMSPESINF-------RRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLPKPD  237 (281)
T ss_dssp             --------CCCCCGGGCCHHHHHH-------CCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTCCCCCCT
T ss_pred             cccccccccCCCCcceeCchhhcc-------CCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCCCCCCCC
Confidence            4332  223457889999999954       346779999999999999998 99999765554444444332 345667


Q ss_pred             CCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q 004959          571 SLSPEGKDFLRCCFQRNPADRPPASLLLEH  600 (721)
Q Consensus       571 ~lS~el~dLI~~cL~~DP~kRPSa~eLL~H  600 (721)
                      .+++++.+||.+||..||++||++.|++++
T Consensus       238 ~~~~~l~~li~~~l~~~p~~Rps~~ell~~  267 (281)
T 3cc6_A          238 LCPPVLYTLMTRCWDYDPSDRPRFTELVCS  267 (281)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCHHHHHHHHHHccCCchhCcCHHHHHHH
Confidence            899999999999999999999999999976

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=5e-44  Score=379.12  Aligned_cols=251  Identities=26%  Similarity=0.483  Sum_probs=213.5

Q ss_pred             CCCeeEeeEEeecCCeEEEEEEECCCCc-----EEEEEEeecCCCCcccHHHHHHHHHHHHHHHhC-CCCCeeeeeeeEE
Q 004959          339 NSQWQKGKLIGRGTFGSVYVASNRETGA-----LCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHL-KHPNIVQYYGSEI  412 (721)
Q Consensus       339 ~~~y~~~k~LG~G~fG~VY~a~~~~tg~-----~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L-~HPnIV~l~g~~~  412 (721)
                      .++|++++.||+|+||.||+|.+..+|+     .||+|.+..    .......+.+.+|+.+|+.+ +||||+++++++.
T Consensus        45 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~----~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~  120 (333)
T 2i1m_A           45 RNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKS----TAHADEKEALMSELKIMSHLGQHENIVNLLGACT  120 (333)
T ss_dssp             TTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECT----TCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             HHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhccc----ccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe
Confidence            3689999999999999999999887665     799998853    22345567899999999999 8999999999999


Q ss_pred             ecCeEEEEEeeccCCCHHHHHHHh-------------cCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCC
Q 004959          413 VEDKFYIYLEYVHPGSINKYVREH-------------CGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDAS  479 (721)
Q Consensus       413 ~~~~~yLVmEy~~gGsL~~~L~~~-------------~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~  479 (721)
                      ..+.+|+||||+.+|+|.+++...             ...+++..++.++.||+.||.|||++||+||||||+||||+.+
T Consensus       121 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~  200 (333)
T 2i1m_A          121 HGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNG  200 (333)
T ss_dssp             SSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEEEGG
T ss_pred             cCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEECCC
Confidence            999999999999999999999754             2458999999999999999999999999999999999999999


Q ss_pred             CceEEeecCCccccCCCcc---cccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhh-CCCCCCchhhH
Q 004959          480 GVVKLADFGMAKHLTGQKA---DLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGA  555 (721)
Q Consensus       480 g~VKL~DFGlA~~l~~~~~---~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLt-G~~PF~~~~~~  555 (721)
                      +.+||+|||++..+.....   .....||+.|+|||++.+       ..++.++|||||||++|+|++ |..||.+....
T Consensus       201 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~  273 (333)
T 2i1m_A          201 HVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFD-------CVYTVQSDVWSYGILLWEIFSLGLNPYPGILVN  273 (333)
T ss_dssp             GEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHH-------CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSS
T ss_pred             CeEEECccccccccccccceeecCCCCCCccccCHHHhcc-------CCCChHHHHHHHHHHHHHHHcCCCCCCcccchh
Confidence            9999999999986643322   123457889999999964       346789999999999999998 99999876555


Q ss_pred             HHHHHHhhc--CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q 004959          556 AAMFKVMRD--TPAIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEH  600 (721)
Q Consensus       556 ~~~~ki~~~--~~~~p~~lS~el~dLI~~cL~~DP~kRPSa~eLL~H  600 (721)
                      ..+..+...  ....+..++.++.+||.+||+.||++|||+.|++++
T Consensus       274 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~  320 (333)
T 2i1m_A          274 SKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSF  320 (333)
T ss_dssp             HHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHH
Confidence            544444433  234566789999999999999999999999999875

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=9.6e-44  Score=376.95  Aligned_cols=250  Identities=26%  Similarity=0.496  Sum_probs=212.1

Q ss_pred             CCCeeEeeEEeecCCeEEEEEE----ECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEE--
Q 004959          339 NSQWQKGKLIGRGTFGSVYVAS----NRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEI--  412 (721)
Q Consensus       339 ~~~y~~~k~LG~G~fG~VY~a~----~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~--  412 (721)
                      ..+|++++.||+|+||.||+|+    +..+|+.||||++..     ......+.+.+|+.+|++++||||+++++++.  
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~-----~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   96 (327)
T 3lxl_A           22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQH-----SGPDQQRDFQREIQILKALHSDFIVKYRGVSYGP   96 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESS-----CCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECS
T ss_pred             hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEecc-----CCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecC
Confidence            4689999999999999999998    577899999999853     23455678999999999999999999999887  


Q ss_pred             ecCeEEEEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccc
Q 004959          413 VEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKH  492 (721)
Q Consensus       413 ~~~~~yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~  492 (721)
                      ....+|+||||+++++|.+++......+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..
T Consensus        97 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~  176 (327)
T 3lxl_A           97 GRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKL  176 (327)
T ss_dssp             SSCEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCGGGCEE
T ss_pred             CCceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEEEccccccee
Confidence            45679999999999999999987667799999999999999999999999999999999999999999999999999987


Q ss_pred             cCCCcc----cccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHH------------
Q 004959          493 LTGQKA----DLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAA------------  556 (721)
Q Consensus       493 l~~~~~----~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~------------  556 (721)
                      +.....    .....||+.|+|||++.+       ..++.++|||||||++|+|++|..||.......            
T Consensus       177 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~  249 (327)
T 3lxl_A          177 LPLDKDYYVVREPGQSPIFWYAPESLSD-------NIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPA  249 (327)
T ss_dssp             CCTTCSEEECSSCCCSCGGGSCHHHHHH-------CEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCH
T ss_pred             cccCCccceeeccCCccccccCHHHhcc-------CCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhccccccccc
Confidence            654332    223558899999999964       346778999999999999999999997644321            


Q ss_pred             --HHHHHhh--cCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q 004959          557 --AMFKVMR--DTPAIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEH  600 (721)
Q Consensus       557 --~~~ki~~--~~~~~p~~lS~el~dLI~~cL~~DP~kRPSa~eLL~H  600 (721)
                        .+.....  .....+..+++++.+||.+||+.||++|||+.|++++
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  297 (327)
T 3lxl_A          250 LSRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQ  297 (327)
T ss_dssp             HHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence              1111221  2345567899999999999999999999999999876

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=9.7e-44  Score=370.76  Aligned_cols=250  Identities=27%  Similarity=0.472  Sum_probs=208.5

Q ss_pred             CCeeEeeEEeecCCeEEEEEE----ECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEec-
Q 004959          340 SQWQKGKLIGRGTFGSVYVAS----NRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVE-  414 (721)
Q Consensus       340 ~~y~~~k~LG~G~fG~VY~a~----~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~-  414 (721)
                      ..|++++.||+|+||.||+|+    +..+|+.||||++....    .....+.+.+|+.+|+.++||||+++++++... 
T Consensus        21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   96 (302)
T 4e5w_A           21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES----GGNHIADLKKEIEILRNLYHENIVKYKGICTEDG   96 (302)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC---------CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC--
T ss_pred             hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccc----cchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCC
Confidence            469999999999999999998    67789999999986321    122346789999999999999999999998876 


Q ss_pred             -CeEEEEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCcccc
Q 004959          415 -DKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHL  493 (721)
Q Consensus       415 -~~~yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l  493 (721)
                       ..+|+||||+.+++|.+++......+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||++..+
T Consensus        97 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~  176 (302)
T 4e5w_A           97 GNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAI  176 (302)
T ss_dssp             -CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred             CceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCCEEECcccccccc
Confidence             6789999999999999999777678999999999999999999999999999999999999999999999999999877


Q ss_pred             CCCcc----cccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchh--------------hH
Q 004959          494 TGQKA----DLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYE--------------GA  555 (721)
Q Consensus       494 ~~~~~----~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~--------------~~  555 (721)
                      .....    .....||..|+|||++.+       ..++.++|||||||++|+|++|..||....              ..
T Consensus       177 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~  249 (302)
T 4e5w_A          177 ETDKEYYTVKDDRDSPVFWYAPECLMQ-------SKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTV  249 (302)
T ss_dssp             CTTCCEEECCCCTTCCGGGCCHHHHHH-------CEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHH
T ss_pred             cCCCcceeccCCCCCCccccCCeeecC-------CCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCH
Confidence            54432    234568899999999965       345678999999999999999998864321              11


Q ss_pred             HHHHHHhh--cCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q 004959          556 AAMFKVMR--DTPAIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEH  600 (721)
Q Consensus       556 ~~~~ki~~--~~~~~p~~lS~el~dLI~~cL~~DP~kRPSa~eLL~H  600 (721)
                      ..+.....  .....+..+++++.+||.+||+.||++|||+.++++.
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  296 (302)
T 4e5w_A          250 TRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEG  296 (302)
T ss_dssp             HHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHH
Confidence            22222222  2345667899999999999999999999999999863

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=2.3e-43  Score=370.37  Aligned_cols=253  Identities=32%  Similarity=0.575  Sum_probs=201.4

Q ss_pred             CCCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeEE
Q 004959          339 NSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFY  418 (721)
Q Consensus       339 ~~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~y  418 (721)
                      ..+|++++.||+|+||.||+|.+..+|+.||||++...  ........+.+.+|+.+|+.++||||+++++++...+..|
T Consensus        31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~  108 (310)
T 2wqm_A           31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIF--DLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELN  108 (310)
T ss_dssp             GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTT--SSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred             ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehh--hccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEE
Confidence            35899999999999999999999999999999998642  2334566778999999999999999999999999999999


Q ss_pred             EEEeeccCCCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCC
Q 004959          419 IYLEYVHPGSINKYVRE---HCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTG  495 (721)
Q Consensus       419 LVmEy~~gGsL~~~L~~---~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~  495 (721)
                      +||||+.+++|.+++..   ....+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+..
T Consensus       109 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~  188 (310)
T 2wqm_A          109 IVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS  188 (310)
T ss_dssp             EEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCC--------
T ss_pred             EEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCCEEEEeccceeeecC
Confidence            99999999999999865   245699999999999999999999999999999999999999999999999999987654


Q ss_pred             Ccc-cccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhh--HHHHHHHhhcC-CC-CCC
Q 004959          496 QKA-DLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEG--AAAMFKVMRDT-PA-IPD  570 (721)
Q Consensus       496 ~~~-~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~--~~~~~ki~~~~-~~-~p~  570 (721)
                      ... .....|++.|+|||++.       ...++.++|||||||++|+|++|..||.+...  ......+.... +. ...
T Consensus       189 ~~~~~~~~~~~~~y~aPE~~~-------~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  261 (310)
T 2wqm_A          189 KTTAAHSLVGTPYYMSPERIH-------ENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSD  261 (310)
T ss_dssp             ----------CCSSCCHHHHT-------TCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTCSCCCCTT
T ss_pred             CCccccccCCCeeEeChHHhC-------CCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcccCCCCccc
Confidence            322 23457999999999984       34678899999999999999999999975422  22223332221 22 235


Q ss_pred             CCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q 004959          571 SLSPEGKDFLRCCFQRNPADRPPASLLLEH  600 (721)
Q Consensus       571 ~lS~el~dLI~~cL~~DP~kRPSa~eLL~H  600 (721)
                      .++.++.+||.+||+.||++||++.+++++
T Consensus       262 ~~~~~l~~li~~~l~~dp~~Rps~~~il~~  291 (310)
T 2wqm_A          262 HYSEELRQLVNMCINPDPEKRPDVTYVYDV  291 (310)
T ss_dssp             TSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ccCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence            689999999999999999999999999875

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.1e-43  Score=366.95  Aligned_cols=249  Identities=23%  Similarity=0.431  Sum_probs=209.6

Q ss_pred             CeeEeeEEeecCCeEEEEEEECCCCc---EEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeE
Q 004959          341 QWQKGKLIGRGTFGSVYVASNRETGA---LCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKF  417 (721)
Q Consensus       341 ~y~~~k~LG~G~fG~VY~a~~~~tg~---~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~  417 (721)
                      .|++++.||+|+||.||+|.+..+++   .||+|.+..    .......+.+.+|+.+|+.++||||+++++++.+.+..
T Consensus        22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~----~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   97 (298)
T 3pls_A           22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSR----ITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGL   97 (298)
T ss_dssp             EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETT----CCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSC
T ss_pred             EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccc----cccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCC
Confidence            57888999999999999998765544   799998853    23445678899999999999999999999999876665


Q ss_pred             -EEEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCC
Q 004959          418 -YIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQ  496 (721)
Q Consensus       418 -yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~  496 (721)
                       ++||||+.+|+|.+++......+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+...
T Consensus        98 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~  177 (298)
T 3pls_A           98 PHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDR  177 (298)
T ss_dssp             CEEEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTG
T ss_pred             cEEEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEeCcCCCcccccCC
Confidence             9999999999999999876678999999999999999999999999999999999999999999999999999865432


Q ss_pred             c-----ccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhC-CCCCCchhhHHHHHHHhhc-CCCCC
Q 004959          497 K-----ADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTG-KPPWSEYEGAAAMFKVMRD-TPAIP  569 (721)
Q Consensus       497 ~-----~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG-~~PF~~~~~~~~~~ki~~~-~~~~p  569 (721)
                      .     ......|++.|+|||++.       ...++.++|||||||++|+|++| .+||......+....+... ....+
T Consensus       178 ~~~~~~~~~~~~~~~~y~aPE~~~-------~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (298)
T 3pls_A          178 EYYSVQQHRHARLPVKWTALESLQ-------TYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRLPQP  250 (298)
T ss_dssp             GGGCSCCSSCTTCGGGGSCHHHHT-------TCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTCCCCCC
T ss_pred             cccccccCcCCCCCccccChhhhc-------cCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCCCCCCC
Confidence            2     223456889999999993       45678899999999999999995 5556555444444444333 34556


Q ss_pred             CCCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q 004959          570 DSLSPEGKDFLRCCFQRNPADRPPASLLLEH  600 (721)
Q Consensus       570 ~~lS~el~dLI~~cL~~DP~kRPSa~eLL~H  600 (721)
                      ..+++++.+||.+||+.||++|||+.++++.
T Consensus       251 ~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~  281 (298)
T 3pls_A          251 EYCPDSLYQVMQQCWEADPAVRPTFRVLVGE  281 (298)
T ss_dssp             TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ccchHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            7789999999999999999999999999864

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=3.3e-44  Score=376.13  Aligned_cols=251  Identities=27%  Similarity=0.509  Sum_probs=211.5

Q ss_pred             CCCeeEeeEEeecCCeEEEEEEE-----CCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhC-CCCCeeeeeeeEE
Q 004959          339 NSQWQKGKLIGRGTFGSVYVASN-----RETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHL-KHPNIVQYYGSEI  412 (721)
Q Consensus       339 ~~~y~~~k~LG~G~fG~VY~a~~-----~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L-~HPnIV~l~g~~~  412 (721)
                      .++|++++.||+|+||.||+|.+     ..+++.||||++..    .......+.+.+|+.+|.++ +||||+++++++.
T Consensus        26 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~----~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~  101 (316)
T 2xir_A           26 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKE----GATHSEHRALMSELKILIHIGHHLNVVNLLGACT  101 (316)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECT----TCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             hhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEeccc----CCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEe
Confidence            36899999999999999999984     46789999999853    22345567899999999999 6999999999987


Q ss_pred             ecC-eEEEEEeeccCCCHHHHHHHhcCC---------------CCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEE
Q 004959          413 VED-KFYIYLEYVHPGSINKYVREHCGA---------------ITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLV  476 (721)
Q Consensus       413 ~~~-~~yLVmEy~~gGsL~~~L~~~~~~---------------Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILl  476 (721)
                      ..+ .+|+||||+.+|+|.+++......               +++..++.++.||+.||.|||++||+||||||+||||
T Consensus       102 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~  181 (316)
T 2xir_A          102 KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILL  181 (316)
T ss_dssp             CTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred             cCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEE
Confidence            754 599999999999999999765322               8999999999999999999999999999999999999


Q ss_pred             cCCCceEEeecCCccccCCCcc---cccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhh-CCCCCCch
Q 004959          477 DASGVVKLADFGMAKHLTGQKA---DLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEY  552 (721)
Q Consensus       477 d~~g~VKL~DFGlA~~l~~~~~---~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLt-G~~PF~~~  552 (721)
                      +.++.+||+|||++..+.....   .....||+.|+|||++.+       ..++.++|||||||++|+|++ |..||.+.
T Consensus       182 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-------~~~~~~~Di~slG~il~~l~t~g~~p~~~~  254 (316)
T 2xir_A          182 SEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD-------RVYTIQSDVWSFGVLLWEIFSLGASPYPGV  254 (316)
T ss_dssp             CGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHH-------CCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred             CCCCCEEECCCccccccccCccceeccCCCcceeecCchhhcc-------ccccchhHHHHHHHHHHHHHhCCCCCCccc
Confidence            9999999999999987654322   123457899999999964       346789999999999999998 99999875


Q ss_pred             hhHHHHHHHhhc--CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q 004959          553 EGAAAMFKVMRD--TPAIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEH  600 (721)
Q Consensus       553 ~~~~~~~ki~~~--~~~~p~~lS~el~dLI~~cL~~DP~kRPSa~eLL~H  600 (721)
                      ...+.+...+..  ....+..+++++.++|.+||+.||++|||+.|+++|
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  304 (316)
T 2xir_A          255 KIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  304 (316)
T ss_dssp             CCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             chhHHHHHHhccCccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            544433333322  345667899999999999999999999999999987

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=4.2e-44  Score=379.74  Aligned_cols=257  Identities=25%  Similarity=0.386  Sum_probs=213.5

Q ss_pred             CCCCeeEeeEEeecCCeEEEEEE-----ECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEE
Q 004959          338 MNSQWQKGKLIGRGTFGSVYVAS-----NRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEI  412 (721)
Q Consensus       338 l~~~y~~~k~LG~G~fG~VY~a~-----~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~  412 (721)
                      ...+|++++.||+|+||.||+|.     +..+++.||||++..    .........+.+|+.+|++++||||+++++++.
T Consensus        28 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~----~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~  103 (327)
T 2yfx_A           28 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPE----VCSEQDELDFLMEALIISKFNHQNIVRCIGVSL  103 (327)
T ss_dssp             CGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCS----SCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             ChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEecc----ccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEc
Confidence            34689999999999999999998     567889999999852    233455668899999999999999999999999


Q ss_pred             ecCeEEEEEeeccCCCHHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCC---CceE
Q 004959          413 VEDKFYIYLEYVHPGSINKYVREHC------GAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDAS---GVVK  483 (721)
Q Consensus       413 ~~~~~yLVmEy~~gGsL~~~L~~~~------~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~---g~VK  483 (721)
                      ..+..|+||||++|++|.+++....      ..+++..++.++.||+.||.|||++||+||||||+||||+.+   +.+|
T Consensus       104 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~k  183 (327)
T 2yfx_A          104 QSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAK  183 (327)
T ss_dssp             SSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEE
T ss_pred             CCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceEE
Confidence            9999999999999999999998753      348999999999999999999999999999999999999854   4699


Q ss_pred             EeecCCccccCCCc---ccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhh-CCCCCCchhhHHHHH
Q 004959          484 LADFGMAKHLTGQK---ADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMF  559 (721)
Q Consensus       484 L~DFGlA~~l~~~~---~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLt-G~~PF~~~~~~~~~~  559 (721)
                      |+|||++..+....   ......||+.|+|||++.+       ..++.++|||||||++|+|++ |..||......+...
T Consensus       184 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~  256 (327)
T 2yfx_A          184 IGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFME-------GIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLE  256 (327)
T ss_dssp             ECCCHHHHHHHC------CCGGGSCGGGCCHHHHHH-------CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHH
T ss_pred             ECccccccccccccccccCCCcCCCcceeCHhHhcC-------CCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHH
Confidence            99999997653322   1223458999999999964       346789999999999999998 999998876666655


Q ss_pred             HHhhc-CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccccc
Q 004959          560 KVMRD-TPAIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKN  605 (721)
Q Consensus       560 ki~~~-~~~~p~~lS~el~dLI~~cL~~DP~kRPSa~eLL~Hp~f~~  605 (721)
                      .+... ....+..++.++.+||.+||+.||++||++.++++|.|+..
T Consensus       257 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~  303 (327)
T 2yfx_A          257 FVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT  303 (327)
T ss_dssp             HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHhcCCCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHh
Confidence            55443 34566789999999999999999999999999999988653

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=1.6e-43  Score=368.76  Aligned_cols=249  Identities=21%  Similarity=0.388  Sum_probs=210.4

Q ss_pred             CCCeeEee-EEeecCCeEEEEEE--ECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecC
Q 004959          339 NSQWQKGK-LIGRGTFGSVYVAS--NRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVED  415 (721)
Q Consensus       339 ~~~y~~~k-~LG~G~fG~VY~a~--~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~  415 (721)
                      ..+|++.+ .||+|+||.||+|.  ...+++.||||++...   .......+.+.+|+.+++.++||||+++++++ ..+
T Consensus        15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~   90 (291)
T 1xbb_A           15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNE---ANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAE   90 (291)
T ss_dssp             GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC--------CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESS
T ss_pred             chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeeccc---ccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCC
Confidence            35799988 99999999999994  4677899999998632   22234467899999999999999999999998 667


Q ss_pred             eEEEEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCC
Q 004959          416 KFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTG  495 (721)
Q Consensus       416 ~~yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~  495 (721)
                      ..|+||||+.+++|.+++... +.+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+..
T Consensus        91 ~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~  169 (291)
T 1xbb_A           91 SWMLVMEMAELGPLNKYLQQN-RHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRA  169 (291)
T ss_dssp             SEEEEEECCTTEEHHHHHHHC-TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCT
T ss_pred             CcEEEEEeCCCCCHHHHHHhC-cCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcEEEccCCcceeecc
Confidence            889999999999999999764 6799999999999999999999999999999999999999999999999999987654


Q ss_pred             Cccc----ccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhh-CCCCCCchhhHHHHHHHhhc-CCCCC
Q 004959          496 QKAD----LSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFKVMRD-TPAIP  569 (721)
Q Consensus       496 ~~~~----~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLt-G~~PF~~~~~~~~~~ki~~~-~~~~p  569 (721)
                      ....    ....|++.|+|||++.+       ..++.++|||||||++|+|++ |..||.+....+....+... ...++
T Consensus       170 ~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~  242 (291)
T 1xbb_A          170 DENYYKAQTHGKWPVKWYAPECINY-------YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCP  242 (291)
T ss_dssp             TCSEEEC----CCCGGGCCHHHHHH-------CEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCC
T ss_pred             CCCcccccccCCCCceeeChHHhcc-------CCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCC
Confidence            3321    22346789999999964       346678999999999999999 99999887666655555443 34567


Q ss_pred             CCCCHHHHHHHHHhcccCCCCCCCHHHHHh
Q 004959          570 DSLSPEGKDFLRCCFQRNPADRPPASLLLE  599 (721)
Q Consensus       570 ~~lS~el~dLI~~cL~~DP~kRPSa~eLL~  599 (721)
                      ..++.++.+||.+||+.||++||++.++++
T Consensus       243 ~~~~~~l~~li~~~l~~dp~~Rps~~~l~~  272 (291)
T 1xbb_A          243 AGCPREMYDLMNLCWTYDVENRPGFAAVEL  272 (291)
T ss_dssp             TTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             CCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            789999999999999999999999999985

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=1.7e-43  Score=368.79  Aligned_cols=250  Identities=25%  Similarity=0.437  Sum_probs=209.5

Q ss_pred             CCeeEeeEEeecCCeEEEEEEECCC---CcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEE-ecC
Q 004959          340 SQWQKGKLIGRGTFGSVYVASNRET---GALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEI-VED  415 (721)
Q Consensus       340 ~~y~~~k~LG~G~fG~VY~a~~~~t---g~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~-~~~  415 (721)
                      ..|++++.||+|+||.||+|.+..+   +..||+|.+..    .......+.+.+|+.+|++++||||+++++++. .++
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~----~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  100 (298)
T 3f66_A           25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNR----ITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEG  100 (298)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETT----CCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSS
T ss_pred             eehhhcceeeecCCceEEEEEEecCCCceeEEEEEeccc----CCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCC
Confidence            4799999999999999999986543   34689998753    234556778999999999999999999999854 566


Q ss_pred             eEEEEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCC
Q 004959          416 KFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTG  495 (721)
Q Consensus       416 ~~yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~  495 (721)
                      ..|+||||+.+|+|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+..
T Consensus       101 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~  180 (298)
T 3f66_A          101 SPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYD  180 (298)
T ss_dssp             CCEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSCGGGCCCSC
T ss_pred             ceEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCCEEECcccccccccc
Confidence            88999999999999999987667899999999999999999999999999999999999999999999999999987654


Q ss_pred             Ccc-----cccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhh-CCCCCCchhhHHHHHHHhhcC-CCC
Q 004959          496 QKA-----DLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFKVMRDT-PAI  568 (721)
Q Consensus       496 ~~~-----~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLt-G~~PF~~~~~~~~~~ki~~~~-~~~  568 (721)
                      ...     .....||+.|+|||++.+       ..++.++|||||||++|+|++ |.+||......+....+.... ...
T Consensus       181 ~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (298)
T 3f66_A          181 KEYYSVHNKTGAKLPVKWMALESLQT-------QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQ  253 (298)
T ss_dssp             GGGCBC-----CCBCGGGSCHHHHHH-------CCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTCCCCC
T ss_pred             cchhccccccCCCCCccccChHHhcC-------CCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCCCCCC
Confidence            322     223457889999999954       346789999999999999999 677777666555555555443 345


Q ss_pred             CCCCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q 004959          569 PDSLSPEGKDFLRCCFQRNPADRPPASLLLEH  600 (721)
Q Consensus       569 p~~lS~el~dLI~~cL~~DP~kRPSa~eLL~H  600 (721)
                      +..+++++.+||.+||+.||++||++.|+++.
T Consensus       254 ~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~  285 (298)
T 3f66_A          254 PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR  285 (298)
T ss_dssp             CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            67789999999999999999999999999864

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.9e-44  Score=394.62  Aligned_cols=259  Identities=23%  Similarity=0.410  Sum_probs=211.8

Q ss_pred             CCCCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecC--
Q 004959          338 MNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVED--  415 (721)
Q Consensus       338 l~~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~--  415 (721)
                      ..+.|++++.||+|+||.||+|.+..+|+.||||++....    .....+.+.+|+.+|++++|||||++++++...+  
T Consensus         7 ~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~   82 (396)
T 4eut_A            7 SNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNIS----FLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTR   82 (396)
T ss_dssp             SSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGG----GGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTC
T ss_pred             CCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEecccc----ccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCC
Confidence            3568999999999999999999999999999999986321    1122456789999999999999999999988765  


Q ss_pred             eEEEEEeeccCCCHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEE----cCCCceEEeecCC
Q 004959          416 KFYIYLEYVHPGSINKYVREHC--GAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLV----DASGVVKLADFGM  489 (721)
Q Consensus       416 ~~yLVmEy~~gGsL~~~L~~~~--~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILl----d~~g~VKL~DFGl  489 (721)
                      ..|+|||||.||+|.+++....  ..+++..++.++.||+.||.|||++||+||||||+||||    +.++.+||+|||+
T Consensus        83 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~  162 (396)
T 4eut_A           83 HKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGA  162 (396)
T ss_dssp             CEEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGGG
T ss_pred             eeEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCCC
Confidence            7899999999999999997542  239999999999999999999999999999999999999    7777899999999


Q ss_pred             ccccCCCcccccCCCCCccCChhhHHHHhhcCC-CCCCcchhhHHHHHHHHHHHhhCCCCCCch----hhHHHHHHHhhc
Q 004959          490 AKHLTGQKADLSMKGSPYWMAPELMMAVMQKGK-SSDSALAVDIWSLGCTIIEMYTGKPPWSEY----EGAAAMFKVMRD  564 (721)
Q Consensus       490 A~~l~~~~~~~s~~GT~~Y~APEvl~~~~~~~k-~~~~s~asDVWSLGVILyELLtG~~PF~~~----~~~~~~~ki~~~  564 (721)
                      ++.+.........+||+.|+|||++.+...... ...++.++|||||||++|||++|+.||...    ...+.+.++...
T Consensus       163 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~  242 (396)
T 4eut_A          163 ARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG  242 (396)
T ss_dssp             CEECCCGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHS
T ss_pred             ceEccCCCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcC
Confidence            998776666566789999999999865211100 123566899999999999999999999642    334455555543


Q ss_pred             CCC-------------------------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q 004959          565 TPA-------------------------IPDSLSPEGKDFLRCCFQRNPADRPPASLLLEH  600 (721)
Q Consensus       565 ~~~-------------------------~p~~lS~el~dLI~~cL~~DP~kRPSa~eLL~H  600 (721)
                      .+.                         +...++..+.+||++||+.||++||++.|++++
T Consensus       243 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~  303 (396)
T 4eut_A          243 KPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAE  303 (396)
T ss_dssp             CCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHH
T ss_pred             CCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHH
Confidence            321                         112245678899999999999999999999765

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=1.4e-43  Score=372.53  Aligned_cols=252  Identities=24%  Similarity=0.419  Sum_probs=205.5

Q ss_pred             CCCeeEeeEEeecCCeEEEEEEECC---CCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecC
Q 004959          339 NSQWQKGKLIGRGTFGSVYVASNRE---TGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVED  415 (721)
Q Consensus       339 ~~~y~~~k~LG~G~fG~VY~a~~~~---tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~  415 (721)
                      .++|++++.||+|+||.||+|.+..   +++.||||++..   ........+.+.+|+.+|++++||||+++++++...+
T Consensus        33 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~---~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~  109 (313)
T 3brb_A           33 RNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKL---DNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMS  109 (313)
T ss_dssp             GGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC------CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC--
T ss_pred             HHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEec---cccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeecc
Confidence            4689999999999999999998765   566899998863   2234556778999999999999999999999988755


Q ss_pred             -----eEEEEEeeccCCCHHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEe
Q 004959          416 -----KFYIYLEYVHPGSINKYVREH-----CGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLA  485 (721)
Q Consensus       416 -----~~yLVmEy~~gGsL~~~L~~~-----~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~  485 (721)
                           ..|+||||+.+|+|.+++...     ...+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+
T Consensus       110 ~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kl~  189 (313)
T 3brb_A          110 SQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVA  189 (313)
T ss_dssp             -----CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTSCEEEC
T ss_pred             ccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEEe
Confidence                 359999999999999998532     3569999999999999999999999999999999999999999999999


Q ss_pred             ecCCccccCCCcc---cccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhh-CCCCCCchhhHHHHHHH
Q 004959          486 DFGMAKHLTGQKA---DLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFKV  561 (721)
Q Consensus       486 DFGlA~~l~~~~~---~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLt-G~~PF~~~~~~~~~~ki  561 (721)
                      |||++..+.....   .....+++.|+|||++.       ...++.++|||||||++|+|++ |..||......+....+
T Consensus       190 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-------~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~  262 (313)
T 3brb_A          190 DFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLA-------DRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYL  262 (313)
T ss_dssp             SCSCC----------------CCGGGSCHHHHH-------SSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHH
T ss_pred             ecCcceecccccccCcccccCCCccccCchhhc-------CCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHH
Confidence            9999987644321   12345788999999995       3457789999999999999999 99999887666655555


Q ss_pred             hhc-CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q 004959          562 MRD-TPAIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEH  600 (721)
Q Consensus       562 ~~~-~~~~p~~lS~el~dLI~~cL~~DP~kRPSa~eLL~H  600 (721)
                      ... ....+..+++++.+||.+||+.||++||++.+++++
T Consensus       263 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~  302 (313)
T 3brb_A          263 LHGHRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQ  302 (313)
T ss_dssp             HTTCCCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             HcCCCCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            544 355677899999999999999999999999999976

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=1.6e-43  Score=372.22  Aligned_cols=254  Identities=21%  Similarity=0.326  Sum_probs=206.7

Q ss_pred             CCCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEe----c
Q 004959          339 NSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIV----E  414 (721)
Q Consensus       339 ~~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~----~  414 (721)
                      .++|++++.||+|+||.||+|.+..+|+.||||++..     ......+.+.+|+.+++.++||||+++++++..    .
T Consensus        28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~-----~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  102 (317)
T 2buj_A           28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILC-----HEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAK  102 (317)
T ss_dssp             TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEE-----SSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTE
T ss_pred             CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEec-----CCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCC
Confidence            3589999999999999999999999999999998853     234566788999999999999999999999873    4


Q ss_pred             CeEEEEEeeccCCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCcc
Q 004959          415 DKFYIYLEYVHPGSINKYVREH---CGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAK  491 (721)
Q Consensus       415 ~~~yLVmEy~~gGsL~~~L~~~---~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~  491 (721)
                      ...|+||||+.+|+|.+++...   ...+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++.
T Consensus       103 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~  182 (317)
T 2buj_A          103 HEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMN  182 (317)
T ss_dssp             EEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCSSCE
T ss_pred             ceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCCEEEEecCcch
Confidence            5789999999999999999763   4679999999999999999999999999999999999999999999999999987


Q ss_pred             ccCCCccc----------ccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhH-HHHHH
Q 004959          492 HLTGQKAD----------LSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGA-AAMFK  560 (721)
Q Consensus       492 ~l~~~~~~----------~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~-~~~~k  560 (721)
                      ........          ....||+.|+|||++.+.    ....++.++|||||||++|+|++|+.||...... .....
T Consensus       183 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~  258 (317)
T 2buj_A          183 QACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQ----SHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVAL  258 (317)
T ss_dssp             ESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCC----SEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHH
T ss_pred             hcccccccccccccccccccccCCcccCCHhHhccC----CCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhH
Confidence            65321111          124589999999998421    1123567899999999999999999999653211 11111


Q ss_pred             HhhcC--CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcc
Q 004959          561 VMRDT--PAIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEHR  601 (721)
Q Consensus       561 i~~~~--~~~p~~lS~el~dLI~~cL~~DP~kRPSa~eLL~Hp  601 (721)
                      .....  ...+..++.++.+||.+||+.||++||++.+++++-
T Consensus       259 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L  301 (317)
T 2buj_A          259 AVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQL  301 (317)
T ss_dssp             HHHCC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             HhhccCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHh
Confidence            11222  233457899999999999999999999999999873

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=7.6e-44  Score=378.27  Aligned_cols=250  Identities=24%  Similarity=0.374  Sum_probs=199.9

Q ss_pred             CCCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecC---
Q 004959          339 NSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVED---  415 (721)
Q Consensus       339 ~~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~---  415 (721)
                      ..+|++++.||+|+||.||+|++.  |+.||||++..      .........+|+.+|++++|||||++++++....   
T Consensus        23 ~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~------~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~   94 (322)
T 3soc_A           23 SMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPI------QDKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVD   94 (322)
T ss_dssp             TEEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECG------GGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSS
T ss_pred             hhhchhhheecccCceEEEEEEEC--CCEEEEEEeec------CchHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCC
Confidence            358999999999999999999876  79999999853      1223445667999999999999999999988754   


Q ss_pred             -eEEEEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhC----------CeeccCCCCCcEEEcCCCceEE
Q 004959          416 -KFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSK----------KTIHRDIKGANLLVDASGVVKL  484 (721)
Q Consensus       416 -~~yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~----------gIIHrDLKPeNILld~~g~VKL  484 (721)
                       .+|+||||+.+|+|.+++..  ..+++..++.++.||+.||.|||++          ||+||||||+||||+.++.+||
T Consensus        95 ~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL  172 (322)
T 3soc_A           95 VDLWLITAFHEKGSLSDFLKA--NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACI  172 (322)
T ss_dssp             EEEEEEEECCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEE
T ss_pred             ceEEEEEecCCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEE
Confidence             47999999999999999976  4699999999999999999999999          9999999999999999999999


Q ss_pred             eecCCccccCCCcc---cccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchh--------
Q 004959          485 ADFGMAKHLTGQKA---DLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYE--------  553 (721)
Q Consensus       485 ~DFGlA~~l~~~~~---~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~--------  553 (721)
                      +|||+++.+.....   ....+||+.|+|||++.+...  ....++.++|||||||++|||++|+.||.+..        
T Consensus       173 ~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~--~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~  250 (322)
T 3soc_A          173 ADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAIN--FQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFE  250 (322)
T ss_dssp             CCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCC--CCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTH
T ss_pred             ccCCcccccccccCccccccCccCccccCHhhcccccc--cCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchh
Confidence            99999987654332   234679999999999953111  01245568899999999999999999996431        


Q ss_pred             -------hHHHHHHHhhcC---CCCCC-----CCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q 004959          554 -------GAAAMFKVMRDT---PAIPD-----SLSPEGKDFLRCCFQRNPADRPPASLLLEH  600 (721)
Q Consensus       554 -------~~~~~~ki~~~~---~~~p~-----~lS~el~dLI~~cL~~DP~kRPSa~eLL~H  600 (721)
                             ....+.......   +.++.     ..+.++.+||.+||+.||++|||+.|+++.
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~  312 (322)
T 3soc_A          251 EEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGER  312 (322)
T ss_dssp             HHHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             hhhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence                   111222222111   11111     123569999999999999999999999874

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=1e-43  Score=380.81  Aligned_cols=253  Identities=23%  Similarity=0.315  Sum_probs=198.4

Q ss_pred             CCCeeEeeEEeecCCeEEEEEEECC---CCcEEEEEEeecCCCCcccH-H-----HHHHHHHHHHHHHhCCCCCeeeeee
Q 004959          339 NSQWQKGKLIGRGTFGSVYVASNRE---TGALCAMKEVDIFPDDPKSA-E-----SIKQLEQEIKVLSHLKHPNIVQYYG  409 (721)
Q Consensus       339 ~~~y~~~k~LG~G~fG~VY~a~~~~---tg~~vAIK~i~~~~~~~~~~-~-----~~k~~~~Ei~iL~~L~HPnIV~l~g  409 (721)
                      .++|++++.||+|+||.||+|.+..   ++..||||++.......... .     ..+.+.+|+.+++.+.||||+++++
T Consensus        36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~  115 (345)
T 2v62_A           36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG  115 (345)
T ss_dssp             SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred             CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence            4689999999999999999999987   88999999986421110000 0     1134668889999999999999999


Q ss_pred             eEEe----cCeEEEEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCC--ceE
Q 004959          410 SEIV----EDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASG--VVK  483 (721)
Q Consensus       410 ~~~~----~~~~yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g--~VK  483 (721)
                      ++..    ....|+||||+ |++|.+++... +.+++..++.++.||+.||.|||++||+||||||+||||+.++  .+|
T Consensus       116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~k  193 (345)
T 2v62_A          116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQN-GTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVY  193 (345)
T ss_dssp             EEEEESSSCEEEEEEEECE-EEEHHHHCBGG-GBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSSTTSEE
T ss_pred             ccccccCCCcEEEEEEecc-CCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCCcEE
Confidence            9888    67899999999 99999999765 4899999999999999999999999999999999999999877  999


Q ss_pred             EeecCCccccCCCcc--------cccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhh-
Q 004959          484 LADFGMAKHLTGQKA--------DLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEG-  554 (721)
Q Consensus       484 L~DFGlA~~l~~~~~--------~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~-  554 (721)
                      |+|||+++.+.....        .....||+.|+|||++.+       ..++.++|||||||+||||++|+.||..... 
T Consensus       194 L~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~Di~slG~il~ell~g~~pf~~~~~~  266 (345)
T 2v62_A          194 LADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKG-------VALSRRSDVEILGYCMLRWLCGKLPWEQNLKD  266 (345)
T ss_dssp             ECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHT-------CCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTC
T ss_pred             EEeCCCceecccccccccchhccccccCCCccccCHHHhcC-------CCCCchhhHHHHHHHHHHHHhCCCCccccccc
Confidence            999999987643321        134579999999999853       4578899999999999999999999965221 


Q ss_pred             HHHHHHH-hhcCCCCC---------CCCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q 004959          555 AAAMFKV-MRDTPAIP---------DSLSPEGKDFLRCCFQRNPADRPPASLLLEH  600 (721)
Q Consensus       555 ~~~~~ki-~~~~~~~p---------~~lS~el~dLI~~cL~~DP~kRPSa~eLL~H  600 (721)
                      ....... ......++         ..++.++.+||.+||+.||++||++++|++.
T Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~  322 (345)
T 2v62_A          267 PVAVQTAKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKI  322 (345)
T ss_dssp             HHHHHHHHHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHH
T ss_pred             cHHHHHHHHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHH
Confidence            1111111 11111122         2789999999999999999999999999874

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=1.2e-43  Score=367.69  Aligned_cols=252  Identities=25%  Similarity=0.469  Sum_probs=205.1

Q ss_pred             CCCeeEeeEEeecCCeEEEEEEECC-CCc--EEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecC
Q 004959          339 NSQWQKGKLIGRGTFGSVYVASNRE-TGA--LCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVED  415 (721)
Q Consensus       339 ~~~y~~~k~LG~G~fG~VY~a~~~~-tg~--~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~  415 (721)
                      ..+|++++.||+|+||.||+|.+.. +++  .||||++...  ........+.+.+|+.++++++||||+++++++....
T Consensus        17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   94 (291)
T 1u46_A           17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPD--VLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP   94 (291)
T ss_dssp             GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC----------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccC--ccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC
Confidence            4589999999999999999998643 333  6899987532  1122345678999999999999999999999987655


Q ss_pred             eEEEEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCC
Q 004959          416 KFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTG  495 (721)
Q Consensus       416 ~~yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~  495 (721)
                       .++||||+.+++|.+++....+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+..
T Consensus        95 -~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~  173 (291)
T 1u46_A           95 -MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQ  173 (291)
T ss_dssp             -CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC
T ss_pred             -ceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCEEEccccccccccc
Confidence             8999999999999999987767899999999999999999999999999999999999999999999999999987654


Q ss_pred             Cccc----ccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhh-CCCCCCchhhHHHHHHHhhcC--CCC
Q 004959          496 QKAD----LSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFKVMRDT--PAI  568 (721)
Q Consensus       496 ~~~~----~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLt-G~~PF~~~~~~~~~~ki~~~~--~~~  568 (721)
                      ....    ....||+.|+|||++.+       ..++.++|||||||++|+|++ |..||......+.+..+....  ...
T Consensus       174 ~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~  246 (291)
T 1u46_A          174 NDDHYVMQEHRKVPFAWCAPESLKT-------RTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPR  246 (291)
T ss_dssp             -CCEEEC-----CCGGGCCHHHHHH-------CEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCC
T ss_pred             cccchhhhccCCCCceeeCchhhcC-------CCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCCCCCC
Confidence            3321    23457889999999964       346778999999999999999 999998877776666665543  344


Q ss_pred             CCCCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q 004959          569 PDSLSPEGKDFLRCCFQRNPADRPPASLLLEH  600 (721)
Q Consensus       569 p~~lS~el~dLI~~cL~~DP~kRPSa~eLL~H  600 (721)
                      +..++.++.++|.+||..||++||++.+++++
T Consensus       247 ~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~  278 (291)
T 1u46_A          247 PEDCPQDIYNVMVQCWAHKPEDRPTFVALRDF  278 (291)
T ss_dssp             CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CcCcCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence            56799999999999999999999999999974

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=2.4e-43  Score=378.53  Aligned_cols=244  Identities=18%  Similarity=0.293  Sum_probs=202.0

Q ss_pred             CCCeeEeeEEeecCCeEEEEEEECCC--------CcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeee----
Q 004959          339 NSQWQKGKLIGRGTFGSVYVASNRET--------GALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQ----  406 (721)
Q Consensus       339 ~~~y~~~k~LG~G~fG~VY~a~~~~t--------g~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~----  406 (721)
                      .++|++++.||+|+||.||+|++..+        ++.||||++...          +.+.+|+.+|++++|||||+    
T Consensus        41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~----------~~~~~E~~~l~~l~h~niv~~~~~  110 (352)
T 2jii_A           41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD----------GRLFNEQNFFQRAAKPLQVNKWKK  110 (352)
T ss_dssp             SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT----------STHHHHHHHHHHHCCHHHHHHHHH
T ss_pred             CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc----------chHHHHHHHHHHhcccchhhhhhh
Confidence            36899999999999999999999874        899999998631          36789999999999999987    


Q ss_pred             -----------eeeeEEe-cCeEEEEEeeccCCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCc
Q 004959          407 -----------YYGSEIV-EDKFYIYLEYVHPGSINKYVREH-CGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGAN  473 (721)
Q Consensus       407 -----------l~g~~~~-~~~~yLVmEy~~gGsL~~~L~~~-~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeN  473 (721)
                                 +++++.. .+..||||||+ +++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|
T Consensus       111 ~~~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~N  189 (352)
T 2jii_A          111 LYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAEN  189 (352)
T ss_dssp             HTTCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGG
T ss_pred             hccCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHH
Confidence                       5677666 67899999999 99999999864 3679999999999999999999999999999999999


Q ss_pred             EEEcCCC--ceEEeecCCccccCCCccc--------ccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHh
Q 004959          474 LLVDASG--VVKLADFGMAKHLTGQKAD--------LSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMY  543 (721)
Q Consensus       474 ILld~~g--~VKL~DFGlA~~l~~~~~~--------~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELL  543 (721)
                      |||+.++  .+||+|||+++.+......        ....||+.|+|||++.       ...++.++|||||||+||+|+
T Consensus       190 Il~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~~Di~slG~il~el~  262 (352)
T 2jii_A          190 IFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHK-------GCGPSRRSDLQSLGYCMLKWL  262 (352)
T ss_dssp             EEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHT-------TCCCCHHHHHHHHHHHHHHHH
T ss_pred             EEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHc-------cCCCCchhhHHHHHHHHHHHH
Confidence            9999988  9999999999876543221        2347999999999984       346788999999999999999


Q ss_pred             hCCCCCCchh-hHHHHHHH----hhcCCCCC------CCCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q 004959          544 TGKPPWSEYE-GAAAMFKV----MRDTPAIP------DSLSPEGKDFLRCCFQRNPADRPPASLLLEH  600 (721)
Q Consensus       544 tG~~PF~~~~-~~~~~~ki----~~~~~~~p------~~lS~el~dLI~~cL~~DP~kRPSa~eLL~H  600 (721)
                      +|+.||.... ....+...    ......+.      ..++.++.+||.+||+.||++||++++|++.
T Consensus       263 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~  330 (352)
T 2jii_A          263 YGFLPWTNCLPNTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNN  330 (352)
T ss_dssp             HSCCTTGGGTTCHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHH
T ss_pred             hCCCCcccCCcCHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHH
Confidence            9999998753 22222222    22222222      2579999999999999999999999999864

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=5.1e-43  Score=390.50  Aligned_cols=242  Identities=27%  Similarity=0.498  Sum_probs=208.0

Q ss_pred             CCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecC-eEE
Q 004959          340 SQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVED-KFY  418 (721)
Q Consensus       340 ~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~-~~y  418 (721)
                      .+|++++.||+|+||.||+|.+.  |+.||||++...   .    ..+.+.+|+.+|++++|||||++++++...+ .+|
T Consensus       193 ~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~---~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  263 (450)
T 1k9a_A          193 KELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKND---A----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLY  263 (450)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSC---T----TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEE
T ss_pred             HHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCc---h----HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceE
Confidence            57999999999999999999875  789999998632   1    2357899999999999999999999987665 799


Q ss_pred             EEEeeccCCCHHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCCc
Q 004959          419 IYLEYVHPGSINKYVREHCG-AITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQK  497 (721)
Q Consensus       419 LVmEy~~gGsL~~~L~~~~~-~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~~  497 (721)
                      ||||||.+|+|.+++..... .+++..+..++.||+.||+|||++||+||||||+||||+.++.+||+|||+++......
T Consensus       264 iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~  343 (450)
T 1k9a_A          264 IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ  343 (450)
T ss_dssp             EEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSCEEECCCTTCEECC---
T ss_pred             EEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCCEEEeeCCCcccccccc
Confidence            99999999999999987643 37999999999999999999999999999999999999999999999999998653322


Q ss_pred             ccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhh-CCCCCCchhhHHHHHHHhhc-CCCCCCCCCHH
Q 004959          498 ADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFKVMRD-TPAIPDSLSPE  575 (721)
Q Consensus       498 ~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLt-G~~PF~~~~~~~~~~ki~~~-~~~~p~~lS~e  575 (721)
                        ....+++.|+|||++.       ...++.++|||||||+||||++ |..||.+....+....+... ....|..++++
T Consensus       344 --~~~~~~~~y~aPE~~~-------~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~p~~~~~~  414 (450)
T 1k9a_A          344 --DTGKLPVKWTAPEALR-------EKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPA  414 (450)
T ss_dssp             -----CCCTTTSCHHHHH-------SSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTTCCCCCCTTCCHH
T ss_pred             --cCCCCCcceeCHHHhc-------CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHH
Confidence              2346789999999995       3457889999999999999998 99999887666655555544 34567889999


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHHh
Q 004959          576 GKDFLRCCFQRNPADRPPASLLLE  599 (721)
Q Consensus       576 l~dLI~~cL~~DP~kRPSa~eLL~  599 (721)
                      +.+||.+||+.||++|||+.+|++
T Consensus       415 l~~li~~cl~~dp~~Rpt~~~l~~  438 (450)
T 1k9a_A          415 VYDVMKNCWHLDAATRPTFLQLRE  438 (450)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHcCCChhHCcCHHHHHH
Confidence            999999999999999999999975

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=2.9e-43  Score=371.09  Aligned_cols=251  Identities=22%  Similarity=0.379  Sum_probs=191.1

Q ss_pred             CCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCC-CCCeeeeeeeEE------
Q 004959          340 SQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLK-HPNIVQYYGSEI------  412 (721)
Q Consensus       340 ~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~-HPnIV~l~g~~~------  412 (721)
                      .+|++++.||+|+||.||+|++..+|+.||||++..     ......+.+.+|+.+|+++. ||||+++++++.      
T Consensus        28 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~-----~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~  102 (337)
T 3ll6_A           28 LRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLS-----NEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEES  102 (337)
T ss_dssp             EEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEE-----SSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTS
T ss_pred             ceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecC-----CchHHHHHHHHHHHHHHHhccCCChhhcccccccccccc
Confidence            479999999999999999999999999999998853     23455678899999999996 999999999984      


Q ss_pred             --ecCeEEEEEeeccCCCHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHhhCC--eeccCCCCCcEEEcCCCceEEee
Q 004959          413 --VEDKFYIYLEYVHPGSINKYVRE--HCGAITESVVRNFTRHILSGLAYLHSKK--TIHRDIKGANLLVDASGVVKLAD  486 (721)
Q Consensus       413 --~~~~~yLVmEy~~gGsL~~~L~~--~~~~Lse~~i~~i~~QIl~AL~yLHs~g--IIHrDLKPeNILld~~g~VKL~D  486 (721)
                        ....+|+||||+. |+|.+++..  ..+.+++..++.++.||+.||.|||++|  |+||||||+||||+.++.+||+|
T Consensus       103 ~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~~kl~D  181 (337)
T 3ll6_A          103 DTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCD  181 (337)
T ss_dssp             TTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSCEEBCC
T ss_pred             ccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCCEEEec
Confidence              3345899999996 799998865  2457999999999999999999999999  99999999999999999999999


Q ss_pred             cCCccccCCCccc-------------ccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchh
Q 004959          487 FGMAKHLTGQKAD-------------LSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYE  553 (721)
Q Consensus       487 FGlA~~l~~~~~~-------------~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~  553 (721)
                      ||++..+......             ...+||+.|+|||++..    .....++.++|||||||++|+|++|..||....
T Consensus       182 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~----~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~  257 (337)
T 3ll6_A          182 FGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDL----YSNFPIGEKQDIWALGCILYLLCFRQHPFEDGA  257 (337)
T ss_dssp             CTTCBCCSSCC-------------------------------C----CTTSCSSHHHHHHHHHHHHHHHHHSSCCC----
T ss_pred             CccceeccccCcccccccccccchhhccccCCCCcCChhhhhc----cccCCCChHHhHHHHHHHHHHHHhCCCCCcchh
Confidence            9999876543221             14569999999999832    124567889999999999999999999997654


Q ss_pred             hHHHHHHHhhcCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhccc
Q 004959          554 GAAAMFKVMRDTPAIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRF  602 (721)
Q Consensus       554 ~~~~~~ki~~~~~~~p~~lS~el~dLI~~cL~~DP~kRPSa~eLL~Hp~  602 (721)
                      .........  ....+..++.++.+||++||+.||++||++.|+++|.+
T Consensus       258 ~~~~~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~  304 (337)
T 3ll6_A          258 KLRIVNGKY--SIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQ  304 (337)
T ss_dssp             --------C--CCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHH
T ss_pred             HHHhhcCcc--cCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence            433322221  12334567888999999999999999999999999854

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=9.7e-44  Score=401.41  Aligned_cols=249  Identities=27%  Similarity=0.482  Sum_probs=215.0

Q ss_pred             CCCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeEE
Q 004959          339 NSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFY  418 (721)
Q Consensus       339 ~~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~y  418 (721)
                      ..+|++++.||+|+||.||+|.++.++..||||++...   ..   ..+.+.+|+.+|++++|||||++++++...+.+|
T Consensus       219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~---~~---~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~  292 (495)
T 1opk_A          219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED---TM---EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY  292 (495)
T ss_dssp             GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSS---SS---CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred             HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCc---cc---chHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEE
Confidence            35799999999999999999999999999999998532   11   2467899999999999999999999999999999


Q ss_pred             EEEeeccCCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCCc
Q 004959          419 IYLEYVHPGSINKYVREH-CGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQK  497 (721)
Q Consensus       419 LVmEy~~gGsL~~~L~~~-~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~~  497 (721)
                      ||||||.+|+|.+++... ...+++..+..++.||+.||+|||++||+||||||+||||+.++.+||+|||+++.+....
T Consensus       293 lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~  372 (495)
T 1opk_A          293 IITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDT  372 (495)
T ss_dssp             EEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEECCTTCC
T ss_pred             EEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCcEEEeecccceeccCCc
Confidence            999999999999999864 3569999999999999999999999999999999999999999999999999998765433


Q ss_pred             c--cccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhh-CCCCCCchhhHHHHHHHhhc-CCCCCCCCC
Q 004959          498 A--DLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFKVMRD-TPAIPDSLS  573 (721)
Q Consensus       498 ~--~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLt-G~~PF~~~~~~~~~~ki~~~-~~~~p~~lS  573 (721)
                      .  .....++..|+|||++.+       ..++.++|||||||+||||++ |..||.+....+....+... ....+..++
T Consensus       373 ~~~~~~~~~~~~y~aPE~~~~-------~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  445 (495)
T 1opk_A          373 YTAHAGAKFPIKWTAPESLAY-------NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCP  445 (495)
T ss_dssp             EECCTTCCCCGGGCCHHHHHH-------CEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCCTTCC
T ss_pred             eeecCCCcCCcceeCHhHHhc-------CCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCC
Confidence            2  223456788999999964       346779999999999999999 99999887655555444433 245677899


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHHhc
Q 004959          574 PEGKDFLRCCFQRNPADRPPASLLLEH  600 (721)
Q Consensus       574 ~el~dLI~~cL~~DP~kRPSa~eLL~H  600 (721)
                      +++.+||.+||+.||++|||+.+|++.
T Consensus       446 ~~l~~li~~cl~~dP~~RPs~~el~~~  472 (495)
T 1opk_A          446 EKVYELMRACWQWNPSDRPSFAEIHQA  472 (495)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence            999999999999999999999999863

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=4e-43  Score=362.53  Aligned_cols=245  Identities=25%  Similarity=0.462  Sum_probs=209.0

Q ss_pred             CCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeEEE
Q 004959          340 SQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYI  419 (721)
Q Consensus       340 ~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~yL  419 (721)
                      ++|++++.||+|+||.||+|.+. ++..||||++....   ..   .+.+.+|+.+|+.++||||+++++++. .+..|+
T Consensus        13 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~   84 (279)
T 1qpc_A           13 ETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGS---MS---PDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYI   84 (279)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTS---SC---HHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEE
T ss_pred             HhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCc---cc---HHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEE
Confidence            58999999999999999999976 57789999885321   11   357889999999999999999999875 556899


Q ss_pred             EEeeccCCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCCcc
Q 004959          420 YLEYVHPGSINKYVREHC-GAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKA  498 (721)
Q Consensus       420 VmEy~~gGsL~~~L~~~~-~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~~~  498 (721)
                      ||||+.+++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+.....
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  164 (279)
T 1qpc_A           85 ITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY  164 (279)
T ss_dssp             EEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCE
T ss_pred             EEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCCEEECCCcccccccCccc
Confidence            999999999999996542 3699999999999999999999999999999999999999999999999999987654332


Q ss_pred             --cccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhh-CCCCCCchhhHHHHHHHhhc-CCCCCCCCCH
Q 004959          499 --DLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFKVMRD-TPAIPDSLSP  574 (721)
Q Consensus       499 --~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLt-G~~PF~~~~~~~~~~ki~~~-~~~~p~~lS~  574 (721)
                        .....|++.|+|||++.+       ..++.++|||||||++|+|++ |..||.+....+....+... ....+..++.
T Consensus       165 ~~~~~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (279)
T 1qpc_A          165 TAREGAKFPIKWTAPEAINY-------GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPE  237 (279)
T ss_dssp             ECCTTCCCCTTTSCHHHHHH-------CEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCH
T ss_pred             ccccCCCCccCccChhhhcc-------CCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhcccCCCCcccccH
Confidence              223457889999999964       346678999999999999999 99999887666666555544 3445678999


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHHh
Q 004959          575 EGKDFLRCCFQRNPADRPPASLLLE  599 (721)
Q Consensus       575 el~dLI~~cL~~DP~kRPSa~eLL~  599 (721)
                      ++.+||.+||..||++|||+.++++
T Consensus       238 ~l~~li~~~l~~~p~~Rps~~~l~~  262 (279)
T 1qpc_A          238 ELYQLMRLCWKERPEDRPTFDYLRS  262 (279)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHHhccChhhCCCHHHHHH
Confidence            9999999999999999999999986

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=6.5e-43  Score=363.84  Aligned_cols=250  Identities=26%  Similarity=0.422  Sum_probs=197.0

Q ss_pred             CCCCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHh--CCCCCeeeeeeeEEe--
Q 004959          338 MNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSH--LKHPNIVQYYGSEIV--  413 (721)
Q Consensus       338 l~~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~--L~HPnIV~l~g~~~~--  413 (721)
                      +.++|++++.||+|+||.||+|.+  +|+.||||++...        ..+.+.+|.+++..  ++||||+++++++..  
T Consensus         6 ~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~--------~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~   75 (301)
T 3q4u_A            6 VARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSR--------DEKSWFRETELYNTVMLRHENILGFIASDMTSR   75 (301)
T ss_dssp             CGGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGG--------GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEE
T ss_pred             ccCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEeccc--------cchhhHHHHHHHHHhhccCcCeeeEEEeecccc
Confidence            456899999999999999999987  5899999988521        12345566666666  789999999998655  


Q ss_pred             --cCeEEEEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHh--------hCCeeccCCCCCcEEEcCCCceE
Q 004959          414 --EDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLH--------SKKTIHRDIKGANLLVDASGVVK  483 (721)
Q Consensus       414 --~~~~yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLH--------s~gIIHrDLKPeNILld~~g~VK  483 (721)
                        ...+|+||||+.+|+|.+++..  ..+++..++.++.||+.||.|||        ++||+||||||+||||+.++.+|
T Consensus        76 ~~~~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~k  153 (301)
T 3q4u_A           76 HSSTQLWLITHYHEMGSLYDYLQL--TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCC  153 (301)
T ss_dssp             TTEEEEEEEECCCTTCBHHHHHTT--CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEE
T ss_pred             CCCceeEEehhhccCCCHHHHHhh--cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEE
Confidence              3568999999999999999954  57999999999999999999999        99999999999999999999999


Q ss_pred             EeecCCccccCCCcc-----cccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhC----------CCC
Q 004959          484 LADFGMAKHLTGQKA-----DLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTG----------KPP  548 (721)
Q Consensus       484 L~DFGlA~~l~~~~~-----~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG----------~~P  548 (721)
                      |+|||+++.......     ....+||+.|+|||++.+..... ...++.++|||||||++|||++|          ..|
T Consensus       154 l~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~-~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~p  232 (301)
T 3q4u_A          154 IADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVD-CFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPP  232 (301)
T ss_dssp             ECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTT-CHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCT
T ss_pred             EeeCCCeeecccccccccccccccccccceeChhhhcCcCCCC-cccCCchhhHHHHHHHHHHHHhhhcCcccccccccc
Confidence            999999976544332     22347999999999995421100 00345689999999999999999          888


Q ss_pred             CCchh----hHHHHHHHhhc---CCCCCC-----CCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q 004959          549 WSEYE----GAAAMFKVMRD---TPAIPD-----SLSPEGKDFLRCCFQRNPADRPPASLLLEH  600 (721)
Q Consensus       549 F~~~~----~~~~~~ki~~~---~~~~p~-----~lS~el~dLI~~cL~~DP~kRPSa~eLL~H  600 (721)
                      |....    ....+......   .+.++.     .++.++.+||.+||+.||++|||+.|+++.
T Consensus       233 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~  296 (301)
T 3q4u_A          233 FYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKT  296 (301)
T ss_dssp             TTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred             ccccCCCCcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHH
Confidence            85421    22233332221   222221     245789999999999999999999999864

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=3.1e-43  Score=392.39  Aligned_cols=247  Identities=25%  Similarity=0.461  Sum_probs=211.4

Q ss_pred             CCCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeEE
Q 004959          339 NSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFY  418 (721)
Q Consensus       339 ~~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~y  418 (721)
                      ..+|++++.||+|+||.||+|.+.. +..||||++...   ..   ..+.+.+|+.+|++++|||||++++++. .+.+|
T Consensus       187 ~~~~~~~~~lG~G~fg~V~~~~~~~-~~~vavK~~~~~---~~---~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~  258 (454)
T 1qcf_A          187 RESLKLEKKLGAGQFGEVWMATYNK-HTKVAVKTMKPG---SM---SVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIY  258 (454)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEETT-TEEEEEEEECTT---SB---CHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCE
T ss_pred             hHHeEEEEEcccCCceEEEEEEECC-ccEEEEEEecCC---Cc---cHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccE
Confidence            3579999999999999999999864 788999998632   11   2467899999999999999999999875 67799


Q ss_pred             EEEeeccCCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCCc
Q 004959          419 IYLEYVHPGSINKYVREH-CGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQK  497 (721)
Q Consensus       419 LVmEy~~gGsL~~~L~~~-~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~~  497 (721)
                      ||||||.+|+|.+++... ...+++..+..++.||+.||+|||++||+||||||+||||+.++.+||+|||+++.+....
T Consensus       259 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~  338 (454)
T 1qcf_A          259 IITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNE  338 (454)
T ss_dssp             EEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHH
T ss_pred             EEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCc
Confidence            999999999999999754 2478999999999999999999999999999999999999999999999999998765432


Q ss_pred             c--cccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhh-CCCCCCchhhHHHHHHHhhc-CCCCCCCCC
Q 004959          498 A--DLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFKVMRD-TPAIPDSLS  573 (721)
Q Consensus       498 ~--~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLt-G~~PF~~~~~~~~~~ki~~~-~~~~p~~lS  573 (721)
                      .  .....++..|+|||++..       ..++.++|||||||+||||++ |+.||.+....+.+..+... ....+..++
T Consensus       339 ~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~  411 (454)
T 1qcf_A          339 YTAREGAKFPIKWTAPEAINF-------GSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCP  411 (454)
T ss_dssp             HHTTCSSSSCGGGSCHHHHHH-------CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCCCCCCTTSC
T ss_pred             eeccCCCcccccccCHHHhcc-------CCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCC
Confidence            1  223457788999999954       347789999999999999999 99999987776666665544 335567899


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHHhc
Q 004959          574 PEGKDFLRCCFQRNPADRPPASLLLEH  600 (721)
Q Consensus       574 ~el~dLI~~cL~~DP~kRPSa~eLL~H  600 (721)
                      +++.+||.+||+.||++|||+++|++.
T Consensus       412 ~~l~~li~~cl~~dp~~RPt~~~i~~~  438 (454)
T 1qcf_A          412 EELYNIMMRCWKNRPEERPTFEYIQSV  438 (454)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHHHccCChhHCcCHHHHHHH
Confidence            999999999999999999999999753

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=7.9e-43  Score=369.39  Aligned_cols=250  Identities=27%  Similarity=0.472  Sum_probs=207.1

Q ss_pred             CCCCCe-eEeeEEeecCCeEEEEEE----ECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeE
Q 004959          337 PMNSQW-QKGKLIGRGTFGSVYVAS----NRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSE  411 (721)
Q Consensus       337 ~l~~~y-~~~k~LG~G~fG~VY~a~----~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~  411 (721)
                      .+..+| ++++.||+|+||.||+|.    +..+|+.||||++...    ......+.+.+|+.+|++++||||+++++++
T Consensus        27 ~~~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~  102 (318)
T 3lxp_A           27 VFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKAD----AGPQHRSGWKQEIDILRTLYHEHIIKYKGCC  102 (318)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTT----CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             eecHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccc----cChHHHHHHHHHHHHHHhCCCcchhhEEEEE
Confidence            345566 999999999999998875    4458999999998632    3445677899999999999999999999999


Q ss_pred             Ee--cCeEEEEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCC
Q 004959          412 IV--EDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGM  489 (721)
Q Consensus       412 ~~--~~~~yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGl  489 (721)
                      .+  ...+|+||||+.+|+|.+++...  .+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+
T Consensus       103 ~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~  180 (318)
T 3lxp_A          103 EDAGAASLQLVMEYVPLGSLRDYLPRH--SIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGL  180 (318)
T ss_dssp             EETTTTEEEEEECCCTTCBHHHHGGGS--CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGG
T ss_pred             ecCCCceEEEEEecccCCcHHHHHhhC--CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCCEEECCccc
Confidence            87  46789999999999999999653  599999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCCcc----cccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHH---------
Q 004959          490 AKHLTGQKA----DLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAA---------  556 (721)
Q Consensus       490 A~~l~~~~~----~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~---------  556 (721)
                      +..+.....    .....||+.|+|||++.+       ..++.++|||||||++|+|++|..||.......         
T Consensus       181 a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~  253 (318)
T 3lxp_A          181 AKAVPEGHEYYRVREDGDSPVFWYAPECLKE-------YKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQG  253 (318)
T ss_dssp             CEECCTTCSEEEC---CCCCGGGCCHHHHHH-------CEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCH
T ss_pred             cccccccccccccccCCCCCceeeChHHhcC-------CCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhccccc
Confidence            987754432    233568899999999964       346678999999999999999999997643211         


Q ss_pred             -----HHHHHhh--cCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHh
Q 004959          557 -----AMFKVMR--DTPAIPDSLSPEGKDFLRCCFQRNPADRPPASLLLE  599 (721)
Q Consensus       557 -----~~~ki~~--~~~~~p~~lS~el~dLI~~cL~~DP~kRPSa~eLL~  599 (721)
                           .+...+.  .....+..++.++.+||++||+.||++|||+.|+++
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~  303 (318)
T 3lxp_A          254 QMTVLRLTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIP  303 (318)
T ss_dssp             HHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             chhHHHHHHHHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence                 1112221  234566789999999999999999999999999985

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=3.1e-44  Score=379.77  Aligned_cols=253  Identities=25%  Similarity=0.360  Sum_probs=205.7

Q ss_pred             CCCCCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCe
Q 004959          337 PMNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDK  416 (721)
Q Consensus       337 ~l~~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~  416 (721)
                      ...++|++.+.||+|+||.||+|.+. +|+.||||++...     .....+.+.+|+.+|+.++||||+++++++...+.
T Consensus        36 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  109 (321)
T 2qkw_B           36 EATNNFDHKFLIGHGVFGKVYKGVLR-DGAKVALKRRTPE-----SSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNE  109 (321)
T ss_dssp             CCCCCCSCCCCSCBCSSSEEEEEECT-TCCEEEEEECCSC-----CSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTC
T ss_pred             HHHhccCccceeecCCCeeEEEEEEC-CCCEEEEEEeccc-----ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCe
Confidence            35578999999999999999999964 6899999987532     12345678999999999999999999999999999


Q ss_pred             EEEEEeeccCCCHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCcccc
Q 004959          417 FYIYLEYVHPGSINKYVREHC---GAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHL  493 (721)
Q Consensus       417 ~yLVmEy~~gGsL~~~L~~~~---~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l  493 (721)
                      .|+||||+++|+|.+++....   ..+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++...
T Consensus       110 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~  189 (321)
T 2qkw_B          110 MILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKG  189 (321)
T ss_dssp             CEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCCEEECCCTTCEEC
T ss_pred             EEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCCEEEeeccccccc
Confidence            999999999999999986542   35899999999999999999999999999999999999999999999999999865


Q ss_pred             CCCc---ccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHH------HHHH-Hhh
Q 004959          494 TGQK---ADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAA------AMFK-VMR  563 (721)
Q Consensus       494 ~~~~---~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~------~~~k-i~~  563 (721)
                      ....   ......||+.|+|||++.+       ..++.++|||||||++|||++|+.||......+      .... ...
T Consensus       190 ~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~  262 (321)
T 2qkw_B          190 TELDQTHLSTVVKGTLGYIDPEYFIK-------GRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNN  262 (321)
T ss_dssp             SSSSCCCCBCCCEEETTTCCHHHHHH-------CBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTT
T ss_pred             ccccccccccccCCCccccCHHHhcC-------CCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhcccc
Confidence            4322   1233558999999999964       346678999999999999999999996532211      0000 000


Q ss_pred             c------CCC----CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhccc
Q 004959          564 D------TPA----IPDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRF  602 (721)
Q Consensus       564 ~------~~~----~p~~lS~el~dLI~~cL~~DP~kRPSa~eLL~Hp~  602 (721)
                      .      .+.    ++..++.++.++|.+||+.||++|||+.|+++|..
T Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~  311 (321)
T 2qkw_B          263 GQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLE  311 (321)
T ss_dssp             TCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             ccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHH
Confidence            0      011    12234567899999999999999999999998753

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.6e-43  Score=384.17  Aligned_cols=250  Identities=24%  Similarity=0.433  Sum_probs=201.7

Q ss_pred             CCeeEeeEEeecCCeEEEEEEECCC---CcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEE-ecC
Q 004959          340 SQWQKGKLIGRGTFGSVYVASNRET---GALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEI-VED  415 (721)
Q Consensus       340 ~~y~~~k~LG~G~fG~VY~a~~~~t---g~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~-~~~  415 (721)
                      ..|++++.||+|+||.||+|.+..+   +..||+|.+..    .......+.+.+|+.+|++++|||||++++++. .++
T Consensus        89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~----~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~  164 (373)
T 3c1x_A           89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNR----ITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEG  164 (373)
T ss_dssp             EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCS----CSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSS
T ss_pred             ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCC----CCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCC
Confidence            4689999999999999999987543   34689998753    223345678999999999999999999999865 456


Q ss_pred             eEEEEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCC
Q 004959          416 KFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTG  495 (721)
Q Consensus       416 ~~yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~  495 (721)
                      ..|+||||+.+|+|.+++......+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.+..
T Consensus       165 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~  244 (373)
T 3c1x_A          165 SPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYD  244 (373)
T ss_dssp             CCEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred             CeEEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCCEEEeeccccccccc
Confidence            88999999999999999987767799999999999999999999999999999999999999999999999999987643


Q ss_pred             Ccc-----cccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhh-CCCCCCchhhHHHHHHHhhc-CCCC
Q 004959          496 QKA-----DLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFKVMRD-TPAI  568 (721)
Q Consensus       496 ~~~-----~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLt-G~~PF~~~~~~~~~~ki~~~-~~~~  568 (721)
                      ...     .....||+.|+|||++.+       ..++.++|||||||+||||++ |.+||......+....+... ....
T Consensus       245 ~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~~~~~~  317 (373)
T 3c1x_A          245 KEFDSVHNKTGAKLPVKWMALESLQT-------QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQ  317 (373)
T ss_dssp             -------------CCGGGSCHHHHHH-------CCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTTCCCCC
T ss_pred             cccccccccCCCCCcccccChHHhcC-------CCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcCCCCCC
Confidence            321     123457889999999964       356789999999999999999 78888776555544444443 3345


Q ss_pred             CCCCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q 004959          569 PDSLSPEGKDFLRCCFQRNPADRPPASLLLEH  600 (721)
Q Consensus       569 p~~lS~el~dLI~~cL~~DP~kRPSa~eLL~H  600 (721)
                      +..++.++.+||.+||+.||++||++.|++++
T Consensus       318 p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~  349 (373)
T 3c1x_A          318 PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR  349 (373)
T ss_dssp             CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            67899999999999999999999999999876

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=7e-43  Score=361.07  Aligned_cols=244  Identities=27%  Similarity=0.487  Sum_probs=201.4

Q ss_pred             CCCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEec-CeE
Q 004959          339 NSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVE-DKF  417 (721)
Q Consensus       339 ~~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~-~~~  417 (721)
                      .++|++++.||+|+||.||+|.+.  |+.||||++...   .    ..+.+.+|+.+|++++||||+++++++... +..
T Consensus        20 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~---~----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   90 (278)
T 1byg_A           20 MKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKND---A----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGL   90 (278)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCC---C------HHHHHTHHHHTTCCCTTBCCEEEEECCC--CC
T ss_pred             hhhceEEeEEecCCCceEEEEEEc--CCEEEEEEecch---h----HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCce
Confidence            368999999999999999999875  889999988521   1    346788999999999999999999986554 579


Q ss_pred             EEEEeeccCCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCC
Q 004959          418 YIYLEYVHPGSINKYVREHC-GAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQ  496 (721)
Q Consensus       418 yLVmEy~~gGsL~~~L~~~~-~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~  496 (721)
                      |+||||+.+++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus        91 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~  170 (278)
T 1byg_A           91 YIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST  170 (278)
T ss_dssp             EEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC-------
T ss_pred             EEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCcEEEeecccccccccc
Confidence            99999999999999997653 23899999999999999999999999999999999999999999999999999865433


Q ss_pred             cccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhh-CCCCCCchhhHHHHHHHhhc-CCCCCCCCCH
Q 004959          497 KADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFKVMRD-TPAIPDSLSP  574 (721)
Q Consensus       497 ~~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLt-G~~PF~~~~~~~~~~ki~~~-~~~~p~~lS~  574 (721)
                      .  ....+++.|+|||++.+       ..++.++|||||||++|+|++ |..||......+....+... ....+..+++
T Consensus       171 ~--~~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (278)
T 1byg_A          171 Q--DTGKLPVKWTAPEALRE-------KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPP  241 (278)
T ss_dssp             -------CCTTTSCHHHHHH-------CCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCCCCCTTCCH
T ss_pred             c--cCCCccccccCHHHhCC-------CCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCcccCCH
Confidence            2  23468899999999954       346779999999999999998 99999876665555555443 3456778999


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHHhc
Q 004959          575 EGKDFLRCCFQRNPADRPPASLLLEH  600 (721)
Q Consensus       575 el~dLI~~cL~~DP~kRPSa~eLL~H  600 (721)
                      ++.++|++||+.||++||++.|+++.
T Consensus       242 ~l~~li~~~l~~~p~~Rps~~~l~~~  267 (278)
T 1byg_A          242 AVYEVMKNCWHLDAAMRPSFLQLREQ  267 (278)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHHhcCChhhCCCHHHHHHH
Confidence            99999999999999999999999863

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=3.9e-43  Score=372.19  Aligned_cols=262  Identities=24%  Similarity=0.379  Sum_probs=193.1

Q ss_pred             CCCCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEe----
Q 004959          338 MNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIV----  413 (721)
Q Consensus       338 l~~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~----  413 (721)
                      ..++|++++.||+|+||.||+|++  +|+.||||++...     .. .....+.|+..+..+.||||+++++.+..    
T Consensus        11 ~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~-----~~-~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~   82 (336)
T 3g2f_A           11 DLDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFA-----NR-QNFINEKNIYRVPLMEHDNIARFIVGDERVTAD   82 (336)
T ss_dssp             CTTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGG-----GH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTT
T ss_pred             ChHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeecc-----ch-hhHHHHHHHHHHHhccCcchhhheecccccccC
Confidence            346899999999999999999976  5899999998631     11 11122344444556899999999986543    


Q ss_pred             -cCeEEEEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhC---------CeeccCCCCCcEEEcCCCceE
Q 004959          414 -EDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSK---------KTIHRDIKGANLLVDASGVVK  483 (721)
Q Consensus       414 -~~~~yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~---------gIIHrDLKPeNILld~~g~VK  483 (721)
                       ...+|||||||++|+|.+++...  .+++..+..++.||+.||.|||++         ||+||||||+||||+.++.+|
T Consensus        83 ~~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~k  160 (336)
T 3g2f_A           83 GRMEYLLVMEYYPNGSLXKYLSLH--TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCV  160 (336)
T ss_dssp             SCEEEEEEECCCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEE
T ss_pred             CCceEEEEEecCCCCcHHHHHhhc--ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEE
Confidence             23679999999999999999754  568999999999999999999999         999999999999999999999


Q ss_pred             EeecCCccccCCCc---------ccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhh
Q 004959          484 LADFGMAKHLTGQK---------ADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEG  554 (721)
Q Consensus       484 L~DFGlA~~l~~~~---------~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~  554 (721)
                      |+|||++..+....         .....+||+.|+|||++.+.........++.++|||||||+||||++|..||.....
T Consensus       161 L~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~  240 (336)
T 3g2f_A          161 ISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGES  240 (336)
T ss_dssp             ECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSC
T ss_pred             EeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccc
Confidence            99999998765322         122457999999999995421111112355689999999999999999777632111


Q ss_pred             -----------------HHHHHHHh---hcCCCCCCC------CCHHHHHHHHHhcccCCCCCCCHHHHH------hccc
Q 004959          555 -----------------AAAMFKVM---RDTPAIPDS------LSPEGKDFLRCCFQRNPADRPPASLLL------EHRF  602 (721)
Q Consensus       555 -----------------~~~~~ki~---~~~~~~p~~------lS~el~dLI~~cL~~DP~kRPSa~eLL------~Hp~  602 (721)
                                       .+.+....   ...+.++..      +++++.+||.+||+.||++|||+.|++      .++|
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~~  320 (336)
T 3g2f_A          241 VPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIW  320 (336)
T ss_dssp             CCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHCC
T ss_pred             hhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHHH
Confidence                             11111111   122333433      334799999999999999999999994      4566


Q ss_pred             cccCCCC
Q 004959          603 LKNSQQP  609 (721)
Q Consensus       603 f~~~~~~  609 (721)
                      -++....
T Consensus       321 ~~~~~~~  327 (336)
T 3g2f_A          321 ERNKSVS  327 (336)
T ss_dssp             CC-----
T ss_pred             HhcccCC
Confidence            6655443

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.6e-42  Score=367.80  Aligned_cols=251  Identities=28%  Similarity=0.495  Sum_probs=209.2

Q ss_pred             CCCCeeEeeEEeecCCeEEEEEE----ECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEe
Q 004959          338 MNSQWQKGKLIGRGTFGSVYVAS----NRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIV  413 (721)
Q Consensus       338 l~~~y~~~k~LG~G~fG~VY~a~----~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~  413 (721)
                      ...+|++++.||+|+||.||+|.    +..+|+.||||++..     ......+.+.+|+.+|++++||||+++++++..
T Consensus        39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~-----~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~  113 (326)
T 2w1i_A           39 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQH-----STEEHLRDFEREIEILKSLQHDNIVKYKGVCYS  113 (326)
T ss_dssp             CGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESS-----CCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC
T ss_pred             CHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEecc-----CCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEe
Confidence            34679999999999999999998    467899999999863     223456789999999999999999999998766


Q ss_pred             cC--eEEEEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCcc
Q 004959          414 ED--KFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAK  491 (721)
Q Consensus       414 ~~--~~yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~  491 (721)
                      .+  .+++||||+++++|.+++......+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++.
T Consensus       114 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kL~Dfg~~~  193 (326)
T 2w1i_A          114 AGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTK  193 (326)
T ss_dssp             ----CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred             cCCCceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCcEEEecCcchh
Confidence            44  7899999999999999998776779999999999999999999999999999999999999999999999999998


Q ss_pred             ccCCCcc----cccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhH------------
Q 004959          492 HLTGQKA----DLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGA------------  555 (721)
Q Consensus       492 ~l~~~~~----~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~------------  555 (721)
                      .+.....    .....++..|+|||++.+       ..++.++|||||||++|+|++|..||......            
T Consensus       194 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~  266 (326)
T 2w1i_A          194 VLPQDKEYYKVKEPGESPIFWYAPESLTE-------SKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQ  266 (326)
T ss_dssp             ECCSSCSEEECSSCCSCCGGGCCHHHHHH-------CEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTH
T ss_pred             hccccccccccccCCCCceeEECchhhcC-------CCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchh
Confidence            7654432    123457888999999964       34677899999999999999999998653211            


Q ss_pred             ---HHHHHHhh--cCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q 004959          556 ---AAMFKVMR--DTPAIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEH  600 (721)
Q Consensus       556 ---~~~~ki~~--~~~~~p~~lS~el~dLI~~cL~~DP~kRPSa~eLL~H  600 (721)
                         ..+...+.  .....+..++.++.+||++||+.||++||++.|+++.
T Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~  316 (326)
T 2w1i_A          267 MIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALR  316 (326)
T ss_dssp             HHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred             hhHHHHHHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence               01112222  2345567899999999999999999999999999863

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=3.2e-42  Score=361.17  Aligned_cols=233  Identities=25%  Similarity=0.398  Sum_probs=193.3

Q ss_pred             CCCCCeeEe-eEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHH-HhCCCCCeeeeeeeEEe-
Q 004959          337 PMNSQWQKG-KLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVL-SHLKHPNIVQYYGSEIV-  413 (721)
Q Consensus       337 ~l~~~y~~~-k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL-~~L~HPnIV~l~g~~~~-  413 (721)
                      .+.++|.+. ++||+|+||.||+|.+..+|+.||||++..          ...+.+|+.++ +.+.||||+++++++.. 
T Consensus        14 ~~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~----------~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~   83 (299)
T 3m2w_A           14 AIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD----------CPKARREVELHWRASQCPHIVRIVDVYENL   83 (299)
T ss_dssp             CGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC----------SHHHHHHHHHHHHHTTSTTBCCEEEEEEEE
T ss_pred             ccccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc----------cHHHHHHHHHHHHhccCCCchhHHhhhhhh
Confidence            345678887 889999999999999999999999999852          13567888887 66689999999999887 


Q ss_pred             ---cCeEEEEEeeccCCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcC---CCceEEee
Q 004959          414 ---EDKFYIYLEYVHPGSINKYVREHC-GAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDA---SGVVKLAD  486 (721)
Q Consensus       414 ---~~~~yLVmEy~~gGsL~~~L~~~~-~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~---~g~VKL~D  486 (721)
                         ...+||||||+.||+|.+++.... ..+++..++.++.||+.||.|||++||+||||||+||||+.   ++.+||+|
T Consensus        84 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~D  163 (299)
T 3m2w_A           84 YAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTD  163 (299)
T ss_dssp             ETTEEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECC
T ss_pred             cCCCceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEec
Confidence               778999999999999999998753 46999999999999999999999999999999999999998   78999999


Q ss_pred             cCCccccCCCcccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHh----
Q 004959          487 FGMAKHLTGQKADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVM----  562 (721)
Q Consensus       487 FGlA~~l~~~~~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~----  562 (721)
                      ||++....+                            ..++.++|||||||++|+|++|..||.............    
T Consensus       164 fg~a~~~~~----------------------------~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~  215 (299)
T 3m2w_A          164 FGFAKETTG----------------------------EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIR  215 (299)
T ss_dssp             CTTCEECTT----------------------------CGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSSC
T ss_pred             ccccccccc----------------------------ccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHHh
Confidence            999875432                            234567999999999999999999998765443322111    


Q ss_pred             hcCCCCC----CCCCHHHHHHHHHhcccCCCCCCCHHHHHhccccccCC
Q 004959          563 RDTPAIP----DSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQ  607 (721)
Q Consensus       563 ~~~~~~p----~~lS~el~dLI~~cL~~DP~kRPSa~eLL~Hp~f~~~~  607 (721)
                      .....++    ..+++++.+||.+||+.||++|||+.|+|+||||++..
T Consensus       216 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~~  264 (299)
T 3m2w_A          216 MGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST  264 (299)
T ss_dssp             TTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTGG
T ss_pred             hccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhcccc
Confidence            1122223    56899999999999999999999999999999998754

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=3.7e-42  Score=362.95  Aligned_cols=241  Identities=30%  Similarity=0.525  Sum_probs=196.7

Q ss_pred             CCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeEEE
Q 004959          340 SQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYI  419 (721)
Q Consensus       340 ~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~yL  419 (721)
                      ++|++.+.||+|+||.||+|.+.  ++.||||++..       ....+.+.+|+.+|++++||||+++++++.  +..|+
T Consensus         8 ~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~-------~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~l   76 (307)
T 2eva_A            8 KEIEVEEVVGRGAFGVVCKAKWR--AKDVAIKQIES-------ESERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCL   76 (307)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEET--TEEEEEEECSS-------TTHHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEE
T ss_pred             hHeeeeeEeecCCCceEEEEEEC--CeeEEEEEecC-------hhHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEE
Confidence            58999999999999999999875  78999998742       123567899999999999999999999876  45899


Q ss_pred             EEeeccCCCHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhh---CCeeccCCCCCcEEEcCCCc-eEEeecCCcccc
Q 004959          420 YLEYVHPGSINKYVREHC--GAITESVVRNFTRHILSGLAYLHS---KKTIHRDIKGANLLVDASGV-VKLADFGMAKHL  493 (721)
Q Consensus       420 VmEy~~gGsL~~~L~~~~--~~Lse~~i~~i~~QIl~AL~yLHs---~gIIHrDLKPeNILld~~g~-VKL~DFGlA~~l  493 (721)
                      ||||++||+|.+++....  ..+++..+..++.||+.||.|||+   +||+||||||+||||+.++. +||+|||++..+
T Consensus        77 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~  156 (307)
T 2eva_A           77 VMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDI  156 (307)
T ss_dssp             EEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC----
T ss_pred             EEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccccc
Confidence            999999999999997642  247899999999999999999999   89999999999999998886 799999999765


Q ss_pred             CCCcccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhh--HHHHHHHh-hcCCCCCC
Q 004959          494 TGQKADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEG--AAAMFKVM-RDTPAIPD  570 (721)
Q Consensus       494 ~~~~~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~--~~~~~ki~-~~~~~~p~  570 (721)
                      ...  .....||+.|+|||++.       ...++.++|||||||++|+|++|+.||.....  ......+. ...+..+.
T Consensus       157 ~~~--~~~~~gt~~y~aPE~~~-------~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  227 (307)
T 2eva_A          157 QTH--MTNNKGSAAWMAPEVFE-------GSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIK  227 (307)
T ss_dssp             ----------CCTTSSCHHHHT-------CCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTCCCCCBT
T ss_pred             ccc--cccCCCCCceEChhhhC-------CCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCCCCCccc
Confidence            432  22356999999999984       45677899999999999999999999975422  22222222 23445667


Q ss_pred             CCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q 004959          571 SLSPEGKDFLRCCFQRNPADRPPASLLLEH  600 (721)
Q Consensus       571 ~lS~el~dLI~~cL~~DP~kRPSa~eLL~H  600 (721)
                      .++.++.+||.+||+.||++|||+.+++++
T Consensus       228 ~~~~~l~~li~~~l~~dp~~Rps~~ell~~  257 (307)
T 2eva_A          228 NLPKPIESLMTRCWSKDPSQRPSMEEIVKI  257 (307)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ccCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence            899999999999999999999999999875

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=8.1e-43  Score=376.24  Aligned_cols=244  Identities=16%  Similarity=0.197  Sum_probs=197.1

Q ss_pred             CCCeeEeeEEeecCCeEEEEE-----EECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCC---CCCeeeeeee
Q 004959          339 NSQWQKGKLIGRGTFGSVYVA-----SNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLK---HPNIVQYYGS  410 (721)
Q Consensus       339 ~~~y~~~k~LG~G~fG~VY~a-----~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~---HPnIV~l~g~  410 (721)
                      ...|++++.||+|+||.||+|     .+..+++.||||++...     .   ...+.+|+.+++.+.   |+||+.++++
T Consensus        64 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-----~---~~~~~~e~~~~~~l~~~~~~~iv~~~~~  135 (365)
T 3e7e_A           64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA-----N---PWEFYIGTQLMERLKPSMQHMFMKFYSA  135 (365)
T ss_dssp             SSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC-----C---HHHHHHHHHHHHHSCGGGGGGBCCEEEE
T ss_pred             CEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC-----C---hhHHHHHHHHHHHhhhhhhhhhhhhhee
Confidence            467999999999999999999     46778999999998521     1   246777888888887   9999999999


Q ss_pred             EEecCeEEEEEeeccCCCHHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcC--------
Q 004959          411 EIVEDKFYIYLEYVHPGSINKYVREH----CGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDA--------  478 (721)
Q Consensus       411 ~~~~~~~yLVmEy~~gGsL~~~L~~~----~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~--------  478 (721)
                      +...+..|||||||.||+|.+++...    ...+++..++.|+.||+.||+|||++|||||||||+||||+.        
T Consensus       136 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~~~  215 (365)
T 3e7e_A          136 HLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDE  215 (365)
T ss_dssp             EECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC---
T ss_pred             eecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCcccc
Confidence            99999999999999999999999752    357999999999999999999999999999999999999988        


Q ss_pred             ---CCceEEeecCCccccC---CCcccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCch
Q 004959          479 ---SGVVKLADFGMAKHLT---GQKADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEY  552 (721)
Q Consensus       479 ---~g~VKL~DFGlA~~l~---~~~~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~  552 (721)
                         ++.+||+|||+++.+.   ........+||+.|||||++.       +..++.++|||||||+||||++|+.||...
T Consensus       216 ~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~~DiwslG~il~elltg~~pf~~~  288 (365)
T 3e7e_A          216 DDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLS-------NKPWNYQIDYFGVAATVYCMLFGTYMKVKN  288 (365)
T ss_dssp             ---CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHT-------TCCBSTHHHHHHHHHHHHHHHHSSCCCEEE
T ss_pred             ccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhc-------CCCCCccccHHHHHHHHHHHHhCCCccccC
Confidence               8999999999997653   233345578999999999994       345788999999999999999999999654


Q ss_pred             hhHHHHHHHhhcCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcc
Q 004959          553 EGAAAMFKVMRDTPAIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEHR  601 (721)
Q Consensus       553 ~~~~~~~ki~~~~~~~p~~lS~el~dLI~~cL~~DP~kRPSa~eLL~Hp  601 (721)
                      .....  .+.....  ....++.+.+++..||+.+|.+|++..+.|.+.
T Consensus       289 ~~~~~--~~~~~~~--~~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~  333 (365)
T 3e7e_A          289 EGGEC--KPEGLFR--RLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQK  333 (365)
T ss_dssp             ETTEE--EECSCCT--TCSSHHHHHHHHHHHHCCCCTTCCCCHHHHHHH
T ss_pred             CCCce--eechhcc--ccCcHHHHHHHHHHHcCCCCCCcchHHHHHHHH
Confidence            32110  0000111  113467889999999999999997655555443

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=9.8e-43  Score=386.47  Aligned_cols=257  Identities=29%  Similarity=0.434  Sum_probs=197.3

Q ss_pred             CCCCCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhC-CCCCeeeeeeeEEecC
Q 004959          337 PMNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHL-KHPNIVQYYGSEIVED  415 (721)
Q Consensus       337 ~l~~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L-~HPnIV~l~g~~~~~~  415 (721)
                      .+.+.|.+.+.||+|+||+||.+. ..+|+.||||++...        ..+.+.+|+.+|+.+ +|||||++++++.+.+
T Consensus        12 ~l~~~~~~~~~LG~G~~g~V~~~~-~~~g~~vAvK~~~~~--------~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~   82 (434)
T 2rio_A           12 SLKNLVVSEKILGYGSSGTVVFQG-SFQGRPVAVKRMLID--------FCDIALMEIKLLTESDDHPNVIRYYCSETTDR   82 (434)
T ss_dssp             SCSSCEEEEEEEEECSTTCEEEEE-ESSSSEEEEEEEEGG--------GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSS
T ss_pred             hhhheeeccCeEeeCCCeEEEEEE-EECCeEEEEEEEcHH--------HHHHHHHHHHHHHhccCCCCcCeEEEEEecCC
Confidence            345678889999999999998754 457999999988531        134678899999876 8999999999999999


Q ss_pred             eEEEEEeeccCCCHHHHHHHhcCC------CCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCC----------
Q 004959          416 KFYIYLEYVHPGSINKYVREHCGA------ITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDAS----------  479 (721)
Q Consensus       416 ~~yLVmEy~~gGsL~~~L~~~~~~------Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~----------  479 (721)
                      .+|||||||. |+|.+++......      ..+..++.++.||+.||.|||++||+||||||+||||+.+          
T Consensus        83 ~~~lv~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~  161 (434)
T 2rio_A           83 FLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTG  161 (434)
T ss_dssp             EEEEEECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTC
T ss_pred             eEEEEEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccC
Confidence            9999999996 6999999754211      1333467899999999999999999999999999999754          


Q ss_pred             ---CceEEeecCCccccCCCcc-----cccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhh-CCCCCC
Q 004959          480 ---GVVKLADFGMAKHLTGQKA-----DLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWS  550 (721)
Q Consensus       480 ---g~VKL~DFGlA~~l~~~~~-----~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLt-G~~PF~  550 (721)
                         +.+||+|||+++.+.....     ....+||+.|+|||++.+.........++.++|||||||++|||++ |..||.
T Consensus       162 ~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~  241 (434)
T 2rio_A          162 AENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFG  241 (434)
T ss_dssp             CCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTC
T ss_pred             CCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCC
Confidence               4899999999987755432     1245799999999999542211123567889999999999999999 999997


Q ss_pred             chhhHHHHHHHhhcCCCCC-------CCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccccc
Q 004959          551 EYEGAAAMFKVMRDTPAIP-------DSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKN  605 (721)
Q Consensus       551 ~~~~~~~~~ki~~~~~~~p-------~~lS~el~dLI~~cL~~DP~kRPSa~eLL~Hp~f~~  605 (721)
                      .....+  ..++......+       ..++.++.+||.+||+.||++|||+.++++||||..
T Consensus       242 ~~~~~~--~~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~f~~  301 (434)
T 2rio_A          242 DKYSRE--SNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWP  301 (434)
T ss_dssp             STTTHH--HHHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSC
T ss_pred             CchhhH--HHHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCccCC
Confidence            654332  22222222211       124588999999999999999999999999999964

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=3.7e-43  Score=371.33  Aligned_cols=253  Identities=24%  Similarity=0.376  Sum_probs=204.0

Q ss_pred             CCCCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeE
Q 004959          338 MNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKF  417 (721)
Q Consensus       338 l~~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~  417 (721)
                      ..++|++.+.||+|+||.||+|.+. +|+.||||++......    .....+.+|+.+|+.++||||+++++++...+..
T Consensus        28 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~  102 (326)
T 3uim_A           28 ASDNFSNKNILGRGGFGKVYKGRLA-DGTLVAVKRLKEERTQ----GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTER  102 (326)
T ss_dssp             TTTSSCSTTEEECCSSSEEEEECCS-SSCCEEEEECCC---------CCCHHHHHHHGGGTCCCTTBCCCCEEECCSSCC
T ss_pred             HhhccccceeEecCCCcEEEEEEec-CCCEEEEEEeccccCc----hHHHHHHHHHHHHHhccCCCccceEEEEecCCce
Confidence            4568999999999999999999854 6999999998642211    1123688999999999999999999999999999


Q ss_pred             EEEEeeccCCCHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHhhC---CeeccCCCCCcEEEcCCCceEEeecCCcc
Q 004959          418 YIYLEYVHPGSINKYVREHC---GAITESVVRNFTRHILSGLAYLHSK---KTIHRDIKGANLLVDASGVVKLADFGMAK  491 (721)
Q Consensus       418 yLVmEy~~gGsL~~~L~~~~---~~Lse~~i~~i~~QIl~AL~yLHs~---gIIHrDLKPeNILld~~g~VKL~DFGlA~  491 (721)
                      ++||||+.+|+|.+++....   ..+++..++.++.||+.||.|||++   ||+||||||+||||+.++.+||+|||++.
T Consensus       103 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~  182 (326)
T 3uim_A          103 LLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK  182 (326)
T ss_dssp             EEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECCCSSCE
T ss_pred             EEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEeccCcccc
Confidence            99999999999999997642   3499999999999999999999999   99999999999999999999999999998


Q ss_pred             ccCCCcc--cccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhh--------HHHHHHH
Q 004959          492 HLTGQKA--DLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEG--------AAAMFKV  561 (721)
Q Consensus       492 ~l~~~~~--~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~--------~~~~~ki  561 (721)
                      .+.....  .....||+.|+|||++.+       ..++.++|||||||++|+|++|..||.....        .+.+...
T Consensus       183 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  255 (326)
T 3uim_A          183 LMDYKDTHVTTAVRGTIGHIAPEYLST-------GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGL  255 (326)
T ss_dssp             ECCSSSSCEECCCCSCGGGCCHHHHHH-------SEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTT
T ss_pred             ccCcccccccccccCCcCccCHHHhcc-------CCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHH
Confidence            7653332  234569999999999964       3467789999999999999999999963211        0111111


Q ss_pred             hhcC-----------CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhccc
Q 004959          562 MRDT-----------PAIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRF  602 (721)
Q Consensus       562 ~~~~-----------~~~p~~lS~el~dLI~~cL~~DP~kRPSa~eLL~Hp~  602 (721)
                      ....           ...+...+.++.+||.+||+.||++|||+.|+++|-.
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~  307 (326)
T 3uim_A          256 LKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE  307 (326)
T ss_dssp             TSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHH
T ss_pred             hhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhc
Confidence            1110           0111223477899999999999999999999999865

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.7e-42  Score=364.83  Aligned_cols=250  Identities=23%  Similarity=0.427  Sum_probs=194.2

Q ss_pred             CCCCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhC--CCCCeeeeeeeEEec-
Q 004959          338 MNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHL--KHPNIVQYYGSEIVE-  414 (721)
Q Consensus       338 l~~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L--~HPnIV~l~g~~~~~-  414 (721)
                      +.++|++++.||+|+||.||+|.+.  |+.||||++...      .  ...+.+|..++..+  +||||+++++++... 
T Consensus        35 ~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~------~--~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~  104 (337)
T 3mdy_A           35 IAKQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTT------E--EASWFRETEIYQTVLMRHENILGFIAADIKGT  104 (337)
T ss_dssp             HHHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGG------G--HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESC
T ss_pred             cccceEEEeEeecCCCeEEEEEEEC--CceEEEEEEecc------c--cchhhhHHHHHHHHhhcCCCeeeEEEEEccCC
Confidence            3468999999999999999999875  899999998521      1  12344455555554  899999999998887 


Q ss_pred             ---CeEEEEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhC--------CeeccCCCCCcEEEcCCCceE
Q 004959          415 ---DKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSK--------KTIHRDIKGANLLVDASGVVK  483 (721)
Q Consensus       415 ---~~~yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~--------gIIHrDLKPeNILld~~g~VK  483 (721)
                         ..+|+||||+.+|+|.+++..  ..+++..++.++.||+.||.|||++        ||+||||||+||||+.++.+|
T Consensus       105 ~~~~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~k  182 (337)
T 3mdy_A          105 GSWTQLYLITDYHENGSLYDYLKS--TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCC  182 (337)
T ss_dssp             GGGCEEEEEECCCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEE
T ss_pred             CCCCceEEEEeccCCCcHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEE
Confidence               789999999999999999965  4799999999999999999999999        999999999999999999999


Q ss_pred             EeecCCccccCCCccc-----ccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhC----------CCC
Q 004959          484 LADFGMAKHLTGQKAD-----LSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTG----------KPP  548 (721)
Q Consensus       484 L~DFGlA~~l~~~~~~-----~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG----------~~P  548 (721)
                      |+|||++..+......     ...+||+.|+|||++.+..... ...++.++|||||||++|||++|          ..|
T Consensus       183 l~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~-~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p  261 (337)
T 3mdy_A          183 IADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRN-HFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLP  261 (337)
T ss_dssp             ECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTT-CTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCT
T ss_pred             EEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCc-cccCccccchHHHHHHHHHHHhccCccccccccccc
Confidence            9999999876543322     2457999999999995421111 01112358999999999999999          777


Q ss_pred             CCchh----hHHHHHHHhh---cCCCCCC-----CCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q 004959          549 WSEYE----GAAAMFKVMR---DTPAIPD-----SLSPEGKDFLRCCFQRNPADRPPASLLLEH  600 (721)
Q Consensus       549 F~~~~----~~~~~~ki~~---~~~~~p~-----~lS~el~dLI~~cL~~DP~kRPSa~eLL~H  600 (721)
                      |....    ....+.....   ..+.++.     .+++++.+||.+||+.||++|||+.|+++|
T Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  325 (337)
T 3mdy_A          262 YHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKT  325 (337)
T ss_dssp             TTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred             HhhhcCCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHH
Confidence            75421    1122222221   1223332     456779999999999999999999999987

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=3.1e-42  Score=399.43  Aligned_cols=254  Identities=22%  Similarity=0.368  Sum_probs=209.8

Q ss_pred             CCeeEee-EEeecCCeEEEEEEEC--CCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCe
Q 004959          340 SQWQKGK-LIGRGTFGSVYVASNR--ETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDK  416 (721)
Q Consensus       340 ~~y~~~k-~LG~G~fG~VY~a~~~--~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~  416 (721)
                      ..+.+.+ .||+|+||.||+|.++  .++..||||++....    .....+.+.+|+.+|++++|||||++++++.. +.
T Consensus       335 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~----~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~  409 (613)
T 2ozo_A          335 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT----EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EA  409 (613)
T ss_dssp             TSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCC----SSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SS
T ss_pred             cceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCC----ChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CC
Confidence            4566665 8999999999999765  456789999986321    12235678999999999999999999999875 56


Q ss_pred             EEEEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCC
Q 004959          417 FYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQ  496 (721)
Q Consensus       417 ~yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~  496 (721)
                      +|||||||.+|+|.+++......+++..+..|+.||+.||+|||++|||||||||+||||+.++.+||+|||+++.+...
T Consensus       410 ~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~  489 (613)
T 2ozo_A          410 LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGAD  489 (613)
T ss_dssp             EEEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC--
T ss_pred             eEEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCC
Confidence            99999999999999999766677999999999999999999999999999999999999999999999999999876543


Q ss_pred             ccc----ccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhh-CCCCCCchhhHHHHHHHhhcC-CCCCC
Q 004959          497 KAD----LSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFKVMRDT-PAIPD  570 (721)
Q Consensus       497 ~~~----~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLt-G~~PF~~~~~~~~~~ki~~~~-~~~p~  570 (721)
                      ...    ....+++.|+|||++.+       ..++.++|||||||+||||++ |+.||.+....+.+..+.... ..++.
T Consensus       490 ~~~~~~~~~~~~~~~y~APE~~~~-------~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~  562 (613)
T 2ozo_A          490 DSYYTARSAGKWPLKWYAPECINF-------RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPP  562 (613)
T ss_dssp             ------------CCTTSCHHHHHH-------CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTTCCCCCCT
T ss_pred             CceeeeccCCCCccceeCHhhhcC-------CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCC
Confidence            221    12346789999999954       357789999999999999998 999999877777666665543 45678


Q ss_pred             CCCHHHHHHHHHhcccCCCCCCCHHHHH---hcccccc
Q 004959          571 SLSPEGKDFLRCCFQRNPADRPPASLLL---EHRFLKN  605 (721)
Q Consensus       571 ~lS~el~dLI~~cL~~DP~kRPSa~eLL---~Hp~f~~  605 (721)
                      .+++++.+||.+||+.||++||++.+|+   ++.|+..
T Consensus       563 ~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~  600 (613)
T 2ozo_A          563 ECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSL  600 (613)
T ss_dssp             TCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred             cCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHh
Confidence            8999999999999999999999999985   4455543

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=1.7e-42  Score=386.56  Aligned_cols=246  Identities=26%  Similarity=0.453  Sum_probs=206.1

Q ss_pred             CCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeEEE
Q 004959          340 SQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYI  419 (721)
Q Consensus       340 ~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~yL  419 (721)
                      ++|++++.||+|+||.||+|.+.. +..||||++....   ..   .+.+.+|+.+|++++|||||++++++.. +.+||
T Consensus       184 ~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~---~~---~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~i  255 (452)
T 1fmk_A          184 ESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGT---MS---PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYI  255 (452)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTS---SC---HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEE
T ss_pred             hHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCC---CC---HHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEE
Confidence            579999999999999999999875 4679999886321   11   3578999999999999999999998765 77999


Q ss_pred             EEeeccCCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCCcc
Q 004959          420 YLEYVHPGSINKYVREH-CGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKA  498 (721)
Q Consensus       420 VmEy~~gGsL~~~L~~~-~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~~~  498 (721)
                      |||||.+|+|.+++... ...+++..+..++.||+.||+|||++||+||||||+||||+.++.+||+|||+++.+.....
T Consensus       256 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~  335 (452)
T 1fmk_A          256 VTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY  335 (452)
T ss_dssp             EECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC-------
T ss_pred             EehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCCEEECCCccceecCCCce
Confidence            99999999999999653 35699999999999999999999999999999999999999999999999999987654322


Q ss_pred             --cccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhh-CCCCCCchhhHHHHHHHhhc-CCCCCCCCCH
Q 004959          499 --DLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFKVMRD-TPAIPDSLSP  574 (721)
Q Consensus       499 --~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLt-G~~PF~~~~~~~~~~ki~~~-~~~~p~~lS~  574 (721)
                        .....++..|+|||++.+       ..++.++|||||||+||||++ |+.||.+....+.+..+... ....+..+++
T Consensus       336 ~~~~~~~~~~~y~aPE~~~~-------~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~  408 (452)
T 1fmk_A          336 TARQGAKFPIKWTAPEAALY-------GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPE  408 (452)
T ss_dssp             -------CCGGGSCHHHHHH-------CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTSCH
T ss_pred             ecccCCcccccccCHhHHhc-------CCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCH
Confidence              123457889999999964       357789999999999999999 99999987776666666554 3456778999


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHHhc
Q 004959          575 EGKDFLRCCFQRNPADRPPASLLLEH  600 (721)
Q Consensus       575 el~dLI~~cL~~DP~kRPSa~eLL~H  600 (721)
                      ++.+||.+||+.||++|||+++|++.
T Consensus       409 ~l~~li~~cl~~dP~~Rpt~~~l~~~  434 (452)
T 1fmk_A          409 SLHDLMCQCWRKEPEERPTFEYLQAF  434 (452)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHHccCChhhCcCHHHHHHH
Confidence            99999999999999999999999863

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=1e-42  Score=364.37  Aligned_cols=249  Identities=24%  Similarity=0.376  Sum_probs=203.3

Q ss_pred             CeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeEEEE
Q 004959          341 QWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYIY  420 (721)
Q Consensus       341 ~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~yLV  420 (721)
                      .|..++.||+|+||.||+|.+  +++.||||++.... ........+.+.+|+.+|+.++||||+++++++.+.+..|+|
T Consensus        32 ~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~-~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv  108 (307)
T 2nru_A           32 ISVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMV-DITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLV  108 (307)
T ss_dssp             TTTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCT-TSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred             ccccCCccccCCCeEEEEEEE--CCceEEEEEEeccc-CcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEE
Confidence            466678999999999999986  58899999986422 122334567899999999999999999999999999999999


Q ss_pred             EeeccCCCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCCcc
Q 004959          421 LEYVHPGSINKYVREH--CGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKA  498 (721)
Q Consensus       421 mEy~~gGsL~~~L~~~--~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~~~  498 (721)
                      |||+.+++|.+++...  ...+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++........
T Consensus       109 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~  188 (307)
T 2nru_A          109 YVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQ  188 (307)
T ss_dssp             EECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSCSS
T ss_pred             EEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCcEEEeecccccccccccc
Confidence            9999999999999743  34699999999999999999999999999999999999999999999999999987644222


Q ss_pred             ---cccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHH----HHHHhhc-------
Q 004959          499 ---DLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAA----MFKVMRD-------  564 (721)
Q Consensus       499 ---~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~----~~ki~~~-------  564 (721)
                         .....||+.|+|||++.+        .++.++|||||||++|+|++|..||........    ...+...       
T Consensus       189 ~~~~~~~~g~~~y~aPE~~~~--------~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  260 (307)
T 2nru_A          189 TVMTSRIVGTTAYMAPEALRG--------EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDY  260 (307)
T ss_dssp             CEECSSCCSCGGGCCHHHHTT--------EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHH
T ss_pred             cccccccCCCcCcCChHHhcC--------CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhh
Confidence               234579999999999842        356789999999999999999999976432211    1111111       


Q ss_pred             ----CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q 004959          565 ----TPAIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEH  600 (721)
Q Consensus       565 ----~~~~p~~lS~el~dLI~~cL~~DP~kRPSa~eLL~H  600 (721)
                          ....+...+.++.++|.+||+.||++||++.+++++
T Consensus       261 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~  300 (307)
T 2nru_A          261 IDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQL  300 (307)
T ss_dssp             SCSSCSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             ccccccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence                111223345778999999999999999999999976

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=4.6e-42  Score=387.65  Aligned_cols=247  Identities=21%  Similarity=0.347  Sum_probs=205.5

Q ss_pred             CCCCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCC-CCeeeeeeeEEecCe
Q 004959          338 MNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKH-PNIVQYYGSEIVEDK  416 (721)
Q Consensus       338 l~~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~H-PnIV~l~g~~~~~~~  416 (721)
                      +.++|+++++||+|+||.||+|++..+|+.||||++......       ..+.+|+.+++.|.| ++|+.+..++...+.
T Consensus         5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-------~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~   77 (483)
T 3sv0_A            5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH-------PQLLYESKIYRILQGGTGIPNVRWFGVEGDY   77 (483)
T ss_dssp             ETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS-------CCHHHHHHHHHHTTTSTTCCCEEEEEEETTE
T ss_pred             cCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc-------HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCE
Confidence            457899999999999999999999999999999987643222       247789999999987 555566666777889


Q ss_pred             EEEEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEE---cCCCceEEeecCCcccc
Q 004959          417 FYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLV---DASGVVKLADFGMAKHL  493 (721)
Q Consensus       417 ~yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILl---d~~g~VKL~DFGlA~~l  493 (721)
                      .||||||+ +++|.+++......+++..++.|+.||+.||.|||++|||||||||+||||   +.++.+||+|||+++.+
T Consensus        78 ~~lvme~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~  156 (483)
T 3sv0_A           78 NVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY  156 (483)
T ss_dssp             EEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred             EEEEEECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcceec
Confidence            99999999 899999998766789999999999999999999999999999999999999   68899999999999876


Q ss_pred             CCCccc--------ccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhh---HHHHHHHh
Q 004959          494 TGQKAD--------LSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEG---AAAMFKVM  562 (721)
Q Consensus       494 ~~~~~~--------~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~---~~~~~ki~  562 (721)
                      ......        ...+||+.|+|||++.       ...++.++||||||||||||++|+.||.+...   .+.+.++.
T Consensus       157 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-------~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~  229 (483)
T 3sv0_A          157 RDTSTHQHIPYRENKNLTGTARYASVNTHL-------GIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKIS  229 (483)
T ss_dssp             BCTTTCCBCCCCCCCCCCSCTTTCCHHHHT-------TCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHH
T ss_pred             cCCccccccccccccccCCCccccCHHHhc-------CCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHh
Confidence            543321        2567999999999994       45678899999999999999999999976432   22222222


Q ss_pred             hc-----CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHh
Q 004959          563 RD-----TPAIPDSLSPEGKDFLRCCFQRNPADRPPASLLLE  599 (721)
Q Consensus       563 ~~-----~~~~p~~lS~el~dLI~~cL~~DP~kRPSa~eLL~  599 (721)
                      ..     ...++..++.++.+||.+||+.||++||++.+|++
T Consensus       230 ~~~~~~~~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~  271 (483)
T 3sv0_A          230 EKKVATSIEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKR  271 (483)
T ss_dssp             HHHHHSCHHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             hccccccHHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence            11     11233578999999999999999999999998764

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=4.4e-42  Score=399.79  Aligned_cols=244  Identities=22%  Similarity=0.411  Sum_probs=204.9

Q ss_pred             eeEEeecCCeEEEEEE--ECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeEEEEEe
Q 004959          345 GKLIGRGTFGSVYVAS--NRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYIYLE  422 (721)
Q Consensus       345 ~k~LG~G~fG~VY~a~--~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~yLVmE  422 (721)
                      .+.||+|+||.||+|.  .+.+++.||||++...   .......+.+.+|+.+|++++|||||++++++. .+.++||||
T Consensus       374 ~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~---~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~-~~~~~lv~E  449 (635)
T 4fl3_A          374 DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNE---ANDPALKDELLAEANVMQQLDNPYIVRMIGICE-AESWMLVME  449 (635)
T ss_dssp             EEEEEECSSEEEEEEEEECSSCEEEEEEEEECGG---GGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEE-SSSEEEEEE
T ss_pred             CCEeccCCCEEEEEEEEcCCCcceEEEEEEeccc---cCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCCEEEEEE
Confidence            4589999999999995  4567789999988632   222334578999999999999999999999886 456899999


Q ss_pred             eccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCCcc----
Q 004959          423 YVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKA----  498 (721)
Q Consensus       423 y~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~~~----  498 (721)
                      ||.+|+|.+++... ..+++..++.|+.||+.||+|||++|||||||||+||||+.++.+||+|||+++.+.....    
T Consensus       450 ~~~~g~L~~~l~~~-~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~  528 (635)
T 4fl3_A          450 MAELGPLNKYLQQN-RHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKA  528 (635)
T ss_dssp             CCTTEEHHHHHHHC-TTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-------
T ss_pred             ccCCCCHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCcccccc
Confidence            99999999999764 6799999999999999999999999999999999999999999999999999987654332    


Q ss_pred             cccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhh-CCCCCCchhhHHHHHHHhhc-CCCCCCCCCHHH
Q 004959          499 DLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFKVMRD-TPAIPDSLSPEG  576 (721)
Q Consensus       499 ~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLt-G~~PF~~~~~~~~~~ki~~~-~~~~p~~lS~el  576 (721)
                      .....||+.|+|||++.+       ..++.++|||||||+||||++ |+.||.+....+....+... ....+..+++++
T Consensus       529 ~~~~~~t~~y~APE~~~~-------~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l  601 (635)
T 4fl3_A          529 QTHGKWPVKWYAPECINY-------YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREM  601 (635)
T ss_dssp             ------CGGGSCHHHHHH-------CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHH
T ss_pred             ccCCCCceeeeChhhhcC-------CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHH
Confidence            123457889999999954       357789999999999999998 99999987776666666554 345678899999


Q ss_pred             HHHHHHhcccCCCCCCCHHHHHhc
Q 004959          577 KDFLRCCFQRNPADRPPASLLLEH  600 (721)
Q Consensus       577 ~dLI~~cL~~DP~kRPSa~eLL~H  600 (721)
                      .+||.+||+.||++||++++|++.
T Consensus       602 ~~li~~cl~~dP~~RPs~~~l~~~  625 (635)
T 4fl3_A          602 YDLMNLCWTYDVENRPGFAAVELR  625 (635)
T ss_dssp             HHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             HHHHHHHcCCCHhHCcCHHHHHHH
Confidence            999999999999999999999754

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=3.1e-42  Score=392.92  Aligned_cols=247  Identities=26%  Similarity=0.452  Sum_probs=211.4

Q ss_pred             CCCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeEE
Q 004959          339 NSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFY  418 (721)
Q Consensus       339 ~~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~y  418 (721)
                      .++|++++.||+|+||.||+|.+.. +..||||++....   ..   .+.+.+|+.+|++++|||||++++++.. +.+|
T Consensus       266 ~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~---~~---~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~  337 (535)
T 2h8h_A          266 RESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGT---MS---PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIY  337 (535)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTS---SC---HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred             hhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCC---CC---HHHHHHHHHHHHhCCCCCEeeEEEEEee-ccce
Confidence            3579999999999999999999875 4679999986321   11   3578999999999999999999998765 7799


Q ss_pred             EEEeeccCCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCCc
Q 004959          419 IYLEYVHPGSINKYVREH-CGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQK  497 (721)
Q Consensus       419 LVmEy~~gGsL~~~L~~~-~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~~  497 (721)
                      ||||||.+|+|.++|... ...+++..+..|+.||+.||+|||++|||||||||+||||+.++.+||+|||+++.+....
T Consensus       338 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~  417 (535)
T 2h8h_A          338 IVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE  417 (535)
T ss_dssp             EEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHH
T ss_pred             EeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCcEEEcccccceecCCCc
Confidence            999999999999999653 3569999999999999999999999999999999999999999999999999998765432


Q ss_pred             c--cccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhh-CCCCCCchhhHHHHHHHhhc-CCCCCCCCC
Q 004959          498 A--DLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFKVMRD-TPAIPDSLS  573 (721)
Q Consensus       498 ~--~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLt-G~~PF~~~~~~~~~~ki~~~-~~~~p~~lS  573 (721)
                      .  .....++..|+|||++.+       ..++.++|||||||+||||++ |+.||.+....+.+..+... ....+..++
T Consensus       418 ~~~~~~~~~~~~y~aPE~~~~-------~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~  490 (535)
T 2h8h_A          418 YTARQGAKFPIKWTAPEAALY-------GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECP  490 (535)
T ss_dssp             HHTTCSTTSCGGGSCHHHHHH-------CCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCC
T ss_pred             eecccCCcCcccccCHHHhcc-------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCC
Confidence            1  223457889999999964       347789999999999999999 99999987776666666554 235567899


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHHhc
Q 004959          574 PEGKDFLRCCFQRNPADRPPASLLLEH  600 (721)
Q Consensus       574 ~el~dLI~~cL~~DP~kRPSa~eLL~H  600 (721)
                      .++.+||.+||+.||++|||+++|++.
T Consensus       491 ~~l~~li~~cl~~dP~~RPt~~~l~~~  517 (535)
T 2h8h_A          491 ESLHDLMCQCWRKEPEERPTFEYLQAF  517 (535)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            999999999999999999999999864

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.4e-42  Score=385.87  Aligned_cols=252  Identities=23%  Similarity=0.376  Sum_probs=196.6

Q ss_pred             CCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhC-CCCCeeeeeeeEEecCeEE
Q 004959          340 SQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHL-KHPNIVQYYGSEIVEDKFY  418 (721)
Q Consensus       340 ~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L-~HPnIV~l~g~~~~~~~~y  418 (721)
                      .+|++.++||+|+||+||. ....+|+.||||++...  .      ...+.+|+.+|+.+ +|||||++++++.+.+..|
T Consensus        24 ~~y~~~~~LG~G~~G~V~~-~~~~~~~~vAvK~~~~~--~------~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~   94 (432)
T 3p23_A           24 ISFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILPE--C------FSFADREVQLLRESDEHPNVIRYFCTEKDRQFQY   94 (432)
T ss_dssp             EEEEEEEEEEECGGGCEEE-EEESSSSEEEEEEECTT--T------EEECHHHHHHHHHSCCCTTBCCEEEEEEETTEEE
T ss_pred             EEEecCCeeecCcCEEEEE-EEEeCCeEEEEEEECHH--H------HHHHHHHHHHHHhccCCCCcCeEEEEEecCCEEE
Confidence            3699999999999999764 33457999999988531  1      12356899999999 7999999999999999999


Q ss_pred             EEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcC---CC--ceEEeecCCcccc
Q 004959          419 IYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDA---SG--VVKLADFGMAKHL  493 (721)
Q Consensus       419 LVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~---~g--~VKL~DFGlA~~l  493 (721)
                      ||||||. |+|.+++......+.+..++.++.||+.||.|||++||+||||||+||||+.   ++  .+||+|||+++.+
T Consensus        95 lv~E~~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~  173 (432)
T 3p23_A           95 IAIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKL  173 (432)
T ss_dssp             EEEECCS-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC
T ss_pred             EEEECCC-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeec
Confidence            9999996 6999999876666777778899999999999999999999999999999953   23  5789999999876


Q ss_pred             CCCc----ccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhh-CCCCCCchhhHHHHHHHhhcCCC-
Q 004959          494 TGQK----ADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFKVMRDTPA-  567 (721)
Q Consensus       494 ~~~~----~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLt-G~~PF~~~~~~~~~~ki~~~~~~-  567 (721)
                      ....    .....+||+.|+|||++.+.    ....++.++|||||||++|||++ |..||.................. 
T Consensus       174 ~~~~~~~~~~~~~~gt~~y~APE~l~~~----~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~  249 (432)
T 3p23_A          174 AVGRHSFSRRSGVPGTEGWIAPEMLSED----CKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDC  249 (432)
T ss_dssp             ------------CCSCTTSCCGGGTSCC-------CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHHHTTCCCCTT
T ss_pred             cCCCcceeeccccCCCcCccChhhhhcc----cccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHHHhccCCccc
Confidence            5432    22346799999999998421    13456678999999999999999 99999765433322222111111 


Q ss_pred             --CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccccc
Q 004959          568 --IPDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKN  605 (721)
Q Consensus       568 --~p~~lS~el~dLI~~cL~~DP~kRPSa~eLL~Hp~f~~  605 (721)
                        .+...+..+.+||.+||+.||++|||+.|+|+||||..
T Consensus       250 ~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~hp~f~~  289 (432)
T 3p23_A          250 LHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWS  289 (432)
T ss_dssp             SCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTSTTTCC
T ss_pred             cCccccccHHHHHHHHHHHhCCHhhCCCHHHHHhCccccC
Confidence              12234567899999999999999999999999999975

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=1.3e-42  Score=365.16  Aligned_cols=255  Identities=22%  Similarity=0.378  Sum_probs=207.0

Q ss_pred             CCCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeEE
Q 004959          339 NSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFY  418 (721)
Q Consensus       339 ~~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~y  418 (721)
                      .++|++++.||+|+||.||+|.+..   .||+|++.......   ...+.+.+|+.++++++||||+++++++...+.+|
T Consensus        32 ~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~  105 (319)
T 2y4i_B           32 FEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNE---DQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLA  105 (319)
T ss_dssp             CSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCC---CCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEE
T ss_pred             HHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCH---HHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceE
Confidence            4689999999999999999998864   49999986432221   12345778999999999999999999999999999


Q ss_pred             EEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCC--
Q 004959          419 IYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQ--  496 (721)
Q Consensus       419 LVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~--  496 (721)
                      +||||+.|++|.+++......+++..++.++.||+.||.|||++||+||||||+||||+ ++.+||+|||++......  
T Consensus       106 iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~~  184 (319)
T 2y4i_B          106 IITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQA  184 (319)
T ss_dssp             EECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC---CCEECCCSCCC-------
T ss_pred             EEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CCCEEEeecCCccccccccc
Confidence            99999999999999977656799999999999999999999999999999999999998 789999999998754321  


Q ss_pred             ----cccccCCCCCccCChhhHHHHhhc--CCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhcCCC--C
Q 004959          497 ----KADLSMKGSPYWMAPELMMAVMQK--GKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPA--I  568 (721)
Q Consensus       497 ----~~~~s~~GT~~Y~APEvl~~~~~~--~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~~~~--~  568 (721)
                          .......||+.|+|||++.+....  .....++.++|||||||++|+|++|..||...........+......  .
T Consensus       185 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~  264 (319)
T 2y4i_B          185 GRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKPNLS  264 (319)
T ss_dssp             ---CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHHTTCCCCCC
T ss_pred             cccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhccCCCCCCC
Confidence                122334689999999998532110  01245788999999999999999999999887766666655544322  2


Q ss_pred             CCCCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q 004959          569 PDSLSPEGKDFLRCCFQRNPADRPPASLLLEH  600 (721)
Q Consensus       569 p~~lS~el~dLI~~cL~~DP~kRPSa~eLL~H  600 (721)
                      +..++.++.+||.+||..||++|||+.++++.
T Consensus       265 ~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~  296 (319)
T 2y4i_B          265 QIGMGKEISDILLFCWAFEQEERPTFTKLMDM  296 (319)
T ss_dssp             CSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHH
T ss_pred             cCCCCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence            23688999999999999999999999999974

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=2.1e-42  Score=381.48  Aligned_cols=256  Identities=16%  Similarity=0.191  Sum_probs=198.3

Q ss_pred             CCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCC-CCee-------------
Q 004959          340 SQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKH-PNIV-------------  405 (721)
Q Consensus       340 ~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~H-PnIV-------------  405 (721)
                      ..|+++++||+|+||+||+|++..+|+.||||++....  .......+.+.+|+.+++.+.| .|+.             
T Consensus        78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~--~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~  155 (413)
T 3dzo_A           78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTE--RPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD  155 (413)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSC--C----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCE
T ss_pred             eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCC--CccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchh
Confidence            45889999999999999999999999999999886321  2222346778999999999987 2211             


Q ss_pred             --ee------eeeEEe-----cCeEEEEEeeccCCCHHHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHhhCCeec
Q 004959          406 --QY------YGSEIV-----EDKFYIYLEYVHPGSINKYVREH------CGAITESVVRNFTRHILSGLAYLHSKKTIH  466 (721)
Q Consensus       406 --~l------~g~~~~-----~~~~yLVmEy~~gGsL~~~L~~~------~~~Lse~~i~~i~~QIl~AL~yLHs~gIIH  466 (721)
                        .+      +.++..     ...++++|+++ +++|.+++...      ...+++..+..++.||+.||+|||++||||
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiH  234 (413)
T 3dzo_A          156 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVH  234 (413)
T ss_dssp             EEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred             hcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCccc
Confidence              11      111111     12467778777 58999988521      345778899999999999999999999999


Q ss_pred             cCCCCCcEEEcCCCceEEeecCCccccCCCcccccCCCCCccCChhhHHHHh--hcC-CCCCCcchhhHHHHHHHHHHHh
Q 004959          467 RDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPYWMAPELMMAVM--QKG-KSSDSALAVDIWSLGCTIIEMY  543 (721)
Q Consensus       467 rDLKPeNILld~~g~VKL~DFGlA~~l~~~~~~~s~~GT~~Y~APEvl~~~~--~~~-k~~~~s~asDVWSLGVILyELL  543 (721)
                      |||||+||||+.++.+||+|||+++.....  ....+| +.|+|||++.+..  +.. ....++.++|||||||+||||+
T Consensus       235 rDiKp~NILl~~~~~~kL~DFG~a~~~~~~--~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~ell  311 (413)
T 3dzo_A          235 TYLRPVDIVLDQRGGVFLTGFEHLVRDGAS--AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIW  311 (413)
T ss_dssp             SCCCGGGEEECTTCCEEECCGGGCEETTEE--ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHH
T ss_pred             CCcccceEEEecCCeEEEEeccceeecCCc--cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHH
Confidence            999999999999999999999999865433  345678 9999999996432  111 3345778999999999999999


Q ss_pred             hCCCCCCchhhHHHHHHHhhcCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccccc
Q 004959          544 TGKPPWSEYEGAAAMFKVMRDTPAIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKN  605 (721)
Q Consensus       544 tG~~PF~~~~~~~~~~ki~~~~~~~p~~lS~el~dLI~~cL~~DP~kRPSa~eLL~Hp~f~~  605 (721)
                      +|+.||......+....+...    ...+++++.+||.+||+.||++||++.++++||||+.
T Consensus       312 tg~~Pf~~~~~~~~~~~~~~~----~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~~~~~~  369 (413)
T 3dzo_A          312 CADLPNTDDAALGGSEWIFRS----CKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQ  369 (413)
T ss_dssp             HSSCCCCTTGGGSCSGGGGSS----CCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHH
T ss_pred             HCCCCCCCcchhhhHHHHHhh----cccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHHH
Confidence            999999876554433333332    2367899999999999999999999999999999974

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=3.7e-41  Score=357.37  Aligned_cols=249  Identities=24%  Similarity=0.378  Sum_probs=200.2

Q ss_pred             CCCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHh--CCCCCeeeeeeeEEecC-
Q 004959          339 NSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSH--LKHPNIVQYYGSEIVED-  415 (721)
Q Consensus       339 ~~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~--L~HPnIV~l~g~~~~~~-  415 (721)
                      .++|++++.||+|+||.||+|.+  +|+.||||++...        ..+.+.+|++++..  ++||||+++++++...+ 
T Consensus        41 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~--------~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~  110 (342)
T 1b6c_B           41 ARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSR--------EERSWFREAEIYQTVMLRHENILGFIAADNKDNG  110 (342)
T ss_dssp             HHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGG--------GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCS
T ss_pred             cccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCch--------hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCC
Confidence            35899999999999999999987  4899999998521        13467788888887  78999999999998876 


Q ss_pred             ---eEEEEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHh--------hCCeeccCCCCCcEEEcCCCceEE
Q 004959          416 ---KFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLH--------SKKTIHRDIKGANLLVDASGVVKL  484 (721)
Q Consensus       416 ---~~yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLH--------s~gIIHrDLKPeNILld~~g~VKL  484 (721)
                         .+|+||||+.+|+|.+++..  ..+++..++.++.||+.||.|||        ++||+||||||+||||+.++.+||
T Consensus       111 ~~~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL  188 (342)
T 1b6c_B          111 TWTQLWLVSDYHEHGSLFDYLNR--YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCI  188 (342)
T ss_dssp             SCCCEEEEECCCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEE
T ss_pred             ccceeEEEEeecCCCcHHHHHhc--cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEE
Confidence               89999999999999999975  47999999999999999999999        899999999999999999999999


Q ss_pred             eecCCccccCCCcc-----cccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhC----------CCCC
Q 004959          485 ADFGMAKHLTGQKA-----DLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTG----------KPPW  549 (721)
Q Consensus       485 ~DFGlA~~l~~~~~-----~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG----------~~PF  549 (721)
                      +|||++........     .....||+.|+|||++.+.... ....++.++|||||||+||||++|          ..||
T Consensus       189 ~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~  267 (342)
T 1b6c_B          189 ADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINM-KHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPY  267 (342)
T ss_dssp             CCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCT-TCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTT
T ss_pred             EECCCceeccccccccccccccCCcCcccCCHhhhcccccc-cccccCCcccHHHHHHHHHHHHhccCcCCcccccccCc
Confidence            99999987654432     2345799999999998532100 001234689999999999999999          7898


Q ss_pred             Cchh----hHHHHHHHh-hc--CCCCCC-----CCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q 004959          550 SEYE----GAAAMFKVM-RD--TPAIPD-----SLSPEGKDFLRCCFQRNPADRPPASLLLEH  600 (721)
Q Consensus       550 ~~~~----~~~~~~ki~-~~--~~~~p~-----~lS~el~dLI~~cL~~DP~kRPSa~eLL~H  600 (721)
                      ....    ..+.+.... ..  .+.++.     .+++.+.+||.+||+.||++|||+.|+++|
T Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~  330 (342)
T 1b6c_B          268 YDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT  330 (342)
T ss_dssp             TTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred             cccCcCcccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHH
Confidence            6532    122233322 21  122222     233578999999999999999999999987

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=6.2e-43  Score=372.57  Aligned_cols=244  Identities=18%  Similarity=0.261  Sum_probs=192.4

Q ss_pred             CCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCC---cccHHHHHHHHHHHHHHHhCC---------CCCeeee
Q 004959          340 SQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDD---PKSAESIKQLEQEIKVLSHLK---------HPNIVQY  407 (721)
Q Consensus       340 ~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~---~~~~~~~k~~~~Ei~iL~~L~---------HPnIV~l  407 (721)
                      ++|++++.||+|+||+||+|++  +|+.||||++......   .......+.+.+|+.+|+.++         |||||++
T Consensus        20 ~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l   97 (336)
T 2vuw_A           20 EKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL   97 (336)
T ss_dssp             HHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred             ccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence            5799999999999999999998  6899999999754321   111223467888999988886         7777777


Q ss_pred             eeeEE-----------------e-------------cCeEEEEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHH
Q 004959          408 YGSEI-----------------V-------------EDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLA  457 (721)
Q Consensus       408 ~g~~~-----------------~-------------~~~~yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~  457 (721)
                      ++++.                 +             .+.+|||||||.+|++.+.+.+  +.+++..++.|+.||+.||.
T Consensus        98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~--~~~~~~~~~~i~~qi~~aL~  175 (336)
T 2vuw_A           98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT--KLSSLATAKSILHQLTASLA  175 (336)
T ss_dssp             EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT--TCCCHHHHHHHHHHHHHHHH
T ss_pred             cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh--cCCCHHHHHHHHHHHHHHHH
Confidence            66543                 2             6789999999999976666643  57899999999999999999


Q ss_pred             HHh-hCCeeccCCCCCcEEEcCCC--------------------ceEEeecCCccccCCCcccccCCCCCccCChhhHHH
Q 004959          458 YLH-SKKTIHRDIKGANLLVDASG--------------------VVKLADFGMAKHLTGQKADLSMKGSPYWMAPELMMA  516 (721)
Q Consensus       458 yLH-s~gIIHrDLKPeNILld~~g--------------------~VKL~DFGlA~~l~~~~~~~s~~GT~~Y~APEvl~~  516 (721)
                      ||| ++||+||||||+||||+.++                    .+||+|||+|+.+...    ..+||+.|||||++.+
T Consensus       176 ~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~----~~~gt~~y~aPE~~~g  251 (336)
T 2vuw_A          176 VAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG----IVVFCDVSMDEDLFTG  251 (336)
T ss_dssp             HHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT----EEECCCCTTCSGGGCC
T ss_pred             HHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC----cEEEeecccChhhhcC
Confidence            999 99999999999999999887                    8999999999876532    3479999999999942


Q ss_pred             HhhcCCCCCCcchhhHHHHHHH-HHHHhhCCCCCCchhhHHHH-HHHhhc---CCC----CCCCCCHHHHHHHHHhcccC
Q 004959          517 VMQKGKSSDSALAVDIWSLGCT-IIEMYTGKPPWSEYEGAAAM-FKVMRD---TPA----IPDSLSPEGKDFLRCCFQRN  587 (721)
Q Consensus       517 ~~~~~k~~~~s~asDVWSLGVI-LyELLtG~~PF~~~~~~~~~-~ki~~~---~~~----~p~~lS~el~dLI~~cL~~D  587 (721)
                             .. +.++||||||++ .++++.|..||.+....... ..+...   ...    .+..+++++++||++||++|
T Consensus       252 -------~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d  323 (336)
T 2vuw_A          252 -------DG-DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS  323 (336)
T ss_dssp             -------CS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGGGSS
T ss_pred             -------CC-ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCcccchhhhhhcCHHHHHHHHHHhccC
Confidence                   22 678999998777 77899999999764322222 222211   111    12247889999999999987


Q ss_pred             CCCCCCHHHHH-hccccc
Q 004959          588 PADRPPASLLL-EHRFLK  604 (721)
Q Consensus       588 P~kRPSa~eLL-~Hp~f~  604 (721)
                           |++|+| +||||+
T Consensus       324 -----sa~e~l~~Hp~f~  336 (336)
T 2vuw_A          324 -----SATDLLCQHSLFK  336 (336)
T ss_dssp             -----SHHHHHHHCGGGC
T ss_pred             -----CHHHHHhcCCCcC
Confidence                 999999 999995

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=4.5e-41  Score=392.66  Aligned_cols=250  Identities=24%  Similarity=0.411  Sum_probs=212.3

Q ss_pred             CCCeeEeeEEeecCCeEEEEEEECCC---CcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecC
Q 004959          339 NSQWQKGKLIGRGTFGSVYVASNRET---GALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVED  415 (721)
Q Consensus       339 ~~~y~~~k~LG~G~fG~VY~a~~~~t---g~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~  415 (721)
                      ..+|++++.||+|+||.||+|.+..+   +..||||.+..    .......+.+.+|+.+|++++|||||++++++ .++
T Consensus       389 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~----~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~-~~~  463 (656)
T 2j0j_A          389 RERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKN----CTSDSVREKFLQEALTMRQFDHPHIVKLIGVI-TEN  463 (656)
T ss_dssp             GGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSS----TTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-CSS
T ss_pred             cccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecc----cCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEE-ecC
Confidence            35799999999999999999998653   56799998752    23345567899999999999999999999987 456


Q ss_pred             eEEEEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCC
Q 004959          416 KFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTG  495 (721)
Q Consensus       416 ~~yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~  495 (721)
                      ..|+||||+.+|+|.+++......+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.+..
T Consensus       464 ~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~vkL~DFG~a~~~~~  543 (656)
T 2j0j_A          464 PVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED  543 (656)
T ss_dssp             SCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCCCCSCCC
T ss_pred             ceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCCEEEEecCCCeecCC
Confidence            78999999999999999987666799999999999999999999999999999999999999999999999999987654


Q ss_pred             Cccc--ccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhh-CCCCCCchhhHHHHHHHhhc-CCCCCCC
Q 004959          496 QKAD--LSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFKVMRD-TPAIPDS  571 (721)
Q Consensus       496 ~~~~--~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLt-G~~PF~~~~~~~~~~ki~~~-~~~~p~~  571 (721)
                      ....  ....||+.|+|||++.+       ..++.++|||||||++|||++ |..||.+....+.+..+... ...++..
T Consensus       544 ~~~~~~~~~~~t~~y~aPE~~~~-------~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~  616 (656)
T 2j0j_A          544 STYYKASKGKLPIKWMAPESINF-------RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPN  616 (656)
T ss_dssp             ----------CCGGGCCHHHHHH-------CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTCCCCCCTT
T ss_pred             CcceeccCCCCCcceeCHHHhcC-------CCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCcc
Confidence            3322  23457889999999954       356789999999999999997 99999987776666666554 3457788


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q 004959          572 LSPEGKDFLRCCFQRNPADRPPASLLLEH  600 (721)
Q Consensus       572 lS~el~dLI~~cL~~DP~kRPSa~eLL~H  600 (721)
                      +++++.+||.+||+.||++||++.+|++.
T Consensus       617 ~~~~l~~li~~~l~~dP~~RPs~~el~~~  645 (656)
T 2j0j_A          617 CPPTLYSLMTKCWAYDPSRRPRFTELKAQ  645 (656)
T ss_dssp             CCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ccHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            99999999999999999999999999864

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=1.7e-40  Score=348.61  Aligned_cols=224  Identities=14%  Similarity=0.099  Sum_probs=188.6

Q ss_pred             CCCCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeE
Q 004959          338 MNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKF  417 (721)
Q Consensus       338 l~~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~  417 (721)
                      +.++|++++.||+|+||.||+|++..+|+.||||++...  .....+..+.+.+|+.++.+++||||+++++++.+.+..
T Consensus        29 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~--~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~  106 (286)
T 3uqc_A           29 ANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQ--GVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGG  106 (286)
T ss_dssp             TTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTT--CCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEE
T ss_pred             ecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcc--cccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcE
Confidence            457899999999999999999999999999999998632  233456678899999999999999999999999999999


Q ss_pred             EEEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCCc
Q 004959          418 YIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQK  497 (721)
Q Consensus       418 yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~~  497 (721)
                      |+||||++|++|.+++..   .....++..|+.||+.||.|||++||+||||||+||||+.+|.+||+++|         
T Consensus       107 ~lv~e~~~g~~L~~~l~~---~~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~~kl~~~~---------  174 (286)
T 3uqc_A          107 LVVAEWIRGGSLQEVADT---SPSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPA---------  174 (286)
T ss_dssp             EEEEECCCEEEHHHHHTT---CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSCEEECSCC---------
T ss_pred             EEEEEecCCCCHHHHHhc---CCChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCCEEEEecc---------
Confidence            999999999999999853   24666788999999999999999999999999999999999999998554         


Q ss_pred             ccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHH---HHhhcCC----CCCC
Q 004959          498 ADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMF---KVMRDTP----AIPD  570 (721)
Q Consensus       498 ~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~---ki~~~~~----~~p~  570 (721)
                                |++|              ++.++|||||||+||||++|+.||.+......+.   +......    .+..
T Consensus       175 ----------~~~~--------------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (286)
T 3uqc_A          175 ----------TMPD--------------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDR  230 (286)
T ss_dssp             ----------CCTT--------------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSCBCCHHHHCT
T ss_pred             ----------ccCC--------------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccCCCChhhccc
Confidence                      3332              4567999999999999999999998754332111   1111111    1235


Q ss_pred             CCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q 004959          571 SLSPEGKDFLRCCFQRNPADRPPASLLLEH  600 (721)
Q Consensus       571 ~lS~el~dLI~~cL~~DP~kRPSa~eLL~H  600 (721)
                      .+++++.+||.+||+.||++| |+.|+++.
T Consensus       231 ~~~~~l~~li~~~l~~dP~~R-s~~el~~~  259 (286)
T 3uqc_A          231 DIPFQISAVAARSVQGDGGIR-SASTLLNL  259 (286)
T ss_dssp             TSCHHHHHHHHHHHCTTSSCC-CHHHHHHH
T ss_pred             CCCHHHHHHHHHHcccCCccC-CHHHHHHH
Confidence            789999999999999999999 99999874

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=4e-42  Score=400.67  Aligned_cols=258  Identities=24%  Similarity=0.386  Sum_probs=210.0

Q ss_pred             CCCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEe-----
Q 004959          339 NSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIV-----  413 (721)
Q Consensus       339 ~~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~-----  413 (721)
                      .++|++++.||+|+||.||+|.+..+|+.||||++..    .......+.+.+|+.+|++++|||||++++++..     
T Consensus        13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~----~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~   88 (676)
T 3qa8_A           13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQ----ELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLA   88 (676)
T ss_dssp             ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCS----CCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCC
T ss_pred             CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecc----cCCHHHHHHHHHHHHHHHhCCCCCCCceeeeeccccccc
Confidence            3689999999999999999999999999999998753    1345567789999999999999999999998765     


Q ss_pred             -cCeEEEEEeeccCCCHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCc---eEEeec
Q 004959          414 -EDKFYIYLEYVHPGSINKYVREHC--GAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGV---VKLADF  487 (721)
Q Consensus       414 -~~~~yLVmEy~~gGsL~~~L~~~~--~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~---VKL~DF  487 (721)
                       .+..|+|||||.||+|.+++....  ..+++..++.++.||+.||.|||++||+||||||+||||+.++.   +||+||
T Consensus        89 ~~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DF  168 (676)
T 3qa8_A           89 PNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDL  168 (676)
T ss_dssp             TTSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSC
T ss_pred             CCCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEccc
Confidence             677899999999999999997642  26999999999999999999999999999999999999997764   899999


Q ss_pred             CCccccCCCcccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHH------
Q 004959          488 GMAKHLTGQKADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKV------  561 (721)
Q Consensus       488 GlA~~l~~~~~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki------  561 (721)
                      |++..+..........||+.|+|||++.       ...++.++|||||||++|+|++|..||........+...      
T Consensus       169 G~a~~~~~~~~~~~~~gt~~Y~APE~l~-------~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~  241 (676)
T 3qa8_A          169 GYAKELDQGELCTEFVGTLQYLAPELLE-------QKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSN  241 (676)
T ss_dssp             CCCCBTTSCCCCCCCCSCCTTCSSCSSC-------CSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC----
T ss_pred             ccccccccccccccccCCcccCChHHhc-------cCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccc
Confidence            9999876665556678999999999983       456788999999999999999999999764322211100      


Q ss_pred             --------hhcCC----------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhccccccCC
Q 004959          562 --------MRDTP----------AIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQ  607 (721)
Q Consensus       562 --------~~~~~----------~~p~~lS~el~dLI~~cL~~DP~kRPSa~eLL~Hp~f~~~~  607 (721)
                              .....          .+...+++++.+||.+||..||++|||+.|+++||||+...
T Consensus       242 ~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~  305 (676)
T 3qa8_A          242 EHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALD  305 (676)
T ss_dssp             --CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHH
T ss_pred             hhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHH
Confidence                    00000          11223578899999999999999999999999999998643

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=7.1e-40  Score=383.27  Aligned_cols=240  Identities=23%  Similarity=0.331  Sum_probs=200.6

Q ss_pred             CCCCeeEeeEEeecCCeEEEEEEECC-CCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCe
Q 004959          338 MNSQWQKGKLIGRGTFGSVYVASNRE-TGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDK  416 (721)
Q Consensus       338 l~~~y~~~k~LG~G~fG~VY~a~~~~-tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~  416 (721)
                      +.++|++++.||+|+||.||+|.+.. +|+.||||++..    .......+.+.+|+.+|.+++|||||++++++...+.
T Consensus        78 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~----~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~  153 (681)
T 2pzi_A           78 VAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVH----SGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDR  153 (681)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCS----SCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECT
T ss_pred             eCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCc----cCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCC
Confidence            44789999999999999999999976 799999998752    2334556788999999999999999999999988765


Q ss_pred             -----EEEEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCcc
Q 004959          417 -----FYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAK  491 (721)
Q Consensus       417 -----~yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~  491 (721)
                           .||||||++|++|.+++..   .+++..++.|+.||+.||.|||++|||||||||+||||+.+ .+||+|||+++
T Consensus       154 ~~~~~~~lv~E~~~g~~L~~~~~~---~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~-~~kl~DFG~a~  229 (681)
T 2pzi_A          154 HGDPVGYIVMEYVGGQSLKRSKGQ---KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-QLKLIDLGAVS  229 (681)
T ss_dssp             TSCEEEEEEEECCCCEECC----C---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS-CEEECCCTTCE
T ss_pred             CCCceeEEEEEeCCCCcHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC-cEEEEecccch
Confidence                 7999999999999988753   79999999999999999999999999999999999999875 99999999998


Q ss_pred             ccCCCcccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhcCCC--CC
Q 004959          492 HLTGQKADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPA--IP  569 (721)
Q Consensus       492 ~l~~~~~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~~~~--~p  569 (721)
                      .+...   ...+||+.|+|||++.+.        ++.++|||||||+||+|++|..||.+....        ..+.  ..
T Consensus       230 ~~~~~---~~~~gt~~y~aPE~~~~~--------~~~~sDi~slG~~l~~l~~g~~~~~~~~~~--------~~~~~~~~  290 (681)
T 2pzi_A          230 RINSF---GYLYGTPGFQAPEIVRTG--------PTVATDIYTVGRTLAALTLDLPTRNGRYVD--------GLPEDDPV  290 (681)
T ss_dssp             ETTCC---SCCCCCTTTSCTTHHHHC--------SCHHHHHHHHHHHHHHHHSCCCEETTEECS--------SCCTTCHH
T ss_pred             hcccC---CccCCCccccCHHHHcCC--------CCCceehhhhHHHHHHHHhCCCCCcccccc--------cccccccc
Confidence            76543   456799999999998641        267899999999999999999998753210        0000  00


Q ss_pred             CCCCHHHHHHHHHhcccCCCCCCCHHHHHhccccc
Q 004959          570 DSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLK  604 (721)
Q Consensus       570 ~~lS~el~dLI~~cL~~DP~kRPSa~eLL~Hp~f~  604 (721)
                      ..+++++.+||.+||+.||++||+..+++.|+|+.
T Consensus       291 ~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~  325 (681)
T 2pzi_A          291 LKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTG  325 (681)
T ss_dssp             HHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred             cccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHH
Confidence            12467899999999999999999999999998875

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.98  E-value=4e-34  Score=328.96  Aligned_cols=232  Identities=14%  Similarity=0.061  Sum_probs=158.7

Q ss_pred             EEeecCCeEEEEEEECCCCcEEEEEEeecCCCC-----cccHHHHHHHHHHHHHHHhC-CCCCeeeeeeeEEecCeEEEE
Q 004959          347 LIGRGTFGSVYVASNRETGALCAMKEVDIFPDD-----PKSAESIKQLEQEIKVLSHL-KHPNIVQYYGSEIVEDKFYIY  420 (721)
Q Consensus       347 ~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~-----~~~~~~~k~~~~Ei~iL~~L-~HPnIV~l~g~~~~~~~~yLV  420 (721)
                      .++.|++|.+..++..-.|+.||+|++.+....     .......+++.+|+++|+++ .|+||+++++++++++..|||
T Consensus       241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV  320 (569)
T 4azs_A          241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV  320 (569)
T ss_dssp             C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred             ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence            567788888888888888999999998753221     12344567899999999999 699999999999999999999


Q ss_pred             EeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCCc-cc
Q 004959          421 LEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQK-AD  499 (721)
Q Consensus       421 mEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~~-~~  499 (721)
                      ||||+|++|.++|... +.+++.   .|+.||+.||+|||++|||||||||+||||+.+|.|||+|||+|+.+.... ..
T Consensus       321 MEyv~G~~L~d~i~~~-~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~~~~  396 (569)
T 4azs_A          321 MEKLPGRLLSDMLAAG-EEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDCSWP  396 (569)
T ss_dssp             EECCCSEEHHHHHHTT-CCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSCEEECCCTTEESCC---CCS
T ss_pred             EecCCCCcHHHHHHhC-CCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCCCEEEeecccCeeCCCCCccc
Confidence            9999999999999875 677764   578999999999999999999999999999999999999999998775443 33


Q ss_pred             ccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhcCCCCCCCCCHHHHHH
Q 004959          500 LSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDSLSPEGKDF  579 (721)
Q Consensus       500 ~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~~~~~p~~lS~el~dL  579 (721)
                      .+.+||+.|||||++.+.        +..++|+|++|+++|+|.+|..+|..     .+.    ..+  +...  .+.++
T Consensus       397 ~t~vGTp~YmAPE~l~g~--------~~~~~d~~s~g~~~~~l~~~~~~~~~-----~l~----~~~--~~~~--~~~~l  455 (569)
T 4azs_A          397 TNLVQSFFVFVNELFAEN--------KSWNGFWRSAPVHPFNLPQPWSNWLY-----AVW----QEP--VERW--NFVLL  455 (569)
T ss_dssp             HHHHHHHHHHHHHHC-------------------------CCCCTTHHHHHH-----HHH----TSC--GGGC--SHHHH
T ss_pred             cCceechhhccHHHhCCC--------CCCcccccccccchhhhccccchhHH-----Hhh----cCC--CCCC--cHHHH
Confidence            457899999999999642        34468999999999988776544321     111    100  0111  24556


Q ss_pred             HHHhcccCCCCCCCHHHHHhcccc
Q 004959          580 LRCCFQRNPADRPPASLLLEHRFL  603 (721)
Q Consensus       580 I~~cL~~DP~kRPSa~eLL~Hp~f  603 (721)
                      +..++..++..|+.......|+|.
T Consensus       456 ~~~l~~~~~~~~~~~~~~~~~~~~  479 (569)
T 4azs_A          456 LALFEKKAKLPSAEQQRGATEQWI  479 (569)
T ss_dssp             HHHHHTGGGSCCGGGSSCCHHHHH
T ss_pred             HHHHhCCCCCCCCChhhhccchhH
Confidence            666777777777766655555554

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.95  E-value=1e-28  Score=282.23  Aligned_cols=190  Identities=16%  Similarity=0.162  Sum_probs=146.6

Q ss_pred             eEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCc---ccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeEEE
Q 004959          343 QKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDP---KSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYI  419 (721)
Q Consensus       343 ~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~---~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~yL  419 (721)
                      ...++||+|+||+||+|.  ..++.+++|++.......   ......+++.+|+++|++++||||+.+..++...+..||
T Consensus       339 ~~~~~LG~G~fg~Vy~~~--~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~l  416 (540)
T 3en9_A          339 IPEHLIGKGAEADIKRDS--YLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRI  416 (540)
T ss_dssp             ---------CCEEEEEEE--CSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEE
T ss_pred             CCCCEEeeCCCEEEEEEE--ECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEE
Confidence            346799999999999994  457899999865322111   112235678999999999999999966666667788899


Q ss_pred             EEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCCccc
Q 004959          420 YLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKAD  499 (721)
Q Consensus       420 VmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~~~~  499 (721)
                      |||||+|++|.+++..         +..++.||+.||.|||++||+||||||+||||+.  .+||+|||+++.+......
T Consensus       417 VmE~~~ggsL~~~l~~---------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~~  485 (540)
T 3en9_A          417 MMSYINGKLAKDVIED---------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDEDK  485 (540)
T ss_dssp             EEECCCSEEHHHHSTT---------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS--SEEECCCTTCEECCCHHHH
T ss_pred             EEECCCCCCHHHHHHH---------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC--eEEEEECccCEECCCcccc
Confidence            9999999999999864         6689999999999999999999999999999988  9999999999987653321


Q ss_pred             --------ccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCC
Q 004959          500 --------LSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWS  550 (721)
Q Consensus       500 --------~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~  550 (721)
                              ...+||+.|||||++....     ..|+..+|+|+..+-.++.+.++.+|.
T Consensus       486 ~~~~~~~~~~~~GT~~y~APEv~~~~~-----~~Y~~~~d~ws~vl~~l~~v~~r~rY~  539 (540)
T 3en9_A          486 AVDLIVFKKAVLSTHHEKFDEIWERFL-----EGYKSVYDRWEIILELMKDVERRARYV  539 (540)
T ss_dssp             HHHHHHHHHHHHHHCGGGHHHHHHHHH-----HHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred             ccchhhhhhhhcCCCCcCCHHHHHHHH-----HHHHHHHhHHHHHHHHHHHHHhccccC
Confidence                    2567999999999997632     224556799999999888888776664

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.91  E-value=1.1e-24  Score=229.02  Aligned_cols=149  Identities=18%  Similarity=0.194  Sum_probs=119.6

Q ss_pred             eeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCC----cccH---------HHHHHHHHHHHHHHhCCCCCeeeee
Q 004959          342 WQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDD----PKSA---------ESIKQLEQEIKVLSHLKHPNIVQYY  408 (721)
Q Consensus       342 y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~----~~~~---------~~~k~~~~Ei~iL~~L~HPnIV~l~  408 (721)
                      |++++.||+|+||.||+|.+ .+|+.||||++......    ....         .....+.+|+.+|++++  | ++++
T Consensus        92 ~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v~  167 (282)
T 1zar_A           92 DAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAVP  167 (282)
T ss_dssp             SEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSSC
T ss_pred             EEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCcC
Confidence            44559999999999999999 88999999998532111    0001         24567899999999999  5 6666


Q ss_pred             eeEEecCeEEEEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecC
Q 004959          409 GSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFG  488 (721)
Q Consensus       409 g~~~~~~~~yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFG  488 (721)
                      +++. .+..|+|||||+|++|.+ +.       ......++.||+.||.|||++||+||||||+||||+ +|.+||+|||
T Consensus       168 ~~~~-~~~~~lvmE~~~g~~L~~-l~-------~~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~~vkl~DFG  237 (282)
T 1zar_A          168 KVYA-WEGNAVLMELIDAKELYR-VR-------VENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EEGIWIIDFP  237 (282)
T ss_dssp             CEEE-EETTEEEEECCCCEEGGG-CC-------CSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TTEEEECCCT
T ss_pred             eEEe-ccceEEEEEecCCCcHHH-cc-------hhhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CCcEEEEECC
Confidence            6554 356799999999999987 41       123567999999999999999999999999999999 9999999999


Q ss_pred             CccccCCCcccccCCCCCccCChhhHHH
Q 004959          489 MAKHLTGQKADLSMKGSPYWMAPELMMA  516 (721)
Q Consensus       489 lA~~l~~~~~~~s~~GT~~Y~APEvl~~  516 (721)
                      +|+.            +..|+|||++..
T Consensus       238 ~a~~------------~~~~~a~e~l~r  253 (282)
T 1zar_A          238 QSVE------------VGEEGWREILER  253 (282)
T ss_dssp             TCEE------------TTSTTHHHHHHH
T ss_pred             CCeE------------CCCCCHHHHHHH
Confidence            9963            455899999853

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.85  E-value=9.3e-22  Score=203.39  Aligned_cols=143  Identities=21%  Similarity=0.244  Sum_probs=110.4

Q ss_pred             CeeEeeEEeecCCeEEEEEEECCCCcE--EEEEEeecCCCCcc-------------------cHHHHHHHHHHHHHHHhC
Q 004959          341 QWQKGKLIGRGTFGSVYVASNRETGAL--CAMKEVDIFPDDPK-------------------SAESIKQLEQEIKVLSHL  399 (721)
Q Consensus       341 ~y~~~k~LG~G~fG~VY~a~~~~tg~~--vAIK~i~~~~~~~~-------------------~~~~~k~~~~Ei~iL~~L  399 (721)
                      -|++++.||+|+||.||+|.+..+|+.  ||||++........                   .......+.+|+.+|.++
T Consensus        48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l  127 (258)
T 1zth_A           48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA  127 (258)
T ss_dssp             EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred             chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence            478999999999999999998778999  99998753211100                   112234688999999999


Q ss_pred             CCCCe--eeeeeeEEecCeEEEEEeeccC-C----CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHh-hCCeeccCCCC
Q 004959          400 KHPNI--VQYYGSEIVEDKFYIYLEYVHP-G----SINKYVREHCGAITESVVRNFTRHILSGLAYLH-SKKTIHRDIKG  471 (721)
Q Consensus       400 ~HPnI--V~l~g~~~~~~~~yLVmEy~~g-G----sL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLH-s~gIIHrDLKP  471 (721)
                      .|++|  ..++++    +..+|||||+.+ |    .|.+++..    +++..+..++.||+.||.||| ++|||||||||
T Consensus       128 ~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~----~~~~~~~~i~~qi~~~l~~lH~~~givHrDlkp  199 (258)
T 1zth_A          128 KEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE----LKELDVEGIFNDVVENVKRLYQEAELVHADLSE  199 (258)
T ss_dssp             HHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG----GGGSCHHHHHHHHHHHHHHHHHTSCEECSSCST
T ss_pred             HhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc----cChHHHHHHHHHHHHHHHHHHHHCCEEeCCCCH
Confidence            88764  333332    467899999942 3    66665432    335578899999999999999 99999999999


Q ss_pred             CcEEEcCCCceEEeecCCcccc
Q 004959          472 ANLLVDASGVVKLADFGMAKHL  493 (721)
Q Consensus       472 eNILld~~g~VKL~DFGlA~~l  493 (721)
                      +||||+.  .++|+|||+|...
T Consensus       200 ~NILl~~--~~~liDFG~a~~~  219 (258)
T 1zth_A          200 YNIMYID--KVYFIDMGQAVTL  219 (258)
T ss_dssp             TSEEESS--SEEECCCTTCEET
T ss_pred             HHEEEcC--cEEEEECcccccC
Confidence            9999988  9999999999754

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.72  E-value=1.5e-18  Score=190.62  Aligned_cols=142  Identities=12%  Similarity=0.117  Sum_probs=101.2

Q ss_pred             CeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCC-------------cccHHHH----HHHHHHHHHHHhCCCCC
Q 004959          341 QWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDD-------------PKSAESI----KQLEQEIKVLSHLKHPN  403 (721)
Q Consensus       341 ~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~-------------~~~~~~~----k~~~~Ei~iL~~L~HPn  403 (721)
                      -|++++.||+|+||.||+|.+. +|+.||||+++.....             .......    ....+|...|.++.+.+
T Consensus        96 iY~I~~~IG~Gk~a~VY~a~d~-~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~g  174 (397)
T 4gyi_A           96 VYSVGSRIGVGKESDIMIVADE-KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEG  174 (397)
T ss_dssp             CSEEEEEEEECSSEEEEEEECT-TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             EEEecCEeeeCCceEEEEEECC-CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcC
Confidence            4899999999999999999975 6999999987531100             0001111    11245677777775444


Q ss_pred             eeeeeeeEEecCeEEEEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCc--
Q 004959          404 IVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGV--  481 (721)
Q Consensus       404 IV~l~g~~~~~~~~yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~--  481 (721)
                      |. +...+.. ...+|||||++|+.|.++.       ....+..++.||+.+|.|||++|||||||||.||||+++|.  
T Consensus       175 v~-vp~p~~~-~~~~LVME~i~G~~L~~l~-------~~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd~~  245 (397)
T 4gyi_A          175 FP-VPEPIAQ-SRHTIVMSLVDALPMRQVS-------SVPDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKDAE  245 (397)
T ss_dssp             CS-CCCEEEE-ETTEEEEECCSCEEGGGCC-------CCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEECSS
T ss_pred             CC-CCeeeec-cCceEEEEecCCccHhhhc-------ccHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCCcc
Confidence            32 1111111 2347999999998886442       22345678899999999999999999999999999988763  


Q ss_pred             --------eEEeecCCccc
Q 004959          482 --------VKLADFGMAKH  492 (721)
Q Consensus       482 --------VKL~DFGlA~~  492 (721)
                              +.|+||+-+..
T Consensus       246 d~~~~~~~~~iID~~Q~V~  264 (397)
T 4gyi_A          246 DPSSITLTPIIIXFPQMVS  264 (397)
T ss_dssp             CTTSEEEEEEECCCTTCEE
T ss_pred             cccccccceEEEEeCCccc
Confidence                    89999998764

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.36  E-value=2.6e-12  Score=131.31  Aligned_cols=139  Identities=14%  Similarity=0.082  Sum_probs=109.9

Q ss_pred             CCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCC-CCCeeeeeeeEEecCeEE
Q 004959          340 SQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLK-HPNIVQYYGSEIVEDKFY  418 (721)
Q Consensus       340 ~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~-HPnIV~l~g~~~~~~~~y  418 (721)
                      ..|++...+|.|+++.||++...  |+.+++|.........     ...+.+|+.+|+.+. +..+.++++++.+.+..|
T Consensus        14 ~~~~~~~~~~g~s~~~v~~~~~~--~~~~vlK~~~~~~~~~-----~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~   86 (263)
T 3tm0_A           14 EKYRCVKDTEGMSPAKVYKLVGE--NENLYLKMTDSRYKGT-----TYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSN   86 (263)
T ss_dssp             TTSEEEECCSCCSSSEEEEEECS--SCEEEEEEECGGGTTS-----TTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEE
T ss_pred             ccceeEeeccCCCCCeEEEEECC--CCcEEEEeCCcccCCC-----HHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceE
Confidence            36888999999999999999743  6899999875311011     125788999999885 667888999888888999


Q ss_pred             EEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhh-------------------------------------
Q 004959          419 IYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHS-------------------------------------  461 (721)
Q Consensus       419 LVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs-------------------------------------  461 (721)
                      +||||++|.+|.+.+.      +......++.+++.+|..||+                                     
T Consensus        87 lv~e~i~G~~l~~~~~------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (263)
T 3tm0_A           87 LLMSEADGVLCSEEYE------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEE  160 (263)
T ss_dssp             EEEECCSSEEHHHHCC------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGST
T ss_pred             EEEEecCCeehhhccC------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccc
Confidence            9999999999876531      122345788899999999998                                     


Q ss_pred             ----------------------CCeeccCCCCCcEEEcCCCceEEeecCCcc
Q 004959          462 ----------------------KKTIHRDIKGANLLVDASGVVKLADFGMAK  491 (721)
Q Consensus       462 ----------------------~gIIHrDLKPeNILld~~g~VKL~DFGlA~  491 (721)
                                            ..++|+|+++.|||++.++.+.|+||+.+.
T Consensus       161 ~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T 3tm0_A          161 DTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             TCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred             cccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence                                  458999999999999876566799999774

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.24  E-value=2e-11  Score=123.19  Aligned_cols=133  Identities=14%  Similarity=0.095  Sum_probs=98.2

Q ss_pred             CeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCC--eeeeeeeEEecCeEE
Q 004959          341 QWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPN--IVQYYGSEIVEDKFY  418 (721)
Q Consensus       341 ~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPn--IV~l~g~~~~~~~~y  418 (721)
                      .|.+..+.+.|..+.||++.. .+|..+++|+....        ....+.+|+.+|+.+.+.+  +.+++++....+..|
T Consensus        21 ~~~~~~~~~gg~~~~v~~~~~-~~g~~~vlK~~~~~--------~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~   91 (264)
T 1nd4_A           21 GYDWAQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSG--------ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDW   91 (264)
T ss_dssp             TCEEEECSCTTSSCEEEEEEC-TTSCCEEEEEECSC--------TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEE
T ss_pred             CCceEecccCCCCceEEEEec-CCCCeEEEEeCCcc--------cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCE
Confidence            456555545666799999964 56788999986421        1135778999998886444  456888887778899


Q ss_pred             EEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCC-----------------------------------
Q 004959          419 IYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKK-----------------------------------  463 (721)
Q Consensus       419 LVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~g-----------------------------------  463 (721)
                      +||||++|.+|.  .    ....   ...++.+++..|..||+..                                   
T Consensus        92 ~v~e~i~G~~l~--~----~~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (264)
T 1nd4_A           92 LLLGEVPGQDLL--S----SHLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEH  162 (264)
T ss_dssp             EEEECCSSEETT--T----SCCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGG
T ss_pred             EEEEecCCcccC--c----CcCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhc
Confidence            999999998884  1    1111   2356677777788887643                                   


Q ss_pred             -----------------------eeccCCCCCcEEEcCCCceEEeecCCcc
Q 004959          464 -----------------------TIHRDIKGANLLVDASGVVKLADFGMAK  491 (721)
Q Consensus       464 -----------------------IIHrDLKPeNILld~~g~VKL~DFGlA~  491 (721)
                                             ++|+|++|.|||++.++.+.|+|||.+.
T Consensus       163 ~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~  213 (264)
T 1nd4_A          163 QGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG  213 (264)
T ss_dssp             TTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred             cCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence                                   9999999999999877667799999875

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.14  E-value=1.1e-10  Score=125.23  Aligned_cols=142  Identities=14%  Similarity=0.190  Sum_probs=104.9

Q ss_pred             EeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCC--CCCeeeeeeeEEec---CeEE
Q 004959          344 KGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLK--HPNIVQYYGSEIVE---DKFY  418 (721)
Q Consensus       344 ~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~--HPnIV~l~g~~~~~---~~~y  418 (721)
                      ..+.|+.|.++.||++...  +..+++|+....  ..........+.+|+.+|+.|.  +..+.+++.++.+.   +..|
T Consensus        42 ~~~~l~~G~sn~~y~v~~~--~~~~vlr~~~~p--~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~  117 (359)
T 3dxp_A           42 SVEQFKGGQSNPTFKLVTP--GQTYVMRAKPGP--KSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAF  117 (359)
T ss_dssp             EEEECCC-CCSCEEEEECS--SCEEEEECCCC------------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCE
T ss_pred             eEEEcCCcccceEEEEEEC--CceEEEEeCCCC--CCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeE
Confidence            4567899999999998754  467888865300  0111112346788999999987  44577888877665   4589


Q ss_pred             EEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhh-------------------------------------
Q 004959          419 IYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHS-------------------------------------  461 (721)
Q Consensus       419 LVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs-------------------------------------  461 (721)
                      +||||++|..+.+..   ...+++.+...++.+++..|..||.                                     
T Consensus       118 ~vme~v~G~~l~~~~---~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  194 (359)
T 3dxp_A          118 YIMEFVSGRVLWDQS---LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESI  194 (359)
T ss_dssp             EEEECCCCBCCCCTT---CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCC
T ss_pred             EEEEecCCeecCCCc---cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCC
Confidence            999999998774321   2347788889999999999999997                                     


Q ss_pred             ---------------------CCeeccCCCCCcEEEcCCCc--eEEeecCCccc
Q 004959          462 ---------------------KKTIHRDIKGANLLVDASGV--VKLADFGMAKH  492 (721)
Q Consensus       462 ---------------------~gIIHrDLKPeNILld~~g~--VKL~DFGlA~~  492 (721)
                                           .++||+|+++.|||++.++.  +.|+||+.+..
T Consensus       195 ~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          195 PAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             HHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred             hHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence                                 36899999999999987753  69999998864

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=99.13  E-value=2.4e-10  Score=119.92  Aligned_cols=190  Identities=16%  Similarity=0.188  Sum_probs=123.5

Q ss_pred             eEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCC-CCC--eeeeeeeEEecC---eEEE
Q 004959          346 KLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLK-HPN--IVQYYGSEIVED---KFYI  419 (721)
Q Consensus       346 k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~-HPn--IV~l~g~~~~~~---~~yL  419 (721)
                      +.|+.|....||++.     ..+++|+..       .......+.+|..+|+.+. +..  +..++......+   ..|+
T Consensus        26 ~~~~~G~~n~v~~v~-----~~~vlR~~~-------~~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~   93 (304)
T 3sg8_A           26 EISGEGNDCIAYEIN-----RDFIFKFPK-------HSRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFA   93 (304)
T ss_dssp             CEEEECSSEEEEEST-----TSEEEEEES-------SHHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCE
T ss_pred             EecCCCCcceEEEEC-----CEEEEEecC-------CcchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceE
Confidence            469999999999863     568899753       1234567899999998874 322  334444333332   3589


Q ss_pred             EEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhh--------------------------------------
Q 004959          420 YLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHS--------------------------------------  461 (721)
Q Consensus       420 VmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs--------------------------------------  461 (721)
                      |||+++|..|.....   ..++..+...++.|++..|..||+                                      
T Consensus        94 vm~~i~G~~l~~~~~---~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  170 (304)
T 3sg8_A           94 GFTKIKGVPLTPLLL---NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQM  170 (304)
T ss_dssp             EEECCCCEECCHHHH---HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHH
T ss_pred             EEcccCCeECCcccc---ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccH
Confidence            999999988875443   247788888888889888888885                                      


Q ss_pred             --------------------CCeeccCCCCCcEEEcC--CCceEEeecCCccccCCCcccccCCCCCccCChhhHHHH--
Q 004959          462 --------------------KKTIHRDIKGANLLVDA--SGVVKLADFGMAKHLTGQKADLSMKGSPYWMAPELMMAV--  517 (721)
Q Consensus       462 --------------------~gIIHrDLKPeNILld~--~g~VKL~DFGlA~~l~~~~~~~s~~GT~~Y~APEvl~~~--  517 (721)
                                          ..++|+|+++.|||++.  .+.+.|+||+.+..-..............-..++.+...  
T Consensus       171 ~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~  250 (304)
T 3sg8_A          171 KKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILN  250 (304)
T ss_dssp             HHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHH
T ss_pred             HHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHH
Confidence                                13799999999999988  456799999988643211110001000001334433221  


Q ss_pred             hhcCCC-CCC----cchhhHHHHHHHHHHHhhCCCCCC
Q 004959          518 MQKGKS-SDS----ALAVDIWSLGCTIIEMYTGKPPWS  550 (721)
Q Consensus       518 ~~~~k~-~~~----s~asDVWSLGVILyELLtG~~PF~  550 (721)
                      .|.... ...    ..-.+.|++|+++|.+.+|..+|.
T Consensus       251 ~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~~  288 (304)
T 3sg8_A          251 HYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDWY  288 (304)
T ss_dssp             HHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHHH
T ss_pred             HcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHHH
Confidence            111100 000    112589999999999999998764

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.66  E-value=2.9e-07  Score=96.99  Aligned_cols=133  Identities=17%  Similarity=0.182  Sum_probs=93.4

Q ss_pred             eeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCC---CeeeeeeeEE-ecCeEEEE
Q 004959          345 GKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHP---NIVQYYGSEI-VEDKFYIY  420 (721)
Q Consensus       345 ~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HP---nIV~l~g~~~-~~~~~yLV  420 (721)
                      .+.++.|....||+.     |..+++|+..       .......+.+|..+|+.|.+.   .|.+.+.+.. ..+..|+|
T Consensus        24 v~~l~~G~~n~v~~v-----g~~~VlR~~~-------~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v   91 (306)
T 3tdw_A           24 VESLGEGFRNYAILV-----NGDWVFRFPK-------SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVG   91 (306)
T ss_dssp             EEEEEECSSEEEEEE-----TTTEEEEEES-------SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEE
T ss_pred             eeecCCCcceeEEEE-----CCEEEEEecC-------CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEE
Confidence            456899999999998     5778899742       223456889999999999752   2445555543 34567899


Q ss_pred             EeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhC--------------------------------------
Q 004959          421 LEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSK--------------------------------------  462 (721)
Q Consensus       421 mEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~--------------------------------------  462 (721)
                      |||++|..|.....   ..++..+...++.|+...|..||+.                                      
T Consensus        92 ~e~i~G~~l~~~~~---~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~  168 (306)
T 3tdw_A           92 YRKVQGQILGEDGM---AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESL  168 (306)
T ss_dssp             EECCCSEECHHHHH---TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHH
T ss_pred             EeccCCeECchhhh---hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhh
Confidence            99999988865321   2344455555555555555555532                                      


Q ss_pred             ----------------------CeeccCCCCCcEEEcC---CCc-eEEeecCCccc
Q 004959          463 ----------------------KTIHRDIKGANLLVDA---SGV-VKLADFGMAKH  492 (721)
Q Consensus       463 ----------------------gIIHrDLKPeNILld~---~g~-VKL~DFGlA~~  492 (721)
                                            .++|+|+++.|||++.   ++. +.|+||+.+..
T Consensus       169 ~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~  224 (306)
T 3tdw_A          169 RDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI  224 (306)
T ss_dssp             HHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred             HHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence                                  4699999999999987   455 48999998864

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.57  E-value=8.1e-07  Score=90.66  Aligned_cols=131  Identities=16%  Similarity=0.129  Sum_probs=94.5

Q ss_pred             EeecCCe-EEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCC-CCCeeeeeeeEEecCeEEEEEeecc
Q 004959          348 IGRGTFG-SVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLK-HPNIVQYYGSEIVEDKFYIYLEYVH  425 (721)
Q Consensus       348 LG~G~fG-~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~-HPnIV~l~g~~~~~~~~yLVmEy~~  425 (721)
                      +..|.-| .||+......+..+++|+-..        .....+.+|..+|+.|. +--|.+++.++.+.+..|+|||+++
T Consensus        32 ~~~G~S~~~v~rl~~~~~~~~~~lk~~~~--------~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~  103 (272)
T 4gkh_A           32 DNVGQSGATIYRLYGKPNAPELFLKHGKG--------SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIP  103 (272)
T ss_dssp             EECSSSSCEEEEEECCTTCCCEEEEEEET--------HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCC
T ss_pred             ccCCCcCCeEEEEEecCCCeEEEEEECCC--------CCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeC
Confidence            4445444 799988777788899997531        23456888999998885 3235677888888899999999999


Q ss_pred             CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhC-------------------------------------------
Q 004959          426 PGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSK-------------------------------------------  462 (721)
Q Consensus       426 gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~-------------------------------------------  462 (721)
                      |.++.+.....     ......++.++...|.-||..                                           
T Consensus       104 G~~~~~~~~~~-----~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  178 (272)
T 4gkh_A          104 GKTAFQVLEEY-----PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQ  178 (272)
T ss_dssp             SEEHHHHHHHC-----GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHH
T ss_pred             CccccccccCC-----HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHH
Confidence            98887665321     112334555566666666621                                           


Q ss_pred             ---------------CeeccCCCCCcEEEcCCCceEEeecCCcc
Q 004959          463 ---------------KTIHRDIKGANLLVDASGVVKLADFGMAK  491 (721)
Q Consensus       463 ---------------gIIHrDLKPeNILld~~g~VKL~DFGlA~  491 (721)
                                     .++|+|+.+.|||++.++.+-|+||+.+.
T Consensus       179 ~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~  222 (272)
T 4gkh_A          179 VWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG  222 (272)
T ss_dssp             HHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             HHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence                           27999999999999987777899999875

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=98.31  E-value=1.1e-06  Score=95.47  Aligned_cols=82  Identities=15%  Similarity=0.154  Sum_probs=49.9

Q ss_pred             EeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCC--CcccHHHHHHHHHHHHHHHhCCC--CC-eeeeeeeEEecCeEE
Q 004959          344 KGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPD--DPKSAESIKQLEQEIKVLSHLKH--PN-IVQYYGSEIVEDKFY  418 (721)
Q Consensus       344 ~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~--~~~~~~~~k~~~~Ei~iL~~L~H--Pn-IV~l~g~~~~~~~~y  418 (721)
                      ..+.||.|.++.||++....+++.|+||.......  .........++..|..+|+.+..  +. +.+++.+  +.+..+
T Consensus        34 ~~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~  111 (397)
T 2olc_A           34 TCQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAV  111 (397)
T ss_dssp             EEEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTE
T ss_pred             EEEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccE
Confidence            35689999999999997666678999998642110  00000012456778888887742  33 3455543  455678


Q ss_pred             EEEeeccCC
Q 004959          419 IYLEYVHPG  427 (721)
Q Consensus       419 LVmEy~~gG  427 (721)
                      +||||+.|.
T Consensus       112 lvmE~l~g~  120 (397)
T 2olc_A          112 TVMEDLSHL  120 (397)
T ss_dssp             EEECCCTTS
T ss_pred             EEEEeCCCc
Confidence            999999864

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=98.25  E-value=8.1e-06  Score=85.50  Aligned_cols=136  Identities=14%  Similarity=0.139  Sum_probs=78.2

Q ss_pred             eeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCC-----CCCeeeee-e--eEEecCe
Q 004959          345 GKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLK-----HPNIVQYY-G--SEIVEDK  416 (721)
Q Consensus       345 ~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~-----HPnIV~l~-g--~~~~~~~  416 (721)
                      .+.|+.|..+.||++...  +..+++|+...      ..   ..+..|+.+++.|.     .|.++... +  +....+.
T Consensus        37 ~~~l~gG~~n~~~~v~~~--~~~~vlk~~~~------~~---~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~  105 (346)
T 2q83_A           37 IDVIQGNQMALVWKVHTD--SGAVCLKRIHR------PE---KKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSF  105 (346)
T ss_dssp             EEECC----CEEEEEEET--TEEEEEEEECS------CH---HHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTE
T ss_pred             eeeccccccCcEEEEEeC--CCCEEEEecCC------CH---HHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCE
Confidence            446677788999998753  34599998752      11   23334555555442     34444311 1  2235677


Q ss_pred             EEEEEeeccCCCHH-----------HHH---HHhcCCC-------------CHHH-------------------------
Q 004959          417 FYIYLEYVHPGSIN-----------KYV---REHCGAI-------------TESV-------------------------  444 (721)
Q Consensus       417 ~yLVmEy~~gGsL~-----------~~L---~~~~~~L-------------se~~-------------------------  444 (721)
                      .++||||++|..+.           ..|   +.....+             .+..                         
T Consensus       106 ~~~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~  185 (346)
T 2q83_A          106 LFVVYDWIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFS  185 (346)
T ss_dssp             EEEEEECCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHH
T ss_pred             EEEEEEeecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHH
Confidence            89999999986432           111   1111111             1100                         


Q ss_pred             ------HHHHHHHHHHHHHHHh-------------hCCeeccCCCCCcEEEcCCCceEEeecCCcc
Q 004959          445 ------VRNFTRHILSGLAYLH-------------SKKTIHRDIKGANLLVDASGVVKLADFGMAK  491 (721)
Q Consensus       445 ------i~~i~~QIl~AL~yLH-------------s~gIIHrDLKPeNILld~~g~VKL~DFGlA~  491 (721)
                            +..+..++..++.+|+             ..++||+|+++.|||++.++.+.|+||+.+.
T Consensus       186 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~  251 (346)
T 2q83_A          186 QLYLQEIDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS  251 (346)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred             HHHHHHHHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence                  1112223444566665             3579999999999999888899999999764

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.19  E-value=1.7e-06  Score=92.17  Aligned_cols=85  Identities=9%  Similarity=0.060  Sum_probs=53.3

Q ss_pred             eeEeeEE-eecCCeEEEEEEEC--C----CCcEEEEEEeecCCC-CcccHHHHHHHHHHHHHHHhCC-C--CCeeeeeee
Q 004959          342 WQKGKLI-GRGTFGSVYVASNR--E----TGALCAMKEVDIFPD-DPKSAESIKQLEQEIKVLSHLK-H--PNIVQYYGS  410 (721)
Q Consensus       342 y~~~k~L-G~G~fG~VY~a~~~--~----tg~~vAIK~i~~~~~-~~~~~~~~k~~~~Ei~iL~~L~-H--PnIV~l~g~  410 (721)
                      ....+.| +.|....+|++...  .    +|+.+++|+...... ....   ...+.+|+.+|+.|. +  -.+.+++.+
T Consensus        22 v~~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~---~~~~~~E~~~l~~L~~~~~vpvP~v~~~   98 (357)
T 3ats_A           22 VTVESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFP---TYRLDHQFEVIRLVGELTDVPVPRVRWI   98 (357)
T ss_dssp             EEEEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSS---CCCHHHHHHHHHHHHHHCCSCCCCEEEE
T ss_pred             eEEEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCc---hhHHHHHHHHHHHHhhcCCCCCCcEEEE
Confidence            3445678 88889999988643  1    266889997532110 0000   124677888887774 2  245667766


Q ss_pred             EEec---CeEEEEEeeccCCCH
Q 004959          411 EIVE---DKFYIYLEYVHPGSI  429 (721)
Q Consensus       411 ~~~~---~~~yLVmEy~~gGsL  429 (721)
                      ..+.   +..|+||||++|..+
T Consensus        99 ~~~~~~~g~~~~v~e~l~G~~l  120 (357)
T 3ats_A           99 ETTGDVLGTPFFLMDYVEGVVP  120 (357)
T ss_dssp             ECSSTTTSSCEEEEECCCCBCC
T ss_pred             ccCCCccCCceEEEEecCCCCh
Confidence            5544   357899999998654

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=97.63  E-value=0.00021  Score=75.93  Aligned_cols=76  Identities=13%  Similarity=0.162  Sum_probs=58.6

Q ss_pred             EeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCC---CCCeeeeeeeEEecCeEEEE
Q 004959          344 KGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLK---HPNIVQYYGSEIVEDKFYIY  420 (721)
Q Consensus       344 ~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~---HPnIV~l~g~~~~~~~~yLV  420 (721)
                      ..+.|+.|....+|+...  ++..+++|+...     .   ....+..|...|+.|.   ...|.+++.+....+..|+|
T Consensus        40 ~~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~-----~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lv  109 (312)
T 3jr1_A           40 HKEKLYSGEMNEIWLIND--EVQTVFVKINER-----S---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLL  109 (312)
T ss_dssp             EEEEECCSSSSEEEEEES--SSCEEEEEEEEG-----G---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEE
T ss_pred             eeEEeCCccceeeeEEEE--CCCeEEEEeCCc-----c---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEE
Confidence            456789999999999874  467899997642     1   1456788988888874   35677888877777889999


Q ss_pred             EeeccCCCH
Q 004959          421 LEYVHPGSI  429 (721)
Q Consensus       421 mEy~~gGsL  429 (721)
                      |||++|..+
T Consensus       110 me~l~G~~~  118 (312)
T 3jr1_A          110 LEALNKSKN  118 (312)
T ss_dssp             EECCCCCCC
T ss_pred             EEeccCCCC
Confidence            999998754

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=97.63  E-value=0.00051  Score=69.51  Aligned_cols=123  Identities=21%  Similarity=0.120  Sum_probs=83.7

Q ss_pred             CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHh-hCCeeccCCCCCcEEEcCCCceEEeecCCccccCCCcccccCCCC
Q 004959          427 GSINKYVREHCGAITESVVRNFTRHILSGLAYLH-SKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGS  505 (721)
Q Consensus       427 GsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLH-s~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~~~~~s~~GT  505 (721)
                      -+|.++|...+++|+|+++|.++.|.+.+|.-+- .+.-..+=+.|..|+|..+|.|.+.+ +.+.           ...
T Consensus        33 vSL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~-----------~~~  100 (229)
T 2yle_A           33 LSLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLAP-AADD-----------AGE  100 (229)
T ss_dssp             EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCEEECC-C-----------------
T ss_pred             ccHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCceeccc-cccc-----------ccc
Confidence            3799999988899999999999999999988772 11212333457999999999998764 2111           122


Q ss_pred             CccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhcCCCCCCCCCHHHHHHHHHhcc
Q 004959          506 PYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDSLSPEGKDFLRCCFQ  585 (721)
Q Consensus       506 ~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~~~~~p~~lS~el~dLI~~cL~  585 (721)
                      ..+.+||.+.        ...+.+.=|||||++||.-+--..|-                 .-+..+|+++..||..|..
T Consensus       101 ~~~~~pe~~~--------~~~te~~~IysLG~tLY~ALDygL~e-----------------~eE~eLS~~LE~LL~~Mt~  155 (229)
T 2yle_A          101 PPPVAGKLGY--------SQCMETEVIESLGIIIYKALDYGLKE-----------------NEERELSPPLEQLIDHMAN  155 (229)
T ss_dssp             ------CCSS--------SSSCHHHHHHHHHHHHHHHHTTTCCT-----------------TEEECCCHHHHHHHHHHTT
T ss_pred             cCCCChhhcc--------ccchHHHHHHHHHHHHHHHhhcCCCc-----------------ccchhhCHHHHHHHHHHHh
Confidence            3456787651        23456788999999999887533331                 2245689999999999976


Q ss_pred             c
Q 004959          586 R  586 (721)
Q Consensus       586 ~  586 (721)
                      -
T Consensus       156 ~  156 (229)
T 2yle_A          156 T  156 (229)
T ss_dssp             C
T ss_pred             c
Confidence            6

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.61  E-value=0.00029  Score=77.17  Aligned_cols=32  Identities=16%  Similarity=0.287  Sum_probs=28.1

Q ss_pred             hhCCeeccCCCCCcEEEcCCCceEEeecCCccc
Q 004959          460 HSKKTIHRDIKGANLLVDASGVVKLADFGMAKH  492 (721)
Q Consensus       460 Hs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~  492 (721)
                      +...++|+|+++.|||++.++ ++|+||+.+..
T Consensus       230 ~~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~  261 (420)
T 2pyw_A          230 RAQALIHGDLHTGSVMVTQDS-TQVIDPEFSFY  261 (420)
T ss_dssp             BCCEEECSCCSGGGEEECSSC-EEECCCTTCEE
T ss_pred             CCCeEEecCCCCCcEEEeCCC-CEEEeCccccc
Confidence            456899999999999998776 99999998864

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.59  E-value=0.00012  Score=76.27  Aligned_cols=136  Identities=10%  Similarity=0.076  Sum_probs=74.9

Q ss_pred             eeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCe-eeeeeeEEecCeEEEE
Q 004959          342 WQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNI-VQYYGSEIVEDKFYIY  420 (721)
Q Consensus       342 y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnI-V~l~g~~~~~~~~yLV  420 (721)
                      |.-.+.|+.|....+|++      ..+++|+.......      .-...+|+.+++.+..-.+ .+++.+  +.+.-++|
T Consensus        20 ~~~i~~l~gG~tN~~~~~------~~~vlR~~~~~~~~------~~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v   85 (301)
T 3dxq_A           20 YTGPLERLGGLTNLVFRA------GDLCLRIPGKGTEE------YINRANEAVAAREAAKAGVSPEVLHV--DPATGVMV   85 (301)
T ss_dssp             CCSCEEEESCSSEEEEEE------TTEEEEEECC----------CCCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEE
T ss_pred             ccceeEcCCcccccccee------eeEEEECCCCCccc------eeCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEE
Confidence            333678999999999998      46888976421111      1123457777776642222 344443  34445789


Q ss_pred             Eeec-cCCCHHH---------------HHHH-h--cCCCC-----HHHHHHHHHH--------------HHHHHHHH---
Q 004959          421 LEYV-HPGSINK---------------YVRE-H--CGAIT-----ESVVRNFTRH--------------ILSGLAYL---  459 (721)
Q Consensus       421 mEy~-~gGsL~~---------------~L~~-~--~~~Ls-----e~~i~~i~~Q--------------Il~AL~yL---  459 (721)
                      +||+ +|..|..               .|.+ +  ...+.     ...+..+..+              +...+..|   
T Consensus        86 ~e~i~~g~~l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~  165 (301)
T 3dxq_A           86 TRYIAGAQTMSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSA  165 (301)
T ss_dssp             EECCTTCEECCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHH
T ss_pred             EeecCCCccCCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHH
Confidence            9999 6654421               0111 0  01010     1111111111              11111111   


Q ss_pred             -h----hCCeeccCCCCCcEEEcCCCceEEeecCCccc
Q 004959          460 -H----SKKTIHRDIKGANLLVDASGVVKLADFGMAKH  492 (721)
Q Consensus       460 -H----s~gIIHrDLKPeNILld~~g~VKL~DFGlA~~  492 (721)
                       .    ...++|+|+.+.||| ..++.+.|+||..+..
T Consensus       166 l~~~~~~~~l~HgDl~~~Nil-~~~~~~~lID~e~a~~  202 (301)
T 3dxq_A          166 LAAHPLPLAACHCDPLCENFL-DTGERMWIVDWEYSGM  202 (301)
T ss_dssp             HHSSCCCCEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred             HHhcCCCceeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence             1    124899999999999 5667889999998763

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.47  E-value=0.00034  Score=73.05  Aligned_cols=141  Identities=15%  Similarity=0.125  Sum_probs=78.6

Q ss_pred             eeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCC-----CCCeeeee-e--eEEe
Q 004959          342 WQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLK-----HPNIVQYY-G--SEIV  413 (721)
Q Consensus       342 y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~-----HPnIV~l~-g--~~~~  413 (721)
                      ....+.|+.|....+|++...  +..+++|+....       .....+..|+.+++.|.     -|.++... |  +...
T Consensus        24 ~~~~~~i~~G~~n~~~~v~~~--~g~~vlk~~~~~-------~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~   94 (322)
T 2ppq_A           24 LTSYKGIAEGVENSNFLLHTT--KDPLILTLYEKR-------VEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGEL   94 (322)
T ss_dssp             EEEEEEECC---EEEEEEEES--SCCEEEEEECC----------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEE
T ss_pred             ceEeeccCCCcccceEEEEeC--CccEEEEEeCCC-------CCHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEE
Confidence            344567888988999998754  336889987521       01124556777776664     23333211 1  1233


Q ss_pred             cCeEEEEEeeccCCCHH-----------HH---HHHhcCCC--------CHHHHHH---------------HHHHHHHHH
Q 004959          414 EDKFYIYLEYVHPGSIN-----------KY---VREHCGAI--------TESVVRN---------------FTRHILSGL  456 (721)
Q Consensus       414 ~~~~yLVmEy~~gGsL~-----------~~---L~~~~~~L--------se~~i~~---------------i~~QIl~AL  456 (721)
                      .+..+++|+|++|..+.           ..   ++.....+        .......               +...+...+
T Consensus        95 ~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~  174 (322)
T 2ppq_A           95 SGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEI  174 (322)
T ss_dssp             TTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHH
T ss_pred             CCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHH
Confidence            56789999999986431           11   11111111        1000000               001134445


Q ss_pred             HHHhh-------CCeeccCCCCCcEEEcCCCceEEeecCCcc
Q 004959          457 AYLHS-------KKTIHRDIKGANLLVDASGVVKLADFGMAK  491 (721)
Q Consensus       457 ~yLHs-------~gIIHrDLKPeNILld~~g~VKL~DFGlA~  491 (721)
                      .+++.       .++||+|+++.|||++.++.+.|+||+.+.
T Consensus       175 ~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~  216 (322)
T 2ppq_A          175 DYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC  216 (322)
T ss_dssp             HHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             HHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence            55542       369999999999999877666899999774

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.35  E-value=0.00042  Score=73.06  Aligned_cols=32  Identities=34%  Similarity=0.361  Sum_probs=27.5

Q ss_pred             hCCeeccCCCCCcEEEcCC----CceEEeecCCccc
Q 004959          461 SKKTIHRDIKGANLLVDAS----GVVKLADFGMAKH  492 (721)
Q Consensus       461 s~gIIHrDLKPeNILld~~----g~VKL~DFGlA~~  492 (721)
                      ...++|+|+.+.|||++.+    +.+.|+||+.+..
T Consensus       182 ~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~  217 (333)
T 3csv_A          182 DMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL  217 (333)
T ss_dssp             CCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred             CCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence            3479999999999999874    6789999998864

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.27  E-value=0.0038  Score=64.36  Aligned_cols=78  Identities=17%  Similarity=0.069  Sum_probs=52.9

Q ss_pred             CeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCC---CeeeeeeeEEecCeE
Q 004959          341 QWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHP---NIVQYYGSEIVEDKF  417 (721)
Q Consensus       341 ~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HP---nIV~l~g~~~~~~~~  417 (721)
                      +..-.+.+|.|..+.||+.+. .+|+.|.+|+....  ....   ...+..|...|+.|..-   .+.+++.+    +.-
T Consensus        16 ~v~~v~~~g~G~~~~vyrv~l-~DG~~~~vK~~~~~--~~~~---~~~~~~Ea~~L~~L~~~~~vpvP~v~~~----~~~   85 (288)
T 3f7w_A           16 EVAAVAERGHSHRWHLYRVEL-ADGTPLFVKALPDD--APAL---DGLFRAEALGLDWLGRSFGSPVPQVAGW----DDR   85 (288)
T ss_dssp             CEEEEEEEEEETTEEEEEEEE-TTSCEEEEEECCTT--CCCC---TTHHHHHHHHHHHHTCSTTCCSCCEEEE----ETT
T ss_pred             CeEEEEecCCCCCeEEEEEEE-CCCCEEEEEEeCCC--Ccch---hhHHHHHHHHHHHHHhhCCCCcceEEec----cCc
Confidence            455678899999999999975 46899999975321  1111   23577899998887421   23444443    234


Q ss_pred             EEEEeeccCCC
Q 004959          418 YIYLEYVHPGS  428 (721)
Q Consensus       418 yLVmEy~~gGs  428 (721)
                      ++||||++++.
T Consensus        86 ~lv~e~l~~~~   96 (288)
T 3f7w_A           86 TLAMEWVDERP   96 (288)
T ss_dssp             EEEEECCCCCC
T ss_pred             eEEEEeecccC
Confidence            78999998764

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=97.20  E-value=0.0012  Score=69.19  Aligned_cols=136  Identities=13%  Similarity=0.087  Sum_probs=77.2

Q ss_pred             eEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCC--Ceeeeeee-----EEecCeEE
Q 004959          346 KLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHP--NIVQYYGS-----EIVEDKFY  418 (721)
Q Consensus       346 k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HP--nIV~l~g~-----~~~~~~~y  418 (721)
                      ..|+ |....||++.. .+|+.+++|.....   ...   ...+..|..+++.|...  .+.+++..     ....+..+
T Consensus        32 ~~l~-g~~n~~y~v~~-~~g~~~vlK~~~~~---~~~---~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~  103 (328)
T 1zyl_A           32 TPLN-SYENRVYQFQD-EDRRRFVVKFYRPE---RWT---ADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYF  103 (328)
T ss_dssp             EEEC-CSSSEEEEECC-TTCCCEEEEEECTT---TSC---HHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEE
T ss_pred             Eeec-CcccceEEEEc-CCCCEEEEEEcCCC---CCC---HHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEE
Confidence            3566 88889998754 34678999987411   111   23556677777776421  13333332     23356778


Q ss_pred             EEEeeccCCCHH-----H------HH---HHhcC--------CCCHHHH----------------------HHHHHHHHH
Q 004959          419 IYLEYVHPGSIN-----K------YV---REHCG--------AITESVV----------------------RNFTRHILS  454 (721)
Q Consensus       419 LVmEy~~gGsL~-----~------~L---~~~~~--------~Lse~~i----------------------~~i~~QIl~  454 (721)
                      +||||++|..+.     .      .+   +....        .+.....                      ..++.+++.
T Consensus       104 ~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~  183 (328)
T 1zyl_A          104 AVFPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIA  183 (328)
T ss_dssp             EEEECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHH
T ss_pred             EEEEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHH
Confidence            999999875431     1      11   11100        1111110                      111222222


Q ss_pred             HHHHH----hhCCeeccCCCCCcEEEcCCCceEEeecCCcc
Q 004959          455 GLAYL----HSKKTIHRDIKGANLLVDASGVVKLADFGMAK  491 (721)
Q Consensus       455 AL~yL----Hs~gIIHrDLKPeNILld~~g~VKL~DFGlA~  491 (721)
                      .+.-+    +...++|+|+++.|||++ + .+.|+||+.+.
T Consensus       184 ~l~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~  222 (328)
T 1zyl_A          184 AVTAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDAR  222 (328)
T ss_dssp             HHHHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCC
T ss_pred             HHHHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCC
Confidence            23222    234689999999999998 4 89999998765

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=97.17  E-value=0.0012  Score=72.80  Aligned_cols=74  Identities=14%  Similarity=0.115  Sum_probs=48.8

Q ss_pred             EeeEEeecCCeEEEEEEECC-------CCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCe-eeeeeeEEecC
Q 004959          344 KGKLIGRGTFGSVYVASNRE-------TGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNI-VQYYGSEIVED  415 (721)
Q Consensus       344 ~~k~LG~G~fG~VY~a~~~~-------tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnI-V~l~g~~~~~~  415 (721)
                      ..+.|+.|....||++....       .+..+++|+...   . ..   ...+.+|..+++.|...+| .++++.+.  +
T Consensus        77 ~v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~---~-~~---~~~li~E~~~l~~L~~~g~~P~l~~~~~--~  147 (429)
T 1nw1_A           77 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN---P-ET---ESHLVAESVIFTLLSERHLGPKLYGIFS--G  147 (429)
T ss_dssp             EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS---C-CC---HHHHHHHHHHHHHHHHTTSSSCEEEEET--T
T ss_pred             EEEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCC---C-Cc---HHHHHHHHHHHHHHHhCCCCCcEEEEeC--C
Confidence            45678889999999998643       357899997631   1 11   1244578888888753333 45666543  2


Q ss_pred             eEEEEEeeccCCC
Q 004959          416 KFYIYLEYVHPGS  428 (721)
Q Consensus       416 ~~yLVmEy~~gGs  428 (721)
                        .+||||++|..
T Consensus       148 --g~v~e~l~G~~  158 (429)
T 1nw1_A          148 --GRLEEYIPSRP  158 (429)
T ss_dssp             --EEEECCCCEEE
T ss_pred             --CEEEEEeCCcc
Confidence              38999998743

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=97.04  E-value=0.0012  Score=72.08  Aligned_cols=136  Identities=15%  Similarity=0.151  Sum_probs=79.7

Q ss_pred             eEEeecCCeEEEEEEECC-------CCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCC-CCCeeeeeeeEEecCeE
Q 004959          346 KLIGRGTFGSVYVASNRE-------TGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLK-HPNIVQYYGSEIVEDKF  417 (721)
Q Consensus       346 k~LG~G~fG~VY~a~~~~-------tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~-HPnIV~l~g~~~~~~~~  417 (721)
                      +.|..|-...+|++....       +++.|.+|+...   ...   ....+.+|..+|+.|. +.-..++++++.+    
T Consensus        56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~---~~~---~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----  125 (379)
T 3feg_A           56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGA---ILQ---GVDSLVLESVMFAILAERSLGPQLYGVFPE----  125 (379)
T ss_dssp             EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC------C---CHHHHHHHHHHHHHHHHTTSSCCEEEEETT----
T ss_pred             EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCC---ccc---hHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----
Confidence            467778888899987642       357899997521   111   1345568999888875 2223455655432    


Q ss_pred             EEEEeeccCCCHH--------------HHHHH-hcC------CC--CHHHHHHHHHHHHH-------------------H
Q 004959          418 YIYLEYVHPGSIN--------------KYVRE-HCG------AI--TESVVRNFTRHILS-------------------G  455 (721)
Q Consensus       418 yLVmEy~~gGsL~--------------~~L~~-~~~------~L--se~~i~~i~~QIl~-------------------A  455 (721)
                      .+||||++|..|.              +.|.+ +..      ..  -+..+..++.|+-.                   .
T Consensus       126 g~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~  205 (379)
T 3feg_A          126 GRLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDE  205 (379)
T ss_dssp             EEEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHH
T ss_pred             ccEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHH
Confidence            2999999985542              11111 111      11  13455666555422                   2


Q ss_pred             HHHHh----h----CCeeccCCCCCcEEEcCC----CceEEeecCCcc
Q 004959          456 LAYLH----S----KKTIHRDIKGANLLVDAS----GVVKLADFGMAK  491 (721)
Q Consensus       456 L~yLH----s----~gIIHrDLKPeNILld~~----g~VKL~DFGlA~  491 (721)
                      +..|.    .    ..++|+|+.+.|||++.+    +.+.|+||..+.
T Consensus       206 ~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~  253 (379)
T 3feg_A          206 MGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS  253 (379)
T ss_dssp             HHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred             HHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence            33332    2    258999999999999876    789999999775

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=97.04  E-value=0.00052  Score=73.58  Aligned_cols=75  Identities=11%  Similarity=0.019  Sum_probs=42.9

Q ss_pred             EeeEEeecCCeEEEEEEECC--------CCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCC-eeeeeeeEEec
Q 004959          344 KGKLIGRGTFGSVYVASNRE--------TGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPN-IVQYYGSEIVE  414 (721)
Q Consensus       344 ~~k~LG~G~fG~VY~a~~~~--------tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPn-IV~l~g~~~~~  414 (721)
                      ..+.|+.|....+|++....        .+..+++|+....   ..   .......|..+|+.|...+ +.++++.+  .
T Consensus        37 ~~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~---~~---~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~  108 (369)
T 3c5i_A           37 RVKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKH---VD---ELYNTISEFEVYKTMSKYKIAPQLLNTF--N  108 (369)
T ss_dssp             EEEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTT---GG---GTSCHHHHHHHHHHHHHTTSSCCEEEEE--T
T ss_pred             EEEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCC---cc---ceecHHHHHHHHHHHHhcCCCCceEEec--C
Confidence            34577888889999997643        1368889975421   11   1112356787877775333 33555443  2


Q ss_pred             CeEEEEEeeccCCC
Q 004959          415 DKFYIYLEYVHPGS  428 (721)
Q Consensus       415 ~~~yLVmEy~~gGs  428 (721)
                        -++||||++|..
T Consensus       109 --~~~v~e~i~G~~  120 (369)
T 3c5i_A          109 --GGRIEEWLYGDP  120 (369)
T ss_dssp             --TEEEEECCCSEE
T ss_pred             --CcEEEEEecCCc
Confidence              368999998754

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=96.96  E-value=0.0064  Score=67.88  Aligned_cols=76  Identities=16%  Similarity=0.079  Sum_probs=48.6

Q ss_pred             EeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCe-eeeeeeEEecCeEEEEEe
Q 004959          344 KGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNI-VQYYGSEIVEDKFYIYLE  422 (721)
Q Consensus       344 ~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnI-V~l~g~~~~~~~~yLVmE  422 (721)
                      ..+.|+.|....+|++.....+..|++|+.........      ...+|..+|+.|...+| .++++++.  +  .+|||
T Consensus       112 ~i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~i------dR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e  181 (458)
T 2qg7_A          112 EFQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEII------NREREKKISCILYNKNIAKKIYVFFT--N--GRIEE  181 (458)
T ss_dssp             EEEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCS------CHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEE
T ss_pred             EEEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhc------CHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEE
Confidence            45678889999999998765457899997642111111      12578888988875444 46666652  2  25999


Q ss_pred             eccCCCH
Q 004959          423 YVHPGSI  429 (721)
Q Consensus       423 y~~gGsL  429 (721)
                      |++|..|
T Consensus       182 ~I~G~~l  188 (458)
T 2qg7_A          182 FMDGYAL  188 (458)
T ss_dssp             CCCSEEC
T ss_pred             eeCCccC
Confidence            9987543

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=96.57  E-value=0.0099  Score=63.23  Aligned_cols=31  Identities=23%  Similarity=0.297  Sum_probs=27.6

Q ss_pred             CCeeccCCCCCcEEEcCCCceEEeecCCccc
Q 004959          462 KKTIHRDIKGANLLVDASGVVKLADFGMAKH  492 (721)
Q Consensus       462 ~gIIHrDLKPeNILld~~g~VKL~DFGlA~~  492 (721)
                      ..++|+|+.+.|||++.++.+.|+||+.+..
T Consensus       206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~  236 (339)
T 3i1a_A          206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML  236 (339)
T ss_dssp             CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred             ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence            4689999999999999888899999988764

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=95.00  E-value=0.15  Score=56.38  Aligned_cols=75  Identities=13%  Similarity=0.006  Sum_probs=46.5

Q ss_pred             EeeEEeecCCeEEEEEEECCC-------CcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCC-eeeeeeeEEecC
Q 004959          344 KGKLIGRGTFGSVYVASNRET-------GALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPN-IVQYYGSEIVED  415 (721)
Q Consensus       344 ~~k~LG~G~fG~VY~a~~~~t-------g~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPn-IV~l~g~~~~~~  415 (721)
                      ..+.|..|-...+|++.....       ++.|++++........      -...+|..+++.|..-+ ..++++.+  . 
T Consensus        74 ~v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~------idR~~E~~~l~~L~~~gi~P~l~~~~--~-  144 (424)
T 3mes_A           74 EVKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKF------YDSKVELDVFRYLSNINIAPNIIADF--P-  144 (424)
T ss_dssp             EEEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-CC------CCHHHHHHHHHHHHHTTSSCCEEEEE--T-
T ss_pred             EEEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcchh------cCHHHHHHHHHHHHhcCCCCCEEEEc--C-
Confidence            456677788899999986521       5789999753211111      12356888877775222 34455432  2 


Q ss_pred             eEEEEEeeccCCC
Q 004959          416 KFYIYLEYVHPGS  428 (721)
Q Consensus       416 ~~yLVmEy~~gGs  428 (721)
                       -++||||++|..
T Consensus       145 -~~~I~efI~G~~  156 (424)
T 3mes_A          145 -EGRIEEFIDGEP  156 (424)
T ss_dssp             -TEEEEECCCSEE
T ss_pred             -CCEEEEEeCCcc
Confidence             378999999865

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=93.87  E-value=0.19  Score=54.53  Aligned_cols=28  Identities=25%  Similarity=0.401  Sum_probs=24.3

Q ss_pred             eeccCCCCCcEEE------cCCCceEEeecCCcc
Q 004959          464 TIHRDIKGANLLV------DASGVVKLADFGMAK  491 (721)
Q Consensus       464 IIHrDLKPeNILl------d~~g~VKL~DFGlA~  491 (721)
                      ++|+|+.+.|||+      ++++.++|+||.+|.
T Consensus       246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~  279 (401)
T 3g15_A          246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSS  279 (401)
T ss_dssp             EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCE
T ss_pred             eEEecCCCCeEEEecCcccCcCCeEEEechHhcc
Confidence            6899999999999      345689999999875

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=83.22  E-value=3.2  Score=41.53  Aligned_cols=116  Identities=9%  Similarity=0.103  Sum_probs=79.8

Q ss_pred             CCCCeeeeeeeEEecCeEEEEEeeccCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcC
Q 004959          400 KHPNIVQYYGSEIVEDKFYIYLEYVHPG-SINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDA  478 (721)
Q Consensus       400 ~HPnIV~l~g~~~~~~~~yLVmEy~~gG-sL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~  478 (721)
                      .||+++.+ .+..+++.+.|.++.-..+ ++.. +    ..++..+.+.++.+|+....+++  .-+|--|.|+||+++.
T Consensus        43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~-i----k~~~~~eKlr~l~ni~~l~~~~~--~r~tf~L~P~NL~f~~  114 (215)
T 4ann_A           43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDN-I----KSFTKNEKLRYLLNIKNLEEVNR--TRYTFVLAPDELFFTR  114 (215)
T ss_dssp             CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGG-G----GGSCHHHHHHHHHHGGGGGGGGG--SSEECCCSGGGEEECT
T ss_pred             cCCcccce-EEEEcccEEEEEEEcCcccCCHHH-H----HhcCHHHHHHHHHHHHHHHHHhc--CceEEEEecceEEEcC
Confidence            68989877 5666777777777665422 3322 3    34778888999999988775443  3466779999999999


Q ss_pred             CCceEEeecCCccccCCCcccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCc
Q 004959          479 SGVVKLADFGMAKHLTGQKADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSE  551 (721)
Q Consensus       479 ~g~VKL~DFGlA~~l~~~~~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~  551 (721)
                      ++.++++-.|+-..+.+           +=+..|-+.                 -.+=|++..++.++..|..
T Consensus       115 ~~~p~i~~RGik~~l~P-----------~~~~ee~fL-----------------~qyKAliiall~~K~~Fe~  159 (215)
T 4ann_A          115 DGLPIAKTRGLQNVVDP-----------LPVSEAEFL-----------------TRYKALVICAFNEKQSFDA  159 (215)
T ss_dssp             TSCEEESCCEETTTBSC-----------CCCCHHHHH-----------------HHHHHHHHHHHCTTCCHHH
T ss_pred             CCCEEEEEccCccCCCC-----------CCCCHHHHH-----------------HHHHHHHHHHHcCCCCHHH
Confidence            99999998876543321           112334332                 2466788899999888753

>4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid}

Probab=81.61  E-value=7.9  Score=38.81  Aligned_cols=116  Identities=15%  Similarity=0.129  Sum_probs=78.3

Q ss_pred             CCCCeeeeeeeEEecCeEEEEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHH-HHhhCCeeccCCCCCcEEEcC
Q 004959          400 KHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLA-YLHSKKTIHRDIKGANLLVDA  478 (721)
Q Consensus       400 ~HPnIV~l~g~~~~~~~~yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~-yLHs~gIIHrDLKPeNILld~  478 (721)
                      .||++ . ..+..+++.+.|.++.-.++.=+..++    .++..+.++++.+|+.... ++  ..-+|--|+|+||+++.
T Consensus        48 ~~~~f-~-~~I~~~eD~~~i~y~~~~~~~~f~~i~----~~~~~eKlrll~nl~~L~~~~~--~~r~tf~l~P~NL~f~~  119 (219)
T 4ano_A           48 VDPCI-V-RDIDVSEDEVKVVIKPPSSFLTFAAIR----KTTLLSRIRAAIHLVSKVKHHS--ARRLIFIVCPENLMFNR  119 (219)
T ss_dssp             SCSSS-E-EEEEECSSEEEEEEECCTTCEEHHHHH----TSCHHHHHHHHHHHHHHHSSCC--SSSEECCCCGGGEEECT
T ss_pred             cCCCC-C-eEEEEeCCEEEEEEEcCcccCcHHHHH----hcCHHHHHHHHHHHHHHHHHhh--hCceeEEEeCceEEEeC
Confidence            57888 3 334466777777777664443333443    4788888888888887666 44  34466779999999999


Q ss_pred             CCceEEeecCCccccCCCcccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCc
Q 004959          479 SGVVKLADFGMAKHLTGQKADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSE  551 (721)
Q Consensus       479 ~g~VKL~DFGlA~~l~~~~~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~  551 (721)
                      ++.++|+-.|+-..+.           |+=+..|-+.                 -.+=|++..++.++.-|..
T Consensus       120 ~~~p~i~hRGi~~~lp-----------P~e~~ee~fl-----------------~qyKali~all~~K~~Fe~  164 (219)
T 4ano_A          120 ALEPFFLHVGVKESLP-----------PDEWDDERLL-----------------REVKATVLALTEGEYRFDE  164 (219)
T ss_dssp             TCCEEESCCEETTTBS-----------SCSCCHHHHH-----------------HHHHHHHHHHTTCSSCHHH
T ss_pred             CCcEEEEEcCCcccCC-----------CCCCCHHHHH-----------------HHHHHHHHHHHcCCCCHHH
Confidence            9999999888654321           1123344442                 2466788889998877753

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	721
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	2e-83
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	3e-78
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	9e-77
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	2e-75
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	9e-74
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	2e-73
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	2e-72
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	1e-71
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	7e-71
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	2e-70
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	4e-70
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	5e-70
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	1e-69
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	1e-69
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	8e-69
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	2e-66
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	2e-65
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	6e-65
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	2e-64
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	3e-64
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	3e-64
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	3e-63
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	3e-63
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	9e-63
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	3e-62
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	4e-62
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	7e-62
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	2e-61
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	2e-61
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	4e-61
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	5e-61
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	2e-60
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	2e-60
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	1e-59
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	3e-59
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	8e-59
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	1e-58
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	2e-58
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	7e-58
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	8e-58
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	8e-58
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	2e-57
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	2e-57
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	4e-57
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	2e-56
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	7e-56
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	9e-56
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	1e-55
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	1e-55
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	5e-55
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	6e-55
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	2e-54
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	2e-53
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	2e-52
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	7e-52
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	3e-51
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	1e-50
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	2e-50
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	3e-49
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	2e-48
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	2e-47
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	5e-39
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	4e-26

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  264 bits (675), Expect = 2e-83
 Identities = 98/273 (35%), Positives = 142/273 (52%), Gaps = 12/273 (4%)

Query: 342 WQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKH 401
           W+    +G G FG VY A N+ET  L A K +D      KS E ++    EI +L+   H
Sbjct: 14  WEIIGELGDGAFGKVYKAQNKETSVLAAAKVID-----TKSEEELEDYMVEIDILASCDH 68

Query: 402 PNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHS 461
           PNIV+   +   E+  +I +E+   G+++  + E    +TES ++   +  L  L YLH 
Sbjct: 69  PNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHD 128

Query: 462 KKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADL-SMKGSPYWMAPELMMAVMQK 520
            K IHRD+K  N+L    G +KLADFG++   T       S  G+PYWMAPE++M    K
Sbjct: 129 NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSK 188

Query: 521 GKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTP---AIPDSLSPEGK 577
            +  D     D+WSLG T+IEM   +PP  E      + K+ +  P   A P   S   K
Sbjct: 189 DRPYDY--KADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNFK 246

Query: 578 DFLRCCFQRNPADRPPASLLLEHRFLK-NSQQP 609
           DFL+ C ++N   R   S LL+H F+  +S +P
Sbjct: 247 DFLKKCLEKNVDARWTTSQLLQHPFVTVDSNKP 279

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  249 bits (637), Expect = 3e-78
 Identities = 80/268 (29%), Positives = 141/268 (52%), Gaps = 12/268 (4%)

Query: 340 SQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHL 399
             ++ G+ +G+G FG+VY+A  +++  + A+K   +F    + A    QL +E+++ SHL
Sbjct: 6   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKV--LFKAQLEKAGVEHQLRREVEIQSHL 63

Query: 400 KHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYL 459
           +HPNI++ YG      + Y+ LEY   G++ + ++       E     +   + + L+Y 
Sbjct: 64  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ-KLSKFDEQRTATYITELANALSYC 122

Query: 460 HSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPYWMAPELMMAVMQ 519
           HSK+ IHRDIK  NLL+ ++G +K+ADFG + H    +   ++ G+  ++ PE++     
Sbjct: 123 HSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT-TLCGTLDYLPPEMIE---- 177

Query: 520 KGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDSLSPEGKDF 579
            G+  D    VD+WSLG    E   GKPP+          ++ R     PD ++   +D 
Sbjct: 178 -GRMHDEK--VDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDL 234

Query: 580 LRCCFQRNPADRPPASLLLEHRFL-KNS 606
           +    + NP+ RP    +LEH ++  NS
Sbjct: 235 ISRLLKHNPSQRPMLREVLEHPWITANS 262

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  247 bits (631), Expect = 9e-77
 Identities = 94/310 (30%), Positives = 154/310 (49%), Gaps = 15/310 (4%)

Query: 326 IPQVAAKPEPLPMNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAES 385
           + ++  K +P      +   + IG G+FG+VY A +     + A+K++       +S E 
Sbjct: 4   VAELFFKDDP---EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMS--YSGKQSNEK 58

Query: 386 IKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVV 445
            + + +E++ L  L+HPN +QY G  + E   ++ +EY   GS +  +  H   + E  +
Sbjct: 59  WQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYC-LGSASDLLEVHKKPLQEVEI 117

Query: 446 RNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGS 505
              T   L GLAYLHS   IHRD+K  N+L+   G+VKL DFG A  +       S  G+
Sbjct: 118 AAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPAN---SFVGT 174

Query: 506 PYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMR-- 563
           PYWMAPE+++A+ +          VD+WSLG T IE+   KPP       +A++ + +  
Sbjct: 175 PYWMAPEVILAMDEGQYDG----KVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNE 230

Query: 564 DTPAIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQPDVPSCSLSFSGMQL 623
                    S   ++F+  C Q+ P DRP + +LL+HRF+   + P V    +  +   +
Sbjct: 231 SPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPPTVIMDLIQRTKDAV 290

Query: 624 TEKPHSPREK 633
            E  +    K
Sbjct: 291 RELDNLQYRK 300

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  242 bits (619), Expect = 2e-75
 Identities = 66/275 (24%), Positives = 120/275 (43%), Gaps = 17/275 (6%)

Query: 336 LPMNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKV 395
           +P    W   + +G G +G V +A NR T    A+K VD+     ++ +  + +++EI +
Sbjct: 1   VPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDM----KRAVDCPENIKKEICI 56

Query: 396 LSHLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSG 455
              L H N+V++YG     +  Y++LEY   G +   +      + E   + F   +++G
Sbjct: 57  NKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPD-IGMPEPDAQRFFHQLMAG 115

Query: 456 LAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMK---GSPYWMAPE 512
           + YLH     HRDIK  NLL+D    +K++DFG+A        +  +    G+  ++APE
Sbjct: 116 VVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 175

Query: 513 LMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPA---IP 569
           L+       +       VD+WS G  +  M  G+ PW +   +   +   ++        
Sbjct: 176 LLKRREFHAE------PVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPW 229

Query: 570 DSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLK 604
             +       L      NP+ R     + + R+  
Sbjct: 230 KKIDSAPLALLHKILVENPSARITIPDIKKDRWYN 264

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  240 bits (614), Expect = 9e-74
 Identities = 74/335 (22%), Positives = 141/335 (42%), Gaps = 18/335 (5%)

Query: 341 QWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLK 400
            +   + +G G FG V+  + R TG   A K V             + + +EI+ +S L+
Sbjct: 27  HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVM-----TPHESDKETVRKEIQTMSVLR 81

Query: 401 HPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLH 460
           HP +V  + +   +++  +  E++  G + + V +    ++E     + R +  GL ++H
Sbjct: 82  HPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH 141

Query: 461 SKKTIHRDIKGANLLV--DASGVVKLADFGMAKHLTGQKADLSMKGSPYWMAPELMMAVM 518
               +H D+K  N++     S  +KL DFG+  HL  +++     G+  + APE+     
Sbjct: 142 ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVA---- 197

Query: 519 QKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDS----LSP 574
            +GK        D+WS+G     + +G  P+        +  V      + DS    +S 
Sbjct: 198 -EGKPVGY--YTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISE 254

Query: 575 EGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQPDVPSCSLSFSGMQLTEKPHSPREKA 634
           +GKDF+R     +P  R      LEH +L     P   S   S    ++ +   +  +  
Sbjct: 255 DGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQIPSSRYTKIRDSIKTKYDAW 314

Query: 635 DAKYDQVAALSSSRSSRKATLESENGRRSHLETSD 669
                 +  +S+  S RK   +  + R +  + S+
Sbjct: 315 PEPLPPLGRISNYSSLRKHRPQEYSIRDAFWDRSE 349

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  237 bits (605), Expect = 2e-73
 Identities = 67/273 (24%), Positives = 118/273 (43%), Gaps = 11/273 (4%)

Query: 341 QWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQ----EIKVL 396
            ++  +++GRG    V    ++ T    A+K +D+      SAE +++L +    E+ +L
Sbjct: 4   NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63

Query: 397 SHLK-HPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSG 455
             +  HPNI+Q   +      F++  + +  G +  Y+ E    ++E   R   R +L  
Sbjct: 64  RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEK-VTLSEKETRKIMRALLEV 122

Query: 456 LAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPYWMAPELMM 515
           +  LH    +HRD+K  N+L+D    +KL DFG +  L   +    + G+P ++APE++ 
Sbjct: 123 ICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIE 182

Query: 516 AVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIP----DS 571
             M           VD+WS G  +  +  G PP+   +    +  +M           D 
Sbjct: 183 CSMNDNHPGYGK-EVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDD 241

Query: 572 LSPEGKDFLRCCFQRNPADRPPASLLLEHRFLK 604
            S   KD +       P  R  A   L H F +
Sbjct: 242 YSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQ 274

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  235 bits (600), Expect = 2e-72
 Identities = 92/273 (33%), Positives = 143/273 (52%), Gaps = 18/273 (6%)

Query: 339 NSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSH 398
             ++ + + IG+G  G+VY A +  TG   A++++++     +     + +  EI V+  
Sbjct: 19  KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNL-----QQQPKKELIINEILVMRE 73

Query: 399 LKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAY 458
            K+PNIV Y  S +V D+ ++ +EY+  GS+   V E C  + E  +    R  L  L +
Sbjct: 74  NKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC--MDEGQIAAVCRECLQALEF 131

Query: 459 LHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLS-MKGSPYWMAPELMMAV 517
           LHS + IHRDIK  N+L+   G VKL DFG    +T +++  S M G+PYWMAPE     
Sbjct: 132 LHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPE----- 186

Query: 518 MQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRD---TPAIPDSLSP 574
           +   K+      VDIWSLG   IEM  G+PP+       A++ +  +       P+ LS 
Sbjct: 187 VVTRKAYGP--KVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSA 244

Query: 575 EGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQ 607
             +DFL  C   +   R  A  LL+H+FLK ++
Sbjct: 245 IFRDFLNRCLDMDVEKRGSAKELLQHQFLKIAK 277

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  234 bits (599), Expect = 1e-71
 Identities = 71/333 (21%), Positives = 139/333 (41%), Gaps = 27/333 (8%)

Query: 333 PEPLPMNS-----QWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIK 387
           P+P+ +        +   + +G G FG V+    + TG +   K ++             
Sbjct: 17  PQPVEVKQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFIN-----TPYPLDKY 71

Query: 388 QLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRN 447
            ++ EI +++ L HP ++  + +   + +  + LE++  G +   +      ++E+ V N
Sbjct: 72  TVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVIN 131

Query: 448 FTRHILSGLAYLHSKKTIHRDIKGANLLVDA--SGVVKLADFGMAKHLTGQKADLSMKGS 505
           + R    GL ++H    +H DIK  N++ +   +  VK+ DFG+A  L   +       +
Sbjct: 132 YMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTAT 191

Query: 506 PYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDT 565
             + APE++                D+W++G     + +G  P++  +    +  V R  
Sbjct: 192 AEFAAPEIVD-------REPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCD 244

Query: 566 PAIP----DSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLK---NSQQPDVPSCSLSF 618
                    S+SPE KDF++   Q+ P  R      LEH +LK   ++    +PS S   
Sbjct: 245 WEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSNLTSRIPS-SRYN 303

Query: 619 SGMQLTEKPHSPREKADAKYDQVAALSSSRSSR 651
              Q  ++ ++          ++A  SS R  R
Sbjct: 304 KIRQKIKEKYADWPAPQPAIGRIANFSSLRKHR 336

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  231 bits (589), Expect = 7e-71
 Identities = 73/267 (27%), Positives = 128/267 (47%), Gaps = 13/267 (4%)

Query: 342 WQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKH 401
           ++ GK++G G+F +V +A    T    A+K ++           +  + +E  V+S L H
Sbjct: 10  FKFGKILGEGSFSTVVLARELATSREYAIKILE--KRHIIKENKVPYVTRERDVMSRLDH 67

Query: 402 PNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHS 461
           P  V+ Y +   ++K Y  L Y   G + KY+R   G+  E+  R +T  I+S L YLH 
Sbjct: 68  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR-KIGSFDETCTRFYTAEIVSALEYLHG 126

Query: 462 KKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADL---SMKGSPYWMAPELMMAVM 518
           K  IHRD+K  N+L++    +++ DFG AK L+ +       S  G+  +++PEL+    
Sbjct: 127 KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLT--- 183

Query: 519 QKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDSLSPEGKD 578
              KS+  +   D+W+LGC I ++  G PP+          K+++     P+   P+ +D
Sbjct: 184 --EKSACKS--SDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARD 239

Query: 579 FLRCCFQRNPADRPPASLLLEHRFLKN 605
            +      +   R     +  +  LK 
Sbjct: 240 LVEKLLVLDATKRLGCEEMEGYGPLKA 266

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  229 bits (584), Expect = 2e-70
 Identities = 70/277 (25%), Positives = 117/277 (42%), Gaps = 17/277 (6%)

Query: 337 PMNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDI-FPDDPKSAESIKQLEQEIKV 395
           P+ SQ+Q G L+G G FGSVY           A+K V+     D     +  ++  E+ +
Sbjct: 1   PLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVL 60

Query: 396 LSHLK--HPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHIL 453
           L  +      +++        D F + LE   P           GA+ E + R+F   +L
Sbjct: 61  LKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVL 120

Query: 454 SGLAYLHSKKTIHRDIKGANLLVDAS-GVVKLADFGMAKHLTGQKADLSMKGSPYWMAPE 512
             + + H+   +HRDIK  N+L+D + G +KL DFG    L          G+  +  PE
Sbjct: 121 EAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYT-DFDGTRVYSPPE 179

Query: 513 LMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDSL 572
            +      G+S        +WSLG  + +M  G  P+   E      +++R        +
Sbjct: 180 WIRYHRYHGRS------AAVWSLGILLYDMVCGDIPFEHDE------EIIRGQVFFRQRV 227

Query: 573 SPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQP 609
           S E +  +R C    P+DRP    +  H ++++   P
Sbjct: 228 SSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLP 264

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  228 bits (582), Expect = 4e-70
 Identities = 72/274 (26%), Positives = 114/274 (41%), Gaps = 22/274 (8%)

Query: 342 WQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKH 401
           ++    IG G++G       +  G +   KE+D       +    + L  E+ +L  LKH
Sbjct: 6   YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDY---GSMTEAEKQMLVSEVNLLRELKH 62

Query: 402 PNIVQYYGSEI--VEDKFYIYLEYVHPGSINKYVREHC---GAITESVVRNFTRHILSGL 456
           PNIV+YY   I       YI +EY   G +   + +       + E  V      +   L
Sbjct: 63  PNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 122

Query: 457 AYLHSK-----KTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADL-SMKGSPYWMA 510
              H +       +HRD+K AN+ +D    VKL DFG+A+ L    +   +  G+PY+M+
Sbjct: 123 KECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMS 182

Query: 511 PELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMR-DTPAIP 569
           PE M        S +     DIWSLGC + E+    PP++ +       K+       IP
Sbjct: 183 PEQM-----NRMSYNE--KSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIP 235

Query: 570 DSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFL 603
              S E  + +          RP    +LE+  +
Sbjct: 236 YRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 269

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  228 bits (582), Expect = 5e-70
 Identities = 59/270 (21%), Positives = 112/270 (41%), Gaps = 20/270 (7%)

Query: 340 SQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHL 399
            Q   G+ IG G+FG+VY           A+K +++      + + ++  + E+ VL   
Sbjct: 8   GQITVGQRIGSGSFGTVYKGKWHGD---VAVKMLNV---TAPTPQQLQAFKNEVGVLRKT 61

Query: 400 KHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYL 459
           +H NI+ + G      +  I  ++    S+  ++           + +  R    G+ YL
Sbjct: 62  RHVNILLFMGYST-APQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYL 120

Query: 460 HSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMK---GSPYWMAPELMMA 516
           H+K  IHRD+K  N+ +     VK+ DFG+A   +        +   GS  WMAPE++  
Sbjct: 121 HAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRM 180

Query: 517 VMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMR------DTPAIPD 570
             +   S       D+++ G  + E+ TG+ P+S       +  ++       D   +  
Sbjct: 181 QDKNPYSF----QSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRS 236

Query: 571 SLSPEGKDFLRCCFQRNPADRPPASLLLEH 600
           +     K  +  C ++   +RP    +L  
Sbjct: 237 NCPKAMKRLMAECLKKKRDERPLFPQILAS 266

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  227 bits (579), Expect = 1e-69
 Identities = 75/270 (27%), Positives = 136/270 (50%), Gaps = 23/270 (8%)

Query: 345 GKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNI 404
              IGRG+F +VY   + ET    A  E+    D   +    ++ ++E ++L  L+HPNI
Sbjct: 14  DIEIGRGSFKTVYKGLDTETTVEVAWCELQ---DRKLTKSERQRFKEEAEMLKGLQHPNI 70

Query: 405 VQYYGS----EIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLH 460
           V++Y S       +    +  E +  G++  Y++     +   V+R++ R IL GL +LH
Sbjct: 71  VRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRF-KVMKIKVLRSWCRQILKGLQFLH 129

Query: 461 SKKT--IHRDIKGANLLVDA-SGVVKLADFGMAKHLTGQKADLSMKGSPYWMAPELMMAV 517
           ++    IHRD+K  N+ +   +G VK+ D G+A       A  ++ G+P +MAPE+    
Sbjct: 130 TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAK-AVIGTPEFMAPEMY--- 185

Query: 518 MQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRD---TPAIPDSLSP 574
             + K  +   +VD+++ G  ++EM T + P+SE + AA +++ +       +      P
Sbjct: 186 --EEKYDE---SVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIP 240

Query: 575 EGKDFLRCCFQRNPADRPPASLLLEHRFLK 604
           E K+ +  C ++N  +R     LL H F +
Sbjct: 241 EVKEIIEGCIRQNKDERYSIKDLLNHAFFQ 270

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  228 bits (583), Expect = 1e-69
 Identities = 67/325 (20%), Positives = 129/325 (39%), Gaps = 27/325 (8%)

Query: 342 WQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKH 401
           +   + +GRG FG V+      +      K V +   D         +++EI +L+  +H
Sbjct: 7   YMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQV------LVKKEISILNIARH 60

Query: 402 PNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHS 461
            NI+  + S    ++  +  E++    I + +      + E  + ++   +   L +LHS
Sbjct: 61  RNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHS 120

Query: 462 KKTIHRDIKGANLLVDA--SGVVKLADFGMAKHLTGQKADLSMKGSPYWMAPELMMAVMQ 519
               H DI+  N++     S  +K+ +FG A+ L        +  +P + APE     + 
Sbjct: 121 HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPE-----VH 175

Query: 520 KGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPD----SLSPE 575
           +     +  A D+WSLG  +  + +G  P+        +  +M       +     +S E
Sbjct: 176 QHDVVST--ATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIE 233

Query: 576 GKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQPDVPSCSLSFSGMQLTEKPHSPREKAD 635
             DF+     +    R  AS  L+H +LK  Q+ +  S  +      +    H       
Sbjct: 234 AMDFVDRLLVKERKSRMTASEALQHPWLK--QKIERVSTKV------IRTLKHRRYYHTL 285

Query: 636 AKYDQVAALSSSRSSRKATLESENG 660
            K D    +S++R S    + S+ G
Sbjct: 286 IKKDLNMVVSAARISCGGAIRSQKG 310

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  226 bits (576), Expect = 8e-69
 Identities = 74/313 (23%), Positives = 126/313 (40%), Gaps = 23/313 (7%)

Query: 339 NSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSH 398
              +    ++G G F  V +A ++ T  L A+K +     + K       +E EI VL  
Sbjct: 8   RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKE----GSMENEIAVLHK 63

Query: 399 LKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAY 458
           +KHPNIV            Y+ ++ V  G +   + E  G  TE         +L  + Y
Sbjct: 64  IKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEK-GFYTERDASRLIFQVLDAVKY 122

Query: 459 LHSKKTIHRDIKGANLLV---DASGVVKLADFGMAKHLTGQKADLSMKGSPYWMAPELMM 515
           LH    +HRD+K  NLL    D    + ++DFG++K         +  G+P ++APE   
Sbjct: 123 LHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPE--- 179

Query: 516 AVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIP----DS 571
             +   K      AVD WS+G     +  G PP+ +   A    ++++          D 
Sbjct: 180 --VLAQKPYSK--AVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDD 235

Query: 572 LSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQPDVPSCSLSFSGMQLTEKPHSPR 631
           +S   KDF+R   +++P  R      L+H ++      D          +    K +  +
Sbjct: 236 ISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAGDTALDKNIHQSVSEQI----KKNFAK 291

Query: 632 EKADAKYDQVAAL 644
            K    ++  A +
Sbjct: 292 SKWKQAFNATAVV 304

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  220 bits (561), Expect = 2e-66
 Identities = 72/267 (26%), Positives = 129/267 (48%), Gaps = 13/267 (4%)

Query: 342 WQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSH-LK 400
           +   K++G+G+FG V++A  ++T    A+K +    D     + ++    E +VLS   +
Sbjct: 4   FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALK--KDVVLMDDDVECTMVEKRVLSLAWE 61

Query: 401 HPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLH 460
           HP +   + +   ++  +  +EY++ G +  +++  C     S    +   I+ GL +LH
Sbjct: 62  HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQS-CHKFDLSRATFYAAEIILGLQFLH 120

Query: 461 SKKTIHRDIKGANLLVDASGVVKLADFGMAKHLT-GQKADLSMKGSPYWMAPELMMAVMQ 519
           SK  ++RD+K  N+L+D  G +K+ADFGM K    G     +  G+P ++APE+++    
Sbjct: 121 SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILL---- 176

Query: 520 KGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDSLSPEGKDF 579
            G+  + +  VD WS G  + EM  G+ P+   +       +  D P  P  L  E KD 
Sbjct: 177 -GQKYNHS--VDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDL 233

Query: 580 LRCCFQRNPADRPPA-SLLLEHRFLKN 605
           L   F R P  R      + +H   + 
Sbjct: 234 LVKLFVREPEKRLGVRGDIRQHPLFRE 260

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  217 bits (553), Expect = 2e-65
 Identities = 65/271 (23%), Positives = 122/271 (45%), Gaps = 17/271 (6%)

Query: 340 SQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHL 399
             +Q  + +G G+FG V++  +R  G   AMK +    +     + ++    E  +LS +
Sbjct: 4   QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLK--KEIVVRLKQVEHTNDERLMLSIV 61

Query: 400 KHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYL 459
            HP I++ +G+     + ++ ++Y+  G     +          V + +   +   L YL
Sbjct: 62  THPFIIRMWGTFQDAQQIFMIMDYI-EGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYL 120

Query: 460 HSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPYWMAPELMMAVMQ 519
           HSK  I+RD+K  N+L+D +G +K+ DFG AK++       ++ G+P ++APE++     
Sbjct: 121 HSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV--TYTLCGTPDYIAPEVV----- 173

Query: 520 KGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDSLSPEGKDF 579
             K  + +  +D WS G  I EM  G  P+ +        K++      P   + + KD 
Sbjct: 174 STKPYNKS--IDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDL 231

Query: 580 LRCCFQRNPADRPP-----ASLLLEHRFLKN 605
           L     R+ + R          +  H + K 
Sbjct: 232 LSRLITRDLSQRLGNLQNGTEDVKNHPWFKE 262

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  216 bits (550), Expect = 6e-65
 Identities = 72/289 (24%), Positives = 131/289 (45%), Gaps = 14/289 (4%)

Query: 339 NSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSH 398
           +  ++K   +G G  G V+  S++ +G + A K + +            Q+ +E++VL  
Sbjct: 5   DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKP----AIRNQIIRELQVLHE 60

Query: 399 LKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAY 458
              P IV +YG+   + +  I +E++  GS+++ +++  G I E ++   +  ++ GL Y
Sbjct: 61  CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKA-GRIPEQILGKVSIAVIKGLTY 119

Query: 459 LHSK-KTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPYWMAPELMMAV 517
           L  K K +HRD+K +N+LV++ G +KL DFG++  L    A+ S  G+  +M+PE +   
Sbjct: 120 LREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN-SFVGTRSYMSPERLQ-- 176

Query: 518 MQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDSLSPEGK 577
              G         DIWS+G +++EM  G+ P    +                    P  +
Sbjct: 177 ---GTHYSV--QSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPR 231

Query: 578 DFLRCCFQRNPADRPPASLLLEHRFLKNSQQPDVPSCSLSFSGMQLTEK 626
              R         RPP ++     ++ N   P +PS   S        K
Sbjct: 232 TPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNK 280

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  216 bits (550), Expect = 2e-64
 Identities = 81/279 (29%), Positives = 142/279 (50%), Gaps = 18/279 (6%)

Query: 336 LPMNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLE-QEIK 394
           L MN  +   ++IGRG FG VY     +TG + AMK +D      K  E++   E   + 
Sbjct: 1   LTMN-DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLS 59

Query: 395 VLSHLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILS 454
           ++S    P IV    +    DK    L+ ++ G ++ ++ +H G  +E+ +R +   I+ 
Sbjct: 60  LVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQH-GVFSEADMRFYAAEIIL 118

Query: 455 GLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPYWMAPELM 514
           GL ++H++  ++RD+K AN+L+D  G V+++D G+A   + +K   S+ G+  +MAPE  
Sbjct: 119 GLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV-GTHGYMAPE-- 175

Query: 515 MAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMF---KVMRDTPAIPDS 571
             V+QKG + DS  + D +SLGC + ++  G  P+ +++           +     +PDS
Sbjct: 176 --VLQKGVAYDS--SADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDS 231

Query: 572 LSPEGKDFLRCCFQRNPADRP-----PASLLLEHRFLKN 605
            SPE +  L    QR+   R       A  + E  F ++
Sbjct: 232 FSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRS 270

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  213 bits (543), Expect = 3e-64
 Identities = 65/288 (22%), Positives = 123/288 (42%), Gaps = 17/288 (5%)

Query: 339 NSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVD-IFPDDPKSAESIKQLEQEIKVLS 397
           +  +  G+ +G G F  V     + TG   A K +        +   S + +E+E+ +L 
Sbjct: 9   DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 68

Query: 398 HLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLA 457
            ++HPN++  +     +    + LE V  G +  ++ E   ++TE     F + IL+G+ 
Sbjct: 69  EIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEK-ESLTEEEATEFLKQILNGVY 127

Query: 458 YLHSKKTIHRDIKGANLLVDASGV----VKLADFGMAKHLTGQKADLSMKGSPYWMAPEL 513
           YLHS +  H D+K  N+++    V    +K+ DFG+A  +       ++ G+P ++APE+
Sbjct: 128 YLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEI 187

Query: 514 MMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRD----TPAIP 569
           +       +        D+WS+G     + +G  P+        +  V            
Sbjct: 188 V-----NYEPLGL--EADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYF 240

Query: 570 DSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQPDVPSCSLS 617
            + S   KDF+R    ++P  R      L+H ++K        S + S
Sbjct: 241 SNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQALSSAWS 288

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  212 bits (540), Expect = 3e-64
 Identities = 67/265 (25%), Positives = 116/265 (43%), Gaps = 22/265 (8%)

Query: 340 SQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHL 399
            + +  + IG+G FG V +      G   A+K +       K+  + +    E  V++ L
Sbjct: 7   KELKLLQTIGKGEFGDVMLG--DYRGNKVAVKCI-------KNDATAQAFLAEASVMTQL 57

Query: 400 KHPNIVQYYGSEIVED-KFYIYLEYVHPGSINKYVREH-CGAITESVVRNFTRHILSGLA 457
           +H N+VQ  G  + E    YI  EY+  GS+  Y+R      +    +  F+  +   + 
Sbjct: 58  RHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAME 117

Query: 458 YLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPYWMAPELMMAV 517
           YL     +HRD+   N+LV    V K++DFG+ K  +  +   + K    W APE     
Sbjct: 118 YLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD--TGKLPVKWTAPE----A 171

Query: 518 MQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFKVMRDT-PAIPDSLSPE 575
           +++ K S      D+WS G  + E+Y+ G+ P+        + +V +      PD   P 
Sbjct: 172 LREKKFST---KSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPA 228

Query: 576 GKDFLRCCFQRNPADRPPASLLLEH 600
             + ++ C+  + A RP    L E 
Sbjct: 229 VYEVMKNCWHLDAAMRPSFLQLREQ 253

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  210 bits (536), Expect = 3e-63
 Identities = 70/300 (23%), Positives = 126/300 (42%), Gaps = 37/300 (12%)

Query: 346 KLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIV 405
             +G G F +VY A ++ T  + A+K++ +           +   +EIK+L  L HPNI+
Sbjct: 4   DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63

Query: 406 QYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTI 465
               +   +    +  +++    +   ++++   +T S ++ +    L GL YLH    +
Sbjct: 64  GLLDAFGHKSNISLVFDFM-ETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWIL 122

Query: 466 HRDIKGANLLVDASGVVKLADFGMAKHL-TGQKADLSMKGSPYWMAPELMMAVMQKGKSS 524
           HRD+K  NLL+D +GV+KLADFG+AK   +  +A      + ++ APEL+      G   
Sbjct: 123 HRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGV-- 180

Query: 525 DSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMR--------------------- 563
                VD+W++GC + E+    P          + ++                       
Sbjct: 181 ----GVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVT 236

Query: 564 -------DTPAIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQPDVPSCSL 616
                      I  +   +  D ++  F  NP  R  A+  L+ ++  N   P  P C L
Sbjct: 237 FKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGP-TPGCQL 295

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  209 bits (533), Expect = 3e-63
 Identities = 67/265 (25%), Positives = 112/265 (42%), Gaps = 18/265 (6%)

Query: 340 SQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHL 399
           S+    + IG G FG V++          A+K +       + A S +   +E +V+  L
Sbjct: 5   SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIR------EGAMSEEDFIEEAEVMMKL 57

Query: 400 KHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYL 459
            HP +VQ YG  + +    +  E++  G ++ Y+R   G      +      +  G+AYL
Sbjct: 58  SHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYL 117

Query: 460 HSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSM--KGSPYWMAPELMMAV 517
                IHRD+   N LV  + V+K++DFGM + +   +   S   K    W +PE    V
Sbjct: 118 EEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPE----V 173

Query: 518 MQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFKVMRD-TPAIPDSLSPE 575
               + S      D+WS G  + E+++ GK P+     +  +  +        P   S  
Sbjct: 174 FSFSRYSS---KSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTH 230

Query: 576 GKDFLRCCFQRNPADRPPASLLLEH 600
               +  C++  P DRP  S LL  
Sbjct: 231 VYQIMNHCWKERPEDRPAFSRLLRQ 255

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  210 bits (536), Expect = 9e-63
 Identities = 76/271 (28%), Positives = 128/271 (47%), Gaps = 16/271 (5%)

Query: 341 QWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLK 400
            +   KL+G+GTFG V +   + TG   AMK +    +   + + +     E +VL + +
Sbjct: 6   DFDYLKLLGKGTFGKVILVREKATGRYYAMKILR--KEVIIAKDEVAHTVTESRVLQNTR 63

Query: 401 HPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLH 460
           HP +     +    D+    +EY + G +  ++       TE   R +   I+S L YLH
Sbjct: 64  HPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERV-FTEERARFYGAEIVSALEYLH 122

Query: 461 SKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMK-GSPYWMAPELMMAVMQ 519
           S+  ++RDIK  NL++D  G +K+ DFG+ K      A +    G+P ++APE++     
Sbjct: 123 SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLE---- 178

Query: 520 KGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDSLSPEGKDF 579
               +D   AVD W LG  + EM  G+ P+   +       ++ +    P +LSPE K  
Sbjct: 179 ---DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSL 235

Query: 580 LRCCFQRNPADRPP-----ASLLLEHRFLKN 605
           L    +++P  R       A  ++EHRF  +
Sbjct: 236 LAGLLKKDPKQRLGGGPSDAKEVMEHRFFLS 266

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  209 bits (533), Expect = 3e-62
 Identities = 68/321 (21%), Positives = 122/321 (38%), Gaps = 41/321 (12%)

Query: 345 GKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHL-KHPN 403
            +++G G  G V    N+ T    A+K +              +  +E+++     + P+
Sbjct: 17  SQVLGLGINGKVLQIFNKRTQEKFALKMLQ----------DCPKARREVELHWRASQCPH 66

Query: 404 IVQYYG----SEIVEDKFYIYLEYVHPGSINKYVREHCG-AITESVVRNFTRHILSGLAY 458
           IV+                I +E +  G +   +++    A TE       + I   + Y
Sbjct: 67  IVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQY 126

Query: 459 LHSKKTIHRDIKGANLLVDA---SGVVKLADFGMAKHLTGQKADLSMKGSPYWMAPELMM 515
           LHS    HRD+K  NLL  +   + ++KL DFG AK  T   +  +   +PY++APE++ 
Sbjct: 127 LHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVL- 185

Query: 516 AVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRD--------TPA 567
                 +  D   + D+WSLG  +  +  G PP+    G A    +              
Sbjct: 186 ----GPEKYDK--SCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNP 239

Query: 568 IPDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQ-PDVPSCSLSF------SG 620
               +S E K  +R   +  P  R   +  + H ++  S + P  P  +           
Sbjct: 240 EWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERW 299

Query: 621 MQLTEKPHSPREKADAKYDQV 641
             + E+  S        Y+Q+
Sbjct: 300 EDVKEEMTSALATMRVDYEQI 320

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  206 bits (525), Expect = 4e-62
 Identities = 67/265 (25%), Positives = 115/265 (43%), Gaps = 18/265 (6%)

Query: 340 SQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHL 399
                 K +G G FG V     R      A+K +       + + S  +  +E KV+ +L
Sbjct: 4   KDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIK------EGSMSEDEFIEEAKVMMNL 56

Query: 400 KHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYL 459
            H  +VQ YG    +   +I  EY+  G +  Y+RE         +    + +   + YL
Sbjct: 57  SHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYL 116

Query: 460 HSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLS--MKGSPYWMAPELMMAV 517
            SK+ +HRD+   N LV+  GVVK++DFG+++++   +   S   K    W  PE++M  
Sbjct: 117 ESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYS 176

Query: 518 MQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFKVMRD-TPAIPDSLSPE 575
               KS       DIW+ G  + E+Y+ GK P+  +  +     + +      P   S +
Sbjct: 177 KFSSKS-------DIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEK 229

Query: 576 GKDFLRCCFQRNPADRPPASLLLEH 600
               +  C+     +RP   +LL +
Sbjct: 230 VYTIMYSCWHEKADERPTFKILLSN 254

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  206 bits (525), Expect = 7e-62
 Identities = 69/276 (25%), Positives = 118/276 (42%), Gaps = 22/276 (7%)

Query: 342 WQKGKLIGRGTFGSVYVASNRET---GALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSH 398
            +  + +G G+FG V               A+K +   PD     E++    +E+  +  
Sbjct: 10  LRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLK--PDVLSQPEAMDDFIREVNAMHS 67

Query: 399 LKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAY 458
           L H N+++ YG  ++     +  E    GS+   +R+H G      +  +   +  G+ Y
Sbjct: 68  LDHRNLIRLYGV-VLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGY 126

Query: 459 LHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSM----KGSPYWMAPELM 514
           L SK+ IHRD+   NLL+    +VK+ DFG+ + L        M    K    W APE +
Sbjct: 127 LESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESL 186

Query: 515 MAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFKVMRD--TPAIPDS 571
                  ++     A D W  G T+ EM+T G+ PW    G+  + K+ ++      P+ 
Sbjct: 187 K-----TRTFSH--ASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPED 239

Query: 572 LSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQ 607
              +  + +  C+   P DRP    L +  FL  +Q
Sbjct: 240 CPQDIYNVMVQCWAHKPEDRPTFVALRD--FLLEAQ 273

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  205 bits (522), Expect = 2e-61
 Identities = 61/270 (22%), Positives = 112/270 (41%), Gaps = 23/270 (8%)

Query: 346 KLIGRGTFGSVYVA--SNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPN 403
           K +G G FG+V       ++     A+K   I  ++        +L  E  V+  L +P 
Sbjct: 13  KELGSGNFGTVKKGYYQMKKVVKTVAVK---ILKNEANDPALKDELLAEANVMQQLDNPY 69

Query: 404 IVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKK 463
           IV+  G     + + + +E    G +NKY++++   + +  +      +  G+ YL    
Sbjct: 70  IVRMIGI-CEAESWMLVMEMAELGPLNKYLQQN-RHVKDKNIIELVHQVSMGMKYLEESN 127

Query: 464 TIHRDIKGANLLVDASGVVKLADFGMAKHLTG----QKADLSMKGSPYWMAPELMMAVMQ 519
            +HRD+   N+L+      K++DFG++K L       KA    K    W APE +     
Sbjct: 128 FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKF 187

Query: 520 KGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFKVMRD-TPAIPDSLSPEGK 577
             KS       D+WS G  + E ++ G+ P+   +G+     + +      P     E  
Sbjct: 188 SSKS-------DVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMY 240

Query: 578 DFLRCCFQRNPADRPPAS---LLLEHRFLK 604
           D +  C+  +  +RP  +   L L + +  
Sbjct: 241 DLMNLCWTYDVENRPGFAAVELRLRNYYYD 270

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  204 bits (521), Expect = 2e-61
 Identities = 65/282 (23%), Positives = 128/282 (45%), Gaps = 22/282 (7%)

Query: 335 PLPMNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIK 394
           P  ++ +++ G+++G G    V++A +       A+K +    D  +      +  +E +
Sbjct: 2   PSHLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLR--ADLARDPSFYLRFRREAQ 59

Query: 395 VLSHLKHPNIVQYYGSEIVEDK----FYIYLEYVHPGSINKYVREHCGAITESVVRNFTR 450
             + L HP IV  Y +   E       YI +EYV   ++   V    G +T         
Sbjct: 60  NAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH-TEGPMTPKRAIEVIA 118

Query: 451 HILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADL----SMKGSP 506
                L + H    IHRD+K AN+++ A+  VK+ DFG+A+ +      +    ++ G+ 
Sbjct: 119 DACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTA 178

Query: 507 YWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTP 566
            +++PE       +G S D+    D++SLGC + E+ TG+PP++     +  ++ +R+ P
Sbjct: 179 QYLSPEQA-----RGDSVDA--RSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDP 231

Query: 567 AIP----DSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLK 604
             P    + LS +    +     +NP +R   +  +    ++
Sbjct: 232 IPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVR 273

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  205 bits (521), Expect = 4e-61
 Identities = 80/298 (26%), Positives = 132/298 (44%), Gaps = 39/298 (13%)

Query: 342 WQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKH 401
           +QK + IG GT+G VY A N+ TG + A+K++ +   D ++        +EI +L  L H
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL---DTETEGVPSTAIREISLLKELNH 60

Query: 402 PNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHS 461
           PNIV+       E+K Y+  E++H              I   +++++   +L GLA+ HS
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 120

Query: 462 KKTIHRDIKGANLLVDASGVVKLADFGMAKHL-TGQKADLSMKGSPYWMAPELMMAVMQK 520
            + +HRD+K  NLL++  G +KLADFG+A+      +       + ++ APE+++     
Sbjct: 121 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYY 180

Query: 521 GKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMR----------------- 563
                   AVDIWSLGC   EM T +  +        +F++ R                 
Sbjct: 181 ST------AVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMP 234

Query: 564 ------------DTPAIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQP 609
                       D   +   L  +G+  L      +P  R  A   L H F ++  +P
Sbjct: 235 DYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 292

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  204 bits (521), Expect = 5e-61
 Identities = 55/270 (20%), Positives = 112/270 (41%), Gaps = 6/270 (2%)

Query: 340 SQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHL 399
           S  +  ++IG G FG V     +  G       +        + +  +    E  ++   
Sbjct: 26  SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSG-YTEKQRRDFLSEASIMGQF 84

Query: 400 KHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYL 459
            HPN++   G         I  E++  GS++ ++R++ G  T   +    R I +G+ YL
Sbjct: 85  DHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYL 144

Query: 460 HSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPYWMAPELMMAVMQ 519
                +HRD+   N+LV+++ V K++DFG+++ L    +D +   +     P    A   
Sbjct: 145 ADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEA 204

Query: 520 KGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFKVMRD-TPAIPDSLSPEGK 577
             +      A D+WS G  + E+ + G+ P+ +      +  + +D     P        
Sbjct: 205 I-QYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPPPMDCPSALH 263

Query: 578 DFLRCCFQRNPADRPPASLLLEH--RFLKN 605
             +  C+Q++   RP    ++    + ++N
Sbjct: 264 QLMLDCWQKDRNHRPKFGQIVNTLDKMIRN 293

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  202 bits (515), Expect = 2e-60
 Identities = 62/268 (23%), Positives = 114/268 (42%), Gaps = 19/268 (7%)

Query: 340 SQWQKGKLIGRGTFGSVYVA---SNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVL 396
            + + G+ IG G FG V+     S        A+K       D       ++  QE   +
Sbjct: 7   ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSD----SVREKFLQEALTM 62

Query: 397 SHLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGL 456
               HP+IV+  G  I E+  +I +E    G +  +++    ++  + +  +   + + L
Sbjct: 63  RQFDHPHIVKLIGV-ITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTAL 121

Query: 457 AYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLS--MKGSPYWMAPELM 514
           AYL SK+ +HRDI   N+LV ++  VKL DFG+++++       +   K    WMAPE +
Sbjct: 122 AYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESI 181

Query: 515 MAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFKVMR-DTPAIPDSL 572
                   S       D+W  G  + E+   G  P+   +    + ++   +   +P + 
Sbjct: 182 NFRRFTSAS-------DVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNC 234

Query: 573 SPEGKDFLRCCFQRNPADRPPASLLLEH 600
            P     +  C+  +P+ RP  + L   
Sbjct: 235 PPTLYSLMTKCWAYDPSRRPRFTELKAQ 262

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  202 bits (515), Expect = 2e-60
 Identities = 59/274 (21%), Positives = 109/274 (39%), Gaps = 23/274 (8%)

Query: 348 IGRGTFGSVYVASNRET--GALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIV 405
           +G G FGSV     R        A+K +    +        +++ +E +++  L +P IV
Sbjct: 17  LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEK----ADTEEMMREAQIMHQLDNPYIV 72

Query: 406 QYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTI 465
           +  G     +   + +E    G ++K++      I  S V      +  G+ YL  K  +
Sbjct: 73  RLIGV-CQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFV 131

Query: 466 HRDIKGANLLVDASGVVKLADFGMAKHLTGQKADL----SMKGSPYWMAPELMMAVMQKG 521
           HRD+   N+L+      K++DFG++K L    +      + K    W APE +       
Sbjct: 132 HRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSS 191

Query: 522 KSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFKVMRDT-PAIPDSLSPEGKDF 579
           +S       D+WS G T+ E  + G+ P+ + +G   M  + +      P    PE    
Sbjct: 192 RS-------DVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPELYAL 244

Query: 580 LRCCFQRNPADRPPAS---LLLEHRFLKNSQQPD 610
           +  C+     DRP        +   +   + + +
Sbjct: 245 MSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVE 278

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  199 bits (508), Expect = 1e-59
 Identities = 65/275 (23%), Positives = 117/275 (42%), Gaps = 22/275 (8%)

Query: 340 SQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHL 399
              +  + +G G FG V++          A+K +       + + S      E  ++  L
Sbjct: 13  ETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLK------QGSMSPDAFLAEANLMKQL 65

Query: 400 KHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGA-ITESVVRNFTRHILSGLAY 458
           +H  +V+ Y     ++  YI  EY+  GS+  +++   G  +T + + +    I  G+A+
Sbjct: 66  QHQRLVRLYAVVT-QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAF 124

Query: 459 LHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADL--SMKGSPYWMAPELMMA 516
           +  +  IHRD++ AN+LV  +   K+ADFG+A+ +   +       K    W APE +  
Sbjct: 125 IEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINY 184

Query: 517 VMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFKVMRDT-PAIPDSLSP 574
                KS       D+WS G  + E+ T G+ P+        +  + R      PD+   
Sbjct: 185 GTFTIKS-------DVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPE 237

Query: 575 EGKDFLRCCFQRNPADRPPASLLLE--HRFLKNSQ 607
           E    +R C++  P DRP    L      F   ++
Sbjct: 238 ELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATE 272

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  200 bits (510), Expect = 3e-59
 Identities = 64/305 (20%), Positives = 117/305 (38%), Gaps = 44/305 (14%)

Query: 333 PEPLPMNSQW-------QKGKLIGRGTFGSVYVASNRETGALCAMKEVDI-FPDDPKSAE 384
                 + +W       + GK++G G FG V  A+           +V +    +   + 
Sbjct: 23  FREYEYDLKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSS 82

Query: 385 SIKQLEQEIKVLSHL-KHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREH------- 436
             + L  E+K+++ L  H NIV   G+  +    Y+  EY   G +  Y+R         
Sbjct: 83  EREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSED 142

Query: 437 ---------------CGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGV 481
                             +T   +  F   +  G+ +L  K  +HRD+   N+LV    V
Sbjct: 143 EIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKV 202

Query: 482 VKLADFGMAKHLTGQKADLSM---KGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCT 538
           VK+ DFG+A+ +      +     +    WMAPE     + +G  +      D+WS G  
Sbjct: 203 VKICDFGLARDIMSDSNYVVRGNARLPVKWMAPE----SLFEGIYTI---KSDVWSYGIL 255

Query: 539 IIEMYT-GKPPWSEYEGAAAMFKVMRD--TPAIPDSLSPEGKDFLRCCFQRNPADRPPAS 595
           + E+++ G  P+      A  +K++++      P   + E    ++ C+  +   RP   
Sbjct: 256 LWEIFSLGVNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFP 315

Query: 596 LLLEH 600
            L   
Sbjct: 316 NLTSF 320

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  200 bits (509), Expect = 8e-59
 Identities = 67/320 (20%), Positives = 121/320 (37%), Gaps = 52/320 (16%)

Query: 339 NSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSH 398
             ++     IG G +G V  A +       A+K++  F          ++  +EIK+L  
Sbjct: 7   GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQ----TYCQRTLREIKILLR 62

Query: 399 LKHPNIVQYYG---SEIVEDKFYIYL-EYVHPGSINKYVREHCGAITESVVRNFTRHILS 454
            +H NI+       +  +E    +YL  ++    + K ++     ++   +  F   IL 
Sbjct: 63  FRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKT--QHLSNDHICYFLYQILR 120

Query: 455 GLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMK----GSPYWMA 510
           GL Y+HS   +HRD+K +NLL++ +  +K+ DFG+A+                 + ++ A
Sbjct: 121 GLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 180

Query: 511 PELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPD 570
           PE+M+      KS      +DIWS+GC + EM + +P +        +  ++    +   
Sbjct: 181 PEIMLNSKGYTKS------IDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQ 234

Query: 571 -------------------------------SLSPEGKDFLRCCFQRNPADRPPASLLLE 599
                                          +   +  D L      NP  R      L 
Sbjct: 235 EDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 294

Query: 600 HRFLKNSQQP-DVPSCSLSF 618
           H +L+    P D P     F
Sbjct: 295 HPYLEQYYDPSDEPIAEAPF 314

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  198 bits (504), Expect = 1e-58
 Identities = 74/300 (24%), Positives = 127/300 (42%), Gaps = 40/300 (13%)

Query: 339 NSQWQKGKLIGRGTFGSVYVASNRET-GALCAMKEVDIFPDDPKSAESIKQLEQEIKVLS 397
           + Q++    IG G +G V+ A + +  G   A+K V +   +     S  +    ++ L 
Sbjct: 6   DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLE 65

Query: 398 HLKHPNIVQYYGSEIV-----EDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHI 452
             +HPN+V+ +    V     E K  +  E+V         +     +    +++    +
Sbjct: 66  TFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQL 125

Query: 453 LSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPYWMAPE 512
           L GL +LHS + +HRD+K  N+LV +SG +KLADFG+A+  + Q A  S+  + ++ APE
Sbjct: 126 LRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPE 185

Query: 513 LMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMR--------- 563
               V+ +   +     VD+WS+GC   EM+  KP +        + K++          
Sbjct: 186 ----VLLQSSYAT---PVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED 238

Query: 564 ------------------DTPAIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKN 605
                                     +   GKD L  C   NPA R  A   L H + ++
Sbjct: 239 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQD 298

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  198 bits (504), Expect = 2e-58
 Identities = 76/293 (25%), Positives = 141/293 (48%), Gaps = 23/293 (7%)

Query: 328 QVAAKPEPLPMNSQWQKGKLIGRGTFGSVYVA---SNRETGALCAMKEVDIFPDDPKSAE 384
            +    E + +   ++  K++G G +G V++    S  +TG L AMK +       + A+
Sbjct: 13  NLTGHAEKVGIE-NFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKK-ATIVQKAK 70

Query: 385 SIKQLEQEIKVLSHLKH-PNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITES 443
           + +    E +VL H++  P +V  + +   E K ++ L+Y++ G +  ++ +     TE 
Sbjct: 71  TTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRER-FTEH 129

Query: 444 VVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLS-- 501
            V+ +   I+  L +LH    I+RDIK  N+L+D++G V L DFG++K     + + +  
Sbjct: 130 EVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYD 189

Query: 502 MKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKV 561
             G+  +MAP+++     +G  S    AVD WSLG  + E+ TG  P++      +  ++
Sbjct: 190 FCGTIEYMAPDIV-----RGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEI 244

Query: 562 MR----DTPAIPDSLSPEGKDFLRCCFQRNPADRPP-----ASLLLEHRFLKN 605
            R      P  P  +S   KD ++    ++P  R       A  + EH F + 
Sbjct: 245 SRRILKSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQK 297

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  196 bits (498), Expect = 7e-58
 Identities = 69/278 (24%), Positives = 122/278 (43%), Gaps = 20/278 (7%)

Query: 340 SQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHL 399
           +       +G G +G VY    ++     A+K +       +    +++  +E  V+  +
Sbjct: 17  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK------EDTMEVEEFLKEAAVMKEI 70

Query: 400 KHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHC-GAITESVVRNFTRHILSGLAY 458
           KHPN+VQ  G    E  FYI  E++  G++  Y+RE     ++  V+      I S + Y
Sbjct: 71  KHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEY 130

Query: 459 LHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLS--MKGSPYWMAPELMMA 516
           L  K  IHRD+   N LV  + +VK+ADFG+++ +TG         K    W APE    
Sbjct: 131 LEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE---- 186

Query: 517 VMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRD--TPAIPDSLSP 574
            +   K S      D+W+ G  + E+ T           + +++++        P+    
Sbjct: 187 SLAYNKFSI---KSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPE 243

Query: 575 EGKDFLRCCFQRNPADRPPASLLLE--HRFLKNSQQPD 610
           +  + +R C+Q NP+DRP  + + +      + S   D
Sbjct: 244 KVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISD 281

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  196 bits (500), Expect = 8e-58
 Identities = 61/277 (22%), Positives = 119/277 (42%), Gaps = 15/277 (5%)

Query: 339 NSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSH 398
            ++++K K++G G FG+VY       G    +        +  S ++ K++  E  V++ 
Sbjct: 8   ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMAS 67

Query: 399 LKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAY 458
           + +P++ +  G   +     +  + +  G +  YVREH   I    + N+   I  G+ Y
Sbjct: 68  VDNPHVCRLLGI-CLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNY 126

Query: 459 LHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSM---KGSPYWMAPELMM 515
           L  ++ +HRD+   N+LV     VK+ DFG+AK L  ++ +      K    WMA E   
Sbjct: 127 LEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE--- 183

Query: 516 AVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFKVMRD-TPAIPDSLS 573
             +     +  +   D+WS G T+ E+ T G  P+     +     + +      P   +
Sbjct: 184 -SILHRIYTHQS---DVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICT 239

Query: 574 PEGKDFLRCCFQRNPADRPPASLLLEH--RFLKNSQQ 608
            +    +  C+  +   RP    L+    +  ++ Q+
Sbjct: 240 IDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQR 276

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  196 bits (498), Expect = 8e-58
 Identities = 58/295 (19%), Positives = 103/295 (34%), Gaps = 38/295 (12%)

Query: 341 QWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLK 400
           +++ G+ IG G+FG +Y+ ++   G   A+K                QL  E K+   ++
Sbjct: 8   RYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLE-------CVKTKHPQLHIESKIYKMMQ 60

Query: 401 HPN-IVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYL 459
               I          D   + +E +   S+           +   V      ++S + Y+
Sbjct: 61  GGVGIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYI 119

Query: 460 HSKKTIHRDIKGANLLV---DASGVVKLADFGMAKHLTGQKADL--------SMKGSPYW 508
           HSK  IHRD+K  N L+       +V + DFG+AK     +           ++ G+  +
Sbjct: 120 HSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARY 179

Query: 509 MAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMR----- 563
            +    + + Q  +        D+ SLG  ++    G  PW   + A    K  R     
Sbjct: 180 ASINTHLGIEQSRRD-------DLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKK 232

Query: 564 ---DTPAIPDSLSPEGKDFLRCCFQRNPADRPPASLL---LEHRFLKNSQQPDVP 612
                  +      E   +L  C      D+P  S L     + F +     D  
Sbjct: 233 MSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYV 287

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  194 bits (495), Expect = 2e-57
 Identities = 69/281 (24%), Positives = 123/281 (43%), Gaps = 22/281 (7%)

Query: 340 SQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHL 399
              +    +G+G FG V++ +   T    A+K +           S +   QE +V+  L
Sbjct: 17  ESLRLEVKLGQGCFGEVWMGTWNGTT-RVAIKTLK------PGTMSPEAFLQEAQVMKKL 69

Query: 400 KHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCG-AITESVVRNFTRHILSGLAY 458
           +H  +VQ Y   + E+  YI  EY+  GS+  +++   G  +    + +    I SG+AY
Sbjct: 70  RHEKLVQLYAV-VSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAY 128

Query: 459 LHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQK--ADLSMKGSPYWMAPELMMA 516
           +     +HRD++ AN+LV  + V K+ADFG+A+ +   +  A    K    W APE    
Sbjct: 129 VERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPE---- 184

Query: 517 VMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFKVMRD-TPAIPDSLSP 574
               G+ +   +  D+WS G  + E+ T G+ P+        + +V R      P     
Sbjct: 185 AALYGRFT---IKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPE 241

Query: 575 EGKDFLRCCFQRNPADRPPASLLLE--HRFLKNSQQPDVPS 613
              D +  C+++ P +RP    L      +  +++    P 
Sbjct: 242 SLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPG 282

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  196 bits (500), Expect = 2e-57
 Identities = 76/270 (28%), Positives = 127/270 (47%), Gaps = 17/270 (6%)

Query: 341 QWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLK 400
           Q+ + K +G G+FG V +  ++E+G   AMK +D         + I+    E ++L  + 
Sbjct: 42  QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILD--KQKVVKLKQIEHTLNEKRILQAVN 99

Query: 401 HPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLH 460
            P +V+   S       Y+ +EYV  G +  ++R   G  +E   R +   I+    YLH
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLH 158

Query: 461 SKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPYWMAPELMMAVMQK 520
           S   I+RD+K  NLL+D  G +++ DFG AK + G+    ++ G+P  +APE+++     
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR--TWTLCGTPEALAPEIIL----- 211

Query: 521 GKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDSLSPEGKDFL 580
            K  + A  VD W+LG  I EM  G PP+   +      K++      P   S + KD L
Sbjct: 212 SKGYNKA--VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLL 269

Query: 581 RCCFQRNPADRPP-----ASLLLEHRFLKN 605
           R   Q +   R        + +  H++   
Sbjct: 270 RNLLQVDLTKRFGNLKNGVNDIKNHKWFAT 299

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  193 bits (492), Expect = 4e-57
 Identities = 71/297 (23%), Positives = 123/297 (41%), Gaps = 42/297 (14%)

Query: 338 MNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLS 397
           M  ++   + IG GT+G VY A N   G   A+K++ +   + +         +EI +L 
Sbjct: 1   ME-KYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRL---EKEDEGIPSTTIREISILK 55

Query: 398 HLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLA 457
            LKH NIV+ Y     + +  +  E++             G +     ++F   +L+G+A
Sbjct: 56  ELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCE-GGLESVTAKSFLLQLLNGIA 114

Query: 458 YLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHL-TGQKADLSMKGSPYWMAPELMMA 516
           Y H ++ +HRD+K  NLL++  G +K+ADFG+A+      +       + ++ AP+++M 
Sbjct: 115 YCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMG 174

Query: 517 VMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMR------------- 563
             +          +DIWS+GC   EM  G P +     A  + ++ R             
Sbjct: 175 SKKYST------TIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNV 228

Query: 564 ----------------DTPAIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLK 604
                              +    L   G D L    + +P  R  A   LEH + K
Sbjct: 229 TELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFK 285

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  191 bits (487), Expect = 2e-56
 Identities = 61/270 (22%), Positives = 107/270 (39%), Gaps = 21/270 (7%)

Query: 340 SQWQKGKLIGRGTFGSVYVASNRETG----ALCAMKEVDIFPDDPKSAESIKQLEQEIKV 395
           S   + K+IG G FG VY    + +        A+K +     +    +       E  +
Sbjct: 7   SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTE----KQRVDFLGEAGI 62

Query: 396 LSHLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSG 455
           +    H NI++  G         I  EY+  G+++K++RE  G  +   +    R I +G
Sbjct: 63  MGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAG 122

Query: 456 LAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADL----SMKGSPYWMAP 511
           + YL +   +HRD+   N+LV+++ V K++DFG+++ L             K    W AP
Sbjct: 123 MKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAP 182

Query: 512 ELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRD--TPAIP 569
           E +        S       D+WS G  + E+ T             + K + D      P
Sbjct: 183 EAISYRKFTSAS-------DVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTP 235

Query: 570 DSLSPEGKDFLRCCFQRNPADRPPASLLLE 599
                     +  C+Q+  A RP  + ++ 
Sbjct: 236 MDCPSAIYQLMMQCWQQERARRPKFADIVS 265

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  192 bits (489), Expect = 7e-56
 Identities = 77/326 (23%), Positives = 128/326 (39%), Gaps = 53/326 (16%)

Query: 325 TIPQVAAKPEPLPMNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAE 384
           T+     +    P    +   K+IG G+FG VY A   ++G L A+K+V          +
Sbjct: 5   TVVATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL---------Q 55

Query: 385 SIKQLEQEIKVLSHLKHPNIVQYYG----SEIVEDKFYIYL--EYVHPG--SINKYVREH 436
             +   +E++++  L H NIV+       S   +D+ Y+ L  +YV      + ++    
Sbjct: 56  DKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRA 115

Query: 437 CGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASG-VVKLADFGMAKHLTG 495
              +    V+ +   +   LAY+HS    HRDIK  NLL+D    V+KL DFG AK L  
Sbjct: 116 KQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR 175

Query: 496 QKADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGA 555
            + ++S   S Y+ APEL+              ++D+WS GC + E+  G+P +    G 
Sbjct: 176 GEPNVSYICSRYYRAPELIFGATDYTS------SIDVWSAGCVLAELLLGQPIFPGDSGV 229

Query: 556 AAMFKVMR-----------------------------DTPAIPDSLSPEGKDFLRCCFQR 586
             + ++++                              T        PE         + 
Sbjct: 230 DQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEY 289

Query: 587 NPADRPPASLLLEHRFLKNSQQPDVP 612
            P  R        H F    + P+V 
Sbjct: 290 TPTARLTPLEACAHSFFDELRDPNVK 315

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  192 bits (488), Expect = 9e-56
 Identities = 73/326 (22%), Positives = 135/326 (41%), Gaps = 51/326 (15%)

Query: 340 SQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHL 399
           + ++  + +G G +G+V  A +  TGA  A+K         +S    K+  +E+++L H+
Sbjct: 18  AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIK---KLYRPFQSELFAKRAYRELRLLKHM 74

Query: 400 KHPNIVQYYGS----EIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSG 455
           +H N++         E ++D    YL     G+    + +H   + E  ++     +L G
Sbjct: 75  RHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKH-EKLGEDRIQFLVYQMLKG 133

Query: 456 LAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPYWMAPELMM 515
           L Y+H+   IHRD+K  NL V+    +K+ DFG+A+    +        + ++ APE+++
Sbjct: 134 LRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMT--GYVVTRWYRAPEVIL 191

Query: 516 AVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMR------------ 563
             M+  +       VDIWS+GC + EM TGK  +   +    + ++M+            
Sbjct: 192 NWMRYTQ------TVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQR 245

Query: 564 -------------------DTPAIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLK 604
                              D  +I  + SP   + L      +   R  A   L H + +
Sbjct: 246 LQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFE 305

Query: 605 N----SQQPDVPSCSLSFSGMQLTEK 626
           +      +P V     SF  +  T  
Sbjct: 306 SLHDTEDEPQVQKYDDSFDDVDRTLD 331

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  190 bits (484), Expect = 1e-55
 Identities = 66/267 (24%), Positives = 110/267 (41%), Gaps = 22/267 (8%)

Query: 345 GKLIGRGTFGSVYVA---SNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKH 401
            ++IGRG FG VY      N      CA+K ++   D       + Q   E  ++    H
Sbjct: 32  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDI----GEVSQFLTEGIIMKDFSH 87

Query: 402 PNIVQYYGSEIV-EDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLH 460
           PN++   G  +  E    + L Y+  G +  ++R      T   +  F   +  G+ +L 
Sbjct: 88  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLA 147

Query: 461 SKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADL-----SMKGSPYWMAPELMM 515
           SKK +HRD+   N ++D    VK+ADFG+A+ +  ++ D        K    WMA E + 
Sbjct: 148 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQ 207

Query: 516 AVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFKVMRDT-PAIPDSLS 573
                 KS       D+WS G  + E+ T G PP+ +         +++      P+   
Sbjct: 208 TQKFTTKS-------DVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCP 260

Query: 574 PEGKDFLRCCFQRNPADRPPASLLLEH 600
               + +  C+      RP  S L+  
Sbjct: 261 DPLYEVMLKCWHPKAEMRPSFSELVSR 287

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  190 bits (483), Expect = 1e-55
 Identities = 64/279 (22%), Positives = 115/279 (41%), Gaps = 27/279 (9%)

Query: 340 SQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHL 399
           +  +   +IG G FG V  A  ++ G         +   +  S +  +    E++VL  L
Sbjct: 10  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRM--KEYASKDDHRDFAGELEVLCKL 67

Query: 400 -KHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHC---------------GAITES 443
             HPNI+   G+       Y+ +EY   G++  ++R+                   ++  
Sbjct: 68  GHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQ 127

Query: 444 VVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMK 503
            + +F   +  G+ YL  K+ IHRD+   N+LV  + V K+ADFG+++           +
Sbjct: 128 QLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGR 187

Query: 504 GSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFKVM 562
               WMA E +   +    S       D+WS G  + E+ + G  P+     A    K+ 
Sbjct: 188 LPVRWMAIESLNYSVYTTNS-------DVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP 240

Query: 563 RD-TPAIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEH 600
           +      P +   E  D +R C++  P +RP  + +L  
Sbjct: 241 QGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 279

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  189 bits (480), Expect = 5e-55
 Identities = 73/315 (23%), Positives = 125/315 (39%), Gaps = 55/315 (17%)

Query: 340 SQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHL 399
           S+++K   IG+GTFG V+ A +R+TG   A+K+V +   + +         +EIK+L  L
Sbjct: 10  SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLM---ENEKEGFPITALREIKILQLL 66

Query: 400 KHPNIVQYYGS--------EIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRH 451
           KH N+V                +   Y+  ++         +       T S ++   + 
Sbjct: 67  KHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLA-GLLSNVLVKFTLSEIKRVMQM 125

Query: 452 ILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADL-----SMKGSP 506
           +L+GL Y+H  K +HRD+K AN+L+   GV+KLADFG+A+  +  K        +   + 
Sbjct: 126 LLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTL 185

Query: 507 YWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTP 566
           ++  PEL++     G        +D+W  GC + EM+T  P          +  + +   
Sbjct: 186 WYRPPELLLGERDYGP------PIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCG 239

Query: 567 AIPD--------------------------------SLSPEGKDFLRCCFQRNPADRPPA 594
           +I                                     P   D +      +PA R  +
Sbjct: 240 SITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDS 299

Query: 595 SLLLEHRFLKNSQQP 609
              L H F  +   P
Sbjct: 300 DDALNHDFFWSDPMP 314

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  188 bits (477), Expect = 6e-55
 Identities = 72/296 (24%), Positives = 124/296 (41%), Gaps = 41/296 (13%)

Query: 341 QWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLK 400
           +++K + IG GT+G+V+ A NRET  + A+K V +  DD           +EI +L  LK
Sbjct: 3   KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGV---PSSALREICLLKELK 59

Query: 401 HPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLH 460
           H NIV+ +     + K  +  E+        Y     G +   +V++F   +L GL + H
Sbjct: 60  HKNIVRLHDVLHSDKKLTLVFEFCDQDLKK-YFDSCNGDLDPEIVKSFLFQLLKGLGFCH 118

Query: 461 SKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKG-SPYWMAPELMMAVMQ 519
           S+  +HRD+K  NLL++ +G +KLA+FG+A+         S +  + ++  P+++     
Sbjct: 119 SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKL 178

Query: 520 KGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVM----------------- 562
              S      +D+WS GC   E+     P           K +                 
Sbjct: 179 YSTS------IDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTK 232

Query: 563 -------------RDTPAIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKN 605
                             +   L+  G+D L+   + NP  R  A   L+H +  +
Sbjct: 233 LPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSD 288

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  186 bits (474), Expect = 2e-54
 Identities = 68/293 (23%), Positives = 126/293 (43%), Gaps = 44/293 (15%)

Query: 340 SQWQKGKLIGRGTFGSVYVA-----SNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIK 394
           +  +  + IG G FG V+ A        E   + A+K +     +  SA+     ++E  
Sbjct: 13  NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLK----EEASADMQADFQREAA 68

Query: 395 VLSHLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCG---------------- 438
           +++   +PNIV+  G   V     +  EY+  G +N+++R                    
Sbjct: 69  LMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRAR 128

Query: 439 -------AITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAK 491
                   ++ +      R + +G+AYL  +K +HRD+   N LV  + VVK+ADFG+++
Sbjct: 129 VSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSR 188

Query: 492 HLTGQ---KADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKP 547
           ++      KAD +      WM PE +       +S       D+W+ G  + E+++ G  
Sbjct: 189 NIYSADYYKADGNDAIPIRWMPPESIFYNRYTTES-------DVWAYGVVLWEIFSYGLQ 241

Query: 548 PWSEYEGAAAMFKVMR-DTPAIPDSLSPEGKDFLRCCFQRNPADRPPASLLLE 599
           P+        ++ V   +  A P++   E  + +R C+ + PADRP    +  
Sbjct: 242 PYYGMAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHR 294

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  185 bits (469), Expect = 2e-53
 Identities = 69/303 (22%), Positives = 124/303 (40%), Gaps = 47/303 (15%)

Query: 333 PEPLPMNSQW-------QKGKLIGRGTFGSVYVA-----SNRETGALCAMKEVDIFPDDP 380
           P  LP + +W         GK +G G FG V  A        +     A+K +       
Sbjct: 9   PTQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPS---- 64

Query: 381 KSAESIKQLEQEIKVLSHLK-HPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHC-- 437
                 + L  E+KVLS+L  H NIV   G+  +     +  EY   G +  ++R     
Sbjct: 65  AHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDS 124

Query: 438 ---------------GAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVV 482
                           A+    + +F+  +  G+A+L SK  IHRD+   N+L+    + 
Sbjct: 125 FICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRIT 184

Query: 483 KLADFGMAKHLTGQKADLS---MKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTI 539
           K+ DFG+A+ +      +     +    WMAPE +   +   +S       D+WS G  +
Sbjct: 185 KICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFES-------DVWSYGIFL 237

Query: 540 IEMYT-GKPPWSEYEGAAAMFKVMRD--TPAIPDSLSPEGKDFLRCCFQRNPADRPPASL 596
            E+++ G  P+      +  +K++++      P+    E  D ++ C+  +P  RP    
Sbjct: 238 WELFSLGSSPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQ 297

Query: 597 LLE 599
           +++
Sbjct: 298 IVQ 300

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  181 bits (460), Expect = 2e-52
 Identities = 48/293 (16%), Positives = 92/293 (31%), Gaps = 38/293 (12%)

Query: 342 WQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKH 401
           ++ G+ IG G+FG ++  +N       A+K      D P       QL  E +    L  
Sbjct: 7   YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAP-------QLRDEYRTYKLLAG 59

Query: 402 PNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHS 461
              +        E    + +  +   S+   +       +   V    + +L+ +  +H 
Sbjct: 60  CTGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHE 119

Query: 462 KKTIHRDIKGANLLVDA-----SGVVKLADFGMAKHLTGQKADL--------SMKGSPYW 508
           K  ++RDIK  N L+       + ++ + DFGM K                 ++ G+  +
Sbjct: 120 KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARY 179

Query: 509 MAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMR----- 563
           M+    +     G+        D+ +LG   +    G  PW   + A    K  R     
Sbjct: 180 MSINTHL-----GREQSR--RDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKK 232

Query: 564 ---DTPAIPDSLSPEGKDFLRCCFQRNPADRPPASLL---LEHRFLKNSQQPD 610
                  +      E   ++           P    L         + +   D
Sbjct: 233 QSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTED 285

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  181 bits (459), Expect = 7e-52
 Identities = 65/306 (21%), Positives = 117/306 (38%), Gaps = 60/306 (19%)

Query: 342 WQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLK- 400
           +Q  + +GRG +  V+ A N        +K +             K++++EIK+L +L+ 
Sbjct: 37  YQLVRKLGRGKYSEVFEAINITNNEKVVVKILK--------PVKKKKIKREIKILENLRG 88

Query: 401 HPNIVQYYGS--EIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAY 458
            PNI+       + V     +  E+V+        ++    +T+  +R +   IL  L Y
Sbjct: 89  GPNIITLADIVKDPVSRTPALVFEHVNNTDF----KQLYQTLTDYDIRFYMYEILKALDY 144

Query: 459 LHSKKTIHRDIKGANLLVDASG-VVKLADFGMAKHLTGQKADLSMKGSPYWMAPELMMAV 517
            HS   +HRD+K  N+++D     ++L D+G+A+     +       S Y+  PEL++  
Sbjct: 145 CHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDY 204

Query: 518 MQKGKSSDSALAVDIWSLGCTIIEMYTGKPPW----SEYEGAAAMFKVM----------- 562
                      ++D+WSLGC +  M   K P+      Y+    + KV+           
Sbjct: 205 QMYDY------SLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDK 258

Query: 563 -----------------------RDTPAIPDSLSPEGKDFLRCCFQRNPADRPPASLLLE 599
                                           +SPE  DFL    + +   R  A   +E
Sbjct: 259 YNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318

Query: 600 HRFLKN 605
           H +   
Sbjct: 319 HPYFYT 324

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  180 bits (456), Expect = 3e-51
 Identities = 71/313 (22%), Positives = 126/313 (40%), Gaps = 49/313 (15%)

Query: 343 QKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHP 402
           Q    +G G +GSV  A + +TG   A+K         +S    K+  +E+++L H+KH 
Sbjct: 21  QNLSPVGSGAYGSVCAAFDTKTGLRVAVK---KLSRPFQSIIHAKRTYRELRLLKHMKHE 77

Query: 403 NIVQYYGS-----EIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLA 457
           N++           + E      + ++    +N  V+  C  +T+  V+     IL GL 
Sbjct: 78  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILRGLK 135

Query: 458 YLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPYWMAPELMMAV 517
           Y+HS   IHRD+K +NL V+    +K+ DFG+A+H   +        + ++ APE+M+  
Sbjct: 136 YIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT--GYVATRWYRAPEIMLNW 193

Query: 518 MQKGKSSDSALAVDIWSLGCTIIEMYTGKPPW---SEYEGAAAMFKVMRDTPA------- 567
           M   +       VDIWS+GC + E+ TG+  +      +    + +++    A       
Sbjct: 194 MHYNQ------TVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 247

Query: 568 ---------------------IPDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNS 606
                                +    +P   D L      +   R  A+  L H +    
Sbjct: 248 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 307

Query: 607 QQPDVPSCSLSFS 619
             PD    +  + 
Sbjct: 308 HDPDDEPVADPYD 320

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  176 bits (448), Expect = 1e-50
 Identities = 65/299 (21%), Positives = 114/299 (38%), Gaps = 32/299 (10%)

Query: 340 SQWQKGKLIGRGTFGSVYVASNR-----ETGALCAMKEVDIFPDDPKSAESIKQLEQEIK 394
            +    + +G+G+FG VY    +     E     A+K V+    +  S     +   E  
Sbjct: 20  EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVN----EAASMRERIEFLNEAS 75

Query: 395 VLSHLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGA---------ITESVV 445
           V+      ++V+  G         + +E +  G +  Y+R    A          + S +
Sbjct: 76  VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKM 135

Query: 446 RNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSM--- 502
                 I  G+AYL++ K +HRD+   N +V     VK+ DFGM + +            
Sbjct: 136 IQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKG 195

Query: 503 KGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTG-KPPWSEYEGAAAMFKV 561
                WM+PE     ++ G  +      D+WS G  + E+ T  + P+        +  V
Sbjct: 196 LLPVRWMSPE----SLKDGVFTT---YSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFV 248

Query: 562 MR-DTPAIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQPDVPSCSLSFS 619
           M       PD+      + +R C+Q NP  RP    ++    +K   +P     S  +S
Sbjct: 249 MEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS--IKEEMEPGFREVSFYYS 305

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  176 bits (446), Expect = 2e-50
 Identities = 67/300 (22%), Positives = 122/300 (40%), Gaps = 46/300 (15%)

Query: 336 LPMNSQW-------QKGKLIGRGTFGSVYVASNRET-------GALCAMKEVDIFPDDPK 381
           LP + +W         GK +G G FG V +A                A+K +        
Sbjct: 2   LPEDPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLK----SDA 57

Query: 382 SAESIKQLEQEIKVLSHL-KHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHC--- 437
           + + +  L  E++++  + KH NI+   G+   +   Y+ +EY   G++ +Y++      
Sbjct: 58  TEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPG 117

Query: 438 ------------GAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLA 485
                         ++   + +    +  G+ YL SKK IHRD+   N+LV    V+K+A
Sbjct: 118 LEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIA 177

Query: 486 DFGMAKHLTGQKADLS---MKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEM 542
           DFG+A+ +            +    WMAPE     +     +      D+WS G  + E+
Sbjct: 178 DFGLARDIHHIDYYKKTTNGRLPVKWMAPE----ALFDRIYTH---QSDVWSFGVLLWEI 230

Query: 543 YTGKPPWSEYEGAAAMFKVMRD--TPAIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEH 600
           +T             +FK++++      P + + E    +R C+   P+ RP    L+E 
Sbjct: 231 FTLGGSPYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 290

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  174 bits (442), Expect = 3e-49
 Identities = 67/348 (19%), Positives = 121/348 (34%), Gaps = 63/348 (18%)

Query: 343 QKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHP 402
           Q  K IG G  G V  A +       A+K         ++    K+  +E+ ++  + H 
Sbjct: 20  QNLKPIGSGAQGIVCAAYDAVLDRNVAIK---KLSRPFQNQTHAKRAYRELVLMKCVNHK 76

Query: 403 NIVQYYGSEIVEDKF------YIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGL 456
           NI+        +         Y+ +E +         +     +    +      +L G+
Sbjct: 77  NIISLLNVFTPQKTLEEFQDVYLVMELMDAN----LCQVIQMELDHERMSYLLYQMLCGI 132

Query: 457 AYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPYWMAPELMMA 516
            +LHS   IHRD+K +N++V +   +K+ DFG+A+             + Y+ APE+++ 
Sbjct: 133 KHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILG 192

Query: 517 VMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDS----- 571
           +  K         VDIWS+GC + EM   K  +   +      KV+              
Sbjct: 193 MGYKEN-------VDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL 245

Query: 572 -------------------------------------LSPEGKDFLRCCFQRNPADRPPA 594
                                                 + + +D L      +PA R   
Sbjct: 246 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISV 305

Query: 595 SLLLEHRFLKNSQQP-DVPSCSLSFSGMQLTEKPHSPREKADAKYDQV 641
              L+H ++     P +V +        QL E+ H+  E  +  Y +V
Sbjct: 306 DDALQHPYINVWYDPAEVEAPPPQIYDKQLDEREHTIEEWKELIYKEV 353

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  171 bits (433), Expect = 2e-48
 Identities = 61/294 (20%), Positives = 106/294 (36%), Gaps = 50/294 (17%)

Query: 345 GKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNI 404
            + IG+G FG V+    +  G   A+K            E     E EI     L+H NI
Sbjct: 8   QESIGKGRFGEVWRG--KWRGEEVAVKIFS------SREERSWFREAEIYQTVMLRHENI 59

Query: 405 VQYYGSEIVED----KFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLH 460
           + +  ++  ++    + ++  +Y   GS+  Y+  +   +T   +        SGLA+LH
Sbjct: 60  LGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLH 117

Query: 461 S--------KKTIHRDIKGANLLVDASGVVKLADFGMAKHL-----TGQKADLSMKGSPY 507
                        HRD+K  N+LV  +G   +AD G+A        T   A     G+  
Sbjct: 118 MEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKR 177

Query: 508 WMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDT-- 565
           +MAPE++   +            DI+++G    E+         +E     +  +  +  
Sbjct: 178 YMAPEVLDDSINMKHFESFK-RADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP 236

Query: 566 ---------------PAIPDSLSPEG-----KDFLRCCFQRNPADRPPASLLLE 599
                          P IP+              +R C+  N A R  A  + +
Sbjct: 237 SVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK 290

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  168 bits (425), Expect = 2e-47
 Identities = 61/285 (21%), Positives = 116/285 (40%), Gaps = 31/285 (10%)

Query: 340 SQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDI-FPDDPKSAESIKQLEQEIKVLSH 398
            + + GK +GRG FG V  A           + V +    +  +    + L  E+K+L H
Sbjct: 13  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72

Query: 399 LKHPNIVQYYGSEIVED--KFYIYLEYVHPGSINKYVREHCG---------------AIT 441
           + H   V        +      + +E+   G+++ Y+R                    +T
Sbjct: 73  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132

Query: 442 ESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADL- 500
              +  ++  +  G+ +L S+K IHRD+   N+L+    VVK+ DFG+A+ +      + 
Sbjct: 133 LEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVR 192

Query: 501 --SMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTG-KPPWSEYEGAAA 557
               +    WMA      +  +  +  S    D+WS G  + E+++    P+   +    
Sbjct: 193 KGDARLPLKWMA---PETIFDRVYTIQS----DVWSFGVLLWEIFSLGASPYPGVKIDEE 245

Query: 558 MFKVMRD--TPAIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEH 600
             + +++      PD  +PE    +  C+   P+ RP  S L+EH
Sbjct: 246 FCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 290

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  145 bits (367), Expect = 5e-39
 Identities = 66/358 (18%), Positives = 126/358 (35%), Gaps = 88/358 (24%)

Query: 339 NSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSH 398
           ++++   + +G G F +V++A +       AMK V             +  E EIK+L  
Sbjct: 12  DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVR------GDKVYTEAAEDEIKLLQR 65

Query: 399 LKHPNIVQ-------------YYGSEIVEDKFYIYLEYVHPGSINKYV--REHCGAITES 443
           +   +  +              + +    +  ++ + +   G     +  +     I   
Sbjct: 66  VNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLI 125

Query: 444 VVRNFTRHILSGLAYLHSKKTI-HRDIKGANLLVDASGV------VKLADFGMAKHLTGQ 496
            V+  ++ +L GL Y+H +  I H DIK  N+L++          +K+AD G A      
Sbjct: 126 YVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEH 185

Query: 497 KADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGA- 555
             +     +  + +PE+++        +      DIWS  C I E+ TG   +   EG  
Sbjct: 186 YTN--SIQTREYRSPEVLL-------GAPWGCGADIWSTACLIFELITGDFLFEPDEGHS 236

Query: 556 --------AAMFKVMRDTPA---------------------------------------I 568
                   A + +++ + P+                                        
Sbjct: 237 YTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKF 296

Query: 569 PDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNS---QQPDVPSCSLSFSGMQL 623
               + E  DFL    Q +P  R  A  L+ H +LK++   ++  VP   L  SG  +
Sbjct: 297 SKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLKDTLGMEEIRVPDRELYGSGSDI 354

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score =  104 bits (259), Expect = 4e-26
 Identities = 35/213 (16%), Positives = 70/213 (32%), Gaps = 42/213 (19%)

Query: 345 GKLIGRGTFGSVYVASNRETGALCAMKEVDI-------------FPDDPKSAESIKQLEQ 391
           GKL+G G   +V+   + E    C +K   +             + D   S  +I+    
Sbjct: 5   GKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARN 63

Query: 392 EIKVLSHLKHPNIVQYYGSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRH 451
           E + L  L+   + + Y      +   + +E +    + +   E+               
Sbjct: 64  EFRALQKLQGLAVPKVYAW----EGNAVLMELIDAKELYRVRVENP--------DEVLDM 111

Query: 452 ILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADLSMKGSPYWMAP 511
           IL  +A  + +  +H D+   N+LV   G + + DF  +  +                  
Sbjct: 112 ILEEVAKFYHRGIVHGDLSQYNVLVSEEG-IWIIDFPQSVEVG------------EEGWR 158

Query: 512 ELMM---AVMQKGKSSDSALAVDIWSLGCTIIE 541
           E++      +    S       DI S    I++
Sbjct: 159 EILERDVRNIITYFSRTYRTEKDINSAIDRILQ 191

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	721
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.91
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.39
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	98.0
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	97.87
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	96.96
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	96.87
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	96.63

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-59  Score=485.49  Aligned_cols=255  Identities=29%  Similarity=0.553  Sum_probs=230.1

Q ss_pred             CCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeEEE
Q 004959          340 SQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYI  419 (721)
Q Consensus       340 ~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~yL  419 (721)
                      ++|++++.||+|+||+||+|+++.+|+.||||++....  .......+.+.+|+.+|++++|||||++++++.+++.+||
T Consensus         6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~--~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i   83 (263)
T d2j4za1           6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQ--LEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL   83 (263)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHH--HHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred             hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHH--ccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEE
Confidence            47999999999999999999999999999999986311  0111234678899999999999999999999999999999


Q ss_pred             EEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCCccc
Q 004959          420 YLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKAD  499 (721)
Q Consensus       420 VmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~~~~  499 (721)
                      |||||+||+|.+++... +.+++.+++.|+.||+.||+|||++|||||||||+||||+.+|.+||+|||+|+...... .
T Consensus        84 vmEy~~~g~L~~~l~~~-~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~~-~  161 (263)
T d2j4za1          84 ILEYAPLGTVYRELQKL-SKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR-R  161 (263)
T ss_dssp             EEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCCC-C
T ss_pred             EEeecCCCcHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCCEeecccceeeecCCCc-c
Confidence            99999999999999865 689999999999999999999999999999999999999999999999999998765433 3


Q ss_pred             ccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhcCCCCCCCCCHHHHHH
Q 004959          500 LSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDSLSPEGKDF  579 (721)
Q Consensus       500 ~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~~~~~p~~lS~el~dL  579 (721)
                      ...+||+.|||||++.       +..++.++|||||||+||||++|+.||.+....+.+.++.+....+|..+++++++|
T Consensus       162 ~~~~Gt~~Y~APE~~~-------~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~l  234 (263)
T d2j4za1         162 TTLCGTLDYLPPEMIE-------GRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDL  234 (263)
T ss_dssp             EETTEEGGGCCHHHHT-------TCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCTTSCHHHHHH
T ss_pred             cccCCCCcccCHHHHc-------CCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCccCCHHHHHH
Confidence            4578999999999994       345778999999999999999999999988888888888888888999999999999


Q ss_pred             HHHhcccCCCCCCCHHHHHhcccccc
Q 004959          580 LRCCFQRNPADRPPASLLLEHRFLKN  605 (721)
Q Consensus       580 I~~cL~~DP~kRPSa~eLL~Hp~f~~  605 (721)
                      |.+||+.||++|||++|+|+||||+.
T Consensus       235 i~~~L~~dp~~R~t~~eil~hp~~~~  260 (263)
T d2j4za1         235 ISRLLKHNPSQRPMLREVLEHPWITA  260 (263)
T ss_dssp             HHHHTCSSGGGSCCHHHHHTCHHHHH
T ss_pred             HHHHccCCHhHCcCHHHHHcCcCcCC
Confidence            99999999999999999999999974

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-58  Score=483.27  Aligned_cols=259  Identities=26%  Similarity=0.469  Sum_probs=219.0

Q ss_pred             CCCCCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCe
Q 004959          337 PMNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDK  416 (721)
Q Consensus       337 ~l~~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~  416 (721)
                      |+.++|++++.||+|+||+||+|+++.+|+.||||++....    ..+..+.+.+|+.+|++++|||||++++++.+++.
T Consensus         2 Pf~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~----~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~   77 (271)
T d1nvra_           2 PFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKR----AVDCPENIKKEICINKMLNHENVVKFYGHRREGNI   77 (271)
T ss_dssp             TTTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-----------CHHHHHHHHHTCCCTTBCCEEEEEEETTE
T ss_pred             CCCcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhh----cchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCce
Confidence            45678999999999999999999999999999999987421    22334678999999999999999999999999999


Q ss_pred             EEEEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCC
Q 004959          417 FYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQ  496 (721)
Q Consensus       417 ~yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~  496 (721)
                      +|||||||+||+|.++|... +.+++.+++.++.||+.||+|||++|||||||||+||||+.++.+||+|||+|+.+...
T Consensus        78 ~~ivmEy~~gg~L~~~l~~~-~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~  156 (271)
T d1nvra_          78 QYLFLEYCSGGELFDRIEPD-IGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYN  156 (271)
T ss_dssp             EEEEEECCTTEEGGGGSBTT-TBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECEET
T ss_pred             eEEEEeccCCCcHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCCEEEccchhheeeccC
Confidence            99999999999999999654 68999999999999999999999999999999999999999999999999999876433


Q ss_pred             c---ccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhcCC---CCCC
Q 004959          497 K---ADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTP---AIPD  570 (721)
Q Consensus       497 ~---~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~~~---~~p~  570 (721)
                      .   .....+||+.|||||++.+      ...++.++|||||||+||||++|+.||.................   ....
T Consensus       157 ~~~~~~~~~~GT~~Y~APE~~~~------~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~  230 (271)
T d1nvra_         157 NRERLLNKMCGTLPYVAPELLKR------REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWK  230 (271)
T ss_dssp             TEECCBCCCCSCGGGSCTHHHHC------SSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTTSTTGG
T ss_pred             CccccccceeeCcCccCHhHhcC------CCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccc
Confidence            2   2345789999999999953      22346789999999999999999999976544333333332222   2235


Q ss_pred             CCCHHHHHHHHHhcccCCCCCCCHHHHHhccccccC
Q 004959          571 SLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNS  606 (721)
Q Consensus       571 ~lS~el~dLI~~cL~~DP~kRPSa~eLL~Hp~f~~~  606 (721)
                      .+++++++||.+||+.||++|||++|+|+||||+..
T Consensus       231 ~~s~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~~  266 (271)
T d1nvra_         231 KIDSAPLALLHKILVENPSARITIPDIKKDRWYNKP  266 (271)
T ss_dssp             GSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCC
T ss_pred             cCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCcC
Confidence            689999999999999999999999999999999754

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-57  Score=480.25  Aligned_cols=253  Identities=35%  Similarity=0.623  Sum_probs=224.8

Q ss_pred             CCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeEEE
Q 004959          340 SQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYI  419 (721)
Q Consensus       340 ~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~yL  419 (721)
                      .+|++.+.||+|+||+||+|+++.+|+.||||++.+....     ..+.+.+|+.+|++++|||||++++++.+.+.+||
T Consensus        20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~-----~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~i   94 (293)
T d1yhwa1          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP-----KKELIINEILVMRENKNPNIVNYLDSYLVGDELWV   94 (293)
T ss_dssp             TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCS-----CHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccCh-----HHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEE
Confidence            4799999999999999999999999999999998743211     13578999999999999999999999999999999


Q ss_pred             EEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCCc-c
Q 004959          420 YLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQK-A  498 (721)
Q Consensus       420 VmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~~-~  498 (721)
                      |||||.||+|.+++.+  +.+++.+++.|+.||+.||+|||++|||||||||+||||+.+|.+||+|||+|+.+.... .
T Consensus        95 vmEy~~gg~L~~~~~~--~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~~  172 (293)
T d1yhwa1          95 VMEYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK  172 (293)
T ss_dssp             EEECCTTCBHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCC
T ss_pred             EEEecCCCcHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcEeeccchhheeecccccc
Confidence            9999999999998865  479999999999999999999999999999999999999999999999999999875443 3


Q ss_pred             cccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhcC---CCCCCCCCHH
Q 004959          499 DLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDT---PAIPDSLSPE  575 (721)
Q Consensus       499 ~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~~---~~~p~~lS~e  575 (721)
                      ....+||+.|||||++.       ...++.++|||||||+||+|++|+.||.+....+.+..+....   ...+..++++
T Consensus       173 ~~~~~gt~~Y~aPE~~~-------~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~  245 (293)
T d1yhwa1         173 RSTMVGTPYWMAPEVVT-------RKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAI  245 (293)
T ss_dssp             BCCCCSCGGGCCHHHHS-------SSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSSGGGSCHH
T ss_pred             ccccccCCCccChhhhc-------CCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCcccCCHH
Confidence            45678999999999994       3567789999999999999999999998877777666665442   3445779999


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHHhccccccC
Q 004959          576 GKDFLRCCFQRNPADRPPASLLLEHRFLKNS  606 (721)
Q Consensus       576 l~dLI~~cL~~DP~kRPSa~eLL~Hp~f~~~  606 (721)
                      +++||.+||+.||++|||++|+|+||||+..
T Consensus       246 ~~~li~~~L~~dP~~R~s~~eil~Hp~~~~~  276 (293)
T d1yhwa1         246 FRDFLNRCLDMDVEKRGSAKELLQHQFLKIA  276 (293)
T ss_dssp             HHHHHHHHTCSSTTTSCCHHHHTTCGGGGGC
T ss_pred             HHHHHHHHccCChhHCcCHHHHhcCHhhCCC
Confidence            9999999999999999999999999999753

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.5e-58  Score=481.21  Aligned_cols=259  Identities=36%  Similarity=0.606  Sum_probs=228.5

Q ss_pred             CCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeEEE
Q 004959          340 SQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYI  419 (721)
Q Consensus       340 ~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~yL  419 (721)
                      +.|++++.||+|+||+||+|+++.+|+.||||++....     ....+.+.+|+++|++++|||||++++++.+++.+||
T Consensus        12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~-----~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~l   86 (288)
T d2jfla1          12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKS-----EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWI   86 (288)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSS-----SGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCC-----HHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEE
Confidence            46999999999999999999999999999999986421     2234678899999999999999999999999999999


Q ss_pred             EEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCCc-c
Q 004959          420 YLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQK-A  498 (721)
Q Consensus       420 VmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~~-~  498 (721)
                      |||||+||+|.+++.+..+.+++.+++.++.||+.||.|||++|||||||||+||||+.+|.+||+|||+|+.+.... .
T Consensus        87 vmEy~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~~  166 (288)
T d2jfla1          87 LIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQR  166 (288)
T ss_dssp             EEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHHHH
T ss_pred             EEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCCEEEEechhhhccCCCccc
Confidence            999999999999988766789999999999999999999999999999999999999999999999999998654332 2


Q ss_pred             cccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhcCC---CCCCCCCHH
Q 004959          499 DLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTP---AIPDSLSPE  575 (721)
Q Consensus       499 ~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~~~---~~p~~lS~e  575 (721)
                      ....+||+.|||||++.+...  ....|+.++|||||||+||||++|+.||.+....+.+.++.....   ..+..++++
T Consensus       167 ~~~~~Gt~~y~APE~l~~~~~--~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s~~  244 (288)
T d2jfla1         167 RDSFIGTPYWMAPEVVMCETS--KDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSN  244 (288)
T ss_dssp             HTCCCSCCTTCCHHHHTTCST--TTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCCCCSSGGGSCHH
T ss_pred             ccccccccccCCHHHHhhccc--CCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCccccCCHH
Confidence            345789999999999954221  334578899999999999999999999998877777777776643   334678999


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHHhcccccc
Q 004959          576 GKDFLRCCFQRNPADRPPASLLLEHRFLKN  605 (721)
Q Consensus       576 l~dLI~~cL~~DP~kRPSa~eLL~Hp~f~~  605 (721)
                      +++||++||+.||++|||++|||+||||+.
T Consensus       245 ~~~li~~~L~~dp~~R~t~~ell~hp~~~~  274 (288)
T d2jfla1         245 FKDFLKKCLEKNVDARWTTSQLLQHPFVTV  274 (288)
T ss_dssp             HHHHHHHHSCSSTTTSCCHHHHTTSGGGCC
T ss_pred             HHHHHHHHccCChhHCcCHHHHhcCcccCC
Confidence            999999999999999999999999999974

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.4e-58  Score=482.50  Aligned_cols=258  Identities=28%  Similarity=0.512  Sum_probs=228.3

Q ss_pred             CCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeEEE
Q 004959          340 SQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYI  419 (721)
Q Consensus       340 ~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~yL  419 (721)
                      ++|++++.||+|+||+||+|+++.+|+.||||++.+..  .......+.+.+|+.+|++++|||||++++++.+++.+||
T Consensus         8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~--~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i   85 (288)
T d1uu3a_           8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRH--IIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYF   85 (288)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHH--HHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEE
T ss_pred             CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHH--ccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEE
Confidence            47999999999999999999999999999999986311  0111234678999999999999999999999999999999


Q ss_pred             EEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCCc--
Q 004959          420 YLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQK--  497 (721)
Q Consensus       420 VmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~~--  497 (721)
                      |||||+||+|.+++... +.+++..++.++.||+.||+|||++|||||||||+||||+.+|.+||+|||+|+.+....  
T Consensus        86 vmEy~~gg~L~~~~~~~-~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~  164 (288)
T d1uu3a_          86 GLSYAKNGELLKYIRKI-GSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQ  164 (288)
T ss_dssp             EECCCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred             EEEccCCCCHHHhhhcc-CCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCceEEecccccceecccCCcc
Confidence            99999999999998765 789999999999999999999999999999999999999999999999999998775432  


Q ss_pred             -ccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhcCCCCCCCCCHHH
Q 004959          498 -ADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDSLSPEG  576 (721)
Q Consensus       498 -~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~~~~~p~~lS~el  576 (721)
                       .....+||+.|||||++.+       ..++.++|||||||+||||++|+.||.+.+..+.+.++......+|..+++++
T Consensus       165 ~~~~~~~GT~~Y~APE~~~~-------~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~  237 (288)
T d1uu3a_         165 ARANSFVGTAQYVSPELLTE-------KSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKA  237 (288)
T ss_dssp             -----CCCCGGGCCHHHHHT-------CCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCTTCCHHH
T ss_pred             cccccccCCccccCceeecc-------CCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcCCCCCCccCCHHH
Confidence             2245689999999999953       45788999999999999999999999998888888888888888999999999


Q ss_pred             HHHHHHhcccCCCCCCCHHH------HHhccccccCC
Q 004959          577 KDFLRCCFQRNPADRPPASL------LLEHRFLKNSQ  607 (721)
Q Consensus       577 ~dLI~~cL~~DP~kRPSa~e------LL~Hp~f~~~~  607 (721)
                      ++||++||+.||++|||++|      +++||||++..
T Consensus       238 ~~li~~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~i~  274 (288)
T d1uu3a_         238 RDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVT  274 (288)
T ss_dssp             HHHHHTTSCSSGGGSTTSGGGTCHHHHHTSGGGTTCC
T ss_pred             HHHHHHHccCCHhHCcCHHHHcCCHHHHcCCccCCCC
Confidence            99999999999999999987      68899998653

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2.3e-57  Score=481.58  Aligned_cols=257  Identities=26%  Similarity=0.443  Sum_probs=210.8

Q ss_pred             CCCCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeE
Q 004959          338 MNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKF  417 (721)
Q Consensus       338 l~~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~  417 (721)
                      +.+.|+++++||+|+||+||+|+++.+|+.||||++......    ...+.+.+|+.+|++++|||||++++++.+++.+
T Consensus         7 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~----~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~   82 (307)
T d1a06a_           7 IRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALE----GKEGSMENEIAVLHKIKHPNIVALDDIYESGGHL   82 (307)
T ss_dssp             GGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC--------------CHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred             CccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhh----hHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence            456799999999999999999999999999999998743211    2235688999999999999999999999999999


Q ss_pred             EEEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEc---CCCceEEeecCCccccC
Q 004959          418 YIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVD---ASGVVKLADFGMAKHLT  494 (721)
Q Consensus       418 yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld---~~g~VKL~DFGlA~~l~  494 (721)
                      |||||||+||+|.++|... +.+++.+++.++.||+.||+|||++|||||||||+|||+.   .++.+||+|||+|+...
T Consensus        83 ~lvmE~~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~  161 (307)
T d1a06a_          83 YLIMQLVSGGELFDRIVEK-GFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMED  161 (307)
T ss_dssp             EEEECCCCSCBHHHHHHTC-SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC-------
T ss_pred             EEEEeccCCCcHHHhhhcc-cCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEcc
Confidence            9999999999999999764 7899999999999999999999999999999999999994   57899999999998776


Q ss_pred             CCcccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhcCCCC----CC
Q 004959          495 GQKADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAI----PD  570 (721)
Q Consensus       495 ~~~~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~~~~~----p~  570 (721)
                      ......+.+||+.|||||++.       +..++.++|||||||+||||++|+.||.+....+....+......+    +.
T Consensus       162 ~~~~~~~~~GT~~y~APE~~~-------~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~  234 (307)
T d1a06a_         162 PGSVLSTACGTPGYVAPEVLA-------QKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWD  234 (307)
T ss_dssp             -----------CTTSCHHHHT-------TCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCCTTTTT
T ss_pred             CCCeeeeeeeCccccCcHHHc-------CCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCCCcccc
Confidence            665566788999999999994       3457889999999999999999999999887777777777765433    35


Q ss_pred             CCCHHHHHHHHHhcccCCCCCCCHHHHHhccccccC
Q 004959          571 SLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNS  606 (721)
Q Consensus       571 ~lS~el~dLI~~cL~~DP~kRPSa~eLL~Hp~f~~~  606 (721)
                      .+|+++++||.+||++||++|||++|+|+||||++.
T Consensus       235 ~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~  270 (307)
T d1a06a_         235 DISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAGD  270 (307)
T ss_dssp             TSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTTSS
T ss_pred             CCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCC
Confidence            789999999999999999999999999999999753

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=7.3e-57  Score=486.34  Aligned_cols=258  Identities=24%  Similarity=0.422  Sum_probs=232.0

Q ss_pred             CCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeEEE
Q 004959          340 SQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYI  419 (721)
Q Consensus       340 ~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~yL  419 (721)
                      ++|++++.||+|+||+||+|+++.+|+.||||++..     ......+.+.+|+.+|++|+|||||++++++.+++.+||
T Consensus        26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~-----~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~i  100 (350)
T d1koaa2          26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMT-----PHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVM  100 (350)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECC-----CSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEE
T ss_pred             cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcc-----cchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence            589999999999999999999999999999999853     223446788999999999999999999999999999999


Q ss_pred             EEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcC--CCceEEeecCCccccCCCc
Q 004959          420 YLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDA--SGVVKLADFGMAKHLTGQK  497 (721)
Q Consensus       420 VmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~--~g~VKL~DFGlA~~l~~~~  497 (721)
                      |||||+||+|.+++.+..+.+++.+++.|+.||+.||+|||++|||||||||+||||+.  ++.+||+|||+|+.+....
T Consensus       101 vmE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~  180 (350)
T d1koaa2         101 IYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ  180 (350)
T ss_dssp             EECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTS
T ss_pred             EEEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheeccccc
Confidence            99999999999999766678999999999999999999999999999999999999964  6789999999999887766


Q ss_pred             ccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhcCCCCC----CCCC
Q 004959          498 ADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIP----DSLS  573 (721)
Q Consensus       498 ~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~~~~~p----~~lS  573 (721)
                      .....+||+.|||||++.+       ..++.++|||||||+||||++|+.||.+.+..+.+..+......++    ..++
T Consensus       181 ~~~~~~gT~~Y~aPEv~~~-------~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s  253 (350)
T d1koaa2         181 SVKVTTGTAEFAAPEVAEG-------KPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGIS  253 (350)
T ss_dssp             CEEEECSCTTTCCHHHHHT-------CCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCCGGGGGCC
T ss_pred             ccceecCcccccCHHHHcC-------CCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCC
Confidence            6667889999999999953       4577899999999999999999999998888888888777655444    4689


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHHhccccccCCCC
Q 004959          574 PEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQP  609 (721)
Q Consensus       574 ~el~dLI~~cL~~DP~kRPSa~eLL~Hp~f~~~~~~  609 (721)
                      +++++||++||+.||++|||++|||+||||+....+
T Consensus       254 ~~~~~li~~~L~~dP~~R~t~~eil~hp~~~~~~~~  289 (350)
T d1koaa2         254 EDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAP  289 (350)
T ss_dssp             HHHHHHHHHHCCSSGGGSCCHHHHHHSTTTSCTTCC
T ss_pred             HHHHHHHHHHccCChhHCcCHHHHhcCcccCCCCCC
Confidence            999999999999999999999999999999876543

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.7e-57  Score=472.24  Aligned_cols=262  Identities=24%  Similarity=0.422  Sum_probs=232.0

Q ss_pred             CCCCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCc-ccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCe
Q 004959          338 MNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDP-KSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDK  416 (721)
Q Consensus       338 l~~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~-~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~  416 (721)
                      +.+.|++++.||+|+||+||+|+++.+|+.||||++.+..... ......+.+.+|+.+|++++|||||++++++.+.+.
T Consensus         8 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~   87 (293)
T d1jksa_           8 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTD   87 (293)
T ss_dssp             GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred             cccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE
Confidence            4568999999999999999999999999999999987533221 112235688999999999999999999999999999


Q ss_pred             EEEEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCC----ceEEeecCCccc
Q 004959          417 FYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASG----VVKLADFGMAKH  492 (721)
Q Consensus       417 ~yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g----~VKL~DFGlA~~  492 (721)
                      +|||||||+||+|.++|... +.+++..++.++.||+.||+|||++|||||||||+|||++.++    .+||+|||+|..
T Consensus        88 ~~iv~E~~~gg~L~~~i~~~-~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~  166 (293)
T d1jksa_          88 VILILELVAGGELFDFLAEK-ESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK  166 (293)
T ss_dssp             EEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEE
T ss_pred             EEEEEEcCCCccccchhccc-cccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhhhh
Confidence            99999999999999999775 6899999999999999999999999999999999999998776    599999999998


Q ss_pred             cCCCcccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhcCCCCC---
Q 004959          493 LTGQKADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIP---  569 (721)
Q Consensus       493 l~~~~~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~~~~~p---  569 (721)
                      +..........||+.|||||++.       ...++.++|||||||+||||++|+.||.+....+.+..+......++   
T Consensus       167 ~~~~~~~~~~~~t~~y~APE~~~-------~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~  239 (293)
T d1jksa_         167 IDFGNEFKNIFGTPEFVAPEIVN-------YEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEY  239 (293)
T ss_dssp             CTTSCBCSCCCCCGGGCCHHHHT-------TCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCHHH
T ss_pred             cCCCccccccCCCCcccCHHHHc-------CCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCchh
Confidence            87666666788999999999994       45678899999999999999999999998888888888777655444   


Q ss_pred             -CCCCHHHHHHHHHhcccCCCCCCCHHHHHhccccccCC
Q 004959          570 -DSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQ  607 (721)
Q Consensus       570 -~~lS~el~dLI~~cL~~DP~kRPSa~eLL~Hp~f~~~~  607 (721)
                       ..+|.++++||++||+.||++|||++|+|+||||+...
T Consensus       240 ~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~  278 (293)
T d1jksa_         240 FSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKD  278 (293)
T ss_dssp             HTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTCC--
T ss_pred             cCCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCC
Confidence             57899999999999999999999999999999998643

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=8.9e-57  Score=486.00  Aligned_cols=258  Identities=23%  Similarity=0.400  Sum_probs=232.3

Q ss_pred             CCCCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeE
Q 004959          338 MNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKF  417 (721)
Q Consensus       338 l~~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~  417 (721)
                      +.+.|++++.||+|+||+||+|+++.+|+.||||++...     .....+.+.+|+.+|++|+|||||+++++|.+++.+
T Consensus        27 ~~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~-----~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~  101 (352)
T d1koba_          27 VYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTP-----YPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEM  101 (352)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-----SHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEE
T ss_pred             cccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCc-----chhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence            346799999999999999999999999999999998632     233456788999999999999999999999999999


Q ss_pred             EEEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEc--CCCceEEeecCCccccCC
Q 004959          418 YIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVD--ASGVVKLADFGMAKHLTG  495 (721)
Q Consensus       418 yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld--~~g~VKL~DFGlA~~l~~  495 (721)
                      |||||||+||+|.+++......+++.+++.|+.||+.||.|||++|||||||||+||||+  .++.|||+|||+|+.+..
T Consensus       102 ~ivmE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~  181 (352)
T d1koba_         102 VLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP  181 (352)
T ss_dssp             EEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCT
T ss_pred             EEEEEcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceecCC
Confidence            999999999999998876666899999999999999999999999999999999999997  578999999999998877


Q ss_pred             CcccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhcCCCCC----CC
Q 004959          496 QKADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIP----DS  571 (721)
Q Consensus       496 ~~~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~~~~~p----~~  571 (721)
                      .......+||+.|||||++.       ...++.++|||||||+||||++|+.||.+....+.+.++......++    ..
T Consensus       182 ~~~~~~~~gt~~y~aPE~~~-------~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~  254 (352)
T d1koba_         182 DEIVKVTTATAEFAAPEIVD-------REPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSS  254 (352)
T ss_dssp             TSCEEEECSSGGGCCHHHHT-------TCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTT
T ss_pred             CCceeeccCcccccCHHHHc-------CCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccC
Confidence            66666788999999999994       45678899999999999999999999999888888888877655443    57


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHHHHhccccccCC
Q 004959          572 LSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQ  607 (721)
Q Consensus       572 lS~el~dLI~~cL~~DP~kRPSa~eLL~Hp~f~~~~  607 (721)
                      +++++++||++||++||++|||++|+|+||||+...
T Consensus       255 ~s~~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~~~  290 (352)
T d1koba_         255 VSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDH  290 (352)
T ss_dssp             SCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSCC
T ss_pred             CCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCCCc
Confidence            899999999999999999999999999999998643

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.2e-57  Score=485.20  Aligned_cols=257  Identities=29%  Similarity=0.491  Sum_probs=232.7

Q ss_pred             CCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeEEE
Q 004959          340 SQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYI  419 (721)
Q Consensus       340 ~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~yL  419 (721)
                      ++|++++.||+|+||+||+|+++.+|+.||||++.+..  .......+.+.+|+.+|++++|||||++++++.+.+.+|+
T Consensus         5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~--~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~i   82 (337)
T d1o6la_           5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEV--IIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCF   82 (337)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHH--HHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEE
T ss_pred             HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhh--ccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeecccccccc
Confidence            47999999999999999999999999999999986321  0111235678899999999999999999999999999999


Q ss_pred             EEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCC-Ccc
Q 004959          420 YLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTG-QKA  498 (721)
Q Consensus       420 VmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~-~~~  498 (721)
                      |||||.||+|.+++... +.++|..++.++.||+.||+|||++|||||||||+||||+.+|.+||+|||+|+.+.. ...
T Consensus        83 v~ey~~gg~L~~~~~~~-~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~~~  161 (337)
T d1o6la_          83 VMEYANGGELFFHLSRE-RVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT  161 (337)
T ss_dssp             EEECCTTCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTCC
T ss_pred             ceeccCCCchhhhhhcc-cCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCCEEEeecccccccccCCcc
Confidence            99999999999999875 7899999999999999999999999999999999999999999999999999987654 334


Q ss_pred             cccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhcCCCCCCCCCHHHHH
Q 004959          499 DLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDSLSPEGKD  578 (721)
Q Consensus       499 ~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~~~~~p~~lS~el~d  578 (721)
                      ....+||+.|||||++.       +..|+.++|||||||+||||++|+.||.+.+..+.+..+......+|..+|+++++
T Consensus       162 ~~~~~GT~~Y~aPE~~~-------~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~d  234 (337)
T d1o6la_         162 MKTFCGTPEYLAPEVLE-------DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKS  234 (337)
T ss_dssp             BCCCEECGGGCCGGGGS-------SSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHH
T ss_pred             cccceeCHHHhhhhhcc-------CCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcCCCCCCccCCHHHHH
Confidence            45688999999999994       45678899999999999999999999999888888888888888999999999999


Q ss_pred             HHHHhcccCCCCCCC-----HHHHHhccccccC
Q 004959          579 FLRCCFQRNPADRPP-----ASLLLEHRFLKNS  606 (721)
Q Consensus       579 LI~~cL~~DP~kRPS-----a~eLL~Hp~f~~~  606 (721)
                      ||++||++||++|++     ++|+++||||++.
T Consensus       235 li~~~L~~dP~~R~~~~~~~~~eil~Hp~f~~i  267 (337)
T d1o6la_         235 LLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSI  267 (337)
T ss_dssp             HHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTC
T ss_pred             HHHhhccCCchhhcccccccHHHHHcCcccccC
Confidence            999999999999994     9999999999864

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.9e-57  Score=470.33  Aligned_cols=254  Identities=28%  Similarity=0.489  Sum_probs=214.2

Q ss_pred             CCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEe--cCeE
Q 004959          340 SQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIV--EDKF  417 (721)
Q Consensus       340 ~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~--~~~~  417 (721)
                      ++|++++.||+|+||+||+|+++.+|+.||||++...   .......+.+.+|+++|++++|||||++++++.+  .+.+
T Consensus         4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~---~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~   80 (269)
T d2java1           4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYG---SMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTL   80 (269)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCT---TSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CE
T ss_pred             hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChh---hCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEE
Confidence            4799999999999999999999999999999998642   2344557789999999999999999999998865  4568


Q ss_pred             EEEEeeccCCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHhhCC-----eeccCCCCCcEEEcCCCceEEeecCC
Q 004959          418 YIYLEYVHPGSINKYVREH---CGAITESVVRNFTRHILSGLAYLHSKK-----TIHRDIKGANLLVDASGVVKLADFGM  489 (721)
Q Consensus       418 yLVmEy~~gGsL~~~L~~~---~~~Lse~~i~~i~~QIl~AL~yLHs~g-----IIHrDLKPeNILld~~g~VKL~DFGl  489 (721)
                      |||||||+||+|.+++.+.   .+.+++..++.++.||+.||.|||++|     ||||||||+||||+.+|.+||+|||+
T Consensus        81 ~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~  160 (269)
T d2java1          81 YIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGL  160 (269)
T ss_dssp             EEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHH
T ss_pred             EEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccc
Confidence            9999999999999998643   467999999999999999999999976     99999999999999999999999999


Q ss_pred             ccccCCCcc-cccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhcC-CC
Q 004959          490 AKHLTGQKA-DLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDT-PA  567 (721)
Q Consensus       490 A~~l~~~~~-~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~~-~~  567 (721)
                      |+.+..... ....+||+.|||||++.       ...++.++|||||||+||||++|+.||.+....+...++.... ..
T Consensus       161 a~~~~~~~~~~~~~~gt~~Y~APE~l~-------~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~~~~  233 (269)
T d2java1         161 ARILNHDTSFAKAFVGTPYYMSPEQMN-------RMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRR  233 (269)
T ss_dssp             HHHC-----------CCCSCCCHHHHT-------TCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCC
T ss_pred             eeecccCCCccccCCCCcccCCHHHHc-------CCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCC
Confidence            998765432 34578999999999994       4567889999999999999999999999887777777776654 45


Q ss_pred             CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccc
Q 004959          568 IPDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFL  603 (721)
Q Consensus       568 ~p~~lS~el~dLI~~cL~~DP~kRPSa~eLL~Hp~f  603 (721)
                      ++..+|+++++||.+||+.||++|||++|||+|||+
T Consensus       234 ~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~hp~i  269 (269)
T d2java1         234 IPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI  269 (269)
T ss_dssp             CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred             CCcccCHHHHHHHHHHcCCChhHCcCHHHHHhCCcC
Confidence            778899999999999999999999999999999996

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=7.2e-56  Score=463.59  Aligned_cols=266  Identities=24%  Similarity=0.417  Sum_probs=236.2

Q ss_pred             CCCCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCccc----HHHHHHHHHHHHHHHhCC-CCCeeeeeeeEE
Q 004959          338 MNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKS----AESIKQLEQEIKVLSHLK-HPNIVQYYGSEI  412 (721)
Q Consensus       338 l~~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~----~~~~k~~~~Ei~iL~~L~-HPnIV~l~g~~~  412 (721)
                      +.++|++++.||+|+||+||+|+++.+|+.||||++.+.......    ....+.+.+|+.+|+++. |||||++++++.
T Consensus         1 f~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~   80 (277)
T d1phka_           1 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE   80 (277)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred             CcccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecc
Confidence            357899999999999999999999999999999999765433222    234567889999999997 999999999999


Q ss_pred             ecCeEEEEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccc
Q 004959          413 VEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKH  492 (721)
Q Consensus       413 ~~~~~yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~  492 (721)
                      +.+.+|||||||+||+|.++|... +.+++..++.|+.||+.||+|||++||+||||||+||||+.++.+||+|||+++.
T Consensus        81 ~~~~~~ivmE~~~~g~L~~~l~~~-~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~  159 (277)
T d1phka_          81 TNTFFFLVFDLMKKGELFDYLTEK-VTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQ  159 (277)
T ss_dssp             CSSEEEEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred             cCcceEEEEEcCCCchHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCCeEEccchheeE
Confidence            999999999999999999999775 6899999999999999999999999999999999999999999999999999998


Q ss_pred             cCCCcccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhcCCCCC---
Q 004959          493 LTGQKADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIP---  569 (721)
Q Consensus       493 l~~~~~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~~~~~p---  569 (721)
                      +.........+||+.|+|||++.+..... ...++.++||||+||+||||++|+.||.+....+....+.......+   
T Consensus       160 ~~~~~~~~~~~gt~~y~~PE~~~~~~~~~-~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~  238 (277)
T d1phka_         160 LDPGEKLREVCGTPSYLAPEIIECSMNDN-HPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPE  238 (277)
T ss_dssp             CCTTCCBCCCCSCGGGCCHHHHHHHHCTT-SCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTT
T ss_pred             ccCCCceeeeeccCCCCCHHHhhcccccc-CCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCCCCCCcc
Confidence            77665556678999999999998765443 34578899999999999999999999999888887777777654433   


Q ss_pred             -CCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccccc
Q 004959          570 -DSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKN  605 (721)
Q Consensus       570 -~~lS~el~dLI~~cL~~DP~kRPSa~eLL~Hp~f~~  605 (721)
                       ..+|+++++||++||+.||++|||++|+|+||||+.
T Consensus       239 ~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~  275 (277)
T d1phka_         239 WDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ  275 (277)
T ss_dssp             GGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCT
T ss_pred             cccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHHHH
Confidence             368999999999999999999999999999999975

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2.5e-56  Score=474.22  Aligned_cols=256  Identities=33%  Similarity=0.617  Sum_probs=225.7

Q ss_pred             CeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeEEEE
Q 004959          341 QWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYIY  420 (721)
Q Consensus       341 ~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~yLV  420 (721)
                      .|++++.||+|+||+||+|+++.+|+.||||++...  ........+.+.+|+.+|++++|||||++++++.+.+.+|||
T Consensus        16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~--~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv   93 (309)
T d1u5ra_          16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYS--GKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV   93 (309)
T ss_dssp             HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECC--SSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchh--hccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEE
Confidence            599999999999999999999999999999998742  233455677899999999999999999999999999999999


Q ss_pred             EeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCCcccc
Q 004959          421 LEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKADL  500 (721)
Q Consensus       421 mEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~~~~~  500 (721)
                      ||||.||+|..++... +.+++.+++.|+.||+.||.|||++|||||||||+||||+.+|.+||+|||+|......   .
T Consensus        94 ~E~~~~g~l~~~~~~~-~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~---~  169 (309)
T d1u5ra_          94 MEYCLGSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA---N  169 (309)
T ss_dssp             EECCSEEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB---C
T ss_pred             EEecCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEEEeecccccccCCC---C
Confidence            9999999997766554 78999999999999999999999999999999999999999999999999999865432   4


Q ss_pred             cCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhcCC--CCCCCCCHHHHH
Q 004959          501 SMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTP--AIPDSLSPEGKD  578 (721)
Q Consensus       501 s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~~~--~~p~~lS~el~d  578 (721)
                      ..+||+.|||||++.+.    ....|+.++|||||||+||||++|..||.+....+.+.++.....  ..+..+++++++
T Consensus       170 ~~~GT~~Y~APE~~~~~----~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~  245 (309)
T d1u5ra_         170 SFVGTPYWMAPEVILAM----DEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRN  245 (309)
T ss_dssp             CCCSCGGGCCHHHHTTT----TSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSCHHHHH
T ss_pred             ccccCccccCHHHHhcc----CCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCCCCCCHHHHH
Confidence            56899999999999542    224578899999999999999999999988877777777766543  234568999999


Q ss_pred             HHHHhcccCCCCCCCHHHHHhccccccC
Q 004959          579 FLRCCFQRNPADRPPASLLLEHRFLKNS  606 (721)
Q Consensus       579 LI~~cL~~DP~kRPSa~eLL~Hp~f~~~  606 (721)
                      ||.+||+.||++|||++|||+||||...
T Consensus       246 li~~~L~~dP~~Rpt~~ell~Hp~~~~~  273 (309)
T d1u5ra_         246 FVDSCLQKIPQDRPTSEVLLKHRFVLRE  273 (309)
T ss_dssp             HHHHHTCSSGGGSCCHHHHTTCHHHHSC
T ss_pred             HHHHHCcCChhHCcCHHHHHhCHHhcCC
Confidence            9999999999999999999999999764

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=2.1e-56  Score=476.07  Aligned_cols=255  Identities=25%  Similarity=0.465  Sum_probs=230.5

Q ss_pred             CCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeEEE
Q 004959          340 SQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYI  419 (721)
Q Consensus       340 ~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~yL  419 (721)
                      ++|++++.||+|+||+||+|+++.+|+.||||++....  .......+.+.+|+.+|++++|||||++++++.+.+.+|+
T Consensus         4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~--~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~i   81 (316)
T d1fota_           4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEI--VVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFM   81 (316)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHH--HHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEE
T ss_pred             hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHH--ccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeee
Confidence            47999999999999999999999999999999986311  0111235678999999999999999999999999999999


Q ss_pred             EEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCCccc
Q 004959          420 YLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKAD  499 (721)
Q Consensus       420 VmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~~~~  499 (721)
                      |||||.||+|..++... ..+++..++.++.||+.||+|||++|||||||||+||||+.+|.+||+|||+|+.+...  .
T Consensus        82 vmE~~~gg~l~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~--~  158 (316)
T d1fota_          82 IMDYIEGGELFSLLRKS-QRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV--T  158 (316)
T ss_dssp             EECCCCSCBHHHHHHHT-SSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC--B
T ss_pred             EeeecCCcccccccccc-ccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCCEEEecCccceEeccc--c
Confidence            99999999999988765 78999999999999999999999999999999999999999999999999999876543  3


Q ss_pred             ccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhcCCCCCCCCCHHHHHH
Q 004959          500 LSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDSLSPEGKDF  579 (721)
Q Consensus       500 ~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~~~~~p~~lS~el~dL  579 (721)
                      .+.+||+.|||||++.       +..++.++|||||||+||||++|+.||.+.+..+.+.++......+|..++++++++
T Consensus       159 ~~~~Gt~~Y~APE~l~-------~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~l  231 (316)
T d1fota_         159 YTLCGTPDYIAPEVVS-------TKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDL  231 (316)
T ss_dssp             CCCCSCTTTCCHHHHT-------TCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCCTTSCHHHHHH
T ss_pred             ccccCcccccCHHHHc-------CCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence            4678999999999994       345778999999999999999999999998888888899888888999999999999


Q ss_pred             HHHhcccCCCCCC-----CHHHHHhccccccC
Q 004959          580 LRCCFQRNPADRP-----PASLLLEHRFLKNS  606 (721)
Q Consensus       580 I~~cL~~DP~kRP-----Sa~eLL~Hp~f~~~  606 (721)
                      |.+||++||++|+     |+++||+||||++.
T Consensus       232 i~~~L~~dp~~R~~~~r~t~~~il~Hp~f~~i  263 (316)
T d1fota_         232 LSRLITRDLSQRLGNLQNGTEDVKNHPWFKEV  263 (316)
T ss_dssp             HHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSC
T ss_pred             HHHHhhhCHHhccccchhhHHHHHcCcccccC
Confidence            9999999999996     99999999999874

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7e-56  Score=462.06  Aligned_cols=252  Identities=29%  Similarity=0.527  Sum_probs=215.8

Q ss_pred             CCe-eEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEe----c
Q 004959          340 SQW-QKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIV----E  414 (721)
Q Consensus       340 ~~y-~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~----~  414 (721)
                      ++| ++.+.||+|+||+||+|+++.+|+.||+|++...   .......+.+.+|+++|++++|||||++++++.+    .
T Consensus         8 gry~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~---~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~   84 (270)
T d1t4ha_           8 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDR---KLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGK   84 (270)
T ss_dssp             SCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGG---GSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSC
T ss_pred             CCEEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchh---hCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccC
Confidence            345 7788999999999999999999999999998642   2234556789999999999999999999999875    3


Q ss_pred             CeEEEEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCC--eeccCCCCCcEEEc-CCCceEEeecCCcc
Q 004959          415 DKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKK--TIHRDIKGANLLVD-ASGVVKLADFGMAK  491 (721)
Q Consensus       415 ~~~yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~g--IIHrDLKPeNILld-~~g~VKL~DFGlA~  491 (721)
                      ..+|||||||+||+|.+++.+. +.+++.+++.|+.||+.||+|||++|  ||||||||+||||+ .++.+||+|||+|+
T Consensus        85 ~~~~ivmE~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~  163 (270)
T d1t4ha_          85 KCIVLVTELMTSGTLKTYLKRF-KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT  163 (270)
T ss_dssp             EEEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred             CEEEEEEeCCCCCcHHHHHhcc-ccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcce
Confidence            5689999999999999999775 68999999999999999999999999  99999999999996 57899999999998


Q ss_pred             ccCCCcccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHh-hcC--CCC
Q 004959          492 HLTGQKADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVM-RDT--PAI  568 (721)
Q Consensus       492 ~l~~~~~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~-~~~--~~~  568 (721)
                      ..... .....+||+.|||||++.+        .++.++|||||||+||||++|+.||.+......+.+.+ ...  ..+
T Consensus       164 ~~~~~-~~~~~~GT~~Y~aPE~~~~--------~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~~~~~  234 (270)
T d1t4ha_         164 LKRAS-FAKAVIGTPEFMAPEMYEE--------KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASF  234 (270)
T ss_dssp             GCCTT-SBEESCSSCCCCCGGGGGT--------CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGG
T ss_pred             eccCC-ccCCcccCccccCHHHhCC--------CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCCCccc
Confidence            64433 3346789999999999842        36789999999999999999999998765555444443 332  234


Q ss_pred             CCCCCHHHHHHHHHhcccCCCCCCCHHHHHhccccc
Q 004959          569 PDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLK  604 (721)
Q Consensus       569 p~~lS~el~dLI~~cL~~DP~kRPSa~eLL~Hp~f~  604 (721)
                      +..+++++++||.+||+.||++|||++|||+||||+
T Consensus       235 ~~~~~~~~~~li~~~l~~dp~~R~s~~ell~Hp~fk  270 (270)
T d1t4ha_         235 DKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ  270 (270)
T ss_dssp             GGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred             CccCCHHHHHHHHHHccCCHhHCcCHHHHhCCcccC
Confidence            456899999999999999999999999999999996

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.2e-57  Score=479.50  Aligned_cols=255  Identities=29%  Similarity=0.554  Sum_probs=214.9

Q ss_pred             CCCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeEE
Q 004959          339 NSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFY  418 (721)
Q Consensus       339 ~~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~y  418 (721)
                      .++|++++.||+|+||+||+|+++.+|+.||||++....    .....+++.+|+.+|++++|||||+++++|.+++.+|
T Consensus         5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~----~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~   80 (322)
T d1s9ja_           5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI----KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS   80 (322)
T ss_dssp             GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCC----CTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEE
T ss_pred             ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhh----CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence            468999999999999999999999999999999987432    1233467899999999999999999999999999999


Q ss_pred             EEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhh-CCeeccCCCCCcEEEcCCCceEEeecCCccccCCCc
Q 004959          419 IYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHS-KKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQK  497 (721)
Q Consensus       419 LVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs-~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~~  497 (721)
                      ||||||.||+|.+++.+. +.+++..++.++.||+.||.|||+ +||+||||||+||||+.+|.+||+|||+|+.+... 
T Consensus        81 iVmEy~~gg~L~~~l~~~-~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~-  158 (322)
T d1s9ja_          81 ICMEHMDGGSLDQVLKKA-GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-  158 (322)
T ss_dssp             EEEECCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH-
T ss_pred             EEEEcCCCCcHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCccccCCC-
Confidence            999999999999999775 679999999999999999999997 59999999999999999999999999999876433 


Q ss_pred             ccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHH------------------
Q 004959          498 ADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMF------------------  559 (721)
Q Consensus       498 ~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~------------------  559 (721)
                      ...+.+||+.|||||++.+       ..|+.++|||||||+||||++|+.||.+.+..+...                  
T Consensus       159 ~~~~~~GT~~Y~APEvl~~-------~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (322)
T d1s9ja_         159 MANSFVGTRSYMSPERLQG-------THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPR  231 (322)
T ss_dssp             TC---CCSSCCCCHHHHHC-------SCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC----------------
T ss_pred             ccccccCCccccCchHHcC-------CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccc
Confidence            2346789999999999963       457778999999999999999999997543221100                  


Q ss_pred             ------------------------HHhhc-CCCCC-CCCCHHHHHHHHHhcccCCCCCCCHHHHHhccccccC
Q 004959          560 ------------------------KVMRD-TPAIP-DSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNS  606 (721)
Q Consensus       560 ------------------------ki~~~-~~~~p-~~lS~el~dLI~~cL~~DP~kRPSa~eLL~Hp~f~~~  606 (721)
                                              .+... .+.++ ..+|.++++||.+||+.||++|||++|+|+||||+..
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~  304 (322)
T d1s9ja_         232 TPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS  304 (322)
T ss_dssp             --------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHH
T ss_pred             cccccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCcC
Confidence                                    00011 11122 2468999999999999999999999999999999853

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.9e-56  Score=474.02  Aligned_cols=256  Identities=21%  Similarity=0.344  Sum_probs=230.5

Q ss_pred             CCCCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeE
Q 004959          338 MNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKF  417 (721)
Q Consensus       338 l~~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~  417 (721)
                      +.++|++++.||+|+||+||+|+++.+|+.||||++.+.      ......+.+|+.+|++++|||||++++++.+++.+
T Consensus         3 ~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~------~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~   76 (321)
T d1tkia_           3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK------GTDQVLVKKEISILNIARHRNILHLHESFESMEEL   76 (321)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC------THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEE
T ss_pred             CccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCC------cccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEE
Confidence            557899999999999999999999999999999998632      12235688999999999999999999999999999


Q ss_pred             EEEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCC--CceEEeecCCccccCC
Q 004959          418 YIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDAS--GVVKLADFGMAKHLTG  495 (721)
Q Consensus       418 yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~--g~VKL~DFGlA~~l~~  495 (721)
                      |||||||.||+|.++|......++|.+++.|+.||+.||+|||++||+||||||+||||+.+  +.+||+|||+++....
T Consensus        77 ~lvmE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~  156 (321)
T d1tkia_          77 VMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP  156 (321)
T ss_dssp             EEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCT
T ss_pred             EEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhcccc
Confidence            99999999999999998765689999999999999999999999999999999999999854  4899999999998766


Q ss_pred             CcccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhcCCCCCC----C
Q 004959          496 QKADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPD----S  571 (721)
Q Consensus       496 ~~~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~~~~~p~----~  571 (721)
                      .......+||+.|+|||++.       ...++.++|||||||+||+|++|..||.+....+.+.++......++.    .
T Consensus       157 ~~~~~~~~~t~~y~ape~~~-------~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~  229 (321)
T d1tkia_         157 GDNFRLLFTAPEYYAPEVHQ-------HDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKE  229 (321)
T ss_dssp             TCEEEEEESCGGGSCHHHHT-------TCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTT
T ss_pred             CCcccccccccccccchhcc-------CCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCChhhccC
Confidence            65556678999999999984       456788999999999999999999999998888888888887666553    6


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHHHHhccccccC
Q 004959          572 LSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNS  606 (721)
Q Consensus       572 lS~el~dLI~~cL~~DP~kRPSa~eLL~Hp~f~~~  606 (721)
                      +|+++++||++||+.||++|||++|+|+||||+..
T Consensus       230 ~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~  264 (321)
T d1tkia_         230 ISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQK  264 (321)
T ss_dssp             SCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred             CCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccC
Confidence            89999999999999999999999999999999753

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=7.9e-56  Score=478.05  Aligned_cols=255  Identities=30%  Similarity=0.491  Sum_probs=231.1

Q ss_pred             CCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeEEE
Q 004959          340 SQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYI  419 (721)
Q Consensus       340 ~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~yL  419 (721)
                      ++|++++.||+|+||+||+|+++.+|+.||||++.+..  .......+.+.+|+++|+.++|||||++++++.+.+.+|+
T Consensus        41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~--~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~  118 (350)
T d1rdqe_          41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQK--VVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYM  118 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHH--HHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred             cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHH--ccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccc
Confidence            58999999999999999999999999999999986311  0111234678899999999999999999999999999999


Q ss_pred             EEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCCccc
Q 004959          420 YLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKAD  499 (721)
Q Consensus       420 VmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~~~~  499 (721)
                      ||||+.||+|..++... +.+++..++.|+.||+.||.|||++|||||||||+||||+.+|.+||+|||+|+.+...  .
T Consensus       119 v~e~~~~g~l~~~l~~~-~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~--~  195 (350)
T d1rdqe_         119 VMEYVAGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR--T  195 (350)
T ss_dssp             EEECCTTCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC--B
T ss_pred             ccccccccchhhhHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCCEEeeeceeeeecccc--c
Confidence            99999999999999775 68999999999999999999999999999999999999999999999999999987543  3


Q ss_pred             ccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhcCCCCCCCCCHHHHHH
Q 004959          500 LSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDSLSPEGKDF  579 (721)
Q Consensus       500 ~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~~~~~p~~lS~el~dL  579 (721)
                      ...+||+.|||||++.       +..++.++|||||||+||||++|+.||.+.+....+.++......++..+++++.+|
T Consensus       196 ~~~~Gt~~Y~APE~~~-------~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~l  268 (350)
T d1rdqe_         196 WTLCGTPEALAPEIIL-------SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDL  268 (350)
T ss_dssp             CCCEECGGGCCHHHHT-------TCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTCCHHHHHH
T ss_pred             ccccCccccCCHHHHc-------CCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCCCCCCccCCHHHHHH
Confidence            4578999999999994       345778999999999999999999999998888888889888888999999999999


Q ss_pred             HHHhcccCCCCCC-----CHHHHHhccccccC
Q 004959          580 LRCCFQRNPADRP-----PASLLLEHRFLKNS  606 (721)
Q Consensus       580 I~~cL~~DP~kRP-----Sa~eLL~Hp~f~~~  606 (721)
                      |++||++||++|+     |+++|++||||++.
T Consensus       269 i~~~L~~dP~kR~~~~r~t~~ell~Hp~f~~~  300 (350)
T d1rdqe_         269 LRNLLQVDLTKRFGNLKNGVNDIKNHKWFATT  300 (350)
T ss_dssp             HHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTC
T ss_pred             HHHHhhhCHHhccccccccHHHHHcCccccCC
Confidence            9999999999995     99999999999865

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.9e-56  Score=464.75  Aligned_cols=259  Identities=26%  Similarity=0.443  Sum_probs=215.5

Q ss_pred             EeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeEEEEEee
Q 004959          344 KGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYIYLEY  423 (721)
Q Consensus       344 ~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~yLVmEy  423 (721)
                      .+++||+|+||+||+|+++.+|+.||||++.............+.+.+|+.+|++++|||||++++++.+++.+||||||
T Consensus         2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~   81 (299)
T d1ua2a_           2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF   81 (299)
T ss_dssp             EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred             cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence            56899999999999999999999999999865332222223346789999999999999999999999999999999999


Q ss_pred             ccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCCc-ccccC
Q 004959          424 VHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQK-ADLSM  502 (721)
Q Consensus       424 ~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~~-~~~s~  502 (721)
                      |.|+++..++ .....+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+.+.... .....
T Consensus        82 ~~~~~~~~~~-~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~~~~~  160 (299)
T d1ua2a_          82 METDLEVIIK-DNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQ  160 (299)
T ss_dssp             CSEEHHHHHT-TCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCCCCCS
T ss_pred             hcchHHhhhh-hcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCccccccCccccccCCCcccccce
Confidence            9887766554 345779999999999999999999999999999999999999999999999999998765443 33457


Q ss_pred             CCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhcCC----------------
Q 004959          503 KGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTP----------------  566 (721)
Q Consensus       503 ~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~~~----------------  566 (721)
                      +||+.|||||++..      ...++.++|||||||+||||++|..||.+....+.+.++.....                
T Consensus       161 ~gt~~y~aPE~~~~------~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~  234 (299)
T d1ua2a_         161 VVTRWYRAPELLFG------ARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDY  234 (299)
T ss_dssp             CCCCTTCCHHHHTT------CSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTC
T ss_pred             ecChhhccHHHHcc------CCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchh
Confidence            89999999999852      34578899999999999999999999998877777766543100                


Q ss_pred             ----C--------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhccccccCCCC
Q 004959          567 ----A--------IPDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQP  609 (721)
Q Consensus       567 ----~--------~p~~lS~el~dLI~~cL~~DP~kRPSa~eLL~Hp~f~~~~~~  609 (721)
                          .        +...+++++++||++||+.||++|||++|+|+||||++...+
T Consensus       235 ~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~p~p  289 (299)
T d1ua2a_         235 VTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGP  289 (299)
T ss_dssp             CCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSCC
T ss_pred             hhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCCCCC
Confidence                0        013568999999999999999999999999999999976544

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=9.8e-55  Score=471.83  Aligned_cols=259  Identities=27%  Similarity=0.423  Sum_probs=221.2

Q ss_pred             CCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCC-CcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeEE
Q 004959          340 SQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPD-DPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFY  418 (721)
Q Consensus       340 ~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~-~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~y  418 (721)
                      ++|+++++||+|+||+||+|+++.+|+.||||++.+... .........+...|+.+|+.++|||||++++++.+.+.+|
T Consensus         4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~   83 (364)
T d1omwa3           4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS   83 (364)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred             HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence            579999999999999999999999999999999863110 0111222333445677888889999999999999999999


Q ss_pred             EEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCCcc
Q 004959          419 IYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKA  498 (721)
Q Consensus       419 LVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~~~  498 (721)
                      ||||||.||+|.++|.+. ..+++..++.|+.||+.||+|||++|||||||||+||||+.+|.+||+|||+|+.+.... 
T Consensus        84 ivmE~~~gg~L~~~l~~~-~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~~~-  161 (364)
T d1omwa3          84 FILDLMNGGDLHYHLSQH-GVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-  161 (364)
T ss_dssp             EEECCCCSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCTTCEECSSSC-
T ss_pred             EEEEecCCCcHHHHHHhc-ccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCcEEEeeeceeeecCCCc-
Confidence            999999999999999775 789999999999999999999999999999999999999999999999999998775443 


Q ss_pred             cccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhh---HHHHHHHhhcCCCCCCCCCHH
Q 004959          499 DLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEG---AAAMFKVMRDTPAIPDSLSPE  575 (721)
Q Consensus       499 ~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~---~~~~~ki~~~~~~~p~~lS~e  575 (721)
                      ....+||+.|||||++.      .+..++.++|||||||+||||++|+.||.+...   ......+......++..++++
T Consensus       162 ~~~~~GT~~y~APE~~~------~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~  235 (364)
T d1omwa3         162 PHASVGTHGYMAPEVLQ------KGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPE  235 (364)
T ss_dssp             CCSCCSCGGGCCHHHHS------TTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSSCCCCCCSSSCHH
T ss_pred             ccccccccccchhHHhh------cCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCHH
Confidence            34568999999999994      234578899999999999999999999976432   223334445566778899999


Q ss_pred             HHHHHHHhcccCCCCCCC-----HHHHHhccccccC
Q 004959          576 GKDFLRCCFQRNPADRPP-----ASLLLEHRFLKNS  606 (721)
Q Consensus       576 l~dLI~~cL~~DP~kRPS-----a~eLL~Hp~f~~~  606 (721)
                      +++||.+||++||++|||     ++||++||||++.
T Consensus       236 ~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~i  271 (364)
T d1omwa3         236 LRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSL  271 (364)
T ss_dssp             HHHHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTTC
T ss_pred             HHHHHHHHcccCHHHhCCCcccCHHHHHcCccccCC
Confidence            999999999999999999     7999999999875

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3e-55  Score=467.92  Aligned_cols=257  Identities=26%  Similarity=0.472  Sum_probs=227.8

Q ss_pred             CCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHH-hCCCCCeeeeeeeEEecCeEE
Q 004959          340 SQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLS-HLKHPNIVQYYGSEIVEDKFY  418 (721)
Q Consensus       340 ~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~-~L~HPnIV~l~g~~~~~~~~y  418 (721)
                      ++|++++.||+|+||+||+|+++.+|+.||||++.+..  .......+.+..|+.++. .++|||||++++++.+.+.+|
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~--~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~y   79 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDV--VLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLF   79 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHH--HHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEE
T ss_pred             CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhh--ccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCcee
Confidence            47999999999999999999999999999999986311  001112355667777665 689999999999999999999


Q ss_pred             EEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCCc-
Q 004959          419 IYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQK-  497 (721)
Q Consensus       419 LVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~~-  497 (721)
                      ||||||+||+|.+++... +.+++.+++.++.||+.||+|||++|||||||||+|||++.+|.+||+|||+++...... 
T Consensus        80 ivmEy~~~g~L~~~i~~~-~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~~  158 (320)
T d1xjda_          80 FVMEYLNGGDLMYHIQSC-HKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA  158 (320)
T ss_dssp             EEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTC
T ss_pred             EEEeecCCCcHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCceeccccchhhhcccccc
Confidence            999999999999999765 789999999999999999999999999999999999999999999999999998765433 


Q ss_pred             ccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhcCCCCCCCCCHHHH
Q 004959          498 ADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDSLSPEGK  577 (721)
Q Consensus       498 ~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~~~~~p~~lS~el~  577 (721)
                      .....+||+.|+|||++.       ...++.++|||||||+||||++|+.||.+....+.+.++....+.+|..+|++++
T Consensus       159 ~~~~~~gt~~y~aPE~~~-------~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~  231 (320)
T d1xjda_         159 KTNTFCGTPDYIAPEILL-------GQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAK  231 (320)
T ss_dssp             CBCCCCSCGGGCCHHHHT-------TCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHH
T ss_pred             cccccCCCCCcCCHHHHc-------CCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCccCCHHHH
Confidence            334578999999999994       4567889999999999999999999999988888888888888899999999999


Q ss_pred             HHHHHhcccCCCCCCCHH-HHHhccccccC
Q 004959          578 DFLRCCFQRNPADRPPAS-LLLEHRFLKNS  606 (721)
Q Consensus       578 dLI~~cL~~DP~kRPSa~-eLL~Hp~f~~~  606 (721)
                      +||++||++||++||++. ||++||||++.
T Consensus       232 dli~~~L~~dP~~R~s~~~~l~~hpff~~~  261 (320)
T d1xjda_         232 DLLVKLFVREPEKRLGVRGDIRQHPLFREI  261 (320)
T ss_dssp             HHHHHHSCSSGGGSBTTBSCGGGSGGGTTC
T ss_pred             HHHHHhcccCCCCCcCHHHHHHhCchhccC
Confidence            999999999999999995 89999999864

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.3e-55  Score=454.83  Aligned_cols=257  Identities=26%  Similarity=0.465  Sum_probs=219.8

Q ss_pred             CCCCCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCc-ccHHHHHHHHHHHHHHHhCC--CCCeeeeeeeEEe
Q 004959          337 PMNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDP-KSAESIKQLEQEIKVLSHLK--HPNIVQYYGSEIV  413 (721)
Q Consensus       337 ~l~~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~-~~~~~~k~~~~Ei~iL~~L~--HPnIV~l~g~~~~  413 (721)
                      |+.++|+++++||+|+||+||+|+++.+|+.||||++....... ......+++.+|+.+|++++  |||||++++++.+
T Consensus         1 pl~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~   80 (273)
T d1xwsa_           1 PLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFER   80 (273)
T ss_dssp             CCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEEC
T ss_pred             CCCCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEee
Confidence            46789999999999999999999999999999999986432111 11111234678999999987  8999999999999


Q ss_pred             cCeEEEEEeeccC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCC-CceEEeecCCcc
Q 004959          414 EDKFYIYLEYVHP-GSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDAS-GVVKLADFGMAK  491 (721)
Q Consensus       414 ~~~~yLVmEy~~g-GsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~-g~VKL~DFGlA~  491 (721)
                      .+.+|+||||+.+ +++.+++... +.+++.+++.++.||+.||+|||++|||||||||+||||+.+ +.+||+|||+|+
T Consensus        81 ~~~~~lv~e~~~~~~~l~~~~~~~-~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~  159 (273)
T d1xwsa_          81 PDSFVLILERPEPVQDLFDFITER-GALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGA  159 (273)
T ss_dssp             SSEEEEEEECCSSEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred             CCeEEEEEEeccCcchHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECccccce
Confidence            9999999999986 5788888765 789999999999999999999999999999999999999854 799999999998


Q ss_pred             ccCCCcccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhcCCCCCCC
Q 004959          492 HLTGQKADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAIPDS  571 (721)
Q Consensus       492 ~l~~~~~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~~~~~p~~  571 (721)
                      ..... ...+.+||+.|||||++.+.      ..++.++|||||||+||||++|+.||....      .+......++..
T Consensus       160 ~~~~~-~~~~~~GT~~y~aPE~~~~~------~~~~~~~DiwSlGvilyell~g~~Pf~~~~------~i~~~~~~~~~~  226 (273)
T d1xwsa_         160 LLKDT-VYTDFDGTRVYSPPEWIRYH------RYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQVFFRQR  226 (273)
T ss_dssp             ECCSS-CBCCCCSCGGGSCHHHHHHS------CBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHCCCCCSSC
T ss_pred             ecccc-cccccccCCCcCCHHHHcCC------CCCCcccccccceeeehhHhhCCCCCCCch------HHhhcccCCCCC
Confidence            65433 34567899999999999752      234668999999999999999999998743      345566678889


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHHHHhccccccCC
Q 004959          572 LSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQ  607 (721)
Q Consensus       572 lS~el~dLI~~cL~~DP~kRPSa~eLL~Hp~f~~~~  607 (721)
                      +|+++++||++||+.||++|||++|+|+||||++..
T Consensus       227 ~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~~  262 (273)
T d1xwsa_         227 VSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVL  262 (273)
T ss_dssp             CCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCC
T ss_pred             CCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCCC
Confidence            999999999999999999999999999999998653

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.9e-54  Score=453.05  Aligned_cols=261  Identities=30%  Similarity=0.534  Sum_probs=218.8

Q ss_pred             CCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeEEE
Q 004959          340 SQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYI  419 (721)
Q Consensus       340 ~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~yL  419 (721)
                      ++|++++.||+|+||+||+|+++.+|+.||||++....   ......+.+.+|+++|++++|||||++++++.+.+.+|+
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~---~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~i   78 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDT---ETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYL   78 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC----------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEE
T ss_pred             CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhh---cChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeE
Confidence            58999999999999999999999999999999986422   222335678899999999999999999999999999999


Q ss_pred             EEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCCc-c
Q 004959          420 YLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQK-A  498 (721)
Q Consensus       420 VmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~~-~  498 (721)
                      |||||.++.+..........+++..++.++.||+.||+|||++|||||||||+|||++.++.+||+|||+|+...... .
T Consensus        79 v~e~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~~  158 (298)
T d1gz8a_          79 VFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT  158 (298)
T ss_dssp             EEECCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSBC
T ss_pred             EEeecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCcceeccCCcceeccCCccc
Confidence            999997554443434445679999999999999999999999999999999999999999999999999998765433 3


Q ss_pred             cccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhcCC------------
Q 004959          499 DLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTP------------  566 (721)
Q Consensus       499 ~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~~~------------  566 (721)
                      ....+||+.|+|||++..      ...++.++|||||||++|+|++|+.||.+.+..+.+.++.....            
T Consensus       159 ~~~~~gt~~y~apE~~~~------~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  232 (298)
T d1gz8a_         159 YTHEVVTLWYRAPEILLG------CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS  232 (298)
T ss_dssp             TTCCBCCCTTCCHHHHTT------CSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGG
T ss_pred             ceeecccceeeehhhhcc------ccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhcccccc
Confidence            345679999999999853      33457789999999999999999999988777666665543100            


Q ss_pred             ------CC-----------CCCCCHHHHHHHHHhcccCCCCCCCHHHHHhccccccCCCC
Q 004959          567 ------AI-----------PDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQP  609 (721)
Q Consensus       567 ------~~-----------p~~lS~el~dLI~~cL~~DP~kRPSa~eLL~Hp~f~~~~~~  609 (721)
                            .+           ...++.++++||++||+.||++|||++|||+||||++..+|
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~~~p  292 (298)
T d1gz8a_         233 MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP  292 (298)
T ss_dssp             STTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTCCCC
T ss_pred             ccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccCCCC
Confidence                  00           12568999999999999999999999999999999987665

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4e-53  Score=444.80  Aligned_cols=259  Identities=30%  Similarity=0.509  Sum_probs=216.2

Q ss_pred             CCCeeEeeEEeecCCeEEEEEEECCC-CcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhC---CCCCeeeeeeeEEe-
Q 004959          339 NSQWQKGKLIGRGTFGSVYVASNRET-GALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHL---KHPNIVQYYGSEIV-  413 (721)
Q Consensus       339 ~~~y~~~k~LG~G~fG~VY~a~~~~t-g~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L---~HPnIV~l~g~~~~-  413 (721)
                      .++|++++.||+|+||+||+|++..+ ++.||||++.........   ...+.+|+.+|+.|   +|||||++++++.. 
T Consensus         6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~---~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~   82 (305)
T d1blxa_           6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGM---PLSTIREVAVLRHLETFEHPNVVRLFDVCTVS   82 (305)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSC---BCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEE
T ss_pred             cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchH---HHHHHHHHHHHHHHhhcCCCCcceeeeeeccc
Confidence            46899999999999999999999766 667999998643222111   12355677766655   79999999998864 


Q ss_pred             ----cCeEEEEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCC
Q 004959          414 ----EDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGM  489 (721)
Q Consensus       414 ----~~~~yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGl  489 (721)
                          ...+|++||||.++.+..........+++..++.++.||+.||+|||++|||||||||+|||++.++.+||+|||+
T Consensus        83 ~~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~dfg~  162 (305)
T d1blxa_          83 RTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGL  162 (305)
T ss_dssp             ECSSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCS
T ss_pred             ccccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCCeeecchhh
Confidence                3578999999998877666655567899999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCCcccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhcC----
Q 004959          490 AKHLTGQKADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDT----  565 (721)
Q Consensus       490 A~~l~~~~~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~~----  565 (721)
                      ++...........+||+.|||||++.       ...|+.++|||||||+||||++|+.||.+....+.+.++....    
T Consensus       163 ~~~~~~~~~~~~~~gT~~Y~APE~~~-------~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~  235 (305)
T d1blxa_         163 ARIYSFQMALTSVVVTLWYRAPEVLL-------QSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPG  235 (305)
T ss_dssp             CCCCCGGGGGCCCCCCCTTCCHHHHT-------TCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred             hhhhcccccCCCcccChhhcCcchhc-------CCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCc
Confidence            98776666667788999999999994       3567889999999999999999999999877777666554310    


Q ss_pred             -----------------------CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhccccccCC
Q 004959          566 -----------------------PAIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQ  607 (721)
Q Consensus       566 -----------------------~~~p~~lS~el~dLI~~cL~~DP~kRPSa~eLL~Hp~f~~~~  607 (721)
                                             ..++..+++++++||++||++||++|||++|+|+||||++..
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i~  300 (305)
T d1blxa_         236 EEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLE  300 (305)
T ss_dssp             GGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCC
T ss_pred             hhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCch
Confidence                                   113356899999999999999999999999999999998754

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=5.9e-53  Score=439.22  Aligned_cols=258  Identities=23%  Similarity=0.424  Sum_probs=216.3

Q ss_pred             CCCCCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecC-
Q 004959          337 PMNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVED-  415 (721)
Q Consensus       337 ~l~~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~-  415 (721)
                      .+.++|++++.||+|+||+||+|+++.+|+.||||++...  ........+.+.+|+.+|+.++|||||++++++...+ 
T Consensus         4 ~l~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~--~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~   81 (277)
T d1o6ya_           4 HLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRAD--LARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETP   81 (277)
T ss_dssp             EETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECST--TTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECS
T ss_pred             CccceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchh--hccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccC
Confidence            3567899999999999999999999999999999998642  2334566778999999999999999999999988754 


Q ss_pred             ---eEEEEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccc
Q 004959          416 ---KFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKH  492 (721)
Q Consensus       416 ---~~yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~  492 (721)
                         .+|||||||+|++|.+++... +.+++.+++.|+.||+.||+|||++|||||||||+||||+.++.++|+|||++..
T Consensus        82 ~~~~~~lvmE~~~g~~L~~~~~~~-~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~  160 (277)
T d1o6ya_          82 AGPLPYIVMEYVDGVTLRDIVHTE-GPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARA  160 (277)
T ss_dssp             SSEEEEEEEECCCEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCTTCEE
T ss_pred             CCceEEEEEECCCCCEehhhhccc-CCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccccceeehhhhhhh
Confidence               489999999999999998765 7899999999999999999999999999999999999999999999999999876


Q ss_pred             cCCCc----ccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhcCCCC
Q 004959          493 LTGQK----ADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTPAI  568 (721)
Q Consensus       493 l~~~~----~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~~~~~  568 (721)
                      +....    .....+||+.|||||++.       ...++.++|||||||+||||++|+.||.+....+.+.+++...+..
T Consensus       161 ~~~~~~~~~~~~~~~Gt~~Y~aPE~~~-------~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~  233 (277)
T d1o6ya_         161 IADSGNSVTQTAAVIGTAQYLSPEQAR-------GDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIP  233 (277)
T ss_dssp             CC----------------TTCCHHHHT-------TCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCC
T ss_pred             hccccccccccccccCcccccCHHHHc-------CCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCC
Confidence            54322    234567999999999984       4567889999999999999999999999888888888777765433


Q ss_pred             ----CCCCCHHHHHHHHHhcccCCCCCCCHHHHHhccccc
Q 004959          569 ----PDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLK  604 (721)
Q Consensus       569 ----p~~lS~el~dLI~~cL~~DP~kRPSa~eLL~Hp~f~  604 (721)
                          ...+|+++.+||.+||++||++||+..+.|.|+|++
T Consensus       234 ~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r  273 (277)
T d1o6ya_         234 PSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVR  273 (277)
T ss_dssp             GGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred             CchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHH
Confidence                357899999999999999999999544444577764

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-53  Score=457.63  Aligned_cols=252  Identities=25%  Similarity=0.395  Sum_probs=213.1

Q ss_pred             CCCeeEe-eEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHh-CCCCCeeeeeeeEEe---
Q 004959          339 NSQWQKG-KLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSH-LKHPNIVQYYGSEIV---  413 (721)
Q Consensus       339 ~~~y~~~-k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~-L~HPnIV~l~g~~~~---  413 (721)
                      .++|++. ++||+|+||+||+|+++.+|+.||||++..          .+.+.+|+.++.+ ++|||||+++++|.+   
T Consensus        10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~----------~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~   79 (335)
T d2ozaa1          10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD----------CPKARREVELHWRASQCPHIVRIVDVYENLYA   79 (335)
T ss_dssp             GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC----------SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEET
T ss_pred             ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC----------cHHHHHHHHHHHHhcCCCCCCeEEEEEeeccc
Confidence            4689876 579999999999999999999999999852          1357789998655 589999999999876   


Q ss_pred             -cCeEEEEEeeccCCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcC---CCceEEeecC
Q 004959          414 -EDKFYIYLEYVHPGSINKYVREHC-GAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDA---SGVVKLADFG  488 (721)
Q Consensus       414 -~~~~yLVmEy~~gGsL~~~L~~~~-~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~---~g~VKL~DFG  488 (721)
                       ...+|||||||+||+|.++|.+.+ ..++|.+++.|+.||+.||+|||++||+||||||+|||++.   .+.+||+|||
T Consensus        80 ~~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG  159 (335)
T d2ozaa1          80 GRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFG  159 (335)
T ss_dssp             TEEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCT
T ss_pred             CCCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccccccccc
Confidence             467999999999999999998653 46999999999999999999999999999999999999975   4579999999


Q ss_pred             CccccCCCcccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHH----Hhhc
Q 004959          489 MAKHLTGQKADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFK----VMRD  564 (721)
Q Consensus       489 lA~~l~~~~~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~k----i~~~  564 (721)
                      +|+...........+||+.|||||++.+       ..|+.++|||||||+||+|++|+.||.+.........    +...
T Consensus       160 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~  232 (335)
T d2ozaa1         160 FAKETTSHNSLTTPCYTPYYVAPEVLGP-------EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMG  232 (335)
T ss_dssp             TCEECCCCCCCCCCSCCCSSCCCCCCCG-------GGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSC
T ss_pred             eeeeccCCCccccccCCcccCCcHHHcC-------CCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcC
Confidence            9998877666677889999999999843       4567899999999999999999999987654433322    2223


Q ss_pred             CCCCCC----CCCHHHHHHHHHhcccCCCCCCCHHHHHhccccccCC
Q 004959          565 TPAIPD----SLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQ  607 (721)
Q Consensus       565 ~~~~p~----~lS~el~dLI~~cL~~DP~kRPSa~eLL~Hp~f~~~~  607 (721)
                      ...+|.    .+|+++++||++||+.||++|||+.|+|+||||.+..
T Consensus       233 ~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~  279 (335)
T d2ozaa1         233 QYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST  279 (335)
T ss_dssp             SSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHTTT
T ss_pred             CCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhCCC
Confidence            333442    5899999999999999999999999999999997543

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.3e-52  Score=442.98  Aligned_cols=250  Identities=24%  Similarity=0.451  Sum_probs=207.6

Q ss_pred             CCeeEeeEEeecCCeEEEEEEECCCCc---EEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCe
Q 004959          340 SQWQKGKLIGRGTFGSVYVASNRETGA---LCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDK  416 (721)
Q Consensus       340 ~~y~~~k~LG~G~fG~VY~a~~~~tg~---~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~  416 (721)
                      +.|+++++||+|+||+||+|+++.+|+   .||||.+..    .......+.+.+|+.+|++++|||||+++|++.+.+.
T Consensus        26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~----~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~  101 (299)
T d1jpaa_          26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKS----GYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTP  101 (299)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCS----SCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred             hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECc----ccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCE
Confidence            579999999999999999999987765   578887642    2344566789999999999999999999999999999


Q ss_pred             EEEEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCC
Q 004959          417 FYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQ  496 (721)
Q Consensus       417 ~yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~  496 (721)
                      +|+|||||+||+|.+++....+.+++.++..|+.||+.||+|||++|||||||||+||||+.++.+||+|||+++.+...
T Consensus       102 ~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~  181 (299)
T d1jpaa_         102 VMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD  181 (299)
T ss_dssp             CEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred             EEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCcEEECCcccceEccCC
Confidence            99999999999999999877678999999999999999999999999999999999999999999999999999876543


Q ss_pred             ccc------ccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhh-CCCCCCchhhHHHHHHHhhcC-CCC
Q 004959          497 KAD------LSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFKVMRDT-PAI  568 (721)
Q Consensus       497 ~~~------~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLt-G~~PF~~~~~~~~~~ki~~~~-~~~  568 (721)
                      ...      ....||+.|||||++.       ...++.++|||||||+||||+| |+.||.+....+.+..+..+. ...
T Consensus       182 ~~~~~~~~~~~~~~t~~y~aPE~~~-------~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~  254 (299)
T d1jpaa_         182 TSDPTYTSALGGKIPIRWTAPEAIQ-------YRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPP  254 (299)
T ss_dssp             --------------CGGGSCHHHHH-------SCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCC
T ss_pred             CCcceeeecccccCCccccCHHHHh-------cCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC
Confidence            322      1245799999999985       3467889999999999999998 899999887777777666543 456


Q ss_pred             CCCCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q 004959          569 PDSLSPEGKDFLRCCFQRNPADRPPASLLLEH  600 (721)
Q Consensus       569 p~~lS~el~dLI~~cL~~DP~kRPSa~eLL~H  600 (721)
                      +..++.++.+||.+||+.||++|||+.||+++
T Consensus       255 ~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~  286 (299)
T d1jpaa_         255 PMDCPSALHQLMLDCWQKDRNHRPKFGQIVNT  286 (299)
T ss_dssp             CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             CccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence            77899999999999999999999999999876

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.3e-53  Score=440.79  Aligned_cols=251  Identities=23%  Similarity=0.422  Sum_probs=209.5

Q ss_pred             CCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeEEE
Q 004959          340 SQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYI  419 (721)
Q Consensus       340 ~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~yL  419 (721)
                      ++|++++.||+|+||+||+|+..   ..||||++.....   .....+.+.+|+.+|++++|||||++++++ .++.+||
T Consensus         8 ~~~~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~~---~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~-~~~~~~l   80 (276)
T d1uwha_           8 GQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAP---TPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAI   80 (276)
T ss_dssp             TCCCCCSEEEECSSCEEEEEESS---SEEEEEECCCSSC---CTTHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEE
T ss_pred             ccEEEEEEEeeCCCcEEEEEEEC---CEEEEEEEEcccC---CHHHHHHHHHHHHHHHhCCCCCEeeeeEEE-eccEEEE
Confidence            57999999999999999999754   3599999864322   234567899999999999999999999976 4567899


Q ss_pred             EEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCCc--
Q 004959          420 YLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQK--  497 (721)
Q Consensus       420 VmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~~--  497 (721)
                      |||||+||+|.+++......+++..+..|+.||+.||+|||++|||||||||+||||+.++.+||+|||+|+......  
T Consensus        81 v~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~  160 (276)
T d1uwha_          81 VTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGS  160 (276)
T ss_dssp             EEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCCSCC-------
T ss_pred             EEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCCEEEccccceeeccccCCc
Confidence            999999999999998776789999999999999999999999999999999999999999999999999998764332  


Q ss_pred             -ccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhcC------CCCCC
Q 004959          498 -ADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDT------PAIPD  570 (721)
Q Consensus       498 -~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~~------~~~p~  570 (721)
                       .....+||+.|||||++.+.    ....++.++|||||||+||||+||+.||.+......+.......      ..++.
T Consensus       161 ~~~~~~~gt~~y~APE~l~~~----~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~  236 (276)
T d1uwha_         161 HQFEQLSGSILWMAPEVIRMQ----DKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRS  236 (276)
T ss_dssp             -----CCCCGGGCCHHHHTTC----SSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCCGGGSCT
T ss_pred             ccccccccCcccCCHHHHhcc----cCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCcchhccc
Confidence             22356799999999999531    23457889999999999999999999998866555554444322      13456


Q ss_pred             CCCHHHHHHHHHhcccCCCCCCCHHHHHhcc
Q 004959          571 SLSPEGKDFLRCCFQRNPADRPPASLLLEHR  601 (721)
Q Consensus       571 ~lS~el~dLI~~cL~~DP~kRPSa~eLL~Hp  601 (721)
                      .+++++.+||.+||+.||++|||+.||+++-
T Consensus       237 ~~~~~l~~li~~cl~~dp~~RPt~~~il~~L  267 (276)
T d1uwha_         237 NCPKAMKRLMAECLKKKRDERPLFPQILASI  267 (276)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             cchHHHHHHHHHHcCCCHhHCcCHHHHHHHH
Confidence            7899999999999999999999999999873

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.2e-52  Score=443.85  Aligned_cols=259  Identities=24%  Similarity=0.448  Sum_probs=213.9

Q ss_pred             CCCCCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecC-
Q 004959          337 PMNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVED-  415 (721)
Q Consensus       337 ~l~~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~-  415 (721)
                      .+.++|++++.||+|+||+||+|+++.+|+.||||++..   ........+.+.+|+.+|+.++|||||+++++|...+ 
T Consensus        15 ~~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~---~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~   91 (346)
T d1cm8a_          15 EVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYR---PFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDET   91 (346)
T ss_dssp             CCBSSEEEEEEC------CEEEEEETTTCCEEEEEECSS---TTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSS
T ss_pred             ecCCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEch---hhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCcc
Confidence            356799999999999999999999999999999999863   2334556788999999999999999999999987655 


Q ss_pred             -----eEEEEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCc
Q 004959          416 -----KFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMA  490 (721)
Q Consensus       416 -----~~yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA  490 (721)
                           .+||||||| |.+|..++..  +.+++..++.++.||+.||+|||++|||||||||+|||++.++.+||+|||+|
T Consensus        92 ~~~~~~~~lv~e~~-~~~l~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a  168 (346)
T d1cm8a_          92 LDDFTDFYLVMPFM-GTDLGKLMKH--EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLA  168 (346)
T ss_dssp             TTTCCCCEEEEECC-SEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             ccccceEEEEEecc-cccHHHHHHh--ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccccccccccccce
Confidence                 579999999 6788877754  57999999999999999999999999999999999999999999999999999


Q ss_pred             cccCCCcccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhc------
Q 004959          491 KHLTGQKADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRD------  564 (721)
Q Consensus       491 ~~l~~~~~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~------  564 (721)
                      +.....  ....+||+.|+|||++.+      ...++.++|||||||+||+|++|+.||.+.+....+..+...      
T Consensus       169 ~~~~~~--~~~~~~t~~y~aPE~~~~------~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~  240 (346)
T d1cm8a_         169 RQADSE--MTGYVVTRWYRAPEVILN------WMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPA  240 (346)
T ss_dssp             EECCSS--CCSSCSCGGGCCTHHHHT------TTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCH
T ss_pred             eccCCc--cccccccccccCHHHHcC------CCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcH
Confidence            876543  345679999999999964      234567899999999999999999999876655554433221      


Q ss_pred             -----------------C--------CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhccccccCCCC
Q 004959          565 -----------------T--------PAIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQP  609 (721)
Q Consensus       565 -----------------~--------~~~p~~lS~el~dLI~~cL~~DP~kRPSa~eLL~Hp~f~~~~~~  609 (721)
                                       .        ..+...+++++.+||.+||+.||++|||+.|||+||||+....+
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~~~  310 (346)
T d1cm8a_         241 EFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDT  310 (346)
T ss_dssp             HHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC--
T ss_pred             HHHhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCCCc
Confidence                             0        11235679999999999999999999999999999999976544

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=1.4e-52  Score=437.48  Aligned_cols=255  Identities=28%  Similarity=0.496  Sum_probs=213.2

Q ss_pred             CCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeEEE
Q 004959          340 SQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYI  419 (721)
Q Consensus       340 ~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~yL  419 (721)
                      ++|++.+.||+|+||+||+|+++ +|+.||||++.....   .....+.+.+|+.+|++++|||||++++++...+..|+
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~---~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i   77 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKE---DEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVL   77 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSG---GGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEE
T ss_pred             CCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhc---ChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeE
Confidence            58999999999999999999986 789999999864321   22234678999999999999999999999999999999


Q ss_pred             EEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCCcc-
Q 004959          420 YLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKA-  498 (721)
Q Consensus       420 VmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~~~-  498 (721)
                      +|||+.++.+..+. ...+.+++..++.|+.||+.||+|||++|||||||||+||||+.++.+||+|||++........ 
T Consensus        78 ~~e~~~~~~~~~~~-~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~~  156 (286)
T d1ob3a_          78 VFEHLDQDLKKLLD-VCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRK  156 (286)
T ss_dssp             EEECCSEEHHHHHH-TSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC----
T ss_pred             EEEeehhhhHHHHH-hhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCCEEecccccceecccCccc
Confidence            99999876666555 4457899999999999999999999999999999999999999999999999999987654332 


Q ss_pred             cccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhcC-------------
Q 004959          499 DLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDT-------------  565 (721)
Q Consensus       499 ~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~~-------------  565 (721)
                      .....|++.|+|||++.+      ...++.++|||||||+||||++|+.||.+....+.+.++....             
T Consensus       157 ~~~~~~~~~y~~pE~~~~------~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  230 (286)
T d1ob3a_         157 YTHEIVTLWYRAPDVLMG------SKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTE  230 (286)
T ss_dssp             -----CCCTTCCHHHHTT------CCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGG
T ss_pred             cceecccchhhhHHHHhC------CCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhh
Confidence            344569999999999953      3456789999999999999999999998876666665543210             


Q ss_pred             ----------------CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccccc
Q 004959          566 ----------------PAIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKN  605 (721)
Q Consensus       566 ----------------~~~p~~lS~el~dLI~~cL~~DP~kRPSa~eLL~Hp~f~~  605 (721)
                                      ......+++++++||++||+.||++|||++|||+||||++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~~  286 (286)
T d1ob3a_         231 LPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE  286 (286)
T ss_dssp             STTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred             hhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCc
Confidence                            0123457899999999999999999999999999999974

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-52  Score=432.57  Aligned_cols=247  Identities=26%  Similarity=0.453  Sum_probs=206.1

Q ss_pred             CCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeEEE
Q 004959          340 SQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYI  419 (721)
Q Consensus       340 ~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~yL  419 (721)
                      ++|++++.||+|+||+||+|.++ +++.||||++...   ...   .+++.+|+++|++++|||||+++|++..++.+||
T Consensus         5 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~---~~~---~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~l   77 (263)
T d1sm2a_           5 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREG---AMS---EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICL   77 (263)
T ss_dssp             SCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSS---SSC---HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred             HHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCC---cCc---HHHHHHHHHHHHhcCCCCcccccceeccCCceEE
Confidence            58999999999999999999986 4778999998632   222   2578999999999999999999999999999999


Q ss_pred             EEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCCccc
Q 004959          420 YLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKAD  499 (721)
Q Consensus       420 VmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~~~~  499 (721)
                      |||||++|+|.+++......+++..+..|+.||+.||+|||+++|+||||||+||||+.++.+||+|||+++.+......
T Consensus        78 v~E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~  157 (263)
T d1sm2a_          78 VFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT  157 (263)
T ss_dssp             EEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC-----------
T ss_pred             EEEecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCCeEecccchheeccCCCce
Confidence            99999999999999877678999999999999999999999999999999999999999999999999999876544322


Q ss_pred             --ccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhh-CCCCCCchhhHHHHHHHhhc-CCCCCCCCCHH
Q 004959          500 --LSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFKVMRD-TPAIPDSLSPE  575 (721)
Q Consensus       500 --~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLt-G~~PF~~~~~~~~~~ki~~~-~~~~p~~lS~e  575 (721)
                        ....||+.|||||++.       ...++.++|||||||+||||+| |.+||......+.+..+... ....|..++++
T Consensus       158 ~~~~~~gt~~y~aPE~l~-------~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~p~~~~~~  230 (263)
T d1sm2a_         158 SSTGTKFPVKWASPEVFS-------FSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTH  230 (263)
T ss_dssp             -------CTTSCCHHHHT-------TCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCCCCCCTTSCHH
T ss_pred             eecceecCcccCChHHhc-------CCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCCCCCccccCHH
Confidence              2356999999999994       4568889999999999999999 57777766666666666554 34567788999


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHHhc
Q 004959          576 GKDFLRCCFQRNPADRPPASLLLEH  600 (721)
Q Consensus       576 l~dLI~~cL~~DP~kRPSa~eLL~H  600 (721)
                      +.+||.+||+.||++|||++||++|
T Consensus       231 l~~li~~cl~~~p~~Rps~~~il~~  255 (263)
T d1sm2a_         231 VYQIMNHCWKERPEDRPAFSRLLRQ  255 (263)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHccCCHhHCcCHHHHHHH
Confidence            9999999999999999999999987

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-51  Score=442.95  Aligned_cols=262  Identities=24%  Similarity=0.417  Sum_probs=214.0

Q ss_pred             CCCCCCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecC
Q 004959          336 LPMNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVED  415 (721)
Q Consensus       336 ~~l~~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~  415 (721)
                      ..+..+|++++.||+|+||+||+|+++.+|+.||||++...    ......+.+.+|+.+|+.++|||||++++++....
T Consensus         4 ~~i~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~----~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~   79 (345)
T d1pmea_           4 FDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPF----EHQTYCQRTLREIKILLRFRHENIIGINDIIRAPT   79 (345)
T ss_dssp             CCCCTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCT----TCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSS
T ss_pred             cCcCCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehh----cChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeecc
Confidence            34567899999999999999999999999999999998632    23455678899999999999999999999987643


Q ss_pred             ----eEEEEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCcc
Q 004959          416 ----KFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAK  491 (721)
Q Consensus       416 ----~~yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~  491 (721)
                          ..+++|+|+.||+|.+++..  ..+++..++.++.||+.||+|||++|||||||||+||||+.++.+||+|||+++
T Consensus        80 ~~~~~~~~l~~~~~~g~L~~~l~~--~~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~  157 (345)
T d1pmea_          80 IEQMKDVYLVTHLMGADLYKLLKT--QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLAR  157 (345)
T ss_dssp             TTTCCCEEEEEECCCEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             ccccceEEEEEeecCCchhhhhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCCEEEcccCcee
Confidence                23444556668999999975  479999999999999999999999999999999999999999999999999998


Q ss_pred             ccCCCcc----cccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhc---
Q 004959          492 HLTGQKA----DLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRD---  564 (721)
Q Consensus       492 ~l~~~~~----~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~---  564 (721)
                      .......    ....+||+.|+|||++..      ...++.++||||+||++|+|++|+.||......+........   
T Consensus       158 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~------~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~  231 (345)
T d1pmea_         158 VADPDHDHTGFLTEYVATRWYRAPEIMLN------SKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGS  231 (345)
T ss_dssp             ECCGGGCBCCTTCCCCSCGGGCCGGGTTT------BCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCS
T ss_pred             eccCCCccceeeccccccceechHHHhhc------CCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccC
Confidence            7654332    234679999999999852      345677999999999999999999999875544433332210   


Q ss_pred             --------------------CC--------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhccccccCCCC
Q 004959          565 --------------------TP--------AIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQP  609 (721)
Q Consensus       565 --------------------~~--------~~p~~lS~el~dLI~~cL~~DP~kRPSa~eLL~Hp~f~~~~~~  609 (721)
                                          .+        .....++.++++||.+||+.||++|||++|+|+||||+....+
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~~~~  304 (345)
T d1pmea_         232 PSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDP  304 (345)
T ss_dssp             CCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTTCCG
T ss_pred             CChhhhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccCCCC
Confidence                                00        1124678999999999999999999999999999999976654

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-52  Score=437.39  Aligned_cols=254  Identities=23%  Similarity=0.390  Sum_probs=218.1

Q ss_pred             CCeeEeeE-EeecCCeEEEEEEECC--CCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCe
Q 004959          340 SQWQKGKL-IGRGTFGSVYVASNRE--TGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDK  416 (721)
Q Consensus       340 ~~y~~~k~-LG~G~fG~VY~a~~~~--tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~  416 (721)
                      ++|.+.+. ||+|+||+||+|.++.  ++..||||++..    .......+++.+|+.+|++++|||||++++++.. +.
T Consensus         8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~----~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~   82 (285)
T d1u59a_           8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQ----GTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EA   82 (285)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECS----SCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SS
T ss_pred             cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEECh----hcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-Ce
Confidence            46888885 9999999999998764  455799999853    2344567889999999999999999999998864 56


Q ss_pred             EEEEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCC
Q 004959          417 FYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQ  496 (721)
Q Consensus       417 ~yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~  496 (721)
                      +|||||||+||+|.+++....+.+++..+..|+.||+.||+|||++|||||||||+||||+.++.+||+|||+++.+...
T Consensus        83 ~~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~  162 (285)
T d1u59a_          83 LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGAD  162 (285)
T ss_dssp             EEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTC
T ss_pred             EEEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCceeeccchhhhccccc
Confidence            89999999999999998766678999999999999999999999999999999999999999999999999999877543


Q ss_pred             cc----cccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhh-CCCCCCchhhHHHHHHHhhc-CCCCCC
Q 004959          497 KA----DLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFKVMRD-TPAIPD  570 (721)
Q Consensus       497 ~~----~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLt-G~~PF~~~~~~~~~~ki~~~-~~~~p~  570 (721)
                      ..    ....+||+.|||||++.+       ..++.++|||||||+||||+| |+.||.+....+.+..+..+ .+.+|.
T Consensus       163 ~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~  235 (285)
T d1u59a_         163 DSYYTARSAGKWPLKWYAPECINF-------RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPP  235 (285)
T ss_dssp             SCEECCCCSSCCCGGGCCHHHHHH-------CEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCCCCT
T ss_pred             ccccccccccccCccccChHHHhC-------CCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCC
Confidence            32    224568999999999964       346779999999999999998 99999987776666666554 356788


Q ss_pred             CCCHHHHHHHHHhcccCCCCCCCHHHH---Hhcccccc
Q 004959          571 SLSPEGKDFLRCCFQRNPADRPPASLL---LEHRFLKN  605 (721)
Q Consensus       571 ~lS~el~dLI~~cL~~DP~kRPSa~eL---L~Hp~f~~  605 (721)
                      .+++++.+||.+||+.||++|||+.+|   |+|+|+.-
T Consensus       236 ~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~~  273 (285)
T d1u59a_         236 ECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSL  273 (285)
T ss_dssp             TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             cCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHh
Confidence            999999999999999999999999888   67788753

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.6e-52  Score=444.49  Aligned_cols=256  Identities=28%  Similarity=0.448  Sum_probs=214.4

Q ss_pred             CCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEec-----
Q 004959          340 SQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVE-----  414 (721)
Q Consensus       340 ~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~-----  414 (721)
                      .+|+.+++||+|+||+||+|+++.+|+.||||++.....         .+.+|+.+|++++|||||+++++|...     
T Consensus        20 ~~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~---------~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~   90 (350)
T d1q5ka_          20 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR---------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKD   90 (350)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS---------SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCS
T ss_pred             CCcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch---------HHHHHHHHHHhcCCCCCCcEEEEEEecCccCC
Confidence            379999999999999999999999999999999864221         234799999999999999999998643     


Q ss_pred             -CeEEEEEeeccCCCHHHHHH--HhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCC-ceEEeecCCc
Q 004959          415 -DKFYIYLEYVHPGSINKYVR--EHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASG-VVKLADFGMA  490 (721)
Q Consensus       415 -~~~yLVmEy~~gGsL~~~L~--~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g-~VKL~DFGlA  490 (721)
                       ..+|||||||.++.+..+..  .....+++.+++.|+.||+.||+|||++|||||||||+||||+.++ .+||+|||++
T Consensus        91 ~~~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a  170 (350)
T d1q5ka_          91 EVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSA  170 (350)
T ss_dssp             CCEEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTC
T ss_pred             ceEEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecccch
Confidence             35899999997654433332  2346799999999999999999999999999999999999999775 8999999999


Q ss_pred             cccCCCcccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhcC-----
Q 004959          491 KHLTGQKADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDT-----  565 (721)
Q Consensus       491 ~~l~~~~~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~~-----  565 (721)
                      +.+.......+.+||+.|+|||++.+      ...++.++|||||||++|||++|+.||......+.+.++....     
T Consensus       171 ~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~  244 (350)
T d1q5ka_         171 KQLVRGEPNVSYICSRYYRAPELIFG------ATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTR  244 (350)
T ss_dssp             EECCTTSCCCSCCSCTTSCCHHHHTT------CSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCH
T ss_pred             hhccCCcccccccccccccChHHhhc------ccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChH
Confidence            98877666677889999999999853      3457889999999999999999999998877666665553210     


Q ss_pred             ------------C------------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhccccccCCCCC
Q 004959          566 ------------P------------AIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQPD  610 (721)
Q Consensus       566 ------------~------------~~p~~lS~el~dLI~~cL~~DP~kRPSa~eLL~Hp~f~~~~~~~  610 (721)
                                  .            .....+++++.+||.+||++||++|||+.|+|+||||++...+.
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~~  313 (350)
T d1q5ka_         245 EQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPN  313 (350)
T ss_dssp             HHHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGCTT
T ss_pred             HhhhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccccCCC
Confidence                        0            11235789999999999999999999999999999998765443

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-52  Score=446.07  Aligned_cols=250  Identities=25%  Similarity=0.453  Sum_probs=213.0

Q ss_pred             CCeeEeeEEeecCCeEEEEEEECCCCc-----EEEEEEeecCCCCcccHHHHHHHHHHHHHHHhC-CCCCeeeeeeeEEe
Q 004959          340 SQWQKGKLIGRGTFGSVYVASNRETGA-----LCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHL-KHPNIVQYYGSEIV  413 (721)
Q Consensus       340 ~~y~~~k~LG~G~fG~VY~a~~~~tg~-----~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L-~HPnIV~l~g~~~~  413 (721)
                      ++|++++.||+|+||+||+|++..+++     .||+|.+...    ........+.+|+.+|.++ +|||||++++++.+
T Consensus        37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~  112 (325)
T d1rjba_          37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEK----ADSSEREALMSELKMMTQLGSHENIVNLLGACTL  112 (325)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccc----cCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEee
Confidence            579999999999999999999876544     6999987532    1223456788999999998 89999999999999


Q ss_pred             cCeEEEEEeeccCCCHHHHHHHhc----------------------CCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCC
Q 004959          414 EDKFYIYLEYVHPGSINKYVREHC----------------------GAITESVVRNFTRHILSGLAYLHSKKTIHRDIKG  471 (721)
Q Consensus       414 ~~~~yLVmEy~~gGsL~~~L~~~~----------------------~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKP  471 (721)
                      .+.+|||||||+||+|.++|....                      ..+++.+++.|+.||+.||+|||++|||||||||
T Consensus       113 ~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDlKp  192 (325)
T d1rjba_         113 SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAA  192 (325)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSG
T ss_pred             CCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCch
Confidence            999999999999999999997643                      3489999999999999999999999999999999


Q ss_pred             CcEEEcCCCceEEeecCCccccCCCccc---ccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhh-CCC
Q 004959          472 ANLLVDASGVVKLADFGMAKHLTGQKAD---LSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKP  547 (721)
Q Consensus       472 eNILld~~g~VKL~DFGlA~~l~~~~~~---~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLt-G~~  547 (721)
                      +|||++.++.+||+|||+|+........   ...+||+.|||||++.+       ..++.++|||||||+||||++ |+.
T Consensus       193 ~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-------~~~~~~~DiwS~Gvil~emlt~g~~  265 (325)
T d1rjba_         193 RNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFE-------GIYTIKSDVWSYGILLWEIFSLGVN  265 (325)
T ss_dssp             GGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHH-------CCCCHHHHHHHHHHHHHHHTTTSCC
T ss_pred             hccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcC-------CCCCcceeccchhHHHHHHHhCCCC
Confidence            9999999999999999999876544322   24568999999999964       457789999999999999997 899


Q ss_pred             CCCchhhHHHHHHHhhcC--CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q 004959          548 PWSEYEGAAAMFKVMRDT--PAIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEH  600 (721)
Q Consensus       548 PF~~~~~~~~~~ki~~~~--~~~p~~lS~el~dLI~~cL~~DP~kRPSa~eLL~H  600 (721)
                      ||.+....+.+.+++...  ...|..+++++++||.+||+.||++|||++||++|
T Consensus       266 Pf~~~~~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~  320 (325)
T d1rjba_         266 PYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF  320 (325)
T ss_dssp             SSTTCCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCCCCHHHHHHHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            998876666666665543  45677899999999999999999999999999987

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.7e-52  Score=434.11  Aligned_cols=247  Identities=22%  Similarity=0.419  Sum_probs=208.5

Q ss_pred             eEEeecCCeEEEEEEEC--CCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeEEEEEee
Q 004959          346 KLIGRGTFGSVYVASNR--ETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYIYLEY  423 (721)
Q Consensus       346 k~LG~G~fG~VY~a~~~--~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~yLVmEy  423 (721)
                      +.||+|+||+||+|.++  .+++.||||++...   .......+.+.+|+.+|++++|||||++++++.. +..||||||
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~---~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~   88 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNE---ANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEM   88 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC--------CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEEC
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChh---hCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEc
Confidence            57999999999999754  45688999998532   2233456789999999999999999999999864 567899999


Q ss_pred             ccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCCccc----
Q 004959          424 VHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKAD----  499 (721)
Q Consensus       424 ~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~~~~----  499 (721)
                      |++|+|.+++... ..+++..+..|+.||+.||+|||++|||||||||+||||+.++.+||+|||+++.+......    
T Consensus        89 ~~~g~L~~~l~~~-~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~  167 (277)
T d1xbba_          89 AELGPLNKYLQQN-RHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ  167 (277)
T ss_dssp             CTTEEHHHHHHHC-TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC-
T ss_pred             CCCCcHHHHHhhc-cCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCcccccchhhhhhccccccccccc
Confidence            9999999999764 67999999999999999999999999999999999999999999999999999876543322    


Q ss_pred             ccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhh-CCCCCCchhhHHHHHHHhhc-CCCCCCCCCHHHH
Q 004959          500 LSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFKVMRD-TPAIPDSLSPEGK  577 (721)
Q Consensus       500 ~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLt-G~~PF~~~~~~~~~~ki~~~-~~~~p~~lS~el~  577 (721)
                      ....||+.|||||++.+       ..++.++|||||||+||||++ |+.||.+....+....+... .+.+|..+++++.
T Consensus       168 ~~~~gt~~y~APE~l~~-------~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~~~  240 (277)
T d1xbba_         168 THGKWPVKWYAPECINY-------YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMY  240 (277)
T ss_dssp             ---CCCGGGCCHHHHHH-------CEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHH
T ss_pred             cccCCCceecCchhhcC-------CCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHHH
Confidence            23569999999999964       346779999999999999997 99999987776666666554 4567888999999


Q ss_pred             HHHHHhcccCCCCCCCHHHH---Hhccccc
Q 004959          578 DFLRCCFQRNPADRPPASLL---LEHRFLK  604 (721)
Q Consensus       578 dLI~~cL~~DP~kRPSa~eL---L~Hp~f~  604 (721)
                      +||.+||+.||++|||+++|   |+|+|+.
T Consensus       241 ~li~~cl~~dp~~RPs~~~i~~~L~~~~~~  270 (277)
T d1xbba_         241 DLMNLCWTYDVENRPGFAAVELRLRNYYYD  270 (277)
T ss_dssp             HHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred             HHHHHHcCCCHhHCcCHHHHHHHhhCHHhh
Confidence            99999999999999999998   4666653

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.4e-52  Score=440.32  Aligned_cols=247  Identities=26%  Similarity=0.457  Sum_probs=212.4

Q ss_pred             CCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeEEE
Q 004959          340 SQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYI  419 (721)
Q Consensus       340 ~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~yL  419 (721)
                      ++|++++.||+|+||+||+|+++.+|+.||||++...   ...   .+++.+|+.+|++++|||||++++++.+.+.+||
T Consensus        17 ~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~---~~~---~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~i   90 (287)
T d1opja_          17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED---TME---VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI   90 (287)
T ss_dssp             GGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTT---CSC---HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred             HHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCc---cch---HHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEE
Confidence            5799999999999999999999999999999988532   222   3578999999999999999999999999999999


Q ss_pred             EEeeccCCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCCcc
Q 004959          420 YLEYVHPGSINKYVREH-CGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKA  498 (721)
Q Consensus       420 VmEy~~gGsL~~~L~~~-~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~~~  498 (721)
                      |||||++|+|.+++... ...+++..+..|+.||+.||+|||++|||||||||+||||+.++.+||+|||+|+.+.....
T Consensus        91 v~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~  170 (287)
T d1opja_          91 ITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY  170 (287)
T ss_dssp             EEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSS
T ss_pred             EeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCcEEEccccceeecCCCCc
Confidence            99999999999999754 46789999999999999999999999999999999999999999999999999987655432


Q ss_pred             c--ccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhc--CCCCCCCCCH
Q 004959          499 D--LSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRD--TPAIPDSLSP  574 (721)
Q Consensus       499 ~--~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~--~~~~p~~lS~  574 (721)
                      .  ....||+.|||||++.+       ..++.++|||||||+||||++|..||........+.+++..  .+..+..+++
T Consensus       171 ~~~~~~~g~~~y~aPE~~~~-------~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~  243 (287)
T d1opja_         171 TAHAGAKFPIKWTAPESLAY-------NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPE  243 (287)
T ss_dssp             EEETTEEECGGGCCHHHHHH-------CCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCCCTTCCH
T ss_pred             eeeccccccccccChHHHcC-------CCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcCCCCCCCccchH
Confidence            2  23458999999999964       35788999999999999999976665444334444444332  3567788999


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHHh
Q 004959          575 EGKDFLRCCFQRNPADRPPASLLLE  599 (721)
Q Consensus       575 el~dLI~~cL~~DP~kRPSa~eLL~  599 (721)
                      ++++||.+||+.||++|||++||++
T Consensus       244 ~l~~li~~cl~~dP~~Rps~~ei~~  268 (287)
T d1opja_         244 KVYELMRACWQWNPSDRPSFAEIHQ  268 (287)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHHcCCCHhHCcCHHHHHH
Confidence            9999999999999999999999976

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-51  Score=434.87  Aligned_cols=259  Identities=28%  Similarity=0.445  Sum_probs=210.7

Q ss_pred             CCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEe------
Q 004959          340 SQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIV------  413 (721)
Q Consensus       340 ~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~------  413 (721)
                      ++|++++.||+|+||+||+|+++.+|+.||||++......   ....+.+.+|+.+|+.++||||+++++++..      
T Consensus        10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~---~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~   86 (318)
T d3blha1          10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEK---EGFPITALREIKILQLLKHENVVNLIEICRTKASPYN   86 (318)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CT---TSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC------
T ss_pred             CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcc---hHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccc
Confidence            6899999999999999999999999999999998643222   2234578899999999999999999998755      


Q ss_pred             --cCeEEEEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCcc
Q 004959          414 --EDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAK  491 (721)
Q Consensus       414 --~~~~yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~  491 (721)
                        ++.+|+|||||.++.+. .+......+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+++
T Consensus        87 ~~~~~~~iv~e~~~~~~~~-~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~dfg~~~  165 (318)
T d3blha1          87 RCKGSIYLVFDFCEHDLAG-LLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLAR  165 (318)
T ss_dssp             ----CEEEEEECCCEEHHH-HHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCE
T ss_pred             ccCceEEEEEeccCCCccc-hhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCcEEeeecceee
Confidence              34689999999876555 444445789999999999999999999999999999999999999999999999999998


Q ss_pred             ccCCCc-----ccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhcCC
Q 004959          492 HLTGQK-----ADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTP  566 (721)
Q Consensus       492 ~l~~~~-----~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~~~  566 (721)
                      .+....     .....+||+.|+|||++.+      ...++.++|||||||++|||++|+.||.+....+.+..+.....
T Consensus       166 ~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~------~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~  239 (318)
T d3blha1         166 AFSLAKNSQPNRYTNRVVTLWYRPPELLLG------ERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCG  239 (318)
T ss_dssp             ECCC-----CCCCCSCCSCGGGCCHHHHTT------CSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC
T ss_pred             ecccccccccccccceecCHHHhhHHHHcC------CCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcC
Confidence            764322     2234679999999999853      23577899999999999999999999988766665554433211


Q ss_pred             CCCC--------------------------------CCCHHHHHHHHHhcccCCCCCCCHHHHHhccccccCCC
Q 004959          567 AIPD--------------------------------SLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQ  608 (721)
Q Consensus       567 ~~p~--------------------------------~lS~el~dLI~~cL~~DP~kRPSa~eLL~Hp~f~~~~~  608 (721)
                      ..+.                                ..++++++||.+||+.||++|||++|+|+||||+....
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~~p~  313 (318)
T d3blha1         240 SITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDPM  313 (318)
T ss_dssp             CCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSSSSC
T ss_pred             CCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhccCCC
Confidence            1100                                13778899999999999999999999999999986543

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.6e-52  Score=431.42  Aligned_cols=251  Identities=24%  Similarity=0.449  Sum_probs=212.7

Q ss_pred             CCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeEEE
Q 004959          340 SQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYI  419 (721)
Q Consensus       340 ~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~yL  419 (721)
                      ++|++++.||+|+||+||+|+++ +++.||||++...   ...   .+.+.+|+.+|++++|||||++++++. ++.+||
T Consensus        13 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~---~~~---~~~~~~E~~~l~~l~HpnIv~~~g~~~-~~~~~i   84 (272)
T d1qpca_          13 ETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQG---SMS---PDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYI   84 (272)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTT---SSC---HHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEE
T ss_pred             HHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccC---cCC---HHHHHHHHHHHHhCCCCCEeEEEeeec-cCCeEE
Confidence            58999999999999999999976 5788999998632   122   357899999999999999999999764 567899


Q ss_pred             EEeeccCCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCCcc
Q 004959          420 YLEYVHPGSINKYVREH-CGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKA  498 (721)
Q Consensus       420 VmEy~~gGsL~~~L~~~-~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~~~  498 (721)
                      |||||++|+|.+++... ...+++..+..|+.||+.||.|||++||+||||||+||||+.++.+||+|||+|+.+.....
T Consensus        85 v~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~  164 (272)
T d1qpca_          85 ITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY  164 (272)
T ss_dssp             EEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCE
T ss_pred             EEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccceeeccccceEEccCCcc
Confidence            99999999999987543 34699999999999999999999999999999999999999999999999999998765432


Q ss_pred             --cccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhC-CCCCCchhhHHHHHHHhhc-CCCCCCCCCH
Q 004959          499 --DLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTG-KPPWSEYEGAAAMFKVMRD-TPAIPDSLSP  574 (721)
Q Consensus       499 --~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG-~~PF~~~~~~~~~~ki~~~-~~~~p~~lS~  574 (721)
                        .....||+.|||||++.+       ..++.++|||||||+||||+|| .+||......+.+..+... .+..|..+++
T Consensus       165 ~~~~~~~gt~~y~APE~~~~-------~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~~~~~p~~~~~  237 (272)
T d1qpca_         165 TAREGAKFPIKWTAPEAINY-------GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPE  237 (272)
T ss_dssp             ECCTTCCCCTTTSCHHHHHH-------CEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCH
T ss_pred             ccccccCCcccccChHHHhC-------CCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCcccChH
Confidence              234679999999999964       3467799999999999999995 5556655555555555554 3556788999


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHHh--cccccc
Q 004959          575 EGKDFLRCCFQRNPADRPPASLLLE--HRFLKN  605 (721)
Q Consensus       575 el~dLI~~cL~~DP~kRPSa~eLL~--Hp~f~~  605 (721)
                      ++.+||++||+.||++|||+.||++  |+||..
T Consensus       238 ~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~fts  270 (272)
T d1qpca_         238 ELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA  270 (272)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhhc
Confidence            9999999999999999999999988  788863

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-51  Score=425.05  Aligned_cols=247  Identities=26%  Similarity=0.456  Sum_probs=219.1

Q ss_pred             CCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeEEE
Q 004959          340 SQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYI  419 (721)
Q Consensus       340 ~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~yL  419 (721)
                      ++|++++.||+|+||+||+|+++ +++.||||++....   ..   .+.+.+|+.+|++++|||||++++++.+++.+|+
T Consensus         4 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~---~~---~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~i   76 (258)
T d1k2pa_           4 KDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGS---MS---EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFI   76 (258)
T ss_dssp             CCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSS---SC---HHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEE
T ss_pred             HHCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCc---CC---HHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEE
Confidence            57899999999999999999985 68899999987422   22   2468899999999999999999999999999999


Q ss_pred             EEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCCccc
Q 004959          420 YLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKAD  499 (721)
Q Consensus       420 VmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~~~~  499 (721)
                      ||||+.+|+|.+++......+++..+..++.||++||.|||++||+||||||+||||+.++.+||+|||+++.+......
T Consensus        77 v~Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~  156 (258)
T d1k2pa_          77 ITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT  156 (258)
T ss_dssp             EEECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCC
T ss_pred             EEEccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCcEEECcchhheeccCCCce
Confidence            99999999999998877788999999999999999999999999999999999999999999999999999876544322


Q ss_pred             --ccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhh-CCCCCCchhhHHHHHHHhhc-CCCCCCCCCHH
Q 004959          500 --LSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFKVMRD-TPAIPDSLSPE  575 (721)
Q Consensus       500 --~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLt-G~~PF~~~~~~~~~~ki~~~-~~~~p~~lS~e  575 (721)
                        ....||+.|+|||++.+       ..++.++|||||||++|||+| |+.||.+....+...++... ....|..++++
T Consensus       157 ~~~~~~~t~~y~aPE~~~~-------~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~  229 (258)
T d1k2pa_         157 SSVGSKFPVRWSPPEVLMY-------SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEK  229 (258)
T ss_dssp             CCCCSCCCGGGCCHHHHHH-------CCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHH
T ss_pred             eecccCCCCCcCCcHHhcC-------CCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCCCCCCcccccHH
Confidence              24669999999999964       356789999999999999998 89999988877777777664 34667889999


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHHhc
Q 004959          576 GKDFLRCCFQRNPADRPPASLLLEH  600 (721)
Q Consensus       576 l~dLI~~cL~~DP~kRPSa~eLL~H  600 (721)
                      +.+||++||+.||++|||++||++|
T Consensus       230 l~~li~~cl~~dP~~RPt~~eil~~  254 (258)
T d1k2pa_         230 VYTIMYSCWHEKADERPTFKILLSN  254 (258)
T ss_dssp             HHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHccCCHhHCcCHHHHHHH
Confidence            9999999999999999999999998

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-50  Score=422.32  Aligned_cols=258  Identities=26%  Similarity=0.454  Sum_probs=218.2

Q ss_pred             CCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeEEE
Q 004959          340 SQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYI  419 (721)
Q Consensus       340 ~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~yL  419 (721)
                      ++|++++.||+|+||+||+|+++.+|+.||||++....   ......+++.+|+.+|+.++|||||++++++.+.+..++
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~---~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~i   78 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDD---DDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTL   78 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSC---SSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred             CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhh---CChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeE
Confidence            47999999999999999999999999999999986432   233456789999999999999999999999999999999


Q ss_pred             EEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCCcc-
Q 004959          420 YLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKA-  498 (721)
Q Consensus       420 VmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~~~-  498 (721)
                      |||++.|++|..++... +.+++..++.++.||+.||+|||++|||||||||+||||+.++.+||+|||+++.+..... 
T Consensus        79 v~~~~~~~~l~~~~~~~-~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~~  157 (292)
T d1unla_          79 VFEFCDQDLKKYFDSCN-GDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRC  157 (292)
T ss_dssp             EEECCSEEHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCSC
T ss_pred             Eeeeccccccccccccc-cccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCceeeeecchhhcccCCCcc
Confidence            99999999888877654 7899999999999999999999999999999999999999999999999999988755433 


Q ss_pred             cccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCC-chhhHHHHHHHhhc-------------
Q 004959          499 DLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWS-EYEGAAAMFKVMRD-------------  564 (721)
Q Consensus       499 ~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~-~~~~~~~~~ki~~~-------------  564 (721)
                      .....+++.|+|||++..      ...++.++|||||||++|||++|+.||. +.+..+.+.++...             
T Consensus       158 ~~~~~~~~~~~~pe~~~~------~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (292)
T d1unla_         158 YSAEVVTLWYRPPDVLFG------AKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMT  231 (292)
T ss_dssp             CCSCCSCGGGCCHHHHTT------CSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGG
T ss_pred             ceeeccccchhhhhHhcc------CCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhh
Confidence            334568899999999853      2346779999999999999999999864 33444444433210             


Q ss_pred             ----------------CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhccccccCC
Q 004959          565 ----------------TPAIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQ  607 (721)
Q Consensus       565 ----------------~~~~p~~lS~el~dLI~~cL~~DP~kRPSa~eLL~Hp~f~~~~  607 (721)
                                      .......+++++.+||++||+.||++|||++|+|+||||++..
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~~~  290 (292)
T d1unla_         232 KLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFC  290 (292)
T ss_dssp             GSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSSCS
T ss_pred             hcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcCCC
Confidence                            1112345789999999999999999999999999999998643

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3e-51  Score=438.15  Aligned_cols=291  Identities=25%  Similarity=0.387  Sum_probs=228.1

Q ss_pred             CCCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEec----
Q 004959          339 NSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVE----  414 (721)
Q Consensus       339 ~~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~----  414 (721)
                      .++|++++.||+|+||+||+|+++.+|+.||||++..   ........+++.+|+.+|++++|||||++++++...    
T Consensus        17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~---~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~   93 (348)
T d2gfsa1          17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR---PFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLE   93 (348)
T ss_dssp             ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSC---TTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTT
T ss_pred             CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECc---hhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccc
Confidence            4689999999999999999999999999999999863   234455667899999999999999999999998643    


Q ss_pred             -CeEEEEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCcccc
Q 004959          415 -DKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHL  493 (721)
Q Consensus       415 -~~~yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l  493 (721)
                       ...++||||+.||+|.+++..  +.+++.+++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++...
T Consensus        94 ~~~~~~i~~~~~gg~L~~~~~~--~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~  171 (348)
T d2gfsa1          94 EFNDVYLVTHLMGADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT  171 (348)
T ss_dssp             TCCCCEEEEECCSEEHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC----CC
T ss_pred             cCceEEEEEeecCCchhhhccc--ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccccccccccccchhccc
Confidence             334666777889999999854  57999999999999999999999999999999999999999999999999999765


Q ss_pred             CCCcccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhcCC-------
Q 004959          494 TGQKADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRDTP-------  566 (721)
Q Consensus       494 ~~~~~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~~~-------  566 (721)
                      ..  ...+..||+.|+|||++.+      ...++.++|||||||++|+|++|+.||.+.+.......+.....       
T Consensus       172 ~~--~~~~~~g~~~y~apE~~~~------~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~  243 (348)
T d2gfsa1         172 DD--EMTGYVATRWYRAPEIMLN------WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL  243 (348)
T ss_dssp             TG--GGSSSCHHHHTSCHHHHTT------CSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred             Cc--ccccccccccccCchhhcC------CccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHh
Confidence            33  3345779999999999853      23456789999999999999999999988766655555433211       


Q ss_pred             ----------------CC--------CCCCCHHHHHHHHHhcccCCCCCCCHHHHHhccccccCCCCCCCCcccccCCCC
Q 004959          567 ----------------AI--------PDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQPDVPSCSLSFSGMQ  622 (721)
Q Consensus       567 ----------------~~--------p~~lS~el~dLI~~cL~~DP~kRPSa~eLL~Hp~f~~~~~~~~~~~~~~~~~~~  622 (721)
                                      ..        ...+++++++||++||+.||++|||++|||+||||++...+........+. ..
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~~~~~~~~~~~~~-~~  322 (348)
T d2gfsa1         244 KKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPYD-QS  322 (348)
T ss_dssp             TTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCTTSCCCCCCCC-CG
T ss_pred             hhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCCCCccCCCCCCCC-Cc
Confidence                            11        135799999999999999999999999999999999876655433322221 22


Q ss_pred             CCCCCCChhHHHhhhHHHHHh
Q 004959          623 LTEKPHSPREKADAKYDQVAA  643 (721)
Q Consensus       623 l~~~~~~~~~~~~~~~d~~~~  643 (721)
                      ..+......+..+..++++..
T Consensus       323 ~~~~~~~~~~~k~~~~~e~~~  343 (348)
T d2gfsa1         323 FESRDLLIDEWKSLTYDEVIS  343 (348)
T ss_dssp             GGGCCCCHHHHHHHHHHHHHT
T ss_pred             ccchhcCHHHHHHHHHHHhhc
Confidence            233333444445555565443

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-51  Score=426.15  Aligned_cols=249  Identities=24%  Similarity=0.416  Sum_probs=207.3

Q ss_pred             CCeeEeeEEeecCCeEEEEEEECCC---CcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCe
Q 004959          340 SQWQKGKLIGRGTFGSVYVASNRET---GALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDK  416 (721)
Q Consensus       340 ~~y~~~k~LG~G~fG~VY~a~~~~t---g~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~  416 (721)
                      ++|++++.||+|+||+||+|++..+   +..||||.+..    .......+.+.+|+.+|++++|||||++++++. ++.
T Consensus         7 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~----~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~   81 (273)
T d1mp8a_           7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKN----CTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENP   81 (273)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTT----TTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSS
T ss_pred             HHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEecc----ccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCe
Confidence            5899999999999999999998754   35688887742    234556678999999999999999999999885 578


Q ss_pred             EEEEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCC
Q 004959          417 FYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQ  496 (721)
Q Consensus       417 ~yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~  496 (721)
                      +|+|||||.+|+|.+++......+++..++.++.||+.||.|||++|||||||||+|||++.++.+||+|||+|+.+...
T Consensus        82 ~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~  161 (273)
T d1mp8a_          82 VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS  161 (273)
T ss_dssp             CEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC----------
T ss_pred             EEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCcEEEccchhheeccCC
Confidence            99999999999999998877778999999999999999999999999999999999999999999999999999876543


Q ss_pred             cc--cccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhh-CCCCCCchhhHHHHHHHhhcC-CCCCCCC
Q 004959          497 KA--DLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFKVMRDT-PAIPDSL  572 (721)
Q Consensus       497 ~~--~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLt-G~~PF~~~~~~~~~~ki~~~~-~~~p~~l  572 (721)
                      ..  .....||+.|+|||++.+       ..++.++|||||||+||||++ |.+||.+....+.+.++.... ..++..+
T Consensus       162 ~~~~~~~~~gt~~y~apE~l~~-------~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~  234 (273)
T d1mp8a_         162 TYYKASKGKLPIKWMAPESINF-------RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNC  234 (273)
T ss_dssp             ---------CCGGGCCHHHHHH-------CCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTC
T ss_pred             cceeccceecCcccchhhHhcc-------CCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCC
Confidence            32  234568999999999964       457789999999999999998 899999887777777766553 5678899


Q ss_pred             CHHHHHHHHHhcccCCCCCCCHHHHHhc
Q 004959          573 SPEGKDFLRCCFQRNPADRPPASLLLEH  600 (721)
Q Consensus       573 S~el~dLI~~cL~~DP~kRPSa~eLL~H  600 (721)
                      ++++.+||.+||+.||++|||+.||++|
T Consensus       235 ~~~~~~li~~cl~~dp~~Rps~~ei~~~  262 (273)
T d1mp8a_         235 PPTLYSLMTKCWAYDPSRRPRFTELKAQ  262 (273)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence            9999999999999999999999999987

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.8e-51  Score=439.20  Aligned_cols=288  Identities=23%  Similarity=0.342  Sum_probs=214.9

Q ss_pred             CCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEe------
Q 004959          340 SQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIV------  413 (721)
Q Consensus       340 ~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~------  413 (721)
                      .+|++++.||+|+||+||+|+++.+|+.||||++...   .......+++.+|+.+|++++|||||+++++|..      
T Consensus        17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~---~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~   93 (355)
T d2b1pa1          17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRP---FQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEE   93 (355)
T ss_dssp             TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEEST---TSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTT
T ss_pred             CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChh---hcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeccccccc
Confidence            5799999999999999999999999999999998642   2345667789999999999999999999999864      


Q ss_pred             cCeEEEEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCcccc
Q 004959          414 EDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHL  493 (721)
Q Consensus       414 ~~~~yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l  493 (721)
                      ...+|+|||||.|+ +.+.+   ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++..
T Consensus        94 ~~~~~iv~Ey~~~~-l~~~~---~~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~  169 (355)
T d2b1pa1          94 FQDVYLVMELMDAN-LCQVI---QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA  169 (355)
T ss_dssp             CCEEEEEEECCSEE-HHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred             CceeEEEEeccchH-HHHhh---hcCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccceeeechhhhhcc
Confidence            36799999999765 44444   257999999999999999999999999999999999999999999999999999887


Q ss_pred             CCCcccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHHhhc---------
Q 004959          494 TGQKADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKVMRD---------  564 (721)
Q Consensus       494 ~~~~~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki~~~---------  564 (721)
                      .........+||+.|+|||++.       +..++.++||||+||++|+|++|+.||.+.+......+++..         
T Consensus       170 ~~~~~~~~~~~t~~y~aPE~l~-------~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~  242 (355)
T d2b1pa1         170 GTSFMMTPYVVTRYYRAPEVIL-------GMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFM  242 (355)
T ss_dssp             -----------CCTTCCHHHHT-------TCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred             ccccccccccccccccChhhhc-------CCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHH
Confidence            6666666778999999999994       346777899999999999999999999876655544443221         


Q ss_pred             -------------CCCCC--------------------CCCCHHHHHHHHHhcccCCCCCCCHHHHHhccccccCCCCC-
Q 004959          565 -------------TPAIP--------------------DSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQQPD-  610 (721)
Q Consensus       565 -------------~~~~p--------------------~~lS~el~dLI~~cL~~DP~kRPSa~eLL~Hp~f~~~~~~~-  610 (721)
                                   .....                    ..+++++++||++||+.||++|||++|||+||||+....+. 
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~~~~~~~  322 (355)
T d2b1pa1         243 KKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDPAE  322 (355)
T ss_dssp             TTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGCCHHH
T ss_pred             HHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCCCCccc
Confidence                         00000                    11467899999999999999999999999999998754321 


Q ss_pred             CCCcccccCCCCCCCCCCChhHHHhhhHHHH
Q 004959          611 VPSCSLSFSGMQLTEKPHSPREKADAKYDQV  641 (721)
Q Consensus       611 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~d~~  641 (721)
                      .........+.++++.....++.++..+.++
T Consensus       323 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  353 (355)
T d2b1pa1         323 VEAPPPQIYDKQLDEREHTIEEWKELIYKEV  353 (355)
T ss_dssp             HTCCCC-------CCCCCCHHHHHHHHHHHH
T ss_pred             ccCCCCCCCCcchhhhhcCHHHHHHHHHHHh
Confidence            1111222333455566666666666666554

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-50  Score=422.75  Aligned_cols=249  Identities=24%  Similarity=0.395  Sum_probs=204.9

Q ss_pred             CCeeEeeEEeecCCeEEEEEEECCCC----cEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecC
Q 004959          340 SQWQKGKLIGRGTFGSVYVASNRETG----ALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVED  415 (721)
Q Consensus       340 ~~y~~~k~LG~G~fG~VY~a~~~~tg----~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~  415 (721)
                      +.|+++++||+|+||+||+|.++.++    ..||||++..    .......+.+.+|+.+|++++|||||+++|++.+.+
T Consensus         7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~----~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~   82 (283)
T d1mqba_           7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKA----GYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYK   82 (283)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECT----TCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred             HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECc----ccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCC
Confidence            47999999999999999999877654    4799998853    223445667899999999999999999999999999


Q ss_pred             eEEEEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCC
Q 004959          416 KFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTG  495 (721)
Q Consensus       416 ~~yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~  495 (721)
                      .+++|||||.+++|.+++......+++.++..++.||+.||+|||+++|+||||||+||||+.++.+||+|||+++.+..
T Consensus        83 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~  162 (283)
T d1mqba_          83 PMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLED  162 (283)
T ss_dssp             SEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred             ceEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCeEEEcccchhhcccC
Confidence            99999999999999999887778899999999999999999999999999999999999999999999999999987654


Q ss_pred             Ccc----cccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCC-CCchhhHHHHHHHhhc-CCCCC
Q 004959          496 QKA----DLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPP-WSEYEGAAAMFKVMRD-TPAIP  569 (721)
Q Consensus       496 ~~~----~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~P-F~~~~~~~~~~ki~~~-~~~~p  569 (721)
                      ...    .....||+.|||||++.       ...++.++|||||||+||||++|..| |.+....+.+..+... .+..+
T Consensus       163 ~~~~~~~~~~~~gt~~Y~APE~l~-------~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~~  235 (283)
T d1mqba_         163 DPEATYTTSGGKIPIRWTAPEAIS-------YRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTP  235 (283)
T ss_dssp             -----------CCCGGGSCHHHHH-------SCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCC
T ss_pred             CCccceEeccCCCCccccCHHHHc-------cCCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhccCCCCCc
Confidence            322    12356899999999994       34678899999999999999996555 4444444444444433 34667


Q ss_pred             CCCCHHHHHHHHHhcccCCCCCCCHHHHHh
Q 004959          570 DSLSPEGKDFLRCCFQRNPADRPPASLLLE  599 (721)
Q Consensus       570 ~~lS~el~dLI~~cL~~DP~kRPSa~eLL~  599 (721)
                      ..++.++.+||.+||+.||++|||+.||++
T Consensus       236 ~~~~~~l~~li~~cl~~~p~~RPt~~eil~  265 (283)
T d1mqba_         236 MDCPSAIYQLMMQCWQQERARRPKFADIVS  265 (283)
T ss_dssp             TTCBHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             hhhHHHHHHHHHHHCcCCHhHCcCHHHHHH
Confidence            789999999999999999999999999987

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=1.3e-50  Score=430.70  Aligned_cols=251  Identities=25%  Similarity=0.400  Sum_probs=210.1

Q ss_pred             CCCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCC-CCCeeeeeeeEEec--C
Q 004959          339 NSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLK-HPNIVQYYGSEIVE--D  415 (721)
Q Consensus       339 ~~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~-HPnIV~l~g~~~~~--~  415 (721)
                      .++|++++.||+|+||+||+|+++.+|+.||||++...    .    .+++.+|+.+|+.+. ||||+++++++...  .
T Consensus        34 ~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~----~----~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~  105 (328)
T d3bqca1          34 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV----K----KKKIKREIKILENLRGGPNIITLADIVKDPVSR  105 (328)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS----C----HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTC
T ss_pred             CcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH----H----HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCC
Confidence            46799999999999999999999999999999998531    1    357889999999995 99999999998754  5


Q ss_pred             eEEEEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCC-ceEEeecCCccccC
Q 004959          416 KFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASG-VVKLADFGMAKHLT  494 (721)
Q Consensus       416 ~~yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g-~VKL~DFGlA~~l~  494 (721)
                      .+|+|||||.+++|..+.    +.+++.+++.++.||+.||.|||++|||||||||+||||+.++ .+||+|||+|+.+.
T Consensus       106 ~~~~v~e~~~~~~L~~~~----~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~  181 (328)
T d3bqca1         106 TPALVFEHVNNTDFKQLY----QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH  181 (328)
T ss_dssp             SEEEEEECCCSCBGGGTT----TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCEECC
T ss_pred             ceeEEEeecCCCcHHHHh----cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeecccccceecc
Confidence            699999999999997653    5699999999999999999999999999999999999998655 69999999999887


Q ss_pred             CCcccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhh-HHHHHHHhh----------
Q 004959          495 GQKADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEG-AAAMFKVMR----------  563 (721)
Q Consensus       495 ~~~~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~-~~~~~ki~~----------  563 (721)
                      ........+||+.|+|||.+.+      ...++.++|||||||++|||++|+.||..... .+....+..          
T Consensus       182 ~~~~~~~~~~t~~y~aPE~~~~------~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~  255 (328)
T d3bqca1         182 PGQEYNVRVASRYFKGPELLVD------YQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDY  255 (328)
T ss_dssp             TTCCCCSCCSCGGGCCHHHHTT------CCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHH
T ss_pred             CCCcccccccCccccCcccccC------CCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhh
Confidence            7666677889999999999853      33467899999999999999999999965322 111111100          


Q ss_pred             ---c------------------------CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhccccccCC
Q 004959          564 ---D------------------------TPAIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEHRFLKNSQ  607 (721)
Q Consensus       564 ---~------------------------~~~~p~~lS~el~dLI~~cL~~DP~kRPSa~eLL~Hp~f~~~~  607 (721)
                         .                        .......++++++|||++||++||++|||++|+|+||||+...
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~v~  326 (328)
T d3bqca1         256 IDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVV  326 (328)
T ss_dssp             HHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTSC
T ss_pred             hhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCC
Confidence               0                        0011134789999999999999999999999999999998753

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.4e-51  Score=432.14  Aligned_cols=250  Identities=25%  Similarity=0.419  Sum_probs=209.6

Q ss_pred             CCeeEeeEEeecCCeEEEEEEECCCCc----EEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecC
Q 004959          340 SQWQKGKLIGRGTFGSVYVASNRETGA----LCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVED  415 (721)
Q Consensus       340 ~~y~~~k~LG~G~fG~VY~a~~~~tg~----~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~  415 (721)
                      .+|+++++||+|+||+||+|.+..+|+    .||+|.+..    ....+..+.+.+|+.+|++++|||||++++++.+ +
T Consensus         9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~----~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~-~   83 (317)
T d1xkka_           9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELRE----ATSPKANKEILDEAYVMASVDNPHVCRLLGICLT-S   83 (317)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC--------CTHHHHHHHHHHHHHCCCTTBCCEEEEEES-S
T ss_pred             HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEecc----ccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-C
Confidence            479999999999999999999988887    467776642    1222345789999999999999999999999876 4


Q ss_pred             eEEEEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCC
Q 004959          416 KFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTG  495 (721)
Q Consensus       416 ~~yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~  495 (721)
                      ..+++|||+.+|+|.+++......+++..++.|+.||+.||+|||++|||||||||+||||+.++.+||+|||+|+.+..
T Consensus        84 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~  163 (317)
T d1xkka_          84 TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA  163 (317)
T ss_dssp             SEEEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTT
T ss_pred             CeeEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCCeEeeccccceeccc
Confidence            57788999999999999988778899999999999999999999999999999999999999999999999999987754


Q ss_pred             Cccc---ccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhh-CCCCCCchhhHHHHHHHhhcC-CCCCC
Q 004959          496 QKAD---LSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFKVMRDT-PAIPD  570 (721)
Q Consensus       496 ~~~~---~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLt-G~~PF~~~~~~~~~~ki~~~~-~~~p~  570 (721)
                      ....   ....||+.|||||++.+       ..++.++|||||||+||||+| |.+||.+....+....+..+. ...|.
T Consensus       164 ~~~~~~~~~~~gt~~y~APE~l~~-------~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~p~  236 (317)
T d1xkka_         164 EEKEYHAEGGKVPIKWMALESILH-------RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPP  236 (317)
T ss_dssp             TCC--------CCTTTSCHHHHHH-------CCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTCCCCCCT
T ss_pred             ccccccccccccCccccChHHHhc-------CCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCc
Confidence            4332   23468999999999964       357889999999999999998 899998876665555554433 56778


Q ss_pred             CCCHHHHHHHHHhcccCCCCCCCHHHHHhcc
Q 004959          571 SLSPEGKDFLRCCFQRNPADRPPASLLLEHR  601 (721)
Q Consensus       571 ~lS~el~dLI~~cL~~DP~kRPSa~eLL~Hp  601 (721)
                      .+++++.+||.+||+.||++|||+.||++|.
T Consensus       237 ~~~~~~~~li~~cl~~dP~~RPs~~eil~~l  267 (317)
T d1xkka_         237 ICTIDVYMIMVKCWMIDADSRPKFRELIIEF  267 (317)
T ss_dssp             TBCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             ccCHHHHHHHHHhCCCChhhCcCHHHHHHHH
Confidence            8999999999999999999999999999983

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-50  Score=431.62  Aligned_cols=260  Identities=28%  Similarity=0.476  Sum_probs=218.7

Q ss_pred             CCeeEeeEEeecCCeEEEEEEE---CCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCC-CCeeeeeeeEEecC
Q 004959          340 SQWQKGKLIGRGTFGSVYVASN---RETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKH-PNIVQYYGSEIVED  415 (721)
Q Consensus       340 ~~y~~~k~LG~G~fG~VY~a~~---~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~H-PnIV~l~g~~~~~~  415 (721)
                      ++|++++.||+|+||+||+|++   +.+|+.||||++.+.... ......+.+.+|+++|++++| |||+++++++.+..
T Consensus        24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~-~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~  102 (322)
T d1vzoa_          24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIV-QKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET  102 (322)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEE-EEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred             hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhc-cchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCC
Confidence            6799999999999999999987   457999999998532110 011123567899999999976 89999999999999


Q ss_pred             eEEEEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCC
Q 004959          416 KFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTG  495 (721)
Q Consensus       416 ~~yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~  495 (721)
                      .+|+||||+.||+|.+++... +.+++..++.++.||+.||+|||++|||||||||+||||+.+|.+||+|||+++.+..
T Consensus       103 ~~~~v~e~~~~~~L~~~i~~~-~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~~~  181 (322)
T d1vzoa_         103 KLHLILDYINGGELFTHLSQR-ERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVA  181 (322)
T ss_dssp             EEEEEECCCCSCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEECCG
T ss_pred             ceeeeeecccccHHHHHHHhc-ccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCCEEEeeccchhhhcc
Confidence            999999999999999999776 6789999999999999999999999999999999999999999999999999987654


Q ss_pred             Cc--ccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHH----HHHHHhhcCCCCC
Q 004959          496 QK--ADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAA----AMFKVMRDTPAIP  569 (721)
Q Consensus       496 ~~--~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~----~~~ki~~~~~~~p  569 (721)
                      ..  ......|++.|+|||.+.+     ....++.++|||||||+||+|++|+.||.+....+    .........+.++
T Consensus       182 ~~~~~~~~~~g~~~~~~pe~~~~-----~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~  256 (322)
T d1vzoa_         182 DETERAYDFCGTIEYMAPDIVRG-----GDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYP  256 (322)
T ss_dssp             GGGGGGCGGGSCCTTCCHHHHTT-----CC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCC
T ss_pred             cccccccccccccccchhHHhhc-----CCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCCCCCc
Confidence            33  2345679999999999954     33456778999999999999999999997654322    2333445566778


Q ss_pred             CCCCHHHHHHHHHhcccCCCCCC-----CHHHHHhccccccC
Q 004959          570 DSLSPEGKDFLRCCFQRNPADRP-----PASLLLEHRFLKNS  606 (721)
Q Consensus       570 ~~lS~el~dLI~~cL~~DP~kRP-----Sa~eLL~Hp~f~~~  606 (721)
                      ..+++++++||++||+.||++||     |++|+++||||+..
T Consensus       257 ~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~i  298 (322)
T d1vzoa_         257 QEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKI  298 (322)
T ss_dssp             TTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTC
T ss_pred             ccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcCC
Confidence            89999999999999999999999     58999999999864

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5e-50  Score=420.92  Aligned_cols=252  Identities=25%  Similarity=0.452  Sum_probs=207.9

Q ss_pred             CCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCeEEE
Q 004959          340 SQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDKFYI  419 (721)
Q Consensus       340 ~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~~yL  419 (721)
                      ++|++++.||+|+||+||+|+++.+ +.||||++...   ...   .+.+.+|+.+|++++|||||++++++. ++.+|+
T Consensus        17 ~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~---~~~---~~~~~~E~~~l~~l~h~nIv~~~g~~~-~~~~~l   88 (285)
T d1fmka3          17 ESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPG---TMS---PEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYI   88 (285)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTT---SSC---HHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEE
T ss_pred             HHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECcc---cCC---HHHHHHHHHHHHhcccCCEeEEEEEEe-cCCeEE
Confidence            5899999999999999999998765 57999998632   222   257899999999999999999999874 567899


Q ss_pred             EEeeccCCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCCcc
Q 004959          420 YLEYVHPGSINKYVREH-CGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKA  498 (721)
Q Consensus       420 VmEy~~gGsL~~~L~~~-~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~~~  498 (721)
                      |||||.+|+|..++... ...+++.++..++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.+.....
T Consensus        89 v~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~  168 (285)
T d1fmka3          89 VTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY  168 (285)
T ss_dssp             EECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC-------
T ss_pred             EEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCcEEEcccchhhhccCCCc
Confidence            99999999999888543 46799999999999999999999999999999999999999999999999999987644332


Q ss_pred             --cccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCC-CCCCchhhHHHHHHHhhc-CCCCCCCCCH
Q 004959          499 --DLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGK-PPWSEYEGAAAMFKVMRD-TPAIPDSLSP  574 (721)
Q Consensus       499 --~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~-~PF~~~~~~~~~~ki~~~-~~~~p~~lS~  574 (721)
                        .....||+.|+|||++..       ..++.++|||||||+||||++|. +||......+.+..+... ....+..+++
T Consensus       169 ~~~~~~~gt~~y~aPE~~~~-------~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~  241 (285)
T d1fmka3         169 TARQGAKFPIKWTAPEAALY-------GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPE  241 (285)
T ss_dssp             -------CCGGGSCHHHHHH-------CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTSCH
T ss_pred             eeeccccccccccChHHHhC-------CCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCCcccCH
Confidence              233569999999999964       45678999999999999999955 555555555556555544 3467888999


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHHh--ccccccC
Q 004959          575 EGKDFLRCCFQRNPADRPPASLLLE--HRFLKNS  606 (721)
Q Consensus       575 el~dLI~~cL~~DP~kRPSa~eLL~--Hp~f~~~  606 (721)
                      ++++||.+||+.||++||++++|++  |+||...
T Consensus       242 ~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~  275 (285)
T d1fmka3         242 SLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST  275 (285)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred             HHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCC
Confidence            9999999999999999999999987  7888754

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7e-50  Score=419.97  Aligned_cols=250  Identities=26%  Similarity=0.487  Sum_probs=201.9

Q ss_pred             CCeeEeeEEeecCCeEEEEEEECC-----CCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhC-CCCCeeeeeeeEEe
Q 004959          340 SQWQKGKLIGRGTFGSVYVASNRE-----TGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHL-KHPNIVQYYGSEIV  413 (721)
Q Consensus       340 ~~y~~~k~LG~G~fG~VY~a~~~~-----tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L-~HPnIV~l~g~~~~  413 (721)
                      ++|++++.||+|+||+||+|.+..     +++.||||++..    .......+.+.+|+.++.++ +|+|||.+++++..
T Consensus        13 ~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~----~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~   88 (299)
T d1ywna1          13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKE----GATHSEHRALMSELKILIHIGHHLNVVNLLGACTK   88 (299)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC--------CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             HHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEcc----ccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeecc
Confidence            579999999999999999998653     457899998752    22344556778888887776 68999999998765


Q ss_pred             c-CeEEEEEeeccCCCHHHHHHHhc---------------CCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEc
Q 004959          414 E-DKFYIYLEYVHPGSINKYVREHC---------------GAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVD  477 (721)
Q Consensus       414 ~-~~~yLVmEy~~gGsL~~~L~~~~---------------~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld  477 (721)
                      . ..+++|||||++|+|.++|....               ..+++.+++.++.||+.||+|||++|||||||||+||||+
T Consensus        89 ~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NILl~  168 (299)
T d1ywna1          89 PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS  168 (299)
T ss_dssp             TTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC
T ss_pred             CCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccceeEC
Confidence            4 56899999999999999997542               3489999999999999999999999999999999999999


Q ss_pred             CCCceEEeecCCccccCCCcc---cccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhC-CCCCCchh
Q 004959          478 ASGVVKLADFGMAKHLTGQKA---DLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTG-KPPWSEYE  553 (721)
Q Consensus       478 ~~g~VKL~DFGlA~~l~~~~~---~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG-~~PF~~~~  553 (721)
                      .++.+||+|||+|+.+.....   ....+||+.|||||++.+       ..++.++|||||||++|||++| .+||.+..
T Consensus       169 ~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~-------~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~  241 (299)
T d1ywna1         169 EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD-------RVYTIQSDVWSFGVLLWEIFSLGASPYPGVK  241 (299)
T ss_dssp             GGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHH-------CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred             CCCcEEEccCcchhhccccccccccCceeeCccccchhHhhc-------CCCCcccceeehHHHHHHHHhCCCCCCCCCC
Confidence            999999999999987654332   234679999999999964       4577899999999999999986 56887765


Q ss_pred             hHHHHHHHhhc--CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q 004959          554 GAAAMFKVMRD--TPAIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEH  600 (721)
Q Consensus       554 ~~~~~~ki~~~--~~~~p~~lS~el~dLI~~cL~~DP~kRPSa~eLL~H  600 (721)
                      ..+.+.+++..  .+..|..+++++++||.+||+.||++|||++||++|
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~  290 (299)
T d1ywna1         242 IDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  290 (299)
T ss_dssp             CSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            55555444433  456778899999999999999999999999999998

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9e-50  Score=422.31  Aligned_cols=250  Identities=26%  Similarity=0.451  Sum_probs=213.2

Q ss_pred             CCeeEeeEEeecCCeEEEEEEECCCCcE--EEEEEeecCCCCcccHHHHHHHHHHHHHHHhC-CCCCeeeeeeeEEecCe
Q 004959          340 SQWQKGKLIGRGTFGSVYVASNRETGAL--CAMKEVDIFPDDPKSAESIKQLEQEIKVLSHL-KHPNIVQYYGSEIVEDK  416 (721)
Q Consensus       340 ~~y~~~k~LG~G~fG~VY~a~~~~tg~~--vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L-~HPnIV~l~g~~~~~~~  416 (721)
                      ++|+++++||+|+||+||+|+++.+|..  ||||.+...    ...+..+.+.+|+++|.++ +|||||++++++.+++.
T Consensus        10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~   85 (309)
T d1fvra_          10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY----ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGY   85 (309)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC----------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTE
T ss_pred             HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcc----cChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCe
Confidence            6899999999999999999999988875  667766422    1223456799999999999 69999999999999999


Q ss_pred             EEEEEeeccCCCHHHHHHHh---------------cCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCc
Q 004959          417 FYIYLEYVHPGSINKYVREH---------------CGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGV  481 (721)
Q Consensus       417 ~yLVmEy~~gGsL~~~L~~~---------------~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~  481 (721)
                      +|+||||++||+|.++|...               ...+++..+..++.||+.||.|||++||+||||||+|||++.++.
T Consensus        86 ~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~~~  165 (309)
T d1fvra_          86 LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYV  165 (309)
T ss_dssp             EEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGC
T ss_pred             eEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCCCc
Confidence            99999999999999999643               357999999999999999999999999999999999999999999


Q ss_pred             eEEeecCCccccCCCcccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCC-CCCCchhhHHHHHH
Q 004959          482 VKLADFGMAKHLTGQKADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGK-PPWSEYEGAAAMFK  560 (721)
Q Consensus       482 VKL~DFGlA~~l~~~~~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~-~PF~~~~~~~~~~k  560 (721)
                      +||+|||+++............||..|+|||.+..       ..++.++|||||||++|||++|. +||.+.+..+.+..
T Consensus       166 ~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~-------~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~  238 (309)
T d1fvra_         166 AKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNY-------SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEK  238 (309)
T ss_dssp             EEECCTTCEESSCEECCC----CCTTTCCHHHHHH-------CEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHH
T ss_pred             eEEccccccccccccccccceecCCcccchHHhcc-------CCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHH
Confidence            99999999987665555556679999999999964       35678999999999999999965 67888777777776


Q ss_pred             Hhhc-CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q 004959          561 VMRD-TPAIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEH  600 (721)
Q Consensus       561 i~~~-~~~~p~~lS~el~dLI~~cL~~DP~kRPSa~eLL~H  600 (721)
                      +..+ .+..+..+++++++||.+||+.||++|||+.||++|
T Consensus       239 i~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~  279 (309)
T d1fvra_         239 LPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS  279 (309)
T ss_dssp             GGGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHhcCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            6554 456778899999999999999999999999999987

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-49  Score=414.89  Aligned_cols=250  Identities=26%  Similarity=0.471  Sum_probs=206.2

Q ss_pred             CCeeEeeEEeecCCeEEEEEEEC-CCC--cEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecCe
Q 004959          340 SQWQKGKLIGRGTFGSVYVASNR-ETG--ALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVEDK  416 (721)
Q Consensus       340 ~~y~~~k~LG~G~fG~VY~a~~~-~tg--~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~~  416 (721)
                      .+|++.+.||+|+||+||+|+.. .++  ..||||++...  .....+..+.+.+|+.+|++++|||||+++|++.+ ..
T Consensus         8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~--~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~   84 (273)
T d1u46a_           8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPD--VLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PP   84 (273)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC----------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SS
T ss_pred             HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChh--hcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cc
Confidence            57999999999999999999854 333  46899987532  22233456789999999999999999999999865 57


Q ss_pred             EEEEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCC
Q 004959          417 FYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQ  496 (721)
Q Consensus       417 ~yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~  496 (721)
                      +++|||||.+|+|.+++....+.+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.+...
T Consensus        85 ~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~~  164 (273)
T d1u46a_          85 MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQN  164 (273)
T ss_dssp             CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC-
T ss_pred             hheeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccceeeccchhhhhcccC
Confidence            89999999999999998877678999999999999999999999999999999999999999999999999999987544


Q ss_pred             ccc----ccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhh-CCCCCCchhhHHHHHHHhhcC--CCCC
Q 004959          497 KAD----LSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFKVMRDT--PAIP  569 (721)
Q Consensus       497 ~~~----~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLt-G~~PF~~~~~~~~~~ki~~~~--~~~p  569 (721)
                      ...    ....|+..|+|||++.+       ..++.++|||||||++|||++ |+.||.+....+.+.++....  +..+
T Consensus       165 ~~~~~~~~~~~~~~~~~aPE~~~~-------~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~~~~~  237 (273)
T d1u46a_         165 DDHYVMQEHRKVPFAWCAPESLKT-------RTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRP  237 (273)
T ss_dssp             CCEEEC-----CCGGGCCHHHHHH-------CEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCC
T ss_pred             CCcceecCccccCcccCCHHHHhC-------CCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCCCCCCc
Confidence            322    23458889999999964       356778999999999999998 899999988888888776654  3556


Q ss_pred             CCCCHHHHHHHHHhcccCCCCCCCHHHHHh
Q 004959          570 DSLSPEGKDFLRCCFQRNPADRPPASLLLE  599 (721)
Q Consensus       570 ~~lS~el~dLI~~cL~~DP~kRPSa~eLL~  599 (721)
                      ..+++++.+||.+||+.||++|||+.||++
T Consensus       238 ~~~~~~l~~li~~cl~~dp~~RPt~~ei~~  267 (273)
T d1u46a_         238 EDCPQDIYNVMVQCWAHKPEDRPTFVALRD  267 (273)
T ss_dssp             TTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            789999999999999999999999999974

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=4e-49  Score=415.54  Aligned_cols=249  Identities=26%  Similarity=0.467  Sum_probs=215.4

Q ss_pred             CCeeEeeEEeecCCeEEEEEEEC-----CCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEec
Q 004959          340 SQWQKGKLIGRGTFGSVYVASNR-----ETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVE  414 (721)
Q Consensus       340 ~~y~~~k~LG~G~fG~VY~a~~~-----~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~  414 (721)
                      ++|++++.||+|+||+||+|+.+     .+++.||||++..    ....+..+++.+|+.+|++++||||+++++++...
T Consensus        13 ~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~----~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~   88 (301)
T d1lufa_          13 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKE----EASADMQADFQREAALMAEFDNPNIVKLLGVCAVG   88 (301)
T ss_dssp             GGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCT----TCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred             HHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEECh----hcChHHHHHHHHHHHHHHhcCCCCcccceeeeccC
Confidence            57999999999999999999865     4668999998753    23345677899999999999999999999999999


Q ss_pred             CeEEEEEeeccCCCHHHHHHHhc-----------------------CCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCC
Q 004959          415 DKFYIYLEYVHPGSINKYVREHC-----------------------GAITESVVRNFTRHILSGLAYLHSKKTIHRDIKG  471 (721)
Q Consensus       415 ~~~yLVmEy~~gGsL~~~L~~~~-----------------------~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKP  471 (721)
                      +..++||||+.+|+|.+++....                       ..+++..+..|+.||+.||+|||++|||||||||
T Consensus        89 ~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDlKp  168 (301)
T d1lufa_          89 KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLAT  168 (301)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSG
T ss_pred             CceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeEEcc
Confidence            99999999999999999996532                       2488999999999999999999999999999999


Q ss_pred             CcEEEcCCCceEEeecCCccccCCCcc---cccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCC-C
Q 004959          472 ANLLVDASGVVKLADFGMAKHLTGQKA---DLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGK-P  547 (721)
Q Consensus       472 eNILld~~g~VKL~DFGlA~~l~~~~~---~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~-~  547 (721)
                      +||||+.++.+||+|||+|+.+.....   ..+.+||+.|||||++.+       ..++.++|||||||+||||++|. +
T Consensus       169 ~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~t~ksDVwS~Gvvl~ell~~~~~  241 (301)
T d1lufa_         169 RNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFY-------NRYTTESDVWAYGVVLWEIFSYGLQ  241 (301)
T ss_dssp             GGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHH-------CCCCHHHHHHHHHHHHHHHHTTTCC
T ss_pred             cceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHcc-------CCCChhhhhccchhhHHHHHccCCC
Confidence            999999999999999999987654332   234678999999999964       45778999999999999999985 6


Q ss_pred             CCCchhhHHHHHHHhhcC-CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHh
Q 004959          548 PWSEYEGAAAMFKVMRDT-PAIPDSLSPEGKDFLRCCFQRNPADRPPASLLLE  599 (721)
Q Consensus       548 PF~~~~~~~~~~ki~~~~-~~~p~~lS~el~dLI~~cL~~DP~kRPSa~eLL~  599 (721)
                      ||.+....+.+..+.... +.+|..+++++.+||.+||+.||++|||+.||++
T Consensus       242 p~~~~~~~e~~~~v~~~~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~  294 (301)
T d1lufa_         242 PYYGMAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHR  294 (301)
T ss_dssp             TTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCCCCHHHHHHHHHcCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            888887777777766553 4567889999999999999999999999999975

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-48  Score=411.70  Aligned_cols=250  Identities=26%  Similarity=0.480  Sum_probs=209.6

Q ss_pred             CCCeeEeeEEeecCCeEEEEEEECCCC-------cEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhC-CCCCeeeeeee
Q 004959          339 NSQWQKGKLIGRGTFGSVYVASNRETG-------ALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHL-KHPNIVQYYGS  410 (721)
Q Consensus       339 ~~~y~~~k~LG~G~fG~VY~a~~~~tg-------~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L-~HPnIV~l~g~  410 (721)
                      .++|++++.||+|+||.||+|++..++       ..||||++..   + ........+.+|..++.++ +|||||+++++
T Consensus        12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~---~-~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~   87 (299)
T d1fgka_          12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKS---D-ATEKDLSDLISEMEMMKMIGKHKNIINLLGA   87 (299)
T ss_dssp             GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCT---T-CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECc---c-cChHHHHHHHHHHHHHHHhcCCCeEEecccc
Confidence            368999999999999999999876544       4799998753   2 2345567888899988888 79999999999


Q ss_pred             EEecCeEEEEEeeccCCCHHHHHHHhc---------------CCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEE
Q 004959          411 EIVEDKFYIYLEYVHPGSINKYVREHC---------------GAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLL  475 (721)
Q Consensus       411 ~~~~~~~yLVmEy~~gGsL~~~L~~~~---------------~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNIL  475 (721)
                      +.+++.+|+|||||.+|+|.++|....               ..+++.+++.++.||+.||+|||++|||||||||+|||
T Consensus        88 ~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~NiL  167 (299)
T d1fgka_          88 CTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVL  167 (299)
T ss_dssp             ECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred             cccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeeccccee
Confidence            999999999999999999999997543               35899999999999999999999999999999999999


Q ss_pred             EcCCCceEEeecCCccccCCCcc---cccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhh-CCCCCCc
Q 004959          476 VDASGVVKLADFGMAKHLTGQKA---DLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSE  551 (721)
Q Consensus       476 ld~~g~VKL~DFGlA~~l~~~~~---~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLt-G~~PF~~  551 (721)
                      ++.++.+||+|||+++.......   .....||+.|+|||++.+       ..|+.++|||||||+||||++ |.+||.+
T Consensus       168 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~-------~~y~~k~DiwS~Gvvl~ell~~g~~p~~~  240 (299)
T d1fgka_         168 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFD-------RIYTHQSDVWSFGVLLWEIFTLGGSPYPG  240 (299)
T ss_dssp             ECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHH-------CCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred             ecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcC-------CCCCchhhhHHhHHHHHHhccCCCCCCCC
Confidence            99999999999999987754332   234679999999999964       457889999999999999998 7999987


Q ss_pred             hhhHHHHHHHhhc-CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHh
Q 004959          552 YEGAAAMFKVMRD-TPAIPDSLSPEGKDFLRCCFQRNPADRPPASLLLE  599 (721)
Q Consensus       552 ~~~~~~~~ki~~~-~~~~p~~lS~el~dLI~~cL~~DP~kRPSa~eLL~  599 (721)
                      ....+.+..+..+ .+..|..+++++.+||.+||+.||++|||+.||++
T Consensus       241 ~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~  289 (299)
T d1fgka_         241 VPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE  289 (299)
T ss_dssp             CCHHHHHHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCHHHHHHHHHcCCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence            7666555554443 45677889999999999999999999999999987

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.5e-49  Score=407.02  Aligned_cols=243  Identities=27%  Similarity=0.497  Sum_probs=203.5

Q ss_pred             CCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEe-cCeEE
Q 004959          340 SQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIV-EDKFY  418 (721)
Q Consensus       340 ~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~-~~~~y  418 (721)
                      ++|++++.||+|+||.||+|.++  |..||||++..   +.    ..+.+.+|+++|++++|||||+++|++.+ .+.+|
T Consensus         7 ~~~~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~i~~---~~----~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~   77 (262)
T d1byga_           7 KELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKN---DA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLY   77 (262)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCC---CC------HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCE
T ss_pred             HHeEEeEEEecCCCeEEEEEEEC--CeEEEEEEECc---HH----HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEE
Confidence            47999999999999999999985  78999999852   11    23578899999999999999999998855 46689


Q ss_pred             EEEeeccCCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCCc
Q 004959          419 IYLEYVHPGSINKYVREH-CGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQK  497 (721)
Q Consensus       419 LVmEy~~gGsL~~~L~~~-~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~~  497 (721)
                      +||||+++|+|.++|... ...+++..++.++.||+.||.|||+++|+||||||+|||++.+|.+||+|||+++..... 
T Consensus        78 lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~-  156 (262)
T d1byga_          78 IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-  156 (262)
T ss_dssp             EEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC--------
T ss_pred             EEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCCEeecccccceecCCC-
Confidence            999999999999999654 245999999999999999999999999999999999999999999999999999865433 


Q ss_pred             ccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhh-CCCCCCchhhHHHHHHHhh-cCCCCCCCCCHH
Q 004959          498 ADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEYEGAAAMFKVMR-DTPAIPDSLSPE  575 (721)
Q Consensus       498 ~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLt-G~~PF~~~~~~~~~~ki~~-~~~~~p~~lS~e  575 (721)
                       .....+|..|+|||++.+       ..++.++|||||||++|||++ |++||......+....+.. ..+.++..++++
T Consensus       157 -~~~~~~~~~y~aPE~l~~-------~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~  228 (262)
T d1byga_         157 -QDTGKLPVKWTAPEALRE-------KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPA  228 (262)
T ss_dssp             ------CCTTTSCHHHHHH-------CCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCCCCCTTCCHH
T ss_pred             -CccccccccCCChHHHhC-------CCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHH
Confidence             234568999999999964       346789999999999999998 7999988776666666654 346778889999


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHHhc
Q 004959          576 GKDFLRCCFQRNPADRPPASLLLEH  600 (721)
Q Consensus       576 l~dLI~~cL~~DP~kRPSa~eLL~H  600 (721)
                      +++||++||+.||++|||+.+|+++
T Consensus       229 ~~~li~~cl~~dP~~Rps~~~l~~~  253 (262)
T d1byga_         229 VYEVMKNCWHLDAAMRPSFLQLREQ  253 (262)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHcccCHhHCcCHHHHHHH
Confidence            9999999999999999999999875

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.3e-48  Score=409.45  Aligned_cols=250  Identities=24%  Similarity=0.384  Sum_probs=216.1

Q ss_pred             CCeeEeeEEeecCCeEEEEEEEC-----CCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEec
Q 004959          340 SQWQKGKLIGRGTFGSVYVASNR-----ETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVE  414 (721)
Q Consensus       340 ~~y~~~k~LG~G~fG~VY~a~~~-----~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~  414 (721)
                      ++|++++.||+|+||+||+|.++     .+++.||||++..    .........+.+|+.+|++++|||||++++++..+
T Consensus        20 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~----~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~   95 (308)
T d1p4oa_          20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNE----AASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG   95 (308)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCT----TSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSS
T ss_pred             HHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECc----ccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecC
Confidence            68999999999999999999875     3467899998852    23445567899999999999999999999999999


Q ss_pred             CeEEEEEeeccCCCHHHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEe
Q 004959          415 DKFYIYLEYVHPGSINKYVREHC---------GAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLA  485 (721)
Q Consensus       415 ~~~yLVmEy~~gGsL~~~L~~~~---------~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~  485 (721)
                      +..++|||||.+|+|.+++....         ..+++..+..++.||+.||.|||+++|+||||||+||||+.++.+||+
T Consensus        96 ~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~~~Kl~  175 (308)
T d1p4oa_          96 QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIG  175 (308)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCEEEC
T ss_pred             CceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCCceEEEe
Confidence            99999999999999999986432         346899999999999999999999999999999999999999999999


Q ss_pred             ecCCccccCCCcc---cccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhC-CCCCCchhhHHHHHHH
Q 004959          486 DFGMAKHLTGQKA---DLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTG-KPPWSEYEGAAAMFKV  561 (721)
Q Consensus       486 DFGlA~~l~~~~~---~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG-~~PF~~~~~~~~~~ki  561 (721)
                      |||+++.+.....   ....+||+.|+|||.+.+       ..++.++|||||||+||||++| .+||.+....+.+..+
T Consensus       176 DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~-------~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i  248 (308)
T d1p4oa_         176 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKD-------GVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFV  248 (308)
T ss_dssp             CTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHH-------CCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHH
T ss_pred             ecccceeccCCcceeeccceecccccCCHHHHcc-------CCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence            9999987654332   233468999999999964       3567789999999999999998 5888887777777766


Q ss_pred             hhc-CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q 004959          562 MRD-TPAIPDSLSPEGKDFLRCCFQRNPADRPPASLLLEH  600 (721)
Q Consensus       562 ~~~-~~~~p~~lS~el~dLI~~cL~~DP~kRPSa~eLL~H  600 (721)
                      ... ....+..+++++.+||.+||+.||++|||+.+|+++
T Consensus       249 ~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~  288 (308)
T d1p4oa_         249 MEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS  288 (308)
T ss_dssp             HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HhCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            654 345678899999999999999999999999999984

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.9e-48  Score=409.29  Aligned_cols=249  Identities=26%  Similarity=0.489  Sum_probs=213.2

Q ss_pred             CCeeEeeEEeecCCeEEEEEEE-----CCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhC-CCCCeeeeeeeEEe
Q 004959          340 SQWQKGKLIGRGTFGSVYVASN-----RETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHL-KHPNIVQYYGSEIV  413 (721)
Q Consensus       340 ~~y~~~k~LG~G~fG~VY~a~~-----~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L-~HPnIV~l~g~~~~  413 (721)
                      ++|++++.||+|+||.||+|++     ..+++.||||++...    ........+.+|+.++..+ +|||||++++++.+
T Consensus        23 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~----~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~   98 (311)
T d1t46a_          23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPS----AHLTEREALMSELKVLSYLGNHMNIVNLLGACTI   98 (311)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTT----CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             HHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcc----cCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEee
Confidence            5899999999999999999975     356789999998632    2344566889999999999 69999999999999


Q ss_pred             cCeEEEEEeeccCCCHHHHHHHhc-----------------CCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEE
Q 004959          414 EDKFYIYLEYVHPGSINKYVREHC-----------------GAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLV  476 (721)
Q Consensus       414 ~~~~yLVmEy~~gGsL~~~L~~~~-----------------~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILl  476 (721)
                      .+.+|||||||++|+|.+++....                 ..+++..+..|+.||+.||+|||++|||||||||+|||+
T Consensus        99 ~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~NIl~  178 (311)
T d1t46a_          99 GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILL  178 (311)
T ss_dssp             SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred             CCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeecccccccccc
Confidence            999999999999999999997542                 258999999999999999999999999999999999999


Q ss_pred             cCCCceEEeecCCccccCCCcc---cccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhh-CCCCCCch
Q 004959          477 DASGVVKLADFGMAKHLTGQKA---DLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYT-GKPPWSEY  552 (721)
Q Consensus       477 d~~g~VKL~DFGlA~~l~~~~~---~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLt-G~~PF~~~  552 (721)
                      +.++.+||+|||+++.+.....   ....+||+.|+|||++.+       ..++.++|||||||+||||+| |.+||...
T Consensus       179 ~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DIwS~G~~l~ellt~g~p~~~~~  251 (311)
T d1t46a_         179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFN-------CVYTFESDVWSYGIFLWELFSLGSSPYPGM  251 (311)
T ss_dssp             ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHH-------CCCCHHHHHHHHHHHHHHHHTTTCCSSTTC
T ss_pred             cccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcC-------CCCCCcccccchHHHHHHHHhCCCCCCCCC
Confidence            9999999999999987654332   234578999999999964       457789999999999999998 67777666


Q ss_pred             hhHHHHHHHhhc--CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHh
Q 004959          553 EGAAAMFKVMRD--TPAIPDSLSPEGKDFLRCCFQRNPADRPPASLLLE  599 (721)
Q Consensus       553 ~~~~~~~ki~~~--~~~~p~~lS~el~dLI~~cL~~DP~kRPSa~eLL~  599 (721)
                      ...+.+.+++..  .+..+..+++++.+||.+||+.||++|||++||++
T Consensus       252 ~~~~~~~~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~  300 (311)
T d1t46a_         252 PVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ  300 (311)
T ss_dssp             CSSHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CHHHHHHHHHhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            655555555443  34556789999999999999999999999999986

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.8e-47  Score=401.18  Aligned_cols=255  Identities=21%  Similarity=0.337  Sum_probs=204.4

Q ss_pred             CCCCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCe-eeeeeeEEecCe
Q 004959          338 MNSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNI-VQYYGSEIVEDK  416 (721)
Q Consensus       338 l~~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnI-V~l~g~~~~~~~  416 (721)
                      +.++|++++.||+|+||+||+|++..+|+.||||++......       +++.+|+++|+.++|+|+ +.+++++.+.+.
T Consensus         5 vg~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-------~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~   77 (299)
T d1ckia_           5 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH-------PQLHIESKIYKMMQGGVGIPTIRWCGAEGDY   77 (299)
T ss_dssp             ETTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS-------CCHHHHHHHHHHSTTSTTCCCEEEEEEETTE
T ss_pred             ECCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC-------HHHHHHHHHHHHccCCCcccEEEEEEecCCE
Confidence            346899999999999999999999999999999988643221       247789999999987665 455566677889


Q ss_pred             EEEEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcC---CCceEEeecCCcccc
Q 004959          417 FYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDA---SGVVKLADFGMAKHL  493 (721)
Q Consensus       417 ~yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~---~g~VKL~DFGlA~~l  493 (721)
                      .++||||+ +++|.+.+......+++..+..++.||+.||+|||++|||||||||+|||++.   +..+||+|||+|+.+
T Consensus        78 ~~ivme~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~  156 (299)
T d1ckia_          78 NVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY  156 (299)
T ss_dssp             EEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEEC
T ss_pred             EEEEEEEc-CCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceec
Confidence            99999999 56777777766678999999999999999999999999999999999999864   457999999999987


Q ss_pred             CCCcc--------cccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhHHHHHHH---h
Q 004959          494 TGQKA--------DLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGAAAMFKV---M  562 (721)
Q Consensus       494 ~~~~~--------~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~~~~~ki---~  562 (721)
                      .....        ....+||+.|||||++.       +..++.++|||||||++|||++|+.||...........+   .
T Consensus       157 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~  229 (299)
T d1ckia_         157 RDARTHQHIPYRENKNLTGTARYASINTHL-------GIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERIS  229 (299)
T ss_dssp             BCTTTCCBCCCCBCCSCCCCSSSCCHHHHT-------TBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHH
T ss_pred             cccccccceeccccCCcCCCccccCHHHHh-------CCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhh
Confidence            54322        23467999999999984       456788999999999999999999999765433322211   1


Q ss_pred             h-----cCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHH---HHhccccccCC
Q 004959          563 R-----DTPAIPDSLSPEGKDFLRCCFQRNPADRPPASL---LLEHRFLKNSQ  607 (721)
Q Consensus       563 ~-----~~~~~p~~lS~el~dLI~~cL~~DP~kRPSa~e---LL~Hp~f~~~~  607 (721)
                      .     ........+++++.+||.+||+.||++||++.+   +|+|+|.+...
T Consensus       230 ~~~~~~~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~~~  282 (299)
T d1ckia_         230 EKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGF  282 (299)
T ss_dssp             HHHHHSCHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHHTC
T ss_pred             cccCCCChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHcCC
Confidence            1     112234678999999999999999999999875   57888765543

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4e-47  Score=403.16  Aligned_cols=247  Identities=24%  Similarity=0.410  Sum_probs=206.0

Q ss_pred             eEeeEEeecCCeEEEEEEECCCC---cEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEe-cCeEE
Q 004959          343 QKGKLIGRGTFGSVYVASNRETG---ALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIV-EDKFY  418 (721)
Q Consensus       343 ~~~k~LG~G~fG~VY~a~~~~tg---~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~-~~~~y  418 (721)
                      ...++||+|+||+||+|++..++   ..||||.+..    .......+++.+|+++|++++|||||+++|++.. +...+
T Consensus        30 ~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~----~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~  105 (311)
T d1r0pa_          30 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNR----ITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL  105 (311)
T ss_dssp             EEEEEEEEETTEEEEEEEECC----CEEEEEEEECC----CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEE
T ss_pred             ccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECc----ccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceE
Confidence            34689999999999999986643   3689998852    2345667889999999999999999999999765 56899


Q ss_pred             EEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecCCccccCCCcc
Q 004959          419 IYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFGMAKHLTGQKA  498 (721)
Q Consensus       419 LVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFGlA~~l~~~~~  498 (721)
                      +|||||++|+|.+++......+++..+..++.||+.||.|||+.+|+||||||+||||++++.+||+|||+++.+.....
T Consensus       106 lv~E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~  185 (311)
T d1r0pa_         106 VVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF  185 (311)
T ss_dssp             EEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTC
T ss_pred             EEEEEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCCEEEecccchhhcccccc
Confidence            99999999999999987767788999999999999999999999999999999999999999999999999987654322


Q ss_pred             c-----ccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCch-hhHHHHHHHhhc-CCCCCCC
Q 004959          499 D-----LSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEY-EGAAAMFKVMRD-TPAIPDS  571 (721)
Q Consensus       499 ~-----~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~-~~~~~~~ki~~~-~~~~p~~  571 (721)
                      .     ....||+.|+|||++..       ..++.++|||||||+||||++|..||... ...+....+..+ .+..|..
T Consensus       186 ~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~~~~~p~~  258 (311)
T d1r0pa_         186 DSVHNKTGAKLPVKWMALESLQT-------QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEY  258 (311)
T ss_dssp             CCTTCTTCSSCCGGGSCHHHHHH-------CCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTCCCCCCTT
T ss_pred             ccceecccccccccccChHHHhc-------CCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCccc
Confidence            2     23568999999999964       35788999999999999999977777543 333333333333 4566788


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q 004959          572 LSPEGKDFLRCCFQRNPADRPPASLLLEH  600 (721)
Q Consensus       572 lS~el~dLI~~cL~~DP~kRPSa~eLL~H  600 (721)
                      +++++.+||.+||+.||++||++.||++|
T Consensus       259 ~~~~l~~li~~cl~~dP~~RPs~~ei~~~  287 (311)
T d1r0pa_         259 CPDPLYEVMLKCWHPKAEMRPSFSELVSR  287 (311)
T ss_dssp             CCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CcHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence            99999999999999999999999999988

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=1.2e-45  Score=387.70  Aligned_cols=246  Identities=17%  Similarity=0.269  Sum_probs=205.2

Q ss_pred             CCCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCC-CCeeeeeeeEEecCeE
Q 004959          339 NSQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKH-PNIVQYYGSEIVEDKF  417 (721)
Q Consensus       339 ~~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~H-PnIV~l~g~~~~~~~~  417 (721)
                      .++|++++.||+|+||+||+|++..+|+.||||++......       ..+.+|+++++.|.| +||+.+++++......
T Consensus         4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-------~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~   76 (293)
T d1csna_           4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA-------PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHN   76 (293)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS-------CCHHHHHHHHHHTTTCTTCCCEEEEEEETTEE
T ss_pred             CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCc-------HHHHHHHHHHHHhcCCCCCCEEEEEeecCCcc
Confidence            46899999999999999999999999999999988643221       246788899999975 8999999999999999


Q ss_pred             EEEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcC-----CCceEEeecCCccc
Q 004959          418 YIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDA-----SGVVKLADFGMAKH  492 (721)
Q Consensus       418 yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~-----~g~VKL~DFGlA~~  492 (721)
                      |+||||+ |++|.+++......+++..+..++.||+.||+|||++|||||||||+||||+.     ++.+||+|||+|+.
T Consensus        77 ~~vme~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~  155 (293)
T d1csna_          77 VLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF  155 (293)
T ss_dssp             EEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred             EEEEEec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEE
Confidence            9999999 68999999877678999999999999999999999999999999999999964     56899999999987


Q ss_pred             cCCCc--------ccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchh---hHHHHHHH
Q 004959          493 LTGQK--------ADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYE---GAAAMFKV  561 (721)
Q Consensus       493 l~~~~--------~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~---~~~~~~ki  561 (721)
                      +....        .....+||+.|||||++.       +..++.++|||||||++|||++|+.||.+..   ......++
T Consensus       156 ~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~-------~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i  228 (293)
T d1csna_         156 YRDPVTKQHIPYREKKNLSGTARYMSINTHL-------GREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERI  228 (293)
T ss_dssp             SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHT-------TCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHH
T ss_pred             cccCccccceeecccCceEEchhhcCHHHhc-------CCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHH
Confidence            64321        123467999999999994       4568889999999999999999999997532   22222222


Q ss_pred             hhc-----CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHh
Q 004959          562 MRD-----TPAIPDSLSPEGKDFLRCCFQRNPADRPPASLLLE  599 (721)
Q Consensus       562 ~~~-----~~~~p~~lS~el~dLI~~cL~~DP~kRPSa~eLL~  599 (721)
                      ...     ...+...+++++.+||..|+..+|++||+++.+.+
T Consensus       229 ~~~~~~~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~  271 (293)
T d1csna_         229 GEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG  271 (293)
T ss_dssp             HHHHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred             HhccCCCChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence            211     11234568899999999999999999999887754

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-45  Score=388.76  Aligned_cols=250  Identities=26%  Similarity=0.335  Sum_probs=193.5

Q ss_pred             CCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEecC----
Q 004959          340 SQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEIVED----  415 (721)
Q Consensus       340 ~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~g~~~~~~----  415 (721)
                      .+|.+.+.||+|+||.||+|++  +|+.||||++...      .......+.|+..+.+++|||||++++++.+++    
T Consensus         3 ~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~------~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~   74 (303)
T d1vjya_           3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSR------EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWT   74 (303)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGG------GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECcc------chhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcce
Confidence            4689999999999999999986  5899999988521      111223345666667889999999999988754    


Q ss_pred             eEEEEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhh--------CCeeccCCCCCcEEEcCCCceEEeec
Q 004959          416 KFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHS--------KKTIHRDIKGANLLVDASGVVKLADF  487 (721)
Q Consensus       416 ~~yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs--------~gIIHrDLKPeNILld~~g~VKL~DF  487 (721)
                      .+|+|||||.+|+|.++|++  ..+++..+..++.||+.||.|||+        +|||||||||+||||+.++.+||+||
T Consensus        75 ~~~lv~Ey~~~g~L~~~l~~--~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DF  152 (303)
T d1vjya_          75 QLWLVSDYHEHGSLFDYLNR--YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL  152 (303)
T ss_dssp             EEEEEEECCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCC
T ss_pred             EEEEEEecccCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEec
Confidence            68999999999999999976  479999999999999999999996        59999999999999999999999999


Q ss_pred             CCccccCCCcc-----cccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchh---------
Q 004959          488 GMAKHLTGQKA-----DLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYE---------  553 (721)
Q Consensus       488 GlA~~l~~~~~-----~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~---------  553 (721)
                      |+++.+.....     ....+||+.|||||++.+... .....++.++|||||||+||||+||..||....         
T Consensus       153 Gl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~  231 (303)
T d1vjya_         153 GLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSIN-MKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDL  231 (303)
T ss_dssp             TTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSC-TTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTT
T ss_pred             CccccccCCCcceeccccceecccCcCChhhcccccc-ccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhc
Confidence            99987654332     224679999999999854211 112236778999999999999999988773211         


Q ss_pred             -----hHHHHHHHhhcC---CCCCCC-----CCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q 004959          554 -----GAAAMFKVMRDT---PAIPDS-----LSPEGKDFLRCCFQRNPADRPPASLLLEH  600 (721)
Q Consensus       554 -----~~~~~~ki~~~~---~~~p~~-----lS~el~dLI~~cL~~DP~kRPSa~eLL~H  600 (721)
                           ....+.......   +.++..     ...++.+||.+||+.||++|||+.||+++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~  291 (303)
T d1vjya_         232 VPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT  291 (303)
T ss_dssp             SCSSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred             ccccchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence                 112222222221   222222     22458899999999999999999999875

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=1.8e-44  Score=386.15  Aligned_cols=253  Identities=24%  Similarity=0.356  Sum_probs=196.1

Q ss_pred             CCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCC-----------CCCeeeee
Q 004959          340 SQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLK-----------HPNIVQYY  408 (721)
Q Consensus       340 ~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~-----------HPnIV~l~  408 (721)
                      ++|++++.||+|+||+||+|+++.+|+.||||++..      .....+.+.+|+.+|+.+.           |+|||+++
T Consensus        13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~------~~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~   86 (362)
T d1q8ya_          13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRG------DKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLL   86 (362)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS------CHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCC
T ss_pred             CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEec------cccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEE
Confidence            469999999999999999999999999999999862      2334467788999888875           57899999


Q ss_pred             eeEEec--CeEEEEEeeccCCCHHHHH--HHhcCCCCHHHHHHHHHHHHHHHHHHhh-CCeeccCCCCCcEEEcCCC---
Q 004959          409 GSEIVE--DKFYIYLEYVHPGSINKYV--REHCGAITESVVRNFTRHILSGLAYLHS-KKTIHRDIKGANLLVDASG---  480 (721)
Q Consensus       409 g~~~~~--~~~yLVmEy~~gGsL~~~L--~~~~~~Lse~~i~~i~~QIl~AL~yLHs-~gIIHrDLKPeNILld~~g---  480 (721)
                      +++...  ...+++|+++..+......  ......+++..++.++.||+.||+|||+ .||+||||||+||||+.++   
T Consensus        87 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~  166 (362)
T d1q8ya_          87 DHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPE  166 (362)
T ss_dssp             EEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTT
T ss_pred             EEeeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCccc
Confidence            887653  5667777777655433332  2334679999999999999999999998 8999999999999998665   


Q ss_pred             ---ceEEeecCCccccCCCcccccCCCCCccCChhhHHHHhhcCCCCCCcchhhHHHHHHHHHHHhhCCCCCCchhhH--
Q 004959          481 ---VVKLADFGMAKHLTGQKADLSMKGSPYWMAPELMMAVMQKGKSSDSALAVDIWSLGCTIIEMYTGKPPWSEYEGA--  555 (721)
Q Consensus       481 ---~VKL~DFGlA~~l~~~~~~~s~~GT~~Y~APEvl~~~~~~~k~~~~s~asDVWSLGVILyELLtG~~PF~~~~~~--  555 (721)
                         .+||+|||.+.....  .....+||+.|+|||++.+       ..++.++|||||||++++|++|+.||......  
T Consensus       167 ~~~~~kl~dfg~s~~~~~--~~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~  237 (362)
T d1q8ya_         167 NLIQIKIADLGNACWYDE--HYTNSIQTREYRSPEVLLG-------APWGCGADIWSTACLIFELITGDFLFEPDEGHSY  237 (362)
T ss_dssp             TEEEEEECCCTTCEETTB--CCCSCCSCGGGCCHHHHHT-------CCCCTHHHHHHHHHHHHHHHHSSCCC--------
T ss_pred             ccceeeEeeccccccccc--ccccccccccccChhhccc-------cCCCccccccchHHHHHHHHHCCCCCCCCccccc
Confidence               499999999986543  3345779999999999863       35677999999999999999999999643221  


Q ss_pred             ----HHHHHHhh------------------------------------------cCCCCCCCCCHHHHHHHHHhcccCCC
Q 004959          556 ----AAMFKVMR------------------------------------------DTPAIPDSLSPEGKDFLRCCFQRNPA  589 (721)
Q Consensus       556 ----~~~~ki~~------------------------------------------~~~~~p~~lS~el~dLI~~cL~~DP~  589 (721)
                          +.+.....                                          .........+++++|||.+||++||+
T Consensus       238 ~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~  317 (362)
T d1q8ya_         238 TKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPR  317 (362)
T ss_dssp             -CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTT
T ss_pred             cchhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChh
Confidence                11111100                                          00111223468899999999999999


Q ss_pred             CCCCHHHHHhccccccCC
Q 004959          590 DRPPASLLLEHRFLKNSQ  607 (721)
Q Consensus       590 kRPSa~eLL~Hp~f~~~~  607 (721)
                      +|||++|+|+||||++..
T Consensus       318 ~Rpta~e~L~Hp~f~~~~  335 (362)
T d1q8ya_         318 KRADAGGLVNHPWLKDTL  335 (362)
T ss_dssp             TCBCHHHHHTCGGGTTCT
T ss_pred             HCcCHHHHhcCcccCCCC
Confidence            999999999999999654

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.91  E-value=3.5e-24  Score=209.26  Aligned_cols=139  Identities=19%  Similarity=0.242  Sum_probs=109.4

Q ss_pred             eeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCC-------------cccHHHHHHHHHHHHHHHhCCCCCeeeee
Q 004959          342 WQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDD-------------PKSAESIKQLEQEIKVLSHLKHPNIVQYY  408 (721)
Q Consensus       342 y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~-------------~~~~~~~k~~~~Ei~iL~~L~HPnIV~l~  408 (721)
                      +.+++.||+|+||+||+|++. +|+.||||++......             .........+..|...|.++.|.+++..+
T Consensus         2 ~~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~   80 (191)
T d1zara2           2 DAIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY   80 (191)
T ss_dssp             SEEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEE
T ss_pred             chhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEE
Confidence            468999999999999999985 6999999986421100             00112234556789999999999999887


Q ss_pred             eeEEecCeEEEEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhCCeeccCCCCCcEEEcCCCceEEeecC
Q 004959          409 GSEIVEDKFYIYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDASGVVKLADFG  488 (721)
Q Consensus       409 g~~~~~~~~yLVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLHs~gIIHrDLKPeNILld~~g~VKL~DFG  488 (721)
                      ++.    ..++||||+.+..+.        .+++..+..++.||+.+|.|||++||+||||||+||||+++ .++|+|||
T Consensus        81 ~~~----~~~lvme~~~~~~~~--------~l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~-~~~liDFG  147 (191)
T d1zara2          81 AWE----GNAVLMELIDAKELY--------RVRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEE-GIWIIDFP  147 (191)
T ss_dssp             EEE----TTEEEEECCCCEEGG--------GCCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETT-EEEECCCT
T ss_pred             Eec----CCEEEEEeecccccc--------chhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCC-CEEEEECC
Confidence            652    237999999876543        25556678899999999999999999999999999999865 58999999


Q ss_pred             CccccC
Q 004959          489 MAKHLT  494 (721)
Q Consensus       489 lA~~l~  494 (721)
                      +|....
T Consensus       148 ~a~~~~  153 (191)
T d1zara2         148 QSVEVG  153 (191)
T ss_dssp             TCEETT
T ss_pred             CcccCC
Confidence            997654

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.39  E-value=5.6e-07  Score=88.93  Aligned_cols=139  Identities=13%  Similarity=0.083  Sum_probs=89.5

Q ss_pred             CCeeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCC-CCCeeeeeeeEEecCeEE
Q 004959          340 SQWQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLK-HPNIVQYYGSEIVEDKFY  418 (721)
Q Consensus       340 ~~y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~-HPnIV~l~g~~~~~~~~y  418 (721)
                      ..|+..+..+.++.+.||+..  ..++.+.+|.........     ...+.+|..+|+.|. +--+.+++.+...++..|
T Consensus        14 ~~~~~~~~~~G~s~~~v~rv~--~~~~~~vlk~~~~~~~~~-----~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~   86 (263)
T d1j7la_          14 EKYRCVKDTEGMSPAKVYKLV--GENENLYLKMTDSRYKGT-----TYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSN   86 (263)
T ss_dssp             TTSEEEECSCCCSSSEEEEEE--CSSCEEEEEEECGGGTTS-----TTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEE
T ss_pred             hceEEEEcCCCCCCCcEEEEE--eCCCeEEEEEcCCCcccc-----hhhHHHHHHHHHHHhccCCCCcEEEEEecCCceE
Confidence            356777765556667999875  346778888764321111     224677888887764 333556777777888999


Q ss_pred             EEEeeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHh--------------------------------------
Q 004959          419 IYLEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLH--------------------------------------  460 (721)
Q Consensus       419 LVmEy~~gGsL~~~L~~~~~~Lse~~i~~i~~QIl~AL~yLH--------------------------------------  460 (721)
                      +||++++|..+......      ......++.++...|..||                                      
T Consensus        87 lv~~~l~G~~~~~~~~~------~~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (263)
T d1j7la_          87 LLMSEADGVLCSEEYED------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEE  160 (263)
T ss_dssp             EEEECCSSEEHHHHTTT------CSCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGST
T ss_pred             EEEEecccccccccccc------cccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccc
Confidence            99999998777543211      0011122333333333333                                      


Q ss_pred             ---------------h------CCeeccCCCCCcEEEcCCCceEEeecCCcc
Q 004959          461 ---------------S------KKTIHRDIKGANLLVDASGVVKLADFGMAK  491 (721)
Q Consensus       461 ---------------s------~gIIHrDLKPeNILld~~g~VKL~DFGlA~  491 (721)
                                     .      ..++|+|+.+.|||+++++.+-|+||+.+.
T Consensus       161 ~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T d1j7la_         161 DTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             TCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             cccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence                           1      137999999999999876666799999775

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=98.00  E-value=5.2e-06  Score=88.20  Aligned_cols=82  Identities=15%  Similarity=0.094  Sum_probs=49.5

Q ss_pred             eeEEeecCCeEEEEEEECCCCcEEEEEEeecC-CCCcc-cHHHHHHHHHHHHHHHhCC-C--CCeeeeeeeEEecCeEEE
Q 004959          345 GKLIGRGTFGSVYVASNRETGALCAMKEVDIF-PDDPK-SAESIKQLEQEIKVLSHLK-H--PNIVQYYGSEIVEDKFYI  419 (721)
Q Consensus       345 ~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~-~~~~~-~~~~~k~~~~Ei~iL~~L~-H--PnIV~l~g~~~~~~~~yL  419 (721)
                      .+.||.|....||++....+|+.|++|...-. ..... ......+...|..+|+.+. +  ..+.+++.+  +++..++
T Consensus        31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l  108 (392)
T d2pula1          31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT  108 (392)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred             EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence            55789999999999998878889999975311 00000 0011234566887777663 2  345556543  5566789


Q ss_pred             EEeeccCCC
Q 004959          420 YLEYVHPGS  428 (721)
Q Consensus       420 VmEy~~gGs  428 (721)
                      |||++.+..
T Consensus       109 vmE~L~~~~  117 (392)
T d2pula1         109 VMEDLSHLK  117 (392)
T ss_dssp             EECCCTTSE
T ss_pred             EEeccCCcc
Confidence            999997654

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=97.87  E-value=1.6e-05  Score=77.80  Aligned_cols=74  Identities=15%  Similarity=0.053  Sum_probs=49.7

Q ss_pred             EEeecC-CeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCC--CCeeeeeeeEEecCeEEEEEee
Q 004959          347 LIGRGT-FGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKH--PNIVQYYGSEIVEDKFYIYLEY  423 (721)
Q Consensus       347 ~LG~G~-fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~H--PnIV~l~g~~~~~~~~yLVmEy  423 (721)
                      .+..|. -+.||+... ..|..+.+|.....  .      ...+..|..+|+.|..  -.+.+++.+..+.+..++||||
T Consensus        17 ~~~~G~s~~~v~r~~~-~~~~~~vlK~~~~~--~------~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~   87 (255)
T d1nd4a_          17 QQTIGCSDAAVFRLSA-QGRPVLFVKTDLSG--A------LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGE   87 (255)
T ss_dssp             ECSCTTSSCEEEEEEC-TTSCCEEEEEECSC--T------TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEEC
T ss_pred             EcCCcccCCeEEEEEe-CCCCEEEEEeCCcc--C------HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEe
Confidence            334444 368998874 45777889975421  1      1246678887777643  2355677777788889999999


Q ss_pred             ccCCCH
Q 004959          424 VHPGSI  429 (721)
Q Consensus       424 ~~gGsL  429 (721)
                      ++|.++
T Consensus        88 i~G~~~   93 (255)
T d1nd4a_          88 VPGQDL   93 (255)
T ss_dssp             CSSEET
T ss_pred             eecccc
Confidence            988654

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=96.96  E-value=0.001  Score=67.87  Aligned_cols=130  Identities=15%  Similarity=0.163  Sum_probs=74.4

Q ss_pred             CeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCC-----eeeee--eeEEecCeEEEEEeecc
Q 004959          353 FGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPN-----IVQYY--GSEIVEDKFYIYLEYVH  425 (721)
Q Consensus       353 fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPn-----IV~l~--g~~~~~~~~yLVmEy~~  425 (721)
                      --.||++.. .+|..|++|+.+-   ...+   .+++..|+.+|..|....     .+..-  ..+...+..+.+++++.
T Consensus        35 EN~vy~v~~-~dg~~~VlK~~rp---~~~s---~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~  107 (325)
T d1zyla1          35 ENRVYQFQD-EDRRRFVVKFYRP---ERWT---ADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVG  107 (325)
T ss_dssp             SSEEEEECC-TTCCCEEEEEECT---TTSC---HHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCC
T ss_pred             cceeEEEEc-CCCCEEEEEEeCC---CCCC---HHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecC
Confidence            358999975 4688999998742   1112   346777888887774222     12221  13455677899999998


Q ss_pred             CCCHH-----H------HH---HHhc--------CC-------------------CCHH---HHHHHHHHHHHHHHHHh-
Q 004959          426 PGSIN-----K------YV---REHC--------GA-------------------ITES---VVRNFTRHILSGLAYLH-  460 (721)
Q Consensus       426 gGsL~-----~------~L---~~~~--------~~-------------------Lse~---~i~~i~~QIl~AL~yLH-  460 (721)
                      |..+.     .      .+   ....        ..                   ++..   .....+.+++..+.-+- 
T Consensus       108 G~~~~~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~  187 (325)
T d1zyla1         108 GRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWR  187 (325)
T ss_dssp             CEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCC
T ss_pred             CcCCCCCCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhcc
Confidence            74321     1      11   1100        01                   1111   12223333443333321 


Q ss_pred             ---hCCeeccCCCCCcEEEcCCCceEEeecCCcc
Q 004959          461 ---SKKTIHRDIKGANLLVDASGVVKLADFGMAK  491 (721)
Q Consensus       461 ---s~gIIHrDLKPeNILld~~g~VKL~DFGlA~  491 (721)
                         ..++||+|+.+.|||++. + ..++||+-+.
T Consensus       188 ~~~p~~liHgDlh~~NvL~~~-~-~~~IDFdd~~  219 (325)
T d1zyla1         188 EDFTVLRLHGDCHAGNILWRD-G-PMFVDLDDAR  219 (325)
T ss_dssp             SCSCCEECCSSCSGGGEEESS-S-EEECCCTTCC
T ss_pred             ccCCceeecCCCCcccEEEeC-C-ceEEechhcc
Confidence               136899999999999964 3 4589999775

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=96.87  E-value=0.0012  Score=69.19  Aligned_cols=74  Identities=15%  Similarity=0.172  Sum_probs=48.8

Q ss_pred             eeEEeecCCeEEEEEEECC-------CCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCCCCCe-eeeeeeEEecCe
Q 004959          345 GKLIGRGTFGSVYVASNRE-------TGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLKHPNI-VQYYGSEIVEDK  416 (721)
Q Consensus       345 ~k~LG~G~fG~VY~a~~~~-------tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~HPnI-V~l~g~~~~~~~  416 (721)
                      ++.|+.|---.+|++....       ..+.|.+++..    .....   -...+|..+++.+.-.+| .++++++..   
T Consensus        47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g----~~~~~---idr~~E~~i~~~ls~~gl~Pkll~~~~~---  116 (395)
T d1nw1a_          47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF----NPETE---SHLVAESVIFTLLSERHLGPKLYGIFSG---  116 (395)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC----SCCCH---HHHHHHHHHHHHHHHTTSSSCEEEEETT---
T ss_pred             EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecC----Ccchh---hHHHHHHHHHHHHHhCCCCCeEEEEcCC---
Confidence            4678889999999997653       34567777653    11121   245678888888863344 467776532   


Q ss_pred             EEEEEeeccCCCH
Q 004959          417 FYIYLEYVHPGSI  429 (721)
Q Consensus       417 ~yLVmEy~~gGsL  429 (721)
                       .+||||++|..|
T Consensus       117 -g~I~efi~g~~l  128 (395)
T d1nw1a_         117 -GRLEEYIPSRPL  128 (395)
T ss_dssp             -EEEECCCCEEEC
T ss_pred             -ceEEEEeccccC
Confidence             689999987543

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=96.63  E-value=0.004  Score=62.43  Aligned_cols=141  Identities=16%  Similarity=0.096  Sum_probs=75.4

Q ss_pred             eeEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHHhCC-----CCCeeeee-e--eEEe
Q 004959          342 WQKGKLIGRGTFGSVYVASNRETGALCAMKEVDIFPDDPKSAESIKQLEQEIKVLSHLK-----HPNIVQYY-G--SEIV  413 (721)
Q Consensus       342 y~~~k~LG~G~fG~VY~a~~~~tg~~vAIK~i~~~~~~~~~~~~~k~~~~Ei~iL~~L~-----HPnIV~l~-g--~~~~  413 (721)
                      .+-.+.|..|---+.|+....  +..|++|+.... .      ..+.+..|+.+|..|.     .|..+... |  +...
T Consensus        20 ~~~~~~i~~G~~N~ny~v~t~--~g~yVLri~~~~-~------~~~~l~~~~~~l~~L~~~g~pvp~pi~~~~g~~~~~~   90 (316)
T d2ppqa1          20 LTSYKGIAEGVENSNFLLHTT--KDPLILTLYEKR-V------EKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGEL   90 (316)
T ss_dssp             EEEEEEECC---EEEEEEEES--SCCEEEEEECC----------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEE
T ss_pred             ceEeecCCCCcccCeEEEEEC--CCcEEEEEcCCC-C------CHHHHHHHHHHHHhhhhccccccccceecCCCcceee
Confidence            334455667777888998754  345999987521 1      1234556677776664     23322221 1  2333


Q ss_pred             cCeEEEEEeeccCCCHHH-----------HH---HHhcCC--------------------------CCHHHHHHHHHHHH
Q 004959          414 EDKFYIYLEYVHPGSINK-----------YV---REHCGA--------------------------ITESVVRNFTRHIL  453 (721)
Q Consensus       414 ~~~~yLVmEy~~gGsL~~-----------~L---~~~~~~--------------------------Lse~~i~~i~~QIl  453 (721)
                      ......++.++.|.....           .+   ......                          .........+..+.
T Consensus        91 ~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  170 (316)
T d2ppqa1          91 SGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEI  170 (316)
T ss_dssp             TTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHH
T ss_pred             ecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcchhHHHHHHHHH
Confidence            556677777776643210           00   100000                          00111222233333


Q ss_pred             HHHHHHhh----CCeeccCCCCCcEEEcCCCceEEeecCCcc
Q 004959          454 SGLAYLHS----KKTIHRDIKGANLLVDASGVVKLADFGMAK  491 (721)
Q Consensus       454 ~AL~yLHs----~gIIHrDLKPeNILld~~g~VKL~DFGlA~  491 (721)
                      ..+.-.+.    .|+||+|+.+.|||++.+..+-|+||+.+.
T Consensus       171 ~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~  212 (316)
T d2ppqa1         171 DYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC  212 (316)
T ss_dssp             HHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             HhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence            33443332    479999999999999988777899999875